data_2m3x_residue save_MolProbity _Software.Sf_category software _Software.Sf_framecode MolProbity _Software.Entry_ID ? _Software.ID 1 _Software.Name MolProbity _Software.Version 4.0 _Software.Details . save_ save_CYRANGE _Software.Sf_category software _Software.Sf_framecode CYRANGE _Software.Entry_ID ? _Software.ID 2 _Software.Name CYRANGE _Software.Version 2.0 _Software.Details . save_ save_Structure_validation_residue _Structure_validation_residue.Sf_category structure_validation _Structure_validation_residue.Sf_framecode Structure_validation_residue _Structure_validation_residue.Entry_ID ? _Structure_validation_residue.List_ID 1 _Structure_validation_residue.PDB_accession_code 2m3x _Structure_validation_residue.Date_analyzed 2016-10-08 loop_ _Residue_analysis_software.Software_ID _Residue_analysis_software.Software_label _Residue_analysis_software.Method_ID _Residue_analysis_software.Method_label _Residue_analysis_software.Entry_ID _Residue_analysis_software.Structure_validation_oneline_list_ID 1 MolProbity . . ? 1 2 CYRANGE . . ? 1 stop_ loop_ _Residue_analysis.ID _Residue_analysis.PDB_model_num _Residue_analysis.Hydrogen_positions _Residue_analysis.MolProbity_flips _Residue_analysis.Cyrange_core_flag _Residue_analysis.Two_letter_chain_ID _Residue_analysis.PDB_strand_ID _Residue_analysis.PDB_residue_no _Residue_analysis.PDB_ins_code _Residue_analysis.PDB_residue_name _Residue_analysis.Assembly_ID _Residue_analysis.Entity_assembly_ID _Residue_analysis.Entity_ID _Residue_analysis.Comp_ID _Residue_analysis.Comp_index_ID _Residue_analysis.Clash_value _Residue_analysis.Clash_source_PDB_atom_name _Residue_analysis.Clash_destination_PDB_atom_name _Residue_analysis.Clash_destination_PDB_strand_ID _Residue_analysis.Clash_destination_PDB_residue_no _Residue_analysis.Clash_destination_PDB_ins_code _Residue_analysis.Clash_destination_PDB_residue_name _Residue_analysis.Cbeta_deviation_value _Residue_analysis.Rotamer_score _Residue_analysis.Rotamer_name _Residue_analysis.Ramachandran_phi _Residue_analysis.Ramachandran_psi _Residue_analysis.Ramachandran_score _Residue_analysis.Ramachandran_evaluation _Residue_analysis.Ramachandran_type _Residue_analysis.Bond_outlier_count _Residue_analysis.Worst_bond _Residue_analysis.Worst_bond_value _Residue_analysis.Worst_bond_sigma _Residue_analysis.Angle_outlier_count _Residue_analysis.Worst_angle _Residue_analysis.Worst_angle_value _Residue_analysis.Worst_angle_sigma _Residue_analysis.RNA_phosphate_perpendicular_outlier _Residue_analysis.RNA_suitness_score _Residue_analysis.RNA_suite_conformer _Residue_analysis.RNA_suite_triage _Residue_analysis.Max_b_factor _Residue_analysis.Tau_angle _Residue_analysis.Omega_dihedral _Residue_analysis.Disulfide_chi1 _Residue_analysis.Disulfide_chi2 _Residue_analysis.Disulfide_chi3 _Residue_analysis.Disulfide_ss_angle _Residue_analysis.Disulfide_ss _Residue_analysis.Disulfide_ss_angle_prime _Residue_analysis.Disulfide_chi2prime _Residue_analysis.Disulfide_chi1prime _Residue_analysis.Outlier_count_separate_geometry _Residue_analysis.Outlier_count _Residue_analysis.Entry_ID _Residue_analysis.Structure_validation_residue_list_ID . 001 nuclear orig core ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 1.9 p . . . . . 0 C--O 1.231 0.125 0 CA-C-O 120.942 0.401 . . . . 18.41 110.564 . . . . . . . . . 0 0 . 1 . 001 nuclear orig core ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 84.7 tt0 -143.85 141.64 30.43 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 116.023 -0.535 . . . . 16.050000000000001 111.114 -179.308 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 4' ' ' LEU . . . . . . . . . . . . . 19.0 tp -122.62 127.84 49.89 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-N 116.019 -0.537 . . . . 13.859999999999999 110.087 177.485 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 5' ' ' LYS . . . . . . . . . . . . . 72.6 mttt -109.81 121.44 45.23 Favored 'General case' 0 C--O 1.234 0.246 0 CA-C-O 120.916 0.389 . . . . 12.23 110.709 178.94 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 31.1 mt -114.33 149.18 36.41 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 115.205 -0.907 . . . . 11.34 110.371 -178.719 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 19.5 ttmm -133.85 139.41 33.35 Favored Pre-proline 0 CA--C 1.536 0.418 0 CA-C-O 119.095 -0.479 . . . . 9.3100000000000005 109.799 175.17 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 8' ' ' PRO . . . . . . . . . . . . . 90.3 Cg_endo -91.82 134.47 1.49 Allowed 'Trans proline' 0 N--CA 1.49 1.293 0 C-N-CA 121.718 1.612 . . . . 9.7699999999999996 111.649 177.427 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 59.0 mt -71.78 -46.54 12.3 Favored Pre-proline 0 C--N 1.329 -0.295 0 CA-C-O 118.723 -0.656 . . . . 13.94 111.838 -179.703 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 92.4 Cg_endo -80.47 146.85 17.5 Favored 'Trans proline' 0 N--CA 1.494 1.556 0 C-N-CA 121.077 1.185 . . . . 14.0 111.582 173.071 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 93.4 mttt -87.09 92.21 8.97 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-O 120.872 0.367 . . . . 12.710000000000001 110.561 -179.942 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 12.4 p -138.63 143.74 31.6 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.292 0 CA-C-N 116.111 -0.495 . . . . 14.199999999999999 110.414 179.672 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 94.8 mt-10 -82.24 131.35 35.23 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.298 -0.41 . . . . 13.84 110.126 178.055 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 14' ' ' LEU . . . . . . . . . . . . . 30.8 mt -93.92 150.32 38.38 Favored Pre-proline 0 C--N 1.328 -0.328 0 CA-C-N 116.358 -0.383 . . . . 13.0 110.164 -179.483 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 15' ' ' PRO . . . . . . . . . . . . . 39.2 Cg_exo -57.9 159.92 16.59 Favored 'Trans proline' 0 N--CA 1.497 1.684 0 C-N-CA 121.213 1.275 . . . . 16.25 111.624 179.515 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 16' ' ' PRO . . . . . . . . . . . . . 39.7 Cg_exo -58.54 -39.78 80.12 Favored 'Trans proline' 0 N--CA 1.497 1.698 0 C-N-CA 121.479 1.453 . . . . 16.989999999999998 112.866 -177.39 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 17' ' ' ASP . . . . . . . . . . . . . 19.5 p-10 -88.4 9.11 24.61 Favored 'General case' 0 C--N 1.326 -0.415 0 N-CA-C 113.22 0.822 . . . . 16.690000000000001 113.22 -178.168 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 18' ' ' PHE . . . . . . . . . . . . . 50.3 t80 -58.27 -48.05 81.68 Favored 'General case' 0 N--CA 1.457 -0.103 0 O-C-N 121.91 -0.494 . . . . 13.779999999999999 110.19 -176.316 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 19' ' ' VAL . . . . . . . . . . . . . 46.4 t -54.8 -47.95 73.93 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.345 0 CA-C-N 116.446 -0.343 . . . . 12.65 111.167 -175.077 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 2.6 p30 -62.71 -38.24 89.65 Favored 'General case' 0 C--N 1.332 -0.175 0 C-N-CA 120.572 -0.451 . . . . 15.76 111.336 -176.245 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 54.7 t -64.34 -46.79 92.09 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.181 0 C-N-CA 120.582 -0.447 . . . . 15.73 110.213 -179.775 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 22' ' ' ILE . . . . . . . . . . . . . 51.6 mm -56.71 -45.26 82.72 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.248 0 C-N-CA 121.036 -0.266 . . . . 13.869999999999999 110.454 178.96 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 23' ' ' ARG . . . . . . . . . . . . . 59.5 ttp180 -53.98 -48.43 70.36 Favored 'General case' 0 C--N 1.329 -0.295 0 C-N-CA 121.179 -0.208 . . . . 16.760000000000002 111.32 -179.273 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 24' ' ' ILE . . . . . . . . . . . . . 76.1 mt -58.97 -46.58 91.47 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.339 0 C-N-CA 120.877 -0.329 . . . . 17.460000000000001 110.86 -177.965 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 99.6 mttt -64.25 -38.08 89.77 Favored 'General case' 0 C--N 1.329 -0.324 0 N-CA-C 112.546 0.572 . . . . 16.82 112.546 -177.948 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 49.7 mt -77.89 -41.6 36.09 Favored 'General case' 0 C--N 1.33 -0.247 0 N-CA-C 113.093 0.775 . . . . 16.620000000000001 113.093 -172.015 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 27' ' ' GLN . . . . . . . . . . . . . 14.3 pt20 -47.69 139.35 7.33 Favored 'General case' 0 N--CA 1.468 0.462 0 N-CA-C 112.77 0.656 . . . . 18.079999999999998 112.77 -174.426 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 100.29 -24.11 33.35 Favored Glycine 0 CA--C 1.535 1.287 0 CA-C-N 115.532 -0.758 . . . . 19.920000000000002 112.259 -175.698 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 98.0 mttt -97.78 155.19 17.14 Favored 'General case' 0 C--O 1.233 0.228 0 CA-C-N 117.369 0.585 . . . . 19.600000000000001 110.993 178.568 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 30' ' ' THR . . . . . . . . . . . . . 29.5 m -104.01 139.2 39.46 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 115.907 -0.588 . . . . 20.68 110.034 176.141 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 34.8 m -126.34 150.58 32.06 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.221 0 CA-C-N 116.408 -0.36 . . . . 17.93 110.719 -178.997 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 32' ' ' ARG . . . . . . . . . . . . . 32.4 ttm105 -134.94 147.33 49.75 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-O 121.16 0.505 . . . . 23.690000000000001 110.31 177.519 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 33' ' ' THR . . . . . . . . . . . . . 15.9 m -52.18 137.93 27.07 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.214 -0.448 . . . . 17.899999999999999 111.534 -177.355 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 100.71 -17.0 57.13 Favored Glycine 0 CA--C 1.532 1.147 0 CA-C-O 119.663 -0.52 . . . . 17.48 113.301 178.819 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 78.6 m-20 -65.8 147.8 52.8 Favored 'General case' 0 N--CA 1.462 0.146 0 CA-C-N 118.022 0.911 . . . . 18.859999999999999 111.125 179.135 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 44.8 t -123.25 129.76 74.7 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.173 0 CA-C-N 115.927 -0.579 . . . . 17.5 109.852 177.888 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 37' ' ' ILE . . . . . . . . . . . . . 65.0 mt -122.57 139.02 50.74 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.279 0 CA-C-N 116.345 -0.389 . . . . 16.620000000000001 109.961 -179.749 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . -112.9 128.79 8.59 Favored Glycine 0 CA--C 1.527 0.787 0 N-CA-C 111.013 -0.835 . . . . 17.550000000000001 111.013 179.281 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 39' ' ' ILE . . . . . . . . . . . . . 76.7 mt -123.9 136.25 60.89 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.22 0 N-CA-C 109.994 -0.373 . . . . 17.100000000000001 109.994 179.046 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 40' ' ' SER . . . . . . . . . . . . . 34.5 t -91.91 118.16 30.48 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-O 120.696 0.284 . . . . 20.75 111.09 178.181 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 41' ' ' ILE . . . . . . . . . . . . . 45.2 mm -120.93 116.71 50.67 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.237 0 CA-C-N 116.283 -0.417 . . . . 18.940000000000001 110.23 178.881 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 7.5 mp 50.92 35.62 12.95 Favored 'General case' 0 N--CA 1.464 0.228 0 CA-C-N 116.345 -0.389 . . . . 21.68 111.751 177.708 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . 76.05 31.13 56.2 Favored Glycine 0 CA--C 1.529 0.946 0 C-N-CA 121.082 -0.58 . . . . 23.0 112.274 177.57 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 44' ' ' LYS . . . . . . . . . . . . . 59.6 tttp -136.64 129.11 30.22 Favored 'General case' 0 C--N 1.33 -0.262 0 N-CA-C 109.484 -0.561 . . . . 20.379999999999999 109.484 176.862 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 82.1 tt0 -81.73 115.08 20.8 Favored 'General case' 0 C--N 1.329 -0.324 0 C-N-CA 120.75 -0.38 . . . . 20.210000000000001 110.663 -178.22 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 46' ' ' VAL . . . . . . . . . . . . . 6.8 p -110.86 125.17 68.16 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.24 0 N-CA-C 109.061 -0.718 . . . . 16.350000000000001 109.061 175.967 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 9.5 mtmp? -99.9 125.61 45.91 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 115.702 -0.681 . . . . 19.030000000000001 111.282 -178.568 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 48' ' ' PHE . . . . . . . . . . . . . 96.0 m-85 -111.26 131.9 54.78 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-N 116.188 -0.46 . . . . 13.44 109.899 177.268 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 49.1 tttm -108.31 139.07 43.55 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.357 -0.383 . . . . 14.85 110.513 178.941 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 50' ' ' VAL . . . . . . . . . . . . . 44.2 t -82.46 111.47 18.9 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.298 0 N-CA-C 109.505 -0.554 . . . . 14.17 109.505 176.683 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 51' ' ' VAL . . . . . . . . . . . . . 45.9 t -77.74 -46.54 26.98 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.321 0 CA-C-N 116.129 -0.487 . . . . 13.24 110.27 -174.014 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 52' ' ' GLN . . . . . . . . . . . . . 59.9 tt0 -157.82 135.35 10.43 Favored 'General case' 0 C--N 1.33 -0.276 0 C-N-CA 120.413 -0.515 . . . . 15.82 111.526 -177.0 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -113.2 118.78 35.63 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 115.401 -0.818 . . . . 16.949999999999999 109.596 173.497 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 54' ' ' TYR . . . . . . . . . . . . . 16.9 t80 -116.91 107.14 46.53 Favored Pre-proline 0 CA--C 1.534 0.351 0 CA-C-O 118.246 -0.883 . . . . 21.390000000000001 110.613 -177.757 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 55' ' ' PRO . . . . . . . . . . . . . 73.0 Cg_endo -76.98 169.98 72.96 Favored 'Cis proline' 0 N--CA 1.499 1.828 0 CA-C-N 121.758 1.664 . . . . 21.239999999999998 112.605 -3.775 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 56' ' ' SER . . . . . . . . . . . . . 13.6 m -105.2 117.73 57.7 Favored Pre-proline 0 CA--C 1.538 0.513 0 CA-C-O 118.41 -0.805 . . . . 21.829999999999998 109.546 176.92 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 57' ' ' PRO . . . . . . . . . . . . . 72.1 Cg_endo -77.84 171.05 68.85 Favored 'Cis proline' 0 N--CA 1.495 1.604 0 CA-C-N 121.968 1.738 . . . . 22.940000000000001 112.422 2.164 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 58' ' ' LEU . . . . . . . . . . . . . 25.6 tp -128.18 138.14 52.35 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 115.789 -0.641 . . . . 18.829999999999998 110.348 -178.735 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 59' ' ' ARG . . . . . . . . . . . . . 59.9 ttt85 -101.12 129.74 47.06 Favored 'General case' 0 C--N 1.326 -0.419 0 CA-C-N 115.949 -0.569 . . . . 22.98 109.549 176.441 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 42.1 t -88.79 116.7 30.86 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.229 0 C-N-CA 120.572 -0.451 . . . . 17.399999999999999 110.496 -176.631 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 94.8 mt-10 -131.14 168.76 16.9 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 115.967 -0.56 . . . . 20.440000000000001 109.581 174.953 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 62' ' ' ASP . . . . . . . . . . . . . 2.1 m-20 -53.91 -34.34 59.25 Favored 'General case' 0 C--N 1.329 -0.312 0 C-N-CA 121.046 -0.262 . . . . 18.68 111.693 -177.783 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 63' ' ' ARG . . . . . . . . . . . . . 28.2 mmm180 -73.87 -17.65 61.02 Favored 'General case' 0 CA--C 1.533 0.313 0 N-CA-C 113.234 0.827 . . . . 22.920000000000002 113.234 -176.169 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 18.0 m -69.94 141.72 53.02 Favored 'General case' 0 C--N 1.332 -0.191 0 CA-C-O 120.838 0.351 . . . . 16.77 111.014 -174.887 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 65' ' ' LYS . . . . . . . . . . . . . 93.8 mttt -88.5 132.66 34.41 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.098 -0.501 . . . . 17.359999999999999 109.988 178.732 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 66' ' ' ILE . . . . . . . . . . . . . 53.7 mt -117.56 131.91 68.9 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.233 0 N-CA-C 110.012 -0.366 . . . . 12.83 110.012 179.921 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 67' ' ' THR . . . . . . . . . . . . . 18.8 m -130.96 135.86 48.03 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-O 121.011 0.434 . . . . 11.24 110.788 178.796 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 68' ' ' LEU . . . . . . . . . . . . . 6.7 mp . . . . . 0 C--N 1.329 -0.314 0 CA-C-N 116.124 -0.489 . . . . 8.5 110.43 176.685 . . . . . . . . 0 0 . 1 . 001 nuclear orig core ' A' A ' 74' ' ' ASP . . . . . . . . . . . . . 29.6 t70 . . . . . 0 C--O 1.231 0.115 0 N-CA-C 110.217 -0.29 . . . . 0.95999999999999996 110.217 . . . . . . . . . 0 0 . 1 . 001 nuclear orig core ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 44.7 t -112.72 122.7 67.39 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.228 0 CA-C-O 121.148 0.499 . . . . 1.3700000000000001 110.243 -179.551 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 76' ' ' LEU . . . . . . . . . . . . . 36.0 mt -124.12 139.24 54.13 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 115.56 -0.745 . . . . 1.75 109.403 177.802 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 77' ' ' GLU . . . . . . . . . . . . . 96.8 mt-10 -129.99 142.24 50.66 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-O 121.136 0.493 . . . . 1.4199999999999999 111.142 -177.224 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 78' ' ' ALA . . . . . . . . . . . . . . . -131.64 136.56 47.83 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 115.479 -0.782 . . . . 1.1699999999999999 109.937 177.334 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 79' ' ' LYS . . . . . . . . . . . . . 38.0 tttp -81.23 119.57 23.79 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-O 120.91 0.386 . . . . 3.4100000000000001 110.939 -176.537 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 80' ' ' ILE . . . . . . . . . . . . . 42.0 mm -139.13 108.45 3.8 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.324 0 N-CA-C 109.089 -0.708 . . . . 1.21 109.089 -178.347 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 81' ' ' LYS . . . . . . . . . . . . . 37.9 tttp -102.78 125.44 49.52 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-O 120.95 0.405 . . . . 3.21 111.114 -176.818 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . 89.01 42.13 5.71 Favored Glycine 0 CA--C 1.526 0.757 0 C-N-CA 121.057 -0.592 . . . . 0.62 111.93 174.993 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 83' ' ' ILE . . . . . . . . . . . . . 72.2 mt -68.14 136.35 26.68 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 N-CA-C 109.641 -0.503 . . . . 1.1899999999999999 109.641 177.01 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 84' ' ' LYS . . . . . . . . . . . . . 40.2 ttpt -104.93 -46.94 4.15 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.35 -0.387 . . . . 1.95 110.306 -178.432 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 85' ' ' ASP . . . . . . . . . . . . . 20.7 t70 -149.49 148.48 29.46 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.068 -0.514 . . . . 0.79000000000000004 110.455 179.319 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 86' ' ' VAL . . . . . . . . . . . . . 43.2 t -130.89 133.31 63.24 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.227 0 CA-C-O 120.955 0.407 . . . . 1.1899999999999999 110.375 -179.887 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 87' ' ' ILE . . . . . . . . . . . . . 45.1 mm -120.55 127.74 75.95 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.231 0 CA-C-N 115.821 -0.627 . . . . 2.0600000000000001 109.781 178.537 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 88' ' ' LEU . . . . . . . . . . . . . 54.5 mt -107.82 135.49 49.14 Favored 'General case' 0 C--N 1.331 -0.221 0 CA-C-N 116.276 -0.42 . . . . 2.1000000000000001 110.974 -179.659 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 89' ' ' ASP . . . . . . . . . . . . . 12.2 t70 -130.78 155.48 46.6 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.005 -0.543 . . . . 0.96999999999999997 109.655 176.988 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 96.8 mt-10 -48.69 -36.35 15.95 Favored 'General case' 0 C--N 1.329 -0.3 0 N-CA-C 112.818 0.673 . . . . 2.4900000000000002 112.818 -171.478 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 91' ' ' ASN . . . . . . . . . . . . . 12.6 t-20 -131.99 22.2 4.54 Favored 'General case' 0 N--CA 1.468 0.452 0 N-CA-C 112.781 0.659 . . . . 2.96 112.781 -177.572 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 92' ' ' LEU . . . . . . . . . . . . . 23.1 mt -150.06 147.1 27.4 Favored 'General case' 0 C--N 1.332 -0.153 0 CA-C-O 120.799 0.333 . . . . 1.95 110.395 -177.348 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 93' ' ' ILE . . . . . . . . . . . . . 70.6 mt -124.24 117.94 52.24 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.272 0 N-CA-C 109.104 -0.702 . . . . 1.2 109.104 175.964 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 94' ' ' VAL . . . . . . . . . . . . . 46.4 t -118.96 127.08 75.82 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.268 0 CA-C-O 120.91 0.386 . . . . 1.1699999999999999 110.028 -178.427 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 95' ' ' VAL . . . . . . . . . . . . . 43.7 t -120.88 132.7 69.72 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.308 0 CA-C-N 115.945 -0.571 . . . . 1.1200000000000001 109.733 179.912 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 96' ' ' ILE . . . . . . . . . . . . . 67.5 mt -114.21 126.94 71.83 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.24 0 N-CA-C 109.215 -0.661 . . . . 1.1799999999999999 109.215 178.859 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 97' ' ' THR . . . . . . . . . . . . . 69.6 p -102.6 155.64 18.15 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-O 121.241 0.543 . . . . 1.1799999999999999 111.228 -176.41 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 98' ' ' GLU . . . . . . . . . . . . . 48.6 mt-10 -54.27 -23.54 15.32 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.017 -0.538 . . . . 2.4199999999999999 112.275 178.279 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 99' ' ' GLU . . . . . . . . . . . . . 95.0 mt-10 -76.82 13.28 1.07 Allowed 'General case' 0 CA--C 1.536 0.406 0 N-CA-C 113.24 0.829 . . . . 2.3399999999999999 113.24 -178.278 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 100' ' ' ASN . . . . . . . . . . . . . 1.7 m120 64.35 36.28 9.2 Favored 'General case' 0 CA--C 1.53 0.19 0 CA-C-O 120.944 0.402 . . . . 0.59999999999999998 110.922 177.545 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 101' ' ' GLU . . . . . . . . . . . . . 84.3 tt0 -122.43 143.93 49.37 Favored 'General case' 0 C--N 1.333 -0.139 0 CA-C-N 116.239 -0.437 . . . . 0.54000000000000004 109.916 178.586 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 102' ' ' VAL . . . . . . . . . . . . . 45.4 t -115.09 126.79 72.77 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.231 0 N-CA-C 109.811 -0.441 . . . . 1.1399999999999999 109.811 -179.713 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 103' ' ' LEU . . . . . . . . . . . . . 27.6 mt -114.69 130.11 56.77 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 115.723 -0.671 . . . . 1.4299999999999999 110.051 177.308 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 104' ' ' ILE . . . . . . . . . . . . . 72.4 mt -116.63 121.44 67.67 Favored 'Isoleucine or valine' 0 C--O 1.234 0.279 0 CA-C-N 116.552 -0.295 . . . . 1.1599999999999999 110.321 -179.193 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 105' ' ' PHE . . . . . . . . . . . . . 88.3 m-85 -120.9 161.26 21.86 Favored 'General case' 0 C--N 1.333 -0.134 0 O-C-N 123.953 0.783 . . . . 0.52000000000000002 109.884 -179.856 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 106' ' ' ASN . . . . . . . . . . . . . 39.0 p30 -95.87 -173.19 2.77 Favored 'General case' 0 C--N 1.33 -0.276 0 N-CA-C 110.065 -0.346 . . . . 0.65000000000000002 110.065 175.314 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 107' ' ' GLN . . . . . . . . . . . . . 61.1 tt0 -60.17 -30.06 69.09 Favored 'General case' 0 C--N 1.329 -0.29 0 N-CA-C 111.936 0.347 . . . . 1.98 111.936 -179.98 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 108' ' ' ASN . . . . . . . . . . . . . 50.7 t30 -82.33 8.66 10.71 Favored 'General case' 0 CA--C 1.537 0.446 0 N-CA-C 113.043 0.757 . . . . 1.8999999999999999 113.043 -177.831 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 109' ' ' LEU . . . . . . . . . . . . . 13.0 tp 61.47 39.83 14.53 Favored 'General case' 0 C--O 1.233 0.193 0 CA-C-O 121.324 0.583 . . . . 1.71 110.975 179.229 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 110' ' ' GLU . . . . . . . . . . . . . 95.2 mt-10 -109.97 152.2 26.17 Favored 'General case' 0 C--N 1.33 -0.244 0 N-CA-C 109.532 -0.544 . . . . 1.9199999999999999 109.532 175.535 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 111' ' ' GLU . . . . . . . . . . . . . 81.2 tt0 -88.02 122.3 31.45 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-O 120.828 0.347 . . . . 1.78 110.941 -175.555 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 112' ' ' LEU . . . . . . . . . . . . . 51.8 mt -106.09 -46.1 4.17 Favored 'General case' 0 C--N 1.332 -0.186 0 CA-C-N 116.14 -0.482 . . . . 1.24 111.139 179.539 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 113' ' ' TYR . . . . . . . . . . . . . 61.4 t80 -136.76 138.23 40.71 Favored 'General case' 0 C--N 1.331 -0.213 0 CA-C-O 120.912 0.386 . . . . 0.82999999999999996 111.545 -176.148 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 114' ' ' ARG . . . . . . . . . . . . . 38.9 ttm180 -132.54 122.89 25.52 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 115.878 -0.601 . . . . 3.1099999999999999 109.773 175.612 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 115' ' ' GLY . . . . . . . . . . . . . . . -150.1 138.62 6.84 Favored Glycine 0 CA--C 1.523 0.543 0 N-CA-C 111.07 -0.812 . . . . 0.47999999999999998 111.07 178.779 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 116' ' ' LYS . . . . . . . . . . . . . 34.0 ttmt -114.95 140.22 49.19 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-O 120.818 0.342 . . . . 2.02 110.079 177.256 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 117' ' ' PHE . . . . . . . . . . . . . 32.4 m-85 -136.89 114.93 11.49 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.147 -0.479 . . . . 0.54000000000000004 109.892 -176.724 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 118' ' ' GLU . . . . . . . . . . . . . 84.2 tt0 -51.39 -49.4 61.61 Favored 'General case' 0 C--N 1.328 -0.358 0 N-CA-C 111.869 0.322 . . . . 2.77 111.869 -176.221 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 119' ' ' ASN . . . . . . . . . . . . . 97.7 m-20 -98.07 31.29 2.77 Favored 'General case' 0 C--N 1.328 -0.335 0 N-CA-C 112.221 0.452 . . . . 2.0800000000000001 112.221 -174.321 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 120' ' ' LEU . . . . . . . . . . . . . 21.8 tp -54.57 120.74 7.12 Favored 'General case' 0 N--CA 1.463 0.19 0 O-C-N 122.243 -0.286 . . . . 1.2 110.71 178.727 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 121' ' ' ASN . . . . . . . . . . . . . 85.9 m-20 -113.81 -44.0 3.22 Favored 'General case' 0 C--N 1.332 -0.181 0 CA-C-N 116.459 -0.337 . . . . 2.21 111.07 -176.465 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 122' ' ' LYS . . . . . . . . . . . . . 84.9 mttt -142.93 145.3 32.9 Favored 'General case' 0 C--N 1.331 -0.227 0 CA-C-O 121.148 0.499 . . . . 2.4399999999999999 111.705 -178.129 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 123' ' ' VAL . . . . . . . . . . . . . 46.4 t -121.8 122.57 67.21 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.249 0 N-CA-C 108.978 -0.749 . . . . 1.1799999999999999 108.978 173.363 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 124' ' ' LEU . . . . . . . . . . . . . 6.8 mp -108.9 122.97 48.32 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 116.272 -0.422 . . . . 2.23 110.349 -177.301 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 125' ' ' VAL . . . . . . . . . . . . . 44.2 t -126.16 125.37 67.69 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.307 0 N-CA-C 109.608 -0.516 . . . . 2.25 109.608 178.825 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 126' ' ' ARG . . . . . . . . . . . . . 81.2 mtt-85 -143.94 123.84 13.5 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-O 121.045 0.45 . . . . 3.6499999999999999 110.774 -179.535 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 127' ' ' ASN . . . . . . . . . . . . . 18.9 t-20 50.91 -105.23 0.19 Allowed 'General case' 0 CA--C 1.543 0.709 0 CA-C-O 118.965 -0.54 . . . . 2.8199999999999998 111.398 179.764 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 128' ' ' ASP . . . . . . . . . . . . . 9.1 p-10 -114.16 -1.51 13.65 Favored 'General case' 0 CA--C 1.537 0.452 0 CA-C-N 119.697 1.135 . . . . 1.1699999999999999 113.522 -177.425 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 129' ' ' LEU . . . . . . . . . . . . . 79.3 mt -105.58 144.24 32.62 Favored 'General case' 0 C--O 1.232 0.162 0 CA-C-N 118.207 0.458 . . . . 2.54 110.876 -177.398 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 130' ' ' VAL . . . . . . . . . . . . . 45.1 t -127.35 134.99 64.6 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.169 0 CA-C-O 121.075 0.464 . . . . 2.0800000000000001 110.251 -179.354 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 131' ' ' VAL . . . . . . . . . . . . . 45.5 t -133.02 135.35 57.04 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.287 0 CA-C-N 116.088 -0.505 . . . . 1.6899999999999999 109.906 177.517 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 132' ' ' ILE . . . . . . . . . . . . . 68.5 mt -113.46 131.17 65.97 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.304 0 N-CA-C 109.381 -0.6 . . . . 1.2 109.381 -179.976 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 133' ' ' ILE . . . . . . . . . . . . . 41.9 mm -118.55 120.77 65.26 Favored 'Isoleucine or valine' 0 C--O 1.233 0.22 0 CA-C-O 120.954 0.407 . . . . 1.25 111.111 -175.384 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 134' ' ' ASP . . . . . . . . . . . . . 3.6 p30 -135.59 146.73 48.26 Favored 'General case' 0 C--N 1.332 -0.196 0 N-CA-C 109.362 -0.607 . . . . 0.55000000000000004 109.362 173.19 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 135' ' ' GLU . . . . . . . . . . . . . 85.9 tt0 -49.88 -23.76 2.1 Favored 'General case' 0 C--N 1.326 -0.454 0 N-CA-C 112.85 0.685 . . . . 2.04 112.85 -172.658 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 136' ' ' GLN . . . . . . . . . . . . . 52.0 mt-30 -87.57 -36.27 17.65 Favored 'General case' 0 C--O 1.234 0.251 0 N-CA-C 112.586 0.587 . . . . 2.54 112.586 -176.203 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 137' ' ' LYS . . . . . . . . . . . . . 40.7 pttt -157.44 167.45 30.18 Favored 'General case' 0 C--N 1.331 -0.197 0 CA-C-O 121.514 0.673 . . . . 2.0 112.277 -172.87 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 138' ' ' LEU . . . . . . . . . . . . . 6.1 tt -121.31 128.74 52.62 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 115.084 -0.962 . . . . 1.5600000000000001 109.701 178.006 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 139' ' ' THR . . . . . . . . . . . . . 28.6 m -111.78 129.9 55.98 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.41 -0.359 . . . . 1.1399999999999999 110.46 -179.411 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 140' ' ' LEU . . . . . . . . . . . . . 21.6 tp -111.75 118.82 36.64 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 115.679 -0.691 . . . . 1.6799999999999999 109.165 179.734 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 141' ' ' ILE . . . . . . . . . . . . . 19.5 mt -119.09 118.02 56.22 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.314 0 N-CA-C 109.569 -0.53 . . . . 1.1399999999999999 109.569 -176.794 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 142' ' ' ARG . . . . . . . . . . . . . 49.5 ttp180 -110.84 124.81 52.78 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 115.354 -0.839 . . . . 3.2599999999999998 110.174 -176.6 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 143' ' ' THR . . . . . . . . . . . . . 27.6 p . . . . . 0 C--O 1.219 -0.525 0 CA-C-O 117.977 -1.011 . . . . 1.54 110.6 -179.242 . . . . . . . . 0 0 . 1 . 001 nuclear orig core ' B' B ' 2' ' ' SER . . . . . . . . . . . . . 2.0 p . . . . . 0 C--O 1.232 0.183 0 CA-C-O 121.125 0.488 . . . . 19.25 110.598 . . . . . . . . . 0 0 . 1 . 001 nuclear orig core ' B' B ' 3' ' ' GLU . . . . . . . . . . . . . 93.2 mt-10 -140.71 141.86 34.9 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-N 115.781 -0.645 . . . . 16.68 110.956 -178.157 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 4' ' ' LEU . . . . . . . . . . . . . 12.7 tp -125.6 130.05 50.87 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 115.986 -0.552 . . . . 14.6 109.874 176.336 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 5' ' ' LYS . . . . . . . . . . . . . 94.8 mttt -106.73 119.77 40.22 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.37 -0.377 . . . . 12.4 110.285 179.839 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 6' ' ' LEU . . . . . . . . . . . . . 75.7 mt -117.13 148.68 41.34 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 115.477 -0.783 . . . . 12.300000000000001 110.257 -176.982 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 7' ' ' LYS . . . . . . . . . . . . . 34.1 ttmt -132.76 134.83 25.08 Favored Pre-proline 0 CA--C 1.535 0.385 0 CA-C-O 118.853 -0.594 . . . . 9.8100000000000005 110.118 177.578 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 8' ' ' PRO . . . . . . . . . . . . . 74.3 Cg_endo -91.61 131.87 1.33 Allowed 'Trans proline' 0 N--CA 1.491 1.329 0 C-N-CA 121.668 1.578 . . . . 10.369999999999999 111.606 176.537 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 9' ' ' LEU . . . . . . . . . . . . . 72.8 mt -70.95 -52.12 10.1 Favored Pre-proline 0 CA--C 1.533 0.295 0 CA-C-O 118.591 -0.718 . . . . 13.619999999999999 112.106 -177.526 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 10' ' ' PRO . . . . . . . . . . . . . 38.4 Cg_endo -68.59 141.8 51.45 Favored 'Trans proline' 0 N--CA 1.498 1.78 0 CA-C-N 120.287 1.138 . . . . 13.99 111.613 175.072 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 11' ' ' LYS . . . . . . . . . . . . . 69.1 mttm -87.04 97.38 10.69 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.408 -0.36 . . . . 12.9 110.645 -179.921 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 12' ' ' VAL . . . . . . . . . . . . . 11.8 p -139.38 142.08 34.05 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.325 0 CA-C-N 116.021 -0.536 . . . . 14.99 110.385 -179.902 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 13' ' ' GLU . . . . . . . . . . . . . 47.7 mt-10 -73.48 120.44 19.08 Favored 'General case' 0 C--N 1.329 -0.317 0 N-CA-C 110.007 -0.368 . . . . 14.92 110.007 177.64 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 14' ' ' LEU . . . . . . . . . . . . . 26.3 mt -95.84 143.16 25.65 Favored Pre-proline 0 CA--C 1.533 0.303 0 CA-C-O 118.928 -0.558 . . . . 14.869999999999999 109.752 179.953 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 15' ' ' PRO . . . . . . . . . . . . . 29.6 Cg_exo -59.82 159.82 23.63 Favored 'Trans proline' 0 N--CA 1.497 1.682 0 C-N-CA 121.253 1.302 . . . . 18.52 111.545 178.764 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 16' ' ' PRO . . . . . . . . . . . . . 37.4 Cg_exo -58.88 -40.11 75.04 Favored 'Trans proline' 0 N--CA 1.498 1.791 0 C-N-CA 121.429 1.419 . . . . 19.219999999999999 112.799 -177.813 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 17' ' ' ASP . . . . . . . . . . . . . 3.1 p30 -87.5 10.88 16.26 Favored 'General case' 0 CA--C 1.536 0.409 0 N-CA-C 113.05 0.759 . . . . 19.809999999999999 113.05 -178.61 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 18' ' ' PHE . . . . . . . . . . . . . 50.2 t80 -58.62 -44.97 90.13 Favored 'General case' 0 CA--C 1.523 -0.095 0 O-C-N 121.902 -0.499 . . . . 16.350000000000001 109.883 -178.348 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 19' ' ' VAL . . . . . . . . . . . . . 13.7 p -56.0 -39.04 55.58 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.283 0 CA-C-N 116.121 -0.491 . . . . 15.529999999999999 110.827 179.838 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 20' ' ' ASP . . . . . . . . . . . . . 31.0 t0 -60.11 -44.91 94.51 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-O 120.767 0.318 . . . . 19.219999999999999 110.717 -179.032 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 21' ' ' VAL . . . . . . . . . . . . . 47.7 t -64.24 -45.82 95.14 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.293 0 C-N-CA 120.757 -0.377 . . . . 18.960000000000001 110.43 -177.813 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 22' ' ' ILE . . . . . . . . . . . . . 51.0 mm -55.82 -47.3 79.75 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.224 0 C-N-CA 121.002 -0.279 . . . . 16.420000000000002 110.651 179.525 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 23' ' ' ARG . . . . . . . . . . . . . 43.7 ttp180 -55.25 -48.11 74.46 Favored 'General case' 0 C--N 1.329 -0.291 0 C-N-CA 121.064 -0.254 . . . . 20.329999999999998 111.346 -178.354 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 24' ' ' ILE . . . . . . . . . . . . . 72.9 mt -59.26 -41.28 83.52 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.297 0 C-N-CA 121.076 -0.25 . . . . 20.949999999999999 110.96 -177.964 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 25' ' ' LYS . . . . . . . . . . . . . 8.3 mtpm? -69.45 -38.91 78.01 Favored 'General case' 0 C--N 1.328 -0.356 0 N-CA-C 112.274 0.472 . . . . 19.640000000000001 112.274 -178.122 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 26' ' ' LEU . . . . . . . . . . . . . 37.9 mt -79.35 -38.08 35.94 Favored 'General case' 0 C--N 1.329 -0.291 0 N-CA-C 113.587 0.958 . . . . 18.5 113.587 -171.457 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 27' ' ' GLN . . . . . . . . . . . . . 9.7 pt20 -46.77 141.08 4.13 Favored 'General case' 0 N--CA 1.47 0.554 0 N-CA-C 112.747 0.647 . . . . 21.329999999999998 112.747 -175.189 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 28' ' ' GLY . . . . . . . . . . . . . . . 100.26 -23.68 34.97 Favored Glycine 0 CA--C 1.533 1.17 0 CA-C-N 115.481 -0.781 . . . . 21.399999999999999 112.289 -176.152 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 29' ' ' LYS . . . . . . . . . . . . . 68.5 mttm -98.06 155.11 17.27 Favored 'General case' 0 C--O 1.233 0.194 0 CA-C-N 117.559 0.679 . . . . 20.77 111.212 178.986 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 30' ' ' THR . . . . . . . . . . . . . 30.7 m -104.93 139.46 39.62 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 115.953 -0.567 . . . . 21.359999999999999 109.936 176.303 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 31' ' ' VAL . . . . . . . . . . . . . 34.8 m -129.78 149.09 33.28 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.252 0 CA-C-O 120.954 0.407 . . . . 18.25 111.167 -177.957 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 32' ' ' ARG . . . . . . . . . . . . . 75.2 mtt85 -124.69 149.15 47.52 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 115.823 -0.626 . . . . 22.77 110.166 177.427 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 33' ' ' THR . . . . . . . . . . . . . 23.6 m -53.83 136.7 39.94 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.369 -0.378 . . . . 17.280000000000001 111.356 -179.053 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 34' ' ' GLY . . . . . . . . . . . . . . . 100.0 -17.11 57.65 Favored Glycine 0 CA--C 1.531 1.053 0 CA-C-O 119.585 -0.564 . . . . 16.84 113.386 177.457 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 35' ' ' ASP . . . . . . . . . . . . . 81.8 m-20 -66.0 146.93 54.11 Favored 'General case' 0 C--O 1.231 0.117 0 CA-C-N 118.111 0.956 . . . . 18.379999999999999 111.17 -179.366 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 36' ' ' VAL . . . . . . . . . . . . . 44.5 t -121.17 128.83 76.07 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.235 0 CA-C-N 115.999 -0.546 . . . . 17.190000000000001 109.698 176.982 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 37' ' ' ILE . . . . . . . . . . . . . 64.6 mt -120.57 138.81 49.84 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.305 0 CA-C-N 116.238 -0.437 . . . . 16.91 110.019 -178.138 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 38' ' ' GLY . . . . . . . . . . . . . . . -106.63 127.24 8.79 Favored Glycine 0 CA--C 1.524 0.615 0 N-CA-C 110.927 -0.869 . . . . 18.219999999999999 110.927 178.424 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 39' ' ' ILE . . . . . . . . . . . . . 76.8 mt -127.72 141.48 46.29 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.264 0 N-CA-C 110.048 -0.353 . . . . 18.239999999999998 110.048 179.583 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 40' ' ' SER . . . . . . . . . . . . . 40.6 t -91.8 118.83 31.06 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-O 120.813 0.34 . . . . 22.140000000000001 110.96 177.189 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 41' ' ' ILE . . . . . . . . . . . . . 47.3 mm -124.7 120.0 57.65 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.213 0 CA-C-N 116.149 -0.478 . . . . 20.260000000000002 110.487 178.989 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 42' ' ' LEU . . . . . . . . . . . . . 7.8 mp 52.06 35.87 17.37 Favored 'General case' 0 C--N 1.331 -0.2 0 CA-C-N 116.301 -0.409 . . . . 22.93 111.638 177.848 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 43' ' ' GLY . . . . . . . . . . . . . . . 72.8 31.5 62.31 Favored Glycine 0 CA--C 1.529 0.956 0 C-N-CA 121.131 -0.557 . . . . 23.789999999999999 112.101 178.375 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 44' ' ' LYS . . . . . . . . . . . . . 85.1 tttt -137.71 131.46 31.39 Favored 'General case' 0 C--N 1.329 -0.311 0 N-CA-C 109.57 -0.53 . . . . 21.050000000000001 109.57 178.416 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 45' ' ' GLU . . . . . . . . . . . . . 81.7 tt0 -80.17 111.0 16.12 Favored 'General case' 0 C--N 1.328 -0.337 0 C-N-CA 120.657 -0.417 . . . . 20.120000000000001 110.238 -179.222 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 46' ' ' VAL . . . . . . . . . . . . . 7.0 p -109.86 128.2 66.16 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.188 0 N-CA-C 109.332 -0.618 . . . . 16.989999999999998 109.332 178.954 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 47' ' ' LYS . . . . . . . . . . . . . 44.0 mttm -98.54 124.28 43.2 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 115.781 -0.645 . . . . 18.579999999999998 110.666 178.409 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 48' ' ' PHE . . . . . . . . . . . . . 96.4 m-85 -108.99 131.79 54.73 Favored 'General case' 0 C--N 1.328 -0.351 0 N-CA-C 109.679 -0.489 . . . . 13.9 109.679 176.013 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 49' ' ' LYS . . . . . . . . . . . . . 42.6 tttp -109.18 137.97 46.26 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.484 -0.326 . . . . 14.449999999999999 110.593 178.246 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 50' ' ' VAL . . . . . . . . . . . . . 48.1 t -82.41 106.85 13.73 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.369 0 N-CA-C 109.156 -0.683 . . . . 14.109999999999999 109.156 175.527 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 51' ' ' VAL . . . . . . . . . . . . . 48.2 t -69.92 -52.35 31.85 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.354 0 N-CA-C 109.476 -0.564 . . . . 12.960000000000001 109.476 -176.113 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 52' ' ' GLN . . . . . . . . . . . . . 46.6 mt-30 -155.14 152.72 29.8 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 115.914 -0.584 . . . . 15.279999999999999 111.61 -179.401 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 53' ' ' ALA . . . . . . . . . . . . . . . -127.27 131.31 50.56 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 115.327 -0.851 . . . . 16.719999999999999 109.847 176.473 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 54' ' ' TYR . . . . . . . . . . . . . 9.8 t80 -129.1 107.5 17.93 Favored Pre-proline 0 CA--C 1.535 0.367 0 CA-C-O 118.337 -0.839 . . . . 21.030000000000001 110.496 -179.829 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 55' ' ' PRO . . . . . . . . . . . . . 73.2 Cg_endo -77.11 170.0 72.77 Favored 'Cis proline' 0 N--CA 1.5 1.882 0 CA-C-N 121.781 1.672 . . . . 21.239999999999998 112.397 -5.952 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 56' ' ' SER . . . . . . . . . . . . . 18.7 m -116.54 133.21 23.03 Favored Pre-proline 0 CA--C 1.538 0.494 0 CA-C-O 118.445 -0.788 . . . . 21.170000000000002 109.433 174.37 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 57' ' ' PRO . . . . . . . . . . . . . 55.4 Cg_endo -71.72 149.04 91.86 Favored 'Cis proline' 0 N--CA 1.497 1.728 0 CA-C-N 121.967 1.738 . . . . 22.289999999999999 111.566 -1.057 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 58' ' ' LEU . . . . . . . . . . . . . 26.7 tp -107.63 136.24 47.73 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.438 -0.347 . . . . 19.170000000000002 110.467 -178.873 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 59' ' ' ARG . . . . . . . . . . . . . 71.3 ttt-85 -106.64 119.23 38.74 Favored 'General case' 0 C--N 1.327 -0.371 0 N-CA-C 109.131 -0.692 . . . . 24.09 109.131 177.239 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 60' ' ' VAL . . . . . . . . . . . . . 44.7 t -78.05 122.27 32.6 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.286 0 C-N-CA 120.753 -0.379 . . . . 19.329999999999998 110.428 -173.96 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 61' ' ' GLU . . . . . . . . . . . . . 46.9 mt-10 -131.0 174.31 10.13 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.065 -0.516 . . . . 21.739999999999998 109.882 176.923 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 62' ' ' ASP . . . . . . . . . . . . . 10.9 t70 -54.29 -32.71 57.06 Favored 'General case' 0 C--N 1.327 -0.381 0 C-N-CA 121.037 -0.265 . . . . 21.649999999999999 111.668 -178.812 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 63' ' ' ARG . . . . . . . . . . . . . 39.9 ptt180 -89.49 5.14 46.75 Favored 'General case' 0 CA--C 1.537 0.452 0 N-CA-C 113.715 1.006 . . . . 24.690000000000001 113.715 -176.152 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 64' ' ' THR . . . . . . . . . . . . . 38.7 m -81.1 130.7 35.14 Favored 'General case' 0 C--N 1.331 -0.2 0 CA-C-N 118.134 0.425 . . . . 18.760000000000002 110.386 -179.717 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 65' ' ' LYS . . . . . . . . . . . . . 91.0 mttt -90.47 130.37 36.54 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.353 -0.385 . . . . 18.940000000000001 110.469 -179.715 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 66' ' ' ILE . . . . . . . . . . . . . 65.1 mt -116.48 132.35 66.37 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.232 0 CA-C-O 120.923 0.392 . . . . 15.210000000000001 110.006 179.456 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 67' ' ' THR . . . . . . . . . . . . . 30.4 m -120.4 139.37 52.91 Favored 'General case' 0 C--N 1.331 -0.22 0 CA-C-N 116.04 -0.527 . . . . 12.77 110.637 -178.938 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 68' ' ' LEU . . . . . . . . . . . . . 6.8 mp . . . . . 0 C--N 1.332 -0.193 0 CA-C-N 116.209 -0.45 . . . . 10.5 110.781 179.692 . . . . . . . . 0 0 . 1 . 001 nuclear orig core ' B' B ' 73' ' ' VAL . . . . . . . . . . . . . 34.5 m . . . . . 0 C--O 1.231 0.08 0 CA-C-O 120.675 0.274 . . . . 1.3500000000000001 110.53 . . . . . . . . . 0 0 . 1 . 001 nuclear orig core ' B' B ' 74' ' ' ASP . . . . . . . . . . . . . 29.8 t0 -94.01 120.23 33.98 Favored 'General case' 0 C--N 1.331 -0.229 0 CA-C-N 116.446 -0.343 . . . . 0.93000000000000005 110.159 -179.631 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 75' ' ' VAL . . . . . . . . . . . . . 43.4 t -118.76 121.77 67.75 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.212 0 CA-C-O 121.046 0.45 . . . . 1.26 110.688 -177.86 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 76' ' ' LEU . . . . . . . . . . . . . 6.0 mp -123.66 146.49 48.18 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-N 115.82 -0.627 . . . . 1.77 109.672 175.284 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 77' ' ' GLU . . . . . . . . . . . . . 98.1 mt-10 -135.54 139.74 44.18 Favored 'General case' 0 N--CA 1.462 0.161 0 CA-C-O 121.015 0.436 . . . . 1.3300000000000001 111.582 -177.642 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 78' ' ' ALA . . . . . . . . . . . . . . . -127.73 137.79 52.56 Favored 'General case' 0 C--N 1.331 -0.223 0 CA-C-N 115.639 -0.71 . . . . 1.3 109.69 175.474 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 79' ' ' LYS . . . . . . . . . . . . . 49.8 pttt -84.64 123.15 30.03 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-O 121.073 0.464 . . . . 3.4900000000000002 110.937 -179.019 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 80' ' ' ILE . . . . . . . . . . . . . 40.0 mm -139.16 117.54 12.51 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.28 0 N-CA-C 109.421 -0.585 . . . . 1.25 109.421 -177.659 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 81' ' ' LYS . . . . . . . . . . . . . 85.4 tttt -104.14 121.79 43.97 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-O 120.795 0.331 . . . . 3.3900000000000001 111.122 -177.292 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 82' ' ' GLY . . . . . . . . . . . . . . . 89.11 42.2 5.67 Favored Glycine 0 CA--C 1.526 0.733 0 C-N-CA 120.648 -0.786 . . . . 0.70999999999999996 112.069 173.618 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 83' ' ' ILE . . . . . . . . . . . . . 69.3 mt -67.43 137.92 23.78 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.282 0 N-CA-C 109.669 -0.493 . . . . 1.1499999999999999 109.669 176.625 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 84' ' ' LYS . . . . . . . . . . . . . 80.5 tttt -93.46 -54.07 3.82 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.078 -0.51 . . . . 2.1600000000000001 110.379 -178.388 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 85' ' ' ASP . . . . . . . . . . . . . 19.5 t70 -156.43 152.92 28.07 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 115.63 -0.714 . . . . 0.69999999999999996 110.138 -179.085 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 86' ' ' VAL . . . . . . . . . . . . . 45.1 t -127.5 131.07 70.57 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.25 0 CA-C-O 121.096 0.474 . . . . 1.26 110.543 -179.092 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 87' ' ' ILE . . . . . . . . . . . . . 5.1 mp -118.94 125.13 74.23 Favored 'Isoleucine or valine' 0 C--O 1.233 0.23 0 CA-C-N 115.668 -0.696 . . . . 2.02 109.276 176.64 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 88' ' ' LEU . . . . . . . . . . . . . 16.6 tp -110.05 127.28 54.75 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-O 120.926 0.393 . . . . 2.29 110.958 -177.415 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 89' ' ' ASP . . . . . . . . . . . . . 14.6 t70 -118.89 158.17 26.21 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 115.813 -0.631 . . . . 0.84999999999999998 109.408 177.09 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 90' ' ' GLU . . . . . . . . . . . . . 95.1 mt-10 -47.31 -40.35 16.83 Favored 'General case' 0 C--N 1.33 -0.265 0 N-CA-C 113.0 0.741 . . . . 2.5099999999999998 113.0 -171.33 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 91' ' ' ASN . . . . . . . . . . . . . 69.9 m-80 -132.09 26.51 4.56 Favored 'General case' 0 N--CA 1.466 0.373 0 N-CA-C 112.469 0.544 . . . . 2.5899999999999999 112.469 -178.023 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 92' ' ' LEU . . . . . . . . . . . . . 84.9 mt -150.51 143.22 24.57 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-O 120.748 0.308 . . . . 2.04 110.448 -178.731 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 93' ' ' ILE . . . . . . . . . . . . . 74.5 mt -118.53 113.37 41.63 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.346 0 N-CA-C 109.257 -0.646 . . . . 1.21 109.257 178.181 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 94' ' ' VAL . . . . . . . . . . . . . 46.1 t -115.35 124.95 72.41 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.201 0 CA-C-O 120.939 0.4 . . . . 1.1399999999999999 109.99 -178.43 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 95' ' ' VAL . . . . . . . . . . . . . 42.7 t -121.91 134.34 65.49 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.285 0 CA-C-N 116.07 -0.514 . . . . 1.1699999999999999 109.881 -179.122 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 96' ' ' ILE . . . . . . . . . . . . . 64.6 mt -112.89 128.71 69.48 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.365 0 N-CA-C 109.075 -0.713 . . . . 1.1799999999999999 109.075 177.831 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 97' ' ' THR . . . . . . . . . . . . . 69.6 p -98.37 158.72 15.4 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-O 121.153 0.501 . . . . 1.1499999999999999 111.082 -178.043 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 98' ' ' GLU . . . . . . . . . . . . . 83.6 tt0 -53.93 -27.66 32.18 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.148 -0.478 . . . . 3.0499999999999998 112.081 -179.819 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 99' ' ' GLU . . . . . . . . . . . . . 95.5 mt-10 -81.31 16.78 1.49 Allowed 'General case' 0 CA--C 1.534 0.363 0 N-CA-C 113.152 0.797 . . . . 2.29 113.152 -176.588 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 100' ' ' ASN . . . . . . . . . . . . . 4.3 m-20 62.89 38.05 11.65 Favored 'General case' 0 N--CA 1.462 0.158 0 CA-C-O 121.073 0.464 . . . . 0.66000000000000003 111.158 177.265 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 101' ' ' GLU . . . . . . . . . . . . . 84.6 tt0 -115.18 144.46 43.65 Favored 'General case' 0 C--N 1.333 -0.132 0 CA-C-N 116.1 -0.5 . . . . 0.68999999999999995 109.738 174.937 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 102' ' ' VAL . . . . . . . . . . . . . 45.0 t -115.5 126.23 72.98 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 CA-C-N 116.257 -0.429 . . . . 1.1899999999999999 110.083 -177.812 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 103' ' ' LEU . . . . . . . . . . . . . 55.6 mt -119.23 132.48 55.93 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 115.789 -0.641 . . . . 1.8600000000000001 110.014 177.15 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 104' ' ' ILE . . . . . . . . . . . . . 66.7 mt -121.34 121.61 65.18 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.236 0 N-CA-C 110.369 -0.234 . . . . 1.22 110.369 179.047 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 105' ' ' PHE . . . . . . . . . . . . . 76.0 m-85 -115.81 166.32 12.09 Favored 'General case' 0 C--N 1.332 -0.175 0 O-C-N 124.205 0.941 . . . . 0.58999999999999997 109.643 177.911 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 106' ' ' ASN . . . . . . . . . . . . . 52.0 p-10 -100.08 -171.57 2.07 Favored 'General case' 0 C--N 1.331 -0.213 0 N-CA-C 110.086 -0.338 . . . . 0.73999999999999999 110.086 173.546 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 107' ' ' GLN . . . . . . . . . . . . . 50.2 tt0 -58.37 -30.15 66.56 Favored 'General case' 0 CA--C 1.532 0.286 0 N-CA-C 111.901 0.334 . . . . 1.8400000000000001 111.901 178.574 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 108' ' ' ASN . . . . . . . . . . . . . 63.6 t30 -83.03 8.16 13.63 Favored 'General case' 0 CA--C 1.535 0.388 0 N-CA-C 113.212 0.819 . . . . 1.9399999999999999 113.212 -177.147 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 109' ' ' LEU . . . . . . . . . . . . . 11.9 tp 60.92 37.43 18.33 Favored 'General case' 0 CA--C 1.53 0.186 0 CA-C-O 120.99 0.424 . . . . 1.75 111.197 179.028 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 110' ' ' GLU . . . . . . . . . . . . . 47.6 mt-10 -110.09 153.09 25.16 Favored 'General case' 0 C--N 1.33 -0.24 0 N-CA-C 109.751 -0.463 . . . . 1.97 109.751 176.436 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 111' ' ' GLU . . . . . . . . . . . . . 73.7 tt0 -86.76 123.17 31.61 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-O 120.855 0.359 . . . . 1.8400000000000001 110.926 -174.931 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 112' ' ' LEU . . . . . . . . . . . . . 32.9 mt -108.9 -46.06 3.69 Favored 'General case' 0 C--N 1.332 -0.186 0 CA-C-N 116.198 -0.455 . . . . 1.3100000000000001 111.27 -179.55 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 113' ' ' TYR . . . . . . . . . . . . . 71.6 t80 -136.83 142.3 42.87 Favored 'General case' 0 N--CA 1.464 0.244 0 CA-C-O 120.778 0.323 . . . . 0.94999999999999996 111.064 -178.202 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 114' ' ' ARG . . . . . . . . . . . . . 25.0 ptt180 -144.52 127.25 16.21 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.05 -0.523 . . . . 3.3700000000000001 110.927 -179.989 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 115' ' ' GLY . . . . . . . . . . . . . . . -150.19 160.46 28.55 Favored Glycine 0 CA--C 1.525 0.659 0 N-CA-C 111.242 -0.743 . . . . 0.56999999999999995 111.242 178.614 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 116' ' ' LYS . . . . . . . . . . . . . 7.9 ttpm? -129.65 134.45 47.69 Favored 'General case' 0 C--N 1.33 -0.267 0 N-CA-C 109.782 -0.451 . . . . 2.21 109.782 175.911 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 117' ' ' PHE . . . . . . . . . . . . . 38.3 m-85 -134.46 113.97 12.39 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-O 120.815 0.34 . . . . 0.56999999999999995 110.258 -176.939 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 118' ' ' GLU . . . . . . . . . . . . . 95.9 mt-10 -55.29 -40.94 71.66 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.424 -0.353 . . . . 2.5600000000000001 111.129 -176.371 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 119' ' ' ASN . . . . . . . . . . . . . 7.2 m120 -102.84 31.12 4.33 Favored 'General case' 0 C--N 1.331 -0.227 0 CA-C-N 116.272 -0.422 . . . . 2.0499999999999998 112.136 -174.431 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 120' ' ' LEU . . . . . . . . . . . . . 18.8 tp -56.23 120.46 7.6 Favored 'General case' 0 N--CA 1.462 0.156 0 C-N-CA 120.971 -0.292 . . . . 1.1899999999999999 110.403 178.418 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 121' ' ' ASN . . . . . . . . . . . . . 64.2 t30 -114.08 -44.1 3.18 Favored 'General case' 0 C--O 1.233 0.186 0 CA-C-N 116.504 -0.316 . . . . 2.4199999999999999 111.239 -175.891 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 122' ' ' LYS . . . . . . . . . . . . . 91.0 mttt -146.22 150.32 35.61 Favored 'General case' 0 C--N 1.331 -0.197 0 CA-C-O 121.192 0.52 . . . . 2.1600000000000001 111.981 -176.339 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 123' ' ' VAL . . . . . . . . . . . . . 45.4 t -124.73 128.86 73.64 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.245 0 CA-C-N 115.651 -0.704 . . . . 1.2 109.391 174.723 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 124' ' ' LEU . . . . . . . . . . . . . 72.5 mt -120.8 132.43 55.02 Favored 'General case' 0 C--N 1.33 -0.273 0 N-CA-C 110.181 -0.303 . . . . 2.1600000000000001 110.181 -178.194 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 125' ' ' VAL . . . . . . . . . . . . . 35.1 m -138.43 132.44 41.61 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.25 0 CA-C-O 120.971 0.415 . . . . 2.3500000000000001 111.085 -179.754 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 126' ' ' ARG . . . . . . . . . . . . . 89.3 mtt-85 -151.58 132.92 14.57 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 115.777 -0.647 . . . . 3.0600000000000001 109.714 176.605 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 127' ' ' ASN . . . . . . . . . . . . . 32.0 t30 56.67 -147.82 0.51 Allowed 'General case' 0 CA--C 1.541 0.623 0 N-CA-C 109.686 -0.487 . . . . 2.71 109.686 -179.415 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 128' ' ' ASP . . . . . . . . . . . . . 4.5 p30 -88.04 16.89 5.46 Favored 'General case' 0 CA--C 1.536 0.433 0 CA-C-N 118.75 0.705 . . . . 1.02 112.725 178.446 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 129' ' ' LEU . . . . . . . . . . . . . 15.0 tp -115.37 136.08 53.46 Favored 'General case' 0 C--O 1.232 0.167 0 O-C-N 122.118 -0.364 . . . . 2.3399999999999999 110.073 179.389 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 130' ' ' VAL . . . . . . . . . . . . . 32.6 m -131.53 144.0 38.81 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.27 0 CA-C-O 120.995 0.426 . . . . 2.1099999999999999 111.0 -178.546 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 131' ' ' VAL . . . . . . . . . . . . . 42.8 t -136.04 140.07 44.65 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 CA-C-N 116.022 -0.536 . . . . 1.3400000000000001 110.34 179.796 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 132' ' ' ILE . . . . . . . . . . . . . 72.4 mt -112.95 133.88 57.37 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.323 0 N-CA-C 109.422 -0.584 . . . . 1.1399999999999999 109.422 178.256 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 133' ' ' ILE . . . . . . . . . . . . . 38.5 mm -114.68 116.97 54.18 Favored 'Isoleucine or valine' 0 C--O 1.233 0.232 0 CA-C-N 116.534 -0.303 . . . . 1.24 110.767 -176.118 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 134' ' ' ASP . . . . . . . . . . . . . 7.6 p-10 -129.61 149.79 51.22 Favored 'General case' 0 C--N 1.331 -0.215 0 N-CA-C 109.594 -0.521 . . . . 0.56000000000000005 109.594 174.963 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 135' ' ' GLU . . . . . . . . . . . . . 85.0 tt0 -49.9 -25.94 3.65 Favored 'General case' 0 C--N 1.327 -0.372 0 N-CA-C 112.719 0.637 . . . . 1.6399999999999999 112.719 -172.113 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 136' ' ' GLN . . . . . . . . . . . . . 53.0 mt-30 -101.82 -25.68 13.73 Favored 'General case' 0 C--O 1.233 0.218 0 N-CA-C 112.892 0.701 . . . . 2.46 112.892 -173.939 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 137' ' ' LYS . . . . . . . . . . . . . 86.5 mttt -144.84 150.67 37.52 Favored 'General case' 0 C--N 1.331 -0.227 0 CA-C-O 121.482 0.658 . . . . 2.3900000000000001 112.559 -168.503 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 138' ' ' LEU . . . . . . . . . . . . . 12.5 tp -112.65 117.6 32.71 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 114.888 -1.051 . . . . 1.3999999999999999 108.78 172.64 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 139' ' ' THR . . . . . . . . . . . . . 22.1 m -110.54 124.97 52.83 Favored 'General case' 0 C--N 1.332 -0.182 0 CA-C-O 120.596 0.236 . . . . 1.1799999999999999 110.753 -177.266 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 140' ' ' LEU . . . . . . . . . . . . . 6.5 tt -116.1 122.73 45.99 Favored 'General case' 0 C--N 1.33 -0.249 0 N-CA-C 109.484 -0.561 . . . . 1.5700000000000001 109.484 -178.261 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 141' ' ' ILE . . . . . . . . . . . . . 19.8 mt -120.71 122.95 69.26 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.298 0 CA-C-O 120.949 0.404 . . . . 1.22 110.015 -175.397 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 142' ' ' ARG . . . . . . . . . . . . . 67.5 mtm180 -104.4 126.38 51.45 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 115.281 -0.872 . . . . 4.0899999999999999 109.938 179.78 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 143' ' ' THR . . . . . . . . . . . . . 23.0 p . . . . . 0 C--O 1.22 -0.497 0 CA-C-O 117.963 -1.018 . . . . 1.46 110.645 -179.576 . . . . . . . . 0 0 . 1 . 001 nuclear orig core ' C' C ' 2' ' ' SER . . . . . . . . . . . . . 51.0 p . . . . . 0 C--O 1.231 0.099 0 CA-C-O 120.996 0.427 . . . . 21.68 110.875 . . . . . . . . . 0 0 . 1 . 001 nuclear orig core ' C' C ' 3' ' ' GLU . . . . . . . . . . . . . 95.2 mt-10 -140.02 142.57 36.22 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 115.832 -0.622 . . . . 19.0 110.711 -179.463 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' C' C ' 4' ' ' LEU . . . . . . . . . . . . . 4.0 tt -123.78 124.02 41.78 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.083 -0.508 . . . . 16.859999999999999 109.788 176.63 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' C' C ' 5' ' ' LYS . . . . . . . . . . . . . 57.3 mttm -100.12 121.7 41.81 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.298 -0.41 . . . . 14.550000000000001 110.866 -179.314 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' C' C ' 6' ' ' LEU . . . . . . . . . . . . . 60.6 mt -117.59 146.3 43.72 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 115.557 -0.747 . . . . 14.02 110.67 -179.437 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' C' C ' 7' ' ' LYS . . . . . . . . . . . . . 38.5 ttmt -138.89 139.14 22.8 Favored Pre-proline 0 CA--C 1.533 0.318 0 CA-C-O 119.115 -0.469 . . . . 11.369999999999999 109.998 174.779 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' C' C ' 8' ' ' PRO . . . . . . . . . . . . . 94.1 Cg_endo -91.95 146.12 3.05 Favored 'Trans proline' 0 N--CA 1.489 1.258 0 C-N-CA 121.82 1.68 . . . . 11.15 112.098 178.817 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' C' C ' 9' ' ' LEU . . . . . . . . . . . . . 70.2 mt -75.89 -46.34 3.93 Favored Pre-proline 0 CA--C 1.533 0.31 0 CA-C-O 118.742 -0.647 . . . . 14.81 111.596 178.035 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' C' C ' 10' ' ' PRO . . . . . . . . . . . . . 84.6 Cg_endo -81.76 142.68 12.85 Favored 'Trans proline' 0 N--CA 1.495 1.574 0 C-N-CA 121.024 1.15 . . . . 14.039999999999999 111.227 172.308 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' C' C ' 11' ' ' LYS . . . . . . . . . . . . . 53.7 tttm -86.33 109.94 19.33 Favored 'General case' 0 C--N 1.331 -0.223 0 C-N-CA 120.68 -0.408 . . . . 12.199999999999999 110.524 -179.254 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' C' C ' 12' ' ' VAL . . . . . . . . . . . . . 11.6 p -147.38 145.62 18.95 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.299 0 CA-C-N 116.003 -0.544 . . . . 13.76 110.402 -179.294 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' C' C ' 13' ' ' GLU . . . . . . . . . . . . . 46.1 mt-10 -81.15 130.28 34.95 Favored 'General case' 0 C--N 1.329 -0.286 0 N-CA-C 110.096 -0.335 . . . . 13.26 110.096 177.91 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' C' C ' 14' ' ' LEU . . . . . . . . . . . . . 17.3 mt -98.78 143.94 27.27 Favored Pre-proline 0 CA--C 1.533 0.326 0 CA-C-O 118.987 -0.53 . . . . 13.07 110.336 -178.215 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' C' C ' 15' ' ' PRO . . . . . . . . . . . . . 23.2 Cg_exo -64.49 161.09 36.49 Favored 'Trans proline' 0 N--CA 1.498 1.754 0 C-N-CA 121.36 1.373 . . . . 16.109999999999999 111.733 176.333 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' C' C ' 16' ' ' PRO . . . . . . . . . . . . . 35.7 Cg_exo -59.12 -35.32 98.18 Favored 'Trans proline' 0 N--CA 1.498 1.748 0 C-N-CA 121.508 1.472 . . . . 16.780000000000001 112.979 -178.545 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' C' C ' 17' ' ' ASP . . . . . . . . . . . . . 11.6 p-10 -83.3 -0.71 50.9 Favored 'General case' 0 CA--C 1.537 0.452 0 N-CA-C 113.35 0.87 . . . . 17.370000000000001 113.35 -177.397 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' C' C ' 18' ' ' PHE . . . . . . . . . . . . . 29.2 t80 -58.34 -44.26 88.65 Favored 'General case' 0 C--N 1.334 -0.107 0 O-C-N 121.972 -0.455 . . . . 14.82 110.082 -177.343 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' C' C ' 19' ' ' VAL . . . . . . . . . . . . . 49.7 t -57.14 -43.96 82.47 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.288 0 CA-C-N 116.132 -0.485 . . . . 15.029999999999999 110.423 -177.737 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' C' C ' 20' ' ' ASP . . . . . . . . . . . . . 2.0 m-20 -60.07 -43.31 95.54 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.551 -0.295 . . . . 17.449999999999999 111.029 -177.653 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' C' C ' 21' ' ' VAL . . . . . . . . . . . . . 46.4 t -63.84 -45.49 96.94 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.289 0 C-N-CA 120.707 -0.397 . . . . 17.609999999999999 110.545 -176.94 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' C' C ' 22' ' ' ILE . . . . . . . . . . . . . 50.6 mm -55.9 -48.58 78.25 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.226 0 C-N-CA 121.038 -0.265 . . . . 16.84 110.71 179.014 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' C' C ' 23' ' ' ARG . . . . . . . . . . . . . 49.3 ttp180 -54.84 -45.76 74.55 Favored 'General case' 0 C--N 1.331 -0.234 0 C-N-CA 120.92 -0.312 . . . . 19.43 111.347 -178.245 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' C' C ' 24' ' ' ILE . . . . . . . . . . . . . 75.5 mt -58.94 -45.33 92.03 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.253 0 C-N-CA 121.013 -0.275 . . . . 20.399999999999999 111.073 -178.696 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' C' C ' 25' ' ' LYS . . . . . . . . . . . . . 53.6 mttm -65.81 -38.1 88.04 Favored 'General case' 0 C--N 1.328 -0.349 0 N-CA-C 112.418 0.525 . . . . 20.059999999999999 112.418 -178.325 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' C' C ' 26' ' ' LEU . . . . . . . . . . . . . 62.8 mt -78.51 -39.82 36.99 Favored 'General case' 0 C--N 1.33 -0.25 0 N-CA-C 113.697 0.999 . . . . 20.370000000000001 113.697 -170.443 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' C' C ' 27' ' ' GLN . . . . . . . . . . . . . 12.1 pt20 -47.39 138.66 7.29 Favored 'General case' 0 N--CA 1.469 0.478 0 N-CA-C 112.827 0.677 . . . . 21.899999999999999 112.827 -174.772 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' C' C ' 28' ' ' GLY . . . . . . . . . . . . . . . 98.62 -22.05 42.86 Favored Glycine 0 CA--C 1.534 1.234 0 CA-C-N 115.772 -0.649 . . . . 24.109999999999999 112.683 -177.737 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' C' C ' 29' ' ' LYS . . . . . . . . . . . . . 63.3 mttp -98.26 155.07 17.37 Favored 'General case' 0 C--N 1.333 -0.129 0 CA-C-N 117.521 0.661 . . . . 23.399999999999999 111.02 -179.964 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' C' C ' 30' ' ' THR . . . . . . . . . . . . . 41.7 m -105.73 135.25 47.49 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.165 -0.47 . . . . 24.760000000000002 109.826 175.33 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' C' C ' 31' ' ' VAL . . . . . . . . . . . . . 34.9 m -130.56 150.5 34.68 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.289 0 CA-C-O 120.979 0.419 . . . . 21.440000000000001 111.171 -177.815 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' C' C ' 32' ' ' ARG . . . . . . . . . . . . . 56.0 ttp180 -131.71 151.0 51.97 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 115.772 -0.649 . . . . 26.43 110.182 177.674 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' C' C ' 33' ' ' THR . . . . . . . . . . . . . 23.5 m -52.92 138.82 29.09 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.423 -0.353 . . . . 20.32 111.436 -177.761 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' C' C ' 34' ' ' GLY . . . . . . . . . . . . . . . 101.25 -17.23 56.08 Favored Glycine 0 CA--C 1.533 1.177 0 CA-C-O 119.695 -0.503 . . . . 19.649999999999999 113.276 179.24 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' C' C ' 35' ' ' ASP . . . . . . . . . . . . . 75.1 m-20 -67.0 152.48 45.7 Favored 'General case' 0 N--CA 1.461 0.103 0 CA-C-N 118.046 0.923 . . . . 21.469999999999999 111.417 178.984 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' C' C ' 36' ' ' VAL . . . . . . . . . . . . . 44.9 t -121.03 130.98 74.12 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.227 0 CA-C-N 115.969 -0.56 . . . . 19.550000000000001 109.99 178.423 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' C' C ' 37' ' ' ILE . . . . . . . . . . . . . 71.9 mt -123.61 140.87 45.83 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.23 0 CA-C-N 116.158 -0.474 . . . . 18.649999999999999 109.858 179.972 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' C' C ' 38' ' ' GLY . . . . . . . . . . . . . . . -113.42 128.93 8.58 Favored Glycine 0 CA--C 1.528 0.851 0 N-CA-C 111.272 -0.731 . . . . 18.91 111.272 -179.548 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' C' C ' 39' ' ' ILE . . . . . . . . . . . . . 68.7 mt -124.83 132.37 71.41 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.199 0 N-CA-C 109.911 -0.403 . . . . 18.359999999999999 109.911 178.395 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' C' C ' 40' ' ' SER . . . . . . . . . . . . . 15.7 t -92.78 117.92 30.53 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-N 116.546 -0.297 . . . . 21.23 111.009 177.093 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' C' C ' 41' ' ' ILE . . . . . . . . . . . . . 47.4 mm -130.89 128.2 62.36 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.217 0 CA-C-O 120.711 0.291 . . . . 18.73 110.223 178.847 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' C' C ' 42' ' ' LEU . . . . . . . . . . . . . 23.1 mt 57.33 33.53 23.42 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.196 -0.456 . . . . 20.859999999999999 111.873 177.985 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' C' C ' 43' ' ' GLY . . . . . . . . . . . . . . . 77.64 -10.1 25.89 Favored Glycine 0 CA--C 1.535 1.311 0 C-N-CA 121.188 -0.529 . . . . 22.32 113.421 177.341 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' C' C ' 44' ' ' LYS . . . . . . . . . . . . . 65.6 tttt -104.87 135.46 46.19 Favored 'General case' 0 C--N 1.332 -0.162 0 CA-C-N 117.938 0.869 . . . . 19.989999999999998 110.105 177.58 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' C' C ' 45' ' ' GLU . . . . . . . . . . . . . 84.6 tt0 -83.72 131.14 34.95 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.36 -0.382 . . . . 20.5 110.91 -179.734 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' C' C ' 46' ' ' VAL . . . . . . . . . . . . . 7.3 p -120.76 130.64 74.36 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.229 0 N-CA-C 109.369 -0.604 . . . . 16.82 109.369 175.99 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' C' C ' 47' ' ' LYS . . . . . . . . . . . . . 66.8 mttm -99.26 126.89 45.17 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 115.877 -0.601 . . . . 19.600000000000001 110.709 178.949 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' C' C ' 48' ' ' PHE . . . . . . . . . . . . . 85.2 m-85 -111.27 131.96 54.74 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.366 -0.379 . . . . 15.050000000000001 110.085 177.921 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' C' C ' 49' ' ' LYS . . . . . . . . . . . . . 78.9 tttt -105.16 136.09 45.3 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.228 -0.442 . . . . 16.59 109.913 178.156 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' C' C ' 50' ' ' VAL . . . . . . . . . . . . . 46.6 t -78.22 107.85 10.81 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.312 0 N-CA-C 109.161 -0.681 . . . . 16.710000000000001 109.161 177.174 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' C' C ' 51' ' ' VAL . . . . . . . . . . . . . 48.9 t -70.22 -47.87 64.71 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.304 0 CA-C-N 115.964 -0.562 . . . . 15.449999999999999 109.956 -174.298 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' C' C ' 52' ' ' GLN . . . . . . . . . . . . . 48.4 tt0 -168.99 140.1 2.43 Favored 'General case' 0 C--N 1.33 -0.255 0 C-N-CA 120.389 -0.524 . . . . 17.390000000000001 111.581 -179.004 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' C' C ' 53' ' ' ALA . . . . . . . . . . . . . . . -109.65 133.3 53.28 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 115.85 -0.614 . . . . 19.600000000000001 109.799 174.922 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' C' C ' 54' ' ' TYR . . . . . . . . . . . . . 10.0 t80 -129.03 107.39 18.03 Favored Pre-proline 0 CA--C 1.534 0.35 0 CA-C-O 118.27 -0.871 . . . . 23.510000000000002 110.389 -179.942 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' C' C ' 55' ' ' PRO . . . . . . . . . . . . . 72.7 Cg_endo -77.21 170.03 72.59 Favored 'Cis proline' 0 N--CA 1.501 1.932 0 CA-C-N 121.798 1.678 . . . . 24.34 112.558 -6.009 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' C' C ' 56' ' ' SER . . . . . . . . . . . . . 20.0 m -116.59 140.21 26.44 Favored Pre-proline 0 CA--C 1.539 0.524 0 CA-C-O 118.616 -0.707 . . . . 24.73 109.737 174.763 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' C' C ' 57' ' ' PRO . . . . . . . . . . . . . 57.0 Cg_endo -73.36 148.01 91.04 Favored 'Cis proline' 0 N--CA 1.499 1.809 0 CA-C-N 121.621 1.615 . . . . 26.280000000000001 111.161 -6.123 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' C' C ' 58' ' ' LEU . . . . . . . . . . . . . 25.1 tp -107.47 139.3 42.18 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-O 120.986 0.422 . . . . 22.27 110.759 -177.487 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' C' C ' 59' ' ' ARG . . . . . . . . . . . . . 54.3 ttp180 -103.91 119.42 38.89 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 115.543 -0.753 . . . . 27.23 109.016 174.598 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' C' C ' 60' ' ' VAL . . . . . . . . . . . . . 40.9 t -72.58 120.18 20.67 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.286 0 C-N-CA 120.872 -0.331 . . . . 21.449999999999999 110.726 -173.092 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' C' C ' 61' ' ' GLU . . . . . . . . . . . . . 94.8 mt-10 -131.03 164.9 24.39 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 115.774 -0.648 . . . . 24.699999999999999 109.764 175.979 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' C' C ' 62' ' ' ASP . . . . . . . . . . . . . 39.4 m-20 -53.87 -32.49 53.32 Favored 'General case' 0 C--N 1.328 -0.349 0 C-N-CA 120.982 -0.287 . . . . 22.780000000000001 111.763 -179.865 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' C' C ' 63' ' ' ARG . . . . . . . . . . . . . 28.5 ptt180 -78.77 0.23 27.73 Favored 'General case' 0 CA--C 1.537 0.468 0 N-CA-C 113.799 1.037 . . . . 26.199999999999999 113.799 -175.445 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' C' C ' 64' ' ' THR . . . . . . . . . . . . . 32.5 m -86.28 136.4 33.17 Favored 'General case' 0 C--N 1.333 -0.148 0 CA-C-N 118.146 0.43 . . . . 20.399999999999999 110.797 -177.926 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' C' C ' 65' ' ' LYS . . . . . . . . . . . . . 62.8 mttm -89.67 131.08 35.83 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.166 -0.47 . . . . 19.690000000000001 110.192 178.924 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' C' C ' 66' ' ' ILE . . . . . . . . . . . . . 58.2 mt -112.2 130.18 66.35 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.254 0 N-CA-C 109.631 -0.507 . . . . 15.960000000000001 109.631 -179.808 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' C' C ' 67' ' ' THR . . . . . . . . . . . . . 26.5 m -124.78 137.34 54.33 Favored 'General case' 0 C--N 1.332 -0.167 0 CA-C-O 121.01 0.433 . . . . 13.69 111.022 -177.307 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' C' C ' 68' ' ' LEU . . . . . . . . . . . . . 53.9 mt . . . . . 0 C--N 1.329 -0.305 0 CA-C-N 115.859 -0.61 . . . . 10.69 110.209 177.806 . . . . . . . . 0 0 . 1 . 001 nuclear orig core ' C' C ' 73' ' ' VAL . . . . . . . . . . . . . 33.8 m . . . . . 0 N--CA 1.462 0.152 0 CA-C-O 120.87 0.367 . . . . 1.4199999999999999 110.48 . . . . . . . . . 0 0 . 1 . 001 nuclear orig core ' C' C ' 74' ' ' ASP . . . . . . . . . . . . . 6.7 t70 -103.36 128.33 50.48 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 115.978 -0.555 . . . . 0.81000000000000005 109.778 -179.514 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' C' C ' 75' ' ' VAL . . . . . . . . . . . . . 41.0 t -114.63 122.9 69.67 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.209 0 CA-C-O 121.063 0.458 . . . . 1.24 110.745 -176.878 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' C' C ' 76' ' ' LEU . . . . . . . . . . . . . 6.8 mp -119.88 139.56 52.2 Favored 'General case' 0 C--N 1.33 -0.277 0 N-CA-C 108.875 -0.787 . . . . 1.6499999999999999 108.875 173.831 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' C' C ' 77' ' ' GLU . . . . . . . . . . . . . 59.6 tt0 -137.29 136.25 37.86 Favored 'General case' 0 C--N 1.333 -0.14 0 C-N-CA 120.496 -0.482 . . . . 1.1799999999999999 111.416 -174.237 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' C' C ' 78' ' ' ALA . . . . . . . . . . . . . . . -124.07 137.43 54.57 Favored 'General case' 0 C--N 1.331 -0.199 0 CA-C-N 115.771 -0.65 . . . . 1.24 109.835 177.45 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' C' C ' 79' ' ' LYS . . . . . . . . . . . . . 68.1 mttm -79.84 120.27 23.85 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-O 120.976 0.417 . . . . 3.6299999999999999 110.621 -179.542 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' C' C ' 80' ' ' ILE . . . . . . . . . . . . . 43.4 mm -139.11 114.05 8.13 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.311 0 N-CA-C 109.13 -0.693 . . . . 1.25 109.13 -176.95 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' C' C ' 81' ' ' LYS . . . . . . . . . . . . . 41.6 tttp -110.22 130.42 55.55 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-O 120.974 0.416 . . . . 3.3799999999999999 111.247 -176.362 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' C' C ' 82' ' ' GLY . . . . . . . . . . . . . . . 89.13 42.08 5.69 Favored Glycine 0 CA--C 1.526 0.722 0 CA-C-N 115.857 -0.61 . . . . 0.55000000000000004 111.692 175.694 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' C' C ' 83' ' ' ILE . . . . . . . . . . . . . 67.7 mt -69.95 138.34 22.26 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.279 0 N-CA-C 109.833 -0.432 . . . . 1.1699999999999999 109.833 178.54 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' C' C ' 84' ' ' LYS . . . . . . . . . . . . . 35.3 tttp -101.01 -54.03 2.9 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.068 -0.515 . . . . 2.29 110.366 -178.658 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' C' C ' 85' ' ' ASP . . . . . . . . . . . . . 13.3 t70 -151.97 151.33 31.06 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 115.862 -0.608 . . . . 0.76000000000000001 110.353 -179.7 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' C' C ' 86' ' ' VAL . . . . . . . . . . . . . 44.6 t -131.06 130.43 63.77 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.235 0 CA-C-O 120.93 0.395 . . . . 1.1699999999999999 110.596 -178.657 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' C' C ' 87' ' ' ILE . . . . . . . . . . . . . 46.1 mm -119.88 127.29 75.88 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.221 0 CA-C-N 115.883 -0.599 . . . . 1.98 109.71 176.297 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' C' C ' 88' ' ' LEU . . . . . . . . . . . . . 14.1 tp -110.02 131.5 55.0 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-O 120.869 0.366 . . . . 2.2400000000000002 110.969 -178.228 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' C' C ' 89' ' ' ASP . . . . . . . . . . . . . 21.8 t70 -123.42 156.68 35.01 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-N 116.087 -0.506 . . . . 0.94999999999999996 109.939 178.389 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' C' C ' 90' ' ' GLU . . . . . . . . . . . . . 81.2 tt0 -46.33 -40.17 11.38 Favored 'General case' 0 C--N 1.33 -0.255 0 N-CA-C 113.048 0.758 . . . . 2.4300000000000002 113.048 -171.738 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' C' C ' 91' ' ' ASN . . . . . . . . . . . . . 6.3 p-10 -132.1 23.03 4.51 Favored 'General case' 0 N--CA 1.468 0.434 0 N-CA-C 112.779 0.659 . . . . 2.7200000000000002 112.779 -178.546 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' C' C ' 92' ' ' LEU . . . . . . . . . . . . . 15.1 mt -149.26 148.79 29.98 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-O 120.734 0.302 . . . . 2.0499999999999998 110.262 -176.504 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' C' C ' 93' ' ' ILE . . . . . . . . . . . . . 75.7 mt -125.84 120.23 56.75 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.262 0 N-CA-C 109.41 -0.589 . . . . 1.1699999999999999 109.41 177.005 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' C' C ' 94' ' ' VAL . . . . . . . . . . . . . 46.4 t -118.65 124.97 74.01 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.244 0 N-CA-C 109.765 -0.457 . . . . 1.1899999999999999 109.765 -179.603 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' C' C ' 95' ' ' VAL . . . . . . . . . . . . . 41.6 t -122.02 134.49 65.13 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.328 0 CA-C-N 116.038 -0.528 . . . . 1.1699999999999999 109.946 -178.226 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' C' C ' 96' ' ' ILE . . . . . . . . . . . . . 62.6 mt -115.85 127.73 73.35 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.341 0 N-CA-C 109.004 -0.739 . . . . 1.1200000000000001 109.004 178.039 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' C' C ' 97' ' ' THR . . . . . . . . . . . . . 81.4 p -99.56 157.45 16.44 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-O 121.199 0.523 . . . . 1.0900000000000001 111.1 -178.262 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' C' C ' 98' ' ' GLU . . . . . . . . . . . . . 85.0 tt0 -54.01 -27.82 34.23 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.065 -0.516 . . . . 2.3300000000000001 112.043 179.771 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' C' C ' 99' ' ' GLU . . . . . . . . . . . . . 94.6 mt-10 -77.49 12.14 1.71 Allowed 'General case' 0 CA--C 1.537 0.458 0 N-CA-C 113.162 0.801 . . . . 2.1000000000000001 113.162 -177.676 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' C' C ' 100' ' ' ASN . . . . . . . . . . . . . 3.4 m-20 63.57 33.59 13.22 Favored 'General case' 0 CA--C 1.532 0.262 0 CA-C-O 120.904 0.383 . . . . 0.51000000000000001 111.565 179.174 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' C' C ' 101' ' ' GLU . . . . . . . . . . . . . 85.1 tt0 -107.71 144.74 34.4 Favored 'General case' 0 C--N 1.333 -0.15 0 N-CA-C 109.715 -0.476 . . . . 0.45000000000000001 109.715 172.833 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' C' C ' 102' ' ' VAL . . . . . . . . . . . . . 45.7 t -115.35 127.08 73.05 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.317 0 CA-C-N 116.255 -0.429 . . . . 1.1699999999999999 109.851 -177.876 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' C' C ' 103' ' ' LEU . . . . . . . . . . . . . 27.0 mt -117.78 131.41 56.59 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-N 115.883 -0.599 . . . . 1.28 110.407 178.526 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' C' C ' 104' ' ' ILE . . . . . . . . . . . . . 68.9 mt -117.34 119.79 62.92 Favored 'Isoleucine or valine' 0 C--O 1.233 0.219 0 N-CA-C 110.132 -0.321 . . . . 1.1799999999999999 110.132 178.308 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' C' C ' 105' ' ' PHE . . . . . . . . . . . . . 95.8 m-85 -120.65 166.9 13.04 Favored 'General case' 0 C--N 1.332 -0.158 0 O-C-N 124.136 0.897 . . . . 0.46000000000000002 110.038 179.676 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' C' C ' 106' ' ' ASN . . . . . . . . . . . . . 35.5 p30 -101.11 -171.94 2.08 Favored 'General case' 0 C--N 1.33 -0.265 0 N-CA-C 110.17 -0.307 . . . . 0.58999999999999997 110.17 173.073 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' C' C ' 107' ' ' GLN . . . . . . . . . . . . . 63.0 tt0 -60.56 -30.29 69.7 Favored 'General case' 0 CA--C 1.531 0.236 0 N-CA-C 111.803 0.298 . . . . 1.6699999999999999 111.803 179.633 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' C' C ' 108' ' ' ASN . . . . . . . . . . . . . 6.6 t30 -82.94 9.28 10.39 Favored 'General case' 0 CA--C 1.536 0.426 0 N-CA-C 112.976 0.732 . . . . 1.76 112.976 -178.375 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' C' C ' 109' ' ' LEU . . . . . . . . . . . . . 7.6 tp 61.24 32.99 19.33 Favored 'General case' 0 CA--C 1.53 0.193 0 O-C-N 122.228 -0.295 . . . . 1.6000000000000001 111.741 179.14 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' C' C ' 110' ' ' GLU . . . . . . . . . . . . . 94.9 mt-10 -100.89 142.3 32.55 Favored 'General case' 0 C--N 1.33 -0.265 0 N-CA-C 109.319 -0.623 . . . . 1.8999999999999999 109.319 174.724 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' C' C ' 111' ' ' GLU . . . . . . . . . . . . . 60.6 tt0 -85.05 121.99 28.61 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-O 120.893 0.378 . . . . 1.8600000000000001 110.807 -175.14 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' C' C ' 112' ' ' LEU . . . . . . . . . . . . . 60.3 mt -99.71 -46.13 5.52 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 115.94 -0.573 . . . . 1.3100000000000001 110.877 179.256 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' C' C ' 113' ' ' TYR . . . . . . . . . . . . . 85.5 t80 -137.15 140.0 41.55 Favored 'General case' 0 N--CA 1.464 0.242 0 CA-C-O 121.078 0.466 . . . . 1.1200000000000001 111.59 -178.1 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' C' C ' 114' ' ' ARG . . . . . . . . . . . . . 41.1 ttm180 -130.5 124.57 32.24 Favored 'General case' 0 C--N 1.331 -0.23 0 CA-C-N 115.361 -0.836 . . . . 3.0699999999999998 109.862 175.993 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' C' C ' 115' ' ' GLY . . . . . . . . . . . . . . . -147.18 159.02 27.91 Favored Glycine 0 CA--C 1.523 0.572 0 N-CA-C 110.56 -1.016 . . . . 0.47999999999999998 110.56 178.474 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' C' C ' 116' ' ' LYS . . . . . . . . . . . . . 77.3 tttt -137.49 133.12 34.25 Favored 'General case' 0 C--N 1.329 -0.305 0 N-CA-C 109.996 -0.372 . . . . 2.1099999999999999 109.996 179.385 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' C' C ' 117' ' ' PHE . . . . . . . . . . . . . 35.6 m-85 -134.18 115.75 14.56 Favored 'General case' 0 C--N 1.331 -0.223 0 CA-C-N 116.386 -0.37 . . . . 0.63 110.226 -174.82 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' C' C ' 118' ' ' GLU . . . . . . . . . . . . . 95.2 mt-10 -54.64 -40.88 69.43 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.472 -0.331 . . . . 2.1099999999999999 111.498 -175.623 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' C' C ' 119' ' ' ASN . . . . . . . . . . . . . 30.6 m120 -100.53 31.16 3.58 Favored 'General case' 0 C--N 1.33 -0.244 0 N-CA-C 112.266 0.469 . . . . 2.1200000000000001 112.266 -173.187 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' C' C ' 120' ' ' LEU . . . . . . . . . . . . . 14.2 tp -53.79 120.03 5.73 Favored 'General case' 0 N--CA 1.464 0.267 0 CA-C-O 120.676 0.274 . . . . 1.1200000000000001 110.907 178.048 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' C' C ' 121' ' ' ASN . . . . . . . . . . . . . 59.9 m-80 -113.92 -44.15 3.19 Favored 'General case' 0 C--N 1.331 -0.2 0 CA-C-N 116.441 -0.345 . . . . 2.27 110.992 -177.699 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' C' C ' 122' ' ' LYS . . . . . . . . . . . . . 97.9 mttt -146.44 150.31 35.38 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-O 121.059 0.457 . . . . 2.3799999999999999 111.644 -178.022 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' C' C ' 123' ' ' VAL . . . . . . . . . . . . . 44.7 t -129.78 127.58 64.31 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.303 0 N-CA-C 109.383 -0.599 . . . . 1.25 109.383 174.536 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' C' C ' 124' ' ' LEU . . . . . . . . . . . . . 71.0 mt -117.18 132.34 56.67 Favored 'General case' 0 N--CA 1.463 0.223 0 CA-C-N 116.547 -0.297 . . . . 2.2599999999999998 110.663 -178.066 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' C' C ' 125' ' ' VAL . . . . . . . . . . . . . 43.7 t -132.63 121.8 45.81 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.206 0 CA-C-N 116.234 -0.439 . . . . 2.2400000000000002 110.283 -179.411 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' C' C ' 126' ' ' ARG . . . . . . . . . . . . . 80.5 mtt85 -152.69 137.31 16.89 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.287 -0.415 . . . . 3.73 110.152 176.647 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' C' C ' 127' ' ' ASN . . . . . . . . . . . . . 20.1 m120 54.82 -154.44 0.28 Allowed 'General case' 0 CA--C 1.539 0.53 0 N-CA-C 110.102 -0.332 . . . . 2.8100000000000001 110.102 178.562 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' C' C ' 128' ' ' ASP . . . . . . . . . . . . . 4.2 p30 -82.9 19.71 1.32 Allowed 'General case' 0 CA--C 1.534 0.332 0 N-CA-C 112.483 0.549 . . . . 1.1100000000000001 112.483 178.543 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' C' C ' 129' ' ' LEU . . . . . . . . . . . . . 15.5 tp -122.75 137.09 55.02 Favored 'General case' 0 C--O 1.233 0.193 0 O-C-N 122.019 -0.426 . . . . 2.54 110.381 179.935 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' C' C ' 130' ' ' VAL . . . . . . . . . . . . . 32.1 m -132.8 143.68 38.89 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.215 0 CA-C-O 120.957 0.408 . . . . 2.0800000000000001 110.379 178.527 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' C' C ' 131' ' ' VAL . . . . . . . . . . . . . 14.1 p -136.05 141.15 42.48 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.283 0 CA-C-N 116.349 -0.387 . . . . 1.52 110.683 179.9 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' C' C ' 132' ' ' ILE . . . . . . . . . . . . . 74.1 mt -114.64 131.84 65.57 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.354 0 N-CA-C 109.196 -0.668 . . . . 1.1299999999999999 109.196 178.751 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' C' C ' 133' ' ' ILE . . . . . . . . . . . . . 42.7 mm -117.37 120.14 63.98 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.232 0 CA-C-O 120.946 0.403 . . . . 1.1299999999999999 110.901 -175.659 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' C' C ' 134' ' ' ASP . . . . . . . . . . . . . 7.2 p-10 -130.79 144.29 51.34 Favored 'General case' 0 C--N 1.33 -0.257 0 N-CA-C 109.072 -0.714 . . . . 0.53000000000000003 109.072 173.689 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' C' C ' 135' ' ' GLU . . . . . . . . . . . . . 84.4 tt0 -49.78 -25.35 2.97 Favored 'General case' 0 C--N 1.327 -0.379 0 N-CA-C 112.852 0.686 . . . . 2.0 112.852 -170.559 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' C' C ' 136' ' ' GLN . . . . . . . . . . . . . 94.7 mt-30 -92.78 -36.97 12.59 Favored 'General case' 0 C--N 1.332 -0.183 0 N-CA-C 112.105 0.409 . . . . 2.7400000000000002 112.105 -177.499 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' C' C ' 137' ' ' LYS . . . . . . . . . . . . . 41.6 mttp -136.83 151.53 49.24 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-O 121.03 0.443 . . . . 1.98 111.1 -168.453 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' C' C ' 138' ' ' LEU . . . . . . . . . . . . . 5.2 tt -118.91 121.47 40.05 Favored 'General case' 0 C--N 1.332 -0.19 0 N-CA-C 109.047 -0.723 . . . . 1.3799999999999999 109.047 173.133 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' C' C ' 139' ' ' THR . . . . . . . . . . . . . 33.1 m -114.19 127.38 55.87 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-O 120.711 0.291 . . . . 1.2 111.066 -176.565 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' C' C ' 140' ' ' LEU . . . . . . . . . . . . . 21.6 tp -111.03 123.84 50.98 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 115.599 -0.728 . . . . 1.8200000000000001 109.158 179.922 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' C' C ' 141' ' ' ILE . . . . . . . . . . . . . 19.5 mt -122.19 121.61 64.38 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.298 0 CA-C-O 120.981 0.419 . . . . 1.21 110.073 -173.906 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' C' C ' 142' ' ' ARG . . . . . . . . . . . . . 59.3 mtp180 . . . . . 0 C--N 1.329 -0.299 0 CA-C-N 115.419 -0.809 . . . . 4.5599999999999996 110.001 178.762 . . . . . . . . 0 0 . 1 . 001 nuclear orig core ' D' D ' 2' ' ' SER . . . . . . . . . . . . . 3.6 p . . . . . 0 C--O 1.232 0.143 0 CA-C-O 120.844 0.354 . . . . 20.190000000000001 110.477 . . . . . . . . . 0 0 . 1 . 001 nuclear orig core ' D' D ' 3' ' ' GLU . . . . . . . . . . . . . 84.7 tt0 -139.71 139.57 36.6 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.137 -0.483 . . . . 17.239999999999998 110.807 -179.434 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' D' D ' 4' ' ' LEU . . . . . . . . . . . . . 15.3 tp -124.42 126.09 45.36 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 115.912 -0.585 . . . . 15.27 110.117 177.695 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' D' D ' 5' ' ' LYS . . . . . . . . . . . . . 46.5 mttm -102.49 120.48 40.59 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.328 -0.396 . . . . 12.65 110.389 177.795 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' D' D ' 6' ' ' LEU . . . . . . . . . . . . . 78.4 mt -117.63 149.25 41.01 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 115.564 -0.744 . . . . 13.039999999999999 110.663 -179.145 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' D' D ' 7' ' ' LYS . . . . . . . . . . . . . 77.5 tttt -136.77 135.68 20.54 Favored Pre-proline 0 CA--C 1.534 0.359 0 CA-C-O 118.764 -0.636 . . . . 10.07 109.792 176.266 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' D' D ' 8' ' ' PRO . . . . . . . . . . . . . 86.9 Cg_endo -87.83 143.91 6.17 Favored 'Trans proline' 0 N--CA 1.492 1.395 0 C-N-CA 121.546 1.497 . . . . 10.67 111.635 178.43 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' D' D ' 9' ' ' LEU . . . . . . . . . . . . . 21.7 mt -79.86 -46.99 1.46 Allowed Pre-proline 0 CA--C 1.533 0.305 0 CA-C-O 118.746 -0.645 . . . . 13.82 111.91 -178.884 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' D' D ' 10' ' ' PRO . . . . . . . . . . . . . 92.3 Cg_endo -80.69 148.9 18.14 Favored 'Trans proline' 0 N--CA 1.495 1.603 0 C-N-CA 121.194 1.263 . . . . 14.25 111.646 174.127 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' D' D ' 11' ' ' LYS . . . . . . . . . . . . . 96.0 mttt -88.71 102.1 14.65 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-O 120.886 0.374 . . . . 13.050000000000001 110.767 179.961 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' D' D ' 12' ' ' VAL . . . . . . . . . . . . . 12.2 p -141.03 143.85 27.61 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 CA-C-N 116.108 -0.496 . . . . 15.210000000000001 110.391 179.145 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' D' D ' 13' ' ' GLU . . . . . . . . . . . . . 45.9 mt-10 -79.72 124.65 28.78 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.408 -0.36 . . . . 15.06 110.38 179.245 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' D' D ' 14' ' ' LEU . . . . . . . . . . . . . 22.7 mt -99.52 147.78 33.81 Favored Pre-proline 0 CA--C 1.534 0.332 0 CA-C-O 119.185 -0.436 . . . . 15.039999999999999 110.534 -178.139 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' D' D ' 15' ' ' PRO . . . . . . . . . . . . . 23.8 Cg_exo -64.1 160.82 36.28 Favored 'Trans proline' 0 N--CA 1.499 1.821 0 C-N-CA 121.298 1.332 . . . . 18.609999999999999 111.816 175.018 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' D' D ' 16' ' ' PRO . . . . . . . . . . . . . 28.1 Cg_exo -60.02 -36.76 88.53 Favored 'Trans proline' 0 N--CA 1.496 1.64 0 C-N-CA 121.486 1.457 . . . . 19.289999999999999 112.795 -178.408 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' D' D ' 17' ' ' ASP . . . . . . . . . . . . . 2.9 p30 -88.27 9.22 23.85 Favored 'General case' 0 CA--C 1.535 0.402 0 N-CA-C 113.189 0.811 . . . . 20.129999999999999 113.189 -177.775 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' D' D ' 18' ' ' PHE . . . . . . . . . . . . . 61.8 t80 -57.53 -42.44 82.87 Favored 'General case' 0 N--CA 1.46 0.042 0 O-C-N 121.983 -0.448 . . . . 16.760000000000002 110.172 -179.443 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' D' D ' 19' ' ' VAL . . . . . . . . . . . . . 48.0 t -56.91 -42.53 78.67 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.321 0 CA-C-N 116.264 -0.426 . . . . 16.27 110.428 -179.353 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' D' D ' 20' ' ' ASP . . . . . . . . . . . . . 18.4 t70 -59.98 -42.16 93.57 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-O 120.8 0.333 . . . . 19.600000000000001 110.89 -178.12 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' D' D ' 21' ' ' VAL . . . . . . . . . . . . . 46.2 t -64.26 -46.61 92.82 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.269 0 C-N-CA 120.793 -0.363 . . . . 19.539999999999999 110.452 -177.938 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' D' D ' 22' ' ' ILE . . . . . . . . . . . . . 49.0 mm -56.23 -44.41 79.25 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.211 0 C-N-CA 120.962 -0.295 . . . . 17.48 110.565 178.651 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' D' D ' 23' ' ' ARG . . . . . . . . . . . . . 55.9 ttp180 -54.15 -49.38 69.39 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-O 120.673 0.273 . . . . 21.219999999999999 111.444 -179.689 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' D' D ' 24' ' ' ILE . . . . . . . . . . . . . 76.9 mt -58.88 -43.01 87.45 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.308 0 CA-C-N 116.48 -0.327 . . . . 22.359999999999999 111.135 -177.474 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' D' D ' 25' ' ' LYS . . . . . . . . . . . . . 63.4 mttm -66.39 -43.25 86.36 Favored 'General case' 0 C--N 1.328 -0.355 0 N-CA-C 112.619 0.6 . . . . 20.969999999999999 112.619 -178.438 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' D' D ' 26' ' ' LEU . . . . . . . . . . . . . 92.8 mt -78.71 -37.54 41.29 Favored 'General case' 0 C--N 1.331 -0.228 0 N-CA-C 113.55 0.944 . . . . 19.879999999999999 113.55 -170.385 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' D' D ' 27' ' ' GLN . . . . . . . . . . . . . 9.7 pt20 -46.75 138.99 5.67 Favored 'General case' 0 N--CA 1.469 0.488 0 N-CA-C 112.765 0.654 . . . . 22.91 112.765 -175.305 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' D' D ' 28' ' ' GLY . . . . . . . . . . . . . . . 100.3 -23.42 35.94 Favored Glycine 0 CA--C 1.534 1.263 0 CA-C-N 115.606 -0.725 . . . . 23.129999999999999 112.393 -176.572 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' D' D ' 29' ' ' LYS . . . . . . . . . . . . . 68.8 mttm -98.44 155.11 17.41 Favored 'General case' 0 C--O 1.233 0.2 0 CA-C-N 117.441 0.621 . . . . 22.27 111.253 179.436 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' D' D ' 30' ' ' THR . . . . . . . . . . . . . 40.8 m -102.98 137.88 40.58 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.034 -0.53 . . . . 22.780000000000001 109.938 175.362 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' D' D ' 31' ' ' VAL . . . . . . . . . . . . . 34.8 m -128.19 154.38 38.79 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.249 0 CA-C-O 120.911 0.386 . . . . 19.359999999999999 110.854 -178.708 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' D' D ' 32' ' ' ARG . . . . . . . . . . . . . 43.6 mtm180 -133.46 151.53 51.8 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 115.742 -0.663 . . . . 23.66 110.307 177.908 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' D' D ' 33' ' ' THR . . . . . . . . . . . . . 31.9 m -53.2 137.77 33.47 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.498 -0.319 . . . . 17.539999999999999 111.458 -178.155 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' D' D ' 34' ' ' GLY . . . . . . . . . . . . . . . 98.91 -17.02 58.8 Favored Glycine 0 CA--C 1.532 1.147 0 CA-C-O 119.65 -0.528 . . . . 16.98 113.365 177.927 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' D' D ' 35' ' ' ASP . . . . . . . . . . . . . 75.2 m-20 -65.72 149.69 49.72 Favored 'General case' 0 C--O 1.231 0.108 0 CA-C-N 118.012 0.906 . . . . 19.02 111.198 179.96 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' D' D ' 36' ' ' VAL . . . . . . . . . . . . . 46.3 t -118.66 130.11 73.96 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.251 0 CA-C-N 115.847 -0.615 . . . . 17.789999999999999 109.682 177.304 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' D' D ' 37' ' ' ILE . . . . . . . . . . . . . 64.1 mt -115.55 136.98 50.62 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.298 0 CA-C-N 116.11 -0.496 . . . . 17.59 109.764 179.912 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' D' D ' 38' ' ' GLY . . . . . . . . . . . . . . . -109.53 127.61 8.55 Favored Glycine 0 CA--C 1.524 0.635 0 N-CA-C 110.73 -0.948 . . . . 18.84 110.73 178.945 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' D' D ' 39' ' ' ILE . . . . . . . . . . . . . 72.2 mt -121.19 130.73 74.37 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.206 0 N-CA-C 109.911 -0.403 . . . . 18.780000000000001 109.911 179.222 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' D' D ' 40' ' ' SER . . . . . . . . . . . . . 78.0 p -92.24 119.18 31.6 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.233 -0.44 . . . . 22.210000000000001 110.74 176.506 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' D' D ' 41' ' ' ILE . . . . . . . . . . . . . 72.6 mt -129.59 116.91 40.53 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.244 0 N-CA-C 109.954 -0.387 . . . . 20.469999999999999 109.954 177.938 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' D' D ' 42' ' ' LEU . . . . . . . . . . . . . 69.8 mt 58.08 33.23 22.96 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.269 -0.423 . . . . 23.100000000000001 111.698 179.173 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' D' D ' 43' ' ' GLY . . . . . . . . . . . . . . . 80.9 -10.13 48.82 Favored Glycine 0 CA--C 1.535 1.293 0 C-N-CA 121.188 -0.53 . . . . 23.870000000000001 113.433 177.303 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' D' D ' 44' ' ' LYS . . . . . . . . . . . . . 94.6 mttt -99.05 137.33 37.73 Favored 'General case' 0 C--N 1.332 -0.173 0 CA-C-N 117.966 0.883 . . . . 21.23 110.285 178.622 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' D' D ' 45' ' ' GLU . . . . . . . . . . . . . 84.7 tt0 -85.21 130.61 34.57 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.257 -0.429 . . . . 20.640000000000001 111.474 -178.686 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' D' D ' 46' ' ' VAL . . . . . . . . . . . . . 7.4 p -125.37 126.2 70.26 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.22 0 N-CA-C 109.275 -0.639 . . . . 17.309999999999999 109.275 173.333 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' D' D ' 47' ' ' LYS . . . . . . . . . . . . . 9.7 mtmp? -101.46 131.27 47.67 Favored 'General case' 0 C--N 1.331 -0.23 0 CA-C-N 116.165 -0.47 . . . . 18.559999999999999 111.688 179.204 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' D' D ' 48' ' ' PHE . . . . . . . . . . . . . 92.2 m-85 -114.58 133.63 55.67 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 115.893 -0.594 . . . . 14.359999999999999 109.985 176.32 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' D' D ' 49' ' ' LYS . . . . . . . . . . . . . 60.7 tttm -105.33 137.61 42.86 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.743 -0.208 . . . . 14.4 110.559 179.065 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' D' D ' 50' ' ' VAL . . . . . . . . . . . . . 44.2 t -81.04 108.35 14.28 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.268 0 N-CA-C 109.275 -0.639 . . . . 14.82 109.275 175.862 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' D' D ' 51' ' ' VAL . . . . . . . . . . . . . 48.4 t -73.23 -47.35 47.23 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.351 0 CA-C-N 116.224 -0.443 . . . . 12.84 110.107 -173.821 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' D' D ' 52' ' ' GLN . . . . . . . . . . . . . 48.4 tt0 -162.54 136.82 6.5 Favored 'General case' 0 C--N 1.331 -0.234 0 C-N-CA 120.354 -0.538 . . . . 14.890000000000001 111.648 -178.378 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' D' D ' 53' ' ' ALA . . . . . . . . . . . . . . . -110.06 131.3 55.18 Favored 'General case' 0 C--N 1.332 -0.19 0 CA-C-N 115.852 -0.613 . . . . 16.93 109.891 175.482 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' D' D ' 54' ' ' TYR . . . . . . . . . . . . . 8.9 t80 -129.02 108.34 18.12 Favored Pre-proline 0 CA--C 1.534 0.361 0 CA-C-O 118.333 -0.842 . . . . 20.91 110.47 179.8 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' D' D ' 55' ' ' PRO . . . . . . . . . . . . . 74.2 Cg_endo -77.14 170.05 72.6 Favored 'Cis proline' 0 N--CA 1.5 1.858 0 CA-C-N 121.831 1.689 . . . . 21.899999999999999 112.481 -5.288 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' D' D ' 56' ' ' SER . . . . . . . . . . . . . 50.1 m -117.29 133.62 23.17 Favored Pre-proline 0 CA--C 1.538 0.515 0 CA-C-O 118.511 -0.757 . . . . 21.68 109.714 175.307 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' D' D ' 57' ' ' PRO . . . . . . . . . . . . . 38.0 Cg_endo -68.09 165.15 72.06 Favored 'Cis proline' 0 N--CA 1.496 1.666 0 CA-C-N 121.828 1.689 . . . . 23.309999999999999 111.217 -3.535 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' D' D ' 58' ' ' LEU . . . . . . . . . . . . . 25.0 tp -130.2 136.29 49.08 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-O 120.937 0.399 . . . . 20.079999999999998 110.891 -179.001 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' D' D ' 59' ' ' ARG . . . . . . . . . . . . . 55.8 ttp180 -101.73 124.39 47.3 Favored 'General case' 0 C--N 1.327 -0.377 0 N-CA-C 109.08 -0.711 . . . . 25.989999999999998 109.08 174.383 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' D' D ' 60' ' ' VAL . . . . . . . . . . . . . 41.3 t -82.12 122.49 36.96 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.304 0 C-N-CA 120.677 -0.409 . . . . 20.84 110.491 -174.538 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' D' D ' 61' ' ' GLU . . . . . . . . . . . . . 45.2 mt-10 -131.13 169.72 15.51 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 115.972 -0.558 . . . . 23.879999999999999 109.74 177.415 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' D' D ' 62' ' ' ASP . . . . . . . . . . . . . 6.9 p-10 -55.3 -32.32 62.34 Favored 'General case' 0 C--N 1.328 -0.366 0 N-CA-C 111.743 0.275 . . . . 23.34 111.743 -179.123 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' D' D ' 63' ' ' ARG . . . . . . . . . . . . . 40.2 ptt180 -77.63 -8.44 57.88 Favored 'General case' 0 CA--C 1.537 0.451 0 N-CA-C 113.669 0.988 . . . . 26.329999999999998 113.669 -176.415 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' D' D ' 64' ' ' THR . . . . . . . . . . . . . 36.9 m -77.29 136.68 38.51 Favored 'General case' 0 C--N 1.333 -0.116 0 CA-C-O 120.902 0.382 . . . . 19.899999999999999 110.73 -176.149 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' D' D ' 65' ' ' LYS . . . . . . . . . . . . . 61.2 mttm -89.51 127.6 35.88 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.026 -0.534 . . . . 19.120000000000001 110.031 178.043 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' D' D ' 66' ' ' ILE . . . . . . . . . . . . . 62.5 mt -113.31 127.78 70.44 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.284 0 N-CA-C 109.66 -0.496 . . . . 15.94 109.66 179.376 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' D' D ' 67' ' ' THR . . . . . . . . . . . . . 18.3 m -124.37 141.74 51.83 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.226 -0.443 . . . . 12.93 110.825 -176.925 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' D' D ' 68' ' ' LEU . . . . . . . . . . . . . 16.6 tp . . . . . 0 C--N 1.329 -0.313 0 CA-C-N 115.938 -0.574 . . . . 11.09 110.038 178.545 . . . . . . . . 0 0 . 1 . 001 nuclear orig core ' D' D ' 73' ' ' VAL . . . . . . . . . . . . . 34.9 m . . . . . 0 N--CA 1.461 0.122 0 CA-C-O 120.841 0.353 . . . . 1.46 110.578 . . . . . . . . . 0 0 . 1 . 001 nuclear orig core ' D' D ' 74' ' ' ASP . . . . . . . . . . . . . 21.5 t70 -100.57 118.49 36.85 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.088 -0.506 . . . . 0.93000000000000005 109.947 179.648 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' D' D ' 75' ' ' VAL . . . . . . . . . . . . . 43.9 t -113.97 122.38 67.97 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.213 0 CA-C-O 121.118 0.485 . . . . 1.3100000000000001 110.555 -177.654 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' D' D ' 76' ' ' LEU . . . . . . . . . . . . . 14.1 mt -125.92 138.26 53.76 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 115.52 -0.764 . . . . 1.8799999999999999 109.059 175.77 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' D' D ' 77' ' ' GLU . . . . . . . . . . . . . 73.3 tt0 -136.43 141.93 43.62 Favored 'General case' 0 C--N 1.332 -0.17 0 CA-C-O 121.118 0.485 . . . . 1.29 111.591 -173.762 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' D' D ' 78' ' ' ALA . . . . . . . . . . . . . . . -127.88 145.12 51.05 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 115.52 -0.764 . . . . 1.23 109.94 177.476 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' D' D ' 79' ' ' LYS . . . . . . . . . . . . . 45.8 mttm -81.48 123.86 28.97 Favored 'General case' 0 C--N 1.331 -0.234 0 C-N-CA 120.753 -0.379 . . . . 3.5600000000000001 110.688 178.913 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' D' D ' 80' ' ' ILE . . . . . . . . . . . . . 42.8 mm -138.46 113.7 9.23 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.343 0 N-CA-C 109.212 -0.662 . . . . 1.24 109.212 -179.15 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' D' D ' 81' ' ' LYS . . . . . . . . . . . . . 58.6 mttp -102.04 121.94 43.14 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-O 120.784 0.326 . . . . 3.6099999999999999 111.243 -176.536 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' D' D ' 82' ' ' GLY . . . . . . . . . . . . . . . 89.07 42.14 5.69 Favored Glycine 0 CA--C 1.525 0.702 0 C-N-CA 120.935 -0.65 . . . . 0.5 112.006 173.702 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' D' D ' 83' ' ' ILE . . . . . . . . . . . . . 76.3 mt -65.69 136.93 25.88 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.257 0 N-CA-C 109.765 -0.457 . . . . 1.2 109.765 177.113 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' D' D ' 84' ' ' LYS . . . . . . . . . . . . . 55.2 tttp -98.66 -53.63 3.25 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.21 -0.45 . . . . 2.1299999999999999 110.275 -178.757 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' D' D ' 85' ' ' ASP . . . . . . . . . . . . . 20.9 t0 -152.86 149.72 28.57 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 115.755 -0.657 . . . . 0.82999999999999996 110.28 -179.756 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' D' D ' 86' ' ' VAL . . . . . . . . . . . . . 40.5 t -133.79 131.16 56.42 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.286 0 CA-C-O 120.973 0.416 . . . . 1.1299999999999999 110.56 -179.702 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' D' D ' 87' ' ' ILE . . . . . . . . . . . . . 45.3 mm -119.85 129.54 75.27 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.243 0 CA-C-N 115.795 -0.639 . . . . 1.8700000000000001 109.695 176.857 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' D' D ' 88' ' ' LEU . . . . . . . . . . . . . 17.0 tp -112.6 135.75 52.96 Favored 'General case' 0 C--N 1.331 -0.203 0 CA-C-O 121.083 0.468 . . . . 2.23 111.289 -177.354 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' D' D ' 89' ' ' ASP . . . . . . . . . . . . . 20.6 t70 -128.62 155.11 45.48 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 115.545 -0.752 . . . . 0.88 109.253 174.587 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' D' D ' 90' ' ' GLU . . . . . . . . . . . . . 82.6 tt0 -46.97 -39.95 13.43 Favored 'General case' 0 C--N 1.33 -0.243 0 N-CA-C 112.964 0.727 . . . . 2.54 112.964 -171.887 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' D' D ' 91' ' ' ASN . . . . . . . . . . . . . 7.4 t-20 -132.07 37.85 3.55 Favored 'General case' 0 N--CA 1.463 0.189 0 CA-C-O 120.836 0.351 . . . . 2.8500000000000001 111.437 -177.223 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' D' D ' 92' ' ' LEU . . . . . . . . . . . . . 11.7 tp -166.09 140.37 4.43 Favored 'General case' 0 C--N 1.33 -0.246 0 C-N-CA 121.01 -0.276 . . . . 2.0499999999999998 110.602 -179.038 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' D' D ' 93' ' ' ILE . . . . . . . . . . . . . 71.3 mt -124.14 122.62 64.75 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.188 0 N-CA-C 109.653 -0.499 . . . . 1.1299999999999999 109.653 178.679 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' D' D ' 94' ' ' VAL . . . . . . . . . . . . . 42.9 t -120.77 125.07 73.64 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.214 0 N-CA-C 109.901 -0.407 . . . . 1.1499999999999999 109.901 179.52 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' D' D ' 95' ' ' VAL . . . . . . . . . . . . . 42.9 t -123.88 135.16 64.42 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.25 0 CA-C-N 116.097 -0.502 . . . . 1.1399999999999999 110.109 -178.448 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' D' D ' 96' ' ' ILE . . . . . . . . . . . . . 58.3 mt -116.59 128.49 73.94 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.28 0 N-CA-C 109.256 -0.646 . . . . 1.1499999999999999 109.256 178.37 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' D' D ' 97' ' ' THR . . . . . . . . . . . . . 81.2 p -103.7 155.79 18.3 Favored 'General case' 0 C--N 1.331 -0.222 0 CA-C-O 121.356 0.598 . . . . 1.1100000000000001 111.561 -176.74 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' D' D ' 98' ' ' GLU . . . . . . . . . . . . . 84.8 tt0 -54.0 -27.26 30.6 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 115.836 -0.62 . . . . 2.6699999999999999 112.191 179.504 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' D' D ' 99' ' ' GLU . . . . . . . . . . . . . 46.0 mp0 -78.93 16.2 0.94 Allowed 'General case' 0 CA--C 1.536 0.406 0 N-CA-C 113.123 0.786 . . . . 2.2999999999999998 113.123 -177.474 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' D' D ' 100' ' ' ASN . . . . . . . . . . . . . 1.8 m-20 63.59 37.34 10.37 Favored 'General case' 0 CA--C 1.529 0.147 0 CA-C-O 121.007 0.432 . . . . 0.62 110.945 176.757 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' D' D ' 101' ' ' GLU . . . . . . . . . . . . . 84.9 tt0 -116.52 144.69 44.03 Favored 'General case' 0 C--N 1.332 -0.157 0 CA-C-N 116.187 -0.461 . . . . 1.1000000000000001 109.892 176.88 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' D' D ' 102' ' ' VAL . . . . . . . . . . . . . 46.7 t -114.98 125.36 72.28 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.32 0 CA-C-N 116.116 -0.493 . . . . 1.1399999999999999 109.815 -179.206 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' D' D ' 103' ' ' LEU . . . . . . . . . . . . . 19.2 mt -117.36 128.93 55.52 Favored 'General case' 0 C--N 1.331 -0.219 0 CA-C-N 115.789 -0.642 . . . . 1.53 110.19 178.08 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' D' D ' 104' ' ' ILE . . . . . . . . . . . . . 71.9 mt -119.09 120.69 64.68 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.278 0 N-CA-C 110.042 -0.355 . . . . 1.1599999999999999 110.042 177.807 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' D' D ' 105' ' ' PHE . . . . . . . . . . . . . 97.4 m-85 -118.47 161.23 20.34 Favored 'General case' 0 C--N 1.332 -0.187 0 O-C-N 124.084 0.865 . . . . 0.45000000000000001 110.129 -178.627 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' D' D ' 106' ' ' ASN . . . . . . . . . . . . . 18.4 p-10 -93.26 -170.63 2.44 Favored 'General case' 0 C--N 1.329 -0.315 0 N-CA-C 109.805 -0.443 . . . . 0.56000000000000005 109.805 172.278 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' D' D ' 107' ' ' GLN . . . . . . . . . . . . . 48.8 tt0 -59.63 -30.2 68.54 Favored 'General case' 0 C--N 1.328 -0.336 0 N-CA-C 112.0 0.37 . . . . 2.23 112.0 -179.849 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' D' D ' 108' ' ' ASN . . . . . . . . . . . . . 13.1 t30 -85.55 8.29 19.86 Favored 'General case' 0 CA--C 1.536 0.428 0 N-CA-C 113.293 0.849 . . . . 1.8400000000000001 113.293 -177.292 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' D' D ' 109' ' ' LEU . . . . . . . . . . . . . 13.6 tp 61.97 43.76 8.84 Favored 'General case' 0 C--N 1.332 -0.18 0 CA-C-O 121.377 0.608 . . . . 1.9099999999999999 110.854 178.797 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' D' D ' 110' ' ' GLU . . . . . . . . . . . . . 77.7 mm-40 -114.23 143.66 44.48 Favored 'General case' 0 C--N 1.331 -0.224 0 CA-C-N 116.035 -0.53 . . . . 2.0800000000000001 109.998 176.557 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' D' D ' 111' ' ' GLU . . . . . . . . . . . . . 96.3 mt-10 -72.03 123.02 21.9 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-O 120.908 0.385 . . . . 1.9199999999999999 111.197 -177.392 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' D' D ' 112' ' ' LEU . . . . . . . . . . . . . 12.3 mt -108.09 -44.89 4.06 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 115.932 -0.576 . . . . 1.23 109.795 175.0 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' D' D ' 113' ' ' TYR . . . . . . . . . . . . . 71.9 t80 -136.62 132.32 34.9 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 115.969 -0.56 . . . . 1.1100000000000001 110.549 178.785 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' D' D ' 114' ' ' ARG . . . . . . . . . . . . . 56.3 ttp180 -139.74 121.75 15.66 Favored 'General case' 0 C--N 1.331 -0.225 0 CA-C-O 120.823 0.344 . . . . 4.0099999999999998 110.498 178.662 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' D' D ' 115' ' ' GLY . . . . . . . . . . . . . . . -150.12 163.07 29.39 Favored Glycine 0 CA--C 1.524 0.604 0 N-CA-C 110.949 -0.86 . . . . 0.56999999999999995 110.949 179.779 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' D' D ' 116' ' ' LYS . . . . . . . . . . . . . 40.2 ttpt -128.84 138.1 51.86 Favored 'General case' 0 C--N 1.331 -0.237 0 N-CA-C 110.098 -0.334 . . . . 2.1099999999999999 110.098 177.84 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' D' D ' 117' ' ' PHE . . . . . . . . . . . . . 42.6 m-85 -135.81 113.89 11.34 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-N 116.334 -0.394 . . . . 0.62 110.148 -177.757 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' D' D ' 118' ' ' GLU . . . . . . . . . . . . . 96.9 mt-10 -56.97 -43.74 81.93 Favored 'General case' 0 C--N 1.328 -0.338 0 C-N-CA 120.883 -0.327 . . . . 2.5899999999999999 110.832 -177.0 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' D' D ' 119' ' ' ASN . . . . . . . . . . . . . 10.1 m120 -96.44 30.98 2.36 Favored 'General case' 0 C--N 1.328 -0.349 0 N-CA-C 112.116 0.413 . . . . 2.2400000000000002 112.116 -174.765 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' D' D ' 120' ' ' LEU . . . . . . . . . . . . . 20.2 tp -57.7 120.0 7.61 Favored 'General case' 0 N--CA 1.461 0.104 0 N-CA-C 110.009 -0.367 . . . . 1.1899999999999999 110.009 176.854 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' D' D ' 121' ' ' ASN . . . . . . . . . . . . . 8.4 t-20 -111.95 -44.1 3.5 Favored 'General case' 0 C--N 1.332 -0.156 0 CA-C-N 116.597 -0.274 . . . . 2.0600000000000001 111.132 -175.423 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' D' D ' 122' ' ' LYS . . . . . . . . . . . . . 98.4 mttt -143.82 145.17 32.15 Favored 'General case' 0 C--N 1.33 -0.274 0 C-N-CA 120.691 -0.404 . . . . 2.3399999999999999 111.728 -177.316 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' D' D ' 123' ' ' VAL . . . . . . . . . . . . . 45.0 t -127.92 128.73 69.41 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.295 0 N-CA-C 109.383 -0.599 . . . . 1.24 109.383 175.318 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' D' D ' 124' ' ' LEU . . . . . . . . . . . . . 8.2 tp -130.81 134.73 47.09 Favored 'General case' 0 C--N 1.332 -0.179 0 CA-C-O 120.932 0.396 . . . . 2.2000000000000002 110.367 -178.292 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' D' D ' 125' ' ' VAL . . . . . . . . . . . . . 35.1 m -130.66 137.53 55.87 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.208 0 CA-C-N 116.251 -0.431 . . . . 2.3100000000000001 110.991 -178.551 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' D' D ' 126' ' ' ARG . . . . . . . . . . . . . 96.7 mtt-85 -148.71 119.21 7.4 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 115.947 -0.57 . . . . 3.8500000000000001 109.934 176.097 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' D' D ' 127' ' ' ASN . . . . . . . . . . . . . 2.0 t30 56.29 -149.06 0.47 Allowed 'General case' 0 CA--C 1.541 0.632 0 N-CA-C 109.723 -0.473 . . . . 2.9500000000000002 109.723 179.669 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' D' D ' 128' ' ' ASP . . . . . . . . . . . . . 11.8 p-10 -80.43 13.06 2.61 Favored 'General case' 0 CA--C 1.537 0.444 0 CA-C-N 118.78 0.718 . . . . 1.1799999999999999 112.93 -179.993 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' D' D ' 129' ' ' LEU . . . . . . . . . . . . . 15.7 tp -110.02 133.15 53.5 Favored 'General case' 0 C--O 1.232 0.175 0 CA-C-N 118.217 0.462 . . . . 2.4100000000000001 110.085 178.423 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' D' D ' 130' ' ' VAL . . . . . . . . . . . . . 41.4 t -122.65 139.81 48.37 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.308 0 CA-C-N 116.578 -0.283 . . . . 1.96 110.498 -176.987 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' D' D ' 131' ' ' VAL . . . . . . . . . . . . . 40.7 t -133.93 134.86 55.62 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.192 0 CA-C-O 121.087 0.47 . . . . 1.29 110.484 177.536 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' D' D ' 132' ' ' ILE . . . . . . . . . . . . . 72.3 mt -117.95 134.07 62.74 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.269 0 CA-C-N 115.61 -0.723 . . . . 1.1399999999999999 109.424 179.294 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' D' D ' 133' ' ' ILE . . . . . . . . . . . . . 29.7 mm -115.35 120.57 65.06 Favored 'Isoleucine or valine' 0 C--O 1.234 0.262 0 CA-C-N 116.5 -0.318 . . . . 1.25 110.763 -175.254 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' D' D ' 134' ' ' ASP . . . . . . . . . . . . . 5.6 p-10 -136.41 148.14 47.63 Favored 'General case' 0 C--N 1.331 -0.203 0 CA-C-N 116.327 -0.397 . . . . 0.59999999999999998 109.946 176.331 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' D' D ' 135' ' ' GLU . . . . . . . . . . . . . 84.6 tt0 -49.85 -28.46 6.51 Favored 'General case' 0 C--O 1.236 0.352 0 N-CA-C 112.582 0.586 . . . . 1.6799999999999999 112.582 -175.277 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' D' D ' 136' ' ' GLN . . . . . . . . . . . . . 94.8 mt-30 -78.26 -36.12 47.29 Favored 'General case' 0 C--N 1.331 -0.223 0 N-CA-C 112.414 0.524 . . . . 2.9399999999999999 112.414 -176.458 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' D' D ' 137' ' ' LYS . . . . . . . . . . . . . 35.3 pttt -170.06 177.0 4.44 Favored 'General case' 0 C--O 1.233 0.217 0 CA-C-O 121.827 0.822 . . . . 1.9399999999999999 113.117 -170.821 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' D' D ' 138' ' ' LEU . . . . . . . . . . . . . 9.5 tp -113.18 129.2 56.59 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 114.233 -1.348 . . . . 1.49 109.797 178.311 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' D' D ' 139' ' ' THR . . . . . . . . . . . . . 36.9 m -112.09 126.02 54.73 Favored 'General case' 0 C--N 1.331 -0.22 0 CA-C-O 120.673 0.273 . . . . 1.1699999999999999 110.616 179.197 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' D' D ' 140' ' ' LEU . . . . . . . . . . . . . 17.1 tp -115.01 124.28 51.23 Favored 'General case' 0 C--N 1.329 -0.299 0 N-CA-C 108.905 -0.776 . . . . 1.71 108.905 179.261 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' D' D ' 141' ' ' ILE . . . . . . . . . . . . . 20.0 mt -119.91 118.54 57.37 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.375 0 N-CA-C 109.808 -0.441 . . . . 1.2 109.808 -175.796 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' D' D ' 142' ' ' ARG . . . . . . . . . . . . . 74.3 ttt180 -109.75 124.02 50.53 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-N 115.141 -0.936 . . . . 3.3799999999999999 110.453 -175.472 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' D' D ' 143' ' ' THR . . . . . . . . . . . . . 22.6 p . . . . . 0 C--O 1.22 -0.485 0 CA-C-O 118.015 -0.993 . . . . 1.8600000000000001 110.601 -179.75 . . . . . . . . 0 0 . 1 . 001 nuclear orig core ' E' E ' 2' ' ' SER . . . . . . . . . . . . . 2.0 p . . . . . 0 N--CA 1.461 0.12 0 CA-C-O 121.075 0.464 . . . . 18.629999999999999 110.299 . . . . . . . . . 0 0 . 1 . 001 nuclear orig core ' E' E ' 3' ' ' GLU . . . . . . . . . . . . . 85.0 tt0 -140.33 139.14 35.37 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-N 115.711 -0.677 . . . . 15.99 110.869 -178.485 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' E' E ' 4' ' ' LEU . . . . . . . . . . . . . 18.8 tp -122.56 126.34 47.55 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 115.987 -0.551 . . . . 14.779999999999999 110.154 177.248 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' E' E ' 5' ' ' LYS . . . . . . . . . . . . . 91.4 mttt -103.43 120.31 40.58 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.238 -0.437 . . . . 12.050000000000001 110.319 178.028 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' E' E ' 6' ' ' LEU . . . . . . . . . . . . . 69.6 mt -118.32 149.9 40.4 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 115.565 -0.743 . . . . 12.51 110.437 -178.68 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' E' E ' 7' ' ' LYS . . . . . . . . . . . . . 59.8 tttm -135.67 141.69 38.06 Favored Pre-proline 0 CA--C 1.534 0.351 0 CA-C-O 119.192 -0.432 . . . . 10.039999999999999 110.039 176.976 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' E' E ' 8' ' ' PRO . . . . . . . . . . . . . 75.1 Cg_endo -88.52 136.97 3.39 Favored 'Trans proline' 0 N--CA 1.49 1.295 0 C-N-CA 121.643 1.562 . . . . 10.59 111.568 178.924 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' E' E ' 9' ' ' LEU . . . . . . . . . . . . . 81.8 mt -77.72 -52.17 1.7 Allowed Pre-proline 0 C--N 1.33 -0.258 0 CA-C-O 119.057 -0.497 . . . . 14.26 111.587 -177.95 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' E' E ' 10' ' ' PRO . . . . . . . . . . . . . 57.2 Cg_endo -73.19 148.3 43.9 Favored 'Trans proline' 0 N--CA 1.496 1.67 0 C-N-CA 121.049 1.166 . . . . 14.41 111.439 172.399 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' E' E ' 11' ' ' LYS . . . . . . . . . . . . . 63.9 mttp -82.91 97.34 8.63 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-O 120.84 0.352 . . . . 12.82 110.853 -179.124 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' E' E ' 12' ' ' VAL . . . . . . . . . . . . . 12.3 p -142.72 144.25 24.6 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.334 0 CA-C-N 116.09 -0.505 . . . . 14.699999999999999 110.422 178.802 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' E' E ' 13' ' ' GLU . . . . . . . . . . . . . 85.0 tt0 -87.0 129.39 34.9 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.312 -0.403 . . . . 14.369999999999999 109.947 177.539 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' E' E ' 14' ' ' LEU . . . . . . . . . . . . . 21.3 mt -91.36 148.19 37.07 Favored Pre-proline 0 CA--C 1.533 0.309 0 C-N-CA 120.804 -0.358 . . . . 13.59 110.51 -176.701 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' E' E ' 15' ' ' PRO . . . . . . . . . . . . . 26.5 Cg_exo -62.22 161.2 27.62 Favored 'Trans proline' 0 N--CA 1.496 1.632 0 C-N-CA 121.321 1.348 . . . . 16.550000000000001 111.84 175.497 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' E' E ' 16' ' ' PRO . . . . . . . . . . . . . 35.7 Cg_exo -59.08 -31.88 96.38 Favored 'Trans proline' 0 N--CA 1.496 1.673 0 C-N-CA 121.45 1.433 . . . . 16.629999999999999 112.704 -178.779 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' E' E ' 17' ' ' ASP . . . . . . . . . . . . . 3.0 p30 -93.58 8.5 40.54 Favored 'General case' 0 CA--C 1.535 0.403 0 N-CA-C 113.302 0.853 . . . . 17.129999999999999 113.302 -176.847 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' E' E ' 18' ' ' PHE . . . . . . . . . . . . . 47.4 t80 -57.93 -44.47 86.93 Favored 'General case' 0 C--N 1.334 -0.105 0 CA-C-N 118.098 0.408 . . . . 15.15 110.184 -178.074 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' E' E ' 19' ' ' VAL . . . . . . . . . . . . . 47.8 t -57.35 -42.95 81.44 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 CA-C-N 116.311 -0.404 . . . . 13.57 110.345 -178.624 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' E' E ' 20' ' ' ASP . . . . . . . . . . . . . 8.5 m-20 -59.2 -41.98 89.86 Favored 'General case' 0 C--N 1.329 -0.32 0 C-N-CA 120.85 -0.34 . . . . 16.079999999999998 110.554 -178.268 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' E' E ' 21' ' ' VAL . . . . . . . . . . . . . 47.1 t -64.78 -46.78 91.03 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.347 0 C-N-CA 120.829 -0.348 . . . . 17.34 110.612 -178.079 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' E' E ' 22' ' ' ILE . . . . . . . . . . . . . 48.3 mm -61.22 -34.65 61.48 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 C-N-CA 120.981 -0.287 . . . . 15.74 111.253 -178.303 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' E' E ' 23' ' ' ARG . . . . . . . . . . . . . 58.3 ttp180 -60.52 -51.58 68.82 Favored 'General case' 0 C--N 1.331 -0.235 0 C-N-CA 120.537 -0.465 . . . . 17.039999999999999 110.164 176.135 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' E' E ' 24' ' ' ILE . . . . . . . . . . . . . 78.5 mt -60.76 -39.3 81.3 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.323 0 CA-C-N 115.968 -0.56 . . . . 19.190000000000001 111.985 -176.467 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' E' E ' 25' ' ' LYS . . . . . . . . . . . . . 11.7 ptmm? -76.67 -39.39 52.28 Favored 'General case' 0 CA--C 1.535 0.37 0 N-CA-C 112.003 0.371 . . . . 19.210000000000001 112.003 -174.615 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' E' E ' 26' ' ' LEU . . . . . . . . . . . . . 30.6 mt -78.82 -32.34 46.19 Favored 'General case' 0 C--N 1.332 -0.183 0 N-CA-C 113.51 0.93 . . . . 18.899999999999999 113.51 -172.267 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' E' E ' 27' ' ' GLN . . . . . . . . . . . . . 10.6 pt20 -46.69 139.02 5.57 Favored 'General case' 0 N--CA 1.471 0.593 0 N-CA-C 112.862 0.689 . . . . 20.23 112.862 -175.481 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' E' E ' 28' ' ' GLY . . . . . . . . . . . . . . . 97.17 -22.17 42.2 Favored Glycine 0 CA--C 1.534 1.245 0 CA-C-N 115.554 -0.748 . . . . 22.390000000000001 112.554 -177.284 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' E' E ' 29' ' ' LYS . . . . . . . . . . . . . 93.1 mttt -98.29 155.14 17.34 Favored 'General case' 0 C--O 1.232 0.176 0 CA-C-N 117.419 0.609 . . . . 22.77 111.136 -179.469 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' E' E ' 30' ' ' THR . . . . . . . . . . . . . 30.5 m -105.68 139.33 40.44 Favored 'General case' 0 C--N 1.332 -0.191 0 CA-C-N 116.029 -0.532 . . . . 22.879999999999999 110.341 177.659 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' E' E ' 31' ' ' VAL . . . . . . . . . . . . . 34.8 m -131.15 154.11 40.15 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.21 0 CA-C-N 116.33 -0.395 . . . . 19.559999999999999 110.821 -179.766 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' E' E ' 32' ' ' ARG . . . . . . . . . . . . . 22.2 ttp180 -136.15 151.32 49.63 Favored 'General case' 0 C--N 1.331 -0.219 0 CA-C-O 121.225 0.535 . . . . 25.210000000000001 110.439 177.004 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' E' E ' 33' ' ' THR . . . . . . . . . . . . . 41.9 m -52.78 138.64 28.75 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 116.258 -0.428 . . . . 18.579999999999998 111.417 -179.228 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' E' E ' 34' ' ' GLY . . . . . . . . . . . . . . . 98.68 -17.1 58.84 Favored Glycine 0 CA--C 1.531 1.092 0 CA-C-N 116.048 -0.524 . . . . 18.030000000000001 113.369 177.312 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' E' E ' 35' ' ' ASP . . . . . . . . . . . . . 80.9 m-20 -66.6 147.39 53.34 Favored 'General case' 0 C--O 1.231 0.129 0 CA-C-N 118.015 0.907 . . . . 20.260000000000002 111.232 179.488 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' E' E ' 36' ' ' VAL . . . . . . . . . . . . . 44.1 t -121.13 128.2 75.99 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.264 0 N-CA-C 109.443 -0.577 . . . . 18.850000000000001 109.443 175.96 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' E' E ' 37' ' ' ILE . . . . . . . . . . . . . 66.4 mt -120.32 139.72 46.71 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.271 0 CA-C-N 116.328 -0.396 . . . . 18.440000000000001 110.156 -177.96 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' E' E ' 38' ' ' GLY . . . . . . . . . . . . . . . -108.22 128.57 9.18 Favored Glycine 0 CA--C 1.524 0.653 0 N-CA-C 110.884 -0.887 . . . . 19.379999999999999 110.884 177.739 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' E' E ' 39' ' ' ILE . . . . . . . . . . . . . 74.4 mt -124.48 135.31 64.22 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.193 0 N-CA-C 110.085 -0.339 . . . . 19.010000000000002 110.085 179.479 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' E' E ' 40' ' ' SER . . . . . . . . . . . . . 34.6 t -92.56 116.96 29.46 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.433 -0.349 . . . . 22.530000000000001 110.86 176.241 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' E' E ' 41' ' ' ILE . . . . . . . . . . . . . 48.5 mm -128.94 128.16 67.03 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.19 0 CA-C-O 120.778 0.323 . . . . 20.190000000000001 110.407 179.37 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' E' E ' 42' ' ' LEU . . . . . . . . . . . . . 56.7 mt 54.59 33.03 18.24 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.194 -0.457 . . . . 22.670000000000002 111.856 177.824 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' E' E ' 43' ' ' GLY . . . . . . . . . . . . . . . 71.16 28.74 69.68 Favored Glycine 0 CA--C 1.532 1.106 0 C-N-CA 121.109 -0.567 . . . . 24.109999999999999 112.176 177.872 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' E' E ' 44' ' ' LYS . . . . . . . . . . . . . 45.9 tttp -141.75 137.7 31.81 Favored 'General case' 0 C--N 1.33 -0.263 0 N-CA-C 109.773 -0.454 . . . . 21.449999999999999 109.773 179.464 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' E' E ' 45' ' ' GLU . . . . . . . . . . . . . 83.7 tt0 -82.36 126.64 32.4 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-O 120.934 0.397 . . . . 21.32 111.18 -176.993 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' E' E ' 46' ' ' VAL . . . . . . . . . . . . . 7.6 p -124.32 129.83 73.84 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.222 0 N-CA-C 109.367 -0.605 . . . . 17.640000000000001 109.367 175.822 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' E' E ' 47' ' ' LYS . . . . . . . . . . . . . 98.7 mttt -101.07 132.61 46.43 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.087 -0.506 . . . . 19.539999999999999 111.364 179.799 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' E' E ' 48' ' ' PHE . . . . . . . . . . . . . 92.3 m-85 -117.01 132.02 56.8 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.267 -0.424 . . . . 14.77 110.364 176.952 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' E' E ' 49' ' ' LYS . . . . . . . . . . . . . 84.6 tttt -106.78 137.28 45.11 Favored 'General case' 0 C--N 1.331 -0.23 0 CA-C-N 116.503 -0.317 . . . . 14.890000000000001 110.45 178.045 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' E' E ' 50' ' ' VAL . . . . . . . . . . . . . 44.7 t -84.29 111.13 19.68 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.258 0 N-CA-C 109.245 -0.65 . . . . 15.1 109.245 175.701 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' E' E ' 51' ' ' VAL . . . . . . . . . . . . . 46.8 t -72.66 -46.72 53.37 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.317 0 CA-C-N 116.265 -0.425 . . . . 13.279999999999999 110.053 -174.269 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' E' E ' 52' ' ' GLN . . . . . . . . . . . . . 46.9 tt0 -169.04 142.6 2.87 Favored 'General case' 0 C--N 1.331 -0.205 0 C-N-CA 120.295 -0.562 . . . . 15.119999999999999 111.776 -178.922 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' E' E ' 53' ' ' ALA . . . . . . . . . . . . . . . -116.13 135.41 53.95 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-N 115.714 -0.675 . . . . 17.09 110.106 176.589 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' E' E ' 54' ' ' TYR . . . . . . . . . . . . . 62.5 t80 -128.94 109.23 18.34 Favored Pre-proline 0 CA--C 1.536 0.427 0 CA-C-O 118.26 -0.876 . . . . 20.390000000000001 110.181 178.688 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' E' E ' 55' ' ' PRO . . . . . . . . . . . . . 74.0 Cg_endo -77.09 170.06 72.65 Favored 'Cis proline' 0 N--CA 1.499 1.826 0 CA-C-N 121.81 1.682 . . . . 21.440000000000001 112.445 -4.544 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' E' E ' 56' ' ' SER . . . . . . . . . . . . . 13.6 m -113.99 126.96 27.34 Favored Pre-proline 0 CA--C 1.538 0.498 0 CA-C-O 118.405 -0.807 . . . . 22.329999999999998 109.476 176.28 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' E' E ' 57' ' ' PRO . . . . . . . . . . . . . 56.9 Cg_endo -72.64 169.04 73.39 Favored 'Cis proline' 0 N--CA 1.497 1.704 0 CA-C-N 122.083 1.78 . . . . 24.07 111.848 -0.096 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' E' E ' 58' ' ' LEU . . . . . . . . . . . . . 28.9 tp -130.0 137.7 50.42 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.139 -0.482 . . . . 19.780000000000001 110.294 179.95 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' E' E ' 59' ' ' ARG . . . . . . . . . . . . . 52.2 ttp180 -105.19 128.75 53.55 Favored 'General case' 0 C--N 1.328 -0.35 0 N-CA-C 109.239 -0.652 . . . . 24.93 109.239 176.106 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' E' E ' 60' ' ' VAL . . . . . . . . . . . . . 41.9 t -85.39 119.08 33.38 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.272 0 C-N-CA 120.607 -0.437 . . . . 18.940000000000001 110.919 -173.992 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' E' E ' 61' ' ' GLU . . . . . . . . . . . . . 47.2 mt-10 -131.03 170.11 14.94 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 115.703 -0.68 . . . . 21.280000000000001 109.492 174.29 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' E' E ' 62' ' ' ASP . . . . . . . . . . . . . 4.5 m-20 -53.23 -32.67 49.46 Favored 'General case' 0 C--N 1.329 -0.308 0 N-CA-C 111.925 0.343 . . . . 19.550000000000001 111.925 -177.609 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' E' E ' 63' ' ' ARG . . . . . . . . . . . . . 98.2 mtt180 -73.13 -22.0 60.62 Favored 'General case' 0 CA--C 1.533 0.289 0 N-CA-C 113.038 0.755 . . . . 22.420000000000002 113.038 -176.188 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' E' E ' 64' ' ' THR . . . . . . . . . . . . . 26.7 m -66.42 137.24 56.71 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-O 120.983 0.42 . . . . 17.350000000000001 111.061 -174.692 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' E' E ' 65' ' ' LYS . . . . . . . . . . . . . 67.5 mttm -89.71 129.79 36.08 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 115.927 -0.579 . . . . 16.41 109.967 177.207 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' E' E ' 66' ' ' ILE . . . . . . . . . . . . . 63.2 mt -118.83 129.57 74.86 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.287 0 N-CA-C 109.849 -0.426 . . . . 13.67 109.849 -179.775 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' E' E ' 67' ' ' THR . . . . . . . . . . . . . 25.9 m -127.38 139.82 52.59 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-O 120.95 0.405 . . . . 10.800000000000001 110.994 -178.165 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' E' E ' 68' ' ' LEU . . . . . . . . . . . . . 65.4 mt . . . . . 0 C--N 1.331 -0.226 0 CA-C-N 116.056 -0.52 . . . . 9.0999999999999996 110.528 177.912 . . . . . . . . 0 0 . 1 . 001 nuclear orig core ' E' E ' 73' ' ' VAL . . . . . . . . . . . . . 26.9 m . . . . . 0 C--O 1.232 0.138 0 CA-C-O 120.972 0.415 . . . . 1.3600000000000001 110.452 . . . . . . . . . 0 0 . 1 . 001 nuclear orig core ' E' E ' 74' ' ' ASP . . . . . . . . . . . . . 21.6 t0 -96.08 119.91 35.42 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 115.907 -0.588 . . . . 0.95999999999999996 109.544 179.853 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' E' E ' 75' ' ' VAL . . . . . . . . . . . . . 41.8 t -107.54 119.32 56.93 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.268 0 CA-C-O 121.071 0.462 . . . . 1.28 110.233 -178.973 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' E' E ' 76' ' ' LEU . . . . . . . . . . . . . 34.8 mt -115.11 137.86 51.54 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 115.592 -0.731 . . . . 1.8200000000000001 109.435 177.232 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' E' E ' 77' ' ' GLU . . . . . . . . . . . . . 98.0 mt-10 -134.06 131.45 38.84 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-O 121.064 0.459 . . . . 1.1699999999999999 111.061 -177.769 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' E' E ' 78' ' ' ALA . . . . . . . . . . . . . . . -119.1 124.07 45.99 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 115.654 -0.703 . . . . 1.25 109.625 176.419 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' E' E ' 79' ' ' LYS . . . . . . . . . . . . . 7.8 ttpm? -74.58 122.82 23.73 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-O 120.876 0.369 . . . . 3.4300000000000002 110.615 -177.162 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' E' E ' 80' ' ' ILE . . . . . . . . . . . . . 39.6 mm -139.06 113.72 7.84 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.298 0 N-CA-C 109.009 -0.737 . . . . 1.22 109.009 -178.443 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' E' E ' 81' ' ' LYS . . . . . . . . . . . . . 29.2 tttp -98.94 118.12 35.0 Favored 'General case' 0 C--N 1.327 -0.397 0 CA-C-N 116.524 -0.307 . . . . 3.4300000000000002 110.646 -175.381 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' E' E ' 82' ' ' GLY . . . . . . . . . . . . . . . 89.16 42.32 5.62 Favored Glycine 0 CA--C 1.527 0.818 0 C-N-CA 120.421 -0.895 . . . . 0.64000000000000001 112.058 175.282 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' E' E ' 83' ' ' ILE . . . . . . . . . . . . . 77.1 mt -61.67 142.37 16.37 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.293 0 N-CA-C 109.704 -0.48 . . . . 1.22 109.704 175.994 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' E' E ' 84' ' ' LYS . . . . . . . . . . . . . 84.9 tttt -98.68 -54.02 3.14 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.11 -0.495 . . . . 2.1400000000000001 110.536 -178.293 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' E' E ' 85' ' ' ASP . . . . . . . . . . . . . 11.6 t70 -156.37 155.67 32.58 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 115.769 -0.651 . . . . 0.82999999999999996 110.254 -178.912 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' E' E ' 86' ' ' VAL . . . . . . . . . . . . . 43.5 t -129.28 130.86 67.86 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.268 0 CA-C-O 121.048 0.451 . . . . 1.1599999999999999 110.622 -178.308 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' E' E ' 87' ' ' ILE . . . . . . . . . . . . . 44.1 mm -118.74 122.81 70.34 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.281 0 CA-C-N 115.651 -0.704 . . . . 2.1000000000000001 109.249 175.653 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' E' E ' 88' ' ' LEU . . . . . . . . . . . . . 14.4 tp -115.03 131.7 56.84 Favored 'General case' 0 C--N 1.331 -0.217 0 CA-C-O 121.014 0.435 . . . . 2.1899999999999999 111.256 -176.072 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' E' E ' 89' ' ' ASP . . . . . . . . . . . . . 21.3 t70 -125.5 154.41 42.12 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 115.788 -0.642 . . . . 0.91000000000000003 109.472 175.427 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' E' E ' 90' ' ' GLU . . . . . . . . . . . . . 48.1 mt-10 -49.46 -34.43 16.79 Favored 'General case' 0 C--N 1.328 -0.336 0 N-CA-C 112.845 0.683 . . . . 2.25 112.845 -171.653 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' E' E ' 91' ' ' ASN . . . . . . . . . . . . . 37.6 p-10 -132.0 32.2 4.07 Favored 'General case' 0 N--CA 1.466 0.33 0 N-CA-C 112.17 0.433 . . . . 2.8999999999999999 112.17 -176.096 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' E' E ' 92' ' ' LEU . . . . . . . . . . . . . 16.0 tp -166.04 141.75 4.87 Favored 'General case' 0 C--N 1.329 -0.292 0 C-N-CA 120.886 -0.326 . . . . 2.02 110.668 179.56 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' E' E ' 93' ' ' ILE . . . . . . . . . . . . . 69.1 mt -121.45 121.75 65.43 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.217 0 N-CA-C 109.722 -0.473 . . . . 1.21 109.722 -179.583 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' E' E ' 94' ' ' VAL . . . . . . . . . . . . . 45.1 t -122.74 126.64 74.21 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.202 0 N-CA-C 109.969 -0.382 . . . . 1.1799999999999999 109.969 179.212 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' E' E ' 95' ' ' VAL . . . . . . . . . . . . . 42.2 t -124.0 135.88 62.15 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.307 0 CA-C-N 116.276 -0.42 . . . . 1.3899999999999999 110.01 -179.377 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' E' E ' 96' ' ' ILE . . . . . . . . . . . . . 59.2 mt -115.38 132.46 64.66 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.248 0 N-CA-C 109.429 -0.582 . . . . 1.1799999999999999 109.429 179.408 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' E' E ' 97' ' ' THR . . . . . . . . . . . . . 68.9 p -103.56 158.92 16.03 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-O 120.906 0.384 . . . . 1.24 110.782 -179.579 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' E' E ' 98' ' ' GLU . . . . . . . . . . . . . 96.9 mt-10 -53.85 -24.21 15.04 Favored 'General case' 0 CA--C 1.533 0.327 0 N-CA-C 112.413 0.523 . . . . 2.6299999999999999 112.413 -179.983 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' E' E ' 99' ' ' GLU . . . . . . . . . . . . . 95.3 mt-10 -78.43 14.36 1.27 Allowed 'General case' 0 CA--C 1.535 0.385 0 N-CA-C 113.218 0.821 . . . . 2.6200000000000001 113.218 -176.7 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' E' E ' 100' ' ' ASN . . . . . . . . . . . . . 2.7 m-20 61.8 38.03 15.11 Favored 'General case' 0 N--CA 1.463 0.193 0 CA-C-O 121.148 0.499 . . . . 0.76000000000000001 110.922 179.221 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' E' E ' 101' ' ' GLU . . . . . . . . . . . . . 61.2 tt0 -119.98 142.35 48.86 Favored 'General case' 0 C--N 1.331 -0.217 0 CA-C-N 116.093 -0.503 . . . . 0.84999999999999998 109.673 176.404 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' E' E ' 102' ' ' VAL . . . . . . . . . . . . . 46.3 t -115.25 130.19 70.22 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.291 0 CA-C-N 116.227 -0.442 . . . . 1.21 110.162 -178.521 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' E' E ' 103' ' ' LEU . . . . . . . . . . . . . 20.0 mt -117.35 133.93 55.41 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 115.502 -0.772 . . . . 1.75 110.066 176.221 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' E' E ' 104' ' ' ILE . . . . . . . . . . . . . 67.0 mt -119.48 124.91 73.81 Favored 'Isoleucine or valine' 0 C--O 1.234 0.284 0 N-CA-C 110.192 -0.299 . . . . 1.1799999999999999 110.192 179.912 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' E' E ' 105' ' ' PHE . . . . . . . . . . . . . 67.4 m-85 -123.92 163.4 21.39 Favored 'General case' 0 C--O 1.232 0.151 0 O-C-N 124.013 0.821 . . . . 0.58999999999999997 110.182 -179.444 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' E' E ' 106' ' ' ASN . . . . . . . . . . . . . 40.1 p30 -98.39 -171.94 2.23 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.421 -0.354 . . . . 0.72999999999999998 110.327 175.651 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' E' E ' 107' ' ' GLN . . . . . . . . . . . . . 59.5 tt0 -58.37 -29.53 66.08 Favored 'General case' 0 CA--C 1.534 0.329 0 N-CA-C 111.858 0.318 . . . . 1.77 111.858 178.774 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' E' E ' 108' ' ' ASN . . . . . . . . . . . . . 7.5 t-20 -83.24 10.95 7.29 Favored 'General case' 0 CA--C 1.536 0.422 0 N-CA-C 112.933 0.716 . . . . 2.1200000000000001 112.933 -177.729 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' E' E ' 109' ' ' LEU . . . . . . . . . . . . . 12.5 tp 54.82 37.66 28.91 Favored 'General case' 0 C--N 1.332 -0.169 0 CA-C-O 121.023 0.44 . . . . 2.02 111.08 -179.509 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' E' E ' 110' ' ' GLU . . . . . . . . . . . . . 95.4 mt-10 -104.78 145.91 29.7 Favored 'General case' 0 C--N 1.331 -0.224 0 N-CA-C 109.704 -0.48 . . . . 1.8899999999999999 109.704 175.275 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' E' E ' 111' ' ' GLU . . . . . . . . . . . . . 80.2 tt0 -83.69 122.15 28.24 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.401 -0.363 . . . . 1.3200000000000001 110.747 -175.783 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' E' E ' 112' ' ' LEU . . . . . . . . . . . . . 49.4 mt -109.14 -45.26 3.79 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-N 116.095 -0.502 . . . . 1.3400000000000001 111.128 -179.275 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' E' E ' 113' ' ' TYR . . . . . . . . . . . . . 58.0 t80 -132.96 137.58 46.62 Favored 'General case' 0 N--CA 1.464 0.238 0 CA-C-O 120.839 0.352 . . . . 1.0600000000000001 111.36 -176.828 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' E' E ' 114' ' ' ARG . . . . . . . . . . . . . 47.5 ttp180 -138.73 123.66 18.88 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 115.831 -0.622 . . . . 3.1800000000000002 110.123 177.361 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' E' E ' 115' ' ' GLY . . . . . . . . . . . . . . . -150.14 140.09 7.78 Favored Glycine 0 CA--C 1.526 0.719 0 C-N-CA 120.737 -0.744 . . . . 0.5 111.356 178.732 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' E' E ' 116' ' ' LYS . . . . . . . . . . . . . 27.5 ttpp -110.37 134.59 52.15 Favored 'General case' 0 C--N 1.33 -0.24 0 N-CA-C 109.748 -0.464 . . . . 2.3100000000000001 109.748 176.618 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' E' E ' 117' ' ' PHE . . . . . . . . . . . . . 31.7 m-85 -135.57 113.9 11.52 Favored 'General case' 0 C--N 1.332 -0.191 0 C-N-CA 120.871 -0.331 . . . . 0.65000000000000002 110.158 -176.817 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' E' E ' 118' ' ' GLU . . . . . . . . . . . . . 96.3 mt-10 -55.59 -45.71 77.36 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.519 -0.31 . . . . 2.4500000000000002 111.176 -176.191 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' E' E ' 119' ' ' ASN . . . . . . . . . . . . . 68.3 m-80 -95.99 30.0 2.56 Favored 'General case' 0 C--N 1.329 -0.287 0 N-CA-C 112.22 0.452 . . . . 2.1200000000000001 112.22 -174.172 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' E' E ' 120' ' ' LEU . . . . . . . . . . . . . 22.0 tp -58.39 122.13 12.54 Favored 'General case' 0 C--N 1.333 -0.149 0 N-CA-C 110.027 -0.36 . . . . 1.26 110.027 177.509 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' E' E ' 121' ' ' ASN . . . . . . . . . . . . . 68.2 m-20 -113.99 -44.07 3.19 Favored 'General case' 0 C--O 1.232 0.147 0 CA-C-N 116.534 -0.303 . . . . 2.2999999999999998 111.094 -178.081 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' E' E ' 122' ' ' LYS . . . . . . . . . . . . . 60.7 mttm -145.1 149.51 35.16 Favored 'General case' 0 C--N 1.332 -0.18 0 CA-C-O 121.28 0.562 . . . . 2.3500000000000001 112.064 -177.028 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' E' E ' 123' ' ' VAL . . . . . . . . . . . . . 47.3 t -126.68 129.66 71.59 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.239 0 CA-C-N 115.627 -0.715 . . . . 1.1599999999999999 109.461 175.536 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' E' E ' 124' ' ' LEU . . . . . . . . . . . . . 57.6 mt -121.98 139.56 53.53 Favored 'General case' 0 N--CA 1.463 0.212 0 CA-C-N 116.551 -0.295 . . . . 1.8799999999999999 110.792 -178.114 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' E' E ' 125' ' ' VAL . . . . . . . . . . . . . 34.3 m -137.23 139.87 43.25 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.239 0 CA-C-O 121.042 0.448 . . . . 2.1600000000000001 111.603 -178.723 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' E' E ' 126' ' ' ARG . . . . . . . . . . . . . 93.4 mtt-85 -147.77 115.57 6.41 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 115.687 -0.688 . . . . 3.9700000000000002 110.19 174.207 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' E' E ' 127' ' ' ASN . . . . . . . . . . . . . 93.4 m-20 53.79 -129.92 2.21 Favored 'General case' 0 CA--C 1.545 0.786 0 CA-C-O 118.557 -0.735 . . . . 2.79 110.552 179.578 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' E' E ' 128' ' ' ASP . . . . . . . . . . . . . 5.1 p30 -91.82 5.78 48.6 Favored 'General case' 0 CA--C 1.536 0.42 0 CA-C-N 120.078 1.308 . . . . 1.0 113.457 -178.216 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' E' E ' 129' ' ' LEU . . . . . . . . . . . . . 15.3 tp -105.41 134.51 48.41 Favored 'General case' 0 C--N 1.333 -0.115 0 CA-C-N 118.17 0.441 . . . . 2.3100000000000001 109.834 178.555 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' E' E ' 130' ' ' VAL . . . . . . . . . . . . . 12.4 p -132.17 143.32 40.37 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.165 0 CA-C-O 121.019 0.438 . . . . 1.9099999999999999 110.705 -177.943 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' E' E ' 131' ' ' VAL . . . . . . . . . . . . . 38.9 t -136.0 140.09 44.66 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.278 0 CA-C-N 116.034 -0.53 . . . . 1.54 110.437 -179.086 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' E' E ' 132' ' ' ILE . . . . . . . . . . . . . 76.3 mt -114.98 133.88 59.78 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.288 0 CA-C-N 115.67 -0.695 . . . . 1.25 109.472 179.515 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' E' E ' 133' ' ' ILE . . . . . . . . . . . . . 38.0 mm -116.57 119.16 61.14 Favored 'Isoleucine or valine' 0 C--O 1.236 0.345 0 CA-C-N 116.537 -0.301 . . . . 1.1399999999999999 110.989 -175.58 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' E' E ' 134' ' ' ASP . . . . . . . . . . . . . 5.8 p-10 -135.21 148.5 49.65 Favored 'General case' 0 C--N 1.332 -0.167 0 N-CA-C 109.809 -0.441 . . . . 0.56000000000000005 109.809 174.753 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' E' E ' 135' ' ' GLU . . . . . . . . . . . . . 44.6 tp10 -50.01 -28.06 6.41 Favored 'General case' 0 C--N 1.329 -0.323 0 N-CA-C 112.702 0.63 . . . . 2.0099999999999998 112.702 -172.222 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' E' E ' 136' ' ' GLN . . . . . . . . . . . . . 95.9 mt-30 -81.98 -37.63 26.33 Favored 'General case' 0 C--O 1.234 0.272 0 N-CA-C 112.683 0.623 . . . . 2.8799999999999999 112.683 -175.694 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' E' E ' 137' ' ' LYS . . . . . . . . . . . . . 20.3 pttp -160.47 169.52 22.85 Favored 'General case' 0 C--O 1.234 0.251 0 CA-C-O 121.825 0.821 . . . . 2.27 113.192 -169.801 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' E' E ' 138' ' ' LEU . . . . . . . . . . . . . 7.7 tp -111.96 127.83 55.98 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 114.085 -1.416 . . . . 1.28 109.459 177.859 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' E' E ' 139' ' ' THR . . . . . . . . . . . . . 27.3 m -113.59 123.59 50.33 Favored 'General case' 0 C--N 1.331 -0.221 0 CA-C-O 120.614 0.245 . . . . 1.1200000000000001 110.39 178.699 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' E' E ' 140' ' ' LEU . . . . . . . . . . . . . 8.1 tp -113.36 121.39 44.21 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 115.884 -0.598 . . . . 1.5900000000000001 109.44 -179.439 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' E' E ' 141' ' ' ILE . . . . . . . . . . . . . 19.4 mt -121.14 122.79 68.46 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.307 0 CA-C-O 121.053 0.454 . . . . 1.1899999999999999 109.791 -176.218 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' E' E ' 142' ' ' ARG . . . . . . . . . . . . . 50.6 ttp180 -117.35 129.46 55.89 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 115.382 -0.826 . . . . 3.54 110.587 -175.51 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' E' E ' 143' ' ' THR . . . . . . . . . . . . . 11.6 p . . . . . 0 C--O 1.22 -0.458 0 CA-C-O 117.938 -1.03 . . . . 1.5700000000000001 110.603 179.642 . . . . . . . . 0 0 . 1 . 001 nuclear orig core ' F' F ' 1' ' ' MET . . . . . . . . . . . . . 26.2 ptt? . . . . . 0 C--O 1.231 0.102 0 CA-C-O 120.945 0.402 . . . . 23.050000000000001 111.283 . . . . . . . . . 0 0 . 1 . 001 nuclear orig core ' F' F ' 2' ' ' SER . . . . . . . . . . . . . 4.4 p -121.85 135.71 54.91 Favored 'General case' 0 C--N 1.332 -0.187 0 CA-C-N 116.001 -0.545 . . . . 20.539999999999999 110.4 177.243 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' F' F ' 3' ' ' GLU . . . . . . . . . . . . . 46.0 mt-10 -141.25 142.74 33.9 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.218 -0.446 . . . . 17.77 111.133 -178.055 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' F' F ' 4' ' ' LEU . . . . . . . . . . . . . 13.5 tp -127.24 133.25 50.24 Favored 'General case' 0 C--N 1.331 -0.202 0 CA-C-N 115.886 -0.597 . . . . 15.619999999999999 109.989 176.813 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' F' F ' 5' ' ' LYS . . . . . . . . . . . . . 92.6 mttt -112.99 120.68 42.22 Favored 'General case' 0 C--O 1.234 0.273 0 CA-C-N 116.409 -0.359 . . . . 13.210000000000001 110.952 -179.573 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' F' F ' 6' ' ' LEU . . . . . . . . . . . . . 35.6 mt -113.91 149.06 35.73 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 115.289 -0.869 . . . . 12.93 110.23 179.713 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' F' F ' 7' ' ' LYS . . . . . . . . . . . . . 42.6 tttt -139.71 142.01 29.9 Favored Pre-proline 0 CA--C 1.533 0.307 0 CA-C-O 119.176 -0.44 . . . . 10.09 110.248 174.553 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' F' F ' 8' ' ' PRO . . . . . . . . . . . . . 85.5 Cg_endo -91.62 139.58 2.32 Favored 'Trans proline' 0 N--CA 1.489 1.241 0 C-N-CA 121.838 1.692 . . . . 10.43 111.782 177.997 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' F' F ' 9' ' ' LEU . . . . . . . . . . . . . 83.6 mt -70.1 -47.57 21.38 Favored Pre-proline 0 CA--C 1.533 0.293 0 CA-C-O 118.656 -0.688 . . . . 14.039999999999999 111.975 179.612 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' F' F ' 10' ' ' PRO . . . . . . . . . . . . . 84.4 Cg_endo -80.52 151.52 19.79 Favored 'Trans proline' 0 N--CA 1.495 1.586 0 C-N-CA 121.172 1.248 . . . . 14.01 111.859 175.615 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' F' F ' 11' ' ' LYS . . . . . . . . . . . . . 28.0 ttpt -83.69 103.75 13.25 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-O 120.81 0.338 . . . . 12.33 110.183 178.286 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' F' F ' 12' ' ' VAL . . . . . . . . . . . . . 12.7 p -141.02 147.41 22.59 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.258 0 CA-C-N 116.164 -0.471 . . . . 14.52 110.574 -178.589 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' F' F ' 13' ' ' GLU . . . . . . . . . . . . . 95.2 mt-10 -85.92 124.89 32.89 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 116.349 -0.387 . . . . 14.23 110.376 179.152 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' F' F ' 14' ' ' LEU . . . . . . . . . . . . . 30.9 mt -99.48 147.37 33.25 Favored Pre-proline 0 CA--C 1.532 0.284 0 CA-C-O 119.163 -0.446 . . . . 14.0 110.471 -179.186 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' F' F ' 15' ' ' PRO . . . . . . . . . . . . . 24.0 Cg_exo -63.85 154.65 68.55 Favored 'Trans proline' 0 N--CA 1.499 1.836 0 C-N-CA 121.354 1.369 . . . . 17.510000000000002 112.07 176.964 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' F' F ' 16' ' ' PRO . . . . . . . . . . . . . 39.8 Cg_exo -59.45 -35.58 95.78 Favored 'Trans proline' 0 N--CA 1.498 1.738 0 C-N-CA 121.368 1.379 . . . . 18.039999999999999 112.381 177.836 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' F' F ' 17' ' ' ASP . . . . . . . . . . . . . 6.1 p-10 -82.92 11.87 5.59 Favored 'General case' 0 C--N 1.327 -0.398 0 N-CA-C 112.95 0.722 . . . . 18.760000000000002 112.95 -179.341 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' F' F ' 18' ' ' PHE . . . . . . . . . . . . . 36.7 t80 -57.34 -44.17 84.05 Favored 'General case' 0 C--O 1.227 -0.11 0 O-C-N 121.914 -0.491 . . . . 15.65 110.196 -178.523 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' F' F ' 19' ' ' VAL . . . . . . . . . . . . . 47.4 t -55.55 -42.1 66.84 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.29 0 CA-C-N 116.417 -0.356 . . . . 15.15 110.786 -177.825 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' F' F ' 20' ' ' ASP . . . . . . . . . . . . . 5.2 t70 -60.14 -44.1 95.2 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-O 120.9 0.381 . . . . 18.079999999999998 110.969 -177.498 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' F' F ' 21' ' ' VAL . . . . . . . . . . . . . 47.5 t -65.6 -47.91 84.58 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.307 0 C-N-CA 120.576 -0.449 . . . . 18.440000000000001 110.593 -178.625 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' F' F ' 22' ' ' ILE . . . . . . . . . . . . . 49.1 mm -55.45 -58.46 4.53 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.315 0 C-N-CA 121.119 -0.232 . . . . 16.719999999999999 111.151 -177.976 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' F' F ' 23' ' ' ARG . . . . . . . . . . . . . 6.1 ptm180 -54.99 -44.0 74.06 Favored 'General case' 0 CA--C 1.53 0.189 0 C-N-CA 120.54 -0.464 . . . . 19.530000000000001 111.632 -173.696 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' F' F ' 24' ' ' ILE . . . . . . . . . . . . . 85.0 mt -60.06 -43.46 92.76 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.223 0 C-N-CA 120.796 -0.361 . . . . 20.960000000000001 111.404 -177.362 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' F' F ' 25' ' ' LYS . . . . . . . . . . . . . 93.3 mttt -71.55 -43.85 65.63 Favored 'General case' 0 C--N 1.33 -0.281 0 N-CA-C 112.823 0.675 . . . . 19.960000000000001 112.823 -177.933 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' F' F ' 26' ' ' LEU . . . . . . . . . . . . . 79.0 mt -79.04 -27.36 43.16 Favored 'General case' 0 C--N 1.329 -0.289 0 N-CA-C 113.777 1.029 . . . . 19.690000000000001 113.777 -169.301 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' F' F ' 27' ' ' GLN . . . . . . . . . . . . . 10.4 pt20 -46.78 139.83 5.07 Favored 'General case' 0 N--CA 1.469 0.523 0 N-CA-C 112.894 0.702 . . . . 21.809999999999999 112.894 -175.741 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' F' F ' 28' ' ' GLY . . . . . . . . . . . . . . . 100.66 -20.41 48.28 Favored Glycine 0 CA--C 1.534 1.221 0 CA-C-N 115.501 -0.772 . . . . 23.210000000000001 112.744 -179.0 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' F' F ' 29' ' ' LYS . . . . . . . . . . . . . 62.0 mttp -96.34 155.08 16.91 Favored 'General case' 0 C--O 1.231 0.101 0 CA-C-N 117.843 0.821 . . . . 22.59 110.99 177.726 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' F' F ' 30' ' ' THR . . . . . . . . . . . . . 30.1 m -107.02 138.97 42.17 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 115.96 -0.564 . . . . 23.59 109.948 177.584 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' F' F ' 31' ' ' VAL . . . . . . . . . . . . . 35.1 m -128.33 152.61 36.68 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.172 0 CA-C-N 116.352 -0.386 . . . . 20.100000000000001 110.779 -179.045 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' F' F ' 32' ' ' ARG . . . . . . . . . . . . . 2.8 mpt_? -131.37 150.72 52.04 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.009 -0.541 . . . . 25.530000000000001 109.976 177.195 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' F' F ' 33' ' ' THR . . . . . . . . . . . . . 14.6 m -53.68 137.39 37.53 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.426 -0.352 . . . . 18.77 111.394 -177.953 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' F' F ' 34' ' ' GLY . . . . . . . . . . . . . . . 99.88 -17.08 57.81 Favored Glycine 0 CA--C 1.533 1.198 0 C-N-CA 121.186 -0.531 . . . . 18.140000000000001 113.348 178.869 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' F' F ' 35' ' ' ASP . . . . . . . . . . . . . 60.1 m-20 -64.92 150.71 47.37 Favored 'General case' 0 C--O 1.231 0.091 0 CA-C-N 117.977 0.888 . . . . 20.129999999999999 111.487 -179.253 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' F' F ' 36' ' ' VAL . . . . . . . . . . . . . 47.7 t -121.91 129.14 75.68 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.205 0 CA-C-N 115.641 -0.709 . . . . 18.530000000000001 109.844 178.037 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' F' F ' 37' ' ' ILE . . . . . . . . . . . . . 73.9 mt -122.09 140.48 45.89 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.245 0 CA-C-N 116.299 -0.41 . . . . 18.129999999999999 110.068 -179.731 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' F' F ' 38' ' ' GLY . . . . . . . . . . . . . . . -110.52 128.68 8.92 Favored Glycine 0 CA--C 1.526 0.761 0 N-CA-C 111.092 -0.803 . . . . 19.07 111.092 179.476 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' F' F ' 39' ' ' ILE . . . . . . . . . . . . . 74.7 mt -123.47 133.35 69.43 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.262 0 N-CA-C 110.087 -0.338 . . . . 18.800000000000001 110.087 178.845 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' F' F ' 40' ' ' SER . . . . . . . . . . . . . 25.0 t -93.46 123.03 36.49 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.509 -0.314 . . . . 22.350000000000001 111.352 177.584 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' F' F ' 41' ' ' ILE . . . . . . . . . . . . . 73.2 mt -123.79 116.41 48.03 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.214 0 CA-C-N 116.348 -0.387 . . . . 20.059999999999999 110.136 176.667 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' F' F ' 42' ' ' LEU . . . . . . . . . . . . . 8.7 mp 51.06 37.08 16.98 Favored 'General case' 0 N--CA 1.465 0.313 0 CA-C-O 121.174 0.511 . . . . 22.579999999999998 111.507 178.694 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' F' F ' 43' ' ' GLY . . . . . . . . . . . . . . . 74.06 32.21 58.82 Favored Glycine 0 CA--C 1.529 0.948 0 C-N-CA 121.163 -0.541 . . . . 23.829999999999998 112.016 178.95 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' F' F ' 44' ' ' LYS . . . . . . . . . . . . . 87.6 tttt -130.62 125.9 35.27 Favored 'General case' 0 C--N 1.331 -0.232 0 N-CA-C 109.535 -0.543 . . . . 21.120000000000001 109.535 177.227 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' F' F ' 45' ' ' GLU . . . . . . . . . . . . . 82.1 tt0 -84.39 115.6 22.61 Favored 'General case' 0 C--N 1.328 -0.369 0 C-N-CA 120.811 -0.356 . . . . 20.710000000000001 110.966 -178.891 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' F' F ' 46' ' ' VAL . . . . . . . . . . . . . 7.3 p -115.25 130.36 69.93 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.243 0 N-CA-C 109.191 -0.67 . . . . 17.239999999999998 109.191 175.38 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' F' F ' 47' ' ' LYS . . . . . . . . . . . . . 63.5 mttp -99.48 125.81 45.3 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 115.97 -0.559 . . . . 19.140000000000001 111.119 179.089 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' F' F ' 48' ' ' PHE . . . . . . . . . . . . . 87.6 m-85 -108.9 131.95 54.53 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.078 -0.51 . . . . 14.5 109.899 176.735 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' F' F ' 49' ' ' LYS . . . . . . . . . . . . . 46.8 tttm -106.31 137.34 44.44 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.222 -0.445 . . . . 15.119999999999999 110.326 179.483 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' F' F ' 50' ' ' VAL . . . . . . . . . . . . . 47.6 t -81.04 107.09 13.0 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.333 0 N-CA-C 109.324 -0.621 . . . . 15.35 109.324 175.769 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' F' F ' 51' ' ' VAL . . . . . . . . . . . . . 56.6 t -70.57 -53.49 22.22 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.312 0 CA-C-N 115.864 -0.607 . . . . 13.92 109.452 -175.282 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' F' F ' 52' ' ' GLN . . . . . . . . . . . . . 88.1 mt-30 -154.34 151.96 29.68 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 115.99 -0.55 . . . . 16.129999999999999 111.822 -178.31 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' F' F ' 53' ' ' ALA . . . . . . . . . . . . . . . -129.68 130.79 45.98 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 115.21 -0.905 . . . . 18.149999999999999 109.552 174.06 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' F' F ' 54' ' ' TYR . . . . . . . . . . . . . 8.3 t80 -129.18 110.55 18.12 Favored Pre-proline 0 CA--C 1.535 0.383 0 CA-C-O 118.214 -0.898 . . . . 22.390000000000001 110.038 177.652 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' F' F ' 55' ' ' PRO . . . . . . . . . . . . . 74.0 Cg_endo -77.16 169.75 73.37 Favored 'Cis proline' 0 N--CA 1.5 1.857 0 CA-C-N 121.999 1.75 . . . . 22.949999999999999 112.666 -2.796 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' F' F ' 56' ' ' SER . . . . . . . . . . . . . 13.6 m -116.82 127.95 26.37 Favored Pre-proline 0 CA--C 1.539 0.554 0 CA-C-O 118.383 -0.818 . . . . 23.18 109.474 176.643 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' F' F ' 57' ' ' PRO . . . . . . . . . . . . . 37.6 Cg_endo -66.95 167.94 55.24 Favored 'Cis proline' 0 N--CA 1.497 1.726 0 CA-C-N 121.994 1.748 . . . . 24.699999999999999 111.466 -1.103 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' F' F ' 58' ' ' LEU . . . . . . . . . . . . . 33.5 tp -129.43 135.82 49.15 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-O 120.935 0.398 . . . . 20.82 110.507 -179.834 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' F' F ' 59' ' ' ARG . . . . . . . . . . . . . 52.5 ttt85 -97.56 127.23 43.35 Favored 'General case' 0 C--N 1.326 -0.417 0 N-CA-C 109.259 -0.645 . . . . 25.879999999999999 109.259 177.237 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' F' F ' 60' ' ' VAL . . . . . . . . . . . . . 42.6 t -82.52 114.68 23.77 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.208 0 C-N-CA 120.564 -0.454 . . . . 20.510000000000002 110.2 -176.169 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' F' F ' 61' ' ' GLU . . . . . . . . . . . . . 95.7 mt-10 -131.14 158.15 41.24 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 115.806 -0.634 . . . . 23.66 110.117 177.844 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' F' F ' 62' ' ' ASP . . . . . . . . . . . . . 4.6 p-10 -55.51 -32.46 62.91 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-N 116.511 -0.313 . . . . 21.75 111.513 177.951 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' F' F ' 63' ' ' ARG . . . . . . . . . . . . . 14.4 ptp180 -75.59 -4.94 42.84 Favored 'General case' 0 CA--C 1.535 0.389 0 N-CA-C 113.578 0.955 . . . . 25.579999999999998 113.578 -177.177 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' F' F ' 64' ' ' THR . . . . . . . . . . . . . 30.5 m -91.76 145.97 24.14 Favored 'General case' 0 C--N 1.332 -0.156 0 CA-C-N 118.271 0.487 . . . . 19.280000000000001 110.376 -178.036 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' F' F ' 65' ' ' LYS . . . . . . . . . . . . . 51.9 mtmt -87.55 124.9 33.97 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-O 121.109 0.481 . . . . 19.390000000000001 110.328 179.998 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' F' F ' 66' ' ' ILE . . . . . . . . . . . . . 71.5 mt -116.29 124.38 72.46 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.289 0 N-CA-C 109.704 -0.48 . . . . 15.44 109.704 -179.555 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' F' F ' 67' ' ' THR . . . . . . . . . . . . . 25.3 m -123.59 146.27 48.28 Favored 'General case' 0 C--N 1.331 -0.223 0 CA-C-O 121.054 0.455 . . . . 12.710000000000001 111.201 -175.776 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' F' F ' 68' ' ' LEU . . . . . . . . . . . . . 8.2 mp . . . . . 0 C--N 1.329 -0.291 0 CA-C-N 115.902 -0.59 . . . . 10.039999999999999 110.664 178.796 . . . . . . . . 0 0 . 1 . 001 nuclear orig core ' F' F ' 73' ' ' VAL . . . . . . . . . . . . . 33.4 m . . . . . 0 C--O 1.231 0.093 0 CA-C-O 120.88 0.371 . . . . 1.3999999999999999 110.737 . . . . . . . . . 0 0 . 1 . 001 nuclear orig core ' F' F ' 74' ' ' ASP . . . . . . . . . . . . . 2.5 t70 -101.35 127.96 47.74 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 115.954 -0.567 . . . . 1.0600000000000001 109.947 179.825 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' F' F ' 75' ' ' VAL . . . . . . . . . . . . . 42.2 t -119.59 124.31 72.68 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.277 0 CA-C-O 120.935 0.398 . . . . 1.25 110.607 -178.273 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' F' F ' 76' ' ' LEU . . . . . . . . . . . . . 5.8 mp -122.48 140.72 52.42 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 115.825 -0.625 . . . . 1.6000000000000001 109.79 175.689 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' F' F ' 77' ' ' GLU . . . . . . . . . . . . . 98.2 mt-10 -133.69 140.75 47.23 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-O 121.075 0.464 . . . . 1.24 111.324 -178.442 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' F' F ' 78' ' ' ALA . . . . . . . . . . . . . . . -130.9 130.2 43.21 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 115.8 -0.636 . . . . 1.22 109.971 176.326 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' F' F ' 79' ' ' LYS . . . . . . . . . . . . . 35.5 mmtt -76.55 119.43 20.37 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-O 121.05 0.452 . . . . 3.3999999999999999 110.847 179.334 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' F' F ' 80' ' ' ILE . . . . . . . . . . . . . 41.1 mm -139.26 100.86 1.45 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.285 0 N-CA-C 108.814 -0.81 . . . . 1.3200000000000001 108.814 -179.093 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' F' F ' 81' ' ' LYS . . . . . . . . . . . . . 81.3 tttt -91.41 127.5 36.88 Favored 'General case' 0 C--N 1.327 -0.388 0 C-N-CA 120.804 -0.358 . . . . 3.6000000000000001 111.085 -174.967 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' F' F ' 82' ' ' GLY . . . . . . . . . . . . . . . 89.16 42.16 5.66 Favored Glycine 0 CA--C 1.525 0.715 0 C-N-CA 120.772 -0.728 . . . . 0.68000000000000005 111.974 174.961 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' F' F ' 83' ' ' ILE . . . . . . . . . . . . . 70.4 mt -72.78 138.02 22.28 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.241 0 N-CA-C 109.611 -0.514 . . . . 1.1899999999999999 109.611 175.802 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' F' F ' 84' ' ' LYS . . . . . . . . . . . . . 55.7 tttp -97.89 -53.99 3.23 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.13 -0.486 . . . . 2.1099999999999999 110.377 -178.325 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' F' F ' 85' ' ' ASP . . . . . . . . . . . . . 22.5 t70 -148.88 148.5 29.93 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 115.92 -0.582 . . . . 0.75 110.54 -177.381 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' F' F ' 86' ' ' VAL . . . . . . . . . . . . . 43.8 t -129.77 130.25 66.58 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.259 0 CA-C-O 120.924 0.393 . . . . 1.1699999999999999 110.49 -179.518 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' F' F ' 87' ' ' ILE . . . . . . . . . . . . . 5.1 mp -115.59 125.66 72.86 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.283 0 CA-C-N 115.8 -0.636 . . . . 2.0 109.352 176.51 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' F' F ' 88' ' ' LEU . . . . . . . . . . . . . 18.1 tp -111.49 131.2 55.39 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-O 121.056 0.455 . . . . 2.3100000000000001 111.297 -176.465 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' F' F ' 89' ' ' ASP . . . . . . . . . . . . . 31.4 t0 -130.99 153.97 48.66 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 115.718 -0.674 . . . . 0.82999999999999996 109.546 176.225 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' F' F ' 90' ' ' GLU . . . . . . . . . . . . . 95.9 mt-10 -49.34 -37.98 26.49 Favored 'General case' 0 C--N 1.328 -0.331 0 N-CA-C 112.749 0.648 . . . . 2.21 112.749 -171.959 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' F' F ' 91' ' ' ASN . . . . . . . . . . . . . 25.6 m120 -122.57 14.54 10.23 Favored 'General case' 0 N--CA 1.469 0.5 0 N-CA-C 113.193 0.812 . . . . 2.8300000000000001 113.193 -176.84 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' F' F ' 92' ' ' LEU . . . . . . . . . . . . . 49.0 mt -148.74 141.52 24.6 Favored 'General case' 0 C--N 1.332 -0.195 0 CA-C-O 120.838 0.351 . . . . 2.1000000000000001 110.516 -175.919 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' F' F ' 93' ' ' ILE . . . . . . . . . . . . . 73.2 mt -124.65 116.17 46.63 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.37 0 N-CA-C 109.063 -0.717 . . . . 1.1299999999999999 109.063 176.256 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' F' F ' 94' ' ' VAL . . . . . . . . . . . . . 45.0 t -117.36 125.16 73.84 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.249 0 N-CA-C 109.907 -0.405 . . . . 1.1299999999999999 109.907 -178.439 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' F' F ' 95' ' ' VAL . . . . . . . . . . . . . 42.2 t -120.84 133.41 67.6 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.344 0 CA-C-N 116.055 -0.52 . . . . 1.1499999999999999 109.766 -179.739 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' F' F ' 96' ' ' ILE . . . . . . . . . . . . . 59.1 mt -114.01 128.11 71.12 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.297 0 N-CA-C 109.124 -0.695 . . . . 1.2 109.124 178.353 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' F' F ' 97' ' ' THR . . . . . . . . . . . . . 62.7 p -101.1 161.37 13.65 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-O 121.034 0.445 . . . . 1.1599999999999999 110.999 -177.65 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' F' F ' 98' ' ' GLU . . . . . . . . . . . . . 97.3 mt-10 -54.03 -26.09 24.71 Favored 'General case' 0 CA--C 1.532 0.284 0 N-CA-C 112.345 0.498 . . . . 2.4700000000000002 112.345 179.958 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' F' F ' 99' ' ' GLU . . . . . . . . . . . . . 95.1 mt-10 -77.69 13.08 1.4 Allowed 'General case' 0 CA--C 1.535 0.384 0 N-CA-C 113.24 0.829 . . . . 2.0600000000000001 113.24 -177.748 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' F' F ' 100' ' ' ASN . . . . . . . . . . . . . 2.9 m-20 61.23 37.61 17.22 Favored 'General case' 0 CA--C 1.529 0.169 0 CA-C-O 121.106 0.479 . . . . 0.73999999999999999 110.955 179.442 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' F' F ' 101' ' ' GLU . . . . . . . . . . . . . 84.0 tt0 -115.93 144.72 43.67 Favored 'General case' 0 C--N 1.334 -0.108 0 CA-C-N 116.062 -0.517 . . . . 0.54000000000000004 109.606 176.182 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' F' F ' 102' ' ' VAL . . . . . . . . . . . . . 45.5 t -114.97 125.35 72.27 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.261 0 CA-C-N 116.291 -0.413 . . . . 1.1599999999999999 109.963 -178.092 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' F' F ' 103' ' ' LEU . . . . . . . . . . . . . 26.4 mt -113.44 128.84 56.59 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 115.621 -0.718 . . . . 1.55 109.909 175.883 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' F' F ' 104' ' ' ILE . . . . . . . . . . . . . 65.3 mt -118.42 119.16 60.37 Favored 'Isoleucine or valine' 0 C--O 1.233 0.229 0 N-CA-C 110.308 -0.256 . . . . 1.2 110.308 -179.25 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' F' F ' 105' ' ' PHE . . . . . . . . . . . . . 49.0 m-85 -118.99 169.45 9.89 Favored 'General case' 0 C--N 1.332 -0.157 0 CA-C-N 115.423 -0.808 . . . . 0.54000000000000004 109.71 177.152 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' F' F ' 106' ' ' ASN . . . . . . . . . . . . . 51.2 p-10 -102.03 -170.15 1.78 Allowed 'General case' 0 C--N 1.33 -0.277 0 N-CA-C 109.886 -0.413 . . . . 0.64000000000000001 109.886 172.987 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' F' F ' 107' ' ' GLN . . . . . . . . . . . . . 48.5 tt0 -59.79 -29.96 68.58 Favored 'General case' 0 C--N 1.33 -0.264 0 N-CA-C 111.766 0.284 . . . . 1.6899999999999999 111.766 178.535 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' F' F ' 108' ' ' ASN . . . . . . . . . . . . . 3.6 t-20 -81.9 9.88 7.39 Favored 'General case' 0 CA--C 1.537 0.459 0 N-CA-C 112.976 0.732 . . . . 1.9399999999999999 112.976 -178.496 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' F' F ' 109' ' ' LEU . . . . . . . . . . . . . 8.1 tp 58.12 36.38 25.85 Favored 'General case' 0 CA--C 1.529 0.164 0 CA-C-O 120.874 0.369 . . . . 1.98 111.461 177.9 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' F' F ' 110' ' ' GLU . . . . . . . . . . . . . 47.2 mt-10 -105.1 151.22 24.28 Favored 'General case' 0 C--N 1.33 -0.241 0 N-CA-C 109.781 -0.451 . . . . 1.71 109.781 176.67 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' F' F ' 111' ' ' GLU . . . . . . . . . . . . . 83.1 tt0 -83.92 121.92 28.03 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-O 120.858 0.361 . . . . 1.71 110.73 -176.634 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' F' F ' 112' ' ' LEU . . . . . . . . . . . . . 37.4 mt -107.77 -46.2 3.85 Favored 'General case' 0 C--N 1.332 -0.181 0 CA-C-N 116.112 -0.494 . . . . 1.27 110.809 179.241 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' F' F ' 113' ' ' TYR . . . . . . . . . . . . . 42.9 t80 -138.82 139.66 38.27 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-N 116.385 -0.37 . . . . 1.03 111.377 -178.249 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' F' F ' 114' ' ' ARG . . . . . . . . . . . . . 23.7 ttp-105 -136.15 123.75 22.29 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 115.913 -0.585 . . . . 2.9300000000000002 110.167 176.234 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' F' F ' 115' ' ' GLY . . . . . . . . . . . . . . . -150.06 155.4 26.22 Favored Glycine 0 CA--C 1.521 0.446 0 N-CA-C 110.855 -0.898 . . . . 0.56000000000000005 110.855 178.677 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' F' F ' 116' ' ' LYS . . . . . . . . . . . . . 33.9 ttmt -127.44 137.78 52.8 Favored 'General case' 0 C--N 1.329 -0.284 0 N-CA-C 109.925 -0.398 . . . . 2.1000000000000001 109.925 177.009 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' F' F ' 117' ' ' PHE . . . . . . . . . . . . . 31.9 m-85 -137.42 114.51 10.77 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.254 -0.43 . . . . 0.58999999999999997 109.932 -176.002 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' F' F ' 118' ' ' GLU . . . . . . . . . . . . . 84.4 tt0 -53.77 -42.36 68.16 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.557 -0.292 . . . . 2.71 111.349 -177.134 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' F' F ' 119' ' ' ASN . . . . . . . . . . . . . 30.8 m-80 -99.51 31.14 3.26 Favored 'General case' 0 C--N 1.33 -0.272 0 N-CA-C 112.075 0.398 . . . . 1.9199999999999999 112.075 -175.062 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' F' F ' 120' ' ' LEU . . . . . . . . . . . . . 25.8 tp -58.53 119.94 7.94 Favored 'General case' 0 C--N 1.332 -0.171 0 N-CA-C 110.033 -0.358 . . . . 1.1299999999999999 110.033 178.34 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' F' F ' 121' ' ' ASN . . . . . . . . . . . . . 48.3 t30 -114.16 -43.98 3.18 Favored 'General case' 0 C--N 1.332 -0.173 0 CA-C-N 116.372 -0.376 . . . . 1.96 110.909 -178.146 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' F' F ' 122' ' ' LYS . . . . . . . . . . . . . 57.1 mttm -141.62 146.81 36.66 Favored 'General case' 0 C--N 1.331 -0.227 0 CA-C-O 121.111 0.481 . . . . 2.4700000000000002 111.577 -176.011 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' F' F ' 123' ' ' VAL . . . . . . . . . . . . . 46.7 t -130.12 129.53 65.47 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.307 0 N-CA-C 109.177 -0.675 . . . . 1.1599999999999999 109.177 173.82 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' F' F ' 124' ' ' LEU . . . . . . . . . . . . . 81.8 mt -130.95 139.81 50.09 Favored 'General case' 0 C--N 1.332 -0.192 0 CA-C-O 121.086 0.469 . . . . 2.1299999999999999 111.322 -175.613 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' F' F ' 125' ' ' VAL . . . . . . . . . . . . . 35.8 m -128.0 131.54 69.43 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.216 0 CA-C-N 115.696 -0.683 . . . . 2.23 110.213 177.689 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' F' F ' 126' ' ' ARG . . . . . . . . . . . . . 77.6 mtt180 -147.39 124.29 11.3 Favored 'General case' 0 C--N 1.327 -0.372 0 N-CA-C 109.656 -0.498 . . . . 3.7799999999999998 109.656 178.639 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' F' F ' 127' ' ' ASN . . . . . . . . . . . . . 18.4 t30 56.85 -152.3 0.39 Allowed 'General case' 0 CA--C 1.54 0.565 0 N-CA-C 109.57 -0.53 . . . . 2.7400000000000002 109.57 -178.828 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' F' F ' 128' ' ' ASP . . . . . . . . . . . . . 20.7 p-10 -81.13 14.65 2.22 Favored 'General case' 0 CA--C 1.537 0.46 0 N-CA-C 112.772 0.656 . . . . 1.0700000000000001 112.772 178.235 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' F' F ' 129' ' ' LEU . . . . . . . . . . . . . 16.5 tp -114.33 137.24 52.06 Favored 'General case' 0 C--O 1.232 0.166 0 O-C-N 122.027 -0.42 . . . . 2.3500000000000001 109.953 179.315 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' F' F ' 130' ' ' VAL . . . . . . . . . . . . . 12.3 p -130.22 141.81 45.39 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.268 0 CA-C-O 120.842 0.353 . . . . 1.9199999999999999 110.528 -178.18 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' F' F ' 131' ' ' VAL . . . . . . . . . . . . . 14.7 p -136.17 143.01 37.1 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.207 0 CA-C-O 121.063 0.458 . . . . 1.54 111.386 -179.584 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' F' F ' 132' ' ' ILE . . . . . . . . . . . . . 70.2 mt -116.15 132.68 64.97 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.32 0 CA-C-N 115.577 -0.738 . . . . 1.1399999999999999 109.044 176.188 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' F' F ' 133' ' ' ILE . . . . . . . . . . . . . 37.3 mm -116.05 121.75 68.12 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.296 0 CA-C-O 120.785 0.326 . . . . 1.1499999999999999 111.386 -173.601 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' F' F ' 134' ' ' ASP . . . . . . . . . . . . . 2.8 p30 -130.68 148.64 52.49 Favored 'General case' 0 C--N 1.331 -0.219 0 N-CA-C 109.534 -0.543 . . . . 0.51000000000000001 109.534 174.294 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' F' F ' 135' ' ' GLU . . . . . . . . . . . . . 84.4 tt0 -50.96 -27.53 7.86 Favored 'General case' 0 C--N 1.326 -0.424 0 N-CA-C 112.955 0.724 . . . . 1.8300000000000001 112.955 -171.939 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' F' F ' 136' ' ' GLN . . . . . . . . . . . . . 98.1 mt-30 -86.18 -27.82 24.31 Favored 'General case' 0 C--O 1.234 0.24 0 N-CA-C 112.845 0.683 . . . . 2.21 112.845 -175.251 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' F' F ' 137' ' ' LYS . . . . . . . . . . . . . 33.2 pttt -170.01 172.72 6.35 Favored 'General case' 0 C--N 1.331 -0.208 0 CA-C-O 121.588 0.708 . . . . 2.2599999999999998 112.378 -173.178 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' F' F ' 138' ' ' LEU . . . . . . . . . . . . . 7.1 tt -120.06 130.17 54.56 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 114.998 -1.001 . . . . 1.4199999999999999 110.048 -179.428 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' F' F ' 139' ' ' THR . . . . . . . . . . . . . 46.5 m -108.51 120.59 42.88 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 116.207 -0.451 . . . . 1.1499999999999999 109.92 177.786 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' F' F ' 140' ' ' LEU . . . . . . . . . . . . . 17.6 tp -109.71 125.85 53.08 Favored 'General case' 0 C--N 1.329 -0.291 0 N-CA-C 109.31 -0.626 . . . . 1.8300000000000001 109.31 -178.015 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' F' F ' 141' ' ' ILE . . . . . . . . . . . . . 19.4 mt -123.46 122.76 65.89 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.275 0 CA-C-O 120.843 0.354 . . . . 1.1799999999999999 110.19 -172.918 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' F' F ' 142' ' ' ARG . . . . . . . . . . . . . 80.6 mtp180 -108.04 126.64 52.97 Favored 'General case' 0 C--N 1.331 -0.219 0 CA-C-N 115.491 -0.777 . . . . 4.4199999999999999 110.269 -179.466 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' F' F ' 143' ' ' THR . . . . . . . . . . . . . 66.5 p . . . . . 0 C--O 1.22 -0.472 0 CA-C-O 118.09 -0.957 . . . . 1.6100000000000001 110.493 179.749 . . . . . . . . 0 0 . 1 . 002 nuclear orig core ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 2.8 p . . . . . 0 N--CA 1.461 0.119 0 CA-C-O 120.896 0.379 . . . . 0.0 110.479 . . . . . . . . . 0 0 . 1 . 002 nuclear orig core ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 84.4 tt0 -140.17 143.36 36.08 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.187 -0.46 . . . . 0.0 110.988 -178.721 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 4' ' ' LEU . . . . . . . . . . . . . 4.9 tt -127.88 127.24 43.06 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 115.864 -0.607 . . . . 0.0 109.997 177.964 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 5' ' ' LYS . . . . . . . . . . . . . 98.0 mttt -108.7 122.8 47.87 Favored 'General case' 0 C--O 1.234 0.249 0 CA-C-O 120.771 0.32 . . . . 0.0 110.909 -179.586 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 22.4 mt -113.99 150.06 34.4 Favored 'General case' 0 C--N 1.332 -0.177 0 CA-C-N 115.393 -0.821 . . . . 0.0 110.065 179.552 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 61.0 tttt -137.95 137.2 20.8 Favored Pre-proline 0 CA--C 1.535 0.377 0 CA-C-O 118.942 -0.552 . . . . 0.0 110.007 175.852 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 8' ' ' PRO . . . . . . . . . . . . . 85.9 Cg_endo -87.61 141.7 5.66 Favored 'Trans proline' 0 N--CA 1.492 1.386 0 C-N-CA 121.541 1.494 . . . . 0.0 111.792 177.575 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 46.7 mt -78.23 -47.07 2.11 Favored Pre-proline 0 CA--C 1.533 0.305 0 CA-C-O 118.745 -0.645 . . . . 0.0 112.275 -179.118 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 92.4 Cg_endo -81.98 153.9 17.05 Favored 'Trans proline' 0 N--CA 1.496 1.655 0 C-N-CA 121.269 1.313 . . . . 0.0 111.901 175.353 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 59.8 mttp -89.38 99.93 12.83 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.458 -0.337 . . . . 0.0 110.82 179.513 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 12.0 p -145.76 143.08 21.78 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.268 0 CA-C-N 116.236 -0.438 . . . . 0.0 110.493 179.198 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 43.9 mp0 -79.88 125.87 30.27 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.379 -0.373 . . . . 0.0 110.148 177.687 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 14' ' ' LEU . . . . . . . . . . . . . 29.5 mt -97.89 154.59 37.75 Favored Pre-proline 0 C--N 1.329 -0.284 0 CA-C-N 116.487 -0.324 . . . . 0.0 111.02 -177.651 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 15' ' ' PRO . . . . . . . . . . . . . 35.4 Cg_exo -59.88 160.6 21.17 Favored 'Trans proline' 0 N--CA 1.497 1.686 0 C-N-CA 121.364 1.376 . . . . 0.0 111.872 177.957 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 16' ' ' PRO . . . . . . . . . . . . . 25.7 Cg_exo -61.33 -43.19 29.74 Favored 'Trans proline' 0 N--CA 1.497 1.686 0 C-N-CA 121.571 1.514 . . . . 0.0 112.571 -179.031 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 17' ' ' ASP . . . . . . . . . . . . . 17.9 p-10 -88.34 17.0 5.57 Favored 'General case' 0 CA--C 1.535 0.371 0 N-CA-C 112.953 0.723 . . . . 0.0 112.953 -177.219 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 18' ' ' PHE . . . . . . . . . . . . . 42.7 t80 -58.27 -45.87 87.07 Favored 'General case' 0 C--N 1.334 -0.087 0 O-C-N 122.142 -0.349 . . . . 0.0 110.081 -178.489 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 19' ' ' VAL . . . . . . . . . . . . . 13.3 p -55.59 -39.69 55.72 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 CA-C-N 116.423 -0.353 . . . . 0.0 110.937 -179.532 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 77.5 m-20 -60.42 -46.65 89.27 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-O 120.926 0.393 . . . . 0.0 110.876 -178.378 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 46.4 t -64.27 -47.25 90.59 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.347 0 CA-C-N 116.365 -0.38 . . . . 0.0 110.561 -177.229 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 22' ' ' ILE . . . . . . . . . . . . . 50.9 mm -56.36 -45.33 81.5 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.218 0 C-N-CA 120.947 -0.301 . . . . 0.0 110.58 179.335 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 23' ' ' ARG . . . . . . . . . . . . . 59.2 ttp180 -54.24 -46.5 72.57 Favored 'General case' 0 C--N 1.33 -0.27 0 C-N-CA 121.164 -0.215 . . . . 0.0 111.366 -179.062 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 24' ' ' ILE . . . . . . . . . . . . . 74.7 mt -58.91 -45.09 92.03 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 C-N-CA 121.137 -0.225 . . . . 0.0 111.057 -179.467 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 93.8 mttt -65.22 -40.66 94.39 Favored 'General case' 0 C--N 1.329 -0.302 0 N-CA-C 112.352 0.501 . . . . 0.0 112.352 -177.89 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 80.1 mt -79.64 -42.19 25.37 Favored 'General case' 0 C--N 1.33 -0.274 0 N-CA-C 112.898 0.703 . . . . 0.0 112.898 -171.575 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 27' ' ' GLN . . . . . . . . . . . . . 9.8 pt20 -46.05 139.51 4.41 Favored 'General case' 0 N--CA 1.469 0.49 0 N-CA-C 112.79 0.663 . . . . 0.0 112.79 -175.292 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 101.33 -28.61 15.21 Favored Glycine 0 CA--C 1.531 1.058 0 CA-C-N 115.483 -0.781 . . . . 0.0 111.973 -176.779 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 90.4 mttt -98.16 155.23 17.26 Favored 'General case' 0 C--O 1.233 0.203 0 CA-C-N 117.267 0.533 . . . . 0.0 111.055 178.452 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 30' ' ' THR . . . . . . . . . . . . . 38.0 m -101.6 138.36 38.69 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.235 -0.438 . . . . 0.0 109.831 175.026 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 34.5 m -126.31 156.45 36.8 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.191 0 CA-C-N 116.45 -0.341 . . . . 0.0 110.675 -178.822 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 32' ' ' ARG . . . . . . . . . . . . . 90.4 mtt180 -132.93 150.39 52.16 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.0 -0.545 . . . . 0.0 110.683 178.858 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 33' ' ' THR . . . . . . . . . . . . . 24.5 m -52.5 139.07 26.24 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.177 -0.465 . . . . 0.0 111.453 -178.643 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 99.47 -17.14 58.13 Favored Glycine 0 CA--C 1.533 1.175 0 CA-C-O 119.631 -0.538 . . . . 0.0 113.29 178.598 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 74.7 m-20 -65.6 148.72 51.27 Favored 'General case' 0 C--N 1.334 -0.073 0 CA-C-N 118.081 0.941 . . . . 0.0 110.954 179.463 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 46.9 t -123.13 130.1 74.58 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.249 0 CA-C-N 115.87 -0.605 . . . . 0.0 109.797 178.241 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 37' ' ' ILE . . . . . . . . . . . . . 63.3 mt -117.57 137.97 49.76 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.275 0 N-CA-C 109.844 -0.428 . . . . 0.0 109.844 -179.742 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . -108.3 128.75 9.25 Favored Glycine 0 CA--C 1.525 0.701 0 N-CA-C 110.957 -0.857 . . . . 0.0 110.957 179.885 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 39' ' ' ILE . . . . . . . . . . . . . 75.8 mt -127.02 135.51 63.41 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.244 0 N-CA-C 110.12 -0.326 . . . . 0.0 110.12 179.4 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 40' ' ' SER . . . . . . . . . . . . . 11.1 p -92.04 115.15 27.82 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.218 -0.447 . . . . 0.0 110.751 176.085 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 41' ' ' ILE . . . . . . . . . . . . . 43.7 mm -120.82 116.78 50.98 Favored 'Isoleucine or valine' 0 N--CA 1.462 0.171 0 CA-C-O 120.772 0.32 . . . . 0.0 110.498 -179.81 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 6.8 mp 50.9 37.12 16.51 Favored 'General case' 0 C--N 1.331 -0.219 0 CA-C-O 121.081 0.467 . . . . 0.0 111.656 177.301 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . 75.16 30.71 58.52 Favored Glycine 0 CA--C 1.528 0.886 0 C-N-CA 121.072 -0.585 . . . . 0.0 112.345 176.67 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 44' ' ' LYS . . . . . . . . . . . . . 16.5 ttmm -136.04 132.69 36.56 Favored 'General case' 0 C--N 1.33 -0.274 0 N-CA-C 109.861 -0.422 . . . . 0.0 109.861 176.652 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 79.0 tt0 -81.79 113.34 19.68 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.408 -0.36 . . . . 0.0 110.747 -178.844 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 46' ' ' VAL . . . . . . . . . . . . . 7.3 p -116.01 125.92 73.31 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.195 0 N-CA-C 109.628 -0.508 . . . . 0.0 109.628 177.936 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 97.1 mttt -100.48 130.0 46.5 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 115.965 -0.561 . . . . 0.0 111.287 178.445 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 48' ' ' PHE . . . . . . . . . . . . . 80.7 m-85 -111.2 131.95 54.71 Favored 'General case' 0 C--N 1.329 -0.296 0 N-CA-C 109.749 -0.463 . . . . 0.0 109.749 175.902 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 85.5 tttt -107.04 137.01 45.92 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.288 -0.415 . . . . 0.0 110.674 -179.172 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 50' ' ' VAL . . . . . . . . . . . . . 42.9 t -81.26 108.78 14.86 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.262 0 N-CA-C 109.462 -0.57 . . . . 0.0 109.462 176.094 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 51' ' ' VAL . . . . . . . . . . . . . 45.2 t -70.2 -49.29 55.97 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.288 0 CA-C-N 115.971 -0.559 . . . . 0.0 109.924 -174.116 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 52' ' ' GLN . . . . . . . . . . . . . 46.6 tt0 -168.13 142.5 3.45 Favored 'General case' 0 C--N 1.33 -0.273 0 C-N-CA 120.082 -0.647 . . . . 0.0 112.009 -177.378 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -113.08 133.39 55.02 Favored 'General case' 0 C--N 1.331 -0.215 0 CA-C-N 115.395 -0.82 . . . . 0.0 109.81 175.496 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 54' ' ' TYR . . . . . . . . . . . . . 50.5 t80 -129.03 107.29 18.02 Favored Pre-proline 0 CA--C 1.534 0.351 0 CA-C-O 118.314 -0.85 . . . . 0.0 110.41 179.709 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 55' ' ' PRO . . . . . . . . . . . . . 72.6 Cg_endo -77.14 169.19 74.92 Favored 'Cis proline' 0 N--CA 1.5 1.884 0 CA-C-N 121.764 1.666 . . . . 0.0 112.291 -4.827 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 56' ' ' SER . . . . . . . . . . . . . 74.7 m -117.3 137.31 23.9 Favored Pre-proline 0 CA--C 1.538 0.49 0 CA-C-O 118.494 -0.765 . . . . 0.0 109.691 175.114 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 57' ' ' PRO . . . . . . . . . . . . . 36.5 Cg_endo -66.72 161.66 75.03 Favored 'Cis proline' 0 N--CA 1.499 1.797 0 CA-C-N 121.746 1.659 . . . . 0.0 111.388 -3.385 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 58' ' ' LEU . . . . . . . . . . . . . 28.8 tp -130.03 137.29 50.18 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-O 120.945 0.403 . . . . 0.0 110.676 -178.785 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 59' ' ' ARG . . . . . . . . . . . . . 73.8 ttt180 -99.11 135.4 40.56 Favored 'General case' 0 C--N 1.327 -0.394 0 N-CA-C 109.513 -0.551 . . . . 0.0 109.513 175.395 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 40.3 t -84.93 116.33 28.28 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.287 0 C-N-CA 120.652 -0.419 . . . . 0.0 110.453 -177.398 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 34.6 tp10 -131.03 155.49 46.78 Favored 'General case' 0 C--N 1.329 -0.288 0 N-CA-C 109.088 -0.708 . . . . 0.0 109.088 177.138 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 62' ' ' ASP . . . . . . . . . . . . . 77.4 m-20 -51.68 -32.26 29.15 Favored 'General case' 0 C--N 1.326 -0.438 0 N-CA-C 112.134 0.42 . . . . 0.0 112.134 -175.787 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 63' ' ' ARG . . . . . . . . . . . . . 34.5 mmt180 -74.48 -21.61 59.49 Favored 'General case' 0 C--N 1.33 -0.281 0 N-CA-C 113.022 0.749 . . . . 0.0 113.022 -175.447 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 20.8 m -63.29 141.44 58.76 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-O 120.849 0.357 . . . . 0.0 110.824 -176.148 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 65' ' ' LYS . . . . . . . . . . . . . 94.4 mttt -84.06 123.96 30.59 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.191 -0.459 . . . . 0.0 109.796 178.013 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 66' ' ' ILE . . . . . . . . . . . . . 54.9 mt -113.83 129.7 69.25 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.247 0 N-CA-C 109.994 -0.373 . . . . 0.0 109.994 -178.803 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 67' ' ' THR . . . . . . . . . . . . . 12.0 m -125.16 136.63 53.78 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-N 116.234 -0.439 . . . . 0.0 110.736 -179.058 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 68' ' ' LEU . . . . . . . . . . . . . 7.4 mp . . . . . 0 C--N 1.331 -0.231 0 CA-C-N 116.04 -0.527 . . . . 0.0 110.906 179.397 . . . . . . . . 0 0 . 1 . 002 nuclear orig core ' A' A ' 74' ' ' ASP . . . . . . . . . . . . . 15.9 t0 . . . . . 0 CA--C 1.523 -0.064 0 N-CA-C 109.93 -0.396 . . . . 0.0 109.93 . . . . . . . . . 0 0 . 1 . 002 nuclear orig core ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 40.9 t -112.98 122.52 67.28 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.271 0 CA-C-O 121.164 0.507 . . . . 0.0 110.432 -178.877 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 76' ' ' LEU . . . . . . . . . . . . . 23.4 mt -119.77 140.52 50.61 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 115.507 -0.77 . . . . 0.0 109.242 178.44 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 77' ' ' GLU . . . . . . . . . . . . . 98.4 mt-10 -136.18 136.96 40.42 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-O 121.102 0.477 . . . . 0.0 111.492 -177.204 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 78' ' ' ALA . . . . . . . . . . . . . . . -125.76 136.15 52.84 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 115.554 -0.748 . . . . 0.0 109.947 176.842 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 79' ' ' LYS . . . . . . . . . . . . . 43.3 mmtm -81.52 113.62 19.69 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.405 -0.361 . . . . 0.0 110.562 -179.48 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 80' ' ' ILE . . . . . . . . . . . . . 28.5 mm -139.22 104.12 2.09 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.355 0 N-CA-C 109.26 -0.644 . . . . 0.0 109.26 -179.633 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 81' ' ' LYS . . . . . . . . . . . . . 60.4 mtpt -99.71 131.42 45.71 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-O 120.851 0.357 . . . . 0.0 110.81 -177.307 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . 89.2 42.07 5.67 Favored Glycine 0 CA--C 1.525 0.707 0 N-CA-C 111.194 -0.762 . . . . 0.0 111.194 178.34 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 83' ' ' ILE . . . . . . . . . . . . . 70.1 mt -71.08 137.54 23.59 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.308 0 N-CA-C 109.486 -0.561 . . . . 0.0 109.486 176.801 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 84' ' ' LYS . . . . . . . . . . . . . 38.1 ttpt -98.91 -52.62 3.51 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-O 120.843 0.354 . . . . 0.0 110.379 -178.687 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 85' ' ' ASP . . . . . . . . . . . . . 12.6 t70 -151.76 153.16 33.77 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.039 -0.528 . . . . 0.0 110.692 -179.167 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 86' ' ' VAL . . . . . . . . . . . . . 41.9 t -131.4 132.97 62.59 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.248 0 CA-C-O 120.964 0.412 . . . . 0.0 110.421 -178.763 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 87' ' ' ILE . . . . . . . . . . . . . 5.1 mp -122.31 129.66 75.13 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.225 0 CA-C-N 115.819 -0.628 . . . . 0.0 109.358 177.351 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 88' ' ' LEU . . . . . . . . . . . . . 25.5 tp -116.28 132.52 56.64 Favored 'General case' 0 C--N 1.331 -0.219 0 CA-C-O 120.995 0.426 . . . . 0.0 111.433 -176.4 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 89' ' ' ASP . . . . . . . . . . . . . 13.4 t70 -127.04 154.84 44.14 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 115.764 -0.653 . . . . 0.0 109.511 175.668 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 96.1 mt-10 -46.72 -39.36 11.42 Favored 'General case' 0 C--N 1.329 -0.288 0 N-CA-C 113.222 0.823 . . . . 0.0 113.222 -171.735 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 91' ' ' ASN . . . . . . . . . . . . . 12.8 m120 -129.56 22.25 5.52 Favored 'General case' 0 N--CA 1.469 0.496 0 N-CA-C 112.802 0.667 . . . . 0.0 112.802 -177.409 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 92' ' ' LEU . . . . . . . . . . . . . 10.1 mt -150.09 141.91 23.74 Favored 'General case' 0 C--N 1.331 -0.209 0 N-CA-C 109.564 -0.532 . . . . 0.0 109.564 -178.094 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 93' ' ' ILE . . . . . . . . . . . . . 72.2 mt -123.99 121.28 61.73 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 N-CA-C 109.412 -0.588 . . . . 0.0 109.412 178.382 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 94' ' ' VAL . . . . . . . . . . . . . 46.3 t -120.3 126.86 75.72 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.264 0 CA-C-O 120.853 0.359 . . . . 0.0 110.145 -178.215 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 95' ' ' VAL . . . . . . . . . . . . . 41.5 t -122.48 134.3 66.1 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.316 0 CA-C-N 116.001 -0.545 . . . . 0.0 109.801 -179.731 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 96' ' ' ILE . . . . . . . . . . . . . 64.4 mt -115.9 126.73 73.53 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.255 0 N-CA-C 109.405 -0.591 . . . . 0.0 109.405 179.221 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 97' ' ' THR . . . . . . . . . . . . . 70.9 p -103.26 157.34 17.08 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-O 121.356 0.598 . . . . 0.0 111.639 -175.505 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 98' ' ' GLU . . . . . . . . . . . . . 81.5 tt0 -53.96 -26.83 27.63 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 115.893 -0.594 . . . . 0.0 112.303 -178.832 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 99' ' ' GLU . . . . . . . . . . . . . 43.2 mt-10 -80.33 17.62 1.03 Allowed 'General case' 0 CA--C 1.533 0.317 0 N-CA-C 113.069 0.766 . . . . 0.0 113.069 -177.096 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 100' ' ' ASN . . . . . . . . . . . . . 3.2 m-20 61.65 37.37 16.08 Favored 'General case' 0 CA--C 1.53 0.174 0 CA-C-O 121.09 0.472 . . . . 0.0 111.014 178.292 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 101' ' ' GLU . . . . . . . . . . . . . 84.2 tt0 -113.12 143.5 44.25 Favored 'General case' 0 C--O 1.232 0.139 0 CA-C-N 116.083 -0.508 . . . . 0.0 109.966 176.52 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 102' ' ' VAL . . . . . . . . . . . . . 46.2 t -114.98 123.8 71.03 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.27 0 N-CA-C 109.658 -0.497 . . . . 0.0 109.658 -179.653 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 103' ' ' LEU . . . . . . . . . . . . . 22.4 mt -115.98 129.51 56.41 Favored 'General case' 0 C--N 1.331 -0.199 0 CA-C-N 115.696 -0.684 . . . . 0.0 110.355 178.36 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 104' ' ' ILE . . . . . . . . . . . . . 70.5 mt -118.29 120.27 63.87 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.246 0 CA-C-N 116.446 -0.343 . . . . 0.0 110.189 179.081 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 105' ' ' PHE . . . . . . . . . . . . . 57.9 m-85 -121.3 165.4 15.55 Favored 'General case' 0 C--N 1.332 -0.168 0 O-C-N 123.932 0.77 . . . . 0.0 110.155 179.478 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 106' ' ' ASN . . . . . . . . . . . . . 40.9 p-10 -96.88 -169.93 1.96 Allowed 'General case' 0 C--N 1.331 -0.205 0 N-CA-C 109.913 -0.403 . . . . 0.0 109.913 173.636 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 107' ' ' GLN . . . . . . . . . . . . . 63.3 tt0 -58.96 -30.1 67.66 Favored 'General case' 0 C--N 1.329 -0.306 0 N-CA-C 111.781 0.289 . . . . 0.0 111.781 178.38 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 108' ' ' ASN . . . . . . . . . . . . . 52.2 t30 -83.47 7.22 17.59 Favored 'General case' 0 CA--C 1.536 0.437 0 N-CA-C 113.304 0.853 . . . . 0.0 113.304 -177.698 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 109' ' ' LEU . . . . . . . . . . . . . 11.4 tp 59.6 37.24 22.65 Favored 'General case' 0 C--N 1.332 -0.165 0 CA-C-O 121.017 0.437 . . . . 0.0 111.349 178.409 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 110' ' ' GLU . . . . . . . . . . . . . 70.7 mm-40 -103.55 152.12 22.09 Favored 'General case' 0 C--N 1.331 -0.216 0 N-CA-C 109.886 -0.413 . . . . 0.0 109.886 176.019 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 111' ' ' GLU . . . . . . . . . . . . . 83.4 tt0 -79.35 121.98 25.8 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-O 120.944 0.402 . . . . 0.0 110.73 -177.598 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 112' ' ' LEU . . . . . . . . . . . . . 28.8 mt -111.32 -46.04 3.34 Favored 'General case' 0 C--N 1.331 -0.229 0 CA-C-N 116.063 -0.517 . . . . 0.0 110.145 178.1 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 113' ' ' TYR . . . . . . . . . . . . . 59.8 t80 -138.99 133.43 31.73 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-N 116.115 -0.493 . . . . 0.0 111.009 179.59 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 114' ' ' ARG . . . . . . . . . . . . . 60.1 ttp180 -137.19 122.91 19.9 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.167 -0.469 . . . . 0.0 110.179 176.692 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 115' ' ' GLY . . . . . . . . . . . . . . . -150.07 146.66 16.06 Favored Glycine 0 CA--C 1.524 0.618 0 N-CA-C 110.91 -0.876 . . . . 0.0 110.91 178.974 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 116' ' ' LYS . . . . . . . . . . . . . 14.1 ttmm -116.42 134.93 54.3 Favored 'General case' 0 C--N 1.33 -0.271 0 N-CA-C 109.932 -0.396 . . . . 0.0 109.932 178.663 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 117' ' ' PHE . . . . . . . . . . . . . 48.8 m-85 -132.55 116.92 17.32 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-O 121.01 0.433 . . . . 0.0 110.331 -176.123 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 118' ' ' GLU . . . . . . . . . . . . . 43.8 mp0 -55.22 -45.06 75.96 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 116.246 -0.434 . . . . 0.0 111.133 -175.529 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 119' ' ' ASN . . . . . . . . . . . . . 35.1 m120 -98.71 31.0 3.06 Favored 'General case' 0 C--N 1.33 -0.24 0 N-CA-C 112.208 0.447 . . . . 0.0 112.208 -174.331 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 120' ' ' LEU . . . . . . . . . . . . . 31.5 tp -56.79 121.4 9.76 Favored 'General case' 0 C--N 1.333 -0.14 0 CA-C-O 120.752 0.31 . . . . 0.0 110.471 178.028 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 121' ' ' ASN . . . . . . . . . . . . . 20.3 m120 -114.05 -44.12 3.18 Favored 'General case' 0 C--N 1.333 -0.146 0 CA-C-N 116.414 -0.357 . . . . 0.0 111.204 -177.328 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 122' ' ' LYS . . . . . . . . . . . . . 96.1 mttt -144.1 149.85 37.2 Favored 'General case' 0 C--N 1.331 -0.205 0 CA-C-O 121.01 0.433 . . . . 0.0 111.72 -175.609 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 123' ' ' VAL . . . . . . . . . . . . . 47.1 t -129.69 130.4 66.81 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.27 0 N-CA-C 109.399 -0.593 . . . . 0.0 109.399 174.658 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 124' ' ' LEU . . . . . . . . . . . . . 69.9 mt -125.07 140.04 53.25 Favored 'General case' 0 N--CA 1.464 0.267 0 CA-C-O 120.782 0.325 . . . . 0.0 111.094 -177.237 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 125' ' ' VAL . . . . . . . . . . . . . 10.4 p -132.22 131.21 60.97 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.19 0 CA-C-N 116.009 -0.541 . . . . 0.0 110.332 -179.928 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 126' ' ' ARG . . . . . . . . . . . . . 35.3 mmt180 -142.3 118.03 10.45 Favored 'General case' 0 C--N 1.332 -0.192 0 CA-C-O 120.841 0.353 . . . . 0.0 110.733 178.44 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 127' ' ' ASN . . . . . . . . . . . . . 18.3 t-20 50.07 -104.89 0.16 Allowed 'General case' 0 CA--C 1.543 0.702 0 CA-C-O 119.098 -0.477 . . . . 0.0 111.664 178.017 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 128' ' ' ASP . . . . . . . . . . . . . 22.6 p-10 -114.08 3.8 15.41 Favored 'General case' 0 CA--C 1.537 0.478 0 CA-C-N 119.562 1.074 . . . . 0.0 113.451 -176.689 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 129' ' ' LEU . . . . . . . . . . . . . 14.4 tp -110.91 139.76 45.96 Favored 'General case' 0 C--N 1.332 -0.191 0 N-CA-C 109.673 -0.491 . . . . 0.0 109.673 178.374 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 130' ' ' VAL . . . . . . . . . . . . . 30.1 m -128.64 140.75 48.4 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.226 0 CA-C-O 120.892 0.377 . . . . 0.0 110.176 178.792 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 131' ' ' VAL . . . . . . . . . . . . . 43.8 t -136.06 140.52 43.78 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 CA-C-O 121.257 0.551 . . . . 0.0 110.458 -178.754 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 132' ' ' ILE . . . . . . . . . . . . . 71.8 mt -114.87 132.17 64.88 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.336 0 CA-C-N 115.415 -0.811 . . . . 0.0 109.302 179.28 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 133' ' ' ILE . . . . . . . . . . . . . 39.0 mm -114.25 118.76 59.44 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.236 0 CA-C-N 116.53 -0.304 . . . . 0.0 110.74 -175.604 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 134' ' ' ASP . . . . . . . . . . . . . 8.1 p-10 -133.63 146.31 50.79 Favored 'General case' 0 C--N 1.33 -0.254 0 N-CA-C 109.587 -0.523 . . . . 0.0 109.587 174.95 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 135' ' ' GLU . . . . . . . . . . . . . 80.1 tt0 -49.85 -24.21 2.32 Favored 'General case' 0 C--N 1.328 -0.359 0 N-CA-C 112.782 0.66 . . . . 0.0 112.782 -172.644 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 136' ' ' GLN . . . . . . . . . . . . . 98.7 mt-30 -93.73 -35.35 12.83 Favored 'General case' 0 C--N 1.333 -0.126 0 N-CA-C 112.294 0.479 . . . . 0.0 112.294 -176.243 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 137' ' ' LYS . . . . . . . . . . . . . 88.6 mttt -142.32 153.62 44.02 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-O 121.59 0.709 . . . . 0.0 112.622 -167.788 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 138' ' ' LEU . . . . . . . . . . . . . 14.3 tp -110.7 116.87 32.06 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 114.725 -1.125 . . . . 0.0 108.76 170.725 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 139' ' ' THR . . . . . . . . . . . . . 31.7 m -107.68 121.14 44.09 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-O 120.558 0.218 . . . . 0.0 110.775 -178.165 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 140' ' ' LEU . . . . . . . . . . . . . 7.4 tt -112.85 122.83 48.82 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 115.885 -0.598 . . . . 0.0 109.426 -179.372 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 141' ' ' ILE . . . . . . . . . . . . . 18.9 mt -124.09 122.57 64.7 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.254 0 CA-C-O 121.007 0.432 . . . . 0.0 109.891 -175.863 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 142' ' ' ARG . . . . . . . . . . . . . 71.4 ttt180 -108.86 125.24 51.78 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 115.443 -0.799 . . . . 0.0 110.468 -179.196 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 143' ' ' THR . . . . . . . . . . . . . 5.6 p . . . . . 0 C--O 1.219 -0.536 0 CA-C-O 118.028 -0.986 . . . . 0.0 110.457 179.799 . . . . . . . . 0 0 . 1 . 002 nuclear orig core ' B' B ' 2' ' ' SER . . . . . . . . . . . . . 90.2 p . . . . . 0 C--O 1.231 0.13 0 CA-C-O 120.795 0.331 . . . . 0.0 110.269 . . . . . . . . . 0 0 . 1 . 002 nuclear orig core ' B' B ' 3' ' ' GLU . . . . . . . . . . . . . 95.2 mt-10 -140.41 143.74 35.8 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.274 -0.421 . . . . 0.0 111.147 -177.712 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 4' ' ' LEU . . . . . . . . . . . . . 38.9 mt -121.32 127.01 50.88 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 115.811 -0.631 . . . . 0.0 110.037 175.939 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 5' ' ' LYS . . . . . . . . . . . . . 91.8 mttt -104.64 120.46 41.37 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.29 -0.414 . . . . 0.0 110.468 178.843 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 6' ' ' LEU . . . . . . . . . . . . . 57.8 mt -115.46 148.03 39.91 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 115.564 -0.744 . . . . 0.0 110.406 -179.171 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 7' ' ' LYS . . . . . . . . . . . . . 82.2 tttt -139.95 137.85 18.84 Favored Pre-proline 0 CA--C 1.534 0.357 0 CA-C-O 119.046 -0.502 . . . . 0.0 109.976 176.86 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 8' ' ' PRO . . . . . . . . . . . . . 98.0 Cg_endo -91.44 142.48 2.9 Favored 'Trans proline' 0 N--CA 1.49 1.295 0 C-N-CA 121.734 1.623 . . . . 0.0 111.718 177.719 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 9' ' ' LEU . . . . . . . . . . . . . 52.8 mt -79.23 -46.71 1.64 Allowed Pre-proline 0 CA--C 1.532 0.278 0 CA-C-O 118.847 -0.597 . . . . 0.0 112.105 -179.055 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 10' ' ' PRO . . . . . . . . . . . . . 65.7 Cg_endo -84.36 156.57 12.63 Favored 'Trans proline' 0 N--CA 1.496 1.663 0 C-N-CA 121.309 1.339 . . . . 0.0 111.631 174.488 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 11' ' ' LYS . . . . . . . . . . . . . 20.0 pttm -86.16 120.85 27.97 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-O 120.998 0.428 . . . . 0.0 110.045 176.494 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 12' ' ' VAL . . . . . . . . . . . . . 12.0 p -151.02 148.79 14.7 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.327 0 CA-C-N 116.081 -0.509 . . . . 0.0 110.637 -178.26 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 13' ' ' GLU . . . . . . . . . . . . . 84.7 tt0 -91.62 116.58 28.99 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.279 -0.419 . . . . 0.0 110.132 177.464 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 14' ' ' LEU . . . . . . . . . . . . . 29.5 mt -98.15 146.52 31.66 Favored Pre-proline 0 CA--C 1.532 0.287 0 CA-C-O 119.171 -0.442 . . . . 0.0 110.425 -177.491 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 15' ' ' PRO . . . . . . . . . . . . . 24.0 Cg_exo -64.01 162.18 30.3 Favored 'Trans proline' 0 N--CA 1.498 1.769 0 C-N-CA 121.335 1.357 . . . . 0.0 111.86 176.409 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 16' ' ' PRO . . . . . . . . . . . . . 27.0 Cg_exo -61.14 -35.34 86.64 Favored 'Trans proline' 0 N--CA 1.497 1.699 0 C-N-CA 121.484 1.456 . . . . 0.0 112.511 -179.585 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 17' ' ' ASP . . . . . . . . . . . . . 7.1 p-10 -85.86 6.27 28.98 Favored 'General case' 0 CA--C 1.535 0.388 0 N-CA-C 113.302 0.852 . . . . 0.0 113.302 -177.226 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 18' ' ' PHE . . . . . . . . . . . . . 51.5 t80 -57.48 -43.41 84.07 Favored 'General case' 0 C--N 1.334 -0.105 0 O-C-N 121.891 -0.506 . . . . 0.0 110.152 -179.038 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 19' ' ' VAL . . . . . . . . . . . . . 12.3 p -56.85 -41.76 76.62 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.345 0 CA-C-N 116.304 -0.407 . . . . 0.0 110.763 -179.509 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 20' ' ' ASP . . . . . . . . . . . . . 71.5 m-20 -60.68 -42.04 96.32 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-O 120.893 0.378 . . . . 0.0 110.881 -178.203 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 21' ' ' VAL . . . . . . . . . . . . . 50.6 t -64.42 -47.17 90.56 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.332 0 CA-C-N 116.314 -0.403 . . . . 0.0 110.512 -178.488 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 22' ' ' ILE . . . . . . . . . . . . . 50.5 mm -57.5 -40.21 73.43 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.281 0 C-N-CA 120.916 -0.313 . . . . 0.0 110.675 179.95 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 23' ' ' ARG . . . . . . . . . . . . . 46.4 ttp180 -55.95 -50.75 69.92 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-O 120.927 0.394 . . . . 0.0 110.774 177.571 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 24' ' ' ILE . . . . . . . . . . . . . 67.7 mt -62.17 -41.23 90.52 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.278 0 CA-C-N 116.047 -0.524 . . . . 0.0 112.078 -176.667 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 25' ' ' LYS . . . . . . . . . . . . . 14.9 pttp -73.32 -34.88 65.93 Favored 'General case' 0 CA--C 1.533 0.324 0 C-N-CA 120.687 -0.405 . . . . 0.0 111.79 -174.125 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 26' ' ' LEU . . . . . . . . . . . . . 75.6 mt -79.86 -43.09 22.94 Favored 'General case' 0 C--N 1.33 -0.255 0 N-CA-C 112.426 0.528 . . . . 0.0 112.426 -174.912 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 27' ' ' GLN . . . . . . . . . . . . . 9.6 pt20 -46.36 139.21 5.0 Favored 'General case' 0 N--CA 1.469 0.478 0 N-CA-C 112.838 0.681 . . . . 0.0 112.838 -175.554 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 28' ' ' GLY . . . . . . . . . . . . . . . 101.35 -29.53 12.32 Favored Glycine 0 CA--C 1.531 1.078 0 CA-C-N 115.355 -0.838 . . . . 0.0 112.031 -177.289 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 29' ' ' LYS . . . . . . . . . . . . . 73.7 mmtt -98.16 155.17 17.29 Favored 'General case' 0 C--N 1.332 -0.196 0 CA-C-N 117.194 0.497 . . . . 0.0 110.964 178.466 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 30' ' ' THR . . . . . . . . . . . . . 27.9 m -92.2 135.43 34.01 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.081 -0.509 . . . . 0.0 109.906 175.107 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 31' ' ' VAL . . . . . . . . . . . . . 34.9 m -122.51 145.09 29.84 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.227 0 CA-C-O 120.896 0.379 . . . . 0.0 110.57 -179.152 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 32' ' ' ARG . . . . . . . . . . . . . 73.1 ttt-85 -136.0 148.86 48.61 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 115.863 -0.608 . . . . 0.0 110.383 178.436 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 33' ' ' THR . . . . . . . . . . . . . 26.8 m -52.62 140.7 22.5 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.357 -0.383 . . . . 0.0 111.493 -178.543 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 34' ' ' GLY . . . . . . . . . . . . . . . 100.17 -17.3 57.23 Favored Glycine 0 CA--C 1.533 1.187 0 CA-C-O 119.675 -0.514 . . . . 0.0 113.159 179.678 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 35' ' ' ASP . . . . . . . . . . . . . 75.5 m-20 -65.96 148.87 51.12 Favored 'General case' 0 C--O 1.231 0.092 0 CA-C-N 118.091 0.946 . . . . 0.0 111.054 178.648 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 36' ' ' VAL . . . . . . . . . . . . . 43.4 t -126.44 130.92 71.85 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.2 0 CA-C-N 116.199 -0.455 . . . . 0.0 109.91 178.414 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 37' ' ' ILE . . . . . . . . . . . . . 65.5 mt -122.73 139.69 48.79 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.237 0 CA-C-N 116.174 -0.466 . . . . 0.0 109.984 -179.758 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 38' ' ' GLY . . . . . . . . . . . . . . . -109.31 128.76 9.13 Favored Glycine 0 CA--C 1.526 0.738 0 N-CA-C 111.086 -0.805 . . . . 0.0 111.086 179.518 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 39' ' ' ILE . . . . . . . . . . . . . 65.5 mt -125.69 126.82 70.82 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.249 0 N-CA-C 109.802 -0.444 . . . . 0.0 109.802 178.621 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 40' ' ' SER . . . . . . . . . . . . . 41.2 t -92.44 117.32 29.81 Favored 'General case' 0 C--N 1.329 -0.307 0 C-N-CA 120.961 -0.296 . . . . 0.0 110.914 177.075 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 41' ' ' ILE . . . . . . . . . . . . . 45.3 mm -130.32 124.64 58.08 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.227 0 CA-C-O 120.722 0.296 . . . . 0.0 110.288 179.45 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 42' ' ' LEU . . . . . . . . . . . . . 77.9 mt 58.54 35.1 24.4 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.19 -0.459 . . . . 0.0 111.678 177.307 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 43' ' ' GLY . . . . . . . . . . . . . . . 77.54 -10.12 25.09 Favored Glycine 0 CA--C 1.534 1.261 0 C-N-CA 121.212 -0.518 . . . . 0.0 113.479 177.586 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 44' ' ' LYS . . . . . . . . . . . . . 60.3 mttp -102.49 130.13 49.21 Favored 'General case' 0 C--O 1.232 0.154 0 CA-C-N 117.977 0.888 . . . . 0.0 110.175 177.505 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 45' ' ' GLU . . . . . . . . . . . . . 38.1 tp10 -84.48 128.14 34.42 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-O 120.797 0.332 . . . . 0.0 110.887 179.552 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 46' ' ' VAL . . . . . . . . . . . . . 7.3 p -119.56 129.44 75.32 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.235 0 N-CA-C 109.617 -0.512 . . . . 0.0 109.617 176.741 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 47' ' ' LYS . . . . . . . . . . . . . 35.0 mmtp -99.78 126.91 45.93 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.074 -0.512 . . . . 0.0 110.885 177.833 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 48' ' ' PHE . . . . . . . . . . . . . 91.2 m-85 -108.68 131.81 54.54 Favored 'General case' 0 C--N 1.33 -0.247 0 N-CA-C 109.824 -0.435 . . . . 0.0 109.824 176.461 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 49' ' ' LYS . . . . . . . . . . . . . 85.0 tttt -108.29 136.83 47.29 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.274 -0.421 . . . . 0.0 110.276 178.698 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 50' ' ' VAL . . . . . . . . . . . . . 44.2 t -78.37 108.47 11.83 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.368 0 N-CA-C 109.318 -0.623 . . . . 0.0 109.318 176.304 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 51' ' ' VAL . . . . . . . . . . . . . 48.0 t -69.68 -48.32 65.9 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.298 0 CA-C-N 116.044 -0.525 . . . . 0.0 109.898 -174.27 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 52' ' ' GLN . . . . . . . . . . . . . 47.5 tt0 -169.2 142.56 2.78 Favored 'General case' 0 C--N 1.33 -0.266 0 C-N-CA 120.256 -0.578 . . . . 0.0 111.774 -178.551 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 53' ' ' ALA . . . . . . . . . . . . . . . -111.83 134.17 53.57 Favored 'General case' 0 C--N 1.332 -0.191 0 CA-C-N 115.594 -0.73 . . . . 0.0 109.867 175.572 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 54' ' ' TYR . . . . . . . . . . . . . 41.8 t80 -129.04 108.01 18.07 Favored Pre-proline 0 CA--C 1.534 0.36 0 CA-C-O 118.279 -0.867 . . . . 0.0 110.387 179.823 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 55' ' ' PRO . . . . . . . . . . . . . 73.7 Cg_endo -77.16 170.11 72.4 Favored 'Cis proline' 0 N--CA 1.5 1.863 0 CA-C-N 121.826 1.688 . . . . 0.0 112.396 -6.059 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 56' ' ' SER . . . . . . . . . . . . . 20.9 m -116.1 135.19 22.74 Favored Pre-proline 0 CA--C 1.539 0.544 0 CA-C-O 118.489 -0.767 . . . . 0.0 109.709 175.874 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 57' ' ' PRO . . . . . . . . . . . . . 60.8 Cg_endo -75.15 161.62 94.38 Favored 'Cis proline' 0 N--CA 1.497 1.714 0 CA-C-N 121.792 1.676 . . . . 0.0 111.346 -4.982 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 58' ' ' LEU . . . . . . . . . . . . . 40.4 tp -129.98 138.54 50.88 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-O 120.922 0.392 . . . . 0.0 110.335 -179.791 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 59' ' ' ARG . . . . . . . . . . . . . 74.3 ttt180 -95.52 125.99 40.5 Favored 'General case' 0 C--N 1.326 -0.456 0 N-CA-C 109.229 -0.656 . . . . 0.0 109.229 175.235 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 60' ' ' VAL . . . . . . . . . . . . . 49.9 t -74.76 114.49 14.76 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.331 0 C-N-CA 120.709 -0.396 . . . . 0.0 110.392 -174.587 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 61' ' ' GLU . . . . . . . . . . . . . 70.9 mm-40 -131.1 164.53 25.26 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 115.901 -0.59 . . . . 0.0 110.021 176.542 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 62' ' ' ASP . . . . . . . . . . . . . 13.4 t70 -52.34 -30.32 27.97 Favored 'General case' 0 C--N 1.328 -0.345 0 N-CA-C 112.149 0.426 . . . . 0.0 112.149 -179.408 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 63' ' ' ARG . . . . . . . . . . . . . 39.9 mmt180 -72.05 -20.8 61.62 Favored 'General case' 0 CA--C 1.533 0.301 0 N-CA-C 112.968 0.729 . . . . 0.0 112.968 -174.837 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 64' ' ' THR . . . . . . . . . . . . . 32.9 m -75.66 139.44 41.98 Favored 'General case' 0 C--N 1.331 -0.207 0 CA-C-O 120.947 0.403 . . . . 0.0 111.0 -175.896 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 65' ' ' LYS . . . . . . . . . . . . . 2.3 mptm? -89.4 137.56 32.22 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 115.882 -0.599 . . . . 0.0 109.994 177.457 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 66' ' ' ILE . . . . . . . . . . . . . 60.3 mt -116.51 130.88 70.59 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.29 0 N-CA-C 110.047 -0.353 . . . . 0.0 110.047 179.602 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 67' ' ' THR . . . . . . . . . . . . . 25.5 m -125.06 137.76 54.2 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 116.241 -0.436 . . . . 0.0 110.932 -178.631 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 68' ' ' LEU . . . . . . . . . . . . . 8.4 mp . . . . . 0 C--N 1.33 -0.275 0 CA-C-N 115.99 -0.55 . . . . 0.0 110.588 178.835 . . . . . . . . 0 0 . 1 . 002 nuclear orig core ' B' B ' 73' ' ' VAL . . . . . . . . . . . . . 28.9 m . . . . . 0 C--O 1.232 0.142 0 N-CA-C 109.909 -0.404 . . . . 0.0 109.909 . . . . . . . . . 0 0 . 1 . 002 nuclear orig core ' B' B ' 74' ' ' ASP . . . . . . . . . . . . . 8.8 t70 -97.28 115.01 26.86 Favored 'General case' 0 C--N 1.329 -0.292 0 N-CA-C 109.803 -0.443 . . . . 0.0 109.803 -178.924 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 75' ' ' VAL . . . . . . . . . . . . . 46.3 t -113.08 120.29 62.71 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.242 0 CA-C-O 121.059 0.457 . . . . 0.0 110.223 -178.164 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 76' ' ' LEU . . . . . . . . . . . . . 26.9 mt -123.45 139.74 53.72 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 115.586 -0.734 . . . . 0.0 109.588 178.739 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 77' ' ' GLU . . . . . . . . . . . . . 97.5 mt-10 -134.61 130.97 37.25 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-O 121.101 0.477 . . . . 0.0 111.18 -178.134 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 78' ' ' ALA . . . . . . . . . . . . . . . -120.97 130.46 53.83 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 115.582 -0.736 . . . . 0.0 109.702 177.005 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 79' ' ' LYS . . . . . . . . . . . . . 9.1 ptpp? -73.7 120.97 20.04 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-O 121.201 0.524 . . . . 0.0 110.381 -179.306 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 80' ' ' ILE . . . . . . . . . . . . . 36.8 mm -139.12 108.66 3.9 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.288 0 N-CA-C 109.133 -0.691 . . . . 0.0 109.133 -177.648 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 81' ' ' LYS . . . . . . . . . . . . . 45.6 tttm -107.52 125.93 51.89 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-O 120.877 0.37 . . . . 0.0 111.205 -175.827 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 82' ' ' GLY . . . . . . . . . . . . . . . 89.18 42.0 5.69 Favored Glycine 0 CA--C 1.525 0.665 0 C-N-CA 120.773 -0.727 . . . . 0.0 111.811 175.005 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 83' ' ' ILE . . . . . . . . . . . . . 69.7 mt -69.15 139.94 19.64 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.315 0 N-CA-C 109.936 -0.394 . . . . 0.0 109.936 178.206 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 84' ' ' LYS . . . . . . . . . . . . . 53.1 tttp -96.74 -51.98 4.09 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.158 -0.474 . . . . 0.0 110.221 -179.199 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 85' ' ' ASP . . . . . . . . . . . . . 3.8 t70 -155.62 155.13 32.73 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 115.784 -0.644 . . . . 0.0 110.386 -179.902 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 86' ' ' VAL . . . . . . . . . . . . . 44.2 t -133.51 132.33 57.53 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.198 0 CA-C-O 121.05 0.452 . . . . 0.0 110.715 -177.957 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 87' ' ' ILE . . . . . . . . . . . . . 46.5 mm -121.26 128.12 75.91 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.194 0 CA-C-N 115.693 -0.685 . . . . 0.0 109.439 175.361 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 88' ' ' LEU . . . . . . . . . . . . . 12.8 tp -113.84 133.17 55.58 Favored 'General case' 0 C--N 1.331 -0.212 0 CA-C-O 120.997 0.427 . . . . 0.0 111.298 -176.793 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 89' ' ' ASP . . . . . . . . . . . . . 6.8 t70 -124.96 157.88 34.99 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-N 115.863 -0.608 . . . . 0.0 109.684 176.375 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 90' ' ' GLU . . . . . . . . . . . . . 44.3 mt-10 -44.99 -45.87 10.83 Favored 'General case' 0 N--CA 1.465 0.285 0 N-CA-C 113.272 0.841 . . . . 0.0 113.272 -172.025 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 91' ' ' ASN . . . . . . . . . . . . . 7.7 p-10 -131.97 37.7 3.58 Favored 'General case' 0 N--CA 1.463 0.22 0 CA-C-O 120.801 0.334 . . . . 0.0 111.373 -176.836 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 92' ' ' LEU . . . . . . . . . . . . . 4.3 tp -166.0 144.09 5.68 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-O 120.812 0.339 . . . . 0.0 110.33 179.916 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 93' ' ' ILE . . . . . . . . . . . . . 62.9 mt -125.42 124.74 67.65 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.279 0 N-CA-C 109.709 -0.478 . . . . 0.0 109.709 -177.658 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 94' ' ' VAL . . . . . . . . . . . . . 46.5 t -122.4 125.92 73.43 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.242 0 N-CA-C 109.917 -0.401 . . . . 0.0 109.917 179.527 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 95' ' ' VAL . . . . . . . . . . . . . 45.4 t -124.01 138.09 54.84 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.32 0 CA-C-N 116.131 -0.486 . . . . 0.0 110.113 -178.749 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 96' ' ' ILE . . . . . . . . . . . . . 61.8 mt -116.44 128.51 73.76 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.315 0 N-CA-C 109.255 -0.646 . . . . 0.0 109.255 178.556 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 97' ' ' THR . . . . . . . . . . . . . 71.8 p -102.9 159.61 15.34 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-O 121.265 0.555 . . . . 0.0 111.436 -175.888 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 98' ' ' GLU . . . . . . . . . . . . . 84.9 tt0 -53.91 -25.73 21.64 Favored 'General case' 0 CA--C 1.532 0.272 0 CA-C-N 116.083 -0.508 . . . . 0.0 112.161 179.327 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 99' ' ' GLU . . . . . . . . . . . . . 41.2 mt-10 -78.66 14.93 1.14 Allowed 'General case' 0 CA--C 1.535 0.39 0 N-CA-C 113.097 0.777 . . . . 0.0 113.097 -177.773 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 100' ' ' ASN . . . . . . . . . . . . . 2.4 m-20 60.63 38.01 18.89 Favored 'General case' 0 CA--C 1.529 0.167 0 CA-C-O 121.018 0.437 . . . . 0.0 110.713 179.481 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 101' ' ' GLU . . . . . . . . . . . . . 84.9 tt0 -117.29 146.31 43.41 Favored 'General case' 0 C--N 1.332 -0.173 0 CA-C-N 116.078 -0.51 . . . . 0.0 109.795 178.189 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 102' ' ' VAL . . . . . . . . . . . . . 44.9 t -114.95 124.74 71.91 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.275 0 CA-C-N 116.258 -0.428 . . . . 0.0 109.85 -178.158 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 103' ' ' LEU . . . . . . . . . . . . . 50.9 mt -115.15 132.69 56.52 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 115.715 -0.675 . . . . 0.0 109.996 178.594 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 104' ' ' ILE . . . . . 0.412 HD11 HG22 ' B' ' 104' ' ' ILE . 66.6 mt -123.22 119.59 58.02 Favored 'Isoleucine or valine' 0 C--O 1.233 0.2 0 N-CA-C 110.375 -0.231 . . . . 0.0 110.375 -178.334 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' B' B ' 105' ' ' PHE . . . . . . . . . . . . . 47.1 m-85 -121.17 164.61 16.62 Favored 'General case' 0 C--N 1.331 -0.211 0 CA-C-N 115.471 -0.786 . . . . 0.0 109.809 178.841 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 106' ' ' ASN . . . . . . . . . . . . . 47.4 p-10 -97.67 -169.98 1.92 Allowed 'General case' 0 C--N 1.33 -0.282 0 N-CA-C 109.652 -0.499 . . . . 0.0 109.652 172.851 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 107' ' ' GLN . . . . . . . . . . . . . 62.6 tt0 -59.67 -30.07 68.5 Favored 'General case' 0 C--N 1.33 -0.27 0 N-CA-C 111.879 0.325 . . . . 0.0 111.879 179.81 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 108' ' ' ASN . . . . . . . . . . . . . 7.0 t30 -83.24 8.76 12.39 Favored 'General case' 0 CA--C 1.536 0.432 0 N-CA-C 113.148 0.796 . . . . 0.0 113.148 -177.535 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 109' ' ' LEU . . . . . . . . . . . . . 11.1 tp 60.99 36.21 18.71 Favored 'General case' 0 CA--C 1.53 0.198 0 CA-C-O 120.838 0.351 . . . . 0.0 111.434 178.845 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 110' ' ' GLU . . . . . . . . . . . . . 95.3 mt-10 -105.9 151.2 24.86 Favored 'General case' 0 C--N 1.33 -0.264 0 N-CA-C 109.898 -0.408 . . . . 0.0 109.898 176.884 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 111' ' ' GLU . . . . . . . . . . . . . 99.4 mt-10 -79.77 121.97 26.03 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-O 120.961 0.41 . . . . 0.0 111.34 -177.107 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 112' ' ' LEU . . . . . . . . . . . . . 16.3 mt -106.6 -45.74 4.16 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 115.894 -0.593 . . . . 0.0 110.086 176.418 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 113' ' ' TYR . . . . . . . . . . . . . 61.1 t80 -141.16 142.92 34.0 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 116.104 -0.498 . . . . 0.0 111.006 -179.488 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 114' ' ' ARG . . . . . . . . . . . . . 83.7 mtp180 -144.86 122.12 11.55 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.097 -0.502 . . . . 0.0 110.285 177.388 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 115' ' ' GLY . . . . . . . . . . . . . . . -150.05 162.59 29.23 Favored Glycine 0 CA--C 1.524 0.646 0 N-CA-C 111.006 -0.837 . . . . 0.0 111.006 179.881 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 116' ' ' LYS . . . . . . . . . . . . . 21.6 ttpt -129.1 140.8 51.42 Favored 'General case' 0 C--N 1.33 -0.267 0 N-CA-C 110.204 -0.295 . . . . 0.0 110.204 179.376 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 117' ' ' PHE . . . . . . . . . . . . . 29.1 m-85 -140.8 113.91 8.48 Favored 'General case' 0 C--N 1.331 -0.215 0 N-CA-C 109.927 -0.397 . . . . 0.0 109.927 -178.919 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 118' ' ' GLU . . . . . . . . . . . . . 70.8 mm-40 -56.19 -40.1 73.44 Favored 'General case' 0 C--N 1.329 -0.304 0 C-N-CA 120.912 -0.315 . . . . 0.0 110.944 -177.164 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 119' ' ' ASN . . . . . . . . . . . . . 80.7 m-20 -98.02 30.73 2.95 Favored 'General case' 0 C--N 1.33 -0.261 0 N-CA-C 112.168 0.432 . . . . 0.0 112.168 -175.502 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 120' ' ' LEU . . . . . . . . . . . . . 15.3 tp -58.29 123.69 16.92 Favored 'General case' 0 C--N 1.332 -0.184 0 N-CA-C 110.177 -0.305 . . . . 0.0 110.177 177.051 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 121' ' ' ASN . . . . . . . . . . . . . 77.7 m-20 -114.09 -44.08 3.18 Favored 'General case' 0 C--N 1.332 -0.195 0 CA-C-N 116.545 -0.298 . . . . 0.0 110.866 -178.475 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 122' ' ' LYS . . . . . . . . . . . . . 97.2 mttt -148.58 153.69 38.71 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-O 121.052 0.453 . . . . 0.0 111.569 -178.288 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 123' ' ' VAL . . . . . . . . . . . . . 46.1 t -133.91 130.87 55.9 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.228 0 CA-C-N 115.95 -0.568 . . . . 0.0 109.658 175.13 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 124' ' ' LEU . . . . . . . . . . . . . 64.5 mt -120.56 138.67 53.74 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.176 -0.465 . . . . 0.0 110.476 -178.206 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 125' ' ' VAL . . . . . . . . . . . . . 11.9 p -133.19 127.35 54.36 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.254 0 CA-C-N 116.463 -0.335 . . . . 0.0 110.266 178.413 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 126' ' ' ARG . . . . . . . . . . . . . 40.8 mmt180 -136.84 116.11 12.61 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.3 -0.409 . . . . 0.0 110.339 -179.707 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 127' ' ' ASN . . . . . . . . . . . . . 47.8 t30 52.67 -106.27 0.28 Allowed 'General case' 0 CA--C 1.543 0.71 0 CA-C-O 119.039 -0.505 . . . . 0.0 111.058 -179.986 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 128' ' ' ASP . . . . . . . . . . . . . 19.0 p-10 -114.09 2.92 15.07 Favored 'General case' 0 CA--C 1.536 0.426 0 CA-C-N 119.665 1.12 . . . . 0.0 113.422 -178.449 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 129' ' ' LEU . . . . . . . . . . . . . 2.5 tt -104.86 135.72 45.7 Favored 'General case' 0 C--N 1.332 -0.17 0 N-CA-C 109.583 -0.525 . . . . 0.0 109.583 179.324 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 130' ' ' VAL . . . . . . . . . . . . . 42.0 t -123.13 139.64 49.25 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.298 0 CA-C-O 120.799 0.333 . . . . 0.0 110.176 -177.678 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 131' ' ' VAL . . . . . . . . . . . . . 39.9 t -135.8 135.17 51.07 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.284 0 CA-C-N 116.235 -0.438 . . . . 0.0 110.162 179.561 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 132' ' ' ILE . . . . . . . . . . . . . 71.1 mt -117.52 132.45 67.3 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 N-CA-C 109.37 -0.604 . . . . 0.0 109.37 178.493 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 133' ' ' ILE . . . . . . . . . . . . . 37.7 mm -117.79 122.31 69.46 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.268 0 CA-C-O 120.617 0.246 . . . . 0.0 111.09 -174.272 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 134' ' ' ASP . . . . . . . . . . . . . 9.1 p-10 -137.38 147.82 45.76 Favored 'General case' 0 C--N 1.331 -0.207 0 CA-C-N 116.179 -0.464 . . . . 0.0 109.794 174.862 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 135' ' ' GLU . . . . . . . . . . . . . 85.5 tt0 -49.78 -24.67 2.5 Favored 'General case' 0 C--N 1.328 -0.333 0 N-CA-C 112.875 0.695 . . . . 0.0 112.875 -173.239 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 136' ' ' GLN . . . . . . . . . . . . . 56.1 tp60 -83.91 -37.64 22.11 Favored 'General case' 0 C--O 1.235 0.316 0 N-CA-C 111.959 0.355 . . . . 0.0 111.959 -175.762 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 137' ' ' LYS . . . . . . . . . . . . . 54.0 pttt -161.28 171.92 17.53 Favored 'General case' 0 C--N 1.331 -0.239 0 CA-C-O 121.558 0.694 . . . . 0.0 112.072 -172.394 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 138' ' ' LEU . . . . . . . . . . . . . 4.7 tt -118.36 126.21 51.62 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 114.962 -1.017 . . . . 0.0 109.649 177.425 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 139' ' ' THR . . . . . . . . . . . . . 16.9 m -106.88 126.19 51.99 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-N 116.24 -0.436 . . . . 0.0 110.616 -178.735 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 140' ' ' LEU . . . . . . . . . . . . . 30.8 tp -114.98 122.51 46.46 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 115.655 -0.702 . . . . 0.0 109.456 -178.405 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 141' ' ' ILE . . . . . . . . . . . . . 19.3 mt -121.86 119.79 59.71 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.282 0 N-CA-C 110.142 -0.318 . . . . 0.0 110.142 -175.039 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 142' ' ' ARG . . . . . . . . . . . . . 82.0 mtm180 -110.18 127.45 54.94 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 115.661 -0.699 . . . . 0.0 110.286 -179.585 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 143' ' ' THR . . . . . . . . . . . . . 41.6 p . . . . . 0 C--O 1.22 -0.467 0 CA-C-O 118.037 -0.982 . . . . 0.0 110.68 -179.436 . . . . . . . . 0 0 . 1 . 002 nuclear orig core ' C' C ' 2' ' ' SER . . . . . . . . . . . . . 2.6 p . . . . . 0 N--CA 1.461 0.113 0 CA-C-O 120.902 0.382 . . . . 0.0 110.336 . . . . . . . . . 0 0 . 1 . 002 nuclear orig core ' C' C ' 3' ' ' GLU . . . . . . . . . . . . . 95.5 mt-10 -140.99 140.34 34.33 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 116.049 -0.523 . . . . 0.0 111.063 -177.9 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' C' C ' 4' ' ' LEU . . . . . . . . . . . . . 16.1 tp -126.62 128.52 46.91 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 115.996 -0.547 . . . . 0.0 110.098 176.508 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' C' C ' 5' ' ' LYS . . . . . . . . . . . . . 97.4 mttt -109.27 121.5 45.31 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.4 -0.363 . . . . 0.0 110.478 179.531 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' C' C ' 6' ' ' LEU . . . . . . . . . . . . . 62.1 mt -116.21 148.8 40.05 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 115.616 -0.72 . . . . 0.0 110.293 -178.398 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' C' C ' 7' ' ' LYS . . . . . . . . . . . . . 75.6 tttt -136.4 138.54 27.16 Favored Pre-proline 0 CA--C 1.535 0.374 0 CA-C-O 118.996 -0.526 . . . . 0.0 110.2 176.774 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' C' C ' 8' ' ' PRO . . . . . . . . . . . . . 94.2 Cg_endo -91.81 142.76 2.74 Favored 'Trans proline' 0 N--CA 1.489 1.263 0 C-N-CA 121.725 1.617 . . . . 0.0 111.664 176.959 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' C' C ' 9' ' ' LEU . . . . . . . . . . . . . 36.9 mt -82.52 -47.83 0.88 Allowed Pre-proline 0 CA--C 1.534 0.343 0 CA-C-O 118.74 -0.647 . . . . 0.0 112.495 -177.681 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' C' C ' 10' ' ' PRO . . . . . . . . . . . . . 94.5 Cg_endo -81.65 161.13 19.2 Favored 'Trans proline' 0 N--CA 1.497 1.694 0 C-N-CA 121.24 1.293 . . . . 0.0 111.969 177.101 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' C' C ' 11' ' ' LYS . . . . . . . . . . . . . 91.0 mttt -86.52 103.11 14.73 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.389 -0.368 . . . . 0.0 110.38 177.825 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' C' C ' 12' ' ' VAL . . . . . . . . . . . . . 11.9 p -141.71 143.61 26.93 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.276 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.371 179.847 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' C' C ' 13' ' ' GLU . . . . . . . . . . . . . 82.5 tt0 -90.82 122.81 33.86 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 116.323 -0.399 . . . . 0.0 109.987 177.967 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' C' C ' 14' ' ' LEU . . . . . . . . . . . . . 25.3 mt -96.9 152.38 38.36 Favored Pre-proline 0 C--N 1.329 -0.311 0 CA-C-N 116.458 -0.337 . . . . 0.0 111.03 -175.973 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' C' C ' 15' ' ' PRO . . . . . . . . . . . . . 26.6 Cg_exo -61.72 163.11 19.48 Favored 'Trans proline' 0 N--CA 1.497 1.711 0 C-N-CA 121.255 1.303 . . . . 0.0 111.892 176.634 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' C' C ' 16' ' ' PRO . . . . . . . . . . . . . 25.2 Cg_exo -61.64 -44.44 21.77 Favored 'Trans proline' 0 N--CA 1.497 1.713 0 C-N-CA 121.516 1.478 . . . . 0.0 112.668 -178.472 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' C' C ' 17' ' ' ASP . . . . . . . . . . . . . 22.3 p-10 -88.72 16.23 7.07 Favored 'General case' 0 C--N 1.327 -0.385 0 N-CA-C 112.994 0.738 . . . . 0.0 112.994 -177.13 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' C' C ' 18' ' ' PHE . . . . . . . . . . . . . 63.4 t80 -57.6 -41.53 81.43 Favored 'General case' 0 C--N 1.335 -0.064 0 O-C-N 122.053 -0.404 . . . . 0.0 110.315 -178.59 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' C' C ' 19' ' ' VAL . . . . . . . . . . . . . 44.3 t -56.26 -45.56 81.22 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.338 0 CA-C-N 116.47 -0.332 . . . . 0.0 110.624 -178.173 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' C' C ' 20' ' ' ASP . . . . . . . . . . . . . 51.4 m-20 -60.6 -40.43 91.77 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-O 120.763 0.316 . . . . 0.0 111.021 -178.295 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' C' C ' 21' ' ' VAL . . . . . . . . . . . . . 48.2 t -64.0 -48.46 85.91 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.328 0 C-N-CA 120.769 -0.373 . . . . 0.0 110.421 -178.373 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' C' C ' 22' ' ' ILE . . . . . . . . . . . . . 51.5 mm -55.61 -44.37 76.41 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.299 0 CA-C-O 120.895 0.379 . . . . 0.0 110.461 178.29 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' C' C ' 23' ' ' ARG . . . . . . . . . . . . . 56.6 ttp180 -52.51 -52.26 55.44 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-O 120.717 0.294 . . . . 0.0 111.609 -179.955 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' C' C ' 24' ' ' ILE . . . . . . . . . . . . . 71.1 mt -59.4 -40.63 82.12 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.294 0 CA-C-N 116.407 -0.361 . . . . 0.0 111.389 -176.338 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' C' C ' 25' ' ' LYS . . . . . . . . . . . . . 91.3 mttt -67.2 -37.83 84.31 Favored 'General case' 0 C--N 1.329 -0.288 0 N-CA-C 112.179 0.437 . . . . 0.0 112.179 -179.53 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' C' C ' 26' ' ' LEU . . . . . . . . . . . . . 68.2 mt -79.13 -41.18 29.15 Favored 'General case' 0 C--N 1.329 -0.295 0 N-CA-C 113.125 0.787 . . . . 0.0 113.125 -171.297 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' C' C ' 27' ' ' GLN . . . . . . . . . . . . . 9.9 pt20 -46.68 139.0 5.57 Favored 'General case' 0 N--CA 1.47 0.558 0 N-CA-C 112.659 0.614 . . . . 0.0 112.659 -176.151 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' C' C ' 28' ' ' GLY . . . . . . . . . . . . . . . 101.13 -26.87 23.07 Favored Glycine 0 CA--C 1.532 1.114 0 CA-C-N 115.536 -0.756 . . . . 0.0 112.213 -177.441 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' C' C ' 29' ' ' LYS . . . . . . . . . . . . . 61.7 mtpt -98.22 155.2 17.29 Favored 'General case' 0 C--N 1.333 -0.138 0 CA-C-N 117.32 0.56 . . . . 0.0 111.2 179.595 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' C' C ' 30' ' ' THR . . . . . . . . . . . . . 36.0 m -105.91 135.63 47.0 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 115.962 -0.563 . . . . 0.0 109.939 175.705 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' C' C ' 31' ' ' VAL . . . . . . . . . . . . . 34.5 m -132.87 158.32 43.24 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.271 0 CA-C-O 120.947 0.403 . . . . 0.0 111.019 -177.587 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' C' C ' 32' ' ' ARG . . . . . . . . . . . . . 50.7 mtp180 -134.89 152.71 51.97 Favored 'General case' 0 C--N 1.331 -0.219 0 CA-C-O 121.353 0.597 . . . . 0.0 110.706 178.736 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' C' C ' 33' ' ' THR . . . . . . . . . . . . . 22.1 m -52.57 140.17 23.68 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 115.997 -0.547 . . . . 0.0 111.509 -178.347 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' C' C ' 34' ' ' GLY . . . . . . . . . . . . . . . 100.0 -17.22 57.51 Favored Glycine 0 CA--C 1.532 1.117 0 CA-C-O 119.553 -0.582 . . . . 0.0 113.258 178.092 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' C' C ' 35' ' ' ASP . . . . . . . . . . . . . 77.5 m-20 -66.06 148.08 52.36 Favored 'General case' 0 N--CA 1.461 0.109 0 CA-C-N 118.148 0.974 . . . . 0.0 110.897 178.836 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' C' C ' 36' ' ' VAL . . . . . . . . . . . . . 44.2 t -124.92 132.8 70.85 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.238 0 CA-C-N 116.169 -0.468 . . . . 0.0 109.955 178.648 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' C' C ' 37' ' ' ILE . . . . . . . . . . . . . 67.8 mt -123.43 141.64 42.97 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.286 0 CA-C-N 116.072 -0.513 . . . . 0.0 110.04 -178.714 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' C' C ' 38' ' ' GLY . . . . . . . . . . . . . . . -111.56 129.0 8.91 Favored Glycine 0 CA--C 1.525 0.673 0 N-CA-C 111.021 -0.832 . . . . 0.0 111.021 179.667 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' C' C ' 39' ' ' ILE . . . . . . . . . . . . . 76.3 mt -125.39 137.34 57.96 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.193 0 CA-C-O 120.731 0.3 . . . . 0.0 110.205 179.805 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' C' C ' 40' ' ' SER . . . . . . . . . . . . . 35.8 t -93.4 124.6 37.5 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.273 -0.421 . . . . 0.0 110.903 175.643 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' C' C ' 41' ' ' ILE . . . . . . . . . . . . . 73.1 mt -130.56 119.59 46.21 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.181 0 CA-C-O 120.845 0.355 . . . . 0.0 110.336 177.757 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' C' C ' 42' ' ' LEU . . . . . . . . . . . . . 7.3 mp 51.71 37.24 19.66 Favored 'General case' 0 C--N 1.331 -0.221 0 CA-C-N 116.06 -0.518 . . . . 0.0 111.489 177.306 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' C' C ' 43' ' ' GLY . . . . . . . . . . . . . . . 72.58 30.88 63.58 Favored Glycine 0 CA--C 1.528 0.892 0 C-N-CA 121.07 -0.586 . . . . 0.0 112.309 176.837 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' C' C ' 44' ' ' LYS . . . . . . . . . . . . . 82.4 tttt -137.75 131.62 31.56 Favored 'General case' 0 C--N 1.33 -0.265 0 N-CA-C 109.692 -0.484 . . . . 0.0 109.692 177.085 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' C' C ' 45' ' ' GLU . . . . . . . . . . . . . 81.2 tt0 -82.91 123.08 29.07 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-O 120.725 0.298 . . . . 0.0 111.179 -177.345 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' C' C ' 46' ' ' VAL . . . . . . . . . . . . . 7.3 p -121.58 128.24 75.77 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.223 0 N-CA-C 109.624 -0.51 . . . . 0.0 109.624 176.212 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' C' C ' 47' ' ' LYS . . . . . . . . . . . . . 66.8 mttm -99.45 129.99 45.68 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.008 -0.542 . . . . 0.0 111.138 178.668 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' C' C ' 48' ' ' PHE . . . . . . . . . . . . . 91.6 m-85 -113.82 131.86 56.09 Favored 'General case' 0 C--N 1.33 -0.269 0 N-CA-C 109.873 -0.418 . . . . 0.0 109.873 176.255 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' C' C ' 49' ' ' LYS . . . . . . . . . . . . . 63.6 tttm -109.28 139.23 44.48 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.528 -0.305 . . . . 0.0 110.7 178.323 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' C' C ' 50' ' ' VAL . . . . . . . . . . . . . 45.7 t -81.17 108.54 14.56 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.352 0 N-CA-C 109.327 -0.62 . . . . 0.0 109.327 175.614 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' C' C ' 51' ' ' VAL . . . . . . . . . . . . . 46.7 t -70.04 -48.66 61.37 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.316 0 CA-C-N 116.131 -0.486 . . . . 0.0 109.8 -174.494 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' C' C ' 52' ' ' GLN . . . . . . . . . . . . . 61.6 tt0 -165.72 148.21 7.51 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.063 -0.517 . . . . 0.0 111.691 -178.964 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' C' C ' 53' ' ' ALA . . . . . . . . . . . . . . . -123.35 133.55 54.11 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 115.655 -0.702 . . . . 0.0 110.01 177.928 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' C' C ' 54' ' ' TYR . . . . . . . . . . . . . 10.3 t80 -129.02 111.98 18.5 Favored Pre-proline 0 CA--C 1.536 0.409 0 CA-C-O 118.179 -0.915 . . . . 0.0 110.483 178.977 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' C' C ' 55' ' ' PRO . . . . . . . . . . . . . 73.2 Cg_endo -77.23 168.27 77.32 Favored 'Cis proline' 0 N--CA 1.501 1.918 0 CA-C-N 122.028 1.76 . . . . 0.0 112.278 -6.782 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' C' C ' 56' ' ' SER . . . . . . . . . . . . . 13.5 m -117.35 132.33 23.59 Favored Pre-proline 0 CA--C 1.539 0.533 0 CA-C-O 118.453 -0.784 . . . . 0.0 109.292 174.21 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' C' C ' 57' ' ' PRO . . . . . . . . . . . . . 54.2 Cg_endo -70.08 147.15 84.72 Favored 'Cis proline' 0 N--CA 1.497 1.735 0 CA-C-N 121.834 1.691 . . . . 0.0 111.573 -0.109 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' C' C ' 58' ' ' LEU . . . . . . . . . . . . . 24.6 tp -108.51 136.51 48.0 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.409 -0.359 . . . . 0.0 110.843 -178.427 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' C' C ' 59' ' ' ARG . . . . . . . . . . . . . 59.2 ttt85 -102.95 121.11 41.86 Favored 'General case' 0 C--N 1.326 -0.421 0 N-CA-C 109.288 -0.634 . . . . 0.0 109.288 175.15 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' C' C ' 60' ' ' VAL . . . . . . . . . . . . . 42.5 t -76.42 118.42 22.78 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.28 0 C-N-CA 120.728 -0.389 . . . . 0.0 110.559 -174.881 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' C' C ' 61' ' ' GLU . . . . . . . . . . . . . 71.0 mm-40 -130.99 162.7 29.18 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 115.984 -0.553 . . . . 0.0 109.779 176.377 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' C' C ' 62' ' ' ASP . . . . . . . . . . . . . 80.3 m-20 -52.41 -30.5 29.66 Favored 'General case' 0 C--N 1.329 -0.302 0 N-CA-C 112.05 0.389 . . . . 0.0 112.05 179.758 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' C' C ' 63' ' ' ARG . . . . . . . . . . . . . 77.1 mtp85 -72.61 -21.85 61.05 Favored 'General case' 0 CA--C 1.533 0.294 0 N-CA-C 112.894 0.702 . . . . 0.0 112.894 -175.956 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' C' C ' 64' ' ' THR . . . . . . . . . . . . . 26.4 m -69.52 137.7 52.72 Favored 'General case' 0 C--N 1.331 -0.215 0 CA-C-O 120.993 0.425 . . . . 0.0 111.292 -174.683 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' C' C ' 65' ' ' LYS . . . . . . . . . . . . . 98.7 mttt -90.08 135.61 33.55 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 115.832 -0.622 . . . . 0.0 110.111 177.561 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' C' C ' 66' ' ' ILE . . . . . . . . . . . . . 64.4 mt -117.66 132.89 66.14 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.224 0 CA-C-O 120.868 0.366 . . . . 0.0 110.166 -179.787 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' C' C ' 67' ' ' THR . . . . . . . . . . . . . 30.1 m -122.39 139.61 53.64 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 115.988 -0.551 . . . . 0.0 110.813 -179.188 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' C' C ' 68' ' ' LEU . . . . . . . . . . . . . 4.1 tt . . . . . 0 C--N 1.329 -0.299 0 CA-C-N 115.982 -0.554 . . . . 0.0 110.29 178.971 . . . . . . . . 0 0 . 1 . 002 nuclear orig core ' C' C ' 73' ' ' VAL . . . . . . . . . . . . . 30.2 m . . . . . 0 N--CA 1.461 0.088 0 CA-C-O 120.658 0.265 . . . . 0.0 110.382 . . . . . . . . . 0 0 . 1 . 002 nuclear orig core ' C' C ' 74' ' ' ASP . . . . . . . . . . . . . 25.8 t0 -98.59 119.91 38.13 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.463 -0.335 . . . . 0.0 110.243 -177.552 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' C' C ' 75' ' ' VAL . . . . . . . . . . . . . 44.2 t -114.84 121.79 67.64 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.222 0 CA-C-O 121.176 0.513 . . . . 0.0 110.379 -179.277 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' C' C ' 76' ' ' LEU . . . . . . . . . . . . . 24.3 mt -118.92 146.58 44.83 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 115.553 -0.749 . . . . 0.0 109.628 178.119 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' C' C ' 77' ' ' GLU . . . . . . . . . . . . . 97.6 mt-10 -138.62 129.35 26.39 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-O 121.051 0.453 . . . . 0.0 111.204 -179.214 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' C' C ' 78' ' ' ALA . . . . . . . . . . . . . . . -116.94 136.5 52.9 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 115.797 -0.638 . . . . 0.0 109.787 177.345 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' C' C ' 79' ' ' LYS . . . . . . . . . . . . . 52.2 pttt -84.79 119.4 25.26 Favored 'General case' 0 C--N 1.331 -0.218 0 CA-C-O 121.237 0.541 . . . . 0.0 111.006 -177.247 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' C' C ' 80' ' ' ILE . . . . . . . . . . . . . 36.0 mm -139.43 117.98 12.26 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.212 0 N-CA-C 109.277 -0.638 . . . . 0.0 109.277 179.946 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' C' C ' 81' ' ' LYS . . . . . . . . . . . . . 57.2 tttm -103.36 122.54 45.05 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-O 120.777 0.322 . . . . 0.0 111.031 -178.037 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' C' C ' 82' ' ' GLY . . . . . . . . . . . . . . . 89.24 42.13 5.64 Favored Glycine 0 CA--C 1.526 0.719 0 C-N-CA 120.819 -0.705 . . . . 0.0 111.831 175.044 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' C' C ' 83' ' ' ILE . . . . . . . . . . . . . 75.3 mt -66.97 137.42 24.87 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.312 0 N-CA-C 109.858 -0.423 . . . . 0.0 109.858 177.318 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' C' C ' 84' ' ' LYS . . . . . . . . . . . . . 80.0 tttt -96.74 -54.02 3.36 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 115.971 -0.558 . . . . 0.0 110.326 -177.727 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' C' C ' 85' ' ' ASP . . . . . . . . . . . . . 8.1 t70 -151.14 150.01 30.15 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 115.748 -0.66 . . . . 0.0 110.407 -177.648 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' C' C ' 86' ' ' VAL . . . . . . . . . . . . . 44.6 t -129.04 129.18 67.87 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.266 0 CA-C-O 120.896 0.379 . . . . 0.0 110.435 -179.483 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' C' C ' 87' ' ' ILE . . . . . . . . . . . . . 5.0 mp -117.45 125.56 74.11 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.288 0 CA-C-N 115.909 -0.587 . . . . 0.0 109.481 176.872 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' C' C ' 88' ' ' LEU . . . . . . . . . . . . . 16.7 tp -110.5 129.68 55.73 Favored 'General case' 0 C--N 1.331 -0.221 0 CA-C-N 116.373 -0.376 . . . . 0.0 110.719 -179.025 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' C' C ' 89' ' ' ASP . . . . . . . . . . . . . 11.9 t70 -126.63 154.75 43.58 Favored 'General case' 0 C--N 1.331 -0.222 0 CA-C-N 116.119 -0.491 . . . . 0.0 109.945 178.0 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' C' C ' 90' ' ' GLU . . . . . . . . . . . . . 77.8 tt0 -45.73 -35.14 4.04 Favored 'General case' 0 C--N 1.329 -0.299 0 N-CA-C 113.332 0.864 . . . . 0.0 113.332 -172.218 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' C' C ' 91' ' ' ASN . . . . . . . . . . . . . 56.7 m-80 -130.87 15.27 5.28 Favored 'General case' 0 N--CA 1.469 0.488 0 N-CA-C 113.309 0.855 . . . . 0.0 113.309 -175.587 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' C' C ' 92' ' ' LEU . . . . . . . . . . . . . 8.5 mt -150.34 151.97 33.71 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 118.131 0.423 . . . . 0.0 110.33 -176.414 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' C' C ' 93' ' ' ILE . . . . . . . . . . . . . 70.1 mt -129.15 119.29 48.63 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.316 0 N-CA-C 109.172 -0.677 . . . . 0.0 109.172 177.342 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' C' C ' 94' ' ' VAL . . . . . . . . . . . . . 45.7 t -119.91 127.98 75.91 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.252 0 CA-C-O 120.875 0.369 . . . . 0.0 110.08 -178.364 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' C' C ' 95' ' ' VAL . . . . . . . . . . . . . 42.5 t -122.46 134.02 66.93 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.25 0 CA-C-N 116.045 -0.525 . . . . 0.0 109.899 -179.984 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' C' C ' 96' ' ' ILE . . . . . . . . . . . . . 64.9 mt -114.54 127.65 71.93 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.386 0 N-CA-C 109.384 -0.599 . . . . 0.0 109.384 179.435 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' C' C ' 97' ' ' THR . . . . . . . . . . . . . 68.1 p -97.8 156.46 16.57 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-O 120.92 0.391 . . . . 0.0 110.732 -179.495 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' C' C ' 98' ' ' GLU . . . . . . . . . . . . . 45.6 tp10 -53.82 -26.5 24.44 Favored 'General case' 0 CA--C 1.534 0.336 0 N-CA-C 112.1 0.407 . . . . 0.0 112.1 -179.531 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' C' C ' 99' ' ' GLU . . . . . . . . . . . . . 28.3 tt0 -79.74 17.26 0.95 Allowed 'General case' 0 CA--C 1.536 0.417 0 N-CA-C 113.004 0.742 . . . . 0.0 113.004 -176.467 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' C' C ' 100' ' ' ASN . . . . . . . . . . . . . 3.0 m-20 62.74 31.39 16.6 Favored 'General case' 0 CA--C 1.532 0.272 0 O-C-N 122.11 -0.369 . . . . 0.0 111.908 176.765 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' C' C ' 101' ' ' GLU . . . . . . . . . . . . . 84.8 tt0 -111.92 142.55 44.18 Favored 'General case' 0 C--N 1.332 -0.165 0 N-CA-C 109.594 -0.521 . . . . 0.0 109.594 173.762 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' C' C ' 102' ' ' VAL . . . . . . . . . . . . . 43.3 t -115.42 129.33 71.87 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.306 0 CA-C-N 116.368 -0.378 . . . . 0.0 110.213 -177.449 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' C' C ' 103' ' ' LEU . . . . . . . . . . . . . 39.9 mt -115.96 129.7 56.5 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 115.601 -0.727 . . . . 0.0 109.822 176.9 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' C' C ' 104' ' ' ILE . . . . . . . . . . . . . 67.4 mt -117.97 121.19 66.73 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.228 0 N-CA-C 110.343 -0.243 . . . . 0.0 110.343 -178.784 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' C' C ' 105' ' ' PHE . . . . . . . . . . . . . 52.7 m-85 -122.66 166.95 14.06 Favored 'General case' 0 C--N 1.333 -0.139 0 O-C-N 123.872 0.732 . . . . 0.0 109.948 179.625 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' C' C ' 106' ' ' ASN . . . . . . . . . . . . . 43.9 p-10 -102.23 -169.97 1.75 Allowed 'General case' 0 C--N 1.33 -0.245 0 N-CA-C 109.972 -0.381 . . . . 0.0 109.972 174.883 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' C' C ' 107' ' ' GLN . . . . . . . . . . . . . 43.2 tt0 -57.19 -29.52 63.75 Favored 'General case' 0 C--N 1.33 -0.274 0 N-CA-C 111.915 0.339 . . . . 0.0 111.915 178.19 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' C' C ' 108' ' ' ASN . . . . . . . . . . . . . 4.0 t-20 -84.67 11.5 8.85 Favored 'General case' 0 CA--C 1.535 0.384 0 N-CA-C 113.009 0.744 . . . . 0.0 113.009 -176.96 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' C' C ' 109' ' ' LEU . . . . . . . . . . . . . 9.7 tp 53.65 37.23 25.56 Favored 'General case' 0 C--O 1.233 0.19 0 CA-C-O 121.064 0.459 . . . . 0.0 111.254 -179.809 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' C' C ' 110' ' ' GLU . . . . . . . . . . . . . 95.8 mt-10 -104.8 145.36 30.48 Favored 'General case' 0 C--N 1.33 -0.25 0 N-CA-C 109.566 -0.531 . . . . 0.0 109.566 175.499 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' C' C ' 111' ' ' GLU . . . . . . . . . . . . . 71.0 tt0 -80.01 121.93 26.1 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-O 120.893 0.377 . . . . 0.0 110.576 -176.738 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' C' C ' 112' ' ' LEU . . . . . . . . . . . . . 10.8 mt -107.66 -46.05 3.9 Favored 'General case' 0 C--N 1.331 -0.218 0 CA-C-N 116.066 -0.515 . . . . 0.0 110.386 -179.54 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' C' C ' 113' ' ' TYR . . . . . . . . . . . . . 55.6 t80 -136.79 142.2 42.94 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-N 116.336 -0.393 . . . . 0.0 111.085 -178.784 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' C' C ' 114' ' ' ARG . . . . . . . . . . . . . 35.9 ptt-85 -142.52 124.59 15.34 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.063 -0.517 . . . . 0.0 110.363 177.507 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' C' C ' 115' ' ' GLY . . . . . . . . . . . . . . . -150.11 162.6 29.25 Favored Glycine 0 CA--C 1.524 0.629 0 N-CA-C 111.123 -0.791 . . . . 0.0 111.123 -179.765 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' C' C ' 116' ' ' LYS . . . . . . . . . . . . . 69.2 tttt -132.09 136.73 47.38 Favored 'General case' 0 C--N 1.329 -0.319 0 N-CA-C 109.797 -0.445 . . . . 0.0 109.797 177.266 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' C' C ' 117' ' ' PHE . . . . . . . . . . . . . 38.2 m-85 -133.67 114.8 13.88 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-O 120.905 0.383 . . . . 0.0 110.179 -175.595 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' C' C ' 118' ' ' GLU . . . . . . . . . . . . . 71.0 mm-40 -51.07 -52.42 43.59 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.454 -0.339 . . . . 0.0 111.792 -176.042 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' C' C ' 119' ' ' ASN . . . . . . . . . . . . . 1.8 m-80 -95.63 31.18 2.09 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.274 -0.421 . . . . 0.0 112.024 -174.193 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' C' C ' 120' ' ' LEU . . . . . . . . . . . . . 18.3 tp -53.57 121.24 7.36 Favored 'General case' 0 N--CA 1.463 0.22 0 O-C-N 122.234 -0.291 . . . . 0.0 110.929 178.704 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' C' C ' 121' ' ' ASN . . . . . . . . . . . . . 69.2 m-20 -113.75 -43.85 3.25 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.341 -0.391 . . . . 0.0 110.929 -177.096 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' C' C ' 122' ' ' LYS . . . . . . . . . . . . . 97.1 mttt -144.69 147.47 33.05 Favored 'General case' 0 C--N 1.332 -0.177 0 CA-C-O 121.154 0.502 . . . . 0.0 111.946 -176.993 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' C' C ' 123' ' ' VAL . . . . . . . . . . . . . 45.6 t -125.82 125.43 68.31 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.259 0 N-CA-C 109.079 -0.711 . . . . 0.0 109.079 173.351 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' C' C ' 124' ' ' LEU . . . . . . . . . . . . . 59.9 mt -123.9 138.76 54.43 Favored 'General case' 0 C--N 1.331 -0.216 0 CA-C-O 120.877 0.37 . . . . 0.0 110.99 -176.232 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' C' C ' 125' ' ' VAL . . . . . . . . . . . . . 35.7 m -133.97 140.51 46.16 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.28 0 CA-C-N 116.018 -0.537 . . . . 0.0 110.365 178.399 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' C' C ' 126' ' ' ARG . . . . . . . . . . . . . 38.9 ttt180 -151.09 122.66 7.95 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-O 120.98 0.419 . . . . 0.0 110.67 177.634 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' C' C ' 127' ' ' ASN . . . . . . . . . . . . . 20.3 t-20 52.08 -107.29 0.32 Allowed 'General case' 0 CA--C 1.543 0.687 0 CA-C-O 118.968 -0.539 . . . . 0.0 111.177 -179.048 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' C' C ' 128' ' ' ASP . . . . . . . . . . . . . 17.7 p-10 -114.17 5.07 15.78 Favored 'General case' 0 N--CA 1.467 0.413 0 CA-C-N 119.654 1.116 . . . . 0.0 113.468 -177.223 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' C' C ' 129' ' ' LEU . . . . . . . . . . . . . 18.3 tp -106.66 138.62 42.49 Favored 'General case' 0 C--O 1.232 0.147 0 O-C-N 122.008 -0.432 . . . . 0.0 110.362 -179.419 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' C' C ' 130' ' ' VAL . . . . . . . . . . . . . 40.4 t -121.33 135.36 61.75 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.227 0 N-CA-C 109.724 -0.472 . . . . 0.0 109.724 179.938 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' C' C ' 131' ' ' VAL . . . . . . . . . . . . . 43.0 t -136.01 136.82 49.42 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.24 0 CA-C-O 120.997 0.427 . . . . 0.0 110.419 179.985 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' C' C ' 132' ' ' ILE . . . . . . . . . . . . . 68.5 mt -118.42 133.87 63.86 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.314 0 CA-C-N 115.853 -0.612 . . . . 0.0 109.491 179.058 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' C' C ' 133' ' ' ILE . . . . . . . . . . . . . 37.6 mm -116.78 119.31 61.62 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.231 0 CA-C-N 116.52 -0.309 . . . . 0.0 110.941 -175.361 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' C' C ' 134' ' ' ASP . . . . . . . . . . . . . 7.4 p-10 -130.13 148.95 52.03 Favored 'General case' 0 C--N 1.332 -0.182 0 N-CA-C 109.727 -0.471 . . . . 0.0 109.727 174.258 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' C' C ' 135' ' ' GLU . . . . . . . . . . . . . 39.2 tp10 -49.95 -24.57 2.63 Favored 'General case' 0 C--N 1.329 -0.302 0 N-CA-C 112.996 0.739 . . . . 0.0 112.996 -170.471 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' C' C ' 136' ' ' GLN . . . . . . . . . . . . . 52.8 mt-30 -104.76 -26.63 12.19 Favored 'General case' 0 N--CA 1.464 0.248 0 N-CA-C 112.773 0.657 . . . . 0.0 112.773 -174.113 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' C' C ' 137' ' ' LYS . . . . . . . . . . . . . 56.6 mtpt -141.15 150.0 42.23 Favored 'General case' 0 C--N 1.332 -0.194 0 CA-C-O 121.404 0.621 . . . . 0.0 112.099 -169.038 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' C' C ' 138' ' ' LEU . . . . . . . . . . . . . 18.1 tp -111.12 120.6 42.86 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 115.054 -0.975 . . . . 0.0 109.045 173.259 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' C' C ' 139' ' ' THR . . . . . . . . . . . . . 27.0 m -109.82 126.02 53.36 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-O 120.82 0.343 . . . . 0.0 110.973 -178.23 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' C' C ' 140' ' ' LEU . . . . . . . . . . . . . 17.7 tp -115.61 122.71 46.42 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 115.471 -0.786 . . . . 0.0 109.309 -179.361 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' C' C ' 141' ' ' ILE . . . . . . . . . . . . . 19.5 mt -121.76 119.42 58.74 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 N-CA-C 109.763 -0.458 . . . . 0.0 109.763 -176.37 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' C' C ' 142' ' ' ARG . . . . . . . . . . . . . 82.6 mtm180 . . . . . 0 C--N 1.33 -0.271 0 CA-C-N 115.691 -0.686 . . . . 0.0 110.721 -177.769 . . . . . . . . 0 0 . 1 . 002 nuclear orig core ' D' D ' 2' ' ' SER . . . . . . . . . . . . . 92.7 p . . . . . 0 C--O 1.231 0.085 0 CA-C-O 121.01 0.433 . . . . 0.0 110.742 . . . . . . . . . 0 0 . 1 . 002 nuclear orig core ' D' D ' 3' ' ' GLU . . . . . . . . . . . . . 47.1 mp0 -139.41 144.58 38.17 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 115.933 -0.576 . . . . 0.0 111.227 -176.669 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' D' D ' 4' ' ' LEU . . . . . . . . . . . . . 16.4 tp -123.32 126.8 47.54 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 115.777 -0.647 . . . . 0.0 109.685 175.187 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' D' D ' 5' ' ' LYS . . . . . . . . . . . . . 88.3 mttt -109.02 121.0 44.21 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.384 -0.371 . . . . 0.0 110.642 -178.542 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' D' D ' 6' ' ' LEU . . . . . . . . . . . . . 47.8 mt -115.48 144.5 43.75 Favored 'General case' 0 C--N 1.331 -0.21 0 CA-C-N 115.87 -0.605 . . . . 0.0 110.256 -179.844 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' D' D ' 7' ' ' LYS . . . . . . . . . . . . . 45.4 tttp -127.37 136.89 29.59 Favored Pre-proline 0 CA--C 1.532 0.278 0 CA-C-O 118.886 -0.578 . . . . 0.0 109.465 175.17 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' D' D ' 8' ' ' PRO . . . . . . . . . . . . . 71.9 Cg_endo -90.41 132.99 1.82 Allowed 'Trans proline' 0 N--CA 1.49 1.319 0 C-N-CA 121.619 1.546 . . . . 0.0 111.858 178.548 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' D' D ' 9' ' ' LEU . . . . . . . . . . . . . 43.0 mt -72.26 -46.99 10.77 Favored Pre-proline 0 C--N 1.329 -0.313 0 CA-C-O 118.69 -0.671 . . . . 0.0 111.963 -179.956 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' D' D ' 10' ' ' PRO . . . . . . . . . . . . . 93.2 Cg_endo -82.37 146.63 13.94 Favored 'Trans proline' 0 N--CA 1.496 1.62 0 C-N-CA 121.178 1.252 . . . . 0.0 111.635 174.978 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' D' D ' 11' ' ' LYS . . . . . . . . . . . . . 25.1 pttm -71.67 119.2 15.49 Favored 'General case' 0 C--N 1.331 -0.203 0 N-CA-C 109.692 -0.484 . . . . 0.0 109.692 177.19 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' D' D ' 12' ' ' VAL . . . . . . . . . . . . . 12.2 p -151.17 149.51 14.07 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.288 0 CA-C-N 116.094 -0.503 . . . . 0.0 111.127 -176.414 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' D' D ' 13' ' ' GLU . . . . . . . . . . . . . 42.5 mt-10 -108.46 109.98 21.38 Favored 'General case' 0 C--N 1.331 -0.227 0 CA-C-N 115.985 -0.552 . . . . 0.0 109.81 175.466 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' D' D ' 14' ' ' LEU . . . . . . . . . . . . . 16.1 mt -97.6 152.1 37.98 Favored Pre-proline 0 CA--C 1.532 0.282 0 CA-C-O 119.398 -0.334 . . . . 0.0 110.915 -176.724 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' D' D ' 15' ' ' PRO . . . . . . . . . . . . . 25.5 Cg_exo -62.36 160.41 31.39 Favored 'Trans proline' 0 N--CA 1.498 1.769 0 C-N-CA 121.337 1.358 . . . . 0.0 111.894 176.999 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' D' D ' 16' ' ' PRO . . . . . . . . . . . . . 27.2 Cg_exo -60.98 -37.79 73.91 Favored 'Trans proline' 0 N--CA 1.498 1.758 0 C-N-CA 121.479 1.453 . . . . 0.0 112.643 -179.7 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' D' D ' 17' ' ' ASP . . . . . . . . . . . . . 11.1 p-10 -81.63 4.9 19.93 Favored 'General case' 0 CA--C 1.536 0.429 0 N-CA-C 113.303 0.853 . . . . 0.0 113.303 -177.501 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' D' D ' 18' ' ' PHE . . . . . . . . . . . . . 52.4 t80 -57.5 -44.26 84.85 Favored 'General case' 0 C--N 1.335 -0.059 0 O-C-N 121.929 -0.482 . . . . 0.0 110.272 -178.286 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' D' D ' 19' ' ' VAL . . . . . . . . . . . . . 44.0 t -55.52 -44.16 75.17 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.289 0 CA-C-N 116.396 -0.365 . . . . 0.0 110.804 -178.144 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' D' D ' 20' ' ' ASP . . . . . . . . . . . . . 13.4 t70 -59.8 -42.2 92.93 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-O 120.888 0.375 . . . . 0.0 110.809 -177.761 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' D' D ' 21' ' ' VAL . . . . . . . . . . . . . 45.2 t -64.31 -46.48 93.08 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.28 0 C-N-CA 120.742 -0.383 . . . . 0.0 110.534 -178.3 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' D' D ' 22' ' ' ILE . . . . . . . . . . . . . 51.4 mm -55.12 -47.38 77.32 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.232 0 C-N-CA 121.087 -0.245 . . . . 0.0 110.662 178.931 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' D' D ' 23' ' ' ARG . . . . . . . . . . . . . 52.6 ttp180 -53.74 -51.92 61.81 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-O 120.659 0.266 . . . . 0.0 111.418 -178.792 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' D' D ' 24' ' ' ILE . . . . . . . . . . . . . 71.2 mt -58.54 -43.15 86.45 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.344 0 C-N-CA 121.034 -0.266 . . . . 0.0 111.451 -175.705 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' D' D ' 25' ' ' LYS . . . . . . . . . . . . . 60.1 mttm -66.67 -43.68 83.82 Favored 'General case' 0 C--N 1.33 -0.269 0 N-CA-C 112.183 0.438 . . . . 0.0 112.183 -177.768 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' D' D ' 26' ' ' LEU . . . . . . . . . . . . . 27.1 mt -81.73 -25.95 34.98 Favored 'General case' 0 C--N 1.329 -0.298 0 N-CA-C 113.1 0.778 . . . . 0.0 113.1 -172.825 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' D' D ' 27' ' ' GLN . . . . . . . . . . . . . 5.8 pt20 -45.76 139.28 4.19 Favored 'General case' 0 N--CA 1.467 0.412 0 N-CA-C 112.819 0.674 . . . . 0.0 112.819 -174.666 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' D' D ' 28' ' ' GLY . . . . . . . . . . . . . . . 100.43 -26.95 22.63 Favored Glycine 0 CA--C 1.532 1.14 0 CA-C-N 115.755 -0.657 . . . . 0.0 112.116 -177.671 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' D' D ' 29' ' ' LYS . . . . . . . . . . . . . 64.0 mttp -96.72 155.09 16.92 Favored 'General case' 0 C--N 1.332 -0.175 0 CA-C-N 117.376 0.588 . . . . 0.0 110.788 178.525 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' D' D ' 30' ' ' THR . . . . . . . . . . . . . 35.3 m -108.11 141.24 40.11 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.196 -0.456 . . . . 0.0 110.489 178.993 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' D' D ' 31' ' ' VAL . . . . . . . . . . . . . 35.4 m -127.96 156.5 39.99 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.234 0 CA-C-N 116.097 -0.501 . . . . 0.0 110.32 179.147 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' D' D ' 32' ' ' ARG . . . . . . . . . . . . . 72.9 ttt-85 -130.17 150.28 51.49 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-O 121.116 0.484 . . . . 0.0 110.456 179.703 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' D' D ' 33' ' ' THR . . . . . . . . . . . . . 14.9 m -52.39 137.15 30.03 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.376 -0.375 . . . . 0.0 111.478 -178.148 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' D' D ' 34' ' ' GLY . . . . . . . . . . . . . . . 100.84 -17.17 56.77 Favored Glycine 0 CA--C 1.533 1.175 0 CA-C-O 119.691 -0.505 . . . . 0.0 113.241 179.021 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' D' D ' 35' ' ' ASP . . . . . . . . . . . . . 73.4 m-20 -66.58 150.96 48.24 Favored 'General case' 0 C--O 1.231 0.124 0 CA-C-N 118.083 0.941 . . . . 0.0 111.364 179.992 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' D' D ' 36' ' ' VAL . . . . . . . . . . . . . 41.9 t -122.01 127.81 75.44 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.228 0 CA-C-N 115.934 -0.575 . . . . 0.0 109.684 177.652 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' D' D ' 37' ' ' ILE . . . . . . . . . . . . . 61.8 mt -121.33 138.53 51.39 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.256 0 N-CA-C 109.882 -0.414 . . . . 0.0 109.882 -179.253 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' D' D ' 38' ' ' GLY . . . . . . . . . . . . . . . -117.52 128.85 8.01 Favored Glycine 0 CA--C 1.526 0.764 0 N-CA-C 111.123 -0.791 . . . . 0.0 111.123 -179.892 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' D' D ' 39' ' ' ILE . . . . . . . . . . . . . 74.5 mt -126.21 136.62 60.29 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.176 0 CA-C-O 120.785 0.326 . . . . 0.0 110.179 178.903 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' D' D ' 40' ' ' SER . . . . . . . . . . . . . 63.7 p -91.59 122.44 34.16 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.219 -0.446 . . . . 0.0 110.816 176.216 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' D' D ' 41' ' ' ILE . . . . . . . . . . . . . 68.3 mt -130.46 117.55 39.78 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.231 0 CA-C-O 120.89 0.376 . . . . 0.0 110.244 178.262 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' D' D ' 42' ' ' LEU . . . . . . . . . . . . . 1.3 tt 54.62 43.73 29.75 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-O 121.419 0.628 . . . . 0.0 110.401 177.603 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' D' D ' 43' ' ' GLY . . . . . . . . . . . . . . . 71.12 19.0 76.96 Favored Glycine 0 CA--C 1.533 1.157 0 C-N-CA 121.211 -0.519 . . . . 0.0 113.089 175.411 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' D' D ' 44' ' ' LYS . . . . . . . . . . . . . 53.1 mttm -131.05 130.5 43.33 Favored 'General case' 0 C--N 1.333 -0.137 0 CA-C-N 117.774 0.787 . . . . 0.0 110.342 178.836 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' D' D ' 45' ' ' GLU . . . . . . . . . . . . . 84.8 tt0 -84.1 124.93 31.63 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 116.499 -0.319 . . . . 0.0 111.258 -178.917 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' D' D ' 46' ' ' VAL . . . . . . . . . . . . . 10.1 p -117.84 124.71 73.46 Favored 'Isoleucine or valine' 0 N--CA 1.462 0.172 0 N-CA-C 109.577 -0.527 . . . . 0.0 109.577 174.549 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' D' D ' 47' ' ' LYS . . . . . . . . . . . . . 64.7 mttp -98.52 124.11 43.07 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.076 -0.511 . . . . 0.0 110.859 178.529 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' D' D ' 48' ' ' PHE . . . . . . . . . . . . . 34.3 m-85 -108.49 131.87 54.39 Favored 'General case' 0 C--N 1.329 -0.324 0 N-CA-C 109.563 -0.532 . . . . 0.0 109.563 176.545 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' D' D ' 49' ' ' LYS . . . . . . . . . . . . . 46.6 tttp -107.48 133.65 51.66 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.367 -0.379 . . . . 0.0 110.137 178.202 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' D' D ' 50' ' ' VAL . . . . . . . . . . . . . 44.1 t -76.63 104.4 4.64 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.325 0 N-CA-C 109.414 -0.587 . . . . 0.0 109.414 177.802 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' D' D ' 51' ' ' VAL . . . . . . . . . . . . . 52.5 t -69.83 -53.38 24.38 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.324 0 CA-C-N 115.985 -0.552 . . . . 0.0 109.646 -175.732 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' D' D ' 52' ' ' GLN . . . . . . . . . . . . . 87.9 mt-30 -153.73 152.2 30.49 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 115.949 -0.569 . . . . 0.0 111.377 -177.752 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' D' D ' 53' ' ' ALA . . . . . . . . . . . . . . . -131.04 129.9 42.58 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 115.231 -0.895 . . . . 0.0 109.55 175.198 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' D' D ' 54' ' ' TYR . . . . . . . . . . . . . 54.3 t80 -128.35 108.01 19.36 Favored Pre-proline 0 CA--C 1.534 0.339 0 CA-C-O 118.179 -0.915 . . . . 0.0 110.276 -179.536 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' D' D ' 55' ' ' PRO . . . . . . . . . . . . . 74.0 Cg_endo -77.09 170.08 72.59 Favored 'Cis proline' 0 N--CA 1.5 1.859 0 CA-C-N 121.754 1.662 . . . . 0.0 112.608 -3.981 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' D' D ' 56' ' ' SER . . . . . . . . . . . . . 13.6 m -112.88 131.72 22.64 Favored Pre-proline 0 CA--C 1.539 0.53 0 CA-C-O 118.438 -0.791 . . . . 0.0 109.666 176.17 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' D' D ' 57' ' ' PRO . . . . . . . . . . . . . 42.2 Cg_endo -69.42 168.17 67.25 Favored 'Cis proline' 0 N--CA 1.496 1.66 0 CA-C-N 121.929 1.725 . . . . 0.0 111.374 -3.732 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' D' D ' 58' ' ' LEU . . . . . . . . . . . . . 44.9 tp -130.24 137.67 50.15 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-O 120.955 0.407 . . . . 0.0 110.256 -179.804 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' D' D ' 59' ' ' ARG . . . . . . . . . . . . . 74.0 ttt180 -104.2 134.47 47.38 Favored 'General case' 0 C--N 1.327 -0.396 0 CA-C-N 115.918 -0.583 . . . . 0.0 109.767 178.033 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' D' D ' 60' ' ' VAL . . . . . . . . . . . . . 42.6 t -76.98 112.91 15.43 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.316 0 C-N-CA 120.821 -0.351 . . . . 0.0 110.183 -177.545 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' D' D ' 61' ' ' GLU . . . . . . . . . . . . . 96.0 mt-10 -131.08 162.05 30.69 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.001 -0.545 . . . . 0.0 110.077 178.944 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' D' D ' 62' ' ' ASP . . . . . . . . . . . . . 6.4 t70 -53.63 -31.86 48.98 Favored 'General case' 0 C--N 1.327 -0.375 0 N-CA-C 111.862 0.319 . . . . 0.0 111.862 -179.092 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' D' D ' 63' ' ' ARG . . . . . . . . . . . . . 39.4 ptt180 -84.66 3.91 34.9 Favored 'General case' 0 CA--C 1.537 0.449 0 N-CA-C 113.774 1.027 . . . . 0.0 113.774 -174.555 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' D' D ' 64' ' ' THR . . . . . . . . . . . . . 25.7 m -92.02 138.84 31.21 Favored 'General case' 0 C--N 1.333 -0.152 0 CA-C-N 118.155 0.434 . . . . 0.0 110.854 -177.805 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' D' D ' 65' ' ' LYS . . . . . . . . . . . . . 68.0 mttm -88.62 127.84 35.57 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.069 -0.514 . . . . 0.0 109.894 177.834 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' D' D ' 66' ' ' ILE . . . . . . . . . . . . . 59.8 mt -115.65 126.43 73.18 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.228 0 N-CA-C 109.684 -0.487 . . . . 0.0 109.684 179.314 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' D' D ' 67' ' ' THR . . . . . . . . . . . . . 28.4 m -126.8 145.04 50.78 Favored 'General case' 0 C--O 1.233 0.216 0 CA-C-O 121.271 0.558 . . . . 0.0 111.637 -175.448 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' D' D ' 68' ' ' LEU . . . . . . . . . . . . . 6.1 tt . . . . . 0 C--N 1.33 -0.281 0 CA-C-N 115.435 -0.802 . . . . 0.0 109.528 175.366 . . . . . . . . 0 0 . 1 . 002 nuclear orig core ' D' D ' 73' ' ' VAL . . . . . . . . . . . . . 35.1 m . . . . . 0 C--O 1.231 0.101 0 CA-C-O 120.966 0.413 . . . . 0.0 111.18 . . . . . . . . . 0 0 . 1 . 002 nuclear orig core ' D' D ' 74' ' ' ASP . . . . . . . . . . . . . 12.5 t0 -94.89 123.24 38.24 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 115.893 -0.594 . . . . 0.0 110.294 -176.873 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' D' D ' 75' ' ' VAL . . . . . . . . . . . . . 47.1 t -116.33 121.9 68.57 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.209 0 CA-C-O 121.143 0.496 . . . . 0.0 110.204 -179.323 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' D' D ' 76' ' ' LEU . . . . . . . . . . . . . 36.8 mt -123.67 144.6 49.54 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 115.547 -0.751 . . . . 0.0 109.68 -179.54 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' D' D ' 77' ' ' GLU . . . . . . . . . . . . . 97.2 mt-10 -137.74 131.29 31.09 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-O 121.096 0.474 . . . . 0.0 111.274 -178.946 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' D' D ' 78' ' ' ALA . . . . . . . . . . . . . . . -118.94 139.82 51.02 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 115.693 -0.685 . . . . 0.0 109.974 177.183 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' D' D ' 79' ' ' LYS . . . . . . . . . . . . . 35.2 tptt -80.47 116.43 20.51 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.513 -0.312 . . . . 0.0 110.818 -177.586 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' D' D ' 80' ' ' ILE . . . . . . . . . . . . . 40.7 mm -139.11 108.18 3.69 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.237 0 CA-C-N 116.325 -0.398 . . . . 0.0 109.971 -176.542 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' D' D ' 81' ' ' LYS . . . . . . . . . . . . . 51.1 mttm -103.56 129.09 50.71 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-O 120.761 0.315 . . . . 0.0 111.18 -179.088 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' D' D ' 82' ' ' GLY . . . . . . . . . . . . . . . 89.05 42.16 5.69 Favored Glycine 0 CA--C 1.524 0.656 0 C-N-CA 120.828 -0.701 . . . . 0.0 111.545 173.64 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' D' D ' 83' ' ' ILE . . . . . . . . . . . . . 72.7 mt -67.15 131.1 32.93 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.365 0 N-CA-C 109.915 -0.402 . . . . 0.0 109.915 178.646 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' D' D ' 84' ' ' LYS . . . . . . . . . . . . . 76.3 tttt -91.15 -50.45 5.83 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-O 121.198 0.523 . . . . 0.0 109.665 179.619 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' D' D ' 85' ' ' ASP . . . . . . . . . . . . . 5.1 t70 -160.43 155.3 24.25 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 115.448 -0.796 . . . . 0.0 110.193 178.939 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' D' D ' 86' ' ' VAL . . . . . . . . . . . . . 40.1 t -131.54 133.31 61.91 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.285 0 CA-C-O 121.039 0.447 . . . . 0.0 110.175 179.699 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' D' D ' 87' ' ' ILE . . . . . . . . . . . . . 44.7 mm -119.05 128.46 75.8 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.294 0 CA-C-N 115.79 -0.641 . . . . 0.0 109.584 178.659 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' D' D ' 88' ' ' LEU . . . . . . . . . . . . . 21.8 tp -108.53 130.14 55.29 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-N 116.282 -0.417 . . . . 0.0 111.117 -177.638 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' D' D ' 89' ' ' ASP . . . . . . . . . . . . . 13.6 t70 -121.68 150.89 41.1 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 115.846 -0.616 . . . . 0.0 109.352 175.691 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' D' D ' 90' ' ' GLU . . . . . . . . . . . . . 43.8 tp10 -47.29 -36.34 9.07 Favored 'General case' 0 C--N 1.331 -0.206 0 N-CA-C 112.868 0.692 . . . . 0.0 112.868 -173.327 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' D' D ' 91' ' ' ASN . . . . . . . . . . . . . 86.9 m-20 -132.14 32.4 4.01 Favored 'General case' 0 N--CA 1.463 0.209 0 N-CA-C 112.097 0.406 . . . . 0.0 112.097 -176.332 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' D' D ' 92' ' ' LEU . . . . . . . . . . . . . 9.0 tp -166.15 151.23 8.32 Favored 'General case' 0 C--N 1.331 -0.223 0 C-N-CA 120.871 -0.332 . . . . 0.0 111.016 179.929 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' D' D ' 93' ' ' ILE . . . . . . . . . . . . . 71.2 mt -125.84 122.7 62.64 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.234 0 N-CA-C 109.429 -0.582 . . . . 0.0 109.429 179.707 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' D' D ' 94' ' ' VAL . . . . . . . . . . . . . 41.9 t -120.1 127.59 75.9 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.186 0 N-CA-C 110.09 -0.337 . . . . 0.0 110.09 -179.201 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' D' D ' 95' ' ' VAL . . . . . . . . . . . . . 44.4 t -123.27 133.47 69.02 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.275 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.042 -179.797 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' D' D ' 96' ' ' ILE . . . . . . . . . . . . . 65.5 mt -115.61 127.52 73.16 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.225 0 N-CA-C 109.559 -0.534 . . . . 0.0 109.559 179.231 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' D' D ' 97' ' ' THR . . . . . . . . . . . . . 66.4 p -100.47 153.58 19.24 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-O 121.081 0.467 . . . . 0.0 110.882 -178.656 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' D' D ' 98' ' ' GLU . . . . . . . . . . . . . 12.7 pt-20 -53.96 -21.71 8.65 Favored 'General case' 0 CA--C 1.534 0.362 0 N-CA-C 112.532 0.567 . . . . 0.0 112.532 -179.409 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' D' D ' 99' ' ' GLU . . . . . . . . . . . . . 96.2 mt-10 -81.34 14.99 2.16 Favored 'General case' 0 CA--C 1.534 0.364 0 N-CA-C 113.077 0.769 . . . . 0.0 113.077 -177.071 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' D' D ' 100' ' ' ASN . . . . . . . . . . . . . 4.7 m-20 62.18 34.86 15.91 Favored 'General case' 0 CA--C 1.53 0.203 0 CA-C-N 118.085 0.402 . . . . 0.0 111.182 -179.904 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' D' D ' 101' ' ' GLU . . . . . . . . . . . . . 83.5 tt0 -112.37 142.04 45.38 Favored 'General case' 0 C--N 1.333 -0.148 0 N-CA-C 109.534 -0.543 . . . . 0.0 109.534 174.552 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' D' D ' 102' ' ' VAL . . . . . . . . . . . . . 46.7 t -115.0 126.57 72.62 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.277 0 N-CA-C 109.847 -0.427 . . . . 0.0 109.847 -178.239 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' D' D ' 103' ' ' LEU . . . . . . . . . . . . . 26.0 mt -116.64 127.87 54.84 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 115.658 -0.701 . . . . 0.0 110.022 177.703 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' D' D ' 104' ' ' ILE . . . . . . . . . . . . . 67.9 mt -117.61 122.68 70.39 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.262 0 CA-C-N 116.408 -0.36 . . . . 0.0 110.219 -179.336 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' D' D ' 105' ' ' PHE . . . . . . . . . . . . . 66.2 m-85 -124.5 163.16 22.45 Favored 'General case' 0 C--N 1.331 -0.202 0 O-C-N 123.804 0.69 . . . . 0.0 109.757 179.521 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' D' D ' 106' ' ' ASN . . . . . . . . . . . . . 45.8 p-10 -96.83 -173.11 2.62 Favored 'General case' 0 C--N 1.329 -0.308 0 N-CA-C 109.59 -0.522 . . . . 0.0 109.59 173.889 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' D' D ' 107' ' ' GLN . . . . . . . . . . . . . 28.6 tt0 -60.85 -23.99 65.55 Favored 'General case' 0 CA--C 1.534 0.337 0 N-CA-C 112.312 0.486 . . . . 0.0 112.312 179.862 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' D' D ' 108' ' ' ASN . . . . . . . . . . . . . 60.6 t30 -86.53 10.22 16.0 Favored 'General case' 0 CA--C 1.536 0.43 0 N-CA-C 113.037 0.754 . . . . 0.0 113.037 -178.737 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' D' D ' 109' ' ' LEU . . . . . . . . . . . . . 12.3 tp 57.04 38.94 29.54 Favored 'General case' 0 C--N 1.332 -0.194 0 CA-C-O 121.152 0.501 . . . . 0.0 111.206 178.885 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' D' D ' 110' ' ' GLU . . . . . . . . . . . . . 70.9 mm-40 -107.1 148.82 28.32 Favored 'General case' 0 C--N 1.33 -0.265 0 N-CA-C 109.832 -0.432 . . . . 0.0 109.832 175.566 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' D' D ' 111' ' ' GLU . . . . . . . . . . . . . 83.1 tt0 -78.16 121.89 24.92 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.27 -0.423 . . . . 0.0 110.821 -177.683 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' D' D ' 112' ' ' LEU . . . . . . . . . . . . . 31.4 mt -109.6 -46.05 3.58 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-N 116.256 -0.429 . . . . 0.0 110.686 179.564 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' D' D ' 113' ' ' TYR . . . . . . . . . . . . . 58.0 t80 -140.71 135.31 31.45 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 116.264 -0.425 . . . . 0.0 110.927 -179.2 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' D' D ' 114' ' ' ARG . . . . . . . . . . . . . 69.6 ttp85 -136.42 122.03 19.65 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.138 -0.483 . . . . 0.0 110.117 178.035 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' D' D ' 115' ' ' GLY . . . . . . . . . . . . . . . -150.03 153.14 24.91 Favored Glycine 0 CA--C 1.524 0.652 0 N-CA-C 110.996 -0.842 . . . . 0.0 110.996 179.015 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' D' D ' 116' ' ' LYS . . . . . . . . . . . . . 63.4 tttt -129.5 132.13 46.82 Favored 'General case' 0 C--N 1.329 -0.321 0 N-CA-C 109.825 -0.435 . . . . 0.0 109.825 177.941 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' D' D ' 117' ' ' PHE . . . . . . . . . . . . . 37.3 m-85 -128.13 117.25 21.27 Favored 'General case' 0 C--N 1.332 -0.187 0 CA-C-O 120.963 0.411 . . . . 0.0 110.232 -175.11 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' D' D ' 118' ' ' GLU . . . . . . . . . . . . . 44.9 tp10 -51.67 -51.21 57.68 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.403 -0.362 . . . . 0.0 111.61 -177.078 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' D' D ' 119' ' ' ASN . . . . . . . . . . . . . 3.6 m120 -94.48 30.95 1.85 Allowed 'General case' 0 C--N 1.329 -0.287 0 N-CA-C 112.249 0.463 . . . . 0.0 112.249 -174.927 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' D' D ' 120' ' ' LEU . . . . . . . . . . . . . 15.6 tp -56.7 121.09 8.97 Favored 'General case' 0 C--N 1.332 -0.167 0 CA-C-O 120.597 0.237 . . . . 0.0 110.41 178.032 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' D' D ' 121' ' ' ASN . . . . . . . . . . . . . 33.1 m120 -114.08 -44.0 3.19 Favored 'General case' 0 C--O 1.232 0.171 0 CA-C-N 116.723 -0.217 . . . . 0.0 111.147 -176.649 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' D' D ' 122' ' ' LYS . . . . . . . . . . . . . 61.4 mtpt -139.13 138.58 37.13 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-O 120.92 0.391 . . . . 0.0 111.314 -176.674 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' D' D ' 123' ' ' VAL . . . . . . . . . . . . . 45.1 t -126.93 126.2 67.98 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.326 0 N-CA-C 109.375 -0.602 . . . . 0.0 109.375 175.26 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' D' D ' 124' ' ' LEU . . . . . . . . . . . . . 59.5 mt -131.21 136.43 48.24 Favored 'General case' 0 C--N 1.332 -0.194 0 CA-C-O 120.95 0.405 . . . . 0.0 110.781 -177.444 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' D' D ' 125' ' ' VAL . . . . . . . . . . . . . 11.6 p -133.95 138.57 50.17 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.284 0 CA-C-N 116.113 -0.494 . . . . 0.0 110.355 178.863 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' D' D ' 126' ' ' ARG . . . . . . . . . . . . . 96.7 mtt180 -149.1 126.82 11.74 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 115.769 -0.65 . . . . 0.0 109.425 177.778 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' D' D ' 127' ' ' ASN . . . . . . . . . . . . . 1.8 t-20 57.63 -147.47 0.51 Allowed 'General case' 0 CA--C 1.541 0.62 0 N-CA-C 109.418 -0.586 . . . . 0.0 109.418 -178.352 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' D' D ' 128' ' ' ASP . . . . . . . . . . . . . 8.7 p-10 -87.32 17.38 4.44 Favored 'General case' 0 CA--C 1.534 0.36 0 CA-C-N 118.892 0.769 . . . . 0.0 112.657 178.03 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' D' D ' 129' ' ' LEU . . . . . . . . . . . . . 13.3 tp -112.5 136.16 52.35 Favored 'General case' 0 C--O 1.231 0.098 0 O-C-N 122.003 -0.435 . . . . 0.0 109.988 179.001 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' D' D ' 130' ' ' VAL . . . . . . . . . . . . . 39.0 t -124.89 140.05 49.19 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.338 0 CA-C-O 120.768 0.318 . . . . 0.0 110.354 -176.646 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' D' D ' 131' ' ' VAL . . . . . . . . . . . . . 44.2 t -136.07 136.48 49.52 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.206 0 CA-C-O 121.144 0.497 . . . . 0.0 110.309 177.459 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' D' D ' 132' ' ' ILE . . . . . . . . . . . . . 71.3 mt -120.41 134.16 64.78 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.229 0 CA-C-N 115.69 -0.686 . . . . 0.0 109.645 -179.105 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' D' D ' 133' ' ' ILE . . . . . . . . . . . . . 43.5 mm -117.44 120.96 66.44 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.215 0 CA-C-O 121.142 0.496 . . . . 0.0 111.045 -175.915 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' D' D ' 134' ' ' ASP . . . . . . . . . . . . . 6.7 p-10 -131.71 145.82 51.84 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 115.671 -0.695 . . . . 0.0 109.449 174.216 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' D' D ' 135' ' ' GLU . . . . . . . . . . . . . 41.2 tp10 -49.74 -24.63 2.43 Favored 'General case' 0 C--N 1.328 -0.361 0 N-CA-C 112.872 0.693 . . . . 0.0 112.872 -171.584 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' D' D ' 136' ' ' GLN . . . . . . . . . . . . . 96.9 mt-30 -94.25 -33.23 13.33 Favored 'General case' 0 C--O 1.232 0.166 0 N-CA-C 112.356 0.502 . . . . 0.0 112.356 -175.932 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' D' D ' 137' ' ' LYS . . . . . . . . . . . . . 54.4 mtmt -148.17 158.11 43.89 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-O 121.388 0.613 . . . . 0.0 112.114 -170.445 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' D' D ' 138' ' ' LEU . . . . . . . . . . . . . 5.6 tt -116.6 124.77 50.62 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 115.219 -0.9 . . . . 0.0 109.323 174.783 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' D' D ' 139' ' ' THR . . . . . . . . . . . . . 34.5 m -110.12 131.1 55.36 Favored 'General case' 0 C--N 1.331 -0.208 0 CA-C-N 116.366 -0.379 . . . . 0.0 110.863 -176.735 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' D' D ' 140' ' ' LEU . . . . . . . . . . . . . 6.1 tt -119.79 124.02 45.12 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 115.543 -0.753 . . . . 0.0 109.303 -178.735 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' D' D ' 141' ' ' ILE . . . . . . . . . . . . . 19.1 mt -121.28 120.25 61.49 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.314 0 CA-C-O 120.779 0.323 . . . . 0.0 110.131 -174.723 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' D' D ' 142' ' ' ARG . . . . . . . . . . . . . 82.8 mtp180 -110.32 127.66 55.15 Favored 'General case' 0 C--N 1.331 -0.226 0 CA-C-N 115.613 -0.722 . . . . 0.0 110.426 -179.039 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' D' D ' 143' ' ' THR . . . . . . . . . . . . . 59.8 p . . . . . 0 C--O 1.22 -0.463 0 CA-C-O 117.942 -1.028 . . . . 0.0 110.575 179.73 . . . . . . . . 0 0 . 1 . 002 nuclear orig core ' E' E ' 2' ' ' SER . . . . . . . . . . . . . 3.6 p . . . . . 0 C--O 1.231 0.084 0 CA-C-O 120.955 0.407 . . . . 0.0 110.46 . . . . . . . . . 0 0 . 1 . 002 nuclear orig core ' E' E ' 3' ' ' GLU . . . . . . . . . . . . . 28.6 tp10 -139.44 137.55 35.71 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 115.745 -0.661 . . . . 0.0 110.503 -176.511 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' E' E ' 4' ' ' LEU . . . . . . . . . . . . . 17.8 tp -124.12 126.15 45.71 Favored 'General case' 0 C--N 1.33 -0.244 0 N-CA-C 109.564 -0.532 . . . . 0.0 109.564 174.525 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' E' E ' 5' ' ' LYS . . . . . . . . . . . . . 66.4 mttm -112.85 122.13 46.75 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-O 120.948 0.404 . . . . 0.0 110.87 -177.668 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' E' E ' 6' ' ' LEU . . . . . . . . . . . . . 59.2 mt -113.89 143.87 43.97 Favored 'General case' 0 C--N 1.331 -0.23 0 CA-C-N 115.199 -0.909 . . . . 0.0 110.161 -179.421 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' E' E ' 7' ' ' LYS . . . . . . . . . . . . . 84.8 tttt -121.05 135.22 24.68 Favored Pre-proline 0 CA--C 1.535 0.398 0 CA-C-O 118.858 -0.591 . . . . 0.0 109.529 176.167 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' E' E ' 8' ' ' PRO . . . . . . . . . . . . . 97.6 Cg_endo -91.19 132.65 1.5 Allowed 'Trans proline' 0 N--CA 1.49 1.275 0 C-N-CA 121.683 1.589 . . . . 0.0 111.765 178.484 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' E' E ' 9' ' ' LEU . . . . . . . . . . . . . 46.9 mt -74.31 -47.02 6.02 Favored Pre-proline 0 CA--C 1.533 0.32 0 CA-C-O 118.709 -0.662 . . . . 0.0 112.176 -177.55 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' E' E ' 10' ' ' PRO . . . . . . . . . . . . . 84.4 Cg_endo -81.41 153.37 18.2 Favored 'Trans proline' 0 N--CA 1.496 1.671 0 C-N-CA 121.158 1.239 . . . . 0.0 111.726 174.95 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' E' E ' 11' ' ' LYS . . . . . . . . . . . . . 57.1 tttm -86.77 99.44 11.8 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.418 -0.356 . . . . 0.0 110.3 178.747 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' E' E ' 12' ' ' VAL . . . . . . . . . . . . . 12.0 p -141.5 147.54 21.98 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.254 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.571 -178.59 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' E' E ' 13' ' ' GLU . . . . . . . . . . . . . 43.1 tp10 -93.76 122.36 36.15 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.059 -0.519 . . . . 0.0 110.045 177.61 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' E' E ' 14' ' ' LEU . . . . . . . . . . . . . 20.7 mt -95.94 148.94 35.33 Favored Pre-proline 0 C--N 1.329 -0.292 0 CA-C-O 119.328 -0.368 . . . . 0.0 110.465 -178.161 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' E' E ' 15' ' ' PRO . . . . . . . . . . . . . 24.8 Cg_exo -62.46 160.25 32.54 Favored 'Trans proline' 0 N--CA 1.497 1.731 0 C-N-CA 121.214 1.276 . . . . 0.0 111.722 177.404 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' E' E ' 16' ' ' PRO . . . . . . . . . . . . . 29.9 Cg_exo -60.06 -32.37 94.7 Favored 'Trans proline' 0 N--CA 1.497 1.685 0 C-N-CA 121.385 1.39 . . . . 0.0 112.718 -178.659 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' E' E ' 17' ' ' ASP . . . . . . . . . . . . . 18.1 p-10 -88.39 4.73 45.25 Favored 'General case' 0 CA--C 1.536 0.422 0 N-CA-C 113.326 0.861 . . . . 0.0 113.326 -177.414 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' E' E ' 18' ' ' PHE . . . . . . . . . . . . . 52.4 t80 -58.23 -43.2 87.64 Favored 'General case' 0 C--N 1.334 -0.077 0 O-C-N 121.998 -0.439 . . . . 0.0 110.042 -178.606 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' E' E ' 19' ' ' VAL . . . . . . . . . . . . . 47.2 t -55.54 -42.81 69.99 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.28 0 CA-C-N 116.33 -0.395 . . . . 0.0 110.585 -179.425 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' E' E ' 20' ' ' ASP . . . . . . . . . . . . . 76.7 m-20 -60.57 -42.99 97.76 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-O 120.801 0.334 . . . . 0.0 110.926 -178.485 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' E' E ' 21' ' ' VAL . . . . . . . . . . . . . 45.7 t -64.01 -46.32 94.24 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.265 0 C-N-CA 120.792 -0.363 . . . . 0.0 110.463 -177.757 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' E' E ' 22' ' ' ILE . . . . . . . . . . . . . 51.5 mm -55.67 -46.29 79.4 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.234 0 CA-C-O 120.788 0.328 . . . . 0.0 110.548 178.45 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' E' E ' 23' ' ' ARG . . . . . . . . . . . . . 54.6 ttp180 -53.1 -50.97 63.35 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-O 120.669 0.271 . . . . 0.0 111.569 -179.887 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' E' E ' 24' ' ' ILE . . . . . . . . . . . . . 74.6 mt -58.35 -47.28 88.22 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.312 0 CA-C-N 116.505 -0.316 . . . . 0.0 111.452 -176.3 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' E' E ' 25' ' ' LYS . . . . . . . . . . . . . 76.0 mttt -65.49 -40.59 93.26 Favored 'General case' 0 C--N 1.329 -0.298 0 N-CA-C 112.428 0.529 . . . . 0.0 112.428 -176.613 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' E' E ' 26' ' ' LEU . . . . . . . . . . . . . 40.6 mt -79.65 -38.6 33.35 Favored 'General case' 0 C--N 1.33 -0.245 0 N-CA-C 113.19 0.811 . . . . 0.0 113.19 -171.143 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' E' E ' 27' ' ' GLN . . . . . . . . . . . . . 13.1 pt20 -46.88 139.46 5.47 Favored 'General case' 0 N--CA 1.468 0.443 0 N-CA-C 112.785 0.661 . . . . 0.0 112.785 -174.976 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' E' E ' 28' ' ' GLY . . . . . . . . . . . . . . . 99.61 -25.54 27.86 Favored Glycine 0 CA--C 1.534 1.229 0 CA-C-N 115.559 -0.746 . . . . 0.0 112.178 -176.209 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' E' E ' 29' ' ' LYS . . . . . . . . . . . . . 95.6 mttt -97.21 155.19 16.95 Favored 'General case' 0 C--O 1.233 0.186 0 CA-C-N 117.324 0.562 . . . . 0.0 110.918 178.935 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' E' E ' 30' ' ' THR . . . . . . . . . . . . . 23.6 m -104.68 137.66 42.16 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 115.922 -0.581 . . . . 0.0 110.035 175.83 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' E' E ' 31' ' ' VAL . . . . . . . . . . . . . 35.2 m -127.82 155.69 39.36 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.235 0 CA-C-N 116.381 -0.372 . . . . 0.0 110.685 -179.235 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' E' E ' 32' ' ' ARG . . . . . . . . . . . . . 78.2 mtt85 -132.6 150.49 52.15 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.079 -0.51 . . . . 0.0 110.402 177.821 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' E' E ' 33' ' ' THR . . . . . . . . . . . . . 22.3 m -52.8 139.1 27.71 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.302 -0.408 . . . . 0.0 111.419 -179.194 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' E' E ' 34' ' ' GLY . . . . . . . . . . . . . . . 101.03 -17.21 56.49 Favored Glycine 0 CA--C 1.532 1.141 0 CA-C-O 119.69 -0.505 . . . . 0.0 113.165 179.751 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' E' E ' 35' ' ' ASP . . . . . . . . . . . . . 73.5 m-20 -66.95 149.64 50.33 Favored 'General case' 0 C--O 1.231 0.104 0 CA-C-N 118.08 0.94 . . . . 0.0 111.147 178.859 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' E' E ' 36' ' ' VAL . . . . . . . . . . . . . 43.1 t -121.83 130.89 74.19 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.24 0 CA-C-N 116.107 -0.497 . . . . 0.0 109.843 178.188 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' E' E ' 37' ' ' ILE . . . . . . . . . . . . . 65.1 mt -121.32 139.18 49.28 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.194 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.0 -178.971 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' E' E ' 38' ' ' GLY . . . . . . . . . . . . . . . -116.66 129.0 8.18 Favored Glycine 0 CA--C 1.525 0.676 0 N-CA-C 111.137 -0.785 . . . . 0.0 111.137 -179.873 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' E' E ' 39' ' ' ILE . . . . . . . . . . . . . 76.5 mt -127.26 139.96 50.44 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.224 0 CA-C-O 120.755 0.312 . . . . 0.0 110.243 179.351 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' E' E ' 40' ' ' SER . . . . . . . . . . . . . 13.3 t -92.6 126.02 37.5 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.288 -0.414 . . . . 0.0 111.059 177.0 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' E' E ' 41' ' ' ILE . . . . . . . . . . . . . 65.5 mt -129.53 117.0 41.12 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.193 0 CA-C-O 120.863 0.363 . . . . 0.0 110.126 177.088 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' E' E ' 42' ' ' LEU . . . . . . . . . . . . . 7.2 mp 51.78 38.18 22.44 Favored 'General case' 0 CA--C 1.53 0.195 0 CA-C-N 116.101 -0.499 . . . . 0.0 111.598 176.747 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' E' E ' 43' ' ' GLY . . . . . . . . . . . . . . . 74.17 29.1 62.96 Favored Glycine 0 CA--C 1.529 0.969 0 C-N-CA 121.156 -0.545 . . . . 0.0 112.51 176.663 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' E' E ' 44' ' ' LYS . . . . . . . . . . . . . 30.0 ttpt -139.13 128.39 24.07 Favored 'General case' 0 C--N 1.33 -0.281 0 N-CA-C 109.523 -0.547 . . . . 0.0 109.523 176.578 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' E' E ' 45' ' ' GLU . . . . . . . . . . . . . 84.3 tt0 -83.1 125.66 31.73 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-O 120.799 0.333 . . . . 0.0 111.305 -177.111 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' E' E ' 46' ' ' VAL . . . . . . . . . . . . . 9.2 p -117.38 124.96 73.7 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.183 0 N-CA-C 109.558 -0.534 . . . . 0.0 109.558 174.852 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' E' E ' 47' ' ' LYS . . . . . . . . . . . . . 62.5 mttp -98.16 126.46 43.64 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.06 -0.518 . . . . 0.0 110.904 177.973 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' E' E ' 48' ' ' PHE . . . . . . . . . . . . . 33.0 m-85 -110.13 131.86 54.68 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.025 -0.534 . . . . 0.0 109.679 176.568 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' E' E ' 49' ' ' LYS . . . . . . . . . . . . . 70.2 tttt -106.53 130.55 54.29 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.378 -0.373 . . . . 0.0 110.159 178.581 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' E' E ' 50' ' ' VAL . . . . . . . . . . . . . 46.4 t -74.73 103.16 2.52 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.258 0 N-CA-C 109.151 -0.685 . . . . 0.0 109.151 176.821 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' E' E ' 51' ' ' VAL . . . . . . . . . . . . . 47.3 t -69.58 -52.97 27.12 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.289 0 N-CA-C 109.478 -0.564 . . . . 0.0 109.478 -174.687 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' E' E ' 52' ' ' GLN . . . . . . . . . . . . . 81.3 mt-30 -154.49 149.93 27.27 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 115.986 -0.552 . . . . 0.0 111.624 -178.101 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' E' E ' 53' ' ' ALA . . . . . . . . . . . . . . . -128.26 133.21 48.75 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 115.305 -0.861 . . . . 0.0 109.542 175.046 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' E' E ' 54' ' ' TYR . . . . . . . . . . . . . 58.8 t80 -129.03 110.44 18.32 Favored Pre-proline 0 C--N 1.327 -0.372 0 CA-C-O 118.202 -0.904 . . . . 0.0 110.191 179.123 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' E' E ' 55' ' ' PRO . . . . . . . . . . . . . 73.7 Cg_endo -77.21 168.36 77.08 Favored 'Cis proline' 0 N--CA 1.5 1.865 0 CA-C-N 121.828 1.689 . . . . 0.0 112.511 -5.453 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' E' E ' 56' ' ' SER . . . . . . . . . . . . . 17.7 m -116.76 131.36 23.96 Favored Pre-proline 0 CA--C 1.537 0.479 0 CA-C-O 118.392 -0.813 . . . . 0.0 109.361 174.104 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' E' E ' 57' ' ' PRO . . . . . . . . . . . . . 38.6 Cg_endo -67.13 164.98 69.45 Favored 'Cis proline' 0 N--CA 1.497 1.72 0 CA-C-N 121.96 1.736 . . . . 0.0 111.522 -0.919 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' E' E ' 58' ' ' LEU . . . . . . . . . . . . . 27.0 tp -130.44 137.0 49.59 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.218 -0.447 . . . . 0.0 110.316 -179.535 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' E' E ' 59' ' ' ARG . . . . . . . . . . . . . 41.1 ttm180 -103.05 132.67 49.14 Favored 'General case' 0 C--N 1.327 -0.373 0 N-CA-C 109.525 -0.546 . . . . 0.0 109.525 176.65 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' E' E ' 60' ' ' VAL . . . . . . . . . . . . . 45.8 t -83.24 115.44 25.65 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.284 0 C-N-CA 120.751 -0.379 . . . . 0.0 110.532 -176.9 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' E' E ' 61' ' ' GLU . . . . . . . . . . . . . 15.6 mm-40 -131.06 163.54 27.41 Favored 'General case' 0 C--N 1.331 -0.23 0 CA-C-N 115.75 -0.659 . . . . 0.0 109.714 175.165 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' E' E ' 62' ' ' ASP . . . . . . . . . . . . . 78.4 m-20 -53.13 -32.35 47.1 Favored 'General case' 0 C--N 1.328 -0.35 0 N-CA-C 111.917 0.34 . . . . 0.0 111.917 -178.95 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' E' E ' 63' ' ' ARG . . . . . . . . . . . . . 84.0 mtt180 -74.03 -22.02 59.72 Favored 'General case' 0 C--N 1.33 -0.26 0 N-CA-C 112.992 0.738 . . . . 0.0 112.992 -176.619 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' E' E ' 64' ' ' THR . . . . . . . . . . . . . 37.8 m -64.78 140.07 58.83 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-O 120.913 0.387 . . . . 0.0 110.835 -175.947 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' E' E ' 65' ' ' LYS . . . . . . . . . . . . . 25.0 mtpp -90.05 123.17 33.7 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.061 -0.518 . . . . 0.0 109.995 179.567 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' E' E ' 66' ' ' ILE . . . . . . . . . . . . . 57.3 mt -113.79 131.13 66.53 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.241 0 CA-C-O 120.85 0.357 . . . . 0.0 110.351 -177.623 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' E' E ' 67' ' ' THR . . . . . . . . . . . . . 30.9 m -132.49 139.84 48.12 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.127 -0.488 . . . . 0.0 111.012 -179.122 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' E' E ' 68' ' ' LEU . . . . . . . . . . . . . 8.1 mp . . . . . 0 C--N 1.329 -0.295 0 CA-C-N 116.039 -0.528 . . . . 0.0 110.203 176.836 . . . . . . . . 0 0 . 1 . 002 nuclear orig core ' E' E ' 73' ' ' VAL . . . . . . . . . . . . . 34.6 m . . . . . 0 C--O 1.232 0.155 0 CA-C-O 120.804 0.335 . . . . 0.0 110.663 . . . . . . . . . 0 0 . 1 . 002 nuclear orig core ' E' E ' 74' ' ' ASP . . . . . . . . . . . . . 26.4 t0 -99.33 120.57 39.78 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.222 -0.445 . . . . 0.0 109.998 -178.901 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' E' E ' 75' ' ' VAL . . . . . . . . . . . . . 46.8 t -112.61 121.3 64.66 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.19 0 CA-C-O 121.031 0.443 . . . . 0.0 110.358 -178.477 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' E' E ' 76' ' ' LEU . . . . . . . . . . . . . 41.2 mt -118.42 144.75 45.72 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 115.626 -0.716 . . . . 0.0 109.737 178.713 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' E' E ' 77' ' ' GLU . . . . . . . . . . . . . 97.3 mt-10 -139.43 130.2 26.07 Favored 'General case' 0 C--N 1.331 -0.205 0 CA-C-O 120.999 0.428 . . . . 0.0 111.327 -179.416 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' E' E ' 78' ' ' ALA . . . . . . . . . . . . . . . -119.16 135.28 54.74 Favored 'General case' 0 C--N 1.331 -0.212 0 CA-C-N 115.797 -0.638 . . . . 0.0 109.775 176.689 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' E' E ' 79' ' ' LYS . . . . . . . . . . . . . 91.0 mttt -77.13 118.62 19.85 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-O 120.882 0.373 . . . . 0.0 110.711 -179.452 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' E' E ' 80' ' ' ILE . . . . . . . . . . . . . 41.1 mm -139.13 106.04 2.75 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.39 0 N-CA-C 109.138 -0.69 . . . . 0.0 109.138 -178.077 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' E' E ' 81' ' ' LYS . . . . . . . . . . . . . 76.0 tttt -105.24 127.34 52.88 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-O 120.895 0.379 . . . . 0.0 111.164 -176.0 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' E' E ' 82' ' ' GLY . . . . . . . . . . . . . . . 89.13 42.09 5.69 Favored Glycine 0 CA--C 1.524 0.638 0 N-CA-C 111.615 -0.594 . . . . 0.0 111.615 176.346 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' E' E ' 83' ' ' ILE . . . . . . . . . . . . . 72.4 mt -69.64 140.18 19.1 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.294 0 N-CA-C 109.836 -0.431 . . . . 0.0 109.836 177.446 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' E' E ' 84' ' ' LYS . . . . . . . . . . . . . 49.4 tttp -98.17 -51.06 4.14 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 115.9 -0.591 . . . . 0.0 110.263 -178.733 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' E' E ' 85' ' ' ASP . . . . . . . . . . . . . 6.5 t70 -155.27 151.72 28.39 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 115.764 -0.653 . . . . 0.0 110.316 179.67 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' E' E ' 86' ' ' VAL . . . . . . . . . . . . . 44.2 t -130.44 131.41 65.24 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.221 0 CA-C-O 120.931 0.395 . . . . 0.0 110.553 -178.719 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' E' E ' 87' ' ' ILE . . . . . . . . . . . . . 5.0 mp -120.6 126.65 75.49 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.22 0 CA-C-N 115.889 -0.596 . . . . 0.0 109.494 176.382 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' E' E ' 88' ' ' LEU . . . . . . . . . . . . . 47.2 mt -116.0 137.76 51.82 Favored 'General case' 0 N--CA 1.462 0.167 0 CA-C-O 121.045 0.45 . . . . 0.0 111.468 -176.88 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' E' E ' 89' ' ' ASP . . . . . . . . . . . . . 8.7 t70 -136.14 156.73 48.27 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 115.655 -0.702 . . . . 0.0 109.584 175.202 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' E' E ' 90' ' ' GLU . . . . . . . . . . . . . 40.8 mp0 -51.23 -34.01 30.45 Favored 'General case' 0 C--N 1.328 -0.326 0 N-CA-C 112.507 0.558 . . . . 0.0 112.507 -171.919 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' E' E ' 91' ' ' ASN . . . . . . . . . . . . . 7.8 m120 -130.28 32.01 4.54 Favored 'General case' 0 N--CA 1.465 0.313 0 N-CA-C 112.062 0.393 . . . . 0.0 112.062 -175.897 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' E' E ' 92' ' ' LEU . . . . . . . . . . . . . 13.8 tp -166.11 141.77 4.82 Favored 'General case' 0 C--N 1.331 -0.239 0 C-N-CA 120.945 -0.302 . . . . 0.0 110.526 179.242 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' E' E ' 93' ' ' ILE . . . . . . . . . . . . . 71.9 mt -128.73 119.48 49.94 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.207 0 N-CA-C 109.121 -0.696 . . . . 0.0 109.121 176.686 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' E' E ' 94' ' ' VAL . . . . . . . . . . . . . 47.6 t -123.53 128.27 74.52 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.286 0 CA-C-O 121.037 0.446 . . . . 0.0 110.019 -178.898 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' E' E ' 95' ' ' VAL . . . . . . . . . . . . . 41.6 t -121.04 135.5 61.02 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.347 0 CA-C-N 115.807 -0.633 . . . . 0.0 109.821 -179.831 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' E' E ' 96' ' ' ILE . . . . . . . . . . . . . 49.9 mt -111.18 126.31 68.56 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.36 0 N-CA-C 108.959 -0.756 . . . . 0.0 108.959 178.041 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' E' E ' 97' ' ' THR . . . . . . . . . . . . . 74.7 p -96.27 155.73 16.64 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-O 121.114 0.483 . . . . 0.0 111.005 -177.747 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' E' E ' 98' ' ' GLU . . . . . . . . . . . . . 79.2 tt0 -53.84 -27.37 29.29 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.153 -0.476 . . . . 0.0 112.1 -179.143 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' E' E ' 99' ' ' GLU . . . . . . . . . . . . . 12.7 pt-20 -81.08 18.01 1.14 Allowed 'General case' 0 CA--C 1.535 0.374 0 N-CA-C 113.181 0.808 . . . . 0.0 113.181 -176.946 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' E' E ' 100' ' ' ASN . . . . . . . . . . . . . 3.4 m-20 63.52 37.43 10.49 Favored 'General case' 0 N--CA 1.463 0.179 0 CA-C-O 121.063 0.459 . . . . 0.0 111.204 176.831 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' E' E ' 101' ' ' GLU . . . . . . . . . . . . . 84.6 tt0 -116.22 146.02 42.67 Favored 'General case' 0 C--N 1.333 -0.131 0 CA-C-N 116.202 -0.454 . . . . 0.0 109.982 175.981 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' E' E ' 102' ' ' VAL . . . . . . . . . . . . . 46.8 t -115.08 126.1 72.57 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.346 0 CA-C-N 116.34 -0.391 . . . . 0.0 110.144 -177.668 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' E' E ' 103' ' ' LEU . . . . . . . . . . . . . 35.1 mt -117.82 128.54 54.95 Favored 'General case' 0 C--N 1.332 -0.169 0 CA-C-N 115.777 -0.647 . . . . 0.0 110.083 176.832 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' E' E ' 104' ' ' ILE . . . . . . . . . . . . . 68.9 mt -119.13 122.71 69.9 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.225 0 CA-C-N 116.722 -0.217 . . . . 0.0 110.422 -179.072 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' E' E ' 105' ' ' PHE . . . . . . . . . . . . . 55.5 m-85 -122.8 166.8 14.39 Favored 'General case' 0 C--O 1.232 0.137 0 O-C-N 123.917 0.76 . . . . 0.0 109.753 179.494 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' E' E ' 106' ' ' ASN . . . . . . . . . . . . . 45.9 p-10 -99.11 -170.04 1.86 Allowed 'General case' 0 C--N 1.33 -0.276 0 N-CA-C 109.758 -0.46 . . . . 0.0 109.758 173.079 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' E' E ' 107' ' ' GLN . . . . . . . . . . . . . 46.9 tt0 -60.61 -30.0 69.57 Favored 'General case' 0 C--N 1.329 -0.289 0 N-CA-C 111.932 0.345 . . . . 0.0 111.932 -179.675 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' E' E ' 108' ' ' ASN . . . . . . . . . . . . . 5.3 t30 -81.96 7.84 12.05 Favored 'General case' 0 CA--C 1.536 0.416 0 N-CA-C 113.108 0.781 . . . . 0.0 113.108 -177.891 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' E' E ' 109' ' ' LEU . . . . . . . . . . . . . 11.4 tp 61.42 35.97 17.53 Favored 'General case' 0 CA--C 1.53 0.19 0 O-C-N 122.106 -0.371 . . . . 0.0 111.442 178.724 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' E' E ' 110' ' ' GLU . . . . . . . . . . . . . 42.8 mt-10 -104.9 143.15 33.55 Favored 'General case' 0 C--N 1.33 -0.256 0 N-CA-C 109.586 -0.524 . . . . 0.0 109.586 175.288 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' E' E ' 111' ' ' GLU . . . . . . . . . . . . . 61.0 tt0 -79.72 121.98 26.01 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-O 120.877 0.37 . . . . 0.0 110.727 -176.661 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' E' E ' 112' ' ' LEU . . . . . . . . . . . . . 20.3 mt -105.98 -46.13 4.18 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 116.123 -0.489 . . . . 0.0 110.665 179.864 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' E' E ' 113' ' ' TYR . . . . . . . . . . . . . 57.1 t80 -134.31 138.26 44.83 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-O 120.901 0.382 . . . . 0.0 111.26 -178.077 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' E' E ' 114' ' ' ARG . . . . . . . . . . . . . 52.7 ttp180 -136.09 123.49 22.0 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 115.842 -0.617 . . . . 0.0 110.325 177.494 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' E' E ' 115' ' ' GLY . . . . . . . . . . . . . . . -150.0 157.98 27.46 Favored Glycine 0 CA--C 1.524 0.601 0 N-CA-C 110.915 -0.874 . . . . 0.0 110.915 179.0 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' E' E ' 116' ' ' LYS . . . . . . . . . . . . . 31.9 ttmt -131.83 138.95 48.7 Favored 'General case' 0 C--N 1.329 -0.303 0 N-CA-C 109.886 -0.413 . . . . 0.0 109.886 177.317 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' E' E ' 117' ' ' PHE . . . . . . . . . . . . . 39.1 m-85 -137.74 114.61 10.65 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-O 120.867 0.365 . . . . 0.0 110.208 -175.769 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' E' E ' 118' ' ' GLU . . . . . . . . . . . . . 81.2 tt0 -52.81 -44.51 66.7 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.493 -0.321 . . . . 0.0 111.503 -177.078 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' E' E ' 119' ' ' ASN . . . . . . . . . . . . . 36.5 m120 -95.77 30.69 2.27 Favored 'General case' 0 C--N 1.33 -0.248 0 N-CA-C 112.262 0.467 . . . . 0.0 112.262 -174.938 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' E' E ' 120' ' ' LEU . . . . . . . . . . . . . 13.9 tp -57.35 121.02 9.19 Favored 'General case' 0 C--N 1.332 -0.169 0 CA-C-O 120.631 0.253 . . . . 0.0 110.385 178.068 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' E' E ' 121' ' ' ASN . . . . . . . . . . . . . 66.7 m-20 -114.09 -44.12 3.17 Favored 'General case' 0 C--N 1.332 -0.188 0 CA-C-N 116.471 -0.331 . . . . 0.0 111.101 -178.794 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' E' E ' 122' ' ' LYS . . . . . . . . . . . . . 63.2 mtpt -145.5 152.12 39.27 Favored 'General case' 0 C--N 1.332 -0.171 0 CA-C-O 121.041 0.448 . . . . 0.0 111.714 -176.447 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' E' E ' 123' ' ' VAL . . . . . . . . . . . . . 47.2 t -130.85 131.95 64.19 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.252 0 CA-C-N 115.943 -0.571 . . . . 0.0 109.482 174.461 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' E' E ' 124' ' ' LEU . . . . . . . . . . . . . 83.0 mt -125.72 140.48 52.66 Favored 'General case' 0 C--N 1.332 -0.181 0 CA-C-O 120.827 0.346 . . . . 0.0 110.911 -177.549 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' E' E ' 125' ' ' VAL . . . . . . . . . . . . . 34.5 m -132.89 142.79 41.37 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.182 0 CA-C-N 116.127 -0.488 . . . . 0.0 110.764 179.878 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' E' E ' 126' ' ' ARG . . . . . . . . . . . . . 96.2 mtt-85 -148.05 112.15 5.18 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.443 177.105 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' E' E ' 127' ' ' ASN . . . . . . . . . . . . . 17.1 m120 53.85 -104.93 0.23 Allowed 'General case' 0 CA--C 1.543 0.699 0 CA-C-O 119.078 -0.487 . . . . 0.0 111.017 179.542 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' E' E ' 128' ' ' ASP . . . . . . . . . . . . . 18.7 p-10 -113.98 3.5 15.38 Favored 'General case' 0 N--CA 1.468 0.453 0 CA-C-N 119.508 1.049 . . . . 0.0 113.473 -177.487 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' E' E ' 129' ' ' LEU . . . . . . . . . . . . . 12.4 tp -104.92 140.47 38.1 Favored 'General case' 0 C--N 1.331 -0.215 0 N-CA-C 109.609 -0.515 . . . . 0.0 109.609 178.034 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' E' E ' 130' ' ' VAL . . . . . . . . . . . . . 13.4 p -132.92 139.2 50.14 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.184 0 CA-C-O 121.132 0.491 . . . . 0.0 110.742 -178.28 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' E' E ' 131' ' ' VAL . . . . . . . . . . . . . 38.4 t -136.11 140.85 43.11 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.267 0 CA-C-N 115.96 -0.564 . . . . 0.0 110.565 -179.792 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' E' E ' 132' ' ' ILE . . . . . . . . . . . . . 70.0 mt -116.17 133.08 63.8 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.27 0 CA-C-N 115.747 -0.66 . . . . 0.0 109.433 178.957 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' E' E ' 133' ' ' ILE . . . . . . . . . . . . . 39.0 mm -116.1 123.26 71.13 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.228 0 CA-C-O 120.678 0.275 . . . . 0.0 111.1 -174.898 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' E' E ' 134' ' ' ASP . . . . . . . . . . . . . 9.3 p-10 -136.18 149.73 48.72 Favored 'General case' 0 C--N 1.331 -0.226 0 CA-C-N 116.253 -0.431 . . . . 0.0 110.101 175.428 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' E' E ' 135' ' ' GLU . . . . . . . . . . . . . 81.5 tt0 -49.96 -27.33 5.22 Favored 'General case' 0 C--N 1.329 -0.299 0 N-CA-C 112.878 0.696 . . . . 0.0 112.878 -173.753 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' E' E ' 136' ' ' GLN . . . . . . . . . . . . . 94.8 mt-30 -83.24 -34.48 25.83 Favored 'General case' 0 C--O 1.233 0.232 0 N-CA-C 112.304 0.483 . . . . 0.0 112.304 -175.621 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' E' E ' 137' ' ' LYS . . . . . . . . . . . . . 15.2 pttp -167.51 174.23 8.04 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-O 121.597 0.713 . . . . 0.0 112.194 -170.941 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' E' E ' 138' ' ' LEU . . . . . . . . . . . . . 6.3 tt -119.42 126.65 51.86 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 114.951 -1.022 . . . . 0.0 109.923 178.652 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' E' E ' 139' ' ' THR . . . . . . . . . . . . . 25.9 m -105.82 122.91 47.06 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.139 -0.482 . . . . 0.0 110.217 179.367 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' E' E ' 140' ' ' LEU . . . . . . . . . . . . . 10.6 tp -111.91 121.48 45.14 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 115.94 -0.573 . . . . 0.0 109.619 -177.428 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' E' E ' 141' ' ' ILE . . . . . . . . . . . . . 19.4 mt -122.0 118.68 56.31 Favored 'Isoleucine or valine' 0 C--O 1.234 0.265 0 CA-C-O 121.168 0.509 . . . . 0.0 110.121 -176.799 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' E' E ' 142' ' ' ARG . . . . . . . . . . . . . 78.6 mtp180 -102.75 110.13 21.96 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 115.058 -0.973 . . . . 0.0 110.114 178.985 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' E' E ' 143' ' ' THR . . . . . . . . . . . . . 69.6 p . . . . . 0 C--O 1.219 -0.538 0 CA-C-O 118.041 -0.98 . . . . 0.0 110.558 -178.561 . . . . . . . . 0 0 . 1 . 002 nuclear orig core ' F' F ' 1' ' ' MET . . . . . . . . . . . . . 25.3 ptp . . . . . 0 C--O 1.232 0.156 0 CA-C-O 120.806 0.336 . . . . 0.0 110.778 . . . . . . . . . 0 0 . 1 . 002 nuclear orig core ' F' F ' 2' ' ' SER . . . . . . . . . . . . . 10.1 p -112.22 134.47 53.75 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.562 179.319 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' F' F ' 3' ' ' GLU . . . . . . . . . . . . . 40.6 mt-10 -139.61 141.6 37.11 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 115.991 -0.55 . . . . 0.0 110.653 -179.544 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' F' F ' 4' ' ' LEU . . . . . . . . . . . . . 3.1 tt -128.01 125.63 39.77 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-N 115.896 -0.593 . . . . 0.0 109.945 179.11 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' F' F ' 5' ' ' LYS . . . . . . . . . . . . . 97.9 mttt -106.28 120.05 40.84 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.297 -0.411 . . . . 0.0 110.655 -179.811 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' F' F ' 6' ' ' LEU . . . . . . . . . . . . . 64.1 mt -114.01 150.06 34.46 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 115.538 -0.756 . . . . 0.0 110.485 -178.88 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' F' F ' 7' ' ' LYS . . . . . . . . . . . . . 82.3 tttt -137.15 134.74 19.03 Favored Pre-proline 0 CA--C 1.534 0.365 0 CA-C-O 118.806 -0.616 . . . . 0.0 109.676 175.021 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' F' F ' 8' ' ' PRO . . . . . . . . . . . . . 71.8 Cg_endo -89.6 135.97 2.61 Favored 'Trans proline' 0 N--CA 1.49 1.319 0 C-N-CA 121.615 1.544 . . . . 0.0 111.483 177.838 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' F' F ' 9' ' ' LEU . . . . . . . . . . . . . 37.9 mt -72.93 -47.1 8.54 Favored Pre-proline 0 CA--C 1.533 0.325 0 CA-C-O 118.689 -0.672 . . . . 0.0 112.318 -177.538 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' F' F ' 10' ' ' PRO . . . . . . . . . . . . . 92.5 Cg_endo -80.68 149.87 18.61 Favored 'Trans proline' 0 N--CA 1.495 1.576 0 C-N-CA 121.104 1.203 . . . . 0.0 111.757 175.586 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' F' F ' 11' ' ' LYS . . . . . . . . . . . . . 83.6 tttt -84.1 96.9 9.06 Favored 'General case' 0 C--N 1.33 -0.275 0 C-N-CA 120.836 -0.346 . . . . 0.0 110.49 179.358 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' F' F ' 12' ' ' VAL . . . . . . . . . . . . . 12.1 p -142.77 144.39 24.36 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.364 0 CA-C-N 116.123 -0.49 . . . . 0.0 110.434 179.678 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' F' F ' 13' ' ' GLU . . . . . . . . . . . . . 43.7 mp0 -85.67 125.37 33.12 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.224 -0.444 . . . . 0.0 110.045 177.666 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' F' F ' 14' ' ' LEU . . . . . . . . . . . . . 45.7 mt -95.15 153.52 39.73 Favored Pre-proline 0 C--N 1.329 -0.303 0 CA-C-N 116.444 -0.344 . . . . 0.0 110.81 -177.8 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' F' F ' 15' ' ' PRO . . . . . . . . . . . . . 36.8 Cg_exo -59.33 160.14 20.67 Favored 'Trans proline' 0 N--CA 1.497 1.7 0 C-N-CA 121.296 1.331 . . . . 0.0 111.704 177.743 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' F' F ' 16' ' ' PRO . . . . . . . . . . . . . 27.5 Cg_exo -60.25 -43.13 36.98 Favored 'Trans proline' 0 N--CA 1.498 1.737 0 C-N-CA 121.381 1.388 . . . . 0.0 112.802 -177.628 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' F' F ' 17' ' ' ASP . . . . . . . . . . . . . 16.3 p-10 -87.72 12.5 12.65 Favored 'General case' 0 C--N 1.326 -0.422 0 N-CA-C 113.182 0.808 . . . . 0.0 113.182 -176.377 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' F' F ' 18' ' ' PHE . . . . . . . . . . . . . 48.1 t80 -58.0 -44.64 87.33 Favored 'General case' 0 C--N 1.334 -0.074 0 O-C-N 122.04 -0.413 . . . . 0.0 110.151 -178.241 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' F' F ' 19' ' ' VAL . . . . . . . . . . . . . 14.6 p -56.46 -42.08 74.18 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.333 0 CA-C-N 116.36 -0.382 . . . . 0.0 110.941 -178.474 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' F' F ' 20' ' ' ASP . . . . . . . . . . . . . 79.9 m-20 -60.98 -42.12 97.77 Favored 'General case' 0 C--O 1.233 0.234 0 CA-C-O 120.884 0.373 . . . . 0.0 110.957 -178.051 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' F' F ' 21' ' ' VAL . . . . . . . . . . . . . 46.9 t -64.0 -47.37 90.74 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 CA-C-N 116.343 -0.39 . . . . 0.0 110.406 -178.395 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' F' F ' 22' ' ' ILE . . . . . . . . . . . . . 50.1 mm -55.96 -43.96 76.67 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.182 0 CA-C-O 120.774 0.321 . . . . 0.0 110.66 178.769 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' F' F ' 23' ' ' ARG . . . . . . . . . . . . . 56.0 ttp180 -52.86 -52.36 57.57 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-O 120.709 0.29 . . . . 0.0 111.519 179.986 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' F' F ' 24' ' ' ILE . . . . . . . . . . . . . 69.3 mt -59.63 -40.62 82.68 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.268 0 CA-C-N 116.414 -0.357 . . . . 0.0 111.273 -177.051 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' F' F ' 25' ' ' LYS . . . . . . . . . . . . . 46.4 mttm -65.46 -42.06 92.7 Favored 'General case' 0 C--N 1.327 -0.377 0 N-CA-C 112.192 0.442 . . . . 0.0 112.192 -178.626 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' F' F ' 26' ' ' LEU . . . . . . . . . . . . . 74.4 mt -80.58 -38.03 30.21 Favored 'General case' 0 C--N 1.33 -0.261 0 N-CA-C 113.39 0.885 . . . . 0.0 113.39 -170.841 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' F' F ' 27' ' ' GLN . . . . . . . . . . . . . 8.6 pt20 -46.48 139.78 4.74 Favored 'General case' 0 N--CA 1.469 0.479 0 N-CA-C 112.871 0.693 . . . . 0.0 112.871 -174.946 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' F' F ' 28' ' ' GLY . . . . . . . . . . . . . . . 99.29 -25.4 28.37 Favored Glycine 0 CA--C 1.533 1.193 0 CA-C-N 115.507 -0.77 . . . . 0.0 112.264 -177.035 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' F' F ' 29' ' ' LYS . . . . . . . . . . . . . 33.5 mmtp -97.61 155.15 17.1 Favored 'General case' 0 C--O 1.233 0.198 0 CA-C-N 117.335 0.568 . . . . 0.0 110.771 178.982 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' F' F ' 30' ' ' THR . . . . . . . . . . . . . 25.2 m -107.21 136.65 46.68 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 115.928 -0.578 . . . . 0.0 109.827 175.428 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' F' F ' 31' ' ' VAL . . . . . . . . . . . . . 35.0 m -129.78 161.15 39.94 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.267 0 CA-C-N 116.473 -0.33 . . . . 0.0 110.814 -177.959 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' F' F ' 32' ' ' ARG . . . . . . . . . . . . . 92.7 mtt180 -132.56 151.22 52.0 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-O 121.307 0.575 . . . . 0.0 110.595 178.88 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' F' F ' 33' ' ' THR . . . . . . . . . . . . . 24.1 m -52.45 140.54 22.18 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.112 -0.494 . . . . 0.0 111.396 -178.467 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' F' F ' 34' ' ' GLY . . . . . . . . . . . . . . . 99.28 -17.09 58.39 Favored Glycine 0 CA--C 1.532 1.135 0 CA-C-O 119.596 -0.558 . . . . 0.0 113.218 178.977 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' F' F ' 35' ' ' ASP . . . . . . . . . . . . . 54.3 m-20 -63.3 150.48 43.18 Favored 'General case' 0 C--O 1.232 0.142 0 CA-C-N 118.09 0.945 . . . . 0.0 111.0 179.365 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' F' F ' 36' ' ' VAL . . . . . . . . . . . . . 42.4 t -125.72 130.44 72.53 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.293 0 CA-C-N 115.801 -0.636 . . . . 0.0 109.706 178.763 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' F' F ' 37' ' ' ILE . . . . . . . . . . . . . 65.2 mt -120.66 138.92 49.57 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.294 0 CA-C-N 116.336 -0.393 . . . . 0.0 110.098 -178.921 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' F' F ' 38' ' ' GLY . . . . . . . . . . . . . . . -109.13 128.86 9.21 Favored Glycine 0 CA--C 1.525 0.689 0 N-CA-C 110.872 -0.891 . . . . 0.0 110.872 179.02 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' F' F ' 39' ' ' ILE . . . . . . . . . . . . . 74.4 mt -123.57 134.91 65.03 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.256 0 N-CA-C 110.176 -0.305 . . . . 0.0 110.176 179.828 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' F' F ' 40' ' ' SER . . . . . . . . . . . . . 88.0 p -92.65 118.63 31.24 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.895 176.383 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' F' F ' 41' ' ' ILE . . . . . . . . . . . . . 44.5 mm -120.48 113.01 38.68 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.263 0 CA-C-O 120.751 0.31 . . . . 0.0 110.247 178.799 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' F' F ' 42' ' ' LEU . . . . . . . . . . . . . 7.9 mp 51.21 37.4 18.37 Favored 'General case' 0 C--N 1.331 -0.223 0 CA-C-N 116.151 -0.477 . . . . 0.0 111.748 177.006 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' F' F ' 43' ' ' GLY . . . . . . . . . . . . . . . 75.95 29.84 58.4 Favored Glycine 0 CA--C 1.53 1.03 0 C-N-CA 121.151 -0.547 . . . . 0.0 112.33 177.606 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' F' F ' 44' ' ' LYS . . . . . . . . . . . . . 60.0 mtpt -135.29 127.88 30.76 Favored 'General case' 0 C--N 1.329 -0.295 0 N-CA-C 109.65 -0.5 . . . . 0.0 109.65 177.062 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' F' F ' 45' ' ' GLU . . . . . . . . . . . . . 84.2 tt0 -82.73 123.42 29.29 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-O 120.822 0.344 . . . . 0.0 111.322 -176.738 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' F' F ' 46' ' ' VAL . . . . . . . . . . . . . 7.1 p -123.23 128.4 74.89 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.202 0 N-CA-C 109.592 -0.521 . . . . 0.0 109.592 175.386 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' F' F ' 47' ' ' LYS . . . . . . . . . . . . . 63.6 mttp -99.53 128.79 45.65 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.125 -0.489 . . . . 0.0 111.229 178.099 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' F' F ' 48' ' ' PHE . . . . . . . . . . . . . 91.5 m-85 -111.64 131.9 54.96 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.023 -0.535 . . . . 0.0 109.746 176.196 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' F' F ' 49' ' ' LYS . . . . . . . . . . . . . 71.9 tttt -106.6 136.18 46.83 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.4 -0.364 . . . . 0.0 110.455 -179.654 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' F' F ' 50' ' ' VAL . . . . . . . . . . . . . 45.4 t -81.11 105.62 11.25 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.292 0 N-CA-C 109.53 -0.544 . . . . 0.0 109.53 176.691 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' F' F ' 51' ' ' VAL . . . . . . . . . . . . . 47.6 t -70.21 -51.96 34.34 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.33 0 CA-C-N 115.879 -0.6 . . . . 0.0 109.73 -174.387 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' F' F ' 52' ' ' GLN . . . . . . . . . . . . . 77.8 mt-30 -154.62 147.67 24.68 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-O 121.175 0.512 . . . . 0.0 111.756 -177.261 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' F' F ' 53' ' ' ALA . . . . . . . . . . . . . . . -122.39 128.84 51.46 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 115.19 -0.914 . . . . 0.0 109.317 175.282 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' F' F ' 54' ' ' TYR . . . . . . . . . . . . . 45.7 t80 -126.77 109.53 22.51 Favored Pre-proline 0 CA--C 1.534 0.335 0 CA-C-O 118.383 -0.817 . . . . 0.0 110.443 -178.479 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' F' F ' 55' ' ' PRO . . . . . . . . . . . . . 74.4 Cg_endo -77.09 170.04 72.69 Favored 'Cis proline' 0 N--CA 1.5 1.902 0 CA-C-N 121.768 1.667 . . . . 0.0 112.536 -5.091 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' F' F ' 56' ' ' SER . . . . . . . . . . . . . 13.7 m -112.27 126.91 27.6 Favored Pre-proline 0 CA--C 1.539 0.542 0 CA-C-O 118.409 -0.805 . . . . 0.0 109.642 176.52 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' F' F ' 57' ' ' PRO . . . . . . . . . . . . . 33.7 Cg_endo -65.27 169.15 41.16 Favored 'Cis proline' 0 N--CA 1.498 1.791 0 CA-C-N 122.083 1.78 . . . . 0.0 111.475 -1.543 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' F' F ' 58' ' ' LEU . . . . . . . . . . . . . 34.0 tp -130.61 137.05 49.45 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-O 120.971 0.415 . . . . 0.0 110.574 -179.313 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' F' F ' 59' ' ' ARG . . . . . . . . . . . . . 71.1 ttt180 -104.68 129.24 52.88 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 115.773 -0.648 . . . . 0.0 109.575 177.695 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' F' F ' 60' ' ' VAL . . . . . . . . . . . . . 42.3 t -86.74 119.17 34.23 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.272 0 C-N-CA 120.744 -0.382 . . . . 0.0 110.353 -176.131 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' F' F ' 61' ' ' GLU . . . . . . . . . . . . . 95.3 mt-10 -131.08 168.04 18.07 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.329 178.28 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' F' F ' 62' ' ' ASP . . . . . . . . . . . . . 55.8 m-20 -54.01 -32.51 54.43 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.641 -0.254 . . . . 0.0 111.641 179.259 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' F' F ' 63' ' ' ARG . . . . . . . . . . . . . 6.8 ptp180 -85.5 9.08 16.85 Favored 'General case' 0 CA--C 1.537 0.447 0 N-CA-C 113.508 0.929 . . . . 0.0 113.508 -175.892 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' F' F ' 64' ' ' THR . . . . . . . . . . . . . 30.1 m -85.43 134.81 34.05 Favored 'General case' 0 C--N 1.333 -0.124 0 CA-C-N 118.085 0.402 . . . . 0.0 110.813 -178.749 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' F' F ' 65' ' ' LYS . . . . . . . . . . . . . 52.4 mtmt -88.74 124.6 34.28 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.234 -0.439 . . . . 0.0 109.932 177.426 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' F' F ' 66' ' ' ILE . . . . . . . . . . . . . 62.3 mt -112.51 128.54 69.12 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.325 0 N-CA-C 109.835 -0.431 . . . . 0.0 109.835 -178.572 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' F' F ' 67' ' ' THR . . . . . . . . . . . . . 28.5 m -126.15 141.82 51.78 Favored 'General case' 0 C--N 1.331 -0.222 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.972 -177.05 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' F' F ' 68' ' ' LEU . . . . . . . . . . . . . 8.5 mp . . . . . 0 C--N 1.329 -0.312 0 CA-C-N 115.966 -0.561 . . . . 0.0 110.104 178.061 . . . . . . . . 0 0 . 1 . 002 nuclear orig core ' F' F ' 73' ' ' VAL . . . . . . . . . . . . . 35.6 m . . . . . 0 C--O 1.232 0.156 0 N-CA-C 109.681 -0.489 . . . . 0.0 109.681 . . . . . . . . . 0 0 . 1 . 002 nuclear orig core ' F' F ' 74' ' ' ASP . . . . . . . . . . . . . 39.7 t0 -88.85 114.91 25.98 Favored 'General case' 0 C--N 1.328 -0.343 0 N-CA-C 109.982 -0.377 . . . . 0.0 109.982 -177.596 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' F' F ' 75' ' ' VAL . . . . . . . . . . . . . 41.4 t -111.05 120.79 62.47 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.287 0 CA-C-O 121.07 0.462 . . . . 0.0 110.242 -178.784 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' F' F ' 76' ' ' LEU . . . . . . . . . . . . . 15.3 mt -128.55 143.81 51.03 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 115.732 -0.667 . . . . 0.0 109.692 179.097 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' F' F ' 77' ' ' GLU . . . . . . . . . . . . . 97.3 mt-10 -131.94 131.26 42.5 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-O 120.989 0.424 . . . . 0.0 111.093 -177.153 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' F' F ' 78' ' ' ALA . . . . . . . . . . . . . . . -117.94 128.38 54.75 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 115.747 -0.661 . . . . 0.0 109.621 177.148 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' F' F ' 79' ' ' LYS . . . . . . . . . . . . . 95.2 mttt -79.93 120.63 24.41 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-O 120.904 0.383 . . . . 0.0 110.857 -177.085 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' F' F ' 80' ' ' ILE . . . . . . . . . . . . . 41.4 mm -139.1 108.68 3.93 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.309 0 N-CA-C 109.072 -0.714 . . . . 0.0 109.072 -177.322 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' F' F ' 81' ' ' LYS . . . . . . . . . . . . . 82.7 tttt -97.53 123.79 41.54 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-O 120.868 0.366 . . . . 0.0 111.239 -175.913 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' F' F ' 82' ' ' GLY . . . . . . . . . . . . . . . 89.22 42.02 5.68 Favored Glycine 0 CA--C 1.526 0.724 0 C-N-CA 120.884 -0.674 . . . . 0.0 111.907 174.647 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' F' F ' 83' ' ' ILE . . . . . . . . . . . . . 71.4 mt -68.7 136.71 25.85 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.304 0 N-CA-C 109.661 -0.496 . . . . 0.0 109.661 176.571 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' F' F ' 84' ' ' LYS . . . . . . . . . . . . . 36.7 ttpt -101.36 -51.31 3.52 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-O 120.868 0.366 . . . . 0.0 110.262 -178.908 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' F' F ' 85' ' ' ASP . . . . . . . . . . . . . 11.9 t70 -148.22 148.65 30.74 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 115.874 -0.603 . . . . 0.0 110.385 -179.752 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' F' F ' 86' ' ' VAL . . . . . . . . . . . . . 46.3 t -133.56 132.95 57.52 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.269 0 CA-C-O 121.0 0.429 . . . . 0.0 110.494 -178.98 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' F' F ' 87' ' ' ILE . . . . . . . . . . . . . 5.0 mp -119.82 127.25 75.87 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.202 0 CA-C-N 115.859 -0.61 . . . . 0.0 109.474 175.901 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' F' F ' 88' ' ' LEU . . . . . . . . . . . . . 12.8 tp -112.6 129.94 56.2 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.3 -0.409 . . . . 0.0 111.022 -177.453 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' F' F ' 89' ' ' ASP . . . . . . . . . . . . . 6.2 t70 -123.94 156.36 36.49 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 115.868 -0.606 . . . . 0.0 109.747 176.794 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' F' F ' 90' ' ' GLU . . . . . . . . . . . . . 96.3 mt-10 -46.15 -41.93 13.21 Favored 'General case' 0 C--N 1.332 -0.192 0 N-CA-C 113.15 0.796 . . . . 0.0 113.15 -172.58 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' F' F ' 91' ' ' ASN . . . . . . . . . . . . . 54.0 m-80 -132.09 36.6 3.64 Favored 'General case' 0 N--CA 1.464 0.259 0 CA-C-O 120.732 0.301 . . . . 0.0 111.569 -176.575 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' F' F ' 92' ' ' LEU . . . . . . . . . . . . . 12.6 tp -166.07 144.98 5.91 Favored 'General case' 0 C--N 1.331 -0.232 0 C-N-CA 120.927 -0.309 . . . . 0.0 110.746 -179.752 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' F' F ' 93' ' ' ILE . . . . . . . . . . . . . 68.7 mt -127.3 123.63 62.31 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.253 0 N-CA-C 109.584 -0.524 . . . . 0.0 109.584 179.795 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' F' F ' 94' ' ' VAL . . . . . . . . . . . . . 47.2 t -123.09 125.4 72.02 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.27 0 N-CA-C 109.907 -0.405 . . . . 0.0 109.907 -179.92 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' F' F ' 95' ' ' VAL . . . . . . . . . . . . . 43.4 t -121.16 135.81 60.13 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.325 0 CA-C-N 115.902 -0.59 . . . . 0.0 109.97 -177.877 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' F' F ' 96' ' ' ILE . . . . . . . . . . . . . 60.3 mt -117.62 126.51 74.76 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.286 0 N-CA-C 109.258 -0.645 . . . . 0.0 109.258 178.58 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' F' F ' 97' ' ' THR . . . . . . . . . . . . . 64.0 p -102.6 157.61 16.81 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-O 121.081 0.467 . . . . 0.0 111.36 -176.432 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' F' F ' 98' ' ' GLU . . . . . . . . . . . . . 12.5 pt-20 -53.88 -22.17 9.33 Favored 'General case' 0 CA--C 1.534 0.345 0 N-CA-C 112.51 0.559 . . . . 0.0 112.51 -179.936 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' F' F ' 99' ' ' GLU . . . . . . . . . . . . . 16.9 tt0 -78.94 14.56 1.34 Allowed 'General case' 0 CA--C 1.537 0.444 0 N-CA-C 112.855 0.687 . . . . 0.0 112.855 -178.061 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' F' F ' 100' ' ' ASN . . . . . . . . . . . . . 3.6 m-20 59.92 38.09 21.23 Favored 'General case' 0 CA--C 1.531 0.214 0 CA-C-O 121.027 0.441 . . . . 0.0 110.599 -179.536 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' F' F ' 101' ' ' GLU . . . . . . . . . . . . . 84.7 tt0 -118.24 143.49 46.51 Favored 'General case' 0 C--N 1.332 -0.163 0 CA-C-N 116.014 -0.539 . . . . 0.0 109.776 178.429 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' F' F ' 102' ' ' VAL . . . . . . . . . . . . . 43.6 t -114.95 126.75 72.61 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.269 0 CA-C-N 116.182 -0.463 . . . . 0.0 109.946 -177.862 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' F' F ' 103' ' ' LEU . . . . . . . . . . . . . 27.0 mt -116.53 130.78 56.94 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 115.665 -0.698 . . . . 0.0 110.267 177.704 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' F' F ' 104' ' ' ILE . . . . . . . . . . . . . 66.5 mt -118.38 120.75 65.28 Favored 'Isoleucine or valine' 0 C--O 1.234 0.25 0 N-CA-C 110.053 -0.351 . . . . 0.0 110.053 179.669 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' F' F ' 105' ' ' PHE . . . . . . . . . . . . . 84.3 m-85 -123.47 164.87 18.08 Favored 'General case' 0 C--N 1.333 -0.15 0 O-C-N 123.928 0.768 . . . . 0.0 109.91 179.742 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' F' F ' 106' ' ' ASN . . . . . . . . . . . . . 45.4 p-10 -100.07 -171.31 2.02 Favored 'General case' 0 C--N 1.331 -0.229 0 N-CA-C 109.88 -0.415 . . . . 0.0 109.88 172.934 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' F' F ' 107' ' ' GLN . . . . . . . . . . . . . 48.7 tt0 -58.67 -28.23 65.54 Favored 'General case' 0 C--N 1.328 -0.365 0 N-CA-C 112.278 0.473 . . . . 0.0 112.278 -178.693 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' F' F ' 108' ' ' ASN . . . . . . . . . . . . . 14.0 t30 -91.4 14.11 15.59 Favored 'General case' 0 CA--C 1.534 0.359 0 N-CA-C 113.177 0.806 . . . . 0.0 113.177 -176.336 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' F' F ' 109' ' ' LEU . . . . . . . . . . . . . 28.2 mt 59.15 37.2 24.09 Favored 'General case' 0 CA--C 1.529 0.144 0 CA-C-O 121.03 0.443 . . . . 0.0 111.551 177.122 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' F' F ' 110' ' ' GLU . . . . . . . . . . . . . 95.7 mt-10 -100.6 150.15 23.01 Favored 'General case' 0 C--N 1.329 -0.285 0 N-CA-C 109.818 -0.438 . . . . 0.0 109.818 176.058 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' F' F ' 111' ' ' GLU . . . . . . . . . . . . . 84.9 tt0 -82.38 122.01 27.45 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-O 120.918 0.389 . . . . 0.0 110.713 -178.255 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' F' F ' 112' ' ' LEU . . . . . . . . . . . . . 60.6 mt -110.91 -46.02 3.39 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.029 -0.532 . . . . 0.0 110.334 178.872 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' F' F ' 113' ' ' TYR . . . . . . . . . . . . . 52.6 t80 -140.96 138.58 33.87 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-O 120.874 0.368 . . . . 0.0 111.393 -179.791 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' F' F ' 114' ' ' ARG . . . . . . . . . . . . . 31.4 ttp180 -138.61 123.02 18.34 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 115.863 -0.608 . . . . 0.0 109.955 176.29 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' F' F ' 115' ' ' GLY . . . . . . . . . . . . . . . -150.08 157.78 27.37 Favored Glycine 0 CA--C 1.523 0.581 0 C-N-CA 120.794 -0.717 . . . . 0.0 111.35 179.002 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' F' F ' 116' ' ' LYS . . . . . . . . . . . . . 39.8 ttpt -127.7 140.74 51.88 Favored 'General case' 0 C--N 1.331 -0.228 0 N-CA-C 110.139 -0.319 . . . . 0.0 110.139 178.446 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' F' F ' 117' ' ' PHE . . . . . . . . . . . . . 44.2 m-85 -136.16 115.01 12.13 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-O 120.865 0.364 . . . . 0.0 110.292 -178.331 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' F' F ' 118' ' ' GLU . . . . . . . . . . . . . 84.9 tt0 -52.23 -46.9 65.89 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.43 -0.35 . . . . 0.0 111.561 -177.515 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' F' F ' 119' ' ' ASN . . . . . . . . . . . . . 18.0 m120 -97.01 31.02 2.51 Favored 'General case' 0 C--N 1.329 -0.285 0 N-CA-C 112.105 0.409 . . . . 0.0 112.105 -175.213 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' F' F ' 120' ' ' LEU . . . . . . . . . . . . . 15.5 tp -56.29 120.11 7.07 Favored 'General case' 0 C--N 1.331 -0.202 0 CA-C-O 120.694 0.283 . . . . 0.0 110.543 178.392 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' F' F ' 121' ' ' ASN . . . . . . . . . . . . . 12.5 m120 -114.06 -44.02 3.19 Favored 'General case' 0 C--N 1.332 -0.181 0 CA-C-N 116.499 -0.319 . . . . 0.0 111.225 -177.53 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' F' F ' 122' ' ' LYS . . . . . . . . . . . . . 88.4 mttt -144.7 153.84 42.14 Favored 'General case' 0 C--N 1.332 -0.195 0 CA-C-O 121.096 0.474 . . . . 0.0 111.912 -176.104 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' F' F ' 123' ' ' VAL . . . . . . . . . . . . . 44.3 t -129.29 129.04 67.23 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.261 0 CA-C-N 115.735 -0.666 . . . . 0.0 109.621 175.428 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' F' F ' 124' ' ' LEU . . . . . . . . . . . . . 34.0 mt -116.69 133.25 56.24 Favored 'General case' 0 C--N 1.331 -0.208 0 CA-C-N 116.305 -0.407 . . . . 0.0 110.275 -179.251 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' F' F ' 125' ' ' VAL . . . . . . . . . . . . . 34.3 m -136.21 139.03 46.33 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.298 0 CA-C-N 116.506 -0.315 . . . . 0.0 110.831 -179.032 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' F' F ' 126' ' ' ARG . . . . . . . . . . . . . 19.2 ttm180 -157.63 127.46 6.11 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-O 120.974 0.416 . . . . 0.0 110.88 175.913 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' F' F ' 127' ' ' ASN . . . . . . . . . . . . . 78.8 m-20 52.9 -113.09 0.74 Allowed 'General case' 0 CA--C 1.544 0.73 0 CA-C-O 118.748 -0.644 . . . . 0.0 110.858 -179.77 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' F' F ' 128' ' ' ASP . . . . . . . . . . . . . 18.9 p-10 -114.17 9.84 17.21 Favored 'General case' 0 CA--C 1.536 0.42 0 CA-C-N 119.978 1.263 . . . . 0.0 113.074 -178.233 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' F' F ' 129' ' ' LEU . . . . . . . . . . . . . 15.1 tp -109.02 138.69 44.97 Favored 'General case' 0 C--O 1.233 0.211 0 O-C-N 122.056 -0.403 . . . . 0.0 109.93 179.123 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' F' F ' 130' ' ' VAL . . . . . . . . . . . . . 43.0 t -125.36 139.49 51.1 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.24 0 CA-C-N 116.311 -0.404 . . . . 0.0 110.002 -178.968 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' F' F ' 131' ' ' VAL . . . . . . . . . . . . . 43.6 t -135.62 135.62 51.14 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.338 0 CA-C-N 116.239 -0.437 . . . . 0.0 109.959 178.287 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' F' F ' 132' ' ' ILE . . . . . . . . . . . . . 69.3 mt -114.41 134.13 58.31 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.323 0 N-CA-C 109.41 -0.589 . . . . 0.0 109.41 -179.926 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' F' F ' 133' ' ' ILE . . . . . . . . . . . . . 39.2 mm -116.22 117.88 56.97 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.211 0 CA-C-N 116.295 -0.411 . . . . 0.0 111.006 -174.594 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' F' F ' 134' ' ' ASP . . . . . . . . . . . . . 7.0 p-10 -129.81 149.64 51.47 Favored 'General case' 0 C--N 1.332 -0.177 0 N-CA-C 109.582 -0.525 . . . . 0.0 109.582 174.085 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' F' F ' 135' ' ' GLU . . . . . . . . . . . . . 39.7 tp10 -49.87 -26.17 3.83 Favored 'General case' 0 C--N 1.327 -0.39 0 N-CA-C 112.988 0.736 . . . . 0.0 112.988 -169.676 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' F' F ' 136' ' ' GLN . . . . . . . . . . . . . 96.9 mt-30 -105.09 -24.27 12.8 Favored 'General case' 0 N--CA 1.466 0.353 0 N-CA-C 113.178 0.807 . . . . 0.0 113.178 -174.654 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' F' F ' 137' ' ' LYS . . . . . . . . . . . . . 38.6 ttpt -140.86 147.75 39.44 Favored 'General case' 0 C--N 1.331 -0.21 0 CA-C-O 121.515 0.674 . . . . 0.0 112.35 -168.32 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' F' F ' 138' ' ' LEU . . . . . . . . . . . . . 16.3 tp -111.67 121.19 44.46 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 114.863 -1.062 . . . . 0.0 109.069 173.567 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' F' F ' 139' ' ' THR . . . . . . . . . . . . . 21.7 m -110.88 126.39 54.64 Favored 'General case' 0 C--N 1.332 -0.179 0 CA-C-O 120.689 0.28 . . . . 0.0 110.963 -178.328 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' F' F ' 140' ' ' LEU . . . . . . . . . . . . . 7.8 tt -114.56 123.45 49.38 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 115.592 -0.731 . . . . 0.0 109.247 179.701 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' F' F ' 141' ' ' ILE . . . . . . . . . . . . . 19.5 mt -122.09 121.42 63.99 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.326 0 CA-C-O 120.988 0.423 . . . . 0.0 109.929 -175.545 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' F' F ' 142' ' ' ARG . . . . . . . . . . . . . 72.3 ttt-85 -113.91 131.43 56.3 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 115.268 -0.878 . . . . 0.0 110.452 -176.917 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' F' F ' 143' ' ' THR . . . . . . . . . . . . . 20.1 p . . . . . 0 C--O 1.221 -0.422 0 CA-C-O 117.991 -1.005 . . . . 0.0 110.522 179.458 . . . . . . . . 0 0 . 1 . 003 nuclear orig core ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 6.7 p . . . . . 0 C--O 1.232 0.169 0 CA-C-O 120.901 0.381 . . . . 0.0 110.96 . . . . . . . . . 0 0 . 1 . 003 nuclear orig core ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 53.7 mp0 -140.96 141.48 34.45 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.065 -0.516 . . . . 0.0 111.005 179.04 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 4' ' ' LEU . . . . . . . . . . . . . 15.8 tp -128.22 130.44 47.97 Favored 'General case' 0 C--N 1.331 -0.206 0 CA-C-N 116.067 -0.515 . . . . 0.0 110.106 175.833 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 5' ' ' LYS . . . . . . . . . . . . . 66.8 mttm -113.71 121.58 44.54 Favored 'General case' 0 C--O 1.235 0.308 0 CA-C-N 116.356 -0.384 . . . . 0.0 110.845 -179.765 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 45.1 mt -114.17 145.46 41.64 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 115.413 -0.812 . . . . 0.0 110.3 -179.271 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 78.6 tttt -131.75 136.96 29.27 Favored Pre-proline 0 CA--C 1.535 0.374 0 CA-C-O 119.011 -0.519 . . . . 0.0 109.934 176.573 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 8' ' ' PRO . . . . . . . . . . . . . 85.5 Cg_endo -91.9 143.32 2.77 Favored 'Trans proline' 0 N--CA 1.491 1.358 0 C-N-CA 121.786 1.657 . . . . 0.0 111.864 178.623 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 43.4 mt -77.94 -47.79 2.19 Favored Pre-proline 0 CA--C 1.534 0.349 0 CA-C-O 118.657 -0.687 . . . . 0.0 112.22 179.787 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 95.0 Cg_endo -81.19 156.21 19.66 Favored 'Trans proline' 0 N--CA 1.496 1.649 0 C-N-CA 121.253 1.302 . . . . 0.0 112.128 177.075 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 62.9 tttm -88.96 107.33 18.96 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.358 -0.383 . . . . 0.0 110.435 177.908 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 12.7 p -147.83 146.29 18.16 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.336 0 CA-C-O 120.814 0.34 . . . . 0.0 110.763 -179.855 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 70.7 mm-40 -84.47 130.28 34.78 Favored 'General case' 0 C--N 1.33 -0.275 0 N-CA-C 109.874 -0.417 . . . . 0.0 109.874 177.033 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 14' ' ' LEU . . . . . . . . . . . . . 32.9 mt -98.56 145.04 29.21 Favored Pre-proline 0 CA--C 1.534 0.357 0 CA-C-O 119.042 -0.504 . . . . 0.0 110.472 -178.653 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 15' ' ' PRO . . . . . . . . . . . . . 24.7 Cg_exo -62.85 160.37 33.61 Favored 'Trans proline' 0 N--CA 1.497 1.722 0 C-N-CA 121.359 1.373 . . . . 0.0 112.053 176.749 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 16' ' ' PRO . . . . . . . . . . . . . 27.8 Cg_exo -60.4 -33.04 94.58 Favored 'Trans proline' 0 N--CA 1.497 1.7 0 C-N-CA 121.556 1.504 . . . . 0.0 112.693 -179.637 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 17' ' ' ASP . . . . . . . . . . . . . 11.0 p-10 -86.16 4.42 38.54 Favored 'General case' 0 CA--C 1.536 0.42 0 N-CA-C 113.264 0.839 . . . . 0.0 113.264 -177.583 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 18' ' ' PHE . . . . . . . . . . . . . 23.0 t80 -57.45 -44.79 85.05 Favored 'General case' 0 N--CA 1.457 -0.093 0 O-C-N 121.878 -0.514 . . . . 0.0 110.252 -177.374 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 19' ' ' VAL . . . . . . . . . . . . . 48.4 t -55.9 -46.07 80.12 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.36 0 CA-C-N 116.449 -0.342 . . . . 0.0 110.823 -177.532 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 79.8 m-20 -59.59 -42.01 91.57 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-O 120.771 0.319 . . . . 0.0 110.951 -176.855 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 48.0 t -64.13 -47.48 89.93 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.25 0 C-N-CA 120.645 -0.422 . . . . 0.0 110.495 -177.701 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 22' ' ' ILE . . . . . . . . . . . . . 51.6 mm -55.82 -47.05 80.1 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.237 0 C-N-CA 120.978 -0.289 . . . . 0.0 110.684 179.631 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 23' ' ' ARG . . . . . . . . . . . . . 50.9 ttp180 -54.35 -49.39 69.89 Favored 'General case' 0 C--N 1.329 -0.286 0 C-N-CA 121.005 -0.278 . . . . 0.0 111.419 -177.626 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 24' ' ' ILE . . . . . . . . . . . . . 74.0 mt -60.32 -45.12 96.87 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.235 0 C-N-CA 121.117 -0.233 . . . . 0.0 111.26 -177.197 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 56.2 mmtt -64.67 -38.7 91.91 Favored 'General case' 0 C--N 1.328 -0.334 0 N-CA-C 112.259 0.466 . . . . 0.0 112.259 -177.571 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 91.2 mt -78.33 -44.8 24.25 Favored 'General case' 0 C--N 1.33 -0.273 0 N-CA-C 112.983 0.734 . . . . 0.0 112.983 -172.27 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 27' ' ' GLN . . . . . . . . . . . . . 11.1 pt20 -47.23 139.41 6.2 Favored 'General case' 0 N--CA 1.469 0.492 0 N-CA-C 112.714 0.635 . . . . 0.0 112.714 -175.495 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 99.37 -26.34 24.74 Favored Glycine 0 CA--C 1.533 1.17 0 CA-C-N 115.613 -0.721 . . . . 0.0 112.245 -177.744 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 89.9 mttt -98.5 155.1 17.43 Favored 'General case' 0 C--O 1.233 0.191 0 CA-C-N 117.248 0.524 . . . . 0.0 111.439 179.756 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 30' ' ' THR . . . . . . . . . . . . . 24.2 m -105.78 135.17 47.68 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 115.717 -0.674 . . . . 0.0 109.774 174.906 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 34.8 m -131.73 157.13 43.1 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.276 0 CA-C-N 116.353 -0.385 . . . . 0.0 111.006 -177.739 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 32' ' ' ARG . . . . . . . . . . . . . 91.6 mtm-85 -130.61 150.42 51.82 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-O 121.289 0.566 . . . . 0.0 110.902 179.43 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 33' ' ' THR . . . . . . . . . . . . . 20.3 m -53.47 140.63 27.43 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.076 -0.511 . . . . 0.0 111.299 -178.634 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 99.63 -17.08 58.06 Favored Glycine 0 CA--C 1.534 1.278 0 C-N-CA 121.116 -0.564 . . . . 0.0 113.155 179.252 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 73.0 m-20 -64.68 148.46 50.96 Favored 'General case' 0 C--O 1.232 0.136 0 CA-C-N 118.081 0.941 . . . . 0.0 111.127 179.278 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 46.5 t -118.94 129.43 75.14 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.208 0 CA-C-N 115.721 -0.672 . . . . 0.0 109.686 178.529 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 37' ' ' ILE . . . . . . . . . . . . . 69.0 mt -121.22 138.73 50.63 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.265 0 CA-C-N 116.14 -0.482 . . . . 0.0 109.907 -179.158 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . -113.53 128.94 8.57 Favored Glycine 0 CA--C 1.526 0.758 0 N-CA-C 110.989 -0.844 . . . . 0.0 110.989 -179.976 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 39' ' ' ILE . . . . . . . . . . . . . 70.7 mt -123.43 136.99 58.22 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.218 0 N-CA-C 110.041 -0.355 . . . . 0.0 110.041 179.478 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 40' ' ' SER . . . . . . . . . . . . . 13.4 p -92.83 121.68 34.45 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.344 -0.389 . . . . 0.0 110.961 176.406 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 41' ' ' ILE . . . . . . . . . . . . . 70.6 mt -129.42 114.1 30.19 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.218 0 N-CA-C 109.756 -0.461 . . . . 0.0 109.756 177.136 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 8.6 mp 57.22 35.29 25.98 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-O 120.954 0.407 . . . . 0.0 111.337 -178.973 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . 77.79 -10.13 26.77 Favored Glycine 0 CA--C 1.536 1.359 0 C-N-CA 121.275 -0.488 . . . . 0.0 113.414 178.218 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 44' ' ' LYS . . . . . . . . . . . . . 25.5 ttpt -91.77 129.97 37.64 Favored 'General case' 0 C--N 1.331 -0.226 0 CA-C-N 117.915 0.858 . . . . 0.0 109.811 176.693 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 84.4 tt0 -84.05 125.97 32.61 Favored 'General case' 0 C--N 1.327 -0.392 0 C-N-CA 120.874 -0.33 . . . . 0.0 110.805 -179.731 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 46' ' ' VAL . . . . . . . . . . . . . 7.5 p -119.4 129.25 75.52 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.187 0 N-CA-C 109.553 -0.536 . . . . 0.0 109.553 176.147 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 59.0 mtpt -100.34 126.39 46.68 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 115.704 -0.68 . . . . 0.0 111.059 179.238 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 48' ' ' PHE . . . . . . . . . . . . . 94.0 m-85 -111.33 131.9 54.81 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.198 -0.456 . . . . 0.0 109.918 176.361 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 78.4 tttt -107.28 135.61 48.5 Favored 'General case' 0 C--N 1.329 -0.322 0 N-CA-C 110.155 -0.313 . . . . 0.0 110.155 178.265 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 50' ' ' VAL . . . . . . . . . . . . . 45.0 t -79.7 109.56 14.41 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.285 0 N-CA-C 109.333 -0.617 . . . . 0.0 109.333 177.047 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 51' ' ' VAL . . . . . . . . . . . . . 49.1 t -72.4 -52.37 24.18 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.321 0 CA-C-N 115.993 -0.548 . . . . 0.0 109.626 -174.885 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 52' ' ' GLN . . . . . . . . . . . . . 90.8 mt-30 -153.42 150.27 28.64 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.061 -0.518 . . . . 0.0 111.769 -177.821 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -130.16 132.81 46.22 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 115.208 -0.905 . . . . 0.0 109.611 174.725 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 54' ' ' TYR . . . . . . . . . . . . . 37.4 t80 -129.07 113.02 18.53 Favored Pre-proline 0 CA--C 1.535 0.392 0 CA-C-O 118.144 -0.931 . . . . 0.0 110.496 179.092 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 55' ' ' PRO . . . . . . . . . . . . . 74.4 Cg_endo -77.11 167.37 79.96 Favored 'Cis proline' 0 N--CA 1.5 1.854 0 CA-C-N 121.97 1.739 . . . . 0.0 112.475 -6.872 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 56' ' ' SER . . . . . . . . . . . . . 13.6 m -116.09 127.02 27.09 Favored Pre-proline 0 CA--C 1.538 0.502 0 CA-C-O 118.427 -0.797 . . . . 0.0 109.239 175.859 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 57' ' ' PRO . . . . . . . . . . . . . 46.7 Cg_endo -69.7 148.65 87.03 Favored 'Cis proline' 0 N--CA 1.498 1.741 0 CA-C-N 122.067 1.774 . . . . 0.0 111.862 0.497 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 58' ' ' LEU . . . . . . . . . . . . . 23.2 tp -107.52 137.18 46.02 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.014 -0.539 . . . . 0.0 110.742 -178.898 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 59' ' ' ARG . . . . . . . . . . . . . 56.9 ttp180 -104.04 120.12 40.39 Favored 'General case' 0 C--N 1.327 -0.383 0 N-CA-C 109.205 -0.665 . . . . 0.0 109.205 174.513 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 40.3 t -81.37 122.35 36.28 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.232 0 C-N-CA 120.626 -0.429 . . . . 0.0 110.74 -173.453 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 91.1 mt-10 -131.07 164.15 26.06 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 115.96 -0.564 . . . . 0.0 109.675 176.567 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 62' ' ' ASP . . . . . . . . . . . . . 44.5 m-20 -53.04 -32.8 48.79 Favored 'General case' 0 C--N 1.328 -0.347 0 N-CA-C 111.852 0.316 . . . . 0.0 111.852 -179.739 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 63' ' ' ARG . . . . . . . . . . . . . 68.4 mtp180 -72.47 -21.79 61.16 Favored 'General case' 0 CA--C 1.534 0.335 0 N-CA-C 112.907 0.706 . . . . 0.0 112.907 -176.354 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 31.1 m -68.77 140.14 55.32 Favored 'General case' 0 C--N 1.331 -0.2 0 CA-C-O 120.86 0.362 . . . . 0.0 111.057 -175.675 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 65' ' ' LYS . . . . . . . . . . . . . 50.3 mtmt -89.5 134.24 34.2 Favored 'General case' 0 C--N 1.331 -0.23 0 CA-C-N 116.11 -0.496 . . . . 0.0 110.444 178.316 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 66' ' ' ILE . . . . . . . . . . . . . 61.0 mt -118.27 132.59 67.67 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.254 0 N-CA-C 109.98 -0.378 . . . . 0.0 109.98 179.917 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 67' ' ' THR . . . . . . . . . . . . . 20.5 m -124.18 136.81 54.46 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-O 121.028 0.442 . . . . 0.0 110.918 -179.362 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 68' ' ' LEU . . . . . . . . . . . . . 30.6 mt . . . . . 0 C--N 1.329 -0.294 0 CA-C-N 115.881 -0.599 . . . . 0.0 110.431 177.498 . . . . . . . . 0 0 . 1 . 003 nuclear orig core ' A' A ' 74' ' ' ASP . . . . . . . . . . . . . 4.9 t70 . . . . . 0 C--O 1.231 0.099 0 N-CA-C 110.275 -0.269 . . . . 0.0 110.275 . . . . . . . . . 0 0 . 1 . 003 nuclear orig core ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 42.8 t -117.8 123.65 71.98 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.26 0 CA-C-O 120.931 0.396 . . . . 0.0 110.646 -177.937 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 76' ' ' LEU . . . . . . . . . . . . . 5.8 mp -121.81 148.48 44.63 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 115.848 -0.615 . . . . 0.0 109.679 175.537 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 77' ' ' GLU . . . . . . . . . . . . . 96.6 mt-10 -137.68 134.93 35.99 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-O 120.991 0.424 . . . . 0.0 111.354 -178.308 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 78' ' ' ALA . . . . . . . . . . . . . . . -119.95 135.44 54.9 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 115.718 -0.674 . . . . 0.0 109.679 176.266 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 79' ' ' LYS . . . . . . . . . . . . . 62.0 mttp -84.78 115.56 22.79 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-O 120.816 0.341 . . . . 0.0 111.078 -176.578 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 80' ' ' ILE . . . . . . . . . . . . . 39.6 mm -139.3 108.56 3.71 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.27 0 N-CA-C 109.301 -0.629 . . . . 0.0 109.301 -178.082 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 81' ' ' LYS . . . . . . . . . . . . . 63.6 mttp -94.53 126.25 39.69 Favored 'General case' 0 C--N 1.33 -0.249 0 C-N-CA 120.629 -0.428 . . . . 0.0 111.175 -179.734 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . 89.08 42.1 5.7 Favored Glycine 0 CA--C 1.527 0.821 0 C-N-CA 120.679 -0.772 . . . . 0.0 112.119 173.798 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 83' ' ' ILE . . . . . . . . . . . . . 72.9 mt -68.84 137.91 23.42 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.291 0 N-CA-C 109.597 -0.52 . . . . 0.0 109.597 176.19 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 84' ' ' LYS . . . . . . . . . . . . . 14.2 ttmm -93.08 -54.05 3.88 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-O 121.104 0.478 . . . . 0.0 110.216 -178.029 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 85' ' ' ASP . . . . . . . . . . . . . 13.1 t70 -151.22 151.41 31.83 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 115.611 -0.722 . . . . 0.0 110.55 -178.725 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 86' ' ' VAL . . . . . . . . . . . . . 44.1 t -128.58 129.43 68.72 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.255 0 CA-C-O 121.016 0.436 . . . . 0.0 110.083 178.914 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 87' ' ' ILE . . . . . . . . . . . . . 5.1 mp -119.33 124.04 72.31 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.207 0 N-CA-C 109.229 -0.656 . . . . 0.0 109.229 178.22 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 88' ' ' LEU . . . . . . . . . . . . . 15.9 tp -113.79 126.74 55.54 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-O 121.077 0.465 . . . . 0.0 111.259 -175.758 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 89' ' ' ASP . . . . . . . . . . . . . 13.0 t70 -121.87 152.45 39.57 Favored 'General case' 0 C--N 1.331 -0.223 0 N-CA-C 109.232 -0.655 . . . . 0.0 109.232 174.994 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 44.4 mt-10 -49.83 -35.18 22.08 Favored 'General case' 0 C--N 1.328 -0.348 0 N-CA-C 112.812 0.671 . . . . 0.0 112.812 -172.179 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 91' ' ' ASN . . . . . . . . . . . . . 87.9 m-20 -126.87 26.77 6.11 Favored 'General case' 0 N--CA 1.467 0.391 0 N-CA-C 112.596 0.591 . . . . 0.0 112.596 -175.272 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 92' ' ' LEU . . . . . . . . . . . . . 7.2 tp -166.2 141.39 4.61 Favored 'General case' 0 C--N 1.33 -0.239 0 CA-C-O 120.728 0.299 . . . . 0.0 110.387 178.233 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 93' ' ' ILE . . . . . . . . . . . . . 68.1 mt -120.61 122.4 67.9 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.267 0 N-CA-C 109.407 -0.59 . . . . 0.0 109.407 179.327 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 94' ' ' VAL . . . . . . . . . . . . . 48.0 t -120.92 125.81 74.47 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.267 0 CA-C-O 120.981 0.419 . . . . 0.0 109.993 -179.864 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 95' ' ' VAL . . . . . . . . . . . . . 44.9 t -119.81 132.25 70.04 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.249 0 CA-C-N 115.867 -0.606 . . . . 0.0 109.543 178.872 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 96' ' ' ILE . . . . . . . . . . . . . 63.3 mt -114.0 125.56 71.31 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.293 0 N-CA-C 109.077 -0.712 . . . . 0.0 109.077 179.069 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 97' ' ' THR . . . . . . . . . . . . . 80.3 p -97.66 156.46 16.53 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-O 121.011 0.434 . . . . 0.0 110.864 -177.78 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 98' ' ' GLU . . . . . . . . . . . . . 84.4 tt0 -53.88 -24.32 15.61 Favored 'General case' 0 CA--C 1.534 0.343 0 N-CA-C 112.163 0.431 . . . . 0.0 112.163 179.348 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 99' ' ' GLU . . . . . . . . . . . . . 96.0 mt-10 -76.4 11.69 1.49 Allowed 'General case' 0 CA--C 1.537 0.451 0 N-CA-C 113.227 0.825 . . . . 0.0 113.227 -178.597 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 100' ' ' ASN . . . . . . . . . . . . . 2.1 m-20 63.2 37.16 11.45 Favored 'General case' 0 CA--C 1.53 0.203 0 CA-C-O 121.005 0.431 . . . . 0.0 111.093 178.601 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 101' ' ' GLU . . . . . . . . . . . . . 68.5 tt0 -117.08 145.41 43.76 Favored 'General case' 0 C--N 1.332 -0.173 0 N-CA-C 109.386 -0.598 . . . . 0.0 109.386 175.654 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 102' ' ' VAL . . . . . . . . . . . . . 43.6 t -117.19 126.2 74.38 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.249 0 N-CA-C 109.869 -0.419 . . . . 0.0 109.869 -178.308 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 103' ' ' LEU . . . . . . . . . . . . . 28.7 mt -115.68 130.53 56.89 Favored 'General case' 0 C--N 1.331 -0.225 0 CA-C-N 115.552 -0.749 . . . . 0.0 110.157 176.409 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 104' ' ' ILE . . . . . . . . . . . . . 67.2 mt -116.78 120.45 65.08 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.294 0 N-CA-C 109.972 -0.381 . . . . 0.0 109.972 179.606 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 105' ' ' PHE . . . . . . . . . . . . . 66.3 m-85 -120.03 166.34 13.51 Favored 'General case' 0 C--N 1.333 -0.143 0 CA-C-N 115.323 -0.853 . . . . 0.0 109.622 179.754 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 106' ' ' ASN . . . . . . . . . . . . . 51.9 p-10 -101.49 -170.96 1.9 Allowed 'General case' 0 C--N 1.33 -0.257 0 N-CA-C 109.976 -0.379 . . . . 0.0 109.976 174.159 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 107' ' ' GLN . . . . . . . . . . . . . 50.4 tt0 -59.6 -28.02 66.81 Favored 'General case' 0 CA--C 1.533 0.301 0 N-CA-C 112.131 0.419 . . . . 0.0 112.131 179.997 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 108' ' ' ASN . . . . . . . . . . . . . 6.0 t-20 -85.22 13.37 6.46 Favored 'General case' 0 CA--C 1.536 0.418 0 N-CA-C 112.81 0.671 . . . . 0.0 112.81 -178.891 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 109' ' ' LEU . . . . . . . . . . . . . 7.1 tp 54.64 37.03 27.42 Favored 'General case' 0 CA--C 1.529 0.161 0 CA-C-O 120.935 0.398 . . . . 0.0 111.385 179.212 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 110' ' ' GLU . . . . . . . . . . . . . 95.6 mt-10 -104.33 148.6 26.2 Favored 'General case' 0 C--N 1.331 -0.216 0 N-CA-C 109.742 -0.466 . . . . 0.0 109.742 175.717 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 111' ' ' GLU . . . . . . . . . . . . . 61.3 tt0 -85.06 121.86 28.45 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-O 120.798 0.332 . . . . 0.0 110.611 -176.434 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 112' ' ' LEU . . . . . . . . . . . . . 15.0 mt -107.48 -46.13 3.91 Favored 'General case' 0 C--N 1.331 -0.225 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.699 179.886 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 113' ' ' TYR . . . . . . . . . . . . . 57.5 t80 -133.05 139.28 47.1 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.399 -0.364 . . . . 0.0 110.802 -178.101 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 114' ' ' ARG . . . . . . . . . . . . . 26.4 ptt180 -141.36 123.07 15.21 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.769 -179.923 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 115' ' ' GLY . . . . . . . . . . . . . . . -150.13 158.81 27.84 Favored Glycine 0 CA--C 1.522 0.471 0 N-CA-C 110.931 -0.868 . . . . 0.0 110.931 179.892 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 116' ' ' LYS . . . . . . . . . . . . . 33.0 ttmt -131.44 135.85 47.48 Favored 'General case' 0 C--N 1.327 -0.379 0 N-CA-C 109.868 -0.419 . . . . 0.0 109.868 177.464 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 117' ' ' PHE . . . . . . . . . . . . . 25.2 m-85 -137.91 113.86 9.9 Favored 'General case' 0 C--N 1.329 -0.319 0 N-CA-C 109.8 -0.444 . . . . 0.0 109.8 -175.805 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 118' ' ' GLU . . . . . . . . . . . . . 84.7 tt0 -56.31 -40.5 74.47 Favored 'General case' 0 C--N 1.33 -0.272 0 C-N-CA 120.787 -0.365 . . . . 0.0 110.959 -177.362 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 119' ' ' ASN . . . . . . . . . . . . . 5.4 m120 -97.5 30.62 2.82 Favored 'General case' 0 C--N 1.33 -0.263 0 N-CA-C 112.251 0.463 . . . . 0.0 112.251 -175.034 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 120' ' ' LEU . . . . . . . . . . . . . 23.9 tp -59.21 120.26 8.89 Favored 'General case' 0 C--N 1.332 -0.167 0 N-CA-C 109.859 -0.422 . . . . 0.0 109.859 176.545 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 121' ' ' ASN . . . . . . . . . . . . . 31.8 m120 -113.49 -44.18 3.24 Favored 'General case' 0 C--N 1.331 -0.223 0 CA-C-N 116.609 -0.268 . . . . 0.0 111.032 -177.162 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 122' ' ' LYS . . . . . . . . . . . . . 60.6 mtpt -143.52 144.42 31.96 Favored 'General case' 0 C--N 1.331 -0.22 0 CA-C-O 121.015 0.435 . . . . 0.0 111.383 -178.46 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 123' ' ' VAL . . . . . . . . . . . . . 47.7 t -128.9 127.53 66.35 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.297 0 N-CA-C 109.298 -0.63 . . . . 0.0 109.298 174.897 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 124' ' ' LEU . . . . . . . . . . . . . 51.8 mt -126.23 132.58 51.71 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-O 120.791 0.329 . . . . 0.0 110.654 -178.636 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 125' ' ' VAL . . . . . . . . . . . . . 11.6 p -134.45 136.0 53.3 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.34 0 CA-C-N 116.111 -0.495 . . . . 0.0 110.375 179.32 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 126' ' ' ARG . . . . . . . . . . . . . 76.2 mtt180 -143.91 127.79 17.35 Favored 'General case' 0 C--N 1.327 -0.395 0 CA-C-N 115.846 -0.615 . . . . 0.0 109.365 178.158 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 127' ' ' ASN . . . . . . . . . . . . . 79.9 m-20 56.83 -134.72 1.24 Allowed 'General case' 0 CA--C 1.544 0.743 0 CA-C-O 118.679 -0.677 . . . . 0.0 109.65 -178.285 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 128' ' ' ASP . . . . . . . . . . . . . 8.4 p-10 -99.06 15.81 24.64 Favored 'General case' 0 CA--C 1.535 0.389 0 CA-C-N 119.923 1.238 . . . . 0.0 113.057 178.641 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 129' ' ' LEU . . . . . . . . . . . . . 7.0 mp -114.27 141.23 47.84 Favored 'General case' 0 N--CA 1.463 0.224 0 N-CA-C 109.874 -0.417 . . . . 0.0 109.874 178.346 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 130' ' ' VAL . . . . . . . . . . . . . 14.6 p -140.06 146.47 24.81 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.234 0 CA-C-O 121.312 0.577 . . . . 0.0 111.682 -176.432 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 131' ' ' VAL . . . . . . . . . . . . . 44.2 t -136.02 139.52 45.7 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.264 0 CA-C-N 115.712 -0.677 . . . . 0.0 110.196 177.105 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 132' ' ' ILE . . . . . . . . . . . . . 70.9 mt -115.58 132.68 64.25 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.335 0 CA-C-N 115.998 -0.547 . . . . 0.0 109.673 -179.82 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 133' ' ' ILE . . . . . . . . . . . . . 41.1 mm -116.94 123.43 71.79 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.241 0 CA-C-O 120.781 0.324 . . . . 0.0 111.078 -175.127 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 134' ' ' ASP . . . . . . . . . . . . . 10.3 p-10 -136.61 149.4 48.0 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-N 116.227 -0.442 . . . . 0.0 109.981 175.255 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 135' ' ' GLU . . . . . . . . . . . . . 41.8 tp10 -49.95 -28.36 6.66 Favored 'General case' 0 C--N 1.327 -0.385 0 N-CA-C 112.673 0.62 . . . . 0.0 112.673 -171.986 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 136' ' ' GLN . . . . . . . . . . . . . 97.6 mt-30 -83.47 -34.96 25.27 Favored 'General case' 0 C--O 1.234 0.242 0 N-CA-C 112.707 0.632 . . . . 0.0 112.707 -175.96 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 137' ' ' LYS . . . . . . . . . . . . . 56.3 pttt -164.08 174.51 11.24 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-O 121.6 0.714 . . . . 0.0 112.529 -171.055 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 138' ' ' LEU . . . . . . . . . . . . . 6.9 tt -121.33 128.43 52.28 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 114.889 -1.05 . . . . 0.0 109.881 177.716 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 139' ' ' THR . . . . . . . . . . . . . 47.0 m -109.26 127.98 54.7 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-N 116.117 -0.492 . . . . 0.0 109.882 178.282 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 140' ' ' LEU . . . . . . . . . . . . . 6.9 tp -114.56 121.36 43.24 Favored 'General case' 0 C--N 1.327 -0.395 0 CA-C-N 115.983 -0.553 . . . . 0.0 109.608 -176.574 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 141' ' ' ILE . . . . . . . . . . . . . 18.9 mt -121.75 118.49 55.91 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.245 0 N-CA-C 109.885 -0.413 . . . . 0.0 109.885 -175.817 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 142' ' ' ARG . . . . . . . . . . . . . 34.4 mmt180 -116.21 134.81 54.51 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 115.557 -0.747 . . . . 0.0 110.054 -178.248 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 143' ' ' THR . . . . . . . . . . . . . 48.8 p . . . . . 0 C--O 1.221 -0.444 0 CA-C-O 118.041 -0.98 . . . . 0.0 110.775 179.363 . . . . . . . . 0 0 . 1 . 003 nuclear orig core ' B' B ' 2' ' ' SER . . . . . . . . . . . . . 96.8 p . . . . . 0 C--O 1.231 0.119 0 CA-C-O 121.003 0.43 . . . . 0.0 110.627 . . . . . . . . . 0 0 . 1 . 003 nuclear orig core ' B' B ' 3' ' ' GLU . . . . . . . . . . . . . 95.3 mt-10 -139.4 141.27 37.54 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 115.879 -0.6 . . . . 0.0 110.804 -179.223 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 4' ' ' LEU . . . . . . . . . . . . . 5.2 tt -126.14 128.01 46.64 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.131 -0.486 . . . . 0.0 109.803 177.342 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 5' ' ' LYS . . . . . . . . . . . . . 92.5 mttt -110.19 122.28 47.27 Favored 'General case' 0 C--O 1.235 0.315 0 CA-C-O 120.873 0.368 . . . . 0.0 111.034 -178.313 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 6' ' ' LEU . . . . . . . . . . . . . 48.9 mt -114.02 148.42 37.02 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 115.296 -0.866 . . . . 0.0 110.536 -179.5 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 7' ' ' LYS . . . . . . . . . . . . . 35.8 ttpt -134.63 139.5 32.7 Favored Pre-proline 0 CA--C 1.534 0.356 0 CA-C-O 119.023 -0.513 . . . . 0.0 110.022 175.683 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 8' ' ' PRO . . . . . . . . . . . . . 84.9 Cg_endo -91.76 141.72 2.62 Favored 'Trans proline' 0 N--CA 1.489 1.257 0 C-N-CA 121.754 1.636 . . . . 0.0 111.61 177.731 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 9' ' ' LEU . . . . . . . . . . . . . 24.1 mt -79.35 -47.62 1.56 Allowed Pre-proline 0 CA--C 1.534 0.343 0 CA-C-O 118.696 -0.669 . . . . 0.0 112.203 -178.397 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 10' ' ' PRO . . . . . . . . . . . . . 89.6 Cg_endo -81.22 155.53 19.37 Favored 'Trans proline' 0 N--CA 1.495 1.581 0 C-N-CA 121.213 1.275 . . . . 0.0 111.95 176.059 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 11' ' ' LYS . . . . . . . . . . . . . 85.5 tttt -83.71 96.02 8.58 Favored 'General case' 0 C--N 1.33 -0.282 0 C-N-CA 120.832 -0.347 . . . . 0.0 110.099 177.465 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 12' ' ' VAL . . . . . . . . . . . . . 12.1 p -136.28 145.64 30.39 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.276 0 CA-C-N 116.1 -0.5 . . . . 0.0 110.411 -178.64 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 13' ' ' GLU . . . . . . . . . . . . . 81.9 tt0 -91.72 126.32 36.76 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.152 -0.476 . . . . 0.0 110.109 178.562 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 14' ' ' LEU . . . . . . . . . . . . . 27.5 mt -98.1 145.25 29.47 Favored Pre-proline 0 CA--C 1.532 0.281 0 CA-C-O 119.167 -0.444 . . . . 0.0 110.365 -177.932 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 15' ' ' PRO . . . . . . . . . . . . . 24.0 Cg_exo -63.71 160.0 38.68 Favored 'Trans proline' 0 N--CA 1.497 1.695 0 C-N-CA 121.331 1.354 . . . . 0.0 111.694 176.144 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 16' ' ' PRO . . . . . . . . . . . . . 37.5 Cg_exo -59.22 -31.6 95.53 Favored 'Trans proline' 0 N--CA 1.495 1.613 0 C-N-CA 121.474 1.45 . . . . 0.0 112.737 -179.747 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 17' ' ' ASP . . . . . . . . . . . . . 10.0 p-10 -88.1 3.97 47.11 Favored 'General case' 0 CA--C 1.536 0.404 0 N-CA-C 113.319 0.859 . . . . 0.0 113.319 -177.323 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 18' ' ' PHE . . . . . . . . . . . . . 39.2 t80 -58.26 -47.03 84.86 Favored 'General case' 0 C--N 1.334 -0.107 0 O-C-N 121.931 -0.481 . . . . 0.0 110.121 -177.64 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 19' ' ' VAL . . . . . . . . . . . . . 47.3 t -56.6 -40.83 71.5 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 CA-C-N 116.249 -0.432 . . . . 0.0 110.54 -178.236 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 20' ' ' ASP . . . . . . . . . . . . . 74.3 m-20 -59.63 -44.79 93.35 Favored 'General case' 0 C--N 1.33 -0.269 0 C-N-CA 120.919 -0.312 . . . . 0.0 110.797 -177.398 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 21' ' ' VAL . . . . . . . . . . . . . 46.9 t -64.69 -45.48 95.14 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.255 0 C-N-CA 120.702 -0.399 . . . . 0.0 110.522 -177.61 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 22' ' ' ILE . . . . . . . . . . . . . 50.7 mm -58.71 -40.59 79.96 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.299 0 C-N-CA 120.98 -0.288 . . . . 0.0 110.826 -179.803 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 23' ' ' ARG . . . . . . . . . . . . . 52.2 ttp180 -56.73 -47.07 80.82 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-O 120.891 0.377 . . . . 0.0 110.515 178.713 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 24' ' ' ILE . . . . . . . . . . . . . 77.3 mt -60.87 -44.8 98.51 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.261 0 CA-C-N 115.979 -0.555 . . . . 0.0 111.822 -178.852 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 25' ' ' LYS . . . . . . . . . . . . . 12.5 pttp -71.69 -36.56 70.63 Favored 'General case' 0 CA--C 1.533 0.309 0 C-N-CA 120.372 -0.531 . . . . 0.0 111.851 -173.042 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 26' ' ' LEU . . . . . . . . . . . . . 24.8 mt -78.94 -42.68 26.33 Favored 'General case' 0 C--N 1.331 -0.228 0 N-CA-C 113.186 0.81 . . . . 0.0 113.186 -173.435 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 27' ' ' GLN . . . . . . . . . . . . . 11.2 pt20 -47.17 138.24 7.16 Favored 'General case' 0 N--CA 1.47 0.553 0 N-CA-C 112.696 0.628 . . . . 0.0 112.696 -175.356 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 28' ' ' GLY . . . . . . . . . . . . . . . 101.5 -25.95 26.26 Favored Glycine 0 CA--C 1.532 1.122 0 CA-C-N 115.669 -0.696 . . . . 0.0 112.295 -176.391 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 29' ' ' LYS . . . . . . . . . . . . . 63.8 mttp -98.14 155.15 17.28 Favored 'General case' 0 C--O 1.232 0.175 0 CA-C-N 117.5 0.65 . . . . 0.0 111.256 178.219 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 30' ' ' THR . . . . . . . . . . . . . 41.3 m -100.49 136.23 40.68 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.015 -0.539 . . . . 0.0 109.83 175.157 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 31' ' ' VAL . . . . . . . . . . . . . 35.2 m -125.78 153.72 33.98 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.314 0 CA-C-O 120.902 0.382 . . . . 0.0 110.622 -178.738 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 32' ' ' ARG . . . . . . . . . . . . . 34.2 ttp180 -132.39 147.55 52.39 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 115.897 -0.592 . . . . 0.0 110.242 178.118 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 33' ' ' THR . . . . . . . . . . . . . 17.0 m -53.42 139.37 30.8 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.394 -0.366 . . . . 0.0 111.355 -178.342 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 34' ' ' GLY . . . . . . . . . . . . . . . 101.1 -17.18 56.42 Favored Glycine 0 CA--C 1.534 1.219 0 CA-C-O 119.69 -0.505 . . . . 0.0 113.274 179.842 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 35' ' ' ASP . . . . . . . . . . . . . 70.5 m-20 -64.46 149.34 48.71 Favored 'General case' 0 C--O 1.232 0.148 0 CA-C-N 118.017 0.908 . . . . 0.0 111.478 179.506 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 36' ' ' VAL . . . . . . . . . . . . . 44.9 t -121.4 130.25 74.82 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.216 0 CA-C-N 115.752 -0.658 . . . . 0.0 109.791 178.148 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 37' ' ' ILE . . . . . . . . . . . . . 69.7 mt -121.7 139.59 48.3 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.267 0 CA-C-N 116.294 -0.412 . . . . 0.0 110.095 -179.548 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 38' ' ' GLY . . . . . . . . . . . . . . . -111.52 128.85 8.85 Favored Glycine 0 CA--C 1.525 0.712 0 N-CA-C 111.017 -0.833 . . . . 0.0 111.017 179.634 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 39' ' ' ILE . . . . . . . . . . . . . 73.9 mt -123.3 137.12 57.71 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.201 0 N-CA-C 110.072 -0.344 . . . . 0.0 110.072 179.521 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 40' ' ' SER . . . . . . . . . . . . . 59.6 p -91.78 115.91 28.45 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.559 -0.291 . . . . 0.0 111.117 177.612 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 41' ' ' ILE . . . . . . . . . . . . . 44.7 mm -121.39 114.2 42.27 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.231 0 N-CA-C 109.772 -0.455 . . . . 0.0 109.772 178.159 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 42' ' ' LEU . . . . . . . . . . . . . 6.4 mp 56.9 35.5 26.44 Favored 'General case' 0 CA--C 1.532 0.26 0 CA-C-O 120.973 0.416 . . . . 0.0 111.342 -179.378 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 43' ' ' GLY . . . . . . . . . . . . . . . 77.91 -10.06 27.93 Favored Glycine 0 CA--C 1.534 1.276 0 C-N-CA 121.249 -0.5 . . . . 0.0 113.472 177.725 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 44' ' ' LYS . . . . . . . . . . . . . 61.1 tttm -96.32 134.33 39.6 Favored 'General case' 0 C--N 1.331 -0.197 0 CA-C-N 117.901 0.851 . . . . 0.0 109.819 176.651 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 45' ' ' GLU . . . . . . . . . . . . . 82.9 tt0 -83.5 127.94 34.11 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-O 120.867 0.365 . . . . 0.0 111.084 -177.863 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 46' ' ' VAL . . . . . . . . . . . . . 7.3 p -120.53 130.07 74.89 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.265 0 N-CA-C 109.315 -0.624 . . . . 0.0 109.315 175.541 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 47' ' ' LYS . . . . . . . . . . . . . 79.8 mttt -100.4 128.64 46.41 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.076 -0.511 . . . . 0.0 111.366 179.317 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 48' ' ' PHE . . . . . . . . . . . . . 92.1 m-85 -112.89 131.91 55.53 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 115.88 -0.6 . . . . 0.0 109.78 176.705 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 49' ' ' LYS . . . . . . . . . . . . . 66.8 tttt -107.19 137.45 45.22 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.48 -0.327 . . . . 0.0 110.64 179.68 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 50' ' ' VAL . . . . . . . . . . . . . 45.0 t -80.71 107.22 12.82 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.241 0 N-CA-C 109.17 -0.678 . . . . 0.0 109.17 175.613 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 51' ' ' VAL . . . . . . . . . . . . . 49.4 t -71.47 -54.14 18.29 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.292 0 N-CA-C 109.493 -0.558 . . . . 0.0 109.493 -174.516 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 52' ' ' GLN . . . . . . . . . . . . . 90.8 mt-30 -154.7 154.07 32.31 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 115.93 -0.577 . . . . 0.0 112.097 -176.74 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 53' ' ' ALA . . . . . . . . . . . . . . . -132.6 134.37 44.83 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 115.191 -0.913 . . . . 0.0 109.784 174.421 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 54' ' ' TYR . . . . . . . . . . . . . 58.6 t80 -129.21 111.31 18.16 Favored Pre-proline 0 CA--C 1.533 0.309 0 CA-C-O 118.147 -0.93 . . . . 0.0 110.344 178.007 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 55' ' ' PRO . . . . . . . . . . . . . 74.4 Cg_endo -77.14 170.15 72.34 Favored 'Cis proline' 0 N--CA 1.5 1.907 0 CA-C-N 121.996 1.749 . . . . 0.0 111.957 -6.859 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 56' ' ' SER . . . . . . . . . . . . . 68.8 m -125.02 136.24 27.85 Favored Pre-proline 0 CA--C 1.538 0.491 0 CA-C-O 118.556 -0.735 . . . . 0.0 109.457 175.969 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 57' ' ' PRO . . . . . . . . . . . . . 37.2 Cg_endo -67.32 160.67 79.1 Favored 'Cis proline' 0 N--CA 1.499 1.852 0 CA-C-N 121.771 1.668 . . . . 0.0 111.689 -2.129 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 58' ' ' LEU . . . . . . . . . . . . . 29.4 tp -129.27 138.07 51.42 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-O 120.993 0.425 . . . . 0.0 110.593 -178.558 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 59' ' ' ARG . . . . . . . . . . . . . 57.2 ttp180 -101.02 121.22 41.39 Favored 'General case' 0 C--N 1.327 -0.38 0 N-CA-C 109.12 -0.696 . . . . 0.0 109.12 174.325 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 60' ' ' VAL . . . . . . . . . . . . . 47.4 t -72.14 122.07 23.77 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.361 0 C-N-CA 120.848 -0.341 . . . . 0.0 110.365 -173.969 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 61' ' ' GLU . . . . . . . . . . . . . 95.4 mt-10 -131.04 165.73 22.57 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.0 -0.546 . . . . 0.0 110.206 179.213 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 62' ' ' ASP . . . . . . . . . . . . . 48.2 m-20 -55.01 -32.61 61.94 Favored 'General case' 0 C--N 1.329 -0.324 0 N-CA-C 111.766 0.284 . . . . 0.0 111.766 -179.25 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 63' ' ' ARG . . . . . . . . . . . . . 32.5 ptt180 -83.35 3.36 31.95 Favored 'General case' 0 CA--C 1.538 0.487 0 N-CA-C 113.583 0.957 . . . . 0.0 113.583 -175.36 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 64' ' ' THR . . . . . . . . . . . . . 40.1 m -85.01 135.29 34.08 Favored 'General case' 0 C--N 1.331 -0.217 0 CA-C-N 118.137 0.426 . . . . 0.0 110.258 -178.997 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 65' ' ' LYS . . . . . . . . . . . . . 99.1 mttt -88.97 127.36 35.66 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.012 179.245 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 66' ' ' ILE . . . . . . . . . . . . . 58.4 mt -112.74 129.48 68.27 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.328 0 N-CA-C 109.859 -0.422 . . . . 0.0 109.859 -178.531 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 67' ' ' THR . . . . . . . . . . . . . 23.9 m -124.46 138.7 54.33 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-O 121.045 0.45 . . . . 0.0 110.801 -177.527 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 68' ' ' LEU . . . . . . . . . . . . . 7.6 mp . . . . . 0 C--N 1.33 -0.281 0 CA-C-N 115.972 -0.558 . . . . 0.0 110.242 177.025 . . . . . . . . 0 0 . 1 . 003 nuclear orig core ' B' B ' 73' ' ' VAL . . . . . . . . . . . . . 33.1 m . . . . . 0 N--CA 1.461 0.097 0 CA-C-O 121.018 0.437 . . . . 0.0 110.983 . . . . . . . . . 0 0 . 1 . 003 nuclear orig core ' B' B ' 74' ' ' ASP . . . . . . . . . . . . . 4.8 t0 -98.93 125.59 44.39 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 115.828 -0.623 . . . . 0.0 110.101 -179.601 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 75' ' ' VAL . . . . . . . . . . . . . 42.9 t -119.14 123.35 71.23 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.286 0 CA-C-O 121.084 0.468 . . . . 0.0 110.509 -179.402 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 76' ' ' LEU . . . . . . . . . . . . . 6.6 mp -120.39 148.38 43.84 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-N 115.691 -0.686 . . . . 0.0 109.741 176.043 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 77' ' ' GLU . . . . . . . . . . . . . 98.5 mt-10 -137.86 138.3 38.97 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-O 121.015 0.436 . . . . 0.0 111.577 -179.024 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 78' ' ' ALA . . . . . . . . . . . . . . . -130.47 134.29 46.97 Favored 'General case' 0 C--N 1.331 -0.227 0 CA-C-N 115.755 -0.657 . . . . 0.0 109.728 175.541 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 79' ' ' LYS . . . . . . . . . . . . . 30.0 ttmt -81.2 119.53 23.72 Favored 'General case' 0 C--N 1.331 -0.204 0 CA-C-O 120.925 0.393 . . . . 0.0 110.603 -179.38 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 80' ' ' ILE . . . . . . . . . . . . . 41.7 mm -139.15 108.43 3.77 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.367 0 N-CA-C 109.201 -0.666 . . . . 0.0 109.201 -177.439 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 81' ' ' LYS . . . . . . . . . . . . . 55.6 mtpt -100.49 129.16 46.4 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-O 120.941 0.4 . . . . 0.0 111.257 -176.642 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 82' ' ' GLY . . . . . . . . . . . . . . . 89.16 42.11 5.67 Favored Glycine 0 CA--C 1.526 0.725 0 C-N-CA 120.956 -0.64 . . . . 0.0 111.726 174.344 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 83' ' ' ILE . . . . . . . . . . . . . 68.2 mt -69.13 136.02 27.16 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.407 0 N-CA-C 109.563 -0.532 . . . . 0.0 109.563 177.625 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 84' ' ' LYS . . . . . . . . . . . . . 25.2 ttpp -100.5 -51.66 3.56 Favored 'General case' 0 C--N 1.332 -0.195 0 CA-C-O 121.002 0.429 . . . . 0.0 110.082 179.938 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 85' ' ' ASP . . . . . . . . . . . . . 13.4 t70 -149.16 147.16 28.11 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 115.812 -0.631 . . . . 0.0 110.358 179.754 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 86' ' ' VAL . . . . . . . . . . . . . 42.7 t -129.34 130.29 67.53 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.24 0 CA-C-O 120.969 0.414 . . . . 0.0 110.251 179.427 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 87' ' ' ILE . . . . . . . . . . . . . 44.6 mm -118.25 125.04 73.99 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.28 0 CA-C-N 115.847 -0.615 . . . . 0.0 109.555 177.347 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 88' ' ' LEU . . . . . . . . . . . . . 44.5 mt -116.84 135.56 53.64 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-O 121.292 0.568 . . . . 0.0 111.688 -177.025 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 89' ' ' ASP . . . . . . . . . . . . . 7.3 t0 -128.58 155.96 44.1 Favored 'General case' 0 C--N 1.327 -0.403 0 CA-C-N 115.156 -0.929 . . . . 0.0 108.642 174.78 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 90' ' ' GLU . . . . . . . . . . . . . 76.9 tt0 -48.67 -36.09 15.27 Favored 'General case' 0 C--N 1.329 -0.285 0 N-CA-C 112.562 0.578 . . . . 0.0 112.562 -172.749 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 91' ' ' ASN . . . . . . . . . . . . . 26.3 m120 -132.07 37.23 3.6 Favored 'General case' 0 CA--C 1.531 0.248 0 N-CA-C 111.757 0.281 . . . . 0.0 111.757 -176.953 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 92' ' ' LEU . . . . . . . . . . . . . 26.3 tp -166.06 139.72 4.28 Favored 'General case' 0 C--N 1.33 -0.265 0 C-N-CA 121.005 -0.278 . . . . 0.0 110.801 -179.377 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 93' ' ' ILE . . . . . . . . . . . . . 72.3 mt -126.39 122.48 61.31 Favored 'Isoleucine or valine' 0 N--CA 1.462 0.157 0 N-CA-C 109.648 -0.501 . . . . 0.0 109.648 178.605 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 94' ' ' VAL . . . . . . . . . . . . . 43.8 t -124.61 126.19 71.28 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.239 0 N-CA-C 109.774 -0.454 . . . . 0.0 109.774 177.994 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 95' ' ' VAL . . . . . . . . . . . . . 44.6 t -120.73 133.59 66.9 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.336 0 CA-C-N 116.009 -0.541 . . . . 0.0 109.806 -179.165 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 96' ' ' ILE . . . . . . . . . . . . . 61.1 mt -115.4 128.29 72.66 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.25 0 N-CA-C 109.257 -0.646 . . . . 0.0 109.257 178.788 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 97' ' ' THR . . . . . . . . . . . . . 82.1 p -102.96 155.62 18.23 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-O 121.279 0.561 . . . . 0.0 111.343 -176.368 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 98' ' ' GLU . . . . . . . . . . . . . 13.2 pt-20 -55.08 -17.02 3.43 Favored 'General case' 0 CA--C 1.535 0.382 0 N-CA-C 112.814 0.672 . . . . 0.0 112.814 179.277 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 99' ' ' GLU . . . . . . . . . . . . . 41.7 mt-10 -85.36 16.29 3.81 Favored 'General case' 0 CA--C 1.535 0.402 0 N-CA-C 112.952 0.723 . . . . 0.0 112.952 -178.674 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 100' ' ' ASN . . . . . . . . . . . . . 3.6 m-20 62.36 38.02 13.34 Favored 'General case' 0 CA--C 1.529 0.166 0 CA-C-O 121.046 0.451 . . . . 0.0 110.869 178.505 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 101' ' ' GLU . . . . . . . . . . . . . 84.3 tt0 -121.26 143.63 49.05 Favored 'General case' 0 C--N 1.332 -0.187 0 CA-C-N 116.2 -0.455 . . . . 0.0 110.045 177.955 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 102' ' ' VAL . . . . . . . . . . . . . 43.9 t -116.73 127.59 74.31 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.28 0 CA-C-N 116.341 -0.39 . . . . 0.0 110.102 -178.671 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 103' ' ' LEU . . . . . . . . . . . . . 6.2 mp -116.86 134.31 54.93 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 115.747 -0.66 . . . . 0.0 110.285 176.745 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 104' ' ' ILE . . . . . . . . . . . . . 71.3 mt -120.87 123.24 69.78 Favored 'Isoleucine or valine' 0 C--O 1.234 0.285 0 CA-C-N 116.612 -0.267 . . . . 0.0 110.56 -178.885 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 105' ' ' PHE . . . . . . . . . . . . . 60.0 m-85 -124.98 167.24 14.99 Favored 'General case' 0 C--O 1.232 0.178 0 O-C-N 124.07 0.856 . . . . 0.0 109.736 -179.665 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 106' ' ' ASN . . . . . . . . . . . . . 44.8 p-10 -104.11 -170.23 1.74 Allowed 'General case' 0 C--N 1.331 -0.237 0 N-CA-C 110.15 -0.315 . . . . 0.0 110.15 174.218 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 107' ' ' GLN . . . . . . . . . . . . . 37.9 tt0 -58.64 -30.11 67.04 Favored 'General case' 0 C--N 1.33 -0.278 0 N-CA-C 112.047 0.388 . . . . 0.0 112.047 -179.603 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 108' ' ' ASN . . . . . . . . . . . . . 5.4 t30 -86.02 10.6 13.74 Favored 'General case' 0 CA--C 1.536 0.43 0 N-CA-C 113.116 0.784 . . . . 0.0 113.116 -176.699 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 109' ' ' LEU . . . . . . . . . . . . . 8.5 tp 59.38 37.63 23.21 Favored 'General case' 0 C--N 1.332 -0.173 0 CA-C-O 121.034 0.445 . . . . 0.0 111.315 178.69 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 110' ' ' GLU . . . . . . . . . . . . . 94.9 mt-10 -105.18 138.5 41.28 Favored 'General case' 0 C--N 1.329 -0.3 0 N-CA-C 109.222 -0.659 . . . . 0.0 109.222 173.718 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 111' ' ' GLU . . . . . . . . . . . . . 47.8 tt0 -85.54 121.77 28.7 Favored 'General case' 0 C--N 1.329 -0.308 0 C-N-CA 120.708 -0.397 . . . . 0.0 110.249 -176.492 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 112' ' ' LEU . . . . . . . . . . . . . 58.2 mt -103.06 -42.89 5.65 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.074 -0.512 . . . . 0.0 110.527 179.687 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 113' ' ' TYR . . . . . . . . . . . . . 64.3 t80 -133.02 141.23 48.16 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.297 -0.411 . . . . 0.0 111.254 -177.1 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 114' ' ' ARG . . . . . . . . . . . . . 36.5 ptt180 -149.27 124.09 9.91 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.092 -0.504 . . . . 0.0 110.541 177.407 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 115' ' ' GLY . . . . . . . . . . . . . . . -150.02 158.9 27.87 Favored Glycine 0 CA--C 1.524 0.601 0 N-CA-C 111.254 -0.739 . . . . 0.0 111.254 179.933 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 116' ' ' LYS . . . . . . . . . . . . . 34.4 ttpt -125.07 134.92 52.32 Favored 'General case' 0 C--N 1.33 -0.257 0 N-CA-C 110.02 -0.363 . . . . 0.0 110.02 178.491 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 117' ' ' PHE . . . . . . . . . . . . . 51.5 m-85 -129.08 115.21 17.38 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-O 120.97 0.414 . . . . 0.0 110.155 -177.064 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 118' ' ' GLU . . . . . . . . . . . . . 95.8 mt-10 -53.6 -49.79 67.03 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.387 -0.37 . . . . 0.0 111.526 -175.633 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 119' ' ' ASN . . . . . . . . . . . . . 87.2 m-20 -96.7 31.13 2.4 Favored 'General case' 0 C--N 1.328 -0.342 0 N-CA-C 112.207 0.447 . . . . 0.0 112.207 -174.169 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 120' ' ' LEU . . . . . . . . . . . . . 17.1 tp -53.44 121.84 8.48 Favored 'General case' 0 N--CA 1.464 0.271 0 CA-C-O 120.599 0.238 . . . . 0.0 110.88 178.062 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 121' ' ' ASN . . . . . . . . . . . . . 34.4 m120 -114.07 -44.17 3.17 Favored 'General case' 0 N--CA 1.463 0.203 0 CA-C-N 116.547 -0.297 . . . . 0.0 111.213 -176.289 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 122' ' ' LYS . . . . . . . . . . . . . 97.2 mttt -144.61 150.7 37.88 Favored 'General case' 0 C--N 1.331 -0.206 0 CA-C-O 120.982 0.42 . . . . 0.0 111.591 -177.386 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 123' ' ' VAL . . . . . . . . . . . . . 45.9 t -130.44 127.94 63.13 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.298 0 N-CA-C 109.437 -0.579 . . . . 0.0 109.437 174.929 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 124' ' ' LEU . . . . . . . . . . . . . 52.7 mt -127.35 138.09 52.94 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-O 120.871 0.367 . . . . 0.0 110.633 -178.067 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 125' ' ' VAL . . . . . . . . . . . . . 34.7 m -135.73 140.09 45.01 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.24 0 CA-C-N 116.221 -0.445 . . . . 0.0 110.885 -179.53 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 126' ' ' ARG . . . . . . . . . . . . . 90.5 mtt-85 -140.69 112.12 7.36 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 115.889 -0.596 . . . . 0.0 110.199 177.117 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 127' ' ' ASN . . . . . . . . . . . . . 26.2 m-20 48.96 -105.01 0.14 Allowed 'General case' 0 CA--C 1.541 0.618 0 CA-C-O 119.299 -0.381 . . . . 0.0 111.79 -179.964 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 128' ' ' ASP . . . . . . . . . . . . . 13.0 p-10 -106.08 1.02 26.01 Favored 'General case' 0 CA--C 1.536 0.414 0 N-CA-C 113.692 0.997 . . . . 0.0 113.692 -174.957 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 129' ' ' LEU . . . . . . . . . . . . . 14.5 tp -104.94 131.82 51.96 Favored 'General case' 0 C--N 1.332 -0.188 0 CA-C-N 118.125 0.421 . . . . 0.0 109.996 178.479 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 130' ' ' VAL . . . . . . . . . . . . . 46.8 t -118.95 132.97 67.3 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.252 0 N-CA-C 109.828 -0.434 . . . . 0.0 109.828 -179.618 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 131' ' ' VAL . . . . . . . . . . . . . 42.1 t -134.96 134.37 53.44 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.196 0 CA-C-O 121.042 0.449 . . . . 0.0 110.416 179.396 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 132' ' ' ILE . . . . . . . . . . . . . 74.0 mt -117.25 133.78 62.91 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 CA-C-N 115.773 -0.649 . . . . 0.0 109.294 -179.799 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 133' ' ' ILE . . . . . . . . . . . . . 43.0 mm -117.62 123.86 72.29 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.224 0 CA-C-O 121.031 0.443 . . . . 0.0 111.086 -173.931 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 134' ' ' ASP . . . . . . . . . . . . . 9.1 p-10 -135.03 144.67 47.43 Favored 'General case' 0 C--N 1.33 -0.242 0 N-CA-C 109.228 -0.656 . . . . 0.0 109.228 173.777 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 135' ' ' GLU . . . . . . . . . . . . . 38.0 tp10 -49.93 -25.56 3.36 Favored 'General case' 0 C--N 1.326 -0.439 0 N-CA-C 112.719 0.637 . . . . 0.0 112.719 -174.553 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 136' ' ' GLN . . . . . . . . . . . . . 47.6 tt0 -80.43 -33.77 36.62 Favored 'General case' 0 C--O 1.233 0.212 0 N-CA-C 112.364 0.505 . . . . 0.0 112.364 -176.705 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 137' ' ' LYS . . . . . . . . . . . . . 57.7 pttt -169.98 175.3 5.16 Favored 'General case' 0 C--N 1.332 -0.182 0 CA-C-O 121.461 0.648 . . . . 0.0 112.182 -174.901 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 138' ' ' LEU . . . . . . . . . . . . . 6.1 tt -120.28 129.47 54.04 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-N 115.221 -0.9 . . . . 0.0 110.188 -179.96 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 139' ' ' THR . . . . . . . . . . . . . 36.2 m -110.19 128.21 55.36 Favored 'General case' 0 C--N 1.332 -0.181 0 CA-C-N 116.341 -0.391 . . . . 0.0 110.656 179.995 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 140' ' ' LEU . . . . . . . . . . . . . 7.4 tt -112.27 124.36 52.29 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 115.656 -0.702 . . . . 0.0 109.2 -179.428 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 141' ' ' ILE . . . . . . . . . . . . . 19.5 mt -124.08 117.46 50.92 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.36 0 CA-C-O 121.053 0.454 . . . . 0.0 109.959 -176.439 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 142' ' ' ARG . . . . . . . . . . . . . 60.0 ttt-85 -107.54 126.51 52.62 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 115.594 -0.73 . . . . 0.0 110.698 -179.195 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 143' ' ' THR . . . . . . . . . . . . . 25.3 p . . . . . 0 C--O 1.221 -0.409 0 CA-C-O 118.248 -0.882 . . . . 0.0 110.938 179.138 . . . . . . . . 0 0 . 1 . 003 nuclear orig core ' C' C ' 2' ' ' SER . . . . . . . . . . . . . 6.9 p . . . . . 0 N--CA 1.461 0.087 0 CA-C-O 120.843 0.354 . . . . 0.0 110.054 . . . . . . . . . 0 0 . 1 . 003 nuclear orig core ' C' C ' 3' ' ' GLU . . . . . . . . . . . . . 95.6 mt-10 -140.77 141.14 34.85 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.107 -0.497 . . . . 0.0 111.134 -177.388 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' C' C ' 4' ' ' LEU . . . . . . . . . . . . . 19.7 tp -125.38 130.38 51.8 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 115.713 -0.676 . . . . 0.0 110.122 176.799 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' C' C ' 5' ' ' LYS . . . . . . . . . . . . . 61.4 mttp -108.4 120.16 41.6 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.483 -0.326 . . . . 0.0 110.66 179.534 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' C' C ' 6' ' ' LEU . . . . . . . . . . . . . 46.6 mt -114.36 147.17 39.57 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 115.499 -0.773 . . . . 0.0 110.459 -178.642 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' C' C ' 7' ' ' LYS . . . . . . . . . . . . . 83.2 tttt -135.15 135.97 23.82 Favored Pre-proline 0 CA--C 1.535 0.402 0 CA-C-O 118.87 -0.586 . . . . 0.0 109.88 175.901 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' C' C ' 8' ' ' PRO . . . . . . . . . . . . . 79.1 Cg_endo -90.5 143.25 3.65 Favored 'Trans proline' 0 N--CA 1.49 1.313 0 C-N-CA 121.745 1.63 . . . . 0.0 111.794 178.255 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' C' C ' 9' ' ' LEU . . . . . . . . . . . . . 41.2 mt -81.59 -48.75 0.99 Allowed Pre-proline 0 CA--C 1.534 0.359 0 CA-C-O 118.706 -0.664 . . . . 0.0 112.527 -178.601 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' C' C ' 10' ' ' PRO . . . . . . . . . . . . . 91.5 Cg_endo -78.97 154.68 25.96 Favored 'Trans proline' 0 N--CA 1.498 1.755 0 C-N-CA 121.113 1.209 . . . . 0.0 111.983 178.161 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' C' C ' 11' ' ' LYS . . . . . . . . . . . . . 72.4 tttt -88.46 94.26 9.81 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-N 116.345 -0.389 . . . . 0.0 110.499 179.47 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' C' C ' 12' ' ' VAL . . . . . . . . . . . . . 13.0 p -141.96 147.99 21.05 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.282 0 CA-C-N 116.236 -0.438 . . . . 0.0 110.533 -179.989 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' C' C ' 13' ' ' GLU . . . . . . . . . . . . . 84.3 tt0 -87.98 128.76 35.39 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.246 -0.434 . . . . 0.0 110.403 179.151 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' C' C ' 14' ' ' LEU . . . . . . . . . . . . . 19.2 mt -98.5 151.39 37.45 Favored Pre-proline 0 CA--C 1.533 0.296 0 CA-C-N 116.467 -0.333 . . . . 0.0 110.677 -178.438 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' C' C ' 15' ' ' PRO . . . . . . . . . . . . . 27.4 Cg_exo -61.84 161.25 26.02 Favored 'Trans proline' 0 N--CA 1.497 1.714 0 C-N-CA 121.395 1.397 . . . . 0.0 112.042 177.298 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' C' C ' 16' ' ' PRO . . . . . . . . . . . . . 26.0 Cg_exo -61.51 -38.55 62.13 Favored 'Trans proline' 0 N--CA 1.497 1.705 0 C-N-CA 121.412 1.408 . . . . 0.0 112.699 179.97 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' C' C ' 17' ' ' ASP . . . . . . . . . . . . . 21.3 p-10 -84.84 9.26 14.71 Favored 'General case' 0 CA--C 1.535 0.403 0 N-CA-C 113.232 0.827 . . . . 0.0 113.232 -176.951 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' C' C ' 18' ' ' PHE . . . . . . . . . . . . . 45.1 t80 -56.83 -48.06 78.89 Favored 'General case' 0 N--CA 1.456 -0.14 0 O-C-N 121.978 -0.451 . . . . 0.0 110.662 -177.287 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' C' C ' 19' ' ' VAL . . . . . . . . . . . . . 14.9 p -54.82 -43.15 66.19 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.259 0 C-N-CA 121.007 -0.277 . . . . 0.0 111.441 -176.404 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' C' C ' 20' ' ' ASP . . . . . . . . . . . . . 42.1 m-20 -62.37 -43.28 99.19 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-O 120.759 0.314 . . . . 0.0 111.217 -177.637 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' C' C ' 21' ' ' VAL . . . . . . . . . . . . . 47.9 t -64.63 -44.38 96.7 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.288 0 C-N-CA 120.637 -0.425 . . . . 0.0 110.534 -177.199 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' C' C ' 22' ' ' ILE . . . . . . . . . . . . . 50.8 mm -56.16 -46.7 81.23 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.21 0 C-N-CA 121.029 -0.268 . . . . 0.0 110.477 178.313 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' C' C ' 23' ' ' ARG . . . . . . . . . . . . . 55.3 ttp180 -54.21 -48.45 71.02 Favored 'General case' 0 C--N 1.33 -0.28 0 C-N-CA 121.06 -0.256 . . . . 0.0 111.336 -178.754 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' C' C ' 24' ' ' ILE . . . . . . . . . . . . . 73.8 mt -59.89 -43.93 93.21 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.331 0 CA-C-N 116.685 -0.234 . . . . 0.0 111.249 -177.815 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' C' C ' 25' ' ' LYS . . . . . . . . . . . . . 80.6 mttt -67.66 -40.43 84.49 Favored 'General case' 0 C--N 1.328 -0.352 0 N-CA-C 112.666 0.617 . . . . 0.0 112.666 -177.164 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' C' C ' 26' ' ' LEU . . . . . . . . . . . . . 36.8 mt -79.19 -39.43 33.38 Favored 'General case' 0 C--N 1.33 -0.274 0 N-CA-C 113.303 0.853 . . . . 0.0 113.303 -171.849 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' C' C ' 27' ' ' GLN . . . . . . . . . . . . . 9.8 pt20 -46.62 140.76 4.2 Favored 'General case' 0 N--CA 1.47 0.533 0 N-CA-C 112.732 0.641 . . . . 0.0 112.732 -175.088 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' C' C ' 28' ' ' GLY . . . . . . . . . . . . . . . 100.97 -24.82 30.61 Favored Glycine 0 CA--C 1.532 1.136 0 CA-C-N 115.388 -0.824 . . . . 0.0 112.31 -177.2 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' C' C ' 29' ' ' LYS . . . . . . . . . . . . . 69.0 mttm -97.42 155.07 17.08 Favored 'General case' 0 C--N 1.331 -0.202 0 CA-C-N 117.609 0.705 . . . . 0.0 110.904 177.317 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' C' C ' 30' ' ' THR . . . . . . . . . . . . . 13.8 m -106.6 133.69 50.9 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.07 -0.514 . . . . 0.0 109.624 175.257 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' C' C ' 31' ' ' VAL . . . . . . . . . . . . . 34.4 m -130.2 156.63 42.45 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.278 0 CA-C-O 120.982 0.42 . . . . 0.0 110.94 -176.823 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' C' C ' 32' ' ' ARG . . . . . . . . . . . . . 36.0 mtp180 -129.77 153.59 48.07 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-O 121.433 0.635 . . . . 0.0 110.84 179.476 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' C' C ' 33' ' ' THR . . . . . . . . . . . . . 24.5 m -53.84 138.85 35.09 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-N 115.907 -0.588 . . . . 0.0 111.231 -179.664 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' C' C ' 34' ' ' GLY . . . . . . . . . . . . . . . 100.95 -17.04 56.85 Favored Glycine 0 CA--C 1.532 1.136 0 CA-C-O 119.678 -0.512 . . . . 0.0 113.307 179.411 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' C' C ' 35' ' ' ASP . . . . . . . . . . . . . 62.7 m-20 -65.58 149.9 49.32 Favored 'General case' 0 C--O 1.232 0.155 0 CA-C-N 118.036 0.918 . . . . 0.0 111.315 179.496 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' C' C ' 36' ' ' VAL . . . . . . . . . . . . . 46.3 t -119.01 128.97 75.78 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.232 0 CA-C-N 115.779 -0.646 . . . . 0.0 109.686 177.836 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' C' C ' 37' ' ' ILE . . . . . . . . . . . . . 70.1 mt -120.35 139.42 47.7 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.255 0 CA-C-N 116.274 -0.421 . . . . 0.0 109.939 -178.568 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' C' C ' 38' ' ' GLY . . . . . . . . . . . . . . . -113.03 128.88 8.61 Favored Glycine 0 CA--C 1.526 0.763 0 N-CA-C 110.977 -0.849 . . . . 0.0 110.977 -179.924 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' C' C ' 39' ' ' ILE . . . . . . . . . . . . . 75.1 mt -123.24 136.97 58.18 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.243 0 N-CA-C 110.085 -0.339 . . . . 0.0 110.085 179.16 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' C' C ' 40' ' ' SER . . . . . . . . . . . . . 84.0 p -93.13 124.24 36.97 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.359 -0.382 . . . . 0.0 110.95 175.883 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' C' C ' 41' ' ' ILE . . . . . . . . . . . . . 72.7 mt -127.5 113.1 30.25 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.225 0 CA-C-O 120.925 0.393 . . . . 0.0 110.213 177.262 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' C' C ' 42' ' ' LEU . . . . . . . . . . . . . 1.3 tt 49.4 47.46 22.38 Favored 'General case' 0 CA--C 1.533 0.318 0 CA-C-O 121.529 0.68 . . . . 0.0 111.357 177.73 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' C' C ' 43' ' ' GLY . . . . . . . . . . . . . . . 70.68 24.16 77.16 Favored Glycine 0 CA--C 1.53 1.01 0 C-N-CA 121.116 -0.564 . . . . 0.0 112.563 175.946 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' C' C ' 44' ' ' LYS . . . . . . . . . . . . . 17.0 ttmm -132.14 129.5 39.93 Favored 'General case' 0 C--N 1.331 -0.215 0 CA-C-N 117.515 0.658 . . . . 0.0 109.956 179.049 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' C' C ' 45' ' ' GLU . . . . . . . . . . . . . 81.6 tt0 -84.07 125.79 32.45 Favored 'General case' 0 C--N 1.327 -0.381 0 C-N-CA 120.856 -0.338 . . . . 0.0 111.148 -177.787 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' C' C ' 46' ' ' VAL . . . . . . . . . . . . . 7.4 p -123.22 129.68 74.76 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.19 0 N-CA-C 109.614 -0.513 . . . . 0.0 109.614 174.773 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' C' C ' 47' ' ' LYS . . . . . . . . . . . . . 64.1 mttp -99.67 129.98 45.85 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.117 -0.492 . . . . 0.0 111.157 177.757 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' C' C ' 48' ' ' PHE . . . . . . . . . . . . . 92.8 m-85 -113.04 132.05 55.55 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 115.792 -0.64 . . . . 0.0 109.769 175.276 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' C' C ' 49' ' ' LYS . . . . . . . . . . . . . 84.1 tttt -106.13 135.43 47.61 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.412 -0.358 . . . . 0.0 110.142 179.359 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' C' C ' 50' ' ' VAL . . . . . . . . . . . . . 44.9 t -81.41 108.13 14.31 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.321 0 N-CA-C 109.304 -0.628 . . . . 0.0 109.304 176.749 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' C' C ' 51' ' ' VAL . . . . . . . . . . . . . 44.0 t -73.31 -51.23 26.6 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.333 0 CA-C-N 116.079 -0.51 . . . . 0.0 109.843 -174.302 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' C' C ' 52' ' ' GLN . . . . . . . . . . . . . 91.3 mt-30 -152.9 151.84 30.83 Favored 'General case' 0 C--N 1.333 -0.148 0 CA-C-O 121.095 0.474 . . . . 0.0 111.743 -178.104 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' C' C ' 53' ' ' ALA . . . . . . . . . . . . . . . -130.05 131.95 46.0 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 115.374 -0.83 . . . . 0.0 109.841 174.525 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' C' C ' 54' ' ' TYR . . . . . . . . . . . . . 15.5 t80 -129.16 111.34 18.24 Favored Pre-proline 0 CA--C 1.536 0.41 0 CA-C-O 118.159 -0.924 . . . . 0.0 110.33 177.423 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' C' C ' 55' ' ' PRO . . . . . . . . . . . . . 73.4 Cg_endo -77.26 167.0 80.73 Favored 'Cis proline' 0 N--CA 1.501 1.92 0 CA-C-N 122.03 1.761 . . . . 0.0 112.356 -6.056 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' C' C ' 56' ' ' SER . . . . . . . . . . . . . 13.6 m -116.89 130.73 24.37 Favored Pre-proline 0 CA--C 1.538 0.503 0 CA-C-O 118.384 -0.817 . . . . 0.0 109.158 174.086 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' C' C ' 57' ' ' PRO . . . . . . . . . . . . . 42.7 Cg_endo -68.42 146.99 80.38 Favored 'Cis proline' 0 N--CA 1.497 1.706 0 CA-C-N 122.011 1.754 . . . . 0.0 111.527 -0.353 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' C' C ' 58' ' ' LEU . . . . . . . . . . . . . 22.7 tp -107.36 135.44 48.84 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.145 -0.479 . . . . 0.0 110.403 -178.876 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' C' C ' 59' ' ' ARG . . . . . . . . . . . . . 48.6 ttt180 -102.08 122.92 45.05 Favored 'General case' 0 C--N 1.326 -0.433 0 N-CA-C 109.134 -0.691 . . . . 0.0 109.134 176.707 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' C' C ' 60' ' ' VAL . . . . . . . . . . . . . 43.8 t -78.26 117.53 23.77 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.207 0 C-N-CA 120.633 -0.427 . . . . 0.0 110.084 -175.565 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' C' C ' 61' ' ' GLU . . . . . . . . . . . . . 95.8 mt-10 -131.06 162.92 28.77 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.025 -0.534 . . . . 0.0 109.992 178.355 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' C' C ' 62' ' ' ASP . . . . . . . . . . . . . 10.0 t0 -53.55 -32.16 49.58 Favored 'General case' 0 C--N 1.327 -0.402 0 N-CA-C 111.834 0.309 . . . . 0.0 111.834 -179.117 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' C' C ' 63' ' ' ARG . . . . . . . . . . . . . 33.6 ptt180 -84.11 3.43 34.81 Favored 'General case' 0 CA--C 1.536 0.424 0 N-CA-C 113.762 1.023 . . . . 0.0 113.762 -174.972 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' C' C ' 64' ' ' THR . . . . . . . . . . . . . 34.8 m -86.53 139.26 31.03 Favored 'General case' 0 C--O 1.232 0.144 0 CA-C-N 118.171 0.442 . . . . 0.0 110.742 -178.003 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' C' C ' 65' ' ' LYS . . . . . . . . . . . . . 98.7 mttt -89.35 127.67 35.83 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.157 -0.474 . . . . 0.0 110.205 178.918 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' C' C ' 66' ' ' ILE . . . . . . . . . . . . . 63.8 mt -114.06 127.46 71.46 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.269 0 N-CA-C 109.638 -0.505 . . . . 0.0 109.638 179.995 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' C' C ' 67' ' ' THR . . . . . . . . . . . . . 22.6 m -123.5 139.24 54.22 Favored 'General case' 0 C--N 1.331 -0.216 0 CA-C-N 116.223 -0.444 . . . . 0.0 110.818 -177.459 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' C' C ' 68' ' ' LEU . . . . . . . . . . . . . 30.4 mt . . . . . 0 C--N 1.329 -0.299 0 CA-C-N 115.881 -0.6 . . . . 0.0 110.124 178.126 . . . . . . . . 0 0 . 1 . 003 nuclear orig core ' C' C ' 73' ' ' VAL . . . . . . . . . . . . . 27.6 m . . . . . 0 C--O 1.23 0.064 0 CA-C-O 121.118 0.485 . . . . 0.0 110.348 . . . . . . . . . 0 0 . 1 . 003 nuclear orig core ' C' C ' 74' ' ' ASP . . . . . . . . . . . . . 13.6 t70 -89.76 119.85 30.51 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 115.743 -0.662 . . . . 0.0 109.717 179.854 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' C' C ' 75' ' ' VAL . . . . . . . . . . . . . 45.1 t -110.43 121.15 62.72 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.203 0 CA-C-O 121.204 0.526 . . . . 0.0 110.327 -178.56 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' C' C ' 76' ' ' LEU . . . . . . . . . . . . . 18.6 mt -121.08 141.69 50.54 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 115.377 -0.829 . . . . 0.0 109.192 177.468 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' C' C ' 77' ' ' GLU . . . . . . . . . . . . . 97.9 mt-10 -134.14 134.02 41.71 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-O 121.204 0.526 . . . . 0.0 111.338 -177.425 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' C' C ' 78' ' ' ALA . . . . . . . . . . . . . . . -122.9 129.51 51.7 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 115.455 -0.793 . . . . 0.0 109.654 176.593 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' C' C ' 79' ' ' LYS . . . . . . . . . . . . . 80.6 tttt -73.98 119.7 18.55 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.477 -0.328 . . . . 0.0 110.241 -179.013 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' C' C ' 80' ' ' ILE . . . . . . . . . . . . . 35.7 mm -139.13 116.21 10.86 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.304 0 N-CA-C 109.403 -0.591 . . . . 0.0 109.403 -176.279 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' C' C ' 81' ' ' LYS . . . . . . . . . . . . . 21.1 pttp -110.73 124.18 51.47 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-O 121.246 0.546 . . . . 0.0 111.284 -177.033 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' C' C ' 82' ' ' GLY . . . . . . . . . . . . . . . 89.2 42.09 5.67 Favored Glycine 0 CA--C 1.528 0.854 0 CA-C-N 115.675 -0.693 . . . . 0.0 112.053 175.677 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' C' C ' 83' ' ' ILE . . . . . . . . . . . . . 68.2 mt -69.56 137.09 24.87 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.248 0 N-CA-C 109.487 -0.56 . . . . 0.0 109.487 176.498 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' C' C ' 84' ' ' LYS . . . . . . . . . . . . . 28.1 ttpp -103.68 -52.13 3.04 Favored 'General case' 0 C--N 1.331 -0.201 0 CA-C-O 120.852 0.358 . . . . 0.0 110.524 -179.104 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' C' C ' 85' ' ' ASP . . . . . . . . . . . . . 13.3 t70 -143.54 145.31 32.44 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.077 -0.511 . . . . 0.0 110.653 -178.597 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' C' C ' 86' ' ' VAL . . . . . . . . . . . . . 44.4 t -127.66 129.2 70.15 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.234 0 CA-C-O 120.871 0.367 . . . . 0.0 110.382 179.89 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' C' C ' 87' ' ' ILE . . . . . . . . . . . . . 43.9 mm -118.5 123.98 72.41 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.26 0 CA-C-N 116.041 -0.527 . . . . 0.0 109.604 176.598 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' C' C ' 88' ' ' LEU . . . . . . . . . . . . . 68.2 mt -113.66 137.22 51.91 Favored 'General case' 0 C--N 1.331 -0.201 0 CA-C-O 121.081 0.467 . . . . 0.0 111.687 -176.347 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' C' C ' 89' ' ' ASP . . . . . . . . . . . . . 10.2 t70 -132.62 156.35 47.08 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 115.631 -0.713 . . . . 0.0 109.204 174.352 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' C' C ' 90' ' ' GLU . . . . . . . . . . . . . 82.0 tt0 -47.4 -41.62 20.35 Favored 'General case' 0 N--CA 1.464 0.228 0 N-CA-C 112.95 0.722 . . . . 0.0 112.95 -171.633 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' C' C ' 91' ' ' ASN . . . . . . . . . . . . . 15.7 p-10 -132.14 38.49 3.49 Favored 'General case' 0 N--CA 1.465 0.298 0 CA-C-O 120.821 0.343 . . . . 0.0 111.345 -177.934 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' C' C ' 92' ' ' LEU . . . . . . . . . . . . . 20.7 tp -164.74 139.88 5.5 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.59 -0.277 . . . . 0.0 110.258 -178.872 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' C' C ' 93' ' ' ILE . . . . . . . . . . . . . 66.3 mt -130.18 124.2 57.53 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.221 0 N-CA-C 109.576 -0.527 . . . . 0.0 109.576 -177.886 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' C' C ' 94' ' ' VAL . . . . . . . . . . . . . 46.7 t -125.81 127.91 71.69 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.265 0 N-CA-C 109.848 -0.427 . . . . 0.0 109.848 178.551 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' C' C ' 95' ' ' VAL . . . . . . . . . . . . . 42.4 t -122.08 136.09 60.06 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.283 0 CA-C-N 115.979 -0.555 . . . . 0.0 109.852 -179.089 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' C' C ' 96' ' ' ILE . . . . . . . . . . . . . 60.4 mt -116.12 127.61 73.66 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.328 0 N-CA-C 109.348 -0.612 . . . . 0.0 109.348 179.51 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' C' C ' 97' ' ' THR . . . . . . . . . . . . . 80.6 p -99.3 157.7 16.22 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-O 120.983 0.42 . . . . 0.0 110.952 -177.81 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' C' C ' 98' ' ' GLU . . . . . . . . . . . . . 96.2 mt-10 -53.98 -25.54 21.41 Favored 'General case' 0 CA--C 1.534 0.336 0 N-CA-C 112.306 0.484 . . . . 0.0 112.306 -179.03 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' C' C ' 99' ' ' GLU . . . . . . . . . . . . . 95.7 mt-10 -79.39 15.79 1.17 Allowed 'General case' 0 CA--C 1.535 0.379 0 N-CA-C 113.197 0.814 . . . . 0.0 113.197 -177.541 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' C' C ' 100' ' ' ASN . . . . . . . . . . . . . 2.6 m-20 62.05 37.27 14.87 Favored 'General case' 0 C--O 1.233 0.216 0 CA-C-O 121.076 0.465 . . . . 0.0 111.064 178.948 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' C' C ' 101' ' ' GLU . . . . . . . . . . . . . 83.6 tt0 -111.96 143.04 43.6 Favored 'General case' 0 C--N 1.333 -0.147 0 N-CA-C 109.611 -0.514 . . . . 0.0 109.611 176.436 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' C' C ' 102' ' ' VAL . . . . . . . . . . . . . 43.7 t -114.97 123.76 70.97 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.275 0 CA-C-N 116.123 -0.489 . . . . 0.0 109.833 -178.753 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' C' C ' 103' ' ' LEU . . . . . . . . . . . . . 69.1 mt -116.58 127.53 54.58 Favored 'General case' 0 C--N 1.331 -0.207 0 CA-C-N 115.76 -0.654 . . . . 0.0 109.902 176.086 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' C' C ' 104' ' ' ILE . . . . . . . . . . . . . 65.2 mt -114.84 123.41 70.49 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.289 0 N-CA-C 109.855 -0.424 . . . . 0.0 109.855 -179.665 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' C' C ' 105' ' ' PHE . . . . . . . . . . . . . 81.9 m-85 -123.53 162.1 23.58 Favored 'General case' 0 C--N 1.331 -0.226 0 O-C-N 123.864 0.728 . . . . 0.0 109.788 -178.333 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' C' C ' 106' ' ' ASN . . . . . . . . . . . . . 38.9 p30 -98.03 -173.98 2.74 Favored 'General case' 0 C--N 1.328 -0.334 0 N-CA-C 109.553 -0.536 . . . . 0.0 109.553 173.942 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' C' C ' 107' ' ' GLN . . . . . . . . . . . . . 45.7 tt0 -59.37 -29.06 67.42 Favored 'General case' 0 CA--C 1.532 0.264 0 N-CA-C 112.004 0.372 . . . . 0.0 112.004 -179.836 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' C' C ' 108' ' ' ASN . . . . . . . . . . . . . 52.9 t30 -81.94 8.59 10.07 Favored 'General case' 0 CA--C 1.537 0.472 0 N-CA-C 113.14 0.792 . . . . 0.0 113.14 -177.485 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' C' C ' 109' ' ' LEU . . . . . . . . . . . . . 13.2 tp 58.9 40.45 22.63 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-O 121.293 0.568 . . . . 0.0 110.981 178.425 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' C' C ' 110' ' ' GLU . . . . . . . . . . . . . 95.9 mt-10 -110.26 147.39 33.92 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.05 -0.523 . . . . 0.0 109.711 174.089 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' C' C ' 111' ' ' GLU . . . . . . . . . . . . . 55.5 tt0 -82.58 121.96 27.48 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.402 -0.363 . . . . 0.0 110.497 -176.043 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' C' C ' 112' ' ' LEU . . . . . . . . . . . . . 24.3 mt -105.37 -46.09 4.3 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.079 -0.51 . . . . 0.0 110.892 -179.549 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' C' C ' 113' ' ' TYR . . . . . . . . . . . . . 55.3 t80 -135.54 140.45 44.73 Favored 'General case' 0 C--N 1.331 -0.239 0 CA-C-N 116.221 -0.445 . . . . 0.0 110.805 -178.881 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' C' C ' 114' ' ' ARG . . . . . . . . . . . . . 36.1 ptt180 -143.61 120.88 11.56 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-O 121.183 0.516 . . . . 0.0 110.902 178.327 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' C' C ' 115' ' ' GLY . . . . . . . . . . . . . . . -150.19 163.04 29.4 Favored Glycine 0 CA--C 1.524 0.631 0 N-CA-C 110.866 -0.894 . . . . 0.0 110.866 -179.328 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' C' C ' 116' ' ' LYS . . . . . . . . . . . . . 40.0 ttpt -128.75 136.13 50.15 Favored 'General case' 0 C--N 1.33 -0.266 0 O-C-N 122.616 -0.343 . . . . 0.0 110.082 177.439 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' C' C ' 117' ' ' PHE . . . . . . . . . . . . . 61.9 m-85 -132.2 114.24 14.24 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-O 120.902 0.382 . . . . 0.0 110.448 -176.263 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' C' C ' 118' ' ' GLU . . . . . . . . . . . . . 70.8 mm-40 -53.47 -50.88 64.38 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.447 -0.342 . . . . 0.0 111.499 -176.205 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' C' C ' 119' ' ' ASN . . . . . . . . . . . . . 83.1 m-20 -94.73 31.06 1.88 Allowed 'General case' 0 C--N 1.329 -0.31 0 N-CA-C 112.187 0.44 . . . . 0.0 112.187 -174.083 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' C' C ' 120' ' ' LEU . . . . . . . . . . . . . 16.7 tp -56.46 124.71 19.1 Favored 'General case' 0 C--O 1.232 0.161 0 CA-C-O 120.659 0.266 . . . . 0.0 110.556 178.484 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' C' C ' 121' ' ' ASN . . . . . . . . . . . . . 35.5 m120 -114.03 -43.97 3.2 Favored 'General case' 0 C--N 1.332 -0.167 0 CA-C-N 116.483 -0.326 . . . . 0.0 111.044 -177.871 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' C' C ' 122' ' ' LYS . . . . . . . . . . . . . 55.5 mttm -145.3 148.09 33.06 Favored 'General case' 0 C--N 1.33 -0.239 0 CA-C-O 121.071 0.463 . . . . 0.0 111.815 -176.937 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' C' C ' 123' ' ' VAL . . . . . . . . . . . . . 45.4 t -128.0 124.23 62.29 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 N-CA-C 108.909 -0.774 . . . . 0.0 108.909 171.965 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' C' C ' 124' ' ' LEU . . . . . . . . . . . . . 11.3 tp -123.29 135.66 54.33 Favored 'General case' 0 C--N 1.332 -0.185 0 CA-C-O 120.765 0.317 . . . . 0.0 110.914 -174.941 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' C' C ' 125' ' ' VAL . . . . . . . . . . . . . 35.7 m -131.34 139.18 51.46 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.229 0 CA-C-N 116.225 -0.443 . . . . 0.0 110.886 -179.507 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' C' C ' 126' ' ' ARG . . . . . . . . . . . . . 89.0 mtt180 -146.6 125.07 12.37 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.167 -0.469 . . . . 0.0 110.51 175.83 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' C' C ' 127' ' ' ASN . . . . . . . . . . . . . 13.4 t-20 51.62 -109.31 0.43 Allowed 'General case' 0 CA--C 1.545 0.753 0 CA-C-O 118.824 -0.608 . . . . 0.0 111.199 -179.989 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' C' C ' 128' ' ' ASP . . . . . . . . . . . . . 14.3 p-10 -114.01 5.76 16.22 Favored 'General case' 0 N--CA 1.468 0.438 0 CA-C-N 119.818 1.19 . . . . 0.0 113.413 -177.918 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' C' C ' 129' ' ' LEU . . . . . . . . . . . . . 13.2 tp -109.89 136.6 48.93 Favored 'General case' 0 C--N 1.334 -0.108 0 N-CA-C 109.718 -0.475 . . . . 0.0 109.718 179.445 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' C' C ' 130' ' ' VAL . . . . . . . . . . . . . 12.9 p -129.54 140.7 48.42 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.205 0 CA-C-O 121.047 0.451 . . . . 0.0 110.46 -179.521 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' C' C ' 131' ' ' VAL . . . . . . . . . . . . . 43.0 t -135.72 138.29 48.07 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.314 0 CA-C-O 121.125 0.488 . . . . 0.0 110.18 179.689 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' C' C ' 132' ' ' ILE . . . . . . . . . . . . . 69.2 mt -110.64 131.23 62.34 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.328 0 CA-C-N 115.527 -0.76 . . . . 0.0 109.11 179.335 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' C' C ' 133' ' ' ILE . . . . . . . . . . . . . 42.4 mm -115.22 119.75 62.69 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.222 0 CA-C-O 120.859 0.361 . . . . 0.0 110.893 -174.716 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' C' C ' 134' ' ' ASP . . . . . . . . . . . . . 8.0 p-10 -132.17 144.24 50.53 Favored 'General case' 0 C--N 1.33 -0.253 0 N-CA-C 109.271 -0.64 . . . . 0.0 109.271 174.7 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' C' C ' 135' ' ' GLU . . . . . . . . . . . . . 84.2 tt0 -49.97 -26.41 4.2 Favored 'General case' 0 C--N 1.327 -0.395 0 N-CA-C 112.774 0.657 . . . . 0.0 112.774 -173.643 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' C' C ' 136' ' ' GLN . . . . . . . . . . . . . 62.8 tt0 -78.95 -36.59 41.39 Favored 'General case' 0 CA--C 1.531 0.217 0 N-CA-C 112.196 0.443 . . . . 0.0 112.196 -177.237 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' C' C ' 137' ' ' LYS . . . . . . . . . . . . . 34.5 pttt -167.27 172.29 9.96 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-O 121.482 0.658 . . . . 0.0 112.025 -173.258 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' C' C ' 138' ' ' LEU . . . . . . . . . . . . . 7.1 tt -117.01 128.78 55.52 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 115.223 -0.899 . . . . 0.0 109.953 179.213 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' C' C ' 139' ' ' THR . . . . . . . . . . . . . 32.7 m -110.46 123.47 49.97 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.164 178.885 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' C' C ' 140' ' ' LEU . . . . . . . . . . . . . 7.0 tt -107.95 123.11 48.13 Favored 'General case' 0 C--N 1.327 -0.408 0 N-CA-C 108.947 -0.76 . . . . 0.0 108.947 -179.49 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' C' C ' 141' ' ' ILE . . . . . . . . . . . . . 20.0 mt -124.96 118.64 53.71 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.248 0 CA-C-O 121.205 0.526 . . . . 0.0 109.944 -176.448 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' C' C ' 142' ' ' ARG . . . . . . . . . . . . . 67.1 ttt-85 . . . . . 0 C--N 1.328 -0.344 0 CA-C-N 115.221 -0.9 . . . . 0.0 109.929 178.919 . . . . . . . . 0 0 . 1 . 003 nuclear orig core ' D' D ' 2' ' ' SER . . . . . . . . . . . . . 2.3 p . . . . . 0 C--O 1.233 0.187 0 CA-C-O 121.002 0.43 . . . . 0.0 110.271 . . . . . . . . . 0 0 . 1 . 003 nuclear orig core ' D' D ' 3' ' ' GLU . . . . . . . . . . . . . 84.3 tt0 -140.03 141.24 36.3 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 115.778 -0.646 . . . . 0.0 110.983 -176.666 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' D' D ' 4' ' ' LEU . . . . . . . . . . . . . 12.6 tp -125.38 127.64 46.9 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-N 115.927 -0.579 . . . . 0.0 110.18 176.568 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' D' D ' 5' ' ' LYS . . . . . . . . . . . . . 98.8 mttt -108.8 121.58 45.38 Favored 'General case' 0 C--O 1.235 0.322 0 CA-C-N 116.532 -0.304 . . . . 0.0 110.905 179.931 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' D' D ' 6' ' ' LEU . . . . . . . . . . . . . 40.5 mt -114.02 148.32 37.19 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-N 115.352 -0.84 . . . . 0.0 110.289 179.989 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' D' D ' 7' ' ' LYS . . . . . . . . . . . . . 57.8 tttm -128.72 137.04 30.1 Favored Pre-proline 0 CA--C 1.535 0.383 0 CA-C-O 118.831 -0.604 . . . . 0.0 109.703 173.62 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' D' D ' 8' ' ' PRO . . . . . . . . . . . . . 90.8 Cg_endo -90.84 134.05 1.77 Allowed 'Trans proline' 0 N--CA 1.491 1.344 0 C-N-CA 121.7 1.6 . . . . 0.0 111.694 178.081 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' D' D ' 9' ' ' LEU . . . . . . . . . . . . . 35.5 mt -73.38 -46.98 7.69 Favored Pre-proline 0 CA--C 1.532 0.277 0 CA-C-O 118.701 -0.666 . . . . 0.0 112.056 -178.845 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' D' D ' 10' ' ' PRO . . . . . . . . . . . . . 91.7 Cg_endo -81.78 150.38 16.42 Favored 'Trans proline' 0 N--CA 1.495 1.614 0 C-N-CA 121.267 1.311 . . . . 0.0 111.64 174.61 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' D' D ' 11' ' ' LYS . . . . . . . . . . . . . 49.9 pttt -85.38 111.29 19.79 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-O 121.626 0.727 . . . . 0.0 110.606 178.367 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' D' D ' 12' ' ' VAL . . . . . . . . . . . . . 12.3 p -151.12 148.28 15.01 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.309 0 CA-C-N 115.57 -0.741 . . . . 0.0 110.348 179.339 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' D' D ' 13' ' ' GLU . . . . . . . . . . . . . 45.5 tp10 -94.0 122.16 36.23 Favored 'General case' 0 C--N 1.33 -0.282 0 N-CA-C 110.002 -0.37 . . . . 0.0 110.002 177.584 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' D' D ' 14' ' ' LEU . . . . . . . . . . . . . 46.4 mt -98.02 152.44 38.05 Favored Pre-proline 0 CA--C 1.532 0.272 0 CA-C-O 119.439 -0.315 . . . . 0.0 110.758 -177.558 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' D' D ' 15' ' ' PRO . . . . . . . . . . . . . 27.8 Cg_exo -61.13 159.84 28.69 Favored 'Trans proline' 0 N--CA 1.497 1.684 0 C-N-CA 121.315 1.343 . . . . 0.0 111.977 177.499 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' D' D ' 16' ' ' PRO . . . . . . . . . . . . . 29.8 Cg_exo -59.96 -36.36 90.31 Favored 'Trans proline' 0 N--CA 1.497 1.692 0 C-N-CA 121.434 1.423 . . . . 0.0 112.742 -178.536 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' D' D ' 17' ' ' ASP . . . . . . . . . . . . . 8.2 p-10 -88.18 8.88 24.95 Favored 'General case' 0 CA--C 1.536 0.404 0 N-CA-C 113.24 0.829 . . . . 0.0 113.24 -177.388 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' D' D ' 18' ' ' PHE . . . . . . . . . . . . . 43.6 t80 -58.16 -46.13 86.22 Favored 'General case' 0 CA--C 1.524 -0.031 0 O-C-N 121.887 -0.508 . . . . 0.0 109.973 -178.391 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' D' D ' 19' ' ' VAL . . . . . . . . . . . . . 13.8 p -57.47 -40.6 75.58 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.34 0 CA-C-N 116.121 -0.49 . . . . 0.0 110.723 -179.519 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' D' D ' 20' ' ' ASP . . . . . . . . . . . . . 22.2 m-20 -59.49 -43.14 93.39 Favored 'General case' 0 C--N 1.331 -0.228 0 C-N-CA 120.88 -0.328 . . . . 0.0 110.846 -178.143 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' D' D ' 21' ' ' VAL . . . . . . . . . . . . . 47.7 t -64.92 -46.3 92.14 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.246 0 C-N-CA 120.717 -0.393 . . . . 0.0 110.472 -178.192 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' D' D ' 22' ' ' ILE . . . . . . . . . . . . . 45.2 mm -59.33 -35.82 60.4 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.256 0 C-N-CA 120.843 -0.343 . . . . 0.0 110.98 -179.872 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' D' D ' 23' ' ' ARG . . . . . . . . . . . . . 33.1 ttp180 -59.45 -49.74 76.63 Favored 'General case' 0 C--N 1.33 -0.242 0 C-N-CA 120.621 -0.432 . . . . 0.0 110.19 176.789 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' D' D ' 24' ' ' ILE . . . . . . . . . . . . . 75.6 mt -61.34 -39.8 83.94 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.322 0 CA-C-N 116.155 -0.475 . . . . 0.0 112.085 -177.034 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' D' D ' 25' ' ' LYS . . . . . . . . . . . . . 10.2 ptmt -75.06 -40.43 60.29 Favored 'General case' 0 CA--C 1.535 0.38 0 C-N-CA 120.537 -0.465 . . . . 0.0 111.98 -175.144 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' D' D ' 26' ' ' LEU . . . . . . . . . . . . . 24.2 mt -79.04 -33.92 44.32 Favored 'General case' 0 C--N 1.331 -0.225 0 N-CA-C 113.337 0.866 . . . . 0.0 113.337 -172.978 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' D' D ' 27' ' ' GLN . . . . . . . . . . . . . 8.7 pt20 -46.55 139.66 4.91 Favored 'General case' 0 N--CA 1.47 0.527 0 N-CA-C 112.726 0.639 . . . . 0.0 112.726 -176.3 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' D' D ' 28' ' ' GLY . . . . . . . . . . . . . . . 100.24 -24.59 31.53 Favored Glycine 0 CA--C 1.534 1.231 0 CA-C-N 115.688 -0.687 . . . . 0.0 112.134 -174.287 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' D' D ' 29' ' ' LYS . . . . . . . . . . . . . 99.4 mttt -97.83 155.22 17.15 Favored 'General case' 0 C--N 1.333 -0.113 0 CA-C-N 117.334 0.567 . . . . 0.0 110.985 178.791 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' D' D ' 30' ' ' THR . . . . . . . . . . . . . 17.8 m -105.56 140.52 38.52 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 115.949 -0.569 . . . . 0.0 110.179 176.447 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' D' D ' 31' ' ' VAL . . . . . . . . . . . . . 35.1 m -126.66 149.51 31.73 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.224 0 CA-C-N 116.398 -0.365 . . . . 0.0 110.793 -179.393 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' D' D ' 32' ' ' ARG . . . . . . . . . . . . . 93.1 mtt180 -129.91 149.18 51.75 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-O 121.29 0.567 . . . . 0.0 110.431 179.348 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' D' D ' 33' ' ' THR . . . . . . . . . . . . . 21.2 m -53.24 137.49 34.37 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.169 -0.468 . . . . 0.0 111.546 -176.671 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' D' D ' 34' ' ' GLY . . . . . . . . . . . . . . . 99.31 -16.98 58.5 Favored Glycine 0 CA--C 1.531 1.067 0 C-N-CA 121.243 -0.503 . . . . 0.0 113.358 177.278 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' D' D ' 35' ' ' ASP . . . . . . . . . . . . . 81.3 m-20 -65.89 147.98 52.51 Favored 'General case' 0 C--O 1.231 0.117 0 CA-C-N 118.045 0.923 . . . . 0.0 111.127 -179.879 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' D' D ' 36' ' ' VAL . . . . . . . . . . . . . 46.4 t -119.95 129.5 75.36 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.266 0 CA-C-N 115.971 -0.559 . . . . 0.0 109.646 176.891 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' D' D ' 37' ' ' ILE . . . . . . . . . . . . . 63.0 mt -119.33 138.02 51.38 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.267 0 N-CA-C 109.864 -0.421 . . . . 0.0 109.864 -178.306 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' D' D ' 38' ' ' GLY . . . . . . . . . . . . . . . -115.77 128.2 7.92 Favored Glycine 0 CA--C 1.526 0.763 0 N-CA-C 110.881 -0.888 . . . . 0.0 110.881 179.04 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' D' D ' 39' ' ' ILE . . . . . . . . . . . . . 68.7 mt -126.15 127.42 70.85 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.223 0 N-CA-C 110.011 -0.366 . . . . 0.0 110.011 179.036 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' D' D ' 40' ' ' SER . . . . . . . . . . . . . 42.5 t -93.12 119.92 32.85 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.509 -0.314 . . . . 0.0 111.03 176.935 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' D' D ' 41' ' ' ILE . . . . . . . . . . . . . 71.6 mt -132.93 129.96 58.21 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.206 0 CA-C-O 120.795 0.331 . . . . 0.0 110.441 178.144 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' D' D ' 42' ' ' LEU . . . . . . . . . . . . . 74.0 mt 56.74 33.01 22.24 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.204 -0.453 . . . . 0.0 111.853 177.401 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' D' D ' 43' ' ' GLY . . . . . . . . . . . . . . . 72.85 24.81 75.34 Favored Glycine 0 CA--C 1.532 1.129 0 C-N-CA 121.149 -0.548 . . . . 0.0 112.55 177.712 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' D' D ' 44' ' ' LYS . . . . . . . . . . . . . 67.3 mttm -136.85 127.01 26.2 Favored 'General case' 0 C--N 1.331 -0.214 0 CA-C-N 117.162 0.481 . . . . 0.0 109.899 178.001 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' D' D ' 45' ' ' GLU . . . . . . . . . . . . . 39.2 tp10 -85.53 126.29 33.74 Favored 'General case' 0 C--N 1.328 -0.349 0 C-N-CA 120.776 -0.369 . . . . 0.0 110.968 -178.979 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' D' D ' 46' ' ' VAL . . . . . . . . . . . . . 9.0 p -118.14 126.43 74.96 Favored 'Isoleucine or valine' 0 C--O 1.233 0.224 0 N-CA-C 109.417 -0.586 . . . . 0.0 109.417 174.778 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' D' D ' 47' ' ' LYS . . . . . . . . . . . . . 62.0 mttp -98.89 125.62 44.35 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 116.111 -0.495 . . . . 0.0 110.886 177.762 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' D' D ' 48' ' ' PHE . . . . . . . . . . . . . 38.4 m-85 -111.22 131.86 54.79 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 115.79 -0.641 . . . . 0.0 109.458 177.166 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' D' D ' 49' ' ' LYS . . . . . . . . . . . . . 46.0 tttp -105.44 133.33 50.37 Favored 'General case' 0 C--N 1.328 -0.355 0 N-CA-C 110.174 -0.306 . . . . 0.0 110.174 178.823 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' D' D ' 50' ' ' VAL . . . . . . . . . . . . . 44.0 t -77.94 103.44 5.01 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.299 0 N-CA-C 109.243 -0.651 . . . . 0.0 109.243 177.894 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' D' D ' 51' ' ' VAL . . . . . . . . . . . . . 48.1 t -72.21 -48.36 49.19 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.324 0 CA-C-N 116.105 -0.498 . . . . 0.0 110.068 -173.664 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' D' D ' 52' ' ' GLN . . . . . . . . . . . . . 62.6 tt0 -159.13 141.44 13.86 Favored 'General case' 0 C--N 1.33 -0.27 0 C-N-CA 120.298 -0.561 . . . . 0.0 111.749 -178.542 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' D' D ' 53' ' ' ALA . . . . . . . . . . . . . . . -120.66 132.41 55.09 Favored 'General case' 0 C--N 1.331 -0.2 0 CA-C-N 115.96 -0.564 . . . . 0.0 109.889 175.172 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' D' D ' 54' ' ' TYR . . . . . . . . . . . . . 71.5 t80 -129.05 111.17 18.37 Favored Pre-proline 0 CA--C 1.534 0.355 0 CA-C-O 118.231 -0.89 . . . . 0.0 110.522 179.522 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' D' D ' 55' ' ' PRO . . . . . . . . . . . . . 72.7 Cg_endo -77.24 169.9 72.89 Favored 'Cis proline' 0 N--CA 1.5 1.872 0 CA-C-N 121.945 1.73 . . . . 0.0 112.086 -7.417 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' D' D ' 56' ' ' SER . . . . . . . . . . . . . 13.7 m -119.27 134.32 23.73 Favored Pre-proline 0 CA--C 1.538 0.507 0 CA-C-O 118.51 -0.757 . . . . 0.0 109.403 174.219 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' D' D ' 57' ' ' PRO . . . . . . . . . . . . . 48.7 Cg_endo -69.85 144.7 77.56 Favored 'Cis proline' 0 N--CA 1.498 1.745 0 CA-C-N 121.857 1.699 . . . . 0.0 111.496 -0.695 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' D' D ' 58' ' ' LEU . . . . . . . . . . . . . 19.6 tp -106.75 134.55 49.72 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.369 -0.378 . . . . 0.0 110.57 -178.756 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' D' D ' 59' ' ' ARG . . . . . . . . . . . . . 19.9 ttm180 -103.59 125.52 50.17 Favored 'General case' 0 C--N 1.327 -0.395 0 N-CA-C 109.158 -0.682 . . . . 0.0 109.158 175.823 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' D' D ' 60' ' ' VAL . . . . . . . . . . . . . 43.1 t -82.23 123.51 38.29 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.25 0 C-N-CA 120.557 -0.457 . . . . 0.0 110.491 -175.659 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' D' D ' 61' ' ' GLU . . . . . . . . . . . . . 95.3 mt-10 -129.71 172.3 11.77 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 115.721 -0.672 . . . . 0.0 109.36 176.689 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' D' D ' 62' ' ' ASP . . . . . . . . . . . . . 69.2 m-20 -53.89 -32.37 53.11 Favored 'General case' 0 C--N 1.328 -0.332 0 C-N-CA 121.068 -0.253 . . . . 0.0 111.636 178.595 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' D' D ' 63' ' ' ARG . . . . . . . . . . . . . 40.7 ptt180 -83.86 -0.38 50.97 Favored 'General case' 0 CA--C 1.537 0.475 0 N-CA-C 113.754 1.02 . . . . 0.0 113.754 -176.037 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' D' D ' 64' ' ' THR . . . . . . . . . . . . . 25.3 m -76.31 132.11 39.61 Favored 'General case' 0 C--N 1.333 -0.127 0 CA-C-N 118.158 0.435 . . . . 0.0 110.733 -176.234 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' D' D ' 65' ' ' LYS . . . . . . . . . . . . . 36.5 ttpt -89.78 122.62 33.03 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.191 -0.459 . . . . 0.0 110.136 179.249 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' D' D ' 66' ' ' ILE . . . . . . . . . . . . . 61.9 mt -112.8 131.98 62.85 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.268 0 N-CA-C 109.918 -0.401 . . . . 0.0 109.918 -178.229 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' D' D ' 67' ' ' THR . . . . . . . . . . . . . 24.4 m -130.05 143.82 51.0 Favored 'General case' 0 C--O 1.234 0.268 0 CA-C-O 121.172 0.51 . . . . 0.0 111.496 -177.835 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' D' D ' 68' ' ' LEU . . . . . . . . . . . . . 8.2 tt . . . . . 0 C--N 1.328 -0.347 0 CA-C-N 115.656 -0.702 . . . . 0.0 109.553 175.908 . . . . . . . . 0 0 . 1 . 003 nuclear orig core ' D' D ' 73' ' ' VAL . . . . . . . . . . . . . 27.4 m . . . . . 0 C--O 1.232 0.132 0 CA-C-O 120.85 0.357 . . . . 0.0 110.41 . . . . . . . . . 0 0 . 1 . 003 nuclear orig core ' D' D ' 74' ' ' ASP . . . . . . . . . . . . . 42.6 t0 -90.87 115.08 27.64 Favored 'General case' 0 C--N 1.326 -0.44 0 CA-C-N 115.981 -0.554 . . . . 0.0 109.719 179.471 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' D' D ' 75' ' ' VAL . . . . . . . . . . . . . 46.0 t -112.27 120.11 61.77 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.264 0 CA-C-O 121.238 0.542 . . . . 0.0 110.279 -178.943 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' D' D ' 76' ' ' LEU . . . . . . . . . . . . . 23.4 mt -122.67 144.33 49.21 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 115.408 -0.815 . . . . 0.0 109.446 179.53 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' D' D ' 77' ' ' GLU . . . . . . . . . . . . . 45.9 mt-10 -135.64 137.31 41.74 Favored 'General case' 0 N--CA 1.463 0.212 0 CA-C-O 121.219 0.533 . . . . 0.0 111.688 -176.914 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' D' D ' 78' ' ' ALA . . . . . . . . . . . . . . . -126.52 131.6 51.56 Favored 'General case' 0 C--N 1.332 -0.184 0 CA-C-N 115.507 -0.77 . . . . 0.0 109.725 175.558 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' D' D ' 79' ' ' LYS . . . . . . . . . . . . . 64.7 mttp -81.32 118.46 22.66 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-O 120.832 0.349 . . . . 0.0 110.718 -177.913 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' D' D ' 80' ' ' ILE . . . . . . . . . . . . . 24.8 mm -139.26 114.71 8.57 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.306 0 N-CA-C 109.57 -0.53 . . . . 0.0 109.57 -177.91 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' D' D ' 81' ' ' LYS . . . . . . . . . . . . . 97.9 mttt -98.64 123.71 43.0 Favored 'General case' 0 C--N 1.33 -0.28 0 C-N-CA 120.907 -0.317 . . . . 0.0 110.993 -179.938 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' D' D ' 82' ' ' GLY . . . . . . . . . . . . . . . 89.21 42.18 5.64 Favored Glycine 0 CA--C 1.524 0.654 0 C-N-CA 120.676 -0.773 . . . . 0.0 112.168 173.057 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' D' D ' 83' ' ' ILE . . . . . . . . . . . . . 73.5 mt -65.4 133.23 30.85 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.279 0 N-CA-C 109.314 -0.625 . . . . 0.0 109.314 175.194 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' D' D ' 84' ' ' LYS . . . . . . . . . . . . . 28.2 ttpp -97.71 -53.14 3.51 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-O 120.981 0.42 . . . . 0.0 110.51 -176.734 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' D' D ' 85' ' ' ASP . . . . . . . . . . . . . 13.9 t70 -147.54 146.67 29.53 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 115.868 -0.606 . . . . 0.0 110.396 -179.475 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' D' D ' 86' ' ' VAL . . . . . . . . . . . . . 45.0 t -128.91 129.39 68.17 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.299 0 CA-C-O 121.01 0.433 . . . . 0.0 110.545 -179.53 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' D' D ' 87' ' ' ILE . . . . . . . . . . . . . 43.6 mm -116.46 121.87 68.55 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.274 0 N-CA-C 109.087 -0.709 . . . . 0.0 109.087 175.451 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' D' D ' 88' ' ' LEU . . . . . . . . . . . . . 10.0 tp -114.93 131.58 56.84 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-O 121.047 0.451 . . . . 0.0 111.327 -174.907 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' D' D ' 89' ' ' ASP . . . . . . . . . . . . . 12.8 t70 -129.62 152.28 49.3 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 115.697 -0.683 . . . . 0.0 109.358 175.359 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' D' D ' 90' ' ' GLU . . . . . . . . . . . . . 95.9 mt-10 -50.65 -31.61 16.72 Favored 'General case' 0 C--N 1.328 -0.366 0 N-CA-C 112.477 0.547 . . . . 0.0 112.477 -173.115 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' D' D ' 91' ' ' ASN . . . . . . . . . . . . . 23.6 p30 -128.54 27.69 5.51 Favored 'General case' 0 N--CA 1.465 0.32 0 N-CA-C 112.607 0.595 . . . . 0.0 112.607 -175.779 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' D' D ' 92' ' ' LEU . . . . . . . . . . . . . 15.1 tp -166.11 143.11 5.24 Favored 'General case' 0 C--N 1.331 -0.196 0 C-N-CA 121.074 -0.25 . . . . 0.0 110.662 179.445 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' D' D ' 93' ' ' ILE . . . . . . . . . . . . . 75.6 mt -126.17 119.66 54.78 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.263 0 N-CA-C 109.552 -0.536 . . . . 0.0 109.552 178.082 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' D' D ' 94' ' ' VAL . . . . . . . . . . . . . 43.8 t -118.3 124.16 72.69 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.255 0 N-CA-C 109.627 -0.509 . . . . 0.0 109.627 178.954 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' D' D ' 95' ' ' VAL . . . . . . . . . . . . . 44.7 t -121.38 132.65 70.15 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.275 0 CA-C-N 116.233 -0.44 . . . . 0.0 109.934 -178.586 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' D' D ' 96' ' ' ILE . . . . . . . . . . . . . 67.7 mt -115.58 127.36 73.18 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 N-CA-C 109.244 -0.65 . . . . 0.0 109.244 179.128 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' D' D ' 97' ' ' THR . . . . . . . . . . . . . 80.5 p -101.47 159.68 15.08 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-O 121.364 0.602 . . . . 0.0 111.48 -176.18 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' D' D ' 98' ' ' GLU . . . . . . . . . . . . . 84.4 tt0 -53.95 -26.46 25.75 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 115.836 -0.62 . . . . 0.0 112.264 179.965 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' D' D ' 99' ' ' GLU . . . . . . . . . . . . . 43.3 mt-10 -79.49 15.64 1.24 Allowed 'General case' 0 CA--C 1.534 0.35 0 N-CA-C 113.115 0.783 . . . . 0.0 113.115 -177.169 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' D' D ' 100' ' ' ASN . . . . . . . . . . . . . 3.2 m-20 61.3 38.02 16.7 Favored 'General case' 0 N--CA 1.463 0.183 0 CA-C-O 121.16 0.505 . . . . 0.0 110.962 178.948 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' D' D ' 101' ' ' GLU . . . . . . . . . . . . . 84.1 tt0 -117.47 142.1 47.55 Favored 'General case' 0 C--N 1.333 -0.14 0 N-CA-C 109.636 -0.505 . . . . 0.0 109.636 176.308 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' D' D ' 102' ' ' VAL . . . . . . . . . . . . . 43.0 t -114.94 126.15 72.44 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.351 0 N-CA-C 109.947 -0.39 . . . . 0.0 109.947 -179.149 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' D' D ' 103' ' ' LEU . . . . . . . . . . . . . 45.7 mt -115.95 133.34 56.13 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 115.728 -0.669 . . . . 0.0 109.948 177.179 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' D' D ' 104' ' ' ILE . . . . . . . . . . . . . 68.2 mt -118.35 120.71 65.18 Favored 'Isoleucine or valine' 0 C--O 1.233 0.221 0 N-CA-C 110.112 -0.329 . . . . 0.0 110.112 -179.475 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' D' D ' 105' ' ' PHE . . . . . . . . . . . . . 55.8 m-85 -122.8 167.35 13.62 Favored 'General case' 0 C--N 1.332 -0.158 0 O-C-N 124.011 0.82 . . . . 0.0 109.933 -179.694 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' D' D ' 106' ' ' ASN . . . . . . . . . . . . . 41.2 p-10 -101.48 -170.84 1.89 Allowed 'General case' 0 C--N 1.331 -0.205 0 N-CA-C 109.95 -0.389 . . . . 0.0 109.95 172.922 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' D' D ' 107' ' ' GLN . . . . . . . . . . . . . 47.4 tt0 -60.57 -29.99 69.51 Favored 'General case' 0 C--N 1.33 -0.273 0 N-CA-C 111.904 0.335 . . . . 0.0 111.904 179.754 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' D' D ' 108' ' ' ASN . . . . . . . . . . . . . 10.8 t30 -82.18 7.41 13.7 Favored 'General case' 0 CA--C 1.537 0.443 0 N-CA-C 113.143 0.794 . . . . 0.0 113.143 -178.026 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' D' D ' 109' ' ' LEU . . . . . . . . . . . . . 10.0 tp 62.31 36.67 14.45 Favored 'General case' 0 CA--C 1.53 0.204 0 CA-C-O 120.881 0.372 . . . . 0.0 111.393 178.082 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' D' D ' 110' ' ' GLU . . . . . . . . . . . . . 70.7 mm-40 -104.57 155.55 18.73 Favored 'General case' 0 C--N 1.33 -0.243 0 N-CA-C 109.503 -0.554 . . . . 0.0 109.503 175.348 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' D' D ' 111' ' ' GLU . . . . . . . . . . . . . 66.2 tt0 -91.07 124.68 35.48 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-O 120.982 0.42 . . . . 0.0 111.0 -176.003 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' D' D ' 112' ' ' LEU . . . . . . . . . . . . . 23.8 mt -108.77 -45.93 3.73 Favored 'General case' 0 C--N 1.331 -0.204 0 CA-C-N 116.097 -0.501 . . . . 0.0 110.861 179.264 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' D' D ' 113' ' ' TYR . . . . . . . . . . . . . 51.1 t80 -138.32 143.18 39.83 Favored 'General case' 0 N--CA 1.462 0.174 0 C-N-CA 120.835 -0.346 . . . . 0.0 111.074 -178.027 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' D' D ' 114' ' ' ARG . . . . . . . . . . . . . 36.2 ptt-85 -142.57 127.8 18.7 Favored 'General case' 0 C--N 1.331 -0.217 0 CA-C-N 116.274 -0.421 . . . . 0.0 110.85 177.094 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' D' D ' 115' ' ' GLY . . . . . . . . . . . . . . . -150.15 141.72 9.04 Favored Glycine 0 CA--C 1.524 0.621 0 N-CA-C 111.439 -0.665 . . . . 0.0 111.439 178.559 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' D' D ' 116' ' ' LYS . . . . . . . . . . . . . 39.5 ttpt -111.74 134.38 53.34 Favored 'General case' 0 C--N 1.331 -0.198 0 N-CA-C 109.485 -0.561 . . . . 0.0 109.485 175.101 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' D' D ' 117' ' ' PHE . . . . . . . . . . . . . 42.1 m-85 -135.79 113.95 11.4 Favored 'General case' 0 C--N 1.331 -0.225 0 CA-C-O 120.967 0.413 . . . . 0.0 110.394 -175.912 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' D' D ' 118' ' ' GLU . . . . . . . . . . . . . 70.7 mm-40 -55.13 -48.76 73.2 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.313 -0.403 . . . . 0.0 111.257 -175.811 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' D' D ' 119' ' ' ASN . . . . . . . . . . . . . 11.7 m-80 -96.01 31.05 2.23 Favored 'General case' 0 C--N 1.328 -0.344 0 N-CA-C 112.149 0.426 . . . . 0.0 112.149 -174.04 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' D' D ' 120' ' ' LEU . . . . . . . . . . . . . 15.7 tp -56.48 122.23 11.48 Favored 'General case' 0 C--N 1.332 -0.175 0 CA-C-O 120.686 0.279 . . . . 0.0 110.391 177.538 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' D' D ' 121' ' ' ASN . . . . . . . . . . . . . 12.5 t-20 -112.17 -44.12 3.46 Favored 'General case' 0 C--N 1.332 -0.18 0 CA-C-N 116.488 -0.323 . . . . 0.0 110.846 -176.027 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' D' D ' 122' ' ' LYS . . . . . . . . . . . . . 98.3 mttt -146.37 149.61 34.1 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-O 121.112 0.482 . . . . 0.0 111.51 -178.489 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' D' D ' 123' ' ' VAL . . . . . . . . . . . . . 46.4 t -130.31 126.33 61.14 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.289 0 N-CA-C 109.25 -0.648 . . . . 0.0 109.25 172.928 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' D' D ' 124' ' ' LEU . . . . . . . . . . . . . 6.2 mp -114.71 137.09 52.34 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-O 120.824 0.345 . . . . 0.0 111.0 -176.52 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' D' D ' 125' ' ' VAL . . . . . . . . . . . . . 44.3 t -122.83 132.15 71.88 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.179 0 CA-C-N 115.911 -0.586 . . . . 0.0 109.939 179.861 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' D' D ' 126' ' ' ARG . . . . . . . . . . . . . 25.7 mmt180 -134.86 104.66 6.08 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 116.124 -0.489 . . . . 0.0 110.215 178.021 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' D' D ' 127' ' ' ASN . . . . . . . . . . . . . 35.0 m120 53.98 -104.98 0.23 Allowed 'General case' 0 CA--C 1.544 0.733 0 CA-C-O 119.053 -0.499 . . . . 0.0 110.922 179.75 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' D' D ' 128' ' ' ASP . . . . . . . . . . . . . 13.8 p-10 -112.33 2.65 16.6 Favored 'General case' 0 CA--C 1.536 0.431 0 CA-C-N 119.579 1.081 . . . . 0.0 113.498 -177.574 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' D' D ' 129' ' ' LEU . . . . . . . . . . . . . 26.1 mt -105.01 148.66 26.51 Favored 'General case' 0 C--O 1.231 0.124 0 N-CA-C 109.726 -0.472 . . . . 0.0 109.726 177.263 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' D' D ' 130' ' ' VAL . . . . . . . . . . . . . 12.7 p -133.04 141.03 45.87 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.233 0 CA-C-O 121.301 0.572 . . . . 0.0 110.784 -177.682 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' D' D ' 131' ' ' VAL . . . . . . . . . . . . . 38.9 t -134.43 135.96 53.4 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 CA-C-N 115.716 -0.675 . . . . 0.0 109.924 178.909 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' D' D ' 132' ' ' ILE . . . . . . . . . . . . . 70.6 mt -113.87 132.21 63.53 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.366 0 N-CA-C 109.394 -0.595 . . . . 0.0 109.394 -178.717 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' D' D ' 133' ' ' ILE . . . . . . . . . . . . . 35.4 mm -117.31 120.39 64.78 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.261 0 CA-C-O 120.837 0.351 . . . . 0.0 110.78 -176.06 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' D' D ' 134' ' ' ASP . . . . . . . . . . . . . 9.3 p-10 -129.89 148.95 51.81 Favored 'General case' 0 C--N 1.329 -0.284 0 N-CA-C 109.419 -0.586 . . . . 0.0 109.419 175.179 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' D' D ' 135' ' ' GLU . . . . . . . . . . . . . 54.6 tt0 -50.03 -25.43 3.38 Favored 'General case' 0 C--N 1.327 -0.39 0 N-CA-C 112.746 0.647 . . . . 0.0 112.746 -172.414 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' D' D ' 136' ' ' GLN . . . . . . . . . . . . . 43.0 tt0 -89.86 -31.1 17.49 Favored 'General case' 0 C--O 1.233 0.208 0 N-CA-C 112.542 0.571 . . . . 0.0 112.542 -174.058 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' D' D ' 137' ' ' LYS . . . . . . . . . . . . . 25.1 pttm -164.07 174.09 11.74 Favored 'General case' 0 C--O 1.232 0.176 0 CA-C-O 121.434 0.635 . . . . 0.0 112.57 -174.373 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' D' D ' 138' ' ' LEU . . . . . . . . . . . . . 7.4 tt -122.44 130.33 52.98 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 115.197 -0.91 . . . . 0.0 110.109 179.564 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' D' D ' 139' ' ' THR . . . . . . . . . . . . . 34.9 m -112.68 129.77 56.28 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-N 116.341 -0.39 . . . . 0.0 110.677 179.914 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' D' D ' 140' ' ' LEU . . . . . . . . . . . . . 19.5 tp -113.98 120.41 40.55 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 115.567 -0.742 . . . . 0.0 109.462 -178.241 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' D' D ' 141' ' ' ILE . . . . . . . . . . . . . 20.1 mt -120.3 119.49 60.07 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.281 0 CA-C-O 121.193 0.52 . . . . 0.0 109.93 -177.589 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' D' D ' 142' ' ' ARG . . . . . . . . . . . . . 84.6 mtm180 -111.17 133.29 53.64 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 114.941 -1.027 . . . . 0.0 110.689 -174.699 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' D' D ' 143' ' ' THR . . . . . . . . . . . . . 48.7 p . . . . . 0 C--O 1.22 -0.465 0 CA-C-O 118.03 -0.986 . . . . 0.0 110.371 179.588 . . . . . . . . 0 0 . 1 . 003 nuclear orig core ' E' E ' 2' ' ' SER . . . . . . . . . . . . . 15.9 p . . . . . 0 N--CA 1.461 0.084 0 CA-C-O 120.92 0.391 . . . . 0.0 110.949 . . . . . . . . . 0 0 . 1 . 003 nuclear orig core ' E' E ' 3' ' ' GLU . . . . . . . . . . . . . 95.7 mt-10 -140.61 139.33 34.88 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 115.992 -0.549 . . . . 0.0 110.927 -179.864 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' E' E ' 4' ' ' LEU . . . . . . . . . . . . . 17.4 tp -122.94 126.76 47.84 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-N 116.071 -0.513 . . . . 0.0 110.155 176.533 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' E' E ' 5' ' ' LYS . . . . . . . . . . . . . 86.4 mttt -106.96 121.6 44.76 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.3 -0.409 . . . . 0.0 110.711 179.024 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' E' E ' 6' ' ' LEU . . . . . . . . . . . . . 75.9 mt -116.78 151.3 36.74 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 115.46 -0.791 . . . . 0.0 110.58 -179.394 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' E' E ' 7' ' ' LYS . . . . . . . . . . . . . 33.9 ttpt -140.32 142.14 28.58 Favored Pre-proline 0 CA--C 1.534 0.338 0 N-CA-C 109.764 -0.458 . . . . 0.0 109.764 175.088 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' E' E ' 8' ' ' PRO . . . . . . . . . . . . . 92.2 Cg_endo -89.03 147.91 5.6 Favored 'Trans proline' 0 N--CA 1.491 1.372 0 C-N-CA 121.654 1.569 . . . . 0.0 112.024 -179.896 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' E' E ' 9' ' ' LEU . . . . . . . . . . . . . 84.3 mt -84.23 -52.07 0.56 Allowed Pre-proline 0 C--N 1.329 -0.284 0 CA-C-O 118.855 -0.593 . . . . 0.0 111.551 -179.94 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' E' E ' 10' ' ' PRO . . . . . . . . . . . . . 61.6 Cg_endo -73.43 155.66 50.56 Favored 'Trans proline' 0 N--CA 1.498 1.762 0 C-N-CA 121.093 1.196 . . . . 0.0 111.898 173.469 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' E' E ' 11' ' ' LYS . . . . . . . . . . . . . 62.1 mtpt -89.07 98.93 12.04 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.433 -0.349 . . . . 0.0 110.749 179.207 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' E' E ' 12' ' ' VAL . . . . . . . . . . . . . 12.6 p -142.68 142.58 26.5 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.288 0 CA-C-N 116.335 -0.393 . . . . 0.0 110.667 179.809 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' E' E ' 13' ' ' GLU . . . . . . . . . . . . . 45.1 mp0 -84.74 128.28 34.53 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 116.267 -0.424 . . . . 0.0 109.86 176.754 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' E' E ' 14' ' ' LEU . . . . . . . . . . . . . 32.3 mt -98.5 148.99 35.29 Favored Pre-proline 0 CA--C 1.533 0.293 0 CA-C-O 119.197 -0.43 . . . . 0.0 110.499 -177.585 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' E' E ' 15' ' ' PRO . . . . . . . . . . . . . 26.3 Cg_exo -62.37 159.96 33.44 Favored 'Trans proline' 0 N--CA 1.497 1.71 0 C-N-CA 121.245 1.296 . . . . 0.0 111.478 174.869 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' E' E ' 16' ' ' PRO . . . . . . . . . . . . . 38.6 Cg_exo -58.68 -34.34 98.86 Favored 'Trans proline' 0 N--CA 1.496 1.666 0 C-N-CA 121.413 1.409 . . . . 0.0 112.899 -178.32 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' E' E ' 17' ' ' ASP . . . . . . . . . . . . . 22.9 p-10 -91.4 8.43 36.3 Favored 'General case' 0 CA--C 1.534 0.362 0 N-CA-C 113.341 0.867 . . . . 0.0 113.341 -177.193 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' E' E ' 18' ' ' PHE . . . . . . . . . . . . . 52.3 t80 -58.19 -43.85 87.77 Favored 'General case' 0 N--CA 1.457 -0.093 0 O-C-N 121.944 -0.472 . . . . 0.0 110.058 -178.162 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' E' E ' 19' ' ' VAL . . . . . . . . . . . . . 48.7 t -58.17 -42.52 83.51 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.304 0 CA-C-N 116.207 -0.452 . . . . 0.0 110.234 -178.909 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' E' E ' 20' ' ' ASP . . . . . . . . . . . . . 7.5 t70 -59.92 -42.09 93.15 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-O 120.833 0.349 . . . . 0.0 110.83 -177.92 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' E' E ' 21' ' ' VAL . . . . . . . . . . . . . 48.3 t -64.73 -46.18 92.94 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.332 0 CA-C-N 116.405 -0.361 . . . . 0.0 110.483 -177.723 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' E' E ' 22' ' ' ILE . . . . . . . . . . . . . 29.3 mm -57.0 -45.13 83.74 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.257 0 N-CA-C 110.172 -0.307 . . . . 0.0 110.172 179.266 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' E' E ' 23' ' ' ARG . . . . . . . . . . . . . 2.3 tmm_? -54.39 -48.77 71.18 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-O 120.573 0.225 . . . . 0.0 111.246 -178.935 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' E' E ' 24' ' ' ILE . . . . . . . . . . . . . 72.8 mt -59.02 -42.98 87.91 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.316 0 C-N-CA 120.943 -0.303 . . . . 0.0 110.963 -177.828 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' E' E ' 25' ' ' LYS . . . . . . . . . . . . . 96.2 mttt -66.34 -41.7 89.21 Favored 'General case' 0 C--N 1.329 -0.293 0 N-CA-C 112.759 0.652 . . . . 0.0 112.759 -178.874 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' E' E ' 26' ' ' LEU . . . . . . . . . . . . . 48.6 mt -78.48 -37.31 43.65 Favored 'General case' 0 C--N 1.327 -0.372 0 N-CA-C 113.689 0.996 . . . . 0.0 113.689 -169.812 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' E' E ' 27' ' ' GLN . . . . . . . . . . . . . 10.4 pt20 -47.23 138.85 6.7 Favored 'General case' 0 N--CA 1.467 0.422 0 N-CA-C 112.765 0.654 . . . . 0.0 112.765 -175.261 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' E' E ' 28' ' ' GLY . . . . . . . . . . . . . . . 101.17 -24.53 31.52 Favored Glycine 0 CA--C 1.532 1.139 0 CA-C-N 115.552 -0.749 . . . . 0.0 112.405 -177.182 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' E' E ' 29' ' ' LYS . . . . . . . . . . . . . 86.5 mttt -98.4 155.06 17.42 Favored 'General case' 0 C--O 1.233 0.198 0 CA-C-N 117.594 0.697 . . . . 0.0 111.381 179.376 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' E' E ' 30' ' ' THR . . . . . . . . . . . . . 30.5 m -104.39 136.7 43.49 Favored 'General case' 0 C--N 1.331 -0.226 0 CA-C-N 116.011 -0.54 . . . . 0.0 110.268 177.42 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' E' E ' 31' ' ' VAL . . . . . . . . . . . . . 35.0 m -132.29 157.06 43.0 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.329 0 CA-C-N 116.327 -0.397 . . . . 0.0 110.831 -179.123 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' E' E ' 32' ' ' ARG . . . . . . . . . . . . . 96.9 mtt180 -132.12 154.84 49.08 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 115.954 -0.566 . . . . 0.0 110.44 176.673 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' E' E ' 33' ' ' THR . . . . . . . . . . . . . 29.1 m -53.53 138.13 34.71 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.307 -0.406 . . . . 0.0 111.279 -178.978 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' E' E ' 34' ' ' GLY . . . . . . . . . . . . . . . 100.16 -17.11 57.51 Favored Glycine 0 CA--C 1.532 1.107 0 CA-C-O 119.616 -0.547 . . . . 0.0 113.295 178.744 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' E' E ' 35' ' ' ASP . . . . . . . . . . . . . 54.1 m-20 -65.37 150.18 48.73 Favored 'General case' 0 C--N 1.334 -0.077 0 CA-C-N 118.019 0.909 . . . . 0.0 111.137 179.818 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' E' E ' 36' ' ' VAL . . . . . . . . . . . . . 44.6 t -121.56 130.0 75.02 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.233 0 CA-C-N 115.67 -0.696 . . . . 0.0 109.76 178.536 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' E' E ' 37' ' ' ILE . . . . . . . . . . . . . 69.7 mt -119.31 138.66 49.27 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.29 0 CA-C-N 116.275 -0.421 . . . . 0.0 109.923 -179.636 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' E' E ' 38' ' ' GLY . . . . . . . . . . . . . . . -112.27 128.95 8.77 Favored Glycine 0 CA--C 1.526 0.77 0 N-CA-C 111.086 -0.806 . . . . 0.0 111.086 -179.505 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' E' E ' 39' ' ' ILE . . . . . . . . . . . . . 71.1 mt -122.03 134.14 66.21 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.275 0 N-CA-C 109.899 -0.408 . . . . 0.0 109.899 178.895 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' E' E ' 40' ' ' SER . . . . . . . . . . . . . 53.8 p -93.39 122.71 36.08 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.323 -0.398 . . . . 0.0 110.857 175.509 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' E' E ' 41' ' ' ILE . . . . . . . . . . . . . 71.4 mt -131.85 114.37 24.57 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.225 0 N-CA-C 110.021 -0.363 . . . . 0.0 110.021 177.678 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' E' E ' 42' ' ' LEU . . . . . . . . . . . . . 7.9 mp 56.6 37.57 28.92 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-O 121.086 0.47 . . . . 0.0 111.074 -179.707 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' E' E ' 43' ' ' GLY . . . . . . . . . . . . . . . 77.42 -10.08 24.53 Favored Glycine 0 CA--C 1.534 1.219 0 C-N-CA 121.296 -0.478 . . . . 0.0 113.473 177.043 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' E' E ' 44' ' ' LYS . . . . . . . . . . . . . 68.7 mttm -93.99 132.97 37.93 Favored 'General case' 0 C--N 1.333 -0.121 0 CA-C-N 118.005 0.903 . . . . 0.0 110.069 178.093 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' E' E ' 45' ' ' GLU . . . . . . . . . . . . . 69.3 tt0 -86.46 127.28 34.83 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.172 -0.467 . . . . 0.0 111.04 -177.816 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' E' E ' 46' ' ' VAL . . . . . . . . . . . . . 7.2 p -124.84 128.13 73.04 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.198 0 CA-C-O 120.943 0.401 . . . . 0.0 109.98 176.627 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' E' E ' 47' ' ' LYS . . . . . . . . . . . . . 72.6 mmtt -100.08 133.91 43.78 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-N 115.972 -0.558 . . . . 0.0 111.525 177.631 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' E' E ' 48' ' ' PHE . . . . . . . . . . . . . 91.1 m-85 -116.34 131.98 56.79 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 115.907 -0.588 . . . . 0.0 109.782 174.046 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' E' E ' 49' ' ' LYS . . . . . . . . . . . . . 82.4 tttt -105.73 136.34 45.53 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.488 -0.324 . . . . 0.0 110.527 -179.927 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' E' E ' 50' ' ' VAL . . . . . . . . . . . . . 45.0 t -80.53 108.67 14.16 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.331 0 N-CA-C 109.196 -0.668 . . . . 0.0 109.196 176.089 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' E' E ' 51' ' ' VAL . . . . . . . . . . . . . 47.5 t -74.63 -47.21 39.75 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.289 0 CA-C-N 116.139 -0.482 . . . . 0.0 110.174 -172.968 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' E' E ' 52' ' ' GLN . . . . . . . . . . . . . 48.2 tt0 -164.85 138.49 4.9 Favored 'General case' 0 C--N 1.331 -0.236 0 C-N-CA 120.155 -0.618 . . . . 0.0 111.749 -177.954 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' E' E ' 53' ' ' ALA . . . . . . . . . . . . . . . -116.46 133.6 55.82 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 115.9 -0.591 . . . . 0.0 110.169 176.835 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' E' E ' 54' ' ' TYR . . . . . . . . . . . . . 38.5 t80 -129.13 112.47 18.4 Favored Pre-proline 0 CA--C 1.535 0.398 0 CA-C-O 118.154 -0.927 . . . . 0.0 110.171 177.607 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' E' E ' 55' ' ' PRO . . . . . . . . . . . . . 72.2 Cg_endo -77.09 168.72 76.23 Favored 'Cis proline' 0 N--CA 1.5 1.904 0 CA-C-N 122.082 1.779 . . . . 0.0 112.426 -5.346 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' E' E ' 56' ' ' SER . . . . . . . . . . . . . 13.6 m -117.57 134.08 23.21 Favored Pre-proline 0 CA--C 1.54 0.562 0 CA-C-O 118.455 -0.783 . . . . 0.0 109.595 174.764 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' E' E ' 57' ' ' PRO . . . . . . . . . . . . . 36.0 Cg_endo -66.36 164.7 65.68 Favored 'Cis proline' 0 N--CA 1.498 1.751 0 CA-C-N 121.862 1.701 . . . . 0.0 111.299 -3.177 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' E' E ' 58' ' ' LEU . . . . . . . . . . . . . 23.4 tp -129.96 138.82 51.06 Favored 'General case' 0 C--N 1.331 -0.222 0 CA-C-O 121.081 0.467 . . . . 0.0 110.584 179.61 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' E' E ' 59' ' ' ARG . . . . . . . . . . . . . 75.1 ttt180 -106.06 123.31 47.8 Favored 'General case' 0 C--N 1.329 -0.295 0 N-CA-C 109.084 -0.71 . . . . 0.0 109.084 174.115 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' E' E ' 60' ' ' VAL . . . . . . . . . . . . . 44.3 t -73.52 118.95 19.69 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.351 0 C-N-CA 120.735 -0.386 . . . . 0.0 110.166 -175.198 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' E' E ' 61' ' ' GLU . . . . . . . . . . . . . 95.0 mt-10 -131.05 162.43 29.84 Favored 'General case' 0 C--N 1.331 -0.222 0 CA-C-N 116.107 -0.497 . . . . 0.0 110.109 178.455 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' E' E ' 62' ' ' ASP . . . . . . . . . . . . . 65.2 m-20 -53.57 -32.84 52.58 Favored 'General case' 0 C--N 1.326 -0.427 0 N-CA-C 111.751 0.278 . . . . 0.0 111.751 -178.898 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' E' E ' 63' ' ' ARG . . . . . . . . . . . . . 27.6 mmm180 -72.69 -21.35 61.07 Favored 'General case' 0 C--N 1.33 -0.267 0 N-CA-C 113.054 0.761 . . . . 0.0 113.054 -176.159 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' E' E ' 64' ' ' THR . . . . . . . . . . . . . 29.6 m -72.56 139.37 47.47 Favored 'General case' 0 C--N 1.331 -0.21 0 CA-C-O 120.869 0.366 . . . . 0.0 111.183 -174.409 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' E' E ' 65' ' ' LYS . . . . . . . . . . . . . 13.1 mptt -89.04 134.34 34.03 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.009 -0.541 . . . . 0.0 109.982 178.68 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' E' E ' 66' ' ' ILE . . . . . . . . . . . . . 64.4 mt -116.96 131.75 68.72 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.326 0 CA-C-O 120.885 0.374 . . . . 0.0 110.076 -179.772 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' E' E ' 67' ' ' THR . . . . . . . . . . . . . 32.5 m -127.6 140.44 52.1 Favored 'General case' 0 C--N 1.332 -0.19 0 CA-C-N 116.047 -0.524 . . . . 0.0 110.821 -178.559 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' E' E ' 68' ' ' LEU . . . . . . . . . . . . . 5.0 tt . . . . . 0 C--N 1.33 -0.243 0 CA-C-N 115.994 -0.548 . . . . 0.0 109.649 177.044 . . . . . . . . 0 0 . 1 . 003 nuclear orig core ' E' E ' 73' ' ' VAL . . . . . . . . . . . . . 33.9 m . . . . . 0 C--O 1.232 0.149 0 CA-C-O 120.866 0.365 . . . . 0.0 110.41 . . . . . . . . . 0 0 . 1 . 003 nuclear orig core ' E' E ' 74' ' ' ASP . . . . . . . . . . . . . 7.3 t0 -95.34 126.44 40.65 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.009 -0.542 . . . . 0.0 110.228 -176.924 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' E' E ' 75' ' ' VAL . . . . . . . . . . . . . 40.4 t -119.17 123.79 71.96 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.205 0 CA-C-O 121.025 0.44 . . . . 0.0 110.583 -178.514 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' E' E ' 76' ' ' LEU . . . . . . . . . . . . . 6.3 mp -123.94 146.24 48.6 Favored 'General case' 0 C--N 1.331 -0.224 0 CA-C-N 115.828 -0.624 . . . . 0.0 109.908 176.195 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' E' E ' 77' ' ' GLU . . . . . . . . . . . . . 45.9 mt-10 -135.69 136.86 41.22 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-O 121.011 0.434 . . . . 0.0 111.22 -178.883 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' E' E ' 78' ' ' ALA . . . . . . . . . . . . . . . -125.95 133.44 51.83 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 115.816 -0.629 . . . . 0.0 109.674 176.145 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' E' E ' 79' ' ' LYS . . . . . . . . . . . . . 84.0 mttt -80.51 120.3 24.31 Favored 'General case' 0 C--N 1.331 -0.215 0 CA-C-O 121.091 0.472 . . . . 0.0 110.754 -178.199 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' E' E ' 80' ' ' ILE . . . . . . . . . . . . . 43.1 mm -139.18 108.68 3.86 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.335 0 N-CA-C 108.961 -0.755 . . . . 0.0 108.961 -176.991 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' E' E ' 81' ' ' LYS . . . . . . . . . . . . . 68.8 mttm -97.84 126.73 43.36 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-O 120.877 0.37 . . . . 0.0 111.199 -176.265 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' E' E ' 82' ' ' GLY . . . . . . . . . . . . . . . 89.08 42.14 5.69 Favored Glycine 0 CA--C 1.527 0.791 0 C-N-CA 120.911 -0.662 . . . . 0.0 111.725 174.992 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' E' E ' 83' ' ' ILE . . . . . . . . . . . . . 75.5 mt -66.83 138.52 22.75 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.314 0 CA-C-O 120.945 0.402 . . . . 0.0 109.94 178.34 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' E' E ' 84' ' ' LYS . . . . . . . . . . . . . 83.8 tttt -99.22 -53.97 3.09 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 115.989 -0.55 . . . . 0.0 110.34 -178.815 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' E' E ' 85' ' ' ASP . . . . . . . . . . . . . 5.9 t0 -154.69 151.4 28.71 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-N 115.746 -0.661 . . . . 0.0 110.044 -178.943 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' E' E ' 86' ' ' VAL . . . . . . . . . . . . . 42.8 t -131.9 130.77 61.7 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.233 0 CA-C-O 120.961 0.41 . . . . 0.0 110.537 -179.181 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' E' E ' 87' ' ' ILE . . . . . . . . . . . . . 44.5 mm -119.04 128.89 75.78 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.221 0 CA-C-N 115.863 -0.608 . . . . 0.0 109.705 177.011 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' E' E ' 88' ' ' LEU . . . . . . . . . . . . . 27.5 mt -114.54 139.33 49.67 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-O 121.151 0.501 . . . . 0.0 111.463 -177.635 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' E' E ' 89' ' ' ASP . . . . . . . . . . . . . 11.6 t70 -132.96 156.83 46.56 Favored 'General case' 0 C--N 1.331 -0.23 0 CA-C-N 115.517 -0.765 . . . . 0.0 109.388 175.39 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' E' E ' 90' ' ' GLU . . . . . . . . . . . . . 96.0 mt-10 -48.44 -38.52 20.0 Favored 'General case' 0 C--N 1.327 -0.371 0 N-CA-C 112.796 0.665 . . . . 0.0 112.796 -171.507 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' E' E ' 91' ' ' ASN . . . . . . . . . . . . . 33.5 m120 -132.11 34.73 3.77 Favored 'General case' 0 N--CA 1.465 0.278 0 C-N-CA 120.961 -0.296 . . . . 0.0 111.703 -176.494 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' E' E ' 92' ' ' LEU . . . . . . . . . . . . . 9.7 tp -166.16 145.55 6.02 Favored 'General case' 0 C--N 1.33 -0.258 0 C-N-CA 120.885 -0.326 . . . . 0.0 110.717 -179.66 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' E' E ' 93' ' ' ILE . . . . . . . . . . . . . 67.7 mt -127.79 125.96 65.98 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.222 0 N-CA-C 109.711 -0.477 . . . . 0.0 109.711 178.989 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' E' E ' 94' ' ' VAL . . . . . . . . . . . . . 47.1 t -122.99 127.14 74.62 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.267 0 N-CA-C 109.797 -0.446 . . . . 0.0 109.797 178.868 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' E' E ' 95' ' ' VAL . . . . . . . . . . . . . 44.2 t -122.93 135.38 63.18 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.294 0 CA-C-N 116.328 -0.396 . . . . 0.0 110.061 -179.252 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' E' E ' 96' ' ' ILE . . . . . . . . . . . . . 61.9 mt -116.31 128.75 73.54 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.326 0 N-CA-C 109.304 -0.628 . . . . 0.0 109.304 179.341 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' E' E ' 97' ' ' THR . . . . . . . . . . . . . 75.7 p -101.67 157.09 17.08 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-O 121.191 0.52 . . . . 0.0 111.371 -177.353 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' E' E ' 98' ' ' GLU . . . . . . . . . . . . . 84.6 tt0 -53.99 -26.66 27.14 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-N 116.008 -0.542 . . . . 0.0 112.133 -179.793 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' E' E ' 99' ' ' GLU . . . . . . . . . . . . . 45.7 mp0 -79.14 16.25 0.99 Allowed 'General case' 0 CA--C 1.536 0.426 0 N-CA-C 113.013 0.746 . . . . 0.0 113.013 -177.931 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' E' E ' 100' ' ' ASN . . . . . . . . . . . . . 3.8 m-20 62.95 38.08 11.44 Favored 'General case' 0 C--O 1.233 0.186 0 CA-C-O 120.952 0.406 . . . . 0.0 110.939 177.397 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' E' E ' 101' ' ' GLU . . . . . . . . . . . . . 84.5 tt0 -116.49 142.5 46.78 Favored 'General case' 0 C--N 1.331 -0.221 0 CA-C-N 116.078 -0.51 . . . . 0.0 109.801 177.124 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' E' E ' 102' ' ' VAL . . . . . . . . . . . . . 46.4 t -115.12 126.46 72.71 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.22 0 N-CA-C 109.87 -0.419 . . . . 0.0 109.87 -178.615 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' E' E ' 103' ' ' LEU . . . . . . . . . . . . . 42.5 mt -118.29 133.43 55.9 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-N 115.692 -0.685 . . . . 0.0 110.249 177.098 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' E' E ' 104' ' ' ILE . . . . . . . . . . . . . 68.5 mt -118.1 123.36 71.53 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.316 0 N-CA-C 109.986 -0.375 . . . . 0.0 109.986 179.632 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' E' E ' 105' ' ' PHE . . . . . . . . . . . . . 75.4 m-85 -122.43 165.69 15.94 Favored 'General case' 0 C--N 1.332 -0.157 0 O-C-N 124.047 0.842 . . . . 0.0 109.607 -179.964 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' E' E ' 106' ' ' ASN . . . . . . . . . . . . . 50.5 p-10 -101.54 -171.23 1.95 Allowed 'General case' 0 C--N 1.331 -0.204 0 N-CA-C 110.002 -0.37 . . . . 0.0 110.002 174.996 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' E' E ' 107' ' ' GLN . . . . . . . . . . . . . 45.8 tt0 -59.13 -29.3 67.29 Favored 'General case' 0 C--N 1.329 -0.3 0 N-CA-C 112.003 0.372 . . . . 0.0 112.003 -179.733 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' E' E ' 108' ' ' ASN . . . . . . . . . . . . . 14.4 t-20 -84.55 10.48 10.89 Favored 'General case' 0 CA--C 1.536 0.42 0 N-CA-C 113.035 0.754 . . . . 0.0 113.035 -177.508 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' E' E ' 109' ' ' LEU . . . . . . . . . . . . . 8.7 tp 58.33 36.77 25.79 Favored 'General case' 0 CA--C 1.531 0.226 0 CA-C-O 121.046 0.45 . . . . 0.0 111.373 179.711 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' E' E ' 110' ' ' GLU . . . . . . . . . . . . . 43.4 mt-10 -103.65 152.84 21.31 Favored 'General case' 0 C--N 1.33 -0.244 0 N-CA-C 109.662 -0.496 . . . . 0.0 109.662 175.676 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' E' E ' 111' ' ' GLU . . . . . . . . . . . . . 58.9 tt0 -87.29 121.91 30.36 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-O 120.914 0.387 . . . . 0.0 110.763 -176.315 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' E' E ' 112' ' ' LEU . . . . . . . . . . . . . 13.8 mt -105.18 -46.06 4.34 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 115.978 -0.556 . . . . 0.0 110.834 -179.895 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' E' E ' 113' ' ' TYR . . . . . . . . . . . . . 65.3 t80 -139.91 143.75 36.79 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.299 -0.41 . . . . 0.0 111.221 -178.431 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' E' E ' 114' ' ' ARG . . . . . . . . . . . . . 38.8 ptt180 -144.55 123.28 12.59 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.096 -0.502 . . . . 0.0 110.796 178.128 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' E' E ' 115' ' ' GLY . . . . . . . . . . . . . . . -150.13 158.81 27.84 Favored Glycine 0 CA--C 1.525 0.703 0 N-CA-C 110.934 -0.866 . . . . 0.0 110.934 178.205 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' E' E ' 116' ' ' LYS . . . . . . . . . . . . . 37.4 ttpt -127.87 139.01 52.88 Favored 'General case' 0 C--N 1.331 -0.224 0 O-C-N 122.634 -0.333 . . . . 0.0 110.29 178.118 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' E' E ' 117' ' ' PHE . . . . . . . . . . . . . 39.8 m-85 -133.75 114.96 13.99 Favored 'General case' 0 C--N 1.329 -0.296 0 N-CA-C 110.0 -0.37 . . . . 0.0 110.0 -178.153 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' E' E ' 118' ' ' GLU . . . . . . . . . . . . . 84.3 tt0 -53.57 -43.2 68.33 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.64 -0.255 . . . . 0.0 111.542 -175.97 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' E' E ' 119' ' ' ASN . . . . . . . . . . . . . 82.3 m-20 -100.17 31.0 3.53 Favored 'General case' 0 C--N 1.33 -0.24 0 N-CA-C 112.154 0.428 . . . . 0.0 112.154 -174.185 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' E' E ' 120' ' ' LEU . . . . . . . . . . . . . 13.9 tp -54.97 121.04 7.82 Favored 'General case' 0 C--N 1.331 -0.207 0 CA-C-O 120.663 0.268 . . . . 0.0 110.745 178.716 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' E' E ' 121' ' ' ASN . . . . . . . . . . . . . 46.1 t30 -114.03 -43.93 3.2 Favored 'General case' 0 C--O 1.232 0.167 0 CA-C-N 116.598 -0.273 . . . . 0.0 111.516 -176.184 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' E' E ' 122' ' ' LYS . . . . . . . . . . . . . 57.9 mtpt -140.08 144.55 36.88 Favored 'General case' 0 C--N 1.332 -0.159 0 CA-C-O 120.938 0.399 . . . . 0.0 111.741 -176.084 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' E' E ' 123' ' ' VAL . . . . . . . . . . . . . 46.7 t -127.1 124.9 65.34 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 N-CA-C 109.381 -0.6 . . . . 0.0 109.381 174.078 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' E' E ' 124' ' ' LEU . . . . . . . . . . . . . 51.6 mt -126.73 139.32 53.23 Favored 'General case' 0 C--N 1.331 -0.201 0 CA-C-O 120.95 0.405 . . . . 0.0 110.967 -177.186 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' E' E ' 125' ' ' VAL . . . . . . . . . . . . . 34.9 m -132.01 139.03 51.28 Favored 'Isoleucine or valine' 0 C--N 1.333 -0.145 0 CA-C-N 116.017 -0.538 . . . . 0.0 110.911 -179.871 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' E' E ' 126' ' ' ARG . . . . . . . . . . . . . 77.1 mtp85 -140.52 109.41 6.04 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 115.958 -0.565 . . . . 0.0 110.29 175.422 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' E' E ' 127' ' ' ASN . . . . . . . . . . . . . 94.5 m-20 53.32 -104.9 0.22 Allowed 'General case' 0 CA--C 1.542 0.663 0 CA-C-O 119.067 -0.492 . . . . 0.0 111.136 -179.897 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' E' E ' 128' ' ' ASP . . . . . . . . . . . . . 14.6 p-10 -113.69 5.41 16.44 Favored 'General case' 0 CA--C 1.537 0.447 0 CA-C-N 119.496 1.044 . . . . 0.0 113.393 -177.334 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' E' E ' 129' ' ' LEU . . . . . . . . . . . . . 3.9 tt -105.11 131.51 52.51 Favored 'General case' 0 C--N 1.332 -0.154 0 N-CA-C 109.367 -0.605 . . . . 0.0 109.367 177.809 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' E' E ' 130' ' ' VAL . . . . . . . . . . . . . 44.2 t -120.6 137.05 55.64 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.218 0 CA-C-O 120.765 0.317 . . . . 0.0 110.165 -177.236 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' E' E ' 131' ' ' VAL . . . . . . . . . . . . . 41.8 t -135.95 138.07 48.0 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.249 0 CA-C-O 121.203 0.525 . . . . 0.0 110.459 178.926 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' E' E ' 132' ' ' ILE . . . . . . . . . . . . . 76.4 mt -119.93 134.0 64.87 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.324 0 CA-C-N 115.513 -0.767 . . . . 0.0 109.51 -179.739 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' E' E ' 133' ' ' ILE . . . . . . . . . . . . . 42.8 mm -117.21 125.32 73.89 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.23 0 CA-C-O 120.798 0.332 . . . . 0.0 110.865 -176.142 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' E' E ' 134' ' ' ASP . . . . . . . . . . . . . 7.7 p-10 -137.03 148.72 47.0 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.0 -0.545 . . . . 0.0 109.568 174.187 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' E' E ' 135' ' ' GLU . . . . . . . . . . . . . 43.5 tp10 -49.81 -25.88 3.48 Favored 'General case' 0 C--N 1.327 -0.377 0 N-CA-C 112.792 0.664 . . . . 0.0 112.792 -171.585 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' E' E ' 136' ' ' GLN . . . . . . . . . . . . . 97.3 mt-30 -96.5 -33.06 11.98 Favored 'General case' 0 CA--C 1.53 0.178 0 N-CA-C 112.476 0.547 . . . . 0.0 112.476 -175.995 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' E' E ' 137' ' ' LYS . . . . . . . . . . . . . 84.5 mttt -141.37 154.56 45.72 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-O 121.233 0.54 . . . . 0.0 111.697 -168.427 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' E' E ' 138' ' ' LEU . . . . . . . . . . . . . 4.5 tt -117.56 119.68 35.74 Favored 'General case' 0 C--N 1.33 -0.246 0 N-CA-C 108.965 -0.754 . . . . 0.0 108.965 171.071 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' E' E ' 139' ' ' THR . . . . . . . . . . . . . 25.3 m -106.05 128.8 54.1 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.454 -0.339 . . . . 0.0 110.712 -176.53 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' E' E ' 140' ' ' LEU . . . . . . . . . . . . . 5.4 tt -116.56 122.85 45.88 Favored 'General case' 0 C--N 1.329 -0.322 0 N-CA-C 109.068 -0.716 . . . . 0.0 109.068 -179.221 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' E' E ' 141' ' ' ILE . . . . . . . . . . . . . 18.9 mt -121.99 118.79 56.69 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.288 0 CA-C-O 121.025 0.44 . . . . 0.0 109.981 -176.757 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' E' E ' 142' ' ' ARG . . . . . . . . . . . . . 84.4 mtp180 -103.7 125.27 50.08 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 115.285 -0.871 . . . . 0.0 110.341 -179.576 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' E' E ' 143' ' ' THR . . . . . . . . . . . . . 43.2 p . . . . . 0 C--O 1.22 -0.472 0 CA-C-O 118.015 -0.993 . . . . 0.0 110.527 -179.781 . . . . . . . . 0 0 . 1 . 003 nuclear orig core ' F' F ' 1' ' ' MET . . . . . . . . . . . . . 27.3 ptm . . . . . 0 C--O 1.232 0.15 0 CA-C-O 120.903 0.383 . . . . 0.0 110.564 . . . . . . . . . 0 0 . 1 . 003 nuclear orig core ' F' F ' 2' ' ' SER . . . . . . . . . . . . . 4.5 p -117.78 130.1 56.09 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.135 177.686 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' F' F ' 3' ' ' GLU . . . . . . . . . . . . . 83.3 tt0 -142.08 137.74 31.23 Favored 'General case' 0 C--N 1.327 -0.4 0 CA-C-N 115.988 -0.551 . . . . 0.0 111.062 -177.928 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' F' F ' 4' ' ' LEU . . . . . . . . . . . . . 17.1 tp -124.54 131.1 53.49 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.059 176.816 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' F' F ' 5' ' ' LYS . . . . . . . . . . . . . 69.0 mttm -110.28 122.29 47.3 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.305 -0.407 . . . . 0.0 110.602 179.962 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' F' F ' 6' ' ' LEU . . . . . . . . . . . . . 30.3 mt -113.88 149.44 35.12 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 115.234 -0.893 . . . . 0.0 109.954 -178.895 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' F' F ' 7' ' ' LYS . . . . . . . . . . . . . 52.4 tttp -137.11 137.15 22.03 Favored Pre-proline 0 CA--C 1.534 0.34 0 CA-C-O 118.857 -0.592 . . . . 0.0 109.994 175.569 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' F' F ' 8' ' ' PRO . . . . . . . . . . . . . 74.3 Cg_endo -91.45 138.41 2.18 Favored 'Trans proline' 0 N--CA 1.49 1.276 0 C-N-CA 121.675 1.583 . . . . 0.0 111.708 177.259 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' F' F ' 9' ' ' LEU . . . . . . . . . . . . . 58.1 mt -74.78 -48.18 4.92 Favored Pre-proline 0 CA--C 1.534 0.336 0 CA-C-O 118.629 -0.7 . . . . 0.0 112.277 -178.881 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' F' F ' 10' ' ' PRO . . . . . . . . . . . . . 95.3 Cg_endo -78.79 156.8 27.6 Favored 'Trans proline' 0 N--CA 1.496 1.653 0 C-N-CA 121.081 1.187 . . . . 0.0 112.008 177.381 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' F' F ' 11' ' ' LYS . . . . . . . . . . . . . 81.8 tttt -87.92 101.76 14.06 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.396 -0.365 . . . . 0.0 110.266 179.32 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' F' F ' 12' ' ' VAL . . . . . . . . . . . . . 12.3 p -143.57 149.3 18.2 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.295 0 CA-C-N 116.2 -0.454 . . . . 0.0 110.744 -178.313 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' F' F ' 13' ' ' GLU . . . . . . . . . . . . . 84.0 tt0 -91.43 127.6 36.94 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.302 -0.408 . . . . 0.0 109.989 177.598 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' F' F ' 14' ' ' LEU . . . . . . . . . . . . . 29.9 mt -98.83 146.04 30.97 Favored Pre-proline 0 CA--C 1.534 0.333 0 CA-C-O 119.183 -0.437 . . . . 0.0 110.632 -177.711 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' F' F ' 15' ' ' PRO . . . . . . . . . . . . . 23.8 Cg_exo -64.44 158.61 48.44 Favored 'Trans proline' 0 N--CA 1.497 1.707 0 C-N-CA 121.401 1.4 . . . . 0.0 111.777 174.309 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' F' F ' 16' ' ' PRO . . . . . . . . . . . . . 37.8 Cg_exo -57.98 -43.51 47.93 Favored 'Trans proline' 0 N--CA 1.496 1.648 0 C-N-CA 121.477 1.451 . . . . 0.0 112.97 -177.834 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' F' F ' 17' ' ' ASP . . . . . . . . . . . . . 23.2 p-10 -82.42 7.73 13.41 Favored 'General case' 0 CA--C 1.536 0.429 0 N-CA-C 113.252 0.834 . . . . 0.0 113.252 -177.615 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' F' F ' 18' ' ' PHE . . . . . . . . . . . . . 45.7 t80 -58.05 -45.11 87.57 Favored 'General case' 0 N--CA 1.458 -0.069 0 O-C-N 121.996 -0.44 . . . . 0.0 110.183 -178.179 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' F' F ' 19' ' ' VAL . . . . . . . . . . . . . 14.4 p -56.98 -41.96 78.12 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.35 0 CA-C-N 116.34 -0.391 . . . . 0.0 110.935 -178.585 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' F' F ' 20' ' ' ASP . . . . . . . . . . . . . 67.6 m-20 -60.85 -42.13 97.23 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-O 120.884 0.373 . . . . 0.0 110.9 -178.125 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' F' F ' 21' ' ' VAL . . . . . . . . . . . . . 52.9 t -64.36 -47.37 89.84 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.32 0 CA-C-N 116.374 -0.376 . . . . 0.0 110.353 -178.107 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' F' F ' 22' ' ' ILE . . . . . . . . . . . . . 51.0 mm -56.72 -43.49 79.47 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.283 0 CA-C-O 120.773 0.32 . . . . 0.0 110.479 178.764 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' F' F ' 23' ' ' ARG . . . . . . . . . . . . . 42.2 ttp180 -54.4 -49.12 70.66 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.632 -0.258 . . . . 0.0 111.432 -179.003 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' F' F ' 24' ' ' ILE . . . . . . . . . . . . . 73.4 mt -59.37 -43.72 90.88 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.284 0 C-N-CA 121.072 -0.251 . . . . 0.0 111.019 -178.071 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' F' F ' 25' ' ' LYS . . . . . . . . . . . . . 99.0 mttt -63.79 -41.8 97.87 Favored 'General case' 0 C--N 1.327 -0.382 0 N-CA-C 112.526 0.565 . . . . 0.0 112.526 -178.255 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' F' F ' 26' ' ' LEU . . . . . . . . . . . . . 93.3 mt -79.49 -41.64 26.98 Favored 'General case' 0 C--N 1.329 -0.318 0 N-CA-C 113.14 0.793 . . . . 0.0 113.14 -172.511 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' F' F ' 27' ' ' GLN . . . . . . . . . . . . . 9.5 pt20 -46.41 142.16 3.19 Favored 'General case' 0 N--CA 1.469 0.482 0 N-CA-C 112.9 0.704 . . . . 0.0 112.9 -173.581 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' F' F ' 28' ' ' GLY . . . . . . . . . . . . . . . 101.26 -29.85 11.64 Favored Glycine 0 CA--C 1.529 0.953 0 CA-C-N 115.15 -0.932 . . . . 0.0 111.941 -177.182 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' F' F ' 29' ' ' LYS . . . . . . . . . . . . . 93.3 mttt -98.62 155.18 17.43 Favored 'General case' 0 C--N 1.332 -0.173 0 CA-C-N 117.329 0.564 . . . . 0.0 111.129 177.981 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' F' F ' 30' ' ' THR . . . . . . . . . . . . . 34.8 m -102.58 138.91 38.86 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.163 -0.471 . . . . 0.0 110.063 176.657 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' F' F ' 31' ' ' VAL . . . . . . . . . . . . . 34.9 m -128.91 158.6 41.47 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.186 0 CA-C-N 116.413 -0.358 . . . . 0.0 110.808 -178.8 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' F' F ' 32' ' ' ARG . . . . . . . . . . . . . 96.9 mtt180 -130.79 151.74 50.89 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 115.922 -0.581 . . . . 0.0 110.5 178.735 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' F' F ' 33' ' ' THR . . . . . . . . . . . . . 18.4 m -53.97 138.78 36.13 Favored 'General case' 0 C--N 1.331 -0.239 0 CA-C-N 116.19 -0.459 . . . . 0.0 111.153 -179.519 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' F' F ' 34' ' ' GLY . . . . . . . . . . . . . . . 101.82 -17.12 55.29 Favored Glycine 0 CA--C 1.534 1.225 0 CA-C-O 119.618 -0.546 . . . . 0.0 113.191 -179.915 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' F' F ' 35' ' ' ASP . . . . . . . . . . . . . 56.7 m-20 -64.71 149.57 48.89 Favored 'General case' 0 C--O 1.232 0.14 0 CA-C-N 118.146 0.973 . . . . 0.0 111.29 179.434 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' F' F ' 36' ' ' VAL . . . . . . . . . . . . . 46.3 t -124.32 130.07 73.76 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.303 0 CA-C-N 115.698 -0.683 . . . . 0.0 109.845 179.565 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' F' F ' 37' ' ' ILE . . . . . . . . . . . . . 69.1 mt -121.97 139.42 49.05 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.219 0 CA-C-N 116.216 -0.447 . . . . 0.0 109.835 179.95 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' F' F ' 38' ' ' GLY . . . . . . . . . . . . . . . -114.41 128.88 8.41 Favored Glycine 0 CA--C 1.526 0.75 0 N-CA-C 110.943 -0.863 . . . . 0.0 110.943 -179.974 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' F' F ' 39' ' ' ILE . . . . . . . . . . . . . 70.8 mt -119.37 129.89 74.69 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.245 0 N-CA-C 109.929 -0.397 . . . . 0.0 109.929 179.059 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' F' F ' 40' ' ' SER . . . . . . . . . . . . . 22.8 t -93.74 118.9 32.03 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.437 -0.347 . . . . 0.0 110.788 175.732 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' F' F ' 41' ' ' ILE . . . . . . . . . . . . . 71.4 mt -124.76 117.06 49.2 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.269 0 CA-C-O 120.787 0.327 . . . . 0.0 110.315 178.808 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' F' F ' 42' ' ' LEU . . . . . . . . . . . . . 6.9 mp 51.04 36.93 16.52 Favored 'General case' 0 N--CA 1.463 0.21 0 CA-C-O 121.143 0.497 . . . . 0.0 111.548 178.17 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' F' F ' 43' ' ' GLY . . . . . . . . . . . . . . . 73.88 30.79 60.95 Favored Glycine 0 CA--C 1.529 0.941 0 C-N-CA 121.184 -0.531 . . . . 0.0 112.324 177.636 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' F' F ' 44' ' ' LYS . . . . . . . . . . . . . 64.1 mttp -132.5 127.21 34.71 Favored 'General case' 0 C--N 1.331 -0.233 0 N-CA-C 109.679 -0.489 . . . . 0.0 109.679 177.231 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' F' F ' 45' ' ' GLU . . . . . . . . . . . . . 80.2 tt0 -84.79 122.77 29.61 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-O 120.843 0.354 . . . . 0.0 111.215 -177.535 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' F' F ' 46' ' ' VAL . . . . . . . . . . . . . 7.6 p -122.2 126.45 74.34 Favored 'Isoleucine or valine' 0 C--O 1.233 0.186 0 N-CA-C 109.329 -0.619 . . . . 0.0 109.329 174.625 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' F' F ' 47' ' ' LYS . . . . . . . . . . . . . 93.7 mttt -100.33 130.48 46.44 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.123 -0.49 . . . . 0.0 111.342 179.871 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' F' F ' 48' ' ' PHE . . . . . . . . . . . . . 91.7 m-85 -114.21 131.79 56.34 Favored 'General case' 0 C--N 1.33 -0.267 0 N-CA-C 109.637 -0.505 . . . . 0.0 109.637 175.095 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' F' F ' 49' ' ' LYS . . . . . . . . . . . . . 37.2 tttp -109.38 139.9 43.76 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.452 -0.34 . . . . 0.0 110.542 179.846 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' F' F ' 50' ' ' VAL . . . . . . . . . . . . . 43.4 t -82.96 108.22 15.5 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.225 0 N-CA-C 109.267 -0.642 . . . . 0.0 109.267 175.513 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' F' F ' 51' ' ' VAL . . . . . . . . . . . . . 48.0 t -73.08 -53.08 19.48 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.32 0 CA-C-N 115.926 -0.579 . . . . 0.0 109.615 -174.404 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' F' F ' 52' ' ' GLN . . . . . . . . . . . . . 88.7 mt-30 -154.09 151.44 29.29 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.022 -0.535 . . . . 0.0 111.972 -177.493 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' F' F ' 53' ' ' ALA . . . . . . . . . . . . . . . -128.18 132.96 48.84 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 115.214 -0.903 . . . . 0.0 109.683 174.975 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' F' F ' 54' ' ' TYR . . . . . . . . . . . . . 25.7 t80 -129.07 108.41 18.06 Favored Pre-proline 0 CA--C 1.535 0.4 0 CA-C-O 118.327 -0.844 . . . . 0.0 110.256 179.07 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' F' F ' 55' ' ' PRO . . . . . . . . . . . . . 73.2 Cg_endo -77.16 169.0 75.4 Favored 'Cis proline' 0 N--CA 1.501 1.919 0 CA-C-N 121.853 1.698 . . . . 0.0 112.453 -5.205 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' F' F ' 56' ' ' SER . . . . . . . . . . . . . 54.3 m -116.72 130.42 24.56 Favored Pre-proline 0 CA--C 1.539 0.536 0 CA-C-O 118.413 -0.803 . . . . 0.0 109.229 174.819 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' F' F ' 57' ' ' PRO . . . . . . . . . . . . . 38.1 Cg_endo -67.15 164.65 70.31 Favored 'Cis proline' 0 N--CA 1.498 1.741 0 CA-C-N 121.991 1.747 . . . . 0.0 111.584 -0.282 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' F' F ' 58' ' ' LEU . . . . . . . . . . . . . 29.7 tp -129.75 136.2 49.35 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-N 116.26 -0.427 . . . . 0.0 110.297 179.702 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' F' F ' 59' ' ' ARG . . . . . . . . . . . . . 70.5 ttt180 -100.42 128.57 46.44 Favored 'General case' 0 C--N 1.326 -0.423 0 N-CA-C 109.188 -0.671 . . . . 0.0 109.188 176.244 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' F' F ' 60' ' ' VAL . . . . . . . . . . . . . 46.9 t -80.65 115.01 22.45 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.254 0 C-N-CA 120.588 -0.445 . . . . 0.0 110.096 -175.075 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' F' F ' 61' ' ' GLU . . . . . . . . . . . . . 95.3 mt-10 -130.99 160.53 34.29 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 115.841 -0.618 . . . . 0.0 109.758 178.221 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' F' F ' 62' ' ' ASP . . . . . . . . . . . . . 15.0 p-10 -53.25 -31.45 43.56 Favored 'General case' 0 C--N 1.327 -0.387 0 N-CA-C 111.925 0.343 . . . . 0.0 111.925 179.944 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' F' F ' 63' ' ' ARG . . . . . . . . . . . . . 39.7 mtp180 -71.86 -22.11 61.57 Favored 'General case' 0 CA--C 1.532 0.27 0 N-CA-C 112.894 0.701 . . . . 0.0 112.894 -176.095 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' F' F ' 64' ' ' THR . . . . . . . . . . . . . 34.2 m -72.73 141.13 48.16 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-O 121.013 0.435 . . . . 0.0 111.013 -175.612 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' F' F ' 65' ' ' LYS . . . . . . . . . . . . . 97.5 mttt -89.18 131.2 35.42 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 115.851 -0.613 . . . . 0.0 109.84 177.635 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' F' F ' 66' ' ' ILE . . . . . . . . . . . . . 59.9 mt -116.01 129.03 73.06 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.228 0 N-CA-C 109.798 -0.445 . . . . 0.0 109.798 179.37 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' F' F ' 67' ' ' THR . . . . . . . . . . . . . 23.8 m -127.05 142.63 51.49 Favored 'General case' 0 C--N 1.331 -0.227 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.892 -178.148 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' F' F ' 68' ' ' LEU . . . . . . . . . . . . . 6.7 mp . . . . . 0 C--N 1.329 -0.314 0 CA-C-N 116.023 -0.535 . . . . 0.0 110.321 176.948 . . . . . . . . 0 0 . 1 . 003 nuclear orig core ' F' F ' 73' ' ' VAL . . . . . . . . . . . . . 24.5 m . . . . . 0 C--O 1.231 0.117 0 CA-C-O 121.356 0.598 . . . . 0.0 110.933 . . . . . . . . . 0 0 . 1 . 003 nuclear orig core ' F' F ' 74' ' ' ASP . . . . . . . . . . . . . 12.3 t0 -99.41 124.1 44.25 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 115.404 -0.816 . . . . 0.0 108.981 176.053 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' F' F ' 75' ' ' VAL . . . . . . . . . . . . . 41.8 t -112.83 124.08 69.13 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.245 0 CA-C-O 121.072 0.463 . . . . 0.0 110.839 -174.35 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' F' F ' 76' ' ' LEU . . . . . . . . . . . . . 5.8 mp -125.76 146.87 49.59 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 115.549 -0.75 . . . . 0.0 109.638 175.394 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' F' F ' 77' ' ' GLU . . . . . . . . . . . . . 97.7 mt-10 -134.22 130.88 37.84 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-O 120.977 0.418 . . . . 0.0 110.889 -178.075 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' F' F ' 78' ' ' ALA . . . . . . . . . . . . . . . -114.47 134.21 55.18 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 115.709 -0.678 . . . . 0.0 109.502 176.806 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' F' F ' 79' ' ' LYS . . . . . . . . . . . . . 25.7 pttm -77.55 119.31 20.95 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-O 121.472 0.653 . . . . 0.0 110.792 -178.644 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' F' F ' 80' ' ' ILE . . . . . . . . . . . . . 36.6 mm -139.26 113.87 7.66 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.282 0 CA-C-N 115.546 -0.752 . . . . 0.0 109.103 -178.795 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' F' F ' 81' ' ' LYS . . . . . . . . . . . . . 24.5 pttm -114.32 128.01 56.14 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-O 120.991 0.424 . . . . 0.0 111.269 -177.252 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' F' F ' 82' ' ' GLY . . . . . . . . . . . . . . . 88.89 42.21 5.73 Favored Glycine 0 CA--C 1.527 0.794 0 N-CA-C 111.483 -0.647 . . . . 0.0 111.483 177.078 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' F' F ' 83' ' ' ILE . . . . . . . . . . . . . 72.9 mt -69.88 140.95 17.79 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 CA-C-O 120.871 0.367 . . . . 0.0 110.197 179.633 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' F' F ' 84' ' ' LYS . . . . . . . . . . . . . 54.7 tttp -101.6 -50.88 3.59 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-N 115.951 -0.568 . . . . 0.0 109.984 178.746 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' F' F ' 85' ' ' ASP . . . . . . . . . . . . . 6.5 t0 -153.71 149.26 27.31 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 115.792 -0.64 . . . . 0.0 110.402 -179.543 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' F' F ' 86' ' ' VAL . . . . . . . . . . . . . 42.1 t -132.2 129.73 60.13 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.185 0 CA-C-O 120.882 0.372 . . . . 0.0 110.319 -179.852 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' F' F ' 87' ' ' ILE . . . . . . . . . . . . . 4.9 mp -120.1 126.65 75.5 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.245 0 N-CA-C 109.548 -0.538 . . . . 0.0 109.548 176.321 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' F' F ' 88' ' ' LEU . . . . . . . . . . . . . 59.0 mt -111.59 136.9 50.17 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-O 121.103 0.478 . . . . 0.0 111.263 -177.798 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' F' F ' 89' ' ' ASP . . . . . . . . . . . . . 12.6 t70 -129.49 153.66 47.77 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 115.646 -0.706 . . . . 0.0 109.285 175.742 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' F' F ' 90' ' ' GLU . . . . . . . . . . . . . 43.6 tp10 -48.47 -33.99 10.33 Favored 'General case' 0 C--N 1.329 -0.326 0 N-CA-C 112.918 0.71 . . . . 0.0 112.918 -172.011 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' F' F ' 91' ' ' ASN . . . . . . . . . . . . . 83.3 m-20 -131.25 27.54 4.79 Favored 'General case' 0 N--CA 1.466 0.343 0 N-CA-C 112.514 0.561 . . . . 0.0 112.514 -175.381 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' F' F ' 92' ' ' LEU . . . . . . . . . . . . . 6.6 tp -166.13 150.46 7.94 Favored 'General case' 0 C--N 1.331 -0.199 0 C-N-CA 120.83 -0.348 . . . . 0.0 110.752 -179.981 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' F' F ' 93' ' ' ILE . . . . . . . . . . . . . 71.8 mt -129.03 126.14 63.95 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.216 0 N-CA-C 109.693 -0.484 . . . . 0.0 109.693 178.927 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' F' F ' 94' ' ' VAL . . . . . . . . . . . . . 44.8 t -121.8 127.16 75.39 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.258 0 N-CA-C 109.735 -0.468 . . . . 0.0 109.735 178.8 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' F' F ' 95' ' ' VAL . . . . . . . . . . . . . 42.4 t -124.16 136.3 60.86 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.25 0 CA-C-N 116.091 -0.504 . . . . 0.0 110.054 -178.361 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' F' F ' 96' ' ' ILE . . . . . . . . . . . . . 47.3 mt -118.27 130.93 72.41 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.235 0 N-CA-C 109.37 -0.604 . . . . 0.0 109.37 179.306 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' F' F ' 97' ' ' THR . . . . . . . . . . . . . 67.3 p -103.16 157.21 17.16 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-O 121.1 0.476 . . . . 0.0 111.101 -178.586 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' F' F ' 98' ' ' GLU . . . . . . . . . . . . . 96.5 mt-10 -53.84 -26.01 22.35 Favored 'General case' 0 C--N 1.328 -0.354 0 N-CA-C 112.424 0.527 . . . . 0.0 112.424 -178.79 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' F' F ' 99' ' ' GLU . . . . . . . . . . . . . 95.7 mt-10 -79.62 16.8 1.0 Allowed 'General case' 0 CA--C 1.534 0.352 0 N-CA-C 113.213 0.82 . . . . 0.0 113.213 -176.126 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' F' F ' 100' ' ' ASN . . . . . . . . . . . . . 3.6 m-20 62.72 37.4 12.68 Favored 'General case' 0 C--O 1.234 0.24 0 CA-C-O 121.212 0.53 . . . . 0.0 111.038 178.136 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' F' F ' 101' ' ' GLU . . . . . . . . . . . . . 84.5 tt0 -117.65 139.85 50.44 Favored 'General case' 0 C--N 1.333 -0.142 0 N-CA-C 109.378 -0.601 . . . . 0.0 109.378 176.217 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' F' F ' 102' ' ' VAL . . . . . . . . . . . . . 45.0 t -117.57 129.89 73.32 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 N-CA-C 109.847 -0.427 . . . . 0.0 109.847 -177.377 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' F' F ' 103' ' ' LEU . . . . . . . . . . . . . 4.7 mp -123.09 137.99 54.78 Favored 'General case' 0 C--N 1.331 -0.219 0 CA-C-N 116.144 -0.48 . . . . 0.0 110.715 178.288 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' F' F ' 104' ' ' ILE . . . . . . . . . . . . . 65.5 mt -117.8 124.7 73.44 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.255 0 CA-C-N 115.802 -0.635 . . . . 0.0 109.882 179.989 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' F' F ' 105' ' ' PHE . . . . . . . . . . . . . 89.9 m-85 -122.43 161.47 23.45 Favored 'General case' 0 C--N 1.332 -0.187 0 O-C-N 123.969 0.793 . . . . 0.0 109.817 179.458 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' F' F ' 106' ' ' ASN . . . . . . . . . . . . . 47.2 p-10 -97.5 -171.35 2.17 Favored 'General case' 0 C--N 1.331 -0.209 0 N-CA-C 109.932 -0.396 . . . . 0.0 109.932 173.132 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' F' F ' 107' ' ' GLN . . . . . . . . . . . . . 48.4 tt0 -57.3 -30.12 64.47 Favored 'General case' 0 C--N 1.328 -0.348 0 N-CA-C 112.043 0.386 . . . . 0.0 112.043 -179.188 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' F' F ' 108' ' ' ASN . . . . . . . . . . . . . 13.0 t-20 -88.73 14.02 11.09 Favored 'General case' 0 CA--C 1.534 0.349 0 N-CA-C 112.973 0.731 . . . . 0.0 112.973 -175.612 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' F' F ' 109' ' ' LEU . . . . . . . . . . . . . 33.5 mt 57.97 33.4 23.15 Favored 'General case' 0 C--O 1.233 0.19 0 N-CA-C 111.756 0.28 . . . . 0.0 111.756 179.247 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' F' F ' 110' ' ' GLU . . . . . . . . . . . . . 43.3 mt-10 -98.05 145.24 26.73 Favored 'General case' 0 C--N 1.33 -0.277 0 N-CA-C 109.594 -0.521 . . . . 0.0 109.594 175.924 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' F' F ' 111' ' ' GLU . . . . . . . . . . . . . 53.7 tt0 -81.24 122.02 26.89 Favored 'General case' 0 C--N 1.328 -0.351 0 C-N-CA 120.725 -0.39 . . . . 0.0 110.487 -176.992 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' F' F ' 112' ' ' LEU . . . . . . . . . . . . . 58.2 mt -106.53 -46.09 4.09 Favored 'General case' 0 C--N 1.331 -0.226 0 CA-C-N 116.135 -0.484 . . . . 0.0 110.42 178.178 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' F' F ' 113' ' ' TYR . . . . . . . . . . . . . 64.6 t80 -138.36 137.08 36.98 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.134 -0.485 . . . . 0.0 111.169 -179.017 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' F' F ' 114' ' ' ARG . . . . . . . . . . . . . 56.1 ttp180 -141.45 121.29 13.55 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.277 -0.419 . . . . 0.0 109.949 174.848 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' F' F ' 115' ' ' GLY . . . . . . . . . . . . . . . -148.52 160.96 28.54 Favored Glycine 0 CA--C 1.524 0.595 0 N-CA-C 111.069 -0.812 . . . . 0.0 111.069 179.826 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' F' F ' 116' ' ' LYS . . . . . . . . . . . . . 40.2 ttpt -124.36 141.93 51.69 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-O 120.64 0.257 . . . . 0.0 110.385 -179.901 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' F' F ' 117' ' ' PHE . . . . . . . . . . . . . 47.4 m-85 -135.24 113.9 11.76 Favored 'General case' 0 C--N 1.332 -0.184 0 CA-C-O 120.907 0.384 . . . . 0.0 110.019 179.459 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' F' F ' 118' ' ' GLU . . . . . . . . . . . . . 82.1 tt0 -53.95 -51.69 63.03 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.457 -0.338 . . . . 0.0 111.376 -176.348 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' F' F ' 119' ' ' ASN . . . . . . . . . . . . . 87.6 m-20 -93.84 31.19 1.65 Allowed 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.052 -0.522 . . . . 0.0 112.19 -174.712 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' F' F ' 120' ' ' LEU . . . . . . . . . . . . . 12.9 tp -54.2 124.08 14.69 Favored 'General case' 0 N--CA 1.462 0.153 0 CA-C-O 120.624 0.249 . . . . 0.0 110.738 178.348 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' F' F ' 121' ' ' ASN . . . . . . . . . . . . . 12.4 m120 -112.15 -44.06 3.47 Favored 'General case' 0 C--O 1.232 0.137 0 CA-C-N 116.62 -0.264 . . . . 0.0 110.944 -176.679 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' F' F ' 122' ' ' LYS . . . . . . . . . . . . . 98.2 mttt -146.66 143.16 28.57 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-O 120.917 0.389 . . . . 0.0 111.387 -178.875 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' F' F ' 123' ' ' VAL . . . . . . . . . . . . . 46.5 t -126.77 127.43 70.01 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.314 0 N-CA-C 109.19 -0.67 . . . . 0.0 109.19 175.049 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' F' F ' 124' ' ' LEU . . . . . . . . . . . . . 13.9 tp -134.05 140.05 46.41 Favored 'General case' 0 C--N 1.331 -0.227 0 CA-C-O 120.947 0.403 . . . . 0.0 110.805 -176.797 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' F' F ' 125' ' ' VAL . . . . . . . . . . . . . 12.2 p -131.51 140.03 49.26 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.215 0 CA-C-N 116.239 -0.437 . . . . 0.0 110.335 178.492 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' F' F ' 126' ' ' ARG . . . . . . . . . . . . . 96.6 mtt-85 -136.97 124.24 21.85 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.064 -0.516 . . . . 0.0 110.402 179.297 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' F' F ' 127' ' ' ASN . . . . . . . . . . . . . 67.7 m-80 52.02 -106.46 0.27 Allowed 'General case' 0 CA--C 1.544 0.73 0 CA-C-O 119.044 -0.503 . . . . 0.0 111.104 179.997 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' F' F ' 128' ' ' ASP . . . . . . . . . . . . . 8.1 p-10 -114.09 1.67 14.68 Favored 'General case' 0 CA--C 1.536 0.414 0 CA-C-N 119.629 1.104 . . . . 0.0 113.459 -177.86 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' F' F ' 129' ' ' LEU . . . . . . . . . . . . . 29.3 mt -107.35 145.12 33.26 Favored 'General case' 0 C--N 1.333 -0.11 0 O-C-N 121.962 -0.461 . . . . 0.0 110.383 -178.571 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' F' F ' 130' ' ' VAL . . . . . . . . . . . . . 43.3 t -122.18 136.31 59.44 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.231 0 CA-C-O 120.909 0.385 . . . . 0.0 110.072 -178.109 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' F' F ' 131' ' ' VAL . . . . . . . . . . . . . 42.4 t -131.69 133.61 61.27 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.247 0 CA-C-N 116.209 -0.451 . . . . 0.0 109.812 177.651 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' F' F ' 132' ' ' ILE . . . . . . . . . . . . . 71.0 mt -119.68 132.14 70.25 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.317 0 CA-C-N 115.966 -0.561 . . . . 0.0 109.536 -179.143 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' F' F ' 133' ' ' ILE . . . . . . . . . . . . . 37.4 mm -116.84 123.39 71.69 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.331 0 CA-C-O 120.916 0.388 . . . . 0.0 110.855 -175.274 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' F' F ' 134' ' ' ASP . . . . . . . . . . . . . 9.3 p-10 -134.07 149.12 51.12 Favored 'General case' 0 C--N 1.329 -0.298 0 N-CA-C 109.606 -0.516 . . . . 0.0 109.606 174.661 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' F' F ' 135' ' ' GLU . . . . . . . . . . . . . 84.3 tt0 -49.87 -26.58 4.19 Favored 'General case' 0 C--N 1.327 -0.386 0 N-CA-C 112.71 0.633 . . . . 0.0 112.71 -173.283 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' F' F ' 136' ' ' GLN . . . . . . . . . . . . . 36.3 tt0 -84.72 -36.47 21.8 Favored 'General case' 0 C--O 1.234 0.289 0 N-CA-C 112.19 0.441 . . . . 0.0 112.19 -174.729 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' F' F ' 137' ' ' LYS . . . . . . . . . . . . . 20.4 pttp -163.08 171.7 16.02 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-O 121.539 0.685 . . . . 0.0 112.375 -171.32 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' F' F ' 138' ' ' LEU . . . . . . . . . . . . . 3.9 tt -116.33 127.64 54.86 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 114.995 -1.002 . . . . 0.0 109.661 178.808 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' F' F ' 139' ' ' THR . . . . . . . . . . . . . 28.4 m -108.46 127.82 54.25 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-O 120.772 0.32 . . . . 0.0 110.676 -179.88 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' F' F ' 140' ' ' LEU . . . . . . . . . . . . . 10.0 tp -113.57 120.48 41.11 Favored 'General case' 0 C--N 1.328 -0.339 0 N-CA-C 109.175 -0.676 . . . . 0.0 109.175 -179.367 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' F' F ' 141' ' ' ILE . . . . . . . . . . . . . 18.9 mt -120.56 118.36 56.29 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.299 0 CA-C-O 120.986 0.422 . . . . 0.0 109.966 -174.76 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' F' F ' 142' ' ' ARG . . . . . . . . . . . . . 83.9 mtm180 -108.86 128.18 54.69 Favored 'General case' 0 C--N 1.332 -0.19 0 CA-C-N 115.543 -0.753 . . . . 0.0 110.318 -179.255 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' F' F ' 143' ' ' THR . . . . . . . . . . . . . 22.6 p . . . . . 0 C--O 1.22 -0.462 0 CA-C-O 117.94 -1.028 . . . . 0.0 110.669 -179.42 . . . . . . . . 0 0 . 1 . 004 nuclear orig core ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 3.8 p . . . . . 0 N--CA 1.463 0.206 0 CA-C-O 121.065 0.459 . . . . 0.0 110.875 . . . . . . . . . 0 0 . 1 . 004 nuclear orig core ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 95.6 mt-10 -140.32 139.57 35.46 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 115.737 -0.665 . . . . 0.0 110.904 -179.974 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 4' ' ' LEU . . . . . . . . . . . . . 18.6 tp -125.91 129.54 49.52 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 115.922 -0.581 . . . . 0.0 110.19 177.641 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 5' ' ' LYS . . . . . . . . . . . . . 64.0 mttp -111.65 121.12 44.29 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.393 -0.367 . . . . 0.0 110.784 179.892 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 18.8 mt -114.09 148.17 37.55 Favored 'General case' 0 C--N 1.332 -0.193 0 CA-C-N 115.52 -0.764 . . . . 0.0 109.771 179.449 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 48.4 tttp -126.09 137.88 31.06 Favored Pre-proline 0 CA--C 1.533 0.3 0 CA-C-O 118.863 -0.589 . . . . 0.0 109.842 174.954 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 8' ' ' PRO . . . . . . . . . . . . . 91.6 Cg_endo -90.51 134.93 2.02 Favored 'Trans proline' 0 N--CA 1.489 1.219 0 C-N-CA 121.729 1.619 . . . . 0.0 111.791 179.182 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 22.1 mt -80.16 -47.92 1.33 Allowed Pre-proline 0 CA--C 1.533 0.307 0 CA-C-O 118.654 -0.688 . . . . 0.0 112.238 -178.844 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 90.8 Cg_endo -79.53 152.26 22.98 Favored 'Trans proline' 0 N--CA 1.497 1.677 0 C-N-CA 121.065 1.176 . . . . 0.0 111.914 176.977 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 22.9 tptm -84.35 92.38 8.01 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.39 -0.368 . . . . 0.0 110.312 178.841 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 12.0 p -139.97 144.11 28.77 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.339 0 CA-C-N 116.151 -0.477 . . . . 0.0 110.441 179.957 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 95.5 mt-10 -89.18 122.23 32.26 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.339 -0.391 . . . . 0.0 110.194 178.063 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 14' ' ' LEU . . . . . . . . . . . . . 28.5 mt -93.91 144.77 28.67 Favored Pre-proline 0 C--N 1.329 -0.29 0 CA-C-O 118.971 -0.538 . . . . 0.0 109.99 -179.354 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 15' ' ' PRO . . . . . . . . . . . . . 31.0 Cg_exo -59.53 159.92 22.19 Favored 'Trans proline' 0 N--CA 1.498 1.757 0 C-N-CA 121.256 1.304 . . . . 0.0 111.713 179.095 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 16' ' ' PRO . . . . . . . . . . . . . 37.0 Cg_exo -58.59 -41.21 66.64 Favored 'Trans proline' 0 N--CA 1.496 1.648 0 C-N-CA 121.477 1.451 . . . . 0.0 112.757 -178.226 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 17' ' ' ASP . . . . . . . . . . . . . 19.1 p-10 -82.34 6.14 18.0 Favored 'General case' 0 CA--C 1.536 0.434 0 N-CA-C 113.274 0.842 . . . . 0.0 113.274 -178.008 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 18' ' ' PHE . . . . . . . . . . . . . 58.1 t80 -57.99 -45.18 87.22 Favored 'General case' 0 C--N 1.334 -0.084 0 O-C-N 121.938 -0.476 . . . . 0.0 110.119 -178.389 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 19' ' ' VAL . . . . . . . . . . . . . 48.3 t -56.33 -43.77 77.98 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.297 0 CA-C-N 116.291 -0.413 . . . . 0.0 110.628 -177.959 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 80.6 m-20 -60.31 -42.61 95.93 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.497 -0.32 . . . . 0.0 110.964 -178.068 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 45.6 t -64.01 -46.48 93.79 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.282 0 C-N-CA 120.846 -0.342 . . . . 0.0 110.56 -177.711 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 22' ' ' ILE . . . . . . . . . . . . . 50.8 mm -55.54 -46.02 78.85 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.241 0 CA-C-O 120.727 0.299 . . . . 0.0 110.549 178.649 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 23' ' ' ARG . . . . . . . . . . . . . 53.7 ttp180 -53.36 -49.15 67.74 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-O 120.711 0.291 . . . . 0.0 111.412 179.959 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 24' ' ' ILE . . . . . . . . . . . . . 73.9 mt -58.81 -40.54 80.18 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.306 0 CA-C-N 116.483 -0.326 . . . . 0.0 111.133 -178.345 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 51.4 mttm -70.91 -37.54 72.94 Favored 'General case' 0 C--N 1.329 -0.308 0 N-CA-C 112.511 0.56 . . . . 0.0 112.511 -178.272 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 67.6 mt -78.73 -35.85 44.14 Favored 'General case' 0 C--N 1.33 -0.265 0 N-CA-C 113.199 0.814 . . . . 0.0 113.199 -170.062 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 27' ' ' GLN . . . . . . . . . . . . . 7.3 pt20 -46.57 135.98 8.07 Favored 'General case' 0 N--CA 1.468 0.426 0 N-CA-C 112.822 0.675 . . . . 0.0 112.822 -176.319 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 101.15 -20.69 46.35 Favored Glycine 0 CA--C 1.535 1.294 0 CA-C-N 115.759 -0.655 . . . . 0.0 112.644 -177.84 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 56.5 mtpt -97.12 155.11 16.96 Favored 'General case' 0 C--O 1.233 0.196 0 CA-C-N 117.695 0.747 . . . . 0.0 111.061 178.84 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 30' ' ' THR . . . . . . . . . . . . . 44.5 m -106.96 133.76 51.13 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 115.95 -0.568 . . . . 0.0 109.613 174.356 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 34.7 m -128.81 153.19 38.02 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.241 0 CA-C-O 121.017 0.437 . . . . 0.0 110.961 -177.43 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 32' ' ' ARG . . . . . . . . . . . . . 96.9 mtt180 -132.81 150.92 52.11 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 115.897 -0.592 . . . . 0.0 110.623 179.365 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 33' ' ' THR . . . . . . . . . . . . . 12.5 m -53.03 139.01 29.23 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.232 -0.44 . . . . 0.0 111.295 -178.638 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 100.65 -17.14 56.99 Favored Glycine 0 CA--C 1.532 1.109 0 C-N-CA 121.205 -0.521 . . . . 0.0 113.232 179.275 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 54.4 m-20 -64.48 151.07 45.3 Favored 'General case' 0 C--O 1.232 0.136 0 CA-C-N 118.099 0.949 . . . . 0.0 111.308 -179.621 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 47.5 t -125.04 128.33 72.96 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.258 0 CA-C-N 115.767 -0.651 . . . . 0.0 109.621 178.223 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 37' ' ' ILE . . . . . . . . . . . . . 64.1 mt -123.41 140.43 47.03 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.173 0 CA-C-N 116.29 -0.414 . . . . 0.0 110.039 -178.656 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . -115.07 128.77 8.26 Favored Glycine 0 CA--C 1.526 0.752 0 N-CA-C 110.815 -0.914 . . . . 0.0 110.815 178.179 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 39' ' ' ILE . . . . . . . . . . . . . 74.5 mt -126.42 138.08 55.79 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.221 0 CA-C-O 120.75 0.31 . . . . 0.0 110.205 -179.907 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 40' ' ' SER . . . . . . . . . . . . . 35.1 t -91.51 113.94 26.34 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.616 175.491 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 41' ' ' ILE . . . . . . . . . . . . . 45.3 mm -119.66 119.99 62.08 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.214 0 CA-C-O 120.76 0.314 . . . . 0.0 110.415 -179.852 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 37.3 mt 52.74 35.08 17.62 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.192 -0.458 . . . . 0.0 111.744 177.007 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . 73.25 31.0 61.91 Favored Glycine 0 CA--C 1.529 0.947 0 C-N-CA 121.106 -0.569 . . . . 0.0 112.264 177.976 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 44' ' ' LYS . . . . . . . . . . . . . 21.0 tptp -141.36 130.8 23.79 Favored 'General case' 0 C--N 1.329 -0.315 0 N-CA-C 109.548 -0.538 . . . . 0.0 109.548 178.142 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 82.7 tt0 -81.53 121.62 26.53 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-O 120.883 0.373 . . . . 0.0 111.277 -176.397 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 46' ' ' VAL . . . . . . . . . . . . . 9.0 p -119.61 124.5 73.02 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.175 0 N-CA-C 109.564 -0.532 . . . . 0.0 109.564 175.754 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 97.7 mttt -98.83 128.71 45.11 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 116.09 -0.505 . . . . 0.0 110.843 178.326 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 48' ' ' PHE . . . . . . . . . . . . . 30.1 m-85 -113.63 131.81 55.99 Favored 'General case' 0 C--N 1.33 -0.267 0 N-CA-C 109.86 -0.422 . . . . 0.0 109.86 177.862 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 83.1 tttt -107.24 135.79 48.16 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 116.39 -0.368 . . . . 0.0 110.193 177.629 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 50' ' ' VAL . . . . . . . . . . . . . 43.9 t -79.52 107.64 12.17 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.33 0 N-CA-C 109.682 -0.488 . . . . 0.0 109.682 178.228 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 51' ' ' VAL . . . . . . . . . . . . . 47.5 t -72.51 -51.95 26.07 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.354 0 CA-C-N 115.872 -0.604 . . . . 0.0 109.619 -176.046 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 52' ' ' GLN . . . . . . . . . . . . . 63.0 mt-30 -155.59 147.62 23.44 Favored 'General case' 0 C--N 1.331 -0.225 0 C-N-CA 120.346 -0.541 . . . . 0.0 111.698 -177.672 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -124.38 132.08 53.52 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 115.231 -0.895 . . . . 0.0 109.419 174.512 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 54' ' ' TYR . . . . . . . . . . . . . 38.3 t80 -129.03 110.69 18.34 Favored Pre-proline 0 CA--C 1.535 0.368 0 CA-C-O 118.181 -0.914 . . . . 0.0 110.353 179.836 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 55' ' ' PRO . . . . . . . . . . . . . 73.8 Cg_endo -77.15 170.01 72.71 Favored 'Cis proline' 0 N--CA 1.501 1.914 0 CA-C-N 121.947 1.731 . . . . 0.0 112.335 -6.405 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 56' ' ' SER . . . . . . . . . . . . . 13.6 m -117.48 132.73 23.43 Favored Pre-proline 0 CA--C 1.539 0.555 0 CA-C-O 118.476 -0.773 . . . . 0.0 109.487 175.185 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 57' ' ' PRO . . . . . . . . . . . . . 43.5 Cg_endo -69.53 148.59 86.52 Favored 'Cis proline' 0 N--CA 1.498 1.785 0 CA-C-N 121.823 1.687 . . . . 0.0 111.348 -2.082 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 58' ' ' LEU . . . . . . . . . . . . . 19.0 tp -107.65 135.83 48.44 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.327 -0.397 . . . . 0.0 110.591 -178.168 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 59' ' ' ARG . . . . . . . . . . . . . 23.0 ttm180 -102.83 123.54 46.68 Favored 'General case' 0 C--N 1.327 -0.4 0 N-CA-C 109.293 -0.632 . . . . 0.0 109.293 175.751 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 40.5 t -82.14 119.8 32.38 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.359 0 CA-C-O 120.933 0.396 . . . . 0.0 110.807 -174.067 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 95.6 mt-10 -130.98 165.33 23.41 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 115.817 -0.629 . . . . 0.0 109.417 175.12 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 62' ' ' ASP . . . . . . . . . . . . . 64.1 m-20 -52.37 -32.01 36.44 Favored 'General case' 0 C--N 1.328 -0.332 0 N-CA-C 111.948 0.351 . . . . 0.0 111.948 -178.548 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 63' ' ' ARG . . . . . . . . . . . . . 74.4 mtt180 -73.41 -21.96 60.35 Favored 'General case' 0 CA--C 1.533 0.291 0 N-CA-C 112.84 0.682 . . . . 0.0 112.84 -175.719 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 30.6 m -69.52 134.58 49.04 Favored 'General case' 0 C--N 1.331 -0.208 0 CA-C-O 120.787 0.327 . . . . 0.0 110.952 -175.823 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 65' ' ' LYS . . . . . . . . . . . . . 57.6 mtmt -90.55 133.77 34.85 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.52 179.206 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 66' ' ' ILE . . . . . . . . . . . . . 65.4 mt -117.12 131.14 70.7 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.234 0 N-CA-C 109.995 -0.372 . . . . 0.0 109.995 -179.84 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 67' ' ' THR . . . . . . . . . . . . . 31.6 m -127.19 143.55 51.23 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.876 -178.645 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 68' ' ' LEU . . . . . . . . . . . . . 15.4 tp . . . . . 0 C--N 1.33 -0.243 0 CA-C-N 116.119 -0.491 . . . . 0.0 110.127 177.596 . . . . . . . . 0 0 . 1 . 004 nuclear orig core ' A' A ' 74' ' ' ASP . . . . . . . . . . . . . 7.1 t70 . . . . . 0 N--CA 1.457 -0.109 0 N-CA-C 109.806 -0.442 . . . . 0.0 109.806 . . . . . . . . . 0 0 . 1 . 004 nuclear orig core ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 42.7 t -113.94 125.04 71.15 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.268 0 CA-C-O 121.154 0.502 . . . . 0.0 110.508 -177.424 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 76' ' ' LEU . . . . . . . . . . . . . 37.7 mt -125.77 140.08 52.98 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 115.578 -0.737 . . . . 0.0 109.73 177.787 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 77' ' ' GLU . . . . . . . . . . . . . 45.9 mt-10 -132.75 136.41 46.34 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-O 120.983 0.42 . . . . 0.0 111.193 -178.751 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 78' ' ' ALA . . . . . . . . . . . . . . . -124.92 136.96 54.25 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-N 115.76 -0.654 . . . . 0.0 110.01 177.128 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 79' ' ' LYS . . . . . . . . . . . . . 74.6 mmtt -78.86 119.55 22.22 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-O 120.808 0.337 . . . . 0.0 110.516 -178.54 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 80' ' ' ILE . . . . . . . . . . . . . 24.2 mm -139.27 113.33 7.05 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.267 0 N-CA-C 109.303 -0.629 . . . . 0.0 109.303 -177.237 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 81' ' ' LYS . . . . . . . . . . . . . 38.5 ttpt -105.86 124.24 49.26 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-O 120.855 0.36 . . . . 0.0 111.226 -177.809 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . 89.12 42.16 5.67 Favored Glycine 0 CA--C 1.525 0.663 0 C-N-CA 120.758 -0.734 . . . . 0.0 111.886 173.655 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 83' ' ' ILE . . . . . . . . . . . . . 72.1 mt -65.64 132.79 31.26 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 CA-C-O 120.973 0.416 . . . . 0.0 110.019 178.185 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 84' ' ' LYS . . . . . . . . . . . . . 30.3 ttmt -91.87 -50.67 5.6 Favored 'General case' 0 C--N 1.331 -0.204 0 CA-C-N 116.067 -0.515 . . . . 0.0 109.883 179.493 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 85' ' ' ASP . . . . . . . . . . . . . 5.7 t70 -159.75 157.0 28.6 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 115.715 -0.675 . . . . 0.0 110.474 179.73 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 86' ' ' VAL . . . . . . . . . . . . . 42.1 t -127.86 132.46 68.78 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.221 0 CA-C-O 121.049 0.452 . . . . 0.0 110.457 -179.038 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 87' ' ' ILE . . . . . . . . . . . . . 43.2 mm -119.64 124.4 72.82 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.216 0 CA-C-N 115.863 -0.608 . . . . 0.0 109.731 177.463 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 88' ' ' LEU . . . . . . . . . . . . . 50.5 mt -108.42 136.68 47.64 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-O 120.986 0.422 . . . . 0.0 111.286 -178.521 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 89' ' ' ASP . . . . . . . . . . . . . 6.5 t70 -130.41 155.36 46.53 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 115.72 -0.673 . . . . 0.0 109.546 176.177 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 96.2 mt-10 -47.29 -36.66 9.51 Favored 'General case' 0 C--N 1.33 -0.253 0 N-CA-C 113.099 0.777 . . . . 0.0 113.099 -172.148 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 91' ' ' ASN . . . . . . . . . . . . . 35.9 t30 -132.1 21.24 4.48 Favored 'General case' 0 N--CA 1.467 0.417 0 N-CA-C 112.95 0.722 . . . . 0.0 112.95 -177.429 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 92' ' ' LEU . . . . . . . . . . . . . 20.2 mt -151.25 150.43 30.56 Favored 'General case' 0 C--N 1.333 -0.152 0 N-CA-C 110.138 -0.319 . . . . 0.0 110.138 -176.597 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 93' ' ' ILE . . . . . . . . . . . . . 76.2 mt -129.09 120.41 51.57 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.186 0 N-CA-C 109.325 -0.62 . . . . 0.0 109.325 176.159 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 94' ' ' VAL . . . . . . . . . . . . . 43.2 t -118.02 127.01 75.3 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.282 0 N-CA-C 109.68 -0.489 . . . . 0.0 109.68 -179.863 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 95' ' ' VAL . . . . . . . . . . . . . 42.8 t -120.78 135.08 62.11 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.36 0 CA-C-N 116.171 -0.468 . . . . 0.0 109.819 -179.258 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 96' ' ' ILE . . . . . . . . . . . . . 58.6 mt -113.99 128.23 71.03 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.338 0 N-CA-C 109.258 -0.645 . . . . 0.0 109.258 179.594 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 97' ' ' THR . . . . . . . . . . . . . 70.6 p -99.67 154.12 18.54 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-O 120.856 0.36 . . . . 0.0 110.686 -179.09 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 98' ' ' GLU . . . . . . . . . . . . . 96.0 mt-10 -54.76 -23.21 16.86 Favored 'General case' 0 CA--C 1.533 0.319 0 N-CA-C 112.451 0.537 . . . . 0.0 112.451 -179.701 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 99' ' ' GLU . . . . . . . . . . . . . 43.0 mt-10 -79.6 16.14 1.16 Allowed 'General case' 0 CA--C 1.535 0.379 0 N-CA-C 113.05 0.759 . . . . 0.0 113.05 -179.458 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 100' ' ' ASN . . . . . . . . . . . . . 3.6 m-20 63.57 37.97 9.97 Favored 'General case' 0 CA--C 1.529 0.144 0 CA-C-O 121.05 0.452 . . . . 0.0 110.967 177.694 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 101' ' ' GLU . . . . . . . . . . . . . 83.0 tt0 -114.38 142.36 46.45 Favored 'General case' 0 C--N 1.332 -0.162 0 CA-C-N 116.118 -0.492 . . . . 0.0 109.731 176.618 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 102' ' ' VAL . . . . . . . . . . . . . 43.6 t -115.14 123.72 71.04 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 N-CA-C 109.693 -0.484 . . . . 0.0 109.693 -179.731 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 103' ' ' LEU . . . . . . . . . . . . . 36.4 mt -116.57 130.6 56.84 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 115.877 -0.601 . . . . 0.0 110.05 178.294 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 104' ' ' ILE . . . . . . . . . . . . . 65.5 mt -115.35 118.95 60.41 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.324 0 N-CA-C 109.934 -0.395 . . . . 0.0 109.934 -179.591 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 105' ' ' PHE . . . . . . . . . . . . . 96.9 m-85 -118.29 162.86 17.57 Favored 'General case' 0 C--O 1.233 0.192 0 O-C-N 124.061 0.851 . . . . 0.0 110.079 -178.643 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 106' ' ' ASN . . . . . . . . . . . . . 53.2 p-10 -96.36 -169.95 2.0 Favored 'General case' 0 C--N 1.329 -0.285 0 N-CA-C 109.297 -0.631 . . . . 0.0 109.297 170.664 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 107' ' ' GLN . . . . . . . . . . . . . 44.1 tt0 -57.82 -27.53 63.25 Favored 'General case' 0 C--N 1.328 -0.335 0 N-CA-C 112.405 0.52 . . . . 0.0 112.405 -178.067 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 108' ' ' ASN . . . . . . . . . . . . . 19.6 t30 -94.63 14.25 21.65 Favored 'General case' 0 CA--C 1.534 0.333 0 N-CA-C 113.033 0.753 . . . . 0.0 113.033 -175.149 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 109' ' ' LEU . . . . . . . . . . . . . 91.4 mt 60.4 34.65 20.6 Favored 'General case' 0 CA--C 1.529 0.162 0 CA-C-O 120.756 0.312 . . . . 0.0 111.679 178.169 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 110' ' ' GLU . . . . . . . . . . . . . 96.2 mt-10 -101.47 141.16 34.75 Favored 'General case' 0 C--N 1.33 -0.265 0 N-CA-C 109.717 -0.475 . . . . 0.0 109.717 175.973 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 111' ' ' GLU . . . . . . . . . . . . . 96.4 mt-10 -73.13 121.86 20.91 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-O 120.945 0.402 . . . . 0.0 111.242 -176.719 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 112' ' ' LEU . . . . . . . . . . . . . 17.3 mt -103.43 -45.04 4.98 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 115.861 -0.608 . . . . 0.0 109.737 173.718 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 113' ' ' TYR . . . . . . . . . . . . . 61.8 t80 -142.03 142.48 32.89 Favored 'General case' 0 C--N 1.331 -0.224 0 CA-C-N 115.8 -0.636 . . . . 0.0 110.158 178.251 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 114' ' ' ARG . . . . . . . . . . . . . 33.6 ptt180 -150.65 123.59 8.71 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-O 120.957 0.408 . . . . 0.0 110.966 178.699 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 115' ' ' GLY . . . . . . . . . . . . . . . -150.2 163.03 29.4 Favored Glycine 0 CA--C 1.524 0.624 0 N-CA-C 110.664 -0.974 . . . . 0.0 110.664 -179.385 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 116' ' ' LYS . . . . . . . . . . . . . 29.8 ttmt -127.51 136.23 51.46 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-O 120.883 0.373 . . . . 0.0 110.185 178.604 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 117' ' ' PHE . . . . . . . . . . . . . 43.0 m-85 -131.44 115.15 15.81 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.12 -0.491 . . . . 0.0 110.161 -177.051 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 118' ' ' GLU . . . . . . . . . . . . . 96.2 mt-10 -54.0 -42.08 68.65 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.564 -0.289 . . . . 0.0 111.356 -176.895 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 119' ' ' ASN . . . . . . . . . . . . . 33.6 m120 -99.75 31.02 3.38 Favored 'General case' 0 CA--C 1.531 0.215 0 N-CA-C 112.132 0.419 . . . . 0.0 112.132 -174.809 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 120' ' ' LEU . . . . . . . . . . . . . 13.4 tp -56.83 121.19 9.28 Favored 'General case' 0 C--N 1.332 -0.177 0 CA-C-O 120.756 0.312 . . . . 0.0 110.562 178.41 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 121' ' ' ASN . . . . . . . . . . . . . 6.2 m120 -113.97 -44.01 3.2 Favored 'General case' 0 C--N 1.331 -0.204 0 CA-C-N 116.324 -0.398 . . . . 0.0 110.876 -178.981 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 122' ' ' LYS . . . . . . . . . . . . . 63.9 mtpt -139.68 144.54 37.64 Favored 'General case' 0 C--N 1.331 -0.211 0 CA-C-O 120.972 0.415 . . . . 0.0 111.631 -175.989 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 123' ' ' VAL . . . . . . . . . . . . . 45.2 t -131.36 122.52 51.02 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.305 0 N-CA-C 109.126 -0.694 . . . . 0.0 109.126 172.788 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 124' ' ' LEU . . . . . . . . . . . . . 14.3 tp -127.87 136.04 50.85 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-O 120.82 0.343 . . . . 0.0 110.813 -176.057 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 125' ' ' VAL . . . . . . . . . . . . . 12.6 p -134.03 137.01 52.88 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.205 0 CA-C-N 116.288 -0.414 . . . . 0.0 110.412 178.938 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 126' ' ' ARG . . . . . . . . . . . . . 26.3 mmt180 -141.77 124.99 16.39 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.118 -0.492 . . . . 0.0 110.368 179.43 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 127' ' ' ASN . . . . . . . . . . . . . 81.8 m-20 51.87 -105.02 0.2 Allowed 'General case' 0 CA--C 1.543 0.691 0 CA-C-N 115.982 -0.554 . . . . 0.0 111.356 178.949 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 128' ' ' ASP . . . . . . . . . . . . . 10.3 p-10 -114.21 0.45 14.22 Favored 'General case' 0 N--CA 1.466 0.368 0 CA-C-N 119.506 1.048 . . . . 0.0 113.656 -175.77 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 129' ' ' LEU . . . . . . . . . . . . . 47.4 mt -111.85 145.71 38.99 Favored 'General case' 0 C--O 1.231 0.117 0 CA-C-N 118.166 0.439 . . . . 0.0 110.344 -179.417 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 130' ' ' VAL . . . . . . . . . . . . . 12.5 p -134.16 141.21 44.38 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.217 0 CA-C-O 121.15 0.5 . . . . 0.0 110.559 -179.843 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 131' ' ' VAL . . . . . . . . . . . . . 44.3 t -135.84 139.6 45.78 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.271 0 CA-C-N 115.985 -0.552 . . . . 0.0 110.109 -179.784 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 132' ' ' ILE . . . . . . . . . . . . . 74.4 mt -118.65 133.42 65.54 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.268 0 CA-C-N 115.708 -0.678 . . . . 0.0 109.49 179.883 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 133' ' ' ILE . . . . . . . . . . . . . 38.1 mm -116.2 121.37 67.35 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.256 0 CA-C-N 116.39 -0.368 . . . . 0.0 110.78 -175.156 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 134' ' ' ASP . . . . . . . . . . . . . 8.4 p-10 -131.94 147.93 52.49 Favored 'General case' 0 C--N 1.332 -0.183 0 N-CA-C 109.871 -0.418 . . . . 0.0 109.871 175.33 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 135' ' ' GLU . . . . . . . . . . . . . 78.8 tt0 -49.86 -26.64 4.22 Favored 'General case' 0 C--N 1.328 -0.336 0 N-CA-C 113.02 0.748 . . . . 0.0 113.02 -172.742 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 136' ' ' GLN . . . . . . . . . . . . . 98.5 mt-30 -85.43 -32.04 22.54 Favored 'General case' 0 C--O 1.234 0.243 0 N-CA-C 112.425 0.528 . . . . 0.0 112.425 -175.428 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 137' ' ' LYS . . . . . . . . . . . . . 48.3 pttt -168.31 173.24 7.86 Favored 'General case' 0 C--N 1.332 -0.161 0 CA-C-O 121.646 0.736 . . . . 0.0 112.417 -173.226 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 138' ' ' LEU . . . . . . . . . . . . . 3.6 tt -115.7 129.11 56.35 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 114.831 -1.077 . . . . 0.0 109.996 -179.572 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 139' ' ' THR . . . . . . . . . . . . . 39.0 m -110.67 123.51 50.16 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 116.221 -0.445 . . . . 0.0 110.223 179.358 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 140' ' ' LEU . . . . . . . . . . . . . 6.1 tt -113.28 122.33 47.09 Favored 'General case' 0 C--N 1.328 -0.351 0 N-CA-C 109.567 -0.531 . . . . 0.0 109.567 -178.961 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 141' ' ' ILE . . . . . . . . . . . . . 19.6 mt -121.67 118.5 55.98 Favored 'Isoleucine or valine' 0 C--O 1.235 0.303 0 CA-C-O 121.104 0.478 . . . . 0.0 109.899 -175.938 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 142' ' ' ARG . . . . . . . . . . . . . 58.9 ttt180 -108.31 132.28 53.87 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 115.298 -0.864 . . . . 0.0 110.734 -177.198 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 143' ' ' THR . . . . . . . . . . . . . 56.0 p . . . . . 0 C--O 1.22 -0.483 0 CA-C-O 118.026 -0.988 . . . . 0.0 110.601 178.934 . . . . . . . . 0 0 . 1 . 004 nuclear orig core ' B' B ' 2' ' ' SER . . . . . . . . . . . . . 6.7 p . . . . . 0 N--CA 1.462 0.171 0 CA-C-O 121.072 0.463 . . . . 0.0 110.88 . . . . . . . . . 0 0 . 1 . 004 nuclear orig core ' B' B ' 3' ' ' GLU . . . . . . . . . . . . . 95.5 mt-10 -141.15 141.56 34.14 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 115.79 -0.641 . . . . 0.0 110.897 -179.226 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 4' ' ' LEU . . . . . . . . . . . . . 18.8 tp -127.15 128.33 45.99 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 115.955 -0.566 . . . . 0.0 110.12 177.056 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 5' ' ' LYS . . . . . . . . . . . . . 83.1 mttt -104.93 119.62 39.45 Favored 'General case' 0 C--O 1.234 0.267 0 CA-C-N 116.084 -0.507 . . . . 0.0 110.462 178.828 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 6' ' ' LEU . . . . . . . . . . . . . 45.1 mt -116.57 144.38 44.44 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 115.458 -0.792 . . . . 0.0 110.313 -178.967 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 7' ' ' LYS . . . . . . . . . . . . . 82.9 tttt -133.05 138.36 31.59 Favored Pre-proline 0 CA--C 1.534 0.328 0 CA-C-O 119.007 -0.521 . . . . 0.0 109.988 177.247 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 8' ' ' PRO . . . . . . . . . . . . . 89.7 Cg_endo -92.09 144.19 2.78 Favored 'Trans proline' 0 N--CA 1.489 1.223 0 C-N-CA 121.717 1.611 . . . . 0.0 111.97 178.155 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 9' ' ' LEU . . . . . . . . . . . . . 62.4 mt -81.09 -47.65 1.11 Allowed Pre-proline 0 CA--C 1.534 0.36 0 CA-C-O 118.637 -0.697 . . . . 0.0 112.319 -179.946 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 10' ' ' PRO . . . . . . . . . . . . . 86.8 Cg_endo -80.3 151.43 20.36 Favored 'Trans proline' 0 N--CA 1.496 1.656 0 C-N-CA 121.125 1.217 . . . . 0.0 111.888 176.999 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 11' ' ' LYS . . . . . . . . . . . . . 96.5 mttt -87.47 96.98 10.58 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.432 -0.349 . . . . 0.0 110.492 178.79 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 12' ' ' VAL . . . . . . . . . . . . . 12.6 p -142.06 147.07 21.9 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.328 0 CA-C-N 116.237 -0.438 . . . . 0.0 110.5 -179.932 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 13' ' ' GLU . . . . . . . . . . . . . 84.4 tt0 -84.92 127.9 34.37 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.253 -0.43 . . . . 0.0 110.055 178.069 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 14' ' ' LEU . . . . . . . . . . . . . 36.5 mt -96.41 149.96 36.51 Favored Pre-proline 0 CA--C 1.533 0.309 0 CA-C-O 119.311 -0.376 . . . . 0.0 110.713 -177.154 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 15' ' ' PRO . . . . . . . . . . . . . 27.8 Cg_exo -60.99 158.39 34.27 Favored 'Trans proline' 0 N--CA 1.499 1.797 0 C-N-CA 121.269 1.313 . . . . 0.0 111.964 178.272 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 16' ' ' PRO . . . . . . . . . . . . . 35.7 Cg_exo -59.09 -41.02 64.85 Favored 'Trans proline' 0 N--CA 1.497 1.692 0 C-N-CA 121.439 1.426 . . . . 0.0 112.714 -179.218 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 17' ' ' ASP . . . . . . . . . . . . . 15.8 p-10 -84.73 11.59 8.79 Favored 'General case' 0 CA--C 1.535 0.388 0 N-CA-C 113.155 0.798 . . . . 0.0 113.155 -178.183 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 18' ' ' PHE . . . . . . . . . . . . . 44.9 t80 -57.6 -45.73 84.94 Favored 'General case' 0 C--N 1.335 -0.064 0 O-C-N 121.949 -0.47 . . . . 0.0 110.305 -177.833 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 19' ' ' VAL . . . . . . . . . . . . . 15.0 p -55.88 -42.21 69.98 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.326 0 CA-C-N 116.475 -0.329 . . . . 0.0 111.075 -177.599 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 20' ' ' ASP . . . . . . . . . . . . . 32.8 m-20 -60.76 -42.85 98.27 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-O 120.9 0.381 . . . . 0.0 110.923 -178.397 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 21' ' ' VAL . . . . . . . . . . . . . 46.9 t -63.8 -45.41 97.25 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.264 0 C-N-CA 120.735 -0.386 . . . . 0.0 110.4 -178.52 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 22' ' ' ILE . . . . . . . . . . . . . 50.7 mm -55.7 -47.13 79.57 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.262 0 C-N-CA 121.001 -0.28 . . . . 0.0 110.592 178.366 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 23' ' ' ARG . . . . . . . . . . . . . 47.0 ttp180 -53.41 -51.66 61.87 Favored 'General case' 0 C--N 1.329 -0.292 0 C-N-CA 121.13 -0.228 . . . . 0.0 111.534 -178.615 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 24' ' ' ILE . . . . . . . . . . . . . 71.9 mt -59.52 -44.24 92.56 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.319 0 C-N-CA 121.112 -0.235 . . . . 0.0 111.163 -177.293 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 25' ' ' LYS . . . . . . . . . . . . . 8.7 mtpm? -64.94 -40.1 94.51 Favored 'General case' 0 C--N 1.328 -0.357 0 N-CA-C 112.178 0.436 . . . . 0.0 112.178 -176.946 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 26' ' ' LEU . . . . . . . . . . . . . 74.6 mt -80.09 -43.41 21.8 Favored 'General case' 0 C--N 1.33 -0.276 0 N-CA-C 112.945 0.72 . . . . 0.0 112.945 -172.106 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 27' ' ' GLN . . . . . . . . . . . . . 10.3 pt20 -46.39 137.67 6.27 Favored 'General case' 0 N--CA 1.469 0.487 0 N-CA-C 112.81 0.67 . . . . 0.0 112.81 -174.996 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 28' ' ' GLY . . . . . . . . . . . . . . . 100.85 -26.31 25.11 Favored Glycine 0 CA--C 1.533 1.196 0 CA-C-N 115.518 -0.765 . . . . 0.0 112.216 -176.575 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 29' ' ' LYS . . . . . . . . . . . . . 35.2 mmtp -97.79 155.08 17.2 Favored 'General case' 0 C--N 1.332 -0.159 0 CA-C-N 117.251 0.526 . . . . 0.0 111.012 179.28 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 30' ' ' THR . . . . . . . . . . . . . 43.5 m -108.01 134.4 50.97 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 115.934 -0.576 . . . . 0.0 109.869 175.202 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 31' ' ' VAL . . . . . . . . . . . . . 34.5 m -129.39 155.56 41.31 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.251 0 CA-C-O 120.9 0.381 . . . . 0.0 111.049 -177.363 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 32' ' ' ARG . . . . . . . . . . . . . 92.5 mtt180 -129.9 152.9 48.87 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-O 121.291 0.567 . . . . 0.0 110.604 179.16 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 33' ' ' THR . . . . . . . . . . . . . 18.2 m -52.82 139.02 28.03 Favored 'General case' 0 C--N 1.331 -0.225 0 CA-C-N 116.228 -0.442 . . . . 0.0 111.39 -179.001 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 34' ' ' GLY . . . . . . . . . . . . . . . 100.31 -17.12 57.34 Favored Glycine 0 CA--C 1.533 1.172 0 C-N-CA 121.219 -0.515 . . . . 0.0 113.224 179.346 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 35' ' ' ASP . . . . . . . . . . . . . 56.1 m-20 -66.04 150.5 48.59 Favored 'General case' 0 C--O 1.23 0.041 0 CA-C-N 118.043 0.922 . . . . 0.0 111.055 179.443 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 36' ' ' VAL . . . . . . . . . . . . . 46.5 t -123.06 129.72 74.86 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.207 0 CA-C-N 115.748 -0.66 . . . . 0.0 109.677 178.39 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 37' ' ' ILE . . . . . . . . . . . . . 64.8 mt -120.1 138.34 50.98 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.297 0 N-CA-C 109.755 -0.461 . . . . 0.0 109.755 179.816 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 38' ' ' GLY . . . . . . . . . . . . . . . -112.36 128.86 8.71 Favored Glycine 0 CA--C 1.525 0.716 0 N-CA-C 110.731 -0.948 . . . . 0.0 110.731 179.552 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 39' ' ' ILE . . . . . . . . . . . . . 73.4 mt -121.12 136.18 58.91 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.277 0 N-CA-C 110.043 -0.354 . . . . 0.0 110.043 179.831 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 40' ' ' SER . . . . . . . . . . . . . 74.6 p -91.65 116.16 28.64 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.246 -0.434 . . . . 0.0 110.78 176.185 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 41' ' ' ILE . . . . . . . . . . . . . 48.1 mm -128.74 118.13 46.42 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.165 0 N-CA-C 110.063 -0.347 . . . . 0.0 110.063 178.711 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 42' ' ' LEU . . . . . . . . . . . . . 38.7 mt 58.1 34.53 24.29 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.212 -0.449 . . . . 0.0 111.52 179.325 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 43' ' ' GLY . . . . . . . . . . . . . . . 77.47 -10.14 24.54 Favored Glycine 0 CA--C 1.535 1.286 0 C-N-CA 121.315 -0.469 . . . . 0.0 113.424 178.047 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 44' ' ' LYS . . . . . . . . . . . . . 47.7 mtmt -98.85 137.47 37.38 Favored 'General case' 0 C--N 1.333 -0.144 0 CA-C-N 117.897 0.848 . . . . 0.0 110.198 177.965 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 45' ' ' GLU . . . . . . . . . . . . . 83.8 tt0 -84.46 128.18 34.44 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.293 -0.412 . . . . 0.0 111.287 -179.409 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 46' ' ' VAL . . . . . . . . . . . . . 7.2 p -120.61 129.14 75.93 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.197 0 N-CA-C 109.508 -0.553 . . . . 0.0 109.508 175.465 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 47' ' ' LYS . . . . . . . . . . . . . 98.8 mttt -99.4 128.32 45.51 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.009 -0.541 . . . . 0.0 111.007 179.001 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 48' ' ' PHE . . . . . . . . . . . . . 93.2 m-85 -113.08 131.85 55.65 Favored 'General case' 0 C--N 1.331 -0.232 0 N-CA-C 109.67 -0.493 . . . . 0.0 109.67 175.041 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 49' ' ' LYS . . . . . . . . . . . . . 79.2 tttt -106.98 136.14 47.35 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.304 -0.407 . . . . 0.0 110.426 -179.777 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 50' ' ' VAL . . . . . . . . . . . . . 42.2 t -80.08 106.99 11.99 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 N-CA-C 109.433 -0.58 . . . . 0.0 109.433 176.799 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 51' ' ' VAL . . . . . . . . . . . . . 46.7 t -75.15 -48.21 32.83 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.286 0 CA-C-N 116.064 -0.516 . . . . 0.0 110.077 -174.044 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 52' ' ' GLN . . . . . . . . . . . . . 62.6 tt0 -159.46 137.05 9.96 Favored 'General case' 0 C--N 1.33 -0.251 0 C-N-CA 120.475 -0.49 . . . . 0.0 111.397 -177.692 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 53' ' ' ALA . . . . . . . . . . . . . . . -114.23 130.76 56.63 Favored 'General case' 0 C--N 1.331 -0.23 0 CA-C-N 115.783 -0.644 . . . . 0.0 109.755 174.561 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 54' ' ' TYR . . . . . . . . . . . . . 30.2 t80 -129.08 110.76 18.29 Favored Pre-proline 0 CA--C 1.535 0.399 0 CA-C-O 118.334 -0.841 . . . . 0.0 110.329 179.495 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 55' ' ' PRO . . . . . . . . . . . . . 73.9 Cg_endo -77.11 170.08 72.56 Favored 'Cis proline' 0 N--CA 1.499 1.823 0 CA-C-N 121.918 1.721 . . . . 0.0 112.44 -4.554 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 56' ' ' SER . . . . . . . . . . . . . 13.7 m -116.18 129.46 25.2 Favored Pre-proline 0 CA--C 1.539 0.548 0 CA-C-O 118.347 -0.835 . . . . 0.0 109.37 175.96 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 57' ' ' PRO . . . . . . . . . . . . . 50.8 Cg_endo -69.99 148.18 86.7 Favored 'Cis proline' 0 N--CA 1.497 1.735 0 CA-C-N 122.053 1.769 . . . . 0.0 111.561 -0.771 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 58' ' ' LEU . . . . . . . . . . . . . 22.4 tp -106.48 135.44 47.97 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-O 120.851 0.357 . . . . 0.0 110.454 -178.994 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 59' ' ' ARG . . . . . . . . . . . . . 52.9 ttp180 -105.82 121.85 44.9 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-N 115.873 -0.603 . . . . 0.0 109.377 177.307 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 60' ' ' VAL . . . . . . . . . . . . . 42.6 t -79.09 122.92 35.31 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.287 0 C-N-CA 120.807 -0.357 . . . . 0.0 110.591 -173.848 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 61' ' ' GLU . . . . . . . . . . . . . 95.5 mt-10 -131.03 165.62 22.8 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.021 -0.536 . . . . 0.0 110.149 178.195 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 62' ' ' ASP . . . . . . . . . . . . . 14.9 p-10 -55.87 -32.59 63.8 Favored 'General case' 0 C--N 1.329 -0.324 0 N-CA-C 111.781 0.289 . . . . 0.0 111.781 -179.147 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 63' ' ' ARG . . . . . . . . . . . . . 11.0 ptm180 -86.41 4.58 38.87 Favored 'General case' 0 CA--C 1.537 0.47 0 N-CA-C 113.527 0.936 . . . . 0.0 113.527 -176.15 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 64' ' ' THR . . . . . . . . . . . . . 31.5 m -83.54 137.86 33.66 Favored 'General case' 0 C--N 1.332 -0.166 0 CA-C-N 118.231 0.469 . . . . 0.0 110.443 -178.22 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 65' ' ' LYS . . . . . . . . . . . . . 67.7 mttm -88.24 123.72 33.15 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.219 -179.911 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 66' ' ' ILE . . . . . . . . . . . . . 62.6 mt -111.94 126.59 69.35 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.283 0 N-CA-C 109.574 -0.528 . . . . 0.0 109.574 179.63 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 67' ' ' THR . . . . . . . . . . . . . 18.4 m -122.08 139.32 53.86 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 116.176 -0.465 . . . . 0.0 110.908 -177.119 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 68' ' ' LEU . . . . . . . . . . . . . 15.7 tp . . . . . 0 C--N 1.329 -0.304 0 CA-C-N 115.841 -0.618 . . . . 0.0 110.236 178.624 . . . . . . . . 0 0 . 1 . 004 nuclear orig core ' B' B ' 73' ' ' VAL . . . . . . . . . . . . . 34.2 m . . . . . 0 C--O 1.232 0.162 0 CA-C-O 120.836 0.35 . . . . 0.0 110.703 . . . . . . . . . 0 0 . 1 . 004 nuclear orig core ' B' B ' 74' ' ' ASP . . . . . . . . . . . . . 13.8 t0 -99.53 123.52 43.87 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.152 -0.476 . . . . 0.0 110.051 -179.444 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 75' ' ' VAL . . . . . . . . . . . . . 41.5 t -115.24 123.89 71.28 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.261 0 CA-C-O 120.905 0.383 . . . . 0.0 110.617 -177.788 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 76' ' ' LEU . . . . . . . . . . . . . 4.4 mp -124.84 144.99 50.01 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 115.934 -0.576 . . . . 0.0 109.697 176.261 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 77' ' ' GLU . . . . . . . . . . . . . 97.4 mt-10 -134.96 138.53 44.13 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-O 121.0 0.429 . . . . 0.0 111.243 -178.068 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 78' ' ' ALA . . . . . . . . . . . . . . . -125.76 130.5 51.61 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 115.697 -0.683 . . . . 0.0 109.674 176.229 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 79' ' ' LYS . . . . . . . . . . . . . 62.1 mtpt -79.02 119.44 22.17 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-O 120.865 0.364 . . . . 0.0 110.898 -177.481 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 80' ' ' ILE . . . . . . . . . . . . . 41.6 mm -139.19 109.31 4.2 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.311 0 N-CA-C 109.138 -0.69 . . . . 0.0 109.138 -177.721 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 81' ' ' LYS . . . . . . . . . . . . . 60.6 tttm -101.81 126.55 48.71 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-O 120.842 0.353 . . . . 0.0 111.223 -176.642 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 82' ' ' GLY . . . . . . . . . . . . . . . 89.2 42.11 5.66 Favored Glycine 0 CA--C 1.527 0.784 0 C-N-CA 120.885 -0.674 . . . . 0.0 112.017 174.193 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 83' ' ' ILE . . . . . . . . . . . . . 72.5 mt -70.13 136.34 26.29 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.269 0 N-CA-C 109.676 -0.49 . . . . 0.0 109.676 176.407 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 84' ' ' LYS . . . . . . . . . . . . . 19.7 ttpp -101.0 -50.14 3.9 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-O 120.9 0.381 . . . . 0.0 110.461 -178.176 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 85' ' ' ASP . . . . . . . . . . . . . 10.8 t70 -147.1 148.13 31.29 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 115.987 -0.551 . . . . 0.0 110.348 -179.729 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 86' ' ' VAL . . . . . . . . . . . . . 42.2 t -130.71 132.62 64.12 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.232 0 CA-C-O 121.05 0.452 . . . . 0.0 110.578 -178.365 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 87' ' ' ILE . . . . . . . . . . . . . 5.1 mp -122.62 123.02 67.47 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.217 0 N-CA-C 109.208 -0.664 . . . . 0.0 109.208 176.102 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 88' ' ' LEU . . . . . . . . . . . . . 33.8 mt -111.66 136.29 51.08 Favored 'General case' 0 C--N 1.332 -0.182 0 CA-C-O 121.223 0.535 . . . . 0.0 111.352 -176.129 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 89' ' ' ASP . . . . . . . . . . . . . 11.3 t70 -129.19 146.25 51.15 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 115.511 -0.768 . . . . 0.0 109.296 175.333 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 90' ' ' GLU . . . . . . . . . . . . . 12.8 pt-20 -51.09 -28.8 11.42 Favored 'General case' 0 C--N 1.328 -0.347 0 N-CA-C 112.522 0.564 . . . . 0.0 112.522 -174.017 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 91' ' ' ASN . . . . . . . . . . . . . 92.1 m-20 -127.26 22.67 6.54 Favored 'General case' 0 N--CA 1.469 0.486 0 N-CA-C 112.8 0.667 . . . . 0.0 112.8 -176.558 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 92' ' ' LEU . . . . . . . . . . . . . 7.4 tp -166.24 148.54 6.94 Favored 'General case' 0 C--N 1.331 -0.237 0 N-CA-C 110.302 -0.258 . . . . 0.0 110.302 179.471 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 93' ' ' ILE . . . . . . . . . . . . . 71.0 mt -128.18 123.97 61.42 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.285 0 N-CA-C 109.848 -0.427 . . . . 0.0 109.848 179.145 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 94' ' ' VAL . . . . . . . . . . . . . 40.8 t -122.13 125.88 73.61 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.182 0 N-CA-C 109.98 -0.378 . . . . 0.0 109.98 179.038 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 95' ' ' VAL . . . . . . . . . . . . . 41.8 t -120.82 134.66 63.54 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.329 0 CA-C-N 116.026 -0.533 . . . . 0.0 109.815 -179.959 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 96' ' ' ILE . . . . . . . . . . . . . 67.4 mt -115.76 126.15 73.18 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.209 0 N-CA-C 109.381 -0.6 . . . . 0.0 109.381 179.071 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 97' ' ' THR . . . . . . . . . . . . . 73.5 p -99.89 158.36 15.86 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-O 121.307 0.575 . . . . 0.0 111.326 -176.404 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 98' ' ' GLU . . . . . . . . . . . . . 43.7 tp10 -53.83 -26.62 25.21 Favored 'General case' 0 CA--C 1.533 0.311 0 CA-C-N 116.052 -0.522 . . . . 0.0 112.267 -179.174 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 99' ' ' GLU . . . . . . . . . . . . . 95.7 mt-10 -79.91 17.6 0.94 Allowed 'General case' 0 CA--C 1.535 0.377 0 N-CA-C 113.151 0.797 . . . . 0.0 113.151 -176.212 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 100' ' ' ASN . . . . . . . . . . . . . 4.2 m-20 62.42 38.1 13.1 Favored 'General case' 0 N--CA 1.463 0.175 0 CA-C-O 121.115 0.484 . . . . 0.0 110.894 177.954 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 101' ' ' GLU . . . . . . . . . . . . . 84.4 tt0 -119.04 141.86 48.34 Favored 'General case' 0 C--N 1.332 -0.184 0 CA-C-N 116.208 -0.451 . . . . 0.0 109.869 177.562 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 102' ' ' VAL . . . . . . . . . . . . . 46.2 t -115.08 127.54 72.6 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.264 0 N-CA-C 109.895 -0.409 . . . . 0.0 109.895 -178.915 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 103' ' ' LEU . . . . . . . . . . . . . 28.8 mt -118.58 131.9 56.2 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-N 115.78 -0.646 . . . . 0.0 110.306 177.845 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 104' ' ' ILE . . . . . . . . . . . . . 71.4 mt -119.52 121.85 67.39 Favored 'Isoleucine or valine' 0 C--O 1.234 0.283 0 CA-C-N 116.606 -0.27 . . . . 0.0 110.426 -179.106 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 105' ' ' PHE . . . . . . . . . . . . . 53.2 m-85 -123.18 168.44 12.42 Favored 'General case' 0 C--N 1.333 -0.122 0 O-C-N 124.115 0.885 . . . . 0.0 109.901 179.499 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 106' ' ' ASN . . . . . . . . . . . . . 44.0 p-10 -100.38 -170.61 1.89 Allowed 'General case' 0 CA--C 1.531 0.217 0 N-CA-C 109.789 -0.448 . . . . 0.0 109.789 171.754 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 107' ' ' GLN . . . . . . . . . . . . . 63.3 tt0 -58.55 -30.06 66.83 Favored 'General case' 0 C--N 1.328 -0.339 0 N-CA-C 111.858 0.318 . . . . 0.0 111.858 179.567 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 108' ' ' ASN . . . . . . . . . . . . . 59.8 t30 -86.85 14.06 7.88 Favored 'General case' 0 CA--C 1.534 0.343 0 N-CA-C 112.923 0.712 . . . . 0.0 112.923 -176.757 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 109' ' ' LEU . . . . . . . . . . . . . 34.5 mt 58.35 33.19 22.91 Favored 'General case' 0 C--N 1.332 -0.188 0 N-CA-C 111.877 0.325 . . . . 0.0 111.877 177.262 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 110' ' ' GLU . . . . . . . . . . . . . 70.5 mm-40 -98.97 138.82 35.52 Favored 'General case' 0 C--N 1.331 -0.226 0 N-CA-C 109.21 -0.663 . . . . 0.0 109.21 174.426 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 111' ' ' GLU . . . . . . . . . . . . . 42.2 tt0 -85.72 121.81 28.91 Favored 'General case' 0 C--N 1.327 -0.408 0 CA-C-O 120.942 0.401 . . . . 0.0 110.574 -176.243 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 112' ' ' LEU . . . . . . . . . . . . . 38.6 mt -105.73 -42.4 5.18 Favored 'General case' 0 C--N 1.331 -0.227 0 CA-C-N 116.007 -0.542 . . . . 0.0 110.466 179.745 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 113' ' ' TYR . . . . . . . . . . . . . 63.9 t80 -132.89 138.7 47.07 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-N 116.274 -0.421 . . . . 0.0 110.883 -178.452 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 114' ' ' ARG . . . . . . . . . . . . . 24.6 ptt180 -147.89 122.22 9.65 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.3 -0.409 . . . . 0.0 110.619 179.126 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 115' ' ' GLY . . . . . . . . . . . . . . . -150.13 148.15 19.1 Favored Glycine 0 CA--C 1.525 0.701 0 C-N-CA 120.682 -0.77 . . . . 0.0 111.451 179.761 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 116' ' ' LYS . . . . . . . . . . . . . 21.3 ttpp -116.44 131.93 56.81 Favored 'General case' 0 C--N 1.33 -0.26 0 N-CA-C 109.717 -0.475 . . . . 0.0 109.717 176.517 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 117' ' ' PHE . . . . . . . . . . . . . 47.5 m-85 -127.12 116.85 21.29 Favored 'General case' 0 C--N 1.331 -0.216 0 CA-C-O 120.945 0.403 . . . . 0.0 110.243 -176.47 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 118' ' ' GLU . . . . . . . . . . . . . 95.8 mt-10 -52.97 -47.03 68.47 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.309 -0.405 . . . . 0.0 111.476 -176.293 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 119' ' ' ASN . . . . . . . . . . . . . 82.6 m-20 -98.16 31.02 2.88 Favored 'General case' 0 C--N 1.33 -0.256 0 N-CA-C 112.173 0.435 . . . . 0.0 112.173 -173.805 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 120' ' ' LEU . . . . . . . . . . . . . 21.4 tp -56.72 121.82 10.69 Favored 'General case' 0 C--N 1.332 -0.184 0 CA-C-O 120.677 0.275 . . . . 0.0 110.466 177.778 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 121' ' ' ASN . . . . . . . . . . . . . 31.4 m120 -113.98 -44.14 3.19 Favored 'General case' 0 N--CA 1.462 0.155 0 CA-C-N 116.554 -0.294 . . . . 0.0 111.323 -176.684 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 122' ' ' LYS . . . . . . . . . . . . . 55.4 mtmt -147.67 152.7 38.28 Favored 'General case' 0 C--N 1.332 -0.172 0 C-N-CA 120.651 -0.42 . . . . 0.0 111.62 -177.701 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 123' ' ' VAL . . . . . . . . . . . . . 46.2 t -132.77 132.18 59.52 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.243 0 CA-C-N 115.919 -0.582 . . . . 0.0 109.862 177.715 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 124' ' ' LEU . . . . . . . . . . . . . 23.9 mt -121.15 136.13 55.03 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.231 -0.44 . . . . 0.0 110.548 -179.059 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 125' ' ' VAL . . . . . . . . . . . . . 43.5 t -130.46 130.73 65.28 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.262 0 CA-C-N 116.335 -0.393 . . . . 0.0 110.019 179.078 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 126' ' ' ARG . . . . . . . . . . . . . 89.8 mtt-85 -142.05 121.14 12.93 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-O 120.935 0.398 . . . . 0.0 110.642 178.578 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 127' ' ' ASN . . . . . . . . . . . . . 58.4 m-80 51.46 -107.75 0.33 Allowed 'General case' 0 CA--C 1.545 0.761 0 CA-C-O 118.881 -0.581 . . . . 0.0 111.146 179.404 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 128' ' ' ASP . . . . . . . . . . . . . 14.7 p-10 -114.19 4.26 15.47 Favored 'General case' 0 CA--C 1.537 0.445 0 CA-C-N 119.802 1.183 . . . . 0.0 113.257 -178.111 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 129' ' ' LEU . . . . . . . . . . . . . 72.6 mt -107.75 144.93 34.21 Favored 'General case' 0 C--O 1.231 0.109 0 CA-C-N 118.142 0.428 . . . . 0.0 110.09 -179.916 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 130' ' ' VAL . . . . . . . . . . . . . 41.4 t -127.67 140.22 49.73 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.185 0 CA-C-O 120.98 0.419 . . . . 0.0 110.156 -177.739 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 131' ' ' VAL . . . . . . . . . . . . . 41.0 t -135.01 134.84 53.23 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.277 0 CA-C-N 116.15 -0.477 . . . . 0.0 110.025 178.317 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 132' ' ' ILE . . . . . . . . . . . . . 69.9 mt -118.07 132.84 66.72 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.274 0 CA-C-N 115.984 -0.553 . . . . 0.0 109.606 -179.468 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 133' ' ' ILE . . . . . . . . . . . . . 34.0 mm -116.0 123.49 71.32 Favored 'Isoleucine or valine' 0 C--O 1.234 0.262 0 CA-C-N 116.511 -0.313 . . . . 0.0 110.894 -175.598 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 134' ' ' ASP . . . . . . . . . . . . . 7.9 p-10 -132.61 155.11 49.31 Favored 'General case' 0 C--N 1.332 -0.196 0 CA-C-N 116.434 -0.348 . . . . 0.0 110.089 174.371 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 135' ' ' GLU . . . . . . . . . . . . . 80.7 tt0 -49.83 -28.66 6.71 Favored 'General case' 0 C--N 1.328 -0.364 0 N-CA-C 113.17 0.804 . . . . 0.0 113.17 -169.951 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 136' ' ' GLN . . . . . . . . . . . . . 97.5 mt-30 -99.22 -24.78 14.73 Favored 'General case' 0 C--O 1.233 0.227 0 N-CA-C 113.096 0.776 . . . . 0.0 113.096 -171.761 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 137' ' ' LYS . . . . . . . . . . . . . 57.0 pttt -161.01 168.25 24.89 Favored 'General case' 0 C--O 1.232 0.163 0 CA-C-O 121.619 0.723 . . . . 0.0 112.56 -173.23 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 138' ' ' LEU . . . . . . . . . . . . . 6.9 tt -120.07 128.36 53.41 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 114.848 -1.069 . . . . 0.0 110.009 178.219 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 139' ' ' THR . . . . . . . . . . . . . 43.1 m -106.49 127.82 53.6 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.068 -0.515 . . . . 0.0 110.28 179.562 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 140' ' ' LEU . . . . . . . . . . . . . 19.3 tp -114.92 119.26 35.95 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 115.795 -0.639 . . . . 0.0 109.674 -177.969 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 141' ' ' ILE . . . . . . . . . . . . . 19.3 mt -119.35 119.91 62.07 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.221 0 CA-C-O 120.95 0.405 . . . . 0.0 110.015 -174.516 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 142' ' ' ARG . . . . . . . . . . . . . 76.2 mtm180 -113.77 126.21 54.96 Favored 'General case' 0 C--N 1.332 -0.166 0 CA-C-N 115.44 -0.8 . . . . 0.0 110.369 -177.97 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 143' ' ' THR . . . . . . . . . . . . . 52.0 p . . . . . 0 C--O 1.22 -0.493 0 CA-C-O 118.123 -0.942 . . . . 0.0 110.527 -179.564 . . . . . . . . 0 0 . 1 . 004 nuclear orig core ' C' C ' 2' ' ' SER . . . . . . . . . . . . . 3.9 p . . . . . 0 N--CA 1.462 0.151 0 CA-C-O 120.861 0.362 . . . . 0.0 110.597 . . . . . . . . . 0 0 . 1 . 004 nuclear orig core ' C' C ' 3' ' ' GLU . . . . . . . . . . . . . 93.6 mt-10 -141.04 140.9 34.33 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 115.974 -0.557 . . . . 0.0 110.879 -179.292 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' C' C ' 4' ' ' LEU . . . . . . . . . . . . . 15.5 tp -125.21 130.29 51.8 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 116.151 -0.477 . . . . 0.0 110.01 175.629 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' C' C ' 5' ' ' LYS . . . . . . . . . . . . . 96.5 mttt -111.77 121.85 46.21 Favored 'General case' 0 C--N 1.332 -0.192 0 CA-C-N 116.686 -0.234 . . . . 0.0 110.939 -178.512 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' C' C ' 6' ' ' LEU . . . . . . . . . . . . . 27.7 mt -114.3 140.91 48.23 Favored 'General case' 0 C--O 1.234 0.27 0 CA-C-N 115.504 -0.771 . . . . 0.0 110.591 -179.506 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' C' C ' 7' ' ' LYS . . . . . . . . . . . . . 41.1 tttp -121.54 137.88 27.6 Favored Pre-proline 0 CA--C 1.534 0.351 0 CA-C-O 118.935 -0.555 . . . . 0.0 109.592 174.934 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' C' C ' 8' ' ' PRO . . . . . . . . . . . . . 86.9 Cg_endo -91.93 134.68 1.49 Allowed 'Trans proline' 0 N--CA 1.488 1.193 0 C-N-CA 121.682 1.588 . . . . 0.0 111.831 178.858 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' C' C ' 9' ' ' LEU . . . . . . . . . . . . . 49.0 mt -76.66 -46.26 3.15 Favored Pre-proline 0 CA--C 1.533 0.319 0 CA-C-O 118.791 -0.623 . . . . 0.0 111.764 -179.908 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' C' C ' 10' ' ' PRO . . . . . . . . . . . . . 79.2 Cg_endo -83.78 140.46 9.19 Favored 'Trans proline' 0 N--CA 1.495 1.575 0 C-N-CA 121.288 1.325 . . . . 0.0 111.408 173.259 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' C' C ' 11' ' ' LYS . . . . . . . . . . . . . 48.8 pttt -78.96 111.34 15.05 Favored 'General case' 0 C--N 1.331 -0.214 0 CA-C-O 121.449 0.642 . . . . 0.0 110.174 178.414 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' C' C ' 12' ' ' VAL . . . . . . . . . . . . . 11.6 p -151.1 151.99 11.79 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.373 0 CA-C-N 115.711 -0.677 . . . . 0.0 110.589 -178.553 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' C' C ' 13' ' ' GLU . . . . . . . . . . . . . 80.6 tt0 -91.04 124.51 35.33 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.303 -0.408 . . . . 0.0 110.082 177.241 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' C' C ' 14' ' ' LEU . . . . . . . . . . . . . 23.8 mt -95.16 150.87 38.29 Favored Pre-proline 0 C--N 1.329 -0.284 0 CA-C-O 119.332 -0.366 . . . . 0.0 110.511 -179.141 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' C' C ' 15' ' ' PRO . . . . . . . . . . . . . 28.2 Cg_exo -60.51 157.86 34.56 Favored 'Trans proline' 0 N--CA 1.496 1.673 0 C-N-CA 121.257 1.305 . . . . 0.0 111.65 177.623 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' C' C ' 16' ' ' PRO . . . . . . . . . . . . . 38.4 Cg_exo -58.27 -39.79 81.52 Favored 'Trans proline' 0 N--CA 1.497 1.722 0 C-N-CA 121.428 1.419 . . . . 0.0 112.634 -178.718 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' C' C ' 17' ' ' ASP . . . . . . . . . . . . . 19.5 p-10 -87.79 12.76 12.13 Favored 'General case' 0 CA--C 1.536 0.421 0 N-CA-C 113.027 0.751 . . . . 0.0 113.027 -177.896 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' C' C ' 18' ' ' PHE . . . . . . . . . . . . . 45.9 t80 -57.85 -41.29 82.05 Favored 'General case' 0 C--O 1.228 -0.046 0 O-C-N 122.008 -0.432 . . . . 0.0 110.271 -178.664 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' C' C ' 19' ' ' VAL . . . . . . . . . . . . . 48.5 t -56.49 -43.83 79.0 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.271 0 CA-C-N 116.529 -0.305 . . . . 0.0 110.429 -179.484 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' C' C ' 20' ' ' ASP . . . . . . . . . . . . . 35.3 m-20 -60.31 -41.18 92.95 Favored 'General case' 0 C--N 1.33 -0.282 0 C-N-CA 120.872 -0.331 . . . . 0.0 110.719 -178.935 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' C' C ' 21' ' ' VAL . . . . . . . . . . . . . 47.9 t -63.33 -49.23 83.77 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 C-N-CA 120.836 -0.346 . . . . 0.0 110.344 -178.232 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' C' C ' 22' ' ' ILE . . . . . . . . . . . . . 50.6 mm -55.63 -47.57 78.79 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.268 0 CA-C-O 120.696 0.284 . . . . 0.0 110.828 179.482 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' C' C ' 23' ' ' ARG . . . . . . . . . . . . . 50.8 ttp180 -53.97 -50.65 66.06 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-O 120.619 0.247 . . . . 0.0 111.444 -177.832 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' C' C ' 24' ' ' ILE . . . . . . . . . . . . . 75.5 mt -58.66 -43.0 86.58 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.286 0 CA-C-N 116.688 -0.233 . . . . 0.0 111.139 -177.454 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' C' C ' 25' ' ' LYS . . . . . . . . . . . . . 42.8 mttm -65.37 -40.88 94.08 Favored 'General case' 0 C--N 1.328 -0.348 0 N-CA-C 112.223 0.453 . . . . 0.0 112.223 -178.264 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' C' C ' 26' ' ' LEU . . . . . . . . . . . . . 91.9 mt -79.98 -39.4 30.16 Favored 'General case' 0 C--N 1.33 -0.253 0 N-CA-C 113.546 0.943 . . . . 0.0 113.546 -170.061 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' C' C ' 27' ' ' GLN . . . . . . . . . . . . . 10.4 pt20 -46.35 138.71 5.36 Favored 'General case' 0 N--CA 1.47 0.527 0 N-CA-C 112.922 0.712 . . . . 0.0 112.922 -174.162 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' C' C ' 28' ' ' GLY . . . . . . . . . . . . . . . 99.95 -27.27 21.06 Favored Glycine 0 CA--C 1.534 1.263 0 CA-C-N 115.47 -0.786 . . . . 0.0 112.175 -177.074 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' C' C ' 29' ' ' LYS . . . . . . . . . . . . . 99.0 mttt -97.83 155.15 17.18 Favored 'General case' 0 C--O 1.234 0.272 0 CA-C-O 121.107 0.48 . . . . 0.0 111.26 179.457 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' C' C ' 30' ' ' THR . . . . . . . . . . . . . 36.2 m -104.82 138.93 40.33 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 115.903 -0.59 . . . . 0.0 110.057 176.14 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' C' C ' 31' ' ' VAL . . . . . . . . . . . . . 35.3 m -126.76 149.94 32.2 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.197 0 CA-C-O 120.878 0.37 . . . . 0.0 110.814 -178.702 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' C' C ' 32' ' ' ARG . . . . . . . . . . . . . 73.8 mtt85 -128.28 148.1 50.63 Favored 'General case' 0 C--N 1.331 -0.239 0 CA-C-N 116.041 -0.527 . . . . 0.0 110.481 178.788 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' C' C ' 33' ' ' THR . . . . . . . . . . . . . 11.2 m -52.68 137.89 29.96 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.292 -0.413 . . . . 0.0 111.497 -177.763 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' C' C ' 34' ' ' GLY . . . . . . . . . . . . . . . 101.31 -17.16 56.09 Favored Glycine 0 CA--C 1.532 1.134 0 CA-C-O 119.643 -0.532 . . . . 0.0 113.241 179.221 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' C' C ' 35' ' ' ASP . . . . . . . . . . . . . 77.9 m-20 -66.47 150.49 48.87 Favored 'General case' 0 N--CA 1.462 0.168 0 CA-C-N 118.062 0.931 . . . . 0.0 110.912 178.917 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' C' C ' 36' ' ' VAL . . . . . . . . . . . . . 43.9 t -124.49 132.57 71.15 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.264 0 CA-C-N 116.107 -0.497 . . . . 0.0 109.908 178.503 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' C' C ' 37' ' ' ILE . . . . . . . . . . . . . 64.3 mt -120.82 139.21 48.79 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.187 0 CA-C-N 116.065 -0.516 . . . . 0.0 109.863 -179.53 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' C' C ' 38' ' ' GLY . . . . . . . . . . . . . . . -116.16 128.7 8.1 Favored Glycine 0 CA--C 1.526 0.752 0 N-CA-C 110.922 -0.871 . . . . 0.0 110.922 178.826 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' C' C ' 39' ' ' ILE . . . . . . . . . . . . . 71.2 mt -124.53 135.27 64.4 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.215 0 CA-C-O 120.733 0.302 . . . . 0.0 110.209 179.806 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' C' C ' 40' ' ' SER . . . . . . . . . . . . . 78.9 p -92.05 121.99 34.12 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.2 -0.455 . . . . 0.0 110.885 176.942 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' C' C ' 41' ' ' ILE . . . . . . . . . . . . . 71.0 mt -130.68 120.69 48.62 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.166 0 CA-C-O 120.772 0.32 . . . . 0.0 110.461 178.07 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' C' C ' 42' ' ' LEU . . . . . . . . . . . . . 76.4 mt 53.21 35.32 19.66 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.141 -0.481 . . . . 0.0 111.703 177.349 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' C' C ' 43' ' ' GLY . . . . . . . . . . . . . . . 72.47 30.44 64.49 Favored Glycine 0 CA--C 1.53 0.994 0 C-N-CA 121.051 -0.595 . . . . 0.0 112.173 178.015 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' C' C ' 44' ' ' LYS . . . . . . . . . . . . . 29.5 ttmt -138.78 128.7 25.16 Favored 'General case' 0 C--N 1.33 -0.258 0 N-CA-C 109.616 -0.513 . . . . 0.0 109.616 178.195 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' C' C ' 45' ' ' GLU . . . . . . . . . . . . . 83.1 tt0 -83.8 124.25 30.73 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-O 120.705 0.288 . . . . 0.0 111.41 -177.566 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' C' C ' 46' ' ' VAL . . . . . . . . . . . . . 10.2 p -115.89 123.1 70.84 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.245 0 N-CA-C 109.485 -0.561 . . . . 0.0 109.485 173.618 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' C' C ' 47' ' ' LYS . . . . . . . . . . . . . 61.9 mtpt -98.3 124.35 42.88 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.03 -0.532 . . . . 0.0 110.76 179.016 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' C' C ' 48' ' ' PHE . . . . . . . . . . . . . 32.7 m-85 -110.78 131.84 54.71 Favored 'General case' 0 C--N 1.33 -0.247 0 N-CA-C 109.659 -0.497 . . . . 0.0 109.659 177.178 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' C' C ' 49' ' ' LYS . . . . . . . . . . . . . 82.8 tttt -106.51 132.36 52.61 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.224 179.068 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' C' C ' 50' ' ' VAL . . . . . . . . . . . . . 42.7 t -75.92 103.54 3.52 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.335 0 N-CA-C 109.432 -0.581 . . . . 0.0 109.432 178.021 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' C' C ' 51' ' ' VAL . . . . . . . . . . . . . 44.9 t -69.47 -54.07 21.56 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 CA-C-N 115.898 -0.592 . . . . 0.0 109.449 -175.437 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' C' C ' 52' ' ' GLN . . . . . . . . . . . . . 89.1 mt-30 -153.27 150.73 29.26 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.007 -0.542 . . . . 0.0 111.531 -177.961 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' C' C ' 53' ' ' ALA . . . . . . . . . . . . . . . -126.92 131.65 51.06 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 115.157 -0.929 . . . . 0.0 109.478 174.637 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' C' C ' 54' ' ' TYR . . . . . . . . . . . . . 78.0 t80 -129.1 109.62 18.13 Favored Pre-proline 0 CA--C 1.534 0.359 0 CA-C-O 118.281 -0.866 . . . . 0.0 110.464 -179.17 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' C' C ' 55' ' ' PRO . . . . . . . . . . . . . 73.6 Cg_endo -77.15 170.02 72.68 Favored 'Cis proline' 0 N--CA 1.501 1.936 0 CA-C-N 121.895 1.713 . . . . 0.0 112.269 -6.057 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' C' C ' 56' ' ' SER . . . . . . . . . . . . . 13.6 m -116.28 131.15 23.96 Favored Pre-proline 0 CA--C 1.538 0.487 0 CA-C-O 118.46 -0.781 . . . . 0.0 109.36 174.972 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' C' C ' 57' ' ' PRO . . . . . . . . . . . . . 55.3 Cg_endo -71.38 146.83 86.3 Favored 'Cis proline' 0 N--CA 1.497 1.73 0 CA-C-N 121.996 1.749 . . . . 0.0 111.531 -1.055 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' C' C ' 58' ' ' LEU . . . . . . . . . . . . . 14.4 tp -105.97 136.59 45.36 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.286 -0.416 . . . . 0.0 110.651 -178.422 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' C' C ' 59' ' ' ARG . . . . . . . . . . . . . 78.6 ttt180 -103.58 122.46 45.02 Favored 'General case' 0 C--N 1.327 -0.394 0 N-CA-C 109.308 -0.627 . . . . 0.0 109.308 175.788 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' C' C ' 60' ' ' VAL . . . . . . . . . . . . . 42.2 t -80.09 123.71 37.21 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.315 0 C-N-CA 120.704 -0.398 . . . . 0.0 110.48 -175.346 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' C' C ' 61' ' ' GLU . . . . . . . . . . . . . 95.6 mt-10 -130.84 164.25 25.62 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 115.705 -0.679 . . . . 0.0 109.745 177.645 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' C' C ' 62' ' ' ASP . . . . . . . . . . . . . 48.1 m-20 -53.37 -32.1 47.76 Favored 'General case' 0 C--N 1.327 -0.371 0 N-CA-C 111.895 0.331 . . . . 0.0 111.895 -179.178 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' C' C ' 63' ' ' ARG . . . . . . . . . . . . . 35.9 ptt180 -88.5 5.17 43.86 Favored 'General case' 0 CA--C 1.537 0.46 0 N-CA-C 113.676 0.991 . . . . 0.0 113.676 -174.929 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' C' C ' 64' ' ' THR . . . . . . . . . . . . . 26.0 m -84.59 141.66 30.52 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-N 118.19 0.45 . . . . 0.0 110.653 -178.7 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' C' C ' 65' ' ' LYS . . . . . . . . . . . . . 98.8 mttt -89.52 133.53 34.54 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-O 121.092 0.473 . . . . 0.0 110.646 -179.195 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' C' C ' 66' ' ' ILE . . . . . . . . . . . . . 60.4 mt -114.15 127.26 71.66 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.237 0 N-CA-C 109.579 -0.526 . . . . 0.0 109.579 179.482 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' C' C ' 67' ' ' THR . . . . . . . . . . . . . 15.1 m -120.5 142.66 49.1 Favored 'General case' 0 C--N 1.331 -0.214 0 CA-C-O 121.176 0.512 . . . . 0.0 111.149 -175.597 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' C' C ' 68' ' ' LEU . . . . . . . . . . . . . 34.2 mt . . . . . 0 C--N 1.329 -0.301 0 CA-C-N 115.761 -0.654 . . . . 0.0 110.534 179.605 . . . . . . . . 0 0 . 1 . 004 nuclear orig core ' C' C ' 73' ' ' VAL . . . . . . . . . . . . . 34.6 m . . . . . 0 CA--C 1.528 0.129 0 CA-C-O 120.469 0.176 . . . . 0.0 110.618 . . . . . . . . . 0 0 . 1 . 004 nuclear orig core ' C' C ' 74' ' ' ASP . . . . . . . . . . . . . 15.7 t0 -96.06 122.75 39.22 Favored 'General case' 0 C--N 1.333 -0.147 0 C-N-CA 120.753 -0.379 . . . . 0.0 110.489 -174.094 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' C' C ' 75' ' ' VAL . . . . . . . . . . . . . 41.2 t -121.07 121.17 64.28 Favored 'Isoleucine or valine' 0 N--CA 1.462 0.166 0 CA-C-O 121.119 0.485 . . . . 0.0 110.498 -179.364 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' C' C ' 76' ' ' LEU . . . . . . . . . . . . . 5.4 mp -118.01 150.78 38.71 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 115.651 -0.704 . . . . 0.0 109.501 175.833 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' C' C ' 77' ' ' GLU . . . . . . . . . . . . . 97.7 mt-10 -136.87 136.59 38.84 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-O 121.042 0.449 . . . . 0.0 111.214 -177.769 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' C' C ' 78' ' ' ALA . . . . . . . . . . . . . . . -124.77 135.91 53.39 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 115.669 -0.696 . . . . 0.0 109.712 176.353 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' C' C ' 79' ' ' LYS . . . . . . . . . . . . . 99.0 mttt -81.73 119.04 23.35 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-O 120.913 0.387 . . . . 0.0 110.757 -178.498 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' C' C ' 80' ' ' ILE . . . . . . . . . . . . . 35.5 mm -139.1 105.6 2.61 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.334 0 N-CA-C 109.22 -0.659 . . . . 0.0 109.22 -178.013 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' C' C ' 81' ' ' LYS . . . . . . . . . . . . . 53.4 mtmt -98.12 125.24 43.04 Favored 'General case' 0 C--N 1.329 -0.314 0 C-N-CA 120.95 -0.3 . . . . 0.0 111.167 -176.934 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' C' C ' 82' ' ' GLY . . . . . . . . . . . . . . . 89.17 42.04 5.69 Favored Glycine 0 CA--C 1.526 0.728 0 C-N-CA 120.786 -0.721 . . . . 0.0 112.048 174.816 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' C' C ' 83' ' ' ILE . . . . . . . . . . . . . 76.5 mt -69.8 138.3 22.38 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.336 0 N-CA-C 109.676 -0.491 . . . . 0.0 109.676 176.749 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' C' C ' 84' ' ' LYS . . . . . . . . . . . . . 38.0 ttpt -101.58 -50.56 3.69 Favored 'General case' 0 C--N 1.331 -0.23 0 CA-C-O 120.942 0.401 . . . . 0.0 110.381 -178.77 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' C' C ' 85' ' ' ASP . . . . . . . . . . . . . 6.6 t0 -149.65 147.51 28.19 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 115.938 -0.574 . . . . 0.0 110.509 -178.572 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' C' C ' 86' ' ' VAL . . . . . . . . . . . . . 43.7 t -129.35 133.64 65.12 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.215 0 CA-C-O 120.925 0.393 . . . . 0.0 110.414 -179.043 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' C' C ' 87' ' ' ILE . . . . . . . . . . . . . 4.9 mp -121.94 127.6 75.42 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.215 0 CA-C-N 115.854 -0.612 . . . . 0.0 109.449 176.62 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' C' C ' 88' ' ' LEU . . . . . . . . . . . . . 22.3 tp -118.07 131.52 56.44 Favored 'General case' 0 C--N 1.331 -0.221 0 CA-C-O 121.078 0.466 . . . . 0.0 111.339 -177.279 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' C' C ' 89' ' ' ASP . . . . . . . . . . . . . 14.0 t70 -130.84 152.02 50.63 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 115.616 -0.72 . . . . 0.0 109.293 174.987 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' C' C ' 90' ' ' GLU . . . . . . . . . . . . . 84.9 tt0 -47.81 -35.73 10.62 Favored 'General case' 0 C--N 1.329 -0.286 0 N-CA-C 113.079 0.77 . . . . 0.0 113.079 -172.299 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' C' C ' 91' ' ' ASN . . . . . . . . . . . . . 35.9 m120 -115.4 2.88 14.03 Favored 'General case' 0 N--CA 1.468 0.462 0 N-CA-C 113.734 1.012 . . . . 0.0 113.734 -174.664 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' C' C ' 92' ' ' LEU . . . . . . . . . . . . . 40.7 mt -148.77 147.31 28.66 Favored 'General case' 0 C--N 1.332 -0.196 0 CA-C-N 118.305 0.502 . . . . 0.0 110.972 -175.228 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' C' C ' 93' ' ' ILE . . . . . . . . . . . . . 69.4 mt -125.18 122.05 62.16 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.278 0 N-CA-C 109.383 -0.599 . . . . 0.0 109.383 176.998 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' C' C ' 94' ' ' VAL . . . . . . . . . . . . . 42.9 t -121.87 127.12 75.34 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.267 0 CA-C-O 120.802 0.334 . . . . 0.0 110.155 -179.448 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' C' C ' 95' ' ' VAL . . . . . . . . . . . . . 45.8 t -122.7 132.64 70.86 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.249 0 CA-C-N 116.094 -0.503 . . . . 0.0 109.786 179.151 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' C' C ' 96' ' ' ILE . . . . . . . . . . . . . 62.7 mt -115.77 128.37 73.05 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.247 0 N-CA-C 109.433 -0.581 . . . . 0.0 109.433 179.75 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' C' C ' 97' ' ' THR . . . . . . . . . . . . . 64.9 p -105.3 163.16 12.82 Favored 'General case' 0 N--CA 1.464 0.233 0 CA-C-O 121.244 0.545 . . . . 0.0 111.68 -174.636 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' C' C ' 98' ' ' GLU . . . . . . . . . . . . . 14.9 mm-40 -53.78 -27.29 28.11 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 115.933 -0.576 . . . . 0.0 112.203 177.676 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' C' C ' 99' ' ' GLU . . . . . . . . . . . . . 71.1 mm-40 -75.26 9.74 1.93 Allowed 'General case' 0 CA--C 1.535 0.395 0 N-CA-C 113.284 0.846 . . . . 0.0 113.284 -177.681 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' C' C ' 100' ' ' ASN . . . . . . . . . . . . . 3.1 m-20 61.03 31.63 19.86 Favored 'General case' 0 CA--C 1.534 0.342 0 CA-C-N 118.268 0.485 . . . . 0.0 111.302 -178.611 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' C' C ' 101' ' ' GLU . . . . . . . . . . . . . 84.5 tt0 -109.63 145.14 36.95 Favored 'General case' 0 C--O 1.233 0.199 0 N-CA-C 109.729 -0.471 . . . . 0.0 109.729 174.569 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' C' C ' 102' ' ' VAL . . . . . . . . . . . . . 45.2 t -114.99 124.12 71.34 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.302 0 CA-C-N 116.137 -0.483 . . . . 0.0 109.783 -179.834 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' C' C ' 103' ' ' LEU . . . . . . . . . . . . . 21.5 mt -112.26 127.69 56.05 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 115.845 -0.616 . . . . 0.0 109.982 176.902 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' C' C ' 104' ' ' ILE . . . . . . . . . . . . . 66.3 mt -116.88 119.74 62.92 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.261 0 N-CA-C 110.268 -0.271 . . . . 0.0 110.268 -179.728 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' C' C ' 105' ' ' PHE . . . . . . . . . . . . . 44.7 m-85 -119.83 168.87 10.66 Favored 'General case' 0 C--N 1.332 -0.158 0 CA-C-N 115.421 -0.809 . . . . 0.0 110.078 179.183 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' C' C ' 106' ' ' ASN . . . . . . . . . . . . . 46.9 p-10 -103.02 -170.48 1.8 Allowed 'General case' 0 CA--C 1.53 0.187 0 N-CA-C 110.018 -0.364 . . . . 0.0 110.018 174.46 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' C' C ' 107' ' ' GLN . . . . . . . . . . . . . 57.0 tt0 -60.94 -23.2 65.12 Favored 'General case' 0 CA--C 1.532 0.272 0 N-CA-C 112.52 0.563 . . . . 0.0 112.52 -179.803 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' C' C ' 108' ' ' ASN . . . . . . . . . . . . . 37.5 t30 -89.88 14.02 13.12 Favored 'General case' 0 CA--C 1.536 0.406 0 N-CA-C 112.89 0.7 . . . . 0.0 112.89 -179.413 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' C' C ' 109' ' ' LEU . . . . . . . . . . . . . 10.4 tp 54.96 37.95 29.68 Favored 'General case' 0 C--O 1.232 0.144 0 CA-C-O 121.036 0.446 . . . . 0.0 111.225 178.732 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' C' C ' 110' ' ' GLU . . . . . . . . . . . . . 70.7 mm-40 -107.98 155.93 19.79 Favored 'General case' 0 C--N 1.331 -0.237 0 N-CA-C 109.921 -0.4 . . . . 0.0 109.921 175.423 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' C' C ' 111' ' ' GLU . . . . . . . . . . . . . 65.8 tt0 -84.56 122.02 28.43 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-N 116.278 -0.419 . . . . 0.0 111.053 -176.245 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' C' C ' 112' ' ' LEU . . . . . . . . . . . . . 36.2 mt -105.44 -46.04 4.3 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.343 -0.39 . . . . 0.0 110.376 177.58 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' C' C ' 113' ' ' TYR . . . . . . . . . . . . . 56.8 t80 -143.68 141.35 30.5 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.301 -0.409 . . . . 0.0 110.966 -179.487 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' C' C ' 114' ' ' ARG . . . . . . . . . . . . . 58.2 ttp180 -139.45 125.27 19.6 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.248 -0.433 . . . . 0.0 110.332 177.642 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' C' C ' 115' ' ' GLY . . . . . . . . . . . . . . . -149.97 151.11 23.23 Favored Glycine 0 CA--C 1.524 0.624 0 N-CA-C 110.905 -0.878 . . . . 0.0 110.905 -179.963 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' C' C ' 116' ' ' LYS . . . . . . . . . . . . . 53.3 tttt -122.09 134.85 54.76 Favored 'General case' 0 C--N 1.328 -0.355 0 N-CA-C 110.021 -0.363 . . . . 0.0 110.021 179.03 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' C' C ' 117' ' ' PHE . . . . . . . . . . . . . 40.9 m-85 -132.31 114.95 15.01 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-N 116.256 -0.429 . . . . 0.0 110.2 -175.921 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' C' C ' 118' ' ' GLU . . . . . . . . . . . . . 43.2 mt-10 -53.32 -44.95 68.8 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.478 -0.328 . . . . 0.0 111.599 -176.625 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' C' C ' 119' ' ' ASN . . . . . . . . . . . . . 30.4 m120 -100.06 31.07 3.46 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.238 -0.437 . . . . 0.0 112.098 -174.271 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' C' C ' 120' ' ' LEU . . . . . . . . . . . . . 13.2 tp -55.39 119.83 6.19 Favored 'General case' 0 N--CA 1.462 0.174 0 C-N-CA 120.984 -0.286 . . . . 0.0 110.696 178.456 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' C' C ' 121' ' ' ASN . . . . . . . . . . . . . 8.2 t-20 -113.98 -44.07 3.19 Favored 'General case' 0 C--N 1.331 -0.209 0 CA-C-N 116.477 -0.329 . . . . 0.0 111.257 -175.884 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' C' C ' 122' ' ' LYS . . . . . . . . . . . . . 95.1 mttt -142.13 148.74 38.8 Favored 'General case' 0 C--N 1.331 -0.216 0 CA-C-O 121.055 0.455 . . . . 0.0 111.602 -176.255 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' C' C ' 123' ' ' VAL . . . . . . . . . . . . . 47.1 t -132.04 124.58 53.21 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.267 0 CA-C-N 115.846 -0.616 . . . . 0.0 109.418 174.222 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' C' C ' 124' ' ' LEU . . . . . . . . . . . . . 6.3 mp -119.71 134.72 55.12 Favored 'General case' 0 N--CA 1.463 0.191 0 CA-C-N 116.453 -0.34 . . . . 0.0 110.711 -178.118 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' C' C ' 125' ' ' VAL . . . . . . . . . . . . . 43.5 t -132.58 124.23 50.95 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.254 0 CA-C-N 116.144 -0.48 . . . . 0.0 110.183 -179.82 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' C' C ' 126' ' ' ARG . . . . . . . . . . . . . 59.9 mtm180 -151.86 135.74 16.42 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.32 -0.4 . . . . 0.0 109.95 176.7 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' C' C ' 127' ' ' ASN . . . . . . . . . . . . . 5.5 m120 55.0 -154.22 0.3 Allowed 'General case' 0 CA--C 1.54 0.559 0 N-CA-C 110.073 -0.343 . . . . 0.0 110.073 177.852 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' C' C ' 128' ' ' ASP . . . . . . . . . . . . . 15.1 p-10 -83.05 20.74 1.16 Allowed 'General case' 0 CA--C 1.533 0.309 0 N-CA-C 112.509 0.559 . . . . 0.0 112.509 178.13 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' C' C ' 129' ' ' LEU . . . . . . . . . . . . . 14.5 tp -123.15 137.1 54.99 Favored 'General case' 0 C--O 1.234 0.269 0 O-C-N 122.052 -0.405 . . . . 0.0 110.311 179.091 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' C' C ' 130' ' ' VAL . . . . . . . . . . . . . 12.3 p -132.74 143.29 40.07 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.255 0 CA-C-O 120.999 0.428 . . . . 0.0 110.2 179.412 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' C' C ' 131' ' ' VAL . . . . . . . . . . . . . 41.5 t -136.04 138.93 46.72 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.37 0 CA-C-N 116.032 -0.531 . . . . 0.0 110.339 -178.436 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' C' C ' 132' ' ' ILE . . . . . . . . . . . . . 71.3 mt -116.09 132.45 65.59 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.323 0 CA-C-N 115.614 -0.721 . . . . 0.0 109.141 177.683 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' C' C ' 133' ' ' ILE . . . . . . . . . . . . . 41.4 mm -116.8 121.61 68.12 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.237 0 CA-C-O 120.753 0.311 . . . . 0.0 110.927 -174.464 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' C' C ' 134' ' ' ASP . . . . . . . . . . . . . 8.1 p-10 -135.42 146.48 48.31 Favored 'General case' 0 C--N 1.332 -0.18 0 CA-C-N 116.006 -0.543 . . . . 0.0 109.589 175.316 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' C' C ' 135' ' ' GLU . . . . . . . . . . . . . 83.2 tt0 -50.53 -27.67 7.09 Favored 'General case' 0 C--N 1.329 -0.321 0 N-CA-C 112.827 0.677 . . . . 0.0 112.827 -172.967 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' C' C ' 136' ' ' GLN . . . . . . . . . . . . . 98.4 mt-30 -79.7 -33.24 41.19 Favored 'General case' 0 C--N 1.331 -0.203 0 N-CA-C 112.263 0.468 . . . . 0.0 112.263 -176.226 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' C' C ' 137' ' ' LYS . . . . . . . . . . . . . 56.1 pttt -169.74 174.7 5.61 Favored 'General case' 0 C--N 1.331 -0.21 0 CA-C-O 121.524 0.678 . . . . 0.0 112.257 -172.894 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' C' C ' 138' ' ' LEU . . . . . . . . . . . . . 6.0 tt -119.14 130.38 55.51 Favored 'General case' 0 C--N 1.331 -0.226 0 CA-C-N 114.973 -1.012 . . . . 0.0 110.236 -179.109 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' C' C ' 139' ' ' THR . . . . . . . . . . . . . 21.7 m -108.52 121.76 45.65 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.141 -0.482 . . . . 0.0 110.755 179.551 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' C' C ' 140' ' ' LEU . . . . . . . . . . . . . 33.3 tp -109.59 118.9 37.8 Favored 'General case' 0 C--N 1.329 -0.283 0 N-CA-C 109.058 -0.719 . . . . 0.0 109.058 -179.975 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' C' C ' 141' ' ' ILE . . . . . . . . . . . . . 22.1 mt -121.82 121.61 64.72 Favored 'Isoleucine or valine' 0 C--O 1.234 0.259 0 CA-C-O 121.089 0.471 . . . . 0.0 110.225 -175.627 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' C' C ' 142' ' ' ARG . . . . . . . . . . . . . 80.6 mtp180 . . . . . 0 C--N 1.33 -0.25 0 CA-C-N 115.273 -0.876 . . . . 0.0 110.111 178.265 . . . . . . . . 0 0 . 1 . 004 nuclear orig core ' D' D ' 2' ' ' SER . . . . . . . . . . . . . 18.2 p . . . . . 0 C--O 1.231 0.131 0 CA-C-O 120.88 0.371 . . . . 0.0 110.274 . . . . . . . . . 0 0 . 1 . 004 nuclear orig core ' D' D ' 3' ' ' GLU . . . . . . . . . . . . . 75.4 tt0 -148.0 139.23 23.46 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.235 -0.439 . . . . 0.0 111.305 -176.816 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' D' D ' 4' ' ' LEU . . . . . . . . . . . . . 16.1 tp -124.01 130.2 52.18 Favored 'General case' 0 C--N 1.331 -0.214 0 CA-C-N 116.051 -0.522 . . . . 0.0 110.031 176.477 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' D' D ' 5' ' ' LYS . . . . . . . . . . . . . 65.3 mttm -112.66 123.22 49.81 Favored 'General case' 0 C--O 1.233 0.215 0 CA-C-N 116.516 -0.311 . . . . 0.0 110.944 -179.734 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' D' D ' 6' ' ' LEU . . . . . . . . . . . . . 55.0 mt -115.72 143.19 45.72 Favored 'General case' 0 N--CA 1.463 0.206 0 CA-C-N 115.609 -0.723 . . . . 0.0 110.63 -179.299 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' D' D ' 7' ' ' LYS . . . . . . . . . . . . . 52.1 tttm -124.36 139.37 32.77 Favored Pre-proline 0 CA--C 1.536 0.409 0 CA-C-O 118.88 -0.581 . . . . 0.0 109.434 175.474 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' D' D ' 8' ' ' PRO . . . . . . . . . . . . . 86.4 Cg_endo -91.72 143.07 2.84 Favored 'Trans proline' 0 N--CA 1.491 1.363 0 C-N-CA 121.707 1.605 . . . . 0.0 112.026 179.647 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' D' D ' 9' ' ' LEU . . . . . . . . . . . . . 48.9 mt -81.98 -46.59 1.01 Allowed Pre-proline 0 CA--C 1.533 0.302 0 CA-C-O 118.757 -0.64 . . . . 0.0 112.113 178.595 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' D' D ' 10' ' ' PRO . . . . . . . . . . . . . 83.6 Cg_endo -83.46 151.5 13.43 Favored 'Trans proline' 0 N--CA 1.495 1.57 0 C-N-CA 121.316 1.344 . . . . 0.0 111.693 174.928 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' D' D ' 11' ' ' LYS . . . . . . . . . . . . . 53.4 pttt -84.98 116.68 23.51 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-O 121.234 0.54 . . . . 0.0 110.144 177.41 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' D' D ' 12' ' ' VAL . . . . . . . . . . . . . 12.1 p -151.06 149.63 14.01 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.223 0 CA-C-N 116.023 -0.535 . . . . 0.0 110.777 -178.457 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' D' D ' 13' ' ' GLU . . . . . . . . . . . . . 84.7 tt0 -99.16 111.69 24.02 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.262 -0.426 . . . . 0.0 110.225 177.164 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' D' D ' 14' ' ' LEU . . . . . . . . . . . . . 20.0 mt -98.37 158.05 33.32 Favored Pre-proline 0 C--N 1.33 -0.274 0 CA-C-N 116.513 -0.312 . . . . 0.0 111.27 -177.469 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' D' D ' 15' ' ' PRO . . . . . . . . . . . . . 23.1 Cg_exo -64.72 161.53 35.48 Favored 'Trans proline' 0 N--CA 1.496 1.671 0 C-N-CA 121.424 1.416 . . . . 0.0 111.876 176.973 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' D' D ' 16' ' ' PRO . . . . . . . . . . . . . 24.6 Cg_exo -62.2 -39.8 45.81 Favored 'Trans proline' 0 N--CA 1.496 1.667 0 C-N-CA 121.53 1.487 . . . . 0.0 112.622 -179.182 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' D' D ' 17' ' ' ASP . . . . . . . . . . . . . 16.2 p-10 -84.66 9.58 13.46 Favored 'General case' 0 CA--C 1.537 0.446 0 N-CA-C 113.175 0.805 . . . . 0.0 113.175 -177.109 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' D' D ' 18' ' ' PHE . . . . . . . . . . . . . 48.0 t80 -56.64 -46.47 81.0 Favored 'General case' 0 C--N 1.334 -0.097 0 O-C-N 121.983 -0.448 . . . . 0.0 110.465 -178.397 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' D' D ' 19' ' ' VAL . . . . . . . . . . . . . 48.0 t -56.65 -42.7 77.22 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.338 0 CA-C-N 116.354 -0.385 . . . . 0.0 110.595 -178.006 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' D' D ' 20' ' ' ASP . . . . . . . . . . . . . 9.9 t0 -59.63 -42.46 92.76 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-O 120.79 0.329 . . . . 0.0 110.839 -177.82 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' D' D ' 21' ' ' VAL . . . . . . . . . . . . . 46.5 t -64.02 -45.96 95.21 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.257 0 C-N-CA 120.806 -0.358 . . . . 0.0 110.479 -178.524 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' D' D ' 22' ' ' ILE . . . . . . . . . . . . . 51.4 mm -54.33 -48.49 67.86 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.258 0 O-C-N 122.289 -0.257 . . . . 0.0 110.812 178.812 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' D' D ' 23' ' ' ARG . . . . . . . . . . . . . 54.1 ttp180 -54.24 -52.12 62.35 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-O 120.793 0.33 . . . . 0.0 111.43 -178.905 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' D' D ' 24' ' ' ILE . . . . . . . . . . . . . 71.4 mt -56.85 -44.2 81.58 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.315 0 CA-C-N 116.541 -0.299 . . . . 0.0 111.271 -174.703 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' D' D ' 25' ' ' LYS . . . . . . . . . . . . . 80.9 mttt -69.34 -43.95 72.64 Favored 'General case' 0 C--N 1.329 -0.311 0 N-CA-C 112.428 0.529 . . . . 0.0 112.428 -177.466 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' D' D ' 26' ' ' LEU . . . . . . . . . . . . . 59.3 mt -83.35 -16.15 47.17 Favored 'General case' 0 C--N 1.329 -0.307 0 N-CA-C 113.786 1.032 . . . . 0.0 113.786 -170.12 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' D' D ' 27' ' ' GLN . . . . . . . . . . . . . 11.0 pt20 -46.65 151.44 0.58 Allowed 'General case' 0 N--CA 1.468 0.439 0 N-CA-C 112.837 0.68 . . . . 0.0 112.837 -177.013 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' D' D ' 28' ' ' GLY . . . . . . . . . . . . . . . 84.74 -18.18 27.07 Favored Glycine 0 CA--C 1.537 1.438 0 CA-C-N 114.937 -1.029 . . . . 0.0 113.055 -173.636 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' D' D ' 29' ' ' LYS . . . . . . . . . . . . . 51.7 mttm -86.5 134.81 33.64 Favored 'General case' 0 CA--C 1.535 0.371 0 CA-C-N 118.273 1.037 . . . . 0.0 112.596 179.343 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' D' D ' 30' ' ' THR . . . . . . . . . . . . . 26.7 m -88.73 132.77 34.46 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 115.531 -0.759 . . . . 0.0 109.593 175.791 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' D' D ' 31' ' ' VAL . . . . . . . . . . . . . 35.0 m -126.46 148.8 31.14 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.29 0 CA-C-O 120.767 0.318 . . . . 0.0 111.066 -177.532 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' D' D ' 32' ' ' ARG . . . . . . . . . . . . . 75.6 mtt180 -131.29 151.07 51.85 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 116.056 -0.52 . . . . 0.0 110.381 177.764 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' D' D ' 33' ' ' THR . . . . . . . . . . . . . 12.6 m -52.93 137.63 32.02 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.243 -0.435 . . . . 0.0 111.43 -178.49 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' D' D ' 34' ' ' GLY . . . . . . . . . . . . . . . 100.74 -17.1 56.97 Favored Glycine 0 CA--C 1.533 1.177 0 CA-C-O 119.642 -0.532 . . . . 0.0 113.228 178.779 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' D' D ' 35' ' ' ASP . . . . . . . . . . . . . 62.1 m-20 -65.34 150.32 48.48 Favored 'General case' 0 C--O 1.232 0.156 0 CA-C-N 118.038 0.919 . . . . 0.0 111.224 -179.733 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' D' D ' 36' ' ' VAL . . . . . . . . . . . . . 46.8 t -121.22 128.27 75.95 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.272 0 CA-C-N 115.776 -0.647 . . . . 0.0 109.682 178.031 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' D' D ' 37' ' ' ILE . . . . . . . . . . . . . 65.2 mt -122.25 139.24 49.8 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.243 0 CA-C-N 116.159 -0.473 . . . . 0.0 109.807 -179.29 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' D' D ' 38' ' ' GLY . . . . . . . . . . . . . . . -118.47 128.9 7.92 Favored Glycine 0 CA--C 1.526 0.721 0 N-CA-C 111.2 -0.76 . . . . 0.0 111.2 -179.613 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' D' D ' 39' ' ' ILE . . . . . . . . . . . . . 70.3 mt -124.7 130.51 73.39 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.179 0 N-CA-C 109.881 -0.414 . . . . 0.0 109.881 178.196 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' D' D ' 40' ' ' SER . . . . . . . . . . . . . 18.4 m -92.47 124.83 36.8 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.301 -0.409 . . . . 0.0 111.116 177.634 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' D' D ' 41' ' ' ILE . . . . . . . . . . . . . 66.8 mt -135.65 122.84 34.97 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.204 0 N-CA-C 110.02 -0.363 . . . . 0.0 110.02 177.749 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' D' D ' 42' ' ' LEU . . . . . . . . . . . . . 68.2 mt 58.2 35.2 24.83 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.176 -0.465 . . . . 0.0 111.522 178.124 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' D' D ' 43' ' ' GLY . . . . . . . . . . . . . . . 77.88 -10.19 27.05 Favored Glycine 0 CA--C 1.534 1.261 0 C-N-CA 121.235 -0.507 . . . . 0.0 113.418 177.278 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' D' D ' 44' ' ' LYS . . . . . . . . . . . . . 57.7 tttm -102.91 131.52 49.78 Favored 'General case' 0 C--N 1.334 -0.071 0 CA-C-N 118.007 0.903 . . . . 0.0 110.144 177.857 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' D' D ' 45' ' ' GLU . . . . . . . . . . . . . 83.6 tt0 -85.77 133.23 34.01 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.328 -0.396 . . . . 0.0 111.539 -179.318 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' D' D ' 46' ' ' VAL . . . . . . . . . . . . . 9.6 p -120.24 123.96 71.67 Favored 'Isoleucine or valine' 0 C--O 1.233 0.208 0 N-CA-C 109.42 -0.585 . . . . 0.0 109.42 173.206 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' D' D ' 47' ' ' LYS . . . . . . . . . . . . . 98.2 mttt -98.72 127.73 44.74 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.092 -0.504 . . . . 0.0 110.79 178.594 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' D' D ' 48' ' ' PHE . . . . . . . . . . . . . 35.9 m-85 -112.17 131.92 55.19 Favored 'General case' 0 C--N 1.33 -0.263 0 N-CA-C 109.714 -0.476 . . . . 0.0 109.714 177.362 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' D' D ' 49' ' ' LYS . . . . . . . . . . . . . 79.5 tttt -107.07 133.04 52.29 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.325 -0.398 . . . . 0.0 109.967 177.531 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' D' D ' 50' ' ' VAL . . . . . . . . . . . . . 43.2 t -76.71 109.83 11.49 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.339 0 N-CA-C 109.631 -0.507 . . . . 0.0 109.631 179.001 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' D' D ' 51' ' ' VAL . . . . . . . . . . . . . 47.3 t -74.17 -48.37 37.65 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.35 0 CA-C-N 116.057 -0.52 . . . . 0.0 109.918 -175.179 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' D' D ' 52' ' ' GLN . . . . . . . . . . . . . 48.4 tt0 -160.72 137.75 9.03 Favored 'General case' 0 C--N 1.33 -0.266 0 C-N-CA 120.299 -0.56 . . . . 0.0 111.595 -178.121 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' D' D ' 53' ' ' ALA . . . . . . . . . . . . . . . -116.64 132.12 56.77 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 115.975 -0.557 . . . . 0.0 109.744 174.619 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' D' D ' 54' ' ' TYR . . . . . . . . . . . . . 50.7 t80 -129.01 112.02 18.51 Favored Pre-proline 0 CA--C 1.535 0.385 0 CA-C-O 118.166 -0.921 . . . . 0.0 110.346 179.12 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' D' D ' 55' ' ' PRO . . . . . . . . . . . . . 73.8 Cg_endo -77.18 168.73 76.1 Favored 'Cis proline' 0 N--CA 1.499 1.822 0 CA-C-N 122.061 1.772 . . . . 0.0 112.368 -6.223 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' D' D ' 56' ' ' SER . . . . . . . . . . . . . 13.5 m -117.11 126.57 27.34 Favored Pre-proline 0 CA--C 1.538 0.505 0 CA-C-O 118.347 -0.835 . . . . 0.0 109.108 174.732 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' D' D ' 57' ' ' PRO . . . . . . . . . . . . . 49.6 Cg_endo -69.55 146.66 82.37 Favored 'Cis proline' 0 N--CA 1.497 1.683 0 CA-C-N 122.063 1.772 . . . . 0.0 112.044 1.934 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' D' D ' 58' ' ' LEU . . . . . . . . . . . . . 17.5 tp -106.28 135.09 48.38 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 115.99 -0.55 . . . . 0.0 110.641 179.745 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' D' D ' 59' ' ' ARG . . . . . . . . . . . . . 1.5 tpm_? -104.58 107.59 18.6 Favored 'General case' 0 C--N 1.327 -0.401 0 N-CA-C 109.01 -0.737 . . . . 0.0 109.01 178.473 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' D' D ' 60' ' ' VAL . . . . . . . . . . . . . 43.1 t -72.69 108.72 4.25 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.378 0 CA-C-O 121.449 0.642 . . . . 0.0 112.005 -174.643 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' D' D ' 61' ' ' GLU . . . . . . . . . . . . . 95.7 mt-10 -125.16 167.21 15.13 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.269 -0.423 . . . . 0.0 109.892 175.624 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' D' D ' 62' ' ' ASP . . . . . . . . . . . . . 7.6 t0 -52.85 -32.36 44.12 Favored 'General case' 0 C--N 1.328 -0.36 0 N-CA-C 112.066 0.395 . . . . 0.0 112.066 -177.035 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' D' D ' 63' ' ' ARG . . . . . . . . . . . . . 34.5 ptt180 -73.66 -17.32 61.16 Favored 'General case' 0 CA--C 1.535 0.38 0 N-CA-C 113.282 0.845 . . . . 0.0 113.282 -175.743 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' D' D ' 64' ' ' THR . . . . . . . . . . . . . 32.6 m -77.54 143.75 38.16 Favored 'General case' 0 C--N 1.331 -0.229 0 CA-C-O 120.872 0.368 . . . . 0.0 111.048 -175.511 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' D' D ' 65' ' ' LYS . . . . . . . . . . . . . 99.1 mttt -89.17 134.62 33.95 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 115.977 -0.556 . . . . 0.0 110.313 178.591 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' D' D ' 66' ' ' ILE . . . . . . . . . . . . . 69.2 mt -118.7 127.66 75.64 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.228 0 N-CA-C 109.733 -0.469 . . . . 0.0 109.733 178.625 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' D' D ' 67' ' ' THR . . . . . . . . . . . . . 20.2 m -116.02 135.87 53.56 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.113 -0.494 . . . . 0.0 110.948 -176.72 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' D' D ' 68' ' ' LEU . . . . . . . . . . . . . 16.7 tp . . . . . 0 C--N 1.33 -0.249 0 CA-C-N 115.726 -0.67 . . . . 0.0 110.319 178.553 . . . . . . . . 0 0 . 1 . 004 nuclear orig core ' D' D ' 73' ' ' VAL . . . . . . . . . . . . . 36.0 m . . . . . 0 C--O 1.231 0.13 0 CA-C-O 120.743 0.306 . . . . 0.0 110.182 . . . . . . . . . 0 0 . 1 . 004 nuclear orig core ' D' D ' 74' ' ' ASP . . . . . . . . . . . . . 18.5 t0 -95.21 116.66 29.04 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.152 -0.477 . . . . 0.0 109.831 -178.45 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' D' D ' 75' ' ' VAL . . . . . . . . . . . . . 44.6 t -111.68 121.95 65.15 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.227 0 CA-C-O 121.164 0.507 . . . . 0.0 110.547 -177.02 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' D' D ' 76' ' ' LEU . . . . . . . . . . . . . 21.7 mt -122.13 140.47 52.5 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 115.563 -0.744 . . . . 0.0 109.514 177.543 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' D' D ' 77' ' ' GLU . . . . . . . . . . . . . 46.7 mt-10 -133.77 135.88 44.19 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-O 120.92 0.39 . . . . 0.0 111.126 -178.136 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' D' D ' 78' ' ' ALA . . . . . . . . . . . . . . . -124.59 127.18 46.98 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 115.729 -0.669 . . . . 0.0 109.998 177.771 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' D' D ' 79' ' ' LYS . . . . . . . . . . . . . 37.0 tptt -75.9 115.72 15.88 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-O 120.864 0.364 . . . . 0.0 110.535 -177.89 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' D' D ' 80' ' ' ILE . . . . . . . . . . . . . 40.4 mm -139.26 111.59 5.62 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.287 0 N-CA-C 109.493 -0.558 . . . . 0.0 109.493 -176.355 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' D' D ' 81' ' ' LYS . . . . . . . . . . . . . 99.1 mttt -101.14 123.82 45.89 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-O 120.855 0.36 . . . . 0.0 110.96 -178.091 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' D' D ' 82' ' ' GLY . . . . . . . . . . . . . . . 89.0 42.35 5.66 Favored Glycine 0 CA--C 1.524 0.647 0 C-N-CA 120.791 -0.718 . . . . 0.0 111.826 175.05 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' D' D ' 83' ' ' ILE . . . . . . . . . . . . . 71.8 mt -63.77 136.73 25.89 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.33 0 N-CA-C 109.607 -0.516 . . . . 0.0 109.607 176.338 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' D' D ' 84' ' ' LYS . . . . . . . . . . . . . 76.7 tttt -95.78 -53.95 3.52 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.107 -0.497 . . . . 0.0 110.412 -177.567 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' D' D ' 85' ' ' ASP . . . . . . . . . . . . . 12.9 t70 -151.43 148.87 28.62 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 115.878 -0.601 . . . . 0.0 110.379 -179.21 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' D' D ' 86' ' ' VAL . . . . . . . . . . . . . 42.2 t -127.84 128.17 68.96 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.28 0 CA-C-O 120.886 0.374 . . . . 0.0 110.379 -179.078 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' D' D ' 87' ' ' ILE . . . . . . . . . . . . . 4.9 mp -122.36 127.39 75.11 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.153 0 CA-C-N 115.994 -0.548 . . . . 0.0 109.634 176.993 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' D' D ' 88' ' ' LEU . . . . . . . . . . . . . 58.5 mt -110.22 134.96 51.7 Favored 'General case' 0 C--N 1.331 -0.204 0 CA-C-O 121.025 0.441 . . . . 0.0 110.802 -179.784 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' D' D ' 89' ' ' ASP . . . . . . . . . . . . . 4.4 t70 -123.82 163.12 21.85 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 115.775 -0.648 . . . . 0.0 109.526 178.265 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' D' D ' 90' ' ' GLU . . . . . . . . . . . . . 43.6 tp10 -44.92 -46.02 10.72 Favored 'General case' 0 N--CA 1.464 0.255 0 N-CA-C 113.158 0.799 . . . . 0.0 113.158 -171.495 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' D' D ' 91' ' ' ASN . . . . . . . . . . . . . 25.5 p30 -132.1 26.93 4.55 Favored 'General case' 0 N--CA 1.465 0.276 0 N-CA-C 112.408 0.521 . . . . 0.0 112.408 -178.837 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' D' D ' 92' ' ' LEU . . . . . . . . . . . . . 15.3 mt -147.72 150.44 34.32 Favored 'General case' 0 C--N 1.332 -0.164 0 CA-C-O 120.738 0.304 . . . . 0.0 110.493 -176.352 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' D' D ' 93' ' ' ILE . . . . . 0.41 HG22 HD12 ' D' ' 93' ' ' ILE . 69.0 mt -126.38 119.55 54.2 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.272 0 N-CA-C 109.363 -0.606 . . . . 0.0 109.363 177.785 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' D' D ' 94' ' ' VAL . . . . . . . . . . . . . 45.2 t -119.69 126.28 75.16 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.282 0 CA-C-O 120.99 0.424 . . . . 0.0 109.892 -179.743 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' D' D ' 95' ' ' VAL . . . . . . . . . . . . . 45.6 t -124.15 136.22 61.1 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.265 0 CA-C-N 116.003 -0.544 . . . . 0.0 110.046 -179.392 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' D' D ' 96' ' ' ILE . . . . . . . . . . . . . 54.4 mt -114.75 128.52 71.82 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.343 0 N-CA-C 108.979 -0.749 . . . . 0.0 108.979 178.539 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' D' D ' 97' ' ' THR . . . . . . . . . . . . . 55.1 p -101.11 160.53 14.31 Favored 'General case' 0 C--N 1.331 -0.216 0 CA-C-O 121.115 0.484 . . . . 0.0 111.416 -175.824 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' D' D ' 98' ' ' GLU . . . . . . . . . . . . . 84.2 tt0 -53.86 -26.97 27.12 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.192 -0.458 . . . . 0.0 112.094 178.399 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' D' D ' 99' ' ' GLU . . . . . . . . . . . . . 43.6 mt-10 -77.83 14.34 1.11 Allowed 'General case' 0 CA--C 1.536 0.409 0 N-CA-C 113.01 0.744 . . . . 0.0 113.01 -178.921 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' D' D ' 100' ' ' ASN . . . . . . . . . . . . . 1.9 m120 63.58 37.87 10.03 Favored 'General case' 0 CA--C 1.529 0.155 0 CA-C-N 118.103 0.411 . . . . 0.0 110.731 177.288 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' D' D ' 101' ' ' GLU . . . . . . . . . . . . . 96.7 mt-10 -113.12 148.21 35.76 Favored 'General case' 0 C--O 1.232 0.152 0 CA-C-N 116.268 -0.424 . . . . 0.0 110.377 177.356 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' D' D ' 102' ' ' VAL . . . . . . . . . . . . . 45.5 t -114.88 121.73 67.55 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.367 0 CA-C-N 115.662 -0.699 . . . . 0.0 109.412 177.811 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' D' D ' 103' ' ' LEU . . . . . . . . . . . . . 21.1 mt -115.0 125.66 53.85 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 115.811 -0.631 . . . . 0.0 109.889 177.531 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' D' D ' 104' ' ' ILE . . . . . . . . . . . . . 69.5 mt -114.77 118.77 59.7 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 N-CA-C 110.038 -0.356 . . . . 0.0 110.038 -179.648 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' D' D ' 105' ' ' PHE . . . . . . . . . . . . . 27.9 m-85 -119.88 166.1 13.74 Favored 'General case' 0 C--N 1.331 -0.216 0 O-C-N 123.972 0.795 . . . . 0.0 109.929 178.513 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' D' D ' 106' ' ' ASN . . . . . . . . . . . . . 41.3 p-10 -98.27 -170.33 1.95 Allowed 'General case' 0 C--N 1.329 -0.313 0 N-CA-C 109.791 -0.448 . . . . 0.0 109.791 174.614 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' D' D ' 107' ' ' GLN . . . . . . . . . . . . . 58.1 tt0 -59.77 -29.79 68.42 Favored 'General case' 0 CA--C 1.532 0.285 0 N-CA-C 111.827 0.306 . . . . 0.0 111.827 178.675 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' D' D ' 108' ' ' ASN . . . . . . . . . . . . . 5.1 t-20 -81.99 3.19 27.49 Favored 'General case' 0 CA--C 1.536 0.442 0 N-CA-C 113.283 0.846 . . . . 0.0 113.283 -177.443 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' D' D ' 109' ' ' LEU . . . . . . . . . . . . . 9.5 tp 64.48 40.94 5.91 Favored 'General case' 0 CA--C 1.53 0.182 0 CA-C-O 121.13 0.491 . . . . 0.0 111.364 177.543 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' D' D ' 110' ' ' GLU . . . . . . . . . . . . . 70.7 mm-40 -111.11 160.97 16.4 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-N 116.226 -0.443 . . . . 0.0 109.954 175.243 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' D' D ' 111' ' ' GLU . . . . . . . . . . . . . 45.1 tp10 -84.55 127.14 33.89 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-O 120.881 0.372 . . . . 0.0 111.065 -177.113 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' D' D ' 112' ' ' LEU . . . . . . . . . . . . . 18.9 mt -113.05 -46.11 3.12 Favored 'General case' 0 C--O 1.233 0.213 0 CA-C-N 116.017 -0.538 . . . . 0.0 110.388 176.825 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' D' D ' 113' ' ' TYR . . . . . . . . . . . . . 59.3 t80 -141.13 140.32 34.1 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.303 -0.408 . . . . 0.0 111.003 -179.939 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' D' D ' 114' ' ' ARG . . . . . . . . . . . . . 36.5 ttp180 -141.83 125.1 16.46 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 116.443 -0.344 . . . . 0.0 110.543 177.95 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' D' D ' 115' ' ' GLY . . . . . . . . . . . . . . . -150.1 160.95 28.75 Favored Glycine 0 CA--C 1.523 0.56 0 N-CA-C 111.124 -0.79 . . . . 0.0 111.124 178.867 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' D' D ' 116' ' ' LYS . . . . . . . . . . . . . 39.4 ttpt -127.25 134.34 50.09 Favored 'General case' 0 C--N 1.33 -0.281 0 N-CA-C 110.119 -0.326 . . . . 0.0 110.119 177.287 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' D' D ' 117' ' ' PHE . . . . . . . . . . . . . 31.5 m-85 -138.32 113.89 9.69 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.241 -0.436 . . . . 0.0 110.059 -176.739 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' D' D ' 118' ' ' GLU . . . . . . . . . . . . . 41.6 mp0 -55.18 -49.22 72.43 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-N 116.45 -0.341 . . . . 0.0 111.436 -174.504 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' D' D ' 119' ' ' ASN . . . . . . . . . . . . . 2.7 p30 -94.5 31.16 1.81 Allowed 'General case' 0 C--N 1.331 -0.216 0 N-CA-C 112.168 0.433 . . . . 0.0 112.168 -175.337 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' D' D ' 120' ' ' LEU . . . . . . . . . . . . . 26.8 tp -55.7 119.91 6.46 Favored 'General case' 0 C--N 1.332 -0.175 0 N-CA-C 110.344 -0.243 . . . . 0.0 110.344 175.831 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' D' D ' 121' ' ' ASN . . . . . . . . . . . . . 86.6 m-20 -114.19 -44.0 3.17 Favored 'General case' 0 N--CA 1.463 0.202 0 N-CA-C 111.569 0.211 . . . . 0.0 111.569 -175.37 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' D' D ' 122' ' ' LYS . . . . . . . . . . . . . 53.4 mtpt -138.59 149.02 44.83 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-O 121.11 0.481 . . . . 0.0 111.534 -175.419 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' D' D ' 123' ' ' VAL . . . . . . . . . . . . . 46.4 t -133.92 126.49 50.55 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.268 0 CA-C-N 116.0 -0.545 . . . . 0.0 109.588 174.108 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' D' D ' 124' ' ' LEU . . . . . . . . . . . . . 7.2 mp -116.99 134.44 54.73 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.311 -0.404 . . . . 0.0 110.571 -177.48 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' D' D ' 125' ' ' VAL . . . . . . . . . . . . . 34.8 m -131.32 125.85 57.65 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.283 0 CA-C-N 116.389 -0.368 . . . . 0.0 110.36 178.492 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' D' D ' 126' ' ' ARG . . . . . . . . . . . . . 91.2 mtt-85 -150.42 126.44 10.51 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.258 -0.428 . . . . 0.0 110.003 179.468 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' D' D ' 127' ' ' ASN . . . . . . . . . . . . . 10.9 t30 55.57 -148.94 0.47 Allowed 'General case' 0 CA--C 1.54 0.575 0 N-CA-C 110.001 -0.37 . . . . 0.0 110.001 179.502 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' D' D ' 128' ' ' ASP . . . . . . . . . . . . . 17.3 p-10 -82.84 15.35 2.73 Favored 'General case' 0 CA--C 1.535 0.388 0 CA-C-N 118.782 0.719 . . . . 0.0 112.931 179.459 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' D' D ' 129' ' ' LEU . . . . . . . . . . . . . 58.6 mt -112.49 138.2 49.59 Favored 'General case' 0 C--O 1.233 0.216 0 CA-C-N 118.171 0.441 . . . . 0.0 110.7 -179.991 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' D' D ' 130' ' ' VAL . . . . . . . . . . . . . 44.7 t -124.16 136.18 61.25 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.217 0 CA-C-N 115.924 -0.58 . . . . 0.0 109.744 179.638 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' D' D ' 131' ' ' VAL . . . . . . . . . . . . . 42.6 t -134.71 134.21 54.09 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.215 0 CA-C-O 120.964 0.411 . . . . 0.0 110.339 179.645 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' D' D ' 132' ' ' ILE . . . . . . . . . . . . . 73.6 mt -115.86 132.83 64.15 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.321 0 CA-C-N 115.963 -0.562 . . . . 0.0 109.509 -179.805 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' D' D ' 133' ' ' ILE . . . . . . . . . . . . . 35.7 mm -118.46 120.04 63.05 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.247 0 CA-C-O 120.847 0.356 . . . . 0.0 110.943 -174.043 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' D' D ' 134' ' ' ASP . . . . . . . . . . . . . 8.1 p-10 -133.11 147.95 52.14 Favored 'General case' 0 C--N 1.332 -0.185 0 N-CA-C 109.801 -0.444 . . . . 0.0 109.801 174.789 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' D' D ' 135' ' ' GLU . . . . . . . . . . . . . 84.1 tt0 -49.76 -23.86 2.04 Favored 'General case' 0 C--N 1.329 -0.32 0 N-CA-C 113.049 0.759 . . . . 0.0 113.049 -170.962 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' D' D ' 136' ' ' GLN . . . . . . . . . . . . . 39.3 tp60 -89.4 -37.68 14.66 Favored 'General case' 0 C--N 1.33 -0.241 0 N-CA-C 112.146 0.425 . . . . 0.0 112.146 -175.366 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' D' D ' 137' ' ' LYS . . . . . . . . . . . . . 57.0 pttt -156.41 166.0 34.69 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-O 121.525 0.679 . . . . 0.0 112.077 -171.185 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' D' D ' 138' ' ' LEU . . . . . . . . . . . . . 4.8 tt -117.7 128.4 54.86 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 115.065 -0.97 . . . . 0.0 109.793 178.115 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' D' D ' 139' ' ' THR . . . . . . . . . . . . . 29.8 m -110.43 127.4 55.1 Favored 'General case' 0 C--N 1.331 -0.224 0 CA-C-N 116.421 -0.354 . . . . 0.0 110.809 -179.59 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' D' D ' 140' ' ' LEU . . . . . . . . . . . . . 9.9 tp -112.61 120.12 40.47 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 115.567 -0.742 . . . . 0.0 109.056 -179.912 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' D' D ' 141' ' ' ILE . . . . . . . . . . . . . 19.6 mt -119.66 117.12 52.77 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.283 0 CA-C-O 121.077 0.465 . . . . 0.0 109.933 -175.823 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' D' D ' 142' ' ' ARG . . . . . . . . . . . . . 58.8 ttp180 -108.85 119.1 38.55 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 115.28 -0.873 . . . . 0.0 110.13 -178.344 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' D' D ' 143' ' ' THR . . . . . . . . . . . . . 54.6 p . . . . . 0 C--O 1.22 -0.465 0 CA-C-O 117.983 -1.008 . . . . 0.0 110.749 -178.596 . . . . . . . . 0 0 . 1 . 004 nuclear orig core ' E' E ' 2' ' ' SER . . . . . . . . . . . . . 3.0 p . . . . . 0 C--O 1.233 0.197 0 CA-C-O 120.944 0.402 . . . . 0.0 110.629 . . . . . . . . . 0 0 . 1 . 004 nuclear orig core ' E' E ' 3' ' ' GLU . . . . . . . . . . . . . 83.4 tt0 -142.27 142.35 32.57 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.034 -0.53 . . . . 0.0 111.203 -178.579 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' E' E ' 4' ' ' LEU . . . . . . . . . . . . . 14.4 tp -123.24 128.58 50.19 Favored 'General case' 0 C--N 1.332 -0.187 0 CA-C-N 115.958 -0.565 . . . . 0.0 110.281 176.85 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' E' E ' 5' ' ' LYS . . . . . . . . . . . . . 75.1 mttt -105.86 121.4 44.0 Favored 'General case' 0 C--O 1.235 0.293 0 CA-C-N 116.306 -0.406 . . . . 0.0 110.57 178.065 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' E' E ' 6' ' ' LEU . . . . . . . . . . . . . 29.3 mt -115.3 149.82 37.22 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 115.531 -0.759 . . . . 0.0 110.251 -179.735 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' E' E ' 7' ' ' LYS . . . . . . . . . . . . . 58.4 tttm -139.6 138.08 19.66 Favored Pre-proline 0 CA--C 1.533 0.305 0 CA-C-O 119.031 -0.509 . . . . 0.0 110.086 175.088 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' E' E ' 8' ' ' PRO . . . . . . . . . . . . . 98.7 Cg_endo -91.44 139.28 2.34 Favored 'Trans proline' 0 N--CA 1.489 1.258 0 C-N-CA 121.716 1.611 . . . . 0.0 111.728 177.396 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' E' E ' 9' ' ' LEU . . . . . . . . . . . . . 57.5 mt -71.46 -46.65 13.36 Favored Pre-proline 0 CA--C 1.533 0.312 0 CA-C-O 118.644 -0.693 . . . . 0.0 112.033 -179.026 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' E' E ' 10' ' ' PRO . . . . . . . . . . . . . 89.9 Cg_endo -82.31 147.36 14.35 Favored 'Trans proline' 0 N--CA 1.495 1.596 0 C-N-CA 121.147 1.231 . . . . 0.0 111.509 174.419 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' E' E ' 11' ' ' LYS . . . . . . . . . . . . . 50.3 pttt -86.51 115.06 23.76 Favored 'General case' 0 C--N 1.331 -0.222 0 CA-C-O 121.383 0.611 . . . . 0.0 110.217 178.122 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' E' E ' 12' ' ' VAL . . . . . . . . . . . . . 11.6 p -151.11 146.59 16.06 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 CA-C-N 115.879 -0.6 . . . . 0.0 110.544 -178.89 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' E' E ' 13' ' ' GLU . . . . . . . . . . . . . 95.8 mt-10 -83.23 118.03 23.35 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.347 -0.388 . . . . 0.0 110.042 177.126 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' E' E ' 14' ' ' LEU . . . . . . . . . . . . . 48.6 mt -96.53 148.8 35.01 Favored Pre-proline 0 C--N 1.33 -0.265 0 CA-C-O 119.282 -0.39 . . . . 0.0 110.665 -177.881 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' E' E ' 15' ' ' PRO . . . . . . . . . . . . . 27.9 Cg_exo -61.31 163.61 16.98 Favored 'Trans proline' 0 N--CA 1.497 1.704 0 C-N-CA 121.339 1.36 . . . . 0.0 112.093 177.015 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' E' E ' 16' ' ' PRO . . . . . . . . . . . . . 24.4 Cg_exo -62.25 -39.58 46.82 Favored 'Trans proline' 0 N--CA 1.497 1.69 0 C-N-CA 121.561 1.508 . . . . 0.0 112.987 -178.296 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' E' E ' 17' ' ' ASP . . . . . . . . . . . . . 22.1 p-10 -85.39 8.42 18.94 Favored 'General case' 0 CA--C 1.535 0.396 0 N-CA-C 113.302 0.853 . . . . 0.0 113.302 -176.304 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' E' E ' 18' ' ' PHE . . . . . . . . . . . . . 32.4 t80 -55.97 -47.87 76.86 Favored 'General case' 0 C--N 1.334 -0.107 0 O-C-N 121.904 -0.498 . . . . 0.0 110.506 -179.359 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' E' E ' 19' ' ' VAL . . . . . . . . . . . . . 14.0 p -56.3 -40.77 68.13 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.272 0 CA-C-N 116.227 -0.442 . . . . 0.0 111.037 -178.985 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' E' E ' 20' ' ' ASP . . . . . . . . . . . . . 20.2 t0 -60.54 -43.78 96.81 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-O 120.793 0.33 . . . . 0.0 111.15 -177.312 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' E' E ' 21' ' ' VAL . . . . . . . . . . . . . 49.1 t -63.67 -46.33 95.0 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.332 0 C-N-CA 120.834 -0.346 . . . . 0.0 110.296 -178.488 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' E' E ' 22' ' ' ILE . . . . . . . . . . . . . 49.3 mm -55.54 -45.79 78.77 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.227 0 C-N-CA 120.956 -0.298 . . . . 0.0 110.707 178.377 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' E' E ' 23' ' ' ARG . . . . . . . . . . . . . 54.7 ttp180 -53.33 -51.0 63.79 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-O 120.584 0.23 . . . . 0.0 111.538 -178.544 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' E' E ' 24' ' ' ILE . . . . . 0.402 HG23 HD11 ' E' ' 24' ' ' ILE . 68.5 mt -59.64 -43.71 91.82 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.287 0 C-N-CA 121.138 -0.225 . . . . 0.0 111.349 -177.221 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' E' E ' 25' ' ' LYS . . . . . . . . . . . . . 97.9 mttt -64.85 -38.45 91.02 Favored 'General case' 0 C--N 1.329 -0.314 0 N-CA-C 112.208 0.447 . . . . 0.0 112.208 -178.247 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' E' E ' 26' ' ' LEU . . . . . . . . . . . . . 37.5 mt -80.47 -41.77 23.79 Favored 'General case' 0 C--N 1.329 -0.302 0 N-CA-C 113.258 0.836 . . . . 0.0 113.258 -171.675 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' E' E ' 27' ' ' GLN . . . . . . . . . . . . . 11.0 pt20 -46.42 142.68 2.91 Favored 'General case' 0 N--CA 1.469 0.486 0 N-CA-C 112.869 0.692 . . . . 0.0 112.869 -174.325 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' E' E ' 28' ' ' GLY . . . . . . . . . . . . . . . 98.75 -28.68 13.98 Favored Glycine 0 CA--C 1.531 1.066 0 CA-C-N 115.479 -0.782 . . . . 0.0 112.02 -177.467 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' E' E ' 29' ' ' LYS . . . . . . . . . . . . . 87.7 mttt -98.07 155.08 17.29 Favored 'General case' 0 C--N 1.331 -0.224 0 CA-C-N 117.235 0.517 . . . . 0.0 111.08 178.808 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' E' E ' 30' ' ' THR . . . . . . . . . . . . . 40.1 m -102.4 137.39 40.71 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.002 -0.544 . . . . 0.0 109.949 175.679 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' E' E ' 31' ' ' VAL . . . . . . . . . . . . . 34.6 m -127.92 152.81 36.48 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.256 0 CA-C-O 120.939 0.4 . . . . 0.0 110.729 -178.23 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' E' E ' 32' ' ' ARG . . . . . . . . . . . . . 61.1 ttt180 -131.09 147.82 52.66 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-O 121.215 0.531 . . . . 0.0 110.628 -179.527 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' E' E ' 33' ' ' THR . . . . . . . . . . . . . 31.4 m -52.56 140.7 22.25 Favored 'General case' 0 C--N 1.331 -0.23 0 CA-C-N 116.293 -0.412 . . . . 0.0 111.453 -178.552 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' E' E ' 34' ' ' GLY . . . . . . . . . . . . . . . 99.51 -17.2 58.01 Favored Glycine 0 CA--C 1.531 1.087 0 CA-C-O 119.681 -0.511 . . . . 0.0 113.247 179.502 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' E' E ' 35' ' ' ASP . . . . . . . . . . . . . 80.0 m-20 -66.88 147.52 53.13 Favored 'General case' 0 C--O 1.232 0.138 0 CA-C-N 118.013 0.906 . . . . 0.0 111.028 178.531 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' E' E ' 36' ' ' VAL . . . . . . . . . . . . . 44.2 t -120.9 129.31 75.81 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.208 0 CA-C-N 116.082 -0.508 . . . . 0.0 109.713 177.527 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' E' E ' 37' ' ' ILE . . . . . . . . . . . . . 67.2 mt -121.01 138.83 50.16 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.289 0 CA-C-N 116.246 -0.434 . . . . 0.0 109.937 -178.951 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' E' E ' 38' ' ' GLY . . . . . . . . . . . . . . . -109.78 128.86 9.11 Favored Glycine 0 CA--C 1.524 0.656 0 N-CA-C 111.159 -0.776 . . . . 0.0 111.159 -179.64 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' E' E ' 39' ' ' ILE . . . . . . . . . . . . . 74.4 mt -123.61 133.73 68.38 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.203 0 N-CA-C 109.976 -0.379 . . . . 0.0 109.976 179.017 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' E' E ' 40' ' ' SER . . . . . . . . . . . . . 59.7 p -92.87 117.4 30.0 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.284 -0.417 . . . . 0.0 110.797 175.465 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' E' E ' 41' ' ' ILE . . . . . . . . . . . . . 43.8 mm -121.05 118.0 54.76 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.224 0 CA-C-O 120.802 0.334 . . . . 0.0 110.379 -179.864 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' E' E ' 42' ' ' LEU . . . . . . . . . . . . . 61.1 mt 52.65 36.3 20.51 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 116.194 -0.457 . . . . 0.0 111.604 176.646 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' E' E ' 43' ' ' GLY . . . . . . . . . . . . . . . 73.04 30.51 63.08 Favored Glycine 0 CA--C 1.529 0.911 0 C-N-CA 121.135 -0.555 . . . . 0.0 112.275 177.816 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' E' E ' 44' ' ' LYS . . . . . . . . . . . . . 68.7 mttm -138.31 134.27 34.08 Favored 'General case' 0 C--N 1.331 -0.234 0 N-CA-C 109.759 -0.46 . . . . 0.0 109.759 177.757 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' E' E ' 45' ' ' GLU . . . . . . . . . . . . . 80.6 tt0 -83.02 124.46 30.44 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-O 120.839 0.352 . . . . 0.0 111.6 -176.192 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' E' E ' 46' ' ' VAL . . . . . . . . . . . . . 7.2 p -124.61 126.44 71.68 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.19 0 N-CA-C 109.478 -0.564 . . . . 0.0 109.478 173.863 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' E' E ' 47' ' ' LYS . . . . . . . . . . . . . 98.9 mttt -99.91 129.66 46.01 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.064 -0.516 . . . . 0.0 111.081 178.994 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' E' E ' 48' ' ' PHE . . . . . . . . . . . . . 91.1 m-85 -112.69 131.9 55.44 Favored 'General case' 0 C--N 1.33 -0.271 0 N-CA-C 109.872 -0.418 . . . . 0.0 109.872 177.035 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' E' E ' 49' ' ' LYS . . . . . . . . . . . . . 80.0 tttt -106.96 135.99 47.57 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.294 -0.412 . . . . 0.0 110.279 179.067 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' E' E ' 50' ' ' VAL . . . . . . . . . . . . . 46.0 t -77.14 105.02 5.56 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.218 0 N-CA-C 109.192 -0.67 . . . . 0.0 109.192 175.585 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' E' E ' 51' ' ' VAL . . . . . . . . . . . . . 48.6 t -68.71 -47.97 73.75 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.362 0 O-C-N 123.563 0.539 . . . . 0.0 109.744 -173.179 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' E' E ' 52' ' ' GLN . . . . . . . . . . . . . 43.2 tt0 -171.03 142.12 1.78 Allowed 'General case' 0 C--N 1.329 -0.318 0 C-N-CA 120.313 -0.555 . . . . 0.0 111.423 -179.709 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' E' E ' 53' ' ' ALA . . . . . . . . . . . . . . . -114.41 136.03 53.45 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 115.697 -0.683 . . . . 0.0 110.14 177.517 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' E' E ' 54' ' ' TYR . . . . . . . . . . . . . 37.0 t80 -128.99 108.6 18.18 Favored Pre-proline 0 CA--C 1.535 0.374 0 CA-C-O 118.245 -0.883 . . . . 0.0 110.206 178.558 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' E' E ' 55' ' ' PRO . . . . . . . . . . . . . 73.4 Cg_endo -77.15 170.01 72.71 Favored 'Cis proline' 0 N--CA 1.499 1.841 0 CA-C-N 121.769 1.667 . . . . 0.0 112.486 -5.025 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' E' E ' 56' ' ' SER . . . . . . . . . . . . . 41.2 m -117.21 131.39 24.03 Favored Pre-proline 0 CA--C 1.539 0.524 0 CA-C-O 118.399 -0.81 . . . . 0.0 109.509 174.768 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' E' E ' 57' ' ' PRO . . . . . . . . . . . . . 57.0 Cg_endo -72.36 148.26 90.9 Favored 'Cis proline' 0 N--CA 1.497 1.719 0 CA-C-N 121.917 1.72 . . . . 0.0 111.54 -1.173 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' E' E ' 58' ' ' LEU . . . . . . . . . . . . . 23.8 tp -108.26 137.11 46.79 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.561 -178.622 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' E' E ' 59' ' ' ARG . . . . . . . . . . . . . 54.0 ttp180 -99.92 126.06 46.01 Favored 'General case' 0 C--N 1.328 -0.341 0 N-CA-C 109.334 -0.617 . . . . 0.0 109.334 174.92 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' E' E ' 60' ' ' VAL . . . . . . . . . . . . . 40.5 t -83.03 120.43 34.36 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.269 0 C-N-CA 120.599 -0.44 . . . . 0.0 110.578 -174.955 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' E' E ' 61' ' ' GLU . . . . . . . . . . . . . 74.7 tt0 -130.8 156.01 45.72 Favored 'General case' 0 C--N 1.329 -0.326 0 N-CA-C 108.989 -0.745 . . . . 0.0 108.989 176.252 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' E' E ' 62' ' ' ASP . . . . . . . . . . . . . 9.8 p-10 -51.01 -30.62 15.78 Favored 'General case' 0 C--N 1.327 -0.385 0 N-CA-C 112.369 0.507 . . . . 0.0 112.369 -175.312 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' E' E ' 63' ' ' ARG . . . . . . . . . . . . . 76.0 mtt180 -77.89 -22.07 50.3 Favored 'General case' 0 CA--C 1.533 0.322 0 N-CA-C 113.149 0.796 . . . . 0.0 113.149 -174.987 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' E' E ' 64' ' ' THR . . . . . . . . . . . . . 28.3 m -63.37 146.16 54.1 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-O 120.872 0.367 . . . . 0.0 110.964 -175.841 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' E' E ' 65' ' ' LYS . . . . . . . . . . . . . 67.5 mttm -89.2 134.37 34.06 Favored 'General case' 0 C--N 1.331 -0.212 0 CA-C-N 116.121 -0.49 . . . . 0.0 110.662 -179.733 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' E' E ' 66' ' ' ILE . . . . . . . . . . . . . 62.4 mt -120.9 130.97 74.08 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.238 0 N-CA-C 109.993 -0.373 . . . . 0.0 109.993 179.224 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' E' E ' 67' ' ' THR . . . . . . . . . . . . . 19.1 m -129.72 142.82 50.64 Favored 'General case' 0 C--N 1.332 -0.175 0 CA-C-O 120.979 0.418 . . . . 0.0 111.042 -178.403 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' E' E ' 68' ' ' LEU . . . . . . . . . . . . . 6.7 mp . . . . . 0 C--N 1.33 -0.24 0 CA-C-N 116.106 -0.497 . . . . 0.0 110.601 177.702 . . . . . . . . 0 0 . 1 . 004 nuclear orig core ' E' E ' 73' ' ' VAL . . . . . . . . . . . . . 36.0 m . . . . . 0 C--O 1.231 0.091 0 N-CA-C 110.008 -0.367 . . . . 0.0 110.008 . . . . . . . . . 0 0 . 1 . 004 nuclear orig core ' E' E ' 74' ' ' ASP . . . . . . . . . . . . . 18.9 t0 -93.85 118.78 31.91 Favored 'General case' 0 C--N 1.328 -0.331 0 N-CA-C 109.978 -0.378 . . . . 0.0 109.978 -177.84 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' E' E ' 75' ' ' VAL . . . . . . . . . . . . . 42.2 t -116.57 121.0 66.66 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.224 0 CA-C-O 121.055 0.455 . . . . 0.0 110.468 -178.445 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' E' E ' 76' ' ' LEU . . . . . . . . . . . . . 7.0 mp -119.01 149.06 42.28 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 115.778 -0.646 . . . . 0.0 109.788 176.961 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' E' E ' 77' ' ' GLU . . . . . . . . . . . . . 96.3 mt-10 -136.97 134.63 36.89 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-O 121.006 0.432 . . . . 0.0 111.333 -178.975 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' E' E ' 78' ' ' ALA . . . . . . . . . . . . . . . -121.28 136.63 54.94 Favored 'General case' 0 C--N 1.331 -0.225 0 CA-C-N 115.671 -0.695 . . . . 0.0 109.85 176.959 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' E' E ' 79' ' ' LYS . . . . . . . . . . . . . 46.3 mmtm -78.48 119.25 21.51 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-O 120.798 0.332 . . . . 0.0 110.611 179.859 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' E' E ' 80' ' ' ILE . . . . . . . . . . . . . 26.4 mm -139.25 110.45 4.85 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.28 0 N-CA-C 108.967 -0.753 . . . . 0.0 108.967 -179.351 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' E' E ' 81' ' ' LYS . . . . . . . . . . . . . 54.8 pttt -103.24 124.56 48.85 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-O 120.948 0.404 . . . . 0.0 111.194 -176.753 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' E' E ' 82' ' ' GLY . . . . . . . . . . . . . . . 88.94 42.2 5.72 Favored Glycine 0 CA--C 1.525 0.695 0 C-N-CA 120.713 -0.756 . . . . 0.0 111.616 174.622 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' E' E ' 83' ' ' ILE . . . . . . . . . . . . . 68.2 mt -66.35 139.7 20.74 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.362 0 N-CA-C 109.779 -0.452 . . . . 0.0 109.779 178.247 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' E' E ' 84' ' ' LYS . . . . . . . . . . . . . 87.6 tttt -101.05 -53.96 2.91 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-N 116.011 -0.54 . . . . 0.0 110.311 -178.217 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' E' E ' 85' ' ' ASP . . . . . . . . . . . . . 9.6 t70 -149.97 146.98 27.33 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 115.754 -0.657 . . . . 0.0 110.187 -178.373 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' E' E ' 86' ' ' VAL . . . . . . . . . . . . . 43.0 t -131.69 129.78 61.61 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.228 0 CA-C-O 121.006 0.431 . . . . 0.0 110.476 -178.495 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' E' E ' 87' ' ' ILE . . . . . . . . . . . . . 4.9 mp -119.94 125.05 73.88 Favored 'Isoleucine or valine' 0 C--O 1.233 0.198 0 CA-C-N 115.943 -0.571 . . . . 0.0 109.481 176.2 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' E' E ' 88' ' ' LEU . . . . . . . . . . . . . 16.8 tp -110.54 129.19 55.85 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-O 120.911 0.386 . . . . 0.0 110.737 -179.185 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' E' E ' 89' ' ' ASP . . . . . . . . . . . . . 9.5 t70 -123.79 154.18 39.92 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-N 116.01 -0.541 . . . . 0.0 109.815 178.709 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' E' E ' 90' ' ' GLU . . . . . . . . . . . . . 43.1 mt-10 -47.82 -38.43 15.89 Favored 'General case' 0 C--N 1.33 -0.241 0 N-CA-C 112.71 0.633 . . . . 0.0 112.71 -172.643 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' E' E ' 91' ' ' ASN . . . . . . . . . . . . . 6.6 t-20 -132.1 34.58 3.79 Favored 'General case' 0 N--CA 1.463 0.217 0 N-CA-C 111.738 0.273 . . . . 0.0 111.738 -176.455 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' E' E ' 92' ' ' LEU . . . . . . . . . . . . . 12.5 tp -166.16 148.76 7.11 Favored 'General case' 0 C--N 1.329 -0.286 0 C-N-CA 120.937 -0.305 . . . . 0.0 110.906 -178.991 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' E' E ' 93' ' ' ILE . . . . . . . . . . . . . 72.9 mt -128.18 123.28 59.98 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.178 0 N-CA-C 109.491 -0.559 . . . . 0.0 109.491 178.222 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' E' E ' 94' ' ' VAL . . . . . . . . . . . . . 44.8 t -123.96 126.12 72.0 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.277 0 CA-C-O 120.875 0.369 . . . . 0.0 110.035 -179.66 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' E' E ' 95' ' ' VAL . . . . . . . . . . . . . 41.8 t -123.77 134.73 65.64 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.252 0 CA-C-N 116.104 -0.498 . . . . 0.0 110.21 -178.419 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' E' E ' 96' ' ' ILE . . . . . . . . . . . . . 58.1 mt -115.51 130.06 70.75 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 N-CA-C 109.287 -0.634 . . . . 0.0 109.287 178.359 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' E' E ' 97' ' ' THR . . . . . . . . . . . . . 80.3 p -102.09 158.44 16.16 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-O 121.257 0.551 . . . . 0.0 111.324 -177.034 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' E' E ' 98' ' ' GLU . . . . . . . . . . . . . 83.5 tt0 -53.86 -27.05 27.61 Favored 'General case' 0 CA--C 1.533 0.313 0 N-CA-C 112.3 0.481 . . . . 0.0 112.3 -179.529 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' E' E ' 99' ' ' GLU . . . . . . . . . . . . . 34.7 tt0 -80.77 18.06 1.05 Allowed 'General case' 0 CA--C 1.536 0.418 0 N-CA-C 112.728 0.64 . . . . 0.0 112.728 -176.619 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' E' E ' 100' ' ' ASN . . . . . . . . . . . . . 3.2 m-20 61.06 37.96 17.52 Favored 'General case' 0 N--CA 1.463 0.176 0 O-C-N 121.955 -0.466 . . . . 0.0 110.819 178.366 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' E' E ' 101' ' ' GLU . . . . . . . . . . . . . 84.2 tt0 -116.74 143.11 46.05 Favored 'General case' 0 C--N 1.331 -0.203 0 CA-C-N 116.159 -0.473 . . . . 0.0 109.75 177.379 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' E' E ' 102' ' ' VAL . . . . . . . . . . . . . 44.0 t -115.52 127.55 73.05 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.367 0 CA-C-N 116.419 -0.355 . . . . 0.0 110.132 -177.804 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' E' E ' 103' ' ' LEU . . . . . . . . . . . . . 28.9 mt -117.96 131.14 56.53 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-N 115.677 -0.692 . . . . 0.0 109.889 177.123 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' E' E ' 104' ' ' ILE . . . . . 0.402 HG21 HD12 ' E' ' 104' ' ' ILE . 67.4 mt -117.66 122.17 69.19 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.26 0 N-CA-C 110.107 -0.331 . . . . 0.0 110.107 -178.336 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' E' E ' 105' ' ' PHE . . . . . . . . . . . . . 91.5 m-85 -124.11 166.4 15.86 Favored 'General case' 0 C--O 1.232 0.151 0 O-C-N 123.985 0.803 . . . . 0.0 110.131 -178.52 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' E' E ' 106' ' ' ASN . . . . . . . . . . . . . 45.6 p-10 -104.04 -172.51 2.12 Favored 'General case' 0 C--N 1.332 -0.172 0 N-CA-C 109.755 -0.461 . . . . 0.0 109.755 171.131 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' E' E ' 107' ' ' GLN . . . . . . . . . . . . . 49.4 tt0 -58.76 -29.99 67.18 Favored 'General case' 0 CA--C 1.532 0.255 0 N-CA-C 112.065 0.394 . . . . 0.0 112.065 -179.72 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' E' E ' 108' ' ' ASN . . . . . . . . . . . . . 48.4 t30 -86.72 12.7 10.15 Favored 'General case' 0 CA--C 1.534 0.34 0 N-CA-C 113.001 0.741 . . . . 0.0 113.001 -176.384 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' E' E ' 109' ' ' LEU . . . . . . . . . . . . . 34.4 mt 58.2 33.34 23.06 Favored 'General case' 0 C--O 1.232 0.168 0 N-CA-C 111.998 0.37 . . . . 0.0 111.998 176.912 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' E' E ' 110' ' ' GLU . . . . . . . . . . . . . 95.5 mt-10 -101.86 129.94 48.21 Favored 'General case' 0 C--N 1.33 -0.25 0 N-CA-C 109.182 -0.673 . . . . 0.0 109.182 174.582 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' E' E ' 111' ' ' GLU . . . . . . . . . . . . . 45.5 tt0 -74.11 121.99 22.02 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-O 121.073 0.463 . . . . 0.0 110.352 -176.108 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' E' E ' 112' ' ' LEU . . . . . . . . . . . . . 35.4 mt -99.62 -46.07 5.57 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 115.795 -0.639 . . . . 0.0 110.461 -179.612 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' E' E ' 113' ' ' TYR . . . . . . . . . . . . . 57.8 t80 -139.22 145.66 39.53 Favored 'General case' 0 C--N 1.331 -0.208 0 CA-C-N 116.317 -0.402 . . . . 0.0 111.197 -178.166 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' E' E ' 114' ' ' ARG . . . . . . . . . . . . . 45.3 ptt85 -147.35 125.27 11.98 Favored 'General case' 0 C--N 1.33 -0.239 0 CA-C-N 116.07 -0.514 . . . . 0.0 110.663 179.062 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' E' E ' 115' ' ' GLY . . . . . . . . . . . . . . . -150.07 159.11 27.96 Favored Glycine 0 CA--C 1.523 0.538 0 N-CA-C 111.105 -0.798 . . . . 0.0 111.105 178.96 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' E' E ' 116' ' ' LYS . . . . . . . . . . . . . 38.4 ttpt -127.07 132.46 50.66 Favored 'General case' 0 C--N 1.33 -0.268 0 N-CA-C 109.809 -0.441 . . . . 0.0 109.809 178.077 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' E' E ' 117' ' ' PHE . . . . . . . . . . . . . 36.6 m-85 -132.14 113.82 13.77 Favored 'General case' 0 C--N 1.331 -0.213 0 CA-C-O 121.014 0.435 . . . . 0.0 110.376 -175.582 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' E' E ' 118' ' ' GLU . . . . . . . . . . . . . 96.3 mt-10 -54.77 -46.93 74.45 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 116.268 -0.424 . . . . 0.0 111.254 -176.728 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' E' E ' 119' ' ' ASN . . . . . . . . . . . . . 24.4 m120 -95.62 31.01 2.13 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.165 -0.471 . . . . 0.0 112.139 -173.523 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' E' E ' 120' ' ' LEU . . . . . . . . . . . . . 14.7 tp -54.92 119.94 6.14 Favored 'General case' 0 N--CA 1.463 0.191 0 C-N-CA 121.019 -0.272 . . . . 0.0 110.752 177.449 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' E' E ' 121' ' ' ASN . . . . . . . . . . . . . 33.3 t-20 -114.09 -43.97 3.19 Favored 'General case' 0 C--N 1.331 -0.22 0 CA-C-N 116.599 -0.273 . . . . 0.0 111.359 -175.181 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' E' E ' 122' ' ' LYS . . . . . . . . . . . . . 36.5 mtmm -143.3 145.22 32.53 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-O 121.121 0.486 . . . . 0.0 111.63 -176.628 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' E' E ' 123' ' ' VAL . . . . . . . . . . . . . 46.8 t -126.67 127.54 70.25 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.22 0 CA-C-N 115.873 -0.603 . . . . 0.0 109.63 176.525 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' E' E ' 124' ' ' LEU . . . . . . . . . . . . . 50.2 mt -130.33 123.56 30.27 Favored 'General case' 0 C--N 1.331 -0.222 0 CA-C-N 116.441 -0.345 . . . . 0.0 110.186 179.751 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' E' E ' 125' ' ' VAL . . . . . . . . . . . . . 33.0 m -143.14 136.43 25.58 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.305 0 CA-C-O 120.816 0.341 . . . . 0.0 111.125 -178.937 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' E' E ' 126' ' ' ARG . . . . . . . . . . . . . 63.3 mtm180 -151.02 131.15 13.49 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-O 121.152 0.501 . . . . 0.0 110.876 177.82 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' E' E ' 127' ' ' ASN . . . . . . . . . . . . . 3.7 m120 52.01 -105.05 0.2 Allowed 'General case' 0 CA--C 1.543 0.677 0 CA-C-N 115.827 -0.624 . . . . 0.0 111.489 178.629 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' E' E ' 128' ' ' ASP . . . . . . . . . . . . . 22.8 p-10 -114.13 1.45 14.59 Favored 'General case' 0 N--CA 1.467 0.409 0 CA-C-N 119.345 0.975 . . . . 0.0 113.461 -174.895 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' E' E ' 129' ' ' LEU . . . . . . . . . . . . . 68.7 mt -105.55 128.91 53.86 Favored 'General case' 0 C--N 1.333 -0.126 0 CA-C-N 118.28 0.491 . . . . 0.0 110.301 179.215 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' E' E ' 130' ' ' VAL . . . . . . . . . . . . . 60.3 t -122.06 128.75 75.67 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.273 0 CA-C-N 115.95 -0.568 . . . . 0.0 109.544 -179.571 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' E' E ' 131' ' ' VAL . . . . . . . . . . . . . 41.8 t -136.03 132.38 50.13 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.227 0 CA-C-O 121.186 0.517 . . . . 0.0 110.288 177.493 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' E' E ' 132' ' ' ILE . . . . . . . . . . . . . 73.5 mt -117.25 131.78 68.96 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.316 0 CA-C-N 115.625 -0.716 . . . . 0.0 109.393 179.784 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' E' E ' 133' ' ' ILE . . . . . . . . . . . . . 36.9 mm -113.04 121.07 64.56 Favored 'Isoleucine or valine' 0 C--O 1.233 0.206 0 CA-C-O 120.741 0.305 . . . . 0.0 111.009 -174.935 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' E' E ' 134' ' ' ASP . . . . . . . . . . . . . 9.7 p-10 -131.73 148.23 52.56 Favored 'General case' 0 C--N 1.332 -0.18 0 N-CA-C 109.727 -0.472 . . . . 0.0 109.727 175.2 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' E' E ' 135' ' ' GLU . . . . . . . . . . . . . 78.2 tt0 -49.9 -26.61 4.27 Favored 'General case' 0 C--N 1.328 -0.331 0 N-CA-C 113.019 0.748 . . . . 0.0 113.019 -171.515 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' E' E ' 136' ' ' GLN . . . . . . . . . . . . . 99.4 mm-40 -86.26 -32.07 21.32 Favored 'General case' 0 C--N 1.331 -0.234 0 N-CA-C 112.411 0.522 . . . . 0.0 112.411 -174.932 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' E' E ' 137' ' ' LYS . . . . . . . . . . . . . 23.8 pttm -167.21 174.04 8.51 Favored 'General case' 0 C--O 1.233 0.191 0 CA-C-O 121.472 0.653 . . . . 0.0 112.429 -172.488 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' E' E ' 138' ' ' LEU . . . . . . . . . . . . . 5.6 tt -118.52 127.32 53.51 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 114.925 -1.034 . . . . 0.0 110.033 179.867 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' E' E ' 139' ' ' THR . . . . . . . . . . . . . 28.4 m -104.51 120.39 41.15 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.042 -0.526 . . . . 0.0 110.257 179.439 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' E' E ' 140' ' ' LEU . . . . . . . . . . . . . 7.7 tt -108.65 120.65 43.08 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 115.824 -0.626 . . . . 0.0 109.427 -179.974 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' E' E ' 141' ' ' ILE . . . . . . . . . . . . . 18.4 mt -123.84 121.2 61.69 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.265 0 CA-C-O 121.012 0.434 . . . . 0.0 109.833 -175.041 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' E' E ' 142' ' ' ARG . . . . . . . . . . . . . 64.5 ttt180 -109.11 124.12 50.29 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 115.689 -0.687 . . . . 0.0 110.22 179.218 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' E' E ' 143' ' ' THR . . . . . . . . . . . . . 55.9 p . . . . . 0 C--O 1.22 -0.467 0 CA-C-O 118.19 -0.909 . . . . 0.0 110.822 -179.542 . . . . . . . . 0 0 . 1 . 004 nuclear orig core ' F' F ' 1' ' ' MET . . . . . . . . . . . . . 27.6 ptm . . . . . 0 C--O 1.23 0.065 0 CA-C-O 120.848 0.356 . . . . 0.0 110.638 . . . . . . . . . 0 0 . 1 . 004 nuclear orig core ' F' F ' 2' ' ' SER . . . . . . . . . . . . . 2.5 p -129.32 128.1 42.45 Favored 'General case' 0 C--N 1.331 -0.198 0 CA-C-N 116.113 -0.494 . . . . 0.0 110.596 179.59 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' F' F ' 3' ' ' GLU . . . . . . . . . . . . . 83.8 tt0 -142.29 141.24 32.41 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.151 -0.477 . . . . 0.0 111.293 -179.984 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' F' F ' 4' ' ' LEU . . . . . . . . . . . . . 17.5 tp -127.31 133.23 50.14 Favored 'General case' 0 C--N 1.331 -0.201 0 CA-C-N 116.04 -0.527 . . . . 0.0 110.272 177.782 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' F' F ' 5' ' ' LYS . . . . . . . . . . . . . 98.5 mttt -112.06 121.32 44.66 Favored 'General case' 0 C--N 1.331 -0.212 0 CA-C-N 116.241 -0.436 . . . . 0.0 110.638 179.829 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' F' F ' 6' ' ' LEU . . . . . . . . . . . . . 69.8 mt -115.02 145.86 41.85 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 115.446 -0.797 . . . . 0.0 110.058 179.948 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' F' F ' 7' ' ' LYS . . . . . . . . . . . . . 40.2 ttmt -128.45 138.58 33.36 Favored Pre-proline 0 CA--C 1.533 0.295 0 CA-C-O 119.052 -0.499 . . . . 0.0 109.879 176.166 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' F' F ' 8' ' ' PRO . . . . . . . . . . . . . 94.4 Cg_endo -92.03 139.38 2.09 Favored 'Trans proline' 0 N--CA 1.488 1.197 0 C-N-CA 121.786 1.658 . . . . 0.0 111.963 178.694 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' F' F ' 9' ' ' LEU . . . . . . . . . . . . . 66.3 mt -74.46 -46.6 5.77 Favored Pre-proline 0 CA--C 1.533 0.314 0 CA-C-O 118.691 -0.671 . . . . 0.0 111.967 178.942 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' F' F ' 10' ' ' PRO . . . . . . . . . . . . . 90.0 Cg_endo -81.04 142.29 13.6 Favored 'Trans proline' 0 N--CA 1.496 1.635 0 C-N-CA 121.076 1.184 . . . . 0.0 111.561 174.035 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' F' F ' 11' ' ' LYS . . . . . . . . . . . . . 80.6 tttt -80.98 101.95 9.84 Favored 'General case' 0 C--N 1.329 -0.295 0 C-N-CA 120.802 -0.359 . . . . 0.0 110.441 179.317 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' F' F ' 12' ' ' VAL . . . . . . . . . . . . . 11.9 p -145.35 147.57 18.55 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.291 0 CA-C-N 116.233 -0.439 . . . . 0.0 110.715 -178.592 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' F' F ' 13' ' ' GLU . . . . . . . . . . . . . 70.7 mm-40 -92.9 123.74 36.38 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.033 176.687 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' F' F ' 14' ' ' LEU . . . . . . . . . . . . . 26.1 mt -96.81 154.48 38.32 Favored Pre-proline 0 C--N 1.329 -0.322 0 CA-C-N 116.426 -0.352 . . . . 0.0 110.69 -178.689 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' F' F ' 15' ' ' PRO . . . . . . . . . . . . . 31.3 Cg_exo -57.04 156.2 25.33 Favored 'Trans proline' 0 N--CA 1.496 1.659 0 C-N-CA 121.335 1.356 . . . . 0.0 111.777 179.636 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' F' F ' 16' ' ' PRO . . . . . . . . . . . . . 35.0 Cg_exo -57.81 -37.76 95.24 Favored 'Trans proline' 0 N--CA 1.497 1.677 0 C-N-CA 121.46 1.44 . . . . 0.0 112.802 -178.627 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' F' F ' 17' ' ' ASP . . . . . . . . . . . . . 19.1 p-10 -90.29 13.36 15.54 Favored 'General case' 0 CA--C 1.537 0.445 0 N-CA-C 113.116 0.784 . . . . 0.0 113.116 -177.38 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' F' F ' 18' ' ' PHE . . . . . . . . . . . . . 46.1 t80 -58.11 -45.32 87.46 Favored 'General case' 0 C--N 1.333 -0.126 0 CA-C-O 120.876 0.37 . . . . 0.0 110.089 -178.512 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' F' F ' 19' ' ' VAL . . . . . . . . . . . . . 48.4 t -57.18 -39.67 68.54 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.322 0 CA-C-N 116.25 -0.432 . . . . 0.0 110.505 -178.131 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' F' F ' 20' ' ' ASP . . . . . . . . . . . . . 10.2 t70 -59.85 -46.46 89.2 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-O 121.095 0.474 . . . . 0.0 110.875 -178.315 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' F' F ' 21' ' ' VAL . . . . . . . . . . . . . 49.5 t -64.19 -48.74 84.34 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.305 0 CA-C-N 116.207 -0.451 . . . . 0.0 110.624 -177.925 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' F' F ' 22' ' ' ILE . . . . . . . . . . . . . 51.0 mm -56.36 -43.45 77.35 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.297 0 CA-C-O 120.888 0.375 . . . . 0.0 110.51 179.135 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' F' F ' 23' ' ' ARG . . . . . . . . . . . . . 41.0 ttp180 -54.2 -47.52 72.0 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.545 -0.298 . . . . 0.0 111.337 -178.535 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' F' F ' 24' ' ' ILE . . . . . . . . . . . . . 73.8 mt -58.68 -44.17 89.26 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.307 0 CA-C-N 116.578 -0.283 . . . . 0.0 111.082 -179.068 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' F' F ' 25' ' ' LYS . . . . . . . . . . . . . 55.8 mttp -64.81 -39.33 93.41 Favored 'General case' 0 N--CA 1.464 0.24 0 N-CA-C 112.461 0.541 . . . . 0.0 112.461 -179.632 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' F' F ' 26' ' ' LEU . . . . . . . . . . . . . 49.7 mt -78.9 -41.72 29.0 Favored 'General case' 0 C--N 1.33 -0.28 0 N-CA-C 113.299 0.851 . . . . 0.0 113.299 -170.114 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' F' F ' 27' ' ' GLN . . . . . . . . . . . . . 10.9 pt20 -46.66 139.65 5.05 Favored 'General case' 0 N--CA 1.469 0.508 0 N-CA-C 112.817 0.673 . . . . 0.0 112.817 -175.11 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' F' F ' 28' ' ' GLY . . . . . . . . . . . . . . . 100.63 -27.97 18.04 Favored Glycine 0 CA--C 1.53 0.995 0 CA-C-N 115.494 -0.775 . . . . 0.0 112.218 -177.382 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' F' F ' 29' ' ' LYS . . . . . . . . . . . . . 98.2 mttt -97.9 155.07 17.24 Favored 'General case' 0 C--O 1.232 0.18 0 CA-C-N 117.33 0.565 . . . . 0.0 111.247 179.056 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' F' F ' 30' ' ' THR . . . . . . . . . . . . . 42.0 m -103.67 140.28 37.8 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 115.892 -0.594 . . . . 0.0 110.162 176.839 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' F' F ' 31' ' ' VAL . . . . . . . . . . . . . 35.5 m -127.48 155.06 38.53 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.303 0 CA-C-N 116.272 -0.422 . . . . 0.0 110.374 179.429 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' F' F ' 32' ' ' ARG . . . . . . . . . . . . . 35.9 ttp180 -134.03 149.31 51.17 Favored 'General case' 0 C--N 1.331 -0.207 0 CA-C-O 121.305 0.574 . . . . 0.0 110.603 178.678 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' F' F ' 33' ' ' THR . . . . . . . . . . . . . 16.3 m -52.51 139.61 24.85 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-N 116.073 -0.512 . . . . 0.0 111.544 -177.939 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' F' F ' 34' ' ' GLY . . . . . . . . . . . . . . . 98.75 -17.23 58.61 Favored Glycine 0 CA--C 1.533 1.175 0 C-N-CA 121.236 -0.507 . . . . 0.0 113.366 178.947 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' F' F ' 35' ' ' ASP . . . . . . . . . . . . . 76.3 m-20 -65.79 150.17 48.97 Favored 'General case' 0 N--CA 1.462 0.161 0 CA-C-N 117.942 0.871 . . . . 0.0 111.291 -179.891 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' F' F ' 36' ' ' VAL . . . . . . . . . . . . . 44.3 t -119.73 128.93 75.91 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.222 0 CA-C-N 115.798 -0.637 . . . . 0.0 109.725 177.882 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' F' F ' 37' ' ' ILE . . . . . . . . . . . . . 68.8 mt -122.22 139.19 49.94 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.248 0 CA-C-N 116.261 -0.427 . . . . 0.0 109.928 -179.275 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' F' F ' 38' ' ' GLY . . . . . . . . . . . . . . . -115.3 128.35 8.04 Favored Glycine 0 CA--C 1.525 0.693 0 N-CA-C 110.859 -0.896 . . . . 0.0 110.859 178.853 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' F' F ' 39' ' ' ILE . . . . . . . . . . . . . 76.3 mt -127.44 138.6 54.29 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.217 0 CA-C-O 120.74 0.305 . . . . 0.0 110.197 179.921 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' F' F ' 40' ' ' SER . . . . . . . . . . . . . 42.6 t -91.96 114.05 26.48 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.274 -0.421 . . . . 0.0 110.981 176.849 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' F' F ' 41' ' ' ILE . . . . . . . . . . . . . 44.3 mm -122.94 121.06 62.3 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.234 0 N-CA-C 109.665 -0.494 . . . . 0.0 109.665 178.645 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' F' F ' 42' ' ' LEU . . . . . . . . . . . . . 84.2 mt 57.71 33.67 23.51 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 116.454 -0.339 . . . . 0.0 111.662 179.606 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' F' F ' 43' ' ' GLY . . . . . . . . . . . . . . . 77.64 -10.2 25.37 Favored Glycine 0 CA--C 1.535 1.288 0 C-N-CA 121.311 -0.471 . . . . 0.0 113.47 178.114 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' F' F ' 44' ' ' LYS . . . . . . . . . . . . . 98.3 mttt -101.05 138.76 37.66 Favored 'General case' 0 C--N 1.334 -0.108 0 CA-C-N 117.898 0.849 . . . . 0.0 110.05 177.436 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' F' F ' 45' ' ' GLU . . . . . . . . . . . . . 80.9 tt0 -83.75 130.08 34.95 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.431 -0.35 . . . . 0.0 111.263 -178.945 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' F' F ' 46' ' ' VAL . . . . . . . . . . . . . 10.4 p -120.55 125.87 74.61 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.209 0 N-CA-C 109.653 -0.499 . . . . 0.0 109.653 174.512 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' F' F ' 47' ' ' LYS . . . . . . . . . . . . . 29.2 mtpp -98.0 124.98 42.74 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 115.984 -0.553 . . . . 0.0 110.622 177.979 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' F' F ' 48' ' ' PHE . . . . . . . . . . . . . 40.8 m-85 -110.15 131.89 54.65 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.251 -0.431 . . . . 0.0 109.893 177.534 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' F' F ' 49' ' ' LYS . . . . . . . . . . . . . 85.6 tttt -106.34 131.39 53.61 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.209 -0.451 . . . . 0.0 109.811 177.158 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' F' F ' 50' ' ' VAL . . . . . . . . . . . . . 43.8 t -75.59 105.92 4.95 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.335 0 N-CA-C 109.384 -0.598 . . . . 0.0 109.384 177.911 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' F' F ' 51' ' ' VAL . . . . . . . . . . . . . 48.1 t -69.17 -48.01 71.23 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.27 0 CA-C-N 116.062 -0.517 . . . . 0.0 109.761 -174.354 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' F' F ' 52' ' ' GLN . . . . . . . . . . . . . 21.4 pt20 -167.01 158.56 12.47 Favored 'General case' 0 C--N 1.331 -0.199 0 C-N-CA 120.249 -0.58 . . . . 0.0 111.79 179.167 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' F' F ' 53' ' ' ALA . . . . . . . . . . . . . . . -133.5 137.04 45.44 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 115.485 -0.779 . . . . 0.0 110.243 179.07 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' F' F ' 54' ' ' TYR . . . . . . . . . . . . . 38.4 t80 -128.98 109.43 18.29 Favored Pre-proline 0 CA--C 1.535 0.372 0 CA-C-O 118.274 -0.87 . . . . 0.0 110.359 -179.425 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' F' F ' 55' ' ' PRO . . . . . . . . . . . . . 74.0 Cg_endo -77.17 169.97 72.77 Favored 'Cis proline' 0 N--CA 1.502 2.002 0 CA-C-N 121.855 1.698 . . . . 0.0 112.145 -7.375 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' F' F ' 56' ' ' SER . . . . . . . . . . . . . 49.0 m -117.82 132.8 23.48 Favored Pre-proline 0 CA--C 1.538 0.483 0 CA-C-O 118.492 -0.766 . . . . 0.0 109.616 175.057 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' F' F ' 57' ' ' PRO . . . . . . . . . . . . . 40.4 Cg_endo -68.56 165.45 72.8 Favored 'Cis proline' 0 N--CA 1.497 1.731 0 CA-C-N 121.88 1.707 . . . . 0.0 111.328 -1.657 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' F' F ' 58' ' ' LEU . . . . . . . . . . . . . 23.4 tp -130.62 137.45 49.63 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-O 120.871 0.367 . . . . 0.0 110.691 -178.049 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' F' F ' 59' ' ' ARG . . . . . . . . . . . . . 57.6 ttt85 -104.05 128.4 51.65 Favored 'General case' 0 C--N 1.328 -0.35 0 N-CA-C 109.464 -0.569 . . . . 0.0 109.464 176.35 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' F' F ' 60' ' ' VAL . . . . . . . . . . . . . 41.1 t -81.48 122.61 36.77 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.267 0 C-N-CA 120.769 -0.372 . . . . 0.0 110.69 -175.159 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' F' F ' 61' ' ' GLU . . . . . . . . . . . . . 44.3 mt-10 -131.12 168.0 18.18 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 115.842 -0.617 . . . . 0.0 109.77 176.892 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' F' F ' 62' ' ' ASP . . . . . . . . . . . . . 10.0 p-10 -55.91 -32.67 63.97 Favored 'General case' 0 C--N 1.329 -0.316 0 N-CA-C 111.803 0.297 . . . . 0.0 111.803 -178.484 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' F' F ' 63' ' ' ARG . . . . . . . . . . . . . 24.5 mmt180 -78.77 -9.33 59.4 Favored 'General case' 0 N--CA 1.467 0.383 0 N-CA-C 113.347 0.869 . . . . 0.0 113.347 -176.772 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' F' F ' 64' ' ' THR . . . . . . . . . . . . . 31.4 m -70.85 138.93 50.67 Favored 'General case' 0 C--N 1.332 -0.165 0 CA-C-O 121.007 0.432 . . . . 0.0 111.148 -175.356 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' F' F ' 65' ' ' LYS . . . . . . . . . . . . . 62.2 mttm -88.95 123.12 32.99 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 115.862 -0.608 . . . . 0.0 109.881 176.425 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' F' F ' 66' ' ' ILE . . . . . . . . . . . . . 61.7 mt -115.2 126.61 72.82 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 N-CA-C 109.779 -0.452 . . . . 0.0 109.779 179.758 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' F' F ' 67' ' ' THR . . . . . . . . . . . . . 28.4 m -125.38 138.76 54.04 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-O 121.126 0.488 . . . . 0.0 111.175 -177.351 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' F' F ' 68' ' ' LEU . . . . . . . . . . . . . 46.3 mt . . . . . 0 C--N 1.329 -0.306 0 CA-C-N 115.753 -0.658 . . . . 0.0 109.959 176.161 . . . . . . . . 0 0 . 1 . 004 nuclear orig core ' F' F ' 73' ' ' VAL . . . . . . . . . . . . . 35.9 m . . . . . 0 C--O 1.231 0.08 0 CA-C-O 121.027 0.441 . . . . 0.0 110.814 . . . . . . . . . 0 0 . 1 . 004 nuclear orig core ' F' F ' 74' ' ' ASP . . . . . . . . . . . . . 13.5 t0 -105.11 117.9 35.18 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 115.849 -0.614 . . . . 0.0 109.741 177.748 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' F' F ' 75' ' ' VAL . . . . . . . . . . . . . 40.1 t -118.06 125.61 74.34 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.267 0 CA-C-O 121.048 0.451 . . . . 0.0 110.61 -178.08 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' F' F ' 76' ' ' LEU . . . . . . . . . . . . . 5.7 mp -126.3 145.42 50.43 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 115.672 -0.695 . . . . 0.0 109.559 176.206 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' F' F ' 77' ' ' GLU . . . . . . . . . . . . . 96.7 mt-10 -132.04 129.11 39.62 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-O 121.02 0.438 . . . . 0.0 110.715 -178.064 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' F' F ' 78' ' ' ALA . . . . . . . . . . . . . . . -115.4 132.62 56.56 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 115.75 -0.659 . . . . 0.0 109.999 178.869 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' F' F ' 79' ' ' LYS . . . . . . . . . . . . . 20.2 tptm -76.91 116.38 17.52 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-O 120.916 0.389 . . . . 0.0 110.791 -177.424 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' F' F ' 80' ' ' ILE . . . . . . . . . . . . . 42.3 mm -139.28 98.45 1.16 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.282 0 N-CA-C 109.152 -0.684 . . . . 0.0 109.152 -176.938 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' F' F ' 81' ' ' LYS . . . . . . . . . . . . . 17.8 pttp -98.4 131.26 44.82 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-O 120.956 0.408 . . . . 0.0 111.454 -175.72 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' F' F ' 82' ' ' GLY . . . . . . . . . . . . . . . 89.12 41.98 5.72 Favored Glycine 0 CA--C 1.524 0.643 0 CA-C-N 115.82 -0.627 . . . . 0.0 111.57 176.076 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' F' F ' 83' ' ' ILE . . . . . . . . . . . . . 65.8 mt -74.59 135.5 27.24 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 N-CA-C 109.453 -0.573 . . . . 0.0 109.453 176.719 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' F' F ' 84' ' ' LYS . . . . . . . . . . . . . 38.0 ttpt -106.94 -42.48 4.91 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-O 120.782 0.325 . . . . 0.0 110.634 -177.805 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' F' F ' 85' ' ' ASP . . . . . . . . . . . . . 9.2 t70 -149.23 149.83 31.6 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.311 -0.404 . . . . 0.0 110.433 179.336 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' F' F ' 86' ' ' VAL . . . . . . . . . . . . . 41.9 t -137.64 136.76 45.9 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.231 0 CA-C-O 120.936 0.398 . . . . 0.0 110.74 -178.915 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' F' F ' 87' ' ' ILE . . . . . . . . . . . . . 4.9 mp -123.83 126.86 73.32 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.251 0 CA-C-N 115.828 -0.624 . . . . 0.0 109.522 176.171 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' F' F ' 88' ' ' LEU . . . . . . . . . . . . . 19.2 tp -114.89 130.26 56.86 Favored 'General case' 0 N--CA 1.463 0.184 0 CA-C-O 121.088 0.47 . . . . 0.0 111.187 -177.525 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' F' F ' 89' ' ' ASP . . . . . . . . . . . . . 4.2 t0 -125.42 156.58 38.6 Favored 'General case' 0 C--N 1.331 -0.207 0 CA-C-N 115.638 -0.71 . . . . 0.0 109.388 175.399 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' F' F ' 90' ' ' GLU . . . . . . . . . . . . . 81.9 tt0 -46.53 -40.89 13.39 Favored 'General case' 0 N--CA 1.463 0.211 0 N-CA-C 113.11 0.781 . . . . 0.0 113.11 -172.445 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' F' F ' 91' ' ' ASN . . . . . . . . . . . . . 71.1 m-80 -132.14 37.75 3.55 Favored 'General case' 0 N--CA 1.465 0.28 0 CA-C-O 120.785 0.326 . . . . 0.0 111.554 -176.479 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' F' F ' 92' ' ' LEU . . . . . . . . . . . . . 17.3 tp -166.08 138.85 4.04 Favored 'General case' 0 C--N 1.33 -0.281 0 C-N-CA 120.931 -0.308 . . . . 0.0 110.589 -179.563 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' F' F ' 93' ' ' ILE . . . . . . . . . . . . . 67.0 mt -124.02 122.42 64.42 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.187 0 N-CA-C 109.769 -0.456 . . . . 0.0 109.769 179.724 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' F' F ' 94' ' ' VAL . . . . . . . . . . . . . 44.8 t -120.92 125.18 73.73 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.222 0 N-CA-C 109.789 -0.448 . . . . 0.0 109.789 178.59 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' F' F ' 95' ' ' VAL . . . . . . . . . . . . . 43.1 t -120.11 134.04 64.88 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.379 0 CA-C-N 116.071 -0.513 . . . . 0.0 109.746 -179.422 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' F' F ' 96' ' ' ILE . . . . . . . . . . . . . 68.4 mt -116.6 127.88 74.1 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.232 0 N-CA-C 109.458 -0.571 . . . . 0.0 109.458 179.31 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' F' F ' 97' ' ' THR . . . . . . . . . . . . . 77.8 p -101.92 162.23 13.06 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-O 121.5 0.667 . . . . 0.0 111.704 -175.362 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' F' F ' 98' ' ' GLU . . . . . . . . . . . . . 82.1 tt0 -53.82 -28.51 35.92 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 115.442 -0.799 . . . . 0.0 112.361 -178.947 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' F' F ' 99' ' ' GLU . . . . . . . . . . . . . 96.0 mt-10 -81.97 18.04 1.42 Allowed 'General case' 0 CA--C 1.534 0.354 0 N-CA-C 113.116 0.784 . . . . 0.0 113.116 -176.356 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' F' F ' 100' ' ' ASN . . . . . . . . . . . . . 2.7 m-20 62.22 37.65 14.07 Favored 'General case' 0 CA--C 1.53 0.185 0 CA-C-O 121.036 0.446 . . . . 0.0 111.047 177.591 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' F' F ' 101' ' ' GLU . . . . . . . . . . . . . 84.7 tt0 -117.1 144.61 44.48 Favored 'General case' 0 C--N 1.332 -0.193 0 N-CA-C 109.719 -0.475 . . . . 0.0 109.719 177.342 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' F' F ' 102' ' ' VAL . . . . . . . . . . . . . 42.4 t -117.47 127.29 74.94 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.23 0 N-CA-C 109.962 -0.385 . . . . 0.0 109.962 -178.446 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' F' F ' 103' ' ' LEU . . . . . . . . . . . . . 31.5 mt -116.33 132.07 56.77 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 115.572 -0.74 . . . . 0.0 110.036 176.699 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' F' F ' 104' ' ' ILE . . . . . . . . . . . . . 66.4 mt -117.73 122.21 69.26 Favored 'Isoleucine or valine' 0 C--O 1.234 0.265 0 N-CA-C 110.238 -0.282 . . . . 0.0 110.238 -178.939 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' F' F ' 105' ' ' PHE . . . . . . . . . . . . . 86.5 m-85 -123.48 164.27 19.27 Favored 'General case' 0 C--N 1.332 -0.165 0 O-C-N 123.936 0.773 . . . . 0.0 110.3 -178.857 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' F' F ' 106' ' ' ASN . . . . . . . . . . . . . 46.0 p-10 -99.73 -169.92 1.82 Allowed 'General case' 0 CA--C 1.53 0.2 0 N-CA-C 109.655 -0.498 . . . . 0.0 109.655 171.849 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' F' F ' 107' ' ' GLN . . . . . . . . . . . . . 41.4 tt0 -57.86 -30.06 65.49 Favored 'General case' 0 C--N 1.327 -0.379 0 N-CA-C 112.117 0.414 . . . . 0.0 112.117 -178.767 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' F' F ' 108' ' ' ASN . . . . . . . . . . . . . 8.8 t30 -91.24 14.11 15.29 Favored 'General case' 0 CA--C 1.535 0.398 0 N-CA-C 113.106 0.78 . . . . 0.0 113.106 -175.558 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' F' F ' 109' ' ' LEU . . . . . . . . . . . . . 40.8 mt 58.12 34.01 23.75 Favored 'General case' 0 CA--C 1.53 0.204 0 CA-C-O 120.718 0.294 . . . . 0.0 111.723 177.914 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' F' F ' 110' ' ' GLU . . . . . . . . . . . . . 96.0 mt-10 -98.92 134.75 41.33 Favored 'General case' 0 C--N 1.329 -0.288 0 N-CA-C 109.408 -0.59 . . . . 0.0 109.408 175.434 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' F' F ' 111' ' ' GLU . . . . . . . . . . . . . 48.4 tt0 -71.7 121.97 19.8 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-O 121.009 0.433 . . . . 0.0 110.729 -175.751 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' F' F ' 112' ' ' LEU . . . . . . . . . . . . . 25.6 mt -105.87 -46.04 4.22 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-N 115.898 -0.592 . . . . 0.0 110.327 178.994 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' F' F ' 113' ' ' TYR . . . . . . . . . . . . . 31.2 t80 -137.95 141.54 40.53 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.11 -0.495 . . . . 0.0 111.05 -179.036 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' F' F ' 114' ' ' ARG . . . . . . . . . . . . . 32.7 ptt180 -141.69 123.58 15.31 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.247 -0.433 . . . . 0.0 110.392 177.206 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' F' F ' 115' ' ' GLY . . . . . . . . . . . . . . . -150.14 160.08 28.38 Favored Glycine 0 CA--C 1.524 0.601 0 N-CA-C 111.16 -0.776 . . . . 0.0 111.16 179.821 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' F' F ' 116' ' ' LYS . . . . . . . . . . . . . 33.4 ttpt -128.96 136.91 50.99 Favored 'General case' 0 C--N 1.33 -0.276 0 N-CA-C 109.908 -0.405 . . . . 0.0 109.908 177.333 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' F' F ' 117' ' ' PHE . . . . . . . . . . . . . 43.4 m-85 -134.1 113.79 12.45 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-O 120.971 0.415 . . . . 0.0 110.238 -177.124 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' F' F ' 118' ' ' GLU . . . . . . . . . . . . . 45.7 tp10 -54.69 -48.88 71.89 Favored 'General case' 0 C--N 1.326 -0.449 0 CA-C-N 116.289 -0.414 . . . . 0.0 111.277 -176.188 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' F' F ' 119' ' ' ASN . . . . . . . . . . . . . 73.3 m-20 -95.17 31.1 1.99 Allowed 'General case' 0 C--N 1.33 -0.275 0 N-CA-C 112.155 0.428 . . . . 0.0 112.155 -173.836 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' F' F ' 120' ' ' LEU . . . . . . . . . . . . . 20.0 tp -54.18 119.91 5.76 Favored 'General case' 0 N--CA 1.464 0.233 0 O-C-N 122.207 -0.308 . . . . 0.0 110.738 177.29 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' F' F ' 121' ' ' ASN . . . . . . . . . . . . . 13.6 t-20 -114.11 -44.03 3.18 Favored 'General case' 0 C--N 1.331 -0.214 0 CA-C-N 116.455 -0.339 . . . . 0.0 110.962 -177.009 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' F' F ' 122' ' ' LYS . . . . . . . . . . . . . 61.9 mtpt -142.0 147.29 36.67 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-O 121.168 0.509 . . . . 0.0 111.233 -177.059 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' F' F ' 123' ' ' VAL . . . . . . . . . . . . . 44.2 t -128.66 125.98 64.39 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.191 0 N-CA-C 109.312 -0.625 . . . . 0.0 109.312 174.679 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' F' F ' 124' ' ' LEU . . . . . . . . . . . . . 6.0 mp -118.17 132.82 56.3 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-O 120.766 0.317 . . . . 0.0 110.696 -177.019 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' F' F ' 125' ' ' VAL . . . . . . . . . . . . . 43.9 t -125.57 127.51 71.69 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.241 0 CA-C-N 116.051 -0.522 . . . . 0.0 110.178 179.918 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' F' F ' 126' ' ' ARG . . . . . . . . . . . . . 40.8 mmt180 -145.22 119.88 9.8 Favored 'General case' 0 C--N 1.328 -0.336 0 N-CA-C 109.478 -0.564 . . . . 0.0 109.478 177.193 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' F' F ' 127' ' ' ASN . . . . . . . . . . . . . 13.8 m120 56.38 -152.73 0.37 Allowed 'General case' 0 CA--C 1.54 0.564 0 N-CA-C 109.737 -0.468 . . . . 0.0 109.737 -179.164 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' F' F ' 128' ' ' ASP . . . . . . . . . . . . . 23.3 p-10 -79.95 14.29 1.87 Allowed 'General case' 0 CA--C 1.537 0.448 0 N-CA-C 112.759 0.652 . . . . 0.0 112.759 177.799 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' F' F ' 129' ' ' LEU . . . . . . . . . . . . . 60.9 mt -109.37 139.75 43.93 Favored 'General case' 0 C--O 1.232 0.181 0 O-C-N 121.955 -0.465 . . . . 0.0 109.747 178.254 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' F' F ' 130' ' ' VAL . . . . . . . . . . . . . 12.1 p -132.34 141.75 44.45 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.235 0 CA-C-O 121.202 0.525 . . . . 0.0 110.562 -177.746 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' F' F ' 131' ' ' VAL . . . . . . . . . . . . . 42.8 t -135.99 135.2 50.58 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.299 0 CA-C-N 115.794 -0.639 . . . . 0.0 110.035 178.63 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' F' F ' 132' ' ' ILE . . . . . . . . . . . . . 69.0 mt -113.52 130.76 66.98 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.332 0 CA-C-N 115.815 -0.629 . . . . 0.0 109.348 -179.784 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' F' F ' 133' ' ' ILE . . . . . . . . . . . . . 36.8 mm -114.59 120.41 64.19 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.216 0 CA-C-O 120.989 0.423 . . . . 0.0 110.914 -175.044 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' F' F ' 134' ' ' ASP . . . . . . . . . . . . . 6.9 p-10 -132.56 147.45 52.35 Favored 'General case' 0 C--N 1.332 -0.181 0 N-CA-C 109.519 -0.549 . . . . 0.0 109.519 176.007 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' F' F ' 135' ' ' GLU . . . . . . . . . . . . . 84.5 tt0 -49.94 -27.57 5.51 Favored 'General case' 0 C--N 1.329 -0.298 0 N-CA-C 112.703 0.631 . . . . 0.0 112.703 -173.008 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' F' F ' 136' ' ' GLN . . . . . . . . . . . . . 98.5 mt-30 -81.36 -34.48 31.71 Favored 'General case' 0 C--O 1.232 0.183 0 N-CA-C 112.181 0.438 . . . . 0.0 112.181 -176.158 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' F' F ' 137' ' ' LYS . . . . . . . . . . . . . 56.3 pttt -168.01 175.04 6.92 Favored 'General case' 0 C--N 1.332 -0.188 0 CA-C-O 121.506 0.669 . . . . 0.0 112.14 -172.482 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' F' F ' 138' ' ' LEU . . . . . . . . . . . . . 8.5 tt -120.13 128.59 53.58 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 115.174 -0.921 . . . . 0.0 110.135 179.205 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' F' F ' 139' ' ' THR . . . . . . . . . . . . . 33.2 m -107.64 122.41 46.65 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-N 116.116 -0.493 . . . . 0.0 110.239 178.906 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' F' F ' 140' ' ' LEU . . . . . . . . . . . . . 6.2 tt -111.03 122.27 47.47 Favored 'General case' 0 C--N 1.329 -0.326 0 N-CA-C 109.189 -0.671 . . . . 0.0 109.189 -179.432 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' F' F ' 141' ' ' ILE . . . . . . . . . . . . . 19.8 mt -121.63 116.36 49.25 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.275 0 CA-C-O 121.086 0.47 . . . . 0.0 109.927 -176.113 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' F' F ' 142' ' ' ARG . . . . . . . . . . . . . 61.6 ttt180 -106.07 127.46 53.2 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 114.921 -1.036 . . . . 0.0 110.619 -176.259 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' F' F ' 143' ' ' THR . . . . . . . . . . . . . 75.8 p . . . . . 0 C--O 1.22 -0.46 0 CA-C-O 118.001 -1.0 . . . . 0.0 110.589 179.192 . . . . . . . . 0 0 . 1 . 005 nuclear orig core ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 13.7 p . . . . . 0 C--O 1.231 0.108 0 CA-C-O 121.11 0.481 . . . . 0.0 110.618 . . . . . . . . . 0 0 . 1 . 005 nuclear orig core ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 84.9 tt0 -140.02 138.94 35.84 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-N 115.724 -0.671 . . . . 0.0 110.676 179.64 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 4' ' ' LEU . . . . . . . . . . . . . 3.0 tt -125.7 126.51 44.76 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 115.734 -0.666 . . . . 0.0 109.698 178.579 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 5' ' ' LYS . . . . . . . . . . . . . 87.8 mttt -108.99 124.34 50.56 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-O 120.655 0.265 . . . . 0.0 110.864 -179.119 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 18.3 mt -122.01 150.29 42.28 Favored 'General case' 0 C--O 1.232 0.163 0 CA-C-N 115.811 -0.631 . . . . 0.0 111.254 -178.879 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 49.3 tttm -138.27 143.47 39.1 Favored Pre-proline 0 C--N 1.329 -0.304 0 CA-C-N 115.757 -0.656 . . . . 0.0 109.792 175.199 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 8' ' ' PRO . . . . . . . . . . . . . 97.5 Cg_endo -89.8 136.72 2.65 Favored 'Trans proline' 0 N--CA 1.489 1.234 0 C-N-CA 121.741 1.628 . . . . 0.0 111.766 178.537 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 40.9 mt -75.9 -45.68 3.93 Favored Pre-proline 0 CA--C 1.532 0.285 0 CA-C-O 119.064 -0.493 . . . . 0.0 111.524 -179.253 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 71.1 Cg_endo -85.1 152.12 10.93 Favored 'Trans proline' 0 N--CA 1.494 1.519 0 C-N-CA 121.234 1.289 . . . . 0.0 111.31 170.534 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 27.5 ttpp -86.23 109.78 19.16 Favored 'General case' 0 C--N 1.33 -0.271 0 C-N-CA 120.702 -0.399 . . . . 0.0 110.235 178.692 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 11.8 p -142.77 145.09 23.55 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.291 0 CA-C-N 116.092 -0.504 . . . . 0.0 110.62 -178.576 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 84.8 tt0 -88.47 121.32 30.72 Favored 'General case' 0 C--N 1.328 -0.344 0 N-CA-C 109.913 -0.403 . . . . 0.0 109.913 176.886 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 14' ' ' LEU . . . . . . . . . . . . . 29.6 mt -98.01 151.56 37.61 Favored Pre-proline 0 C--N 1.33 -0.268 0 CA-C-N 116.354 -0.384 . . . . 0.0 110.976 -176.277 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 15' ' ' PRO . . . . . . . . . . . . . 24.5 Cg_exo -63.31 161.13 31.95 Favored 'Trans proline' 0 N--CA 1.497 1.723 0 C-N-CA 121.322 1.348 . . . . 0.0 111.666 175.436 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 16' ' ' PRO . . . . . . . . . . . . . 26.6 Cg_exo -60.73 -34.0 92.39 Favored 'Trans proline' 0 N--CA 1.496 1.646 0 C-N-CA 121.478 1.452 . . . . 0.0 112.966 -177.722 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 17' ' ' ASP . . . . . . . . . . . . . 18.8 p-10 -90.62 6.6 43.17 Favored 'General case' 0 CA--C 1.537 0.465 0 N-CA-C 113.402 0.89 . . . . 0.0 113.402 -176.833 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 18' ' ' PHE . . . . . . . . . . . . . 49.6 t80 -57.59 -42.93 84.18 Favored 'General case' 0 C--N 1.334 -0.105 0 CA-C-O 120.952 0.406 . . . . 0.0 110.291 -178.021 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 19' ' ' VAL . . . . . . . . . . . . . 47.8 t -57.16 -43.57 81.84 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.346 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.358 -178.827 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 4.2 m-20 -60.15 -41.33 92.54 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.525 -0.307 . . . . 0.0 110.882 -178.381 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 47.0 t -63.58 -46.17 95.66 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 C-N-CA 120.85 -0.34 . . . . 0.0 110.296 -177.385 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 22' ' ' ILE . . . . . . . . . . . . . 51.0 mm -55.54 -48.63 77.13 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.237 0 CA-C-O 120.81 0.338 . . . . 0.0 110.714 178.778 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 23' ' ' ARG . . . . . . . . . . . . . 55.9 ttp180 -54.31 -48.77 70.93 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.629 -0.26 . . . . 0.0 111.568 -178.057 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 24' ' ' ILE . . . . . . . . . . . . . 78.5 mt -60.11 -42.7 90.92 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.269 0 C-N-CA 121.052 -0.259 . . . . 0.0 111.54 -176.791 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 51.1 mttm -65.13 -40.49 94.52 Favored 'General case' 0 C--N 1.328 -0.327 0 N-CA-C 112.21 0.448 . . . . 0.0 112.21 -179.12 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 37.6 mt -78.96 -40.06 32.83 Favored 'General case' 0 C--N 1.33 -0.271 0 N-CA-C 113.526 0.935 . . . . 0.0 113.526 -171.366 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 27' ' ' GLN . . . . . . . . . . . . . 9.8 pt20 -46.88 141.91 3.75 Favored 'General case' 0 N--CA 1.47 0.545 0 N-CA-C 112.82 0.674 . . . . 0.0 112.82 -175.207 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 97.72 -30.0 10.06 Favored Glycine 0 CA--C 1.531 1.044 0 CA-C-N 115.652 -0.703 . . . . 0.0 111.984 -177.529 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 48.8 mtmt -99.3 155.3 17.58 Favored 'General case' 0 C--O 1.233 0.227 0 CA-C-O 120.993 0.425 . . . . 0.0 111.324 179.304 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 30' ' ' THR . . . . . . . . . . . . . 20.8 m -105.57 140.55 38.49 Favored 'General case' 0 C--N 1.331 -0.212 0 CA-C-N 115.91 -0.586 . . . . 0.0 110.166 176.657 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 35.5 m -129.54 161.43 39.08 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.187 0 CA-C-N 116.41 -0.359 . . . . 0.0 110.848 -179.138 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 32' ' ' ARG . . . . . . . . . . . . . 79.7 mtt85 -127.28 147.37 50.23 Favored 'General case' 0 C--N 1.331 -0.212 0 CA-C-O 121.291 0.567 . . . . 0.0 110.776 179.093 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 33' ' ' THR . . . . . . . . . . . . . 29.2 m -53.91 140.69 29.98 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.248 -0.433 . . . . 0.0 111.146 -179.879 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 98.83 -17.13 58.69 Favored Glycine 0 CA--C 1.532 1.144 0 C-N-CA 121.131 -0.557 . . . . 0.0 113.232 179.33 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 76.1 m-20 -64.63 150.26 47.37 Favored 'General case' 0 C--O 1.232 0.147 0 CA-C-N 118.096 0.948 . . . . 0.0 111.241 179.813 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 45.0 t -119.07 129.65 74.91 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.247 0 CA-C-N 115.713 -0.676 . . . . 0.0 109.81 178.85 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 37' ' ' ILE . . . . . . . . . . . . . 69.2 mt -119.94 138.28 51.03 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.273 0 CA-C-N 116.171 -0.468 . . . . 0.0 109.759 179.414 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . -113.74 128.98 8.56 Favored Glycine 0 CA--C 1.525 0.707 0 N-CA-C 111.029 -0.828 . . . . 0.0 111.029 -179.255 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 39' ' ' ILE . . . . . . . . . . . . . 72.4 mt -123.55 133.97 67.69 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.231 0 N-CA-C 110.188 -0.301 . . . . 0.0 110.188 179.079 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 40' ' ' SER . . . . . . . . . . . . . 45.2 t -93.0 113.93 26.34 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.455 -0.338 . . . . 0.0 110.776 175.597 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 41' ' ' ILE . . . . . . . . . . . . . 44.9 mm -121.51 123.44 69.59 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.265 0 CA-C-O 120.778 0.323 . . . . 0.0 110.45 179.997 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 34.5 mt 52.57 34.09 14.91 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.235 -0.438 . . . . 0.0 111.791 177.292 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . 72.52 32.16 62.28 Favored Glycine 0 CA--C 1.53 0.988 0 C-N-CA 121.113 -0.565 . . . . 0.0 111.889 178.747 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 44' ' ' LYS . . . . . . . . . . . . . 33.7 ttmt -139.21 130.48 26.82 Favored 'General case' 0 C--N 1.329 -0.314 0 N-CA-C 109.767 -0.457 . . . . 0.0 109.767 179.188 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 84.0 tt0 -82.62 122.38 28.03 Favored 'General case' 0 C--N 1.329 -0.29 0 C-N-CA 120.755 -0.378 . . . . 0.0 111.003 -177.848 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 46' ' ' VAL . . . . . . . . . . . . . 7.1 p -120.64 129.1 75.98 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.227 0 N-CA-C 109.338 -0.616 . . . . 0.0 109.338 174.682 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 59.7 mtpt -100.32 127.05 46.71 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 115.748 -0.66 . . . . 0.0 110.858 179.624 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 48' ' ' PHE . . . . . . . . . . . . . 89.5 m-85 -110.44 131.87 54.68 Favored 'General case' 0 C--N 1.33 -0.275 0 N-CA-C 110.017 -0.364 . . . . 0.0 110.017 176.919 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 86.2 tttt -106.33 133.94 50.24 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.258 -0.428 . . . . 0.0 110.415 179.892 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 50' ' ' VAL . . . . . . . . . . . . . 42.1 t -77.76 105.38 6.7 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.236 0 N-CA-C 109.165 -0.68 . . . . 0.0 109.165 176.177 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 51' ' ' VAL . . . . . . . . . . . . . 48.9 t -69.79 -48.52 63.97 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.295 0 CA-C-N 116.022 -0.535 . . . . 0.0 110.146 -173.16 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 52' ' ' GLN . . . . . . . . . . . . . 61.8 tt0 -163.96 144.62 8.51 Favored 'General case' 0 C--N 1.329 -0.296 0 C-N-CA 120.288 -0.565 . . . . 0.0 111.811 -177.911 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -115.18 133.04 56.39 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 115.559 -0.746 . . . . 0.0 109.79 176.016 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 54' ' ' TYR . . . . . . . . . . . . . 9.5 t80 -129.04 108.41 18.09 Favored Pre-proline 0 CA--C 1.535 0.379 0 CA-C-O 118.182 -0.914 . . . . 0.0 110.464 178.499 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 55' ' ' PRO . . . . . . . . . . . . . 72.0 Cg_endo -76.96 168.89 75.87 Favored 'Cis proline' 0 N--CA 1.501 1.952 0 CA-C-N 121.941 1.729 . . . . 0.0 112.408 -4.945 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 56' ' ' SER . . . . . . . . . . . . . 14.4 m -112.33 128.0 26.1 Favored Pre-proline 0 CA--C 1.539 0.535 0 CA-C-O 118.366 -0.826 . . . . 0.0 109.673 176.961 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 57' ' ' PRO . . . . . . . . . . . . . 35.2 Cg_endo -65.72 168.86 44.6 Favored 'Cis proline' 0 N--CA 1.497 1.715 0 CA-C-N 122.029 1.76 . . . . 0.0 111.45 -2.862 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 58' ' ' LEU . . . . . . . . . . . . . 30.0 tp -129.95 135.71 48.63 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-O 120.887 0.375 . . . . 0.0 110.707 -179.41 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 59' ' ' ARG . . . . . . . . . . . . . 52.9 ttt180 -106.99 129.12 54.83 Favored 'General case' 0 C--N 1.328 -0.335 0 N-CA-C 108.688 -0.856 . . . . 0.0 108.688 176.521 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 40.6 t -89.85 126.23 42.75 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.183 0 C-N-CA 120.385 -0.526 . . . . 0.0 111.36 -172.607 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 49.8 mp0 -131.07 168.55 17.21 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 115.58 -0.737 . . . . 0.0 109.077 171.917 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 62' ' ' ASP . . . . . . . . . . . . . 18.2 p-10 -53.87 -32.6 53.72 Favored 'General case' 0 C--N 1.329 -0.323 0 C-N-CA 120.931 -0.308 . . . . 0.0 111.815 -178.449 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 63' ' ' ARG . . . . . . . . . . . . . 98.4 mtt180 -71.97 -22.14 61.49 Favored 'General case' 0 CA--C 1.532 0.273 0 N-CA-C 112.896 0.702 . . . . 0.0 112.896 -177.299 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 50.9 m -67.37 130.24 42.43 Favored 'General case' 0 C--N 1.332 -0.193 0 N-CA-C 110.125 -0.324 . . . . 0.0 110.125 -178.275 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 65' ' ' LYS . . . . . . . . . . . . . 50.3 mtmt -89.23 135.79 33.38 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.222 -0.445 . . . . 0.0 110.538 179.825 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 66' ' ' ILE . . . . . 0.404 HD11 HG23 ' A' ' 66' ' ' ILE . 65.1 mt -114.8 130.95 68.36 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.229 0 N-CA-C 109.736 -0.468 . . . . 0.0 109.736 -178.408 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 67' ' ' THR . . . . . . . . . . . . . 23.4 m -117.63 134.73 54.57 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.123 -0.49 . . . . 0.0 110.608 -178.524 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 68' ' ' LEU . . . . . . . . . . . . . 15.4 tp . . . . . 0 C--N 1.329 -0.309 0 CA-C-N 115.891 -0.595 . . . . 0.0 110.472 179.585 . . . . . . . . 0 0 . 1 . 005 nuclear orig core ' A' A ' 74' ' ' ASP . . . . . . . . . . . . . 13.6 t70 . . . . . 0 N--CA 1.459 0.023 0 N-CA-C 109.557 -0.535 . . . . 0.0 109.557 . . . . . . . . . 0 0 . 1 . 005 nuclear orig core ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 41.4 t -122.59 124.26 70.28 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.203 0 CA-C-O 121.077 0.465 . . . . 0.0 110.909 -175.203 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 76' ' ' LEU . . . . . . . . . . . . . 5.1 mp -126.38 147.05 49.83 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 115.664 -0.698 . . . . 0.0 109.603 174.852 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 77' ' ' GLU . . . . . . . . . . . . . 45.9 mt-10 -135.1 140.52 45.55 Favored 'General case' 0 C--N 1.331 -0.207 0 CA-C-O 121.015 0.436 . . . . 0.0 111.425 -178.443 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 78' ' ' ALA . . . . . . . . . . . . . . . -129.92 131.33 45.96 Favored 'General case' 0 C--N 1.331 -0.22 0 CA-C-N 115.774 -0.648 . . . . 0.0 109.842 176.513 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 79' ' ' LYS . . . . . . . . . . . . . 16.3 ptpt -74.94 122.57 23.65 Favored 'General case' 0 C--N 1.331 -0.222 0 CA-C-O 121.281 0.562 . . . . 0.0 111.087 -176.801 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 80' ' ' ILE . . . . . . . . . . . . . 41.2 mm -139.22 110.57 4.95 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.318 0 CA-C-N 115.779 -0.646 . . . . 0.0 109.289 -177.875 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 81' ' ' LYS . . . . . . . . . . . . . 60.6 mttp -101.37 125.56 48.03 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-O 120.914 0.388 . . . . 0.0 111.293 -178.234 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . 89.15 42.07 5.69 Favored Glycine 0 CA--C 1.525 0.702 0 C-N-CA 121.105 -0.569 . . . . 0.0 111.894 174.254 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 83' ' ' ILE . . . . . . . . . . . . . 71.4 mt -69.55 133.3 32.09 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.33 0 N-CA-C 109.489 -0.56 . . . . 0.0 109.489 175.999 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 84' ' ' LYS . . . . . . . . . . . . . 35.7 ttpt -101.58 -49.58 3.97 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-O 120.742 0.306 . . . . 0.0 110.398 -177.881 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 85' ' ' ASP . . . . . . . . . . . . . 5.6 t70 -150.87 151.26 31.97 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.242 -0.435 . . . . 0.0 110.483 -179.972 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 86' ' ' VAL . . . . . . . . . . . . . 41.0 t -133.89 137.62 52.0 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.261 0 CA-C-O 121.014 0.435 . . . . 0.0 110.537 -179.061 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 87' ' ' ILE . . . . . . . . . . . . . 5.0 mp -121.0 130.69 74.42 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.21 0 CA-C-N 115.701 -0.681 . . . . 0.0 109.699 178.134 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 88' ' ' LEU . . . . . . . . . . . . . 15.9 tp -111.79 132.83 54.4 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-O 120.858 0.361 . . . . 0.0 110.743 -178.893 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 89' ' ' ASP . . . . . . . . . . . . . 46.4 t0 -130.6 160.31 34.58 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.161 178.584 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 84.6 tt0 -45.77 -43.1 12.83 Favored 'General case' 0 CA--C 1.532 0.257 0 N-CA-C 113.06 0.763 . . . . 0.0 113.06 -171.392 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 91' ' ' ASN . . . . . . . . . . . . . 3.0 m120 -131.96 26.49 4.6 Favored 'General case' 0 N--CA 1.467 0.394 0 N-CA-C 112.471 0.545 . . . . 0.0 112.471 -178.286 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 92' ' ' LEU . . . . . . . . . . . . . 18.6 mt -148.58 144.47 27.28 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-O 120.759 0.314 . . . . 0.0 110.508 -176.693 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 93' ' ' ILE . . . . . . . . . . . . . 69.3 mt -125.23 116.69 47.65 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.306 0 N-CA-C 108.822 -0.807 . . . . 0.0 108.822 175.694 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 94' ' ' VAL . . . . . . . . . . . . . 44.3 t -117.62 127.85 74.93 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.286 0 N-CA-C 109.904 -0.406 . . . . 0.0 109.904 -177.807 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 95' ' ' VAL . . . . . . . . . . . . . 43.1 t -121.38 133.94 66.31 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.339 0 CA-C-N 116.027 -0.533 . . . . 0.0 109.813 -179.822 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 96' ' ' ILE . . . . . . . . . . . . . 66.8 mt -114.57 125.17 71.82 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.355 0 N-CA-C 109.254 -0.647 . . . . 0.0 109.254 178.63 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 97' ' ' THR . . . . . . . . . . . . . 74.7 p -97.37 156.29 16.52 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-O 121.401 0.62 . . . . 0.0 111.091 -177.388 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 98' ' ' GLU . . . . . . . . . . . . . 84.9 tt0 -53.86 -27.25 28.84 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 115.831 -0.622 . . . . 0.0 112.242 -179.163 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 99' ' ' GLU . . . . . . . . . . . . . 18.8 tp10 -80.8 16.71 1.34 Allowed 'General case' 0 CA--C 1.538 0.491 0 N-CA-C 112.741 0.645 . . . . 0.0 112.741 -176.538 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 100' ' ' ASN . . . . . . . . . . . . . 4.5 m-20 63.43 33.33 13.79 Favored 'General case' 0 C--O 1.233 0.233 0 O-C-N 122.013 -0.43 . . . . 0.0 111.694 177.478 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 101' ' ' GLU . . . . . . . . . . . . . 84.6 tt0 -111.3 142.72 43.16 Favored 'General case' 0 C--N 1.333 -0.147 0 N-CA-C 109.654 -0.498 . . . . 0.0 109.654 173.754 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 102' ' ' VAL . . . . . . . . . . . . . 46.7 t -115.06 127.3 72.67 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.294 0 CA-C-N 116.167 -0.47 . . . . 0.0 109.942 -177.711 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 103' ' ' LEU . . . . . . . . . . . . . 30.5 mt -117.8 129.55 55.74 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 115.809 -0.632 . . . . 0.0 110.279 177.267 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 104' ' ' ILE . . . . . . . . . . . . . 70.9 mt -118.35 120.86 65.65 Favored 'Isoleucine or valine' 0 C--O 1.234 0.244 0 N-CA-C 110.198 -0.297 . . . . 0.0 110.198 179.927 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 105' ' ' PHE . . . . . . . . . . . . . 54.3 m-85 -121.99 164.8 17.03 Favored 'General case' 0 C--N 1.333 -0.15 0 O-C-N 123.87 0.731 . . . . 0.0 109.781 179.377 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 106' ' ' ASN . . . . . . . . . . . . . 45.9 p-10 -99.04 -169.95 1.85 Allowed 'General case' 0 C--N 1.331 -0.219 0 N-CA-C 110.021 -0.363 . . . . 0.0 110.021 174.563 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 107' ' ' GLN . . . . . . . . . . . . . 40.0 tt0 -59.73 -30.1 68.59 Favored 'General case' 0 C--N 1.33 -0.268 0 N-CA-C 111.988 0.366 . . . . 0.0 111.988 -179.744 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 108' ' ' ASN . . . . . . . . . . . . . 51.7 t30 -82.85 8.83 11.29 Favored 'General case' 0 CA--C 1.536 0.425 0 N-CA-C 113.19 0.811 . . . . 0.0 113.19 -178.0 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 109' ' ' LEU . . . . . . . . . . . . . 12.2 tp 58.98 39.02 24.06 Favored 'General case' 0 C--N 1.332 -0.184 0 CA-C-O 121.162 0.506 . . . . 0.0 111.009 178.966 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 110' ' ' GLU . . . . . . . . . . . . . 70.7 mm-40 -106.91 155.41 19.79 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 116.299 -0.41 . . . . 0.0 109.998 176.595 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 111' ' ' GLU . . . . . . . . . . . . . 84.4 tt0 -83.54 121.92 27.87 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-O 120.835 0.35 . . . . 0.0 110.787 -177.364 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 112' ' ' LEU . . . . . . . . . . . . . 38.5 mt -109.02 -46.0 3.68 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 116.178 -0.465 . . . . 0.0 110.495 177.949 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 113' ' ' TYR . . . . . . . . . . . . . 63.0 t80 -140.29 138.01 34.63 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-O 120.804 0.335 . . . . 0.0 111.388 -179.383 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 114' ' ' ARG . . . . . . . . . . . . . 68.9 ttp85 -136.37 124.82 23.46 Favored 'General case' 0 C--N 1.331 -0.239 0 CA-C-N 115.946 -0.57 . . . . 0.0 110.274 177.535 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 115' ' ' GLY . . . . . . . . . . . . . . . -150.03 157.12 27.08 Favored Glycine 0 CA--C 1.522 0.524 0 N-CA-C 110.784 -0.926 . . . . 0.0 110.784 179.099 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 116' ' ' LYS . . . . . . . . . . . . . 69.8 tttt -134.68 132.23 38.65 Favored 'General case' 0 C--N 1.329 -0.305 0 N-CA-C 109.958 -0.386 . . . . 0.0 109.958 177.641 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 117' ' ' PHE . . . . . . . . . . . . . 39.9 m-85 -127.41 120.6 28.8 Favored 'General case' 0 N--CA 1.463 0.2 0 CA-C-N 116.308 -0.406 . . . . 0.0 110.073 -174.761 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 118' ' ' GLU . . . . . . . . . . . . . 95.6 mt-10 -54.35 -45.89 72.82 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 116.421 -0.354 . . . . 0.0 111.314 -175.851 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 119' ' ' ASN . . . . . . . . . . . . . 88.3 m-20 -101.31 31.11 3.84 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.137 -0.483 . . . . 0.0 112.076 -174.285 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 120' ' ' LEU . . . . . . . . . . . . . 15.0 tp -54.98 119.97 6.21 Favored 'General case' 0 N--CA 1.463 0.214 0 O-C-N 122.264 -0.272 . . . . 0.0 110.615 179.724 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 121' ' ' ASN . . . . . . . . . . . . . 23.9 t-20 -114.18 -44.07 3.17 Favored 'General case' 0 C--O 1.232 0.143 0 CA-C-N 116.487 -0.324 . . . . 0.0 111.151 -177.072 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 122' ' ' LYS . . . . . . . . . . . . . 63.6 mtpt -139.26 142.16 37.78 Favored 'General case' 0 C--N 1.331 -0.225 0 CA-C-O 120.99 0.424 . . . . 0.0 111.594 -175.59 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 123' ' ' VAL . . . . . . . . . . . . . 48.0 t -126.17 125.75 68.32 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 N-CA-C 109.01 -0.737 . . . . 0.0 109.01 173.001 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 124' ' ' LEU . . . . . . . . . . . . . 78.5 mt -121.42 131.13 53.99 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-O 120.843 0.354 . . . . 0.0 110.77 -175.853 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 125' ' ' VAL . . . . . . . . . . . . . 44.5 t -126.15 126.29 69.27 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.239 0 CA-C-N 115.98 -0.555 . . . . 0.0 109.742 178.52 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 126' ' ' ARG . . . . . . . . . . . . . 82.4 mtt85 -150.9 129.24 12.03 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.299 -0.41 . . . . 0.0 110.045 177.729 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 127' ' ' ASN . . . . . . . . . . . . . 8.8 t-20 56.21 -152.42 0.38 Allowed 'General case' 0 CA--C 1.54 0.581 0 N-CA-C 109.736 -0.468 . . . . 0.0 109.736 179.755 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 128' ' ' ASP . . . . . . . . . . . . . 23.4 p-10 -83.06 18.13 1.76 Allowed 'General case' 0 CA--C 1.536 0.414 0 N-CA-C 112.628 0.603 . . . . 0.0 112.628 178.303 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 129' ' ' LEU . . . . . . . . . . . . . 11.7 tp -117.35 137.2 52.61 Favored 'General case' 0 C--O 1.234 0.241 0 O-C-N 122.079 -0.388 . . . . 0.0 110.472 179.765 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 130' ' ' VAL . . . . . . . . . . . . . 42.0 t -125.84 138.73 53.59 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.188 0 CA-C-N 116.276 -0.42 . . . . 0.0 109.963 -179.424 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 131' ' ' VAL . . . . . . . . . . . . . 35.1 m -136.1 143.98 34.49 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.282 0 CA-C-O 121.152 0.501 . . . . 0.0 111.163 178.143 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 132' ' ' ILE . . . . . . . . . . . . . 69.9 mt -120.9 134.03 65.63 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 CA-C-N 115.657 -0.702 . . . . 0.0 109.606 179.966 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 133' ' ' ILE . . . . . . . . . . . . . 40.8 mm -116.68 117.83 56.75 Favored 'Isoleucine or valine' 0 C--O 1.233 0.224 0 CA-C-O 120.965 0.412 . . . . 0.0 110.711 -176.684 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 134' ' ' ASP . . . . . . . . . . . . . 8.0 p-10 -131.49 148.47 52.64 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 115.844 -0.616 . . . . 0.0 109.408 174.717 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 135' ' ' GLU . . . . . . . . . . . . . 84.8 tt0 -49.76 -24.44 2.35 Favored 'General case' 0 C--N 1.327 -0.399 0 N-CA-C 112.835 0.68 . . . . 0.0 112.835 -171.947 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 136' ' ' GLN . . . . . . . . . . . . . 51.2 tt0 -101.67 -27.72 12.9 Favored 'General case' 0 C--O 1.233 0.212 0 N-CA-C 112.58 0.585 . . . . 0.0 112.58 -173.789 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 137' ' ' LYS . . . . . . . . . . . . . 49.6 mttm -142.13 149.23 39.53 Favored 'General case' 0 C--N 1.332 -0.17 0 N-CA-C 112.766 0.654 . . . . 0.0 112.766 -170.51 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 138' ' ' LEU . . . . . . . . . . . . . 9.9 tp -110.4 118.66 36.87 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 114.891 -1.049 . . . . 0.0 108.732 170.973 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 139' ' ' THR . . . . . . . . . . . . . 31.5 m -111.05 127.47 55.55 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-O 120.67 0.271 . . . . 0.0 110.86 -177.283 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 140' ' ' LEU . . . . . . . . . . . . . 7.3 tt -116.05 122.66 45.84 Favored 'General case' 0 C--N 1.329 -0.292 0 N-CA-C 109.251 -0.648 . . . . 0.0 109.251 179.913 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 141' ' ' ILE . . . . . . . . . . . . . 19.0 mt -120.6 123.45 70.41 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.273 0 CA-C-O 120.87 0.367 . . . . 0.0 110.112 -174.378 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 142' ' ' ARG . . . . . . . . . . . . . 76.4 mtp180 -110.94 127.61 55.54 Favored 'General case' 0 C--N 1.331 -0.229 0 CA-C-N 115.521 -0.763 . . . . 0.0 110.164 -178.507 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 143' ' ' THR . . . . . . . . . . . . . 42.0 p . . . . . 0 C--O 1.219 -0.505 0 CA-C-O 118.024 -0.988 . . . . 0.0 110.593 -179.524 . . . . . . . . 0 0 . 1 . 005 nuclear orig core ' B' B ' 2' ' ' SER . . . . . . . . . . . . . 5.2 p . . . . . 0 C--O 1.233 0.191 0 CA-C-O 121.034 0.445 . . . . 0.0 111.03 . . . . . . . . . 0 0 . 1 . 005 nuclear orig core ' B' B ' 3' ' ' GLU . . . . . . . . . . . . . 33.8 tp10 -139.55 136.4 34.43 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 115.786 -0.643 . . . . 0.0 110.402 -178.52 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 4' ' ' LEU . . . . . . . . . . . . . 21.3 tp -124.49 128.77 49.48 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-O 120.714 0.292 . . . . 0.0 110.355 176.028 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 5' ' ' LYS . . . . . . . . . . . . . 98.3 mttt -105.5 120.94 42.89 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.344 -0.389 . . . . 0.0 110.539 179.074 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 6' ' ' LEU . . . . . . . . . . . . . 79.8 mt -118.21 147.62 43.2 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 115.587 -0.733 . . . . 0.0 110.549 -179.474 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 7' ' ' LYS . . . . . . . . . . . . . 73.5 tttt -134.79 140.11 34.3 Favored Pre-proline 0 CA--C 1.534 0.332 0 CA-C-O 118.985 -0.531 . . . . 0.0 110.038 176.193 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 8' ' ' PRO . . . . . . . . . . . . . 88.1 Cg_endo -91.79 137.17 1.86 Allowed 'Trans proline' 0 N--CA 1.489 1.25 0 C-N-CA 121.649 1.566 . . . . 0.0 111.559 177.804 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 9' ' ' LEU . . . . . . . . . . . . . 68.3 mt -72.32 -46.21 10.55 Favored Pre-proline 0 CA--C 1.533 0.32 0 CA-C-O 118.937 -0.554 . . . . 0.0 111.905 -178.682 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 10' ' ' PRO . . . . . . . . . . . . . 78.1 Cg_endo -84.37 152.09 12.08 Favored 'Trans proline' 0 N--CA 1.495 1.575 0 C-N-CA 121.318 1.345 . . . . 0.0 111.734 172.597 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 11' ' ' LYS . . . . . . . . . . . . . 67.5 mttm -88.91 99.9 12.76 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-O 120.81 0.338 . . . . 0.0 110.614 178.104 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 12' ' ' VAL . . . . . . . . . . . . . 12.6 p -140.91 142.42 30.09 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.28 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.362 179.239 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 13' ' ' GLU . . . . . . . . . . . . . 96.1 mt-10 -78.62 129.26 34.56 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.365 -0.379 . . . . 0.0 110.168 178.166 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 14' ' ' LEU . . . . . . . . . . . . . 29.9 mt -98.03 148.66 34.8 Favored Pre-proline 0 C--N 1.329 -0.301 0 CA-C-O 119.223 -0.417 . . . . 0.0 110.282 -179.016 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 15' ' ' PRO . . . . . . . . . . . . . 30.0 Cg_exo -60.67 160.46 24.55 Favored 'Trans proline' 0 N--CA 1.497 1.681 0 C-N-CA 121.322 1.348 . . . . 0.0 111.492 176.117 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 16' ' ' PRO . . . . . . . . . . . . . 38.8 Cg_exo -58.72 -33.81 98.57 Favored 'Trans proline' 0 N--CA 1.497 1.704 0 C-N-CA 121.375 1.384 . . . . 0.0 112.795 -177.993 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 17' ' ' ASP . . . . . . . . . . . . . 11.6 p-10 -93.76 9.83 35.5 Favored 'General case' 0 CA--C 1.535 0.381 0 N-CA-C 113.287 0.847 . . . . 0.0 113.287 -177.147 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 18' ' ' PHE . . . . . . . . . . . . . 44.4 t80 -58.49 -47.21 84.82 Favored 'General case' 0 C--N 1.334 -0.082 0 CA-C-O 120.963 0.411 . . . . 0.0 110.084 -177.961 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 19' ' ' VAL . . . . . . . . . . . . . 49.0 t -57.41 -40.65 75.66 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.339 0 CA-C-N 116.277 -0.42 . . . . 0.0 110.361 -178.737 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 20' ' ' ASP . . . . . . . . . . . . . 79.8 m-20 -60.4 -43.73 96.38 Favored 'General case' 0 C--N 1.331 -0.205 0 C-N-CA 120.936 -0.306 . . . . 0.0 110.968 -178.272 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 21' ' ' VAL . . . . . . . . . . . . . 49.1 t -64.4 -47.35 89.88 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.262 0 C-N-CA 120.753 -0.379 . . . . 0.0 110.359 -177.448 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 22' ' ' ILE . . . . . . . . . . . . . 48.9 mm -56.29 -46.53 81.61 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.258 0 CA-C-O 120.813 0.34 . . . . 0.0 110.598 179.501 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 23' ' ' ARG . . . . . . . . . . . . . 47.9 ttp180 -54.64 -50.61 67.74 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.532 -0.304 . . . . 0.0 111.391 -178.6 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 24' ' ' ILE . . . . . . . . . . . . . 76.1 mt -60.06 -40.5 83.43 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.268 0 C-N-CA 121.073 -0.251 . . . . 0.0 111.432 -176.78 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 25' ' ' LYS . . . . . . . . . . . . . 52.2 mtmt -66.9 -38.93 87.17 Favored 'General case' 0 C--N 1.328 -0.329 0 N-CA-C 112.114 0.413 . . . . 0.0 112.114 -179.833 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 26' ' ' LEU . . . . . . . . . . . . . 93.3 mt -78.49 -40.49 35.22 Favored 'General case' 0 C--N 1.331 -0.21 0 N-CA-C 113.175 0.806 . . . . 0.0 113.175 -172.441 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 27' ' ' GLN . . . . . . . . . . . . . 9.5 pt20 -46.83 139.06 5.71 Favored 'General case' 0 N--CA 1.471 0.591 0 N-CA-C 112.635 0.605 . . . . 0.0 112.635 -175.467 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 28' ' ' GLY . . . . . . . . . . . . . . . 97.68 -23.08 37.48 Favored Glycine 0 CA--C 1.535 1.283 0 CA-C-N 115.573 -0.74 . . . . 0.0 112.319 -175.931 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 29' ' ' LYS . . . . . . . . . . . . . 96.3 mttt -98.41 155.08 17.41 Favored 'General case' 0 C--O 1.233 0.234 0 CA-C-N 117.486 0.643 . . . . 0.0 111.143 179.135 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 30' ' ' THR . . . . . . . . . . . . . 38.6 m -98.38 137.88 36.44 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-N 116.073 -0.512 . . . . 0.0 110.07 176.091 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 31' ' ' VAL . . . . . . . . . . . . . 34.7 m -128.04 148.48 32.6 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.267 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.902 -178.349 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 32' ' ' ARG . . . . . . . . . . . . . 80.3 mtt180 -133.4 150.72 51.79 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-O 121.326 0.584 . . . . 0.0 110.627 177.83 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 33' ' ' THR . . . . . . . . . . . . . 23.1 m -53.39 138.57 32.77 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.034 -0.53 . . . . 0.0 111.279 -178.369 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 34' ' ' GLY . . . . . . . . . . . . . . . 100.35 -17.22 57.17 Favored Glycine 0 CA--C 1.533 1.178 0 CA-C-O 119.537 -0.591 . . . . 0.0 113.243 178.252 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 35' ' ' ASP . . . . . . . . . . . . . 77.7 m-20 -65.33 148.26 52.0 Favored 'General case' 0 C--N 1.333 -0.132 0 CA-C-N 118.131 0.965 . . . . 0.0 111.043 179.808 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 36' ' ' VAL . . . . . . . . . . . . . 44.5 t -121.06 129.72 75.41 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.228 0 CA-C-N 115.852 -0.613 . . . . 0.0 109.842 178.387 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 37' ' ' ILE . . . . . . . . . . . . . 65.3 mt -117.82 137.84 50.44 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.261 0 CA-C-N 116.19 -0.459 . . . . 0.0 109.843 -179.83 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 38' ' ' GLY . . . . . . . . . . . . . . . -110.6 128.58 8.86 Favored Glycine 0 CA--C 1.526 0.764 0 N-CA-C 110.986 -0.845 . . . . 0.0 110.986 179.561 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 39' ' ' ILE . . . . . . . . . . . . . 73.6 mt -124.34 134.66 66.06 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.178 0 N-CA-C 110.015 -0.365 . . . . 0.0 110.015 179.039 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 40' ' ' SER . . . . . . . . . . . . . 43.0 t -92.62 117.56 30.1 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.535 -0.302 . . . . 0.0 110.873 176.201 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 41' ' ' ILE . . . . . . . . . . . . . 45.3 mm -122.75 114.38 42.06 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.159 0 CA-C-O 120.897 0.38 . . . . 0.0 110.546 179.261 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 42' ' ' LEU . . . . . . . . . . . . . 9.2 tp 53.58 37.84 26.82 Favored 'General case' 0 C--N 1.331 -0.216 0 CA-C-N 116.094 -0.503 . . . . 0.0 111.399 176.862 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 43' ' ' GLY . . . . . . . . . . . . . . . 74.62 25.28 70.38 Favored Glycine 0 CA--C 1.531 1.075 0 C-N-CA 121.126 -0.559 . . . . 0.0 112.725 177.563 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 44' ' ' LYS . . . . . . . . . . . . . 34.6 mmtp -130.18 129.31 43.28 Favored 'General case' 0 C--N 1.331 -0.207 0 N-CA-C 109.546 -0.538 . . . . 0.0 109.546 177.682 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 45' ' ' GLU . . . . . . . . . . . . . 81.1 tt0 -83.1 118.98 23.93 Favored 'General case' 0 C--N 1.329 -0.295 0 C-N-CA 120.762 -0.375 . . . . 0.0 110.762 -179.173 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 46' ' ' VAL . . . . . . . . . . . . . 7.4 p -118.6 126.75 75.42 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.216 0 N-CA-C 109.288 -0.634 . . . . 0.0 109.288 176.489 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 47' ' ' LYS . . . . . . . . . . . . . 56.3 mtmt -100.67 128.73 46.61 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 115.84 -0.618 . . . . 0.0 111.304 178.85 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 48' ' ' PHE . . . . . . . . . . . . . 94.3 m-85 -110.73 131.87 54.68 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 115.999 -0.546 . . . . 0.0 109.774 176.089 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 49' ' ' LYS . . . . . . . . . . . . . 36.1 tttp -106.58 135.64 47.75 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.407 -0.36 . . . . 0.0 110.407 -179.498 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 50' ' ' VAL . . . . . . . . . . . . . 43.7 t -80.18 108.76 13.96 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.207 0 N-CA-C 109.257 -0.646 . . . . 0.0 109.257 176.488 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 51' ' ' VAL . . . . . . . . . . . . . 46.0 t -73.39 -47.94 43.93 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.273 0 CA-C-N 116.141 -0.481 . . . . 0.0 110.11 -174.125 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 52' ' ' GLN . . . . . . . . . . . . . 59.8 tt0 -162.6 140.84 8.57 Favored 'General case' 0 C--N 1.33 -0.262 0 C-N-CA 120.401 -0.52 . . . . 0.0 111.343 -177.37 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 53' ' ' ALA . . . . . . . . . . . . . . . -114.82 131.67 56.74 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 115.45 -0.795 . . . . 0.0 109.971 175.56 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 54' ' ' TYR . . . . . . . . . . . . . 30.9 t80 -129.12 111.54 18.31 Favored Pre-proline 0 CA--C 1.535 0.386 0 CA-C-O 118.302 -0.856 . . . . 0.0 110.232 177.598 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 55' ' ' PRO . . . . . . . . . . . . . 73.5 Cg_endo -77.18 167.94 78.3 Favored 'Cis proline' 0 N--CA 1.499 1.835 0 CA-C-N 121.985 1.745 . . . . 0.0 112.373 -5.955 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 56' ' ' SER . . . . . . . . . . . . . 13.6 m -117.34 134.87 23.06 Favored Pre-proline 0 CA--C 1.538 0.51 0 CA-C-O 118.574 -0.727 . . . . 0.0 109.493 174.049 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 57' ' ' PRO . . . . . . . . . . . . . 39.8 Cg_endo -68.11 146.66 78.64 Favored 'Cis proline' 0 N--CA 1.498 1.744 0 CA-C-N 121.87 1.704 . . . . 0.0 111.329 -3.06 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 58' ' ' LEU . . . . . . . . . . . . . 16.3 tp -107.2 136.8 46.41 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.282 -0.417 . . . . 0.0 110.584 -177.599 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 59' ' ' ARG . . . . . . . . . . . . . 51.2 ttp180 -104.64 119.9 40.07 Favored 'General case' 0 C--N 1.328 -0.342 0 N-CA-C 109.315 -0.624 . . . . 0.0 109.315 175.975 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 60' ' ' VAL . . . . . . . . . . . . . 48.7 t -73.37 122.53 26.47 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.252 0 C-N-CA 120.662 -0.415 . . . . 0.0 110.154 -175.214 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 61' ' ' GLU . . . . . . . . . . . . . 95.8 mt-10 -131.05 163.39 27.71 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 115.934 -0.575 . . . . 0.0 110.422 -179.21 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 62' ' ' ASP . . . . . . . . . . . . . 12.5 t70 -55.15 -32.73 62.34 Favored 'General case' 0 C--N 1.327 -0.401 0 CA-C-N 116.426 -0.352 . . . . 0.0 111.523 178.59 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 63' ' ' ARG . . . . . . . . . . . . . 13.1 ptp180 -89.84 9.6 26.86 Favored 'General case' 0 CA--C 1.534 0.337 0 N-CA-C 113.522 0.934 . . . . 0.0 113.522 -176.016 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 64' ' ' THR . . . . . . . . . . . . . 39.4 m -91.41 133.41 35.49 Favored 'General case' 0 C--N 1.332 -0.16 0 CA-C-N 118.198 0.454 . . . . 0.0 110.087 179.667 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 65' ' ' LYS . . . . . . . . . . . . . 57.6 mtmt -90.0 132.55 35.3 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-O 120.987 0.422 . . . . 0.0 110.648 -177.664 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 66' ' ' ILE . . . . . . . . . . . . . 60.7 mt -114.84 127.84 72.21 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.358 0 N-CA-C 109.755 -0.461 . . . . 0.0 109.755 -179.269 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 67' ' ' THR . . . . . . . . . . . . . 30.6 m -119.12 138.84 52.63 Favored 'General case' 0 C--N 1.332 -0.186 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.941 -176.91 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 68' ' ' LEU . . . . . . . . . . . . . 14.8 tp . . . . . 0 C--N 1.329 -0.324 0 CA-C-N 115.913 -0.585 . . . . 0.0 110.065 178.223 . . . . . . . . 0 0 . 1 . 005 nuclear orig core ' B' B ' 73' ' ' VAL . . . . . . . . . . . . . 35.1 m . . . . . 0 N--CA 1.463 0.214 0 CA-C-O 120.859 0.361 . . . . 0.0 111.091 . . . . . . . . . 0 0 . 1 . 005 nuclear orig core ' B' B ' 74' ' ' ASP . . . . . . . . . . . . . 38.7 t0 -99.11 122.95 43.02 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 115.963 -0.562 . . . . 0.0 109.94 -178.975 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 75' ' ' VAL . . . . . . . . . . . . . 40.0 t -119.9 124.13 72.18 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.264 0 CA-C-O 121.063 0.459 . . . . 0.0 110.802 -177.609 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 76' ' ' LEU . . . . . . . . . . . . . 5.7 mp -119.65 142.12 48.74 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 115.687 -0.688 . . . . 0.0 109.426 174.696 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 77' ' ' GLU . . . . . . . . . . . . . 97.4 mt-10 -135.6 130.75 34.93 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-O 121.117 0.484 . . . . 0.0 111.011 -177.789 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 78' ' ' ALA . . . . . . . . . . . . . . . -117.46 134.93 54.29 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 115.619 -0.718 . . . . 0.0 109.725 177.007 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 79' ' ' LYS . . . . . . . . . . . . . 90.0 mttt -75.49 115.87 15.61 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-O 120.903 0.382 . . . . 0.0 110.236 -179.041 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 80' ' ' ILE . . . . . . . . . . . . . 44.0 mm -139.09 119.35 14.69 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.328 0 N-CA-C 109.346 -0.613 . . . . 0.0 109.346 -176.836 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 81' ' ' LYS . . . . . . . . . . . . . 60.0 tttm -117.92 129.67 55.76 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-O 120.924 0.392 . . . . 0.0 111.088 -176.964 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 82' ' ' GLY . . . . . . . . . . . . . . . 88.96 42.13 5.73 Favored Glycine 0 CA--C 1.524 0.651 0 CA-C-N 115.883 -0.599 . . . . 0.0 112.089 175.687 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 83' ' ' ILE . . . . . . . . . . . . . 73.9 mt -73.72 133.01 32.52 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.249 0 N-CA-C 109.229 -0.656 . . . . 0.0 109.229 175.398 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 84' ' ' LYS . . . . . . . . . . . . . 38.4 ttpt -102.47 -45.1 5.17 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.567 -0.288 . . . . 0.0 110.567 -176.94 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 85' ' ' ASP . . . . . . . . . . . . . 9.1 t70 -147.68 149.44 32.46 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.293 -0.412 . . . . 0.0 110.518 -179.914 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 86' ' ' VAL . . . . . . . . . . . . . 40.3 t -130.79 134.55 61.71 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.251 0 CA-C-O 121.002 0.429 . . . . 0.0 110.485 -179.208 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 87' ' ' ILE . . . . . . . . . . . . . 5.0 mp -121.8 125.89 73.89 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.214 0 CA-C-N 115.841 -0.618 . . . . 0.0 109.385 176.51 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 88' ' ' LEU . . . . . . . . . . . . . 8.3 tp -117.91 134.19 55.18 Favored 'General case' 0 C--N 1.331 -0.224 0 CA-C-O 120.9 0.381 . . . . 0.0 111.088 -176.058 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 89' ' ' ASP . . . . . . . . . . . . . 12.4 t70 -134.84 160.12 39.24 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 115.948 -0.569 . . . . 0.0 109.859 177.943 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 90' ' ' GLU . . . . . . . . . . . . . 95.6 mt-10 -48.14 -37.75 16.25 Favored 'General case' 0 C--N 1.331 -0.226 0 N-CA-C 112.991 0.737 . . . . 0.0 112.991 -171.637 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 91' ' ' ASN . . . . . . . . . . . . . 12.2 m120 -130.01 22.35 5.33 Favored 'General case' 0 N--CA 1.468 0.468 0 N-CA-C 112.813 0.672 . . . . 0.0 112.813 -176.621 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 92' ' ' LEU . . . . . . . . . . . . . 51.0 mt -148.45 141.23 24.63 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-O 120.773 0.32 . . . . 0.0 110.599 -178.237 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 93' ' ' ILE . . . . . . . . . . . . . 73.2 mt -124.42 112.78 33.65 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.322 0 N-CA-C 108.858 -0.793 . . . . 0.0 108.858 176.195 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 94' ' ' VAL . . . . . . . . . . . . . 46.1 t -116.58 127.85 74.09 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.284 0 CA-C-O 120.923 0.392 . . . . 0.0 110.038 -177.681 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 95' ' ' VAL . . . . . . . . . . . . . 42.3 t -121.08 132.7 69.86 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.388 0 CA-C-N 115.885 -0.598 . . . . 0.0 109.595 -179.556 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 96' ' ' ILE . . . . . . . . . . . . . 72.4 mt -115.11 125.16 72.33 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.251 0 N-CA-C 109.192 -0.67 . . . . 0.0 109.192 178.259 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 97' ' ' THR . . . . . . . . . . . . . 80.7 p -98.67 160.42 14.29 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-O 121.33 0.586 . . . . 0.0 111.302 -175.868 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 98' ' ' GLU . . . . . . . . . . . . . 84.3 tt0 -53.84 -26.72 25.77 Favored 'General case' 0 C--N 1.327 -0.385 0 CA-C-N 115.683 -0.69 . . . . 0.0 112.249 179.843 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 99' ' ' GLU . . . . . . . . . . . . . 69.4 mm-40 -79.04 11.59 2.67 Favored 'General case' 0 CA--C 1.536 0.432 0 N-CA-C 113.227 0.825 . . . . 0.0 113.227 -177.36 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 100' ' ' ASN . . . . . . . . . . . . . 3.3 m-20 62.71 32.31 16.2 Favored 'General case' 0 CA--C 1.533 0.29 0 CA-C-N 118.233 0.469 . . . . 0.0 111.756 -179.796 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 101' ' ' GLU . . . . . . . . . . . . . 84.2 tt0 -107.79 144.18 35.31 Favored 'General case' 0 C--N 1.332 -0.187 0 N-CA-C 109.714 -0.476 . . . . 0.0 109.714 171.559 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 102' ' ' VAL . . . . . . . . . . . . . 44.5 t -116.28 126.49 73.78 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.246 0 N-CA-C 110.055 -0.35 . . . . 0.0 110.055 -178.957 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 103' ' ' LEU . . . . . . . . . . . . . 63.7 mt -114.48 131.77 56.51 Favored 'General case' 0 C--N 1.331 -0.23 0 CA-C-N 115.641 -0.709 . . . . 0.0 109.58 178.112 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 104' ' ' ILE . . . . . . . . . . . . . 62.3 mt -122.17 118.64 56.07 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.242 0 N-CA-C 110.293 -0.262 . . . . 0.0 110.293 -178.857 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 105' ' ' PHE . . . . . . . . . . . . . 41.3 m-85 -119.84 165.31 14.76 Favored 'General case' 0 C--N 1.331 -0.196 0 O-C-N 123.986 0.804 . . . . 0.0 109.717 178.032 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 106' ' ' ASN . . . . . . . . . . . . . 46.8 p-10 -98.07 -169.89 1.89 Allowed 'General case' 0 C--N 1.329 -0.313 0 N-CA-C 109.664 -0.495 . . . . 0.0 109.664 172.591 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 107' ' ' GLN . . . . . . . . . . . . . 28.0 tt0 -59.83 -30.21 68.78 Favored 'General case' 0 C--N 1.329 -0.29 0 N-CA-C 111.938 0.347 . . . . 0.0 111.938 -179.905 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 108' ' ' ASN . . . . . . . . . . . . . 14.8 t-20 -83.59 9.32 11.74 Favored 'General case' 0 CA--C 1.538 0.515 0 N-CA-C 113.09 0.774 . . . . 0.0 113.09 -178.354 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 109' ' ' LEU . . . . . . . . . . . . . 9.2 tp 60.38 36.32 20.41 Favored 'General case' 0 C--N 1.332 -0.179 0 CA-C-O 120.918 0.39 . . . . 0.0 111.495 178.921 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 110' ' ' GLU . . . . . . . . . . . . . 70.7 mm-40 -105.65 149.82 26.0 Favored 'General case' 0 C--N 1.33 -0.24 0 N-CA-C 109.978 -0.378 . . . . 0.0 109.978 177.094 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 111' ' ' GLU . . . . . . . . . . . . . 47.2 mp0 -76.86 126.41 30.93 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-O 121.035 0.445 . . . . 0.0 111.357 -177.249 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 112' ' ' LEU . . . . . . . . . . . . . 39.5 mt -110.07 -46.05 3.51 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 115.821 -0.627 . . . . 0.0 109.967 174.974 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 113' ' ' TYR . . . . . . . . . . . . . 65.5 t80 -143.62 140.52 30.17 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 115.975 -0.557 . . . . 0.0 111.134 179.752 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 114' ' ' ARG . . . . . . . . . . . . . 93.2 mtt180 -139.51 125.66 19.98 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.54 173.665 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 115' ' ' GLY . . . . . . . . . . . . . . . -150.16 162.92 29.36 Favored Glycine 0 CA--C 1.524 0.623 0 N-CA-C 111.083 -0.807 . . . . 0.0 111.083 179.491 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 116' ' ' LYS . . . . . . . . . . . . . 87.6 tttt -131.22 135.14 47.12 Favored 'General case' 0 C--N 1.33 -0.277 0 N-CA-C 109.832 -0.432 . . . . 0.0 109.832 177.412 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 117' ' ' PHE . . . . . . . . . . . . . 33.4 m-85 -136.46 114.16 11.12 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.327 -0.397 . . . . 0.0 110.393 -174.789 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 118' ' ' GLU . . . . . . . . . . . . . 83.4 tt0 -52.3 -47.68 65.8 Favored 'General case' 0 C--N 1.327 -0.408 0 CA-C-N 116.475 -0.33 . . . . 0.0 111.618 -176.999 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 119' ' ' ASN . . . . . . . . . . . . . 50.3 m-80 -97.4 30.94 2.66 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.192 -0.458 . . . . 0.0 112.175 -173.826 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 120' ' ' LEU . . . . . . . . . . . . . 12.8 tp -57.15 122.31 12.11 Favored 'General case' 0 C--N 1.332 -0.19 0 C-N-CA 120.987 -0.285 . . . . 0.0 110.318 177.98 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 121' ' ' ASN . . . . . . . . . . . . . 26.3 m120 -113.29 -44.2 3.27 Favored 'General case' 0 C--O 1.232 0.162 0 CA-C-N 116.652 -0.249 . . . . 0.0 111.101 -176.965 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 122' ' ' LYS . . . . . . . . . . . . . 97.1 mttt -148.22 150.65 34.11 Favored 'General case' 0 C--N 1.331 -0.208 0 CA-C-O 121.061 0.458 . . . . 0.0 111.701 -178.684 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 123' ' ' VAL . . . . . . . . . . . . . 43.9 t -127.38 129.09 70.58 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.233 0 N-CA-C 109.447 -0.575 . . . . 0.0 109.447 174.716 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 124' ' ' LEU . . . . . . . . . . . . . 6.1 mp -122.06 134.57 54.78 Favored 'General case' 0 C--N 1.332 -0.184 0 CA-C-O 120.863 0.363 . . . . 0.0 110.757 -178.538 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 125' ' ' VAL . . . . . . . . . . . . . 43.2 t -125.28 128.23 72.59 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.283 0 CA-C-N 115.933 -0.576 . . . . 0.0 109.765 178.21 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 126' ' ' ARG . . . . . . . . . . . . . 30.5 ttm180 -149.15 122.01 8.74 Favored 'General case' 0 C--N 1.33 -0.276 0 N-CA-C 109.809 -0.441 . . . . 0.0 109.809 178.368 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 127' ' ' ASN . . . . . . . . . . . . . 76.9 m-20 56.37 -151.55 0.4 Allowed 'General case' 0 CA--C 1.541 0.609 0 N-CA-C 109.771 -0.455 . . . . 0.0 109.771 179.742 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 128' ' ' ASP . . . . . . . . . . . . . 19.7 p-10 -80.18 15.43 1.54 Allowed 'General case' 0 CA--C 1.535 0.383 0 N-CA-C 112.861 0.689 . . . . 0.0 112.861 178.797 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 129' ' ' LEU . . . . . . . . . . . . . 15.6 tp -111.84 133.66 53.9 Favored 'General case' 0 C--O 1.232 0.133 0 O-C-N 122.0 -0.438 . . . . 0.0 110.287 179.158 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 130' ' ' VAL . . . . . . . . . . . . . 47.7 t -121.91 135.3 62.47 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.222 0 N-CA-C 109.759 -0.46 . . . . 0.0 109.759 -179.953 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 131' ' ' VAL . . . . . . . . . . . . . 42.8 t -134.83 135.62 52.95 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.253 0 CA-C-O 121.029 0.442 . . . . 0.0 110.594 -179.533 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 132' ' ' ILE . . . . . . . . . . . . . 73.1 mt -117.51 132.69 66.57 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.26 0 CA-C-N 115.676 -0.693 . . . . 0.0 109.392 178.84 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 133' ' ' ILE . . . . . . . . . . . . . 44.6 mm -116.34 122.32 69.49 Favored 'Isoleucine or valine' 0 C--O 1.234 0.251 0 CA-C-N 116.55 -0.296 . . . . 0.0 110.931 -176.014 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 134' ' ' ASP . . . . . . . . . . . . . 7.2 p-10 -133.0 146.7 52.01 Favored 'General case' 0 C--N 1.33 -0.258 0 N-CA-C 109.714 -0.476 . . . . 0.0 109.714 174.628 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 135' ' ' GLU . . . . . . . . . . . . . 84.7 tt0 -49.87 -26.27 3.91 Favored 'General case' 0 C--N 1.326 -0.445 0 N-CA-C 112.916 0.71 . . . . 0.0 112.916 -173.321 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 136' ' ' GLN . . . . . . . . . . . . . 61.4 tt0 -84.55 -32.4 23.86 Favored 'General case' 0 C--N 1.331 -0.231 0 N-CA-C 112.42 0.526 . . . . 0.0 112.42 -175.488 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 137' ' ' LYS . . . . . . . . . . . . . 18.1 pttp -168.64 172.74 7.81 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-O 121.436 0.636 . . . . 0.0 112.245 -172.536 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 138' ' ' LEU . . . . . . . . . . . . . 5.3 tt -117.72 130.1 56.11 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 115.113 -0.948 . . . . 0.0 110.025 -179.217 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 139' ' ' THR . . . . . . . . . . . . . 42.2 m -111.53 126.74 55.3 Favored 'General case' 0 C--N 1.331 -0.223 0 CA-C-N 116.147 -0.479 . . . . 0.0 110.384 179.833 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 140' ' ' LEU . . . . . . . . . . . . . 5.6 tt -114.18 124.02 51.03 Favored 'General case' 0 C--N 1.329 -0.322 0 N-CA-C 109.261 -0.644 . . . . 0.0 109.261 -179.65 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 141' ' ' ILE . . . . . . . . . . . . . 19.1 mt -121.94 125.71 73.53 Favored 'Isoleucine or valine' 0 C--O 1.234 0.266 0 CA-C-O 120.818 0.342 . . . . 0.0 110.15 -173.783 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 142' ' ' ARG . . . . . . . . . . . . . 72.0 mtm180 -114.23 133.94 55.27 Favored 'General case' 0 C--O 1.233 0.233 0 CA-C-N 115.66 -0.7 . . . . 0.0 109.82 -179.267 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 143' ' ' THR . . . . . . . . . . . . . 60.6 p . . . . . 0 C--O 1.219 -0.514 0 CA-C-O 117.957 -1.02 . . . . 0.0 110.449 179.207 . . . . . . . . 0 0 . 1 . 005 nuclear orig core ' C' C ' 2' ' ' SER . . . . . . . . . . . . . 2.9 p . . . . . 0 C--O 1.232 0.173 0 CA-C-O 120.862 0.363 . . . . 0.0 110.329 . . . . . . . . . 0 0 . 1 . 005 nuclear orig core ' C' C ' 3' ' ' GLU . . . . . . . . . . . . . 94.2 mt-10 -138.51 141.54 39.36 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 115.902 -0.59 . . . . 0.0 110.721 -176.769 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' C' C ' 4' ' ' LEU . . . . . . . . . . . . . 25.2 tp -126.37 126.73 44.36 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.054 -0.521 . . . . 0.0 110.039 176.198 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' C' C ' 5' ' ' LYS . . . . . . . . . . . . . 62.7 mttp -103.83 120.96 42.07 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.508 -0.315 . . . . 0.0 110.647 179.354 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' C' C ' 6' ' ' LEU . . . . . . . . . . . . . 43.1 mt -116.79 143.03 46.16 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 115.536 -0.756 . . . . 0.0 110.556 -178.598 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' C' C ' 7' ' ' LYS . . . . . . . . . . . . . 54.8 tttm -134.3 139.58 33.31 Favored Pre-proline 0 CA--C 1.534 0.349 0 CA-C-O 119.117 -0.468 . . . . 0.0 109.997 176.164 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' C' C ' 8' ' ' PRO . . . . . . . . . . . . . 88.7 Cg_endo -91.94 143.79 2.81 Favored 'Trans proline' 0 N--CA 1.491 1.35 0 C-N-CA 121.721 1.614 . . . . 0.0 111.888 177.812 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' C' C ' 9' ' ' LEU . . . . . . . . . . . . . 63.9 mt -79.2 -48.28 1.55 Allowed Pre-proline 0 CA--C 1.535 0.385 0 CA-C-O 118.638 -0.696 . . . . 0.0 112.242 -179.93 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' C' C ' 10' ' ' PRO . . . . . . . . . . . . . 94.0 Cg_endo -79.51 153.78 23.82 Favored 'Trans proline' 0 N--CA 1.497 1.697 0 C-N-CA 121.149 1.232 . . . . 0.0 111.819 176.949 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' C' C ' 11' ' ' LYS . . . . . . . . . . . . . 51.6 tptt -87.19 96.64 10.39 Favored 'General case' 0 C--N 1.331 -0.226 0 CA-C-N 116.373 -0.376 . . . . 0.0 110.315 178.861 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' C' C ' 12' ' ' VAL . . . . . . . . . . . . . 12.0 p -143.86 143.44 23.93 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.284 0 CA-C-N 116.219 -0.446 . . . . 0.0 110.462 179.019 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' C' C ' 13' ' ' GLU . . . . . . . . . . . . . 12.8 pt-20 -88.09 128.15 35.42 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.351 -0.386 . . . . 0.0 110.296 177.751 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' C' C ' 14' ' ' LEU . . . . . . . . . . . . . 24.4 mt -98.22 153.01 38.26 Favored Pre-proline 0 C--N 1.329 -0.291 0 CA-C-N 116.232 -0.44 . . . . 0.0 110.369 -178.473 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' C' C ' 15' ' ' PRO . . . . . . . . . . . . . 33.6 Cg_exo -59.66 159.97 22.52 Favored 'Trans proline' 0 N--CA 1.495 1.616 0 C-N-CA 121.31 1.34 . . . . 0.0 111.621 178.082 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' C' C ' 16' ' ' PRO . . . . . . . . . . . . . 32.2 Cg_exo -59.42 -32.56 96.68 Favored 'Trans proline' 0 N--CA 1.498 1.743 0 C-N-CA 121.435 1.423 . . . . 0.0 112.714 -177.855 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' C' C ' 17' ' ' ASP . . . . . . . . . . . . . 9.5 p-10 -94.13 9.96 35.7 Favored 'General case' 0 CA--C 1.535 0.388 0 N-CA-C 113.211 0.819 . . . . 0.0 113.211 -177.301 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' C' C ' 18' ' ' PHE . . . . . . . . . . . . . 48.9 t80 -58.13 -42.67 86.33 Favored 'General case' 0 C--O 1.231 0.091 0 O-C-N 121.987 -0.446 . . . . 0.0 110.111 -178.511 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' C' C ' 19' ' ' VAL . . . . . . . . . . . . . 48.7 t -57.7 -42.13 80.96 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.352 0 CA-C-N 116.332 -0.395 . . . . 0.0 110.311 -179.311 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' C' C ' 20' ' ' ASP . . . . . . . . . . . . . 13.6 t70 -60.64 -42.09 96.22 Favored 'General case' 0 C--N 1.329 -0.304 0 C-N-CA 120.988 -0.285 . . . . 0.0 110.99 -178.642 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' C' C ' 21' ' ' VAL . . . . . . . . . . . . . 47.5 t -64.04 -47.56 89.8 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.284 0 C-N-CA 120.713 -0.395 . . . . 0.0 110.38 -177.973 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' C' C ' 22' ' ' ILE . . . . . . . . . . . . . 51.0 mm -56.67 -43.99 80.28 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.279 0 CA-C-O 120.668 0.27 . . . . 0.0 110.456 178.689 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' C' C ' 23' ' ' ARG . . . . . . . . . . . . . 60.3 ttp180 -54.11 -49.03 70.08 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-O 120.627 0.251 . . . . 0.0 111.419 -179.373 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' C' C ' 24' ' ' ILE . . . . . . . . . . . . . 75.7 mt -59.96 -42.35 89.2 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.295 0 CA-C-N 116.592 -0.276 . . . . 0.0 111.003 -178.348 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' C' C ' 25' ' ' LYS . . . . . . . . . . . . . 54.9 mtmt -67.2 -36.49 81.85 Favored 'General case' 0 C--N 1.328 -0.355 0 N-CA-C 112.299 0.481 . . . . 0.0 112.299 -179.088 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' C' C ' 26' ' ' LEU . . . . . . . . . . . . . 46.9 mt -77.74 -43.62 30.33 Favored 'General case' 0 C--N 1.33 -0.26 0 N-CA-C 112.899 0.703 . . . . 0.0 112.899 -172.373 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' C' C ' 27' ' ' GLN . . . . . . . . . . . . . 10.6 pt20 -46.91 138.13 6.68 Favored 'General case' 0 N--CA 1.47 0.539 0 N-CA-C 112.564 0.579 . . . . 0.0 112.564 -175.673 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' C' C ' 28' ' ' GLY . . . . . . . . . . . . . . . 100.6 -26.12 25.79 Favored Glycine 0 CA--C 1.533 1.172 0 CA-C-N 115.645 -0.707 . . . . 0.0 112.174 -176.652 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' C' C ' 29' ' ' LYS . . . . . . . . . . . . . 60.3 mmtt -98.06 155.17 17.25 Favored 'General case' 0 C--O 1.232 0.145 0 CA-C-N 117.257 0.529 . . . . 0.0 111.174 178.327 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' C' C ' 30' ' ' THR . . . . . . . . . . . . . 37.7 m -105.94 136.4 45.66 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 115.807 -0.633 . . . . 0.0 109.561 174.26 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' C' C ' 31' ' ' VAL . . . . . . . . . . . . . 34.9 m -127.4 153.75 36.97 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.234 0 CA-C-O 121.172 0.51 . . . . 0.0 111.169 -176.442 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' C' C ' 32' ' ' ARG . . . . . . . . . . . . . 78.2 mtm180 -130.53 150.07 51.91 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 115.537 -0.756 . . . . 0.0 110.26 178.663 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' C' C ' 33' ' ' THR . . . . . . . . . . . . . 24.3 m -53.68 138.95 33.74 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-N 116.453 -0.34 . . . . 0.0 111.285 -178.863 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' C' C ' 34' ' ' GLY . . . . . . . . . . . . . . . 101.0 -17.14 56.66 Favored Glycine 0 CA--C 1.532 1.154 0 CA-C-O 119.621 -0.544 . . . . 0.0 113.306 179.209 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' C' C ' 35' ' ' ASP . . . . . . . . . . . . . 72.5 m-20 -65.25 148.41 51.73 Favored 'General case' 0 C--O 1.232 0.166 0 CA-C-N 118.054 0.927 . . . . 0.0 111.069 179.421 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' C' C ' 36' ' ' VAL . . . . . . . . . . . . . 43.8 t -122.42 131.68 72.69 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.237 0 CA-C-N 115.933 -0.576 . . . . 0.0 109.871 179.111 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' C' C ' 37' ' ' ILE . . . . . . . . . . . . . 67.1 mt -121.06 138.16 52.4 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 CA-C-N 116.114 -0.494 . . . . 0.0 109.902 179.794 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' C' C ' 38' ' ' GLY . . . . . . . . . . . . . . . -112.42 128.63 8.59 Favored Glycine 0 CA--C 1.525 0.692 0 N-CA-C 111.071 -0.812 . . . . 0.0 111.071 179.562 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' C' C ' 39' ' ' ILE . . . . . . . . . . . . . 74.7 mt -124.85 137.13 58.53 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.184 0 N-CA-C 110.128 -0.323 . . . . 0.0 110.128 179.449 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' C' C ' 40' ' ' SER . . . . . . . . . . . . . 41.4 t -92.44 114.06 26.51 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 116.445 -0.343 . . . . 0.0 110.755 176.213 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' C' C ' 41' ' ' ILE . . . . . . . . . . . . . 42.7 mm -119.99 120.67 63.84 Favored 'Isoleucine or valine' 0 N--CA 1.462 0.167 0 CA-C-O 120.737 0.304 . . . . 0.0 110.59 179.879 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' C' C ' 42' ' ' LEU . . . . . . . . . . . . . 47.3 mt 51.85 34.84 14.17 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-N 116.308 -0.405 . . . . 0.0 111.856 176.435 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' C' C ' 43' ' ' GLY . . . . . . . . . . . . . . . 72.88 33.24 60.17 Favored Glycine 0 CA--C 1.529 0.907 0 C-N-CA 121.017 -0.611 . . . . 0.0 111.961 178.665 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' C' C ' 44' ' ' LYS . . . . . . . . . . . . . 55.6 tptt -140.7 129.61 23.2 Favored 'General case' 0 C--N 1.33 -0.268 0 N-CA-C 109.4 -0.593 . . . . 0.0 109.4 178.622 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' C' C ' 45' ' ' GLU . . . . . . . . . . . . . 83.6 tt0 -81.71 119.39 23.78 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-O 120.928 0.394 . . . . 0.0 110.658 -177.782 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' C' C ' 46' ' ' VAL . . . . . . . . . . . . . 7.4 p -117.56 127.06 75.03 Favored 'Isoleucine or valine' 0 C--N 1.333 -0.12 0 N-CA-C 109.303 -0.629 . . . . 0.0 109.303 176.765 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' C' C ' 47' ' ' LYS . . . . . . . . . . . . . 68.0 mttm -100.37 127.36 46.7 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 115.827 -0.624 . . . . 0.0 111.001 179.312 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' C' C ' 48' ' ' PHE . . . . . . . . . . . . . 93.8 m-85 -109.94 131.92 54.62 Favored 'General case' 0 C--N 1.328 -0.347 0 N-CA-C 109.81 -0.441 . . . . 0.0 109.81 175.632 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' C' C ' 49' ' ' LYS . . . . . . . . . . . . . 85.6 tttt -107.75 135.63 48.84 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.437 -0.347 . . . . 0.0 110.385 178.857 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' C' C ' 50' ' ' VAL . . . . . . . . . . . . . 44.6 t -79.76 107.25 11.97 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 N-CA-C 109.198 -0.668 . . . . 0.0 109.198 176.261 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' C' C ' 51' ' ' VAL . . . . . . . . . . . . . 48.4 t -70.36 -46.96 68.97 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.316 0 N-CA-C 109.856 -0.424 . . . . 0.0 109.856 -174.339 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' C' C ' 52' ' ' GLN . . . . . . . . . . . . . 37.4 tt0 -167.14 142.44 4.09 Favored 'General case' 0 C--N 1.33 -0.241 0 C-N-CA 120.314 -0.554 . . . . 0.0 111.711 -179.887 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' C' C ' 53' ' ' ALA . . . . . . . . . . . . . . . -114.69 133.79 55.6 Favored 'General case' 0 C--N 1.331 -0.227 0 CA-C-N 115.761 -0.654 . . . . 0.0 109.745 175.113 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' C' C ' 54' ' ' TYR . . . . . . . . . . . . . 64.2 t80 -129.08 112.81 18.5 Favored Pre-proline 0 CA--C 1.534 0.348 0 CA-C-O 118.259 -0.877 . . . . 0.0 110.52 -179.963 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' C' C ' 55' ' ' PRO . . . . . . . . . . . . . 73.4 Cg_endo -77.18 168.19 77.58 Favored 'Cis proline' 0 N--CA 1.501 1.964 0 CA-C-N 122.05 1.768 . . . . 0.0 112.083 -7.607 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' C' C ' 56' ' ' SER . . . . . . . . . . . . . 14.0 m -117.22 140.42 27.16 Favored Pre-proline 0 CA--C 1.539 0.52 0 CA-C-O 118.599 -0.715 . . . . 0.0 109.828 174.518 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' C' C ' 57' ' ' PRO . . . . . . . . . . . . . 51.5 Cg_endo -70.82 144.2 78.18 Favored 'Cis proline' 0 N--CA 1.498 1.742 0 CA-C-N 121.575 1.598 . . . . 0.0 111.2 -3.742 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' C' C ' 58' ' ' LEU . . . . . . . . . . . . . 16.9 tp -107.49 135.88 48.22 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-O 120.796 0.331 . . . . 0.0 110.981 -176.199 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' C' C ' 59' ' ' ARG . . . . . . . . . . . . . 55.7 ttt180 -101.68 126.06 48.45 Favored 'General case' 0 C--N 1.327 -0.405 0 N-CA-C 109.15 -0.685 . . . . 0.0 109.15 174.254 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' C' C ' 60' ' ' VAL . . . . . . . . . . . . . 42.5 t -83.65 124.48 39.69 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.264 0 C-N-CA 120.64 -0.424 . . . . 0.0 110.549 -175.426 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' C' C ' 61' ' ' GLU . . . . . . . . . . . . . 95.6 mt-10 -129.02 170.74 13.1 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 115.68 -0.691 . . . . 0.0 109.881 177.238 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' C' C ' 62' ' ' ASP . . . . . . . . . . . . . 81.6 m-20 -54.81 -32.51 60.45 Favored 'General case' 0 C--N 1.327 -0.372 0 C-N-CA 121.048 -0.261 . . . . 0.0 111.695 -178.877 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' C' C ' 63' ' ' ARG . . . . . . . . . . . . . 9.2 ptm180 -86.73 6.21 32.47 Favored 'General case' 0 CA--C 1.536 0.415 0 N-CA-C 113.623 0.972 . . . . 0.0 113.623 -175.474 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' C' C ' 64' ' ' THR . . . . . . . . . . . . . 19.8 m -73.36 135.91 44.34 Favored 'General case' 0 C--N 1.332 -0.186 0 CA-C-N 118.138 0.427 . . . . 0.0 110.799 -177.814 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' C' C ' 65' ' ' LYS . . . . . . . . . . . . . 25.3 mtpp -89.94 119.21 30.11 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.098 -0.501 . . . . 0.0 110.001 178.062 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' C' C ' 66' ' ' ILE . . . . . . . . . . . . . 65.6 mt -114.56 131.18 67.41 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.277 0 CA-C-O 120.83 0.348 . . . . 0.0 110.07 -178.681 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' C' C ' 67' ' ' THR . . . . . . . . . . . . . 21.3 m -123.01 134.65 54.3 Favored 'General case' 0 C--N 1.331 -0.224 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.478 -179.253 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' C' C ' 68' ' ' LEU . . . . . . . . . . . . . 21.5 tp . . . . . 0 C--N 1.33 -0.275 0 CA-C-N 115.876 -0.602 . . . . 0.0 110.802 -179.809 . . . . . . . . 0 0 . 1 . 005 nuclear orig core ' C' C ' 73' ' ' VAL . . . . . . . . . . . . . 33.0 m . . . . . 0 C--O 1.233 0.236 0 N-CA-C 109.243 -0.651 . . . . 0.0 109.243 . . . . . . . . . 0 0 . 1 . 005 nuclear orig core ' C' C ' 74' ' ' ASP . . . . . . . . . . . . . 7.4 t0 -89.13 114.88 26.2 Favored 'General case' 0 C--N 1.331 -0.211 0 N-CA-C 109.09 -0.707 . . . . 0.0 109.09 -178.753 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' C' C ' 75' ' ' VAL . . . . . . . . . . . . . 42.3 t -124.52 122.0 62.85 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.266 0 CA-C-O 121.054 0.454 . . . . 0.0 110.652 -175.109 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' C' C ' 76' ' ' LEU . . . . . . . . . . . . . 6.4 mp -118.92 144.54 46.37 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 115.584 -0.735 . . . . 0.0 109.378 175.332 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' C' C ' 77' ' ' GLU . . . . . . . . . . . . . 96.3 mt-10 -134.07 137.49 44.68 Favored 'General case' 0 C--N 1.331 -0.219 0 CA-C-O 120.998 0.428 . . . . 0.0 111.081 -177.653 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' C' C ' 78' ' ' ALA . . . . . . . . . . . . . . . -125.1 135.69 52.93 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 115.738 -0.665 . . . . 0.0 109.79 176.568 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' C' C ' 79' ' ' LYS . . . . . . . . . . . . . 61.6 mmtt -78.0 118.5 20.35 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-O 121.002 0.43 . . . . 0.0 110.949 -177.815 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' C' C ' 80' ' ' ILE . . . . . . . . . . . . . 41.5 mm -139.1 106.55 2.96 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.327 0 N-CA-C 109.107 -0.701 . . . . 0.0 109.107 -178.951 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' C' C ' 81' ' ' LYS . . . . . . . . . . . . . 99.4 mttt -100.2 127.34 46.48 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-O 120.928 0.394 . . . . 0.0 110.949 -178.145 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' C' C ' 82' ' ' GLY . . . . . . . . . . . . . . . 89.04 42.1 5.71 Favored Glycine 0 CA--C 1.524 0.634 0 C-N-CA 120.968 -0.634 . . . . 0.0 111.722 176.057 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' C' C ' 83' ' ' ILE . . . . . . . . . . . . . 72.5 mt -66.47 137.26 25.21 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.321 0 N-CA-C 109.634 -0.506 . . . . 0.0 109.634 176.339 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' C' C ' 84' ' ' LYS . . . . . . . . . . . . . 39.6 ttpt -101.02 -50.66 3.74 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-O 120.894 0.378 . . . . 0.0 110.389 -179.066 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' C' C ' 85' ' ' ASP . . . . . . . . . . . . . 12.7 t70 -152.44 151.1 30.37 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.078 -0.51 . . . . 0.0 110.783 -179.894 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' C' C ' 86' ' ' VAL . . . . . . . . . . . . . 42.4 t -128.15 131.19 69.54 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.222 0 CA-C-O 120.895 0.379 . . . . 0.0 110.261 179.362 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' C' C ' 87' ' ' ILE . . . . . . . . . . . . . 5.0 mp -122.98 131.58 73.01 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.251 0 CA-C-N 116.178 -0.464 . . . . 0.0 109.781 178.884 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' C' C ' 88' ' ' LEU . . . . . . . . . . . . . 80.8 mt -109.31 139.61 44.04 Favored 'General case' 0 C--N 1.331 -0.212 0 CA-C-O 121.03 0.443 . . . . 0.0 111.181 -179.354 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' C' C ' 89' ' ' ASP . . . . . . . . . . . . . 13.6 t70 -129.23 156.25 44.26 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 115.667 -0.697 . . . . 0.0 109.624 177.562 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' C' C ' 90' ' ' GLU . . . . . . . . . . . . . 85.3 tt0 -45.93 -38.77 7.93 Favored 'General case' 0 CA--C 1.532 0.265 0 N-CA-C 113.101 0.778 . . . . 0.0 113.101 -172.151 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' C' C ' 91' ' ' ASN . . . . . . . . . . . . . 78.9 m-20 -132.07 21.48 4.49 Favored 'General case' 0 N--CA 1.469 0.485 0 N-CA-C 112.799 0.666 . . . . 0.0 112.799 -178.035 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' C' C ' 92' ' ' LEU . . . . . . . . . . . . . 40.4 mt -150.59 152.26 33.81 Favored 'General case' 0 C--N 1.331 -0.217 0 CA-C-O 120.997 0.427 . . . . 0.0 110.678 -176.423 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' C' C ' 93' ' ' ILE . . . . . . . . . . . . . 69.8 mt -125.35 123.33 64.79 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.335 0 N-CA-C 109.141 -0.689 . . . . 0.0 109.141 175.727 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' C' C ' 94' ' ' VAL . . . . . . . . . . . . . 42.3 t -119.74 128.78 75.91 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.284 0 CA-C-O 120.964 0.411 . . . . 0.0 110.079 -179.192 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' C' C ' 95' ' ' VAL . . . . . . . . . . . . . 45.5 t -120.48 134.18 64.78 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.322 0 CA-C-N 115.94 -0.573 . . . . 0.0 109.655 179.89 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' C' C ' 96' ' ' ILE . . . . . . . . . . . . . 66.9 mt -115.59 127.05 73.3 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.309 0 N-CA-C 109.283 -0.636 . . . . 0.0 109.283 178.845 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' C' C ' 97' ' ' THR . . . . . . . . . . . . . 68.6 p -100.87 158.22 16.14 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-O 121.139 0.495 . . . . 0.0 111.115 -176.819 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' C' C ' 98' ' ' GLU . . . . . . . . . . . . . 84.6 tt0 -53.85 -26.31 23.87 Favored 'General case' 0 CA--C 1.534 0.335 0 CA-C-N 116.22 -0.445 . . . . 0.0 112.172 179.861 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' C' C ' 99' ' ' GLU . . . . . . . . . . . . . 18.2 tp10 -76.8 9.97 2.52 Favored 'General case' 0 CA--C 1.538 0.517 0 N-CA-C 113.007 0.743 . . . . 0.0 113.007 -177.929 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' C' C ' 100' ' ' ASN . . . . . . . . . . . . . 3.6 m-20 63.32 33.48 13.96 Favored 'General case' 0 N--CA 1.464 0.258 0 O-C-N 121.984 -0.447 . . . . 0.0 111.57 -179.812 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' C' C ' 101' ' ' GLU . . . . . . . . . . . . . 84.7 tt0 -108.64 143.99 36.97 Favored 'General case' 0 C--N 1.332 -0.167 0 N-CA-C 109.666 -0.494 . . . . 0.0 109.666 172.038 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' C' C ' 102' ' ' VAL . . . . . . . . . . . . . 46.9 t -115.61 126.1 73.03 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.27 0 N-CA-C 109.72 -0.474 . . . . 0.0 109.72 -177.958 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' C' C ' 103' ' ' LEU . . . . . . . . . . . . . 30.9 mt -117.3 130.77 56.76 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-N 115.856 -0.611 . . . . 0.0 110.334 177.845 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' C' C ' 104' ' ' ILE . . . . . . . . . . . . . 64.0 mt -118.28 121.29 66.82 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.207 0 N-CA-C 110.07 -0.345 . . . . 0.0 110.07 179.383 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' C' C ' 105' ' ' PHE . . . . . . . . . . . . . 45.4 m-85 -121.63 167.55 12.78 Favored 'General case' 0 C--N 1.332 -0.182 0 O-C-N 123.851 0.719 . . . . 0.0 109.883 177.993 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' C' C ' 106' ' ' ASN . . . . . . . . . . . . . 45.2 p-10 -97.29 -169.93 1.93 Allowed 'General case' 0 C--N 1.331 -0.209 0 N-CA-C 109.879 -0.415 . . . . 0.0 109.879 173.677 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' C' C ' 107' ' ' GLN . . . . . . . . . . . . . 48.9 tt0 -59.57 -30.13 68.43 Favored 'General case' 0 CA--C 1.532 0.251 0 N-CA-C 111.9 0.333 . . . . 0.0 111.9 179.84 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' C' C ' 108' ' ' ASN . . . . . . . . . . . . . 51.6 t30 -83.78 9.85 10.91 Favored 'General case' 0 CA--C 1.536 0.424 0 N-CA-C 113.062 0.764 . . . . 0.0 113.062 -178.195 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' C' C ' 109' ' ' LEU . . . . . . . . . . . . . 8.0 tp 59.85 36.29 21.93 Favored 'General case' 0 C--N 1.331 -0.223 0 CA-C-O 120.853 0.359 . . . . 0.0 111.366 179.085 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' C' C ' 110' ' ' GLU . . . . . . . . . . . . . 96.0 mt-10 -103.38 150.1 24.13 Favored 'General case' 0 C--N 1.33 -0.26 0 N-CA-C 109.957 -0.386 . . . . 0.0 109.957 176.06 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' C' C ' 111' ' ' GLU . . . . . . . . . . . . . 71.6 tt0 -81.98 121.99 27.21 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-O 120.886 0.374 . . . . 0.0 111.111 -174.713 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' C' C ' 112' ' ' LEU . . . . . . . . . . . . . 34.1 mt -107.08 -46.09 3.99 Favored 'General case' 0 C--N 1.331 -0.21 0 CA-C-N 116.16 -0.473 . . . . 0.0 110.76 178.049 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' C' C ' 113' ' ' TYR . . . . . . . . . . . . . 60.7 t80 -139.34 139.72 37.33 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.201 -0.454 . . . . 0.0 111.14 -178.047 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' C' C ' 114' ' ' ARG . . . . . . . . . . . . . 59.1 ttp180 -137.6 125.53 22.69 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 115.956 -0.565 . . . . 0.0 110.224 177.321 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' C' C ' 115' ' ' GLY . . . . . . . . . . . . . . . -149.98 153.25 24.98 Favored Glycine 0 CA--C 1.523 0.573 0 N-CA-C 110.262 -1.135 . . . . 0.0 110.262 178.505 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' C' C ' 116' ' ' LYS . . . . . . . . . . . . . 59.0 tttm -131.5 128.98 40.48 Favored 'General case' 0 C--N 1.329 -0.325 0 N-CA-C 109.65 -0.5 . . . . 0.0 109.65 179.388 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' C' C ' 117' ' ' PHE . . . . . . . . . . . . . 26.1 m-85 -132.91 117.64 17.94 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.329 -0.396 . . . . 0.0 110.029 -173.153 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' C' C ' 118' ' ' GLU . . . . . . . . . . . . . 95.8 mt-10 -55.18 -39.46 69.58 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.521 -0.308 . . . . 0.0 111.043 -177.774 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' C' C ' 119' ' ' ASN . . . . . . . . . . . . . 29.5 m120 -100.7 30.98 3.7 Favored 'General case' 0 C--N 1.33 -0.271 0 N-CA-C 112.229 0.455 . . . . 0.0 112.229 -173.896 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' C' C ' 120' ' ' LEU . . . . . . . . . . . . . 17.1 tp -57.76 122.56 13.14 Favored 'General case' 0 N--CA 1.462 0.16 0 C-N-CA 120.845 -0.342 . . . . 0.0 110.121 177.462 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' C' C ' 121' ' ' ASN . . . . . . . . . . . . . 21.9 t-20 -112.79 -44.03 3.36 Favored 'General case' 0 C--N 1.332 -0.183 0 CA-C-N 116.554 -0.294 . . . . 0.0 111.41 -175.968 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' C' C ' 122' ' ' LYS . . . . . . . . . . . . . 31.4 ttmt -158.57 151.04 21.84 Favored 'General case' 0 C--N 1.332 -0.188 0 C-N-CA 120.546 -0.462 . . . . 0.0 111.156 -176.721 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' C' C ' 123' ' ' VAL . . . . . . . . . . . . . 41.9 t -122.42 131.91 72.22 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.218 0 CA-C-N 116.19 -0.459 . . . . 0.0 109.957 177.687 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' C' C ' 124' ' ' LEU . . . . . . . . . . . . . 7.2 mp -116.76 133.67 55.74 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-N 116.147 -0.479 . . . . 0.0 109.999 179.28 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' C' C ' 125' ' ' VAL . . . . . . . . . . . . . 35.2 m -135.25 139.68 46.46 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.289 0 CA-C-O 120.843 0.354 . . . . 0.0 110.922 -179.479 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' C' C ' 126' ' ' ARG . . . . . . . . . . . . . 38.8 ttt180 -163.32 133.63 4.44 Favored 'General case' 0 C--N 1.329 -0.298 0 N-CA-C 109.525 -0.546 . . . . 0.0 109.525 177.015 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' C' C ' 127' ' ' ASN . . . . . . . . . . . . . 33.4 m120 56.85 -155.13 0.32 Allowed 'General case' 0 CA--C 1.538 0.503 0 N-CA-C 109.627 -0.508 . . . . 0.0 109.627 -177.843 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' C' C ' 128' ' ' ASP . . . . . . . . . . . . . 11.6 p-10 -82.31 16.92 1.84 Allowed 'General case' 0 CA--C 1.536 0.421 0 N-CA-C 112.642 0.608 . . . . 0.0 112.642 177.705 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' C' C ' 129' ' ' LEU . . . . . . . . . . . . . 49.3 mt -115.74 142.45 46.73 Favored 'General case' 0 C--O 1.231 0.116 0 O-C-N 122.077 -0.39 . . . . 0.0 110.279 179.723 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' C' C ' 130' ' ' VAL . . . . . . . . . . . . . 32.5 m -134.77 146.8 30.12 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.249 0 CA-C-O 120.986 0.422 . . . . 0.0 110.947 -179.333 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' C' C ' 131' ' ' VAL . . . . . . . . . . . . . 39.1 t -135.99 137.86 48.2 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.299 0 CA-C-N 116.087 -0.506 . . . . 0.0 110.157 178.43 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' C' C ' 132' ' ' ILE . . . . . . . . . . . . . 70.2 mt -112.96 131.75 63.68 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.357 0 N-CA-C 109.341 -0.614 . . . . 0.0 109.341 179.933 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' C' C ' 133' ' ' ILE . . . . . . . . . . . . . 36.6 mm -113.64 122.33 67.57 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.256 0 CA-C-O 120.837 0.351 . . . . 0.0 110.79 -176.15 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' C' C ' 134' ' ' ASP . . . . . . . . . . . . . 9.4 p-10 -132.97 150.06 52.19 Favored 'General case' 0 C--N 1.331 -0.222 0 CA-C-N 116.107 -0.497 . . . . 0.0 109.66 174.741 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' C' C ' 135' ' ' GLU . . . . . . . . . . . . . 40.3 tp10 -50.0 -29.02 7.79 Favored 'General case' 0 C--N 1.327 -0.398 0 N-CA-C 112.715 0.635 . . . . 0.0 112.715 -171.873 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' C' C ' 136' ' ' GLN . . . . . . . . . . . . . 99.6 mm-40 -85.87 -29.52 23.62 Favored 'General case' 0 C--N 1.33 -0.247 0 N-CA-C 112.896 0.702 . . . . 0.0 112.896 -174.086 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' C' C ' 137' ' ' LYS . . . . . . . . . . . . . 21.0 pttm -168.97 173.16 7.12 Favored 'General case' 0 C--O 1.234 0.242 0 CA-C-O 121.496 0.665 . . . . 0.0 112.477 -171.975 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' C' C ' 138' ' ' LEU . . . . . . . . . . . . . 7.3 tt -120.71 129.38 53.63 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 115.088 -0.96 . . . . 0.0 109.869 179.594 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' C' C ' 139' ' ' THR . . . . . . . . . . . . . 38.0 m -109.76 128.5 55.33 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 116.112 -0.495 . . . . 0.0 110.444 179.703 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' C' C ' 140' ' ' LEU . . . . . . . . . . . . . 5.9 tt -112.01 122.64 48.33 Favored 'General case' 0 C--N 1.329 -0.305 0 N-CA-C 109.039 -0.726 . . . . 0.0 109.039 -179.39 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' C' C ' 141' ' ' ILE . . . . . . . . . . . . . 19.5 mt -121.86 121.39 64.13 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.333 0 CA-C-O 120.98 0.419 . . . . 0.0 109.93 -176.298 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' C' C ' 142' ' ' ARG . . . . . . . . . . . . . 78.9 mtm180 . . . . . 0 C--N 1.329 -0.295 0 CA-C-N 115.463 -0.79 . . . . 0.0 110.169 -178.379 . . . . . . . . 0 0 . 1 . 005 nuclear orig core ' D' D ' 2' ' ' SER . . . . . . . . . . . . . 6.5 p . . . . . 0 N--CA 1.462 0.156 0 CA-C-O 120.774 0.321 . . . . 0.0 110.752 . . . . . . . . . 0 0 . 1 . 005 nuclear orig core ' D' D ' 3' ' ' GLU . . . . . . . . . . . . . 94.9 mt-10 -140.54 140.14 35.15 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.14 -0.482 . . . . 0.0 110.986 -179.044 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' D' D ' 4' ' ' LEU . . . . . . . . . . . . . 21.0 tp -126.31 128.01 46.46 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 116.129 -0.487 . . . . 0.0 110.223 176.912 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' D' D ' 5' ' ' LYS . . . . . . . . . . . . . 64.1 mttp -107.39 122.19 46.11 Favored 'General case' 0 C--O 1.234 0.274 0 CA-C-N 116.456 -0.338 . . . . 0.0 110.696 178.726 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' D' D ' 6' ' ' LEU . . . . . . . . . . . . . 73.3 mt -118.32 144.12 46.1 Favored 'General case' 0 C--N 1.331 -0.223 0 CA-C-N 115.683 -0.69 . . . . 0.0 110.778 -178.947 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' D' D ' 7' ' ' LYS . . . . . . . . . . . . . 59.3 tttm -133.95 141.76 40.91 Favored Pre-proline 0 CA--C 1.535 0.382 0 CA-C-O 119.12 -0.466 . . . . 0.0 110.158 176.727 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' D' D ' 8' ' ' PRO . . . . . . . . . . . . . 87.5 Cg_endo -91.52 140.64 2.57 Favored 'Trans proline' 0 N--CA 1.49 1.273 0 C-N-CA 121.748 1.632 . . . . 0.0 111.711 177.759 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' D' D ' 9' ' ' LEU . . . . . . . . . . . . . 53.5 mt -77.08 -48.06 2.6 Favored Pre-proline 0 CA--C 1.533 0.301 0 CA-C-O 118.799 -0.619 . . . . 0.0 112.464 -178.707 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' D' D ' 10' ' ' PRO . . . . . . . . . . . . . 85.2 Cg_endo -80.3 160.54 23.03 Favored 'Trans proline' 0 N--CA 1.495 1.605 0 C-N-CA 121.187 1.258 . . . . 0.0 112.071 176.92 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' D' D ' 11' ' ' LYS . . . . . . . . . . . . . 52.6 mttm -88.69 100.62 13.26 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.317 -0.402 . . . . 0.0 110.151 178.241 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' D' D ' 12' ' ' VAL . . . . . . . . . . . . . 12.9 p -145.77 147.34 18.53 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.263 0 CA-C-N 116.363 -0.38 . . . . 0.0 110.882 -178.888 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' D' D ' 13' ' ' GLU . . . . . . . . . . . . . 70.7 mm-40 -92.12 124.0 35.88 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.069 177.526 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' D' D ' 14' ' ' LEU . . . . . . . . . . . . . 36.4 mt -98.02 154.73 37.63 Favored Pre-proline 0 C--N 1.33 -0.258 0 CA-C-N 116.426 -0.352 . . . . 0.0 110.958 -177.88 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' D' D ' 15' ' ' PRO . . . . . . . . . . . . . 28.7 Cg_exo -60.6 154.82 51.74 Favored 'Trans proline' 0 N--CA 1.496 1.661 0 C-N-CA 121.405 1.403 . . . . 0.0 111.857 177.941 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' D' D ' 16' ' ' PRO . . . . . . . . . . . . . 36.4 Cg_exo -58.21 -37.13 96.72 Favored 'Trans proline' 0 N--CA 1.496 1.65 0 C-N-CA 121.4 1.4 . . . . 0.0 112.703 179.749 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' D' D ' 17' ' ' ASP . . . . . . . . . . . . . 15.0 p-10 -87.38 13.46 9.84 Favored 'General case' 0 CA--C 1.536 0.414 0 N-CA-C 112.981 0.734 . . . . 0.0 112.981 -178.384 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' D' D ' 18' ' ' PHE . . . . . . . . . . . . . 48.3 t80 -58.24 -45.09 88.39 Favored 'General case' 0 C--N 1.334 -0.104 0 O-C-N 122.145 -0.347 . . . . 0.0 110.14 -177.997 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' D' D ' 19' ' ' VAL . . . . . . . . . . . . . 14.6 p -55.7 -41.38 64.99 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.305 0 CA-C-N 116.478 -0.328 . . . . 0.0 111.073 -178.364 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' D' D ' 20' ' ' ASP . . . . . . . . . . . . . 71.5 m-20 -61.09 -43.76 98.4 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-O 120.818 0.342 . . . . 0.0 111.06 -178.329 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' D' D ' 21' ' ' VAL . . . . . . . . . . . . . 46.8 t -65.04 -46.78 90.36 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.318 0 C-N-CA 120.71 -0.396 . . . . 0.0 110.565 -177.285 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' D' D ' 22' ' ' ILE . . . . . . . . . . . . . 50.1 mm -56.7 -43.69 79.77 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.207 0 C-N-CA 120.959 -0.297 . . . . 0.0 110.493 179.378 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' D' D ' 23' ' ' ARG . . . . . . . . . . . . . 26.8 ttm-85 -52.93 -53.96 41.84 Favored 'General case' 0 C--N 1.331 -0.213 0 CA-C-O 121.413 0.625 . . . . 0.0 111.393 179.293 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' D' D ' 24' ' ' ILE . . . . . . . . . . . . . 78.8 mt -59.34 -41.06 83.06 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.356 0 CA-C-N 115.282 -0.872 . . . . 0.0 111.368 -173.524 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' D' D ' 25' ' ' LYS . . . . . . . . . . . . . 68.0 mttm -69.55 -41.63 75.66 Favored 'General case' 0 C--N 1.33 -0.278 0 N-CA-C 112.651 0.611 . . . . 0.0 112.651 -179.434 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' D' D ' 26' ' ' LEU . . . . . . . . . . . . . 60.4 mt -78.62 -33.86 47.05 Favored 'General case' 0 C--N 1.33 -0.262 0 N-CA-C 113.674 0.99 . . . . 0.0 113.674 -170.323 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' D' D ' 27' ' ' GLN . . . . . . . . . . . . . 10.4 pt20 -46.74 139.95 4.93 Favored 'General case' 0 N--CA 1.469 0.505 0 N-CA-C 112.863 0.69 . . . . 0.0 112.863 -174.884 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' D' D ' 28' ' ' GLY . . . . . . . . . . . . . . . 96.82 -21.39 46.27 Favored Glycine 0 CA--C 1.534 1.239 0 CA-C-N 115.728 -0.669 . . . . 0.0 112.531 -177.458 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' D' D ' 29' ' ' LYS . . . . . . . . . . . . . 35.1 mmtp -97.34 155.07 17.05 Favored 'General case' 0 C--O 1.232 0.16 0 CA-C-N 117.605 0.703 . . . . 0.0 110.783 179.407 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' D' D ' 30' ' ' THR . . . . . . . . . . . . . 32.0 m -106.0 137.1 44.49 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.043 -0.526 . . . . 0.0 109.868 176.165 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' D' D ' 31' ' ' VAL . . . . . . . . . . . . . 35.1 m -128.5 152.78 37.11 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.243 0 CA-C-O 121.026 0.441 . . . . 0.0 111.057 -178.088 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' D' D ' 32' ' ' ARG . . . . . . . . . . . . . 76.5 mtm180 -130.6 149.37 52.29 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 115.767 -0.652 . . . . 0.0 110.44 178.084 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' D' D ' 33' ' ' THR . . . . . . . . . . . . . 19.4 m -53.44 139.16 31.53 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.449 -0.342 . . . . 0.0 111.392 -178.238 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' D' D ' 34' ' ' GLY . . . . . . . . . . . . . . . 99.58 -17.02 58.2 Favored Glycine 0 CA--C 1.531 1.084 0 CA-C-O 119.684 -0.509 . . . . 0.0 113.296 179.378 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' D' D ' 35' ' ' ASP . . . . . . . . . . . . . 76.7 m-20 -66.17 148.74 51.38 Favored 'General case' 0 N--CA 1.461 0.107 0 CA-C-N 118.056 0.928 . . . . 0.0 111.074 179.145 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' D' D ' 36' ' ' VAL . . . . . . . . . . . . . 44.4 t -120.19 130.56 74.19 Favored 'Isoleucine or valine' 0 C--N 1.333 -0.133 0 CA-C-N 115.811 -0.631 . . . . 0.0 109.981 179.042 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' D' D ' 37' ' ' ILE . . . . . . . . . . . . . 68.3 mt -119.75 137.76 52.56 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.262 0 N-CA-C 109.721 -0.474 . . . . 0.0 109.721 179.103 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' D' D ' 38' ' ' GLY . . . . . . . . . . . . . . . -111.05 128.57 8.79 Favored Glycine 0 CA--C 1.524 0.633 0 N-CA-C 111.394 -0.682 . . . . 0.0 111.394 -178.955 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' D' D ' 39' ' ' ILE . . . . . . . . . . . . . 73.9 mt -129.99 130.47 66.18 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.217 0 N-CA-C 109.817 -0.438 . . . . 0.0 109.817 177.838 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' D' D ' 40' ' ' SER . . . . . . . . . . . . . 59.6 p -92.28 115.19 27.86 Favored 'General case' 0 C--N 1.33 -0.281 0 C-N-CA 120.912 -0.315 . . . . 0.0 110.875 176.968 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' D' D ' 41' ' ' ILE . . . . . . . . . . . . . 44.1 mm -123.39 124.48 69.85 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.223 0 N-CA-C 109.996 -0.372 . . . . 0.0 109.996 -179.754 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' D' D ' 42' ' ' LEU . . . . . . . . . . . . . 56.1 mt 57.67 34.16 24.14 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.362 -0.381 . . . . 0.0 111.729 178.274 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' D' D ' 43' ' ' GLY . . . . . . . . . . . . . . . 77.94 -10.05 28.25 Favored Glycine 0 CA--C 1.535 1.308 0 C-N-CA 121.28 -0.486 . . . . 0.0 113.407 177.713 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' D' D ' 44' ' ' LYS . . . . . . . . . . . . . 61.0 tttm -101.31 130.99 47.57 Favored 'General case' 0 C--N 1.331 -0.211 0 CA-C-N 117.914 0.857 . . . . 0.0 109.846 176.869 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' D' D ' 45' ' ' GLU . . . . . . . . . . . . . 43.3 tp10 -83.23 128.17 34.26 Favored 'General case' 0 C--N 1.329 -0.293 0 C-N-CA 120.817 -0.353 . . . . 0.0 110.727 -179.113 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' D' D ' 46' ' ' VAL . . . . . . . . . . . . . 7.3 p -121.67 131.2 73.63 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.227 0 CA-C-O 121.11 0.481 . . . . 0.0 109.704 177.363 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' D' D ' 47' ' ' LYS . . . . . . . . . . . . . 37.1 mtmm -100.47 128.06 46.64 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 115.879 -0.601 . . . . 0.0 111.069 176.349 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' D' D ' 48' ' ' PHE . . . . . . . . . . . . . 89.9 m-85 -107.97 131.96 54.0 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.077 -0.51 . . . . 0.0 109.75 176.125 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' D' D ' 49' ' ' LYS . . . . . . . . . . . . . 82.8 tttt -107.17 134.57 50.09 Favored 'General case' 0 C--N 1.327 -0.385 0 CA-C-N 116.289 -0.414 . . . . 0.0 110.379 179.856 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' D' D ' 50' ' ' VAL . . . . . . . . . . . . . 46.8 t -76.95 108.68 10.39 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.297 0 N-CA-C 109.037 -0.727 . . . . 0.0 109.037 175.709 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' D' D ' 51' ' ' VAL . . . . . . . . . . . . . 51.0 t -70.67 -47.16 65.82 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.329 0 CA-C-N 116.131 -0.486 . . . . 0.0 109.868 -174.338 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' D' D ' 52' ' ' GLN . . . . . . . . . . . . . 49.6 tt0 -167.94 142.08 3.47 Favored 'General case' 0 C--N 1.33 -0.275 0 C-N-CA 120.308 -0.557 . . . . 0.0 111.567 -179.907 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' D' D ' 53' ' ' ALA . . . . . . . . . . . . . . . -115.76 132.87 56.51 Favored 'General case' 0 C--N 1.331 -0.196 0 CA-C-N 115.745 -0.661 . . . . 0.0 110.024 176.255 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' D' D ' 54' ' ' TYR . . . . . . . . . . . . . 75.4 t80 -129.14 112.19 18.35 Favored Pre-proline 0 CA--C 1.536 0.413 0 CA-C-O 118.291 -0.861 . . . . 0.0 110.319 178.503 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' D' D ' 55' ' ' PRO . . . . . . . . . . . . . 73.0 Cg_endo -77.21 170.01 72.62 Favored 'Cis proline' 0 N--CA 1.499 1.836 0 CA-C-N 121.995 1.748 . . . . 0.0 112.119 -5.61 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' D' D ' 56' ' ' SER . . . . . . . . . . . . . 13.5 m -117.2 132.05 23.7 Favored Pre-proline 0 CA--C 1.538 0.502 0 CA-C-O 118.464 -0.779 . . . . 0.0 109.454 175.666 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' D' D ' 57' ' ' PRO . . . . . . . . . . . . . 45.3 Cg_endo -69.37 146.86 82.54 Favored 'Cis proline' 0 N--CA 1.496 1.667 0 CA-C-N 121.902 1.715 . . . . 0.0 111.532 -0.835 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' D' D ' 58' ' ' LEU . . . . . . . . . . . . . 27.2 tp -107.61 135.23 49.4 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.275 -0.421 . . . . 0.0 110.527 -179.035 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' D' D ' 59' ' ' ARG . . . . . . . . . . . . . 52.7 ttp180 -102.43 125.28 49.09 Favored 'General case' 0 C--N 1.328 -0.356 0 N-CA-C 109.482 -0.562 . . . . 0.0 109.482 177.101 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' D' D ' 60' ' ' VAL . . . . . . . . . . . . . 41.2 t -81.44 121.37 34.74 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.2 0 C-N-CA 120.745 -0.382 . . . . 0.0 110.505 -174.917 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' D' D ' 61' ' ' GLU . . . . . . . . . . . . . 96.1 mt-10 -131.13 159.92 36.25 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 115.73 -0.668 . . . . 0.0 109.929 177.213 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' D' D ' 62' ' ' ASP . . . . . . . . . . . . . 10.8 t70 -53.66 -32.3 51.02 Favored 'General case' 0 C--N 1.327 -0.376 0 N-CA-C 111.722 0.268 . . . . 0.0 111.722 179.648 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' D' D ' 63' ' ' ARG . . . . . . . . . . . . . 27.8 ptt180 -85.78 5.05 34.19 Favored 'General case' 0 CA--C 1.537 0.459 0 N-CA-C 113.771 1.026 . . . . 0.0 113.771 -175.634 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' D' D ' 64' ' ' THR . . . . . . . . . . . . . 39.9 m -86.19 143.67 27.86 Favored 'General case' 0 C--N 1.332 -0.184 0 CA-C-N 118.002 0.365 . . . . 0.0 110.411 -179.728 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' D' D ' 65' ' ' LYS . . . . . . . . . . . . . 98.7 mttt -87.21 126.08 34.58 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.438 -0.346 . . . . 0.0 110.104 179.968 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' D' D ' 66' ' ' ILE . . . . . . . . . . . . . 65.5 mt -117.71 128.33 74.91 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.295 0 N-CA-C 109.862 -0.422 . . . . 0.0 109.862 -178.969 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' D' D ' 67' ' ' THR . . . . . . . . . . . . . 25.4 m -121.86 136.8 54.94 Favored 'General case' 0 C--N 1.331 -0.202 0 CA-C-O 121.05 0.452 . . . . 0.0 110.981 -177.65 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' D' D ' 68' ' ' LEU . . . . . . . . . . . . . 19.0 tp . . . . . 0 C--N 1.331 -0.231 0 CA-C-N 115.914 -0.585 . . . . 0.0 110.635 179.593 . . . . . . . . 0 0 . 1 . 005 nuclear orig core ' D' D ' 73' ' ' VAL . . . . . . . . . . . . . 35.4 m . . . . . 0 C--O 1.231 0.098 0 N-CA-C 109.984 -0.376 . . . . 0.0 109.984 . . . . . . . . . 0 0 . 1 . 005 nuclear orig core ' D' D ' 74' ' ' ASP . . . . . . . . . . . . . 12.8 t70 -91.47 118.56 30.67 Favored 'General case' 0 C--N 1.331 -0.217 0 N-CA-C 109.953 -0.388 . . . . 0.0 109.953 -178.832 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' D' D ' 75' ' ' VAL . . . . . . . . . . . . . 45.8 t -117.36 123.67 72.06 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.239 0 CA-C-O 121.184 0.516 . . . . 0.0 110.507 -177.328 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' D' D ' 76' ' ' LEU . . . . . . . . . . . . . 14.6 mt -125.85 144.61 50.59 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-N 115.463 -0.79 . . . . 0.0 109.347 177.726 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' D' D ' 77' ' ' GLU . . . . . . . . . . . . . 97.0 mt-10 -135.67 138.33 42.7 Favored 'General case' 0 C--N 1.332 -0.183 0 CA-C-O 121.029 0.443 . . . . 0.0 111.583 -176.739 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' D' D ' 78' ' ' ALA . . . . . . . . . . . . . . . -127.14 135.28 50.49 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 115.627 -0.715 . . . . 0.0 109.675 175.772 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' D' D ' 79' ' ' LYS . . . . . . . . . . . . . 22.7 tptm -78.08 121.83 24.8 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-O 120.914 0.388 . . . . 0.0 110.647 -177.604 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' D' D ' 80' ' ' ILE . . . . . . . . . . . . . 43.2 mm -139.22 113.21 7.0 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.325 0 N-CA-C 108.995 -0.743 . . . . 0.0 108.995 -178.358 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' D' D ' 81' ' ' LYS . . . . . . . . . . . . . 76.2 tttt -103.09 123.24 46.27 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-O 120.749 0.309 . . . . 0.0 111.134 -175.809 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' D' D ' 82' ' ' GLY . . . . . . . . . . . . . . . 89.15 42.19 5.65 Favored Glycine 0 CA--C 1.528 0.871 0 C-N-CA 120.925 -0.655 . . . . 0.0 112.356 173.422 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' D' D ' 83' ' ' ILE . . . . . . . . . . . . . 71.4 mt -70.84 139.43 19.99 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.245 0 N-CA-C 109.706 -0.479 . . . . 0.0 109.706 176.359 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' D' D ' 84' ' ' LYS . . . . . . . . . . . . . 38.9 ttpt -107.16 -47.28 3.71 Favored 'General case' 0 C--N 1.331 -0.197 0 CA-C-N 116.451 -0.34 . . . . 0.0 110.631 -178.316 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' D' D ' 85' ' ' ASP . . . . . . . . . . . . . 9.9 t70 -148.35 148.13 30.02 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.253 -0.43 . . . . 0.0 110.489 -179.439 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' D' D ' 86' ' ' VAL . . . . . . . . . . . . . 42.4 t -133.25 134.48 57.39 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.252 0 CA-C-O 121.032 0.444 . . . . 0.0 110.425 179.442 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' D' D ' 87' ' ' ILE . . . . . . . . . . . . . 46.0 mm -120.09 127.52 75.9 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.29 0 CA-C-N 115.799 -0.637 . . . . 0.0 109.658 178.403 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' D' D ' 88' ' ' LEU . . . . . . . . . . . . . 18.2 tp -109.66 127.06 54.3 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-O 120.937 0.398 . . . . 0.0 110.898 -178.612 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' D' D ' 89' ' ' ASP . . . . . . . . . . . . . 13.7 t70 -117.96 154.68 31.54 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 115.926 -0.579 . . . . 0.0 109.559 177.124 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' D' D ' 90' ' ' GLU . . . . . . . . . . . . . 96.3 mt-10 -49.0 -38.63 23.95 Favored 'General case' 0 C--N 1.329 -0.311 0 N-CA-C 112.748 0.648 . . . . 0.0 112.748 -172.195 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' D' D ' 91' ' ' ASN . . . . . . . . . . . . . 37.5 t30 -132.06 35.64 3.71 Favored 'General case' 0 N--CA 1.464 0.258 0 C-N-CA 120.91 -0.316 . . . . 0.0 111.654 -177.797 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' D' D ' 92' ' ' LEU . . . . . . . . . . . . . 9.2 tp -166.06 146.66 6.53 Favored 'General case' 0 C--N 1.33 -0.244 0 C-N-CA 120.8 -0.36 . . . . 0.0 110.815 -179.304 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' D' D ' 93' ' ' ILE . . . . . . . . . . . . . 71.2 mt -125.71 123.66 64.93 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.262 0 N-CA-C 109.501 -0.555 . . . . 0.0 109.501 179.975 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' D' D ' 94' ' ' VAL . . . . . . . . . . . . . 46.4 t -124.41 129.69 73.82 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.24 0 CA-C-O 121.011 0.434 . . . . 0.0 110.236 179.893 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' D' D ' 95' ' ' VAL . . . . . . . . . . . . . 42.8 t -121.8 135.68 61.14 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.294 0 CA-C-N 115.86 -0.609 . . . . 0.0 109.821 -179.255 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' D' D ' 96' ' ' ILE . . . . . . . . . . . . . 67.8 mt -117.93 128.03 75.11 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.239 0 N-CA-C 109.561 -0.533 . . . . 0.0 109.561 179.043 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' D' D ' 97' ' ' THR . . . . . . . . . . . . . 65.8 p -100.12 159.53 15.03 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-O 121.102 0.477 . . . . 0.0 111.067 -178.16 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' D' D ' 98' ' ' GLU . . . . . . . . . . . . . 44.4 mt-10 -54.49 -26.32 30.71 Favored 'General case' 0 C--N 1.329 -0.319 0 N-CA-C 112.296 0.48 . . . . 0.0 112.296 -179.89 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' D' D ' 99' ' ' GLU . . . . . . . . . . . . . 95.4 mt-10 -76.08 10.77 1.74 Allowed 'General case' 0 CA--C 1.536 0.427 0 N-CA-C 113.326 0.862 . . . . 0.0 113.326 -177.557 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' D' D ' 100' ' ' ASN . . . . . . . . . . . . . 4.4 m-20 64.16 34.64 10.86 Favored 'General case' 0 N--CA 1.463 0.22 0 CA-C-O 120.971 0.415 . . . . 0.0 111.418 179.836 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' D' D ' 101' ' ' GLU . . . . . . . . . . . . . 84.7 tt0 -112.38 141.8 45.67 Favored 'General case' 0 C--N 1.334 -0.102 0 N-CA-C 109.778 -0.453 . . . . 0.0 109.778 173.72 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' D' D ' 102' ' ' VAL . . . . . . . . . . . . . 44.1 t -116.62 128.95 73.85 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.336 0 N-CA-C 109.988 -0.375 . . . . 0.0 109.988 -178.643 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' D' D ' 103' ' ' LEU . . . . . . . . . . . . . 52.9 mt -117.7 134.43 54.91 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 115.747 -0.661 . . . . 0.0 110.202 177.509 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' D' D ' 104' ' ' ILE . . . . . . . . . . . . . 67.9 mt -119.67 123.41 70.96 Favored 'Isoleucine or valine' 0 C--O 1.234 0.288 0 N-CA-C 110.35 -0.241 . . . . 0.0 110.35 -179.39 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' D' D ' 105' ' ' PHE . . . . . . . . . . . . . 63.9 m-85 -123.69 166.56 15.32 Favored 'General case' 0 C--N 1.333 -0.133 0 O-C-N 123.913 0.758 . . . . 0.0 109.666 179.577 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' D' D ' 106' ' ' ASN . . . . . . . . . . . . . 44.7 p-10 -101.45 -169.97 1.77 Allowed 'General case' 0 C--N 1.331 -0.235 0 N-CA-C 109.82 -0.437 . . . . 0.0 109.82 174.474 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' D' D ' 107' ' ' GLN . . . . . . . . . . . . . 62.2 tt0 -59.73 -30.14 68.63 Favored 'General case' 0 C--N 1.33 -0.273 0 N-CA-C 111.887 0.329 . . . . 0.0 111.887 179.82 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' D' D ' 108' ' ' ASN . . . . . . . . . . . . . 13.1 t-20 -82.05 7.02 14.41 Favored 'General case' 0 CA--C 1.537 0.46 0 N-CA-C 113.067 0.766 . . . . 0.0 113.067 -177.723 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' D' D ' 109' ' ' LEU . . . . . . . . . . . . . 8.0 tp 60.29 36.28 20.67 Favored 'General case' 0 C--N 1.332 -0.163 0 CA-C-O 120.878 0.371 . . . . 0.0 111.488 179.246 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' D' D ' 110' ' ' GLU . . . . . . . . . . . . . 43.1 mt-10 -104.83 150.77 24.54 Favored 'General case' 0 C--N 1.332 -0.176 0 N-CA-C 109.603 -0.517 . . . . 0.0 109.603 175.424 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' D' D ' 111' ' ' GLU . . . . . . . . . . . . . 67.8 tt0 -84.68 121.87 28.28 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-O 120.907 0.384 . . . . 0.0 110.722 -175.774 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' D' D ' 112' ' ' LEU . . . . . . . . . . . . . 11.4 mt -104.29 -46.07 4.51 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.016 -0.538 . . . . 0.0 110.489 179.36 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' D' D ' 113' ' ' TYR . . . . . . . . . . . . . 64.9 t80 -140.95 145.01 35.47 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.189 -0.46 . . . . 0.0 111.319 -178.236 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' D' D ' 114' ' ' ARG . . . . . . . . . . . . . 39.0 ptt85 -142.5 127.75 18.71 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 115.994 -0.548 . . . . 0.0 110.615 177.134 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' D' D ' 115' ' ' GLY . . . . . . . . . . . . . . . -150.06 151.79 23.8 Favored Glycine 0 CA--C 1.522 0.48 0 N-CA-C 110.724 -0.95 . . . . 0.0 110.724 178.788 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' D' D ' 116' ' ' LYS . . . . . . . . . . . . . 79.1 tttt -128.37 128.82 45.24 Favored 'General case' 0 C--N 1.328 -0.335 0 N-CA-C 109.842 -0.429 . . . . 0.0 109.842 178.531 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' D' D ' 117' ' ' PHE . . . . . . . . . . . . . 33.3 m-85 -125.86 117.97 24.48 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.283 -0.417 . . . . 0.0 110.154 -174.302 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' D' D ' 118' ' ' GLU . . . . . . . . . . . . . 96.0 mt-10 -55.02 -43.01 73.3 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.558 -0.292 . . . . 0.0 111.144 -176.615 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' D' D ' 119' ' ' ASN . . . . . . . . . . . . . 26.7 m120 -99.93 30.98 3.46 Favored 'General case' 0 C--N 1.331 -0.235 0 N-CA-C 112.176 0.435 . . . . 0.0 112.176 -174.273 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' D' D ' 120' ' ' LEU . . . . . . . . . . . . . 17.3 tp -56.11 119.87 6.6 Favored 'General case' 0 C--O 1.232 0.136 0 C-N-CA 120.925 -0.31 . . . . 0.0 110.613 178.539 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' D' D ' 121' ' ' ASN . . . . . . . . . . . . . 15.8 t-20 -114.16 -44.09 3.17 Favored 'General case' 0 C--N 1.332 -0.183 0 CA-C-N 116.592 -0.276 . . . . 0.0 111.416 -177.648 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' D' D ' 122' ' ' LYS . . . . . . . . . . . . . 96.5 mttt -145.23 150.38 36.59 Favored 'General case' 0 C--N 1.332 -0.153 0 C-N-CA 120.54 -0.464 . . . . 0.0 111.828 -176.671 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' D' D ' 123' ' ' VAL . . . . . . . . . . . . . 43.8 t -130.59 130.46 64.86 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.275 0 CA-C-N 115.951 -0.568 . . . . 0.0 109.753 176.318 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' D' D ' 124' ' ' LEU . . . . . . . . . . . . . 75.5 mt -131.1 135.61 47.65 Favored 'General case' 0 C--N 1.331 -0.208 0 CA-C-N 116.628 -0.26 . . . . 0.0 110.536 -179.643 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' D' D ' 125' ' ' VAL . . . . . . . . . . . . . 34.2 m -141.66 151.32 19.18 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.306 0 CA-C-O 121.007 0.432 . . . . 0.0 111.337 -179.09 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' D' D ' 126' ' ' ARG . . . . . . . . . . . . . 35.8 ptt-85 -154.15 129.75 9.97 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 115.873 -0.603 . . . . 0.0 110.549 175.965 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' D' D ' 127' ' ' ASN . . . . . . . . . . . . . 6.8 m120 51.91 -109.39 0.44 Allowed 'General case' 0 CA--C 1.546 0.809 0 CA-C-O 118.925 -0.559 . . . . 0.0 111.154 -179.927 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' D' D ' 128' ' ' ASP . . . . . . . . . . . . . 18.5 p-10 -114.13 2.92 15.04 Favored 'General case' 0 N--CA 1.468 0.438 0 CA-C-N 119.755 1.161 . . . . 0.0 113.443 -177.998 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' D' D ' 129' ' ' LEU . . . . . . . . . . . . . 48.7 mt -106.82 139.26 41.52 Favored 'General case' 0 C--N 1.333 -0.115 0 N-CA-C 109.558 -0.534 . . . . 0.0 109.558 179.12 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' D' D ' 130' ' ' VAL . . . . . . . . . . . . . 32.7 m -137.25 144.26 32.29 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.246 0 CA-C-O 121.167 0.508 . . . . 0.0 111.263 -178.322 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' D' D ' 131' ' ' VAL . . . . . . . . . . . . . 41.7 t -136.04 139.69 45.34 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.286 0 CA-C-N 115.878 -0.601 . . . . 0.0 110.243 178.199 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' D' D ' 132' ' ' ILE . . . . . . . . . . . . . 73.7 mt -117.14 133.31 64.28 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 CA-C-N 115.496 -0.774 . . . . 0.0 109.28 179.997 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' D' D ' 133' ' ' ILE . . . . . . . . . . . . . 40.8 mm -115.73 124.27 71.98 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.236 0 CA-C-O 120.72 0.295 . . . . 0.0 110.966 -175.034 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' D' D ' 134' ' ' ASP . . . . . . . . . . . . . 9.5 p-10 -136.46 146.4 46.29 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 115.972 -0.558 . . . . 0.0 109.719 175.548 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' D' D ' 135' ' ' GLU . . . . . . . . . . . . . 86.2 tt0 -50.27 -24.63 3.03 Favored 'General case' 0 C--N 1.327 -0.379 0 N-CA-C 112.85 0.685 . . . . 0.0 112.85 -175.014 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' D' D ' 136' ' ' GLN . . . . . . . . . . . . . 53.1 mt-30 -82.89 -32.48 27.32 Favored 'General case' 0 C--O 1.234 0.241 0 N-CA-C 112.384 0.512 . . . . 0.0 112.384 -177.15 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' D' D ' 137' ' ' LYS . . . . . . . . . . . . . 52.5 pttt -170.09 175.63 4.95 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-O 121.474 0.654 . . . . 0.0 112.295 -173.567 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' D' D ' 138' ' ' LEU . . . . . . . . . . . . . 7.5 tt -119.68 127.5 52.95 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 115.184 -0.916 . . . . 0.0 109.944 177.65 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' D' D ' 139' ' ' THR . . . . . . . . . . . . . 44.6 m -110.16 127.3 54.84 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 116.243 -0.435 . . . . 0.0 110.129 -179.896 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' D' D ' 140' ' ' LEU . . . . . . . . . . . . . 8.1 tt -117.07 126.23 52.53 Favored 'General case' 0 C--N 1.329 -0.311 0 N-CA-C 109.498 -0.556 . . . . 0.0 109.498 -178.708 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' D' D ' 141' ' ' ILE . . . . . . . . . . . . . 19.1 mt -123.37 121.4 62.67 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.281 0 N-CA-C 109.733 -0.469 . . . . 0.0 109.733 -175.627 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' D' D ' 142' ' ' ARG . . . . . . . . . . . . . 29.5 ttp180 -115.66 128.07 55.64 Favored 'General case' 0 C--N 1.331 -0.212 0 CA-C-N 115.696 -0.683 . . . . 0.0 110.331 -177.205 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' D' D ' 143' ' ' THR . . . . . . . . . . . . . 35.4 p . . . . . 0 C--O 1.22 -0.487 0 CA-C-O 117.976 -1.011 . . . . 0.0 110.53 -179.7 . . . . . . . . 0 0 . 1 . 005 nuclear orig core ' E' E ' 2' ' ' SER . . . . . . . . . . . . . 5.3 p . . . . . 0 C--O 1.231 0.094 0 CA-C-O 120.818 0.342 . . . . 0.0 110.129 . . . . . . . . . 0 0 . 1 . 005 nuclear orig core ' E' E ' 3' ' ' GLU . . . . . . . . . . . . . 84.9 tt0 -144.41 141.35 29.58 Favored 'General case' 0 C--N 1.327 -0.409 0 CA-C-N 116.198 -0.456 . . . . 0.0 111.182 -178.63 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' E' E ' 4' ' ' LEU . . . . . . . . . . . . . 20.1 tp -122.73 132.07 54.07 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-N 116.04 -0.527 . . . . 0.0 110.102 176.235 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' E' E ' 5' ' ' LYS . . . . . . . . . . . . . 50.2 mtmt -108.27 119.02 38.28 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 116.353 -0.385 . . . . 0.0 110.69 -179.604 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' E' E ' 6' ' ' LEU . . . . . . . . . . . . . 54.8 mt -114.15 142.19 46.55 Favored 'General case' 0 C--N 1.331 -0.229 0 O-C-N 123.86 0.725 . . . . 0.0 111.169 -178.165 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' E' E ' 7' ' ' LYS . . . . . . . . . . . . . 65.5 tttt -132.97 138.48 31.94 Favored Pre-proline 0 CA--C 1.534 0.356 0 CA-C-O 118.922 -0.561 . . . . 0.0 109.672 176.152 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' E' E ' 8' ' ' PRO . . . . . . . . . . . . . 78.1 Cg_endo -90.99 146.55 3.68 Favored 'Trans proline' 0 N--CA 1.49 1.317 0 C-N-CA 121.691 1.594 . . . . 0.0 112.083 178.671 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' E' E ' 9' ' ' LEU . . . . . . . . . . . . . 54.8 mt -86.0 -48.55 0.55 Allowed Pre-proline 0 CA--C 1.535 0.392 0 CA-C-O 118.518 -0.753 . . . . 0.0 112.499 -179.845 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' E' E ' 10' ' ' PRO . . . . . . . . . . . . . 95.6 Cg_endo -78.41 157.13 29.14 Favored 'Trans proline' 0 N--CA 1.496 1.645 0 C-N-CA 121.22 1.28 . . . . 0.0 112.002 178.651 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' E' E ' 11' ' ' LYS . . . . . . . . . . . . . 92.5 mttt -85.18 92.2 8.34 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.311 -0.404 . . . . 0.0 110.539 179.383 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' E' E ' 12' ' ' VAL . . . . . . . . . . . . . 12.6 p -142.5 143.42 25.93 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.281 0 CA-C-N 116.372 -0.376 . . . . 0.0 110.61 179.819 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' E' E ' 13' ' ' GLU . . . . . . . . . . . . . 41.7 mt-10 -93.28 132.49 37.42 Favored 'General case' 0 C--N 1.329 -0.307 0 N-CA-C 109.926 -0.398 . . . . 0.0 109.926 177.349 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' E' E ' 14' ' ' LEU . . . . . . . . . . . . . 21.2 mt -98.5 149.76 36.05 Favored Pre-proline 0 CA--C 1.534 0.342 0 CA-C-O 119.318 -0.373 . . . . 0.0 110.737 -176.351 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' E' E ' 15' ' ' PRO . . . . . . . . . . . . . 23.5 Cg_exo -64.26 161.21 35.16 Favored 'Trans proline' 0 N--CA 1.498 1.791 0 C-N-CA 121.291 1.328 . . . . 0.0 111.971 175.841 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' E' E ' 16' ' ' PRO . . . . . . . . . . . . . 29.7 Cg_exo -59.9 -34.81 95.16 Favored 'Trans proline' 0 N--CA 1.498 1.774 0 C-N-CA 121.451 1.434 . . . . 0.0 112.938 -178.536 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' E' E ' 17' ' ' ASP . . . . . . . . . . . . . 16.5 p-10 -83.91 0.99 45.53 Favored 'General case' 0 CA--C 1.538 0.488 0 N-CA-C 113.375 0.88 . . . . 0.0 113.375 -177.738 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' E' E ' 18' ' ' PHE . . . . . . . . . . . . . 45.9 t80 -57.92 -42.27 84.46 Favored 'General case' 0 C--N 1.333 -0.124 0 O-C-N 121.938 -0.476 . . . . 0.0 110.228 -177.426 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' E' E ' 19' ' ' VAL . . . . . . . . . . . . . 46.7 t -56.19 -45.74 81.05 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.244 0 CA-C-N 116.44 -0.346 . . . . 0.0 110.62 -178.003 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' E' E ' 20' ' ' ASP . . . . . . . . . . . . . 81.3 m-20 -60.14 -40.18 88.92 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-O 120.833 0.349 . . . . 0.0 110.936 -178.217 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' E' E ' 21' ' ' VAL . . . . . . . . . . . . . 46.2 t -63.78 -47.02 92.8 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.265 0 C-N-CA 120.675 -0.41 . . . . 0.0 110.381 -178.262 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' E' E ' 22' ' ' ILE . . . . . . . . . . . . . 51.7 mm -55.28 -46.74 78.22 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.274 0 C-N-CA 121.131 -0.228 . . . . 0.0 110.771 179.304 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' E' E ' 23' ' ' ARG . . . . . . . . . . . . . 34.6 ttp180 -54.42 -49.36 70.14 Favored 'General case' 0 C--N 1.33 -0.267 0 C-N-CA 121.023 -0.271 . . . . 0.0 111.454 -178.841 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' E' E ' 24' ' ' ILE . . . . . . . . . . . . . 70.3 mt -59.88 -44.13 93.6 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.257 0 CA-C-N 116.549 -0.296 . . . . 0.0 111.223 -177.172 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' E' E ' 25' ' ' LYS . . . . . . . . . . . . . 50.9 mmtt -64.46 -41.85 96.28 Favored 'General case' 0 C--N 1.328 -0.336 0 N-CA-C 112.406 0.521 . . . . 0.0 112.406 -178.027 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' E' E ' 26' ' ' LEU . . . . . . . . . . . . . 28.8 mt -78.54 -41.59 31.76 Favored 'General case' 0 C--N 1.33 -0.269 0 N-CA-C 113.252 0.834 . . . . 0.0 113.252 -171.181 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' E' E ' 27' ' ' GLN . . . . . . . . . . . . . 10.2 pt20 -46.58 139.03 5.4 Favored 'General case' 0 N--CA 1.469 0.502 0 N-CA-C 112.787 0.662 . . . . 0.0 112.787 -175.056 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' E' E ' 28' ' ' GLY . . . . . . . . . . . . . . . 98.77 -27.04 21.61 Favored Glycine 0 CA--C 1.533 1.174 0 CA-C-N 115.528 -0.76 . . . . 0.0 112.226 -177.247 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' E' E ' 29' ' ' LYS . . . . . . . . . . . . . 46.0 mtmt -98.12 155.16 17.28 Favored 'General case' 0 C--N 1.331 -0.203 0 CA-C-N 117.168 0.484 . . . . 0.0 111.182 179.35 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' E' E ' 30' ' ' THR . . . . . . . . . . . . . 28.8 m -104.15 137.71 41.7 Favored 'General case' 0 C--N 1.331 -0.222 0 CA-C-N 115.908 -0.587 . . . . 0.0 110.149 175.957 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' E' E ' 31' ' ' VAL . . . . . . . . . . . . . 35.2 m -130.6 153.51 39.18 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 CA-C-N 116.361 -0.381 . . . . 0.0 110.94 -178.709 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' E' E ' 32' ' ' ARG . . . . . . . . . . . . . 87.8 mtm-85 -128.1 149.21 50.51 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.138 -0.483 . . . . 0.0 110.653 179.432 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' E' E ' 33' ' ' THR . . . . . . . . . . . . . 29.9 m -53.46 139.22 31.51 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.372 -0.376 . . . . 0.0 111.376 -178.524 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' E' E ' 34' ' ' GLY . . . . . . . . . . . . . . . 99.35 -17.14 58.24 Favored Glycine 0 CA--C 1.532 1.111 0 CA-C-O 119.707 -0.496 . . . . 0.0 113.312 179.217 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' E' E ' 35' ' ' ASP . . . . . . . . . . . . . 77.8 m-20 -66.3 148.62 51.58 Favored 'General case' 0 C--O 1.231 0.129 0 CA-C-N 118.02 0.91 . . . . 0.0 111.078 179.189 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' E' E ' 36' ' ' VAL . . . . . . . . . . . . . 43.9 t -119.91 129.68 75.13 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.2 0 CA-C-N 115.78 -0.645 . . . . 0.0 109.822 178.267 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' E' E ' 37' ' ' ILE . . . . . . . . . . . . . 67.5 mt -116.88 137.51 50.53 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.272 0 N-CA-C 109.739 -0.467 . . . . 0.0 109.739 179.437 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' E' E ' 38' ' ' GLY . . . . . . . . . . . . . . . -114.72 128.67 8.26 Favored Glycine 0 CA--C 1.525 0.672 0 N-CA-C 111.143 -0.783 . . . . 0.0 111.143 -179.164 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' E' E ' 39' ' ' ILE . . . . . . . . . . . . . 77.2 mt -122.41 134.4 65.73 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.249 0 N-CA-C 109.974 -0.38 . . . . 0.0 109.974 178.787 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' E' E ' 40' ' ' SER . . . . . . . . . . . . . 59.8 p -92.74 119.04 31.72 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.441 -0.345 . . . . 0.0 110.829 175.7 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' E' E ' 41' ' ' ILE . . . . . . . . . . . . . 72.3 mt -126.37 122.23 60.76 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.215 0 CA-C-N 116.553 -0.294 . . . . 0.0 110.32 178.652 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' E' E ' 42' ' ' LEU . . . . . . . . . . . . . 44.4 mt 52.11 34.25 13.8 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.251 -0.431 . . . . 0.0 111.853 177.675 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' E' E ' 43' ' ' GLY . . . . . . . . . . . . . . . 72.23 33.2 62.05 Favored Glycine 0 CA--C 1.529 0.935 0 C-N-CA 121.053 -0.594 . . . . 0.0 111.796 179.002 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' E' E ' 44' ' ' LYS . . . . . . . . . . . . . 44.2 tttp -138.35 128.76 26.13 Favored 'General case' 0 C--N 1.328 -0.33 0 N-CA-C 109.696 -0.483 . . . . 0.0 109.696 179.711 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' E' E ' 45' ' ' GLU . . . . . . . . . . . . . 83.7 tt0 -83.03 121.78 27.46 Favored 'General case' 0 C--N 1.328 -0.347 0 C-N-CA 120.786 -0.366 . . . . 0.0 111.127 -177.639 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' E' E ' 46' ' ' VAL . . . . . . . . . . . . . 7.5 p -119.94 125.88 74.73 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.194 0 N-CA-C 109.298 -0.63 . . . . 0.0 109.298 175.087 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' E' E ' 47' ' ' LYS . . . . . . . . . . . . . 96.5 mttt -100.87 129.78 46.78 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 115.964 -0.562 . . . . 0.0 111.437 179.442 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' E' E ' 48' ' ' PHE . . . . . . . . . . . . . 91.7 m-85 -112.73 131.81 55.5 Favored 'General case' 0 C--N 1.33 -0.253 0 N-CA-C 109.612 -0.514 . . . . 0.0 109.612 174.507 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' E' E ' 49' ' ' LYS . . . . . . . . . . . . . 68.5 tttt -107.87 137.42 45.91 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.643 -0.253 . . . . 0.0 110.715 179.817 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' E' E ' 50' ' ' VAL . . . . . . . . . . . . . 46.7 t -81.04 106.57 12.37 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.281 0 N-CA-C 109.175 -0.676 . . . . 0.0 109.175 175.148 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' E' E ' 51' ' ' VAL . . . . . . . . . . . . . 48.0 t -69.68 -53.99 21.64 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.324 0 N-CA-C 109.479 -0.563 . . . . 0.0 109.479 -176.302 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' E' E ' 52' ' ' GLN . . . . . . . . . . . . . 93.7 mt-30 -152.53 154.55 35.67 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.097 -0.501 . . . . 0.0 111.714 -179.226 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' E' E ' 53' ' ' ALA . . . . . . . . . . . . . . . -130.49 132.33 45.59 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 115.168 -0.924 . . . . 0.0 109.764 176.056 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' E' E ' 54' ' ' TYR . . . . . . . . . . . . . 57.9 t80 -129.1 108.82 18.04 Favored Pre-proline 0 CA--C 1.534 0.351 0 CA-C-O 118.312 -0.851 . . . . 0.0 110.368 -179.767 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' E' E ' 55' ' ' PRO . . . . . . . . . . . . . 73.8 Cg_endo -77.21 170.03 72.57 Favored 'Cis proline' 0 N--CA 1.499 1.813 0 CA-C-N 121.808 1.682 . . . . 0.0 112.583 -5.154 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' E' E ' 56' ' ' SER . . . . . . . . . . . . . 13.8 m -116.12 128.97 25.57 Favored Pre-proline 0 CA--C 1.539 0.53 0 CA-C-O 118.356 -0.83 . . . . 0.0 109.139 174.425 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' E' E ' 57' ' ' PRO . . . . . . . . . . . . . 54.3 Cg_endo -70.7 149.63 91.18 Favored 'Cis proline' 0 N--CA 1.497 1.684 0 CA-C-N 121.993 1.747 . . . . 0.0 111.733 0.454 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' E' E ' 58' ' ' LEU . . . . . . . . . . . . . 25.3 tp -108.39 136.53 47.86 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.572 -179.426 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' E' E ' 59' ' ' ARG . . . . . . . . . . . . . 72.8 ttt180 -104.55 125.96 51.19 Favored 'General case' 0 C--N 1.326 -0.438 0 N-CA-C 109.14 -0.689 . . . . 0.0 109.14 176.0 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' E' E ' 60' ' ' VAL . . . . . . . . . . . . . 45.8 t -80.44 118.07 27.48 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.213 0 C-N-CA 120.521 -0.471 . . . . 0.0 110.48 -174.765 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' E' E ' 61' ' ' GLU . . . . . . . . . . . . . 95.0 mt-10 -131.02 162.81 28.97 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 115.786 -0.643 . . . . 0.0 109.563 176.326 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' E' E ' 62' ' ' ASP . . . . . . . . . . . . . 21.1 p-10 -56.27 -33.12 65.17 Favored 'General case' 0 C--N 1.328 -0.328 0 N-CA-C 111.854 0.316 . . . . 0.0 111.854 -177.15 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' E' E ' 63' ' ' ARG . . . . . . . . . . . . . 27.1 mmm180 -73.31 -17.36 61.32 Favored 'General case' 0 CA--C 1.533 0.317 0 N-CA-C 113.178 0.807 . . . . 0.0 113.178 -177.08 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' E' E ' 64' ' ' THR . . . . . . . . . . . . . 25.7 m -70.07 139.25 52.56 Favored 'General case' 0 C--N 1.332 -0.156 0 CA-C-O 120.865 0.364 . . . . 0.0 110.987 -175.235 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' E' E ' 65' ' ' LYS . . . . . . . . . . . . . 64.4 mttm -86.06 133.94 33.86 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.041 -0.527 . . . . 0.0 109.922 178.167 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' E' E ' 66' ' ' ILE . . . . . . . . . . . . . 64.3 mt -114.31 125.59 71.65 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.29 0 N-CA-C 109.57 -0.53 . . . . 0.0 109.57 178.839 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' E' E ' 67' ' ' THR . . . . . . . . . . . . . 29.5 m -118.12 137.53 52.89 Favored 'General case' 0 C--N 1.331 -0.213 0 CA-C-N 116.06 -0.518 . . . . 0.0 110.555 -178.013 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' E' E ' 68' ' ' LEU . . . . . . . . . . . . . 19.6 tp . . . . . 0 C--N 1.327 -0.37 0 CA-C-N 115.79 -0.641 . . . . 0.0 110.466 -179.222 . . . . . . . . 0 0 . 1 . 005 nuclear orig core ' E' E ' 73' ' ' VAL . . . . . . . . . . . . . 34.2 m . . . . . 0 C--O 1.232 0.134 0 CA-C-O 120.621 0.248 . . . . 0.0 110.597 . . . . . . . . . 0 0 . 1 . 005 nuclear orig core ' E' E ' 74' ' ' ASP . . . . . . . . . . . . . 33.7 t0 -86.46 117.59 25.35 Favored 'General case' 0 C--N 1.33 -0.259 0 C-N-CA 120.933 -0.307 . . . . 0.0 110.187 -173.862 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' E' E ' 75' ' ' VAL . . . . . . . . . . . . . 46.4 t -117.28 120.78 65.99 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.235 0 CA-C-O 121.126 0.489 . . . . 0.0 110.191 -178.439 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' E' E ' 76' ' ' LEU . . . . . . . . . . . . . 15.7 mt -123.32 142.22 51.17 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 115.559 -0.746 . . . . 0.0 109.502 178.688 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' E' E ' 77' ' ' GLU . . . . . . . . . . . . . 97.1 mt-10 -135.4 129.58 33.53 Favored 'General case' 0 C--N 1.331 -0.227 0 CA-C-O 121.064 0.459 . . . . 0.0 111.058 -177.221 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' E' E ' 78' ' ' ALA . . . . . . . . . . . . . . . -116.25 126.54 53.73 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 115.649 -0.705 . . . . 0.0 109.586 177.24 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' E' E ' 79' ' ' LYS . . . . . . . . . . . . . 48.0 pttt -76.72 119.18 20.16 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-O 121.284 0.564 . . . . 0.0 110.962 -177.386 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' E' E ' 80' ' ' ILE . . . . . . . . . . . . . 26.8 mm -139.25 106.11 2.71 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.244 0 CA-C-N 115.563 -0.744 . . . . 0.0 109.09 -178.932 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' E' E ' 81' ' ' LYS . . . . . . . . . . . . . 53.1 mtmt -99.5 129.19 45.65 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-O 120.925 0.393 . . . . 0.0 110.865 -178.678 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' E' E ' 82' ' ' GLY . . . . . . . . . . . . . . . 89.16 42.18 5.65 Favored Glycine 0 CA--C 1.525 0.666 0 C-N-CA 120.915 -0.66 . . . . 0.0 111.701 175.423 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' E' E ' 83' ' ' ILE . . . . . . . . . . . . . 75.2 mt -67.95 138.16 23.16 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.302 0 N-CA-C 109.771 -0.455 . . . . 0.0 109.771 176.48 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' E' E ' 84' ' ' LYS . . . . . . . . . . . . . 58.6 tttp -95.06 -52.76 4.08 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.122 -0.49 . . . . 0.0 109.956 -179.702 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' E' E ' 85' ' ' ASP . . . . . . . . . . . . . 6.5 t70 -155.72 153.58 30.15 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 115.792 -0.64 . . . . 0.0 110.371 -179.458 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' E' E ' 86' ' ' VAL . . . . . . . . . . . . . 43.0 t -130.29 132.67 64.86 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.258 0 CA-C-O 120.991 0.424 . . . . 0.0 110.498 -179.628 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' E' E ' 87' ' ' ILE . . . . . . . . . . . . . 45.2 mm -116.95 125.72 74.0 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.252 0 CA-C-N 115.722 -0.672 . . . . 0.0 109.55 176.745 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' E' E ' 88' ' ' LEU . . . . . . . . . . . . . 16.8 tp -110.11 129.87 55.63 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-O 120.852 0.358 . . . . 0.0 110.946 -177.436 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' E' E ' 89' ' ' ASP . . . . . . . . . . . . . 13.9 t70 -125.47 155.7 40.08 Favored 'General case' 0 C--N 1.331 -0.221 0 CA-C-N 116.085 -0.507 . . . . 0.0 109.936 177.637 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' E' E ' 90' ' ' GLU . . . . . . . . . . . . . 45.3 tp10 -45.84 -38.84 7.75 Favored 'General case' 0 C--N 1.33 -0.282 0 N-CA-C 113.132 0.79 . . . . 0.0 113.132 -172.167 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' E' E ' 91' ' ' ASN . . . . . . . . . . . . . 20.9 t30 -132.04 22.37 4.52 Favored 'General case' 0 N--CA 1.468 0.462 0 N-CA-C 112.87 0.692 . . . . 0.0 112.87 -177.147 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' E' E ' 92' ' ' LEU . . . . . . . . . . . . . 10.2 mt -149.48 147.14 27.87 Favored 'General case' 0 C--N 1.332 -0.167 0 N-CA-C 110.191 -0.3 . . . . 0.0 110.191 -177.025 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' E' E ' 93' ' ' ILE . . . . . . . . . . . . . 67.6 mt -124.34 119.57 56.88 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.203 0 N-CA-C 109.199 -0.667 . . . . 0.0 109.199 176.213 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' E' E ' 94' ' ' VAL . . . . . . . . . . . . . 45.7 t -118.84 127.44 75.74 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.252 0 N-CA-C 109.849 -0.426 . . . . 0.0 109.849 -179.482 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' E' E ' 95' ' ' VAL . . . . . . . . . . . . . 44.0 t -123.99 135.8 62.38 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.324 0 CA-C-N 116.135 -0.484 . . . . 0.0 110.177 -178.404 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' E' E ' 96' ' ' ILE . . . . . . . . . . . . . 57.7 mt -117.19 129.19 74.12 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.287 0 N-CA-C 109.269 -0.641 . . . . 0.0 109.269 178.117 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' E' E ' 97' ' ' THR . . . . . . . . . . . . . 78.5 p -103.63 158.16 16.56 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-O 121.185 0.517 . . . . 0.0 111.282 -177.431 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' E' E ' 98' ' ' GLU . . . . . . . . . . . . . 70.6 mm-40 -54.23 -25.62 24.12 Favored 'General case' 0 C--N 1.33 -0.247 0 N-CA-C 112.408 0.521 . . . . 0.0 112.408 -179.754 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' E' E ' 99' ' ' GLU . . . . . . . . . . . . . 47.2 mp0 -78.19 14.33 1.21 Allowed 'General case' 0 CA--C 1.535 0.402 0 N-CA-C 113.136 0.791 . . . . 0.0 113.136 -178.032 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' E' E ' 100' ' ' ASN . . . . . . . . . . . . . 3.6 m-20 62.21 37.33 14.32 Favored 'General case' 0 CA--C 1.53 0.201 0 CA-C-O 120.994 0.426 . . . . 0.0 110.997 178.741 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' E' E ' 101' ' ' GLU . . . . . . . . . . . . . 84.7 tt0 -113.99 144.14 43.58 Favored 'General case' 0 C--N 1.331 -0.198 0 CA-C-N 116.02 -0.536 . . . . 0.0 109.735 176.244 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' E' E ' 102' ' ' VAL . . . . . . . . . . . . . 44.3 t -114.98 126.0 72.45 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.299 0 CA-C-N 116.225 -0.443 . . . . 0.0 109.914 -178.803 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' E' E ' 103' ' ' LEU . . . . . . . . . . . . . 21.5 mt -118.29 132.08 56.31 Favored 'General case' 0 C--N 1.331 -0.217 0 CA-C-N 115.662 -0.699 . . . . 0.0 110.31 178.778 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' E' E ' 104' ' ' ILE . . . . . . . . . . . . . 69.7 mt -120.14 123.57 70.96 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.266 0 N-CA-C 110.063 -0.347 . . . . 0.0 110.063 178.601 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' E' E ' 105' ' ' PHE . . . . . . . . . . . . . 70.8 m-85 -124.88 162.43 24.41 Favored 'General case' 0 C--N 1.333 -0.15 0 O-C-N 123.848 0.718 . . . . 0.0 109.89 179.336 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' E' E ' 106' ' ' ASN . . . . . . . . . . . . . 46.0 p-10 -97.22 -170.46 2.03 Favored 'General case' 0 C--N 1.33 -0.266 0 N-CA-C 109.981 -0.377 . . . . 0.0 109.981 174.143 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' E' E ' 107' ' ' GLN . . . . . . . . . . . . . 55.6 tp60 -59.71 -30.07 68.55 Favored 'General case' 0 CA--C 1.531 0.214 0 N-CA-C 111.911 0.337 . . . . 0.0 111.911 179.911 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' E' E ' 108' ' ' ASN . . . . . . . . . . . . . 52.0 t30 -81.92 8.21 11.01 Favored 'General case' 0 CA--C 1.535 0.384 0 N-CA-C 113.109 0.781 . . . . 0.0 113.109 -177.601 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' E' E ' 109' ' ' LEU . . . . . . . . . . . . . 12.7 tp 58.39 38.79 25.75 Favored 'General case' 0 C--N 1.332 -0.183 0 CA-C-O 121.105 0.479 . . . . 0.0 110.901 179.339 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' E' E ' 110' ' ' GLU . . . . . . . . . . . . . 70.8 mm-40 -105.23 149.14 26.22 Favored 'General case' 0 C--N 1.332 -0.192 0 N-CA-C 109.925 -0.398 . . . . 0.0 109.925 176.798 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' E' E ' 111' ' ' GLU . . . . . . . . . . . . . 84.5 tt0 -78.39 121.83 25.01 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 116.419 -0.355 . . . . 0.0 110.616 -177.402 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' E' E ' 112' ' ' LEU . . . . . . . . . . . . . 18.4 mt -110.17 -46.11 3.49 Favored 'General case' 0 C--N 1.331 -0.21 0 CA-C-N 116.283 -0.417 . . . . 0.0 110.697 179.174 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' E' E ' 113' ' ' TYR . . . . . . . . . . . . . 64.3 t80 -138.89 136.27 35.35 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.262 -0.426 . . . . 0.0 111.045 -179.147 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' E' E ' 114' ' ' ARG . . . . . . . . . . . . . 70.1 ttp85 -138.53 120.37 15.37 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-N 116.025 -0.534 . . . . 0.0 110.277 176.695 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' E' E ' 115' ' ' GLY . . . . . . . . . . . . . . . -150.14 145.65 13.95 Favored Glycine 0 CA--C 1.524 0.641 0 N-CA-C 110.842 -0.903 . . . . 0.0 110.842 178.118 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' E' E ' 116' ' ' LYS . . . . . . . . . . . . . 28.4 ttmt -115.26 136.59 52.95 Favored 'General case' 0 C--N 1.331 -0.23 0 O-C-N 122.565 -0.374 . . . . 0.0 110.171 177.94 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' E' E ' 117' ' ' PHE . . . . . . . . . . . . . 58.5 m-85 -131.46 117.37 18.74 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 116.15 -0.477 . . . . 0.0 110.129 -177.018 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' E' E ' 118' ' ' GLU . . . . . . . . . . . . . 96.2 mt-10 -54.43 -41.64 69.6 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.507 -0.315 . . . . 0.0 111.486 -175.31 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' E' E ' 119' ' ' ASN . . . . . . . . . . . . . 19.0 m120 -104.05 31.1 4.73 Favored 'General case' 0 C--N 1.33 -0.249 0 N-CA-C 112.129 0.418 . . . . 0.0 112.129 -173.885 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' E' E ' 120' ' ' LEU . . . . . . . . . . . . . 21.3 tp -56.65 123.29 14.36 Favored 'General case' 0 C--N 1.332 -0.16 0 C-N-CA 121.118 -0.233 . . . . 0.0 110.412 178.555 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' E' E ' 121' ' ' ASN . . . . . . . . . . . . . 27.2 m120 -114.13 -44.28 3.15 Favored 'General case' 0 N--CA 1.462 0.165 0 CA-C-N 116.759 -0.201 . . . . 0.0 111.353 -176.829 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' E' E ' 122' ' ' LYS . . . . . . . . . . . . . 94.4 mttt -147.73 151.52 36.23 Favored 'General case' 0 C--N 1.332 -0.191 0 CA-C-O 121.03 0.443 . . . . 0.0 111.715 -176.963 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' E' E ' 123' ' ' VAL . . . . . . . . . . . . . 42.7 t -132.91 133.13 59.14 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.181 0 N-CA-C 109.633 -0.506 . . . . 0.0 109.633 175.249 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' E' E ' 124' ' ' LEU . . . . . . . . . . . . . 69.9 mt -130.09 137.72 50.33 Favored 'General case' 0 C--N 1.331 -0.197 0 CA-C-N 116.452 -0.34 . . . . 0.0 110.842 -178.772 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' E' E ' 125' ' ' VAL . . . . . . . . . . . . . 11.8 p -136.95 137.17 47.24 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.262 0 CA-C-N 116.385 -0.37 . . . . 0.0 110.651 179.669 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' E' E ' 126' ' ' ARG . . . . . . . . . . . . . 83.3 mtt180 -146.06 130.28 17.54 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.679 177.226 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' E' E ' 127' ' ' ASN . . . . . . . . . . . . . 36.3 t30 50.64 -112.22 0.59 Allowed 'General case' 0 CA--C 1.545 0.761 0 CA-C-O 118.64 -0.695 . . . . 0.0 111.46 178.751 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' E' E ' 128' ' ' ASP . . . . . . . . . . . . . 17.3 p-10 -112.59 8.16 19.07 Favored 'General case' 0 N--CA 1.468 0.435 0 CA-C-N 120.157 1.344 . . . . 0.0 113.317 -177.317 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' E' E ' 129' ' ' LEU . . . . . . . . . . . . . 15.5 tp -116.38 137.49 52.11 Favored 'General case' 0 C--N 1.333 -0.139 0 N-CA-C 109.745 -0.465 . . . . 0.0 109.745 178.89 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' E' E ' 130' ' ' VAL . . . . . . . . . . . . . 12.7 p -132.62 143.39 39.86 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.198 0 CA-C-O 121.143 0.497 . . . . 0.0 110.563 -179.556 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' E' E ' 131' ' ' VAL . . . . . . . . . . . . . 39.3 t -135.53 140.72 44.08 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.246 0 CA-C-N 115.969 -0.559 . . . . 0.0 110.383 -178.941 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' E' E ' 132' ' ' ILE . . . . . . . . . . . . . 70.3 mt -115.93 132.86 64.17 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.316 0 CA-C-N 115.752 -0.658 . . . . 0.0 109.355 179.292 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' E' E ' 133' ' ' ILE . . . . . . . . . . . . . 41.9 mm -116.24 124.15 72.18 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.238 0 CA-C-O 120.896 0.379 . . . . 0.0 111.064 -175.061 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' E' E ' 134' ' ' ASP . . . . . . . . . . . . . 7.8 p-10 -135.35 149.76 49.79 Favored 'General case' 0 C--N 1.331 -0.205 0 CA-C-N 116.075 -0.511 . . . . 0.0 109.677 174.574 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' E' E ' 135' ' ' GLU . . . . . . . . . . . . . 40.2 tp10 -50.76 -28.38 9.09 Favored 'General case' 0 C--N 1.327 -0.377 0 N-CA-C 112.709 0.633 . . . . 0.0 112.709 -173.088 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' E' E ' 136' ' ' GLN . . . . . . . . . . . . . 98.3 mt-30 -84.55 -29.82 25.58 Favored 'General case' 0 C--O 1.233 0.229 0 N-CA-C 112.882 0.697 . . . . 0.0 112.882 -175.432 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' E' E ' 137' ' ' LYS . . . . . . . . . . . . . 58.9 pttt -168.86 175.35 5.98 Favored 'General case' 0 C--N 1.332 -0.171 0 CA-C-O 121.609 0.719 . . . . 0.0 112.449 -172.879 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' E' E ' 138' ' ' LEU . . . . . . . . . . . . . 8.6 tt -121.62 129.42 52.81 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 114.997 -1.001 . . . . 0.0 109.958 178.475 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' E' E ' 139' ' ' THR . . . . . . . . . . . . . 43.7 m -109.1 128.22 54.82 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.188 179.316 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' E' E ' 140' ' ' LEU . . . . . . . . . . . . . 7.2 tt -112.81 125.25 54.14 Favored 'General case' 0 C--N 1.328 -0.35 0 N-CA-C 109.174 -0.676 . . . . 0.0 109.174 -178.828 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' E' E ' 141' ' ' ILE . . . . . . . . . . . . . 19.4 mt -123.57 119.29 56.86 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.277 0 CA-C-O 121.132 0.492 . . . . 0.0 110.09 -176.469 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' E' E ' 142' ' ' ARG . . . . . . . . . . . . . 77.6 ttt-85 -106.39 130.0 54.28 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 115.001 -1.0 . . . . 0.0 110.226 -179.882 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' E' E ' 143' ' ' THR . . . . . . . . . . . . . 44.6 p . . . . . 0 C--O 1.219 -0.514 0 CA-C-O 117.959 -1.02 . . . . 0.0 110.547 179.112 . . . . . . . . 0 0 . 1 . 005 nuclear orig core ' F' F ' 1' ' ' MET . . . . . . . . . . . . . 26.2 ptt? . . . . . 0 C--O 1.232 0.154 0 CA-C-O 120.841 0.353 . . . . 0.0 110.957 . . . . . . . . . 0 0 . 1 . 005 nuclear orig core ' F' F ' 2' ' ' SER . . . . . . . . . . . . . 14.3 p -130.8 135.33 47.65 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.083 -0.508 . . . . 0.0 110.082 178.419 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' F' F ' 3' ' ' GLU . . . . . . . . . . . . . 46.8 mp0 -139.45 141.15 37.45 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.146 -0.479 . . . . 0.0 111.321 -176.615 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' F' F ' 4' ' ' LEU . . . . . . . . . . . . . 57.6 mt -118.94 124.97 48.35 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 115.606 -0.725 . . . . 0.0 109.85 173.96 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' F' F ' 5' ' ' LYS . . . . . . . . . . . . . 98.3 mttt -102.36 119.81 39.44 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.459 -0.337 . . . . 0.0 110.144 177.646 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' F' F ' 6' ' ' LEU . . . . . . . . . . . . . 70.5 mt -119.45 144.32 47.03 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 115.416 -0.811 . . . . 0.0 110.421 -177.9 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' F' F ' 7' ' ' LYS . . . . . . . . . . . . . 47.4 tttm -134.64 142.78 43.86 Favored Pre-proline 0 CA--C 1.534 0.354 0 CA-C-O 119.2 -0.428 . . . . 0.0 110.142 177.331 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' F' F ' 8' ' ' PRO . . . . . . . . . . . . . 85.0 Cg_endo -92.16 143.35 2.63 Favored 'Trans proline' 0 N--CA 1.49 1.319 0 C-N-CA 121.749 1.633 . . . . 0.0 111.714 176.997 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' F' F ' 9' ' ' LEU . . . . . . . . . . . . . 62.0 mt -76.74 -47.02 3.04 Favored Pre-proline 0 CA--C 1.535 0.367 0 CA-C-O 118.691 -0.671 . . . . 0.0 112.041 179.735 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' F' F ' 10' ' ' PRO . . . . . . . . . . . . . 85.4 Cg_endo -81.71 150.2 16.5 Favored 'Trans proline' 0 N--CA 1.495 1.59 0 C-N-CA 121.185 1.257 . . . . 0.0 111.54 174.604 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' F' F ' 11' ' ' LYS . . . . . . . . . . . . . 54.0 pttt -86.95 113.12 22.45 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-O 121.552 0.692 . . . . 0.0 110.949 179.981 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' F' F ' 12' ' ' VAL . . . . . . . . . . . . . 13.3 p -151.09 148.34 14.99 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.194 0 CA-C-N 115.736 -0.666 . . . . 0.0 110.458 178.901 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' F' F ' 13' ' ' GLU . . . . . . . . . . . . . 45.3 mt-10 -88.0 124.19 33.48 Favored 'General case' 0 C--N 1.331 -0.224 0 CA-C-O 120.759 0.314 . . . . 0.0 110.595 177.836 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' F' F ' 14' ' ' LEU . . . . . . . . . . . . . 22.8 mt -99.77 154.61 37.16 Favored Pre-proline 0 CA--C 1.532 0.285 0 CA-C-N 116.276 -0.42 . . . . 0.0 111.012 -178.282 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' F' F ' 15' ' ' PRO . . . . . . . . . . . . . 27.7 Cg_exo -62.05 162.99 20.83 Favored 'Trans proline' 0 N--CA 1.498 1.736 0 C-N-CA 121.423 1.415 . . . . 0.0 111.963 176.07 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' F' F ' 16' ' ' PRO . . . . . . . . . . . . . 21.5 Cg_exo -64.61 -37.07 39.07 Favored 'Trans proline' 0 N--CA 1.497 1.705 0 C-N-CA 121.592 1.528 . . . . 0.0 112.724 -179.512 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' F' F ' 17' ' ' ASP . . . . . . . . . . . . . 12.7 p-10 -87.09 12.11 12.25 Favored 'General case' 0 CA--C 1.535 0.391 0 N-CA-C 113.142 0.793 . . . . 0.0 113.142 -177.149 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' F' F ' 18' ' ' PHE . . . . . . . . . . . . . 41.1 t80 -56.44 -41.85 77.15 Favored 'General case' 0 CA--C 1.526 0.047 0 O-C-N 121.939 -0.476 . . . . 0.0 110.375 -179.56 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' F' F ' 19' ' ' VAL . . . . . . . . . . . . . 44.3 t -55.98 -43.51 75.28 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.285 0 CA-C-N 116.399 -0.364 . . . . 0.0 110.579 -178.627 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' F' F ' 20' ' ' ASP . . . . . . . . . . . . . 29.8 t0 -59.88 -43.09 94.95 Favored 'General case' 0 C--N 1.33 -0.274 0 C-N-CA 120.915 -0.314 . . . . 0.0 110.784 -177.811 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' F' F ' 21' ' ' VAL . . . . . . . . . . . . . 45.4 t -63.33 -46.44 95.51 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.277 0 C-N-CA 120.63 -0.428 . . . . 0.0 110.437 -177.748 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' F' F ' 22' ' ' ILE . . . . . . . . . . . . . 51.4 mm -55.98 -47.11 80.54 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.275 0 C-N-CA 120.905 -0.318 . . . . 0.0 110.808 179.793 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' F' F ' 23' ' ' ARG . . . . . . . . . . . . . 55.4 ttp180 -55.02 -47.19 75.03 Favored 'General case' 0 C--N 1.331 -0.239 0 C-N-CA 120.932 -0.307 . . . . 0.0 111.303 -178.194 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' F' F ' 24' ' ' ILE . . . . . . . . . . . . . 75.5 mt -59.17 -42.58 87.23 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.268 0 C-N-CA 120.939 -0.304 . . . . 0.0 111.212 -177.672 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' F' F ' 25' ' ' LYS . . . . . . . . . . . . . 50.3 mttm -67.74 -39.57 84.23 Favored 'General case' 0 C--N 1.33 -0.266 0 N-CA-C 112.67 0.619 . . . . 0.0 112.67 -179.51 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' F' F ' 26' ' ' LEU . . . . . . . . . . . . . 95.8 mt -77.37 -39.85 45.96 Favored 'General case' 0 C--N 1.329 -0.307 0 N-CA-C 113.17 0.804 . . . . 0.0 113.17 -170.486 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' F' F ' 27' ' ' GLN . . . . . . . . . . . . . 10.4 pt20 -46.7 139.99 4.86 Favored 'General case' 0 N--CA 1.469 0.476 0 N-CA-C 112.785 0.661 . . . . 0.0 112.785 -174.501 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' F' F ' 28' ' ' GLY . . . . . . . . . . . . . . . 100.56 -29.29 12.67 Favored Glycine 0 CA--C 1.531 1.045 0 CA-C-N 115.592 -0.731 . . . . 0.0 112.016 -177.642 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' F' F ' 29' ' ' LYS . . . . . . . . . . . . . 72.8 mttt -97.92 155.08 17.25 Favored 'General case' 0 C--O 1.233 0.199 0 CA-C-N 117.203 0.501 . . . . 0.0 111.163 178.236 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' F' F ' 30' ' ' THR . . . . . . . . . . . . . 29.6 m -100.67 139.16 36.74 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 115.899 -0.591 . . . . 0.0 109.822 175.272 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' F' F ' 31' ' ' VAL . . . . . . . . . . . . . 35.0 m -122.08 149.55 25.45 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.259 0 CA-C-O 120.926 0.393 . . . . 0.0 110.823 -178.105 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' F' F ' 32' ' ' ARG . . . . . . . . . . . . . 39.1 ttp180 -132.95 147.86 52.28 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-N 115.669 -0.696 . . . . 0.0 110.314 177.582 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' F' F ' 33' ' ' THR . . . . . . . . . . . . . 27.4 m -53.61 137.34 37.16 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.418 -0.355 . . . . 0.0 111.281 -179.348 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' F' F ' 34' ' ' GLY . . . . . . . . . . . . . . . 101.76 -17.22 55.2 Favored Glycine 0 CA--C 1.532 1.108 0 CA-C-O 119.7 -0.5 . . . . 0.0 113.348 178.813 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' F' F ' 35' ' ' ASP . . . . . . . . . . . . . 78.8 m-20 -65.79 147.73 52.91 Favored 'General case' 0 N--CA 1.462 0.147 0 CA-C-N 118.015 0.907 . . . . 0.0 111.058 179.472 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' F' F ' 36' ' ' VAL . . . . . . . . . . . . . 44.3 t -122.97 129.62 74.99 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.267 0 CA-C-N 116.115 -0.493 . . . . 0.0 109.815 178.431 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' F' F ' 37' ' ' ILE . . . . . . . . . . . . . 68.0 mt -119.62 138.64 49.58 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.184 0 CA-C-N 116.123 -0.489 . . . . 0.0 109.846 -179.972 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' F' F ' 38' ' ' GLY . . . . . . . . . . . . . . . -110.58 128.65 8.9 Favored Glycine 0 CA--C 1.525 0.683 0 N-CA-C 111.19 -0.764 . . . . 0.0 111.19 -179.653 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' F' F ' 39' ' ' ILE . . . . . . . . . . . . . 72.5 mt -127.13 128.07 70.09 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.233 0 N-CA-C 109.922 -0.399 . . . . 0.0 109.922 178.537 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' F' F ' 40' ' ' SER . . . . . . . . . . . . . 30.8 t -92.42 121.19 33.65 Favored 'General case' 0 C--N 1.329 -0.305 0 C-N-CA 120.823 -0.351 . . . . 0.0 110.677 175.967 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' F' F ' 41' ' ' ILE . . . . . . . . . . . . . 71.1 mt -127.45 123.99 62.81 Favored 'Isoleucine or valine' 0 N--CA 1.462 0.159 0 CA-C-O 120.935 0.398 . . . . 0.0 110.582 -179.226 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' F' F ' 42' ' ' LEU . . . . . . . . . . . . . 7.0 tp 52.58 37.65 23.78 Favored 'General case' 0 C--N 1.331 -0.219 0 CA-C-N 116.062 -0.517 . . . . 0.0 111.671 175.661 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' F' F ' 43' ' ' GLY . . . . . . . . . . . . . . . 73.18 28.16 66.84 Favored Glycine 0 CA--C 1.53 1.025 0 C-N-CA 121.073 -0.584 . . . . 0.0 112.567 176.569 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' F' F ' 44' ' ' LYS . . . . . . . . . . . . . 62.8 tttm -140.59 126.38 19.28 Favored 'General case' 0 C--N 1.33 -0.272 0 N-CA-C 109.474 -0.565 . . . . 0.0 109.474 177.234 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' F' F ' 45' ' ' GLU . . . . . . . . . . . . . 34.7 tp10 -82.82 124.31 30.18 Favored 'General case' 0 C--N 1.328 -0.331 0 C-N-CA 120.718 -0.393 . . . . 0.0 110.836 -176.876 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' F' F ' 46' ' ' VAL . . . . . . . . . . . . . 7.6 p -120.8 129.45 75.64 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.204 0 N-CA-C 109.561 -0.533 . . . . 0.0 109.561 177.285 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' F' F ' 47' ' ' LYS . . . . . . . . . . . . . 61.3 mmtt -100.23 130.09 46.32 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 115.935 -0.575 . . . . 0.0 111.104 178.572 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' F' F ' 48' ' ' PHE . . . . . . . . . . . . . 94.2 m-85 -112.61 131.86 55.42 Favored 'General case' 0 C--N 1.331 -0.233 0 N-CA-C 109.638 -0.504 . . . . 0.0 109.638 175.795 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' F' F ' 49' ' ' LYS . . . . . . . . . . . . . 48.9 tttp -108.7 136.71 47.83 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.314 -0.403 . . . . 0.0 110.612 179.936 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' F' F ' 50' ' ' VAL . . . . . . . . . . . . . 46.8 t -78.92 106.46 9.92 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.333 0 N-CA-C 108.91 -0.774 . . . . 0.0 108.91 175.155 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' F' F ' 51' ' ' VAL . . . . . . . . . . . . . 47.3 t -74.81 -47.43 37.8 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.327 0 CA-C-N 116.075 -0.511 . . . . 0.0 110.139 -172.957 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' F' F ' 52' ' ' GLN . . . . . . . . . . . . . 57.5 tt0 -160.72 137.84 9.1 Favored 'General case' 0 C--N 1.33 -0.281 0 C-N-CA 120.465 -0.494 . . . . 0.0 111.351 -177.466 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' F' F ' 53' ' ' ALA . . . . . . . . . . . . . . . -114.75 131.79 56.66 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 115.964 -0.562 . . . . 0.0 109.983 174.494 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' F' F ' 54' ' ' TYR . . . . . . . . . . . . . 33.7 t80 -129.01 109.16 18.2 Favored Pre-proline 0 C--N 1.328 -0.334 0 CA-C-O 118.302 -0.856 . . . . 0.0 110.492 179.271 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' F' F ' 55' ' ' PRO . . . . . . . . . . . . . 74.0 Cg_endo -77.14 168.51 76.76 Favored 'Cis proline' 0 N--CA 1.499 1.841 0 CA-C-N 121.951 1.733 . . . . 0.0 112.292 -5.819 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' F' F ' 56' ' ' SER . . . . . . . . . . . . . 69.2 m -117.5 134.78 23.12 Favored Pre-proline 0 CA--C 1.539 0.524 0 CA-C-O 118.466 -0.778 . . . . 0.0 109.704 175.126 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' F' F ' 57' ' ' PRO . . . . . . . . . . . . . 57.6 Cg_endo -73.14 162.82 90.92 Favored 'Cis proline' 0 N--CA 1.496 1.619 0 CA-C-N 121.806 1.681 . . . . 0.0 111.375 -3.501 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' F' F ' 58' ' ' LEU . . . . . . . . . . . . . 33.6 tp -130.0 137.84 50.5 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-O 120.851 0.357 . . . . 0.0 110.793 -178.658 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' F' F ' 59' ' ' ARG . . . . . . . . . . . . . 32.2 ttp180 -99.65 127.52 45.76 Favored 'General case' 0 C--N 1.327 -0.374 0 N-CA-C 109.335 -0.617 . . . . 0.0 109.335 175.459 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' F' F ' 60' ' ' VAL . . . . . . . . . . . . . 41.2 t -80.96 123.15 37.27 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.266 0 C-N-CA 120.598 -0.441 . . . . 0.0 110.506 -175.073 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' F' F ' 61' ' ' GLU . . . . . . . . . . . . . 42.9 mt-10 -131.13 171.38 13.34 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 115.608 -0.724 . . . . 0.0 109.674 176.483 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' F' F ' 62' ' ' ASP . . . . . . . . . . . . . 83.8 m-20 -54.27 -32.59 56.58 Favored 'General case' 0 C--N 1.329 -0.308 0 C-N-CA 120.968 -0.293 . . . . 0.0 111.752 -179.279 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' F' F ' 63' ' ' ARG . . . . . . . . . . . . . 25.0 ptt180 -83.9 2.25 39.46 Favored 'General case' 0 CA--C 1.537 0.455 0 N-CA-C 113.727 1.01 . . . . 0.0 113.727 -175.263 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' F' F ' 64' ' ' THR . . . . . . . . . . . . . 28.4 m -78.44 136.8 37.71 Favored 'General case' 0 C--N 1.333 -0.133 0 CA-C-N 118.119 0.418 . . . . 0.0 110.705 -177.621 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' F' F ' 65' ' ' LYS . . . . . . . . . . . . . 24.6 mtpp -90.35 127.04 36.07 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.037 -0.529 . . . . 0.0 110.218 179.275 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' F' F ' 66' ' ' ILE . . . . . . . . . . . . . 4.3 mp -113.87 131.47 65.65 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.262 0 N-CA-C 110.012 -0.366 . . . . 0.0 110.012 179.628 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' F' F ' 67' ' ' THR . . . . . . . . . . . . . 20.9 m -122.19 132.62 54.54 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-O 121.069 0.462 . . . . 0.0 110.331 178.525 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' F' F ' 68' ' ' LEU . . . . . . . . . . . . . 6.2 tt . . . . . 0 C--N 1.328 -0.337 0 CA-C-N 115.825 -0.625 . . . . 0.0 110.002 -179.982 . . . . . . . . 0 0 . 1 . 005 nuclear orig core ' F' F ' 73' ' ' VAL . . . . . . . . . . . . . 34.8 m . . . . . 0 N--CA 1.46 0.045 0 CA-C-O 121.109 0.481 . . . . 0.0 111.154 . . . . . . . . . 0 0 . 1 . 005 nuclear orig core ' F' F ' 74' ' ' ASP . . . . . . . . . . . . . 12.8 t70 -101.82 123.72 46.24 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 115.542 -0.754 . . . . 0.0 109.594 177.464 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' F' F ' 75' ' ' VAL . . . . . . . . . . . . . 45.1 t -111.86 123.92 68.1 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.253 0 CA-C-O 121.145 0.498 . . . . 0.0 110.527 -178.105 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' F' F ' 76' ' ' LEU . . . . . . . . . . . . . 29.1 mt -123.86 142.23 51.31 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 115.533 -0.758 . . . . 0.0 109.418 177.661 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' F' F ' 77' ' ' GLU . . . . . . . . . . . . . 97.8 mt-10 -133.92 137.98 45.24 Favored 'General case' 0 C--N 1.331 -0.227 0 CA-C-O 121.018 0.437 . . . . 0.0 111.312 -178.145 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' F' F ' 78' ' ' ALA . . . . . . . . . . . . . . . -128.11 136.36 51.06 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 115.718 -0.673 . . . . 0.0 109.722 176.35 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' F' F ' 79' ' ' LYS . . . . . . . . . . . . . 19.8 pttp -79.46 123.76 27.83 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-O 121.187 0.518 . . . . 0.0 111.142 -177.893 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' F' F ' 80' ' ' ILE . . . . . . . . . . . . . 40.6 mm -139.21 112.73 6.57 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.279 0 CA-C-N 115.725 -0.671 . . . . 0.0 109.278 -178.199 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' F' F ' 81' ' ' LYS . . . . . . . . . . . . . 47.0 tptt -102.1 123.43 45.96 Favored 'General case' 0 C--N 1.329 -0.287 0 C-N-CA 120.921 -0.312 . . . . 0.0 111.072 -177.474 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' F' F ' 82' ' ' GLY . . . . . . . . . . . . . . . 89.07 42.15 5.69 Favored Glycine 0 CA--C 1.525 0.657 0 C-N-CA 120.722 -0.752 . . . . 0.0 111.954 173.551 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' F' F ' 83' ' ' ILE . . . . . . . . . . . . . 72.4 mt -64.04 137.47 24.75 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.29 0 N-CA-C 109.915 -0.402 . . . . 0.0 109.915 178.139 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' F' F ' 84' ' ' LYS . . . . . . . . . . . . . 82.2 tttt -99.43 -53.8 3.12 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 115.999 -0.546 . . . . 0.0 110.42 -178.975 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' F' F ' 85' ' ' ASP . . . . . . . . . . . . . 8.6 t0 -154.96 153.01 30.39 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 115.748 -0.66 . . . . 0.0 109.972 -179.706 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' F' F ' 86' ' ' VAL . . . . . . . . . . . . . 43.2 t -128.85 131.59 68.22 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.24 0 CA-C-O 120.9 0.381 . . . . 0.0 110.767 -178.016 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' F' F ' 87' ' ' ILE . . . . . . . . . . . . . 42.4 mm -118.22 124.26 72.84 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.245 0 CA-C-N 115.782 -0.644 . . . . 0.0 109.503 175.164 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' F' F ' 88' ' ' LEU . . . . . . . . . . . . . 14.8 tp -112.96 131.9 55.56 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-O 120.938 0.399 . . . . 0.0 111.36 -176.185 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' F' F ' 89' ' ' ASP . . . . . . . . . . . . . 13.5 t70 -131.08 151.52 51.35 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 115.861 -0.609 . . . . 0.0 109.442 175.932 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' F' F ' 90' ' ' GLU . . . . . . . . . . . . . 46.6 tp10 -48.96 -35.05 14.19 Favored 'General case' 0 C--N 1.329 -0.32 0 N-CA-C 112.712 0.634 . . . . 0.0 112.712 -172.49 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' F' F ' 91' ' ' ASN . . . . . . . . . . . . . 12.7 p30 -123.36 14.58 9.64 Favored 'General case' 0 N--CA 1.47 0.534 0 N-CA-C 113.452 0.908 . . . . 0.0 113.452 -175.883 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' F' F ' 92' ' ' LEU . . . . . . . . . . . . . 8.1 mt -151.66 143.17 23.53 Favored 'General case' 0 C--N 1.332 -0.171 0 N-CA-C 109.797 -0.446 . . . . 0.0 109.797 -177.101 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' F' F ' 93' ' ' ILE . . . . . . . . . . . . . 71.0 mt -127.26 117.13 46.39 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.346 0 N-CA-C 108.892 -0.781 . . . . 0.0 108.892 176.186 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' F' F ' 94' ' ' VAL . . . . . . . . . . . . . 48.4 t -121.71 128.11 75.67 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.257 0 CA-C-O 121.147 0.498 . . . . 0.0 110.189 -178.174 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' F' F ' 95' ' ' VAL . . . . . . . . . . . . . 45.2 t -120.78 135.08 62.12 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.358 0 CA-C-N 115.524 -0.762 . . . . 0.0 109.644 -179.168 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' F' F ' 96' ' ' ILE . . . . . . . . . . . . . 62.0 mt -111.66 129.03 67.8 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.358 0 N-CA-C 108.789 -0.819 . . . . 0.0 108.789 178.137 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' F' F ' 97' ' ' THR . . . . . . . . . . . . . 58.1 p -103.93 157.08 17.34 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-O 121.335 0.588 . . . . 0.0 111.235 -176.77 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' F' F ' 98' ' ' GLU . . . . . . . . . . . . . 85.4 tt0 -53.93 -24.03 14.97 Favored 'General case' 0 CA--C 1.534 0.36 0 CA-C-N 115.866 -0.606 . . . . 0.0 112.314 179.581 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' F' F ' 99' ' ' GLU . . . . . . . . . . . . . 41.3 tt0 -79.74 16.69 1.06 Allowed 'General case' 0 CA--C 1.54 0.561 0 N-CA-C 112.401 0.519 . . . . 0.0 112.401 -178.354 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' F' F ' 100' ' ' ASN . . . . . . . . . . . . . 2.2 m-20 60.05 37.39 21.14 Favored 'General case' 0 CA--C 1.53 0.209 0 O-C-N 121.675 -0.64 . . . . 0.0 110.818 178.367 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' F' F ' 101' ' ' GLU . . . . . . . . . . . . . 85.1 tt0 -117.1 145.38 43.81 Favored 'General case' 0 C--N 1.332 -0.186 0 CA-C-N 116.018 -0.537 . . . . 0.0 109.876 178.075 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' F' F ' 102' ' ' VAL . . . . . . . . . . . . . 46.2 t -115.51 124.79 72.36 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.372 0 N-CA-C 109.776 -0.453 . . . . 0.0 109.776 -178.83 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' F' F ' 103' ' ' LEU . . . . . . . . . . . . . 56.3 mt -114.47 129.92 56.69 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 115.83 -0.623 . . . . 0.0 110.016 176.961 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' F' F ' 104' ' ' ILE . . . . . 0.418 HD12 HG22 ' F' ' 104' ' ' ILE . 68.9 mt -117.93 118.43 58.25 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.27 0 N-CA-C 109.909 -0.404 . . . . 0.0 109.909 -179.811 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' F' F ' 105' ' ' PHE . . . . . . . . . . . . . 36.0 m-85 -119.36 164.18 16.08 Favored 'General case' 0 C--N 1.332 -0.163 0 O-C-N 123.898 0.749 . . . . 0.0 109.647 179.715 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' F' F ' 106' ' ' ASN . . . . . . . . . . . . . 44.3 p-10 -100.03 -170.65 1.91 Allowed 'General case' 0 C--N 1.33 -0.259 0 N-CA-C 109.808 -0.441 . . . . 0.0 109.808 173.575 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' F' F ' 107' ' ' GLN . . . . . . . . . . . . . 27.7 tt0 -59.75 -29.88 68.47 Favored 'General case' 0 C--N 1.329 -0.29 0 N-CA-C 111.944 0.35 . . . . 0.0 111.944 179.201 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' F' F ' 108' ' ' ASN . . . . . . . . . . . . . 16.6 t-20 -81.88 6.92 14.28 Favored 'General case' 0 CA--C 1.537 0.445 0 N-CA-C 113.232 0.827 . . . . 0.0 113.232 -177.948 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' F' F ' 109' ' ' LEU . . . . . . . . . . . . . 11.1 tp 62.4 36.68 14.18 Favored 'General case' 0 C--O 1.233 0.186 0 O-C-N 122.054 -0.404 . . . . 0.0 111.436 177.248 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' F' F ' 110' ' ' GLU . . . . . . . . . . . . . 70.9 mm-40 -109.58 156.96 19.53 Favored 'General case' 0 C--N 1.331 -0.237 0 N-CA-C 110.107 -0.331 . . . . 0.0 110.107 177.127 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' F' F ' 111' ' ' GLU . . . . . . . . . . . . . 46.4 mp0 -83.69 122.03 28.07 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-O 120.941 0.401 . . . . 0.0 111.053 -178.501 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' F' F ' 112' ' ' LEU . . . . . . . . . . . . . 29.5 mt -104.87 -45.97 4.42 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 115.987 -0.552 . . . . 0.0 109.941 175.117 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' F' F ' 113' ' ' TYR . . . . . . . . . . . . . 64.5 t80 -138.6 137.42 36.93 Favored 'General case' 0 C--N 1.33 -0.239 0 CA-C-N 115.988 -0.551 . . . . 0.0 110.842 -179.7 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' F' F ' 114' ' ' ARG . . . . . . . . . . . . . 83.4 mtm180 -139.61 122.66 16.77 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.448 -0.342 . . . . 0.0 110.315 176.254 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' F' F ' 115' ' ' GLY . . . . . . . . . . . . . . . -150.05 163.0 29.36 Favored Glycine 0 CA--C 1.526 0.722 0 N-CA-C 111.211 -0.756 . . . . 0.0 111.211 -179.937 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' F' F ' 116' ' ' LYS . . . . . . . . . . . . . 8.0 ttpm? -127.47 139.76 52.6 Favored 'General case' 0 C--N 1.33 -0.248 0 N-CA-C 110.074 -0.343 . . . . 0.0 110.074 178.368 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' F' F ' 117' ' ' PHE . . . . . . . . . . . . . 51.8 m-85 -136.44 113.96 10.95 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 116.397 -0.365 . . . . 0.0 110.054 -178.679 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' F' F ' 118' ' ' GLU . . . . . . . . . . . . . 96.1 mt-10 -55.1 -42.9 73.5 Favored 'General case' 0 C--N 1.33 -0.268 0 C-N-CA 121.0 -0.28 . . . . 0.0 111.13 -176.35 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' F' F ' 119' ' ' ASN . . . . . . . . . . . . . 2.4 m120 -97.97 31.0 2.83 Favored 'General case' 0 C--N 1.33 -0.258 0 N-CA-C 112.096 0.406 . . . . 0.0 112.096 -175.107 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' F' F ' 120' ' ' LEU . . . . . . . . . . . . . 14.8 tp -57.6 119.99 7.54 Favored 'General case' 0 C--N 1.333 -0.139 0 N-CA-C 110.264 -0.273 . . . . 0.0 110.264 178.166 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' F' F ' 121' ' ' ASN . . . . . . . . . . . . . 26.5 m120 -114.0 -43.95 3.2 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-N 116.487 -0.324 . . . . 0.0 110.832 -178.376 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' F' F ' 122' ' ' LYS . . . . . . . . . . . . . 38.3 ttpt -144.76 141.5 29.27 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-O 120.87 0.367 . . . . 0.0 111.28 -176.773 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' F' F ' 123' ' ' VAL . . . . . . . . . . . . . 46.1 t -126.69 127.19 69.9 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.315 0 N-CA-C 109.21 -0.663 . . . . 0.0 109.21 173.255 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' F' F ' 124' ' ' LEU . . . . . . . . . . . . . 16.2 tp -129.08 137.67 51.4 Favored 'General case' 0 C--N 1.331 -0.225 0 CA-C-O 121.034 0.445 . . . . 0.0 111.013 -176.344 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' F' F ' 125' ' ' VAL . . . . . . . . . . . . . 42.3 t -125.14 131.26 72.67 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.259 0 CA-C-N 115.844 -0.616 . . . . 0.0 109.624 177.864 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' F' F ' 126' ' ' ARG . . . . . . . . . . . . . 57.9 ttt180 -147.45 126.79 13.08 Favored 'General case' 0 C--N 1.329 -0.284 0 N-CA-C 109.46 -0.571 . . . . 0.0 109.46 178.858 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' F' F ' 127' ' ' ASN . . . . . . . . . . . . . 79.7 m-20 56.49 -147.13 0.53 Allowed 'General case' 0 CA--C 1.541 0.61 0 N-CA-C 109.682 -0.488 . . . . 0.0 109.682 -178.033 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' F' F ' 128' ' ' ASP . . . . . . . . . . . . . 24.1 p-10 -87.91 18.15 4.38 Favored 'General case' 0 CA--C 1.537 0.46 0 CA-C-N 118.901 0.773 . . . . 0.0 112.605 178.639 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' F' F ' 129' ' ' LEU . . . . . . . . . . . . . 15.6 tp -113.63 137.35 51.71 Favored 'General case' 0 N--CA 1.461 0.116 0 CA-C-N 117.99 0.359 . . . . 0.0 110.315 178.65 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' F' F ' 130' ' ' VAL . . . . . . . . . . . . . 46.1 t -121.89 135.9 60.53 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.215 0 CA-C-N 116.086 -0.506 . . . . 0.0 109.732 -179.963 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' F' F ' 131' ' ' VAL . . . . . . . . . . . . . 41.4 t -134.8 136.35 52.28 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.264 0 CA-C-O 121.104 0.478 . . . . 0.0 110.697 -179.454 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' F' F ' 132' ' ' ILE . . . . . . . . . . . . . 72.2 mt -116.62 132.93 64.84 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.234 0 CA-C-N 115.667 -0.697 . . . . 0.0 109.49 178.598 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' F' F ' 133' ' ' ILE . . . . . . . . . . . . . 42.7 mm -116.83 122.01 69.02 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.242 0 CA-C-O 120.764 0.316 . . . . 0.0 110.802 -176.629 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' F' F ' 134' ' ' ASP . . . . . . . . . . . . . 7.8 p-10 -133.42 146.23 51.0 Favored 'General case' 0 C--N 1.329 -0.29 0 N-CA-C 109.297 -0.631 . . . . 0.0 109.297 174.338 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' F' F ' 135' ' ' GLU . . . . . . . . . . . . . 84.6 tt0 -50.07 -27.79 6.15 Favored 'General case' 0 C--N 1.328 -0.333 0 N-CA-C 112.645 0.609 . . . . 0.0 112.645 -174.212 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' F' F ' 136' ' ' GLN . . . . . . . . . . . . . 95.7 mt-30 -79.09 -34.65 43.39 Favored 'General case' 0 C--O 1.232 0.174 0 N-CA-C 112.35 0.5 . . . . 0.0 112.35 -176.847 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' F' F ' 137' ' ' LYS . . . . . . . . . . . . . 49.8 pttt -170.06 176.2 4.75 Favored 'General case' 0 C--N 1.331 -0.227 0 CA-C-O 121.489 0.661 . . . . 0.0 112.577 -173.143 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' F' F ' 138' ' ' LEU . . . . . . . . . . . . . 6.7 tt -119.36 130.99 55.63 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 115.107 -0.951 . . . . 0.0 110.111 179.875 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' F' F ' 139' ' ' THR . . . . . . . . . . . . . 39.7 m -111.42 129.67 55.95 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.198 -0.455 . . . . 0.0 110.359 179.412 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' F' F ' 140' ' ' LEU . . . . . . . . . . . . . 8.5 tt -113.73 125.42 54.1 Favored 'General case' 0 C--N 1.328 -0.365 0 N-CA-C 109.515 -0.55 . . . . 0.0 109.515 -178.867 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' F' F ' 141' ' ' ILE . . . . . . . . . . . . . 19.0 mt -124.55 125.91 70.91 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.371 0 N-CA-C 109.873 -0.417 . . . . 0.0 109.873 -175.64 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' F' F ' 142' ' ' ARG . . . . . . . . . . . . . 23.4 tpt180 -120.37 135.42 55.03 Favored 'General case' 0 C--N 1.332 -0.193 0 CA-C-N 115.973 -0.558 . . . . 0.0 109.936 -178.458 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' F' F ' 143' ' ' THR . . . . . . . . . . . . . 23.9 p . . . . . 0 C--O 1.22 -0.49 0 CA-C-O 118.025 -0.988 . . . . 0.0 110.485 179.776 . . . . . . . . 0 0 . 1 . 006 nuclear orig core ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 2.9 p . . . . . 0 C--O 1.232 0.148 0 CA-C-O 120.941 0.401 . . . . 0.0 110.677 . . . . . . . . . 0 0 . 1 . 006 nuclear orig core ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 85.4 tt0 -139.71 139.97 36.7 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.092 -0.503 . . . . 0.0 110.909 -179.333 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 4' ' ' LEU . . . . . . . . . . . . . 22.1 tp -121.74 125.7 47.18 Favored 'General case' 0 C--N 1.332 -0.185 0 CA-C-N 115.781 -0.645 . . . . 0.0 110.065 178.256 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 5' ' ' LYS . . . . . . . . . . . . . 64.7 mttp -101.73 121.24 41.7 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.437 -0.347 . . . . 0.0 110.656 178.923 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 85.8 mt -116.34 145.96 42.8 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 115.622 -0.717 . . . . 0.0 110.574 -179.76 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 82.6 tttt -139.34 135.31 17.05 Favored Pre-proline 0 CA--C 1.533 0.326 0 CA-C-O 118.905 -0.569 . . . . 0.0 109.723 177.01 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 8' ' ' PRO . . . . . . . . . . . . . 96.1 Cg_endo -89.49 142.87 4.35 Favored 'Trans proline' 0 N--CA 1.491 1.333 0 C-N-CA 121.621 1.547 . . . . 0.0 111.728 177.954 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 46.3 mt -77.07 -46.44 2.77 Favored Pre-proline 0 C--N 1.329 -0.317 0 CA-C-O 118.889 -0.577 . . . . 0.0 111.644 -179.374 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 94.8 Cg_endo -82.67 144.87 12.71 Favored 'Trans proline' 0 N--CA 1.493 1.497 0 C-N-CA 121.174 1.249 . . . . 0.0 111.361 172.159 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 64.4 mttp -86.58 100.63 12.55 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-O 121.037 0.446 . . . . 0.0 110.596 178.967 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 11.6 p -137.52 145.36 29.42 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.26 0 CA-C-N 115.762 -0.654 . . . . 0.0 110.022 179.765 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 84.1 tt0 -82.13 116.42 21.69 Favored 'General case' 0 C--N 1.329 -0.299 0 N-CA-C 109.973 -0.38 . . . . 0.0 109.973 178.938 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 14' ' ' LEU . . . . . . . . . . . . . 17.9 mt -92.82 153.18 42.12 Favored Pre-proline 0 C--N 1.33 -0.25 0 CA-C-N 116.224 -0.443 . . . . 0.0 110.864 -176.387 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 15' ' ' PRO . . . . . . . . . . . . . 31.1 Cg_exo -60.22 156.58 39.46 Favored 'Trans proline' 0 N--CA 1.495 1.578 0 C-N-CA 121.314 1.343 . . . . 0.0 111.876 177.744 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 16' ' ' PRO . . . . . . . . . . . . . 38.0 Cg_exo -58.02 -38.07 93.38 Favored 'Trans proline' 0 N--CA 1.497 1.714 0 C-N-CA 121.441 1.427 . . . . 0.0 112.777 -177.681 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 17' ' ' ASP . . . . . . . . . . . . . 18.7 p-10 -89.72 10.51 23.08 Favored 'General case' 0 CA--C 1.535 0.393 0 N-CA-C 113.313 0.857 . . . . 0.0 113.313 -176.482 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 18' ' ' PHE . . . . . . . . . . . . . 44.1 t80 -58.09 -44.58 87.68 Favored 'General case' 0 C--N 1.334 -0.068 0 O-C-N 122.047 -0.408 . . . . 0.0 110.121 -177.624 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 19' ' ' VAL . . . . . . . . . . . . . 47.2 t -57.96 -44.6 87.13 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.318 0 CA-C-N 116.251 -0.431 . . . . 0.0 110.4 -178.647 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 14.7 t70 -59.52 -40.23 86.46 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-O 120.829 0.347 . . . . 0.0 110.75 -177.462 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 47.2 t -64.53 -48.61 84.27 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.304 0 CA-C-N 116.382 -0.372 . . . . 0.0 110.251 -178.514 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 22' ' ' ILE . . . . . . . . . . . . . 51.5 mm -55.18 -42.26 64.69 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.242 0 CA-C-O 120.833 0.349 . . . . 0.0 110.605 179.441 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 23' ' ' ARG . . . . . . . . . . . . . 54.5 ttp180 -53.89 -53.58 50.6 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.464 -0.335 . . . . 0.0 111.49 179.577 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 24' ' ' ILE . . . . . . . . . . . . . 71.9 mt -61.24 -38.76 80.52 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.335 0 CA-C-N 116.56 -0.291 . . . . 0.0 111.508 -177.18 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 59.9 mmtt -65.88 -40.94 92.07 Favored 'General case' 0 C--N 1.329 -0.311 0 N-CA-C 112.104 0.409 . . . . 0.0 112.104 179.884 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 75.7 mt -78.41 -38.18 42.15 Favored 'General case' 0 C--N 1.33 -0.266 0 N-CA-C 113.312 0.856 . . . . 0.0 113.312 -171.205 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 27' ' ' GLN . . . . . . . . . . . . . 9.4 pt20 -46.99 140.22 5.01 Favored 'General case' 0 N--CA 1.47 0.552 0 N-CA-C 112.732 0.641 . . . . 0.0 112.732 -175.541 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 98.22 -26.08 25.09 Favored Glycine 0 CA--C 1.533 1.18 0 CA-C-N 115.58 -0.737 . . . . 0.0 112.242 -176.194 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 58.6 mtpt -98.07 155.12 17.28 Favored 'General case' 0 C--O 1.232 0.177 0 CA-C-N 117.117 0.458 . . . . 0.0 110.764 179.358 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 30' ' ' THR . . . . . . . . . . . . . 25.9 m -103.3 138.35 40.2 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.293 -0.412 . . . . 0.0 110.021 176.63 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 34.3 m -129.19 150.9 35.06 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.215 0 CA-C-O 121.066 0.46 . . . . 0.0 111.145 -178.179 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 32' ' ' ARG . . . . . . . . . . . . . 83.7 mtt180 -132.64 152.85 51.55 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 115.589 -0.732 . . . . 0.0 110.168 177.492 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 33' ' ' THR . . . . . . . . . . . . . 20.9 m -53.35 137.23 35.73 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.3 -0.409 . . . . 0.0 111.359 -177.685 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 102.06 -16.94 55.21 Favored Glycine 0 CA--C 1.532 1.122 0 CA-C-O 119.655 -0.525 . . . . 0.0 113.386 177.619 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 72.3 m-20 -64.26 148.31 50.48 Favored 'General case' 0 N--CA 1.461 0.112 0 CA-C-N 118.125 0.963 . . . . 0.0 110.987 179.494 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 44.7 t -125.83 133.23 69.54 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.19 0 CA-C-N 116.017 -0.538 . . . . 0.0 110.001 179.52 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 37' ' ' ILE . . . . . . . . . . . . . 68.6 mt -122.43 140.18 47.07 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.255 0 CA-C-N 116.081 -0.509 . . . . 0.0 109.981 179.849 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . -113.17 128.91 8.61 Favored Glycine 0 CA--C 1.527 0.815 0 N-CA-C 110.978 -0.849 . . . . 0.0 110.978 179.485 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 39' ' ' ILE . . . . . . . . . . . . . 71.9 mt -122.97 130.14 74.65 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.2 0 N-CA-C 110.091 -0.337 . . . . 0.0 110.091 179.793 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 40' ' ' SER . . . . . . . . . . . . . 35.8 t -94.58 124.79 38.82 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.483 -0.326 . . . . 0.0 111.007 175.377 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 41' ' ' ILE . . . . . . . . . . . . . 71.9 mt -133.42 123.79 47.34 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.247 0 CA-C-O 120.907 0.384 . . . . 0.0 110.567 177.183 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 10.9 tp 52.51 35.93 19.06 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 115.994 -0.548 . . . . 0.0 111.695 177.319 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . 73.23 28.38 66.31 Favored Glycine 0 CA--C 1.53 1.007 0 C-N-CA 121.169 -0.539 . . . . 0.0 112.46 176.6 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 44' ' ' LYS . . . . . . . . . . . . . 94.5 mttt -134.9 129.98 35.19 Favored 'General case' 0 C--N 1.332 -0.189 0 CA-C-N 117.044 0.422 . . . . 0.0 110.01 177.268 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 68.0 tt0 -86.96 125.78 34.29 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 116.067 -0.515 . . . . 0.0 111.371 -175.8 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 46' ' ' VAL . . . . . . . . . . . . . 7.1 p -125.17 129.77 73.16 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.19 0 CA-C-O 120.926 0.393 . . . . 0.0 110.02 175.744 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 56.5 mmtt -100.53 130.91 46.66 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 115.865 -0.607 . . . . 0.0 111.768 177.896 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 48' ' ' PHE . . . . . . . . . . . . . 93.8 m-85 -113.86 131.89 56.1 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.071 -0.513 . . . . 0.0 109.929 175.022 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 83.1 tttt -106.62 137.76 44.03 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.382 -0.372 . . . . 0.0 110.492 179.357 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 50' ' ' VAL . . . . . . . . . . . . . 44.5 t -81.3 105.98 11.86 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.297 0 N-CA-C 108.991 -0.744 . . . . 0.0 108.991 174.735 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 51' ' ' VAL . . . . . . . . . . . . . 45.6 t -69.54 -48.13 67.95 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.349 0 CA-C-N 116.05 -0.523 . . . . 0.0 110.016 -173.075 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 52' ' ' GLN . . . . . . . . . . . . . 48.0 tt0 -167.89 139.9 3.04 Favored 'General case' 0 C--N 1.328 -0.348 0 C-N-CA 120.362 -0.535 . . . . 0.0 111.651 -177.816 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -110.47 131.93 54.62 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 115.839 -0.619 . . . . 0.0 109.882 174.776 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 54' ' ' TYR . . . . . . . . . . . . . 40.7 t80 -129.07 110.66 18.28 Favored Pre-proline 0 CA--C 1.535 0.381 0 CA-C-O 118.292 -0.861 . . . . 0.0 110.546 179.769 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 55' ' ' PRO . . . . . . . . . . . . . 71.7 Cg_endo -77.22 166.96 80.91 Favored 'Cis proline' 0 N--CA 1.5 1.866 0 CA-C-N 121.874 1.705 . . . . 0.0 111.978 -7.102 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 56' ' ' SER . . . . . . . . . . . . . 51.3 m -118.02 141.97 30.18 Favored Pre-proline 0 CA--C 1.538 0.519 0 CA-C-O 118.699 -0.667 . . . . 0.0 109.596 174.132 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 57' ' ' PRO . . . . . . . . . . . . . 43.9 Cg_endo -68.96 142.87 70.55 Favored 'Cis proline' 0 N--CA 1.499 1.807 0 CA-C-N 121.484 1.566 . . . . 0.0 111.205 -3.006 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 58' ' ' LEU . . . . . . . . . . . . . 29.7 tp -107.75 136.05 48.14 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-O 120.729 0.3 . . . . 0.0 110.877 -177.849 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 59' ' ' ARG . . . . . . . . . . . . . 66.5 ttt180 -101.79 122.2 43.51 Favored 'General case' 0 C--N 1.326 -0.426 0 N-CA-C 109.099 -0.704 . . . . 0.0 109.099 175.919 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 43.9 t -76.18 120.88 27.03 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.263 0 C-N-CA 120.68 -0.408 . . . . 0.0 110.639 -173.964 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 43.7 mt-10 -131.04 165.38 23.34 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 115.954 -0.566 . . . . 0.0 109.838 175.181 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 62' ' ' ASP . . . . . . . . . . . . . 9.5 p-10 -55.51 -32.55 62.97 Favored 'General case' 0 C--N 1.329 -0.311 0 N-CA-C 111.89 0.33 . . . . 0.0 111.89 -177.289 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 63' ' ' ARG . . . . . . . . . . . . . 24.3 ptt180 -79.76 -4.4 51.79 Favored 'General case' 0 CA--C 1.536 0.441 0 N-CA-C 113.753 1.02 . . . . 0.0 113.753 -174.945 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 24.6 m -75.08 136.07 41.18 Favored 'General case' 0 C--N 1.333 -0.118 0 CA-C-N 118.118 0.417 . . . . 0.0 110.453 -177.943 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 65' ' ' LYS . . . . . . . . . . . . . 3.0 mptp? -88.35 128.12 35.5 Favored 'General case' 0 C--N 1.328 -0.329 0 N-CA-C 109.689 -0.486 . . . . 0.0 109.689 -179.86 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 66' ' ' ILE . . . . . 0.409 HG22 HD13 ' A' ' 66' ' ' ILE . 59.2 mt -112.03 131.96 62.01 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.244 0 N-CA-C 109.807 -0.442 . . . . 0.0 109.807 -179.223 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 67' ' ' THR . . . . . . . . . . . . . 27.5 m -123.95 137.15 54.66 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.138 -0.483 . . . . 0.0 110.744 -179.142 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 68' ' ' LEU . . . . . . . . . . . . . 3.6 tt . . . . . 0 C--N 1.329 -0.302 0 N-CA-C 109.37 -0.604 . . . . 0.0 109.37 178.072 . . . . . . . . 0 0 . 1 . 006 nuclear orig core ' A' A ' 74' ' ' ASP . . . . . . . . . . . . . 40.5 t0 . . . . . 0 N--CA 1.46 0.036 0 N-CA-C 110.11 -0.33 . . . . 0.0 110.11 . . . . . . . . . 0 0 . 1 . 006 nuclear orig core ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 44.8 t -112.52 121.64 65.24 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.211 0 CA-C-O 121.081 0.467 . . . . 0.0 110.259 179.961 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 76' ' ' LEU . . . . . . . . . . . . . 35.1 mt -125.42 140.59 52.66 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 115.571 -0.74 . . . . 0.0 109.539 179.381 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 77' ' ' GLU . . . . . . . . . . . . . 96.8 mt-10 -133.94 143.96 48.52 Favored 'General case' 0 C--N 1.332 -0.185 0 CA-C-O 121.153 0.501 . . . . 0.0 111.622 -177.166 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 78' ' ' ALA . . . . . . . . . . . . . . . -130.62 133.64 46.32 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 115.435 -0.802 . . . . 0.0 109.886 175.574 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 79' ' ' LYS . . . . . . . . . . . . . 36.6 ttpt -82.26 117.83 22.66 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.358 -0.383 . . . . 0.0 110.634 -178.019 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 80' ' ' ILE . . . . . . . . . . . . . 42.7 mm -139.06 113.07 7.1 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.285 0 N-CA-C 109.156 -0.683 . . . . 0.0 109.156 -178.142 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 81' ' ' LYS . . . . . . . . . . . . . 6.3 mtmp? -100.5 124.69 46.37 Favored 'General case' 0 C--N 1.327 -0.409 0 CA-C-O 120.913 0.387 . . . . 0.0 111.116 -176.637 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . 89.25 42.05 5.66 Favored Glycine 0 CA--C 1.525 0.691 0 C-N-CA 120.961 -0.638 . . . . 0.0 111.642 176.259 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 83' ' ' ILE . . . . . . . . . . . . . 74.9 mt -68.06 132.58 32.6 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.309 0 N-CA-C 109.575 -0.528 . . . . 0.0 109.575 176.694 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 84' ' ' LYS . . . . . . . . . . . . . 39.6 ttpt -95.05 -53.41 3.82 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-O 120.986 0.422 . . . . 0.0 110.365 -177.96 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 85' ' ' ASP . . . . . . . . . . . . . 7.9 t70 -149.69 151.87 34.39 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 115.944 -0.571 . . . . 0.0 110.696 -179.131 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 86' ' ' VAL . . . . . . . . . . . . . 44.1 t -130.67 131.65 64.66 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.267 0 CA-C-N 116.339 -0.392 . . . . 0.0 110.305 179.444 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 87' ' ' ILE . . . . . . . . . . . . . 5.1 mp -118.47 126.1 74.86 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.273 0 N-CA-C 109.564 -0.532 . . . . 0.0 109.564 177.027 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 88' ' ' LEU . . . . . . . . . . . . . 15.7 tp -109.79 130.41 55.52 Favored 'General case' 0 C--N 1.332 -0.191 0 CA-C-N 116.34 -0.391 . . . . 0.0 110.687 -178.534 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 89' ' ' ASP . . . . . . . . . . . . . 9.8 t70 -125.88 156.94 38.86 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 116.107 -0.497 . . . . 0.0 109.964 179.091 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 84.8 tt0 -46.48 -38.24 8.94 Favored 'General case' 0 C--N 1.33 -0.248 0 N-CA-C 113.088 0.773 . . . . 0.0 113.088 -172.068 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 91' ' ' ASN . . . . . . . . . . . . . 2.7 t-20 -132.06 20.99 4.49 Favored 'General case' 0 N--CA 1.47 0.532 0 N-CA-C 112.925 0.713 . . . . 0.0 112.925 -177.518 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 92' ' ' LEU . . . . . . . . . . . . . 28.4 mt -149.55 147.71 28.5 Favored 'General case' 0 C--N 1.331 -0.225 0 CA-C-O 120.78 0.324 . . . . 0.0 110.617 -175.938 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 93' ' ' ILE . . . . . . . . . . . . . 70.1 mt -126.22 119.47 54.21 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.264 0 N-CA-C 109.197 -0.668 . . . . 0.0 109.197 176.538 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 94' ' ' VAL . . . . . . . . . . . . . 44.1 t -120.11 127.77 75.91 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.253 0 N-CA-C 109.957 -0.386 . . . . 0.0 109.957 -179.275 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 95' ' ' VAL . . . . . . . . . . . . . 45.9 t -123.32 134.58 65.86 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.208 0 CA-C-N 116.082 -0.508 . . . . 0.0 109.939 -179.433 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 96' ' ' ILE . . . . . . . . . . . . . 63.4 mt -116.86 128.03 74.34 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.284 0 N-CA-C 109.434 -0.58 . . . . 0.0 109.434 -179.726 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 97' ' ' THR . . . . . . . . . . . . . 75.3 p -100.36 155.57 17.73 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-O 121.214 0.531 . . . . 0.0 111.286 -177.501 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 98' ' ' GLU . . . . . . . . . . . . . 84.9 tt0 -53.94 -25.84 22.48 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-N 115.954 -0.566 . . . . 0.0 112.34 179.851 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 99' ' ' GLU . . . . . . . . . . . . . 34.4 tt0 -80.41 17.95 0.99 Allowed 'General case' 0 CA--C 1.54 0.594 0 N-CA-C 112.553 0.575 . . . . 0.0 112.553 -177.164 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 100' ' ' ASN . . . . . . . . . . . . . 3.5 m-20 63.11 36.44 12.2 Favored 'General case' 0 CA--C 1.53 0.174 0 O-C-N 121.931 -0.481 . . . . 0.0 111.221 176.077 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 101' ' ' GLU . . . . . . . . . . . . . 84.8 tt0 -116.72 142.88 46.33 Favored 'General case' 0 C--N 1.332 -0.189 0 CA-C-N 116.318 -0.401 . . . . 0.0 109.942 175.788 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 102' ' ' VAL . . . . . . . . . . . . . 45.0 t -117.11 126.55 74.53 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.262 0 CA-C-N 116.193 -0.458 . . . . 0.0 109.947 -178.06 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 103' ' ' LEU . . . . . . . . . . . . . 6.3 mp -118.43 133.73 55.64 Favored 'General case' 0 C--N 1.331 -0.227 0 CA-C-N 116.045 -0.525 . . . . 0.0 110.283 176.759 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 104' ' ' ILE . . . . . . . . . . . . . 70.4 mt -121.27 122.6 67.82 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.235 0 CA-C-N 116.542 -0.299 . . . . 0.0 110.21 -179.045 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 105' ' ' PHE . . . . . . . . . . . . . 39.0 m-85 -123.41 164.52 18.72 Favored 'General case' 0 C--N 1.332 -0.173 0 O-C-N 123.839 0.712 . . . . 0.0 109.809 179.754 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 106' ' ' ASN . . . . . . . . . . . . . 41.7 p-10 -97.55 -169.9 1.92 Allowed 'General case' 0 C--N 1.33 -0.254 0 N-CA-C 109.989 -0.374 . . . . 0.0 109.989 174.315 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 107' ' ' GLN . . . . . . . . . . . . . 27.5 tt0 -60.2 -27.29 67.04 Favored 'General case' 0 CA--C 1.533 0.308 0 N-CA-C 112.002 0.371 . . . . 0.0 112.002 177.925 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 108' ' ' ASN . . . . . . . . . . . . . 10.2 t-20 -81.87 4.21 23.23 Favored 'General case' 0 CA--C 1.536 0.419 0 N-CA-C 113.232 0.827 . . . . 0.0 113.232 -178.95 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 109' ' ' LEU . . . . . . . . . . . . . 12.5 tp 61.03 38.26 17.38 Favored 'General case' 0 C--O 1.234 0.26 0 CA-C-O 120.973 0.415 . . . . 0.0 111.072 179.109 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 110' ' ' GLU . . . . . . . . . . . . . 95.2 mt-10 -111.16 149.89 30.26 Favored 'General case' 0 C--N 1.332 -0.189 0 CA-C-N 116.539 -0.3 . . . . 0.0 110.332 177.086 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 111' ' ' GLU . . . . . . . . . . . . . 98.4 mt-10 -73.12 125.04 26.78 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-O 120.977 0.418 . . . . 0.0 111.48 -178.823 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 112' ' ' LEU . . . . . . . . . . . . . 21.7 mt -109.95 -45.95 3.55 Favored 'General case' 0 C--N 1.331 -0.221 0 CA-C-N 115.819 -0.628 . . . . 0.0 109.917 174.669 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 113' ' ' TYR . . . . . . . . . . . . . 63.7 t80 -141.55 142.55 33.52 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 115.877 -0.601 . . . . 0.0 110.608 178.782 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 114' ' ' ARG . . . . . . . . . . . . . 33.8 ptt-85 -149.14 124.07 9.99 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-O 121.059 0.457 . . . . 0.0 110.789 177.325 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 115' ' ' GLY . . . . . . . . . . . . . . . -150.11 163.03 29.38 Favored Glycine 0 CA--C 1.524 0.636 0 N-CA-C 110.964 -0.854 . . . . 0.0 110.964 -179.12 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 116' ' ' LYS . . . . . . . . . . . . . 34.5 ttmt -130.07 134.98 47.74 Favored 'General case' 0 C--N 1.33 -0.244 0 N-CA-C 110.088 -0.338 . . . . 0.0 110.088 177.928 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 117' ' ' PHE . . . . . . . . . . . . . 33.4 m-85 -130.93 117.39 19.17 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.403 -0.362 . . . . 0.0 110.297 -175.711 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 118' ' ' GLU . . . . . . . . . . . . . 48.9 mp0 -56.08 -43.37 77.95 Favored 'General case' 0 C--N 1.328 -0.352 0 C-N-CA 120.759 -0.376 . . . . 0.0 111.104 -175.025 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 119' ' ' ASN . . . . . . . . . . . . . 71.1 m-80 -100.26 31.08 3.52 Favored 'General case' 0 C--N 1.329 -0.299 0 N-CA-C 112.259 0.466 . . . . 0.0 112.259 -172.737 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 120' ' ' LEU . . . . . . . . . . . . . 11.1 tp -55.82 120.76 7.86 Favored 'General case' 0 C--O 1.232 0.138 0 C-N-CA 121.078 -0.249 . . . . 0.0 110.491 177.199 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 121' ' ' ASN . . . . . . . . . . . . . 33.1 m120 -114.02 -44.06 3.19 Favored 'General case' 0 N--CA 1.463 0.205 0 CA-C-N 116.654 -0.248 . . . . 0.0 111.035 -176.793 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 122' ' ' LYS . . . . . . . . . . . . . 89.0 mttt -143.58 144.89 32.12 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-O 120.942 0.401 . . . . 0.0 111.352 -177.628 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 123' ' ' VAL . . . . . . . . . . . . . 45.7 t -130.53 131.17 65.18 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.27 0 N-CA-C 109.387 -0.597 . . . . 0.0 109.387 175.27 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 124' ' ' LEU . . . . . . . . . . . . . 10.1 tp -131.43 136.27 47.84 Favored 'General case' 0 C--N 1.331 -0.199 0 CA-C-O 120.824 0.345 . . . . 0.0 111.151 -176.857 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 125' ' ' VAL . . . . . . . . . . . . . 45.0 t -127.58 129.96 70.38 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.232 0 CA-C-N 116.059 -0.519 . . . . 0.0 109.751 177.061 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 126' ' ' ARG . . . . . . . . . . . . . 63.0 ttm-85 -141.63 124.73 16.32 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-O 120.944 0.402 . . . . 0.0 110.603 179.851 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 127' ' ' ASN . . . . . . . . . . . . . 23.1 m120 50.58 -109.79 0.42 Allowed 'General case' 0 CA--C 1.545 0.754 0 CA-C-O 118.832 -0.604 . . . . 0.0 111.293 179.738 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 128' ' ' ASP . . . . . . . . . . . . . 9.9 p-10 -114.08 8.67 17.09 Favored 'General case' 0 N--CA 1.469 0.516 0 CA-C-N 119.875 1.216 . . . . 0.0 113.158 -179.124 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 129' ' ' LEU . . . . . . . . . . . . . 18.1 tp -107.75 134.99 49.92 Favored 'General case' 0 C--N 1.332 -0.166 0 CA-C-N 117.956 0.344 . . . . 0.0 110.123 179.643 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 130' ' ' VAL . . . . . . . . . . . . . 44.0 t -116.69 132.69 65.64 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.253 0 N-CA-C 109.583 -0.525 . . . . 0.0 109.583 179.617 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 131' ' ' VAL . . . . . . . . . . . . . 40.7 t -132.89 133.99 58.55 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.253 0 CA-C-O 121.034 0.445 . . . . 0.0 110.474 -179.258 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 132' ' ' ILE . . . . . . . . . . . . . 74.6 mt -118.45 130.66 72.99 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 CA-C-N 115.72 -0.673 . . . . 0.0 109.204 177.718 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 133' ' ' ILE . . . . . . . . . . . . . 40.0 mm -116.68 123.39 71.6 Favored 'Isoleucine or valine' 0 C--O 1.234 0.262 0 CA-C-O 120.933 0.397 . . . . 0.0 111.071 -174.228 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 134' ' ' ASP . . . . . . . . . . . . . 6.8 p-10 -136.45 146.33 46.23 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-N 116.006 -0.543 . . . . 0.0 109.557 175.227 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 135' ' ' GLU . . . . . . . . . . . . . 38.9 tp10 -50.32 -27.94 7.04 Favored 'General case' 0 C--N 1.328 -0.36 0 N-CA-C 112.598 0.592 . . . . 0.0 112.598 -173.592 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 136' ' ' GLN . . . . . . . . . . . . . 97.8 mt-30 -76.04 -37.23 58.59 Favored 'General case' 0 C--O 1.234 0.246 0 N-CA-C 112.34 0.496 . . . . 0.0 112.34 -177.903 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 137' ' ' LYS . . . . . . . . . . . . . 47.5 pttt -168.02 175.0 6.93 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-O 121.607 0.718 . . . . 0.0 112.19 -171.593 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 138' ' ' LEU . . . . . . . . . . . . . 6.3 tt -118.94 128.57 54.54 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 115.13 -0.941 . . . . 0.0 110.039 179.247 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 139' ' ' THR . . . . . . . . . . . . . 31.5 m -108.03 126.02 52.24 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.285 -0.416 . . . . 0.0 110.291 179.885 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 140' ' ' LEU . . . . . . . . . . . . . 36.5 tp -113.04 122.95 49.13 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 115.722 -0.672 . . . . 0.0 109.305 -179.364 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 141' ' ' ILE . . . . . . . . . . . . . 19.0 mt -121.84 119.82 59.81 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 CA-C-O 120.955 0.407 . . . . 0.0 110.052 -174.411 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 142' ' ' ARG . . . . . . . . . . . . . 54.8 mtp180 -105.09 123.22 47.44 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 115.583 -0.735 . . . . 0.0 110.165 178.856 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 143' ' ' THR . . . . . . . . . . . . . 31.8 p . . . . . 0 C--O 1.221 -0.446 0 CA-C-O 117.98 -1.01 . . . . 0.0 110.515 -179.672 . . . . . . . . 0 0 . 1 . 006 nuclear orig core ' B' B ' 2' ' ' SER . . . . . . . . . . . . . 13.5 p . . . . . 0 C--O 1.233 0.197 0 CA-C-O 120.923 0.392 . . . . 0.0 110.9 . . . . . . . . . 0 0 . 1 . 006 nuclear orig core ' B' B ' 3' ' ' GLU . . . . . . . . . . . . . 46.9 mp0 -140.65 147.37 39.21 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.181 -0.463 . . . . 0.0 111.33 -178.746 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 4' ' ' LEU . . . . . . . . . . . . . 17.8 tp -127.02 127.71 45.19 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 115.702 -0.681 . . . . 0.0 109.947 174.718 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 5' ' ' LYS . . . . . . . . . . . . . 92.5 mttt -109.51 121.23 44.72 Favored 'General case' 0 C--O 1.234 0.27 0 CA-C-O 120.815 0.34 . . . . 0.0 110.855 178.919 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 6' ' ' LEU . . . . . . . . . . . . . 58.1 mt -115.08 147.24 40.44 Favored 'General case' 0 C--N 1.331 -0.211 0 CA-C-N 115.375 -0.83 . . . . 0.0 110.716 -179.097 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 7' ' ' LYS . . . . . . . . . . . . . 69.5 tttt -134.89 138.02 28.63 Favored Pre-proline 0 CA--C 1.534 0.355 0 CA-C-O 118.955 -0.545 . . . . 0.0 109.989 175.78 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 8' ' ' PRO . . . . . . . . . . . . . 75.1 Cg_endo -90.06 139.67 3.16 Favored 'Trans proline' 0 N--CA 1.489 1.249 0 C-N-CA 121.7 1.6 . . . . 0.0 111.574 178.213 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 9' ' ' LEU . . . . . . . . . . . . . 26.8 mt -77.27 -51.91 1.91 Allowed Pre-proline 0 CA--C 1.531 0.239 0 CA-C-O 119.138 -0.458 . . . . 0.0 111.313 -177.488 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 10' ' ' PRO . . . . . . . . . . . . . 71.7 Cg_endo -76.56 149.86 31.03 Favored 'Trans proline' 0 N--CA 1.497 1.682 0 C-N-CA 121.156 1.238 . . . . 0.0 111.399 170.671 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 11' ' ' LYS . . . . . . . . . . . . . 25.1 pttm -84.91 117.02 23.66 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-O 121.45 0.643 . . . . 0.0 110.61 178.254 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 12' ' ' VAL . . . . . . . . . . . . . 12.8 p -151.06 148.04 15.2 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 CA-C-N 115.653 -0.703 . . . . 0.0 110.493 -179.44 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 13' ' ' GLU . . . . . . . . . . . . . 84.7 tt0 -91.03 125.5 35.84 Favored 'General case' 0 C--N 1.329 -0.321 0 N-CA-C 110.034 -0.358 . . . . 0.0 110.034 177.827 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 14' ' ' LEU . . . . . . . . . . . . . 28.2 mt -97.87 149.86 36.17 Favored Pre-proline 0 CA--C 1.533 0.291 0 CA-C-N 116.357 -0.383 . . . . 0.0 110.718 -176.583 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 15' ' ' PRO . . . . . . . . . . . . . 24.0 Cg_exo -63.69 161.28 32.75 Favored 'Trans proline' 0 N--CA 1.497 1.689 0 C-N-CA 121.402 1.401 . . . . 0.0 111.866 175.648 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 16' ' ' PRO . . . . . . . . . . . . . 27.4 Cg_exo -60.35 -35.64 90.42 Favored 'Trans proline' 0 N--CA 1.498 1.745 0 C-N-CA 121.451 1.434 . . . . 0.0 112.789 -178.535 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 17' ' ' ASP . . . . . . . . . . . . . 9.4 p-10 -89.13 8.07 31.85 Favored 'General case' 0 CA--C 1.536 0.426 0 N-CA-C 113.245 0.831 . . . . 0.0 113.245 -177.428 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 18' ' ' PHE . . . . . . . . . . . . . 47.5 t80 -58.27 -44.97 88.67 Favored 'General case' 0 C--N 1.334 -0.108 0 O-C-N 122.041 -0.412 . . . . 0.0 110.031 -178.017 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 19' ' ' VAL . . . . . . . . . . . . . 13.8 p -55.66 -41.27 64.19 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.36 0 CA-C-N 116.283 -0.417 . . . . 0.0 111.058 -178.984 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 20' ' ' ASP . . . . . . . . . . . . . 75.6 m-20 -60.9 -43.49 98.44 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-O 120.951 0.405 . . . . 0.0 110.888 -178.154 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 21' ' ' VAL . . . . . . . . . . . . . 47.4 t -65.07 -46.39 91.46 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.281 0 CA-C-N 116.331 -0.395 . . . . 0.0 110.555 -177.556 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 22' ' ' ILE . . . . . . . . . . . . . 50.9 mm -55.15 -46.52 77.68 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.259 0 CA-C-O 120.817 0.341 . . . . 0.0 110.645 179.483 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 23' ' ' ARG . . . . . . . . . . . . . 26.8 ttm-85 -53.65 -54.08 42.87 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-O 121.16 0.505 . . . . 0.0 111.385 -179.727 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 24' ' ' ILE . . . . . . . . . . . . . 77.3 mt -60.66 -36.72 72.47 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.373 0 CA-C-N 115.61 -0.723 . . . . 0.0 111.581 -173.675 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 25' ' ' LYS . . . . . . . . . . . . . 57.5 mttm -70.71 -42.86 70.07 Favored 'General case' 0 C--N 1.33 -0.281 0 N-CA-C 112.551 0.574 . . . . 0.0 112.551 179.781 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 26' ' ' LEU . . . . . . . . . . . . . 34.3 mt -77.75 -35.84 51.34 Favored 'General case' 0 C--N 1.331 -0.23 0 N-CA-C 113.15 0.796 . . . . 0.0 113.15 -170.748 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 27' ' ' GLN . . . . . . . . . . . . . 5.3 pt20 -46.97 140.91 4.44 Favored 'General case' 0 N--CA 1.468 0.462 0 N-CA-C 112.747 0.647 . . . . 0.0 112.747 -175.808 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 28' ' ' GLY . . . . . . . . . . . . . . . 99.96 -24.79 30.76 Favored Glycine 0 CA--C 1.534 1.223 0 CA-C-N 115.624 -0.716 . . . . 0.0 112.261 -176.733 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 29' ' ' LYS . . . . . . . . . . . . . 47.2 mtmt -98.24 155.15 17.32 Favored 'General case' 0 C--N 1.332 -0.187 0 CA-C-N 117.339 0.57 . . . . 0.0 111.269 179.64 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 30' ' ' THR . . . . . . . . . . . . . 38.9 m -107.19 138.48 43.3 Favored 'General case' 0 C--N 1.331 -0.209 0 CA-C-N 115.914 -0.585 . . . . 0.0 109.901 176.62 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 31' ' ' VAL . . . . . . . . . . . . . 34.1 m -131.72 155.89 42.09 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.206 0 CA-C-O 120.99 0.424 . . . . 0.0 111.551 -176.866 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 32' ' ' ARG . . . . . . . . . . . . . 36.3 mtp180 -129.28 152.69 48.57 Favored 'General case' 0 C--O 1.233 0.236 0 CA-C-N 115.667 -0.697 . . . . 0.0 110.688 176.802 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 33' ' ' THR . . . . . . . . . . . . . 24.6 m -53.57 139.71 30.77 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.203 -0.453 . . . . 0.0 111.253 -179.075 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 34' ' ' GLY . . . . . . . . . . . . . . . 99.43 -17.13 58.18 Favored Glycine 0 CA--C 1.532 1.109 0 CA-C-O 119.486 -0.619 . . . . 0.0 113.304 177.69 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 35' ' ' ASP . . . . . . . . . . . . . 76.1 m-20 -65.09 148.25 52.0 Favored 'General case' 0 C--O 1.232 0.178 0 CA-C-N 118.116 0.958 . . . . 0.0 110.97 179.346 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 36' ' ' VAL . . . . . . . . . . . . . 45.7 t -122.52 131.52 73.05 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.241 0 CA-C-N 115.969 -0.559 . . . . 0.0 109.85 178.58 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 37' ' ' ILE . . . . . . . . . . . . . 66.7 mt -118.68 138.52 49.12 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 CA-C-N 116.128 -0.487 . . . . 0.0 109.89 -179.462 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 38' ' ' GLY . . . . . . . . . . . . . . . -109.83 128.69 9.02 Favored Glycine 0 CA--C 1.526 0.757 0 N-CA-C 110.871 -0.892 . . . . 0.0 110.871 179.5 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 39' ' ' ILE . . . . . . . . . . . . . 71.7 mt -124.62 131.46 72.67 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.246 0 N-CA-C 110.047 -0.353 . . . . 0.0 110.047 179.437 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 40' ' ' SER . . . . . . . . . . . . . 31.5 t -92.86 119.99 32.75 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.332 -0.395 . . . . 0.0 110.675 175.819 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 41' ' ' ILE . . . . . . . . . . . . . 70.4 mt -131.54 119.99 44.23 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.202 0 N-CA-C 110.223 -0.288 . . . . 0.0 110.223 178.418 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 42' ' ' LEU . . . . . . . . . . . . . 30.1 mt 56.87 33.83 23.8 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.227 -0.442 . . . . 0.0 111.84 178.729 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 43' ' ' GLY . . . . . . . . . . . . . . . 81.05 -10.13 49.78 Favored Glycine 0 CA--C 1.535 1.302 0 C-N-CA 121.24 -0.505 . . . . 0.0 113.584 176.482 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 44' ' ' LYS . . . . . . . . . . . . . 93.4 mttt -100.03 134.43 42.96 Favored 'General case' 0 C--N 1.333 -0.126 0 CA-C-N 117.821 0.81 . . . . 0.0 110.188 177.563 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 45' ' ' GLU . . . . . . . . . . . . . 85.0 tt0 -85.71 130.5 34.55 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 116.213 -0.449 . . . . 0.0 111.217 -179.815 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 46' ' ' VAL . . . . . . . . . . . . . 7.3 p -124.46 129.85 73.73 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.211 0 N-CA-C 109.605 -0.517 . . . . 0.0 109.605 175.714 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 47' ' ' LYS . . . . . . . . . . . . . 79.9 mttt -101.08 130.75 47.16 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.006 -0.543 . . . . 0.0 111.171 177.674 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 48' ' ' PHE . . . . . . . . . . . . . 93.5 m-85 -112.46 132.0 55.28 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 116.478 -0.328 . . . . 0.0 110.131 176.102 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 49' ' ' LYS . . . . . . . . . . . . . 68.5 tttt -106.04 135.54 47.3 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.352 -0.386 . . . . 0.0 110.398 179.123 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 50' ' ' VAL . . . . . . . . . . . . . 43.4 t -81.96 110.18 16.92 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.243 0 N-CA-C 109.435 -0.58 . . . . 0.0 109.435 177.001 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 51' ' ' VAL . . . . . . . . . . . . . 47.5 t -75.53 -47.04 35.63 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.295 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.092 -173.964 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 52' ' ' GLN . . . . . . . . . . . . . 62.8 tt0 -160.83 137.26 8.57 Favored 'General case' 0 C--N 1.332 -0.186 0 C-N-CA 120.165 -0.614 . . . . 0.0 112.193 -177.917 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 53' ' ' ALA . . . . . . . . . . . . . . . -112.51 130.35 56.03 Favored 'General case' 0 C--N 1.331 -0.211 0 CA-C-N 115.741 -0.663 . . . . 0.0 109.312 172.295 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 54' ' ' TYR . . . . . . . . . . . . . 47.4 t80 -129.05 110.22 18.26 Favored Pre-proline 0 C--N 1.328 -0.341 0 CA-C-O 118.22 -0.895 . . . . 0.0 110.689 -178.342 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 55' ' ' PRO . . . . . . . . . . . . . 72.8 Cg_endo -77.31 170.11 72.23 Favored 'Cis proline' 0 N--CA 1.5 1.909 0 CA-C-N 121.949 1.732 . . . . 0.0 112.22 -6.177 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 56' ' ' SER . . . . . . . . . . . . . 13.7 m -116.24 135.88 22.91 Favored Pre-proline 0 CA--C 1.539 0.536 0 CA-C-O 118.491 -0.766 . . . . 0.0 109.329 175.143 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 57' ' ' PRO . . . . . . . . . . . . . 53.1 Cg_endo -70.34 145.57 81.06 Favored 'Cis proline' 0 N--CA 1.498 1.755 0 CA-C-N 121.795 1.677 . . . . 0.0 111.452 -1.546 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 58' ' ' LEU . . . . . . . . . . . . . 29.2 tp -108.34 138.3 44.85 Favored 'General case' 0 C--N 1.331 -0.225 0 CA-C-N 116.271 -0.422 . . . . 0.0 110.866 -177.865 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 59' ' ' ARG . . . . . . . . . . . . . 55.7 ttt180 -103.52 127.05 50.99 Favored 'General case' 0 C--N 1.328 -0.333 0 N-CA-C 109.341 -0.614 . . . . 0.0 109.341 174.543 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 60' ' ' VAL . . . . . . . . . . . . . 42.2 t -82.2 117.27 27.88 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.285 0 C-N-CA 120.74 -0.384 . . . . 0.0 110.327 -176.486 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 61' ' ' GLU . . . . . . . . . . . . . 77.5 tt0 -131.2 156.83 44.68 Favored 'General case' 0 C--N 1.329 -0.302 0 N-CA-C 109.12 -0.696 . . . . 0.0 109.12 176.158 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 62' ' ' ASP . . . . . . . . . . . . . 5.6 t70 -50.11 -30.99 12.24 Favored 'General case' 0 C--N 1.328 -0.363 0 N-CA-C 112.223 0.453 . . . . 0.0 112.223 -178.987 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 63' ' ' ARG . . . . . . . . . . . . . 20.5 mtp-105 -72.12 -22.08 61.38 Favored 'General case' 0 CA--C 1.533 0.311 0 N-CA-C 113.063 0.764 . . . . 0.0 113.063 -176.398 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 64' ' ' THR . . . . . . . . . . . . . 27.1 m -69.55 144.05 53.21 Favored 'General case' 0 C--N 1.331 -0.209 0 CA-C-O 120.92 0.39 . . . . 0.0 111.122 -174.989 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 65' ' ' LYS . . . . . . . . . . . . . 85.1 mttt -89.18 130.08 35.66 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.062 -0.517 . . . . 0.0 110.126 178.739 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 66' ' ' ILE . . . . . . . . . . . . . 67.6 mt -115.53 131.94 66.4 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.223 0 N-CA-C 109.886 -0.413 . . . . 0.0 109.886 -179.762 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 67' ' ' THR . . . . . . . . . . . . . 32.7 m -127.54 140.44 52.13 Favored 'General case' 0 C--N 1.331 -0.225 0 CA-C-O 121.232 0.539 . . . . 0.0 110.999 -178.235 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 68' ' ' LEU . . . . . . . . . . . . . 41.5 mt . . . . . 0 C--N 1.33 -0.276 0 CA-C-N 115.768 -0.651 . . . . 0.0 109.978 177.349 . . . . . . . . 0 0 . 1 . 006 nuclear orig core ' B' B ' 73' ' ' VAL . . . . . . . . . . . . . 27.7 m . . . . . 0 C--O 1.231 0.098 0 CA-C-O 120.874 0.368 . . . . 0.0 110.488 . . . . . . . . . 0 0 . 1 . 006 nuclear orig core ' B' B ' 74' ' ' ASP . . . . . . . . . . . . . 31.9 t0 -102.88 116.96 33.57 Favored 'General case' 0 C--N 1.33 -0.27 0 N-CA-C 109.467 -0.568 . . . . 0.0 109.467 176.867 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 75' ' ' VAL . . . . . . . . . . . . . 42.1 t -114.04 124.41 70.67 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.26 0 CA-C-O 121.057 0.456 . . . . 0.0 110.704 -176.148 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 76' ' ' LEU . . . . . . . . . . . . . 7.3 mp -122.39 144.25 49.15 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 115.71 -0.677 . . . . 0.0 109.841 175.864 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 77' ' ' GLU . . . . . . . . . . . . . 97.7 mt-10 -134.6 130.28 36.24 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-O 121.07 0.462 . . . . 0.0 110.837 -178.887 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 78' ' ' ALA . . . . . . . . . . . . . . . -117.68 128.24 54.72 Favored 'General case' 0 C--N 1.331 -0.221 0 CA-C-N 115.8 -0.636 . . . . 0.0 109.938 177.966 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 79' ' ' LYS . . . . . . . . . . . . . 49.0 tptt -75.65 118.75 18.81 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.306 -0.406 . . . . 0.0 110.62 -177.37 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 80' ' ' ILE . . . . . . . . . . . . . 38.1 mm -139.11 106.24 2.84 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.325 0 N-CA-C 109.278 -0.638 . . . . 0.0 109.278 -177.588 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 81' ' ' LYS . . . . . . . . . . . . . 86.1 mttt -93.56 126.85 38.94 Favored 'General case' 0 C--N 1.328 -0.368 0 C-N-CA 120.709 -0.397 . . . . 0.0 111.086 -178.636 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 82' ' ' GLY . . . . . . . . . . . . . . . 89.04 42.14 5.7 Favored Glycine 0 CA--C 1.525 0.71 0 C-N-CA 120.811 -0.709 . . . . 0.0 111.839 174.092 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 83' ' ' ILE . . . . . . . . . . . . . 71.6 mt -70.28 131.46 34.22 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.312 0 N-CA-C 109.339 -0.615 . . . . 0.0 109.339 176.128 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 84' ' ' LYS . . . . . . . . . . . . . 38.5 ttpt -99.05 -43.99 6.47 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.568 -0.287 . . . . 0.0 110.389 -178.272 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 85' ' ' ASP . . . . . . . . . . . . . 9.7 t70 -155.48 154.26 31.56 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.356 -0.384 . . . . 0.0 110.792 179.348 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 86' ' ' VAL . . . . . . . . . . . . . 44.5 t -132.93 134.36 58.2 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.183 0 CA-C-O 120.959 0.409 . . . . 0.0 110.502 -179.476 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 87' ' ' ILE . . . . . . . . . . . . . 44.3 mm -121.03 128.47 76.07 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.274 0 CA-C-N 115.798 -0.637 . . . . 0.0 109.593 178.7 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 88' ' ' LEU . . . . . . . . . . . . . 17.4 tp -115.17 133.19 56.26 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-O 120.985 0.421 . . . . 0.0 111.116 -178.04 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 89' ' ' ASP . . . . . . . . . . . . . 7.0 t70 -127.42 159.9 33.08 Favored 'General case' 0 C--N 1.332 -0.17 0 CA-C-N 115.898 -0.592 . . . . 0.0 109.574 176.822 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 90' ' ' GLU . . . . . . . . . . . . . 96.3 mt-10 -47.15 -38.07 11.04 Favored 'General case' 0 C--N 1.33 -0.272 0 N-CA-C 113.2 0.815 . . . . 0.0 113.2 -171.009 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 91' ' ' ASN . . . . . . . . . . . . . 1.2 p30 -132.04 20.69 4.5 Favored 'General case' 0 N--CA 1.468 0.442 0 N-CA-C 113.038 0.755 . . . . 0.0 113.038 -176.736 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 92' ' ' LEU . . . . . . . . . . . . . 57.5 mt -149.01 146.93 28.0 Favored 'General case' 0 C--N 1.331 -0.204 0 CA-C-O 120.767 0.318 . . . . 0.0 110.64 -177.038 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 93' ' ' ILE . . . . . 0.403 HD12 HG23 ' B' ' 93' ' ' ILE . 67.1 mt -123.89 119.86 58.08 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.291 0 N-CA-C 109.236 -0.653 . . . . 0.0 109.236 178.231 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' B' B ' 94' ' ' VAL . . . . . . . . . . . . . 44.7 t -118.76 128.28 75.64 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.257 0 N-CA-C 109.829 -0.434 . . . . 0.0 109.829 -179.076 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 95' ' ' VAL . . . . . . . . . . . . . 42.6 t -121.73 134.1 66.08 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.304 0 CA-C-N 116.138 -0.483 . . . . 0.0 109.829 -179.882 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 96' ' ' ILE . . . . . . . . . . . . . 63.7 mt -115.13 127.1 72.82 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.21 0 N-CA-C 109.411 -0.589 . . . . 0.0 109.411 179.95 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 97' ' ' THR . . . . . . . . . . . . . 66.4 p -102.6 157.71 16.75 Favored 'General case' 0 C--N 1.331 -0.222 0 CA-C-O 121.394 0.616 . . . . 0.0 111.376 -176.74 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 98' ' ' GLU . . . . . . . . . . . . . 84.0 tt0 -53.9 -25.54 20.61 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 115.867 -0.606 . . . . 0.0 112.317 179.834 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 99' ' ' GLU . . . . . . . . . . . . . 45.8 mp0 -77.69 14.37 1.06 Allowed 'General case' 0 CA--C 1.535 0.403 0 N-CA-C 113.161 0.8 . . . . 0.0 113.161 -177.206 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 100' ' ' ASN . . . . . . . . . . . . . 3.2 m-20 62.32 38.04 13.45 Favored 'General case' 0 CA--C 1.529 0.169 0 CA-C-O 121.05 0.453 . . . . 0.0 110.747 178.699 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 101' ' ' GLU . . . . . . . . . . . . . 84.7 tt0 -120.61 141.76 50.03 Favored 'General case' 0 C--N 1.332 -0.163 0 CA-C-N 116.098 -0.501 . . . . 0.0 109.75 177.214 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 102' ' ' VAL . . . . . . . . . . . . . 44.9 t -114.97 127.63 72.45 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.297 0 CA-C-N 116.331 -0.395 . . . . 0.0 109.972 -178.297 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 103' ' ' LEU . . . . . . . . . . . . . 6.7 mp -117.25 132.83 56.54 Favored 'General case' 0 C--N 1.331 -0.227 0 CA-C-N 115.763 -0.653 . . . . 0.0 110.273 176.988 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 104' ' ' ILE . . . . . . . . . . . . . 67.3 mt -118.24 121.69 67.79 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.24 0 CA-C-N 116.037 -0.529 . . . . 0.0 110.031 179.662 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 105' ' ' PHE . . . . . . . . . . . . . 56.7 m-85 -120.37 161.72 20.71 Favored 'General case' 0 C--N 1.331 -0.219 0 O-C-N 123.98 0.8 . . . . 0.0 109.651 178.64 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 106' ' ' ASN . . . . . . . . . . . . . 44.2 p-10 -93.97 -169.95 2.2 Favored 'General case' 0 C--N 1.33 -0.249 0 N-CA-C 110.053 -0.351 . . . . 0.0 110.053 175.019 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 107' ' ' GLN . . . . . . . . . . . . . 61.4 tt0 -58.91 -30.03 67.51 Favored 'General case' 0 C--N 1.33 -0.258 0 N-CA-C 111.876 0.324 . . . . 0.0 111.876 179.333 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 108' ' ' ASN . . . . . . . . . . . . . 6.8 t30 -83.66 7.94 15.96 Favored 'General case' 0 CA--C 1.536 0.406 0 N-CA-C 113.193 0.812 . . . . 0.0 113.193 -177.274 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 109' ' ' LEU . . . . . . . . . . . . . 12.0 tp 60.78 37.66 18.64 Favored 'General case' 0 C--O 1.232 0.181 0 CA-C-O 120.962 0.41 . . . . 0.0 111.211 179.074 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 110' ' ' GLU . . . . . . . . . . . . . 95.4 mt-10 -107.34 151.24 25.76 Favored 'General case' 0 C--N 1.331 -0.238 0 N-CA-C 109.925 -0.398 . . . . 0.0 109.925 176.174 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 111' ' ' GLU . . . . . . . . . . . . . 84.8 tt0 -82.01 123.24 28.73 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-O 120.939 0.399 . . . . 0.0 111.175 -175.626 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 112' ' ' LEU . . . . . . . . . . . . . 33.7 mt -108.36 -46.0 3.79 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 115.933 -0.576 . . . . 0.0 110.481 177.443 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 113' ' ' TYR . . . . . . . . . . . . . 60.5 t80 -140.61 137.68 33.84 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.163 -0.471 . . . . 0.0 110.921 -179.053 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 114' ' ' ARG . . . . . . . . . . . . . 56.9 ttp180 -147.0 124.98 12.0 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-O 120.991 0.424 . . . . 0.0 110.386 175.866 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 115' ' ' GLY . . . . . . . . . . . . . . . -150.15 156.53 26.78 Favored Glycine 0 CA--C 1.526 0.737 0 N-CA-C 110.95 -0.86 . . . . 0.0 110.95 179.164 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 116' ' ' LYS . . . . . . . . . . . . . 35.0 ttpt -118.69 138.45 52.62 Favored 'General case' 0 C--O 1.233 0.189 0 CA-C-O 120.73 0.3 . . . . 0.0 110.288 179.18 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 117' ' ' PHE . . . . . . . . . . . . . 24.0 m-85 -135.78 114.07 11.53 Favored 'General case' 0 C--N 1.329 -0.299 0 N-CA-C 109.733 -0.469 . . . . 0.0 109.733 -178.973 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 118' ' ' GLU . . . . . . . . . . . . . 96.3 mt-10 -54.97 -42.22 72.12 Favored 'General case' 0 C--N 1.329 -0.29 0 C-N-CA 120.874 -0.33 . . . . 0.0 111.223 -176.234 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 119' ' ' ASN . . . . . . . . . . . . . 2.5 m120 -97.32 31.13 2.58 Favored 'General case' 0 C--N 1.33 -0.257 0 N-CA-C 112.148 0.425 . . . . 0.0 112.148 -174.97 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 120' ' ' LEU . . . . . . . . . . . . . 18.7 tp -57.13 121.85 11.03 Favored 'General case' 0 C--N 1.332 -0.174 0 N-CA-C 110.278 -0.268 . . . . 0.0 110.278 177.253 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 121' ' ' ASN . . . . . . . . . . . . . 57.9 m-20 -113.98 -44.17 3.18 Favored 'General case' 0 C--N 1.332 -0.186 0 CA-C-N 116.667 -0.242 . . . . 0.0 111.309 -176.766 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 122' ' ' LYS . . . . . . . . . . . . . 98.3 mttt -146.67 149.76 34.09 Favored 'General case' 0 C--O 1.232 0.171 0 C-N-CA 120.442 -0.503 . . . . 0.0 112.008 -177.951 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 123' ' ' VAL . . . . . . . . . . . . . 48.8 t -119.41 127.78 75.85 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.218 0 CA-C-N 115.697 -0.683 . . . . 0.0 109.163 174.326 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 124' ' ' LEU . . . . . . . . . . . . . 31.6 mt -120.89 136.01 55.04 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 116.531 -0.304 . . . . 0.0 110.633 -176.255 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 125' ' ' VAL . . . . . . . . . . . . . 42.6 t -131.1 131.45 63.84 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.264 0 CA-C-N 116.306 -0.406 . . . . 0.0 110.266 179.121 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 126' ' ' ARG . . . . . . . . . . . . . 27.7 mtp180 -151.55 129.73 11.93 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.113 -0.494 . . . . 0.0 109.842 176.619 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 127' ' ' ASN . . . . . . . . . . . . . 32.5 t30 56.2 -152.45 0.38 Allowed 'General case' 0 CA--C 1.54 0.565 0 N-CA-C 109.7 -0.481 . . . . 0.0 109.7 -179.119 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 128' ' ' ASP . . . . . . . . . . . . . 15.9 p-10 -83.6 18.04 2.03 Favored 'General case' 0 CA--C 1.537 0.45 0 CA-C-N 118.526 0.603 . . . . 0.0 112.562 177.558 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 129' ' ' LEU . . . . . . . . . . . . . 41.1 mt -115.24 144.92 42.99 Favored 'General case' 0 C--O 1.232 0.179 0 CA-C-N 117.956 0.344 . . . . 0.0 110.24 179.69 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 130' ' ' VAL . . . . . . . . . . . . . 32.3 m -129.31 143.21 41.89 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.232 0 CA-C-O 120.93 0.395 . . . . 0.0 110.6 -178.512 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 131' ' ' VAL . . . . . . . . . . . . . 38.0 t -136.1 141.34 41.87 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.254 0 CA-C-O 121.079 0.466 . . . . 0.0 110.551 -178.844 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 132' ' ' ILE . . . . . . . . . . . . . 74.1 mt -118.39 131.38 71.34 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.262 0 CA-C-N 115.805 -0.634 . . . . 0.0 109.396 178.726 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 133' ' ' ILE . . . . . . . . . . . . . 41.8 mm -117.11 125.12 73.75 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.235 0 CA-C-O 120.785 0.326 . . . . 0.0 111.158 -174.035 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 134' ' ' ASP . . . . . . . . . . . . . 9.7 p-10 -136.09 148.01 48.09 Favored 'General case' 0 C--N 1.332 -0.167 0 N-CA-C 109.514 -0.55 . . . . 0.0 109.514 172.89 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 135' ' ' GLU . . . . . . . . . . . . . 44.3 tp10 -49.92 -27.26 5.02 Favored 'General case' 0 C--N 1.326 -0.45 0 N-CA-C 112.873 0.694 . . . . 0.0 112.873 -172.668 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 136' ' ' GLN . . . . . . . . . . . . . 53.8 mt-30 -85.23 -30.46 23.82 Favored 'General case' 0 C--N 1.33 -0.24 0 N-CA-C 112.694 0.627 . . . . 0.0 112.694 -175.113 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 137' ' ' LYS . . . . . . . . . . . . . 22.9 pttm -167.62 171.18 10.44 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-O 121.518 0.675 . . . . 0.0 112.483 -173.024 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 138' ' ' LEU . . . . . . . . . . . . . 6.4 tt -121.11 130.02 53.56 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 115.059 -0.973 . . . . 0.0 110.164 -178.521 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 139' ' ' THR . . . . . . . . . . . . . 29.2 m -109.57 125.38 52.47 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-N 116.26 -0.427 . . . . 0.0 110.291 178.593 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 140' ' ' LEU . . . . . . . . . . . . . 15.0 tp -114.24 119.24 36.35 Favored 'General case' 0 C--N 1.328 -0.328 0 N-CA-C 109.412 -0.588 . . . . 0.0 109.412 -178.015 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 141' ' ' ILE . . . . . . . . . . . . . 22.1 mt -120.08 121.18 65.2 Favored 'Isoleucine or valine' 0 C--O 1.234 0.248 0 CA-C-O 121.067 0.461 . . . . 0.0 110.217 -175.731 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 142' ' ' ARG . . . . . . . . . . . . . 85.3 mtm180 -107.13 127.23 53.31 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 115.219 -0.9 . . . . 0.0 110.435 -178.748 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 143' ' ' THR . . . . . . . . . . . . . 76.5 p . . . . . 0 C--O 1.22 -0.472 0 CA-C-O 117.976 -1.011 . . . . 0.0 110.537 179.778 . . . . . . . . 0 0 . 1 . 006 nuclear orig core ' C' C ' 2' ' ' SER . . . . . . . . . . . . . 5.7 p . . . . . 0 N--CA 1.461 0.104 0 CA-C-O 121.071 0.463 . . . . 0.0 110.818 . . . . . . . . . 0 0 . 1 . 006 nuclear orig core ' C' C ' 3' ' ' GLU . . . . . . . . . . . . . 85.1 tt0 -142.12 140.44 32.48 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 115.801 -0.636 . . . . 0.0 111.001 -179.832 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' C' C ' 4' ' ' LEU . . . . . . . . . . . . . 15.9 tp -121.89 126.53 48.9 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 115.887 -0.597 . . . . 0.0 110.093 177.171 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' C' C ' 5' ' ' LYS . . . . . . . . . . . . . 99.0 mttt -104.64 121.0 42.65 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.414 -0.357 . . . . 0.0 110.572 178.577 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' C' C ' 6' ' ' LEU . . . . . . . . . . . . . 75.7 mt -116.63 148.71 40.71 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 115.43 -0.804 . . . . 0.0 110.284 -178.959 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' C' C ' 7' ' ' LYS . . . . . . . . . . . . . 64.2 tttm -133.18 136.04 26.68 Favored Pre-proline 0 CA--C 1.534 0.365 0 CA-C-O 118.929 -0.558 . . . . 0.0 109.91 177.084 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' C' C ' 8' ' ' PRO . . . . . . . . . . . . . 84.7 Cg_endo -90.61 140.64 3.07 Favored 'Trans proline' 0 N--CA 1.491 1.365 0 C-N-CA 121.716 1.611 . . . . 0.0 111.571 178.063 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' C' C ' 9' ' ' LEU . . . . . . . . . . . . . 68.6 mt -75.13 -47.53 4.55 Favored Pre-proline 0 CA--C 1.534 0.345 0 CA-C-O 118.712 -0.661 . . . . 0.0 112.311 -178.689 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' C' C ' 10' ' ' PRO . . . . . . . . . . . . . 91.4 Cg_endo -81.49 152.57 17.76 Favored 'Trans proline' 0 N--CA 1.497 1.715 0 C-N-CA 121.312 1.341 . . . . 0.0 111.987 176.038 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' C' C ' 11' ' ' LYS . . . . . . . . . . . . . 50.0 tttm -89.23 102.2 14.86 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.426 -0.352 . . . . 0.0 110.373 178.282 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' C' C ' 12' ' ' VAL . . . . . . . . . . . . . 12.8 p -147.36 145.7 18.89 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.359 0 CA-C-N 116.313 -0.403 . . . . 0.0 110.802 -179.461 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' C' C ' 13' ' ' GLU . . . . . . . . . . . . . 39.6 mt-10 -83.72 122.15 28.25 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.324 -0.398 . . . . 0.0 109.99 175.613 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' C' C ' 14' ' ' LEU . . . . . . . . . . . . . 27.4 mt -94.68 153.92 40.08 Favored Pre-proline 0 C--N 1.329 -0.288 0 CA-C-N 116.456 -0.338 . . . . 0.0 110.83 -177.699 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' C' C ' 15' ' ' PRO . . . . . . . . . . . . . 36.0 Cg_exo -58.35 154.96 37.84 Favored 'Trans proline' 0 N--CA 1.495 1.588 0 C-N-CA 121.268 1.312 . . . . 0.0 111.724 178.576 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' C' C ' 16' ' ' PRO . . . . . . . . . . . . . 34.2 Cg_exo -57.85 -33.61 97.21 Favored 'Trans proline' 0 N--CA 1.497 1.701 0 C-N-CA 121.483 1.455 . . . . 0.0 112.817 -179.098 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' C' C ' 17' ' ' ASP . . . . . . . . . . . . . 20.8 p-10 -90.1 8.79 30.98 Favored 'General case' 0 CA--C 1.536 0.41 0 N-CA-C 113.45 0.907 . . . . 0.0 113.45 -176.671 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' C' C ' 18' ' ' PHE . . . . . . . . . . . . . 35.4 t80 -58.4 -45.8 87.65 Favored 'General case' 0 N--CA 1.457 -0.094 0 O-C-N 121.972 -0.455 . . . . 0.0 110.122 -177.212 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' C' C ' 19' ' ' VAL . . . . . . . . . . . . . 14.2 p -56.51 -41.33 72.47 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.411 0 CA-C-N 116.269 -0.423 . . . . 0.0 110.889 -178.916 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' C' C ' 20' ' ' ASP . . . . . . . . . . . . . 68.8 m-20 -60.73 -42.83 98.09 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-O 120.83 0.348 . . . . 0.0 111.076 -178.191 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' C' C ' 21' ' ' VAL . . . . . . . . . . . . . 48.7 t -64.44 -48.52 84.78 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.32 0 CA-C-N 116.311 -0.404 . . . . 0.0 110.403 -177.566 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' C' C ' 22' ' ' ILE . . . . . . . . . . . . . 48.8 mm -55.73 -46.37 79.64 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.221 0 CA-C-O 120.869 0.366 . . . . 0.0 110.738 -179.742 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' C' C ' 23' ' ' ARG . . . . . . . . . . . . . 59.9 ttp180 -53.48 -51.7 61.91 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-O 120.777 0.323 . . . . 0.0 111.566 -178.719 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' C' C ' 24' ' ' ILE . . . . . . . . . . . . . 74.9 mt -60.12 -41.42 86.49 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.269 0 CA-C-N 116.6 -0.273 . . . . 0.0 111.214 -176.631 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' C' C ' 25' ' ' LYS . . . . . . . . . . . . . 53.6 mmtt -63.78 -39.97 95.54 Favored 'General case' 0 C--N 1.328 -0.33 0 N-CA-C 112.107 0.41 . . . . 0.0 112.107 -179.948 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' C' C ' 26' ' ' LEU . . . . . . . . . . . . . 87.7 mt -78.48 -41.12 33.47 Favored 'General case' 0 C--N 1.33 -0.252 0 N-CA-C 113.539 0.94 . . . . 0.0 113.539 -170.715 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' C' C ' 27' ' ' GLN . . . . . . . . . . . . . 11.3 pt20 -47.24 139.85 5.85 Favored 'General case' 0 N--CA 1.469 0.509 0 N-CA-C 112.75 0.648 . . . . 0.0 112.75 -174.237 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' C' C ' 28' ' ' GLY . . . . . . . . . . . . . . . 99.33 -26.75 23.12 Favored Glycine 0 CA--C 1.532 1.127 0 CA-C-N 115.633 -0.712 . . . . 0.0 112.217 -177.723 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' C' C ' 29' ' ' LYS . . . . . . . . . . . . . 98.9 mttt -98.51 155.06 17.45 Favored 'General case' 0 C--O 1.232 0.181 0 CA-C-N 117.273 0.536 . . . . 0.0 111.254 179.662 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' C' C ' 30' ' ' THR . . . . . . . . . . . . . 23.5 m -103.88 137.3 42.08 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-N 115.957 -0.565 . . . . 0.0 110.092 176.392 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' C' C ' 31' ' ' VAL . . . . . . . . . . . . . 34.8 m -130.51 154.07 40.01 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.245 0 CA-C-O 120.947 0.403 . . . . 0.0 110.971 -178.523 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' C' C ' 32' ' ' ARG . . . . . . . . . . . . . 95.6 mtt180 -130.11 151.58 50.49 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 116.013 -0.539 . . . . 0.0 110.466 178.502 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' C' C ' 33' ' ' THR . . . . . . . . . . . . . 29.3 m -53.4 139.25 31.07 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-O 120.851 0.358 . . . . 0.0 111.225 -178.314 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' C' C ' 34' ' ' GLY . . . . . . . . . . . . . . . 100.63 -17.05 57.14 Favored Glycine 0 CA--C 1.532 1.136 0 CA-C-O 119.671 -0.516 . . . . 0.0 113.244 179.732 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' C' C ' 35' ' ' ASP . . . . . . . . . . . . . 64.4 m-20 -65.65 150.81 47.85 Favored 'General case' 0 C--O 1.231 0.089 0 CA-C-N 118.028 0.914 . . . . 0.0 110.891 178.461 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' C' C ' 36' ' ' VAL . . . . . . . . . . . . . 43.7 t -124.38 133.61 68.89 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.188 0 CA-C-N 116.044 -0.526 . . . . 0.0 110.027 179.056 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' C' C ' 37' ' ' ILE . . . . . . . . . . . . . 69.9 mt -119.98 139.73 46.35 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.25 0 CA-C-N 116.087 -0.506 . . . . 0.0 109.842 179.882 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' C' C ' 38' ' ' GLY . . . . . . . . . . . . . . . -114.22 128.73 8.37 Favored Glycine 0 CA--C 1.526 0.727 0 N-CA-C 111.214 -0.754 . . . . 0.0 111.214 -179.82 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' C' C ' 39' ' ' ILE . . . . . . . . . . . . . 70.8 mt -125.34 130.84 72.84 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.267 0 N-CA-C 109.791 -0.448 . . . . 0.0 109.791 178.371 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' C' C ' 40' ' ' SER . . . . . . . . . . . . . 31.3 t -93.18 113.95 26.32 Favored 'General case' 0 C--N 1.33 -0.24 0 C-N-CA 120.747 -0.381 . . . . 0.0 110.817 176.185 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' C' C ' 41' ' ' ILE . . . . . . . . . . . . . 43.9 mm -123.82 121.79 63.12 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.204 0 CA-C-N 116.484 -0.326 . . . . 0.0 110.237 -179.413 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' C' C ' 42' ' ' LEU . . . . . . . . . . . . . 72.4 mt 57.68 35.33 25.51 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-N 116.349 -0.387 . . . . 0.0 111.8 177.118 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' C' C ' 43' ' ' GLY . . . . . . . . . . . . . . . 78.3 -10.18 30.01 Favored Glycine 0 CA--C 1.533 1.169 0 C-N-CA 121.178 -0.534 . . . . 0.0 113.449 177.248 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' C' C ' 44' ' ' LYS . . . . . . . . . . . . . 68.7 mttm -100.24 131.71 46.02 Favored 'General case' 0 C--N 1.333 -0.125 0 CA-C-N 118.016 0.908 . . . . 0.0 110.078 176.51 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' C' C ' 45' ' ' GLU . . . . . . . . . . . . . 31.5 tp10 -84.37 127.02 33.75 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.396 -0.366 . . . . 0.0 110.459 -179.905 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' C' C ' 46' ' ' VAL . . . . . . . . . . . . . 7.6 p -121.09 128.15 76.0 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.243 0 CA-C-O 121.116 0.484 . . . . 0.0 109.807 178.36 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' C' C ' 47' ' ' LYS . . . . . . . . . . . . . 62.8 mttp -100.57 130.66 46.66 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 115.903 -0.59 . . . . 0.0 111.459 178.058 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' C' C ' 48' ' ' PHE . . . . . . . . . . . . . 94.9 m-85 -113.95 131.95 56.13 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 115.915 -0.584 . . . . 0.0 109.873 176.023 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' C' C ' 49' ' ' LYS . . . . . . . . . . . . . 84.4 tttt -106.53 136.53 46.14 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.471 -0.331 . . . . 0.0 110.518 179.975 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' C' C ' 50' ' ' VAL . . . . . . . . . . . . . 43.6 t -80.99 109.3 15.21 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.302 0 N-CA-C 109.311 -0.626 . . . . 0.0 109.311 177.252 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' C' C ' 51' ' ' VAL . . . . . . . . . . . . . 47.9 t -73.96 -47.55 42.24 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.39 0 CA-C-N 116.148 -0.478 . . . . 0.0 110.11 -173.781 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' C' C ' 52' ' ' GLN . . . . . . . . . . . . . 61.9 tt0 -163.86 139.43 6.31 Favored 'General case' 0 C--N 1.331 -0.222 0 C-N-CA 120.218 -0.593 . . . . 0.0 111.912 -177.724 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' C' C ' 53' ' ' ALA . . . . . . . . . . . . . . . -112.94 133.67 54.8 Favored 'General case' 0 C--N 1.332 -0.195 0 CA-C-N 115.66 -0.7 . . . . 0.0 109.853 175.445 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' C' C ' 54' ' ' TYR . . . . . . . . . . . . . 48.9 t80 -129.08 111.14 18.33 Favored Pre-proline 0 CA--C 1.536 0.415 0 CA-C-O 118.172 -0.918 . . . . 0.0 110.456 179.263 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' C' C ' 55' ' ' PRO . . . . . . . . . . . . . 72.5 Cg_endo -77.17 168.09 77.89 Favored 'Cis proline' 0 N--CA 1.497 1.726 0 CA-C-N 121.883 1.708 . . . . 0.0 112.213 -6.24 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' C' C ' 56' ' ' SER . . . . . . . . . . . . . 48.1 m -117.32 136.5 23.48 Favored Pre-proline 0 CA--C 1.539 0.525 0 CA-C-O 118.518 -0.754 . . . . 0.0 109.683 174.652 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' C' C ' 57' ' ' PRO . . . . . . . . . . . . . 36.8 Cg_endo -66.95 145.99 73.87 Favored 'Cis proline' 0 N--CA 1.499 1.795 0 CA-C-N 121.822 1.687 . . . . 0.0 111.383 -3.473 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' C' C ' 58' ' ' LEU . . . . . . . . . . . . . 20.6 tp -107.76 136.17 47.95 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.505 -0.316 . . . . 0.0 110.699 -177.796 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' C' C ' 59' ' ' ARG . . . . . . . . . . . . . 71.3 ttt180 -104.58 124.42 49.29 Favored 'General case' 0 C--N 1.328 -0.355 0 N-CA-C 109.247 -0.649 . . . . 0.0 109.247 175.462 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' C' C ' 60' ' ' VAL . . . . . . . . . . . . . 42.3 t -79.73 126.23 39.14 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.251 0 C-N-CA 120.663 -0.415 . . . . 0.0 110.492 -174.459 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' C' C ' 61' ' ' GLU . . . . . . . . . . . . . 96.4 mt-10 -131.05 160.97 33.07 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 115.712 -0.676 . . . . 0.0 109.967 178.507 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' C' C ' 62' ' ' ASP . . . . . . . . . . . . . 11.7 t70 -53.76 -32.49 52.49 Favored 'General case' 0 C--N 1.328 -0.363 0 N-CA-C 111.822 0.304 . . . . 0.0 111.822 -179.154 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' C' C ' 63' ' ' ARG . . . . . . . . . . . . . 38.0 ptt180 -88.38 6.19 38.55 Favored 'General case' 0 CA--C 1.537 0.447 0 N-CA-C 113.688 0.996 . . . . 0.0 113.688 -175.616 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' C' C ' 64' ' ' THR . . . . . . . . . . . . . 38.2 m -81.12 142.51 33.22 Favored 'General case' 0 C--N 1.331 -0.2 0 CA-C-N 118.03 0.377 . . . . 0.0 110.549 -179.404 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' C' C ' 65' ' ' LYS . . . . . . . . . . . . . 68.4 mttm -89.26 129.9 35.75 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.237 179.543 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' C' C ' 66' ' ' ILE . . . . . . . . . . . . . 64.7 mt -116.93 130.1 72.4 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.217 0 N-CA-C 109.758 -0.46 . . . . 0.0 109.758 178.86 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' C' C ' 67' ' ' THR . . . . . . . . . . . . . 36.0 m -126.47 140.23 52.63 Favored 'General case' 0 C--N 1.331 -0.22 0 CA-C-O 121.069 0.461 . . . . 0.0 111.065 -177.119 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' C' C ' 68' ' ' LEU . . . . . . . . . . . . . 6.4 tt . . . . . 0 C--N 1.33 -0.276 0 CA-C-N 115.763 -0.653 . . . . 0.0 109.446 176.562 . . . . . . . . 0 0 . 1 . 006 nuclear orig core ' C' C ' 73' ' ' VAL . . . . . . . . . . . . . 18.7 m . . . . . 0 N--CA 1.461 0.12 0 CA-C-O 121.201 0.524 . . . . 0.0 110.541 . . . . . . . . . 0 0 . 1 . 006 nuclear orig core ' C' C ' 74' ' ' ASP . . . . . . . . . . . . . 13.7 t0 -97.52 123.72 41.49 Favored 'General case' 0 C--N 1.326 -0.417 0 CA-C-N 115.508 -0.769 . . . . 0.0 109.34 178.262 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' C' C ' 75' ' ' VAL . . . . . . . . . . . . . 42.1 t -112.65 121.23 64.56 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.257 0 CA-C-O 121.187 0.518 . . . . 0.0 110.621 -176.221 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' C' C ' 76' ' ' LEU . . . . . . . . . . . . . 7.6 mp -119.09 141.32 48.87 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 115.58 -0.737 . . . . 0.0 109.496 175.673 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' C' C ' 77' ' ' GLU . . . . . . . . . . . . . 46.3 mt-10 -132.23 137.0 47.38 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-O 121.059 0.457 . . . . 0.0 110.994 -178.515 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' C' C ' 78' ' ' ALA . . . . . . . . . . . . . . . -127.39 135.68 50.81 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 115.727 -0.67 . . . . 0.0 109.889 177.152 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' C' C ' 79' ' ' LYS . . . . . . . . . . . . . 54.9 pttt -83.85 120.87 26.58 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-O 121.31 0.576 . . . . 0.0 110.932 -178.516 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' C' C ' 80' ' ' ILE . . . . . . . . . . . . . 39.6 mm -139.18 115.92 10.34 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.274 0 CA-C-N 115.738 -0.665 . . . . 0.0 109.359 -177.769 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' C' C ' 81' ' ' LYS . . . . . . . . . . . . . 99.3 mttt -101.09 125.48 47.71 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-O 120.828 0.347 . . . . 0.0 111.156 -178.172 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' C' C ' 82' ' ' GLY . . . . . . . . . . . . . . . 89.13 42.2 5.66 Favored Glycine 0 CA--C 1.524 0.624 0 C-N-CA 120.714 -0.755 . . . . 0.0 111.772 173.117 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' C' C ' 83' ' ' ILE . . . . . . . . . . . . . 74.8 mt -65.61 134.91 29.18 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.374 0 N-CA-C 109.606 -0.516 . . . . 0.0 109.606 176.841 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' C' C ' 84' ' ' LYS . . . . . . . . . . . . . 51.0 tttp -99.09 -53.96 3.11 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-O 121.061 0.458 . . . . 0.0 110.375 -179.148 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' C' C ' 85' ' ' ASP . . . . . . . . . . . . . 10.1 t70 -148.78 146.37 28.0 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 115.786 -0.643 . . . . 0.0 110.284 -179.082 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' C' C ' 86' ' ' VAL . . . . . . . . . . . . . 43.7 t -127.14 127.61 69.63 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.196 0 CA-C-O 120.783 0.325 . . . . 0.0 110.414 -179.558 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' C' C ' 87' ' ' ILE . . . . . . . . . . . . . 44.6 mm -120.53 126.71 75.55 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.27 0 CA-C-N 115.996 -0.547 . . . . 0.0 109.766 177.935 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' C' C ' 88' ' ' LEU . . . . . . . . . . . . . 74.6 mt -107.25 139.61 41.44 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-O 121.006 0.432 . . . . 0.0 111.037 -179.314 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' C' C ' 89' ' ' ASP . . . . . . . . . . . . . 6.0 t70 -130.3 154.06 48.01 Favored 'General case' 0 C--N 1.328 -0.328 0 N-CA-C 109.302 -0.629 . . . . 0.0 109.302 176.253 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' C' C ' 90' ' ' GLU . . . . . . . . . . . . . 84.9 tt0 -47.91 -34.79 9.53 Favored 'General case' 0 C--N 1.33 -0.253 0 N-CA-C 112.972 0.73 . . . . 0.0 112.972 -172.07 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' C' C ' 91' ' ' ASN . . . . . . . . . . . . . 86.9 m-20 -132.03 19.51 4.53 Favored 'General case' 0 N--CA 1.468 0.464 0 N-CA-C 113.124 0.787 . . . . 0.0 113.124 -178.437 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' C' C ' 92' ' ' LEU . . . . . . . . . . . . . 48.5 mt -148.66 148.55 30.21 Favored 'General case' 0 C--N 1.331 -0.218 0 CA-C-O 120.644 0.259 . . . . 0.0 110.35 -177.702 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' C' C ' 93' ' ' ILE . . . . . . . . . . . . . 70.5 mt -126.94 118.39 50.33 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.345 0 N-CA-C 109.148 -0.686 . . . . 0.0 109.148 176.42 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' C' C ' 94' ' ' VAL . . . . . . . . . . . . . 46.3 t -118.89 126.29 75.19 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.281 0 CA-C-O 121.028 0.442 . . . . 0.0 110.022 -179.035 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' C' C ' 95' ' ' VAL . . . . . . . . . . . . . 44.7 t -119.91 133.1 67.77 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.382 0 CA-C-N 115.788 -0.642 . . . . 0.0 109.648 179.386 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' C' C ' 96' ' ' ILE . . . . . . . . . . . . . 63.9 mt -111.77 127.74 68.76 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.349 0 N-CA-C 109.089 -0.708 . . . . 0.0 109.089 178.016 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' C' C ' 97' ' ' THR . . . . . . . . . . . . . 80.9 p -97.83 157.91 15.82 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-O 121.159 0.504 . . . . 0.0 110.979 -178.071 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' C' C ' 98' ' ' GLU . . . . . . . . . . . . . 82.1 tt0 -53.73 -25.53 19.02 Favored 'General case' 0 CA--C 1.533 0.323 0 CA-C-N 116.105 -0.498 . . . . 0.0 112.145 179.509 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' C' C ' 99' ' ' GLU . . . . . . . . . . . . . 95.4 mt-10 -80.12 15.34 1.54 Allowed 'General case' 0 CA--C 1.535 0.398 0 N-CA-C 113.191 0.811 . . . . 0.0 113.191 -176.714 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' C' C ' 100' ' ' ASN . . . . . . . . . . . . . 3.3 m-20 61.96 37.89 14.71 Favored 'General case' 0 N--CA 1.463 0.198 0 CA-C-O 121.105 0.479 . . . . 0.0 110.939 179.001 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' C' C ' 101' ' ' GLU . . . . . . . . . . . . . 84.5 tt0 -117.99 144.43 45.54 Favored 'General case' 0 C--N 1.332 -0.172 0 CA-C-N 116.074 -0.512 . . . . 0.0 109.755 176.764 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' C' C ' 102' ' ' VAL . . . . . . . . . . . . . 44.7 t -115.14 126.26 72.67 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.253 0 CA-C-N 116.284 -0.416 . . . . 0.0 110.14 -176.75 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' C' C ' 103' ' ' LEU . . . . . . . . . . . . . 29.5 mt -115.25 127.14 55.29 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-N 115.686 -0.688 . . . . 0.0 109.932 175.905 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' C' C ' 104' ' ' ILE . . . . . . . . . . . . . 66.7 mt -116.33 120.32 64.57 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.225 0 N-CA-C 110.15 -0.315 . . . . 0.0 110.15 179.737 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' C' C ' 105' ' ' PHE . . . . . . . . . . . . . 47.8 m-85 -119.8 166.41 13.3 Favored 'General case' 0 C--N 1.332 -0.178 0 CA-C-N 115.415 -0.812 . . . . 0.0 109.535 178.364 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' C' C ' 106' ' ' ASN . . . . . . . . . . . . . 43.0 p-10 -99.5 -170.07 1.85 Allowed 'General case' 0 C--N 1.33 -0.261 0 N-CA-C 109.993 -0.373 . . . . 0.0 109.993 174.988 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' C' C ' 107' ' ' GLN . . . . . . . . . . . . . 29.7 tt0 -58.51 -30.07 66.77 Favored 'General case' 0 C--N 1.329 -0.313 0 N-CA-C 111.984 0.365 . . . . 0.0 111.984 179.287 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' C' C ' 108' ' ' ASN . . . . . . . . . . . . . 13.5 t-20 -84.05 7.57 18.16 Favored 'General case' 0 CA--C 1.536 0.439 0 N-CA-C 113.204 0.816 . . . . 0.0 113.204 -176.903 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' C' C ' 109' ' ' LEU . . . . . . . . . . . . . 10.6 tp 61.39 38.39 16.15 Favored 'General case' 0 C--N 1.332 -0.189 0 CA-C-O 121.131 0.491 . . . . 0.0 111.19 179.192 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' C' C ' 110' ' ' GLU . . . . . . . . . . . . . 96.8 mt-10 -105.38 153.29 21.86 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.219 -0.446 . . . . 0.0 109.928 176.85 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' C' C ' 111' ' ' GLU . . . . . . . . . . . . . 83.2 tt0 -85.67 121.9 29.01 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-O 120.768 0.318 . . . . 0.0 110.587 -178.508 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' C' C ' 112' ' ' LEU . . . . . . . . . . . . . 61.6 mt -111.61 -46.14 3.29 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.258 -0.428 . . . . 0.0 110.741 179.623 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' C' C ' 113' ' ' TYR . . . . . . . . . . . . . 55.8 t80 -137.17 134.72 36.64 Favored 'General case' 0 C--N 1.331 -0.223 0 CA-C-N 116.434 -0.348 . . . . 0.0 110.966 -179.094 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' C' C ' 114' ' ' ARG . . . . . . . . . . . . . 31.6 ttp180 -135.62 124.03 23.39 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.34 -0.391 . . . . 0.0 110.164 176.604 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' C' C ' 115' ' ' GLY . . . . . . . . . . . . . . . -150.05 162.68 29.26 Favored Glycine 0 CA--C 1.523 0.567 0 N-CA-C 111.038 -0.825 . . . . 0.0 111.038 179.334 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' C' C ' 116' ' ' LYS . . . . . . . . . . . . . 30.0 ttpt -131.28 137.85 49.02 Favored 'General case' 0 C--N 1.33 -0.248 0 N-CA-C 109.941 -0.392 . . . . 0.0 109.941 178.42 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' C' C ' 117' ' ' PHE . . . . . . . . . . . . . 39.2 m-85 -135.11 113.93 11.89 Favored 'General case' 0 C--N 1.331 -0.23 0 N-CA-C 109.919 -0.4 . . . . 0.0 109.919 -178.55 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' C' C ' 118' ' ' GLU . . . . . . . . . . . . . 44.1 mt-10 -57.07 -42.12 80.07 Favored 'General case' 0 C--N 1.328 -0.34 0 C-N-CA 120.774 -0.37 . . . . 0.0 110.886 -176.324 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' C' C ' 119' ' ' ASN . . . . . . . . . . . . . 3.9 p30 -100.51 31.19 3.56 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.232 -0.44 . . . . 0.0 111.964 -175.674 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' C' C ' 120' ' ' LEU . . . . . . . . . . . . . 14.2 tp -54.03 125.9 20.6 Favored 'General case' 0 N--CA 1.463 0.195 0 CA-C-O 120.487 0.184 . . . . 0.0 110.776 177.996 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' C' C ' 121' ' ' ASN . . . . . . . . . . . . . 16.6 m120 -112.72 -44.14 3.36 Favored 'General case' 0 C--O 1.231 0.12 0 C-N-CA 121.125 -0.23 . . . . 0.0 111.415 -176.422 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' C' C ' 122' ' ' LYS . . . . . . . . . . . . . 97.7 mttt -148.3 149.38 31.75 Favored 'General case' 0 C--N 1.332 -0.189 0 C-N-CA 120.557 -0.457 . . . . 0.0 111.879 -177.593 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' C' C ' 123' ' ' VAL . . . . . . . . . . . . . 44.3 t -130.18 126.92 62.47 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.325 0 N-CA-C 109.117 -0.697 . . . . 0.0 109.117 172.908 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' C' C ' 124' ' ' LEU . . . . . . . . . . . . . 12.1 tp -127.97 138.38 52.6 Favored 'General case' 0 N--CA 1.463 0.208 0 CA-C-O 120.859 0.362 . . . . 0.0 111.371 -175.661 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' C' C ' 125' ' ' VAL . . . . . . . . . . . . . 35.6 m -126.19 133.02 69.82 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.241 0 CA-C-N 115.942 -0.572 . . . . 0.0 110.436 177.715 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' C' C ' 126' ' ' ARG . . . . . . . . . . . . . 24.4 mmt180 -139.38 116.48 11.05 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.312 -0.404 . . . . 0.0 110.537 178.367 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' C' C ' 127' ' ' ASN . . . . . . . . . . . . . 17.8 m-80 52.1 -105.03 0.2 Allowed 'General case' 0 CA--C 1.543 0.68 0 CA-C-O 119.173 -0.441 . . . . 0.0 111.255 178.578 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' C' C ' 128' ' ' ASP . . . . . . . . . . . . . 21.2 p-10 -113.95 1.19 14.63 Favored 'General case' 0 N--CA 1.469 0.487 0 CA-C-N 119.501 1.046 . . . . 0.0 113.423 -176.916 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' C' C ' 129' ' ' LEU . . . . . . . . . . . . . 12.1 tp -108.13 137.77 45.54 Favored 'General case' 0 C--N 1.332 -0.166 0 N-CA-C 109.728 -0.471 . . . . 0.0 109.728 179.155 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' C' C ' 130' ' ' VAL . . . . . . . . . . . . . 13.0 p -126.74 137.97 56.21 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.235 0 CA-C-O 121.035 0.445 . . . . 0.0 110.131 179.906 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' C' C ' 131' ' ' VAL . . . . . . . . . . . . . 42.3 t -135.73 141.14 42.9 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.274 0 CA-C-O 121.16 0.505 . . . . 0.0 110.495 -177.358 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' C' C ' 132' ' ' ILE . . . . . . . . . . . . . 73.6 mt -115.92 132.1 66.4 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.345 0 CA-C-N 115.477 -0.783 . . . . 0.0 109.051 177.838 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' C' C ' 133' ' ' ILE . . . . . . . . . . . . . 43.3 mm -113.36 122.21 67.04 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.242 0 CA-C-O 120.9 0.381 . . . . 0.0 110.494 -175.715 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' C' C ' 134' ' ' ASP . . . . . . . . . . . . . 7.4 p-10 -135.17 146.98 49.26 Favored 'General case' 0 C--N 1.331 -0.209 0 CA-C-N 116.045 -0.525 . . . . 0.0 109.892 178.063 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' C' C ' 135' ' ' GLU . . . . . . . . . . . . . 85.2 tt0 -50.01 -27.9 6.16 Favored 'General case' 0 C--N 1.326 -0.417 0 N-CA-C 112.738 0.644 . . . . 0.0 112.738 -174.536 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' C' C ' 136' ' ' GLN . . . . . . . . . . . . . 97.3 mt-30 -79.81 -34.23 39.71 Favored 'General case' 0 C--O 1.233 0.232 0 N-CA-C 112.456 0.539 . . . . 0.0 112.456 -176.818 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' C' C ' 137' ' ' LYS . . . . . . . . . . . . . 53.1 pttt -169.99 177.06 4.46 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-O 121.551 0.691 . . . . 0.0 112.31 -172.289 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' C' C ' 138' ' ' LEU . . . . . . . . . . . . . 5.7 tt -116.32 126.38 53.44 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 115.126 -0.943 . . . . 0.0 109.634 176.547 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' C' C ' 139' ' ' THR . . . . . . . . . . . . . 28.4 m -106.65 123.24 47.82 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.305 -0.407 . . . . 0.0 110.158 -179.638 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' C' C ' 140' ' ' LEU . . . . . . . . . . . . . 5.7 tt -108.78 120.77 43.46 Favored 'General case' 0 C--N 1.329 -0.321 0 N-CA-C 109.114 -0.699 . . . . 0.0 109.114 -178.311 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' C' C ' 141' ' ' ILE . . . . . . . . . . . . . 21.1 mt -123.38 118.91 55.98 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.286 0 CA-C-O 121.211 0.529 . . . . 0.0 109.833 -177.153 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' C' C ' 142' ' ' ARG . . . . . . . . . . . . . 47.0 ttt180 . . . . . 0 C--N 1.328 -0.333 0 CA-C-N 115.207 -0.906 . . . . 0.0 110.002 179.838 . . . . . . . . 0 0 . 1 . 006 nuclear orig core ' D' D ' 2' ' ' SER . . . . . . . . . . . . . 3.2 p . . . . . 0 C--O 1.23 0.068 0 CA-C-O 120.788 0.327 . . . . 0.0 110.219 . . . . . . . . . 0 0 . 1 . 006 nuclear orig core ' D' D ' 3' ' ' GLU . . . . . . . . . . . . . 95.6 mt-10 -141.02 139.67 34.17 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-O 120.971 0.415 . . . . 0.0 111.074 -178.985 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' D' D ' 4' ' ' LEU . . . . . . . . . . . . . 20.1 tp -123.55 125.21 44.46 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 115.889 -0.596 . . . . 0.0 110.108 176.402 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' D' D ' 5' ' ' LYS . . . . . . . . . . . . . 54.2 mtmt -104.22 118.06 35.72 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.156 -0.474 . . . . 0.0 110.725 179.493 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' D' D ' 6' ' ' LEU . . . . . . . . . . . . . 26.3 mt -115.15 146.0 41.81 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 115.632 -0.713 . . . . 0.0 110.087 179.877 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' D' D ' 7' ' ' LYS . . . . . . . . . . . . . 74.2 tttt -131.93 139.56 35.44 Favored Pre-proline 0 CA--C 1.534 0.347 0 CA-C-O 119.164 -0.446 . . . . 0.0 109.841 176.763 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' D' D ' 8' ' ' PRO . . . . . . . . . . . . . 84.4 Cg_endo -91.96 139.23 2.1 Favored 'Trans proline' 0 N--CA 1.49 1.306 0 C-N-CA 121.776 1.651 . . . . 0.0 111.802 177.782 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' D' D ' 9' ' ' LEU . . . . . . . . . . . . . 59.0 mt -76.14 -46.93 3.65 Favored Pre-proline 0 CA--C 1.533 0.313 0 CA-C-O 118.818 -0.611 . . . . 0.0 112.146 -179.59 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' D' D ' 10' ' ' PRO . . . . . . . . . . . . . 89.1 Cg_endo -81.88 147.06 14.98 Favored 'Trans proline' 0 N--CA 1.495 1.582 0 C-N-CA 121.269 1.313 . . . . 0.0 111.614 174.175 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' D' D ' 11' ' ' LYS . . . . . . . . . . . . . 83.9 tttt -85.07 99.81 11.28 Favored 'General case' 0 C--N 1.33 -0.263 0 C-N-CA 120.801 -0.36 . . . . 0.0 110.136 178.84 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' D' D ' 12' ' ' VAL . . . . . . . . . . . . . 12.2 p -140.84 144.38 27.03 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.257 0 CA-C-N 116.219 -0.446 . . . . 0.0 110.65 -177.788 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' D' D ' 13' ' ' GLU . . . . . . . . . . . . . 43.4 mt-10 -77.69 130.32 36.65 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.253 -0.43 . . . . 0.0 110.02 176.687 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' D' D ' 14' ' ' LEU . . . . . . . . . . . . . 27.3 mt -97.88 146.1 30.89 Favored Pre-proline 0 C--N 1.329 -0.286 0 CA-C-O 119.096 -0.478 . . . . 0.0 109.996 -179.717 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' D' D ' 15' ' ' PRO . . . . . . . . . . . . . 26.9 Cg_exo -61.83 158.69 36.73 Favored 'Trans proline' 0 N--CA 1.498 1.741 0 C-N-CA 121.261 1.307 . . . . 0.0 111.693 177.144 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' D' D ' 16' ' ' PRO . . . . . . . . . . . . . 38.7 Cg_exo -58.79 -34.06 98.79 Favored 'Trans proline' 0 N--CA 1.497 1.711 0 C-N-CA 121.516 1.477 . . . . 0.0 112.898 -178.196 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' D' D ' 17' ' ' ASP . . . . . . . . . . . . . 17.3 p-10 -92.45 9.65 33.43 Favored 'General case' 0 CA--C 1.535 0.389 0 N-CA-C 113.322 0.86 . . . . 0.0 113.322 -177.348 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' D' D ' 18' ' ' PHE . . . . . . . . . . . . . 50.7 t80 -58.15 -45.71 86.93 Favored 'General case' 0 N--CA 1.457 -0.115 0 CA-C-O 121.04 0.448 . . . . 0.0 110.219 -177.709 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' D' D ' 19' ' ' VAL . . . . . . . . . . . . . 47.3 t -56.24 -44.01 78.17 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.337 0 CA-C-N 116.085 -0.507 . . . . 0.0 110.557 -177.493 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' D' D ' 20' ' ' ASP . . . . . . . . . . . . . 44.4 t0 -59.86 -43.41 94.7 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-O 120.729 0.3 . . . . 0.0 110.95 -177.338 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' D' D ' 21' ' ' VAL . . . . . . . . . . . . . 47.5 t -63.93 -46.65 93.49 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.305 0 C-N-CA 120.702 -0.399 . . . . 0.0 110.506 -177.086 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' D' D ' 22' ' ' ILE . . . . . . . . . . . . . 51.4 mm -55.87 -47.95 79.01 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.275 0 C-N-CA 120.946 -0.301 . . . . 0.0 110.774 179.937 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' D' D ' 23' ' ' ARG . . . . . . . . . . . . . 60.8 ttp180 -54.93 -48.76 72.7 Favored 'General case' 0 C--N 1.331 -0.233 0 C-N-CA 121.06 -0.256 . . . . 0.0 111.347 -178.143 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' D' D ' 24' ' ' ILE . . . . . . . . . . . . . 77.0 mt -59.33 -41.96 85.85 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.357 0 C-N-CA 121.027 -0.269 . . . . 0.0 111.21 -177.126 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' D' D ' 25' ' ' LYS . . . . . . . . . . . . . 73.5 mmtt -65.49 -43.58 89.75 Favored 'General case' 0 C--N 1.329 -0.312 0 N-CA-C 112.445 0.535 . . . . 0.0 112.445 -179.54 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' D' D ' 26' ' ' LEU . . . . . . . . . . . . . 83.8 mt -78.26 -36.15 47.19 Favored 'General case' 0 C--N 1.329 -0.308 0 N-CA-C 113.287 0.847 . . . . 0.0 113.287 -170.181 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' D' D ' 27' ' ' GLN . . . . . . . . . . . . . 4.6 pt20 -46.3 137.08 6.61 Favored 'General case' 0 N--CA 1.467 0.391 0 N-CA-C 112.871 0.693 . . . . 0.0 112.871 -174.709 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' D' D ' 28' ' ' GLY . . . . . . . . . . . . . . . 99.43 -25.37 28.52 Favored Glycine 0 CA--C 1.533 1.186 0 CA-C-N 115.883 -0.598 . . . . 0.0 112.374 -178.383 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' D' D ' 29' ' ' LYS . . . . . . . . . . . . . 54.7 mtmt -97.88 155.2 17.18 Favored 'General case' 0 C--N 1.332 -0.187 0 CA-C-N 117.341 0.57 . . . . 0.0 111.253 179.76 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' D' D ' 30' ' ' THR . . . . . . . . . . . . . 25.0 m -106.46 138.39 42.72 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 115.908 -0.587 . . . . 0.0 109.992 176.654 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' D' D ' 31' ' ' VAL . . . . . . . . . . . . . 35.8 m -128.85 155.96 41.12 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.239 0 CA-C-N 116.303 -0.408 . . . . 0.0 110.876 -178.486 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' D' D ' 32' ' ' ARG . . . . . . . . . . . . . 77.5 mtt85 -129.46 148.09 51.34 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-N 116.06 -0.518 . . . . 0.0 110.697 178.811 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' D' D ' 33' ' ' THR . . . . . . . . . . . . . 26.7 m -53.87 140.15 31.38 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.34 -0.391 . . . . 0.0 111.27 -179.703 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' D' D ' 34' ' ' GLY . . . . . . . . . . . . . . . 100.71 -17.1 56.99 Favored Glycine 0 CA--C 1.532 1.118 0 CA-C-O 119.618 -0.545 . . . . 0.0 113.306 179.541 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' D' D ' 35' ' ' ASP . . . . . . . . . . . . . 78.7 m-20 -66.51 147.87 52.68 Favored 'General case' 0 C--O 1.232 0.167 0 CA-C-N 118.017 0.909 . . . . 0.0 111.179 178.881 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' D' D ' 36' ' ' VAL . . . . . . . . . . . . . 45.1 t -121.63 129.81 75.18 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.206 0 CA-C-N 116.003 -0.544 . . . . 0.0 109.728 177.317 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' D' D ' 37' ' ' ILE . . . . . . . . . . . . . 68.0 mt -122.64 140.14 47.35 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.264 0 CA-C-N 116.293 -0.412 . . . . 0.0 110.109 -178.332 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' D' D ' 38' ' ' GLY . . . . . . . . . . . . . . . -108.96 128.74 9.18 Favored Glycine 0 CA--C 1.526 0.719 0 N-CA-C 111.086 -0.806 . . . . 0.0 111.086 179.166 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' D' D ' 39' ' ' ILE . . . . . . . . . . . . . 74.6 mt -125.54 140.81 47.29 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.258 0 N-CA-C 110.104 -0.332 . . . . 0.0 110.104 179.445 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' D' D ' 40' ' ' SER . . . . . . . . . . . . . 36.3 t -92.13 117.57 29.98 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.41 -0.359 . . . . 0.0 110.828 175.998 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' D' D ' 41' ' ' ILE . . . . . . . . . . . . . 48.1 mm -130.03 123.35 56.13 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.243 0 N-CA-C 110.174 -0.306 . . . . 0.0 110.174 178.852 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' D' D ' 42' ' ' LEU . . . . . . . . . . . . . 9.0 tp 58.09 33.45 23.18 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.241 -0.436 . . . . 0.0 111.68 178.674 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' D' D ' 43' ' ' GLY . . . . . . . . . . . . . . . 77.02 -10.04 21.96 Favored Glycine 0 CA--C 1.534 1.262 0 C-N-CA 121.258 -0.496 . . . . 0.0 113.517 178.152 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' D' D ' 44' ' ' LYS . . . . . . . . . . . . . 99.2 mttt -103.06 146.26 28.64 Favored 'General case' 0 C--N 1.334 -0.081 0 CA-C-N 117.884 0.842 . . . . 0.0 110.081 178.443 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' D' D ' 45' ' ' GLU . . . . . . . . . . . . . 81.8 tt0 -83.85 127.42 33.82 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.377 -0.374 . . . . 0.0 110.797 -179.51 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' D' D ' 46' ' ' VAL . . . . . . . . . . . . . 7.4 p -122.11 128.8 75.66 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.183 0 N-CA-C 109.521 -0.548 . . . . 0.0 109.521 176.393 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' D' D ' 47' ' ' LYS . . . . . . . . . . . . . 89.8 mttt -100.1 130.0 46.2 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 115.993 -0.549 . . . . 0.0 111.28 178.969 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' D' D ' 48' ' ' PHE . . . . . . . . . . . . . 92.0 m-85 -113.43 131.77 55.89 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.01 176.541 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' D' D ' 49' ' ' LYS . . . . . . . . . . . . . 80.7 tttt -108.34 137.6 46.04 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 116.309 -0.405 . . . . 0.0 110.337 178.797 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' D' D ' 50' ' ' VAL . . . . . . . . . . . . . 44.1 t -82.39 109.71 16.7 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.288 0 N-CA-C 109.521 -0.548 . . . . 0.0 109.521 176.81 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' D' D ' 51' ' ' VAL . . . . . . . . . . . . . 47.8 t -72.82 -48.79 43.91 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.326 0 CA-C-N 115.794 -0.639 . . . . 0.0 110.043 -175.228 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' D' D ' 52' ' ' GLN . . . . . . . . . . . . . 49.7 tt0 -162.96 142.09 8.7 Favored 'General case' 0 C--N 1.332 -0.168 0 C-N-CA 120.037 -0.665 . . . . 0.0 111.941 -178.663 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' D' D ' 53' ' ' ALA . . . . . . . . . . . . . . . -116.83 132.63 56.65 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 115.766 -0.652 . . . . 0.0 109.998 175.577 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' D' D ' 54' ' ' TYR . . . . . . . . . . . . . 67.1 t80 -129.01 111.97 18.51 Favored Pre-proline 0 CA--C 1.535 0.379 0 CA-C-O 118.204 -0.903 . . . . 0.0 110.487 179.384 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' D' D ' 55' ' ' PRO . . . . . . . . . . . . . 74.4 Cg_endo -77.2 169.32 74.5 Favored 'Cis proline' 0 N--CA 1.499 1.848 0 CA-C-N 122.027 1.76 . . . . 0.0 112.198 -5.979 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' D' D ' 56' ' ' SER . . . . . . . . . . . . . 13.6 m -115.24 128.96 25.49 Favored Pre-proline 0 CA--C 1.539 0.525 0 CA-C-O 118.388 -0.815 . . . . 0.0 109.424 176.521 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' D' D ' 57' ' ' PRO . . . . . . . . . . . . . 56.7 Cg_endo -71.77 148.13 89.82 Favored 'Cis proline' 0 N--CA 1.497 1.688 0 CA-C-N 121.958 1.735 . . . . 0.0 111.62 0.19 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' D' D ' 58' ' ' LEU . . . . . . . . . . . . . 14.2 tp -107.69 135.73 48.63 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 116.296 -0.411 . . . . 0.0 110.559 -178.567 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' D' D ' 59' ' ' ARG . . . . . . . . . . . . . 43.6 ttp180 -106.19 124.47 49.64 Favored 'General case' 0 C--N 1.327 -0.41 0 N-CA-C 109.324 -0.621 . . . . 0.0 109.324 175.891 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' D' D ' 60' ' ' VAL . . . . . . . . . . . . . 41.4 t -79.98 120.99 32.47 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.299 0 C-N-CA 120.741 -0.384 . . . . 0.0 110.352 -175.46 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' D' D ' 61' ' ' GLU . . . . . . . . . . . . . 42.6 mt-10 -130.97 170.22 14.77 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.066 -0.515 . . . . 0.0 110.129 178.425 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' D' D ' 62' ' ' ASP . . . . . . . . . . . . . 45.1 m-20 -54.31 -32.54 56.79 Favored 'General case' 0 C--N 1.327 -0.379 0 N-CA-C 111.847 0.314 . . . . 0.0 111.847 -178.151 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' D' D ' 63' ' ' ARG . . . . . . . . . . . . . 30.7 ptt180 -88.47 4.41 46.64 Favored 'General case' 0 CA--C 1.537 0.446 0 N-CA-C 113.751 1.019 . . . . 0.0 113.751 -175.011 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' D' D ' 64' ' ' THR . . . . . . . . . . . . . 32.3 m -85.4 136.97 33.23 Favored 'General case' 0 C--N 1.332 -0.163 0 CA-C-O 120.934 0.397 . . . . 0.0 110.628 -178.609 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' D' D ' 65' ' ' LYS . . . . . . . . . . . . . 90.5 mttt -89.61 129.79 36.01 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.096 -0.502 . . . . 0.0 110.223 179.306 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' D' D ' 66' ' ' ILE . . . . . . . . . . . . . 62.5 mt -113.55 128.6 70.33 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.26 0 N-CA-C 109.575 -0.528 . . . . 0.0 109.575 178.684 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' D' D ' 67' ' ' THR . . . . . . . . . . . . . 27.0 m -122.3 138.73 54.41 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-O 120.991 0.424 . . . . 0.0 111.118 -176.31 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' D' D ' 68' ' ' LEU . . . . . . . . . . . . . 7.3 mp . . . . . 0 C--N 1.33 -0.264 0 CA-C-N 115.863 -0.608 . . . . 0.0 110.282 177.706 . . . . . . . . 0 0 . 1 . 006 nuclear orig core ' D' D ' 73' ' ' VAL . . . . . . . . . . . . . 15.6 m . . . . . 0 N--CA 1.462 0.161 0 CA-C-O 120.993 0.425 . . . . 0.0 110.667 . . . . . . . . . 0 0 . 1 . 006 nuclear orig core ' D' D ' 74' ' ' ASP . . . . . . . . . . . . . 5.0 t70 -108.77 118.87 37.92 Favored 'General case' 0 C--N 1.328 -0.362 0 N-CA-C 109.288 -0.634 . . . . 0.0 109.288 174.541 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' D' D ' 75' ' ' VAL . . . . . . . . . . . . . 41.9 t -113.74 125.68 71.06 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.214 0 CA-C-O 121.059 0.457 . . . . 0.0 110.898 -175.854 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' D' D ' 76' ' ' LEU . . . . . . . . . . . . . 5.6 mp -125.56 146.42 49.69 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 115.581 -0.736 . . . . 0.0 109.538 174.953 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' D' D ' 77' ' ' GLU . . . . . . . . . . . . . 99.2 mt-10 -134.23 131.23 38.27 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-O 121.134 0.492 . . . . 0.0 111.291 -176.95 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' D' D ' 78' ' ' ALA . . . . . . . . . . . . . . . -118.38 121.72 41.06 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 115.69 -0.686 . . . . 0.0 109.558 176.647 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' D' D ' 79' ' ' LYS . . . . . . . . . . . . . 19.2 pttp -71.77 122.65 21.04 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-O 121.134 0.492 . . . . 0.0 110.96 -178.091 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' D' D ' 80' ' ' ILE . . . . . . . . . . . . . 37.4 mm -139.19 108.87 3.94 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.355 0 N-CA-C 109.023 -0.732 . . . . 0.0 109.023 -178.122 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' D' D ' 81' ' ' LYS . . . . . . . . . . . . . 50.7 pttt -97.59 123.7 41.58 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-O 120.941 0.401 . . . . 0.0 111.152 -177.617 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' D' D ' 82' ' ' GLY . . . . . . . . . . . . . . . 88.97 42.26 5.69 Favored Glycine 0 CA--C 1.525 0.699 0 C-N-CA 120.718 -0.753 . . . . 0.0 111.533 174.649 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' D' D ' 83' ' ' ILE . . . . . . . . . . . . . 75.3 mt -65.91 137.17 25.41 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.332 0 N-CA-C 109.809 -0.441 . . . . 0.0 109.809 178.106 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' D' D ' 84' ' ' LYS . . . . . . . . . . . . . 50.9 tttp -98.59 -54.18 3.1 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.246 -0.434 . . . . 0.0 110.283 -179.469 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' D' D ' 85' ' ' ASP . . . . . . . . . . . . . 13.4 t70 -151.77 150.89 30.67 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 115.902 -0.59 . . . . 0.0 110.456 -179.474 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' D' D ' 86' ' ' VAL . . . . . . . . . . . . . 42.5 t -129.86 129.79 66.18 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.248 0 CA-C-O 120.974 0.416 . . . . 0.0 110.598 -179.058 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' D' D ' 87' ' ' ILE . . . . . . . . . . . . . 45.2 mm -118.83 125.79 74.75 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.286 0 CA-C-N 115.826 -0.625 . . . . 0.0 109.373 175.31 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' D' D ' 88' ' ' LEU . . . . . . . . . . . . . 30.8 mt -118.65 138.84 52.33 Favored 'General case' 0 C--N 1.332 -0.188 0 CA-C-O 121.316 0.579 . . . . 0.0 111.941 -175.427 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' D' D ' 89' ' ' ASP . . . . . . . . . . . . . 12.2 t0 -136.09 151.72 50.11 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 115.171 -0.922 . . . . 0.0 108.764 174.725 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' D' D ' 90' ' ' GLU . . . . . . . . . . . . . 83.5 tt0 -49.0 -31.8 8.13 Favored 'General case' 0 C--N 1.329 -0.32 0 N-CA-C 112.876 0.695 . . . . 0.0 112.876 -172.829 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' D' D ' 91' ' ' ASN . . . . . . . . . . . . . 12.4 p30 -117.24 3.07 12.62 Favored 'General case' 0 N--CA 1.469 0.513 0 N-CA-C 113.815 1.043 . . . . 0.0 113.815 -174.867 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' D' D ' 92' ' ' LEU . . . . . . . . . . . . . 17.7 mt -148.47 148.45 30.29 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 118.241 0.473 . . . . 0.0 110.647 -175.421 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' D' D ' 93' ' ' ILE . . . . . . . . . . . . . 75.9 mt -129.65 118.36 44.84 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.285 0 N-CA-C 109.233 -0.654 . . . . 0.0 109.233 176.949 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' D' D ' 94' ' ' VAL . . . . . . . . . . . . . 44.7 t -118.29 125.12 74.05 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.288 0 N-CA-C 109.884 -0.413 . . . . 0.0 109.884 -178.786 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' D' D ' 95' ' ' VAL . . . . . . . . . . . . . 43.5 t -120.91 134.09 65.45 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.343 0 CA-C-N 116.133 -0.485 . . . . 0.0 109.841 -179.703 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' D' D ' 96' ' ' ILE . . . . . . . . . . . . . 68.6 mt -114.42 126.71 72.01 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.339 0 N-CA-C 109.042 -0.725 . . . . 0.0 109.042 178.439 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' D' D ' 97' ' ' THR . . . . . . . . . . . . . 79.7 p -98.82 158.15 15.82 Favored 'General case' 0 C--N 1.331 -0.239 0 CA-C-O 121.176 0.512 . . . . 0.0 111.124 -176.965 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' D' D ' 98' ' ' GLU . . . . . . . . . . . . . 83.1 tt0 -53.98 -27.3 30.61 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-N 116.093 -0.503 . . . . 0.0 112.065 179.843 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' D' D ' 99' ' ' GLU . . . . . . . . . . . . . 96.6 mt-10 -78.07 13.48 1.43 Allowed 'General case' 0 CA--C 1.536 0.421 0 N-CA-C 113.294 0.85 . . . . 0.0 113.294 -176.852 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' D' D ' 100' ' ' ASN . . . . . . . . . . . . . 3.2 m-20 62.49 32.93 16.4 Favored 'General case' 0 N--CA 1.464 0.266 0 CA-C-O 120.898 0.38 . . . . 0.0 111.637 179.155 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' D' D ' 101' ' ' GLU . . . . . . . . . . . . . 84.6 tt0 -109.59 144.4 37.95 Favored 'General case' 0 C--N 1.334 -0.105 0 N-CA-C 109.709 -0.478 . . . . 0.0 109.709 173.247 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' D' D ' 102' ' ' VAL . . . . . . . . . . . . . 45.9 t -114.94 125.88 72.37 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.331 0 CA-C-N 116.113 -0.494 . . . . 0.0 109.858 -178.181 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' D' D ' 103' ' ' LEU . . . . . . . . . . . . . 53.1 mt -117.71 129.77 55.92 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 115.998 -0.546 . . . . 0.0 110.331 177.553 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' D' D ' 104' ' ' ILE . . . . . . . . . . . . . 70.3 mt -118.15 119.58 61.83 Favored 'Isoleucine or valine' 0 C--O 1.234 0.256 0 CA-C-N 116.393 -0.367 . . . . 0.0 110.173 -179.692 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' D' D ' 105' ' ' PHE . . . . . . . . . . . . . 46.6 m-85 -121.55 168.15 12.07 Favored 'General case' 0 C--N 1.332 -0.194 0 O-C-N 123.879 0.737 . . . . 0.0 109.738 179.794 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' D' D ' 106' ' ' ASN . . . . . . . . . . . . . 44.0 p-10 -99.42 -170.2 1.87 Allowed 'General case' 0 C--N 1.331 -0.217 0 N-CA-C 109.734 -0.469 . . . . 0.0 109.734 172.036 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' D' D ' 107' ' ' GLN . . . . . . . . . . . . . 59.3 tt0 -59.37 -30.03 68.12 Favored 'General case' 0 C--N 1.329 -0.31 0 N-CA-C 111.824 0.305 . . . . 0.0 111.824 -179.724 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' D' D ' 108' ' ' ASN . . . . . . . . . . . . . 11.8 t-20 -86.56 13.53 8.34 Favored 'General case' 0 CA--C 1.535 0.399 0 N-CA-C 112.904 0.705 . . . . 0.0 112.904 -177.152 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' D' D ' 109' ' ' LEU . . . . . . . . . . . . . 21.7 mt 58.51 34.03 23.58 Favored 'General case' 0 C--O 1.233 0.198 0 CA-C-O 120.73 0.3 . . . . 0.0 111.747 177.563 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' D' D ' 110' ' ' GLU . . . . . . . . . . . . . 96.1 mt-10 -99.73 138.8 36.31 Favored 'General case' 0 C--N 1.33 -0.28 0 N-CA-C 109.455 -0.572 . . . . 0.0 109.455 175.222 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' D' D ' 111' ' ' GLU . . . . . . . . . . . . . 48.3 tt0 -79.67 121.86 25.83 Favored 'General case' 0 C--N 1.327 -0.373 0 C-N-CA 120.759 -0.376 . . . . 0.0 110.293 -176.402 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' D' D ' 112' ' ' LEU . . . . . . . . . . . . . 26.6 mt -105.79 -46.01 4.24 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.019 -0.537 . . . . 0.0 110.432 179.656 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' D' D ' 113' ' ' TYR . . . . . . . . . . . . . 61.3 t80 -135.91 138.85 42.83 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.089 -0.505 . . . . 0.0 110.838 -179.041 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' D' D ' 114' ' ' ARG . . . . . . . . . . . . . 39.6 ptt180 -141.6 126.38 18.07 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-O 120.941 0.401 . . . . 0.0 110.681 176.913 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' D' D ' 115' ' ' GLY . . . . . . . . . . . . . . . -150.06 163.08 29.38 Favored Glycine 0 CA--C 1.522 0.515 0 N-CA-C 110.604 -0.999 . . . . 0.0 110.604 -179.723 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' D' D ' 116' ' ' LYS . . . . . . . . . . . . . 72.4 tttt -134.35 134.07 41.35 Favored 'General case' 0 C--N 1.33 -0.257 0 N-CA-C 110.093 -0.336 . . . . 0.0 110.093 179.192 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' D' D ' 117' ' ' PHE . . . . . . . . . . . . . 39.2 m-85 -134.03 114.01 12.74 Favored 'General case' 0 C--N 1.331 -0.209 0 CA-C-N 116.328 -0.396 . . . . 0.0 110.124 -175.18 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' D' D ' 118' ' ' GLU . . . . . . . . . . . . . 45.0 tp10 -53.49 -43.82 68.54 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.467 -0.333 . . . . 0.0 111.526 -175.665 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' D' D ' 119' ' ' ASN . . . . . . . . . . . . . 80.4 m-20 -99.69 31.04 3.36 Favored 'General case' 0 C--N 1.332 -0.175 0 N-CA-C 112.319 0.489 . . . . 0.0 112.319 -173.875 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' D' D ' 120' ' ' LEU . . . . . . . . . . . . . 15.0 tp -57.44 122.72 13.31 Favored 'General case' 0 C--N 1.331 -0.213 0 N-CA-C 110.162 -0.31 . . . . 0.0 110.162 177.386 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' D' D ' 121' ' ' ASN . . . . . . . . . . . . . 73.8 m-20 -114.02 -44.15 3.18 Favored 'General case' 0 C--O 1.232 0.153 0 CA-C-N 116.689 -0.232 . . . . 0.0 111.378 -176.883 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' D' D ' 122' ' ' LYS . . . . . . . . . . . . . 98.0 mttt -143.83 147.02 33.5 Favored 'General case' 0 C--N 1.333 -0.15 0 CA-C-O 121.072 0.463 . . . . 0.0 111.657 -178.36 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' D' D ' 123' ' ' VAL . . . . . . . . . . . . . 45.4 t -127.21 124.33 63.96 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.256 0 N-CA-C 109.302 -0.629 . . . . 0.0 109.302 174.158 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' D' D ' 124' ' ' LEU . . . . . . . . . . . . . 7.2 mp -115.39 131.49 56.91 Favored 'General case' 0 C--N 1.331 -0.229 0 CA-C-N 116.306 -0.406 . . . . 0.0 110.617 -177.898 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' D' D ' 125' ' ' VAL . . . . . . . . . . . . . 45.9 t -126.72 126.83 69.39 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.243 0 CA-C-N 116.128 -0.487 . . . . 0.0 109.999 179.49 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' D' D ' 126' ' ' ARG . . . . . . . . . . . . . 69.6 ttt180 -155.22 141.13 18.22 Favored 'General case' 0 C--N 1.328 -0.356 0 N-CA-C 109.527 -0.545 . . . . 0.0 109.527 177.542 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' D' D ' 127' ' ' ASN . . . . . . . . . . . . . 9.7 p30 48.73 -151.84 0.13 Allowed 'General case' 0 CA--C 1.54 0.593 0 CA-C-O 119.299 -0.381 . . . . 0.0 110.897 178.989 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' D' D ' 128' ' ' ASP . . . . . . . . . . . . . 12.7 p-10 -84.49 22.71 1.23 Allowed 'General case' 0 CA--C 1.535 0.385 0 CA-C-N 118.61 0.641 . . . . 0.0 112.264 177.705 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' D' D ' 129' ' ' LEU . . . . . . . . . . . . . 13.4 tp -120.72 137.02 54.7 Favored 'General case' 0 C--O 1.233 0.216 0 CA-C-O 121.061 0.458 . . . . 0.0 110.508 -179.605 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' D' D ' 130' ' ' VAL . . . . . . . . . . . . . 45.0 t -123.24 136.01 61.32 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.218 0 CA-C-N 115.949 -0.569 . . . . 0.0 109.61 178.26 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' D' D ' 131' ' ' VAL . . . . . . . . . . . . . 42.2 t -134.9 136.82 51.63 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.238 0 CA-C-O 121.186 0.517 . . . . 0.0 110.516 179.957 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' D' D ' 132' ' ' ILE . . . . . . . . . . . . . 72.1 mt -117.55 133.89 62.87 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.295 0 CA-C-N 115.639 -0.71 . . . . 0.0 109.63 -179.579 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' D' D ' 133' ' ' ILE . . . . . . . . . . . . . 43.1 mm -118.55 122.21 68.92 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.19 0 CA-C-O 120.961 0.41 . . . . 0.0 110.947 -176.221 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' D' D ' 134' ' ' ASP . . . . . . . . . . . . . 8.0 p-10 -135.11 148.04 49.69 Favored 'General case' 0 C--N 1.329 -0.299 0 N-CA-C 109.3 -0.63 . . . . 0.0 109.3 173.029 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' D' D ' 135' ' ' GLU . . . . . . . . . . . . . 43.5 tp10 -49.83 -24.74 2.59 Favored 'General case' 0 C--N 1.327 -0.386 0 N-CA-C 112.768 0.655 . . . . 0.0 112.768 -171.671 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' D' D ' 136' ' ' GLN . . . . . . . . . . . . . 46.5 tt0 -102.83 -24.65 13.69 Favored 'General case' 0 CA--C 1.533 0.298 0 N-CA-C 112.96 0.726 . . . . 0.0 112.96 -173.995 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' D' D ' 137' ' ' LYS . . . . . . . . . . . . . 97.3 mttt -143.65 152.77 41.77 Favored 'General case' 0 C--N 1.331 -0.201 0 CA-C-O 121.168 0.508 . . . . 0.0 111.821 -172.574 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' D' D ' 138' ' ' LEU . . . . . . . . . . . . . 4.4 tt -120.41 121.8 39.32 Favored 'General case' 0 C--N 1.33 -0.262 0 N-CA-C 109.079 -0.712 . . . . 0.0 109.079 172.434 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' D' D ' 139' ' ' THR . . . . . . . . . . . . . 34.3 m -111.23 130.4 55.66 Favored 'General case' 0 C--N 1.332 -0.193 0 CA-C-O 120.734 0.302 . . . . 0.0 111.036 -175.683 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' D' D ' 140' ' ' LEU . . . . . . . . . . . . . 5.6 tt -116.98 122.54 44.53 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 115.618 -0.719 . . . . 0.0 109.238 -179.683 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' D' D ' 141' ' ' ILE . . . . . . . . . . . . . 18.8 mt -121.6 122.74 67.83 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.248 0 CA-C-O 120.888 0.375 . . . . 0.0 110.085 -175.663 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' D' D ' 142' ' ' ARG . . . . . . . . . . . . . 73.4 mtp180 -110.9 125.95 54.2 Favored 'General case' 0 C--N 1.331 -0.22 0 CA-C-N 115.682 -0.69 . . . . 0.0 110.16 -179.534 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' D' D ' 143' ' ' THR . . . . . . . . . . . . . 66.6 p . . . . . 0 C--O 1.219 -0.503 0 CA-C-O 118.074 -0.965 . . . . 0.0 110.492 -179.796 . . . . . . . . 0 0 . 1 . 006 nuclear orig core ' E' E ' 2' ' ' SER . . . . . . . . . . . . . 6.4 p . . . . . 0 N--CA 1.462 0.166 0 CA-C-O 121.033 0.444 . . . . 0.0 110.994 . . . . . . . . . 0 0 . 1 . 006 nuclear orig core ' E' E ' 3' ' ' GLU . . . . . . . . . . . . . 95.1 mt-10 -140.91 141.95 34.49 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 115.876 -0.602 . . . . 0.0 110.961 -179.238 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' E' E ' 4' ' ' LEU . . . . . . . . . . . . . 15.0 tp -126.77 126.16 42.95 Favored 'General case' 0 C--N 1.331 -0.206 0 CA-C-N 116.091 -0.504 . . . . 0.0 109.97 176.516 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' E' E ' 5' ' ' LYS . . . . . . . . . . . . . 68.6 mttm -106.11 122.2 45.7 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-O 120.844 0.355 . . . . 0.0 110.826 178.426 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' E' E ' 6' ' ' LEU . . . . . . . . . . . . . 74.6 mt -118.59 146.56 44.52 Favored 'General case' 0 C--N 1.331 -0.209 0 CA-C-N 115.535 -0.757 . . . . 0.0 110.311 179.765 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' E' E ' 7' ' ' LYS . . . . . . . . . . . . . 80.0 tttt -135.66 140.24 33.26 Favored Pre-proline 0 CA--C 1.534 0.335 0 CA-C-O 119.093 -0.479 . . . . 0.0 110.254 176.985 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' E' E ' 8' ' ' PRO . . . . . . . . . . . . . 88.8 Cg_endo -91.98 143.39 2.74 Favored 'Trans proline' 0 N--CA 1.49 1.311 0 C-N-CA 121.827 1.685 . . . . 0.0 111.934 177.773 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' E' E ' 9' ' ' LEU . . . . . . . . . . . . . 60.8 mt -77.37 -47.51 2.52 Favored Pre-proline 0 CA--C 1.533 0.317 0 CA-C-O 118.688 -0.673 . . . . 0.0 112.226 179.533 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' E' E ' 10' ' ' PRO . . . . . . . . . . . . . 94.8 Cg_endo -80.26 142.82 15.31 Favored 'Trans proline' 0 N--CA 1.495 1.582 0 C-N-CA 121.133 1.222 . . . . 0.0 111.518 175.905 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' E' E ' 11' ' ' LYS . . . . . . . . . . . . . 46.0 pttt -83.76 113.38 20.86 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-O 121.496 0.665 . . . . 0.0 110.879 -179.74 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' E' E ' 12' ' ' VAL . . . . . . . . . . . . . 12.2 p -151.18 148.54 14.8 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.284 0 CA-C-N 115.649 -0.705 . . . . 0.0 110.377 179.873 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' E' E ' 13' ' ' GLU . . . . . . . . . . . . . 43.0 mt-10 -83.78 116.03 22.51 Favored 'General case' 0 C--N 1.329 -0.313 0 N-CA-C 110.144 -0.317 . . . . 0.0 110.144 177.658 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' E' E ' 14' ' ' LEU . . . . . . . . . . . . . 31.1 mt -99.33 143.53 26.59 Favored Pre-proline 0 CA--C 1.533 0.309 0 CA-C-O 119.09 -0.481 . . . . 0.0 110.279 -179.439 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' E' E ' 15' ' ' PRO . . . . . . . . . . . . . 25.7 Cg_exo -62.55 157.34 47.11 Favored 'Trans proline' 0 N--CA 1.498 1.774 0 C-N-CA 121.342 1.361 . . . . 0.0 112.013 177.682 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' E' E ' 16' ' ' PRO . . . . . . . . . . . . . 31.4 Cg_exo -59.76 -34.43 95.93 Favored 'Trans proline' 0 N--CA 1.498 1.752 0 C-N-CA 121.452 1.435 . . . . 0.0 112.782 179.969 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' E' E ' 17' ' ' ASP . . . . . . . . . . . . . 9.1 p-10 -83.32 4.43 27.24 Favored 'General case' 0 CA--C 1.537 0.465 0 N-CA-C 113.26 0.837 . . . . 0.0 113.26 -177.462 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' E' E ' 18' ' ' PHE . . . . . . . . . . . . . 33.8 t80 -58.06 -44.69 87.63 Favored 'General case' 0 C--N 1.334 -0.07 0 O-C-N 121.884 -0.51 . . . . 0.0 109.898 -178.574 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' E' E ' 19' ' ' VAL . . . . . . . . . . . . . 48.5 t -58.3 -40.33 77.45 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.361 0 CA-C-N 116.037 -0.529 . . . . 0.0 110.525 -178.725 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' E' E ' 20' ' ' ASP . . . . . . . . . . . . . 11.8 t70 -58.85 -43.74 90.86 Favored 'General case' 0 C--O 1.234 0.268 0 CA-C-O 120.947 0.403 . . . . 0.0 110.772 -177.223 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' E' E ' 21' ' ' VAL . . . . . . . . . . . . . 48.4 t -65.8 -51.98 55.24 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.291 0 C-N-CA 120.662 -0.415 . . . . 0.0 110.517 -179.011 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' E' E ' 22' ' ' ILE . . . . . . . . . . . . . 50.4 mm -55.24 -54.09 28.29 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.295 0 C-N-CA 120.901 -0.32 . . . . 0.0 111.168 -176.665 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' E' E ' 23' ' ' ARG . . . . . . . . . . . . . 13.8 ptm180 -58.52 -44.45 89.52 Favored 'General case' 0 C--N 1.33 -0.249 0 C-N-CA 120.773 -0.371 . . . . 0.0 111.721 -172.973 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' E' E ' 24' ' ' ILE . . . . . . . . . . . . . 86.9 mt -64.18 -34.97 72.29 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.303 0 C-N-CA 120.767 -0.373 . . . . 0.0 111.355 -177.714 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' E' E ' 25' ' ' LYS . . . . . . . . . . . . . 34.4 mmtp -67.87 -44.07 77.93 Favored 'General case' 0 C--N 1.33 -0.27 0 N-CA-C 112.09 0.404 . . . . 0.0 112.09 177.365 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' E' E ' 26' ' ' LEU . . . . . . . . . . . . . 75.8 mt -85.49 -23.79 27.63 Favored 'General case' 0 C--N 1.329 -0.294 0 N-CA-C 114.065 1.135 . . . . 0.0 114.065 -170.266 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' E' E ' 27' ' ' GLN . . . . . . . . . . . . . 8.3 pt20 -47.63 145.66 2.58 Favored 'General case' 0 N--CA 1.47 0.535 0 N-CA-C 112.553 0.575 . . . . 0.0 112.553 -176.152 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' E' E ' 28' ' ' GLY . . . . . . . . . . . . . . . 99.77 -23.82 34.58 Favored Glycine 0 CA--C 1.532 1.121 0 CA-C-N 115.512 -0.767 . . . . 0.0 112.2 -175.28 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' E' E ' 29' ' ' LYS . . . . . . . . . . . . . 79.9 mttt -94.54 155.06 17.09 Favored 'General case' 0 C--O 1.233 0.212 0 CA-C-N 117.577 0.689 . . . . 0.0 110.518 177.153 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' E' E ' 30' ' ' THR . . . . . . . . . . . . . 26.9 m -107.48 138.5 43.57 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 116.116 -0.493 . . . . 0.0 110.128 178.056 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' E' E ' 31' ' ' VAL . . . . . . . . . . . . . 34.7 m -127.24 151.66 34.36 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.199 0 CA-C-O 121.005 0.431 . . . . 0.0 110.893 -179.161 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' E' E ' 32' ' ' ARG . . . . . . . . . . . . . 55.0 ttt180 -128.32 150.09 50.23 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 115.893 -0.594 . . . . 0.0 110.073 179.389 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' E' E ' 33' ' ' THR . . . . . . . . . . . . . 23.2 m -52.59 137.62 30.08 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-O 120.733 0.302 . . . . 0.0 111.528 -177.357 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' E' E ' 34' ' ' GLY . . . . . . . . . . . . . . . 100.03 -17.04 57.73 Favored Glycine 0 CA--C 1.533 1.183 0 CA-C-O 119.671 -0.516 . . . . 0.0 113.313 178.763 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' E' E ' 35' ' ' ASP . . . . . . . . . . . . . 76.7 m-20 -67.22 149.88 49.83 Favored 'General case' 0 N--CA 1.462 0.144 0 CA-C-N 117.983 0.891 . . . . 0.0 111.266 179.043 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' E' E ' 36' ' ' VAL . . . . . . . . . . . . . 44.8 t -121.23 130.5 74.59 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.186 0 CA-C-N 115.966 -0.561 . . . . 0.0 109.956 178.464 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' E' E ' 37' ' ' ILE . . . . . . . . . . . . . 69.9 mt -121.27 139.09 49.52 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.279 0 CA-C-N 116.139 -0.482 . . . . 0.0 109.85 179.839 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' E' E ' 38' ' ' GLY . . . . . . . . . . . . . . . -114.33 129.38 8.68 Favored Glycine 0 CA--C 1.527 0.784 0 N-CA-C 111.53 -0.628 . . . . 0.0 111.53 -177.791 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' E' E ' 39' ' ' ILE . . . . . . . . . . . . . 69.9 mt -121.85 136.76 57.71 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.189 0 N-CA-C 109.829 -0.434 . . . . 0.0 109.829 177.765 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' E' E ' 40' ' ' SER . . . . . . . . . . . . . 39.7 t -92.88 113.98 26.41 Favored 'General case' 0 C--N 1.33 -0.264 0 C-N-CA 120.935 -0.306 . . . . 0.0 110.895 176.167 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' E' E ' 41' ' ' ILE . . . . . . . . . . . . . 47.9 mm -120.87 113.2 39.01 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.167 0 N-CA-C 110.157 -0.312 . . . . 0.0 110.157 179.196 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' E' E ' 42' ' ' LEU . . . . . . . . . . . . . 7.0 mp 57.01 36.17 27.41 Favored 'General case' 0 CA--C 1.533 0.298 0 CA-C-O 120.84 0.352 . . . . 0.0 111.232 179.681 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' E' E ' 43' ' ' GLY . . . . . . . . . . . . . . . 77.74 -10.17 26.21 Favored Glycine 0 CA--C 1.535 1.29 0 C-N-CA 121.245 -0.502 . . . . 0.0 113.566 177.708 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' E' E ' 44' ' ' LYS . . . . . . . . . . . . . 49.4 tptt -94.95 132.91 39.27 Favored 'General case' 0 C--N 1.332 -0.19 0 CA-C-N 117.763 0.781 . . . . 0.0 109.695 176.821 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' E' E ' 45' ' ' GLU . . . . . . . . . . . . . 84.5 tt0 -83.49 125.82 32.14 Favored 'General case' 0 C--N 1.328 -0.359 0 C-N-CA 120.838 -0.345 . . . . 0.0 111.003 -178.796 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' E' E ' 46' ' ' VAL . . . . . . . . . . . . . 7.2 p -119.44 124.68 73.42 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.231 0 N-CA-C 109.311 -0.626 . . . . 0.0 109.311 175.268 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' E' E ' 47' ' ' LYS . . . . . . . . . . . . . 60.6 mttp -99.36 128.34 45.47 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 115.976 -0.557 . . . . 0.0 111.11 178.486 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' E' E ' 48' ' ' PHE . . . . . . . . . . . . . 95.7 m-85 -110.2 131.87 54.67 Favored 'General case' 0 C--N 1.329 -0.321 0 N-CA-C 109.687 -0.486 . . . . 0.0 109.687 175.44 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' E' E ' 49' ' ' LYS . . . . . . . . . . . . . 61.9 tttm -106.99 136.6 46.58 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.485 -0.325 . . . . 0.0 110.283 178.984 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' E' E ' 50' ' ' VAL . . . . . . . . . . . . . 45.7 t -75.4 107.29 5.98 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.34 0 N-CA-C 109.023 -0.732 . . . . 0.0 109.023 175.715 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' E' E ' 51' ' ' VAL . . . . . . . . . . . . . 47.0 t -71.34 -48.07 55.98 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.261 0 O-C-N 123.511 0.507 . . . . 0.0 109.856 -174.063 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' E' E ' 52' ' ' GLN . . . . . . . . . . . . . 48.2 tt0 -168.11 135.65 2.19 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 116.051 -0.522 . . . . 0.0 111.445 -179.142 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' E' E ' 53' ' ' ALA . . . . . . . . . . . . . . . -110.34 131.44 55.05 Favored 'General case' 0 C--N 1.331 -0.23 0 CA-C-N 115.943 -0.571 . . . . 0.0 109.865 176.114 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' E' E ' 54' ' ' TYR . . . . . . . . . . . . . 34.0 t80 -129.07 108.0 18.01 Favored Pre-proline 0 CA--C 1.535 0.389 0 CA-C-O 118.28 -0.867 . . . . 0.0 110.379 -179.735 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' E' E ' 55' ' ' PRO . . . . . . . . . . . . . 73.9 Cg_endo -77.09 170.02 72.74 Favored 'Cis proline' 0 N--CA 1.499 1.833 0 CA-C-N 121.85 1.697 . . . . 0.0 112.369 -5.351 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' E' E ' 56' ' ' SER . . . . . . . . . . . . . 48.9 m -115.9 137.12 23.1 Favored Pre-proline 0 CA--C 1.538 0.518 0 CA-C-O 118.51 -0.757 . . . . 0.0 109.565 175.547 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' E' E ' 57' ' ' PRO . . . . . . . . . . . . . 59.7 Cg_endo -73.76 146.79 87.89 Favored 'Cis proline' 0 N--CA 1.497 1.712 0 CA-C-N 121.705 1.644 . . . . 0.0 111.553 -2.481 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' E' E ' 58' ' ' LEU . . . . . . . . . . . . . 31.1 tp -108.38 138.3 44.91 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.375 -0.375 . . . . 0.0 110.762 -177.509 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' E' E ' 59' ' ' ARG . . . . . . . . . . . . . 55.8 ttp180 -102.04 128.71 48.37 Favored 'General case' 0 C--N 1.327 -0.387 0 N-CA-C 109.266 -0.642 . . . . 0.0 109.266 175.837 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' E' E ' 60' ' ' VAL . . . . . . . . . . . . . 42.3 t -84.88 116.36 28.31 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.233 0 C-N-CA 120.743 -0.383 . . . . 0.0 110.815 -173.235 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' E' E ' 61' ' ' GLU . . . . . . . . . . . . . 95.8 mt-10 -131.25 159.47 37.72 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 115.909 -0.587 . . . . 0.0 110.139 175.095 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' E' E ' 62' ' ' ASP . . . . . . . . . . . . . 81.4 m-20 -54.43 -30.79 53.75 Favored 'General case' 0 C--N 1.329 -0.319 0 N-CA-C 111.893 0.331 . . . . 0.0 111.893 179.507 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' E' E ' 63' ' ' ARG . . . . . . . . . . . . . 39.0 ptt180 -78.4 -1.18 32.2 Favored 'General case' 0 CA--C 1.538 0.487 0 N-CA-C 113.72 1.007 . . . . 0.0 113.72 -175.8 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' E' E ' 64' ' ' THR . . . . . . . . . . . . . 31.6 m -93.4 148.25 22.23 Favored 'General case' 0 C--N 1.331 -0.199 0 CA-C-N 118.168 0.44 . . . . 0.0 110.305 -179.134 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' E' E ' 65' ' ' LYS . . . . . . . . . . . . . 43.7 mtmt -86.31 122.44 30.29 Favored 'General case' 0 C--N 1.329 -0.287 0 C-N-CA 120.654 -0.419 . . . . 0.0 110.213 179.413 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' E' E ' 66' ' ' ILE . . . . . . . . . . . . . 61.0 mt -112.26 125.71 69.57 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.246 0 N-CA-C 109.393 -0.595 . . . . 0.0 109.393 179.91 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' E' E ' 67' ' ' THR . . . . . . . . . . . . . 27.8 m -119.33 138.12 53.25 Favored 'General case' 0 C--N 1.331 -0.202 0 CA-C-N 116.235 -0.439 . . . . 0.0 110.891 -175.749 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' E' E ' 68' ' ' LEU . . . . . . . . . . . . . 4.4 tt . . . . . 0 C--N 1.329 -0.31 0 CA-C-N 115.788 -0.642 . . . . 0.0 109.725 178.191 . . . . . . . . 0 0 . 1 . 006 nuclear orig core ' E' E ' 73' ' ' VAL . . . . . . . . . . . . . 35.9 m . . . . . 0 C--O 1.233 0.187 0 CA-C-O 120.8 0.333 . . . . 0.0 110.667 . . . . . . . . . 0 0 . 1 . 006 nuclear orig core ' E' E ' 74' ' ' ASP . . . . . . . . . . . . . 6.0 t70 -103.04 122.3 44.35 Favored 'General case' 0 C--N 1.329 -0.296 0 N-CA-C 109.614 -0.513 . . . . 0.0 109.614 -178.937 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' E' E ' 75' ' ' VAL . . . . . . . . . . . . . 40.5 t -119.37 125.73 74.68 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.241 0 CA-C-O 121.095 0.474 . . . . 0.0 110.808 -176.699 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' E' E ' 76' ' ' LEU . . . . . . . . . . . . . 6.0 mp -120.51 143.37 48.59 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 115.659 -0.7 . . . . 0.0 109.586 174.701 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' E' E ' 77' ' ' GLU . . . . . . . . . . . . . 47.1 mt-10 -134.99 129.05 33.57 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-O 121.022 0.439 . . . . 0.0 110.768 -178.563 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' E' E ' 78' ' ' ALA . . . . . . . . . . . . . . . -114.47 133.6 55.63 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 115.802 -0.635 . . . . 0.0 109.865 177.854 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' E' E ' 79' ' ' LYS . . . . . . . . . . . . . 83.3 tttt -78.8 114.87 18.09 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.332 -0.395 . . . . 0.0 109.981 -179.792 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' E' E ' 80' ' ' ILE . . . . . . . . . . . . . 41.9 mm -138.14 121.16 19.77 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.255 0 N-CA-C 109.864 -0.421 . . . . 0.0 109.864 -175.551 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' E' E ' 81' ' ' LYS . . . . . . . . . . . . . 9.6 mtmp? -110.92 126.9 55.22 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-O 120.962 0.41 . . . . 0.0 111.02 -178.426 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' E' E ' 82' ' ' GLY . . . . . . . . . . . . . . . 89.06 42.12 5.7 Favored Glycine 0 CA--C 1.525 0.679 0 C-N-CA 121.003 -0.618 . . . . 0.0 112.025 174.403 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' E' E ' 83' ' ' ILE . . . . . . . . . . . . . 74.7 mt -67.78 133.26 31.88 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.246 0 N-CA-C 109.719 -0.474 . . . . 0.0 109.719 177.329 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' E' E ' 84' ' ' LYS . . . . . . . . . . . . . 83.0 tttt -97.21 -54.15 3.25 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 115.999 -0.546 . . . . 0.0 110.465 -176.979 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' E' E ' 85' ' ' ASP . . . . . . . . . . . . . 13.8 t70 -152.15 149.87 29.24 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 115.604 -0.726 . . . . 0.0 110.163 -179.226 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' E' E ' 86' ' ' VAL . . . . . . . . . . . . . 44.0 t -133.5 131.08 57.31 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.297 0 CA-C-O 120.97 0.414 . . . . 0.0 110.523 -179.66 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' E' E ' 87' ' ' ILE . . . . . . . . . . . . . 46.9 mm -120.07 126.53 75.38 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.254 0 CA-C-N 115.846 -0.616 . . . . 0.0 109.585 176.241 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' E' E ' 88' ' ' LEU . . . . . . . . . . . . . 53.6 mt -110.96 135.75 51.0 Favored 'General case' 0 C--N 1.331 -0.218 0 CA-C-O 121.153 0.501 . . . . 0.0 111.375 -176.243 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' E' E ' 89' ' ' ASP . . . . . . . . . . . . . 7.8 t0 -128.84 150.52 50.3 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 115.596 -0.729 . . . . 0.0 109.034 175.045 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' E' E ' 90' ' ' GLU . . . . . . . . . . . . . 44.1 mt-10 -49.12 -32.82 10.65 Favored 'General case' 0 C--N 1.329 -0.31 0 N-CA-C 112.864 0.69 . . . . 0.0 112.864 -172.339 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' E' E ' 91' ' ' ASN . . . . . . . . . . . . . 65.7 m-80 -131.86 28.68 4.51 Favored 'General case' 0 N--CA 1.467 0.388 0 N-CA-C 112.412 0.523 . . . . 0.0 112.412 -176.208 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' E' E ' 92' ' ' LEU . . . . . . . . . . . . . 9.0 tp -166.2 145.7 6.02 Favored 'General case' 0 C--N 1.33 -0.258 0 N-CA-C 110.207 -0.294 . . . . 0.0 110.207 179.623 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' E' E ' 93' ' ' ILE . . . . . 0.4 HG23 HD12 ' E' ' 93' ' ' ILE . 69.2 mt -127.72 125.17 64.72 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.202 0 N-CA-C 109.795 -0.446 . . . . 0.0 109.795 179.857 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' E' E ' 94' ' ' VAL . . . . . . . . . . . . . 45.8 t -120.88 125.91 74.6 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.22 0 N-CA-C 109.688 -0.486 . . . . 0.0 109.688 179.255 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' E' E ' 95' ' ' VAL . . . . . . . . . . . . . 43.3 t -122.52 135.18 63.44 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.236 0 CA-C-N 116.205 -0.452 . . . . 0.0 109.979 -178.471 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' E' E ' 96' ' ' ILE . . . . . . . . . . . . . 57.1 mt -116.27 130.11 71.57 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 N-CA-C 109.372 -0.603 . . . . 0.0 109.372 179.224 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' E' E ' 97' ' ' THR . . . . . . . . . . . . . 72.9 p -102.23 154.85 18.64 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-O 121.184 0.516 . . . . 0.0 111.056 -178.778 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' E' E ' 98' ' ' GLU . . . . . . . . . . . . . 96.8 mt-10 -54.23 -23.26 14.07 Favored 'General case' 0 CA--C 1.533 0.318 0 N-CA-C 112.366 0.506 . . . . 0.0 112.366 178.932 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' E' E ' 99' ' ' GLU . . . . . . . . . . . . . 32.5 tt0 -79.09 14.69 1.35 Allowed 'General case' 0 CA--C 1.539 0.523 0 N-CA-C 112.688 0.625 . . . . 0.0 112.688 -177.97 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' E' E ' 100' ' ' ASN . . . . . . . . . . . . . 4.4 m-20 62.35 38.06 13.35 Favored 'General case' 0 C--O 1.231 0.117 0 O-C-N 121.801 -0.562 . . . . 0.0 111.002 178.817 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' E' E ' 101' ' ' GLU . . . . . . . . . . . . . 84.9 tt0 -118.01 142.64 47.16 Favored 'General case' 0 C--N 1.331 -0.212 0 CA-C-N 115.996 -0.547 . . . . 0.0 109.845 176.263 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' E' E ' 102' ' ' VAL . . . . . . . . . . . . . 45.5 t -114.97 128.51 72.09 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.306 0 N-CA-C 109.811 -0.44 . . . . 0.0 109.811 -178.688 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' E' E ' 103' ' ' LEU . . . . . . . . . . . . . 51.0 mt -120.29 134.85 55.18 Favored 'General case' 0 C--N 1.331 -0.219 0 CA-C-N 115.865 -0.607 . . . . 0.0 110.382 178.222 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' E' E ' 104' ' ' ILE . . . . . . . . . . . . . 67.8 mt -118.78 124.36 73.03 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.304 0 N-CA-C 110.077 -0.342 . . . . 0.0 110.077 -179.745 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' E' E ' 105' ' ' PHE . . . . . . . . . . . . . 92.2 m-85 -124.07 162.77 22.84 Favored 'General case' 0 C--N 1.332 -0.194 0 O-C-N 123.912 0.758 . . . . 0.0 109.984 -179.981 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' E' E ' 106' ' ' ASN . . . . . . . . . . . . . 47.7 p-10 -98.59 -170.5 1.95 Allowed 'General case' 0 C--N 1.33 -0.279 0 N-CA-C 109.871 -0.418 . . . . 0.0 109.871 174.551 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' E' E ' 107' ' ' GLN . . . . . . . . . . . . . 46.0 tt0 -60.18 -30.07 69.1 Favored 'General case' 0 C--N 1.329 -0.297 0 N-CA-C 111.987 0.366 . . . . 0.0 111.987 -178.827 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' E' E ' 108' ' ' ASN . . . . . . . . . . . . . 59.9 t30 -84.86 10.16 12.34 Favored 'General case' 0 CA--C 1.536 0.439 0 N-CA-C 113.154 0.798 . . . . 0.0 113.154 -177.632 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' E' E ' 109' ' ' LEU . . . . . . . . . . . . . 8.4 tp 58.6 37.18 25.4 Favored 'General case' 0 C--N 1.331 -0.198 0 CA-C-O 121.065 0.459 . . . . 0.0 111.232 179.476 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' E' E ' 110' ' ' GLU . . . . . . . . . . . . . 70.5 mm-40 -103.4 142.16 34.71 Favored 'General case' 0 C--N 1.329 -0.303 0 N-CA-C 109.358 -0.608 . . . . 0.0 109.358 174.908 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' E' E ' 111' ' ' GLU . . . . . . . . . . . . . 71.6 tt0 -78.36 121.77 24.9 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-O 120.94 0.4 . . . . 0.0 110.387 -175.199 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' E' E ' 112' ' ' LEU . . . . . . . . . . . . . 15.3 mt -106.21 -46.02 4.16 Favored 'General case' 0 C--N 1.331 -0.196 0 CA-C-N 116.08 -0.509 . . . . 0.0 110.778 -178.913 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' E' E ' 113' ' ' TYR . . . . . . . . . . . . . 59.0 t80 -137.31 144.38 42.58 Favored 'General case' 0 C--N 1.331 -0.223 0 CA-C-N 116.204 -0.453 . . . . 0.0 111.012 -178.4 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' E' E ' 114' ' ' ARG . . . . . . . . . . . . . 48.1 ptt85 -147.12 125.75 12.53 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.271 -0.422 . . . . 0.0 111.003 179.073 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' E' E ' 115' ' ' GLY . . . . . . . . . . . . . . . -149.98 153.95 25.4 Favored Glycine 0 CA--C 1.525 0.678 0 N-CA-C 111.231 -0.748 . . . . 0.0 111.231 178.206 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' E' E ' 116' ' ' LYS . . . . . . . . . . . . . 25.9 ttpp -124.83 132.49 53.33 Favored 'General case' 0 C--N 1.331 -0.212 0 N-CA-C 109.942 -0.392 . . . . 0.0 109.942 178.352 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' E' E ' 117' ' ' PHE . . . . . . . . . . . . . 48.5 m-85 -130.68 115.9 17.32 Favored 'General case' 0 C--N 1.331 -0.206 0 CA-C-O 120.928 0.394 . . . . 0.0 110.373 -175.568 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' E' E ' 118' ' ' GLU . . . . . . . . . . . . . 46.1 tp10 -52.84 -51.11 62.2 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.36 -0.382 . . . . 0.0 111.784 -174.734 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' E' E ' 119' ' ' ASN . . . . . . . . . . . . . 3.2 p30 -98.45 31.31 2.88 Favored 'General case' 0 C--N 1.33 -0.274 0 N-CA-C 112.197 0.443 . . . . 0.0 112.197 -174.418 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' E' E ' 120' ' ' LEU . . . . . . . . . . . . . 14.5 tp -51.71 124.81 13.24 Favored 'General case' 0 N--CA 1.464 0.237 0 CA-C-O 120.535 0.207 . . . . 0.0 111.057 178.025 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' E' E ' 121' ' ' ASN . . . . . . . . . . . . . 15.6 m120 -113.55 -44.06 3.25 Favored 'General case' 0 C--O 1.232 0.183 0 CA-C-N 116.727 -0.215 . . . . 0.0 111.285 -176.495 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' E' E ' 122' ' ' LYS . . . . . . . . . . . . . 98.8 mttt -145.36 148.53 33.48 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-O 121.049 0.452 . . . . 0.0 111.826 -176.737 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' E' E ' 123' ' ' VAL . . . . . . . . . . . . . 45.6 t -129.41 130.93 67.6 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.293 0 N-CA-C 109.396 -0.594 . . . . 0.0 109.396 175.462 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' E' E ' 124' ' ' LEU . . . . . . . . . . . . . 19.7 tp -130.26 133.97 46.9 Favored 'General case' 0 C--N 1.332 -0.163 0 CA-C-O 120.791 0.329 . . . . 0.0 110.748 -177.179 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' E' E ' 125' ' ' VAL . . . . . . . . . . . . . 11.1 p -133.67 135.49 55.49 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.25 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.303 179.776 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' E' E ' 126' ' ' ARG . . . . . . . . . . . . . 20.8 ttm180 -144.39 121.86 11.71 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.307 -0.406 . . . . 0.0 110.626 178.331 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' E' E ' 127' ' ' ASN . . . . . . . . . . . . . 4.3 m120 49.41 -106.39 0.2 Allowed 'General case' 0 CA--C 1.545 0.77 0 CA-C-O 118.957 -0.544 . . . . 0.0 111.639 178.994 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' E' E ' 128' ' ' ASP . . . . . . . . . . . . . 11.6 p-10 -114.09 4.0 15.47 Favored 'General case' 0 N--CA 1.468 0.468 0 CA-C-N 119.693 1.133 . . . . 0.0 113.408 -177.21 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' E' E ' 129' ' ' LEU . . . . . . . . . . . . . 15.5 tp -107.13 132.67 52.75 Favored 'General case' 0 C--N 1.333 -0.147 0 N-CA-C 109.561 -0.533 . . . . 0.0 109.561 178.617 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' E' E ' 130' ' ' VAL . . . . . . . . . . . . . 41.5 t -122.92 136.55 59.35 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.243 0 CA-C-O 120.668 0.271 . . . . 0.0 110.349 -177.309 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' E' E ' 131' ' ' VAL . . . . . . . . . . . . . 27.1 m -136.07 140.81 43.23 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.236 0 CA-C-O 121.166 0.508 . . . . 0.0 111.274 177.579 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' E' E ' 132' ' ' ILE . . . . . . . . . . . . . 75.5 mt -121.22 132.4 70.67 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.384 0 CA-C-N 115.39 -0.823 . . . . 0.0 109.171 178.125 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' E' E ' 133' ' ' ILE . . . . . . . . . . . . . 33.2 mm -115.37 121.17 66.65 Favored 'Isoleucine or valine' 0 C--O 1.234 0.251 0 CA-C-O 120.898 0.38 . . . . 0.0 111.237 -173.464 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' E' E ' 134' ' ' ASP . . . . . . . . . . . . . 7.3 p-10 -133.59 146.53 51.05 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 115.904 -0.589 . . . . 0.0 109.584 175.724 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' E' E ' 135' ' ' GLU . . . . . . . . . . . . . 39.2 tp10 -49.93 -26.8 4.49 Favored 'General case' 0 C--N 1.326 -0.422 0 N-CA-C 112.815 0.672 . . . . 0.0 112.815 -173.407 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' E' E ' 136' ' ' GLN . . . . . . . . . . . . . 49.7 tt0 -81.91 -32.99 30.66 Favored 'General case' 0 C--O 1.234 0.274 0 N-CA-C 112.328 0.492 . . . . 0.0 112.328 -175.968 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' E' E ' 137' ' ' LYS . . . . . . . . . . . . . 50.7 pttt -170.06 173.04 6.14 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-O 121.451 0.643 . . . . 0.0 112.27 -172.967 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' E' E ' 138' ' ' LEU . . . . . . . . . . . . . 6.6 tt -118.33 129.13 55.26 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 115.212 -0.904 . . . . 0.0 110.055 179.521 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' E' E ' 139' ' ' THR . . . . . . . . . . . . . 24.4 m -106.87 130.25 54.58 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.439 -0.346 . . . . 0.0 110.516 -179.803 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' E' E ' 140' ' ' LEU . . . . . . . . . . . . . 51.2 tp -118.34 127.21 53.48 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 115.784 -0.644 . . . . 0.0 109.413 -177.766 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' E' E ' 141' ' ' ILE . . . . . . . . . . . . . 19.1 mt -123.49 122.38 64.92 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 CA-C-N 116.397 -0.365 . . . . 0.0 110.143 -174.996 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' E' E ' 142' ' ' ARG . . . . . . . . . . . . . 84.4 mtp180 -108.77 129.41 55.38 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-N 115.523 -0.762 . . . . 0.0 110.455 179.46 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' E' E ' 143' ' ' THR . . . . . . . . . . . . . 40.0 p . . . . . 0 C--O 1.221 -0.442 0 CA-C-O 117.961 -1.018 . . . . 0.0 110.605 179.145 . . . . . . . . 0 0 . 1 . 006 nuclear orig core ' F' F ' 1' ' ' MET . . . . . . . . . . . . . 24.2 ptp . . . . . 0 C--O 1.231 0.125 0 CA-C-O 120.784 0.326 . . . . 0.0 110.728 . . . . . . . . . 0 0 . 1 . 006 nuclear orig core ' F' F ' 2' ' ' SER . . . . . . . . . . . . . 4.5 p -115.79 131.19 57.01 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.107 -0.497 . . . . 0.0 110.098 177.249 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' F' F ' 3' ' ' GLU . . . . . . . . . . . . . 84.8 tt0 -142.75 141.07 31.67 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.054 -0.521 . . . . 0.0 111.08 -178.304 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' F' F ' 4' ' ' LEU . . . . . . . . . . . . . 18.0 tp -127.41 132.52 50.1 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 115.883 -0.599 . . . . 0.0 110.216 178.097 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' F' F ' 5' ' ' LYS . . . . . . . . . . . . . 68.6 mttm -112.03 121.06 43.95 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-N 116.338 -0.392 . . . . 0.0 110.665 179.477 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' F' F ' 6' ' ' LEU . . . . . . . . . . . . . 68.4 mt -116.61 144.76 44.0 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 115.451 -0.795 . . . . 0.0 110.158 -178.394 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' F' F ' 7' ' ' LYS . . . . . . . . . . . . . 1.7 ttmp? -130.56 135.25 27.1 Favored Pre-proline 0 CA--C 1.534 0.351 0 CA-C-O 118.848 -0.596 . . . . 0.0 110.293 177.627 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' F' F ' 8' ' ' PRO . . . . . . . . . . . . . 62.9 Cg_endo -91.03 137.91 2.26 Favored 'Trans proline' 0 N--CA 1.49 1.265 0 C-N-CA 121.715 1.61 . . . . 0.0 111.348 175.75 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' F' F ' 9' ' ' LEU . . . . . . . . . . . . . 50.6 mt -77.01 -47.45 2.72 Favored Pre-proline 0 CA--C 1.532 0.274 0 CA-C-O 118.762 -0.637 . . . . 0.0 112.241 -176.693 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' F' F ' 10' ' ' PRO . . . . . . . . . . . . . 93.0 Cg_endo -82.03 151.21 16.17 Favored 'Trans proline' 0 N--CA 1.498 1.744 0 C-N-CA 121.178 1.252 . . . . 0.0 111.607 174.956 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' F' F ' 11' ' ' LYS . . . . . . . . . . . . . 19.5 pttp -84.6 114.02 21.68 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-O 121.623 0.725 . . . . 0.0 110.682 178.166 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' F' F ' 12' ' ' VAL . . . . . . . . . . . . . 11.5 p -151.05 148.79 14.69 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.241 0 CA-C-N 115.534 -0.757 . . . . 0.0 110.059 179.918 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' F' F ' 13' ' ' GLU . . . . . . . . . . . . . 84.8 tt0 -89.58 122.87 33.15 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-O 120.822 0.344 . . . . 0.0 110.246 178.458 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' F' F ' 14' ' ' LEU . . . . . . . . . . . . . 21.1 mt -97.61 151.48 37.64 Favored Pre-proline 0 C--N 1.33 -0.266 0 CA-C-N 116.293 -0.412 . . . . 0.0 110.431 -178.342 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' F' F ' 15' ' ' PRO . . . . . . . . . . . . . 27.0 Cg_exo -61.17 156.58 44.38 Favored 'Trans proline' 0 N--CA 1.496 1.676 0 C-N-CA 121.21 1.273 . . . . 0.0 111.577 177.381 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' F' F ' 16' ' ' PRO . . . . . . . . . . . . . 39.5 Cg_exo -58.78 -35.66 98.27 Favored 'Trans proline' 0 N--CA 1.496 1.621 0 C-N-CA 121.436 1.424 . . . . 0.0 112.708 -179.62 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' F' F ' 17' ' ' ASP . . . . . . . . . . . . . 12.4 p-10 -88.24 11.17 17.2 Favored 'General case' 0 CA--C 1.536 0.427 0 N-CA-C 113.12 0.785 . . . . 0.0 113.12 -178.211 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' F' F ' 18' ' ' PHE . . . . . . . . . . . . . 61.6 t80 -58.06 -43.52 86.95 Favored 'General case' 0 C--N 1.333 -0.111 0 O-C-N 121.994 -0.441 . . . . 0.0 110.131 -178.232 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' F' F ' 19' ' ' VAL . . . . . . . . . . . . . 48.5 t -57.01 -42.06 78.54 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.308 0 CA-C-N 116.256 -0.429 . . . . 0.0 110.416 -178.568 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' F' F ' 20' ' ' ASP . . . . . . . . . . . . . 17.0 t0 -59.95 -42.59 94.36 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-O 120.872 0.368 . . . . 0.0 110.882 -178.303 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' F' F ' 21' ' ' VAL . . . . . . . . . . . . . 48.0 t -64.55 -46.23 93.23 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.285 0 C-N-CA 120.84 -0.344 . . . . 0.0 110.518 -177.988 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' F' F ' 22' ' ' ILE . . . . . . . . . . . . . 48.5 mm -56.34 -45.04 81.35 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.177 0 C-N-CA 120.92 -0.312 . . . . 0.0 110.583 178.968 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' F' F ' 23' ' ' ARG . . . . . . . . . . . . . 56.6 ttp180 -54.39 -48.55 71.42 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-O 120.738 0.304 . . . . 0.0 111.305 -179.27 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' F' F ' 24' ' ' ILE . . . . . . . . . . . . . 72.4 mt -59.19 -44.3 91.54 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.21 0 CA-C-N 116.493 -0.321 . . . . 0.0 110.935 -178.047 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' F' F ' 25' ' ' LYS . . . . . . . . . . . . . 44.8 mtpt -63.91 -43.31 96.33 Favored 'General case' 0 C--N 1.328 -0.347 0 N-CA-C 112.357 0.502 . . . . 0.0 112.357 -177.997 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' F' F ' 26' ' ' LEU . . . . . . . . . . . . . 67.7 mt -79.18 -40.95 29.55 Favored 'General case' 0 C--N 1.33 -0.273 0 N-CA-C 113.428 0.899 . . . . 0.0 113.428 -170.551 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' F' F ' 27' ' ' GLN . . . . . . . . . . . . . 9.9 pt20 -46.67 137.66 6.73 Favored 'General case' 0 N--CA 1.468 0.449 0 N-CA-C 112.871 0.693 . . . . 0.0 112.871 -174.607 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' F' F ' 28' ' ' GLY . . . . . . . . . . . . . . . 100.47 -25.85 26.76 Favored Glycine 0 CA--C 1.533 1.181 0 CA-C-N 115.571 -0.741 . . . . 0.0 112.312 -177.589 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' F' F ' 29' ' ' LYS . . . . . . . . . . . . . 55.1 mmtt -97.4 155.17 17.03 Favored 'General case' 0 C--O 1.232 0.169 0 CA-C-N 117.272 0.536 . . . . 0.0 111.304 178.253 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' F' F ' 30' ' ' THR . . . . . . . . . . . . . 26.6 m -107.09 134.28 50.45 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 115.517 -0.765 . . . . 0.0 109.577 174.802 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' F' F ' 31' ' ' VAL . . . . . . . . . . . . . 35.0 m -130.1 158.94 42.54 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.226 0 CA-C-O 120.926 0.393 . . . . 0.0 110.918 -177.086 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' F' F ' 32' ' ' ARG . . . . . . . . . . . . . 34.9 mtp180 -131.46 152.82 50.36 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-O 121.458 0.647 . . . . 0.0 110.94 179.095 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' F' F ' 33' ' ' THR . . . . . . . . . . . . . 16.8 m -53.53 139.67 30.64 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 115.786 -0.643 . . . . 0.0 111.22 -179.417 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' F' F ' 34' ' ' GLY . . . . . . . . . . . . . . . 101.81 -17.05 55.45 Favored Glycine 0 CA--C 1.533 1.181 0 CA-C-O 119.635 -0.536 . . . . 0.0 113.287 179.261 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' F' F ' 35' ' ' ASP . . . . . . . . . . . . . 72.0 m-20 -64.9 148.4 51.53 Favored 'General case' 0 N--CA 1.461 0.106 0 CA-C-N 118.073 0.936 . . . . 0.0 111.19 178.98 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' F' F ' 36' ' ' VAL . . . . . . . . . . . . . 44.3 t -124.01 131.82 72.32 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.179 0 CA-C-N 115.929 -0.578 . . . . 0.0 109.906 179.844 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' F' F ' 37' ' ' ILE . . . . . . . . . . . . . 68.4 mt -122.93 139.9 48.32 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.195 0 CA-C-N 116.076 -0.511 . . . . 0.0 109.777 179.702 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' F' F ' 38' ' ' GLY . . . . . . . . . . . . . . . -115.2 128.99 8.35 Favored Glycine 0 CA--C 1.526 0.742 0 N-CA-C 110.904 -0.878 . . . . 0.0 110.904 179.508 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' F' F ' 39' ' ' ILE . . . . . . . . . . . . . 72.6 mt -123.69 136.21 60.91 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.229 0 CA-C-O 120.722 0.296 . . . . 0.0 110.359 -179.18 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' F' F ' 40' ' ' SER . . . . . . . . . . . . . 48.0 t -93.77 120.3 33.86 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.326 -0.397 . . . . 0.0 110.654 173.833 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' F' F ' 41' ' ' ILE . . . . . . . . . . . . . 72.3 mt -125.84 121.07 58.91 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.243 0 CA-C-O 120.817 0.341 . . . . 0.0 110.343 178.337 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' F' F ' 42' ' ' LEU . . . . . . . . . . . . . 7.0 mp 50.94 35.09 11.72 Favored 'General case' 0 CA--C 1.532 0.256 0 CA-C-O 121.131 0.491 . . . . 0.0 111.636 178.326 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' F' F ' 43' ' ' GLY . . . . . . . . . . . . . . . 73.03 32.84 60.18 Favored Glycine 0 CA--C 1.527 0.839 0 C-N-CA 121.132 -0.556 . . . . 0.0 112.076 177.842 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' F' F ' 44' ' ' LYS . . . . . . . . . . . . . 44.7 tttp -137.54 130.01 29.65 Favored 'General case' 0 C--N 1.329 -0.288 0 N-CA-C 109.539 -0.541 . . . . 0.0 109.539 178.318 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' F' F ' 45' ' ' GLU . . . . . . . . . . . . . 77.5 tt0 -84.15 123.59 30.25 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.529 -0.305 . . . . 0.0 111.336 -175.462 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' F' F ' 46' ' ' VAL . . . . . . . . . . . . . 7.2 p -124.7 130.31 73.44 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.207 0 CA-C-O 120.918 0.389 . . . . 0.0 109.994 176.876 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' F' F ' 47' ' ' LYS . . . . . . . . . . . . . 33.8 mmtp -99.75 132.22 45.23 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 115.906 -0.588 . . . . 0.0 111.298 177.647 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' F' F ' 48' ' ' PHE . . . . . . . . . . . . . 95.4 m-85 -115.8 131.87 56.81 Favored 'General case' 0 C--N 1.331 -0.208 0 N-CA-C 109.603 -0.517 . . . . 0.0 109.603 174.449 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' F' F ' 49' ' ' LYS . . . . . . . . . . . . . 82.4 tttt -108.92 135.88 49.38 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.338 -0.392 . . . . 0.0 110.51 179.553 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' F' F ' 50' ' ' VAL . . . . . . . . . . . . . 47.1 t -79.03 105.82 8.98 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.253 0 N-CA-C 109.127 -0.694 . . . . 0.0 109.127 176.061 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' F' F ' 51' ' ' VAL . . . . . . . . . . . . . 46.3 t -70.54 -53.48 22.33 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.298 0 CA-C-N 115.887 -0.597 . . . . 0.0 109.579 -174.271 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' F' F ' 52' ' ' GLN . . . . . . . . . . . . . 90.9 mt-30 -153.75 152.05 30.3 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 115.974 -0.557 . . . . 0.0 111.742 -178.114 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' F' F ' 53' ' ' ALA . . . . . . . . . . . . . . . -128.42 132.92 48.47 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 115.317 -0.856 . . . . 0.0 109.765 174.547 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' F' F ' 54' ' ' TYR . . . . . . . . . . . . . 82.3 t80 -129.13 111.67 18.31 Favored Pre-proline 0 CA--C 1.535 0.368 0 CA-C-O 118.298 -0.858 . . . . 0.0 110.402 179.473 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' F' F ' 55' ' ' PRO . . . . . . . . . . . . . 73.6 Cg_endo -77.05 169.6 73.93 Favored 'Cis proline' 0 N--CA 1.5 1.854 0 CA-C-N 122.023 1.758 . . . . 0.0 112.226 -6.227 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' F' F ' 56' ' ' SER . . . . . . . . . . . . . 13.6 m -116.43 124.66 29.26 Favored Pre-proline 0 CA--C 1.539 0.554 0 CA-C-O 118.37 -0.824 . . . . 0.0 109.219 176.102 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' F' F ' 57' ' ' PRO . . . . . . . . . . . . . 53.9 Cg_endo -69.55 149.32 87.88 Favored 'Cis proline' 0 N--CA 1.498 1.754 0 CA-C-N 122.063 1.773 . . . . 0.0 112.086 2.128 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' F' F ' 58' ' ' LEU . . . . . . . . . . . . . 21.4 tp -108.63 136.3 48.45 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.111 -0.495 . . . . 0.0 110.619 -179.569 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' F' F ' 59' ' ' ARG . . . . . . . . . . . . . 40.9 ttm180 -103.75 123.4 46.98 Favored 'General case' 0 C--N 1.329 -0.291 0 N-CA-C 109.346 -0.613 . . . . 0.0 109.346 175.867 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' F' F ' 60' ' ' VAL . . . . . . . . . . . . . 42.1 t -81.91 124.09 38.73 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.269 0 C-N-CA 120.638 -0.425 . . . . 0.0 110.362 -175.581 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' F' F ' 61' ' ' GLU . . . . . . . . . . . . . 79.3 tt0 -131.09 157.47 43.0 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 115.74 -0.664 . . . . 0.0 109.27 179.367 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' F' F ' 62' ' ' ASP . . . . . . . . . . . . . 10.5 t0 -51.56 -32.48 28.39 Favored 'General case' 0 C--N 1.328 -0.368 0 N-CA-C 112.138 0.422 . . . . 0.0 112.138 -176.692 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' F' F ' 63' ' ' ARG . . . . . . . . . . . . . 16.7 ptp180 -89.4 10.05 23.98 Favored 'General case' 0 N--CA 1.466 0.36 0 N-CA-C 113.613 0.968 . . . . 0.0 113.613 -176.157 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' F' F ' 64' ' ' THR . . . . . . . . . . . . . 22.4 m -80.15 143.34 33.95 Favored 'General case' 0 C--N 1.331 -0.21 0 CA-C-N 118.001 0.364 . . . . 0.0 110.63 -178.508 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' F' F ' 65' ' ' LYS . . . . . . . . . . . . . 95.9 mttt -87.47 126.69 35.05 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.169 -0.468 . . . . 0.0 110.008 179.372 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' F' F ' 66' ' ' ILE . . . . . . . . . . . . . 66.6 mt -118.2 129.52 74.41 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.288 0 N-CA-C 109.903 -0.406 . . . . 0.0 109.903 -179.404 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' F' F ' 67' ' ' THR . . . . . . . . . . . . . 24.4 m -121.0 138.97 53.91 Favored 'General case' 0 C--N 1.331 -0.207 0 CA-C-N 116.248 -0.433 . . . . 0.0 110.856 -178.189 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' F' F ' 68' ' ' LEU . . . . . . . . . . . . . 15.2 tp . . . . . 0 C--N 1.332 -0.172 0 CA-C-N 115.929 -0.578 . . . . 0.0 110.347 179.155 . . . . . . . . 0 0 . 1 . 006 nuclear orig core ' F' F ' 73' ' ' VAL . . . . . . . . . . . . . 34.6 m . . . . . 0 C--O 1.231 0.091 0 CA-C-O 120.861 0.362 . . . . 0.0 110.193 . . . . . . . . . 0 0 . 1 . 006 nuclear orig core ' F' F ' 74' ' ' ASP . . . . . . . . . . . . . 7.5 t0 -97.6 124.77 42.0 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.138 -0.483 . . . . 0.0 110.157 -177.769 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' F' F ' 75' ' ' VAL . . . . . . . . . . . . . 42.7 t -113.42 125.93 70.77 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.247 0 CA-C-O 121.078 0.466 . . . . 0.0 110.446 -178.745 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' F' F ' 76' ' ' LEU . . . . . . . . . . . . . 27.0 mt -128.78 149.54 50.68 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 115.671 -0.695 . . . . 0.0 109.727 178.737 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' F' F ' 77' ' ' GLU . . . . . . . . . . . . . 47.2 mt-10 -136.05 140.31 43.73 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-O 121.004 0.43 . . . . 0.0 111.44 -176.526 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' F' F ' 78' ' ' ALA . . . . . . . . . . . . . . . -124.03 126.62 46.58 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 115.663 -0.698 . . . . 0.0 109.56 175.906 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' F' F ' 79' ' ' LYS . . . . . . . . . . . . . 53.7 pttt -80.06 123.93 28.29 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-O 121.133 0.492 . . . . 0.0 111.341 -176.714 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' F' F ' 80' ' ' ILE . . . . . . . . . . . . . 39.5 mm -139.14 118.49 13.58 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.238 0 CA-C-N 115.901 -0.591 . . . . 0.0 109.692 -178.287 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' F' F ' 81' ' ' LYS . . . . . . . . . . . . . 40.2 mmtt -96.1 118.87 33.55 Favored 'General case' 0 C--N 1.327 -0.374 0 C-N-CA 120.905 -0.318 . . . . 0.0 111.205 179.667 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' F' F ' 82' ' ' GLY . . . . . . . . . . . . . . . 89.19 42.17 5.65 Favored Glycine 0 CA--C 1.526 0.747 0 C-N-CA 120.654 -0.784 . . . . 0.0 112.027 172.202 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' F' F ' 83' ' ' ILE . . . . . . . . . . . . . 73.1 mt -64.47 134.21 29.35 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.294 0 N-CA-C 109.505 -0.554 . . . . 0.0 109.505 175.835 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' F' F ' 84' ' ' LYS . . . . . . . . . . . . . 36.5 ttpt -97.73 -53.97 3.26 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-O 120.992 0.425 . . . . 0.0 110.14 -179.346 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' F' F ' 85' ' ' ASP . . . . . . . . . . . . . 9.1 t70 -149.35 151.56 34.33 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 115.745 -0.661 . . . . 0.0 110.503 -179.472 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' F' F ' 86' ' ' VAL . . . . . . . . . . . . . 44.6 t -126.67 130.58 71.63 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.218 0 CA-C-O 120.952 0.406 . . . . 0.0 110.321 -178.986 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' F' F ' 87' ' ' ILE . . . . . . . . . . . . . 43.4 mm -119.2 126.2 75.14 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.304 0 CA-C-N 115.84 -0.618 . . . . 0.0 109.388 177.961 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' F' F ' 88' ' ' LEU . . . . . . . . . . . . . 13.0 tp -116.94 135.32 53.8 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-O 120.976 0.417 . . . . 0.0 111.394 -175.943 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' F' F ' 89' ' ' ASP . . . . . . . . . . . . . 6.1 t70 -132.17 156.31 46.65 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 115.812 -0.631 . . . . 0.0 109.457 175.228 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' F' F ' 90' ' ' GLU . . . . . . . . . . . . . 96.6 mt-10 -48.03 -36.95 13.78 Favored 'General case' 0 C--N 1.33 -0.28 0 N-CA-C 113.176 0.806 . . . . 0.0 113.176 -171.123 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' F' F ' 91' ' ' ASN . . . . . . . . . . . . . 35.3 m120 -123.44 13.14 9.45 Favored 'General case' 0 N--CA 1.468 0.466 0 N-CA-C 113.555 0.946 . . . . 0.0 113.555 -174.763 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' F' F ' 92' ' ' LEU . . . . . . . . . . . . . 44.3 mt -149.73 147.98 28.69 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-N 117.925 0.33 . . . . 0.0 110.721 -176.577 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' F' F ' 93' ' ' ILE . . . . . . . . . . . . . 74.0 mt -122.71 118.3 54.62 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.268 0 N-CA-C 109.102 -0.703 . . . . 0.0 109.102 175.736 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' F' F ' 94' ' ' VAL . . . . . . . . . . . . . 45.5 t -117.42 127.28 74.91 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.249 0 N-CA-C 109.743 -0.466 . . . . 0.0 109.743 -179.054 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' F' F ' 95' ' ' VAL . . . . . . . . . . . . . 43.0 t -123.21 134.94 64.77 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.364 0 CA-C-N 116.1 -0.5 . . . . 0.0 109.964 -178.958 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' F' F ' 96' ' ' ILE . . . . . . . . . . . . . 65.8 mt -115.45 126.28 72.95 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.308 0 N-CA-C 109.259 -0.645 . . . . 0.0 109.259 178.718 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' F' F ' 97' ' ' THR . . . . . . . . . . . . . 69.4 p -99.75 155.93 17.37 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-O 121.228 0.537 . . . . 0.0 110.957 -177.341 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' F' F ' 98' ' ' GLU . . . . . . . . . . . . . 84.9 tt0 -53.87 -24.91 17.45 Favored 'General case' 0 CA--C 1.536 0.422 0 CA-C-N 116.057 -0.519 . . . . 0.0 112.267 179.658 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' F' F ' 99' ' ' GLU . . . . . . . . . . . . . 96.8 mt-10 -77.55 12.89 1.42 Allowed 'General case' 0 CA--C 1.537 0.45 0 N-CA-C 113.301 0.852 . . . . 0.0 113.301 -177.924 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' F' F ' 100' ' ' ASN . . . . . . . . . . . . . 2.2 m-20 61.84 33.62 17.55 Favored 'General case' 0 N--CA 1.464 0.262 0 CA-C-N 118.099 0.409 . . . . 0.0 111.315 -179.74 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' F' F ' 101' ' ' GLU . . . . . . . . . . . . . 54.4 tt0 -110.27 143.69 40.07 Favored 'General case' 0 C--N 1.333 -0.137 0 N-CA-C 109.571 -0.529 . . . . 0.0 109.571 174.189 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' F' F ' 102' ' ' VAL . . . . . . . . . . . . . 46.7 t -115.39 127.16 73.06 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.295 0 N-CA-C 109.84 -0.429 . . . . 0.0 109.84 -178.39 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' F' F ' 103' ' ' LEU . . . . . . . . . . . . . 19.7 mt -118.64 132.58 56.18 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 115.864 -0.607 . . . . 0.0 110.715 178.711 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' F' F ' 104' ' ' ILE . . . . . . . . . . . . . 63.8 mt -116.85 120.65 65.68 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.277 0 N-CA-C 109.81 -0.441 . . . . 0.0 109.81 177.921 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' F' F ' 105' ' ' PHE . . . . . . . . . . . . . 92.3 m-85 -120.43 162.78 18.95 Favored 'General case' 0 C--N 1.332 -0.157 0 O-C-N 123.859 0.724 . . . . 0.0 109.91 -179.906 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' F' F ' 106' ' ' ASN . . . . . . . . . . . . . 45.6 p-10 -97.62 -174.09 2.81 Favored 'General case' 0 C--N 1.33 -0.268 0 N-CA-C 109.593 -0.521 . . . . 0.0 109.593 172.214 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' F' F ' 107' ' ' GLN . . . . . . . . . . . . . 21.6 tt0 -62.21 -19.24 62.95 Favored 'General case' 0 CA--C 1.536 0.429 0 N-CA-C 112.586 0.588 . . . . 0.0 112.586 -178.725 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' F' F ' 108' ' ' ASN . . . . . . . . . . . . . 17.2 t30 -95.68 14.09 24.23 Favored 'General case' 0 CA--C 1.535 0.393 0 N-CA-C 113.124 0.787 . . . . 0.0 113.124 -178.259 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' F' F ' 109' ' ' LEU . . . . . . . . . . . . . 52.5 mt 58.98 38.92 24.1 Favored 'General case' 0 C--O 1.232 0.155 0 CA-C-O 121.139 0.495 . . . . 0.0 111.395 178.095 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' F' F ' 110' ' ' GLU . . . . . . . . . . . . . 96.5 mt-10 -106.14 156.9 17.97 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.15 -0.477 . . . . 0.0 109.95 176.055 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' F' F ' 111' ' ' GLU . . . . . . . . . . . . . 84.5 tt0 -86.98 121.91 30.1 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-O 120.884 0.374 . . . . 0.0 111.107 -177.258 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' F' F ' 112' ' ' LEU . . . . . . . . . . . . . 31.4 mt -108.43 -45.95 3.79 Favored 'General case' 0 C--N 1.332 -0.189 0 CA-C-N 116.054 -0.521 . . . . 0.0 110.448 176.735 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' F' F ' 113' ' ' TYR . . . . . . . . . . . . . 55.5 t80 -141.86 138.55 32.21 Favored 'General case' 0 C--N 1.331 -0.229 0 C-N-CA 120.614 -0.434 . . . . 0.0 111.319 179.947 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' F' F ' 114' ' ' ARG . . . . . . . . . . . . . 23.7 ttm180 -138.1 124.2 20.28 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.232 -0.44 . . . . 0.0 110.195 176.539 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' F' F ' 115' ' ' GLY . . . . . . . . . . . . . . . -150.17 159.64 28.2 Favored Glycine 0 CA--C 1.525 0.676 0 N-CA-C 110.798 -0.921 . . . . 0.0 110.798 178.283 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' F' F ' 116' ' ' LYS . . . . . . . . . . . . . 55.4 tttt -132.6 135.33 45.83 Favored 'General case' 0 C--N 1.329 -0.305 0 N-CA-C 110.098 -0.334 . . . . 0.0 110.098 178.714 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' F' F ' 117' ' ' PHE . . . . . . . . . . . . . 26.3 m-85 -137.72 116.31 12.11 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-O 120.799 0.333 . . . . 0.0 110.309 -174.611 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' F' F ' 118' ' ' GLU . . . . . . . . . . . . . 46.0 tp10 -53.96 -44.58 70.85 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.594 -0.276 . . . . 0.0 111.309 -177.621 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' F' F ' 119' ' ' ASN . . . . . . . . . . . . . 11.7 m120 -97.09 31.1 2.51 Favored 'General case' 0 C--N 1.329 -0.309 0 N-CA-C 112.202 0.445 . . . . 0.0 112.202 -174.497 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' F' F ' 120' ' ' LEU . . . . . . . . . . . . . 15.5 tp -57.76 122.53 13.06 Favored 'General case' 0 C--N 1.333 -0.126 0 N-CA-C 110.225 -0.287 . . . . 0.0 110.225 177.744 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' F' F ' 121' ' ' ASN . . . . . . . . . . . . . 88.6 m-20 -113.75 -43.95 3.23 Favored 'General case' 0 C--N 1.333 -0.124 0 CA-C-N 116.66 -0.246 . . . . 0.0 111.232 -176.729 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' F' F ' 122' ' ' LYS . . . . . . . . . . . . . 51.2 mttm -143.74 144.73 31.96 Favored 'General case' 0 C--N 1.33 -0.25 0 C-N-CA 120.629 -0.428 . . . . 0.0 111.669 -177.408 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' F' F ' 123' ' ' VAL . . . . . . . . . . . . . 43.9 t -127.18 127.84 69.77 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.249 0 N-CA-C 109.328 -0.619 . . . . 0.0 109.328 174.795 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' F' F ' 124' ' ' LEU . . . . . . . . . . . . . 56.5 mt -128.78 139.2 52.3 Favored 'General case' 0 C--N 1.331 -0.211 0 CA-C-O 120.792 0.33 . . . . 0.0 110.933 -176.653 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' F' F ' 125' ' ' VAL . . . . . . . . . . . . . 12.8 p -137.88 137.72 44.63 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.249 0 CA-C-N 116.344 -0.389 . . . . 0.0 110.569 178.487 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' F' F ' 126' ' ' ARG . . . . . . . . . . . . . 55.2 ttt180 -163.87 135.31 4.68 Favored 'General case' 0 C--N 1.33 -0.243 0 N-CA-C 109.803 -0.443 . . . . 0.0 109.803 177.775 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' F' F ' 127' ' ' ASN . . . . . . . . . . . . . 77.7 m-20 55.39 -153.34 0.33 Allowed 'General case' 0 CA--C 1.541 0.607 0 N-CA-C 109.974 -0.38 . . . . 0.0 109.974 -179.791 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' F' F ' 128' ' ' ASP . . . . . . . . . . . . . 10.4 p-10 -80.76 16.06 1.54 Allowed 'General case' 0 CA--C 1.535 0.386 0 N-CA-C 112.815 0.672 . . . . 0.0 112.815 179.439 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' F' F ' 129' ' ' LEU . . . . . . . . . . . . . 38.5 mt -117.51 138.32 51.97 Favored 'General case' 0 C--O 1.231 0.106 0 CA-C-N 118.131 0.423 . . . . 0.0 110.371 179.778 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' F' F ' 130' ' ' VAL . . . . . . . . . . . . . 12.9 p -132.07 141.0 46.59 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.217 0 N-CA-C 109.919 -0.4 . . . . 0.0 109.919 175.983 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' F' F ' 131' ' ' VAL . . . . . . . . . . . . . 39.4 t -134.58 140.77 45.03 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.218 0 CA-C-O 121.13 0.491 . . . . 0.0 110.636 -175.24 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' F' F ' 132' ' ' ILE . . . . . . . . . . . . . 71.4 mt -119.28 130.75 73.53 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.316 0 CA-C-N 115.526 -0.761 . . . . 0.0 109.133 177.451 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' F' F ' 133' ' ' ILE . . . . . . . . . . . . . 41.4 mm -117.87 123.49 71.75 Favored 'Isoleucine or valine' 0 C--O 1.233 0.221 0 CA-C-O 120.773 0.321 . . . . 0.0 111.041 -175.184 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' F' F ' 134' ' ' ASP . . . . . . . . . . . . . 8.5 p-10 -135.63 146.51 47.94 Favored 'General case' 0 C--N 1.33 -0.25 0 N-CA-C 109.57 -0.53 . . . . 0.0 109.57 173.268 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' F' F ' 135' ' ' GLU . . . . . . . . . . . . . 40.6 tp10 -49.87 -25.83 3.51 Favored 'General case' 0 C--N 1.327 -0.387 0 N-CA-C 112.725 0.639 . . . . 0.0 112.725 -173.259 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' F' F ' 136' ' ' GLN . . . . . . . . . . . . . 61.7 tt0 -82.39 -35.7 27.44 Favored 'General case' 0 C--O 1.233 0.236 0 N-CA-C 112.269 0.47 . . . . 0.0 112.269 -176.333 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' F' F ' 137' ' ' LYS . . . . . . . . . . . . . 45.6 pttt -165.12 167.98 17.68 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-O 121.486 0.66 . . . . 0.0 112.12 -172.315 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' F' F ' 138' ' ' LEU . . . . . . . . . . . . . 7.3 tt -118.34 130.79 56.22 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 115.169 -0.923 . . . . 0.0 109.866 -179.526 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' F' F ' 139' ' ' THR . . . . . . . . . . . . . 38.0 m -113.1 126.22 55.23 Favored 'General case' 0 C--N 1.331 -0.21 0 CA-C-N 116.328 -0.396 . . . . 0.0 110.773 179.92 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' F' F ' 140' ' ' LEU . . . . . . . . . . . . . 18.7 tp -109.85 122.77 48.28 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 115.526 -0.761 . . . . 0.0 108.973 178.745 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' F' F ' 141' ' ' ILE . . . . . . . . . . . . . 19.6 mt -122.04 119.48 58.69 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.32 0 N-CA-C 109.594 -0.521 . . . . 0.0 109.594 -177.158 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' F' F ' 142' ' ' ARG . . . . . . . . . . . . . 66.4 ttp85 -110.92 128.85 55.96 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 115.488 -0.778 . . . . 0.0 110.57 -176.415 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' F' F ' 143' ' ' THR . . . . . . . . . . . . . 39.4 p . . . . . 0 C--O 1.222 -0.37 0 CA-C-O 117.952 -1.023 . . . . 0.0 110.558 -179.983 . . . . . . . . 0 0 . 1 . 007 nuclear orig core ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 88.8 p . . . . . 0 C--O 1.231 0.107 0 CA-C-O 120.849 0.356 . . . . 0.0 110.48 . . . . . . . . . 0 0 . 1 . 007 nuclear orig core ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 85.2 tt0 -140.5 142.53 35.25 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-N 116.149 -0.478 . . . . 0.0 111.057 -177.527 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 4' ' ' LEU . . . . . . . . . . . . . 19.0 tp -122.99 127.57 49.0 Favored 'General case' 0 C--N 1.331 -0.198 0 CA-C-N 115.964 -0.562 . . . . 0.0 110.148 177.046 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 5' ' ' LYS . . . . . . . . . . . . . 98.8 mttt -106.71 122.88 47.24 Favored 'General case' 0 C--O 1.234 0.244 0 CA-C-N 116.543 -0.299 . . . . 0.0 110.641 179.275 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 63.5 mt -116.08 144.65 43.85 Favored 'General case' 0 N--CA 1.464 0.235 0 CA-C-N 115.859 -0.609 . . . . 0.0 110.692 -179.241 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 85.0 tttt -125.81 131.22 23.94 Favored Pre-proline 0 CA--C 1.536 0.433 0 CA-C-O 118.583 -0.722 . . . . 0.0 109.523 175.758 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 8' ' ' PRO . . . . . . . . . . . . . 96.1 Cg_endo -83.56 137.79 8.12 Favored 'Trans proline' 0 N--CA 1.494 1.529 0 C-N-CA 121.295 1.33 . . . . 0.0 112.078 177.851 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 67.4 mt -77.95 -47.87 2.18 Favored Pre-proline 0 CA--C 1.534 0.352 0 CA-C-O 118.548 -0.739 . . . . 0.0 112.084 179.165 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 72.2 Cg_endo -77.8 151.34 27.99 Favored 'Trans proline' 0 N--CA 1.497 1.679 0 CA-C-N 120.28 1.136 . . . . 0.0 111.642 176.36 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 23.2 tptm -85.67 95.15 9.27 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.421 -0.354 . . . . 0.0 110.55 -179.336 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 12.1 p -143.7 144.33 23.29 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.319 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.552 -179.92 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 45.6 mp0 -90.4 127.23 36.14 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.334 -0.393 . . . . 0.0 109.963 177.58 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 14' ' ' LEU . . . . . . . . . . . . . 37.2 mt -97.87 146.89 32.24 Favored Pre-proline 0 CA--C 1.533 0.29 0 CA-C-O 119.19 -0.433 . . . . 0.0 110.371 -177.44 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 15' ' ' PRO . . . . . . . . . . . . . 26.2 Cg_exo -61.29 162.32 20.55 Favored 'Trans proline' 0 N--CA 1.498 1.759 0 C-N-CA 121.345 1.363 . . . . 0.0 111.939 178.148 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 16' ' ' PRO . . . . . . . . . . . . . 34.8 Cg_exo -59.34 -38.64 83.42 Favored 'Trans proline' 0 N--CA 1.496 1.629 0 C-N-CA 121.541 1.494 . . . . 0.0 112.907 -177.699 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 17' ' ' ASP . . . . . . . . . . . . . 18.9 p-10 -86.52 6.34 31.09 Favored 'General case' 0 CA--C 1.537 0.443 0 N-CA-C 113.303 0.853 . . . . 0.0 113.303 -178.161 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 18' ' ' PHE . . . . . . . . . . . . . 39.2 t80 -58.33 -43.09 88.07 Favored 'General case' 0 C--N 1.334 -0.108 0 O-C-N 121.982 -0.449 . . . . 0.0 110.103 -178.212 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 19' ' ' VAL . . . . . . . . . . . . . 47.5 t -56.69 -41.14 73.79 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.282 0 CA-C-N 116.243 -0.435 . . . . 0.0 110.468 -179.405 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 5.7 t70 -59.77 -42.0 92.33 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-O 120.873 0.368 . . . . 0.0 110.534 -179.002 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 47.9 t -63.86 -46.18 94.97 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.325 0 CA-C-N 116.242 -0.435 . . . . 0.0 110.301 -178.971 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 22' ' ' ILE . . . . . . . . . . . . . 51.6 mm -55.03 -47.93 76.41 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.282 0 CA-C-O 120.572 0.225 . . . . 0.0 110.819 179.241 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 23' ' ' ARG . . . . . . . . . . . . . 30.8 ttp180 -54.53 -51.5 64.97 Favored 'General case' 0 C--N 1.329 -0.307 0 C-N-CA 121.121 -0.232 . . . . 0.0 111.332 -177.813 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 24' ' ' ILE . . . . . . . . . . . . . 72.9 mt -59.53 -41.3 84.37 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.277 0 C-N-CA 121.031 -0.267 . . . . 0.0 111.232 -176.881 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 60.7 mtpt -68.67 -41.9 78.64 Favored 'General case' 0 C--N 1.328 -0.333 0 N-CA-C 112.45 0.537 . . . . 0.0 112.45 -177.324 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 95.3 mt -79.57 -37.46 36.32 Favored 'General case' 0 C--N 1.33 -0.266 0 N-CA-C 113.152 0.797 . . . . 0.0 113.152 -171.365 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 27' ' ' GLN . . . . . . . . . . . . . 9.1 pt20 -46.33 140.48 4.09 Favored 'General case' 0 N--CA 1.47 0.544 0 N-CA-C 112.802 0.667 . . . . 0.0 112.802 -175.273 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 100.97 -25.44 28.33 Favored Glycine 0 CA--C 1.532 1.14 0 CA-C-N 115.575 -0.739 . . . . 0.0 112.229 -176.089 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 96.9 mttt -98.18 155.1 17.33 Favored 'General case' 0 C--O 1.233 0.185 0 CA-C-N 117.451 0.625 . . . . 0.0 111.192 179.267 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 30' ' ' THR . . . . . . . . . . . . . 41.5 m -100.96 138.73 37.62 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.138 -0.483 . . . . 0.0 110.273 177.154 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 34.7 m -131.3 148.52 32.81 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.247 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.79 -178.971 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 32' ' ' ARG . . . . . . . . . . . . . 23.0 ttm180 -130.06 146.69 51.74 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.163 -0.471 . . . . 0.0 110.26 178.166 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 33' ' ' THR . . . . . . . . . . . . . 29.6 m -52.39 139.18 25.36 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-O 120.777 0.323 . . . . 0.0 111.469 -178.285 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 98.91 -17.25 58.48 Favored Glycine 0 CA--C 1.534 1.23 0 CA-C-O 119.737 -0.479 . . . . 0.0 113.135 -179.907 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 78.1 m-20 -67.67 149.19 50.35 Favored 'General case' 0 C--N 1.334 -0.09 0 CA-C-N 117.948 0.874 . . . . 0.0 111.346 179.065 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 46.3 t -117.01 126.45 74.44 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.179 0 CA-C-N 115.652 -0.703 . . . . 0.0 109.441 176.513 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 37' ' ' ILE . . . . . . . . . . . . . 64.0 mt -118.36 137.15 53.25 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.297 0 N-CA-C 109.866 -0.42 . . . . 0.0 109.866 -179.118 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . -114.74 128.51 8.19 Favored Glycine 0 CA--C 1.524 0.656 0 N-CA-C 110.876 -0.889 . . . . 0.0 110.876 179.304 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 39' ' ' ILE . . . . . . . . . . . . . 70.4 mt -124.45 127.36 72.99 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.224 0 N-CA-C 110.08 -0.341 . . . . 0.0 110.08 179.223 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 40' ' ' SER . . . . . . . . . . . . . 27.5 t -92.84 119.04 31.76 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.312 -0.403 . . . . 0.0 110.931 176.727 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 41' ' ' ILE . . . . . 0.4 HD11 HG23 ' A' ' 41' ' ' ILE . 71.7 mt -134.02 129.13 53.92 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.211 0 CA-C-O 121.017 0.436 . . . . 0.0 110.462 178.491 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 8.3 tp 54.75 33.4 19.5 Favored 'General case' 0 CA--C 1.531 0.244 0 CA-C-N 115.958 -0.565 . . . . 0.0 111.737 177.523 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . 71.52 29.02 68.48 Favored Glycine 0 CA--C 1.53 0.996 0 C-N-CA 121.046 -0.597 . . . . 0.0 112.253 177.794 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 44' ' ' LYS . . . . . . . . . . . . . 81.3 tttt -139.1 127.4 22.75 Favored 'General case' 0 C--N 1.33 -0.255 0 N-CA-C 109.739 -0.467 . . . . 0.0 109.739 178.833 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 84.8 tt0 -85.24 125.78 33.15 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-N 116.375 -0.375 . . . . 0.0 111.423 -178.395 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 46' ' ' VAL . . . . . . . . . . . . . 9.6 p -118.69 124.41 73.1 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.172 0 N-CA-C 109.434 -0.58 . . . . 0.0 109.434 173.587 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 61.9 mtpt -98.49 124.27 43.12 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 116.046 -0.525 . . . . 0.0 110.523 177.726 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 48' ' ' PHE . . . . . . . . . . . . . 38.9 m-85 -111.1 131.81 54.78 Favored 'General case' 0 C--N 1.328 -0.344 0 N-CA-C 109.555 -0.535 . . . . 0.0 109.555 177.573 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 43.0 tttp -106.42 131.92 53.06 Favored 'General case' 0 C--N 1.328 -0.345 0 N-CA-C 109.936 -0.394 . . . . 0.0 109.936 178.638 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 50' ' ' VAL . . . . . . . . . . . . . 46.0 t -75.38 106.58 5.27 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.332 0 N-CA-C 109.336 -0.616 . . . . 0.0 109.336 178.068 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 51' ' ' VAL . . . . . . . . . . . . . 44.6 t -71.17 -49.65 47.12 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.288 0 CA-C-N 116.165 -0.471 . . . . 0.0 109.79 -174.789 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 52' ' ' GLN . . . . . . . . . . . . . 43.3 tt0 -162.73 136.88 6.33 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 115.88 -0.6 . . . . 0.0 111.289 -178.102 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -115.9 132.84 56.53 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 115.968 -0.56 . . . . 0.0 109.999 176.119 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 54' ' ' TYR . . . . . . . . . . . . . 11.6 t80 -129.06 110.64 18.3 Favored Pre-proline 0 CA--C 1.534 0.346 0 CA-C-O 118.157 -0.925 . . . . 0.0 110.192 178.466 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 55' ' ' PRO . . . . . . . . . . . . . 72.7 Cg_endo -77.22 170.13 72.29 Favored 'Cis proline' 0 N--CA 1.501 1.931 0 CA-C-N 122.024 1.758 . . . . 0.0 112.49 -6.054 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 56' ' ' SER . . . . . . . . . . . . . 48.9 m -124.01 137.55 29.11 Favored Pre-proline 0 CA--C 1.538 0.514 0 CA-C-O 118.532 -0.747 . . . . 0.0 109.546 174.904 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 57' ' ' PRO . . . . . . . . . . . . . 37.8 Cg_endo -67.52 145.52 74.37 Favored 'Cis proline' 0 N--CA 1.498 1.778 0 CA-C-N 121.687 1.638 . . . . 0.0 111.487 -2.894 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 58' ' ' LEU . . . . . . . . . . . . . 20.7 tp -107.99 137.95 45.09 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.256 -0.429 . . . . 0.0 110.47 -178.768 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 59' ' ' ARG . . . . . . . . . . . . . 56.7 ttp180 -103.31 120.61 41.1 Favored 'General case' 0 C--N 1.328 -0.366 0 N-CA-C 109.133 -0.691 . . . . 0.0 109.133 174.917 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 42.2 t -72.95 118.53 18.29 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.276 0 C-N-CA 120.766 -0.374 . . . . 0.0 110.647 -173.8 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 70.6 mm-40 -131.02 159.12 38.45 Favored 'General case' 0 C--N 1.331 -0.216 0 CA-C-N 115.951 -0.568 . . . . 0.0 109.734 176.909 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 62' ' ' ASP . . . . . . . . . . . . . 11.0 p-10 -53.34 -31.43 44.3 Favored 'General case' 0 C--N 1.328 -0.343 0 N-CA-C 112.034 0.383 . . . . 0.0 112.034 -178.27 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 63' ' ' ARG . . . . . . . . . . . . . 86.2 mtt-85 -72.02 -21.94 61.48 Favored 'General case' 0 CA--C 1.533 0.324 0 N-CA-C 112.888 0.699 . . . . 0.0 112.888 -175.444 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 33.3 m -70.1 143.75 52.31 Favored 'General case' 0 C--N 1.332 -0.191 0 CA-C-O 120.988 0.423 . . . . 0.0 111.209 -174.479 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 65' ' ' LYS . . . . . . . . . . . . . 1.1 mptm? -89.54 134.8 33.95 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 115.839 -0.619 . . . . 0.0 110.013 177.827 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 66' ' ' ILE . . . . . . . . . . . . . 58.9 mt -114.82 130.36 69.39 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.27 0 N-CA-C 109.771 -0.455 . . . . 0.0 109.771 178.394 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 67' ' ' THR . . . . . . . . . . . . . 30.8 m -124.47 142.1 51.58 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-O 121.247 0.546 . . . . 0.0 111.136 -177.253 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 68' ' ' LEU . . . . . . . . . . . . . 2.6 tt . . . . . 0 C--N 1.331 -0.224 0 CA-C-N 115.544 -0.753 . . . . 0.0 109.68 178.485 . . . . . . . . 0 0 . 1 . 007 nuclear orig core ' A' A ' 74' ' ' ASP . . . . . . . . . . . . . 13.0 t70 . . . . . 0 CA--C 1.521 -0.166 0 N-CA-C 110.229 -0.285 . . . . 0.0 110.229 . . . . . . . . . 0 0 . 1 . 007 nuclear orig core ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 45.7 t -117.37 117.92 56.82 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 CA-C-O 121.192 0.52 . . . . 0.0 109.919 -179.439 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 76' ' ' LEU . . . . . . . . . . . . . 14.9 mt -120.9 142.92 49.25 Favored 'General case' 0 C--N 1.327 -0.403 0 CA-C-N 115.453 -0.794 . . . . 0.0 109.3 178.552 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 77' ' ' GLU . . . . . . . . . . . . . 96.8 mt-10 -135.31 128.91 32.66 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-O 121.16 0.505 . . . . 0.0 110.527 -177.548 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 78' ' ' ALA . . . . . . . . . . . . . . . -113.0 130.71 56.04 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 115.582 -0.735 . . . . 0.0 109.478 177.353 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 79' ' ' LYS . . . . . . . . . . . . . 84.2 tttt -76.07 112.7 12.79 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-O 120.963 0.411 . . . . 0.0 110.532 -177.193 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 80' ' ' ILE . . . . . . . . . . . . . 42.4 mm -139.08 109.95 4.7 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.346 0 CA-C-N 115.768 -0.651 . . . . 0.0 109.316 -177.727 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 81' ' ' LYS . . . . . . . . . . . . . 48.5 mtmt -108.64 130.76 55.32 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-O 120.875 0.369 . . . . 0.0 110.728 -178.321 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . 89.06 42.18 5.68 Favored Glycine 0 CA--C 1.525 0.708 0 C-N-CA 120.794 -0.717 . . . . 0.0 111.434 176.806 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 83' ' ' ILE . . . . . . . . . . . . . 73.5 mt -68.49 136.16 26.99 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.297 0 N-CA-C 109.872 -0.418 . . . . 0.0 109.872 177.423 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 84' ' ' LYS . . . . . . . . . . . . . 50.0 tttp -93.05 -50.45 5.52 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.213 -0.448 . . . . 0.0 110.18 -179.341 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 85' ' ' ASP . . . . . . . . . . . . . 6.6 t0 -157.22 154.97 30.05 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 115.908 -0.587 . . . . 0.0 110.517 179.734 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 86' ' ' VAL . . . . . . . . . . . . . 42.7 t -129.81 132.34 65.91 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.201 0 CA-C-O 120.974 0.416 . . . . 0.0 110.552 -178.862 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 87' ' ' ILE . . . . . . . . . . . . . 5.0 mp -121.84 128.83 75.79 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.193 0 CA-C-N 115.957 -0.565 . . . . 0.0 109.629 176.887 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 88' ' ' LEU . . . . . . . . . . . . . 75.2 mt -112.6 135.96 52.7 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-O 120.997 0.427 . . . . 0.0 111.268 -177.826 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 89' ' ' ASP . . . . . . . . . . . . . 13.6 t70 -133.02 152.4 51.97 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 115.754 -0.657 . . . . 0.0 109.532 175.613 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 97.4 mt-10 -48.56 -36.27 15.14 Favored 'General case' 0 C--N 1.329 -0.319 0 N-CA-C 113.036 0.754 . . . . 0.0 113.036 -172.678 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 91' ' ' ASN . . . . . . . . . . . . . 81.8 m-20 -121.96 12.19 10.42 Favored 'General case' 0 N--CA 1.468 0.473 0 N-CA-C 113.379 0.881 . . . . 0.0 113.379 -176.268 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 92' ' ' LEU . . . . . . . . . . . . . 11.8 mt -148.68 145.3 27.64 Favored 'General case' 0 C--N 1.332 -0.185 0 CA-C-N 118.101 0.41 . . . . 0.0 110.455 -175.701 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 93' ' ' ILE . . . . . . . . . . . . . 66.8 mt -120.95 117.81 54.21 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.294 0 N-CA-C 108.942 -0.762 . . . . 0.0 108.942 174.499 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 94' ' ' VAL . . . . . . . . . . . . . 46.2 t -118.83 128.2 75.69 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.24 0 CA-C-O 120.82 0.343 . . . . 0.0 110.224 -177.097 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 95' ' ' VAL . . . . . . . . . . . . . 44.2 t -125.63 137.25 58.28 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.334 0 CA-C-N 116.115 -0.493 . . . . 0.0 109.916 179.977 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 96' ' ' ILE . . . . . . . . . . . . . 57.0 mt -116.6 128.45 73.95 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.325 0 N-CA-C 109.098 -0.705 . . . . 0.0 109.098 178.575 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 97' ' ' THR . . . . . . . . . . . . . 81.7 p -102.59 159.96 14.99 Favored 'General case' 0 C--N 1.331 -0.223 0 CA-C-O 121.099 0.476 . . . . 0.0 111.471 -175.202 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 98' ' ' GLU . . . . . . . . . . . . . 84.8 tt0 -53.86 -27.5 30.37 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.168 -0.469 . . . . 0.0 112.037 179.443 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 99' ' ' GLU . . . . . . . . . . . . . 42.8 mt-10 -79.62 15.83 1.24 Allowed 'General case' 0 CA--C 1.535 0.398 0 N-CA-C 113.07 0.767 . . . . 0.0 113.07 -178.393 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 100' ' ' ASN . . . . . . . . . . . . . 3.3 m-20 62.37 30.97 17.46 Favored 'General case' 0 CA--C 1.532 0.279 0 N-CA-C 111.832 0.308 . . . . 0.0 111.832 177.663 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 101' ' ' GLU . . . . . . . . . . . . . 98.5 mt-10 -101.28 150.58 22.84 Favored 'General case' 0 C--N 1.333 -0.128 0 CA-C-O 120.78 0.324 . . . . 0.0 110.851 171.687 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 102' ' ' VAL . . . . . . . . . . . . . 47.3 t -117.83 124.44 73.08 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.379 0 CA-C-N 115.469 -0.787 . . . . 0.0 109.208 176.442 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 103' ' ' LEU . . . . . . . . . . . . . 40.2 mt -116.44 130.06 56.56 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 115.925 -0.58 . . . . 0.0 110.261 178.602 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 104' ' ' ILE . . . . . . . . . . . . . 68.0 mt -118.76 117.94 56.13 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.291 0 N-CA-C 109.948 -0.39 . . . . 0.0 109.948 179.194 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 105' ' ' PHE . . . . . . . . . . . . . 40.1 m-85 -118.5 163.96 16.0 Favored 'General case' 0 C--N 1.332 -0.19 0 O-C-N 124.086 0.866 . . . . 0.0 110.255 179.282 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 106' ' ' ASN . . . . . . . . . . . . . 43.6 p-10 -98.69 -169.91 1.86 Allowed 'General case' 0 C--N 1.33 -0.263 0 N-CA-C 109.898 -0.408 . . . . 0.0 109.898 173.506 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 107' ' ' GLN . . . . . . . . . . . . . 41.2 tt0 -58.67 -29.89 66.93 Favored 'General case' 0 C--N 1.329 -0.322 0 N-CA-C 112.01 0.374 . . . . 0.0 112.01 179.242 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 108' ' ' ASN . . . . . . . . . . . . . 8.3 t-20 -83.55 6.61 19.91 Favored 'General case' 0 CA--C 1.537 0.458 0 N-CA-C 113.298 0.851 . . . . 0.0 113.298 -177.509 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 109' ' ' LEU . . . . . . . . . . . . . 9.1 tp 61.98 36.24 15.72 Favored 'General case' 0 CA--C 1.53 0.2 0 CA-C-O 120.877 0.37 . . . . 0.0 111.536 178.595 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 110' ' ' GLU . . . . . . . . . . . . . 70.8 mm-40 -105.6 152.27 23.31 Favored 'General case' 0 C--N 1.332 -0.189 0 CA-C-N 116.516 -0.311 . . . . 0.0 110.196 177.443 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 111' ' ' GLU . . . . . . . . . . . . . 98.6 mt-10 -80.9 122.06 26.76 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-O 120.878 0.371 . . . . 0.0 111.193 -178.486 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 112' ' ' LEU . . . . . . . . . . . . . 19.2 mt -108.55 -46.01 3.76 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 115.969 -0.56 . . . . 0.0 110.054 176.165 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 113' ' ' TYR . . . . . . . . . . . . . 57.7 t80 -134.74 133.06 39.52 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 116.284 -0.416 . . . . 0.0 110.735 179.184 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 114' ' ' ARG . . . . . . . . . . . . . 55.1 ttp180 -138.11 123.44 19.42 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.262 -0.426 . . . . 0.0 110.006 178.089 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 115' ' ' GLY . . . . . . . . . . . . . . . -150.12 162.84 29.33 Favored Glycine 0 CA--C 1.523 0.553 0 N-CA-C 110.902 -0.879 . . . . 0.0 110.902 -178.522 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 116' ' ' LYS . . . . . . . . . . . . . 76.3 tttt -131.9 131.02 42.36 Favored 'General case' 0 C--N 1.33 -0.278 0 N-CA-C 110.082 -0.34 . . . . 0.0 110.082 178.184 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 117' ' ' PHE . . . . . . . . . . . . . 47.9 m-85 -130.03 117.34 19.88 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 116.238 -0.437 . . . . 0.0 110.25 -177.196 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 118' ' ' GLU . . . . . . . . . . . . . 97.5 mt-10 -53.81 -43.69 69.57 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 116.433 -0.349 . . . . 0.0 111.363 -176.803 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 119' ' ' ASN . . . . . . . . . . . . . 2.8 m-20 -101.98 31.09 4.06 Favored 'General case' 0 C--N 1.331 -0.214 0 N-CA-C 112.089 0.403 . . . . 0.0 112.089 -174.786 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 120' ' ' LEU . . . . . . . . . . . . . 13.8 tp -55.04 120.07 6.38 Favored 'General case' 0 N--CA 1.462 0.169 0 CA-C-O 120.62 0.248 . . . . 0.0 110.666 178.65 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 121' ' ' ASN . . . . . . . . . . . . . 32.7 t-20 -110.77 -44.11 3.7 Favored 'General case' 0 C--N 1.332 -0.189 0 CA-C-N 116.565 -0.288 . . . . 0.0 111.137 -176.543 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 122' ' ' LYS . . . . . . . . . . . . . 90.6 mttt -148.23 152.03 36.49 Favored 'General case' 0 C--N 1.331 -0.204 0 CA-C-O 121.129 0.49 . . . . 0.0 111.955 -177.996 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 123' ' ' VAL . . . . . . . . . . . . . 42.2 t -129.45 124.66 60.24 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.268 0 CA-C-N 115.685 -0.689 . . . . 0.0 109.158 172.407 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 124' ' ' LEU . . . . . . . . . . . . . 6.2 mp -118.1 141.67 48.23 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-O 120.765 0.316 . . . . 0.0 111.004 -175.65 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 125' ' ' VAL . . . . . . . . . . . . . 41.2 t -129.17 135.66 61.39 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.209 0 CA-C-N 116.24 -0.436 . . . . 0.0 110.427 -179.901 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 126' ' ' ARG . . . . . . . . . . . . . 26.3 mmt85 -139.48 109.92 6.6 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.081 -0.509 . . . . 0.0 110.215 176.712 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 127' ' ' ASN . . . . . . . . . . . . . 79.1 m-20 51.96 -104.83 0.19 Allowed 'General case' 0 CA--C 1.543 0.691 0 CA-C-O 119.1 -0.476 . . . . 0.0 111.341 179.521 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 128' ' ' ASP . . . . . . . . . . . . . 18.7 p-10 -110.3 -2.13 16.88 Favored 'General case' 0 CA--C 1.536 0.439 0 CA-C-N 119.513 1.051 . . . . 0.0 113.459 -176.105 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 129' ' ' LEU . . . . . . . . . . . . . 27.5 mt -104.99 143.89 32.56 Favored 'General case' 0 C--N 1.332 -0.17 0 N-CA-C 109.721 -0.474 . . . . 0.0 109.721 178.557 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 130' ' ' VAL . . . . . . . . . . . . . 12.2 p -132.23 142.06 43.72 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.212 0 CA-C-O 121.147 0.499 . . . . 0.0 110.507 -178.92 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 131' ' ' VAL . . . . . . . . . . . . . 40.9 t -134.39 138.09 50.43 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.252 0 CA-C-N 115.917 -0.583 . . . . 0.0 110.315 -178.236 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 132' ' ' ILE . . . . . . . . . . . . . 70.7 mt -113.98 131.52 65.67 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.341 0 N-CA-C 109.137 -0.69 . . . . 0.0 109.137 178.308 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 133' ' ' ILE . . . . . . . . . . . . . 40.2 mm -115.65 121.02 66.43 Favored 'Isoleucine or valine' 0 C--O 1.234 0.257 0 CA-C-O 120.665 0.269 . . . . 0.0 110.993 -174.501 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 134' ' ' ASP . . . . . . . . . . . . . 9.7 p-10 -134.72 146.39 49.39 Favored 'General case' 0 C--N 1.331 -0.215 0 CA-C-N 115.984 -0.553 . . . . 0.0 109.66 174.509 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 135' ' ' GLU . . . . . . . . . . . . . 85.2 tt0 -49.89 -26.49 4.13 Favored 'General case' 0 C--N 1.328 -0.33 0 N-CA-C 112.792 0.664 . . . . 0.0 112.792 -173.946 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 136' ' ' GLN . . . . . . . . . . . . . 43.2 tt0 -80.03 -35.19 37.58 Favored 'General case' 0 C--O 1.233 0.205 0 N-CA-C 112.124 0.416 . . . . 0.0 112.124 -176.644 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 137' ' ' LYS . . . . . . . . . . . . . 50.3 pttt -167.61 171.47 10.21 Favored 'General case' 0 C--N 1.331 -0.208 0 CA-C-O 121.527 0.68 . . . . 0.0 112.244 -172.5 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 138' ' ' LEU . . . . . . . . . . . . . 4.3 tt -114.83 127.34 55.66 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 115.053 -0.976 . . . . 0.0 109.821 178.269 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 139' ' ' THR . . . . . . . . . . . . . 22.8 m -107.08 125.41 51.01 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.323 -0.399 . . . . 0.0 110.458 179.609 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 140' ' ' LEU . . . . . . . . . . . . . 14.9 tp -113.49 119.64 38.25 Favored 'General case' 0 C--N 1.328 -0.365 0 N-CA-C 109.252 -0.647 . . . . 0.0 109.252 -178.371 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 141' ' ' ILE . . . . . . . . . . . . . 19.4 mt -119.65 120.91 64.86 Favored 'Isoleucine or valine' 0 C--O 1.234 0.269 0 CA-C-O 120.949 0.404 . . . . 0.0 110.046 -175.977 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 142' ' ' ARG . . . . . . . . . . . . . 73.3 mtm180 -107.32 129.48 54.89 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 115.38 -0.827 . . . . 0.0 110.258 179.575 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 143' ' ' THR . . . . . . . . . . . . . 32.1 p . . . . . 0 C--O 1.22 -0.448 0 CA-C-O 118.045 -0.979 . . . . 0.0 110.618 179.691 . . . . . . . . 0 0 . 1 . 007 nuclear orig core ' B' B ' 2' ' ' SER . . . . . . . . . . . . . 3.6 p . . . . . 0 C--O 1.232 0.183 0 CA-C-O 120.895 0.379 . . . . 0.0 110.411 . . . . . . . . . 0 0 . 1 . 007 nuclear orig core ' B' B ' 3' ' ' GLU . . . . . . . . . . . . . 95.1 mt-10 -140.62 140.63 35.1 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-N 116.094 -0.503 . . . . 0.0 110.882 -178.445 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 4' ' ' LEU . . . . . . . . . . . . . 16.5 tp -126.21 127.5 45.76 Favored 'General case' 0 C--N 1.331 -0.216 0 CA-C-N 115.971 -0.559 . . . . 0.0 110.36 177.441 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 5' ' ' LYS . . . . . . . . . . . . . 98.1 mttt -104.37 120.95 42.37 Favored 'General case' 0 C--O 1.234 0.237 0 CA-C-N 116.287 -0.415 . . . . 0.0 110.336 177.727 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 6' ' ' LEU . . . . . . . . . . . . . 54.3 mt -117.14 148.0 41.94 Favored 'General case' 0 C--N 1.331 -0.227 0 CA-C-N 115.499 -0.773 . . . . 0.0 110.613 -178.501 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 7' ' ' LYS . . . . . . . . . . . . . 79.4 tttt -138.84 141.04 29.14 Favored Pre-proline 0 CA--C 1.534 0.344 0 CA-C-O 119.135 -0.46 . . . . 0.0 110.163 175.505 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 8' ' ' PRO . . . . . . . . . . . . . 88.0 Cg_endo -92.04 142.11 2.53 Favored 'Trans proline' 0 N--CA 1.49 1.287 0 C-N-CA 121.792 1.661 . . . . 0.0 111.723 177.438 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 9' ' ' LEU . . . . . . . . . . . . . 57.8 mt -77.36 -46.78 2.6 Favored Pre-proline 0 CA--C 1.534 0.348 0 CA-C-O 118.671 -0.68 . . . . 0.0 112.175 -179.736 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 10' ' ' PRO . . . . . . . . . . . . . 86.5 Cg_endo -81.75 150.47 16.51 Favored 'Trans proline' 0 N--CA 1.495 1.612 0 C-N-CA 121.266 1.311 . . . . 0.0 111.79 175.232 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 11' ' ' LYS . . . . . . . . . . . . . 28.2 ttpp -88.87 99.72 12.61 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-O 120.778 0.323 . . . . 0.0 110.541 179.742 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 12' ' ' VAL . . . . . . . . . . . . . 12.6 p -143.68 148.02 19.39 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.29 0 CA-C-N 116.261 -0.427 . . . . 0.0 110.559 -179.398 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 13' ' ' GLU . . . . . . . . . . . . . 44.5 mp0 -84.51 126.09 32.98 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.315 -0.402 . . . . 0.0 110.298 178.676 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 14' ' ' LEU . . . . . . . . . . . . . 47.9 mt -98.63 148.27 34.32 Favored Pre-proline 0 CA--C 1.532 0.284 0 CA-C-O 119.168 -0.444 . . . . 0.0 110.498 -179.415 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 15' ' ' PRO . . . . . . . . . . . . . 24.7 Cg_exo -63.16 159.62 38.24 Favored 'Trans proline' 0 N--CA 1.497 1.73 0 C-N-CA 121.301 1.334 . . . . 0.0 111.831 176.518 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 16' ' ' PRO . . . . . . . . . . . . . 28.8 Cg_exo -60.18 -33.69 94.73 Favored 'Trans proline' 0 N--CA 1.497 1.722 0 C-N-CA 121.52 1.48 . . . . 0.0 112.677 -178.998 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 17' ' ' ASP . . . . . . . . . . . . . 10.6 p-10 -82.79 1.07 40.86 Favored 'General case' 0 CA--C 1.537 0.458 0 N-CA-C 113.281 0.845 . . . . 0.0 113.281 -177.617 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 18' ' ' PHE . . . . . . . . . . . . . 36.2 t80 -57.61 -45.04 85.84 Favored 'General case' 0 C--N 1.334 -0.106 0 O-C-N 121.962 -0.461 . . . . 0.0 110.23 -178.182 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 19' ' ' VAL . . . . . . . . . . . . . 46.9 t -57.08 -43.99 82.24 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.349 0 CA-C-N 116.263 -0.426 . . . . 0.0 110.492 -178.407 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 20' ' ' ASP . . . . . . . . . . . . . 40.8 m-20 -59.76 -42.54 93.5 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-O 120.742 0.306 . . . . 0.0 110.948 -177.467 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 21' ' ' VAL . . . . . . . . . . . . . 46.8 t -63.85 -48.31 86.86 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.241 0 C-N-CA 120.724 -0.391 . . . . 0.0 110.515 -177.792 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 22' ' ' ILE . . . . . . . . . . . . . 50.4 mm -55.57 -46.92 79.25 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.258 0 C-N-CA 120.997 -0.281 . . . . 0.0 110.798 179.639 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 23' ' ' ARG . . . . . . . . . . . . . 57.8 ttp180 -53.8 -50.39 66.23 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-O 120.594 0.235 . . . . 0.0 111.449 -178.152 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 24' ' ' ILE . . . . . . . . . . . . . 74.8 mt -60.13 -42.96 91.89 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.317 0 CA-C-N 116.57 -0.286 . . . . 0.0 111.304 -177.462 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 25' ' ' LYS . . . . . . . . . . . . . 70.7 mmtt -65.13 -38.44 90.65 Favored 'General case' 0 C--N 1.33 -0.265 0 N-CA-C 112.127 0.417 . . . . 0.0 112.127 -178.73 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 26' ' ' LEU . . . . . . . . . . . . . 83.4 mt -77.9 -44.77 26.02 Favored 'General case' 0 C--N 1.329 -0.307 0 N-CA-C 112.747 0.647 . . . . 0.0 112.747 -172.119 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 27' ' ' GLN . . . . . . . . . . . . . 10.7 pt20 -46.98 137.88 7.01 Favored 'General case' 0 N--CA 1.469 0.489 0 N-CA-C 112.751 0.648 . . . . 0.0 112.751 -176.168 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 28' ' ' GLY . . . . . . . . . . . . . . . 100.66 -28.82 14.15 Favored Glycine 0 CA--C 1.533 1.195 0 CA-C-N 115.619 -0.718 . . . . 0.0 111.978 -177.066 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 29' ' ' LYS . . . . . . . . . . . . . 93.3 mttt -98.84 155.19 17.5 Favored 'General case' 0 C--O 1.233 0.216 0 CA-C-O 121.053 0.454 . . . . 0.0 111.133 179.285 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 30' ' ' THR . . . . . . . . . . . . . 27.3 m -104.28 137.39 42.26 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.136 -0.484 . . . . 0.0 110.065 175.884 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 31' ' ' VAL . . . . . . . . . . . . . 34.9 m -130.56 155.84 42.07 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.308 0 CA-C-N 116.375 -0.375 . . . . 0.0 110.927 -178.133 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 32' ' ' ARG . . . . . . . . . . . . . 66.2 mtp180 -132.29 152.9 51.16 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-O 121.334 0.588 . . . . 0.0 110.835 179.084 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 33' ' ' THR . . . . . . . . . . . . . 23.9 m -53.27 140.06 27.77 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 115.985 -0.552 . . . . 0.0 111.378 -178.245 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 34' ' ' GLY . . . . . . . . . . . . . . . 99.28 -17.02 58.48 Favored Glycine 0 CA--C 1.532 1.121 0 CA-C-O 119.611 -0.549 . . . . 0.0 113.279 178.273 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 35' ' ' ASP . . . . . . . . . . . . . 77.0 m-20 -66.1 147.71 52.92 Favored 'General case' 0 C--O 1.231 0.109 0 CA-C-N 118.06 0.93 . . . . 0.0 110.888 178.6 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 36' ' ' VAL . . . . . . . . . . . . . 44.3 t -124.58 131.06 73.24 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.271 0 CA-C-N 116.07 -0.514 . . . . 0.0 109.927 178.853 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 37' ' ' ILE . . . . . . . . . . . . . 64.8 mt -120.47 138.97 49.22 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.277 0 CA-C-N 116.197 -0.456 . . . . 0.0 109.951 -179.69 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 38' ' ' GLY . . . . . . . . . . . . . . . -109.22 128.7 9.12 Favored Glycine 0 CA--C 1.526 0.729 0 N-CA-C 111.171 -0.772 . . . . 0.0 111.171 179.969 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 39' ' ' ILE . . . . . . . . . . . . . 72.1 mt -124.38 130.12 73.7 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.256 0 N-CA-C 109.779 -0.452 . . . . 0.0 109.779 178.422 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 40' ' ' SER . . . . . . . . . . . . . 78.6 p -91.42 117.02 29.32 Favored 'General case' 0 C--N 1.329 -0.294 0 C-N-CA 120.973 -0.291 . . . . 0.0 111.02 178.512 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 41' ' ' ILE . . . . . . . . . . . . . 47.1 mm -130.32 125.07 58.94 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.23 0 CA-C-O 120.778 0.323 . . . . 0.0 110.191 179.512 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 42' ' ' LEU . . . . . . . . . . . . . 52.8 mt 57.8 34.23 24.16 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.246 -0.433 . . . . 0.0 111.782 177.802 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 43' ' ' GLY . . . . . . . . . . . . . . . 77.7 -10.08 26.42 Favored Glycine 0 CA--C 1.534 1.279 0 C-N-CA 121.265 -0.493 . . . . 0.0 113.456 177.525 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 44' ' ' LYS . . . . . . . . . . . . . 39.1 mtpt -104.83 133.93 48.81 Favored 'General case' 0 C--N 1.333 -0.121 0 CA-C-N 117.952 0.876 . . . . 0.0 109.855 177.086 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 45' ' ' GLU . . . . . . . . . . . . . 36.3 tp10 -84.6 129.25 34.87 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.425 -0.352 . . . . 0.0 110.864 -179.475 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 46' ' ' VAL . . . . . . . . . . . . . 7.5 p -116.79 129.62 73.0 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.224 0 N-CA-C 109.312 -0.625 . . . . 0.0 109.312 176.599 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 47' ' ' LYS . . . . . . . . . . . . . 58.9 mtpt -99.99 126.8 46.22 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 115.912 -0.585 . . . . 0.0 111.032 179.134 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 48' ' ' PHE . . . . . . . . . . . . . 92.4 m-85 -109.86 131.88 54.66 Favored 'General case' 0 C--N 1.331 -0.213 0 CA-C-N 116.318 -0.401 . . . . 0.0 110.047 176.454 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 49' ' ' LYS . . . . . . . . . . . . . 62.4 tttm -107.64 137.42 45.7 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 116.276 -0.42 . . . . 0.0 110.509 179.2 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 50' ' ' VAL . . . . . . . . . . . . . 45.5 t -80.29 107.42 12.65 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.286 0 N-CA-C 109.135 -0.691 . . . . 0.0 109.135 174.615 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 51' ' ' VAL . . . . . . . . . . . . . 47.8 t -73.5 -47.3 45.9 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.374 0 CA-C-N 116.35 -0.386 . . . . 0.0 110.024 -173.773 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 52' ' ' GLN . . . . . . . . . . . . . 43.3 tt0 -162.17 137.07 7.02 Favored 'General case' 0 C--N 1.33 -0.279 0 C-N-CA 120.418 -0.513 . . . . 0.0 111.606 -178.964 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 53' ' ' ALA . . . . . . . . . . . . . . . -113.47 133.01 55.44 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 115.782 -0.645 . . . . 0.0 109.987 175.35 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 54' ' ' TYR . . . . . . . . . . . . . 12.5 t80 -129.11 112.65 18.44 Favored Pre-proline 0 CA--C 1.534 0.358 0 CA-C-O 118.32 -0.848 . . . . 0.0 110.469 179.208 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 55' ' ' PRO . . . . . . . . . . . . . 73.9 Cg_endo -77.07 169.61 73.87 Favored 'Cis proline' 0 N--CA 1.499 1.8 0 CA-C-N 121.934 1.726 . . . . 0.0 112.195 -6.412 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 56' ' ' SER . . . . . . . . . . . . . 13.6 m -116.83 131.02 24.15 Favored Pre-proline 0 CA--C 1.54 0.559 0 CA-C-O 118.37 -0.824 . . . . 0.0 109.474 176.097 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 57' ' ' PRO . . . . . . . . . . . . . 48.4 Cg_endo -69.99 148.2 86.74 Favored 'Cis proline' 0 N--CA 1.497 1.683 0 CA-C-N 121.937 1.728 . . . . 0.0 111.573 -1.349 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 58' ' ' LEU . . . . . . . . . . . . . 25.8 tp -107.74 135.38 49.25 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.384 -0.371 . . . . 0.0 110.744 -178.399 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 59' ' ' ARG . . . . . . . . . . . . . 55.0 ttt180 -101.96 121.15 41.6 Favored 'General case' 0 C--N 1.327 -0.382 0 N-CA-C 109.297 -0.631 . . . . 0.0 109.297 176.14 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 60' ' ' VAL . . . . . . . . . . . . . 44.4 t -78.97 123.19 35.62 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.263 0 C-N-CA 120.694 -0.402 . . . . 0.0 110.36 -174.987 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 61' ' ' GLU . . . . . . . . . . . . . 95.7 mt-10 -131.03 165.57 22.93 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.062 -0.517 . . . . 0.0 110.057 178.269 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 62' ' ' ASP . . . . . . . . . . . . . 18.0 p-10 -54.61 -32.64 59.19 Favored 'General case' 0 C--N 1.328 -0.329 0 C-N-CA 120.975 -0.29 . . . . 0.0 111.675 179.872 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 63' ' ' ARG . . . . . . . . . . . . . 10.8 ptm180 -85.21 7.29 22.52 Favored 'General case' 0 CA--C 1.537 0.452 0 N-CA-C 113.523 0.934 . . . . 0.0 113.523 -176.273 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 64' ' ' THR . . . . . . . . . . . . . 33.0 m -83.84 138.48 33.19 Favored 'General case' 0 C--N 1.332 -0.17 0 CA-C-N 118.135 0.425 . . . . 0.0 110.76 -178.319 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 65' ' ' LYS . . . . . . . . . . . . . 69.2 mttm -89.99 129.27 36.34 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.106 -0.497 . . . . 0.0 110.281 178.541 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 66' ' ' ILE . . . . . . . . . . . . . 63.0 mt -116.84 130.37 71.83 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.292 0 N-CA-C 109.935 -0.395 . . . . 0.0 109.935 179.454 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 67' ' ' THR . . . . . . . . . . . . . 25.5 m -123.3 136.69 54.81 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.596 -179.513 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 68' ' ' LEU . . . . . . . . . . . . . 17.7 tp . . . . . 0 C--N 1.33 -0.275 0 CA-C-N 116.039 -0.528 . . . . 0.0 110.551 179.515 . . . . . . . . 0 0 . 1 . 007 nuclear orig core ' B' B ' 73' ' ' VAL . . . . . . . . . . . . . 31.0 m . . . . . 0 C--O 1.231 0.123 0 CA-C-O 120.902 0.382 . . . . 0.0 110.668 . . . . . . . . . 0 0 . 1 . 007 nuclear orig core ' B' B ' 74' ' ' ASP . . . . . . . . . . . . . 7.5 t70 -102.84 120.69 41.05 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.041 -0.527 . . . . 0.0 109.731 179.695 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 75' ' ' VAL . . . . . . . . . . . . . 42.5 t -113.74 122.21 67.42 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.219 0 CA-C-O 121.087 0.47 . . . . 0.0 110.531 -177.76 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 76' ' ' LEU . . . . . . . . . . . . . 32.6 mt -119.85 145.57 46.53 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 115.575 -0.739 . . . . 0.0 109.434 177.471 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 77' ' ' GLU . . . . . . . . . . . . . 98.0 mt-10 -136.46 134.24 37.46 Favored 'General case' 0 C--N 1.332 -0.187 0 CA-C-O 121.189 0.518 . . . . 0.0 111.18 -178.095 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 78' ' ' ALA . . . . . . . . . . . . . . . -122.22 123.76 42.22 Favored 'General case' 0 C--N 1.331 -0.224 0 CA-C-N 115.62 -0.718 . . . . 0.0 109.666 176.471 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 79' ' ' LYS . . . . . . . . . . . . . 45.9 pttt -73.6 121.04 20.03 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-O 121.295 0.569 . . . . 0.0 110.811 -177.832 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 80' ' ' ILE . . . . . . . . . . . . . 40.4 mm -139.33 112.49 6.22 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.267 0 CA-C-N 115.658 -0.701 . . . . 0.0 109.267 -177.799 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 81' ' ' LYS . . . . . . . . . . . . . 28.9 mtpt -99.46 122.31 42.38 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-O 120.845 0.355 . . . . 0.0 111.113 -177.789 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 82' ' ' GLY . . . . . . . . . . . . . . . 89.22 42.2 5.63 Favored Glycine 0 CA--C 1.525 0.694 0 C-N-CA 120.738 -0.744 . . . . 0.0 111.808 174.362 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 83' ' ' ILE . . . . . . . . . . . . . 68.5 mt -61.92 135.39 26.55 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.33 0 N-CA-C 109.727 -0.472 . . . . 0.0 109.727 176.938 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 84' ' ' LYS . . . . . . . . . . . . . 75.6 tttt -94.39 -51.6 4.71 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.129 -0.487 . . . . 0.0 109.988 -179.312 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 85' ' ' ASP . . . . . . . . . . . . . 11.6 t70 -157.86 152.14 24.57 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 115.666 -0.697 . . . . 0.0 110.347 178.979 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 86' ' ' VAL . . . . . . . . . . . . . 42.6 t -127.41 129.46 70.58 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.275 0 CA-C-O 120.897 0.38 . . . . 0.0 110.313 -179.541 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 87' ' ' ILE . . . . . . . . . . . . . 44.7 mm -119.55 128.95 75.88 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.312 0 CA-C-N 115.985 -0.552 . . . . 0.0 109.755 177.984 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 88' ' ' LEU . . . . . . . . . . . . . 47.7 mt -111.85 138.12 48.88 Favored 'General case' 0 C--N 1.332 -0.185 0 CA-C-O 121.057 0.456 . . . . 0.0 111.791 -176.645 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 89' ' ' ASP . . . . . . . . . . . . . 13.4 t70 -132.87 155.34 49.2 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 115.401 -0.818 . . . . 0.0 109.226 174.876 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 90' ' ' GLU . . . . . . . . . . . . . 35.0 tt0 -47.54 -37.21 11.72 Favored 'General case' 0 N--CA 1.465 0.301 0 N-CA-C 113.005 0.743 . . . . 0.0 113.005 -171.409 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 91' ' ' ASN . . . . . . . . . . . . . 4.1 t-20 -129.59 20.3 5.63 Favored 'General case' 0 N--CA 1.469 0.507 0 N-CA-C 112.823 0.675 . . . . 0.0 112.823 -177.005 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 92' ' ' LEU . . . . . . . . . . . . . 19.6 mt -148.73 143.25 26.29 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-O 120.822 0.344 . . . . 0.0 110.288 -177.427 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 93' ' ' ILE . . . . . . . . . . . . . 71.3 mt -121.54 117.0 51.2 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.331 0 N-CA-C 108.947 -0.76 . . . . 0.0 108.947 175.755 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 94' ' ' VAL . . . . . . . . . . . . . 46.8 t -114.37 123.51 70.12 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.292 0 N-CA-C 109.728 -0.471 . . . . 0.0 109.728 -179.102 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 95' ' ' VAL . . . . . . . . . . . . . 44.1 t -119.95 132.0 70.83 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.321 0 CA-C-N 116.032 -0.531 . . . . 0.0 109.767 -179.447 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 96' ' ' ILE . . . . . . . . . . . . . 66.1 mt -114.48 127.93 71.76 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.33 0 N-CA-C 109.073 -0.714 . . . . 0.0 109.073 178.471 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 97' ' ' THR . . . . . . . . . . . . . 61.3 p -102.31 154.9 18.61 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-O 121.061 0.457 . . . . 0.0 111.094 -177.644 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 98' ' ' GLU . . . . . . . . . . . . . 98.0 mt-10 -53.96 -22.2 9.77 Favored 'General case' 0 CA--C 1.533 0.302 0 N-CA-C 112.355 0.502 . . . . 0.0 112.355 178.177 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 99' ' ' GLU . . . . . . . . . . . . . 95.9 mt-10 -76.54 11.67 1.54 Allowed 'General case' 0 CA--C 1.537 0.468 0 N-CA-C 113.149 0.796 . . . . 0.0 113.149 -178.939 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 100' ' ' ASN . . . . . . . . . . . . . 2.4 m-20 61.96 37.94 14.66 Favored 'General case' 0 CA--C 1.529 0.172 0 CA-C-O 121.077 0.465 . . . . 0.0 110.836 179.785 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 101' ' ' GLU . . . . . . . . . . . . . 84.6 tt0 -120.39 142.02 49.57 Favored 'General case' 0 C--N 1.332 -0.193 0 N-CA-C 109.564 -0.532 . . . . 0.0 109.564 176.215 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 102' ' ' VAL . . . . . . . . . . . . . 45.9 t -114.92 127.57 72.41 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.238 0 N-CA-C 109.976 -0.379 . . . . 0.0 109.976 -178.362 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 103' ' ' LEU . . . . . . . . . . . . . 55.6 mt -116.77 131.89 56.84 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 115.641 -0.709 . . . . 0.0 110.335 177.771 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 104' ' ' ILE . . . . . . . . . . . . . 66.2 mt -115.97 119.35 61.63 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.256 0 CA-C-N 116.375 -0.375 . . . . 0.0 110.03 178.511 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 105' ' ' PHE . . . . . . . . . . . . . 34.7 m-85 -119.59 167.1 12.33 Favored 'General case' 0 C--N 1.333 -0.142 0 O-C-N 123.995 0.809 . . . . 0.0 109.994 178.657 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 106' ' ' ASN . . . . . . . . . . . . . 44.3 p-10 -104.02 -169.98 1.71 Allowed 'General case' 0 C--N 1.331 -0.232 0 N-CA-C 110.078 -0.341 . . . . 0.0 110.078 174.631 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 107' ' ' GLN . . . . . . . . . . . . . 41.0 tt0 -59.64 -29.9 68.35 Favored 'General case' 0 CA--C 1.531 0.244 0 N-CA-C 111.963 0.357 . . . . 0.0 111.963 179.612 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 108' ' ' ASN . . . . . . . . . . . . . 4.9 t-20 -82.87 6.77 17.34 Favored 'General case' 0 CA--C 1.537 0.45 0 N-CA-C 113.171 0.804 . . . . 0.0 113.171 -177.749 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 109' ' ' LEU . . . . . . . . . . . . . 12.0 tp 61.85 37.76 15.15 Favored 'General case' 0 CA--C 1.53 0.18 0 CA-C-O 120.948 0.404 . . . . 0.0 111.294 178.188 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 110' ' ' GLU . . . . . . . . . . . . . 96.0 mt-10 -107.66 165.59 11.32 Favored 'General case' 0 C--N 1.331 -0.218 0 CA-C-N 116.342 -0.39 . . . . 0.0 110.123 176.9 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 111' ' ' GLU . . . . . . . . . . . . . 45.4 tp10 -89.1 125.51 35.06 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-O 120.928 0.394 . . . . 0.0 111.0 -177.452 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 112' ' ' LEU . . . . . . . . . . . . . 17.4 mt -109.62 -46.05 3.58 Favored 'General case' 0 C--N 1.332 -0.19 0 CA-C-N 115.991 -0.55 . . . . 0.0 110.404 177.201 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 113' ' ' TYR . . . . . . . . . . . . . 64.4 t80 -145.42 140.31 27.53 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.226 -0.443 . . . . 0.0 111.382 -179.398 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 114' ' ' ARG . . . . . . . . . . . . . 21.3 ttm180 -132.39 127.8 36.21 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-N 116.006 -0.543 . . . . 0.0 109.842 175.627 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 115' ' ' GLY . . . . . . . . . . . . . . . -150.1 131.35 3.58 Favored Glycine 0 CA--C 1.523 0.573 0 N-CA-C 111.137 -0.785 . . . . 0.0 111.137 178.334 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 116' ' ' LYS . . . . . . . . . . . . . 28.4 ttpp -106.68 133.24 51.65 Favored 'General case' 0 C--N 1.331 -0.235 0 N-CA-C 109.664 -0.495 . . . . 0.0 109.664 176.85 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 117' ' ' PHE . . . . . . . . . . . . . 39.4 m-85 -136.01 113.92 11.23 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-O 120.903 0.382 . . . . 0.0 110.246 -175.591 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 118' ' ' GLU . . . . . . . . . . . . . 97.0 mt-10 -54.34 -44.01 71.73 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.485 -0.325 . . . . 0.0 111.279 -177.628 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 119' ' ' ASN . . . . . . . . . . . . . 83.9 m-20 -96.67 31.03 2.41 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 116.182 -0.463 . . . . 0.0 112.146 -174.661 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 120' ' ' LEU . . . . . . . . . . . . . 14.9 tp -57.04 120.25 7.68 Favored 'General case' 0 C--N 1.333 -0.137 0 CA-C-O 120.641 0.258 . . . . 0.0 110.33 177.447 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 121' ' ' ASN . . . . . . . . . . . . . 61.1 m-80 -113.6 -44.0 3.25 Favored 'General case' 0 C--N 1.332 -0.156 0 CA-C-N 116.627 -0.26 . . . . 0.0 111.084 -177.357 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 122' ' ' LYS . . . . . . . . . . . . . 88.6 mttt -147.4 149.8 33.43 Favored 'General case' 0 C--N 1.331 -0.197 0 CA-C-O 121.221 0.534 . . . . 0.0 111.744 -178.035 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 123' ' ' VAL . . . . . . . . . . . . . 44.6 t -128.19 129.2 69.29 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.263 0 CA-C-N 115.71 -0.677 . . . . 0.0 109.589 175.506 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 124' ' ' LEU . . . . . . . . . . . . . 83.8 mt -123.63 131.93 53.74 Favored 'General case' 0 C--N 1.331 -0.224 0 CA-C-N 116.396 -0.366 . . . . 0.0 110.573 -179.041 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 125' ' ' VAL . . . . . . . . . . . . . 11.2 p -131.12 122.86 52.46 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.232 0 CA-C-N 116.163 -0.471 . . . . 0.0 109.835 177.161 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 126' ' ' ARG . . . . . . . . . . . . . 88.8 mtt180 -147.45 128.82 14.86 Favored 'General case' 0 C--N 1.33 -0.252 0 N-CA-C 109.62 -0.511 . . . . 0.0 109.62 -179.802 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 127' ' ' ASN . . . . . . . . . . . . . 32.0 m120 55.95 -151.94 0.39 Allowed 'General case' 0 CA--C 1.541 0.616 0 N-CA-C 109.784 -0.451 . . . . 0.0 109.784 -178.749 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 128' ' ' ASP . . . . . . . . . . . . . 19.4 p-10 -83.69 19.73 1.59 Allowed 'General case' 0 CA--C 1.536 0.412 0 CA-C-N 118.67 0.668 . . . . 0.0 112.49 177.337 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 129' ' ' LEU . . . . . . . . . . . . . 2.0 tt -116.41 131.81 56.85 Favored 'General case' 0 C--O 1.232 0.156 0 N-CA-C 109.96 -0.385 . . . . 0.0 109.96 -179.92 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 130' ' ' VAL . . . . . . . . . . . . . 44.7 t -124.19 138.26 54.38 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.228 0 CA-C-O 120.765 0.317 . . . . 0.0 110.146 -178.826 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 131' ' ' VAL . . . . . . . . . . . . . 41.2 t -136.1 137.75 48.14 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.261 0 CA-C-O 121.037 0.446 . . . . 0.0 110.444 179.851 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 132' ' ' ILE . . . . . . . . . . . . . 73.5 mt -119.84 133.39 66.76 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.254 0 N-CA-C 109.342 -0.614 . . . . 0.0 109.342 178.68 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 133' ' ' ILE . . . . . . . . . . . . . 40.1 mm -117.44 121.71 68.22 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.29 0 CA-C-O 120.824 0.345 . . . . 0.0 111.205 -174.498 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 134' ' ' ASP . . . . . . . . . . . . . 6.8 p-10 -132.07 147.25 52.43 Favored 'General case' 0 C--N 1.332 -0.178 0 CA-C-N 115.852 -0.613 . . . . 0.0 109.521 173.831 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 135' ' ' GLU . . . . . . . . . . . . . 43.7 tp10 -49.9 -26.72 4.37 Favored 'General case' 0 C--N 1.328 -0.33 0 N-CA-C 112.904 0.705 . . . . 0.0 112.904 -170.756 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 136' ' ' GLN . . . . . . . . . . . . . 96.9 mt-30 -92.88 -34.76 13.69 Favored 'General case' 0 C--N 1.331 -0.232 0 N-CA-C 112.381 0.511 . . . . 0.0 112.381 -175.475 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 137' ' ' LYS . . . . . . . . . . . . . 55.4 mtmt -145.49 154.98 42.81 Favored 'General case' 0 C--N 1.33 -0.239 0 CA-C-O 121.474 0.654 . . . . 0.0 111.856 -170.141 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 138' ' ' LEU . . . . . . . . . . . . . 4.2 tt -113.31 123.05 49.22 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 115.144 -0.935 . . . . 0.0 108.981 174.403 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 139' ' ' THR . . . . . . . . . . . . . 33.1 m -107.61 128.48 54.58 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-O 120.848 0.356 . . . . 0.0 110.852 -177.218 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 140' ' ' LEU . . . . . . . . . . . . . 18.8 tp -114.08 121.53 44.09 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 115.45 -0.796 . . . . 0.0 109.355 -179.28 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 141' ' ' ILE . . . . . . . . . . . . . 19.5 mt -120.86 120.13 61.5 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.342 0 N-CA-C 109.855 -0.424 . . . . 0.0 109.855 -175.733 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 142' ' ' ARG . . . . . . . . . . . . . 73.5 mtm180 -111.01 129.23 55.96 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 115.55 -0.75 . . . . 0.0 110.547 -179.401 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 143' ' ' THR . . . . . . . . . . . . . 39.9 p . . . . . 0 C--O 1.222 -0.373 0 CA-C-O 117.959 -1.02 . . . . 0.0 110.56 179.939 . . . . . . . . 0 0 . 1 . 007 nuclear orig core ' C' C ' 2' ' ' SER . . . . . . . . . . . . . 25.9 p . . . . . 0 C--O 1.231 0.086 0 CA-C-O 120.911 0.386 . . . . 0.0 110.312 . . . . . . . . . 0 0 . 1 . 007 nuclear orig core ' C' C ' 3' ' ' GLU . . . . . . . . . . . . . 95.7 mt-10 -139.42 141.8 37.48 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.191 -0.459 . . . . 0.0 111.014 -178.021 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' C' C ' 4' ' ' LEU . . . . . . . . . . . . . 16.9 tp -125.11 125.83 44.37 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 115.724 -0.671 . . . . 0.0 110.197 177.165 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' C' C ' 5' ' ' LYS . . . . . . . . . . . . . 60.5 mttp -105.23 121.53 44.04 Favored 'General case' 0 C--O 1.234 0.25 0 CA-C-N 116.505 -0.316 . . . . 0.0 110.282 177.632 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' C' C ' 6' ' ' LEU . . . . . . . . . . . . . 53.2 mt -114.46 145.71 41.55 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-N 115.623 -0.717 . . . . 0.0 110.917 -178.058 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' C' C ' 7' ' ' LYS . . . . . . . . . . . . . 25.9 ttpt -132.7 134.53 24.77 Favored Pre-proline 0 CA--C 1.536 0.412 0 CA-C-O 118.884 -0.579 . . . . 0.0 109.64 176.449 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' C' C ' 8' ' ' PRO . . . . . . . . . . . . . 86.5 Cg_endo -90.67 133.3 1.75 Allowed 'Trans proline' 0 N--CA 1.489 1.228 0 C-N-CA 121.624 1.55 . . . . 0.0 111.343 174.095 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' C' C ' 9' ' ' LEU . . . . . . . . . . . . . 62.1 mt -69.13 -48.21 27.59 Favored Pre-proline 0 CA--C 1.533 0.325 0 CA-C-O 118.608 -0.711 . . . . 0.0 112.48 -177.085 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' C' C ' 10' ' ' PRO . . . . . . . . . . . . . 90.0 Cg_endo -78.81 146.83 21.17 Favored 'Trans proline' 0 N--CA 1.495 1.59 0 C-N-CA 121.109 1.206 . . . . 0.0 111.817 177.367 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' C' C ' 11' ' ' LYS . . . . . . . . . . . . . 62.0 tttm -78.55 91.39 4.57 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.436 -0.347 . . . . 0.0 110.424 179.185 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' C' C ' 12' ' ' VAL . . . . . . . . . . . . . 12.4 p -139.63 146.15 25.77 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.308 0 CA-C-N 116.297 -0.41 . . . . 0.0 110.485 -179.705 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' C' C ' 13' ' ' GLU . . . . . . . . . . . . . 44.7 tp10 -90.26 129.37 36.51 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.33 -0.396 . . . . 0.0 110.298 179.351 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' C' C ' 14' ' ' LEU . . . . . . . . . . . . . 27.3 mt -97.99 152.36 38.02 Favored Pre-proline 0 CA--C 1.531 0.246 0 CA-C-N 116.33 -0.395 . . . . 0.0 110.653 -178.323 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' C' C ' 15' ' ' PRO . . . . . . . . . . . . . 27.2 Cg_exo -61.31 159.01 32.77 Favored 'Trans proline' 0 N--CA 1.499 1.795 0 C-N-CA 121.307 1.338 . . . . 0.0 111.815 177.265 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' C' C ' 16' ' ' PRO . . . . . . . . . . . . . 39.8 Cg_exo -58.63 -39.37 83.27 Favored 'Trans proline' 0 N--CA 1.498 1.74 0 C-N-CA 121.483 1.455 . . . . 0.0 112.871 -178.481 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' C' C ' 17' ' ' ASP . . . . . . . . . . . . . 12.9 p-10 -85.81 8.51 19.73 Favored 'General case' 0 CA--C 1.536 0.44 0 N-CA-C 113.176 0.806 . . . . 0.0 113.176 -177.738 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' C' C ' 18' ' ' PHE . . . . . . . . . . . . . 55.0 t80 -58.1 -45.53 87.06 Favored 'General case' 0 C--N 1.333 -0.118 0 O-C-N 122.077 -0.389 . . . . 0.0 110.178 -177.925 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' C' C ' 19' ' ' VAL . . . . . . . . . . . . . 13.8 p -55.88 -41.69 67.9 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.371 0 CA-C-N 116.336 -0.393 . . . . 0.0 111.006 -178.244 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' C' C ' 20' ' ' ASP . . . . . . . . . . . . . 11.3 t70 -60.82 -42.03 96.91 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-O 120.977 0.418 . . . . 0.0 110.655 -178.831 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' C' C ' 21' ' ' VAL . . . . . . . . . . . . . 47.3 t -64.04 -45.47 96.58 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.248 0 CA-C-N 116.244 -0.434 . . . . 0.0 110.442 -178.138 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' C' C ' 22' ' ' ILE . . . . . . . . . . . . . 51.5 mm -55.4 -47.25 78.41 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.265 0 C-N-CA 121.056 -0.258 . . . . 0.0 110.661 179.037 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' C' C ' 23' ' ' ARG . . . . . . . . . . . . . 54.0 ttp180 -54.35 -49.83 68.86 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-O 120.671 0.272 . . . . 0.0 111.411 -179.068 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' C' C ' 24' ' ' ILE . . . . . . . . . . . . . 73.1 mt -59.34 -41.76 85.26 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.314 0 CA-C-N 116.566 -0.288 . . . . 0.0 111.422 -176.889 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' C' C ' 25' ' ' LYS . . . . . . . . . . . . . 49.6 mttm -67.28 -42.64 83.46 Favored 'General case' 0 C--N 1.329 -0.32 0 N-CA-C 112.351 0.5 . . . . 0.0 112.351 -178.791 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' C' C ' 26' ' ' LEU . . . . . . . . . . . . . 92.6 mt -78.34 -37.91 43.38 Favored 'General case' 0 C--N 1.33 -0.272 0 N-CA-C 113.116 0.784 . . . . 0.0 113.116 -170.651 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' C' C ' 27' ' ' GLN . . . . . . . . . . . . . 9.3 pt20 -46.87 139.12 5.72 Favored 'General case' 0 N--CA 1.47 0.531 0 N-CA-C 112.918 0.71 . . . . 0.0 112.918 -175.016 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' C' C ' 28' ' ' GLY . . . . . . . . . . . . . . . 100.01 -26.69 23.51 Favored Glycine 0 CA--C 1.533 1.17 0 CA-C-N 115.493 -0.776 . . . . 0.0 112.207 -177.505 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' C' C ' 29' ' ' LYS . . . . . . . . . . . . . 60.8 mttp -98.24 155.12 17.34 Favored 'General case' 0 C--O 1.232 0.169 0 CA-C-N 117.264 0.532 . . . . 0.0 111.071 179.555 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' C' C ' 30' ' ' THR . . . . . . . . . . . . . 32.8 m -110.0 133.52 53.1 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-N 116.048 -0.523 . . . . 0.0 110.186 176.823 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' C' C ' 31' ' ' VAL . . . . . . . . . . . . . 35.0 m -133.45 164.3 35.32 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.267 0 CA-C-N 116.265 -0.425 . . . . 0.0 110.364 -179.641 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' C' C ' 32' ' ' ARG . . . . . . . . . . . . . 29.9 ttp180 -132.53 153.59 50.8 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-O 121.294 0.569 . . . . 0.0 110.605 179.232 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' C' C ' 33' ' ' THR . . . . . . . . . . . . . 28.8 m -52.41 140.35 22.46 Favored 'General case' 0 C--N 1.331 -0.227 0 CA-C-N 116.127 -0.488 . . . . 0.0 111.561 -178.327 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' C' C ' 34' ' ' GLY . . . . . . . . . . . . . . . 100.02 -17.2 57.52 Favored Glycine 0 CA--C 1.533 1.181 0 CA-C-O 119.713 -0.493 . . . . 0.0 113.199 179.875 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' C' C ' 35' ' ' ASP . . . . . . . . . . . . . 60.7 m-20 -66.77 149.73 50.12 Favored 'General case' 0 C--O 1.232 0.164 0 CA-C-N 118.074 0.937 . . . . 0.0 111.2 178.918 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' C' C ' 36' ' ' VAL . . . . . . . . . . . . . 45.2 t -123.65 130.44 74.05 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.261 0 CA-C-N 115.897 -0.592 . . . . 0.0 109.825 178.905 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' C' C ' 37' ' ' ILE . . . . . . . . . . . . . 62.1 mt -122.15 139.2 49.84 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.265 0 CA-C-N 116.259 -0.428 . . . . 0.0 109.898 -178.84 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' C' C ' 38' ' ' GLY . . . . . . . . . . . . . . . -109.83 128.74 9.05 Favored Glycine 0 CA--C 1.525 0.696 0 N-CA-C 111.192 -0.763 . . . . 0.0 111.192 179.744 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' C' C ' 39' ' ' ILE . . . . . . . . . . . . . 68.8 mt -120.76 130.96 74.02 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.19 0 N-CA-C 109.944 -0.391 . . . . 0.0 109.944 178.406 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' C' C ' 40' ' ' SER . . . . . . . . . . . . . 32.8 t -93.12 122.58 35.65 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.423 -0.353 . . . . 0.0 111.099 177.324 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' C' C ' 41' ' ' ILE . . . . . . . . . . . . . 70.3 mt -129.75 120.24 49.66 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.206 0 CA-C-O 120.881 0.372 . . . . 0.0 110.325 177.405 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' C' C ' 42' ' ' LEU . . . . . . . . . . . . . 62.6 mt 52.84 36.13 20.67 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 116.02 -0.536 . . . . 0.0 111.677 177.163 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' C' C ' 43' ' ' GLY . . . . . . . . . . . . . . . 72.64 30.0 64.74 Favored Glycine 0 CA--C 1.529 0.967 0 C-N-CA 121.108 -0.567 . . . . 0.0 112.284 177.615 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' C' C ' 44' ' ' LYS . . . . . . . . . . . . . 62.3 mtpt -134.65 129.06 34.27 Favored 'General case' 0 C--N 1.331 -0.222 0 N-CA-C 109.645 -0.502 . . . . 0.0 109.645 177.809 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' C' C ' 45' ' ' GLU . . . . . . . . . . . . . 84.5 tt0 -84.23 122.2 28.55 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-O 120.871 0.367 . . . . 0.0 111.304 -178.255 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' C' C ' 46' ' ' VAL . . . . . . . . . . . . . 7.6 p -119.03 125.6 74.64 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.168 0 N-CA-C 109.06 -0.718 . . . . 0.0 109.06 173.643 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' C' C ' 47' ' ' LYS . . . . . . . . . . . . . 97.9 mttt -99.62 126.87 45.7 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.099 -0.5 . . . . 0.0 111.151 -179.843 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' C' C ' 48' ' ' PHE . . . . . . . . . . . . . 93.6 m-85 -110.39 131.78 54.75 Favored 'General case' 0 C--N 1.329 -0.289 0 N-CA-C 109.624 -0.51 . . . . 0.0 109.624 176.76 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' C' C ' 49' ' ' LYS . . . . . . . . . . . . . 71.4 tttt -108.79 136.83 47.71 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.388 -0.369 . . . . 0.0 110.459 179.075 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' C' C ' 50' ' ' VAL . . . . . . . . . . . . . 48.0 t -78.87 105.36 8.0 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.278 0 N-CA-C 109.087 -0.709 . . . . 0.0 109.087 175.899 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' C' C ' 51' ' ' VAL . . . . . . . . . . . . . 46.8 t -69.19 -48.96 65.75 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.291 0 CA-C-N 116.07 -0.514 . . . . 0.0 109.843 -173.922 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' C' C ' 52' ' ' GLN . . . . . . . . . . . . . 32.3 tt0 -162.43 143.23 10.12 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-N 115.949 -0.569 . . . . 0.0 111.522 -179.1 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' C' C ' 53' ' ' ALA . . . . . . . . . . . . . . . -122.58 133.85 54.54 Favored 'General case' 0 C--N 1.331 -0.212 0 CA-C-N 115.786 -0.643 . . . . 0.0 109.718 176.714 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' C' C ' 54' ' ' TYR . . . . . . . . . . . . . 14.9 t80 -129.08 113.08 18.52 Favored Pre-proline 0 CA--C 1.535 0.397 0 CA-C-O 118.041 -0.981 . . . . 0.0 110.345 179.265 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' C' C ' 55' ' ' PRO . . . . . . . . . . . . . 73.7 Cg_endo -77.08 169.15 75.09 Favored 'Cis proline' 0 N--CA 1.501 1.967 0 CA-C-N 122.017 1.756 . . . . 0.0 112.214 -6.95 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' C' C ' 56' ' ' SER . . . . . . . . . . . . . 13.5 m -117.74 135.95 23.51 Favored Pre-proline 0 CA--C 1.539 0.533 0 CA-C-O 118.549 -0.738 . . . . 0.0 109.825 175.681 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' C' C ' 57' ' ' PRO . . . . . . . . . . . . . 36.5 Cg_endo -67.22 164.68 70.47 Favored 'Cis proline' 0 N--CA 1.496 1.665 0 CA-C-N 121.743 1.658 . . . . 0.0 111.231 -4.318 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' C' C ' 58' ' ' LEU . . . . . . . . . . . . . 42.4 tp -130.71 138.4 49.99 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-O 121.126 0.489 . . . . 0.0 110.777 -178.737 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' C' C ' 59' ' ' ARG . . . . . . . . . . . . . 51.1 ttt180 -104.1 125.81 50.72 Favored 'General case' 0 C--N 1.327 -0.395 0 N-CA-C 108.939 -0.763 . . . . 0.0 108.939 173.297 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' C' C ' 60' ' ' VAL . . . . . . . . . . . . . 44.1 t -78.94 122.46 34.2 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.319 0 CA-C-O 120.937 0.398 . . . . 0.0 110.609 -174.135 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' C' C ' 61' ' ' GLU . . . . . . . . . . . . . 43.1 mt-10 -131.03 166.04 21.89 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 115.79 -0.641 . . . . 0.0 109.697 174.739 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' C' C ' 62' ' ' ASP . . . . . . . . . . . . . 81.0 m-20 -52.87 -31.85 41.69 Favored 'General case' 0 C--N 1.328 -0.369 0 N-CA-C 111.971 0.36 . . . . 0.0 111.971 -179.883 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' C' C ' 63' ' ' ARG . . . . . . . . . . . . . 21.0 mmm180 -71.17 -21.88 62.11 Favored 'General case' 0 CA--C 1.534 0.351 0 N-CA-C 112.76 0.652 . . . . 0.0 112.76 -176.128 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' C' C ' 64' ' ' THR . . . . . . . . . . . . . 25.3 m -72.12 136.3 46.49 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-O 120.933 0.397 . . . . 0.0 110.947 -175.829 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' C' C ' 65' ' ' LYS . . . . . . . . . . . . . 96.9 mttt -89.8 131.45 35.74 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.011 -0.54 . . . . 0.0 110.144 179.221 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' C' C ' 66' ' ' ILE . . . . . . . . . . . . . 64.0 mt -116.67 130.52 71.38 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.256 0 CA-C-O 120.89 0.376 . . . . 0.0 110.121 -179.892 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' C' C ' 67' ' ' THR . . . . . . . . . . . . . 21.7 m -129.19 142.5 50.85 Favored 'General case' 0 C--N 1.332 -0.185 0 CA-C-N 116.084 -0.507 . . . . 0.0 110.787 -178.846 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' C' C ' 68' ' ' LEU . . . . . . . . . . . . . 7.1 mp . . . . . 0 C--N 1.33 -0.248 0 CA-C-N 116.081 -0.509 . . . . 0.0 110.417 178.631 . . . . . . . . 0 0 . 1 . 007 nuclear orig core ' C' C ' 73' ' ' VAL . . . . . . . . . . . . . 26.8 m . . . . . 0 C--O 1.231 0.121 0 N-CA-C 109.802 -0.444 . . . . 0.0 109.802 . . . . . . . . . 0 0 . 1 . 007 nuclear orig core ' C' C ' 74' ' ' ASP . . . . . . . . . . . . . 14.0 t70 -91.35 115.24 27.87 Favored 'General case' 0 C--N 1.328 -0.33 0 N-CA-C 109.921 -0.4 . . . . 0.0 109.921 -178.351 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' C' C ' 75' ' ' VAL . . . . . . . . . . . . . 45.6 t -113.1 120.29 62.72 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.268 0 CA-C-O 121.094 0.473 . . . . 0.0 110.216 -178.446 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' C' C ' 76' ' ' LEU . . . . . . . . . . . . . 19.8 mt -123.18 144.94 49.02 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 115.605 -0.725 . . . . 0.0 109.585 179.452 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' C' C ' 77' ' ' GLU . . . . . . . . . . . . . 46.2 mt-10 -134.31 133.5 40.78 Favored 'General case' 0 C--N 1.332 -0.188 0 CA-C-O 121.042 0.449 . . . . 0.0 111.149 -178.804 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' C' C ' 78' ' ' ALA . . . . . . . . . . . . . . . -118.94 135.75 54.43 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 115.713 -0.676 . . . . 0.0 109.808 176.461 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' C' C ' 79' ' ' LYS . . . . . . . . . . . . . 62.5 mtpt -80.7 115.3 20.13 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-O 120.813 0.34 . . . . 0.0 110.869 -177.627 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' C' C ' 80' ' ' ILE . . . . . . . . . . . . . 37.2 mm -139.23 104.61 2.22 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.281 0 N-CA-C 109.284 -0.636 . . . . 0.0 109.284 -178.527 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' C' C ' 81' ' ' LYS . . . . . . . . . . . . . 93.1 mttt -97.65 128.48 44.38 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-O 120.782 0.325 . . . . 0.0 110.839 -178.766 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' C' C ' 82' ' ' GLY . . . . . . . . . . . . . . . 89.08 42.25 5.66 Favored Glycine 0 CA--C 1.524 0.655 0 N-CA-C 111.176 -0.77 . . . . 0.0 111.176 176.685 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' C' C ' 83' ' ' ILE . . . . . . . . . . . . . 73.6 mt -67.37 132.3 32.5 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.306 0 N-CA-C 109.771 -0.455 . . . . 0.0 109.771 177.689 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' C' C ' 84' ' ' LYS . . . . . . . . . . . . . 76.4 tttt -95.42 -54.06 3.53 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.22 -0.445 . . . . 0.0 110.311 -178.736 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' C' C ' 85' ' ' ASP . . . . . . . . . . . . . 7.4 t0 -149.81 146.3 27.07 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 115.806 -0.634 . . . . 0.0 110.39 -178.652 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' C' C ' 86' ' ' VAL . . . . . . . . . . . . . 42.6 t -124.31 129.5 73.96 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.216 0 CA-C-O 120.858 0.361 . . . . 0.0 110.291 -179.597 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' C' C ' 87' ' ' ILE . . . . . . . . . . . . . 45.1 mm -120.18 126.15 74.97 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.268 0 CA-C-N 115.957 -0.565 . . . . 0.0 109.738 177.637 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' C' C ' 88' ' ' LEU . . . . . . . . . . . . . 19.9 tp -115.15 134.72 54.91 Favored 'General case' 0 C--N 1.332 -0.171 0 CA-C-O 120.992 0.425 . . . . 0.0 111.222 -177.736 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' C' C ' 89' ' ' ASP . . . . . . . . . . . . . 5.6 t70 -131.53 162.23 30.77 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 115.861 -0.609 . . . . 0.0 109.562 176.43 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' C' C ' 90' ' ' GLU . . . . . . . . . . . . . 43.2 mt-10 -46.94 -41.9 16.83 Favored 'General case' 0 N--CA 1.464 0.26 0 N-CA-C 113.015 0.746 . . . . 0.0 113.015 -171.224 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' C' C ' 91' ' ' ASN . . . . . . . . . . . . . 1.8 p30 -132.04 28.29 4.48 Favored 'General case' 0 N--CA 1.466 0.329 0 N-CA-C 112.301 0.482 . . . . 0.0 112.301 -177.773 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' C' C ' 92' ' ' LEU . . . . . . . . . . . . . 16.1 mt -148.62 142.33 25.57 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-O 120.689 0.281 . . . . 0.0 110.35 -177.38 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' C' C ' 93' ' ' ILE . . . . . . . . . . . . . 72.9 mt -125.25 116.58 47.27 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.286 0 N-CA-C 109.143 -0.688 . . . . 0.0 109.143 176.11 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' C' C ' 94' ' ' VAL . . . . . . . . . . . . . 45.2 t -118.54 127.73 75.53 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.29 0 CA-C-O 120.959 0.409 . . . . 0.0 109.939 -178.795 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' C' C ' 95' ' ' VAL . . . . . . . . . . . . . 44.0 t -122.59 132.78 70.53 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.373 0 CA-C-N 115.96 -0.564 . . . . 0.0 109.854 -179.524 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' C' C ' 96' ' ' ILE . . . . . . . . . . . . . 58.6 mt -113.12 125.58 70.4 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.327 0 N-CA-C 109.058 -0.719 . . . . 0.0 109.058 178.066 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' C' C ' 97' ' ' THR . . . . . . . . . . . . . 71.5 p -98.95 154.53 17.99 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-O 121.197 0.522 . . . . 0.0 111.108 -177.758 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' C' C ' 98' ' ' GLU . . . . . . . . . . . . . 85.1 tt0 -53.82 -25.48 19.62 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 115.959 -0.564 . . . . 0.0 112.341 179.771 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' C' C ' 99' ' ' GLU . . . . . . . . . . . . . 37.0 tt0 -81.07 17.96 1.14 Allowed 'General case' 0 CA--C 1.539 0.525 0 N-CA-C 112.625 0.602 . . . . 0.0 112.625 -177.436 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' C' C ' 100' ' ' ASN . . . . . . . . . . . . . 2.7 m-20 62.39 32.77 16.72 Favored 'General case' 0 N--CA 1.464 0.259 0 O-C-N 121.85 -0.531 . . . . 0.0 111.836 176.276 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' C' C ' 101' ' ' GLU . . . . . . . . . . . . . 84.8 tt0 -113.06 144.82 41.96 Favored 'General case' 0 C--N 1.332 -0.155 0 N-CA-C 109.812 -0.44 . . . . 0.0 109.812 174.14 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' C' C ' 102' ' ' VAL . . . . . . . . . . . . . 45.7 t -115.09 127.43 72.65 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.293 0 CA-C-N 116.244 -0.435 . . . . 0.0 109.926 -177.695 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' C' C ' 103' ' ' LEU . . . . . . . . . . . . . 50.6 mt -117.38 131.53 56.76 Favored 'General case' 0 C--N 1.331 -0.215 0 CA-C-N 115.881 -0.6 . . . . 0.0 110.132 178.531 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' C' C ' 104' ' ' ILE . . . . . . . . . . . . . 65.1 mt -122.56 122.65 66.61 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.227 0 CA-C-O 120.568 0.223 . . . . 0.0 110.46 -179.657 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' C' C ' 105' ' ' PHE . . . . . . . . . . . . . 47.7 m-85 -124.07 164.64 19.0 Favored 'General case' 0 C--N 1.331 -0.225 0 CA-C-N 115.596 -0.729 . . . . 0.0 109.843 178.432 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' C' C ' 106' ' ' ASN . . . . . . . . . . . . . 42.9 p-10 -96.29 -171.41 2.29 Favored 'General case' 0 C--N 1.331 -0.212 0 N-CA-C 109.992 -0.373 . . . . 0.0 109.992 174.929 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' C' C ' 107' ' ' GLN . . . . . . . . . . . . . 40.1 tt0 -60.23 -29.46 68.77 Favored 'General case' 0 C--N 1.329 -0.32 0 N-CA-C 111.96 0.355 . . . . 0.0 111.96 -179.659 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' C' C ' 108' ' ' ASN . . . . . . . . . . . . . 12.1 t30 -83.95 6.16 22.83 Favored 'General case' 0 CA--C 1.536 0.441 0 N-CA-C 113.277 0.843 . . . . 0.0 113.277 -177.468 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' C' C ' 109' ' ' LEU . . . . . . . . . . . . . 12.0 tp 62.09 41.67 10.64 Favored 'General case' 0 C--N 1.332 -0.164 0 CA-C-O 121.383 0.611 . . . . 0.0 110.98 178.657 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' C' C ' 110' ' ' GLU . . . . . . . . . . . . . 96.2 mt-10 -108.55 155.97 20.04 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.139 -0.482 . . . . 0.0 110.014 176.094 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' C' C ' 111' ' ' GLU . . . . . . . . . . . . . 83.7 tt0 -79.97 121.93 26.09 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.394 -0.366 . . . . 0.0 110.683 -179.121 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' C' C ' 112' ' ' LEU . . . . . . . . . . . . . 17.9 mt -112.44 -46.03 3.2 Favored 'General case' 0 C--N 1.331 -0.212 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.306 177.026 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' C' C ' 113' ' ' TYR . . . . . . . . . . . . . 62.7 t80 -147.07 137.2 23.35 Favored 'General case' 0 C--N 1.33 -0.243 0 C-N-CA 120.606 -0.438 . . . . 0.0 111.462 179.991 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' C' C ' 114' ' ' ARG . . . . . . . . . . . . . 93.2 mtt180 -137.67 127.83 26.05 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.131 -0.486 . . . . 0.0 110.096 173.876 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' C' C ' 115' ' ' GLY . . . . . . . . . . . . . . . -149.99 162.89 29.31 Favored Glycine 0 CA--C 1.524 0.596 0 N-CA-C 110.682 -0.967 . . . . 0.0 110.682 179.337 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' C' C ' 116' ' ' LYS . . . . . . . . . . . . . 75.2 tttt -132.31 138.5 47.84 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-O 120.856 0.36 . . . . 0.0 110.143 179.287 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' C' C ' 117' ' ' PHE . . . . . . . . . . . . . 33.4 m-85 -136.28 116.72 13.71 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.158 -0.474 . . . . 0.0 109.812 -177.113 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' C' C ' 118' ' ' GLU . . . . . . . . . . . . . 45.7 mp0 -56.01 -40.62 73.65 Favored 'General case' 0 C--N 1.329 -0.304 0 C-N-CA 120.803 -0.359 . . . . 0.0 110.92 -175.758 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' C' C ' 119' ' ' ASN . . . . . . . . . . . . . 30.5 m120 -100.07 31.19 3.42 Favored 'General case' 0 CA--C 1.53 0.21 0 N-CA-C 112.103 0.408 . . . . 0.0 112.103 -174.912 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' C' C ' 120' ' ' LEU . . . . . . . . . . . . . 15.0 tp -57.34 119.9 7.25 Favored 'General case' 0 C--N 1.333 -0.148 0 C-N-CA 121.005 -0.278 . . . . 0.0 110.352 178.087 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' C' C ' 121' ' ' ASN . . . . . . . . . . . . . 46.8 m-80 -114.15 -44.1 3.17 Favored 'General case' 0 C--N 1.332 -0.195 0 CA-C-N 116.571 -0.286 . . . . 0.0 111.245 -177.705 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' C' C ' 122' ' ' LYS . . . . . . . . . . . . . 75.7 mttt -143.35 149.22 37.44 Favored 'General case' 0 C--N 1.331 -0.222 0 CA-C-O 121.066 0.46 . . . . 0.0 111.834 -176.312 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' C' C ' 123' ' ' VAL . . . . . . . . . . . . . 43.1 t -128.62 130.96 69.03 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.227 0 N-CA-C 109.266 -0.642 . . . . 0.0 109.266 174.847 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' C' C ' 124' ' ' LEU . . . . . . . . . . . . . 13.3 tp -130.27 138.3 50.43 Favored 'General case' 0 C--N 1.332 -0.184 0 CA-C-O 120.837 0.351 . . . . 0.0 110.916 -177.484 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' C' C ' 125' ' ' VAL . . . . . . . . . . . . . 34.9 m -129.74 138.82 53.19 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.229 0 CA-C-N 116.127 -0.488 . . . . 0.0 110.603 179.939 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' C' C ' 126' ' ' ARG . . . . . . . . . . . . . 77.9 mtp85 -147.17 121.88 9.87 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-O 120.868 0.366 . . . . 0.0 110.938 178.162 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' C' C ' 127' ' ' ASN . . . . . . . . . . . . . 9.5 m120 51.02 -105.11 0.19 Allowed 'General case' 0 CA--C 1.544 0.739 0 CA-C-N 116.113 -0.494 . . . . 0.0 111.437 178.684 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' C' C ' 128' ' ' ASP . . . . . . . . . . . . . 12.6 p-10 -114.13 -0.32 14.02 Favored 'General case' 0 CA--C 1.537 0.461 0 CA-C-N 119.504 1.047 . . . . 0.0 113.372 -177.37 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' C' C ' 129' ' ' LEU . . . . . . . . . . . . . 58.3 mt -105.01 143.65 32.89 Favored 'General case' 0 C--O 1.232 0.166 0 CA-C-N 118.135 0.425 . . . . 0.0 110.373 -179.465 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' C' C ' 130' ' ' VAL . . . . . . . . . . . . . 44.9 t -124.4 136.97 58.81 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.284 0 N-CA-C 109.642 -0.503 . . . . 0.0 109.642 -179.956 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' C' C ' 131' ' ' VAL . . . . . . . . . . . . . 41.3 t -134.55 137.62 51.0 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.248 0 CA-C-O 121.194 0.521 . . . . 0.0 110.376 179.974 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' C' C ' 132' ' ' ILE . . . . . . . . . . . . . 73.3 mt -118.85 133.71 64.82 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.29 0 CA-C-N 115.54 -0.755 . . . . 0.0 109.366 179.565 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' C' C ' 133' ' ' ILE . . . . . . . . . . . . . 37.7 mm -117.02 121.62 68.21 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.229 0 CA-C-N 116.462 -0.336 . . . . 0.0 110.889 -175.035 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' C' C ' 134' ' ' ASP . . . . . . . . . . . . . 7.9 p-10 -133.57 145.86 50.46 Favored 'General case' 0 C--N 1.332 -0.163 0 N-CA-C 109.652 -0.499 . . . . 0.0 109.652 174.067 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' C' C ' 135' ' ' GLU . . . . . . . . . . . . . 80.4 tt0 -49.75 -23.0 1.58 Allowed 'General case' 0 C--N 1.327 -0.403 0 N-CA-C 113.055 0.761 . . . . 0.0 113.055 -171.356 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' C' C ' 136' ' ' GLN . . . . . . . . . . . . . 44.6 tt0 -105.0 -22.56 13.1 Favored 'General case' 0 N--CA 1.465 0.294 0 N-CA-C 113.075 0.769 . . . . 0.0 113.075 -174.976 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' C' C ' 137' ' ' LYS . . . . . . . . . . . . . 78.4 mttt -145.37 153.09 40.85 Favored 'General case' 0 C--N 1.333 -0.143 0 CA-C-O 121.538 0.685 . . . . 0.0 112.22 -172.342 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' C' C ' 138' ' ' LEU . . . . . . . . . . . . . 14.6 tp -115.2 122.16 45.18 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 115.064 -0.971 . . . . 0.0 109.237 173.743 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' C' C ' 139' ' ' THR . . . . . . . . . . . . . 24.4 m -111.79 126.5 55.14 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-O 120.584 0.23 . . . . 0.0 111.011 -177.817 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' C' C ' 140' ' ' LEU . . . . . . . . . . . . . 15.0 tp -117.84 122.5 43.54 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 115.796 -0.638 . . . . 0.0 109.387 -178.976 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' C' C ' 141' ' ' ILE . . . . . . . . . . . . . 19.1 mt -121.7 123.05 68.51 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.252 0 CA-C-O 120.853 0.359 . . . . 0.0 110.127 -176.317 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' C' C ' 142' ' ' ARG . . . . . . . . . . . . . 84.2 mtp180 . . . . . 0 C--N 1.329 -0.293 0 CA-C-N 115.521 -0.763 . . . . 0.0 110.536 -178.696 . . . . . . . . 0 0 . 1 . 007 nuclear orig core ' D' D ' 2' ' ' SER . . . . . . . . . . . . . 1.8 p . . . . . 0 C--O 1.231 0.119 0 CA-C-O 120.863 0.363 . . . . 0.0 110.178 . . . . . . . . . 0 0 . 1 . 007 nuclear orig core ' D' D ' 3' ' ' GLU . . . . . . . . . . . . . 93.3 mt-10 -139.99 143.17 36.34 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-N 116.042 -0.526 . . . . 0.0 111.403 -175.819 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' D' D ' 4' ' ' LEU . . . . . . . . . . . . . 20.9 tp -126.53 129.52 48.77 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 115.776 -0.647 . . . . 0.0 109.751 175.49 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' D' D ' 5' ' ' LYS . . . . . . . . . . . . . 99.7 mttt -113.43 122.43 47.3 Favored 'General case' 0 C--O 1.235 0.336 0 CA-C-N 116.581 -0.281 . . . . 0.0 111.069 -178.624 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' D' D ' 6' ' ' LEU . . . . . . . . . . . . . 43.7 mt -114.0 143.34 44.91 Favored 'General case' 0 C--N 1.332 -0.19 0 CA-C-N 115.49 -0.777 . . . . 0.0 110.202 -179.958 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' D' D ' 7' ' ' LYS . . . . . . . . . . . . . 31.3 ttpt -125.88 138.57 32.32 Favored Pre-proline 0 CA--C 1.534 0.346 0 CA-C-O 118.917 -0.564 . . . . 0.0 109.637 175.601 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' D' D ' 8' ' ' PRO . . . . . . . . . . . . . 85.9 Cg_endo -91.14 135.22 1.8 Allowed 'Trans proline' 0 N--CA 1.489 1.23 0 C-N-CA 121.71 1.607 . . . . 0.0 112.049 179.537 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' D' D ' 9' ' ' LEU . . . . . . . . . . . . . 35.3 mt -73.81 -46.78 6.91 Favored Pre-proline 0 C--N 1.329 -0.313 0 CA-C-O 118.715 -0.66 . . . . 0.0 111.865 179.527 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' D' D ' 10' ' ' PRO . . . . . . . . . . . . . 89.4 Cg_endo -81.77 153.17 17.32 Favored 'Trans proline' 0 N--CA 1.495 1.588 0 C-N-CA 121.179 1.253 . . . . 0.0 111.574 174.71 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' D' D ' 11' ' ' LYS . . . . . . . . . . . . . 62.7 tttm -87.6 99.08 11.78 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-O 120.893 0.378 . . . . 0.0 110.443 178.863 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' D' D ' 12' ' ' VAL . . . . . . . . . . . . . 12.2 p -140.47 145.46 25.8 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.293 0 CA-C-N 116.108 -0.496 . . . . 0.0 110.352 179.971 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' D' D ' 13' ' ' GLU . . . . . . . . . . . . . 84.6 tt0 -90.1 125.45 35.43 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.317 -0.401 . . . . 0.0 110.029 178.588 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' D' D ' 14' ' ' LEU . . . . . . . . . . . . . 21.1 mt -96.77 151.17 37.7 Favored Pre-proline 0 C--N 1.329 -0.309 0 CA-C-N 116.404 -0.362 . . . . 0.0 110.692 -177.669 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' D' D ' 15' ' ' PRO . . . . . . . . . . . . . 26.7 Cg_exo -61.61 157.38 42.29 Favored 'Trans proline' 0 N--CA 1.497 1.697 0 C-N-CA 121.225 1.283 . . . . 0.0 111.669 176.812 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' D' D ' 16' ' ' PRO . . . . . . . . . . . . . 37.2 Cg_exo -57.59 -36.21 98.63 Favored 'Trans proline' 0 N--CA 1.496 1.66 0 C-N-CA 121.461 1.441 . . . . 0.0 112.981 -177.466 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' D' D ' 17' ' ' ASP . . . . . . . . . . . . . 22.4 p-10 -92.03 9.06 34.86 Favored 'General case' 0 CA--C 1.535 0.403 0 N-CA-C 113.418 0.896 . . . . 0.0 113.418 -175.988 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' D' D ' 18' ' ' PHE . . . . . . . . . . . . . 62.4 t80 -57.09 -47.61 80.63 Favored 'General case' 0 C--N 1.333 -0.145 0 O-C-N 121.837 -0.539 . . . . 0.0 110.483 -177.585 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' D' D ' 19' ' ' VAL . . . . . . . . . . . . . 44.3 t -55.57 -51.0 62.7 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.382 0 CA-C-N 116.281 -0.418 . . . . 0.0 111.235 -174.429 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' D' D ' 20' ' ' ASP . . . . . . . . . . . . . 2.3 p-10 -59.33 -37.27 77.39 Favored 'General case' 0 N--CA 1.464 0.228 0 C-N-CA 120.381 -0.527 . . . . 0.0 111.252 -176.32 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' D' D ' 21' ' ' VAL . . . . . . . . . . . . . 59.7 t -63.0 -45.15 99.61 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.266 0 C-N-CA 120.314 -0.555 . . . . 0.0 110.191 179.885 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' D' D ' 22' ' ' ILE . . . . . . . . . . . . . 46.1 mm -57.39 -39.46 68.45 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.317 0 C-N-CA 120.961 -0.296 . . . . 0.0 110.475 178.36 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' D' D ' 23' ' ' ARG . . . . . . . . . . . . . 55.5 ttp180 -57.26 -49.97 74.38 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-O 121.057 0.456 . . . . 0.0 110.437 176.751 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' D' D ' 24' ' ' ILE . . . . . . . . . . . . . 76.6 mt -60.0 -38.89 78.56 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.34 0 CA-C-N 116.028 -0.533 . . . . 0.0 111.858 -176.884 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' D' D ' 25' ' ' LYS . . . . . . . . . . . . . 25.9 pttt -76.64 -40.82 47.97 Favored 'General case' 0 CA--C 1.534 0.36 0 C-N-CA 120.343 -0.543 . . . . 0.0 112.112 -174.426 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' D' D ' 26' ' ' LEU . . . . . . . . . . . . . 14.7 mt -79.35 -28.39 42.0 Favored 'General case' 0 CA--C 1.53 0.211 0 N-CA-C 113.172 0.804 . . . . 0.0 113.172 -171.828 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' D' D ' 27' ' ' GLN . . . . . . . . . . . . . 10.2 pt20 -46.37 141.68 3.4 Favored 'General case' 0 N--CA 1.471 0.589 0 N-CA-C 112.931 0.715 . . . . 0.0 112.931 -175.518 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' D' D ' 28' ' ' GLY . . . . . . . . . . . . . . . 100.36 -25.85 26.74 Favored Glycine 0 CA--C 1.532 1.117 0 CA-C-N 115.58 -0.736 . . . . 0.0 112.189 -176.55 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' D' D ' 29' ' ' LYS . . . . . . . . . . . . . 53.2 mttm -97.65 155.13 17.13 Favored 'General case' 0 C--N 1.332 -0.162 0 CA-C-N 117.422 0.611 . . . . 0.0 110.854 178.45 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' D' D ' 30' ' ' THR . . . . . . . . . . . . . 33.4 m -106.19 140.64 38.83 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.235 -0.438 . . . . 0.0 110.24 176.946 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' D' D ' 31' ' ' VAL . . . . . . . . . . . . . 35.0 m -127.82 155.03 39.03 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.198 0 CA-C-O 120.819 0.342 . . . . 0.0 110.875 -178.581 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' D' D ' 32' ' ' ARG . . . . . . . . . . . . . 43.6 mtp180 -133.31 152.57 51.93 Favored 'General case' 0 C--N 1.331 -0.203 0 CA-C-N 115.854 -0.612 . . . . 0.0 110.675 177.719 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' D' D ' 33' ' ' THR . . . . . . . . . . . . . 18.8 m -53.46 139.14 31.72 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.034 -0.53 . . . . 0.0 111.387 -179.256 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' D' D ' 34' ' ' GLY . . . . . . . . . . . . . . . 99.84 -17.2 57.69 Favored Glycine 0 CA--C 1.533 1.202 0 C-N-CA 121.123 -0.56 . . . . 0.0 113.284 178.13 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' D' D ' 35' ' ' ASP . . . . . . . . . . . . . 77.3 m-20 -66.12 147.79 52.8 Favored 'General case' 0 C--O 1.231 0.112 0 CA-C-N 118.053 0.927 . . . . 0.0 111.064 179.444 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' D' D ' 36' ' ' VAL . . . . . . . . . . . . . 45.0 t -122.23 129.61 75.19 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.241 0 CA-C-N 115.933 -0.576 . . . . 0.0 109.751 177.775 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' D' D ' 37' ' ' ILE . . . . . . . . . . . . . 63.9 mt -120.14 137.91 52.44 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.254 0 CA-C-N 116.289 -0.414 . . . . 0.0 110.031 -179.381 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' D' D ' 38' ' ' GLY . . . . . . . . . . . . . . . -112.65 127.72 8.12 Favored Glycine 0 CA--C 1.526 0.746 0 N-CA-C 110.828 -0.909 . . . . 0.0 110.828 178.557 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' D' D ' 39' ' ' ILE . . . . . . . . . . . . . 70.8 mt -124.76 131.0 73.24 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.282 0 N-CA-C 110.113 -0.329 . . . . 0.0 110.113 179.58 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' D' D ' 40' ' ' SER . . . . . . . . . . . . . 53.1 p -91.94 123.05 35.02 Favored 'General case' 0 C--N 1.331 -0.2 0 CA-C-N 116.292 -0.413 . . . . 0.0 110.928 177.555 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' D' D ' 41' ' ' ILE . . . . . . . . . . . . . 72.9 mt -132.34 122.43 48.03 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.229 0 CA-C-N 116.469 -0.332 . . . . 0.0 110.344 177.756 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' D' D ' 42' ' ' LEU . . . . . . . . . . . . . 52.9 mt 53.87 35.9 22.84 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.161 -0.472 . . . . 0.0 111.742 176.821 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' D' D ' 43' ' ' GLY . . . . . . . . . . . . . . . 72.85 28.03 67.75 Favored Glycine 0 CA--C 1.53 1.031 0 C-N-CA 121.171 -0.537 . . . . 0.0 112.457 177.241 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' D' D ' 44' ' ' LYS . . . . . . . . . . . . . 48.7 mtmt -138.12 128.24 25.8 Favored 'General case' 0 C--N 1.331 -0.206 0 N-CA-C 109.778 -0.453 . . . . 0.0 109.778 177.77 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' D' D ' 45' ' ' GLU . . . . . . . . . . . . . 84.5 tt0 -84.62 125.92 32.89 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.515 -0.311 . . . . 0.0 111.444 -177.939 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' D' D ' 46' ' ' VAL . . . . . . . . . . . . . 8.9 p -118.58 124.39 73.06 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.23 0 N-CA-C 109.22 -0.659 . . . . 0.0 109.22 173.553 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' D' D ' 47' ' ' LYS . . . . . . . . . . . . . 91.8 mttt -98.96 124.86 44.21 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 116.087 -0.506 . . . . 0.0 110.845 178.362 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' D' D ' 48' ' ' PHE . . . . . . . . . . . . . 31.7 m-85 -108.03 131.86 54.15 Favored 'General case' 0 C--N 1.329 -0.32 0 N-CA-C 109.626 -0.509 . . . . 0.0 109.626 176.812 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' D' D ' 49' ' ' LYS . . . . . . . . . . . . . 82.2 tttt -106.79 132.08 53.17 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.246 -0.434 . . . . 0.0 110.123 178.718 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' D' D ' 50' ' ' VAL . . . . . . . . . . . . . 45.7 t -75.65 105.02 4.24 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.323 0 N-CA-C 109.257 -0.645 . . . . 0.0 109.257 177.5 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' D' D ' 51' ' ' VAL . . . . . . . . . . . . . 47.7 t -71.61 -51.43 32.7 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.273 0 CA-C-N 116.04 -0.527 . . . . 0.0 109.774 -174.687 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' D' D ' 52' ' ' GLN . . . . . . . . . . . . . 55.0 mt-30 -155.35 147.48 23.62 Favored 'General case' 0 C--N 1.33 -0.256 0 C-N-CA 120.343 -0.543 . . . . 0.0 111.789 -177.862 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' D' D ' 53' ' ' ALA . . . . . . . . . . . . . . . -124.47 130.8 53.14 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 115.291 -0.868 . . . . 0.0 109.51 173.909 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' D' D ' 54' ' ' TYR . . . . . . . . . . . . . 16.0 t80 -128.97 108.19 18.19 Favored Pre-proline 0 CA--C 1.534 0.341 0 CA-C-O 118.272 -0.871 . . . . 0.0 110.458 -179.465 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' D' D ' 55' ' ' PRO . . . . . . . . . . . . . 74.2 Cg_endo -77.16 170.0 72.71 Favored 'Cis proline' 0 N--CA 1.499 1.845 0 CA-C-N 121.86 1.7 . . . . 0.0 112.422 -5.915 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' D' D ' 56' ' ' SER . . . . . . . . . . . . . 19.6 m -116.85 133.19 23.1 Favored Pre-proline 0 CA--C 1.539 0.533 0 CA-C-O 118.465 -0.778 . . . . 0.0 109.487 174.826 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' D' D ' 57' ' ' PRO . . . . . . . . . . . . . 49.0 Cg_endo -69.91 164.18 80.32 Favored 'Cis proline' 0 N--CA 1.497 1.726 0 CA-C-N 121.848 1.696 . . . . 0.0 111.485 -1.898 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' D' D ' 58' ' ' LEU . . . . . . . . . . . . . 37.4 tp -130.23 138.05 50.35 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-O 120.886 0.374 . . . . 0.0 110.589 -179.355 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' D' D ' 59' ' ' ARG . . . . . . . . . . . . . 30.1 ttm180 -99.66 132.51 44.96 Favored 'General case' 0 C--N 1.327 -0.396 0 CA-C-N 115.85 -0.614 . . . . 0.0 109.617 176.236 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' D' D ' 60' ' ' VAL . . . . . . . . . . . . . 42.9 t -82.34 114.79 23.78 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.259 0 C-N-CA 120.787 -0.365 . . . . 0.0 110.238 -178.092 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' D' D ' 61' ' ' GLU . . . . . . . . . . . . . 96.0 mt-10 -131.19 169.43 15.93 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.079 -0.51 . . . . 0.0 109.928 176.709 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' D' D ' 62' ' ' ASP . . . . . . . . . . . . . 10.1 p-10 -55.26 -32.58 62.45 Favored 'General case' 0 C--N 1.329 -0.3 0 C-N-CA 120.904 -0.319 . . . . 0.0 111.572 178.716 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' D' D ' 63' ' ' ARG . . . . . . . . . . . . . 16.8 ptp180 -82.51 7.66 13.82 Favored 'General case' 0 CA--C 1.536 0.407 0 N-CA-C 113.504 0.927 . . . . 0.0 113.504 -176.743 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' D' D ' 64' ' ' THR . . . . . . . . . . . . . 28.5 m -91.65 134.31 34.81 Favored 'General case' 0 C--N 1.333 -0.133 0 CA-C-N 118.167 0.439 . . . . 0.0 110.618 -179.385 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' D' D ' 65' ' ' LYS . . . . . . . . . . . . . 23.0 mtpp -89.86 127.6 36.03 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.034 -0.53 . . . . 0.0 110.268 179.589 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' D' D ' 66' ' ' ILE . . . . . . . . . . . . . 65.0 mt -117.35 132.84 65.97 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.25 0 CA-C-O 120.805 0.336 . . . . 0.0 110.291 -178.327 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' D' D ' 67' ' ' THR . . . . . . . . . . . . . 23.1 m -128.7 144.19 51.1 Favored 'General case' 0 N--CA 1.463 0.217 0 CA-C-N 116.094 -0.503 . . . . 0.0 110.941 -179.139 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' D' D ' 68' ' ' LEU . . . . . . . . . . . . . 15.8 tp . . . . . 0 C--N 1.331 -0.225 0 CA-C-N 115.916 -0.584 . . . . 0.0 110.622 179.348 . . . . . . . . 0 0 . 1 . 007 nuclear orig core ' D' D ' 73' ' ' VAL . . . . . . . . . . . . . 34.7 m . . . . . 0 CA--C 1.528 0.113 0 N-CA-C 109.801 -0.444 . . . . 0.0 109.801 . . . . . . . . . 0 0 . 1 . 007 nuclear orig core ' D' D ' 74' ' ' ASP . . . . . . . . . . . . . 13.7 t70 -97.75 116.88 30.83 Favored 'General case' 0 C--N 1.33 -0.259 0 C-N-CA 120.86 -0.336 . . . . 0.0 110.149 -177.257 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' D' D ' 75' ' ' VAL . . . . . . . . . . . . . 45.3 t -112.76 122.09 66.27 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.212 0 CA-C-O 121.086 0.469 . . . . 0.0 110.218 -178.617 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' D' D ' 76' ' ' LEU . . . . . . . . . . . . . 29.7 mt -126.78 143.2 51.32 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 115.623 -0.717 . . . . 0.0 109.433 179.28 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' D' D ' 77' ' ' GLU . . . . . . . . . . . . . 39.4 tt0 -138.44 138.97 38.67 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-O 121.052 0.453 . . . . 0.0 111.228 -177.156 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' D' D ' 78' ' ' ALA . . . . . . . . . . . . . . . -122.94 142.01 51.29 Favored 'General case' 0 C--N 1.331 -0.239 0 CA-C-N 115.881 -0.6 . . . . 0.0 110.063 177.613 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' D' D ' 79' ' ' LYS . . . . . . . . . . . . . 84.4 tttt -84.7 119.2 24.98 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-O 120.743 0.306 . . . . 0.0 110.741 -178.263 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' D' D ' 80' ' ' ILE . . . . . . . . . . . . . 38.2 mm -139.13 113.33 7.27 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.283 0 N-CA-C 109.763 -0.458 . . . . 0.0 109.763 -178.302 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' D' D ' 81' ' ' LYS . . . . . . . . . . . . . 39.2 tptt -105.12 125.56 51.11 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-O 120.734 0.302 . . . . 0.0 110.814 -178.275 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' D' D ' 82' ' ' GLY . . . . . . . . . . . . . . . 89.16 42.16 5.66 Favored Glycine 0 CA--C 1.526 0.726 0 C-N-CA 120.83 -0.7 . . . . 0.0 111.473 174.986 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' D' D ' 83' ' ' ILE . . . . . . . . . . . . . 71.5 mt -67.92 137.02 25.41 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.286 0 N-CA-C 109.897 -0.408 . . . . 0.0 109.897 177.78 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' D' D ' 84' ' ' LYS . . . . . . . . . . . . . 42.8 tttp -95.11 -52.31 4.26 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 116.139 -0.482 . . . . 0.0 110.075 -179.63 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' D' D ' 85' ' ' ASP . . . . . . . . . . . . . 10.9 t70 -158.48 154.32 26.6 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 115.694 -0.685 . . . . 0.0 110.252 178.632 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' D' D ' 86' ' ' VAL . . . . . . . . . . . . . 43.3 t -130.11 132.86 65.05 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.223 0 CA-C-O 120.935 0.398 . . . . 0.0 110.563 -178.939 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' D' D ' 87' ' ' ILE . . . . . . . . . . . . . 5.0 mp -120.48 128.37 76.0 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.272 0 CA-C-N 115.851 -0.613 . . . . 0.0 109.516 176.752 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' D' D ' 88' ' ' LEU . . . . . . . . . . . . . 16.6 tp -114.17 134.46 54.89 Favored 'General case' 0 C--N 1.331 -0.218 0 CA-C-O 121.066 0.46 . . . . 0.0 110.949 -177.652 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' D' D ' 89' ' ' ASP . . . . . . . . . . . . . 7.6 t70 -130.49 160.93 32.62 Favored 'General case' 0 C--N 1.332 -0.187 0 CA-C-N 115.849 -0.614 . . . . 0.0 109.734 177.046 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' D' D ' 90' ' ' GLU . . . . . . . . . . . . . 71.0 mm-40 -46.63 -40.11 12.45 Favored 'General case' 0 C--N 1.329 -0.289 0 N-CA-C 113.117 0.784 . . . . 0.0 113.117 -171.517 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' D' D ' 91' ' ' ASN . . . . . . . . . . . . . 82.4 m-20 -132.04 25.44 4.59 Favored 'General case' 0 N--CA 1.467 0.403 0 N-CA-C 112.665 0.617 . . . . 0.0 112.665 -177.015 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' D' D ' 92' ' ' LEU . . . . . . . . . . . . . 18.1 mt -149.76 143.36 25.36 Favored 'General case' 0 C--N 1.331 -0.223 0 CA-C-O 120.622 0.249 . . . . 0.0 110.382 -177.361 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' D' D ' 93' ' ' ILE . . . . . . . . . . . . . 73.4 mt -126.19 115.1 41.39 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.345 0 N-CA-C 109.19 -0.67 . . . . 0.0 109.19 176.022 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' D' D ' 94' ' ' VAL . . . . . . . . . . . . . 45.1 t -117.82 126.4 74.79 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.267 0 CA-C-O 120.878 0.371 . . . . 0.0 110.049 -177.857 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' D' D ' 95' ' ' VAL . . . . . . . . . . . . . 43.4 t -120.63 134.01 65.46 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 CA-C-N 115.918 -0.583 . . . . 0.0 109.824 179.978 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' D' D ' 96' ' ' ILE . . . . . . . . . . . . . 63.3 mt -112.58 126.88 70.03 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 N-CA-C 108.951 -0.759 . . . . 0.0 108.951 178.466 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' D' D ' 97' ' ' THR . . . . . . . . . . . . . 81.7 p -99.34 156.95 16.73 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-O 121.21 0.529 . . . . 0.0 111.154 -177.036 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' D' D ' 98' ' ' GLU . . . . . . . . . . . . . 45.9 tp10 -53.85 -27.61 30.9 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.193 -0.458 . . . . 0.0 112.182 -179.529 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' D' D ' 99' ' ' GLU . . . . . . . . . . . . . 40.8 tt0 -79.78 16.31 1.17 Allowed 'General case' 0 CA--C 1.538 0.517 0 N-CA-C 112.666 0.617 . . . . 0.0 112.666 -176.808 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' D' D ' 100' ' ' ASN . . . . . . . . . . . . . 4.2 m-20 61.24 34.37 18.74 Favored 'General case' 0 CA--C 1.531 0.245 0 O-C-N 121.749 -0.595 . . . . 0.0 111.399 177.828 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' D' D ' 101' ' ' GLU . . . . . . . . . . . . . 84.9 tt0 -111.79 145.65 39.02 Favored 'General case' 0 C--N 1.331 -0.2 0 N-CA-C 109.594 -0.521 . . . . 0.0 109.594 173.604 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' D' D ' 102' ' ' VAL . . . . . . . . . . . . . 45.5 t -114.93 125.98 72.39 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.356 0 CA-C-N 116.275 -0.421 . . . . 0.0 110.125 -177.502 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' D' D ' 103' ' ' LEU . . . . . . . . . . . . . 29.8 mt -117.55 128.28 54.81 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 115.794 -0.639 . . . . 0.0 110.232 177.441 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' D' D ' 104' ' ' ILE . . . . . . . . . . . . . 67.3 mt -119.45 122.18 68.3 Favored 'Isoleucine or valine' 0 C--O 1.235 0.299 0 N-CA-C 110.403 -0.221 . . . . 0.0 110.403 -179.612 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' D' D ' 105' ' ' PHE . . . . . . . . . . . . . 62.4 m-85 -120.78 165.16 15.53 Favored 'General case' 0 C--O 1.232 0.147 0 O-C-N 123.95 0.781 . . . . 0.0 109.804 179.126 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' D' D ' 106' ' ' ASN . . . . . . . . . . . . . 43.3 p-10 -99.56 -170.1 1.85 Allowed 'General case' 0 C--N 1.33 -0.249 0 N-CA-C 109.78 -0.452 . . . . 0.0 109.78 172.708 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' D' D ' 107' ' ' GLN . . . . . . . . . . . . . 50.9 tt0 -57.65 -29.79 64.88 Favored 'General case' 0 C--N 1.328 -0.337 0 N-CA-C 112.033 0.383 . . . . 0.0 112.033 179.707 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' D' D ' 108' ' ' ASN . . . . . . . . . . . . . 15.1 t-20 -88.07 13.43 11.18 Favored 'General case' 0 CA--C 1.535 0.386 0 N-CA-C 112.917 0.71 . . . . 0.0 112.917 -176.215 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' D' D ' 109' ' ' LEU . . . . . . . . . . . . . 29.4 mt 57.64 34.81 24.97 Favored 'General case' 0 CA--C 1.53 0.182 0 O-C-N 122.108 -0.37 . . . . 0.0 111.661 177.98 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' D' D ' 110' ' ' GLU . . . . . . . . . . . . . 43.3 mt-10 -101.3 153.99 19.17 Favored 'General case' 0 C--N 1.331 -0.235 0 N-CA-C 109.984 -0.376 . . . . 0.0 109.984 176.991 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' D' D ' 111' ' ' GLU . . . . . . . . . . . . . 80.6 tt0 -82.7 121.96 27.54 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.383 -0.371 . . . . 0.0 110.589 -178.246 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' D' D ' 112' ' ' LEU . . . . . . . . . . . . . 25.5 mt -110.92 -46.05 3.39 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 116.293 -0.412 . . . . 0.0 110.444 178.354 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' D' D ' 113' ' ' TYR . . . . . . . . . . . . . 46.8 t80 -137.93 136.3 36.89 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-O 120.839 0.352 . . . . 0.0 111.061 -179.679 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' D' D ' 114' ' ' ARG . . . . . . . . . . . . . 60.1 ttt180 -138.01 121.45 17.17 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 115.931 -0.577 . . . . 0.0 110.257 177.034 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' D' D ' 115' ' ' GLY . . . . . . . . . . . . . . . -150.07 162.44 29.19 Favored Glycine 0 CA--C 1.525 0.677 0 N-CA-C 110.977 -0.849 . . . . 0.0 110.977 179.506 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' D' D ' 116' ' ' LYS . . . . . . . . . . . . . 70.3 tttt -136.72 137.5 40.0 Favored 'General case' 0 C--N 1.328 -0.36 0 N-CA-C 110.124 -0.324 . . . . 0.0 110.124 178.762 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' D' D ' 117' ' ' PHE . . . . . . . . . . . . . 26.3 m-85 -135.61 117.59 15.29 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 116.403 -0.362 . . . . 0.0 110.198 -176.135 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' D' D ' 118' ' ' GLU . . . . . . . . . . . . . 96.0 mt-10 -54.17 -44.96 71.94 Favored 'General case' 0 C--N 1.33 -0.27 0 C-N-CA 120.937 -0.305 . . . . 0.0 111.392 -176.316 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' D' D ' 119' ' ' ASN . . . . . . . . . . . . . 3.2 m-20 -97.78 31.04 2.75 Favored 'General case' 0 C--N 1.329 -0.317 0 N-CA-C 112.143 0.423 . . . . 0.0 112.143 -174.838 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' D' D ' 120' ' ' LEU . . . . . . . . . . . . . 20.3 tp -56.48 122.61 12.35 Favored 'General case' 0 C--O 1.233 0.197 0 CA-C-O 120.587 0.232 . . . . 0.0 110.407 178.01 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' D' D ' 121' ' ' ASN . . . . . . . . . . . . . 53.4 m-20 -114.11 -44.13 3.17 Favored 'General case' 0 C--N 1.332 -0.18 0 CA-C-N 116.707 -0.224 . . . . 0.0 111.394 -176.325 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' D' D ' 122' ' ' LYS . . . . . . . . . . . . . 26.1 ttmt -149.97 147.52 27.97 Favored 'General case' 0 C--N 1.332 -0.177 0 C-N-CA 120.417 -0.513 . . . . 0.0 111.563 -176.312 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' D' D ' 123' ' ' VAL . . . . . . . . . . . . . 43.9 t -126.73 134.35 66.45 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.181 0 CA-C-N 116.038 -0.528 . . . . 0.0 109.731 177.742 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' D' D ' 124' ' ' LEU . . . . . . . . . . . . . 65.7 mt -130.08 142.7 50.58 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-O 120.809 0.338 . . . . 0.0 110.986 -178.275 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' D' D ' 125' ' ' VAL . . . . . . . . . . . . . 35.1 m -132.79 140.25 47.84 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.243 0 CA-C-N 116.26 -0.427 . . . . 0.0 110.569 178.416 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' D' D ' 126' ' ' ARG . . . . . . . . . . . . . 95.3 mtt-85 -144.26 119.09 9.89 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.443 -0.344 . . . . 0.0 110.617 178.74 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' D' D ' 127' ' ' ASN . . . . . . . . . . . . . 84.9 m-20 51.36 -104.98 0.19 Allowed 'General case' 0 CA--C 1.543 0.697 0 CA-C-O 119.095 -0.479 . . . . 0.0 111.334 179.707 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' D' D ' 128' ' ' ASP . . . . . . . . . . . . . 18.9 p-10 -114.19 1.35 14.51 Favored 'General case' 0 N--CA 1.468 0.442 0 CA-C-N 119.548 1.067 . . . . 0.0 113.371 -177.794 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' D' D ' 129' ' ' LEU . . . . . . . . . . . . . 58.8 mt -104.96 144.84 31.24 Favored 'General case' 0 C--N 1.334 -0.108 0 O-C-N 121.961 -0.462 . . . . 0.0 110.246 179.881 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' D' D ' 130' ' ' VAL . . . . . . . . . . . . . 42.4 t -124.48 139.56 50.38 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.214 0 CA-C-N 116.375 -0.375 . . . . 0.0 110.009 -178.107 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' D' D ' 131' ' ' VAL . . . . . . . . . . . . . 42.6 t -134.55 135.37 53.8 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.24 0 CA-C-O 121.065 0.459 . . . . 0.0 110.271 179.275 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' D' D ' 132' ' ' ILE . . . . . . . . . . . . . 73.2 mt -118.47 130.82 72.77 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.282 0 CA-C-N 115.657 -0.701 . . . . 0.0 109.354 179.068 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' D' D ' 133' ' ' ILE . . . . . . . . . . . . . 43.1 mm -115.83 121.95 68.45 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.249 0 CA-C-O 120.975 0.417 . . . . 0.0 110.912 -175.992 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' D' D ' 134' ' ' ASP . . . . . . . . . . . . . 7.2 p-10 -133.43 146.08 50.86 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 115.826 -0.625 . . . . 0.0 109.507 174.615 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' D' D ' 135' ' ' GLU . . . . . . . . . . . . . 85.9 tt0 -49.8 -23.02 1.64 Allowed 'General case' 0 C--N 1.328 -0.36 0 N-CA-C 113.022 0.749 . . . . 0.0 113.022 -171.573 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' D' D ' 136' ' ' GLN . . . . . . . . . . . . . 50.2 tt0 -100.18 -31.57 11.33 Favored 'General case' 0 N--CA 1.462 0.175 0 N-CA-C 112.342 0.497 . . . . 0.0 112.342 -176.07 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' D' D ' 137' ' ' LYS . . . . . . . . . . . . . 88.4 mttt -140.45 153.11 46.16 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-O 121.288 0.566 . . . . 0.0 111.644 -171.057 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' D' D ' 138' ' ' LEU . . . . . . . . . . . . . 5.5 tt -116.87 120.52 38.72 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 115.488 -0.778 . . . . 0.0 109.017 171.733 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' D' D ' 139' ' ' THR . . . . . . . . . . . . . 30.5 m -108.38 128.11 54.48 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 116.322 -0.399 . . . . 0.0 110.744 -176.451 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' D' D ' 140' ' ' LEU . . . . . . . . . . . . . 14.0 tp -117.54 122.6 44.1 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 115.619 -0.719 . . . . 0.0 109.354 -178.811 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' D' D ' 141' ' ' ILE . . . . . . . . . . . . . 19.1 mt -120.92 119.64 60.02 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.274 0 N-CA-C 109.964 -0.384 . . . . 0.0 109.964 -175.404 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' D' D ' 142' ' ' ARG . . . . . . . . . . . . . 74.3 mtm180 -106.93 131.31 54.15 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 115.782 -0.645 . . . . 0.0 110.481 -178.318 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' D' D ' 143' ' ' THR . . . . . . . . . . . . . 44.6 p . . . . . 0 C--O 1.22 -0.466 0 CA-C-O 117.984 -1.008 . . . . 0.0 110.591 179.798 . . . . . . . . 0 0 . 1 . 007 nuclear orig core ' E' E ' 2' ' ' SER . . . . . . . . . . . . . 98.5 p . . . . . 0 C--O 1.232 0.155 0 CA-C-O 120.952 0.406 . . . . 0.0 110.664 . . . . . . . . . 0 0 . 1 . 007 nuclear orig core ' E' E ' 3' ' ' GLU . . . . . . . . . . . . . 85.0 tt0 -140.33 144.73 36.48 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.107 -0.497 . . . . 0.0 111.109 -178.025 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' E' E ' 4' ' ' LEU . . . . . . . . . . . . . 16.3 tp -127.56 134.59 49.72 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 115.852 -0.613 . . . . 0.0 110.131 177.426 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' E' E ' 5' ' ' LYS . . . . . . . . . . . . . 68.9 mttm -115.23 122.67 46.7 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.635 -0.257 . . . . 0.0 110.997 -178.808 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' E' E ' 6' ' ' LEU . . . . . . . . . . . . . 58.5 mt -114.34 142.52 46.21 Favored 'General case' 0 N--CA 1.462 0.163 0 CA-C-N 115.564 -0.744 . . . . 0.0 110.095 178.601 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' E' E ' 7' ' ' LYS . . . . . . . . . . . . . 79.3 tttt -122.49 136.19 26.33 Favored Pre-proline 0 CA--C 1.534 0.348 0 CA-C-O 118.775 -0.631 . . . . 0.0 109.781 176.634 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' E' E ' 8' ' ' PRO . . . . . . . . . . . . . 89.4 Cg_endo -91.36 131.49 1.38 Allowed 'Trans proline' 0 N--CA 1.49 1.279 0 C-N-CA 121.741 1.627 . . . . 0.0 111.705 178.089 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' E' E ' 9' ' ' LEU . . . . . . . . . . . . . 59.4 mt -72.01 -47.86 11.11 Favored Pre-proline 0 CA--C 1.534 0.335 0 CA-C-O 118.563 -0.732 . . . . 0.0 112.286 -178.642 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' E' E ' 10' ' ' PRO . . . . . . . . . . . . . 95.1 Cg_endo -79.61 152.37 22.81 Favored 'Trans proline' 0 N--CA 1.497 1.713 0 C-N-CA 121.166 1.244 . . . . 0.0 111.916 177.145 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' E' E ' 11' ' ' LYS . . . . . . . . . . . . . 97.7 mttt -83.86 91.92 7.67 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.366 -0.379 . . . . 0.0 110.262 178.34 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' E' E ' 12' ' ' VAL . . . . . . . . . . . . . 12.2 p -139.0 145.15 28.05 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.257 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.476 -178.931 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' E' E ' 13' ' ' GLU . . . . . . . . . . . . . 44.6 mp0 -91.6 125.93 36.51 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.235 -0.439 . . . . 0.0 110.179 178.671 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' E' E ' 14' ' ' LEU . . . . . . . . . . . . . 20.8 mt -97.93 149.99 36.29 Favored Pre-proline 0 CA--C 1.532 0.287 0 CA-C-O 119.331 -0.366 . . . . 0.0 110.562 -178.843 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' E' E ' 15' ' ' PRO . . . . . . . . . . . . . 27.4 Cg_exo -61.02 158.74 32.76 Favored 'Trans proline' 0 N--CA 1.496 1.675 0 C-N-CA 121.317 1.345 . . . . 0.0 111.943 177.979 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' E' E ' 16' ' ' PRO . . . . . . . . . . . . . 29.8 Cg_exo -59.68 -34.85 96.15 Favored 'Trans proline' 0 N--CA 1.496 1.675 0 C-N-CA 121.403 1.402 . . . . 0.0 112.76 -178.938 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' E' E ' 17' ' ' ASP . . . . . . . . . . . . . 8.3 p-10 -85.03 4.73 32.49 Favored 'General case' 0 C--N 1.327 -0.401 0 N-CA-C 113.322 0.86 . . . . 0.0 113.322 -177.497 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' E' E ' 18' ' ' PHE . . . . . . . . . . . . . 44.0 t80 -57.95 -44.85 87.24 Favored 'General case' 0 N--CA 1.457 -0.091 0 O-C-N 121.836 -0.54 . . . . 0.0 110.187 -178.315 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' E' E ' 19' ' ' VAL . . . . . . . . . . . . . 46.6 t -56.78 -44.99 82.88 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 CA-C-N 116.152 -0.476 . . . . 0.0 110.544 -178.304 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' E' E ' 20' ' ' ASP . . . . . . . . . . . . . 80.1 m-20 -59.54 -41.9 91.12 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-O 120.772 0.32 . . . . 0.0 110.808 -177.233 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' E' E ' 21' ' ' VAL . . . . . . . . . . . . . 46.9 t -64.55 -46.79 91.6 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.284 0 C-N-CA 120.809 -0.356 . . . . 0.0 110.621 -177.801 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' E' E ' 22' ' ' ILE . . . . . . . . . . . . . 51.4 mm -57.26 -39.98 70.97 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.217 0 C-N-CA 120.902 -0.319 . . . . 0.0 110.774 -179.562 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' E' E ' 23' ' ' ARG . . . . . . . . . . . . . 34.2 ttp180 -56.91 -50.28 73.02 Favored 'General case' 0 N--CA 1.464 0.255 0 CA-C-O 121.08 0.466 . . . . 0.0 110.443 177.326 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' E' E ' 24' ' ' ILE . . . . . . . . . . . . . 70.6 mt -61.16 -38.65 80.17 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.327 0 CA-C-N 115.807 -0.633 . . . . 0.0 112.072 -176.739 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' E' E ' 25' ' ' LYS . . . . . . . . . . . . . 14.7 pttp -78.34 -36.42 46.29 Favored 'General case' 0 CA--C 1.534 0.348 0 C-N-CA 120.606 -0.437 . . . . 0.0 112.007 -174.049 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' E' E ' 26' ' ' LEU . . . . . . . . . . . . . 47.6 mt -79.74 -35.06 39.38 Favored 'General case' 0 C--N 1.33 -0.266 0 N-CA-C 113.046 0.758 . . . . 0.0 113.046 -173.022 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' E' E ' 27' ' ' GLN . . . . . . . . . . . . . 9.6 pt20 -46.82 139.75 5.18 Favored 'General case' 0 N--CA 1.468 0.465 0 N-CA-C 112.906 0.706 . . . . 0.0 112.906 -175.49 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' E' E ' 28' ' ' GLY . . . . . . . . . . . . . . . 100.54 -25.94 26.44 Favored Glycine 0 CA--C 1.533 1.166 0 CA-C-N 115.511 -0.768 . . . . 0.0 112.304 -177.991 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' E' E ' 29' ' ' LYS . . . . . . . . . . . . . 98.9 mttt -98.3 155.12 17.36 Favored 'General case' 0 C--N 1.332 -0.167 0 CA-C-N 117.423 0.611 . . . . 0.0 111.175 179.439 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' E' E ' 30' ' ' THR . . . . . . . . . . . . . 31.2 m -102.72 137.14 41.33 Favored 'General case' 0 C--N 1.331 -0.199 0 CA-C-N 116.105 -0.498 . . . . 0.0 110.204 177.069 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' E' E ' 31' ' ' VAL . . . . . . . . . . . . . 34.9 m -128.98 154.27 39.74 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.26 0 CA-C-N 116.444 -0.344 . . . . 0.0 110.816 -179.226 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' E' E ' 32' ' ' ARG . . . . . . . . . . . . . 94.8 mtt180 -131.67 149.08 52.61 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-O 121.179 0.514 . . . . 0.0 110.611 178.332 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' E' E ' 33' ' ' THR . . . . . . . . . . . . . 22.3 m -53.44 139.74 29.84 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.22 -0.446 . . . . 0.0 111.357 -179.382 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' E' E ' 34' ' ' GLY . . . . . . . . . . . . . . . 99.69 -17.12 57.94 Favored Glycine 0 CA--C 1.532 1.126 0 CA-C-O 119.62 -0.545 . . . . 0.0 113.263 179.36 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' E' E ' 35' ' ' ASP . . . . . . . . . . . . . 78.3 m-20 -66.67 148.5 51.82 Favored 'General case' 0 C--N 1.333 -0.152 0 CA-C-N 118.041 0.921 . . . . 0.0 111.078 178.934 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' E' E ' 36' ' ' VAL . . . . . . . . . . . . . 44.3 t -120.97 129.91 75.21 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.262 0 CA-C-N 115.933 -0.576 . . . . 0.0 109.785 178.236 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' E' E ' 37' ' ' ILE . . . . . . . . . . . . . 63.8 mt -119.79 136.96 55.23 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.257 0 N-CA-C 109.751 -0.463 . . . . 0.0 109.751 -179.636 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' E' E ' 38' ' ' GLY . . . . . . . . . . . . . . . -114.97 128.72 8.25 Favored Glycine 0 CA--C 1.524 0.644 0 N-CA-C 111.006 -0.838 . . . . 0.0 111.006 -179.77 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' E' E ' 39' ' ' ILE . . . . . . . . . . . . . 72.5 mt -126.47 127.67 70.63 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.232 0 N-CA-C 110.143 -0.317 . . . . 0.0 110.143 179.142 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' E' E ' 40' ' ' SER . . . . . . . . . . . . . 7.4 m -92.7 119.35 32.01 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.295 -0.411 . . . . 0.0 110.595 175.423 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' E' E ' 41' ' ' ILE . . . . . . . . . . . . . 69.3 mt -129.73 126.57 62.98 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.175 0 CA-C-O 120.951 0.405 . . . . 0.0 110.49 179.769 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' E' E ' 42' ' ' LEU . . . . . . . . . . . . . 30.7 mt 54.1 33.8 18.57 Favored 'General case' 0 C--N 1.331 -0.223 0 CA-C-N 116.033 -0.53 . . . . 0.0 111.781 177.395 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' E' E ' 43' ' ' GLY . . . . . . . . . . . . . . . 72.36 29.54 66.04 Favored Glycine 0 CA--C 1.529 0.936 0 C-N-CA 121.127 -0.559 . . . . 0.0 112.296 177.811 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' E' E ' 44' ' ' LYS . . . . . . . . . . . . . 83.6 tttt -139.43 126.92 21.61 Favored 'General case' 0 C--N 1.331 -0.225 0 N-CA-C 109.637 -0.505 . . . . 0.0 109.637 178.217 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' E' E ' 45' ' ' GLU . . . . . . . . . . . . . 47.1 tt0 -85.65 126.59 34.05 Favored 'General case' 0 C--N 1.327 -0.397 0 CA-C-N 116.229 -0.441 . . . . 0.0 111.539 -175.483 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' E' E ' 46' ' ' VAL . . . . . . . . . . . . . 9.9 p -123.21 126.08 72.9 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.198 0 N-CA-C 109.966 -0.383 . . . . 0.0 109.966 174.457 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' E' E ' 47' ' ' LYS . . . . . . . . . . . . . 33.8 mmtp -99.48 127.44 45.54 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 115.967 -0.561 . . . . 0.0 110.877 176.223 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' E' E ' 48' ' ' PHE . . . . . . . . . . . . . 34.6 m-85 -109.78 131.7 54.82 Favored 'General case' 0 C--N 1.329 -0.289 0 N-CA-C 109.444 -0.576 . . . . 0.0 109.444 175.506 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' E' E ' 49' ' ' LYS . . . . . . . . . . . . . 46.2 tttp -107.67 132.12 53.67 Favored 'General case' 0 C--N 1.327 -0.38 0 N-CA-C 110.08 -0.341 . . . . 0.0 110.08 178.081 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' E' E ' 50' ' ' VAL . . . . . . . . . . . . . 46.7 t -76.58 104.42 4.61 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.268 0 N-CA-C 109.188 -0.671 . . . . 0.0 109.188 177.022 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' E' E ' 51' ' ' VAL . . . . . . . . . . . . . 48.3 t -69.74 -52.94 27.02 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.363 0 N-CA-C 109.609 -0.515 . . . . 0.0 109.609 -174.959 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' E' E ' 52' ' ' GLN . . . . . . . . . . . . . 91.1 mt-30 -153.64 153.69 32.79 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-O 121.253 0.549 . . . . 0.0 111.783 -178.08 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' E' E ' 53' ' ' ALA . . . . . . . . . . . . . . . -130.57 132.69 45.68 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 115.02 -0.991 . . . . 0.0 109.621 174.978 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' E' E ' 54' ' ' TYR . . . . . . . . . . . . . 40.4 t80 -129.0 107.65 18.1 Favored Pre-proline 0 CA--C 1.535 0.397 0 CA-C-O 118.138 -0.934 . . . . 0.0 110.36 179.893 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' E' E ' 55' ' ' PRO . . . . . . . . . . . . . 72.8 Cg_endo -77.17 168.07 77.94 Favored 'Cis proline' 0 N--CA 1.5 1.891 0 CA-C-N 121.783 1.672 . . . . 0.0 112.713 -5.278 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' E' E ' 56' ' ' SER . . . . . . . . . . . . . 68.4 m -118.2 132.89 23.54 Favored Pre-proline 0 CA--C 1.539 0.553 0 CA-C-O 118.377 -0.821 . . . . 0.0 109.463 173.77 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' E' E ' 57' ' ' PRO . . . . . . . . . . . . . 34.4 Cg_endo -66.19 163.97 66.91 Favored 'Cis proline' 0 N--CA 1.496 1.675 0 CA-C-N 121.95 1.732 . . . . 0.0 111.66 -1.788 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' E' E ' 58' ' ' LEU . . . . . . . . . . . . . 33.5 tp -130.07 136.83 49.79 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.104 -0.498 . . . . 0.0 110.281 -179.537 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' E' E ' 59' ' ' ARG . . . . . . . . . . . . . 41.8 ttm180 -102.72 123.58 46.67 Favored 'General case' 0 C--N 1.327 -0.403 0 CA-C-N 115.791 -0.64 . . . . 0.0 109.31 176.349 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' E' E ' 60' ' ' VAL . . . . . . . . . . . . . 45.8 t -71.99 116.97 14.7 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.294 0 C-N-CA 120.803 -0.359 . . . . 0.0 110.331 -174.584 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' E' E ' 61' ' ' GLU . . . . . . . . . . . . . 95.7 mt-10 -131.05 159.5 37.36 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 115.816 -0.629 . . . . 0.0 109.761 176.475 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' E' E ' 62' ' ' ASP . . . . . . . . . . . . . 13.8 t70 -52.48 -31.94 37.57 Favored 'General case' 0 C--N 1.328 -0.357 0 N-CA-C 111.953 0.353 . . . . 0.0 111.953 -179.209 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' E' E ' 63' ' ' ARG . . . . . . . . . . . . . 37.3 mtp180 -72.22 -21.89 61.34 Favored 'General case' 0 C--N 1.33 -0.281 0 N-CA-C 112.954 0.724 . . . . 0.0 112.954 -175.935 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' E' E ' 64' ' ' THR . . . . . . . . . . . . . 28.4 m -69.33 136.77 52.25 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-O 120.93 0.395 . . . . 0.0 110.865 -175.988 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' E' E ' 65' ' ' LYS . . . . . . . . . . . . . 92.1 mttt -89.31 127.91 35.83 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-N 115.97 -0.559 . . . . 0.0 109.917 177.987 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' E' E ' 66' ' ' ILE . . . . . . . . . . . . . 64.4 mt -114.49 129.33 70.73 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 N-CA-C 110.008 -0.368 . . . . 0.0 110.008 -179.705 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' E' E ' 67' ' ' THR . . . . . . . . . . . . . 30.2 m -122.74 142.27 50.89 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-O 121.16 0.505 . . . . 0.0 111.11 -177.644 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' E' E ' 68' ' ' LEU . . . . . . . . . . . . . 17.6 tp . . . . . 0 C--N 1.33 -0.25 0 CA-C-N 115.563 -0.744 . . . . 0.0 109.898 177.491 . . . . . . . . 0 0 . 1 . 007 nuclear orig core ' E' E ' 73' ' ' VAL . . . . . . . . . . . . . 27.0 m . . . . . 0 C--O 1.231 0.102 0 CA-C-O 120.893 0.378 . . . . 0.0 110.752 . . . . . . . . . 0 0 . 1 . 007 nuclear orig core ' E' E ' 74' ' ' ASP . . . . . . . . . . . . . 28.2 t0 -98.77 119.6 37.78 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.028 -0.533 . . . . 0.0 110.023 -178.762 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' E' E ' 75' ' ' VAL . . . . . . . . . . . . . 42.7 t -112.64 123.43 68.32 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.256 0 CA-C-O 120.987 0.422 . . . . 0.0 110.427 -178.263 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' E' E ' 76' ' ' LEU . . . . . . . . . . . . . 27.0 mt -125.02 142.64 51.36 Favored 'General case' 0 C--N 1.331 -0.239 0 CA-C-N 115.842 -0.617 . . . . 0.0 109.772 177.492 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' E' E ' 77' ' ' GLU . . . . . . . . . . . . . 97.6 mt-10 -135.22 131.24 36.42 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-O 121.005 0.431 . . . . 0.0 111.123 -177.747 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' E' E ' 78' ' ' ALA . . . . . . . . . . . . . . . -118.06 135.86 53.92 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 115.814 -0.63 . . . . 0.0 109.67 176.588 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' E' E ' 79' ' ' LYS . . . . . . . . . . . . . 90.0 mttt -79.65 118.46 21.5 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-O 121.003 0.43 . . . . 0.0 110.677 -178.864 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' E' E ' 80' ' ' ILE . . . . . . . . . . . . . 41.1 mm -139.12 114.09 8.15 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.376 0 N-CA-C 108.944 -0.761 . . . . 0.0 108.944 -178.502 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' E' E ' 81' ' ' LYS . . . . . . . . . . . . . 56.2 pttt -111.06 129.46 55.91 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-O 121.009 0.433 . . . . 0.0 111.628 -174.253 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' E' E ' 82' ' ' GLY . . . . . . . . . . . . . . . 89.13 42.04 5.7 Favored Glycine 0 CA--C 1.526 0.728 0 N-CA-C 111.524 -0.63 . . . . 0.0 111.524 175.974 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' E' E ' 83' ' ' ILE . . . . . 0.413 HG23 HD12 ' E' ' 83' ' ' ILE . 69.1 mt -74.23 138.62 20.76 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.342 0 N-CA-C 109.833 -0.432 . . . . 0.0 109.833 178.145 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' E' E ' 84' ' ' LYS . . . . . . . . . . . . . 39.4 ttpt -102.49 -47.4 4.47 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.302 -0.408 . . . . 0.0 110.163 -179.756 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' E' E ' 85' ' ' ASP . . . . . . . . . . . . . 45.5 t0 -148.91 147.06 28.21 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 115.987 -0.551 . . . . 0.0 110.608 179.876 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' E' E ' 86' ' ' VAL . . . . . . . . . . . . . 42.4 t -127.84 131.46 69.73 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.266 0 CA-C-O 120.902 0.382 . . . . 0.0 110.404 -179.208 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' E' E ' 87' ' ' ILE . . . . . . . . . . . . . 46.7 mm -121.4 125.12 73.26 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.271 0 CA-C-N 115.955 -0.566 . . . . 0.0 109.686 176.772 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' E' E ' 88' ' ' LEU . . . . . . . . . . . . . 18.3 tp -114.26 130.49 56.65 Favored 'General case' 0 C--N 1.332 -0.163 0 CA-C-O 120.924 0.392 . . . . 0.0 111.074 -177.445 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' E' E ' 89' ' ' ASP . . . . . . . . . . . . . 13.0 t70 -127.33 154.79 44.52 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 115.957 -0.565 . . . . 0.0 109.896 177.16 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' E' E ' 90' ' ' GLU . . . . . . . . . . . . . 96.8 mt-10 -48.1 -36.93 14.15 Favored 'General case' 0 C--N 1.329 -0.313 0 N-CA-C 112.923 0.712 . . . . 0.0 112.923 -172.722 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' E' E ' 91' ' ' ASN . . . . . . . . . . . . . 87.6 m-20 -132.0 33.76 3.89 Favored 'General case' 0 N--CA 1.465 0.31 0 N-CA-C 111.939 0.348 . . . . 0.0 111.939 -175.942 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' E' E ' 92' ' ' LEU . . . . . . . . . . . . . 17.3 tp -166.12 141.66 4.77 Favored 'General case' 0 C--N 1.329 -0.308 0 C-N-CA 121.027 -0.269 . . . . 0.0 110.719 179.46 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' E' E ' 93' ' ' ILE . . . . . . . . . . . . . 72.8 mt -121.86 120.42 61.48 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.27 0 N-CA-C 109.138 -0.69 . . . . 0.0 109.138 178.017 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' E' E ' 94' ' ' VAL . . . . . . . . . . . . . 47.1 t -121.4 125.74 74.03 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.261 0 CA-C-O 121.052 0.453 . . . . 0.0 109.986 -177.763 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' E' E ' 95' ' ' VAL . . . . . . . . . . . . . 43.0 t -121.27 132.81 69.7 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.245 0 CA-C-N 115.873 -0.603 . . . . 0.0 109.847 -179.257 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' E' E ' 96' ' ' ILE . . . . . . . . . . . . . 66.7 mt -115.48 124.19 71.72 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.273 0 N-CA-C 109.147 -0.686 . . . . 0.0 109.147 178.395 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' E' E ' 97' ' ' THR . . . . . . . . . . . . . 77.1 p -99.9 155.02 17.9 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-O 121.523 0.678 . . . . 0.0 111.595 -174.657 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' E' E ' 98' ' ' GLU . . . . . . . . . . . . . 84.7 tt0 -54.03 -26.72 27.87 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 115.548 -0.751 . . . . 0.0 112.141 179.726 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' E' E ' 99' ' ' GLU . . . . . . . . . . . . . 96.3 mt-10 -79.76 16.72 1.06 Allowed 'General case' 0 CA--C 1.537 0.454 0 N-CA-C 113.126 0.788 . . . . 0.0 113.126 -177.369 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' E' E ' 100' ' ' ASN . . . . . . . . . . . . . 4.2 m-20 62.81 37.38 12.39 Favored 'General case' 0 CA--C 1.53 0.198 0 CA-C-O 121.073 0.463 . . . . 0.0 111.048 178.168 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' E' E ' 101' ' ' GLU . . . . . . . . . . . . . 84.7 tt0 -116.46 143.98 44.89 Favored 'General case' 0 C--N 1.333 -0.139 0 CA-C-N 116.159 -0.473 . . . . 0.0 109.909 176.939 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' E' E ' 102' ' ' VAL . . . . . . . . . . . . . 46.4 t -115.0 125.68 72.38 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.27 0 N-CA-C 109.803 -0.443 . . . . 0.0 109.803 -179.468 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' E' E ' 103' ' ' LEU . . . . . . . . . . . . . 27.7 mt -118.94 128.69 54.65 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-N 115.732 -0.667 . . . . 0.0 110.251 177.783 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' E' E ' 104' ' ' ILE . . . . . . . . . . . . . 66.4 mt -117.66 122.67 70.36 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.2 0 N-CA-C 110.028 -0.36 . . . . 0.0 110.028 179.787 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' E' E ' 105' ' ' PHE . . . . . . . . . . . . . 91.6 m-85 -122.75 166.08 15.53 Favored 'General case' 0 N--CA 1.462 0.129 0 O-C-N 123.999 0.812 . . . . 0.0 110.131 -179.464 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' E' E ' 106' ' ' ASN . . . . . . . . . . . . . 48.7 p-10 -102.94 -172.59 2.14 Favored 'General case' 0 C--N 1.331 -0.196 0 N-CA-C 109.888 -0.412 . . . . 0.0 109.888 172.378 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' E' E ' 107' ' ' GLN . . . . . . . . . . . . . 53.3 tp60 -59.16 -27.9 66.1 Favored 'General case' 0 C--N 1.329 -0.294 0 N-CA-C 112.239 0.459 . . . . 0.0 112.239 -178.586 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' E' E ' 108' ' ' ASN . . . . . . . . . . . . . 8.4 t-20 -88.24 14.06 10.17 Favored 'General case' 0 CA--C 1.533 0.306 0 N-CA-C 112.92 0.711 . . . . 0.0 112.92 -176.918 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' E' E ' 109' ' ' LEU . . . . . . . . . . . . . 41.4 mt 57.99 34.53 24.36 Favored 'General case' 0 CA--C 1.531 0.224 0 CA-C-O 120.718 0.294 . . . . 0.0 111.643 178.514 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' E' E ' 110' ' ' GLU . . . . . . . . . . . . . 43.5 mt-10 -101.49 154.51 18.76 Favored 'General case' 0 C--N 1.33 -0.272 0 N-CA-C 109.28 -0.637 . . . . 0.0 109.28 174.968 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' E' E ' 111' ' ' GLU . . . . . . . . . . . . . 41.6 tt0 -90.96 121.83 33.12 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-O 121.048 0.451 . . . . 0.0 110.987 -175.444 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' E' E ' 112' ' ' LEU . . . . . . . . . . . . . 90.4 mt -101.23 -46.15 5.13 Favored 'General case' 0 C--N 1.332 -0.195 0 CA-C-N 115.803 -0.635 . . . . 0.0 110.388 178.675 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' E' E ' 113' ' ' TYR . . . . . . . . . . . . . 59.8 t80 -139.17 136.56 35.2 Favored 'General case' 0 C--N 1.331 -0.211 0 CA-C-N 116.174 -0.467 . . . . 0.0 111.355 -177.475 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' E' E ' 114' ' ' ARG . . . . . . . . . . . . . 57.3 ttp180 -135.05 120.15 18.75 Favored 'General case' 0 C--N 1.331 -0.22 0 CA-C-N 115.943 -0.572 . . . . 0.0 110.107 177.239 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' E' E ' 115' ' ' GLY . . . . . . . . . . . . . . . -150.07 149.39 21.29 Favored Glycine 0 CA--C 1.524 0.617 0 N-CA-C 111.073 -0.811 . . . . 0.0 111.073 178.281 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' E' E ' 116' ' ' LYS . . . . . . . . . . . . . 34.3 ttmt -125.8 136.45 53.13 Favored 'General case' 0 C--N 1.33 -0.266 0 N-CA-C 109.977 -0.379 . . . . 0.0 109.977 176.042 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' E' E ' 117' ' ' PHE . . . . . . . . . . . . . 40.1 m-85 -129.65 115.97 18.14 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.167 -0.47 . . . . 0.0 110.136 -176.584 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' E' E ' 118' ' ' GLU . . . . . . . . . . . . . 85.4 tt0 -53.7 -46.18 70.63 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.493 -0.322 . . . . 0.0 111.451 -177.133 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' E' E ' 119' ' ' ASN . . . . . . . . . . . . . 86.7 m-20 -96.99 31.07 2.49 Favored 'General case' 0 C--N 1.331 -0.2 0 N-CA-C 112.11 0.411 . . . . 0.0 112.11 -175.8 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' E' E ' 120' ' ' LEU . . . . . . . . . . . . . 10.4 tp -56.12 121.06 8.55 Favored 'General case' 0 C--N 1.332 -0.161 0 O-C-N 122.313 -0.242 . . . . 0.0 110.449 178.343 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' E' E ' 121' ' ' ASN . . . . . . . . . . . . . 31.1 m120 -113.82 -44.07 3.21 Favored 'General case' 0 C--N 1.331 -0.217 0 CA-C-N 116.734 -0.212 . . . . 0.0 111.245 -175.765 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' E' E ' 122' ' ' LYS . . . . . . . . . . . . . 97.9 mttt -146.5 147.3 31.04 Favored 'General case' 0 C--N 1.332 -0.194 0 C-N-CA 120.488 -0.485 . . . . 0.0 111.389 -177.705 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' E' E ' 123' ' ' VAL . . . . . . . . . . . . . 44.6 t -130.61 129.11 64.11 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.252 0 CA-C-N 115.982 -0.554 . . . . 0.0 109.678 176.759 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' E' E ' 124' ' ' LEU . . . . . . . . . . . . . 6.5 mp -126.49 131.06 51.71 Favored 'General case' 0 C--N 1.331 -0.205 0 N-CA-C 109.999 -0.371 . . . . 0.0 109.999 -179.513 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' E' E ' 125' ' ' VAL . . . . . . . . . . . . . 33.7 m -139.7 137.02 39.8 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.342 0 CA-C-O 120.766 0.317 . . . . 0.0 110.792 -179.071 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' E' E ' 126' ' ' ARG . . . . . . . . . . . . . 74.5 ttt-85 -143.91 127.73 17.28 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.708 -179.683 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' E' E ' 127' ' ' ASN . . . . . . . . . . . . . 4.6 m120 51.24 -106.62 0.26 Allowed 'General case' 0 CA--C 1.544 0.713 0 CA-C-O 118.982 -0.532 . . . . 0.0 111.594 179.064 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' E' E ' 128' ' ' ASP . . . . . . . . . . . . . 23.7 p-10 -114.16 1.86 14.69 Favored 'General case' 0 CA--C 1.536 0.406 0 CA-C-N 119.675 1.125 . . . . 0.0 113.582 -175.854 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' E' E ' 129' ' ' LEU . . . . . . . . . . . . . 13.5 tp -112.79 136.43 52.41 Favored 'General case' 0 C--N 1.333 -0.135 0 N-CA-C 109.771 -0.455 . . . . 0.0 109.771 179.605 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' E' E ' 130' ' ' VAL . . . . . . . . . . . . . 32.4 m -132.74 142.89 41.22 Favored 'Isoleucine or valine' 0 C--O 1.233 0.198 0 CA-C-O 121.115 0.484 . . . . 0.0 110.976 -179.18 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' E' E ' 131' ' ' VAL . . . . . . . . . . . . . 41.4 t -136.12 138.63 46.98 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.338 0 CA-C-N 115.986 -0.552 . . . . 0.0 109.981 178.37 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' E' E ' 132' ' ' ILE . . . . . . . . . . . . . 74.1 mt -113.57 133.75 58.52 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.312 0 CA-C-N 115.665 -0.698 . . . . 0.0 109.508 -179.568 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' E' E ' 133' ' ' ILE . . . . . . . . . . . . . 42.6 mm -116.04 122.62 69.99 Favored 'Isoleucine or valine' 0 C--O 1.233 0.225 0 CA-C-O 120.991 0.424 . . . . 0.0 110.928 -176.18 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' E' E ' 134' ' ' ASP . . . . . . . . . . . . . 10.5 p-10 -134.86 147.59 49.92 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 115.84 -0.618 . . . . 0.0 109.537 174.625 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' E' E ' 135' ' ' GLU . . . . . . . . . . . . . 84.6 tt0 -49.76 -26.64 4.04 Favored 'General case' 0 C--N 1.325 -0.463 0 N-CA-C 112.811 0.671 . . . . 0.0 112.811 -171.627 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' E' E ' 136' ' ' GLN . . . . . . . . . . . . . 96.8 mt-30 -83.6 -37.88 22.34 Favored 'General case' 0 C--O 1.234 0.243 0 N-CA-C 112.332 0.493 . . . . 0.0 112.332 -176.243 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' E' E ' 137' ' ' LYS . . . . . . . . . . . . . 19.5 pttp -159.91 174.09 14.93 Favored 'General case' 0 C--N 1.331 -0.209 0 CA-C-O 121.51 0.671 . . . . 0.0 112.296 -171.834 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' E' E ' 138' ' ' LEU . . . . . . . . . . . . . 8.1 tt -121.91 130.5 53.39 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 114.926 -1.034 . . . . 0.0 109.732 177.599 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' E' E ' 139' ' ' THR . . . . . . . . . . . . . 40.8 m -113.07 125.51 54.46 Favored 'General case' 0 C--N 1.331 -0.23 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.716 -178.558 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' E' E ' 140' ' ' LEU . . . . . . . . . . . . . 8.7 tt -107.65 122.57 46.98 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 115.636 -0.711 . . . . 0.0 109.288 -179.502 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' E' E ' 141' ' ' ILE . . . . . . . . . . . . . 19.2 mt -125.07 118.87 54.25 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.288 0 CA-C-O 121.066 0.46 . . . . 0.0 109.886 -177.692 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' E' E ' 142' ' ' ARG . . . . . . . . . . . . . 77.4 ttt-85 -110.94 119.3 38.62 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 115.474 -0.785 . . . . 0.0 109.822 -179.428 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' E' E ' 143' ' ' THR . . . . . . . . . . . . . 71.4 p . . . . . 0 C--O 1.221 -0.442 0 CA-C-O 117.951 -1.023 . . . . 0.0 110.623 -178.14 . . . . . . . . 0 0 . 1 . 007 nuclear orig core ' F' F ' 1' ' ' MET . . . . . . . . . . . . . 25.3 ptp . . . . . 0 C--O 1.23 0.076 0 CA-C-O 120.687 0.279 . . . . 0.0 110.691 . . . . . . . . . 0 0 . 1 . 007 nuclear orig core ' F' F ' 2' ' ' SER . . . . . . . . . . . . . 2.2 p -122.52 125.24 45.35 Favored 'General case' 0 C--N 1.331 -0.227 0 CA-C-O 121.096 0.474 . . . . 0.0 110.564 178.426 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' F' F ' 3' ' ' GLU . . . . . . . . . . . . . 85.1 tt0 -144.49 144.56 31.41 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-N 115.942 -0.572 . . . . 0.0 111.184 -178.973 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' F' F ' 4' ' ' LEU . . . . . . . . . . . . . 12.1 tp -126.11 135.32 51.57 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 115.782 -0.645 . . . . 0.0 110.292 178.092 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' F' F ' 5' ' ' LYS . . . . . . . . . . . . . 98.9 mttt -111.37 121.57 45.59 Favored 'General case' 0 C--O 1.235 0.316 0 CA-C-N 116.345 -0.389 . . . . 0.0 110.505 179.764 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' F' F ' 6' ' ' LEU . . . . . . . . . . . . . 78.7 mt -116.93 147.24 42.4 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 115.735 -0.666 . . . . 0.0 110.538 -178.981 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' F' F ' 7' ' ' LYS . . . . . . . . . . . . . 55.0 tttt -137.45 140.38 30.27 Favored Pre-proline 0 CA--C 1.534 0.328 0 CA-C-O 119.201 -0.428 . . . . 0.0 110.1 177.035 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' F' F ' 8' ' ' PRO . . . . . . . . . . . . . 93.5 Cg_endo -91.55 143.2 2.95 Favored 'Trans proline' 0 N--CA 1.49 1.303 0 C-N-CA 121.764 1.643 . . . . 0.0 111.717 177.781 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' F' F ' 9' ' ' LEU . . . . . . . . . . . . . 41.6 mt -79.81 -47.41 1.45 Allowed Pre-proline 0 CA--C 1.535 0.373 0 CA-C-O 118.686 -0.673 . . . . 0.0 112.42 -178.594 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' F' F ' 10' ' ' PRO . . . . . . . . . . . . . 86.1 Cg_endo -80.67 155.98 21.11 Favored 'Trans proline' 0 N--CA 1.496 1.638 0 C-N-CA 121.243 1.296 . . . . 0.0 111.951 176.252 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' F' F ' 11' ' ' LYS . . . . . . . . . . . . . 53.9 tptt -88.01 99.32 12.07 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.393 -0.367 . . . . 0.0 110.39 179.094 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' F' F ' 12' ' ' VAL . . . . . . . . . . . . . 11.9 p -145.94 143.21 21.51 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.305 0 CA-C-N 116.118 -0.492 . . . . 0.0 110.378 179.03 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' F' F ' 13' ' ' GLU . . . . . . . . . . . . . 43.8 mt-10 -85.91 124.27 32.19 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.373 -0.376 . . . . 0.0 110.219 177.677 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' F' F ' 14' ' ' LEU . . . . . . . . . . . . . 18.7 mt -94.76 152.19 39.59 Favored Pre-proline 0 C--N 1.329 -0.298 0 CA-C-N 116.315 -0.402 . . . . 0.0 110.544 -178.695 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' F' F ' 15' ' ' PRO . . . . . . . . . . . . . 39.7 Cg_exo -58.43 157.31 27.19 Favored 'Trans proline' 0 N--CA 1.498 1.752 0 C-N-CA 121.235 1.29 . . . . 0.0 111.796 179.586 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' F' F ' 16' ' ' PRO . . . . . . . . . . . . . 32.1 Cg_exo -59.5 -37.92 86.21 Favored 'Trans proline' 0 N--CA 1.497 1.729 0 C-N-CA 121.42 1.414 . . . . 0.0 112.672 -178.182 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' F' F ' 17' ' ' ASP . . . . . . . . . . . . . 15.2 p-10 -87.59 11.25 15.48 Favored 'General case' 0 CA--C 1.535 0.387 0 N-CA-C 113.074 0.768 . . . . 0.0 113.074 -178.149 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' F' F ' 18' ' ' PHE . . . . . . . . . . . . . 45.2 t80 -58.28 -43.33 87.92 Favored 'General case' 0 CA--C 1.522 -0.114 0 O-C-N 121.863 -0.523 . . . . 0.0 110.089 -178.524 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' F' F ' 19' ' ' VAL . . . . . . . . . . . . . 46.8 t -55.54 -42.77 69.81 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.323 0 CA-C-N 116.354 -0.384 . . . . 0.0 110.675 -178.583 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' F' F ' 20' ' ' ASP . . . . . . . . . . . . . 81.2 m-20 -60.2 -44.94 94.71 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-O 120.859 0.362 . . . . 0.0 110.857 -177.97 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' F' F ' 21' ' ' VAL . . . . . . . . . . . . . 48.7 t -64.13 -46.71 92.83 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.309 0 C-N-CA 120.788 -0.365 . . . . 0.0 110.547 -177.52 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' F' F ' 22' ' ' ILE . . . . . . . . . . . . . 49.4 mm -55.88 -46.63 80.25 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.257 0 CA-C-O 120.633 0.254 . . . . 0.0 110.597 179.375 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' F' F ' 23' ' ' ARG . . . . . . . . . . . . . 53.9 ttp180 -54.11 -47.91 71.32 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-O 120.607 0.242 . . . . 0.0 111.349 -178.502 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' F' F ' 24' ' ' ILE . . . . . . . . . . . . . 72.2 mt -59.12 -44.51 91.76 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.285 0 CA-C-N 116.677 -0.238 . . . . 0.0 111.098 -178.405 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' F' F ' 25' ' ' LYS . . . . . . . . . . . . . 67.6 mttm -65.05 -39.75 93.75 Favored 'General case' 0 C--N 1.328 -0.339 0 N-CA-C 112.429 0.529 . . . . 0.0 112.429 -177.977 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' F' F ' 26' ' ' LEU . . . . . . . . . . . . . 63.6 mt -78.62 -43.27 26.71 Favored 'General case' 0 C--N 1.331 -0.229 0 N-CA-C 112.882 0.697 . . . . 0.0 112.882 -171.824 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' F' F ' 27' ' ' GLN . . . . . . . . . . . . . 10.5 pt20 -46.73 139.4 5.33 Favored 'General case' 0 N--CA 1.467 0.41 0 N-CA-C 112.883 0.697 . . . . 0.0 112.883 -174.641 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' F' F ' 28' ' ' GLY . . . . . . . . . . . . . . . 99.82 -25.57 27.76 Favored Glycine 0 CA--C 1.533 1.199 0 CA-C-N 115.472 -0.786 . . . . 0.0 112.197 -176.154 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' F' F ' 29' ' ' LYS . . . . . . . . . . . . . 91.4 mttt -98.0 155.22 17.21 Favored 'General case' 0 C--O 1.233 0.197 0 CA-C-N 117.242 0.521 . . . . 0.0 110.929 178.091 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' F' F ' 30' ' ' THR . . . . . . . . . . . . . 26.0 m -107.28 134.57 50.16 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 115.894 -0.594 . . . . 0.0 109.565 173.9 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' F' F ' 31' ' ' VAL . . . . . . . . . . . . . 34.9 m -125.98 153.5 34.18 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.214 0 CA-C-O 120.924 0.393 . . . . 0.0 110.938 -176.978 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' F' F ' 32' ' ' ARG . . . . . . . . . . . . . 47.8 ttp180 -126.46 147.07 49.86 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 116.044 -0.525 . . . . 0.0 110.334 179.421 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' F' F ' 33' ' ' THR . . . . . . . . . . . . . 15.8 m -52.84 138.74 28.86 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.323 -0.399 . . . . 0.0 111.46 -177.514 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' F' F ' 34' ' ' GLY . . . . . . . . . . . . . . . 101.17 -17.22 56.23 Favored Glycine 0 CA--C 1.535 1.287 0 CA-C-O 119.662 -0.521 . . . . 0.0 113.253 179.248 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' F' F ' 35' ' ' ASP . . . . . . . . . . . . . 78.5 m-20 -66.06 149.06 50.85 Favored 'General case' 0 N--CA 1.461 0.11 0 CA-C-N 117.947 0.873 . . . . 0.0 110.938 178.645 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' F' F ' 36' ' ' VAL . . . . . . . . . . . . . 44.1 t -122.25 131.99 72.01 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.219 0 CA-C-N 116.034 -0.53 . . . . 0.0 109.967 179.178 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' F' F ' 37' ' ' ILE . . . . . . . . . . . . . 66.0 mt -120.76 139.3 48.43 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.247 0 CA-C-N 115.973 -0.558 . . . . 0.0 109.667 179.7 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' F' F ' 38' ' ' GLY . . . . . . . . . . . . . . . -114.49 128.9 8.41 Favored Glycine 0 CA--C 1.525 0.686 0 N-CA-C 111.371 -0.692 . . . . 0.0 111.371 -178.536 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' F' F ' 39' ' ' ILE . . . . . . . . . . . . . 72.1 mt -125.19 129.41 73.2 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.188 0 N-CA-C 109.896 -0.409 . . . . 0.0 109.896 178.014 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' F' F ' 40' ' ' SER . . . . . . . . . . . . . 28.8 t -92.47 121.82 34.31 Favored 'General case' 0 C--N 1.329 -0.301 0 C-N-CA 120.997 -0.281 . . . . 0.0 110.834 176.935 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' F' F ' 41' ' ' ILE . . . . . . . . . . . . . 72.9 mt -133.98 124.96 47.84 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.224 0 CA-C-O 120.774 0.321 . . . . 0.0 110.253 179.304 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' F' F ' 42' ' ' LEU . . . . . . . . . . . . . 60.6 mt 58.29 33.65 23.33 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-N 116.145 -0.48 . . . . 0.0 111.798 178.082 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' F' F ' 43' ' ' GLY . . . . . . . . . . . . . . . 77.66 -10.23 25.37 Favored Glycine 0 CA--C 1.536 1.361 0 C-N-CA 121.268 -0.492 . . . . 0.0 113.456 178.203 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' F' F ' 44' ' ' LYS . . . . . . . . . . . . . 27.1 mtpp -100.52 130.58 46.61 Favored 'General case' 0 C--N 1.332 -0.171 0 CA-C-N 117.852 0.826 . . . . 0.0 109.891 176.937 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' F' F ' 45' ' ' GLU . . . . . . . . . . . . . 38.2 tp10 -84.53 128.46 34.61 Favored 'General case' 0 C--N 1.33 -0.271 0 C-N-CA 120.884 -0.326 . . . . 0.0 110.808 179.877 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' F' F ' 46' ' ' VAL . . . . . . . . . . . . . 7.6 p -119.89 128.57 75.93 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.242 0 N-CA-C 109.702 -0.481 . . . . 0.0 109.702 177.543 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' F' F ' 47' ' ' LYS . . . . . . . . . . . . . 64.9 mttp -100.25 130.17 46.34 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 115.948 -0.569 . . . . 0.0 111.214 178.975 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' F' F ' 48' ' ' PHE . . . . . . . . . . . . . 92.2 m-85 -113.46 131.87 55.87 Favored 'General case' 0 C--N 1.33 -0.267 0 N-CA-C 109.721 -0.474 . . . . 0.0 109.721 176.024 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' F' F ' 49' ' ' LYS . . . . . . . . . . . . . 54.1 tttm -107.83 137.79 45.22 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.545 -0.298 . . . . 0.0 110.622 179.197 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' F' F ' 50' ' ' VAL . . . . . . . . . . . . . 44.5 t -79.17 107.23 11.39 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.282 0 N-CA-C 109.179 -0.674 . . . . 0.0 109.179 175.22 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' F' F ' 51' ' ' VAL . . . . . . . . . . . . . 46.0 t -70.52 -52.78 26.24 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.339 0 CA-C-N 115.934 -0.576 . . . . 0.0 109.585 -174.664 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' F' F ' 52' ' ' GLN . . . . . . . . . . . . . 46.9 mt-30 -155.73 153.6 30.18 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.058 -0.519 . . . . 0.0 111.669 -177.527 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' F' F ' 53' ' ' ALA . . . . . . . . . . . . . . . -128.97 132.44 47.57 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 115.292 -0.867 . . . . 0.0 109.889 175.546 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' F' F ' 54' ' ' TYR . . . . . . . . . . . . . 27.1 t80 -129.01 107.71 18.08 Favored Pre-proline 0 CA--C 1.535 0.378 0 CA-C-O 118.238 -0.887 . . . . 0.0 110.43 -179.849 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' F' F ' 55' ' ' PRO . . . . . . . . . . . . . 73.7 Cg_endo -77.1 170.1 72.53 Favored 'Cis proline' 0 N--CA 1.5 1.862 0 CA-C-N 121.787 1.674 . . . . 0.0 112.364 -5.812 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' F' F ' 56' ' ' SER . . . . . . . . . . . . . 45.5 m -115.61 131.44 23.65 Favored Pre-proline 0 CA--C 1.538 0.507 0 CA-C-O 118.499 -0.763 . . . . 0.0 109.448 175.74 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' F' F ' 57' ' ' PRO . . . . . . . . . . . . . 53.7 Cg_endo -70.88 149.04 90.61 Favored 'Cis proline' 0 N--CA 1.496 1.675 0 CA-C-N 121.955 1.734 . . . . 0.0 111.577 -1.899 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' F' F ' 58' ' ' LEU . . . . . . . . . . . . . 23.8 tp -108.29 136.43 47.95 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.219 -0.446 . . . . 0.0 110.725 -177.449 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' F' F ' 59' ' ' ARG . . . . . . . . . . . . . 70.7 ttt180 -103.02 126.12 50.06 Favored 'General case' 0 C--N 1.327 -0.384 0 N-CA-C 109.117 -0.697 . . . . 0.0 109.117 175.744 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' F' F ' 60' ' ' VAL . . . . . . . . . . . . . 41.2 t -91.07 123.21 43.12 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.303 0 C-N-CA 120.663 -0.415 . . . . 0.0 111.014 -174.059 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' F' F ' 61' ' ' GLU . . . . . . . . . . . . . 96.1 mt-10 -131.13 172.06 12.55 Favored 'General case' 0 C--N 1.329 -0.317 0 N-CA-C 109.407 -0.59 . . . . 0.0 109.407 173.055 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' F' F ' 62' ' ' ASP . . . . . . . . . . . . . 73.3 m-20 -54.22 -32.67 56.47 Favored 'General case' 0 C--N 1.328 -0.334 0 C-N-CA 121.029 -0.268 . . . . 0.0 111.583 179.299 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' F' F ' 63' ' ' ARG . . . . . . . . . . . . . 13.5 ptm180 -74.56 -11.91 60.33 Favored 'General case' 0 CA--C 1.535 0.394 0 N-CA-C 113.409 0.892 . . . . 0.0 113.409 -177.298 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' F' F ' 64' ' ' THR . . . . . . . . . . . . . 37.6 m -74.67 138.72 43.04 Favored 'General case' 0 C--O 1.233 0.193 0 O-C-N 122.096 -0.377 . . . . 0.0 110.75 -176.09 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' F' F ' 65' ' ' LYS . . . . . . . . . . . . . 55.5 mtmt -89.24 129.12 35.86 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.149 -0.478 . . . . 0.0 110.141 177.863 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' F' F ' 66' ' ' ILE . . . . . . . . . . . . . 65.3 mt -114.75 129.84 70.19 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.295 0 N-CA-C 109.899 -0.408 . . . . 0.0 109.899 -179.835 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' F' F ' 67' ' ' THR . . . . . . . . . . . . . 24.8 m -118.82 135.51 54.5 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-N 116.076 -0.511 . . . . 0.0 110.464 179.862 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' F' F ' 68' ' ' LEU . . . . . . . . . . . . . 6.5 tt . . . . . 0 C--N 1.329 -0.295 0 CA-C-N 115.912 -0.586 . . . . 0.0 110.01 179.062 . . . . . . . . 0 0 . 1 . 007 nuclear orig core ' F' F ' 73' ' ' VAL . . . . . . . . . . . . . 34.4 m . . . . . 0 C--O 1.231 0.131 0 N-CA-C 110.118 -0.327 . . . . 0.0 110.118 . . . . . . . . . 0 0 . 1 . 007 nuclear orig core ' F' F ' 74' ' ' ASP . . . . . . . . . . . . . 24.1 t0 -96.37 121.9 38.67 Favored 'General case' 0 C--N 1.33 -0.263 0 C-N-CA 120.941 -0.304 . . . . 0.0 110.186 -177.302 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' F' F ' 75' ' ' VAL . . . . . . . . . . . . . 41.0 t -121.29 124.68 72.52 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.214 0 CA-C-O 121.039 0.447 . . . . 0.0 110.913 -177.781 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' F' F ' 76' ' ' LEU . . . . . . . . . . . . . 7.5 mp -121.57 143.73 49.13 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 115.61 -0.723 . . . . 0.0 109.512 176.473 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' F' F ' 77' ' ' GLU . . . . . . . . . . . . . 98.3 mt-10 -134.78 140.83 46.2 Favored 'General case' 0 N--CA 1.463 0.186 0 CA-C-O 121.091 0.472 . . . . 0.0 111.617 -178.16 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' F' F ' 78' ' ' ALA . . . . . . . . . . . . . . . -133.95 141.2 47.21 Favored 'General case' 0 C--N 1.331 -0.223 0 CA-C-N 115.706 -0.679 . . . . 0.0 110.229 176.248 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' F' F ' 79' ' ' LYS . . . . . . . . . . . . . 10.0 mtpm? -82.19 119.96 24.74 Favored 'General case' 0 C--N 1.331 -0.225 0 CA-C-O 120.934 0.397 . . . . 0.0 110.801 -178.868 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' F' F ' 80' ' ' ILE . . . . . . . . . . . . . 42.2 mm -139.23 102.09 1.65 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 N-CA-C 109.165 -0.679 . . . . 0.0 109.165 -178.705 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' F' F ' 81' ' ' LYS . . . . . . . . . . . . . 54.6 mtpt -97.21 127.71 43.42 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-O 120.957 0.408 . . . . 0.0 111.133 -176.92 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' F' F ' 82' ' ' GLY . . . . . . . . . . . . . . . 89.16 42.12 5.67 Favored Glycine 0 CA--C 1.525 0.695 0 C-N-CA 120.937 -0.649 . . . . 0.0 111.522 175.793 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' F' F ' 83' ' ' ILE . . . . . . . . . . . . . 71.9 mt -67.49 138.03 23.55 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.297 0 N-CA-C 109.89 -0.411 . . . . 0.0 109.89 178.407 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' F' F ' 84' ' ' LYS . . . . . . . . . . . . . 56.3 tttp -99.63 -51.91 3.62 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.02 -0.536 . . . . 0.0 110.173 -179.726 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' F' F ' 85' ' ' ASP . . . . . . . . . . . . . 7.9 t70 -156.85 153.31 28.02 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 115.811 -0.632 . . . . 0.0 110.293 -179.914 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' F' F ' 86' ' ' VAL . . . . . . . . . . . . . 41.9 t -133.36 134.75 56.96 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.246 0 CA-C-O 121.083 0.468 . . . . 0.0 110.548 -179.128 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' F' F ' 87' ' ' ILE . . . . . . . . . . . . . 45.1 mm -119.36 128.16 75.85 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.25 0 CA-C-N 115.666 -0.697 . . . . 0.0 109.733 176.892 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' F' F ' 88' ' ' LEU . . . . . . . . . . . . . 63.9 mt -114.54 133.62 55.65 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-O 121.078 0.466 . . . . 0.0 111.173 -178.754 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' F' F ' 89' ' ' ASP . . . . . . . . . . . . . 8.8 t70 -131.89 154.62 49.03 Favored 'General case' 0 C--N 1.327 -0.385 0 CA-C-N 115.667 -0.697 . . . . 0.0 109.425 177.094 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' F' F ' 90' ' ' GLU . . . . . . . . . . . . . 83.9 tt0 -47.49 -32.98 5.73 Favored 'General case' 0 C--N 1.328 -0.33 0 N-CA-C 113.031 0.752 . . . . 0.0 113.031 -172.483 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' F' F ' 91' ' ' ASN . . . . . . . . . . . . . 35.0 m120 -124.47 7.82 8.34 Favored 'General case' 0 N--CA 1.469 0.489 0 N-CA-C 113.613 0.968 . . . . 0.0 113.613 -175.128 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' F' F ' 92' ' ' LEU . . . . . . . . . . . . . 27.5 mt -147.15 148.57 31.69 Favored 'General case' 0 C--N 1.333 -0.14 0 CA-C-N 118.247 0.476 . . . . 0.0 110.965 -175.464 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' F' F ' 93' ' ' ILE . . . . . . . . . . . . . 74.0 mt -126.52 116.45 45.26 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.286 0 N-CA-C 109.105 -0.702 . . . . 0.0 109.105 175.846 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' F' F ' 94' ' ' VAL . . . . . . . . . . . . . 46.1 t -118.79 128.59 75.64 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.193 0 CA-C-O 120.827 0.346 . . . . 0.0 110.101 -177.967 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' F' F ' 95' ' ' VAL . . . . . . . . . . . . . 42.1 t -123.27 134.98 64.68 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.317 0 CA-C-N 116.079 -0.509 . . . . 0.0 109.871 -179.853 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' F' F ' 96' ' ' ILE . . . . . . . . . . . . . 59.8 mt -115.25 129.22 71.85 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.282 0 N-CA-C 109.324 -0.621 . . . . 0.0 109.324 178.822 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' F' F ' 97' ' ' THR . . . . . . . . . . . . . 82.5 p -100.72 158.83 15.66 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-O 121.298 0.571 . . . . 0.0 111.157 -177.95 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' F' F ' 98' ' ' GLU . . . . . . . . . . . . . 46.4 tp10 -53.74 -27.2 27.02 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.011 -0.541 . . . . 0.0 112.259 -179.436 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' F' F ' 99' ' ' GLU . . . . . . . . . . . . . 39.4 tt0 -80.25 17.87 0.97 Allowed 'General case' 0 CA--C 1.539 0.555 0 N-CA-C 112.679 0.622 . . . . 0.0 112.679 -176.822 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' F' F ' 100' ' ' ASN . . . . . . . . . . . . . 4.1 m-20 61.05 38.0 17.52 Favored 'General case' 0 N--CA 1.462 0.166 0 O-C-N 121.857 -0.527 . . . . 0.0 111.017 176.792 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' F' F ' 101' ' ' GLU . . . . . . . . . . . . . 84.8 tt0 -117.66 143.08 46.51 Favored 'General case' 0 C--N 1.331 -0.226 0 N-CA-C 109.574 -0.528 . . . . 0.0 109.574 175.838 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' F' F ' 102' ' ' VAL . . . . . . . . . . . . . 44.9 t -116.73 126.59 74.25 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.353 0 CA-C-N 116.319 -0.4 . . . . 0.0 110.107 -176.986 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' F' F ' 103' ' ' LEU . . . . . . . . . . . . . 6.8 mp -118.42 135.31 54.42 Favored 'General case' 0 C--N 1.331 -0.215 0 CA-C-N 115.752 -0.658 . . . . 0.0 110.01 176.446 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' F' F ' 104' ' ' ILE . . . . . . . . . . . . . 72.4 mt -123.67 122.24 64.39 Favored 'Isoleucine or valine' 0 C--O 1.234 0.246 0 CA-C-N 116.503 -0.317 . . . . 0.0 110.29 -178.525 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' F' F ' 105' ' ' PHE . . . . . . . . . . . . . 47.5 m-85 -121.16 166.5 13.85 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 115.314 -0.857 . . . . 0.0 109.92 179.778 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' F' F ' 106' ' ' ASN . . . . . . . . . . . . . 42.3 p-10 -99.7 -169.89 1.81 Allowed 'General case' 0 C--N 1.33 -0.25 0 N-CA-C 109.821 -0.437 . . . . 0.0 109.821 172.992 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' F' F ' 107' ' ' GLN . . . . . . . . . . . . . 29.5 tt0 -60.44 -30.07 69.42 Favored 'General case' 0 C--N 1.329 -0.317 0 N-CA-C 111.734 0.272 . . . . 0.0 111.734 178.857 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' F' F ' 108' ' ' ASN . . . . . . . . . . . . . 10.1 t-20 -81.96 4.93 20.79 Favored 'General case' 0 CA--C 1.537 0.458 0 N-CA-C 113.305 0.854 . . . . 0.0 113.305 -178.833 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' F' F ' 109' ' ' LEU . . . . . . . . . . . . . 6.0 tp 63.4 38.51 10.02 Favored 'General case' 0 C--O 1.232 0.167 0 CA-C-O 121.107 0.479 . . . . 0.0 111.377 177.158 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' F' F ' 110' ' ' GLU . . . . . . . . . . . . . 70.7 mm-40 -107.76 152.44 24.36 Favored 'General case' 0 C--N 1.331 -0.23 0 CA-C-N 116.256 -0.429 . . . . 0.0 110.12 176.03 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' F' F ' 111' ' ' GLU . . . . . . . . . . . . . 98.6 mt-10 -78.58 125.83 29.91 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-O 120.944 0.402 . . . . 0.0 111.188 -178.542 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' F' F ' 112' ' ' LEU . . . . . . . . . . . . . 8.4 mt -111.97 -46.04 3.26 Favored 'General case' 0 C--N 1.332 -0.159 0 CA-C-N 116.012 -0.54 . . . . 0.0 109.905 176.336 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' F' F ' 113' ' ' TYR . . . . . . . . . . . . . 49.5 t80 -139.69 140.94 36.97 Favored 'General case' 0 C--N 1.332 -0.19 0 CA-C-N 116.128 -0.487 . . . . 0.0 110.773 -179.637 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' F' F ' 114' ' ' ARG . . . . . . . . . . . . . 42.4 ptt85 -150.96 118.75 6.16 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-O 121.043 0.449 . . . . 0.0 110.959 179.731 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' F' F ' 115' ' ' GLY . . . . . . . . . . . . . . . -150.28 162.98 29.41 Favored Glycine 0 CA--C 1.527 0.786 0 N-CA-C 111.177 -0.769 . . . . 0.0 111.177 -178.846 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' F' F ' 116' ' ' LYS . . . . . . . . . . . . . 26.6 ttpp -122.41 144.84 48.79 Favored 'General case' 0 C--N 1.33 -0.245 0 O-C-N 122.644 -0.327 . . . . 0.0 110.172 176.457 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' F' F ' 117' ' ' PHE . . . . . . . . . . . . . 45.4 m-85 -138.22 113.9 9.76 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-O 121.035 0.445 . . . . 0.0 110.278 179.771 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' F' F ' 118' ' ' GLU . . . . . . . . . . . . . 84.7 tt0 -52.53 -50.17 63.39 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-N 116.385 -0.371 . . . . 0.0 111.702 -176.016 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' F' F ' 119' ' ' ASN . . . . . . . . . . . . . 72.2 m-80 -95.78 30.98 2.18 Favored 'General case' 0 C--N 1.329 -0.285 0 N-CA-C 112.246 0.462 . . . . 0.0 112.246 -174.458 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' F' F ' 120' ' ' LEU . . . . . . . . . . . . . 17.3 tp -55.29 120.75 7.54 Favored 'General case' 0 C--N 1.332 -0.163 0 CA-C-O 120.703 0.287 . . . . 0.0 110.77 178.392 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' F' F ' 121' ' ' ASN . . . . . . . . . . . . . 37.2 t30 -114.16 -44.05 3.17 Favored 'General case' 0 C--N 1.333 -0.125 0 CA-C-N 116.6 -0.273 . . . . 0.0 111.039 -177.995 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' F' F ' 122' ' ' LYS . . . . . . . . . . . . . 61.2 mtpt -140.6 148.54 41.1 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-O 121.045 0.45 . . . . 0.0 111.584 -175.461 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' F' F ' 123' ' ' VAL . . . . . . . . . . . . . 45.0 t -132.6 133.19 59.76 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.274 0 N-CA-C 109.374 -0.602 . . . . 0.0 109.374 174.761 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' F' F ' 124' ' ' LEU . . . . . . . . . . . . . 66.8 mt -131.74 136.05 47.3 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-O 120.988 0.423 . . . . 0.0 111.201 -176.415 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' F' F ' 125' ' ' VAL . . . . . . . . . . . . . 38.7 t -129.2 135.19 62.48 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.207 0 CA-C-N 115.73 -0.668 . . . . 0.0 110.067 -179.582 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' F' F ' 126' ' ' ARG . . . . . . . . . . . . . 17.1 ptp180 -165.18 142.78 6.02 Favored 'General case' 0 C--N 1.331 -0.202 0 CA-C-O 121.004 0.431 . . . . 0.0 110.414 176.31 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' F' F ' 127' ' ' ASN . . . . . . . . . . . . . 1.3 t-20 54.74 -155.13 0.26 Allowed 'General case' 0 CA--C 1.538 0.517 0 N-CA-C 110.104 -0.332 . . . . 0.0 110.104 -179.656 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' F' F ' 128' ' ' ASP . . . . . . . . . . . . . 23.1 p-10 -84.12 20.71 1.51 Allowed 'General case' 0 CA--C 1.534 0.35 0 CA-C-N 118.325 0.511 . . . . 0.0 112.347 176.481 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' F' F ' 129' ' ' LEU . . . . . . . . . . . . . 46.2 mt -121.09 144.47 48.54 Favored 'General case' 0 C--O 1.234 0.246 0 O-C-N 122.053 -0.405 . . . . 0.0 110.438 -179.376 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' F' F ' 130' ' ' VAL . . . . . . . . . . . . . 11.1 p -134.19 139.76 47.51 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.268 0 CA-C-N 116.286 -0.415 . . . . 0.0 110.016 178.832 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' F' F ' 131' ' ' VAL . . . . . . . . . . . . . 34.6 m -136.06 146.49 29.23 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.254 0 CA-C-O 121.268 0.556 . . . . 0.0 111.286 -178.265 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' F' F ' 132' ' ' ILE . . . . . . . . . . . . . 68.2 mt -121.91 133.97 66.64 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.299 0 CA-C-N 115.389 -0.823 . . . . 0.0 109.497 179.645 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' F' F ' 133' ' ' ILE . . . . . . . . . . . . . 37.3 mm -115.57 117.52 55.85 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.267 0 CA-C-N 116.463 -0.335 . . . . 0.0 110.828 -175.984 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' F' F ' 134' ' ' ASP . . . . . . . . . . . . . 8.0 p-10 -129.92 146.65 51.63 Favored 'General case' 0 C--N 1.33 -0.245 0 N-CA-C 109.649 -0.501 . . . . 0.0 109.649 175.526 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' F' F ' 135' ' ' GLU . . . . . . . . . . . . . 41.5 tp10 -49.93 -23.04 1.75 Allowed 'General case' 0 C--N 1.327 -0.371 0 N-CA-C 112.799 0.666 . . . . 0.0 112.799 -172.207 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' F' F ' 136' ' ' GLN . . . . . . . . . . . . . 48.1 tt0 -101.38 -28.73 12.43 Favored 'General case' 0 CA--C 1.531 0.215 0 N-CA-C 112.481 0.549 . . . . 0.0 112.481 -174.801 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' F' F ' 137' ' ' LYS . . . . . . . . . . . . . 76.6 mttt -141.95 151.74 42.85 Favored 'General case' 0 C--O 1.233 0.22 0 CA-C-O 121.363 0.601 . . . . 0.0 112.378 -170.714 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' F' F ' 138' ' ' LEU . . . . . . . . . . . . . 24.3 tp -109.14 119.14 38.63 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 115.011 -0.995 . . . . 0.0 108.941 170.251 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' F' F ' 139' ' ' THR . . . . . . . . . . . . . 33.0 m -108.19 123.73 49.2 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-O 120.751 0.31 . . . . 0.0 110.914 -177.263 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' F' F ' 140' ' ' LEU . . . . . . . . . . . . . 12.4 tp -115.82 120.61 39.81 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 115.601 -0.727 . . . . 0.0 109.503 -179.219 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' F' F ' 141' ' ' ILE . . . . . . . . . . . . . 19.7 mt -118.97 121.18 66.19 Favored 'Isoleucine or valine' 0 C--O 1.235 0.302 0 N-CA-C 109.801 -0.444 . . . . 0.0 109.801 -176.676 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' F' F ' 142' ' ' ARG . . . . . . . . . . . . . 73.8 mtm180 -111.56 126.82 55.4 Favored 'General case' 0 C--N 1.332 -0.175 0 CA-C-N 115.798 -0.637 . . . . 0.0 110.125 -178.348 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' F' F ' 143' ' ' THR . . . . . . . . . . . . . 25.8 p . . . . . 0 C--O 1.221 -0.443 0 CA-C-O 118.235 -0.888 . . . . 0.0 110.998 -179.368 . . . . . . . . 0 0 . 1 . 008 nuclear orig core ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 5.0 p . . . . . 0 N--CA 1.461 0.112 0 CA-C-O 120.988 0.423 . . . . 0.0 110.781 . . . . . . . . . 0 0 . 1 . 008 nuclear orig core ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 41.2 mt-10 -140.4 140.74 35.53 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 115.985 -0.552 . . . . 0.0 111.029 -179.332 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 4' ' ' LEU . . . . . . . . . . . . . 3.0 tt -124.2 126.3 45.89 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 115.918 -0.583 . . . . 0.0 109.707 177.338 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 5' ' ' LYS . . . . . . . . . . . . . 63.9 mttp -106.91 120.24 41.51 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-O 120.69 0.281 . . . . 0.0 110.807 -179.791 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 37.2 mt -114.66 145.64 41.79 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 115.502 -0.772 . . . . 0.0 110.742 -178.573 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 53.6 tttm -137.78 140.56 30.05 Favored Pre-proline 0 CA--C 1.534 0.35 0 CA-C-O 119.104 -0.474 . . . . 0.0 109.791 174.36 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 8' ' ' PRO . . . . . . . . . . . . . 88.4 Cg_endo -91.81 144.71 3.01 Favored 'Trans proline' 0 N--CA 1.489 1.23 0 C-N-CA 121.775 1.65 . . . . 0.0 111.83 177.931 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 62.7 mt -78.64 -46.51 1.91 Allowed Pre-proline 0 CA--C 1.532 0.277 0 CA-C-O 118.859 -0.591 . . . . 0.0 111.906 179.663 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 75.5 Cg_endo -83.93 144.98 11.11 Favored 'Trans proline' 0 N--CA 1.494 1.543 0 C-N-CA 121.219 1.28 . . . . 0.0 111.516 173.362 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 22.3 pttm -74.53 116.44 15.22 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-O 121.319 0.58 . . . . 0.0 110.437 177.639 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 12.3 p -150.41 147.32 16.04 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.359 0 CA-C-N 115.682 -0.69 . . . . 0.0 110.56 -177.966 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 84.6 tt0 -95.73 121.98 38.02 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.394 -0.366 . . . . 0.0 110.099 177.881 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 14' ' ' LEU . . . . . . . . . . . . . 21.9 mt -99.14 144.03 27.48 Favored Pre-proline 0 CA--C 1.533 0.324 0 CA-C-O 119.093 -0.48 . . . . 0.0 110.521 -176.718 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 15' ' ' PRO . . . . . . . . . . . . . 23.6 Cg_exo -64.76 161.66 35.08 Favored 'Trans proline' 0 N--CA 1.498 1.754 0 C-N-CA 121.292 1.328 . . . . 0.0 111.933 175.209 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 16' ' ' PRO . . . . . . . . . . . . . 27.1 Cg_exo -60.67 -31.97 92.67 Favored 'Trans proline' 0 N--CA 1.496 1.643 0 C-N-CA 121.538 1.492 . . . . 0.0 112.79 -178.96 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 17' ' ' ASP . . . . . . . . . . . . . 10.0 p-10 -83.16 -2.41 55.42 Favored 'General case' 0 CA--C 1.535 0.386 0 N-CA-C 113.351 0.871 . . . . 0.0 113.351 -176.556 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 18' ' ' PHE . . . . . . . . . . . . . 45.5 t80 -57.45 -43.76 84.2 Favored 'General case' 0 C--O 1.23 0.035 0 O-C-N 121.913 -0.492 . . . . 0.0 110.236 -178.478 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 19' ' ' VAL . . . . . . . . . . . . . 48.5 t -57.02 -44.1 82.18 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.314 0 CA-C-N 116.269 -0.423 . . . . 0.0 110.485 -178.497 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 18.2 t70 -59.69 -41.81 91.55 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-O 120.757 0.313 . . . . 0.0 110.902 -177.651 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 43.8 t -64.32 -47.28 90.32 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.274 0 C-N-CA 120.692 -0.403 . . . . 0.0 110.459 -177.948 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 22' ' ' ILE . . . . . . . . . . . . . 50.2 mm -57.3 -42.05 79.48 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.244 0 C-N-CA 120.801 -0.359 . . . . 0.0 110.591 179.942 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 23' ' ' ARG . . . . . . . . . . . . . 56.5 ttp180 -55.8 -50.31 70.85 Favored 'General case' 0 C--N 1.331 -0.211 0 CA-C-O 120.928 0.394 . . . . 0.0 110.899 179.73 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 24' ' ' ILE . . . . . . . . . . . . . 77.5 mt -60.44 -41.02 86.01 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.251 0 CA-C-N 116.09 -0.505 . . . . 0.0 111.67 -176.961 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 16.5 ptpt -72.49 -37.57 68.41 Favored 'General case' 0 CA--C 1.535 0.376 0 C-N-CA 120.622 -0.431 . . . . 0.0 112.115 -175.15 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 43.9 mt -79.84 -39.5 30.52 Favored 'General case' 0 C--N 1.331 -0.209 0 N-CA-C 113.383 0.883 . . . . 0.0 113.383 -173.406 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 27' ' ' GLN . . . . . . . . . . . . . 9.9 pt20 -46.49 141.24 3.76 Favored 'General case' 0 N--CA 1.469 0.503 0 N-CA-C 112.958 0.725 . . . . 0.0 112.958 -173.492 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 97.26 -25.97 24.82 Favored Glycine 0 CA--C 1.534 1.262 0 CA-C-N 115.553 -0.749 . . . . 0.0 112.164 -177.304 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 84.0 mttt -97.94 155.14 17.22 Favored 'General case' 0 C--O 1.233 0.21 0 CA-C-N 117.232 0.516 . . . . 0.0 110.943 179.812 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 30' ' ' THR . . . . . . . . . . . . . 29.1 m -106.86 137.62 44.57 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.142 -0.481 . . . . 0.0 110.101 177.168 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 34.8 m -130.2 159.45 42.21 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.202 0 CA-C-N 116.321 -0.4 . . . . 0.0 110.84 -178.8 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 32' ' ' ARG . . . . . . . . . . . . . 82.2 mtm180 -132.82 150.93 52.11 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-O 121.31 0.576 . . . . 0.0 110.682 178.357 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 33' ' ' THR . . . . . . . . . . . . . 22.0 m -53.4 139.82 29.34 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.074 -0.512 . . . . 0.0 111.312 -178.764 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 100.11 -17.15 57.49 Favored Glycine 0 CA--C 1.532 1.119 0 CA-C-O 119.591 -0.561 . . . . 0.0 113.226 178.881 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 76.6 m-20 -66.08 147.98 52.52 Favored 'General case' 0 C--O 1.233 0.187 0 CA-C-N 118.078 0.939 . . . . 0.0 111.155 178.857 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 44.0 t -122.79 131.53 73.08 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.224 0 CA-C-N 115.937 -0.574 . . . . 0.0 109.906 178.871 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 37' ' ' ILE . . . . . . . . . . . . . 69.0 mt -120.95 139.01 49.5 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.253 0 CA-C-N 116.167 -0.469 . . . . 0.0 110.008 -179.683 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . -109.43 128.85 9.16 Favored Glycine 0 CA--C 1.527 0.785 0 N-CA-C 110.975 -0.85 . . . . 0.0 110.975 179.663 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 39' ' ' ILE . . . . . . . . . . . . . 77.6 mt -126.06 135.9 62.46 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.229 0 CA-C-O 120.765 0.317 . . . . 0.0 110.181 179.612 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 40' ' ' SER . . . . . . . . . . . . . 36.6 t -93.87 122.28 36.19 Favored 'General case' 0 C--N 1.331 -0.239 0 CA-C-N 116.309 -0.405 . . . . 0.0 110.902 175.149 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 41' ' ' ILE . . . . . . . . . . . . . 70.6 mt -133.36 127.43 53.89 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.202 0 CA-C-O 120.841 0.353 . . . . 0.0 110.376 178.662 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 83.4 mt 53.66 33.04 15.71 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 116.203 -0.453 . . . . 0.0 111.959 177.788 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . 72.39 29.37 66.22 Favored Glycine 0 CA--C 1.529 0.952 0 C-N-CA 121.112 -0.566 . . . . 0.0 112.313 177.839 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 44' ' ' LYS . . . . . . . . . . . . . 60.3 mttm -137.36 136.5 37.98 Favored 'General case' 0 C--N 1.331 -0.215 0 N-CA-C 109.862 -0.422 . . . . 0.0 109.862 178.723 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 84.4 tt0 -83.81 122.02 28.11 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.459 -0.337 . . . . 0.0 110.899 -179.688 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 46' ' ' VAL . . . . . . . . . . . . . 7.3 p -122.07 130.06 74.87 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.212 0 N-CA-C 109.547 -0.538 . . . . 0.0 109.547 176.221 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 64.3 mttp -100.66 128.4 46.72 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.011 -0.541 . . . . 0.0 110.994 178.935 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 48' ' ' PHE . . . . . . . . . . . . . 91.0 m-85 -111.12 131.89 54.72 Favored 'General case' 0 C--N 1.33 -0.272 0 N-CA-C 109.698 -0.482 . . . . 0.0 109.698 176.035 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 84.5 tttt -109.12 136.89 47.87 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.356 -0.383 . . . . 0.0 110.729 -179.558 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 50' ' ' VAL . . . . . . . . . . . . . 44.0 t -80.49 106.22 11.33 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.317 0 N-CA-C 109.178 -0.675 . . . . 0.0 109.178 175.159 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 51' ' ' VAL . . . . . . . . . . . . . 47.0 t -70.55 -53.21 23.47 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.354 0 N-CA-C 109.493 -0.558 . . . . 0.0 109.493 -175.035 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 52' ' ' GLN . . . . . . . . . . . . . 90.5 mt-30 -153.85 153.55 32.31 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-O 121.258 0.552 . . . . 0.0 111.796 -178.575 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -129.06 132.11 47.4 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 115.072 -0.967 . . . . 0.0 109.552 175.041 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 54' ' ' TYR . . . . . . . . . . . . . 25.1 t80 -129.03 110.1 18.28 Favored Pre-proline 0 CA--C 1.536 0.41 0 CA-C-O 118.197 -0.906 . . . . 0.0 110.048 179.391 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 55' ' ' PRO . . . . . . . . . . . . . 74.2 Cg_endo -77.17 170.01 72.67 Favored 'Cis proline' 0 N--CA 1.499 1.851 0 CA-C-N 121.877 1.706 . . . . 0.0 112.542 -4.103 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 56' ' ' SER . . . . . . . . . . . . . 13.6 m -115.55 127.61 26.65 Favored Pre-proline 0 CA--C 1.538 0.485 0 CA-C-O 118.344 -0.836 . . . . 0.0 109.506 176.214 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 57' ' ' PRO . . . . . . . . . . . . . 38.0 Cg_endo -66.6 168.5 50.82 Favored 'Cis proline' 0 N--CA 1.498 1.739 0 CA-C-N 122.081 1.779 . . . . 0.0 111.41 -0.657 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 58' ' ' LEU . . . . . . . . . . . . . 32.7 tp -130.55 136.15 48.63 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-O 120.926 0.393 . . . . 0.0 110.622 -178.997 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 59' ' ' ARG . . . . . . . . . . . . . 49.3 ttp180 -103.69 127.65 51.12 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 115.974 -0.557 . . . . 0.0 109.554 177.303 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 41.7 t -79.67 120.89 31.89 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.181 0 C-N-CA 120.57 -0.452 . . . . 0.0 110.143 -176.247 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 90.7 mt-10 -131.05 161.16 32.63 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 115.86 -0.609 . . . . 0.0 109.88 179.956 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 62' ' ' ASP . . . . . . . . . . . . . 12.7 t70 -54.34 -32.26 56.37 Favored 'General case' 0 C--N 1.328 -0.345 0 C-N-CA 120.926 -0.309 . . . . 0.0 111.714 177.728 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 63' ' ' ARG . . . . . . . . . . . . . 8.1 ptp180 -87.79 9.86 20.35 Favored 'General case' 0 CA--C 1.535 0.391 0 N-CA-C 113.568 0.951 . . . . 0.0 113.568 -175.405 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 39.5 m -92.2 141.0 29.06 Favored 'General case' 0 C--N 1.334 -0.085 0 CA-C-N 118.199 0.454 . . . . 0.0 110.437 -179.426 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 65' ' ' LYS . . . . . . . . . . . . . 67.0 mttm -88.82 127.16 35.61 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.151 -0.477 . . . . 0.0 110.258 179.915 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 66' ' ' ILE . . . . . . . . . . . . . 67.2 mt -115.18 129.13 71.93 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.236 0 N-CA-C 109.87 -0.419 . . . . 0.0 109.87 179.741 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 67' ' ' THR . . . . . . . . . . . . . 31.0 m -126.7 139.4 53.18 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-O 121.076 0.465 . . . . 0.0 111.107 -177.404 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 68' ' ' LEU . . . . . . . . . . . . . 33.8 mt . . . . . 0 C--N 1.33 -0.253 0 CA-C-N 115.825 -0.625 . . . . 0.0 110.229 176.481 . . . . . . . . 0 0 . 1 . 008 nuclear orig core ' A' A ' 74' ' ' ASP . . . . . . . . . . . . . 12.1 t70 . . . . . 0 CA--C 1.523 -0.062 0 N-CA-C 109.713 -0.477 . . . . 0.0 109.713 . . . . . . . . . 0 0 . 1 . 008 nuclear orig core ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 42.4 t -110.98 121.06 62.99 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.263 0 CA-C-O 121.17 0.509 . . . . 0.0 110.534 -177.671 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 76' ' ' LEU . . . . . . . . . . . . . 29.7 mt -123.9 137.48 54.63 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 115.483 -0.781 . . . . 0.0 109.083 177.149 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 77' ' ' GLU . . . . . . . . . . . . . 33.5 tt0 -136.7 135.84 38.53 Favored 'General case' 0 C--N 1.33 -0.257 0 C-N-CA 120.745 -0.382 . . . . 0.0 111.111 -175.727 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 78' ' ' ALA . . . . . . . . . . . . . . . -124.72 140.77 52.63 Favored 'General case' 0 N--CA 1.463 0.211 0 CA-C-N 116.059 -0.518 . . . . 0.0 110.281 179.064 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 79' ' ' LYS . . . . . . . . . . . . . 63.6 mttp -83.25 123.66 29.81 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.358 -0.383 . . . . 0.0 110.546 -179.501 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 80' ' ' ILE . . . . . . . . . . . . . 23.3 mm -139.23 114.1 7.96 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.247 0 N-CA-C 108.967 -0.753 . . . . 0.0 108.967 -178.822 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 81' ' ' LYS . . . . . . . . . . . . . 84.2 tttt -103.16 123.92 47.62 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-O 120.92 0.39 . . . . 0.0 111.35 -175.696 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . 89.1 42.17 5.68 Favored Glycine 0 CA--C 1.525 0.707 0 C-N-CA 120.95 -0.643 . . . . 0.0 111.933 173.185 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 83' ' ' ILE . . . . . . . . . . . . . 71.2 mt -68.33 136.9 25.54 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.287 0 N-CA-C 109.847 -0.427 . . . . 0.0 109.847 177.925 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 84' ' ' LYS . . . . . . . . . . . . . 28.6 ttpp -99.66 -48.29 4.78 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.086 -0.506 . . . . 0.0 109.999 179.858 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 85' ' ' ASP . . . . . . . . . . . . . 8.9 t70 -153.36 149.09 27.48 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 115.842 -0.617 . . . . 0.0 110.542 179.303 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 86' ' ' VAL . . . . . . . . . . . . . 45.0 t -128.16 130.51 69.6 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.218 0 CA-C-O 120.917 0.389 . . . . 0.0 110.245 179.558 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 87' ' ' ILE . . . . . . . . . . . . . 5.1 mp -122.1 126.18 74.03 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.23 0 CA-C-N 116.007 -0.542 . . . . 0.0 109.58 177.721 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 88' ' ' LEU . . . . . . . . . . . . . 39.0 mt -113.21 137.99 50.64 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-O 121.207 0.527 . . . . 0.0 111.294 -178.104 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 89' ' ' ASP . . . . . . . . . . . . . 13.0 t70 -128.8 157.75 40.59 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 115.376 -0.829 . . . . 0.0 109.008 175.781 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 85.0 tt0 -46.79 -37.9 9.32 Favored 'General case' 0 C--N 1.33 -0.271 0 N-CA-C 112.97 0.73 . . . . 0.0 112.97 -172.07 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 91' ' ' ASN . . . . . . . . . . . . . 28.7 p30 -132.06 23.91 4.56 Favored 'General case' 0 N--CA 1.465 0.306 0 N-CA-C 112.863 0.69 . . . . 0.0 112.863 -177.89 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 92' ' ' LEU . . . . . . . . . . . . . 9.8 mt -149.24 144.45 26.54 Favored 'General case' 0 C--N 1.331 -0.206 0 N-CA-C 110.131 -0.322 . . . . 0.0 110.131 -177.547 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 93' ' ' ILE . . . . . . . . . . . . . 75.8 mt -127.69 119.0 50.63 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.247 0 N-CA-C 109.428 -0.582 . . . . 0.0 109.428 177.757 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 94' ' ' VAL . . . . . . . . . . . . . 45.5 t -121.39 128.3 75.87 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.261 0 CA-C-O 120.925 0.393 . . . . 0.0 110.133 179.984 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 95' ' ' VAL . . . . . . . . . . . . . 47.2 t -122.63 134.1 66.82 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.298 0 CA-C-N 115.863 -0.608 . . . . 0.0 109.754 -179.307 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 96' ' ' ILE . . . . . . . . . . . . . 60.0 mt -115.21 130.02 70.45 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.294 0 N-CA-C 109.273 -0.64 . . . . 0.0 109.273 179.127 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 97' ' ' THR . . . . . . . . . . . . . 73.1 p -103.81 156.28 17.94 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-O 121.253 0.549 . . . . 0.0 111.243 -178.107 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 98' ' ' GLU . . . . . . . . . . . . . 96.2 mt-10 -54.95 -26.89 39.45 Favored 'General case' 0 CA--C 1.532 0.276 0 CA-C-N 116.091 -0.504 . . . . 0.0 112.325 -179.041 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 99' ' ' GLU . . . . . . . . . . . . . 12.7 pt-20 -78.9 16.67 0.85 Allowed 'General case' 0 CA--C 1.535 0.382 0 N-CA-C 113.261 0.838 . . . . 0.0 113.261 -177.638 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 100' ' ' ASN . . . . . . . . . . . . . 3.1 m-20 63.53 37.59 10.35 Favored 'General case' 0 C--O 1.232 0.147 0 CA-C-O 121.072 0.463 . . . . 0.0 111.106 176.992 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 101' ' ' GLU . . . . . . . . . . . . . 85.0 tt0 -116.36 142.63 46.59 Favored 'General case' 0 C--N 1.331 -0.238 0 N-CA-C 109.709 -0.478 . . . . 0.0 109.709 175.819 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 102' ' ' VAL . . . . . . . . . . . . . 46.6 t -117.4 125.79 74.23 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.29 0 CA-C-N 116.179 -0.464 . . . . 0.0 109.908 -178.057 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 103' ' ' LEU . . . . . . . . . . . . . 6.3 mp -116.5 134.57 54.7 Favored 'General case' 0 N--CA 1.463 0.185 0 CA-C-N 115.813 -0.631 . . . . 0.0 110.287 177.311 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 104' ' ' ILE . . . . . . . . . . . . . 66.0 mt -121.39 120.94 63.37 Favored 'Isoleucine or valine' 0 C--O 1.234 0.261 0 N-CA-C 110.051 -0.352 . . . . 0.0 110.051 -179.065 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 105' ' ' PHE . . . . . . . . . . . . . 66.3 m-85 -120.89 164.7 16.28 Favored 'General case' 0 C--N 1.331 -0.234 0 O-C-N 124.012 0.82 . . . . 0.0 109.688 179.593 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 106' ' ' ASN . . . . . . . . . . . . . 44.2 p-10 -100.88 -171.13 1.95 Allowed 'General case' 0 C--N 1.33 -0.276 0 N-CA-C 109.737 -0.468 . . . . 0.0 109.737 172.842 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 107' ' ' GLN . . . . . . . . . . . . . 29.7 tt0 -60.83 -27.59 68.19 Favored 'General case' 0 CA--C 1.533 0.31 0 N-CA-C 111.96 0.355 . . . . 0.0 111.96 178.785 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 108' ' ' ASN . . . . . . . . . . . . . 6.3 t-20 -81.97 6.0 17.4 Favored 'General case' 0 CA--C 1.538 0.501 0 N-CA-C 113.06 0.763 . . . . 0.0 113.06 -178.693 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 109' ' ' LEU . . . . . . . . . . . . . 11.2 tp 61.58 37.52 16.17 Favored 'General case' 0 C--O 1.233 0.204 0 CA-C-O 120.952 0.406 . . . . 0.0 111.3 178.319 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 110' ' ' GLU . . . . . . . . . . . . . 43.2 mt-10 -109.02 153.97 22.87 Favored 'General case' 0 C--N 1.33 -0.245 0 N-CA-C 110.091 -0.337 . . . . 0.0 110.091 177.375 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 111' ' ' GLU . . . . . . . . . . . . . 98.3 mt-10 -81.7 121.94 27.02 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-O 120.974 0.416 . . . . 0.0 111.098 -179.814 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 112' ' ' LEU . . . . . . . . . . . . . 21.3 mt -107.45 -45.47 4.07 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 115.887 -0.597 . . . . 0.0 109.963 175.835 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 113' ' ' TYR . . . . . . . . . . . . . 50.4 t80 -139.37 140.51 37.48 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 115.944 -0.571 . . . . 0.0 110.502 179.678 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 114' ' ' ARG . . . . . . . . . . . . . 32.0 ptt180 -150.92 120.74 7.06 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-O 120.917 0.389 . . . . 0.0 110.818 178.476 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 115' ' ' GLY . . . . . . . . . . . . . . . -150.24 163.04 29.42 Favored Glycine 0 CA--C 1.525 0.7 0 N-CA-C 111.314 -0.714 . . . . 0.0 111.314 -179.309 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 116' ' ' LYS . . . . . . . . . . . . . 36.2 ttpt -122.87 136.63 54.93 Favored 'General case' 0 C--N 1.33 -0.261 0 N-CA-C 109.671 -0.492 . . . . 0.0 109.671 175.988 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 117' ' ' PHE . . . . . . . . . . . . . 43.9 m-85 -134.21 115.55 14.3 Favored 'General case' 0 C--N 1.331 -0.22 0 CA-C-O 121.006 0.431 . . . . 0.0 110.343 -176.791 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 118' ' ' GLU . . . . . . . . . . . . . 84.2 tt0 -52.31 -49.16 64.75 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.271 -0.422 . . . . 0.0 111.785 -175.574 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 119' ' ' ASN . . . . . . . . . . . . . 86.2 m-20 -97.57 31.02 2.69 Favored 'General case' 0 C--N 1.33 -0.273 0 N-CA-C 112.284 0.475 . . . . 0.0 112.284 -173.791 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 120' ' ' LEU . . . . . . . . . . . . . 14.7 tp -58.24 121.8 11.63 Favored 'General case' 0 C--N 1.332 -0.177 0 N-CA-C 110.039 -0.356 . . . . 0.0 110.039 177.354 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 121' ' ' ASN . . . . . . . . . . . . . 72.7 m-20 -113.47 -44.05 3.26 Favored 'General case' 0 C--N 1.331 -0.203 0 CA-C-N 116.537 -0.301 . . . . 0.0 111.044 -177.176 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 122' ' ' LYS . . . . . . . . . . . . . 98.9 mttt -144.62 149.07 35.12 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-O 121.068 0.461 . . . . 0.0 111.689 -177.409 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 123' ' ' VAL . . . . . . . . . . . . . 40.3 t -128.81 129.63 68.4 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.305 0 N-CA-C 109.124 -0.695 . . . . 0.0 109.124 173.723 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 124' ' ' LEU . . . . . . . . . . . . . 66.2 mt -124.6 133.68 53.19 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-O 120.892 0.377 . . . . 0.0 111.017 -176.162 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 125' ' ' VAL . . . . . . . . . . . . . 42.0 t -124.92 125.07 69.08 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.239 0 CA-C-N 115.866 -0.606 . . . . 0.0 109.619 177.257 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 126' ' ' ARG . . . . . . . . . . . . . 84.7 mtt180 -149.08 130.35 14.62 Favored 'General case' 0 C--N 1.328 -0.35 0 N-CA-C 110.034 -0.358 . . . . 0.0 110.034 179.058 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 127' ' ' ASN . . . . . . . . . . . . . 3.4 t-20 55.75 -151.72 0.39 Allowed 'General case' 0 CA--C 1.54 0.57 0 N-CA-C 109.841 -0.429 . . . . 0.0 109.841 -179.514 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 128' ' ' ASP . . . . . . . . . . . . . 18.8 p-10 -83.64 17.27 2.31 Favored 'General case' 0 CA--C 1.535 0.37 0 N-CA-C 112.695 0.628 . . . . 0.0 112.695 178.44 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 129' ' ' LEU . . . . . . . . . . . . . 47.4 mt -116.96 138.87 51.27 Favored 'General case' 0 C--O 1.232 0.133 0 CA-C-N 118.1 0.409 . . . . 0.0 110.697 179.563 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 130' ' ' VAL . . . . . . . . . . . . . 45.6 t -124.66 138.64 53.39 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.215 0 CA-C-N 116.127 -0.488 . . . . 0.0 109.814 179.419 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 131' ' ' VAL . . . . . . . . . . . . . 35.3 m -136.0 144.36 33.56 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.24 0 CA-C-O 121.236 0.541 . . . . 0.0 111.359 -179.738 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 132' ' ' ILE . . . . . . . . . . . . . 73.9 mt -117.36 133.64 63.49 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.297 0 CA-C-N 115.326 -0.852 . . . . 0.0 109.269 179.202 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 133' ' ' ILE . . . . . . . . . . . . . 40.9 mm -116.03 119.09 60.87 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.255 0 CA-C-O 120.806 0.336 . . . . 0.0 111.159 -175.204 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 134' ' ' ASP . . . . . . . . . . . . . 8.0 p-10 -133.85 145.59 49.83 Favored 'General case' 0 C--N 1.331 -0.212 0 N-CA-C 109.365 -0.605 . . . . 0.0 109.365 174.181 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 135' ' ' GLU . . . . . . . . . . . . . 43.3 tp10 -50.03 -28.01 6.38 Favored 'General case' 0 C--N 1.327 -0.375 0 N-CA-C 112.616 0.598 . . . . 0.0 112.616 -172.755 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 136' ' ' GLN . . . . . . . . . . . . . 97.4 mt-30 -78.11 -37.19 46.88 Favored 'General case' 0 C--N 1.331 -0.221 0 N-CA-C 112.35 0.5 . . . . 0.0 112.35 -177.188 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 137' ' ' LYS . . . . . . . . . . . . . 53.4 pttt -165.85 172.87 11.17 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-O 121.683 0.754 . . . . 0.0 112.271 -171.964 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 138' ' ' LEU . . . . . . . . . . . . . 6.5 tt -118.14 130.93 56.4 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 114.902 -1.045 . . . . 0.0 109.787 178.359 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 139' ' ' THR . . . . . . . . . . . . . 37.2 m -108.16 129.93 55.15 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.353 179.727 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 140' ' ' LEU . . . . . . . . . . . . . 36.7 tp -113.46 121.83 45.47 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 115.478 -0.783 . . . . 0.0 109.254 -178.298 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 141' ' ' ILE . . . . . . . . . . . . . 19.8 mt -119.65 116.26 50.11 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.292 0 N-CA-C 109.797 -0.446 . . . . 0.0 109.797 -176.42 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 142' ' ' ARG . . . . . . . . . . . . . 84.3 mtp180 -104.88 124.17 49.0 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 115.329 -0.851 . . . . 0.0 110.537 -178.832 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 143' ' ' THR . . . . . . . . . . . . . 37.0 p . . . . . 0 C--O 1.221 -0.412 0 CA-C-O 117.972 -1.013 . . . . 0.0 110.595 -179.912 . . . . . . . . 0 0 . 1 . 008 nuclear orig core ' B' B ' 2' ' ' SER . . . . . . . . . . . . . 6.1 p . . . . . 0 C--O 1.233 0.193 0 CA-C-O 121.026 0.441 . . . . 0.0 110.481 . . . . . . . . . 0 0 . 1 . 008 nuclear orig core ' B' B ' 3' ' ' GLU . . . . . . . . . . . . . 84.6 tt0 -141.24 139.35 33.74 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 115.901 -0.591 . . . . 0.0 111.188 -179.108 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 4' ' ' LEU . . . . . . . . . . . . . 48.4 mt -119.75 129.77 54.65 Favored 'General case' 0 C--N 1.331 -0.212 0 CA-C-N 115.791 -0.64 . . . . 0.0 110.37 176.814 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 5' ' ' LYS . . . . . . . . . . . . . 59.9 mttp -104.75 119.22 38.48 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.167 -0.47 . . . . 0.0 110.257 177.187 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 6' ' ' LEU . . . . . . . . . . . . . 62.4 mt -117.46 144.16 45.3 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 115.516 -0.766 . . . . 0.0 110.075 -178.395 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 7' ' ' LYS . . . . . . . . . . . . . 33.7 ttpt -132.71 140.26 37.2 Favored Pre-proline 0 CA--C 1.532 0.279 0 CA-C-O 119.176 -0.44 . . . . 0.0 110.231 176.549 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 8' ' ' PRO . . . . . . . . . . . . . 91.5 Cg_endo -91.98 134.74 1.47 Allowed 'Trans proline' 0 N--CA 1.488 1.191 0 C-N-CA 121.795 1.663 . . . . 0.0 111.543 176.864 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 9' ' ' LEU . . . . . . . . . . . . . 26.8 mt -70.19 -46.99 21.33 Favored Pre-proline 0 CA--C 1.533 0.308 0 CA-C-O 118.683 -0.675 . . . . 0.0 112.026 -178.855 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 10' ' ' PRO . . . . . . . . . . . . . 94.6 Cg_endo -81.89 155.26 17.66 Favored 'Trans proline' 0 N--CA 1.496 1.631 0 C-N-CA 121.29 1.327 . . . . 0.0 111.883 175.372 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 11' ' ' LYS . . . . . . . . . . . . . 38.6 mmtm -88.18 102.6 14.96 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-O 120.793 0.33 . . . . 0.0 110.65 178.105 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 12' ' ' VAL . . . . . . . . . . . . . 12.2 p -146.45 146.47 18.89 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.26 0 CA-C-N 116.207 -0.451 . . . . 0.0 110.267 178.946 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 13' ' ' GLU . . . . . . . . . . . . . 80.6 tt0 -86.54 131.32 34.2 Favored 'General case' 0 C--N 1.33 -0.269 0 N-CA-C 109.941 -0.392 . . . . 0.0 109.941 178.312 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 14' ' ' LEU . . . . . . . . . . . . . 29.5 mt -96.57 151.67 38.11 Favored Pre-proline 0 CA--C 1.533 0.32 0 CA-C-N 116.402 -0.363 . . . . 0.0 110.814 -176.703 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 15' ' ' PRO . . . . . . . . . . . . . 25.8 Cg_exo -62.03 158.64 37.93 Favored 'Trans proline' 0 N--CA 1.497 1.735 0 C-N-CA 121.273 1.315 . . . . 0.0 111.93 176.793 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 16' ' ' PRO . . . . . . . . . . . . . 37.9 Cg_exo -58.71 -38.99 86.29 Favored 'Trans proline' 0 N--CA 1.498 1.741 0 C-N-CA 121.388 1.392 . . . . 0.0 112.835 -178.899 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 17' ' ' ASP . . . . . . . . . . . . . 10.7 p-10 -87.67 10.26 18.71 Favored 'General case' 0 CA--C 1.535 0.371 0 N-CA-C 113.279 0.844 . . . . 0.0 113.279 -176.951 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 18' ' ' PHE . . . . . . . . . . . . . 42.7 t80 -58.0 -44.95 87.5 Favored 'General case' 0 N--CA 1.457 -0.087 0 O-C-N 121.973 -0.454 . . . . 0.0 110.26 -177.489 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 19' ' ' VAL . . . . . . . . . . . . . 13.6 p -56.15 -41.68 70.27 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.327 0 CA-C-N 116.62 -0.263 . . . . 0.0 110.958 -178.589 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 20' ' ' ASP . . . . . . . . . . . . . 82.5 m-20 -60.83 -43.53 98.14 Favored 'General case' 0 C--N 1.331 -0.21 0 CA-C-O 120.799 0.333 . . . . 0.0 110.82 -178.278 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 21' ' ' VAL . . . . . . . . . . . . . 49.1 t -63.94 -48.46 86.05 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.285 0 C-N-CA 120.744 -0.383 . . . . 0.0 110.509 -177.347 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 22' ' ' ILE . . . . . . . . . . . . . 49.8 mm -55.61 -47.06 79.35 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.274 0 C-N-CA 120.978 -0.289 . . . . 0.0 110.892 -179.34 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 23' ' ' ARG . . . . . . . . . . . . . 45.7 ttp180 -55.69 -48.94 74.25 Favored 'General case' 0 C--N 1.33 -0.255 0 C-N-CA 120.83 -0.348 . . . . 0.0 111.234 -177.841 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 24' ' ' ILE . . . . . . . . . . . . . 76.3 mt -59.85 -41.63 86.39 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.215 0 C-N-CA 121.081 -0.248 . . . . 0.0 111.203 -177.407 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 25' ' ' LYS . . . . . . . . . . . . . 40.3 mmtm -64.08 -43.03 96.67 Favored 'General case' 0 C--N 1.329 -0.3 0 N-CA-C 112.216 0.451 . . . . 0.0 112.216 -179.593 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 26' ' ' LEU . . . . . . . . . . . . . 71.4 mt -78.69 -38.51 39.05 Favored 'General case' 0 C--N 1.328 -0.327 0 N-CA-C 113.502 0.927 . . . . 0.0 113.502 -169.888 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 27' ' ' GLN . . . . . . . . . . . . . 10.3 pt20 -47.52 140.13 6.21 Favored 'General case' 0 N--CA 1.469 0.51 0 N-CA-C 112.704 0.631 . . . . 0.0 112.704 -174.788 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 28' ' ' GLY . . . . . . . . . . . . . . . 98.73 -27.46 19.64 Favored Glycine 0 CA--C 1.532 1.137 0 CA-C-N 115.53 -0.759 . . . . 0.0 112.179 -178.438 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 29' ' ' LYS . . . . . . . . . . . . . 61.3 mtpt -98.25 155.03 17.38 Favored 'General case' 0 C--N 1.332 -0.181 0 CA-C-N 117.314 0.557 . . . . 0.0 111.06 179.602 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 30' ' ' THR . . . . . . . . . . . . . 30.1 m -94.54 136.73 34.51 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.032 -0.531 . . . . 0.0 110.003 176.321 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 31' ' ' VAL . . . . . . . . . . . . . 35.1 m -124.87 148.4 29.28 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.228 0 CA-C-N 116.308 -0.406 . . . . 0.0 110.549 -179.798 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 32' ' ' ARG . . . . . . . . . . . . . 33.6 ttm180 -136.02 146.52 47.24 Favored 'General case' 0 C--N 1.331 -0.219 0 CA-C-O 121.267 0.555 . . . . 0.0 110.583 178.501 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 33' ' ' THR . . . . . . . . . . . . . 22.8 m -53.04 139.93 26.72 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.206 -0.452 . . . . 0.0 111.317 -178.56 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 34' ' ' GLY . . . . . . . . . . . . . . . 101.23 -17.18 56.19 Favored Glycine 0 CA--C 1.534 1.254 0 CA-C-O 119.669 -0.517 . . . . 0.0 113.172 -179.989 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 35' ' ' ASP . . . . . . . . . . . . . 80.2 m-20 -66.57 146.99 53.9 Favored 'General case' 0 N--CA 1.461 0.108 0 CA-C-N 118.024 0.912 . . . . 0.0 111.086 178.421 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 36' ' ' VAL . . . . . . . . . . . . . 43.6 t -123.1 130.99 74.06 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.258 0 CA-C-N 116.009 -0.541 . . . . 0.0 109.781 177.898 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 37' ' ' ILE . . . . . . . . . . . . . 66.7 mt -122.17 138.84 51.02 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.289 0 CA-C-N 116.285 -0.416 . . . . 0.0 110.093 -179.401 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 38' ' ' GLY . . . . . . . . . . . . . . . -108.76 128.63 9.15 Favored Glycine 0 CA--C 1.526 0.746 0 N-CA-C 110.995 -0.842 . . . . 0.0 110.995 178.878 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 39' ' ' ILE . . . . . . . . . . . . . 74.6 mt -125.77 136.84 59.61 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.21 0 N-CA-C 110.16 -0.311 . . . . 0.0 110.16 179.766 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 40' ' ' SER . . . . . . . . . . . . . 38.0 t -92.59 115.33 28.0 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.363 -0.38 . . . . 0.0 110.832 175.822 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 41' ' ' ILE . . . . . . . . . . . . . 44.3 mm -121.48 119.1 58.03 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.198 0 CA-C-N 116.509 -0.314 . . . . 0.0 110.412 -179.905 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 42' ' ' LEU . . . . . . . . . . . . . 9.6 tp 53.27 36.88 23.86 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.194 -0.457 . . . . 0.0 111.576 176.964 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 43' ' ' GLY . . . . . . . . . . . . . . . 72.99 27.26 69.06 Favored Glycine 0 CA--C 1.53 0.993 0 C-N-CA 121.145 -0.55 . . . . 0.0 112.591 177.02 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 44' ' ' LYS . . . . . . . . . . . . . 97.8 mttt -136.67 134.91 37.76 Favored 'General case' 0 C--N 1.331 -0.212 0 N-CA-C 109.58 -0.526 . . . . 0.0 109.58 177.47 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 45' ' ' GLU . . . . . . . . . . . . . 84.3 tt0 -82.82 122.55 28.36 Favored 'General case' 0 C--N 1.329 -0.321 0 C-N-CA 120.701 -0.4 . . . . 0.0 111.066 -177.726 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 46' ' ' VAL . . . . . . . . . . . . . 7.1 p -121.04 128.53 76.08 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.206 0 N-CA-C 109.391 -0.596 . . . . 0.0 109.391 175.768 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 47' ' ' LYS . . . . . . . . . . . . . 68.5 mttm -100.31 126.87 46.69 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 115.979 -0.555 . . . . 0.0 110.971 178.335 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 48' ' ' PHE . . . . . . . . . . . . . 90.3 m-85 -109.14 131.95 54.58 Favored 'General case' 0 C--N 1.331 -0.228 0 N-CA-C 109.697 -0.483 . . . . 0.0 109.697 176.661 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 49' ' ' LYS . . . . . . . . . . . . . 83.1 tttt -108.54 135.5 49.7 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.282 -0.417 . . . . 0.0 110.371 179.037 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 50' ' ' VAL . . . . . . . . . . . . . 47.4 t -79.8 106.84 11.49 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.273 0 N-CA-C 109.164 -0.68 . . . . 0.0 109.164 175.906 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 51' ' ' VAL . . . . . . . . . . . . . 47.9 t -72.65 -48.62 45.55 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.273 0 CA-C-N 115.961 -0.563 . . . . 0.0 110.098 -173.547 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 52' ' ' GLN . . . . . . . . . . . . . 62.5 tt0 -161.83 145.58 12.4 Favored 'General case' 0 C--N 1.33 -0.246 0 C-N-CA 120.207 -0.597 . . . . 0.0 111.597 -177.341 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 53' ' ' ALA . . . . . . . . . . . . . . . -122.71 134.73 54.45 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 115.877 -0.602 . . . . 0.0 109.852 175.852 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 54' ' ' TYR . . . . . . . . . . . . . 31.2 t80 -129.07 111.71 18.4 Favored Pre-proline 0 CA--C 1.534 0.361 0 CA-C-O 118.331 -0.842 . . . . 0.0 110.506 -179.716 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 55' ' ' PRO . . . . . . . . . . . . . 74.3 Cg_endo -77.18 168.28 77.37 Favored 'Cis proline' 0 N--CA 1.5 1.882 0 CA-C-N 121.832 1.69 . . . . 0.0 112.005 -8.089 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 56' ' ' SER . . . . . . . . . . . . . 49.8 m -117.03 136.38 23.3 Favored Pre-proline 0 CA--C 1.537 0.468 0 CA-C-O 118.525 -0.75 . . . . 0.0 109.796 175.952 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 57' ' ' PRO . . . . . . . . . . . . . 43.1 Cg_endo -69.61 163.52 81.22 Favored 'Cis proline' 0 N--CA 1.497 1.714 0 CA-C-N 121.794 1.677 . . . . 0.0 111.259 -4.277 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 58' ' ' LEU . . . . . . . . . . . . . 20.8 tp -130.4 138.95 50.61 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-O 120.811 0.338 . . . . 0.0 110.829 -178.583 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 59' ' ' ARG . . . . . . . . . . . . . 55.9 ttp180 -99.18 124.17 44.02 Favored 'General case' 0 C--N 1.328 -0.352 0 N-CA-C 109.2 -0.667 . . . . 0.0 109.2 174.035 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 60' ' ' VAL . . . . . . . . . . . . . 40.7 t -73.77 125.35 32.77 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.289 0 C-N-CA 120.595 -0.442 . . . . 0.0 110.341 -175.113 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 61' ' ' GLU . . . . . . . . . . . . . 95.9 mt-10 -130.26 160.9 32.48 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 115.837 -0.619 . . . . 0.0 110.092 179.699 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 62' ' ' ASP . . . . . . . . . . . . . 7.3 p-10 -56.08 -32.9 64.56 Favored 'General case' 0 C--N 1.328 -0.349 0 C-N-CA 120.852 -0.339 . . . . 0.0 111.435 178.69 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 63' ' ' ARG . . . . . . . . . . . . . 15.5 ptm180 -82.59 6.7 16.82 Favored 'General case' 0 CA--C 1.537 0.473 0 N-CA-C 113.52 0.933 . . . . 0.0 113.52 -177.361 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 64' ' ' THR . . . . . . . . . . . . . 21.3 m -87.2 139.39 30.61 Favored 'General case' 0 C--N 1.333 -0.13 0 CA-C-N 118.119 0.418 . . . . 0.0 110.611 -178.262 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 65' ' ' LYS . . . . . . . . . . . . . 48.7 mtmt -88.89 128.71 35.68 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.082 -0.508 . . . . 0.0 110.373 179.291 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 66' ' ' ILE . . . . . . . . . . . . . 66.9 mt -117.73 128.31 74.94 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.261 0 N-CA-C 109.783 -0.451 . . . . 0.0 109.783 179.928 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 67' ' ' THR . . . . . . . . . . . . . 25.2 m -122.2 135.88 54.83 Favored 'General case' 0 C--N 1.332 -0.172 0 CA-C-O 121.074 0.464 . . . . 0.0 110.727 -179.096 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 68' ' ' LEU . . . . . . . . . . . . . 8.0 mp . . . . . 0 C--N 1.33 -0.276 0 CA-C-N 115.815 -0.63 . . . . 0.0 110.344 178.781 . . . . . . . . 0 0 . 1 . 008 nuclear orig core ' B' B ' 73' ' ' VAL . . . . . . . . . . . . . 34.9 m . . . . . 0 C--O 1.23 0.074 0 CA-C-O 121.052 0.453 . . . . 0.0 110.828 . . . . . . . . . 0 0 . 1 . 008 nuclear orig core ' B' B ' 74' ' ' ASP . . . . . . . . . . . . . 12.8 t70 -94.07 121.33 35.45 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 115.679 -0.691 . . . . 0.0 109.686 178.067 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 75' ' ' VAL . . . . . . . . . . . . . 45.8 t -110.29 122.57 65.06 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.236 0 CA-C-O 121.246 0.545 . . . . 0.0 110.42 -178.378 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 76' ' ' LEU . . . . . . . . . . . . . 26.7 mt -126.93 146.56 50.27 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 115.39 -0.823 . . . . 0.0 109.422 178.687 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 77' ' ' GLU . . . . . . . . . . . . . 97.6 mt-10 -134.35 138.8 45.18 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-O 121.089 0.471 . . . . 0.0 111.193 -177.346 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 78' ' ' ALA . . . . . . . . . . . . . . . -125.29 130.54 52.22 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 115.636 -0.711 . . . . 0.0 109.607 176.203 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 79' ' ' LYS . . . . . . . . . . . . . 79.4 tttt -78.45 119.48 21.81 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-O 120.906 0.384 . . . . 0.0 110.636 -176.508 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 80' ' ' ILE . . . . . . . . . . . . . 37.6 mm -139.24 105.02 2.32 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.325 0 N-CA-C 108.926 -0.768 . . . . 0.0 108.926 -178.807 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 81' ' ' LYS . . . . . . . . . . . . . 56.1 pttt -98.54 127.98 44.68 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-O 120.936 0.398 . . . . 0.0 111.557 -176.71 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 82' ' ' GLY . . . . . . . . . . . . . . . 89.14 42.12 5.67 Favored Glycine 0 CA--C 1.526 0.766 0 C-N-CA 121.036 -0.602 . . . . 0.0 111.975 175.148 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 83' ' ' ILE . . . . . . . . . . . . . 74.2 mt -71.81 138.88 20.72 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 N-CA-C 109.646 -0.502 . . . . 0.0 109.646 176.478 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 84' ' ' LYS . . . . . . . . . . . . . 33.1 ttpt -99.88 -52.94 3.3 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-O 120.938 0.399 . . . . 0.0 110.177 -179.802 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 85' ' ' ASP . . . . . . . . . . . . . 11.1 t70 -145.88 147.43 31.77 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 115.915 -0.584 . . . . 0.0 110.518 -178.813 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 86' ' ' VAL . . . . . . . . . . . . . 44.9 t -128.06 131.88 69.04 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.254 0 CA-C-O 120.81 0.338 . . . . 0.0 110.496 -179.105 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 87' ' ' ILE . . . . . . . . . . . . . 5.1 mp -122.26 127.15 75.1 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.168 0 N-CA-C 109.692 -0.485 . . . . 0.0 109.692 177.434 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 88' ' ' LEU . . . . . . . . . . . . . 17.4 tp -111.22 131.63 54.97 Favored 'General case' 0 C--N 1.331 -0.201 0 CA-C-O 120.954 0.407 . . . . 0.0 110.934 -178.471 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 89' ' ' ASP . . . . . . . . . . . . . 5.9 t70 -126.09 155.33 41.77 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.014 -0.539 . . . . 0.0 109.73 178.039 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 90' ' ' GLU . . . . . . . . . . . . . 84.2 tt0 -47.12 -38.52 11.68 Favored 'General case' 0 CA--C 1.531 0.248 0 N-CA-C 112.888 0.699 . . . . 0.0 112.888 -172.181 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 91' ' ' ASN . . . . . . . . . . . . . 14.7 m120 -128.09 17.42 6.66 Favored 'General case' 0 N--CA 1.469 0.482 0 N-CA-C 113.007 0.743 . . . . 0.0 113.007 -177.085 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 92' ' ' LEU . . . . . . . . . . . . . 35.6 mt -147.91 144.46 28.09 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-O 120.801 0.334 . . . . 0.0 110.433 -176.171 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 93' ' ' ILE . . . . . . . . . . . . . 70.5 mt -122.84 115.32 45.49 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.373 0 N-CA-C 109.056 -0.72 . . . . 0.0 109.056 177.376 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 94' ' ' VAL . . . . . . . . . . . . . 42.6 t -117.32 126.84 74.81 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.283 0 CA-C-O 120.901 0.381 . . . . 0.0 110.178 -177.111 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 95' ' ' VAL . . . . . . . . . . . . . 46.5 t -122.39 133.18 69.41 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.337 0 CA-C-N 115.933 -0.576 . . . . 0.0 109.773 179.874 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 96' ' ' ILE . . . . . . . . . . . . . 66.0 mt -115.21 125.22 72.43 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.329 0 N-CA-C 109.315 -0.624 . . . . 0.0 109.315 179.097 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 97' ' ' THR . . . . . . . . . . . . . 80.4 p -99.75 158.0 16.09 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-O 121.202 0.525 . . . . 0.0 111.191 -176.127 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 98' ' ' GLU . . . . . . . . . . . . . 44.9 mt-10 -53.95 -26.12 24.03 Favored 'General case' 0 C--N 1.329 -0.319 0 N-CA-C 112.308 0.485 . . . . 0.0 112.308 -179.268 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 99' ' ' GLU . . . . . . . . . . . . . 70.0 mm-40 -78.84 15.73 1.02 Allowed 'General case' 0 CA--C 1.535 0.371 0 N-CA-C 113.203 0.816 . . . . 0.0 113.203 -176.829 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 100' ' ' ASN . . . . . . . . . . . . . 2.4 m-20 62.24 38.01 13.74 Favored 'General case' 0 N--CA 1.463 0.2 0 CA-C-O 121.118 0.485 . . . . 0.0 110.996 178.647 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 101' ' ' GLU . . . . . . . . . . . . . 84.6 tt0 -116.77 142.79 46.46 Favored 'General case' 0 C--N 1.331 -0.224 0 CA-C-N 116.021 -0.536 . . . . 0.0 109.917 176.486 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 102' ' ' VAL . . . . . . . . . . . . . 43.2 t -114.96 125.0 72.17 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.327 0 N-CA-C 109.738 -0.467 . . . . 0.0 109.738 -178.957 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 103' ' ' LEU . . . . . . . . . . . . . 57.5 mt -115.23 131.52 56.9 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 115.637 -0.71 . . . . 0.0 109.906 177.819 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 104' ' ' ILE . . . . . . . . . . . . . 67.4 mt -118.82 118.39 57.61 Favored 'Isoleucine or valine' 0 C--O 1.234 0.271 0 N-CA-C 110.096 -0.335 . . . . 0.0 110.096 -178.831 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 105' ' ' PHE . . . . . . . . . . . . . 68.8 m-85 -115.07 162.95 16.31 Favored 'General case' 0 C--N 1.332 -0.191 0 O-C-N 124.196 0.935 . . . . 0.0 109.893 179.265 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 106' ' ' ASN . . . . . . . . . . . . . 45.0 p-10 -102.62 -170.11 1.76 Allowed 'General case' 0 C--N 1.329 -0.3 0 N-CA-C 109.801 -0.444 . . . . 0.0 109.801 174.392 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 107' ' ' GLN . . . . . . . . . . . . . 60.3 tt0 -58.52 -28.27 65.28 Favored 'General case' 0 C--N 1.33 -0.248 0 N-CA-C 111.968 0.359 . . . . 0.0 111.968 177.682 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 108' ' ' ASN . . . . . . . . . . . . . 10.6 t-20 -84.11 7.09 19.9 Favored 'General case' 0 CA--C 1.536 0.439 0 N-CA-C 113.235 0.828 . . . . 0.0 113.235 -177.625 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 109' ' ' LEU . . . . . . . . . . . . . 6.5 tp 60.52 36.61 19.97 Favored 'General case' 0 C--O 1.233 0.197 0 CA-C-O 120.891 0.377 . . . . 0.0 111.414 178.745 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 110' ' ' GLU . . . . . . . . . . . . . 70.8 mm-40 -115.45 150.64 36.14 Favored 'General case' 0 C--N 1.331 -0.215 0 CA-C-O 120.723 0.297 . . . . 0.0 110.321 177.117 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 111' ' ' GLU . . . . . . . . . . . . . 24.7 mm-40 -78.14 122.69 25.97 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-O 121.188 0.518 . . . . 0.0 111.762 -177.752 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 112' ' ' LEU . . . . . . . . . . . . . 57.7 mt -102.94 -42.63 5.76 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 115.449 -0.796 . . . . 0.0 110.137 173.622 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 113' ' ' TYR . . . . . . . . . . . . . 56.3 t80 -139.12 140.81 38.05 Favored 'General case' 0 N--CA 1.463 0.205 0 CA-C-O 120.978 0.418 . . . . 0.0 111.329 -179.677 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 114' ' ' ARG . . . . . . . . . . . . . 66.4 mtm180 -139.85 125.27 19.06 Favored 'General case' 0 C--N 1.331 -0.22 0 CA-C-N 115.794 -0.639 . . . . 0.0 110.247 177.515 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 115' ' ' GLY . . . . . . . . . . . . . . . -150.03 153.12 24.9 Favored Glycine 0 CA--C 1.524 0.604 0 C-N-CA 120.697 -0.763 . . . . 0.0 111.581 179.46 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 116' ' ' LYS . . . . . . . . . . . . . 39.8 ttpt -122.16 135.15 54.75 Favored 'General case' 0 C--N 1.33 -0.258 0 N-CA-C 109.602 -0.518 . . . . 0.0 109.602 176.104 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 117' ' ' PHE . . . . . . . . . . . . . 47.1 m-85 -134.92 113.96 12.06 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-O 121.037 0.446 . . . . 0.0 110.335 -176.611 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 118' ' ' GLU . . . . . . . . . . . . . 84.8 tt0 -53.41 -49.87 66.38 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.384 -0.371 . . . . 0.0 111.485 -176.771 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 119' ' ' ASN . . . . . . . . . . . . . 19.6 m-80 -94.21 30.99 1.77 Allowed 'General case' 0 C--N 1.329 -0.284 0 N-CA-C 112.111 0.412 . . . . 0.0 112.111 -174.591 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 120' ' ' LEU . . . . . . . . . . . . . 14.9 tp -57.42 122.88 13.65 Favored 'General case' 0 C--N 1.332 -0.188 0 N-CA-C 110.28 -0.267 . . . . 0.0 110.28 178.289 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 121' ' ' ASN . . . . . . . . . . . . . 80.9 m-20 -114.01 -44.07 3.19 Favored 'General case' 0 C--N 1.331 -0.204 0 CA-C-N 116.628 -0.26 . . . . 0.0 111.215 -176.617 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 122' ' ' LYS . . . . . . . . . . . . . 54.0 mttm -143.34 145.71 32.92 Favored 'General case' 0 C--N 1.331 -0.199 0 C-N-CA 120.593 -0.443 . . . . 0.0 111.478 -177.406 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 123' ' ' VAL . . . . . . . . . . . . . 46.3 t -126.31 128.54 71.59 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.259 0 N-CA-C 109.38 -0.6 . . . . 0.0 109.38 175.522 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 124' ' ' LEU . . . . . . . . . . . . . 40.4 mt -126.84 136.45 52.37 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-O 120.812 0.339 . . . . 0.0 110.773 -177.292 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 125' ' ' VAL . . . . . . . . . . . . . 11.4 p -136.23 130.39 47.83 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.298 0 CA-C-N 116.338 -0.392 . . . . 0.0 110.134 177.244 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 126' ' ' ARG . . . . . . . . . . . . . 29.5 mmm180 -138.17 119.91 15.2 Favored 'General case' 0 C--N 1.331 -0.201 0 CA-C-N 116.281 -0.418 . . . . 0.0 110.417 -178.977 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 127' ' ' ASN . . . . . . . . . . . . . 78.3 m-20 50.14 -104.85 0.16 Allowed 'General case' 0 CA--C 1.544 0.713 0 CA-C-O 119.176 -0.44 . . . . 0.0 111.794 176.622 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 128' ' ' ASP . . . . . . . . . . . . . 18.1 p-10 -110.54 -0.43 17.34 Favored 'General case' 0 CA--C 1.536 0.415 0 N-CA-C 113.752 1.019 . . . . 0.0 113.752 -174.759 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 129' ' ' LEU . . . . . . . . . . . . . 83.7 mt -111.01 144.22 40.47 Favored 'General case' 0 C--N 1.332 -0.175 0 O-C-N 121.972 -0.455 . . . . 0.0 110.273 179.349 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 130' ' ' VAL . . . . . . . . . . . . . 13.6 p -130.81 138.58 53.25 Favored 'Isoleucine or valine' 0 C--O 1.233 0.214 0 CA-C-O 121.188 0.518 . . . . 0.0 110.423 178.706 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 131' ' ' VAL . . . . . . . . . . . . . 37.5 t -135.11 138.95 48.06 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.263 0 CA-C-N 115.858 -0.61 . . . . 0.0 110.47 -175.773 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 132' ' ' ILE . . . . . . . . . . . . . 70.1 mt -117.22 129.77 73.21 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.283 0 CA-C-N 115.866 -0.606 . . . . 0.0 109.409 178.869 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 133' ' ' ILE . . . . . . . . . . . . . 43.5 mm -114.0 119.46 61.22 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.244 0 CA-C-O 120.815 0.34 . . . . 0.0 110.652 -176.183 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 134' ' ' ASP . . . . . . . . . . . . . 9.0 p-10 -134.43 143.04 47.33 Favored 'General case' 0 C--N 1.33 -0.27 0 N-CA-C 109.586 -0.524 . . . . 0.0 109.586 177.05 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 135' ' ' GLU . . . . . . . . . . . . . 85.7 tt0 -49.93 -25.84 3.63 Favored 'General case' 0 C--N 1.328 -0.347 0 N-CA-C 112.594 0.59 . . . . 0.0 112.594 -174.316 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 136' ' ' GLN . . . . . . . . . . . . . 53.2 mt-30 -78.95 -38.28 37.48 Favored 'General case' 0 CA--C 1.531 0.216 0 N-CA-C 112.138 0.422 . . . . 0.0 112.138 -178.016 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 137' ' ' LYS . . . . . . . . . . . . . 19.6 ptpt -162.77 174.46 12.44 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-O 121.49 0.662 . . . . 0.0 111.958 -173.458 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 138' ' ' LEU . . . . . . . . . . . . . 6.1 tt -117.88 126.77 53.0 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 115.098 -0.956 . . . . 0.0 109.568 177.007 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 139' ' ' THR . . . . . . . . . . . . . 28.6 m -108.78 124.86 51.26 Favored 'General case' 0 C--N 1.331 -0.204 0 CA-C-N 116.372 -0.376 . . . . 0.0 110.619 -178.882 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 140' ' ' LEU . . . . . . . . . . . . . 17.9 tp -112.17 119.02 36.95 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 115.579 -0.737 . . . . 0.0 109.124 -179.449 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 141' ' ' ILE . . . . . . . . . . . . . 19.9 mt -119.29 121.11 65.74 Favored 'Isoleucine or valine' 0 C--O 1.235 0.309 0 CA-C-O 121.236 0.541 . . . . 0.0 110.375 -176.209 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 142' ' ' ARG . . . . . . . . . . . . . 7.8 mmm180 -94.75 117.34 29.97 Favored 'General case' 0 C--N 1.331 -0.224 0 CA-C-N 114.861 -1.063 . . . . 0.0 109.718 177.86 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 143' ' ' THR . . . . . . . . . . . . . 6.0 p . . . . . 0 C--O 1.221 -0.444 0 CA-C-O 117.929 -1.034 . . . . 0.0 110.523 -177.914 . . . . . . . . 0 0 . 1 . 008 nuclear orig core ' C' C ' 2' ' ' SER . . . . . . . . . . . . . 3.1 p . . . . . 0 C--O 1.232 0.135 0 CA-C-O 121.041 0.448 . . . . 0.0 110.41 . . . . . . . . . 0 0 . 1 . 008 nuclear orig core ' C' C ' 3' ' ' GLU . . . . . . . . . . . . . 96.0 mt-10 -140.35 141.1 35.68 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 115.72 -0.673 . . . . 0.0 110.951 -177.886 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' C' C ' 4' ' ' LEU . . . . . . . . . . . . . 18.3 tp -123.19 127.06 48.12 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 115.771 -0.65 . . . . 0.0 109.799 175.795 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' C' C ' 5' ' ' LYS . . . . . . . . . . . . . 98.8 mttt -110.41 119.77 40.28 Favored 'General case' 0 C--O 1.234 0.26 0 CA-C-N 116.427 -0.352 . . . . 0.0 110.789 -179.257 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' C' C ' 6' ' ' LEU . . . . . . . . . . . . . 70.9 mt -114.8 143.98 44.23 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 115.302 -0.863 . . . . 0.0 110.277 -179.187 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' C' C ' 7' ' ' LYS . . . . . . . . . . . . . 51.3 tttm -128.26 133.29 24.99 Favored Pre-proline 0 CA--C 1.535 0.39 0 CA-C-O 118.777 -0.63 . . . . 0.0 110.102 177.442 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' C' C ' 8' ' ' PRO . . . . . . . . . . . . . 73.4 Cg_endo -89.01 136.32 2.95 Favored 'Trans proline' 0 N--CA 1.491 1.378 0 C-N-CA 121.61 1.54 . . . . 0.0 111.501 176.699 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' C' C ' 9' ' ' LEU . . . . . . . . . . . . . 75.8 mt -75.29 -52.08 3.16 Favored Pre-proline 0 CA--C 1.533 0.32 0 CA-C-O 118.712 -0.661 . . . . 0.0 112.02 -177.312 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' C' C ' 10' ' ' PRO . . . . . . . . . . . . . 60.4 Cg_endo -72.95 150.23 48.54 Favored 'Trans proline' 0 N--CA 1.5 1.866 0 C-N-CA 121.085 1.19 . . . . 0.0 111.948 174.375 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' C' C ' 11' ' ' LYS . . . . . . . . . . . . . 41.0 mtpt -89.13 100.78 13.49 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.502 -0.317 . . . . 0.0 110.825 179.391 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' C' C ' 12' ' ' VAL . . . . . . . . . . . . . 12.4 p -146.24 143.39 21.09 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.336 0 CA-C-N 116.265 -0.425 . . . . 0.0 110.579 179.223 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' C' C ' 13' ' ' GLU . . . . . . . . . . . . . 95.0 mt-10 -81.09 123.99 28.85 Favored 'General case' 0 C--N 1.33 -0.274 0 N-CA-C 109.98 -0.378 . . . . 0.0 109.98 177.916 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' C' C ' 14' ' ' LEU . . . . . . . . . . . . . 28.2 mt -98.27 152.31 37.92 Favored Pre-proline 0 CA--C 1.532 0.287 0 CA-C-N 116.425 -0.352 . . . . 0.0 110.601 -179.046 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' C' C ' 15' ' ' PRO . . . . . . . . . . . . . 34.3 Cg_exo -58.41 156.07 32.74 Favored 'Trans proline' 0 N--CA 1.497 1.693 0 C-N-CA 121.323 1.348 . . . . 0.0 111.854 178.088 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' C' C ' 16' ' ' PRO . . . . . . . . . . . . . 39.3 Cg_exo -58.85 -34.36 99.01 Favored 'Trans proline' 0 N--CA 1.496 1.64 0 C-N-CA 121.475 1.45 . . . . 0.0 112.677 -179.821 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' C' C ' 17' ' ' ASP . . . . . . . . . . . . . 19.4 p-10 -85.3 9.78 14.37 Favored 'General case' 0 CA--C 1.535 0.375 0 N-CA-C 113.081 0.771 . . . . 0.0 113.081 -177.545 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' C' C ' 18' ' ' PHE . . . . . . . . . . . . . 34.7 t80 -56.79 -42.15 78.96 Favored 'General case' 0 C--N 1.333 -0.118 0 O-C-N 121.939 -0.476 . . . . 0.0 110.365 -179.378 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' C' C ' 19' ' ' VAL . . . . . . . . . . . . . 53.1 t -56.43 -44.47 80.34 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 CA-C-N 116.361 -0.381 . . . . 0.0 110.469 -179.335 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' C' C ' 20' ' ' ASP . . . . . . . . . . . . . 82.8 m-20 -59.8 -42.5 93.55 Favored 'General case' 0 C--N 1.329 -0.308 0 C-N-CA 120.817 -0.353 . . . . 0.0 110.785 -178.271 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' C' C ' 21' ' ' VAL . . . . . . . . . . . . . 56.2 t -63.37 -47.75 90.45 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.303 0 C-N-CA 120.736 -0.385 . . . . 0.0 110.464 -177.294 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' C' C ' 22' ' ' ILE . . . . . . . . . . . . . 51.3 mm -55.42 -48.75 76.64 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.326 0 C-N-CA 121.077 -0.249 . . . . 0.0 110.8 -179.976 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' C' C ' 23' ' ' ARG . . . . . . . . . . . . . 55.4 ttp180 -55.66 -47.8 76.09 Favored 'General case' 0 C--N 1.33 -0.276 0 C-N-CA 120.806 -0.358 . . . . 0.0 111.415 -177.314 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' C' C ' 24' ' ' ILE . . . . . . . . . . . . . 75.8 mt -59.29 -42.01 85.87 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.311 0 C-N-CA 121.089 -0.244 . . . . 0.0 111.315 -177.284 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' C' C ' 25' ' ' LYS . . . . . . . . . . . . . 93.3 mttt -67.82 -43.79 78.78 Favored 'General case' 0 C--N 1.331 -0.219 0 N-CA-C 112.6 0.592 . . . . 0.0 112.6 -178.903 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' C' C ' 26' ' ' LEU . . . . . . . . . . . . . 70.6 mt -78.31 -33.96 48.98 Favored 'General case' 0 C--N 1.329 -0.313 0 N-CA-C 113.548 0.944 . . . . 0.0 113.548 -169.967 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' C' C ' 27' ' ' GLN . . . . . . . . . . . . . 6.2 pt20 -46.76 138.79 5.86 Favored 'General case' 0 N--CA 1.467 0.385 0 N-CA-C 112.971 0.73 . . . . 0.0 112.971 -173.925 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' C' C ' 28' ' ' GLY . . . . . . . . . . . . . . . 100.05 -27.18 21.51 Favored Glycine 0 CA--C 1.532 1.116 0 CA-C-N 115.614 -0.721 . . . . 0.0 112.214 -178.906 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' C' C ' 29' ' ' LYS . . . . . . . . . . . . . 61.8 mttp -97.96 155.21 17.2 Favored 'General case' 0 C--O 1.232 0.159 0 CA-C-N 117.341 0.571 . . . . 0.0 111.301 179.475 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' C' C ' 30' ' ' THR . . . . . . . . . . . . . 37.3 m -104.92 139.95 38.89 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-N 115.954 -0.566 . . . . 0.0 109.898 175.817 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' C' C ' 31' ' ' VAL . . . . . . . . . . . . . 34.7 m -127.31 152.26 35.13 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.218 0 CA-C-O 120.947 0.403 . . . . 0.0 111.077 -178.048 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' C' C ' 32' ' ' ARG . . . . . . . . . . . . . 97.1 mtt180 -126.35 149.47 49.17 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 115.834 -0.621 . . . . 0.0 110.622 177.912 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' C' C ' 33' ' ' THR . . . . . . . . . . . . . 17.6 m -53.65 138.81 33.93 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-N 116.118 -0.492 . . . . 0.0 111.308 -178.658 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' C' C ' 34' ' ' GLY . . . . . . . . . . . . . . . 100.2 -17.15 57.4 Favored Glycine 0 CA--C 1.533 1.194 0 CA-C-O 119.672 -0.515 . . . . 0.0 113.333 178.967 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' C' C ' 35' ' ' ASP . . . . . . . . . . . . . 77.5 m-20 -65.53 148.35 51.88 Favored 'General case' 0 N--CA 1.462 0.142 0 CA-C-N 117.965 0.883 . . . . 0.0 110.922 178.869 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' C' C ' 36' ' ' VAL . . . . . . . . . . . . . 41.4 t -120.53 131.52 72.49 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.258 0 CA-C-N 116.007 -0.542 . . . . 0.0 109.858 178.943 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' C' C ' 37' ' ' ILE . . . . . . . . . . . . . 67.1 mt -118.68 138.11 50.46 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.225 0 CA-C-N 116.082 -0.508 . . . . 0.0 109.682 179.276 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' C' C ' 38' ' ' GLY . . . . . . . . . . . . . . . -114.85 128.75 8.28 Favored Glycine 0 CA--C 1.525 0.67 0 N-CA-C 111.006 -0.838 . . . . 0.0 111.006 -179.878 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' C' C ' 39' ' ' ILE . . . . . . . . . . . . . 73.0 mt -123.21 137.35 56.89 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.186 0 N-CA-C 110.252 -0.277 . . . . 0.0 110.252 179.585 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' C' C ' 40' ' ' SER . . . . . . . . . . . . . 99.5 p -91.69 117.71 30.0 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.329 -0.396 . . . . 0.0 110.713 175.767 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' C' C ' 41' ' ' ILE . . . . . . . . . . . . . 72.0 mt -127.79 121.48 56.64 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.202 0 CA-C-O 120.902 0.382 . . . . 0.0 110.397 178.82 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' C' C ' 42' ' ' LEU . . . . . . . . . . . . . 10.8 tp 52.3 35.61 17.5 Favored 'General case' 0 CA--C 1.531 0.23 0 CA-C-N 116.036 -0.529 . . . . 0.0 111.614 177.087 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' C' C ' 43' ' ' GLY . . . . . . . . . . . . . . . 72.07 31.88 63.73 Favored Glycine 0 CA--C 1.529 0.92 0 C-N-CA 121.183 -0.532 . . . . 0.0 111.972 178.047 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' C' C ' 44' ' ' LYS . . . . . . . . . . . . . 40.7 ttpt -138.79 129.75 26.58 Favored 'General case' 0 C--N 1.329 -0.313 0 N-CA-C 109.609 -0.515 . . . . 0.0 109.609 178.743 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' C' C ' 45' ' ' GLU . . . . . . . . . . . . . 84.6 tt0 -82.6 118.23 23.14 Favored 'General case' 0 C--N 1.328 -0.335 0 C-N-CA 120.753 -0.379 . . . . 0.0 110.673 -178.768 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' C' C ' 46' ' ' VAL . . . . . . . . . . . . . 7.5 p -114.94 127.36 72.52 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.153 0 N-CA-C 109.285 -0.635 . . . . 0.0 109.285 176.795 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' C' C ' 47' ' ' LYS . . . . . . . . . . . . . 64.2 mttp -100.45 128.15 46.59 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 115.817 -0.629 . . . . 0.0 111.306 179.724 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' C' C ' 48' ' ' PHE . . . . . . . . . . . . . 94.9 m-85 -111.83 131.86 55.07 Favored 'General case' 0 C--N 1.329 -0.283 0 N-CA-C 109.652 -0.499 . . . . 0.0 109.652 174.956 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' C' C ' 49' ' ' LYS . . . . . . . . . . . . . 41.8 tttp -107.57 136.57 47.12 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.619 -0.264 . . . . 0.0 110.427 179.287 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' C' C ' 50' ' ' VAL . . . . . . . . . . . . . 46.4 t -79.87 108.75 13.69 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.305 0 N-CA-C 109.164 -0.68 . . . . 0.0 109.164 176.273 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' C' C ' 51' ' ' VAL . . . . . . . . . . . . . 46.8 t -73.24 -51.63 25.13 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.293 0 CA-C-N 116.153 -0.476 . . . . 0.0 109.737 -175.336 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' C' C ' 52' ' ' GLN . . . . . . . . . . . . . 86.2 mt-30 -154.03 149.17 26.91 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-O 121.334 0.587 . . . . 0.0 112.077 -178.007 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' C' C ' 53' ' ' ALA . . . . . . . . . . . . . . . -124.25 130.31 52.3 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 115.091 -0.958 . . . . 0.0 109.5 172.885 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' C' C ' 54' ' ' TYR . . . . . . . . . . . . . 45.5 t80 -128.97 107.08 18.1 Favored Pre-proline 0 CA--C 1.535 0.386 0 CA-C-O 118.24 -0.886 . . . . 0.0 110.593 -179.383 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' C' C ' 55' ' ' PRO . . . . . . . . . . . . . 73.3 Cg_endo -77.1 168.68 76.34 Favored 'Cis proline' 0 N--CA 1.499 1.827 0 CA-C-N 121.821 1.686 . . . . 0.0 112.243 -5.413 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' C' C ' 56' ' ' SER . . . . . . . . . . . . . 71.1 m -116.57 133.26 23.03 Favored Pre-proline 0 CA--C 1.537 0.472 0 CA-C-O 118.544 -0.741 . . . . 0.0 109.342 174.989 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' C' C ' 57' ' ' PRO . . . . . . . . . . . . . 55.3 Cg_endo -70.79 146.27 83.94 Favored 'Cis proline' 0 N--CA 1.498 1.745 0 CA-C-N 121.844 1.694 . . . . 0.0 111.688 -0.561 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' C' C ' 58' ' ' LEU . . . . . . . . . . . . . 31.4 tp -108.03 137.63 45.7 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.085 -0.507 . . . . 0.0 110.605 -178.7 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' C' C ' 59' ' ' ARG . . . . . . . . . . . . . 37.1 ttm180 -98.91 133.56 43.02 Favored 'General case' 0 C--N 1.328 -0.355 0 N-CA-C 109.453 -0.573 . . . . 0.0 109.453 175.273 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' C' C ' 60' ' ' VAL . . . . . . . . . . . . . 40.1 t -87.01 113.8 25.16 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.236 0 C-N-CA 120.616 -0.434 . . . . 0.0 110.386 -178.112 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' C' C ' 61' ' ' GLU . . . . . . . . . . . . . 15.7 mm-40 -131.1 163.66 27.17 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 115.944 -0.571 . . . . 0.0 109.769 174.246 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' C' C ' 62' ' ' ASP . . . . . . . . . . . . . 81.8 m-20 -52.32 -32.21 36.79 Favored 'General case' 0 C--N 1.329 -0.309 0 N-CA-C 111.802 0.297 . . . . 0.0 111.802 177.743 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' C' C ' 63' ' ' ARG . . . . . . . . . . . . . 41.4 mtp180 -72.07 -22.07 61.42 Favored 'General case' 0 CA--C 1.533 0.299 0 N-CA-C 112.884 0.698 . . . . 0.0 112.884 -176.484 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' C' C ' 64' ' ' THR . . . . . . . . . . . . . 40.5 m -72.27 138.12 47.22 Favored 'General case' 0 C--N 1.332 -0.186 0 CA-C-O 120.918 0.39 . . . . 0.0 110.657 -176.467 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' C' C ' 65' ' ' LYS . . . . . . . . . . . . . 38.8 ttpt -88.63 127.11 35.56 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 115.989 -0.551 . . . . 0.0 110.239 179.549 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' C' C ' 66' ' ' ILE . . . . . . . . . . . . . 72.5 mt -112.96 132.09 62.72 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.28 0 CA-C-O 120.892 0.377 . . . . 0.0 110.064 -178.053 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' C' C ' 67' ' ' THR . . . . . . . . . . . . . 23.4 m -125.29 137.26 54.07 Favored 'General case' 0 C--N 1.331 -0.212 0 CA-C-N 116.091 -0.504 . . . . 0.0 110.655 -179.239 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' C' C ' 68' ' ' LEU . . . . . . . . . . . . . 13.8 tp . . . . . 0 C--N 1.33 -0.245 0 CA-C-N 115.887 -0.597 . . . . 0.0 110.527 179.841 . . . . . . . . 0 0 . 1 . 008 nuclear orig core ' C' C ' 73' ' ' VAL . . . . . . . . . . . . . 34.6 m . . . . . 0 N--CA 1.462 0.159 0 CA-C-O 120.752 0.31 . . . . 0.0 110.369 . . . . . . . . . 0 0 . 1 . 008 nuclear orig core ' C' C ' 74' ' ' ASP . . . . . . . . . . . . . 42.3 t0 -104.55 121.52 43.66 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-N 116.332 -0.394 . . . . 0.0 110.183 -177.966 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' C' C ' 75' ' ' VAL . . . . . . . . . . . . . 40.6 t -118.24 125.91 74.62 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.326 0 CA-C-O 121.107 0.479 . . . . 0.0 111.005 -176.462 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' C' C ' 76' ' ' LEU . . . . . . . . . . . . . 6.8 mp -121.53 143.99 48.96 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 115.601 -0.727 . . . . 0.0 109.732 174.681 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' C' C ' 77' ' ' GLU . . . . . . . . . . . . . 97.0 mt-10 -134.47 130.67 37.06 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-O 120.988 0.423 . . . . 0.0 111.016 -177.995 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' C' C ' 78' ' ' ALA . . . . . . . . . . . . . . . -117.98 134.09 55.29 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 115.663 -0.699 . . . . 0.0 109.766 176.933 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' C' C ' 79' ' ' LYS . . . . . . . . . . . . . 49.2 mtmt -77.47 120.71 22.85 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-O 120.967 0.413 . . . . 0.0 110.967 -177.956 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' C' C ' 80' ' ' ILE . . . . . . . . . . . . . 42.1 mm -139.09 108.54 3.87 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.322 0 N-CA-C 108.933 -0.765 . . . . 0.0 108.933 -179.009 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' C' C ' 81' ' ' LYS . . . . . . . . . . . . . 44.0 mtmt -101.44 123.34 45.34 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-O 120.723 0.297 . . . . 0.0 111.257 -176.382 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' C' C ' 82' ' ' GLY . . . . . . . . . . . . . . . 89.07 42.43 5.62 Favored Glycine 0 CA--C 1.526 0.738 0 C-N-CA 120.652 -0.785 . . . . 0.0 111.794 174.674 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' C' C ' 83' ' ' ILE . . . . . . . . . . . . . 68.0 mt -65.29 137.03 25.73 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 CA-C-O 121.001 0.429 . . . . 0.0 109.862 177.733 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' C' C ' 84' ' ' LYS . . . . . . . . . . . . . 46.3 tttp -92.94 -52.52 4.55 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 115.942 -0.572 . . . . 0.0 109.94 179.891 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' C' C ' 85' ' ' ASP . . . . . . . . . . . . . 7.0 t70 -154.33 151.98 29.71 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 115.478 -0.783 . . . . 0.0 110.321 -179.225 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' C' C ' 86' ' ' VAL . . . . . . . . . . . . . 43.4 t -130.46 129.76 64.8 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.287 0 CA-C-N 116.47 -0.332 . . . . 0.0 110.495 -179.485 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' C' C ' 87' ' ' ILE . . . . . . . . . . . . . 5.1 mp -119.37 128.78 75.85 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.285 0 N-CA-C 109.405 -0.591 . . . . 0.0 109.405 176.184 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' C' C ' 88' ' ' LEU . . . . . . . . . . . . . 23.7 tp -117.58 135.96 53.61 Favored 'General case' 0 C--N 1.331 -0.216 0 CA-C-O 121.014 0.435 . . . . 0.0 111.556 -176.126 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' C' C ' 89' ' ' ASP . . . . . . . . . . . . . 10.9 t70 -130.01 154.31 47.53 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 115.665 -0.698 . . . . 0.0 109.19 174.537 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' C' C ' 90' ' ' GLU . . . . . . . . . . . . . 96.6 mt-10 -49.81 -35.0 21.26 Favored 'General case' 0 C--N 1.33 -0.261 0 N-CA-C 112.718 0.636 . . . . 0.0 112.718 -172.277 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' C' C ' 91' ' ' ASN . . . . . . . . . . . . . 86.2 m-20 -130.29 32.61 4.44 Favored 'General case' 0 N--CA 1.465 0.294 0 N-CA-C 111.99 0.367 . . . . 0.0 111.99 -175.902 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' C' C ' 92' ' ' LEU . . . . . . . . . . . . . 8.7 tp -166.1 145.75 6.15 Favored 'General case' 0 C--N 1.331 -0.228 0 C-N-CA 120.933 -0.307 . . . . 0.0 110.782 178.67 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' C' C ' 93' ' ' ILE . . . . . . . . . . . . . 68.0 mt -125.93 124.08 65.47 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.181 0 N-CA-C 109.586 -0.524 . . . . 0.0 109.586 179.391 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' C' C ' 94' ' ' VAL . . . . . . . . . . . . . 43.3 t -122.64 125.21 72.21 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.223 0 N-CA-C 109.937 -0.394 . . . . 0.0 109.937 179.344 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' C' C ' 95' ' ' VAL . . . . . . . . . . . . . 43.8 t -124.08 134.67 65.94 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.299 0 CA-C-N 116.305 -0.407 . . . . 0.0 110.168 -179.461 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' C' C ' 96' ' ' ILE . . . . . . . . . . . . . 61.1 mt -118.99 130.52 73.7 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.238 0 N-CA-C 109.457 -0.571 . . . . 0.0 109.457 179.54 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' C' C ' 97' ' ' THR . . . . . . . . . . . . . 81.1 p -103.46 158.44 16.35 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-O 121.088 0.47 . . . . 0.0 111.44 -177.295 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' C' C ' 98' ' ' GLU . . . . . . . . . . . . . 98.1 mt-10 -53.97 -26.5 26.09 Favored 'General case' 0 CA--C 1.532 0.257 0 N-CA-C 112.392 0.516 . . . . 0.0 112.392 179.998 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' C' C ' 99' ' ' GLU . . . . . . . . . . . . . 95.8 mt-10 -77.78 14.05 1.18 Allowed 'General case' 0 CA--C 1.535 0.391 0 N-CA-C 113.302 0.853 . . . . 0.0 113.302 -177.23 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' C' C ' 100' ' ' ASN . . . . . . . . . . . . . 4.6 m-20 63.01 37.95 11.35 Favored 'General case' 0 C--O 1.232 0.142 0 CA-C-O 121.08 0.467 . . . . 0.0 111.033 178.489 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' C' C ' 101' ' ' GLU . . . . . . . . . . . . . 84.9 tt0 -117.65 140.11 50.1 Favored 'General case' 0 C--N 1.333 -0.151 0 CA-C-N 116.083 -0.508 . . . . 0.0 109.646 175.697 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' C' C ' 102' ' ' VAL . . . . . . . . . . . . . 45.7 t -115.16 128.83 72.18 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.263 0 CA-C-N 116.311 -0.404 . . . . 0.0 110.063 -178.667 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' C' C ' 103' ' ' LEU . . . . . . . . . . . . . 6.1 mp -118.4 132.94 56.24 Favored 'General case' 0 C--N 1.331 -0.201 0 CA-C-N 115.695 -0.684 . . . . 0.0 110.131 176.904 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' C' C ' 104' ' ' ILE . . . . . . . . . . . . . 67.9 mt -117.92 122.48 69.82 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.228 0 CA-C-N 116.328 -0.397 . . . . 0.0 109.972 -179.766 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' C' C ' 105' ' ' PHE . . . . . . . . . . . . . 67.1 m-85 -123.16 164.67 18.24 Favored 'General case' 0 C--N 1.333 -0.132 0 O-C-N 123.916 0.76 . . . . 0.0 109.777 -179.972 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' C' C ' 106' ' ' ASN . . . . . . . . . . . . . 47.3 p-10 -102.42 -172.08 2.07 Favored 'General case' 0 C--N 1.33 -0.246 0 N-CA-C 110.151 -0.315 . . . . 0.0 110.151 174.688 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' C' C ' 107' ' ' GLN . . . . . . . . . . . . . 29.1 tt0 -58.81 -28.07 65.67 Favored 'General case' 0 C--N 1.329 -0.311 0 N-CA-C 112.086 0.402 . . . . 0.0 112.086 179.166 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' C' C ' 108' ' ' ASN . . . . . . . . . . . . . 7.9 t-20 -84.75 12.12 7.85 Favored 'General case' 0 CA--C 1.537 0.453 0 N-CA-C 112.89 0.7 . . . . 0.0 112.89 -177.956 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' C' C ' 109' ' ' LEU . . . . . . . . . . . . . 10.7 tp 53.8 37.22 25.89 Favored 'General case' 0 C--N 1.333 -0.148 0 CA-C-O 121.089 0.471 . . . . 0.0 111.315 179.409 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' C' C ' 110' ' ' GLU . . . . . . . . . . . . . 96.0 mt-10 -105.98 141.88 36.64 Favored 'General case' 0 C--N 1.33 -0.272 0 N-CA-C 109.325 -0.62 . . . . 0.0 109.325 174.528 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' C' C ' 111' ' ' GLU . . . . . . . . . . . . . 51.4 tt0 -79.61 121.92 25.87 Favored 'General case' 0 C--N 1.328 -0.332 0 C-N-CA 120.693 -0.403 . . . . 0.0 110.286 -176.478 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' C' C ' 112' ' ' LEU . . . . . . . . . . . . . 34.3 mt -102.85 -46.11 4.79 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.034 -0.53 . . . . 0.0 110.72 -179.668 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' C' C ' 113' ' ' TYR . . . . . . . . . . . . . 59.1 t80 -137.45 140.8 41.46 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.034 -0.53 . . . . 0.0 110.927 -177.824 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' C' C ' 114' ' ' ARG . . . . . . . . . . . . . 28.5 ptt180 -144.83 126.08 14.75 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-O 120.93 0.395 . . . . 0.0 110.664 176.56 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' C' C ' 115' ' ' GLY . . . . . . . . . . . . . . . -150.01 151.8 23.82 Favored Glycine 0 CA--C 1.524 0.61 0 N-CA-C 111.131 -0.788 . . . . 0.0 111.131 179.297 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' C' C ' 116' ' ' LYS . . . . . . . . . . . . . 39.7 ttpt -119.53 132.55 55.78 Favored 'General case' 0 C--N 1.329 -0.296 0 N-CA-C 110.006 -0.368 . . . . 0.0 110.006 178.185 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' C' C ' 117' ' ' PHE . . . . . . . . . . . . . 37.5 m-85 -128.93 113.8 15.66 Favored 'General case' 0 C--N 1.329 -0.286 0 N-CA-C 109.878 -0.416 . . . . 0.0 109.878 -178.257 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' C' C ' 118' ' ' GLU . . . . . . . . . . . . . 85.1 tt0 -55.54 -38.49 69.35 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-N 116.398 -0.364 . . . . 0.0 111.339 -175.308 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' C' C ' 119' ' ' ASN . . . . . . . . . . . . . 10.5 p-10 -108.73 31.14 5.87 Favored 'General case' 0 N--CA 1.463 0.196 0 N-CA-C 112.237 0.458 . . . . 0.0 112.237 -173.106 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' C' C ' 120' ' ' LEU . . . . . . . . . . . . . 15.0 tp -54.36 126.81 24.71 Favored 'General case' 0 N--CA 1.463 0.21 0 O-C-N 122.358 -0.213 . . . . 0.0 110.683 177.024 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' C' C ' 121' ' ' ASN . . . . . . . . . . . . . 27.1 m120 -110.56 -44.22 3.72 Favored 'General case' 0 C--N 1.332 -0.187 0 C-N-CA 121.169 -0.212 . . . . 0.0 111.173 -177.06 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' C' C ' 122' ' ' LYS . . . . . . . . . . . . . 95.2 mttt -148.36 148.15 30.05 Favored 'General case' 0 C--N 1.331 -0.229 0 CA-C-O 121.028 0.442 . . . . 0.0 111.44 -178.266 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' C' C ' 123' ' ' VAL . . . . . . . . . . . . . 47.0 t -127.42 128.33 69.83 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.223 0 N-CA-C 109.569 -0.53 . . . . 0.0 109.569 174.769 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' C' C ' 124' ' ' LEU . . . . . . . . . . . . . 67.9 mt -126.45 135.22 51.1 Favored 'General case' 0 C--N 1.331 -0.217 0 CA-C-N 116.494 -0.321 . . . . 0.0 110.626 -178.785 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' C' C ' 125' ' ' VAL . . . . . . . . . . . . . 12.4 p -138.05 137.45 44.5 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.284 0 CA-C-N 116.442 -0.345 . . . . 0.0 110.524 179.141 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' C' C ' 126' ' ' ARG . . . . . . . . . . . . . 90.6 mtt180 -143.96 123.32 13.08 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.565 178.676 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' C' C ' 127' ' ' ASN . . . . . . . . . . . . . 1.9 m-80 51.67 -105.02 0.19 Allowed 'General case' 0 CA--C 1.544 0.723 0 CA-C-O 119.134 -0.46 . . . . 0.0 111.279 -179.814 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' C' C ' 128' ' ' ASP . . . . . . . . . . . . . 8.9 p-10 -114.11 1.99 14.77 Favored 'General case' 0 CA--C 1.536 0.406 0 CA-C-N 119.538 1.063 . . . . 0.0 113.49 -176.53 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' C' C ' 129' ' ' LEU . . . . . . . . . . . . . 54.4 mt -104.97 135.49 46.21 Favored 'General case' 0 C--N 1.332 -0.185 0 CA-C-N 118.193 0.451 . . . . 0.0 110.401 179.618 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' C' C ' 130' ' ' VAL . . . . . . . . . . . . . 47.2 t -123.35 135.16 64.15 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.22 0 N-CA-C 109.913 -0.403 . . . . 0.0 109.913 179.991 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' C' C ' 131' ' ' VAL . . . . . . . . . . . . . 42.0 t -134.32 135.37 54.29 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.344 0 CA-C-O 121.125 0.488 . . . . 0.0 110.103 178.257 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' C' C ' 132' ' ' ILE . . . . . . . . . . . . . 72.5 mt -115.35 130.2 70.31 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.361 0 CA-C-N 115.498 -0.774 . . . . 0.0 109.179 -179.682 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' C' C ' 133' ' ' ILE . . . . . . . . . . . . . 44.6 mm -114.06 120.03 62.78 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.248 0 CA-C-O 120.981 0.419 . . . . 0.0 110.631 -176.226 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' C' C ' 134' ' ' ASP . . . . . . . . . . . . . 6.7 p-10 -129.58 149.51 51.31 Favored 'General case' 0 C--N 1.331 -0.23 0 CA-C-N 115.97 -0.559 . . . . 0.0 109.539 176.117 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' C' C ' 135' ' ' GLU . . . . . . . . . . . . . 41.4 tp10 -49.96 -27.05 4.81 Favored 'General case' 0 C--N 1.327 -0.378 0 N-CA-C 112.806 0.669 . . . . 0.0 112.806 -169.927 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' C' C ' 136' ' ' GLN . . . . . . . . . . . . . 30.7 tt0 -103.67 -22.82 13.51 Favored 'General case' 0 N--CA 1.465 0.282 0 N-CA-C 113.093 0.775 . . . . 0.0 113.093 -173.402 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' C' C ' 137' ' ' LYS . . . . . . . . . . . . . 54.0 mtmt -148.77 157.16 43.24 Favored 'General case' 0 C--N 1.332 -0.153 0 CA-C-O 121.212 0.529 . . . . 0.0 112.008 -170.649 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' C' C ' 138' ' ' LEU . . . . . . . . . . . . . 5.5 tt -120.18 125.48 48.29 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 115.568 -0.742 . . . . 0.0 109.444 175.312 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' C' C ' 139' ' ' THR . . . . . . . . . . . . . 37.6 m -111.57 131.57 55.15 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-O 120.762 0.315 . . . . 0.0 111.126 -176.463 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' C' C ' 140' ' ' LEU . . . . . . . . . . . . . 14.3 tp -116.35 122.5 45.06 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 115.527 -0.761 . . . . 0.0 109.428 -179.67 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' C' C ' 141' ' ' ILE . . . . . . . . . . . . . 19.5 mt -120.77 119.45 59.59 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.29 0 N-CA-C 109.687 -0.486 . . . . 0.0 109.687 -177.258 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' C' C ' 142' ' ' ARG . . . . . . . . . . . . . 53.2 ttt180 . . . . . 0 C--N 1.328 -0.349 0 CA-C-N 115.301 -0.863 . . . . 0.0 110.501 -176.341 . . . . . . . . 0 0 . 1 . 008 nuclear orig core ' D' D ' 2' ' ' SER . . . . . . . . . . . . . 4.2 p . . . . . 0 C--O 1.232 0.143 0 CA-C-O 121.167 0.508 . . . . 0.0 110.698 . . . . . . . . . 0 0 . 1 . 008 nuclear orig core ' D' D ' 3' ' ' GLU . . . . . . . . . . . . . 84.8 tt0 -141.28 141.97 33.92 Favored 'General case' 0 C--N 1.326 -0.423 0 CA-C-N 115.578 -0.737 . . . . 0.0 111.121 -178.25 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' D' D ' 4' ' ' LEU . . . . . . . . . . . . . 65.2 mt -119.9 128.98 54.14 Favored 'General case' 0 C--N 1.331 -0.224 0 CA-C-N 115.739 -0.664 . . . . 0.0 110.436 176.303 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' D' D ' 5' ' ' LYS . . . . . . . . . . . . . 61.1 mttp -106.02 119.55 39.49 Favored 'General case' 0 C--O 1.235 0.322 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.303 176.62 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' D' D ' 6' ' ' LEU . . . . . . . . . . . . . 73.2 mt -118.18 152.08 36.36 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-N 115.457 -0.792 . . . . 0.0 110.726 -177.72 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' D' D ' 7' ' ' LYS . . . . . . . . . . . . . 29.2 ttpt -143.27 140.92 18.28 Favored Pre-proline 0 CA--C 1.534 0.354 0 CA-C-O 119.19 -0.434 . . . . 0.0 110.067 174.33 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' D' D ' 8' ' ' PRO . . . . . . . . . . . . . 93.9 Cg_endo -89.27 138.23 3.25 Favored 'Trans proline' 0 N--CA 1.489 1.23 0 C-N-CA 121.752 1.635 . . . . 0.0 111.555 177.875 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' D' D ' 9' ' ' LEU . . . . . . . . . . . . . 84.9 mt -70.85 -48.81 14.59 Favored Pre-proline 0 C--N 1.329 -0.306 0 CA-C-O 119.143 -0.456 . . . . 0.0 111.045 -178.824 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' D' D ' 10' ' ' PRO . . . . . . . . . . . . . 95.6 Cg_endo -79.75 138.44 13.36 Favored 'Trans proline' 0 N--CA 1.495 1.57 0 C-N-CA 121.098 1.198 . . . . 0.0 111.228 169.398 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' D' D ' 11' ' ' LYS . . . . . . . . . . . . . 82.3 tttt -87.88 102.86 15.11 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-O 120.886 0.375 . . . . 0.0 110.472 -178.923 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' D' D ' 12' ' ' VAL . . . . . . . . . . . . . 12.1 p -140.77 147.86 22.43 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.248 0 CA-C-N 116.127 -0.488 . . . . 0.0 110.518 -179.391 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' D' D ' 13' ' ' GLU . . . . . . . . . . . . . 95.2 mt-10 -78.93 123.36 27.19 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 116.3 -0.409 . . . . 0.0 110.041 178.392 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' D' D ' 14' ' ' LEU . . . . . . . . . . . . . 21.8 mt -98.55 153.88 37.76 Favored Pre-proline 0 C--N 1.33 -0.24 0 CA-C-N 116.427 -0.351 . . . . 0.0 111.103 -178.072 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' D' D ' 15' ' ' PRO . . . . . . . . . . . . . 37.9 Cg_exo -59.72 158.8 26.85 Favored 'Trans proline' 0 N--CA 1.497 1.717 0 C-N-CA 121.359 1.373 . . . . 0.0 111.83 178.295 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' D' D ' 16' ' ' PRO . . . . . . . . . . . . . 26.4 Cg_exo -60.47 -37.96 77.21 Favored 'Trans proline' 0 N--CA 1.498 1.787 0 C-N-CA 121.424 1.416 . . . . 0.0 112.911 -177.347 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' D' D ' 17' ' ' ASP . . . . . . . . . . . . . 22.6 p-10 -89.93 11.01 21.71 Favored 'General case' 0 CA--C 1.537 0.464 0 N-CA-C 113.303 0.853 . . . . 0.0 113.303 -176.47 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' D' D ' 18' ' ' PHE . . . . . . . . . . . . . 51.2 t80 -57.97 -42.81 85.83 Favored 'General case' 0 C--O 1.227 -0.081 0 O-C-N 121.996 -0.44 . . . . 0.0 110.113 -178.933 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' D' D ' 19' ' ' VAL . . . . . . . . . . . . . 48.2 t -57.34 -41.22 77.93 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.306 0 CA-C-N 116.234 -0.439 . . . . 0.0 110.391 -178.624 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' D' D ' 20' ' ' ASP . . . . . . . . . . . . . 79.7 m-20 -59.9 -43.53 94.77 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-O 120.798 0.333 . . . . 0.0 110.876 -177.916 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' D' D ' 21' ' ' VAL . . . . . . . . . . . . . 45.4 t -64.63 -46.46 92.37 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.312 0 C-N-CA 120.719 -0.392 . . . . 0.0 110.527 -177.801 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' D' D ' 22' ' ' ILE . . . . . . . . . . . . . 50.3 mm -56.44 -45.6 81.86 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.276 0 CA-C-O 120.727 0.299 . . . . 0.0 110.571 179.215 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' D' D ' 23' ' ' ARG . . . . . . . . . . . . . 59.4 ttp180 -53.34 -49.7 66.56 Favored 'General case' 0 C--N 1.331 -0.224 0 CA-C-O 120.835 0.35 . . . . 0.0 111.412 -178.704 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' D' D ' 24' ' ' ILE . . . . . . . . . . . . . 72.9 mt -59.61 -45.76 93.83 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.262 0 CA-C-N 116.281 -0.418 . . . . 0.0 111.136 -177.32 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' D' D ' 25' ' ' LYS . . . . . . . . . . . . . 59.4 mtpt -65.32 -37.35 86.83 Favored 'General case' 0 C--N 1.33 -0.263 0 N-CA-C 112.354 0.502 . . . . 0.0 112.354 -177.121 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' D' D ' 26' ' ' LEU . . . . . . . . . . . . . 25.9 mt -78.25 -45.68 22.26 Favored 'General case' 0 C--N 1.329 -0.296 0 N-CA-C 112.979 0.733 . . . . 0.0 112.979 -172.781 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' D' D ' 27' ' ' GLN . . . . . . . . . . . . . 11.3 pt20 -46.89 138.52 6.29 Favored 'General case' 0 N--CA 1.468 0.452 0 N-CA-C 112.728 0.64 . . . . 0.0 112.728 -175.68 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' D' D ' 28' ' ' GLY . . . . . . . . . . . . . . . 100.89 -26.6 24.04 Favored Glycine 0 CA--C 1.534 1.223 0 CA-C-N 115.542 -0.754 . . . . 0.0 112.274 -176.596 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' D' D ' 29' ' ' LYS . . . . . . . . . . . . . 65.8 mttm -98.74 155.12 17.51 Favored 'General case' 0 C--N 1.332 -0.154 0 CA-C-N 117.261 0.53 . . . . 0.0 111.217 179.259 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' D' D ' 30' ' ' THR . . . . . . . . . . . . . 17.7 m -102.73 137.13 41.35 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.185 -0.461 . . . . 0.0 110.084 176.128 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' D' D ' 31' ' ' VAL . . . . . . . . . . . . . 33.8 m -130.87 156.88 43.04 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.263 0 CA-C-O 120.816 0.341 . . . . 0.0 110.857 -179.158 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' D' D ' 32' ' ' ARG . . . . . . . . . . . . . 60.9 ttt180 -134.62 150.0 50.63 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 115.992 -0.549 . . . . 0.0 110.218 178.283 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' D' D ' 33' ' ' THR . . . . . . . . . . . . . 31.7 m -52.38 140.17 22.79 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-O 120.826 0.346 . . . . 0.0 111.421 -177.737 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' D' D ' 34' ' ' GLY . . . . . . . . . . . . . . . 99.68 -17.1 57.99 Favored Glycine 0 CA--C 1.531 1.053 0 C-N-CA 121.199 -0.524 . . . . 0.0 113.286 179.105 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' D' D ' 35' ' ' ASP . . . . . . . . . . . . . 72.5 m-20 -65.16 149.1 50.49 Favored 'General case' 0 C--O 1.231 0.101 0 CA-C-N 118.086 0.943 . . . . 0.0 111.141 179.427 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' D' D ' 36' ' ' VAL . . . . . . . . . . . . . 46.1 t -123.1 131.13 73.81 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.223 0 CA-C-N 115.683 -0.69 . . . . 0.0 109.798 178.409 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' D' D ' 37' ' ' ILE . . . . . . . . . . . . . 71.5 mt -119.59 139.79 45.75 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.251 0 CA-C-N 116.166 -0.47 . . . . 0.0 109.958 -179.709 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' D' D ' 38' ' ' GLY . . . . . . . . . . . . . . . -113.01 128.74 8.55 Favored Glycine 0 CA--C 1.526 0.721 0 N-CA-C 111.051 -0.82 . . . . 0.0 111.051 179.492 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' D' D ' 39' ' ' ILE . . . . . . . . . . . . . 68.3 mt -123.28 133.65 68.53 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.185 0 N-CA-C 110.103 -0.332 . . . . 0.0 110.103 179.241 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' D' D ' 40' ' ' SER . . . . . . . . . . . . . 93.4 p -92.69 122.67 35.32 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.394 -0.366 . . . . 0.0 110.729 175.859 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' D' D ' 41' ' ' ILE . . . . . . . . . . . . . 68.2 mt -129.04 119.64 49.76 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.219 0 CA-C-O 120.754 0.312 . . . . 0.0 110.482 178.218 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' D' D ' 42' ' ' LEU . . . . . . . . . . . . . 10.4 tp 51.94 37.21 20.4 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.143 -0.48 . . . . 0.0 111.594 176.907 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' D' D ' 43' ' ' GLY . . . . . . . . . . . . . . . 72.96 30.13 63.84 Favored Glycine 0 CA--C 1.528 0.886 0 C-N-CA 121.007 -0.616 . . . . 0.0 112.34 177.512 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' D' D ' 44' ' ' LYS . . . . . . . . . . . . . 81.9 mttt -136.57 129.39 30.78 Favored 'General case' 0 C--N 1.329 -0.313 0 N-CA-C 109.667 -0.494 . . . . 0.0 109.667 177.925 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' D' D ' 45' ' ' GLU . . . . . . . . . . . . . 85.2 tt0 -83.56 123.42 29.74 Favored 'General case' 0 C--N 1.329 -0.3 0 C-N-CA 120.812 -0.355 . . . . 0.0 111.141 -177.854 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' D' D ' 46' ' ' VAL . . . . . . . . . . . . . 7.7 p -120.97 128.3 76.06 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.231 0 N-CA-C 109.481 -0.563 . . . . 0.0 109.481 175.972 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' D' D ' 47' ' ' LYS . . . . . . . . . . . . . 35.3 mtmm -102.11 129.72 48.52 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 115.809 -0.632 . . . . 0.0 111.645 -179.892 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' D' D ' 48' ' ' PHE . . . . . . . . . . . . . 88.3 m-85 -112.8 131.97 55.46 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.368 -0.378 . . . . 0.0 110.37 177.224 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' D' D ' 49' ' ' LYS . . . . . . . . . . . . . 60.5 tttt -106.01 137.39 44.0 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.517 -0.31 . . . . 0.0 110.576 178.796 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' D' D ' 50' ' ' VAL . . . . . . . . . . . . . 45.5 t -84.82 107.84 16.24 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.241 0 N-CA-C 109.198 -0.667 . . . . 0.0 109.198 174.735 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' D' D ' 51' ' ' VAL . . . . . . . . . . . . . 47.2 t -73.07 -47.61 47.1 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.302 0 CA-C-N 116.153 -0.476 . . . . 0.0 110.159 -173.099 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' D' D ' 52' ' ' GLN . . . . . . . . . . . . . 62.8 tt0 -161.4 139.18 9.16 Favored 'General case' 0 C--N 1.331 -0.226 0 C-N-CA 120.231 -0.588 . . . . 0.0 111.884 -177.321 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' D' D ' 53' ' ' ALA . . . . . . . . . . . . . . . -115.96 133.61 55.85 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 115.655 -0.702 . . . . 0.0 109.609 174.144 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' D' D ' 54' ' ' TYR . . . . . . . . . . . . . 44.3 t80 -128.94 110.77 18.49 Favored Pre-proline 0 CA--C 1.537 0.449 0 CA-C-O 118.112 -0.947 . . . . 0.0 110.489 -179.531 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' D' D ' 55' ' ' PRO . . . . . . . . . . . . . 73.6 Cg_endo -77.13 169.9 73.03 Favored 'Cis proline' 0 N--CA 1.5 1.869 0 CA-C-N 121.853 1.698 . . . . 0.0 112.155 -6.987 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' D' D ' 56' ' ' SER . . . . . . . . . . . . . 49.1 m -117.79 135.01 23.19 Favored Pre-proline 0 CA--C 1.54 0.574 0 CA-C-O 118.42 -0.8 . . . . 0.0 109.949 175.901 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' D' D ' 57' ' ' PRO . . . . . . . . . . . . . 38.3 Cg_endo -68.45 163.73 77.04 Favored 'Cis proline' 0 N--CA 1.498 1.773 0 CA-C-N 121.875 1.705 . . . . 0.0 111.361 -3.754 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' D' D ' 58' ' ' LEU . . . . . . . . . . . . . 37.4 tp -129.78 137.94 50.79 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-O 120.877 0.37 . . . . 0.0 110.595 -179.866 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' D' D ' 59' ' ' ARG . . . . . . . . . . . . . 62.0 ttm-85 -100.62 121.28 41.35 Favored 'General case' 0 C--N 1.326 -0.414 0 N-CA-C 109.142 -0.688 . . . . 0.0 109.142 174.593 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' D' D ' 60' ' ' VAL . . . . . . . . . . . . . 42.3 t -74.54 124.81 32.92 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 C-N-CA 120.778 -0.369 . . . . 0.0 110.391 -173.786 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' D' D ' 61' ' ' GLU . . . . . . . . . . . . . 70.5 mm-40 -131.01 163.39 27.68 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 115.913 -0.585 . . . . 0.0 109.868 177.569 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' D' D ' 62' ' ' ASP . . . . . . . . . . . . . 14.9 p-10 -55.67 -31.64 62.56 Favored 'General case' 0 C--N 1.328 -0.346 0 N-CA-C 111.749 0.278 . . . . 0.0 111.749 -178.898 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' D' D ' 63' ' ' ARG . . . . . . . . . . . . . 10.0 ptm180 -83.68 6.75 19.81 Favored 'General case' 0 CA--C 1.536 0.438 0 N-CA-C 113.553 0.946 . . . . 0.0 113.553 -176.121 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' D' D ' 64' ' ' THR . . . . . . . . . . . . . 29.3 m -85.64 139.68 31.2 Favored 'General case' 0 C--N 1.332 -0.184 0 CA-C-N 118.192 0.451 . . . . 0.0 110.651 -179.074 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' D' D ' 65' ' ' LYS . . . . . . . . . . . . . 38.1 mtmt -89.07 132.6 34.7 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.273 -0.421 . . . . 0.0 110.419 179.657 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' D' D ' 66' ' ' ILE . . . . . 0.404 HG21 HD12 ' D' ' 66' ' ' ILE . 61.6 mt -120.38 128.16 75.97 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.221 0 CA-C-N 116.366 -0.379 . . . . 0.0 110.046 -177.244 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' D' D ' 67' ' ' THR . . . . . . . . . . . . . 27.8 m -130.21 142.65 50.55 Favored 'General case' 0 C--N 1.332 -0.177 0 CA-C-O 120.978 0.418 . . . . 0.0 111.234 -178.638 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' D' D ' 68' ' ' LEU . . . . . . . . . . . . . 7.2 mp . . . . . 0 C--N 1.329 -0.297 0 CA-C-N 116.049 -0.523 . . . . 0.0 110.65 177.827 . . . . . . . . 0 0 . 1 . 008 nuclear orig core ' D' D ' 73' ' ' VAL . . . . . . . . . . . . . 2.5 m . . . . . 0 N--CA 1.463 0.202 0 CA-C-O 120.98 0.419 . . . . 0.0 110.262 . . . . . . . . . 0 0 . 1 . 008 nuclear orig core ' D' D ' 74' ' ' ASP . . . . . . . . . . . . . 15.3 t0 -99.06 118.81 36.67 Favored 'General case' 0 C--N 1.325 -0.497 0 N-CA-C 108.829 -0.804 . . . . 0.0 108.829 173.894 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' D' D ' 75' ' ' VAL . . . . . . . . . . . . . 47.8 t -110.19 122.04 64.07 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.218 0 CA-C-O 121.132 0.491 . . . . 0.0 110.671 -176.325 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' D' D ' 76' ' ' LEU . . . . . . . . . . . . . 5.1 mp -124.08 138.66 54.41 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 115.657 -0.701 . . . . 0.0 109.28 174.5 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' D' D ' 77' ' ' GLU . . . . . . . . . . . . . 69.3 tt0 -134.37 136.9 43.71 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-O 120.955 0.407 . . . . 0.0 110.803 -177.801 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' D' D ' 78' ' ' ALA . . . . . . . . . . . . . . . -121.52 138.59 54.23 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 115.959 -0.564 . . . . 0.0 110.434 178.774 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' D' D ' 79' ' ' LYS . . . . . . . . . . . . . 7.6 ttpm? -77.75 115.38 17.46 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 116.438 -0.346 . . . . 0.0 110.419 179.582 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' D' D ' 80' ' ' ILE . . . . . . . . . . . . . 42.1 mm -139.06 108.09 3.68 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.273 0 N-CA-C 109.328 -0.619 . . . . 0.0 109.328 -178.369 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' D' D ' 81' ' ' LYS . . . . . . . . . . . . . 55.1 pttt -106.76 129.82 54.57 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-O 120.921 0.391 . . . . 0.0 111.518 -176.33 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' D' D ' 82' ' ' GLY . . . . . . . . . . . . . . . 88.95 42.19 5.72 Favored Glycine 0 CA--C 1.526 0.778 0 N-CA-C 111.529 -0.628 . . . . 0.0 111.529 176.752 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' D' D ' 83' ' ' ILE . . . . . . . . . . . . . 73.3 mt -71.92 138.76 20.95 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.32 0 N-CA-C 109.718 -0.475 . . . . 0.0 109.718 178.064 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' D' D ' 84' ' ' LYS . . . . . . . . . . . . . 50.4 tttp -95.7 -53.87 3.56 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 116.023 -0.535 . . . . 0.0 110.207 -178.136 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' D' D ' 85' ' ' ASP . . . . . . . . . . . . . 8.3 t70 -152.55 152.26 31.66 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 115.795 -0.639 . . . . 0.0 110.14 -179.594 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' D' D ' 86' ' ' VAL . . . . . . . . . . . . . 46.6 t -127.74 129.07 70.01 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.224 0 CA-C-O 120.883 0.373 . . . . 0.0 110.44 -179.041 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' D' D ' 87' ' ' ILE . . . . . . . . . . . . . 44.5 mm -117.97 127.5 75.2 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.217 0 CA-C-N 115.941 -0.572 . . . . 0.0 109.461 176.682 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' D' D ' 88' ' ' LEU . . . . . . . . . . . . . 12.5 tp -113.98 131.63 56.26 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-O 120.998 0.427 . . . . 0.0 111.154 -176.861 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' D' D ' 89' ' ' ASP . . . . . . . . . . . . . 13.8 t70 -123.88 152.08 42.76 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 115.78 -0.646 . . . . 0.0 109.432 176.837 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' D' D ' 90' ' ' GLU . . . . . . . . . . . . . 46.2 tp10 -47.84 -36.85 12.65 Favored 'General case' 0 CA--C 1.531 0.242 0 N-CA-C 112.735 0.643 . . . . 0.0 112.735 -172.967 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' D' D ' 91' ' ' ASN . . . . . . . . . . . . . 28.7 m120 -132.02 32.39 4.04 Favored 'General case' 0 N--CA 1.466 0.338 0 C-N-CA 120.846 -0.342 . . . . 0.0 111.916 -176.508 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' D' D ' 92' ' ' LEU . . . . . . . . . . . . . 9.7 tp -166.11 148.14 6.97 Favored 'General case' 0 C--N 1.329 -0.291 0 C-N-CA 121.008 -0.277 . . . . 0.0 110.591 -179.839 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' D' D ' 93' ' ' ILE . . . . . . . . . . . . . 64.1 mt -127.06 124.54 64.68 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.284 0 N-CA-C 109.58 -0.526 . . . . 0.0 109.58 -179.356 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' D' D ' 94' ' ' VAL . . . . . . . . . . . . . 46.7 t -124.08 127.74 73.64 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.234 0 CA-C-O 121.004 0.431 . . . . 0.0 110.181 179.99 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' D' D ' 95' ' ' VAL . . . . . . . . . . . . . 44.6 t -121.88 135.47 61.9 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.261 0 CA-C-N 116.054 -0.521 . . . . 0.0 109.931 179.984 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' D' D ' 96' ' ' ILE . . . . . . . . . . . . . 66.2 mt -116.3 129.49 72.64 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 N-CA-C 109.356 -0.609 . . . . 0.0 109.356 178.82 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' D' D ' 97' ' ' THR . . . . . . . . . . . . . 79.6 p -100.0 158.48 15.8 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-O 121.02 0.438 . . . . 0.0 111.105 -177.334 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' D' D ' 98' ' ' GLU . . . . . . . . . . . . . 97.1 mt-10 -54.06 -26.36 26.43 Favored 'General case' 0 C--N 1.329 -0.288 0 N-CA-C 112.219 0.451 . . . . 0.0 112.219 -179.795 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' D' D ' 99' ' ' GLU . . . . . . . . . . . . . 41.0 mt-10 -80.04 16.85 1.1 Allowed 'General case' 0 CA--C 1.536 0.412 0 N-CA-C 112.99 0.737 . . . . 0.0 112.99 -177.759 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' D' D ' 100' ' ' ASN . . . . . . . . . . . . . 3.3 m-20 63.16 37.94 10.99 Favored 'General case' 0 N--CA 1.463 0.197 0 CA-C-O 121.05 0.452 . . . . 0.0 111.085 177.453 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' D' D ' 101' ' ' GLU . . . . . . . . . . . . . 98.2 mt-10 -112.18 146.0 38.87 Favored 'General case' 0 C--N 1.332 -0.162 0 CA-C-N 116.2 -0.455 . . . . 0.0 110.419 174.981 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' D' D ' 102' ' ' VAL . . . . . . . . . . . . . 45.3 t -117.01 127.18 74.69 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.363 0 CA-C-N 115.762 -0.654 . . . . 0.0 109.606 179.134 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' D' D ' 103' ' ' LEU . . . . . . . . . . . . . 7.4 mp -119.45 129.76 54.92 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 115.883 -0.599 . . . . 0.0 110.207 175.716 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' D' D ' 104' ' ' ILE . . . . . . . . . . . . . 73.8 mt -114.13 122.22 67.81 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.335 0 CA-C-N 116.024 -0.534 . . . . 0.0 109.885 -179.341 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' D' D ' 105' ' ' PHE . . . . . . . . . . . . . 85.8 m-85 -119.23 160.03 22.94 Favored 'General case' 0 C--N 1.331 -0.229 0 O-C-N 124.17 0.919 . . . . 0.0 109.894 179.96 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' D' D ' 106' ' ' ASN . . . . . . . . . . . . . 42.8 p-10 -95.04 -170.22 2.15 Favored 'General case' 0 C--N 1.329 -0.321 0 N-CA-C 109.557 -0.534 . . . . 0.0 109.557 172.799 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' D' D ' 107' ' ' GLN . . . . . . . . . . . . . 58.2 tt0 -61.07 -25.57 67.03 Favored 'General case' 0 C--N 1.329 -0.314 0 N-CA-C 112.123 0.416 . . . . 0.0 112.123 178.54 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' D' D ' 108' ' ' ASN . . . . . . . . . . . . . 5.7 t-20 -83.66 3.2 33.93 Favored 'General case' 0 CA--C 1.538 0.518 0 N-CA-C 113.133 0.79 . . . . 0.0 113.133 -178.703 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' D' D ' 109' ' ' LEU . . . . . . . . . . . . . 9.1 tp 62.86 37.23 12.35 Favored 'General case' 0 C--O 1.232 0.151 0 CA-C-O 120.945 0.402 . . . . 0.0 111.36 179.39 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' D' D ' 110' ' ' GLU . . . . . . . . . . . . . 96.3 mt-10 -106.82 149.95 26.86 Favored 'General case' 0 C--N 1.331 -0.216 0 N-CA-C 110.025 -0.361 . . . . 0.0 110.025 176.458 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' D' D ' 111' ' ' GLU . . . . . . . . . . . . . 43.0 tp10 -79.67 121.98 25.98 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-O 121.114 0.483 . . . . 0.0 110.803 -176.889 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' D' D ' 112' ' ' LEU . . . . . . . . . . . . . 28.4 mt -103.93 -46.08 4.58 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 115.747 -0.661 . . . . 0.0 110.119 176.541 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' D' D ' 113' ' ' TYR . . . . . . . . . . . . . 65.2 t80 -142.53 135.5 28.37 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.226 -0.443 . . . . 0.0 111.33 -179.614 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' D' D ' 114' ' ' ARG . . . . . . . . . . . . . 79.0 ttt-85 -139.98 121.94 15.62 Favored 'General case' 0 C--N 1.331 -0.229 0 CA-C-N 116.321 -0.399 . . . . 0.0 110.121 177.17 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' D' D ' 115' ' ' GLY . . . . . . . . . . . . . . . -150.15 161.98 29.07 Favored Glycine 0 CA--C 1.525 0.656 0 N-CA-C 110.982 -0.847 . . . . 0.0 110.982 -178.761 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' D' D ' 116' ' ' LYS . . . . . . . . . . . . . 39.0 ttpt -120.08 137.32 54.2 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-O 120.741 0.305 . . . . 0.0 110.307 178.622 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' D' D ' 117' ' ' PHE . . . . . . . . . . . . . 31.6 m-85 -133.39 113.95 13.13 Favored 'General case' 0 C--N 1.33 -0.244 0 N-CA-C 109.859 -0.423 . . . . 0.0 109.859 179.224 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' D' D ' 118' ' ' GLU . . . . . . . . . . . . . 95.9 mt-10 -55.72 -44.8 77.83 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.33 -0.396 . . . . 0.0 111.228 -174.898 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' D' D ' 119' ' ' ASN . . . . . . . . . . . . . 20.2 m120 -95.89 30.93 2.23 Favored 'General case' 0 C--N 1.33 -0.275 0 N-CA-C 112.132 0.419 . . . . 0.0 112.132 -174.11 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' D' D ' 120' ' ' LEU . . . . . . . . . . . . . 13.3 tp -57.35 119.74 6.99 Favored 'General case' 0 C--N 1.334 -0.083 0 C-N-CA 120.984 -0.287 . . . . 0.0 110.259 178.078 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' D' D ' 121' ' ' ASN . . . . . . . . . . . . . 73.4 m-20 -114.12 -44.06 3.17 Favored 'General case' 0 C--N 1.332 -0.156 0 CA-C-N 116.409 -0.359 . . . . 0.0 111.118 -178.405 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' D' D ' 122' ' ' LYS . . . . . . . . . . . . . 63.1 mtpt -141.96 148.73 39.09 Favored 'General case' 0 C--N 1.331 -0.219 0 CA-C-O 121.079 0.466 . . . . 0.0 111.607 -176.611 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' D' D ' 123' ' ' VAL . . . . . . . . . . . . . 43.9 t -131.53 125.9 57.1 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.252 0 CA-C-N 115.854 -0.612 . . . . 0.0 109.512 174.565 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' D' D ' 124' ' ' LEU . . . . . . . . . . . . . 49.7 mt -122.79 137.46 54.92 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-O 120.74 0.305 . . . . 0.0 110.697 -178.157 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' D' D ' 125' ' ' VAL . . . . . . . . . . . . . 34.8 m -129.69 130.1 66.69 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.25 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.789 179.735 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' D' D ' 126' ' ' ARG . . . . . . . . . . . . . 83.0 mtt180 -144.94 118.96 9.37 Favored 'General case' 0 C--N 1.328 -0.348 0 N-CA-C 109.56 -0.533 . . . . 0.0 109.56 177.164 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' D' D ' 127' ' ' ASN . . . . . . . . . . . . . 30.8 m120 56.73 -149.05 0.47 Allowed 'General case' 0 CA--C 1.54 0.596 0 N-CA-C 109.648 -0.501 . . . . 0.0 109.648 -178.229 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' D' D ' 128' ' ' ASP . . . . . . . . . . . . . 23.3 p-10 -82.41 12.96 3.92 Favored 'General case' 0 CA--C 1.536 0.429 0 CA-C-N 118.773 0.715 . . . . 0.0 112.88 178.364 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' D' D ' 129' ' ' LEU . . . . . . . . . . . . . 16.1 tp -108.64 134.98 50.64 Favored 'General case' 0 C--O 1.233 0.196 0 CA-C-N 118.261 0.482 . . . . 0.0 110.088 178.637 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' D' D ' 130' ' ' VAL . . . . . . . . . . . . . 44.0 t -126.26 141.36 46.05 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.303 0 CA-C-O 120.929 0.395 . . . . 0.0 110.623 -177.539 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' D' D ' 131' ' ' VAL . . . . . . . . . . . . . 42.6 t -133.63 133.99 56.8 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.305 0 CA-C-N 116.049 -0.523 . . . . 0.0 110.126 177.994 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' D' D ' 132' ' ' ILE . . . . . . . . . . . . . 65.8 mt -118.41 134.0 63.42 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.343 0 N-CA-C 109.364 -0.606 . . . . 0.0 109.364 178.834 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' D' D ' 133' ' ' ILE . . . . . . . . . . . . . 37.6 mm -117.14 123.56 71.96 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.254 0 CA-C-O 120.619 0.247 . . . . 0.0 111.122 -174.367 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' D' D ' 134' ' ' ASP . . . . . . . . . . . . . 9.8 p-10 -135.82 147.62 48.36 Favored 'General case' 0 C--N 1.331 -0.202 0 N-CA-C 109.537 -0.542 . . . . 0.0 109.537 173.295 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' D' D ' 135' ' ' GLU . . . . . . . . . . . . . 85.2 tt0 -49.9 -27.7 5.58 Favored 'General case' 0 C--N 1.328 -0.356 0 N-CA-C 112.89 0.7 . . . . 0.0 112.89 -170.184 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' D' D ' 136' ' ' GLN . . . . . . . . . . . . . 98.0 mt-30 -82.21 -40.03 22.26 Favored 'General case' 0 C--O 1.235 0.297 0 N-CA-C 112.185 0.439 . . . . 0.0 112.185 -176.92 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' D' D ' 137' ' ' LYS . . . . . . . . . . . . . 56.6 pttt -156.73 167.04 31.66 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-O 121.523 0.678 . . . . 0.0 112.294 -169.745 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' D' D ' 138' ' ' LEU . . . . . . . . . . . . . 6.0 tt -116.24 127.74 55.01 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 115.06 -0.973 . . . . 0.0 109.664 178.156 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' D' D ' 139' ' ' THR . . . . . . . . . . . . . 29.0 m -106.71 126.62 52.52 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-N 116.281 -0.418 . . . . 0.0 110.712 -178.313 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' D' D ' 140' ' ' LEU . . . . . . . . . . . . . 21.1 tp -111.51 122.83 48.86 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 115.664 -0.698 . . . . 0.0 109.191 179.553 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' D' D ' 141' ' ' ILE . . . . . . . . . . . . . 19.5 mt -121.16 118.89 57.61 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.279 0 N-CA-C 109.87 -0.419 . . . . 0.0 109.87 -174.664 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' D' D ' 142' ' ' ARG . . . . . . . . . . . . . 48.5 mtm180 -109.0 127.97 54.55 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 115.481 -0.781 . . . . 0.0 110.098 -178.527 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' D' D ' 143' ' ' THR . . . . . . . . . . . . . 6.9 p . . . . . 0 C--O 1.22 -0.497 0 CA-C-O 117.989 -1.005 . . . . 0.0 110.61 -179.472 . . . . . . . . 0 0 . 1 . 008 nuclear orig core ' E' E ' 2' ' ' SER . . . . . . . . . . . . . 2.9 p . . . . . 0 C--O 1.231 0.107 0 CA-C-O 120.99 0.424 . . . . 0.0 110.449 . . . . . . . . . 0 0 . 1 . 008 nuclear orig core ' E' E ' 3' ' ' GLU . . . . . . . . . . . . . 84.7 tt0 -141.99 141.59 32.88 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.089 -0.505 . . . . 0.0 111.06 -179.302 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' E' E ' 4' ' ' LEU . . . . . . . . . . . . . 17.0 tp -126.12 126.86 44.85 Favored 'General case' 0 C--N 1.332 -0.195 0 CA-C-N 116.136 -0.483 . . . . 0.0 110.257 177.664 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' E' E ' 5' ' ' LYS . . . . . . . . . . . . . 61.6 mttp -107.06 121.39 44.39 Favored 'General case' 0 C--O 1.235 0.319 0 CA-C-N 116.251 -0.431 . . . . 0.0 110.7 178.5 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' E' E ' 6' ' ' LEU . . . . . . . . . . . . . 72.6 mt -116.84 146.25 43.02 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 115.326 -0.852 . . . . 0.0 110.46 -178.784 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' E' E ' 7' ' ' LYS . . . . . . . . . . . . . 55.6 tttm -135.24 139.75 32.55 Favored Pre-proline 0 CA--C 1.534 0.351 0 CA-C-O 119.135 -0.459 . . . . 0.0 110.361 176.927 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' E' E ' 8' ' ' PRO . . . . . . . . . . . . . 84.7 Cg_endo -91.85 139.46 2.19 Favored 'Trans proline' 0 N--CA 1.489 1.262 0 C-N-CA 121.694 1.596 . . . . 0.0 111.632 176.602 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' E' E ' 9' ' ' LEU . . . . . . . . . . . . . 38.7 mt -76.03 -48.4 3.52 Favored Pre-proline 0 CA--C 1.534 0.363 0 CA-C-O 118.631 -0.7 . . . . 0.0 112.569 -178.036 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' E' E ' 10' ' ' PRO . . . . . . . . . . . . . 91.3 Cg_endo -80.06 157.13 23.49 Favored 'Trans proline' 0 N--CA 1.497 1.723 0 C-N-CA 121.315 1.343 . . . . 0.0 111.912 178.126 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' E' E ' 11' ' ' LYS . . . . . . . . . . . . . 17.4 pttp -83.17 112.54 19.93 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-O 121.55 0.691 . . . . 0.0 110.428 176.84 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' E' E ' 12' ' ' VAL . . . . . . . . . . . . . 12.5 p -151.13 151.19 12.65 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.248 0 CA-C-N 115.629 -0.714 . . . . 0.0 110.58 -178.769 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' E' E ' 13' ' ' GLU . . . . . . . . . . . . . 96.5 mt-10 -97.71 121.68 39.9 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.3 -0.409 . . . . 0.0 110.351 177.679 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' E' E ' 14' ' ' LEU . . . . . . . . . . . . . 39.4 mt -98.45 137.65 20.72 Favored Pre-proline 0 CA--C 1.534 0.351 0 CA-C-O 118.808 -0.615 . . . . 0.0 110.213 -179.377 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' E' E ' 15' ' ' PRO . . . . . . . . . . . . . 25.3 Cg_exo -62.59 162.24 25.25 Favored 'Trans proline' 0 N--CA 1.498 1.765 0 C-N-CA 121.299 1.333 . . . . 0.0 112.013 176.942 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' E' E ' 16' ' ' PRO . . . . . . . . . . . . . 28.1 Cg_exo -59.95 -32.71 95.48 Favored 'Trans proline' 0 N--CA 1.497 1.691 0 C-N-CA 121.568 1.512 . . . . 0.0 112.931 -178.219 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' E' E ' 17' ' ' ASP . . . . . . . . . . . . . 10.1 p-10 -81.52 -3.93 54.54 Favored 'General case' 0 CA--C 1.535 0.383 0 N-CA-C 113.357 0.873 . . . . 0.0 113.357 -177.451 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' E' E ' 18' ' ' PHE . . . . . . . . . . . . . 30.0 t80 -56.62 -44.49 81.24 Favored 'General case' 0 C--N 1.334 -0.09 0 O-C-N 121.885 -0.509 . . . . 0.0 110.242 -179.182 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' E' E ' 19' ' ' VAL . . . . . . . . . . . . . 14.4 p -57.38 -40.67 75.66 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.329 0 CA-C-N 116.346 -0.388 . . . . 0.0 110.698 -179.707 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' E' E ' 20' ' ' ASP . . . . . . . . . . . . . 8.2 t70 -60.33 -42.74 96.29 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-O 120.921 0.391 . . . . 0.0 110.781 -177.827 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' E' E ' 21' ' ' VAL . . . . . . . . . . . . . 46.4 t -64.46 -47.33 89.78 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.297 0 CA-C-N 116.331 -0.395 . . . . 0.0 110.476 -177.751 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' E' E ' 22' ' ' ILE . . . . . . . . . . . . . 49.1 mm -57.5 -42.04 80.11 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.362 0 C-N-CA 120.934 -0.306 . . . . 0.0 110.673 -179.633 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' E' E ' 23' ' ' ARG . . . . . . . . . . . . . 61.9 ttp180 -54.8 -51.09 66.87 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-O 120.981 0.42 . . . . 0.0 110.9 178.935 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' E' E ' 24' ' ' ILE . . . . . . . . . . . . . 73.0 mt -60.85 -41.64 89.47 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.355 0 CA-C-N 115.92 -0.582 . . . . 0.0 111.764 -176.564 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' E' E ' 25' ' ' LYS . . . . . . . . . . . . . 15.1 ptpt -70.39 -39.64 74.4 Favored 'General case' 0 CA--C 1.535 0.373 0 N-CA-C 112.174 0.435 . . . . 0.0 112.174 -174.804 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' E' E ' 26' ' ' LEU . . . . . . . . . . . . . 15.4 mt -78.87 -39.27 35.61 Favored 'General case' 0 C--N 1.33 -0.278 0 N-CA-C 113.268 0.84 . . . . 0.0 113.268 -171.291 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' E' E ' 27' ' ' GLN . . . . . . . . . . . . . 10.5 pt20 -47.0 135.69 9.21 Favored 'General case' 0 N--CA 1.469 0.499 0 N-CA-C 112.763 0.653 . . . . 0.0 112.763 -175.13 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' E' E ' 28' ' ' GLY . . . . . . . . . . . . . . . 101.05 -24.02 33.44 Favored Glycine 0 CA--C 1.534 1.259 0 CA-C-N 115.606 -0.725 . . . . 0.0 112.378 -176.784 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' E' E ' 29' ' ' LYS . . . . . . . . . . . . . 91.8 mttt -98.82 155.17 17.51 Favored 'General case' 0 C--O 1.233 0.208 0 CA-C-N 117.443 0.622 . . . . 0.0 111.311 179.534 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' E' E ' 30' ' ' THR . . . . . . . . . . . . . 28.8 m -109.39 138.57 45.55 Favored 'General case' 0 C--N 1.331 -0.209 0 CA-C-N 116.27 -0.423 . . . . 0.0 110.005 175.841 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' E' E ' 31' ' ' VAL . . . . . . . . . . . . . 34.5 m -132.13 160.92 42.16 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.22 0 CA-C-N 116.392 -0.367 . . . . 0.0 110.857 -178.95 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' E' E ' 32' ' ' ARG . . . . . . . . . . . . . 63.5 mtt85 -130.44 149.04 52.3 Favored 'General case' 0 C--N 1.332 -0.19 0 CA-C-O 121.199 0.523 . . . . 0.0 110.667 177.303 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' E' E ' 33' ' ' THR . . . . . . . . . . . . . 31.5 m -53.59 141.38 25.91 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.129 -0.487 . . . . 0.0 111.259 -179.581 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' E' E ' 34' ' ' GLY . . . . . . . . . . . . . . . 99.28 -17.16 58.27 Favored Glycine 0 CA--C 1.533 1.2 0 CA-C-O 119.643 -0.532 . . . . 0.0 113.156 179.874 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' E' E ' 35' ' ' ASP . . . . . . . . . . . . . 78.8 m-20 -66.5 147.72 52.9 Favored 'General case' 0 C--O 1.232 0.145 0 CA-C-N 118.026 0.913 . . . . 0.0 110.999 178.163 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' E' E ' 36' ' ' VAL . . . . . . . . . . . . . 46.9 t -119.85 129.78 74.99 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.212 0 CA-C-N 115.829 -0.623 . . . . 0.0 109.829 178.611 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' E' E ' 37' ' ' ILE . . . . . . . . . . . . . 66.7 mt -120.13 138.18 51.55 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.269 0 N-CA-C 109.748 -0.464 . . . . 0.0 109.748 179.833 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' E' E ' 38' ' ' GLY . . . . . . . . . . . . . . . -113.77 128.78 8.46 Favored Glycine 0 CA--C 1.524 0.624 0 N-CA-C 111.389 -0.684 . . . . 0.0 111.389 -179.024 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' E' E ' 39' ' ' ILE . . . . . . . . . . . . . 71.2 mt -122.51 126.74 74.52 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.24 0 N-CA-C 109.747 -0.464 . . . . 0.0 109.747 177.336 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' E' E ' 40' ' ' SER . . . . . . . . . . . . . 43.1 t -92.16 119.51 31.88 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.442 -0.344 . . . . 0.0 110.786 177.162 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' E' E ' 41' ' ' ILE . . . . . . . . . . . . . 71.8 mt -131.47 123.9 53.55 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.225 0 N-CA-C 110.052 -0.351 . . . . 0.0 110.052 178.594 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' E' E ' 42' ' ' LEU . . . . . . . . . . . . . 82.6 mt 57.8 33.74 23.58 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.2 -0.455 . . . . 0.0 111.87 178.485 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' E' E ' 43' ' ' GLY . . . . . . . . . . . . . . . 77.87 -10.15 27.25 Favored Glycine 0 CA--C 1.535 1.306 0 C-N-CA 121.274 -0.489 . . . . 0.0 113.431 177.79 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' E' E ' 44' ' ' LYS . . . . . . . . . . . . . 62.8 tttm -98.78 127.24 44.65 Favored 'General case' 0 C--O 1.232 0.138 0 CA-C-N 117.808 0.804 . . . . 0.0 109.696 176.723 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' E' E ' 45' ' ' GLU . . . . . . . . . . . . . 39.2 tp10 -84.76 126.84 33.77 Favored 'General case' 0 C--N 1.328 -0.336 0 C-N-CA 120.811 -0.356 . . . . 0.0 110.662 -179.935 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' E' E ' 46' ' ' VAL . . . . . . . . . . . . . 7.6 p -117.09 128.71 74.41 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.199 0 N-CA-C 109.368 -0.604 . . . . 0.0 109.368 176.585 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' E' E ' 47' ' ' LYS . . . . . . . . . . . . . 64.6 mttp -100.32 129.35 46.29 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 115.884 -0.598 . . . . 0.0 111.142 179.052 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' E' E ' 48' ' ' PHE . . . . . . . . . . . . . 93.5 m-85 -112.19 131.86 55.23 Favored 'General case' 0 C--N 1.33 -0.27 0 N-CA-C 109.604 -0.517 . . . . 0.0 109.604 175.889 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' E' E ' 49' ' ' LYS . . . . . . . . . . . . . 52.5 tttp -108.05 135.46 49.37 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 116.434 -0.348 . . . . 0.0 110.332 179.244 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' E' E ' 50' ' ' VAL . . . . . . . . . . . . . 46.2 t -78.43 106.53 9.29 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.281 0 N-CA-C 108.954 -0.758 . . . . 0.0 108.954 175.317 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' E' E ' 51' ' ' VAL . . . . . . . . . . . . . 51.5 t -71.74 -47.05 58.89 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.319 0 CA-C-N 116.18 -0.464 . . . . 0.0 110.106 -172.98 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' E' E ' 52' ' ' GLN . . . . . . . . . . . . . 46.9 tt0 -163.5 136.86 5.6 Favored 'General case' 0 C--N 1.329 -0.297 0 C-N-CA 120.175 -0.61 . . . . 0.0 111.834 -178.281 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' E' E ' 53' ' ' ALA . . . . . . . . . . . . . . . -113.01 134.36 54.55 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 115.721 -0.672 . . . . 0.0 109.699 174.566 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' E' E ' 54' ' ' TYR . . . . . . . . . . . . . 24.8 t80 -129.03 111.28 18.4 Favored Pre-proline 0 CA--C 1.536 0.419 0 CA-C-O 118.17 -0.919 . . . . 0.0 110.555 -179.889 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' E' E ' 55' ' ' PRO . . . . . . . . . . . . . 73.6 Cg_endo -77.08 168.8 76.03 Favored 'Cis proline' 0 N--CA 1.501 1.946 0 CA-C-N 121.899 1.714 . . . . 0.0 112.068 -7.245 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' E' E ' 56' ' ' SER . . . . . . . . . . . . . 27.0 m -115.04 131.27 23.61 Favored Pre-proline 0 CA--C 1.539 0.525 0 CA-C-O 118.456 -0.783 . . . . 0.0 109.533 176.24 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' E' E ' 57' ' ' PRO . . . . . . . . . . . . . 36.5 Cg_endo -66.6 164.17 68.67 Favored 'Cis proline' 0 N--CA 1.496 1.671 0 CA-C-N 121.957 1.734 . . . . 0.0 111.503 -1.501 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' E' E ' 58' ' ' LEU . . . . . . . . . . . . . 28.7 tp -129.45 135.47 48.7 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.436 -0.347 . . . . 0.0 110.623 -179.693 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' E' E ' 59' ' ' ARG . . . . . . . . . . . . . 73.5 ttt-85 -103.21 127.2 50.59 Favored 'General case' 0 C--N 1.327 -0.4 0 N-CA-C 109.028 -0.73 . . . . 0.0 109.028 175.504 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' E' E ' 60' ' ' VAL . . . . . . . . . . . . . 40.1 t -87.41 124.39 40.75 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.305 0 C-N-CA 120.767 -0.373 . . . . 0.0 110.878 -173.071 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' E' E ' 61' ' ' GLU . . . . . . . . . . . . . 40.6 mt-10 -131.01 166.52 20.82 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.01 -0.541 . . . . 0.0 109.703 176.002 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' E' E ' 62' ' ' ASP . . . . . . . . . . . . . 5.5 t70 -53.57 -32.92 52.87 Favored 'General case' 0 C--N 1.329 -0.318 0 N-CA-C 111.746 0.276 . . . . 0.0 111.746 -179.166 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' E' E ' 63' ' ' ARG . . . . . . . . . . . . . 35.2 mmt180 -73.51 -19.07 61.02 Favored 'General case' 0 N--CA 1.465 0.318 0 N-CA-C 113.023 0.749 . . . . 0.0 113.023 -176.863 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' E' E ' 64' ' ' THR . . . . . . . . . . . . . 25.0 m -66.23 141.9 57.89 Favored 'General case' 0 C--N 1.331 -0.2 0 CA-C-O 120.862 0.363 . . . . 0.0 110.876 -174.935 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' E' E ' 65' ' ' LYS . . . . . . . . . . . . . 92.1 mttt -87.83 128.71 35.34 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 115.995 -0.548 . . . . 0.0 109.893 178.285 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' E' E ' 66' ' ' ILE . . . . . . . . . . . . . 51.7 mt -116.18 131.24 69.27 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 N-CA-C 110.036 -0.357 . . . . 0.0 110.036 179.82 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' E' E ' 67' ' ' THR . . . . . . . . . . . . . 22.5 m -127.26 135.82 51.13 Favored 'General case' 0 C--N 1.332 -0.157 0 CA-C-O 121.036 0.446 . . . . 0.0 110.948 -179.89 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' E' E ' 68' ' ' LEU . . . . . . . . . . . . . 32.8 mt . . . . . 0 C--N 1.329 -0.283 0 CA-C-N 115.938 -0.574 . . . . 0.0 110.337 176.918 . . . . . . . . 0 0 . 1 . 008 nuclear orig core ' E' E ' 73' ' ' VAL . . . . . . . . . . . . . 33.5 m . . . . . 0 N--CA 1.465 0.281 0 CA-C-O 121.019 0.438 . . . . 0.0 110.784 . . . . . . . . . 0 0 . 1 . 008 nuclear orig core ' E' E ' 74' ' ' ASP . . . . . . . . . . . . . 5.0 t70 -100.13 120.12 39.38 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 115.859 -0.609 . . . . 0.0 109.795 -178.613 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' E' E ' 75' ' ' VAL . . . . . . . . . . . . . 44.0 t -119.75 126.4 75.27 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.246 0 CA-C-O 121.014 0.435 . . . . 0.0 110.749 -176.262 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' E' E ' 76' ' ' LEU . . . . . . . . . . . . . 5.9 mp -124.03 149.65 45.83 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 115.671 -0.695 . . . . 0.0 109.683 175.503 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' E' E ' 77' ' ' GLU . . . . . . . . . . . . . 96.2 mt-10 -136.01 131.54 35.14 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-O 121.022 0.439 . . . . 0.0 110.989 -178.646 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' E' E ' 78' ' ' ALA . . . . . . . . . . . . . . . -115.12 140.8 48.77 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 115.71 -0.677 . . . . 0.0 109.822 177.367 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' E' E ' 79' ' ' LYS . . . . . . . . . . . . . 69.4 mttm -87.99 116.73 26.36 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-O 120.846 0.355 . . . . 0.0 111.223 -176.442 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' E' E ' 80' ' ' ILE . . . . . . . . . . . . . 40.1 mm -139.19 102.32 1.69 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.312 0 N-CA-C 109.074 -0.713 . . . . 0.0 109.074 179.438 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' E' E ' 81' ' ' LYS . . . . . . . . . . . . . 41.0 tttp -91.3 126.15 36.29 Favored 'General case' 0 C--N 1.328 -0.351 0 C-N-CA 120.695 -0.402 . . . . 0.0 110.892 -177.171 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' E' E ' 82' ' ' GLY . . . . . . . . . . . . . . . 89.12 42.08 5.69 Favored Glycine 0 CA--C 1.524 0.629 0 C-N-CA 120.885 -0.674 . . . . 0.0 111.721 176.038 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' E' E ' 83' ' ' ILE . . . . . . . . . . . . . 72.6 mt -69.61 137.95 23.12 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.37 0 N-CA-C 109.711 -0.478 . . . . 0.0 109.711 177.027 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' E' E ' 84' ' ' LYS . . . . . . . . . . . . . 38.9 ttpt -100.87 -49.27 4.19 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-O 120.752 0.31 . . . . 0.0 110.234 -179.378 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' E' E ' 85' ' ' ASP . . . . . . . . . . . . . 9.0 t70 -151.85 154.06 35.42 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.243 -0.435 . . . . 0.0 110.7 -178.771 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' E' E ' 86' ' ' VAL . . . . . . . . . . . . . 44.6 t -132.57 136.36 56.14 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.22 0 CA-C-O 121.003 0.43 . . . . 0.0 110.392 -179.812 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' E' E ' 87' ' ' ILE . . . . . . . . . . . . . 47.4 mm -122.74 128.14 75.15 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.289 0 CA-C-N 115.71 -0.677 . . . . 0.0 109.674 178.919 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' E' E ' 88' ' ' LEU . . . . . . . . . . . . . 70.3 mt -111.99 136.52 51.22 Favored 'General case' 0 C--N 1.332 -0.185 0 CA-C-O 121.094 0.473 . . . . 0.0 111.396 -177.759 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' E' E ' 89' ' ' ASP . . . . . . . . . . . . . 9.5 t70 -127.2 154.87 44.28 Favored 'General case' 0 C--N 1.33 -0.274 0 N-CA-C 109.067 -0.716 . . . . 0.0 109.067 175.576 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' E' E ' 90' ' ' GLU . . . . . . . . . . . . . 82.9 tt0 -48.04 -34.32 9.34 Favored 'General case' 0 C--N 1.331 -0.235 0 N-CA-C 112.933 0.716 . . . . 0.0 112.933 -171.74 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' E' E ' 91' ' ' ASN . . . . . . . . . . . . . 13.6 p30 -131.99 18.25 4.59 Favored 'General case' 0 N--CA 1.468 0.454 0 N-CA-C 113.207 0.818 . . . . 0.0 113.207 -177.717 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' E' E ' 92' ' ' LEU . . . . . . . . . . . . . 25.3 mt -146.98 151.08 36.39 Favored 'General case' 0 C--N 1.332 -0.175 0 CA-C-N 117.861 0.301 . . . . 0.0 110.404 -177.069 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' E' E ' 93' ' ' ILE . . . . . . . . . . . . . 67.1 mt -127.1 121.73 58.49 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.213 0 N-CA-C 109.43 -0.582 . . . . 0.0 109.43 178.189 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' E' E ' 94' ' ' VAL . . . . . . . . . . . . . 45.9 t -120.62 129.91 75.1 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.291 0 CA-C-O 120.889 0.376 . . . . 0.0 110.013 -179.816 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' E' E ' 95' ' ' VAL . . . . . . . . . . . . . 44.3 t -122.7 136.0 60.94 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 CA-C-N 116.015 -0.539 . . . . 0.0 109.867 -179.562 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' E' E ' 96' ' ' ILE . . . . . . . . . . . . . 63.1 mt -118.26 127.18 75.41 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.232 0 N-CA-C 109.402 -0.592 . . . . 0.0 109.402 178.896 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' E' E ' 97' ' ' THR . . . . . . . . . . . . . 77.8 p -100.75 158.52 15.9 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-O 121.083 0.468 . . . . 0.0 111.106 -177.464 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' E' E ' 98' ' ' GLU . . . . . . . . . . . . . 47.1 tp10 -53.85 -26.32 23.93 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.279 -0.419 . . . . 0.0 112.105 -179.861 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' E' E ' 99' ' ' GLU . . . . . . . . . . . . . 96.0 mt-10 -76.1 11.61 1.42 Allowed 'General case' 0 CA--C 1.535 0.381 0 N-CA-C 113.404 0.89 . . . . 0.0 113.404 -177.204 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' E' E ' 100' ' ' ASN . . . . . . . . . . . . . 4.0 m-20 63.42 37.67 10.55 Favored 'General case' 0 CA--C 1.529 0.156 0 CA-C-O 121.143 0.497 . . . . 0.0 111.023 179.792 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' E' E ' 101' ' ' GLU . . . . . . . . . . . . . 85.0 tt0 -114.97 140.07 49.32 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.025 -0.534 . . . . 0.0 109.6 175.559 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' E' E ' 102' ' ' VAL . . . . . . . . . . . . . 47.5 t -114.88 126.1 72.37 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.243 0 N-CA-C 109.795 -0.446 . . . . 0.0 109.795 -178.508 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' E' E ' 103' ' ' LEU . . . . . . . . . . . . . 45.7 mt -119.15 133.15 55.95 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 115.768 -0.651 . . . . 0.0 110.483 178.233 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' E' E ' 104' ' ' ILE . . . . . . . . . . . . . 69.4 mt -119.0 122.42 69.28 Favored 'Isoleucine or valine' 0 C--O 1.235 0.296 0 CA-C-N 116.399 -0.364 . . . . 0.0 110.41 -179.618 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' E' E ' 105' ' ' PHE . . . . . . . . . . . . . 61.9 m-85 -121.72 167.1 13.34 Favored 'General case' 0 C--N 1.333 -0.142 0 O-C-N 124.013 0.821 . . . . 0.0 109.498 178.208 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' E' E ' 106' ' ' ASN . . . . . . . . . . . . . 46.3 p-10 -101.05 -170.36 1.83 Allowed 'General case' 0 C--N 1.33 -0.261 0 N-CA-C 109.95 -0.389 . . . . 0.0 109.95 172.99 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' E' E ' 107' ' ' GLN . . . . . . . . . . . . . 58.6 tt0 -58.99 -29.82 67.5 Favored 'General case' 0 C--N 1.328 -0.327 0 N-CA-C 111.902 0.334 . . . . 0.0 111.902 -179.998 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' E' E ' 108' ' ' ASN . . . . . . . . . . . . . 51.3 t30 -84.77 11.32 9.35 Favored 'General case' 0 CA--C 1.535 0.4 0 N-CA-C 112.838 0.681 . . . . 0.0 112.838 -177.307 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' E' E ' 109' ' ' LEU . . . . . . . . . . . . . 17.8 mt 57.58 36.46 26.82 Favored 'General case' 0 CA--C 1.53 0.185 0 CA-C-O 120.898 0.38 . . . . 0.0 111.342 178.63 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' E' E ' 110' ' ' GLU . . . . . . . . . . . . . 70.4 mm-40 -101.87 138.18 39.18 Favored 'General case' 0 C--N 1.33 -0.281 0 N-CA-C 109.172 -0.677 . . . . 0.0 109.172 174.909 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' E' E ' 111' ' ' GLU . . . . . . . . . . . . . 73.1 tt0 -82.55 121.81 27.27 Favored 'General case' 0 C--N 1.33 -0.28 0 C-N-CA 120.665 -0.414 . . . . 0.0 110.029 -176.655 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' E' E ' 112' ' ' LEU . . . . . . . . . . . . . 22.5 mt -108.95 -44.76 3.92 Favored 'General case' 0 C--N 1.332 -0.195 0 CA-C-N 116.129 -0.487 . . . . 0.0 110.789 -177.655 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' E' E ' 113' ' ' TYR . . . . . . . . . . . . . 50.9 t80 -132.91 137.07 46.51 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.365 -0.38 . . . . 0.0 110.911 -177.739 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' E' E ' 114' ' ' ARG . . . . . . . . . . . . . 16.3 ptm180 -143.31 126.95 17.0 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-O 121.034 0.445 . . . . 0.0 110.664 176.57 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' E' E ' 115' ' ' GLY . . . . . . . . . . . . . . . -150.11 140.27 7.9 Favored Glycine 0 CA--C 1.524 0.64 0 N-CA-C 111.147 -0.781 . . . . 0.0 111.147 178.599 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' E' E ' 116' ' ' LYS . . . . . . . . . . . . . 39.6 ttpt -104.89 128.98 53.33 Favored 'General case' 0 C--N 1.33 -0.269 0 N-CA-C 109.721 -0.474 . . . . 0.0 109.721 175.67 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' E' E ' 117' ' ' PHE . . . . . . . . . . . . . 69.8 m-85 -125.68 114.96 19.36 Favored 'General case' 0 C--N 1.331 -0.22 0 CA-C-O 121.019 0.438 . . . . 0.0 110.129 -177.268 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' E' E ' 118' ' ' GLU . . . . . . . . . . . . . 96.0 mt-10 -54.55 -41.35 69.68 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.462 -0.336 . . . . 0.0 111.265 -175.825 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' E' E ' 119' ' ' ASN . . . . . . . . . . . . . 69.9 m-80 -104.07 31.07 4.76 Favored 'General case' 0 C--O 1.234 0.246 0 CA-C-N 116.229 -0.441 . . . . 0.0 112.111 -173.92 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' E' E ' 120' ' ' LEU . . . . . . . . . . . . . 11.7 tp -56.24 120.05 6.95 Favored 'General case' 0 N--CA 1.462 0.147 0 CA-C-O 120.715 0.293 . . . . 0.0 110.311 178.884 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' E' E ' 121' ' ' ASN . . . . . . . . . . . . . 45.7 m-80 -114.34 -44.03 3.15 Favored 'General case' 0 C--O 1.232 0.153 0 CA-C-N 116.385 -0.37 . . . . 0.0 111.169 -176.655 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' E' E ' 122' ' ' LYS . . . . . . . . . . . . . 97.8 mttt -142.59 147.62 36.16 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-O 121.021 0.439 . . . . 0.0 111.596 -175.915 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' E' E ' 123' ' ' VAL . . . . . . . . . . . . . 44.1 t -127.09 129.16 71.07 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.275 0 N-CA-C 109.278 -0.638 . . . . 0.0 109.278 174.126 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' E' E ' 124' ' ' LEU . . . . . . . . . . . . . 38.1 mt -129.52 137.06 50.58 Favored 'General case' 0 C--N 1.331 -0.202 0 CA-C-O 120.838 0.352 . . . . 0.0 110.948 -178.394 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' E' E ' 125' ' ' VAL . . . . . . . . . . . . . 12.8 p -137.55 138.22 44.88 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.255 0 CA-C-N 116.282 -0.417 . . . . 0.0 110.329 177.908 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' E' E ' 126' ' ' ARG . . . . . . . . . . . . . 37.8 mtp180 -146.2 127.67 15.01 Favored 'General case' 0 C--N 1.331 -0.229 0 CA-C-O 120.954 0.406 . . . . 0.0 110.839 179.159 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' E' E ' 127' ' ' ASN . . . . . . . . . . . . . 62.1 t30 49.55 -104.93 0.15 Allowed 'General case' 0 CA--C 1.543 0.684 0 CA-C-O 118.953 -0.546 . . . . 0.0 111.826 179.157 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' E' E ' 128' ' ' ASP . . . . . . . . . . . . . 12.0 p-10 -114.19 0.61 14.28 Favored 'General case' 0 CA--C 1.537 0.445 0 CA-C-N 119.612 1.096 . . . . 0.0 113.591 -175.148 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' E' E ' 129' ' ' LEU . . . . . . . . . . . . . 84.3 mt -112.32 145.16 40.52 Favored 'General case' 0 C--N 1.333 -0.133 0 CA-C-N 118.203 0.456 . . . . 0.0 110.03 179.839 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' E' E ' 130' ' ' VAL . . . . . . . . . . . . . 12.0 p -131.95 141.93 44.26 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.175 0 CA-C-O 121.059 0.457 . . . . 0.0 110.25 179.954 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' E' E ' 131' ' ' VAL . . . . . . . . . . . . . 27.0 t -135.42 139.32 46.92 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.315 0 CA-C-N 115.961 -0.563 . . . . 0.0 110.397 -177.348 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' E' E ' 132' ' ' ILE . . . . . . . . . . . . . 74.6 mt -115.97 130.45 70.65 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.332 0 N-CA-C 109.215 -0.661 . . . . 0.0 109.215 178.582 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' E' E ' 133' ' ' ILE . . . . . . . . . . . . . 39.5 mm -116.47 123.08 71.14 Favored 'Isoleucine or valine' 0 N--CA 1.462 0.159 0 CA-C-O 120.727 0.299 . . . . 0.0 110.923 -174.662 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' E' E ' 134' ' ' ASP . . . . . . . . . . . . . 12.1 p-10 -136.47 151.71 49.76 Favored 'General case' 0 C--N 1.332 -0.173 0 N-CA-C 109.883 -0.414 . . . . 0.0 109.883 174.422 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' E' E ' 135' ' ' GLU . . . . . . . . . . . . . 41.2 tp10 -50.05 -26.42 4.35 Favored 'General case' 0 C--N 1.328 -0.343 0 N-CA-C 113.025 0.75 . . . . 0.0 113.025 -171.781 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' E' E ' 136' ' ' GLN . . . . . . . . . . . . . 47.1 tt0 -91.47 -25.11 19.46 Favored 'General case' 0 C--O 1.234 0.264 0 N-CA-C 112.977 0.732 . . . . 0.0 112.977 -173.121 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' E' E ' 137' ' ' LYS . . . . . . . . . . . . . 22.6 pttm -170.06 171.36 7.02 Favored 'General case' 0 C--O 1.232 0.148 0 CA-C-O 121.501 0.667 . . . . 0.0 112.659 -172.522 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' E' E ' 138' ' ' LEU . . . . . . . . . . . . . 5.1 tt -122.28 129.01 51.78 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 115.009 -0.996 . . . . 0.0 109.817 179.727 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' E' E ' 139' ' ' THR . . . . . . . . . . . . . 43.5 m -111.46 127.61 55.74 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.528 -0.306 . . . . 0.0 110.354 179.288 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' E' E ' 140' ' ' LEU . . . . . . . . . . . . . 11.9 tp -114.27 123.34 49.3 Favored 'General case' 0 C--N 1.33 -0.268 0 N-CA-C 109.554 -0.535 . . . . 0.0 109.554 -178.976 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' E' E ' 141' ' ' ILE . . . . . . . . . . . . . 19.6 mt -121.5 124.79 72.54 Favored 'Isoleucine or valine' 0 C--O 1.234 0.253 0 CA-C-O 120.943 0.401 . . . . 0.0 110.261 -174.648 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' E' E ' 142' ' ' ARG . . . . . . . . . . . . . 82.2 mtp180 -108.68 128.13 54.59 Favored 'General case' 0 C--N 1.331 -0.222 0 CA-C-N 115.229 -0.896 . . . . 0.0 110.181 -178.654 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' E' E ' 143' ' ' THR . . . . . . . . . . . . . 24.9 p . . . . . 0 C--O 1.221 -0.412 0 CA-C-O 117.964 -1.017 . . . . 0.0 110.52 -179.754 . . . . . . . . 0 0 . 1 . 008 nuclear orig core ' F' F ' 1' ' ' MET . . . . . . . . . . . . . 25.2 ptp . . . . . 0 CA--C 1.527 0.084 0 CA-C-O 120.725 0.298 . . . . 0.0 110.789 . . . . . . . . . 0 0 . 1 . 008 nuclear orig core ' F' F ' 2' ' ' SER . . . . . . . . . . . . . 2.5 p -131.03 125.44 33.28 Favored 'General case' 0 C--N 1.331 -0.224 0 CA-C-N 116.461 -0.336 . . . . 0.0 110.358 178.738 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' F' F ' 3' ' ' GLU . . . . . . . . . . . . . 93.9 mt-10 -139.47 139.66 37.07 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 116.144 -0.48 . . . . 0.0 111.056 -176.439 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' F' F ' 4' ' ' LEU . . . . . . . . . . . . . 20.6 tp -123.24 127.66 48.9 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 115.805 -0.634 . . . . 0.0 109.91 175.387 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' F' F ' 5' ' ' LYS . . . . . . . . . . . . . 90.9 mttt -109.76 122.25 47.07 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 116.466 -0.334 . . . . 0.0 110.829 179.891 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' F' F ' 6' ' ' LEU . . . . . . . . . . . . . 71.7 mt -116.69 147.2 42.2 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 115.551 -0.75 . . . . 0.0 110.094 179.274 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' F' F ' 7' ' ' LYS . . . . . . . . . . . . . 39.4 ttmt -137.44 142.29 36.8 Favored Pre-proline 0 CA--C 1.533 0.319 0 CA-C-O 119.298 -0.382 . . . . 0.0 110.043 175.845 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' F' F ' 8' ' ' PRO . . . . . . . . . . . . . 87.7 Cg_endo -90.51 143.89 3.75 Favored 'Trans proline' 0 N--CA 1.489 1.244 0 C-N-CA 121.761 1.641 . . . . 0.0 111.846 178.376 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' F' F ' 9' ' ' LEU . . . . . . . . . . . . . 50.4 mt -76.84 -47.97 2.81 Favored Pre-proline 0 CA--C 1.534 0.347 0 CA-C-O 118.709 -0.663 . . . . 0.0 112.27 -179.652 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' F' F ' 10' ' ' PRO . . . . . . . . . . . . . 84.5 Cg_endo -80.41 157.76 22.48 Favored 'Trans proline' 0 N--CA 1.497 1.702 0 C-N-CA 121.237 1.291 . . . . 0.0 111.967 176.561 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' F' F ' 11' ' ' LYS . . . . . . . . . . . . . 53.3 mttm -87.48 100.54 12.84 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-O 120.817 0.341 . . . . 0.0 110.539 178.049 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' F' F ' 12' ' ' VAL . . . . . . . . . . . . . 11.4 p -139.97 144.2 28.62 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.275 0 CA-C-N 116.05 -0.523 . . . . 0.0 110.071 179.281 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' F' F ' 13' ' ' GLU . . . . . . . . . . . . . 41.6 tp10 -91.01 116.67 28.97 Favored 'General case' 0 C--N 1.329 -0.325 0 N-CA-C 109.989 -0.374 . . . . 0.0 109.989 178.611 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' F' F ' 14' ' ' LEU . . . . . . . . . . . . . 23.0 mt -98.24 153.67 37.98 Favored Pre-proline 0 C--N 1.33 -0.269 0 CA-C-N 116.251 -0.431 . . . . 0.0 111.177 -176.124 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' F' F ' 15' ' ' PRO . . . . . . . . . . . . . 37.4 Cg_exo -59.7 156.88 35.11 Favored 'Trans proline' 0 N--CA 1.497 1.733 0 C-N-CA 121.332 1.355 . . . . 0.0 112.132 179.065 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' F' F ' 16' ' ' PRO . . . . . . . . . . . . . 28.1 Cg_exo -60.68 -34.34 92.17 Favored 'Trans proline' 0 N--CA 1.497 1.701 0 C-N-CA 121.404 1.403 . . . . 0.0 112.187 178.043 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' F' F ' 17' ' ' ASP . . . . . . . . . . . . . 15.1 p-10 -85.11 12.29 8.07 Favored 'General case' 0 CA--C 1.536 0.427 0 N-CA-C 113.113 0.783 . . . . 0.0 113.113 -177.939 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' F' F ' 18' ' ' PHE . . . . . . . . . . . . . 33.4 t80 -57.83 -42.36 84.2 Favored 'General case' 0 C--N 1.333 -0.115 0 O-C-N 121.988 -0.445 . . . . 0.0 110.142 -179.678 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' F' F ' 19' ' ' VAL . . . . . . . . . . . . . 49.8 t -55.89 -52.98 43.18 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.316 0 CA-C-N 116.352 -0.385 . . . . 0.0 111.102 -176.675 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' F' F ' 20' ' ' ASP . . . . . . . . . . . . . 2.5 p-10 -59.82 -36.25 76.38 Favored 'General case' 0 N--CA 1.464 0.268 0 C-N-CA 120.582 -0.447 . . . . 0.0 111.342 -176.452 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' F' F ' 21' ' ' VAL . . . . . . . . . . . . . 51.7 t -63.93 -47.13 91.96 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.239 0 C-N-CA 120.575 -0.45 . . . . 0.0 110.34 -179.853 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' F' F ' 22' ' ' ILE . . . . . . . . . . . . . 49.2 mm -55.54 -48.35 77.48 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.219 0 CA-C-O 120.736 0.303 . . . . 0.0 110.505 178.129 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' F' F ' 23' ' ' ARG . . . . . . . . . . . . . 53.2 ttp180 -54.41 -49.54 69.7 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.521 -0.309 . . . . 0.0 111.572 -177.109 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' F' F ' 24' ' ' ILE . . . . . . . . . . . . . 78.0 mt -59.16 -46.15 92.24 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.316 0 C-N-CA 120.971 -0.291 . . . . 0.0 111.166 -176.7 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' F' F ' 25' ' ' LYS . . . . . . . . . . . . . 90.8 mttt -64.76 -44.05 91.34 Favored 'General case' 0 C--N 1.33 -0.275 0 N-CA-C 112.54 0.57 . . . . 0.0 112.54 -177.25 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' F' F ' 26' ' ' LEU . . . . . . . . . . . . . 61.4 mt -83.67 -24.16 31.44 Favored 'General case' 0 C--N 1.329 -0.302 0 N-CA-C 113.467 0.914 . . . . 0.0 113.467 -171.508 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' F' F ' 27' ' ' GLN . . . . . . . . . . . . . 6.4 pt20 -46.15 136.58 6.76 Favored 'General case' 0 CA--C 1.534 0.351 0 N-CA-C 112.813 0.671 . . . . 0.0 112.813 -174.633 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' F' F ' 28' ' ' GLY . . . . . . . . . . . . . . . 100.53 -21.56 43.58 Favored Glycine 0 CA--C 1.533 1.214 0 CA-C-N 115.701 -0.681 . . . . 0.0 112.786 -178.623 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' F' F ' 29' ' ' LYS . . . . . . . . . . . . . 63.2 mttp -97.79 155.08 17.2 Favored 'General case' 0 C--N 1.331 -0.199 0 CA-C-N 117.604 0.702 . . . . 0.0 111.144 179.125 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' F' F ' 30' ' ' THR . . . . . . . . . . . . . 24.2 m -104.7 139.23 39.82 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.196 177.366 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' F' F ' 31' ' ' VAL . . . . . . . . . . . . . 34.3 m -129.33 157.45 42.1 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.19 0 CA-C-O 120.856 0.36 . . . . 0.0 110.915 -178.741 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' F' F ' 32' ' ' ARG . . . . . . . . . . . . . 93.4 mtt180 -133.74 152.33 51.85 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 115.959 -0.564 . . . . 0.0 110.779 177.934 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' F' F ' 33' ' ' THR . . . . . . . . . . . . . 28.5 m -53.31 139.97 28.33 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.133 -0.485 . . . . 0.0 111.399 -178.852 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' F' F ' 34' ' ' GLY . . . . . . . . . . . . . . . 99.21 -17.17 58.33 Favored Glycine 0 CA--C 1.532 1.118 0 C-N-CA 121.16 -0.543 . . . . 0.0 113.222 178.81 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' F' F ' 35' ' ' ASP . . . . . . . . . . . . . 76.0 m-20 -65.83 148.66 51.42 Favored 'General case' 0 C--O 1.232 0.176 0 CA-C-N 118.065 0.933 . . . . 0.0 111.188 179.092 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' F' F ' 36' ' ' VAL . . . . . . . . . . . . . 45.0 t -122.3 129.76 75.06 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.243 0 CA-C-N 115.981 -0.554 . . . . 0.0 109.874 178.468 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' F' F ' 37' ' ' ILE . . . . . . . . . . . . . 66.1 mt -119.77 138.79 49.24 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.201 0 CA-C-N 116.21 -0.45 . . . . 0.0 109.933 -179.776 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' F' F ' 38' ' ' GLY . . . . . . . . . . . . . . . -110.76 128.78 8.93 Favored Glycine 0 CA--C 1.525 0.691 0 N-CA-C 111.193 -0.763 . . . . 0.0 111.193 -179.331 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' F' F ' 39' ' ' ILE . . . . . . . . . . . . . 72.9 mt -123.85 132.69 70.96 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.216 0 N-CA-C 110.137 -0.32 . . . . 0.0 110.137 178.89 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' F' F ' 40' ' ' SER . . . . . . . . . . . . . 23.0 t -92.7 118.86 31.51 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.332 -0.394 . . . . 0.0 110.685 175.34 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' F' F ' 41' ' ' ILE . . . . . . . . . . . . . 70.5 mt -130.69 125.33 58.47 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.229 0 CA-C-O 120.884 0.374 . . . . 0.0 110.469 179.219 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' F' F ' 42' ' ' LEU . . . . . . . . . . . . . 48.3 mt 51.94 34.46 13.69 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 115.994 -0.548 . . . . 0.0 111.913 176.833 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' F' F ' 43' ' ' GLY . . . . . . . . . . . . . . . 72.92 31.36 62.18 Favored Glycine 0 CA--C 1.53 0.993 0 C-N-CA 121.076 -0.583 . . . . 0.0 112.187 177.089 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' F' F ' 44' ' ' LYS . . . . . . . . . . . . . 40.6 ttpt -138.31 130.89 29.23 Favored 'General case' 0 C--N 1.329 -0.314 0 N-CA-C 109.613 -0.514 . . . . 0.0 109.613 178.081 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' F' F ' 45' ' ' GLU . . . . . . . . . . . . . 84.6 tt0 -83.06 118.91 23.86 Favored 'General case' 0 C--N 1.328 -0.351 0 C-N-CA 120.815 -0.354 . . . . 0.0 110.847 -179.66 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' F' F ' 46' ' ' VAL . . . . . . . . . . . . . 7.6 p -119.13 126.74 75.62 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.27 0 N-CA-C 109.375 -0.602 . . . . 0.0 109.375 176.623 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' F' F ' 47' ' ' LYS . . . . . . . . . . . . . 61.0 mttm -100.12 130.61 46.28 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.033 -0.53 . . . . 0.0 111.342 177.813 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' F' F ' 48' ' ' PHE . . . . . . . . . . . . . 90.0 m-85 -111.03 131.91 54.67 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 115.969 -0.559 . . . . 0.0 109.777 175.589 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' F' F ' 49' ' ' LYS . . . . . . . . . . . . . 83.6 tttt -106.81 134.68 49.6 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 116.213 -0.448 . . . . 0.0 110.379 -179.559 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' F' F ' 50' ' ' VAL . . . . . . . . . . . . . 46.8 t -77.07 106.98 7.68 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.283 0 N-CA-C 109.142 -0.688 . . . . 0.0 109.142 176.368 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' F' F ' 51' ' ' VAL . . . . . . . . . . . . . 47.9 t -69.57 -47.95 68.76 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.325 0 CA-C-N 115.932 -0.577 . . . . 0.0 109.979 -173.278 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' F' F ' 52' ' ' GLN . . . . . . . . . . . . . 61.1 tt0 -168.22 148.39 4.8 Favored 'General case' 0 C--N 1.331 -0.22 0 C-N-CA 120.228 -0.589 . . . . 0.0 111.678 -178.838 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' F' F ' 53' ' ' ALA . . . . . . . . . . . . . . . -123.25 132.07 53.9 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 115.651 -0.704 . . . . 0.0 109.86 176.492 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' F' F ' 54' ' ' TYR . . . . . . . . . . . . . 54.3 t80 -129.04 110.11 18.27 Favored Pre-proline 0 CA--C 1.535 0.385 0 CA-C-O 118.317 -0.849 . . . . 0.0 110.166 179.92 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' F' F ' 55' ' ' PRO . . . . . . . . . . . . . 73.9 Cg_endo -77.07 170.03 72.74 Favored 'Cis proline' 0 N--CA 1.497 1.713 0 CA-C-N 121.861 1.7 . . . . 0.0 112.27 -4.661 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' F' F ' 56' ' ' SER . . . . . . . . . . . . . 13.5 m -113.93 131.91 22.91 Favored Pre-proline 0 CA--C 1.538 0.484 0 CA-C-O 118.513 -0.756 . . . . 0.0 109.326 175.652 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' F' F ' 57' ' ' PRO . . . . . . . . . . . . . 55.6 Cg_endo -71.33 166.88 76.79 Favored 'Cis proline' 0 N--CA 1.498 1.757 0 CA-C-N 121.923 1.722 . . . . 0.0 111.643 -0.321 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' F' F ' 58' ' ' LEU . . . . . . . . . . . . . 35.3 tp -129.54 137.34 50.72 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.271 -0.422 . . . . 0.0 110.152 179.491 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' F' F ' 59' ' ' ARG . . . . . . . . . . . . . 38.5 ttm180 -103.71 133.89 47.95 Favored 'General case' 0 C--N 1.327 -0.381 0 N-CA-C 109.706 -0.479 . . . . 0.0 109.706 177.836 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' F' F ' 60' ' ' VAL . . . . . . . . . . . . . 44.1 t -85.28 111.38 20.65 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.264 0 C-N-CA 120.761 -0.376 . . . . 0.0 110.36 -176.428 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' F' F ' 61' ' ' GLU . . . . . . . . . . . . . 95.5 mt-10 -131.06 165.26 23.63 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 115.835 -0.621 . . . . 0.0 109.677 176.043 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' F' F ' 62' ' ' ASP . . . . . . . . . . . . . 19.9 p-10 -53.7 -32.47 51.98 Favored 'General case' 0 C--N 1.328 -0.365 0 N-CA-C 111.85 0.315 . . . . 0.0 111.85 -179.42 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' F' F ' 63' ' ' ARG . . . . . . . . . . . . . 81.3 mtp180 -72.97 -21.93 60.78 Favored 'General case' 0 CA--C 1.533 0.299 0 N-CA-C 113.041 0.756 . . . . 0.0 113.041 -176.313 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' F' F ' 64' ' ' THR . . . . . . . . . . . . . 17.8 m -71.17 142.01 50.7 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-O 120.952 0.406 . . . . 0.0 111.09 -174.568 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' F' F ' 65' ' ' LYS . . . . . . . . . . . . . 39.7 mtpt -89.48 125.46 35.19 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 115.883 -0.599 . . . . 0.0 109.925 178.784 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' F' F ' 66' ' ' ILE . . . . . . . . . . . . . 68.1 mt -119.07 131.64 71.25 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.339 0 CA-C-O 120.874 0.368 . . . . 0.0 110.277 -178.15 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' F' F ' 67' ' ' THR . . . . . . . . . . . . . 26.1 m -123.98 136.89 54.6 Favored 'General case' 0 C--N 1.331 -0.215 0 CA-C-N 116.015 -0.539 . . . . 0.0 110.742 -179.048 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' F' F ' 68' ' ' LEU . . . . . . . . . . . . . 5.7 tt . . . . . 0 C--N 1.33 -0.25 0 CA-C-N 115.968 -0.56 . . . . 0.0 110.515 179.485 . . . . . . . . 0 0 . 1 . 008 nuclear orig core ' F' F ' 73' ' ' VAL . . . . . . . . . . . . . 35.9 m . . . . . 0 C--O 1.232 0.132 0 CA-C-O 120.837 0.351 . . . . 0.0 110.686 . . . . . . . . . 0 0 . 1 . 008 nuclear orig core ' F' F ' 74' ' ' ASP . . . . . . . . . . . . . 19.5 t0 -107.05 123.04 47.64 Favored 'General case' 0 C--N 1.328 -0.329 0 N-CA-C 109.584 -0.525 . . . . 0.0 109.584 179.156 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' F' F ' 75' ' ' VAL . . . . . . . . . . . . . 46.2 t -117.34 126.26 74.48 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.233 0 CA-C-O 121.173 0.511 . . . . 0.0 110.771 -177.43 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' F' F ' 76' ' ' LEU . . . . . . . . . . . . . 6.5 mp -122.82 143.66 49.7 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 115.463 -0.79 . . . . 0.0 109.128 174.546 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' F' F ' 77' ' ' GLU . . . . . . . . . . . . . 30.1 tt0 -135.85 140.76 44.42 Favored 'General case' 0 C--N 1.331 -0.225 0 C-N-CA 120.734 -0.386 . . . . 0.0 111.273 -174.73 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' F' F ' 78' ' ' ALA . . . . . . . . . . . . . . . -130.16 134.96 47.68 Favored 'General case' 0 C--N 1.331 -0.239 0 CA-C-N 115.933 -0.576 . . . . 0.0 110.013 176.762 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' F' F ' 79' ' ' LYS . . . . . . . . . . . . . 31.1 ttmt -82.4 125.71 31.36 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-O 120.74 0.305 . . . . 0.0 110.822 -178.607 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' F' F ' 80' ' ' ILE . . . . . . . . . . . . . 28.0 mm -139.12 114.81 8.98 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.265 0 N-CA-C 109.062 -0.718 . . . . 0.0 109.062 -177.8 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' F' F ' 81' ' ' LYS . . . . . . . . . . . . . 70.1 tttt -103.69 122.11 44.36 Favored 'General case' 0 C--N 1.328 -0.334 0 C-N-CA 121.027 -0.269 . . . . 0.0 111.116 -175.884 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' F' F ' 82' ' ' GLY . . . . . . . . . . . . . . . 89.09 42.18 5.68 Favored Glycine 0 CA--C 1.525 0.66 0 C-N-CA 120.715 -0.755 . . . . 0.0 111.892 174.789 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' F' F ' 83' ' ' ILE . . . . . . . . . . . . . 69.0 mt -65.27 136.49 26.6 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.243 0 N-CA-C 109.91 -0.404 . . . . 0.0 109.91 178.044 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' F' F ' 84' ' ' LYS . . . . . . . . . . . . . 29.0 ttmt -94.32 -51.78 4.64 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.088 -0.506 . . . . 0.0 109.93 179.482 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' F' F ' 85' ' ' ASP . . . . . . . . . . . . . 4.3 t70 -157.29 153.59 27.7 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 115.621 -0.718 . . . . 0.0 110.504 -179.659 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' F' F ' 86' ' ' VAL . . . . . . . . . . . . . 43.8 t -131.52 133.41 61.85 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.232 0 CA-C-O 120.98 0.419 . . . . 0.0 110.356 -179.181 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' F' F ' 87' ' ' ILE . . . . . . . . . . . . . 5.0 mp -120.37 126.29 75.1 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.241 0 CA-C-N 115.943 -0.572 . . . . 0.0 109.528 177.765 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' F' F ' 88' ' ' LEU . . . . . . . . . . . . . 10.7 tp -109.5 128.2 55.0 Favored 'General case' 0 C--N 1.331 -0.226 0 CA-C-O 120.902 0.382 . . . . 0.0 110.895 -177.929 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' F' F ' 89' ' ' ASP . . . . . . . . . . . . . 4.2 t0 -120.69 158.14 28.1 Favored 'General case' 0 C--N 1.329 -0.286 0 N-CA-C 109.497 -0.557 . . . . 0.0 109.497 177.441 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' F' F ' 90' ' ' GLU . . . . . . . . . . . . . 84.0 tt0 -45.12 -46.19 11.68 Favored 'General case' 0 N--CA 1.465 0.291 0 N-CA-C 112.985 0.735 . . . . 0.0 112.985 -172.484 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' F' F ' 91' ' ' ASN . . . . . . . . . . . . . 79.4 m-20 -132.05 30.84 4.22 Favored 'General case' 0 N--CA 1.465 0.29 0 N-CA-C 112.189 0.44 . . . . 0.0 112.189 -179.608 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' F' F ' 92' ' ' LEU . . . . . . . . . . . . . 7.2 mt -150.35 140.94 22.56 Favored 'General case' 0 C--N 1.331 -0.204 0 N-CA-C 109.564 -0.532 . . . . 0.0 109.564 -178.088 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' F' F ' 93' ' ' ILE . . . . . . . . . . . . . 73.5 mt -124.01 119.45 56.87 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.289 0 N-CA-C 109.338 -0.616 . . . . 0.0 109.338 178.997 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' F' F ' 94' ' ' VAL . . . . . . . . . . . . . 44.0 t -119.55 126.59 75.46 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.198 0 CA-C-O 120.892 0.377 . . . . 0.0 109.998 -179.648 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' F' F ' 95' ' ' VAL . . . . . . . . . . . . . 44.1 t -121.58 133.14 69.01 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.298 0 CA-C-N 116.101 -0.5 . . . . 0.0 109.738 179.623 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' F' F ' 96' ' ' ILE . . . . . . . . . . . . . 64.3 mt -114.26 126.15 71.71 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.326 0 N-CA-C 109.234 -0.654 . . . . 0.0 109.234 178.88 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' F' F ' 97' ' ' THR . . . . . . . . . . . . . 64.6 p -98.62 154.8 17.67 Favored 'General case' 0 C--N 1.327 -0.385 0 CA-C-O 121.109 0.48 . . . . 0.0 110.952 -178.311 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' F' F ' 98' ' ' GLU . . . . . . . . . . . . . 83.4 tt0 -53.89 -23.5 12.91 Favored 'General case' 0 CA--C 1.535 0.371 0 N-CA-C 112.419 0.525 . . . . 0.0 112.419 179.966 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' F' F ' 99' ' ' GLU . . . . . . . . . . . . . 13.8 mm-40 -77.54 13.92 1.14 Allowed 'General case' 0 CA--C 1.536 0.431 0 N-CA-C 113.272 0.841 . . . . 0.0 113.272 -178.444 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' F' F ' 100' ' ' ASN . . . . . . . . . . . . . 2.2 m-20 63.65 37.73 9.95 Favored 'General case' 0 N--CA 1.463 0.212 0 CA-C-O 121.111 0.481 . . . . 0.0 110.948 178.322 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' F' F ' 101' ' ' GLU . . . . . . . . . . . . . 84.9 tt0 -120.09 140.93 50.3 Favored 'General case' 0 C--N 1.333 -0.151 0 CA-C-N 116.203 -0.453 . . . . 0.0 109.853 176.68 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' F' F ' 102' ' ' VAL . . . . . . . . . . . . . 43.2 t -115.03 126.74 72.7 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 CA-C-N 116.197 -0.456 . . . . 0.0 109.881 -178.32 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' F' F ' 103' ' ' LEU . . . . . . . . . . . . . 6.2 mp -117.29 134.89 54.27 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 115.994 -0.548 . . . . 0.0 110.294 177.784 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' F' F ' 104' ' ' ILE . . . . . . . . . . . . . 66.3 mt -119.0 122.22 68.78 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.218 0 CA-C-N 116.422 -0.354 . . . . 0.0 110.217 -179.147 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' F' F ' 105' ' ' PHE . . . . . . . . . . . . . 79.3 m-85 -120.54 161.46 21.27 Favored 'General case' 0 C--N 1.331 -0.235 0 O-C-N 124.046 0.841 . . . . 0.0 109.987 179.614 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' F' F ' 106' ' ' ASN . . . . . . . . . . . . . 46.8 p-10 -97.4 -169.85 1.92 Allowed 'General case' 0 CA--C 1.531 0.228 0 N-CA-C 110.19 -0.3 . . . . 0.0 110.19 175.559 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' F' F ' 107' ' ' GLN . . . . . . . . . . . . . 63.0 tt0 -59.0 -30.09 67.72 Favored 'General case' 0 C--N 1.33 -0.271 0 N-CA-C 111.954 0.353 . . . . 0.0 111.954 179.618 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' F' F ' 108' ' ' ASN . . . . . . . . . . . . . 8.5 t-20 -83.98 11.76 7.32 Favored 'General case' 0 CA--C 1.536 0.428 0 N-CA-C 112.877 0.695 . . . . 0.0 112.877 -178.124 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' F' F ' 109' ' ' LEU . . . . . . . . . . . . . 10.5 tp 54.96 35.41 24.49 Favored 'General case' 0 C--N 1.331 -0.201 0 CA-C-O 120.902 0.382 . . . . 0.0 111.431 -179.602 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' F' F ' 110' ' ' GLU . . . . . . . . . . . . . 94.9 mt-10 -104.46 147.06 28.0 Favored 'General case' 0 C--N 1.331 -0.233 0 N-CA-C 109.335 -0.617 . . . . 0.0 109.335 175.38 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' F' F ' 111' ' ' GLU . . . . . . . . . . . . . 64.8 tt0 -81.47 121.95 26.92 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-O 120.913 0.387 . . . . 0.0 110.639 -174.97 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' F' F ' 112' ' ' LEU . . . . . . . . . . . . . 16.9 mt -104.7 -46.04 4.44 Favored 'General case' 0 C--N 1.331 -0.227 0 CA-C-N 116.04 -0.527 . . . . 0.0 110.623 179.513 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' F' F ' 113' ' ' TYR . . . . . . . . . . . . . 49.5 t80 -137.25 146.04 44.28 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.166 -0.47 . . . . 0.0 111.026 -177.919 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' F' F ' 114' ' ' ARG . . . . . . . . . . . . . 37.6 ptt180 -148.58 126.58 12.0 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.141 -0.481 . . . . 0.0 110.779 178.505 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' F' F ' 115' ' ' GLY . . . . . . . . . . . . . . . -150.16 142.78 9.98 Favored Glycine 0 CA--C 1.524 0.641 0 N-CA-C 111.062 -0.815 . . . . 0.0 111.062 179.159 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' F' F ' 116' ' ' LYS . . . . . . . . . . . . . 39.1 ttpt -112.37 134.09 54.09 Favored 'General case' 0 C--N 1.331 -0.236 0 N-CA-C 109.694 -0.484 . . . . 0.0 109.694 176.908 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' F' F ' 117' ' ' PHE . . . . . . . . . . . . . 28.1 m-85 -136.54 114.38 11.25 Favored 'General case' 0 C--N 1.329 -0.313 0 N-CA-C 110.055 -0.35 . . . . 0.0 110.055 -175.351 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' F' F ' 118' ' ' GLU . . . . . . . . . . . . . 43.7 mt-10 -54.94 -44.1 74.0 Favored 'General case' 0 C--N 1.33 -0.274 0 C-N-CA 120.883 -0.327 . . . . 0.0 111.348 -176.618 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' F' F ' 119' ' ' ASN . . . . . . . . . . . . . 30.6 m120 -94.87 30.49 2.07 Favored 'General case' 0 C--N 1.33 -0.263 0 N-CA-C 112.161 0.43 . . . . 0.0 112.161 -174.659 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' F' F ' 120' ' ' LEU . . . . . . . . . . . . . 22.0 tp -57.5 120.08 7.65 Favored 'General case' 0 C--N 1.331 -0.211 0 C-N-CA 120.925 -0.31 . . . . 0.0 110.293 177.577 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' F' F ' 121' ' ' ASN . . . . . . . . . . . . . 76.2 m-20 -111.63 -44.1 3.55 Favored 'General case' 0 C--N 1.331 -0.221 0 CA-C-N 116.425 -0.352 . . . . 0.0 110.711 -179.273 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' F' F ' 122' ' ' LYS . . . . . . . . . . . . . 97.0 mttt -146.93 145.08 29.67 Favored 'General case' 0 C--N 1.331 -0.216 0 C-N-CA 120.536 -0.466 . . . . 0.0 111.899 -179.316 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' F' F ' 123' ' ' VAL . . . . . . . . . . . . . 45.1 t -122.95 125.86 72.89 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.234 0 N-CA-C 108.998 -0.742 . . . . 0.0 108.998 171.531 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' F' F ' 124' ' ' LEU . . . . . . . . . . . . . 3.3 tt -125.26 131.86 53.03 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.461 -0.336 . . . . 0.0 110.482 -175.28 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' F' F ' 125' ' ' VAL . . . . . . . . . . . . . 11.7 p -131.14 135.95 58.78 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.224 0 CA-C-N 116.377 -0.374 . . . . 0.0 110.502 178.961 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' F' F ' 126' ' ' ARG . . . . . . . . . . . . . 96.6 mtt180 -149.43 128.37 12.63 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 116.109 -0.496 . . . . 0.0 110.873 177.333 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' F' F ' 127' ' ' ASN . . . . . . . . . . . . . 17.3 t-20 50.46 -106.77 0.24 Allowed 'General case' 0 CA--C 1.543 0.677 0 CA-C-O 118.975 -0.536 . . . . 0.0 111.543 178.85 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' F' F ' 128' ' ' ASP . . . . . . . . . . . . . 18.7 p-10 -114.14 5.17 15.85 Favored 'General case' 0 N--CA 1.469 0.476 0 CA-C-N 119.667 1.121 . . . . 0.0 113.531 -176.332 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' F' F ' 129' ' ' LEU . . . . . . . . . . . . . 61.9 mt -109.39 137.52 47.12 Favored 'General case' 0 C--O 1.232 0.159 0 CA-C-N 118.155 0.434 . . . . 0.0 110.702 -179.428 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' F' F ' 130' ' ' VAL . . . . . . . . . . . . . 44.4 t -124.02 132.0 72.05 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.194 0 N-CA-C 109.609 -0.515 . . . . 0.0 109.609 177.596 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' F' F ' 131' ' ' VAL . . . . . . . . . . . . . 41.4 t -135.56 137.08 50.06 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.208 0 CA-C-O 121.091 0.472 . . . . 0.0 110.511 -179.452 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' F' F ' 132' ' ' ILE . . . . . . . . . . . . . 71.0 mt -118.26 132.82 66.99 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.239 0 CA-C-N 115.815 -0.629 . . . . 0.0 109.542 178.717 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' F' F ' 133' ' ' ILE . . . . . . . . . . . . . 43.1 mm -118.31 124.6 73.37 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.238 0 CA-C-N 116.519 -0.31 . . . . 0.0 111.205 -174.758 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' F' F ' 134' ' ' ASP . . . . . . . . . . . . . 13.9 p-10 -140.52 151.42 44.76 Favored 'General case' 0 C--N 1.332 -0.19 0 N-CA-C 109.737 -0.468 . . . . 0.0 109.737 172.655 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' F' F ' 135' ' ' GLU . . . . . . . . . . . . . 42.5 tp10 -50.89 -27.44 7.5 Favored 'General case' 0 C--N 1.328 -0.357 0 N-CA-C 112.971 0.73 . . . . 0.0 112.971 -171.028 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' F' F ' 136' ' ' GLN . . . . . . . . . . . . . 99.3 mm-40 -86.28 -29.62 22.93 Favored 'General case' 0 C--O 1.233 0.23 0 N-CA-C 112.705 0.631 . . . . 0.0 112.705 -174.332 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' F' F ' 137' ' ' LYS . . . . . . . . . . . . . 55.7 pttt -164.95 169.11 16.84 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-O 121.524 0.678 . . . . 0.0 112.545 -170.605 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' F' F ' 138' ' ' LEU . . . . . . . . . . . . . 5.3 tt -122.26 127.52 50.01 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 114.986 -1.006 . . . . 0.0 109.598 178.565 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' F' F ' 139' ' ' THR . . . . . . . . . . . . . 35.0 m -108.07 124.59 50.43 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.423 -0.353 . . . . 0.0 110.333 -179.299 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' F' F ' 140' ' ' LEU . . . . . . . . . . . . . 14.5 tp -113.0 120.2 40.56 Favored 'General case' 0 C--N 1.329 -0.284 0 N-CA-C 109.337 -0.616 . . . . 0.0 109.337 -179.069 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' F' F ' 141' ' ' ILE . . . . . . . . . . . . . 18.9 mt -120.94 121.96 66.48 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.28 0 CA-C-O 120.961 0.41 . . . . 0.0 110.052 -175.364 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' F' F ' 142' ' ' ARG . . . . . . . . . . . . . 75.3 mtp180 -105.84 117.18 33.37 Favored 'General case' 0 C--O 1.232 0.163 0 CA-C-N 115.548 -0.751 . . . . 0.0 109.945 179.113 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' F' F ' 143' ' ' THR . . . . . . . . . . . . . 18.8 p . . . . . 0 C--O 1.219 -0.505 0 CA-C-O 118.029 -0.986 . . . . 0.0 110.663 -179.015 . . . . . . . . 0 0 . 1 . 009 nuclear orig core ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 5.3 p . . . . . 0 CA--C 1.523 -0.081 0 N-CA-C 110.013 -0.365 . . . . 0.0 110.013 . . . . . . . . . 0 0 . 1 . 009 nuclear orig core ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 84.9 tt0 -146.14 143.85 29.59 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.27 -0.423 . . . . 0.0 111.371 -178.232 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 4' ' ' LEU . . . . . . . . . . . . . 16.8 tp -127.54 132.84 49.84 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 115.937 -0.574 . . . . 0.0 110.079 176.934 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 5' ' ' LYS . . . . . . . . . . . . . 91.6 mttt -112.05 120.64 42.55 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.589 -179.555 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 71.5 mt -115.95 142.67 46.47 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 115.471 -0.786 . . . . 0.0 110.305 -178.685 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 39.4 ttmt -122.71 138.42 29.42 Favored Pre-proline 0 CA--C 1.532 0.286 0 CA-C-O 118.991 -0.528 . . . . 0.0 109.807 176.013 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 8' ' ' PRO . . . . . . . . . . . . . 91.3 Cg_endo -91.44 131.76 1.37 Allowed 'Trans proline' 0 N--CA 1.489 1.229 0 C-N-CA 121.702 1.602 . . . . 0.0 111.803 178.688 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 41.2 mt -71.91 -46.98 11.88 Favored Pre-proline 0 C--N 1.327 -0.376 0 CA-C-O 118.648 -0.691 . . . . 0.0 112.004 -179.388 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 83.6 Cg_endo -81.05 150.42 17.93 Favored 'Trans proline' 0 N--CA 1.495 1.581 0 C-N-CA 121.213 1.276 . . . . 0.0 111.878 175.412 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 68.8 mttm -88.85 99.33 12.3 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.401 -0.363 . . . . 0.0 110.496 178.932 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 12.4 p -144.52 149.16 17.52 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.282 0 CA-C-N 116.239 -0.437 . . . . 0.0 110.522 -179.494 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 44.2 mp0 -90.48 120.61 31.72 Favored 'General case' 0 C--N 1.331 -0.208 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.436 179.064 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 14' ' ' LEU . . . . . . . . . . . . . 24.2 mt -98.24 154.23 37.74 Favored Pre-proline 0 C--N 1.329 -0.291 0 CA-C-N 116.351 -0.386 . . . . 0.0 110.867 -179.744 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 15' ' ' PRO . . . . . . . . . . . . . 37.5 Cg_exo -59.63 155.93 39.84 Favored 'Trans proline' 0 N--CA 1.497 1.729 0 C-N-CA 121.272 1.315 . . . . 0.0 111.615 177.742 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 16' ' ' PRO . . . . . . . . . . . . . 35.8 Cg_exo -58.18 -38.29 91.84 Favored 'Trans proline' 0 N--CA 1.496 1.643 0 C-N-CA 121.491 1.461 . . . . 0.0 112.697 -179.514 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 17' ' ' ASP . . . . . . . . . . . . . 15.9 p-10 -85.18 10.69 11.59 Favored 'General case' 0 CA--C 1.534 0.363 0 N-CA-C 113.215 0.82 . . . . 0.0 113.215 -177.816 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 18' ' ' PHE . . . . . . . . . . . . . 42.1 t80 -58.2 -42.3 85.86 Favored 'General case' 0 N--CA 1.458 -0.046 0 O-C-N 121.95 -0.469 . . . . 0.0 110.116 -179.158 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 19' ' ' VAL . . . . . . . . . . . . . 12.6 p -55.9 -40.51 62.74 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.287 0 CA-C-N 116.436 -0.347 . . . . 0.0 110.709 179.65 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 53.9 m-20 -60.59 -44.0 96.74 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-O 120.83 0.348 . . . . 0.0 110.722 -179.394 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 47.0 t -63.64 -47.13 92.67 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.324 0 CA-C-N 116.358 -0.383 . . . . 0.0 110.587 -177.643 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 22' ' ' ILE . . . . . . . . . . . . . 50.7 mm -54.97 -49.51 70.52 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.204 0 O-C-N 122.227 -0.296 . . . . 0.0 110.835 179.3 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 23' ' ' ARG . . . . . . . . . . . . . 34.8 ttp180 -54.04 -49.32 69.21 Favored 'General case' 0 C--N 1.33 -0.247 0 C-N-CA 121.043 -0.263 . . . . 0.0 111.53 -178.339 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 24' ' ' ILE . . . . . . . . . . . . . 79.1 mt -58.85 -42.0 84.45 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.281 0 C-N-CA 121.181 -0.208 . . . . 0.0 111.428 -177.147 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 45.2 mttm -67.97 -42.13 81.33 Favored 'General case' 0 C--N 1.328 -0.347 0 N-CA-C 112.212 0.449 . . . . 0.0 112.212 -178.442 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 81.6 mt -80.19 -34.72 37.22 Favored 'General case' 0 C--N 1.328 -0.34 0 N-CA-C 113.501 0.926 . . . . 0.0 113.501 -169.64 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 27' ' ' GLN . . . . . . . . . . . . . 9.7 pt20 -46.64 141.52 3.75 Favored 'General case' 0 N--CA 1.467 0.412 0 N-CA-C 112.876 0.695 . . . . 0.0 112.876 -174.84 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 100.25 -26.89 22.83 Favored Glycine 0 CA--C 1.534 1.225 0 CA-C-N 115.644 -0.707 . . . . 0.0 112.166 -177.485 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 49.2 mtpt -97.52 155.04 17.13 Favored 'General case' 0 C--O 1.233 0.205 0 CA-C-N 117.322 0.561 . . . . 0.0 110.976 178.802 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 30' ' ' THR . . . . . . . . . . . . . 25.6 m -106.21 137.71 43.67 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.189 -0.459 . . . . 0.0 110.007 176.436 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 34.9 m -129.14 159.21 41.43 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.275 0 CA-C-N 116.409 -0.359 . . . . 0.0 110.866 -178.286 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 32' ' ' ARG . . . . . . . . . . . . . 76.7 mtm180 -133.46 150.82 51.73 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-O 121.209 0.528 . . . . 0.0 110.564 178.391 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 33' ' ' THR . . . . . . . . . . . . . 13.6 m -52.69 140.23 24.12 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.203 -0.453 . . . . 0.0 111.416 -178.148 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 100.53 -17.16 57.08 Favored Glycine 0 CA--C 1.532 1.111 0 CA-C-O 119.805 -0.442 . . . . 0.0 113.315 179.673 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 74.1 m-20 -66.82 149.31 50.76 Favored 'General case' 0 N--CA 1.461 0.098 0 CA-C-N 118.021 0.91 . . . . 0.0 111.205 178.931 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 45.3 t -119.42 129.87 74.74 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.2 0 CA-C-N 115.915 -0.584 . . . . 0.0 109.737 178.007 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 37' ' ' ILE . . . . . . . . . . . . . 64.1 mt -120.48 138.71 50.1 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.238 0 CA-C-N 116.091 -0.504 . . . . 0.0 109.854 -179.332 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . -116.52 128.8 8.11 Favored Glycine 0 CA--C 1.525 0.701 0 N-CA-C 111.052 -0.819 . . . . 0.0 111.052 179.953 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 39' ' ' ILE . . . . . . . . . . . . . 71.1 mt -126.72 134.24 66.71 Favored 'Isoleucine or valine' 0 C--N 1.333 -0.138 0 CA-C-O 120.822 0.344 . . . . 0.0 110.219 178.988 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 40' ' ' SER . . . . . . . . . . . . . 8.6 t -92.79 114.52 27.1 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.224 -0.444 . . . . 0.0 110.938 175.139 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 41' ' ' ILE . . . . . . . . . . . . . 44.3 mm -121.79 119.37 58.57 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.232 0 CA-C-O 120.87 0.367 . . . . 0.0 110.353 179.912 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 9.4 tp 55.45 36.63 27.52 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.182 -0.463 . . . . 0.0 111.483 177.254 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . 72.43 24.9 75.53 Favored Glycine 0 CA--C 1.532 1.111 0 C-N-CA 121.14 -0.553 . . . . 0.0 112.659 177.929 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 44' ' ' LYS . . . . . . . . . . . . . 43.4 mmtm -132.02 130.9 41.98 Favored 'General case' 0 C--N 1.332 -0.174 0 CA-C-N 117.28 0.54 . . . . 0.0 109.748 178.609 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 84.0 tt0 -83.32 121.22 26.84 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.479 -0.328 . . . . 0.0 111.154 -178.286 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 46' ' ' VAL . . . . . . . . . . . . . 11.2 p -119.73 121.41 66.09 Favored 'Isoleucine or valine' 0 C--O 1.232 0.166 0 N-CA-C 109.6 -0.518 . . . . 0.0 109.6 173.935 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 51.9 mtmt -98.72 126.48 44.35 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 115.968 -0.56 . . . . 0.0 110.657 178.243 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 48' ' ' PHE . . . . . . . . . . . . . 46.2 m-85 -110.99 131.85 54.7 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.201 -0.454 . . . . 0.0 109.816 178.631 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 80.9 tttt -106.43 130.89 54.16 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.362 -0.381 . . . . 0.0 110.044 178.329 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 50' ' ' VAL . . . . . . . . . . . . . 43.3 t -75.04 105.54 4.1 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.322 0 N-CA-C 109.414 -0.587 . . . . 0.0 109.414 177.785 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 51' ' ' VAL . . . . . . . . . . . . . 45.8 t -71.24 -51.95 30.54 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.363 0 CA-C-N 116.053 -0.521 . . . . 0.0 109.713 -175.015 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 52' ' ' GLN . . . . . . . . . . . . . 87.1 mt-30 -153.74 151.91 30.16 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-O 121.146 0.498 . . . . 0.0 111.44 -178.313 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -128.08 133.69 49.08 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 115.253 -0.885 . . . . 0.0 109.828 175.819 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 54' ' ' TYR . . . . . . . . . . . . . 58.1 t80 -129.03 108.81 18.15 Favored Pre-proline 0 CA--C 1.535 0.373 0 CA-C-O 118.363 -0.827 . . . . 0.0 110.324 -179.421 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 55' ' ' PRO . . . . . . . . . . . . . 73.5 Cg_endo -77.14 170.13 72.39 Favored 'Cis proline' 0 N--CA 1.499 1.845 0 CA-C-N 121.766 1.666 . . . . 0.0 112.372 -5.47 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 56' ' ' SER . . . . . . . . . . . . . 32.3 m -115.54 127.2 26.99 Favored Pre-proline 0 CA--C 1.538 0.494 0 CA-C-O 118.384 -0.817 . . . . 0.0 109.322 175.495 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 57' ' ' PRO . . . . . . . . . . . . . 36.9 Cg_endo -66.28 167.43 53.59 Favored 'Cis proline' 0 N--CA 1.497 1.682 0 CA-C-N 121.977 1.742 . . . . 0.0 111.708 0.063 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 58' ' ' LEU . . . . . . . . . . . . . 28.5 tp -130.98 137.26 49.16 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.136 -0.484 . . . . 0.0 110.447 -179.912 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 59' ' ' ARG . . . . . . . . . . . . . 70.8 ttt180 -102.44 130.94 49.38 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 116.149 -0.478 . . . . 0.0 109.791 177.163 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 40.8 t -80.43 112.39 18.39 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 CA-C-O 120.878 0.37 . . . . 0.0 110.397 -177.101 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 83.0 tt0 -131.0 155.41 46.87 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 115.84 -0.618 . . . . 0.0 109.461 177.433 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 62' ' ' ASP . . . . . . . . . . . . . 76.3 m-20 -50.5 -30.38 12.72 Favored 'General case' 0 C--N 1.328 -0.356 0 N-CA-C 112.208 0.447 . . . . 0.0 112.208 179.733 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 63' ' ' ARG . . . . . . . . . . . . . 77.2 mtp180 -71.99 -21.6 61.55 Favored 'General case' 0 CA--C 1.534 0.352 0 N-CA-C 112.843 0.682 . . . . 0.0 112.843 -176.768 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 27.5 m -71.59 139.3 49.33 Favored 'General case' 0 C--N 1.332 -0.159 0 CA-C-O 120.971 0.415 . . . . 0.0 111.0 -176.687 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 65' ' ' LYS . . . . . . . . . . . . . 55.0 mtmt -89.09 134.51 33.97 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-N 115.902 -0.59 . . . . 0.0 109.896 176.714 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 66' ' ' ILE . . . . . . . . . . . . . 63.3 mt -115.55 129.83 71.18 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.259 0 N-CA-C 109.925 -0.398 . . . . 0.0 109.925 -178.643 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 67' ' ' THR . . . . . . . . . . . . . 24.5 m -120.02 135.78 54.8 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.851 -179.148 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 68' ' ' LEU . . . . . . . . . . . . . 6.6 tt . . . . . 0 C--N 1.329 -0.309 0 CA-C-N 115.701 -0.681 . . . . 0.0 110.039 178.168 . . . . . . . . 0 0 . 1 . 009 nuclear orig core ' A' A ' 74' ' ' ASP . . . . . . . . . . . . . 9.0 t0 . . . . . 0 C--O 1.231 0.103 0 N-CA-C 109.904 -0.406 . . . . 0.0 109.904 . . . . . . . . . 0 0 . 1 . 009 nuclear orig core ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 41.0 t -114.26 121.98 67.46 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.255 0 CA-C-O 121.213 0.53 . . . . 0.0 110.521 -178.321 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 76' ' ' LEU . . . . . . . . . . . . . 29.9 mt -117.74 141.29 48.57 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 115.446 -0.797 . . . . 0.0 109.165 176.28 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 77' ' ' GLU . . . . . . . . . . . . . 16.8 tt0 -137.31 133.53 35.05 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-O 120.851 0.358 . . . . 0.0 111.135 -176.11 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 78' ' ' ALA . . . . . . . . . . . . . . . -125.99 141.06 52.13 Favored 'General case' 0 C--N 1.331 -0.202 0 CA-C-N 116.058 -0.519 . . . . 0.0 110.457 178.913 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 79' ' ' LYS . . . . . . . . . . . . . 45.0 mmtt -79.63 121.89 25.85 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.382 -0.372 . . . . 0.0 110.38 177.992 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 80' ' ' ILE . . . . . . . . . . . . . 38.5 mm -138.9 107.41 3.5 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.343 0 N-CA-C 109.386 -0.598 . . . . 0.0 109.386 -179.413 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 81' ' ' LYS . . . . . . . . . . . . . 28.7 ttpp -103.25 125.22 49.8 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-O 120.811 0.339 . . . . 0.0 111.64 -175.321 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . 89.19 42.05 5.68 Favored Glycine 0 CA--C 1.524 0.646 0 C-N-CA 121.102 -0.57 . . . . 0.0 112.012 172.48 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 83' ' ' ILE . . . . . . . . . . . . . 71.3 mt -72.85 136.75 24.87 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 N-CA-C 109.851 -0.426 . . . . 0.0 109.851 176.965 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 84' ' ' LYS . . . . . . . . . . . . . 39.6 ttpt -100.54 -48.14 4.64 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-O 120.966 0.412 . . . . 0.0 110.105 -179.438 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 85' ' ' ASP . . . . . . . . . . . . . 6.3 t70 -151.41 152.51 33.17 Favored 'General case' 0 C--N 1.331 -0.23 0 CA-C-N 115.891 -0.595 . . . . 0.0 110.548 179.1 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 86' ' ' VAL . . . . . . . . . . . . . 41.5 t -131.16 133.64 62.3 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.266 0 CA-C-O 121.034 0.445 . . . . 0.0 110.664 -178.461 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 87' ' ' ILE . . . . . . . . . . . . . 44.2 mm -119.75 125.48 74.36 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.247 0 CA-C-N 115.757 -0.656 . . . . 0.0 109.434 175.924 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 88' ' ' LEU . . . . . . . . . . . . . 14.5 tp -110.74 134.2 52.68 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-O 121.018 0.437 . . . . 0.0 111.309 -176.069 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 89' ' ' ASP . . . . . . . . . . . . . 12.9 t70 -127.5 155.1 44.28 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 115.875 -0.602 . . . . 0.0 109.829 177.497 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 43.1 tp10 -45.61 -44.09 12.78 Favored 'General case' 0 N--CA 1.465 0.308 0 N-CA-C 113.105 0.78 . . . . 0.0 113.105 -172.432 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 91' ' ' ASN . . . . . . . . . . . . . 66.0 m-80 -128.3 24.42 5.9 Favored 'General case' 0 N--CA 1.467 0.42 0 N-CA-C 112.547 0.573 . . . . 0.0 112.547 -178.421 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 92' ' ' LEU . . . . . . . . . . . . . 13.8 mt -149.78 145.68 26.76 Favored 'General case' 0 C--N 1.332 -0.169 0 N-CA-C 109.689 -0.486 . . . . 0.0 109.689 -176.832 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 93' ' ' ILE . . . . . . . . . . . . . 68.2 mt -128.47 118.54 48.0 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.306 0 N-CA-C 109.491 -0.559 . . . . 0.0 109.491 179.003 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 94' ' ' VAL . . . . . . . . . . . . . 46.4 t -118.53 126.14 74.91 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.252 0 N-CA-C 109.92 -0.4 . . . . 0.0 109.92 -179.6 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 95' ' ' VAL . . . . . . . . . . . . . 42.1 t -122.21 135.15 63.25 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.317 0 CA-C-N 116.054 -0.521 . . . . 0.0 109.988 -179.336 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 96' ' ' ILE . . . . . . . . . . . . . 67.1 mt -114.07 127.1 71.64 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.291 0 N-CA-C 109.366 -0.605 . . . . 0.0 109.366 179.075 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 97' ' ' THR . . . . . . . . . . . . . 68.0 p -100.08 156.73 17.02 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-O 121.397 0.617 . . . . 0.0 111.442 -176.879 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 98' ' ' GLU . . . . . . . . . . . . . 97.5 mt-10 -53.93 -25.79 22.13 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 115.822 -0.626 . . . . 0.0 112.312 -179.983 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 99' ' ' GLU . . . . . . . . . . . . . 41.5 mt-10 -80.4 18.11 0.96 Allowed 'General case' 0 CA--C 1.534 0.353 0 N-CA-C 113.003 0.742 . . . . 0.0 113.003 -177.148 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 100' ' ' ASN . . . . . . . . . . . . . 1.8 m120 63.87 35.48 10.95 Favored 'General case' 0 CA--C 1.531 0.222 0 CA-C-O 120.93 0.395 . . . . 0.0 111.145 176.634 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 101' ' ' GLU . . . . . . . . . . . . . 85.0 tt0 -118.47 142.33 47.68 Favored 'General case' 0 C--N 1.333 -0.14 0 N-CA-C 110.018 -0.364 . . . . 0.0 110.018 178.369 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 102' ' ' VAL . . . . . . . . . . . . . 45.6 t -116.39 126.67 73.97 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.297 0 N-CA-C 109.851 -0.425 . . . . 0.0 109.851 -178.686 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 103' ' ' LEU . . . . . . . . . . . . . 6.1 mp -118.37 133.48 55.84 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-N 115.807 -0.633 . . . . 0.0 110.458 177.95 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 104' ' ' ILE . . . . . . . . . . . . . 64.5 mt -117.88 119.54 61.85 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.22 0 CA-C-N 116.441 -0.345 . . . . 0.0 110.216 -179.761 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 105' ' ' PHE . . . . . . . . . . . . . 85.3 m-85 -114.87 165.26 13.04 Favored 'General case' 0 C--N 1.333 -0.146 0 O-C-N 124.042 0.839 . . . . 0.0 109.873 178.194 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 106' ' ' ASN . . . . . . . . . . . . . 49.3 p-10 -100.93 -170.27 1.82 Allowed 'General case' 0 C--N 1.331 -0.236 0 N-CA-C 109.636 -0.505 . . . . 0.0 109.636 171.727 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 107' ' ' GLN . . . . . . . . . . . . . 28.8 tt0 -58.06 -28.63 64.71 Favored 'General case' 0 C--N 1.328 -0.347 0 N-CA-C 112.261 0.467 . . . . 0.0 112.261 -179.201 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 108' ' ' ASN . . . . . . . . . . . . . 12.1 t-20 -90.88 14.19 14.4 Favored 'General case' 0 CA--C 1.533 0.314 0 N-CA-C 112.942 0.719 . . . . 0.0 112.942 -176.059 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 109' ' ' LEU . . . . . . . . . . . . . 63.4 mt 57.68 33.76 23.63 Favored 'General case' 0 CA--C 1.53 0.176 0 O-C-N 122.211 -0.306 . . . . 0.0 111.738 179.193 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 110' ' ' GLU . . . . . . . . . . . . . 70.6 mm-40 -99.66 140.83 33.29 Favored 'General case' 0 C--N 1.331 -0.225 0 N-CA-C 109.334 -0.617 . . . . 0.0 109.334 174.527 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 111' ' ' GLU . . . . . . . . . . . . . 47.5 tt0 -81.06 121.89 26.63 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-O 120.889 0.376 . . . . 0.0 110.714 -176.04 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 112' ' ' LEU . . . . . . . . . . . . . 30.9 mt -104.72 -46.02 4.44 Favored 'General case' 0 C--N 1.331 -0.219 0 CA-C-N 115.992 -0.549 . . . . 0.0 110.588 -179.857 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 113' ' ' TYR . . . . . . . . . . . . . 59.4 t80 -135.31 141.12 45.58 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.235 -0.439 . . . . 0.0 110.813 -178.682 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 114' ' ' ARG . . . . . . . . . . . . . 44.5 ptt85 -146.54 121.18 9.8 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.396 -0.366 . . . . 0.0 110.7 178.962 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 115' ' ' GLY . . . . . . . . . . . . . . . -150.15 160.4 28.52 Favored Glycine 0 CA--C 1.525 0.665 0 N-CA-C 111.008 -0.837 . . . . 0.0 111.008 179.296 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 116' ' ' LYS . . . . . . . . . . . . . 27.8 ttmt -125.59 137.41 53.9 Favored 'General case' 0 C--N 1.33 -0.248 0 N-CA-C 109.883 -0.414 . . . . 0.0 109.883 176.966 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 117' ' ' PHE . . . . . . . . . . . . . 44.1 m-85 -134.34 114.93 13.48 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.265 -0.425 . . . . 0.0 110.351 -175.513 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 118' ' ' GLU . . . . . . . . . . . . . 84.1 tt0 -50.62 -53.07 33.73 Favored 'General case' 0 C--N 1.329 -0.305 0 N-CA-C 111.98 0.363 . . . . 0.0 111.98 -176.019 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 119' ' ' ASN . . . . . . . . . . . . . 73.5 m-20 -94.94 31.01 1.94 Allowed 'General case' 0 C--N 1.33 -0.246 0 N-CA-C 112.308 0.484 . . . . 0.0 112.308 -173.505 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 120' ' ' LEU . . . . . . . . . . . . . 16.9 tp -56.4 123.07 13.42 Favored 'General case' 0 C--N 1.332 -0.178 0 C-N-CA 120.87 -0.332 . . . . 0.0 110.528 177.281 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 121' ' ' ASN . . . . . . . . . . . . . 9.9 m120 -114.09 -44.12 3.17 Favored 'General case' 0 C--N 1.331 -0.212 0 CA-C-N 116.55 -0.296 . . . . 0.0 110.985 -177.494 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 122' ' ' LYS . . . . . . . . . . . . . 91.4 mttt -145.15 148.78 33.97 Favored 'General case' 0 C--N 1.331 -0.209 0 CA-C-O 121.028 0.442 . . . . 0.0 111.728 -177.362 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 123' ' ' VAL . . . . . . . . . . . . . 44.6 t -128.63 125.73 64.0 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 N-CA-C 109.071 -0.714 . . . . 0.0 109.071 173.403 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 124' ' ' LEU . . . . . . . . . . . . . 5.8 mp -122.65 142.83 50.24 Favored 'General case' 0 C--N 1.332 -0.188 0 CA-C-O 120.836 0.351 . . . . 0.0 111.014 -175.68 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 125' ' ' VAL . . . . . . . . . . . . . 35.5 m -137.37 140.58 41.7 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.265 0 CA-C-N 115.999 -0.546 . . . . 0.0 110.581 179.053 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 126' ' ' ARG . . . . . . . . . . . . . 7.2 ptm85 -153.18 131.1 11.73 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-O 120.906 0.384 . . . . 0.0 110.577 176.068 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 127' ' ' ASN . . . . . . . . . . . . . 30.5 m120 50.6 -110.54 0.47 Allowed 'General case' 0 CA--C 1.545 0.763 0 CA-C-O 118.86 -0.591 . . . . 0.0 111.229 -179.691 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 128' ' ' ASP . . . . . . . . . . . . . 8.9 p-10 -114.11 7.79 16.8 Favored 'General case' 0 N--CA 1.468 0.428 0 CA-C-N 119.878 1.217 . . . . 0.0 113.314 -178.081 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 129' ' ' LEU . . . . . . . . . . . . . 11.8 tp -108.92 138.5 45.16 Favored 'General case' 0 C--N 1.332 -0.167 0 CA-C-N 118.153 0.433 . . . . 0.0 110.423 -178.825 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 130' ' ' VAL . . . . . . . . . . . . . 44.5 t -121.56 136.29 58.96 Favored 'Isoleucine or valine' 0 N--CA 1.462 0.169 0 N-CA-C 109.691 -0.485 . . . . 0.0 109.691 179.843 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 131' ' ' VAL . . . . . . . . . . . . . 39.0 t -134.46 136.31 52.95 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.235 0 CA-C-O 120.974 0.416 . . . . 0.0 110.504 -178.84 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 132' ' ' ILE . . . . . . . . . . . . . 71.0 mt -116.77 131.39 69.56 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 CA-C-N 115.746 -0.661 . . . . 0.0 109.267 178.722 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 133' ' ' ILE . . . . . . . . . . . . . 42.7 mm -119.36 122.3 68.69 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.223 0 CA-C-O 120.746 0.308 . . . . 0.0 110.987 -174.793 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 134' ' ' ASP . . . . . . . . . . . . . 16.6 p-10 -138.82 146.86 41.8 Favored 'General case' 0 C--N 1.332 -0.163 0 CA-C-N 116.272 -0.422 . . . . 0.0 109.872 173.744 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 135' ' ' GLU . . . . . . . . . . . . . 77.8 tt0 -49.9 -23.05 1.73 Allowed 'General case' 0 C--N 1.329 -0.305 0 N-CA-C 113.606 0.965 . . . . 0.0 113.606 -168.013 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 136' ' ' GLN . . . . . . . . . . . . . 22.3 pt20 -96.69 -27.21 14.88 Favored 'General case' 0 C--O 1.235 0.293 0 N-CA-C 112.551 0.574 . . . . 0.0 112.551 -174.011 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 137' ' ' LYS . . . . . . . . . . . . . 53.7 pttt -156.01 165.32 36.8 Favored 'General case' 0 C--O 1.233 0.205 0 CA-C-O 121.599 0.714 . . . . 0.0 112.125 -176.95 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 138' ' ' LEU . . . . . . . . . . . . . 6.0 tt -119.58 127.04 52.6 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 115.02 -0.991 . . . . 0.0 109.416 176.375 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 139' ' ' THR . . . . . . . . . . . . . 34.1 m -111.78 131.08 55.57 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.368 -0.378 . . . . 0.0 110.572 -178.458 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 140' ' ' LEU . . . . . . . . . . . . . 12.7 tp -117.31 123.81 47.44 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 115.657 -0.701 . . . . 0.0 109.273 -178.328 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 141' ' ' ILE . . . . . . . . . . . . . 19.5 mt -120.28 118.76 57.84 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.332 0 CA-C-O 120.983 0.42 . . . . 0.0 109.88 -174.859 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 142' ' ' ARG . . . . . . . . . . . . . 29.6 tpt85 -105.3 122.08 45.2 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 115.302 -0.863 . . . . 0.0 109.932 -178.251 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 143' ' ' THR . . . . . . . . . . . . . 57.2 p . . . . . 0 C--O 1.221 -0.445 0 CA-C-O 117.949 -1.024 . . . . 0.0 110.632 -178.721 . . . . . . . . 0 0 . 1 . 009 nuclear orig core ' B' B ' 2' ' ' SER . . . . . . . . . . . . . 2.9 p . . . . . 0 N--CA 1.462 0.171 0 CA-C-O 120.881 0.372 . . . . 0.0 110.913 . . . . . . . . . 0 0 . 1 . 009 nuclear orig core ' B' B ' 3' ' ' GLU . . . . . . . . . . . . . 84.9 tt0 -144.21 143.15 30.92 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.14 -0.482 . . . . 0.0 111.206 179.998 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 4' ' ' LEU . . . . . . . . . . . . . 15.5 tp -127.04 132.88 50.61 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 115.892 -0.595 . . . . 0.0 110.187 177.264 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 5' ' ' LYS . . . . . . . . . . . . . 95.8 mttt -112.61 122.25 47.13 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.326 -0.397 . . . . 0.0 110.799 -179.279 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 6' ' ' LEU . . . . . . . . . . . . . 38.7 mt -114.05 141.0 47.99 Favored 'General case' 0 C--N 1.332 -0.19 0 CA-C-N 115.506 -0.77 . . . . 0.0 110.266 -179.452 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 7' ' ' LYS . . . . . . . . . . . . . 74.6 tttt -121.97 136.26 26.08 Favored Pre-proline 0 CA--C 1.535 0.385 0 CA-C-O 118.839 -0.601 . . . . 0.0 109.697 176.304 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 8' ' ' PRO . . . . . . . . . . . . . 84.4 Cg_endo -90.47 135.31 2.1 Favored 'Trans proline' 0 N--CA 1.491 1.349 0 C-N-CA 121.656 1.57 . . . . 0.0 112.011 178.357 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 9' ' ' LEU . . . . . . . . . . . . . 53.9 mt -74.2 -47.93 5.96 Favored Pre-proline 0 CA--C 1.535 0.366 0 CA-C-O 118.628 -0.701 . . . . 0.0 112.336 -179.738 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 10' ' ' PRO . . . . . . . . . . . . . 97.4 Cg_endo -79.11 151.98 24.01 Favored 'Trans proline' 0 N--CA 1.497 1.677 0 C-N-CA 121.092 1.195 . . . . 0.0 111.882 177.563 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 11' ' ' LYS . . . . . . . . . . . . . 62.1 tttm -81.27 95.7 7.05 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.333 -0.394 . . . . 0.0 110.167 178.341 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 12' ' ' VAL . . . . . . . . . . . . . 12.3 p -141.69 146.43 23.09 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.321 0 CA-C-N 116.273 -0.421 . . . . 0.0 110.752 -177.629 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 13' ' ' GLU . . . . . . . . . . . . . 85.2 tt0 -99.5 114.61 27.69 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.067 -0.515 . . . . 0.0 109.895 176.581 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 14' ' ' LEU . . . . . . . . . . . . . 32.2 mt -92.46 160.6 34.48 Favored Pre-proline 0 C--N 1.328 -0.33 0 CA-C-N 116.328 -0.396 . . . . 0.0 111.115 -176.341 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 15' ' ' PRO . . . . . . . . . . . . . 35.3 Cg_exo -57.64 155.26 32.51 Favored 'Trans proline' 0 N--CA 1.496 1.62 0 C-N-CA 121.341 1.361 . . . . 0.0 111.874 -179.464 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 16' ' ' PRO . . . . . . . . . . . . . 33.7 Cg_exo -57.19 -40.91 79.22 Favored 'Trans proline' 0 N--CA 1.498 1.74 0 C-N-CA 121.347 1.364 . . . . 0.0 112.734 -178.262 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 17' ' ' ASP . . . . . . . . . . . . . 16.9 p-10 -89.46 15.69 8.85 Favored 'General case' 0 CA--C 1.534 0.362 0 N-CA-C 112.929 0.714 . . . . 0.0 112.929 -177.239 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 18' ' ' PHE . . . . . . . . . . . . . 27.3 t80 -57.14 -39.9 76.11 Favored 'General case' 0 C--O 1.227 -0.089 0 O-C-N 122.052 -0.405 . . . . 0.0 110.438 -179.07 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 19' ' ' VAL . . . . . . . . . . . . . 46.0 t -54.91 -44.59 73.57 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.201 0 CA-C-O 120.762 0.315 . . . . 0.0 110.584 -179.96 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 20' ' ' ASP . . . . . . . . . . . . . 74.8 m-20 -59.92 -40.99 90.76 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.482 -0.326 . . . . 0.0 110.631 -179.738 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 21' ' ' VAL . . . . . . . . . . . . . 47.5 t -62.69 -45.08 99.7 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.305 0 CA-C-N 116.448 -0.342 . . . . 0.0 110.265 -178.526 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 22' ' ' ILE . . . . . . . . . . . . . 51.0 mm -55.14 -49.74 69.52 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.332 0 C-N-CA 121.136 -0.226 . . . . 0.0 110.649 178.224 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 23' ' ' ARG . . . . . . . . . . . . . 58.7 ttp180 -53.83 -47.05 71.29 Favored 'General case' 0 C--N 1.33 -0.281 0 C-N-CA 121.079 -0.248 . . . . 0.0 111.538 -179.019 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 24' ' ' ILE . . . . . . . . . . . . . 70.9 mt -57.88 -45.42 87.53 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.322 0 C-N-CA 121.065 -0.254 . . . . 0.0 111.067 -177.224 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 25' ' ' LYS . . . . . . . . . . . . . 46.1 mtmt -70.21 -34.19 72.61 Favored 'General case' 0 C--N 1.328 -0.34 0 N-CA-C 112.378 0.51 . . . . 0.0 112.378 -177.607 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 26' ' ' LEU . . . . . . . . . . . . . 31.2 mt -80.87 -38.17 28.59 Favored 'General case' 0 C--N 1.331 -0.232 0 N-CA-C 113.579 0.955 . . . . 0.0 113.579 -171.514 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 27' ' ' GLN . . . . . . . . . . . . . 11.3 pt20 -45.39 139.42 3.64 Favored 'General case' 0 N--CA 1.47 0.557 0 N-CA-C 113.071 0.767 . . . . 0.0 113.071 -173.2 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 28' ' ' GLY . . . . . . . . . . . . . . . 98.27 -27.17 20.58 Favored Glycine 0 CA--C 1.532 1.124 0 CA-C-N 115.53 -0.759 . . . . 0.0 112.257 -178.003 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 29' ' ' LYS . . . . . . . . . . . . . 99.1 mttt -97.46 155.18 17.05 Favored 'General case' 0 C--O 1.233 0.22 0 CA-C-N 117.257 0.529 . . . . 0.0 111.066 179.159 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 30' ' ' THR . . . . . . . . . . . . . 34.7 m -105.26 138.57 41.25 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 115.879 -0.601 . . . . 0.0 110.035 176.108 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 31' ' ' VAL . . . . . . . . . . . . . 34.6 m -127.52 151.38 34.29 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.225 0 CA-C-O 120.925 0.393 . . . . 0.0 110.855 -178.634 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 32' ' ' ARG . . . . . . . . . . . . . 58.3 ttp180 -127.18 148.8 50.18 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.042 -0.526 . . . . 0.0 110.551 179.43 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 33' ' ' THR . . . . . . . . . . . . . 25.4 m -52.93 137.43 32.56 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.339 -0.391 . . . . 0.0 111.289 179.985 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 34' ' ' GLY . . . . . . . . . . . . . . . 100.96 -17.17 56.64 Favored Glycine 0 CA--C 1.533 1.175 0 C-N-CA 121.191 -0.528 . . . . 0.0 113.202 179.764 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 35' ' ' ASP . . . . . . . . . . . . . 57.3 m-20 -65.75 151.26 47.0 Favored 'General case' 0 C--O 1.232 0.168 0 CA-C-N 118.007 0.903 . . . . 0.0 111.089 179.86 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 36' ' ' VAL . . . . . . . . . . . . . 45.1 t -123.93 130.36 73.91 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.245 0 CA-C-N 116.048 -0.524 . . . . 0.0 109.868 178.717 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 37' ' ' ILE . . . . . . . . . . . . . 62.1 mt -120.09 137.63 53.29 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.206 0 CA-C-N 116.136 -0.484 . . . . 0.0 109.919 -179.969 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 38' ' ' GLY . . . . . . . . . . . . . . . -118.72 128.78 7.84 Favored Glycine 0 CA--C 1.525 0.712 0 N-CA-C 111.028 -0.829 . . . . 0.0 111.028 179.597 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 39' ' ' ILE . . . . . . . . . . . . . 70.8 mt -126.7 131.85 70.74 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.245 0 CA-C-O 120.825 0.345 . . . . 0.0 110.158 178.87 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 40' ' ' SER . . . . . . . . . . . . . 33.6 t -91.66 120.9 32.84 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.28 -0.418 . . . . 0.0 110.797 177.039 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 41' ' ' ILE . . . . . . . . . . . . . 72.7 mt -133.84 126.49 50.83 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.18 0 CA-C-O 120.884 0.373 . . . . 0.0 110.539 178.772 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 42' ' ' LEU . . . . . . . . . . . . . 42.7 mt 54.79 34.64 22.31 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-N 116.018 -0.537 . . . . 0.0 111.79 176.15 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 43' ' ' GLY . . . . . . . . . . . . . . . 71.89 29.36 67.28 Favored Glycine 0 CA--C 1.531 1.053 0 C-N-CA 121.027 -0.606 . . . . 0.0 112.311 177.683 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 44' ' ' LYS . . . . . . . . . . . . . 53.6 tttm -141.53 127.11 18.95 Favored 'General case' 0 C--N 1.33 -0.259 0 N-CA-C 109.754 -0.461 . . . . 0.0 109.754 178.144 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 45' ' ' GLU . . . . . . . . . . . . . 80.4 tt0 -84.07 123.36 29.95 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 116.441 -0.345 . . . . 0.0 111.133 -178.386 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 46' ' ' VAL . . . . . . . . . . . . . 10.6 p -115.59 120.83 65.86 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.195 0 N-CA-C 109.473 -0.566 . . . . 0.0 109.473 175.034 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 47' ' ' LYS . . . . . . . . . . . . . 52.2 mtpt -99.2 126.98 45.11 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.047 -0.524 . . . . 0.0 110.968 178.248 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 48' ' ' PHE . . . . . . . . . . . . . 37.7 m-85 -110.12 132.0 54.55 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.049 -0.523 . . . . 0.0 109.746 176.7 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 49' ' ' LYS . . . . . . . . . . . . . 85.6 tttt -106.21 132.05 52.73 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.319 -0.401 . . . . 0.0 110.002 178.407 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 50' ' ' VAL . . . . . . . . . . . . . 44.4 t -76.19 105.46 5.12 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.392 0 N-CA-C 109.471 -0.566 . . . . 0.0 109.471 178.252 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 51' ' ' VAL . . . . . . . . . . . . . 50.6 t -73.41 -46.42 49.27 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.261 0 CA-C-N 116.042 -0.526 . . . . 0.0 110.089 -174.05 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 52' ' ' GLN . . . . . . . . . . . . . 30.6 tt0 -157.87 144.4 17.72 Favored 'General case' 0 C--N 1.332 -0.166 0 C-N-CA 120.09 -0.644 . . . . 0.0 111.894 -178.085 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 53' ' ' ALA . . . . . . . . . . . . . . . -123.5 130.91 53.38 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 115.442 -0.799 . . . . 0.0 109.775 176.364 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 54' ' ' TYR . . . . . . . . . . . . . 64.8 t80 -128.95 109.84 18.37 Favored Pre-proline 0 CA--C 1.535 0.377 0 CA-C-O 118.15 -0.928 . . . . 0.0 110.449 179.99 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 55' ' ' PRO . . . . . . . . . . . . . 74.1 Cg_endo -77.05 169.94 73.01 Favored 'Cis proline' 0 N--CA 1.499 1.841 0 CA-C-N 121.993 1.748 . . . . 0.0 112.436 -5.299 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 56' ' ' SER . . . . . . . . . . . . . 13.6 m -114.95 126.14 28.19 Favored Pre-proline 0 CA--C 1.537 0.463 0 CA-C-O 118.416 -0.802 . . . . 0.0 109.241 175.824 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 57' ' ' PRO . . . . . . . . . . . . . 61.3 Cg_endo -74.18 152.65 98.5 Favored 'Cis proline' 0 N--CA 1.495 1.61 0 CA-C-N 121.976 1.741 . . . . 0.0 111.873 1.36 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 58' ' ' LEU . . . . . . . . . . . . . 17.8 tp -109.44 136.09 49.41 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.165 -0.471 . . . . 0.0 110.819 -178.292 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 59' ' ' ARG . . . . . . . . . . . . . 57.4 ttp180 -105.2 126.2 51.82 Favored 'General case' 0 C--N 1.329 -0.319 0 N-CA-C 109.509 -0.552 . . . . 0.0 109.509 176.076 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 60' ' ' VAL . . . . . . . . . . . . . 40.4 t -83.23 121.03 35.58 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.315 0 C-N-CA 120.694 -0.402 . . . . 0.0 111.046 -174.498 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 61' ' ' GLU . . . . . . . . . . . . . 95.4 mt-10 -131.01 165.68 22.65 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 115.674 -0.694 . . . . 0.0 109.424 175.243 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 62' ' ' ASP . . . . . . . . . . . . . 79.8 m-20 -52.47 -33.45 44.6 Favored 'General case' 0 C--N 1.329 -0.324 0 N-CA-C 112.056 0.391 . . . . 0.0 112.056 -175.64 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 63' ' ' ARG . . . . . . . . . . . . . 65.8 mtp180 -76.58 -21.97 54.89 Favored 'General case' 0 C--N 1.329 -0.297 0 N-CA-C 113.088 0.773 . . . . 0.0 113.088 -175.512 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 64' ' ' THR . . . . . . . . . . . . . 29.8 m -61.1 138.28 58.21 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-O 120.915 0.388 . . . . 0.0 111.164 -175.137 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 65' ' ' LYS . . . . . . . . . . . . . 55.6 mttm -89.99 133.32 34.87 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 115.913 -0.585 . . . . 0.0 110.38 179.129 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 66' ' ' ILE . . . . . . . . . . . . . 66.8 mt -120.05 129.84 74.98 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.202 0 N-CA-C 109.93 -0.396 . . . . 0.0 109.93 178.0 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 67' ' ' THR . . . . . . . . . . . . . 31.4 m -121.33 140.13 52.5 Favored 'General case' 0 C--N 1.331 -0.213 0 CA-C-N 116.062 -0.517 . . . . 0.0 111.002 -178.352 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 68' ' ' LEU . . . . . . . . . . . . . 6.1 tt . . . . . 0 C--N 1.331 -0.225 0 CA-C-N 115.863 -0.608 . . . . 0.0 110.238 178.882 . . . . . . . . 0 0 . 1 . 009 nuclear orig core ' B' B ' 73' ' ' VAL . . . . . . . . . . . . . 35.5 m . . . . . 0 C--O 1.232 0.179 0 N-CA-C 109.882 -0.414 . . . . 0.0 109.882 . . . . . . . . . 0 0 . 1 . 009 nuclear orig core ' B' B ' 74' ' ' ASP . . . . . . . . . . . . . 27.6 t0 -99.86 116.46 31.98 Favored 'General case' 0 C--N 1.331 -0.217 0 C-N-CA 120.794 -0.363 . . . . 0.0 110.041 -178.804 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 75' ' ' VAL . . . . . . . . . . . . . 44.4 t -114.97 123.13 70.36 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.217 0 CA-C-O 120.96 0.41 . . . . 0.0 110.401 -177.658 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 76' ' ' LEU . . . . . . . . . . . . . 26.0 mt -125.31 146.95 49.33 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 115.775 -0.648 . . . . 0.0 109.65 178.806 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 77' ' ' GLU . . . . . . . . . . . . . 96.8 mt-10 -138.48 141.95 39.42 Favored 'General case' 0 C--N 1.332 -0.188 0 CA-C-O 121.016 0.436 . . . . 0.0 111.57 -177.656 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 78' ' ' ALA . . . . . . . . . . . . . . . -129.81 139.41 51.24 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 115.801 -0.636 . . . . 0.0 110.003 175.827 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 79' ' ' LYS . . . . . . . . . . . . . 98.2 mttt -79.4 119.54 22.56 Favored 'General case' 0 C--N 1.331 -0.198 0 CA-C-O 120.78 0.324 . . . . 0.0 110.937 -178.128 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 80' ' ' ILE . . . . . . . . . . . . . 25.9 mm -139.19 113.08 6.91 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 N-CA-C 109.171 -0.678 . . . . 0.0 109.171 -178.673 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 81' ' ' LYS . . . . . . . . . . . . . 62.4 mttm -108.99 127.27 53.93 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-O 121.04 0.448 . . . . 0.0 111.376 -177.173 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 82' ' ' GLY . . . . . . . . . . . . . . . 89.15 41.99 5.71 Favored Glycine 0 CA--C 1.526 0.747 0 CA-C-N 115.833 -0.621 . . . . 0.0 111.823 174.199 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 83' ' ' ILE . . . . . . . . . . . . . 71.0 mt -72.95 140.44 17.88 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.318 0 N-CA-C 110.099 -0.334 . . . . 0.0 110.099 178.329 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 84' ' ' LYS . . . . . . . . . . . . . 28.5 ttmt -97.53 -53.22 3.51 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.174 -0.466 . . . . 0.0 109.94 179.175 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 85' ' ' ASP . . . . . . . . . . . . . 7.0 t70 -152.38 151.51 30.92 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 115.76 -0.655 . . . . 0.0 110.556 -179.535 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 86' ' ' VAL . . . . . . . . . . . . . 42.8 t -128.82 130.11 68.52 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.24 0 CA-C-O 120.912 0.387 . . . . 0.0 110.289 -179.238 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 87' ' ' ILE . . . . . . . . . . . . . 5.1 mp -119.44 128.26 75.86 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.178 0 N-CA-C 109.531 -0.544 . . . . 0.0 109.531 177.134 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 88' ' ' LEU . . . . . . . . . . . . . 57.0 mt -114.34 140.89 48.26 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-O 121.204 0.526 . . . . 0.0 111.263 -177.764 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 89' ' ' ASP . . . . . . . . . . . . . 5.0 t70 -132.27 158.94 40.53 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 115.376 -0.829 . . . . 0.0 109.457 176.517 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 90' ' ' GLU . . . . . . . . . . . . . 83.0 tt0 -46.33 -41.68 13.7 Favored 'General case' 0 C--N 1.331 -0.238 0 N-CA-C 112.975 0.731 . . . . 0.0 112.975 -173.19 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 91' ' ' ASN . . . . . . . . . . . . . 9.5 p-10 -132.19 38.01 3.52 Favored 'General case' 0 N--CA 1.464 0.231 0 CA-C-O 120.704 0.288 . . . . 0.0 111.391 -177.696 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 92' ' ' LEU . . . . . . . . . . . . . 11.6 tp -163.45 142.23 8.11 Favored 'General case' 0 C--N 1.331 -0.226 0 C-N-CA 120.865 -0.334 . . . . 0.0 110.89 -177.978 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 93' ' ' ILE . . . . . . . . . . . . . 76.9 mt -127.65 119.08 50.92 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 N-CA-C 109.284 -0.635 . . . . 0.0 109.284 177.715 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 94' ' ' VAL . . . . . . . . . . . . . 47.3 t -123.44 127.11 74.07 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.234 0 CA-C-O 120.978 0.418 . . . . 0.0 110.123 -179.8 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 95' ' ' VAL . . . . . . . . . . . . . 41.9 t -121.97 137.18 56.43 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.337 0 CA-C-N 115.741 -0.663 . . . . 0.0 109.91 -178.377 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 96' ' ' ILE . . . . . . . . . . . . . 58.0 mt -114.75 127.8 72.12 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.263 0 N-CA-C 109.362 -0.607 . . . . 0.0 109.362 179.126 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 97' ' ' THR . . . . . . . . . . . . . 67.6 p -102.5 154.34 19.19 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-O 121.199 0.524 . . . . 0.0 111.383 -177.626 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 98' ' ' GLU . . . . . . . . . . . . . 46.5 tp10 -53.95 -25.56 21.24 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 115.984 -0.553 . . . . 0.0 112.207 179.751 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 99' ' ' GLU . . . . . . . . . . . . . 32.6 tt0 -78.82 16.74 0.82 Allowed 'General case' 0 CA--C 1.537 0.469 0 N-CA-C 112.812 0.671 . . . . 0.0 112.812 -177.82 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 100' ' ' ASN . . . . . . . . . . . . . 4.1 m-20 61.67 37.94 15.59 Favored 'General case' 0 CA--C 1.53 0.181 0 O-C-N 121.894 -0.503 . . . . 0.0 110.855 178.066 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 101' ' ' GLU . . . . . . . . . . . . . 84.5 tt0 -116.54 143.35 45.71 Favored 'General case' 0 C--N 1.333 -0.149 0 CA-C-N 115.935 -0.575 . . . . 0.0 109.724 177.603 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 102' ' ' VAL . . . . . . . . . . . . . 44.7 t -114.98 125.05 72.2 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.331 0 CA-C-N 116.206 -0.452 . . . . 0.0 109.857 -178.822 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 103' ' ' LEU . . . . . . . . . . . . . 24.2 mt -116.84 128.26 55.09 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 115.807 -0.633 . . . . 0.0 110.348 177.84 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 104' ' ' ILE . . . . . . . . . . . . . 68.1 mt -120.39 121.04 64.57 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.26 0 CA-C-N 116.64 -0.254 . . . . 0.0 110.428 179.688 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 105' ' ' PHE . . . . . . . . . . . . . 52.5 m-85 -121.85 166.77 13.88 Favored 'General case' 0 C--N 1.333 -0.139 0 CA-C-N 115.674 -0.693 . . . . 0.0 109.678 178.611 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 106' ' ' ASN . . . . . . . . . . . . . 45.1 p-10 -99.57 -171.02 1.99 Allowed 'General case' 0 C--N 1.329 -0.285 0 N-CA-C 109.876 -0.416 . . . . 0.0 109.876 173.318 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 107' ' ' GLN . . . . . . . . . . . . . 45.4 tt0 -60.23 -29.63 68.87 Favored 'General case' 0 C--N 1.329 -0.293 0 N-CA-C 112.001 0.371 . . . . 0.0 112.001 179.979 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 108' ' ' ASN . . . . . . . . . . . . . 4.5 t-20 -82.49 7.34 14.64 Favored 'General case' 0 CA--C 1.536 0.431 0 N-CA-C 113.163 0.801 . . . . 0.0 113.163 -177.633 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 109' ' ' LEU . . . . . . . . . . . . . 12.5 tp 61.63 38.18 15.53 Favored 'General case' 0 C--N 1.333 -0.139 0 CA-C-O 121.165 0.507 . . . . 0.0 111.205 179.073 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 110' ' ' GLU . . . . . . . . . . . . . 95.7 mt-10 -108.07 148.13 30.21 Favored 'General case' 0 C--N 1.33 -0.281 0 N-CA-C 109.539 -0.541 . . . . 0.0 109.539 174.871 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 111' ' ' GLU . . . . . . . . . . . . . 49.3 tt0 -83.21 122.03 27.87 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-O 120.896 0.379 . . . . 0.0 111.023 -175.624 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 112' ' ' LEU . . . . . . . . . . . . . 84.8 mt -104.83 -46.03 4.41 Favored 'General case' 0 C--N 1.331 -0.203 0 CA-C-N 116.025 -0.534 . . . . 0.0 110.591 178.844 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 113' ' ' TYR . . . . . . . . . . . . . 42.3 t80 -137.15 136.71 38.48 Favored 'General case' 0 C--N 1.331 -0.223 0 CA-C-N 116.357 -0.383 . . . . 0.0 111.363 -177.823 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 114' ' ' ARG . . . . . . . . . . . . . 46.2 ttp180 -137.17 125.64 23.51 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 115.913 -0.585 . . . . 0.0 110.039 176.474 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 115' ' ' GLY . . . . . . . . . . . . . . . -150.03 154.71 25.85 Favored Glycine 0 CA--C 1.525 0.667 0 C-N-CA 120.756 -0.735 . . . . 0.0 111.271 178.932 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 116' ' ' LYS . . . . . . . . . . . . . 30.8 ttpt -128.62 130.67 47.62 Favored 'General case' 0 C--N 1.329 -0.304 0 N-CA-C 109.797 -0.446 . . . . 0.0 109.797 177.778 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 117' ' ' PHE . . . . . . . . . . . . . 46.1 m-85 -128.79 116.21 19.13 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-O 120.926 0.393 . . . . 0.0 110.464 -175.987 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 118' ' ' GLU . . . . . . . . . . . . . 95.9 mt-10 -52.65 -46.76 67.29 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.361 -0.381 . . . . 0.0 111.573 -176.942 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 119' ' ' ASN . . . . . . . . . . . . . 9.8 m120 -99.57 30.97 3.35 Favored 'General case' 0 C--N 1.33 -0.272 0 N-CA-C 112.22 0.452 . . . . 0.0 112.22 -174.35 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 120' ' ' LEU . . . . . . . . . . . . . 15.8 tp -54.21 125.78 20.47 Favored 'General case' 0 N--CA 1.462 0.17 0 CA-C-O 120.718 0.294 . . . . 0.0 110.984 179.22 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 121' ' ' ASN . . . . . . . . . . . . . 31.3 m120 -107.92 -44.1 4.28 Favored 'General case' 0 C--N 1.331 -0.212 0 CA-C-N 116.367 -0.379 . . . . 0.0 110.806 -177.98 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 122' ' ' LYS . . . . . . . . . . . . . 1.2 ptpm? -160.29 157.35 27.9 Favored 'General case' 0 C--N 1.332 -0.19 0 CA-C-O 121.231 0.538 . . . . 0.0 112.056 -179.348 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 123' ' ' VAL . . . . . . . . . . . . . 46.8 t -127.23 131.51 70.53 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.224 0 CA-C-N 115.587 -0.733 . . . . 0.0 109.526 176.707 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 124' ' ' LEU . . . . . . . . . . . . . 14.4 tp -126.8 138.81 53.41 Favored 'General case' 0 N--CA 1.463 0.19 0 CA-C-N 116.496 -0.32 . . . . 0.0 110.541 -177.988 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 125' ' ' VAL . . . . . . . . . . . . . 34.7 m -132.68 141.99 43.6 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.182 0 CA-C-O 120.835 0.35 . . . . 0.0 111.328 -177.654 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 126' ' ' ARG . . . . . . . . . . . . . 88.9 mtt180 -146.57 118.07 7.97 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.658 175.128 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 127' ' ' ASN . . . . . . . . . . . . . 75.2 m-80 52.0 -106.43 0.27 Allowed 'General case' 0 CA--C 1.544 0.715 0 CA-C-O 118.97 -0.538 . . . . 0.0 111.256 178.996 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 128' ' ' ASP . . . . . . . . . . . . . 15.5 p-10 -114.07 3.16 15.18 Favored 'General case' 0 N--CA 1.469 0.484 0 CA-C-N 119.649 1.113 . . . . 0.0 113.295 -177.893 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 129' ' ' LEU . . . . . . . . . . . . . 15.6 tp -105.34 135.48 46.65 Favored 'General case' 0 C--N 1.332 -0.184 0 N-CA-C 109.553 -0.536 . . . . 0.0 109.553 178.084 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 130' ' ' VAL . . . . . . . . . . . . . 41.1 t -124.63 140.46 47.79 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.235 0 N-CA-C 110.136 -0.32 . . . . 0.0 110.136 -177.751 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 131' ' ' VAL . . . . . . . . . . . . . 41.5 t -133.51 135.07 56.39 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 CA-C-O 120.963 0.411 . . . . 0.0 110.145 178.788 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 132' ' ' ILE . . . . . . . . . . . . . 70.1 mt -116.92 131.41 69.68 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.314 0 N-CA-C 109.197 -0.668 . . . . 0.0 109.197 178.297 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 133' ' ' ILE . . . . . . . . . . . . . 43.3 mm -115.94 120.94 66.3 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.316 0 CA-C-N 116.406 -0.361 . . . . 0.0 110.819 -174.901 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 134' ' ' ASP . . . . . . . . . . . . . 8.6 p-10 -134.37 147.48 50.52 Favored 'General case' 0 C--N 1.331 -0.2 0 N-CA-C 109.545 -0.539 . . . . 0.0 109.545 174.346 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 135' ' ' GLU . . . . . . . . . . . . . 84.9 tt0 -49.84 -24.36 2.39 Favored 'General case' 0 C--N 1.328 -0.357 0 N-CA-C 112.894 0.702 . . . . 0.0 112.894 -172.537 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 136' ' ' GLN . . . . . . . . . . . . . 96.1 mt-30 -99.81 -27.93 13.39 Favored 'General case' 0 N--CA 1.463 0.182 0 N-CA-C 112.727 0.64 . . . . 0.0 112.727 -174.672 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 137' ' ' LYS . . . . . . . . . . . . . 94.4 mttt -141.94 150.66 41.73 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-O 121.467 0.651 . . . . 0.0 112.296 -169.531 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 138' ' ' LEU . . . . . . . . . . . . . 11.3 tp -112.06 118.48 35.53 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 114.988 -1.005 . . . . 0.0 108.987 170.945 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 139' ' ' THR . . . . . . . . . . . . . 25.6 m -110.38 125.22 52.98 Favored 'General case' 0 C--N 1.331 -0.216 0 CA-C-O 120.644 0.259 . . . . 0.0 111.127 -177.014 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 140' ' ' LEU . . . . . . . . . . . . . 23.3 tp -114.56 122.8 47.65 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 115.652 -0.704 . . . . 0.0 109.354 179.586 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 141' ' ' ILE . . . . . . . . . . . . . 19.3 mt -121.87 125.16 72.86 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.247 0 CA-C-O 120.856 0.36 . . . . 0.0 110.199 -174.094 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 142' ' ' ARG . . . . . . . . . . . . . 79.0 mtp180 -114.53 129.38 56.66 Favored 'General case' 0 C--N 1.331 -0.212 0 CA-C-N 115.67 -0.695 . . . . 0.0 110.351 -179.34 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 143' ' ' THR . . . . . . . . . . . . . 26.0 p . . . . . 0 C--O 1.221 -0.424 0 CA-C-O 118.015 -0.993 . . . . 0.0 110.525 179.749 . . . . . . . . 0 0 . 1 . 009 nuclear orig core ' C' C ' 2' ' ' SER . . . . . . . . . . . . . 2.3 p . . . . . 0 C--O 1.232 0.15 0 CA-C-O 121.008 0.433 . . . . 0.0 110.36 . . . . . . . . . 0 0 . 1 . 009 nuclear orig core ' C' C ' 3' ' ' GLU . . . . . . . . . . . . . 85.3 tt0 -140.12 141.6 36.09 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 115.795 -0.639 . . . . 0.0 111.088 -177.001 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' C' C ' 4' ' ' LEU . . . . . . . . . . . . . 13.2 tp -124.11 130.39 52.46 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 115.765 -0.652 . . . . 0.0 110.116 177.497 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' C' C ' 5' ' ' LYS . . . . . . . . . . . . . 53.5 mttp -108.65 120.35 42.21 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.185 -0.462 . . . . 0.0 110.541 179.817 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' C' C ' 6' ' ' LEU . . . . . . . . . . . . . 55.4 mt -114.48 147.93 38.6 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 115.427 -0.806 . . . . 0.0 110.45 -178.827 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' C' C ' 7' ' ' LYS . . . . . . . . . . . . . 78.7 tttt -139.85 138.87 20.4 Favored Pre-proline 0 CA--C 1.534 0.328 0 CA-C-O 119.081 -0.485 . . . . 0.0 110.162 176.249 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' C' C ' 8' ' ' PRO . . . . . . . . . . . . . 98.2 Cg_endo -92.08 144.43 2.81 Favored 'Trans proline' 0 N--CA 1.49 1.267 0 C-N-CA 121.69 1.593 . . . . 0.0 111.812 177.482 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' C' C ' 9' ' ' LEU . . . . . . . . . . . . . 53.0 mt -74.94 -47.1 4.88 Favored Pre-proline 0 CA--C 1.534 0.353 0 CA-C-O 118.699 -0.667 . . . . 0.0 112.051 -179.524 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' C' C ' 10' ' ' PRO . . . . . . . . . . . . . 96.5 Cg_endo -82.28 156.56 17.04 Favored 'Trans proline' 0 N--CA 1.496 1.64 0 C-N-CA 121.221 1.281 . . . . 0.0 111.808 175.27 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' C' C ' 11' ' ' LYS . . . . . . . . . . . . . 59.3 tttm -88.7 106.57 18.42 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.428 -0.351 . . . . 0.0 110.24 178.32 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' C' C ' 12' ' ' VAL . . . . . . . . . . . . . 12.4 p -140.46 148.47 22.19 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.243 0 CA-C-N 116.248 -0.433 . . . . 0.0 110.632 -178.659 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' C' C ' 13' ' ' GLU . . . . . . . . . . . . . 83.2 tt0 -90.91 122.0 33.23 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 116.131 -0.486 . . . . 0.0 110.21 178.522 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' C' C ' 14' ' ' LEU . . . . . . . . . . . . . 35.5 mt -98.55 151.84 37.64 Favored Pre-proline 0 CA--C 1.532 0.282 0 CA-C-N 116.383 -0.371 . . . . 0.0 110.948 -176.706 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' C' C ' 15' ' ' PRO . . . . . . . . . . . . . 24.2 Cg_exo -63.96 158.01 49.75 Favored 'Trans proline' 0 N--CA 1.497 1.722 0 C-N-CA 121.266 1.311 . . . . 0.0 111.721 174.871 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' C' C ' 16' ' ' PRO . . . . . . . . . . . . . 39.4 Cg_exo -58.72 -38.87 86.86 Favored 'Trans proline' 0 N--CA 1.496 1.665 0 C-N-CA 121.409 1.406 . . . . 0.0 112.776 -178.965 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' C' C ' 17' ' ' ASP . . . . . . . . . . . . . 12.7 p-10 -87.95 11.94 14.54 Favored 'General case' 0 CA--C 1.536 0.424 0 N-CA-C 113.148 0.796 . . . . 0.0 113.148 -177.402 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' C' C ' 18' ' ' PHE . . . . . . . . . . . . . 44.9 t80 -57.95 -44.74 87.17 Favored 'General case' 0 C--N 1.335 -0.065 0 O-C-N 122.007 -0.433 . . . . 0.0 110.113 -178.826 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' C' C ' 19' ' ' VAL . . . . . . . . . . . . . 12.7 p -56.94 -41.61 77.15 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.357 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.726 -179.145 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' C' C ' 20' ' ' ASP . . . . . . . . . . . . . 79.6 m-20 -60.65 -42.93 97.97 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-O 120.843 0.354 . . . . 0.0 111.015 -177.709 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' C' C ' 21' ' ' VAL . . . . . . . . . . . . . 47.1 t -63.94 -47.98 88.18 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.338 0 C-N-CA 120.782 -0.367 . . . . 0.0 110.383 -178.076 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' C' C ' 22' ' ' ILE . . . . . . . . . . . . . 46.4 mm -58.11 -38.49 67.96 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.298 0 CA-C-O 120.841 0.353 . . . . 0.0 110.56 179.407 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' C' C ' 23' ' ' ARG . . . . . . . . . . . . . 56.3 ttp180 -55.53 -48.24 75.01 Favored 'General case' 0 C--N 1.33 -0.253 0 O-C-N 122.094 -0.379 . . . . 0.0 110.845 177.429 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' C' C ' 24' ' ' ILE . . . . . . . . . . . . . 67.2 mt -60.24 -41.9 88.54 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.358 0 CA-C-N 116.148 -0.478 . . . . 0.0 111.75 -177.776 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' C' C ' 25' ' ' LYS . . . . . . . . . . . . . 16.1 ptmt -72.33 -36.08 68.76 Favored 'General case' 0 CA--C 1.534 0.328 0 C-N-CA 120.561 -0.455 . . . . 0.0 112.077 -176.044 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' C' C ' 26' ' ' LEU . . . . . . . . . . . . . 78.3 mt -78.54 -41.78 31.19 Favored 'General case' 0 C--N 1.33 -0.247 0 N-CA-C 112.887 0.699 . . . . 0.0 112.887 -172.952 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' C' C ' 27' ' ' GLN . . . . . . . . . . . . . 9.9 pt20 -46.38 138.53 5.56 Favored 'General case' 0 N--CA 1.468 0.466 0 N-CA-C 112.812 0.671 . . . . 0.0 112.812 -175.338 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' C' C ' 28' ' ' GLY . . . . . . . . . . . . . . . 100.62 -26.65 23.82 Favored Glycine 0 CA--C 1.532 1.119 0 CA-C-N 115.55 -0.75 . . . . 0.0 112.135 -177.891 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' C' C ' 29' ' ' LYS . . . . . . . . . . . . . 59.7 mmtt -97.82 155.23 17.14 Favored 'General case' 0 C--O 1.233 0.217 0 CA-C-N 117.445 0.623 . . . . 0.0 111.019 178.699 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' C' C ' 30' ' ' THR . . . . . . . . . . . . . 40.5 m -100.08 135.79 40.97 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 115.883 -0.599 . . . . 0.0 109.688 174.24 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' C' C ' 31' ' ' VAL . . . . . . . . . . . . . 34.9 m -125.91 154.8 35.23 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.211 0 CA-C-N 116.5 -0.318 . . . . 0.0 110.602 -178.367 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' C' C ' 32' ' ' ARG . . . . . . . . . . . . . 46.3 ttt180 -135.71 149.13 49.13 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-O 121.225 0.536 . . . . 0.0 110.667 179.624 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' C' C ' 33' ' ' THR . . . . . . . . . . . . . 18.2 m -52.48 140.51 22.35 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.286 -0.415 . . . . 0.0 111.426 -178.339 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' C' C ' 34' ' ' GLY . . . . . . . . . . . . . . . 99.71 -17.04 58.03 Favored Glycine 0 CA--C 1.532 1.11 0 CA-C-O 119.656 -0.524 . . . . 0.0 113.224 179.073 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' C' C ' 35' ' ' ASP . . . . . . . . . . . . . 72.6 m-20 -64.59 149.19 49.33 Favored 'General case' 0 C--O 1.231 0.1 0 CA-C-N 118.13 0.965 . . . . 0.0 111.081 179.426 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' C' C ' 36' ' ' VAL . . . . . . . . . . . . . 45.6 t -126.01 130.69 72.24 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.249 0 CA-C-N 115.995 -0.548 . . . . 0.0 109.838 178.477 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' C' C ' 37' ' ' ILE . . . . . . . . . . . . . 66.6 mt -121.93 139.69 48.2 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.299 0 CA-C-N 116.292 -0.413 . . . . 0.0 110.194 -178.953 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' C' C ' 38' ' ' GLY . . . . . . . . . . . . . . . -108.7 128.85 9.25 Favored Glycine 0 CA--C 1.526 0.748 0 N-CA-C 110.96 -0.856 . . . . 0.0 110.96 179.285 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' C' C ' 39' ' ' ILE . . . . . . . . . . . . . 72.6 mt -125.78 132.22 71.02 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.181 0 N-CA-C 110.191 -0.3 . . . . 0.0 110.191 179.829 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' C' C ' 40' ' ' SER . . . . . . . . . . . . . 27.6 t -92.78 122.16 34.9 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.418 -0.356 . . . . 0.0 110.886 175.581 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' C' C ' 41' ' ' ILE . . . . . . . . . . . . . 72.3 mt -131.01 116.89 35.43 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.223 0 CA-C-O 121.031 0.443 . . . . 0.0 110.55 178.699 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' C' C ' 42' ' ' LEU . . . . . . . . . . . . . 1.3 tt 51.46 47.4 24.89 Favored 'General case' 0 CA--C 1.531 0.217 0 CA-C-N 115.768 -0.651 . . . . 0.0 111.208 175.996 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' C' C ' 43' ' ' GLY . . . . . . . . . . . . . . . 70.17 21.38 77.09 Favored Glycine 0 CA--C 1.531 1.075 0 C-N-CA 121.081 -0.58 . . . . 0.0 112.79 175.016 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' C' C ' 44' ' ' LYS . . . . . . . . . . . . . 59.4 mtpt -131.65 128.35 38.88 Favored 'General case' 0 C--N 1.331 -0.212 0 CA-C-N 117.692 0.746 . . . . 0.0 110.098 179.068 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' C' C ' 45' ' ' GLU . . . . . . . . . . . . . 83.2 tt0 -83.8 123.14 29.58 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 116.441 -0.345 . . . . 0.0 110.997 -179.68 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' C' C ' 46' ' ' VAL . . . . . . . . . . . . . 7.2 p -123.15 128.26 74.92 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.204 0 N-CA-C 109.722 -0.473 . . . . 0.0 109.722 176.669 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' C' C ' 47' ' ' LYS . . . . . . . . . . . . . 63.2 mttp -100.19 128.65 46.23 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.085 -0.507 . . . . 0.0 111.089 177.664 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' C' C ' 48' ' ' PHE . . . . . . . . . . . . . 91.1 m-85 -110.5 131.83 54.71 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.206 -0.452 . . . . 0.0 109.863 176.346 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' C' C ' 49' ' ' LYS . . . . . . . . . . . . . 79.2 tttt -108.61 137.99 45.66 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.377 -0.374 . . . . 0.0 110.424 178.978 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' C' C ' 50' ' ' VAL . . . . . . . . . . . . . 44.9 t -79.73 106.28 10.55 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.335 0 N-CA-C 109.335 -0.617 . . . . 0.0 109.335 175.828 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' C' C ' 51' ' ' VAL . . . . . . . . . . . . . 48.2 t -69.81 -47.67 68.69 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.284 0 CA-C-N 116.052 -0.522 . . . . 0.0 109.863 -173.486 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' C' C ' 52' ' ' GLN . . . . . . . . . . . . . 21.4 pt20 -167.85 158.88 11.11 Favored 'General case' 0 C--N 1.332 -0.192 0 C-N-CA 120.165 -0.614 . . . . 0.0 111.643 179.482 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' C' C ' 53' ' ' ALA . . . . . . . . . . . . . . . -135.56 138.68 43.24 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 115.564 -0.743 . . . . 0.0 110.229 178.94 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' C' C ' 54' ' ' TYR . . . . . . . . . . . . . 63.6 t80 -128.9 110.31 18.52 Favored Pre-proline 0 CA--C 1.534 0.36 0 CA-C-O 118.156 -0.926 . . . . 0.0 110.259 179.772 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' C' C ' 55' ' ' PRO . . . . . . . . . . . . . 73.4 Cg_endo -77.17 170.06 72.55 Favored 'Cis proline' 0 N--CA 1.501 1.926 0 CA-C-N 121.908 1.717 . . . . 0.0 112.236 -7.91 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' C' C ' 56' ' ' SER . . . . . . . . . . . . . 51.1 m -121.24 134.6 24.49 Favored Pre-proline 0 CA--C 1.537 0.457 0 CA-C-O 118.582 -0.723 . . . . 0.0 109.619 175.09 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' C' C ' 57' ' ' PRO . . . . . . . . . . . . . 36.3 Cg_endo -66.41 164.68 66.05 Favored 'Cis proline' 0 N--CA 1.499 1.799 0 CA-C-N 121.841 1.693 . . . . 0.0 111.521 -2.944 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' C' C ' 58' ' ' LEU . . . . . . . . . . . . . 32.8 tp -130.77 139.68 50.25 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-O 120.947 0.403 . . . . 0.0 110.663 -178.338 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' C' C ' 59' ' ' ARG . . . . . . . . . . . . . 55.2 ttm-85 -96.1 129.5 43.37 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-N 115.762 -0.654 . . . . 0.0 109.338 174.367 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' C' C ' 60' ' ' VAL . . . . . . . . . . . . . 40.9 t -86.14 121.11 37.02 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.268 0 C-N-CA 120.624 -0.431 . . . . 0.0 110.4 -177.917 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' C' C ' 61' ' ' GLU . . . . . . . . . . . . . 71.6 tt0 -130.57 157.66 42.1 Favored 'General case' 0 C--N 1.329 -0.31 0 N-CA-C 109.113 -0.699 . . . . 0.0 109.113 177.523 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' C' C ' 62' ' ' ASP . . . . . . . . . . . . . 12.8 t70 -51.22 -32.28 23.45 Favored 'General case' 0 C--N 1.327 -0.404 0 N-CA-C 112.07 0.396 . . . . 0.0 112.07 -178.282 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' C' C ' 63' ' ' ARG . . . . . . . . . . . . . 98.2 mtt180 -77.18 -21.94 53.21 Favored 'General case' 0 CA--C 1.533 0.29 0 N-CA-C 112.857 0.688 . . . . 0.0 112.857 -177.812 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' C' C ' 64' ' ' THR . . . . . . . . . . . . . 20.0 m -57.46 141.8 46.27 Favored 'General case' 0 C--N 1.331 -0.207 0 CA-C-O 120.842 0.353 . . . . 0.0 110.642 -176.478 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' C' C ' 65' ' ' LYS . . . . . . . . . . . . . 40.2 ttpt -89.13 121.44 31.45 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.1 -0.5 . . . . 0.0 110.279 -179.63 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' C' C ' 66' ' ' ILE . . . . . . . . . . . . . 63.1 mt -113.5 129.15 69.82 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.241 0 N-CA-C 109.87 -0.418 . . . . 0.0 109.87 -179.718 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' C' C ' 67' ' ' THR . . . . . . . . . . . . . 18.8 m -129.08 143.86 51.0 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-O 121.142 0.496 . . . . 0.0 111.236 -177.433 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' C' C ' 68' ' ' LEU . . . . . . . . . . . . . 17.1 tp . . . . . 0 C--N 1.329 -0.323 0 CA-C-N 115.827 -0.624 . . . . 0.0 110.092 177.58 . . . . . . . . 0 0 . 1 . 009 nuclear orig core ' C' C ' 73' ' ' VAL . . . . . . . . . . . . . 35.5 m . . . . . 0 C--O 1.232 0.15 0 N-CA-C 109.598 -0.519 . . . . 0.0 109.598 . . . . . . . . . 0 0 . 1 . 009 nuclear orig core ' C' C ' 74' ' ' ASP . . . . . . . . . . . . . 27.6 t0 -98.71 119.81 38.08 Favored 'General case' 0 C--N 1.331 -0.203 0 C-N-CA 120.805 -0.358 . . . . 0.0 110.193 -176.185 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' C' C ' 75' ' ' VAL . . . . . . . . . . . . . 40.6 t -119.13 121.9 67.87 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.237 0 CA-C-O 121.094 0.473 . . . . 0.0 110.63 -178.009 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' C' C ' 76' ' ' LEU . . . . . . . . . . . . . 7.1 mp -117.25 139.78 50.37 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 115.669 -0.696 . . . . 0.0 109.402 175.437 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' C' C ' 77' ' ' GLU . . . . . . . . . . . . . 98.0 mt-10 -135.47 129.08 32.6 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-O 121.072 0.463 . . . . 0.0 111.007 -178.401 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' C' C ' 78' ' ' ALA . . . . . . . . . . . . . . . -117.66 136.69 53.15 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 115.638 -0.71 . . . . 0.0 109.957 177.778 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' C' C ' 79' ' ' LYS . . . . . . . . . . . . . 68.4 mmtt -73.37 116.01 13.42 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.512 -0.313 . . . . 0.0 110.16 -179.107 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' C' C ' 80' ' ' ILE . . . . . . . . . . . . . 39.7 mm -139.09 110.63 5.13 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.303 0 N-CA-C 109.56 -0.533 . . . . 0.0 109.56 -177.433 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' C' C ' 81' ' ' LYS . . . . . . . . . . . . . 99.5 mttt -112.56 128.73 56.44 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-O 120.95 0.405 . . . . 0.0 110.775 -178.852 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' C' C ' 82' ' ' GLY . . . . . . . . . . . . . . . 89.08 42.16 5.68 Favored Glycine 0 CA--C 1.525 0.679 0 C-N-CA 121.024 -0.608 . . . . 0.0 111.649 176.835 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' C' C ' 83' ' ' ILE . . . . . . . . . . . . . 72.0 mt -69.51 136.17 26.78 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.22 0 N-CA-C 109.718 -0.475 . . . . 0.0 109.718 177.23 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' C' C ' 84' ' ' LYS . . . . . . . . . . . . . 60.2 tttp -97.81 -53.56 3.37 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.054 -0.521 . . . . 0.0 110.195 -178.187 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' C' C ' 85' ' ' ASP . . . . . . . . . . . . . 13.1 t70 -151.17 148.67 28.54 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 115.746 -0.661 . . . . 0.0 110.232 -179.342 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' C' C ' 86' ' ' VAL . . . . . . . . . . . . . 41.4 t -129.2 129.62 67.63 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.264 0 CA-C-O 120.944 0.402 . . . . 0.0 110.397 -179.294 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' C' C ' 87' ' ' ILE . . . . . . . . . . . . . 44.6 mm -119.14 126.0 74.97 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.263 0 CA-C-N 115.923 -0.58 . . . . 0.0 109.657 177.097 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' C' C ' 88' ' ' LEU . . . . . . . . . . . . . 19.4 tp -109.82 123.4 49.49 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-O 121.005 0.431 . . . . 0.0 110.826 -178.333 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' C' C ' 89' ' ' ASP . . . . . . . . . . . . . 13.6 t70 -113.61 156.86 22.92 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 115.81 -0.632 . . . . 0.0 109.336 176.325 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' C' C ' 90' ' ' GLU . . . . . . . . . . . . . 81.8 tt0 -45.14 -42.28 8.82 Favored 'General case' 0 N--CA 1.465 0.282 0 N-CA-C 113.266 0.839 . . . . 0.0 113.266 -171.694 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' C' C ' 91' ' ' ASN . . . . . . . . . . . . . 73.1 m-20 -132.02 25.19 4.6 Favored 'General case' 0 N--CA 1.467 0.377 0 N-CA-C 112.652 0.612 . . . . 0.0 112.652 -178.539 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' C' C ' 92' ' ' LEU . . . . . . . . . . . . . 38.1 mt -148.17 142.02 25.74 Favored 'General case' 0 C--N 1.332 -0.19 0 N-CA-C 110.171 -0.307 . . . . 0.0 110.171 -177.635 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' C' C ' 93' ' ' ILE . . . . . . . . . . . . . 62.7 mt -118.62 116.9 52.72 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.266 0 N-CA-C 109.425 -0.583 . . . . 0.0 109.425 179.986 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' C' C ' 94' ' ' VAL . . . . . . . . . . . . . 44.2 t -119.39 124.13 72.45 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.2 0 CA-C-O 121.026 0.441 . . . . 0.0 110.075 -179.671 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' C' C ' 95' ' ' VAL . . . . . . . . . . . . . 42.7 t -121.23 135.35 61.68 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.297 0 CA-C-N 115.803 -0.635 . . . . 0.0 109.96 -179.258 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' C' C ' 96' ' ' ILE . . . . . . . . . . . . . 60.4 mt -115.9 128.86 73.04 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.288 0 N-CA-C 109.411 -0.588 . . . . 0.0 109.411 178.264 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' C' C ' 97' ' ' THR . . . . . . . . . . . . . 80.5 p -98.67 160.08 14.51 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-O 121.08 0.467 . . . . 0.0 110.828 -179.184 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' C' C ' 98' ' ' GLU . . . . . . . . . . . . . 97.6 mt-10 -53.82 -25.73 20.86 Favored 'General case' 0 CA--C 1.532 0.265 0 N-CA-C 112.257 0.465 . . . . 0.0 112.257 -179.927 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' C' C ' 99' ' ' GLU . . . . . . . . . . . . . 43.2 mt-10 -79.86 16.37 1.18 Allowed 'General case' 0 CA--C 1.535 0.375 0 N-CA-C 113.071 0.767 . . . . 0.0 113.071 -177.732 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' C' C ' 100' ' ' ASN . . . . . . . . . . . . . 3.9 m-20 61.83 38.07 15.0 Favored 'General case' 0 CA--C 1.529 0.155 0 CA-C-O 121.12 0.486 . . . . 0.0 110.91 178.27 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' C' C ' 101' ' ' GLU . . . . . . . . . . . . . 84.7 tt0 -113.18 141.42 46.96 Favored 'General case' 0 C--N 1.331 -0.199 0 CA-C-N 116.159 -0.473 . . . . 0.0 109.854 176.55 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' C' C ' 102' ' ' VAL . . . . . . . . . . . . . 46.1 t -114.86 125.08 72.09 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.272 0 CA-C-N 116.221 -0.445 . . . . 0.0 109.917 -178.55 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' C' C ' 103' ' ' LEU . . . . . . . . . . . . . 16.8 mt -116.65 129.83 56.38 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 115.616 -0.72 . . . . 0.0 110.182 177.763 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' C' C ' 104' ' ' ILE . . . . . . . . . . . . . 61.5 mt -117.7 120.71 65.53 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.286 0 N-CA-C 110.296 -0.261 . . . . 0.0 110.296 179.028 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' C' C ' 105' ' ' PHE . . . . . . . . . . . . . 46.0 m-85 -120.75 163.28 18.35 Favored 'General case' 0 C--N 1.332 -0.171 0 O-C-N 123.97 0.794 . . . . 0.0 109.654 177.86 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' C' C ' 106' ' ' ASN . . . . . . . . . . . . . 45.8 p-10 -97.42 -171.02 2.11 Favored 'General case' 0 C--N 1.331 -0.219 0 N-CA-C 109.783 -0.451 . . . . 0.0 109.783 173.719 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' C' C ' 107' ' ' GLN . . . . . . . . . . . . . 51.1 tt0 -59.67 -28.69 67.49 Favored 'General case' 0 C--N 1.329 -0.309 0 N-CA-C 112.043 0.386 . . . . 0.0 112.043 179.687 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' C' C ' 108' ' ' ASN . . . . . . . . . . . . . 24.6 t30 -84.88 11.94 8.37 Favored 'General case' 0 CA--C 1.537 0.447 0 N-CA-C 112.955 0.724 . . . . 0.0 112.955 -178.012 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' C' C ' 109' ' ' LEU . . . . . . . . . . . . . 11.6 tp 55.76 38.19 29.79 Favored 'General case' 0 C--O 1.232 0.154 0 CA-C-O 121.099 0.476 . . . . 0.0 111.338 178.722 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' C' C ' 110' ' ' GLU . . . . . . . . . . . . . 70.7 mm-40 -101.97 148.91 24.78 Favored 'General case' 0 C--N 1.328 -0.336 0 N-CA-C 109.636 -0.505 . . . . 0.0 109.636 175.707 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' C' C ' 111' ' ' GLU . . . . . . . . . . . . . 82.8 tt0 -81.85 121.91 27.05 Favored 'General case' 0 C--N 1.326 -0.415 0 CA-C-O 120.834 0.349 . . . . 0.0 110.357 -179.45 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' C' C ' 112' ' ' LEU . . . . . . . . . . . . . 34.1 mt -111.56 -46.04 3.31 Favored 'General case' 0 C--N 1.331 -0.203 0 CA-C-N 116.107 -0.497 . . . . 0.0 110.595 -179.689 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' C' C ' 113' ' ' TYR . . . . . . . . . . . . . 56.9 t80 -138.58 135.29 34.83 Favored 'General case' 0 C--N 1.33 -0.259 0 C-N-CA 120.772 -0.371 . . . . 0.0 111.332 -179.154 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' C' C ' 114' ' ' ARG . . . . . . . . . . . . . 63.8 ttp85 -137.88 122.08 18.07 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 115.949 -0.569 . . . . 0.0 110.026 178.956 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' C' C ' 115' ' ' GLY . . . . . . . . . . . . . . . -150.12 142.81 10.02 Favored Glycine 0 CA--C 1.525 0.671 0 C-N-CA 120.79 -0.719 . . . . 0.0 111.336 178.826 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' C' C ' 116' ' ' LYS . . . . . . . . . . . . . 38.8 ttpt -111.49 132.94 54.13 Favored 'General case' 0 C--N 1.33 -0.25 0 N-CA-C 109.782 -0.451 . . . . 0.0 109.782 176.379 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' C' C ' 117' ' ' PHE . . . . . . . . . . . . . 57.8 m-85 -130.69 113.97 14.82 Favored 'General case' 0 C--N 1.332 -0.193 0 CA-C-O 120.983 0.421 . . . . 0.0 110.385 -176.631 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' C' C ' 118' ' ' GLU . . . . . . . . . . . . . 71.0 mm-40 -54.28 -47.52 72.27 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.284 -0.416 . . . . 0.0 111.283 -177.276 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' C' C ' 119' ' ' ASN . . . . . . . . . . . . . 33.3 m120 -94.63 30.99 1.87 Allowed 'General case' 0 C--N 1.33 -0.251 0 N-CA-C 112.194 0.442 . . . . 0.0 112.194 -175.043 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' C' C ' 120' ' ' LEU . . . . . . . . . . . . . 13.7 tp -57.64 121.21 9.82 Favored 'General case' 0 C--N 1.332 -0.165 0 N-CA-C 110.204 -0.295 . . . . 0.0 110.204 177.163 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' C' C ' 121' ' ' ASN . . . . . . . . . . . . . 94.2 m-20 -114.01 -43.91 3.2 Favored 'General case' 0 C--O 1.232 0.171 0 CA-C-N 116.484 -0.326 . . . . 0.0 111.338 -176.113 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' C' C ' 122' ' ' LYS . . . . . . . . . . . . . 39.5 ttpt -150.97 148.88 28.93 Favored 'General case' 0 C--N 1.331 -0.227 0 CA-C-O 121.04 0.448 . . . . 0.0 111.637 -176.617 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' C' C ' 123' ' ' VAL . . . . . . . . . . . . . 44.9 t -128.65 133.87 65.62 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.227 0 CA-C-N 116.007 -0.542 . . . . 0.0 109.737 177.417 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' C' C ' 124' ' ' LEU . . . . . . . . . . . . . 79.5 mt -128.93 139.35 52.16 Favored 'General case' 0 C--N 1.331 -0.201 0 CA-C-O 120.759 0.314 . . . . 0.0 110.942 -178.595 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' C' C ' 125' ' ' VAL . . . . . . . . . . . . . 35.6 m -133.17 128.93 56.58 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.206 0 CA-C-N 116.254 -0.43 . . . . 0.0 110.53 178.242 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' C' C ' 126' ' ' ARG . . . . . . . . . . . . . 91.0 mtt180 -150.78 128.33 11.48 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.419 -0.355 . . . . 0.0 110.177 178.199 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' C' C ' 127' ' ' ASN . . . . . . . . . . . . . 77.5 m-20 54.52 -151.58 0.36 Allowed 'General case' 0 CA--C 1.541 0.6 0 CA-C-O 119.449 -0.31 . . . . 0.0 110.228 178.017 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' C' C ' 128' ' ' ASP . . . . . . . . . . . . . 23.5 p-10 -81.03 18.14 1.09 Allowed 'General case' 0 CA--C 1.536 0.405 0 N-CA-C 112.881 0.697 . . . . 0.0 112.881 -179.62 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' C' C ' 129' ' ' LEU . . . . . . . . . . . . . 15.9 tp -123.92 137.02 54.69 Favored 'General case' 0 C--O 1.232 0.165 0 CA-C-N 117.983 0.356 . . . . 0.0 110.185 178.715 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' C' C ' 130' ' ' VAL . . . . . . . . . . . . . 32.1 m -131.78 145.81 34.4 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.197 0 CA-C-O 120.905 0.383 . . . . 0.0 110.327 178.575 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' C' C ' 131' ' ' VAL . . . . . . . . . . . . . 40.7 t -136.1 140.49 43.8 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.325 0 CA-C-O 121.058 0.456 . . . . 0.0 110.553 -177.704 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' C' C ' 132' ' ' ILE . . . . . . . . . . . . . 73.9 mt -116.8 129.68 72.92 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 CA-C-N 115.585 -0.734 . . . . 0.0 109.032 177.45 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' C' C ' 133' ' ' ILE . . . . . . . . . . . . . 40.3 mm -114.06 121.84 66.99 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.275 0 CA-C-O 120.698 0.285 . . . . 0.0 110.942 -174.428 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' C' C ' 134' ' ' ASP . . . . . . . . . . . . . 9.0 p-10 -135.23 146.54 48.72 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.116 -0.493 . . . . 0.0 109.786 175.501 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' C' C ' 135' ' ' GLU . . . . . . . . . . . . . 81.2 tt0 -49.92 -25.41 3.21 Favored 'General case' 0 CA--C 1.533 0.325 0 N-CA-C 112.77 0.656 . . . . 0.0 112.77 -175.465 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' C' C ' 136' ' ' GLN . . . . . . . . . . . . . 58.3 tp60 -80.88 -34.28 33.7 Favored 'General case' 0 C--O 1.233 0.2 0 N-CA-C 112.036 0.384 . . . . 0.0 112.036 -176.032 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' C' C ' 137' ' ' LYS . . . . . . . . . . . . . 40.3 pttt -169.57 175.49 5.38 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-O 121.522 0.677 . . . . 0.0 112.085 -173.597 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' C' C ' 138' ' ' LEU . . . . . . . . . . . . . 4.8 tt -117.74 125.34 50.47 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 115.05 -0.977 . . . . 0.0 109.81 177.931 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' C' C ' 139' ' ' THR . . . . . . . . . . . . . 28.6 m -105.18 124.01 48.81 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.312 -0.404 . . . . 0.0 110.497 179.701 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' C' C ' 140' ' ' LEU . . . . . . . . . . . . . 19.6 tp -110.68 117.89 34.71 Favored 'General case' 0 C--N 1.329 -0.302 0 N-CA-C 109.046 -0.724 . . . . 0.0 109.046 -179.496 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' C' C ' 141' ' ' ILE . . . . . . . . . . . . . 19.9 mt -118.63 121.29 66.63 Favored 'Isoleucine or valine' 0 C--O 1.234 0.25 0 CA-C-O 121.24 0.543 . . . . 0.0 109.877 -175.496 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' C' C ' 142' ' ' ARG . . . . . . . . . . . . . 70.5 mtt180 . . . . . 0 C--N 1.33 -0.274 0 CA-C-N 115.042 -0.981 . . . . 0.0 110.112 -177.952 . . . . . . . . 0 0 . 1 . 009 nuclear orig core ' D' D ' 2' ' ' SER . . . . . . . . . . . . . 12.7 p . . . . . 0 N--CA 1.462 0.156 0 CA-C-O 121.164 0.507 . . . . 0.0 110.677 . . . . . . . . . 0 0 . 1 . 009 nuclear orig core ' D' D ' 3' ' ' GLU . . . . . . . . . . . . . 84.9 tt0 -143.99 140.87 29.85 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 115.748 -0.66 . . . . 0.0 111.161 -178.709 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' D' D ' 4' ' ' LEU . . . . . . . . . . . . . 19.2 tp -124.56 131.74 53.47 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.014 -0.539 . . . . 0.0 110.06 177.093 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' D' D ' 5' ' ' LYS . . . . . . . . . . . . . 77.9 mttt -111.93 120.91 43.51 Favored 'General case' 0 C--O 1.234 0.259 0 CA-C-N 116.365 -0.379 . . . . 0.0 110.767 -179.406 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' D' D ' 6' ' ' LEU . . . . . . . . . . . . . 54.5 mt -114.57 142.47 46.39 Favored 'General case' 0 C--N 1.332 -0.174 0 CA-C-N 115.553 -0.749 . . . . 0.0 110.163 -179.563 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' D' D ' 7' ' ' LYS . . . . . . . . . . . . . 31.0 ttpt -122.3 136.87 26.86 Favored Pre-proline 0 CA--C 1.534 0.351 0 CA-C-O 118.84 -0.6 . . . . 0.0 109.602 175.794 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' D' D ' 8' ' ' PRO . . . . . . . . . . . . . 98.8 Cg_endo -91.22 131.78 1.44 Allowed 'Trans proline' 0 N--CA 1.489 1.255 0 C-N-CA 121.687 1.591 . . . . 0.0 111.799 178.215 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' D' D ' 9' ' ' LEU . . . . . . . . . . . . . 36.1 mt -72.8 -47.48 8.83 Favored Pre-proline 0 CA--C 1.535 0.38 0 CA-C-O 118.49 -0.767 . . . . 0.0 112.128 -178.593 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' D' D ' 10' ' ' PRO . . . . . . . . . . . . . 75.8 Cg_endo -78.62 149.1 23.53 Favored 'Trans proline' 0 N--CA 1.496 1.623 0 CA-C-N 120.347 1.159 . . . . 0.0 111.794 176.397 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' D' D ' 11' ' ' LYS . . . . . . . . . . . . . 53.7 mttp -85.51 95.85 9.43 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.481 -0.327 . . . . 0.0 110.693 -179.721 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' D' D ' 12' ' ' VAL . . . . . . . . . . . . . 12.1 p -144.35 145.19 21.79 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.278 0 CA-C-N 116.285 -0.416 . . . . 0.0 110.43 179.361 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' D' D ' 13' ' ' GLU . . . . . . . . . . . . . 95.7 mt-10 -90.11 122.09 32.76 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.254 -0.43 . . . . 0.0 110.271 178.681 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' D' D ' 14' ' ' LEU . . . . . . . . . . . . . 23.1 mt -98.07 154.34 37.77 Favored Pre-proline 0 CA--C 1.532 0.265 0 CA-C-N 116.283 -0.417 . . . . 0.0 111.174 -177.874 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' D' D ' 15' ' ' PRO . . . . . . . . . . . . . 36.6 Cg_exo -59.35 162.29 14.88 Favored 'Trans proline' 0 N--CA 1.496 1.669 0 C-N-CA 121.4 1.4 . . . . 0.0 112.079 178.581 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' D' D ' 16' ' ' PRO . . . . . . . . . . . . . 23.7 Cg_exo -63.01 -41.42 28.83 Favored 'Trans proline' 0 N--CA 1.497 1.703 0 C-N-CA 121.493 1.462 . . . . 0.0 112.815 -179.175 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' D' D ' 17' ' ' ASP . . . . . . . . . . . . . 22.8 p-10 -82.91 9.53 9.81 Favored 'General case' 0 CA--C 1.537 0.47 0 N-CA-C 113.241 0.83 . . . . 0.0 113.241 -176.859 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' D' D ' 18' ' ' PHE . . . . . . . . . . . . . 29.3 t80 -56.98 -41.81 79.09 Favored 'General case' 0 C--N 1.334 -0.09 0 O-C-N 121.986 -0.446 . . . . 0.0 110.369 -179.562 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' D' D ' 19' ' ' VAL . . . . . . . . . . . . . 46.5 t -56.23 -44.44 79.35 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.252 0 CA-C-N 116.327 -0.397 . . . . 0.0 110.599 -179.379 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' D' D ' 20' ' ' ASP . . . . . . . . . . . . . 41.6 m-20 -59.81 -41.26 90.87 Favored 'General case' 0 C--N 1.33 -0.247 0 C-N-CA 120.84 -0.344 . . . . 0.0 110.943 -178.091 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' D' D ' 21' ' ' VAL . . . . . . . . . . . . . 47.2 t -63.66 -47.54 90.78 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 C-N-CA 120.759 -0.377 . . . . 0.0 110.494 -178.357 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' D' D ' 22' ' ' ILE . . . . . . . . . . . . . 49.8 mm -54.78 -47.28 74.55 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.273 0 C-N-CA 120.97 -0.292 . . . . 0.0 110.798 178.907 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' D' D ' 23' ' ' ARG . . . . . . . . . . . . . 53.2 ttp180 -53.74 -52.0 61.55 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-O 120.609 0.242 . . . . 0.0 111.533 -178.953 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' D' D ' 24' ' ' ILE . . . . . . . . . . . . . 76.7 mt -58.61 -41.26 81.6 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.377 0 CA-C-N 116.749 -0.205 . . . . 0.0 111.367 -176.339 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' D' D ' 25' ' ' LYS . . . . . . . . . . . . . 73.0 mmtt -68.4 -42.29 79.23 Favored 'General case' 0 C--N 1.329 -0.292 0 N-CA-C 112.277 0.473 . . . . 0.0 112.277 -178.338 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' D' D ' 26' ' ' LEU . . . . . . . . . . . . . 33.1 mt -80.47 -34.31 35.99 Favored 'General case' 0 C--N 1.33 -0.258 0 N-CA-C 113.661 0.986 . . . . 0.0 113.661 -169.41 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' D' D ' 27' ' ' GLN . . . . . . . . . . . . . 9.1 pt20 -46.1 139.71 4.34 Favored 'General case' 0 N--CA 1.469 0.489 0 N-CA-C 112.853 0.686 . . . . 0.0 112.853 -175.17 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' D' D ' 28' ' ' GLY . . . . . . . . . . . . . . . 101.05 -27.01 22.54 Favored Glycine 0 CA--C 1.532 1.144 0 CA-C-N 115.657 -0.701 . . . . 0.0 112.163 -175.99 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' D' D ' 29' ' ' LYS . . . . . . . . . . . . . 64.9 mttp -97.65 155.09 17.15 Favored 'General case' 0 C--O 1.233 0.226 0 CA-C-N 117.336 0.568 . . . . 0.0 110.986 178.751 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' D' D ' 30' ' ' THR . . . . . . . . . . . . . 40.1 m -106.77 140.63 39.32 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.232 -0.44 . . . . 0.0 110.151 177.251 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' D' D ' 31' ' ' VAL . . . . . . . . . . . . . 34.9 m -128.22 156.12 40.21 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.19 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.851 -179.125 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' D' D ' 32' ' ' ARG . . . . . . . . . . . . . 67.3 ttt180 -131.65 147.0 52.48 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 115.974 -0.557 . . . . 0.0 110.314 178.285 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' D' D ' 33' ' ' THR . . . . . . . . . . . . . 22.8 m -52.52 139.22 25.94 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-O 120.762 0.315 . . . . 0.0 111.502 -178.329 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' D' D ' 34' ' ' GLY . . . . . . . . . . . . . . . 99.67 -17.05 58.07 Favored Glycine 0 CA--C 1.533 1.159 0 CA-C-O 119.762 -0.466 . . . . 0.0 113.32 179.26 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' D' D ' 35' ' ' ASP . . . . . . . . . . . . . 76.7 m-20 -66.44 149.24 50.72 Favored 'General case' 0 N--CA 1.46 0.074 0 CA-C-N 117.992 0.896 . . . . 0.0 111.17 179.787 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' D' D ' 36' ' ' VAL . . . . . . . . . . . . . 45.6 t -120.18 128.9 76.0 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.202 0 CA-C-N 115.749 -0.66 . . . . 0.0 109.687 177.439 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' D' D ' 37' ' ' ILE . . . . . . . . . . . . . 64.1 mt -121.37 138.85 50.38 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.229 0 CA-C-N 116.194 -0.457 . . . . 0.0 109.889 -179.145 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' D' D ' 38' ' ' GLY . . . . . . . . . . . . . . . -117.97 128.87 7.97 Favored Glycine 0 CA--C 1.526 0.749 0 N-CA-C 110.97 -0.852 . . . . 0.0 110.97 -179.943 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' D' D ' 39' ' ' ILE . . . . . . . . . . . . . 71.5 mt -128.05 129.83 69.64 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.198 0 N-CA-C 110.036 -0.357 . . . . 0.0 110.036 178.815 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' D' D ' 40' ' ' SER . . . . . . . . . . . . . 87.2 p -92.16 123.73 35.72 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.267 -0.424 . . . . 0.0 110.861 176.804 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' D' D ' 41' ' ' ILE . . . . . . . . . . . . . 71.9 mt -134.14 121.04 36.83 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.263 0 CA-C-O 120.993 0.425 . . . . 0.0 110.278 177.82 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' D' D ' 42' ' ' LEU . . . . . . . . . . . . . 1.3 tt 57.81 44.78 19.66 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-O 121.42 0.629 . . . . 0.0 110.187 178.46 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' D' D ' 43' ' ' GLY . . . . . . . . . . . . . . . 72.36 -5.75 13.89 Favored Glycine 0 CA--C 1.534 1.276 0 C-N-CA 121.146 -0.549 . . . . 0.0 113.644 175.897 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' D' D ' 44' ' ' LYS . . . . . . . . . . . . . 22.9 tptm -109.27 126.05 52.93 Favored 'General case' 0 N--CA 1.462 0.129 0 CA-C-N 118.141 0.971 . . . . 0.0 110.183 -178.908 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' D' D ' 45' ' ' GLU . . . . . . . . . . . . . 43.6 tp10 -84.69 130.31 34.72 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-O 120.816 0.341 . . . . 0.0 111.124 -179.482 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' D' D ' 46' ' ' VAL . . . . . . . . . . . . . 10.3 p -120.3 126.99 75.86 Favored 'Isoleucine or valine' 0 N--CA 1.462 0.167 0 N-CA-C 109.818 -0.438 . . . . 0.0 109.818 175.25 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' D' D ' 47' ' ' LYS . . . . . . . . . . . . . 86.4 mttt -99.09 126.16 44.77 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 115.912 -0.585 . . . . 0.0 110.931 178.248 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' D' D ' 48' ' ' PHE . . . . . . . . . . . . . 34.2 m-85 -111.43 131.97 54.8 Favored 'General case' 0 C--N 1.331 -0.207 0 N-CA-C 109.812 -0.44 . . . . 0.0 109.812 177.665 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' D' D ' 49' ' ' LYS . . . . . . . . . . . . . 38.4 tttp -107.71 132.15 53.66 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.362 -0.381 . . . . 0.0 110.274 177.655 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' D' D ' 50' ' ' VAL . . . . . . . . . . . . . 45.5 t -76.56 104.11 4.38 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.332 0 N-CA-C 109.361 -0.607 . . . . 0.0 109.361 177.06 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' D' D ' 51' ' ' VAL . . . . . . . . . . . . . 47.5 t -69.48 -53.2 26.11 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.341 0 N-CA-C 109.554 -0.536 . . . . 0.0 109.554 -175.692 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' D' D ' 52' ' ' GLN . . . . . . . . . . . . . 81.8 mt-30 -154.86 152.45 29.79 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.053 -0.522 . . . . 0.0 111.677 -178.381 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' D' D ' 53' ' ' ALA . . . . . . . . . . . . . . . -129.29 133.29 47.4 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 115.361 -0.836 . . . . 0.0 109.703 175.539 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' D' D ' 54' ' ' TYR . . . . . . . . . . . . . 45.8 t80 -129.0 109.69 18.28 Favored Pre-proline 0 CA--C 1.535 0.397 0 CA-C-O 118.162 -0.923 . . . . 0.0 110.463 179.217 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' D' D ' 55' ' ' PRO . . . . . . . . . . . . . 73.7 Cg_endo -77.17 167.47 79.58 Favored 'Cis proline' 0 N--CA 1.5 1.871 0 CA-C-N 121.808 1.681 . . . . 0.0 112.103 -6.676 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' D' D ' 56' ' ' SER . . . . . . . . . . . . . 62.7 m -117.41 133.04 23.27 Favored Pre-proline 0 CA--C 1.54 0.567 0 CA-C-O 118.437 -0.792 . . . . 0.0 109.458 174.803 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' D' D ' 57' ' ' PRO . . . . . . . . . . . . . 38.4 Cg_endo -67.7 164.5 72.51 Favored 'Cis proline' 0 N--CA 1.498 1.774 0 CA-C-N 121.881 1.707 . . . . 0.0 111.433 -1.407 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' D' D ' 58' ' ' LEU . . . . . . . . . . . . . 24.0 tp -130.73 138.05 49.8 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 116.321 -0.399 . . . . 0.0 110.612 -179.478 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' D' D ' 59' ' ' ARG . . . . . . . . . . . . . 56.7 ttp180 -103.24 127.96 50.4 Favored 'General case' 0 C--N 1.328 -0.342 0 N-CA-C 109.362 -0.607 . . . . 0.0 109.362 174.882 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' D' D ' 60' ' ' VAL . . . . . . . . . . . . . 43.5 t -78.48 119.47 27.57 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.28 0 C-N-CA 120.75 -0.38 . . . . 0.0 110.836 -174.591 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' D' D ' 61' ' ' GLU . . . . . . . . . . . . . 15.6 mm-40 -131.09 161.33 32.31 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 115.729 -0.669 . . . . 0.0 109.666 175.378 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' D' D ' 62' ' ' ASP . . . . . . . . . . . . . 54.0 m-20 -52.6 -31.65 37.51 Favored 'General case' 0 C--N 1.328 -0.343 0 N-CA-C 112.085 0.402 . . . . 0.0 112.085 -178.252 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' D' D ' 63' ' ' ARG . . . . . . . . . . . . . 79.7 mtp180 -73.2 -21.91 60.57 Favored 'General case' 0 CA--C 1.532 0.256 0 N-CA-C 112.949 0.722 . . . . 0.0 112.949 -175.41 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' D' D ' 64' ' ' THR . . . . . . . . . . . . . 25.7 m -69.31 139.96 54.33 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-O 120.951 0.405 . . . . 0.0 110.965 -175.752 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' D' D ' 65' ' ' LYS . . . . . . . . . . . . . 67.5 mttm -89.34 132.14 35.09 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 115.945 -0.57 . . . . 0.0 110.134 178.341 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' D' D ' 66' ' ' ILE . . . . . . . . . . . . . 62.7 mt -117.51 129.52 73.85 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.261 0 N-CA-C 109.893 -0.41 . . . . 0.0 109.893 179.446 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' D' D ' 67' ' ' THR . . . . . . . . . . . . . 25.5 m -122.86 137.47 54.93 Favored 'General case' 0 C--N 1.332 -0.181 0 CA-C-N 116.128 -0.487 . . . . 0.0 110.769 -178.872 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' D' D ' 68' ' ' LEU . . . . . . . . . . . . . 14.9 tp . . . . . 0 C--N 1.33 -0.241 0 CA-C-N 115.964 -0.562 . . . . 0.0 110.348 178.805 . . . . . . . . 0 0 . 1 . 009 nuclear orig core ' D' D ' 73' ' ' VAL . . . . . . . . . . . . . 30.3 m . . . . . 0 C--O 1.231 0.128 0 CA-C-O 120.936 0.398 . . . . 0.0 110.404 . . . . . . . . . 0 0 . 1 . 009 nuclear orig core ' D' D ' 74' ' ' ASP . . . . . . . . . . . . . 15.2 t0 -97.04 124.46 41.04 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 115.997 -0.547 . . . . 0.0 109.59 178.905 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' D' D ' 75' ' ' VAL . . . . . . . . . . . . . 41.9 t -116.75 125.29 73.62 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.211 0 CA-C-O 121.091 0.472 . . . . 0.0 110.891 -175.29 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' D' D ' 76' ' ' LEU . . . . . . . . . . . . . 5.7 mp -125.73 144.71 50.5 Favored 'General case' 0 C--N 1.331 -0.205 0 CA-C-N 115.704 -0.68 . . . . 0.0 109.55 173.896 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' D' D ' 77' ' ' GLU . . . . . . . . . . . . . 98.0 mt-10 -133.52 131.03 39.31 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-O 120.961 0.41 . . . . 0.0 111.007 -177.666 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' D' D ' 78' ' ' ALA . . . . . . . . . . . . . . . -116.13 130.95 57.04 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 115.833 -0.621 . . . . 0.0 109.697 177.516 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' D' D ' 79' ' ' LYS . . . . . . . . . . . . . 88.1 mttt -77.34 123.85 27.07 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-O 120.854 0.359 . . . . 0.0 110.906 -177.059 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' D' D ' 80' ' ' ILE . . . . . . . . . . . . . 39.5 mm -139.1 114.4 8.56 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.277 0 N-CA-C 109.309 -0.626 . . . . 0.0 109.309 -177.858 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' D' D ' 81' ' ' LYS . . . . . . . . . . . . . 69.3 mttm -100.48 118.93 37.68 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-O 120.793 0.33 . . . . 0.0 111.245 -177.234 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' D' D ' 82' ' ' GLY . . . . . . . . . . . . . . . 89.17 42.22 5.64 Favored Glycine 0 CA--C 1.526 0.738 0 C-N-CA 120.668 -0.777 . . . . 0.0 111.989 172.888 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' D' D ' 83' ' ' ILE . . . . . . . . . . . . . 72.3 mt -61.99 135.92 25.97 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.341 0 N-CA-C 109.835 -0.431 . . . . 0.0 109.835 176.434 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' D' D ' 84' ' ' LYS . . . . . . . . . . . . . 15.5 ttmm -95.21 -51.45 4.61 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-O 121.118 0.485 . . . . 0.0 109.744 179.115 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' D' D ' 85' ' ' ASP . . . . . . . . . . . . . 7.5 t70 -158.38 154.9 27.73 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 115.548 -0.751 . . . . 0.0 110.145 179.105 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' D' D ' 86' ' ' VAL . . . . . . . . . . . . . 44.4 t -130.56 133.98 62.81 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.176 0 CA-C-O 121.055 0.455 . . . . 0.0 110.459 -179.436 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' D' D ' 87' ' ' ILE . . . . . . . . . . . . . 44.3 mm -119.25 125.72 74.7 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.253 0 CA-C-N 115.653 -0.703 . . . . 0.0 109.664 177.657 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' D' D ' 88' ' ' LEU . . . . . . . . . . . . . 14.2 tp -108.14 127.17 53.58 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.299 -0.409 . . . . 0.0 110.848 -178.331 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' D' D ' 89' ' ' ASP . . . . . . . . . . . . . 13.6 t70 -121.22 154.41 36.32 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.002 -0.545 . . . . 0.0 109.843 178.23 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' D' D ' 90' ' ' GLU . . . . . . . . . . . . . 82.3 tt0 -46.32 -37.58 7.61 Favored 'General case' 0 C--N 1.33 -0.271 0 N-CA-C 113.079 0.77 . . . . 0.0 113.079 -172.754 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' D' D ' 91' ' ' ASN . . . . . . . . . . . . . 13.4 t-20 -132.0 22.02 4.53 Favored 'General case' 0 N--CA 1.469 0.477 0 N-CA-C 112.779 0.659 . . . . 0.0 112.779 -177.446 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' D' D ' 92' ' ' LEU . . . . . . . . . . . . . 19.9 mt -150.49 144.15 25.19 Favored 'General case' 0 C--N 1.331 -0.204 0 CA-C-O 120.773 0.321 . . . . 0.0 110.269 -176.59 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' D' D ' 93' ' ' ILE . . . . . . . . . . . . . 74.6 mt -121.78 115.08 45.33 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.276 0 N-CA-C 109.168 -0.678 . . . . 0.0 109.168 176.944 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' D' D ' 94' ' ' VAL . . . . . . . . . . . . . 46.8 t -118.06 127.04 75.32 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.217 0 CA-C-O 121.071 0.462 . . . . 0.0 110.111 -177.883 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' D' D ' 95' ' ' VAL . . . . . . . . . . . . . 41.1 t -121.42 134.55 64.41 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.277 0 CA-C-N 115.769 -0.651 . . . . 0.0 109.772 -179.678 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' D' D ' 96' ' ' ILE . . . . . . . . . . . . . 63.4 mt -113.57 127.58 70.84 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.287 0 N-CA-C 109.209 -0.663 . . . . 0.0 109.209 178.381 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' D' D ' 97' ' ' THR . . . . . . . . . . . . . 59.9 p -101.44 156.15 17.63 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-O 121.289 0.566 . . . . 0.0 111.379 -177.106 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' D' D ' 98' ' ' GLU . . . . . . . . . . . . . 45.5 tp10 -53.81 -26.65 25.1 Favored 'General case' 0 CA--C 1.533 0.32 0 CA-C-N 116.009 -0.542 . . . . 0.0 112.075 179.309 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' D' D ' 99' ' ' GLU . . . . . . . . . . . . . 96.7 mt-10 -79.97 17.49 0.96 Allowed 'General case' 0 CA--C 1.534 0.357 0 N-CA-C 113.084 0.772 . . . . 0.0 113.084 -177.217 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' D' D ' 100' ' ' ASN . . . . . . . . . . . . . 2.7 m-20 62.41 37.65 13.45 Favored 'General case' 0 C--O 1.233 0.19 0 CA-C-O 121.004 0.43 . . . . 0.0 110.959 177.456 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' D' D ' 101' ' ' GLU . . . . . . . . . . . . . 84.5 tt0 -116.27 143.64 45.26 Favored 'General case' 0 C--N 1.332 -0.173 0 CA-C-N 116.22 -0.445 . . . . 0.0 109.864 177.356 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' D' D ' 102' ' ' VAL . . . . . . . . . . . . . 45.3 t -114.93 124.37 71.52 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.267 0 CA-C-N 116.103 -0.499 . . . . 0.0 109.842 -179.122 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' D' D ' 103' ' ' LEU . . . . . . . . . . . . . 30.9 mt -115.88 131.31 56.98 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-N 115.815 -0.63 . . . . 0.0 110.464 178.075 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' D' D ' 104' ' ' ILE . . . . . 0.404 HG23 HD12 ' D' ' 104' ' ' ILE . 68.9 mt -120.77 120.1 61.49 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.302 0 N-CA-C 110.268 -0.271 . . . . 0.0 110.268 179.425 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' D' D ' 105' ' ' PHE . . . . . . . . . . . . . 59.1 m-85 -121.64 166.95 13.49 Favored 'General case' 0 C--N 1.333 -0.149 0 O-C-N 123.886 0.741 . . . . 0.0 110.043 178.494 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' D' D ' 106' ' ' ASN . . . . . . . . . . . . . 45.2 p-10 -104.1 -170.63 1.8 Allowed 'General case' 0 CA--C 1.531 0.227 0 N-CA-C 110.088 -0.338 . . . . 0.0 110.088 173.187 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' D' D ' 107' ' ' GLN . . . . . . . . . . . . . 63.3 tt0 -57.56 -29.77 64.69 Favored 'General case' 0 C--N 1.33 -0.255 0 N-CA-C 112.071 0.396 . . . . 0.0 112.071 179.338 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' D' D ' 108' ' ' ASN . . . . . . . . . . . . . 10.8 t30 -87.3 12.62 11.46 Favored 'General case' 0 CA--C 1.536 0.415 0 N-CA-C 113.045 0.757 . . . . 0.0 113.045 -176.295 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' D' D ' 109' ' ' LEU . . . . . . . . . . . . . 24.9 mt 55.1 36.75 27.66 Favored 'General case' 0 CA--C 1.528 0.132 0 CA-C-O 120.943 0.401 . . . . 0.0 111.43 178.665 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' D' D ' 110' ' ' GLU . . . . . . . . . . . . . 95.8 mt-10 -102.28 148.86 24.93 Favored 'General case' 0 C--N 1.33 -0.251 0 N-CA-C 109.689 -0.485 . . . . 0.0 109.689 175.917 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' D' D ' 111' ' ' GLU . . . . . . . . . . . . . 79.9 tt0 -79.34 122.0 25.82 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.339 -0.392 . . . . 0.0 110.565 -178.027 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' D' D ' 112' ' ' LEU . . . . . . . . . . . . . 43.4 mt -109.05 -46.01 3.67 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-N 116.128 -0.487 . . . . 0.0 110.245 178.677 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' D' D ' 113' ' ' TYR . . . . . . . . . . . . . 60.3 t80 -140.94 137.49 33.14 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.32 -0.4 . . . . 0.0 111.147 -179.959 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' D' D ' 114' ' ' ARG . . . . . . . . . . . . . 68.5 ttp85 -140.72 119.25 12.3 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 115.881 -0.6 . . . . 0.0 109.98 177.377 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' D' D ' 115' ' ' GLY . . . . . . . . . . . . . . . -150.08 151.13 23.24 Favored Glycine 0 CA--C 1.523 0.588 0 N-CA-C 110.919 -0.872 . . . . 0.0 110.919 179.554 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' D' D ' 116' ' ' LYS . . . . . . . . . . . . . 35.2 ttmt -124.29 140.0 53.38 Favored 'General case' 0 C--N 1.329 -0.298 0 N-CA-C 109.968 -0.382 . . . . 0.0 109.968 177.449 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' D' D ' 117' ' ' PHE . . . . . . . . . . . . . 28.9 m-85 -136.16 118.89 16.08 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.04 -176.232 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' D' D ' 118' ' ' GLU . . . . . . . . . . . . . 96.1 mt-10 -53.45 -46.55 69.91 Favored 'General case' 0 C--N 1.33 -0.278 0 C-N-CA 121.041 -0.264 . . . . 0.0 111.307 -177.88 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' D' D ' 119' ' ' ASN . . . . . . . . . . . . . 24.3 m120 -95.87 31.04 2.19 Favored 'General case' 0 C--N 1.331 -0.216 0 CA-C-N 116.149 -0.478 . . . . 0.0 112.198 -175.891 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' D' D ' 120' ' ' LEU . . . . . . . . . . . . . 19.4 tp -57.59 122.04 11.78 Favored 'General case' 0 C--O 1.231 0.123 0 N-CA-C 110.077 -0.342 . . . . 0.0 110.077 177.271 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' D' D ' 121' ' ' ASN . . . . . . . . . . . . . 29.2 t-20 -113.56 -44.0 3.26 Favored 'General case' 0 C--O 1.233 0.199 0 CA-C-N 116.683 -0.235 . . . . 0.0 111.329 -175.37 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' D' D ' 122' ' ' LYS . . . . . . . . . . . . . 34.7 ttmt -150.98 141.81 22.85 Favored 'General case' 0 C--N 1.331 -0.201 0 C-N-CA 120.513 -0.475 . . . . 0.0 111.703 -177.457 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' D' D ' 123' ' ' VAL . . . . . . . . . . . . . 46.5 t -119.57 127.87 75.87 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.231 0 N-CA-C 108.972 -0.751 . . . . 0.0 108.972 173.539 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' D' D ' 124' ' ' LEU . . . . . . . . . . . . . 17.7 tp -127.16 140.72 52.05 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-O 120.867 0.365 . . . . 0.0 110.924 -175.506 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' D' D ' 125' ' ' VAL . . . . . . . . . . . . . 35.6 m -126.82 140.91 47.65 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.276 0 CA-C-N 116.065 -0.516 . . . . 0.0 110.629 179.787 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' D' D ' 126' ' ' ARG . . . . . . . . . . . . . 47.7 ttt180 -159.34 134.08 7.98 Favored 'General case' 0 C--N 1.329 -0.318 0 N-CA-C 109.53 -0.544 . . . . 0.0 109.53 178.287 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' D' D ' 127' ' ' ASN . . . . . . . . . . . . . 1.6 t-20 56.68 -154.0 0.35 Allowed 'General case' 0 CA--C 1.537 0.47 0 N-CA-C 109.588 -0.523 . . . . 0.0 109.588 -178.333 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' D' D ' 128' ' ' ASP . . . . . . . . . . . . . 13.7 p-10 -84.99 20.7 1.79 Allowed 'General case' 0 CA--C 1.535 0.381 0 CA-C-N 118.433 0.561 . . . . 0.0 112.346 177.178 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' D' D ' 129' ' ' LEU . . . . . . . . . . . . . 59.1 mt -122.87 150.3 43.07 Favored 'General case' 0 C--O 1.233 0.228 0 O-C-N 122.119 -0.363 . . . . 0.0 110.307 -179.699 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' D' D ' 130' ' ' VAL . . . . . . . . . . . . . 12.9 p -134.46 147.15 30.07 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.205 0 CA-C-O 120.891 0.377 . . . . 0.0 110.412 -179.16 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' D' D ' 131' ' ' VAL . . . . . . . . . . . . . 14.9 p -136.23 142.84 37.48 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.211 0 CA-C-O 121.121 0.486 . . . . 0.0 110.904 -179.528 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' D' D ' 132' ' ' ILE . . . . . . . . . . . . . 72.4 mt -115.63 131.41 68.09 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.231 0 CA-C-N 115.689 -0.687 . . . . 0.0 109.374 178.333 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' D' D ' 133' ' ' ILE . . . . . . . . . . . . . 42.5 mm -115.61 124.23 71.85 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.307 0 CA-C-O 120.878 0.371 . . . . 0.0 110.911 -175.597 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' D' D ' 134' ' ' ASP . . . . . . . . . . . . . 10.3 p-10 -137.46 146.33 44.17 Favored 'General case' 0 C--N 1.331 -0.201 0 CA-C-N 116.103 -0.499 . . . . 0.0 109.762 174.294 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' D' D ' 135' ' ' GLU . . . . . . . . . . . . . 84.9 tt0 -49.87 -25.95 3.63 Favored 'General case' 0 C--N 1.329 -0.309 0 N-CA-C 112.776 0.658 . . . . 0.0 112.776 -173.798 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' D' D ' 136' ' ' GLN . . . . . . . . . . . . . 48.0 tt0 -81.91 -34.04 30.12 Favored 'General case' 0 C--N 1.331 -0.231 0 N-CA-C 111.939 0.348 . . . . 0.0 111.939 -175.828 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' D' D ' 137' ' ' LYS . . . . . . . . . . . . . 53.7 pttt -167.78 175.3 6.99 Favored 'General case' 0 C--N 1.331 -0.223 0 CA-C-O 121.561 0.696 . . . . 0.0 112.079 -173.396 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' D' D ' 138' ' ' LEU . . . . . . . . . . . . . 5.5 tt -119.2 129.6 55.05 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 115.095 -0.957 . . . . 0.0 109.853 179.07 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' D' D ' 139' ' ' THR . . . . . . . . . . . . . 39.1 m -112.49 124.22 52.02 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.289 -0.414 . . . . 0.0 110.353 178.829 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' D' D ' 140' ' ' LEU . . . . . . . . . . . . . 31.7 tp -112.07 124.97 53.57 Favored 'General case' 0 C--N 1.327 -0.378 0 N-CA-C 109.186 -0.672 . . . . 0.0 109.186 -178.663 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' D' D ' 141' ' ' ILE . . . . . . . . . . . . . 19.7 mt -121.99 117.16 51.44 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.292 0 CA-C-O 120.954 0.406 . . . . 0.0 109.983 -173.071 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' D' D ' 142' ' ' ARG . . . . . . . . . . . . . 78.6 mtp180 -107.11 125.26 50.83 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-N 115.382 -0.826 . . . . 0.0 110.445 -177.35 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' D' D ' 143' ' ' THR . . . . . . . . . . . . . 25.4 p . . . . . 0 C--O 1.219 -0.544 0 CA-C-O 118.004 -0.998 . . . . 0.0 110.61 -179.748 . . . . . . . . 0 0 . 1 . 009 nuclear orig core ' E' E ' 2' ' ' SER . . . . . . . . . . . . . 2.0 p . . . . . 0 C--O 1.233 0.207 0 CA-C-O 121.014 0.435 . . . . 0.0 110.67 . . . . . . . . . 0 0 . 1 . 009 nuclear orig core ' E' E ' 3' ' ' GLU . . . . . . . . . . . . . 66.3 tt0 -144.87 142.52 29.98 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-N 115.794 -0.639 . . . . 0.0 111.251 -175.29 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' E' E ' 4' ' ' LEU . . . . . . . . . . . . . 15.9 tp -123.37 135.0 53.94 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 115.918 -0.583 . . . . 0.0 110.001 175.583 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' E' E ' 5' ' ' LYS . . . . . . . . . . . . . 89.9 mttt -115.42 121.98 44.41 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.581 -0.281 . . . . 0.0 110.89 -179.125 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' E' E ' 6' ' ' LEU . . . . . . . . . . . . . 69.4 mt -114.48 145.93 41.3 Favored 'General case' 0 C--N 1.331 -0.225 0 CA-C-N 115.808 -0.633 . . . . 0.0 110.19 178.227 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' E' E ' 7' ' ' LYS . . . . . . . . . . . . . 26.3 ttpp -127.76 142.58 44.69 Favored Pre-proline 0 CA--C 1.533 0.323 0 CA-C-O 119.129 -0.462 . . . . 0.0 109.826 175.928 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' E' E ' 8' ' ' PRO . . . . . . . . . . . . . 87.2 Cg_endo -91.04 132.49 1.54 Allowed 'Trans proline' 0 N--CA 1.489 1.234 0 C-N-CA 121.652 1.568 . . . . 0.0 111.843 178.769 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' E' E ' 9' ' ' LEU . . . . . . . . . . . . . 71.6 mt -71.0 -47.17 14.73 Favored Pre-proline 0 CA--C 1.534 0.331 0 CA-C-O 118.663 -0.684 . . . . 0.0 112.111 -179.696 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' E' E ' 10' ' ' PRO . . . . . . . . . . . . . 98.3 Cg_endo -79.96 155.95 23.37 Favored 'Trans proline' 0 N--CA 1.495 1.614 0 C-N-CA 121.106 1.204 . . . . 0.0 111.878 175.573 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' E' E ' 11' ' ' LYS . . . . . . . . . . . . . 62.4 mttp -88.14 96.03 10.38 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-O 120.774 0.321 . . . . 0.0 110.695 179.696 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' E' E ' 12' ' ' VAL . . . . . . . . . . . . . 12.5 p -143.35 147.01 20.74 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.248 0 CA-C-N 116.231 -0.44 . . . . 0.0 110.37 179.228 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' E' E ' 13' ' ' GLU . . . . . . . . . . . . . 84.8 tt0 -92.06 123.59 35.53 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.321 -0.399 . . . . 0.0 110.276 179.175 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' E' E ' 14' ' ' LEU . . . . . . . . . . . . . 41.7 mt -97.9 149.01 35.28 Favored Pre-proline 0 CA--C 1.533 0.307 0 CA-C-O 119.352 -0.356 . . . . 0.0 110.6 -178.099 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' E' E ' 15' ' ' PRO . . . . . . . . . . . . . 26.1 Cg_exo -62.08 157.57 43.58 Favored 'Trans proline' 0 N--CA 1.498 1.751 0 C-N-CA 121.349 1.366 . . . . 0.0 111.906 177.412 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' E' E ' 16' ' ' PRO . . . . . . . . . . . . . 34.0 Cg_exo -59.36 -37.85 87.89 Favored 'Trans proline' 0 N--CA 1.498 1.758 0 C-N-CA 121.49 1.46 . . . . 0.0 112.875 -179.228 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' E' E ' 17' ' ' ASP . . . . . . . . . . . . . 18.2 p-10 -79.43 1.86 23.95 Favored 'General case' 0 CA--C 1.538 0.499 0 N-CA-C 113.327 0.862 . . . . 0.0 113.327 -177.34 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' E' E ' 18' ' ' PHE . . . . . . . . . . . . . 46.9 t80 -57.61 -47.18 82.88 Favored 'General case' 0 N--CA 1.458 -0.074 0 O-C-N 121.97 -0.456 . . . . 0.0 110.142 -178.605 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' E' E ' 19' ' ' VAL . . . . . . . . . . . . . 13.8 p -55.34 -41.49 62.11 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.319 0 CA-C-N 116.26 -0.427 . . . . 0.0 111.095 -178.553 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' E' E ' 20' ' ' ASP . . . . . . . . . . . . . 9.5 t0 -60.44 -43.16 97.11 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-O 120.925 0.393 . . . . 0.0 110.899 -177.977 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' E' E ' 21' ' ' VAL . . . . . . . . . . . . . 47.2 t -64.34 -45.98 94.45 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.287 0 CA-C-N 116.272 -0.422 . . . . 0.0 110.496 -178.177 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' E' E ' 22' ' ' ILE . . . . . . . . . . . . . 50.2 mm -54.63 -47.09 73.05 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.287 0 CA-C-O 120.676 0.275 . . . . 0.0 110.753 178.809 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' E' E ' 23' ' ' ARG . . . . . . . . . . . . . 25.1 ttm-85 -53.3 -54.17 40.28 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-O 121.258 0.551 . . . . 0.0 111.677 179.963 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' E' E ' 24' ' ' ILE . . . . . . . . . . . . . 76.4 mt -61.0 -36.52 72.94 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.38 0 CA-C-N 115.67 -0.696 . . . . 0.0 111.59 -172.857 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' E' E ' 25' ' ' LYS . . . . . . . . . . . . . 64.1 mttm -75.22 -40.66 58.91 Favored 'General case' 0 C--N 1.33 -0.267 0 N-CA-C 112.349 0.5 . . . . 0.0 112.349 -178.855 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' E' E ' 26' ' ' LEU . . . . . . . . . . . . . 75.9 mt -80.22 -25.64 39.52 Favored 'General case' 0 C--N 1.331 -0.201 0 N-CA-C 113.195 0.813 . . . . 0.0 113.195 -171.112 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' E' E ' 27' ' ' GLN . . . . . . . . . . . . . 4.2 pt20 -46.38 136.67 7.1 Favored 'General case' 0 N--CA 1.469 0.495 0 N-CA-C 112.594 0.59 . . . . 0.0 112.594 -177.368 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' E' E ' 28' ' ' GLY . . . . . . . . . . . . . . . 99.8 -21.06 46.67 Favored Glycine 0 CA--C 1.535 1.305 0 CA-C-N 115.824 -0.626 . . . . 0.0 112.661 -177.162 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' E' E ' 29' ' ' LYS . . . . . . . . . . . . . 61.1 mttp -97.02 155.14 16.91 Favored 'General case' 0 C--O 1.233 0.218 0 CA-C-N 117.471 0.636 . . . . 0.0 110.935 179.492 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' E' E ' 30' ' ' THR . . . . . . . . . . . . . 28.5 m -108.65 137.45 46.57 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.042 -0.526 . . . . 0.0 110.031 176.748 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' E' E ' 31' ' ' VAL . . . . . . . . . . . . . 35.3 m -130.35 152.77 37.98 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.223 0 CA-C-O 120.919 0.39 . . . . 0.0 110.778 -178.751 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' E' E ' 32' ' ' ARG . . . . . . . . . . . . . 37.9 ttm180 -133.23 148.23 51.99 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-O 121.246 0.546 . . . . 0.0 110.398 179.568 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' E' E ' 33' ' ' THR . . . . . . . . . . . . . 16.4 m -52.11 139.33 23.49 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.244 -0.434 . . . . 0.0 111.624 -177.145 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' E' E ' 34' ' ' GLY . . . . . . . . . . . . . . . 101.03 -17.24 56.45 Favored Glycine 0 CA--C 1.534 1.235 0 CA-C-O 119.667 -0.519 . . . . 0.0 113.201 179.051 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' E' E ' 35' ' ' ASP . . . . . . . . . . . . . 79.2 m-20 -66.78 147.3 53.43 Favored 'General case' 0 N--CA 1.462 0.163 0 CA-C-N 118.026 0.913 . . . . 0.0 111.229 179.25 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' E' E ' 36' ' ' VAL . . . . . . . . . . . . . 45.8 t -122.51 129.1 75.49 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.204 0 CA-C-N 115.779 -0.646 . . . . 0.0 109.737 177.802 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' E' E ' 37' ' ' ILE . . . . . . . . . . . . . 63.2 mt -123.16 139.23 50.53 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.256 0 CA-C-N 116.286 -0.416 . . . . 0.0 109.953 -179.011 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' E' E ' 38' ' ' GLY . . . . . . . . . . . . . . . -115.46 128.65 8.16 Favored Glycine 0 CA--C 1.524 0.605 0 N-CA-C 110.982 -0.847 . . . . 0.0 110.982 178.661 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' E' E ' 39' ' ' ILE . . . . . . . . . . . . . 68.7 mt -126.98 125.71 67.05 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.271 0 N-CA-C 110.019 -0.363 . . . . 0.0 110.019 179.501 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' E' E ' 40' ' ' SER . . . . . . . . . . . . . 24.0 t -91.99 118.66 30.99 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.388 -0.369 . . . . 0.0 110.794 176.545 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' E' E ' 41' ' ' ILE . . . . . . . . . . . . . 70.9 mt -130.35 131.05 65.63 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.227 0 CA-C-O 120.927 0.394 . . . . 0.0 110.299 179.283 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' E' E ' 42' ' ' LEU . . . . . . . . . . . . . 47.3 mt 54.94 33.47 20.15 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-N 116.039 -0.528 . . . . 0.0 111.817 177.954 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' E' E ' 43' ' ' GLY . . . . . . . . . . . . . . . 71.77 28.99 68.03 Favored Glycine 0 CA--C 1.53 0.983 0 C-N-CA 121.075 -0.583 . . . . 0.0 112.299 178.094 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' E' E ' 44' ' ' LYS . . . . . . . . . . . . . 20.0 tptm -142.43 125.92 16.75 Favored 'General case' 0 C--N 1.331 -0.205 0 N-CA-C 109.748 -0.464 . . . . 0.0 109.748 178.46 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' E' E ' 45' ' ' GLU . . . . . . . . . . . . . 41.0 tp10 -85.21 128.6 34.74 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-O 120.843 0.354 . . . . 0.0 111.589 -177.413 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' E' E ' 46' ' ' VAL . . . . . . . . . . . . . 8.9 p -120.15 127.74 75.92 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.188 0 N-CA-C 109.525 -0.546 . . . . 0.0 109.525 174.261 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' E' E ' 47' ' ' LYS . . . . . . . . . . . . . 52.7 mtpt -98.55 124.41 43.28 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.035 -0.529 . . . . 0.0 110.792 178.01 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' E' E ' 48' ' ' PHE . . . . . . . . . . . . . 37.6 m-85 -109.27 131.82 54.7 Favored 'General case' 0 C--N 1.33 -0.265 0 N-CA-C 109.782 -0.451 . . . . 0.0 109.782 178.069 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' E' E ' 49' ' ' LYS . . . . . . . . . . . . . 76.8 tttt -108.63 132.58 53.75 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.417 -0.356 . . . . 0.0 110.344 178.009 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' E' E ' 50' ' ' VAL . . . . . . . . . . . . . 45.6 t -76.29 105.07 4.83 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.367 0 N-CA-C 109.249 -0.649 . . . . 0.0 109.249 176.087 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' E' E ' 51' ' ' VAL . . . . . . . . . . . . . 47.0 t -68.64 -53.92 24.32 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.351 0 N-CA-C 109.401 -0.592 . . . . 0.0 109.401 -175.64 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' E' E ' 52' ' ' GLN . . . . . . . . . . . . . 80.8 mt-30 -155.7 154.61 31.78 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 115.967 -0.561 . . . . 0.0 111.584 -178.163 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' E' E ' 53' ' ' ALA . . . . . . . . . . . . . . . -130.9 132.17 44.97 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 115.371 -0.831 . . . . 0.0 109.667 174.91 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' E' E ' 54' ' ' TYR . . . . . . . . . . . . . 39.7 t80 -129.07 108.92 18.1 Favored Pre-proline 0 CA--C 1.534 0.353 0 CA-C-O 118.273 -0.87 . . . . 0.0 110.421 179.892 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' E' E ' 55' ' ' PRO . . . . . . . . . . . . . 73.2 Cg_endo -77.21 169.89 72.94 Favored 'Cis proline' 0 N--CA 1.5 1.866 0 CA-C-N 121.84 1.693 . . . . 0.0 112.32 -6.428 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' E' E ' 56' ' ' SER . . . . . . . . . . . . . 13.6 m -117.22 134.71 23.03 Favored Pre-proline 0 CA--C 1.539 0.528 0 CA-C-O 118.401 -0.809 . . . . 0.0 109.45 174.031 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' E' E ' 57' ' ' PRO . . . . . . . . . . . . . 50.8 Cg_endo -70.07 146.79 83.81 Favored 'Cis proline' 0 N--CA 1.496 1.672 0 CA-C-N 121.85 1.696 . . . . 0.0 111.519 -1.379 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' E' E ' 58' ' ' LEU . . . . . . . . . . . . . 33.6 tp -107.89 138.76 43.57 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-O 120.87 0.367 . . . . 0.0 110.689 -177.838 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' E' E ' 59' ' ' ARG . . . . . . . . . . . . . 72.7 ttt180 -102.66 131.59 49.34 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 115.813 -0.63 . . . . 0.0 109.679 176.952 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' E' E ' 60' ' ' VAL . . . . . . . . . . . . . 41.7 t -86.29 118.65 33.08 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.213 0 C-N-CA 120.775 -0.37 . . . . 0.0 110.602 -177.167 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' E' E ' 61' ' ' GLU . . . . . . . . . . . . . 96.6 mt-10 -131.11 158.17 41.13 Favored 'General case' 0 C--N 1.331 -0.229 0 CA-C-N 115.874 -0.603 . . . . 0.0 109.748 177.302 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' E' E ' 62' ' ' ASP . . . . . . . . . . . . . 48.5 m-20 -52.44 -32.94 41.92 Favored 'General case' 0 C--N 1.329 -0.324 0 N-CA-C 111.816 0.302 . . . . 0.0 111.816 -178.663 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' E' E ' 63' ' ' ARG . . . . . . . . . . . . . 75.5 mtp180 -78.91 -19.96 50.53 Favored 'General case' 0 CA--C 1.533 0.301 0 N-CA-C 113.153 0.797 . . . . 0.0 113.153 -176.258 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' E' E ' 64' ' ' THR . . . . . . . . . . . . . 24.9 m -66.34 149.2 50.74 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-O 120.993 0.425 . . . . 0.0 111.117 -174.739 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' E' E ' 65' ' ' LYS . . . . . . . . . . . . . 24.6 mtpp -89.67 127.26 35.9 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 115.964 -0.562 . . . . 0.0 110.651 179.997 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' E' E ' 66' ' ' ILE . . . . . . . . . . . . . 64.1 mt -117.64 128.52 74.84 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.272 0 N-CA-C 109.842 -0.429 . . . . 0.0 109.842 177.476 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' E' E ' 67' ' ' THR . . . . . . . . . . . . . 28.8 m -120.56 137.76 54.23 Favored 'General case' 0 C--N 1.331 -0.229 0 CA-C-O 121.123 0.487 . . . . 0.0 110.928 -178.587 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' E' E ' 68' ' ' LEU . . . . . . . . . . . . . 13.3 tp . . . . . 0 C--N 1.33 -0.279 0 CA-C-N 115.706 -0.679 . . . . 0.0 110.254 178.44 . . . . . . . . 0 0 . 1 . 009 nuclear orig core ' E' E ' 73' ' ' VAL . . . . . . . . . . . . . 35.2 m . . . . . 0 N--CA 1.462 0.125 0 CA-C-O 120.709 0.29 . . . . 0.0 110.466 . . . . . . . . . 0 0 . 1 . 009 nuclear orig core ' E' E ' 74' ' ' ASP . . . . . . . . . . . . . 10.8 t70 -98.04 118.04 33.74 Favored 'General case' 0 C--N 1.33 -0.274 0 N-CA-C 109.935 -0.394 . . . . 0.0 109.935 -178.471 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' E' E ' 75' ' ' VAL . . . . . . . . . . . . . 42.0 t -112.32 122.65 66.97 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.2 0 CA-C-O 121.09 0.471 . . . . 0.0 110.369 -178.31 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' E' E ' 76' ' ' LEU . . . . . . . . . . . . . 29.9 mt -122.79 137.62 54.87 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 115.63 -0.713 . . . . 0.0 109.432 178.398 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' E' E ' 77' ' ' GLU . . . . . . . . . . . . . 96.4 mt-10 -133.27 140.3 47.39 Favored 'General case' 0 C--N 1.331 -0.217 0 CA-C-O 121.035 0.445 . . . . 0.0 111.301 -177.29 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' E' E ' 78' ' ' ALA . . . . . . . . . . . . . . . -130.12 129.62 43.76 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 115.678 -0.692 . . . . 0.0 109.957 176.377 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' E' E ' 79' ' ' LYS . . . . . . . . . . . . . 32.7 mmtp -75.24 119.09 18.9 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-O 120.949 0.404 . . . . 0.0 110.58 -179.428 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' E' E ' 80' ' ' ILE . . . . . . . . . . . . . 22.7 mm -139.25 112.53 6.36 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.269 0 N-CA-C 108.947 -0.76 . . . . 0.0 108.947 -178.578 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' E' E ' 81' ' ' LYS . . . . . . . . . . . . . 40.6 mttp -99.72 126.75 45.82 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-O 120.875 0.369 . . . . 0.0 111.293 -176.07 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' E' E ' 82' ' ' GLY . . . . . . . . . . . . . . . 89.11 42.21 5.66 Favored Glycine 0 CA--C 1.526 0.744 0 C-N-CA 120.989 -0.624 . . . . 0.0 111.892 174.119 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' E' E ' 83' ' ' ILE . . . . . . . . . . . . . 69.8 mt -67.93 137.99 23.5 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.34 0 N-CA-C 109.793 -0.447 . . . . 0.0 109.793 177.099 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' E' E ' 84' ' ' LYS . . . . . . . . . . . . . 70.4 tttt -100.24 -53.63 3.08 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.165 -0.471 . . . . 0.0 110.226 -178.58 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' E' E ' 85' ' ' ASP . . . . . . . . . . . . . 8.5 t70 -151.23 148.45 28.23 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 115.837 -0.619 . . . . 0.0 110.387 -178.985 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' E' E ' 86' ' ' VAL . . . . . . . . . . . . . 43.7 t -129.47 129.42 66.93 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.269 0 CA-C-O 120.928 0.394 . . . . 0.0 110.377 -179.648 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' E' E ' 87' ' ' ILE . . . . . . . . . . . . . 4.6 mp -122.19 134.28 65.93 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.255 0 CA-C-N 115.972 -0.558 . . . . 0.0 109.709 178.593 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' E' E ' 88' ' ' LEU . . . . . . . . . . . . . 10.2 tp -111.59 134.89 52.85 Favored 'General case' 0 C--N 1.331 -0.205 0 CA-C-O 121.105 0.479 . . . . 0.0 111.059 -178.206 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' E' E ' 89' ' ' ASP . . . . . . . . . . . . . 4.7 t70 -121.53 159.12 27.01 Favored 'General case' 0 C--N 1.331 -0.205 0 CA-C-N 115.651 -0.704 . . . . 0.0 109.634 177.515 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' E' E ' 90' ' ' GLU . . . . . . . . . . . . . 84.3 tt0 -44.97 -44.37 9.8 Favored 'General case' 0 N--CA 1.465 0.301 0 N-CA-C 113.094 0.775 . . . . 0.0 113.094 -172.224 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' E' E ' 91' ' ' ASN . . . . . . . . . . . . . 23.8 m120 -132.02 26.34 4.59 Favored 'General case' 0 N--CA 1.467 0.419 0 N-CA-C 112.401 0.519 . . . . 0.0 112.401 -179.427 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' E' E ' 92' ' ' LEU . . . . . . . . . . . . . 12.8 mt -149.24 151.88 35.02 Favored 'General case' 0 C--N 1.333 -0.143 0 N-CA-C 110.105 -0.332 . . . . 0.0 110.105 -176.159 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' E' E ' 93' ' ' ILE . . . . . . . . . . . . . 72.2 mt -127.71 121.98 57.93 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.28 0 N-CA-C 109.349 -0.612 . . . . 0.0 109.349 177.812 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' E' E ' 94' ' ' VAL . . . . . . . . . . . . . 44.6 t -118.07 128.1 75.19 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.294 0 CA-C-O 120.813 0.34 . . . . 0.0 110.119 -178.343 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' E' E ' 95' ' ' VAL . . . . . . . . . . . . . 43.6 t -122.19 135.11 63.37 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.381 0 CA-C-N 115.986 -0.552 . . . . 0.0 109.996 -179.238 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' E' E ' 96' ' ' ILE . . . . . . . . . . . . . 62.2 mt -115.3 128.04 72.65 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.346 0 N-CA-C 109.241 -0.652 . . . . 0.0 109.241 178.392 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' E' E ' 97' ' ' THR . . . . . . . . . . . . . 66.5 p -101.32 155.74 17.86 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-O 121.056 0.455 . . . . 0.0 111.04 -177.521 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' E' E ' 98' ' ' GLU . . . . . . . . . . . . . 97.1 mt-10 -53.91 -26.22 24.08 Favored 'General case' 0 CA--C 1.532 0.265 0 N-CA-C 112.194 0.442 . . . . 0.0 112.194 179.874 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' E' E ' 99' ' ' GLU . . . . . . . . . . . . . 97.0 mt-10 -78.86 15.53 1.06 Allowed 'General case' 0 CA--C 1.535 0.37 0 N-CA-C 113.167 0.803 . . . . 0.0 113.167 -177.383 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' E' E ' 100' ' ' ASN . . . . . . . . . . . . . 3.6 m-20 61.54 37.41 16.4 Favored 'General case' 0 CA--C 1.529 0.17 0 CA-C-O 120.974 0.416 . . . . 0.0 111.124 178.728 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' E' E ' 101' ' ' GLU . . . . . . . . . . . . . 80.9 tt0 -115.23 145.45 42.41 Favored 'General case' 0 C--N 1.332 -0.173 0 CA-C-N 115.951 -0.568 . . . . 0.0 109.616 175.803 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' E' E ' 102' ' ' VAL . . . . . . . . . . . . . 43.4 t -115.59 125.98 72.97 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.335 0 CA-C-N 116.318 -0.401 . . . . 0.0 110.143 -177.043 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' E' E ' 103' ' ' LEU . . . . . . . . . . . . . 23.4 mt -117.92 130.5 56.26 Favored 'General case' 0 C--N 1.331 -0.226 0 CA-C-N 115.888 -0.596 . . . . 0.0 110.15 177.747 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' E' E ' 104' ' ' ILE . . . . . . . . . . . . . 68.8 mt -119.9 120.85 64.45 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.189 0 CA-C-O 120.646 0.26 . . . . 0.0 110.308 179.02 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' E' E ' 105' ' ' PHE . . . . . . . . . . . . . 55.6 m-85 -119.86 166.5 13.21 Favored 'General case' 0 C--N 1.332 -0.18 0 CA-C-N 115.352 -0.84 . . . . 0.0 109.796 178.618 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' E' E ' 106' ' ' ASN . . . . . . . . . . . . . 47.1 p-10 -97.87 -169.94 1.91 Allowed 'General case' 0 C--N 1.331 -0.231 0 N-CA-C 109.708 -0.478 . . . . 0.0 109.708 172.972 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' E' E ' 107' ' ' GLN . . . . . . . . . . . . . 39.0 tp60 -60.89 -28.17 68.69 Favored 'General case' 0 CA--C 1.533 0.295 0 N-CA-C 112.012 0.375 . . . . 0.0 112.012 179.564 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' E' E ' 108' ' ' ASN . . . . . . . . . . . . . 15.6 t-20 -82.94 9.43 10.07 Favored 'General case' 0 CA--C 1.536 0.42 0 N-CA-C 112.94 0.718 . . . . 0.0 112.94 -179.125 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' E' E ' 109' ' ' LEU . . . . . . . . . . . . . 9.4 tp 57.78 36.92 26.94 Favored 'General case' 0 C--O 1.232 0.164 0 CA-C-O 120.877 0.37 . . . . 0.0 111.278 179.973 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' E' E ' 110' ' ' GLU . . . . . . . . . . . . . 96.6 mt-10 -102.14 150.07 23.64 Favored 'General case' 0 C--N 1.331 -0.23 0 N-CA-C 109.788 -0.449 . . . . 0.0 109.788 176.364 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' E' E ' 111' ' ' GLU . . . . . . . . . . . . . 68.0 tt0 -83.24 121.93 27.75 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 116.47 -0.332 . . . . 0.0 110.846 -176.509 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' E' E ' 112' ' ' LEU . . . . . . . . . . . . . 13.4 mt -110.47 -45.99 3.46 Favored 'General case' 0 C--N 1.332 -0.182 0 CA-C-N 116.228 -0.442 . . . . 0.0 110.553 179.685 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' E' E ' 113' ' ' TYR . . . . . . . . . . . . . 57.3 t80 -135.77 133.74 38.26 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.341 -0.391 . . . . 0.0 110.936 -178.346 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' E' E ' 114' ' ' ARG . . . . . . . . . . . . . 76.7 ttt180 -134.57 120.18 19.32 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.14 -0.482 . . . . 0.0 110.054 176.938 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' E' E ' 115' ' ' GLY . . . . . . . . . . . . . . . -148.32 162.46 28.82 Favored Glycine 0 CA--C 1.524 0.635 0 N-CA-C 110.694 -0.962 . . . . 0.0 110.694 -179.773 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' E' E ' 116' ' ' LYS . . . . . . . . . . . . . 33.6 ttmt -136.81 139.09 41.5 Favored 'General case' 0 C--N 1.327 -0.371 0 N-CA-C 110.224 -0.287 . . . . 0.0 110.224 -179.623 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' E' E ' 117' ' ' PHE . . . . . . . . . . . . . 32.9 m-85 -137.51 113.94 10.21 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-O 121.047 0.451 . . . . 0.0 110.272 -176.487 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' E' E ' 118' ' ' GLU . . . . . . . . . . . . . 96.5 mt-10 -53.59 -45.6 70.07 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.142 -0.481 . . . . 0.0 111.514 -176.425 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' E' E ' 119' ' ' ASN . . . . . . . . . . . . . 32.7 m120 -96.55 30.93 2.41 Favored 'General case' 0 C--N 1.329 -0.299 0 N-CA-C 112.306 0.484 . . . . 0.0 112.306 -174.316 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' E' E ' 120' ' ' LEU . . . . . . . . . . . . . 12.9 tp -56.24 122.94 12.94 Favored 'General case' 0 C--N 1.332 -0.191 0 C-N-CA 121.139 -0.224 . . . . 0.0 110.559 177.645 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' E' E ' 121' ' ' ASN . . . . . . . . . . . . . 44.7 t30 -114.07 -44.01 3.19 Favored 'General case' 0 C--N 1.333 -0.131 0 CA-C-N 116.684 -0.235 . . . . 0.0 111.559 -176.641 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' E' E ' 122' ' ' LYS . . . . . . . . . . . . . 33.6 ttpt -149.1 149.16 30.61 Favored 'General case' 0 C--N 1.332 -0.158 0 CA-C-O 121.077 0.465 . . . . 0.0 111.431 -174.647 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' E' E ' 123' ' ' VAL . . . . . . . . . . . . . 45.7 t -126.52 136.49 60.67 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.265 0 CA-C-N 116.11 -0.495 . . . . 0.0 109.935 179.126 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' E' E ' 124' ' ' LEU . . . . . . . . . . . . . 57.3 mt -129.86 138.32 50.91 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-O 120.714 0.292 . . . . 0.0 110.655 -178.926 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' E' E ' 125' ' ' VAL . . . . . . . . . . . . . 35.7 m -135.9 143.67 35.58 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.269 0 CA-C-N 116.341 -0.391 . . . . 0.0 110.644 178.509 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' E' E ' 126' ' ' ARG . . . . . . . . . . . . . 67.6 ttt180 -162.02 122.09 2.51 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 116.128 -0.487 . . . . 0.0 110.103 177.921 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' E' E ' 127' ' ' ASN . . . . . . . . . . . . . 3.7 t-20 56.02 -149.58 0.45 Allowed 'General case' 0 CA--C 1.54 0.591 0 N-CA-C 109.973 -0.38 . . . . 0.0 109.973 179.822 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' E' E ' 128' ' ' ASP . . . . . . . . . . . . . 14.2 p-10 -80.01 13.54 2.21 Favored 'General case' 0 CA--C 1.536 0.441 0 N-CA-C 112.879 0.696 . . . . 0.0 112.879 -179.792 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' E' E ' 129' ' ' LEU . . . . . . . . . . . . . 39.6 mt -110.82 138.58 47.03 Favored 'General case' 0 C--O 1.231 0.129 0 CA-C-N 118.143 0.429 . . . . 0.0 109.981 178.053 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' E' E ' 130' ' ' VAL . . . . . . . . . . . . . 30.6 m -132.63 140.76 46.78 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.185 0 CA-C-O 120.957 0.408 . . . . 0.0 110.377 178.478 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' E' E ' 131' ' ' VAL . . . . . . . . . . . . . 39.7 t -136.06 139.31 46.02 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.256 0 CA-C-O 121.166 0.507 . . . . 0.0 110.392 -178.419 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' E' E ' 132' ' ' ILE . . . . . . . . . . . . . 68.1 mt -116.63 130.95 70.62 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.325 0 CA-C-N 115.552 -0.749 . . . . 0.0 109.379 179.932 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' E' E ' 133' ' ' ILE . . . . . . . . . . . . . 41.8 mm -114.47 119.12 60.59 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.214 0 CA-C-O 121.026 0.441 . . . . 0.0 110.797 -176.07 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' E' E ' 134' ' ' ASP . . . . . . . . . . . . . 7.0 p-10 -128.18 147.44 50.57 Favored 'General case' 0 C--N 1.33 -0.259 0 N-CA-C 109.649 -0.5 . . . . 0.0 109.649 175.684 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' E' E ' 135' ' ' GLU . . . . . . . . . . . . . 85.6 tt0 -49.81 -24.21 2.28 Favored 'General case' 0 C--N 1.327 -0.371 0 N-CA-C 112.971 0.73 . . . . 0.0 112.971 -171.084 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' E' E ' 136' ' ' GLN . . . . . . . . . . . . . 63.0 tt0 -100.03 -31.16 11.58 Favored 'General case' 0 CA--C 1.529 0.165 0 N-CA-C 112.145 0.424 . . . . 0.0 112.145 -175.318 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' E' E ' 137' ' ' LYS . . . . . . . . . . . . . 74.5 mttt -142.23 155.52 45.26 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-O 121.384 0.612 . . . . 0.0 111.818 -169.66 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' E' E ' 138' ' ' LEU . . . . . . . . . . . . . 4.4 tt -116.47 120.98 40.51 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 115.323 -0.853 . . . . 0.0 109.054 171.772 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' E' E ' 139' ' ' THR . . . . . . . . . . . . . 26.3 m -108.39 126.39 52.82 Favored 'General case' 0 C--N 1.331 -0.204 0 CA-C-N 116.381 -0.372 . . . . 0.0 110.974 -176.764 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' E' E ' 140' ' ' LEU . . . . . . . . . . . . . 15.4 tp -112.34 122.43 47.71 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 115.486 -0.779 . . . . 0.0 109.418 -179.618 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' E' E ' 141' ' ' ILE . . . . . . . . . . . . . 19.2 mt -123.14 121.36 62.83 Favored 'Isoleucine or valine' 0 C--O 1.234 0.259 0 N-CA-C 109.778 -0.452 . . . . 0.0 109.778 -177.339 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' E' E ' 142' ' ' ARG . . . . . . . . . . . . . 29.2 ttp180 -118.68 127.06 53.22 Favored 'General case' 0 C--N 1.331 -0.22 0 CA-C-N 115.437 -0.801 . . . . 0.0 110.276 -177.7 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' E' E ' 143' ' ' THR . . . . . . . . . . . . . 72.9 p . . . . . 0 C--O 1.221 -0.432 0 CA-C-O 118.108 -0.948 . . . . 0.0 110.677 -179.265 . . . . . . . . 0 0 . 1 . 009 nuclear orig core ' F' F ' 1' ' ' MET . . . . . . . . . . . . . 26.2 ptt? . . . . . 0 C--O 1.231 0.082 0 CA-C-O 120.782 0.325 . . . . 0.0 110.7 . . . . . . . . . 0 0 . 1 . 009 nuclear orig core ' F' F ' 2' ' ' SER . . . . . . . . . . . . . 9.1 p -126.83 147.62 50.01 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-N 116.261 -0.427 . . . . 0.0 110.684 179.985 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' F' F ' 3' ' ' GLU . . . . . . . . . . . . . 81.9 tt0 -140.78 140.13 34.71 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.068 -0.515 . . . . 0.0 111.132 -178.424 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' F' F ' 4' ' ' LEU . . . . . . . . . . . . . 18.1 tp -122.1 131.11 53.8 Favored 'General case' 0 C--N 1.332 -0.185 0 CA-C-N 115.971 -0.559 . . . . 0.0 109.907 176.418 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' F' F ' 5' ' ' LYS . . . . . . . . . . . . . 64.1 mttp -109.72 121.14 44.54 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.238 -0.437 . . . . 0.0 110.576 -179.041 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' F' F ' 6' ' ' LEU . . . . . . . . . . . . . 63.0 mt -114.0 149.33 35.51 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 115.467 -0.788 . . . . 0.0 110.811 -177.878 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' F' F ' 7' ' ' LYS . . . . . . . . . . . . . 29.6 ttpt -135.0 134.87 22.07 Favored Pre-proline 0 CA--C 1.534 0.357 0 CA-C-O 118.929 -0.558 . . . . 0.0 109.728 176.72 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' F' F ' 8' ' ' PRO . . . . . . . . . . . . . 97.1 Cg_endo -91.05 131.2 1.46 Allowed 'Trans proline' 0 N--CA 1.49 1.265 0 C-N-CA 121.73 1.62 . . . . 0.0 111.396 175.331 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' F' F ' 9' ' ' LEU . . . . . . . . . . . . . 27.9 mt -68.63 -46.84 35.11 Favored Pre-proline 0 CA--C 1.532 0.28 0 CA-C-O 118.791 -0.623 . . . . 0.0 111.509 -177.067 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' F' F ' 10' ' ' PRO . . . . . . . . . . . . . 98.4 Cg_endo -80.71 140.96 13.37 Favored 'Trans proline' 0 N--CA 1.496 1.643 0 C-N-CA 121.012 1.141 . . . . 0.0 111.25 171.542 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' F' F ' 11' ' ' LYS . . . . . . . . . . . . . 54.0 tttp -84.82 106.47 16.38 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-O 120.86 0.362 . . . . 0.0 110.586 -179.433 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' F' F ' 12' ' ' VAL . . . . . . . . . . . . . 12.2 p -142.98 148.72 19.23 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.344 0 CA-C-N 116.101 -0.5 . . . . 0.0 110.497 -179.758 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' F' F ' 13' ' ' GLU . . . . . . . . . . . . . 43.8 tp10 -82.18 117.07 22.04 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.211 -0.449 . . . . 0.0 109.984 177.74 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' F' F ' 14' ' ' LEU . . . . . . . . . . . . . 32.3 mt -89.61 149.79 43.0 Favored Pre-proline 0 C--N 1.33 -0.263 0 CA-C-O 119.326 -0.369 . . . . 0.0 110.618 -177.62 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' F' F ' 15' ' ' PRO . . . . . . . . . . . . . 26.0 Cg_exo -61.67 159.12 33.94 Favored 'Trans proline' 0 N--CA 1.496 1.631 0 C-N-CA 121.186 1.257 . . . . 0.0 111.627 176.756 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' F' F ' 16' ' ' PRO . . . . . . . . . . . . . 38.5 Cg_exo -58.52 -36.17 97.73 Favored 'Trans proline' 0 N--CA 1.497 1.712 0 C-N-CA 121.386 1.391 . . . . 0.0 112.931 -177.499 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' F' F ' 17' ' ' ASP . . . . . . . . . . . . . 7.2 p-10 -90.77 8.42 34.76 Favored 'General case' 0 CA--C 1.535 0.372 0 N-CA-C 113.393 0.886 . . . . 0.0 113.393 -176.867 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' F' F ' 18' ' ' PHE . . . . . . . . . . . . . 34.9 t80 -58.42 -45.45 88.42 Favored 'General case' 0 C--O 1.231 0.102 0 O-C-N 121.983 -0.448 . . . . 0.0 110.018 -178.187 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' F' F ' 19' ' ' VAL . . . . . . . . . . . . . 13.2 p -57.22 -40.66 75.04 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.372 0 CA-C-N 116.156 -0.475 . . . . 0.0 110.571 179.939 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' F' F ' 20' ' ' ASP . . . . . . . . . . . . . 65.8 m-20 -60.02 -43.12 95.48 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-O 120.798 0.333 . . . . 0.0 110.84 -178.013 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' F' F ' 21' ' ' VAL . . . . . . . . . . . . . 46.6 t -64.06 -47.33 90.76 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.284 0 CA-C-N 116.398 -0.365 . . . . 0.0 110.377 -178.183 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' F' F ' 22' ' ' ILE . . . . . . . . . . . . . 49.9 mm -57.73 -39.24 69.43 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.353 0 CA-C-O 120.793 0.33 . . . . 0.0 110.896 -179.941 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' F' F ' 23' ' ' ARG . . . . . . . . . . . . . 54.6 ttp180 -57.13 -50.55 72.45 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-O 120.904 0.383 . . . . 0.0 110.562 177.243 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' F' F ' 24' ' ' ILE . . . . . . . . . . . . . 72.8 mt -61.0 -40.1 84.44 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.287 0 CA-C-N 115.986 -0.552 . . . . 0.0 111.968 -176.979 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' F' F ' 25' ' ' LYS . . . . . . . . . . . . . 13.8 pttp -75.48 -35.18 60.9 Favored 'General case' 0 CA--C 1.534 0.348 0 C-N-CA 120.671 -0.412 . . . . 0.0 112.046 -174.03 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' F' F ' 26' ' ' LEU . . . . . . . . . . . . . 34.3 mt -80.32 -41.42 24.89 Favored 'General case' 0 C--N 1.33 -0.256 0 N-CA-C 112.841 0.682 . . . . 0.0 112.841 -174.762 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' F' F ' 27' ' ' GLN . . . . . . . . . . . . . 9.0 pt20 -46.3 139.63 4.63 Favored 'General case' 0 N--CA 1.467 0.392 0 N-CA-C 113.006 0.743 . . . . 0.0 113.006 -174.551 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' F' F ' 28' ' ' GLY . . . . . . . . . . . . . . . 99.61 -25.85 26.66 Favored Glycine 0 CA--C 1.534 1.243 0 CA-C-N 115.539 -0.755 . . . . 0.0 112.199 -175.362 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' F' F ' 29' ' ' LYS . . . . . . . . . . . . . 25.7 mtpp -98.43 155.18 17.37 Favored 'General case' 0 C--N 1.333 -0.146 0 CA-C-N 117.18 0.49 . . . . 0.0 111.167 179.648 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' F' F ' 30' ' ' THR . . . . . . . . . . . . . 29.8 m -101.17 137.73 39.14 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.036 -0.529 . . . . 0.0 109.96 175.657 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' F' F ' 31' ' ' VAL . . . . . . . . . . . . . 35.3 m -129.26 154.24 39.82 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.254 0 CA-C-O 120.94 0.4 . . . . 0.0 110.742 -179.754 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' F' F ' 32' ' ' ARG . . . . . . . . . . . . . 80.8 mtm180 -132.53 148.29 52.38 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 115.849 -0.614 . . . . 0.0 110.335 178.395 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' F' F ' 33' ' ' THR . . . . . . . . . . . . . 25.3 m -52.79 138.01 30.33 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.344 -0.389 . . . . 0.0 111.418 -178.688 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' F' F ' 34' ' ' GLY . . . . . . . . . . . . . . . 101.64 -17.14 55.56 Favored Glycine 0 CA--C 1.532 1.155 0 CA-C-O 119.697 -0.501 . . . . 0.0 113.28 179.369 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' F' F ' 35' ' ' ASP . . . . . . . . . . . . . 73.3 m-20 -65.84 149.17 50.61 Favored 'General case' 0 C--O 1.232 0.136 0 CA-C-N 117.981 0.89 . . . . 0.0 110.952 179.23 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' F' F ' 36' ' ' VAL . . . . . . . . . . . . . 45.8 t -126.0 131.61 71.54 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.289 0 CA-C-N 116.049 -0.523 . . . . 0.0 109.854 178.302 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' F' F ' 37' ' ' ILE . . . . . . . . . . . . . 65.2 mt -121.06 139.15 49.18 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.233 0 CA-C-N 116.162 -0.472 . . . . 0.0 109.891 -178.995 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' F' F ' 38' ' ' GLY . . . . . . . . . . . . . . . -110.36 128.8 9.0 Favored Glycine 0 CA--C 1.525 0.662 0 N-CA-C 111.059 -0.816 . . . . 0.0 111.059 179.916 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' F' F ' 39' ' ' ILE . . . . . . . . . . . . . 73.7 mt -123.9 133.68 68.59 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.185 0 N-CA-C 110.049 -0.352 . . . . 0.0 110.049 179.347 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' F' F ' 40' ' ' SER . . . . . . . . . . . . . 99.8 p -93.23 123.66 36.66 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.398 -0.364 . . . . 0.0 111.0 176.298 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' F' F ' 41' ' ' ILE . . . . . . . . . . . . . 70.9 mt -131.21 120.69 47.28 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.209 0 CA-C-O 120.918 0.39 . . . . 0.0 110.345 177.869 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' F' F ' 42' ' ' LEU . . . . . . . . . . . . . 48.9 mt 52.76 35.45 18.64 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.011 -0.54 . . . . 0.0 111.699 177.166 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' F' F ' 43' ' ' GLY . . . . . . . . . . . . . . . 72.31 31.48 63.55 Favored Glycine 0 CA--C 1.53 1.027 0 C-N-CA 121.139 -0.553 . . . . 0.0 112.142 178.064 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' F' F ' 44' ' ' LYS . . . . . . . . . . . . . 58.8 mtpt -135.91 131.49 35.28 Favored 'General case' 0 C--N 1.33 -0.278 0 N-CA-C 109.714 -0.476 . . . . 0.0 109.714 177.783 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' F' F ' 45' ' ' GLU . . . . . . . . . . . . . 83.8 tt0 -83.6 119.39 24.68 Favored 'General case' 0 C--N 1.328 -0.343 0 C-N-CA 120.844 -0.342 . . . . 0.0 111.219 -178.631 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' F' F ' 46' ' ' VAL . . . . . . . . . . . . . 7.7 p -118.66 122.75 70.21 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.198 0 N-CA-C 109.195 -0.669 . . . . 0.0 109.195 174.824 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' F' F ' 47' ' ' LYS . . . . . . . . . . . . . 55.5 mtmt -100.22 128.64 46.25 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 115.999 -0.546 . . . . 0.0 111.303 -179.815 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' F' F ' 48' ' ' PHE . . . . . . . . . . . . . 93.6 m-85 -110.55 131.92 54.64 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-N 116.099 -0.501 . . . . 0.0 109.872 177.529 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' F' F ' 49' ' ' LYS . . . . . . . . . . . . . 84.3 tttt -107.77 137.09 46.4 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.281 -0.418 . . . . 0.0 110.683 179.339 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' F' F ' 50' ' ' VAL . . . . . . . . . . . . . 43.5 t -82.32 106.29 13.07 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.24 0 N-CA-C 109.279 -0.637 . . . . 0.0 109.279 175.389 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' F' F ' 51' ' ' VAL . . . . . . . . . . . . . 47.7 t -71.06 -52.58 26.32 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.373 0 N-CA-C 109.707 -0.479 . . . . 0.0 109.707 -174.475 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' F' F ' 52' ' ' GLN . . . . . . . . . . . . . 88.5 mt-30 -154.81 153.67 31.56 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-O 121.206 0.527 . . . . 0.0 111.748 -176.64 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' F' F ' 53' ' ' ALA . . . . . . . . . . . . . . . -132.17 133.01 43.72 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 115.333 -0.849 . . . . 0.0 109.526 174.42 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' F' F ' 54' ' ' TYR . . . . . . . . . . . . . 17.2 t80 -129.13 111.47 18.29 Favored Pre-proline 0 CA--C 1.535 0.385 0 CA-C-O 118.16 -0.924 . . . . 0.0 110.204 179.088 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' F' F ' 55' ' ' PRO . . . . . . . . . . . . . 73.9 Cg_endo -77.14 168.88 75.76 Favored 'Cis proline' 0 N--CA 1.5 1.876 0 CA-C-N 121.872 1.704 . . . . 0.0 112.321 -6.644 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' F' F ' 56' ' ' SER . . . . . . . . . . . . . 13.4 m -117.32 135.04 23.05 Favored Pre-proline 0 CA--C 1.539 0.531 0 CA-C-O 118.477 -0.773 . . . . 0.0 109.627 175.243 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' F' F ' 57' ' ' PRO . . . . . . . . . . . . . 35.4 Cg_endo -66.38 164.68 65.91 Favored 'Cis proline' 0 N--CA 1.498 1.774 0 CA-C-N 121.809 1.682 . . . . 0.0 111.338 -3.225 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' F' F ' 58' ' ' LEU . . . . . . . . . . . . . 16.4 tp -130.77 139.08 50.21 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-O 120.996 0.427 . . . . 0.0 110.38 179.738 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' F' F ' 59' ' ' ARG . . . . . . . . . . . . . 60.3 ttm-85 -104.48 127.93 52.29 Favored 'General case' 0 C--N 1.327 -0.397 0 N-CA-C 109.152 -0.685 . . . . 0.0 109.152 174.986 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' F' F ' 60' ' ' VAL . . . . . . . . . . . . . 41.6 t -81.0 119.38 30.55 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.271 0 C-N-CA 120.732 -0.387 . . . . 0.0 110.604 -174.941 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' F' F ' 61' ' ' GLU . . . . . . . . . . . . . 95.5 mt-10 -131.05 163.07 28.43 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 115.853 -0.612 . . . . 0.0 109.689 175.301 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' F' F ' 62' ' ' ASP . . . . . . . . . . . . . 41.2 m-20 -52.51 -31.64 36.35 Favored 'General case' 0 C--N 1.328 -0.354 0 N-CA-C 112.045 0.387 . . . . 0.0 112.045 -178.942 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' F' F ' 63' ' ' ARG . . . . . . . . . . . . . 79.3 mtt85 -72.94 -22.03 60.79 Favored 'General case' 0 CA--C 1.533 0.324 0 N-CA-C 112.896 0.702 . . . . 0.0 112.896 -176.205 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' F' F ' 64' ' ' THR . . . . . . . . . . . . . 20.3 m -72.54 141.48 48.47 Favored 'General case' 0 C--N 1.331 -0.206 0 CA-C-O 120.833 0.349 . . . . 0.0 110.999 -175.755 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' F' F ' 65' ' ' LYS . . . . . . . . . . . . . 67.1 mttm -90.01 137.09 32.63 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.009 -0.541 . . . . 0.0 110.49 179.578 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' F' F ' 66' ' ' ILE . . . . . . . . . . . . . 60.4 mt -119.33 130.03 74.5 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.268 0 N-CA-C 109.68 -0.489 . . . . 0.0 109.68 177.856 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' F' F ' 67' ' ' THR . . . . . . . . . . . . . 31.9 m -125.97 145.33 50.33 Favored 'General case' 0 C--N 1.331 -0.21 0 CA-C-O 121.089 0.471 . . . . 0.0 111.37 -176.81 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' F' F ' 68' ' ' LEU . . . . . . . . . . . . . 4.8 tt . . . . . 0 C--N 1.33 -0.25 0 CA-C-N 115.721 -0.672 . . . . 0.0 109.786 176.553 . . . . . . . . 0 0 . 1 . 009 nuclear orig core ' F' F ' 73' ' ' VAL . . . . . . . . . . . . . 34.9 m . . . . . 0 C--O 1.232 0.162 0 N-CA-C 110.305 -0.258 . . . . 0.0 110.305 . . . . . . . . . 0 0 . 1 . 009 nuclear orig core ' F' F ' 74' ' ' ASP . . . . . . . . . . . . . 47.4 t0 -84.98 114.92 22.51 Favored 'General case' 0 C--N 1.33 -0.264 0 C-N-CA 120.524 -0.47 . . . . 0.0 110.381 -171.112 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' F' F ' 75' ' ' VAL . . . . . . . . . . . . . 46.5 t -118.16 117.89 56.28 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.27 0 CA-C-O 121.178 0.513 . . . . 0.0 109.74 178.643 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' F' F ' 76' ' ' LEU . . . . . . . . . . . . . 13.9 mt -120.86 142.44 49.66 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 115.453 -0.794 . . . . 0.0 109.216 179.385 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' F' F ' 77' ' ' GLU . . . . . . . . . . . . . 97.7 mt-10 -135.49 130.05 34.08 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-O 121.225 0.536 . . . . 0.0 111.343 -176.713 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' F' F ' 78' ' ' ALA . . . . . . . . . . . . . . . -118.7 134.46 55.11 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-N 115.47 -0.786 . . . . 0.0 109.649 176.373 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' F' F ' 79' ' ' LYS . . . . . . . . . . . . . 39.7 mtmt -83.81 115.44 22.24 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-O 120.958 0.408 . . . . 0.0 110.751 -178.784 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' F' F ' 80' ' ' ILE . . . . . . . . . . . . . 24.0 mm -139.19 114.73 8.74 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.323 0 CA-C-N 115.722 -0.672 . . . . 0.0 109.266 -177.93 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' F' F ' 81' ' ' LYS . . . . . . . . . . . . . 75.6 mttt -101.65 126.49 48.5 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-O 120.802 0.334 . . . . 0.0 111.029 -178.086 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' F' F ' 82' ' ' GLY . . . . . . . . . . . . . . . 89.04 42.14 5.7 Favored Glycine 0 CA--C 1.525 0.718 0 C-N-CA 120.905 -0.665 . . . . 0.0 111.933 175.423 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' F' F ' 83' ' ' ILE . . . . . . . . . . . . . 74.1 mt -66.69 138.41 22.98 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 N-CA-C 109.634 -0.506 . . . . 0.0 109.634 176.461 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' F' F ' 84' ' ' LYS . . . . . . . . . . . . . 53.8 tttp -99.34 -51.85 3.68 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.597 -176.729 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' F' F ' 85' ' ' ASP . . . . . . . . . . . . . 7.3 t70 -154.7 154.81 33.49 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.024 -0.534 . . . . 0.0 110.633 -179.807 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' F' F ' 86' ' ' VAL . . . . . . . . . . . . . 41.4 t -130.68 132.6 64.2 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.258 0 CA-C-O 121.032 0.444 . . . . 0.0 110.535 -179.516 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' F' F ' 87' ' ' ILE . . . . . . . . . . . . . 45.1 mm -120.76 128.37 76.04 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.229 0 CA-C-N 115.72 -0.673 . . . . 0.0 109.582 177.738 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' F' F ' 88' ' ' LEU . . . . . . . . . . . . . 37.4 mt -109.39 138.72 45.33 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-O 121.159 0.504 . . . . 0.0 111.312 -178.389 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' F' F ' 89' ' ' ASP . . . . . . . . . . . . . 11.7 t70 -130.07 154.89 47.0 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 115.485 -0.78 . . . . 0.0 109.197 175.319 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' F' F ' 90' ' ' GLU . . . . . . . . . . . . . 84.8 tt0 -46.12 -39.1 8.98 Favored 'General case' 0 N--CA 1.465 0.276 0 N-CA-C 113.175 0.806 . . . . 0.0 113.175 -172.315 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' F' F ' 91' ' ' ASN . . . . . . . . . . . . . 14.5 p30 -132.09 25.03 4.58 Favored 'General case' 0 N--CA 1.467 0.393 0 N-CA-C 112.71 0.633 . . . . 0.0 112.71 -178.391 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' F' F ' 92' ' ' LEU . . . . . . . . . . . . . 13.6 mt -150.38 147.22 27.32 Favored 'General case' 0 C--N 1.331 -0.218 0 N-CA-C 109.963 -0.384 . . . . 0.0 109.963 -177.398 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' F' F ' 93' ' ' ILE . . . . . . . . . . . . . 71.3 mt -126.98 117.79 48.66 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.269 0 N-CA-C 109.294 -0.632 . . . . 0.0 109.294 178.705 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' F' F ' 94' ' ' VAL . . . . . . . . . . . . . 44.3 t -118.09 127.98 75.22 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.217 0 N-CA-C 109.955 -0.387 . . . . 0.0 109.955 -178.584 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' F' F ' 95' ' ' VAL . . . . . . . . . . . . . 42.7 t -124.31 134.35 66.9 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.293 0 CA-C-N 116.18 -0.463 . . . . 0.0 109.992 -179.409 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' F' F ' 96' ' ' ILE . . . . . . . . . . . . . 57.5 mt -113.27 129.9 68.18 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.284 0 N-CA-C 109.423 -0.584 . . . . 0.0 109.423 178.722 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' F' F ' 97' ' ' THR . . . . . . . . . . . . . 59.7 p -102.1 156.92 17.24 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-O 120.946 0.403 . . . . 0.0 110.782 179.958 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' F' F ' 98' ' ' GLU . . . . . . . . . . . . . 97.8 mt-10 -53.95 -24.42 16.45 Favored 'General case' 0 CA--C 1.533 0.304 0 N-CA-C 112.344 0.498 . . . . 0.0 112.344 179.854 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' F' F ' 99' ' ' GLU . . . . . . . . . . . . . 97.1 mt-10 -75.49 9.07 2.38 Favored 'General case' 0 CA--C 1.536 0.435 0 N-CA-C 113.402 0.889 . . . . 0.0 113.402 -178.22 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' F' F ' 100' ' ' ASN . . . . . . . . . . . . . 4.2 m-20 63.07 33.94 14.2 Favored 'General case' 0 CA--C 1.532 0.263 0 CA-C-N 118.131 0.423 . . . . 0.0 111.332 -178.512 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' F' F ' 101' ' ' GLU . . . . . . . . . . . . . 84.0 tt0 -110.1 142.29 41.77 Favored 'General case' 0 C--N 1.333 -0.146 0 N-CA-C 109.475 -0.565 . . . . 0.0 109.475 172.39 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' F' F ' 102' ' ' VAL . . . . . . . . . . . . . 45.6 t -114.9 124.57 71.68 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.319 0 CA-C-N 116.226 -0.443 . . . . 0.0 109.814 -179.242 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' F' F ' 103' ' ' LEU . . . . . . . . . . . . . 26.1 mt -112.27 132.55 54.89 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 115.508 -0.769 . . . . 0.0 109.798 177.245 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' F' F ' 104' ' ' ILE . . . . . . . . . . . . . 69.9 mt -123.02 117.8 52.84 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.286 0 N-CA-C 109.983 -0.377 . . . . 0.0 109.983 -178.84 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' F' F ' 105' ' ' PHE . . . . . . . . . . . . . 20.8 m-85 -120.3 165.68 14.53 Favored 'General case' 0 C--N 1.331 -0.221 0 CA-C-N 115.568 -0.742 . . . . 0.0 109.892 179.838 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' F' F ' 106' ' ' ASN . . . . . . . . . . . . . 45.8 p-10 -98.67 -169.96 1.87 Allowed 'General case' 0 C--N 1.329 -0.288 0 N-CA-C 109.702 -0.481 . . . . 0.0 109.702 173.993 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' F' F ' 107' ' ' GLN . . . . . . . . . . . . . 45.4 tt0 -58.85 -28.09 65.75 Favored 'General case' 0 C--N 1.327 -0.379 0 N-CA-C 112.168 0.433 . . . . 0.0 112.168 179.272 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' F' F ' 108' ' ' ASN . . . . . . . . . . . . . 14.1 t30 -86.22 10.24 15.23 Favored 'General case' 0 CA--C 1.535 0.377 0 N-CA-C 113.136 0.791 . . . . 0.0 113.136 -177.72 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' F' F ' 109' ' ' LEU . . . . . . . . . . . . . 9.9 tp 59.7 35.89 22.34 Favored 'General case' 0 C--O 1.233 0.187 0 O-C-N 122.106 -0.371 . . . . 0.0 111.426 178.612 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' F' F ' 110' ' ' GLU . . . . . . . . . . . . . 70.9 mm-40 -106.79 149.9 26.88 Favored 'General case' 0 C--N 1.33 -0.275 0 N-CA-C 110.207 -0.294 . . . . 0.0 110.207 177.168 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' F' F ' 111' ' ' GLU . . . . . . . . . . . . . 98.5 mt-10 -77.85 122.11 25.01 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.264 -0.426 . . . . 0.0 111.389 -176.944 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' F' F ' 112' ' ' LEU . . . . . . . . . . . . . 17.8 mt -107.45 -44.71 4.24 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 115.928 -0.578 . . . . 0.0 109.954 176.21 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' F' F ' 113' ' ' TYR . . . . . . . . . . . . . 42.1 t80 -141.59 137.44 31.91 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.054 -0.521 . . . . 0.0 110.987 -179.3 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' F' F ' 114' ' ' ARG . . . . . . . . . . . . . 23.9 ttm180 -138.13 125.76 22.19 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.109 -0.496 . . . . 0.0 109.869 175.823 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' F' F ' 115' ' ' GLY . . . . . . . . . . . . . . . -150.12 142.07 9.36 Favored Glycine 0 CA--C 1.524 0.597 0 N-CA-C 110.756 -0.938 . . . . 0.0 110.756 178.454 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' F' F ' 116' ' ' LYS . . . . . . . . . . . . . 84.8 tttt -118.76 128.06 54.13 Favored 'General case' 0 C--N 1.33 -0.25 0 N-CA-C 109.693 -0.484 . . . . 0.0 109.693 177.754 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' F' F ' 117' ' ' PHE . . . . . . . . . . . . . 22.7 m-85 -129.57 117.48 20.49 Favored 'General case' 0 C--N 1.332 -0.166 0 CA-C-O 120.921 0.391 . . . . 0.0 110.32 -172.954 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' F' F ' 118' ' ' GLU . . . . . . . . . . . . . 43.4 mt-10 -52.35 -49.27 64.66 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.349 -0.387 . . . . 0.0 111.765 -176.242 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' F' F ' 119' ' ' ASN . . . . . . . . . . . . . 90.3 m-20 -97.32 31.06 2.6 Favored 'General case' 0 C--N 1.33 -0.24 0 N-CA-C 112.164 0.431 . . . . 0.0 112.164 -174.293 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' F' F ' 120' ' ' LEU . . . . . . . . . . . . . 12.5 tp -56.33 124.32 17.64 Favored 'General case' 0 C--N 1.331 -0.21 0 CA-C-O 120.588 0.233 . . . . 0.0 110.604 178.273 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' F' F ' 121' ' ' ASN . . . . . . . . . . . . . 31.4 m120 -114.08 -44.04 3.18 Favored 'General case' 0 C--N 1.331 -0.198 0 CA-C-N 116.524 -0.307 . . . . 0.0 111.149 -177.327 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' F' F ' 122' ' ' LYS . . . . . . . . . . . . . 98.6 mttt -144.35 148.79 35.18 Favored 'General case' 0 C--N 1.332 -0.194 0 CA-C-O 121.198 0.523 . . . . 0.0 112.028 -175.921 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' F' F ' 123' ' ' VAL . . . . . . . . . . . . . 45.6 t -127.42 124.5 63.92 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.239 0 CA-C-N 115.624 -0.716 . . . . 0.0 109.078 172.711 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' F' F ' 124' ' ' LEU . . . . . . . . . . . . . 57.9 mt -118.93 138.8 52.53 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-O 120.837 0.351 . . . . 0.0 111.078 -175.567 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' F' F ' 125' ' ' VAL . . . . . . . . . . . . . 34.3 m -130.34 129.58 64.99 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.273 0 CA-C-N 115.961 -0.563 . . . . 0.0 110.284 177.888 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' F' F ' 126' ' ' ARG . . . . . . . . . . . . . 31.1 mmt180 -135.9 108.11 7.26 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.224 -0.444 . . . . 0.0 110.29 179.074 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' F' F ' 127' ' ' ASN . . . . . . . . . . . . . 42.1 m-80 54.26 -104.81 0.23 Allowed 'General case' 0 CA--C 1.541 0.628 0 CA-C-O 119.163 -0.446 . . . . 0.0 110.934 179.403 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' F' F ' 128' ' ' ASP . . . . . . . . . . . . . 7.5 p-10 -111.41 1.6 17.1 Favored 'General case' 0 N--CA 1.468 0.437 0 CA-C-N 119.45 1.023 . . . . 0.0 113.447 -176.053 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' F' F ' 129' ' ' LEU . . . . . . . . . . . . . 38.2 mt -104.97 141.82 35.88 Favored 'General case' 0 C--O 1.231 0.131 0 CA-C-N 118.195 0.452 . . . . 0.0 110.257 178.915 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' F' F ' 130' ' ' VAL . . . . . . . . . . . . . 44.0 t -123.37 137.08 57.9 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.224 0 CA-C-N 116.268 -0.424 . . . . 0.0 109.916 -179.275 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' F' F ' 131' ' ' VAL . . . . . . . . . . . . . 42.7 t -135.69 136.44 50.35 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.29 0 CA-C-O 121.041 0.448 . . . . 0.0 110.408 179.326 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' F' F ' 132' ' ' ILE . . . . . . . . . . . . . 67.7 mt -117.71 130.2 72.96 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.232 0 CA-C-N 115.74 -0.664 . . . . 0.0 109.286 179.567 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' F' F ' 133' ' ' ILE . . . . . . . . . . . . . 41.9 mm -118.06 120.02 63.22 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.227 0 CA-C-O 120.831 0.348 . . . . 0.0 111.221 -174.329 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' F' F ' 134' ' ' ASP . . . . . . . . . . . . . 7.1 p-10 -131.58 145.59 51.78 Favored 'General case' 0 C--N 1.332 -0.173 0 N-CA-C 109.422 -0.584 . . . . 0.0 109.422 173.403 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' F' F ' 135' ' ' GLU . . . . . . . . . . . . . 73.6 tt0 -49.92 -22.97 1.71 Allowed 'General case' 0 C--N 1.329 -0.322 0 N-CA-C 113.286 0.847 . . . . 0.0 113.286 -170.615 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' F' F ' 136' ' ' GLN . . . . . . . . . . . . . 57.1 tp60 -99.04 -34.08 10.55 Favored 'General case' 0 C--N 1.331 -0.225 0 N-CA-C 111.94 0.348 . . . . 0.0 111.94 -176.135 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' F' F ' 137' ' ' LYS . . . . . . . . . . . . . 57.5 mtpt -138.77 151.84 47.43 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-O 121.13 0.491 . . . . 0.0 111.128 -169.612 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' F' F ' 138' ' ' LEU . . . . . . . . . . . . . 5.2 tt -119.29 122.76 42.63 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 115.809 -0.632 . . . . 0.0 109.437 174.445 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' F' F ' 139' ' ' THR . . . . . . . . . . . . . 19.8 m -110.36 130.39 55.56 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-N 116.323 -0.399 . . . . 0.0 110.838 -177.27 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' F' F ' 140' ' ' LEU . . . . . . . . . . . . . 8.9 tt -118.75 123.58 45.2 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 115.821 -0.627 . . . . 0.0 109.404 -179.232 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' F' F ' 141' ' ' ILE . . . . . . . . . . . . . 19.8 mt -120.47 120.72 63.56 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.309 0 CA-C-O 121.039 0.447 . . . . 0.0 109.887 -175.698 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' F' F ' 142' ' ' ARG . . . . . . . . . . . . . 68.9 ttt180 -110.69 130.77 55.48 Favored 'General case' 0 C--N 1.331 -0.22 0 CA-C-N 115.2 -0.909 . . . . 0.0 110.717 -175.494 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' F' F ' 143' ' ' THR . . . . . . . . . . . . . 41.2 p . . . . . 0 C--O 1.22 -0.475 0 CA-C-O 118.158 -0.925 . . . . 0.0 110.958 179.469 . . . . . . . . 0 0 . 1 . 010 nuclear orig core ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 10.5 p . . . . . 0 CA--C 1.523 -0.085 0 CA-C-O 120.867 0.365 . . . . 0.0 110.588 . . . . . . . . . 0 0 . 1 . 010 nuclear orig core ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 95.7 mt-10 -141.06 136.8 32.37 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.111 -0.495 . . . . 0.0 110.746 179.836 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 4' ' ' LEU . . . . . . . . . . . . . 14.5 tp -125.42 132.05 52.81 Favored 'General case' 0 C--N 1.332 -0.176 0 CA-C-N 116.114 -0.494 . . . . 0.0 110.218 177.616 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 5' ' ' LYS . . . . . . . . . . . . . 97.9 mttt -110.26 120.88 43.87 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.145 -0.479 . . . . 0.0 110.403 179.342 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 66.3 mt -117.44 145.81 43.89 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 115.535 -0.757 . . . . 0.0 110.157 -178.864 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 25.8 ttpp -135.69 139.78 31.86 Favored Pre-proline 0 CA--C 1.534 0.334 0 CA-C-O 119.087 -0.483 . . . . 0.0 110.156 176.929 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 8' ' ' PRO . . . . . . . . . . . . . 92.7 Cg_endo -91.84 141.12 2.49 Favored 'Trans proline' 0 N--CA 1.489 1.227 0 C-N-CA 121.806 1.67 . . . . 0.0 111.766 177.157 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 58.8 mt -75.8 -49.65 3.46 Favored Pre-proline 0 CA--C 1.533 0.324 0 CA-C-O 118.507 -0.759 . . . . 0.0 112.588 -178.588 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 74.2 Cg_endo -76.33 155.56 36.94 Favored 'Trans proline' 0 N--CA 1.498 1.751 0 C-N-CA 121.062 1.175 . . . . 0.0 112.171 -179.436 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 27.0 tptp -87.74 92.47 9.12 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.117 -0.492 . . . . 0.0 110.468 179.42 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 12.6 p -143.63 148.75 18.66 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.32 0 CA-C-O 120.889 0.376 . . . . 0.0 110.837 -179.181 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 42.4 mp0 -87.68 129.6 35.09 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.1 -0.5 . . . . 0.0 110.332 178.47 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 14' ' ' LEU . . . . . . . . . . . . . 34.5 mt -99.24 151.66 37.49 Favored Pre-proline 0 C--N 1.33 -0.281 0 CA-C-N 116.41 -0.359 . . . . 0.0 110.813 -179.38 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 15' ' ' PRO . . . . . . . . . . . . . 27.4 Cg_exo -61.24 155.67 50.13 Favored 'Trans proline' 0 N--CA 1.497 1.717 0 C-N-CA 121.348 1.365 . . . . 0.0 111.624 177.051 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 16' ' ' PRO . . . . . . . . . . . . . 39.4 Cg_exo -58.58 -38.0 91.71 Favored 'Trans proline' 0 N--CA 1.498 1.74 0 C-N-CA 121.347 1.365 . . . . 0.0 112.798 -178.398 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 17' ' ' ASP . . . . . . . . . . . . . 12.3 p-10 -87.12 10.56 16.33 Favored 'General case' 0 CA--C 1.535 0.402 0 N-CA-C 113.231 0.826 . . . . 0.0 113.231 -177.476 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 18' ' ' PHE . . . . . . . . . . . . . 44.1 t80 -57.76 -43.14 85.26 Favored 'General case' 0 C--N 1.334 -0.085 0 O-C-N 121.942 -0.474 . . . . 0.0 110.229 -178.327 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 19' ' ' VAL . . . . . . . . . . . . . 48.1 t -56.32 -43.97 78.5 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.325 0 CA-C-N 116.291 -0.413 . . . . 0.0 110.64 -178.399 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 66.4 m-20 -59.57 -42.99 93.72 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-O 121.059 0.457 . . . . 0.0 110.815 -177.681 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 46.0 t -64.21 -48.79 84.09 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.253 0 CA-C-N 116.349 -0.387 . . . . 0.0 110.669 -177.856 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 22' ' ' ILE . . . . . . . . . . . . . 50.1 mm -55.65 -43.66 73.99 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.211 0 C-N-CA 120.911 -0.316 . . . . 0.0 110.689 179.861 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 23' ' ' ARG . . . . . . . . . . . . . 53.8 ttp180 -52.92 -51.92 59.62 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-O 120.55 0.214 . . . . 0.0 111.554 -179.367 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 24' ' ' ILE . . . . . . . . . . . . . 73.1 mt -60.01 -41.47 86.32 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.37 0 C-N-CA 121.095 -0.242 . . . . 0.0 111.295 -178.218 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 69.6 mmtt -64.19 -40.76 96.78 Favored 'General case' 0 C--N 1.328 -0.345 0 N-CA-C 112.187 0.44 . . . . 0.0 112.187 -178.516 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 36.1 mt -79.61 -42.45 24.89 Favored 'General case' 0 C--N 1.329 -0.307 0 N-CA-C 113.025 0.75 . . . . 0.0 113.025 -171.289 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 27' ' ' GLN . . . . . . . . . . . . . 9.6 pt20 -46.4 140.08 4.45 Favored 'General case' 0 N--CA 1.469 0.492 0 N-CA-C 112.808 0.67 . . . . 0.0 112.808 -175.447 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 101.19 -27.93 18.35 Favored Glycine 0 CA--C 1.531 1.05 0 CA-C-N 115.591 -0.731 . . . . 0.0 112.214 -177.67 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 99.2 mttt -98.57 155.06 17.48 Favored 'General case' 0 C--O 1.232 0.18 0 CA-C-N 117.338 0.569 . . . . 0.0 111.228 179.095 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 30' ' ' THR . . . . . . . . . . . . . 49.3 m -105.29 135.54 46.48 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.117 -0.492 . . . . 0.0 109.709 174.994 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 34.4 m -129.26 159.99 40.67 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.206 0 CA-C-O 120.803 0.335 . . . . 0.0 110.996 -177.768 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 32' ' ' ARG . . . . . . . . . . . . . 38.2 ttm180 -130.66 147.88 52.39 Favored 'General case' 0 C--N 1.331 -0.217 0 CA-C-N 116.008 -0.542 . . . . 0.0 110.357 179.17 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 33' ' ' THR . . . . . . . . . . . . . 30.6 m -52.2 140.73 20.51 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-O 120.849 0.357 . . . . 0.0 111.386 -179.099 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 99.65 -17.13 57.96 Favored Glycine 0 CA--C 1.533 1.207 0 C-N-CA 121.156 -0.545 . . . . 0.0 113.202 -179.455 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 60.7 m-20 -64.92 150.1 48.47 Favored 'General case' 0 C--O 1.231 0.129 0 CA-C-N 118.059 0.93 . . . . 0.0 111.205 179.686 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 45.8 t -124.44 130.88 73.43 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.221 0 CA-C-N 115.762 -0.654 . . . . 0.0 109.838 178.963 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 37' ' ' ILE . . . . . . . . . . . . . 66.9 mt -122.89 139.86 48.4 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.221 0 CA-C-N 116.181 -0.463 . . . . 0.0 109.929 -179.647 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . -108.93 128.87 9.24 Favored Glycine 0 CA--C 1.525 0.668 0 N-CA-C 111.034 -0.826 . . . . 0.0 111.034 179.456 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 39' ' ' ILE . . . . . . . . . . . . . 70.3 mt -124.93 137.67 56.79 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.282 0 N-CA-C 110.008 -0.367 . . . . 0.0 110.008 179.59 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 40' ' ' SER . . . . . . . . . . . . . 53.6 p -91.37 114.28 26.76 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.443 -0.344 . . . . 0.0 110.789 176.697 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 41' ' ' ILE . . . . . . . . . . . . . 43.3 mm -121.69 113.44 39.17 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.185 0 N-CA-C 109.939 -0.393 . . . . 0.0 109.939 179.075 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 85.6 mt 58.83 35.46 24.26 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.36 -0.382 . . . . 0.0 111.475 178.61 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . 77.57 -10.14 25.24 Favored Glycine 0 CA--C 1.534 1.264 0 C-N-CA 121.283 -0.484 . . . . 0.0 113.434 178.419 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 44' ' ' LYS . . . . . . . . . . . . . 18.7 tptm -97.13 135.17 39.48 Favored 'General case' 0 C--N 1.333 -0.149 0 CA-C-N 117.941 0.87 . . . . 0.0 109.767 176.918 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 85.9 tt0 -82.38 123.96 29.58 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-O 120.802 0.334 . . . . 0.0 110.959 -178.977 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 46' ' ' VAL . . . . . . . . . . . . . 7.4 p -118.64 127.44 75.62 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.217 0 N-CA-C 109.465 -0.568 . . . . 0.0 109.465 176.765 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 62.3 mtpt -99.57 127.73 45.66 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.027 -0.533 . . . . 0.0 110.981 179.318 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 48' ' ' PHE . . . . . . . . . . . . . 86.8 m-85 -110.65 131.85 54.7 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.41 -0.359 . . . . 0.0 110.132 177.425 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 77.7 tttt -108.93 136.59 48.23 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.115 -0.493 . . . . 0.0 110.464 179.117 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 50' ' ' VAL . . . . . . . . . . . . . 44.6 t -81.0 106.19 11.86 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.288 0 N-CA-C 109.357 -0.609 . . . . 0.0 109.357 175.612 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 51' ' ' VAL . . . . . . . . . . . . . 55.3 t -69.38 -48.29 68.15 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.255 0 CA-C-N 116.065 -0.516 . . . . 0.0 109.89 -173.896 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 52' ' ' GLN . . . . . . . . . . . . . 21.5 pt20 -164.34 158.21 18.44 Favored 'General case' 0 C--N 1.331 -0.215 0 C-N-CA 120.198 -0.601 . . . . 0.0 111.786 179.549 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -135.87 136.4 40.53 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-N 115.292 -0.867 . . . . 0.0 110.062 179.126 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 54' ' ' TYR . . . . . . . . . . . . . 41.5 t80 -129.15 113.23 18.45 Favored Pre-proline 0 CA--C 1.535 0.368 0 CA-C-O 118.164 -0.922 . . . . 0.0 110.126 177.5 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 55' ' ' PRO . . . . . . . . . . . . . 74.3 Cg_endo -77.11 167.82 78.7 Favored 'Cis proline' 0 N--CA 1.499 1.804 0 CA-C-N 122.01 1.754 . . . . 0.0 112.343 -6.878 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 56' ' ' SER . . . . . . . . . . . . . 13.7 m -117.6 131.53 24.04 Favored Pre-proline 0 CA--C 1.539 0.531 0 CA-C-O 118.389 -0.815 . . . . 0.0 109.609 175.526 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 57' ' ' PRO . . . . . . . . . . . . . 36.6 Cg_endo -66.73 167.28 56.98 Favored 'Cis proline' 0 N--CA 1.498 1.756 0 CA-C-N 121.937 1.727 . . . . 0.0 111.253 -2.472 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 58' ' ' LEU . . . . . . . . . . . . . 34.5 tp -130.47 136.48 49.04 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.348 -0.387 . . . . 0.0 110.525 -179.831 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 59' ' ' ARG . . . . . . . . . . . . . 58.2 ttp180 -101.67 121.0 41.22 Favored 'General case' 0 C--N 1.326 -0.422 0 N-CA-C 109.164 -0.68 . . . . 0.0 109.164 175.721 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 43.7 t -76.28 120.29 26.05 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.308 0 C-N-CA 120.723 -0.391 . . . . 0.0 110.637 -173.049 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 95.0 mt-10 -131.02 163.21 28.09 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 115.78 -0.646 . . . . 0.0 109.726 176.891 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 62' ' ' ASP . . . . . . . . . . . . . 77.8 m-20 -53.99 -32.27 53.57 Favored 'General case' 0 C--N 1.329 -0.318 0 C-N-CA 120.981 -0.288 . . . . 0.0 111.695 -179.793 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 63' ' ' ARG . . . . . . . . . . . . . 39.7 ptt180 -78.47 2.35 19.25 Favored 'General case' 0 CA--C 1.537 0.465 0 N-CA-C 113.682 0.993 . . . . 0.0 113.682 -175.738 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 29.0 m -89.55 139.49 30.48 Favored 'General case' 0 C--N 1.333 -0.121 0 CA-C-N 118.131 0.423 . . . . 0.0 110.91 -178.446 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 65' ' ' LYS . . . . . . . . . . . . . 98.2 mttt -88.83 129.71 35.53 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.076 -0.511 . . . . 0.0 110.2 178.579 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 66' ' ' ILE . . . . . . . . . . . . . 60.6 mt -115.27 129.75 70.99 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.275 0 N-CA-C 109.903 -0.406 . . . . 0.0 109.903 179.296 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 67' ' ' THR . . . . . . . . . . . . . 25.7 m -120.25 136.97 54.48 Favored 'General case' 0 C--N 1.331 -0.224 0 CA-C-N 116.061 -0.518 . . . . 0.0 110.674 -179.587 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 68' ' ' LEU . . . . . . . . . . . . . 6.6 tt . . . . . 0 C--N 1.329 -0.312 0 CA-C-N 115.863 -0.608 . . . . 0.0 110.158 178.778 . . . . . . . . 0 0 . 1 . 010 nuclear orig core ' A' A ' 74' ' ' ASP . . . . . . . . . . . . . 30.7 t0 . . . . . 0 C--O 1.229 -0.019 0 N-CA-C 109.617 -0.512 . . . . 0.0 109.617 . . . . . . . . . 0 0 . 1 . 010 nuclear orig core ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 39.4 t -112.71 122.76 67.51 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.207 0 CA-C-O 120.953 0.406 . . . . 0.0 110.481 -177.897 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 76' ' ' LEU . . . . . . . . . . . . . 25.0 mt -125.64 149.27 48.57 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 115.844 -0.616 . . . . 0.0 109.829 178.195 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 77' ' ' GLU . . . . . . . . . . . . . 96.8 mt-10 -137.03 138.04 40.04 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-O 121.015 0.436 . . . . 0.0 111.213 -177.986 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 78' ' ' ALA . . . . . . . . . . . . . . . -123.1 136.61 54.87 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 115.642 -0.708 . . . . 0.0 109.813 177.076 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 79' ' ' LYS . . . . . . . . . . . . . 24.9 pttm -79.3 119.82 22.9 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-O 121.262 0.553 . . . . 0.0 111.018 -177.479 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 80' ' ' ILE . . . . . . . . . . . . . 35.7 mm -139.28 104.67 2.21 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.252 0 CA-C-N 115.75 -0.659 . . . . 0.0 109.33 179.822 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 81' ' ' LYS . . . . . . . . . . . . . 99.3 mttt -102.21 127.03 49.33 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-O 120.958 0.409 . . . . 0.0 111.211 -176.726 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . 89.29 42.03 5.65 Favored Glycine 0 CA--C 1.525 0.673 0 N-CA-C 111.504 -0.638 . . . . 0.0 111.504 175.883 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 83' ' ' ILE . . . . . . . . . . . . . 71.0 mt -69.66 137.49 24.04 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.298 0 N-CA-C 109.77 -0.455 . . . . 0.0 109.77 176.749 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 84' ' ' LYS . . . . . . . . . . . . . 6.9 ttpm? -101.96 -48.56 4.21 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.102 179.362 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 85' ' ' ASP . . . . . . . . . . . . . 11.1 t70 -150.44 151.39 32.69 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 115.85 -0.614 . . . . 0.0 110.38 -179.721 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 86' ' ' VAL . . . . . . . . . . . . . 45.1 t -131.33 132.88 62.78 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.283 0 CA-C-O 120.958 0.409 . . . . 0.0 110.447 -179.134 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 87' ' ' ILE . . . . . . . . . . . . . 5.1 mp -119.31 123.64 71.62 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.206 0 N-CA-C 109.169 -0.678 . . . . 0.0 109.169 175.891 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 88' ' ' LEU . . . . . . . . . . . . . 23.2 mt -114.0 129.71 56.59 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.164 -0.471 . . . . 0.0 111.148 -176.089 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 89' ' ' ASP . . . . . . . . . . . . . 13.6 t70 -124.02 154.6 39.64 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 115.83 -0.623 . . . . 0.0 109.677 176.709 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 41.6 mp0 -50.69 -37.33 40.66 Favored 'General case' 0 C--N 1.329 -0.316 0 N-CA-C 112.396 0.517 . . . . 0.0 112.396 -171.789 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 91' ' ' ASN . . . . . . . . . . . . . 20.2 p-10 -132.23 35.64 3.68 Favored 'General case' 0 N--CA 1.464 0.268 0 CA-C-O 120.679 0.276 . . . . 0.0 111.727 -177.112 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 92' ' ' LEU . . . . . . . . . . . . . 7.1 tp -166.12 139.76 4.24 Favored 'General case' 0 C--N 1.33 -0.282 0 N-CA-C 110.08 -0.341 . . . . 0.0 110.08 179.792 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 93' ' ' ILE . . . . . . . . . . . . . 66.7 mt -124.93 122.96 64.63 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.178 0 N-CA-C 109.749 -0.463 . . . . 0.0 109.749 -178.758 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 94' ' ' VAL . . . . . . . . . . . . . 41.8 t -125.6 127.84 71.9 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.181 0 CA-C-O 120.958 0.408 . . . . 0.0 110.142 179.44 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 95' ' ' VAL . . . . . . . . . . . . . 47.7 t -120.58 135.41 60.9 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.343 0 CA-C-N 115.909 -0.587 . . . . 0.0 109.875 -179.951 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 96' ' ' ILE . . . . . . . . . . . . . 65.7 mt -114.08 127.04 71.68 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.279 0 N-CA-C 109.341 -0.615 . . . . 0.0 109.341 178.388 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 97' ' ' THR . . . . . . . . . . . . . 67.8 p -97.72 162.8 13.1 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-O 121.331 0.586 . . . . 0.0 111.316 -176.918 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 98' ' ' GLU . . . . . . . . . . . . . 79.7 tt0 -53.84 -29.05 39.36 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 115.86 -0.609 . . . . 0.0 112.1 -178.993 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 99' ' ' GLU . . . . . . . . . . . . . 95.6 mt-10 -79.2 13.38 1.88 Allowed 'General case' 0 CA--C 1.534 0.365 0 N-CA-C 113.224 0.824 . . . . 0.0 113.224 -176.936 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 100' ' ' ASN . . . . . . . . . . . . . 4.0 m-20 61.18 34.41 18.88 Favored 'General case' 0 CA--C 1.53 0.179 0 CA-C-N 118.058 0.39 . . . . 0.0 111.414 -179.388 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 101' ' ' GLU . . . . . . . . . . . . . 84.0 tt0 -107.74 143.99 35.5 Favored 'General case' 0 C--N 1.333 -0.138 0 N-CA-C 109.537 -0.542 . . . . 0.0 109.537 172.993 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 102' ' ' VAL . . . . . . . . . . . . . 42.6 t -115.52 125.98 72.91 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.302 0 CA-C-N 116.273 -0.421 . . . . 0.0 110.007 -177.195 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 103' ' ' LEU . . . . . . . . . . . . . 66.2 mt -116.72 130.77 56.93 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 115.767 -0.651 . . . . 0.0 110.189 176.749 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 104' ' ' ILE . . . . . . . . . . . . . 68.6 mt -118.63 123.33 71.38 Favored 'Isoleucine or valine' 0 C--O 1.234 0.247 0 N-CA-C 110.26 -0.274 . . . . 0.0 110.26 -178.854 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 105' ' ' PHE . . . . . . . . . . . . . 67.6 m-85 -122.99 163.7 19.94 Favored 'General case' 0 C--O 1.232 0.148 0 O-C-N 124.003 0.815 . . . . 0.0 110.136 -178.176 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 106' ' ' ASN . . . . . . . . . . . . . 43.5 p-10 -97.77 -169.9 1.9 Allowed 'General case' 0 C--N 1.329 -0.283 0 N-CA-C 109.566 -0.531 . . . . 0.0 109.566 171.93 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 107' ' ' GLN . . . . . . . . . . . . . 31.7 tt0 -57.38 -29.68 64.26 Favored 'General case' 0 C--N 1.328 -0.348 0 N-CA-C 111.988 0.366 . . . . 0.0 111.988 178.983 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 108' ' ' ASN . . . . . . . . . . . . . 6.1 t-20 -86.98 11.57 13.29 Favored 'General case' 0 CA--C 1.536 0.421 0 N-CA-C 113.09 0.774 . . . . 0.0 113.09 -175.792 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 109' ' ' LEU . . . . . . . . . . . . . 41.6 mt 57.69 37.03 27.21 Favored 'General case' 0 C--N 1.332 -0.181 0 CA-C-O 120.88 0.372 . . . . 0.0 111.475 177.303 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 110' ' ' GLU . . . . . . . . . . . . . 43.5 mt-10 -104.73 146.72 28.56 Favored 'General case' 0 C--N 1.331 -0.228 0 N-CA-C 110.108 -0.33 . . . . 0.0 110.108 176.475 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 111' ' ' GLU . . . . . . . . . . . . . 99.3 mt-10 -76.89 121.98 24.19 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-O 120.92 0.39 . . . . 0.0 110.928 -178.57 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 112' ' ' LEU . . . . . . . . . . . . . 49.0 mt -110.12 -45.69 3.56 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 115.941 -0.572 . . . . 0.0 110.158 177.575 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 113' ' ' TYR . . . . . . . . . . . . . 64.8 t80 -134.15 135.86 43.4 Favored 'General case' 0 C--N 1.332 -0.187 0 CA-C-N 116.119 -0.491 . . . . 0.0 110.99 179.845 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 114' ' ' ARG . . . . . . . . . . . . . 83.3 mtp180 -135.17 123.25 22.81 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 116.043 -0.526 . . . . 0.0 110.248 177.937 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 115' ' ' GLY . . . . . . . . . . . . . . . -150.08 158.8 27.83 Favored Glycine 0 CA--C 1.524 0.625 0 N-CA-C 110.854 -0.898 . . . . 0.0 110.854 178.761 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 116' ' ' LYS . . . . . . . . . . . . . 79.8 tttt -134.18 131.76 38.99 Favored 'General case' 0 C--N 1.329 -0.32 0 N-CA-C 110.016 -0.365 . . . . 0.0 110.016 178.199 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 117' ' ' PHE . . . . . . . . . . . . . 20.0 m-85 -136.36 114.07 11.1 Favored 'General case' 0 C--N 1.331 -0.216 0 CA-C-N 116.362 -0.381 . . . . 0.0 110.066 -174.65 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 118' ' ' GLU . . . . . . . . . . . . . 96.1 mt-10 -54.5 -38.57 66.63 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.557 -0.292 . . . . 0.0 111.283 -177.945 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 119' ' ' ASN . . . . . . . . . . . . . 7.9 m-80 -100.44 30.53 3.85 Favored 'General case' 0 C--N 1.331 -0.232 0 N-CA-C 112.142 0.423 . . . . 0.0 112.142 -175.24 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 120' ' ' LEU . . . . . . . . . . . . . 16.3 tp -58.33 122.27 12.83 Favored 'General case' 0 C--N 1.331 -0.196 0 N-CA-C 110.084 -0.339 . . . . 0.0 110.084 177.322 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 121' ' ' ASN . . . . . . . . . . . . . 60.8 t30 -114.13 -44.09 3.17 Favored 'General case' 0 N--CA 1.462 0.169 0 CA-C-N 116.712 -0.222 . . . . 0.0 111.426 -176.986 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 122' ' ' LYS . . . . . . . . . . . . . 98.5 mttt -147.02 150.69 35.6 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-O 121.016 0.436 . . . . 0.0 111.665 -176.39 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 123' ' ' VAL . . . . . . . . . . . . . 40.9 t -128.79 129.16 68.31 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.319 0 CA-C-N 115.89 -0.596 . . . . 0.0 109.414 174.691 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 124' ' ' LEU . . . . . . . . . . . . . 52.6 mt -117.2 132.94 56.53 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-O 120.723 0.297 . . . . 0.0 110.372 -178.787 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 125' ' ' VAL . . . . . . . . . . . . . 34.9 m -134.32 133.75 55.19 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.252 0 CA-C-N 116.152 -0.477 . . . . 0.0 111.045 -178.092 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 126' ' ' ARG . . . . . . . . . . . . . 14.9 ptm180 -163.4 137.19 5.82 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.185 -0.461 . . . . 0.0 109.85 175.291 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 127' ' ' ASN . . . . . . . . . . . . . 69.4 m-20 55.56 -154.82 0.29 Allowed 'General case' 0 CA--C 1.539 0.531 0 N-CA-C 109.818 -0.438 . . . . 0.0 109.818 -178.77 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 128' ' ' ASP . . . . . . . . . . . . . 23.8 p-10 -84.65 22.25 1.36 Allowed 'General case' 0 CA--C 1.534 0.334 0 CA-C-N 118.383 0.538 . . . . 0.0 112.339 177.419 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 129' ' ' LEU . . . . . . . . . . . . . 16.5 tp -118.58 138.92 52.23 Favored 'General case' 0 C--O 1.234 0.249 0 O-C-N 122.112 -0.367 . . . . 0.0 110.178 178.764 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 130' ' ' VAL . . . . . . . . . . . . . 12.3 p -135.37 140.35 44.99 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.2 0 CA-C-O 120.96 0.41 . . . . 0.0 110.396 -178.773 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 131' ' ' VAL . . . . . . . . . . . . . 14.6 p -136.17 141.12 42.42 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.233 0 CA-C-O 120.981 0.42 . . . . 0.0 110.891 179.29 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 132' ' ' ILE . . . . . . . . . . . . . 73.4 mt -112.96 134.02 56.93 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.292 0 CA-C-N 115.859 -0.61 . . . . 0.0 109.637 179.756 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 133' ' ' ILE . . . . . . . . . . . . . 41.7 mm -117.66 124.35 72.94 Favored 'Isoleucine or valine' 0 C--O 1.233 0.198 0 CA-C-O 120.806 0.336 . . . . 0.0 110.976 -176.192 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 134' ' ' ASP . . . . . . . . . . . . . 7.1 p-10 -136.61 148.46 47.49 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.253 -0.43 . . . . 0.0 109.85 175.747 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 135' ' ' GLU . . . . . . . . . . . . . 83.0 tt0 -50.02 -26.9 4.76 Favored 'General case' 0 C--N 1.328 -0.341 0 N-CA-C 112.67 0.619 . . . . 0.0 112.67 -174.66 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 136' ' ' GLN . . . . . . . . . . . . . 94.3 mt-30 -82.67 -32.44 28.14 Favored 'General case' 0 C--N 1.33 -0.251 0 N-CA-C 112.344 0.498 . . . . 0.0 112.344 -175.596 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 137' ' ' LYS . . . . . . . . . . . . . 56.5 pttt -170.01 176.63 4.62 Favored 'General case' 0 C--N 1.333 -0.133 0 CA-C-O 121.592 0.71 . . . . 0.0 112.29 -172.795 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 138' ' ' LEU . . . . . . . . . . . . . 7.5 tt -122.18 130.17 52.96 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-N 115.006 -0.997 . . . . 0.0 110.045 179.201 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 139' ' ' THR . . . . . . . . . . . . . 85.2 m -115.42 124.54 51.43 Favored 'General case' 0 C--N 1.331 -0.224 0 CA-C-N 116.253 -0.431 . . . . 0.0 110.212 179.206 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 140' ' ' LEU . . . . . . . . . . . . . 21.0 tp -111.86 125.93 54.55 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.005 -0.543 . . . . 0.0 109.606 -178.979 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 141' ' ' ILE . . . . . . . . . . . . . 19.6 mt -123.31 124.56 70.14 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.252 0 CA-C-O 120.996 0.427 . . . . 0.0 110.234 -172.814 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 142' ' ' ARG . . . . . . . . . . . . . 81.1 mtp180 -111.84 125.78 54.38 Favored 'General case' 0 C--O 1.233 0.22 0 CA-C-N 115.429 -0.805 . . . . 0.0 109.843 -178.895 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 143' ' ' THR . . . . . . . . . . . . . 40.0 p . . . . . 0 C--O 1.22 -0.452 0 CA-C-O 118.014 -0.994 . . . . 0.0 110.555 -179.226 . . . . . . . . 0 0 . 1 . 010 nuclear orig core ' B' B ' 2' ' ' SER . . . . . . . . . . . . . 4.9 p . . . . . 0 N--CA 1.461 0.096 0 CA-C-O 120.797 0.332 . . . . 0.0 110.585 . . . . . . . . . 0 0 . 1 . 010 nuclear orig core ' B' B ' 3' ' ' GLU . . . . . . . . . . . . . 40.7 mt-10 -141.08 141.44 34.25 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.243 -0.435 . . . . 0.0 111.09 -178.962 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 4' ' ' LEU . . . . . . . . . . . . . 16.4 tp -125.9 129.82 50.09 Favored 'General case' 0 C--N 1.333 -0.143 0 CA-C-N 116.011 -0.541 . . . . 0.0 109.912 176.047 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 5' ' ' LYS . . . . . . . . . . . . . 57.1 mttp -108.79 123.24 48.71 Favored 'General case' 0 C--O 1.236 0.359 0 CA-C-N 116.625 -0.262 . . . . 0.0 110.891 -179.394 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 6' ' ' LEU . . . . . . . . . . . . . 66.6 mt -114.62 145.88 41.48 Favored 'General case' 0 C--N 1.331 -0.223 0 CA-C-N 115.71 -0.677 . . . . 0.0 110.557 179.646 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 7' ' ' LYS . . . . . . . . . . . . . 83.7 tttt -128.12 142.0 43.08 Favored Pre-proline 0 CA--C 1.533 0.303 0 CA-C-O 119.057 -0.497 . . . . 0.0 109.787 175.569 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 8' ' ' PRO . . . . . . . . . . . . . 93.7 Cg_endo -90.37 136.06 2.26 Favored 'Trans proline' 0 N--CA 1.49 1.318 0 C-N-CA 121.717 1.611 . . . . 0.0 111.832 179.131 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 9' ' ' LEU . . . . . . . . . . . . . 28.0 mt -82.96 -47.2 0.84 Allowed Pre-proline 0 CA--C 1.535 0.401 0 CA-C-O 118.631 -0.699 . . . . 0.0 112.061 -179.358 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 10' ' ' PRO . . . . . . . . . . . . . 83.8 Cg_endo -82.53 157.03 16.52 Favored 'Trans proline' 0 N--CA 1.495 1.592 0 C-N-CA 121.29 1.326 . . . . 0.0 111.802 175.688 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 11' ' ' LYS . . . . . . . . . . . . . 18.2 pttp -86.03 110.38 19.46 Favored 'General case' 0 C--N 1.331 -0.216 0 CA-C-O 121.523 0.677 . . . . 0.0 110.329 177.42 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 12' ' ' VAL . . . . . . . . . . . . . 12.0 p -151.07 149.53 14.09 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.359 0 CA-C-N 115.72 -0.673 . . . . 0.0 110.329 -179.978 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 13' ' ' GLU . . . . . . . . . . . . . 42.0 tp10 -95.73 120.6 36.28 Favored 'General case' 0 C--N 1.329 -0.293 0 C-N-CA 120.853 -0.339 . . . . 0.0 110.217 177.714 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 14' ' ' LEU . . . . . . . . . . . . . 37.2 mt -97.94 149.05 35.32 Favored Pre-proline 0 CA--C 1.533 0.316 0 CA-C-O 119.318 -0.372 . . . . 0.0 110.592 -177.736 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 15' ' ' PRO . . . . . . . . . . . . . 26.7 Cg_exo -61.8 157.11 44.55 Favored 'Trans proline' 0 N--CA 1.499 1.83 0 C-N-CA 121.286 1.324 . . . . 0.0 111.663 176.998 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 16' ' ' PRO . . . . . . . . . . . . . 39.1 Cg_exo -58.97 -33.95 98.94 Favored 'Trans proline' 0 N--CA 1.497 1.685 0 C-N-CA 121.416 1.411 . . . . 0.0 112.498 179.584 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 17' ' ' ASP . . . . . . . . . . . . . 18.7 p-10 -88.02 9.69 21.54 Favored 'General case' 0 CA--C 1.536 0.413 0 N-CA-C 113.234 0.828 . . . . 0.0 113.234 -177.791 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 18' ' ' PHE . . . . . . . . . . . . . 43.5 t80 -58.32 -46.49 86.08 Favored 'General case' 0 CA--C 1.523 -0.06 0 O-C-N 121.965 -0.459 . . . . 0.0 109.996 -177.983 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 19' ' ' VAL . . . . . . . . . . . . . 12.9 p -53.91 -41.4 48.95 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.328 0 CA-C-N 116.501 -0.318 . . . . 0.0 111.188 -178.422 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 20' ' ' ASP . . . . . . . . . . . . . 81.2 m-20 -60.82 -45.15 95.57 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-O 120.935 0.398 . . . . 0.0 110.83 -178.841 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 21' ' ' VAL . . . . . . . . . . . . . 40.7 t -64.16 -44.32 97.54 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.287 0 CA-C-N 116.272 -0.422 . . . . 0.0 110.654 -177.614 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 22' ' ' ILE . . . . . . . . . . . . . 50.3 mm -59.68 -40.01 81.16 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.199 0 C-N-CA 120.816 -0.354 . . . . 0.0 110.829 -179.65 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 23' ' ' ARG . . . . . . . . . . . . . 57.7 ttp180 -55.16 -49.14 72.6 Favored 'General case' 0 N--CA 1.463 0.219 0 CA-C-O 121.103 0.478 . . . . 0.0 110.692 177.736 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 24' ' ' ILE . . . . . . . . . . . . . 72.4 mt -60.39 -42.85 92.43 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 CA-C-N 115.729 -0.668 . . . . 0.0 111.845 -177.047 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 25' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -72.01 -37.43 69.79 Favored 'General case' 0 CA--C 1.535 0.37 0 N-CA-C 112.103 0.409 . . . . 0.0 112.103 -175.157 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' B' B ' 26' ' ' LEU . . . . . . . . . . . . . 40.4 mt -79.54 -39.7 31.25 Favored 'General case' 0 C--N 1.331 -0.231 0 N-CA-C 112.91 0.707 . . . . 0.0 112.91 -172.569 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 27' ' ' GLN . . . . . . . . . . . . . 9.6 pt20 -45.78 139.03 4.36 Favored 'General case' 0 N--CA 1.469 0.523 0 N-CA-C 112.84 0.682 . . . . 0.0 112.84 -175.095 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 28' ' ' GLY . . . . . . . . . . . . . . . 102.01 -26.65 23.57 Favored Glycine 0 CA--C 1.531 1.066 0 CA-C-N 115.367 -0.833 . . . . 0.0 112.191 -176.737 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 29' ' ' LYS . . . . . . . . . . . . . 54.8 mtpt -98.59 155.18 17.42 Favored 'General case' 0 C--O 1.233 0.198 0 CA-C-N 117.523 0.661 . . . . 0.0 111.237 179.058 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 30' ' ' THR . . . . . . . . . . . . . 53.7 m -101.03 139.43 36.73 Favored 'General case' 0 C--N 1.331 -0.216 0 CA-C-N 116.045 -0.525 . . . . 0.0 110.1 176.03 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 31' ' ' VAL . . . . . . . . . . . . . 34.5 m -130.47 155.4 41.7 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.305 0 CA-C-N 116.142 -0.481 . . . . 0.0 110.413 179.394 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 32' ' ' ARG . . . . . . . . . . . . . 71.5 ttt-85 -135.41 150.25 49.84 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-O 121.048 0.451 . . . . 0.0 110.24 178.211 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 33' ' ' THR . . . . . . . . . . . . . 19.8 m -52.28 137.67 28.2 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-O 120.894 0.378 . . . . 0.0 111.634 -177.068 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 34' ' ' GLY . . . . . . . . . . . . . . . 101.97 -17.2 54.86 Favored Glycine 0 CA--C 1.533 1.179 0 CA-C-O 119.622 -0.543 . . . . 0.0 113.21 179.087 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 35' ' ' ASP . . . . . . . . . . . . . 76.3 m-20 -67.28 148.58 51.51 Favored 'General case' 0 N--CA 1.462 0.128 0 CA-C-N 118.087 0.943 . . . . 0.0 111.299 179.514 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 36' ' ' VAL . . . . . . . . . . . . . 46.3 t -121.44 131.15 73.74 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.198 0 CA-C-N 115.935 -0.575 . . . . 0.0 109.873 177.737 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 37' ' ' ILE . . . . . . . . . . . . . 63.8 mt -121.27 138.57 51.21 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.299 0 CA-C-N 116.26 -0.427 . . . . 0.0 109.957 -179.921 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 38' ' ' GLY . . . . . . . . . . . . . . . -114.42 127.52 7.78 Favored Glycine 0 CA--C 1.524 0.636 0 N-CA-C 111.01 -0.836 . . . . 0.0 111.01 179.126 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 39' ' ' ILE . . . . . . . . . . . . . 70.8 mt -128.94 130.92 68.57 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.213 0 N-CA-C 110.003 -0.369 . . . . 0.0 110.003 178.685 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 40' ' ' SER . . . . . . . . . . . . . 59.7 p -90.93 118.19 30.12 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.422 -0.354 . . . . 0.0 110.693 176.959 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 41' ' ' ILE . . . . . . . . . . . . . 48.2 mm -125.08 116.95 48.58 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.19 0 CA-C-O 120.974 0.416 . . . . 0.0 110.237 179.686 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 42' ' ' LEU . . . . . . . . . . . . . 1.3 tt 56.65 45.58 21.8 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-O 121.414 0.626 . . . . 0.0 110.366 178.217 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 43' ' ' GLY . . . . . . . . . . . . . . . 75.16 -9.65 12.21 Favored Glycine 0 CA--C 1.534 1.238 0 CA-C-N 116.062 -0.517 . . . . 0.0 113.726 175.378 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 44' ' ' LYS . . . . . . . . . . . . . 46.8 tttp -107.29 126.9 53.03 Favored 'General case' 0 C--N 1.333 -0.121 0 CA-C-N 118.064 0.932 . . . . 0.0 110.189 -179.216 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 45' ' ' GLU . . . . . . . . . . . . . 42.6 tp10 -83.51 128.84 34.83 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-O 120.829 0.347 . . . . 0.0 111.222 -178.781 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 46' ' ' VAL . . . . . . . . . . . . . 8.7 p -120.18 127.08 75.88 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.198 0 N-CA-C 109.574 -0.528 . . . . 0.0 109.574 176.004 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 47' ' ' LYS . . . . . . . . . . . . . 87.0 mttt -98.94 124.82 44.16 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.03 -0.532 . . . . 0.0 110.603 177.092 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 48' ' ' PHE . . . . . . . . . . . . . 40.5 m-85 -108.96 131.8 54.71 Favored 'General case' 0 C--N 1.327 -0.379 0 N-CA-C 109.698 -0.482 . . . . 0.0 109.698 177.145 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 49' ' ' LYS . . . . . . . . . . . . . 84.3 tttt -107.89 134.71 50.44 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.452 -0.34 . . . . 0.0 110.406 178.21 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 50' ' ' VAL . . . . . . . . . . . . . 43.4 t -76.34 104.86 4.72 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.303 0 N-CA-C 109.25 -0.648 . . . . 0.0 109.25 176.729 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 51' ' ' VAL . . . . . . . . . . . . . 47.0 t -69.6 -49.79 55.87 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.275 0 CA-C-N 116.088 -0.505 . . . . 0.0 109.799 -174.428 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 52' ' ' GLN . . . . . . . . . . . . . 34.2 tt0 -161.91 145.05 11.99 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 115.928 -0.578 . . . . 0.0 111.569 -178.458 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 53' ' ' ALA . . . . . . . . . . . . . . . -120.71 133.57 55.34 Favored 'General case' 0 C--N 1.331 -0.219 0 CA-C-N 115.792 -0.64 . . . . 0.0 110.051 176.963 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 54' ' ' TYR . . . . . . . . . . . . . 45.9 t80 -129.06 109.63 18.19 Favored Pre-proline 0 CA--C 1.534 0.362 0 CA-C-O 118.27 -0.871 . . . . 0.0 110.243 178.276 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 55' ' ' PRO . . . . . . . . . . . . . 73.6 Cg_endo -77.11 168.24 77.54 Favored 'Cis proline' 0 N--CA 1.5 1.862 0 CA-C-N 121.818 1.685 . . . . 0.0 112.518 -5.921 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 56' ' ' SER . . . . . . . . . . . . . 50.5 m -117.3 134.02 23.13 Favored Pre-proline 0 CA--C 1.539 0.532 0 CA-C-O 118.418 -0.801 . . . . 0.0 109.557 174.851 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 57' ' ' PRO . . . . . . . . . . . . . 35.2 Cg_endo -66.27 164.37 66.14 Favored 'Cis proline' 0 N--CA 1.497 1.713 0 CA-C-N 121.838 1.692 . . . . 0.0 111.341 -2.547 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 58' ' ' LEU . . . . . . . . . . . . . 20.7 tp -129.78 136.05 49.16 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-O 120.966 0.413 . . . . 0.0 110.321 -179.061 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 59' ' ' ARG . . . . . . . . . . . . . 36.4 ttm180 -104.47 126.89 51.98 Favored 'General case' 0 C--N 1.326 -0.455 0 N-CA-C 109.169 -0.678 . . . . 0.0 109.169 175.69 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 60' ' ' VAL . . . . . . . . . . . . . 49.3 t -77.3 117.51 22.43 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.243 0 C-N-CA 120.638 -0.425 . . . . 0.0 109.933 -176.159 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 61' ' ' GLU . . . . . . . . . . . . . 94.9 mt-10 -130.99 167.9 18.27 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.088 -0.505 . . . . 0.0 110.247 -179.789 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 62' ' ' ASP . . . . . . . . . . . . . 24.6 t0 -54.26 -32.5 56.28 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-N 116.506 -0.315 . . . . 0.0 111.799 -178.816 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 63' ' ' ARG . . . . . . . . . . . . . 5.0 ptp180 -88.9 10.14 22.35 Favored 'General case' 0 CA--C 1.534 0.353 0 N-CA-C 113.499 0.926 . . . . 0.0 113.499 -175.147 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 64' ' ' THR . . . . . . . . . . . . . 27.2 m -94.02 134.4 36.46 Favored 'General case' 0 C--N 1.333 -0.122 0 CA-C-N 118.199 0.454 . . . . 0.0 110.507 -179.557 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 65' ' ' LYS . . . . . . . . . . . . . 67.2 mttm -90.7 133.31 35.24 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.011 -0.54 . . . . 0.0 110.616 179.706 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 66' ' ' ILE . . . . . . . . . . . . . 61.5 mt -110.75 129.6 65.64 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.21 0 N-CA-C 109.737 -0.468 . . . . 0.0 109.737 178.959 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 67' ' ' THR . . . . . . . . . . . . . 27.5 m -123.47 145.52 48.76 Favored 'General case' 0 C--N 1.331 -0.23 0 CA-C-N 116.055 -0.52 . . . . 0.0 110.644 -178.277 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 68' ' ' LEU . . . . . . . . . . . . . 52.9 mt . . . . . 0 C--N 1.331 -0.228 0 CA-C-N 115.931 -0.577 . . . . 0.0 111.135 -178.442 . . . . . . . . 0 0 . 1 . 010 nuclear orig core ' B' B ' 73' ' ' VAL . . . . . . . . . . . . . 34.5 m . . . . . 0 C--O 1.233 0.201 0 N-CA-C 109.629 -0.508 . . . . 0.0 109.629 . . . . . . . . . 0 0 . 1 . 010 nuclear orig core ' B' B ' 74' ' ' ASP . . . . . . . . . . . . . 28.9 t0 -84.85 115.35 22.7 Favored 'General case' 0 C--N 1.329 -0.323 0 C-N-CA 120.474 -0.49 . . . . 0.0 110.242 -170.972 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 75' ' ' VAL . . . . . . . . . . . . . 40.8 t -120.26 122.19 67.66 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.211 0 CA-C-O 121.099 0.476 . . . . 0.0 110.55 -177.842 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 76' ' ' LEU . . . . . . . . . . . . . 5.9 mp -119.25 137.64 53.53 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 115.609 -0.723 . . . . 0.0 109.288 174.627 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 77' ' ' GLU . . . . . . . . . . . . . 96.8 mt-10 -129.6 138.11 51.08 Favored 'General case' 0 C--N 1.331 -0.208 0 CA-C-O 121.159 0.504 . . . . 0.0 111.106 -176.405 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 78' ' ' ALA . . . . . . . . . . . . . . . -127.35 129.19 47.17 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 115.591 -0.731 . . . . 0.0 109.681 176.785 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 79' ' ' LYS . . . . . . . . . . . . . 79.9 tttt -76.35 119.34 20.09 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.413 -0.358 . . . . 0.0 110.304 -178.294 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 80' ' ' ILE . . . . . . . . . . . . . 40.6 mm -139.2 113.86 7.75 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.306 0 N-CA-C 109.469 -0.567 . . . . 0.0 109.469 -175.027 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 81' ' ' LYS . . . . . . . . . . . . . 86.9 tttt -99.33 122.89 43.1 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-O 120.82 0.343 . . . . 0.0 111.214 -177.219 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 82' ' ' GLY . . . . . . . . . . . . . . . 89.15 42.18 5.66 Favored Glycine 0 CA--C 1.526 0.752 0 C-N-CA 120.683 -0.77 . . . . 0.0 112.413 171.715 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 83' ' ' ILE . . . . . . . . . . . . . 71.3 mt -63.83 137.93 23.9 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.283 0 N-CA-C 109.484 -0.562 . . . . 0.0 109.484 174.818 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 84' ' ' LYS . . . . . . . . . . . . . 36.7 ttpt -106.58 -51.22 2.98 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-O 120.878 0.37 . . . . 0.0 110.352 -178.152 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 85' ' ' ASP . . . . . . . . . . . . . 13.1 t70 -145.25 146.16 31.58 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 115.969 -0.559 . . . . 0.0 110.54 -178.108 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 86' ' ' VAL . . . . . . . . . . . . . 46.2 t -129.97 131.89 65.89 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.263 0 CA-C-O 120.996 0.427 . . . . 0.0 110.448 -179.098 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 87' ' ' ILE . . . . . . . . . . . . . 5.0 mp -120.47 127.29 75.9 Favored 'Isoleucine or valine' 0 C--O 1.233 0.22 0 CA-C-N 115.86 -0.609 . . . . 0.0 109.494 176.846 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 88' ' ' LEU . . . . . . . . . . . . . 13.7 tp -113.68 132.93 55.61 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-O 120.963 0.411 . . . . 0.0 111.284 -177.036 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 89' ' ' ASP . . . . . . . . . . . . . 11.4 t70 -130.38 155.25 46.69 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 115.745 -0.661 . . . . 0.0 109.675 176.602 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 90' ' ' GLU . . . . . . . . . . . . . 84.4 tt0 -45.74 -48.56 15.27 Favored 'General case' 0 N--CA 1.466 0.34 0 N-CA-C 112.798 0.666 . . . . 0.0 112.798 -173.194 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 91' ' ' ASN . . . . . . . . . . . . . 2.6 p30 -126.04 39.33 3.97 Favored 'General case' 0 N--CA 1.465 0.294 0 CA-C-O 120.958 0.409 . . . . 0.0 110.966 -177.904 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 92' ' ' LEU . . . . . . . . . . . . . 10.8 tp -165.5 140.17 4.87 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.312 -0.404 . . . . 0.0 110.383 -179.376 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 93' ' ' ILE . . . . . . . . . . . . . 69.6 mt -128.77 122.56 57.3 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.289 0 N-CA-C 109.294 -0.632 . . . . 0.0 109.294 179.55 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 94' ' ' VAL . . . . . . . . . . . . . 46.4 t -122.54 128.62 75.42 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.229 0 CA-C-O 120.947 0.403 . . . . 0.0 110.147 -178.838 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 95' ' ' VAL . . . . . . . . . . . . . 42.1 t -123.16 134.28 66.67 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.283 0 CA-C-N 116.017 -0.538 . . . . 0.0 109.834 -179.785 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 96' ' ' ILE . . . . . . . . . . . . . 62.1 mt -117.8 129.92 73.47 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.237 0 N-CA-C 109.464 -0.569 . . . . 0.0 109.464 179.845 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 97' ' ' THR . . . . . . . . . . . . . 70.8 p -103.38 161.2 14.04 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-O 121.23 0.538 . . . . 0.0 111.547 -176.522 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 98' ' ' GLU . . . . . . . . . . . . . 71.0 mm-40 -53.79 -27.42 29.06 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 115.97 -0.559 . . . . 0.0 112.149 178.679 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 99' ' ' GLU . . . . . . . . . . . . . 95.5 mt-10 -76.6 11.8 1.51 Allowed 'General case' 0 CA--C 1.536 0.433 0 N-CA-C 113.235 0.828 . . . . 0.0 113.235 -178.113 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 100' ' ' ASN . . . . . . . . . . . . . 6.2 m-20 61.24 37.61 17.19 Favored 'General case' 0 CA--C 1.528 0.116 0 CA-C-O 120.912 0.387 . . . . 0.0 110.984 179.524 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 101' ' ' GLU . . . . . . . . . . . . . 85.0 tt0 -113.44 142.89 45.36 Favored 'General case' 0 C--N 1.331 -0.197 0 N-CA-C 109.606 -0.516 . . . . 0.0 109.606 174.321 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 102' ' ' VAL . . . . . . . . . . . . . 40.3 t -115.69 125.67 72.95 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.312 0 CA-C-N 116.158 -0.474 . . . . 0.0 109.968 -178.173 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 103' ' ' LEU . . . . . . . . . . . . . 23.5 mt -115.87 126.97 54.64 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 115.736 -0.665 . . . . 0.0 109.959 176.296 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 104' ' ' ILE . . . . . . . . . . . . . 66.2 mt -117.38 120.26 64.32 Favored 'Isoleucine or valine' 0 C--O 1.235 0.29 0 CA-C-N 116.612 -0.267 . . . . 0.0 110.355 -179.429 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 105' ' ' PHE . . . . . . . . . . . . . 17.7 m-85 -122.97 168.4 12.37 Favored 'General case' 0 C--N 1.332 -0.188 0 O-C-N 123.797 0.686 . . . . 0.0 109.949 178.686 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 106' ' ' ASN . . . . . . . . . . . . . 41.7 p-10 -96.93 -169.86 1.94 Allowed 'General case' 0 C--N 1.329 -0.316 0 N-CA-C 109.627 -0.508 . . . . 0.0 109.627 173.485 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 107' ' ' GLN . . . . . . . . . . . . . 60.4 tt0 -59.5 -30.04 68.28 Favored 'General case' 0 CA--C 1.532 0.274 0 C-N-CA 120.968 -0.293 . . . . 0.0 111.775 178.438 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 108' ' ' ASN . . . . . . . . . . . . . 4.8 t-20 -82.0 5.76 18.22 Favored 'General case' 0 CA--C 1.537 0.47 0 N-CA-C 113.167 0.803 . . . . 0.0 113.167 -178.053 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 109' ' ' LEU . . . . . . . . . . . . . 10.2 tp 61.97 37.8 14.73 Favored 'General case' 0 C--N 1.332 -0.166 0 O-C-N 122.047 -0.408 . . . . 0.0 111.377 178.106 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 110' ' ' GLU . . . . . . . . . . . . . 70.9 mm-40 -103.17 159.41 15.56 Favored 'General case' 0 C--N 1.33 -0.277 0 N-CA-C 109.749 -0.463 . . . . 0.0 109.749 175.688 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 111' ' ' GLU . . . . . . . . . . . . . 84.0 tt0 -85.17 123.31 30.53 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-O 120.974 0.416 . . . . 0.0 111.053 -177.397 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 112' ' ' LEU . . . . . . . . . . . . . 12.7 mt -110.04 -45.96 3.53 Favored 'General case' 0 C--N 1.331 -0.216 0 CA-C-N 115.884 -0.598 . . . . 0.0 110.144 176.776 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 113' ' ' TYR . . . . . . . . . . . . . 63.8 t80 -141.46 138.23 32.71 Favored 'General case' 0 C--N 1.331 -0.217 0 CA-C-N 116.212 -0.449 . . . . 0.0 111.152 179.977 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 114' ' ' ARG . . . . . . . . . . . . . 67.0 ttt180 -138.62 119.58 14.37 Favored 'General case' 0 C--N 1.332 -0.191 0 CA-C-N 116.015 -0.539 . . . . 0.0 110.132 178.41 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 115' ' ' GLY . . . . . . . . . . . . . . . -150.15 158.04 27.49 Favored Glycine 0 CA--C 1.525 0.696 0 C-N-CA 120.666 -0.778 . . . . 0.0 111.367 179.342 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 116' ' ' LYS . . . . . . . . . . . . . 29.8 ttmt -130.81 139.31 50.17 Favored 'General case' 0 C--N 1.331 -0.231 0 N-CA-C 109.898 -0.408 . . . . 0.0 109.898 176.643 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 117' ' ' PHE . . . . . . . . . . . . . 30.7 m-85 -135.84 114.5 11.9 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.329 -0.396 . . . . 0.0 110.372 -176.047 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 118' ' ' GLU . . . . . . . . . . . . . 96.0 mt-10 -52.82 -47.63 67.52 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.351 -0.386 . . . . 0.0 111.579 -176.473 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 119' ' ' ASN . . . . . . . . . . . . . 32.4 m120 -94.91 31.03 1.93 Allowed 'General case' 0 C--N 1.331 -0.238 0 N-CA-C 112.199 0.444 . . . . 0.0 112.199 -174.553 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 120' ' ' LEU . . . . . . . . . . . . . 11.8 tp -56.48 120.46 7.75 Favored 'General case' 0 C--N 1.332 -0.156 0 CA-C-O 120.728 0.299 . . . . 0.0 110.504 177.68 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 121' ' ' ASN . . . . . . . . . . . . . 64.3 t30 -112.53 -44.09 3.4 Favored 'General case' 0 C--N 1.331 -0.23 0 CA-C-N 116.317 -0.401 . . . . 0.0 110.874 -176.502 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 122' ' ' LYS . . . . . . . . . . . . . 34.2 mtmm -147.45 145.97 29.37 Favored 'General case' 0 C--N 1.331 -0.217 0 CA-C-O 121.08 0.467 . . . . 0.0 111.445 -178.191 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 123' ' ' VAL . . . . . . . . . . . . . 46.6 t -125.92 129.64 72.39 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.24 0 CA-C-N 115.831 -0.622 . . . . 0.0 109.409 176.395 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 124' ' ' LEU . . . . . . . . . . . . . 44.9 mt -118.88 128.33 54.34 Favored 'General case' 0 C--N 1.331 -0.239 0 CA-C-N 116.308 -0.405 . . . . 0.0 110.431 -179.204 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 125' ' ' VAL . . . . . . . . . . . . . 47.7 t -130.61 124.35 56.78 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.324 0 CA-C-N 116.141 -0.481 . . . . 0.0 109.824 179.105 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 126' ' ' ARG . . . . . . . . . . . . . 37.0 mtm105 -145.0 119.72 9.83 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-O 120.973 0.416 . . . . 0.0 110.195 178.248 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 127' ' ' ASN . . . . . . . . . . . . . 89.8 m-20 55.44 -130.17 1.99 Allowed 'General case' 0 CA--C 1.545 0.759 0 CA-C-O 118.516 -0.754 . . . . 0.0 110.196 -179.398 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 128' ' ' ASP . . . . . . . . . . . . . 11.5 p-10 -97.23 10.05 40.55 Favored 'General case' 0 CA--C 1.536 0.417 0 CA-C-N 120.04 1.291 . . . . 0.0 113.237 -178.1 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 129' ' ' LEU . . . . . . . . . . . . . 6.2 tt -109.05 133.57 52.82 Favored 'General case' 0 C--O 1.232 0.178 0 CA-C-N 118.28 0.491 . . . . 0.0 110.065 -179.923 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 130' ' ' VAL . . . . . . . . . . . . . 46.4 t -125.89 137.35 57.99 Favored 'Isoleucine or valine' 0 N--CA 1.462 0.175 0 CA-C-O 120.953 0.406 . . . . 0.0 110.453 -176.947 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 131' ' ' VAL . . . . . . . . . . . . . 46.9 t -136.1 135.4 50.15 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.277 0 CA-C-N 116.137 -0.483 . . . . 0.0 110.187 178.414 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 132' ' ' ILE . . . . . . . . . . . . . 74.1 mt -120.28 131.65 71.99 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.271 0 N-CA-C 109.708 -0.479 . . . . 0.0 109.708 -179.833 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 133' ' ' ILE . . . . . . . . . . . . . 39.0 mm -117.83 121.47 67.46 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.271 0 CA-C-N 116.493 -0.321 . . . . 0.0 110.868 -176.989 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 134' ' ' ASP . . . . . . . . . . . . . 8.8 p-10 -132.69 149.43 52.29 Favored 'General case' 0 CA--C 1.528 0.128 0 N-CA-C 109.898 -0.408 . . . . 0.0 109.898 173.837 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 135' ' ' GLU . . . . . . . . . . . . . 85.4 tt0 -49.89 -25.5 3.25 Favored 'General case' 0 C--N 1.328 -0.357 0 N-CA-C 113.083 0.771 . . . . 0.0 113.083 -170.315 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 136' ' ' GLN . . . . . . . . . . . . . 97.5 mt-30 -92.86 -29.95 15.68 Favored 'General case' 0 C--N 1.33 -0.269 0 N-CA-C 112.581 0.585 . . . . 0.0 112.581 -173.932 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 137' ' ' LYS . . . . . . . . . . . . . 43.8 pttt -161.11 165.69 29.22 Favored 'General case' 0 C--O 1.233 0.212 0 CA-C-O 121.475 0.655 . . . . 0.0 112.19 -173.221 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 138' ' ' LEU . . . . . . . . . . . . . 7.0 tt -117.44 129.92 56.14 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 115.103 -0.953 . . . . 0.0 110.01 178.798 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 139' ' ' THR . . . . . . . . . . . . . 31.0 m -112.57 128.18 56.29 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.157 -0.474 . . . . 0.0 110.51 -179.888 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 140' ' ' LEU . . . . . . . . . . . . . 11.5 tp -117.1 120.82 39.51 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 115.814 -0.63 . . . . 0.0 109.352 -178.761 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 141' ' ' ILE . . . . . . . . . . . . . 19.9 mt -116.96 119.69 62.78 Favored 'Isoleucine or valine' 0 C--O 1.233 0.193 0 CA-C-O 121.037 0.446 . . . . 0.0 110.417 -173.657 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 142' ' ' ARG . . . . . . . . . . . . . 84.2 mtp180 -108.06 133.77 51.89 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 115.009 -0.996 . . . . 0.0 110.507 -177.565 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 143' ' ' THR . . . . . . . . . . . . . 15.1 p . . . . . 0 C--O 1.219 -0.503 0 CA-C-O 117.907 -1.044 . . . . 0.0 110.984 179.886 . . . . . . . . 0 0 . 1 . 010 nuclear orig core ' C' C ' 2' ' ' SER . . . . . . . . . . . . . 3.3 p . . . . . 0 C--O 1.231 0.126 0 CA-C-O 120.935 0.398 . . . . 0.0 110.487 . . . . . . . . . 0 0 . 1 . 010 nuclear orig core ' C' C ' 3' ' ' GLU . . . . . . . . . . . . . 95.3 mt-10 -140.29 139.34 35.47 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.057 -0.52 . . . . 0.0 110.953 -178.34 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' C' C ' 4' ' ' LEU . . . . . . . . . . . . . 20.2 tp -127.05 128.48 46.35 Favored 'General case' 0 C--N 1.331 -0.221 0 CA-C-N 115.891 -0.595 . . . . 0.0 109.838 176.067 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' C' C ' 5' ' ' LYS . . . . . . . . . . . . . 96.3 mttt -112.48 122.8 48.73 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-O 120.769 0.318 . . . . 0.0 110.872 -178.581 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' C' C ' 6' ' ' LEU . . . . . . . . . . . . . 47.8 mt -114.24 142.61 46.05 Favored 'General case' 0 N--CA 1.462 0.143 0 CA-C-N 115.404 -0.817 . . . . 0.0 110.271 -179.451 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' C' C ' 7' ' ' LYS . . . . . . . . . . . . . 40.1 ttmt -123.45 137.16 28.05 Favored Pre-proline 0 CA--C 1.533 0.305 0 CA-C-O 119.001 -0.523 . . . . 0.0 109.622 175.545 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' C' C ' 8' ' ' PRO . . . . . . . . . . . . . 85.4 Cg_endo -91.83 136.01 1.69 Allowed 'Trans proline' 0 N--CA 1.489 1.231 0 C-N-CA 121.692 1.595 . . . . 0.0 111.895 179.314 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' C' C ' 9' ' ' LEU . . . . . . . . . . . . . 71.1 mt -74.62 -47.65 5.3 Favored Pre-proline 0 CA--C 1.534 0.35 0 CA-C-O 118.578 -0.725 . . . . 0.0 112.283 -179.744 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' C' C ' 10' ' ' PRO . . . . . . . . . . . . . 85.4 Cg_endo -80.15 151.49 20.81 Favored 'Trans proline' 0 N--CA 1.496 1.623 0 C-N-CA 121.162 1.241 . . . . 0.0 111.898 176.82 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' C' C ' 11' ' ' LYS . . . . . . . . . . . . . 50.5 tttp -87.21 98.25 11.22 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-O 120.752 0.311 . . . . 0.0 110.444 178.813 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' C' C ' 12' ' ' VAL . . . . . . . . . . . . . 11.9 p -144.55 144.88 21.86 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.289 0 CA-C-N 116.198 -0.455 . . . . 0.0 110.433 179.954 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' C' C ' 13' ' ' GLU . . . . . . . . . . . . . 95.2 mt-10 -82.05 126.76 32.37 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-N 116.352 -0.385 . . . . 0.0 110.041 177.846 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' C' C ' 14' ' ' LEU . . . . . . . . . . . . . 46.3 mt -95.48 148.48 34.68 Favored Pre-proline 0 C--N 1.329 -0.29 0 CA-C-O 119.235 -0.412 . . . . 0.0 110.4 -179.11 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' C' C ' 15' ' ' PRO . . . . . . . . . . . . . 38.8 Cg_exo -58.65 156.86 30.03 Favored 'Trans proline' 0 N--CA 1.496 1.651 0 C-N-CA 121.187 1.258 . . . . 0.0 111.772 178.97 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' C' C ' 16' ' ' PRO . . . . . . . . . . . . . 35.5 Cg_exo -58.49 -42.84 50.97 Favored 'Trans proline' 0 N--CA 1.498 1.762 0 C-N-CA 121.315 1.344 . . . . 0.0 112.703 -177.206 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' C' C ' 17' ' ' ASP . . . . . . . . . . . . . 12.8 p-10 -86.86 13.21 9.35 Favored 'General case' 0 C--N 1.327 -0.402 0 N-CA-C 112.999 0.741 . . . . 0.0 112.999 -177.961 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' C' C ' 18' ' ' PHE . . . . . . . . . . . . . 44.2 t80 -57.63 -50.52 72.87 Favored 'General case' 0 N--CA 1.456 -0.166 0 O-C-N 121.991 -0.443 . . . . 0.0 110.459 -176.958 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' C' C ' 19' ' ' VAL . . . . . . . . . . . . . 13.9 p -54.25 -40.46 47.62 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.285 0 CA-C-N 116.493 -0.321 . . . . 0.0 111.209 -177.911 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' C' C ' 20' ' ' ASP . . . . . . . . . . . . . 82.5 m-20 -60.53 -44.75 95.75 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-O 120.969 0.414 . . . . 0.0 110.86 -178.566 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' C' C ' 21' ' ' VAL . . . . . . . . . . . . . 46.4 t -64.16 -44.48 97.56 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.319 0 CA-C-N 116.291 -0.413 . . . . 0.0 110.396 -178.141 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' C' C ' 22' ' ' ILE . . . . . . . . . . . . . 50.6 mm -55.9 -44.71 78.8 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.248 0 C-N-CA 121.026 -0.269 . . . . 0.0 110.712 179.019 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' C' C ' 23' ' ' ARG . . . . . . . . . . . . . 55.5 ttp180 -53.8 -50.61 65.74 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-O 120.674 0.274 . . . . 0.0 111.439 179.727 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' C' C ' 24' ' ' ILE . . . . . . . . . . . . . 66.9 mt -58.34 -42.18 83.24 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.274 0 CA-C-N 116.558 -0.292 . . . . 0.0 110.884 -178.183 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' C' C ' 25' ' ' LYS . . . . . . . . . . . . . 53.1 mtpt -66.71 -43.82 83.29 Favored 'General case' 0 C--N 1.328 -0.367 0 N-CA-C 112.531 0.567 . . . . 0.0 112.531 -177.481 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' C' C ' 26' ' ' LEU . . . . . . . . . . . . . 62.9 mt -80.47 -36.23 33.74 Favored 'General case' 0 C--N 1.33 -0.256 0 N-CA-C 113.542 0.941 . . . . 0.0 113.542 -169.117 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' C' C ' 27' ' ' GLN . . . . . . . . . . . . . 10.0 pt20 -46.81 141.01 4.21 Favored 'General case' 0 N--CA 1.47 0.573 0 N-CA-C 112.674 0.62 . . . . 0.0 112.674 -176.006 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' C' C ' 28' ' ' GLY . . . . . . . . . . . . . . . 101.23 -25.77 27.02 Favored Glycine 0 CA--C 1.532 1.107 0 CA-C-N 115.752 -0.658 . . . . 0.0 112.235 -175.959 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' C' C ' 29' ' ' LYS . . . . . . . . . . . . . 73.3 mmtt -97.24 155.11 17.0 Favored 'General case' 0 C--O 1.234 0.247 0 CA-C-N 117.462 0.631 . . . . 0.0 111.191 178.46 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' C' C ' 30' ' ' THR . . . . . . . . . . . . . 23.7 m -104.8 136.01 45.11 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 115.807 -0.633 . . . . 0.0 109.785 174.841 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' C' C ' 31' ' ' VAL . . . . . . . . . . . . . 34.3 m -128.34 154.79 39.53 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.254 0 CA-C-O 120.918 0.39 . . . . 0.0 111.022 -176.916 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' C' C ' 32' ' ' ARG . . . . . . . . . . . . . 94.3 mtm-85 -133.32 150.37 51.87 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-O 121.249 0.547 . . . . 0.0 110.625 178.351 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' C' C ' 33' ' ' THR . . . . . . . . . . . . . 25.9 m -52.45 139.89 23.8 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 116.188 -0.46 . . . . 0.0 111.513 -178.327 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' C' C ' 34' ' ' GLY . . . . . . . . . . . . . . . 99.29 -17.06 58.4 Favored Glycine 0 CA--C 1.532 1.143 0 CA-C-O 119.533 -0.593 . . . . 0.0 113.214 179.228 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' C' C ' 35' ' ' ASP . . . . . . . . . . . . . 59.6 m-20 -63.15 149.76 44.48 Favored 'General case' 0 C--O 1.231 0.126 0 CA-C-N 118.138 0.969 . . . . 0.0 110.911 179.205 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' C' C ' 36' ' ' VAL . . . . . . . . . . . . . 42.0 t -122.45 129.33 75.34 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.251 0 CA-C-N 115.897 -0.592 . . . . 0.0 109.766 179.068 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' C' C ' 37' ' ' ILE . . . . . . . . . . . . . 66.2 mt -122.93 138.65 52.28 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.226 0 CA-C-N 116.265 -0.425 . . . . 0.0 109.968 179.815 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' C' C ' 38' ' ' GLY . . . . . . . . . . . . . . . -118.93 129.0 7.91 Favored Glycine 0 CA--C 1.525 0.683 0 N-CA-C 110.891 -0.884 . . . . 0.0 110.891 178.978 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' C' C ' 39' ' ' ILE . . . . . . . . . . . . . 70.2 mt -125.07 134.53 66.66 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.241 0 CA-C-O 120.764 0.316 . . . . 0.0 110.297 179.269 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' C' C ' 40' ' ' SER . . . . . . . . . . . . . 36.3 t -91.3 117.87 30.02 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.078 -0.51 . . . . 0.0 110.723 176.196 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' C' C ' 41' ' ' ILE . . . . . . . . . . . . . 65.7 mt -126.5 122.25 60.63 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.164 0 CA-C-O 120.816 0.341 . . . . 0.0 110.209 179.506 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' C' C ' 42' ' ' LEU . . . . . . . . . . . . . 5.5 mp 52.9 35.88 20.25 Favored 'General case' 0 CA--C 1.532 0.279 0 CA-C-N 116.186 -0.461 . . . . 0.0 111.399 178.099 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' C' C ' 43' ' ' GLY . . . . . . . . . . . . . . . 73.87 27.99 65.73 Favored Glycine 0 CA--C 1.531 1.087 0 C-N-CA 121.15 -0.548 . . . . 0.0 112.542 176.528 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' C' C ' 44' ' ' LYS . . . . . . . . . . . . . 95.7 mttt -139.52 128.71 23.9 Favored 'General case' 0 C--N 1.33 -0.282 0 N-CA-C 109.744 -0.465 . . . . 0.0 109.744 176.971 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' C' C ' 45' ' ' GLU . . . . . . . . . . . . . 85.2 tt0 -84.08 127.75 34.11 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-O 120.882 0.372 . . . . 0.0 111.533 -177.473 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' C' C ' 46' ' ' VAL . . . . . . . . . . . . . 9.3 p -118.41 126.76 75.34 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.21 0 N-CA-C 109.569 -0.53 . . . . 0.0 109.569 174.342 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' C' C ' 47' ' ' LYS . . . . . . . . . . . . . 75.9 mttt -98.28 123.89 42.61 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.044 -0.526 . . . . 0.0 110.808 178.315 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' C' C ' 48' ' ' PHE . . . . . . . . . . . . . 34.5 m-85 -109.18 131.77 54.75 Favored 'General case' 0 C--N 1.329 -0.299 0 N-CA-C 109.691 -0.485 . . . . 0.0 109.691 176.75 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' C' C ' 49' ' ' LYS . . . . . . . . . . . . . 49.1 tttp -107.37 132.54 53.04 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.432 -0.349 . . . . 0.0 110.164 177.638 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' C' C ' 50' ' ' VAL . . . . . . . . . . . . . 44.5 t -75.6 107.25 6.19 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.327 0 N-CA-C 109.594 -0.521 . . . . 0.0 109.594 178.314 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' C' C ' 51' ' ' VAL . . . . . . . . . . . . . 47.1 t -68.94 -49.12 66.12 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.305 0 CA-C-N 116.116 -0.493 . . . . 0.0 109.721 -175.594 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' C' C ' 52' ' ' GLN . . . . . . . . . . . . . 49.1 tt0 -162.84 143.03 9.38 Favored 'General case' 0 C--N 1.329 -0.291 0 C-N-CA 120.211 -0.596 . . . . 0.0 111.773 -178.836 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' C' C ' 53' ' ' ALA . . . . . . . . . . . . . . . -114.86 130.92 56.97 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 115.32 -0.855 . . . . 0.0 109.456 174.096 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' C' C ' 54' ' ' TYR . . . . . . . . . . . . . 22.2 t80 -128.62 110.27 19.0 Favored Pre-proline 0 CA--C 1.534 0.363 0 CA-C-O 118.34 -0.838 . . . . 0.0 110.306 -178.891 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' C' C ' 55' ' ' PRO . . . . . . . . . . . . . 74.5 Cg_endo -77.23 170.06 72.46 Favored 'Cis proline' 0 N--CA 1.499 1.831 0 CA-C-N 121.827 1.688 . . . . 0.0 112.367 -5.623 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' C' C ' 56' ' ' SER . . . . . . . . . . . . . 13.8 m -114.73 129.13 25.25 Favored Pre-proline 0 CA--C 1.538 0.496 0 CA-C-O 118.451 -0.785 . . . . 0.0 109.451 175.855 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' C' C ' 57' ' ' PRO . . . . . . . . . . . . . 59.6 Cg_endo -73.61 148.95 93.29 Favored 'Cis proline' 0 N--CA 1.497 1.689 0 CA-C-N 121.99 1.747 . . . . 0.0 111.759 -0.352 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' C' C ' 58' ' ' LEU . . . . . . . . . . . . . 23.8 tp -108.3 136.6 47.68 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.376 -0.374 . . . . 0.0 110.836 -178.174 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' C' C ' 59' ' ' ARG . . . . . . . . . . . . . 60.1 ttm-85 -103.13 123.21 46.25 Favored 'General case' 0 C--N 1.329 -0.323 0 N-CA-C 109.242 -0.651 . . . . 0.0 109.242 174.779 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' C' C ' 60' ' ' VAL . . . . . . . . . . . . . 44.1 t -80.56 121.6 34.28 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.264 0 C-N-CA 120.712 -0.395 . . . . 0.0 110.246 -176.94 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' C' C ' 61' ' ' GLU . . . . . . . . . . . . . 40.3 mt-10 -130.72 172.37 12.05 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 115.958 -0.565 . . . . 0.0 109.863 178.821 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' C' C ' 62' ' ' ASP . . . . . . . . . . . . . 60.1 m-20 -54.92 -32.52 61.28 Favored 'General case' 0 C--N 1.328 -0.365 0 N-CA-C 111.773 0.286 . . . . 0.0 111.773 -178.978 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' C' C ' 63' ' ' ARG . . . . . . . . . . . . . 17.5 ptm180 -88.92 6.31 39.94 Favored 'General case' 0 CA--C 1.536 0.437 0 N-CA-C 113.507 0.929 . . . . 0.0 113.507 -176.226 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' C' C ' 64' ' ' THR . . . . . . . . . . . . . 32.8 m -82.39 131.53 35.22 Favored 'General case' 0 C--N 1.331 -0.203 0 CA-C-N 118.143 0.429 . . . . 0.0 110.559 -178.874 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' C' C ' 65' ' ' LYS . . . . . . . . . . . . . 96.6 mttt -88.77 129.34 35.58 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.155 -0.475 . . . . 0.0 110.104 179.744 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' C' C ' 66' ' ' ILE . . . . . . . . . . . . . 64.2 mt -114.17 130.36 68.52 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.252 0 N-CA-C 109.82 -0.437 . . . . 0.0 109.82 179.305 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' C' C ' 67' ' ' THR . . . . . . . . . . . . . 22.4 m -121.53 140.09 52.66 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-N 116.118 -0.492 . . . . 0.0 111.0 -177.732 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' C' C ' 68' ' ' LEU . . . . . . . . . . . . . 44.1 mt . . . . . 0 C--N 1.33 -0.267 0 CA-C-N 115.832 -0.622 . . . . 0.0 110.415 178.173 . . . . . . . . 0 0 . 1 . 010 nuclear orig core ' C' C ' 73' ' ' VAL . . . . . . . . . . . . . 27.6 m . . . . . 0 C--O 1.232 0.133 0 CA-C-O 120.815 0.34 . . . . 0.0 110.191 . . . . . . . . . 0 0 . 1 . 010 nuclear orig core ' C' C ' 74' ' ' ASP . . . . . . . . . . . . . 3.1 t70 -105.53 121.68 44.44 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.273 -0.421 . . . . 0.0 109.964 -178.563 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' C' C ' 75' ' ' VAL . . . . . . . . . . . . . 40.4 t -117.47 123.77 72.19 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.229 0 CA-C-O 121.095 0.474 . . . . 0.0 110.566 -177.41 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' C' C ' 76' ' ' LEU . . . . . . . . . . . . . 7.0 mp -117.86 142.0 47.8 Favored 'General case' 0 C--N 1.332 -0.189 0 CA-C-N 115.683 -0.689 . . . . 0.0 109.468 176.147 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' C' C ' 77' ' ' GLU . . . . . . . . . . . . . 96.5 mt-10 -133.02 136.94 46.3 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-O 121.022 0.439 . . . . 0.0 111.259 -178.261 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' C' C ' 78' ' ' ALA . . . . . . . . . . . . . . . -126.84 135.44 51.0 Favored 'General case' 0 C--N 1.331 -0.225 0 CA-C-N 115.8 -0.636 . . . . 0.0 109.877 176.428 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' C' C ' 79' ' ' LYS . . . . . . . . . . . . . 90.6 mttt -74.72 122.82 23.85 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-O 120.802 0.334 . . . . 0.0 110.553 -179.678 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' C' C ' 80' ' ' ILE . . . . . . . . . . . . . 26.0 mm -139.16 113.36 7.27 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.306 0 N-CA-C 109.059 -0.719 . . . . 0.0 109.059 -178.47 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' C' C ' 81' ' ' LYS . . . . . . . . . . . . . 19.5 pttp -105.88 124.69 49.97 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-O 121.02 0.438 . . . . 0.0 111.363 -176.225 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' C' C ' 82' ' ' GLY . . . . . . . . . . . . . . . 88.99 42.09 5.73 Favored Glycine 0 CA--C 1.525 0.702 0 C-N-CA 120.73 -0.748 . . . . 0.0 111.75 173.152 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' C' C ' 83' ' ' ILE . . . . . . . . . . . . . 72.9 mt -65.75 136.14 27.2 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.311 0 CA-C-O 121.001 0.429 . . . . 0.0 110.081 178.668 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' C' C ' 84' ' ' LYS . . . . . . . . . . . . . 33.8 tttp -97.42 -53.54 3.43 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 115.824 -0.625 . . . . 0.0 110.128 -178.988 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' C' C ' 85' ' ' ASP . . . . . . . . . . . . . 12.7 t70 -153.99 153.16 31.48 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 115.596 -0.729 . . . . 0.0 110.251 179.569 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' C' C ' 86' ' ' VAL . . . . . . . . . . . . . 47.2 t -129.75 131.32 66.69 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.258 0 CA-C-O 121.003 0.43 . . . . 0.0 110.552 -179.312 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' C' C ' 87' ' ' ILE . . . . . . . . . . . . . 4.8 mp -119.92 127.28 75.88 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.236 0 CA-C-N 115.738 -0.664 . . . . 0.0 109.509 175.529 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' C' C ' 88' ' ' LEU . . . . . . . . . . . . . 11.0 tp -112.66 130.19 56.13 Favored 'General case' 0 C--N 1.331 -0.198 0 CA-C-O 120.994 0.425 . . . . 0.0 111.083 -177.144 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' C' C ' 89' ' ' ASP . . . . . . . . . . . . . 6.3 t70 -128.64 154.25 46.45 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 115.884 -0.598 . . . . 0.0 109.749 177.087 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' C' C ' 90' ' ' GLU . . . . . . . . . . . . . 81.4 tt0 -47.52 -41.41 20.95 Favored 'General case' 0 N--CA 1.464 0.229 0 N-CA-C 112.915 0.709 . . . . 0.0 112.915 -172.952 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' C' C ' 91' ' ' ASN . . . . . . . . . . . . . 19.7 m120 -121.54 16.79 11.25 Favored 'General case' 0 N--CA 1.467 0.401 0 N-CA-C 113.255 0.835 . . . . 0.0 113.255 -175.938 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' C' C ' 92' ' ' LEU . . . . . . . . . . . . . 55.2 mt -150.97 142.78 23.8 Favored 'General case' 0 C--N 1.332 -0.193 0 CA-C-O 120.818 0.342 . . . . 0.0 110.33 -177.096 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' C' C ' 93' ' ' ILE . . . . . . . . . . . . . 69.1 mt -123.28 115.41 45.45 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.32 0 N-CA-C 108.904 -0.776 . . . . 0.0 108.904 175.767 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' C' C ' 94' ' ' VAL . . . . . . . . . . . . . 45.2 t -116.58 123.9 72.11 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.308 0 CA-C-O 120.886 0.374 . . . . 0.0 110.085 -176.765 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' C' C ' 95' ' ' VAL . . . . . . . . . . . . . 42.2 t -121.04 131.92 71.79 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 CA-C-N 116.001 -0.545 . . . . 0.0 109.788 -179.815 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' C' C ' 96' ' ' ILE . . . . . . . . . . . . . 62.9 mt -112.94 127.16 70.33 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.284 0 N-CA-C 109.366 -0.605 . . . . 0.0 109.366 179.439 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' C' C ' 97' ' ' THR . . . . . . . . . . . . . 81.0 p -96.89 154.36 17.34 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-O 120.896 0.379 . . . . 0.0 110.733 -178.965 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' C' C ' 98' ' ' GLU . . . . . . . . . . . . . 97.3 mt-10 -53.91 -25.85 22.27 Favored 'General case' 0 C--N 1.328 -0.329 0 N-CA-C 112.335 0.495 . . . . 0.0 112.335 -179.722 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' C' C ' 99' ' ' GLU . . . . . . . . . . . . . 94.3 mt-10 -77.11 12.27 1.5 Allowed 'General case' 0 CA--C 1.537 0.466 0 N-CA-C 113.218 0.822 . . . . 0.0 113.218 -178.147 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' C' C ' 100' ' ' ASN . . . . . . . . . . . . . 4.0 m-20 65.08 32.81 10.03 Favored 'General case' 0 CA--C 1.531 0.248 0 CA-C-N 117.998 0.363 . . . . 0.0 111.68 178.242 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' C' C ' 101' ' ' GLU . . . . . . . . . . . . . 84.6 tt0 -112.26 143.48 43.27 Favored 'General case' 0 C--O 1.232 0.162 0 N-CA-C 109.457 -0.572 . . . . 0.0 109.457 173.149 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' C' C ' 102' ' ' VAL . . . . . . . . . . . . . 45.3 t -115.52 127.76 72.99 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.336 0 CA-C-O 120.886 0.374 . . . . 0.0 110.165 -177.591 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' C' C ' 103' ' ' LEU . . . . . . . . . . . . . 42.0 mt -114.8 127.42 55.72 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 115.489 -0.778 . . . . 0.0 109.874 176.518 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' C' C ' 104' ' ' ILE . . . . . . . . . . . . . 66.7 mt -116.48 118.52 59.05 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.292 0 N-CA-C 110.054 -0.351 . . . . 0.0 110.054 179.955 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' C' C ' 105' ' ' PHE . . . . . . . . . . . . . 63.8 m-85 -118.37 164.85 14.63 Favored 'General case' 0 C--N 1.333 -0.146 0 O-C-N 123.952 0.782 . . . . 0.0 110.523 179.613 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' C' C ' 106' ' ' ASN . . . . . . . . . . . . . 45.8 p-10 -97.96 -169.97 1.91 Allowed 'General case' 0 C--N 1.33 -0.28 0 N-CA-C 109.699 -0.482 . . . . 0.0 109.699 171.868 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' C' C ' 107' ' ' GLN . . . . . . . . . . . . . 58.7 tt0 -57.66 -29.11 64.35 Favored 'General case' 0 C--N 1.329 -0.291 0 N-CA-C 112.044 0.387 . . . . 0.0 112.044 -179.682 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' C' C ' 108' ' ' ASN . . . . . . . . . . . . . 50.8 t30 -90.4 14.08 13.85 Favored 'General case' 0 CA--C 1.534 0.329 0 N-CA-C 113.103 0.779 . . . . 0.0 113.103 -175.661 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' C' C ' 109' ' ' LEU . . . . . . . . . . . . . 59.9 mt 58.43 35.69 24.89 Favored 'General case' 0 CA--C 1.529 0.165 0 CA-C-O 120.775 0.321 . . . . 0.0 111.651 176.783 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' C' C ' 110' ' ' GLU . . . . . . . . . . . . . 95.4 mt-10 -101.78 152.85 20.38 Favored 'General case' 0 C--N 1.33 -0.254 0 N-CA-C 109.566 -0.531 . . . . 0.0 109.566 175.313 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' C' C ' 111' ' ' GLU . . . . . . . . . . . . . 44.0 tp10 -82.21 121.93 27.25 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-O 120.903 0.382 . . . . 0.0 110.954 -177.673 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' C' C ' 112' ' ' LEU . . . . . . . . . . . . . 17.6 mt -106.53 -45.94 4.12 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.006 -0.543 . . . . 0.0 110.147 177.319 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' C' C ' 113' ' ' TYR . . . . . . . . . . . . . 59.6 t80 -137.88 135.56 36.26 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.079 -0.51 . . . . 0.0 110.929 179.153 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' C' C ' 114' ' ' ARG . . . . . . . . . . . . . 41.1 ttm180 -135.7 119.82 17.67 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.027 -0.533 . . . . 0.0 110.038 177.474 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' C' C ' 115' ' ' GLY . . . . . . . . . . . . . . . -150.03 159.14 27.98 Favored Glycine 0 CA--C 1.525 0.664 0 N-CA-C 111.016 -0.834 . . . . 0.0 111.016 179.168 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' C' C ' 116' ' ' LYS . . . . . . . . . . . . . 69.4 tttt -131.15 130.32 42.91 Favored 'General case' 0 C--N 1.329 -0.316 0 N-CA-C 109.963 -0.384 . . . . 0.0 109.963 178.122 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' C' C ' 117' ' ' PHE . . . . . . . . . . . . . 41.7 m-85 -125.83 117.3 23.09 Favored 'General case' 0 C--N 1.331 -0.215 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.228 -175.271 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' C' C ' 118' ' ' GLU . . . . . . . . . . . . . 81.9 tt0 -51.94 -46.68 64.82 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.428 -0.351 . . . . 0.0 111.702 -176.422 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' C' C ' 119' ' ' ASN . . . . . . . . . . . . . 83.6 m-20 -101.47 31.26 3.82 Favored 'General case' 0 C--N 1.33 -0.239 0 N-CA-C 112.174 0.435 . . . . 0.0 112.174 -173.971 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' C' C ' 120' ' ' LEU . . . . . . . . . . . . . 13.8 tp -53.53 122.97 10.83 Favored 'General case' 0 N--CA 1.464 0.254 0 CA-C-O 120.832 0.349 . . . . 0.0 111.078 179.506 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' C' C ' 121' ' ' ASN . . . . . . . . . . . . . 9.9 t-20 -112.86 -44.07 3.35 Favored 'General case' 0 C--N 1.331 -0.199 0 CA-C-N 116.257 -0.429 . . . . 0.0 110.746 -177.507 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' C' C ' 122' ' ' LYS . . . . . . . . . . . . . 98.4 mttt -147.98 148.53 30.84 Favored 'General case' 0 C--N 1.332 -0.181 0 CA-C-O 121.061 0.458 . . . . 0.0 111.855 -178.593 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' C' C ' 123' ' ' VAL . . . . . . . . . . . . . 45.1 t -129.41 124.58 60.17 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.316 0 N-CA-C 109.175 -0.676 . . . . 0.0 109.175 173.278 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' C' C ' 124' ' ' LEU . . . . . . . . . . . . . 48.0 mt -129.55 143.79 50.98 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-O 120.946 0.403 . . . . 0.0 110.988 -176.175 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' C' C ' 125' ' ' VAL . . . . . . . . . . . . . 11.4 p -135.95 138.64 47.23 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.249 0 CA-C-N 115.881 -0.599 . . . . 0.0 110.235 178.752 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' C' C ' 126' ' ' ARG . . . . . . . . . . . . . 26.8 ttm180 -144.46 127.64 16.66 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-N 116.209 -0.45 . . . . 0.0 110.224 178.557 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' C' C ' 127' ' ' ASN . . . . . . . . . . . . . 80.7 m-20 53.16 -110.4 0.53 Allowed 'General case' 0 CA--C 1.545 0.772 0 CA-C-O 118.843 -0.599 . . . . 0.0 110.927 -179.402 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' C' C ' 128' ' ' ASP . . . . . . . . . . . . . 19.0 p-10 -114.2 5.64 15.96 Favored 'General case' 0 CA--C 1.536 0.416 0 CA-C-N 119.893 1.224 . . . . 0.0 113.384 -177.819 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' C' C ' 129' ' ' LEU . . . . . . . . . . . . . 58.4 mt -108.6 141.11 41.01 Favored 'General case' 0 C--N 1.334 -0.093 0 CA-C-N 118.133 0.424 . . . . 0.0 110.351 -179.185 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' C' C ' 130' ' ' VAL . . . . . . . . . . . . . 42.5 t -122.69 136.73 58.54 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.246 0 N-CA-C 109.884 -0.413 . . . . 0.0 109.884 -179.806 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' C' C ' 131' ' ' VAL . . . . . . . . . . . . . 44.3 t -134.63 135.14 53.88 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.214 0 CA-C-O 121.066 0.46 . . . . 0.0 110.342 -179.591 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' C' C ' 132' ' ' ILE . . . . . . . . . . . . . 68.9 mt -118.43 131.21 71.86 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.264 0 CA-C-N 115.753 -0.658 . . . . 0.0 109.371 178.854 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' C' C ' 133' ' ' ILE . . . . . . . . . . . . . 40.4 mm -116.07 122.77 70.33 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.237 0 CA-C-N 116.515 -0.311 . . . . 0.0 110.913 -175.301 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' C' C ' 134' ' ' ASP . . . . . . . . . . . . . 7.1 p-10 -133.62 148.74 51.58 Favored 'General case' 0 C--N 1.331 -0.224 0 N-CA-C 110.043 -0.354 . . . . 0.0 110.043 174.934 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' C' C ' 135' ' ' GLU . . . . . . . . . . . . . 81.3 tt0 -49.72 -25.11 2.69 Favored 'General case' 0 C--N 1.327 -0.384 0 N-CA-C 112.99 0.737 . . . . 0.0 112.99 -172.206 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' C' C ' 136' ' ' GLN . . . . . . . . . . . . . 63.1 tt0 -88.51 -37.52 15.69 Favored 'General case' 0 C--O 1.234 0.24 0 N-CA-C 112.111 0.411 . . . . 0.0 112.111 -175.656 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' C' C ' 137' ' ' LYS . . . . . . . . . . . . . 45.0 pttt -159.44 169.08 24.7 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-O 121.568 0.699 . . . . 0.0 112.252 -171.34 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' C' C ' 138' ' ' LEU . . . . . . . . . . . . . 6.4 tt -116.33 126.43 53.51 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 114.942 -1.027 . . . . 0.0 109.829 178.362 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' C' C ' 139' ' ' THR . . . . . . . . . . . . . 49.8 m -107.73 128.4 54.54 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.178 -0.464 . . . . 0.0 110.357 179.928 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' C' C ' 140' ' ' LEU . . . . . . . . . . . . . 9.5 tp -114.36 122.65 47.34 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 115.736 -0.665 . . . . 0.0 109.368 -178.748 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' C' C ' 141' ' ' ILE . . . . . . . . . . . . . 19.6 mt -120.18 124.57 72.9 Favored 'Isoleucine or valine' 0 C--O 1.234 0.238 0 CA-C-O 120.912 0.387 . . . . 0.0 110.034 -173.402 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' C' C ' 142' ' ' ARG . . . . . . . . . . . . . 64.9 mtt180 . . . . . 0 C--O 1.233 0.19 0 CA-C-N 115.574 -0.739 . . . . 0.0 110.05 -175.77 . . . . . . . . 0 0 . 1 . 010 nuclear orig core ' D' D ' 2' ' ' SER . . . . . . . . . . . . . 99.1 p . . . . . 0 N--CA 1.462 0.149 0 CA-C-O 120.998 0.428 . . . . 0.0 110.761 . . . . . . . . . 0 0 . 1 . 010 nuclear orig core ' D' D ' 3' ' ' GLU . . . . . . . . . . . . . 95.7 mt-10 -141.65 145.28 34.77 Favored 'General case' 0 C--N 1.331 -0.223 0 CA-C-N 116.031 -0.531 . . . . 0.0 111.246 -177.56 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' D' D ' 4' ' ' LEU . . . . . . . . . . . . . 15.4 tp -125.58 129.45 49.71 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-N 116.047 -0.524 . . . . 0.0 109.936 174.828 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' D' D ' 5' ' ' LYS . . . . . . . . . . . . . 52.4 mttm -110.63 123.63 50.37 Favored 'General case' 0 C--O 1.233 0.235 0 CA-C-O 120.71 0.291 . . . . 0.0 110.857 -179.248 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' D' D ' 6' ' ' LEU . . . . . . . . . . . . . 68.9 mt -116.63 144.57 44.24 Favored 'General case' 0 C--N 1.333 -0.148 0 CA-C-N 115.739 -0.664 . . . . 0.0 110.554 179.838 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' D' D ' 7' ' ' LYS . . . . . . . . . . . . . 55.3 tttm -126.93 141.84 41.79 Favored Pre-proline 0 CA--C 1.533 0.305 0 N-CA-C 109.704 -0.48 . . . . 0.0 109.704 175.293 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' D' D ' 8' ' ' PRO . . . . . . . . . . . . . 87.5 Cg_endo -91.4 144.15 3.17 Favored 'Trans proline' 0 N--CA 1.49 1.308 0 C-N-CA 121.645 1.563 . . . . 0.0 112.271 179.577 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' D' D ' 9' ' ' LEU . . . . . . . . . . . . . 49.6 mt -85.46 -47.17 0.61 Allowed Pre-proline 0 C--N 1.328 -0.334 0 CA-C-O 118.645 -0.693 . . . . 0.0 112.024 178.131 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' D' D ' 10' ' ' PRO . . . . . . . . . . . . . 86.4 Cg_endo -81.03 154.88 19.62 Favored 'Trans proline' 0 N--CA 1.495 1.605 0 C-N-CA 121.244 1.296 . . . . 0.0 111.8 175.956 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' D' D ' 11' ' ' LYS . . . . . . . . . . . . . 60.3 mttp -87.79 95.16 9.98 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-O 120.846 0.355 . . . . 0.0 110.654 178.824 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' D' D ' 12' ' ' VAL . . . . . . . . . . . . . 11.3 p -142.08 139.07 30.51 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.268 0 CA-C-N 116.133 -0.485 . . . . 0.0 110.303 178.691 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' D' D ' 13' ' ' GLU . . . . . . . . . . . . . 42.2 mp0 -82.5 127.15 33.04 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.311 -0.404 . . . . 0.0 110.06 178.313 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' D' D ' 14' ' ' LEU . . . . . . . . . . . . . 47.0 mt -93.68 149.69 37.53 Favored Pre-proline 0 C--N 1.329 -0.288 0 CA-C-O 119.207 -0.425 . . . . 0.0 110.27 -178.917 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' D' D ' 15' ' ' PRO . . . . . . . . . . . . . 25.6 Cg_exo -61.74 159.41 33.05 Favored 'Trans proline' 0 N--CA 1.497 1.7 0 C-N-CA 121.158 1.238 . . . . 0.0 111.381 177.007 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' D' D ' 16' ' ' PRO . . . . . . . . . . . . . 26.5 Cg_exo -60.78 -31.98 92.42 Favored 'Trans proline' 0 N--CA 1.497 1.731 0 C-N-CA 121.368 1.378 . . . . 0.0 112.362 -179.343 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' D' D ' 17' ' ' ASP . . . . . . . . . . . . . 10.2 p-10 -90.38 9.19 29.94 Favored 'General case' 0 CA--C 1.536 0.423 0 N-CA-C 113.166 0.802 . . . . 0.0 113.166 -178.506 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' D' D ' 18' ' ' PHE . . . . . . . . . . . . . 41.2 t80 -57.86 -46.73 84.38 Favored 'General case' 0 CA--C 1.522 -0.108 0 O-C-N 122.006 -0.434 . . . . 0.0 110.298 -176.915 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' D' D ' 19' ' ' VAL . . . . . . . . . . . . . 45.9 t -55.33 -44.25 74.67 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.259 0 CA-C-N 116.379 -0.373 . . . . 0.0 110.8 -177.555 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' D' D ' 20' ' ' ASP . . . . . . . . . . . . . 75.6 m-20 -59.87 -43.63 94.61 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-O 120.86 0.362 . . . . 0.0 110.965 -176.918 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' D' D ' 21' ' ' VAL . . . . . . . . . . . . . 48.9 t -64.62 -47.68 87.93 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.251 0 C-N-CA 120.817 -0.353 . . . . 0.0 110.54 -177.861 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' D' D ' 22' ' ' ILE . . . . . . . . . . . . . 47.1 mm -56.05 -44.4 78.47 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.282 0 CA-C-O 120.796 0.332 . . . . 0.0 110.557 179.3 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' D' D ' 23' ' ' ARG . . . . . . . . . . . . . 54.6 ttp180 -53.22 -52.29 59.4 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-O 120.848 0.356 . . . . 0.0 111.378 -179.662 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' D' D ' 24' ' ' ILE . . . . . . . . . . . . . 71.8 mt -59.08 -40.94 82.02 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.268 0 CA-C-N 116.232 -0.44 . . . . 0.0 111.404 -176.561 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' D' D ' 25' ' ' LYS . . . . . . . . . . . . . 55.8 mmtt -67.89 -39.88 83.57 Favored 'General case' 0 C--N 1.33 -0.279 0 N-CA-C 112.462 0.541 . . . . 0.0 112.462 -178.796 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' D' D ' 26' ' ' LEU . . . . . . . . . . . . . 76.2 mt -78.29 -39.29 40.31 Favored 'General case' 0 C--N 1.329 -0.284 0 N-CA-C 113.255 0.835 . . . . 0.0 113.255 -169.825 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' D' D ' 27' ' ' GLN . . . . . . . . . . . . . 10.1 pt20 -46.6 138.67 5.74 Favored 'General case' 0 N--CA 1.47 0.559 0 N-CA-C 112.742 0.645 . . . . 0.0 112.742 -175.81 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' D' D ' 28' ' ' GLY . . . . . . . . . . . . . . . 102.34 -26.3 24.71 Favored Glycine 0 CA--C 1.533 1.174 0 CA-C-N 115.638 -0.71 . . . . 0.0 112.297 -176.767 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' D' D ' 29' ' ' LYS . . . . . . . . . . . . . 61.5 mttm -98.45 155.19 17.37 Favored 'General case' 0 CA--C 1.528 0.105 0 CA-C-N 117.364 0.582 . . . . 0.0 111.045 178.191 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' D' D ' 30' ' ' THR . . . . . . . . . . . . . 55.5 m -107.2 138.72 42.87 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-N 116.155 -0.475 . . . . 0.0 109.906 175.937 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' D' D ' 31' ' ' VAL . . . . . . . . . . . . . 34.7 m -130.43 159.07 42.78 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.232 0 CA-C-O 120.817 0.341 . . . . 0.0 111.019 -178.016 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' D' D ' 32' ' ' ARG . . . . . . . . . . . . . 96.8 mtt180 -132.58 149.07 52.37 Favored 'General case' 0 C--N 1.332 -0.176 0 CA-C-N 115.934 -0.576 . . . . 0.0 110.662 178.65 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' D' D ' 33' ' ' THR . . . . . . . . . . . . . 18.7 m -52.96 140.4 24.93 Favored 'General case' 0 C--N 1.331 -0.23 0 CA-C-N 116.33 -0.396 . . . . 0.0 111.412 -179.387 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' D' D ' 34' ' ' GLY . . . . . . . . . . . . . . . 99.17 -17.1 58.48 Favored Glycine 0 CA--C 1.532 1.13 0 CA-C-O 119.62 -0.545 . . . . 0.0 113.274 179.335 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' D' D ' 35' ' ' ASP . . . . . . . . . . . . . 77.9 m-20 -66.61 148.9 51.26 Favored 'General case' 0 C--O 1.231 0.112 0 CA-C-N 118.037 0.919 . . . . 0.0 111.131 179.076 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' D' D ' 36' ' ' VAL . . . . . . . . . . . . . 45.5 t -119.56 128.7 75.88 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.213 0 CA-C-N 115.931 -0.577 . . . . 0.0 109.734 177.962 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' D' D ' 37' ' ' ILE . . . . . . . . . . . . . 63.3 mt -120.1 138.25 51.29 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.271 0 CA-C-N 116.158 -0.474 . . . . 0.0 109.83 -179.179 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' D' D ' 38' ' ' GLY . . . . . . . . . . . . . . . -118.38 128.86 7.91 Favored Glycine 0 CA--C 1.524 0.638 0 N-CA-C 111.058 -0.817 . . . . 0.0 111.058 -179.859 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' D' D ' 39' ' ' ILE . . . . . . . . . . . . . 68.0 mt -123.88 129.78 74.2 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.196 0 N-CA-C 110.026 -0.361 . . . . 0.0 110.026 178.808 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' D' D ' 40' ' ' SER . . . . . . . . . . . . . 20.3 t -92.09 117.42 29.82 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.142 -0.481 . . . . 0.0 110.734 176.453 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' D' D ' 41' ' ' ILE . . . . . . . . . . . . . 72.6 mt -131.95 122.56 49.43 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.232 0 CA-C-O 120.813 0.34 . . . . 0.0 110.095 178.376 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' D' D ' 42' ' ' LEU . . . . . . . . . . . . . 76.3 mt 58.3 34.9 24.48 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.023 -0.535 . . . . 0.0 111.506 179.012 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' D' D ' 43' ' ' GLY . . . . . . . . . . . . . . . 77.23 -10.15 22.8 Favored Glycine 0 CA--C 1.535 1.342 0 CA-C-O 119.785 -0.453 . . . . 0.0 113.427 178.123 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' D' D ' 44' ' ' LYS . . . . . . . . . . . . . 21.4 tptm -99.86 128.21 45.97 Favored 'General case' 0 C--N 1.332 -0.175 0 CA-C-N 117.915 0.858 . . . . 0.0 110.064 178.452 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' D' D ' 45' ' ' GLU . . . . . . . . . . . . . 85.0 tt0 -85.25 129.65 34.76 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.393 -0.367 . . . . 0.0 111.239 179.911 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' D' D ' 46' ' ' VAL . . . . . . . . . . . . . 10.3 p -119.14 124.19 72.69 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.16 0 N-CA-C 109.654 -0.499 . . . . 0.0 109.654 174.82 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' D' D ' 47' ' ' LYS . . . . . . . . . . . . . 63.6 mttp -98.19 125.07 43.08 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.072 -0.513 . . . . 0.0 110.614 177.24 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' D' D ' 48' ' ' PHE . . . . . . . . . . . . . 40.0 m-85 -111.4 131.83 54.9 Favored 'General case' 0 C--N 1.329 -0.29 0 N-CA-C 109.481 -0.562 . . . . 0.0 109.481 176.985 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' D' D ' 49' ' ' LYS . . . . . . . . . . . . . 42.2 tttp -107.36 132.1 53.52 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.29 -0.413 . . . . 0.0 110.206 179.08 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' D' D ' 50' ' ' VAL . . . . . . . . . . . . . 41.9 t -74.86 105.03 3.59 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.289 0 N-CA-C 109.34 -0.615 . . . . 0.0 109.34 177.495 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' D' D ' 51' ' ' VAL . . . . . . . . . . . . . 51.4 t -72.3 -48.6 47.55 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.331 0 CA-C-N 116.182 -0.463 . . . . 0.0 109.996 -174.038 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' D' D ' 52' ' ' GLN . . . . . . . . . . . . . 60.2 tt0 -162.21 148.21 13.13 Favored 'General case' 0 C--N 1.329 -0.29 0 C-N-CA 120.242 -0.583 . . . . 0.0 111.757 -179.21 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' D' D ' 53' ' ' ALA . . . . . . . . . . . . . . . -126.33 134.47 51.09 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 115.597 -0.729 . . . . 0.0 110.117 177.892 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' D' D ' 54' ' ' TYR . . . . . . . . . . . . . 59.9 t80 -129.09 111.06 18.3 Favored Pre-proline 0 CA--C 1.535 0.376 0 CA-C-O 118.198 -0.906 . . . . 0.0 110.086 177.879 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' D' D ' 55' ' ' PRO . . . . . . . . . . . . . 72.5 Cg_endo -77.19 169.93 72.86 Favored 'Cis proline' 0 N--CA 1.5 1.887 0 CA-C-N 121.932 1.726 . . . . 0.0 112.643 -4.822 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' D' D ' 56' ' ' SER . . . . . . . . . . . . . 13.6 m -118.49 130.82 24.55 Favored Pre-proline 0 CA--C 1.539 0.545 0 CA-C-O 118.431 -0.795 . . . . 0.0 109.743 174.737 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' D' D ' 57' ' ' PRO . . . . . . . . . . . . . 32.9 Cg_endo -65.16 167.65 46.12 Favored 'Cis proline' 0 N--CA 1.498 1.753 0 CA-C-N 121.953 1.733 . . . . 0.0 111.147 -2.952 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' D' D ' 58' ' ' LEU . . . . . . . . . . . . . 14.9 tp -128.38 134.79 48.9 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-O 121.069 0.461 . . . . 0.0 110.255 -179.812 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' D' D ' 59' ' ' ARG . . . . . . . . . . . . . 58.6 ttt-85 -103.05 119.58 39.11 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 115.406 -0.815 . . . . 0.0 109.133 176.817 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' D' D ' 60' ' ' VAL . . . . . . . . . . . . . 40.6 t -74.17 117.07 17.57 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.315 0 C-N-CA 120.867 -0.333 . . . . 0.0 110.731 -172.939 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' D' D ' 61' ' ' GLU . . . . . . . . . . . . . 40.5 mt-10 -131.08 161.18 32.62 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 115.982 -0.554 . . . . 0.0 109.952 175.977 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' D' D ' 62' ' ' ASP . . . . . . . . . . . . . 61.6 m-20 -52.09 -31.43 30.44 Favored 'General case' 0 C--N 1.328 -0.33 0 N-CA-C 112.157 0.428 . . . . 0.0 112.157 -177.664 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' D' D ' 63' ' ' ARG . . . . . . . . . . . . . 78.3 mtp180 -72.58 -22.04 61.05 Favored 'General case' 0 CA--C 1.532 0.268 0 N-CA-C 113.091 0.775 . . . . 0.0 113.091 -174.607 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' D' D ' 64' ' ' THR . . . . . . . . . . . . . 34.5 m -71.2 140.39 50.45 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-O 120.888 0.375 . . . . 0.0 111.244 -175.118 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' D' D ' 65' ' ' LYS . . . . . . . . . . . . . 3.9 mptp? -90.06 138.76 31.24 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 115.85 -0.614 . . . . 0.0 110.261 178.196 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' D' D ' 66' ' ' ILE . . . . . . . . . . . . . 60.6 mt -114.1 128.25 71.15 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.231 0 N-CA-C 109.658 -0.497 . . . . 0.0 109.658 178.754 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' D' D ' 67' ' ' THR . . . . . . . . . . . . . 15.5 m -122.35 146.71 47.07 Favored 'General case' 0 C--N 1.332 -0.159 0 CA-C-O 121.233 0.54 . . . . 0.0 111.133 -176.253 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' D' D ' 68' ' ' LEU . . . . . . . . . . . . . 15.1 tp . . . . . 0 C--N 1.33 -0.268 0 CA-C-N 115.647 -0.706 . . . . 0.0 110.765 -179.467 . . . . . . . . 0 0 . 1 . 010 nuclear orig core ' D' D ' 73' ' ' VAL . . . . . . . . . . . . . 33.5 m . . . . . 0 C--O 1.232 0.134 0 N-CA-C 110.124 -0.324 . . . . 0.0 110.124 . . . . . . . . . 0 0 . 1 . 010 nuclear orig core ' D' D ' 74' ' ' ASP . . . . . . . . . . . . . 22.4 t0 -84.56 118.36 24.29 Favored 'General case' 0 C--N 1.33 -0.258 0 C-N-CA 120.601 -0.44 . . . . 0.0 110.295 -172.538 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' D' D ' 75' ' ' VAL . . . . . . . . . . . . . 39.4 t -122.22 121.93 65.15 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.271 0 CA-C-O 120.961 0.41 . . . . 0.0 110.659 -176.948 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' D' D ' 76' ' ' LEU . . . . . . . . . . . . . 5.8 mp -122.03 149.13 43.94 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 115.735 -0.666 . . . . 0.0 109.39 174.861 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' D' D ' 77' ' ' GLU . . . . . . . . . . . . . 96.5 mt-10 -136.68 137.12 39.67 Favored 'General case' 0 C--N 1.332 -0.189 0 CA-C-O 121.16 0.505 . . . . 0.0 111.516 -176.644 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' D' D ' 78' ' ' ALA . . . . . . . . . . . . . . . -123.58 135.37 53.94 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 115.587 -0.733 . . . . 0.0 109.414 175.156 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' D' D ' 79' ' ' LYS . . . . . . . . . . . . . 59.4 mtpt -82.73 120.63 25.84 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-O 120.907 0.384 . . . . 0.0 111.129 -176.42 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' D' D ' 80' ' ' ILE . . . . . . . . . . . . . 40.2 mm -139.19 105.8 2.63 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.305 0 N-CA-C 109.103 -0.703 . . . . 0.0 109.103 -178.769 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' D' D ' 81' ' ' LYS . . . . . . . . . . . . . 19.2 pttp -98.14 128.69 44.77 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-O 120.869 0.366 . . . . 0.0 111.225 -176.544 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' D' D ' 82' ' ' GLY . . . . . . . . . . . . . . . 89.21 41.99 5.69 Favored Glycine 0 CA--C 1.524 0.651 0 C-N-CA 120.685 -0.769 . . . . 0.0 111.52 176.2 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' D' D ' 83' ' ' ILE . . . . . . . . . . . . . 71.7 mt -65.3 139.25 21.67 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.328 0 CA-C-O 121.009 0.433 . . . . 0.0 110.046 178.86 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' D' D ' 84' ' ' LYS . . . . . . . . . . . . . 59.5 tttm -99.17 -53.93 3.11 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 115.89 -0.595 . . . . 0.0 109.906 -179.609 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' D' D ' 85' ' ' ASP . . . . . . . . . . . . . 13.4 t70 -156.7 150.11 24.37 Favored 'General case' 0 C--N 1.326 -0.42 0 CA-C-N 115.646 -0.706 . . . . 0.0 110.187 -179.991 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' D' D ' 86' ' ' VAL . . . . . . . . . . . . . 42.8 t -128.41 128.74 68.6 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.279 0 CA-C-O 120.93 0.395 . . . . 0.0 110.41 -179.227 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' D' D ' 87' ' ' ILE . . . . . . . . . . . . . 44.1 mm -118.08 127.63 75.26 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.284 0 CA-C-N 115.824 -0.626 . . . . 0.0 109.488 176.679 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' D' D ' 88' ' ' LEU . . . . . . . . . . . . . 18.7 tp -112.74 133.65 54.65 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-O 121.137 0.494 . . . . 0.0 111.123 -177.64 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' D' D ' 89' ' ' ASP . . . . . . . . . . . . . 10.7 t70 -125.35 158.51 34.07 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 115.587 -0.733 . . . . 0.0 109.431 176.256 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' D' D ' 90' ' ' GLU . . . . . . . . . . . . . 96.0 mt-10 -46.74 -37.74 8.96 Favored 'General case' 0 C--N 1.331 -0.237 0 N-CA-C 113.17 0.804 . . . . 0.0 113.17 -172.138 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' D' D ' 91' ' ' ASN . . . . . . . . . . . . . 4.7 p-10 -132.04 23.35 4.54 Favored 'General case' 0 N--CA 1.467 0.413 0 N-CA-C 112.815 0.672 . . . . 0.0 112.815 -177.747 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' D' D ' 92' ' ' LEU . . . . . . . . . . . . . 16.5 mt -148.97 144.45 26.79 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-O 120.858 0.361 . . . . 0.0 110.56 -176.522 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' D' D ' 93' ' ' ILE . . . . . . . . . . . . . 71.4 mt -122.6 115.31 45.61 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.316 0 N-CA-C 109.224 -0.658 . . . . 0.0 109.224 176.728 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' D' D ' 94' ' ' VAL . . . . . . . . . . . . . 44.9 t -117.06 123.0 71.31 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.267 0 N-CA-C 109.867 -0.42 . . . . 0.0 109.867 -178.932 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' D' D ' 95' ' ' VAL . . . . . . . . . . . . . 42.0 t -120.18 133.75 65.89 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.236 0 CA-C-N 116.021 -0.536 . . . . 0.0 110.025 -178.039 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' D' D ' 96' ' ' ILE . . . . . . . . . . . . . 56.1 mt -113.88 130.76 67.46 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 N-CA-C 109.124 -0.695 . . . . 0.0 109.124 177.145 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' D' D ' 97' ' ' THR . . . . . . . . . . . . . 68.6 p -103.48 157.18 17.21 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-O 120.872 0.368 . . . . 0.0 110.988 -178.638 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' D' D ' 98' ' ' GLU . . . . . . . . . . . . . 97.4 mt-10 -53.89 -22.89 10.96 Favored 'General case' 0 CA--C 1.535 0.375 0 N-CA-C 112.307 0.484 . . . . 0.0 112.307 179.121 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' D' D ' 99' ' ' GLU . . . . . . . . . . . . . 95.6 mt-10 -77.49 12.55 1.54 Allowed 'General case' 0 CA--C 1.536 0.441 0 N-CA-C 113.208 0.818 . . . . 0.0 113.208 -178.714 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' D' D ' 100' ' ' ASN . . . . . . . . . . . . . 3.0 m-20 61.85 37.46 15.36 Favored 'General case' 0 CA--C 1.531 0.217 0 CA-C-O 121.023 0.439 . . . . 0.0 110.979 179.833 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' D' D ' 101' ' ' GLU . . . . . . . . . . . . . 85.4 tt0 -116.84 145.63 43.43 Favored 'General case' 0 C--N 1.333 -0.137 0 CA-C-N 116.086 -0.506 . . . . 0.0 109.886 176.239 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' D' D ' 102' ' ' VAL . . . . . . . . . . . . . 42.9 t -117.64 127.1 75.07 Favored 'Isoleucine or valine' 0 C--O 1.233 0.224 0 CA-C-N 116.277 -0.42 . . . . 0.0 109.929 -178.284 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' D' D ' 103' ' ' LEU . . . . . . . . . . . . . 63.0 mt -119.57 134.61 55.15 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 115.991 -0.549 . . . . 0.0 110.511 178.058 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' D' D ' 104' ' ' ILE . . . . . . . . . . . . . 66.1 mt -120.99 120.18 61.52 Favored 'Isoleucine or valine' 0 C--O 1.234 0.252 0 CA-C-N 116.567 -0.288 . . . . 0.0 110.513 -179.09 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' D' D ' 105' ' ' PHE . . . . . . . . . . . . . 54.2 m-85 -120.53 167.71 12.11 Favored 'General case' 0 N--CA 1.462 0.146 0 O-C-N 124.066 0.854 . . . . 0.0 109.829 177.707 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' D' D ' 106' ' ' ASN . . . . . . . . . . . . . 47.5 p-10 -104.04 -170.39 1.77 Allowed 'General case' 0 CA--C 1.532 0.264 0 N-CA-C 110.221 -0.288 . . . . 0.0 110.221 173.091 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' D' D ' 107' ' ' GLN . . . . . . . . . . . . . 61.7 tt0 -57.75 -29.85 65.12 Favored 'General case' 0 CA--C 1.532 0.286 0 N-CA-C 111.97 0.359 . . . . 0.0 111.97 178.987 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' D' D ' 108' ' ' ASN . . . . . . . . . . . . . 10.2 t-20 -86.52 12.7 9.81 Favored 'General case' 0 CA--C 1.535 0.367 0 N-CA-C 112.922 0.712 . . . . 0.0 112.922 -176.681 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' D' D ' 109' ' ' LEU . . . . . . . . . . . . . 26.4 mt 56.76 32.34 21.06 Favored 'General case' 0 CA--C 1.53 0.211 0 N-CA-C 111.75 0.278 . . . . 0.0 111.75 179.356 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' D' D ' 110' ' ' GLU . . . . . . . . . . . . . 69.3 mm-40 -98.27 143.38 28.81 Favored 'General case' 0 C--N 1.33 -0.28 0 N-CA-C 109.258 -0.645 . . . . 0.0 109.258 175.372 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' D' D ' 111' ' ' GLU . . . . . . . . . . . . . 58.9 tt0 -83.33 121.88 27.72 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-O 121.082 0.467 . . . . 0.0 110.344 -177.162 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' D' D ' 112' ' ' LEU . . . . . . . . . . . . . 23.7 mt -104.31 -45.83 4.57 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 115.816 -0.629 . . . . 0.0 110.413 -178.759 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' D' D ' 113' ' ' TYR . . . . . . . . . . . . . 61.1 t80 -140.39 140.75 35.56 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.096 -0.502 . . . . 0.0 111.008 -178.361 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' D' D ' 114' ' ' ARG . . . . . . . . . . . . . 35.6 ptt-85 -142.21 125.41 16.41 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.305 -0.407 . . . . 0.0 110.489 176.427 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' D' D ' 115' ' ' GLY . . . . . . . . . . . . . . . -150.14 159.79 28.26 Favored Glycine 0 CA--C 1.522 0.522 0 N-CA-C 110.691 -0.964 . . . . 0.0 110.691 179.203 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' D' D ' 116' ' ' LYS . . . . . . . . . . . . . 2.1 ttmp? -127.84 138.95 52.88 Favored 'General case' 0 C--N 1.329 -0.312 0 N-CA-C 110.027 -0.361 . . . . 0.0 110.027 177.566 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' D' D ' 117' ' ' PHE . . . . . . . . . . . . . 43.8 m-85 -135.68 113.89 11.43 Favored 'General case' 0 C--N 1.331 -0.23 0 CA-C-N 116.207 -0.451 . . . . 0.0 109.895 -177.032 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' D' D ' 118' ' ' GLU . . . . . . . . . . . . . 70.8 mm-40 -54.69 -42.66 71.68 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.448 -0.342 . . . . 0.0 111.294 -176.3 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' D' D ' 119' ' ' ASN . . . . . . . . . . . . . 19.9 m120 -100.94 31.03 3.75 Favored 'General case' 0 C--N 1.331 -0.227 0 N-CA-C 112.188 0.44 . . . . 0.0 112.188 -174.287 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' D' D ' 120' ' ' LEU . . . . . . . . . . . . . 16.3 tp -56.96 121.1 9.14 Favored 'General case' 0 N--CA 1.462 0.167 0 C-N-CA 121.009 -0.276 . . . . 0.0 110.345 177.727 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' D' D ' 121' ' ' ASN . . . . . . . . . . . . . 60.5 m-20 -114.2 -44.06 3.16 Favored 'General case' 0 C--N 1.332 -0.154 0 CA-C-N 116.678 -0.237 . . . . 0.0 111.26 -176.898 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' D' D ' 122' ' ' LYS . . . . . . . . . . . . . 39.0 ttpt -144.82 143.12 30.47 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-O 120.953 0.406 . . . . 0.0 111.343 -175.976 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' D' D ' 123' ' ' VAL . . . . . . . . . . . . . 43.6 t -128.77 134.23 64.8 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.219 0 CA-C-N 116.172 -0.467 . . . . 0.0 109.762 177.18 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' D' D ' 124' ' ' LEU . . . . . . . . . . . . . 59.0 mt -129.51 135.27 48.41 Favored 'General case' 0 C--N 1.331 -0.196 0 CA-C-O 120.815 0.341 . . . . 0.0 110.949 -179.048 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' D' D ' 125' ' ' VAL . . . . . . . . . . . . . 10.6 p -132.33 131.12 60.67 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.274 0 CA-C-N 116.11 -0.496 . . . . 0.0 109.958 177.526 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' D' D ' 126' ' ' ARG . . . . . . . . . . . . . 53.8 ttm-85 -143.08 116.04 8.83 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.462 -0.335 . . . . 0.0 110.815 -178.72 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' D' D ' 127' ' ' ASN . . . . . . . . . . . . . 3.1 m120 51.97 -105.0 0.2 Allowed 'General case' 0 CA--C 1.544 0.721 0 CA-C-O 119.172 -0.442 . . . . 0.0 111.323 178.214 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' D' D ' 128' ' ' ASP . . . . . . . . . . . . . 19.1 p-10 -113.9 3.95 15.62 Favored 'General case' 0 CA--C 1.538 0.496 0 CA-C-N 119.42 1.009 . . . . 0.0 113.426 -176.208 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' D' D ' 129' ' ' LEU . . . . . . . . . . . . . 21.6 tp -110.43 137.01 48.71 Favored 'General case' 0 C--N 1.331 -0.222 0 CA-C-N 118.047 0.385 . . . . 0.0 110.05 178.857 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' D' D ' 130' ' ' VAL . . . . . . . . . . . . . 54.6 t -124.99 137.25 58.2 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.284 0 CA-C-O 120.833 0.349 . . . . 0.0 110.15 -179.475 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' D' D ' 131' ' ' VAL . . . . . . . . . . . . . 42.9 t -135.98 136.27 49.84 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.274 0 CA-C-N 116.271 -0.422 . . . . 0.0 110.363 179.698 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' D' D ' 132' ' ' ILE . . . . . . . . . . . . . 74.1 mt -119.33 133.37 66.35 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.298 0 N-CA-C 109.52 -0.548 . . . . 0.0 109.52 178.784 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' D' D ' 133' ' ' ILE . . . . . . . . . . . . . 40.4 mm -119.12 124.3 72.88 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.223 0 CA-C-O 120.829 0.347 . . . . 0.0 111.315 -174.831 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' D' D ' 134' ' ' ASP . . . . . . . . . . . . . 9.7 p-10 -137.68 150.1 47.07 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-N 116.307 -0.406 . . . . 0.0 109.932 173.637 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' D' D ' 135' ' ' GLU . . . . . . . . . . . . . 86.0 tt0 -49.77 -22.93 1.57 Allowed 'General case' 0 C--N 1.328 -0.359 0 N-CA-C 113.067 0.765 . . . . 0.0 113.067 -174.21 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' D' D ' 136' ' ' GLN . . . . . . . . . . . . . 63.1 tt0 -93.16 -28.76 16.11 Favored 'General case' 0 C--O 1.234 0.265 0 N-CA-C 112.384 0.512 . . . . 0.0 112.384 -174.004 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' D' D ' 137' ' ' LYS . . . . . . . . . . . . . 47.7 pttt -166.04 170.58 13.4 Favored 'General case' 0 C--N 1.332 -0.185 0 CA-C-O 121.55 0.69 . . . . 0.0 112.317 -172.849 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' D' D ' 138' ' ' LEU . . . . . . . . . . . . . 5.6 tt -121.96 128.61 51.7 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 114.882 -1.053 . . . . 0.0 109.836 178.797 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' D' D ' 139' ' ' THR . . . . . . . . . . . . . 26.4 m -109.69 132.65 53.95 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-N 116.198 -0.455 . . . . 0.0 110.629 -179.254 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' D' D ' 140' ' ' LEU . . . . . . . . . . . . . 12.1 tp -118.58 124.14 46.74 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 115.583 -0.735 . . . . 0.0 109.381 -178.425 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' D' D ' 141' ' ' ILE . . . . . . . . . . . . . 19.6 mt -120.48 119.62 60.32 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.344 0 N-CA-C 109.87 -0.418 . . . . 0.0 109.87 -175.795 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' D' D ' 142' ' ' ARG . . . . . . . . . . . . . 7.8 mmm180 -109.03 126.13 52.81 Favored 'General case' 0 C--N 1.331 -0.227 0 CA-C-N 115.496 -0.775 . . . . 0.0 110.508 -177.857 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' D' D ' 143' ' ' THR . . . . . . . . . . . . . 49.5 p . . . . . 0 C--O 1.219 -0.501 0 CA-C-O 117.998 -1.001 . . . . 0.0 110.627 -179.864 . . . . . . . . 0 0 . 1 . 010 nuclear orig core ' E' E ' 2' ' ' SER . . . . . . . . . . . . . 94.5 p . . . . . 0 C--O 1.233 0.19 0 CA-C-O 121.106 0.479 . . . . 0.0 110.637 . . . . . . . . . 0 0 . 1 . 010 nuclear orig core ' E' E ' 3' ' ' GLU . . . . . . . . . . . . . 82.4 tt0 -140.63 143.99 35.49 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 115.935 -0.575 . . . . 0.0 110.851 -177.842 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' E' E ' 4' ' ' LEU . . . . . . . . . . . . . 20.6 tp -124.86 130.87 53.24 Favored 'General case' 0 C--N 1.331 -0.216 0 CA-C-N 116.016 -0.538 . . . . 0.0 110.176 177.673 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' E' E ' 5' ' ' LYS . . . . . . . . . . . . . 61.3 mttp -108.44 121.84 45.78 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-O 120.876 0.37 . . . . 0.0 110.616 178.856 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' E' E ' 6' ' ' LEU . . . . . . . . . . . . . 67.2 mt -114.05 150.21 34.31 Favored 'General case' 0 C--N 1.331 -0.217 0 CA-C-N 115.548 -0.751 . . . . 0.0 110.702 -179.982 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' E' E ' 7' ' ' LYS . . . . . . . . . . . . . 84.6 tttt -140.46 140.11 22.06 Favored Pre-proline 0 CA--C 1.534 0.354 0 CA-C-O 119.09 -0.481 . . . . 0.0 110.02 175.189 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' E' E ' 8' ' ' PRO . . . . . . . . . . . . . 95.2 Cg_endo -92.01 143.7 2.76 Favored 'Trans proline' 0 N--CA 1.49 1.315 0 C-N-CA 121.765 1.643 . . . . 0.0 111.73 177.593 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' E' E ' 9' ' ' LEU . . . . . . . . . . . . . 60.7 mt -78.36 -47.51 1.99 Allowed Pre-proline 0 CA--C 1.533 0.298 0 CA-C-O 118.715 -0.66 . . . . 0.0 112.242 -179.257 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' E' E ' 10' ' ' PRO . . . . . . . . . . . . . 92.9 Cg_endo -80.36 153.84 21.26 Favored 'Trans proline' 0 N--CA 1.496 1.63 0 C-N-CA 121.067 1.178 . . . . 0.0 111.904 176.129 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' E' E ' 11' ' ' LYS . . . . . . . . . . . . . 55.7 mtmt -88.35 98.95 11.89 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.376 -0.374 . . . . 0.0 110.604 179.312 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' E' E ' 12' ' ' VAL . . . . . . . . . . . . . 11.2 p -145.06 144.04 21.91 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.294 0 CA-C-N 116.111 -0.495 . . . . 0.0 110.357 -179.718 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' E' E ' 13' ' ' GLU . . . . . . . . . . . . . 95.4 mt-10 -85.02 121.51 27.9 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.176 -0.465 . . . . 0.0 109.972 177.774 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' E' E ' 14' ' ' LEU . . . . . . . . . . . . . 20.0 mt -93.62 156.5 39.58 Favored Pre-proline 0 C--N 1.329 -0.323 0 CA-C-N 116.349 -0.387 . . . . 0.0 110.784 -177.188 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' E' E ' 15' ' ' PRO . . . . . . . . . . . . . 27.0 Cg_exo -60.73 155.07 50.8 Favored 'Trans proline' 0 N--CA 1.496 1.625 0 C-N-CA 121.354 1.369 . . . . 0.0 111.764 179.614 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' E' E ' 16' ' ' PRO . . . . . . . . . . . . . 32.3 Cg_exo -57.63 -36.48 98.51 Favored 'Trans proline' 0 N--CA 1.497 1.689 0 C-N-CA 121.328 1.352 . . . . 0.0 112.572 179.598 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' E' E ' 17' ' ' ASP . . . . . . . . . . . . . 8.8 p-10 -88.74 13.78 11.65 Favored 'General case' 0 CA--C 1.535 0.389 0 N-CA-C 113.027 0.751 . . . . 0.0 113.027 -177.74 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' E' E ' 18' ' ' PHE . . . . . . . . . . . . . 40.8 t80 -58.43 -44.37 89.08 Favored 'General case' 0 C--N 1.333 -0.134 0 O-C-N 121.968 -0.457 . . . . 0.0 110.198 -178.599 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' E' E ' 19' ' ' VAL . . . . . . . . . . . . . 14.4 p -58.42 -46.42 89.46 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.354 0 CA-C-N 116.459 -0.337 . . . . 0.0 111.807 -174.83 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' E' E ' 20' ' ' ASP . . . . . . . . . . . . . 2.7 p-10 -64.75 -36.17 83.44 Favored 'General case' 0 N--CA 1.463 0.224 0 C-N-CA 120.655 -0.418 . . . . 0.0 111.169 -177.383 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' E' E ' 21' ' ' VAL . . . . . . . . . . . . . 48.2 t -63.95 -48.19 87.2 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.217 0 C-N-CA 120.632 -0.427 . . . . 0.0 110.193 179.374 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' E' E ' 22' ' ' ILE . . . . . . . . . . . . . 51.0 mm -56.17 -43.09 75.15 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.216 0 C-N-CA 121.019 -0.272 . . . . 0.0 110.416 177.321 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' E' E ' 23' ' ' ARG . . . . . . . . . . . . . 43.2 ttp180 -52.1 -51.11 59.84 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-O 120.723 0.297 . . . . 0.0 111.498 -179.457 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' E' E ' 24' ' ' ILE . . . . . . . . . . . . . 70.3 mt -59.78 -41.69 86.4 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.256 0 CA-C-N 116.471 -0.331 . . . . 0.0 110.963 -179.047 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' E' E ' 25' ' ' LYS . . . . . . . . . . . . . 60.6 mtpt -62.98 -41.85 99.68 Favored 'General case' 0 C--N 1.327 -0.388 0 N-CA-C 112.076 0.399 . . . . 0.0 112.076 -178.598 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' E' E ' 26' ' ' LEU . . . . . . . . . . . . . 72.4 mt -80.42 -39.65 27.88 Favored 'General case' 0 C--N 1.33 -0.256 0 N-CA-C 113.27 0.841 . . . . 0.0 113.27 -170.916 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' E' E ' 27' ' ' GLN . . . . . . . . . . . . . 9.1 pt20 -46.59 135.08 8.93 Favored 'General case' 0 N--CA 1.468 0.462 0 N-CA-C 113.003 0.742 . . . . 0.0 113.003 -174.768 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' E' E ' 28' ' ' GLY . . . . . . . . . . . . . . . 100.44 -21.79 42.68 Favored Glycine 0 CA--C 1.534 1.251 0 CA-C-N 115.523 -0.762 . . . . 0.0 112.719 -178.416 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' E' E ' 29' ' ' LYS . . . . . . . . . . . . . 65.6 mttm -98.79 155.12 17.52 Favored 'General case' 0 C--O 1.232 0.177 0 CA-C-N 117.512 0.656 . . . . 0.0 111.29 -179.767 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' E' E ' 30' ' ' THR . . . . . . . . . . . . . 38.1 m -104.07 133.64 48.66 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 115.901 -0.591 . . . . 0.0 109.73 175.223 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' E' E ' 31' ' ' VAL . . . . . . . . . . . . . 33.6 m -131.72 154.91 41.14 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.211 0 CA-C-O 121.03 0.443 . . . . 0.0 111.343 -176.984 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' E' E ' 32' ' ' ARG . . . . . . . . . . . . . 55.7 mtp180 -132.25 152.33 51.4 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 115.771 -0.65 . . . . 0.0 110.436 177.553 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' E' E ' 33' ' ' THR . . . . . . . . . . . . . 20.5 m -53.18 139.68 28.36 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.271 -0.422 . . . . 0.0 111.322 -179.121 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' E' E ' 34' ' ' GLY . . . . . . . . . . . . . . . 100.82 -17.28 56.61 Favored Glycine 0 CA--C 1.532 1.126 0 CA-C-O 119.608 -0.551 . . . . 0.0 113.279 179.709 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' E' E ' 35' ' ' ASP . . . . . . . . . . . . . 66.7 m-20 -65.93 149.58 49.99 Favored 'General case' 0 C--O 1.231 0.131 0 CA-C-N 118.036 0.918 . . . . 0.0 110.998 179.059 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' E' E ' 36' ' ' VAL . . . . . . . . . . . . . 46.4 t -122.1 131.75 72.48 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.196 0 CA-C-N 115.911 -0.586 . . . . 0.0 110.134 179.825 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' E' E ' 37' ' ' ILE . . . . . . . . . . . . . 67.7 mt -119.92 139.02 48.62 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.245 0 CA-C-N 116.086 -0.506 . . . . 0.0 109.797 178.637 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' E' E ' 38' ' ' GLY . . . . . . . . . . . . . . . -113.48 128.99 8.6 Favored Glycine 0 CA--C 1.526 0.741 0 N-CA-C 111.139 -0.784 . . . . 0.0 111.139 -179.614 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' E' E ' 39' ' ' ILE . . . . . . . . . . . . . 72.1 mt -123.43 135.78 62.15 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.186 0 N-CA-C 110.015 -0.365 . . . . 0.0 110.015 178.656 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' E' E ' 40' ' ' SER . . . . . . . . . . . . . 30.0 t -92.67 123.02 35.65 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.225 -0.443 . . . . 0.0 110.835 175.8 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' E' E ' 41' ' ' ILE . . . . . . . . . . . . . 71.4 mt -131.34 114.57 26.36 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.214 0 N-CA-C 110.08 -0.341 . . . . 0.0 110.08 177.69 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' E' E ' 42' ' ' LEU . . . . . . . . . . . . . 84.4 mt 58.11 33.28 23.01 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.038 -0.528 . . . . 0.0 111.797 178.893 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' E' E ' 43' ' ' GLY . . . . . . . . . . . . . . . 83.24 -10.18 59.18 Favored Glycine 0 CA--C 1.535 1.283 0 C-N-CA 121.156 -0.545 . . . . 0.0 113.497 177.018 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' E' E ' 44' ' ' LYS . . . . . . . . . . . . . 64.6 mttp -98.46 136.18 38.96 Favored 'General case' 0 C--N 1.333 -0.115 0 CA-C-N 117.892 0.846 . . . . 0.0 110.271 177.785 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' E' E ' 45' ' ' GLU . . . . . . . . . . . . . 84.3 tt0 -85.26 128.87 34.85 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-N 116.464 -0.334 . . . . 0.0 111.373 179.946 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' E' E ' 46' ' ' VAL . . . . . . . . . . . . . 7.4 p -121.8 126.33 74.47 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.18 0 N-CA-C 109.457 -0.571 . . . . 0.0 109.457 174.697 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' E' E ' 47' ' ' LYS . . . . . . . . . . . . . 61.6 mttm -100.06 129.18 46.08 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-N 116.052 -0.522 . . . . 0.0 111.162 179.004 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' E' E ' 48' ' ' PHE . . . . . . . . . . . . . 92.6 m-85 -111.43 131.93 54.83 Favored 'General case' 0 C--N 1.332 -0.182 0 CA-C-N 116.28 -0.418 . . . . 0.0 109.954 176.28 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' E' E ' 49' ' ' LYS . . . . . . . . . . . . . 54.8 tttp -107.68 137.17 46.17 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.464 -0.335 . . . . 0.0 110.564 179.368 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' E' E ' 50' ' ' VAL . . . . . . . . . . . . . 45.6 t -79.92 108.25 13.2 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.25 0 N-CA-C 109.258 -0.645 . . . . 0.0 109.258 174.894 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' E' E ' 51' ' ' VAL . . . . . . . . . . . . . 48.7 t -71.46 -47.62 57.74 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.326 0 CA-C-N 116.223 -0.444 . . . . 0.0 110.004 -173.795 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' E' E ' 52' ' ' GLN . . . . . . . . . . . . . 62.3 tt0 -166.13 143.83 5.45 Favored 'General case' 0 C--N 1.329 -0.307 0 C-N-CA 120.441 -0.504 . . . . 0.0 111.847 -178.952 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' E' E ' 53' ' ' ALA . . . . . . . . . . . . . . . -119.66 134.11 55.36 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 115.915 -0.584 . . . . 0.0 109.774 175.599 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' E' E ' 54' ' ' TYR . . . . . . . . . . . . . 10.9 t80 -129.1 112.33 18.42 Favored Pre-proline 0 CA--C 1.534 0.348 0 CA-C-O 118.191 -0.909 . . . . 0.0 110.028 177.917 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' E' E ' 55' ' ' PRO . . . . . . . . . . . . . 71.7 Cg_endo -77.2 170.17 72.2 Favored 'Cis proline' 0 N--CA 1.5 1.911 0 CA-C-N 122.002 1.751 . . . . 0.0 112.527 -5.94 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' E' E ' 56' ' ' SER . . . . . . . . . . . . . 15.8 m -123.47 139.02 31.12 Favored Pre-proline 0 CA--C 1.539 0.545 0 CA-C-O 118.553 -0.737 . . . . 0.0 109.443 174.06 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' E' E ' 57' ' ' PRO . . . . . . . . . . . . . 37.6 Cg_endo -67.45 145.2 73.48 Favored 'Cis proline' 0 N--CA 1.498 1.773 0 CA-C-N 121.616 1.613 . . . . 0.0 111.53 -3.128 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' E' E ' 58' ' ' LEU . . . . . . . . . . . . . 16.2 tp -107.99 139.05 43.19 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-O 120.999 0.428 . . . . 0.0 110.837 -177.331 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' E' E ' 59' ' ' ARG . . . . . . . . . . . . . 21.3 ttm180 -102.45 122.54 44.52 Favored 'General case' 0 C--N 1.327 -0.389 0 N-CA-C 108.985 -0.746 . . . . 0.0 108.985 173.393 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' E' E ' 60' ' ' VAL . . . . . . . . . . . . . 45.6 t -81.55 119.17 30.62 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.35 0 C-N-CA 120.689 -0.404 . . . . 0.0 110.634 -174.281 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' E' E ' 61' ' ' GLU . . . . . . . . . . . . . 95.5 mt-10 -131.19 160.96 33.3 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 115.765 -0.652 . . . . 0.0 109.71 175.422 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' E' E ' 62' ' ' ASP . . . . . . . . . . . . . 10.9 p-10 -52.77 -29.93 30.08 Favored 'General case' 0 C--N 1.328 -0.363 0 N-CA-C 112.067 0.395 . . . . 0.0 112.067 -179.302 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' E' E ' 63' ' ' ARG . . . . . . . . . . . . . 60.0 mtp180 -72.35 -22.06 61.22 Favored 'General case' 0 CA--C 1.533 0.295 0 N-CA-C 113.002 0.742 . . . . 0.0 113.002 -175.616 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' E' E ' 64' ' ' THR . . . . . . . . . . . . . 36.8 m -66.7 142.27 57.48 Favored 'General case' 0 C--N 1.331 -0.225 0 CA-C-O 120.983 0.421 . . . . 0.0 110.913 -176.444 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' E' E ' 65' ' ' LYS . . . . . . . . . . . . . 46.6 mtmt -88.4 129.52 35.4 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 115.938 -0.574 . . . . 0.0 109.912 177.684 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' E' E ' 66' ' ' ILE . . . . . . . . . . . . . 60.7 mt -113.54 126.65 71.03 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.347 0 N-CA-C 109.976 -0.379 . . . . 0.0 109.976 -178.089 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' E' E ' 67' ' ' THR . . . . . . . . . . . . . 25.8 m -127.14 149.73 49.82 Favored 'General case' 0 C--N 1.331 -0.226 0 CA-C-O 121.147 0.498 . . . . 0.0 111.112 -176.896 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' E' E ' 68' ' ' LEU . . . . . . . . . . . . . 72.3 mt . . . . . 0 C--N 1.33 -0.282 0 CA-C-N 115.909 -0.587 . . . . 0.0 110.791 179.543 . . . . . . . . 0 0 . 1 . 010 nuclear orig core ' E' E ' 73' ' ' VAL . . . . . . . . . . . . . 32.6 m . . . . . 0 C--O 1.231 0.105 0 CA-C-O 120.775 0.321 . . . . 0.0 110.634 . . . . . . . . . 0 0 . 1 . 010 nuclear orig core ' E' E ' 74' ' ' ASP . . . . . . . . . . . . . 42.1 t0 -93.3 122.54 35.8 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-N 116.348 -0.387 . . . . 0.0 110.264 -175.607 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' E' E ' 75' ' ' VAL . . . . . . . . . . . . . 41.3 t -116.97 123.34 71.71 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.237 0 CA-C-O 121.051 0.453 . . . . 0.0 110.345 -178.845 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' E' E ' 76' ' ' LEU . . . . . . . . . . . . . 20.4 mt -123.82 148.73 46.47 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 115.659 -0.701 . . . . 0.0 109.64 178.518 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' E' E ' 77' ' ' GLU . . . . . . . . . . . . . 46.0 mt-10 -139.1 136.39 35.14 Favored 'General case' 0 C--N 1.331 -0.208 0 CA-C-O 121.052 0.453 . . . . 0.0 111.334 -177.946 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' E' E ' 78' ' ' ALA . . . . . . . . . . . . . . . -123.42 134.82 53.91 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 115.707 -0.678 . . . . 0.0 109.724 176.28 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' E' E ' 79' ' ' LYS . . . . . . . . . . . . . 77.8 mttt -77.98 121.51 24.3 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-O 120.791 0.329 . . . . 0.0 110.837 -177.065 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' E' E ' 80' ' ' ILE . . . . . . . . . . . . . 38.2 mm -139.21 109.95 4.57 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.327 0 N-CA-C 109.538 -0.541 . . . . 0.0 109.538 -178.571 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' E' E ' 81' ' ' LYS . . . . . . . . . . . . . 15.4 ptpt -103.85 126.84 51.26 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-O 121.114 0.483 . . . . 0.0 111.102 -177.808 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' E' E ' 82' ' ' GLY . . . . . . . . . . . . . . . 89.13 42.11 5.68 Favored Glycine 0 CA--C 1.524 0.624 0 N-CA-C 111.512 -0.635 . . . . 0.0 111.512 175.047 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' E' E ' 83' ' ' ILE . . . . . . . . . . . . . 72.0 mt -67.63 140.24 19.57 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.293 0 CA-C-O 120.889 0.376 . . . . 0.0 110.132 179.252 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' E' E ' 84' ' ' LYS . . . . . . . . . . . . . 82.6 tttt -100.82 -53.85 2.96 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 115.895 -0.593 . . . . 0.0 110.089 -179.403 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' E' E ' 85' ' ' ASP . . . . . . . . . . . . . 5.8 t70 -157.57 155.66 30.58 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 115.731 -0.668 . . . . 0.0 110.477 -178.577 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' E' E ' 86' ' ' VAL . . . . . . . . . . . . . 42.9 t -133.27 132.67 58.26 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.258 0 CA-C-O 121.02 0.438 . . . . 0.0 110.533 -178.662 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' E' E ' 87' ' ' ILE . . . . . . . . . . . . . 43.3 mm -117.63 130.5 72.42 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.259 0 CA-C-N 115.813 -0.631 . . . . 0.0 109.503 174.714 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' E' E ' 88' ' ' LEU . . . . . . . . . . . . . 18.6 tp -114.7 134.61 54.95 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-O 121.127 0.489 . . . . 0.0 111.493 -175.995 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' E' E ' 89' ' ' ASP . . . . . . . . . . . . . 7.0 t70 -127.39 155.37 43.74 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 115.605 -0.725 . . . . 0.0 109.426 174.931 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' E' E ' 90' ' ' GLU . . . . . . . . . . . . . 96.0 mt-10 -47.49 -42.07 22.16 Favored 'General case' 0 N--CA 1.463 0.217 0 N-CA-C 112.781 0.659 . . . . 0.0 112.781 -172.862 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' E' E ' 91' ' ' ASN . . . . . . . . . . . . . 87.2 m-20 -132.02 39.9 3.39 Favored 'General case' 0 C--O 1.233 0.227 0 CA-C-O 120.871 0.367 . . . . 0.0 111.161 -178.279 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' E' E ' 92' ' ' LEU . . . . . . . . . . . . . 10.5 tp -166.11 141.77 4.82 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.517 -0.311 . . . . 0.0 110.521 -179.579 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' E' E ' 93' ' ' ILE . . . . . . . . . . . . . 65.1 mt -126.98 124.34 64.4 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.283 0 N-CA-C 109.695 -0.483 . . . . 0.0 109.695 -178.965 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' E' E ' 94' ' ' VAL . . . . . . . . . . . . . 41.9 t -121.64 124.7 72.2 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.28 0 N-CA-C 109.794 -0.447 . . . . 0.0 109.794 179.71 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' E' E ' 95' ' ' VAL . . . . . . . . . . . . . 45.6 t -122.53 135.5 62.43 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.237 0 CA-C-N 116.443 -0.344 . . . . 0.0 110.147 -178.952 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' E' E ' 96' ' ' ILE . . . . . . . . . . . . . 60.0 mt -117.54 130.99 71.56 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.294 0 CA-C-N 115.954 -0.566 . . . . 0.0 109.476 179.155 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' E' E ' 97' ' ' THR . . . . . . . . . . . . . 40.7 p -101.01 157.37 16.8 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-O 121.095 0.474 . . . . 0.0 111.127 -179.403 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' E' E ' 98' ' ' GLU . . . . . . . . . . . . . 46.0 mt-10 -54.85 -29.49 55.4 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.231 -0.44 . . . . 0.0 112.138 -179.216 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' E' E ' 99' ' ' GLU . . . . . . . . . . . . . 71.2 mm-40 -78.64 14.18 1.39 Allowed 'General case' 0 CA--C 1.536 0.409 0 N-CA-C 113.124 0.787 . . . . 0.0 113.124 -177.361 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' E' E ' 100' ' ' ASN . . . . . . . . . . . . . 38.1 m-20 63.46 36.23 11.46 Favored 'General case' 0 N--CA 1.462 0.141 0 CA-C-O 120.947 0.403 . . . . 0.0 111.585 178.728 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' E' E ' 101' ' ' GLU . . . . . . . . . . . . . 84.8 tt0 -107.38 140.21 40.67 Favored 'General case' 0 C--N 1.331 -0.201 0 N-CA-C 109.372 -0.603 . . . . 0.0 109.372 170.989 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' E' E ' 102' ' ' VAL . . . . . . . . . . . . . 47.9 t -115.1 128.53 72.24 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.269 0 CA-C-N 116.256 -0.429 . . . . 0.0 109.9 -178.187 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' E' E ' 103' ' ' LEU . . . . . . . . . . . . . 31.0 mt -120.42 131.31 54.73 Favored 'General case' 0 C--N 1.331 -0.215 0 CA-C-N 115.757 -0.656 . . . . 0.0 110.368 177.43 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' E' E ' 104' ' ' ILE . . . . . . . . . . . . . 65.8 mt -117.64 121.61 67.87 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.241 0 CA-C-N 116.346 -0.388 . . . . 0.0 110.007 179.038 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' E' E ' 105' ' ' PHE . . . . . . . . . . . . . 75.6 m-85 -121.87 165.24 16.21 Favored 'General case' 0 C--N 1.332 -0.158 0 O-C-N 123.885 0.741 . . . . 0.0 109.823 179.819 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' E' E ' 106' ' ' ASN . . . . . . . . . . . . . 46.6 p-10 -100.21 -169.99 1.81 Allowed 'General case' 0 C--N 1.329 -0.291 0 N-CA-C 109.716 -0.476 . . . . 0.0 109.716 173.437 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' E' E ' 107' ' ' GLN . . . . . . . . . . . . . 46.7 tt0 -59.27 -30.06 68.02 Favored 'General case' 0 C--N 1.329 -0.301 0 N-CA-C 111.89 0.33 . . . . 0.0 111.89 179.2 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' E' E ' 108' ' ' ASN . . . . . . . . . . . . . 58.6 t30 -82.19 6.94 15.01 Favored 'General case' 0 CA--C 1.536 0.429 0 N-CA-C 113.161 0.8 . . . . 0.0 113.161 -177.536 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' E' E ' 109' ' ' LEU . . . . . . . . . . . . . 7.4 tp 59.69 34.79 22.21 Favored 'General case' 0 C--O 1.232 0.167 0 O-C-N 122.07 -0.394 . . . . 0.0 111.602 179.42 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' E' E ' 110' ' ' GLU . . . . . . . . . . . . . 42.7 mt-10 -101.9 148.67 25.05 Favored 'General case' 0 C--N 1.33 -0.282 0 N-CA-C 109.52 -0.548 . . . . 0.0 109.52 175.118 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' E' E ' 111' ' ' GLU . . . . . . . . . . . . . 53.0 tt0 -81.98 121.97 27.2 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-O 120.849 0.357 . . . . 0.0 110.759 -176.288 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' E' E ' 112' ' ' LEU . . . . . . . . . . . . . 14.5 mt -106.91 -45.89 4.07 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.071 -0.513 . . . . 0.0 110.594 -179.958 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' E' E ' 113' ' ' TYR . . . . . . . . . . . . . 49.4 t80 -134.88 134.85 41.13 Favored 'General case' 0 C--N 1.331 -0.209 0 CA-C-N 116.28 -0.418 . . . . 0.0 111.026 -178.489 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' E' E ' 114' ' ' ARG . . . . . . . . . . . . . 78.7 ttt-85 -134.06 121.74 21.97 Favored 'General case' 0 C--N 1.331 -0.2 0 CA-C-N 116.04 -0.527 . . . . 0.0 110.262 179.655 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' E' E ' 115' ' ' GLY . . . . . . . . . . . . . . . -150.11 146.67 16.06 Favored Glycine 0 CA--C 1.523 0.553 0 N-CA-C 111.114 -0.794 . . . . 0.0 111.114 179.007 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' E' E ' 116' ' ' LYS . . . . . . . . . . . . . 61.8 tttm -128.04 126.88 42.13 Favored 'General case' 0 C--N 1.33 -0.267 0 N-CA-C 109.734 -0.469 . . . . 0.0 109.734 177.087 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' E' E ' 117' ' ' PHE . . . . . . . . . . . . . 33.6 m-85 -125.22 117.28 23.5 Favored 'General case' 0 N--CA 1.463 0.203 0 CA-C-O 121.037 0.446 . . . . 0.0 110.455 -174.47 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' E' E ' 118' ' ' GLU . . . . . . . . . . . . . 84.0 tt0 -52.08 -50.76 60.93 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.367 -0.379 . . . . 0.0 111.537 -177.891 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' E' E ' 119' ' ' ASN . . . . . . . . . . . . . 23.9 m120 -94.53 31.17 1.82 Allowed 'General case' 0 C--N 1.33 -0.243 0 N-CA-C 112.2 0.444 . . . . 0.0 112.2 -174.735 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' E' E ' 120' ' ' LEU . . . . . . . . . . . . . 20.5 tp -56.4 124.51 18.34 Favored 'General case' 0 N--CA 1.462 0.136 0 C-N-CA 120.992 -0.283 . . . . 0.0 110.448 177.789 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' E' E ' 121' ' ' ASN . . . . . . . . . . . . . 33.6 m120 -113.58 -43.97 3.26 Favored 'General case' 0 C--N 1.331 -0.217 0 CA-C-N 116.588 -0.278 . . . . 0.0 111.137 -175.948 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' E' E ' 122' ' ' LYS . . . . . . . . . . . . . 39.6 ttpt -148.59 147.29 28.83 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-O 121.016 0.436 . . . . 0.0 111.419 -176.888 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' E' E ' 123' ' ' VAL . . . . . . . . . . . . . 46.2 t -132.41 135.71 57.41 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.281 0 CA-C-N 116.021 -0.536 . . . . 0.0 109.644 176.06 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' E' E ' 124' ' ' LEU . . . . . . . . . . . . . 37.8 mt -132.8 141.63 48.58 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-O 120.791 0.329 . . . . 0.0 110.973 -178.567 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' E' E ' 125' ' ' VAL . . . . . . . . . . . . . 10.6 p -139.26 141.54 35.55 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.23 0 CA-C-N 116.258 -0.428 . . . . 0.0 110.309 177.964 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' E' E ' 126' ' ' ARG . . . . . . . . . . . . . 35.0 ptt-85 -150.88 126.77 10.36 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.09 -0.505 . . . . 0.0 110.579 178.486 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' E' E ' 127' ' ' ASN . . . . . . . . . . . . . 39.2 m-20 49.17 -107.37 0.23 Allowed 'General case' 0 CA--C 1.546 0.807 0 CA-C-O 119.033 -0.508 . . . . 0.0 111.792 178.715 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' E' E ' 128' ' ' ASP . . . . . . . . . . . . . 11.2 p-10 -114.06 11.88 17.78 Favored 'General case' 0 N--CA 1.467 0.408 0 CA-C-N 119.627 1.103 . . . . 0.0 113.416 -175.33 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' E' E ' 129' ' ' LEU . . . . . . . . . . . . . 81.9 mt -120.04 140.74 50.53 Favored 'General case' 0 C--N 1.333 -0.143 0 CA-C-N 118.058 0.39 . . . . 0.0 110.274 178.978 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' E' E ' 130' ' ' VAL . . . . . . . . . . . . . 46.2 t -128.25 138.91 53.35 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.212 0 N-CA-C 109.741 -0.466 . . . . 0.0 109.741 -179.988 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' E' E ' 131' ' ' VAL . . . . . . . . . . . . . 41.6 t -134.53 138.03 50.34 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.321 0 CA-C-N 116.287 -0.415 . . . . 0.0 110.242 -179.725 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' E' E ' 132' ' ' ILE . . . . . . . . . . . . . 72.9 mt -119.55 132.61 68.85 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.306 0 N-CA-C 109.374 -0.602 . . . . 0.0 109.374 179.942 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' E' E ' 133' ' ' ILE . . . . . . . . . . . . . 39.7 mm -117.64 119.23 61.02 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.253 0 CA-C-N 116.307 -0.406 . . . . 0.0 110.883 -175.991 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' E' E ' 134' ' ' ASP . . . . . . . . . . . . . 8.1 p-10 -131.68 146.46 52.19 Favored 'General case' 0 C--N 1.331 -0.217 0 N-CA-C 109.536 -0.542 . . . . 0.0 109.536 174.504 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' E' E ' 135' ' ' GLU . . . . . . . . . . . . . 43.5 tp10 -49.88 -23.66 2.05 Favored 'General case' 0 C--N 1.328 -0.344 0 N-CA-C 112.941 0.719 . . . . 0.0 112.941 -172.061 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' E' E ' 136' ' ' GLN . . . . . . . . . . . . . 55.6 tp60 -100.97 -27.91 13.03 Favored 'General case' 0 C--O 1.233 0.237 0 N-CA-C 112.46 0.541 . . . . 0.0 112.46 -174.838 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' E' E ' 137' ' ' LYS . . . . . . . . . . . . . 86.6 mttt -142.39 151.35 41.76 Favored 'General case' 0 C--N 1.332 -0.193 0 CA-C-O 121.464 0.649 . . . . 0.0 112.188 -170.396 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' E' E ' 138' ' ' LEU . . . . . . . . . . . . . 14.3 tp -112.49 122.21 47.05 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 115.11 -0.95 . . . . 0.0 108.925 171.977 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' E' E ' 139' ' ' THR . . . . . . . . . . . . . 24.0 m -114.61 124.08 50.95 Favored 'General case' 0 C--N 1.331 -0.212 0 CA-C-O 120.82 0.343 . . . . 0.0 110.868 -177.92 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' E' E ' 140' ' ' LEU . . . . . . . . . . . . . 13.2 tp -111.48 118.48 35.88 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 115.5 -0.773 . . . . 0.0 108.926 178.73 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' E' E ' 141' ' ' ILE . . . . . . . . . . . . . 19.6 mt -119.77 114.31 43.8 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.193 0 N-CA-C 109.726 -0.472 . . . . 0.0 109.726 -176.009 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' E' E ' 142' ' ' ARG . . . . . . . . . . . . . 79.5 mtm180 -90.98 113.67 25.98 Favored 'General case' 0 C--N 1.326 -0.43 0 CA-C-N 115.882 -0.599 . . . . 0.0 110.621 178.039 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' E' E ' 143' ' ' THR . . . . . . . . . . . . . 2.4 p . . . . . 0 C--O 1.221 -0.447 0 CA-C-O 117.951 -1.023 . . . . 0.0 110.559 -179.229 . . . . . . . . 0 0 . 1 . 010 nuclear orig core ' F' F ' 1' ' ' MET . . . . . . . . . . . . . 25.1 ptt? . . . . . 0 C--O 1.233 0.199 0 CA-C-O 120.835 0.35 . . . . 0.0 110.772 . . . . . . . . . 0 0 . 1 . 010 nuclear orig core ' F' F ' 2' ' ' SER . . . . . . . . . . . . . 6.3 p -116.12 132.9 56.53 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 116.255 -0.429 . . . . 0.0 110.142 178.42 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' F' F ' 3' ' ' GLU . . . . . . . . . . . . . 95.7 mt-10 -140.8 138.04 33.78 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.095 -0.502 . . . . 0.0 110.829 -178.351 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' F' F ' 4' ' ' LEU . . . . . . . . . . . . . 23.4 tp -123.92 125.31 44.4 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 115.994 -0.548 . . . . 0.0 109.971 175.956 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' F' F ' 5' ' ' LYS . . . . . . . . . . . . . 62.2 mttp -103.78 119.14 38.31 Favored 'General case' 0 C--O 1.234 0.281 0 CA-C-N 116.32 -0.4 . . . . 0.0 110.457 178.395 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' F' F ' 6' ' ' LEU . . . . . . . . . . . . . 58.1 mt -115.08 141.6 47.79 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 115.398 -0.819 . . . . 0.0 110.223 -178.488 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' F' F ' 7' ' ' LYS . . . . . . . . . . . . . 35.3 ttpt -121.45 136.24 25.73 Favored Pre-proline 0 CA--C 1.534 0.359 0 CA-C-O 118.784 -0.627 . . . . 0.0 109.896 176.627 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' F' F ' 8' ' ' PRO . . . . . . . . . . . . . 95.8 Cg_endo -91.92 133.23 1.32 Allowed 'Trans proline' 0 N--CA 1.489 1.25 0 C-N-CA 121.698 1.599 . . . . 0.0 111.901 178.048 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' F' F ' 9' ' ' LEU . . . . . . . . . . . . . 57.6 mt -73.31 -47.2 7.74 Favored Pre-proline 0 CA--C 1.534 0.336 0 CA-C-O 118.616 -0.707 . . . . 0.0 112.13 -179.117 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' F' F ' 10' ' ' PRO . . . . . . . . . . . . . 97.2 Cg_endo -81.54 147.6 15.78 Favored 'Trans proline' 0 N--CA 1.496 1.622 0 C-N-CA 121.226 1.284 . . . . 0.0 111.504 175.817 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' F' F ' 11' ' ' LYS . . . . . . . . . . . . . 32.3 ttmt -86.51 90.7 8.31 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-O 120.941 0.401 . . . . 0.0 110.498 179.469 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' F' F ' 12' ' ' VAL . . . . . . . . . . . . . 12.6 p -136.11 147.57 28.04 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.252 0 CA-C-N 116.064 -0.517 . . . . 0.0 110.29 179.562 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' F' F ' 13' ' ' GLU . . . . . . . . . . . . . 84.9 tt0 -85.55 130.08 34.66 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.391 -0.368 . . . . 0.0 110.464 179.685 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' F' F ' 14' ' ' LEU . . . . . . . . . . . . . 22.9 mt -97.72 150.7 37.05 Favored Pre-proline 0 C--N 1.33 -0.252 0 CA-C-N 116.207 -0.451 . . . . 0.0 110.354 -179.506 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' F' F ' 15' ' ' PRO . . . . . . . . . . . . . 29.9 Cg_exo -60.36 158.56 30.71 Favored 'Trans proline' 0 N--CA 1.496 1.653 0 C-N-CA 121.199 1.266 . . . . 0.0 111.9 178.096 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' F' F ' 16' ' ' PRO . . . . . . . . . . . . . 39.0 Cg_exo -58.54 -44.37 37.77 Favored 'Trans proline' 0 N--CA 1.497 1.713 0 C-N-CA 121.445 1.43 . . . . 0.0 112.662 -178.373 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' F' F ' 17' ' ' ASP . . . . . . . . . . . . . 12.3 p-10 -83.29 12.89 4.74 Favored 'General case' 0 CA--C 1.536 0.426 0 N-CA-C 112.973 0.731 . . . . 0.0 112.973 -178.718 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' F' F ' 18' ' ' PHE . . . . . . . . . . . . . 51.4 t80 -56.98 -41.18 77.93 Favored 'General case' 0 C--O 1.227 -0.108 0 O-C-N 122.016 -0.427 . . . . 0.0 110.477 -178.537 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' F' F ' 19' ' ' VAL . . . . . . . . . . . . . 47.0 t -55.78 -44.95 79.17 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.244 0 CA-C-N 116.57 -0.287 . . . . 0.0 110.649 -178.726 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' F' F ' 20' ' ' ASP . . . . . . . . . . . . . 83.1 m-20 -59.95 -41.91 92.92 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-O 120.847 0.356 . . . . 0.0 110.723 -178.851 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' F' F ' 21' ' ' VAL . . . . . . . . . . . . . 57.6 t -63.86 -46.91 92.94 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.303 0 CA-C-N 116.377 -0.374 . . . . 0.0 110.727 -177.809 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' F' F ' 22' ' ' ILE . . . . . . . . . . . . . 51.6 mm -55.59 -46.37 79.15 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.206 0 CA-C-O 120.694 0.283 . . . . 0.0 110.566 178.628 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' F' F ' 23' ' ' ARG . . . . . . . . . . . . . 41.6 ttp180 -54.39 -51.62 64.27 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.71 -0.223 . . . . 0.0 111.489 -179.502 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' F' F ' 24' ' ' ILE . . . . . . . . . . . . . 75.9 mt -58.65 -44.36 89.52 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.323 0 CA-C-N 116.652 -0.249 . . . . 0.0 111.433 -175.861 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' F' F ' 25' ' ' LYS . . . . . . . . . . . . . 95.3 mttt -68.14 -42.7 79.74 Favored 'General case' 0 C--N 1.328 -0.337 0 N-CA-C 112.331 0.493 . . . . 0.0 112.331 -176.928 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' F' F ' 26' ' ' LEU . . . . . . . . . . . . . 80.0 mt -78.81 -38.19 38.86 Favored 'General case' 0 C--N 1.329 -0.326 0 N-CA-C 112.984 0.735 . . . . 0.0 112.984 -170.636 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' F' F ' 27' ' ' GLN . . . . . . . . . . . . . 9.7 pt20 -46.97 139.42 5.62 Favored 'General case' 0 N--CA 1.47 0.547 0 N-CA-C 112.633 0.605 . . . . 0.0 112.633 -176.431 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' F' F ' 28' ' ' GLY . . . . . . . . . . . . . . . 101.05 -25.36 28.62 Favored Glycine 0 CA--C 1.533 1.202 0 CA-C-N 115.437 -0.801 . . . . 0.0 112.197 -176.058 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' F' F ' 29' ' ' LYS . . . . . . . . . . . . . 95.1 mttt -97.98 155.2 17.21 Favored 'General case' 0 C--O 1.233 0.192 0 CA-C-N 117.427 0.614 . . . . 0.0 111.01 178.5 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' F' F ' 30' ' ' THR . . . . . . . . . . . . . 21.7 m -107.13 135.93 47.83 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 115.882 -0.599 . . . . 0.0 109.913 175.41 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' F' F ' 31' ' ' VAL . . . . . . . . . . . . . 34.5 m -132.12 156.73 42.76 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.207 0 CA-C-O 120.876 0.369 . . . . 0.0 111.159 -177.107 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' F' F ' 32' ' ' ARG . . . . . . . . . . . . . 82.8 mtt180 -132.18 152.53 51.24 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-O 121.333 0.587 . . . . 0.0 110.673 179.214 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' F' F ' 33' ' ' THR . . . . . . . . . . . . . 18.3 m -52.87 139.95 25.72 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.096 -0.502 . . . . 0.0 111.311 -178.758 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' F' F ' 34' ' ' GLY . . . . . . . . . . . . . . . 100.18 -17.3 57.21 Favored Glycine 0 CA--C 1.533 1.172 0 CA-C-O 119.619 -0.545 . . . . 0.0 113.242 179.274 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' F' F ' 35' ' ' ASP . . . . . . . . . . . . . 74.3 m-20 -67.15 150.03 49.69 Favored 'General case' 0 N--CA 1.46 0.07 0 CA-C-N 118.086 0.943 . . . . 0.0 110.991 178.774 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' F' F ' 36' ' ' VAL . . . . . . . . . . . . . 44.3 t -122.47 130.3 74.62 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.205 0 CA-C-N 116.055 -0.52 . . . . 0.0 109.909 178.44 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' F' F ' 37' ' ' ILE . . . . . . . . . . . . . 69.6 mt -122.34 140.87 44.88 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.218 0 CA-C-N 116.105 -0.498 . . . . 0.0 110.017 -178.527 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' F' F ' 38' ' ' GLY . . . . . . . . . . . . . . . -115.82 128.85 8.21 Favored Glycine 0 CA--C 1.526 0.744 0 N-CA-C 111.179 -0.768 . . . . 0.0 111.179 179.736 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' F' F ' 39' ' ' ILE . . . . . . . . . . . . . 76.3 mt -127.63 140.23 49.7 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.228 0 CA-C-O 120.746 0.308 . . . . 0.0 110.218 179.247 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' F' F ' 40' ' ' SER . . . . . . . . . . . . . 52.8 p -93.32 115.85 28.42 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 116.298 -0.41 . . . . 0.0 111.19 176.229 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' F' F ' 41' ' ' ILE . . . . . . . . . . . . . 44.8 mm -122.58 118.99 56.91 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.214 0 N-CA-C 110.19 -0.3 . . . . 0.0 110.19 178.72 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' F' F ' 42' ' ' LEU . . . . . . . . . . . . . 69.2 mt 55.89 35.64 25.82 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.191 -0.458 . . . . 0.0 111.63 177.412 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' F' F ' 43' ' ' GLY . . . . . . . . . . . . . . . 73.22 23.75 76.88 Favored Glycine 0 CA--C 1.532 1.144 0 C-N-CA 121.151 -0.547 . . . . 0.0 112.795 177.818 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' F' F ' 44' ' ' LYS . . . . . . . . . . . . . 34.7 mmtp -131.5 133.81 45.49 Favored 'General case' 0 C--N 1.331 -0.206 0 CA-C-N 117.264 0.532 . . . . 0.0 109.572 177.538 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' F' F ' 45' ' ' GLU . . . . . . . . . . . . . 85.9 tt0 -82.7 120.21 25.3 Favored 'General case' 0 C--N 1.329 -0.322 0 C-N-CA 120.745 -0.382 . . . . 0.0 110.89 -179.331 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' F' F ' 46' ' ' VAL . . . . . . . . . . . . . 11.2 p -116.83 124.28 72.71 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.154 0 N-CA-C 109.647 -0.501 . . . . 0.0 109.647 175.724 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' F' F ' 47' ' ' LYS . . . . . . . . . . . . . 55.3 mttp -98.58 126.5 44.18 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-N 116.101 -0.5 . . . . 0.0 110.955 179.208 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' F' F ' 48' ' ' PHE . . . . . . . . . . . . . 29.1 m-85 -109.3 131.82 54.71 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.168 -0.469 . . . . 0.0 109.971 177.056 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' F' F ' 49' ' ' LYS . . . . . . . . . . . . . 37.5 tttp -107.66 132.31 53.46 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-N 116.24 -0.436 . . . . 0.0 110.091 177.751 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' F' F ' 50' ' ' VAL . . . . . . . . . . . . . 42.4 t -75.53 107.05 5.86 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.345 0 N-CA-C 109.453 -0.573 . . . . 0.0 109.453 178.151 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' F' F ' 51' ' ' VAL . . . . . . . . . . . . . 47.4 t -74.5 -48.75 34.09 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.309 0 N-CA-C 109.759 -0.46 . . . . 0.0 109.759 -175.661 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' F' F ' 52' ' ' GLN . . . . . . . . . . . . . 49.4 tt0 -160.11 137.15 9.3 Favored 'General case' 0 C--N 1.33 -0.28 0 C-N-CA 120.316 -0.553 . . . . 0.0 111.568 -179.262 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' F' F ' 53' ' ' ALA . . . . . . . . . . . . . . . -113.46 133.06 55.41 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 115.708 -0.678 . . . . 0.0 109.81 175.94 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' F' F ' 54' ' ' TYR . . . . . . . . . . . . . 65.3 t80 -129.18 112.63 18.35 Favored Pre-proline 0 CA--C 1.535 0.386 0 CA-C-O 118.292 -0.861 . . . . 0.0 110.294 178.219 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' F' F ' 55' ' ' PRO . . . . . . . . . . . . . 73.2 Cg_endo -77.18 168.08 77.89 Favored 'Cis proline' 0 N--CA 1.499 1.822 0 CA-C-N 121.935 1.727 . . . . 0.0 112.238 -5.903 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' F' F ' 56' ' ' SER . . . . . . . . . . . . . 13.9 m -116.66 130.51 24.49 Favored Pre-proline 0 CA--C 1.538 0.484 0 CA-C-O 118.536 -0.745 . . . . 0.0 109.413 174.906 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' F' F ' 57' ' ' PRO . . . . . . . . . . . . . 39.3 Cg_endo -67.46 146.74 76.93 Favored 'Cis proline' 0 N--CA 1.498 1.76 0 CA-C-N 121.898 1.713 . . . . 0.0 111.434 -0.786 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' F' F ' 58' ' ' LEU . . . . . . . . . . . . . 20.6 tp -106.12 135.82 46.91 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.409 -0.359 . . . . 0.0 110.492 -178.634 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' F' F ' 59' ' ' ARG . . . . . . . . . . . . . 39.3 ttm180 -105.76 126.55 52.29 Favored 'General case' 0 C--N 1.326 -0.438 0 N-CA-C 109.211 -0.663 . . . . 0.0 109.211 175.889 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' F' F ' 60' ' ' VAL . . . . . . . . . . . . . 46.6 t -83.58 119.6 33.15 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.27 0 C-N-CA 120.665 -0.414 . . . . 0.0 110.514 -175.624 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' F' F ' 61' ' ' GLU . . . . . . . . . . . . . 91.6 mt-10 -130.98 165.72 22.55 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 115.926 -0.579 . . . . 0.0 109.775 177.507 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' F' F ' 62' ' ' ASP . . . . . . . . . . . . . 59.7 m-20 -53.34 -32.46 49.25 Favored 'General case' 0 C--N 1.329 -0.303 0 N-CA-C 111.858 0.318 . . . . 0.0 111.858 -178.563 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' F' F ' 63' ' ' ARG . . . . . . . . . . . . . 92.7 mtt180 -74.72 -22.06 59.03 Favored 'General case' 0 C--N 1.33 -0.25 0 N-CA-C 113.02 0.748 . . . . 0.0 113.02 -176.796 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' F' F ' 64' ' ' THR . . . . . . . . . . . . . 39.5 m -65.89 136.52 56.24 Favored 'General case' 0 C--N 1.331 -0.197 0 CA-C-O 120.894 0.378 . . . . 0.0 110.95 -174.547 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' F' F ' 65' ' ' LYS . . . . . . . . . . . . . 96.8 mttt -89.75 133.01 34.92 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 115.912 -0.586 . . . . 0.0 110.153 177.512 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' F' F ' 66' ' ' ILE . . . . . . . . . . . . . 4.7 mp -113.29 125.54 70.57 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.284 0 N-CA-C 109.596 -0.52 . . . . 0.0 109.596 178.65 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' F' F ' 67' ' ' THR . . . . . . . . . . . . . 25.6 m -120.59 141.89 49.89 Favored 'General case' 0 C--N 1.331 -0.204 0 CA-C-N 116.111 -0.495 . . . . 0.0 110.997 -176.235 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' F' F ' 68' ' ' LEU . . . . . . . . . . . . . 25.4 tp . . . . . 0 C--N 1.329 -0.315 0 CA-C-N 115.823 -0.626 . . . . 0.0 110.344 179.021 . . . . . . . . 0 0 . 1 . 010 nuclear orig core ' F' F ' 73' ' ' VAL . . . . . . . . . . . . . 3.1 m . . . . . 0 C--O 1.232 0.154 0 CA-C-O 121.227 0.537 . . . . 0.0 111.25 . . . . . . . . . 0 0 . 1 . 010 nuclear orig core ' F' F ' 74' ' ' ASP . . . . . . . . . . . . . 13.2 t0 -96.42 115.81 28.03 Favored 'General case' 0 C--N 1.325 -0.469 0 N-CA-C 108.271 -1.011 . . . . 0.0 108.271 171.175 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' F' F ' 75' ' ' VAL . . . . . . . . . . . . . 42.9 t -107.39 124.77 63.53 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.268 0 CA-C-O 121.156 0.503 . . . . 0.0 111.064 -171.235 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' F' F ' 76' ' ' LEU . . . . . . . . . . . . . 24.3 mt -125.24 133.59 52.65 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 115.399 -0.819 . . . . 0.0 109.442 176.452 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' F' F ' 77' ' ' GLU . . . . . . . . . . . . . 98.3 mt-10 -129.35 136.41 49.96 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-O 121.046 0.451 . . . . 0.0 111.126 -178.147 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' F' F ' 78' ' ' ALA . . . . . . . . . . . . . . . -128.2 138.14 52.34 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 115.748 -0.66 . . . . 0.0 109.868 177.124 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' F' F ' 79' ' ' LYS . . . . . . . . . . . . . 19.9 pttp -76.07 121.9 23.47 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-O 121.193 0.52 . . . . 0.0 110.599 -179.025 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' F' F ' 80' ' ' ILE . . . . . . . . . . . . . 39.1 mm -139.22 116.58 11.18 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.282 0 N-CA-C 109.25 -0.648 . . . . 0.0 109.25 -178.242 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' F' F ' 81' ' ' LYS . . . . . . . . . . . . . 83.7 tttt -112.56 126.39 55.29 Favored 'General case' 0 C--N 1.331 -0.215 0 CA-C-O 120.958 0.408 . . . . 0.0 111.206 -176.139 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' F' F ' 82' ' ' GLY . . . . . . . . . . . . . . . 89.0 42.24 5.69 Favored Glycine 0 CA--C 1.525 0.714 0 C-N-CA 120.86 -0.686 . . . . 0.0 111.569 174.652 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' F' F ' 83' ' ' ILE . . . . . . . . . . . . . 72.8 mt -69.15 141.81 16.89 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.342 0 CA-C-O 120.975 0.417 . . . . 0.0 110.001 178.446 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' F' F ' 84' ' ' LYS . . . . . . . . . . . . . 57.0 tttp -103.59 -52.57 2.96 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 115.884 -0.598 . . . . 0.0 110.356 -178.663 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' F' F ' 85' ' ' ASP . . . . . . . . . . . . . 11.1 t70 -153.55 155.56 36.4 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 115.988 -0.551 . . . . 0.0 110.587 -178.904 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' F' F ' 86' ' ' VAL . . . . . . . . . . . . . 45.1 t -130.72 133.39 63.41 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.236 0 CA-C-O 120.976 0.417 . . . . 0.0 110.682 -177.765 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' F' F ' 87' ' ' ILE . . . . . . . . . . . . . 46.1 mm -124.76 126.61 71.77 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.221 0 CA-C-N 115.883 -0.599 . . . . 0.0 109.748 176.432 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' F' F ' 88' ' ' LEU . . . . . . . . . . . . . 36.4 mt -116.22 136.54 52.92 Favored 'General case' 0 N--CA 1.464 0.239 0 CA-C-O 121.129 0.49 . . . . 0.0 111.504 -177.02 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' F' F ' 89' ' ' ASP . . . . . . . . . . . . . 10.6 t70 -130.01 159.33 37.04 Favored 'General case' 0 C--N 1.331 -0.221 0 CA-C-N 115.566 -0.743 . . . . 0.0 109.605 175.439 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' F' F ' 90' ' ' GLU . . . . . . . . . . . . . 95.4 mt-10 -46.7 -39.34 11.32 Favored 'General case' 0 CA--C 1.531 0.237 0 N-CA-C 113.118 0.784 . . . . 0.0 113.118 -171.68 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' F' F ' 91' ' ' ASN . . . . . . . . . . . . . 23.9 p30 -131.73 23.55 4.66 Favored 'General case' 0 N--CA 1.466 0.35 0 N-CA-C 112.725 0.639 . . . . 0.0 112.725 -177.383 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' F' F ' 92' ' ' LEU . . . . . . . . . . . . . 16.3 mt -148.7 141.13 24.24 Favored 'General case' 0 C--N 1.33 -0.243 0 N-CA-C 110.137 -0.32 . . . . 0.0 110.137 -176.691 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' F' F ' 93' ' ' ILE . . . . . . . . . . . . . 69.6 mt -124.93 117.39 50.02 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.362 0 N-CA-C 109.604 -0.517 . . . . 0.0 109.604 179.029 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' F' F ' 94' ' ' VAL . . . . . . . . . . . . . 46.7 t -117.13 127.07 74.78 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.242 0 CA-C-O 120.959 0.409 . . . . 0.0 110.106 179.844 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' F' F ' 95' ' ' VAL . . . . . . . . . . . . . 47.7 t -121.59 132.51 70.58 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.322 0 CA-C-N 115.844 -0.616 . . . . 0.0 109.626 178.799 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' F' F ' 96' ' ' ILE . . . . . . . . . . . . . 63.0 mt -113.71 129.09 70.18 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.269 0 N-CA-C 109.351 -0.611 . . . . 0.0 109.351 179.476 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' F' F ' 97' ' ' THR . . . . . . . . . . . . . 72.8 p -101.21 158.34 16.11 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-O 121.136 0.493 . . . . 0.0 111.121 -178.299 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' F' F ' 98' ' ' GLU . . . . . . . . . . . . . 96.9 mt-10 -54.0 -25.79 22.8 Favored 'General case' 0 CA--C 1.532 0.274 0 N-CA-C 112.316 0.487 . . . . 0.0 112.316 -179.037 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' F' F ' 99' ' ' GLU . . . . . . . . . . . . . 71.4 mm-40 -80.7 16.68 1.32 Allowed 'General case' 0 CA--C 1.535 0.385 0 N-CA-C 113.031 0.752 . . . . 0.0 113.031 -177.298 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' F' F ' 100' ' ' ASN . . . . . . . . . . . . . 3.8 m-20 62.11 37.57 14.48 Favored 'General case' 0 C--N 1.332 -0.156 0 CA-C-O 121.076 0.465 . . . . 0.0 111.088 177.847 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' F' F ' 101' ' ' GLU . . . . . . . . . . . . . 84.0 tt0 -114.79 143.12 45.59 Favored 'General case' 0 C--N 1.333 -0.111 0 N-CA-C 109.704 -0.48 . . . . 0.0 109.704 175.922 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' F' F ' 102' ' ' VAL . . . . . . . . . . . . . 43.0 t -115.22 125.02 72.37 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 CA-C-N 116.146 -0.479 . . . . 0.0 110.055 -178.184 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' F' F ' 103' ' ' LEU . . . . . . . . . . . . . 20.2 mt -114.1 128.64 56.47 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 115.695 -0.684 . . . . 0.0 109.973 176.251 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' F' F ' 104' ' ' ILE . . . . . . . . . . . . . 71.2 mt -117.49 118.97 60.31 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.253 0 N-CA-C 110.371 -0.233 . . . . 0.0 110.371 179.999 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' F' F ' 105' ' ' PHE . . . . . . . . . . . . . 66.0 m-85 -117.54 166.3 12.53 Favored 'General case' 0 C--N 1.333 -0.152 0 CA-C-N 115.455 -0.793 . . . . 0.0 109.898 178.401 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' F' F ' 106' ' ' ASN . . . . . . . . . . . . . 44.4 p-10 -100.4 -169.98 1.8 Allowed 'General case' 0 C--N 1.33 -0.275 0 N-CA-C 109.91 -0.404 . . . . 0.0 109.91 173.988 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' F' F ' 107' ' ' GLN . . . . . . . . . . . . . 30.1 tt0 -59.38 -29.99 68.1 Favored 'General case' 0 C--N 1.329 -0.298 0 N-CA-C 111.855 0.317 . . . . 0.0 111.855 178.221 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' F' F ' 108' ' ' ASN . . . . . . . . . . . . . 14.1 t-20 -81.98 5.17 20.05 Favored 'General case' 0 CA--C 1.537 0.448 0 N-CA-C 113.276 0.843 . . . . 0.0 113.276 -177.796 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' F' F ' 109' ' ' LEU . . . . . . . . . . . . . 9.9 tp 62.61 36.28 13.77 Favored 'General case' 0 CA--C 1.53 0.2 0 O-C-N 122.073 -0.392 . . . . 0.0 111.476 178.119 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' F' F ' 110' ' ' GLU . . . . . . . . . . . . . 96.0 mt-10 -108.1 156.24 19.5 Favored 'General case' 0 C--N 1.332 -0.193 0 N-CA-C 109.894 -0.41 . . . . 0.0 109.894 176.304 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' F' F ' 111' ' ' GLU . . . . . . . . . . . . . 46.2 tp10 -82.91 123.05 29.03 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-O 121.02 0.438 . . . . 0.0 110.852 -177.479 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' F' F ' 112' ' ' LEU . . . . . . . . . . . . . 12.5 mt -108.3 -46.01 3.8 Favored 'General case' 0 C--N 1.332 -0.184 0 CA-C-N 115.93 -0.577 . . . . 0.0 110.136 177.577 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' F' F ' 113' ' ' TYR . . . . . . . . . . . . . 62.3 t80 -140.67 136.54 32.75 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.443 -0.344 . . . . 0.0 110.981 179.863 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' F' F ' 114' ' ' ARG . . . . . . . . . . . . . 59.6 ttp180 -137.97 125.25 21.74 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.28 -0.418 . . . . 0.0 110.169 177.536 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' F' F ' 115' ' ' GLY . . . . . . . . . . . . . . . -150.2 161.87 29.05 Favored Glycine 0 CA--C 1.524 0.613 0 N-CA-C 111.167 -0.773 . . . . 0.0 111.167 179.94 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' F' F ' 116' ' ' LYS . . . . . . . . . . . . . 36.3 ttpt -128.27 134.55 48.97 Favored 'General case' 0 C--N 1.33 -0.273 0 N-CA-C 109.855 -0.424 . . . . 0.0 109.855 178.09 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' F' F ' 117' ' ' PHE . . . . . . . . . . . . . 39.9 m-85 -133.33 113.84 13.04 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-O 120.968 0.414 . . . . 0.0 110.404 -176.412 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' F' F ' 118' ' ' GLU . . . . . . . . . . . . . 44.0 mp0 -57.55 -44.1 84.93 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.088 -0.505 . . . . 0.0 110.71 -175.011 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' F' F ' 119' ' ' ASN . . . . . . . . . . . . . 14.8 m120 -99.12 30.99 3.2 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.201 -0.454 . . . . 0.0 112.192 -173.722 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' F' F ' 120' ' ' LEU . . . . . . . . . . . . . 14.2 tp -55.49 121.6 9.38 Favored 'General case' 0 C--O 1.232 0.16 0 O-C-N 122.235 -0.29 . . . . 0.0 110.671 177.78 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' F' F ' 121' ' ' ASN . . . . . . . . . . . . . 38.6 m-80 -113.9 -44.14 3.2 Favored 'General case' 0 C--N 1.332 -0.183 0 CA-C-N 116.544 -0.298 . . . . 0.0 111.301 -177.756 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' F' F ' 122' ' ' LYS . . . . . . . . . . . . . 33.6 ttpt -145.27 143.5 30.26 Favored 'General case' 0 C--N 1.331 -0.21 0 C-N-CA 120.66 -0.416 . . . . 0.0 111.639 -176.514 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' F' F ' 123' ' ' VAL . . . . . . . . . . . . . 42.1 t -124.86 131.65 72.34 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.237 0 N-CA-C 109.385 -0.598 . . . . 0.0 109.385 175.15 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' F' F ' 124' ' ' LEU . . . . . . . . . . . . . 9.6 tt -133.9 130.75 38.22 Favored 'General case' 0 C--N 1.332 -0.194 0 CA-C-O 121.073 0.464 . . . . 0.0 111.105 -178.402 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' F' F ' 125' ' ' VAL . . . . . . . . . . . . . 43.3 t -121.16 133.54 67.44 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.233 0 CA-C-N 115.783 -0.644 . . . . 0.0 109.543 176.867 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' F' F ' 126' ' ' ARG . . . . . . . . . . . . . 36.6 ptt-85 -142.83 125.03 15.4 Favored 'General case' 0 C--N 1.331 -0.226 0 CA-C-O 121.021 0.438 . . . . 0.0 111.087 179.759 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' F' F ' 127' ' ' ASN . . . . . . . . . . . . . 58.8 m-80 49.21 -105.06 0.15 Allowed 'General case' 0 CA--C 1.544 0.738 0 CA-C-N 116.126 -0.488 . . . . 0.0 111.748 177.42 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' F' F ' 128' ' ' ASP . . . . . . . . . . . . . 8.8 p-10 -114.15 1.79 14.67 Favored 'General case' 0 CA--C 1.534 0.359 0 CA-C-N 119.524 1.057 . . . . 0.0 113.57 -176.366 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' F' F ' 129' ' ' LEU . . . . . . . . . . . . . 82.9 mt -113.7 145.7 40.94 Favored 'General case' 0 C--N 1.333 -0.131 0 O-C-N 121.92 -0.488 . . . . 0.0 110.5 -178.805 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' F' F ' 130' ' ' VAL . . . . . . . . . . . . . 45.7 t -125.41 135.78 62.91 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.22 0 CA-C-N 116.123 -0.49 . . . . 0.0 109.769 179.955 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' F' F ' 131' ' ' VAL . . . . . . . . . . . . . 27.5 m -136.03 143.1 37.01 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.251 0 CA-C-O 121.356 0.598 . . . . 0.0 111.126 178.774 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' F' F ' 132' ' ' ILE . . . . . . . . . . . . . 70.7 mt -123.6 133.95 67.74 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.288 0 CA-C-N 115.219 -0.9 . . . . 0.0 109.502 -179.336 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' F' F ' 133' ' ' ILE . . . . . . . . . . . . . 39.6 mm -115.57 122.01 68.48 Favored 'Isoleucine or valine' 0 C--O 1.233 0.225 0 CA-C-O 120.735 0.302 . . . . 0.0 110.89 -176.165 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' F' F ' 134' ' ' ASP . . . . . . . . . . . . . 6.7 p-10 -131.98 146.39 52.06 Favored 'General case' 0 C--N 1.331 -0.216 0 N-CA-C 109.457 -0.571 . . . . 0.0 109.457 174.098 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' F' F ' 135' ' ' GLU . . . . . . . . . . . . . 42.7 tp10 -49.82 -23.9 2.12 Favored 'General case' 0 C--N 1.328 -0.348 0 N-CA-C 112.883 0.697 . . . . 0.0 112.883 -171.406 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' F' F ' 136' ' ' GLN . . . . . . . . . . . . . 94.3 mt-30 -92.73 -37.21 12.49 Favored 'General case' 0 C--N 1.332 -0.185 0 N-CA-C 112.115 0.413 . . . . 0.0 112.115 -176.284 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' F' F ' 137' ' ' LYS . . . . . . . . . . . . . 45.9 mtmt -148.48 159.17 44.31 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-O 121.512 0.672 . . . . 0.0 111.819 -168.968 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' F' F ' 138' ' ' LEU . . . . . . . . . . . . . 5.0 tt -115.43 124.74 51.93 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 115.173 -0.921 . . . . 0.0 109.365 175.737 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' F' F ' 139' ' ' THR . . . . . . . . . . . . . 27.5 m -108.27 129.52 55.21 Favored 'General case' 0 C--N 1.331 -0.22 0 CA-C-N 116.437 -0.347 . . . . 0.0 110.878 -177.523 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' F' F ' 140' ' ' LEU . . . . . . . . . . . . . 5.9 tt -117.31 122.56 44.25 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 115.607 -0.724 . . . . 0.0 109.109 -178.427 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' F' F ' 141' ' ' ILE . . . . . . . . . . . . . 19.3 mt -120.06 116.97 52.02 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.345 0 N-CA-C 109.815 -0.439 . . . . 0.0 109.815 -175.969 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' F' F ' 142' ' ' ARG . . . . . . . . . . . . . 56.4 ttp180 -104.67 129.04 52.9 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 115.445 -0.798 . . . . 0.0 110.638 -178.829 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' F' F ' 143' ' ' THR . . . . . . . . . . . . . 55.8 p . . . . . 0 C--O 1.221 -0.427 0 CA-C-O 117.962 -1.018 . . . . 0.0 110.467 178.603 . . . . . . . . 0 0 . 1 . 011 nuclear orig core ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 2.8 p . . . . . 0 C--O 1.232 0.14 0 CA-C-O 120.867 0.365 . . . . 0.0 110.609 . . . . . . . . . 0 0 . 1 . 011 nuclear orig core ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 84.9 tt0 -141.74 138.14 32.15 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.097 -0.501 . . . . 0.0 110.856 179.501 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 4' ' ' LEU . . . . . . . . . . . . . 12.7 tp -123.27 133.19 54.2 Favored 'General case' 0 C--N 1.332 -0.155 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.166 177.157 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 5' ' ' LYS . . . . . . . . . . . . . 95.6 mttt -108.48 120.62 42.94 Favored 'General case' 0 C--O 1.234 0.271 0 CA-C-N 116.421 -0.354 . . . . 0.0 110.417 179.737 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 56.2 mt -115.89 148.23 40.22 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 115.457 -0.792 . . . . 0.0 110.715 -177.755 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 31.9 ttpt -138.57 140.59 28.29 Favored Pre-proline 0 CA--C 1.534 0.357 0 CA-C-O 119.164 -0.446 . . . . 0.0 110.075 175.421 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 8' ' ' PRO . . . . . . . . . . . . . 85.5 Cg_endo -92.02 141.96 2.52 Favored 'Trans proline' 0 N--CA 1.491 1.332 0 C-N-CA 121.734 1.622 . . . . 0.0 111.802 177.794 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 51.2 mt -77.4 -48.19 2.42 Favored Pre-proline 0 CA--C 1.534 0.338 0 CA-C-O 118.649 -0.691 . . . . 0.0 112.435 -179.459 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 90.1 Cg_endo -79.82 156.66 24.1 Favored 'Trans proline' 0 N--CA 1.496 1.636 0 C-N-CA 121.15 1.233 . . . . 0.0 111.812 177.292 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 61.6 tttm -87.97 95.66 10.21 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.378 -0.374 . . . . 0.0 110.281 178.292 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 12.4 p -140.14 144.57 27.68 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.263 0 CA-C-N 116.145 -0.479 . . . . 0.0 110.532 -179.43 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 95.6 mt-10 -82.18 127.13 32.85 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.234 -0.439 . . . . 0.0 110.07 177.392 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 14' ' ' LEU . . . . . . . . . . . . . 23.9 mt -97.94 139.42 21.28 Favored Pre-proline 0 CA--C 1.533 0.318 0 CA-C-O 118.796 -0.621 . . . . 0.0 109.767 179.871 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 15' ' ' PRO . . . . . . . . . . . . . 26.6 Cg_exo -60.99 160.57 25.27 Favored 'Trans proline' 0 N--CA 1.498 1.758 0 C-N-CA 121.161 1.241 . . . . 0.0 111.713 178.348 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 16' ' ' PRO . . . . . . . . . . . . . 30.7 Cg_exo -59.66 -32.71 96.29 Favored 'Trans proline' 0 N--CA 1.499 1.794 0 C-N-CA 121.396 1.397 . . . . 0.0 112.863 -177.618 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 17' ' ' ASP . . . . . . . . . . . . . 9.6 p-10 -91.56 6.1 47.0 Favored 'General case' 0 CA--C 1.538 0.498 0 N-CA-C 113.254 0.835 . . . . 0.0 113.254 -177.275 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 18' ' ' PHE . . . . . . . . . . . . . 47.1 t80 -58.54 -46.08 87.55 Favored 'General case' 0 C--N 1.333 -0.122 0 CA-C-O 120.985 0.421 . . . . 0.0 109.975 -178.356 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 19' ' ' VAL . . . . . . . . . . . . . 48.5 t -57.37 -40.9 76.95 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.328 0 CA-C-N 116.074 -0.512 . . . . 0.0 110.41 -178.784 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 9.2 t70 -60.07 -44.11 94.98 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-O 120.743 0.306 . . . . 0.0 111.099 -177.613 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 49.0 t -64.66 -46.71 91.53 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.248 0 C-N-CA 120.694 -0.402 . . . . 0.0 110.512 -177.893 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 22' ' ' ILE . . . . . . . . . . . . . 50.7 mm -56.19 -45.19 80.85 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.246 0 C-N-CA 120.915 -0.314 . . . . 0.0 110.626 178.912 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 23' ' ' ARG . . . . . . . . . . . . . 55.7 ttp180 -54.76 -49.82 69.92 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-O 120.658 0.266 . . . . 0.0 111.296 -178.626 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 24' ' ' ILE . . . . . . . . . . . . . 75.9 mt -59.72 -42.22 87.92 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.249 0 CA-C-N 116.574 -0.285 . . . . 0.0 111.178 -177.522 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 99.4 mttt -67.6 -38.16 83.6 Favored 'General case' 0 C--N 1.328 -0.362 0 N-CA-C 112.604 0.594 . . . . 0.0 112.604 -178.686 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 83.1 mt -78.13 -41.27 35.55 Favored 'General case' 0 C--N 1.33 -0.261 0 N-CA-C 113.144 0.794 . . . . 0.0 113.144 -172.168 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 27' ' ' GLN . . . . . . . . . . . . . 10.5 pt20 -46.98 138.06 6.85 Favored 'General case' 0 N--CA 1.47 0.551 0 N-CA-C 112.704 0.631 . . . . 0.0 112.704 -175.675 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 101.63 -26.43 24.48 Favored Glycine 0 CA--C 1.532 1.115 0 CA-C-N 115.571 -0.74 . . . . 0.0 112.306 -177.331 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 71.6 mmtt -98.17 155.14 17.3 Favored 'General case' 0 C--N 1.331 -0.209 0 CA-C-N 117.51 0.655 . . . . 0.0 111.097 177.802 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 30' ' ' THR . . . . . . . . . . . . . 41.4 m -105.33 137.52 43.01 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 115.895 -0.593 . . . . 0.0 109.862 176.068 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 34.8 m -129.51 157.38 42.24 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.245 0 CA-C-N 116.354 -0.385 . . . . 0.0 110.798 -178.468 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 32' ' ' ARG . . . . . . . . . . . . . 73.5 mtt85 -131.37 153.13 49.97 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-O 121.282 0.563 . . . . 0.0 110.701 177.899 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 33' ' ' THR . . . . . . . . . . . . . 22.7 m -53.02 139.66 27.32 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.051 -0.522 . . . . 0.0 111.397 -177.84 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 99.13 -16.99 58.66 Favored Glycine 0 CA--C 1.533 1.17 0 CA-C-O 119.593 -0.56 . . . . 0.0 113.327 178.345 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 61.3 m-20 -62.81 148.82 45.81 Favored 'General case' 0 C--O 1.231 0.11 0 CA-C-N 118.044 0.922 . . . . 0.0 111.084 179.696 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 45.1 t -123.66 130.69 73.93 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.257 0 CA-C-N 115.585 -0.734 . . . . 0.0 109.853 179.343 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 37' ' ' ILE . . . . . . . . . . . . . 69.6 mt -122.71 139.19 50.32 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.237 0 CA-C-N 116.248 -0.433 . . . . 0.0 110.04 -179.773 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . -110.72 128.78 8.94 Favored Glycine 0 CA--C 1.525 0.665 0 N-CA-C 111.037 -0.825 . . . . 0.0 111.037 179.556 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 39' ' ' ILE . . . . . . . . . . . . . 72.1 mt -123.06 135.62 62.51 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.257 0 N-CA-C 110.109 -0.33 . . . . 0.0 110.109 179.33 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 40' ' ' SER . . . . . . . . . . . . . 41.5 t -93.6 116.91 29.44 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.394 -0.366 . . . . 0.0 111.039 176.01 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 41' ' ' ILE . . . . . . . . . . . . . 44.2 mm -121.53 115.26 45.99 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.241 0 CA-C-N 116.476 -0.329 . . . . 0.0 110.333 179.34 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 78.5 mt 54.38 37.07 26.89 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-O 120.93 0.395 . . . . 0.0 111.548 176.942 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . 74.13 24.46 73.54 Favored Glycine 0 CA--C 1.532 1.123 0 C-N-CA 121.061 -0.59 . . . . 0.0 112.797 177.622 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 44' ' ' LYS . . . . . . . . . . . . . 70.0 mmtt -130.36 132.54 45.85 Favored 'General case' 0 C--N 1.331 -0.223 0 N-CA-C 109.57 -0.529 . . . . 0.0 109.57 177.74 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 81.3 tt0 -84.02 122.5 28.87 Favored 'General case' 0 C--N 1.329 -0.308 0 C-N-CA 120.74 -0.384 . . . . 0.0 111.099 -178.142 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 46' ' ' VAL . . . . . . . . . . . . . 7.1 p -120.86 128.15 76.03 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.194 0 N-CA-C 109.356 -0.609 . . . . 0.0 109.356 175.241 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 60.3 mttp -100.48 127.78 46.73 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 115.988 -0.551 . . . . 0.0 111.015 179.277 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 48' ' ' PHE . . . . . . . . . . . . . 92.2 m-85 -110.48 131.83 54.71 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.368 -0.378 . . . . 0.0 110.099 176.44 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 45.5 tttp -108.46 136.96 47.21 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.246 -0.433 . . . . 0.0 110.598 179.158 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 50' ' ' VAL . . . . . . . . . . . . . 47.0 t -82.33 107.35 14.18 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.33 0 N-CA-C 109.161 -0.681 . . . . 0.0 109.161 175.416 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 51' ' ' VAL . . . . . . . . . . . . . 47.8 t -71.68 -52.26 26.96 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.364 0 CA-C-N 115.952 -0.567 . . . . 0.0 109.668 -174.295 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 52' ' ' GLN . . . . . . . . . . . . . 90.8 mt-30 -152.94 151.09 29.93 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-O 121.182 0.515 . . . . 0.0 111.572 -177.755 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -126.46 131.88 51.57 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 115.214 -0.903 . . . . 0.0 109.639 175.087 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 54' ' ' TYR . . . . . . . . . . . . . 51.7 t80 -128.93 108.43 18.29 Favored Pre-proline 0 CA--C 1.533 0.323 0 CA-C-O 118.294 -0.86 . . . . 0.0 110.421 -179.826 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 55' ' ' PRO . . . . . . . . . . . . . 73.4 Cg_endo -77.12 170.0 72.77 Favored 'Cis proline' 0 N--CA 1.499 1.837 0 CA-C-N 121.809 1.682 . . . . 0.0 112.501 -5.54 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 56' ' ' SER . . . . . . . . . . . . . 15.2 m -115.27 129.05 25.41 Favored Pre-proline 0 CA--C 1.539 0.554 0 CA-C-O 118.448 -0.787 . . . . 0.0 109.462 174.994 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 57' ' ' PRO . . . . . . . . . . . . . 38.4 Cg_endo -67.48 165.73 67.61 Favored 'Cis proline' 0 N--CA 1.498 1.741 0 CA-C-N 121.979 1.742 . . . . 0.0 111.517 -0.601 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 58' ' ' LEU . . . . . . . . . . . . . 27.9 tp -129.28 135.89 49.35 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.268 179.646 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 59' ' ' ARG . . . . . . . . . . . . . 74.0 ttt180 -104.72 128.69 52.89 Favored 'General case' 0 C--N 1.326 -0.421 0 N-CA-C 109.188 -0.671 . . . . 0.0 109.188 176.562 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 46.2 t -79.92 122.4 35.06 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.212 0 C-N-CA 120.566 -0.453 . . . . 0.0 109.982 -175.945 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 78.9 tt0 -130.75 157.82 41.78 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 115.713 -0.676 . . . . 0.0 109.264 -179.511 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 62' ' ' ASP . . . . . . . . . . . . . 79.9 m-20 -51.58 -32.21 27.62 Favored 'General case' 0 C--N 1.328 -0.339 0 N-CA-C 112.125 0.417 . . . . 0.0 112.125 -177.642 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 63' ' ' ARG . . . . . . . . . . . . . 46.8 ptt85 -88.97 5.11 45.69 Favored 'General case' 0 CA--C 1.538 0.518 0 N-CA-C 113.767 1.025 . . . . 0.0 113.767 -175.598 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 30.4 m -80.14 141.03 36.12 Favored 'General case' 0 C--N 1.331 -0.206 0 CA-C-N 117.981 0.355 . . . . 0.0 110.742 -178.483 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 65' ' ' LYS . . . . . . . . . . . . . 97.0 mttt -88.67 131.36 35.03 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.237 -0.438 . . . . 0.0 110.262 178.895 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 66' ' ' ILE . . . . . . . . . . . . . 59.1 mt -115.26 126.45 72.83 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.297 0 N-CA-C 109.502 -0.555 . . . . 0.0 109.502 179.061 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 67' ' ' THR . . . . . . . . . . . . . 26.4 m -117.56 136.61 53.15 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-O 121.05 0.452 . . . . 0.0 110.731 -177.756 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 68' ' ' LEU . . . . . . . . . . . . . 6.3 tt . . . . . 0 C--N 1.329 -0.307 0 CA-C-N 115.782 -0.645 . . . . 0.0 109.69 178.277 . . . . . . . . 0 0 . 1 . 011 nuclear orig core ' A' A ' 74' ' ' ASP . . . . . . . . . . . . . 30.2 t0 . . . . . 0 C--O 1.23 0.06 0 N-CA-C 109.845 -0.428 . . . . 0.0 109.845 . . . . . . . . . 0 0 . 1 . 011 nuclear orig core ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 43.5 t -115.7 124.27 71.95 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.215 0 CA-C-O 121.071 0.462 . . . . 0.0 110.467 -178.62 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 76' ' ' LEU . . . . . . . . . . . . . 6.3 mp -118.35 138.52 52.36 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 115.692 -0.685 . . . . 0.0 109.501 175.569 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 77' ' ' GLU . . . . . . . . . . . . . 96.8 mt-10 -134.15 136.3 43.71 Favored 'General case' 0 C--N 1.331 -0.204 0 CA-C-O 121.079 0.466 . . . . 0.0 111.017 -179.222 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 78' ' ' ALA . . . . . . . . . . . . . . . -124.81 141.68 51.95 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 115.632 -0.713 . . . . 0.0 110.077 177.704 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 79' ' ' LYS . . . . . . . . . . . . . 11.4 mptt -81.52 109.83 16.35 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-O 120.858 0.361 . . . . 0.0 110.379 -179.922 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 80' ' ' ILE . . . . . . . . . . . . . 41.5 mm -139.09 103.77 2.04 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.356 0 N-CA-C 109.2 -0.667 . . . . 0.0 109.2 -178.122 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 81' ' ' LYS . . . . . . . . . . . . . 19.7 pttp -112.38 140.39 47.15 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-O 121.002 0.429 . . . . 0.0 111.335 -176.857 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . 89.2 42.07 5.67 Favored Glycine 0 CA--C 1.526 0.724 0 N-CA-C 110.865 -0.894 . . . . 0.0 110.865 178.599 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 83' ' ' ILE . . . . . . . . . . . . . 70.7 mt -75.79 140.94 16.5 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.333 0 CA-C-O 120.88 0.372 . . . . 0.0 110.205 -179.139 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 84' ' ' LYS . . . . . . . . . . . . . 58.0 tttp -95.13 -53.4 3.82 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 115.904 -0.589 . . . . 0.0 109.991 179.597 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 85' ' ' ASP . . . . . . . . . . . . . 10.2 t70 -155.04 154.16 32.06 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 115.629 -0.714 . . . . 0.0 110.349 -179.627 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 86' ' ' VAL . . . . . . . . . . . . . 41.6 t -126.01 131.09 72.12 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.205 0 CA-C-O 120.925 0.393 . . . . 0.0 110.422 -179.197 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 87' ' ' ILE . . . . . . . . . . . . . 46.0 mm -120.33 124.75 73.19 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.285 0 CA-C-N 115.849 -0.614 . . . . 0.0 109.39 177.423 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 88' ' ' LEU . . . . . . . . . . . . . 30.1 mt -118.66 136.1 54.1 Favored 'General case' 0 C--N 1.331 -0.22 0 CA-C-O 121.209 0.528 . . . . 0.0 111.29 -176.147 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 89' ' ' ASP . . . . . . . . . . . . . 6.6 t0 -131.13 157.91 41.87 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 115.448 -0.796 . . . . 0.0 109.533 177.759 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 14.2 pt-20 -46.4 -36.93 6.96 Favored 'General case' 0 C--N 1.33 -0.272 0 N-CA-C 113.218 0.822 . . . . 0.0 113.218 -172.326 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 91' ' ' ASN . . . . . . . . . . . . . 11.9 t-20 -131.99 20.81 4.52 Favored 'General case' 0 N--CA 1.468 0.467 0 N-CA-C 112.93 0.715 . . . . 0.0 112.93 -177.083 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 92' ' ' LEU . . . . . . . . . . . . . 35.2 mt -147.52 142.61 27.09 Favored 'General case' 0 C--N 1.33 -0.267 0 N-CA-C 110.323 -0.251 . . . . 0.0 110.323 -177.625 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 93' ' ' ILE . . . . . . . . . . . . . 71.5 mt -125.34 116.02 45.48 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.336 0 N-CA-C 109.416 -0.587 . . . . 0.0 109.416 179.09 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 94' ' ' VAL . . . . . . . . . . . . . 46.7 t -119.13 126.79 75.67 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.295 0 CA-C-O 121.001 0.429 . . . . 0.0 110.114 -178.814 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 95' ' ' VAL . . . . . . . . . . . . . 47.3 t -118.66 131.16 72.26 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.376 0 CA-C-N 115.704 -0.68 . . . . 0.0 109.455 178.982 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 96' ' ' ILE . . . . . . . . . . . . . 65.6 mt -112.04 125.82 69.37 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.299 0 N-CA-C 109.127 -0.694 . . . . 0.0 109.127 178.699 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 97' ' ' THR . . . . . . . . . . . . . 71.2 p -98.25 157.1 16.37 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-O 121.216 0.532 . . . . 0.0 111.06 -177.22 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 98' ' ' GLU . . . . . . . . . . . . . 97.1 mt-10 -54.34 -24.25 18.61 Favored 'General case' 0 C--N 1.329 -0.322 0 N-CA-C 112.434 0.531 . . . . 0.0 112.434 -179.571 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 99' ' ' GLU . . . . . . . . . . . . . 35.3 tt0 -80.78 16.74 1.33 Allowed 'General case' 0 CA--C 1.538 0.51 0 N-CA-C 112.642 0.608 . . . . 0.0 112.642 -177.551 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 100' ' ' ASN . . . . . . . . . . . . . 3.4 m-20 61.83 37.91 15.1 Favored 'General case' 0 C--O 1.232 0.153 0 O-C-N 121.91 -0.494 . . . . 0.0 111.151 178.129 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 101' ' ' GLU . . . . . . . . . . . . . 84.7 tt0 -116.31 144.55 44.1 Favored 'General case' 0 C--N 1.331 -0.214 0 CA-C-N 116.165 -0.471 . . . . 0.0 109.858 176.501 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 102' ' ' VAL . . . . . . . . . . . . . 41.3 t -115.8 125.54 72.99 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.26 0 CA-C-N 116.207 -0.451 . . . . 0.0 110.177 -178.299 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 103' ' ' LEU . . . . . . . . . . . . . 22.6 mt -116.25 127.86 55.1 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 115.782 -0.645 . . . . 0.0 109.867 175.811 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 104' ' ' ILE . . . . . . . . . . . . . 62.4 mt -118.15 122.55 69.91 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.295 0 N-CA-C 110.342 -0.244 . . . . 0.0 110.342 179.639 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 105' ' ' PHE . . . . . . . . . . . . . 62.4 m-85 -120.18 163.58 17.52 Favored 'General case' 0 C--N 1.332 -0.182 0 O-C-N 124.136 0.897 . . . . 0.0 109.679 178.689 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 106' ' ' ASN . . . . . . . . . . . . . 46.8 p-10 -95.24 -170.69 2.23 Favored 'General case' 0 C--N 1.331 -0.232 0 N-CA-C 109.752 -0.462 . . . . 0.0 109.752 173.23 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 107' ' ' GLN . . . . . . . . . . . . . 49.3 tt0 -59.32 -30.1 68.12 Favored 'General case' 0 C--N 1.33 -0.278 0 N-CA-C 111.879 0.326 . . . . 0.0 111.879 179.144 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 108' ' ' ASN . . . . . . . . . . . . . 6.8 t-20 -82.23 9.68 8.31 Favored 'General case' 0 CA--C 1.536 0.438 0 N-CA-C 113.052 0.76 . . . . 0.0 113.052 -177.809 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 109' ' ' LEU . . . . . . . . . . . . . 11.1 tp 58.03 35.71 25.43 Favored 'General case' 0 CA--C 1.531 0.215 0 CA-C-O 120.965 0.412 . . . . 0.0 111.409 179.203 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 110' ' ' GLU . . . . . . . . . . . . . 70.7 mm-40 -104.98 143.53 33.05 Favored 'General case' 0 C--N 1.331 -0.222 0 N-CA-C 109.264 -0.643 . . . . 0.0 109.264 174.812 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 111' ' ' GLU . . . . . . . . . . . . . 62.6 tt0 -81.64 121.97 27.02 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-O 121.058 0.456 . . . . 0.0 110.678 -175.144 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 112' ' ' LEU . . . . . . . . . . . . . 29.5 mt -104.58 -45.62 4.57 Favored 'General case' 0 C--N 1.331 -0.211 0 CA-C-N 115.935 -0.575 . . . . 0.0 110.736 179.716 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 113' ' ' TYR . . . . . . . . . . . . . 63.6 t80 -133.02 135.69 45.57 Favored 'General case' 0 C--N 1.331 -0.218 0 CA-C-N 116.376 -0.375 . . . . 0.0 111.277 -177.604 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 114' ' ' ARG . . . . . . . . . . . . . 55.6 ttp180 -133.98 121.22 21.31 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 115.868 -0.605 . . . . 0.0 110.109 177.333 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 115' ' ' GLY . . . . . . . . . . . . . . . -150.12 160.8 28.68 Favored Glycine 0 CA--C 1.524 0.642 0 N-CA-C 111.013 -0.835 . . . . 0.0 111.013 -179.987 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 116' ' ' LYS . . . . . . . . . . . . . 33.4 ttmt -135.97 139.43 43.2 Favored 'General case' 0 C--N 1.328 -0.368 0 N-CA-C 109.971 -0.381 . . . . 0.0 109.971 177.312 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 117' ' ' PHE . . . . . . . . . . . . . 39.9 m-85 -136.88 114.68 11.28 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-O 121.053 0.454 . . . . 0.0 110.312 -175.127 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 118' ' ' GLU . . . . . . . . . . . . . 96.6 mt-10 -53.38 -45.06 69.1 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 116.287 -0.415 . . . . 0.0 111.664 -175.413 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 119' ' ' ASN . . . . . . . . . . . . . 69.5 m-80 -98.66 31.08 3.02 Favored 'General case' 0 C--N 1.33 -0.271 0 N-CA-C 112.255 0.465 . . . . 0.0 112.255 -173.035 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 120' ' ' LEU . . . . . . . . . . . . . 26.8 tp -56.44 122.53 12.15 Favored 'General case' 0 C--N 1.332 -0.171 0 C-N-CA 121.059 -0.256 . . . . 0.0 110.494 177.638 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 121' ' ' ASN . . . . . . . . . . . . . 34.9 m120 -114.0 -44.15 3.18 Favored 'General case' 0 C--O 1.232 0.149 0 CA-C-N 116.687 -0.233 . . . . 0.0 111.181 -178.373 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 122' ' ' LYS . . . . . . . . . . . . . 97.3 mttt -148.31 152.92 37.92 Favored 'General case' 0 C--N 1.332 -0.156 0 CA-C-O 121.126 0.489 . . . . 0.0 111.468 -177.896 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 123' ' ' VAL . . . . . . . . . . . . . 45.0 t -127.19 132.41 69.72 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.217 0 CA-C-N 115.897 -0.592 . . . . 0.0 109.679 176.931 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 124' ' ' LEU . . . . . . . . . . . . . 75.8 mt -126.67 131.04 51.5 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.455 -0.339 . . . . 0.0 110.307 -179.993 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 125' ' ' VAL . . . . . . . . . . . . . 35.3 m -136.59 138.85 46.02 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.258 0 CA-C-O 120.844 0.354 . . . . 0.0 110.829 -179.748 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 126' ' ' ARG . . . . . . . . . . . . . 14.5 ptm180 -165.96 143.55 5.53 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.066 -0.515 . . . . 0.0 110.081 177.216 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 127' ' ' ASN . . . . . . . . . . . . . 4.3 t30 55.24 -153.82 0.31 Allowed 'General case' 0 CA--C 1.539 0.539 0 N-CA-C 110.017 -0.364 . . . . 0.0 110.017 -179.844 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 128' ' ' ASP . . . . . . . . . . . . . 8.2 p-10 -83.66 18.53 1.89 Allowed 'General case' 0 CA--C 1.535 0.37 0 N-CA-C 112.679 0.622 . . . . 0.0 112.679 179.269 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 129' ' ' LEU . . . . . . . . . . . . . 15.5 tp -122.94 138.25 54.72 Favored 'General case' 0 C--O 1.232 0.157 0 O-C-N 121.983 -0.448 . . . . 0.0 110.503 -179.608 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 130' ' ' VAL . . . . . . . . . . . . . 32.7 m -131.23 141.75 45.19 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.184 0 CA-C-O 120.805 0.336 . . . . 0.0 110.449 177.578 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 131' ' ' VAL . . . . . . . . . . . . . 47.9 t -136.14 138.61 46.99 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.285 0 CA-C-O 121.274 0.559 . . . . 0.0 110.682 -179.526 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 132' ' ' ILE . . . . . . . . . . . . . 72.1 mt -111.74 133.27 57.92 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.329 0 CA-C-N 115.41 -0.814 . . . . 0.0 109.135 178.089 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 133' ' ' ILE . . . . . . . . . . . . . 43.4 mm -114.82 120.04 63.35 Favored 'Isoleucine or valine' 0 C--O 1.233 0.229 0 CA-C-O 120.884 0.373 . . . . 0.0 110.964 -175.294 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 134' ' ' ASP . . . . . . . . . . . . . 6.2 p-10 -130.46 144.83 51.65 Favored 'General case' 0 C--N 1.331 -0.227 0 N-CA-C 109.366 -0.605 . . . . 0.0 109.366 173.83 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 135' ' ' GLU . . . . . . . . . . . . . 43.4 tp10 -49.78 -24.97 2.65 Favored 'General case' 0 C--N 1.328 -0.334 0 N-CA-C 112.793 0.664 . . . . 0.0 112.793 -170.799 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 136' ' ' GLN . . . . . . . . . . . . . 96.0 mt-30 -91.53 -40.08 11.57 Favored 'General case' 0 C--N 1.331 -0.231 0 N-CA-C 112.305 0.483 . . . . 0.0 112.305 -177.389 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 137' ' ' LYS . . . . . . . . . . . . . 61.2 mtpt -141.96 155.81 45.47 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-O 121.34 0.59 . . . . 0.0 111.718 -167.989 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 138' ' ' LEU . . . . . . . . . . . . . 5.9 tt -116.0 124.69 51.13 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 115.519 -0.764 . . . . 0.0 109.177 173.832 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 139' ' ' THR . . . . . . . . . . . . . 31.1 m -111.12 124.38 52.08 Favored 'General case' 0 C--N 1.331 -0.196 0 CA-C-N 116.438 -0.346 . . . . 0.0 110.794 -176.993 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 140' ' ' LEU . . . . . . . . . . . . . 9.9 tt -112.07 126.85 55.62 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 115.762 -0.653 . . . . 0.0 109.591 -178.468 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 141' ' ' ILE . . . . . . . . . . . . . 19.5 mt -125.21 123.88 66.15 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.302 0 CA-C-O 121.008 0.432 . . . . 0.0 109.873 -176.543 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 142' ' ' ARG . . . . . . . . . . . . . 61.5 ttt180 -110.06 124.88 52.27 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 115.119 -0.946 . . . . 0.0 110.459 -177.794 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 143' ' ' THR . . . . . . . . . . . . . 9.3 p . . . . . 0 C--O 1.22 -0.49 0 CA-C-O 117.979 -1.01 . . . . 0.0 110.592 179.959 . . . . . . . . 0 0 . 1 . 011 nuclear orig core ' B' B ' 2' ' ' SER . . . . . . . . . . . . . 11.6 p . . . . . 0 C--O 1.231 0.125 0 CA-C-O 120.953 0.406 . . . . 0.0 110.549 . . . . . . . . . 0 0 . 1 . 011 nuclear orig core ' B' B ' 3' ' ' GLU . . . . . . . . . . . . . 95.0 mt-10 -140.91 140.48 34.5 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 115.941 -0.572 . . . . 0.0 111.0 -178.762 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' B' B ' 4' ' ' LEU . . . . . . . . . . . . . 18.2 tp -125.23 130.73 52.68 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 115.915 -0.584 . . . . 0.0 110.119 176.558 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' B' B ' 5' ' ' LYS . . . . . . . . . . . . . 93.6 mttt -112.19 121.43 44.9 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-O 120.843 0.354 . . . . 0.0 110.569 179.588 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' B' B ' 6' ' ' LEU . . . . . . . . . . . . . 62.7 mt -114.1 147.16 39.22 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 115.388 -0.823 . . . . 0.0 111.157 -177.869 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' B' B ' 7' ' ' LYS . . . . . . . . . . . . . 79.4 tttt -137.0 140.26 31.0 Favored Pre-proline 0 CA--C 1.534 0.333 0 CA-C-N 116.07 -0.514 . . . . 0.0 109.724 175.715 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' B' B ' 8' ' ' PRO . . . . . . . . . . . . . 89.4 Cg_endo -91.58 146.45 3.31 Favored 'Trans proline' 0 N--CA 1.491 1.333 0 C-N-CA 121.735 1.624 . . . . 0.0 111.972 178.968 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' B' B ' 9' ' ' LEU . . . . . . . . . . . . . 41.4 mt -82.57 -46.84 0.91 Allowed Pre-proline 0 CA--C 1.534 0.353 0 CA-C-O 118.78 -0.628 . . . . 0.0 111.909 179.317 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' B' B ' 10' ' ' PRO . . . . . . . . . . . . . 94.3 Cg_endo -82.05 155.84 17.42 Favored 'Trans proline' 0 N--CA 1.495 1.56 0 C-N-CA 121.253 1.302 . . . . 0.0 111.767 174.433 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' B' B ' 11' ' ' LYS . . . . . . . . . . . . . 92.2 mttt -88.53 98.43 11.64 Favored 'General case' 0 C--N 1.329 -0.316 0 C-N-CA 120.883 -0.327 . . . . 0.0 110.513 178.725 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' B' B ' 12' ' ' VAL . . . . . . . . . . . . . 12.2 p -140.34 147.4 23.34 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.302 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.433 -179.976 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' B' B ' 13' ' ' GLU . . . . . . . . . . . . . 43.0 tp10 -89.21 129.93 35.7 Favored 'General case' 0 C--N 1.329 -0.298 0 N-CA-C 109.862 -0.421 . . . . 0.0 109.862 178.298 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' B' B ' 14' ' ' LEU . . . . . . . . . . . . . 53.8 mt -97.33 147.58 33.16 Favored Pre-proline 0 CA--C 1.532 0.286 0 CA-C-O 119.196 -0.43 . . . . 0.0 110.727 -176.94 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' B' B ' 15' ' ' PRO . . . . . . . . . . . . . 24.4 Cg_exo -63.31 161.11 32.03 Favored 'Trans proline' 0 N--CA 1.498 1.738 0 C-N-CA 121.248 1.299 . . . . 0.0 111.762 175.881 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' B' B ' 16' ' ' PRO . . . . . . . . . . . . . 31.2 Cg_exo -59.24 -38.15 87.22 Favored 'Trans proline' 0 N--CA 1.497 1.721 0 C-N-CA 121.471 1.447 . . . . 0.0 112.78 -177.706 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' B' B ' 17' ' ' ASP . . . . . . . . . . . . . 18.2 p-10 -88.79 9.44 24.58 Favored 'General case' 0 CA--C 1.536 0.419 0 N-CA-C 113.243 0.831 . . . . 0.0 113.243 -177.735 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' B' B ' 18' ' ' PHE . . . . . . . . . . . . . 34.2 t80 -58.25 -43.74 88.01 Favored 'General case' 0 C--N 1.334 -0.081 0 O-C-N 122.023 -0.423 . . . . 0.0 109.9 -178.446 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' B' B ' 19' ' ' VAL . . . . . . . . . . . . . 53.9 t -56.92 -42.91 79.54 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.369 0 CA-C-N 116.18 -0.464 . . . . 0.0 110.494 -179.479 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' B' B ' 20' ' ' ASP . . . . . . . . . . . . . 10.4 t0 -60.04 -42.6 94.77 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-O 120.847 0.356 . . . . 0.0 111.049 -177.796 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' B' B ' 21' ' ' VAL . . . . . . . . . . . . . 51.3 t -64.25 -47.01 91.67 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.335 0 CA-C-N 116.448 -0.342 . . . . 0.0 110.515 -177.685 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' B' B ' 22' ' ' ILE . . . . . . . . . . . . . 49.7 mm -56.48 -45.42 81.97 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.252 0 C-N-CA 120.982 -0.287 . . . . 0.0 110.572 178.819 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' B' B ' 23' ' ' ARG . . . . . . . . . . . . . 24.8 ttp180 -53.8 -50.16 66.75 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-O 120.58 0.229 . . . . 0.0 111.48 -178.446 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' B' B ' 24' ' ' ILE . . . . . . . . . . . . . 73.9 mt -59.86 -45.15 95.27 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.316 0 CA-C-N 116.574 -0.284 . . . . 0.0 111.281 -176.536 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' B' B ' 25' ' ' LYS . . . . . . . . . . . . . 50.2 mttm -65.44 -39.28 91.86 Favored 'General case' 0 C--N 1.329 -0.289 0 N-CA-C 112.607 0.595 . . . . 0.0 112.607 -177.629 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' B' B ' 26' ' ' LEU . . . . . . . . . . . . . 26.8 mt -77.55 -43.19 32.69 Favored 'General case' 0 C--N 1.33 -0.272 0 N-CA-C 112.763 0.653 . . . . 0.0 112.763 -172.838 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' B' B ' 27' ' ' GLN . . . . . . . . . . . . . 10.6 pt20 -47.0 137.49 7.42 Favored 'General case' 0 N--CA 1.469 0.51 0 N-CA-C 112.629 0.603 . . . . 0.0 112.629 -177.071 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' B' B ' 28' ' ' GLY . . . . . . . . . . . . . . . 100.72 -26.84 23.13 Favored Glycine 0 CA--C 1.533 1.183 0 CA-C-N 115.565 -0.743 . . . . 0.0 112.209 -176.477 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' B' B ' 29' ' ' LYS . . . . . . . . . . . . . 94.8 mttt -98.38 155.13 17.38 Favored 'General case' 0 C--O 1.232 0.166 0 CA-C-N 117.219 0.509 . . . . 0.0 110.842 178.555 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' B' B ' 30' ' ' THR . . . . . . . . . . . . . 28.5 m -103.04 136.45 42.82 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.279 -0.419 . . . . 0.0 109.962 175.269 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' B' B ' 31' ' ' VAL . . . . . . . . . . . . . 35.5 m -128.99 153.39 38.52 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.216 0 CA-C-O 121.047 0.451 . . . . 0.0 111.019 -177.856 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' B' B ' 32' ' ' ARG . . . . . . . . . . . . . 90.0 mtm-85 -128.81 148.98 50.92 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 115.905 -0.589 . . . . 0.0 110.457 178.877 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' B' B ' 33' ' ' THR . . . . . . . . . . . . . 18.7 m -53.42 138.6 32.86 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.326 -0.397 . . . . 0.0 111.279 -177.978 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' B' B ' 34' ' ' GLY . . . . . . . . . . . . . . . 101.06 -17.1 56.62 Favored Glycine 0 CA--C 1.533 1.167 0 CA-C-O 119.609 -0.55 . . . . 0.0 113.284 179.574 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' B' B ' 35' ' ' ASP . . . . . . . . . . . . . 69.0 m-20 -64.26 148.88 49.18 Favored 'General case' 0 C--N 1.334 -0.106 0 CA-C-N 118.07 0.935 . . . . 0.0 111.029 179.537 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' B' B ' 36' ' ' VAL . . . . . . . . . . . . . 45.6 t -123.8 131.58 72.77 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.215 0 CA-C-N 115.774 -0.648 . . . . 0.0 109.8 178.899 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' B' B ' 37' ' ' ILE . . . . . . . . . . . . . 65.6 mt -121.2 139.23 49.04 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.217 0 CA-C-N 116.197 -0.456 . . . . 0.0 109.973 -179.925 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' B' B ' 38' ' ' GLY . . . . . . . . . . . . . . . -112.31 128.78 8.68 Favored Glycine 0 CA--C 1.526 0.767 0 N-CA-C 111.033 -0.827 . . . . 0.0 111.033 179.799 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' B' B ' 39' ' ' ILE . . . . . . . . . . . . . 71.6 mt -124.12 134.81 65.56 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.21 0 N-CA-C 110.091 -0.337 . . . . 0.0 110.091 179.199 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' B' B ' 40' ' ' SER . . . . . . . . . . . . . 95.0 p -93.64 124.49 37.66 Favored 'General case' 0 C--N 1.331 -0.225 0 CA-C-N 116.338 -0.392 . . . . 0.0 111.096 176.24 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' B' B ' 41' ' ' ILE . . . . . . . . . . . . . 75.0 mt -130.63 122.5 52.87 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.254 0 CA-C-N 116.488 -0.324 . . . . 0.0 110.331 176.749 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' B' B ' 42' ' ' LEU . . . . . . . . . . . . . 6.6 tp 52.16 36.03 18.11 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 116.279 -0.419 . . . . 0.0 111.652 176.823 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' B' B ' 43' ' ' GLY . . . . . . . . . . . . . . . 71.84 32.56 63.7 Favored Glycine 0 CA--C 1.529 0.964 0 C-N-CA 121.085 -0.578 . . . . 0.0 112.033 178.543 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' B' B ' 44' ' ' LYS . . . . . . . . . . . . . 84.8 tttt -137.19 127.18 25.87 Favored 'General case' 0 C--N 1.328 -0.356 0 N-CA-C 109.74 -0.467 . . . . 0.0 109.74 178.915 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' B' B ' 45' ' ' GLU . . . . . . . . . . . . . 84.7 tt0 -83.01 122.84 28.83 Favored 'General case' 0 C--N 1.327 -0.409 0 CA-C-O 120.802 0.334 . . . . 0.0 110.923 -178.874 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' B' B ' 46' ' ' VAL . . . . . . . . . . . . . 7.6 p -120.16 127.74 75.92 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.229 0 N-CA-C 109.35 -0.611 . . . . 0.0 109.35 175.35 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' B' B ' 47' ' ' LYS . . . . . . . . . . . . . 58.2 mtpt -101.26 128.14 47.53 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 115.798 -0.637 . . . . 0.0 111.148 -179.658 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' B' B ' 48' ' ' PHE . . . . . . . . . . . . . 95.6 m-85 -112.44 131.94 55.3 Favored 'General case' 0 C--N 1.331 -0.223 0 CA-C-N 116.335 -0.393 . . . . 0.0 110.196 176.946 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' B' B ' 49' ' ' LYS . . . . . . . . . . . . . 74.4 tttt -108.39 137.45 46.33 Favored 'General case' 0 C--N 1.331 -0.229 0 CA-C-N 116.449 -0.342 . . . . 0.0 110.664 179.022 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' B' B ' 50' ' ' VAL . . . . . . . . . . . . . 47.1 t -82.88 110.59 18.1 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.254 0 N-CA-C 109.434 -0.58 . . . . 0.0 109.434 176.265 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' B' B ' 51' ' ' VAL . . . . . . . . . . . . . 47.5 t -73.78 -51.53 24.27 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.231 0 CA-C-N 116.108 -0.496 . . . . 0.0 109.754 -174.774 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' B' B ' 52' ' ' GLN . . . . . . . . . . . . . 92.6 mt-30 -153.26 152.82 31.61 Favored 'General case' 0 C--N 1.331 -0.211 0 CA-C-O 121.176 0.513 . . . . 0.0 111.82 -177.739 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' B' B ' 53' ' ' ALA . . . . . . . . . . . . . . . -132.27 133.59 44.28 Favored 'General case' 0 C--N 1.327 -0.404 0 CA-C-N 115.113 -0.949 . . . . 0.0 109.677 174.9 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' B' B ' 54' ' ' TYR . . . . . . . . . . . . . 63.1 t80 -129.2 113.6 18.43 Favored Pre-proline 0 CA--C 1.536 0.411 0 CA-C-O 118.077 -0.963 . . . . 0.0 110.569 179.07 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' B' B ' 55' ' ' PRO . . . . . . . . . . . . . 71.8 Cg_endo -77.25 164.11 87.57 Favored 'Cis proline' 0 N--CA 1.5 1.879 0 CA-C-N 121.993 1.748 . . . . 0.0 112.123 -8.831 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' B' B ' 56' ' ' SER . . . . . . . . . . . . . 13.7 m -114.03 132.82 22.51 Favored Pre-proline 0 CA--C 1.539 0.52 0 CA-C-O 118.495 -0.764 . . . . 0.0 109.388 175.173 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' B' B ' 57' ' ' PRO . . . . . . . . . . . . . 43.5 Cg_endo -69.02 143.81 73.45 Favored 'Cis proline' 0 N--CA 1.498 1.763 0 CA-C-N 121.865 1.702 . . . . 0.0 111.439 -0.713 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' B' B ' 58' ' ' LEU . . . . . . . . . . . . . 24.2 tp -105.68 135.51 46.96 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.382 -0.372 . . . . 0.0 110.667 -178.282 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' B' B ' 59' ' ' ARG . . . . . . . . . . . . . 41.7 ttm180 -99.98 121.54 41.51 Favored 'General case' 0 C--N 1.326 -0.438 0 N-CA-C 108.983 -0.747 . . . . 0.0 108.983 174.133 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' B' B ' 60' ' ' VAL . . . . . . . . . . . . . 39.9 t -79.53 122.57 35.02 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.225 0 C-N-CA 120.587 -0.445 . . . . 0.0 110.205 -174.107 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' B' B ' 61' ' ' GLU . . . . . . . . . . . . . 34.9 tp10 -130.89 156.7 44.61 Favored 'General case' 0 C--N 1.329 -0.32 0 N-CA-C 109.071 -0.715 . . . . 0.0 109.071 179.131 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' B' B ' 62' ' ' ASP . . . . . . . . . . . . . 5.5 t70 -51.42 -32.53 26.83 Favored 'General case' 0 C--N 1.326 -0.454 0 N-CA-C 111.946 0.35 . . . . 0.0 111.946 -178.945 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' B' B ' 63' ' ' ARG . . . . . . . . . . . . . 48.0 mmm-85 -73.91 -19.17 60.78 Favored 'General case' 0 CA--C 1.536 0.431 0 N-CA-C 113.095 0.776 . . . . 0.0 113.095 -176.928 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' B' B ' 64' ' ' THR . . . . . . . . . . . . . 32.0 m -67.9 141.69 56.3 Favored 'General case' 0 C--N 1.331 -0.209 0 CA-C-O 120.978 0.418 . . . . 0.0 111.114 -175.307 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' B' B ' 65' ' ' LYS . . . . . . . . . . . . . 68.4 mttm -90.23 132.88 35.26 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 115.833 -0.621 . . . . 0.0 110.322 179.639 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' B' B ' 66' ' ' ILE . . . . . . . . . . . . . 66.4 mt -112.56 131.2 64.75 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.239 0 N-CA-C 109.865 -0.42 . . . . 0.0 109.865 179.574 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' B' B ' 67' ' ' THR . . . . . . . . . . . . . 22.6 m -126.05 142.84 51.35 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-N 115.989 -0.551 . . . . 0.0 110.917 -177.723 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' B' B ' 68' ' ' LEU . . . . . . . . . . . . . 16.5 tp . . . . . 0 C--N 1.328 -0.336 0 CA-C-N 115.845 -0.616 . . . . 0.0 109.829 177.282 . . . . . . . . 0 0 . 1 . 011 nuclear orig core ' B' B ' 73' ' ' VAL . . . . . . . . . . . . . 27.6 m . . . . . 0 C--O 1.232 0.164 0 N-CA-C 109.422 -0.584 . . . . 0.0 109.422 . . . . . . . . . 0 0 . 1 . 011 nuclear orig core ' B' B ' 74' ' ' ASP . . . . . . . . . . . . . 36.2 t0 -92.62 123.71 36.12 Favored 'General case' 0 C--N 1.327 -0.397 0 CA-C-N 116.252 -0.431 . . . . 0.0 110.195 -176.764 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' B' B ' 75' ' ' VAL . . . . . . . . . . . . . 43.0 t -118.23 123.64 71.92 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.267 0 CA-C-O 121.16 0.505 . . . . 0.0 110.455 -178.592 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' B' B ' 76' ' ' LEU . . . . . . . . . . . . . 5.7 mp -123.48 146.04 48.36 Favored 'General case' 0 C--N 1.331 -0.22 0 CA-C-N 115.572 -0.74 . . . . 0.0 109.554 175.812 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' B' B ' 77' ' ' GLU . . . . . . . . . . . . . 96.9 mt-10 -134.5 132.29 39.05 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-O 121.085 0.469 . . . . 0.0 111.106 -178.267 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' B' B ' 78' ' ' ALA . . . . . . . . . . . . . . . -117.18 136.81 52.77 Favored 'General case' 0 C--N 1.331 -0.229 0 CA-C-N 115.657 -0.701 . . . . 0.0 109.91 176.898 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' B' B ' 79' ' ' LYS . . . . . . . . . . . . . 55.6 mtmt -85.37 112.8 21.16 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.501 -0.318 . . . . 0.0 110.721 -178.359 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' B' B ' 80' ' ' ILE . . . . . . . . . . . . . 41.0 mm -139.04 104.2 2.18 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.302 0 N-CA-C 109.33 -0.619 . . . . 0.0 109.33 -178.164 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' B' B ' 81' ' ' LYS . . . . . . . . . . . . . 52.9 pttt -98.99 130.87 45.36 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-O 120.923 0.392 . . . . 0.0 111.123 -178.497 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' B' B ' 82' ' ' GLY . . . . . . . . . . . . . . . 89.22 42.1 5.66 Favored Glycine 0 CA--C 1.524 0.649 0 N-CA-C 111.191 -0.764 . . . . 0.0 111.191 178.087 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' B' B ' 83' ' ' ILE . . . . . . . . . . . . . 66.6 mt -70.23 135.55 27.94 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.342 0 N-CA-C 109.539 -0.541 . . . . 0.0 109.539 177.676 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' B' B ' 84' ' ' LYS . . . . . . . . . . . . . 16.4 ttmm -89.37 -52.24 5.14 Favored 'General case' 0 C--N 1.328 -0.36 0 N-CA-C 109.734 -0.469 . . . . 0.0 109.734 179.687 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' B' B ' 85' ' ' ASP . . . . . . . . . . . . . 8.5 t70 -160.46 154.39 22.84 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 115.615 -0.72 . . . . 0.0 110.476 178.845 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' B' B ' 86' ' ' VAL . . . . . . . . . . . . . 40.5 t -128.34 131.47 69.03 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.259 0 CA-C-O 120.89 0.376 . . . . 0.0 110.194 179.985 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' B' B ' 87' ' ' ILE . . . . . . . . . . . . . 5.0 mp -120.54 127.12 75.89 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.238 0 CA-C-N 116.021 -0.536 . . . . 0.0 109.755 177.855 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' B' B ' 88' ' ' LEU . . . . . . . . . . . . . 42.4 mt -104.75 139.78 39.04 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 116.248 -0.433 . . . . 0.0 111.0 -179.842 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' B' B ' 89' ' ' ASP . . . . . . . . . . . . . 9.5 t70 -132.98 158.4 42.77 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 115.922 -0.581 . . . . 0.0 109.672 176.917 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' B' B ' 90' ' ' GLU . . . . . . . . . . . . . 43.0 mt-10 -46.83 -39.69 12.43 Favored 'General case' 0 C--N 1.329 -0.306 0 N-CA-C 113.139 0.792 . . . . 0.0 113.139 -170.469 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' B' B ' 91' ' ' ASN . . . . . . . . . . . . . 29.2 m-80 -131.99 21.33 4.52 Favored 'General case' 0 N--CA 1.468 0.444 0 N-CA-C 113.044 0.757 . . . . 0.0 113.044 -177.591 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' B' B ' 92' ' ' LEU . . . . . . . . . . . . . 34.1 mt -150.37 150.34 31.28 Favored 'General case' 0 C--N 1.331 -0.222 0 CA-C-O 120.766 0.317 . . . . 0.0 110.451 -176.923 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' B' B ' 93' ' ' ILE . . . . . . . . . . . . . 73.3 mt -127.07 121.48 57.97 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.251 0 N-CA-C 109.133 -0.691 . . . . 0.0 109.133 175.361 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' B' B ' 94' ' ' VAL . . . . . . . . . . . . . 46.9 t -118.64 126.25 75.05 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.215 0 N-CA-C 109.814 -0.439 . . . . 0.0 109.814 -179.192 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' B' B ' 95' ' ' VAL . . . . . . . . . . . . . 46.5 t -118.91 133.19 66.56 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.316 0 CA-C-N 115.901 -0.591 . . . . 0.0 109.643 -179.951 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' B' B ' 96' ' ' ILE . . . . . . . . . . . . . 64.4 mt -111.91 126.22 69.28 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.317 0 N-CA-C 109.081 -0.711 . . . . 0.0 109.081 178.982 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' B' B ' 97' ' ' THR . . . . . . . . . . . . . 74.3 p -99.34 154.12 18.44 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-O 121.192 0.52 . . . . 0.0 111.117 -176.877 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' B' B ' 98' ' ' GLU . . . . . . . . . . . . . 84.9 tt0 -53.88 -25.51 20.34 Favored 'General case' 0 CA--C 1.535 0.372 0 CA-C-N 116.069 -0.514 . . . . 0.0 112.231 -179.513 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' B' B ' 99' ' ' GLU . . . . . . . . . . . . . 45.5 mp0 -80.91 18.08 1.08 Allowed 'General case' 0 CA--C 1.535 0.386 0 N-CA-C 112.989 0.737 . . . . 0.0 112.989 -176.619 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' B' B ' 100' ' ' ASN . . . . . . . . . . . . . 3.1 m-20 62.4 37.97 13.24 Favored 'General case' 0 C--O 1.232 0.171 0 CA-C-O 121.193 0.52 . . . . 0.0 110.997 178.121 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' B' B ' 101' ' ' GLU . . . . . . . . . . . . . 84.8 tt0 -118.77 144.77 46.08 Favored 'General case' 0 C--N 1.332 -0.175 0 CA-C-N 116.211 -0.449 . . . . 0.0 109.954 177.136 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' B' B ' 102' ' ' VAL . . . . . . . . . . . . . 44.1 t -115.09 125.34 72.37 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.29 0 N-CA-C 109.797 -0.445 . . . . 0.0 109.797 -178.034 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' B' B ' 103' ' ' LEU . . . . . . . . . . . . . 34.6 mt -117.07 130.23 56.52 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-N 115.814 -0.63 . . . . 0.0 110.006 177.874 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' B' B ' 104' ' ' ILE . . . . . . . . . . . . . 69.7 mt -118.05 122.73 70.37 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.249 0 N-CA-C 110.222 -0.288 . . . . 0.0 110.222 -179.115 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' B' B ' 105' ' ' PHE . . . . . . . . . . . . . 90.9 m-85 -122.77 164.31 18.59 Favored 'General case' 0 C--N 1.332 -0.168 0 O-C-N 123.783 0.677 . . . . 0.0 110.236 -178.496 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' B' B ' 106' ' ' ASN . . . . . . . . . . . . . 49.6 p-10 -98.14 -170.74 2.02 Favored 'General case' 0 C--N 1.33 -0.28 0 N-CA-C 109.866 -0.42 . . . . 0.0 109.866 174.933 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' B' B ' 107' ' ' GLN . . . . . . . . . . . . . 58.9 tt0 -58.24 -30.01 66.2 Favored 'General case' 0 C--N 1.328 -0.332 0 N-CA-C 112.038 0.384 . . . . 0.0 112.038 -178.407 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' B' B ' 108' ' ' ASN . . . . . . . . . . . . . 10.6 t-20 -89.88 14.02 13.11 Favored 'General case' 0 CA--C 1.534 0.348 0 N-CA-C 113.098 0.777 . . . . 0.0 113.098 -176.033 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' B' B ' 109' ' ' LEU . . . . . . . . . . . . . 14.5 mt 58.61 35.38 24.49 Favored 'General case' 0 C--N 1.331 -0.201 0 CA-C-O 120.924 0.392 . . . . 0.0 111.502 179.628 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' B' B ' 110' ' ' GLU . . . . . . . . . . . . . 96.5 mt-10 -101.92 143.3 31.97 Favored 'General case' 0 C--N 1.328 -0.34 0 N-CA-C 109.189 -0.671 . . . . 0.0 109.189 174.392 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' B' B ' 111' ' ' GLU . . . . . . . . . . . . . 51.1 tt0 -81.23 121.83 26.65 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-O 120.97 0.414 . . . . 0.0 110.653 -175.299 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' B' B ' 112' ' ' LEU . . . . . . . . . . . . . 23.2 mt -103.67 -46.09 4.63 Favored 'General case' 0 C--N 1.331 -0.212 0 CA-C-N 115.88 -0.6 . . . . 0.0 110.691 179.668 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' B' B ' 113' ' ' TYR . . . . . . . . . . . . . 58.7 t80 -137.67 146.73 44.19 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.961 -178.929 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' B' B ' 114' ' ' ARG . . . . . . . . . . . . . 30.4 ptt180 -149.69 124.58 9.92 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-N 116.158 -0.473 . . . . 0.0 111.051 -178.527 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' B' B ' 115' ' ' GLY . . . . . . . . . . . . . . . -150.16 162.42 29.21 Favored Glycine 0 CA--C 1.525 0.692 0 N-CA-C 110.928 -0.869 . . . . 0.0 110.928 178.806 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' B' B ' 116' ' ' LYS . . . . . . . . . . . . . 38.3 ttpt -131.95 138.67 48.42 Favored 'General case' 0 C--N 1.33 -0.259 0 N-CA-C 109.979 -0.378 . . . . 0.0 109.979 177.13 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' B' B ' 117' ' ' PHE . . . . . . . . . . . . . 41.8 m-85 -136.37 117.31 14.23 Favored 'General case' 0 C--N 1.331 -0.227 0 C-N-CA 120.874 -0.331 . . . . 0.0 110.362 -175.716 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' B' B ' 118' ' ' GLU . . . . . . . . . . . . . 70.6 mm-40 -54.11 -45.23 71.82 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.616 -0.265 . . . . 0.0 111.246 -177.515 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' B' B ' 119' ' ' ASN . . . . . . . . . . . . . 84.1 m-20 -98.87 31.06 3.09 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.181 -0.463 . . . . 0.0 112.171 -174.479 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' B' B ' 120' ' ' LEU . . . . . . . . . . . . . 23.0 tp -56.23 120.78 8.13 Favored 'General case' 0 C--N 1.332 -0.17 0 CA-C-O 120.626 0.25 . . . . 0.0 110.393 178.512 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' B' B ' 121' ' ' ASN . . . . . . . . . . . . . 34.3 m120 -109.66 -44.21 3.9 Favored 'General case' 0 N--CA 1.462 0.152 0 CA-C-N 116.649 -0.251 . . . . 0.0 111.211 -176.118 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' B' B ' 122' ' ' LYS . . . . . . . . . . . . . 94.3 mttt -147.94 148.14 30.47 Favored 'General case' 0 C--N 1.333 -0.139 0 C-N-CA 120.392 -0.523 . . . . 0.0 111.966 -177.918 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' B' B ' 123' ' ' VAL . . . . . . . . . . . . . 48.0 t -124.09 128.17 73.88 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.255 0 N-CA-C 109.251 -0.648 . . . . 0.0 109.251 173.792 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' B' B ' 124' ' ' LEU . . . . . . . . . . . . . 12.9 tp -129.07 132.42 47.43 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-O 120.651 0.262 . . . . 0.0 110.729 -177.092 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' B' B ' 125' ' ' VAL . . . . . . . . . . . . . 12.3 p -135.45 136.08 51.17 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.23 0 CA-C-O 120.735 0.302 . . . . 0.0 110.393 179.095 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' B' B ' 126' ' ' ARG . . . . . . . . . . . . . 96.4 mtt180 -148.72 134.16 18.58 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-O 120.977 0.418 . . . . 0.0 111.052 179.583 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' B' B ' 127' ' ' ASN . . . . . . . . . . . . . 86.3 m-20 50.32 -111.52 0.52 Allowed 'General case' 0 CA--C 1.545 0.778 0 CA-C-O 118.786 -0.626 . . . . 0.0 111.398 178.827 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' B' B ' 128' ' ' ASP . . . . . . . . . . . . . 8.2 p-10 -114.12 8.62 17.01 Favored 'General case' 0 CA--C 1.536 0.423 0 CA-C-N 119.908 1.231 . . . . 0.0 113.322 -176.934 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' B' B ' 129' ' ' LEU . . . . . . . . . . . . . 42.3 mt -117.72 144.75 44.99 Favored 'General case' 0 C--O 1.232 0.134 0 CA-C-N 118.028 0.376 . . . . 0.0 110.197 179.73 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' B' B ' 130' ' ' VAL . . . . . . . . . . . . . 12.1 p -132.97 140.31 47.58 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.212 0 CA-C-O 120.967 0.413 . . . . 0.0 110.366 -179.572 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' B' B ' 131' ' ' VAL . . . . . . . . . . . . . 44.1 t -136.01 139.95 44.9 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.287 0 CA-C-N 116.046 -0.524 . . . . 0.0 110.337 -178.531 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' B' B ' 132' ' ' ILE . . . . . . . . . . . . . 74.4 mt -115.92 131.43 68.39 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.364 0 CA-C-N 115.548 -0.751 . . . . 0.0 109.05 177.735 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' B' B ' 133' ' ' ILE . . . . . . . . . . . . . 42.9 mm -114.86 121.07 66.2 Favored 'Isoleucine or valine' 0 C--O 1.234 0.252 0 CA-C-O 120.867 0.365 . . . . 0.0 111.027 -174.744 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' B' B ' 134' ' ' ASP . . . . . . . . . . . . . 6.3 p-10 -129.74 146.41 51.5 Favored 'General case' 0 C--N 1.332 -0.191 0 CA-C-N 115.834 -0.621 . . . . 0.0 109.485 174.605 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' B' B ' 135' ' ' GLU . . . . . . . . . . . . . 41.7 tp10 -49.9 -24.25 2.4 Favored 'General case' 0 C--N 1.328 -0.369 0 N-CA-C 112.976 0.732 . . . . 0.0 112.976 -169.808 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' B' B ' 136' ' ' GLN . . . . . . . . . . . . . 21.3 pt20 -102.4 -30.45 11.02 Favored 'General case' 0 CA--C 1.532 0.255 0 N-CA-C 112.709 0.633 . . . . 0.0 112.709 -174.603 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' B' B ' 137' ' ' LYS . . . . . . . . . . . . . 27.4 mtpp -141.48 153.86 45.2 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-O 121.278 0.561 . . . . 0.0 111.519 -172.044 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' B' B ' 138' ' ' LEU . . . . . . . . . . . . . 5.0 tt -114.94 124.43 51.66 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 115.615 -0.72 . . . . 0.0 109.382 174.72 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' B' B ' 139' ' ' THR . . . . . . . . . . . . . 44.0 m -108.04 122.97 47.96 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.471 -0.331 . . . . 0.0 110.727 -177.994 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' B' B ' 140' ' ' LEU . . . . . . . . . . . . . 38.8 tp -112.97 121.56 45.0 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 115.665 -0.698 . . . . 0.0 109.322 -179.294 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' B' B ' 141' ' ' ILE . . . . . . . . . . . . . 19.2 mt -123.91 125.84 71.63 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.268 0 CA-C-O 121.012 0.434 . . . . 0.0 109.937 -176.991 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' B' B ' 142' ' ' ARG . . . . . . . . . . . . . 72.7 mtp180 -108.53 124.01 49.8 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 115.304 -0.862 . . . . 0.0 110.344 179.716 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' B' B ' 143' ' ' THR . . . . . . . . . . . . . 77.2 p . . . . . 0 C--O 1.219 -0.501 0 CA-C-O 118.016 -0.992 . . . . 0.0 110.522 -179.316 . . . . . . . . 0 0 . 1 . 011 nuclear orig core ' C' C ' 2' ' ' SER . . . . . . . . . . . . . 5.5 p . . . . . 0 C--O 1.231 0.09 0 CA-C-O 120.799 0.333 . . . . 0.0 110.128 . . . . . . . . . 0 0 . 1 . 011 nuclear orig core ' C' C ' 3' ' ' GLU . . . . . . . . . . . . . 94.7 mt-10 -141.28 136.6 31.78 Favored 'General case' 0 C--N 1.327 -0.407 0 CA-C-N 116.129 -0.487 . . . . 0.0 111.066 -178.681 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' C' C ' 4' ' ' LEU . . . . . . . . . . . . . 15.2 tp -123.04 126.38 46.99 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 115.983 -0.553 . . . . 0.0 109.806 175.554 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' C' C ' 5' ' ' LYS . . . . . . . . . . . . . 69.2 mttm -113.49 121.49 44.41 Favored 'General case' 0 C--N 1.331 -0.221 0 CA-C-N 116.371 -0.377 . . . . 0.0 110.669 -179.267 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' C' C ' 6' ' ' LEU . . . . . . . . . . . . . 58.2 mt -115.83 143.57 45.22 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 115.415 -0.812 . . . . 0.0 110.264 -178.726 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' C' C ' 7' ' ' LYS . . . . . . . . . . . . . 82.8 tttt -124.19 135.17 26.09 Favored Pre-proline 0 CA--C 1.534 0.359 0 CA-C-O 118.792 -0.623 . . . . 0.0 109.575 175.098 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' C' C ' 8' ' ' PRO . . . . . . . . . . . . . 88.3 Cg_endo -91.27 137.99 2.18 Favored 'Trans proline' 0 N--CA 1.49 1.317 0 C-N-CA 121.665 1.577 . . . . 0.0 111.901 179.357 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' C' C ' 9' ' ' LEU . . . . . . . . . . . . . 65.1 mt -71.8 -47.44 12.02 Favored Pre-proline 0 CA--C 1.533 0.312 0 CA-C-O 118.725 -0.655 . . . . 0.0 112.071 179.628 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' C' C ' 10' ' ' PRO . . . . . . . . . . . . . 98.7 Cg_endo -79.53 151.95 22.78 Favored 'Trans proline' 0 N--CA 1.495 1.57 0 C-N-CA 121.156 1.237 . . . . 0.0 111.779 175.696 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' C' C ' 11' ' ' LYS . . . . . . . . . . . . . 64.3 mttp -88.32 91.83 8.93 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-O 120.783 0.325 . . . . 0.0 110.69 179.807 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' C' C ' 12' ' ' VAL . . . . . . . . . . . . . 12.6 p -140.47 145.93 25.13 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.325 0 CA-C-N 116.16 -0.473 . . . . 0.0 110.34 178.684 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' C' C ' 13' ' ' GLU . . . . . . . . . . . . . 13.9 pt-20 -86.81 134.07 33.59 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.784 179.828 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' C' C ' 14' ' ' LEU . . . . . . . . . . . . . 50.0 mt -97.65 149.33 35.6 Favored Pre-proline 0 CA--C 1.532 0.28 0 CA-C-O 119.244 -0.407 . . . . 0.0 110.27 179.492 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' C' C ' 15' ' ' PRO . . . . . . . . . . . . . 26.8 Cg_exo -60.7 160.23 25.49 Favored 'Trans proline' 0 N--CA 1.498 1.786 0 C-N-CA 121.321 1.347 . . . . 0.0 111.834 178.584 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' C' C ' 16' ' ' PRO . . . . . . . . . . . . . 33.7 Cg_exo -59.17 -41.99 54.81 Favored 'Trans proline' 0 N--CA 1.497 1.705 0 C-N-CA 121.5 1.467 . . . . 0.0 112.587 -178.16 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' C' C ' 17' ' ' ASP . . . . . . . . . . . . . 8.7 p-10 -85.27 11.07 10.78 Favored 'General case' 0 CA--C 1.537 0.456 0 N-CA-C 113.065 0.765 . . . . 0.0 113.065 -178.816 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' C' C ' 18' ' ' PHE . . . . . . . . . . . . . 51.3 t80 -58.21 -42.96 87.36 Favored 'General case' 0 C--N 1.333 -0.109 0 O-C-N 122.06 -0.4 . . . . 0.0 110.082 -177.54 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' C' C ' 19' ' ' VAL . . . . . . . . . . . . . 48.3 t -57.54 -42.09 80.34 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.319 0 CA-C-N 116.385 -0.37 . . . . 0.0 110.522 -177.919 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' C' C ' 20' ' ' ASP . . . . . . . . . . . . . 83.4 m-20 -59.86 -43.52 94.65 Favored 'General case' 0 C--O 1.234 0.261 0 CA-C-O 120.96 0.409 . . . . 0.0 110.848 -178.493 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' C' C ' 21' ' ' VAL . . . . . . . . . . . . . 49.1 t -64.39 -48.54 84.81 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.251 0 CA-C-N 116.376 -0.374 . . . . 0.0 110.433 -178.097 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' C' C ' 22' ' ' ILE . . . . . . . . . . . . . 51.7 mm -56.68 -43.05 78.31 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.254 0 C-N-CA 121.079 -0.248 . . . . 0.0 110.574 179.175 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' C' C ' 23' ' ' ARG . . . . . . . . . . . . . 47.3 ttp180 -55.06 -46.64 75.38 Favored 'General case' 0 C--N 1.33 -0.255 0 C-N-CA 121.065 -0.254 . . . . 0.0 111.212 -178.495 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' C' C ' 24' ' ' ILE . . . . . . . . . . . . . 72.4 mt -59.57 -42.95 89.8 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.229 0 C-N-CA 120.869 -0.333 . . . . 0.0 110.758 179.571 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' C' C ' 25' ' ' LYS . . . . . . . . . . . . . 45.9 mmtt -62.0 -43.35 99.03 Favored 'General case' 0 C--N 1.328 -0.36 0 N-CA-C 112.037 0.384 . . . . 0.0 112.037 -179.425 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' C' C ' 26' ' ' LEU . . . . . . . . . . . . . 92.8 mt -79.67 -39.28 31.73 Favored 'General case' 0 C--N 1.329 -0.288 0 N-CA-C 113.646 0.98 . . . . 0.0 113.646 -169.899 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' C' C ' 27' ' ' GLN . . . . . . . . . . . . . 9.9 pt20 -46.77 137.51 7.02 Favored 'General case' 0 N--CA 1.469 0.502 0 N-CA-C 112.925 0.713 . . . . 0.0 112.925 -173.627 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' C' C ' 28' ' ' GLY . . . . . . . . . . . . . . . 99.47 -25.53 27.9 Favored Glycine 0 CA--C 1.533 1.179 0 CA-C-N 115.45 -0.796 . . . . 0.0 112.367 -176.934 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' C' C ' 29' ' ' LYS . . . . . . . . . . . . . 68.5 mttm -98.38 155.16 17.36 Favored 'General case' 0 C--O 1.233 0.187 0 CA-C-N 117.256 0.528 . . . . 0.0 111.061 179.537 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' C' C ' 30' ' ' THR . . . . . . . . . . . . . 25.9 m -108.59 139.92 42.69 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.149 176.267 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' C' C ' 31' ' ' VAL . . . . . . . . . . . . . 34.6 m -130.06 153.92 39.63 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.277 0 CA-C-N 116.292 -0.413 . . . . 0.0 110.9 -178.738 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' C' C ' 32' ' ' ARG . . . . . . . . . . . . . 84.3 mtm180 -128.82 147.55 50.81 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-O 121.325 0.583 . . . . 0.0 110.702 179.436 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' C' C ' 33' ' ' THR . . . . . . . . . . . . . 19.0 m -53.58 139.8 30.57 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.133 -0.485 . . . . 0.0 111.329 -178.902 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' C' C ' 34' ' ' GLY . . . . . . . . . . . . . . . 98.45 -17.13 58.92 Favored Glycine 0 CA--C 1.533 1.207 0 CA-C-O 119.706 -0.496 . . . . 0.0 113.266 178.969 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' C' C ' 35' ' ' ASP . . . . . . . . . . . . . 81.9 m-20 -66.75 149.34 50.69 Favored 'General case' 0 N--CA 1.461 0.109 0 CA-C-N 118.017 0.908 . . . . 0.0 111.044 178.978 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' C' C ' 36' ' ' VAL . . . . . . . . . . . . . 43.6 t -118.71 128.27 75.6 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.211 0 CA-C-N 116.154 -0.475 . . . . 0.0 109.725 176.832 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' C' C ' 37' ' ' ILE . . . . . . . . . . . . . 61.6 mt -119.46 137.47 53.27 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.251 0 CA-C-N 116.105 -0.498 . . . . 0.0 109.867 -179.515 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' C' C ' 38' ' ' GLY . . . . . . . . . . . . . . . -115.45 127.9 7.82 Favored Glycine 0 CA--C 1.525 0.668 0 N-CA-C 110.95 -0.86 . . . . 0.0 110.95 178.971 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' C' C ' 39' ' ' ILE . . . . . . . . . . . . . 70.5 mt -126.72 127.78 70.41 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.232 0 N-CA-C 109.905 -0.405 . . . . 0.0 109.905 178.493 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' C' C ' 40' ' ' SER . . . . . . . . . . . . . 60.4 p -91.97 119.63 31.88 Favored 'General case' 0 C--N 1.33 -0.264 0 C-N-CA 120.968 -0.293 . . . . 0.0 110.667 176.463 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' C' C ' 41' ' ' ILE . . . . . . . . . . . . . 73.3 mt -131.45 130.33 62.62 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.215 0 CA-C-O 120.868 0.366 . . . . 0.0 110.367 179.708 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' C' C ' 42' ' ' LEU . . . . . . . . . . . . . 72.8 mt 57.38 33.06 22.76 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 116.105 -0.498 . . . . 0.0 111.895 177.589 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' C' C ' 43' ' ' GLY . . . . . . . . . . . . . . . 72.55 23.06 78.57 Favored Glycine 0 CA--C 1.532 1.138 0 C-N-CA 121.132 -0.556 . . . . 0.0 112.727 177.882 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' C' C ' 44' ' ' LYS . . . . . . . . . . . . . 33.4 ttmt -139.09 129.56 25.73 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 117.315 0.557 . . . . 0.0 109.746 178.379 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' C' C ' 45' ' ' GLU . . . . . . . . . . . . . 45.9 tp10 -84.14 129.66 34.89 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-O 120.836 0.35 . . . . 0.0 111.279 -177.172 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' C' C ' 46' ' ' VAL . . . . . . . . . . . . . 9.1 p -122.75 126.12 73.43 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.246 0 N-CA-C 109.409 -0.589 . . . . 0.0 109.409 174.578 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' C' C ' 47' ' ' LYS . . . . . . . . . . . . . 64.3 mttm -100.03 128.76 46.07 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.03 -0.532 . . . . 0.0 111.339 179.068 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' C' C ' 48' ' ' PHE . . . . . . . . . . . . . 28.4 m-85 -112.51 131.97 55.32 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 116.015 -0.539 . . . . 0.0 109.795 177.549 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' C' C ' 49' ' ' LYS . . . . . . . . . . . . . 46.2 tttp -105.45 132.21 51.91 Favored 'General case' 0 C--N 1.329 -0.315 0 N-CA-C 109.812 -0.44 . . . . 0.0 109.812 177.741 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' C' C ' 50' ' ' VAL . . . . . . . . . . . . . 46.2 t -72.86 106.03 2.74 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.324 0 N-CA-C 109.454 -0.573 . . . . 0.0 109.454 178.454 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' C' C ' 51' ' ' VAL . . . . . . . . . . . . . 49.0 t -68.5 -50.61 54.8 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.279 0 N-CA-C 109.5 -0.556 . . . . 0.0 109.5 -176.357 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' C' C ' 52' ' ' GLN . . . . . . . . . . . . . 21.5 pt20 -162.67 157.81 22.31 Favored 'General case' 0 C--N 1.331 -0.201 0 CA-C-N 115.908 -0.587 . . . . 0.0 111.649 179.239 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' C' C ' 53' ' ' ALA . . . . . . . . . . . . . . . -130.97 132.61 45.16 Favored 'General case' 0 C--N 1.326 -0.422 0 CA-C-N 115.176 -0.92 . . . . 0.0 109.817 178.165 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' C' C ' 54' ' ' TYR . . . . . . . . . . . . . 29.3 t80 -128.98 108.37 18.19 Favored Pre-proline 0 CA--C 1.534 0.358 0 CA-C-O 118.204 -0.903 . . . . 0.0 110.413 -179.008 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' C' C ' 55' ' ' PRO . . . . . . . . . . . . . 73.1 Cg_endo -77.16 170.03 72.63 Favored 'Cis proline' 0 N--CA 1.501 1.916 0 CA-C-N 121.833 1.69 . . . . 0.0 112.451 -5.776 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' C' C ' 56' ' ' SER . . . . . . . . . . . . . 14.5 m -114.23 128.34 25.91 Favored Pre-proline 0 CA--C 1.54 0.568 0 CA-C-O 118.368 -0.825 . . . . 0.0 109.348 175.356 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' C' C ' 57' ' ' PRO . . . . . . . . . . . . . 57.0 Cg_endo -71.97 149.5 92.95 Favored 'Cis proline' 0 N--CA 1.497 1.689 0 CA-C-N 121.98 1.743 . . . . 0.0 111.857 -0.556 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' C' C ' 58' ' ' LEU . . . . . . . . . . . . . 24.9 tp -108.64 137.03 47.26 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.294 -0.412 . . . . 0.0 110.643 -178.622 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' C' C ' 59' ' ' ARG . . . . . . . . . . . . . 57.0 ttm-85 -107.11 127.53 53.57 Favored 'General case' 0 C--N 1.329 -0.321 0 N-CA-C 109.322 -0.621 . . . . 0.0 109.322 175.95 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' C' C ' 60' ' ' VAL . . . . . . . . . . . . . 40.9 t -81.71 120.69 33.75 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.231 0 CA-C-O 121.074 0.464 . . . . 0.0 110.968 -173.733 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' C' C ' 61' ' ' GLU . . . . . . . . . . . . . 80.4 tt0 -131.15 158.21 41.08 Favored 'General case' 0 C--N 1.33 -0.275 0 N-CA-C 108.73 -0.841 . . . . 0.0 108.73 174.729 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' C' C ' 62' ' ' ASP . . . . . . . . . . . . . 52.8 m-20 -49.82 -32.2 13.56 Favored 'General case' 0 C--N 1.329 -0.294 0 N-CA-C 112.352 0.501 . . . . 0.0 112.352 -178.146 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' C' C ' 63' ' ' ARG . . . . . . . . . . . . . 26.7 mmm180 -71.25 -20.79 62.19 Favored 'General case' 0 CA--C 1.536 0.415 0 N-CA-C 112.999 0.741 . . . . 0.0 112.999 -176.357 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' C' C ' 64' ' ' THR . . . . . . . . . . . . . 36.8 m -67.87 141.76 56.31 Favored 'General case' 0 C--N 1.331 -0.239 0 CA-C-O 121.051 0.453 . . . . 0.0 111.222 -175.592 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' C' C ' 65' ' ' LYS . . . . . . . . . . . . . 63.6 mttm -89.65 132.94 34.89 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 115.749 -0.66 . . . . 0.0 109.86 177.35 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' C' C ' 66' ' ' ILE . . . . . . . . . . . . . 63.1 mt -118.59 132.04 69.61 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.22 0 N-CA-C 110.055 -0.35 . . . . 0.0 110.055 -179.276 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' C' C ' 67' ' ' THR . . . . . . . . . . . . . 25.9 m -129.24 139.08 51.97 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-O 121.048 0.451 . . . . 0.0 111.26 -178.348 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' C' C ' 68' ' ' LEU . . . . . . . . . . . . . 39.3 mt . . . . . 0 C--N 1.33 -0.248 0 CA-C-N 115.891 -0.595 . . . . 0.0 110.165 176.066 . . . . . . . . 0 0 . 1 . 011 nuclear orig core ' C' C ' 73' ' ' VAL . . . . . . . . . . . . . 32.9 m . . . . . 0 C--O 1.23 0.068 0 CA-C-O 120.888 0.375 . . . . 0.0 110.782 . . . . . . . . . 0 0 . 1 . 011 nuclear orig core ' C' C ' 74' ' ' ASP . . . . . . . . . . . . . 10.8 t70 -97.04 122.29 39.87 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.109 -0.496 . . . . 0.0 109.734 179.222 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' C' C ' 75' ' ' VAL . . . . . . . . . . . . . 46.0 t -116.98 125.54 73.93 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.196 0 CA-C-O 120.879 0.371 . . . . 0.0 110.698 -175.27 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' C' C ' 76' ' ' LEU . . . . . . . . . . . . . 19.4 mt -131.51 145.57 51.82 Favored 'General case' 0 C--N 1.333 -0.148 0 CA-C-N 116.012 -0.54 . . . . 0.0 110.488 179.559 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' C' C ' 77' ' ' GLU . . . . . . . . . . . . . 33.1 mp0 -135.48 141.92 45.42 Favored 'General case' 0 C--N 1.331 -0.225 0 CA-C-O 121.136 0.493 . . . . 0.0 111.046 178.345 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' C' C ' 78' ' ' ALA . . . . . . . . . . . . . . . -126.57 135.03 50.73 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 115.677 -0.692 . . . . 0.0 109.86 176.184 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' C' C ' 79' ' ' LYS . . . . . . . . . . . . . 76.5 tttt -81.73 111.19 17.76 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.315 -0.402 . . . . 0.0 110.57 -177.57 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' C' C ' 80' ' ' ILE . . . . . . . . . . . . . 42.8 mm -139.14 105.92 2.7 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.341 0 N-CA-C 109.15 -0.685 . . . . 0.0 109.15 -177.45 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' C' C ' 81' ' ' LYS . . . . . . . . . . . . . 32.1 ttpt -102.24 132.29 48.27 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-O 120.921 0.391 . . . . 0.0 110.845 -176.213 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' C' C ' 82' ' ' GLY . . . . . . . . . . . . . . . 89.19 42.09 5.67 Favored Glycine 0 CA--C 1.526 0.78 0 N-CA-C 111.563 -0.615 . . . . 0.0 111.563 177.623 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' C' C ' 83' ' ' ILE . . . . . . . . . . . . . 69.1 mt -79.26 141.87 14.78 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.284 0 N-CA-C 109.717 -0.475 . . . . 0.0 109.717 177.562 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' C' C ' 84' ' ' LYS . . . . . . . . . . . . . 38.8 ttpt -101.08 -54.02 2.89 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.309 -0.405 . . . . 0.0 110.464 -178.454 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' C' C ' 85' ' ' ASP . . . . . . . . . . . . . 7.2 t0 -146.46 150.61 35.94 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.097 -0.501 . . . . 0.0 110.781 -176.949 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' C' C ' 86' ' ' VAL . . . . . . . . . . . . . 44.1 t -128.12 131.2 69.58 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.259 0 CA-C-N 116.34 -0.391 . . . . 0.0 110.275 -179.065 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' C' C ' 87' ' ' ILE . . . . . . . . . . . . . 44.9 mm -118.61 126.84 75.5 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.254 0 N-CA-C 109.696 -0.483 . . . . 0.0 109.696 176.827 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' C' C ' 88' ' ' LEU . . . . . . . . . . . . . 13.7 tp -115.61 130.21 56.78 Favored 'General case' 0 C--N 1.331 -0.227 0 CA-C-O 120.964 0.411 . . . . 0.0 111.067 -177.014 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' C' C ' 89' ' ' ASP . . . . . . . . . . . . . 6.1 t0 -126.1 152.57 45.71 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 115.836 -0.62 . . . . 0.0 109.449 176.829 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' C' C ' 90' ' ' GLU . . . . . . . . . . . . . 84.8 tt0 -48.23 -35.72 12.5 Favored 'General case' 0 C--N 1.329 -0.312 0 N-CA-C 112.751 0.648 . . . . 0.0 112.751 -173.219 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' C' C ' 91' ' ' ASN . . . . . . . . . . . . . 85.1 m-20 -131.97 33.59 3.92 Favored 'General case' 0 N--CA 1.465 0.314 0 N-CA-C 111.877 0.325 . . . . 0.0 111.877 -176.804 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' C' C ' 92' ' ' LEU . . . . . . . . . . . . . 8.2 tp -166.07 142.6 5.11 Favored 'General case' 0 C--N 1.331 -0.215 0 C-N-CA 121.014 -0.274 . . . . 0.0 110.566 -179.002 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' C' C ' 93' ' ' ILE . . . . . . . . . . . . . 74.0 mt -127.14 125.17 65.8 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.26 0 N-CA-C 109.493 -0.558 . . . . 0.0 109.493 178.227 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' C' C ' 94' ' ' VAL . . . . . . . . . . . . . 45.2 t -127.1 129.83 71.11 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.259 0 CA-C-O 120.968 0.414 . . . . 0.0 110.197 179.914 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' C' C ' 95' ' ' VAL . . . . . . . . . . . . . 42.3 t -121.35 134.4 64.84 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.339 0 CA-C-N 115.936 -0.574 . . . . 0.0 109.76 179.324 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' C' C ' 96' ' ' ILE . . . . . . . . . . . . . 64.1 mt -116.15 128.71 73.37 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 N-CA-C 109.371 -0.604 . . . . 0.0 109.371 179.64 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' C' C ' 97' ' ' THR . . . . . . . . . . . . . 73.3 p -101.82 160.56 14.37 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-O 121.185 0.517 . . . . 0.0 111.13 -177.577 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' C' C ' 98' ' ' GLU . . . . . . . . . . . . . 12.5 pt-20 -54.04 -25.94 24.0 Favored 'General case' 0 C--N 1.328 -0.337 0 N-CA-C 112.39 0.515 . . . . 0.0 112.39 -178.108 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' C' C ' 99' ' ' GLU . . . . . . . . . . . . . 95.5 mt-10 -79.87 15.44 1.43 Allowed 'General case' 0 CA--C 1.536 0.404 0 N-CA-C 113.131 0.789 . . . . 0.0 113.131 -176.164 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' C' C ' 100' ' ' ASN . . . . . . . . . . . . . 3.5 m-20 61.82 37.35 15.54 Favored 'General case' 0 CA--C 1.531 0.245 0 CA-C-O 121.047 0.451 . . . . 0.0 110.995 179.499 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' C' C ' 101' ' ' GLU . . . . . . . . . . . . . 84.9 tt0 -114.82 141.27 48.12 Favored 'General case' 0 C--N 1.332 -0.159 0 CA-C-N 116.071 -0.513 . . . . 0.0 109.62 175.98 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' C' C ' 102' ' ' VAL . . . . . . . . . . . . . 43.7 t -116.46 127.01 74.19 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.341 0 CA-C-N 116.298 -0.41 . . . . 0.0 110.047 -178.122 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' C' C ' 103' ' ' LEU . . . . . . . . . . . . . 40.6 mt -114.85 130.14 56.83 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 115.719 -0.673 . . . . 0.0 110.071 176.496 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' C' C ' 104' ' ' ILE . . . . . . . . . . . . . 66.4 mt -114.95 122.22 68.62 Favored 'Isoleucine or valine' 0 C--O 1.234 0.254 0 N-CA-C 110.161 -0.311 . . . . 0.0 110.161 -178.693 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' C' C ' 105' ' ' PHE . . . . . . . . . . . . . 81.2 m-85 -123.24 163.57 20.41 Favored 'General case' 0 C--O 1.231 0.121 0 O-C-N 124.02 0.825 . . . . 0.0 109.591 -179.17 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' C' C ' 106' ' ' ASN . . . . . . . . . . . . . 47.4 p-10 -98.32 -170.61 1.99 Allowed 'General case' 0 C--N 1.33 -0.265 0 N-CA-C 109.828 -0.434 . . . . 0.0 109.828 173.525 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' C' C ' 107' ' ' GLN . . . . . . . . . . . . . 49.0 tt0 -59.44 -30.1 68.25 Favored 'General case' 0 C--N 1.33 -0.273 0 N-CA-C 112.128 0.418 . . . . 0.0 112.128 -179.252 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' C' C ' 108' ' ' ASN . . . . . . . . . . . . . 30.7 t30 -84.75 9.2 14.67 Favored 'General case' 0 CA--C 1.536 0.419 0 N-CA-C 113.181 0.808 . . . . 0.0 113.181 -177.009 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' C' C ' 109' ' ' LEU . . . . . . . . . . . . . 12.4 tp 61.56 37.51 16.24 Favored 'General case' 0 CA--C 1.53 0.188 0 CA-C-O 120.993 0.425 . . . . 0.0 111.249 178.573 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' C' C ' 110' ' ' GLU . . . . . . . . . . . . . 95.3 mt-10 -105.12 149.55 25.78 Favored 'General case' 0 C--N 1.33 -0.254 0 N-CA-C 109.687 -0.486 . . . . 0.0 109.687 175.584 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' C' C ' 111' ' ' GLU . . . . . . . . . . . . . 74.1 tt0 -87.45 121.92 30.52 Favored 'General case' 0 C--N 1.33 -0.272 0 C-N-CA 120.77 -0.372 . . . . 0.0 110.583 -175.31 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' C' C ' 112' ' ' LEU . . . . . . . . . . . . . 17.8 mt -108.01 -45.98 3.86 Favored 'General case' 0 C--N 1.332 -0.176 0 CA-C-N 115.992 -0.549 . . . . 0.0 110.78 -179.856 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' C' C ' 113' ' ' TYR . . . . . . . . . . . . . 46.8 t80 -135.55 141.89 45.27 Favored 'General case' 0 C--N 1.331 -0.23 0 CA-C-N 116.361 -0.381 . . . . 0.0 111.213 -178.179 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' C' C ' 114' ' ' ARG . . . . . . . . . . . . . 38.8 ptt180 -142.48 125.26 15.99 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.254 -0.43 . . . . 0.0 110.475 176.757 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' C' C ' 115' ' ' GLY . . . . . . . . . . . . . . . -150.09 162.25 29.14 Favored Glycine 0 CA--C 1.524 0.628 0 C-N-CA 120.693 -0.765 . . . . 0.0 111.55 -179.92 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' C' C ' 116' ' ' LYS . . . . . . . . . . . . . 39.1 ttpt -125.83 135.52 52.07 Favored 'General case' 0 C--N 1.332 -0.185 0 N-CA-C 109.866 -0.42 . . . . 0.0 109.866 176.994 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' C' C ' 117' ' ' PHE . . . . . . . . . . . . . 64.3 m-85 -130.65 113.81 14.64 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-O 120.856 0.36 . . . . 0.0 110.365 -178.256 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' C' C ' 118' ' ' GLU . . . . . . . . . . . . . 14.3 mm-40 -55.76 -48.19 75.71 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 116.397 -0.365 . . . . 0.0 111.056 -175.916 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' C' C ' 119' ' ' ASN . . . . . . . . . . . . . 68.1 m-80 -97.19 31.11 2.54 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.005 -0.543 . . . . 0.0 112.12 -174.185 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' C' C ' 120' ' ' LEU . . . . . . . . . . . . . 13.8 tp -52.63 119.88 5.04 Favored 'General case' 0 N--CA 1.466 0.325 0 O-C-N 122.238 -0.289 . . . . 0.0 111.029 178.999 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' C' C ' 121' ' ' ASN . . . . . . . . . . . . . 90.9 m-20 -113.93 -44.05 3.2 Favored 'General case' 0 C--N 1.331 -0.226 0 CA-C-N 116.317 -0.401 . . . . 0.0 111.242 -177.959 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' C' C ' 122' ' ' LYS . . . . . . . . . . . . . 38.4 ttpt -143.9 143.44 31.28 Favored 'General case' 0 C--N 1.333 -0.113 0 C-N-CA 120.507 -0.477 . . . . 0.0 111.577 -177.163 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' C' C ' 123' ' ' VAL . . . . . . . . . . . . . 43.9 t -126.41 127.44 70.5 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.285 0 N-CA-C 109.148 -0.686 . . . . 0.0 109.148 173.773 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' C' C ' 124' ' ' LEU . . . . . . . . . . . . . 8.7 tt -131.39 133.03 44.84 Favored 'General case' 0 N--CA 1.463 0.219 0 CA-C-O 120.961 0.41 . . . . 0.0 111.142 -176.377 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' C' C ' 125' ' ' VAL . . . . . . . . . . . . . 35.8 m -126.68 144.96 35.11 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.238 0 CA-C-N 115.798 -0.637 . . . . 0.0 110.441 179.607 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' C' C ' 126' ' ' ARG . . . . . . . . . . . . . 34.8 ttm180 -150.0 117.04 5.95 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-O 120.996 0.427 . . . . 0.0 110.412 177.819 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' C' C ' 127' ' ' ASN . . . . . . . . . . . . . 96.2 m-20 53.77 -107.6 0.37 Allowed 'General case' 0 CA--C 1.542 0.651 0 CA-C-N 116.0 -0.546 . . . . 0.0 110.859 -178.268 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' C' C ' 128' ' ' ASP . . . . . . . . . . . . . 8.4 p-10 -114.13 1.9 14.73 Favored 'General case' 0 CA--C 1.537 0.447 0 CA-C-N 119.742 1.156 . . . . 0.0 113.271 -177.994 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' C' C ' 129' ' ' LEU . . . . . . . . . . . . . 12.7 tp -105.15 139.59 39.58 Favored 'General case' 0 C--O 1.232 0.156 0 N-CA-C 109.429 -0.582 . . . . 0.0 109.429 178.789 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' C' C ' 130' ' ' VAL . . . . . . . . . . . . . 12.2 p -135.81 140.29 44.54 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.21 0 CA-C-O 121.295 0.569 . . . . 0.0 110.869 -177.564 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' C' C ' 131' ' ' VAL . . . . . . . . . . . . . 35.6 m -136.11 146.43 29.26 Favored 'Isoleucine or valine' 0 C--O 1.234 0.251 0 CA-C-N 115.793 -0.64 . . . . 0.0 110.935 178.782 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' C' C ' 132' ' ' ILE . . . . . . . . . . . . . 68.1 mt -122.88 134.0 67.32 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.293 0 CA-C-N 115.596 -0.729 . . . . 0.0 109.521 179.69 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' C' C ' 133' ' ' ILE . . . . . . . . . . . . . 42.7 mm -116.26 120.43 64.89 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.212 0 CA-C-N 116.548 -0.297 . . . . 0.0 110.733 -176.996 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' C' C ' 134' ' ' ASP . . . . . . . . . . . . . 6.1 p-10 -131.83 146.56 52.21 Favored 'General case' 0 C--N 1.331 -0.214 0 CA-C-N 116.21 -0.45 . . . . 0.0 109.806 176.379 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' C' C ' 135' ' ' GLU . . . . . . . . . . . . . 84.2 tt0 -50.0 -26.31 4.17 Favored 'General case' 0 C--N 1.328 -0.359 0 N-CA-C 112.937 0.718 . . . . 0.0 112.937 -170.779 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' C' C ' 136' ' ' GLN . . . . . . . . . . . . . 97.4 mt-30 -92.6 -35.47 13.53 Favored 'General case' 0 C--N 1.331 -0.196 0 N-CA-C 112.461 0.541 . . . . 0.0 112.461 -176.819 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' C' C ' 137' ' ' LYS . . . . . . . . . . . . . 54.4 mtmt -147.14 157.97 43.79 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-O 121.501 0.667 . . . . 0.0 112.048 -169.543 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' C' C ' 138' ' ' LEU . . . . . . . . . . . . . 6.9 tt -116.08 126.26 53.5 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 115.203 -0.908 . . . . 0.0 109.317 174.621 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' C' C ' 139' ' ' THR . . . . . . . . . . . . . 33.8 m -111.47 127.98 55.86 Favored 'General case' 0 C--N 1.331 -0.212 0 CA-C-N 116.401 -0.363 . . . . 0.0 110.713 -177.831 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' C' C ' 140' ' ' LEU . . . . . . . . . . . . . 9.0 tt -115.39 122.84 47.06 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 115.48 -0.782 . . . . 0.0 109.203 -179.781 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' C' C ' 141' ' ' ILE . . . . . . . . . . . . . 20.2 mt -120.5 117.72 54.24 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.27 0 CA-C-O 120.973 0.416 . . . . 0.0 110.046 -176.309 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' C' C ' 142' ' ' ARG . . . . . . . . . . . . . 62.6 ttp85 . . . . . 0 C--N 1.331 -0.205 0 CA-C-N 115.096 -0.956 . . . . 0.0 110.621 -177.72 . . . . . . . . 0 0 . 1 . 011 nuclear orig core ' D' D ' 2' ' ' SER . . . . . . . . . . . . . 5.8 p . . . . . 0 N--CA 1.461 0.087 0 CA-C-O 120.822 0.344 . . . . 0.0 110.354 . . . . . . . . . 0 0 . 1 . 011 nuclear orig core ' D' D ' 3' ' ' GLU . . . . . . . . . . . . . 94.2 mt-10 -141.28 137.92 32.82 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-N 116.072 -0.513 . . . . 0.0 111.014 -178.376 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' D' D ' 4' ' ' LEU . . . . . . . . . . . . . 15.5 tp -122.49 128.69 51.15 Favored 'General case' 0 C--N 1.33 -0.282 0 N-CA-C 109.86 -0.422 . . . . 0.0 109.86 175.695 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' D' D ' 5' ' ' LYS . . . . . . . . . . . . . 55.7 mttp -107.93 119.13 38.6 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.432 -0.349 . . . . 0.0 110.48 179.699 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' D' D ' 6' ' ' LEU . . . . . . . . . . . . . 71.3 mt -114.8 145.7 41.84 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 115.464 -0.789 . . . . 0.0 110.386 -177.698 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' D' D ' 7' ' ' LYS . . . . . . . . . . . . . 52.3 tttm -135.0 137.66 27.64 Favored Pre-proline 0 CA--C 1.534 0.329 0 CA-C-O 118.966 -0.54 . . . . 0.0 109.818 176.757 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' D' D ' 8' ' ' PRO . . . . . . . . . . . . . 94.0 Cg_endo -91.48 143.92 3.09 Favored 'Trans proline' 0 N--CA 1.49 1.322 0 C-N-CA 121.652 1.568 . . . . 0.0 111.877 178.495 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' D' D ' 9' ' ' LEU . . . . . . . . . . . . . 69.5 mt -80.31 -48.46 1.26 Allowed Pre-proline 0 C--N 1.328 -0.331 0 CA-C-O 118.467 -0.778 . . . . 0.0 112.372 -179.488 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' D' D ' 10' ' ' PRO . . . . . . . . . . . . . 77.7 Cg_endo -77.64 151.73 28.85 Favored 'Trans proline' 0 N--CA 1.496 1.635 0 C-N-CA 121.09 1.193 . . . . 0.0 112.009 177.618 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' D' D ' 11' ' ' LYS . . . . . . . . . . . . . 24.8 mtmt -88.29 92.32 9.12 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.311 -0.404 . . . . 0.0 110.616 179.965 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' D' D ' 12' ' ' VAL . . . . . . . . . . . . . 12.4 p -139.61 148.67 23.02 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.242 0 CA-C-N 116.073 -0.512 . . . . 0.0 110.454 -179.972 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' D' D ' 13' ' ' GLU . . . . . . . . . . . . . 84.6 tt0 -88.38 125.34 34.66 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.251 -0.431 . . . . 0.0 109.962 177.321 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' D' D ' 14' ' ' LEU . . . . . . . . . . . . . 38.2 mt -97.94 150.79 37.12 Favored Pre-proline 0 CA--C 1.531 0.249 0 CA-C-N 116.297 -0.41 . . . . 0.0 110.719 -176.328 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' D' D ' 15' ' ' PRO . . . . . . . . . . . . . 25.3 Cg_exo -62.66 155.61 57.88 Favored 'Trans proline' 0 N--CA 1.497 1.722 0 C-N-CA 121.347 1.365 . . . . 0.0 111.939 176.732 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' D' D ' 16' ' ' PRO . . . . . . . . . . . . . 35.4 Cg_exo -59.8 -30.65 92.47 Favored 'Trans proline' 0 N--CA 1.498 1.736 0 C-N-CA 121.345 1.363 . . . . 0.0 112.57 179.331 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' D' D ' 17' ' ' ASP . . . . . . . . . . . . . 7.9 p-10 -84.09 3.26 35.51 Favored 'General case' 0 C--N 1.327 -0.384 0 N-CA-C 113.329 0.862 . . . . 0.0 113.329 -177.448 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' D' D ' 18' ' ' PHE . . . . . . . . . . . . . 10.8 t80 -57.99 -45.98 85.93 Favored 'General case' 0 C--O 1.227 -0.118 0 O-C-N 121.871 -0.518 . . . . 0.0 110.058 -177.819 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' D' D ' 19' ' ' VAL . . . . . . . . . . . . . 48.6 t -56.23 -42.82 74.71 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.273 0 CA-C-N 116.168 -0.469 . . . . 0.0 110.61 -178.075 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' D' D ' 20' ' ' ASP . . . . . . . . . . . . . 83.3 m-20 -60.05 -44.05 94.94 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-O 120.782 0.325 . . . . 0.0 111.231 -177.338 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' D' D ' 21' ' ' VAL . . . . . . . . . . . . . 46.7 t -64.8 -45.6 94.55 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 C-N-CA 120.72 -0.392 . . . . 0.0 110.528 -177.532 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' D' D ' 22' ' ' ILE . . . . . . . . . . . . . 51.3 mm -56.63 -45.83 82.62 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.168 0 C-N-CA 120.87 -0.332 . . . . 0.0 110.547 179.386 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' D' D ' 23' ' ' ARG . . . . . . . . . . . . . 54.8 ttp180 -54.2 -49.52 69.18 Favored 'General case' 0 C--N 1.33 -0.258 0 C-N-CA 121.09 -0.244 . . . . 0.0 111.315 -178.165 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' D' D ' 24' ' ' ILE . . . . . 0.407 HD13 HG21 ' D' ' 24' ' ' ILE . 71.8 mt -60.32 -43.1 92.92 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.216 0 C-N-CA 121.059 -0.256 . . . . 0.0 111.32 -178.478 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' D' D ' 25' ' ' LYS . . . . . . . . . . . . . 62.4 mtpt -65.13 -40.99 95.22 Favored 'General case' 0 C--N 1.329 -0.323 0 N-CA-C 112.32 0.489 . . . . 0.0 112.32 -177.499 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' D' D ' 26' ' ' LEU . . . . . . . . . . . . . 45.2 mt -79.15 -41.61 28.09 Favored 'General case' 0 C--N 1.329 -0.324 0 N-CA-C 113.354 0.872 . . . . 0.0 113.354 -171.202 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' D' D ' 27' ' ' GLN . . . . . . . . . . . . . 10.2 pt20 -46.43 137.52 6.47 Favored 'General case' 0 N--CA 1.469 0.512 0 N-CA-C 112.823 0.675 . . . . 0.0 112.823 -174.882 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' D' D ' 28' ' ' GLY . . . . . . . . . . . . . . . 100.17 -27.27 21.12 Favored Glycine 0 CA--C 1.532 1.146 0 CA-C-N 115.591 -0.731 . . . . 0.0 112.249 -177.765 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' D' D ' 29' ' ' LYS . . . . . . . . . . . . . 97.2 mttt -98.21 155.24 17.27 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 117.142 0.471 . . . . 0.0 111.123 179.218 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' D' D ' 30' ' ' THR . . . . . . . . . . . . . 28.2 m -101.0 138.52 37.94 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 115.953 -0.567 . . . . 0.0 110.172 176.044 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' D' D ' 31' ' ' VAL . . . . . . . . . . . . . 34.9 m -131.07 152.57 37.76 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.255 0 CA-C-N 116.32 -0.4 . . . . 0.0 110.759 -179.586 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' D' D ' 32' ' ' ARG . . . . . . . . . . . . . 58.5 ttp180 -129.28 148.98 51.26 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-O 121.202 0.525 . . . . 0.0 110.673 179.676 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' D' D ' 33' ' ' THR . . . . . . . . . . . . . 27.4 m -53.52 138.96 32.65 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 116.276 -0.42 . . . . 0.0 111.24 179.964 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' D' D ' 34' ' ' GLY . . . . . . . . . . . . . . . 100.51 -17.11 57.17 Favored Glycine 0 CA--C 1.531 1.077 0 C-N-CA 121.272 -0.489 . . . . 0.0 113.225 -179.871 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' D' D ' 35' ' ' ASP . . . . . . . . . . . . . 69.3 m-20 -65.67 149.76 49.58 Favored 'General case' 0 C--O 1.232 0.147 0 CA-C-N 118.014 0.907 . . . . 0.0 111.314 179.564 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' D' D ' 36' ' ' VAL . . . . . . . . . . . . . 45.6 t -121.72 129.58 75.36 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.23 0 CA-C-N 115.774 -0.648 . . . . 0.0 109.771 177.511 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' D' D ' 37' ' ' ILE . . . . . . . . . . . . . 69.2 mt -121.41 138.98 49.97 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.282 0 CA-C-N 116.3 -0.409 . . . . 0.0 109.956 -179.504 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' D' D ' 38' ' ' GLY . . . . . . . . . . . . . . . -109.08 128.79 9.18 Favored Glycine 0 CA--C 1.526 0.762 0 N-CA-C 111.073 -0.811 . . . . 0.0 111.073 179.914 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' D' D ' 39' ' ' ILE . . . . . . . . . . . . . 71.7 mt -123.83 136.08 61.39 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.234 0 CA-C-O 120.842 0.353 . . . . 0.0 110.091 179.728 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' D' D ' 40' ' ' SER . . . . . . . . . . . . . 59.9 p -92.88 114.23 26.73 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.245 -0.434 . . . . 0.0 110.641 174.335 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' D' D ' 41' ' ' ILE . . . . . . . . . . . . . 47.0 mm -122.91 112.85 35.65 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.211 0 CA-C-O 120.724 0.297 . . . . 0.0 110.379 179.473 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' D' D ' 42' ' ' LEU . . . . . . . . . . . . . 1.3 tt 55.23 45.79 25.05 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-O 121.443 0.639 . . . . 0.0 110.521 178.111 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' D' D ' 43' ' ' GLY . . . . . . . . . . . . . . . 74.99 -9.67 11.15 Favored Glycine 0 CA--C 1.535 1.324 0 C-N-CA 121.342 -0.456 . . . . 0.0 113.712 175.687 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' D' D ' 44' ' ' LYS . . . . . . . . . . . . . 22.0 tptp -100.37 134.19 43.68 Favored 'General case' 0 C--N 1.331 -0.206 0 CA-C-N 117.927 0.863 . . . . 0.0 110.153 -178.998 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' D' D ' 45' ' ' GLU . . . . . . . . . . . . . 84.8 tt0 -83.29 123.03 29.21 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 116.458 -0.337 . . . . 0.0 110.732 -179.869 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' D' D ' 46' ' ' VAL . . . . . . . . . . . . . 7.1 p -123.49 127.64 74.26 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.182 0 N-CA-C 109.715 -0.476 . . . . 0.0 109.715 177.643 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' D' D ' 47' ' ' LYS . . . . . . . . . . . . . 63.7 mttp -100.23 129.98 46.3 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 115.954 -0.566 . . . . 0.0 111.172 178.59 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' D' D ' 48' ' ' PHE . . . . . . . . . . . . . 90.7 m-85 -113.19 131.89 55.7 Favored 'General case' 0 C--N 1.331 -0.213 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.09 177.054 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' D' D ' 49' ' ' LYS . . . . . . . . . . . . . 82.5 tttt -107.92 137.14 46.44 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.489 179.262 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' D' D ' 50' ' ' VAL . . . . . . . . . . . . . 46.4 t -83.04 108.79 16.13 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.312 0 N-CA-C 109.311 -0.625 . . . . 0.0 109.311 176.219 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' D' D ' 51' ' ' VAL . . . . . . . . . . . . . 46.1 t -73.4 -50.76 28.78 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.328 0 CA-C-N 116.142 -0.481 . . . . 0.0 109.907 -174.573 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' D' D ' 52' ' ' GLN . . . . . . . . . . . . . 92.4 mt-30 -152.72 154.22 34.81 Favored 'General case' 0 C--N 1.332 -0.18 0 CA-C-O 121.285 0.564 . . . . 0.0 111.552 -178.167 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' D' D ' 53' ' ' ALA . . . . . . . . . . . . . . . -132.56 132.59 42.74 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 115.212 -0.904 . . . . 0.0 109.788 175.832 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' D' D ' 54' ' ' TYR . . . . . . . . . . . . . 41.7 t80 -129.08 109.23 18.11 Favored Pre-proline 0 CA--C 1.534 0.364 0 CA-C-O 118.251 -0.88 . . . . 0.0 110.355 179.509 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' D' D ' 55' ' ' PRO . . . . . . . . . . . . . 73.2 Cg_endo -77.18 168.91 75.62 Favored 'Cis proline' 0 N--CA 1.5 1.873 0 CA-C-N 121.839 1.692 . . . . 0.0 112.43 -6.826 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' D' D ' 56' ' ' SER . . . . . . . . . . . . . 13.6 m -116.98 129.49 25.28 Favored Pre-proline 0 CA--C 1.538 0.49 0 CA-C-O 118.459 -0.781 . . . . 0.0 109.262 173.911 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' D' D ' 57' ' ' PRO . . . . . . . . . . . . . 56.1 Cg_endo -71.65 149.4 92.36 Favored 'Cis proline' 0 N--CA 1.498 1.768 0 CA-C-N 122.002 1.751 . . . . 0.0 111.691 0.37 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' D' D ' 58' ' ' LEU . . . . . . . . . . . . . 23.7 tp -108.98 137.99 46.03 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.176 -0.466 . . . . 0.0 110.843 -177.723 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' D' D ' 59' ' ' ARG . . . . . . . . . . . . . 31.7 ttp180 -102.23 122.87 45.03 Favored 'General case' 0 C--N 1.329 -0.315 0 N-CA-C 109.158 -0.682 . . . . 0.0 109.158 175.111 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' D' D ' 60' ' ' VAL . . . . . . . . . . . . . 43.3 t -79.84 122.37 34.93 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.262 0 C-N-CA 120.703 -0.399 . . . . 0.0 110.802 -173.36 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' D' D ' 61' ' ' GLU . . . . . . . . . . . . . 84.1 mt-10 -131.1 161.18 32.66 Favored 'General case' 0 C--N 1.332 -0.184 0 CA-C-N 115.91 -0.586 . . . . 0.0 109.562 177.214 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' D' D ' 62' ' ' ASP . . . . . . . . . . . . . 79.0 m-20 -53.3 -33.16 52.15 Favored 'General case' 0 C--N 1.329 -0.291 0 N-CA-C 111.782 0.29 . . . . 0.0 111.782 178.319 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' D' D ' 63' ' ' ARG . . . . . . . . . . . . . 92.8 mtt-85 -72.97 -21.97 60.77 Favored 'General case' 0 CA--C 1.533 0.324 0 N-CA-C 113.004 0.742 . . . . 0.0 113.004 -176.004 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' D' D ' 64' ' ' THR . . . . . . . . . . . . . 30.8 m -65.2 141.72 58.56 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-O 120.974 0.416 . . . . 0.0 111.085 -174.509 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' D' D ' 65' ' ' LYS . . . . . . . . . . . . . 68.9 mttm -87.7 131.31 34.51 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 115.787 -0.642 . . . . 0.0 109.915 178.17 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' D' D ' 66' ' ' ILE . . . . . . . . . . . . . 60.0 mt -116.27 124.93 73.05 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.272 0 N-CA-C 109.552 -0.536 . . . . 0.0 109.552 179.375 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' D' D ' 67' ' ' THR . . . . . . . . . . . . . 22.7 m -121.28 144.0 48.86 Favored 'General case' 0 C--O 1.233 0.218 0 CA-C-O 121.035 0.445 . . . . 0.0 111.242 -175.307 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' D' D ' 68' ' ' LEU . . . . . . . . . . . . . 14.2 tp . . . . . 0 C--N 1.33 -0.245 0 CA-C-N 115.834 -0.621 . . . . 0.0 110.465 179.486 . . . . . . . . 0 0 . 1 . 011 nuclear orig core ' D' D ' 73' ' ' VAL . . . . . . . . . . . . . 33.5 m . . . . . 0 C--O 1.233 0.196 0 CA-C-O 120.978 0.418 . . . . 0.0 111.003 . . . . . . . . . 0 0 . 1 . 011 nuclear orig core ' D' D ' 74' ' ' ASP . . . . . . . . . . . . . 27.4 t0 -95.56 120.91 36.63 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 115.834 -0.621 . . . . 0.0 109.838 179.872 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' D' D ' 75' ' ' VAL . . . . . . . . . . . . . 42.9 t -112.02 122.76 66.92 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.234 0 CA-C-O 121.245 0.545 . . . . 0.0 110.337 -178.454 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' D' D ' 76' ' ' LEU . . . . . . . . . . . . . 33.7 mt -120.79 142.36 49.66 Favored 'General case' 0 C--N 1.331 -0.225 0 CA-C-N 115.555 -0.748 . . . . 0.0 109.617 177.814 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' D' D ' 77' ' ' GLU . . . . . . . . . . . . . 97.5 mt-10 -135.23 136.98 42.15 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-O 121.091 0.472 . . . . 0.0 111.382 -178.091 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' D' D ' 78' ' ' ALA . . . . . . . . . . . . . . . -124.83 138.37 54.27 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 115.706 -0.679 . . . . 0.0 109.816 176.804 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' D' D ' 79' ' ' LYS . . . . . . . . . . . . . 62.0 mttp -81.54 118.07 22.45 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-O 120.871 0.367 . . . . 0.0 110.666 -178.568 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' D' D ' 80' ' ' ILE . . . . . . . . . . . . . 42.3 mm -139.07 107.27 3.28 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.306 0 N-CA-C 109.264 -0.643 . . . . 0.0 109.264 -178.408 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' D' D ' 81' ' ' LYS . . . . . . . . . . . . . 38.0 ttpt -102.13 128.12 48.76 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-O 120.817 0.341 . . . . 0.0 110.932 -178.054 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' D' D ' 82' ' ' GLY . . . . . . . . . . . . . . . 89.05 42.17 5.69 Favored Glycine 0 CA--C 1.524 0.615 0 C-N-CA 120.725 -0.75 . . . . 0.0 111.444 174.817 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' D' D ' 83' ' ' ILE . . . . . . . . . . . . . 72.4 mt -68.25 134.88 29.5 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.264 0 N-CA-C 109.838 -0.43 . . . . 0.0 109.838 178.319 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' D' D ' 84' ' ' LYS . . . . . . . . . . . . . 30.8 tttp -94.15 -52.71 4.26 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 115.886 -0.597 . . . . 0.0 110.046 -178.22 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' D' D ' 85' ' ' ASP . . . . . . . . . . . . . 6.4 t70 -156.98 154.84 30.28 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 115.767 -0.651 . . . . 0.0 110.167 179.021 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' D' D ' 86' ' ' VAL . . . . . . . . . . . . . 44.5 t -128.72 133.61 66.05 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.219 0 CA-C-O 121.046 0.451 . . . . 0.0 110.791 179.964 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' D' D ' 87' ' ' ILE . . . . . . . . . . . . . 44.2 mm -114.62 122.39 68.64 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.249 0 CA-C-N 115.619 -0.718 . . . . 0.0 109.216 175.304 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' D' D ' 88' ' ' LEU . . . . . . . . . . . . . 34.8 mt -110.92 134.07 52.86 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-O 121.085 0.469 . . . . 0.0 111.34 -176.013 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' D' D ' 89' ' ' ASP . . . . . . . . . . . . . 9.8 t70 -131.92 154.94 48.74 Favored 'General case' 0 C--N 1.331 -0.211 0 CA-C-N 115.793 -0.639 . . . . 0.0 109.508 175.686 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' D' D ' 90' ' ' GLU . . . . . . . . . . . . . 84.7 tt0 -48.33 -38.13 18.31 Favored 'General case' 0 C--N 1.329 -0.284 0 N-CA-C 112.802 0.668 . . . . 0.0 112.802 -171.902 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' D' D ' 91' ' ' ASN . . . . . . . . . . . . . 35.0 m120 -132.0 36.74 3.64 Favored 'General case' 0 N--CA 1.466 0.328 0 N-CA-C 111.782 0.29 . . . . 0.0 111.782 -177.167 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' D' D ' 92' ' ' LEU . . . . . . . . . . . . . 12.9 tp -166.0 145.31 6.11 Favored 'General case' 0 C--N 1.332 -0.195 0 C-N-CA 120.827 -0.349 . . . . 0.0 110.91 -179.393 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' D' D ' 93' ' ' ILE . . . . . . . . . . . . . 68.1 mt -130.26 120.48 49.08 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.189 0 N-CA-C 109.579 -0.526 . . . . 0.0 109.579 -179.684 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' D' D ' 94' ' ' VAL . . . . . . . . . . . . . 46.9 t -121.66 126.13 74.31 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.253 0 N-CA-C 109.723 -0.473 . . . . 0.0 109.723 179.038 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' D' D ' 95' ' ' VAL . . . . . . . . . . . . . 44.1 t -121.16 134.79 63.4 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.236 0 CA-C-N 116.354 -0.385 . . . . 0.0 110.125 -178.902 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' D' D ' 96' ' ' ILE . . . . . . . . . . . . . 63.8 mt -113.68 128.63 70.47 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.316 0 N-CA-C 109.257 -0.646 . . . . 0.0 109.257 178.841 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' D' D ' 97' ' ' THR . . . . . . . . . . . . . 65.8 p -95.35 159.17 15.13 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-O 120.865 0.364 . . . . 0.0 110.443 179.746 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' D' D ' 98' ' ' GLU . . . . . . . . . . . . . 97.4 mt-10 -53.98 -27.5 31.91 Favored 'General case' 0 C--N 1.328 -0.36 0 N-CA-C 112.215 0.45 . . . . 0.0 112.215 -179.372 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' D' D ' 99' ' ' GLU . . . . . . . . . . . . . 45.8 mp0 -76.59 7.92 4.07 Favored 'General case' 0 CA--C 1.536 0.41 0 N-CA-C 113.502 0.927 . . . . 0.0 113.502 -176.733 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' D' D ' 100' ' ' ASN . . . . . . . . . . . . . 4.1 m-20 65.7 35.95 6.62 Favored 'General case' 0 N--CA 1.464 0.238 0 CA-C-N 118.133 0.424 . . . . 0.0 111.335 -178.064 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' D' D ' 101' ' ' GLU . . . . . . . . . . . . . 85.2 tt0 -109.93 142.68 40.94 Favored 'General case' 0 C--N 1.332 -0.179 0 N-CA-C 109.361 -0.607 . . . . 0.0 109.361 172.187 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' D' D ' 102' ' ' VAL . . . . . . . . . . . . . 44.5 t -115.02 126.86 72.72 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.312 0 CA-C-N 116.39 -0.368 . . . . 0.0 110.229 -175.84 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' D' D ' 103' ' ' LEU . . . . . . . . . . . . . 39.3 mt -116.62 129.91 56.43 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 115.678 -0.692 . . . . 0.0 109.897 175.629 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' D' D ' 104' ' ' ILE . . . . . . . . . . . . . 66.6 mt -117.7 124.41 73.02 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.259 0 N-CA-C 110.079 -0.341 . . . . 0.0 110.079 -179.996 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' D' D ' 105' ' ' PHE . . . . . . . . . . . . . 52.9 m-85 -123.72 163.54 20.91 Favored 'General case' 0 C--N 1.333 -0.142 0 O-C-N 123.963 0.79 . . . . 0.0 109.72 -179.376 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' D' D ' 106' ' ' ASN . . . . . . . . . . . . . 45.1 p-10 -97.86 -170.41 1.98 Allowed 'General case' 0 C--N 1.33 -0.281 0 N-CA-C 109.859 -0.422 . . . . 0.0 109.859 175.073 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' D' D ' 107' ' ' GLN . . . . . . . . . . . . . 62.4 tt0 -58.37 -30.04 66.46 Favored 'General case' 0 C--N 1.329 -0.297 0 N-CA-C 111.771 0.286 . . . . 0.0 111.771 179.097 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' D' D ' 108' ' ' ASN . . . . . . . . . . . . . 18.0 t30 -83.8 6.86 19.78 Favored 'General case' 0 CA--C 1.537 0.442 0 N-CA-C 113.389 0.885 . . . . 0.0 113.389 -176.53 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' D' D ' 109' ' ' LEU . . . . . . . . . . . . . 11.0 tp 62.37 37.54 13.68 Favored 'General case' 0 C--O 1.232 0.152 0 CA-C-O 120.957 0.408 . . . . 0.0 111.29 177.972 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' D' D ' 110' ' ' GLU . . . . . . . . . . . . . 95.5 mt-10 -106.44 153.99 21.47 Favored 'General case' 0 C--N 1.331 -0.198 0 CA-C-N 116.518 -0.31 . . . . 0.0 110.198 176.487 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' D' D ' 111' ' ' GLU . . . . . . . . . . . . . 85.0 tt0 -82.31 121.89 27.26 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.366 -0.379 . . . . 0.0 110.761 -177.721 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' D' D ' 112' ' ' LEU . . . . . . . . . . . . . 16.1 mt -110.44 -46.13 3.45 Favored 'General case' 0 C--N 1.331 -0.214 0 CA-C-N 116.198 -0.456 . . . . 0.0 110.723 179.367 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' D' D ' 113' ' ' TYR . . . . . . . . . . . . . 49.2 t80 -136.4 138.25 41.36 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-N 116.361 -0.381 . . . . 0.0 111.106 -179.104 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' D' D ' 114' ' ' ARG . . . . . . . . . . . . . 60.2 ttp180 -137.25 121.72 18.33 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 115.995 -0.548 . . . . 0.0 110.205 176.438 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' D' D ' 115' ' ' GLY . . . . . . . . . . . . . . . -150.05 162.2 29.12 Favored Glycine 0 CA--C 1.523 0.548 0 N-CA-C 110.481 -1.048 . . . . 0.0 110.481 178.903 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' D' D ' 116' ' ' LYS . . . . . . . . . . . . . 54.6 tttm -137.61 133.81 34.81 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.917 0.359 . . . . 0.0 110.219 -179.824 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' D' D ' 117' ' ' PHE . . . . . . . . . . . . . 38.5 m-85 -129.27 115.43 17.6 Favored 'General case' 0 C--N 1.331 -0.2 0 CA-C-O 120.901 0.381 . . . . 0.0 110.393 -175.689 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' D' D ' 118' ' ' GLU . . . . . . . . . . . . . 46.0 tp10 -52.86 -49.86 64.94 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.462 -0.336 . . . . 0.0 111.492 -176.792 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' D' D ' 119' ' ' ASN . . . . . . . . . . . . . 31.3 m120 -94.75 31.07 1.89 Allowed 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.257 -0.429 . . . . 0.0 112.138 -174.099 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' D' D ' 120' ' ' LEU . . . . . . . . . . . . . 17.9 tp -54.87 121.67 9.15 Favored 'General case' 0 C--N 1.332 -0.166 0 CA-C-O 120.698 0.285 . . . . 0.0 110.809 179.078 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' D' D ' 121' ' ' ASN . . . . . . . . . . . . . 15.0 m120 -114.03 -44.07 3.19 Favored 'General case' 0 C--N 1.331 -0.217 0 CA-C-N 116.356 -0.384 . . . . 0.0 110.909 -178.3 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' D' D ' 122' ' ' LYS . . . . . . . . . . . . . 59.9 mtpt -142.91 148.77 37.49 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-O 121.066 0.46 . . . . 0.0 111.74 -176.98 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' D' D ' 123' ' ' VAL . . . . . . . . . . . . . 44.5 t -131.33 128.2 61.11 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.246 0 CA-C-N 115.857 -0.611 . . . . 0.0 109.428 173.765 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' D' D ' 124' ' ' LEU . . . . . . . . . . . . . 60.8 mt -121.52 134.89 55.05 Favored 'General case' 0 C--N 1.331 -0.203 0 CA-C-N 116.357 -0.383 . . . . 0.0 110.558 -178.417 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' D' D ' 125' ' ' VAL . . . . . . . . . . . . . 40.8 t -130.19 131.8 65.54 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.266 0 CA-C-N 116.315 -0.402 . . . . 0.0 110.129 -179.785 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' D' D ' 126' ' ' ARG . . . . . . . . . . . . . 96.2 mtt-85 -140.08 117.69 11.55 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.333 -0.394 . . . . 0.0 110.627 178.487 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' D' D ' 127' ' ' ASN . . . . . . . . . . . . . 82.8 m-20 51.27 -104.96 0.18 Allowed 'General case' 0 CA--C 1.544 0.746 0 CA-C-O 119.032 -0.509 . . . . 0.0 111.408 178.718 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' D' D ' 128' ' ' ASP . . . . . . . . . . . . . 22.8 p-10 -114.03 1.1 14.54 Favored 'General case' 0 N--CA 1.468 0.473 0 CA-C-N 119.518 1.054 . . . . 0.0 113.489 -177.467 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' D' D ' 129' ' ' LEU . . . . . . . . . . . . . 44.7 mt -105.01 141.03 37.32 Favored 'General case' 0 C--O 1.231 0.129 0 CA-C-N 118.105 0.411 . . . . 0.0 110.078 179.245 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' D' D ' 130' ' ' VAL . . . . . . . . . . . . . 44.3 t -126.15 137.63 57.14 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.247 0 CA-C-N 116.388 -0.369 . . . . 0.0 110.153 -178.203 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' D' D ' 131' ' ' VAL . . . . . . . . . . . . . 44.2 t -134.13 134.17 55.48 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.324 0 CA-C-O 121.005 0.431 . . . . 0.0 110.011 177.629 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' D' D ' 132' ' ' ILE . . . . . . . . . . . . . 68.0 mt -117.28 133.61 63.48 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.297 0 CA-C-N 115.919 -0.582 . . . . 0.0 109.49 179.927 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' D' D ' 133' ' ' ILE . . . . . . . . . . . . . 37.1 mm -117.05 120.89 66.43 Favored 'Isoleucine or valine' 0 C--O 1.233 0.206 0 CA-C-O 120.682 0.277 . . . . 0.0 111.093 -175.218 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' D' D ' 134' ' ' ASP . . . . . . . . . . . . . 8.1 p-10 -132.91 147.06 52.29 Favored 'General case' 0 C--N 1.331 -0.234 0 N-CA-C 109.276 -0.638 . . . . 0.0 109.276 174.403 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' D' D ' 135' ' ' GLU . . . . . . . . . . . . . 84.4 tt0 -49.91 -26.42 4.11 Favored 'General case' 0 C--N 1.329 -0.316 0 N-CA-C 112.9 0.704 . . . . 0.0 112.9 -172.222 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' D' D ' 136' ' ' GLN . . . . . . . . . . . . . 31.4 tt0 -83.61 -34.29 25.15 Favored 'General case' 0 C--N 1.331 -0.224 0 N-CA-C 112.399 0.518 . . . . 0.0 112.399 -175.559 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' D' D ' 137' ' ' LYS . . . . . . . . . . . . . 20.5 pttp -168.35 172.37 8.47 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-O 121.544 0.688 . . . . 0.0 112.221 -172.076 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' D' D ' 138' ' ' LEU . . . . . . . . . . . . . 7.7 tt -120.03 131.16 55.03 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 115.093 -0.958 . . . . 0.0 110.258 -178.46 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' D' D ' 139' ' ' THR . . . . . . . . . . . . . 33.8 m -109.04 130.08 55.47 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 116.133 -0.485 . . . . 0.0 110.675 -179.497 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' D' D ' 140' ' ' LEU . . . . . . . . . . . . . 27.1 tp -114.9 121.15 42.32 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 115.765 -0.652 . . . . 0.0 109.315 -179.201 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' D' D ' 141' ' ' ILE . . . . . . . . . . . . . 19.5 mt -119.85 121.96 67.41 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.222 0 N-CA-C 109.858 -0.423 . . . . 0.0 109.858 -175.158 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' D' D ' 142' ' ' ARG . . . . . . . . . . . . . 81.5 mtm180 -116.61 131.59 56.91 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 115.496 -0.775 . . . . 0.0 110.299 -176.823 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' D' D ' 143' ' ' THR . . . . . . . . . . . . . 59.5 p . . . . . 0 C--O 1.221 -0.421 0 CA-C-O 118.044 -0.979 . . . . 0.0 110.62 -179.819 . . . . . . . . 0 0 . 1 . 011 nuclear orig core ' E' E ' 2' ' ' SER . . . . . . . . . . . . . 2.1 p . . . . . 0 C--O 1.232 0.142 0 N-CA-C 109.944 -0.391 . . . . 0.0 109.944 . . . . . . . . . 0 0 . 1 . 011 nuclear orig core ' E' E ' 3' ' ' GLU . . . . . . . . . . . . . 80.4 tt0 -143.48 142.3 31.11 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 116.149 -0.478 . . . . 0.0 111.246 -175.384 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' E' E ' 4' ' ' LEU . . . . . . . . . . . . . 16.8 tp -122.26 132.24 54.33 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-N 116.079 -0.509 . . . . 0.0 110.163 176.172 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' E' E ' 5' ' ' LYS . . . . . . . . . . . . . 52.0 mttp -107.25 119.61 39.85 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.469 -0.332 . . . . 0.0 110.51 178.597 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' E' E ' 6' ' ' LEU . . . . . . . . . . . . . 37.6 mt -114.19 147.33 39.09 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 115.354 -0.839 . . . . 0.0 110.669 -178.571 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' E' E ' 7' ' ' LYS . . . . . . . . . . . . . 47.6 tttp -138.47 141.3 30.85 Favored Pre-proline 0 CA--C 1.534 0.343 0 CA-C-O 119.128 -0.463 . . . . 0.0 110.075 174.811 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' E' E ' 8' ' ' PRO . . . . . . . . . . . . . 73.7 Cg_endo -91.51 141.36 2.7 Favored 'Trans proline' 0 N--CA 1.49 1.298 0 C-N-CA 121.664 1.576 . . . . 0.0 111.561 176.047 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' E' E ' 9' ' ' LEU . . . . . . . . . . . . . 67.7 mt -77.2 -47.68 2.59 Favored Pre-proline 0 CA--C 1.533 0.322 0 CA-C-O 118.645 -0.693 . . . . 0.0 112.428 -179.288 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' E' E ' 10' ' ' PRO . . . . . . . . . . . . . 90.6 Cg_endo -79.98 155.36 23.09 Favored 'Trans proline' 0 N--CA 1.496 1.642 0 C-N-CA 121.282 1.321 . . . . 0.0 111.892 176.733 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' E' E ' 11' ' ' LYS . . . . . . . . . . . . . 28.2 ttpt -88.29 92.33 9.12 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-O 120.833 0.349 . . . . 0.0 110.532 178.876 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' E' E ' 12' ' ' VAL . . . . . . . . . . . . . 12.5 p -141.39 143.88 27.02 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.283 0 CA-C-N 116.241 -0.436 . . . . 0.0 110.343 178.68 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' E' E ' 13' ' ' GLU . . . . . . . . . . . . . 15.2 pt-20 -87.13 131.13 34.25 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.362 -0.381 . . . . 0.0 110.704 179.345 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' E' E ' 14' ' ' LEU . . . . . . . . . . . . . 17.5 mt -98.41 155.08 37.25 Favored Pre-proline 0 C--N 1.33 -0.266 0 CA-C-N 116.246 -0.433 . . . . 0.0 110.686 -179.967 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' E' E ' 15' ' ' PRO . . . . . . . . . . . . . 26.5 Cg_exo -61.57 160.07 29.62 Favored 'Trans proline' 0 N--CA 1.496 1.647 0 C-N-CA 121.363 1.375 . . . . 0.0 111.667 176.233 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' E' E ' 16' ' ' PRO . . . . . . . . . . . . . 34.7 Cg_exo -58.87 -40.76 68.97 Favored 'Trans proline' 0 N--CA 1.496 1.667 0 C-N-CA 121.4 1.4 . . . . 0.0 112.963 -177.304 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' E' E ' 17' ' ' ASP . . . . . . . . . . . . . 23.5 p-10 -89.01 11.33 18.58 Favored 'General case' 0 C--N 1.326 -0.417 0 N-CA-C 113.156 0.799 . . . . 0.0 113.156 -177.175 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' E' E ' 18' ' ' PHE . . . . . . . . . . . . . 47.1 t80 -58.04 -43.75 87.0 Favored 'General case' 0 C--N 1.334 -0.1 0 O-C-N 121.944 -0.473 . . . . 0.0 109.972 -179.619 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' E' E ' 19' ' ' VAL . . . . . . . . . . . . . 47.8 t -57.54 -39.3 68.51 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.309 0 CA-C-N 116.028 -0.533 . . . . 0.0 110.406 179.206 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' E' E ' 20' ' ' ASP . . . . . . . . . . . . . 28.3 t0 -58.94 -43.61 91.26 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-O 120.691 0.281 . . . . 0.0 110.579 -178.507 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' E' E ' 21' ' ' VAL . . . . . . . . . . . . . 52.4 t -64.22 -45.14 97.13 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.326 0 C-N-CA 120.689 -0.404 . . . . 0.0 110.354 -178.642 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' E' E ' 22' ' ' ILE . . . . . . . . . . . . . 49.3 mm -58.93 -41.59 83.48 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.327 0 C-N-CA 120.969 -0.292 . . . . 0.0 110.908 -179.929 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' E' E ' 23' ' ' ARG . . . . . . . . . . . . . 42.6 ttp180 -57.07 -47.02 82.01 Favored 'General case' 0 C--N 1.331 -0.209 0 C-N-CA 120.7 -0.4 . . . . 0.0 110.522 178.899 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' E' E ' 24' ' ' ILE . . . . . . . . . . . . . 79.6 mt -61.63 -44.95 99.5 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.302 0 CA-C-N 116.153 -0.476 . . . . 0.0 111.88 -178.559 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' E' E ' 25' ' ' LYS . . . . . . . . . . . . . 13.6 pttp -70.1 -36.21 74.71 Favored 'General case' 0 CA--C 1.533 0.307 0 C-N-CA 120.487 -0.485 . . . . 0.0 111.61 -173.729 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' E' E ' 26' ' ' LEU . . . . . . . . . . . . . 20.7 mt -79.05 -40.52 31.11 Favored 'General case' 0 C--N 1.33 -0.254 0 N-CA-C 112.86 0.689 . . . . 0.0 112.86 -174.482 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' E' E ' 27' ' ' GLN . . . . . . . . . . . . . 8.4 pt20 -47.32 139.47 6.36 Favored 'General case' 0 N--CA 1.467 0.4 0 N-CA-C 112.795 0.665 . . . . 0.0 112.795 -174.644 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' E' E ' 28' ' ' GLY . . . . . . . . . . . . . . . 98.77 -26.63 23.29 Favored Glycine 0 CA--C 1.534 1.239 0 CA-C-N 115.582 -0.736 . . . . 0.0 112.184 -176.021 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' E' E ' 29' ' ' LYS . . . . . . . . . . . . . 98.8 mttt -98.07 155.2 17.24 Favored 'General case' 0 C--O 1.233 0.202 0 CA-C-N 117.116 0.458 . . . . 0.0 111.154 179.21 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' E' E ' 30' ' ' THR . . . . . . . . . . . . . 24.6 m -104.82 137.11 43.1 Favored 'General case' 0 C--N 1.332 -0.186 0 CA-C-N 115.851 -0.613 . . . . 0.0 109.79 174.643 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' E' E ' 31' ' ' VAL . . . . . . . . . . . . . 34.9 m -127.94 159.37 39.01 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.19 0 CA-C-N 116.416 -0.356 . . . . 0.0 110.747 -178.185 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' E' E ' 32' ' ' ARG . . . . . . . . . . . . . 73.9 mtt85 -133.79 149.42 51.42 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-O 121.394 0.616 . . . . 0.0 110.773 179.241 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' E' E ' 33' ' ' THR . . . . . . . . . . . . . 18.4 m -53.54 140.09 29.47 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.143 -0.48 . . . . 0.0 111.18 -179.327 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' E' E ' 34' ' ' GLY . . . . . . . . . . . . . . . 100.69 -17.23 56.82 Favored Glycine 0 CA--C 1.533 1.164 0 CA-C-O 119.622 -0.544 . . . . 0.0 113.151 179.517 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' E' E ' 35' ' ' ASP . . . . . . . . . . . . . 77.1 m-20 -65.78 147.51 53.27 Favored 'General case' 0 C--N 1.333 -0.121 0 CA-C-N 118.058 0.929 . . . . 0.0 111.067 178.764 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' E' E ' 36' ' ' VAL . . . . . . . . . . . . . 45.3 t -125.02 131.71 72.21 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.245 0 CA-C-N 115.843 -0.617 . . . . 0.0 109.874 178.455 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' E' E ' 37' ' ' ILE . . . . . . . . . . . . . 68.1 mt -122.46 139.18 50.17 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.26 0 CA-C-N 116.331 -0.395 . . . . 0.0 109.948 -179.79 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' E' E ' 38' ' ' GLY . . . . . . . . . . . . . . . -111.79 128.63 8.7 Favored Glycine 0 CA--C 1.525 0.714 0 N-CA-C 111.243 -0.743 . . . . 0.0 111.243 179.928 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' E' E ' 39' ' ' ILE . . . . . . . . . . . . . 73.1 mt -127.74 129.94 70.14 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.229 0 N-CA-C 109.984 -0.376 . . . . 0.0 109.984 178.512 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' E' E ' 40' ' ' SER . . . . . . . . . . . . . 43.4 t -92.25 113.91 26.31 Favored 'General case' 0 C--N 1.329 -0.303 0 C-N-CA 120.997 -0.281 . . . . 0.0 110.92 177.501 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' E' E ' 41' ' ' ILE . . . . . . . . . . . . . 45.2 mm -123.06 124.45 70.24 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.207 0 N-CA-C 109.864 -0.421 . . . . 0.0 109.864 179.853 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' E' E ' 42' ' ' LEU . . . . . . . . . . . . . 55.6 mt 57.48 34.47 24.66 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.35 -0.387 . . . . 0.0 111.681 178.755 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' E' E ' 43' ' ' GLY . . . . . . . . . . . . . . . 77.6 -10.1 25.67 Favored Glycine 0 CA--C 1.535 1.314 0 C-N-CA 121.297 -0.478 . . . . 0.0 113.396 177.601 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' E' E ' 44' ' ' LYS . . . . . . . . . . . . . 60.2 tttm -101.65 130.29 47.97 Favored 'General case' 0 C--N 1.332 -0.172 0 CA-C-N 117.976 0.888 . . . . 0.0 109.814 177.396 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' E' E ' 45' ' ' GLU . . . . . . . . . . . . . 39.6 tp10 -83.8 128.72 34.74 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.389 -0.369 . . . . 0.0 110.813 -178.57 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' E' E ' 46' ' ' VAL . . . . . . . . . . . . . 7.3 p -120.64 132.24 70.72 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.277 0 N-CA-C 109.659 -0.497 . . . . 0.0 109.659 177.509 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' E' E ' 47' ' ' LYS . . . . . . . . . . . . . 62.5 mttp -100.72 127.95 46.95 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 115.929 -0.578 . . . . 0.0 111.088 177.245 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' E' E ' 48' ' ' PHE . . . . . . . . . . . . . 92.4 m-85 -109.61 131.73 54.79 Favored 'General case' 0 C--N 1.329 -0.298 0 N-CA-C 109.57 -0.53 . . . . 0.0 109.57 175.304 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' E' E ' 49' ' ' LYS . . . . . . . . . . . . . 47.5 tttp -111.57 139.12 47.28 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.661 -0.245 . . . . 0.0 110.656 -179.953 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' E' E ' 50' ' ' VAL . . . . . . . . . . . . . 45.1 t -83.49 108.42 16.03 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.307 0 N-CA-C 109.34 -0.615 . . . . 0.0 109.34 175.731 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' E' E ' 51' ' ' VAL . . . . . . . . . . . . . 46.7 t -74.2 -50.84 25.83 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.305 0 CA-C-N 116.117 -0.492 . . . . 0.0 109.955 -174.461 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' E' E ' 52' ' ' GLN . . . . . . . . . . . . . 92.2 mt-30 -152.69 152.7 32.03 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-O 121.18 0.514 . . . . 0.0 111.766 -178.54 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' E' E ' 53' ' ' ALA . . . . . . . . . . . . . . . -130.69 131.89 45.08 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 115.213 -0.903 . . . . 0.0 109.762 175.644 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' E' E ' 54' ' ' TYR . . . . . . . . . . . . . 39.5 t80 -129.07 108.96 18.09 Favored Pre-proline 0 CA--C 1.535 0.398 0 CA-C-O 118.306 -0.854 . . . . 0.0 110.277 179.348 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' E' E ' 55' ' ' PRO . . . . . . . . . . . . . 73.7 Cg_endo -77.27 169.28 74.53 Favored 'Cis proline' 0 N--CA 1.499 1.825 0 CA-C-N 121.829 1.689 . . . . 0.0 112.384 -4.473 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' E' E ' 56' ' ' SER . . . . . . . . . . . . . 14.5 m -113.88 122.62 34.44 Favored Pre-proline 0 CA--C 1.539 0.535 0 CA-C-O 118.309 -0.853 . . . . 0.0 109.372 175.275 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' E' E ' 57' ' ' PRO . . . . . . . . . . . . . 42.0 Cg_endo -67.72 167.96 59.48 Favored 'Cis proline' 0 N--CA 1.498 1.787 0 CA-C-N 122.104 1.787 . . . . 0.0 112.076 2.004 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' E' E ' 58' ' ' LEU . . . . . . . . . . . . . 25.6 tp -130.05 137.96 50.5 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-N 115.915 -0.584 . . . . 0.0 110.317 179.875 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' E' E ' 59' ' ' ARG . . . . . . . . . . . . . 66.6 ttt180 -102.36 134.34 45.82 Favored 'General case' 0 C--N 1.329 -0.298 0 N-CA-C 109.671 -0.492 . . . . 0.0 109.671 176.267 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' E' E ' 60' ' ' VAL . . . . . . . . . . . . . 41.1 t -90.34 122.53 41.81 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.192 0 C-N-CA 120.586 -0.446 . . . . 0.0 110.614 -177.851 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' E' E ' 61' ' ' GLU . . . . . . . . . . . . . 77.5 tt0 -131.06 158.14 41.17 Favored 'General case' 0 C--N 1.33 -0.269 0 N-CA-C 109.069 -0.715 . . . . 0.0 109.069 176.696 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' E' E ' 62' ' ' ASP . . . . . . . . . . . . . 64.2 m-20 -52.98 -34.3 55.46 Favored 'General case' 0 C--N 1.328 -0.355 0 N-CA-C 111.686 0.254 . . . . 0.0 111.686 -179.03 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' E' E ' 63' ' ' ARG . . . . . . . . . . . . . 22.6 mmt85 -78.67 -13.02 60.03 Favored 'General case' 0 CA--C 1.535 0.37 0 N-CA-C 113.384 0.883 . . . . 0.0 113.384 -178.549 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' E' E ' 64' ' ' THR . . . . . . . . . . . . . 18.2 m -64.58 146.71 54.23 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-O 120.977 0.417 . . . . 0.0 111.022 -175.654 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' E' E ' 65' ' ' LYS . . . . . . . . . . . . . 22.6 mtpp -86.32 127.2 34.76 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 115.736 -0.665 . . . . 0.0 110.32 -179.883 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' E' E ' 66' ' ' ILE . . . . . . . . . . . . . 60.4 mt -118.2 128.09 75.28 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.307 0 N-CA-C 109.774 -0.454 . . . . 0.0 109.774 178.458 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' E' E ' 67' ' ' THR . . . . . . . . . . . . . 30.7 m -125.88 144.16 50.78 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-O 121.052 0.453 . . . . 0.0 111.168 -176.989 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' E' E ' 68' ' ' LEU . . . . . . . . . . . . . 13.4 tp . . . . . 0 C--N 1.33 -0.255 0 CA-C-N 115.754 -0.657 . . . . 0.0 110.192 179.098 . . . . . . . . 0 0 . 1 . 011 nuclear orig core ' E' E ' 73' ' ' VAL . . . . . . . . . . . . . 35.3 m . . . . . 0 CA--C 1.527 0.086 0 N-CA-C 110.315 -0.254 . . . . 0.0 110.315 . . . . . . . . . 0 0 . 1 . 011 nuclear orig core ' E' E ' 74' ' ' ASP . . . . . . . . . . . . . 22.0 t0 -104.04 125.04 50.09 Favored 'General case' 0 C--N 1.332 -0.191 0 C-N-CA 121.02 -0.272 . . . . 0.0 110.27 -178.885 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' E' E ' 75' ' ' VAL . . . . . . . . . . . . . 46.3 t -121.48 124.12 71.09 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.258 0 CA-C-O 121.049 0.452 . . . . 0.0 110.691 -178.86 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' E' E ' 76' ' ' LEU . . . . . . . . . . . . . 6.4 mp -121.39 149.21 43.31 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-N 115.764 -0.653 . . . . 0.0 109.787 176.027 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' E' E ' 77' ' ' GLU . . . . . . . . . . . . . 97.1 mt-10 -138.38 134.45 34.18 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-O 121.028 0.442 . . . . 0.0 111.214 -179.604 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' E' E ' 78' ' ' ALA . . . . . . . . . . . . . . . -121.33 136.18 55.0 Favored 'General case' 0 C--N 1.331 -0.21 0 CA-C-N 115.763 -0.653 . . . . 0.0 109.773 176.709 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' E' E ' 79' ' ' LYS . . . . . . . . . . . . . 40.7 mttm -81.4 117.3 21.74 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-O 120.828 0.347 . . . . 0.0 110.949 -177.478 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' E' E ' 80' ' ' ILE . . . . . . . . . . . . . 38.4 mm -139.28 106.07 2.68 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.27 0 N-CA-C 109.164 -0.68 . . . . 0.0 109.164 -179.475 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' E' E ' 81' ' ' LYS . . . . . . . . . . . . . 42.4 mtmt -99.61 126.74 45.66 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-O 121.041 0.448 . . . . 0.0 111.056 -177.992 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' E' E ' 82' ' ' GLY . . . . . . . . . . . . . . . 89.1 42.23 5.66 Favored Glycine 0 CA--C 1.525 0.695 0 C-N-CA 120.881 -0.676 . . . . 0.0 111.615 176.34 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' E' E ' 83' ' ' ILE . . . . . . . . . . . . . 75.3 mt -68.93 137.09 25.03 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.271 0 N-CA-C 109.734 -0.469 . . . . 0.0 109.734 177.149 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' E' E ' 84' ' ' LYS . . . . . . . . . . . . . 29.8 ttmt -92.49 -51.65 5.03 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-O 121.091 0.472 . . . . 0.0 109.8 -179.958 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' E' E ' 85' ' ' ASP . . . . . . . . . . . . . 5.8 t70 -156.19 152.26 27.63 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 115.492 -0.776 . . . . 0.0 110.234 -179.93 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' E' E ' 86' ' ' VAL . . . . . . . . . . . . . 44.1 t -128.07 130.62 69.75 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.27 0 CA-C-O 120.866 0.365 . . . . 0.0 110.258 179.718 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' E' E ' 87' ' ' ILE . . . . . . . . . . . . . 45.4 mm -117.3 124.19 72.73 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.291 0 CA-C-N 115.907 -0.588 . . . . 0.0 109.5 176.771 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' E' E ' 88' ' ' LEU . . . . . . . . . . . . . 13.4 tp -113.64 131.92 55.96 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-O 121.144 0.497 . . . . 0.0 111.218 -175.75 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' E' E ' 89' ' ' ASP . . . . . . . . . . . . . 9.5 t70 -125.94 153.92 43.58 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 115.63 -0.714 . . . . 0.0 109.312 174.679 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' E' E ' 90' ' ' GLU . . . . . . . . . . . . . 96.2 mt-10 -49.05 -34.55 13.77 Favored 'General case' 0 C--N 1.328 -0.367 0 N-CA-C 112.804 0.668 . . . . 0.0 112.804 -172.402 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' E' E ' 91' ' ' ASN . . . . . . . . . . . . . 85.1 m-20 -132.08 33.03 3.95 Favored 'General case' 0 N--CA 1.465 0.3 0 N-CA-C 112.099 0.407 . . . . 0.0 112.099 -176.285 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' E' E ' 92' ' ' LEU . . . . . . . . . . . . . 14.2 tp -166.05 143.8 5.53 Favored 'General case' 0 C--N 1.331 -0.231 0 C-N-CA 120.994 -0.282 . . . . 0.0 110.819 179.767 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' E' E ' 93' ' ' ILE . . . . . 0.412 HD12 HG23 ' E' ' 93' ' ' ILE . 69.9 mt -124.45 118.6 54.05 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.244 0 N-CA-C 109.577 -0.527 . . . . 0.0 109.577 179.863 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' E' E ' 94' ' ' VAL . . . . . . . . . . . . . 46.4 t -118.75 125.77 74.7 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.213 0 N-CA-C 109.73 -0.47 . . . . 0.0 109.73 179.333 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' E' E ' 95' ' ' VAL . . . . . . . . . . . . . 41.8 t -122.97 133.71 68.25 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.356 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.03 -179.08 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' E' E ' 96' ' ' ILE . . . . . . . . . . . . . 60.9 mt -115.42 127.79 72.87 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.324 0 N-CA-C 109.217 -0.66 . . . . 0.0 109.217 178.658 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' E' E ' 97' ' ' THR . . . . . . . . . . . . . 68.2 p -99.56 155.42 17.59 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-O 120.98 0.419 . . . . 0.0 110.678 -178.876 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' E' E ' 98' ' ' GLU . . . . . . . . . . . . . 45.2 mt-10 -55.64 -23.58 28.72 Favored 'General case' 0 CA--C 1.533 0.325 0 N-CA-C 112.366 0.506 . . . . 0.0 112.366 -179.717 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' E' E ' 99' ' ' GLU . . . . . . . . . . . . . 96.4 mt-10 -76.95 13.06 1.14 Allowed 'General case' 0 CA--C 1.536 0.431 0 N-CA-C 113.192 0.812 . . . . 0.0 113.192 -179.273 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' E' E ' 100' ' ' ASN . . . . . . . . . . . . . 4.0 m-20 63.69 38.07 9.63 Favored 'General case' 0 CA--C 1.529 0.149 0 CA-C-O 121.065 0.459 . . . . 0.0 111.076 178.129 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' E' E ' 101' ' ' GLU . . . . . . . . . . . . . 85.3 tt0 -118.58 144.15 46.3 Favored 'General case' 0 C--N 1.333 -0.134 0 CA-C-N 115.922 -0.581 . . . . 0.0 109.731 176.064 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' E' E ' 102' ' ' VAL . . . . . . . . . . . . . 47.2 t -116.13 127.58 73.69 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.238 0 CA-C-N 116.307 -0.406 . . . . 0.0 110.221 -177.244 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' E' E ' 103' ' ' LEU . . . . . . . . . . . . . 27.9 mt -117.73 132.99 56.39 Favored 'General case' 0 C--N 1.331 -0.213 0 CA-C-N 115.632 -0.713 . . . . 0.0 110.196 176.768 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' E' E ' 104' ' ' ILE . . . . . . . . . . . . . 67.6 mt -120.99 123.35 69.92 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.238 0 N-CA-C 110.198 -0.297 . . . . 0.0 110.198 179.378 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' E' E ' 105' ' ' PHE . . . . . . . . . . . . . 55.8 m-85 -124.91 165.69 17.64 Favored 'General case' 0 C--N 1.332 -0.164 0 O-C-N 123.896 0.748 . . . . 0.0 109.813 179.278 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' E' E ' 106' ' ' ASN . . . . . . . . . . . . . 47.3 p-10 -101.84 -170.96 1.9 Allowed 'General case' 0 C--N 1.331 -0.237 0 N-CA-C 109.966 -0.383 . . . . 0.0 109.966 173.568 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' E' E ' 107' ' ' GLN . . . . . . . . . . . . . 50.3 tt0 -58.57 -30.2 66.98 Favored 'General case' 0 C--N 1.329 -0.299 0 N-CA-C 111.998 0.37 . . . . 0.0 111.998 179.638 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' E' E ' 108' ' ' ASN . . . . . . . . . . . . . 58.1 t30 -83.11 10.79 7.39 Favored 'General case' 0 CA--C 1.537 0.463 0 N-CA-C 112.987 0.736 . . . . 0.0 112.987 -177.422 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' E' E ' 109' ' ' LEU . . . . . . . . . . . . . 8.6 tp 55.09 37.61 29.18 Favored 'General case' 0 C--N 1.332 -0.186 0 CA-C-O 121.039 0.447 . . . . 0.0 111.277 179.006 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' E' E ' 110' ' ' GLU . . . . . . . . . . . . . 70.6 mm-40 -102.9 154.94 18.71 Favored 'General case' 0 C--N 1.331 -0.235 0 N-CA-C 109.771 -0.455 . . . . 0.0 109.771 176.319 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' E' E ' 111' ' ' GLU . . . . . . . . . . . . . 85.0 tt0 -82.84 121.94 27.59 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-O 120.908 0.385 . . . . 0.0 110.598 -177.924 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' E' E ' 112' ' ' LEU . . . . . . . . . . . . . 18.8 mt -108.6 -45.92 3.76 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 115.964 -0.562 . . . . 0.0 110.38 178.34 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' E' E ' 113' ' ' TYR . . . . . . . . . . . . . 64.2 t80 -142.03 139.96 32.48 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.37 -0.377 . . . . 0.0 111.573 -179.9 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' E' E ' 114' ' ' ARG . . . . . . . . . . . . . 59.3 ttp180 -140.71 121.93 14.83 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.031 -0.531 . . . . 0.0 110.104 176.835 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' E' E ' 115' ' ' GLY . . . . . . . . . . . . . . . -150.06 161.35 28.87 Favored Glycine 0 CA--C 1.525 0.698 0 N-CA-C 111.296 -0.721 . . . . 0.0 111.296 178.563 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' E' E ' 116' ' ' LYS . . . . . . . . . . . . . 40.0 ttpt -130.9 140.7 50.23 Favored 'General case' 0 C--N 1.331 -0.215 0 N-CA-C 110.253 -0.277 . . . . 0.0 110.253 179.002 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' E' E ' 117' ' ' PHE . . . . . . . . . . . . . 30.3 m-85 -139.11 114.01 9.33 Favored 'General case' 0 C--N 1.331 -0.214 0 C-N-CA 120.839 -0.344 . . . . 0.0 110.188 -178.517 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' E' E ' 118' ' ' GLU . . . . . . . . . . . . . 95.9 mt-10 -54.83 -41.44 70.7 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 116.47 -0.332 . . . . 0.0 111.216 -176.401 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' E' E ' 119' ' ' ASN . . . . . . . . . . . . . 28.4 m120 -100.36 30.96 3.6 Favored 'General case' 0 C--N 1.33 -0.249 0 N-CA-C 112.176 0.435 . . . . 0.0 112.176 -174.016 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' E' E ' 120' ' ' LEU . . . . . . . . . . . . . 24.8 tp -57.57 119.98 7.51 Favored 'General case' 0 C--N 1.332 -0.155 0 C-N-CA 120.903 -0.319 . . . . 0.0 110.179 177.546 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' E' E ' 121' ' ' ASN . . . . . . . . . . . . . 21.1 m120 -114.19 -44.02 3.17 Favored 'General case' 0 N--CA 1.462 0.149 0 CA-C-N 116.553 -0.294 . . . . 0.0 111.319 -176.708 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' E' E ' 122' ' ' LYS . . . . . . . . . . . . . 35.8 mtmm -140.17 146.29 38.57 Favored 'General case' 0 C--N 1.331 -0.224 0 CA-C-O 121.032 0.444 . . . . 0.0 111.618 -175.825 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' E' E ' 123' ' ' VAL . . . . . . . . . . . . . 44.3 t -128.58 130.81 69.05 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.269 0 CA-C-N 115.998 -0.547 . . . . 0.0 109.796 177.038 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' E' E ' 124' ' ' LEU . . . . . . . . . . . . . 45.9 mt -123.39 129.7 51.66 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-N 116.49 -0.323 . . . . 0.0 110.597 179.645 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' E' E ' 125' ' ' VAL . . . . . . . . . . . . . 42.2 t -132.71 126.72 54.94 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.248 0 CA-C-N 116.231 -0.44 . . . . 0.0 109.982 178.68 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' E' E ' 126' ' ' ARG . . . . . . . . . . . . . 51.8 mmm-85 -140.05 125.14 18.63 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-O 120.918 0.389 . . . . 0.0 110.329 177.996 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' E' E ' 127' ' ' ASN . . . . . . . . . . . . . 67.3 m-80 51.25 -111.61 0.56 Allowed 'General case' 0 CA--C 1.546 0.794 0 CA-C-O 118.598 -0.715 . . . . 0.0 111.172 179.817 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' E' E ' 128' ' ' ASP . . . . . . . . . . . . . 11.6 p-10 -114.14 9.97 17.28 Favored 'General case' 0 CA--C 1.535 0.384 0 CA-C-N 120.089 1.313 . . . . 0.0 113.26 -178.357 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' E' E ' 129' ' ' LEU . . . . . . . . . . . . . 17.2 tp -109.52 138.33 46.05 Favored 'General case' 0 C--O 1.233 0.216 0 O-C-N 121.987 -0.445 . . . . 0.0 110.053 179.199 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' E' E ' 130' ' ' VAL . . . . . . . . . . . . . 41.2 t -125.02 137.19 58.43 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.226 0 CA-C-O 120.958 0.409 . . . . 0.0 110.494 -176.802 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' E' E ' 131' ' ' VAL . . . . . . . . . . . . . 41.8 t -135.82 136.68 49.9 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.259 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.242 177.39 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' E' E ' 132' ' ' ILE . . . . . . . . . . . . . 71.6 mt -118.3 132.98 66.58 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.337 0 CA-C-N 115.886 -0.597 . . . . 0.0 109.446 -179.031 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' E' E ' 133' ' ' ILE . . . . . . . . . . . . . 40.3 mm -117.16 123.77 72.22 Favored 'Isoleucine or valine' 0 C--O 1.233 0.214 0 CA-C-O 121.001 0.429 . . . . 0.0 111.053 -174.914 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' E' E ' 134' ' ' ASP . . . . . . . . . . . . . 6.7 p-10 -131.07 152.75 50.04 Favored 'General case' 0 C--N 1.332 -0.157 0 CA-C-N 116.048 -0.524 . . . . 0.0 109.786 174.723 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' E' E ' 135' ' ' GLU . . . . . . . . . . . . . 46.4 tp10 -49.93 -28.33 6.58 Favored 'General case' 0 C--N 1.328 -0.356 0 N-CA-C 112.91 0.707 . . . . 0.0 112.91 -169.263 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' E' E ' 136' ' ' GLN . . . . . . . . . . . . . 52.7 mt-30 -105.03 -24.96 12.73 Favored 'General case' 0 N--CA 1.464 0.275 0 N-CA-C 112.982 0.734 . . . . 0.0 112.982 -173.767 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' E' E ' 137' ' ' LYS . . . . . . . . . . . . . 59.6 mtpt -143.11 154.14 43.62 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-O 121.229 0.538 . . . . 0.0 111.891 -169.589 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' E' E ' 138' ' ' LEU . . . . . . . . . . . . . 5.7 tt -119.09 124.18 46.27 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 115.546 -0.752 . . . . 0.0 109.378 174.587 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' E' E ' 139' ' ' THR . . . . . . . . . . . . . 30.6 m -110.39 130.54 55.53 Favored 'General case' 0 C--N 1.331 -0.229 0 CA-C-O 120.795 0.331 . . . . 0.0 110.774 -177.173 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' E' E ' 140' ' ' LEU . . . . . . . . . . . . . 12.6 tp -116.52 125.29 51.7 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 115.664 -0.698 . . . . 0.0 109.429 -178.093 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' E' E ' 141' ' ' ILE . . . . . . . . . . . . . 19.3 mt -122.56 117.75 52.99 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.308 0 N-CA-C 109.736 -0.468 . . . . 0.0 109.736 -177.205 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' E' E ' 142' ' ' ARG . . . . . . . . . . . . . 81.2 mtp180 -108.1 128.45 54.69 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 115.39 -0.823 . . . . 0.0 110.398 -176.473 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' E' E ' 143' ' ' THR . . . . . . . . . . . . . 77.8 p . . . . . 0 C--O 1.22 -0.459 0 CA-C-O 118.058 -0.972 . . . . 0.0 110.48 -179.994 . . . . . . . . 0 0 . 1 . 011 nuclear orig core ' F' F ' 1' ' ' MET . . . . . . . . . . . . . 27.4 ptm . . . . . 0 C--O 1.231 0.116 0 CA-C-O 120.814 0.34 . . . . 0.0 110.756 . . . . . . . . . 0 0 . 1 . 011 nuclear orig core ' F' F ' 2' ' ' SER . . . . . . . . . . . . . 7.4 p -118.99 133.92 55.52 Favored 'General case' 0 C--N 1.331 -0.21 0 CA-C-O 121.157 0.503 . . . . 0.0 110.356 177.9 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' F' F ' 3' ' ' GLU . . . . . . . . . . . . . 84.7 tt0 -145.19 142.32 29.46 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 115.878 -0.601 . . . . 0.0 110.965 179.951 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' F' F ' 4' ' ' LEU . . . . . . . . . . . . . 17.5 tp -121.34 128.21 52.05 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 115.84 -0.618 . . . . 0.0 109.998 176.597 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' F' F ' 5' ' ' LYS . . . . . . . . . . . . . 62.4 mttp -108.3 121.0 44.0 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.415 -0.357 . . . . 0.0 110.745 179.407 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' F' F ' 6' ' ' LEU . . . . . . . . . . . . . 23.8 mt -114.23 148.47 37.33 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 115.331 -0.85 . . . . 0.0 110.46 -179.461 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' F' F ' 7' ' ' LYS . . . . . . . . . . . . . 77.1 tttt -128.5 138.27 32.7 Favored Pre-proline 0 CA--C 1.533 0.302 0 CA-C-O 118.85 -0.595 . . . . 0.0 109.681 173.518 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' F' F ' 8' ' ' PRO . . . . . . . . . . . . . 95.7 Cg_endo -91.48 135.38 1.72 Allowed 'Trans proline' 0 N--CA 1.49 1.288 0 C-N-CA 121.727 1.618 . . . . 0.0 111.953 178.373 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' F' F ' 9' ' ' LEU . . . . . . . . . . . . . 55.6 mt -75.94 -46.98 3.85 Favored Pre-proline 0 CA--C 1.534 0.338 0 CA-C-O 118.777 -0.63 . . . . 0.0 111.725 179.639 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' F' F ' 10' ' ' PRO . . . . . . . . . . . . . 78.9 Cg_endo -82.86 149.04 13.9 Favored 'Trans proline' 0 N--CA 1.495 1.579 0 C-N-CA 121.246 1.297 . . . . 0.0 111.531 174.098 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' F' F ' 11' ' ' LYS . . . . . . . . . . . . . 53.8 pttt -86.59 112.17 21.32 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-O 121.588 0.709 . . . . 0.0 110.592 178.035 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' F' F ' 12' ' ' VAL . . . . . . . . . . . . . 12.2 p -151.15 149.22 14.32 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.253 0 CA-C-N 115.621 -0.718 . . . . 0.0 110.545 -179.673 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' F' F ' 13' ' ' GLU . . . . . . . . . . . . . 95.7 mt-10 -87.74 125.74 34.59 Favored 'General case' 0 C--N 1.329 -0.283 0 N-CA-C 109.85 -0.426 . . . . 0.0 109.85 176.224 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' F' F ' 14' ' ' LEU . . . . . . . . . . . . . 31.4 mt -97.86 150.71 37.04 Favored Pre-proline 0 C--N 1.33 -0.254 0 CA-C-O 119.407 -0.33 . . . . 0.0 110.679 -178.378 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' F' F ' 15' ' ' PRO . . . . . . . . . . . . . 28.1 Cg_exo -60.69 159.56 27.98 Favored 'Trans proline' 0 N--CA 1.497 1.702 0 C-N-CA 121.297 1.331 . . . . 0.0 112.007 177.826 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' F' F ' 16' ' ' PRO . . . . . . . . . . . . . 31.6 Cg_exo -59.76 -44.27 32.26 Favored 'Trans proline' 0 N--CA 1.497 1.689 0 C-N-CA 121.495 1.463 . . . . 0.0 112.688 -178.594 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' F' F ' 17' ' ' ASP . . . . . . . . . . . . . 9.1 p-10 -83.8 12.55 5.86 Favored 'General case' 0 CA--C 1.534 0.345 0 N-CA-C 113.156 0.799 . . . . 0.0 113.156 -177.709 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' F' F ' 18' ' ' PHE . . . . . . . . . . . . . 52.6 t80 -57.46 -43.77 84.28 Favored 'General case' 0 N--CA 1.458 -0.07 0 O-C-N 121.986 -0.447 . . . . 0.0 110.332 -178.39 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' F' F ' 19' ' ' VAL . . . . . . . . . . . . . 47.7 t -56.48 -44.06 79.5 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.302 0 CA-C-N 116.332 -0.394 . . . . 0.0 110.54 -178.11 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' F' F ' 20' ' ' ASP . . . . . . . . . . . . . 64.0 m-20 -60.01 -42.52 94.48 Favored 'General case' 0 C--N 1.329 -0.288 0 C-N-CA 120.905 -0.318 . . . . 0.0 110.951 -178.115 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' F' F ' 21' ' ' VAL . . . . . . . . . . . . . 50.6 t -64.5 -46.75 91.81 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.246 0 C-N-CA 120.745 -0.382 . . . . 0.0 110.691 -177.556 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' F' F ' 22' ' ' ILE . . . . . . . . . . . . . 51.4 mm -55.49 -46.79 78.95 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.224 0 C-N-CA 120.957 -0.297 . . . . 0.0 110.625 179.623 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' F' F ' 23' ' ' ARG . . . . . . . . . . . . . 55.9 ttp180 -54.8 -50.8 67.63 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-O 120.645 0.26 . . . . 0.0 111.314 -178.707 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' F' F ' 24' ' ' ILE . . . . . . . . . . . . . 75.6 mt -59.48 -41.86 86.0 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.268 0 CA-C-N 116.536 -0.302 . . . . 0.0 111.499 -176.266 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' F' F ' 25' ' ' LYS . . . . . . . . . . . . . 40.5 mmtt -66.41 -43.93 84.41 Favored 'General case' 0 C--N 1.329 -0.291 0 N-CA-C 112.468 0.544 . . . . 0.0 112.468 -178.655 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' F' F ' 26' ' ' LEU . . . . . . . . . . . . . 58.0 mt -78.77 -35.1 45.03 Favored 'General case' 0 C--N 1.33 -0.271 0 N-CA-C 113.77 1.026 . . . . 0.0 113.77 -169.837 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' F' F ' 27' ' ' GLN . . . . . . . . . . . . . 10.3 pt20 -47.39 139.41 6.58 Favored 'General case' 0 N--CA 1.469 0.524 0 N-CA-C 112.758 0.651 . . . . 0.0 112.758 -175.653 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' F' F ' 28' ' ' GLY . . . . . . . . . . . . . . . 101.22 -24.46 31.74 Favored Glycine 0 CA--C 1.534 1.274 0 CA-C-N 115.536 -0.756 . . . . 0.0 112.308 -176.242 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' F' F ' 29' ' ' LYS . . . . . . . . . . . . . 55.2 mttp -97.35 155.1 17.04 Favored 'General case' 0 C--O 1.231 0.129 0 CA-C-N 117.535 0.667 . . . . 0.0 111.253 178.589 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' F' F ' 30' ' ' THR . . . . . . . . . . . . . 41.2 m -106.17 137.49 44.02 Favored 'General case' 0 C--N 1.331 -0.23 0 CA-C-N 116.02 -0.536 . . . . 0.0 109.854 175.828 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' F' F ' 31' ' ' VAL . . . . . . . . . . . . . 34.6 m -130.21 153.08 38.42 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.243 0 CA-C-O 121.055 0.455 . . . . 0.0 111.192 -177.49 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' F' F ' 32' ' ' ARG . . . . . . . . . . . . . 55.5 mtp180 -128.92 152.53 48.46 Favored 'General case' 0 C--N 1.332 -0.187 0 CA-C-N 115.749 -0.66 . . . . 0.0 110.668 177.885 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' F' F ' 33' ' ' THR . . . . . . . . . . . . . 14.0 m -54.09 137.83 39.18 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 115.98 -0.554 . . . . 0.0 111.26 -179.206 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' F' F ' 34' ' ' GLY . . . . . . . . . . . . . . . 101.68 -17.17 55.44 Favored Glycine 0 CA--C 1.533 1.159 0 CA-C-O 119.59 -0.561 . . . . 0.0 113.354 178.804 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' F' F ' 35' ' ' ASP . . . . . . . . . . . . . 75.2 m-20 -65.88 148.03 52.43 Favored 'General case' 0 N--CA 1.461 0.091 0 CA-C-N 118.09 0.945 . . . . 0.0 111.192 179.469 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' F' F ' 36' ' ' VAL . . . . . . . . . . . . . 47.2 t -120.48 129.07 75.98 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.196 0 CA-C-N 115.872 -0.604 . . . . 0.0 109.829 178.789 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' F' F ' 37' ' ' ILE . . . . . . . . . . . . . 63.3 mt -122.29 138.85 51.08 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.226 0 CA-C-N 116.19 -0.459 . . . . 0.0 109.963 -178.958 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' F' F ' 38' ' ' GLY . . . . . . . . . . . . . . . -115.03 128.74 8.25 Favored Glycine 0 CA--C 1.526 0.72 0 N-CA-C 111.143 -0.783 . . . . 0.0 111.143 179.411 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' F' F ' 39' ' ' ILE . . . . . . . . . . . . . 76.6 mt -125.91 138.32 54.91 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.212 0 CA-C-O 120.808 0.337 . . . . 0.0 110.421 179.659 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' F' F ' 40' ' ' SER . . . . . . . . . . . . . 23.0 t -92.71 114.69 27.32 Favored 'General case' 0 C--N 1.332 -0.192 0 CA-C-N 116.335 -0.393 . . . . 0.0 111.059 176.131 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' F' F ' 41' ' ' ILE . . . . . . . . . . . . . 44.6 mm -121.43 122.75 68.05 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.215 0 CA-C-O 120.846 0.355 . . . . 0.0 110.303 179.274 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' F' F ' 42' ' ' LEU . . . . . . . . . . . . . 9.1 tp 52.84 35.38 18.73 Favored 'General case' 0 CA--C 1.532 0.252 0 CA-C-N 116.254 -0.43 . . . . 0.0 111.643 177.128 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' F' F ' 43' ' ' GLY . . . . . . . . . . . . . . . 72.15 30.41 65.26 Favored Glycine 0 CA--C 1.529 0.966 0 C-N-CA 121.058 -0.591 . . . . 0.0 112.165 178.066 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' F' F ' 44' ' ' LYS . . . . . . . . . . . . . 85.9 tttt -139.71 130.66 26.24 Favored 'General case' 0 C--N 1.33 -0.259 0 N-CA-C 109.564 -0.532 . . . . 0.0 109.564 178.886 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' F' F ' 45' ' ' GLU . . . . . . . . . . . . . 85.1 tt0 -82.5 121.66 27.05 Favored 'General case' 0 C--N 1.326 -0.425 0 CA-C-O 120.9 0.381 . . . . 0.0 110.985 -177.496 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' F' F ' 46' ' ' VAL . . . . . . . . . . . . . 9.7 p -118.2 125.74 74.48 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.171 0 N-CA-C 109.385 -0.598 . . . . 0.0 109.385 175.434 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' F' F ' 47' ' ' LYS . . . . . . . . . . . . . 98.8 mttt -98.84 125.56 44.26 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 115.948 -0.569 . . . . 0.0 110.705 179.1 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' F' F ' 48' ' ' PHE . . . . . . . . . . . . . 31.5 m-85 -110.56 131.89 54.66 Favored 'General case' 0 C--N 1.33 -0.267 0 N-CA-C 109.8 -0.444 . . . . 0.0 109.8 178.062 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' F' F ' 49' ' ' LYS . . . . . . . . . . . . . 46.1 tttp -107.05 132.75 52.61 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.26 -0.427 . . . . 0.0 110.081 178.337 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' F' F ' 50' ' ' VAL . . . . . . . . . . . . . 46.5 t -76.47 104.22 4.38 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.295 0 N-CA-C 109.263 -0.644 . . . . 0.0 109.263 177.215 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' F' F ' 51' ' ' VAL . . . . . . . . . . . . . 49.0 t -72.45 -52.41 23.86 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.298 0 N-CA-C 109.538 -0.541 . . . . 0.0 109.538 -175.239 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' F' F ' 52' ' ' GLN . . . . . . . . . . . . . 86.6 mt-30 -151.77 140.73 21.09 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-O 121.245 0.545 . . . . 0.0 111.675 -178.99 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' F' F ' 53' ' ' ALA . . . . . . . . . . . . . . . -116.22 127.58 54.88 Favored 'General case' 0 C--N 1.325 -0.46 0 CA-C-N 114.918 -1.037 . . . . 0.0 109.491 174.712 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' F' F ' 54' ' ' TYR . . . . . . . . . . . . . 27.4 t80 -125.92 109.06 25.02 Favored Pre-proline 0 CA--C 1.534 0.359 0 CA-C-O 118.21 -0.9 . . . . 0.0 110.511 -179.342 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' F' F ' 55' ' ' PRO . . . . . . . . . . . . . 73.3 Cg_endo -77.24 170.09 72.39 Favored 'Cis proline' 0 N--CA 1.501 1.914 0 CA-C-N 121.852 1.697 . . . . 0.0 112.658 -4.617 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' F' F ' 56' ' ' SER . . . . . . . . . . . . . 13.5 m -113.51 126.88 27.49 Favored Pre-proline 0 CA--C 1.54 0.585 0 CA-C-O 118.32 -0.848 . . . . 0.0 109.271 174.511 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' F' F ' 57' ' ' PRO . . . . . . . . . . . . . 57.3 Cg_endo -72.47 150.4 95.01 Favored 'Cis proline' 0 N--CA 1.496 1.66 0 CA-C-N 122.053 1.769 . . . . 0.0 111.692 0.043 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' F' F ' 58' ' ' LEU . . . . . . . . . . . . . 29.6 tp -107.9 137.36 46.03 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.221 -0.445 . . . . 0.0 110.659 -178.143 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' F' F ' 59' ' ' ARG . . . . . . . . . . . . . 73.6 ttt-85 -101.67 123.86 46.36 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 115.845 -0.616 . . . . 0.0 109.498 176.034 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' F' F ' 60' ' ' VAL . . . . . . . . . . . . . 44.6 t -76.51 114.9 17.38 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.239 0 C-N-CA 120.658 -0.417 . . . . 0.0 110.109 -177.426 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' F' F ' 61' ' ' GLU . . . . . . . . . . . . . 84.6 tt0 -131.11 154.21 48.54 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 115.759 -0.655 . . . . 0.0 109.503 179.532 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' F' F ' 62' ' ' ASP . . . . . . . . . . . . . 9.7 t0 -51.54 -32.59 28.6 Favored 'General case' 0 C--N 1.327 -0.376 0 N-CA-C 112.0 0.37 . . . . 0.0 112.0 -177.924 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' F' F ' 63' ' ' ARG . . . . . . . . . . . . . 27.2 mmm180 -72.4 -22.03 61.18 Favored 'General case' 0 N--CA 1.466 0.353 0 N-CA-C 112.934 0.716 . . . . 0.0 112.934 -177.627 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' F' F ' 64' ' ' THR . . . . . . . . . . . . . 21.6 m -67.84 137.87 55.65 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-O 120.825 0.345 . . . . 0.0 110.979 -175.461 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' F' F ' 65' ' ' LYS . . . . . . . . . . . . . 55.9 mtmt -88.95 140.21 29.67 Favored 'General case' 0 C--N 1.331 -0.224 0 CA-C-N 116.224 -0.444 . . . . 0.0 110.573 178.351 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' F' F ' 66' ' ' ILE . . . . . . . . . . . . . 4.3 mp -116.13 127.4 73.74 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.244 0 N-CA-C 109.755 -0.461 . . . . 0.0 109.755 -179.184 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' F' F ' 67' ' ' THR . . . . . . . . . . . . . 21.4 m -124.82 136.95 54.28 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-O 121.002 0.429 . . . . 0.0 110.873 -177.431 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' F' F ' 68' ' ' LEU . . . . . . . . . . . . . 15.9 tp . . . . . 0 C--N 1.33 -0.271 0 CA-C-N 116.099 -0.501 . . . . 0.0 110.561 178.241 . . . . . . . . 0 0 . 1 . 011 nuclear orig core ' F' F ' 73' ' ' VAL . . . . . . . . . . . . . 31.1 m . . . . . 0 N--CA 1.462 0.168 0 CA-C-O 120.789 0.328 . . . . 0.0 110.165 . . . . . . . . . 0 0 . 1 . 011 nuclear orig core ' F' F ' 74' ' ' ASP . . . . . . . . . . . . . 13.5 t70 -95.49 118.72 32.71 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.296 -0.411 . . . . 0.0 110.24 -177.575 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' F' F ' 75' ' ' VAL . . . . . . . . . . . . . 40.3 t -114.82 124.59 71.63 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.241 0 CA-C-O 121.043 0.449 . . . . 0.0 110.297 -178.746 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' F' F ' 76' ' ' LEU . . . . . . . . . . . . . 15.0 mt -128.78 146.15 50.99 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 115.661 -0.7 . . . . 0.0 109.723 178.88 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' F' F ' 77' ' ' GLU . . . . . . . . . . . . . 97.6 mt-10 -135.38 135.94 41.07 Favored 'General case' 0 C--N 1.331 -0.198 0 CA-C-O 121.075 0.464 . . . . 0.0 111.32 -178.502 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' F' F ' 78' ' ' ALA . . . . . . . . . . . . . . . -121.51 140.97 51.51 Favored 'General case' 0 C--N 1.332 -0.184 0 CA-C-N 115.775 -0.648 . . . . 0.0 109.735 176.09 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' F' F ' 79' ' ' LYS . . . . . . . . . . . . . 96.1 mttt -85.26 115.1 22.84 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-O 120.909 0.385 . . . . 0.0 110.865 -178.3 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' F' F ' 80' ' ' ILE . . . . . . . . . . . . . 39.7 mm -139.09 108.39 3.8 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.325 0 N-CA-C 109.239 -0.652 . . . . 0.0 109.239 -178.197 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' F' F ' 81' ' ' LYS . . . . . . . . . . . . . 39.2 ttpt -106.66 134.91 49.07 Favored 'General case' 0 C--N 1.331 -0.226 0 CA-C-O 120.939 0.4 . . . . 0.0 111.178 -177.242 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' F' F ' 82' ' ' GLY . . . . . . . . . . . . . . . 89.09 41.92 5.74 Favored Glycine 0 CA--C 1.523 0.556 0 N-CA-C 111.114 -0.795 . . . . 0.0 111.114 176.404 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' F' F ' 83' ' ' ILE . . . . . . . . . . . . . 68.0 mt -78.13 130.69 35.88 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.363 0 N-CA-C 109.525 -0.546 . . . . 0.0 109.525 178.398 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' F' F ' 84' ' ' LYS . . . . . . . . . . . . . 38.2 ttpt -95.73 -46.35 6.63 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-O 120.863 0.363 . . . . 0.0 110.147 -178.783 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' F' F ' 85' ' ' ASP . . . . . . . . . . . . . 7.2 t70 -152.08 149.15 28.51 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.111 -0.495 . . . . 0.0 110.629 178.581 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' F' F ' 86' ' ' VAL . . . . . . . . . . . . . 42.1 t -126.84 132.7 69.77 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.26 0 CA-C-O 120.859 0.361 . . . . 0.0 110.448 -179.524 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' F' F ' 87' ' ' ILE . . . . . . . . . . . . . 45.5 mm -119.27 124.59 73.33 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.223 0 N-CA-C 109.412 -0.588 . . . . 0.0 109.412 176.439 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' F' F ' 88' ' ' LEU . . . . . . . . . . . . . 16.8 tp -112.36 130.51 55.94 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-O 121.116 0.484 . . . . 0.0 111.19 -176.912 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' F' F ' 89' ' ' ASP . . . . . . . . . . . . . 9.1 t70 -123.64 155.15 38.27 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-N 115.754 -0.657 . . . . 0.0 109.388 175.443 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' F' F ' 90' ' ' GLU . . . . . . . . . . . . . 84.5 tt0 -47.59 -40.55 19.57 Favored 'General case' 0 C--N 1.329 -0.287 0 N-CA-C 112.818 0.673 . . . . 0.0 112.818 -172.07 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' F' F ' 91' ' ' ASN . . . . . . . . . . . . . 33.6 m120 -132.16 38.96 3.45 Favored 'General case' 0 CA--C 1.53 0.187 0 CA-C-O 120.856 0.36 . . . . 0.0 111.496 -178.208 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' F' F ' 92' ' ' LEU . . . . . . . . . . . . . 12.5 tp -166.0 139.63 4.3 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.593 -0.276 . . . . 0.0 110.325 -178.613 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' F' F ' 93' ' ' ILE . . . . . . . . . . . . . 68.2 mt -125.65 122.76 63.08 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.18 0 N-CA-C 109.588 -0.523 . . . . 0.0 109.588 179.851 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' F' F ' 94' ' ' VAL . . . . . . . . . . . . . 45.1 t -122.2 128.41 75.51 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.206 0 CA-C-O 120.977 0.417 . . . . 0.0 109.957 179.703 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' F' F ' 95' ' ' VAL . . . . . . . . . . . . . 41.3 t -119.91 132.93 68.26 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.323 0 CA-C-N 115.899 -0.591 . . . . 0.0 109.744 179.951 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' F' F ' 96' ' ' ILE . . . . . . . . . . . . . 69.5 mt -112.85 124.03 69.1 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 N-CA-C 108.96 -0.756 . . . . 0.0 108.96 177.912 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' F' F ' 97' ' ' THR . . . . . . . . . . . . . 43.6 p -98.51 155.89 17.05 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-O 121.544 0.688 . . . . 0.0 111.545 -175.424 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' F' F ' 98' ' ' GLU . . . . . . . . . . . . . 84.5 tt0 -54.11 -27.38 32.72 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 115.54 -0.755 . . . . 0.0 112.151 -179.864 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' F' F ' 99' ' ' GLU . . . . . . . . . . . . . 95.4 mt-10 -80.32 14.98 1.73 Allowed 'General case' 0 CA--C 1.535 0.381 0 N-CA-C 113.173 0.805 . . . . 0.0 113.173 -176.538 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' F' F ' 100' ' ' ASN . . . . . . . . . . . . . 3.6 m-20 63.0 35.38 13.22 Favored 'General case' 0 C--O 1.233 0.236 0 CA-C-N 118.126 0.421 . . . . 0.0 111.392 179.229 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' F' F ' 101' ' ' GLU . . . . . . . . . . . . . 85.0 tt0 -113.64 145.03 41.92 Favored 'General case' 0 C--N 1.331 -0.238 0 N-CA-C 109.633 -0.506 . . . . 0.0 109.633 174.393 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' F' F ' 102' ' ' VAL . . . . . . . . . . . . . 45.4 t -115.1 125.75 72.49 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.281 0 CA-C-N 116.22 -0.445 . . . . 0.0 109.929 -178.202 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' F' F ' 103' ' ' LEU . . . . . . . . . . . . . 61.2 mt -117.46 129.12 55.63 Favored 'General case' 0 C--N 1.332 -0.191 0 CA-C-N 115.743 -0.662 . . . . 0.0 110.325 177.445 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' F' F ' 104' ' ' ILE . . . . . . . . . . . . . 67.1 mt -119.04 124.49 73.25 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.181 0 N-CA-C 110.11 -0.33 . . . . 0.0 110.11 179.494 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' F' F ' 105' ' ' PHE . . . . . . . . . . . . . 88.9 m-85 -123.41 163.39 20.92 Favored 'General case' 0 C--O 1.232 0.168 0 O-C-N 123.954 0.784 . . . . 0.0 109.937 -179.497 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' F' F ' 106' ' ' ASN . . . . . . . . . . . . . 46.3 p-10 -97.66 -173.09 2.54 Favored 'General case' 0 C--N 1.33 -0.252 0 N-CA-C 109.821 -0.437 . . . . 0.0 109.821 171.821 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' F' F ' 107' ' ' GLN . . . . . . . . . . . . . 55.4 tt0 -60.12 -26.4 66.22 Favored 'General case' 0 C--N 1.328 -0.332 0 N-CA-C 112.19 0.441 . . . . 0.0 112.19 -178.823 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' F' F ' 108' ' ' ASN . . . . . . . . . . . . . 11.9 t-20 -88.68 13.99 11.08 Favored 'General case' 0 CA--C 1.535 0.389 0 N-CA-C 112.865 0.691 . . . . 0.0 112.865 -177.824 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' F' F ' 109' ' ' LEU . . . . . . . . . . . . . 43.2 mt 58.25 34.17 23.84 Favored 'General case' 0 CA--C 1.53 0.202 0 O-C-N 122.138 -0.351 . . . . 0.0 111.84 177.464 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' F' F ' 110' ' ' GLU . . . . . . . . . . . . . 70.5 mm-40 -103.14 142.95 33.27 Favored 'General case' 0 C--N 1.329 -0.31 0 N-CA-C 109.006 -0.738 . . . . 0.0 109.006 173.315 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' F' F ' 111' ' ' GLU . . . . . . . . . . . . . 51.1 tt0 -85.28 121.78 28.51 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-O 121.017 0.437 . . . . 0.0 110.538 -175.41 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' F' F ' 112' ' ' LEU . . . . . . . . . . . . . 44.8 mt -100.95 -42.96 6.21 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 115.708 -0.678 . . . . 0.0 110.68 179.636 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' F' F ' 113' ' ' TYR . . . . . . . . . . . . . 57.5 t80 -133.09 136.54 45.92 Favored 'General case' 0 C--N 1.331 -0.2 0 CA-C-N 116.329 -0.396 . . . . 0.0 111.221 -177.85 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' F' F ' 114' ' ' ARG . . . . . . . . . . . . . 69.8 ttt180 -137.53 118.61 14.41 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 115.716 -0.675 . . . . 0.0 110.142 178.197 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' F' F ' 115' ' ' GLY . . . . . . . . . . . . . . . -149.99 162.3 29.13 Favored Glycine 0 CA--C 1.524 0.605 0 C-N-CA 120.693 -0.765 . . . . 0.0 111.405 179.746 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' F' F ' 116' ' ' LYS . . . . . . . . . . . . . 74.2 tttt -136.97 140.42 42.17 Favored 'General case' 0 C--N 1.328 -0.338 0 N-CA-C 110.085 -0.339 . . . . 0.0 110.085 178.401 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' F' F ' 117' ' ' PHE . . . . . . . . . . . . . 34.8 m-85 -136.6 113.88 10.76 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.309 -0.405 . . . . 0.0 110.214 -177.45 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' F' F ' 118' ' ' GLU . . . . . . . . . . . . . 84.9 tt0 -53.79 -48.93 69.32 Favored 'General case' 0 C--N 1.329 -0.307 0 C-N-CA 121.112 -0.235 . . . . 0.0 111.292 -177.39 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' F' F ' 119' ' ' ASN . . . . . . . . . . . . . 6.0 m120 -92.98 31.12 1.46 Allowed 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 116.273 -0.421 . . . . 0.0 111.999 -175.464 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' F' F ' 120' ' ' LEU . . . . . . . . . . . . . 25.2 tp -55.56 122.77 12.05 Favored 'General case' 0 N--CA 1.462 0.173 0 CA-C-O 120.698 0.285 . . . . 0.0 110.535 178.413 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' F' F ' 121' ' ' ASN . . . . . . . . . . . . . 3.8 m-20 -113.86 -44.03 3.21 Favored 'General case' 0 C--O 1.232 0.146 0 CA-C-N 116.426 -0.352 . . . . 0.0 111.162 -176.189 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' F' F ' 122' ' ' LYS . . . . . . . . . . . . . 39.2 ttpt -146.01 141.6 27.83 Favored 'General case' 0 C--N 1.33 -0.24 0 C-N-CA 120.689 -0.404 . . . . 0.0 111.531 -175.1 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' F' F ' 123' ' ' VAL . . . . . . . . . . . . . 43.9 t -129.28 131.45 67.56 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.267 0 N-CA-C 109.486 -0.561 . . . . 0.0 109.486 174.786 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' F' F ' 124' ' ' LEU . . . . . . . . . . . . . 14.6 tp -127.37 131.85 50.28 Favored 'General case' 0 N--CA 1.464 0.227 0 CA-C-O 120.859 0.362 . . . . 0.0 110.919 -178.718 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' F' F ' 125' ' ' VAL . . . . . . . . . . . . . 45.4 t -126.13 129.43 72.17 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.218 0 CA-C-N 115.992 -0.549 . . . . 0.0 110.059 179.362 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' F' F ' 126' ' ' ARG . . . . . . . . . . . . . 42.0 ttm180 -154.22 131.26 10.99 Favored 'General case' 0 C--N 1.33 -0.27 0 N-CA-C 109.808 -0.441 . . . . 0.0 109.808 177.306 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' F' F ' 127' ' ' ASN . . . . . . . . . . . . . 3.4 t-20 56.67 -155.02 0.32 Allowed 'General case' 0 CA--C 1.538 0.507 0 N-CA-C 109.595 -0.521 . . . . 0.0 109.595 -178.319 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' F' F ' 128' ' ' ASP . . . . . . . . . . . . . 22.1 p-10 -82.5 17.24 1.81 Allowed 'General case' 0 CA--C 1.539 0.52 0 N-CA-C 112.491 0.552 . . . . 0.0 112.491 176.879 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' F' F ' 129' ' ' LEU . . . . . . . . . . . . . 16.5 tp -116.37 137.36 52.22 Favored 'General case' 0 C--O 1.232 0.18 0 N-CA-C 109.934 -0.395 . . . . 0.0 109.934 179.148 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' F' F ' 130' ' ' VAL . . . . . . . . . . . . . 12.6 p -136.9 143.37 35.19 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.25 0 CA-C-O 121.033 0.444 . . . . 0.0 110.663 -179.951 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' F' F ' 131' ' ' VAL . . . . . . . . . . . . . 32.5 m -136.09 146.94 28.42 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.275 0 CA-C-O 121.238 0.542 . . . . 0.0 110.912 178.804 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' F' F ' 132' ' ' ILE . . . . . . . . . . . . . 73.2 mt -122.36 134.01 66.88 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.228 0 CA-C-N 115.505 -0.771 . . . . 0.0 109.581 -179.572 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' F' F ' 133' ' ' ILE . . . . . . . . . . . . . 40.1 mm -115.91 122.79 70.3 Favored 'Isoleucine or valine' 0 C--O 1.234 0.262 0 CA-C-N 116.353 -0.385 . . . . 0.0 110.86 -176.304 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' F' F ' 134' ' ' ASP . . . . . . . . . . . . . 7.3 p-10 -131.88 150.97 52.0 Favored 'General case' 0 C--N 1.331 -0.23 0 CA-C-N 116.128 -0.487 . . . . 0.0 109.744 174.441 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' F' F ' 135' ' ' GLU . . . . . . . . . . . . . 85.6 tt0 -49.92 -25.86 3.62 Favored 'General case' 0 C--N 1.327 -0.378 0 N-CA-C 112.896 0.702 . . . . 0.0 112.896 -170.738 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' F' F ' 136' ' ' GLN . . . . . . . . . . . . . 97.8 mt-30 -105.05 -25.22 12.62 Favored 'General case' 0 N--CA 1.464 0.266 0 N-CA-C 113.015 0.746 . . . . 0.0 113.015 -175.081 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' F' F ' 137' ' ' LYS . . . . . . . . . . . . . 66.2 mttm -140.27 150.21 43.77 Favored 'General case' 0 C--N 1.331 -0.217 0 CA-C-O 121.587 0.708 . . . . 0.0 112.529 -167.529 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' F' F ' 138' ' ' LEU . . . . . . . . . . . . . 13.0 tp -112.99 121.55 44.98 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 114.787 -1.097 . . . . 0.0 109.003 173.103 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' F' F ' 139' ' ' THR . . . . . . . . . . . . . 31.8 m -113.95 126.96 55.73 Favored 'General case' 0 C--N 1.331 -0.215 0 CA-C-O 120.837 0.351 . . . . 0.0 110.862 -178.761 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' F' F ' 140' ' ' LEU . . . . . . . . . . . . . 8.8 tt -116.34 124.13 49.34 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 115.577 -0.738 . . . . 0.0 109.354 179.913 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' F' F ' 141' ' ' ILE . . . . . . . . . . . . . 19.3 mt -121.48 120.88 63.11 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.275 0 CA-C-O 120.923 0.392 . . . . 0.0 109.971 -175.199 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' F' F ' 142' ' ' ARG . . . . . . . . . . . . . 34.7 tpt85 -110.22 127.07 54.77 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-N 115.337 -0.847 . . . . 0.0 109.965 -178.136 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' F' F ' 143' ' ' THR . . . . . . . . . . . . . 34.4 p . . . . . 0 C--O 1.22 -0.458 0 CA-C-O 118.02 -0.991 . . . . 0.0 110.656 -179.748 . . . . . . . . 0 0 . 1 . 012 nuclear orig core ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 1.7 p . . . . . 0 C--O 1.233 0.19 0 CA-C-O 121.377 0.608 . . . . 0.0 110.336 . . . . . . . . . 0 0 . 1 . 012 nuclear orig core ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 85.1 tt0 -143.05 142.1 31.47 Favored 'General case' 0 C--N 1.327 -0.399 0 CA-C-N 115.451 -0.795 . . . . 0.0 111.114 -178.325 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 4' ' ' LEU . . . . . . . . . . . . . 18.9 tp -123.93 128.18 49.05 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 115.887 -0.597 . . . . 0.0 109.952 176.922 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 5' ' ' LYS . . . . . . . . . . . . . 95.2 mttt -107.24 122.56 46.79 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.572 -0.285 . . . . 0.0 110.71 -179.873 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 58.1 mt -115.54 147.65 40.45 Favored 'General case' 0 C--N 1.331 -0.215 0 CA-C-N 115.577 -0.738 . . . . 0.0 110.244 -179.123 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 26.5 ttpp -125.98 139.7 34.98 Favored Pre-proline 0 CA--C 1.532 0.284 0 CA-C-O 118.983 -0.532 . . . . 0.0 109.725 174.244 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 8' ' ' PRO . . . . . . . . . . . . . 83.7 Cg_endo -91.75 133.61 1.42 Allowed 'Trans proline' 0 N--CA 1.489 1.224 0 C-N-CA 121.786 1.657 . . . . 0.0 111.808 178.275 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 73.2 mt -75.64 -47.01 4.14 Favored Pre-proline 0 CA--C 1.534 0.339 0 CA-C-O 118.527 -0.749 . . . . 0.0 111.948 179.03 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 73.9 Cg_endo -77.88 145.66 22.71 Favored 'Trans proline' 0 N--CA 1.496 1.635 0 CA-C-N 120.427 1.188 . . . . 0.0 111.656 175.154 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 58.1 mttm -84.76 89.53 7.54 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-O 120.815 0.34 . . . . 0.0 110.701 -179.781 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 12.3 p -139.55 146.24 25.72 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.293 0 CA-C-N 116.096 -0.502 . . . . 0.0 110.289 178.989 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 45.4 tp10 -89.47 129.35 35.97 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.342 -0.39 . . . . 0.0 110.254 178.554 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 14' ' ' LEU . . . . . . . . . . . . . 35.2 mt -97.36 144.88 28.69 Favored Pre-proline 0 C--N 1.329 -0.3 0 CA-C-O 119.14 -0.457 . . . . 0.0 110.05 -179.01 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 15' ' ' PRO . . . . . . . . . . . . . 24.8 Cg_exo -61.83 163.03 20.03 Favored 'Trans proline' 0 N--CA 1.498 1.783 0 C-N-CA 121.268 1.312 . . . . 0.0 111.751 178.447 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 16' ' ' PRO . . . . . . . . . . . . . 31.7 Cg_exo -59.52 -36.07 94.1 Favored 'Trans proline' 0 N--CA 1.497 1.698 0 C-N-CA 121.562 1.508 . . . . 0.0 112.971 -177.502 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 17' ' ' ASP . . . . . . . . . . . . . 7.9 p-10 -84.64 0.16 51.24 Favored 'General case' 0 CA--C 1.537 0.459 0 N-CA-C 113.274 0.842 . . . . 0.0 113.274 -177.748 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 18' ' ' PHE . . . . . . . . . . . . . 35.3 t80 -58.64 -43.75 89.85 Favored 'General case' 0 C--N 1.333 -0.128 0 O-C-N 121.95 -0.469 . . . . 0.0 109.963 -177.75 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 19' ' ' VAL . . . . . . . . . . . . . 53.3 t -57.19 -42.51 80.0 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.253 0 CA-C-N 116.155 -0.475 . . . . 0.0 110.383 -179.366 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 19.1 t0 -60.02 -42.89 95.33 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-O 120.775 0.322 . . . . 0.0 111.057 -177.869 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 45.4 t -64.38 -46.49 92.86 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.269 0 C-N-CA 120.784 -0.367 . . . . 0.0 110.361 -177.693 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 22' ' ' ILE . . . . . . . . . . . . . 51.9 mm -56.27 -44.23 78.97 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.223 0 CA-C-O 120.73 0.3 . . . . 0.0 110.54 178.633 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 23' ' ' ARG . . . . . . . . . . . . . 57.3 ttp180 -54.53 -47.82 72.71 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-O 120.774 0.321 . . . . 0.0 111.305 -179.934 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 24' ' ' ILE . . . . . . . . . . . . . 79.9 mt -59.15 -41.41 83.62 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.295 0 CA-C-N 116.438 -0.346 . . . . 0.0 111.022 -178.574 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 58.3 mttm -67.48 -41.0 85.31 Favored 'General case' 0 C--N 1.328 -0.343 0 N-CA-C 112.571 0.582 . . . . 0.0 112.571 -179.006 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 79.5 mt -77.92 -38.67 45.05 Favored 'General case' 0 C--N 1.331 -0.233 0 N-CA-C 113.512 0.93 . . . . 0.0 113.512 -170.227 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 27' ' ' GLN . . . . . . . . . . . . . 9.7 pt20 -46.94 138.62 6.26 Favored 'General case' 0 N--CA 1.468 0.429 0 N-CA-C 112.796 0.665 . . . . 0.0 112.796 -174.722 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 101.13 -25.69 27.36 Favored Glycine 0 CA--C 1.533 1.165 0 CA-C-N 115.609 -0.723 . . . . 0.0 112.341 -177.865 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 69.8 mmtt -98.31 155.18 17.33 Favored 'General case' 0 C--N 1.333 -0.128 0 CA-C-N 117.4 0.6 . . . . 0.0 111.31 178.443 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 30' ' ' THR . . . . . . . . . . . . . 40.2 m -108.88 139.87 43.13 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 115.804 -0.634 . . . . 0.0 109.792 175.244 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 33.6 m -130.69 155.77 42.08 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.222 0 CA-C-O 121.032 0.444 . . . . 0.0 111.144 -177.542 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 32' ' ' ARG . . . . . . . . . . . . . 61.5 mtt85 -129.02 150.58 50.37 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-N 115.862 -0.608 . . . . 0.0 110.733 178.36 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 33' ' ' THR . . . . . . . . . . . . . 23.3 m -53.26 138.91 31.09 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.054 -0.521 . . . . 0.0 111.39 -178.087 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 100.65 -17.2 56.91 Favored Glycine 0 CA--C 1.534 1.266 0 CA-C-O 119.607 -0.552 . . . . 0.0 113.232 178.526 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 79.5 m-20 -66.44 147.31 53.48 Favored 'General case' 0 N--CA 1.461 0.097 0 CA-C-N 118.008 0.904 . . . . 0.0 111.117 178.63 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 42.1 t -121.74 130.35 74.68 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.288 0 CA-C-N 116.083 -0.508 . . . . 0.0 109.865 178.403 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 37' ' ' ILE . . . . . . . . . . . . . 68.4 mt -120.4 138.55 50.56 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.279 0 CA-C-N 116.161 -0.472 . . . . 0.0 109.877 -179.813 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . -117.48 128.72 7.96 Favored Glycine 0 CA--C 1.526 0.735 0 N-CA-C 110.636 -0.986 . . . . 0.0 110.636 178.611 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 39' ' ' ILE . . . . . . . . . . . . . 69.9 mt -123.75 132.46 71.34 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.24 0 CA-C-O 120.735 0.302 . . . . 0.0 110.3 -179.986 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 40' ' ' SER . . . . . . . . . . . . . 30.1 t -92.37 118.35 30.83 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.14 -0.482 . . . . 0.0 110.605 175.698 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 41' ' ' ILE . . . . . . . . . . . . . 69.2 mt -130.71 122.5 52.67 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.234 0 CA-C-O 120.849 0.357 . . . . 0.0 110.499 178.612 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 45.8 mt 55.12 33.91 21.45 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.033 -0.53 . . . . 0.0 111.897 176.666 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . 72.81 28.4 67.09 Favored Glycine 0 CA--C 1.531 1.046 0 C-N-CA 121.016 -0.611 . . . . 0.0 112.375 178.026 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 44' ' ' LYS . . . . . . . . . . . . . 26.4 ttpp -137.24 127.61 26.5 Favored 'General case' 0 C--N 1.331 -0.228 0 N-CA-C 109.54 -0.541 . . . . 0.0 109.54 177.288 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 67.6 tt0 -86.05 126.68 34.35 Favored 'General case' 0 C--N 1.327 -0.392 0 CA-C-N 116.336 -0.393 . . . . 0.0 111.12 -176.851 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 46' ' ' VAL . . . . . . . . . . . . . 10.2 p -119.55 126.81 75.68 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.172 0 N-CA-C 109.909 -0.404 . . . . 0.0 109.909 175.436 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 72.7 mmtt -98.2 125.54 43.29 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 115.927 -0.579 . . . . 0.0 110.752 176.148 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 48' ' ' PHE . . . . . . . . . . . . . 32.8 m-85 -112.16 131.61 55.36 Favored 'General case' 0 C--N 1.329 -0.295 0 N-CA-C 109.185 -0.672 . . . . 0.0 109.185 174.651 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 42.2 tttp -108.4 132.92 53.27 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.484 -0.325 . . . . 0.0 110.208 178.931 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 50' ' ' VAL . . . . . . . . . . . . . 41.3 t -76.23 103.99 4.04 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.332 0 N-CA-C 109.21 -0.663 . . . . 0.0 109.21 177.427 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 51' ' ' VAL . . . . . . . . . . . . . 47.8 t -69.65 -50.19 52.21 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.347 0 CA-C-N 116.086 -0.506 . . . . 0.0 109.801 -174.722 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 52' ' ' GLN . . . . . . . . . . . . . 62.2 tt0 -160.3 140.15 11.25 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 115.875 -0.602 . . . . 0.0 111.724 -177.84 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -112.76 130.67 55.99 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-N 115.735 -0.666 . . . . 0.0 109.709 175.017 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 54' ' ' TYR . . . . . . . . . . . . . 59.5 t80 -129.16 107.94 17.89 Favored Pre-proline 0 CA--C 1.535 0.394 0 CA-C-O 118.324 -0.846 . . . . 0.0 110.457 -179.661 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 55' ' ' PRO . . . . . . . . . . . . . 73.7 Cg_endo -77.1 170.09 72.56 Favored 'Cis proline' 0 N--CA 1.499 1.821 0 CA-C-N 121.829 1.689 . . . . 0.0 112.339 -5.624 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 56' ' ' SER . . . . . . . . . . . . . 20.1 m -114.5 130.71 23.8 Favored Pre-proline 0 CA--C 1.539 0.526 0 CA-C-O 118.412 -0.804 . . . . 0.0 109.506 175.441 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 57' ' ' PRO . . . . . . . . . . . . . 55.2 Cg_endo -71.44 146.99 86.78 Favored 'Cis proline' 0 N--CA 1.496 1.664 0 CA-C-N 121.947 1.731 . . . . 0.0 111.622 -0.914 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 58' ' ' LEU . . . . . . . . . . . . . 22.3 tp -106.53 135.28 48.31 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.28 -0.418 . . . . 0.0 110.22 -179.506 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 59' ' ' ARG . . . . . . . . . . . . . 56.7 ttt85 -105.55 127.12 52.85 Favored 'General case' 0 C--N 1.326 -0.426 0 N-CA-C 109.2 -0.667 . . . . 0.0 109.2 176.639 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 43.4 t -86.03 124.1 40.01 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.234 0 C-N-CA 120.588 -0.445 . . . . 0.0 110.61 -174.528 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 96.0 mt-10 -131.02 172.48 12.04 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 115.774 -0.648 . . . . 0.0 109.877 177.999 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 62' ' ' ASP . . . . . . . . . . . . . 7.5 p-10 -55.56 -32.75 63.25 Favored 'General case' 0 C--N 1.328 -0.339 0 C-N-CA 120.922 -0.311 . . . . 0.0 111.557 179.42 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 63' ' ' ARG . . . . . . . . . . . . . 25.8 ptt180 -86.33 3.74 42.18 Favored 'General case' 0 CA--C 1.537 0.477 0 N-CA-C 113.724 1.009 . . . . 0.0 113.724 -176.94 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 30.7 m -83.51 135.29 34.71 Favored 'General case' 0 C--N 1.333 -0.135 0 CA-C-N 118.04 0.382 . . . . 0.0 110.612 -177.427 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 65' ' ' LYS . . . . . . . . . . . . . 52.1 mtmt -89.72 129.28 36.15 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.064 -0.517 . . . . 0.0 110.503 179.556 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 66' ' ' ILE . . . . . 0.415 HD11 HG23 ' A' ' 66' ' ' ILE . 66.4 mt -114.45 129.08 71.1 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.309 0 N-CA-C 109.41 -0.589 . . . . 0.0 109.41 177.61 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 67' ' ' THR . . . . . . . . . . . . . 22.0 m -125.74 144.64 50.54 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.215 -0.448 . . . . 0.0 111.345 -175.66 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 68' ' ' LEU . . . . . . . . . . . . . 5.6 tt . . . . . 0 C--N 1.329 -0.299 0 CA-C-N 115.805 -0.634 . . . . 0.0 109.43 175.788 . . . . . . . . 0 0 . 1 . 012 nuclear orig core ' A' A ' 74' ' ' ASP . . . . . . . . . . . . . 25.1 t0 . . . . . 0 CA--C 1.524 -0.027 0 N-CA-C 110.507 -0.183 . . . . 0.0 110.507 . . . . . . . . . 0 0 . 1 . 012 nuclear orig core ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 40.0 t -118.67 121.01 65.91 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.212 0 CA-C-O 120.955 0.407 . . . . 0.0 110.52 -178.561 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 76' ' ' LEU . . . . . . . . . . . . . 7.5 mp -117.3 141.31 48.46 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 115.79 -0.641 . . . . 0.0 109.502 175.608 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 77' ' ' GLU . . . . . . . . . . . . . 97.0 mt-10 -132.56 136.13 46.39 Favored 'General case' 0 C--N 1.331 -0.197 0 CA-C-O 121.151 0.5 . . . . 0.0 111.465 -177.724 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 78' ' ' ALA . . . . . . . . . . . . . . . -124.24 131.45 53.53 Favored 'General case' 0 C--N 1.332 -0.185 0 CA-C-N 115.482 -0.781 . . . . 0.0 109.7 176.079 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 79' ' ' LYS . . . . . . . . . . . . . 99.2 mttt -78.31 117.48 19.6 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-O 120.918 0.39 . . . . 0.0 110.714 -177.533 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 80' ' ' ILE . . . . . . . . . . . . . 38.7 mm -139.24 111.47 5.55 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.311 0 N-CA-C 109.241 -0.652 . . . . 0.0 109.241 -177.448 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 81' ' ' LYS . . . . . . . . . . . . . 20.0 pttp -106.31 127.41 53.23 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-O 121.165 0.507 . . . . 0.0 111.608 -176.721 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . 89.01 42.16 5.71 Favored Glycine 0 CA--C 1.525 0.691 0 C-N-CA 120.883 -0.675 . . . . 0.0 111.832 174.267 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 83' ' ' ILE . . . . . . . . . . . . . 71.1 mt -71.49 138.0 22.58 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.231 0 N-CA-C 109.921 -0.4 . . . . 0.0 109.921 178.314 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 84' ' ' LYS . . . . . . . . . . . . . 31.0 ttmt -88.96 -53.09 4.75 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 115.943 -0.572 . . . . 0.0 109.788 -179.605 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 85' ' ' ASP . . . . . . . . . . . . . 7.2 t0 -157.39 151.91 25.19 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 115.51 -0.768 . . . . 0.0 110.136 179.637 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 86' ' ' VAL . . . . . . . . . . . . . 41.9 t -126.59 131.7 70.99 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.187 0 CA-C-O 120.956 0.408 . . . . 0.0 110.375 -179.138 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 87' ' ' ILE . . . . . . . . . . . . . 5.0 mp -117.37 124.75 73.43 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.224 0 N-CA-C 109.351 -0.611 . . . . 0.0 109.351 175.998 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 88' ' ' LEU . . . . . . . . . . . . . 10.6 tp -111.88 129.54 56.13 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-O 120.991 0.424 . . . . 0.0 111.098 -176.15 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 89' ' ' ASP . . . . . . . . . . . . . 13.4 t70 -125.22 150.55 46.9 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-N 115.789 -0.641 . . . . 0.0 109.535 175.428 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 84.4 tt0 -48.67 -34.88 12.68 Favored 'General case' 0 C--N 1.328 -0.351 0 N-CA-C 112.772 0.656 . . . . 0.0 112.772 -172.946 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 91' ' ' ASN . . . . . . . . . . . . . 25.1 m120 -130.48 29.79 4.79 Favored 'General case' 0 N--CA 1.468 0.459 0 N-CA-C 112.184 0.439 . . . . 0.0 112.184 -176.559 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 92' ' ' LEU . . . . . . . . . . . . . 12.4 tp -166.09 141.99 4.9 Favored 'General case' 0 C--N 1.33 -0.275 0 C-N-CA 121.103 -0.239 . . . . 0.0 110.384 179.569 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 93' ' ' ILE . . . . . . . . . . . . . 74.2 mt -124.79 123.49 65.93 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.23 0 N-CA-C 109.609 -0.515 . . . . 0.0 109.609 179.191 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 94' ' ' VAL . . . . . . . . . . . . . 45.5 t -122.56 126.87 74.66 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.241 0 N-CA-C 109.876 -0.416 . . . . 0.0 109.876 179.856 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 95' ' ' VAL . . . . . . . . . . . . . 47.8 t -121.46 132.53 70.47 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.292 0 CA-C-N 116.028 -0.533 . . . . 0.0 109.862 -179.293 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 96' ' ' ILE . . . . . . . . . . . . . 57.3 mt -112.83 126.42 70.22 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.337 0 N-CA-C 109.021 -0.733 . . . . 0.0 109.021 178.62 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 97' ' ' THR . . . . . . . . . . . . . 72.9 p -101.73 154.27 19.05 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-O 121.265 0.555 . . . . 0.0 111.137 -176.426 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 98' ' ' GLU . . . . . . . . . . . . . 48.0 tp10 -54.14 -25.92 24.84 Favored 'General case' 0 CA--C 1.535 0.366 0 CA-C-N 116.111 -0.495 . . . . 0.0 112.107 -179.809 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 99' ' ' GLU . . . . . . . . . . . . . 40.0 tt0 -80.13 18.11 0.91 Allowed 'General case' 0 CA--C 1.539 0.522 0 N-CA-C 112.573 0.582 . . . . 0.0 112.573 -176.688 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 100' ' ' ASN . . . . . . . . . . . . . 2.9 m-20 62.97 37.12 12.09 Favored 'General case' 0 CA--C 1.529 0.163 0 O-C-N 121.738 -0.601 . . . . 0.0 111.141 176.378 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 101' ' ' GLU . . . . . . . . . . . . . 84.5 tt0 -118.71 143.09 47.09 Favored 'General case' 0 C--N 1.332 -0.182 0 CA-C-N 116.072 -0.513 . . . . 0.0 109.925 176.231 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 102' ' ' VAL . . . . . . . . . . . . . 47.0 t -114.97 125.57 72.33 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.278 0 N-CA-C 109.761 -0.459 . . . . 0.0 109.761 179.858 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 103' ' ' LEU . . . . . . . . . . . . . 54.4 mt -116.71 135.12 54.03 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 115.732 -0.667 . . . . 0.0 109.955 178.886 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 104' ' ' ILE . . . . . . . . . . . . . 72.9 mt -122.97 123.09 67.25 Favored 'Isoleucine or valine' 0 C--O 1.234 0.246 0 N-CA-C 110.349 -0.241 . . . . 0.0 110.349 -178.674 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 105' ' ' PHE . . . . . . . . . . . . . 85.5 m-85 -123.82 165.43 17.35 Favored 'General case' 0 C--O 1.232 0.184 0 O-C-N 123.996 0.81 . . . . 0.0 110.071 -178.618 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 106' ' ' ASN . . . . . . . . . . . . . 47.4 p-10 -101.3 -169.96 1.77 Allowed 'General case' 0 C--N 1.329 -0.317 0 N-CA-C 109.577 -0.527 . . . . 0.0 109.577 171.769 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 107' ' ' GLN . . . . . . . . . . . . . 47.7 tt0 -59.01 -29.97 67.65 Favored 'General case' 0 C--N 1.329 -0.312 0 N-CA-C 112.006 0.373 . . . . 0.0 112.006 -178.975 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 108' ' ' ASN . . . . . . . . . . . . . 6.7 t-20 -87.07 12.31 11.73 Favored 'General case' 0 CA--C 1.533 0.321 0 N-CA-C 113.015 0.746 . . . . 0.0 113.015 -176.653 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 109' ' ' LEU . . . . . . . . . . . . . 24.9 mt 58.56 37.03 25.5 Favored 'General case' 0 C--O 1.233 0.191 0 CA-C-O 120.828 0.346 . . . . 0.0 111.497 177.245 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 110' ' ' GLU . . . . . . . . . . . . . 95.4 mt-10 -104.66 146.87 28.32 Favored 'General case' 0 C--N 1.329 -0.293 0 N-CA-C 110.013 -0.365 . . . . 0.0 110.013 176.513 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 111' ' ' GLU . . . . . . . . . . . . . 98.8 mt-10 -76.16 121.94 23.59 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-O 120.989 0.423 . . . . 0.0 111.204 -178.304 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 112' ' ' LEU . . . . . . . . . . . . . 50.3 mt -107.47 -45.81 3.99 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 115.767 -0.651 . . . . 0.0 110.033 175.985 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 113' ' ' TYR . . . . . . . . . . . . . 63.2 t80 -140.64 138.71 34.55 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.012 -0.54 . . . . 0.0 110.859 179.973 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 114' ' ' ARG . . . . . . . . . . . . . 36.5 mtm105 -144.03 124.15 13.67 Favored 'General case' 0 C--N 1.331 -0.221 0 CA-C-N 116.388 -0.369 . . . . 0.0 110.494 176.309 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 115' ' ' GLY . . . . . . . . . . . . . . . -150.15 143.66 10.98 Favored Glycine 0 CA--C 1.524 0.614 0 N-CA-C 110.939 -0.864 . . . . 0.0 110.939 179.345 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 116' ' ' LYS . . . . . . . . . . . . . 35.3 ttmt -114.15 140.43 48.53 Favored 'General case' 0 C--N 1.331 -0.201 0 CA-C-O 120.861 0.362 . . . . 0.0 110.054 177.032 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 117' ' ' PHE . . . . . . . . . . . . . 32.5 m-85 -137.63 115.04 11.09 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.19 -0.459 . . . . 0.0 109.889 -176.487 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 118' ' ' GLU . . . . . . . . . . . . . 96.0 mt-10 -54.64 -44.12 72.91 Favored 'General case' 0 C--N 1.328 -0.335 0 C-N-CA 120.965 -0.294 . . . . 0.0 111.321 -175.698 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 119' ' ' ASN . . . . . . . . . . . . . 25.1 m120 -96.44 30.58 2.5 Favored 'General case' 0 C--N 1.33 -0.248 0 N-CA-C 112.29 0.478 . . . . 0.0 112.29 -174.878 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 120' ' ' LEU . . . . . . . . . . . . . 28.7 tp -60.6 126.74 28.55 Favored 'General case' 0 C--N 1.332 -0.189 0 N-CA-C 109.83 -0.433 . . . . 0.0 109.83 177.287 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 121' ' ' ASN . . . . . . . . . . . . . 55.8 m-80 -110.88 -44.09 3.68 Favored 'General case' 0 C--N 1.331 -0.225 0 CA-C-N 116.361 -0.381 . . . . 0.0 111.128 -176.863 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 122' ' ' LYS . . . . . . . . . . . . . 56.2 pttt -161.44 159.21 27.82 Favored 'General case' 0 C--N 1.332 -0.167 0 C-N-CA 120.428 -0.509 . . . . 0.0 111.84 -179.266 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 123' ' ' VAL . . . . . . . . . . . . . 38.0 t -131.18 135.86 58.89 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.221 0 CA-C-N 116.094 -0.503 . . . . 0.0 110.321 -179.481 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 124' ' ' LEU . . . . . . . . . . . . . 46.0 mt -119.85 130.53 54.92 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.068 -0.514 . . . . 0.0 109.788 177.773 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 125' ' ' VAL . . . . . . . . . . . . . 13.6 p -138.29 137.49 43.91 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.2 0 CA-C-O 121.073 0.464 . . . . 0.0 111.166 -179.026 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 126' ' ' ARG . . . . . . . . . . . . . 14.0 ptm180 -163.28 135.97 5.41 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 115.804 -0.634 . . . . 0.0 109.776 175.673 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 127' ' ' ASN . . . . . . . . . . . . . 78.6 m-20 55.34 -154.55 0.3 Allowed 'General case' 0 CA--C 1.539 0.544 0 N-CA-C 110.074 -0.343 . . . . 0.0 110.074 179.875 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 128' ' ' ASP . . . . . . . . . . . . . 20.0 p-10 -80.15 15.49 1.51 Allowed 'General case' 0 CA--C 1.536 0.411 0 N-CA-C 112.938 0.718 . . . . 0.0 112.938 179.394 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 129' ' ' LEU . . . . . . . . . . . . . 13.9 tp -119.68 132.42 55.67 Favored 'General case' 0 C--O 1.232 0.142 0 CA-C-N 118.154 0.434 . . . . 0.0 110.223 179.575 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 130' ' ' VAL . . . . . . . . . . . . . 14.1 p -138.87 145.36 27.88 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.292 0 CA-C-O 120.979 0.418 . . . . 0.0 110.604 178.912 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 131' ' ' VAL . . . . . . . . . . . . . 43.1 t -135.04 138.68 48.57 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.252 0 CA-C-N 116.18 -0.464 . . . . 0.0 110.223 179.3 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 132' ' ' ILE . . . . . . . . . . . . . 67.6 mt -112.52 131.68 63.36 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.331 0 N-CA-C 109.349 -0.611 . . . . 0.0 109.349 179.849 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 133' ' ' ILE . . . . . . . . . . . . . 43.8 mm -115.02 123.21 70.48 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.254 0 CA-C-O 120.667 0.27 . . . . 0.0 111.083 -174.945 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 134' ' ' ASP . . . . . . . . . . . . . 7.2 p-10 -135.93 147.64 48.2 Favored 'General case' 0 C--N 1.332 -0.186 0 N-CA-C 109.584 -0.524 . . . . 0.0 109.584 172.896 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 135' ' ' GLU . . . . . . . . . . . . . 84.6 tt0 -49.81 -27.65 5.3 Favored 'General case' 0 C--N 1.327 -0.409 0 N-CA-C 112.767 0.654 . . . . 0.0 112.767 -172.749 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 136' ' ' GLN . . . . . . . . . . . . . 48.2 tt0 -83.57 -32.76 25.63 Favored 'General case' 0 C--O 1.235 0.323 0 N-CA-C 112.34 0.496 . . . . 0.0 112.34 -174.967 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 137' ' ' LYS . . . . . . . . . . . . . 52.0 pttt -167.04 169.88 12.49 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-O 121.497 0.665 . . . . 0.0 112.098 -172.365 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 138' ' ' LEU . . . . . . . . . . . . . 8.8 tt -119.87 129.25 54.3 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 115.273 -0.876 . . . . 0.0 110.065 179.439 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 139' ' ' THR . . . . . . . . . . . . . 44.4 m -110.03 127.01 54.57 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.084 -0.507 . . . . 0.0 110.294 179.657 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 140' ' ' LEU . . . . . . . . . . . . . 8.7 tt -110.8 123.33 49.87 Favored 'General case' 0 C--N 1.328 -0.329 0 N-CA-C 109.421 -0.585 . . . . 0.0 109.421 179.782 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 141' ' ' ILE . . . . . . . . . . . . . 18.9 mt -124.64 123.59 66.33 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.259 0 CA-C-O 120.964 0.412 . . . . 0.0 109.933 -175.336 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 142' ' ' ARG . . . . . . . . . . . . . 69.4 ttt180 -111.59 119.73 39.69 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 115.75 -0.659 . . . . 0.0 109.587 178.598 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 143' ' ' THR . . . . . . . . . . . . . 71.0 p . . . . . 0 C--O 1.22 -0.46 0 CA-C-O 117.981 -1.009 . . . . 0.0 110.606 -178.451 . . . . . . . . 0 0 . 1 . 012 nuclear orig core ' B' B ' 2' ' ' SER . . . . . . . . . . . . . 9.6 p . . . . . 0 C--O 1.233 0.212 0 CA-C-O 120.963 0.411 . . . . 0.0 110.558 . . . . . . . . . 0 0 . 1 . 012 nuclear orig core ' B' B ' 3' ' ' GLU . . . . . . . . . . . . . 95.0 mt-10 -139.84 142.39 36.6 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.021 -0.536 . . . . 0.0 110.954 -178.532 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' B' B ' 4' ' ' LEU . . . . . . . . . . . . . 4.3 tt -126.14 124.73 41.19 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 115.829 -0.623 . . . . 0.0 109.559 176.899 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' B' B ' 5' ' ' LYS . . . . . . . . . . . . . 96.1 mttt -108.12 120.87 43.58 Favored 'General case' 0 C--O 1.234 0.265 0 CA-C-O 120.755 0.312 . . . . 0.0 110.913 -178.2 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' B' B ' 6' ' ' LEU . . . . . . . . . . . . . 54.4 mt -114.82 148.96 37.79 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 115.439 -0.8 . . . . 0.0 110.656 -178.992 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' B' B ' 7' ' ' LYS . . . . . . . . . . . . . 26.3 ttpp -136.53 140.78 33.33 Favored Pre-proline 0 CA--C 1.532 0.267 0 CA-C-O 119.166 -0.445 . . . . 0.0 109.991 174.701 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' B' B ' 8' ' ' PRO . . . . . . . . . . . . . 87.9 Cg_endo -91.88 138.98 2.09 Favored 'Trans proline' 0 N--CA 1.49 1.274 0 C-N-CA 121.756 1.638 . . . . 0.0 111.638 177.645 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' B' B ' 9' ' ' LEU . . . . . . . . . . . . . 69.0 mt -73.65 -46.99 7.2 Favored Pre-proline 0 CA--C 1.534 0.357 0 CA-C-O 118.682 -0.675 . . . . 0.0 111.961 -179.991 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' B' B ' 10' ' ' PRO . . . . . . . . . . . . . 83.1 Cg_endo -81.36 150.81 17.43 Favored 'Trans proline' 0 N--CA 1.497 1.7 0 C-N-CA 121.166 1.244 . . . . 0.0 111.824 174.738 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' B' B ' 11' ' ' LYS . . . . . . . . . . . . . 39.4 ttpt -87.6 94.26 9.67 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.442 -0.345 . . . . 0.0 110.325 178.648 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' B' B ' 12' ' ' VAL . . . . . . . . . . . . . 12.0 p -140.07 142.19 32.29 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.297 0 CA-C-N 116.211 -0.449 . . . . 0.0 110.394 179.252 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' B' B ' 13' ' ' GLU . . . . . . . . . . . . . 41.9 mt-10 -75.69 132.24 40.41 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-O 120.802 0.335 . . . . 0.0 110.251 178.623 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' B' B ' 14' ' ' LEU . . . . . . . . . . . . . 30.5 mt -98.32 153.16 38.16 Favored Pre-proline 0 C--N 1.33 -0.253 0 CA-C-N 116.346 -0.388 . . . . 0.0 110.666 -179.224 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' B' B ' 15' ' ' PRO . . . . . . . . . . . . . 27.7 Cg_exo -61.12 154.12 59.66 Favored 'Trans proline' 0 N--CA 1.496 1.667 0 C-N-CA 121.276 1.317 . . . . 0.0 111.599 177.626 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' B' B ' 16' ' ' PRO . . . . . . . . . . . . . 33.9 Cg_exo -57.74 -36.44 98.39 Favored 'Trans proline' 0 N--CA 1.498 1.751 0 C-N-CA 121.389 1.393 . . . . 0.0 112.793 -178.896 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' B' B ' 17' ' ' ASP . . . . . . . . . . . . . 18.0 p-10 -92.43 15.04 14.89 Favored 'General case' 0 C--N 1.327 -0.383 0 N-CA-C 113.02 0.748 . . . . 0.0 113.02 -177.489 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' B' B ' 18' ' ' PHE . . . . . . . . . . . . . 44.4 t80 -58.38 -44.69 89.0 Favored 'General case' 0 C--O 1.228 -0.078 0 O-C-N 122.008 -0.432 . . . . 0.0 110.057 -177.722 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' B' B ' 19' ' ' VAL . . . . . . . . . . . . . 48.4 t -56.91 -42.97 79.59 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.305 0 CA-C-N 116.055 -0.521 . . . . 0.0 110.53 -178.346 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' B' B ' 20' ' ' ASP . . . . . . . . . . . . . 32.9 t0 -59.59 -43.49 93.67 Favored 'General case' 0 C--N 1.329 -0.315 0 C-N-CA 120.887 -0.325 . . . . 0.0 111.026 -177.22 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' B' B ' 21' ' ' VAL . . . . . . . . . . . . . 45.1 t -64.88 -46.52 91.58 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.248 0 C-N-CA 120.716 -0.393 . . . . 0.0 110.43 -178.116 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' B' B ' 22' ' ' ILE . . . . . . . . . . . . . 50.9 mm -57.8 -38.87 67.98 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.324 0 CA-C-O 120.668 0.271 . . . . 0.0 110.407 179.272 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' B' B ' 23' ' ' ARG . . . . . . . . . . . . . 57.1 ttp180 -55.84 -49.87 72.11 Favored 'General case' 0 C--N 1.331 -0.216 0 CA-C-O 120.976 0.417 . . . . 0.0 110.558 177.861 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' B' B ' 24' ' ' ILE . . . . . . . . . . . . . 74.0 mt -60.85 -43.85 96.45 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.334 0 CA-C-N 115.834 -0.621 . . . . 0.0 111.73 -177.398 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' B' B ' 25' ' ' LYS . . . . . . . . . . . . . 14.8 pttp -72.97 -36.62 67.14 Favored 'General case' 0 CA--C 1.533 0.298 0 C-N-CA 120.526 -0.47 . . . . 0.0 111.901 -172.933 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' B' B ' 26' ' ' LEU . . . . . . . . . . . . . 42.0 mt -80.21 -41.78 24.53 Favored 'General case' 0 C--N 1.331 -0.22 0 N-CA-C 113.185 0.809 . . . . 0.0 113.185 -173.796 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' B' B ' 27' ' ' GLN . . . . . . . . . . . . . 10.6 pt20 -47.18 139.28 6.19 Favored 'General case' 0 N--CA 1.469 0.484 0 N-CA-C 112.73 0.641 . . . . 0.0 112.73 -174.539 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' B' B ' 28' ' ' GLY . . . . . . . . . . . . . . . 99.48 -26.0 26.08 Favored Glycine 0 CA--C 1.533 1.179 0 CA-C-N 115.687 -0.688 . . . . 0.0 112.255 -176.877 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' B' B ' 29' ' ' LYS . . . . . . . . . . . . . 56.4 mtmt -98.9 155.16 17.54 Favored 'General case' 0 C--O 1.232 0.164 0 CA-C-N 117.247 0.523 . . . . 0.0 111.103 179.425 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' B' B ' 30' ' ' THR . . . . . . . . . . . . . 31.4 m -105.38 137.73 42.72 Favored 'General case' 0 C--N 1.332 -0.195 0 CA-C-N 116.101 -0.499 . . . . 0.0 110.094 176.949 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' B' B ' 31' ' ' VAL . . . . . . . . . . . . . 34.3 m -130.71 160.41 41.93 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.236 0 CA-C-O 120.911 0.386 . . . . 0.0 110.971 -178.372 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' B' B ' 32' ' ' ARG . . . . . . . . . . . . . 80.3 mtm180 -134.24 149.26 50.95 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 115.907 -0.588 . . . . 0.0 110.477 177.844 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' B' B ' 33' ' ' THR . . . . . . . . . . . . . 24.7 m -53.41 141.63 24.11 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.443 -0.344 . . . . 0.0 111.39 -178.363 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' B' B ' 34' ' ' GLY . . . . . . . . . . . . . . . 99.49 -17.13 58.12 Favored Glycine 0 CA--C 1.533 1.194 0 CA-C-O 119.687 -0.507 . . . . 0.0 113.23 179.762 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' B' B ' 35' ' ' ASP . . . . . . . . . . . . . 76.1 m-20 -65.33 147.99 52.47 Favored 'General case' 0 C--O 1.231 0.123 0 CA-C-N 118.037 0.919 . . . . 0.0 111.041 178.739 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' B' B ' 36' ' ' VAL . . . . . . . . . . . . . 46.7 t -120.58 129.96 75.03 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.204 0 CA-C-N 115.829 -0.623 . . . . 0.0 109.887 179.099 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' B' B ' 37' ' ' ILE . . . . . . . . . . . . . 69.9 mt -120.31 139.18 48.42 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.219 0 N-CA-C 109.841 -0.429 . . . . 0.0 109.841 179.848 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' B' B ' 38' ' ' GLY . . . . . . . . . . . . . . . -114.04 128.74 8.4 Favored Glycine 0 CA--C 1.525 0.691 0 N-CA-C 111.256 -0.738 . . . . 0.0 111.256 -179.683 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' B' B ' 39' ' ' ILE . . . . . . . . . . . . . 69.4 mt -122.9 127.97 75.01 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.218 0 N-CA-C 109.64 -0.504 . . . . 0.0 109.64 177.418 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' B' B ' 40' ' ' SER . . . . . . . . . . . . . 56.3 p -91.95 118.12 30.45 Favored 'General case' 0 C--N 1.33 -0.257 0 C-N-CA 120.908 -0.317 . . . . 0.0 110.75 177.527 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' B' B ' 41' ' ' ILE . . . . . . . . . . . . . 73.8 mt -134.63 128.25 50.68 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.234 0 CA-C-O 120.732 0.301 . . . . 0.0 110.266 178.786 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' B' B ' 42' ' ' LEU . . . . . . . . . . . . . 49.3 mt 57.76 33.08 22.8 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.24 -0.436 . . . . 0.0 111.858 178.543 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' B' B ' 43' ' ' GLY . . . . . . . . . . . . . . . 77.29 -10.05 23.77 Favored Glycine 0 CA--C 1.535 1.334 0 C-N-CA 121.276 -0.487 . . . . 0.0 113.472 178.03 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' B' B ' 44' ' ' LYS . . . . . . . . . . . . . 65.3 tttm -102.22 129.91 48.75 Favored 'General case' 0 C--O 1.233 0.195 0 CA-C-N 117.948 0.874 . . . . 0.0 109.964 177.224 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' B' B ' 45' ' ' GLU . . . . . . . . . . . . . 44.7 tp10 -84.7 125.66 32.71 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.43 -0.35 . . . . 0.0 110.55 178.998 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' B' B ' 46' ' ' VAL . . . . . . . . . . . . . 7.5 p -113.74 128.77 70.48 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.258 0 N-CA-C 109.336 -0.616 . . . . 0.0 109.336 177.108 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' B' B ' 47' ' ' LYS . . . . . . . . . . . . . 93.5 mttt -100.05 126.58 46.27 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 115.849 -0.614 . . . . 0.0 111.12 178.725 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' B' B ' 48' ' ' PHE . . . . . . . . . . . . . 95.3 m-85 -109.48 131.9 54.64 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.079 -0.51 . . . . 0.0 109.679 176.358 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' B' B ' 49' ' ' LYS . . . . . . . . . . . . . 86.4 tttt -107.12 134.73 49.8 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.18 -0.463 . . . . 0.0 110.366 179.25 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' B' B ' 50' ' ' VAL . . . . . . . . . . . . . 46.2 t -79.0 106.42 9.97 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.336 0 N-CA-C 109.167 -0.679 . . . . 0.0 109.167 175.695 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' B' B ' 51' ' ' VAL . . . . . . . . . . . . . 52.5 t -69.9 -52.81 27.73 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.354 0 N-CA-C 109.613 -0.514 . . . . 0.0 109.613 -174.844 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' B' B ' 52' ' ' GLN . . . . . . . . . . . . . 90.7 mt-30 -153.75 151.64 29.82 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-O 121.274 0.559 . . . . 0.0 111.86 -178.114 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' B' B ' 53' ' ' ALA . . . . . . . . . . . . . . . -127.29 132.55 50.29 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 115.065 -0.971 . . . . 0.0 109.323 174.561 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' B' B ' 54' ' ' TYR . . . . . . . . . . . . . 39.7 t80 -129.06 109.78 18.2 Favored Pre-proline 0 CA--C 1.533 0.318 0 CA-C-O 118.183 -0.913 . . . . 0.0 110.381 -179.697 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' B' B ' 55' ' ' PRO . . . . . . . . . . . . . 73.6 Cg_endo -77.1 170.1 72.53 Favored 'Cis proline' 0 N--CA 1.502 2.006 0 CA-C-N 121.907 1.717 . . . . 0.0 112.594 -5.443 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' B' B ' 56' ' ' SER . . . . . . . . . . . . . 15.5 m -116.56 128.05 26.29 Favored Pre-proline 0 CA--C 1.539 0.537 0 CA-C-O 118.409 -0.805 . . . . 0.0 109.37 175.276 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' B' B ' 57' ' ' PRO . . . . . . . . . . . . . 36.6 Cg_endo -66.2 166.04 59.15 Favored 'Cis proline' 0 N--CA 1.499 1.799 0 CA-C-N 121.986 1.745 . . . . 0.0 111.662 -0.113 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' B' B ' 58' ' ' LEU . . . . . . . . . . . . . 29.7 tp -130.21 135.92 48.66 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.318 -0.401 . . . . 0.0 110.734 -179.716 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' B' B ' 59' ' ' ARG . . . . . . . . . . . . . 58.2 ttp180 -101.82 126.75 48.76 Favored 'General case' 0 C--N 1.328 -0.366 0 N-CA-C 109.237 -0.653 . . . . 0.0 109.237 175.815 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' B' B ' 60' ' ' VAL . . . . . . . . . . . . . 46.9 t -78.56 117.98 24.96 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.192 0 C-N-CA 120.546 -0.462 . . . . 0.0 109.915 -177.352 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' B' B ' 61' ' ' GLU . . . . . . . . . . . . . 74.4 tt0 -131.12 159.6 37.16 Favored 'General case' 0 C--N 1.328 -0.337 0 N-CA-C 109.422 -0.584 . . . . 0.0 109.422 -179.504 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' B' B ' 62' ' ' ASP . . . . . . . . . . . . . 52.2 m-20 -51.51 -32.17 26.62 Favored 'General case' 0 C--N 1.328 -0.355 0 N-CA-C 112.074 0.398 . . . . 0.0 112.074 -179.367 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' B' B ' 63' ' ' ARG . . . . . . . . . . . . . 14.5 ptm180 -85.15 5.4 30.06 Favored 'General case' 0 CA--C 1.535 0.403 0 N-CA-C 113.733 1.012 . . . . 0.0 113.733 -175.739 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' B' B ' 64' ' ' THR . . . . . . . . . . . . . 24.4 m -89.72 136.4 33.06 Favored 'General case' 0 C--N 1.332 -0.18 0 CA-C-N 118.151 0.432 . . . . 0.0 110.401 -178.647 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' B' B ' 65' ' ' LYS . . . . . . . . . . . . . 55.1 mtmt -89.1 128.38 35.76 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.299 -0.41 . . . . 0.0 110.31 -179.994 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' B' B ' 66' ' ' ILE . . . . . . . . . . . . . 66.1 mt -113.68 127.18 71.16 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.294 0 N-CA-C 109.638 -0.504 . . . . 0.0 109.638 179.998 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' B' B ' 67' ' ' THR . . . . . . . . . . . . . 23.4 m -126.97 144.09 51.11 Favored 'General case' 0 C--N 1.332 -0.185 0 CA-C-N 116.122 -0.49 . . . . 0.0 111.069 -175.903 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' B' B ' 68' ' ' LEU . . . . . . . . . . . . . 42.8 mt . . . . . 0 C--N 1.329 -0.316 0 CA-C-N 115.942 -0.572 . . . . 0.0 110.61 177.887 . . . . . . . . 0 0 . 1 . 012 nuclear orig core ' B' B ' 73' ' ' VAL . . . . . . . . . . . . . 33.8 m . . . . . 0 C--O 1.23 0.058 0 CA-C-O 120.66 0.267 . . . . 0.0 110.376 . . . . . . . . . 0 0 . 1 . 012 nuclear orig core ' B' B ' 74' ' ' ASP . . . . . . . . . . . . . 38.8 t0 -95.66 119.28 33.89 Favored 'General case' 0 C--N 1.329 -0.287 0 N-CA-C 110.121 -0.326 . . . . 0.0 110.121 -177.644 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' B' B ' 75' ' ' VAL . . . . . . . . . . . . . 40.6 t -122.52 125.2 72.31 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.295 0 CA-C-O 121.142 0.496 . . . . 0.0 110.818 -177.652 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' B' B ' 76' ' ' LEU . . . . . . . . . . . . . 5.9 mp -121.99 145.29 48.27 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 115.67 -0.695 . . . . 0.0 109.619 175.361 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' B' B ' 77' ' ' GLU . . . . . . . . . . . . . 97.3 mt-10 -134.38 132.06 38.97 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-O 121.061 0.458 . . . . 0.0 111.133 -178.634 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' B' B ' 78' ' ' ALA . . . . . . . . . . . . . . . -120.84 134.28 55.29 Favored 'General case' 0 C--N 1.33 -0.239 0 CA-C-N 115.761 -0.654 . . . . 0.0 109.84 177.028 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' B' B ' 79' ' ' LYS . . . . . . . . . . . . . 94.4 mttt -79.1 120.79 24.14 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-O 120.809 0.337 . . . . 0.0 110.566 -178.575 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' B' B ' 80' ' ' ILE . . . . . . . . . . . . . 26.8 mm -139.09 110.06 4.76 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.28 0 N-CA-C 109.148 -0.686 . . . . 0.0 109.148 -177.465 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' B' B ' 81' ' ' LYS . . . . . . . . . . . . . 49.0 pttt -99.42 123.39 43.66 Favored 'General case' 0 C--N 1.33 -0.283 0 CA-C-O 121.104 0.478 . . . . 0.0 111.419 -176.778 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' B' B ' 82' ' ' GLY . . . . . . . . . . . . . . . 88.85 42.18 5.76 Favored Glycine 0 CA--C 1.524 0.617 0 C-N-CA 120.769 -0.729 . . . . 0.0 111.664 173.404 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' B' B ' 83' ' ' ILE . . . . . . . . . . . . . 76.8 mt -64.38 135.13 28.45 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.285 0 N-CA-C 109.861 -0.422 . . . . 0.0 109.861 178.669 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' B' B ' 84' ' ' LYS . . . . . . . . . . . . . 84.7 tttt -92.63 -53.85 4.02 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 115.903 -0.589 . . . . 0.0 110.348 -177.326 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' B' B ' 85' ' ' ASP . . . . . . . . . . . . . 3.7 t70 -158.29 158.01 33.58 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 115.678 -0.692 . . . . 0.0 110.147 -178.783 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' B' B ' 86' ' ' VAL . . . . . . . . . . . . . 40.3 t -135.56 134.08 51.87 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.248 0 CA-C-O 121.023 0.44 . . . . 0.0 110.746 -177.69 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' B' B ' 87' ' ' ILE . . . . . . . . . . . . . 44.2 mm -117.48 127.68 74.88 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.226 0 CA-C-N 115.751 -0.659 . . . . 0.0 109.389 174.386 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' B' B ' 88' ' ' LEU . . . . . . . . . . . . . 17.3 tp -112.55 133.06 54.81 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-O 121.01 0.434 . . . . 0.0 111.19 -176.673 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' B' B ' 89' ' ' ASP . . . . . . . . . . . . . 9.0 t0 -128.22 150.51 50.0 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 115.743 -0.662 . . . . 0.0 109.43 176.591 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' B' B ' 90' ' ' GLU . . . . . . . . . . . . . 84.3 tt0 -48.03 -37.63 15.32 Favored 'General case' 0 CA--C 1.531 0.25 0 N-CA-C 112.612 0.597 . . . . 0.0 112.612 -173.336 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' B' B ' 91' ' ' ASN . . . . . . . . . . . . . 84.9 m-20 -131.6 35.07 3.85 Favored 'General case' 0 N--CA 1.465 0.285 0 CA-C-O 120.816 0.341 . . . . 0.0 111.639 -177.301 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' B' B ' 92' ' ' LEU . . . . . . . . . . . . . 11.6 tp -166.07 142.41 5.05 Favored 'General case' 0 C--N 1.331 -0.22 0 CA-C-O 120.673 0.273 . . . . 0.0 110.339 179.723 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' B' B ' 93' ' ' ILE . . . . . . . . . . . . . 70.1 mt -125.47 124.36 66.77 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.343 0 N-CA-C 109.622 -0.51 . . . . 0.0 109.622 -179.896 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' B' B ' 94' ' ' VAL . . . . . . . . . . . . . 41.0 t -124.79 127.33 72.58 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.252 0 N-CA-C 110.008 -0.368 . . . . 0.0 110.008 179.39 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' B' B ' 95' ' ' VAL . . . . . . . . . . . . . 40.1 t -123.37 137.67 55.88 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.293 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.036 -179.48 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' B' B ' 96' ' ' ILE . . . . . . . . . . . . . 65.1 mt -116.46 130.43 71.29 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.256 0 N-CA-C 109.158 -0.682 . . . . 0.0 109.158 178.254 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' B' B ' 97' ' ' THR . . . . . . . . . . . . . 65.4 p -103.96 155.78 18.38 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-O 121.029 0.443 . . . . 0.0 111.255 -177.324 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' B' B ' 98' ' ' GLU . . . . . . . . . . . . . 85.1 tt0 -54.04 -24.54 17.49 Favored 'General case' 0 CA--C 1.534 0.332 0 N-CA-C 112.068 0.396 . . . . 0.0 112.068 178.922 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' B' B ' 99' ' ' GLU . . . . . . . . . . . . . 70.9 mm-40 -76.4 13.49 0.94 Allowed 'General case' 0 CA--C 1.535 0.4 0 N-CA-C 113.2 0.815 . . . . 0.0 113.2 -179.333 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' B' B ' 100' ' ' ASN . . . . . . . . . . . . . 2.3 m-20 64.62 38.1 7.37 Favored 'General case' 0 C--O 1.232 0.15 0 CA-C-O 120.988 0.423 . . . . 0.0 110.788 177.813 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' B' B ' 101' ' ' GLU . . . . . . . . . . . . . 46.2 mt-10 -115.84 143.94 44.72 Favored 'General case' 0 C--N 1.332 -0.16 0 CA-C-N 116.074 -0.512 . . . . 0.0 110.399 177.078 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' B' B ' 102' ' ' VAL . . . . . . . . . . . . . 47.2 t -115.11 126.46 72.7 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.357 0 N-CA-C 109.245 -0.65 . . . . 0.0 109.245 176.864 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' B' B ' 103' ' ' LEU . . . . . . . . . . . . . 6.4 mp -121.9 132.88 54.8 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-N 116.008 -0.542 . . . . 0.0 110.386 177.796 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' B' B ' 104' ' ' ILE . . . . . . . . . . . . . 71.6 mt -117.62 124.77 73.5 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.315 0 CA-C-N 115.834 -0.621 . . . . 0.0 109.914 -179.092 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' B' B ' 105' ' ' PHE . . . . . . . . . . . . . 75.9 m-85 -123.46 162.23 23.25 Favored 'General case' 0 C--N 1.331 -0.222 0 O-C-N 123.985 0.803 . . . . 0.0 109.823 179.786 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' B' B ' 106' ' ' ASN . . . . . . . . . . . . . 47.9 p-10 -97.22 -170.41 2.02 Favored 'General case' 0 C--N 1.329 -0.31 0 N-CA-C 109.919 -0.4 . . . . 0.0 109.919 173.939 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' B' B ' 107' ' ' GLN . . . . . . . . . . . . . 47.5 tt0 -59.0 -30.05 67.69 Favored 'General case' 0 C--N 1.329 -0.287 0 N-CA-C 111.888 0.329 . . . . 0.0 111.888 179.607 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' B' B ' 108' ' ' ASN . . . . . . . . . . . . . 56.4 t30 -83.96 7.76 17.32 Favored 'General case' 0 CA--C 1.536 0.412 0 N-CA-C 113.259 0.837 . . . . 0.0 113.259 -177.022 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' B' B ' 109' ' ' LEU . . . . . . . . . . . . . 9.8 tp 60.52 36.35 20.0 Favored 'General case' 0 CA--C 1.529 0.165 0 CA-C-O 120.965 0.412 . . . . 0.0 111.413 178.613 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' B' B ' 110' ' ' GLU . . . . . . . . . . . . . 70.6 mm-40 -101.35 147.5 26.25 Favored 'General case' 0 C--N 1.329 -0.322 0 N-CA-C 109.685 -0.487 . . . . 0.0 109.685 175.837 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' B' B ' 111' ' ' GLU . . . . . . . . . . . . . 85.2 tt0 -79.51 121.95 25.85 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-O 120.94 0.4 . . . . 0.0 110.483 -177.508 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' B' B ' 112' ' ' LEU . . . . . . . . . . . . . 20.5 mt -108.26 -46.04 3.8 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 115.911 -0.586 . . . . 0.0 110.548 179.379 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' B' B ' 113' ' ' TYR . . . . . . . . . . . . . 64.4 t80 -140.27 135.17 32.01 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.145 -0.48 . . . . 0.0 111.364 -178.667 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' B' B ' 114' ' ' ARG . . . . . . . . . . . . . 71.6 ttt180 -142.16 125.16 16.2 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.306 -0.406 . . . . 0.0 110.158 176.141 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' B' B ' 115' ' ' GLY . . . . . . . . . . . . . . . -150.04 149.14 21.0 Favored Glycine 0 CA--C 1.523 0.582 0 N-CA-C 111.175 -0.77 . . . . 0.0 111.175 179.115 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' B' B ' 116' ' ' LYS . . . . . . . . . . . . . 35.3 ttpt -114.22 131.75 56.36 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-O 120.732 0.301 . . . . 0.0 110.422 178.283 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' B' B ' 117' ' ' PHE . . . . . . . . . . . . . 43.1 m-85 -129.46 113.94 15.52 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.279 -0.419 . . . . 0.0 109.938 -179.244 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' B' B ' 118' ' ' GLU . . . . . . . . . . . . . 84.6 tt0 -54.91 -48.5 73.0 Favored 'General case' 0 C--N 1.329 -0.318 0 C-N-CA 120.901 -0.319 . . . . 0.0 111.419 -175.601 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' B' B ' 119' ' ' ASN . . . . . . . . . . . . . 91.0 m-20 -94.44 31.2 1.79 Allowed 'General case' 0 C--N 1.33 -0.279 0 N-CA-C 112.187 0.44 . . . . 0.0 112.187 -174.199 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' B' B ' 120' ' ' LEU . . . . . . . . . . . . . 21.9 tp -53.28 123.67 12.51 Favored 'General case' 0 N--CA 1.464 0.254 0 CA-C-O 120.713 0.292 . . . . 0.0 110.953 178.221 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' B' B ' 121' ' ' ASN . . . . . . . . . . . . . 43.2 m-20 -106.37 -44.16 4.59 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-N 116.337 -0.392 . . . . 0.0 110.909 -177.533 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' B' B ' 122' ' ' LYS . . . . . . . . . . . . . 50.7 pttt -161.14 157.73 26.41 Favored 'General case' 0 C--N 1.331 -0.225 0 C-N-CA 120.454 -0.498 . . . . 0.0 112.204 -179.462 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' B' B ' 123' ' ' VAL . . . . . . . . . . . . . 44.0 t -125.6 131.16 72.4 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.246 0 CA-C-N 115.805 -0.634 . . . . 0.0 109.845 177.522 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' B' B ' 124' ' ' LEU . . . . . . . . . . . . . 76.8 mt -116.73 133.3 56.17 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.301 -0.408 . . . . 0.0 110.392 179.979 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' B' B ' 125' ' ' VAL . . . . . . . . . . . . . 47.3 t -131.74 129.51 61.27 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.215 0 CA-C-N 116.284 -0.417 . . . . 0.0 110.228 -179.057 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' B' B ' 126' ' ' ARG . . . . . . . . . . . . . 77.0 mtt180 -141.3 119.79 12.36 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-O 121.076 0.465 . . . . 0.0 110.458 176.538 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' B' B ' 127' ' ' ASN . . . . . . . . . . . . . 42.4 t-20 50.63 -106.47 0.24 Allowed 'General case' 0 CA--C 1.543 0.711 0 CA-C-O 119.003 -0.523 . . . . 0.0 111.37 -179.106 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' B' B ' 128' ' ' ASP . . . . . . . . . . . . . 11.7 p-10 -114.12 2.51 14.92 Favored 'General case' 0 N--CA 1.467 0.407 0 CA-C-N 119.642 1.11 . . . . 0.0 113.466 -177.334 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' B' B ' 129' ' ' LEU . . . . . . . . . . . . . 11.6 tp -104.96 136.85 43.68 Favored 'General case' 0 C--O 1.232 0.134 0 CA-C-N 118.267 0.485 . . . . 0.0 109.849 -179.916 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' B' B ' 130' ' ' VAL . . . . . . . . . . . . . 43.0 t -125.14 138.08 55.51 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.268 0 CA-C-O 121.061 0.457 . . . . 0.0 110.406 -176.885 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' B' B ' 131' ' ' VAL . . . . . . . . . . . . . 44.2 t -134.52 135.24 54.01 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.34 0 CA-C-N 115.895 -0.593 . . . . 0.0 110.008 177.915 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' B' B ' 132' ' ' ILE . . . . . . . . . . . . . 73.7 mt -115.79 132.28 65.69 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.281 0 N-CA-C 109.501 -0.555 . . . . 0.0 109.501 179.752 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' B' B ' 133' ' ' ILE . . . . . . . . . . . . . 42.7 mm -116.33 125.14 73.24 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.226 0 CA-C-N 116.569 -0.287 . . . . 0.0 111.074 -174.624 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' B' B ' 134' ' ' ASP . . . . . . . . . . . . . 10.1 p-10 -137.45 150.07 47.34 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 116.19 -0.459 . . . . 0.0 109.846 173.378 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' B' B ' 135' ' ' GLU . . . . . . . . . . . . . 40.1 tp10 -49.91 -27.2 4.91 Favored 'General case' 0 C--N 1.327 -0.371 0 N-CA-C 112.791 0.663 . . . . 0.0 112.791 -172.066 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' B' B ' 136' ' ' GLN . . . . . . . . . . . . . 63.2 tt0 -87.14 -33.72 19.32 Favored 'General case' 0 C--N 1.331 -0.221 0 N-CA-C 112.497 0.554 . . . . 0.0 112.497 -174.747 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' B' B ' 137' ' ' LYS . . . . . . . . . . . . . 48.3 pttt -162.1 171.22 17.84 Favored 'General case' 0 C--N 1.332 -0.181 0 CA-C-O 121.537 0.684 . . . . 0.0 112.525 -171.445 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' B' B ' 138' ' ' LEU . . . . . . . . . . . . . 7.2 tt -121.45 128.74 52.45 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 114.918 -1.037 . . . . 0.0 109.896 178.531 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' B' B ' 139' ' ' THR . . . . . . . . . . . . . 39.4 m -108.18 127.13 53.55 Favored 'General case' 0 C--N 1.331 -0.221 0 CA-C-N 116.292 -0.413 . . . . 0.0 110.425 -179.929 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' B' B ' 140' ' ' LEU . . . . . . . . . . . . . 29.6 tp -112.2 120.9 43.35 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 115.788 -0.642 . . . . 0.0 109.531 -179.09 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' B' B ' 141' ' ' ILE . . . . . . . . . . . . . 19.1 mt -121.72 119.63 59.35 Favored 'Isoleucine or valine' 0 C--O 1.233 0.198 0 CA-C-O 121.09 0.471 . . . . 0.0 110.282 -175.249 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' B' B ' 142' ' ' ARG . . . . . . . . . . . . . 83.1 mtp180 -108.03 125.87 52.06 Favored 'General case' 0 C--N 1.331 -0.217 0 CA-C-N 115.206 -0.906 . . . . 0.0 110.091 179.044 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' B' B ' 143' ' ' THR . . . . . . . . . . . . . 15.2 p . . . . . 0 C--O 1.219 -0.501 0 CA-C-O 118.046 -0.978 . . . . 0.0 110.495 179.831 . . . . . . . . 0 0 . 1 . 012 nuclear orig core ' C' C ' 2' ' ' SER . . . . . . . . . . . . . 4.1 p . . . . . 0 C--O 1.231 0.103 0 CA-C-O 120.85 0.357 . . . . 0.0 110.826 . . . . . . . . . 0 0 . 1 . 012 nuclear orig core ' C' C ' 3' ' ' GLU . . . . . . . . . . . . . 57.0 mp0 -140.49 140.35 35.3 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.074 -0.512 . . . . 0.0 110.867 179.267 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' C' C ' 4' ' ' LEU . . . . . . . . . . . . . 14.8 tp -125.17 127.94 47.6 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.046 -0.525 . . . . 0.0 110.111 176.46 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' C' C ' 5' ' ' LYS . . . . . . . . . . . . . 87.9 mttt -109.3 122.93 48.41 Favored 'General case' 0 C--O 1.235 0.294 0 CA-C-O 120.66 0.267 . . . . 0.0 110.888 178.929 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' C' C ' 6' ' ' LEU . . . . . . . . . . . . . 67.2 mt -114.72 145.07 42.49 Favored 'General case' 0 N--CA 1.463 0.216 0 CA-C-N 115.676 -0.693 . . . . 0.0 110.362 179.491 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' C' C ' 7' ' ' LYS . . . . . . . . . . . . . 73.6 tttt -125.25 137.02 28.99 Favored Pre-proline 0 CA--C 1.534 0.335 0 CA-C-O 118.866 -0.588 . . . . 0.0 109.703 174.635 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' C' C ' 8' ' ' PRO . . . . . . . . . . . . . 83.5 Cg_endo -92.04 132.68 1.24 Allowed 'Trans proline' 0 N--CA 1.489 1.249 0 C-N-CA 121.663 1.575 . . . . 0.0 111.759 178.528 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' C' C ' 9' ' ' LEU . . . . . . . . . . . . . 55.7 mt -69.63 -46.74 25.76 Favored Pre-proline 0 CA--C 1.532 0.272 0 CA-C-O 118.742 -0.647 . . . . 0.0 112.079 -179.557 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' C' C ' 10' ' ' PRO . . . . . . . . . . . . . 88.4 Cg_endo -80.79 155.65 20.61 Favored 'Trans proline' 0 N--CA 1.495 1.611 0 C-N-CA 121.184 1.256 . . . . 0.0 111.78 174.769 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' C' C ' 11' ' ' LYS . . . . . . . . . . . . . 79.1 mttt -87.7 101.37 13.6 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.415 -0.357 . . . . 0.0 110.503 178.978 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' C' C ' 12' ' ' VAL . . . . . . . . . . . . . 12.2 p -145.33 144.36 21.45 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.299 0 CA-C-N 116.299 -0.41 . . . . 0.0 110.836 -179.251 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' C' C ' 13' ' ' GLU . . . . . . . . . . . . . 43.5 mt-10 -92.36 126.23 37.35 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.252 -0.431 . . . . 0.0 109.879 176.25 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' C' C ' 14' ' ' LEU . . . . . . . . . . . . . 17.3 mt -97.22 152.81 38.49 Favored Pre-proline 0 C--N 1.33 -0.267 0 CA-C-N 116.501 -0.318 . . . . 0.0 110.742 -177.649 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' C' C ' 15' ' ' PRO . . . . . . . . . . . . . 33.6 Cg_exo -59.77 159.23 25.44 Favored 'Trans proline' 0 N--CA 1.496 1.67 0 C-N-CA 121.311 1.341 . . . . 0.0 111.884 178.348 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' C' C ' 16' ' ' PRO . . . . . . . . . . . . . 29.6 Cg_exo -59.9 -34.84 95.15 Favored 'Trans proline' 0 N--CA 1.497 1.725 0 C-N-CA 121.383 1.389 . . . . 0.0 112.811 -177.675 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' C' C ' 17' ' ' ASP . . . . . . . . . . . . . 10.7 p-10 -90.18 8.74 31.46 Favored 'General case' 0 CA--C 1.536 0.423 0 N-CA-C 113.284 0.846 . . . . 0.0 113.284 -176.896 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' C' C ' 18' ' ' PHE . . . . . . . . . . . . . 53.6 t80 -57.8 -45.55 85.91 Favored 'General case' 0 C--N 1.334 -0.101 0 O-C-N 122.057 -0.402 . . . . 0.0 110.33 -178.516 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' C' C ' 19' ' ' VAL . . . . . . . . . . . . . 48.7 t -56.75 -42.11 76.62 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.289 0 CA-C-N 116.523 -0.308 . . . . 0.0 110.414 -178.633 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' C' C ' 20' ' ' ASP . . . . . . . . . . . . . 14.9 t0 -59.7 -44.0 93.87 Favored 'General case' 0 C--N 1.328 -0.352 0 C-N-CA 120.841 -0.343 . . . . 0.0 110.762 -177.939 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' C' C ' 21' ' ' VAL . . . . . . . . . . . . . 45.3 t -64.8 -46.28 92.51 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.279 0 C-N-CA 120.753 -0.379 . . . . 0.0 110.498 -177.636 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' C' C ' 22' ' ' ILE . . . . . . . . . . . . . 50.3 mm -56.9 -39.98 68.76 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.333 0 C-N-CA 120.983 -0.287 . . . . 0.0 110.637 179.957 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' C' C ' 23' ' ' ARG . . . . . . . . . . . . . 45.1 ttp180 -57.26 -50.38 73.09 Favored 'General case' 0 C--N 1.331 -0.21 0 C-N-CA 120.673 -0.411 . . . . 0.0 110.386 177.194 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' C' C ' 24' ' ' ILE . . . . . . . . . . . . . 71.8 mt -60.44 -39.84 82.35 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.335 0 CA-C-N 115.995 -0.548 . . . . 0.0 111.827 -176.824 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' C' C ' 25' ' ' LYS . . . . . . . . . . . . . 14.9 pttp -77.11 -37.28 54.56 Favored 'General case' 0 CA--C 1.534 0.33 0 C-N-CA 120.592 -0.443 . . . . 0.0 111.938 -173.597 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' C' C ' 26' ' ' LEU . . . . . . . . . . . . . 49.0 mt -79.43 -32.42 42.82 Favored 'General case' 0 C--N 1.333 -0.146 0 N-CA-C 113.479 0.918 . . . . 0.0 113.479 -173.083 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' C' C ' 27' ' ' GLN . . . . . . . . . . . . . 11.0 pt20 -46.32 139.54 4.72 Favored 'General case' 0 N--CA 1.47 0.538 0 N-CA-C 112.922 0.712 . . . . 0.0 112.922 -174.839 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' C' C ' 28' ' ' GLY . . . . . . . . . . . . . . . 99.86 -26.66 23.58 Favored Glycine 0 CA--C 1.531 1.084 0 CA-C-N 115.697 -0.683 . . . . 0.0 112.255 -177.528 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' C' C ' 29' ' ' LYS . . . . . . . . . . . . . 94.0 mttt -97.09 155.09 16.96 Favored 'General case' 0 C--N 1.332 -0.193 0 CA-C-N 117.351 0.575 . . . . 0.0 110.854 178.237 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' C' C ' 30' ' ' THR . . . . . . . . . . . . . 28.5 m -107.27 138.13 44.02 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 116.104 -0.498 . . . . 0.0 110.104 177.072 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' C' C ' 31' ' ' VAL . . . . . . . . . . . . . 34.4 m -127.51 151.97 34.99 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.244 0 CA-C-N 116.242 -0.435 . . . . 0.0 110.571 -179.393 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' C' C ' 32' ' ' ARG . . . . . . . . . . . . . 67.0 ttt180 -132.74 149.83 52.23 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-O 121.179 0.514 . . . . 0.0 110.267 179.809 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' C' C ' 33' ' ' THR . . . . . . . . . . . . . 26.1 m -52.82 138.4 29.56 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.368 -0.378 . . . . 0.0 111.499 -177.394 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' C' C ' 34' ' ' GLY . . . . . . . . . . . . . . . 101.42 -17.21 55.81 Favored Glycine 0 CA--C 1.534 1.278 0 CA-C-O 119.651 -0.527 . . . . 0.0 113.17 179.444 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' C' C ' 35' ' ' ASP . . . . . . . . . . . . . 75.2 m-20 -66.56 148.34 52.03 Favored 'General case' 0 N--CA 1.461 0.111 0 CA-C-N 118.072 0.936 . . . . 0.0 111.224 178.869 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' C' C ' 36' ' ' VAL . . . . . . . . . . . . . 42.5 t -121.5 129.0 75.97 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.247 0 CA-C-N 115.88 -0.6 . . . . 0.0 109.809 177.638 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' C' C ' 37' ' ' ILE . . . . . . . . . . . . . 64.5 mt -120.92 138.15 52.32 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.244 0 CA-C-N 116.237 -0.438 . . . . 0.0 109.948 -179.811 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' C' C ' 38' ' ' GLY . . . . . . . . . . . . . . . -116.47 126.93 7.25 Favored Glycine 0 CA--C 1.524 0.645 0 N-CA-C 110.828 -0.909 . . . . 0.0 110.828 178.402 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' C' C ' 39' ' ' ILE . . . . . . . . . . . . . 72.1 mt -123.71 131.18 73.45 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.247 0 N-CA-C 110.136 -0.32 . . . . 0.0 110.136 179.395 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' C' C ' 40' ' ' SER . . . . . . . . . . . . . 54.4 p -91.33 117.51 29.72 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.43 -0.35 . . . . 0.0 110.823 177.615 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' C' C ' 41' ' ' ILE . . . . . . . . . . . . . 72.6 mt -134.4 127.51 50.47 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.197 0 N-CA-C 110.067 -0.346 . . . . 0.0 110.067 177.857 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' C' C ' 42' ' ' LEU . . . . . . . . . . . . . 9.5 tp 57.73 34.72 24.8 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.163 -0.471 . . . . 0.0 111.562 178.258 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' C' C ' 43' ' ' GLY . . . . . . . . . . . . . . . 77.42 -10.08 24.52 Favored Glycine 0 CA--C 1.534 1.261 0 C-N-CA 121.334 -0.46 . . . . 0.0 113.467 177.32 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' C' C ' 44' ' ' LYS . . . . . . . . . . . . . 95.0 mttt -104.65 134.26 48.12 Favored 'General case' 0 C--N 1.333 -0.11 0 CA-C-N 117.993 0.897 . . . . 0.0 110.361 178.357 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' C' C ' 45' ' ' GLU . . . . . . . . . . . . . 84.8 tt0 -85.85 128.68 34.88 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.337 -0.392 . . . . 0.0 110.866 178.275 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' C' C ' 46' ' ' VAL . . . . . . . . . . . . . 9.7 p -115.38 124.57 72.05 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.167 0 N-CA-C 109.417 -0.586 . . . . 0.0 109.417 175.219 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' C' C ' 47' ' ' LYS . . . . . . . . . . . . . 98.5 mttt -98.96 122.91 42.84 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.021 -0.536 . . . . 0.0 110.673 178.562 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' C' C ' 48' ' ' PHE . . . . . . . . . . . . . 40.2 m-85 -109.78 131.86 54.68 Favored 'General case' 0 C--N 1.329 -0.283 0 N-CA-C 109.607 -0.516 . . . . 0.0 109.607 177.5 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' C' C ' 49' ' ' LYS . . . . . . . . . . . . . 48.5 tttp -108.12 133.64 52.11 Favored 'General case' 0 C--N 1.329 -0.285 0 N-CA-C 109.96 -0.385 . . . . 0.0 109.96 178.201 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' C' C ' 50' ' ' VAL . . . . . . . . . . . . . 44.5 t -74.91 107.04 5.1 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.322 0 N-CA-C 109.261 -0.644 . . . . 0.0 109.261 177.854 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' C' C ' 51' ' ' VAL . . . . . . . . . . . . . 46.4 t -71.14 -48.91 52.29 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.252 0 CA-C-N 116.155 -0.475 . . . . 0.0 109.731 -174.735 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' C' C ' 52' ' ' GLN . . . . . . . . . . . . . 50.3 tt0 -163.73 139.49 6.49 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 115.823 -0.626 . . . . 0.0 111.442 -178.859 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' C' C ' 53' ' ' ALA . . . . . . . . . . . . . . . -116.13 132.88 56.53 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-N 115.78 -0.646 . . . . 0.0 109.728 174.863 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' C' C ' 54' ' ' TYR . . . . . . . . . . . . . 46.8 t80 -129.02 111.88 18.48 Favored Pre-proline 0 CA--C 1.535 0.397 0 CA-C-O 118.22 -0.895 . . . . 0.0 110.395 179.455 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' C' C ' 55' ' ' PRO . . . . . . . . . . . . . 73.2 Cg_endo -77.27 169.04 75.18 Favored 'Cis proline' 0 N--CA 1.501 1.912 0 CA-C-N 121.897 1.713 . . . . 0.0 112.22 -6.949 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' C' C ' 56' ' ' SER . . . . . . . . . . . . . 15.4 m -116.84 137.21 23.57 Favored Pre-proline 0 CA--C 1.538 0.495 0 CA-C-O 118.552 -0.737 . . . . 0.0 109.667 175.477 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' C' C ' 57' ' ' PRO . . . . . . . . . . . . . 48.6 Cg_endo -70.38 145.67 81.44 Favored 'Cis proline' 0 N--CA 1.497 1.701 0 CA-C-N 121.683 1.637 . . . . 0.0 111.334 -3.955 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' C' C ' 58' ' ' LEU . . . . . . . . . . . . . 19.3 tp -106.89 135.91 47.64 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.469 -0.332 . . . . 0.0 110.659 -177.402 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' C' C ' 59' ' ' ARG . . . . . . . . . . . . . 28.6 ttm180 -100.97 126.77 47.65 Favored 'General case' 0 C--N 1.327 -0.409 0 N-CA-C 109.51 -0.552 . . . . 0.0 109.51 176.134 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' C' C ' 60' ' ' VAL . . . . . . . . . . . . . 43.3 t -76.01 116.4 18.96 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.249 0 C-N-CA 120.729 -0.388 . . . . 0.0 110.047 -177.202 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' C' C ' 61' ' ' GLU . . . . . . . . . . . . . 95.8 mt-10 -131.02 167.32 19.24 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 115.84 -0.618 . . . . 0.0 110.104 178.994 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' C' C ' 62' ' ' ASP . . . . . . . . . . . . . 12.1 p-10 -55.65 -32.47 63.22 Favored 'General case' 0 C--N 1.328 -0.351 0 N-CA-C 111.837 0.31 . . . . 0.0 111.837 -178.46 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' C' C ' 63' ' ' ARG . . . . . . . . . . . . . 40.4 ptt180 -82.52 0.52 42.17 Favored 'General case' 0 CA--C 1.537 0.463 0 N-CA-C 113.749 1.018 . . . . 0.0 113.749 -175.068 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' C' C ' 64' ' ' THR . . . . . . . . . . . . . 33.2 m -82.55 134.33 35.19 Favored 'General case' 0 C--N 1.333 -0.151 0 CA-C-N 118.159 0.436 . . . . 0.0 110.903 -176.258 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' C' C ' 65' ' ' LYS . . . . . . . . . . . . . 53.6 mtmt -89.26 127.35 35.76 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 115.935 -0.575 . . . . 0.0 109.879 177.017 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' C' C ' 66' ' ' ILE . . . . . . . . . . . . . 64.5 mt -111.82 126.6 69.23 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.314 0 N-CA-C 109.656 -0.498 . . . . 0.0 109.656 -179.115 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' C' C ' 67' ' ' THR . . . . . . . . . . . . . 23.5 m -124.49 144.69 49.96 Favored 'General case' 0 C--N 1.331 -0.229 0 CA-C-O 121.281 0.562 . . . . 0.0 111.227 -175.453 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' C' C ' 68' ' ' LEU . . . . . . . . . . . . . 20.6 tp . . . . . 0 C--N 1.328 -0.352 0 CA-C-N 115.573 -0.74 . . . . 0.0 110.243 177.731 . . . . . . . . 0 0 . 1 . 012 nuclear orig core ' C' C ' 73' ' ' VAL . . . . . . . . . . . . . 31.5 m . . . . . 0 N--CA 1.463 0.184 0 CA-C-O 121.077 0.465 . . . . 0.0 110.844 . . . . . . . . . 0 0 . 1 . 012 nuclear orig core ' C' C ' 74' ' ' ASP . . . . . . . . . . . . . 26.0 t0 -98.47 122.07 41.2 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-N 115.571 -0.741 . . . . 0.0 109.411 177.19 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' C' C ' 75' ' ' VAL . . . . . . . . . . . . . 44.3 t -114.09 123.78 70.09 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.226 0 CA-C-O 121.095 0.474 . . . . 0.0 110.742 -176.38 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' C' C ' 76' ' ' LEU . . . . . . . . . . . . . 5.9 mp -124.93 144.8 50.16 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 115.669 -0.696 . . . . 0.0 109.696 175.288 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' C' C ' 77' ' ' GLU . . . . . . . . . . . . . 97.3 mt-10 -134.12 134.92 42.78 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-O 120.98 0.419 . . . . 0.0 111.141 -178.219 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' C' C ' 78' ' ' ALA . . . . . . . . . . . . . . . -120.19 135.44 54.98 Favored 'General case' 0 C--N 1.331 -0.219 0 CA-C-N 115.825 -0.625 . . . . 0.0 109.953 177.166 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' C' C ' 79' ' ' LYS . . . . . . . . . . . . . 28.9 mtpp -84.0 117.1 23.17 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-O 120.81 0.338 . . . . 0.0 110.79 -177.91 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' C' C ' 80' ' ' ILE . . . . . . . . . . . . . 41.6 mm -139.15 112.15 6.2 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.28 0 N-CA-C 109.355 -0.609 . . . . 0.0 109.355 -177.877 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' C' C ' 81' ' ' LYS . . . . . . . . . . . . . 49.6 pttt -98.72 125.96 44.19 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-O 120.969 0.414 . . . . 0.0 111.402 -177.922 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' C' C ' 82' ' ' GLY . . . . . . . . . . . . . . . 89.05 42.18 5.69 Favored Glycine 0 CA--C 1.526 0.73 0 C-N-CA 121.003 -0.618 . . . . 0.0 112.013 174.25 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' C' C ' 83' ' ' ILE . . . . . . . . . . . . . 72.7 mt -71.23 135.57 27.71 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.281 0 N-CA-C 109.326 -0.62 . . . . 0.0 109.326 176.038 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' C' C ' 84' ' ' LYS . . . . . . . . . . . . . 28.4 ttpp -102.68 -51.27 3.35 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-O 120.913 0.387 . . . . 0.0 110.597 -177.289 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' C' C ' 85' ' ' ASP . . . . . . . . . . . . . 8.5 t0 -143.69 144.07 31.7 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.008 -0.542 . . . . 0.0 110.545 -178.651 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' C' C ' 86' ' ' VAL . . . . . . . . . . . . . 42.9 t -125.91 131.19 72.1 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 CA-C-O 120.897 0.38 . . . . 0.0 110.24 179.742 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' C' C ' 87' ' ' ILE . . . . . . . . . . . . . 5.1 mp -119.23 125.39 74.41 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.261 0 N-CA-C 109.573 -0.528 . . . . 0.0 109.573 176.808 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' C' C ' 88' ' ' LEU . . . . . . . . . . . . . 11.6 tp -115.91 131.35 56.96 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-O 120.992 0.425 . . . . 0.0 110.992 -177.159 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' C' C ' 89' ' ' ASP . . . . . . . . . . . . . 9.5 t70 -128.19 158.86 36.93 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-N 115.906 -0.588 . . . . 0.0 109.495 176.625 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' C' C ' 90' ' ' GLU . . . . . . . . . . . . . 83.7 tt0 -46.92 -38.81 11.12 Favored 'General case' 0 CA--C 1.531 0.217 0 N-CA-C 113.029 0.752 . . . . 0.0 113.029 -171.905 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' C' C ' 91' ' ' ASN . . . . . . . . . . . . . 30.5 t30 -132.09 26.36 4.56 Favored 'General case' 0 N--CA 1.467 0.416 0 N-CA-C 112.552 0.575 . . . . 0.0 112.552 -177.553 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' C' C ' 92' ' ' LEU . . . . . . . . . . . . . 9.2 mt -149.32 142.38 24.91 Favored 'General case' 0 C--N 1.331 -0.238 0 N-CA-C 109.98 -0.378 . . . . 0.0 109.98 -177.843 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' C' C ' 93' ' ' ILE . . . . . . . . . . . . . 75.3 mt -127.43 117.71 47.66 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.283 0 N-CA-C 109.38 -0.6 . . . . 0.0 109.38 177.256 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' C' C ' 94' ' ' VAL . . . . . . . . . . . . . 44.1 t -122.9 127.55 74.84 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.225 0 CA-C-O 120.959 0.409 . . . . 0.0 110.066 -179.229 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' C' C ' 95' ' ' VAL . . . . . . . . . . . . . 44.8 t -120.34 132.62 69.47 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.355 0 CA-C-N 115.886 -0.597 . . . . 0.0 109.688 -179.982 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' C' C ' 96' ' ' ILE . . . . . . . . . . . . . 66.3 mt -115.58 128.5 72.79 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.243 0 N-CA-C 109.218 -0.66 . . . . 0.0 109.218 178.789 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' C' C ' 97' ' ' THR . . . . . . . . . . . . . 67.6 p -101.53 160.46 14.42 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-O 121.144 0.497 . . . . 0.0 111.131 -176.949 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' C' C ' 98' ' ' GLU . . . . . . . . . . . . . 96.8 mt-10 -54.01 -26.6 27.14 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.117 -0.492 . . . . 0.0 112.284 -179.318 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' C' C ' 99' ' ' GLU . . . . . . . . . . . . . 71.0 mm-40 -79.18 15.65 1.13 Allowed 'General case' 0 CA--C 1.534 0.342 0 N-CA-C 113.183 0.808 . . . . 0.0 113.183 -177.549 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' C' C ' 100' ' ' ASN . . . . . . . . . . . . . 3.2 m-20 61.6 38.08 15.7 Favored 'General case' 0 N--CA 1.463 0.191 0 CA-C-O 121.14 0.495 . . . . 0.0 110.978 178.476 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' C' C ' 101' ' ' GLU . . . . . . . . . . . . . 84.6 tt0 -114.44 141.14 48.05 Favored 'General case' 0 C--N 1.332 -0.169 0 CA-C-N 116.108 -0.496 . . . . 0.0 109.762 176.306 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' C' C ' 102' ' ' VAL . . . . . . . . . . . . . 43.0 t -115.13 125.79 72.52 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.324 0 CA-C-N 116.17 -0.468 . . . . 0.0 109.894 -178.234 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' C' C ' 103' ' ' LEU . . . . . . . . . . . . . 34.9 mt -115.41 129.0 56.44 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 115.732 -0.667 . . . . 0.0 109.9 175.821 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' C' C ' 104' ' ' ILE . . . . . . . . . . . . . 65.1 mt -117.19 120.56 65.37 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.193 0 N-CA-C 110.261 -0.274 . . . . 0.0 110.261 -178.273 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' C' C ' 105' ' ' PHE . . . . . . . . . . . . . 56.9 m-85 -122.12 166.27 14.82 Favored 'General case' 0 C--N 1.333 -0.119 0 O-C-N 124.009 0.818 . . . . 0.0 109.722 178.931 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' C' C ' 106' ' ' ASN . . . . . . . . . . . . . 46.3 p-10 -101.07 -171.15 1.95 Allowed 'General case' 0 C--N 1.331 -0.203 0 N-CA-C 110.062 -0.347 . . . . 0.0 110.062 173.714 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' C' C ' 107' ' ' GLN . . . . . . . . . . . . . 46.2 tt0 -60.34 -26.97 66.98 Favored 'General case' 0 CA--C 1.533 0.31 0 N-CA-C 112.142 0.423 . . . . 0.0 112.142 179.494 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' C' C ' 108' ' ' ASN . . . . . . . . . . . . . 53.3 t30 -84.2 6.96 20.62 Favored 'General case' 0 CA--C 1.537 0.459 0 N-CA-C 113.159 0.8 . . . . 0.0 113.159 -178.343 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' C' C ' 109' ' ' LEU . . . . . . . . . . . . . 11.9 tp 61.64 36.86 16.42 Favored 'General case' 0 C--O 1.232 0.177 0 CA-C-O 120.932 0.396 . . . . 0.0 111.405 179.013 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' C' C ' 110' ' ' GLU . . . . . . . . . . . . . 95.7 mt-10 -108.01 153.46 23.06 Favored 'General case' 0 C--N 1.33 -0.262 0 N-CA-C 109.6 -0.519 . . . . 0.0 109.6 175.059 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' C' C ' 111' ' ' GLU . . . . . . . . . . . . . 55.8 tt0 -90.73 124.14 34.87 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-O 121.017 0.437 . . . . 0.0 111.146 -174.694 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' C' C ' 112' ' ' LEU . . . . . . . . . . . . . 25.6 mt -106.84 -46.07 4.04 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 115.87 -0.604 . . . . 0.0 110.914 179.787 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' C' C ' 113' ' ' TYR . . . . . . . . . . . . . 49.0 t80 -137.63 141.44 41.21 Favored 'General case' 0 C--N 1.331 -0.209 0 CA-C-N 116.319 -0.401 . . . . 0.0 110.802 -177.367 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' C' C ' 114' ' ' ARG . . . . . . . . . . . . . 36.7 ptt-85 -145.39 125.03 13.25 Favored 'General case' 0 C--N 1.331 -0.235 0 C-N-CA 120.94 -0.304 . . . . 0.0 110.825 178.002 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' C' C ' 115' ' ' GLY . . . . . . . . . . . . . . . -150.19 160.78 28.69 Favored Glycine 0 CA--C 1.525 0.666 0 C-N-CA 120.699 -0.762 . . . . 0.0 111.408 179.791 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' C' C ' 116' ' ' LYS . . . . . . . . . . . . . 36.7 ttpt -125.75 130.15 50.91 Favored 'General case' 0 C--N 1.331 -0.219 0 N-CA-C 109.412 -0.588 . . . . 0.0 109.412 174.344 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' C' C ' 117' ' ' PHE . . . . . . . . . . . . . 49.9 m-85 -130.56 114.64 15.72 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-O 120.958 0.409 . . . . 0.0 110.598 -174.215 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' C' C ' 118' ' ' GLU . . . . . . . . . . . . . 46.2 tp10 -52.88 -51.28 61.72 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.301 -0.409 . . . . 0.0 111.622 -176.086 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' C' C ' 119' ' ' ASN . . . . . . . . . . . . . 28.9 m120 -95.41 31.01 2.07 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.259 -0.428 . . . . 0.0 112.075 -174.103 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' C' C ' 120' ' ' LEU . . . . . . . . . . . . . 19.3 tp -54.94 122.54 11.09 Favored 'General case' 0 C--O 1.232 0.157 0 CA-C-O 120.729 0.299 . . . . 0.0 110.813 179.228 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' C' C ' 121' ' ' ASN . . . . . . . . . . . . . 17.3 m120 -103.26 -44.07 5.28 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.399 -0.364 . . . . 0.0 110.681 -177.316 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' C' C ' 122' ' ' LYS . . . . . . . . . . . . . 24.2 pttm -166.96 155.11 9.71 Favored 'General case' 0 C--N 1.331 -0.219 0 C-N-CA 120.572 -0.451 . . . . 0.0 111.843 -179.732 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' C' C ' 123' ' ' VAL . . . . . . . . . . . . . 43.0 t -123.33 135.26 63.82 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.284 0 CA-C-N 116.021 -0.536 . . . . 0.0 109.626 176.82 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' C' C ' 124' ' ' LEU . . . . . . . . . . . . . 31.5 mt -128.19 142.19 51.25 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-O 120.954 0.407 . . . . 0.0 110.977 -177.604 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' C' C ' 125' ' ' VAL . . . . . . . . . . . . . 35.9 m -133.48 141.18 45.07 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.293 0 CA-C-N 115.994 -0.548 . . . . 0.0 110.55 178.16 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' C' C ' 126' ' ' ARG . . . . . . . . . . . . . 19.6 ttm180 -162.86 127.61 3.1 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.122 -0.49 . . . . 0.0 109.72 178.196 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' C' C ' 127' ' ' ASN . . . . . . . . . . . . . 36.0 m120 56.4 -150.78 0.43 Allowed 'General case' 0 CA--C 1.541 0.627 0 N-CA-C 109.519 -0.548 . . . . 0.0 109.519 -176.494 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' C' C ' 128' ' ' ASP . . . . . . . . . . . . . 12.7 p-10 -82.35 16.32 2.1 Favored 'General case' 0 CA--C 1.535 0.393 0 CA-C-N 118.875 0.761 . . . . 0.0 112.762 178.725 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' C' C ' 129' ' ' LEU . . . . . . . . . . . . . 17.9 tp -107.22 133.31 51.98 Favored 'General case' 0 C--O 1.232 0.141 0 CA-C-N 118.084 0.402 . . . . 0.0 110.51 179.845 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' C' C ' 130' ' ' VAL . . . . . . . . . . . . . 45.2 t -121.71 133.25 68.72 Favored 'Isoleucine or valine' 0 C--N 1.333 -0.144 0 N-CA-C 109.374 -0.602 . . . . 0.0 109.374 177.787 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' C' C ' 131' ' ' VAL . . . . . . . . . . . . . 43.9 t -135.28 136.61 51.09 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.208 0 CA-C-O 121.084 0.468 . . . . 0.0 110.919 -177.904 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' C' C ' 132' ' ' ILE . . . . . . . . . . . . . 69.8 mt -116.69 128.91 73.94 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.292 0 CA-C-N 115.658 -0.701 . . . . 0.0 109.231 178.302 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' C' C ' 133' ' ' ILE . . . . . . . . . . . . . 42.1 mm -114.49 123.58 70.3 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.213 0 CA-C-O 120.741 0.305 . . . . 0.0 110.947 -175.239 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' C' C ' 134' ' ' ASP . . . . . . . . . . . . . 8.9 p-10 -135.31 146.65 48.68 Favored 'General case' 0 C--N 1.331 -0.2 0 N-CA-C 109.553 -0.536 . . . . 0.0 109.553 173.396 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' C' C ' 135' ' ' GLU . . . . . . . . . . . . . 85.4 tt0 -50.09 -26.17 4.18 Favored 'General case' 0 C--N 1.327 -0.405 0 N-CA-C 112.878 0.695 . . . . 0.0 112.878 -172.696 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' C' C ' 136' ' ' GLN . . . . . . . . . . . . . 96.1 mt-30 -85.18 -30.63 23.77 Favored 'General case' 0 C--O 1.234 0.278 0 N-CA-C 112.581 0.585 . . . . 0.0 112.581 -175.384 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' C' C ' 137' ' ' LYS . . . . . . . . . . . . . 19.8 pttp -168.19 170.14 10.41 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-O 121.513 0.673 . . . . 0.0 112.242 -173.29 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' C' C ' 138' ' ' LEU . . . . . . . . . . . . . 7.4 tt -118.89 128.16 54.17 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 115.126 -0.943 . . . . 0.0 109.933 -179.9 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' C' C ' 139' ' ' THR . . . . . . . . . . . . . 39.1 m -109.03 126.11 52.78 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-N 116.246 -0.434 . . . . 0.0 110.09 178.63 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' C' C ' 140' ' ' LEU . . . . . . . . . . . . . 9.0 tp -112.77 123.4 50.22 Favored 'General case' 0 C--N 1.329 -0.303 0 N-CA-C 109.292 -0.633 . . . . 0.0 109.292 -178.588 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' C' C ' 141' ' ' ILE . . . . . . . . . . . . . 19.0 mt -121.9 125.53 73.33 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.29 0 CA-C-O 121.085 0.469 . . . . 0.0 110.303 -173.887 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' C' C ' 142' ' ' ARG . . . . . . . . . . . . . 23.2 mmm180 . . . . . 0 C--N 1.33 -0.27 0 CA-C-N 115.459 -0.791 . . . . 0.0 109.93 179.13 . . . . . . . . 0 0 . 1 . 012 nuclear orig core ' D' D ' 2' ' ' SER . . . . . . . . . . . . . 4.4 p . . . . . 0 C--O 1.231 0.091 0 CA-C-O 121.009 0.433 . . . . 0.0 110.374 . . . . . . . . . 0 0 . 1 . 012 nuclear orig core ' D' D ' 3' ' ' GLU . . . . . . . . . . . . . 85.0 tt0 -141.12 139.65 34.0 Favored 'General case' 0 C--N 1.326 -0.424 0 CA-C-N 115.873 -0.603 . . . . 0.0 111.147 -177.957 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' D' D ' 4' ' ' LEU . . . . . . . . . . . . . 18.0 tp -123.68 125.61 45.09 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 115.936 -0.575 . . . . 0.0 110.084 176.956 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' D' D ' 5' ' ' LYS . . . . . . . . . . . . . 67.1 mttm -104.22 119.91 40.0 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.218 -0.446 . . . . 0.0 110.401 178.768 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' D' D ' 6' ' ' LEU . . . . . . . . . . . . . 59.1 mt -116.32 147.31 41.69 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 115.393 -0.821 . . . . 0.0 110.324 -178.241 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' D' D ' 7' ' ' LYS . . . . . . . . . . . . . 83.7 tttt -134.67 136.23 25.03 Favored Pre-proline 0 CA--C 1.535 0.372 0 CA-C-O 118.931 -0.557 . . . . 0.0 109.844 176.254 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' D' D ' 8' ' ' PRO . . . . . . . . . . . . . 90.2 Cg_endo -91.6 140.59 2.52 Favored 'Trans proline' 0 N--CA 1.488 1.195 0 C-N-CA 121.751 1.634 . . . . 0.0 111.506 177.323 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' D' D ' 9' ' ' LEU . . . . . . . . . . . . . 62.3 mt -75.55 -47.9 4.07 Favored Pre-proline 0 CA--C 1.534 0.355 0 CA-C-O 118.586 -0.721 . . . . 0.0 112.336 -178.525 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' D' D ' 10' ' ' PRO . . . . . . . . . . . . . 88.1 Cg_endo -80.01 154.92 22.81 Favored 'Trans proline' 0 N--CA 1.497 1.689 0 C-N-CA 121.224 1.282 . . . . 0.0 112.187 177.166 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' D' D ' 11' ' ' LYS . . . . . . . . . . . . . 55.0 tptt -85.97 100.0 11.83 Favored 'General case' 0 C--N 1.328 -0.329 0 N-CA-C 109.914 -0.402 . . . . 0.0 109.914 176.767 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' D' D ' 12' ' ' VAL . . . . . . . . . . . . . 12.2 p -141.17 146.14 24.04 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.346 0 CA-C-O 120.956 0.408 . . . . 0.0 110.819 -178.386 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' D' D ' 13' ' ' GLU . . . . . . . . . . . . . 95.6 mt-10 -93.57 114.86 27.31 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 115.99 -0.55 . . . . 0.0 109.76 176.324 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' D' D ' 14' ' ' LEU . . . . . . . . . . . . . 38.8 mt -87.75 151.96 50.8 Favored Pre-proline 0 C--N 1.329 -0.304 0 CA-C-N 116.442 -0.344 . . . . 0.0 110.718 -177.164 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' D' D ' 15' ' ' PRO . . . . . . . . . . . . . 33.7 Cg_exo -57.34 158.66 18.07 Favored 'Trans proline' 0 N--CA 1.496 1.62 0 C-N-CA 121.26 1.306 . . . . 0.0 111.809 179.511 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' D' D ' 16' ' ' PRO . . . . . . . . . . . . . 30.7 Cg_exo -59.31 -36.64 94.15 Favored 'Trans proline' 0 N--CA 1.497 1.701 0 C-N-CA 121.432 1.421 . . . . 0.0 112.845 -177.776 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' D' D ' 17' ' ' ASP . . . . . . . . . . . . . 22.0 p-10 -89.96 11.29 20.94 Favored 'General case' 0 CA--C 1.537 0.46 0 N-CA-C 113.139 0.792 . . . . 0.0 113.139 -177.939 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' D' D ' 18' ' ' PHE . . . . . . . . . . . . . 47.7 t80 -58.0 -42.97 86.34 Favored 'General case' 0 N--CA 1.457 -0.108 0 O-C-N 121.983 -0.448 . . . . 0.0 110.16 -178.451 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' D' D ' 19' ' ' VAL . . . . . . . . . . . . . 48.1 t -57.51 -42.48 81.06 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.326 0 CA-C-N 116.244 -0.435 . . . . 0.0 110.376 -179.067 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' D' D ' 20' ' ' ASP . . . . . . . . . . . . . 11.7 t70 -59.62 -42.8 93.48 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-O 120.756 0.313 . . . . 0.0 110.857 -177.802 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' D' D ' 21' ' ' VAL . . . . . . . . . . . . . 46.5 t -64.42 -47.6 88.74 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.303 0 C-N-CA 120.74 -0.384 . . . . 0.0 110.507 -177.999 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' D' D ' 22' ' ' ILE . . . . . . . . . . . . . 49.9 mm -58.53 -38.46 70.72 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.283 0 C-N-CA 120.904 -0.319 . . . . 0.0 110.734 -179.644 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' D' D ' 23' ' ' ARG . . . . . . . . . . . . . 55.1 ttp180 -56.62 -49.23 75.56 Favored 'General case' 0 C--N 1.331 -0.22 0 CA-C-O 120.837 0.351 . . . . 0.0 110.533 178.066 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' D' D ' 24' ' ' ILE . . . . . . . . . . . . . 74.5 mt -61.26 -43.45 96.53 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.272 0 CA-C-N 116.04 -0.527 . . . . 0.0 111.968 -177.883 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' D' D ' 25' ' ' LYS . . . . . . . . . . . . . 15.1 pttp -71.65 -36.59 70.75 Favored 'General case' 0 CA--C 1.533 0.315 0 C-N-CA 120.364 -0.534 . . . . 0.0 111.702 -173.621 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' D' D ' 26' ' ' LEU . . . . . . . . . . . . . 18.9 mt -78.16 -43.38 28.86 Favored 'General case' 0 C--N 1.332 -0.177 0 N-CA-C 112.735 0.643 . . . . 0.0 112.735 -173.558 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' D' D ' 27' ' ' GLN . . . . . . . . . . . . . 11.1 pt20 -47.58 137.86 8.62 Favored 'General case' 0 N--CA 1.468 0.472 0 N-CA-C 112.647 0.61 . . . . 0.0 112.647 -175.946 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' D' D ' 28' ' ' GLY . . . . . . . . . . . . . . . 100.17 -27.38 20.6 Favored Glycine 0 CA--C 1.534 1.231 0 CA-C-N 115.631 -0.713 . . . . 0.0 112.013 -176.35 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' D' D ' 29' ' ' LYS . . . . . . . . . . . . . 56.1 mttm -98.52 155.16 17.41 Favored 'General case' 0 C--O 1.233 0.215 0 CA-C-N 117.144 0.472 . . . . 0.0 110.979 179.267 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' D' D ' 30' ' ' THR . . . . . . . . . . . . . 39.5 m -106.38 139.46 40.83 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 116.13 -0.486 . . . . 0.0 110.03 175.668 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' D' D ' 31' ' ' VAL . . . . . . . . . . . . . 34.5 m -128.66 158.67 40.97 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.289 0 CA-C-N 116.305 -0.407 . . . . 0.0 110.847 -178.304 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' D' D ' 32' ' ' ARG . . . . . . . . . . . . . 59.7 mtm180 -135.5 149.48 49.52 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.048 -0.523 . . . . 0.0 110.587 178.415 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' D' D ' 33' ' ' THR . . . . . . . . . . . . . 25.6 m -53.67 139.88 30.94 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.346 -0.388 . . . . 0.0 111.323 -178.186 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' D' D ' 34' ' ' GLY . . . . . . . . . . . . . . . 100.47 -17.13 57.18 Favored Glycine 0 CA--C 1.533 1.185 0 CA-C-O 119.702 -0.499 . . . . 0.0 113.304 178.672 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' D' D ' 35' ' ' ASP . . . . . . . . . . . . . 79.9 m-20 -66.2 147.88 52.66 Favored 'General case' 0 C--O 1.232 0.143 0 CA-C-N 118.053 0.926 . . . . 0.0 111.14 178.931 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' D' D ' 36' ' ' VAL . . . . . . . . . . . . . 45.1 t -123.42 131.13 73.68 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.224 0 CA-C-N 116.007 -0.542 . . . . 0.0 109.908 178.111 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' D' D ' 37' ' ' ILE . . . . . . . . . . . . . 66.4 mt -122.36 139.69 48.52 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.268 0 CA-C-N 116.28 -0.418 . . . . 0.0 110.042 -178.454 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' D' D ' 38' ' ' GLY . . . . . . . . . . . . . . . -111.81 128.77 8.76 Favored Glycine 0 CA--C 1.526 0.759 0 N-CA-C 111.08 -0.808 . . . . 0.0 111.08 179.472 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' D' D ' 39' ' ' ILE . . . . . . . . . . . . . 71.2 mt -122.54 134.18 66.5 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.187 0 N-CA-C 110.077 -0.342 . . . . 0.0 110.077 179.071 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' D' D ' 40' ' ' SER . . . . . . . . . . . . . 35.0 t -93.58 124.32 37.49 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.412 -0.358 . . . . 0.0 111.009 176.6 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' D' D ' 41' ' ' ILE . . . . . . . . . . . . . 71.3 mt -129.22 118.41 46.13 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.171 0 CA-C-O 120.826 0.346 . . . . 0.0 110.371 177.954 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' D' D ' 42' ' ' LEU . . . . . . . . . . . . . 56.2 mt 51.94 35.96 17.2 Favored 'General case' 0 C--O 1.233 0.201 0 CA-C-N 116.182 -0.463 . . . . 0.0 111.882 176.107 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' D' D ' 43' ' ' GLY . . . . . . . . . . . . . . . 73.98 31.65 59.65 Favored Glycine 0 CA--C 1.53 0.988 0 C-N-CA 121.115 -0.564 . . . . 0.0 112.123 178.162 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' D' D ' 44' ' ' LYS . . . . . . . . . . . . . 53.4 tttm -137.21 128.28 27.66 Favored 'General case' 0 C--N 1.329 -0.316 0 N-CA-C 109.536 -0.542 . . . . 0.0 109.536 177.94 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' D' D ' 45' ' ' GLU . . . . . . . . . . . . . 84.4 tt0 -83.83 123.14 29.6 Favored 'General case' 0 C--N 1.329 -0.318 0 C-N-CA 120.748 -0.381 . . . . 0.0 111.244 -177.766 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' D' D ' 46' ' ' VAL . . . . . . . . . . . . . 7.5 p -121.06 127.2 75.88 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.226 0 N-CA-C 109.342 -0.614 . . . . 0.0 109.342 175.497 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' D' D ' 47' ' ' LYS . . . . . . . . . . . . . 97.9 mttt -100.83 130.28 46.82 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.121 -0.491 . . . . 0.0 111.486 179.702 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' D' D ' 48' ' ' PHE . . . . . . . . . . . . . 93.6 m-85 -114.13 131.84 56.28 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.11 -0.495 . . . . 0.0 109.72 176.1 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' D' D ' 49' ' ' LYS . . . . . . . . . . . . . 71.5 tttt -108.66 138.66 44.62 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.628 -0.26 . . . . 0.0 110.494 179.148 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' D' D ' 50' ' ' VAL . . . . . . . . . . . . . 45.4 t -81.55 109.87 16.27 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.259 0 N-CA-C 109.443 -0.577 . . . . 0.0 109.443 177.047 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' D' D ' 51' ' ' VAL . . . . . . . . . . . . . 47.6 t -73.92 -47.63 42.11 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.304 0 CA-C-N 116.131 -0.486 . . . . 0.0 110.11 -174.322 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' D' D ' 52' ' ' GLN . . . . . . . . . . . . . 49.5 tt0 -162.65 139.09 7.54 Favored 'General case' 0 C--N 1.331 -0.219 0 C-N-CA 120.21 -0.596 . . . . 0.0 111.731 -178.126 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' D' D ' 53' ' ' ALA . . . . . . . . . . . . . . . -110.09 130.77 55.48 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 115.573 -0.739 . . . . 0.0 109.49 173.764 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' D' D ' 54' ' ' TYR . . . . . . . . . . . . . 24.9 t80 -126.76 108.09 22.67 Favored Pre-proline 0 CA--C 1.534 0.353 0 CA-C-O 118.379 -0.819 . . . . 0.0 110.553 -177.669 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' D' D ' 55' ' ' PRO . . . . . . . . . . . . . 73.3 Cg_endo -77.17 170.02 72.66 Favored 'Cis proline' 0 N--CA 1.5 1.896 0 CA-C-N 121.747 1.66 . . . . 0.0 112.139 -6.248 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' D' D ' 56' ' ' SER . . . . . . . . . . . . . 20.3 m -110.56 128.35 25.49 Favored Pre-proline 0 CA--C 1.538 0.511 0 CA-C-O 118.435 -0.793 . . . . 0.0 109.674 176.441 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' D' D ' 57' ' ' PRO . . . . . . . . . . . . . 46.6 Cg_endo -70.21 165.44 77.92 Favored 'Cis proline' 0 N--CA 1.496 1.676 0 CA-C-N 121.932 1.726 . . . . 0.0 111.677 -0.455 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' D' D ' 58' ' ' LEU . . . . . . . . . . . . . 25.0 tp -129.92 135.99 48.97 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.441 -0.345 . . . . 0.0 110.538 -179.234 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' D' D ' 59' ' ' ARG . . . . . . . . . . . . . 76.3 ttt180 -105.31 134.37 48.53 Favored 'General case' 0 C--N 1.327 -0.388 0 N-CA-C 109.419 -0.586 . . . . 0.0 109.419 175.725 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' D' D ' 60' ' ' VAL . . . . . . . . . . . . . 43.9 t -88.58 123.07 40.75 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.275 0 C-N-CA 120.644 -0.423 . . . . 0.0 110.359 -177.062 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' D' D ' 61' ' ' GLU . . . . . . . . . . . . . 94.7 mt-10 -131.09 173.42 11.03 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.077 -0.51 . . . . 0.0 109.962 177.242 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' D' D ' 62' ' ' ASP . . . . . . . . . . . . . 75.9 m-20 -54.39 -32.81 57.95 Favored 'General case' 0 C--N 1.327 -0.376 0 C-N-CA 120.964 -0.294 . . . . 0.0 111.635 179.786 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' D' D ' 63' ' ' ARG . . . . . . . . . . . . . 26.4 ptt180 -87.41 5.25 39.74 Favored 'General case' 0 CA--C 1.537 0.476 0 N-CA-C 113.652 0.982 . . . . 0.0 113.652 -176.32 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' D' D ' 64' ' ' THR . . . . . . . . . . . . . 28.5 m -82.3 133.74 35.25 Favored 'General case' 0 C--N 1.331 -0.211 0 CA-C-N 118.027 0.376 . . . . 0.0 110.602 -178.724 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' D' D ' 65' ' ' LYS . . . . . . . . . . . . . 87.1 mttt -89.71 124.62 34.77 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 116.106 -0.497 . . . . 0.0 110.02 178.75 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' D' D ' 66' ' ' ILE . . . . . . . . . . . . . 58.8 mt -113.6 129.4 69.49 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.305 0 N-CA-C 109.68 -0.489 . . . . 0.0 109.68 179.329 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' D' D ' 67' ' ' THR . . . . . . . . . . . . . 24.4 m -127.82 138.55 52.75 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-O 121.063 0.458 . . . . 0.0 111.124 -177.672 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' D' D ' 68' ' ' LEU . . . . . . . . . . . . . 7.0 mp . . . . . 0 C--N 1.331 -0.206 0 CA-C-N 115.927 -0.579 . . . . 0.0 109.908 176.217 . . . . . . . . 0 0 . 1 . 012 nuclear orig core ' D' D ' 73' ' ' VAL . . . . . . . . . . . . . 26.9 m . . . . . 0 C--O 1.23 0.071 0 N-CA-C 109.815 -0.439 . . . . 0.0 109.815 . . . . . . . . . 0 0 . 1 . 012 nuclear orig core ' D' D ' 74' ' ' ASP . . . . . . . . . . . . . 30.3 t0 -104.21 117.22 33.7 Favored 'General case' 0 C--N 1.33 -0.274 0 N-CA-C 109.884 -0.413 . . . . 0.0 109.884 179.466 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' D' D ' 75' ' ' VAL . . . . . . . . . . . . . 46.7 t -119.63 126.15 75.04 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.281 0 CA-C-O 121.066 0.46 . . . . 0.0 110.817 -176.91 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' D' D ' 76' ' ' LEU . . . . . . . . . . . . . 5.5 mp -125.23 143.97 50.69 Favored 'General case' 0 C--N 1.332 -0.178 0 CA-C-N 115.71 -0.677 . . . . 0.0 109.787 175.388 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' D' D ' 77' ' ' GLU . . . . . . . . . . . . . 97.1 mt-10 -133.63 136.42 44.8 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-O 120.986 0.422 . . . . 0.0 111.074 -178.31 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' D' D ' 78' ' ' ALA . . . . . . . . . . . . . . . -124.31 132.85 53.58 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 115.883 -0.598 . . . . 0.0 109.919 176.953 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' D' D ' 79' ' ' LYS . . . . . . . . . . . . . 59.5 mtpt -79.26 117.09 19.94 Favored 'General case' 0 C--N 1.331 -0.225 0 CA-C-N 116.312 -0.404 . . . . 0.0 110.644 -178.027 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' D' D ' 80' ' ' ILE . . . . . . . . . . . . . 43.3 mm -139.16 112.16 6.2 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.322 0 N-CA-C 109.079 -0.711 . . . . 0.0 109.079 -177.426 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' D' D ' 81' ' ' LYS . . . . . . . . . . . . . 55.4 pttt -104.6 129.44 52.71 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-O 120.995 0.426 . . . . 0.0 111.65 -175.909 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' D' D ' 82' ' ' GLY . . . . . . . . . . . . . . . 89.12 42.11 5.68 Favored Glycine 0 CA--C 1.524 0.653 0 CA-C-N 115.835 -0.621 . . . . 0.0 111.701 174.478 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' D' D ' 83' ' ' ILE . . . . . . . . . . . . . 69.2 mt -73.21 136.87 24.55 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.27 0 N-CA-C 109.526 -0.546 . . . . 0.0 109.526 177.207 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' D' D ' 84' ' ' LYS . . . . . . . . . . . . . 39.7 ttpt -102.25 -48.42 4.2 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-O 120.849 0.357 . . . . 0.0 110.517 -178.348 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' D' D ' 85' ' ' ASP . . . . . . . . . . . . . 12.8 t70 -146.8 145.2 29.83 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.7 -179.33 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' D' D ' 86' ' ' VAL . . . . . . . . . . . . . 43.7 t -126.38 129.56 71.9 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.223 0 CA-C-N 116.325 -0.398 . . . . 0.0 110.204 179.855 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' D' D ' 87' ' ' ILE . . . . . . . . . . . . . 5.0 mp -122.27 128.16 75.4 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.227 0 N-CA-C 109.865 -0.42 . . . . 0.0 109.865 177.689 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' D' D ' 88' ' ' LEU . . . . . . . . . . . . . 68.4 mt -112.01 136.18 51.68 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-O 121.011 0.434 . . . . 0.0 111.211 -178.814 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' D' D ' 89' ' ' ASP . . . . . . . . . . . . . 9.1 t70 -130.12 154.28 47.65 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 115.812 -0.631 . . . . 0.0 109.55 175.334 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' D' D ' 90' ' ' GLU . . . . . . . . . . . . . 96.2 mt-10 -48.92 -37.4 19.76 Favored 'General case' 0 C--N 1.329 -0.325 0 N-CA-C 112.773 0.657 . . . . 0.0 112.773 -172.207 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' D' D ' 91' ' ' ASN . . . . . . . . . . . . . 86.5 m-20 -132.03 33.39 3.92 Favored 'General case' 0 N--CA 1.465 0.297 0 N-CA-C 111.914 0.338 . . . . 0.0 111.914 -176.966 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' D' D ' 92' ' ' LEU . . . . . . . . . . . . . 7.4 tp -166.06 142.37 5.04 Favored 'General case' 0 C--N 1.332 -0.17 0 C-N-CA 120.952 -0.299 . . . . 0.0 110.635 -179.344 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' D' D ' 93' ' ' ILE . . . . . . . . . . . . . 73.8 mt -124.05 124.81 69.72 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.261 0 N-CA-C 109.479 -0.563 . . . . 0.0 109.479 178.605 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' D' D ' 94' ' ' VAL . . . . . . . . . . . . . 43.8 t -123.34 125.89 72.45 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.188 0 CA-C-O 120.972 0.415 . . . . 0.0 109.96 -179.798 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' D' D ' 95' ' ' VAL . . . . . . . . . . . . . 44.6 t -120.78 131.46 72.8 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.261 0 CA-C-N 115.964 -0.562 . . . . 0.0 109.643 179.31 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' D' D ' 96' ' ' ILE . . . . . . . . . . . . . 63.2 mt -115.72 128.04 73.11 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.256 0 N-CA-C 109.446 -0.575 . . . . 0.0 109.446 -179.282 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' D' D ' 97' ' ' THR . . . . . . . . . . . . . 70.7 p -100.9 159.15 15.44 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-O 121.152 0.501 . . . . 0.0 111.111 -177.307 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' D' D ' 98' ' ' GLU . . . . . . . . . . . . . 46.5 tp10 -53.9 -26.53 25.55 Favored 'General case' 0 C--N 1.327 -0.392 0 CA-C-N 116.079 -0.509 . . . . 0.0 112.098 179.751 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' D' D ' 99' ' ' GLU . . . . . . . . . . . . . 19.9 tp10 -79.72 16.76 1.04 Allowed 'General case' 0 CA--C 1.539 0.524 0 N-CA-C 112.777 0.658 . . . . 0.0 112.777 -175.998 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' D' D ' 100' ' ' ASN . . . . . . . . . . . . . 3.7 m-20 60.88 30.87 19.91 Favored 'General case' 0 CA--C 1.532 0.285 0 O-C-N 121.958 -0.464 . . . . 0.0 111.682 178.424 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' D' D ' 101' ' ' GLU . . . . . . . . . . . . . 84.7 tt0 -112.53 144.21 42.39 Favored 'General case' 0 C--N 1.332 -0.157 0 N-CA-C 109.548 -0.538 . . . . 0.0 109.548 175.045 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' D' D ' 102' ' ' VAL . . . . . . . . . . . . . 44.3 t -118.71 130.12 73.99 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.252 0 CA-C-O 120.954 0.407 . . . . 0.0 110.16 -176.587 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' D' D ' 103' ' ' LEU . . . . . . . . . . . . . 21.2 mt -113.01 129.65 56.42 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 115.435 -0.802 . . . . 0.0 109.989 176.359 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' D' D ' 104' ' ' ILE . . . . . . . . . . . . . 66.3 mt -115.46 120.14 63.85 Favored 'Isoleucine or valine' 0 C--O 1.234 0.248 0 N-CA-C 110.169 -0.308 . . . . 0.0 110.169 -179.604 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' D' D ' 105' ' ' PHE . . . . . . . . . . . . . 73.5 m-85 -123.83 167.08 14.55 Favored 'General case' 0 C--N 1.333 -0.117 0 O-C-N 123.876 0.735 . . . . 0.0 109.976 -179.736 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' D' D ' 106' ' ' ASN . . . . . . . . . . . . . 48.8 p-10 -102.97 -170.81 1.85 Allowed 'General case' 0 C--N 1.33 -0.256 0 N-CA-C 109.903 -0.406 . . . . 0.0 109.903 172.762 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' D' D ' 107' ' ' GLN . . . . . . . . . . . . . 42.9 tt0 -61.23 -29.25 69.72 Favored 'General case' 0 N--CA 1.464 0.249 0 N-CA-C 111.902 0.334 . . . . 0.0 111.902 -179.893 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' D' D ' 108' ' ' ASN . . . . . . . . . . . . . 4.2 t-20 -81.9 11.7 4.77 Favored 'General case' 0 CA--C 1.538 0.511 0 N-CA-C 112.771 0.656 . . . . 0.0 112.771 -179.498 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' D' D ' 109' ' ' LEU . . . . . . . . . . . . . 10.9 tp 54.58 36.72 26.56 Favored 'General case' 0 C--O 1.233 0.202 0 CA-C-O 120.982 0.42 . . . . 0.0 111.4 178.554 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' D' D ' 110' ' ' GLU . . . . . . . . . . . . . 95.3 mt-10 -103.02 143.22 32.86 Favored 'General case' 0 C--N 1.328 -0.328 0 N-CA-C 109.369 -0.604 . . . . 0.0 109.369 175.091 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' D' D ' 111' ' ' GLU . . . . . . . . . . . . . 73.7 tt0 -82.67 121.87 27.41 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-O 121.017 0.437 . . . . 0.0 110.296 -176.479 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' D' D ' 112' ' ' LEU . . . . . . . . . . . . . 45.9 mt -107.0 -45.96 4.03 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-N 115.86 -0.609 . . . . 0.0 110.65 -179.137 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' D' D ' 113' ' ' TYR . . . . . . . . . . . . . 55.3 t80 -135.23 138.53 43.65 Favored 'General case' 0 C--N 1.332 -0.188 0 CA-C-O 120.845 0.355 . . . . 0.0 111.278 -178.567 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' D' D ' 114' ' ' ARG . . . . . . . . . . . . . 70.1 ttt180 -136.13 123.81 22.41 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 115.914 -0.584 . . . . 0.0 110.077 177.67 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' D' D ' 115' ' ' GLY . . . . . . . . . . . . . . . -149.96 157.46 27.23 Favored Glycine 0 CA--C 1.523 0.591 0 N-CA-C 111.136 -0.786 . . . . 0.0 111.136 -179.91 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' D' D ' 116' ' ' LYS . . . . . . . . . . . . . 67.3 tttt -131.77 129.79 41.02 Favored 'General case' 0 C--N 1.328 -0.352 0 N-CA-C 109.734 -0.469 . . . . 0.0 109.734 178.846 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' D' D ' 117' ' ' PHE . . . . . . . . . . . . . 49.0 m-85 -125.17 114.23 18.72 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.289 -0.414 . . . . 0.0 110.184 -174.837 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' D' D ' 118' ' ' GLU . . . . . . . . . . . . . 48.7 mp0 -56.9 -46.14 82.12 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.344 -0.389 . . . . 0.0 110.851 -175.297 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' D' D ' 119' ' ' ASN . . . . . . . . . . . . . 23.9 m120 -97.36 31.1 2.6 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.099 -0.5 . . . . 0.0 112.109 -174.678 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' D' D ' 120' ' ' LEU . . . . . . . . . . . . . 7.2 tt -54.91 120.1 6.37 Favored 'General case' 0 N--CA 1.462 0.148 0 CA-C-O 120.817 0.341 . . . . 0.0 110.598 178.337 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' D' D ' 121' ' ' ASN . . . . . . . . . . . . . 43.3 m-20 -105.11 -44.03 4.88 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 116.303 -0.408 . . . . 0.0 110.874 -176.731 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' D' D ' 122' ' ' LYS . . . . . . . . . . . . . 55.8 pttt -162.41 153.89 18.14 Favored 'General case' 0 C--N 1.331 -0.204 0 C-N-CA 120.427 -0.509 . . . . 0.0 112.028 -179.118 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' D' D ' 123' ' ' VAL . . . . . . . . . . . . . 42.0 t -125.81 136.49 60.67 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.248 0 CA-C-N 115.806 -0.633 . . . . 0.0 109.948 179.663 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' D' D ' 124' ' ' LEU . . . . . . . . . . . . . 48.4 mt -125.72 131.13 52.61 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.278 -0.419 . . . . 0.0 110.133 178.782 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' D' D ' 125' ' ' VAL . . . . . . . . . . . . . 13.5 p -134.88 134.06 53.7 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.259 0 CA-C-O 121.113 0.482 . . . . 0.0 110.809 179.616 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' D' D ' 126' ' ' ARG . . . . . . . . . . . . . 79.0 mtp180 -147.6 122.69 10.13 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 115.513 -0.767 . . . . 0.0 109.301 177.969 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' D' D ' 127' ' ' ASN . . . . . . . . . . . . . 1.5 t-20 57.03 -148.65 0.49 Allowed 'General case' 0 CA--C 1.542 0.643 0 N-CA-C 109.579 -0.526 . . . . 0.0 109.579 -178.371 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' D' D ' 128' ' ' ASP . . . . . . . . . . . . . 19.7 p-10 -81.44 12.99 3.23 Favored 'General case' 0 CA--C 1.538 0.488 0 N-CA-C 113.044 0.757 . . . . 0.0 113.044 178.507 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' D' D ' 129' ' ' LEU . . . . . . . . . . . . . 32.9 mt -107.41 133.0 52.57 Favored 'General case' 0 C--O 1.231 0.128 0 N-CA-C 109.542 -0.54 . . . . 0.0 109.542 178.545 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' D' D ' 130' ' ' VAL . . . . . . . . . . . . . 14.7 p -138.32 139.69 41.31 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.204 0 CA-C-O 121.273 0.559 . . . . 0.0 111.314 -179.758 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' D' D ' 131' ' ' VAL . . . . . . . . . . . . . 46.4 t -136.08 140.16 44.43 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.237 0 CA-C-N 115.784 -0.644 . . . . 0.0 110.271 179.446 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' D' D ' 132' ' ' ILE . . . . . . . . . . . . . 72.4 mt -116.78 133.99 61.73 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.263 0 CA-C-N 115.966 -0.561 . . . . 0.0 109.754 -179.717 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' D' D ' 133' ' ' ILE . . . . . . . . . . . . . 42.8 mm -114.25 123.64 70.11 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.222 0 CA-C-N 116.603 -0.271 . . . . 0.0 110.926 -176.434 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' D' D ' 134' ' ' ASP . . . . . . . . . . . . . 7.0 p-10 -135.21 147.95 49.49 Favored 'General case' 0 C--N 1.332 -0.16 0 N-CA-C 109.637 -0.505 . . . . 0.0 109.637 174.459 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' D' D ' 135' ' ' GLU . . . . . . . . . . . . . 84.9 tt0 -50.06 -28.2 6.74 Favored 'General case' 0 C--N 1.328 -0.355 0 N-CA-C 112.923 0.712 . . . . 0.0 112.923 -171.287 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' D' D ' 136' ' ' GLN . . . . . . . . . . . . . 97.2 mt-30 -83.26 -35.11 25.59 Favored 'General case' 0 C--O 1.234 0.253 0 N-CA-C 112.538 0.569 . . . . 0.0 112.538 -175.829 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' D' D ' 137' ' ' LYS . . . . . . . . . . . . . 24.8 pttm -163.36 172.07 15.14 Favored 'General case' 0 C--N 1.331 -0.217 0 CA-C-O 121.525 0.678 . . . . 0.0 112.413 -171.455 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' D' D ' 138' ' ' LEU . . . . . . . . . . . . . 5.9 tt -117.36 127.6 54.21 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 114.938 -1.028 . . . . 0.0 109.748 178.512 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' D' D ' 139' ' ' THR . . . . . . . . . . . . . 36.9 m -107.64 125.76 51.74 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.207 -0.451 . . . . 0.0 110.187 -179.414 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' D' D ' 140' ' ' LEU . . . . . . . . . . . . . 6.1 tt -113.06 119.34 37.52 Favored 'General case' 0 C--N 1.327 -0.392 0 CA-C-N 115.824 -0.626 . . . . 0.0 109.651 -176.951 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' D' D ' 141' ' ' ILE . . . . . . . . . . . . . 22.2 mt -123.05 125.48 72.21 Favored 'Isoleucine or valine' 0 C--O 1.234 0.244 0 CA-C-O 121.033 0.444 . . . . 0.0 110.396 -175.03 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' D' D ' 142' ' ' ARG . . . . . . . . . . . . . 61.4 mmt-85 -121.96 129.33 52.41 Favored 'General case' 0 C--N 1.331 -0.203 0 CA-C-N 115.548 -0.751 . . . . 0.0 110.466 -178.62 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' D' D ' 143' ' ' THR . . . . . . . . . . . . . 41.1 p . . . . . 0 C--O 1.219 -0.55 0 CA-C-O 118.046 -0.978 . . . . 0.0 110.6 -179.874 . . . . . . . . 0 0 . 1 . 012 nuclear orig core ' E' E ' 2' ' ' SER . . . . . . . . . . . . . 2.4 p . . . . . 0 C--O 1.231 0.082 0 CA-C-O 120.958 0.409 . . . . 0.0 110.395 . . . . . . . . . 0 0 . 1 . 012 nuclear orig core ' E' E ' 3' ' ' GLU . . . . . . . . . . . . . 84.8 tt0 -142.6 142.84 32.2 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.083 -0.508 . . . . 0.0 111.045 179.238 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' E' E ' 4' ' ' LEU . . . . . . . . . . . . . 21.4 tp -122.01 128.19 51.14 Favored 'General case' 0 C--N 1.331 -0.21 0 CA-C-N 115.875 -0.602 . . . . 0.0 110.183 177.918 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' E' E ' 5' ' ' LYS . . . . . . . . . . . . . 89.2 mttt -105.43 121.11 43.24 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.3 -0.409 . . . . 0.0 110.485 178.298 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' E' E ' 6' ' ' LEU . . . . . . . . . . . . . 29.6 mt -116.79 150.29 38.56 Favored 'General case' 0 C--N 1.332 -0.187 0 CA-C-N 115.289 -0.869 . . . . 0.0 110.735 -178.097 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' E' E ' 7' ' ' LYS . . . . . . . . . . . . . 23.7 ttmt -138.35 135.32 18.16 Favored Pre-proline 0 CA--C 1.535 0.392 0 CA-C-O 118.846 -0.597 . . . . 0.0 109.933 174.984 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' E' E ' 8' ' ' PRO . . . . . . . . . . . . . 93.1 Cg_endo -90.72 143.11 3.45 Favored 'Trans proline' 0 N--CA 1.492 1.43 0 C-N-CA 121.602 1.535 . . . . 0.0 111.837 178.394 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' E' E ' 9' ' ' LEU . . . . . . . . . . . . . 35.3 mt -78.14 -47.67 2.09 Favored Pre-proline 0 CA--C 1.533 0.307 0 CA-C-O 118.759 -0.638 . . . . 0.0 112.099 -179.179 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' E' E ' 10' ' ' PRO . . . . . . . . . . . . . 76.8 Cg_endo -82.31 145.38 13.48 Favored 'Trans proline' 0 N--CA 1.495 1.593 0 C-N-CA 121.235 1.29 . . . . 0.0 111.681 175.689 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' E' E ' 11' ' ' LYS . . . . . . . . . . . . . 53.3 pttt -85.27 114.72 22.57 Favored 'General case' 0 C--N 1.331 -0.214 0 CA-C-O 121.453 0.644 . . . . 0.0 110.326 177.426 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' E' E ' 12' ' ' VAL . . . . . . . . . . . . . 12.1 p -151.11 150.93 12.92 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.299 0 CA-C-N 115.732 -0.667 . . . . 0.0 110.83 -177.538 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' E' E ' 13' ' ' GLU . . . . . . . . . . . . . 14.6 mm-40 -86.93 122.38 30.72 Favored 'General case' 0 C--N 1.331 -0.239 0 N-CA-C 110.019 -0.363 . . . . 0.0 110.019 175.901 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' E' E ' 14' ' ' LEU . . . . . . . . . . . . . 46.3 mt -98.7 149.54 35.84 Favored Pre-proline 0 CA--C 1.533 0.308 0 CA-C-O 119.318 -0.372 . . . . 0.0 110.632 -178.533 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' E' E ' 15' ' ' PRO . . . . . . . . . . . . . 24.6 Cg_exo -62.94 161.7 28.46 Favored 'Trans proline' 0 N--CA 1.499 1.818 0 C-N-CA 121.297 1.331 . . . . 0.0 111.876 176.81 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' E' E ' 16' ' ' PRO . . . . . . . . . . . . . 25.8 Cg_exo -61.28 -37.46 73.09 Favored 'Trans proline' 0 N--CA 1.499 1.807 0 C-N-CA 121.546 1.498 . . . . 0.0 112.967 -177.719 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' E' E ' 17' ' ' ASP . . . . . . . . . . . . . 13.0 p-10 -89.34 8.2 31.81 Favored 'General case' 0 CA--C 1.536 0.406 0 N-CA-C 113.351 0.871 . . . . 0.0 113.351 -176.786 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' E' E ' 18' ' ' PHE . . . . . . . . . . . . . 42.7 t80 -58.18 -42.78 86.82 Favored 'General case' 0 C--N 1.334 -0.086 0 O-C-N 121.925 -0.485 . . . . 0.0 110.099 -178.267 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' E' E ' 19' ' ' VAL . . . . . . . . . . . . . 54.9 t -57.12 -43.09 80.8 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.352 0 CA-C-N 116.225 -0.443 . . . . 0.0 110.306 -179.678 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' E' E ' 20' ' ' ASP . . . . . . . . . . . . . 75.2 m-20 -59.83 -41.74 91.99 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-O 120.782 0.325 . . . . 0.0 110.928 -177.846 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' E' E ' 21' ' ' VAL . . . . . . . . . . . . . 44.7 t -63.81 -46.36 94.61 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 C-N-CA 120.79 -0.364 . . . . 0.0 110.328 -177.76 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' E' E ' 22' ' ' ILE . . . . . . . . . . . . . 49.7 mm -55.95 -47.0 80.6 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.275 0 C-N-CA 120.971 -0.292 . . . . 0.0 110.827 178.932 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' E' E ' 23' ' ' ARG . . . . . . . . . . . . . 55.5 ttp180 -54.8 -48.73 72.38 Favored 'General case' 0 C--N 1.33 -0.275 0 C-N-CA 120.982 -0.287 . . . . 0.0 111.461 -178.323 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' E' E ' 24' ' ' ILE . . . . . . . . . . . . . 81.2 mt -59.0 -44.68 91.72 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.332 0 C-N-CA 121.102 -0.239 . . . . 0.0 111.179 -177.035 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' E' E ' 25' ' ' LYS . . . . . . . . . . . . . 57.3 mttm -64.5 -40.07 94.97 Favored 'General case' 0 C--N 1.327 -0.406 0 N-CA-C 112.356 0.502 . . . . 0.0 112.356 -178.48 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' E' E ' 26' ' ' LEU . . . . . . . . . . . . . 47.2 mt -79.27 -40.65 29.98 Favored 'General case' 0 C--N 1.33 -0.271 0 N-CA-C 113.573 0.953 . . . . 0.0 113.573 -171.367 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' E' E ' 27' ' ' GLN . . . . . . . . . . . . . 10.3 pt20 -46.7 137.04 7.33 Favored 'General case' 0 N--CA 1.47 0.544 0 N-CA-C 112.75 0.648 . . . . 0.0 112.75 -174.591 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' E' E ' 28' ' ' GLY . . . . . . . . . . . . . . . 100.52 -25.86 26.73 Favored Glycine 0 CA--C 1.534 1.222 0 CA-C-N 115.531 -0.759 . . . . 0.0 112.252 -176.082 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' E' E ' 29' ' ' LYS . . . . . . . . . . . . . 62.2 mttp -97.94 155.22 17.19 Favored 'General case' 0 C--N 1.332 -0.175 0 CA-C-N 117.265 0.532 . . . . 0.0 111.148 179.073 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' E' E ' 30' ' ' THR . . . . . . . . . . . . . 34.4 m -105.2 140.79 37.82 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 115.78 -0.645 . . . . 0.0 110.075 176.184 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' E' E ' 31' ' ' VAL . . . . . . . . . . . . . 35.0 m -126.44 151.16 32.67 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.234 0 CA-C-O 121.004 0.43 . . . . 0.0 111.229 -177.791 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' E' E ' 32' ' ' ARG . . . . . . . . . . . . . 67.0 mtp85 -128.12 151.04 49.69 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 115.68 -0.691 . . . . 0.0 110.846 177.362 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' E' E ' 33' ' ' THR . . . . . . . . . . . . . 15.2 m -54.29 139.34 36.67 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 115.987 -0.552 . . . . 0.0 111.186 -178.817 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' E' E ' 34' ' ' GLY . . . . . . . . . . . . . . . 98.77 -17.16 58.68 Favored Glycine 0 CA--C 1.533 1.162 0 C-N-CA 121.019 -0.61 . . . . 0.0 113.306 178.27 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' E' E ' 35' ' ' ASP . . . . . . . . . . . . . 73.3 m-20 -63.88 149.86 46.16 Favored 'General case' 0 C--O 1.231 0.09 0 CA-C-N 118.081 0.941 . . . . 0.0 111.016 179.685 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' E' E ' 36' ' ' VAL . . . . . . . . . . . . . 44.6 t -124.08 130.16 73.89 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.217 0 CA-C-N 116.05 -0.523 . . . . 0.0 109.923 178.971 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' E' E ' 37' ' ' ILE . . . . . . . . . . . . . 62.6 mt -122.03 140.41 46.04 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.244 0 CA-C-N 116.378 -0.374 . . . . 0.0 110.069 -179.465 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' E' E ' 38' ' ' GLY . . . . . . . . . . . . . . . -114.06 128.84 8.44 Favored Glycine 0 CA--C 1.524 0.638 0 N-CA-C 111.086 -0.806 . . . . 0.0 111.086 178.766 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' E' E ' 39' ' ' ILE . . . . . . . . . . . . . 71.7 mt -122.59 135.87 61.25 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.217 0 N-CA-C 110.075 -0.343 . . . . 0.0 110.075 178.935 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' E' E ' 40' ' ' SER . . . . . . . . . . . . . 53.0 p -93.4 117.37 29.99 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.519 -0.31 . . . . 0.0 111.202 176.015 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' E' E ' 41' ' ' ILE . . . . . . . . . . . . . 44.4 mm -121.71 121.61 64.83 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.181 0 CA-C-N 116.469 -0.332 . . . . 0.0 110.118 178.176 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' E' E ' 42' ' ' LEU . . . . . . . . . . . . . 83.8 mt 52.53 33.66 13.87 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.43 -0.35 . . . . 0.0 111.853 177.41 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' E' E ' 43' ' ' GLY . . . . . . . . . . . . . . . 73.22 32.09 60.68 Favored Glycine 0 CA--C 1.529 0.915 0 C-N-CA 121.049 -0.596 . . . . 0.0 112.125 178.797 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' E' E ' 44' ' ' LYS . . . . . . . . . . . . . 80.2 tttt -138.72 130.37 27.61 Favored 'General case' 0 C--N 1.33 -0.257 0 N-CA-C 109.482 -0.562 . . . . 0.0 109.482 179.064 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' E' E ' 45' ' ' GLU . . . . . . . . . . . . . 82.0 tt0 -83.1 124.83 30.85 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-O 120.799 0.333 . . . . 0.0 111.248 -176.144 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' E' E ' 46' ' ' VAL . . . . . . . . . . . . . 7.3 p -122.09 128.11 75.48 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.175 0 N-CA-C 109.493 -0.558 . . . . 0.0 109.493 174.909 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' E' E ' 47' ' ' LYS . . . . . . . . . . . . . 94.6 mttt -100.27 129.56 46.29 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.035 -0.53 . . . . 0.0 111.38 179.099 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' E' E ' 48' ' ' PHE . . . . . . . . . . . . . 95.3 m-85 -113.27 132.01 55.7 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.088 -0.505 . . . . 0.0 109.826 175.383 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' E' E ' 49' ' ' LYS . . . . . . . . . . . . . 80.6 tttt -105.51 137.74 42.84 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.41 -0.359 . . . . 0.0 110.21 179.278 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' E' E ' 50' ' ' VAL . . . . . . . . . . . . . 42.1 t -78.06 107.3 9.8 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.332 0 N-CA-C 109.533 -0.543 . . . . 0.0 109.533 177.427 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' E' E ' 51' ' ' VAL . . . . . . . . . . . . . 52.1 t -71.54 -48.76 50.96 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.288 0 CA-C-N 116.082 -0.508 . . . . 0.0 109.882 -174.557 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' E' E ' 52' ' ' GLN . . . . . . . . . . . . . 62.5 tt0 -167.46 138.68 3.05 Favored 'General case' 0 C--N 1.331 -0.211 0 C-N-CA 120.323 -0.551 . . . . 0.0 111.682 -179.271 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' E' E ' 53' ' ' ALA . . . . . . . . . . . . . . . -107.19 130.82 54.67 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 115.669 -0.696 . . . . 0.0 109.642 175.098 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' E' E ' 54' ' ' TYR . . . . . . . . . . . . . 30.1 t80 -127.65 106.9 20.76 Favored Pre-proline 0 CA--C 1.534 0.348 0 CA-C-O 118.39 -0.814 . . . . 0.0 110.598 -177.975 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' E' E ' 55' ' ' PRO . . . . . . . . . . . . . 73.1 Cg_endo -77.19 170.07 72.49 Favored 'Cis proline' 0 N--CA 1.5 1.867 0 CA-C-N 121.725 1.652 . . . . 0.0 112.323 -5.726 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' E' E ' 56' ' ' SER . . . . . . . . . . . . . 16.3 m -111.39 129.99 23.52 Favored Pre-proline 0 CA--C 1.538 0.502 0 CA-C-O 118.414 -0.803 . . . . 0.0 109.48 175.272 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' E' E ' 57' ' ' PRO . . . . . . . . . . . . . 56.9 Cg_endo -72.36 147.7 89.56 Favored 'Cis proline' 0 N--CA 1.497 1.702 0 CA-C-N 121.956 1.734 . . . . 0.0 111.792 -0.918 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' E' E ' 58' ' ' LEU . . . . . . . . . . . . . 18.1 tp -108.08 136.6 47.49 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.32 -0.4 . . . . 0.0 110.534 -179.203 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' E' E ' 59' ' ' ARG . . . . . . . . . . . . . 32.2 ttm180 -106.1 130.02 54.08 Favored 'General case' 0 C--N 1.328 -0.329 0 N-CA-C 109.565 -0.532 . . . . 0.0 109.565 176.35 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' E' E ' 60' ' ' VAL . . . . . . . . . . . . . 40.4 t -86.71 123.0 39.47 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.219 0 C-N-CA 120.544 -0.463 . . . . 0.0 110.487 -176.904 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' E' E ' 61' ' ' GLU . . . . . . . . . . . . . 95.0 mt-10 -131.01 170.79 14.01 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 115.895 -0.593 . . . . 0.0 109.909 177.727 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' E' E ' 62' ' ' ASP . . . . . . . . . . . . . 60.3 m-20 -55.0 -33.63 62.73 Favored 'General case' 0 C--N 1.328 -0.361 0 N-CA-C 111.827 0.306 . . . . 0.0 111.827 -177.627 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' E' E ' 63' ' ' ARG . . . . . . . . . . . . . 40.0 ptt180 -89.55 5.28 46.25 Favored 'General case' 0 CA--C 1.536 0.438 0 N-CA-C 113.818 1.044 . . . . 0.0 113.818 -175.496 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' E' E ' 64' ' ' THR . . . . . . . . . . . . . 31.4 m -76.27 139.85 41.3 Favored 'General case' 0 C--N 1.332 -0.184 0 CA-C-O 120.851 0.358 . . . . 0.0 110.859 -177.874 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' E' E ' 65' ' ' LYS . . . . . . . . . . . . . 99.6 mttt -88.32 129.4 35.4 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.05 -0.523 . . . . 0.0 110.192 178.601 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' E' E ' 66' ' ' ILE . . . . . . . . . . . . . 57.7 mt -114.04 127.34 71.49 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.312 0 N-CA-C 109.728 -0.471 . . . . 0.0 109.728 -179.705 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' E' E ' 67' ' ' THR . . . . . . . . . . . . . 26.9 m -128.26 139.11 52.61 Favored 'General case' 0 C--N 1.331 -0.221 0 CA-C-O 121.063 0.459 . . . . 0.0 111.001 -177.426 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' E' E ' 68' ' ' LEU . . . . . . . . . . . . . 7.7 mp . . . . . 0 C--N 1.328 -0.331 0 CA-C-N 115.922 -0.581 . . . . 0.0 110.28 176.778 . . . . . . . . 0 0 . 1 . 012 nuclear orig core ' E' E ' 73' ' ' VAL . . . . . . . . . . . . . 32.8 m . . . . . 0 C--O 1.231 0.121 0 CA-C-O 120.808 0.337 . . . . 0.0 110.421 . . . . . . . . . 0 0 . 1 . 012 nuclear orig core ' E' E ' 74' ' ' ASP . . . . . . . . . . . . . 46.8 t0 -92.29 118.82 31.28 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.161 -0.472 . . . . 0.0 109.925 -179.615 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' E' E ' 75' ' ' VAL . . . . . . . . . . . . . 38.9 t -119.35 121.22 65.94 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.208 0 CA-C-O 120.988 0.423 . . . . 0.0 110.373 -179.756 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' E' E ' 76' ' ' LEU . . . . . . . . . . . . . 5.1 mp -122.26 146.41 47.31 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 115.851 -0.613 . . . . 0.0 109.752 176.527 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' E' E ' 77' ' ' GLU . . . . . . . . . . . . . 97.9 mt-10 -135.8 133.39 37.83 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-O 121.021 0.439 . . . . 0.0 111.125 -179.208 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' E' E ' 78' ' ' ALA . . . . . . . . . . . . . . . -121.81 133.28 54.9 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 115.729 -0.669 . . . . 0.0 109.727 176.364 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' E' E ' 79' ' ' LYS . . . . . . . . . . . . . 49.1 tptt -80.01 118.04 21.39 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-O 120.899 0.38 . . . . 0.0 110.477 -177.3 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' E' E ' 80' ' ' ILE . . . . . . . . . . . . . 41.2 mm -139.17 109.25 4.18 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.288 0 N-CA-C 109.235 -0.654 . . . . 0.0 109.235 -177.369 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' E' E ' 81' ' ' LYS . . . . . . . . . . . . . 57.5 pttt -102.23 127.31 49.24 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-O 120.938 0.399 . . . . 0.0 111.493 -177.283 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' E' E ' 82' ' ' GLY . . . . . . . . . . . . . . . 89.09 42.09 5.7 Favored Glycine 0 CA--C 1.526 0.735 0 C-N-CA 120.637 -0.792 . . . . 0.0 111.78 173.852 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' E' E ' 83' ' ' ILE . . . . . . . . . . . . . 74.0 mt -68.28 138.61 22.19 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.28 0 N-CA-C 109.932 -0.396 . . . . 0.0 109.932 178.203 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' E' E ' 84' ' ' LYS . . . . . . . . . . . . . 23.5 ttmt -95.92 -53.58 3.63 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.09 -0.505 . . . . 0.0 110.306 -179.721 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' E' E ' 85' ' ' ASP . . . . . . . . . . . . . 12.4 t70 -154.49 157.67 38.73 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 115.724 -0.671 . . . . 0.0 110.33 -178.401 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' E' E ' 86' ' ' VAL . . . . . . . . . . . . . 42.0 t -137.02 136.13 47.63 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.307 0 CA-C-O 120.939 0.4 . . . . 0.0 110.67 -178.172 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' E' E ' 87' ' ' ILE . . . . . . . . . . . . . 5.1 mp -119.78 127.58 75.88 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 CA-C-N 115.774 -0.648 . . . . 0.0 109.42 176.608 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' E' E ' 88' ' ' LEU . . . . . . . . . . . . . 18.8 tp -115.69 136.41 53.09 Favored 'General case' 0 C--N 1.332 -0.192 0 CA-C-O 121.02 0.438 . . . . 0.0 111.406 -177.0 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' E' E ' 89' ' ' ASP . . . . . . . . . . . . . 42.0 t0 -134.87 160.75 37.26 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 115.777 -0.647 . . . . 0.0 109.729 176.532 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' E' E ' 90' ' ' GLU . . . . . . . . . . . . . 96.3 mt-10 -47.65 -37.6 13.15 Favored 'General case' 0 N--CA 1.463 0.179 0 N-CA-C 113.064 0.764 . . . . 0.0 113.064 -171.82 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' E' E ' 91' ' ' ASN . . . . . . . . . . . . . 5.2 p30 -132.06 23.89 4.56 Favored 'General case' 0 N--CA 1.469 0.483 0 N-CA-C 112.79 0.663 . . . . 0.0 112.79 -176.833 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' E' E ' 92' ' ' LEU . . . . . . . . . . . . . 44.5 mt -148.39 141.2 24.66 Favored 'General case' 0 C--N 1.331 -0.225 0 CA-C-O 120.823 0.344 . . . . 0.0 110.589 -178.556 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' E' E ' 93' ' ' ILE . . . . . . . . . . . . . 72.1 mt -123.7 114.27 40.79 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.362 0 N-CA-C 109.098 -0.705 . . . . 0.0 109.098 176.288 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' E' E ' 94' ' ' VAL . . . . . . . . . . . . . 43.7 t -116.55 127.02 74.28 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.236 0 N-CA-C 109.823 -0.436 . . . . 0.0 109.823 -178.741 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' E' E ' 95' ' ' VAL . . . . . . . . . . . . . 43.9 t -123.21 135.02 64.55 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 CA-C-N 116.217 -0.447 . . . . 0.0 109.934 -179.059 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' E' E ' 96' ' ' ILE . . . . . . . . . . . . . 65.2 mt -115.31 127.4 72.9 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.351 0 N-CA-C 109.391 -0.596 . . . . 0.0 109.391 178.506 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' E' E ' 97' ' ' THR . . . . . . . . . . . . . 66.7 p -101.8 157.29 16.95 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-O 121.05 0.452 . . . . 0.0 111.077 -177.852 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' E' E ' 98' ' ' GLU . . . . . . . . . . . . . 12.8 pt-20 -55.63 -21.7 19.1 Favored 'General case' 0 CA--C 1.533 0.314 0 N-CA-C 112.669 0.618 . . . . 0.0 112.669 -179.42 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' E' E ' 99' ' ' GLU . . . . . . . . . . . . . 48.4 mp0 -78.74 14.29 1.38 Allowed 'General case' 0 CA--C 1.537 0.463 0 N-CA-C 113.04 0.755 . . . . 0.0 113.04 -179.68 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' E' E ' 100' ' ' ASN . . . . . . . . . . . . . 3.0 m-20 62.76 37.88 12.2 Favored 'General case' 0 C--O 1.233 0.201 0 CA-C-O 121.068 0.461 . . . . 0.0 110.949 178.24 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' E' E ' 101' ' ' GLU . . . . . . . . . . . . . 84.9 tt0 -118.99 141.69 48.45 Favored 'General case' 0 C--N 1.332 -0.164 0 CA-C-N 116.014 -0.539 . . . . 0.0 109.895 177.223 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' E' E ' 102' ' ' VAL . . . . . . . . . . . . . 46.5 t -114.93 127.47 72.46 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.293 0 CA-C-N 116.324 -0.398 . . . . 0.0 110.041 -178.68 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' E' E ' 103' ' ' LEU . . . . . . . . . . . . . 25.7 mt -117.08 132.54 56.66 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 115.561 -0.745 . . . . 0.0 110.503 177.82 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' E' E ' 104' ' ' ILE . . . . . . . . . . . . . 65.9 mt -119.53 122.16 68.17 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.237 0 N-CA-C 110.22 -0.289 . . . . 0.0 110.22 178.782 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' E' E ' 105' ' ' PHE . . . . . . . . . . . . . 47.2 m-85 -122.26 162.3 21.71 Favored 'General case' 0 C--N 1.333 -0.146 0 O-C-N 124.005 0.815 . . . . 0.0 109.981 177.748 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' E' E ' 106' ' ' ASN . . . . . . . . . . . . . 41.4 p-10 -97.03 -169.93 1.95 Allowed 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.606 -0.27 . . . . 0.0 110.499 175.554 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' E' E ' 107' ' ' GLN . . . . . . . . . . . . . 46.4 tt0 -56.15 -30.2 61.83 Favored 'General case' 0 CA--C 1.531 0.247 0 N-CA-C 112.05 0.389 . . . . 0.0 112.05 -179.516 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' E' E ' 108' ' ' ASN . . . . . . . . . . . . . 30.6 t30 -90.79 12.9 17.82 Favored 'General case' 0 CA--C 1.535 0.373 0 N-CA-C 113.41 0.893 . . . . 0.0 113.41 -175.356 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' E' E ' 109' ' ' LEU . . . . . . . . . . . . . 11.3 tp 58.8 38.92 24.61 Favored 'General case' 0 C--N 1.331 -0.212 0 CA-C-O 121.168 0.508 . . . . 0.0 111.103 178.552 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' E' E ' 110' ' ' GLU . . . . . . . . . . . . . 96.0 mt-10 -102.64 151.93 21.78 Favored 'General case' 0 C--N 1.329 -0.292 0 N-CA-C 109.788 -0.449 . . . . 0.0 109.788 175.419 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' E' E ' 111' ' ' GLU . . . . . . . . . . . . . 85.1 tt0 -81.68 121.98 27.05 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-O 120.922 0.391 . . . . 0.0 110.507 -178.872 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' E' E ' 112' ' ' LEU . . . . . . . . . . . . . 17.5 mt -110.04 -45.98 3.53 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 115.962 -0.563 . . . . 0.0 110.518 179.185 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' E' E ' 113' ' ' TYR . . . . . . . . . . . . . 58.7 t80 -140.72 136.87 33.02 Favored 'General case' 0 C--N 1.331 -0.227 0 C-N-CA 120.771 -0.372 . . . . 0.0 111.398 -179.06 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' E' E ' 114' ' ' ARG . . . . . . . . . . . . . 22.0 ttm180 -135.69 124.77 24.36 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 115.958 -0.564 . . . . 0.0 109.721 174.979 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' E' E ' 115' ' ' GLY . . . . . . . . . . . . . . . -149.38 148.79 20.48 Favored Glycine 0 CA--C 1.525 0.701 0 N-CA-C 111.12 -0.792 . . . . 0.0 111.12 178.758 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' E' E ' 116' ' ' LYS . . . . . . . . . . . . . 40.3 ttpt -119.86 136.85 54.33 Favored 'General case' 0 C--N 1.33 -0.266 0 N-CA-C 110.096 -0.335 . . . . 0.0 110.096 179.172 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' E' E ' 117' ' ' PHE . . . . . . . . . . . . . 46.1 m-85 -134.49 116.11 14.72 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-N 116.302 -0.408 . . . . 0.0 110.229 -177.148 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' E' E ' 118' ' ' GLU . . . . . . . . . . . . . 84.8 tt0 -53.64 -45.07 70.07 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 116.597 -0.274 . . . . 0.0 111.515 -177.252 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' E' E ' 119' ' ' ASN . . . . . . . . . . . . . 4.2 m-80 -99.27 31.12 3.2 Favored 'General case' 0 C--N 1.33 -0.263 0 N-CA-C 112.156 0.428 . . . . 0.0 112.156 -175.225 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' E' E ' 120' ' ' LEU . . . . . . . . . . . . . 15.0 tp -55.22 120.69 7.42 Favored 'General case' 0 C--N 1.333 -0.151 0 O-C-N 122.308 -0.245 . . . . 0.0 110.694 178.465 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' E' E ' 121' ' ' ASN . . . . . . . . . . . . . 72.1 m-20 -108.82 -44.05 4.1 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.478 -0.328 . . . . 0.0 111.084 -176.728 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' E' E ' 122' ' ' LYS . . . . . . . . . . . . . 57.2 pttt -162.4 160.21 26.14 Favored 'General case' 0 CA--C 1.529 0.143 0 C-N-CA 120.43 -0.508 . . . . 0.0 112.064 -178.59 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' E' E ' 123' ' ' VAL . . . . . . . . . . . . . 42.1 t -129.08 137.87 55.99 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.201 0 CA-C-N 115.947 -0.57 . . . . 0.0 109.86 179.011 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' E' E ' 124' ' ' LEU . . . . . . . . . . . . . 80.9 mt -124.94 140.35 53.0 Favored 'General case' 0 C--N 1.332 -0.189 0 CA-C-O 120.87 0.367 . . . . 0.0 110.794 -179.007 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' E' E ' 125' ' ' VAL . . . . . . . . . . . . . 46.5 t -127.55 133.95 66.66 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.234 0 CA-C-N 116.105 -0.498 . . . . 0.0 109.822 178.118 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' E' E ' 126' ' ' ARG . . . . . . . . . . . . . 49.3 ttt85 -138.57 113.76 9.43 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-O 120.884 0.374 . . . . 0.0 110.28 -179.647 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' E' E ' 127' ' ' ASN . . . . . . . . . . . . . 12.1 m120 53.04 -104.82 0.21 Allowed 'General case' 0 CA--C 1.543 0.68 0 CA-C-O 119.2 -0.429 . . . . 0.0 111.196 179.513 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' E' E ' 128' ' ' ASP . . . . . . . . . . . . . 13.5 p-10 -113.57 0.78 14.76 Favored 'General case' 0 N--CA 1.467 0.422 0 CA-C-N 119.447 1.021 . . . . 0.0 113.549 -176.108 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' E' E ' 129' ' ' LEU . . . . . . . . . . . . . 71.4 mt -108.18 147.36 31.43 Favored 'General case' 0 C--N 1.332 -0.174 0 O-C-N 121.952 -0.467 . . . . 0.0 110.061 179.454 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' E' E ' 130' ' ' VAL . . . . . . . . . . . . . 12.4 p -129.42 140.05 50.15 Favored 'Isoleucine or valine' 0 C--O 1.233 0.22 0 CA-C-O 120.981 0.42 . . . . 0.0 110.595 -178.831 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' E' E ' 131' ' ' VAL . . . . . . . . . . . . . 40.7 t -135.94 139.28 46.25 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.25 0 CA-C-N 115.953 -0.567 . . . . 0.0 110.425 -178.506 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' E' E ' 132' ' ' ILE . . . . . . . . . . . . . 73.2 mt -114.09 133.51 59.88 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 N-CA-C 109.406 -0.59 . . . . 0.0 109.406 178.838 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' E' E ' 133' ' ' ILE . . . . . . . . . . . . . 43.3 mm -115.34 123.3 70.75 Favored 'Isoleucine or valine' 0 C--O 1.234 0.251 0 CA-C-O 120.936 0.398 . . . . 0.0 111.113 -174.36 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' E' E ' 134' ' ' ASP . . . . . . . . . . . . . 9.5 p-10 -136.18 147.41 47.66 Favored 'General case' 0 C--N 1.331 -0.224 0 N-CA-C 109.337 -0.616 . . . . 0.0 109.337 173.666 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' E' E ' 135' ' ' GLU . . . . . . . . . . . . . 43.3 tp10 -51.33 -28.06 11.28 Favored 'General case' 0 C--N 1.327 -0.408 0 N-CA-C 112.641 0.608 . . . . 0.0 112.641 -172.893 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' E' E ' 136' ' ' GLN . . . . . . . . . . . . . 97.6 mt-30 -80.48 -31.62 37.28 Favored 'General case' 0 C--N 1.33 -0.239 0 N-CA-C 112.629 0.603 . . . . 0.0 112.629 -176.63 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' E' E ' 137' ' ' LYS . . . . . . . . . . . . . 17.6 ptpt -170.08 175.26 5.1 Favored 'General case' 0 C--N 1.331 -0.227 0 CA-C-O 121.526 0.679 . . . . 0.0 112.374 -171.669 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' E' E ' 138' ' ' LEU . . . . . . . . . . . . . 7.8 tt -123.16 130.16 52.39 Favored 'General case' 0 C--N 1.331 -0.199 0 CA-C-N 115.145 -0.934 . . . . 0.0 110.23 -179.524 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' E' E ' 139' ' ' THR . . . . . . . . . . . . . 35.1 m -107.26 125.88 51.71 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.245 -0.434 . . . . 0.0 110.442 179.518 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' E' E ' 140' ' ' LEU . . . . . . . . . . . . . 19.0 tp -113.84 121.37 43.81 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 115.788 -0.642 . . . . 0.0 109.555 -177.594 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' E' E ' 141' ' ' ILE . . . . . . . . . . . . . 19.3 mt -122.01 119.9 59.89 Favored 'Isoleucine or valine' 0 C--O 1.235 0.296 0 CA-C-O 120.974 0.416 . . . . 0.0 110.081 -177.229 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' E' E ' 142' ' ' ARG . . . . . . . . . . . . . 78.0 mtp180 -103.9 123.85 47.88 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 115.264 -0.88 . . . . 0.0 110.382 179.644 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' E' E ' 143' ' ' THR . . . . . . . . . . . . . 37.3 p . . . . . 0 C--O 1.22 -0.456 0 CA-C-O 118.028 -0.987 . . . . 0.0 110.648 -179.989 . . . . . . . . 0 0 . 1 . 012 nuclear orig core ' F' F ' 1' ' ' MET . . . . . . . . . . . . . 25.6 ptp . . . . . 0 C--O 1.233 0.203 0 CA-C-O 120.803 0.335 . . . . 0.0 111.006 . . . . . . . . . 0 0 . 1 . 012 nuclear orig core ' F' F ' 2' ' ' SER . . . . . . . . . . . . . 11.8 p -111.89 135.46 52.48 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.135 -0.484 . . . . 0.0 110.403 178.676 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' F' F ' 3' ' ' GLU . . . . . . . . . . . . . 95.5 mt-10 -140.81 141.87 34.7 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.117 -0.492 . . . . 0.0 110.982 -177.817 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' F' F ' 4' ' ' LEU . . . . . . . . . . . . . 28.6 tp -128.42 128.62 44.8 Favored 'General case' 0 C--N 1.331 -0.22 0 CA-C-N 115.928 -0.578 . . . . 0.0 110.22 176.869 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' F' F ' 5' ' ' LYS . . . . . . . . . . . . . 99.0 mttt -108.16 121.61 45.21 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-O 120.954 0.407 . . . . 0.0 110.538 178.376 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' F' F ' 6' ' ' LEU . . . . . . . . . . . . . 70.3 mt -116.41 148.49 40.63 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 115.364 -0.835 . . . . 0.0 110.483 -179.122 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' F' F ' 7' ' ' LYS . . . . . . . . . . . . . 78.0 tttt -139.57 139.02 21.11 Favored Pre-proline 0 CA--C 1.533 0.305 0 CA-C-O 119.086 -0.483 . . . . 0.0 109.924 175.894 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' F' F ' 8' ' ' PRO . . . . . . . . . . . . . 93.5 Cg_endo -91.41 145.11 3.3 Favored 'Trans proline' 0 N--CA 1.491 1.34 0 C-N-CA 121.724 1.616 . . . . 0.0 111.944 178.414 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' F' F ' 9' ' ' LEU . . . . . . . . . . . . . 64.4 mt -80.89 -47.67 1.15 Allowed Pre-proline 0 CA--C 1.534 0.331 0 CA-C-O 118.671 -0.68 . . . . 0.0 112.078 179.805 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' F' F ' 10' ' ' PRO . . . . . . . . . . . . . 88.5 Cg_endo -80.81 145.24 15.84 Favored 'Trans proline' 0 N--CA 1.497 1.686 0 C-N-CA 121.104 1.203 . . . . 0.0 111.555 175.995 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' F' F ' 11' ' ' LYS . . . . . . . . . . . . . 39.0 pttt -78.56 111.33 14.51 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-O 121.563 0.697 . . . . 0.0 110.382 177.873 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' F' F ' 12' ' ' VAL . . . . . . . . . . . . . 11.7 p -151.02 144.83 16.76 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.351 0 CA-C-N 115.629 -0.714 . . . . 0.0 110.512 -178.292 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' F' F ' 13' ' ' GLU . . . . . . . . . . . . . 40.1 mt-10 -86.25 124.55 32.75 Favored 'General case' 0 C--N 1.33 -0.26 0 N-CA-C 109.965 -0.383 . . . . 0.0 109.965 177.015 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' F' F ' 14' ' ' LEU . . . . . . . . . . . . . 19.3 mt -96.76 148.05 33.85 Favored Pre-proline 0 C--N 1.33 -0.273 0 CA-C-O 119.184 -0.436 . . . . 0.0 110.072 -179.263 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' F' F ' 15' ' ' PRO . . . . . . . . . . . . . 28.3 Cg_exo -60.54 159.13 28.99 Favored 'Trans proline' 0 N--CA 1.497 1.705 0 C-N-CA 121.28 1.32 . . . . 0.0 111.439 177.318 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' F' F ' 16' ' ' PRO . . . . . . . . . . . . . 38.7 Cg_exo -58.49 -35.95 98.04 Favored 'Trans proline' 0 N--CA 1.496 1.668 0 C-N-CA 121.418 1.412 . . . . 0.0 112.639 -178.617 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' F' F ' 17' ' ' ASP . . . . . . . . . . . . . 7.3 p-10 -91.66 11.55 24.06 Favored 'General case' 0 CA--C 1.535 0.396 0 N-CA-C 113.152 0.797 . . . . 0.0 113.152 -177.637 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' F' F ' 18' ' ' PHE . . . . . . . . . . . . . 52.2 t80 -58.29 -45.47 87.89 Favored 'General case' 0 C--N 1.333 -0.112 0 O-C-N 122.02 -0.425 . . . . 0.0 110.075 -177.67 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' F' F ' 19' ' ' VAL . . . . . . . . . . . . . 13.7 p -55.89 -40.99 65.21 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 CA-C-N 116.114 -0.494 . . . . 0.0 110.904 -179.125 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' F' F ' 20' ' ' ASP . . . . . . . . . . . . . 80.7 m-20 -61.22 -42.84 99.29 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-O 120.818 0.342 . . . . 0.0 110.975 -178.558 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' F' F ' 21' ' ' VAL . . . . . . . . . . . . . 48.1 t -63.84 -46.07 95.32 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.291 0 C-N-CA 120.759 -0.376 . . . . 0.0 110.318 -178.03 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' F' F ' 22' ' ' ILE . . . . . . . . . . . . . 49.2 mm -56.58 -46.02 82.47 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.258 0 C-N-CA 120.948 -0.301 . . . . 0.0 110.622 178.917 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' F' F ' 23' ' ' ARG . . . . . . . . . . . . . 25.8 ttp180 -54.33 -49.43 69.75 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-O 120.594 0.235 . . . . 0.0 111.418 -178.843 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' F' F ' 24' ' ' ILE . . . . . . . . . . . . . 77.1 mt -59.71 -44.07 92.87 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.368 0 CA-C-N 116.629 -0.259 . . . . 0.0 111.291 -177.194 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' F' F ' 25' ' ' LYS . . . . . . . . . . . . . 62.8 mttm -66.18 -38.18 87.41 Favored 'General case' 0 C--N 1.327 -0.371 0 N-CA-C 112.28 0.474 . . . . 0.0 112.28 -178.455 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' F' F ' 26' ' ' LEU . . . . . . . . . . . . . 58.2 mt -79.13 -40.52 30.8 Favored 'General case' 0 C--N 1.33 -0.241 0 N-CA-C 113.349 0.87 . . . . 0.0 113.349 -172.446 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' F' F ' 27' ' ' GLN . . . . . . . . . . . . . 11.2 pt20 -47.1 141.49 4.28 Favored 'General case' 0 N--CA 1.47 0.534 0 N-CA-C 112.726 0.639 . . . . 0.0 112.726 -174.359 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' F' F ' 28' ' ' GLY . . . . . . . . . . . . . . . 96.91 -25.76 25.39 Favored Glycine 0 CA--C 1.534 1.227 0 CA-C-N 115.626 -0.715 . . . . 0.0 112.1 -176.638 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' F' F ' 29' ' ' LYS . . . . . . . . . . . . . 59.1 mtpt -98.33 155.1 17.37 Favored 'General case' 0 C--O 1.233 0.217 0 CA-C-N 117.275 0.538 . . . . 0.0 111.002 179.284 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' F' F ' 30' ' ' THR . . . . . . . . . . . . . 31.4 m -111.45 139.27 47.0 Favored 'General case' 0 C--N 1.331 -0.217 0 CA-C-N 116.093 -0.503 . . . . 0.0 110.217 175.743 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' F' F ' 31' ' ' VAL . . . . . . . . . . . . . 35.2 m -134.37 164.43 34.26 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.225 0 CA-C-O 120.796 0.331 . . . . 0.0 110.981 -179.22 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' F' F ' 32' ' ' ARG . . . . . . . . . . . . . 77.9 mtp180 -131.3 153.97 49.01 Favored 'General case' 0 C--N 1.331 -0.223 0 CA-C-O 121.227 0.537 . . . . 0.0 110.735 177.908 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' F' F ' 33' ' ' THR . . . . . . . . . . . . . 32.3 m -53.78 140.94 28.41 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.221 -0.445 . . . . 0.0 111.222 -179.603 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' F' F ' 34' ' ' GLY . . . . . . . . . . . . . . . 99.9 -17.13 57.72 Favored Glycine 0 CA--C 1.531 1.068 0 C-N-CA 121.211 -0.519 . . . . 0.0 113.26 179.371 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' F' F ' 35' ' ' ASP . . . . . . . . . . . . . 65.6 m-20 -65.23 149.34 50.1 Favored 'General case' 0 C--O 1.231 0.121 0 CA-C-N 118.089 0.945 . . . . 0.0 111.188 179.044 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' F' F ' 36' ' ' VAL . . . . . . . . . . . . . 46.4 t -122.71 130.16 74.69 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.256 0 CA-C-N 115.78 -0.645 . . . . 0.0 109.867 178.909 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' F' F ' 37' ' ' ILE . . . . . . . . . . . . . 69.7 mt -122.07 139.47 48.95 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.234 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.044 -179.524 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' F' F ' 38' ' ' GLY . . . . . . . . . . . . . . . -113.86 129.17 8.64 Favored Glycine 0 CA--C 1.525 0.703 0 N-CA-C 111.115 -0.794 . . . . 0.0 111.115 -179.933 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' F' F ' 39' ' ' ILE . . . . . . . . . . . . . 67.7 mt -120.0 133.73 65.79 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.216 0 N-CA-C 110.084 -0.339 . . . . 0.0 110.084 178.964 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' F' F ' 40' ' ' SER . . . . . . . . . . . . . 53.6 p -93.4 120.04 33.21 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.343 -0.389 . . . . 0.0 110.844 175.399 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' F' F ' 41' ' ' ILE . . . . . . . . . . . . . 68.9 mt -129.81 122.55 54.94 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.179 0 CA-C-O 120.787 0.327 . . . . 0.0 110.462 177.903 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' F' F ' 42' ' ' LEU . . . . . . . . . . . . . 8.9 tp 52.23 35.11 16.0 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-N 116.131 -0.486 . . . . 0.0 111.628 177.308 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' F' F ' 43' ' ' GLY . . . . . . . . . . . . . . . 72.07 32.32 63.32 Favored Glycine 0 CA--C 1.529 0.952 0 C-N-CA 121.05 -0.595 . . . . 0.0 111.907 178.253 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' F' F ' 44' ' ' LYS . . . . . . . . . . . . . 54.4 tttp -137.94 128.79 27.02 Favored 'General case' 0 C--N 1.329 -0.296 0 N-CA-C 109.668 -0.493 . . . . 0.0 109.668 179.259 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' F' F ' 45' ' ' GLU . . . . . . . . . . . . . 84.6 tt0 -84.23 124.68 31.46 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-O 120.878 0.37 . . . . 0.0 111.298 -178.215 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' F' F ' 46' ' ' VAL . . . . . . . . . . . . . 7.1 p -121.0 127.74 75.99 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.209 0 N-CA-C 109.299 -0.63 . . . . 0.0 109.299 174.261 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' F' F ' 47' ' ' LYS . . . . . . . . . . . . . 93.1 mttt -99.98 127.24 46.21 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.062 -0.517 . . . . 0.0 111.006 179.583 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' F' F ' 48' ' ' PHE . . . . . . . . . . . . . 94.0 m-85 -111.07 131.96 54.65 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.305 -0.407 . . . . 0.0 109.951 175.961 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' F' F ' 49' ' ' LYS . . . . . . . . . . . . . 84.0 tttt -107.24 135.5 48.65 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.281 -0.418 . . . . 0.0 110.218 179.457 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' F' F ' 50' ' ' VAL . . . . . . . . . . . . . 46.4 t -79.38 108.02 12.47 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.295 0 N-CA-C 109.22 -0.659 . . . . 0.0 109.22 176.541 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' F' F ' 51' ' ' VAL . . . . . . . . . . . . . 47.8 t -70.9 -48.11 58.54 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.267 0 CA-C-N 115.991 -0.549 . . . . 0.0 109.974 -173.768 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' F' F ' 52' ' ' GLN . . . . . . . . . . . . . 63.2 tt0 -163.67 140.08 6.83 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.05 -0.523 . . . . 0.0 111.553 -178.233 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' F' F ' 53' ' ' ALA . . . . . . . . . . . . . . . -111.9 130.49 55.81 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-N 115.565 -0.743 . . . . 0.0 109.54 174.137 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' F' F ' 54' ' ' TYR . . . . . . . . . . . . . 41.8 t80 -129.06 110.16 18.24 Favored Pre-proline 0 C--N 1.327 -0.38 0 CA-C-O 118.358 -0.829 . . . . 0.0 110.484 -179.3 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' F' F ' 55' ' ' PRO . . . . . . . . . . . . . 73.8 Cg_endo -76.99 169.69 73.74 Favored 'Cis proline' 0 N--CA 1.498 1.783 0 CA-C-N 121.906 1.716 . . . . 0.0 112.296 -4.343 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' F' F ' 56' ' ' SER . . . . . . . . . . . . . 13.7 m -113.45 128.03 26.16 Favored Pre-proline 0 CA--C 1.539 0.553 0 CA-C-O 118.448 -0.787 . . . . 0.0 109.383 176.706 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' F' F ' 57' ' ' PRO . . . . . . . . . . . . . 38.5 Cg_endo -66.96 165.35 67.11 Favored 'Cis proline' 0 N--CA 1.497 1.693 0 CA-C-N 121.924 1.723 . . . . 0.0 111.463 0.388 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' F' F ' 58' ' ' LEU . . . . . . . . . . . . . 27.7 tp -129.26 135.76 49.2 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-O 120.934 0.397 . . . . 0.0 110.612 -179.31 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' F' F ' 59' ' ' ARG . . . . . . . . . . . . . 40.6 ttm180 -106.56 137.21 44.98 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-N 115.897 -0.592 . . . . 0.0 109.569 176.309 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' F' F ' 60' ' ' VAL . . . . . . . . . . . . . 44.2 t -91.0 122.7 42.66 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 C-N-CA 120.601 -0.44 . . . . 0.0 110.272 -178.178 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' F' F ' 61' ' ' GLU . . . . . . . . . . . . . 70.6 mm-40 -131.09 167.76 18.57 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 115.938 -0.574 . . . . 0.0 110.006 177.208 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' F' F ' 62' ' ' ASP . . . . . . . . . . . . . 75.1 m-20 -54.68 -32.95 60.16 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-N 116.58 -0.282 . . . . 0.0 111.748 -178.715 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' F' F ' 63' ' ' ARG . . . . . . . . . . . . . 7.0 ptp180 -89.45 8.55 30.36 Favored 'General case' 0 CA--C 1.536 0.413 0 N-CA-C 113.527 0.936 . . . . 0.0 113.527 -175.499 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' F' F ' 64' ' ' THR . . . . . . . . . . . . . 30.3 m -85.2 137.77 32.79 Favored 'General case' 0 C--O 1.232 0.155 0 CA-C-N 118.115 0.416 . . . . 0.0 110.343 -178.644 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' F' F ' 65' ' ' LYS . . . . . . . . . . . . . 97.3 mttt -88.58 125.94 35.03 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-N 116.27 -0.423 . . . . 0.0 110.041 -179.899 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' F' F ' 66' ' ' ILE . . . . . . . . . . . . . 64.9 mt -115.24 128.77 72.3 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.279 0 N-CA-C 109.812 -0.44 . . . . 0.0 109.812 -179.825 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' F' F ' 67' ' ' THR . . . . . . . . . . . . . 18.6 m -124.65 138.7 54.29 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.74 -177.726 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' F' F ' 68' ' ' LEU . . . . . . . . . . . . . 7.1 mp . . . . . 0 C--N 1.329 -0.288 0 CA-C-N 115.895 -0.593 . . . . 0.0 110.226 177.218 . . . . . . . . 0 0 . 1 . 012 nuclear orig core ' F' F ' 73' ' ' VAL . . . . . . . . . . . . . 27.5 m . . . . . 0 C--O 1.232 0.172 0 CA-C-O 121.248 0.547 . . . . 0.0 111.079 . . . . . . . . . 0 0 . 1 . 012 nuclear orig core ' F' F ' 74' ' ' ASP . . . . . . . . . . . . . 33.5 t0 -96.61 119.83 35.81 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 115.477 -0.783 . . . . 0.0 109.236 176.583 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' F' F ' 75' ' ' VAL . . . . . . . . . . . . . 42.0 t -109.6 123.15 65.25 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.247 0 CA-C-O 121.178 0.514 . . . . 0.0 110.521 -176.73 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' F' F ' 76' ' ' LEU . . . . . . . . . . . . . 23.8 mt -128.9 141.27 51.33 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 115.485 -0.78 . . . . 0.0 109.281 177.508 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' F' F ' 77' ' ' GLU . . . . . . . . . . . . . 45.7 tt0 -136.76 133.07 35.62 Favored 'General case' 0 C--N 1.331 -0.225 0 C-N-CA 120.736 -0.386 . . . . 0.0 110.978 -176.354 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' F' F ' 78' ' ' ALA . . . . . . . . . . . . . . . -120.6 135.55 55.07 Favored 'General case' 0 C--N 1.332 -0.177 0 CA-C-N 116.259 -0.428 . . . . 0.0 110.281 179.796 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' F' F ' 79' ' ' LYS . . . . . . . . . . . . . 87.1 mttt -79.49 120.87 24.48 Favored 'General case' 0 C--N 1.331 -0.209 0 CA-C-O 120.853 0.359 . . . . 0.0 110.787 -179.242 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' F' F ' 80' ' ' ILE . . . . . . . . . . . . . 37.2 mm -139.14 108.16 3.65 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.314 0 N-CA-C 108.869 -0.789 . . . . 0.0 108.869 -177.78 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' F' F ' 81' ' ' LYS . . . . . . . . . . . . . 79.5 tttt -99.96 125.79 46.02 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-O 120.837 0.351 . . . . 0.0 111.43 -174.834 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' F' F ' 82' ' ' GLY . . . . . . . . . . . . . . . 89.05 42.14 5.7 Favored Glycine 0 CA--C 1.525 0.683 0 C-N-CA 120.956 -0.64 . . . . 0.0 111.617 174.417 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' F' F ' 83' ' ' ILE . . . . . . . . . . . . . 68.5 mt -68.83 138.23 22.78 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.29 0 CA-C-O 120.921 0.391 . . . . 0.0 110.019 179.695 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' F' F ' 84' ' ' LYS . . . . . . . . . . . . . 38.2 tttp -99.91 -53.12 3.25 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 115.924 -0.58 . . . . 0.0 110.158 -179.475 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' F' F ' 85' ' ' ASP . . . . . . . . . . . . . 11.1 t0 -151.85 148.31 27.66 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 115.748 -0.66 . . . . 0.0 110.241 179.72 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' F' F ' 86' ' ' VAL . . . . . . . . . . . . . 45.3 t -125.94 130.24 72.33 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.191 0 CA-C-O 120.898 0.38 . . . . 0.0 110.308 -179.309 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' F' F ' 87' ' ' ILE . . . . . . . . . . . . . 46.2 mm -121.75 130.21 74.8 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.246 0 CA-C-N 115.926 -0.579 . . . . 0.0 109.948 177.365 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' F' F ' 88' ' ' LEU . . . . . . . . . . . . . 58.5 mt -108.17 137.25 46.47 Favored 'General case' 0 C--N 1.332 -0.194 0 CA-C-O 121.04 0.448 . . . . 0.0 111.361 -177.966 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' F' F ' 89' ' ' ASP . . . . . . . . . . . . . 13.8 t70 -126.58 153.14 45.67 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 115.653 -0.703 . . . . 0.0 109.489 176.695 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' F' F ' 90' ' ' GLU . . . . . . . . . . . . . 84.8 tt0 -47.54 -36.12 10.0 Favored 'General case' 0 C--N 1.329 -0.288 0 N-CA-C 112.851 0.686 . . . . 0.0 112.851 -172.259 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' F' F ' 91' ' ' ASN . . . . . . . . . . . . . 16.9 t30 -131.96 19.99 4.55 Favored 'General case' 0 N--CA 1.468 0.435 0 N-CA-C 112.995 0.739 . . . . 0.0 112.995 -178.411 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' F' F ' 92' ' ' LEU . . . . . . . . . . . . . 35.7 mt -150.28 152.83 35.12 Favored 'General case' 0 C--N 1.331 -0.209 0 CA-C-O 120.824 0.345 . . . . 0.0 110.513 -177.114 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' F' F ' 93' ' ' ILE . . . . . . . . . . . . . 71.9 mt -126.77 121.27 57.99 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.379 0 N-CA-C 109.319 -0.623 . . . . 0.0 109.319 177.206 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' F' F ' 94' ' ' VAL . . . . . . . . . . . . . 45.4 t -117.47 125.83 74.27 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.268 0 N-CA-C 109.829 -0.434 . . . . 0.0 109.829 -178.907 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' F' F ' 95' ' ' VAL . . . . . . . . . . . . . 46.1 t -122.16 133.03 69.72 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.291 0 CA-C-N 116.071 -0.513 . . . . 0.0 109.919 -179.468 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' F' F ' 96' ' ' ILE . . . . . . . . . . . . . 57.4 mt -114.77 127.77 72.15 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.323 0 N-CA-C 109.141 -0.689 . . . . 0.0 109.141 178.473 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' F' F ' 97' ' ' THR . . . . . . . . . . . . . 74.0 p -99.33 159.34 15.08 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-O 121.139 0.495 . . . . 0.0 111.423 -177.303 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' F' F ' 98' ' ' GLU . . . . . . . . . . . . . 12.6 pt-20 -54.69 -28.02 44.62 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.091 -0.504 . . . . 0.0 112.263 -179.135 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' F' F ' 99' ' ' GLU . . . . . . . . . . . . . 70.9 mm-40 -80.28 14.39 1.97 Allowed 'General case' 0 CA--C 1.535 0.397 0 N-CA-C 113.084 0.772 . . . . 0.0 113.084 -177.684 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' F' F ' 100' ' ' ASN . . . . . . . . . . . . . 5.3 m-20 62.09 35.25 15.91 Favored 'General case' 0 C--N 1.332 -0.164 0 CA-C-O 120.96 0.41 . . . . 0.0 111.354 179.56 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' F' F ' 101' ' ' GLU . . . . . . . . . . . . . 84.5 tt0 -106.61 143.0 35.35 Favored 'General case' 0 C--N 1.333 -0.145 0 N-CA-C 109.513 -0.551 . . . . 0.0 109.513 172.008 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' F' F ' 102' ' ' VAL . . . . . . . . . . . . . 43.2 t -115.02 125.45 72.34 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.311 0 N-CA-C 109.823 -0.436 . . . . 0.0 109.823 -177.867 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' F' F ' 103' ' ' LEU . . . . . . . . . . . . . 42.5 mt -116.81 129.13 55.9 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 115.762 -0.654 . . . . 0.0 110.17 177.508 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' F' F ' 104' ' ' ILE . . . . . . . . . . . . . 70.3 mt -118.36 119.43 61.24 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.261 0 N-CA-C 110.118 -0.327 . . . . 0.0 110.118 179.187 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' F' F ' 105' ' ' PHE . . . . . . . . . . . . . 65.8 m-85 -119.81 166.32 13.42 Favored 'General case' 0 C--N 1.331 -0.202 0 O-C-N 124.169 0.918 . . . . 0.0 109.591 178.858 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' F' F ' 106' ' ' ASN . . . . . . . . . . . . . 43.6 p-10 -99.3 -170.91 1.98 Allowed 'General case' 0 C--N 1.329 -0.284 0 N-CA-C 109.756 -0.461 . . . . 0.0 109.756 171.834 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' F' F ' 107' ' ' GLN . . . . . . . . . . . . . 43.0 tp60 -57.82 -27.91 63.58 Favored 'General case' 0 CA--C 1.533 0.323 0 N-CA-C 112.005 0.372 . . . . 0.0 112.005 -179.815 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' F' F ' 108' ' ' ASN . . . . . . . . . . . . . 23.5 t30 -90.47 13.85 14.6 Favored 'General case' 0 CA--C 1.534 0.336 0 N-CA-C 113.067 0.766 . . . . 0.0 113.067 -175.997 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' F' F ' 109' ' ' LEU . . . . . . . . . . . . . 47.5 mt 57.95 38.0 26.85 Favored 'General case' 0 C--O 1.232 0.144 0 CA-C-O 120.975 0.416 . . . . 0.0 111.468 177.292 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' F' F ' 110' ' ' GLU . . . . . . . . . . . . . 95.7 mt-10 -102.07 155.12 18.39 Favored 'General case' 0 C--N 1.329 -0.319 0 N-CA-C 109.939 -0.393 . . . . 0.0 109.939 176.076 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' F' F ' 111' ' ' GLU . . . . . . . . . . . . . 84.9 tt0 -85.85 121.91 29.17 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-O 120.914 0.388 . . . . 0.0 110.698 -178.067 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' F' F ' 112' ' ' LEU . . . . . . . . . . . . . 32.5 mt -111.8 -45.97 3.29 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.043 -0.526 . . . . 0.0 110.414 178.297 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' F' F ' 113' ' ' TYR . . . . . . . . . . . . . 63.3 t80 -138.79 135.79 35.0 Favored 'General case' 0 C--N 1.331 -0.213 0 CA-C-N 116.43 -0.35 . . . . 0.0 111.117 179.351 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' F' F ' 114' ' ' ARG . . . . . . . . . . . . . 59.6 ttp180 -137.69 122.3 18.55 Favored 'General case' 0 C--N 1.331 -0.227 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.308 177.65 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' F' F ' 115' ' ' GLY . . . . . . . . . . . . . . . -150.08 161.1 28.79 Favored Glycine 0 CA--C 1.525 0.668 0 N-CA-C 111.053 -0.819 . . . . 0.0 111.053 177.943 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' F' F ' 116' ' ' LYS . . . . . . . . . . . . . 83.4 tttt -134.9 128.97 33.59 Favored 'General case' 0 C--N 1.33 -0.274 0 N-CA-C 109.972 -0.381 . . . . 0.0 109.972 177.703 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' F' F ' 117' ' ' PHE . . . . . . . . . . . . . 30.8 m-85 -129.03 118.85 23.23 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 116.402 -0.363 . . . . 0.0 110.047 -174.778 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' F' F ' 118' ' ' GLU . . . . . . . . . . . . . 95.9 mt-10 -55.59 -40.25 71.77 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.469 -0.332 . . . . 0.0 110.987 -177.264 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' F' F ' 119' ' ' ASN . . . . . . . . . . . . . 19.1 m120 -101.28 30.99 3.88 Favored 'General case' 0 C--N 1.33 -0.257 0 N-CA-C 112.047 0.388 . . . . 0.0 112.047 -175.022 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' F' F ' 120' ' ' LEU . . . . . . . . . . . . . 17.5 tp -58.08 124.48 19.5 Favored 'General case' 0 C--N 1.333 -0.15 0 CA-C-O 120.752 0.311 . . . . 0.0 110.221 178.781 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' F' F ' 121' ' ' ASN . . . . . . . . . . . . . 17.6 m120 -109.23 -44.19 3.99 Favored 'General case' 0 C--N 1.331 -0.222 0 CA-C-N 116.328 -0.396 . . . . 0.0 111.116 -176.962 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' F' F ' 122' ' ' LYS . . . . . . . . . . . . . 19.5 ptpt -163.65 163.15 24.42 Favored 'General case' 0 C--N 1.331 -0.199 0 CA-C-O 121.099 0.476 . . . . 0.0 111.726 -179.043 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' F' F ' 123' ' ' VAL . . . . . . . . . . . . . 42.2 t -132.95 137.15 54.38 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.251 0 CA-C-N 116.023 -0.535 . . . . 0.0 110.006 178.613 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' F' F ' 124' ' ' LEU . . . . . . . . . . . . . 80.0 mt -120.77 138.52 53.97 Favored 'General case' 0 C--N 1.331 -0.224 0 CA-C-N 116.293 -0.412 . . . . 0.0 110.535 -179.418 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' F' F ' 125' ' ' VAL . . . . . . . . . . . . . 12.0 p -133.63 130.28 56.25 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.246 0 CA-C-O 120.938 0.399 . . . . 0.0 110.785 179.641 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' F' F ' 126' ' ' ARG . . . . . . . . . . . . . 79.4 mtt85 -151.32 125.12 9.1 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 115.851 -0.613 . . . . 0.0 109.948 175.469 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' F' F ' 127' ' ' ASN . . . . . . . . . . . . . 17.3 m120 55.99 -149.32 0.46 Allowed 'General case' 0 CA--C 1.54 0.579 0 N-CA-C 109.897 -0.408 . . . . 0.0 109.897 178.99 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' F' F ' 128' ' ' ASP . . . . . . . . . . . . . 24.3 p-10 -82.17 13.08 3.67 Favored 'General case' 0 CA--C 1.537 0.446 0 N-CA-C 112.995 0.739 . . . . 0.0 112.995 -179.96 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' F' F ' 129' ' ' LEU . . . . . . . . . . . . . 19.9 tp -112.5 133.45 54.56 Favored 'General case' 0 C--O 1.232 0.182 0 CA-C-N 118.171 0.441 . . . . 0.0 110.104 179.196 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' F' F ' 130' ' ' VAL . . . . . . . . . . . . . 33.7 m -131.55 141.56 45.46 Favored 'Isoleucine or valine' 0 C--O 1.232 0.136 0 CA-C-O 120.782 0.325 . . . . 0.0 110.506 -179.651 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' F' F ' 131' ' ' VAL . . . . . . . . . . . . . 40.0 t -136.09 140.29 44.17 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.305 0 CA-C-O 120.986 0.422 . . . . 0.0 110.525 -179.104 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' F' F ' 132' ' ' ILE . . . . . . . . . . . . . 69.4 mt -115.16 133.8 60.28 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.249 0 N-CA-C 109.255 -0.646 . . . . 0.0 109.255 178.035 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' F' F ' 133' ' ' ILE . . . . . . . . . . . . . 42.7 mm -115.11 124.4 71.7 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.229 0 CA-C-N 116.568 -0.287 . . . . 0.0 110.859 -175.051 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' F' F ' 134' ' ' ASP . . . . . . . . . . . . . 7.2 p-10 -134.6 147.5 50.23 Favored 'General case' 0 C--N 1.332 -0.195 0 N-CA-C 109.605 -0.517 . . . . 0.0 109.605 174.089 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' F' F ' 135' ' ' GLU . . . . . . . . . . . . . 85.2 tt0 -50.7 -27.55 7.3 Favored 'General case' 0 C--N 1.328 -0.335 0 N-CA-C 112.822 0.675 . . . . 0.0 112.822 -173.129 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' F' F ' 136' ' ' GLN . . . . . . . . . . . . . 97.5 mt-30 -81.55 -32.47 32.2 Favored 'General case' 0 C--N 1.331 -0.239 0 N-CA-C 112.663 0.616 . . . . 0.0 112.663 -176.784 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' F' F ' 137' ' ' LYS . . . . . . . . . . . . . 53.3 pttt -169.02 173.54 6.83 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-O 121.562 0.696 . . . . 0.0 112.576 -172.458 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' F' F ' 138' ' ' LEU . . . . . . . . . . . . . 4.6 tt -117.07 129.74 56.19 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 115.113 -0.949 . . . . 0.0 109.923 179.622 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' F' F ' 139' ' ' THR . . . . . . . . . . . . . 33.2 m -112.22 124.68 52.97 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.421 -0.354 . . . . 0.0 110.199 178.917 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' F' F ' 140' ' ' LEU . . . . . . . . . . . . . 7.8 tt -113.86 125.19 53.79 Favored 'General case' 0 C--N 1.33 -0.281 0 N-CA-C 109.326 -0.62 . . . . 0.0 109.326 -178.724 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' F' F ' 141' ' ' ILE . . . . . . . . . . . . . 20.1 mt -121.98 125.32 72.97 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.272 0 CA-C-O 121.03 0.443 . . . . 0.0 110.022 -175.39 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' F' F ' 142' ' ' ARG . . . . . . . . . . . . . 39.1 tpt85 -113.8 128.04 56.25 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 115.132 -0.94 . . . . 0.0 109.944 -177.403 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' F' F ' 143' ' ' THR . . . . . . . . . . . . . 23.5 p . . . . . 0 C--O 1.22 -0.49 0 CA-C-O 117.953 -1.023 . . . . 0.0 110.516 -179.328 . . . . . . . . 0 0 . 1 . 013 nuclear orig core ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 2.6 p . . . . . 0 N--CA 1.461 0.095 0 CA-C-O 120.924 0.392 . . . . 0.0 110.711 . . . . . . . . . 0 0 . 1 . 013 nuclear orig core ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 82.8 tt0 -145.87 144.03 29.96 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.169 -0.469 . . . . 0.0 111.011 179.58 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 4' ' ' LEU . . . . . . . . . . . . . 14.8 tp -125.9 132.43 52.14 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.069 -0.514 . . . . 0.0 110.109 177.227 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 5' ' ' LYS . . . . . . . . . . . . . 68.3 mttm -109.75 122.74 48.18 Favored 'General case' 0 C--O 1.233 0.195 0 CA-C-N 116.345 -0.389 . . . . 0.0 110.823 179.941 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 31.2 mt -113.84 150.0 34.21 Favored 'General case' 0 C--N 1.331 -0.217 0 CA-C-N 115.349 -0.841 . . . . 0.0 110.196 -179.781 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 81.9 tttt -133.0 138.8 32.65 Favored Pre-proline 0 CA--C 1.534 0.332 0 CA-C-O 118.949 -0.548 . . . . 0.0 109.525 174.077 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 8' ' ' PRO . . . . . . . . . . . . . 88.5 Cg_endo -91.66 141.3 2.61 Favored 'Trans proline' 0 N--CA 1.489 1.253 0 C-N-CA 121.747 1.631 . . . . 0.0 112.16 179.741 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 62.5 mt -77.41 -47.4 2.51 Favored Pre-proline 0 CA--C 1.535 0.393 0 CA-C-O 118.69 -0.672 . . . . 0.0 112.074 178.729 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 97.8 Cg_endo -81.77 152.98 17.26 Favored 'Trans proline' 0 N--CA 1.495 1.604 0 C-N-CA 121.293 1.329 . . . . 0.0 111.995 176.088 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 46.3 tttp -88.68 98.08 11.49 Favored 'General case' 0 C--N 1.331 -0.237 0 C-N-CA 120.89 -0.324 . . . . 0.0 110.189 177.682 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 12.3 p -141.47 147.94 21.6 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.308 0 CA-C-N 116.283 -0.417 . . . . 0.0 110.673 -178.48 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 93.6 mt-10 -88.94 124.35 34.15 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.259 -0.428 . . . . 0.0 109.993 177.904 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 14' ' ' LEU . . . . . . . . . . . . . 26.2 mt -98.15 149.81 36.1 Favored Pre-proline 0 CA--C 1.534 0.335 0 CA-C-O 119.266 -0.397 . . . . 0.0 110.508 -179.25 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 15' ' ' PRO . . . . . . . . . . . . . 26.9 Cg_exo -62.06 158.55 38.52 Favored 'Trans proline' 0 N--CA 1.498 1.744 0 C-N-CA 121.282 1.322 . . . . 0.0 112.015 177.416 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 16' ' ' PRO . . . . . . . . . . . . . 32.9 Cg_exo -59.78 -35.66 93.64 Favored 'Trans proline' 0 N--CA 1.498 1.765 0 C-N-CA 121.384 1.389 . . . . 0.0 112.676 -179.739 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 17' ' ' ASP . . . . . . . . . . . . . 18.7 p-10 -86.91 8.81 21.5 Favored 'General case' 0 C--N 1.327 -0.376 0 N-CA-C 113.276 0.843 . . . . 0.0 113.276 -177.644 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 18' ' ' PHE . . . . . . . . . . . . . 37.9 t80 -58.12 -47.86 81.99 Favored 'General case' 0 N--CA 1.457 -0.081 0 O-C-N 121.963 -0.46 . . . . 0.0 110.194 -177.158 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 19' ' ' VAL . . . . . . . . . . . . . 14.8 p -55.92 -41.3 66.79 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.339 0 CA-C-N 116.359 -0.382 . . . . 0.0 111.141 -177.614 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 49.8 m-20 -60.26 -44.74 95.04 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-O 120.805 0.336 . . . . 0.0 111.045 -177.387 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 47.0 t -64.78 -48.44 84.47 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.283 0 C-N-CA 120.726 -0.39 . . . . 0.0 110.495 -177.648 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 22' ' ' ILE . . . . . . . . . . . . . 44.5 mm -56.92 -43.86 81.3 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.247 0 CA-C-O 120.777 0.322 . . . . 0.0 110.489 179.957 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 23' ' ' ARG . . . . . . . . . . . . . 32.1 ttp180 -54.58 -49.76 69.62 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.65 -0.25 . . . . 0.0 111.283 -178.637 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 24' ' ' ILE . . . . . . . . . . . . . 75.9 mt -59.41 -41.39 84.3 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.238 0 C-N-CA 120.971 -0.291 . . . . 0.0 111.148 -177.622 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 91.9 mttt -64.97 -43.47 92.56 Favored 'General case' 0 C--N 1.329 -0.295 0 N-CA-C 112.439 0.533 . . . . 0.0 112.439 -179.437 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 88.7 mt -79.75 -36.81 36.74 Favored 'General case' 0 C--N 1.331 -0.217 0 N-CA-C 113.589 0.959 . . . . 0.0 113.589 -170.541 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 27' ' ' GLN . . . . . . . . . . . . . 9.1 pt20 -47.13 142.17 3.9 Favored 'General case' 0 N--CA 1.469 0.508 0 N-CA-C 112.699 0.629 . . . . 0.0 112.699 -175.04 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 99.15 -24.99 30.02 Favored Glycine 0 CA--C 1.534 1.237 0 CA-C-N 115.591 -0.732 . . . . 0.0 112.251 -176.155 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 68.3 mttm -97.52 155.15 17.08 Favored 'General case' 0 C--O 1.232 0.177 0 CA-C-N 117.399 0.599 . . . . 0.0 111.028 178.635 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 30' ' ' THR . . . . . . . . . . . . . 30.2 m -103.25 137.68 41.06 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 115.887 -0.597 . . . . 0.0 109.933 176.13 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 35.2 m -126.33 153.52 34.89 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.248 0 CA-C-N 116.404 -0.362 . . . . 0.0 110.468 -179.4 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 32' ' ' ARG . . . . . . . . . . . . . 60.3 ttp180 -131.23 148.58 52.71 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.048 -0.524 . . . . 0.0 110.458 179.293 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 33' ' ' THR . . . . . . . . . . . . . 17.2 m -53.12 138.7 30.61 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.266 -0.425 . . . . 0.0 111.365 -177.936 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 99.91 -17.2 57.62 Favored Glycine 0 CA--C 1.532 1.155 0 CA-C-O 119.718 -0.49 . . . . 0.0 113.228 179.873 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 72.9 m-20 -66.2 151.73 46.35 Favored 'General case' 0 C--N 1.334 -0.107 0 CA-C-N 118.039 0.92 . . . . 0.0 111.288 179.404 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 45.2 t -122.73 130.46 74.47 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.198 0 CA-C-N 115.756 -0.656 . . . . 0.0 109.884 177.784 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 37' ' ' ILE . . . . . . . . . . . . . 65.3 mt -120.66 138.06 52.37 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.231 0 CA-C-N 116.18 -0.464 . . . . 0.0 109.834 -179.921 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . -116.04 128.55 8.05 Favored Glycine 0 CA--C 1.525 0.665 0 N-CA-C 110.991 -0.844 . . . . 0.0 110.991 179.582 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 39' ' ' ILE . . . . . . . . . . . . . 75.1 mt -126.82 134.28 66.59 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.226 0 CA-C-O 120.695 0.283 . . . . 0.0 110.285 179.445 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 40' ' ' SER . . . . . . . . . . . . . 53.2 p -92.39 114.61 27.2 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-N 116.225 -0.443 . . . . 0.0 110.758 175.949 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 41' ' ' ILE . . . . . . . . . . . . . 43.1 mm -120.47 117.42 53.26 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.26 0 CA-C-O 120.937 0.398 . . . . 0.0 110.601 179.545 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 1.3 tt 51.66 45.96 27.29 Favored 'General case' 0 CA--C 1.531 0.248 0 CA-C-O 121.404 0.621 . . . . 0.0 111.004 176.701 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . 70.76 21.68 78.01 Favored Glycine 0 CA--C 1.532 1.138 0 C-N-CA 121.175 -0.536 . . . . 0.0 112.851 175.523 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 44' ' ' LYS . . . . . . . . . . . . . 56.5 mttm -133.14 129.31 37.71 Favored 'General case' 0 C--N 1.332 -0.178 0 CA-C-N 117.55 0.675 . . . . 0.0 110.09 179.195 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 84.5 tt0 -83.95 123.81 30.36 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 116.552 -0.294 . . . . 0.0 111.067 -178.568 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 46' ' ' VAL . . . . . . . . . . . . . 10.4 p -121.21 124.17 71.49 Favored 'Isoleucine or valine' 0 C--O 1.233 0.194 0 N-CA-C 109.687 -0.486 . . . . 0.0 109.687 174.674 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 93.8 mttt -99.6 127.18 45.69 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.095 -0.502 . . . . 0.0 110.783 177.702 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 48' ' ' PHE . . . . . . . . . . . . . 35.8 m-85 -110.81 131.95 54.61 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 115.855 -0.612 . . . . 0.0 109.666 177.593 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 84.2 tttt -106.52 135.78 47.44 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.246 -0.434 . . . . 0.0 110.215 179.058 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 50' ' ' VAL . . . . . . . . . . . . . 45.1 t -79.21 105.33 8.38 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.317 0 N-CA-C 109.549 -0.537 . . . . 0.0 109.549 177.622 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 51' ' ' VAL . . . . . . . . . . . . . 50.5 t -70.14 -54.32 19.33 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.366 0 N-CA-C 109.36 -0.607 . . . . 0.0 109.36 -176.347 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 52' ' ' GLN . . . . . . . . . . . . . 91.7 mt-30 -153.52 154.35 34.16 Favored 'General case' 0 C--N 1.331 -0.22 0 CA-C-N 115.913 -0.585 . . . . 0.0 111.595 -178.864 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -129.35 134.34 47.85 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 115.148 -0.933 . . . . 0.0 109.779 175.984 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 54' ' ' TYR . . . . . . . . . . . . . 57.3 t80 -128.75 107.24 18.54 Favored Pre-proline 0 CA--C 1.534 0.345 0 CA-C-O 118.281 -0.866 . . . . 0.0 110.449 -178.891 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 55' ' ' PRO . . . . . . . . . . . . . 73.5 Cg_endo -77.16 170.07 72.52 Favored 'Cis proline' 0 N--CA 1.5 1.854 0 CA-C-N 121.688 1.639 . . . . 0.0 112.405 -5.77 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 56' ' ' SER . . . . . . . . . . . . . 32.6 m -113.93 126.94 27.38 Favored Pre-proline 0 CA--C 1.54 0.57 0 CA-C-O 118.31 -0.852 . . . . 0.0 109.51 175.486 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 57' ' ' PRO . . . . . . . . . . . . . 52.7 Cg_endo -71.06 167.21 75.33 Favored 'Cis proline' 0 N--CA 1.497 1.677 0 CA-C-N 122.084 1.78 . . . . 0.0 111.89 -0.387 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 58' ' ' LEU . . . . . . . . . . . . . 18.9 tp -130.57 138.27 50.09 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.232 -0.44 . . . . 0.0 110.542 -179.426 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 59' ' ' ARG . . . . . . . . . . . . . 55.2 ttp180 -105.38 128.17 53.36 Favored 'General case' 0 C--N 1.329 -0.317 0 N-CA-C 109.118 -0.697 . . . . 0.0 109.118 175.031 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 40.2 t -82.84 123.12 38.22 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.196 0 C-N-CA 120.581 -0.448 . . . . 0.0 110.638 -173.835 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 95.1 mt-10 -131.07 168.76 16.87 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 115.78 -0.646 . . . . 0.0 109.998 177.958 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 62' ' ' ASP . . . . . . . . . . . . . 51.7 m-20 -54.36 -32.4 56.83 Favored 'General case' 0 C--N 1.329 -0.283 0 N-CA-C 111.747 0.277 . . . . 0.0 111.747 -179.712 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 63' ' ' ARG . . . . . . . . . . . . . 41.0 ptt180 -87.45 5.65 37.87 Favored 'General case' 0 CA--C 1.537 0.473 0 N-CA-C 113.712 1.004 . . . . 0.0 113.712 -174.999 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 28.8 m -87.4 139.14 30.85 Favored 'General case' 0 C--N 1.332 -0.179 0 CA-C-N 117.994 0.361 . . . . 0.0 110.537 -179.867 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 65' ' ' LYS . . . . . . . . . . . . . 61.8 mttm -87.63 130.44 34.77 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.096 -0.502 . . . . 0.0 110.281 179.154 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 66' ' ' ILE . . . . . . . . . . . . . 57.7 mt -115.47 124.93 72.47 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.316 0 N-CA-C 109.436 -0.579 . . . . 0.0 109.436 178.231 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 67' ' ' THR . . . . . . . . . . . . . 24.9 m -129.42 148.3 51.32 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-O 121.189 0.518 . . . . 0.0 111.531 -175.608 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 68' ' ' LEU . . . . . . . . . . . . . 4.0 tt . . . . . 0 C--N 1.329 -0.294 0 CA-C-N 115.764 -0.653 . . . . 0.0 109.589 176.52 . . . . . . . . 0 0 . 1 . 013 nuclear orig core ' A' A ' 74' ' ' ASP . . . . . . . . . . . . . 5.3 t0 . . . . . 0 N--CA 1.457 -0.106 0 N-CA-C 109.655 -0.498 . . . . 0.0 109.655 . . . . . . . . . 0 0 . 1 . 013 nuclear orig core ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 42.4 t -115.09 122.36 69.0 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.178 0 CA-C-O 121.038 0.446 . . . . 0.0 110.572 -177.783 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 76' ' ' LEU . . . . . . . . . . . . . 5.2 mp -121.09 142.87 49.44 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 115.623 -0.717 . . . . 0.0 109.739 176.386 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 77' ' ' GLU . . . . . . . . . . . . . 45.9 mt-10 -134.65 137.54 43.71 Favored 'General case' 0 C--N 1.331 -0.196 0 CA-C-O 120.955 0.407 . . . . 0.0 111.158 -179.355 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 78' ' ' ALA . . . . . . . . . . . . . . . -126.68 144.32 50.96 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 115.934 -0.576 . . . . 0.0 110.299 177.92 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 79' ' ' LYS . . . . . . . . . . . . . 40.8 mmtm -82.99 116.04 22.09 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.392 -0.367 . . . . 0.0 110.688 -179.541 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 80' ' ' ILE . . . . . . . . . . . . . 39.5 mm -139.09 110.69 5.16 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.286 0 N-CA-C 109.42 -0.585 . . . . 0.0 109.42 -179.288 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 81' ' ' LYS . . . . . . . . . . . . . 63.8 tttt -111.26 132.59 54.24 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-O 120.877 0.37 . . . . 0.0 111.064 -178.05 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . 89.04 42.11 5.71 Favored Glycine 0 CA--C 1.524 0.654 0 N-CA-C 111.432 -0.667 . . . . 0.0 111.432 175.46 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 83' ' ' ILE . . . . . . . . . . . . . 72.4 mt -76.54 137.68 22.12 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.326 0 N-CA-C 109.673 -0.491 . . . . 0.0 109.673 178.364 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 84' ' ' LYS . . . . . . . . . . . . . 39.3 ttpt -98.27 -48.14 5.18 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-N 116.241 -0.436 . . . . 0.0 110.036 -179.07 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 85' ' ' ASP . . . . . . . . . . . . . 5.5 t70 -155.12 155.77 34.58 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.089 -0.505 . . . . 0.0 110.814 179.357 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 86' ' ' VAL . . . . . . . . . . . . . 41.6 t -132.24 135.79 57.51 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.222 0 CA-C-O 120.962 0.411 . . . . 0.0 110.803 -178.423 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 87' ' ' ILE . . . . . . . . . . . . . 47.9 mm -119.22 123.59 71.6 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.308 0 CA-C-N 115.883 -0.599 . . . . 0.0 109.632 175.027 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 88' ' ' LEU . . . . . . . . . . . . . 14.2 tp -111.46 130.58 55.67 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-O 120.816 0.341 . . . . 0.0 110.89 -177.798 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 89' ' ' ASP . . . . . . . . . . . . . 6.9 t0 -130.89 156.02 45.76 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.048 -0.523 . . . . 0.0 109.704 178.328 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 79.5 tt0 -47.86 -39.61 19.12 Favored 'General case' 0 C--N 1.33 -0.27 0 N-CA-C 112.845 0.683 . . . . 0.0 112.845 -171.675 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 91' ' ' ASN . . . . . . . . . . . . . 16.4 m120 -123.58 14.98 9.52 Favored 'General case' 0 N--CA 1.467 0.406 0 N-CA-C 113.312 0.856 . . . . 0.0 113.312 -175.884 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 92' ' ' LEU . . . . . . . . . . . . . 33.4 mt -149.82 146.03 26.92 Favored 'General case' 0 C--N 1.331 -0.225 0 CA-C-N 117.93 0.332 . . . . 0.0 110.52 -176.214 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 93' ' ' ILE . . . . . . . . . . . . . 73.6 mt -127.62 116.92 45.12 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.331 0 N-CA-C 109.113 -0.699 . . . . 0.0 109.113 175.913 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 94' ' ' VAL . . . . . . . . . . . . . 45.0 t -116.7 126.87 74.36 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.278 0 N-CA-C 109.889 -0.412 . . . . 0.0 109.889 -177.941 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 95' ' ' VAL . . . . . . . . . . . . . 43.0 t -121.06 133.93 66.11 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.293 0 CA-C-N 116.177 -0.465 . . . . 0.0 109.807 179.465 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 96' ' ' ILE . . . . . . . . . . . . . 66.3 mt -113.52 126.1 70.9 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.365 0 N-CA-C 109.071 -0.714 . . . . 0.0 109.071 178.818 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 97' ' ' THR . . . . . . . . . . . . . 72.5 p -101.75 158.24 16.26 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-O 121.519 0.676 . . . . 0.0 111.593 -175.701 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 98' ' ' GLU . . . . . . . . . . . . . 82.4 tt0 -53.83 -27.3 28.73 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 115.549 -0.75 . . . . 0.0 112.295 179.991 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 99' ' ' GLU . . . . . . . . . . . . . 95.3 mt-10 -78.83 14.42 1.36 Allowed 'General case' 0 CA--C 1.535 0.369 0 N-CA-C 113.282 0.845 . . . . 0.0 113.282 -176.866 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 100' ' ' ASN . . . . . . . . . . . . . 3.2 m-20 61.03 37.5 17.92 Favored 'General case' 0 CA--C 1.53 0.211 0 CA-C-O 121.08 0.467 . . . . 0.0 110.891 -179.782 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 101' ' ' GLU . . . . . . . . . . . . . 84.3 tt0 -115.78 145.78 42.51 Favored 'General case' 0 C--O 1.232 0.16 0 CA-C-N 116.142 -0.481 . . . . 0.0 109.732 176.473 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 102' ' ' VAL . . . . . . . . . . . . . 45.7 t -114.95 125.3 72.24 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.298 0 N-CA-C 109.805 -0.442 . . . . 0.0 109.805 -177.332 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 103' ' ' LEU . . . . . . . . . . . . . 39.0 mt -116.3 126.48 53.6 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 115.634 -0.712 . . . . 0.0 110.185 177.263 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 104' ' ' ILE . . . . . . . . . . . . . 64.3 mt -117.59 120.11 63.75 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.214 0 N-CA-C 110.142 -0.318 . . . . 0.0 110.142 -179.993 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 105' ' ' PHE . . . . . . . . . . . . . 68.6 m-85 -119.95 165.57 14.47 Favored 'General case' 0 C--N 1.332 -0.19 0 O-C-N 123.818 0.698 . . . . 0.0 109.526 178.94 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 106' ' ' ASN . . . . . . . . . . . . . 36.7 p-10 -99.59 -170.33 1.88 Allowed 'General case' 0 C--N 1.331 -0.218 0 N-CA-C 109.952 -0.388 . . . . 0.0 109.952 174.926 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 107' ' ' GLN . . . . . . . . . . . . . 48.6 tp60 -59.47 -30.15 68.32 Favored 'General case' 0 C--N 1.328 -0.328 0 N-CA-C 111.94 0.348 . . . . 0.0 111.94 179.474 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 108' ' ' ASN . . . . . . . . . . . . . 4.7 t-20 -84.35 9.19 13.78 Favored 'General case' 0 CA--C 1.537 0.477 0 N-CA-C 113.204 0.816 . . . . 0.0 113.204 -177.326 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 109' ' ' LEU . . . . . . . . . . . . . 9.8 tp 61.67 35.04 17.23 Favored 'General case' 0 CA--C 1.531 0.222 0 CA-C-O 120.868 0.366 . . . . 0.0 111.545 178.64 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 110' ' ' GLU . . . . . . . . . . . . . 70.6 mm-40 -104.86 142.92 33.89 Favored 'General case' 0 C--N 1.33 -0.276 0 N-CA-C 109.373 -0.603 . . . . 0.0 109.373 174.719 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 111' ' ' GLU . . . . . . . . . . . . . 48.7 tt0 -83.63 121.85 27.81 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-O 120.892 0.377 . . . . 0.0 110.201 -176.725 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 112' ' ' LEU . . . . . . . . . . . . . 52.2 mt -105.1 -42.25 5.35 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 115.86 -0.609 . . . . 0.0 110.619 -179.526 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 113' ' ' TYR . . . . . . . . . . . . . 51.7 t80 -133.05 131.61 40.84 Favored 'General case' 0 C--N 1.331 -0.204 0 CA-C-O 121.01 0.433 . . . . 0.0 111.042 -179.095 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 114' ' ' ARG . . . . . . . . . . . . . 57.1 ttt180 -132.48 119.01 20.02 Favored 'General case' 0 C--N 1.331 -0.226 0 CA-C-N 115.745 -0.661 . . . . 0.0 109.812 177.242 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 115' ' ' GLY . . . . . . . . . . . . . . . -150.14 159.28 28.04 Favored Glycine 0 CA--C 1.522 0.522 0 N-CA-C 110.766 -0.934 . . . . 0.0 110.766 179.136 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 116' ' ' LYS . . . . . . . . . . . . . 34.3 ttmt -130.24 139.61 50.78 Favored 'General case' 0 C--N 1.329 -0.296 0 N-CA-C 110.03 -0.359 . . . . 0.0 110.03 177.646 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 117' ' ' PHE . . . . . . . . . . . . . 49.1 m-85 -134.87 113.96 12.09 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.288 -0.415 . . . . 0.0 110.012 -176.832 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 118' ' ' GLU . . . . . . . . . . . . . 79.6 tt0 -53.72 -43.28 68.91 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.64 -0.254 . . . . 0.0 111.263 -176.47 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 119' ' ' ASN . . . . . . . . . . . . . 32.5 m120 -99.31 30.99 3.26 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.091 -0.504 . . . . 0.0 112.119 -174.781 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 120' ' ' LEU . . . . . . . . . . . . . 15.4 tp -55.24 122.83 11.96 Favored 'General case' 0 N--CA 1.462 0.171 0 CA-C-O 120.751 0.31 . . . . 0.0 110.66 179.22 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 121' ' ' ASN . . . . . . . . . . . . . 64.9 t30 -113.33 -44.15 3.27 Favored 'General case' 0 C--N 1.331 -0.197 0 CA-C-N 116.362 -0.381 . . . . 0.0 111.046 -176.871 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 122' ' ' LYS . . . . . . . . . . . . . 93.4 mttt -144.26 148.1 34.43 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-O 121.057 0.456 . . . . 0.0 112.014 -177.869 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 123' ' ' VAL . . . . . . . . . . . . . 45.6 t -126.66 123.59 63.33 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.288 0 N-CA-C 109.066 -0.716 . . . . 0.0 109.066 172.567 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 124' ' ' LEU . . . . . . . . . . . . . 62.1 mt -125.74 136.93 53.72 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-O 120.855 0.36 . . . . 0.0 111.047 -176.954 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 125' ' ' VAL . . . . . . . . . . . . . 11.4 p -134.75 130.31 52.69 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.308 0 CA-C-N 115.967 -0.56 . . . . 0.0 110.148 178.196 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 126' ' ' ARG . . . . . . . . . . . . . 35.7 mmt180 -140.46 127.2 20.42 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.186 179.14 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 127' ' ' ASN . . . . . . . . . . . . . 12.5 t-20 52.04 -111.58 0.59 Allowed 'General case' 0 CA--C 1.544 0.742 0 CA-C-O 118.696 -0.668 . . . . 0.0 110.933 -179.969 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 128' ' ' ASP . . . . . . . . . . . . . 13.3 p-10 -114.06 8.6 17.09 Favored 'General case' 0 CA--C 1.537 0.45 0 CA-C-N 120.073 1.306 . . . . 0.0 113.23 179.918 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 129' ' ' LEU . . . . . . . . . . . . . 14.3 tp -106.41 135.61 47.61 Favored 'General case' 0 C--O 1.231 0.115 0 CA-C-N 118.037 0.38 . . . . 0.0 110.144 -179.993 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 130' ' ' VAL . . . . . . . . . . . . . 43.1 t -119.82 135.86 58.79 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.202 0 N-CA-C 109.831 -0.433 . . . . 0.0 109.831 -179.475 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 131' ' ' VAL . . . . . . . . . . . . . 21.0 m -136.04 138.8 46.88 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.239 0 CA-C-O 121.314 0.578 . . . . 0.0 110.94 177.928 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 132' ' ' ILE . . . . . . . . . . . . . 72.2 mt -118.86 131.12 72.58 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.319 0 CA-C-N 115.353 -0.84 . . . . 0.0 109.001 178.871 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 133' ' ' ILE . . . . . . . . . . . . . 39.3 mm -115.86 123.96 71.73 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.271 0 CA-C-N 116.596 -0.275 . . . . 0.0 110.747 -174.211 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 134' ' ' ASP . . . . . . . . . . . . . 13.4 p-10 -136.02 154.57 51.02 Favored 'General case' 0 C--N 1.332 -0.181 0 CA-C-N 116.295 -0.412 . . . . 0.0 110.086 176.409 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 135' ' ' GLU . . . . . . . . . . . . . 75.9 tt0 -50.02 -29.27 8.38 Favored 'General case' 0 C--N 1.328 -0.346 0 N-CA-C 113.4 0.889 . . . . 0.0 113.4 -168.815 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 136' ' ' GLN . . . . . . . . . . . . . 14.5 pt20 -99.83 -17.01 17.86 Favored 'General case' 0 C--O 1.235 0.34 0 N-CA-C 113.596 0.962 . . . . 0.0 113.596 -171.233 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 137' ' ' LYS . . . . . . . . . . . . . 19.2 pttp -168.04 172.2 9.01 Favored 'General case' 0 C--O 1.232 0.152 0 CA-C-O 121.692 0.758 . . . . 0.0 112.661 -175.41 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 138' ' ' LEU . . . . . . . . . . . . . 7.0 tt -123.26 129.55 51.52 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 114.71 -1.132 . . . . 0.0 110.01 178.985 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 139' ' ' THR . . . . . . . . . . . . . 30.4 m -108.3 127.99 54.35 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-N 116.247 -0.433 . . . . 0.0 110.579 179.69 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 140' ' ' LEU . . . . . . . . . . . . . 29.1 tp -111.93 123.33 50.02 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 115.61 -0.723 . . . . 0.0 109.159 -179.074 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 141' ' ' ILE . . . . . . . . . . . . . 19.6 mt -122.13 121.57 64.34 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.354 0 CA-C-O 120.911 0.386 . . . . 0.0 110.07 -174.662 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 142' ' ' ARG . . . . . . . . . . . . . 77.6 mtp180 -105.04 118.51 36.71 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 115.588 -0.733 . . . . 0.0 109.836 179.413 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 143' ' ' THR . . . . . . . . . . . . . 73.0 p . . . . . 0 C--O 1.221 -0.428 0 CA-C-O 117.976 -1.011 . . . . 0.0 110.592 -178.69 . . . . . . . . 0 0 . 1 . 013 nuclear orig core ' B' B ' 2' ' ' SER . . . . . . . . . . . . . 3.1 p . . . . . 0 C--O 1.23 0.06 0 N-CA-C 110.077 -0.342 . . . . 0.0 110.077 . . . . . . . . . 0 0 . 1 . 013 nuclear orig core ' B' B ' 3' ' ' GLU . . . . . . . . . . . . . 78.2 tt0 -140.64 137.57 33.7 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.622 -179.4 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' B' B ' 4' ' ' LEU . . . . . . . . . . . . . 12.6 tp -121.77 127.67 50.89 Favored 'General case' 0 C--N 1.331 -0.2 0 CA-C-N 116.096 -0.502 . . . . 0.0 110.143 177.501 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' B' B ' 5' ' ' LYS . . . . . . . . . . . . . 94.9 mttt -102.44 121.27 42.01 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.34 -0.391 . . . . 0.0 110.422 178.2 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' B' B ' 6' ' ' LEU . . . . . . . . . . . . . 59.5 mt -116.34 148.43 40.6 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-N 115.538 -0.756 . . . . 0.0 110.507 -178.98 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' B' B ' 7' ' ' LYS . . . . . . . . . . . . . 47.8 tttp -137.67 138.3 23.91 Favored Pre-proline 0 CA--C 1.534 0.341 0 CA-C-O 118.935 -0.555 . . . . 0.0 110.14 175.502 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' B' B ' 8' ' ' PRO . . . . . . . . . . . . . 98.9 Cg_endo -91.98 138.31 1.95 Allowed 'Trans proline' 0 N--CA 1.491 1.326 0 C-N-CA 121.803 1.669 . . . . 0.0 111.544 176.51 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' B' B ' 9' ' ' LEU . . . . . . . . . . . . . 65.7 mt -73.27 -47.33 7.77 Favored Pre-proline 0 CA--C 1.533 0.326 0 CA-C-O 118.751 -0.642 . . . . 0.0 112.238 -178.583 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' B' B ' 10' ' ' PRO . . . . . . . . . . . . . 87.8 Cg_endo -81.16 152.58 18.51 Favored 'Trans proline' 0 N--CA 1.496 1.672 0 C-N-CA 121.234 1.29 . . . . 0.0 111.894 175.807 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' B' B ' 11' ' ' LYS . . . . . . . . . . . . . 68.1 mttm -85.54 102.91 13.92 Favored 'General case' 0 C--N 1.33 -0.24 0 N-CA-C 110.106 -0.331 . . . . 0.0 110.106 177.459 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' B' B ' 12' ' ' VAL . . . . . . . . . . . . . 12.2 p -139.79 145.31 26.84 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.281 0 CA-C-N 116.335 -0.393 . . . . 0.0 110.722 -178.242 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' B' B ' 13' ' ' GLU . . . . . . . . . . . . . 95.5 mt-10 -87.83 121.32 30.11 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.094 -0.503 . . . . 0.0 109.887 177.13 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' B' B ' 14' ' ' LEU . . . . . . . . . . . . . 16.3 mt -97.71 153.0 38.43 Favored Pre-proline 0 C--N 1.329 -0.321 0 CA-C-N 116.498 -0.319 . . . . 0.0 110.678 -176.931 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' B' B ' 15' ' ' PRO . . . . . . . . . . . . . 26.0 Cg_exo -62.24 155.67 55.34 Favored 'Trans proline' 0 N--CA 1.497 1.713 0 C-N-CA 121.288 1.325 . . . . 0.0 111.581 176.076 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' B' B ' 16' ' ' PRO . . . . . . . . . . . . . 35.0 Cg_exo -58.0 -35.75 98.54 Favored 'Trans proline' 0 N--CA 1.498 1.742 0 C-N-CA 121.418 1.412 . . . . 0.0 112.704 -179.619 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' B' B ' 17' ' ' ASP . . . . . . . . . . . . . 17.8 p-10 -89.15 11.53 18.36 Favored 'General case' 0 C--N 1.327 -0.39 0 N-CA-C 113.202 0.816 . . . . 0.0 113.202 -177.462 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' B' B ' 18' ' ' PHE . . . . . . . . . . . . . 47.3 t80 -58.1 -42.64 86.13 Favored 'General case' 0 C--N 1.334 -0.088 0 O-C-N 121.905 -0.497 . . . . 0.0 110.023 -178.174 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' B' B ' 19' ' ' VAL . . . . . . . . . . . . . 49.1 t -58.0 -42.89 83.8 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.319 0 CA-C-N 116.438 -0.346 . . . . 0.0 110.283 -178.42 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' B' B ' 20' ' ' ASP . . . . . . . . . . . . . 81.2 m-20 -59.66 -42.16 92.19 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-O 120.796 0.331 . . . . 0.0 110.91 -177.955 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' B' B ' 21' ' ' VAL . . . . . . . . . . . . . 47.0 t -64.35 -49.31 81.53 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.321 0 CA-C-N 116.361 -0.381 . . . . 0.0 110.412 -178.215 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' B' B ' 22' ' ' ILE . . . . . . . . . . . . . 49.5 mm -56.89 -43.29 80.06 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.271 0 C-N-CA 120.993 -0.283 . . . . 0.0 110.542 179.592 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' B' B ' 23' ' ' ARG . . . . . . . . . . . . . 38.3 ttp180 -54.17 -49.63 68.86 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-O 120.732 0.301 . . . . 0.0 111.303 -178.73 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' B' B ' 24' ' ' ILE . . . . . . . . . . . . . 69.6 mt -60.44 -41.92 89.22 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.265 0 CA-C-N 116.416 -0.357 . . . . 0.0 110.899 -178.573 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' B' B ' 25' ' ' LYS . . . . . . . . . . . . . 88.4 mttt -64.91 -40.17 94.66 Favored 'General case' 0 C--N 1.328 -0.344 0 N-CA-C 112.469 0.544 . . . . 0.0 112.469 -179.096 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' B' B ' 26' ' ' LEU . . . . . . . . . . . . . 57.8 mt -77.81 -41.81 35.95 Favored 'General case' 0 C--N 1.33 -0.276 0 N-CA-C 113.141 0.793 . . . . 0.0 113.141 -171.408 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' B' B ' 27' ' ' GLN . . . . . . . . . . . . . 10.3 pt20 -46.86 135.62 9.0 Favored 'General case' 0 N--CA 1.469 0.516 0 N-CA-C 112.717 0.636 . . . . 0.0 112.717 -175.929 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' B' B ' 28' ' ' GLY . . . . . . . . . . . . . . . 101.06 -25.38 28.51 Favored Glycine 0 CA--C 1.533 1.161 0 CA-C-N 115.671 -0.695 . . . . 0.0 112.483 -177.792 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' B' B ' 29' ' ' LYS . . . . . . . . . . . . . 97.5 mttt -98.63 155.09 17.48 Favored 'General case' 0 C--N 1.331 -0.207 0 CA-C-N 117.398 0.599 . . . . 0.0 111.163 178.78 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' B' B ' 30' ' ' THR . . . . . . . . . . . . . 25.7 m -104.65 137.71 42.06 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.076 -0.511 . . . . 0.0 109.921 175.186 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' B' B ' 31' ' ' VAL . . . . . . . . . . . . . 34.5 m -128.26 155.64 40.02 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.254 0 CA-C-O 120.824 0.345 . . . . 0.0 110.894 -178.798 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' B' B ' 32' ' ' ARG . . . . . . . . . . . . . 97.1 mtt180 -133.51 149.93 51.7 Favored 'General case' 0 C--N 1.331 -0.225 0 CA-C-O 121.193 0.521 . . . . 0.0 110.654 177.823 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' B' B ' 33' ' ' THR . . . . . . . . . . . . . 23.6 m -53.21 139.64 28.65 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.237 -0.438 . . . . 0.0 111.419 -178.2 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' B' B ' 34' ' ' GLY . . . . . . . . . . . . . . . 99.4 -17.12 58.22 Favored Glycine 0 CA--C 1.531 1.092 0 C-N-CA 121.18 -0.533 . . . . 0.0 113.28 178.891 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' B' B ' 35' ' ' ASP . . . . . . . . . . . . . 75.6 m-20 -65.79 148.95 50.95 Favored 'General case' 0 C--O 1.232 0.145 0 CA-C-N 118.109 0.954 . . . . 0.0 111.152 179.631 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' B' B ' 36' ' ' VAL . . . . . . . . . . . . . 42.5 t -122.71 130.59 74.39 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.207 0 CA-C-N 115.938 -0.574 . . . . 0.0 109.966 177.7 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' B' B ' 37' ' ' ILE . . . . . . . . . . . . . 66.4 mt -121.63 139.23 49.36 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.305 0 N-CA-C 109.772 -0.455 . . . . 0.0 109.772 -179.721 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' B' B ' 38' ' ' GLY . . . . . . . . . . . . . . . -113.37 128.8 8.53 Favored Glycine 0 CA--C 1.526 0.77 0 N-CA-C 111.384 -0.686 . . . . 0.0 111.384 -178.673 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' B' B ' 39' ' ' ILE . . . . . . . . . . . . . 68.5 mt -123.89 127.91 73.95 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.204 0 N-CA-C 109.771 -0.455 . . . . 0.0 109.771 178.084 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' B' B ' 40' ' ' SER . . . . . . . . . . . . . 30.6 t -93.81 123.15 36.96 Favored 'General case' 0 C--N 1.329 -0.294 0 C-N-CA 120.923 -0.311 . . . . 0.0 111.005 176.589 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' B' B ' 41' ' ' ILE . . . . . . . . . . . . . 70.4 mt -131.73 125.67 56.09 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.233 0 CA-C-O 120.877 0.37 . . . . 0.0 110.588 178.834 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' B' B ' 42' ' ' LEU . . . . . . . . . . . . . 9.9 tp 54.62 35.45 23.69 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.067 -0.515 . . . . 0.0 111.623 176.88 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' B' B ' 43' ' ' GLY . . . . . . . . . . . . . . . 71.96 27.29 70.75 Favored Glycine 0 CA--C 1.531 1.087 0 C-N-CA 121.078 -0.582 . . . . 0.0 112.392 177.34 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' B' B ' 44' ' ' LYS . . . . . . . . . . . . . 91.4 mttt -138.05 126.84 23.82 Favored 'General case' 0 C--N 1.331 -0.211 0 N-CA-C 109.434 -0.58 . . . . 0.0 109.434 178.292 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' B' B ' 45' ' ' GLU . . . . . . . . . . . . . 29.1 tp10 -85.25 129.22 34.85 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-O 120.801 0.334 . . . . 0.0 111.233 -175.887 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' B' B ' 46' ' ' VAL . . . . . . . . . . . . . 7.4 p -122.36 129.48 75.26 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.2 0 N-CA-C 109.435 -0.58 . . . . 0.0 109.435 174.865 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' B' B ' 47' ' ' LYS . . . . . . . . . . . . . 69.0 mmtt -100.42 128.26 46.53 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.023 -0.535 . . . . 0.0 111.336 177.545 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' B' B ' 48' ' ' PHE . . . . . . . . . . . . . 91.7 m-85 -109.93 131.84 54.69 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 115.954 -0.566 . . . . 0.0 109.58 175.096 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' B' B ' 49' ' ' LYS . . . . . . . . . . . . . 41.5 tttp -108.62 137.63 46.25 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.422 -0.353 . . . . 0.0 110.365 179.638 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' B' B ' 50' ' ' VAL . . . . . . . . . . . . . 44.8 t -78.98 107.1 11.05 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.213 0 N-CA-C 109.326 -0.62 . . . . 0.0 109.326 176.352 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' B' B ' 51' ' ' VAL . . . . . . . . . . . . . 46.4 t -69.0 -48.97 67.06 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.329 0 CA-C-N 115.935 -0.575 . . . . 0.0 109.8 -174.097 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' B' B ' 52' ' ' GLN . . . . . . . . . . . . . 60.1 tt0 -170.1 147.93 3.28 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 115.838 -0.619 . . . . 0.0 111.274 -178.863 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' B' B ' 53' ' ' ALA . . . . . . . . . . . . . . . -122.77 136.78 54.98 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.085 -0.507 . . . . 0.0 110.34 178.843 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' B' B ' 54' ' ' TYR . . . . . . . . . . . . . 47.0 t80 -129.16 111.84 18.29 Favored Pre-proline 0 CA--C 1.535 0.387 0 CA-C-O 118.265 -0.874 . . . . 0.0 110.212 177.995 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' B' B ' 55' ' ' PRO . . . . . . . . . . . . . 73.4 Cg_endo -77.17 167.88 78.46 Favored 'Cis proline' 0 N--CA 1.5 1.901 0 CA-C-N 121.932 1.726 . . . . 0.0 112.127 -6.991 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' B' B ' 56' ' ' SER . . . . . . . . . . . . . 24.0 m -117.22 133.12 23.21 Favored Pre-proline 0 CA--C 1.537 0.476 0 CA-C-O 118.492 -0.766 . . . . 0.0 109.576 175.102 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' B' B ' 57' ' ' PRO . . . . . . . . . . . . . 36.4 Cg_endo -66.34 164.0 67.66 Favored 'Cis proline' 0 N--CA 1.499 1.809 0 CA-C-N 121.953 1.733 . . . . 0.0 111.375 -2.504 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' B' B ' 58' ' ' LEU . . . . . . . . . . . . . 23.0 tp -129.27 135.72 49.15 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.328 -0.396 . . . . 0.0 110.513 -179.217 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' B' B ' 59' ' ' ARG . . . . . . . . . . . . . 74.7 ttt180 -102.45 126.86 49.62 Favored 'General case' 0 C--N 1.327 -0.376 0 N-CA-C 109.241 -0.652 . . . . 0.0 109.241 175.362 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' B' B ' 60' ' ' VAL . . . . . . . . . . . . . 40.7 t -81.35 121.81 35.39 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.322 0 C-N-CA 120.634 -0.426 . . . . 0.0 110.402 -175.045 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' B' B ' 61' ' ' GLU . . . . . . . . . . . . . 95.1 mt-10 -131.11 165.38 23.4 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 115.803 -0.635 . . . . 0.0 109.634 176.698 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' B' B ' 62' ' ' ASP . . . . . . . . . . . . . 80.0 m-20 -53.82 -32.62 53.41 Favored 'General case' 0 C--N 1.328 -0.364 0 N-CA-C 111.787 0.291 . . . . 0.0 111.787 -179.852 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' B' B ' 63' ' ' ARG . . . . . . . . . . . . . 24.7 mmm180 -72.82 -18.96 61.41 Favored 'General case' 0 CA--C 1.535 0.379 0 N-CA-C 113.092 0.775 . . . . 0.0 113.092 -177.085 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' B' B ' 64' ' ' THR . . . . . . . . . . . . . 25.8 m -72.44 138.98 47.47 Favored 'General case' 0 C--N 1.331 -0.204 0 CA-C-O 120.962 0.411 . . . . 0.0 111.24 -174.642 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' B' B ' 65' ' ' LYS . . . . . . . . . . . . . 98.4 mttt -90.81 136.45 33.06 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 115.887 -0.597 . . . . 0.0 110.429 178.615 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' B' B ' 66' ' ' ILE . . . . . . . . . . . . . 60.6 mt -117.1 129.33 73.82 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.233 0 N-CA-C 109.662 -0.496 . . . . 0.0 109.662 179.147 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' B' B ' 67' ' ' THR . . . . . . . . . . . . . 28.0 m -125.74 144.85 50.45 Favored 'General case' 0 N--CA 1.463 0.205 0 CA-C-O 121.133 0.492 . . . . 0.0 111.581 -175.581 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' B' B ' 68' ' ' LEU . . . . . . . . . . . . . 4.4 tt . . . . . 0 C--N 1.33 -0.252 0 CA-C-N 115.614 -0.721 . . . . 0.0 109.559 177.026 . . . . . . . . 0 0 . 1 . 013 nuclear orig core ' B' B ' 73' ' ' VAL . . . . . . . . . . . . . 33.8 m . . . . . 0 C--O 1.232 0.151 0 N-CA-C 109.616 -0.512 . . . . 0.0 109.616 . . . . . . . . . 0 0 . 1 . 013 nuclear orig core ' B' B ' 74' ' ' ASP . . . . . . . . . . . . . 12.6 t70 -96.62 121.2 38.19 Favored 'General case' 0 C--N 1.33 -0.264 0 C-N-CA 120.779 -0.369 . . . . 0.0 110.346 -176.082 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' B' B ' 75' ' ' VAL . . . . . . . . . . . . . 41.3 t -115.87 126.04 73.23 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.184 0 CA-C-O 121.057 0.456 . . . . 0.0 110.66 -178.263 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' B' B ' 76' ' ' LEU . . . . . . . . . . . . . 15.6 mt -127.59 148.16 50.36 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 115.587 -0.733 . . . . 0.0 109.367 176.929 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' B' B ' 77' ' ' GLU . . . . . . . . . . . . . 98.0 mt-10 -136.87 141.44 42.78 Favored 'General case' 0 C--N 1.333 -0.125 0 CA-C-O 121.173 0.511 . . . . 0.0 111.532 -176.423 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' B' B ' 78' ' ' ALA . . . . . . . . . . . . . . . -127.01 133.5 50.52 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 115.529 -0.76 . . . . 0.0 109.794 176.394 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' B' B ' 79' ' ' LYS . . . . . . . . . . . . . 85.8 tttt -78.12 116.68 18.76 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-O 120.891 0.377 . . . . 0.0 110.728 -177.608 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' B' B ' 80' ' ' ILE . . . . . . . . . . . . . 37.9 mm -139.15 108.43 3.77 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.302 0 N-CA-C 109.432 -0.581 . . . . 0.0 109.432 -176.447 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' B' B ' 81' ' ' LYS . . . . . . . . . . . . . 38.6 ttpt -104.36 127.7 52.07 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-O 120.839 0.352 . . . . 0.0 110.939 -177.629 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' B' B ' 82' ' ' GLY . . . . . . . . . . . . . . . 89.05 42.13 5.7 Favored Glycine 0 CA--C 1.525 0.675 0 C-N-CA 120.847 -0.692 . . . . 0.0 111.687 175.522 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' B' B ' 83' ' ' ILE . . . . . 0.417 HD13 HG21 ' B' ' 83' ' ' ILE . 72.2 mt -70.12 136.05 26.9 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.339 0 N-CA-C 109.669 -0.493 . . . . 0.0 109.669 177.515 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' B' B ' 84' ' ' LYS . . . . . . . . . . . . . 81.1 tttt -94.19 -52.12 4.51 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 115.996 -0.547 . . . . 0.0 110.307 -179.025 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' B' B ' 85' ' ' ASP . . . . . . . . . . . . . 9.5 t70 -156.33 155.79 32.85 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 115.838 -0.619 . . . . 0.0 110.439 179.936 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' B' B ' 86' ' ' VAL . . . . . . . . . . . . . 42.5 t -126.35 133.67 68.21 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.18 0 CA-C-O 121.048 0.451 . . . . 0.0 110.67 -178.338 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' B' B ' 87' ' ' ILE . . . . . . . . . . . . . 44.7 mm -118.42 121.15 66.4 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.282 0 CA-C-N 115.644 -0.707 . . . . 0.0 109.245 175.264 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' B' B ' 88' ' ' LEU . . . . . . . . . . . . . 17.7 tp -109.98 132.51 54.09 Favored 'General case' 0 C--N 1.332 -0.194 0 CA-C-O 120.907 0.384 . . . . 0.0 111.428 -175.055 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' B' B ' 89' ' ' ASP . . . . . . . . . . . . . 9.8 t70 -129.49 153.33 48.09 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 115.91 -0.586 . . . . 0.0 109.56 175.869 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' B' B ' 90' ' ' GLU . . . . . . . . . . . . . 83.5 tt0 -48.21 -36.33 13.54 Favored 'General case' 0 C--N 1.329 -0.294 0 N-CA-C 112.738 0.644 . . . . 0.0 112.738 -172.641 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' B' B ' 91' ' ' ASN . . . . . . . . . . . . . 7.1 p30 -132.09 29.37 4.37 Favored 'General case' 0 N--CA 1.466 0.341 0 N-CA-C 112.301 0.482 . . . . 0.0 112.301 -177.378 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' B' B ' 92' ' ' LEU . . . . . . . . . . . . . 5.0 mt -154.78 143.16 20.48 Favored 'General case' 0 C--N 1.331 -0.213 0 N-CA-C 109.809 -0.441 . . . . 0.0 109.809 -178.474 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' B' B ' 93' ' ' ILE . . . . . . . . . . . . . 70.6 mt -123.38 112.26 32.75 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.213 0 N-CA-C 108.926 -0.768 . . . . 0.0 108.926 176.752 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' B' B ' 94' ' ' VAL . . . . . . . . . . . . . 46.3 t -116.05 125.56 73.2 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.258 0 N-CA-C 109.589 -0.523 . . . . 0.0 109.589 -179.599 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' B' B ' 95' ' ' VAL . . . . . . . . . . . . . 43.2 t -122.93 135.81 61.79 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.349 0 CA-C-N 116.127 -0.488 . . . . 0.0 109.976 -178.141 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' B' B ' 96' ' ' ILE . . . . . . . . . . . . . 63.8 mt -111.6 127.58 68.67 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.355 0 N-CA-C 109.075 -0.713 . . . . 0.0 109.075 178.145 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' B' B ' 97' ' ' THR . . . . . . . . . . . . . 78.4 p -101.18 156.79 17.22 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-O 120.967 0.413 . . . . 0.0 111.136 -177.479 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' B' B ' 98' ' ' GLU . . . . . . . . . . . . . 13.5 pt-20 -53.87 -23.62 13.16 Favored 'General case' 0 CA--C 1.533 0.319 0 N-CA-C 112.434 0.531 . . . . 0.0 112.434 -179.97 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' B' B ' 99' ' ' GLU . . . . . . . . . . . . . 95.6 mt-10 -79.24 14.5 1.48 Allowed 'General case' 0 CA--C 1.536 0.433 0 N-CA-C 112.969 0.729 . . . . 0.0 112.969 -178.212 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' B' B ' 100' ' ' ASN . . . . . . . . . . . . . 2.4 m-20 61.71 37.95 15.47 Favored 'General case' 0 CA--C 1.529 0.169 0 CA-C-O 121.081 0.467 . . . . 0.0 110.893 178.9 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' B' B ' 101' ' ' GLU . . . . . . . . . . . . . 83.5 tt0 -116.53 144.74 43.98 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-N 116.039 -0.528 . . . . 0.0 109.728 176.561 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' B' B ' 102' ' ' VAL . . . . . . . . . . . . . 46.1 t -114.94 123.6 70.78 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.314 0 N-CA-C 109.592 -0.521 . . . . 0.0 109.592 -179.942 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' B' B ' 103' ' ' LEU . . . . . . . . . . . . . 70.9 mt -114.34 131.78 56.43 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 115.806 -0.634 . . . . 0.0 110.255 178.411 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' B' B ' 104' ' ' ILE . . . . . . . . . . . . . 66.7 mt -117.9 117.54 55.26 Favored 'Isoleucine or valine' 0 C--O 1.234 0.252 0 CA-C-N 116.441 -0.345 . . . . 0.0 110.247 -178.756 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' B' B ' 105' ' ' PHE . . . . . . . . . . . . . 82.7 m-85 -117.43 163.29 16.6 Favored 'General case' 0 C--N 1.332 -0.157 0 O-C-N 124.241 0.963 . . . . 0.0 109.846 -179.906 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' B' B ' 106' ' ' ASN . . . . . . . . . . . . . 52.9 p-10 -102.41 -172.26 2.1 Favored 'General case' 0 C--N 1.331 -0.211 0 N-CA-C 109.757 -0.46 . . . . 0.0 109.757 171.256 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' B' B ' 107' ' ' GLN . . . . . . . . . . . . . 48.9 tt0 -58.45 -29.73 66.4 Favored 'General case' 0 C--N 1.328 -0.329 0 N-CA-C 112.227 0.454 . . . . 0.0 112.227 -178.066 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' B' B ' 108' ' ' ASN . . . . . . . . . . . . . 11.7 t-20 -88.74 14.16 10.8 Favored 'General case' 0 CA--C 1.535 0.385 0 N-CA-C 112.862 0.69 . . . . 0.0 112.862 -176.22 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' B' B ' 109' ' ' LEU . . . . . . . . . . . . . 71.6 mt 58.61 35.53 24.56 Favored 'General case' 0 C--O 1.234 0.238 0 CA-C-O 120.822 0.344 . . . . 0.0 111.547 178.771 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' B' B ' 110' ' ' GLU . . . . . . . . . . . . . 43.3 mt-10 -105.27 141.32 37.0 Favored 'General case' 0 C--N 1.329 -0.299 0 N-CA-C 109.771 -0.455 . . . . 0.0 109.771 176.35 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' B' B ' 111' ' ' GLU . . . . . . . . . . . . . 97.7 mt-10 -77.29 125.51 29.44 Favored 'General case' 0 C--N 1.327 -0.399 0 CA-C-N 116.331 -0.395 . . . . 0.0 111.257 -176.77 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' B' B ' 112' ' ' LEU . . . . . . . . . . . . . 11.6 mt -106.71 -45.99 4.08 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.041 -0.527 . . . . 0.0 110.176 176.889 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' B' B ' 113' ' ' TYR . . . . . . . . . . . . . 55.9 t80 -140.45 140.69 35.43 Favored 'General case' 0 C--N 1.33 -0.243 0 C-N-CA 120.74 -0.384 . . . . 0.0 110.956 -178.84 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' B' B ' 114' ' ' ARG . . . . . . . . . . . . . 21.0 mtp-105 -139.36 126.22 20.88 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.244 -0.435 . . . . 0.0 110.209 176.04 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' B' B ' 115' ' ' GLY . . . . . . . . . . . . . . . -150.07 142.81 10.03 Favored Glycine 0 CA--C 1.523 0.532 0 N-CA-C 111.229 -0.748 . . . . 0.0 111.229 179.826 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' B' B ' 116' ' ' LYS . . . . . . . . . . . . . 39.1 ttpt -112.02 132.82 54.57 Favored 'General case' 0 C--N 1.33 -0.245 0 N-CA-C 109.774 -0.454 . . . . 0.0 109.774 177.955 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' B' B ' 117' ' ' PHE . . . . . . . . . . . . . 40.9 m-85 -134.27 113.87 12.42 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-O 120.942 0.401 . . . . 0.0 110.198 -176.532 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' B' B ' 118' ' ' GLU . . . . . . . . . . . . . 95.8 mt-10 -56.34 -41.93 76.9 Favored 'General case' 0 C--N 1.326 -0.426 0 CA-C-N 116.13 -0.487 . . . . 0.0 111.196 -174.594 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' B' B ' 119' ' ' ASN . . . . . . . . . . . . . 88.5 m-20 -100.6 31.12 3.61 Favored 'General case' 0 C--N 1.329 -0.295 0 N-CA-C 112.213 0.449 . . . . 0.0 112.213 -173.853 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' B' B ' 120' ' ' LEU . . . . . . . . . . . . . 9.7 tp -55.25 122.03 10.18 Favored 'General case' 0 N--CA 1.462 0.158 0 C-N-CA 121.044 -0.262 . . . . 0.0 110.674 178.062 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' B' B ' 121' ' ' ASN . . . . . . . . . . . . . 3.5 m-20 -114.09 -44.14 3.17 Favored 'General case' 0 C--N 1.332 -0.153 0 CA-C-N 116.63 -0.259 . . . . 0.0 111.18 -176.242 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' B' B ' 122' ' ' LYS . . . . . . . . . . . . . 16.1 ttmm -151.79 142.65 22.97 Favored 'General case' 0 C--N 1.331 -0.206 0 C-N-CA 120.363 -0.535 . . . . 0.0 111.712 -176.828 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' B' B ' 123' ' ' VAL . . . . . . . . . . . . . 46.2 t -120.72 130.79 74.18 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.256 0 CA-C-N 115.825 -0.625 . . . . 0.0 109.628 177.139 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' B' B ' 124' ' ' LEU . . . . . . . . . . . . . 75.4 mt -127.83 138.48 52.72 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-O 120.831 0.348 . . . . 0.0 110.692 -178.424 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' B' B ' 125' ' ' VAL . . . . . . . . . . . . . 35.0 m -130.7 143.15 41.78 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.245 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.909 -179.567 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' B' B ' 126' ' ' ARG . . . . . . . . . . . . . 94.3 mtt-85 -148.34 117.72 6.94 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 115.832 -0.622 . . . . 0.0 109.397 176.205 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' B' B ' 127' ' ' ASN . . . . . . . . . . . . . 79.8 m-20 56.61 -143.35 0.71 Allowed 'General case' 0 CA--C 1.541 0.615 0 CA-C-O 119.138 -0.458 . . . . 0.0 109.773 -179.39 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' B' B ' 128' ' ' ASP . . . . . . . . . . . . . 12.0 p-10 -85.76 10.28 14.06 Favored 'General case' 0 CA--C 1.535 0.396 0 CA-C-N 119.248 0.931 . . . . 0.0 113.229 179.953 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' B' B ' 129' ' ' LEU . . . . . . . . . . . . . 28.2 mt -111.22 145.15 39.22 Favored 'General case' 0 N--CA 1.463 0.189 0 O-C-N 121.841 -0.537 . . . . 0.0 109.762 179.112 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' B' B ' 130' ' ' VAL . . . . . . . . . . . . . 32.6 m -137.13 148.09 26.53 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.262 0 CA-C-O 121.315 0.578 . . . . 0.0 111.923 -175.943 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' B' B ' 131' ' ' VAL . . . . . . . . . . . . . 43.9 t -136.14 137.7 48.14 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.225 0 CA-C-N 115.535 -0.757 . . . . 0.0 110.087 177.504 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' B' B ' 132' ' ' ILE . . . . . . . . . . . . . 75.3 mt -118.77 132.02 69.87 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.287 0 CA-C-N 116.028 -0.533 . . . . 0.0 109.669 -179.757 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' B' B ' 133' ' ' ILE . . . . . . . . . . . . . 41.0 mm -115.62 122.83 70.23 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.251 0 CA-C-N 116.414 -0.357 . . . . 0.0 110.883 -175.339 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' B' B ' 134' ' ' ASP . . . . . . . . . . . . . 9.3 p-10 -136.91 144.24 43.37 Favored 'General case' 0 C--N 1.331 -0.222 0 N-CA-C 109.691 -0.485 . . . . 0.0 109.691 173.282 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' B' B ' 135' ' ' GLU . . . . . . . . . . . . . 33.0 tp10 -49.91 -24.38 2.48 Favored 'General case' 0 C--N 1.326 -0.431 0 N-CA-C 112.806 0.669 . . . . 0.0 112.806 -172.394 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' B' B ' 136' ' ' GLN . . . . . . . . . . . . . 48.1 tt0 -82.51 -38.57 23.65 Favored 'General case' 0 C--N 1.332 -0.168 0 N-CA-C 112.082 0.401 . . . . 0.0 112.082 -176.934 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' B' B ' 137' ' ' LYS . . . . . . . . . . . . . 58.7 pttt -160.01 168.55 25.37 Favored 'General case' 0 C--O 1.234 0.256 0 CA-C-O 121.495 0.664 . . . . 0.0 112.119 -173.1 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' B' B ' 138' ' ' LEU . . . . . . . . . . . . . 5.1 tt -116.39 127.45 54.65 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 115.155 -0.93 . . . . 0.0 109.781 178.38 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' B' B ' 139' ' ' THR . . . . . . . . . . . . . 31.8 m -109.79 124.83 51.96 Favored 'General case' 0 C--N 1.331 -0.217 0 CA-C-O 120.738 0.304 . . . . 0.0 110.381 179.926 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' B' B ' 140' ' ' LEU . . . . . . . . . . . . . 11.2 tp -114.86 117.27 30.23 Favored 'General case' 0 C--N 1.328 -0.367 0 N-CA-C 108.897 -0.779 . . . . 0.0 108.897 -179.183 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' B' B ' 141' ' ' ILE . . . . . . . . . . . . . 18.9 mt -117.22 117.01 53.85 Favored 'Isoleucine or valine' 0 C--O 1.236 0.361 0 CA-C-O 121.129 0.49 . . . . 0.0 110.069 -174.373 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' B' B ' 142' ' ' ARG . . . . . . . . . . . . . 2.0 mtp85 -103.72 135.01 46.09 Favored 'General case' 0 C--N 1.331 -0.201 0 CA-C-N 115.033 -0.985 . . . . 0.0 109.824 -177.353 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' B' B ' 143' ' ' THR . . . . . . . . . . . . . 72.7 p . . . . . 0 C--O 1.22 -0.478 0 CA-C-O 118.241 -0.885 . . . . 0.0 110.763 -179.722 . . . . . . . . 0 0 . 1 . 013 nuclear orig core ' C' C ' 2' ' ' SER . . . . . . . . . . . . . 2.4 p . . . . . 0 N--CA 1.462 0.149 0 CA-C-O 120.902 0.382 . . . . 0.0 110.274 . . . . . . . . . 0 0 . 1 . 013 nuclear orig core ' C' C ' 3' ' ' GLU . . . . . . . . . . . . . 84.2 tt0 -139.77 140.1 36.62 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 115.918 -0.583 . . . . 0.0 111.045 -177.244 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' C' C ' 4' ' ' LEU . . . . . . . . . . . . . 18.0 tp -126.7 130.16 49.83 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.028 -0.533 . . . . 0.0 110.203 177.752 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' C' C ' 5' ' ' LYS . . . . . . . . . . . . . 61.4 mttp -109.06 119.8 40.63 Favored 'General case' 0 C--O 1.233 0.22 0 CA-C-O 120.9 0.381 . . . . 0.0 110.693 179.054 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' C' C ' 6' ' ' LEU . . . . . . . . . . . . . 36.6 mt -115.04 148.82 38.38 Favored 'General case' 0 C--N 1.331 -0.211 0 CA-C-N 115.359 -0.837 . . . . 0.0 110.554 179.495 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' C' C ' 7' ' ' LYS . . . . . . . . . . . . . 25.9 ttpp -135.25 135.29 22.36 Favored Pre-proline 0 CA--C 1.535 0.392 0 CA-C-O 118.773 -0.632 . . . . 0.0 109.966 176.418 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' C' C ' 8' ' ' PRO . . . . . . . . . . . . . 89.7 Cg_endo -88.82 136.6 3.12 Favored 'Trans proline' 0 N--CA 1.492 1.383 0 C-N-CA 121.534 1.489 . . . . 0.0 111.515 176.344 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' C' C ' 9' ' ' LEU . . . . . . . . . . . . . 51.1 mt -73.32 -47.62 7.57 Favored Pre-proline 0 CA--C 1.534 0.335 0 CA-C-O 118.616 -0.707 . . . . 0.0 112.17 -178.237 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' C' C ' 10' ' ' PRO . . . . . . . . . . . . . 97.8 Cg_endo -79.8 145.57 18.06 Favored 'Trans proline' 0 N--CA 1.495 1.598 0 C-N-CA 121.104 1.202 . . . . 0.0 111.639 175.381 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' C' C ' 11' ' ' LYS . . . . . . . . . . . . . 52.9 pttt -78.43 111.88 14.9 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-O 121.601 0.715 . . . . 0.0 110.561 179.026 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' C' C ' 12' ' ' VAL . . . . . . . . . . . . . 12.4 p -151.11 148.32 14.99 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.295 0 CA-C-N 115.609 -0.723 . . . . 0.0 110.612 -179.437 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' C' C ' 13' ' ' GLU . . . . . . . . . . . . . 49.1 mp0 -91.65 120.78 32.72 Favored 'General case' 0 C--N 1.331 -0.236 0 N-CA-C 109.752 -0.462 . . . . 0.0 109.752 174.997 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' C' C ' 14' ' ' LEU . . . . . . . . . . . . . 14.7 mt -89.01 152.11 47.88 Favored Pre-proline 0 C--N 1.329 -0.287 0 CA-C-N 116.501 -0.318 . . . . 0.0 110.768 -176.984 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' C' C ' 15' ' ' PRO . . . . . . . . . . . . . 37.0 Cg_exo -59.8 162.33 16.11 Favored 'Trans proline' 0 N--CA 1.498 1.768 0 C-N-CA 121.329 1.353 . . . . 0.0 111.835 176.771 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' C' C ' 16' ' ' PRO . . . . . . . . . . . . . 37.9 Cg_exo -58.46 -44.02 41.13 Favored 'Trans proline' 0 N--CA 1.497 1.731 0 C-N-CA 121.444 1.429 . . . . 0.0 112.861 -177.242 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' C' C ' 17' ' ' ASP . . . . . . . . . . . . . 23.3 p-10 -92.44 17.05 10.53 Favored 'General case' 0 CA--C 1.536 0.433 0 N-CA-C 112.924 0.712 . . . . 0.0 112.924 -176.964 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' C' C ' 18' ' ' PHE . . . . . . . . . . . . . 52.8 t80 -57.24 -41.8 80.25 Favored 'General case' 0 C--N 1.333 -0.128 0 O-C-N 122.106 -0.371 . . . . 0.0 110.227 -179.193 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' C' C ' 19' ' ' VAL . . . . . . . . . . . . . 48.7 t -56.93 -43.41 80.51 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.303 0 CA-C-N 116.434 -0.348 . . . . 0.0 110.317 -179.468 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' C' C ' 20' ' ' ASP . . . . . . . . . . . . . 16.4 m-20 -60.1 -42.57 94.97 Favored 'General case' 0 C--N 1.33 -0.272 0 C-N-CA 120.98 -0.288 . . . . 0.0 111.173 -178.821 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' C' C ' 21' ' ' VAL . . . . . . . . . . . . . 48.3 t -63.96 -46.62 93.52 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.278 0 C-N-CA 120.794 -0.362 . . . . 0.0 110.37 -177.491 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' C' C ' 22' ' ' ILE . . . . . . . . . . . . . 51.4 mm -56.42 -45.82 81.88 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.208 0 CA-C-O 120.747 0.308 . . . . 0.0 110.423 178.221 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' C' C ' 23' ' ' ARG . . . . . . . . . . . . . 50.6 ttp180 -54.6 -47.83 72.9 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.589 -0.278 . . . . 0.0 111.488 -178.501 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' C' C ' 24' ' ' ILE . . . . . . . . . . . . . 76.5 mt -59.85 -44.09 93.38 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.362 0 CA-C-O 120.606 0.241 . . . . 0.0 111.045 -178.376 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' C' C ' 25' ' ' LYS . . . . . . . . . . . . . 54.7 mtmt -64.62 -41.44 96.19 Favored 'General case' 0 C--N 1.327 -0.377 0 N-CA-C 112.367 0.506 . . . . 0.0 112.367 -178.332 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' C' C ' 26' ' ' LEU . . . . . . . . . . . . . 79.6 mt -79.2 -40.35 31.0 Favored 'General case' 0 C--N 1.33 -0.266 0 N-CA-C 113.416 0.895 . . . . 0.0 113.416 -171.397 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' C' C ' 27' ' ' GLN . . . . . . . . . . . . . 9.9 pt20 -46.78 139.5 5.32 Favored 'General case' 0 N--CA 1.47 0.526 0 N-CA-C 112.703 0.631 . . . . 0.0 112.703 -175.041 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' C' C ' 28' ' ' GLY . . . . . . . . . . . . . . . 100.72 -26.19 25.54 Favored Glycine 0 CA--C 1.534 1.271 0 CA-C-N 115.467 -0.788 . . . . 0.0 112.179 -176.586 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' C' C ' 29' ' ' LYS . . . . . . . . . . . . . 99.1 mttt -98.6 155.12 17.46 Favored 'General case' 0 C--N 1.331 -0.198 0 CA-C-N 117.411 0.605 . . . . 0.0 111.365 179.277 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' C' C ' 30' ' ' THR . . . . . . . . . . . . . 38.1 m -103.28 135.91 44.03 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 115.886 -0.597 . . . . 0.0 109.979 175.758 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' C' C ' 31' ' ' VAL . . . . . . . . . . . . . 34.7 m -130.01 152.95 38.17 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.229 0 CA-C-O 120.934 0.397 . . . . 0.0 110.867 -178.597 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' C' C ' 32' ' ' ARG . . . . . . . . . . . . . 34.5 ttp180 -130.59 149.84 52.07 Favored 'General case' 0 C--N 1.331 -0.221 0 CA-C-N 116.027 -0.533 . . . . 0.0 110.452 179.519 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' C' C ' 33' ' ' THR . . . . . . . . . . . . . 19.1 m -52.65 139.17 26.77 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.241 -0.436 . . . . 0.0 111.498 -177.111 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' C' C ' 34' ' ' GLY . . . . . . . . . . . . . . . 100.21 -17.19 57.34 Favored Glycine 0 CA--C 1.533 1.165 0 CA-C-O 119.644 -0.531 . . . . 0.0 113.179 179.321 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' C' C ' 35' ' ' ASP . . . . . . . . . . . . . 70.9 m-20 -65.41 149.24 50.35 Favored 'General case' 0 C--O 1.231 0.083 0 CA-C-N 118.087 0.944 . . . . 0.0 111.276 179.303 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' C' C ' 36' ' ' VAL . . . . . . . . . . . . . 45.2 t -123.3 130.71 74.12 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.215 0 CA-C-N 115.735 -0.666 . . . . 0.0 109.658 178.065 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' C' C ' 37' ' ' ILE . . . . . . . . . . . . . 67.8 mt -121.06 138.57 51.04 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.24 0 CA-C-N 116.306 -0.406 . . . . 0.0 110.05 -179.609 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' C' C ' 38' ' ' GLY . . . . . . . . . . . . . . . -110.47 128.77 8.97 Favored Glycine 0 CA--C 1.525 0.703 0 N-CA-C 110.859 -0.896 . . . . 0.0 110.859 179.263 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' C' C ' 39' ' ' ILE . . . . . . . . . . . . . 73.2 mt -122.68 129.56 75.11 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.226 0 N-CA-C 110.069 -0.345 . . . . 0.0 110.069 179.812 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' C' C ' 40' ' ' SER . . . . . . . . . . . . . 87.3 p -93.15 120.34 33.34 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.425 -0.352 . . . . 0.0 110.991 176.744 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' C' C ' 41' ' ' ILE . . . . . . . . . . . . . 70.2 mt -133.3 127.49 54.17 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.258 0 CA-C-O 120.886 0.374 . . . . 0.0 110.446 177.955 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' C' C ' 42' ' ' LEU . . . . . . . . . . . . . 11.2 tp 53.23 34.53 17.85 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.035 -0.53 . . . . 0.0 111.593 177.1 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' C' C ' 43' ' ' GLY . . . . . . . . . . . . . . . 71.2 31.07 66.62 Favored Glycine 0 CA--C 1.531 1.061 0 C-N-CA 121.094 -0.574 . . . . 0.0 111.941 177.907 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' C' C ' 44' ' ' LYS . . . . . . . . . . . . . 80.5 tttt -138.43 126.83 23.14 Favored 'General case' 0 C--N 1.329 -0.296 0 N-CA-C 109.751 -0.463 . . . . 0.0 109.751 179.834 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' C' C ' 45' ' ' GLU . . . . . . . . . . . . . 81.9 tt0 -84.37 122.83 29.49 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-N 116.45 -0.341 . . . . 0.0 111.003 -178.398 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' C' C ' 46' ' ' VAL . . . . . . . . . . . . . 7.2 p -119.88 130.29 74.38 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.302 0 N-CA-C 109.449 -0.574 . . . . 0.0 109.449 175.877 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' C' C ' 47' ' ' LYS . . . . . . . . . . . . . 64.9 mttp -100.27 127.86 46.47 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 115.979 -0.555 . . . . 0.0 111.356 178.768 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' C' C ' 48' ' ' PHE . . . . . . . . . . . . . 94.6 m-85 -111.33 131.88 54.83 Favored 'General case' 0 C--N 1.33 -0.273 0 N-CA-C 109.674 -0.491 . . . . 0.0 109.674 175.495 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' C' C ' 49' ' ' LYS . . . . . . . . . . . . . 83.3 tttt -108.48 137.06 47.06 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.401 -0.363 . . . . 0.0 110.654 179.869 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' C' C ' 50' ' ' VAL . . . . . . . . . . . . . 41.0 t -83.21 107.57 15.01 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.243 0 N-CA-C 109.421 -0.585 . . . . 0.0 109.421 176.465 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' C' C ' 51' ' ' VAL . . . . . . . . . . . . . 48.9 t -72.46 -53.48 19.23 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.275 0 N-CA-C 109.581 -0.525 . . . . 0.0 109.581 -175.455 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' C' C ' 52' ' ' GLN . . . . . . . . . . . . . 90.9 mt-30 -154.07 151.6 29.5 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.02 -0.536 . . . . 0.0 111.832 -177.647 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' C' C ' 53' ' ' ALA . . . . . . . . . . . . . . . -130.12 133.78 46.88 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 115.318 -0.855 . . . . 0.0 109.827 174.463 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' C' C ' 54' ' ' TYR . . . . . . . . . . . . . 53.7 t80 -129.16 111.27 18.22 Favored Pre-proline 0 CA--C 1.535 0.377 0 CA-C-O 118.267 -0.873 . . . . 0.0 110.395 178.662 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' C' C ' 55' ' ' PRO . . . . . . . . . . . . . 73.3 Cg_endo -77.1 166.33 82.64 Favored 'Cis proline' 0 N--CA 1.499 1.84 0 CA-C-N 121.919 1.721 . . . . 0.0 112.348 -6.855 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' C' C ' 56' ' ' SER . . . . . . . . . . . . . 20.3 m -116.74 135.94 23.09 Favored Pre-proline 0 CA--C 1.538 0.519 0 CA-C-O 118.423 -0.798 . . . . 0.0 109.363 173.775 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' C' C ' 57' ' ' PRO . . . . . . . . . . . . . 49.4 Cg_endo -70.0 146.03 81.58 Favored 'Cis proline' 0 N--CA 1.497 1.733 0 CA-C-N 121.832 1.69 . . . . 0.0 111.473 -1.837 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' C' C ' 58' ' ' LEU . . . . . . . . . . . . . 31.9 tp -108.16 137.65 45.77 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.331 -0.395 . . . . 0.0 110.696 -177.704 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' C' C ' 59' ' ' ARG . . . . . . . . . . . . . 55.6 ttp180 -102.89 125.23 49.56 Favored 'General case' 0 C--N 1.327 -0.377 0 N-CA-C 109.227 -0.657 . . . . 0.0 109.227 174.653 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' C' C ' 60' ' ' VAL . . . . . . . . . . . . . 45.8 t -79.66 120.78 31.66 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.293 0 C-N-CA 120.689 -0.404 . . . . 0.0 110.65 -174.717 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' C' C ' 61' ' ' GLU . . . . . . . . . . . . . 43.3 mt-10 -131.03 163.05 28.44 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 115.747 -0.661 . . . . 0.0 109.675 176.542 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' C' C ' 62' ' ' ASP . . . . . . . . . . . . . 9.3 p-10 -53.36 -32.58 49.93 Favored 'General case' 0 C--N 1.328 -0.342 0 N-CA-C 111.894 0.331 . . . . 0.0 111.894 -178.634 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' C' C ' 63' ' ' ARG . . . . . . . . . . . . . 47.8 mtp180 -73.52 -21.5 60.37 Favored 'General case' 0 CA--C 1.534 0.335 0 N-CA-C 113.033 0.753 . . . . 0.0 113.033 -176.216 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' C' C ' 64' ' ' THR . . . . . . . . . . . . . 30.2 m -61.53 138.53 58.29 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-O 120.973 0.416 . . . . 0.0 111.341 -174.02 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' C' C ' 65' ' ' LYS . . . . . . . . . . . . . 40.5 ttpt -89.34 120.37 30.62 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 115.821 -0.627 . . . . 0.0 109.946 177.631 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' C' C ' 66' ' ' ILE . . . . . . . . . . . . . 64.0 mt -113.19 130.26 67.42 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.201 0 CA-C-O 120.894 0.378 . . . . 0.0 109.989 -178.434 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' C' C ' 67' ' ' THR . . . . . . . . . . . . . 25.5 m -129.41 147.36 51.22 Favored 'General case' 0 C--N 1.332 -0.186 0 CA-C-N 116.106 -0.497 . . . . 0.0 111.173 -177.815 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' C' C ' 68' ' ' LEU . . . . . . . . . . . . . 62.8 mt . . . . . 0 C--N 1.329 -0.303 0 CA-C-N 115.851 -0.613 . . . . 0.0 110.381 177.038 . . . . . . . . 0 0 . 1 . 013 nuclear orig core ' C' C ' 73' ' ' VAL . . . . . . . . . . . . . 33.2 m . . . . . 0 C--O 1.231 0.093 0 CA-C-O 120.978 0.418 . . . . 0.0 110.718 . . . . . . . . . 0 0 . 1 . 013 nuclear orig core ' C' C ' 74' ' ' ASP . . . . . . . . . . . . . 27.7 t0 -102.16 121.62 42.58 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 115.698 -0.683 . . . . 0.0 109.405 176.745 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' C' C ' 75' ' ' VAL . . . . . . . . . . . . . 43.1 t -110.82 121.32 63.33 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.249 0 CA-C-O 121.056 0.455 . . . . 0.0 110.825 -175.543 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' C' C ' 76' ' ' LEU . . . . . . . . . . . . . 21.9 mt -117.86 141.9 47.91 Favored 'General case' 0 C--N 1.331 -0.206 0 CA-C-N 115.598 -0.728 . . . . 0.0 109.693 176.114 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' C' C ' 77' ' ' GLU . . . . . . . . . . . . . 97.9 mt-10 -136.2 135.53 39.2 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-O 120.98 0.419 . . . . 0.0 111.307 -178.168 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' C' C ' 78' ' ' ALA . . . . . . . . . . . . . . . -124.61 134.56 52.88 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 115.627 -0.715 . . . . 0.0 109.882 176.801 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' C' C ' 79' ' ' LYS . . . . . . . . . . . . . 66.3 mmtt -78.54 121.25 24.36 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-O 120.976 0.417 . . . . 0.0 110.597 179.851 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' C' C ' 80' ' ' ILE . . . . . . . . . . . . . 42.2 mm -139.06 115.06 9.41 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.305 0 N-CA-C 109.291 -0.633 . . . . 0.0 109.291 -178.422 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' C' C ' 81' ' ' LYS . . . . . . . . . . . . . 46.7 pttt -104.11 123.37 47.13 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-O 121.085 0.469 . . . . 0.0 111.096 -178.437 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' C' C ' 82' ' ' GLY . . . . . . . . . . . . . . . 89.07 42.13 5.69 Favored Glycine 0 CA--C 1.525 0.697 0 C-N-CA 120.701 -0.761 . . . . 0.0 111.838 174.358 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' C' C ' 83' ' ' ILE . . . . . . . . . . . . . 70.6 mt -64.22 138.45 23.04 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.272 0 N-CA-C 109.73 -0.471 . . . . 0.0 109.73 177.691 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' C' C ' 84' ' ' LYS . . . . . . . . . . . . . 77.4 tttt -100.14 -51.15 3.75 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 115.995 -0.548 . . . . 0.0 110.465 -177.325 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' C' C ' 85' ' ' ASP . . . . . . . . . . . . . 5.1 t0 -156.51 152.26 27.13 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.014 -0.539 . . . . 0.0 110.319 -179.707 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' C' C ' 86' ' ' VAL . . . . . . . . . . . . . 44.0 t -130.16 132.73 65.04 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.229 0 CA-C-O 121.021 0.438 . . . . 0.0 110.622 -179.461 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' C' C ' 87' ' ' ILE . . . . . . . . . . . . . 43.5 mm -122.04 125.19 72.75 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.29 0 CA-C-N 115.948 -0.569 . . . . 0.0 109.604 176.098 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' C' C ' 88' ' ' LEU . . . . . . . . . . . . . 14.8 tp -111.03 129.27 55.96 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-O 120.84 0.352 . . . . 0.0 111.139 -177.145 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' C' C ' 89' ' ' ASP . . . . . . . . . . . . . 12.6 t70 -121.38 151.25 40.36 Favored 'General case' 0 C--N 1.33 -0.258 0 N-CA-C 109.555 -0.535 . . . . 0.0 109.555 176.67 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' C' C ' 90' ' ' GLU . . . . . . . . . . . . . 83.5 tt0 -48.86 -33.24 10.24 Favored 'General case' 0 C--N 1.328 -0.342 0 N-CA-C 112.64 0.607 . . . . 0.0 112.64 -173.082 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' C' C ' 91' ' ' ASN . . . . . . . . . . . . . 79.2 m-20 -131.99 28.14 4.5 Favored 'General case' 0 N--CA 1.466 0.333 0 N-CA-C 112.411 0.523 . . . . 0.0 112.411 -175.764 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' C' C ' 92' ' ' LEU . . . . . . . . . . . . . 11.7 tp -166.2 150.94 8.05 Favored 'General case' 0 C--N 1.33 -0.245 0 C-N-CA 120.835 -0.346 . . . . 0.0 110.851 -179.281 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' C' C ' 93' ' ' ILE . . . . . . . . . . . . . 69.0 mt -126.87 125.72 67.21 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.173 0 N-CA-C 109.757 -0.46 . . . . 0.0 109.757 179.629 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' C' C ' 94' ' ' VAL . . . . . . . . . . . . . 43.2 t -123.14 128.67 75.1 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.238 0 N-CA-C 110.077 -0.342 . . . . 0.0 110.077 178.957 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' C' C ' 95' ' ' VAL . . . . . . . . . . . . . 40.9 t -124.23 136.86 59.08 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.235 0 CA-C-O 120.933 0.397 . . . . 0.0 110.072 -179.406 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' C' C ' 96' ' ' ILE . . . . . . . . . . . . . 59.7 mt -114.31 130.11 69.16 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.335 0 N-CA-C 109.266 -0.642 . . . . 0.0 109.266 179.035 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' C' C ' 97' ' ' THR . . . . . . . . . . . . . 68.1 p -102.93 154.36 19.29 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-O 121.253 0.549 . . . . 0.0 111.192 -177.704 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' C' C ' 98' ' ' GLU . . . . . . . . . . . . . 84.0 tt0 -53.86 -24.61 16.41 Favored 'General case' 0 CA--C 1.533 0.322 0 N-CA-C 112.299 0.481 . . . . 0.0 112.299 179.625 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' C' C ' 99' ' ' GLU . . . . . . . . . . . . . 13.8 mm-40 -77.67 14.71 0.97 Allowed 'General case' 0 CA--C 1.535 0.391 0 N-CA-C 113.266 0.839 . . . . 0.0 113.266 -177.471 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' C' C ' 100' ' ' ASN . . . . . . . . . . . . . 2.9 m-20 62.89 38.05 11.64 Favored 'General case' 0 N--CA 1.464 0.245 0 CA-C-O 121.116 0.484 . . . . 0.0 110.757 178.686 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' C' C ' 101' ' ' GLU . . . . . . . . . . . . . 83.6 tt0 -122.36 145.97 47.77 Favored 'General case' 0 C--N 1.331 -0.217 0 CA-C-N 116.182 -0.463 . . . . 0.0 109.924 177.773 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' C' C ' 102' ' ' VAL . . . . . . . . . . . . . 44.1 t -114.95 129.26 71.44 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.232 0 CA-C-N 116.302 -0.408 . . . . 0.0 110.047 -177.396 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' C' C ' 103' ' ' LEU . . . . . . . . . . . . . 27.6 mt -119.63 131.55 55.49 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 115.59 -0.732 . . . . 0.0 110.131 177.06 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' C' C ' 104' ' ' ILE . . . . . . . . . . . . . 72.3 mt -117.15 125.07 73.73 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.276 0 N-CA-C 109.816 -0.438 . . . . 0.0 109.816 178.872 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' C' C ' 105' ' ' PHE . . . . . . . . . . . . . 93.8 m-85 -122.49 163.44 19.89 Favored 'General case' 0 C--O 1.232 0.144 0 O-C-N 123.904 0.752 . . . . 0.0 109.945 -177.909 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' C' C ' 106' ' ' ASN . . . . . . . . . . . . . 44.9 p-10 -101.08 -171.25 1.96 Allowed 'General case' 0 C--N 1.332 -0.19 0 CA-C-N 116.549 -0.296 . . . . 0.0 110.249 174.755 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' C' C ' 107' ' ' GLN . . . . . . . . . . . . . 40.4 tt0 -58.32 -29.51 65.97 Favored 'General case' 0 CA--C 1.533 0.297 0 N-CA-C 112.027 0.38 . . . . 0.0 112.027 -179.972 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' C' C ' 108' ' ' ASN . . . . . . . . . . . . . 5.1 t-20 -85.27 7.9 20.51 Favored 'General case' 0 CA--C 1.538 0.506 0 N-CA-C 113.279 0.844 . . . . 0.0 113.279 -176.559 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' C' C ' 109' ' ' LEU . . . . . . . . . . . . . 10.7 tp 60.07 36.97 21.3 Favored 'General case' 0 CA--C 1.531 0.225 0 CA-C-O 120.98 0.419 . . . . 0.0 111.28 179.513 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' C' C ' 110' ' ' GLU . . . . . . . . . . . . . 70.6 mm-40 -108.83 147.96 31.3 Favored 'General case' 0 C--N 1.33 -0.269 0 N-CA-C 109.653 -0.499 . . . . 0.0 109.653 175.199 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' C' C ' 111' ' ' GLU . . . . . . . . . . . . . 55.4 tt0 -82.57 121.92 27.42 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-O 120.958 0.409 . . . . 0.0 111.022 -174.122 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' C' C ' 112' ' ' LEU . . . . . . . . . . . . . 11.8 mt -103.28 -46.2 4.67 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 115.936 -0.574 . . . . 0.0 110.888 179.47 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' C' C ' 113' ' ' TYR . . . . . . . . . . . . . 64.2 t80 -133.34 136.6 45.48 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 116.464 -0.335 . . . . 0.0 111.397 -177.444 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' C' C ' 114' ' ' ARG . . . . . . . . . . . . . 35.8 ttp180 -135.44 121.0 19.36 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 115.918 -0.583 . . . . 0.0 110.316 177.841 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' C' C ' 115' ' ' GLY . . . . . . . . . . . . . . . -150.01 145.44 13.54 Favored Glycine 0 CA--C 1.524 0.638 0 N-CA-C 111.062 -0.815 . . . . 0.0 111.062 178.122 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' C' C ' 116' ' ' LYS . . . . . . . . . . . . . 34.6 ttpt -117.16 138.34 51.73 Favored 'General case' 0 C--N 1.33 -0.249 0 N-CA-C 109.9 -0.407 . . . . 0.0 109.9 177.974 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' C' C ' 117' ' ' PHE . . . . . . . . . . . . . 46.1 m-85 -135.47 113.97 11.66 Favored 'General case' 0 C--N 1.33 -0.264 0 N-CA-C 109.941 -0.392 . . . . 0.0 109.941 -178.573 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' C' C ' 118' ' ' GLU . . . . . . . . . . . . . 45.8 tp10 -55.05 -42.66 72.98 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.391 -0.368 . . . . 0.0 111.211 -176.304 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' C' C ' 119' ' ' ASN . . . . . . . . . . . . . 4.7 m120 -99.81 31.11 3.37 Favored 'General case' 0 C--N 1.33 -0.247 0 N-CA-C 112.255 0.465 . . . . 0.0 112.255 -173.852 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' C' C ' 120' ' ' LEU . . . . . . . . . . . . . 15.9 tp -56.02 119.99 6.75 Favored 'General case' 0 N--CA 1.461 0.118 0 CA-C-O 120.783 0.325 . . . . 0.0 110.377 177.603 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' C' C ' 121' ' ' ASN . . . . . . . . . . . . . 7.8 t-20 -113.84 -44.1 3.21 Favored 'General case' 0 C--N 1.332 -0.157 0 CA-C-N 116.457 -0.338 . . . . 0.0 110.944 -176.208 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' C' C ' 122' ' ' LYS . . . . . . . . . . . . . 61.8 mtpt -140.23 146.17 38.32 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-O 121.079 0.466 . . . . 0.0 111.518 -177.682 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' C' C ' 123' ' ' VAL . . . . . . . . . . . . . 47.7 t -124.16 126.88 72.93 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.319 0 CA-C-N 115.816 -0.629 . . . . 0.0 109.582 175.557 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' C' C ' 124' ' ' LEU . . . . . . . . . . . . . 50.9 mt -114.5 127.75 55.97 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.141 -0.481 . . . . 0.0 110.126 -179.331 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' C' C ' 125' ' ' VAL . . . . . . . . . . . . . 41.4 t -135.6 121.93 32.3 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.33 0 CA-C-O 120.765 0.317 . . . . 0.0 110.259 179.478 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' C' C ' 126' ' ' ARG . . . . . . . . . . . . . 79.0 mtt85 -151.39 136.15 17.19 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 116.094 -0.503 . . . . 0.0 109.696 175.831 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' C' C ' 127' ' ' ASN . . . . . . . . . . . . . 75.6 m-20 56.13 -152.1 0.38 Allowed 'General case' 0 CA--C 1.539 0.532 0 N-CA-C 109.702 -0.481 . . . . 0.0 109.702 -178.202 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' C' C ' 128' ' ' ASP . . . . . . . . . . . . . 20.2 p-10 -88.08 21.54 2.72 Favored 'General case' 0 CA--C 1.534 0.346 0 CA-C-N 118.596 0.635 . . . . 0.0 112.377 176.806 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' C' C ' 129' ' ' LEU . . . . . . . . . . . . . 1.4 tt -115.43 134.67 54.87 Favored 'General case' 0 C--O 1.235 0.312 0 O-C-N 122.039 -0.413 . . . . 0.0 109.963 -179.338 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' C' C ' 130' ' ' VAL . . . . . . . . . . . . . 41.6 t -123.06 139.88 48.45 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.313 0 CA-C-O 121.017 0.437 . . . . 0.0 110.579 -175.788 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' C' C ' 131' ' ' VAL . . . . . . . . . . . . . 41.4 t -135.99 135.8 50.14 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.278 0 CA-C-N 116.097 -0.501 . . . . 0.0 110.266 178.209 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' C' C ' 132' ' ' ILE . . . . . . . . . . . . . 71.8 mt -117.44 131.53 69.88 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.314 0 N-CA-C 109.502 -0.555 . . . . 0.0 109.502 179.297 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' C' C ' 133' ' ' ILE . . . . . . . . . . . . . 35.7 mm -115.6 119.62 62.36 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.25 0 CA-C-O 120.803 0.335 . . . . 0.0 110.86 -176.387 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' C' C ' 134' ' ' ASP . . . . . . . . . . . . . 5.9 p-10 -129.71 148.81 51.63 Favored 'General case' 0 C--N 1.332 -0.193 0 CA-C-N 116.016 -0.538 . . . . 0.0 109.734 176.502 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' C' C ' 135' ' ' GLU . . . . . . . . . . . . . 75.2 tt0 -50.29 -27.55 6.31 Favored 'General case' 0 C--N 1.328 -0.333 0 N-CA-C 113.096 0.776 . . . . 0.0 113.096 -170.884 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' C' C ' 136' ' ' GLN . . . . . . . . . . . . . 13.9 pt20 -101.94 -14.65 17.11 Favored 'General case' 0 CA--C 1.535 0.378 0 N-CA-C 113.514 0.931 . . . . 0.0 113.514 -172.237 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' C' C ' 137' ' ' LYS . . . . . . . . . . . . . 13.3 ptpt -168.52 168.2 11.17 Favored 'General case' 0 N--CA 1.462 0.175 0 CA-C-O 121.622 0.725 . . . . 0.0 112.228 178.743 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' C' C ' 138' ' ' LEU . . . . . . . . . . . . . 5.8 tt -119.39 129.57 54.87 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 114.957 -1.019 . . . . 0.0 109.737 179.395 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' C' C ' 139' ' ' THR . . . . . . . . . . . . . 38.6 m -110.29 130.04 55.62 Favored 'General case' 0 C--N 1.331 -0.214 0 CA-C-N 116.449 -0.341 . . . . 0.0 110.488 -179.218 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' C' C ' 140' ' ' LEU . . . . . . . . . . . . . 15.2 tp -115.71 125.29 52.62 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 115.688 -0.687 . . . . 0.0 109.41 -178.661 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' C' C ' 141' ' ' ILE . . . . . . . . . . . . . 19.2 mt -122.73 117.4 51.77 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.24 0 CA-C-O 120.861 0.362 . . . . 0.0 110.032 -175.33 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' C' C ' 142' ' ' ARG . . . . . . . . . . . . . 81.3 mtm180 . . . . . 0 C--N 1.331 -0.196 0 CA-C-N 115.499 -0.773 . . . . 0.0 109.939 179.917 . . . . . . . . 0 0 . 1 . 013 nuclear orig core ' D' D ' 2' ' ' SER . . . . . . . . . . . . . 2.5 p . . . . . 0 C--O 1.231 0.096 0 CA-C-O 120.897 0.379 . . . . 0.0 110.36 . . . . . . . . . 0 0 . 1 . 013 nuclear orig core ' D' D ' 3' ' ' GLU . . . . . . . . . . . . . 83.7 tt0 -141.54 142.26 33.54 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-N 115.931 -0.577 . . . . 0.0 111.056 -177.123 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' D' D ' 4' ' ' LEU . . . . . . . . . . . . . 21.6 tp -124.81 129.77 51.08 Favored 'General case' 0 C--N 1.331 -0.213 0 CA-C-N 116.109 -0.496 . . . . 0.0 110.192 175.803 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' D' D ' 5' ' ' LYS . . . . . . . . . . . . . 68.7 mttm -104.7 120.08 40.51 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-N 116.25 -0.432 . . . . 0.0 110.542 178.635 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' D' D ' 6' ' ' LEU . . . . . . . . . . . . . 45.5 mt -115.22 146.76 41.12 Favored 'General case' 0 C--N 1.331 -0.223 0 CA-C-N 115.389 -0.823 . . . . 0.0 110.236 -179.872 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' D' D ' 7' ' ' LYS . . . . . . . . . . . . . 85.5 tttt -132.71 131.76 22.26 Favored Pre-proline 0 CA--C 1.537 0.453 0 CA-C-O 118.67 -0.681 . . . . 0.0 110.2 176.465 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' D' D ' 8' ' ' PRO . . . . . . . . . . . . . 95.1 Cg_endo -87.37 140.78 5.55 Favored 'Trans proline' 0 N--CA 1.491 1.362 0 C-N-CA 121.508 1.472 . . . . 0.0 111.632 175.776 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' D' D ' 9' ' ' LEU . . . . . . . . . . . . . 37.2 mt -79.98 -49.21 1.3 Allowed Pre-proline 0 CA--C 1.535 0.376 0 CA-C-O 118.566 -0.731 . . . . 0.0 112.494 -177.927 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' D' D ' 10' ' ' PRO . . . . . . . . . . . . . 85.6 Cg_endo -77.5 154.32 31.29 Favored 'Trans proline' 0 N--CA 1.498 1.752 0 C-N-CA 121.183 1.255 . . . . 0.0 112.27 179.808 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' D' D ' 11' ' ' LYS . . . . . . . . . . . . . 80.8 tttt -88.1 100.18 12.75 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 116.236 -0.438 . . . . 0.0 110.382 178.438 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' D' D ' 12' ' ' VAL . . . . . . . . . . . . . 12.3 p -143.94 147.89 19.31 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.273 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.667 -178.985 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' D' D ' 13' ' ' GLU . . . . . . . . . . . . . 70.7 mm-40 -81.55 123.14 28.4 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.229 -0.441 . . . . 0.0 109.999 177.13 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' D' D ' 14' ' ' LEU . . . . . . . . . . . . . 18.2 mt -98.12 147.02 32.51 Favored Pre-proline 0 CA--C 1.532 0.285 0 CA-C-O 119.158 -0.448 . . . . 0.0 110.444 -179.203 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' D' D ' 15' ' ' PRO . . . . . . . . . . . . . 27.1 Cg_exo -61.8 156.0 51.02 Favored 'Trans proline' 0 N--CA 1.499 1.807 0 C-N-CA 121.316 1.344 . . . . 0.0 112.004 177.489 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' D' D ' 16' ' ' PRO . . . . . . . . . . . . . 32.1 Cg_exo -59.85 -37.2 87.77 Favored 'Trans proline' 0 N--CA 1.497 1.689 0 C-N-CA 121.398 1.399 . . . . 0.0 112.55 178.962 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' D' D ' 17' ' ' ASP . . . . . . . . . . . . . 8.8 p-10 -87.53 15.77 6.29 Favored 'General case' 0 CA--C 1.536 0.419 0 N-CA-C 112.869 0.692 . . . . 0.0 112.869 -177.529 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' D' D ' 18' ' ' PHE . . . . . . . . . . . . . 35.7 t80 -56.38 -47.34 79.13 Favored 'General case' 0 C--N 1.334 -0.089 0 O-C-N 122.031 -0.418 . . . . 0.0 110.536 -178.283 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' D' D ' 19' ' ' VAL . . . . . . . . . . . . . 48.5 t -55.05 -40.89 56.28 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.259 0 C-N-CA 121.139 -0.224 . . . . 0.0 110.915 -177.337 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' D' D ' 20' ' ' ASP . . . . . . . . . . . . . 70.0 m-20 -60.06 -45.01 94.29 Favored 'General case' 0 C--N 1.331 -0.233 0 C-N-CA 120.864 -0.335 . . . . 0.0 110.959 -178.143 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' D' D ' 21' ' ' VAL . . . . . . . . . . . . . 47.5 t -65.52 -46.27 90.26 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.336 0 C-N-CA 120.631 -0.428 . . . . 0.0 110.585 -178.316 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' D' D ' 22' ' ' ILE . . . . . . . . . . . . . 49.4 mm -55.61 -58.67 4.01 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.295 0 C-N-CA 121.074 -0.25 . . . . 0.0 111.038 -178.101 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' D' D ' 23' ' ' ARG . . . . . . . . . . . . . 12.2 ptm180 -55.83 -42.78 76.25 Favored 'General case' 0 C--N 1.332 -0.183 0 C-N-CA 120.71 -0.396 . . . . 0.0 111.747 -174.662 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' D' D ' 24' ' ' ILE . . . . . . . . . . . . . 74.4 mt -59.78 -42.66 89.59 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.321 0 C-N-CA 120.871 -0.331 . . . . 0.0 111.314 -177.502 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' D' D ' 25' ' ' LYS . . . . . . . . . . . . . 97.5 mttt -69.08 -42.02 76.76 Favored 'General case' 0 C--N 1.329 -0.298 0 N-CA-C 112.457 0.54 . . . . 0.0 112.457 -179.808 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' D' D ' 26' ' ' LEU . . . . . . . . . . . . . 86.9 mt -78.87 -30.9 45.32 Favored 'General case' 0 C--N 1.329 -0.3 0 N-CA-C 113.708 1.003 . . . . 0.0 113.708 -169.851 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' D' D ' 27' ' ' GLN . . . . . . . . . . . . . 10.7 pt20 -47.45 141.4 4.98 Favored 'General case' 0 N--CA 1.469 0.497 0 N-CA-C 112.679 0.622 . . . . 0.0 112.679 -175.223 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' D' D ' 28' ' ' GLY . . . . . . . . . . . . . . . 100.07 -22.38 40.43 Favored Glycine 0 CA--C 1.533 1.158 0 CA-C-N 115.709 -0.678 . . . . 0.0 112.495 -177.109 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' D' D ' 29' ' ' LYS . . . . . . . . . . . . . 74.2 mmtt -96.59 155.02 16.95 Favored 'General case' 0 C--O 1.232 0.137 0 CA-C-N 117.588 0.694 . . . . 0.0 110.721 177.901 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' D' D ' 30' ' ' THR . . . . . . . . . . . . . 32.3 m -106.6 136.76 45.83 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.154 -0.475 . . . . 0.0 109.885 176.225 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' D' D ' 31' ' ' VAL . . . . . . . . . . . . . 34.8 m -129.47 156.27 41.8 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.203 0 CA-C-O 120.907 0.384 . . . . 0.0 110.864 -178.289 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' D' D ' 32' ' ' ARG . . . . . . . . . . . . . 54.0 ttp180 -133.99 150.82 51.28 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 115.857 -0.611 . . . . 0.0 110.384 178.652 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' D' D ' 33' ' ' THR . . . . . . . . . . . . . 27.4 m -53.06 139.99 26.66 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.419 -0.355 . . . . 0.0 111.339 -179.37 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' D' D ' 34' ' ' GLY . . . . . . . . . . . . . . . 99.74 -17.18 57.81 Favored Glycine 0 CA--C 1.533 1.181 0 CA-C-O 119.762 -0.466 . . . . 0.0 113.218 179.909 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' D' D ' 35' ' ' ASP . . . . . . . . . . . . . 73.4 m-20 -66.89 149.21 50.92 Favored 'General case' 0 C--O 1.231 0.122 0 CA-C-N 118.019 0.909 . . . . 0.0 111.3 178.609 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' D' D ' 36' ' ' VAL . . . . . . . . . . . . . 45.9 t -122.24 129.46 75.31 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.286 0 CA-C-N 115.815 -0.63 . . . . 0.0 109.692 177.463 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' D' D ' 37' ' ' ILE . . . . . . . . . . . . . 66.6 mt -119.9 138.08 51.65 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.264 0 CA-C-N 116.367 -0.379 . . . . 0.0 110.042 -178.942 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' D' D ' 38' ' ' GLY . . . . . . . . . . . . . . . -112.3 128.79 8.69 Favored Glycine 0 CA--C 1.524 0.653 0 N-CA-C 111.009 -0.836 . . . . 0.0 111.009 179.487 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' D' D ' 39' ' ' ILE . . . . . . . . . . . . . 72.1 mt -122.91 132.58 71.1 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.184 0 N-CA-C 110.039 -0.356 . . . . 0.0 110.039 179.319 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' D' D ' 40' ' ' SER . . . . . . . . . . . . . 13.6 t -92.51 119.41 31.97 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.474 -0.33 . . . . 0.0 110.647 176.153 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' D' D ' 41' ' ' ILE . . . . . . . . . . . . . 73.0 mt -131.1 115.99 31.74 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.208 0 CA-C-O 120.987 0.422 . . . . 0.0 110.691 179.51 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' D' D ' 42' ' ' LEU . . . . . . . . . . . . . 1.4 tt 52.58 48.17 23.12 Favored 'General case' 0 CA--C 1.532 0.288 0 CA-C-N 115.738 -0.665 . . . . 0.0 110.989 175.9 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' D' D ' 43' ' ' GLY . . . . . . . . . . . . . . . 70.19 16.44 73.13 Favored Glycine 0 CA--C 1.534 1.266 0 C-N-CA 121.064 -0.589 . . . . 0.0 113.089 174.75 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' D' D ' 44' ' ' LYS . . . . . . . . . . . . . 53.3 mtmt -128.38 130.01 47.07 Favored 'General case' 0 C--N 1.333 -0.133 0 CA-C-N 117.788 0.794 . . . . 0.0 110.304 179.629 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' D' D ' 45' ' ' GLU . . . . . . . . . . . . . 81.4 tt0 -84.84 124.51 31.67 Favored 'General case' 0 C--N 1.327 -0.406 0 CA-C-N 116.451 -0.341 . . . . 0.0 110.737 -179.858 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' D' D ' 46' ' ' VAL . . . . . . . . . . . . . 7.3 p -122.26 127.06 75.07 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.235 0 N-CA-C 109.651 -0.5 . . . . 0.0 109.651 176.498 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' D' D ' 47' ' ' LYS . . . . . . . . . . . . . 99.3 mttt -101.03 130.66 47.07 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.008 -0.542 . . . . 0.0 111.481 178.171 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' D' D ' 48' ' ' PHE . . . . . . . . . . . . . 92.1 m-85 -113.86 131.95 56.08 Favored 'General case' 0 C--N 1.329 -0.303 0 N-CA-C 109.559 -0.534 . . . . 0.0 109.559 174.592 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' D' D ' 49' ' ' LYS . . . . . . . . . . . . . 80.6 tttt -107.99 137.44 45.98 Favored 'General case' 0 C--N 1.329 -0.309 0 N-CA-C 110.284 -0.265 . . . . 0.0 110.284 178.8 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' D' D ' 50' ' ' VAL . . . . . . . . . . . . . 45.6 t -81.69 109.2 15.61 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.252 0 N-CA-C 109.236 -0.653 . . . . 0.0 109.236 176.889 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' D' D ' 51' ' ' VAL . . . . . . . . . . . . . 48.8 t -74.35 -47.07 41.96 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.278 0 CA-C-N 115.902 -0.59 . . . . 0.0 110.213 -173.809 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' D' D ' 52' ' ' GLN . . . . . . . . . . . . . 31.2 tt0 -163.88 142.49 7.63 Favored 'General case' 0 C--N 1.332 -0.19 0 C-N-CA 120.26 -0.576 . . . . 0.0 111.789 -178.432 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' D' D ' 53' ' ' ALA . . . . . . . . . . . . . . . -118.55 132.33 56.21 Favored 'General case' 0 C--N 1.332 -0.184 0 CA-C-N 115.812 -0.631 . . . . 0.0 110.194 177.207 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' D' D ' 54' ' ' TYR . . . . . . . . . . . . . 55.0 t80 -128.98 107.92 18.14 Favored Pre-proline 0 CA--C 1.534 0.362 0 CA-C-O 118.252 -0.88 . . . . 0.0 110.557 -179.849 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' D' D ' 55' ' ' PRO . . . . . . . . . . . . . 73.8 Cg_endo -77.27 170.08 72.37 Favored 'Cis proline' 0 N--CA 1.501 1.914 0 CA-C-N 121.89 1.711 . . . . 0.0 112.274 -5.67 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' D' D ' 56' ' ' SER . . . . . . . . . . . . . 32.8 m -116.46 133.57 22.97 Favored Pre-proline 0 CA--C 1.539 0.547 0 CA-C-O 118.418 -0.801 . . . . 0.0 109.408 174.447 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' D' D ' 57' ' ' PRO . . . . . . . . . . . . . 41.9 Cg_endo -67.8 166.33 66.7 Favored 'Cis proline' 0 N--CA 1.499 1.8 0 CA-C-N 121.874 1.705 . . . . 0.0 111.524 -1.446 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' D' D ' 58' ' ' LEU . . . . . . . . . . . . . 38.5 tp -129.27 138.03 51.41 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.239 -0.437 . . . . 0.0 110.173 179.657 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' D' D ' 59' ' ' ARG . . . . . . . . . . . . . 72.7 ttt-85 -101.95 129.32 48.19 Favored 'General case' 0 C--N 1.329 -0.306 0 N-CA-C 109.405 -0.591 . . . . 0.0 109.405 178.013 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' D' D ' 60' ' ' VAL . . . . . . . . . . . . . 41.5 t -78.5 113.77 18.23 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.299 0 C-N-CA 120.782 -0.367 . . . . 0.0 110.255 -176.165 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' D' D ' 61' ' ' GLU . . . . . . . . . . . . . 82.8 tt0 -131.24 151.57 51.35 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 115.913 -0.585 . . . . 0.0 109.66 175.998 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' D' D ' 62' ' ' ASP . . . . . . . . . . . . . 50.6 m-20 -49.58 -32.08 11.92 Favored 'General case' 0 C--N 1.327 -0.396 0 N-CA-C 112.129 0.418 . . . . 0.0 112.129 179.394 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' D' D ' 63' ' ' ARG . . . . . . . . . . . . . 35.0 mtp180 -75.0 -21.75 58.95 Favored 'General case' 0 CA--C 1.533 0.32 0 N-CA-C 113.1 0.778 . . . . 0.0 113.1 -174.859 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' D' D ' 64' ' ' THR . . . . . . . . . . . . . 23.1 m -70.23 146.72 50.48 Favored 'General case' 0 C--N 1.331 -0.222 0 CA-C-O 120.726 0.298 . . . . 0.0 110.995 -175.536 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' D' D ' 65' ' ' LYS . . . . . . . . . . . . . 40.2 ttpt -88.28 121.64 30.9 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-O 121.068 0.461 . . . . 0.0 110.306 179.64 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' D' D ' 66' ' ' ILE . . . . . . . . . . . . . 69.1 mt -113.75 125.22 70.99 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.271 0 N-CA-C 109.556 -0.535 . . . . 0.0 109.556 -178.24 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' D' D ' 67' ' ' THR . . . . . . . . . . . . . 10.8 m -123.92 141.73 51.78 Favored 'General case' 0 C--N 1.331 -0.216 0 CA-C-O 121.062 0.458 . . . . 0.0 111.295 -174.57 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' D' D ' 68' ' ' LEU . . . . . . . . . . . . . 5.7 tt . . . . . 0 C--N 1.329 -0.3 0 CA-C-N 115.746 -0.661 . . . . 0.0 109.735 177.132 . . . . . . . . 0 0 . 1 . 013 nuclear orig core ' D' D ' 73' ' ' VAL . . . . . . . . . . . . . 34.5 m . . . . . 0 N--CA 1.461 0.078 0 CA-C-O 120.512 0.196 . . . . 0.0 110.534 . . . . . . . . . 0 0 . 1 . 013 nuclear orig core ' D' D ' 74' ' ' ASP . . . . . . . . . . . . . 15.6 t0 -100.85 116.48 32.82 Favored 'General case' 0 C--N 1.332 -0.162 0 N-CA-C 109.965 -0.383 . . . . 0.0 109.965 -178.795 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' D' D ' 75' ' ' VAL . . . . . . . . . . . . . 45.2 t -113.77 124.08 70.07 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.196 0 CA-C-O 121.057 0.456 . . . . 0.0 110.304 -177.992 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' D' D ' 76' ' ' LEU . . . . . . . . . . . . . 19.2 mt -127.85 145.51 50.91 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 115.726 -0.67 . . . . 0.0 109.872 179.014 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' D' D ' 77' ' ' GLU . . . . . . . . . . . . . 97.0 mt-10 -134.03 138.62 45.48 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-O 121.092 0.472 . . . . 0.0 111.359 -178.526 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' D' D ' 78' ' ' ALA . . . . . . . . . . . . . . . -125.2 138.83 54.13 Favored 'General case' 0 C--N 1.331 -0.226 0 CA-C-N 115.743 -0.662 . . . . 0.0 109.708 176.301 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' D' D ' 79' ' ' LYS . . . . . . . . . . . . . 69.2 mttm -75.12 122.8 24.15 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-O 120.913 0.387 . . . . 0.0 110.797 -177.865 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' D' D ' 80' ' ' ILE . . . . . . . . . . . . . 24.5 mm -139.11 114.42 8.54 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.263 0 N-CA-C 109.29 -0.633 . . . . 0.0 109.29 -177.09 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' D' D ' 81' ' ' LYS . . . . . . . . . . . . . 61.7 mttp -113.42 123.24 49.61 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-O 120.866 0.365 . . . . 0.0 111.493 -175.722 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' D' D ' 82' ' ' GLY . . . . . . . . . . . . . . . 89.04 42.08 5.72 Favored Glycine 0 CA--C 1.525 0.715 0 C-N-CA 121.004 -0.617 . . . . 0.0 112.006 174.201 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' D' D ' 83' ' ' ILE . . . . . . . . . . . . . 68.9 mt -68.74 137.39 24.48 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.269 0 N-CA-C 109.992 -0.373 . . . . 0.0 109.992 178.668 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' D' D ' 84' ' ' LYS . . . . . . . . . . . . . 25.6 ttpt -105.94 -47.27 3.9 Favored 'General case' 0 C--N 1.331 -0.217 0 CA-C-N 116.455 -0.339 . . . . 0.0 110.165 177.91 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' D' D ' 85' ' ' ASP . . . . . . . . . . . . . 12.0 t70 -150.34 151.04 32.27 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.043 -0.526 . . . . 0.0 110.441 -179.272 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' D' D ' 86' ' ' VAL . . . . . . . . . . . . . 40.5 t -138.13 137.01 44.7 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.235 0 CA-C-O 121.029 0.443 . . . . 0.0 110.764 -179.266 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' D' D ' 87' ' ' ILE . . . . . . . . . . . . . 46.2 mm -122.16 130.65 74.38 Favored 'Isoleucine or valine' 0 C--O 1.233 0.192 0 CA-C-N 115.781 -0.645 . . . . 0.0 109.793 177.159 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' D' D ' 88' ' ' LEU . . . . . . . . . . . . . 18.8 tp -116.85 132.16 56.77 Favored 'General case' 0 C--N 1.331 -0.201 0 CA-C-O 121.021 0.439 . . . . 0.0 111.161 -177.623 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' D' D ' 89' ' ' ASP . . . . . . . . . . . . . 5.5 t70 -130.66 156.29 45.15 Favored 'General case' 0 C--N 1.331 -0.204 0 CA-C-N 115.835 -0.621 . . . . 0.0 109.668 175.483 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' D' D ' 90' ' ' GLU . . . . . . . . . . . . . 83.9 tt0 -47.04 -39.49 12.9 Favored 'General case' 0 C--N 1.331 -0.201 0 N-CA-C 112.97 0.73 . . . . 0.0 112.97 -172.359 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' D' D ' 91' ' ' ASN . . . . . . . . . . . . . 21.6 p-10 -131.99 36.03 3.7 Favored 'General case' 0 C--O 1.233 0.22 0 N-CA-C 111.767 0.284 . . . . 0.0 111.767 -176.215 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' D' D ' 92' ' ' LEU . . . . . . . . . . . . . 16.0 tp -165.86 138.73 4.17 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-O 120.754 0.312 . . . . 0.0 110.605 -179.821 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' D' D ' 93' ' ' ILE . . . . . . . . . . . . . 73.2 mt -124.27 123.11 65.74 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.204 0 N-CA-C 109.431 -0.581 . . . . 0.0 109.431 179.55 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' D' D ' 94' ' ' VAL . . . . . . . . . . . . . 46.0 t -124.03 128.2 73.94 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.299 0 N-CA-C 109.897 -0.409 . . . . 0.0 109.897 -178.783 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' D' D ' 95' ' ' VAL . . . . . . . . . . . . . 40.7 t -123.78 135.28 63.99 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.346 0 CA-C-N 116.133 -0.485 . . . . 0.0 109.965 -178.611 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' D' D ' 96' ' ' ILE . . . . . . . . . . . . . 66.2 mt -117.13 128.47 74.49 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.237 0 N-CA-C 109.394 -0.595 . . . . 0.0 109.394 178.661 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' D' D ' 97' ' ' THR . . . . . . . . . . . . . 71.2 p -104.35 157.06 17.41 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-O 121.388 0.613 . . . . 0.0 111.502 -176.56 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' D' D ' 98' ' ' GLU . . . . . . . . . . . . . 12.8 pt-20 -54.85 -24.49 23.33 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 115.73 -0.668 . . . . 0.0 112.492 -179.444 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' D' D ' 99' ' ' GLU . . . . . . . . . . . . . 14.8 mm-40 -80.2 16.8 1.16 Allowed 'General case' 0 CA--C 1.536 0.441 0 N-CA-C 112.959 0.725 . . . . 0.0 112.959 -178.578 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' D' D ' 100' ' ' ASN . . . . . . . . . . . . . 4.2 m-20 62.47 37.84 13.13 Favored 'General case' 0 C--O 1.233 0.198 0 CA-C-O 121.019 0.437 . . . . 0.0 110.976 178.344 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' D' D ' 101' ' ' GLU . . . . . . . . . . . . . 84.4 tt0 -114.99 140.84 48.71 Favored 'General case' 0 C--N 1.331 -0.213 0 CA-C-N 116.127 -0.488 . . . . 0.0 109.912 177.364 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' D' D ' 102' ' ' VAL . . . . . . . . . . . . . 44.7 t -114.83 124.77 71.81 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.287 0 N-CA-C 109.656 -0.498 . . . . 0.0 109.656 179.282 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' D' D ' 103' ' ' LEU . . . . . . . . . . . . . 22.0 mt -116.6 133.6 55.82 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 115.805 -0.634 . . . . 0.0 110.155 179.055 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' D' D ' 104' ' ' ILE . . . . . . . . . . . . . 69.1 mt -121.73 121.92 65.59 Favored 'Isoleucine or valine' 0 C--O 1.234 0.239 0 CA-C-N 116.577 -0.283 . . . . 0.0 110.323 -178.35 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' D' D ' 105' ' ' PHE . . . . . . . . . . . . . 74.1 m-85 -123.81 165.81 16.68 Favored 'General case' 0 C--N 1.333 -0.141 0 O-C-N 123.994 0.808 . . . . 0.0 109.937 179.933 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' D' D ' 106' ' ' ASN . . . . . . . . . . . . . 49.8 p-10 -100.54 -174.03 2.55 Favored 'General case' 0 C--N 1.331 -0.209 0 N-CA-C 109.816 -0.438 . . . . 0.0 109.816 171.422 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' D' D ' 107' ' ' GLN . . . . . . . . . . . . . 34.7 tp60 -59.21 -25.37 63.92 Favored 'General case' 0 CA--C 1.533 0.313 0 N-CA-C 112.331 0.493 . . . . 0.0 112.331 -178.016 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' D' D ' 108' ' ' ASN . . . . . . . . . . . . . 9.7 t30 -91.45 14.17 15.52 Favored 'General case' 0 CA--C 1.534 0.365 0 N-CA-C 112.9 0.704 . . . . 0.0 112.9 -176.553 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' D' D ' 109' ' ' LEU . . . . . . . . . . . . . 76.8 mt 58.77 33.57 23.15 Favored 'General case' 0 CA--C 1.529 0.172 0 CA-C-O 120.789 0.328 . . . . 0.0 111.864 179.162 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' D' D ' 110' ' ' GLU . . . . . . . . . . . . . 70.5 mm-40 -100.21 134.82 42.58 Favored 'General case' 0 C--N 1.329 -0.284 0 N-CA-C 108.932 -0.766 . . . . 0.0 108.932 173.85 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' D' D ' 111' ' ' GLU . . . . . . . . . . . . . 45.2 tt0 -82.18 121.79 27.06 Favored 'General case' 0 C--N 1.328 -0.355 0 C-N-CA 120.643 -0.423 . . . . 0.0 110.519 -174.566 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' D' D ' 112' ' ' LEU . . . . . . . . . . . . . 34.2 mt -97.85 -45.99 6.11 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 115.851 -0.613 . . . . 0.0 110.552 179.282 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' D' D ' 113' ' ' TYR . . . . . . . . . . . . . 58.6 t80 -140.84 144.7 35.49 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.072 -0.513 . . . . 0.0 111.1 -177.854 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' D' D ' 114' ' ' ARG . . . . . . . . . . . . . 33.4 ptt180 -145.89 125.11 12.95 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 115.825 -0.625 . . . . 0.0 110.21 173.617 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' D' D ' 115' ' ' GLY . . . . . . . . . . . . . . . -149.98 143.14 10.38 Favored Glycine 0 CA--C 1.523 0.536 0 N-CA-C 110.82 -0.912 . . . . 0.0 110.82 -179.706 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' D' D ' 116' ' ' LYS . . . . . . . . . . . . . 31.4 ttmt -115.86 132.53 56.62 Favored 'General case' 0 C--N 1.329 -0.318 0 N-CA-C 109.974 -0.38 . . . . 0.0 109.974 179.184 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' D' D ' 117' ' ' PHE . . . . . . . . . . . . . 52.0 m-85 -123.52 116.27 22.91 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.123 -0.49 . . . . 0.0 110.087 -177.085 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' D' D ' 118' ' ' GLU . . . . . . . . . . . . . 84.1 tt0 -53.69 -48.47 69.48 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.576 -0.284 . . . . 0.0 111.355 -176.63 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' D' D ' 119' ' ' ASN . . . . . . . . . . . . . 87.0 m-20 -95.25 31.05 2.02 Favored 'General case' 0 C--N 1.33 -0.27 0 N-CA-C 112.203 0.446 . . . . 0.0 112.203 -174.964 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' D' D ' 120' ' ' LEU . . . . . . . . . . . . . 14.6 tp -55.34 120.32 6.92 Favored 'General case' 0 C--N 1.331 -0.202 0 CA-C-O 120.714 0.292 . . . . 0.0 110.525 178.298 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' D' D ' 121' ' ' ASN . . . . . . . . . . . . . 60.3 m-80 -113.99 -44.1 3.19 Favored 'General case' 0 C--O 1.231 0.109 0 CA-C-N 116.522 -0.308 . . . . 0.0 111.332 -176.795 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' D' D ' 122' ' ' LYS . . . . . . . . . . . . . 53.3 mttm -140.86 145.7 36.54 Favored 'General case' 0 C--N 1.331 -0.219 0 CA-C-O 120.965 0.412 . . . . 0.0 111.665 -177.647 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' D' D ' 123' ' ' VAL . . . . . . . . . . . . . 45.5 t -131.58 127.51 59.48 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.258 0 CA-C-N 116.014 -0.539 . . . . 0.0 109.696 175.319 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' D' D ' 124' ' ' LEU . . . . . . . . . . . . . 14.2 tp -131.29 133.47 45.41 Favored 'General case' 0 C--N 1.33 -0.251 0 N-CA-C 110.108 -0.33 . . . . 0.0 110.108 179.13 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' D' D ' 125' ' ' VAL . . . . . . . . . . . . . 32.8 m -141.24 138.5 33.39 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 CA-C-O 120.883 0.373 . . . . 0.0 111.074 -178.89 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' D' D ' 126' ' ' ARG . . . . . . . . . . . . . 98.5 mtt180 -144.04 131.05 20.5 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 115.933 -0.576 . . . . 0.0 110.249 178.64 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' D' D ' 127' ' ' ASN . . . . . . . . . . . . . 56.5 t30 52.84 -113.46 0.77 Allowed 'General case' 0 CA--C 1.546 0.813 0 CA-C-O 118.626 -0.702 . . . . 0.0 110.849 179.366 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' D' D ' 128' ' ' ASP . . . . . . . . . . . . . 12.9 p-10 -114.03 12.65 18.01 Favored 'General case' 0 CA--C 1.536 0.416 0 CA-C-N 120.126 1.33 . . . . 0.0 113.144 179.929 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' D' D ' 129' ' ' LEU . . . . . . . . . . . . . 15.8 tp -107.0 131.92 53.52 Favored 'General case' 0 C--O 1.232 0.171 0 N-CA-C 110.002 -0.37 . . . . 0.0 110.002 179.095 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' D' D ' 130' ' ' VAL . . . . . . . . . . . . . 46.5 t -122.7 133.76 67.88 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.246 0 CA-C-O 120.773 0.321 . . . . 0.0 110.353 -177.0 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' D' D ' 131' ' ' VAL . . . . . . . . . . . . . 42.8 t -135.52 133.55 52.03 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.191 0 CA-C-O 121.093 0.473 . . . . 0.0 110.204 176.441 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' D' D ' 132' ' ' ILE . . . . . . . . . . . . . 72.5 mt -122.15 134.0 66.73 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.25 0 CA-C-N 115.743 -0.662 . . . . 0.0 109.606 -178.728 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' D' D ' 133' ' ' ILE . . . . . . . . . . . . . 40.3 mm -114.98 124.39 71.6 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.251 0 CA-C-O 120.693 0.282 . . . . 0.0 110.92 -175.298 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' D' D ' 134' ' ' ASP . . . . . . . . . . . . . 9.6 p-10 -134.63 147.83 50.27 Favored 'General case' 0 C--N 1.332 -0.179 0 N-CA-C 109.721 -0.474 . . . . 0.0 109.721 174.804 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' D' D ' 135' ' ' GLU . . . . . . . . . . . . . 43.2 tp10 -50.49 -29.48 10.56 Favored 'General case' 0 C--N 1.329 -0.296 0 N-CA-C 112.845 0.683 . . . . 0.0 112.845 -171.43 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' D' D ' 136' ' ' GLN . . . . . . . . . . . . . 98.7 mt-30 -81.17 -32.71 33.48 Favored 'General case' 0 C--N 1.331 -0.197 0 N-CA-C 112.63 0.604 . . . . 0.0 112.63 -176.016 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' D' D ' 137' ' ' LYS . . . . . . . . . . . . . 37.7 pttt -167.67 172.87 8.93 Favored 'General case' 0 C--N 1.331 -0.223 0 CA-C-O 121.625 0.726 . . . . 0.0 112.261 -172.234 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' D' D ' 138' ' ' LEU . . . . . . . . . . . . . 5.5 tt -115.06 127.64 55.75 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 115.029 -0.987 . . . . 0.0 109.828 179.158 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' D' D ' 139' ' ' THR . . . . . . . . . . . . . 28.1 m -106.2 124.86 50.24 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.143 -0.481 . . . . 0.0 110.145 -179.675 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' D' D ' 140' ' ' LEU . . . . . . . . . . . . . 11.6 tp -115.67 121.65 43.17 Favored 'General case' 0 C--N 1.327 -0.376 0 N-CA-C 109.311 -0.626 . . . . 0.0 109.311 -178.54 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' D' D ' 141' ' ' ILE . . . . . . . . . . . . . 19.5 mt -119.13 116.75 51.95 Favored 'Isoleucine or valine' 0 C--O 1.234 0.274 0 CA-C-O 120.924 0.392 . . . . 0.0 109.966 -174.847 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' D' D ' 142' ' ' ARG . . . . . . . . . . . . . 81.7 mtp180 -106.87 131.23 54.2 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-N 115.27 -0.877 . . . . 0.0 110.626 -177.751 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' D' D ' 143' ' ' THR . . . . . . . . . . . . . 33.6 p . . . . . 0 C--O 1.221 -0.441 0 CA-C-O 117.907 -1.045 . . . . 0.0 110.893 179.624 . . . . . . . . 0 0 . 1 . 013 nuclear orig core ' E' E ' 2' ' ' SER . . . . . . . . . . . . . 11.1 p . . . . . 0 C--O 1.233 0.19 0 CA-C-O 120.896 0.379 . . . . 0.0 110.646 . . . . . . . . . 0 0 . 1 . 013 nuclear orig core ' E' E ' 3' ' ' GLU . . . . . . . . . . . . . 77.6 tt0 -141.0 140.7 34.37 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.773 179.787 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' E' E ' 4' ' ' LEU . . . . . . . . . . . . . 5.2 tt -125.82 128.28 47.42 Favored 'General case' 0 C--N 1.331 -0.215 0 CA-C-N 116.087 -0.506 . . . . 0.0 110.124 177.79 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' E' E ' 5' ' ' LYS . . . . . . . . . . . . . 68.9 mttm -105.04 122.59 46.19 Favored 'General case' 0 C--O 1.235 0.291 0 CA-C-N 116.428 -0.351 . . . . 0.0 110.868 -179.307 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' E' E ' 6' ' ' LEU . . . . . . . . . . . . . 64.6 mt -114.61 148.99 37.3 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-N 115.633 -0.712 . . . . 0.0 110.899 -179.153 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' E' E ' 7' ' ' LYS . . . . . . . . . . . . . 79.6 tttt -138.61 134.38 17.29 Favored Pre-proline 0 CA--C 1.535 0.387 0 CA-C-O 118.893 -0.575 . . . . 0.0 109.909 174.676 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' E' E ' 8' ' ' PRO . . . . . . . . . . . . . 88.8 Cg_endo -88.63 142.29 4.9 Favored 'Trans proline' 0 N--CA 1.492 1.42 0 C-N-CA 121.536 1.49 . . . . 0.0 111.624 177.497 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' E' E ' 9' ' ' LEU . . . . . . . . . . . . . 73.7 mt -76.03 -47.27 3.71 Favored Pre-proline 0 CA--C 1.534 0.341 0 CA-C-O 118.792 -0.623 . . . . 0.0 112.058 -178.432 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' E' E ' 10' ' ' PRO . . . . . . . . . . . . . 97.7 Cg_endo -82.34 149.1 14.91 Favored 'Trans proline' 0 N--CA 1.495 1.603 0 C-N-CA 121.276 1.318 . . . . 0.0 111.712 174.463 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' E' E ' 11' ' ' LYS . . . . . . . . . . . . . 59.8 mttp -88.47 97.6 11.16 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-O 120.886 0.374 . . . . 0.0 110.558 178.648 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' E' E ' 12' ' ' VAL . . . . . . . . . . . . . 11.9 p -139.54 148.28 23.45 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.274 0 CA-C-N 115.946 -0.57 . . . . 0.0 110.216 179.79 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' E' E ' 13' ' ' GLU . . . . . . . . . . . . . 81.1 tt0 -81.95 121.72 26.86 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.35 -0.386 . . . . 0.0 109.974 179.085 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' E' E ' 14' ' ' LEU . . . . . . . . . . . . . 31.2 mt -95.89 150.48 37.38 Favored Pre-proline 0 CA--C 1.532 0.271 0 CA-C-N 116.355 -0.384 . . . . 0.0 110.466 -178.581 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' E' E ' 15' ' ' PRO . . . . . . . . . . . . . 33.1 Cg_exo -60.09 158.91 27.98 Favored 'Trans proline' 0 N--CA 1.497 1.728 0 C-N-CA 121.182 1.254 . . . . 0.0 112.024 178.9 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' E' E ' 16' ' ' PRO . . . . . . . . . . . . . 26.8 Cg_exo -60.69 -44.05 28.59 Favored 'Trans proline' 0 N--CA 1.497 1.708 0 C-N-CA 121.453 1.435 . . . . 0.0 112.962 -178.106 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' E' E ' 17' ' ' ASP . . . . . . . . . . . . . 14.3 p-10 -82.69 9.83 8.81 Favored 'General case' 0 C--N 1.327 -0.388 0 N-CA-C 113.259 0.837 . . . . 0.0 113.259 -176.772 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' E' E ' 18' ' ' PHE . . . . . . . . . . . . . 48.0 t80 -57.45 -42.95 83.49 Favored 'General case' 0 N--CA 1.457 -0.089 0 O-C-N 121.896 -0.502 . . . . 0.0 110.243 -178.539 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' E' E ' 19' ' ' VAL . . . . . . . . . . . . . 47.7 t -56.88 -44.63 82.56 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.362 0 CA-C-N 116.384 -0.371 . . . . 0.0 110.473 -177.945 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' E' E ' 20' ' ' ASP . . . . . . . . . . . . . 72.3 m-20 -59.61 -41.31 90.07 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-O 120.773 0.32 . . . . 0.0 110.78 -177.824 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' E' E ' 21' ' ' VAL . . . . . . . . . . . . . 46.4 t -64.24 -46.36 93.6 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.323 0 C-N-CA 120.725 -0.39 . . . . 0.0 110.476 -178.239 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' E' E ' 22' ' ' ILE . . . . . . . . . . . . . 48.6 mm -61.6 -35.58 68.03 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.266 0 C-N-CA 121.034 -0.267 . . . . 0.0 111.058 -179.852 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' E' E ' 23' ' ' ARG . . . . . . . . . . . . . 58.1 ttp180 -57.38 -47.79 80.74 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-O 120.965 0.412 . . . . 0.0 110.355 176.971 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' E' E ' 24' ' ' ILE . . . . . . . . . . . . . 76.0 mt -61.83 -46.67 96.0 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.238 0 CA-C-N 115.928 -0.578 . . . . 0.0 112.02 -178.037 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' E' E ' 25' ' ' LYS . . . . . . . . . . . . . 12.6 ptmm? -68.45 -35.17 77.21 Favored 'General case' 0 CA--C 1.532 0.283 0 C-N-CA 120.632 -0.427 . . . . 0.0 111.824 -174.05 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' E' E ' 26' ' ' LEU . . . . . . . . . . . . . 63.3 mt -79.19 -46.45 17.88 Favored 'General case' 0 C--N 1.331 -0.219 0 N-CA-C 112.963 0.727 . . . . 0.0 112.963 -174.918 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' E' E ' 27' ' ' GLN . . . . . . . . . . . . . 11.1 pt20 -46.52 140.84 4.05 Favored 'General case' 0 N--CA 1.468 0.466 0 N-CA-C 112.937 0.717 . . . . 0.0 112.937 -173.786 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' E' E ' 28' ' ' GLY . . . . . . . . . . . . . . . 100.72 -29.93 11.37 Favored Glycine 0 CA--C 1.53 1.01 0 CA-C-N 115.382 -0.827 . . . . 0.0 112.0 -176.776 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' E' E ' 29' ' ' LYS . . . . . . . . . . . . . 98.4 mttt -99.52 155.3 17.64 Favored 'General case' 0 C--O 1.234 0.273 0 CA-C-N 117.137 0.469 . . . . 0.0 111.58 179.435 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' E' E ' 30' ' ' THR . . . . . . . . . . . . . 32.2 m -97.12 140.03 32.23 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 115.93 -0.577 . . . . 0.0 110.266 176.203 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' E' E ' 31' ' ' VAL . . . . . . . . . . . . . 35.1 m -131.13 153.7 39.52 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.238 0 CA-C-N 116.234 -0.439 . . . . 0.0 110.711 -179.616 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' E' E ' 32' ' ' ARG . . . . . . . . . . . . . 75.9 mtt180 -132.7 150.1 52.2 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.04 -0.527 . . . . 0.0 110.489 178.476 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' E' E ' 33' ' ' THR . . . . . . . . . . . . . 26.6 m -53.17 140.56 25.71 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 116.241 -0.436 . . . . 0.0 111.416 -178.016 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' E' E ' 34' ' ' GLY . . . . . . . . . . . . . . . 99.62 -17.22 57.86 Favored Glycine 0 CA--C 1.531 1.082 0 C-N-CA 121.208 -0.52 . . . . 0.0 113.259 179.447 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' E' E ' 35' ' ' ASP . . . . . . . . . . . . . 75.9 m-20 -66.11 148.89 51.14 Favored 'General case' 0 C--N 1.334 -0.098 0 CA-C-N 118.092 0.946 . . . . 0.0 110.908 178.272 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' E' E ' 36' ' ' VAL . . . . . . . . . . . . . 44.1 t -123.76 132.52 71.24 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.214 0 CA-C-N 116.096 -0.502 . . . . 0.0 109.918 178.166 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' E' E ' 37' ' ' ILE . . . . . . . . . . . . . 66.8 mt -118.43 138.79 47.99 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.317 0 CA-C-N 116.12 -0.491 . . . . 0.0 109.766 -179.648 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' E' E ' 38' ' ' GLY . . . . . . . . . . . . . . . -110.87 128.77 8.91 Favored Glycine 0 CA--C 1.526 0.751 0 N-CA-C 111.171 -0.771 . . . . 0.0 111.171 -179.337 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' E' E ' 39' ' ' ILE . . . . . . . . . . . . . 77.0 mt -123.84 136.05 61.5 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.199 0 CA-C-O 120.791 0.329 . . . . 0.0 110.123 179.018 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' E' E ' 40' ' ' SER . . . . . . . . . . . . . 78.0 p -93.64 124.07 37.38 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.705 174.8 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' E' E ' 41' ' ' ILE . . . . . . . . . . . . . 70.7 mt -127.82 118.62 49.4 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.2 0 CA-C-O 120.919 0.39 . . . . 0.0 110.373 177.785 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' E' E ' 42' ' ' LEU . . . . . . . . . . . . . 44.4 mt 51.37 34.32 11.64 Favored 'General case' 0 CA--C 1.531 0.213 0 CA-C-N 116.202 -0.454 . . . . 0.0 111.952 177.621 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' E' E ' 43' ' ' GLY . . . . . . . . . . . . . . . 74.65 32.4 57.41 Favored Glycine 0 CA--C 1.528 0.898 0 C-N-CA 121.138 -0.553 . . . . 0.0 112.095 178.303 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' E' E ' 44' ' ' LYS . . . . . . . . . . . . . 47.8 tptt -137.14 131.32 32.43 Favored 'General case' 0 C--N 1.33 -0.253 0 N-CA-C 109.549 -0.537 . . . . 0.0 109.549 177.776 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' E' E ' 45' ' ' GLU . . . . . . . . . . . . . 69.0 tt0 -85.13 123.3 30.49 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 116.538 -0.301 . . . . 0.0 111.415 -174.666 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' E' E ' 46' ' ' VAL . . . . . . . . . . . . . 7.1 p -124.99 128.7 73.27 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.21 0 CA-C-O 120.904 0.383 . . . . 0.0 110.056 176.412 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' E' E ' 47' ' ' LYS . . . . . . . . . . . . . 34.9 mmtp -101.77 132.81 47.3 Favored 'General case' 0 C--N 1.331 -0.21 0 CA-C-N 115.934 -0.575 . . . . 0.0 111.653 177.604 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' E' E ' 48' ' ' PHE . . . . . . . . . . . . . 89.6 m-85 -114.73 131.9 56.62 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-N 115.922 -0.581 . . . . 0.0 109.734 174.258 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' E' E ' 49' ' ' LYS . . . . . . . . . . . . . 57.6 tttm -106.67 139.8 40.54 Favored 'General case' 0 C--O 1.233 0.23 0 CA-C-N 116.69 -0.232 . . . . 0.0 110.586 179.426 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' E' E ' 50' ' ' VAL . . . . . . . . . . . . . 47.2 t -80.88 108.14 13.92 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.282 0 N-CA-C 109.155 -0.683 . . . . 0.0 109.155 176.026 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' E' E ' 51' ' ' VAL . . . . . . . . . . . . . 47.8 t -71.31 -47.88 57.27 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.309 0 CA-C-N 116.158 -0.474 . . . . 0.0 110.125 -174.266 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' E' E ' 52' ' ' GLN . . . . . . . . . . . . . 48.3 tt0 -164.86 141.58 5.95 Favored 'General case' 0 C--N 1.332 -0.169 0 C-N-CA 120.128 -0.629 . . . . 0.0 111.693 -178.338 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' E' E ' 53' ' ' ALA . . . . . . . . . . . . . . . -115.0 133.11 56.32 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 115.764 -0.653 . . . . 0.0 110.001 176.5 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' E' E ' 54' ' ' TYR . . . . . . . . . . . . . 13.7 t80 -129.19 110.89 18.14 Favored Pre-proline 0 CA--C 1.534 0.364 0 CA-C-O 118.198 -0.906 . . . . 0.0 110.358 178.556 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' E' E ' 55' ' ' PRO . . . . . . . . . . . . . 72.3 Cg_endo -77.28 170.13 72.23 Favored 'Cis proline' 0 N--CA 1.5 1.862 0 CA-C-N 122.062 1.772 . . . . 0.0 112.075 -6.444 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' E' E ' 56' ' ' SER . . . . . . . . . . . . . 48.8 m -123.18 139.09 30.97 Favored Pre-proline 0 CA--C 1.538 0.485 0 CA-C-O 118.501 -0.761 . . . . 0.0 109.505 174.758 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' E' E ' 57' ' ' PRO . . . . . . . . . . . . . 36.7 Cg_endo -67.07 144.29 69.51 Favored 'Cis proline' 0 N--CA 1.499 1.849 0 CA-C-N 121.764 1.666 . . . . 0.0 111.489 -3.54 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' E' E ' 58' ' ' LEU . . . . . . . . . . . . . 19.6 tp -108.37 136.33 48.18 Favored 'General case' 0 C--N 1.331 -0.239 0 CA-C-N 116.313 -0.403 . . . . 0.0 111.024 -176.905 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' E' E ' 59' ' ' ARG . . . . . . . . . . . . . 74.5 ttt180 -103.63 123.78 47.62 Favored 'General case' 0 C--N 1.329 -0.32 0 N-CA-C 108.823 -0.806 . . . . 0.0 108.823 173.04 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' E' E ' 60' ' ' VAL . . . . . . . . . . . . . 43.9 t -81.67 123.02 37.51 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.258 0 C-N-CA 120.475 -0.49 . . . . 0.0 110.58 -173.367 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' E' E ' 61' ' ' GLU . . . . . . . . . . . . . 70.6 mm-40 -131.09 165.06 24.09 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 115.824 -0.625 . . . . 0.0 109.727 176.471 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' E' E ' 62' ' ' ASP . . . . . . . . . . . . . 11.7 t0 -52.62 -30.83 33.49 Favored 'General case' 0 C--N 1.328 -0.338 0 N-CA-C 111.983 0.364 . . . . 0.0 111.983 -179.822 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' E' E ' 63' ' ' ARG . . . . . . . . . . . . . 90.8 mtt-85 -71.78 -22.01 61.64 Favored 'General case' 0 CA--C 1.533 0.302 0 N-CA-C 112.829 0.677 . . . . 0.0 112.829 -176.309 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' E' E ' 64' ' ' THR . . . . . . . . . . . . . 27.3 m -73.03 136.82 45.08 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-O 120.844 0.354 . . . . 0.0 111.203 -174.246 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' E' E ' 65' ' ' LYS . . . . . . . . . . . . . 57.2 mtmt -90.08 132.61 35.32 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 115.956 -0.566 . . . . 0.0 110.454 177.946 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' E' E ' 66' ' ' ILE . . . . . . . . . . . . . 66.4 mt -112.62 128.2 69.43 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.283 0 N-CA-C 109.571 -0.529 . . . . 0.0 109.571 178.837 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' E' E ' 67' ' ' THR . . . . . . . . . . . . . 21.9 m -122.85 144.67 49.05 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-O 121.219 0.533 . . . . 0.0 111.317 -175.425 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' E' E ' 68' ' ' LEU . . . . . . . . . . . . . 6.2 tt . . . . . 0 C--N 1.33 -0.281 0 CA-C-N 115.601 -0.727 . . . . 0.0 109.96 178.698 . . . . . . . . 0 0 . 1 . 013 nuclear orig core ' E' E ' 73' ' ' VAL . . . . . . . . . . . . . 27.0 m . . . . . 0 N--CA 1.461 0.112 0 CA-C-O 121.078 0.466 . . . . 0.0 110.564 . . . . . . . . . 0 0 . 1 . 013 nuclear orig core ' E' E ' 74' ' ' ASP . . . . . . . . . . . . . 19.2 t0 -98.88 117.77 34.14 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 115.729 -0.669 . . . . 0.0 109.514 178.306 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' E' E ' 75' ' ' VAL . . . . . . . . . . . . . 43.3 t -109.0 119.34 58.38 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.251 0 CA-C-O 121.034 0.445 . . . . 0.0 110.279 -178.235 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' E' E ' 76' ' ' LEU . . . . . . . . . . . . . 28.7 mt -119.77 143.24 47.93 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 115.653 -0.703 . . . . 0.0 109.731 178.254 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' E' E ' 77' ' ' GLU . . . . . . . . . . . . . 97.2 mt-10 -134.86 129.38 34.35 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-O 121.071 0.463 . . . . 0.0 111.011 -178.294 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' E' E ' 78' ' ' ALA . . . . . . . . . . . . . . . -115.1 127.11 55.39 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 115.707 -0.679 . . . . 0.0 109.531 177.121 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' E' E ' 79' ' ' LYS . . . . . . . . . . . . . 95.4 mttt -75.18 117.7 17.3 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-O 121.014 0.435 . . . . 0.0 110.747 -177.793 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' E' E ' 80' ' ' ILE . . . . . . . . . . . . . 25.2 mm -139.27 111.23 5.33 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.378 0 N-CA-C 108.918 -0.771 . . . . 0.0 108.918 -178.601 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' E' E ' 81' ' ' LYS . . . . . . . . . . . . . 20.4 pttp -101.55 128.48 47.79 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-O 121.179 0.514 . . . . 0.0 111.402 -176.883 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' E' E ' 82' ' ' GLY . . . . . . . . . . . . . . . 89.19 42.14 5.66 Favored Glycine 0 CA--C 1.527 0.789 0 CA-C-N 115.697 -0.683 . . . . 0.0 111.858 175.6 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' E' E ' 83' ' ' ILE . . . . . . . . . . . . . 68.6 mt -69.37 137.37 24.36 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.337 0 N-CA-C 109.675 -0.491 . . . . 0.0 109.675 176.737 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' E' E ' 84' ' ' LYS . . . . . . . . . . . . . 23.4 ttpp -104.72 -51.73 3.01 Favored 'General case' 0 C--N 1.331 -0.212 0 CA-C-O 120.935 0.398 . . . . 0.0 110.252 179.968 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' E' E ' 85' ' ' ASP . . . . . . . . . . . . . 11.3 t70 -147.88 148.73 31.16 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 115.988 -0.551 . . . . 0.0 110.525 -178.865 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' E' E ' 86' ' ' VAL . . . . . . . . . . . . . 43.3 t -130.37 133.58 63.67 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.212 0 CA-C-O 120.984 0.421 . . . . 0.0 110.621 -179.498 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' E' E ' 87' ' ' ILE . . . . . . . . . . . . . 43.3 mm -119.31 122.87 70.16 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 CA-C-N 115.769 -0.651 . . . . 0.0 109.374 176.532 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' E' E ' 88' ' ' LEU . . . . . . . . . . . . . 60.4 mt -113.4 133.06 55.37 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-O 120.962 0.41 . . . . 0.0 111.312 -176.86 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' E' E ' 89' ' ' ASP . . . . . . . . . . . . . 6.5 t0 -134.2 157.56 45.93 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 115.821 -0.627 . . . . 0.0 109.72 176.627 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' E' E ' 90' ' ' GLU . . . . . . . . . . . . . 82.6 tt0 -46.41 -39.08 9.9 Favored 'General case' 0 C--N 1.329 -0.287 0 N-CA-C 113.295 0.85 . . . . 0.0 113.295 -170.588 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' E' E ' 91' ' ' ASN . . . . . . . . . . . . . 44.2 t30 -124.54 11.64 8.6 Favored 'General case' 0 N--CA 1.469 0.499 0 N-CA-C 113.528 0.936 . . . . 0.0 113.528 -174.231 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' E' E ' 92' ' ' LEU . . . . . . . . . . . . . 18.5 mt -148.22 143.48 27.04 Favored 'General case' 0 C--N 1.333 -0.141 0 CA-C-N 117.941 0.337 . . . . 0.0 110.36 -176.322 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' E' E ' 93' ' ' ILE . . . . . . . . . . . . . 70.1 mt -123.98 117.37 50.73 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.294 0 N-CA-C 109.222 -0.658 . . . . 0.0 109.222 176.724 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' E' E ' 94' ' ' VAL . . . . . . . . . . . . . 44.5 t -116.59 125.99 73.83 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.281 0 N-CA-C 109.791 -0.448 . . . . 0.0 109.791 -179.44 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' E' E ' 95' ' ' VAL . . . . . . . . . . . . . 43.4 t -118.81 133.45 65.61 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.34 0 CA-C-N 115.987 -0.552 . . . . 0.0 109.83 -179.601 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' E' E ' 96' ' ' ILE . . . . . . . . . . . . . 68.7 mt -114.17 127.11 71.74 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.305 0 N-CA-C 109.255 -0.646 . . . . 0.0 109.255 178.085 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' E' E ' 97' ' ' THR . . . . . . . . . . . . . 76.4 p -99.59 158.94 15.4 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-O 121.207 0.527 . . . . 0.0 111.117 -177.242 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' E' E ' 98' ' ' GLU . . . . . . . . . . . . . 96.8 mt-10 -53.82 -25.69 20.65 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.079 -0.509 . . . . 0.0 112.181 179.296 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' E' E ' 99' ' ' GLU . . . . . . . . . . . . . 34.7 tt0 -79.34 15.29 1.27 Allowed 'General case' 0 CA--C 1.539 0.533 0 N-CA-C 112.623 0.601 . . . . 0.0 112.623 -177.277 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' E' E ' 100' ' ' ASN . . . . . . . . . . . . . 2.8 m-20 61.16 37.94 17.21 Favored 'General case' 0 CA--C 1.53 0.186 0 O-C-N 121.815 -0.553 . . . . 0.0 110.936 178.752 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' E' E ' 101' ' ' GLU . . . . . . . . . . . . . 84.0 tt0 -115.27 145.11 42.78 Favored 'General case' 0 C--N 1.332 -0.182 0 CA-C-N 116.023 -0.535 . . . . 0.0 109.8 176.89 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' E' E ' 102' ' ' VAL . . . . . . . . . . . . . 45.5 t -115.02 124.22 71.46 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.331 0 CA-C-N 116.121 -0.491 . . . . 0.0 109.867 -178.251 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' E' E ' 103' ' ' LEU . . . . . . . . . . . . . 22.3 mt -118.48 128.16 54.32 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 115.8 -0.636 . . . . 0.0 110.144 176.667 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' E' E ' 104' ' ' ILE . . . . . . . . . . . . . 71.5 mt -118.42 122.28 69.14 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.257 0 N-CA-C 110.284 -0.265 . . . . 0.0 110.284 -179.652 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' E' E ' 105' ' ' PHE . . . . . . . . . . . . . 71.3 m-85 -120.79 165.84 14.58 Favored 'General case' 0 C--N 1.332 -0.161 0 O-C-N 124.035 0.835 . . . . 0.0 110.265 -179.985 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' E' E ' 106' ' ' ASN . . . . . . . . . . . . . 53.4 p-10 -99.35 -169.98 1.84 Allowed 'General case' 0 C--N 1.331 -0.236 0 N-CA-C 109.826 -0.435 . . . . 0.0 109.826 172.731 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' E' E ' 107' ' ' GLN . . . . . . . . . . . . . 38.7 tp60 -57.45 -27.77 62.75 Favored 'General case' 0 CA--C 1.534 0.334 0 N-CA-C 112.193 0.442 . . . . 0.0 112.193 -177.889 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' E' E ' 108' ' ' ASN . . . . . . . . . . . . . 9.1 t-20 -93.68 14.34 19.38 Favored 'General case' 0 CA--C 1.534 0.351 0 N-CA-C 113.136 0.791 . . . . 0.0 113.136 -175.453 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' E' E ' 109' ' ' LEU . . . . . . . . . . . . . 72.5 mt 58.72 35.81 24.57 Favored 'General case' 0 CA--C 1.53 0.176 0 CA-C-O 120.881 0.372 . . . . 0.0 111.55 179.494 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' E' E ' 110' ' ' GLU . . . . . . . . . . . . . 95.9 mt-10 -99.26 148.19 24.39 Favored 'General case' 0 C--N 1.33 -0.282 0 N-CA-C 109.774 -0.454 . . . . 0.0 109.774 175.894 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' E' E ' 111' ' ' GLU . . . . . . . . . . . . . 57.1 tt0 -79.9 122.86 27.2 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.399 -0.364 . . . . 0.0 111.016 -176.273 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' E' E ' 112' ' ' LEU . . . . . . . . . . . . . 17.0 mt -109.89 -45.98 3.55 Favored 'General case' 0 C--N 1.331 -0.202 0 CA-C-N 116.207 -0.451 . . . . 0.0 110.616 177.584 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' E' E ' 113' ' ' TYR . . . . . . . . . . . . . 53.2 t80 -138.47 135.5 35.23 Favored 'General case' 0 C--N 1.331 -0.238 0 C-N-CA 120.837 -0.345 . . . . 0.0 111.079 -179.318 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' E' E ' 114' ' ' ARG . . . . . . . . . . . . . 61.3 ttp180 -136.19 123.45 21.83 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-N 116.228 -0.442 . . . . 0.0 110.373 178.047 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' E' E ' 115' ' ' GLY . . . . . . . . . . . . . . . -150.14 158.91 27.88 Favored Glycine 0 CA--C 1.526 0.726 0 N-CA-C 111.181 -0.768 . . . . 0.0 111.181 177.956 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' E' E ' 116' ' ' LYS . . . . . . . . . . . . . 39.5 ttpt -127.75 137.46 52.44 Favored 'General case' 0 C--N 1.331 -0.238 0 N-CA-C 109.497 -0.557 . . . . 0.0 109.497 175.105 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' E' E ' 117' ' ' PHE . . . . . . . . . . . . . 37.1 m-85 -139.75 113.89 8.95 Favored 'General case' 0 C--N 1.331 -0.209 0 C-N-CA 120.697 -0.401 . . . . 0.0 110.214 -177.094 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' E' E ' 118' ' ' GLU . . . . . . . . . . . . . 96.1 mt-10 -56.86 -43.92 81.66 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.398 -0.364 . . . . 0.0 110.891 -176.67 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' E' E ' 119' ' ' ASN . . . . . . . . . . . . . 79.0 m-20 -93.87 28.66 2.32 Favored 'General case' 0 C--N 1.329 -0.299 0 N-CA-C 112.312 0.486 . . . . 0.0 112.312 -174.943 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' E' E ' 120' ' ' LEU . . . . . . . . . . . . . 18.6 tp -59.3 123.46 16.79 Favored 'General case' 0 C--N 1.333 -0.122 0 N-CA-C 109.945 -0.391 . . . . 0.0 109.945 177.645 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' E' E ' 121' ' ' ASN . . . . . . . . . . . . . 67.3 m-80 -114.13 -43.92 3.19 Favored 'General case' 0 C--N 1.332 -0.19 0 CA-C-N 116.509 -0.314 . . . . 0.0 110.953 -177.526 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' E' E ' 122' ' ' LYS . . . . . . . . . . . . . 98.6 mttt -144.03 148.05 34.69 Favored 'General case' 0 C--N 1.332 -0.195 0 CA-C-O 121.089 0.471 . . . . 0.0 111.714 -177.109 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' E' E ' 123' ' ' VAL . . . . . . . . . . . . . 45.8 t -127.95 129.97 69.82 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.341 0 N-CA-C 109.183 -0.673 . . . . 0.0 109.183 173.528 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' E' E ' 124' ' ' LEU . . . . . . . . . . . . . 28.2 mt -129.31 137.74 51.19 Favored 'General case' 0 N--CA 1.463 0.206 0 CA-C-O 121.047 0.451 . . . . 0.0 111.036 -176.147 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' E' E ' 125' ' ' VAL . . . . . . . . . . . . . 41.4 t -124.71 129.46 73.63 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.225 0 CA-C-N 115.77 -0.65 . . . . 0.0 109.922 179.725 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' E' E ' 126' ' ' ARG . . . . . . . . . . . . . 43.4 mmm-85 -140.61 115.32 9.56 Favored 'General case' 0 C--N 1.329 -0.298 0 N-CA-C 109.416 -0.587 . . . . 0.0 109.416 177.869 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' E' E ' 127' ' ' ASN . . . . . . . . . . . . . 78.5 m-20 56.02 -149.84 0.45 Allowed 'General case' 0 CA--C 1.541 0.629 0 N-CA-C 109.838 -0.43 . . . . 0.0 109.838 -179.93 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' E' E ' 128' ' ' ASP . . . . . . . . . . . . . 38.4 p30 -80.01 14.19 1.93 Allowed 'General case' 0 CA--C 1.535 0.39 0 N-CA-C 112.932 0.716 . . . . 0.0 112.932 179.136 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' E' E ' 129' ' ' LEU . . . . . . . . . . . . . 14.3 tp -111.93 136.46 51.22 Favored 'General case' 0 C--O 1.232 0.141 0 N-CA-C 109.688 -0.486 . . . . 0.0 109.688 177.289 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' E' E ' 130' ' ' VAL . . . . . . . . . . . . . 11.3 p -129.09 140.75 48.4 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.254 0 CA-C-O 120.934 0.397 . . . . 0.0 110.341 -177.924 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' E' E ' 131' ' ' VAL . . . . . . . . . . . . . 35.1 m -136.05 145.1 31.56 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.252 0 CA-C-O 121.237 0.541 . . . . 0.0 111.292 -179.096 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' E' E ' 132' ' ' ILE . . . . . . . . . . . . . 72.5 mt -118.94 133.69 64.98 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.32 0 CA-C-N 115.269 -0.878 . . . . 0.0 109.243 179.986 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' E' E ' 133' ' ' ILE . . . . . . . . . . . . . 39.5 mm -115.37 119.84 62.96 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.274 0 CA-C-O 120.722 0.296 . . . . 0.0 110.885 -175.399 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' E' E ' 134' ' ' ASP . . . . . . . . . . . . . 9.5 p-10 -131.79 148.26 52.55 Favored 'General case' 0 C--N 1.332 -0.173 0 N-CA-C 109.542 -0.54 . . . . 0.0 109.542 175.221 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' E' E ' 135' ' ' GLU . . . . . . . . . . . . . 84.8 tt0 -49.87 -27.61 5.4 Favored 'General case' 0 C--N 1.326 -0.422 0 N-CA-C 112.796 0.665 . . . . 0.0 112.796 -172.567 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' E' E ' 136' ' ' GLN . . . . . . . . . . . . . 98.4 mt-30 -81.85 -34.45 30.11 Favored 'General case' 0 C--N 1.33 -0.249 0 N-CA-C 112.746 0.647 . . . . 0.0 112.746 -176.192 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' E' E ' 137' ' ' LYS . . . . . . . . . . . . . 54.1 pttt -167.93 171.53 9.71 Favored 'General case' 0 C--N 1.332 -0.196 0 CA-C-O 121.66 0.743 . . . . 0.0 112.573 -171.131 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' E' E ' 138' ' ' LEU . . . . . . . . . . . . . 3.4 tt -114.05 127.91 56.15 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 114.73 -1.123 . . . . 0.0 109.679 -179.958 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' E' E ' 139' ' ' THR . . . . . . . . . . . . . 30.5 m -108.86 128.02 54.55 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-O 120.715 0.293 . . . . 0.0 110.401 179.219 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' E' E ' 140' ' ' LEU . . . . . . . . . . . . . 8.0 tt -117.57 124.34 48.44 Favored 'General case' 0 C--N 1.329 -0.285 0 N-CA-C 109.359 -0.608 . . . . 0.0 109.359 -178.594 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' E' E ' 141' ' ' ILE . . . . . . . . . . . . . 19.5 mt -120.94 121.73 65.87 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.305 0 N-CA-C 109.714 -0.476 . . . . 0.0 109.714 -175.431 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' E' E ' 142' ' ' ARG . . . . . . . . . . . . . 73.7 ttt180 -112.7 130.21 56.13 Favored 'General case' 0 C--N 1.331 -0.208 0 CA-C-N 115.709 -0.678 . . . . 0.0 110.407 -176.89 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' E' E ' 143' ' ' THR . . . . . . . . . . . . . 50.8 p . . . . . 0 C--O 1.22 -0.475 0 CA-C-O 117.997 -1.001 . . . . 0.0 110.603 -179.81 . . . . . . . . 0 0 . 1 . 013 nuclear orig core ' F' F ' 1' ' ' MET . . . . . . . . . . . . . 25.6 ptp . . . . . 0 CA--C 1.527 0.06 0 CA-C-O 120.766 0.317 . . . . 0.0 110.615 . . . . . . . . . 0 0 . 1 . 013 nuclear orig core ' F' F ' 2' ' ' SER . . . . . . . . . . . . . 3.0 p -110.51 127.54 55.22 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-O 121.134 0.492 . . . . 0.0 110.449 178.916 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' F' F ' 3' ' ' GLU . . . . . . . . . . . . . 84.2 tt0 -140.17 139.14 35.66 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 115.69 -0.687 . . . . 0.0 110.771 -178.827 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' F' F ' 4' ' ' LEU . . . . . . . . . . . . . 19.1 tp -122.13 124.75 44.62 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 115.985 -0.552 . . . . 0.0 110.376 178.497 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' F' F ' 5' ' ' LYS . . . . . . . . . . . . . 97.9 mttt -101.92 118.84 37.75 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.146 -0.479 . . . . 0.0 110.28 177.261 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' F' F ' 6' ' ' LEU . . . . . . . . . . . . . 31.0 mt -114.99 148.28 38.99 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 115.486 -0.779 . . . . 0.0 110.242 -179.07 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' F' F ' 7' ' ' LYS . . . . . . . . . . . . . 52.3 tttp -137.2 140.71 31.84 Favored Pre-proline 0 CA--C 1.534 0.34 0 CA-C-O 119.124 -0.465 . . . . 0.0 110.047 175.433 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' F' F ' 8' ' ' PRO . . . . . . . . . . . . . 89.3 Cg_endo -91.85 139.37 2.17 Favored 'Trans proline' 0 N--CA 1.49 1.293 0 C-N-CA 121.736 1.624 . . . . 0.0 111.745 177.898 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' F' F ' 9' ' ' LEU . . . . . . . . . . . . . 46.1 mt -77.68 -47.66 2.34 Favored Pre-proline 0 CA--C 1.534 0.35 0 CA-C-O 118.682 -0.675 . . . . 0.0 112.237 -179.663 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' F' F ' 10' ' ' PRO . . . . . . . . . . . . . 86.2 Cg_endo -80.6 152.93 20.18 Favored 'Trans proline' 0 N--CA 1.495 1.616 0 C-N-CA 121.185 1.257 . . . . 0.0 111.89 176.064 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' F' F ' 11' ' ' LYS . . . . . . . . . . . . . 60.7 tttm -88.8 93.66 9.66 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-O 120.818 0.342 . . . . 0.0 110.456 179.038 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' F' F ' 12' ' ' VAL . . . . . . . . . . . . . 13.0 p -141.38 143.34 27.86 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.231 0 CA-C-N 116.318 -0.401 . . . . 0.0 110.701 -179.525 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' F' F ' 13' ' ' GLU . . . . . . . . . . . . . 45.9 mp0 -77.67 132.83 38.38 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.29 -0.414 . . . . 0.0 110.255 178.065 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' F' F ' 14' ' ' LEU . . . . . . . . . . . . . 31.0 mt -98.37 147.74 33.55 Favored Pre-proline 0 CA--C 1.533 0.307 0 CA-C-O 119.185 -0.436 . . . . 0.0 110.233 -179.738 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' F' F ' 15' ' ' PRO . . . . . . . . . . . . . 25.8 Cg_exo -62.17 158.95 36.94 Favored 'Trans proline' 0 N--CA 1.498 1.741 0 C-N-CA 121.335 1.356 . . . . 0.0 111.876 176.793 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' F' F ' 16' ' ' PRO . . . . . . . . . . . . . 38.7 Cg_exo -58.56 -41.17 67.31 Favored 'Trans proline' 0 N--CA 1.498 1.785 0 C-N-CA 121.497 1.465 . . . . 0.0 112.808 -177.72 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' F' F ' 17' ' ' ASP . . . . . . . . . . . . . 19.2 p-10 -85.71 9.02 17.55 Favored 'General case' 0 C--N 1.326 -0.414 0 N-CA-C 113.23 0.826 . . . . 0.0 113.23 -177.609 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' F' F ' 18' ' ' PHE . . . . . . . . . . . . . 36.7 t80 -58.34 -45.43 88.14 Favored 'General case' 0 C--N 1.333 -0.114 0 O-C-N 121.998 -0.439 . . . . 0.0 110.152 -177.594 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' F' F ' 19' ' ' VAL . . . . . . . . . . . . . 13.6 p -56.69 -41.51 74.63 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.329 0 CA-C-N 116.25 -0.432 . . . . 0.0 110.954 -178.738 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' F' F ' 20' ' ' ASP . . . . . . . . . . . . . 30.0 m-20 -60.53 -43.5 97.07 Favored 'General case' 0 C--N 1.331 -0.198 0 C-N-CA 120.937 -0.305 . . . . 0.0 111.12 -178.087 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' F' F ' 21' ' ' VAL . . . . . . . . . . . . . 47.0 t -64.58 -46.11 93.52 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.255 0 C-N-CA 120.834 -0.346 . . . . 0.0 110.519 -177.498 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' F' F ' 22' ' ' ILE . . . . . . . . . . . . . 51.5 mm -57.46 -41.05 77.93 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.288 0 C-N-CA 121.089 -0.244 . . . . 0.0 110.628 179.418 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' F' F ' 23' ' ' ARG . . . . . . . . . . . . . 32.0 ttp180 -56.14 -48.29 76.55 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-O 120.945 0.402 . . . . 0.0 110.718 178.04 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' F' F ' 24' ' ' ILE . . . . . . . . . . . . . 73.0 mt -61.66 -42.48 94.38 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.306 0 CA-C-N 116.014 -0.539 . . . . 0.0 111.941 -177.969 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' F' F ' 25' ' ' LYS . . . . . . . . . . . . . 16.4 pttp -73.58 -35.07 65.4 Favored 'General case' 0 CA--C 1.533 0.314 0 C-N-CA 120.537 -0.465 . . . . 0.0 111.801 -173.326 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' F' F ' 26' ' ' LEU . . . . . . . . . . . . . 64.5 mt -79.07 -43.06 24.94 Favored 'General case' 0 C--N 1.33 -0.258 0 N-CA-C 112.971 0.73 . . . . 0.0 112.971 -174.528 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' F' F ' 27' ' ' GLN . . . . . . . . . . . . . 10.6 pt20 -46.73 139.67 5.12 Favored 'General case' 0 N--CA 1.469 0.505 0 N-CA-C 112.884 0.698 . . . . 0.0 112.884 -174.54 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' F' F ' 28' ' ' GLY . . . . . . . . . . . . . . . 100.31 -29.99 11.1 Favored Glycine 0 CA--C 1.529 0.948 0 CA-C-N 115.471 -0.786 . . . . 0.0 111.971 -177.915 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' F' F ' 29' ' ' LYS . . . . . . . . . . . . . 98.1 mttt -98.09 155.2 17.25 Favored 'General case' 0 C--O 1.233 0.19 0 CA-C-O 121.061 0.458 . . . . 0.0 111.035 177.988 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' F' F ' 30' ' ' THR . . . . . . . . . . . . . 23.9 m -103.91 139.43 39.09 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.019 -0.537 . . . . 0.0 109.994 175.816 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' F' F ' 31' ' ' VAL . . . . . . . . . . . . . 34.9 m -127.34 157.61 38.93 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.288 0 CA-C-N 116.254 -0.43 . . . . 0.0 110.514 -179.125 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' F' F ' 32' ' ' ARG . . . . . . . . . . . . . 56.3 ttp180 -133.77 151.92 51.73 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-O 121.178 0.514 . . . . 0.0 110.612 179.569 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' F' F ' 33' ' ' THR . . . . . . . . . . . . . 20.7 m -53.09 138.43 31.06 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 116.221 -0.445 . . . . 0.0 111.406 -178.489 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' F' F ' 34' ' ' GLY . . . . . . . . . . . . . . . 100.84 -17.08 56.9 Favored Glycine 0 CA--C 1.534 1.223 0 CA-C-O 119.584 -0.565 . . . . 0.0 113.262 179.16 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' F' F ' 35' ' ' ASP . . . . . . . . . . . . . 63.2 m-20 -65.13 149.45 49.88 Favored 'General case' 0 N--CA 1.461 0.096 0 CA-C-N 118.006 0.903 . . . . 0.0 111.308 179.602 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' F' F ' 36' ' ' VAL . . . . . . . . . . . . . 45.8 t -125.15 129.63 73.2 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.196 0 CA-C-N 115.686 -0.688 . . . . 0.0 109.71 178.399 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' F' F ' 37' ' ' ILE . . . . . . . . . . . . . 68.4 mt -122.29 138.92 50.85 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.265 0 N-CA-C 109.839 -0.43 . . . . 0.0 109.839 -179.948 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' F' F ' 38' ' ' GLY . . . . . . . . . . . . . . . -111.07 128.87 8.93 Favored Glycine 0 CA--C 1.524 0.654 0 N-CA-C 111.191 -0.764 . . . . 0.0 111.191 -179.372 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' F' F ' 39' ' ' ILE . . . . . . . . . . . . . 72.4 mt -122.57 136.47 59.28 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.215 0 N-CA-C 109.902 -0.407 . . . . 0.0 109.902 179.014 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' F' F ' 40' ' ' SER . . . . . . . . . . . . . 21.8 t -92.74 118.32 30.95 Favored 'General case' 0 C--N 1.33 -0.25 0 C-N-CA 120.956 -0.298 . . . . 0.0 110.802 176.26 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' F' F ' 41' ' ' ILE . . . . . . . . . . . . . 47.8 mm -128.77 115.77 38.38 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.207 0 CA-C-O 120.811 0.339 . . . . 0.0 110.273 178.331 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' F' F ' 42' ' ' LEU . . . . . . . . . . . . . 11.4 tp 57.14 37.16 28.34 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 116.137 -0.483 . . . . 0.0 111.386 178.428 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' F' F ' 43' ' ' GLY . . . . . . . . . . . . . . . 77.67 -10.09 26.21 Favored Glycine 0 CA--C 1.534 1.268 0 C-N-CA 121.316 -0.469 . . . . 0.0 113.5 177.074 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' F' F ' 44' ' ' LYS . . . . . . . . . . . . . 38.7 mmtm -97.52 135.5 39.27 Favored 'General case' 0 C--N 1.332 -0.193 0 CA-C-N 117.966 0.883 . . . . 0.0 110.17 177.277 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' F' F ' 45' ' ' GLU . . . . . . . . . . . . . 82.7 tt0 -84.65 125.99 32.96 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.358 -0.383 . . . . 0.0 110.819 179.873 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' F' F ' 46' ' ' VAL . . . . . . . . . . . . . 7.3 p -119.34 126.44 75.34 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.159 0 N-CA-C 109.437 -0.579 . . . . 0.0 109.437 176.135 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' F' F ' 47' ' ' LYS . . . . . . . . . . . . . 60.4 mttp -100.1 127.46 46.33 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 115.865 -0.607 . . . . 0.0 111.007 178.806 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' F' F ' 48' ' ' PHE . . . . . . . . . . . . . 93.9 m-85 -109.89 131.91 54.64 Favored 'General case' 0 C--N 1.33 -0.262 0 N-CA-C 109.817 -0.438 . . . . 0.0 109.817 175.925 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' F' F ' 49' ' ' LYS . . . . . . . . . . . . . 53.7 tttp -108.44 138.83 44.09 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.406 -0.361 . . . . 0.0 110.349 179.128 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' F' F ' 50' ' ' VAL . . . . . . . . . . . . . 45.2 t -81.77 108.69 15.13 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.257 0 N-CA-C 109.384 -0.598 . . . . 0.0 109.384 176.226 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' F' F ' 51' ' ' VAL . . . . . . . . . . . . . 48.5 t -74.89 -48.06 34.66 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.276 0 CA-C-N 115.988 -0.551 . . . . 0.0 110.068 -174.015 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' F' F ' 52' ' ' GLN . . . . . . . . . . . . . 62.6 tt0 -158.7 133.94 8.52 Favored 'General case' 0 C--N 1.331 -0.23 0 C-N-CA 120.241 -0.584 . . . . 0.0 111.811 -177.518 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' F' F ' 53' ' ' ALA . . . . . . . . . . . . . . . -108.22 127.29 53.71 Favored 'General case' 0 C--N 1.332 -0.185 0 CA-C-N 115.667 -0.697 . . . . 0.0 109.644 174.395 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' F' F ' 54' ' ' TYR . . . . . . . . . . . . . 56.5 t80 -123.38 107.45 32.24 Favored Pre-proline 0 CA--C 1.534 0.346 0 CA-C-O 118.304 -0.855 . . . . 0.0 110.643 -178.606 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' F' F ' 55' ' ' PRO . . . . . . . . . . . . . 74.0 Cg_endo -76.96 169.86 73.28 Favored 'Cis proline' 0 N--CA 1.5 1.887 0 CA-C-N 121.725 1.652 . . . . 0.0 112.434 -5.681 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' F' F ' 56' ' ' SER . . . . . . . . . . . . . 25.1 m -108.52 124.55 34.1 Favored Pre-proline 0 CA--C 1.538 0.51 0 CA-C-O 118.372 -0.823 . . . . 0.0 109.561 175.819 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' F' F ' 57' ' ' PRO . . . . . . . . . . . . . 48.1 Cg_endo -70.19 166.66 74.6 Favored 'Cis proline' 0 N--CA 1.498 1.771 0 CA-C-N 122.106 1.788 . . . . 0.0 111.824 0.391 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' F' F ' 58' ' ' LEU . . . . . . . . . . . . . 24.2 tp -129.09 135.37 48.81 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.137 -0.483 . . . . 0.0 110.296 -179.926 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' F' F ' 59' ' ' ARG . . . . . . . . . . . . . 52.1 ttp180 -104.56 131.87 51.46 Favored 'General case' 0 C--N 1.327 -0.4 0 N-CA-C 109.68 -0.489 . . . . 0.0 109.68 178.749 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' F' F ' 60' ' ' VAL . . . . . . . . . . . . . 45.3 t -86.2 123.22 39.45 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.214 0 C-N-CA 120.671 -0.411 . . . . 0.0 110.404 -175.469 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' F' F ' 61' ' ' GLU . . . . . . . . . . . . . 95.3 mt-10 -131.06 166.26 21.43 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 115.942 -0.572 . . . . 0.0 110.14 177.806 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' F' F ' 62' ' ' ASP . . . . . . . . . . . . . 64.0 m-20 -54.92 -32.75 61.5 Favored 'General case' 0 C--N 1.327 -0.382 0 C-N-CA 121.096 -0.242 . . . . 0.0 111.604 179.536 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' F' F ' 63' ' ' ARG . . . . . . . . . . . . . 10.3 ptm180 -87.78 6.91 32.88 Favored 'General case' 0 CA--C 1.537 0.446 0 N-CA-C 113.59 0.959 . . . . 0.0 113.59 -176.73 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' F' F ' 64' ' ' THR . . . . . . . . . . . . . 11.8 m -82.41 139.98 33.72 Favored 'General case' 0 C--N 1.333 -0.137 0 CA-C-N 118.051 0.387 . . . . 0.0 110.655 -177.967 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' F' F ' 65' ' ' LYS . . . . . . . . . . . . . 97.9 mttt -89.15 125.05 34.89 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.085 179.21 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' F' F ' 66' ' ' ILE . . . . . . . . . . . . . 59.4 mt -116.36 127.93 73.83 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.262 0 N-CA-C 109.679 -0.489 . . . . 0.0 109.679 179.0 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' F' F ' 67' ' ' THR . . . . . . . . . . . . . 25.1 m -129.13 145.63 51.25 Favored 'General case' 0 C--N 1.331 -0.214 0 CA-C-O 121.112 0.482 . . . . 0.0 111.42 -176.658 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' F' F ' 68' ' ' LEU . . . . . . . . . . . . . 15.5 tp . . . . . 0 C--N 1.33 -0.243 0 CA-C-N 115.79 -0.641 . . . . 0.0 109.527 175.899 . . . . . . . . 0 0 . 1 . 013 nuclear orig core ' F' F ' 73' ' ' VAL . . . . . . . . . . . . . 35.8 m . . . . . 0 C--O 1.232 0.137 0 N-CA-C 109.694 -0.484 . . . . 0.0 109.694 . . . . . . . . . 0 0 . 1 . 013 nuclear orig core ' F' F ' 74' ' ' ASP . . . . . . . . . . . . . 7.2 t70 -90.64 115.17 27.54 Favored 'General case' 0 C--N 1.331 -0.226 0 C-N-CA 120.645 -0.422 . . . . 0.0 110.31 -173.593 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' F' F ' 75' ' ' VAL . . . . . . . . . . . . . 44.5 t -114.89 120.45 64.55 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.228 0 CA-C-O 121.038 0.447 . . . . 0.0 110.085 -179.272 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' F' F ' 76' ' ' LEU . . . . . . . . . . . . . 20.6 mt -124.47 144.29 50.17 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 115.662 -0.699 . . . . 0.0 109.717 179.34 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' F' F ' 77' ' ' GLU . . . . . . . . . . . . . 46.6 mt-10 -134.11 135.86 43.48 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-O 121.073 0.463 . . . . 0.0 111.286 -177.761 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' F' F ' 78' ' ' ALA . . . . . . . . . . . . . . . -122.64 127.71 49.7 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 115.483 -0.78 . . . . 0.0 109.457 175.712 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' F' F ' 79' ' ' LYS . . . . . . . . . . . . . 37.7 tttp -79.79 120.29 23.86 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-O 120.993 0.425 . . . . 0.0 110.828 -175.785 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' F' F ' 80' ' ' ILE . . . . . . . . . . . . . 37.5 mm -139.3 108.85 3.84 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.291 0 N-CA-C 108.983 -0.747 . . . . 0.0 108.983 -179.289 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' F' F ' 81' ' ' LYS . . . . . . . . . . . . . 39.7 ttpt -99.26 123.69 43.74 Favored 'General case' 0 C--N 1.329 -0.298 0 C-N-CA 120.862 -0.335 . . . . 0.0 110.97 -176.236 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' F' F ' 82' ' ' GLY . . . . . . . . . . . . . . . 89.21 42.18 5.64 Favored Glycine 0 CA--C 1.525 0.708 0 C-N-CA 120.7 -0.762 . . . . 0.0 111.677 176.368 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' F' F ' 83' ' ' ILE . . . . . . . . . . . . . 75.3 mt -67.2 140.31 19.57 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.338 0 N-CA-C 109.875 -0.417 . . . . 0.0 109.875 177.603 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' F' F ' 84' ' ' LYS . . . . . . . . . . . . . 47.0 tttp -100.82 -53.94 2.94 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.029 -0.532 . . . . 0.0 110.654 -178.644 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' F' F ' 85' ' ' ASP . . . . . . . . . . . . . 13.5 t70 -146.22 149.43 33.9 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 115.916 -0.584 . . . . 0.0 110.705 -178.095 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' F' F ' 86' ' ' VAL . . . . . . . . . . . . . 41.3 t -128.51 127.56 67.09 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.221 0 CA-C-O 120.815 0.341 . . . . 0.0 110.364 -179.782 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' F' F ' 87' ' ' ILE . . . . . . . . . . . . . 44.4 mm -120.84 130.39 74.67 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.223 0 CA-C-N 116.071 -0.513 . . . . 0.0 109.923 178.674 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' F' F ' 88' ' ' LEU . . . . . . . . . . . . . 27.1 mt -115.47 137.4 52.09 Favored 'General case' 0 C--N 1.332 -0.182 0 CA-C-O 120.951 0.405 . . . . 0.0 111.069 -178.946 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' F' F ' 89' ' ' ASP . . . . . . . . . . . . . 7.4 t70 -135.31 162.19 33.28 Favored 'General case' 0 C--N 1.331 -0.239 0 CA-C-N 115.999 -0.546 . . . . 0.0 110.084 177.335 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' F' F ' 90' ' ' GLU . . . . . . . . . . . . . 96.4 mt-10 -45.15 -48.14 12.27 Favored 'General case' 0 N--CA 1.465 0.307 0 N-CA-C 113.149 0.796 . . . . 0.0 113.149 -171.263 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' F' F ' 91' ' ' ASN . . . . . . . . . . . . . 21.0 t-20 -132.04 39.91 3.39 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-O 120.974 0.416 . . . . 0.0 110.861 -177.606 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' F' F ' 92' ' ' LEU . . . . . . . . . . . . . 10.7 tp -163.45 138.01 6.14 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.355 -0.384 . . . . 0.0 110.89 -177.539 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' F' F ' 93' ' ' ILE . . . . . . . . . . . . . 69.0 mt -122.3 124.81 71.79 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.311 0 N-CA-C 109.226 -0.657 . . . . 0.0 109.226 177.29 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' F' F ' 94' ' ' VAL . . . . . . . . . . . . . 45.8 t -123.54 128.62 74.68 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.258 0 CA-C-O 120.983 0.42 . . . . 0.0 110.069 -178.931 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' F' F ' 95' ' ' VAL . . . . . . . . . . . . . 44.4 t -121.58 134.76 63.89 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.314 0 CA-C-N 115.921 -0.581 . . . . 0.0 109.724 178.958 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' F' F ' 96' ' ' ILE . . . . . . . . . . . . . 61.6 mt -114.47 127.71 71.83 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.354 0 N-CA-C 109.146 -0.687 . . . . 0.0 109.146 178.493 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' F' F ' 97' ' ' THR . . . . . . . . . . . . . 58.3 p -98.5 159.5 14.91 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-O 121.102 0.477 . . . . 0.0 111.177 -177.498 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' F' F ' 98' ' ' GLU . . . . . . . . . . . . . 80.4 tt0 -53.88 -28.16 34.55 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.171 -0.468 . . . . 0.0 112.092 -179.622 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' F' F ' 99' ' ' GLU . . . . . . . . . . . . . 95.6 mt-10 -79.96 16.5 1.17 Allowed 'General case' 0 CA--C 1.535 0.392 0 N-CA-C 113.043 0.757 . . . . 0.0 113.043 -177.263 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' F' F ' 100' ' ' ASN . . . . . . . . . . . . . 4.2 m-20 62.48 38.04 12.95 Favored 'General case' 0 CA--C 1.53 0.198 0 CA-C-O 121.009 0.433 . . . . 0.0 111.072 177.757 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' F' F ' 101' ' ' GLU . . . . . . . . . . . . . 83.6 tt0 -111.8 144.05 41.74 Favored 'General case' 0 C--N 1.332 -0.186 0 CA-C-N 116.004 -0.544 . . . . 0.0 109.775 175.891 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' F' F ' 102' ' ' VAL . . . . . . . . . . . . . 42.7 t -115.02 125.09 72.24 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.293 0 N-CA-C 109.798 -0.445 . . . . 0.0 109.798 -178.67 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' F' F ' 103' ' ' LEU . . . . . . . . . . . . . 44.1 mt -118.3 131.63 56.33 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 115.725 -0.67 . . . . 0.0 110.046 178.395 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' F' F ' 104' ' ' ILE . . . . . . . . . . . . . 67.3 mt -121.09 123.09 69.25 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.245 0 CA-C-O 120.66 0.266 . . . . 0.0 110.374 -179.787 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' F' F ' 105' ' ' PHE . . . . . . . . . . . . . 48.7 m-85 -123.95 167.42 14.17 Favored 'General case' 0 C--N 1.333 -0.122 0 CA-C-N 115.358 -0.837 . . . . 0.0 109.885 178.931 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' F' F ' 106' ' ' ASN . . . . . . . . . . . . . 36.8 p-10 -98.74 -169.97 1.86 Allowed 'General case' 0 C--N 1.331 -0.207 0 N-CA-C 109.866 -0.42 . . . . 0.0 109.866 172.919 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' F' F ' 107' ' ' GLN . . . . . . . . . . . . . 49.2 tt0 -58.6 -30.08 66.94 Favored 'General case' 0 C--N 1.329 -0.31 0 N-CA-C 112.048 0.388 . . . . 0.0 112.048 -179.339 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' F' F ' 108' ' ' ASN . . . . . . . . . . . . . 5.7 t30 -91.33 14.01 15.77 Favored 'General case' 0 CA--C 1.535 0.394 0 N-CA-C 113.153 0.797 . . . . 0.0 113.153 -176.631 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' F' F ' 109' ' ' LEU . . . . . . . . . . . . . 30.7 mt 59.25 34.61 23.12 Favored 'General case' 0 C--N 1.332 -0.167 0 N-CA-C 111.992 0.367 . . . . 0.0 111.992 177.019 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' F' F ' 110' ' ' GLU . . . . . . . . . . . . . 95.9 mt-10 -98.64 136.37 38.81 Favored 'General case' 0 C--N 1.328 -0.338 0 N-CA-C 109.049 -0.723 . . . . 0.0 109.049 173.187 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' F' F ' 111' ' ' GLU . . . . . . . . . . . . . 56.1 tt0 -78.64 121.9 25.27 Favored 'General case' 0 C--N 1.327 -0.401 0 CA-C-O 120.898 0.38 . . . . 0.0 110.743 -173.727 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' F' F ' 112' ' ' LEU . . . . . . . . . . . . . 15.3 mt -103.73 -45.97 4.65 Favored 'General case' 0 C--N 1.331 -0.204 0 CA-C-N 115.868 -0.606 . . . . 0.0 110.703 179.574 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' F' F ' 113' ' ' TYR . . . . . . . . . . . . . 44.5 t80 -136.26 141.88 43.93 Favored 'General case' 0 C--N 1.331 -0.239 0 CA-C-N 116.193 -0.458 . . . . 0.0 111.181 -177.174 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' F' F ' 114' ' ' ARG . . . . . . . . . . . . . 32.3 ptt180 -147.06 123.25 10.86 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.107 -0.497 . . . . 0.0 110.826 176.893 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' F' F ' 115' ' ' GLY . . . . . . . . . . . . . . . -150.09 163.02 29.37 Favored Glycine 0 CA--C 1.523 0.554 0 N-CA-C 110.789 -0.924 . . . . 0.0 110.789 179.472 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' F' F ' 116' ' ' LYS . . . . . . . . . . . . . 38.3 ttpt -130.17 135.77 48.54 Favored 'General case' 0 C--N 1.329 -0.295 0 O-C-N 122.627 -0.337 . . . . 0.0 110.123 179.066 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' F' F ' 117' ' ' PHE . . . . . . . . . . . . . 48.6 m-85 -133.58 114.85 14.01 Favored 'General case' 0 C--N 1.331 -0.206 0 CA-C-O 120.967 0.413 . . . . 0.0 110.176 -176.95 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' F' F ' 118' ' ' GLU . . . . . . . . . . . . . 70.6 mm-40 -54.54 -41.1 69.34 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 116.412 -0.358 . . . . 0.0 111.371 -176.319 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' F' F ' 119' ' ' ASN . . . . . . . . . . . . . 85.6 m-20 -100.73 31.04 3.68 Favored 'General case' 0 C--N 1.33 -0.276 0 N-CA-C 112.176 0.435 . . . . 0.0 112.176 -173.919 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' F' F ' 120' ' ' LEU . . . . . . . . . . . . . 15.0 tp -56.59 119.92 6.91 Favored 'General case' 0 C--N 1.332 -0.19 0 CA-C-O 120.707 0.289 . . . . 0.0 110.379 178.254 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' F' F ' 121' ' ' ASN . . . . . . . . . . . . . 72.9 m-20 -114.15 -44.13 3.16 Favored 'General case' 0 C--N 1.333 -0.141 0 CA-C-N 116.368 -0.378 . . . . 0.0 111.282 -177.647 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' F' F ' 122' ' ' LYS . . . . . . . . . . . . . 53.4 mtmt -145.3 151.27 38.08 Favored 'General case' 0 C--N 1.331 -0.239 0 CA-C-O 121.042 0.449 . . . . 0.0 111.749 -176.234 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' F' F ' 123' ' ' VAL . . . . . . . . . . . . . 46.7 t -130.8 127.97 62.3 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.235 0 CA-C-N 116.01 -0.541 . . . . 0.0 109.545 174.697 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' F' F ' 124' ' ' LEU . . . . . . . . . . . . . 41.2 mt -115.99 136.99 52.52 Favored 'General case' 0 C--N 1.331 -0.196 0 CA-C-N 116.307 -0.406 . . . . 0.0 110.709 -178.736 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' F' F ' 125' ' ' VAL . . . . . . . . . . . . . 35.1 m -128.43 138.16 55.4 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.209 0 CA-C-N 116.265 -0.425 . . . . 0.0 110.817 -179.359 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' F' F ' 126' ' ' ARG . . . . . . . . . . . . . 96.3 mtt-85 -143.9 111.44 5.98 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.102 -0.499 . . . . 0.0 110.38 177.155 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' F' F ' 127' ' ' ASN . . . . . . . . . . . . . 79.1 m-20 53.13 -104.95 0.22 Allowed 'General case' 0 CA--C 1.544 0.722 0 CA-C-O 119.122 -0.466 . . . . 0.0 111.057 -179.847 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' F' F ' 128' ' ' ASP . . . . . . . . . . . . . 12.3 p-10 -113.98 0.17 14.28 Favored 'General case' 0 CA--C 1.536 0.434 0 CA-C-N 119.509 1.049 . . . . 0.0 113.386 -177.531 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' F' F ' 129' ' ' LEU . . . . . . . . . . . . . 9.9 mp -105.0 147.84 27.38 Favored 'General case' 0 CA--C 1.523 -0.096 0 N-CA-C 109.669 -0.493 . . . . 0.0 109.669 177.842 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' F' F ' 130' ' ' VAL . . . . . . . . . . . . . 13.1 p -137.37 145.19 29.88 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.245 0 CA-C-O 121.23 0.538 . . . . 0.0 110.87 -176.757 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' F' F ' 131' ' ' VAL . . . . . . . . . . . . . 44.1 t -134.61 136.97 51.97 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.294 0 CA-C-N 115.722 -0.672 . . . . 0.0 109.869 178.079 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' F' F ' 132' ' ' ILE . . . . . . . . . . . . . 71.1 mt -114.18 132.2 63.92 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.335 0 N-CA-C 109.452 -0.573 . . . . 0.0 109.452 -178.825 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' F' F ' 133' ' ' ILE . . . . . . . . . . . . . 43.0 mm -117.77 121.8 68.28 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.27 0 CA-C-O 120.791 0.329 . . . . 0.0 110.621 -176.041 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' F' F ' 134' ' ' ASP . . . . . . . . . . . . . 7.1 p-10 -132.38 148.56 52.42 Favored 'General case' 0 C--N 1.33 -0.249 0 N-CA-C 109.578 -0.527 . . . . 0.0 109.578 174.934 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' F' F ' 135' ' ' GLU . . . . . . . . . . . . . 32.3 tp10 -49.9 -24.4 2.48 Favored 'General case' 0 C--N 1.328 -0.328 0 N-CA-C 112.943 0.72 . . . . 0.0 112.943 -169.775 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' F' F ' 136' ' ' GLN . . . . . . . . . . . . . 60.7 tt0 -105.02 -26.42 12.15 Favored 'General case' 0 N--CA 1.466 0.327 0 N-CA-C 112.748 0.647 . . . . 0.0 112.748 -174.637 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' F' F ' 137' ' ' LYS . . . . . . . . . . . . . 77.3 mttt -141.7 154.0 45.02 Favored 'General case' 0 C--N 1.331 -0.198 0 CA-C-O 121.252 0.549 . . . . 0.0 111.798 -171.731 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' F' F ' 138' ' ' LEU . . . . . . . . . . . . . 6.1 tt -120.29 124.97 46.9 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 115.616 -0.72 . . . . 0.0 109.299 173.765 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' F' F ' 139' ' ' THR . . . . . . . . . . . . . 31.1 m -114.21 129.83 56.63 Favored 'General case' 0 C--N 1.332 -0.191 0 CA-C-N 116.385 -0.37 . . . . 0.0 110.757 -177.362 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' F' F ' 140' ' ' LEU . . . . . . . . . . . . . 7.4 tt -116.87 121.53 41.75 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 115.686 -0.688 . . . . 0.0 109.387 -179.119 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' F' F ' 141' ' ' ILE . . . . . . . . . . . . . 19.0 mt -121.37 118.5 56.2 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.253 0 N-CA-C 109.778 -0.453 . . . . 0.0 109.778 -176.764 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' F' F ' 142' ' ' ARG . . . . . . . . . . . . . 61.7 ttt180 -110.87 127.77 55.55 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 115.5 -0.773 . . . . 0.0 110.403 -176.86 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' F' F ' 143' ' ' THR . . . . . . . . . . . . . 42.3 p . . . . . 0 C--O 1.22 -0.458 0 CA-C-O 117.989 -1.005 . . . . 0.0 110.66 -179.706 . . . . . . . . 0 0 . 1 . 014 nuclear orig core ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 41.1 p . . . . . 0 N--CA 1.461 0.108 0 CA-C-O 120.915 0.388 . . . . 0.0 110.485 . . . . . . . . . 0 0 . 1 . 014 nuclear orig core ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 95.2 mt-10 -140.54 142.71 35.16 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.174 -0.466 . . . . 0.0 111.243 -178.162 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 4' ' ' LEU . . . . . . . . . . . . . 56.0 mt -119.73 130.1 54.83 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 115.819 -0.628 . . . . 0.0 110.317 175.319 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 5' ' ' LYS . . . . . . . . . . . . . 67.1 mttm -107.38 120.57 42.52 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.306 -0.406 . . . . 0.0 110.436 177.242 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 73.9 mt -116.82 150.81 37.74 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 115.532 -0.758 . . . . 0.0 110.378 -179.238 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 74.8 tttt -140.69 139.11 19.33 Favored Pre-proline 0 CA--C 1.534 0.335 0 CA-C-O 119.167 -0.444 . . . . 0.0 110.092 175.594 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 8' ' ' PRO . . . . . . . . . . . . . 86.4 Cg_endo -91.76 140.99 2.52 Favored 'Trans proline' 0 N--CA 1.49 1.267 0 C-N-CA 121.733 1.622 . . . . 0.0 111.672 176.971 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 68.8 mt -74.05 -47.93 6.22 Favored Pre-proline 0 C--N 1.328 -0.348 0 CA-C-O 118.622 -0.704 . . . . 0.0 112.243 -178.473 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 89.0 Cg_endo -80.76 146.36 16.58 Favored 'Trans proline' 0 N--CA 1.495 1.614 0 C-N-CA 121.211 1.274 . . . . 0.0 111.931 176.419 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 63.3 mttm -85.8 95.82 9.55 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-O 120.943 0.401 . . . . 0.0 110.416 178.234 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 11.7 p -139.87 149.23 22.34 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.277 0 CA-C-N 115.894 -0.594 . . . . 0.0 110.348 -179.465 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 45.5 tp10 -87.25 122.21 30.73 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 116.337 -0.392 . . . . 0.0 110.322 178.966 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 14' ' ' LEU . . . . . . . . . . . . . 44.7 mt -97.91 157.65 34.23 Favored Pre-proline 0 C--N 1.329 -0.296 0 CA-C-N 116.163 -0.471 . . . . 0.0 110.861 -179.188 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 15' ' ' PRO . . . . . . . . . . . . . 36.9 Cg_exo -59.56 158.31 28.26 Favored 'Trans proline' 0 N--CA 1.496 1.663 0 C-N-CA 121.413 1.408 . . . . 0.0 111.875 178.719 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 16' ' ' PRO . . . . . . . . . . . . . 33.4 Cg_exo -59.2 -42.65 48.27 Favored 'Trans proline' 0 N--CA 1.496 1.649 0 C-N-CA 121.516 1.478 . . . . 0.0 112.84 -177.606 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 17' ' ' ASP . . . . . . . . . . . . . 7.9 p-10 -87.43 13.42 10.01 Favored 'General case' 0 CA--C 1.536 0.414 0 N-CA-C 113.072 0.767 . . . . 0.0 113.072 -177.06 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 18' ' ' PHE . . . . . . . . . . . . . 42.0 t80 -57.16 -45.45 83.61 Favored 'General case' 0 C--N 1.334 -0.088 0 O-C-N 122.041 -0.412 . . . . 0.0 110.238 -178.994 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 19' ' ' VAL . . . . . . . . . . . . . 47.0 t -57.43 -43.37 82.53 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.262 0 CA-C-N 116.154 -0.475 . . . . 0.0 110.378 -178.451 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 32.0 m-20 -59.1 -41.96 89.37 Favored 'General case' 0 C--N 1.331 -0.224 0 C-N-CA 120.916 -0.314 . . . . 0.0 111.082 -177.634 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 46.9 t -64.55 -44.46 96.83 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.264 0 C-N-CA 120.709 -0.396 . . . . 0.0 110.427 -178.372 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 22' ' ' ILE . . . . . . . . . . . . . 50.9 mm -56.94 -40.14 70.11 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 C-N-CA 120.987 -0.285 . . . . 0.0 110.567 178.709 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 23' ' ' ARG . . . . . . . . . . . . . 53.4 ttp180 -57.13 -48.88 77.58 Favored 'General case' 0 C--N 1.331 -0.214 0 CA-C-O 121.018 0.437 . . . . 0.0 110.468 177.136 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 24' ' ' ILE . . . . . . . . . . . . . 72.7 mt -61.15 -39.5 82.63 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.324 0 CA-C-N 115.839 -0.619 . . . . 0.0 111.944 -177.089 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 16.6 pttp -77.35 -36.07 54.1 Favored 'General case' 0 CA--C 1.535 0.389 0 C-N-CA 120.537 -0.465 . . . . 0.0 111.806 -174.218 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 83.4 mt -77.89 -38.55 45.57 Favored 'General case' 0 C--N 1.33 -0.275 0 N-CA-C 112.979 0.733 . . . . 0.0 112.979 -173.304 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 27' ' ' GLN . . . . . . . . . . . . . 10.1 pt20 -46.92 139.84 5.23 Favored 'General case' 0 N--CA 1.469 0.48 0 N-CA-C 112.867 0.691 . . . . 0.0 112.867 -175.265 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 100.77 -27.76 19.06 Favored Glycine 0 CA--C 1.532 1.122 0 CA-C-N 115.573 -0.739 . . . . 0.0 112.166 -177.544 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 38.0 mmtm -97.84 155.12 17.2 Favored 'General case' 0 C--O 1.232 0.169 0 CA-C-N 117.202 0.501 . . . . 0.0 111.095 178.159 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 30' ' ' THR . . . . . . . . . . . . . 32.3 m -98.92 137.0 38.11 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.107 -0.497 . . . . 0.0 109.884 175.55 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 34.7 m -126.44 151.73 33.27 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.222 0 CA-C-O 120.826 0.346 . . . . 0.0 110.655 -179.296 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 32' ' ' ARG . . . . . . . . . . . . . 76.2 ttt-85 -136.09 149.12 48.58 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.089 -0.505 . . . . 0.0 110.448 178.59 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 33' ' ' THR . . . . . . . . . . . . . 32.1 m -52.92 139.81 26.4 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.386 -0.37 . . . . 0.0 111.301 -178.448 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 100.87 -17.17 56.74 Favored Glycine 0 CA--C 1.533 1.172 0 CA-C-O 119.744 -0.476 . . . . 0.0 113.218 179.644 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 76.7 m-20 -66.69 147.94 52.59 Favored 'General case' 0 N--CA 1.461 0.099 0 CA-C-N 118.028 0.914 . . . . 0.0 111.149 178.728 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 44.6 t -124.25 130.15 73.78 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.197 0 CA-C-N 115.882 -0.599 . . . . 0.0 109.8 178.02 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 37' ' ' ILE . . . . . . . . . . . . . 66.7 mt -122.37 139.65 48.66 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.234 0 CA-C-N 116.266 -0.425 . . . . 0.0 110.126 -179.019 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . -110.18 128.78 9.02 Favored Glycine 0 CA--C 1.526 0.74 0 N-CA-C 111.053 -0.819 . . . . 0.0 111.053 179.586 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 39' ' ' ILE . . . . . . . . . . . . . 73.7 mt -123.87 135.09 64.65 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.171 0 N-CA-C 110.247 -0.279 . . . . 0.0 110.247 179.585 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 40' ' ' SER . . . . . . . . . . . . . 96.6 p -92.97 120.94 33.81 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.398 -0.365 . . . . 0.0 110.984 176.07 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 41' ' ' ILE . . . . . . . . . . . . . 48.1 mm -128.62 115.06 35.92 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.187 0 CA-C-O 120.834 0.35 . . . . 0.0 110.371 177.698 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 1.3 tt 54.52 44.47 28.71 Favored 'General case' 0 CA--C 1.532 0.251 0 CA-C-O 121.392 0.615 . . . . 0.0 110.546 177.636 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . 70.64 16.28 73.96 Favored Glycine 0 CA--C 1.534 1.278 0 C-N-CA 121.093 -0.575 . . . . 0.0 113.12 175.469 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 44' ' ' LYS . . . . . . . . . . . . . 58.5 mtpt -124.05 132.61 53.7 Favored 'General case' 0 C--N 1.332 -0.17 0 CA-C-N 117.765 0.783 . . . . 0.0 109.902 179.413 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 84.8 tt0 -84.46 123.28 30.07 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 116.444 -0.344 . . . . 0.0 111.115 -179.156 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 46' ' ' VAL . . . . . . . . . . . . . 7.3 p -121.64 128.49 75.8 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.244 0 N-CA-C 109.333 -0.617 . . . . 0.0 109.333 175.731 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 66.6 mttm -100.77 128.58 46.76 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.099 -0.5 . . . . 0.0 111.259 178.602 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 48' ' ' PHE . . . . . . . . . . . . . 93.1 m-85 -110.81 131.79 54.75 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-N 116.129 -0.487 . . . . 0.0 109.811 175.603 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 78.5 tttt -108.61 137.41 46.6 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 116.314 -0.403 . . . . 0.0 110.382 179.342 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 50' ' ' VAL . . . . . . . . . . . . . 45.8 t -79.95 109.72 14.79 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.366 0 N-CA-C 109.275 -0.639 . . . . 0.0 109.275 176.326 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 51' ' ' VAL . . . . . . . . . . . . . 55.9 t -71.47 -47.31 59.39 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.324 0 CA-C-N 116.055 -0.521 . . . . 0.0 109.895 -173.795 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 52' ' ' GLN . . . . . . . . . . . . . 61.6 tt0 -171.14 142.14 1.74 Allowed 'General case' 0 C--N 1.33 -0.244 0 C-N-CA 120.145 -0.622 . . . . 0.0 111.557 -178.657 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -114.38 136.08 53.38 Favored 'General case' 0 C--N 1.331 -0.239 0 CA-C-N 115.711 -0.677 . . . . 0.0 109.99 176.135 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 54' ' ' TYR . . . . . . . . . . . . . 30.5 t80 -129.07 108.33 18.04 Favored Pre-proline 0 CA--C 1.536 0.433 0 CA-C-O 118.21 -0.9 . . . . 0.0 110.393 179.616 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 55' ' ' PRO . . . . . . . . . . . . . 73.8 Cg_endo -77.17 169.99 72.71 Favored 'Cis proline' 0 N--CA 1.5 1.873 0 CA-C-N 121.824 1.687 . . . . 0.0 112.318 -5.371 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 56' ' ' SER . . . . . . . . . . . . . 66.6 m -117.45 136.51 23.55 Favored Pre-proline 0 CA--C 1.538 0.514 0 CA-C-O 118.482 -0.771 . . . . 0.0 109.885 175.688 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 57' ' ' PRO . . . . . . . . . . . . . 50.5 Cg_endo -71.24 163.09 86.6 Favored 'Cis proline' 0 N--CA 1.497 1.706 0 CA-C-N 121.791 1.675 . . . . 0.0 111.291 -5.867 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 58' ' ' LEU . . . . . . . . . . . . . 39.4 tp -129.69 138.69 51.3 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-O 121.042 0.449 . . . . 0.0 110.67 -179.205 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 59' ' ' ARG . . . . . . . . . . . . . 41.6 ttm180 -95.58 125.5 40.22 Favored 'General case' 0 C--N 1.326 -0.449 0 CA-C-N 115.717 -0.674 . . . . 0.0 109.219 174.177 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 39.9 t -77.18 116.57 20.73 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.241 0 C-N-CA 120.678 -0.409 . . . . 0.0 110.332 -175.082 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 70.6 mm-40 -131.22 161.77 31.48 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.018 -0.537 . . . . 0.0 109.756 175.977 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 62' ' ' ASP . . . . . . . . . . . . . 81.4 m-20 -52.32 -28.0 17.53 Favored 'General case' 0 C--N 1.328 -0.335 0 N-CA-C 112.034 0.383 . . . . 0.0 112.034 177.816 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 63' ' ' ARG . . . . . . . . . . . . . 77.6 mtp85 -70.77 -22.01 62.44 Favored 'General case' 0 CA--C 1.534 0.331 0 N-CA-C 112.879 0.696 . . . . 0.0 112.879 -176.444 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 29.6 m -80.63 142.05 34.38 Favored 'General case' 0 C--N 1.331 -0.227 0 CA-C-O 121.041 0.448 . . . . 0.0 111.119 -175.239 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 65' ' ' LYS . . . . . . . . . . . . . 96.8 mttt -90.11 138.18 31.73 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 115.902 -0.59 . . . . 0.0 110.066 179.176 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 66' ' ' ILE . . . . . . . . . . . . . 63.9 mt -117.55 129.75 73.52 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.212 0 N-CA-C 110.03 -0.359 . . . . 0.0 110.03 179.329 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 67' ' ' THR . . . . . . . . . . . . . 33.4 m -127.19 142.34 51.51 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-O 121.091 0.472 . . . . 0.0 110.861 -178.855 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 68' ' ' LEU . . . . . . . . . . . . . 15.4 tp . . . . . 0 C--N 1.33 -0.275 0 CA-C-N 116.081 -0.509 . . . . 0.0 110.187 178.057 . . . . . . . . 0 0 . 1 . 014 nuclear orig core ' A' A ' 74' ' ' ASP . . . . . . . . . . . . . 10.5 t0 . . . . . 0 CA--C 1.523 -0.084 0 N-CA-C 109.903 -0.406 . . . . 0.0 109.903 . . . . . . . . . 0 0 . 1 . 014 nuclear orig core ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 43.9 t -111.63 120.67 62.62 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.254 0 CA-C-O 121.249 0.547 . . . . 0.0 110.329 -178.635 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 76' ' ' LEU . . . . . . . . . . . . . 18.3 mt -121.38 139.44 53.44 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 115.463 -0.79 . . . . 0.0 109.035 176.787 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 77' ' ' GLU . . . . . . . . . . . . . 26.0 tt0 -135.71 141.62 44.94 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-O 120.986 0.422 . . . . 0.0 111.361 -174.476 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 78' ' ' ALA . . . . . . . . . . . . . . . -132.14 135.26 46.26 Favored 'General case' 0 C--N 1.331 -0.201 0 CA-C-N 115.821 -0.627 . . . . 0.0 110.073 176.572 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 79' ' ' LYS . . . . . . . . . . . . . 62.3 mtpt -77.95 123.28 26.6 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-O 120.868 0.366 . . . . 0.0 110.43 -179.616 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 80' ' ' ILE . . . . . . . . . . . . . 38.1 mm -139.19 108.81 3.92 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.257 0 N-CA-C 109.018 -0.734 . . . . 0.0 109.018 -176.87 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 81' ' ' LYS . . . . . . . . . . . . . 95.0 mttt -102.48 125.63 49.27 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-O 120.897 0.379 . . . . 0.0 111.148 -176.12 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . 89.06 42.05 5.72 Favored Glycine 0 CA--C 1.524 0.618 0 C-N-CA 120.818 -0.706 . . . . 0.0 111.547 174.644 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 83' ' ' ILE . . . . . . . . . . . . . 73.5 mt -68.12 135.7 27.95 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.339 0 N-CA-C 109.674 -0.491 . . . . 0.0 109.674 177.939 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 84' ' ' LYS . . . . . . . . . . . . . 82.9 tttt -96.84 -53.51 3.51 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.025 -0.534 . . . . 0.0 110.18 -179.136 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 85' ' ' ASP . . . . . . . . . . . . . 8.7 t70 -154.52 151.74 29.26 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 115.627 -0.715 . . . . 0.0 110.327 -179.916 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 86' ' ' VAL . . . . . . . . . . . . . 44.1 t -130.15 132.22 65.37 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.298 0 CA-C-O 121.049 0.452 . . . . 0.0 110.383 179.774 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 87' ' ' ILE . . . . . . . . . . . . . 5.1 mp -117.78 124.09 72.59 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.242 0 N-CA-C 108.975 -0.75 . . . . 0.0 108.975 176.255 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 88' ' ' LEU . . . . . . . . . . . . . 14.4 tp -112.39 128.45 56.31 Favored 'General case' 0 C--N 1.331 -0.226 0 CA-C-O 121.073 0.463 . . . . 0.0 111.309 -175.497 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 89' ' ' ASP . . . . . . . . . . . . . 5.9 t70 -120.65 155.47 33.75 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 115.831 -0.622 . . . . 0.0 109.415 175.833 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 44.4 mp0 -51.02 -36.35 39.07 Favored 'General case' 0 C--N 1.328 -0.33 0 N-CA-C 112.464 0.542 . . . . 0.0 112.464 -171.448 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 91' ' ' ASN . . . . . . . . . . . . . 84.8 m-20 -132.05 33.07 3.95 Favored 'General case' 0 N--CA 1.465 0.309 0 N-CA-C 111.963 0.357 . . . . 0.0 111.963 -176.729 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 92' ' ' LEU . . . . . . . . . . . . . 10.4 tp -166.09 146.63 6.48 Favored 'General case' 0 C--N 1.331 -0.217 0 C-N-CA 120.997 -0.281 . . . . 0.0 110.593 179.525 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 93' ' ' ILE . . . . . . . . . . . . . 63.8 mt -127.09 125.81 67.03 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.238 0 N-CA-C 109.724 -0.473 . . . . 0.0 109.724 -179.611 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 94' ' ' VAL . . . . . . . . . . . . . 45.1 t -122.21 126.04 73.76 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.197 0 N-CA-C 109.742 -0.466 . . . . 0.0 109.742 177.874 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 95' ' ' VAL . . . . . . . . . . . . . 43.5 t -122.61 134.95 64.27 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.235 0 N-CA-C 110.055 -0.35 . . . . 0.0 110.055 -179.047 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 96' ' ' ILE . . . . . . . . . . . . . 61.6 mt -114.43 129.86 69.76 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.322 0 N-CA-C 109.341 -0.614 . . . . 0.0 109.341 178.632 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 97' ' ' THR . . . . . . . . . . . . . 63.4 p -100.26 156.74 17.05 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-O 121.01 0.434 . . . . 0.0 110.814 -179.706 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 98' ' ' GLU . . . . . . . . . . . . . 45.6 tp10 -54.01 -28.1 36.02 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.304 -0.407 . . . . 0.0 112.071 -178.233 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 99' ' ' GLU . . . . . . . . . . . . . 96.0 mt-10 -79.78 16.89 1.02 Allowed 'General case' 0 CA--C 1.534 0.363 0 N-CA-C 113.218 0.821 . . . . 0.0 113.218 -175.465 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 100' ' ' ASN . . . . . . . . . . . . . 3.7 m-20 62.93 37.91 11.61 Favored 'General case' 0 N--CA 1.464 0.232 0 CA-C-O 121.159 0.504 . . . . 0.0 111.021 177.973 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 101' ' ' GLU . . . . . . . . . . . . . 84.5 tt0 -116.8 144.03 44.97 Favored 'General case' 0 C--N 1.332 -0.169 0 N-CA-C 109.583 -0.525 . . . . 0.0 109.583 175.262 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 102' ' ' VAL . . . . . . . . . . . . . 41.1 t -116.4 128.55 73.7 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.283 0 CA-C-O 120.923 0.392 . . . . 0.0 110.187 -176.035 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 103' ' ' LEU . . . . . . . . . . . . . 27.0 mt -118.21 130.29 55.99 Favored 'General case' 0 C--N 1.331 -0.239 0 CA-C-N 115.643 -0.708 . . . . 0.0 110.053 176.215 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 104' ' ' ILE . . . . . . . . . . . . . 70.3 mt -117.85 122.67 70.3 Favored 'Isoleucine or valine' 0 C--O 1.234 0.259 0 N-CA-C 110.136 -0.32 . . . . 0.0 110.136 179.822 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 105' ' ' PHE . . . . . . . . . . . . . 80.7 m-85 -122.11 164.19 18.17 Favored 'General case' 0 C--N 1.331 -0.208 0 O-C-N 124.037 0.836 . . . . 0.0 110.143 -178.353 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 106' ' ' ASN . . . . . . . . . . . . . 44.3 p-10 -100.54 -170.05 1.81 Allowed 'General case' 0 C--N 1.331 -0.198 0 N-CA-C 109.884 -0.413 . . . . 0.0 109.884 172.35 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 107' ' ' GLN . . . . . . . . . . . . . 30.2 tt0 -59.16 -29.99 67.84 Favored 'General case' 0 C--N 1.328 -0.329 0 N-CA-C 112.008 0.374 . . . . 0.0 112.008 -179.508 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 108' ' ' ASN . . . . . . . . . . . . . 3.0 t-20 -84.67 8.31 17.38 Favored 'General case' 0 CA--C 1.536 0.413 0 N-CA-C 113.271 0.841 . . . . 0.0 113.271 -176.751 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 109' ' ' LEU . . . . . . . . . . . . . 11.3 tp 61.6 36.51 16.74 Favored 'General case' 0 C--O 1.233 0.185 0 CA-C-O 120.89 0.376 . . . . 0.0 111.309 178.823 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 110' ' ' GLU . . . . . . . . . . . . . 16.1 mm-40 -103.35 155.46 18.46 Favored 'General case' 0 C--N 1.33 -0.282 0 N-CA-C 109.847 -0.427 . . . . 0.0 109.847 176.056 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 111' ' ' GLU . . . . . . . . . . . . . 44.6 tp10 -84.83 121.96 28.47 Favored 'General case' 0 C--N 1.331 -0.231 0 C-N-CA 120.807 -0.357 . . . . 0.0 110.791 -178.092 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 112' ' ' LEU . . . . . . . . . . . . . 49.7 mt -107.0 -46.05 4.01 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.091 -0.504 . . . . 0.0 110.397 177.735 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 113' ' ' TYR . . . . . . . . . . . . . 60.0 t80 -136.35 135.45 38.85 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.22 -0.446 . . . . 0.0 110.863 179.68 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 114' ' ' ARG . . . . . . . . . . . . . 61.5 ttp85 -135.66 119.09 16.84 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 116.086 -0.506 . . . . 0.0 110.028 178.624 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 115' ' ' GLY . . . . . . . . . . . . . . . -150.04 159.56 28.15 Favored Glycine 0 CA--C 1.523 0.586 0 C-N-CA 120.693 -0.765 . . . . 0.0 111.441 179.855 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 116' ' ' LYS . . . . . . . . . . . . . 39.3 ttpt -130.04 138.26 50.67 Favored 'General case' 0 C--N 1.33 -0.282 0 N-CA-C 109.858 -0.423 . . . . 0.0 109.858 176.47 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 117' ' ' PHE . . . . . . . . . . . . . 38.6 m-85 -137.38 114.04 10.38 Favored 'General case' 0 C--N 1.329 -0.319 0 N-CA-C 110.121 -0.325 . . . . 0.0 110.121 -176.453 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 118' ' ' GLU . . . . . . . . . . . . . 21.7 pt-20 -55.54 -39.71 70.92 Favored 'General case' 0 C--N 1.33 -0.276 0 C-N-CA 120.942 -0.303 . . . . 0.0 111.08 -176.615 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 119' ' ' ASN . . . . . . . . . . . . . 92.8 m-20 -100.01 29.98 3.97 Favored 'General case' 0 C--N 1.33 -0.251 0 N-CA-C 112.252 0.464 . . . . 0.0 112.252 -175.182 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 120' ' ' LEU . . . . . . . . . . . . . 13.8 tp -59.72 120.36 9.35 Favored 'General case' 0 C--N 1.331 -0.209 0 N-CA-C 109.775 -0.454 . . . . 0.0 109.775 177.751 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 121' ' ' ASN . . . . . . . . . . . . . 83.3 m-20 -113.31 -43.99 3.29 Favored 'General case' 0 C--N 1.332 -0.188 0 CA-C-N 116.578 -0.283 . . . . 0.0 111.027 -176.819 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 122' ' ' LYS . . . . . . . . . . . . . 93.4 mttt -144.2 146.93 33.01 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-O 121.054 0.454 . . . . 0.0 111.672 -178.354 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 123' ' ' VAL . . . . . . . . . . . . . 44.2 t -123.22 123.45 67.77 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.334 0 N-CA-C 109.375 -0.602 . . . . 0.0 109.375 174.474 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 124' ' ' LEU . . . . . . . . . . . . . 7.3 mp -114.03 127.23 55.85 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.308 -0.405 . . . . 0.0 110.209 -179.064 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 125' ' ' VAL . . . . . . . . . . . . . 11.4 p -135.31 134.08 52.56 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.328 0 CA-C-N 116.504 -0.316 . . . . 0.0 110.326 -179.602 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 126' ' ' ARG . . . . . . . . . . . . . 44.8 ttt180 -146.4 119.67 8.94 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.471 178.903 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 127' ' ' ASN . . . . . . . . . . . . . 19.1 t-20 51.26 -104.88 0.18 Allowed 'General case' 0 CA--C 1.544 0.72 0 CA-C-O 119.121 -0.466 . . . . 0.0 111.42 179.309 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 128' ' ' ASP . . . . . . . . . . . . . 20.1 p-10 -112.12 0.35 15.87 Favored 'General case' 0 N--CA 1.468 0.45 0 CA-C-N 119.448 1.022 . . . . 0.0 113.653 -174.444 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 129' ' ' LEU . . . . . . . . . . . . . 76.3 mt -107.63 138.85 43.1 Favored 'General case' 0 C--O 1.231 0.117 0 CA-C-N 118.33 0.514 . . . . 0.0 110.358 179.676 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 130' ' ' VAL . . . . . . . . . . . . . 44.0 t -127.7 135.63 62.6 Favored 'Isoleucine or valine' 0 N--CA 1.462 0.156 0 CA-C-O 120.925 0.393 . . . . 0.0 110.248 -178.932 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 131' ' ' VAL . . . . . . . . . . . . . 40.9 t -134.01 134.16 55.78 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.283 0 CA-C-N 116.083 -0.508 . . . . 0.0 110.006 178.144 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 132' ' ' ILE . . . . . . . . . . . . . 72.2 mt -111.25 129.78 65.95 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.317 0 N-CA-C 109.363 -0.606 . . . . 0.0 109.363 179.653 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 133' ' ' ILE . . . . . . . . . . . . . 41.9 mm -113.67 118.8 59.26 Favored 'Isoleucine or valine' 0 C--O 1.234 0.265 0 CA-C-O 120.92 0.39 . . . . 0.0 110.865 -175.426 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 134' ' ' ASP . . . . . . . . . . . . . 8.6 p-10 -131.03 147.03 52.58 Favored 'General case' 0 C--N 1.331 -0.218 0 N-CA-C 109.303 -0.629 . . . . 0.0 109.303 174.823 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 135' ' ' GLU . . . . . . . . . . . . . 39.0 tp10 -49.89 -28.15 6.2 Favored 'General case' 0 C--N 1.326 -0.417 0 N-CA-C 112.662 0.616 . . . . 0.0 112.662 -172.564 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 136' ' ' GLN . . . . . . . . . . . . . 97.8 mt-30 -82.59 -33.71 27.92 Favored 'General case' 0 C--N 1.331 -0.226 0 N-CA-C 112.806 0.669 . . . . 0.0 112.806 -176.073 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 137' ' ' LYS . . . . . . . . . . . . . 53.7 pttt -166.33 172.98 10.48 Favored 'General case' 0 C--O 1.232 0.165 0 CA-C-O 121.72 0.772 . . . . 0.0 112.746 -172.458 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 138' ' ' LEU . . . . . . . . . . . . . 4.2 tt -117.83 128.88 55.28 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-N 114.767 -1.106 . . . . 0.0 109.798 179.479 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 139' ' ' THR . . . . . . . . . . . . . 29.2 m -108.9 127.27 53.9 Favored 'General case' 0 C--N 1.331 -0.23 0 CA-C-N 116.422 -0.354 . . . . 0.0 110.241 178.611 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 140' ' ' LEU . . . . . . . . . . . . . 7.4 tt -111.48 121.77 46.08 Favored 'General case' 0 C--N 1.327 -0.382 0 N-CA-C 109.347 -0.612 . . . . 0.0 109.347 -178.594 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 141' ' ' ILE . . . . . . . . . . . . . 19.3 mt -121.08 120.62 62.73 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 CA-C-O 120.955 0.407 . . . . 0.0 110.181 -175.275 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 142' ' ' ARG . . . . . . . . . . . . . 76.4 mtp180 -106.87 122.11 45.75 Favored 'General case' 0 C--N 1.33 -0.239 0 CA-C-N 115.258 -0.883 . . . . 0.0 109.758 179.527 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 143' ' ' THR . . . . . . . . . . . . . 27.6 p . . . . . 0 C--O 1.22 -0.468 0 CA-C-O 117.996 -1.002 . . . . 0.0 110.523 179.907 . . . . . . . . 0 0 . 1 . 014 nuclear orig core ' B' B ' 2' ' ' SER . . . . . . . . . . . . . 2.8 p . . . . . 0 C--O 1.23 0.055 0 CA-C-O 120.642 0.258 . . . . 0.0 110.425 . . . . . . . . . 0 0 . 1 . 014 nuclear orig core ' B' B ' 3' ' ' GLU . . . . . . . . . . . . . 84.5 tt0 -139.95 139.1 36.04 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-O 120.996 0.426 . . . . 0.0 111.114 -179.248 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' B' B ' 4' ' ' LEU . . . . . . . . . . . . . 4.7 tt -123.24 125.32 44.86 Favored 'General case' 0 C--N 1.331 -0.22 0 CA-C-N 115.689 -0.687 . . . . 0.0 109.752 177.868 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' B' B ' 5' ' ' LYS . . . . . . . . . . . . . 62.7 mttp -106.07 122.57 46.45 Favored 'General case' 0 C--O 1.234 0.269 0 CA-C-O 120.841 0.353 . . . . 0.0 110.877 -179.551 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' B' B ' 6' ' ' LEU . . . . . . . . . . . . . 79.2 mt -114.08 154.43 27.75 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 115.367 -0.833 . . . . 0.0 110.787 -179.179 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' B' B ' 7' ' ' LYS . . . . . . . . . . . . . 62.9 tttm -143.23 140.54 17.89 Favored Pre-proline 0 CA--C 1.533 0.326 0 CA-C-O 119.152 -0.452 . . . . 0.0 110.057 174.007 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' B' B ' 8' ' ' PRO . . . . . . . . . . . . . 71.8 Cg_endo -90.27 139.56 3.01 Favored 'Trans proline' 0 N--CA 1.49 1.282 0 C-N-CA 121.723 1.615 . . . . 0.0 111.407 176.959 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' B' B ' 9' ' ' LEU . . . . . . . . . . . . . 53.6 mt -77.68 -46.69 2.43 Favored Pre-proline 0 C--N 1.329 -0.308 0 CA-C-O 118.811 -0.614 . . . . 0.0 112.102 -177.486 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' B' B ' 10' ' ' PRO . . . . . . . . . . . . . 76.8 Cg_endo -84.08 157.72 13.3 Favored 'Trans proline' 0 N--CA 1.495 1.609 0 C-N-CA 121.353 1.369 . . . . 0.0 111.686 173.771 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' B' B ' 11' ' ' LYS . . . . . . . . . . . . . 24.5 pttm -86.91 114.64 23.71 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-O 121.527 0.68 . . . . 0.0 110.544 177.417 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' B' B ' 12' ' ' VAL . . . . . . . . . . . . . 12.4 p -151.01 148.67 14.79 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.289 0 CA-C-N 115.659 -0.7 . . . . 0.0 110.447 -179.886 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' B' B ' 13' ' ' GLU . . . . . . . . . . . . . 84.5 tt0 -89.06 119.58 29.7 Favored 'General case' 0 C--N 1.329 -0.326 0 N-CA-C 109.877 -0.416 . . . . 0.0 109.877 176.494 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' B' B ' 14' ' ' LEU . . . . . . . . . . . . . 21.4 mt -93.92 147.54 33.68 Favored Pre-proline 0 C--N 1.329 -0.317 0 CA-C-O 119.102 -0.475 . . . . 0.0 110.479 -176.91 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' B' B ' 15' ' ' PRO . . . . . . . . . . . . . 25.3 Cg_exo -62.65 160.41 32.58 Favored 'Trans proline' 0 N--CA 1.497 1.733 0 C-N-CA 121.284 1.322 . . . . 0.0 112.001 177.714 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' B' B ' 16' ' ' PRO . . . . . . . . . . . . . 39.0 Cg_exo -58.88 -44.13 38.07 Favored 'Trans proline' 0 N--CA 1.498 1.781 0 C-N-CA 121.365 1.377 . . . . 0.0 112.892 -178.716 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' B' B ' 17' ' ' ASP . . . . . . . . . . . . . 11.1 p-10 -83.77 10.33 9.74 Favored 'General case' 0 C--N 1.327 -0.404 0 N-CA-C 113.169 0.803 . . . . 0.0 113.169 -177.03 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' B' B ' 18' ' ' PHE . . . . . . . . . . . . . 36.1 t80 -57.91 -43.03 85.91 Favored 'General case' 0 C--N 1.334 -0.084 0 O-C-N 121.975 -0.453 . . . . 0.0 110.088 -178.746 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' B' B ' 19' ' ' VAL . . . . . . . . . . . . . 48.3 t -57.4 -43.39 82.47 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.352 0 CA-C-N 116.247 -0.433 . . . . 0.0 110.403 -179.514 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' B' B ' 20' ' ' ASP . . . . . . . . . . . . . 53.6 m-20 -59.97 -42.57 94.44 Favored 'General case' 0 C--N 1.331 -0.204 0 C-N-CA 120.979 -0.288 . . . . 0.0 110.996 -177.299 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' B' B ' 21' ' ' VAL . . . . . . . . . . . . . 48.3 t -64.53 -45.53 95.34 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.319 0 C-N-CA 120.728 -0.389 . . . . 0.0 110.433 -178.089 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' B' B ' 22' ' ' ILE . . . . . . . . . . . . . 50.0 mm -58.73 -40.63 80.14 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.318 0 C-N-CA 121.081 -0.247 . . . . 0.0 110.681 179.227 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' B' B ' 23' ' ' ARG . . . . . . . . . . . . . 46.2 ttp180 -56.15 -48.29 76.56 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-O 120.984 0.421 . . . . 0.0 110.585 178.503 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' B' B ' 24' ' ' ILE . . . . . . . . . . . . . 72.5 mt -61.5 -45.19 99.15 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.274 0 CA-C-N 115.94 -0.573 . . . . 0.0 111.769 -177.966 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' B' B ' 25' ' ' LYS . . . . . . . . . . . . . 15.6 pttp -71.22 -37.35 72.05 Favored 'General case' 0 CA--C 1.534 0.36 0 C-N-CA 120.615 -0.434 . . . . 0.0 111.838 -172.545 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' B' B ' 26' ' ' LEU . . . . . . . . . . . . . 23.7 mt -80.5 -42.23 22.86 Favored 'General case' 0 C--N 1.33 -0.245 0 N-CA-C 113.096 0.776 . . . . 0.0 113.096 -174.674 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' B' B ' 27' ' ' GLN . . . . . . . . . . . . . 10.5 pt20 -47.0 139.98 5.21 Favored 'General case' 0 N--CA 1.469 0.487 0 N-CA-C 112.751 0.649 . . . . 0.0 112.751 -174.875 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' B' B ' 28' ' ' GLY . . . . . . . . . . . . . . . 99.92 -24.51 31.85 Favored Glycine 0 CA--C 1.533 1.187 0 CA-C-N 115.525 -0.762 . . . . 0.0 112.274 -175.539 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' B' B ' 29' ' ' LYS . . . . . . . . . . . . . 65.2 mttm -98.79 155.09 17.53 Favored 'General case' 0 C--O 1.233 0.187 0 CA-C-N 117.288 0.544 . . . . 0.0 111.009 179.525 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' B' B ' 30' ' ' THR . . . . . . . . . . . . . 31.8 m -100.21 135.26 41.92 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.196 -0.457 . . . . 0.0 109.885 175.436 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' B' B ' 31' ' ' VAL . . . . . . . . . . . . . 35.0 m -127.84 154.46 38.4 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.245 0 CA-C-O 120.897 0.379 . . . . 0.0 110.967 -178.379 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' B' B ' 32' ' ' ARG . . . . . . . . . . . . . 85.6 mtm180 -133.32 151.03 51.85 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 115.823 -0.626 . . . . 0.0 110.396 178.259 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' B' B ' 33' ' ' THR . . . . . . . . . . . . . 23.7 m -53.29 138.51 32.23 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.338 -0.392 . . . . 0.0 111.362 -178.336 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' B' B ' 34' ' ' GLY . . . . . . . . . . . . . . . 101.11 -17.05 56.62 Favored Glycine 0 CA--C 1.531 1.084 0 CA-C-O 119.658 -0.523 . . . . 0.0 113.269 178.978 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' B' B ' 35' ' ' ASP . . . . . . . . . . . . . 69.2 m-20 -64.55 148.93 49.75 Favored 'General case' 0 N--CA 1.461 0.107 0 CA-C-N 118.123 0.962 . . . . 0.0 111.018 179.098 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' B' B ' 36' ' ' VAL . . . . . . . . . . . . . 45.3 t -125.47 132.02 71.49 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.217 0 CA-C-N 115.825 -0.625 . . . . 0.0 109.869 179.157 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' B' B ' 37' ' ' ILE . . . . . . . . . . . . . 68.5 mt -120.22 138.07 51.97 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.234 0 CA-C-N 116.141 -0.482 . . . . 0.0 109.853 179.624 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' B' B ' 38' ' ' GLY . . . . . . . . . . . . . . . -108.05 128.74 9.27 Favored Glycine 0 CA--C 1.524 0.61 0 N-CA-C 110.872 -0.891 . . . . 0.0 110.872 179.848 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' B' B ' 39' ' ' ILE . . . . . . . . . . . . . 75.5 mt -125.63 137.12 58.69 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.259 0 N-CA-C 110.186 -0.302 . . . . 0.0 110.186 179.994 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' B' B ' 40' ' ' SER . . . . . . . . . . . . . 42.2 p -92.8 119.17 31.88 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.378 -0.374 . . . . 0.0 110.924 176.227 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' B' B ' 41' ' ' ILE . . . . . . . . . . . . . 47.6 mm -129.59 117.91 43.66 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.189 0 CA-C-O 120.716 0.293 . . . . 0.0 110.325 178.69 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' B' B ' 42' ' ' LEU . . . . . . . . . . . . . 51.0 mt 57.88 34.32 24.21 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.317 -0.401 . . . . 0.0 111.819 177.7 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' B' B ' 43' ' ' GLY . . . . . . . . . . . . . . . 78.74 -10.1 33.45 Favored Glycine 0 CA--C 1.534 1.236 0 C-N-CA 121.215 -0.517 . . . . 0.0 113.438 177.539 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' B' B ' 44' ' ' LYS . . . . . . . . . . . . . 72.9 mmtt -97.82 138.63 34.88 Favored 'General case' 0 C--N 1.333 -0.132 0 CA-C-N 117.854 0.827 . . . . 0.0 109.946 176.912 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' B' B ' 45' ' ' GLU . . . . . . . . . . . . . 84.8 tt0 -84.07 125.16 31.85 Favored 'General case' 0 C--N 1.328 -0.35 0 C-N-CA 120.874 -0.33 . . . . 0.0 110.76 179.447 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' B' B ' 46' ' ' VAL . . . . . . . . . . . . . 7.4 p -121.77 127.8 75.57 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.182 0 N-CA-C 109.627 -0.509 . . . . 0.0 109.627 177.603 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' B' B ' 47' ' ' LYS . . . . . . . . . . . . . 64.0 mttp -100.45 130.43 46.53 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 115.91 -0.586 . . . . 0.0 111.16 178.911 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' B' B ' 48' ' ' PHE . . . . . . . . . . . . . 93.6 m-85 -112.73 131.84 55.49 Favored 'General case' 0 C--N 1.33 -0.258 0 N-CA-C 109.889 -0.411 . . . . 0.0 109.889 175.748 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' B' B ' 49' ' ' LYS . . . . . . . . . . . . . 85.6 tttt -108.82 139.73 43.24 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.279 -0.418 . . . . 0.0 110.846 -178.499 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' B' B ' 50' ' ' VAL . . . . . . . . . . . . . 46.2 t -83.13 108.0 15.39 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.346 0 N-CA-C 109.301 -0.629 . . . . 0.0 109.301 174.852 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' B' B ' 51' ' ' VAL . . . . . . . . . . . . . 47.7 t -72.7 -48.11 47.43 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.306 0 CA-C-N 116.118 -0.492 . . . . 0.0 110.001 -173.06 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' B' B ' 52' ' ' GLN . . . . . . . . . . . . . 60.4 tt0 -165.25 146.97 7.63 Favored 'General case' 0 C--N 1.33 -0.246 0 C-N-CA 120.266 -0.574 . . . . 0.0 111.863 -177.972 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' B' B ' 53' ' ' ALA . . . . . . . . . . . . . . . -123.23 134.54 54.11 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 115.677 -0.692 . . . . 0.0 109.929 176.48 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' B' B ' 54' ' ' TYR . . . . . . . . . . . . . 33.4 t80 -129.14 112.16 18.35 Favored Pre-proline 0 CA--C 1.535 0.403 0 CA-C-O 118.184 -0.912 . . . . 0.0 110.289 178.726 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' B' B ' 55' ' ' PRO . . . . . . . . . . . . . 73.5 Cg_endo -77.11 169.22 74.86 Favored 'Cis proline' 0 N--CA 1.5 1.904 0 CA-C-N 121.99 1.747 . . . . 0.0 112.212 -6.698 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' B' B ' 56' ' ' SER . . . . . . . . . . . . . 13.8 m -117.25 137.19 23.76 Favored Pre-proline 0 CA--C 1.537 0.467 0 CA-C-O 118.537 -0.744 . . . . 0.0 109.802 175.296 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' B' B ' 57' ' ' PRO . . . . . . . . . . . . . 32.4 Cg_endo -65.71 162.94 67.82 Favored 'Cis proline' 0 N--CA 1.498 1.757 0 CA-C-N 121.761 1.665 . . . . 0.0 111.309 -4.724 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' B' B ' 58' ' ' LEU . . . . . . . . . . . . . 31.7 tp -129.18 137.52 51.2 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-O 120.945 0.402 . . . . 0.0 110.511 -178.651 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' B' B ' 59' ' ' ARG . . . . . . . . . . . . . 27.0 ttm180 -101.49 127.43 48.18 Favored 'General case' 0 C--N 1.327 -0.392 0 N-CA-C 109.301 -0.629 . . . . 0.0 109.301 176.151 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' B' B ' 60' ' ' VAL . . . . . . . . . . . . . 46.9 t -79.57 117.73 25.82 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.33 0 C-N-CA 120.677 -0.409 . . . . 0.0 110.095 -175.967 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' B' B ' 61' ' ' GLU . . . . . . . . . . . . . 70.8 mm-40 -131.06 161.83 31.17 Favored 'General case' 0 C--N 1.331 -0.208 0 CA-C-N 116.047 -0.524 . . . . 0.0 110.284 178.846 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' B' B ' 62' ' ' ASP . . . . . . . . . . . . . 67.4 m-20 -54.53 -32.45 58.22 Favored 'General case' 0 C--N 1.327 -0.396 0 CA-C-N 116.463 -0.335 . . . . 0.0 111.748 -179.901 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' B' B ' 63' ' ' ARG . . . . . . . . . . . . . 13.8 ptp180 -84.24 10.09 11.29 Favored 'General case' 0 CA--C 1.535 0.398 0 N-CA-C 113.471 0.915 . . . . 0.0 113.471 -175.854 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' B' B ' 64' ' ' THR . . . . . . . . . . . . . 32.3 m -94.92 143.0 26.82 Favored 'General case' 0 C--O 1.231 0.128 0 CA-C-N 118.02 0.373 . . . . 0.0 110.632 -179.73 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' B' B ' 65' ' ' LYS . . . . . . . . . . . . . 92.3 mttt -88.52 129.0 35.56 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.155 -0.475 . . . . 0.0 110.267 179.633 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' B' B ' 66' ' ' ILE . . . . . . . . . . . . . 59.5 mt -115.08 130.21 69.99 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.196 0 N-CA-C 109.707 -0.479 . . . . 0.0 109.707 179.479 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' B' B ' 67' ' ' THR . . . . . . . . . . . . . 28.0 m -132.49 144.68 50.61 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-O 121.111 0.482 . . . . 0.0 111.3 -177.923 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' B' B ' 68' ' ' LEU . . . . . . . . . . . . . 7.3 mp . . . . . 0 C--N 1.329 -0.296 0 CA-C-N 115.96 -0.564 . . . . 0.0 109.94 174.79 . . . . . . . . 0 0 . 1 . 014 nuclear orig core ' B' B ' 73' ' ' VAL . . . . . . . . . . . . . 34.6 m . . . . . 0 C--O 1.232 0.14 0 CA-C-O 120.793 0.33 . . . . 0.0 110.603 . . . . . . . . . 0 0 . 1 . 014 nuclear orig core ' B' B ' 74' ' ' ASP . . . . . . . . . . . . . 36.1 t0 -94.66 117.57 30.34 Favored 'General case' 0 C--N 1.329 -0.309 0 N-CA-C 109.669 -0.493 . . . . 0.0 109.669 -179.443 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' B' B ' 75' ' ' VAL . . . . . . . . . . . . . 44.0 t -117.9 124.66 73.4 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.287 0 CA-C-O 121.123 0.487 . . . . 0.0 110.771 -176.382 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' B' B ' 76' ' ' LEU . . . . . . . . . . . . . 5.3 mp -122.55 148.45 45.18 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 115.539 -0.755 . . . . 0.0 109.47 174.964 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' B' B ' 77' ' ' GLU . . . . . . . . . . . . . 45.8 mt-10 -135.05 139.52 44.85 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-O 120.999 0.428 . . . . 0.0 111.471 -177.645 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' B' B ' 78' ' ' ALA . . . . . . . . . . . . . . . -128.39 132.29 48.52 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 115.701 -0.681 . . . . 0.0 109.642 175.585 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' B' B ' 79' ' ' LYS . . . . . . . . . . . . . 84.5 mttt -76.72 121.45 23.31 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-O 121.077 0.465 . . . . 0.0 110.851 -178.072 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' B' B ' 80' ' ' ILE . . . . . . . . . . . . . 43.5 mm -139.19 109.36 4.23 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.27 0 N-CA-C 108.963 -0.754 . . . . 0.0 108.963 -177.854 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' B' B ' 81' ' ' LYS . . . . . . . . . . . . . 93.5 mttt -101.98 124.38 47.5 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-O 120.916 0.388 . . . . 0.0 111.346 -176.244 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' B' B ' 82' ' ' GLY . . . . . . . . . . . . . . . 89.07 42.16 5.69 Favored Glycine 0 CA--C 1.526 0.72 0 C-N-CA 120.956 -0.64 . . . . 0.0 111.841 174.666 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' B' B ' 83' ' ' ILE . . . . . . . . . . . . . 69.0 mt -67.39 136.86 25.85 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.28 0 N-CA-C 109.632 -0.507 . . . . 0.0 109.632 177.116 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' B' B ' 84' ' ' LYS . . . . . . . . . . . . . 38.6 ttpt -101.56 -52.4 3.23 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-O 121.022 0.439 . . . . 0.0 110.422 -178.673 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' B' B ' 85' ' ' ASP . . . . . . . . . . . . . 10.7 t70 -145.46 147.77 32.55 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 115.943 -0.571 . . . . 0.0 110.458 -178.644 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' B' B ' 86' ' ' VAL . . . . . . . . . . . . . 42.2 t -129.68 130.85 67.0 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.26 0 CA-C-O 120.905 0.383 . . . . 0.0 110.373 -179.617 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' B' B ' 87' ' ' ILE . . . . . . . . . . . . . 5.0 mp -119.74 123.74 71.54 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.214 0 N-CA-C 109.313 -0.625 . . . . 0.0 109.313 176.105 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' B' B ' 88' ' ' LEU . . . . . . . . . . . . . 17.9 tp -111.01 127.77 55.64 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-O 121.038 0.447 . . . . 0.0 110.972 -177.774 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' B' B ' 89' ' ' ASP . . . . . . . . . . . . . 8.2 t70 -121.61 152.12 39.64 Favored 'General case' 0 C--N 1.331 -0.201 0 CA-C-N 115.797 -0.638 . . . . 0.0 109.6 177.005 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' B' B ' 90' ' ' GLU . . . . . . . . . . . . . 96.4 mt-10 -48.84 -36.24 16.43 Favored 'General case' 0 C--N 1.328 -0.337 0 N-CA-C 112.642 0.608 . . . . 0.0 112.642 -173.04 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' B' B ' 91' ' ' ASN . . . . . . . . . . . . . 30.5 m120 -132.21 32.87 3.93 Favored 'General case' 0 N--CA 1.466 0.336 0 N-CA-C 111.909 0.337 . . . . 0.0 111.909 -177.001 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' B' B ' 92' ' ' LEU . . . . . . . . . . . . . 15.5 tp -166.13 144.42 5.66 Favored 'General case' 0 C--N 1.331 -0.206 0 C-N-CA 121.028 -0.269 . . . . 0.0 110.574 179.722 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' B' B ' 93' ' ' ILE . . . . . . . . . . . . . 70.1 mt -123.36 122.38 65.09 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.279 0 N-CA-C 109.594 -0.521 . . . . 0.0 109.594 178.741 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' B' B ' 94' ' ' VAL . . . . . . . . . . . . . 47.3 t -120.65 125.03 73.63 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 N-CA-C 109.776 -0.453 . . . . 0.0 109.776 179.281 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' B' B ' 95' ' ' VAL . . . . . . . . . . . . . 43.5 t -124.04 134.6 66.11 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.325 0 CA-C-N 116.286 -0.415 . . . . 0.0 109.976 -178.726 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' B' B ' 96' ' ' ILE . . . . . . . . . . . . . 58.3 mt -117.6 126.96 75.04 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.255 0 N-CA-C 109.367 -0.605 . . . . 0.0 109.367 179.343 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' B' B ' 97' ' ' THR . . . . . . . . . . . . . 77.1 p -98.32 157.72 16.01 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-O 121.188 0.518 . . . . 0.0 111.137 -178.086 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' B' B ' 98' ' ' GLU . . . . . . . . . . . . . 80.2 tt0 -53.92 -29.23 41.26 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 116.1 -0.5 . . . . 0.0 112.059 -178.675 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' B' B ' 99' ' ' GLU . . . . . . . . . . . . . 39.3 tt0 -80.01 15.89 1.35 Allowed 'General case' 0 CA--C 1.541 0.61 0 N-CA-C 112.599 0.592 . . . . 0.0 112.599 -176.074 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' B' B ' 100' ' ' ASN . . . . . . . . . . . . . 4.8 m-20 63.8 33.18 12.98 Favored 'General case' 0 CA--C 1.532 0.271 0 O-C-N 121.873 -0.517 . . . . 0.0 111.703 177.859 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' B' B ' 101' ' ' GLU . . . . . . . . . . . . . 84.7 tt0 -106.47 141.94 36.95 Favored 'General case' 0 C--N 1.331 -0.215 0 N-CA-C 109.506 -0.553 . . . . 0.0 109.506 172.179 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' B' B ' 102' ' ' VAL . . . . . . . . . . . . . 45.2 t -116.89 128.18 74.35 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.299 0 N-CA-C 109.805 -0.443 . . . . 0.0 109.805 -177.813 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' B' B ' 103' ' ' LEU . . . . . . . . . . . . . 26.8 mt -118.8 131.2 56.09 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 115.839 -0.619 . . . . 0.0 110.611 178.185 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' B' B ' 104' ' ' ILE . . . . . . . . . . . . . 69.7 mt -116.17 120.12 63.93 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.245 0 N-CA-C 109.72 -0.474 . . . . 0.0 109.72 178.076 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' B' B ' 105' ' ' PHE . . . . . . . . . . . . . 70.7 m-85 -123.13 163.87 19.74 Favored 'General case' 0 C--N 1.331 -0.207 0 O-C-N 123.81 0.694 . . . . 0.0 109.722 179.867 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' B' B ' 106' ' ' ASN . . . . . . . . . . . . . 48.1 p-10 -98.87 -170.75 1.98 Allowed 'General case' 0 C--N 1.329 -0.298 0 N-CA-C 109.754 -0.461 . . . . 0.0 109.754 172.742 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' B' B ' 107' ' ' GLN . . . . . . . . . . . . . 44.7 tt0 -61.04 -30.05 70.08 Favored 'General case' 0 C--N 1.328 -0.369 0 N-CA-C 111.851 0.315 . . . . 0.0 111.851 -179.159 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' B' B ' 108' ' ' ASN . . . . . . . . . . . . . 13.7 t-20 -82.77 6.4 18.27 Favored 'General case' 0 CA--C 1.537 0.469 0 N-CA-C 113.215 0.821 . . . . 0.0 113.215 -178.421 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' B' B ' 109' ' ' LEU . . . . . . . . . . . . . 10.7 tp 61.95 39.34 13.59 Favored 'General case' 0 C--O 1.233 0.209 0 CA-C-O 121.246 0.546 . . . . 0.0 111.197 178.267 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' B' B ' 110' ' ' GLU . . . . . . . . . . . . . 70.8 mm-40 -105.77 157.83 17.17 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.105 176.419 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' B' B ' 111' ' ' GLU . . . . . . . . . . . . . 84.6 tt0 -83.17 121.99 27.8 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-O 120.901 0.381 . . . . 0.0 111.064 -176.613 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' B' B ' 112' ' ' LEU . . . . . . . . . . . . . 34.0 mt -108.29 -46.09 3.79 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-N 115.959 -0.564 . . . . 0.0 110.133 176.462 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' B' B ' 113' ' ' TYR . . . . . . . . . . . . . 63.0 t80 -143.39 135.94 27.32 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.091 -0.504 . . . . 0.0 111.182 179.141 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' B' B ' 114' ' ' ARG . . . . . . . . . . . . . 26.3 ttm180 -133.16 122.7 24.41 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.235 -0.439 . . . . 0.0 109.88 175.669 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' B' B ' 115' ' ' GLY . . . . . . . . . . . . . . . -150.08 152.34 24.27 Favored Glycine 0 CA--C 1.523 0.556 0 N-CA-C 110.69 -0.964 . . . . 0.0 110.69 179.293 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' B' B ' 116' ' ' LYS . . . . . . . . . . . . . 60.8 tttm -129.2 127.46 41.36 Favored 'General case' 0 C--N 1.328 -0.343 0 N-CA-C 109.697 -0.482 . . . . 0.0 109.697 178.351 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' B' B ' 117' ' ' PHE . . . . . . . . . . . . . 49.8 m-85 -123.27 114.06 19.72 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.258 -0.428 . . . . 0.0 110.257 -174.917 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' B' B ' 118' ' ' GLU . . . . . . . . . . . . . 84.7 tt0 -53.99 -43.29 69.86 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 116.363 -0.381 . . . . 0.0 111.357 -176.716 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' B' B ' 119' ' ' ASN . . . . . . . . . . . . . 17.7 m-80 -99.26 31.01 3.23 Favored 'General case' 0 C--N 1.33 -0.257 0 N-CA-C 112.275 0.472 . . . . 0.0 112.275 -174.203 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' B' B ' 120' ' ' LEU . . . . . . . . . . . . . 21.3 tp -56.4 120.26 7.37 Favored 'General case' 0 C--O 1.232 0.148 0 C-N-CA 121.014 -0.274 . . . . 0.0 110.445 177.877 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' B' B ' 121' ' ' ASN . . . . . . . . . . . . . 72.2 m-20 -114.16 -43.99 3.17 Favored 'General case' 0 C--O 1.232 0.181 0 CA-C-N 116.574 -0.284 . . . . 0.0 111.162 -177.283 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' B' B ' 122' ' ' LYS . . . . . . . . . . . . . 95.1 mttt -145.55 150.43 36.4 Favored 'General case' 0 C--N 1.329 -0.283 0 C-N-CA 120.69 -0.404 . . . . 0.0 111.489 -177.17 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' B' B ' 123' ' ' VAL . . . . . . . . . . . . . 43.8 t -132.77 133.26 59.36 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.235 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.107 177.896 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' B' B ' 124' ' ' LEU . . . . . . . . . . . . . 77.8 mt -120.76 130.53 54.07 Favored 'General case' 0 C--O 1.233 0.202 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.596 178.745 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' B' B ' 125' ' ' VAL . . . . . . . . . . . . . 44.8 t -128.21 128.04 68.16 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.281 0 N-CA-C 109.861 -0.422 . . . . 0.0 109.861 179.054 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' B' B ' 126' ' ' ARG . . . . . . . . . . . . . 73.3 mtp85 -140.4 115.06 9.49 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-O 120.812 0.339 . . . . 0.0 110.792 179.468 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' B' B ' 127' ' ' ASN . . . . . . . . . . . . . 21.0 t-20 51.39 -104.91 0.18 Allowed 'General case' 0 CA--C 1.544 0.718 0 CA-C-O 119.131 -0.461 . . . . 0.0 111.382 178.367 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' B' B ' 128' ' ' ASP . . . . . . . . . . . . . 18.3 p-10 -114.0 2.51 15.01 Favored 'General case' 0 N--CA 1.468 0.436 0 CA-C-N 119.562 1.074 . . . . 0.0 113.432 -177.14 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' B' B ' 129' ' ' LEU . . . . . . . . . . . . . 13.3 tp -106.45 136.89 45.41 Favored 'General case' 0 C--N 1.331 -0.218 0 CA-C-N 118.146 0.43 . . . . 0.0 109.909 178.835 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' B' B ' 130' ' ' VAL . . . . . . . . . . . . . 42.5 t -124.7 136.18 61.52 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.242 0 CA-C-O 120.881 0.372 . . . . 0.0 110.314 -177.358 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' B' B ' 131' ' ' VAL . . . . . . . . . . . . . 46.4 t -134.81 133.83 53.94 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.214 0 CA-C-N 116.264 -0.425 . . . . 0.0 110.187 177.984 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' B' B ' 132' ' ' ILE . . . . . . . . . . . . . 75.7 mt -117.59 133.73 63.43 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.343 0 N-CA-C 109.64 -0.504 . . . . 0.0 109.64 -179.688 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' B' B ' 133' ' ' ILE . . . . . . . . . . . . . 35.6 mm -115.76 123.25 70.93 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.242 0 CA-C-O 120.748 0.309 . . . . 0.0 111.064 -175.448 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' B' B ' 134' ' ' ASP . . . . . . . . . . . . . 9.8 p-10 -134.09 149.77 51.13 Favored 'General case' 0 C--N 1.331 -0.22 0 N-CA-C 109.621 -0.511 . . . . 0.0 109.621 174.755 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' B' B ' 135' ' ' GLU . . . . . . . . . . . . . 40.8 tp10 -50.05 -30.05 10.04 Favored 'General case' 0 C--N 1.328 -0.338 0 N-CA-C 112.651 0.612 . . . . 0.0 112.651 -170.896 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' B' B ' 136' ' ' GLN . . . . . . . . . . . . . 98.2 mt-30 -81.41 -36.4 29.54 Favored 'General case' 0 C--N 1.329 -0.3 0 N-CA-C 112.687 0.625 . . . . 0.0 112.687 -175.981 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' B' B ' 137' ' ' LYS . . . . . . . . . . . . . 20.4 pttm -163.07 172.52 14.82 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-O 121.626 0.727 . . . . 0.0 112.391 -169.706 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' B' B ' 138' ' ' LEU . . . . . . . . . . . . . 6.7 tt -118.53 129.16 55.19 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 114.94 -1.027 . . . . 0.0 109.842 178.27 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' B' B ' 139' ' ' THR . . . . . . . . . . . . . 31.5 m -108.23 128.16 54.47 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.207 -0.452 . . . . 0.0 110.328 -179.857 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' B' B ' 140' ' ' LEU . . . . . . . . . . . . . 9.4 tp -114.02 122.56 47.28 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 115.763 -0.653 . . . . 0.0 109.567 -178.058 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' B' B ' 141' ' ' ILE . . . . . . . . . . . . . 19.6 mt -121.37 119.71 59.85 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.34 0 N-CA-C 109.949 -0.389 . . . . 0.0 109.949 -175.322 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' B' B ' 142' ' ' ARG . . . . . . . . . . . . . 45.2 ttp180 -114.05 127.9 56.15 Favored 'General case' 0 C--N 1.331 -0.229 0 CA-C-N 115.517 -0.765 . . . . 0.0 110.314 -177.216 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' B' B ' 143' ' ' THR . . . . . . . . . . . . . 20.3 p . . . . . 0 C--O 1.22 -0.489 0 CA-C-O 118.09 -0.957 . . . . 0.0 110.625 -179.661 . . . . . . . . 0 0 . 1 . 014 nuclear orig core ' C' C ' 2' ' ' SER . . . . . . . . . . . . . 5.5 p . . . . . 0 N--CA 1.461 0.123 0 CA-C-O 121.119 0.485 . . . . 0.0 110.954 . . . . . . . . . 0 0 . 1 . 014 nuclear orig core ' C' C ' 3' ' ' GLU . . . . . . . . . . . . . 45.9 mp0 -139.45 142.19 37.41 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 115.785 -0.643 . . . . 0.0 110.707 179.232 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' C' C ' 4' ' ' LEU . . . . . . . . . . . . . 14.3 tp -124.52 127.42 47.4 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 116.085 -0.507 . . . . 0.0 110.214 176.593 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' C' C ' 5' ' ' LYS . . . . . . . . . . . . . 60.7 mttp -104.41 121.1 42.71 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.404 -0.362 . . . . 0.0 110.538 177.926 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' C' C ' 6' ' ' LEU . . . . . . . . . . . . . 54.8 mt -116.8 149.94 39.14 Favored 'General case' 0 C--N 1.331 -0.225 0 CA-C-N 115.603 -0.726 . . . . 0.0 110.927 -178.155 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' C' C ' 7' ' ' LYS . . . . . . . . . . . . . 59.7 tttm -138.07 142.91 37.39 Favored Pre-proline 0 CA--C 1.534 0.341 0 CA-C-N 116.28 -0.418 . . . . 0.0 109.958 175.448 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' C' C ' 8' ' ' PRO . . . . . . . . . . . . . 96.7 Cg_endo -91.46 143.39 3.02 Favored 'Trans proline' 0 N--CA 1.49 1.317 0 C-N-CA 121.763 1.642 . . . . 0.0 112.01 179.04 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' C' C ' 9' ' ' LEU . . . . . . . . . . . . . 50.5 mt -85.57 -48.19 0.58 Allowed Pre-proline 0 CA--C 1.534 0.363 0 CA-C-O 118.661 -0.685 . . . . 0.0 112.393 -179.544 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' C' C ' 10' ' ' PRO . . . . . . . . . . . . . 90.8 Cg_endo -79.97 157.97 23.93 Favored 'Trans proline' 0 N--CA 1.497 1.677 0 C-N-CA 121.17 1.247 . . . . 0.0 111.99 176.976 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' C' C ' 11' ' ' LYS . . . . . . . . . . . . . 1.9 ttmp? -88.35 95.35 10.16 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 116.333 -0.394 . . . . 0.0 110.548 179.358 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' C' C ' 12' ' ' VAL . . . . . . . . . . . . . 12.7 p -144.78 147.34 19.18 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.284 0 CA-C-N 116.296 -0.411 . . . . 0.0 110.669 -179.596 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' C' C ' 13' ' ' GLU . . . . . . . . . . . . . 84.7 tt0 -94.09 129.54 40.59 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.348 -0.387 . . . . 0.0 110.145 177.685 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' C' C ' 14' ' ' LEU . . . . . . . . . . . . . 18.3 mt -97.47 153.05 38.5 Favored Pre-proline 0 C--N 1.329 -0.304 0 CA-C-N 116.458 -0.337 . . . . 0.0 110.9 -176.575 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' C' C ' 15' ' ' PRO . . . . . . . . . . . . . 25.6 Cg_exo -62.48 162.19 25.08 Favored 'Trans proline' 0 N--CA 1.498 1.753 0 C-N-CA 121.242 1.295 . . . . 0.0 111.939 176.905 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' C' C ' 16' ' ' PRO . . . . . . . . . . . . . 25.6 Cg_exo -61.32 -36.58 78.32 Favored 'Trans proline' 0 N--CA 1.499 1.811 0 C-N-CA 121.423 1.415 . . . . 0.0 112.611 -178.488 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' C' C ' 17' ' ' ASP . . . . . . . . . . . . . 19.4 p-10 -89.5 9.72 25.51 Favored 'General case' 0 CA--C 1.535 0.4 0 N-CA-C 113.35 0.87 . . . . 0.0 113.35 -176.882 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' C' C ' 18' ' ' PHE . . . . . . . . . . . . . 47.3 t80 -58.07 -43.24 86.86 Favored 'General case' 0 C--O 1.227 -0.101 0 O-C-N 122.051 -0.406 . . . . 0.0 110.078 -178.281 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' C' C ' 19' ' ' VAL . . . . . . . . . . . . . 54.6 t -57.04 -42.17 78.85 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.321 0 CA-C-N 116.415 -0.357 . . . . 0.0 110.458 -178.751 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' C' C ' 20' ' ' ASP . . . . . . . . . . . . . 38.7 t0 -59.59 -43.52 93.66 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-O 120.874 0.369 . . . . 0.0 110.814 -178.153 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' C' C ' 21' ' ' VAL . . . . . . . . . . . . . 48.2 t -64.81 -46.01 93.3 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.326 0 CA-C-N 116.34 -0.391 . . . . 0.0 110.511 -178.23 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' C' C ' 22' ' ' ILE . . . . . . . . . . . . . 50.5 mm -59.77 -37.84 73.21 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.311 0 C-N-CA 120.946 -0.302 . . . . 0.0 110.779 -179.353 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' C' C ' 23' ' ' ARG . . . . . . . . . . . . . 36.7 ttp180 -57.75 -49.15 77.53 Favored 'General case' 0 C--N 1.33 -0.263 0 C-N-CA 120.689 -0.404 . . . . 0.0 110.457 178.187 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' C' C ' 24' ' ' ILE . . . . . . . . . . . . . 74.1 mt -61.45 -44.55 98.74 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.295 0 CA-C-N 116.1 -0.5 . . . . 0.0 111.952 -177.225 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' C' C ' 25' ' ' LYS . . . . . . . . . . . . . 0.7 OUTLIER -70.06 -34.52 73.31 Favored 'General case' 0 CA--C 1.534 0.361 0 C-N-CA 120.834 -0.346 . . . . 0.0 111.815 -174.676 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' C' C ' 26' ' ' LEU . . . . . . . . . . . . . 89.4 mt -78.78 -45.03 21.89 Favored 'General case' 0 C--N 1.331 -0.22 0 N-CA-C 113.085 0.772 . . . . 0.0 113.085 -174.18 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' C' C ' 27' ' ' GLN . . . . . . . . . . . . . 11.3 pt20 -47.29 139.78 6.03 Favored 'General case' 0 N--CA 1.469 0.517 0 N-CA-C 112.674 0.62 . . . . 0.0 112.674 -174.542 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' C' C ' 28' ' ' GLY . . . . . . . . . . . . . . . 99.75 -25.42 28.33 Favored Glycine 0 CA--C 1.535 1.286 0 CA-C-N 115.497 -0.774 . . . . 0.0 112.235 -176.535 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' C' C ' 29' ' ' LYS . . . . . . . . . . . . . 90.2 mttt -97.95 155.17 17.21 Favored 'General case' 0 C--O 1.232 0.169 0 CA-C-N 117.285 0.543 . . . . 0.0 110.963 178.755 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' C' C ' 30' ' ' THR . . . . . . . . . . . . . 24.8 m -106.65 136.63 46.13 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.034 -0.53 . . . . 0.0 109.977 175.515 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' C' C ' 31' ' ' VAL . . . . . . . . . . . . . 34.8 m -132.11 158.05 43.22 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.219 0 CA-C-O 120.889 0.375 . . . . 0.0 111.211 -177.378 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' C' C ' 32' ' ' ARG . . . . . . . . . . . . . 75.2 mtp180 -134.24 153.22 51.98 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-O 121.299 0.571 . . . . 0.0 110.809 178.656 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' C' C ' 33' ' ' THR . . . . . . . . . . . . . 28.0 m -53.52 139.74 30.39 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 116.066 -0.515 . . . . 0.0 111.317 -179.047 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' C' C ' 34' ' ' GLY . . . . . . . . . . . . . . . 99.78 -17.23 57.69 Favored Glycine 0 CA--C 1.533 1.173 0 CA-C-O 119.67 -0.517 . . . . 0.0 113.289 178.21 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' C' C ' 35' ' ' ASP . . . . . . . . . . . . . 79.2 m-20 -66.6 147.9 52.64 Favored 'General case' 0 C--O 1.232 0.172 0 CA-C-N 118.072 0.936 . . . . 0.0 111.166 178.901 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' C' C ' 36' ' ' VAL . . . . . . . . . . . . . 43.1 t -121.79 129.8 75.15 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.239 0 CA-C-N 116.039 -0.528 . . . . 0.0 109.696 177.282 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' C' C ' 37' ' ' ILE . . . . . . . . . . . . . 68.0 mt -120.84 139.57 47.69 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.322 0 CA-C-N 116.343 -0.39 . . . . 0.0 110.052 -178.726 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' C' C ' 38' ' ' GLY . . . . . . . . . . . . . . . -110.62 128.76 8.94 Favored Glycine 0 CA--C 1.526 0.728 0 N-CA-C 111.208 -0.757 . . . . 0.0 111.208 -179.953 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' C' C ' 39' ' ' ILE . . . . . . . . . . . . . 72.8 mt -123.52 137.94 55.04 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.255 0 N-CA-C 109.965 -0.383 . . . . 0.0 109.965 178.999 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' C' C ' 40' ' ' SER . . . . . . . . . . . . . 46.7 t -92.2 113.93 26.33 Favored 'General case' 0 C--N 1.329 -0.296 0 C-N-CA 120.896 -0.321 . . . . 0.0 110.742 176.479 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' C' C ' 41' ' ' ILE . . . . . . . . . . . . . 45.2 mm -122.54 114.91 44.33 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.214 0 N-CA-C 110.026 -0.361 . . . . 0.0 110.026 179.093 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' C' C ' 42' ' ' LEU . . . . . . . . . . . . . 79.5 mt 57.33 35.11 25.66 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.456 -0.338 . . . . 0.0 111.686 178.806 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' C' C ' 43' ' ' GLY . . . . . . . . . . . . . . . 77.98 -10.14 28.05 Favored Glycine 0 CA--C 1.534 1.249 0 C-N-CA 121.311 -0.471 . . . . 0.0 113.575 177.903 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' C' C ' 44' ' ' LYS . . . . . . . . . . . . . 61.9 tttm -96.1 134.2 39.44 Favored 'General case' 0 C--N 1.333 -0.111 0 CA-C-N 117.742 0.771 . . . . 0.0 109.762 176.445 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' C' C ' 45' ' ' GLU . . . . . . . . . . . . . 84.5 tt0 -83.04 123.63 29.66 Favored 'General case' 0 C--N 1.328 -0.335 0 C-N-CA 120.789 -0.365 . . . . 0.0 110.629 -179.73 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' C' C ' 46' ' ' VAL . . . . . . . . . . . . . 7.3 p -117.71 127.26 75.08 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.257 0 N-CA-C 109.448 -0.575 . . . . 0.0 109.448 177.235 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' C' C ' 47' ' ' LYS . . . . . . . . . . . . . 54.8 mtpt -99.51 127.99 45.6 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 115.848 -0.614 . . . . 0.0 110.89 178.858 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' C' C ' 48' ' ' PHE . . . . . . . . . . . . . 92.2 m-85 -110.98 131.97 54.6 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.272 -0.422 . . . . 0.0 110.017 176.153 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' C' C ' 49' ' ' LYS . . . . . . . . . . . . . 78.7 tttt -107.64 135.66 48.7 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.409 -0.36 . . . . 0.0 110.207 179.479 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' C' C ' 50' ' ' VAL . . . . . . . . . . . . . 43.9 t -81.16 109.57 15.64 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.272 0 N-CA-C 109.408 -0.59 . . . . 0.0 109.408 176.833 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' C' C ' 51' ' ' VAL . . . . . . . . . . . . . 48.8 t -70.12 -47.91 65.1 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.292 0 N-CA-C 109.785 -0.45 . . . . 0.0 109.785 -174.923 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' C' C ' 52' ' ' GLN . . . . . . . . . . . . . 46.1 tt0 -168.11 139.95 2.92 Favored 'General case' 0 C--N 1.33 -0.267 0 C-N-CA 120.278 -0.569 . . . . 0.0 111.638 -179.217 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' C' C ' 53' ' ' ALA . . . . . . . . . . . . . . . -110.59 133.45 53.3 Favored 'General case' 0 C--N 1.33 -0.239 0 CA-C-N 115.673 -0.694 . . . . 0.0 109.904 176.059 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' C' C ' 54' ' ' TYR . . . . . . . . . . . . . 30.3 t80 -129.08 112.12 18.42 Favored Pre-proline 0 CA--C 1.536 0.44 0 CA-C-O 118.247 -0.882 . . . . 0.0 110.551 179.396 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' C' C ' 55' ' ' PRO . . . . . . . . . . . . . 72.6 Cg_endo -77.07 165.79 84.0 Favored 'Cis proline' 0 N--CA 1.499 1.826 0 CA-C-N 121.953 1.733 . . . . 0.0 112.205 -7.299 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' C' C ' 56' ' ' SER . . . . . . . . . . . . . 41.8 m -113.82 130.8 23.49 Favored Pre-proline 0 CA--C 1.538 0.492 0 CA-C-O 118.529 -0.748 . . . . 0.0 109.337 175.072 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' C' C ' 57' ' ' PRO . . . . . . . . . . . . . 50.0 Cg_endo -69.55 145.47 79.04 Favored 'Cis proline' 0 N--CA 1.498 1.738 0 CA-C-N 121.885 1.709 . . . . 0.0 111.626 0.711 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' C' C ' 58' ' ' LEU . . . . . . . . . . . . . 21.8 tp -108.16 134.53 50.89 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.291 -0.413 . . . . 0.0 110.761 -178.784 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' C' C ' 59' ' ' ARG . . . . . . . . . . . . . 31.5 ttm180 -100.78 128.55 46.78 Favored 'General case' 0 C--N 1.328 -0.361 0 N-CA-C 109.325 -0.62 . . . . 0.0 109.325 175.227 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' C' C ' 60' ' ' VAL . . . . . . . . . . . . . 44.2 t -84.35 116.94 28.93 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.266 0 C-N-CA 120.613 -0.435 . . . . 0.0 110.411 -177.522 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' C' C ' 61' ' ' GLU . . . . . . . . . . . . . 65.2 mm-40 -126.14 163.68 22.59 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-N 115.744 -0.662 . . . . 0.0 109.774 176.862 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' C' C ' 62' ' ' ASP . . . . . . . . . . . . . 62.7 m-20 -52.72 -32.38 42.62 Favored 'General case' 0 C--N 1.329 -0.32 0 N-CA-C 111.794 0.294 . . . . 0.0 111.794 178.921 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' C' C ' 63' ' ' ARG . . . . . . . . . . . . . 92.6 mtt-85 -73.69 -22.08 60.04 Favored 'General case' 0 CA--C 1.533 0.312 0 N-CA-C 112.922 0.712 . . . . 0.0 112.922 -177.163 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' C' C ' 64' ' ' THR . . . . . . . . . . . . . 35.7 m -67.82 136.83 54.74 Favored 'General case' 0 C--N 1.332 -0.187 0 CA-C-O 120.982 0.42 . . . . 0.0 110.999 -173.631 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' C' C ' 65' ' ' LYS . . . . . . . . . . . . . 55.2 mtmt -90.56 132.11 35.9 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 115.807 -0.633 . . . . 0.0 110.578 178.484 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' C' C ' 66' ' ' ILE . . . . . . . . . . . . . 64.8 mt -113.65 128.55 70.48 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.258 0 N-CA-C 109.645 -0.502 . . . . 0.0 109.645 178.909 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' C' C ' 67' ' ' THR . . . . . . . . . . . . . 18.0 m -127.27 142.67 51.41 Favored 'General case' 0 C--O 1.233 0.218 0 CA-C-O 121.047 0.451 . . . . 0.0 111.11 -177.147 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' C' C ' 68' ' ' LEU . . . . . . . . . . . . . 13.7 tp . . . . . 0 C--N 1.328 -0.343 0 CA-C-N 115.912 -0.586 . . . . 0.0 109.832 176.975 . . . . . . . . 0 0 . 1 . 014 nuclear orig core ' C' C ' 73' ' ' VAL . . . . . . . . . . . . . 35.9 m . . . . . 0 C--O 1.232 0.143 0 N-CA-C 110.043 -0.355 . . . . 0.0 110.043 . . . . . . . . . 0 0 . 1 . 014 nuclear orig core ' C' C ' 74' ' ' ASP . . . . . . . . . . . . . 21.4 t0 -99.06 122.9 42.9 Favored 'General case' 0 C--N 1.329 -0.291 0 C-N-CA 120.896 -0.322 . . . . 0.0 110.24 -177.552 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' C' C ' 75' ' ' VAL . . . . . . . . . . . . . 41.5 t -119.96 123.33 70.6 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.2 0 CA-C-O 121.044 0.449 . . . . 0.0 110.527 -179.225 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' C' C ' 76' ' ' LEU . . . . . . . . . . . . . 5.3 mp -119.49 147.63 44.2 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 115.671 -0.695 . . . . 0.0 109.788 176.285 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' C' C ' 77' ' ' GLU . . . . . . . . . . . . . 97.8 mt-10 -136.06 134.37 38.36 Favored 'General case' 0 C--N 1.331 -0.211 0 CA-C-O 121.074 0.464 . . . . 0.0 111.327 -179.303 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' C' C ' 78' ' ' ALA . . . . . . . . . . . . . . . -124.22 133.45 53.52 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 115.696 -0.684 . . . . 0.0 109.603 176.083 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' C' C ' 79' ' ' LYS . . . . . . . . . . . . . 50.0 mtpt -81.52 119.07 23.29 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-O 120.975 0.417 . . . . 0.0 110.697 -178.273 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' C' C ' 80' ' ' ILE . . . . . . . . . . . . . 44.1 mm -139.18 103.09 1.83 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.338 0 N-CA-C 109.009 -0.737 . . . . 0.0 109.009 -177.1 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' C' C ' 81' ' ' LYS . . . . . . . . . . . . . 73.2 mttt -92.2 127.9 37.85 Favored 'General case' 0 C--N 1.328 -0.359 0 C-N-CA 120.644 -0.422 . . . . 0.0 111.037 -176.776 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' C' C ' 82' ' ' GLY . . . . . . . . . . . . . . . 88.98 42.18 5.71 Favored Glycine 0 CA--C 1.523 0.591 0 C-N-CA 120.889 -0.672 . . . . 0.0 112.204 173.978 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' C' C ' 83' ' ' ILE . . . . . . . . . . . . . 67.9 mt -71.26 131.89 33.96 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.217 0 N-CA-C 109.306 -0.627 . . . . 0.0 109.306 176.206 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' C' C ' 84' ' ' LYS . . . . . . . . . . . . . 28.0 ttpp -101.47 -45.73 5.21 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-O 120.724 0.297 . . . . 0.0 110.741 -176.375 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' C' C ' 85' ' ' ASP . . . . . . . . . . . . . 9.1 t70 -148.25 147.08 28.97 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.324 -0.398 . . . . 0.0 110.674 179.897 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' C' C ' 86' ' ' VAL . . . . . . . . . . . . . 44.2 t -131.74 132.41 61.96 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.229 0 CA-C-O 120.967 0.413 . . . . 0.0 110.683 -178.827 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' C' C ' 87' ' ' ILE . . . . . . . . . . . . . 5.1 mp -122.9 130.42 74.48 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.256 0 CA-C-N 115.79 -0.641 . . . . 0.0 109.439 175.814 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' C' C ' 88' ' ' LEU . . . . . . . . . . . . . 23.9 tp -115.49 132.53 56.59 Favored 'General case' 0 N--CA 1.463 0.22 0 CA-C-O 120.991 0.424 . . . . 0.0 111.484 -177.086 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' C' C ' 89' ' ' ASP . . . . . . . . . . . . . 13.8 t70 -120.63 156.62 31.29 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 115.709 -0.678 . . . . 0.0 109.477 175.747 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' C' C ' 90' ' ' GLU . . . . . . . . . . . . . 70.9 mm-40 -48.05 -42.32 28.17 Favored 'General case' 0 N--CA 1.465 0.29 0 N-CA-C 112.723 0.638 . . . . 0.0 112.723 -171.629 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' C' C ' 91' ' ' ASN . . . . . . . . . . . . . 6.3 p30 -132.07 38.49 3.5 Favored 'General case' 0 C--O 1.233 0.223 0 CA-C-O 120.692 0.282 . . . . 0.0 111.488 -178.316 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' C' C ' 92' ' ' LEU . . . . . . . . . . . . . 9.9 tp -165.7 145.19 6.4 Favored 'General case' 0 C--N 1.332 -0.191 0 C-N-CA 120.754 -0.378 . . . . 0.0 110.6 -178.966 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' C' C ' 93' ' ' ILE . . . . . . . . . . . . . 55.9 mt -123.53 125.76 71.99 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.226 0 N-CA-C 109.814 -0.439 . . . . 0.0 109.814 -177.715 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' C' C ' 94' ' ' VAL . . . . . . . . . . . . . 45.8 t -124.01 126.41 72.4 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.221 0 N-CA-C 109.872 -0.418 . . . . 0.0 109.872 178.781 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' C' C ' 95' ' ' VAL . . . . . . . . . . . . . 42.4 t -126.63 137.76 56.82 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.229 0 CA-C-N 116.285 -0.416 . . . . 0.0 110.374 -178.203 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' C' C ' 96' ' ' ILE . . . . . . . . . . . . . 54.8 mt -116.65 129.44 73.14 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.28 0 N-CA-C 109.276 -0.638 . . . . 0.0 109.276 178.505 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' C' C ' 97' ' ' THR . . . . . . . . . . . . . 64.6 p -106.08 157.73 17.33 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-O 121.334 0.588 . . . . 0.0 111.628 -175.955 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' C' C ' 98' ' ' GLU . . . . . . . . . . . . . 12.8 pt-20 -53.87 -23.7 13.46 Favored 'General case' 0 CA--C 1.535 0.375 0 CA-C-N 115.818 -0.628 . . . . 0.0 112.491 179.013 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' C' C ' 99' ' ' GLU . . . . . . . . . . . . . 96.5 mt-10 -77.76 13.31 1.37 Allowed 'General case' 0 CA--C 1.536 0.433 0 N-CA-C 113.074 0.768 . . . . 0.0 113.074 -178.321 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' C' C ' 100' ' ' ASN . . . . . . . . . . . . . 1.9 m-20 61.78 37.53 15.54 Favored 'General case' 0 N--CA 1.463 0.18 0 CA-C-O 120.995 0.426 . . . . 0.0 110.759 179.599 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' C' C ' 101' ' ' GLU . . . . . . . . . . . . . 84.4 tt0 -118.92 145.21 45.94 Favored 'General case' 0 C--O 1.232 0.184 0 CA-C-N 116.058 -0.519 . . . . 0.0 109.919 179.221 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' C' C ' 102' ' ' VAL . . . . . . . . . . . . . 46.8 t -114.98 125.32 72.27 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 N-CA-C 109.646 -0.501 . . . . 0.0 109.646 -179.096 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' C' C ' 103' ' ' LEU . . . . . . . . . . . . . 37.5 mt -116.14 131.77 56.85 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-N 115.707 -0.678 . . . . 0.0 110.423 178.567 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' C' C ' 104' ' ' ILE . . . . . . . . . . . . . 66.3 mt -118.46 121.34 66.83 Favored 'Isoleucine or valine' 0 C--O 1.234 0.277 0 CA-C-N 116.332 -0.395 . . . . 0.0 110.003 177.892 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' C' C ' 105' ' ' PHE . . . . . . . . . . . . . 80.0 m-85 -120.65 162.76 19.13 Favored 'General case' 0 C--N 1.331 -0.219 0 O-C-N 123.994 0.809 . . . . 0.0 109.905 -179.749 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' C' C ' 106' ' ' ASN . . . . . . . . . . . . . 46.4 p-10 -101.09 -170.59 1.86 Allowed 'General case' 0 C--N 1.329 -0.296 0 N-CA-C 110.013 -0.366 . . . . 0.0 110.013 173.76 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' C' C ' 107' ' ' GLN . . . . . . . . . . . . . 46.2 tt0 -58.67 -29.87 66.92 Favored 'General case' 0 C--N 1.329 -0.293 0 N-CA-C 111.942 0.349 . . . . 0.0 111.942 -179.999 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' C' C ' 108' ' ' ASN . . . . . . . . . . . . . 9.7 t30 -85.12 9.98 13.39 Favored 'General case' 0 CA--C 1.535 0.381 0 N-CA-C 113.137 0.791 . . . . 0.0 113.137 -177.177 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' C' C ' 109' ' ' LEU . . . . . . . . . . . . . 8.7 tp 59.18 36.25 23.83 Favored 'General case' 0 C--O 1.232 0.159 0 O-C-N 122.159 -0.338 . . . . 0.0 111.406 178.441 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' C' C ' 110' ' ' GLU . . . . . . . . . . . . . 95.6 mt-10 -105.17 159.81 15.57 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-O 120.758 0.313 . . . . 0.0 110.35 177.766 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' C' C ' 111' ' ' GLU . . . . . . . . . . . . . 84.6 tt0 -84.67 121.98 28.42 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.309 -0.405 . . . . 0.0 110.851 -178.402 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' C' C ' 112' ' ' LEU . . . . . . . . . . . . . 14.7 mt -109.93 -46.07 3.53 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-N 116.081 -0.509 . . . . 0.0 110.158 177.211 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' C' C ' 113' ' ' TYR . . . . . . . . . . . . . 53.2 t80 -139.33 136.94 35.34 Favored 'General case' 0 C--N 1.331 -0.224 0 CA-C-N 116.254 -0.43 . . . . 0.0 111.082 179.854 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' C' C ' 114' ' ' ARG . . . . . . . . . . . . . 71.3 ttp85 -139.09 121.11 15.63 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.054 -0.521 . . . . 0.0 110.18 177.785 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' C' C ' 115' ' ' GLY . . . . . . . . . . . . . . . -150.06 159.85 28.28 Favored Glycine 0 CA--C 1.524 0.634 0 N-CA-C 110.908 -0.877 . . . . 0.0 110.908 178.316 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' C' C ' 116' ' ' LYS . . . . . . . . . . . . . 1.4 ttmp? -131.73 142.64 49.85 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-O 120.822 0.344 . . . . 0.0 110.288 178.491 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' C' C ' 117' ' ' PHE . . . . . . . . . . . . . 31.0 m-85 -138.92 115.46 10.56 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.182 -0.463 . . . . 0.0 109.948 -177.183 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' C' C ' 118' ' ' GLU . . . . . . . . . . . . . 82.9 tt0 -52.9 -48.81 66.93 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.528 -0.305 . . . . 0.0 111.662 -176.005 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' C' C ' 119' ' ' ASN . . . . . . . . . . . . . 4.0 p30 -97.25 31.13 2.55 Favored 'General case' 0 C--N 1.33 -0.259 0 N-CA-C 112.101 0.408 . . . . 0.0 112.101 -175.349 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' C' C ' 120' ' ' LEU . . . . . . . . . . . . . 15.1 tp -52.96 126.55 20.82 Favored 'General case' 0 N--CA 1.463 0.212 0 CA-C-O 120.45 0.167 . . . . 0.0 110.862 177.813 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' C' C ' 121' ' ' ASN . . . . . . . . . . . . . 51.3 t30 -113.76 -44.2 3.21 Favored 'General case' 0 C--N 1.33 -0.258 0 C-N-CA 121.165 -0.214 . . . . 0.0 111.258 -176.133 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' C' C ' 122' ' ' LYS . . . . . . . . . . . . . 88.2 mttt -148.08 151.91 36.46 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-O 121.016 0.436 . . . . 0.0 111.81 -177.267 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' C' C ' 123' ' ' VAL . . . . . . . . . . . . . 42.9 t -131.12 128.92 62.67 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 CA-C-N 115.949 -0.569 . . . . 0.0 109.503 173.865 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' C' C ' 124' ' ' LEU . . . . . . . . . . . . . 62.0 mt -122.35 136.79 54.96 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.43 -0.35 . . . . 0.0 110.308 -178.814 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' C' C ' 125' ' ' VAL . . . . . . . . . . . . . 12.9 p -133.16 134.59 57.52 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.219 0 CA-C-O 120.997 0.427 . . . . 0.0 110.768 -179.463 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' C' C ' 126' ' ' ARG . . . . . . . . . . . . . 88.8 mtt180 -151.67 135.24 16.2 Favored 'General case' 0 C--N 1.327 -0.37 0 N-CA-C 109.094 -0.706 . . . . 0.0 109.094 176.123 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' C' C ' 127' ' ' ASN . . . . . . . . . . . . . 9.7 p30 48.88 -150.37 0.17 Allowed 'General case' 0 CA--C 1.541 0.62 0 CA-C-O 119.431 -0.318 . . . . 0.0 110.932 179.078 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' C' C ' 128' ' ' ASP . . . . . . . . . . . . . 10.2 p-10 -81.83 18.05 1.38 Allowed 'General case' 0 CA--C 1.535 0.4 0 N-CA-C 112.723 0.638 . . . . 0.0 112.723 179.393 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' C' C ' 129' ' ' LEU . . . . . . . . . . . . . 73.0 mt -117.6 137.66 52.46 Favored 'General case' 0 C--O 1.233 0.184 0 O-C-N 122.083 -0.386 . . . . 0.0 110.416 179.477 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' C' C ' 130' ' ' VAL . . . . . . . . . . . . . 43.8 t -128.72 140.45 49.21 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.212 0 CA-C-N 116.254 -0.43 . . . . 0.0 110.091 -179.151 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' C' C ' 131' ' ' VAL . . . . . . . . . . . . . 41.4 t -135.46 135.27 51.83 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.226 0 CA-C-O 121.033 0.445 . . . . 0.0 110.273 178.504 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' C' C ' 132' ' ' ILE . . . . . . . . . . . . . 70.6 mt -114.51 133.31 61.0 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.352 0 CA-C-N 115.741 -0.663 . . . . 0.0 109.399 179.263 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' C' C ' 133' ' ' ILE . . . . . . . . . . . . . 39.5 mm -114.8 122.77 69.59 Favored 'Isoleucine or valine' 0 C--O 1.234 0.237 0 CA-C-O 120.714 0.292 . . . . 0.0 110.817 -175.389 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' C' C ' 134' ' ' ASP . . . . . . . . . . . . . 8.2 p-10 -131.92 150.61 52.1 Favored 'General case' 0 C--N 1.331 -0.2 0 N-CA-C 109.855 -0.424 . . . . 0.0 109.855 176.091 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' C' C ' 135' ' ' GLU . . . . . . . . . . . . . 84.7 tt0 -49.89 -26.97 4.58 Favored 'General case' 0 C--N 1.327 -0.39 0 N-CA-C 112.902 0.704 . . . . 0.0 112.902 -172.117 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' C' C ' 136' ' ' GLN . . . . . . . . . . . . . 94.0 mt-30 -93.35 -24.71 18.01 Favored 'General case' 0 C--N 1.33 -0.281 0 N-CA-C 113.088 0.774 . . . . 0.0 113.088 -172.626 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' C' C ' 137' ' ' LYS . . . . . . . . . . . . . 55.6 pttt -170.0 173.72 5.87 Favored 'General case' 0 C--O 1.232 0.163 0 CA-C-O 121.583 0.706 . . . . 0.0 112.553 -173.432 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' C' C ' 138' ' ' LEU . . . . . . . . . . . . . 4.4 tt -118.51 129.75 55.54 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 114.967 -1.015 . . . . 0.0 109.937 179.592 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' C' C ' 139' ' ' THR . . . . . . . . . . . . . 25.9 m -109.83 124.75 51.87 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.406 -0.361 . . . . 0.0 110.319 178.834 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' C' C ' 140' ' ' LEU . . . . . . . . . . . . . 7.9 tt -111.52 125.18 53.63 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 115.705 -0.679 . . . . 0.0 109.381 -178.665 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' C' C ' 141' ' ' ILE . . . . . . . . . . . . . 19.3 mt -125.08 120.16 57.66 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.251 0 CA-C-O 120.993 0.425 . . . . 0.0 110.058 -176.011 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' C' C ' 142' ' ' ARG . . . . . . . . . . . . . 59.3 ttp180 . . . . . 0 C--N 1.331 -0.21 0 CA-C-N 115.574 -0.739 . . . . 0.0 110.19 179.352 . . . . . . . . 0 0 . 1 . 014 nuclear orig core ' D' D ' 2' ' ' SER . . . . . . . . . . . . . 2.8 p . . . . . 0 N--CA 1.462 0.131 0 CA-C-O 120.801 0.334 . . . . 0.0 110.521 . . . . . . . . . 0 0 . 1 . 014 nuclear orig core ' D' D ' 3' ' ' GLU . . . . . . . . . . . . . 95.8 mt-10 -141.3 140.51 33.85 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.168 -0.469 . . . . 0.0 111.166 -179.217 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' D' D ' 4' ' ' LEU . . . . . . . . . . . . . 17.8 tp -125.34 131.57 52.98 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 115.928 -0.578 . . . . 0.0 110.062 176.139 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' D' D ' 5' ' ' LYS . . . . . . . . . . . . . 95.2 mttt -109.8 119.93 40.88 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.424 -0.353 . . . . 0.0 110.577 179.514 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' D' D ' 6' ' ' LEU . . . . . . . . . . . . . 51.5 mt -115.07 145.77 41.98 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 115.365 -0.834 . . . . 0.0 110.555 -177.821 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' D' D ' 7' ' ' LYS . . . . . . . . . . . . . 61.8 tttp -132.65 134.36 24.6 Favored Pre-proline 0 CA--C 1.537 0.458 0 CA-C-O 118.7 -0.667 . . . . 0.0 109.966 177.153 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' D' D ' 8' ' ' PRO . . . . . . . . . . . . . 90.5 Cg_endo -89.54 139.39 3.39 Favored 'Trans proline' 0 N--CA 1.491 1.336 0 C-N-CA 121.437 1.425 . . . . 0.0 111.634 176.531 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' D' D ' 9' ' ' LEU . . . . . . . . . . . . . 55.0 mt -78.02 -47.8 2.15 Favored Pre-proline 0 CA--C 1.533 0.301 0 CA-C-O 118.65 -0.69 . . . . 0.0 112.417 -178.356 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' D' D ' 10' ' ' PRO . . . . . . . . . . . . . 84.2 Cg_endo -80.33 152.53 20.79 Favored 'Trans proline' 0 N--CA 1.497 1.711 0 C-N-CA 121.232 1.288 . . . . 0.0 111.83 176.725 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' D' D ' 11' ' ' LYS . . . . . . . . . . . . . 53.5 tttp -87.97 98.37 11.47 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-O 120.924 0.392 . . . . 0.0 110.373 178.767 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' D' D ' 12' ' ' VAL . . . . . . . . . . . . . 11.9 p -141.12 147.07 22.83 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.262 0 CA-C-N 116.037 -0.529 . . . . 0.0 110.432 -179.538 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' D' D ' 13' ' ' GLU . . . . . . . . . . . . . 96.1 mt-10 -84.87 124.01 31.13 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.347 -0.388 . . . . 0.0 110.371 179.06 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' D' D ' 14' ' ' LEU . . . . . . . . . . . . . 39.8 mt -98.88 144.82 28.87 Favored Pre-proline 0 CA--C 1.534 0.356 0 CA-C-O 119.005 -0.522 . . . . 0.0 110.186 -179.511 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' D' D ' 15' ' ' PRO . . . . . . . . . . . . . 25.2 Cg_exo -62.38 159.32 36.26 Favored 'Trans proline' 0 N--CA 1.497 1.728 0 C-N-CA 121.247 1.298 . . . . 0.0 111.964 177.091 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' D' D ' 16' ' ' PRO . . . . . . . . . . . . . 38.2 Cg_exo -58.32 -41.25 68.13 Favored 'Trans proline' 0 N--CA 1.498 1.758 0 C-N-CA 121.463 1.442 . . . . 0.0 112.948 -178.467 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' D' D ' 17' ' ' ASP . . . . . . . . . . . . . 14.5 p-10 -81.9 5.99 17.22 Favored 'General case' 0 C--N 1.326 -0.432 0 N-CA-C 113.208 0.818 . . . . 0.0 113.208 -177.599 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' D' D ' 18' ' ' PHE . . . . . . . . . . . . . 55.1 t80 -57.59 -42.33 82.97 Favored 'General case' 0 N--CA 1.457 -0.075 0 O-C-N 121.937 -0.477 . . . . 0.0 110.228 -179.514 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' D' D ' 19' ' ' VAL . . . . . . . . . . . . . 47.7 t -56.63 -43.26 78.45 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.263 0 CA-C-N 116.301 -0.409 . . . . 0.0 110.371 -179.358 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' D' D ' 20' ' ' ASP . . . . . . . . . . . . . 81.4 m-20 -60.48 -41.95 95.26 Favored 'General case' 0 C--N 1.33 -0.26 0 C-N-CA 120.981 -0.288 . . . . 0.0 110.895 -178.085 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' D' D ' 21' ' ' VAL . . . . . . . . . . . . . 47.2 t -64.18 -47.93 87.87 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.27 0 C-N-CA 120.742 -0.383 . . . . 0.0 110.35 -177.821 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' D' D ' 22' ' ' ILE . . . . . . . . . . . . . 50.7 mm -56.11 -46.36 80.96 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.25 0 CA-C-O 120.762 0.315 . . . . 0.0 110.604 179.205 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' D' D ' 23' ' ' ARG . . . . . . . . . . . . . 52.8 ttp180 -54.9 -50.53 68.53 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 116.535 -0.302 . . . . 0.0 111.518 -178.064 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' D' D ' 24' ' ' ILE . . . . . . . . . . . . . 74.9 mt -60.16 -42.17 89.23 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 C-N-CA 121.056 -0.258 . . . . 0.0 111.351 -176.397 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' D' D ' 25' ' ' LYS . . . . . . . . . . . . . 43.6 mtmt -66.85 -39.81 87.7 Favored 'General case' 0 C--N 1.329 -0.316 0 N-CA-C 112.386 0.513 . . . . 0.0 112.386 -178.72 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' D' D ' 26' ' ' LEU . . . . . . . . . . . . . 92.2 mt -78.48 -40.92 34.04 Favored 'General case' 0 C--N 1.331 -0.23 0 N-CA-C 112.881 0.697 . . . . 0.0 112.881 -173.096 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' D' D ' 27' ' ' GLN . . . . . . . . . . . . . 9.1 pt20 -46.61 140.39 4.46 Favored 'General case' 0 N--CA 1.469 0.496 0 N-CA-C 112.691 0.626 . . . . 0.0 112.691 -176.082 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' D' D ' 28' ' ' GLY . . . . . . . . . . . . . . . 99.51 -26.51 24.08 Favored Glycine 0 CA--C 1.532 1.126 0 CA-C-N 115.511 -0.768 . . . . 0.0 112.144 -176.394 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' D' D ' 29' ' ' LYS . . . . . . . . . . . . . 98.7 mttt -97.86 155.2 17.17 Favored 'General case' 0 C--O 1.234 0.269 0 CA-C-N 117.267 0.534 . . . . 0.0 111.134 178.59 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' D' D ' 30' ' ' THR . . . . . . . . . . . . . 18.5 m -105.8 135.58 46.96 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.002 -0.544 . . . . 0.0 109.695 174.922 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' D' D ' 31' ' ' VAL . . . . . . . . . . . . . 35.1 m -128.35 159.68 39.43 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.245 0 CA-C-N 116.382 -0.372 . . . . 0.0 110.681 -177.916 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' D' D ' 32' ' ' ARG . . . . . . . . . . . . . 57.8 ttp180 -132.75 149.8 52.24 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-O 121.22 0.533 . . . . 0.0 110.507 179.561 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' D' D ' 33' ' ' THR . . . . . . . . . . . . . 22.4 m -53.1 139.58 28.07 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 116.333 -0.394 . . . . 0.0 111.326 -178.412 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' D' D ' 34' ' ' GLY . . . . . . . . . . . . . . . 101.26 -17.05 56.36 Favored Glycine 0 CA--C 1.532 1.155 0 CA-C-O 119.645 -0.53 . . . . 0.0 113.251 179.703 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' D' D ' 35' ' ' ASP . . . . . . . . . . . . . 62.8 m-20 -64.09 148.59 49.49 Favored 'General case' 0 C--O 1.231 0.1 0 CA-C-N 118.037 0.918 . . . . 0.0 111.222 179.102 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' D' D ' 36' ' ' VAL . . . . . . . . . . . . . 45.7 t -124.71 128.82 73.62 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.234 0 CA-C-N 115.577 -0.738 . . . . 0.0 109.541 178.185 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' D' D ' 37' ' ' ILE . . . . . . . . . . . . . 66.0 mt -121.21 138.32 52.0 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.256 0 CA-C-N 116.273 -0.421 . . . . 0.0 110.02 -179.293 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' D' D ' 38' ' ' GLY . . . . . . . . . . . . . . . -108.38 128.53 9.14 Favored Glycine 0 CA--C 1.524 0.646 0 N-CA-C 110.754 -0.938 . . . . 0.0 110.754 178.408 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' D' D ' 39' ' ' ILE . . . . . . . . . . . . . 71.9 mt -123.23 138.16 54.13 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.265 0 N-CA-C 109.934 -0.395 . . . . 0.0 109.934 179.803 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' D' D ' 40' ' ' SER . . . . . . . . . . . . . 79.2 p -90.32 118.47 29.84 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.316 -0.402 . . . . 0.0 110.55 176.654 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' D' D ' 41' ' ' ILE . . . . . . . . . . . . . 48.5 mm -129.5 116.11 37.6 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.266 0 CA-C-N 116.453 -0.339 . . . . 0.0 110.177 179.269 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' D' D ' 42' ' ' LEU . . . . . . . . . . . . . 78.1 mt 57.46 35.77 26.27 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.217 -0.447 . . . . 0.0 111.568 177.991 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' D' D ' 43' ' ' GLY . . . . . . . . . . . . . . . 77.79 -10.1 26.99 Favored Glycine 0 CA--C 1.534 1.237 0 C-N-CA 121.303 -0.475 . . . . 0.0 113.537 177.141 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' D' D ' 44' ' ' LYS . . . . . . . . . . . . . 48.5 tttp -101.52 139.8 36.68 Favored 'General case' 0 C--N 1.333 -0.128 0 CA-C-N 117.838 0.819 . . . . 0.0 109.831 177.123 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' D' D ' 45' ' ' GLU . . . . . . . . . . . . . 84.5 tt0 -83.54 127.81 34.02 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-O 120.957 0.408 . . . . 0.0 110.931 -179.201 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' D' D ' 46' ' ' VAL . . . . . . . . . . . . . 7.4 p -121.15 126.9 75.66 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.169 0 N-CA-C 109.339 -0.615 . . . . 0.0 109.339 176.294 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' D' D ' 47' ' ' LYS . . . . . . . . . . . . . 66.3 mttm -100.31 130.12 46.38 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.166 -0.47 . . . . 0.0 111.415 179.063 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' D' D ' 48' ' ' PHE . . . . . . . . . . . . . 95.4 m-85 -112.96 131.99 55.53 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 115.97 -0.559 . . . . 0.0 109.769 176.192 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' D' D ' 49' ' ' LYS . . . . . . . . . . . . . 81.6 tttt -108.31 137.81 45.65 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.297 -0.41 . . . . 0.0 110.497 179.644 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' D' D ' 50' ' ' VAL . . . . . . . . . . . . . 46.2 t -82.41 107.05 13.94 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.287 0 N-CA-C 109.169 -0.678 . . . . 0.0 109.169 175.785 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' D' D ' 51' ' ' VAL . . . . . . . . . . . . . 46.2 t -72.15 -52.38 24.85 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.318 0 CA-C-N 116.041 -0.527 . . . . 0.0 109.683 -174.442 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' D' D ' 52' ' ' GLN . . . . . . . . . . . . . 91.6 mt-30 -152.43 151.57 30.94 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-O 121.291 0.567 . . . . 0.0 111.595 -178.011 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' D' D ' 53' ' ' ALA . . . . . . . . . . . . . . . -127.01 130.66 50.45 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 115.012 -0.995 . . . . 0.0 109.871 176.658 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' D' D ' 54' ' ' TYR . . . . . . . . . . . . . 68.2 t80 -128.66 106.78 18.74 Favored Pre-proline 0 C--N 1.327 -0.384 0 CA-C-O 118.355 -0.831 . . . . 0.0 110.248 -179.776 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' D' D ' 55' ' ' PRO . . . . . . . . . . . . . 73.3 Cg_endo -77.13 170.07 72.56 Favored 'Cis proline' 0 N--CA 1.501 1.919 0 CA-C-N 121.786 1.674 . . . . 0.0 112.631 -3.156 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' D' D ' 56' ' ' SER . . . . . . . . . . . . . 13.6 m -112.15 121.35 39.55 Favored Pre-proline 0 CA--C 1.539 0.522 0 CA-C-O 118.258 -0.877 . . . . 0.0 109.447 175.584 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' D' D ' 57' ' ' PRO . . . . . . . . . . . . . 54.3 Cg_endo -70.6 170.99 59.53 Favored 'Cis proline' 0 N--CA 1.497 1.704 0 CA-C-N 122.11 1.789 . . . . 0.0 112.109 1.35 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' D' D ' 58' ' ' LEU . . . . . . . . . . . . . 19.3 tp -130.15 137.6 50.21 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 115.885 -0.598 . . . . 0.0 110.246 -179.285 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' D' D ' 59' ' ' ARG . . . . . . . . . . . . . 32.6 ttp180 -106.77 126.74 52.69 Favored 'General case' 0 C--N 1.328 -0.338 0 N-CA-C 109.367 -0.605 . . . . 0.0 109.367 176.169 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' D' D ' 60' ' ' VAL . . . . . . . . . . . . . 47.8 t -83.35 122.4 37.51 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.239 0 C-N-CA 120.667 -0.413 . . . . 0.0 110.384 -174.544 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' D' D ' 61' ' ' GLU . . . . . . . . . . . . . 93.8 mt-10 -131.09 166.94 19.97 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-N 115.794 -0.639 . . . . 0.0 110.081 179.656 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' D' D ' 62' ' ' ASP . . . . . . . . . . . . . 81.9 m-20 -55.41 -32.91 63.05 Favored 'General case' 0 C--N 1.328 -0.363 0 C-N-CA 120.951 -0.3 . . . . 0.0 111.49 179.085 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' D' D ' 63' ' ' ARG . . . . . . . . . . . . . 7.4 ptp180 -89.49 10.13 23.92 Favored 'General case' 0 CA--C 1.535 0.389 0 N-CA-C 113.408 0.892 . . . . 0.0 113.408 -176.225 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' D' D ' 64' ' ' THR . . . . . . . . . . . . . 28.6 m -90.91 137.36 32.42 Favored 'General case' 0 C--O 1.232 0.147 0 CA-C-N 118.126 0.421 . . . . 0.0 110.24 -179.732 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' D' D ' 65' ' ' LYS . . . . . . . . . . . . . 2.2 mptp? -88.52 129.25 35.51 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 116.228 -0.442 . . . . 0.0 110.303 -178.317 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' D' D ' 66' ' ' ILE . . . . . . . . . . . . . 63.6 mt -114.68 129.93 69.95 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.298 0 N-CA-C 109.713 -0.477 . . . . 0.0 109.713 178.594 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' D' D ' 67' ' ' THR . . . . . . . . . . . . . 26.7 m -121.73 136.68 54.94 Favored 'General case' 0 C--N 1.33 -0.239 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.536 -179.22 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' D' D ' 68' ' ' LEU . . . . . . . . . . . . . 19.1 tp . . . . . 0 C--N 1.33 -0.283 0 CA-C-N 115.936 -0.574 . . . . 0.0 110.218 178.819 . . . . . . . . 0 0 . 1 . 014 nuclear orig core ' D' D ' 73' ' ' VAL . . . . . . . . . . . . . 30.2 m . . . . . 0 C--O 1.232 0.155 0 N-CA-C 109.566 -0.531 . . . . 0.0 109.566 . . . . . . . . . 0 0 . 1 . 014 nuclear orig core ' D' D ' 74' ' ' ASP . . . . . . . . . . . . . 33.2 t0 -96.06 115.04 26.83 Favored 'General case' 0 C--N 1.329 -0.314 0 N-CA-C 109.82 -0.437 . . . . 0.0 109.82 179.384 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' D' D ' 75' ' ' VAL . . . . . . . . . . . . . 40.0 t -113.42 123.76 69.39 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.206 0 CA-C-O 121.069 0.461 . . . . 0.0 110.24 -178.721 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' D' D ' 76' ' ' LEU . . . . . . . . . . . . . 22.0 mt -126.26 140.42 52.54 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 115.706 -0.679 . . . . 0.0 109.782 179.05 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' D' D ' 77' ' ' GLU . . . . . . . . . . . . . 97.2 mt-10 -133.21 134.39 44.0 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-O 121.018 0.437 . . . . 0.0 111.242 -178.635 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' D' D ' 78' ' ' ALA . . . . . . . . . . . . . . . -124.63 132.82 53.4 Favored 'General case' 0 C--N 1.331 -0.202 0 CA-C-N 115.766 -0.652 . . . . 0.0 109.936 177.026 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' D' D ' 79' ' ' LYS . . . . . . . . . . . . . 98.3 mttt -77.85 119.01 20.73 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-O 120.948 0.404 . . . . 0.0 110.924 -177.673 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' D' D ' 80' ' ' ILE . . . . . . . . . . . . . 41.3 mm -139.17 110.56 4.99 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.271 0 N-CA-C 109.034 -0.728 . . . . 0.0 109.034 -177.839 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' D' D ' 81' ' ' LYS . . . . . . . . . . . . . 84.3 mttt -104.16 127.0 51.73 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-O 120.765 0.316 . . . . 0.0 111.213 -177.023 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' D' D ' 82' ' ' GLY . . . . . . . . . . . . . . . 88.21 42.2 5.98 Favored Glycine 0 CA--C 1.525 0.667 0 C-N-CA 120.621 -0.8 . . . . 0.0 111.857 173.807 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' D' D ' 83' ' ' ILE . . . . . . . . . . . . . 73.1 mt -71.01 134.27 30.31 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.323 0 N-CA-C 109.858 -0.423 . . . . 0.0 109.858 178.093 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' D' D ' 84' ' ' LYS . . . . . . . . . . . . . 53.3 tttp -89.18 -53.43 4.57 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.09 -0.505 . . . . 0.0 110.063 -179.504 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' D' D ' 85' ' ' ASP . . . . . . . . . . . . . 13.2 t70 -151.52 149.52 29.31 Favored 'General case' 0 C--N 1.327 -0.396 0 CA-C-N 115.671 -0.695 . . . . 0.0 110.529 -179.033 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' D' D ' 86' ' ' VAL . . . . . . . . . . . . . 41.0 t -127.48 128.32 69.72 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.242 0 CA-C-O 120.848 0.356 . . . . 0.0 110.069 178.971 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' D' D ' 87' ' ' ILE . . . . . . . . . . . . . 44.5 mm -116.73 126.38 74.15 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.253 0 N-CA-C 109.582 -0.525 . . . . 0.0 109.582 177.452 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' D' D ' 88' ' ' LEU . . . . . . . . . . . . . 13.0 tp -111.89 133.27 54.19 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-O 121.099 0.476 . . . . 0.0 111.108 -176.864 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' D' D ' 89' ' ' ASP . . . . . . . . . . . . . 12.3 t70 -127.34 158.15 38.03 Favored 'General case' 0 C--N 1.331 -0.23 0 CA-C-N 115.705 -0.679 . . . . 0.0 109.424 176.021 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' D' D ' 90' ' ' GLU . . . . . . . . . . . . . 96.4 mt-10 -46.94 -39.46 12.38 Favored 'General case' 0 C--N 1.33 -0.261 0 N-CA-C 113.066 0.765 . . . . 0.0 113.066 -171.342 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' D' D ' 91' ' ' ASN . . . . . . . . . . . . . 87.1 m-20 -132.04 26.05 4.58 Favored 'General case' 0 N--CA 1.467 0.424 0 N-CA-C 112.631 0.604 . . . . 0.0 112.631 -177.742 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' D' D ' 92' ' ' LEU . . . . . . . . . . . . . 10.2 mt -151.37 144.26 24.49 Favored 'General case' 0 C--N 1.329 -0.285 0 N-CA-C 109.962 -0.384 . . . . 0.0 109.962 -177.706 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' D' D ' 93' ' ' ILE . . . . . . . . . . . . . 70.9 mt -126.92 117.72 48.53 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 N-CA-C 109.241 -0.652 . . . . 0.0 109.241 178.133 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' D' D ' 94' ' ' VAL . . . . . . . . . . . . . 44.3 t -118.99 125.71 74.73 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.271 0 N-CA-C 109.77 -0.455 . . . . 0.0 109.77 -178.832 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' D' D ' 95' ' ' VAL . . . . . . . . . . . . . 45.3 t -121.04 132.8 69.59 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.294 0 CA-C-N 115.949 -0.568 . . . . 0.0 109.79 -179.411 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' D' D ' 96' ' ' ILE . . . . . . . . . . . . . 63.2 mt -113.35 125.12 70.57 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.325 0 N-CA-C 109.114 -0.698 . . . . 0.0 109.114 178.72 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' D' D ' 97' ' ' THR . . . . . . . . . . . . . 69.2 p -99.49 157.34 16.5 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-O 121.315 0.579 . . . . 0.0 111.312 -176.471 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' D' D ' 98' ' ' GLU . . . . . . . . . . . . . 78.2 tt0 -53.89 -24.37 15.82 Favored 'General case' 0 CA--C 1.534 0.364 0 CA-C-N 115.953 -0.567 . . . . 0.0 112.245 178.846 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' D' D ' 99' ' ' GLU . . . . . . . . . . . . . 36.1 tt0 -78.4 13.7 1.47 Allowed 'General case' 0 CA--C 1.54 0.586 0 N-CA-C 112.684 0.624 . . . . 0.0 112.684 -177.438 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' D' D ' 100' ' ' ASN . . . . . . . . . . . . . 3.2 m-20 61.32 38.02 16.65 Favored 'General case' 0 CA--C 1.53 0.175 0 O-C-N 121.871 -0.518 . . . . 0.0 110.974 179.651 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' D' D ' 101' ' ' GLU . . . . . . . . . . . . . 84.4 tt0 -118.79 143.94 46.61 Favored 'General case' 0 C--N 1.331 -0.2 0 CA-C-N 115.947 -0.57 . . . . 0.0 109.72 176.932 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' D' D ' 102' ' ' VAL . . . . . . . . . . . . . 47.4 t -115.0 124.65 71.87 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.323 0 CA-C-N 116.251 -0.432 . . . . 0.0 109.863 -178.537 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' D' D ' 103' ' ' LEU . . . . . . . . . . . . . 69.5 mt -114.13 129.89 56.61 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 115.842 -0.617 . . . . 0.0 109.971 176.823 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' D' D ' 104' ' ' ILE . . . . . . . . . . . . . 66.7 mt -120.0 119.47 60.25 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.225 0 N-CA-C 110.087 -0.338 . . . . 0.0 110.087 -178.028 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' D' D ' 105' ' ' PHE . . . . . . . . . . . . . 54.2 m-85 -121.42 162.77 19.85 Favored 'General case' 0 C--N 1.331 -0.219 0 O-C-N 123.998 0.811 . . . . 0.0 109.661 179.959 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' D' D ' 106' ' ' ASN . . . . . . . . . . . . . 41.1 p-10 -95.52 -169.99 2.07 Favored 'General case' 0 C--N 1.33 -0.272 0 N-CA-C 109.782 -0.451 . . . . 0.0 109.782 173.2 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' D' D ' 107' ' ' GLN . . . . . . . . . . . . . 45.1 tt0 -58.64 -30.04 66.99 Favored 'General case' 0 C--N 1.329 -0.313 0 N-CA-C 111.847 0.314 . . . . 0.0 111.847 178.951 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' D' D ' 108' ' ' ASN . . . . . . . . . . . . . 21.1 t-20 -84.17 6.61 21.85 Favored 'General case' 0 CA--C 1.536 0.425 0 N-CA-C 113.339 0.866 . . . . 0.0 113.339 -176.68 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' D' D ' 109' ' ' LEU . . . . . . . . . . . . . 11.6 tp 62.23 37.71 13.98 Favored 'General case' 0 CA--C 1.531 0.219 0 CA-C-O 121.013 0.435 . . . . 0.0 111.196 178.456 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' D' D ' 110' ' ' GLU . . . . . . . . . . . . . 42.9 mt-10 -107.26 151.49 25.39 Favored 'General case' 0 C--N 1.33 -0.273 0 N-CA-C 109.859 -0.423 . . . . 0.0 109.859 176.016 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' D' D ' 111' ' ' GLU . . . . . . . . . . . . . 97.7 mt-10 -79.02 121.94 25.56 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-O 121.008 0.432 . . . . 0.0 111.136 -178.575 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' D' D ' 112' ' ' LEU . . . . . . . . . . . . . 29.9 mt -106.92 -45.9 4.06 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 115.888 -0.596 . . . . 0.0 109.811 175.468 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' D' D ' 113' ' ' TYR . . . . . . . . . . . . . 53.4 t80 -141.23 142.92 33.92 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 115.858 -0.61 . . . . 0.0 110.381 179.485 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' D' D ' 114' ' ' ARG . . . . . . . . . . . . . 35.6 ptt-85 -150.58 124.06 9.01 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-O 121.128 0.49 . . . . 0.0 110.841 177.316 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' D' D ' 115' ' ' GLY . . . . . . . . . . . . . . . -150.19 163.0 29.39 Favored Glycine 0 CA--C 1.525 0.673 0 N-CA-C 111.076 -0.81 . . . . 0.0 111.076 -179.417 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' D' D ' 116' ' ' LYS . . . . . . . . . . . . . 34.0 ttpt -131.03 134.55 46.78 Favored 'General case' 0 C--N 1.33 -0.265 0 N-CA-C 109.846 -0.428 . . . . 0.0 109.846 177.717 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' D' D ' 117' ' ' PHE . . . . . . . . . . . . . 26.3 m-85 -133.07 120.44 21.31 Favored 'General case' 0 C--N 1.331 -0.218 0 CA-C-O 120.894 0.378 . . . . 0.0 110.232 -174.915 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' D' D ' 118' ' ' GLU . . . . . . . . . . . . . 46.4 tp10 -51.52 -52.08 49.84 Favored 'General case' 0 C--N 1.328 -0.351 0 N-CA-C 112.01 0.374 . . . . 0.0 112.01 -174.757 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' D' D ' 119' ' ' ASN . . . . . . . . . . . . . 3.3 p30 -100.06 31.28 3.38 Favored 'General case' 0 C--N 1.33 -0.265 0 N-CA-C 112.173 0.434 . . . . 0.0 112.173 -173.735 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' D' D ' 120' ' ' LEU . . . . . . . . . . . . . 14.1 tp -52.92 125.95 18.76 Favored 'General case' 0 N--CA 1.464 0.229 0 O-C-N 122.343 -0.223 . . . . 0.0 110.985 178.263 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' D' D ' 121' ' ' ASN . . . . . . . . . . . . . 4.3 t-20 -113.96 -44.15 3.19 Favored 'General case' 0 C--N 1.331 -0.229 0 C-N-CA 121.129 -0.229 . . . . 0.0 111.218 -176.839 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' D' D ' 122' ' ' LYS . . . . . . . . . . . . . 49.3 mttm -141.98 146.91 36.14 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-O 120.983 0.42 . . . . 0.0 111.908 -177.309 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' D' D ' 123' ' ' VAL . . . . . . . . . . . . . 43.7 t -130.44 123.28 55.01 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.261 0 N-CA-C 109.22 -0.659 . . . . 0.0 109.22 173.106 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' D' D ' 124' ' ' LEU . . . . . . . . . . . . . 6.2 mp -122.97 139.31 54.21 Favored 'General case' 0 C--N 1.332 -0.173 0 CA-C-O 120.93 0.395 . . . . 0.0 111.222 -175.763 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' D' D ' 125' ' ' VAL . . . . . . . . . . . . . 11.0 p -133.15 131.99 58.52 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.194 0 CA-C-N 115.921 -0.581 . . . . 0.0 110.239 178.182 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' D' D ' 126' ' ' ARG . . . . . . . . . . . . . 55.9 mtp180 -144.49 120.91 10.98 Favored 'General case' 0 C--N 1.331 -0.23 0 CA-C-N 116.482 -0.326 . . . . 0.0 110.947 179.012 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' D' D ' 127' ' ' ASN . . . . . . . . . . . . . 30.8 m120 49.96 -105.97 0.2 Allowed 'General case' 0 CA--C 1.543 0.696 0 CA-C-O 119.043 -0.503 . . . . 0.0 111.546 178.537 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' D' D ' 128' ' ' ASP . . . . . . . . . . . . . 12.0 p-10 -114.06 4.76 15.79 Favored 'General case' 0 N--CA 1.468 0.456 0 CA-C-N 119.684 1.129 . . . . 0.0 113.372 -178.455 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' D' D ' 129' ' ' LEU . . . . . . . . . . . . . 11.4 tp -106.01 131.27 53.5 Favored 'General case' 0 C--N 1.332 -0.19 0 N-CA-C 109.867 -0.42 . . . . 0.0 109.867 178.845 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' D' D ' 130' ' ' VAL . . . . . . . . . . . . . 44.1 t -119.23 134.06 64.06 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.283 0 N-CA-C 109.603 -0.517 . . . . 0.0 109.603 178.77 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' D' D ' 131' ' ' VAL . . . . . . . . . . . . . 40.4 t -136.06 135.22 50.38 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.246 0 CA-C-O 121.054 0.454 . . . . 0.0 110.504 -178.948 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' D' D ' 132' ' ' ILE . . . . . . . . . . . . . 68.4 mt -115.69 133.39 62.22 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.271 0 CA-C-N 115.75 -0.659 . . . . 0.0 109.24 177.317 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' D' D ' 133' ' ' ILE . . . . . . . . . . . . . 36.9 mm -116.67 120.69 65.76 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.308 0 CA-C-N 116.356 -0.384 . . . . 0.0 110.743 -174.093 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' D' D ' 134' ' ' ASP . . . . . . . . . . . . . 18.9 p-10 -138.93 150.87 46.4 Favored 'General case' 0 C--N 1.331 -0.202 0 N-CA-C 109.821 -0.437 . . . . 0.0 109.821 173.682 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' D' D ' 135' ' ' GLU . . . . . . . . . . . . . 39.8 tp10 -50.07 -25.92 3.91 Favored 'General case' 0 C--N 1.328 -0.356 0 N-CA-C 113.389 0.885 . . . . 0.0 113.389 -168.375 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' D' D ' 136' ' ' GLN . . . . . . . . . . . . . 20.5 pt20 -99.02 -18.15 17.91 Favored 'General case' 0 N--CA 1.464 0.262 0 N-CA-C 113.566 0.95 . . . . 0.0 113.566 -172.356 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' D' D ' 137' ' ' LYS . . . . . . . . . . . . . 54.6 pttt -161.61 166.73 26.44 Favored 'General case' 0 C--O 1.233 0.193 0 CA-C-O 121.999 0.904 . . . . 0.0 113.344 -175.146 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' D' D ' 138' ' ' LEU . . . . . . . . . . . . . 12.2 tp -117.1 125.73 51.73 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 114.143 -1.389 . . . . 0.0 109.345 176.043 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' D' D ' 139' ' ' THR . . . . . . . . . . . . . 19.4 m -108.41 123.19 48.47 Favored 'General case' 0 C--N 1.331 -0.209 0 CA-C-O 120.705 0.288 . . . . 0.0 110.485 179.289 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' D' D ' 140' ' ' LEU . . . . . . . . . . . . . 7.6 tt -112.81 120.74 42.51 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 115.568 -0.742 . . . . 0.0 109.136 -179.09 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' D' D ' 141' ' ' ILE . . . . . . . . . . . . . 19.3 mt -120.91 120.24 61.76 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.367 0 CA-C-O 121.007 0.432 . . . . 0.0 109.953 -176.152 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' D' D ' 142' ' ' ARG . . . . . . . . . . . . . 71.5 ttt180 -106.89 120.28 41.61 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 115.332 -0.849 . . . . 0.0 110.188 -179.778 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' D' D ' 143' ' ' THR . . . . . . . . . . . . . 73.2 p . . . . . 0 C--O 1.22 -0.469 0 CA-C-O 118.011 -0.995 . . . . 0.0 110.63 -179.295 . . . . . . . . 0 0 . 1 . 014 nuclear orig core ' E' E ' 2' ' ' SER . . . . . . . . . . . . . 6.4 p . . . . . 0 C--O 1.232 0.158 0 CA-C-O 121.038 0.447 . . . . 0.0 110.961 . . . . . . . . . 0 0 . 1 . 014 nuclear orig core ' E' E ' 3' ' ' GLU . . . . . . . . . . . . . 83.5 tt0 -141.27 142.18 33.91 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 115.804 -0.634 . . . . 0.0 110.893 179.946 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' E' E ' 4' ' ' LEU . . . . . . . . . . . . . 3.6 tt -123.44 123.32 40.4 Favored 'General case' 0 C--N 1.33 -0.251 0 N-CA-C 109.702 -0.481 . . . . 0.0 109.702 177.978 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' E' E ' 5' ' ' LYS . . . . . . . . . . . . . 49.1 mtmt -103.31 119.62 39.21 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.205 -0.452 . . . . 0.0 111.035 -179.263 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' E' E ' 6' ' ' LEU . . . . . . . . . . . . . 15.1 mt -116.01 153.36 31.8 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 115.731 -0.668 . . . . 0.0 110.585 178.768 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' E' E ' 7' ' ' LYS . . . . . . . . . . . . . 59.5 tttp -135.02 136.89 25.86 Favored Pre-proline 0 CA--C 1.534 0.35 0 CA-C-O 119.047 -0.502 . . . . 0.0 109.987 174.609 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' E' E ' 8' ' ' PRO . . . . . . . . . . . . . 88.5 Cg_endo -91.4 137.58 2.07 Favored 'Trans proline' 0 N--CA 1.49 1.287 0 C-N-CA 121.76 1.64 . . . . 0.0 111.366 178.119 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' E' E ' 9' ' ' LEU . . . . . . . . . . . . . 27.0 mt -83.03 -47.66 0.81 Allowed Pre-proline 0 CA--C 1.533 0.309 0 CA-C-O 118.743 -0.646 . . . . 0.0 112.429 -177.133 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' E' E ' 10' ' ' PRO . . . . . . . . . . . . . 62.8 Cg_endo -83.75 156.22 13.73 Favored 'Trans proline' 0 N--CA 1.495 1.609 0 C-N-CA 121.39 1.393 . . . . 0.0 112.151 177.115 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' E' E ' 11' ' ' LYS . . . . . . . . . . . . . 20.2 pttp -78.93 116.59 19.34 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-O 121.286 0.565 . . . . 0.0 110.286 175.523 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' E' E ' 12' ' ' VAL . . . . . . . . . . . . . 12.6 p -150.65 151.99 11.95 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.28 0 CA-C-N 115.779 -0.646 . . . . 0.0 110.756 -177.192 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' E' E ' 13' ' ' GLU . . . . . . . . . . . . . 13.0 pt-20 -91.88 130.95 37.54 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.555 178.394 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' E' E ' 14' ' ' LEU . . . . . . . . . . . . . 31.4 mt -99.87 130.69 25.89 Favored Pre-proline 0 CA--C 1.536 0.437 0 CA-C-O 118.715 -0.66 . . . . 0.0 110.621 -178.341 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' E' E ' 15' ' ' PRO . . . . . . . . . . . . . 23.0 Cg_exo -65.1 161.16 38.35 Favored 'Trans proline' 0 N--CA 1.499 1.842 0 C-N-CA 121.301 1.334 . . . . 0.0 111.893 175.826 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' E' E ' 16' ' ' PRO . . . . . . . . . . . . . 30.4 Cg_exo -59.96 -32.94 95.79 Favored 'Trans proline' 0 N--CA 1.496 1.627 0 C-N-CA 121.442 1.428 . . . . 0.0 112.635 -179.096 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' E' E ' 17' ' ' ASP . . . . . . . . . . . . . 11.3 p-10 -91.13 14.44 14.16 Favored 'General case' 0 CA--C 1.535 0.38 0 N-CA-C 112.989 0.737 . . . . 0.0 112.989 -178.412 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' E' E ' 18' ' ' PHE . . . . . . . . . . . . . 47.8 t80 -55.82 -49.13 74.11 Favored 'General case' 0 C--N 1.334 -0.076 0 O-C-N 121.977 -0.452 . . . . 0.0 110.7 -177.839 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' E' E ' 19' ' ' VAL . . . . . . . . . . . . . 47.5 t -55.77 -42.33 69.6 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.304 0 CA-C-N 116.578 -0.283 . . . . 0.0 110.723 -176.703 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' E' E ' 20' ' ' ASP . . . . . . . . . . . . . 60.5 m-20 -60.12 -43.03 95.95 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-O 120.849 0.357 . . . . 0.0 110.922 -177.85 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' E' E ' 21' ' ' VAL . . . . . . . . . . . . . 44.9 t -64.98 -47.54 87.69 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.306 0 C-N-CA 120.718 -0.393 . . . . 0.0 110.415 -178.036 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' E' E ' 22' ' ' ILE . . . . . . . . . . . . . 50.2 mm -55.71 -58.72 3.92 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.263 0 C-N-CA 120.92 -0.312 . . . . 0.0 111.108 -178.3 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' E' E ' 23' ' ' ARG . . . . . . . . . . . . . 7.5 ptm180 -56.48 -43.44 79.63 Favored 'General case' 0 C--N 1.332 -0.177 0 C-N-CA 120.618 -0.433 . . . . 0.0 111.859 -173.783 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' E' E ' 24' ' ' ILE . . . . . . . . . . . . . 78.0 mt -60.79 -43.68 95.88 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.293 0 C-N-CA 120.996 -0.281 . . . . 0.0 111.588 -176.682 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' E' E ' 25' ' ' LYS . . . . . . . . . . . . . 98.3 mttt -71.07 -40.73 71.42 Favored 'General case' 0 C--N 1.329 -0.299 0 N-CA-C 112.421 0.526 . . . . 0.0 112.421 -178.365 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' E' E ' 26' ' ' LEU . . . . . . . . . . . . . 77.1 mt -80.31 -32.59 37.98 Favored 'General case' 0 C--N 1.329 -0.289 0 N-CA-C 113.708 1.003 . . . . 0.0 113.708 -170.859 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' E' E ' 27' ' ' GLN . . . . . . . . . . . . . 9.8 pt20 -47.41 142.13 4.38 Favored 'General case' 0 N--CA 1.469 0.516 0 N-CA-C 112.602 0.593 . . . . 0.0 112.602 -175.61 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' E' E ' 28' ' ' GLY . . . . . . . . . . . . . . . 99.02 -22.17 42.27 Favored Glycine 0 CA--C 1.532 1.149 0 CA-C-N 115.63 -0.714 . . . . 0.0 112.561 -177.494 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' E' E ' 29' ' ' LYS . . . . . . . . . . . . . 28.5 mmtp -96.5 154.97 16.97 Favored 'General case' 0 C--O 1.231 0.122 0 CA-C-N 117.734 0.767 . . . . 0.0 110.846 178.424 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' E' E ' 30' ' ' THR . . . . . . . . . . . . . 41.2 m -110.13 138.64 46.22 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-N 115.803 -0.635 . . . . 0.0 110.307 178.446 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' E' E ' 31' ' ' VAL . . . . . . . . . . . . . 34.7 m -133.4 159.33 42.9 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.247 0 CA-C-N 116.233 -0.44 . . . . 0.0 111.026 -179.159 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' E' E ' 32' ' ' ARG . . . . . . . . . . . . . 77.8 mtp180 -131.98 153.34 50.43 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 115.874 -0.603 . . . . 0.0 110.424 176.408 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' E' E ' 33' ' ' THR . . . . . . . . . . . . . 30.6 m -53.1 139.68 27.8 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.37 -0.377 . . . . 0.0 111.395 -177.915 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' E' E ' 34' ' ' GLY . . . . . . . . . . . . . . . 99.39 -17.14 58.2 Favored Glycine 0 CA--C 1.532 1.153 0 CA-C-O 119.601 -0.555 . . . . 0.0 113.274 178.157 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' E' E ' 35' ' ' ASP . . . . . . . . . . . . . 74.2 m-20 -65.37 148.08 52.33 Favored 'General case' 0 N--CA 1.461 0.112 0 CA-C-N 118.043 0.921 . . . . 0.0 111.211 179.318 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' E' E ' 36' ' ' VAL . . . . . . . . . . . . . 44.4 t -119.61 129.59 75.15 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 CA-C-N 115.649 -0.705 . . . . 0.0 109.705 178.875 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' E' E ' 37' ' ' ILE . . . . . . . . . . . . . 68.9 mt -121.17 139.03 49.62 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.29 0 CA-C-N 116.272 -0.422 . . . . 0.0 109.971 -179.374 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' E' E ' 38' ' ' GLY . . . . . . . . . . . . . . . -112.19 128.7 8.67 Favored Glycine 0 CA--C 1.525 0.701 0 N-CA-C 110.502 -1.039 . . . . 0.0 110.502 177.698 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' E' E ' 39' ' ' ILE . . . . . . . . . . . . . 72.1 mt -123.1 133.42 69.14 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.279 0 N-CA-C 109.944 -0.391 . . . . 0.0 109.944 -179.522 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' E' E ' 40' ' ' SER . . . . . . . . . . . . . 43.2 t -93.44 120.62 33.93 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.444 -0.344 . . . . 0.0 110.949 176.281 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' E' E ' 41' ' ' ILE . . . . . . . . . . . . . 73.6 mt -122.47 114.79 43.89 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.195 0 CA-C-O 120.955 0.407 . . . . 0.0 110.104 177.856 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' E' E ' 42' ' ' LEU . . . . . . . . . . . . . 1.3 tt 51.01 44.18 28.68 Favored 'General case' 0 CA--C 1.532 0.274 0 CA-C-O 121.479 0.656 . . . . 0.0 110.829 177.866 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' E' E ' 43' ' ' GLY . . . . . . . . . . . . . . . 71.26 27.8 71.07 Favored Glycine 0 CA--C 1.531 1.084 0 C-N-CA 121.113 -0.565 . . . . 0.0 112.392 176.095 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' E' E ' 44' ' ' LYS . . . . . . . . . . . . . 61.2 tttm -133.9 129.88 36.99 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-N 117.188 0.494 . . . . 0.0 109.952 178.8 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' E' E ' 45' ' ' GLU . . . . . . . . . . . . . 82.6 tt0 -83.35 122.92 29.11 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-O 120.873 0.368 . . . . 0.0 111.274 -177.008 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' E' E ' 46' ' ' VAL . . . . . . . . . . . . . 7.4 p -122.53 128.41 75.36 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.228 0 N-CA-C 109.441 -0.577 . . . . 0.0 109.441 175.213 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' E' E ' 47' ' ' LYS . . . . . . . . . . . . . 62.5 mtpt -100.56 133.14 45.43 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 115.992 -0.549 . . . . 0.0 111.262 179.943 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' E' E ' 48' ' ' PHE . . . . . . . . . . . . . 96.0 m-85 -120.47 132.06 55.04 Favored 'General case' 0 C--N 1.331 -0.219 0 CA-C-N 116.102 -0.499 . . . . 0.0 110.075 176.897 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' E' E ' 49' ' ' LYS . . . . . . . . . . . . . 60.6 tttm -106.32 137.73 43.76 Favored 'General case' 0 C--O 1.233 0.202 0 CA-C-N 116.504 -0.316 . . . . 0.0 110.418 178.076 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' E' E ' 50' ' ' VAL . . . . . . . . . . . . . 44.0 t -80.45 105.22 9.9 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.279 0 N-CA-C 109.133 -0.692 . . . . 0.0 109.133 175.101 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' E' E ' 51' ' ' VAL . . . . . . . . . . . . . 48.0 t -70.18 -49.32 55.87 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.35 0 CA-C-N 115.956 -0.566 . . . . 0.0 109.968 -174.057 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' E' E ' 52' ' ' GLN . . . . . . . . . . . . . 60.0 tt0 -163.31 140.09 7.25 Favored 'General case' 0 C--N 1.332 -0.183 0 C-N-CA 120.179 -0.608 . . . . 0.0 111.681 -179.185 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' E' E ' 53' ' ' ALA . . . . . . . . . . . . . . . -113.64 130.96 56.31 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 115.821 -0.627 . . . . 0.0 109.907 176.238 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' E' E ' 54' ' ' TYR . . . . . . . . . . . . . 65.1 t80 -129.08 109.98 18.19 Favored Pre-proline 0 CA--C 1.535 0.385 0 CA-C-O 118.274 -0.869 . . . . 0.0 110.207 179.588 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' E' E ' 55' ' ' PRO . . . . . . . . . . . . . 73.4 Cg_endo -77.18 170.1 72.43 Favored 'Cis proline' 0 N--CA 1.499 1.838 0 CA-C-N 121.948 1.731 . . . . 0.0 112.541 -3.918 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' E' E ' 56' ' ' SER . . . . . . . . . . . . . 13.4 m -115.12 128.97 25.46 Favored Pre-proline 0 CA--C 1.539 0.546 0 CA-C-O 118.356 -0.83 . . . . 0.0 109.315 175.412 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' E' E ' 57' ' ' PRO . . . . . . . . . . . . . 44.3 Cg_endo -68.27 166.56 68.16 Favored 'Cis proline' 0 N--CA 1.497 1.722 0 CA-C-N 122.037 1.763 . . . . 0.0 111.576 0.407 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' E' E ' 58' ' ' LEU . . . . . . . . . . . . . 23.3 tp -129.84 138.57 51.06 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-O 121.022 0.439 . . . . 0.0 110.417 -179.148 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' E' E ' 59' ' ' ARG . . . . . . . . . . . . . 55.3 ttp180 -107.1 130.16 54.72 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 115.632 -0.713 . . . . 0.0 109.51 176.969 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' E' E ' 60' ' ' VAL . . . . . . . . . . . . . 43.7 t -77.74 119.9 27.35 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.252 0 C-N-CA 120.74 -0.384 . . . . 0.0 110.266 -177.079 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' E' E ' 61' ' ' GLU . . . . . . . . . . . . . 43.0 mt-10 -130.95 155.06 47.43 Favored 'General case' 0 C--N 1.331 -0.213 0 CA-C-N 115.944 -0.571 . . . . 0.0 110.528 179.148 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' E' E ' 62' ' ' ASP . . . . . . . . . . . . . 28.6 m-20 -54.61 -32.99 59.73 Favored 'General case' 0 C--N 1.326 -0.429 0 CA-C-N 116.491 -0.322 . . . . 0.0 111.777 179.683 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' E' E ' 63' ' ' ARG . . . . . . . . . . . . . 9.3 ptm180 -88.96 7.66 33.5 Favored 'General case' 0 CA--C 1.536 0.441 0 N-CA-C 113.652 0.982 . . . . 0.0 113.652 -175.082 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' E' E ' 64' ' ' THR . . . . . . . . . . . . . 23.3 m -89.51 146.15 24.81 Favored 'General case' 0 C--N 1.331 -0.196 0 CA-C-N 118.066 0.394 . . . . 0.0 110.319 179.648 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' E' E ' 65' ' ' LYS . . . . . . . . . . . . . 94.7 mttt -84.74 121.82 28.22 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-O 120.841 0.353 . . . . 0.0 110.211 179.914 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' E' E ' 66' ' ' ILE . . . . . . . . . . . . . 58.1 mt -112.52 122.53 66.91 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.263 0 N-CA-C 109.237 -0.653 . . . . 0.0 109.237 179.648 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' E' E ' 67' ' ' THR . . . . . . . . . . . . . 9.6 m -129.95 143.41 50.78 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-O 121.127 0.489 . . . . 0.0 111.679 -172.911 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' E' E ' 68' ' ' LEU . . . . . . . . . . . . . 7.9 mp . . . . . 0 C--N 1.331 -0.239 0 CA-C-N 115.799 -0.637 . . . . 0.0 109.631 173.859 . . . . . . . . 0 0 . 1 . 014 nuclear orig core ' E' E ' 73' ' ' VAL . . . . . . . . . . . . . 32.9 m . . . . . 0 C--O 1.231 0.131 0 CA-C-O 121.0 0.428 . . . . 0.0 111.226 . . . . . . . . . 0 0 . 1 . 014 nuclear orig core ' E' E ' 74' ' ' ASP . . . . . . . . . . . . . 10.6 t0 -101.07 124.11 46.28 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 115.777 -0.647 . . . . 0.0 109.882 178.366 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' E' E ' 75' ' ' VAL . . . . . . . . . . . . . 41.7 t -111.53 125.02 68.82 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.224 0 CA-C-O 121.133 0.492 . . . . 0.0 110.622 -178.111 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' E' E ' 76' ' ' LEU . . . . . . . . . . . . . 42.5 mt -121.28 143.45 49.16 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 115.593 -0.731 . . . . 0.0 109.6 177.22 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' E' E ' 77' ' ' GLU . . . . . . . . . . . . . 97.9 mt-10 -136.47 134.66 37.88 Favored 'General case' 0 C--N 1.331 -0.201 0 CA-C-O 120.996 0.427 . . . . 0.0 111.462 -178.662 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' E' E ' 78' ' ' ALA . . . . . . . . . . . . . . . -121.86 137.11 54.91 Favored 'General case' 0 C--N 1.331 -0.206 0 CA-C-N 115.728 -0.669 . . . . 0.0 109.751 175.738 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' E' E ' 79' ' ' LYS . . . . . . . . . . . . . 61.5 mtpt -84.49 120.73 26.66 Favored 'General case' 0 C--N 1.331 -0.219 0 CA-C-O 120.884 0.373 . . . . 0.0 110.831 -178.166 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' E' E ' 80' ' ' ILE . . . . . . . . . . . . . 22.6 mm -139.16 124.84 22.38 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.231 0 CA-C-N 115.937 -0.574 . . . . 0.0 109.688 -177.235 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' E' E ' 81' ' ' LYS . . . . . . . . . . . . . 64.8 mmtt -110.22 123.85 50.54 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-O 120.837 0.351 . . . . 0.0 111.419 -179.169 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' E' E ' 82' ' ' GLY . . . . . . . . . . . . . . . 89.06 42.15 5.69 Favored Glycine 0 CA--C 1.524 0.638 0 C-N-CA 120.698 -0.763 . . . . 0.0 112.044 171.664 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' E' E ' 83' ' ' ILE . . . . . . . . . . . . . 71.9 mt -61.66 135.92 25.73 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.335 0 CA-C-O 120.958 0.408 . . . . 0.0 109.957 178.691 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' E' E ' 84' ' ' LYS . . . . . . . . . . . . . 72.7 tttt -96.54 -50.8 4.58 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 115.739 -0.664 . . . . 0.0 110.021 -179.001 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' E' E ' 85' ' ' ASP . . . . . . . . . . . . . 6.1 t0 -156.12 150.11 25.25 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 115.54 -0.755 . . . . 0.0 110.075 179.261 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' E' E ' 86' ' ' VAL . . . . . . . . . . . . . 45.7 t -129.1 129.29 67.77 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.268 0 CA-C-O 120.92 0.391 . . . . 0.0 110.315 -179.26 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' E' E ' 87' ' ' ILE . . . . . . . . . . . . . 43.1 mm -118.39 125.18 74.13 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.285 0 CA-C-N 115.99 -0.55 . . . . 0.0 109.767 176.489 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' E' E ' 88' ' ' LEU . . . . . . . . . . . . . 52.1 mt -111.04 136.03 50.67 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-O 121.078 0.466 . . . . 0.0 111.437 -178.14 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' E' E ' 89' ' ' ASP . . . . . . . . . . . . . 13.8 t70 -131.42 153.56 49.58 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 115.537 -0.756 . . . . 0.0 109.319 175.384 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' E' E ' 90' ' ' GLU . . . . . . . . . . . . . 46.2 tp10 -47.28 -39.2 14.03 Favored 'General case' 0 N--CA 1.464 0.264 0 N-CA-C 112.817 0.673 . . . . 0.0 112.817 -172.872 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' E' E ' 91' ' ' ASN . . . . . . . . . . . . . 30.2 m120 -132.11 35.51 3.71 Favored 'General case' 0 N--CA 1.464 0.258 0 C-N-CA 120.974 -0.29 . . . . 0.0 111.743 -177.336 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' E' E ' 92' ' ' LEU . . . . . . . . . . . . . 11.3 tp -166.1 145.82 6.19 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-O 120.781 0.324 . . . . 0.0 110.775 -179.835 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' E' E ' 93' ' ' ILE . . . . . . . . . . . . . 72.1 mt -130.63 125.64 59.16 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.24 0 N-CA-C 109.716 -0.475 . . . . 0.0 109.716 -179.736 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' E' E ' 94' ' ' VAL . . . . . . . . . . . . . 44.3 t -122.89 126.39 73.73 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.292 0 N-CA-C 109.722 -0.473 . . . . 0.0 109.722 178.986 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' E' E ' 95' ' ' VAL . . . . . . . . . . . . . 45.5 t -123.71 132.73 70.89 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.207 0 N-CA-C 109.915 -0.402 . . . . 0.0 109.915 -178.863 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' E' E ' 96' ' ' ILE . . . . . . . . . . . . . 56.0 mt -118.1 134.64 61.08 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.308 0 N-CA-C 109.125 -0.694 . . . . 0.0 109.125 179.51 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' E' E ' 97' ' ' THR . . . . . . . . . . . . . 58.0 p -109.86 157.29 19.36 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-O 121.357 0.599 . . . . 0.0 111.452 -177.174 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' E' E ' 98' ' ' GLU . . . . . . . . . . . . . 96.4 mt-10 -55.13 -22.1 15.56 Favored 'General case' 0 C--N 1.329 -0.306 0 N-CA-C 112.531 0.567 . . . . 0.0 112.531 179.204 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' E' E ' 99' ' ' GLU . . . . . . . . . . . . . 38.4 tt0 -78.75 14.93 1.16 Allowed 'General case' 0 CA--C 1.54 0.57 0 N-CA-C 112.52 0.563 . . . . 0.0 112.52 -178.614 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' E' E ' 100' ' ' ASN . . . . . . . . . . . . . 2.8 m-20 61.96 37.88 14.7 Favored 'General case' 0 CA--C 1.529 0.167 0 O-C-N 121.763 -0.585 . . . . 0.0 110.857 178.537 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' E' E ' 101' ' ' GLU . . . . . . . . . . . . . 84.5 tt0 -120.57 143.57 48.55 Favored 'General case' 0 C--N 1.333 -0.134 0 CA-C-N 116.051 -0.522 . . . . 0.0 109.73 177.821 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' E' E ' 102' ' ' VAL . . . . . . . . . . . . . 41.1 t -120.94 130.85 74.22 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.267 0 CA-C-N 116.313 -0.403 . . . . 0.0 110.049 -178.247 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' E' E ' 103' ' ' LEU . . . . . . . . . . . . . 5.2 mp -121.33 136.8 54.92 Favored 'General case' 0 C--N 1.331 -0.203 0 CA-C-N 115.938 -0.574 . . . . 0.0 110.486 176.456 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' E' E ' 104' ' ' ILE . . . . . . . . . . . . . 68.2 mt -117.56 122.46 69.89 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.297 0 CA-C-N 115.639 -0.71 . . . . 0.0 109.688 -179.551 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' E' E ' 105' ' ' PHE . . . . . . . . . . . . . 55.5 m-85 -123.26 165.76 16.4 Favored 'General case' 0 C--N 1.331 -0.207 0 O-C-N 123.961 0.788 . . . . 0.0 109.455 179.421 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' E' E ' 106' ' ' ASN . . . . . . . . . . . . . 44.0 p-10 -101.65 -171.84 2.05 Favored 'General case' 0 C--N 1.331 -0.225 0 N-CA-C 109.891 -0.411 . . . . 0.0 109.891 173.746 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' E' E ' 107' ' ' GLN . . . . . . . . . . . . . 43.2 tt0 -60.27 -29.88 69.09 Favored 'General case' 0 C--N 1.328 -0.347 0 N-CA-C 111.912 0.338 . . . . 0.0 111.912 179.886 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' E' E ' 108' ' ' ASN . . . . . . . . . . . . . 60.5 t30 -81.9 6.51 15.61 Favored 'General case' 0 CA--C 1.536 0.405 0 N-CA-C 113.278 0.844 . . . . 0.0 113.278 -177.944 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' E' E ' 109' ' ' LEU . . . . . . . . . . . . . 8.8 tp 62.1 36.45 15.23 Favored 'General case' 0 C--O 1.232 0.163 0 CA-C-O 120.966 0.412 . . . . 0.0 111.533 177.905 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' E' E ' 110' ' ' GLU . . . . . . . . . . . . . 70.9 mm-40 -104.26 148.63 26.12 Favored 'General case' 0 C--N 1.329 -0.315 0 N-CA-C 109.807 -0.442 . . . . 0.0 109.807 175.796 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' E' E ' 111' ' ' GLU . . . . . . . . . . . . . 77.3 tt0 -80.22 122.03 26.35 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.429 -0.351 . . . . 0.0 110.971 -176.528 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' E' E ' 112' ' ' LEU . . . . . . . . . . . . . 26.7 mt -105.02 -46.18 4.34 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 116.29 -0.414 . . . . 0.0 110.725 178.596 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' E' E ' 113' ' ' TYR . . . . . . . . . . . . . 64.5 t80 -143.75 139.8 29.61 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.353 -0.385 . . . . 0.0 111.376 -178.875 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' E' E ' 114' ' ' ARG . . . . . . . . . . . . . 60.8 ttp180 -141.07 120.89 13.49 Favored 'General case' 0 C--N 1.33 -0.239 0 CA-C-N 116.274 -0.421 . . . . 0.0 110.165 176.008 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' E' E ' 115' ' ' GLY . . . . . . . . . . . . . . . -150.01 161.7 28.96 Favored Glycine 0 CA--C 1.524 0.652 0 N-CA-C 110.898 -0.881 . . . . 0.0 110.898 178.557 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' E' E ' 116' ' ' LYS . . . . . . . . . . . . . 32.8 ttmt -128.72 139.56 52.16 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-O 120.777 0.322 . . . . 0.0 110.411 179.462 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' E' E ' 117' ' ' PHE . . . . . . . . . . . . . 43.5 m-85 -131.6 115.48 16.14 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.233 -0.44 . . . . 0.0 110.187 -176.949 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' E' E ' 118' ' ' GLU . . . . . . . . . . . . . 96.3 mt-10 -54.64 -46.5 73.95 Favored 'General case' 0 C--N 1.329 -0.299 0 C-N-CA 121.003 -0.279 . . . . 0.0 111.408 -176.004 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' E' E ' 119' ' ' ASN . . . . . . . . . . . . . 28.6 m120 -97.4 31.04 2.63 Favored 'General case' 0 C--N 1.33 -0.269 0 N-CA-C 112.318 0.488 . . . . 0.0 112.318 -174.22 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' E' E ' 120' ' ' LEU . . . . . . . . . . . . . 19.0 tp -55.43 120.82 7.73 Favored 'General case' 0 C--O 1.232 0.175 0 C-N-CA 121.197 -0.201 . . . . 0.0 110.688 178.125 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' E' E ' 121' ' ' ASN . . . . . . . . . . . . . 31.4 m120 -114.04 -44.15 3.18 Favored 'General case' 0 C--N 1.332 -0.195 0 CA-C-N 116.689 -0.232 . . . . 0.0 111.361 -177.321 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' E' E ' 122' ' ' LYS . . . . . . . . . . . . . 93.5 mttt -146.95 154.09 40.85 Favored 'General case' 0 C--N 1.331 -0.222 0 CA-C-O 121.064 0.459 . . . . 0.0 111.895 -176.313 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' E' E ' 123' ' ' VAL . . . . . . . . . . . . . 43.3 t -132.69 133.8 59.07 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.27 0 CA-C-N 115.971 -0.559 . . . . 0.0 110.089 177.142 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' E' E ' 124' ' ' LEU . . . . . . . . . . . . . 54.4 mt -124.17 134.97 53.18 Favored 'General case' 0 C--N 1.33 -0.239 0 CA-C-N 116.591 -0.277 . . . . 0.0 110.545 179.846 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' E' E ' 125' ' ' VAL . . . . . . . . . . . . . 35.4 m -134.75 135.67 53.07 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.255 0 CA-C-N 116.454 -0.339 . . . . 0.0 110.836 -179.685 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' E' E ' 126' ' ' ARG . . . . . . . . . . . . . 29.9 mtp180 -148.87 124.79 10.61 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-O 121.01 0.433 . . . . 0.0 110.974 175.925 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' E' E ' 127' ' ' ASN . . . . . . . . . . . . . 23.0 t-20 49.92 -106.52 0.22 Allowed 'General case' 0 CA--C 1.543 0.708 0 CA-C-N 116.094 -0.503 . . . . 0.0 111.544 179.066 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' E' E ' 128' ' ' ASP . . . . . . . . . . . . . 23.7 p-10 -114.01 3.26 15.26 Favored 'General case' 0 N--CA 1.467 0.413 0 CA-C-N 119.63 1.105 . . . . 0.0 113.469 -177.014 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' E' E ' 129' ' ' LEU . . . . . . . . . . . . . 15.1 tp -105.23 134.94 47.51 Favored 'General case' 0 C--N 1.334 -0.106 0 N-CA-C 109.876 -0.416 . . . . 0.0 109.876 179.182 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' E' E ' 130' ' ' VAL . . . . . . . . . . . . . 44.6 t -124.29 135.58 63.26 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.246 0 N-CA-C 109.925 -0.398 . . . . 0.0 109.925 -179.532 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' E' E ' 131' ' ' VAL . . . . . . . . . . . . . 43.4 t -134.01 133.94 55.88 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.262 0 CA-C-O 121.037 0.446 . . . . 0.0 110.094 179.004 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' E' E ' 132' ' ' ILE . . . . . . . . . . . . . 71.0 mt -114.71 132.36 64.12 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.322 0 CA-C-N 115.808 -0.633 . . . . 0.0 109.306 179.36 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' E' E ' 133' ' ' ILE . . . . . . . . . . . . . 39.3 mm -114.93 120.0 63.32 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.231 0 CA-C-O 120.892 0.377 . . . . 0.0 110.954 -174.909 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' E' E ' 134' ' ' ASP . . . . . . . . . . . . . 9.2 p-10 -132.91 145.3 50.8 Favored 'General case' 0 C--N 1.33 -0.25 0 N-CA-C 109.35 -0.611 . . . . 0.0 109.35 174.516 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' E' E ' 135' ' ' GLU . . . . . . . . . . . . . 76.9 tt0 -49.92 -25.72 3.5 Favored 'General case' 0 C--N 1.327 -0.397 0 N-CA-C 112.859 0.688 . . . . 0.0 112.859 -171.304 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' E' E ' 136' ' ' GLN . . . . . . . . . . . . . 44.2 tt0 -82.69 -38.1 23.86 Favored 'General case' 0 C--O 1.233 0.226 0 N-CA-C 112.136 0.421 . . . . 0.0 112.136 -176.172 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' E' E ' 137' ' ' LYS . . . . . . . . . . . . . 18.2 pttp -160.74 169.25 23.14 Favored 'General case' 0 C--O 1.233 0.207 0 CA-C-O 121.451 0.643 . . . . 0.0 112.126 -173.351 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' E' E ' 138' ' ' LEU . . . . . . . . . . . . . 5.9 tt -114.6 127.4 55.76 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 115.221 -0.899 . . . . 0.0 109.63 177.446 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' E' E ' 139' ' ' THR . . . . . . . . . . . . . 23.4 m -105.21 124.03 48.84 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.275 -179.37 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' E' E ' 140' ' ' LEU . . . . . . . . . . . . . 35.4 tp -110.79 119.94 40.76 Favored 'General case' 0 C--N 1.327 -0.384 0 N-CA-C 109.287 -0.635 . . . . 0.0 109.287 -179.153 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' E' E ' 141' ' ' ILE . . . . . . . . . . . . . 19.3 mt -121.26 117.11 51.73 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.353 0 CA-C-O 121.002 0.43 . . . . 0.0 109.863 -176.211 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' E' E ' 142' ' ' ARG . . . . . . . . . . . . . 73.9 mtp180 -103.76 129.08 51.11 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 115.433 -0.803 . . . . 0.0 110.417 179.653 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' E' E ' 143' ' ' THR . . . . . . . . . . . . . 11.9 p . . . . . 0 C--O 1.219 -0.506 0 CA-C-O 117.997 -1.001 . . . . 0.0 110.531 179.999 . . . . . . . . 0 0 . 1 . 014 nuclear orig core ' F' F ' 1' ' ' MET . . . . . . . . . . . . . 22.4 ptm . . . . . 0 N--CA 1.456 -0.152 0 CA-C-O 120.647 0.261 . . . . 0.0 110.81 . . . . . . . . . 0 0 . 1 . 014 nuclear orig core ' F' F ' 2' ' ' SER . . . . . . . . . . . . . 3.5 p -121.95 129.07 52.2 Favored 'General case' 0 C--N 1.331 -0.217 0 CA-C-O 120.904 0.383 . . . . 0.0 110.624 178.75 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' F' F ' 3' ' ' GLU . . . . . . . . . . . . . 95.0 mt-10 -140.16 141.43 36.03 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.025 -0.534 . . . . 0.0 111.141 -177.573 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' F' F ' 4' ' ' LEU . . . . . . . . . . . . . 15.5 tp -125.49 126.99 45.76 Favored 'General case' 0 C--N 1.331 -0.225 0 CA-C-N 115.832 -0.622 . . . . 0.0 110.198 176.828 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' F' F ' 5' ' ' LYS . . . . . . . . . . . . . 95.4 mttt -105.35 120.97 42.92 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.412 -0.358 . . . . 0.0 110.812 178.886 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' F' F ' 6' ' ' LEU . . . . . . . . . . . . . 77.6 mt -116.09 150.27 37.61 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-N 115.495 -0.775 . . . . 0.0 110.371 -179.885 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' F' F ' 7' ' ' LYS . . . . . . . . . . . . . 58.3 tttp -140.96 137.87 17.47 Favored Pre-proline 0 CA--C 1.535 0.369 0 CA-C-O 119.025 -0.512 . . . . 0.0 110.26 176.52 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' F' F ' 8' ' ' PRO . . . . . . . . . . . . . 80.9 Cg_endo -91.73 143.76 2.93 Favored 'Trans proline' 0 N--CA 1.491 1.333 0 C-N-CA 121.69 1.593 . . . . 0.0 111.65 177.065 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' F' F ' 9' ' ' LEU . . . . . . . . . . . . . 64.7 mt -76.69 -48.67 2.86 Favored Pre-proline 0 CA--C 1.534 0.33 0 CA-C-O 118.606 -0.712 . . . . 0.0 112.529 -177.796 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' F' F ' 10' ' ' PRO . . . . . . . . . . . . . 83.7 Cg_endo -79.62 147.71 19.92 Favored 'Trans proline' 0 N--CA 1.497 1.729 0 C-N-CA 121.166 1.244 . . . . 0.0 111.627 178.033 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' F' F ' 11' ' ' LYS . . . . . . . . . . . . . 53.5 pttt -79.36 108.85 13.19 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-O 121.778 0.799 . . . . 0.0 110.315 177.563 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' F' F ' 12' ' ' VAL . . . . . . . . . . . . . 11.7 p -148.37 145.25 18.53 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.291 0 CA-C-N 115.425 -0.807 . . . . 0.0 110.12 -179.134 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' F' F ' 13' ' ' GLU . . . . . . . . . . . . . 41.0 tp10 -87.78 123.18 32.31 Favored 'General case' 0 C--N 1.329 -0.312 0 N-CA-C 109.884 -0.413 . . . . 0.0 109.884 179.165 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' F' F ' 14' ' ' LEU . . . . . . . . . . . . . 33.5 mt -98.09 149.08 35.36 Favored Pre-proline 0 CA--C 1.532 0.288 0 CA-C-N 116.404 -0.362 . . . . 0.0 110.644 -177.258 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' F' F ' 15' ' ' PRO . . . . . . . . . . . . . 25.4 Cg_exo -62.62 159.54 36.36 Favored 'Trans proline' 0 N--CA 1.498 1.791 0 C-N-CA 121.25 1.3 . . . . 0.0 111.978 176.86 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' F' F ' 16' ' ' PRO . . . . . . . . . . . . . 27.9 Cg_exo -60.47 -34.83 92.51 Favored 'Trans proline' 0 N--CA 1.496 1.639 0 C-N-CA 121.414 1.409 . . . . 0.0 112.494 -179.659 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' F' F ' 17' ' ' ASP . . . . . . . . . . . . . 22.2 p-10 -88.04 10.79 17.89 Favored 'General case' 0 CA--C 1.535 0.393 0 N-CA-C 113.024 0.75 . . . . 0.0 113.024 -178.431 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' F' F ' 18' ' ' PHE . . . . . . . . . . . . . 30.1 t80 -58.01 -42.01 84.32 Favored 'General case' 0 N--CA 1.457 -0.115 0 O-C-N 121.932 -0.48 . . . . 0.0 110.158 -178.507 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' F' F ' 19' ' ' VAL . . . . . . . . . . . . . 49.1 t -56.35 -42.86 75.61 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.282 0 CA-C-N 116.469 -0.332 . . . . 0.0 110.41 -179.676 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' F' F ' 20' ' ' ASP . . . . . . . . . . . . . 81.7 m-20 -60.15 -43.0 96.08 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.428 -0.351 . . . . 0.0 110.884 -178.049 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' F' F ' 21' ' ' VAL . . . . . . . . . . . . . 48.7 t -64.18 -48.11 87.08 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.309 0 C-N-CA 120.832 -0.347 . . . . 0.0 110.548 -177.39 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' F' F ' 22' ' ' ILE . . . . . . . . . . . . . 50.1 mm -55.9 -47.44 79.83 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.312 0 C-N-CA 121.036 -0.266 . . . . 0.0 110.74 -179.978 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' F' F ' 23' ' ' ARG . . . . . . . . . . . . . 54.6 ttp180 -55.38 -48.8 73.76 Favored 'General case' 0 C--N 1.33 -0.276 0 C-N-CA 121.038 -0.265 . . . . 0.0 111.337 -178.291 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' F' F ' 24' ' ' ILE . . . . . . . . . . . . . 73.9 mt -58.48 -41.98 83.18 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.281 0 CA-C-O 120.706 0.288 . . . . 0.0 110.799 -177.378 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' F' F ' 25' ' ' LYS . . . . . . . . . . . . . 51.7 mtpt -65.55 -43.66 89.21 Favored 'General case' 0 C--N 1.327 -0.382 0 N-CA-C 112.319 0.489 . . . . 0.0 112.319 -178.697 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' F' F ' 26' ' ' LEU . . . . . . . . . . . . . 79.5 mt -79.74 -33.2 40.97 Favored 'General case' 0 C--N 1.331 -0.201 0 N-CA-C 113.874 1.064 . . . . 0.0 113.874 -169.549 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' F' F ' 27' ' ' GLN . . . . . . . . . . . . . 10.8 pt20 -46.76 139.42 5.35 Favored 'General case' 0 N--CA 1.469 0.507 0 N-CA-C 113.027 0.751 . . . . 0.0 113.027 -173.497 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' F' F ' 28' ' ' GLY . . . . . . . . . . . . . . . 99.35 -23.61 35.58 Favored Glycine 0 CA--C 1.535 1.292 0 CA-C-N 115.442 -0.799 . . . . 0.0 112.451 -178.962 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' F' F ' 29' ' ' LYS . . . . . . . . . . . . . 61.1 mttp -97.89 155.15 17.2 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 117.527 0.664 . . . . 0.0 111.136 179.682 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' F' F ' 30' ' ' THR . . . . . . . . . . . . . 36.3 m -104.61 137.01 43.09 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 115.931 -0.577 . . . . 0.0 109.852 175.586 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' F' F ' 31' ' ' VAL . . . . . . . . . . . . . 34.9 m -129.64 153.54 38.94 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.21 0 CA-C-O 121.003 0.43 . . . . 0.0 110.953 -178.379 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' F' F ' 32' ' ' ARG . . . . . . . . . . . . . 38.9 ttm180 -133.66 149.41 51.55 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 115.991 -0.549 . . . . 0.0 110.454 -179.991 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' F' F ' 33' ' ' THR . . . . . . . . . . . . . 21.4 m -52.17 138.7 25.27 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.307 -0.406 . . . . 0.0 111.563 -176.17 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' F' F ' 34' ' ' GLY . . . . . . . . . . . . . . . 100.48 -17.1 57.21 Favored Glycine 0 CA--C 1.533 1.209 0 CA-C-O 119.64 -0.533 . . . . 0.0 113.326 178.536 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' F' F ' 35' ' ' ASP . . . . . . . . . . . . . 80.2 m-20 -66.2 147.37 53.42 Favored 'General case' 0 C--N 1.332 -0.155 0 CA-C-N 118.014 0.907 . . . . 0.0 110.953 178.856 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' F' F ' 36' ' ' VAL . . . . . . . . . . . . . 46.3 t -122.32 129.99 74.88 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.197 0 CA-C-N 115.965 -0.561 . . . . 0.0 109.849 178.225 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' F' F ' 37' ' ' ILE . . . . . . . . . . . . . 69.3 mt -121.83 139.93 47.38 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.247 0 CA-C-N 116.194 -0.457 . . . . 0.0 109.955 -179.138 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' F' F ' 38' ' ' GLY . . . . . . . . . . . . . . . -113.64 128.74 8.46 Favored Glycine 0 CA--C 1.526 0.743 0 N-CA-C 111.282 -0.727 . . . . 0.0 111.282 -179.928 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' F' F ' 39' ' ' ILE . . . . . . . . . . . . . 70.0 mt -121.03 134.94 62.8 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.171 0 N-CA-C 109.959 -0.386 . . . . 0.0 109.959 178.269 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' F' F ' 40' ' ' SER . . . . . . . . . . . . . 87.4 p -92.16 120.68 32.97 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 116.422 -0.353 . . . . 0.0 110.62 175.537 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' F' F ' 41' ' ' ILE . . . . . . . . . . . . . 72.2 mt -132.36 117.56 32.45 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.207 0 CA-C-O 120.757 0.313 . . . . 0.0 110.157 178.554 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' F' F ' 42' ' ' LEU . . . . . . . . . . . . . 8.4 tp 57.95 35.85 25.67 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.176 -0.466 . . . . 0.0 111.363 178.515 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' F' F ' 43' ' ' GLY . . . . . . . . . . . . . . . 77.41 -10.08 24.43 Favored Glycine 0 CA--C 1.535 1.326 0 C-N-CA 121.26 -0.495 . . . . 0.0 113.381 177.431 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' F' F ' 44' ' ' LYS . . . . . . . . . . . . . 59.2 tttm -98.28 134.29 41.51 Favored 'General case' 0 C--N 1.333 -0.126 0 CA-C-N 117.996 0.898 . . . . 0.0 109.897 177.905 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' F' F ' 45' ' ' GLU . . . . . . . . . . . . . 82.3 tt0 -84.53 128.14 34.43 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.325 -0.398 . . . . 0.0 110.903 -179.423 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' F' F ' 46' ' ' VAL . . . . . . . . . . . . . 7.3 p -121.87 126.84 75.1 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.211 0 N-CA-C 109.632 -0.507 . . . . 0.0 109.632 175.936 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' F' F ' 47' ' ' LYS . . . . . . . . . . . . . 59.5 mtpt -100.58 128.85 46.5 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 115.895 -0.593 . . . . 0.0 111.24 179.573 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' F' F ' 48' ' ' PHE . . . . . . . . . . . . . 95.8 m-85 -113.28 131.88 55.76 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.279 -0.419 . . . . 0.0 110.064 176.361 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' F' F ' 49' ' ' LYS . . . . . . . . . . . . . 57.0 tttm -108.66 139.69 43.09 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.47 -0.332 . . . . 0.0 110.471 178.326 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' F' F ' 50' ' ' VAL . . . . . . . . . . . . . 45.2 t -82.22 109.18 15.96 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.308 0 N-CA-C 109.137 -0.69 . . . . 0.0 109.137 175.66 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' F' F ' 51' ' ' VAL . . . . . . . . . . . . . 47.0 t -73.5 -48.4 41.48 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.294 0 CA-C-N 116.015 -0.539 . . . . 0.0 110.032 -173.81 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' F' F ' 52' ' ' GLN . . . . . . . . . . . . . 61.4 tt0 -163.82 139.48 6.38 Favored 'General case' 0 C--N 1.33 -0.239 0 C-N-CA 120.264 -0.574 . . . . 0.0 111.817 -177.604 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' F' F ' 53' ' ' ALA . . . . . . . . . . . . . . . -116.63 131.45 56.95 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 115.832 -0.622 . . . . 0.0 110.108 175.839 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' F' F ' 54' ' ' TYR . . . . . . . . . . . . . 69.0 t80 -129.12 110.63 18.22 Favored Pre-proline 0 CA--C 1.534 0.352 0 CA-C-O 118.343 -0.837 . . . . 0.0 110.393 178.959 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' F' F ' 55' ' ' PRO . . . . . . . . . . . . . 73.9 Cg_endo -77.1 170.1 72.53 Favored 'Cis proline' 0 N--CA 1.499 1.831 0 CA-C-N 121.977 1.742 . . . . 0.0 112.292 -5.93 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' F' F ' 56' ' ' SER . . . . . . . . . . . . . 14.3 m -116.16 135.55 22.83 Favored Pre-proline 0 CA--C 1.54 0.571 0 CA-C-O 118.425 -0.798 . . . . 0.0 109.678 176.155 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' F' F ' 57' ' ' PRO . . . . . . . . . . . . . 56.8 Cg_endo -72.47 148.94 92.67 Favored 'Cis proline' 0 N--CA 1.496 1.651 0 CA-C-N 121.694 1.641 . . . . 0.0 111.339 -3.024 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' F' F ' 58' ' ' LEU . . . . . . . . . . . . . 37.7 tp -107.43 137.78 44.85 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-O 120.929 0.395 . . . . 0.0 110.688 -177.096 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' F' F ' 59' ' ' ARG . . . . . . . . . . . . . 61.0 ttt180 -98.92 125.81 44.44 Favored 'General case' 0 C--N 1.325 -0.457 0 CA-C-N 115.783 -0.644 . . . . 0.0 109.292 176.527 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' F' F ' 60' ' ' VAL . . . . . . . . . . . . . 42.0 t -84.34 114.87 25.45 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.246 0 C-N-CA 120.642 -0.423 . . . . 0.0 110.352 -174.975 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' F' F ' 61' ' ' GLU . . . . . . . . . . . . . 41.0 mt-10 -131.16 160.94 33.29 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 115.931 -0.577 . . . . 0.0 109.827 177.329 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' F' F ' 62' ' ' ASP . . . . . . . . . . . . . 74.4 m-20 -53.24 -32.49 48.58 Favored 'General case' 0 C--N 1.329 -0.283 0 N-CA-C 111.858 0.318 . . . . 0.0 111.858 -179.789 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' F' F ' 63' ' ' ARG . . . . . . . . . . . . . 83.1 mtp180 -72.87 -22.03 60.84 Favored 'General case' 0 CA--C 1.533 0.306 0 N-CA-C 112.913 0.708 . . . . 0.0 112.913 -177.048 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' F' F ' 64' ' ' THR . . . . . . . . . . . . . 32.5 m -69.55 142.67 53.57 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-O 120.82 0.343 . . . . 0.0 110.815 -175.455 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' F' F ' 65' ' ' LYS . . . . . . . . . . . . . 97.7 mttt -88.73 123.22 32.95 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.066 -0.515 . . . . 0.0 110.065 179.698 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' F' F ' 66' ' ' ILE . . . . . . . . . . . . . 63.0 mt -113.58 129.35 69.54 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.295 0 N-CA-C 109.702 -0.481 . . . . 0.0 109.702 -179.916 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' F' F ' 67' ' ' THR . . . . . . . . . . . . . 28.1 m -128.26 142.65 51.09 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.144 -0.48 . . . . 0.0 111.082 -177.473 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' F' F ' 68' ' ' LEU . . . . . . . . . . . . . 4.8 tt . . . . . 0 C--N 1.33 -0.272 0 CA-C-N 115.876 -0.602 . . . . 0.0 109.484 177.135 . . . . . . . . 0 0 . 1 . 014 nuclear orig core ' F' F ' 73' ' ' VAL . . . . . . . . . . . . . 29.6 m . . . . . 0 N--CA 1.461 0.077 0 CA-C-O 121.203 0.525 . . . . 0.0 111.471 . . . . . . . . . 0 0 . 1 . 014 nuclear orig core ' F' F ' 74' ' ' ASP . . . . . . . . . . . . . 10.0 t70 -102.96 119.32 38.64 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 115.441 -0.8 . . . . 0.0 109.503 175.898 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' F' F ' 75' ' ' VAL . . . . . . . . . . . . . 44.9 t -111.13 123.89 67.43 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.217 0 CA-C-O 121.15 0.5 . . . . 0.0 110.556 -177.347 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' F' F ' 76' ' ' LEU . . . . . . . . . . . . . 25.9 mt -125.93 147.37 49.51 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 115.561 -0.745 . . . . 0.0 109.615 178.546 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' F' F ' 77' ' ' GLU . . . . . . . . . . . . . 98.4 mt-10 -136.24 135.6 39.18 Favored 'General case' 0 C--N 1.331 -0.204 0 CA-C-O 121.134 0.493 . . . . 0.0 111.457 -177.318 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' F' F ' 78' ' ' ALA . . . . . . . . . . . . . . . -123.34 129.2 50.98 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 115.493 -0.776 . . . . 0.0 109.699 176.14 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' F' F ' 79' ' ' LYS . . . . . . . . . . . . . 96.8 mttt -76.88 119.23 20.36 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-O 120.915 0.388 . . . . 0.0 110.836 -178.585 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' F' F ' 80' ' ' ILE . . . . . . . . . . . . . 42.6 mm -139.09 116.68 11.64 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.326 0 N-CA-C 108.781 -0.822 . . . . 0.0 108.781 -178.186 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' F' F ' 81' ' ' LYS . . . . . . . . . . . . . 17.6 ptpt -105.96 127.72 53.34 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-O 121.303 0.573 . . . . 0.0 111.323 -175.696 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' F' F ' 82' ' ' GLY . . . . . . . . . . . . . . . 88.75 42.17 5.8 Favored Glycine 0 CA--C 1.525 0.684 0 CA-C-N 115.725 -0.67 . . . . 0.0 111.838 173.795 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' F' F ' 83' ' ' ILE . . . . . . . . . . . . . 74.6 mt -69.88 140.91 17.86 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.292 0 CA-C-O 121.043 0.449 . . . . 0.0 110.053 179.021 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' F' F ' 84' ' ' LYS . . . . . . . . . . . . . 67.5 tttt -99.75 -53.98 3.04 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 115.868 -0.605 . . . . 0.0 110.204 -178.869 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' F' F ' 85' ' ' ASP . . . . . . . . . . . . . 5.6 t70 -155.38 155.78 34.23 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 115.817 -0.629 . . . . 0.0 110.134 -179.021 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' F' F ' 86' ' ' VAL . . . . . . . . . . . . . 44.3 t -135.6 135.66 51.18 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.238 0 CA-C-O 121.038 0.447 . . . . 0.0 110.806 -178.135 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' F' F ' 87' ' ' ILE . . . . . . . . . . . . . 44.2 mm -119.38 128.5 75.85 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.199 0 CA-C-N 115.708 -0.678 . . . . 0.0 109.466 176.139 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' F' F ' 88' ' ' LEU . . . . . . . . . . . . . 24.0 tp -111.98 131.51 55.35 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-O 120.89 0.376 . . . . 0.0 110.996 -177.803 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' F' F ' 89' ' ' ASP . . . . . . . . . . . . . 10.0 t70 -126.09 154.05 43.63 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 116.036 -0.529 . . . . 0.0 109.597 176.39 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' F' F ' 90' ' ' GLU . . . . . . . . . . . . . 46.5 tp10 -47.29 -38.36 12.43 Favored 'General case' 0 C--N 1.33 -0.253 0 N-CA-C 112.794 0.665 . . . . 0.0 112.794 -172.394 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' F' F ' 91' ' ' ASN . . . . . . . . . . . . . 15.0 t-20 -132.06 33.34 3.92 Favored 'General case' 0 N--CA 1.466 0.353 0 C-N-CA 120.883 -0.327 . . . . 0.0 111.855 -175.889 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' F' F ' 92' ' ' LEU . . . . . . . . . . . . . 10.1 tp -166.12 148.31 7.01 Favored 'General case' 0 C--N 1.332 -0.169 0 C-N-CA 120.705 -0.398 . . . . 0.0 111.043 179.205 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' F' F ' 93' ' ' ILE . . . . . . . . . . . . . 67.4 mt -125.55 124.49 66.9 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.211 0 N-CA-C 109.588 -0.523 . . . . 0.0 109.588 -179.883 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' F' F ' 94' ' ' VAL . . . . . . . . . . . . . 43.7 t -122.27 126.57 74.45 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.186 0 N-CA-C 109.91 -0.404 . . . . 0.0 109.91 179.466 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' F' F ' 95' ' ' VAL . . . . . . . . . . . . . 46.3 t -123.59 135.0 64.81 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.175 0 CA-C-N 116.338 -0.392 . . . . 0.0 110.103 -179.175 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' F' F ' 96' ' ' ILE . . . . . . . . . . . . . 65.1 mt -116.48 130.64 70.95 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.265 0 N-CA-C 109.38 -0.6 . . . . 0.0 109.38 178.606 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' F' F ' 97' ' ' THR . . . . . . . . . . . . . 81.5 p -101.3 159.86 14.9 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-O 121.039 0.447 . . . . 0.0 111.19 -179.154 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' F' F ' 98' ' ' GLU . . . . . . . . . . . . . 45.1 mt-10 -54.35 -26.32 29.31 Favored 'General case' 0 C--N 1.328 -0.359 0 N-CA-C 112.257 0.465 . . . . 0.0 112.257 -179.497 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' F' F ' 99' ' ' GLU . . . . . . . . . . . . . 14.3 mm-40 -78.53 14.86 1.14 Allowed 'General case' 0 CA--C 1.535 0.366 0 N-CA-C 113.183 0.808 . . . . 0.0 113.183 -178.012 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' F' F ' 100' ' ' ASN . . . . . . . . . . . . . 7.6 m-20 60.13 37.46 20.85 Favored 'General case' 0 CA--C 1.529 0.138 0 CA-C-O 121.019 0.437 . . . . 0.0 111.091 -179.845 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' F' F ' 101' ' ' GLU . . . . . . . . . . . . . 84.7 tt0 -112.04 141.03 46.22 Favored 'General case' 0 C--N 1.331 -0.223 0 CA-C-N 116.023 -0.535 . . . . 0.0 109.659 174.09 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' F' F ' 102' ' ' VAL . . . . . . . . . . . . . 42.8 t -114.98 127.8 72.39 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.293 0 N-CA-C 109.9 -0.408 . . . . 0.0 109.9 -178.848 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' F' F ' 103' ' ' LEU . . . . . . . . . . . . . 6.4 mp -117.6 134.48 54.83 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 115.668 -0.696 . . . . 0.0 110.164 176.739 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' F' F ' 104' ' ' ILE . . . . . . . . . . . . . 66.2 mt -117.37 123.87 72.32 Favored 'Isoleucine or valine' 0 C--O 1.233 0.211 0 CA-C-N 116.267 -0.424 . . . . 0.0 109.957 -179.601 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' F' F ' 105' ' ' PHE . . . . . . . . . . . . . 92.3 m-85 -123.25 161.36 24.72 Favored 'General case' 0 C--N 1.332 -0.184 0 O-C-N 123.992 0.808 . . . . 0.0 109.97 -179.548 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' F' F ' 106' ' ' ASN . . . . . . . . . . . . . 44.3 p-10 -99.42 -171.74 2.13 Favored 'General case' 0 C--N 1.33 -0.277 0 N-CA-C 110.209 -0.293 . . . . 0.0 110.209 175.266 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' F' F ' 107' ' ' GLN . . . . . . . . . . . . . 50.7 tt0 -58.87 -28.21 65.92 Favored 'General case' 0 C--N 1.329 -0.316 0 N-CA-C 112.176 0.436 . . . . 0.0 112.176 179.7 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' F' F ' 108' ' ' ASN . . . . . . . . . . . . . 2.7 t-20 -85.63 7.75 22.11 Favored 'General case' 0 CA--C 1.538 0.486 0 N-CA-C 113.252 0.834 . . . . 0.0 113.252 -176.857 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' F' F ' 109' ' ' LEU . . . . . . . . . . . . . 11.7 tp 59.94 38.13 21.15 Favored 'General case' 0 CA--C 1.53 0.181 0 CA-C-O 121.086 0.47 . . . . 0.0 111.166 178.984 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' F' F ' 110' ' ' GLU . . . . . . . . . . . . . 95.7 mt-10 -108.22 148.76 29.5 Favored 'General case' 0 C--N 1.33 -0.267 0 N-CA-C 109.73 -0.47 . . . . 0.0 109.73 175.274 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' F' F ' 111' ' ' GLU . . . . . . . . . . . . . 60.0 tt0 -83.51 121.88 27.8 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-O 120.774 0.321 . . . . 0.0 110.725 -175.763 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' F' F ' 112' ' ' LEU . . . . . . . . . . . . . 27.7 mt -106.92 -46.05 4.03 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.1 -0.5 . . . . 0.0 110.814 179.673 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' F' F ' 113' ' ' TYR . . . . . . . . . . . . . 60.1 t80 -134.86 141.88 46.47 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 116.437 -0.347 . . . . 0.0 111.229 -178.227 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' F' F ' 114' ' ' ARG . . . . . . . . . . . . . 36.9 ptt180 -146.61 121.05 9.66 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.738 178.12 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' F' F ' 115' ' ' GLY . . . . . . . . . . . . . . . -150.12 149.75 21.69 Favored Glycine 0 CA--C 1.526 0.744 0 N-CA-C 111.203 -0.759 . . . . 0.0 111.203 178.332 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' F' F ' 116' ' ' LYS . . . . . . . . . . . . . 35.1 ttmt -115.35 136.77 52.75 Favored 'General case' 0 C--N 1.331 -0.233 0 N-CA-C 110.133 -0.321 . . . . 0.0 110.133 176.678 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' F' F ' 117' ' ' PHE . . . . . . . . . . . . . 44.1 m-85 -132.35 114.52 14.48 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-O 120.974 0.416 . . . . 0.0 110.137 -177.344 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' F' F ' 118' ' ' GLU . . . . . . . . . . . . . 96.2 mt-10 -53.97 -46.94 71.8 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.336 -0.393 . . . . 0.0 111.427 -175.775 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' F' F ' 119' ' ' ASN . . . . . . . . . . . . . 28.6 m120 -94.43 31.06 1.81 Allowed 'General case' 0 C--N 1.328 -0.342 0 N-CA-C 112.165 0.432 . . . . 0.0 112.165 -174.334 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' F' F ' 120' ' ' LEU . . . . . . . . . . . . . 16.0 tp -57.35 119.98 7.39 Favored 'General case' 0 C--N 1.332 -0.169 0 N-CA-C 110.175 -0.305 . . . . 0.0 110.175 177.657 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' F' F ' 121' ' ' ASN . . . . . . . . . . . . . 81.2 m-20 -114.1 -44.08 3.17 Favored 'General case' 0 C--O 1.233 0.223 0 CA-C-N 116.365 -0.379 . . . . 0.0 111.026 -178.419 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' F' F ' 122' ' ' LYS . . . . . . . . . . . . . 98.4 mttt -145.77 149.55 34.57 Favored 'General case' 0 C--N 1.333 -0.128 0 CA-C-O 121.092 0.472 . . . . 0.0 111.856 -178.319 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' F' F ' 123' ' ' VAL . . . . . . . . . . . . . 46.8 t -124.92 126.66 71.64 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.211 0 CA-C-N 115.694 -0.684 . . . . 0.0 109.497 175.043 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' F' F ' 124' ' ' LEU . . . . . . . . . . . . . 6.2 mp -117.88 133.94 55.43 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.473 -0.331 . . . . 0.0 110.434 -179.314 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' F' F ' 125' ' ' VAL . . . . . . . . . . . . . 12.0 p -133.77 135.91 54.74 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.285 0 CA-C-N 116.233 -0.44 . . . . 0.0 110.522 -179.875 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' F' F ' 126' ' ' ARG . . . . . . . . . . . . . 95.9 mtt-85 -143.31 116.88 9.17 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.115 -0.493 . . . . 0.0 110.267 177.716 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' F' F ' 127' ' ' ASN . . . . . . . . . . . . . 64.3 t30 52.56 -104.98 0.21 Allowed 'General case' 0 CA--C 1.544 0.744 0 CA-C-O 118.986 -0.53 . . . . 0.0 111.357 179.74 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' F' F ' 128' ' ' ASP . . . . . . . . . . . . . 8.6 p-10 -114.08 4.43 15.64 Favored 'General case' 0 CA--C 1.537 0.463 0 CA-C-N 119.526 1.057 . . . . 0.0 113.547 -176.623 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' F' F ' 129' ' ' LEU . . . . . . . . . . . . . 14.6 tp -107.37 139.0 42.53 Favored 'General case' 0 C--N 1.332 -0.173 0 CA-C-N 118.207 0.458 . . . . 0.0 110.292 179.693 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' F' F ' 130' ' ' VAL . . . . . . . . . . . . . 41.3 t -126.71 137.14 58.73 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.233 0 CA-C-O 120.942 0.401 . . . . 0.0 110.424 -178.339 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' F' F ' 131' ' ' VAL . . . . . . . . . . . . . 43.0 t -136.02 136.46 49.63 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.271 0 CA-C-N 116.239 -0.437 . . . . 0.0 110.198 176.916 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' F' F ' 132' ' ' ILE . . . . . . . . . . . . . 77.5 mt -116.57 133.16 64.07 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.257 0 CA-C-N 115.908 -0.587 . . . . 0.0 109.605 -179.071 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' F' F ' 133' ' ' ILE . . . . . . . . . . . . . 41.2 mm -116.53 125.26 73.44 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.249 0 CA-C-N 116.377 -0.374 . . . . 0.0 111.112 -174.66 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' F' F ' 134' ' ' ASP . . . . . . . . . . . . . 11.7 p-10 -139.02 151.6 46.94 Favored 'General case' 0 C--N 1.333 -0.135 0 CA-C-N 116.198 -0.455 . . . . 0.0 109.912 174.037 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' F' F ' 135' ' ' GLU . . . . . . . . . . . . . 84.8 tt0 -50.82 -27.94 8.39 Favored 'General case' 0 C--N 1.33 -0.267 0 N-CA-C 112.862 0.69 . . . . 0.0 112.862 -172.513 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' F' F ' 136' ' ' GLN . . . . . . . . . . . . . 96.9 mt-30 -84.9 -30.02 24.73 Favored 'General case' 0 C--N 1.329 -0.291 0 N-CA-C 112.63 0.604 . . . . 0.0 112.63 -174.663 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' F' F ' 137' ' ' LYS . . . . . . . . . . . . . 56.7 pttt -169.08 173.16 7.01 Favored 'General case' 0 C--O 1.233 0.212 0 CA-C-O 121.683 0.754 . . . . 0.0 112.672 -170.267 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' F' F ' 138' ' ' LEU . . . . . . . . . . . . . 4.7 tt -121.73 128.9 52.29 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 114.77 -1.105 . . . . 0.0 109.673 178.862 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' F' F ' 139' ' ' THR . . . . . . . . . . . . . 42.1 m -111.71 126.09 54.67 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.443 -0.344 . . . . 0.0 110.146 179.402 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' F' F ' 140' ' ' LEU . . . . . . . . . . . . . 6.3 tt -113.0 124.14 51.94 Favored 'General case' 0 C--N 1.329 -0.291 0 N-CA-C 109.579 -0.526 . . . . 0.0 109.579 -178.625 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' F' F ' 141' ' ' ILE . . . . . . . . . . . . . 19.4 mt -122.55 120.42 60.91 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.309 0 CA-C-O 121.014 0.435 . . . . 0.0 110.049 -175.128 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' F' F ' 142' ' ' ARG . . . . . . . . . . . . . 67.7 ttt180 -111.4 126.97 55.5 Favored 'General case' 0 C--N 1.332 -0.17 0 CA-C-N 115.376 -0.829 . . . . 0.0 110.492 -177.114 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' F' F ' 143' ' ' THR . . . . . . . . . . . . . 56.0 p . . . . . 0 C--O 1.219 -0.52 0 CA-C-O 118.12 -0.943 . . . . 0.0 110.623 179.921 . . . . . . . . 0 0 . 1 . 015 nuclear orig core ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 40.9 p . . . . . 0 C--O 1.232 0.165 0 CA-C-O 120.84 0.352 . . . . 0.0 110.384 . . . . . . . . . 0 0 . 1 . 015 nuclear orig core ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 95.2 mt-10 -141.32 140.56 33.83 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.194 -0.457 . . . . 0.0 111.355 -177.861 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 4' ' ' LEU . . . . . . . . . . . . . 75.9 mt -121.82 128.38 51.6 Favored 'General case' 0 C--O 1.233 0.226 0 CA-C-N 115.951 -0.568 . . . . 0.0 110.17 174.884 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 5' ' ' LYS . . . . . . . . . . . . . 68.5 mttm -107.55 122.15 46.09 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.451 -0.341 . . . . 0.0 110.259 177.769 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 70.5 mt -118.14 144.29 45.8 Favored 'General case' 0 C--N 1.331 -0.224 0 CA-C-N 115.769 -0.65 . . . . 0.0 110.287 -179.105 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 59.3 tttm -121.64 135.13 24.89 Favored Pre-proline 0 CA--C 1.534 0.363 0 CA-C-O 118.675 -0.679 . . . . 0.0 109.603 175.475 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 8' ' ' PRO . . . . . . . . . . . . . 84.9 Cg_endo -90.04 131.79 1.86 Allowed 'Trans proline' 0 N--CA 1.488 1.176 0 C-N-CA 121.605 1.537 . . . . 0.0 111.735 178.054 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 28.2 mt -73.65 -47.4 7.06 Favored Pre-proline 0 CA--C 1.535 0.384 0 CA-C-O 118.604 -0.712 . . . . 0.0 111.972 -179.072 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 95.5 Cg_endo -79.76 151.04 21.66 Favored 'Trans proline' 0 N--CA 1.497 1.697 0 C-N-CA 121.056 1.171 . . . . 0.0 111.873 176.049 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 19.2 ttpp -85.65 107.06 17.37 Favored 'General case' 0 C--N 1.33 -0.27 0 C-N-CA 120.885 -0.326 . . . . 0.0 110.31 178.895 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 12.0 p -149.22 147.68 16.34 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.323 0 CA-C-N 116.352 -0.385 . . . . 0.0 110.805 -179.153 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 94.7 mt-10 -95.75 110.05 22.26 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.087 -0.506 . . . . 0.0 109.668 175.843 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 14' ' ' LEU . . . . . . . . . . . . . 51.2 mt -86.54 148.78 47.39 Favored Pre-proline 0 CA--C 1.533 0.307 0 CA-C-O 119.303 -0.379 . . . . 0.0 110.481 -176.793 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 15' ' ' PRO . . . . . . . . . . . . . 28.6 Cg_exo -61.03 159.57 29.28 Favored 'Trans proline' 0 N--CA 1.497 1.685 0 C-N-CA 121.269 1.313 . . . . 0.0 111.738 177.263 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 16' ' ' PRO . . . . . . . . . . . . . 32.7 Cg_exo -59.75 -35.89 93.14 Favored 'Trans proline' 0 N--CA 1.498 1.74 0 C-N-CA 121.374 1.383 . . . . 0.0 112.692 -178.736 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 17' ' ' ASP . . . . . . . . . . . . . 8.5 p-10 -84.03 4.85 28.14 Favored 'General case' 0 CA--C 1.536 0.423 0 N-CA-C 113.26 0.837 . . . . 0.0 113.26 -177.959 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 18' ' ' PHE . . . . . . . . . . . . . 40.2 t80 -58.47 -46.03 87.43 Favored 'General case' 0 N--CA 1.456 -0.145 0 O-C-N 121.912 -0.493 . . . . 0.0 109.978 -178.699 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 19' ' ' VAL . . . . . . . . . . . . . 47.9 t -57.12 -41.22 77.3 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.368 0 CA-C-N 116.236 -0.438 . . . . 0.0 110.479 -177.743 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 74.9 m-20 -60.34 -45.16 94.43 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-O 120.756 0.313 . . . . 0.0 111.043 -177.356 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 46.5 t -64.98 -46.46 91.52 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.276 0 C-N-CA 120.692 -0.403 . . . . 0.0 110.436 -177.761 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 22' ' ' ILE . . . . . . . . . . . . . 51.6 mm -57.32 -42.36 80.16 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.218 0 CA-C-O 120.899 0.38 . . . . 0.0 110.362 178.389 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 23' ' ' ARG . . . . . . . . . . . . . 59.7 ttp180 -53.71 -49.17 68.67 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-O 120.794 0.33 . . . . 0.0 111.278 -179.223 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 24' ' ' ILE . . . . . . . . . . . . . 70.2 mt -60.67 -41.48 88.33 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.255 0 CA-C-N 116.497 -0.32 . . . . 0.0 110.935 -179.488 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 52.9 mmtt -63.15 -37.4 87.07 Favored 'General case' 0 C--N 1.329 -0.314 0 N-CA-C 112.073 0.397 . . . . 0.0 112.073 179.239 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 58.9 mt -79.06 -42.4 26.51 Favored 'General case' 0 C--N 1.329 -0.297 0 N-CA-C 113.347 0.869 . . . . 0.0 113.347 -172.125 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 27' ' ' GLN . . . . . . . . . . . . . 10.3 pt20 -47.37 140.68 5.42 Favored 'General case' 0 N--CA 1.47 0.545 0 N-CA-C 112.716 0.636 . . . . 0.0 112.716 -174.735 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 98.09 -25.21 28.55 Favored Glycine 0 CA--C 1.532 1.147 0 CA-C-N 115.541 -0.754 . . . . 0.0 112.398 -178.627 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 69.1 mttm -97.73 155.11 17.17 Favored 'General case' 0 C--N 1.332 -0.181 0 CA-C-N 117.397 0.598 . . . . 0.0 110.81 179.375 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 30' ' ' THR . . . . . . . . . . . . . 33.1 m -102.96 137.53 41.03 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.242 -0.435 . . . . 0.0 110.076 177.297 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 35.0 m -126.67 151.4 33.28 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.251 0 CA-C-N 116.325 -0.398 . . . . 0.0 110.97 -178.998 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 32' ' ' ARG . . . . . . . . . . . . . 62.0 mtt85 -133.26 148.71 51.97 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 115.665 -0.698 . . . . 0.0 110.202 176.645 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 33' ' ' THR . . . . . . . . . . . . . 21.5 m -53.4 138.24 33.59 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-O 120.86 0.362 . . . . 0.0 111.372 -177.644 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 101.0 -17.05 56.79 Favored Glycine 0 CA--C 1.533 1.165 0 CA-C-O 119.656 -0.525 . . . . 0.0 113.359 178.587 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 80.3 m-20 -66.5 150.03 49.57 Favored 'General case' 0 N--CA 1.463 0.202 0 CA-C-N 118.043 0.922 . . . . 0.0 111.359 179.592 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 46.2 t -122.58 129.59 75.11 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.236 0 CA-C-N 116.029 -0.532 . . . . 0.0 109.852 177.524 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 37' ' ' ILE . . . . . . . . . . . . . 62.1 mt -122.08 139.83 47.87 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.235 0 CA-C-N 116.228 -0.442 . . . . 0.0 109.962 -178.495 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . -117.01 128.3 7.82 Favored Glycine 0 CA--C 1.524 0.605 0 N-CA-C 110.89 -0.884 . . . . 0.0 110.89 178.284 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 39' ' ' ILE . . . . . . . . . . . . . 75.6 mt -127.25 132.46 69.58 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.29 0 CA-C-O 120.765 0.317 . . . . 0.0 110.199 179.754 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 40' ' ' SER . . . . . . . . . . . . . 13.0 t -93.04 122.18 35.14 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.304 -0.407 . . . . 0.0 110.923 176.419 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 41' ' ' ILE . . . . . . . . . . . . . 5.1 mp -128.72 120.83 53.37 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.232 0 N-CA-C 109.902 -0.407 . . . . 0.0 109.902 176.728 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 6.8 mp 56.62 35.42 26.07 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-O 121.088 0.47 . . . . 0.0 111.203 -179.704 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . 80.14 -10.14 43.27 Favored Glycine 0 CA--C 1.533 1.198 0 C-N-CA 121.255 -0.498 . . . . 0.0 113.538 176.169 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 44' ' ' LYS . . . . . . . . . . . . . 61.7 mttp -99.68 131.25 45.79 Favored 'General case' 0 C--O 1.23 0.049 0 CA-C-N 117.891 0.846 . . . . 0.0 110.207 178.419 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 83.0 tt0 -85.57 131.06 34.43 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.371 -0.377 . . . . 0.0 111.301 -178.989 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 46' ' ' VAL . . . . . . . . . . . . . 10.0 p -123.09 125.06 71.51 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.167 0 N-CA-C 109.565 -0.531 . . . . 0.0 109.565 173.786 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 66.6 mttm -99.28 127.07 45.23 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.133 -0.485 . . . . 0.0 111.042 177.856 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 48' ' ' PHE . . . . . . . . . . . . . 39.4 m-85 -112.68 131.81 55.47 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 115.918 -0.583 . . . . 0.0 110.004 178.656 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 77.8 tttt -106.4 132.36 52.52 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.471 -0.331 . . . . 0.0 110.231 178.204 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 50' ' ' VAL . . . . . . . . . . . . . 45.3 t -75.63 105.16 4.34 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.244 0 N-CA-C 109.401 -0.592 . . . . 0.0 109.401 178.002 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 51' ' ' VAL . . . . . . . . . . . . . 48.5 t -69.73 -49.64 56.29 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 N-CA-C 109.751 -0.463 . . . . 0.0 109.751 -175.035 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 52' ' ' GLN . . . . . . . . . . . . . 62.7 tt0 -167.01 147.42 5.61 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 115.971 -0.559 . . . . 0.0 111.498 -178.718 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -123.11 134.99 54.19 Favored 'General case' 0 C--N 1.332 -0.19 0 CA-C-N 116.035 -0.53 . . . . 0.0 109.972 176.884 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 54' ' ' TYR . . . . . . . . . . . . . 64.0 t80 -129.11 113.88 18.58 Favored Pre-proline 0 CA--C 1.535 0.375 0 CA-C-O 118.103 -0.951 . . . . 0.0 110.246 178.443 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 55' ' ' PRO . . . . . . . . . . . . . 72.8 Cg_endo -77.16 170.15 72.31 Favored 'Cis proline' 0 N--CA 1.501 1.956 0 CA-C-N 122.154 1.805 . . . . 0.0 111.842 -8.476 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 56' ' ' SER . . . . . . . . . . . . . 14.7 m -123.67 141.91 37.8 Favored Pre-proline 0 CA--C 1.538 0.51 0 CA-C-O 118.755 -0.641 . . . . 0.0 109.81 175.483 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 57' ' ' PRO . . . . . . . . . . . . . 37.1 Cg_endo -67.27 158.39 82.78 Favored 'Cis proline' 0 N--CA 1.5 1.892 0 CA-C-N 121.466 1.559 . . . . 0.0 111.179 -5.023 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 58' ' ' LEU . . . . . . . . . . . . . 27.9 tp -128.44 137.19 51.71 Favored 'General case' 0 C--N 1.331 -0.223 0 CA-C-O 120.833 0.349 . . . . 0.0 110.808 -178.201 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 59' ' ' ARG . . . . . . . . . . . . . 57.2 ttp180 -100.34 122.92 43.88 Favored 'General case' 0 C--N 1.328 -0.357 0 N-CA-C 108.919 -0.771 . . . . 0.0 108.919 173.613 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 40.1 t -70.25 124.62 26.74 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.327 0 C-N-CA 120.718 -0.393 . . . . 0.0 110.396 -174.21 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 42.9 mt-10 -131.04 160.69 33.88 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 115.851 -0.613 . . . . 0.0 109.907 176.798 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 62' ' ' ASP . . . . . . . . . . . . . 70.6 m-20 -52.36 -31.72 35.0 Favored 'General case' 0 CA--C 1.533 0.314 0 N-CA-C 111.957 0.355 . . . . 0.0 111.957 179.137 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 63' ' ' ARG . . . . . . . . . . . . . 79.3 mtp180 -71.41 -21.74 61.95 Favored 'General case' 0 CA--C 1.532 0.281 0 N-CA-C 113.026 0.75 . . . . 0.0 113.026 -175.5 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 19.4 m -70.81 140.56 51.25 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-O 120.948 0.404 . . . . 0.0 111.288 -173.786 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 65' ' ' LYS . . . . . . . . . . . . . 97.8 mttt -89.24 136.7 32.88 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-N 115.936 -0.575 . . . . 0.0 109.972 177.407 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 66' ' ' ILE . . . . . . . . . . . . . 65.4 mt -123.02 128.8 75.27 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.264 0 N-CA-C 110.009 -0.367 . . . . 0.0 110.009 -178.575 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 67' ' ' THR . . . . . . . . . . . . . 9.3 m -124.04 144.24 49.96 Favored 'General case' 0 N--CA 1.463 0.213 0 CA-C-O 120.951 0.405 . . . . 0.0 111.421 -176.224 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 68' ' ' LEU . . . . . . . . . . . . . 5.9 tt . . . . . 0 C--N 1.332 -0.158 0 CA-C-N 116.041 -0.527 . . . . 0.0 110.283 178.83 . . . . . . . . 0 0 . 1 . 015 nuclear orig core ' A' A ' 74' ' ' ASP . . . . . . . . . . . . . 17.9 t0 . . . . . 0 N--CA 1.457 -0.097 0 N-CA-C 109.744 -0.465 . . . . 0.0 109.744 . . . . . . . . . 0 0 . 1 . 015 nuclear orig core ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 40.6 t -115.75 124.48 72.21 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.311 0 CA-C-O 121.061 0.458 . . . . 0.0 110.682 -176.163 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 76' ' ' LEU . . . . . . . . . . . . . 6.4 mp -122.43 142.72 50.25 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-N 115.848 -0.615 . . . . 0.0 110.007 176.358 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 77' ' ' GLU . . . . . . . . . . . . . 96.8 mt-10 -134.38 143.12 47.44 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-O 121.097 0.475 . . . . 0.0 111.242 179.739 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 78' ' ' ALA . . . . . . . . . . . . . . . -129.83 145.17 51.59 Favored 'General case' 0 C--N 1.332 -0.185 0 CA-C-N 115.712 -0.676 . . . . 0.0 109.997 176.492 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 79' ' ' LYS . . . . . . . . . . . . . 33.8 mmtm -77.39 116.7 18.2 Favored 'General case' 0 C--N 1.331 -0.219 0 CA-C-N 116.374 -0.375 . . . . 0.0 110.405 179.538 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 80' ' ' ILE . . . . . . . . . . . . . 35.3 mm -139.11 106.78 3.04 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.251 0 N-CA-C 109.26 -0.644 . . . . 0.0 109.26 -178.243 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 81' ' ' LYS . . . . . . . . . . . . . 38.7 tttp -109.77 130.93 55.47 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-O 120.971 0.415 . . . . 0.0 111.104 -177.135 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . 88.99 42.07 5.73 Favored Glycine 0 CA--C 1.525 0.689 0 C-N-CA 121.03 -0.605 . . . . 0.0 111.66 175.336 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 83' ' ' ILE . . . . . . . . . . . . . 67.9 mt -74.02 137.1 23.9 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.265 0 N-CA-C 110.007 -0.368 . . . . 0.0 110.007 179.307 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 84' ' ' LYS . . . . . . . . . . . . . 58.0 tttp -96.26 -52.88 3.82 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-N 116.007 -0.542 . . . . 0.0 109.875 179.035 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 85' ' ' ASP . . . . . . . . . . . . . 4.0 t70 -155.67 157.26 36.37 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 115.871 -0.604 . . . . 0.0 110.593 -179.101 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 86' ' ' VAL . . . . . . . . . . . . . 45.2 t -132.37 135.89 57.16 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.204 0 CA-C-O 120.994 0.426 . . . . 0.0 110.408 179.856 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 87' ' ' ILE . . . . . . . . . . . . . 42.3 mm -116.16 123.14 71.03 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.356 0 N-CA-C 109.161 -0.681 . . . . 0.0 109.161 176.968 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 88' ' ' LEU . . . . . . . . . . . . . 14.0 tp -109.61 130.47 55.51 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-O 121.075 0.464 . . . . 0.0 110.956 -176.597 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 89' ' ' ASP . . . . . . . . . . . . . 10.9 t70 -128.95 154.86 46.16 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-N 115.87 -0.604 . . . . 0.0 109.489 177.162 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 76.2 tt0 -48.22 -35.58 12.17 Favored 'General case' 0 C--N 1.329 -0.307 0 N-CA-C 112.808 0.669 . . . . 0.0 112.808 -172.444 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 91' ' ' ASN . . . . . . . . . . . . . 94.5 m-20 -128.43 18.3 6.4 Favored 'General case' 0 N--CA 1.469 0.487 0 N-CA-C 113.127 0.788 . . . . 0.0 113.127 -176.519 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 92' ' ' LEU . . . . . . . . . . . . . 28.5 mt -149.66 147.48 28.15 Favored 'General case' 0 C--N 1.331 -0.226 0 CA-C-O 121.0 0.429 . . . . 0.0 110.752 -177.637 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 93' ' ' ILE . . . . . . . . . . . . . 65.7 mt -127.0 113.48 32.86 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.315 0 N-CA-C 108.892 -0.781 . . . . 0.0 108.892 177.284 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 94' ' ' VAL . . . . . . . . . . . . . 45.4 t -116.08 129.42 72.5 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.241 0 N-CA-C 110.044 -0.354 . . . . 0.0 110.044 -177.93 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 95' ' ' VAL . . . . . . . . . . . . . 41.4 t -122.74 135.17 63.69 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.388 0 CA-C-N 116.111 -0.495 . . . . 0.0 110.078 -178.338 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 96' ' ' ILE . . . . . . . . . . . . . 66.0 mt -115.62 128.61 72.8 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.271 0 N-CA-C 109.364 -0.606 . . . . 0.0 109.364 178.278 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 97' ' ' THR . . . . . . . . . . . . . 79.0 p -102.43 159.51 15.36 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-O 121.132 0.492 . . . . 0.0 111.386 -177.675 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 98' ' ' GLU . . . . . . . . . . . . . 45.6 mt-10 -54.06 -25.88 23.86 Favored 'General case' 0 CA--C 1.532 0.264 0 N-CA-C 112.335 0.494 . . . . 0.0 112.335 179.736 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 99' ' ' GLU . . . . . . . . . . . . . 95.8 mt-10 -77.84 13.48 1.35 Allowed 'General case' 0 CA--C 1.535 0.37 0 N-CA-C 113.167 0.803 . . . . 0.0 113.167 -178.048 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 100' ' ' ASN . . . . . . . . . . . . . 3.3 m-20 60.87 36.59 18.93 Favored 'General case' 0 CA--C 1.529 0.173 0 CA-C-O 120.956 0.408 . . . . 0.0 110.998 -179.833 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 101' ' ' GLU . . . . . . . . . . . . . 82.9 tt0 -113.59 143.22 44.92 Favored 'General case' 0 C--N 1.332 -0.178 0 N-CA-C 109.381 -0.6 . . . . 0.0 109.381 176.348 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 102' ' ' VAL . . . . . . . . . . . . . 43.1 t -115.29 125.74 72.64 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.356 0 CA-C-O 120.909 0.385 . . . . 0.0 109.996 -177.625 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 103' ' ' LEU . . . . . . . . . . . . . 23.4 mt -114.15 130.92 56.59 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 115.518 -0.764 . . . . 0.0 109.966 176.667 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 104' ' ' ILE . . . . . . . . . . . . . 67.8 mt -119.37 118.84 58.77 Favored 'Isoleucine or valine' 0 C--O 1.234 0.27 0 N-CA-C 110.118 -0.327 . . . . 0.0 110.118 -179.846 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 105' ' ' PHE . . . . . . . . . . . . . 79.7 m-85 -117.98 164.07 15.64 Favored 'General case' 0 C--N 1.332 -0.182 0 O-C-N 123.979 0.799 . . . . 0.0 109.604 178.04 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 106' ' ' ASN . . . . . . . . . . . . . 44.2 p-10 -101.11 -170.49 1.85 Allowed 'General case' 0 C--N 1.331 -0.22 0 N-CA-C 109.992 -0.373 . . . . 0.0 109.992 173.652 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 107' ' ' GLN . . . . . . . . . . . . . 57.9 tt0 -57.43 -29.99 64.61 Favored 'General case' 0 CA--C 1.534 0.36 0 N-CA-C 111.839 0.311 . . . . 0.0 111.839 178.673 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 108' ' ' ASN . . . . . . . . . . . . . 60.3 t30 -83.94 7.42 18.37 Favored 'General case' 0 CA--C 1.536 0.434 0 N-CA-C 113.373 0.879 . . . . 0.0 113.373 -176.515 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 109' ' ' LEU . . . . . . . . . . . . . 11.2 tp 60.32 37.38 20.3 Favored 'General case' 0 CA--C 1.53 0.194 0 CA-C-O 120.955 0.407 . . . . 0.0 111.208 179.434 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 110' ' ' GLU . . . . . . . . . . . . . 70.8 mm-40 -106.88 160.95 15.13 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 116.466 -0.334 . . . . 0.0 110.169 177.85 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 111' ' ' GLU . . . . . . . . . . . . . 83.0 tt0 -85.31 122.75 29.92 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.312 -0.404 . . . . 0.0 110.801 -178.15 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 112' ' ' LEU . . . . . . . . . . . . . 17.0 mt -111.19 -46.11 3.35 Favored 'General case' 0 C--N 1.332 -0.189 0 CA-C-N 116.223 -0.444 . . . . 0.0 110.566 177.176 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 113' ' ' TYR . . . . . . . . . . . . . 46.8 t80 -141.67 139.71 33.05 Favored 'General case' 0 C--N 1.332 -0.195 0 CA-C-N 116.371 -0.377 . . . . 0.0 110.97 179.895 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 114' ' ' ARG . . . . . . . . . . . . . 58.7 ttp180 -143.09 116.02 8.81 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.068 -0.515 . . . . 0.0 110.125 178.921 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 115' ' ' GLY . . . . . . . . . . . . . . . -150.26 163.05 29.43 Favored Glycine 0 CA--C 1.525 0.678 0 N-CA-C 111.0 -0.84 . . . . 0.0 111.0 -179.506 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 116' ' ' LYS . . . . . . . . . . . . . 34.5 ttmt -128.38 137.54 51.94 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-O 120.723 0.297 . . . . 0.0 110.27 177.229 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 117' ' ' PHE . . . . . . . . . . . . . 54.4 m-85 -131.47 114.95 15.54 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.324 -0.398 . . . . 0.0 110.286 -177.007 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 118' ' ' GLU . . . . . . . . . . . . . 46.4 tp10 -53.76 -47.81 70.35 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.554 -0.294 . . . . 0.0 111.491 -176.067 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 119' ' ' ASN . . . . . . . . . . . . . 6.4 m120 -97.14 31.02 2.55 Favored 'General case' 0 C--N 1.329 -0.302 0 N-CA-C 112.088 0.403 . . . . 0.0 112.088 -174.126 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 120' ' ' LEU . . . . . . . . . . . . . 12.3 tp -56.63 122.22 11.55 Favored 'General case' 0 C--N 1.331 -0.224 0 C-N-CA 121.026 -0.27 . . . . 0.0 110.496 179.08 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 121' ' ' ASN . . . . . . . . . . . . . 29.2 m120 -112.78 -44.01 3.37 Favored 'General case' 0 C--O 1.232 0.157 0 CA-C-N 116.564 -0.289 . . . . 0.0 111.115 -177.299 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 122' ' ' LYS . . . . . . . . . . . . . 96.1 mttt -146.42 149.17 33.2 Favored 'General case' 0 C--N 1.331 -0.218 0 CA-C-O 120.996 0.427 . . . . 0.0 111.725 -179.544 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 123' ' ' VAL . . . . . . . . . . . . . 44.5 t -126.87 123.48 62.77 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.327 0 N-CA-C 108.971 -0.752 . . . . 0.0 108.971 171.628 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 124' ' ' LEU . . . . . . . . . . . . . 13.6 tp -120.54 137.31 54.45 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.395 -0.366 . . . . 0.0 110.537 -175.703 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 125' ' ' VAL . . . . . . . . . . . . . 43.9 t -125.36 132.76 70.67 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.243 0 CA-C-N 116.101 -0.499 . . . . 0.0 110.27 -179.412 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 126' ' ' ARG . . . . . . . . . . . . . 40.3 mmt180 -131.77 108.06 9.19 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 115.96 -0.563 . . . . 0.0 109.933 176.686 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 127' ' ' ASN . . . . . . . . . . . . . 7.8 m120 54.12 -104.83 0.23 Allowed 'General case' 0 CA--C 1.543 0.688 0 CA-C-O 119.037 -0.506 . . . . 0.0 110.935 179.85 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 128' ' ' ASP . . . . . . . . . . . . . 7.5 p-10 -113.31 4.17 16.28 Favored 'General case' 0 N--CA 1.468 0.458 0 CA-C-N 119.575 1.08 . . . . 0.0 113.387 -176.886 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 129' ' ' LEU . . . . . . . . . . . . . 76.3 mt -104.97 139.51 39.57 Favored 'General case' 0 C--N 1.332 -0.162 0 CA-C-N 118.17 0.441 . . . . 0.0 110.051 177.412 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 130' ' ' VAL . . . . . . . . . . . . . 44.8 t -120.5 135.45 60.68 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.223 0 CA-C-N 116.271 -0.422 . . . . 0.0 110.004 -177.485 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 131' ' ' VAL . . . . . . . . . . . . . 42.7 t -132.6 132.53 59.94 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.29 0 CA-C-O 120.985 0.421 . . . . 0.0 109.993 177.562 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 132' ' ' ILE . . . . . . . . . . . . . 70.8 mt -115.3 130.76 69.31 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 N-CA-C 109.251 -0.648 . . . . 0.0 109.251 178.903 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 133' ' ' ILE . . . . . . . . . . . . . 43.1 mm -115.97 121.11 66.72 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.287 0 CA-C-N 116.305 -0.407 . . . . 0.0 110.531 -175.651 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 134' ' ' ASP . . . . . . . . . . . . . 7.1 p-10 -133.0 149.98 52.19 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.045 -0.525 . . . . 0.0 109.626 175.8 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 135' ' ' GLU . . . . . . . . . . . . . 78.7 tt0 -49.79 -25.99 3.54 Favored 'General case' 0 C--N 1.327 -0.391 0 N-CA-C 113.005 0.743 . . . . 0.0 113.005 -169.244 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 136' ' ' GLN . . . . . . . . . . . . . 87.7 mt-30 -103.95 -27.43 12.17 Favored 'General case' 0 N--CA 1.465 0.32 0 N-CA-C 112.955 0.724 . . . . 0.0 112.955 -174.745 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 137' ' ' LYS . . . . . . . . . . . . . 60.5 mtpt -140.48 152.54 45.7 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-O 121.333 0.587 . . . . 0.0 111.775 -170.227 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 138' ' ' LEU . . . . . . . . . . . . . 5.1 tt -117.7 121.69 41.53 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 115.504 -0.771 . . . . 0.0 109.145 172.684 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 139' ' ' THR . . . . . . . . . . . . . 26.5 m -108.5 126.63 53.13 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.425 -0.352 . . . . 0.0 110.604 -177.242 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 140' ' ' LEU . . . . . . . . . . . . . 12.9 tp -113.63 119.07 36.19 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 115.651 -0.704 . . . . 0.0 109.156 -179.73 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 141' ' ' ILE . . . . . . . . . . . . . 19.4 mt -119.02 120.73 64.88 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.328 0 N-CA-C 109.851 -0.426 . . . . 0.0 109.851 -174.734 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 142' ' ' ARG . . . . . . . . . . . . . 81.1 mtm180 -110.7 125.46 53.5 Favored 'General case' 0 C--N 1.331 -0.218 0 CA-C-N 115.677 -0.692 . . . . 0.0 110.203 -178.493 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 143' ' ' THR . . . . . . . . . . . . . 82.3 p . . . . . 0 C--O 1.22 -0.483 0 CA-C-O 118.04 -0.981 . . . . 0.0 110.589 -179.199 . . . . . . . . 0 0 . 1 . 015 nuclear orig core ' B' B ' 2' ' ' SER . . . . . . . . . . . . . 7.0 p . . . . . 0 C--O 1.231 0.13 0 CA-C-O 120.994 0.425 . . . . 0.0 110.59 . . . . . . . . . 0 0 . 1 . 015 nuclear orig core ' B' B ' 3' ' ' GLU . . . . . . . . . . . . . 92.4 mt-10 -141.74 142.02 33.26 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 115.977 -0.556 . . . . 0.0 110.821 -179.299 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' B' B ' 4' ' ' LEU . . . . . . . . . . . . . 18.6 tp -127.41 130.95 50.26 Favored 'General case' 0 C--N 1.331 -0.23 0 CA-C-N 116.37 -0.377 . . . . 0.0 110.219 176.179 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' B' B ' 5' ' ' LYS . . . . . . . . . . . . . 68.5 mttm -110.64 120.46 42.49 Favored 'General case' 0 C--N 1.331 -0.215 0 CA-C-N 116.347 -0.388 . . . . 0.0 110.581 179.393 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' B' B ' 6' ' ' LEU . . . . . . . . . . . . . 65.5 mt -114.82 147.94 39.15 Favored 'General case' 0 C--N 1.331 -0.225 0 CA-C-N 115.303 -0.862 . . . . 0.0 110.687 -178.492 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' B' B ' 7' ' ' LYS . . . . . . . . . . . . . 74.7 tttt -133.55 135.06 24.42 Favored Pre-proline 0 CA--C 1.535 0.366 0 CA-C-O 118.848 -0.596 . . . . 0.0 109.933 176.174 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' B' B ' 8' ' ' PRO . . . . . . . . . . . . . 93.9 Cg_endo -90.79 142.26 3.25 Favored 'Trans proline' 0 N--CA 1.489 1.263 0 C-N-CA 121.666 1.577 . . . . 0.0 111.721 177.579 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' B' B ' 9' ' ' LEU . . . . . . . . . . . . . 47.0 mt -81.13 -47.22 1.13 Allowed Pre-proline 0 CA--C 1.533 0.323 0 CA-C-O 118.714 -0.66 . . . . 0.0 112.258 -178.544 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' B' B ' 10' ' ' PRO . . . . . . . . . . . . . 86.5 Cg_endo -80.69 150.46 18.85 Favored 'Trans proline' 0 N--CA 1.497 1.722 0 C-N-CA 121.179 1.253 . . . . 0.0 111.879 175.17 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' B' B ' 11' ' ' LYS . . . . . . . . . . . . . 33.9 ttmt -85.65 100.04 11.7 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-O 120.879 0.371 . . . . 0.0 110.57 178.463 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' B' B ' 12' ' ' VAL . . . . . . . . . . . . . 12.1 p -143.66 138.82 25.7 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.273 0 CA-C-N 116.125 -0.489 . . . . 0.0 110.493 179.22 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' B' B ' 13' ' ' GLU . . . . . . . . . . . . . 15.0 mm-40 -74.93 129.49 37.74 Favored 'General case' 0 C--N 1.329 -0.316 0 N-CA-C 109.955 -0.387 . . . . 0.0 109.955 177.098 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' B' B ' 14' ' ' LEU . . . . . . . . . . . . . 33.2 mt -97.86 146.32 31.26 Favored Pre-proline 0 CA--C 1.533 0.304 0 CA-C-O 119.142 -0.456 . . . . 0.0 110.265 -179.379 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' B' B ' 15' ' ' PRO . . . . . . . . . . . . . 26.2 Cg_exo -61.96 160.04 31.36 Favored 'Trans proline' 0 N--CA 1.498 1.768 0 C-N-CA 121.251 1.3 . . . . 0.0 112.001 177.818 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' B' B ' 16' ' ' PRO . . . . . . . . . . . . . 27.5 Cg_exo -60.37 -35.04 92.69 Favored 'Trans proline' 0 N--CA 1.496 1.634 0 C-N-CA 121.452 1.435 . . . . 0.0 112.659 -179.446 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' B' B ' 17' ' ' ASP . . . . . . . . . . . . . 10.3 p-10 -87.61 9.49 21.07 Favored 'General case' 0 CA--C 1.535 0.399 0 N-CA-C 113.168 0.803 . . . . 0.0 113.168 -178.073 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' B' B ' 18' ' ' PHE . . . . . . . . . . . . . 28.8 t80 -57.25 -41.38 79.51 Favored 'General case' 0 CA--C 1.527 0.073 0 O-C-N 121.939 -0.476 . . . . 0.0 110.296 -178.971 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' B' B ' 19' ' ' VAL . . . . . . . . . . . . . 50.0 t -56.94 -42.73 79.28 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 CA-C-N 116.399 -0.364 . . . . 0.0 110.396 -179.983 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' B' B ' 20' ' ' ASP . . . . . . . . . . . . . 4.9 t70 -60.28 -39.68 87.76 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-O 120.849 0.357 . . . . 0.0 110.747 -178.603 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' B' B ' 21' ' ' VAL . . . . . . . . . . . . . 46.2 t -64.28 -47.99 87.37 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.314 0 C-N-CA 120.755 -0.378 . . . . 0.0 110.24 -179.316 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' B' B ' 22' ' ' ILE . . . . . . . . . . . . . 51.7 mm -55.59 -58.04 5.93 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.237 0 C-N-CA 120.954 -0.298 . . . . 0.0 111.171 -178.38 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' B' B ' 23' ' ' ARG . . . . . . . . . . . . . 12.0 ptm180 -55.85 -42.97 76.59 Favored 'General case' 0 CA--C 1.531 0.223 0 C-N-CA 120.527 -0.469 . . . . 0.0 111.792 -173.797 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' B' B ' 24' ' ' ILE . . . . . . . . . . . . . 75.5 mt -60.81 -44.17 96.98 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.264 0 C-N-CA 120.815 -0.354 . . . . 0.0 111.421 -177.958 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' B' B ' 25' ' ' LYS . . . . . . . . . . . . . 68.6 mttm -67.71 -42.66 81.64 Favored 'General case' 0 C--N 1.329 -0.311 0 N-CA-C 112.558 0.577 . . . . 0.0 112.558 -178.306 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' B' B ' 26' ' ' LEU . . . . . . . . . . . . . 29.3 mt -79.45 -35.83 39.77 Favored 'General case' 0 C--N 1.33 -0.265 0 N-CA-C 113.522 0.934 . . . . 0.0 113.522 -170.782 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' B' B ' 27' ' ' GLN . . . . . . . . . . . . . 9.4 pt20 -47.13 138.62 6.69 Favored 'General case' 0 N--CA 1.47 0.556 0 N-CA-C 112.742 0.645 . . . . 0.0 112.742 -175.502 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' B' B ' 28' ' ' GLY . . . . . . . . . . . . . . . 98.4 -23.19 37.24 Favored Glycine 0 CA--C 1.534 1.279 0 CA-C-N 115.636 -0.711 . . . . 0.0 112.386 -177.298 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' B' B ' 29' ' ' LYS . . . . . . . . . . . . . 64.6 mttp -97.64 155.1 17.14 Favored 'General case' 0 C--O 1.233 0.229 0 CA-C-N 117.382 0.591 . . . . 0.0 111.084 179.297 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' B' B ' 30' ' ' THR . . . . . . . . . . . . . 27.4 m -102.95 135.87 43.82 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.119 -0.491 . . . . 0.0 109.87 175.565 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' B' B ' 31' ' ' VAL . . . . . . . . . . . . . 34.9 m -128.48 153.85 38.51 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.212 0 CA-C-O 120.928 0.394 . . . . 0.0 110.706 -178.161 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' B' B ' 32' ' ' ARG . . . . . . . . . . . . . 91.8 mtm-85 -132.68 147.71 52.33 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-O 121.283 0.563 . . . . 0.0 110.883 179.868 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' B' B ' 33' ' ' THR . . . . . . . . . . . . . 26.4 m -53.23 140.18 27.19 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.127 -0.488 . . . . 0.0 111.344 -177.971 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' B' B ' 34' ' ' GLY . . . . . . . . . . . . . . . 100.15 -17.09 57.55 Favored Glycine 0 CA--C 1.533 1.166 0 CA-C-O 119.608 -0.551 . . . . 0.0 113.22 179.574 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' B' B ' 35' ' ' ASP . . . . . . . . . . . . . 76.9 m-20 -65.19 148.92 50.82 Favored 'General case' 0 C--N 1.333 -0.109 0 CA-C-N 118.037 0.918 . . . . 0.0 111.08 178.924 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' B' B ' 36' ' ' VAL . . . . . . . . . . . . . 46.8 t -120.53 129.95 75.02 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.275 0 CA-C-N 115.83 -0.623 . . . . 0.0 109.625 177.337 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' B' B ' 37' ' ' ILE . . . . . . . . . . . . . 70.0 mt -118.8 138.93 47.91 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.274 0 CA-C-N 116.137 -0.483 . . . . 0.0 109.867 -178.242 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' B' B ' 38' ' ' GLY . . . . . . . . . . . . . . . -115.36 128.88 8.28 Favored Glycine 0 CA--C 1.525 0.707 0 N-CA-C 110.915 -0.874 . . . . 0.0 110.915 179.596 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' B' B ' 39' ' ' ILE . . . . . . . . . . . . . 76.2 mt -125.09 137.0 59.07 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.28 0 N-CA-C 110.195 -0.298 . . . . 0.0 110.195 -179.839 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' B' B ' 40' ' ' SER . . . . . . . . . . . . . 32.0 t -93.12 122.94 36.02 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.346 -0.388 . . . . 0.0 110.726 175.181 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' B' B ' 41' ' ' ILE . . . . . . . . . . . . . 71.4 mt -129.19 118.33 45.98 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.226 0 CA-C-O 120.929 0.395 . . . . 0.0 110.344 178.367 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' B' B ' 42' ' ' LEU . . . . . . . . . . . . . 1.3 tt 50.68 45.27 27.16 Favored 'General case' 0 N--CA 1.465 0.288 0 CA-C-O 121.421 0.629 . . . . 0.0 111.047 176.621 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' B' B ' 43' ' ' GLY . . . . . . . . . . . . . . . 70.43 24.7 76.56 Favored Glycine 0 CA--C 1.531 1.064 0 C-N-CA 121.093 -0.575 . . . . 0.0 112.585 175.433 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' B' B ' 44' ' ' LYS . . . . . . . . . . . . . 35.5 ttpt -136.57 133.43 36.38 Favored 'General case' 0 C--N 1.333 -0.145 0 CA-C-N 117.438 0.619 . . . . 0.0 110.213 179.672 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' B' B ' 45' ' ' GLU . . . . . . . . . . . . . 68.0 tt0 -84.08 127.8 34.14 Favored 'General case' 0 C--N 1.326 -0.419 0 CA-C-N 116.437 -0.347 . . . . 0.0 111.203 -177.096 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' B' B ' 46' ' ' VAL . . . . . . . . . . . . . 7.5 p -125.51 128.38 72.42 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.2 0 CA-C-O 121.138 0.494 . . . . 0.0 109.837 175.88 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' B' B ' 47' ' ' LYS . . . . . . . . . . . . . 34.0 mmtp -100.29 131.78 46.03 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 115.789 -0.641 . . . . 0.0 111.457 178.417 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' B' B ' 48' ' ' PHE . . . . . . . . . . . . . 96.3 m-85 -118.04 131.98 56.41 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 115.976 -0.556 . . . . 0.0 109.812 175.313 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' B' B ' 49' ' ' LYS . . . . . . . . . . . . . 83.4 tttt -106.95 138.68 42.66 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.757 -0.202 . . . . 0.0 110.468 178.984 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' B' B ' 50' ' ' VAL . . . . . . . . . . . . . 43.4 t -84.14 108.57 16.57 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.298 0 N-CA-C 109.423 -0.584 . . . . 0.0 109.423 176.768 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' B' B ' 51' ' ' VAL . . . . . . . . . . . . . 47.1 t -73.51 -51.79 23.9 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.277 0 CA-C-N 116.022 -0.536 . . . . 0.0 109.842 -174.603 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' B' B ' 52' ' ' GLN . . . . . . . . . . . . . 88.0 mt-30 -153.89 151.45 29.48 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-N 116.06 -0.518 . . . . 0.0 111.769 -177.912 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' B' B ' 53' ' ' ALA . . . . . . . . . . . . . . . -130.85 134.61 46.96 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 115.371 -0.832 . . . . 0.0 109.651 174.468 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' B' B ' 54' ' ' TYR . . . . . . . . . . . . . 35.8 t80 -129.09 114.2 18.65 Favored Pre-proline 0 CA--C 1.535 0.366 0 CA-C-O 118.062 -0.97 . . . . 0.0 110.407 178.669 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' B' B ' 55' ' ' PRO . . . . . . . . . . . . . 74.1 Cg_endo -77.2 166.19 82.81 Favored 'Cis proline' 0 N--CA 1.5 1.875 0 CA-C-N 122.181 1.815 . . . . 0.0 112.081 -7.468 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' B' B ' 56' ' ' SER . . . . . . . . . . . . . 13.7 m -115.79 127.38 26.83 Favored Pre-proline 0 CA--C 1.538 0.502 0 CA-C-O 118.436 -0.793 . . . . 0.0 109.048 175.297 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' B' B ' 57' ' ' PRO . . . . . . . . . . . . . 44.3 Cg_endo -68.09 146.95 79.3 Favored 'Cis proline' 0 N--CA 1.498 1.75 0 CA-C-N 121.981 1.743 . . . . 0.0 111.855 2.007 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' B' B ' 58' ' ' LEU . . . . . . . . . . . . . 22.7 tp -108.31 137.1 46.85 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.158 -0.473 . . . . 0.0 110.556 -179.381 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' B' B ' 59' ' ' ARG . . . . . . . . . . . . . 23.6 ttm180 -100.91 124.85 47.22 Favored 'General case' 0 C--N 1.326 -0.434 0 N-CA-C 109.341 -0.614 . . . . 0.0 109.341 176.281 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' B' B ' 60' ' ' VAL . . . . . . . . . . . . . 40.9 t -82.68 120.16 33.56 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.281 0 C-N-CA 120.739 -0.385 . . . . 0.0 110.684 -174.374 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' B' B ' 61' ' ' GLU . . . . . . . . . . . . . 71.0 mm-40 -131.17 155.98 46.1 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 115.926 -0.579 . . . . 0.0 109.845 175.138 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' B' B ' 62' ' ' ASP . . . . . . . . . . . . . 21.6 m-20 -52.25 -33.86 43.45 Favored 'General case' 0 C--N 1.328 -0.33 0 N-CA-C 111.842 0.312 . . . . 0.0 111.842 -179.998 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' B' B ' 63' ' ' ARG . . . . . . . . . . . . . 94.6 mtt180 -73.17 -21.89 60.6 Favored 'General case' 0 CA--C 1.532 0.273 0 N-CA-C 113.05 0.759 . . . . 0.0 113.05 -176.559 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' B' B ' 64' ' ' THR . . . . . . . . . . . . . 27.1 m -62.61 143.42 57.31 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-O 120.731 0.3 . . . . 0.0 110.514 -176.983 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' B' B ' 65' ' ' LYS . . . . . . . . . . . . . 54.6 mttm -85.18 124.17 31.53 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.283 -0.417 . . . . 0.0 110.097 179.38 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' B' B ' 66' ' ' ILE . . . . . . . . . . . . . 58.2 mt -115.22 124.06 71.44 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.307 0 N-CA-C 109.646 -0.502 . . . . 0.0 109.646 -179.42 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' B' B ' 67' ' ' THR . . . . . . . . . . . . . 14.4 m -127.64 144.58 51.06 Favored 'General case' 0 C--N 1.333 -0.151 0 CA-C-O 121.01 0.433 . . . . 0.0 111.118 -176.617 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' B' B ' 68' ' ' LEU . . . . . . . . . . . . . 6.5 mp . . . . . 0 C--N 1.33 -0.28 0 CA-C-N 116.132 -0.485 . . . . 0.0 110.901 178.538 . . . . . . . . 0 0 . 1 . 015 nuclear orig core ' B' B ' 73' ' ' VAL . . . . . . . . . . . . . 34.7 m . . . . . 0 C--O 1.232 0.17 0 CA-C-O 120.676 0.274 . . . . 0.0 110.83 . . . . . . . . . 0 0 . 1 . 015 nuclear orig core ' B' B ' 74' ' ' ASP . . . . . . . . . . . . . 19.3 t0 -104.62 123.61 47.87 Favored 'General case' 0 C--N 1.331 -0.225 0 CA-C-N 116.389 -0.368 . . . . 0.0 110.087 -179.699 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' B' B ' 75' ' ' VAL . . . . . . . . . . . . . 42.6 t -117.44 121.72 68.24 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.221 0 CA-C-O 120.993 0.425 . . . . 0.0 110.538 -178.381 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' B' B ' 76' ' ' LEU . . . . . . . . . . . . . 5.7 mp -120.99 142.09 50.11 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 115.846 -0.615 . . . . 0.0 109.904 176.012 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' B' B ' 77' ' ' GLU . . . . . . . . . . . . . 97.5 mt-10 -133.59 134.89 43.85 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-O 121.01 0.433 . . . . 0.0 110.962 -178.991 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' B' B ' 78' ' ' ALA . . . . . . . . . . . . . . . -122.82 140.88 52.45 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 115.896 -0.593 . . . . 0.0 109.977 177.26 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' B' B ' 79' ' ' LYS . . . . . . . . . . . . . 70.4 mmtt -75.0 115.86 15.09 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-O 120.972 0.415 . . . . 0.0 110.442 179.905 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' B' B ' 80' ' ' ILE . . . . . . . . . . . . . 35.2 mm -139.04 105.87 2.74 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.328 0 N-CA-C 109.022 -0.733 . . . . 0.0 109.022 -178.302 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' B' B ' 81' ' ' LYS . . . . . . . . . . . . . 54.6 pttt -115.44 132.29 56.67 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-O 121.1 0.476 . . . . 0.0 111.195 -177.313 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' B' B ' 82' ' ' GLY . . . . . . . . . . . . . . . 89.07 42.09 5.71 Favored Glycine 0 CA--C 1.526 0.731 0 N-CA-C 111.135 -0.786 . . . . 0.0 111.135 179.239 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' B' B ' 83' ' ' ILE . . . . . . . . . . . . . 72.6 mt -71.55 139.27 20.1 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.293 0 CA-C-O 120.827 0.346 . . . . 0.0 110.162 -179.813 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' B' B ' 84' ' ' LYS . . . . . . . . . . . . . 15.2 ttmm -96.55 -54.07 3.37 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-O 121.179 0.514 . . . . 0.0 109.939 178.2 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' B' B ' 85' ' ' ASP . . . . . . . . . . . . . 8.9 t70 -155.44 146.41 22.45 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 115.508 -0.769 . . . . 0.0 110.125 -179.425 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' B' B ' 86' ' ' VAL . . . . . . . . . . . . . 43.6 t -124.2 129.2 74.16 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.256 0 CA-C-O 120.93 0.395 . . . . 0.0 110.249 179.888 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' B' B ' 87' ' ' ILE . . . . . . . . . . . . . 44.2 mm -118.34 124.76 73.61 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.262 0 CA-C-N 115.887 -0.597 . . . . 0.0 109.496 177.297 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' B' B ' 88' ' ' LEU . . . . . . . . . . . . . 15.3 tp -114.26 124.36 51.84 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-O 121.088 0.471 . . . . 0.0 111.238 -176.898 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' B' B ' 89' ' ' ASP . . . . . . . . . . . . . 5.7 t70 -112.44 159.61 18.58 Favored 'General case' 0 C--N 1.33 -0.24 0 N-CA-C 108.99 -0.744 . . . . 0.0 108.99 175.419 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' B' B ' 90' ' ' GLU . . . . . . . . . . . . . 94.5 mt-10 -48.28 -42.61 31.3 Favored 'General case' 0 N--CA 1.465 0.291 0 N-CA-C 112.689 0.626 . . . . 0.0 112.689 -171.479 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' B' B ' 91' ' ' ASN . . . . . . . . . . . . . 33.8 p-10 -132.2 37.06 3.58 Favored 'General case' 0 N--CA 1.464 0.251 0 N-CA-C 111.753 0.279 . . . . 0.0 111.753 -178.691 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' B' B ' 92' ' ' LEU . . . . . . . . . . . . . 15.9 tp -160.6 140.1 10.82 Favored 'General case' 0 C--N 1.331 -0.237 0 C-N-CA 120.826 -0.35 . . . . 0.0 110.667 -177.877 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' B' B ' 93' ' ' ILE . . . . . 0.401 HD12 HG21 ' B' ' 93' ' ' ILE . 68.2 mt -122.7 123.12 67.61 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.198 0 N-CA-C 109.679 -0.489 . . . . 0.0 109.679 -178.663 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' B' B ' 94' ' ' VAL . . . . . . . . . . . . . 46.8 t -124.46 125.77 70.8 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.243 0 N-CA-C 109.718 -0.475 . . . . 0.0 109.718 177.629 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' B' B ' 95' ' ' VAL . . . . . . . . . . . . . 44.4 t -122.3 133.44 68.56 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.341 0 CA-C-N 116.022 -0.536 . . . . 0.0 109.789 -179.178 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' B' B ' 96' ' ' ILE . . . . . . . . . . . . . 51.7 mt -114.07 127.33 71.53 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.329 0 N-CA-C 108.782 -0.822 . . . . 0.0 108.782 178.301 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' B' B ' 97' ' ' THR . . . . . . . . . . . . . 82.7 p -99.0 153.76 18.61 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-O 121.292 0.568 . . . . 0.0 111.279 -176.85 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' B' B ' 98' ' ' GLU . . . . . . . . . . . . . 73.0 tt0 -53.97 -24.02 15.21 Favored 'General case' 0 C--N 1.325 -0.471 0 CA-C-N 115.811 -0.631 . . . . 0.0 112.166 179.322 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' B' B ' 99' ' ' GLU . . . . . . . . . . . . . 91.1 mt-10 -82.07 16.09 2.07 Favored 'General case' 0 CA--C 1.535 0.389 0 N-CA-C 113.082 0.771 . . . . 0.0 113.082 -176.981 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' B' B ' 100' ' ' ASN . . . . . . . . . . . . . 2.7 m-20 64.78 36.97 7.66 Favored 'General case' 0 CA--C 1.53 0.201 0 CA-C-O 121.001 0.429 . . . . 0.0 111.343 177.218 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' B' B ' 101' ' ' GLU . . . . . . . . . . . . . 82.7 tt0 -118.1 145.05 45.15 Favored 'General case' 0 C--N 1.331 -0.199 0 CA-C-N 116.147 -0.479 . . . . 0.0 110.031 175.294 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' B' B ' 102' ' ' VAL . . . . . . . . . . . . . 44.4 t -118.13 128.5 75.18 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.295 0 N-CA-C 110.137 -0.32 . . . . 0.0 110.137 -179.286 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' B' B ' 103' ' ' LEU . . . . . . . . . . . . . 6.1 mp -120.95 135.37 55.22 Favored 'General case' 0 C--N 1.331 -0.224 0 CA-C-N 115.94 -0.573 . . . . 0.0 110.489 177.642 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' B' B ' 104' ' ' ILE . . . . . . . . . . . . . 70.0 mt -121.82 124.74 72.11 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.276 0 CA-C-N 116.509 -0.314 . . . . 0.0 110.454 -179.848 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' B' B ' 105' ' ' PHE . . . . . . . . . . . . . 62.8 m-85 -123.23 166.0 15.98 Favored 'General case' 0 C--O 1.232 0.134 0 O-C-N 124.033 0.833 . . . . 0.0 109.873 -179.534 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' B' B ' 106' ' ' ASN . . . . . . . . . . . . . 43.7 p-10 -102.52 -170.66 1.84 Allowed 'General case' 0 CA--C 1.53 0.197 0 N-CA-C 110.164 -0.309 . . . . 0.0 110.164 173.894 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' B' B ' 107' ' ' GLN . . . . . . . . . . . . . 40.4 tt0 -59.05 -30.09 67.79 Favored 'General case' 0 C--N 1.33 -0.267 0 N-CA-C 112.085 0.402 . . . . 0.0 112.085 -179.265 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' B' B ' 108' ' ' ASN . . . . . . . . . . . . . 5.3 t30 -85.53 11.03 11.42 Favored 'General case' 0 CA--C 1.536 0.412 0 N-CA-C 113.052 0.76 . . . . 0.0 113.052 -176.915 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' B' B ' 109' ' ' LEU . . . . . . . . . . . . . 9.0 tp 60.59 34.81 20.15 Favored 'General case' 0 C--N 1.331 -0.215 0 CA-C-O 120.758 0.313 . . . . 0.0 111.558 178.905 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' B' B ' 110' ' ' GLU . . . . . . . . . . . . . 95.7 mt-10 -103.01 147.02 27.47 Favored 'General case' 0 C--N 1.33 -0.258 0 N-CA-C 109.68 -0.489 . . . . 0.0 109.68 176.205 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' B' B ' 111' ' ' GLU . . . . . . . . . . . . . 55.5 tt0 -85.49 121.88 28.83 Favored 'General case' 0 C--N 1.328 -0.362 0 C-N-CA 120.831 -0.348 . . . . 0.0 110.68 -177.273 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' B' B ' 112' ' ' LEU . . . . . . . . . . . . . 37.3 mt -104.39 -46.03 4.5 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.122 -0.49 . . . . 0.0 110.88 179.151 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' B' B ' 113' ' ' TYR . . . . . . . . . . . . . 66.3 t80 -136.5 144.9 44.55 Favored 'General case' 0 N--CA 1.464 0.23 0 CA-C-O 120.969 0.414 . . . . 0.0 111.132 -179.053 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' B' B ' 114' ' ' ARG . . . . . . . . . . . . . 14.3 ptt180 -146.55 124.39 11.94 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 115.621 -0.718 . . . . 0.0 110.365 178.765 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' B' B ' 115' ' ' GLY . . . . . . . . . . . . . . . -150.16 155.26 26.14 Favored Glycine 0 CA--C 1.523 0.539 0 N-CA-C 110.908 -0.877 . . . . 0.0 110.908 -179.948 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' B' B ' 116' ' ' LYS . . . . . . . . . . . . . 19.8 ttmt -126.66 140.46 52.4 Favored 'General case' 0 C--N 1.331 -0.228 0 N-CA-C 109.638 -0.504 . . . . 0.0 109.638 178.667 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' B' B ' 117' ' ' PHE . . . . . . . . . . . . . 32.2 m-85 -138.51 114.02 9.68 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-O 120.935 0.398 . . . . 0.0 110.258 -176.35 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' B' B ' 118' ' ' GLU . . . . . . . . . . . . . 75.1 tt0 -53.42 -49.73 66.7 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 116.528 -0.306 . . . . 0.0 111.432 -176.638 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' B' B ' 119' ' ' ASN . . . . . . . . . . . . . 33.7 m120 -91.45 30.47 1.3 Allowed 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.081 -0.508 . . . . 0.0 112.213 -174.324 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' B' B ' 120' ' ' LEU . . . . . . . . . . . . . 14.2 tp -56.73 122.14 11.42 Favored 'General case' 0 C--N 1.332 -0.154 0 CA-C-O 120.666 0.27 . . . . 0.0 110.459 178.579 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' B' B ' 121' ' ' ASN . . . . . . . . . . . . . 44.8 m-20 -114.01 -44.08 3.19 Favored 'General case' 0 C--N 1.332 -0.174 0 CA-C-N 116.485 -0.325 . . . . 0.0 110.956 -176.844 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' B' B ' 122' ' ' LYS . . . . . . . . . . . . . 99.1 mttt -143.76 148.64 35.91 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-O 121.027 0.441 . . . . 0.0 111.448 -177.765 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' B' B ' 123' ' ' VAL . . . . . . . . . . . . . 45.2 t -125.0 125.85 70.21 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.292 0 CA-C-N 115.885 -0.598 . . . . 0.0 109.572 175.605 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' B' B ' 124' ' ' LEU . . . . . . . . . . . . . 28.2 mt -112.08 125.44 54.1 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 116.239 -0.437 . . . . 0.0 110.333 -179.448 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' B' B ' 125' ' ' VAL . . . . . . . . . . . . . 44.2 t -133.54 126.4 51.71 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.276 0 CA-C-N 116.495 -0.32 . . . . 0.0 110.365 -179.124 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' B' B ' 126' ' ' ARG . . . . . . . . . . . . . 69.2 ttt-85 -162.61 141.67 9.0 Favored 'General case' 0 C--N 1.329 -0.32 0 N-CA-C 109.611 -0.515 . . . . 0.0 109.611 175.094 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' B' B ' 127' ' ' ASN . . . . . . . . . . . . . 10.1 p30 48.88 -151.99 0.13 Allowed 'General case' 0 CA--C 1.54 0.563 0 CA-C-O 119.373 -0.346 . . . . 0.0 111.001 178.988 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' B' B ' 128' ' ' ASP . . . . . . . . . . . . . 13.7 p-10 -83.55 21.54 1.19 Allowed 'General case' 0 CA--C 1.533 0.307 0 CA-C-N 118.512 0.596 . . . . 0.0 112.517 179.271 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' B' B ' 129' ' ' LEU . . . . . . . . . . . . . 17.1 tp -119.66 135.23 54.9 Favored 'General case' 0 C--O 1.233 0.235 0 CA-C-O 120.969 0.414 . . . . 0.0 110.327 179.541 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' B' B ' 130' ' ' VAL . . . . . . . . . . . . . 44.6 t -128.58 135.65 61.88 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.233 0 CA-C-N 115.961 -0.563 . . . . 0.0 109.802 179.322 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' B' B ' 131' ' ' VAL . . . . . . . . . . . . . 43.1 t -133.82 135.59 55.05 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.285 0 CA-C-O 120.924 0.392 . . . . 0.0 110.16 179.705 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' B' B ' 132' ' ' ILE . . . . . . . . . . . . . 72.8 mt -116.22 129.76 72.1 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.327 0 N-CA-C 109.341 -0.614 . . . . 0.0 109.341 -179.958 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' B' B ' 133' ' ' ILE . . . . . . . . . . . . . 41.9 mm -116.72 120.51 65.22 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.21 0 CA-C-O 120.807 0.337 . . . . 0.0 110.859 -175.779 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' B' B ' 134' ' ' ASP . . . . . . . . . . . . . 7.7 p-10 -134.22 145.59 49.31 Favored 'General case' 0 C--N 1.33 -0.265 0 N-CA-C 109.601 -0.518 . . . . 0.0 109.601 175.11 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' B' B ' 135' ' ' GLU . . . . . . . . . . . . . 73.9 tt0 -49.96 -25.45 3.3 Favored 'General case' 0 C--N 1.329 -0.309 0 N-CA-C 112.975 0.731 . . . . 0.0 112.975 -170.578 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' B' B ' 136' ' ' GLN . . . . . . . . . . . . . 97.1 mt-30 -96.81 -31.83 12.42 Favored 'General case' 0 C--O 1.234 0.276 0 N-CA-C 112.256 0.465 . . . . 0.0 112.256 -176.291 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' B' B ' 137' ' ' LYS . . . . . . . . . . . . . 92.5 mttt -139.53 152.87 47.27 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-O 121.172 0.511 . . . . 0.0 111.48 -170.408 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' B' B ' 138' ' ' LEU . . . . . . . . . . . . . 6.2 tt -119.34 119.55 34.33 Favored 'General case' 0 C--N 1.327 -0.4 0 N-CA-C 108.977 -0.749 . . . . 0.0 108.977 172.682 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' B' B ' 139' ' ' THR . . . . . . . . . . . . . 28.3 m -111.16 130.32 55.67 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-O 120.655 0.264 . . . . 0.0 110.803 -175.899 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' B' B ' 140' ' ' LEU . . . . . . . . . . . . . 10.6 tp -115.28 120.62 40.28 Favored 'General case' 0 C--N 1.328 -0.353 0 N-CA-C 109.299 -0.63 . . . . 0.0 109.299 -179.526 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' B' B ' 141' ' ' ILE . . . . . . . . . . . . . 19.5 mt -119.88 124.92 73.69 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.242 0 CA-C-O 121.077 0.465 . . . . 0.0 110.158 -175.044 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' B' B ' 142' ' ' ARG . . . . . . . . . . . . . 82.1 mtp180 -108.35 121.66 45.38 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 115.404 -0.816 . . . . 0.0 110.004 179.472 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' B' B ' 143' ' ' THR . . . . . . . . . . . . . 81.2 p . . . . . 0 C--O 1.219 -0.516 0 CA-C-O 117.932 -1.032 . . . . 0.0 110.747 -178.885 . . . . . . . . 0 0 . 1 . 015 nuclear orig core ' C' C ' 2' ' ' SER . . . . . . . . . . . . . 8.0 p . . . . . 0 C--O 1.232 0.179 0 CA-C-O 121.094 0.473 . . . . 0.0 111.146 . . . . . . . . . 0 0 . 1 . 015 nuclear orig core ' C' C ' 3' ' ' GLU . . . . . . . . . . . . . 47.7 mp0 -137.72 140.44 40.71 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 115.81 -0.632 . . . . 0.0 110.578 179.789 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' C' C ' 4' ' ' LEU . . . . . . . . . . . . . 13.4 tp -123.19 128.66 50.34 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 115.813 -0.63 . . . . 0.0 109.923 178.259 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' C' C ' 5' ' ' LYS . . . . . . . . . . . . . 61.3 mttp -108.89 119.61 40.07 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.538 -0.301 . . . . 0.0 110.922 -179.801 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' C' C ' 6' ' ' LEU . . . . . . . . . . . . . 38.8 mt -114.04 147.68 38.28 Favored 'General case' 0 C--N 1.331 -0.227 0 CA-C-N 115.279 -0.873 . . . . 0.0 110.232 179.286 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' C' C ' 7' ' ' LYS . . . . . . . . . . . . . 75.1 tttt -136.87 137.15 22.48 Favored Pre-proline 0 CA--C 1.534 0.33 0 CA-C-O 118.999 -0.524 . . . . 0.0 110.113 176.763 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' C' C ' 8' ' ' PRO . . . . . . . . . . . . . 98.5 Cg_endo -90.86 139.67 2.7 Favored 'Trans proline' 0 N--CA 1.491 1.328 0 C-N-CA 121.646 1.564 . . . . 0.0 111.813 177.839 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' C' C ' 9' ' ' LEU . . . . . . . . . . . . . 37.9 mt -76.3 -48.09 3.31 Favored Pre-proline 0 CA--C 1.533 0.307 0 CA-C-O 118.649 -0.691 . . . . 0.0 112.288 -179.242 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' C' C ' 10' ' ' PRO . . . . . . . . . . . . . 81.4 Cg_endo -78.26 147.36 23.11 Favored 'Trans proline' 0 N--CA 1.496 1.666 0 C-N-CA 121.003 1.135 . . . . 0.0 111.648 176.714 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' C' C ' 11' ' ' LYS . . . . . . . . . . . . . 7.3 ttpm? -86.56 87.69 7.5 Favored 'General case' 0 C--N 1.33 -0.273 0 C-N-CA 120.846 -0.342 . . . . 0.0 110.428 -179.652 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' C' C ' 12' ' ' VAL . . . . . . . . . . . . . 11.6 p -136.32 143.45 35.68 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.271 0 CA-C-N 116.03 -0.532 . . . . 0.0 110.324 179.776 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' C' C ' 13' ' ' GLU . . . . . . . . . . . . . 94.8 mt-10 -79.03 131.03 36.14 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.349 -0.387 . . . . 0.0 110.581 -179.664 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' C' C ' 14' ' ' LEU . . . . . . . . . . . . . 21.2 mt -99.42 152.52 37.83 Favored Pre-proline 0 CA--C 1.532 0.276 0 CA-C-N 116.275 -0.421 . . . . 0.0 110.787 179.236 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' C' C ' 15' ' ' PRO . . . . . . . . . . . . . 26.6 Cg_exo -61.91 157.28 44.26 Favored 'Trans proline' 0 N--CA 1.498 1.738 0 C-N-CA 121.312 1.341 . . . . 0.0 111.793 175.961 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' C' C ' 16' ' ' PRO . . . . . . . . . . . . . 33.1 Cg_exo -57.47 -41.62 70.01 Favored 'Trans proline' 0 N--CA 1.497 1.694 0 C-N-CA 121.418 1.412 . . . . 0.0 112.901 -178.478 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' C' C ' 17' ' ' ASP . . . . . . . . . . . . . 19.8 p-10 -86.35 11.93 11.21 Favored 'General case' 0 CA--C 1.536 0.433 0 N-CA-C 113.105 0.78 . . . . 0.0 113.105 -177.64 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' C' C ' 18' ' ' PHE . . . . . . . . . . . . . 51.7 t80 -57.59 -43.33 84.53 Favored 'General case' 0 C--N 1.334 -0.08 0 O-C-N 121.986 -0.446 . . . . 0.0 110.171 -178.431 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' C' C ' 19' ' ' VAL . . . . . . . . . . . . . 14.9 p -56.59 -41.94 74.89 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.243 0 CA-C-N 116.29 -0.414 . . . . 0.0 110.919 -178.732 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' C' C ' 20' ' ' ASP . . . . . . . . . . . . . 34.7 m-20 -60.44 -41.59 94.36 Favored 'General case' 0 C--N 1.331 -0.222 0 CA-C-O 120.831 0.348 . . . . 0.0 110.9 -178.758 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' C' C ' 21' ' ' VAL . . . . . . . . . . . . . 48.6 t -63.69 -46.96 93.23 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.287 0 CA-C-N 116.343 -0.389 . . . . 0.0 110.261 -178.828 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' C' C ' 22' ' ' ILE . . . . . . . . . . . . . 50.3 mm -56.68 -45.31 82.64 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.243 0 CA-C-O 120.822 0.344 . . . . 0.0 110.577 178.851 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' C' C ' 23' ' ' ARG . . . . . . . . . . . . . 49.1 ttp180 -54.22 -49.0 70.45 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.649 -0.25 . . . . 0.0 111.374 -178.018 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' C' C ' 24' ' ' ILE . . . . . . . . . . . . . 73.2 mt -59.49 -43.8 91.48 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.321 0 CA-C-O 120.864 0.364 . . . . 0.0 110.842 -178.751 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' C' C ' 25' ' ' LYS . . . . . . . . . . . . . 60.6 mtpt -62.61 -40.52 97.19 Favored 'General case' 0 C--N 1.327 -0.409 0 N-CA-C 112.113 0.412 . . . . 0.0 112.113 -178.298 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' C' C ' 26' ' ' LEU . . . . . . . . . . . . . 89.8 mt -79.86 -43.43 22.32 Favored 'General case' 0 C--N 1.33 -0.246 0 N-CA-C 113.352 0.871 . . . . 0.0 113.352 -171.759 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' C' C ' 27' ' ' GLN . . . . . . . . . . . . . 10.3 pt20 -46.78 138.62 6.05 Favored 'General case' 0 N--CA 1.468 0.468 0 N-CA-C 112.822 0.675 . . . . 0.0 112.822 -173.813 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' C' C ' 28' ' ' GLY . . . . . . . . . . . . . . . 100.22 -25.87 26.66 Favored Glycine 0 CA--C 1.533 1.174 0 CA-C-N 115.402 -0.817 . . . . 0.0 112.359 -177.338 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' C' C ' 29' ' ' LYS . . . . . . . . . . . . . 63.0 mttp -98.71 155.09 17.51 Favored 'General case' 0 C--N 1.332 -0.194 0 CA-C-N 117.396 0.598 . . . . 0.0 111.367 179.779 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' C' C ' 30' ' ' THR . . . . . . . . . . . . . 28.6 m -96.87 136.4 37.48 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 115.985 -0.552 . . . . 0.0 110.012 175.445 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' C' C ' 31' ' ' VAL . . . . . . . . . . . . . 34.9 m -128.94 148.76 33.26 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.316 0 CA-C-N 116.282 -0.417 . . . . 0.0 110.654 -179.368 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' C' C ' 32' ' ' ARG . . . . . . . . . . . . . 53.9 ttp180 -131.34 147.78 52.61 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-O 121.191 0.52 . . . . 0.0 110.332 178.661 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' C' C ' 33' ' ' THR . . . . . . . . . . . . . 17.5 m -52.99 138.82 29.47 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.383 -0.371 . . . . 0.0 111.46 -177.4 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' C' C ' 34' ' ' GLY . . . . . . . . . . . . . . . 101.51 -17.2 55.68 Favored Glycine 0 CA--C 1.533 1.214 0 CA-C-O 119.66 -0.522 . . . . 0.0 113.135 -179.782 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' C' C ' 35' ' ' ASP . . . . . . . . . . . . . 67.2 m-20 -65.14 149.84 49.2 Favored 'General case' 0 C--O 1.231 0.127 0 CA-C-N 118.046 0.923 . . . . 0.0 111.249 179.127 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' C' C ' 36' ' ' VAL . . . . . . . . . . . . . 46.0 t -123.3 131.46 73.13 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.239 0 CA-C-N 115.788 -0.642 . . . . 0.0 109.835 177.784 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' C' C ' 37' ' ' ILE . . . . . . . . . . . . . 69.7 mt -120.57 139.36 48.08 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.234 0 CA-C-N 116.254 -0.43 . . . . 0.0 109.984 -179.115 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' C' C ' 38' ' ' GLY . . . . . . . . . . . . . . . -113.83 128.84 8.48 Favored Glycine 0 CA--C 1.526 0.721 0 N-CA-C 111.095 -0.802 . . . . 0.0 111.095 -179.972 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' C' C ' 39' ' ' ILE . . . . . . . . . . . . . 72.8 mt -123.18 133.44 69.09 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.265 0 N-CA-C 110.026 -0.361 . . . . 0.0 110.026 179.116 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' C' C ' 40' ' ' SER . . . . . . . . . . . . . 85.8 p -92.11 122.64 34.8 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.454 -0.339 . . . . 0.0 110.684 176.222 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' C' C ' 41' ' ' ILE . . . . . . . . . . . . . 73.3 mt -135.39 118.13 22.65 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.176 0 CA-C-O 120.95 0.405 . . . . 0.0 110.467 178.738 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' C' C ' 42' ' ' LEU . . . . . . . . . . . . . 1.4 tt 55.17 45.48 25.87 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-O 121.496 0.665 . . . . 0.0 110.424 177.79 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' C' C ' 43' ' ' GLY . . . . . . . . . . . . . . . 74.99 -10.01 10.4 Favored Glycine 0 CA--C 1.535 1.31 0 C-N-CA 121.239 -0.505 . . . . 0.0 113.761 174.679 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' C' C ' 44' ' ' LYS . . . . . . . . . . . . . 93.1 mttt -104.79 137.61 42.32 Favored 'General case' 0 C--N 1.334 -0.103 0 CA-C-N 118.116 0.958 . . . . 0.0 110.6 -179.464 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' C' C ' 45' ' ' GLU . . . . . . . . . . . . . 79.5 tt0 -85.58 130.0 34.68 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.247 -0.433 . . . . 0.0 111.002 179.453 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' C' C ' 46' ' ' VAL . . . . . . . . . . . . . 7.4 p -123.24 127.96 74.69 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.247 0 N-CA-C 109.587 -0.523 . . . . 0.0 109.587 175.369 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' C' C ' 47' ' ' LYS . . . . . . . . . . . . . 57.3 mtmt -101.47 129.71 47.58 Favored 'General case' 0 C--N 1.331 -0.201 0 CA-C-N 115.888 -0.596 . . . . 0.0 111.626 179.824 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' C' C ' 48' ' ' PHE . . . . . . . . . . . . . 93.1 m-85 -113.85 132.07 56.03 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.079 -0.509 . . . . 0.0 110.154 176.861 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' C' C ' 49' ' ' LYS . . . . . . . . . . . . . 77.8 tttt -106.18 139.56 40.5 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.558 -0.292 . . . . 0.0 110.635 178.978 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' C' C ' 50' ' ' VAL . . . . . . . . . . . . . 44.9 t -83.64 105.61 13.38 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.252 0 N-CA-C 109.194 -0.669 . . . . 0.0 109.194 174.64 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' C' C ' 51' ' ' VAL . . . . . . . . . . . . . 48.7 t -69.65 -54.89 17.13 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.39 0 CA-C-N 115.791 -0.64 . . . . 0.0 109.513 -175.041 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' C' C ' 52' ' ' GLN . . . . . . . . . . . . . 88.5 mt-30 -155.26 154.36 32.04 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 115.882 -0.599 . . . . 0.0 111.906 -177.561 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' C' C ' 53' ' ' ALA . . . . . . . . . . . . . . . -131.6 132.49 44.11 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 115.334 -0.848 . . . . 0.0 109.782 174.1 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' C' C ' 54' ' ' TYR . . . . . . . . . . . . . 19.8 t80 -129.11 110.45 18.21 Favored Pre-proline 0 CA--C 1.533 0.32 0 CA-C-O 118.142 -0.932 . . . . 0.0 110.092 177.224 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' C' C ' 55' ' ' PRO . . . . . . . . . . . . . 72.7 Cg_endo -77.1 170.1 72.51 Favored 'Cis proline' 0 N--CA 1.5 1.869 0 CA-C-N 121.983 1.744 . . . . 0.0 112.326 -4.973 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' C' C ' 56' ' ' SER . . . . . . . . . . . . . 67.2 m -128.19 138.9 33.98 Favored Pre-proline 0 CA--C 1.536 0.429 0 CA-C-O 118.585 -0.721 . . . . 0.0 109.32 174.039 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' C' C ' 57' ' ' PRO . . . . . . . . . . . . . 40.4 Cg_endo -68.53 143.12 70.03 Favored 'Cis proline' 0 N--CA 1.498 1.789 0 CA-C-N 121.662 1.629 . . . . 0.0 111.678 -1.093 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' C' C ' 58' ' ' LEU . . . . . . . . . . . . . 27.8 tp -107.58 138.03 44.54 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.055 -0.52 . . . . 0.0 110.764 -176.085 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' C' C ' 59' ' ' ARG . . . . . . . . . . . . . 43.1 ttp180 -101.44 119.31 38.57 Favored 'General case' 0 C--N 1.328 -0.354 0 N-CA-C 108.894 -0.78 . . . . 0.0 108.894 173.698 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' C' C ' 60' ' ' VAL . . . . . . . . . . . . . 45.0 t -72.25 120.04 19.97 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.258 0 C-N-CA 120.644 -0.423 . . . . 0.0 110.3 -173.677 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' C' C ' 61' ' ' GLU . . . . . . . . . . . . . 42.8 mt-10 -131.04 162.61 29.42 Favored 'General case' 0 C--N 1.331 -0.23 0 CA-C-N 116.03 -0.532 . . . . 0.0 110.284 178.411 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' C' C ' 62' ' ' ASP . . . . . . . . . . . . . 7.7 p-10 -56.19 -32.54 64.46 Favored 'General case' 0 C--N 1.329 -0.304 0 N-CA-C 111.922 0.342 . . . . 0.0 111.922 -178.412 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' C' C ' 63' ' ' ARG . . . . . . . . . . . . . 40.4 ptt180 -81.4 3.83 23.05 Favored 'General case' 0 CA--C 1.537 0.452 0 N-CA-C 113.746 1.017 . . . . 0.0 113.746 -175.582 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' C' C ' 64' ' ' THR . . . . . . . . . . . . . 26.4 m -87.99 138.75 31.17 Favored 'General case' 0 C--N 1.332 -0.166 0 CA-C-N 118.103 0.41 . . . . 0.0 110.48 -179.061 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' C' C ' 65' ' ' LYS . . . . . . . . . . . . . 95.4 mttt -87.93 128.31 35.37 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.373 -0.376 . . . . 0.0 110.127 -179.755 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' C' C ' 66' ' ' ILE . . . . . . . . . . . . . 59.1 mt -115.64 131.62 67.48 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.215 0 N-CA-C 109.936 -0.394 . . . . 0.0 109.936 -179.329 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' C' C ' 67' ' ' THR . . . . . . . . . . . . . 26.3 m -124.69 138.21 54.31 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-N 116.151 -0.477 . . . . 0.0 110.723 -179.689 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' C' C ' 68' ' ' LEU . . . . . . . . . . . . . 48.2 mt . . . . . 0 C--N 1.33 -0.248 0 CA-C-N 115.902 -0.59 . . . . 0.0 110.297 177.367 . . . . . . . . 0 0 . 1 . 015 nuclear orig core ' C' C ' 73' ' ' VAL . . . . . . . . . . . . . 30.4 m . . . . . 0 C--O 1.231 0.125 0 N-CA-C 110.138 -0.319 . . . . 0.0 110.138 . . . . . . . . . 0 0 . 1 . 015 nuclear orig core ' C' C ' 74' ' ' ASP . . . . . . . . . . . . . 13.6 t0 -96.38 119.04 34.15 Favored 'General case' 0 C--N 1.33 -0.253 0 N-CA-C 109.919 -0.401 . . . . 0.0 109.919 -177.498 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' C' C ' 75' ' ' VAL . . . . . . . . . . . . . 43.2 t -119.44 122.95 70.25 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.208 0 CA-C-O 121.125 0.488 . . . . 0.0 110.811 -176.954 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' C' C ' 76' ' ' LEU . . . . . . . . . . . . . 5.8 mp -121.05 141.48 50.72 Favored 'General case' 0 C--N 1.331 -0.205 0 CA-C-N 115.647 -0.706 . . . . 0.0 109.12 174.112 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' C' C ' 77' ' ' GLU . . . . . . . . . . . . . 31.3 tt0 -132.08 132.13 43.02 Favored 'General case' 0 C--N 1.331 -0.209 0 CA-C-O 120.841 0.353 . . . . 0.0 110.902 -176.161 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' C' C ' 78' ' ' ALA . . . . . . . . . . . . . . . -119.1 142.44 47.9 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 116.002 -0.545 . . . . 0.0 109.869 177.454 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' C' C ' 79' ' ' LYS . . . . . . . . . . . . . 81.3 tttt -84.45 119.73 25.47 Favored 'General case' 0 C--N 1.328 -0.332 0 C-N-CA 120.934 -0.307 . . . . 0.0 110.58 -178.69 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' C' C ' 80' ' ' ILE . . . . . . . . . . . . . 44.8 mm -138.26 117.94 14.96 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.27 0 N-CA-C 109.533 -0.543 . . . . 0.0 109.533 -177.486 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' C' C ' 81' ' ' LYS . . . . . . . . . . . . . 59.4 mtmt -112.83 125.69 54.62 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.407 -0.361 . . . . 0.0 111.37 -176.298 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' C' C ' 82' ' ' GLY . . . . . . . . . . . . . . . 89.13 42.11 5.68 Favored Glycine 0 CA--C 1.524 0.595 0 C-N-CA 120.865 -0.683 . . . . 0.0 111.458 175.485 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' C' C ' 83' ' ' ILE . . . . . . . . . . . . . 70.1 mt -67.59 132.77 32.34 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.291 0 N-CA-C 109.835 -0.431 . . . . 0.0 109.835 178.909 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' C' C ' 84' ' ' LYS . . . . . . . . . . . . . 59.4 tttp -93.5 -49.25 6.0 Favored 'General case' 0 C--N 1.327 -0.407 0 CA-C-N 116.011 -0.54 . . . . 0.0 109.837 179.967 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' C' C ' 85' ' ' ASP . . . . . . . . . . . . . 5.1 t0 -159.84 153.14 22.15 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 115.71 -0.677 . . . . 0.0 110.28 179.031 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' C' C ' 86' ' ' VAL . . . . . . . . . . . . . 42.6 t -125.92 131.75 71.46 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.274 0 CA-C-O 120.868 0.366 . . . . 0.0 110.199 -179.939 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' C' C ' 87' ' ' ILE . . . . . . . . . . . . . 44.2 mm -120.13 129.27 75.68 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.264 0 CA-C-N 116.027 -0.533 . . . . 0.0 109.632 178.981 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' C' C ' 88' ' ' LEU . . . . . . . . . . . . . 12.4 tp -112.31 130.77 55.84 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-O 120.985 0.421 . . . . 0.0 111.296 -175.857 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' C' C ' 89' ' ' ASP . . . . . . . . . . . . . 13.1 t70 -125.27 152.01 45.2 Favored 'General case' 0 C--N 1.33 -0.249 0 N-CA-C 109.272 -0.64 . . . . 0.0 109.272 175.016 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' C' C ' 90' ' ' GLU . . . . . . . . . . . . . 95.4 mt-10 -48.92 -37.8 20.93 Favored 'General case' 0 C--N 1.329 -0.324 0 N-CA-C 112.754 0.649 . . . . 0.0 112.754 -171.804 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' C' C ' 91' ' ' ASN . . . . . . . . . . . . . 14.7 m-80 -125.49 16.7 8.23 Favored 'General case' 0 N--CA 1.468 0.474 0 N-CA-C 113.21 0.819 . . . . 0.0 113.21 -177.352 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' C' C ' 92' ' ' LEU . . . . . . . . . . . . . 12.5 mt -148.86 143.26 26.15 Favored 'General case' 0 C--N 1.333 -0.114 0 N-CA-C 110.112 -0.329 . . . . 0.0 110.112 -176.605 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' C' C ' 93' ' ' ILE . . . . . . . . . . . . . 73.7 mt -121.23 119.27 58.7 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.353 0 N-CA-C 109.157 -0.683 . . . . 0.0 109.157 177.55 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' C' C ' 94' ' ' VAL . . . . . . . . . . . . . 45.3 t -118.73 127.16 75.68 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.201 0 CA-C-O 121.023 0.439 . . . . 0.0 110.061 -178.314 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' C' C ' 95' ' ' VAL . . . . . . . . . . . . . 44.9 t -118.97 132.91 67.5 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.357 0 CA-C-N 115.784 -0.644 . . . . 0.0 109.519 178.681 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' C' C ' 96' ' ' ILE . . . . . . . . . . . . . 68.3 mt -112.67 126.06 70.01 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.346 0 N-CA-C 109.214 -0.662 . . . . 0.0 109.214 178.775 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' C' C ' 97' ' ' THR . . . . . . . . . . . . . 60.6 p -99.76 158.27 15.91 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-O 121.313 0.578 . . . . 0.0 111.386 -176.904 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' C' C ' 98' ' ' GLU . . . . . . . . . . . . . 83.8 tt0 -53.88 -26.71 26.17 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.049 -0.523 . . . . 0.0 112.23 179.73 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' C' C ' 99' ' ' GLU . . . . . . . . . . . . . 71.0 mm-40 -78.87 15.35 1.1 Allowed 'General case' 0 CA--C 1.534 0.353 0 N-CA-C 113.185 0.809 . . . . 0.0 113.185 -177.691 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' C' C ' 100' ' ' ASN . . . . . . . . . . . . . 4.1 m-20 60.88 38.16 17.97 Favored 'General case' 0 C--O 1.232 0.146 0 CA-C-O 121.101 0.477 . . . . 0.0 110.823 179.833 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' C' C ' 101' ' ' GLU . . . . . . . . . . . . . 83.7 tt0 -114.83 144.36 43.65 Favored 'General case' 0 C--N 1.332 -0.16 0 CA-C-N 116.001 -0.545 . . . . 0.0 109.64 177.016 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' C' C ' 102' ' ' VAL . . . . . . . . . . . . . 44.4 t -114.93 124.84 71.98 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.306 0 N-CA-C 109.919 -0.401 . . . . 0.0 109.919 -178.156 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' C' C ' 103' ' ' LEU . . . . . . . . . . . . . 28.7 mt -113.64 131.28 56.2 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 115.717 -0.674 . . . . 0.0 110.198 176.6 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' C' C ' 104' ' ' ILE . . . . . . . . . . . . . 73.5 mt -120.36 119.06 58.76 Favored 'Isoleucine or valine' 0 C--O 1.235 0.325 0 N-CA-C 110.295 -0.261 . . . . 0.0 110.295 -179.79 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' C' C ' 105' ' ' PHE . . . . . . . . . . . . . 79.7 m-85 -120.19 167.37 12.32 Favored 'General case' 0 C--N 1.331 -0.217 0 O-C-N 124.205 0.941 . . . . 0.0 109.766 178.956 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' C' C ' 106' ' ' ASN . . . . . . . . . . . . . 39.7 p-10 -103.77 -169.91 1.7 Allowed 'General case' 0 CA--C 1.53 0.181 0 N-CA-C 109.703 -0.48 . . . . 0.0 109.703 171.394 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' C' C ' 107' ' ' GLN . . . . . . . . . . . . . 50.0 tt0 -58.69 -30.12 67.15 Favored 'General case' 0 C--N 1.329 -0.302 0 N-CA-C 111.862 0.319 . . . . 0.0 111.862 179.361 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' C' C ' 108' ' ' ASN . . . . . . . . . . . . . 45.7 t30 -89.21 12.88 14.66 Favored 'General case' 0 CA--C 1.535 0.393 0 N-CA-C 113.048 0.759 . . . . 0.0 113.048 -176.855 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' C' C ' 109' ' ' LEU . . . . . . . . . . . . . 63.3 mt 58.28 35.72 25.12 Favored 'General case' 0 C--N 1.332 -0.182 0 CA-C-O 120.755 0.312 . . . . 0.0 111.767 175.934 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' C' C ' 110' ' ' GLU . . . . . . . . . . . . . 70.3 mm-40 -103.91 135.28 45.74 Favored 'General case' 0 C--N 1.33 -0.264 0 N-CA-C 110.014 -0.365 . . . . 0.0 110.014 175.238 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' C' C ' 111' ' ' GLU . . . . . . . . . . . . . 98.1 mt-10 -67.14 123.62 20.78 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-O 121.044 0.45 . . . . 0.0 111.071 -178.39 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' C' C ' 112' ' ' LEU . . . . . . . . . . . . . 13.9 mt -105.99 -43.88 4.74 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-N 115.793 -0.64 . . . . 0.0 109.946 175.78 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' C' C ' 113' ' ' TYR . . . . . . . . . . . . . 65.0 t80 -143.86 140.76 29.96 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.236 -0.438 . . . . 0.0 111.637 -179.315 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' C' C ' 114' ' ' ARG . . . . . . . . . . . . . 37.2 ttm180 -136.31 128.1 29.16 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 115.797 -0.638 . . . . 0.0 109.96 174.026 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' C' C ' 115' ' ' GLY . . . . . . . . . . . . . . . -150.04 159.41 28.09 Favored Glycine 0 CA--C 1.526 0.774 0 N-CA-C 111.169 -0.772 . . . . 0.0 111.169 177.441 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' C' C ' 116' ' ' LYS . . . . . . . . . . . . . 33.7 ttpt -130.81 136.6 48.85 Favored 'General case' 0 C--N 1.33 -0.244 0 N-CA-C 109.974 -0.38 . . . . 0.0 109.974 177.555 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' C' C ' 117' ' ' PHE . . . . . . . . . . . . . 40.8 m-85 -135.14 117.14 15.3 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-O 120.703 0.287 . . . . 0.0 110.39 -176.672 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' C' C ' 118' ' ' GLU . . . . . . . . . . . . . 70.6 mm-40 -54.65 -46.32 73.96 Favored 'General case' 0 C--N 1.329 -0.29 0 C-N-CA 120.996 -0.282 . . . . 0.0 111.38 -177.014 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' C' C ' 119' ' ' ASN . . . . . . . . . . . . . 6.0 m120 -95.99 30.99 2.24 Favored 'General case' 0 C--N 1.329 -0.322 0 N-CA-C 112.046 0.387 . . . . 0.0 112.046 -175.457 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' C' C ' 120' ' ' LEU . . . . . . . . . . . . . 14.0 tp -57.82 120.93 9.3 Favored 'General case' 0 C--O 1.232 0.154 0 CA-C-O 120.679 0.276 . . . . 0.0 110.39 179.008 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' C' C ' 121' ' ' ASN . . . . . . . . . . . . . 93.9 m-20 -114.16 -43.96 3.18 Favored 'General case' 0 C--N 1.331 -0.217 0 CA-C-N 116.38 -0.373 . . . . 0.0 111.311 -178.304 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' C' C ' 122' ' ' LYS . . . . . . . . . . . . . 97.2 mttt -144.28 151.11 38.93 Favored 'General case' 0 C--N 1.331 -0.215 0 C-N-CA 120.647 -0.421 . . . . 0.0 111.848 -175.993 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' C' C ' 123' ' ' VAL . . . . . . . . . . . . . 46.1 t -132.08 128.59 59.4 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.311 0 N-CA-C 109.259 -0.645 . . . . 0.0 109.259 172.159 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' C' C ' 124' ' ' LEU . . . . . . . . . . . . . 8.7 tp -128.31 143.27 51.0 Favored 'General case' 0 N--CA 1.464 0.245 0 CA-C-O 120.726 0.298 . . . . 0.0 110.91 -175.845 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' C' C ' 125' ' ' VAL . . . . . . . . . . . . . 35.0 m -130.19 143.84 39.78 Favored 'Isoleucine or valine' 0 C--O 1.232 0.177 0 CA-C-N 116.35 -0.386 . . . . 0.0 111.254 -178.637 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' C' C ' 126' ' ' ARG . . . . . . . . . . . . . 96.0 mtt-85 -149.73 124.9 10.08 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 116.246 -0.434 . . . . 0.0 110.781 175.634 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' C' C ' 127' ' ' ASN . . . . . . . . . . . . . 24.8 m120 49.63 -109.18 0.35 Allowed 'General case' 0 CA--C 1.545 0.764 0 CA-C-O 118.828 -0.606 . . . . 0.0 111.649 178.938 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' C' C ' 128' ' ' ASP . . . . . . . . . . . . . 19.5 p-10 -114.09 7.3 16.68 Favored 'General case' 0 N--CA 1.469 0.482 0 CA-C-N 119.891 1.223 . . . . 0.0 113.371 -177.442 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' C' C ' 129' ' ' LEU . . . . . . . . . . . . . 42.1 mt -113.7 147.88 37.4 Favored 'General case' 0 C--O 1.232 0.14 0 N-CA-C 109.795 -0.446 . . . . 0.0 109.795 178.723 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' C' C ' 130' ' ' VAL . . . . . . . . . . . . . 12.9 p -133.62 143.18 39.55 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.222 0 CA-C-O 121.166 0.508 . . . . 0.0 110.511 -179.758 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' C' C ' 131' ' ' VAL . . . . . . . . . . . . . 41.1 t -132.92 138.4 51.82 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.248 0 CA-C-N 115.848 -0.614 . . . . 0.0 110.234 -178.068 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' C' C ' 132' ' ' ILE . . . . . . . . . . . . . 72.2 mt -116.8 133.86 62.15 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.331 0 N-CA-C 109.308 -0.627 . . . . 0.0 109.308 179.471 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' C' C ' 133' ' ' ILE . . . . . . . . . . . . . 40.1 mm -117.02 122.89 71.08 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.245 0 CA-C-N 116.673 -0.239 . . . . 0.0 110.81 -174.756 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' C' C ' 134' ' ' ASP . . . . . . . . . . . . . 7.2 p-10 -135.59 150.28 49.63 Favored 'General case' 0 C--N 1.331 -0.225 0 N-CA-C 110.003 -0.369 . . . . 0.0 110.003 175.55 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' C' C ' 135' ' ' GLU . . . . . . . . . . . . . 44.8 tp10 -50.67 -28.08 8.26 Favored 'General case' 0 C--N 1.328 -0.361 0 N-CA-C 112.756 0.65 . . . . 0.0 112.756 -173.218 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' C' C ' 136' ' ' GLN . . . . . . . . . . . . . 96.9 mt-30 -86.17 -29.22 23.41 Favored 'General case' 0 C--N 1.33 -0.253 0 N-CA-C 112.805 0.669 . . . . 0.0 112.805 -174.98 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' C' C ' 137' ' ' LYS . . . . . . . . . . . . . 43.1 pttt -170.14 173.67 5.77 Favored 'General case' 0 C--N 1.332 -0.189 0 CA-C-O 121.53 0.681 . . . . 0.0 112.503 -172.544 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' C' C ' 138' ' ' LEU . . . . . . . . . . . . . 5.5 tt -118.55 128.62 54.74 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 114.967 -1.015 . . . . 0.0 109.766 179.168 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' C' C ' 139' ' ' THR . . . . . . . . . . . . . 31.9 m -107.09 128.16 54.13 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.43 -0.35 . . . . 0.0 110.281 179.798 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' C' C ' 140' ' ' LEU . . . . . . . . . . . . . 11.0 tp -114.6 121.42 43.38 Favored 'General case' 0 C--N 1.328 -0.339 0 N-CA-C 109.23 -0.655 . . . . 0.0 109.23 -178.718 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' C' C ' 141' ' ' ILE . . . . . . . . . . . . . 20.1 mt -119.28 121.6 66.97 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 CA-C-O 121.032 0.444 . . . . 0.0 110.04 -175.803 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' C' C ' 142' ' ' ARG . . . . . . . . . . . . . 69.5 mtt180 . . . . . 0 C--N 1.329 -0.312 0 CA-C-N 114.989 -1.005 . . . . 0.0 109.849 -175.263 . . . . . . . . 0 0 . 1 . 015 nuclear orig core ' D' D ' 2' ' ' SER . . . . . . . . . . . . . 25.2 p . . . . . 0 N--CA 1.461 0.082 0 CA-C-O 120.913 0.387 . . . . 0.0 110.574 . . . . . . . . . 0 0 . 1 . 015 nuclear orig core ' D' D ' 3' ' ' GLU . . . . . . . . . . . . . 95.3 mt-10 -141.13 138.78 33.72 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.1 -0.5 . . . . 0.0 111.489 -177.498 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' D' D ' 4' ' ' LEU . . . . . . . . . . . . . 70.1 mt -118.96 127.74 53.75 Favored 'General case' 0 C--N 1.331 -0.214 0 CA-C-N 115.953 -0.567 . . . . 0.0 110.079 174.392 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' D' D ' 5' ' ' LYS . . . . . . . . . . . . . 98.7 mttt -109.67 122.4 47.38 Favored 'General case' 0 C--O 1.235 0.311 0 CA-C-O 120.673 0.273 . . . . 0.0 110.659 177.225 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' D' D ' 6' ' ' LEU . . . . . . . . . . . . . 46.8 mt -113.94 146.55 39.93 Favored 'General case' 0 C--N 1.331 -0.219 0 CA-C-N 115.435 -0.802 . . . . 0.0 109.919 179.786 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' D' D ' 7' ' ' LYS . . . . . . . . . . . . . 76.4 tttt -131.28 137.63 31.01 Favored Pre-proline 0 CA--C 1.533 0.318 0 CA-C-O 118.935 -0.555 . . . . 0.0 109.732 175.74 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' D' D ' 8' ' ' PRO . . . . . . . . . . . . . 85.9 Cg_endo -90.96 135.18 1.86 Allowed 'Trans proline' 0 N--CA 1.489 1.225 0 C-N-CA 121.705 1.603 . . . . 0.0 111.825 179.316 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' D' D ' 9' ' ' LEU . . . . . . . . . . . . . 38.0 mt -73.3 -45.13 7.86 Favored Pre-proline 0 CA--C 1.533 0.311 0 CA-C-O 119.019 -0.515 . . . . 0.0 111.036 179.79 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' D' D ' 10' ' ' PRO . . . . . . . . . . . . . 64.5 Cg_endo -86.11 152.82 9.6 Favored 'Trans proline' 0 N--CA 1.492 1.425 0 C-N-CA 121.241 1.294 . . . . 0.0 111.066 169.041 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' D' D ' 11' ' ' LYS . . . . . . . . . . . . . 25.5 pttm -86.1 119.86 26.86 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-O 121.291 0.567 . . . . 0.0 110.461 177.084 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' D' D ' 12' ' ' VAL . . . . . . . . . . . . . 13.1 p -150.47 143.29 17.22 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.327 0 CA-C-N 115.928 -0.578 . . . . 0.0 110.523 -179.966 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' D' D ' 13' ' ' GLU . . . . . . . . . . . . . 43.3 mt-10 -90.36 110.47 21.55 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.296 -0.411 . . . . 0.0 110.04 177.808 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' D' D ' 14' ' ' LEU . . . . . . . . . . . . . 15.8 mt -88.08 153.05 51.47 Favored Pre-proline 0 C--N 1.33 -0.281 0 CA-C-N 116.345 -0.389 . . . . 0.0 110.646 -178.154 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' D' D ' 15' ' ' PRO . . . . . . . . . . . . . 25.4 Cg_exo -62.58 155.16 60.19 Favored 'Trans proline' 0 N--CA 1.497 1.679 0 C-N-CA 121.267 1.311 . . . . 0.0 111.35 175.17 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' D' D ' 16' ' ' PRO . . . . . . . . . . . . . 36.5 Cg_exo -58.02 -35.64 98.61 Favored 'Trans proline' 0 N--CA 1.497 1.723 0 C-N-CA 121.318 1.345 . . . . 0.0 112.923 -178.68 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' D' D ' 17' ' ' ASP . . . . . . . . . . . . . 10.8 p-10 -85.48 5.96 28.99 Favored 'General case' 0 CA--C 1.536 0.411 0 N-CA-C 113.336 0.865 . . . . 0.0 113.336 -176.508 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' D' D ' 18' ' ' PHE . . . . . . . . . . . . . 42.3 t80 -58.37 -44.49 88.9 Favored 'General case' 0 C--N 1.334 -0.101 0 O-C-N 121.939 -0.475 . . . . 0.0 109.892 -179.251 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' D' D ' 19' ' ' VAL . . . . . . . . . . . . . 47.6 t -56.76 -42.6 77.79 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.284 0 CA-C-N 116.243 -0.435 . . . . 0.0 110.316 -179.423 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' D' D ' 20' ' ' ASP . . . . . . . . . . . . . 9.6 t70 -59.47 -42.59 92.39 Favored 'General case' 0 C--N 1.33 -0.278 0 C-N-CA 120.853 -0.339 . . . . 0.0 110.72 -177.522 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' D' D ' 21' ' ' VAL . . . . . . . . . . . . . 47.3 t -64.42 -46.37 93.12 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 C-N-CA 120.754 -0.378 . . . . 0.0 110.646 -177.611 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' D' D ' 22' ' ' ILE . . . . . . . . . . . . . 45.4 mm -58.57 -40.27 78.38 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.267 0 C-N-CA 121.05 -0.26 . . . . 0.0 110.758 -179.449 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' D' D ' 23' ' ' ARG . . . . . . . . . . . . . 35.4 ttp180 -57.73 -49.64 75.88 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-O 121.148 0.499 . . . . 0.0 110.32 177.285 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' D' D ' 24' ' ' ILE . . . . . . . . . . . . . 66.0 mt -60.96 -38.41 79.32 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.304 0 CA-C-N 115.737 -0.665 . . . . 0.0 111.841 -176.781 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' D' D ' 25' ' ' LYS . . . . . . . . . . . . . 35.5 pttt -77.21 -37.57 53.14 Favored 'General case' 0 CA--C 1.534 0.341 0 C-N-CA 120.396 -0.521 . . . . 0.0 111.864 -174.952 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' D' D ' 26' ' ' LEU . . . . . . . . . . . . . 72.0 mt -77.7 -32.42 52.99 Favored 'General case' 0 C--N 1.331 -0.238 0 N-CA-C 113.237 0.828 . . . . 0.0 113.237 -172.354 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' D' D ' 27' ' ' GLN . . . . . . . . . . . . . 5.8 pt20 -45.71 135.71 6.58 Favored 'General case' 0 N--CA 1.469 0.517 0 N-CA-C 112.951 0.723 . . . . 0.0 112.951 -175.49 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' D' D ' 28' ' ' GLY . . . . . . . . . . . . . . . 99.37 -24.76 30.93 Favored Glycine 0 CA--C 1.534 1.223 0 CA-C-N 115.62 -0.718 . . . . 0.0 112.441 -177.713 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' D' D ' 29' ' ' LYS . . . . . . . . . . . . . 69.0 mttm -98.05 155.17 17.25 Favored 'General case' 0 C--N 1.333 -0.12 0 CA-C-N 117.29 0.545 . . . . 0.0 111.002 179.599 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' D' D ' 30' ' ' THR . . . . . . . . . . . . . 21.6 m -101.1 140.19 35.74 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.36 -0.382 . . . . 0.0 110.465 178.206 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' D' D ' 31' ' ' VAL . . . . . . . . . . . . . 34.9 m -130.14 150.4 34.58 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.232 0 CA-C-N 116.232 -0.44 . . . . 0.0 110.992 -179.418 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' D' D ' 32' ' ' ARG . . . . . . . . . . . . . 82.0 mtm180 -135.42 151.09 50.1 Favored 'General case' 0 C--N 1.331 -0.23 0 CA-C-O 121.258 0.551 . . . . 0.0 110.672 178.275 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' D' D ' 33' ' ' THR . . . . . . . . . . . . . 29.3 m -53.65 139.93 30.6 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.273 -0.421 . . . . 0.0 111.193 -179.49 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' D' D ' 34' ' ' GLY . . . . . . . . . . . . . . . 101.01 -17.02 56.82 Favored Glycine 0 CA--C 1.532 1.131 0 CA-C-O 119.703 -0.498 . . . . 0.0 113.244 179.609 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' D' D ' 35' ' ' ASP . . . . . . . . . . . . . 67.5 m-20 -65.15 148.63 51.33 Favored 'General case' 0 C--O 1.232 0.133 0 CA-C-N 118.103 0.951 . . . . 0.0 110.999 178.739 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' D' D ' 36' ' ' VAL . . . . . . . . . . . . . 45.4 t -126.75 131.76 70.79 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.232 0 CA-C-N 116.044 -0.525 . . . . 0.0 109.935 179.444 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' D' D ' 37' ' ' ILE . . . . . . . . . . . . . 63.0 mt -124.89 139.78 50.01 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.215 0 CA-C-N 116.226 -0.443 . . . . 0.0 110.173 -179.09 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' D' D ' 38' ' ' GLY . . . . . . . . . . . . . . . -113.83 128.41 8.28 Favored Glycine 0 CA--C 1.526 0.724 0 N-CA-C 110.741 -0.944 . . . . 0.0 110.741 177.73 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' D' D ' 39' ' ' ILE . . . . . . . . . . . . . 70.6 mt -126.92 137.72 57.0 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.282 0 CA-C-O 120.654 0.264 . . . . 0.0 110.297 -179.758 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' D' D ' 40' ' ' SER . . . . . . . . . . . . . 42.9 t -92.11 120.8 33.06 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.307 -0.406 . . . . 0.0 110.755 176.058 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' D' D ' 41' ' ' ILE . . . . . . . . . . . . . 67.7 mt -126.57 117.51 48.4 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.193 0 CA-C-O 120.707 0.289 . . . . 0.0 110.268 178.672 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' D' D ' 42' ' ' LEU . . . . . . . . . . . . . 8.2 mp 50.94 39.13 22.05 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-O 121.094 0.474 . . . . 0.0 111.729 177.262 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' D' D ' 43' ' ' GLY . . . . . . . . . . . . . . . 75.36 26.57 65.55 Favored Glycine 0 CA--C 1.531 1.077 0 C-N-CA 121.218 -0.515 . . . . 0.0 112.669 175.742 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' D' D ' 44' ' ' LYS . . . . . . . . . . . . . 98.8 mttt -136.56 129.35 30.76 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 117.142 0.471 . . . . 0.0 109.798 176.606 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' D' D ' 45' ' ' GLU . . . . . . . . . . . . . 73.0 tt0 -84.16 123.38 30.02 Favored 'General case' 0 C--N 1.329 -0.314 0 C-N-CA 120.788 -0.365 . . . . 0.0 110.8 -178.102 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' D' D ' 46' ' ' VAL . . . . . . . . . . . . . 11.3 p -117.22 127.29 74.79 Favored 'Isoleucine or valine' 0 C--O 1.233 0.196 0 N-CA-C 109.832 -0.433 . . . . 0.0 109.832 176.368 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' D' D ' 47' ' ' LYS . . . . . . . . . . . . . 34.3 mmtp -98.23 122.91 41.96 Favored 'General case' 0 C--N 1.327 -0.404 0 CA-C-N 115.927 -0.578 . . . . 0.0 110.659 177.165 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' D' D ' 48' ' ' PHE . . . . . . . . . . . . . 30.6 m-85 -108.32 131.79 54.37 Favored 'General case' 0 C--N 1.33 -0.276 0 N-CA-C 109.668 -0.493 . . . . 0.0 109.668 175.693 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' D' D ' 49' ' ' LYS . . . . . . . . . . . . . 60.1 tttm -108.82 136.12 48.9 Favored 'General case' 0 C--N 1.329 -0.316 0 N-CA-C 110.04 -0.355 . . . . 0.0 110.04 175.858 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' D' D ' 50' ' ' VAL . . . . . . . . . . . . . 45.3 t -77.63 107.05 8.71 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.343 0 N-CA-C 109.176 -0.675 . . . . 0.0 109.176 176.487 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' D' D ' 51' ' ' VAL . . . . . . . . . . . . . 45.0 t -70.96 -48.75 54.27 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.315 0 CA-C-N 116.132 -0.486 . . . . 0.0 109.781 -174.221 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' D' D ' 52' ' ' GLN . . . . . . . . . . . . . 62.2 tt0 -164.66 139.8 5.55 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 115.983 -0.553 . . . . 0.0 111.187 -176.614 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' D' D ' 53' ' ' ALA . . . . . . . . . . . . . . . -120.37 135.87 54.89 Favored 'General case' 0 C--N 1.332 -0.191 0 CA-C-N 116.009 -0.541 . . . . 0.0 109.868 174.342 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' D' D ' 54' ' ' TYR . . . . . . . . . . . . . 43.7 t80 -129.11 116.58 18.9 Favored Pre-proline 0 CA--C 1.536 0.413 0 CA-C-O 118.091 -0.957 . . . . 0.0 110.338 178.226 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' D' D ' 55' ' ' PRO . . . . . . . . . . . . . 73.8 Cg_endo -77.13 170.07 72.57 Favored 'Cis proline' 0 N--CA 1.501 1.94 0 CA-C-N 122.015 1.756 . . . . 0.0 111.56 -9.836 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' D' D ' 56' ' ' SER . . . . . . . . . . . . . 13.7 m -128.03 141.72 42.15 Favored Pre-proline 0 CA--C 1.536 0.41 0 CA-C-O 118.625 -0.702 . . . . 0.0 109.575 174.777 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' D' D ' 57' ' ' PRO . . . . . . . . . . . . . 49.8 Cg_endo -69.94 141.71 67.49 Favored 'Cis proline' 0 N--CA 1.5 1.859 0 CA-C-N 121.489 1.567 . . . . 0.0 111.689 -1.082 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' D' D ' 58' ' ' LEU . . . . . . . . . . . . . 28.1 tp -108.53 138.74 44.34 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-N 116.381 -0.372 . . . . 0.0 110.881 -177.989 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' D' D ' 59' ' ' ARG . . . . . . . . . . . . . 66.9 ttp85 -99.67 124.14 44.61 Favored 'General case' 0 C--N 1.328 -0.332 0 N-CA-C 109.099 -0.704 . . . . 0.0 109.099 173.323 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' D' D ' 60' ' ' VAL . . . . . . . . . . . . . 41.1 t -72.78 120.28 21.12 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.254 0 CA-C-O 120.964 0.411 . . . . 0.0 110.51 -175.066 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' D' D ' 61' ' ' GLU . . . . . . . . . . . . . 74.7 tt0 -131.09 156.79 44.62 Favored 'General case' 0 C--N 1.328 -0.331 0 N-CA-C 108.874 -0.787 . . . . 0.0 108.874 175.991 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' D' D ' 62' ' ' ASP . . . . . . . . . . . . . 53.1 m-20 -49.6 -30.37 8.67 Favored 'General case' 0 CA--C 1.534 0.336 0 N-CA-C 112.378 0.51 . . . . 0.0 112.378 -179.169 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' D' D ' 63' ' ' ARG . . . . . . . . . . . . . 94.2 mtt180 -72.5 -21.96 61.12 Favored 'General case' 0 CA--C 1.533 0.3 0 N-CA-C 113.118 0.784 . . . . 0.0 113.118 -175.217 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' D' D ' 64' ' ' THR . . . . . . . . . . . . . 34.2 m -66.57 139.78 57.93 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-O 120.871 0.367 . . . . 0.0 110.913 -176.257 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' D' D ' 65' ' ' LYS . . . . . . . . . . . . . 99.4 mttt -89.09 130.69 35.49 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.093 -0.503 . . . . 0.0 109.906 176.971 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' D' D ' 66' ' ' ILE . . . . . . . . . . . . . 4.0 mp -112.39 124.14 68.79 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.229 0 N-CA-C 109.518 -0.549 . . . . 0.0 109.518 178.517 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' D' D ' 67' ' ' THR . . . . . . . . . . . . . 24.4 m -119.94 137.34 54.11 Favored 'General case' 0 C--N 1.331 -0.208 0 CA-C-O 121.102 0.477 . . . . 0.0 110.877 -176.985 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' D' D ' 68' ' ' LEU . . . . . . . . . . . . . 17.3 tp . . . . . 0 C--N 1.328 -0.326 0 CA-C-N 115.831 -0.622 . . . . 0.0 109.99 178.084 . . . . . . . . 0 0 . 1 . 015 nuclear orig core ' D' D ' 73' ' ' VAL . . . . . . . . . . . . . 35.2 m . . . . . 0 C--O 1.231 0.103 0 CA-C-O 120.684 0.278 . . . . 0.0 110.254 . . . . . . . . . 0 0 . 1 . 015 nuclear orig core ' D' D ' 74' ' ' ASP . . . . . . . . . . . . . 17.9 t0 -99.85 123.73 44.4 Favored 'General case' 0 C--N 1.331 -0.233 0 N-CA-C 110.04 -0.356 . . . . 0.0 110.04 -178.242 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' D' D ' 75' ' ' VAL . . . . . . . . . . . . . 43.3 t -117.96 122.82 70.62 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.197 0 CA-C-O 120.922 0.391 . . . . 0.0 110.494 -177.862 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' D' D ' 76' ' ' LEU . . . . . . . . . . . . . 8.0 mp -124.42 149.33 46.87 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 115.848 -0.615 . . . . 0.0 109.737 176.25 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' D' D ' 77' ' ' GLU . . . . . . . . . . . . . 97.2 mt-10 -136.3 136.6 39.9 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-O 121.049 0.452 . . . . 0.0 111.138 -178.476 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' D' D ' 78' ' ' ALA . . . . . . . . . . . . . . . -119.23 128.75 54.49 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 115.707 -0.679 . . . . 0.0 109.803 176.511 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' D' D ' 79' ' ' LYS . . . . . . . . . . . . . 32.9 ttmt -79.46 118.05 20.98 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-O 120.963 0.411 . . . . 0.0 110.986 -176.348 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' D' D ' 80' ' ' ILE . . . . . . . . . . . . . 37.1 mm -139.2 104.37 2.16 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.272 0 N-CA-C 109.067 -0.716 . . . . 0.0 109.067 -178.848 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' D' D ' 81' ' ' LYS . . . . . . . . . . . . . 84.5 tttt -95.0 125.56 39.75 Favored 'General case' 0 C--N 1.329 -0.287 0 C-N-CA 120.758 -0.377 . . . . 0.0 110.944 -177.277 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' D' D ' 82' ' ' GLY . . . . . . . . . . . . . . . 89.03 42.2 5.69 Favored Glycine 0 CA--C 1.524 0.594 0 N-CA-C 111.237 -0.745 . . . . 0.0 111.237 176.401 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' D' D ' 83' ' ' ILE . . . . . . . . . . . . . 71.1 mt -65.4 131.51 31.18 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.273 0 N-CA-C 109.68 -0.489 . . . . 0.0 109.68 177.521 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' D' D ' 84' ' ' LYS . . . . . . . . . . . . . 48.6 tttp -89.97 -50.54 5.96 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.025 -0.534 . . . . 0.0 109.947 -179.117 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' D' D ' 85' ' ' ASP . . . . . . . . . . . . . 10.0 t70 -159.85 153.12 22.1 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 115.653 -0.703 . . . . 0.0 110.173 178.366 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' D' D ' 86' ' ' VAL . . . . . . . . . . . . . 41.3 t -127.4 132.63 69.23 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.244 0 CA-C-O 120.965 0.412 . . . . 0.0 110.48 -179.328 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' D' D ' 87' ' ' ILE . . . . . . . . . . . . . 5.0 mp -119.95 122.83 69.55 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.238 0 N-CA-C 109.329 -0.619 . . . . 0.0 109.329 176.471 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' D' D ' 88' ' ' LEU . . . . . . . . . . . . . 86.1 mt -109.49 137.18 47.72 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-O 121.157 0.503 . . . . 0.0 111.307 -177.73 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' D' D ' 89' ' ' ASP . . . . . . . . . . . . . 8.6 t70 -131.48 156.47 45.6 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 115.598 -0.728 . . . . 0.0 109.29 176.499 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' D' D ' 90' ' ' GLU . . . . . . . . . . . . . 48.1 mp0 -50.85 -29.07 10.85 Favored 'General case' 0 C--N 1.327 -0.387 0 N-CA-C 112.544 0.572 . . . . 0.0 112.544 -171.177 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' D' D ' 91' ' ' ASN . . . . . . . . . . . . . 54.0 t30 -131.61 13.74 4.94 Favored 'General case' 0 N--CA 1.468 0.464 0 N-CA-C 113.307 0.854 . . . . 0.0 113.307 -176.228 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' D' D ' 92' ' ' LEU . . . . . . . . . . . . . 41.8 mt -147.82 148.72 31.2 Favored 'General case' 0 C--N 1.331 -0.204 0 CA-C-N 118.04 0.382 . . . . 0.0 110.55 -176.85 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' D' D ' 93' ' ' ILE . . . . . . . . . . . . . 72.3 mt -126.09 114.08 37.03 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.357 0 N-CA-C 109.063 -0.717 . . . . 0.0 109.063 175.845 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' D' D ' 94' ' ' VAL . . . . . . . . . . . . . 42.3 t -115.29 125.49 72.56 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.24 0 N-CA-C 109.816 -0.438 . . . . 0.0 109.816 -178.945 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' D' D ' 95' ' ' VAL . . . . . . . . . . . . . 44.6 t -119.29 133.24 66.77 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.283 0 CA-C-N 116.056 -0.52 . . . . 0.0 109.813 -179.83 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' D' D ' 96' ' ' ILE . . . . . . . . . . . . . 64.2 mt -111.7 126.0 69.05 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.358 0 N-CA-C 108.804 -0.813 . . . . 0.0 108.804 177.239 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' D' D ' 97' ' ' THR . . . . . . . . . . . . . 60.3 p -99.82 159.89 14.72 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-O 121.215 0.531 . . . . 0.0 111.388 -176.315 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' D' D ' 98' ' ' GLU . . . . . . . . . . . . . 81.0 tt0 -53.89 -26.28 24.23 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.043 -0.526 . . . . 0.0 112.12 179.254 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' D' D ' 99' ' ' GLU . . . . . . . . . . . . . 95.6 mt-10 -78.01 13.07 1.53 Allowed 'General case' 0 CA--C 1.536 0.432 0 N-CA-C 113.146 0.795 . . . . 0.0 113.146 -177.794 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' D' D ' 100' ' ' ASN . . . . . . . . . . . . . 3.0 m-20 60.47 37.74 19.61 Favored 'General case' 0 CA--C 1.529 0.167 0 CA-C-O 121.126 0.489 . . . . 0.0 110.961 -179.443 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' D' D ' 101' ' ' GLU . . . . . . . . . . . . . 83.4 tt0 -113.74 145.5 41.28 Favored 'General case' 0 C--N 1.332 -0.169 0 N-CA-C 109.45 -0.574 . . . . 0.0 109.45 176.097 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' D' D ' 102' ' ' VAL . . . . . . . . . . . . . 46.3 t -114.82 121.44 66.91 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.319 0 N-CA-C 109.615 -0.513 . . . . 0.0 109.615 -178.817 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' D' D ' 103' ' ' LEU . . . . . . . . . . . . . 39.0 mt -115.31 127.59 55.54 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 115.705 -0.68 . . . . 0.0 109.925 177.593 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' D' D ' 104' ' ' ILE . . . . . . . . . . . . . 68.4 mt -118.87 120.5 64.24 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.271 0 N-CA-C 110.164 -0.31 . . . . 0.0 110.164 -178.627 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' D' D ' 105' ' ' PHE . . . . . . . . . . . . . 54.8 m-85 -119.72 165.91 13.9 Favored 'General case' 0 C--N 1.331 -0.202 0 O-C-N 123.978 0.798 . . . . 0.0 109.542 179.268 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' D' D ' 106' ' ' ASN . . . . . . . . . . . . . 39.2 p-10 -97.32 -173.0 2.54 Favored 'General case' 0 C--N 1.329 -0.294 0 N-CA-C 109.683 -0.488 . . . . 0.0 109.683 172.597 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' D' D ' 107' ' ' GLN . . . . . . . . . . . . . 43.3 tp60 -58.77 -27.68 65.2 Favored 'General case' 0 CA--C 1.534 0.355 0 N-CA-C 111.78 0.289 . . . . 0.0 111.78 178.382 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' D' D ' 108' ' ' ASN . . . . . . . . . . . . . 9.2 t30 -84.54 9.6 13.15 Favored 'General case' 0 CA--C 1.536 0.415 0 N-CA-C 113.147 0.795 . . . . 0.0 113.147 -177.17 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' D' D ' 109' ' ' LEU . . . . . . . . . . . . . 18.8 mt 58.89 34.34 23.6 Favored 'General case' 0 CA--C 1.53 0.21 0 CA-C-O 120.942 0.401 . . . . 0.0 111.804 178.777 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' D' D ' 110' ' ' GLU . . . . . . . . . . . . . 70.7 mm-40 -107.25 141.52 38.44 Favored 'General case' 0 C--N 1.33 -0.275 0 N-CA-C 108.998 -0.742 . . . . 0.0 108.998 173.14 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' D' D ' 111' ' ' GLU . . . . . . . . . . . . . 52.1 tt0 -85.04 123.38 30.51 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-O 121.186 0.517 . . . . 0.0 111.07 -173.369 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' D' D ' 112' ' ' LEU . . . . . . . . . . . . . 30.4 mt -101.35 -43.23 6.02 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 115.625 -0.716 . . . . 0.0 110.89 178.852 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' D' D ' 113' ' ' TYR . . . . . . . . . . . . . 43.9 t80 -133.01 135.98 45.76 Favored 'General case' 0 C--N 1.332 -0.164 0 CA-C-O 120.784 0.326 . . . . 0.0 111.548 -176.367 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' D' D ' 114' ' ' ARG . . . . . . . . . . . . . 32.3 ttm180 -134.19 120.26 19.84 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-N 115.892 -0.594 . . . . 0.0 110.067 176.664 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' D' D ' 115' ' ' GLY . . . . . . . . . . . . . . . -150.01 159.73 28.22 Favored Glycine 0 CA--C 1.523 0.555 0 N-CA-C 110.825 -0.91 . . . . 0.0 110.825 178.659 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' D' D ' 116' ' ' LYS . . . . . . . . . . . . . 32.9 ttmt -136.05 139.7 43.27 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-O 120.817 0.341 . . . . 0.0 110.288 178.067 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' D' D ' 117' ' ' PHE . . . . . . . . . . . . . 20.4 m-85 -138.19 119.97 15.25 Favored 'General case' 0 C--N 1.331 -0.236 0 N-CA-C 109.911 -0.404 . . . . 0.0 109.911 -177.427 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' D' D ' 118' ' ' GLU . . . . . . . . . . . . . 96.1 mt-10 -55.51 -40.17 71.42 Favored 'General case' 0 C--N 1.329 -0.326 0 C-N-CA 120.916 -0.313 . . . . 0.0 110.915 -178.224 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' D' D ' 119' ' ' ASN . . . . . . . . . . . . . 78.3 m-20 -97.23 28.94 3.38 Favored 'General case' 0 C--N 1.331 -0.218 0 N-CA-C 112.35 0.5 . . . . 0.0 112.35 -174.795 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' D' D ' 120' ' ' LEU . . . . . . . . . . . . . 16.7 tp -58.18 119.97 7.81 Favored 'General case' 0 C--N 1.333 -0.131 0 N-CA-C 110.125 -0.324 . . . . 0.0 110.125 178.237 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' D' D ' 121' ' ' ASN . . . . . . . . . . . . . 66.2 t30 -114.01 -44.22 3.17 Favored 'General case' 0 C--N 1.331 -0.227 0 CA-C-N 116.511 -0.313 . . . . 0.0 111.273 -177.053 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' D' D ' 122' ' ' LYS . . . . . . . . . . . . . 59.8 mttm -146.7 154.5 41.5 Favored 'General case' 0 C--N 1.33 -0.241 0 C-N-CA 120.653 -0.419 . . . . 0.0 111.739 -176.434 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' D' D ' 123' ' ' VAL . . . . . . . . . . . . . 43.8 t -131.71 129.95 61.66 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.243 0 CA-C-N 115.971 -0.559 . . . . 0.0 109.731 175.221 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' D' D ' 124' ' ' LEU . . . . . . . . . . . . . 30.3 mt -118.92 133.7 55.66 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-N 116.31 -0.405 . . . . 0.0 110.623 -179.164 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' D' D ' 125' ' ' VAL . . . . . . . . . . . . . 45.3 t -129.01 124.41 60.81 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 N-CA-C 109.895 -0.409 . . . . 0.0 109.895 178.153 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' D' D ' 126' ' ' ARG . . . . . . . . . . . . . 44.1 mtp180 -148.87 130.92 15.33 Favored 'General case' 0 C--N 1.329 -0.296 0 N-CA-C 109.69 -0.485 . . . . 0.0 109.69 179.189 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' D' D ' 127' ' ' ASN . . . . . . . . . . . . . 37.2 t30 56.32 -152.54 0.38 Allowed 'General case' 0 CA--C 1.539 0.527 0 N-CA-C 109.742 -0.466 . . . . 0.0 109.742 -179.943 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' D' D ' 128' ' ' ASP . . . . . . . . . . . . . 12.3 p-10 -84.05 18.67 2.01 Favored 'General case' 0 CA--C 1.536 0.428 0 CA-C-N 118.506 0.594 . . . . 0.0 112.602 177.936 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' D' D ' 129' ' ' LEU . . . . . . . . . . . . . 15.3 tp -117.82 138.83 51.82 Favored 'General case' 0 C--O 1.232 0.181 0 O-C-N 122.172 -0.33 . . . . 0.0 110.164 179.632 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' D' D ' 130' ' ' VAL . . . . . . . . . . . . . 12.5 p -129.11 141.18 47.27 Favored 'Isoleucine or valine' 0 N--CA 1.462 0.171 0 CA-C-O 121.133 0.492 . . . . 0.0 110.248 179.891 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' D' D ' 131' ' ' VAL . . . . . . . . . . . . . 58.8 t -136.06 137.56 48.47 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.276 0 CA-C-N 115.85 -0.614 . . . . 0.0 110.555 -177.197 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' D' D ' 132' ' ' ILE . . . . . . . . . . . . . 74.4 mt -114.14 133.94 58.59 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.243 0 CA-C-N 115.881 -0.599 . . . . 0.0 109.441 179.296 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' D' D ' 133' ' ' ILE . . . . . . . . . . . . . 42.9 mm -116.29 122.23 69.27 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.243 0 CA-C-O 120.822 0.344 . . . . 0.0 110.8 -175.323 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' D' D ' 134' ' ' ASP . . . . . . . . . . . . . 7.2 p-10 -136.03 146.04 46.69 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.148 -0.478 . . . . 0.0 109.838 175.248 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' D' D ' 135' ' ' GLU . . . . . . . . . . . . . 80.6 tt0 -49.85 -22.97 1.65 Allowed 'General case' 0 C--N 1.328 -0.344 0 N-CA-C 113.076 0.769 . . . . 0.0 113.076 -171.464 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' D' D ' 136' ' ' GLN . . . . . . . . . . . . . 13.3 pt20 -100.9 -30.44 11.66 Favored 'General case' 0 N--CA 1.464 0.249 0 N-CA-C 112.674 0.62 . . . . 0.0 112.674 -175.587 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' D' D ' 137' ' ' LYS . . . . . . . . . . . . . 87.3 mttt -142.6 158.05 44.07 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-O 121.407 0.622 . . . . 0.0 112.129 -173.019 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' D' D ' 138' ' ' LEU . . . . . . . . . . . . . 4.6 tt -118.48 122.13 41.96 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-N 115.174 -0.921 . . . . 0.0 108.883 171.459 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' D' D ' 139' ' ' THR . . . . . . . . . . . . . 28.0 m -111.16 125.06 53.39 Favored 'General case' 0 C--N 1.332 -0.162 0 CA-C-O 120.644 0.259 . . . . 0.0 110.899 -176.71 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' D' D ' 140' ' ' LEU . . . . . . . . . . . . . 7.7 tt -114.03 125.68 54.27 Favored 'General case' 0 C--N 1.327 -0.388 0 N-CA-C 109.294 -0.632 . . . . 0.0 109.294 -179.265 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' D' D ' 141' ' ' ILE . . . . . . . . . . . . . 19.7 mt -123.28 120.37 60.08 Favored 'Isoleucine or valine' 0 C--O 1.235 0.311 0 N-CA-C 109.715 -0.476 . . . . 0.0 109.715 -176.146 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' D' D ' 142' ' ' ARG . . . . . . . . . . . . . 61.2 ttt180 -114.51 127.24 55.7 Favored 'General case' 0 C--N 1.332 -0.177 0 CA-C-N 115.448 -0.796 . . . . 0.0 110.327 -176.347 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' D' D ' 143' ' ' THR . . . . . . . . . . . . . 28.7 p . . . . . 0 C--O 1.219 -0.516 0 CA-C-O 118.018 -0.992 . . . . 0.0 110.597 -179.68 . . . . . . . . 0 0 . 1 . 015 nuclear orig core ' E' E ' 2' ' ' SER . . . . . . . . . . . . . 4.9 p . . . . . 0 N--CA 1.462 0.164 0 CA-C-O 121.103 0.478 . . . . 0.0 110.67 . . . . . . . . . 0 0 . 1 . 015 nuclear orig core ' E' E ' 3' ' ' GLU . . . . . . . . . . . . . 79.8 tt0 -145.83 143.06 29.4 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 115.884 -0.598 . . . . 0.0 111.021 -178.003 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' E' E ' 4' ' ' LEU . . . . . . . . . . . . . 15.1 tp -123.59 135.37 53.93 Favored 'General case' 0 C--N 1.331 -0.217 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.281 177.359 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' E' E ' 5' ' ' LYS . . . . . . . . . . . . . 90.3 mttt -109.09 120.04 41.34 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.23 -0.441 . . . . 0.0 110.38 178.87 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' E' E ' 6' ' ' LEU . . . . . . . . . . . . . 59.4 mt -116.58 142.89 46.3 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 115.63 -0.713 . . . . 0.0 111.096 -177.815 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' E' E ' 7' ' ' LYS . . . . . . . . . . . . . 60.3 tttm -133.89 140.6 36.92 Favored Pre-proline 0 CA--C 1.534 0.338 0 CA-C-O 119.015 -0.517 . . . . 0.0 110.033 176.522 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' E' E ' 8' ' ' PRO . . . . . . . . . . . . . 98.1 Cg_endo -90.78 143.73 3.5 Favored 'Trans proline' 0 N--CA 1.49 1.314 0 C-N-CA 121.804 1.669 . . . . 0.0 111.866 178.247 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' E' E ' 9' ' ' LEU . . . . . . . . . . . . . 43.6 mt -84.08 -48.26 0.7 Allowed Pre-proline 0 CA--C 1.534 0.342 0 CA-C-O 118.683 -0.675 . . . . 0.0 112.389 -179.205 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' E' E ' 10' ' ' PRO . . . . . . . . . . . . . 88.1 Cg_endo -79.91 158.02 24.13 Favored 'Trans proline' 0 N--CA 1.496 1.642 0 C-N-CA 121.258 1.305 . . . . 0.0 111.845 177.408 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' E' E ' 11' ' ' LYS . . . . . . . . . . . . . 39.3 ttpt -88.0 94.84 9.91 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-O 120.863 0.363 . . . . 0.0 110.422 179.47 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' E' E ' 12' ' ' VAL . . . . . . . . . . . . . 12.4 p -143.15 143.47 24.86 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.286 0 CA-C-N 116.23 -0.441 . . . . 0.0 110.583 179.099 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' E' E ' 13' ' ' GLU . . . . . . . . . . . . . 70.6 mm-40 -84.4 132.62 34.56 Favored 'General case' 0 C--N 1.33 -0.254 0 N-CA-C 109.951 -0.388 . . . . 0.0 109.951 177.263 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' E' E ' 14' ' ' LEU . . . . . . . . . . . . . 48.8 mt -97.97 147.7 33.43 Favored Pre-proline 0 CA--C 1.532 0.278 0 CA-C-O 119.309 -0.376 . . . . 0.0 110.381 -178.151 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' E' E ' 15' ' ' PRO . . . . . . . . . . . . . 24.9 Cg_exo -62.69 161.72 27.49 Favored 'Trans proline' 0 N--CA 1.498 1.749 0 C-N-CA 121.25 1.3 . . . . 0.0 111.825 175.98 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' E' E ' 16' ' ' PRO . . . . . . . . . . . . . 31.2 Cg_exo -59.38 -39.51 76.21 Favored 'Trans proline' 0 N--CA 1.497 1.691 0 C-N-CA 121.422 1.414 . . . . 0.0 112.661 -178.219 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' E' E ' 17' ' ' ASP . . . . . . . . . . . . . 22.8 p-10 -88.71 11.28 18.03 Favored 'General case' 0 CA--C 1.535 0.387 0 N-CA-C 113.172 0.805 . . . . 0.0 113.172 -177.646 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' E' E ' 18' ' ' PHE . . . . . . . . . . . . . 43.5 t80 -57.82 -44.53 86.46 Favored 'General case' 0 C--N 1.335 -0.056 0 O-C-N 122.014 -0.429 . . . . 0.0 110.121 -178.059 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' E' E ' 19' ' ' VAL . . . . . . . . . . . . . 47.6 t -58.16 -41.52 80.99 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.336 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.309 -179.069 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' E' E ' 20' ' ' ASP . . . . . . . . . . . . . 76.2 m-20 -59.72 -42.35 92.89 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-O 120.851 0.358 . . . . 0.0 110.805 -177.655 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' E' E ' 21' ' ' VAL . . . . . . . . . . . . . 47.0 t -64.6 -47.87 87.2 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.294 0 CA-C-N 116.36 -0.382 . . . . 0.0 110.42 -178.194 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' E' E ' 22' ' ' ILE . . . . . . . . . . . . . 49.6 mm -56.05 -45.03 80.32 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.256 0 CA-C-O 120.727 0.299 . . . . 0.0 110.662 179.102 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' E' E ' 23' ' ' ARG . . . . . . . . . . . . . 59.4 ttp180 -54.09 -49.94 67.94 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-O 120.694 0.283 . . . . 0.0 111.388 -178.313 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' E' E ' 24' ' ' ILE . . . . . . . . . . . . . 71.2 mt -60.06 -44.59 95.25 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.271 0 CA-C-N 116.626 -0.261 . . . . 0.0 111.105 -178.044 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' E' E ' 25' ' ' LYS . . . . . . . . . . . . . 83.4 mttt -64.84 -37.91 89.21 Favored 'General case' 0 C--N 1.329 -0.308 0 N-CA-C 112.394 0.516 . . . . 0.0 112.394 -177.694 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' E' E ' 26' ' ' LEU . . . . . . . . . . . . . 50.0 mt -79.27 -42.19 26.42 Favored 'General case' 0 C--N 1.331 -0.221 0 N-CA-C 113.53 0.937 . . . . 0.0 113.53 -172.046 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' E' E ' 27' ' ' GLN . . . . . . . . . . . . . 11.1 pt20 -46.83 141.88 3.71 Favored 'General case' 0 N--CA 1.469 0.491 0 N-CA-C 112.905 0.705 . . . . 0.0 112.905 -173.772 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' E' E ' 28' ' ' GLY . . . . . . . . . . . . . . . 97.75 -26.26 23.96 Favored Glycine 0 CA--C 1.531 1.086 0 CA-C-N 115.418 -0.81 . . . . 0.0 112.184 -177.818 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' E' E ' 29' ' ' LYS . . . . . . . . . . . . . 69.5 mttm -97.77 155.12 17.18 Favored 'General case' 0 C--N 1.331 -0.222 0 CA-C-N 117.365 0.583 . . . . 0.0 110.976 178.249 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' E' E ' 30' ' ' THR . . . . . . . . . . . . . 19.2 m -106.79 137.12 45.42 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 115.931 -0.577 . . . . 0.0 109.727 175.149 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' E' E ' 31' ' ' VAL . . . . . . . . . . . . . 35.0 m -128.17 154.97 39.5 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.253 0 CA-C-O 120.973 0.416 . . . . 0.0 110.862 -177.691 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' E' E ' 32' ' ' ARG . . . . . . . . . . . . . 59.1 ttm-85 -127.24 146.1 50.54 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.04 -0.527 . . . . 0.0 110.327 -179.972 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' E' E ' 33' ' ' THR . . . . . . . . . . . . . 18.6 m -53.08 139.26 28.91 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.469 -0.332 . . . . 0.0 111.355 -177.861 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' E' E ' 34' ' ' GLY . . . . . . . . . . . . . . . 101.13 -17.13 56.44 Favored Glycine 0 CA--C 1.532 1.156 0 CA-C-O 119.674 -0.514 . . . . 0.0 113.243 -179.826 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' E' E ' 35' ' ' ASP . . . . . . . . . . . . . 78.8 m-20 -66.51 149.03 51.05 Favored 'General case' 0 C--O 1.23 0.071 0 CA-C-N 118.018 0.909 . . . . 0.0 111.198 178.542 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' E' E ' 36' ' ' VAL . . . . . . . . . . . . . 44.0 t -123.38 131.95 72.25 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.18 0 CA-C-N 115.865 -0.607 . . . . 0.0 109.786 177.985 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' E' E ' 37' ' ' ILE . . . . . . . . . . . . . 67.8 mt -121.91 140.65 45.21 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.21 0 CA-C-N 116.256 -0.429 . . . . 0.0 109.952 -178.936 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' E' E ' 38' ' ' GLY . . . . . . . . . . . . . . . -110.71 128.81 8.95 Favored Glycine 0 CA--C 1.527 0.802 0 N-CA-C 111.348 -0.701 . . . . 0.0 111.348 -179.528 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' E' E ' 39' ' ' ILE . . . . . . . . . . . . . 72.8 mt -123.83 134.25 67.0 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.207 0 N-CA-C 110.135 -0.32 . . . . 0.0 110.135 179.134 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' E' E ' 40' ' ' SER . . . . . . . . . . . . . 19.5 p -93.57 114.19 26.47 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.508 -0.314 . . . . 0.0 110.993 176.214 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' E' E ' 41' ' ' ILE . . . . . . . . . . . . . 44.7 mm -121.58 124.46 71.75 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.269 0 CA-C-O 120.789 0.328 . . . . 0.0 110.334 179.074 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' E' E ' 42' ' ' LEU . . . . . . . . . . . . . 57.7 mt 52.0 33.06 11.11 Favored 'General case' 0 C--N 1.331 -0.23 0 CA-C-N 116.254 -0.43 . . . . 0.0 111.933 177.359 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' E' E ' 43' ' ' GLY . . . . . . . . . . . . . . . 72.4 33.65 61.22 Favored Glycine 0 CA--C 1.529 0.932 0 C-N-CA 121.091 -0.576 . . . . 0.0 111.749 178.747 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' E' E ' 44' ' ' LYS . . . . . . . . . . . . . 21.1 tptm -138.86 131.23 28.54 Favored 'General case' 0 C--N 1.329 -0.3 0 N-CA-C 109.463 -0.569 . . . . 0.0 109.463 179.539 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' E' E ' 45' ' ' GLU . . . . . . . . . . . . . 80.9 tt0 -82.52 119.25 23.99 Favored 'General case' 0 C--N 1.328 -0.359 0 C-N-CA 120.795 -0.362 . . . . 0.0 110.941 -177.267 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' E' E ' 46' ' ' VAL . . . . . . . . . . . . . 7.4 p -119.97 126.44 75.29 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.18 0 N-CA-C 109.451 -0.574 . . . . 0.0 109.451 176.26 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' E' E ' 47' ' ' LYS . . . . . . . . . . . . . 63.2 mttp -99.97 129.53 46.05 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 115.898 -0.592 . . . . 0.0 111.206 178.916 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' E' E ' 48' ' ' PHE . . . . . . . . . . . . . 87.4 m-85 -112.01 131.8 55.18 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.062 -0.517 . . . . 0.0 110.191 177.162 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' E' E ' 49' ' ' LYS . . . . . . . . . . . . . 79.0 tttt -107.71 135.71 48.68 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.343 -0.39 . . . . 0.0 110.63 -179.666 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' E' E ' 50' ' ' VAL . . . . . . . . . . . . . 45.9 t -81.41 107.55 13.72 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.242 0 N-CA-C 109.123 -0.695 . . . . 0.0 109.123 175.406 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' E' E ' 51' ' ' VAL . . . . . . . . . . . . . 42.9 t -73.14 -50.85 29.01 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.346 0 CA-C-N 115.994 -0.548 . . . . 0.0 109.791 -174.399 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' E' E ' 52' ' ' GLN . . . . . . . . . . . . . 70.2 mt-30 -154.92 155.1 33.69 Favored 'General case' 0 C--N 1.331 -0.218 0 CA-C-O 121.135 0.493 . . . . 0.0 111.699 -179.332 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' E' E ' 53' ' ' ALA . . . . . . . . . . . . . . . -131.68 133.78 45.24 Favored 'General case' 0 C--N 1.33 -0.283 0 CA-C-N 115.364 -0.835 . . . . 0.0 109.886 175.629 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' E' E ' 54' ' ' TYR . . . . . . . . . . . . . 57.7 t80 -129.13 109.08 18.03 Favored Pre-proline 0 CA--C 1.534 0.344 0 CA-C-O 118.284 -0.865 . . . . 0.0 110.439 179.399 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' E' E ' 55' ' ' PRO . . . . . . . . . . . . . 72.8 Cg_endo -77.1 169.8 73.32 Favored 'Cis proline' 0 N--CA 1.498 1.746 0 CA-C-N 121.911 1.718 . . . . 0.0 112.356 -5.457 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' E' E ' 56' ' ' SER . . . . . . . . . . . . . 30.7 m -116.6 129.03 25.57 Favored Pre-proline 0 CA--C 1.538 0.516 0 CA-C-O 118.368 -0.825 . . . . 0.0 109.404 175.244 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' E' E ' 57' ' ' PRO . . . . . . . . . . . . . 42.6 Cg_endo -68.97 148.93 85.87 Favored 'Cis proline' 0 N--CA 1.498 1.771 0 CA-C-N 122.052 1.768 . . . . 0.0 111.815 -0.586 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' E' E ' 58' ' ' LEU . . . . . . . . . . . . . 23.5 tp -108.2 138.53 44.32 Favored 'General case' 0 C--N 1.331 -0.222 0 CA-C-N 116.101 -0.499 . . . . 0.0 110.667 -178.304 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' E' E ' 59' ' ' ARG . . . . . . . . . . . . . 60.6 ttt180 -103.44 131.33 50.63 Favored 'General case' 0 C--N 1.328 -0.346 0 N-CA-C 109.404 -0.591 . . . . 0.0 109.404 175.872 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' E' E ' 60' ' ' VAL . . . . . . . . . . . . . 42.1 t -89.71 119.0 36.1 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.287 0 C-N-CA 120.669 -0.412 . . . . 0.0 110.516 -176.483 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' E' E ' 61' ' ' GLU . . . . . . . . . . . . . 95.1 mt-10 -131.18 167.46 19.12 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.104 -0.498 . . . . 0.0 110.002 176.525 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' E' E ' 62' ' ' ASP . . . . . . . . . . . . . 80.5 m-20 -54.4 -32.71 57.77 Favored 'General case' 0 C--N 1.328 -0.365 0 N-CA-C 111.678 0.251 . . . . 0.0 111.678 -179.712 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' E' E ' 63' ' ' ARG . . . . . . . . . . . . . 11.1 ptm180 -85.7 6.41 27.81 Favored 'General case' 0 CA--C 1.536 0.423 0 N-CA-C 113.551 0.945 . . . . 0.0 113.551 -175.505 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' E' E ' 64' ' ' THR . . . . . . . . . . . . . 23.8 m -85.66 138.68 31.98 Favored 'General case' 0 C--N 1.332 -0.155 0 CA-C-N 118.237 0.472 . . . . 0.0 110.591 -179.09 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' E' E ' 65' ' ' LYS . . . . . . . . . . . . . 48.7 mtmt -87.68 129.78 35.02 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-O 120.949 0.404 . . . . 0.0 110.322 178.565 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' E' E ' 66' ' ' ILE . . . . . . . . . . . . . 58.8 mt -113.11 124.87 70.18 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.316 0 N-CA-C 109.504 -0.554 . . . . 0.0 109.504 179.73 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' E' E ' 67' ' ' THR . . . . . . . . . . . . . 17.8 m -115.48 137.78 51.7 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-O 121.077 0.465 . . . . 0.0 110.663 -177.582 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' E' E ' 68' ' ' LEU . . . . . . . . . . . . . 15.8 tp . . . . . 0 C--N 1.329 -0.319 0 CA-C-N 115.817 -0.628 . . . . 0.0 110.772 -178.333 . . . . . . . . 0 0 . 1 . 015 nuclear orig core ' E' E ' 73' ' ' VAL . . . . . . . . . . . . . 30.1 m . . . . . 0 C--O 1.231 0.13 0 CA-C-O 120.905 0.383 . . . . 0.0 111.143 . . . . . . . . . 0 0 . 1 . 015 nuclear orig core ' E' E ' 74' ' ' ASP . . . . . . . . . . . . . 12.3 t70 -91.28 122.78 34.19 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 115.882 -0.599 . . . . 0.0 110.48 -174.048 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' E' E ' 75' ' ' VAL . . . . . . . . . . . . . 44.3 t -116.99 120.71 65.92 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.248 0 CA-C-O 121.14 0.495 . . . . 0.0 110.134 178.98 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' E' E ' 76' ' ' LEU . . . . . . . . . . . . . 16.5 mt -122.31 143.23 49.75 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 115.603 -0.726 . . . . 0.0 109.75 178.098 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' E' E ' 77' ' ' GLU . . . . . . . . . . . . . 96.0 mt-10 -136.89 135.51 37.88 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-O 121.048 0.451 . . . . 0.0 111.112 -177.804 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' E' E ' 78' ' ' ALA . . . . . . . . . . . . . . . -119.93 139.69 52.05 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 115.643 -0.708 . . . . 0.0 109.795 176.678 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' E' E ' 79' ' ' LYS . . . . . . . . . . . . . 54.7 mttp -87.94 114.5 24.62 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.412 -0.358 . . . . 0.0 110.774 -177.058 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' E' E ' 80' ' ' ILE . . . . . . . . . . . . . 33.4 mm -139.05 103.7 2.04 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.325 0 N-CA-C 109.252 -0.647 . . . . 0.0 109.252 -178.703 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' E' E ' 81' ' ' LYS . . . . . . . . . . . . . 37.9 ttpt -98.12 130.51 44.89 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-O 120.93 0.395 . . . . 0.0 110.547 -178.5 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' E' E ' 82' ' ' GLY . . . . . . . . . . . . . . . 89.15 42.13 5.67 Favored Glycine 0 CA--C 1.523 0.563 0 N-CA-C 111.142 -0.783 . . . . 0.0 111.142 178.053 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' E' E ' 83' ' ' ILE . . . . . . . . . . . . . 71.8 mt -72.43 135.38 27.91 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.291 0 N-CA-C 109.323 -0.621 . . . . 0.0 109.323 176.459 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' E' E ' 84' ' ' LYS . . . . . . . . . . . . . 31.4 ttpt -100.0 -50.67 3.92 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-O 120.888 0.375 . . . . 0.0 110.528 -177.062 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' E' E ' 85' ' ' ASP . . . . . . . . . . . . . 8.1 t70 -147.24 150.17 34.32 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.109 -0.496 . . . . 0.0 110.655 -178.783 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' E' E ' 86' ' ' VAL . . . . . . . . . . . . . 42.5 t -131.28 130.71 63.33 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.202 0 CA-C-O 120.993 0.425 . . . . 0.0 110.527 -179.333 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' E' E ' 87' ' ' ILE . . . . . . . . . . . . . 43.6 mm -118.59 125.59 74.5 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.189 0 N-CA-C 109.444 -0.576 . . . . 0.0 109.444 175.843 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' E' E ' 88' ' ' LEU . . . . . . . . . . . . . 17.2 tp -112.98 128.83 56.6 Favored 'General case' 0 C--N 1.331 -0.201 0 CA-C-O 120.924 0.392 . . . . 0.0 111.135 -176.949 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' E' E ' 89' ' ' ASP . . . . . . . . . . . . . 6.7 t70 -125.95 156.28 40.03 Favored 'General case' 0 C--N 1.331 -0.22 0 CA-C-N 115.988 -0.551 . . . . 0.0 109.927 177.172 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' E' E ' 90' ' ' GLU . . . . . . . . . . . . . 64.0 tt0 -45.73 -46.19 14.88 Favored 'General case' 0 N--CA 1.464 0.238 0 N-CA-C 112.988 0.736 . . . . 0.0 112.988 -172.166 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' E' E ' 91' ' ' ASN . . . . . . . . . . . . . 41.0 t30 -132.17 39.98 3.37 Favored 'General case' 0 C--N 1.332 -0.173 0 CA-C-O 121.124 0.488 . . . . 0.0 110.882 -177.647 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' E' E ' 92' ' ' LEU . . . . . . . . . . . . . 11.9 tp -165.39 138.14 4.36 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.243 -0.435 . . . . 0.0 110.168 -178.453 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' E' E ' 93' ' ' ILE . . . . . . . . . . . . . 70.8 mt -126.08 125.17 67.47 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.29 0 N-CA-C 109.905 -0.406 . . . . 0.0 109.905 -178.531 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' E' E ' 94' ' ' VAL . . . . . . . . . . . . . 43.7 t -122.87 126.61 74.06 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.187 0 N-CA-C 109.938 -0.393 . . . . 0.0 109.938 179.369 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' E' E ' 95' ' ' VAL . . . . . . . . . . . . . 43.7 t -121.43 133.79 66.83 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.317 0 CA-C-N 116.1 -0.5 . . . . 0.0 109.699 179.555 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' E' E ' 96' ' ' ILE . . . . . . . . . . . . . 68.4 mt -117.36 129.63 73.54 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.283 0 N-CA-C 109.348 -0.612 . . . . 0.0 109.348 -179.778 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' E' E ' 97' ' ' THR . . . . . . . . . . . . . 61.6 p -105.31 162.42 13.44 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-O 121.549 0.69 . . . . 0.0 111.896 -174.53 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' E' E ' 98' ' ' GLU . . . . . . . . . . . . . 13.1 mm-40 -53.8 -28.91 38.0 Favored 'General case' 0 CA--C 1.531 0.241 0 CA-C-N 115.727 -0.669 . . . . 0.0 112.121 179.254 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' E' E ' 99' ' ' GLU . . . . . . . . . . . . . 95.2 mt-10 -79.53 16.92 0.95 Allowed 'General case' 0 CA--C 1.535 0.402 0 N-CA-C 113.164 0.801 . . . . 0.0 113.164 -175.032 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' E' E ' 100' ' ' ASN . . . . . . . . . . . . . 4.0 m-20 62.11 38.12 14.07 Favored 'General case' 0 N--CA 1.463 0.208 0 CA-C-O 121.094 0.473 . . . . 0.0 110.84 177.935 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' E' E ' 101' ' ' GLU . . . . . . . . . . . . . 83.3 tt0 -120.41 143.04 48.67 Favored 'General case' 0 C--N 1.331 -0.203 0 CA-C-N 116.184 -0.462 . . . . 0.0 109.979 178.242 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' E' E ' 102' ' ' VAL . . . . . . . . . . . . . 43.1 t -115.03 127.71 72.48 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.282 0 CA-C-N 116.262 -0.426 . . . . 0.0 109.938 179.135 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' E' E ' 103' ' ' LEU . . . . . . . . . . . . . 6.3 mp -116.34 131.53 56.92 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-N 115.676 -0.693 . . . . 0.0 109.786 175.954 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' E' E ' 104' ' ' ILE . . . . . . . . . . . . . 69.7 mt -118.74 123.69 71.94 Favored 'Isoleucine or valine' 0 C--O 1.234 0.269 0 N-CA-C 110.118 -0.327 . . . . 0.0 110.118 -179.004 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' E' E ' 105' ' ' PHE . . . . . . . . . . . . . 57.5 m-85 -124.6 164.28 20.17 Favored 'General case' 0 C--N 1.332 -0.191 0 O-C-N 124.07 0.856 . . . . 0.0 109.774 -179.725 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' E' E ' 106' ' ' ASN . . . . . . . . . . . . . 44.1 p-10 -96.71 -169.87 1.96 Allowed 'General case' 0 C--N 1.331 -0.199 0 N-CA-C 110.114 -0.328 . . . . 0.0 110.114 173.749 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' E' E ' 107' ' ' GLN . . . . . . . . . . . . . 46.5 tt0 -58.2 -30.04 66.15 Favored 'General case' 0 C--N 1.33 -0.279 0 N-CA-C 111.927 0.344 . . . . 0.0 111.927 -179.897 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' E' E ' 108' ' ' ASN . . . . . . . . . . . . . 11.9 t-20 -88.58 13.29 12.43 Favored 'General case' 0 CA--C 1.535 0.389 0 N-CA-C 113.037 0.754 . . . . 0.0 113.037 -176.578 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' E' E ' 109' ' ' LEU . . . . . . . . . . . . . 21.2 mt 57.06 33.81 23.92 Favored 'General case' 0 CA--C 1.53 0.196 0 N-CA-C 111.812 0.301 . . . . 0.0 111.812 179.01 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' E' E ' 110' ' ' GLU . . . . . . . . . . . . . 96.0 mt-10 -100.19 132.7 45.41 Favored 'General case' 0 C--N 1.329 -0.311 0 N-CA-C 109.171 -0.677 . . . . 0.0 109.171 174.688 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' E' E ' 111' ' ' GLU . . . . . . . . . . . . . 52.6 tt0 -74.79 121.84 22.39 Favored 'General case' 0 C--N 1.327 -0.385 0 CA-C-O 121.017 0.437 . . . . 0.0 110.875 -173.606 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' E' E ' 112' ' ' LEU . . . . . . . . . . . . . 73.4 mt -100.64 -46.12 5.28 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 115.872 -0.603 . . . . 0.0 110.61 179.519 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' E' E ' 113' ' ' TYR . . . . . . . . . . . . . 64.2 t80 -140.89 143.66 34.8 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.121 -0.491 . . . . 0.0 111.277 -177.237 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' E' E ' 114' ' ' ARG . . . . . . . . . . . . . 47.0 ptt85 -144.25 126.14 15.32 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.09 -0.504 . . . . 0.0 110.603 176.417 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' E' E ' 115' ' ' GLY . . . . . . . . . . . . . . . -150.03 147.52 17.83 Favored Glycine 0 CA--C 1.524 0.646 0 N-CA-C 111.11 -0.796 . . . . 0.0 111.11 179.203 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' E' E ' 116' ' ' LYS . . . . . . . . . . . . . 37.1 ttpt -118.72 135.53 54.44 Favored 'General case' 0 C--N 1.33 -0.264 0 N-CA-C 109.92 -0.4 . . . . 0.0 109.92 177.64 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' E' E ' 117' ' ' PHE . . . . . . . . . . . . . 43.0 m-85 -127.25 115.42 19.03 Favored 'General case' 0 C--N 1.331 -0.211 0 CA-C-N 116.215 -0.448 . . . . 0.0 109.914 -177.2 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' E' E ' 118' ' ' GLU . . . . . . . . . . . . . 96.1 mt-10 -53.99 -48.26 70.58 Favored 'General case' 0 C--N 1.33 -0.282 0 C-N-CA 121.005 -0.278 . . . . 0.0 111.344 -176.364 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' E' E ' 119' ' ' ASN . . . . . . . . . . . . . 65.7 m-80 -95.69 31.13 2.12 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 115.964 -0.562 . . . . 0.0 112.074 -174.828 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' E' E ' 120' ' ' LEU . . . . . . . . . . . . . 17.5 tp -53.23 119.92 5.34 Favored 'General case' 0 N--CA 1.463 0.215 0 CA-C-O 120.795 0.331 . . . . 0.0 110.909 179.421 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' E' E ' 121' ' ' ASN . . . . . . . . . . . . . 43.2 m-80 -114.13 -44.13 3.17 Favored 'General case' 0 C--N 1.333 -0.15 0 CA-C-N 116.273 -0.421 . . . . 0.0 111.102 -177.581 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' E' E ' 122' ' ' LYS . . . . . . . . . . . . . 18.7 mtpp -139.79 142.5 36.7 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.33 -0.395 . . . . 0.0 111.706 -174.876 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' E' E ' 123' ' ' VAL . . . . . . . . . . . . . 46.4 t -132.81 126.16 53.7 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.377 0 N-CA-C 109.339 -0.615 . . . . 0.0 109.339 172.953 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' E' E ' 124' ' ' LEU . . . . . . . . . . . . . 7.4 tp -129.09 130.94 47.13 Favored 'General case' 0 C--O 1.232 0.179 0 CA-C-O 120.939 0.4 . . . . 0.0 110.538 -178.114 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' E' E ' 125' ' ' VAL . . . . . . . . . . . . . 41.5 t -124.75 133.17 70.12 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.218 0 CA-C-N 116.014 -0.539 . . . . 0.0 109.884 179.345 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' E' E ' 126' ' ' ARG . . . . . . . . . . . . . 34.7 ttm180 -155.68 124.04 5.88 Favored 'General case' 0 C--N 1.328 -0.327 0 N-CA-C 109.619 -0.512 . . . . 0.0 109.619 179.06 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' E' E ' 127' ' ' ASN . . . . . . . . . . . . . 32.1 t30 57.97 -154.44 0.36 Allowed 'General case' 0 CA--C 1.538 0.487 0 N-CA-C 109.296 -0.631 . . . . 0.0 109.296 -175.936 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' E' E ' 128' ' ' ASP . . . . . . . . . . . . . 9.0 p-10 -80.94 16.5 1.45 Allowed 'General case' 0 CA--C 1.536 0.424 0 N-CA-C 112.51 0.559 . . . . 0.0 112.51 176.635 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' E' E ' 129' ' ' LEU . . . . . . . . . . . . . 26.3 tp -107.7 131.28 54.59 Favored 'General case' 0 C--O 1.232 0.155 0 O-C-N 122.019 -0.426 . . . . 0.0 110.014 177.865 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' E' E ' 130' ' ' VAL . . . . . . . . . . . . . 44.6 t -125.3 134.93 65.58 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.27 0 N-CA-C 109.843 -0.428 . . . . 0.0 109.843 -179.352 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' E' E ' 131' ' ' VAL . . . . . . . . . . . . . 43.4 t -134.05 133.42 56.01 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.252 0 CA-C-O 121.137 0.494 . . . . 0.0 110.252 178.388 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' E' E ' 132' ' ' ILE . . . . . . . . . . . . . 73.1 mt -119.63 132.96 67.95 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.252 0 CA-C-N 115.601 -0.727 . . . . 0.0 109.411 179.648 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' E' E ' 133' ' ' ILE . . . . . . . . . . . . . 42.8 mm -118.03 123.27 71.41 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.277 0 CA-C-O 120.886 0.374 . . . . 0.0 111.2 -174.029 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' E' E ' 134' ' ' ASP . . . . . . . . . . . . . 5.3 p-10 -127.38 151.6 48.58 Favored 'General case' 0 C--N 1.331 -0.227 0 CA-C-N 115.843 -0.617 . . . . 0.0 109.6 173.397 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' E' E ' 135' ' ' GLU . . . . . . . . . . . . . 43.2 tp10 -49.73 -26.38 3.76 Favored 'General case' 0 C--N 1.329 -0.314 0 N-CA-C 112.86 0.689 . . . . 0.0 112.86 -169.859 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' E' E ' 136' ' ' GLN . . . . . . . . . . . . . 97.3 mt-30 -102.9 -31.12 10.41 Favored 'General case' 0 N--CA 1.464 0.228 0 N-CA-C 112.851 0.686 . . . . 0.0 112.851 -174.345 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' E' E ' 137' ' ' LYS . . . . . . . . . . . . . 27.7 ttpp -144.17 153.91 42.59 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-O 121.223 0.535 . . . . 0.0 111.673 -166.689 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' E' E ' 138' ' ' LEU . . . . . . . . . . . . . 6.8 tt -118.73 126.31 51.61 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 115.616 -0.72 . . . . 0.0 110.056 178.388 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' E' E ' 139' ' ' THR . . . . . . . . . . . . . 33.4 m -107.45 125.44 51.25 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.095 -179.901 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' E' E ' 140' ' ' LEU . . . . . . . . . . . . . 7.5 tp -113.91 120.25 40.06 Favored 'General case' 0 C--N 1.329 -0.299 0 N-CA-C 109.065 -0.717 . . . . 0.0 109.065 -179.948 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' E' E ' 141' ' ' ILE . . . . . . . . . . . . . 18.3 mt -120.99 126.09 74.8 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.268 0 CA-C-O 120.894 0.378 . . . . 0.0 110.459 -172.779 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' E' E ' 142' ' ' ARG . . . . . . . . . . . . . 77.9 mtp180 -109.12 130.65 55.48 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 115.651 -0.704 . . . . 0.0 109.977 176.571 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' E' E ' 143' ' ' THR . . . . . . . . . . . . . 58.9 p . . . . . 0 C--O 1.22 -0.453 0 CA-C-O 118.025 -0.988 . . . . 0.0 110.452 -179.937 . . . . . . . . 0 0 . 1 . 015 nuclear orig core ' F' F ' 1' ' ' MET . . . . . . . . . . . . . 26.1 ptt? . . . . . 0 C--O 1.232 0.14 0 CA-C-O 120.914 0.388 . . . . 0.0 111.126 . . . . . . . . . 0 0 . 1 . 015 nuclear orig core ' F' F ' 2' ' ' SER . . . . . . . . . . . . . 7.6 p -111.57 139.94 46.6 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.028 -0.533 . . . . 0.0 110.31 178.26 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' F' F ' 3' ' ' GLU . . . . . . . . . . . . . 81.1 tt0 -143.79 143.89 31.55 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.333 -0.394 . . . . 0.0 111.356 -176.836 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' F' F ' 4' ' ' LEU . . . . . . . . . . . . . 24.1 tp -124.52 129.87 51.42 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 115.872 -0.604 . . . . 0.0 109.87 175.305 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' F' F ' 5' ' ' LYS . . . . . . . . . . . . . 99.3 mttt -110.58 122.08 46.88 Favored 'General case' 0 C--O 1.234 0.26 0 CA-C-N 116.395 -0.366 . . . . 0.0 110.901 -179.513 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' F' F ' 6' ' ' LEU . . . . . . . . . . . . . 32.8 mt -114.52 146.69 40.42 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 115.342 -0.845 . . . . 0.0 110.263 -179.264 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' F' F ' 7' ' ' LYS . . . . . . . . . . . . . 36.7 ttmt -132.92 137.76 30.35 Favored Pre-proline 0 CA--C 1.534 0.338 0 CA-C-O 118.974 -0.536 . . . . 0.0 109.805 174.758 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' F' F ' 8' ' ' PRO . . . . . . . . . . . . . 83.6 Cg_endo -91.52 141.65 2.74 Favored 'Trans proline' 0 N--CA 1.49 1.305 0 C-N-CA 121.773 1.649 . . . . 0.0 112.014 179.359 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' F' F ' 9' ' ' LEU . . . . . . . . . . . . . 37.6 mt -78.44 -46.59 2.01 Favored Pre-proline 0 CA--C 1.534 0.328 0 CA-C-O 118.765 -0.636 . . . . 0.0 111.735 179.056 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' F' F ' 10' ' ' PRO . . . . . . . . . . . . . 91.1 Cg_endo -83.08 145.96 12.54 Favored 'Trans proline' 0 N--CA 1.494 1.54 0 C-N-CA 121.218 1.279 . . . . 0.0 111.52 173.452 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' F' F ' 11' ' ' LYS . . . . . . . . . . . . . 19.8 pttp -84.01 116.78 23.0 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-O 121.324 0.583 . . . . 0.0 110.545 177.988 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' F' F ' 12' ' ' VAL . . . . . . . . . . . . . 11.9 p -151.06 143.88 16.71 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.306 0 CA-C-N 115.662 -0.699 . . . . 0.0 110.274 -179.662 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' F' F ' 13' ' ' GLU . . . . . . . . . . . . . 43.3 mt-10 -83.13 117.16 22.69 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.517 -0.311 . . . . 0.0 110.26 178.53 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' F' F ' 14' ' ' LEU . . . . . . . . . . . . . 34.7 mt -98.41 142.31 24.38 Favored Pre-proline 0 CA--C 1.534 0.358 0 CA-C-O 118.997 -0.525 . . . . 0.0 109.853 -179.695 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' F' F ' 15' ' ' PRO . . . . . . . . . . . . . 26.4 Cg_exo -61.22 160.93 24.79 Favored 'Trans proline' 0 N--CA 1.497 1.724 0 C-N-CA 121.202 1.268 . . . . 0.0 111.828 178.282 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' F' F ' 16' ' ' PRO . . . . . . . . . . . . . 32.7 Cg_exo -59.55 -37.52 88.23 Favored 'Trans proline' 0 N--CA 1.497 1.684 0 C-N-CA 121.508 1.472 . . . . 0.0 112.633 -178.303 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' F' F ' 17' ' ' ASP . . . . . . . . . . . . . 13.6 p-10 -86.44 7.94 23.83 Favored 'General case' 0 CA--C 1.536 0.423 0 N-CA-C 113.132 0.79 . . . . 0.0 113.132 -177.989 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' F' F ' 18' ' ' PHE . . . . . . . . . . . . . 52.0 t80 -58.26 -43.8 88.05 Favored 'General case' 0 N--CA 1.457 -0.102 0 O-C-N 121.985 -0.447 . . . . 0.0 109.991 -179.55 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' F' F ' 19' ' ' VAL . . . . . . . . . . . . . 47.1 t -57.33 -40.86 76.65 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.324 0 CA-C-N 116.112 -0.494 . . . . 0.0 110.322 -179.626 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' F' F ' 20' ' ' ASP . . . . . . . . . . . . . 36.6 t0 -60.37 -43.56 96.46 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-O 120.769 0.319 . . . . 0.0 110.974 -178.258 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' F' F ' 21' ' ' VAL . . . . . . . . . . . . . 47.3 t -64.35 -45.94 94.53 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.279 0 C-N-CA 120.821 -0.352 . . . . 0.0 110.361 -178.382 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' F' F ' 22' ' ' ILE . . . . . . . . . . . . . 50.9 mm -56.21 -43.36 76.15 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.271 0 CA-C-O 120.768 0.318 . . . . 0.0 110.49 177.957 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' F' F ' 23' ' ' ARG . . . . . . . . . . . . . 58.8 ttp180 -55.26 -49.09 72.94 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-O 120.723 0.296 . . . . 0.0 111.182 179.693 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' F' F ' 24' ' ' ILE . . . . . . . . . . . . . 73.7 mt -59.32 -41.34 83.88 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.293 0 CA-C-N 116.447 -0.342 . . . . 0.0 111.042 -177.608 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' F' F ' 25' ' ' LYS . . . . . . . . . . . . . 48.0 mttm -69.04 -42.53 76.2 Favored 'General case' 0 C--N 1.328 -0.344 0 N-CA-C 112.696 0.628 . . . . 0.0 112.696 -178.056 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' F' F ' 26' ' ' LEU . . . . . . . . . . . . . 53.6 mt -79.47 -34.58 41.34 Favored 'General case' 0 C--N 1.331 -0.225 0 N-CA-C 113.72 1.007 . . . . 0.0 113.72 -170.451 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' F' F ' 27' ' ' GLN . . . . . . . . . . . . . 8.3 pt20 -46.67 138.37 6.1 Favored 'General case' 0 N--CA 1.469 0.486 0 N-CA-C 112.998 0.74 . . . . 0.0 112.998 -174.18 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' F' F ' 28' ' ' GLY . . . . . . . . . . . . . . . 100.23 -24.58 31.55 Favored Glycine 0 CA--C 1.533 1.163 0 CA-C-N 115.528 -0.76 . . . . 0.0 112.525 -177.963 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' F' F ' 29' ' ' LYS . . . . . . . . . . . . . 68.7 mttm -98.04 155.08 17.28 Favored 'General case' 0 C--O 1.232 0.177 0 CA-C-N 117.387 0.594 . . . . 0.0 111.337 179.637 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' F' F ' 30' ' ' THR . . . . . . . . . . . . . 29.5 m -105.92 139.43 40.49 Favored 'General case' 0 C--N 1.331 -0.218 0 CA-C-N 115.928 -0.578 . . . . 0.0 110.345 177.989 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' F' F ' 31' ' ' VAL . . . . . . . . . . . . . 34.4 m -129.9 156.71 42.33 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.271 0 CA-C-N 116.357 -0.383 . . . . 0.0 110.616 179.918 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' F' F ' 32' ' ' ARG . . . . . . . . . . . . . 68.1 mtm180 -131.68 152.41 50.89 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-O 121.099 0.476 . . . . 0.0 110.853 177.55 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' F' F ' 33' ' ' THR . . . . . . . . . . . . . 19.8 m -53.39 138.69 32.46 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.304 -0.407 . . . . 0.0 111.175 -179.534 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' F' F ' 34' ' ' GLY . . . . . . . . . . . . . . . 99.59 -17.21 57.91 Favored Glycine 0 CA--C 1.532 1.151 0 C-N-CA 121.211 -0.519 . . . . 0.0 113.268 178.869 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' F' F ' 35' ' ' ASP . . . . . . . . . . . . . 74.3 m-20 -66.83 149.87 49.95 Favored 'General case' 0 N--CA 1.462 0.145 0 CA-C-N 118.076 0.938 . . . . 0.0 111.191 178.98 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' F' F ' 36' ' ' VAL . . . . . . . . . . . . . 43.9 t -121.83 130.0 74.97 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.209 0 N-CA-C 109.607 -0.516 . . . . 0.0 109.607 177.018 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' F' F ' 37' ' ' ILE . . . . . . . . . . . . . 66.2 mt -121.29 138.48 51.52 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.245 0 CA-C-N 116.186 -0.461 . . . . 0.0 109.978 -178.627 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' F' F ' 38' ' ' GLY . . . . . . . . . . . . . . . -113.61 128.02 8.12 Favored Glycine 0 CA--C 1.524 0.652 0 N-CA-C 110.936 -0.866 . . . . 0.0 110.936 179.219 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' F' F ' 39' ' ' ILE . . . . . . . . . . . . . 78.4 mt -127.9 140.49 49.02 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.186 0 CA-C-O 120.789 0.328 . . . . 0.0 110.265 179.2 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' F' F ' 40' ' ' SER . . . . . . . . . . . . . 42.7 t -91.26 115.5 28.07 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.226 -0.443 . . . . 0.0 110.649 176.392 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' F' F ' 41' ' ' ILE . . . . . . . . . . . . . 44.8 mm -119.62 113.22 40.24 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.231 0 N-CA-C 109.961 -0.385 . . . . 0.0 109.961 178.439 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' F' F ' 42' ' ' LEU . . . . . . . . . . . . . 69.1 mt 57.62 36.1 26.39 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.415 -0.357 . . . . 0.0 111.498 179.5 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' F' F ' 43' ' ' GLY . . . . . . . . . . . . . . . 80.34 -10.2 44.35 Favored Glycine 0 CA--C 1.533 1.197 0 C-N-CA 121.289 -0.482 . . . . 0.0 113.517 177.306 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' F' F ' 44' ' ' LYS . . . . . . . . . . . . . 42.8 tttp -99.6 134.68 42.14 Favored 'General case' 0 C--N 1.333 -0.132 0 CA-C-N 117.831 0.816 . . . . 0.0 110.007 177.339 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' F' F ' 45' ' ' GLU . . . . . . . . . . . . . 83.8 tt0 -82.61 127.99 33.89 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-O 120.797 0.332 . . . . 0.0 110.838 -179.014 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' F' F ' 46' ' ' VAL . . . . . . . . . . . . . 10.7 p -121.63 126.11 74.32 Favored 'Isoleucine or valine' 0 C--N 1.333 -0.15 0 N-CA-C 109.639 -0.504 . . . . 0.0 109.639 175.759 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' F' F ' 47' ' ' LYS . . . . . . . . . . . . . 97.7 mttt -99.23 124.82 44.6 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.044 -0.525 . . . . 0.0 110.807 178.235 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' F' F ' 48' ' ' PHE . . . . . . . . . . . . . 32.6 m-85 -108.84 131.89 54.54 Favored 'General case' 0 C--N 1.33 -0.277 0 N-CA-C 109.798 -0.445 . . . . 0.0 109.798 176.548 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' F' F ' 49' ' ' LYS . . . . . . . . . . . . . 34.6 tttp -106.86 135.51 48.29 Favored 'General case' 0 C--N 1.328 -0.355 0 N-CA-C 109.849 -0.426 . . . . 0.0 109.849 177.518 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' F' F ' 50' ' ' VAL . . . . . . . . . . . . . 45.2 t -76.99 106.82 7.37 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.308 0 N-CA-C 109.438 -0.579 . . . . 0.0 109.438 178.027 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' F' F ' 51' ' ' VAL . . . . . . . . . . . . . 47.0 t -73.91 -47.87 41.19 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.324 0 CA-C-N 116.22 -0.446 . . . . 0.0 109.982 -175.009 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' F' F ' 52' ' ' GLN . . . . . . . . . . . . . 63.0 tt0 -159.75 143.85 14.7 Favored 'General case' 0 C--N 1.33 -0.275 0 C-N-CA 120.422 -0.511 . . . . 0.0 111.447 -177.874 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' F' F ' 53' ' ' ALA . . . . . . . . . . . . . . . -123.64 132.9 53.97 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 115.747 -0.66 . . . . 0.0 109.778 175.004 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' F' F ' 54' ' ' TYR . . . . . . . . . . . . . 25.9 t80 -129.2 111.59 18.21 Favored Pre-proline 0 CA--C 1.536 0.416 0 CA-C-O 118.13 -0.938 . . . . 0.0 110.386 178.931 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' F' F ' 55' ' ' PRO . . . . . . . . . . . . . 73.6 Cg_endo -77.26 161.25 93.12 Favored 'Cis proline' 0 N--CA 1.499 1.821 0 CA-C-N 121.943 1.729 . . . . 0.0 112.407 -6.835 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' F' F ' 56' ' ' SER . . . . . . . . . . . . . 60.8 m -108.76 130.78 22.32 Favored Pre-proline 0 CA--C 1.539 0.557 0 CA-C-O 118.434 -0.793 . . . . 0.0 109.487 175.304 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' F' F ' 57' ' ' PRO . . . . . . . . . . . . . 36.5 Cg_endo -66.31 163.13 70.1 Favored 'Cis proline' 0 N--CA 1.498 1.78 0 CA-C-N 121.972 1.74 . . . . 0.0 111.601 -1.3 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' F' F ' 58' ' ' LEU . . . . . . . . . . . . . 15.7 tp -129.37 138.98 51.84 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-O 121.026 0.441 . . . . 0.0 110.405 -178.131 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' F' F ' 59' ' ' ARG . . . . . . . . . . . . . 74.2 ttt180 -104.68 136.31 44.44 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 115.836 -0.62 . . . . 0.0 109.683 176.244 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' F' F ' 60' ' ' VAL . . . . . . . . . . . . . 43.3 t -85.35 116.72 29.14 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.262 0 C-N-CA 120.662 -0.415 . . . . 0.0 110.234 -178.345 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' F' F ' 61' ' ' GLU . . . . . . . . . . . . . 39.1 tp10 -131.06 155.54 46.72 Favored 'General case' 0 C--N 1.328 -0.362 0 N-CA-C 109.005 -0.739 . . . . 0.0 109.005 176.856 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' F' F ' 62' ' ' ASP . . . . . . . . . . . . . 13.9 t70 -51.04 -32.37 21.55 Favored 'General case' 0 C--N 1.327 -0.391 0 N-CA-C 112.011 0.374 . . . . 0.0 112.011 -178.868 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' F' F ' 63' ' ' ARG . . . . . . . . . . . . . 87.6 mtt180 -73.21 -22.06 60.52 Favored 'General case' 0 CA--C 1.534 0.335 0 N-CA-C 112.908 0.707 . . . . 0.0 112.908 -176.801 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' F' F ' 64' ' ' THR . . . . . . . . . . . . . 18.9 m -71.8 143.02 49.65 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-O 120.929 0.395 . . . . 0.0 110.88 -175.3 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' F' F ' 65' ' ' LYS . . . . . . . . . . . . . 91.4 mttt -87.71 129.91 34.99 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 115.973 -0.558 . . . . 0.0 110.049 178.809 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' F' F ' 66' ' ' ILE . . . . . . . . . . . . . 58.2 mt -115.9 125.57 73.08 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.226 0 N-CA-C 109.579 -0.526 . . . . 0.0 109.579 178.32 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' F' F ' 67' ' ' THR . . . . . . . . . . . . . 24.6 m -121.79 142.3 50.35 Favored 'General case' 0 C--N 1.331 -0.227 0 CA-C-O 121.008 0.432 . . . . 0.0 111.215 -176.246 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' F' F ' 68' ' ' LEU . . . . . . . . . . . . . 4.9 tt . . . . . 0 C--N 1.328 -0.346 0 CA-C-N 115.743 -0.662 . . . . 0.0 109.85 178.173 . . . . . . . . 0 0 . 1 . 015 nuclear orig core ' F' F ' 73' ' ' VAL . . . . . . . . . . . . . 35.6 m . . . . . 0 N--CA 1.461 0.115 0 CA-C-O 120.902 0.382 . . . . 0.0 110.702 . . . . . . . . . 0 0 . 1 . 015 nuclear orig core ' F' F ' 74' ' ' ASP . . . . . . . . . . . . . 14.4 t0 -104.47 118.42 36.57 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.017 -0.538 . . . . 0.0 109.784 179.341 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' F' F ' 75' ' ' VAL . . . . . . . . . . . . . 42.9 t -115.55 124.17 71.76 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.301 0 CA-C-O 120.965 0.412 . . . . 0.0 110.658 -177.466 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' F' F ' 76' ' ' LEU . . . . . . . . . . . . . 8.7 mp -122.61 150.73 42.25 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-N 115.74 -0.664 . . . . 0.0 109.687 175.945 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' F' F ' 77' ' ' GLU . . . . . . . . . . . . . 98.9 mt-10 -135.59 141.47 45.14 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-O 121.183 0.516 . . . . 0.0 111.816 -175.984 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' F' F ' 78' ' ' ALA . . . . . . . . . . . . . . . -127.81 143.83 51.11 Favored 'General case' 0 C--N 1.331 -0.204 0 CA-C-N 115.518 -0.764 . . . . 0.0 109.82 175.868 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' F' F ' 79' ' ' LYS . . . . . . . . . . . . . 37.8 mtmt -95.26 112.33 24.05 Favored 'General case' 0 C--N 1.33 -0.239 0 CA-C-O 120.738 0.304 . . . . 0.0 111.074 -176.89 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' F' F ' 80' ' ' ILE . . . . . . . . . . . . . 39.3 mm -139.23 112.67 6.5 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.238 0 N-CA-C 109.404 -0.591 . . . . 0.0 109.404 -179.265 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' F' F ' 81' ' ' LYS . . . . . . . . . . . . . 56.3 pttt -106.67 131.48 53.76 Favored 'General case' 0 N--CA 1.464 0.242 0 CA-C-O 120.961 0.41 . . . . 0.0 111.389 -178.223 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' F' F ' 82' ' ' GLY . . . . . . . . . . . . . . . 89.13 41.95 5.72 Favored Glycine 0 CA--C 1.527 0.804 0 C-N-CA 121.018 -0.61 . . . . 0.0 111.813 176.154 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' F' F ' 83' ' ' ILE . . . . . . . . . . . . . 74.5 mt -77.13 137.9 21.55 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 N-CA-C 109.351 -0.611 . . . . 0.0 109.351 176.329 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' F' F ' 84' ' ' LYS . . . . . . . . . . . . . 19.3 ttpt -101.47 -46.85 4.86 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.431 -0.35 . . . . 0.0 110.527 -176.897 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' F' F ' 85' ' ' ASP . . . . . . . . . . . . . 13.7 t70 -143.72 146.6 33.29 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.448 -0.342 . . . . 0.0 110.479 -179.176 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' F' F ' 86' ' ' VAL . . . . . . . . . . . . . 44.7 t -128.96 128.86 67.81 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.215 0 CA-C-O 120.91 0.386 . . . . 0.0 110.405 -178.847 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' F' F ' 87' ' ' ILE . . . . . . . . . . . . . 44.7 mm -121.35 128.36 75.91 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.235 0 N-CA-C 109.359 -0.608 . . . . 0.0 109.359 177.903 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' F' F ' 88' ' ' LEU . . . . . . . . . . . . . 62.1 mt -120.21 139.26 52.92 Favored 'General case' 0 C--N 1.332 -0.194 0 CA-C-O 121.207 0.527 . . . . 0.0 111.882 -175.277 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' F' F ' 89' ' ' ASP . . . . . . . . . . . . . 13.4 t70 -133.61 154.92 50.52 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 115.423 -0.808 . . . . 0.0 109.436 175.394 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' F' F ' 90' ' ' GLU . . . . . . . . . . . . . 44.2 mt-10 -49.46 -36.78 23.7 Favored 'General case' 0 C--N 1.329 -0.294 0 N-CA-C 112.832 0.678 . . . . 0.0 112.832 -171.805 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' F' F ' 91' ' ' ASN . . . . . . . . . . . . . 9.1 m120 -127.1 22.11 6.69 Favored 'General case' 0 N--CA 1.468 0.449 0 N-CA-C 112.869 0.692 . . . . 0.0 112.869 -176.651 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' F' F ' 92' ' ' LEU . . . . . . . . . . . . . 5.8 mt -153.49 144.4 22.79 Favored 'General case' 0 C--N 1.331 -0.199 0 N-CA-C 109.573 -0.528 . . . . 0.0 109.573 -177.894 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' F' F ' 93' ' ' ILE . . . . . . . . . . . . . 71.2 mt -127.28 122.25 59.34 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.288 0 N-CA-C 109.407 -0.59 . . . . 0.0 109.407 178.41 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' F' F ' 94' ' ' VAL . . . . . . . . . . . . . 43.5 t -121.95 126.97 75.22 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.242 0 CA-C-O 120.911 0.386 . . . . 0.0 110.014 -179.821 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' F' F ' 95' ' ' VAL . . . . . . . . . . . . . 44.0 t -120.47 133.25 67.78 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.384 0 CA-C-N 115.963 -0.562 . . . . 0.0 109.662 179.671 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' F' F ' 96' ' ' ILE . . . . . . . . . . . . . 66.9 mt -114.99 124.54 71.75 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.231 0 N-CA-C 109.121 -0.696 . . . . 0.0 109.121 178.726 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' F' F ' 97' ' ' THR . . . . . . . . . . . . . 45.3 p -98.28 156.75 16.56 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-O 121.114 0.483 . . . . 0.0 111.474 -176.139 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' F' F ' 98' ' ' GLU . . . . . . . . . . . . . 96.7 mt-10 -54.09 -26.35 26.68 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 116.037 -0.529 . . . . 0.0 112.027 178.307 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' F' F ' 99' ' ' GLU . . . . . . . . . . . . . 34.6 tt0 -79.33 17.03 0.88 Allowed 'General case' 0 CA--C 1.538 0.51 0 N-CA-C 112.582 0.586 . . . . 0.0 112.582 -176.83 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' F' F ' 100' ' ' ASN . . . . . . . . . . . . . 2.0 m120 64.18 36.2 9.68 Favored 'General case' 0 CA--C 1.531 0.224 0 O-C-N 121.84 -0.538 . . . . 0.0 110.984 176.002 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' F' F ' 101' ' ' GLU . . . . . . . . . . . . . 79.1 tt0 -117.15 142.88 46.46 Favored 'General case' 0 C--O 1.231 0.099 0 N-CA-C 109.917 -0.401 . . . . 0.0 109.917 178.248 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' F' F ' 102' ' ' VAL . . . . . . . . . . . . . 43.4 t -115.56 125.16 72.66 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.312 0 N-CA-C 109.728 -0.471 . . . . 0.0 109.728 -179.848 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' F' F ' 103' ' ' LEU . . . . . . . . . . . . . 40.0 mt -117.08 131.06 57.01 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 115.972 -0.558 . . . . 0.0 110.606 178.256 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' F' F ' 104' ' ' ILE . . . . . . . . . . . . . 67.0 mt -117.19 120.08 63.87 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.221 0 CA-C-N 116.405 -0.361 . . . . 0.0 110.314 -179.477 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' F' F ' 105' ' ' PHE . . . . . . . . . . . . . 76.1 m-85 -121.58 167.4 12.93 Favored 'General case' 0 C--O 1.231 0.128 0 O-C-N 124.092 0.87 . . . . 0.0 109.688 178.238 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' F' F ' 106' ' ' ASN . . . . . . . . . . . . . 43.0 p-10 -104.09 -170.99 1.85 Allowed 'General case' 0 C--N 1.332 -0.172 0 N-CA-C 109.657 -0.497 . . . . 0.0 109.657 170.653 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' F' F ' 107' ' ' GLN . . . . . . . . . . . . . 50.3 tt0 -58.41 -29.98 66.51 Favored 'General case' 0 C--N 1.328 -0.338 0 N-CA-C 111.925 0.343 . . . . 0.0 111.925 179.735 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' F' F ' 108' ' ' ASN . . . . . . . . . . . . . 47.1 t30 -88.22 13.7 10.89 Favored 'General case' 0 CA--C 1.534 0.359 0 N-CA-C 112.91 0.707 . . . . 0.0 112.91 -176.484 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' F' F ' 109' ' ' LEU . . . . . . . . . . . . . 82.1 mt 57.2 33.6 23.55 Favored 'General case' 0 CA--C 1.529 0.173 0 N-CA-C 111.823 0.305 . . . . 0.0 111.823 176.875 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' F' F ' 110' ' ' GLU . . . . . . . . . . . . . 95.8 mt-10 -100.0 138.61 36.84 Favored 'General case' 0 C--N 1.331 -0.239 0 N-CA-C 109.339 -0.615 . . . . 0.0 109.339 175.616 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' F' F ' 111' ' ' GLU . . . . . . . . . . . . . 56.7 tt0 -75.49 121.9 23.05 Favored 'General case' 0 C--N 1.328 -0.338 0 C-N-CA 120.64 -0.424 . . . . 0.0 110.532 -175.727 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' F' F ' 112' ' ' LEU . . . . . . . . . . . . . 32.4 mt -104.36 -46.02 4.51 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.065 -0.516 . . . . 0.0 110.657 179.715 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' F' F ' 113' ' ' TYR . . . . . . . . . . . . . 58.8 t80 -143.16 141.06 31.06 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 116.247 -0.433 . . . . 0.0 111.295 -179.35 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' F' F ' 114' ' ' ARG . . . . . . . . . . . . . 39.0 ptt180 -137.81 123.76 20.16 Favored 'General case' 0 C--N 1.331 -0.203 0 CA-C-N 115.837 -0.619 . . . . 0.0 110.252 178.124 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' F' F ' 115' ' ' GLY . . . . . . . . . . . . . . . -150.08 160.94 28.74 Favored Glycine 0 CA--C 1.523 0.582 0 C-N-CA 120.565 -0.826 . . . . 0.0 111.472 -179.289 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' F' F ' 116' ' ' LYS . . . . . . . . . . . . . 32.5 ttpt -127.18 141.4 51.75 Favored 'General case' 0 C--N 1.33 -0.249 0 N-CA-C 109.838 -0.431 . . . . 0.0 109.838 176.487 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' F' F ' 117' ' ' PHE . . . . . . . . . . . . . 43.0 m-85 -141.17 113.82 8.28 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.408 -0.36 . . . . 0.0 110.061 -179.545 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' F' F ' 118' ' ' GLU . . . . . . . . . . . . . 95.9 mt-10 -55.6 -44.13 76.7 Favored 'General case' 0 C--N 1.329 -0.321 0 C-N-CA 120.867 -0.333 . . . . 0.0 111.093 -176.252 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' F' F ' 119' ' ' ASN . . . . . . . . . . . . . 3.5 m120 -98.72 31.11 3.03 Favored 'General case' 0 C--N 1.33 -0.246 0 N-CA-C 112.216 0.45 . . . . 0.0 112.216 -174.387 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' F' F ' 120' ' ' LEU . . . . . . . . . . . . . 17.5 tp -57.04 121.03 9.04 Favored 'General case' 0 N--CA 1.463 0.206 0 N-CA-C 110.092 -0.336 . . . . 0.0 110.092 177.475 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' F' F ' 121' ' ' ASN . . . . . . . . . . . . . 5.3 t30 -114.08 -44.11 3.18 Favored 'General case' 0 C--N 1.332 -0.182 0 C-N-CA 121.208 -0.197 . . . . 0.0 111.25 -176.75 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' F' F ' 122' ' ' LYS . . . . . . . . . . . . . 86.3 mttt -142.97 147.87 35.9 Favored 'General case' 0 C--N 1.332 -0.19 0 CA-C-O 121.164 0.507 . . . . 0.0 111.788 -178.986 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' F' F ' 123' ' ' VAL . . . . . . . . . . . . . 42.9 t -128.74 129.56 68.49 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.186 0 CA-C-N 115.729 -0.668 . . . . 0.0 109.553 174.823 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' F' F ' 124' ' ' LEU . . . . . . . . . . . . . 21.7 mt -123.81 135.32 53.71 Favored 'General case' 0 C--N 1.331 -0.212 0 CA-C-O 120.81 0.338 . . . . 0.0 110.679 -178.841 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' F' F ' 125' ' ' VAL . . . . . . . . . . . . . 11.7 p -136.86 123.95 30.91 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.273 0 CA-C-N 116.233 -0.44 . . . . 0.0 110.214 178.0 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' F' F ' 126' ' ' ARG . . . . . . . . . . . . . 89.6 mtt180 -152.94 132.92 13.33 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.053 -0.521 . . . . 0.0 109.873 178.938 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' F' F ' 127' ' ' ASN . . . . . . . . . . . . . 3.9 m120 55.58 -151.76 0.38 Allowed 'General case' 0 CA--C 1.541 0.602 0 N-CA-C 109.898 -0.408 . . . . 0.0 109.898 179.38 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' F' F ' 128' ' ' ASP . . . . . . . . . . . . . 19.7 p-10 -81.35 15.3 2.05 Favored 'General case' 0 CA--C 1.536 0.417 0 CA-C-N 118.643 0.656 . . . . 0.0 112.764 178.675 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' F' F ' 129' ' ' LEU . . . . . . . . . . . . . 31.7 mt -111.05 131.14 55.31 Favored 'General case' 0 C--O 1.233 0.213 0 O-C-N 121.936 -0.477 . . . . 0.0 110.651 179.588 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' F' F ' 130' ' ' VAL . . . . . . . . . . . . . 41.2 t -122.15 133.64 67.85 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.223 0 N-CA-C 109.115 -0.698 . . . . 0.0 109.115 176.839 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' F' F ' 131' ' ' VAL . . . . . . . . . . . . . 42.6 t -135.73 137.4 49.3 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.213 0 CA-C-O 121.049 0.452 . . . . 0.0 110.694 -176.852 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' F' F ' 132' ' ' ILE . . . . . . . . . . . . . 67.7 mt -120.55 133.42 67.29 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.242 0 CA-C-N 115.748 -0.66 . . . . 0.0 109.604 179.732 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' F' F ' 133' ' ' ILE . . . . . . . . . . . . . 40.5 mm -119.8 120.6 63.79 Favored 'Isoleucine or valine' 0 C--O 1.234 0.269 0 CA-C-O 120.876 0.37 . . . . 0.0 110.949 -177.294 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' F' F ' 134' ' ' ASP . . . . . . . . . . . . . 7.2 p-10 -134.16 146.9 50.62 Favored 'General case' 0 C--N 1.329 -0.285 0 N-CA-C 109.497 -0.556 . . . . 0.0 109.497 174.562 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' F' F ' 135' ' ' GLU . . . . . . . . . . . . . 52.6 tt0 -49.86 -25.96 3.62 Favored 'General case' 0 C--N 1.328 -0.358 0 N-CA-C 112.948 0.722 . . . . 0.0 112.948 -170.145 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' F' F ' 136' ' ' GLN . . . . . . . . . . . . . 60.8 tp60 -99.2 -31.2 11.85 Favored 'General case' 0 C--N 1.332 -0.183 0 N-CA-C 112.384 0.512 . . . . 0.0 112.384 -174.767 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' F' F ' 137' ' ' LYS . . . . . . . . . . . . . 89.4 mttt -139.85 153.9 47.16 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-O 121.214 0.53 . . . . 0.0 111.532 -170.515 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' F' F ' 138' ' ' LEU . . . . . . . . . . . . . 4.3 tt -121.37 126.85 50.43 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 115.625 -0.716 . . . . 0.0 109.32 174.171 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' F' F ' 139' ' ' THR . . . . . . . . . . . . . 31.8 m -116.67 134.21 55.09 Favored 'General case' 0 N--CA 1.462 0.144 0 CA-C-O 120.891 0.377 . . . . 0.0 111.385 -176.338 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' F' F ' 140' ' ' LEU . . . . . . . . . . . . . 24.0 tp -120.99 122.65 40.6 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 115.387 -0.824 . . . . 0.0 109.167 179.721 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' F' F ' 141' ' ' ILE . . . . . . . . . . . . . 19.2 mt -119.87 125.24 74.09 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.323 0 CA-C-O 120.974 0.416 . . . . 0.0 110.278 -175.638 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' F' F ' 142' ' ' ARG . . . . . . . . . . . . . 43.1 mtm180 -107.59 124.67 50.29 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 115.205 -0.907 . . . . 0.0 110.134 178.948 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' F' F ' 143' ' ' THR . . . . . . . . . . . . . 21.5 p . . . . . 0 C--O 1.221 -0.443 0 CA-C-O 117.991 -1.004 . . . . 0.0 110.584 179.852 . . . . . . . . 0 0 . 1 . 016 nuclear orig core ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 5.0 p . . . . . 0 C--O 1.231 0.08 0 CA-C-O 120.932 0.396 . . . . 0.0 110.362 . . . . . . . . . 0 0 . 1 . 016 nuclear orig core ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 95.5 mt-10 -141.85 142.42 33.12 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.115 -0.493 . . . . 0.0 111.242 -178.061 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 4' ' ' LEU . . . . . . . . . . . . . 18.1 tp -124.32 124.45 42.41 Favored 'General case' 0 C--N 1.331 -0.218 0 CA-C-N 115.757 -0.656 . . . . 0.0 109.848 175.718 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 5' ' ' LYS . . . . . . . . . . . . . 98.0 mttt -105.09 120.55 41.79 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.65 -179.7 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 37.8 mt -115.37 148.81 38.86 Favored 'General case' 0 C--N 1.332 -0.183 0 CA-C-N 115.624 -0.716 . . . . 0.0 110.237 -178.414 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 21.3 ttpt -129.83 135.53 27.64 Favored Pre-proline 0 CA--C 1.534 0.339 0 CA-C-O 118.851 -0.595 . . . . 0.0 109.443 174.276 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 8' ' ' PRO . . . . . . . . . . . . . 76.8 Cg_endo -91.54 135.54 1.72 Allowed 'Trans proline' 0 N--CA 1.489 1.239 0 C-N-CA 121.694 1.596 . . . . 0.0 111.683 177.52 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 48.6 mt -72.15 -47.24 10.99 Favored Pre-proline 0 CA--C 1.533 0.309 0 CA-C-O 118.594 -0.717 . . . . 0.0 112.171 -178.988 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 83.4 Cg_endo -80.8 148.65 17.75 Favored 'Trans proline' 0 N--CA 1.496 1.666 0 C-N-CA 121.217 1.278 . . . . 0.0 111.753 175.905 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 51.2 tptt -85.2 96.05 9.36 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.466 -0.334 . . . . 0.0 110.275 179.234 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 12.5 p -142.52 149.65 18.98 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.243 0 CA-C-N 116.25 -0.432 . . . . 0.0 110.692 -178.326 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 83.1 tt0 -89.92 129.48 36.27 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-N 116.163 -0.471 . . . . 0.0 110.551 179.378 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 14' ' ' LEU . . . . . . . . . . . . . 48.3 mt -98.44 153.06 38.16 Favored Pre-proline 0 CA--C 1.532 0.282 0 CA-C-N 116.425 -0.352 . . . . 0.0 110.888 -178.872 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 15' ' ' PRO . . . . . . . . . . . . . 30.1 Cg_exo -61.19 159.88 28.78 Favored 'Trans proline' 0 N--CA 1.497 1.705 0 C-N-CA 121.356 1.371 . . . . 0.0 111.963 176.627 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 16' ' ' PRO . . . . . . . . . . . . . 31.6 Cg_exo -59.72 -42.17 48.8 Favored 'Trans proline' 0 N--CA 1.495 1.613 0 C-N-CA 121.475 1.45 . . . . 0.0 112.648 -179.068 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 17' ' ' ASP . . . . . . . . . . . . . 13.1 p-10 -84.13 11.65 7.72 Favored 'General case' 0 CA--C 1.535 0.383 0 N-CA-C 113.129 0.789 . . . . 0.0 113.129 -177.676 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 18' ' ' PHE . . . . . . . . . . . . . 31.2 t80 -57.12 -45.04 83.81 Favored 'General case' 0 N--CA 1.458 -0.074 0 O-C-N 121.917 -0.489 . . . . 0.0 110.433 -178.408 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 19' ' ' VAL . . . . . . . . . . . . . 48.0 t -57.06 -41.06 76.85 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.245 0 CA-C-N 116.371 -0.377 . . . . 0.0 110.534 -178.711 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 68.8 m-20 -59.79 -43.38 94.43 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-O 120.899 0.381 . . . . 0.0 110.703 -178.342 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 45.4 t -64.34 -46.56 92.77 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.321 0 CA-C-N 116.281 -0.418 . . . . 0.0 110.56 -178.231 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 22' ' ' ILE . . . . . . . . . . . . . 50.6 mm -55.11 -47.07 77.63 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.222 0 C-N-CA 120.99 -0.284 . . . . 0.0 110.828 179.272 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 23' ' ' ARG . . . . . . . . . . . . . 56.5 ttp180 -54.12 -50.03 67.82 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-O 120.697 0.284 . . . . 0.0 111.329 -179.021 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 24' ' ' ILE . . . . . . . . . . . . . 74.0 mt -58.91 -42.31 85.52 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.239 0 CA-C-N 116.432 -0.349 . . . . 0.0 111.25 -178.157 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 61.9 mtpt -67.76 -41.77 82.8 Favored 'General case' 0 C--N 1.328 -0.354 0 N-CA-C 112.404 0.52 . . . . 0.0 112.404 -177.405 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 49.2 mt -79.43 -37.38 37.21 Favored 'General case' 0 C--N 1.33 -0.28 0 N-CA-C 113.368 0.877 . . . . 0.0 113.368 -169.495 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 27' ' ' GLN . . . . . . . . . . . . . 9.9 pt20 -46.84 136.19 8.39 Favored 'General case' 0 N--CA 1.47 0.553 0 N-CA-C 112.728 0.64 . . . . 0.0 112.728 -176.09 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 99.72 -23.99 33.94 Favored Glycine 0 CA--C 1.534 1.252 0 CA-C-N 115.624 -0.716 . . . . 0.0 112.448 -176.633 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 28.8 mtpp -97.91 155.17 17.2 Favored 'General case' 0 C--O 1.233 0.209 0 CA-C-N 117.344 0.572 . . . . 0.0 111.005 179.983 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 30' ' ' THR . . . . . . . . . . . . . 33.8 m -105.53 138.03 42.39 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.143 -0.481 . . . . 0.0 110.118 176.848 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 35.2 m -129.95 149.48 33.65 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.271 0 CA-C-O 121.018 0.437 . . . . 0.0 110.933 -179.27 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 32' ' ' ARG . . . . . . . . . . . . . 29.5 ttm105 -130.05 148.01 51.86 Favored 'General case' 0 C--N 1.331 -0.239 0 CA-C-N 115.905 -0.589 . . . . 0.0 110.233 178.9 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 33' ' ' THR . . . . . . . . . . . . . 25.4 m -52.24 138.07 27.08 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.397 -0.365 . . . . 0.0 111.496 -177.58 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 100.28 -17.1 57.41 Favored Glycine 0 CA--C 1.533 1.161 0 CA-C-O 119.649 -0.528 . . . . 0.0 113.288 178.862 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 72.6 m-20 -65.85 149.85 49.52 Favored 'General case' 0 C--O 1.231 0.128 0 CA-C-N 118.053 0.927 . . . . 0.0 111.199 -179.965 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 45.6 t -119.8 129.3 75.57 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.275 0 CA-C-N 115.904 -0.589 . . . . 0.0 109.701 177.548 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 37' ' ' ILE . . . . . . . . . . . . . 63.8 mt -120.0 137.24 54.49 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.266 0 CA-C-N 116.162 -0.472 . . . . 0.0 109.797 -179.647 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . -116.45 128.86 8.14 Favored Glycine 0 CA--C 1.525 0.672 0 N-CA-C 110.848 -0.901 . . . . 0.0 110.848 179.948 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 39' ' ' ILE . . . . . . . . . . . . . 68.3 mt -126.66 129.94 71.62 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.169 0 N-CA-C 110.056 -0.349 . . . . 0.0 110.056 179.238 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 40' ' ' SER . . . . . . . . . . . . . 16.8 p -91.31 119.0 30.98 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.1 -0.5 . . . . 0.0 110.4 175.49 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 41' ' ' ILE . . . . . . . . . . . . . 70.2 mt -127.26 113.74 33.5 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.197 0 N-CA-C 110.113 -0.329 . . . . 0.0 110.113 -179.546 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 7.8 mp 56.62 39.25 29.89 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-O 121.247 0.546 . . . . 0.0 110.913 179.184 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . 79.38 -10.23 37.33 Favored Glycine 0 CA--C 1.533 1.172 0 C-N-CA 121.252 -0.499 . . . . 0.0 113.653 175.952 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 44' ' ' LYS . . . . . . . . . . . . . 78.7 tttt -98.27 126.49 43.78 Favored 'General case' 0 C--N 1.333 -0.11 0 CA-C-N 117.913 0.856 . . . . 0.0 110.094 177.882 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 77.3 tt0 -84.9 127.45 34.16 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.372 -0.376 . . . . 0.0 111.081 -179.427 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 46' ' ' VAL . . . . . . . . . . . . . 10.9 p -123.07 125.18 71.73 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.187 0 N-CA-C 110.085 -0.339 . . . . 0.0 110.085 175.874 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 99.1 mttt -99.34 127.88 45.41 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.057 -0.52 . . . . 0.0 111.024 177.248 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 48' ' ' PHE . . . . . . . . . . . . . 34.2 m-85 -112.49 131.91 55.34 Favored 'General case' 0 C--N 1.33 -0.279 0 N-CA-C 109.605 -0.517 . . . . 0.0 109.605 176.913 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 85.9 tttt -105.07 134.36 48.29 Favored 'General case' 0 C--N 1.328 -0.363 0 N-CA-C 110.084 -0.339 . . . . 0.0 110.084 177.562 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 50' ' ' VAL . . . . . . . . . . . . . 43.2 t -77.84 105.09 6.41 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.371 0 N-CA-C 109.491 -0.559 . . . . 0.0 109.491 177.908 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 51' ' ' VAL . . . . . . . . . . . . . 46.9 t -72.88 -47.99 46.81 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.335 0 CA-C-N 116.018 -0.537 . . . . 0.0 110.075 -174.145 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 52' ' ' GLN . . . . . . . . . . . . . 44.4 tt0 -158.44 135.53 9.91 Favored 'General case' 0 C--N 1.33 -0.27 0 C-N-CA 120.274 -0.571 . . . . 0.0 111.796 -177.954 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -110.23 129.44 55.72 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 115.839 -0.619 . . . . 0.0 109.649 175.032 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 54' ' ' TYR . . . . . . . . . . . . . 60.2 t80 -129.03 106.64 18.02 Favored Pre-proline 0 CA--C 1.535 0.378 0 CA-C-O 118.373 -0.823 . . . . 0.0 110.546 -178.437 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 55' ' ' PRO . . . . . . . . . . . . . 73.0 Cg_endo -77.13 168.94 75.59 Favored 'Cis proline' 0 N--CA 1.499 1.81 0 CA-C-N 121.67 1.632 . . . . 0.0 112.458 -5.766 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 56' ' ' SER . . . . . . . . . . . . . 74.3 m -118.01 134.42 23.31 Favored Pre-proline 0 CA--C 1.539 0.556 0 CA-C-O 118.486 -0.769 . . . . 0.0 109.473 174.494 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 57' ' ' PRO . . . . . . . . . . . . . 51.7 Cg_endo -70.78 146.98 85.78 Favored 'Cis proline' 0 N--CA 1.497 1.699 0 CA-C-N 121.88 1.707 . . . . 0.0 111.347 -1.911 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 58' ' ' LEU . . . . . . . . . . . . . 20.6 tp -108.0 136.3 47.93 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 116.39 -0.368 . . . . 0.0 110.86 -177.944 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 59' ' ' ARG . . . . . . . . . . . . . 55.8 ttp180 -104.31 117.94 35.42 Favored 'General case' 0 C--N 1.327 -0.389 0 N-CA-C 109.052 -0.721 . . . . 0.0 109.052 174.018 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 42.4 t -71.55 122.13 23.08 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.353 0 CA-C-N 116.353 -0.385 . . . . 0.0 110.698 -173.114 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 95.4 mt-10 -131.07 165.32 23.51 Favored 'General case' 0 C--N 1.331 -0.225 0 CA-C-N 115.795 -0.639 . . . . 0.0 110.033 177.28 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 62' ' ' ASP . . . . . . . . . . . . . 14.9 m-20 -55.19 -32.68 62.39 Favored 'General case' 0 C--N 1.329 -0.315 0 N-CA-C 111.758 0.281 . . . . 0.0 111.758 -179.252 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 63' ' ' ARG . . . . . . . . . . . . . 17.6 ptm180 -81.35 6.56 13.99 Favored 'General case' 0 CA--C 1.535 0.399 0 N-CA-C 113.524 0.935 . . . . 0.0 113.524 -176.512 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 34.4 m -91.41 136.16 33.31 Favored 'General case' 0 C--O 1.232 0.147 0 CA-C-N 118.26 0.482 . . . . 0.0 110.751 -179.754 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 65' ' ' LYS . . . . . . . . . . . . . 68.7 mttm -89.51 135.42 33.61 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.005 -0.543 . . . . 0.0 110.319 179.473 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 66' ' ' ILE . . . . . . . . . . . . . 4.3 mp -116.45 127.42 74.06 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.282 0 N-CA-C 109.552 -0.536 . . . . 0.0 109.552 178.76 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 67' ' ' THR . . . . . . . . . . . . . 25.0 m -131.38 148.66 52.68 Favored 'General case' 0 N--CA 1.464 0.237 0 CA-C-O 121.137 0.494 . . . . 0.0 111.944 -175.376 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 68' ' ' LEU . . . . . . . . . . . . . 8.5 mp . . . . . 0 C--N 1.331 -0.219 0 CA-C-N 115.629 -0.714 . . . . 0.0 109.909 175.356 . . . . . . . . 0 0 . 1 . 016 nuclear orig core ' A' A ' 74' ' ' ASP . . . . . . . . . . . . . 13.3 t70 . . . . . 0 N--CA 1.458 -0.07 0 N-CA-C 110.432 -0.21 . . . . 0.0 110.432 . . . . . . . . . 0 0 . 1 . 016 nuclear orig core ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 41.4 t -124.91 124.11 67.08 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.206 0 CA-C-O 121.141 0.496 . . . . 0.0 110.691 -176.481 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 76' ' ' LEU . . . . . . . . . . . . . 6.4 mp -122.1 150.14 42.58 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 115.586 -0.734 . . . . 0.0 109.22 173.841 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 77' ' ' GLU . . . . . . . . . . . . . 97.0 mt-10 -137.86 137.07 37.74 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-O 121.126 0.489 . . . . 0.0 111.237 -178.073 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 78' ' ' ALA . . . . . . . . . . . . . . . -125.06 129.61 50.6 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 115.708 -0.678 . . . . 0.0 109.532 175.803 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 79' ' ' LYS . . . . . . . . . . . . . 39.2 ttpt -73.69 120.15 18.89 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-O 120.795 0.331 . . . . 0.0 110.575 -177.848 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 80' ' ' ILE . . . . . . . . . . . . . 25.9 mm -139.34 98.48 1.15 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.326 0 N-CA-C 109.268 -0.642 . . . . 0.0 109.268 -178.238 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 81' ' ' LYS . . . . . . . . . . . . . 56.2 mtmt -95.75 127.22 41.59 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-O 120.982 0.42 . . . . 0.0 110.97 -177.896 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . 89.18 42.08 5.67 Favored Glycine 0 CA--C 1.525 0.675 0 N-CA-C 111.566 -0.614 . . . . 0.0 111.566 176.43 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 83' ' ' ILE . . . . . . . . . . . . . 69.0 mt -67.26 137.86 23.94 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.289 0 N-CA-C 109.657 -0.497 . . . . 0.0 109.657 176.871 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 84' ' ' LYS . . . . . . . . . . . . . 54.5 tttp -95.46 -49.91 5.22 Favored 'General case' 0 C--N 1.327 -0.395 0 CA-C-N 116.15 -0.477 . . . . 0.0 109.868 -179.031 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 85' ' ' ASP . . . . . . . . . . . . . 10.4 t70 -159.16 149.95 19.77 Favored 'General case' 0 C--N 1.327 -0.401 0 CA-C-N 115.589 -0.732 . . . . 0.0 110.239 178.605 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 86' ' ' VAL . . . . . . . . . . . . . 42.1 t -130.12 131.32 65.94 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.275 0 CA-C-O 120.898 0.38 . . . . 0.0 110.237 179.241 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 87' ' ' ILE . . . . . . . . . . . . . 5.1 mp -119.07 129.01 75.77 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.281 0 CA-C-N 115.89 -0.596 . . . . 0.0 109.395 178.383 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 88' ' ' LEU . . . . . . . . . . . . . 13.3 tp -118.58 133.24 56.01 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-O 121.069 0.461 . . . . 0.0 111.302 -176.078 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 89' ' ' ASP . . . . . . . . . . . . . 12.8 t70 -130.92 159.03 38.63 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 115.637 -0.71 . . . . 0.0 109.38 175.109 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 95.8 mt-10 -47.41 -37.69 11.92 Favored 'General case' 0 C--N 1.33 -0.241 0 N-CA-C 113.029 0.751 . . . . 0.0 113.029 -172.362 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 91' ' ' ASN . . . . . . . . . . . . . 69.7 m-80 -132.11 36.38 3.65 Favored 'General case' 0 N--CA 1.464 0.235 0 N-CA-C 111.877 0.325 . . . . 0.0 111.877 -175.443 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 92' ' ' LEU . . . . . . . . . . . . . 19.3 tp -166.07 139.68 4.26 Favored 'General case' 0 C--N 1.332 -0.181 0 C-N-CA 120.836 -0.346 . . . . 0.0 110.99 -179.288 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 93' ' ' ILE . . . . . . . . . . . . . 68.9 mt -126.27 118.03 50.22 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.164 0 N-CA-C 109.089 -0.708 . . . . 0.0 109.089 177.625 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 94' ' ' VAL . . . . . . . . . . . . . 42.9 t -120.25 127.0 75.87 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.289 0 N-CA-C 109.903 -0.406 . . . . 0.0 109.903 -179.004 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 95' ' ' VAL . . . . . . . . . . . . . 42.7 t -120.89 134.04 65.6 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.311 0 CA-C-N 116.131 -0.486 . . . . 0.0 109.983 -179.435 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 96' ' ' ILE . . . . . . . . . . . . . 57.5 mt -115.42 127.62 72.92 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.324 0 N-CA-C 109.155 -0.683 . . . . 0.0 109.155 178.105 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 97' ' ' THR . . . . . . . . . . . . . 59.4 p -101.95 153.31 19.98 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-O 121.015 0.436 . . . . 0.0 110.955 -177.752 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 98' ' ' GLU . . . . . . . . . . . . . 96.4 mt-10 -53.9 -23.4 12.62 Favored 'General case' 0 CA--C 1.534 0.36 0 N-CA-C 112.297 0.481 . . . . 0.0 112.297 179.426 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 99' ' ' GLU . . . . . . . . . . . . . 95.0 mt-10 -78.79 15.27 1.1 Allowed 'General case' 0 CA--C 1.536 0.419 0 N-CA-C 113.121 0.785 . . . . 0.0 113.121 -177.536 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 100' ' ' ASN . . . . . . . . . . . . . 3.6 m-20 64.01 38.07 8.86 Favored 'General case' 0 N--CA 1.463 0.188 0 CA-C-O 120.972 0.415 . . . . 0.0 110.965 177.435 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 101' ' ' GLU . . . . . . . . . . . . . 83.4 tt0 -119.22 142.82 47.68 Favored 'General case' 0 C--N 1.332 -0.165 0 CA-C-N 116.177 -0.465 . . . . 0.0 109.876 176.551 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 102' ' ' VAL . . . . . . . . . . . . . 45.5 t -115.77 126.46 73.31 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.283 0 CA-C-N 116.117 -0.492 . . . . 0.0 109.759 -178.845 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 103' ' ' LEU . . . . . . . . . . . . . 46.6 mt -120.48 132.41 55.19 Favored 'General case' 0 C--N 1.331 -0.202 0 CA-C-N 115.992 -0.549 . . . . 0.0 110.517 178.313 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 104' ' ' ILE . . . . . . . . . . . . . 67.7 mt -118.95 122.43 69.33 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.256 0 CA-C-N 116.332 -0.395 . . . . 0.0 110.324 -178.48 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 105' ' ' PHE . . . . . . . . . . . . . 85.8 m-85 -123.99 165.06 18.1 Favored 'General case' 0 C--O 1.232 0.17 0 O-C-N 123.895 0.747 . . . . 0.0 109.892 -179.527 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 106' ' ' ASN . . . . . . . . . . . . . 46.8 p-10 -100.63 -171.36 2.0 Favored 'General case' 0 C--N 1.331 -0.21 0 N-CA-C 109.742 -0.466 . . . . 0.0 109.742 172.665 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 107' ' ' GLN . . . . . . . . . . . . . 29.4 tt0 -61.09 -29.85 70.0 Favored 'General case' 0 C--N 1.329 -0.285 0 N-CA-C 111.974 0.361 . . . . 0.0 111.974 -178.642 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 108' ' ' ASN . . . . . . . . . . . . . 3.8 t-20 -83.54 10.69 8.44 Favored 'General case' 0 CA--C 1.537 0.457 0 N-CA-C 113.014 0.746 . . . . 0.0 113.014 -178.303 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 109' ' ' LEU . . . . . . . . . . . . . 7.6 tp 57.72 37.72 27.32 Favored 'General case' 0 CA--C 1.529 0.172 0 CA-C-O 121.206 0.527 . . . . 0.0 111.341 179.277 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 110' ' ' GLU . . . . . . . . . . . . . 70.8 mm-40 -103.93 142.7 33.97 Favored 'General case' 0 C--N 1.33 -0.266 0 N-CA-C 109.33 -0.619 . . . . 0.0 109.33 174.071 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 111' ' ' GLU . . . . . . . . . . . . . 48.6 tt0 -79.14 121.94 25.63 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-N 116.454 -0.339 . . . . 0.0 110.893 -176.062 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 112' ' ' LEU . . . . . . . . . . . . . 44.1 mt -102.93 -46.12 4.76 Favored 'General case' 0 C--N 1.33 -0.239 0 CA-C-N 116.128 -0.487 . . . . 0.0 110.515 179.589 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 113' ' ' TYR . . . . . . . . . . . . . 63.9 t80 -140.59 145.02 36.17 Favored 'General case' 0 C--N 1.332 -0.182 0 CA-C-N 116.397 -0.365 . . . . 0.0 111.061 -179.682 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 114' ' ' ARG . . . . . . . . . . . . . 39.0 ptt180 -144.59 126.7 15.58 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.085 -0.507 . . . . 0.0 110.462 178.807 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 115' ' ' GLY . . . . . . . . . . . . . . . -150.05 150.75 22.85 Favored Glycine 0 CA--C 1.524 0.602 0 C-N-CA 120.682 -0.77 . . . . 0.0 111.192 179.654 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 116' ' ' LYS . . . . . . . . . . . . . 27.5 ttpp -123.45 135.77 54.26 Favored 'General case' 0 C--N 1.33 -0.274 0 N-CA-C 109.687 -0.486 . . . . 0.0 109.687 177.27 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 117' ' ' PHE . . . . . . . . . . . . . 36.2 m-85 -134.07 113.92 12.62 Favored 'General case' 0 C--N 1.33 -0.262 0 N-CA-C 110.037 -0.357 . . . . 0.0 110.037 -177.291 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 118' ' ' GLU . . . . . . . . . . . . . 83.5 tt0 -55.09 -44.72 75.16 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.383 -0.371 . . . . 0.0 111.185 -177.123 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 119' ' ' ASN . . . . . . . . . . . . . 85.2 m-20 -95.48 30.99 2.1 Favored 'General case' 0 C--N 1.33 -0.264 0 N-CA-C 112.214 0.45 . . . . 0.0 112.214 -175.649 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 120' ' ' LEU . . . . . . . . . . . . . 24.8 tp -57.63 122.16 12.08 Favored 'General case' 0 C--N 1.333 -0.132 0 N-CA-C 110.141 -0.318 . . . . 0.0 110.141 176.656 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 121' ' ' ASN . . . . . . . . . . . . . 61.5 m-20 -114.05 -43.99 3.19 Favored 'General case' 0 C--N 1.332 -0.187 0 CA-C-N 116.647 -0.251 . . . . 0.0 110.998 -176.773 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 122' ' ' LYS . . . . . . . . . . . . . 98.1 mttt -145.91 150.87 36.91 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-O 121.061 0.457 . . . . 0.0 111.505 -177.596 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 123' ' ' VAL . . . . . . . . . . . . . 43.5 t -128.75 131.16 68.72 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.253 0 CA-C-N 115.955 -0.566 . . . . 0.0 109.695 176.516 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 124' ' ' LEU . . . . . . . . . . . . . 34.0 mt -121.76 128.75 52.1 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.277 -0.419 . . . . 0.0 110.16 -179.547 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 125' ' ' VAL . . . . . . . . . . . . . 35.6 m -140.07 141.45 33.71 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 CA-C-O 120.862 0.363 . . . . 0.0 110.81 179.688 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 126' ' ' ARG . . . . . . . . . . . . . 51.0 ttp180 -161.29 129.66 4.4 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.07 -0.514 . . . . 0.0 110.622 177.502 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 127' ' ' ASN . . . . . . . . . . . . . 6.1 m120 52.77 -111.24 0.58 Allowed 'General case' 0 CA--C 1.544 0.741 0 CA-C-O 118.871 -0.585 . . . . 0.0 111.024 179.347 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 128' ' ' ASP . . . . . . . . . . . . . 11.9 p-10 -114.04 12.21 17.89 Favored 'General case' 0 N--CA 1.466 0.337 0 CA-C-N 119.892 1.224 . . . . 0.0 113.244 -177.747 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 129' ' ' LEU . . . . . . . . . . . . . 30.5 mt -107.7 134.11 51.15 Favored 'General case' 0 C--N 1.333 -0.147 0 O-C-N 121.968 -0.457 . . . . 0.0 110.136 178.013 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 130' ' ' VAL . . . . . . . . . . . . . 45.5 t -125.08 131.02 73.03 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.229 0 N-CA-C 109.58 -0.526 . . . . 0.0 109.58 178.759 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 131' ' ' VAL . . . . . . . . . . . . . 42.2 t -135.61 133.81 51.75 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.307 0 CA-C-O 120.999 0.428 . . . . 0.0 110.192 178.514 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 132' ' ' ILE . . . . . . . . . . . . . 74.6 mt -114.48 130.63 68.47 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.378 0 CA-C-N 115.81 -0.632 . . . . 0.0 109.308 179.44 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 133' ' ' ILE . . . . . . . . . . . . . 42.9 mm -114.56 119.24 60.96 Favored 'Isoleucine or valine' 0 C--O 1.234 0.263 0 CA-C-O 120.874 0.368 . . . . 0.0 110.748 -175.353 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 134' ' ' ASP . . . . . . . . . . . . . 9.6 p-10 -133.94 147.95 51.12 Favored 'General case' 0 C--N 1.331 -0.225 0 N-CA-C 109.678 -0.489 . . . . 0.0 109.678 176.282 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 135' ' ' GLU . . . . . . . . . . . . . 78.8 tt0 -49.9 -27.84 5.81 Favored 'General case' 0 C--N 1.328 -0.368 0 N-CA-C 112.833 0.679 . . . . 0.0 112.833 -173.698 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 136' ' ' GLN . . . . . . . . . . . . . 48.2 tt0 -79.05 -37.39 39.11 Favored 'General case' 0 C--O 1.233 0.229 0 N-CA-C 111.973 0.361 . . . . 0.0 111.973 -176.064 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 137' ' ' LYS . . . . . . . . . . . . . 51.8 pttt -166.32 175.46 8.22 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-O 121.689 0.756 . . . . 0.0 112.197 -171.129 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 138' ' ' LEU . . . . . . . . . . . . . 4.8 tt -119.46 128.45 54.02 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 114.877 -1.056 . . . . 0.0 109.757 178.7 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 139' ' ' THR . . . . . . . . . . . . . 19.5 m -109.12 124.08 50.23 Favored 'General case' 0 C--N 1.331 -0.205 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.598 -179.496 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 140' ' ' LEU . . . . . . . . . . . . . 48.0 tp -112.09 120.43 41.82 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 115.982 -0.554 . . . . 0.0 109.574 -179.166 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 141' ' ' ILE . . . . . . . . . . . . . 19.1 mt -122.95 120.65 61.18 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.278 0 CA-C-O 120.993 0.425 . . . . 0.0 110.088 -176.198 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 142' ' ' ARG . . . . . . . . . . . . . 22.3 mtp-105 -97.59 121.23 39.25 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 115.463 -0.79 . . . . 0.0 109.976 176.49 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 143' ' ' THR . . . . . . . . . . . . . 48.2 p . . . . . 0 C--O 1.22 -0.459 0 CA-C-O 118.051 -0.976 . . . . 0.0 110.423 179.339 . . . . . . . . 0 0 . 1 . 016 nuclear orig core ' B' B ' 2' ' ' SER . . . . . . . . . . . . . 2.3 p . . . . . 0 C--O 1.23 0.066 0 N-CA-C 110.017 -0.364 . . . . 0.0 110.017 . . . . . . . . . 0 0 . 1 . 016 nuclear orig core ' B' B ' 3' ' ' GLU . . . . . . . . . . . . . 81.3 tt0 -140.94 142.46 34.36 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-N 116.172 -0.467 . . . . 0.0 111.158 -176.266 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' B' B ' 4' ' ' LEU . . . . . . . . . . . . . 11.4 tp -123.6 130.95 53.43 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 115.946 -0.57 . . . . 0.0 109.744 176.298 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' B' B ' 5' ' ' LYS . . . . . . . . . . . . . 91.5 mttt -110.87 121.43 45.33 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 116.31 -0.405 . . . . 0.0 110.729 -178.307 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' B' B ' 6' ' ' LEU . . . . . . . . . . . . . 55.9 mt -116.54 151.27 36.51 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 115.569 -0.741 . . . . 0.0 110.653 -178.856 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' B' B ' 7' ' ' LYS . . . . . . . . . . . . . 59.1 tttt -139.04 135.42 17.46 Favored Pre-proline 0 CA--C 1.535 0.396 0 CA-C-O 118.966 -0.54 . . . . 0.0 110.152 175.936 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' B' B ' 8' ' ' PRO . . . . . . . . . . . . . 94.7 Cg_endo -92.04 144.79 2.89 Favored 'Trans proline' 0 N--CA 1.49 1.274 0 C-N-CA 121.814 1.676 . . . . 0.0 111.632 177.359 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' B' B ' 9' ' ' LEU . . . . . . . . . . . . . 47.3 mt -86.54 -47.91 0.52 Allowed Pre-proline 0 CA--C 1.534 0.345 0 CA-C-O 118.701 -0.666 . . . . 0.0 112.646 -177.981 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' B' B ' 10' ' ' PRO . . . . . . . . . . . . . 97.3 Cg_endo -81.91 160.77 18.54 Favored 'Trans proline' 0 N--CA 1.495 1.616 0 C-N-CA 121.421 1.414 . . . . 0.0 112.063 177.802 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' B' B ' 11' ' ' LYS . . . . . . . . . . . . . 52.5 pttt -85.67 121.67 28.67 Favored 'General case' 0 C--N 1.331 -0.196 0 CA-C-O 120.953 0.406 . . . . 0.0 110.377 178.145 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' B' B ' 12' ' ' VAL . . . . . . . . . . . . . 12.5 p -151.09 144.81 16.7 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.251 0 CA-C-N 116.226 -0.443 . . . . 0.0 110.705 -179.971 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' B' B ' 13' ' ' GLU . . . . . . . . . . . . . 81.4 tt0 -91.88 108.98 20.32 Favored 'General case' 0 C--N 1.329 -0.325 0 N-CA-C 109.718 -0.475 . . . . 0.0 109.718 176.263 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' B' B ' 14' ' ' LEU . . . . . . . . . . . . . 81.2 mt -84.44 143.41 41.56 Favored Pre-proline 0 CA--C 1.534 0.343 0 CA-C-O 119.168 -0.444 . . . . 0.0 110.666 -175.923 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' B' B ' 15' ' ' PRO . . . . . . . . . . . . . 24.8 Cg_exo -63.06 163.33 22.97 Favored 'Trans proline' 0 N--CA 1.497 1.703 0 C-N-CA 121.301 1.334 . . . . 0.0 111.879 175.608 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' B' B ' 16' ' ' PRO . . . . . . . . . . . . . 29.6 Cg_exo -60.17 -39.17 71.28 Favored 'Trans proline' 0 N--CA 1.496 1.671 0 C-N-CA 121.478 1.452 . . . . 0.0 112.846 -178.105 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' B' B ' 17' ' ' ASP . . . . . . . . . . . . . 20.1 p-10 -90.74 12.5 18.96 Favored 'General case' 0 CA--C 1.536 0.423 0 N-CA-C 113.161 0.8 . . . . 0.0 113.161 -176.814 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' B' B ' 18' ' ' PHE . . . . . . . . . . . . . 33.9 t80 -56.21 -46.0 79.66 Favored 'General case' 0 C--N 1.334 -0.104 0 O-C-N 121.937 -0.477 . . . . 0.0 110.671 -178.364 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' B' B ' 19' ' ' VAL . . . . . . . . . . . . . 46.6 t -55.48 -43.54 72.64 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.277 0 CA-C-N 116.61 -0.268 . . . . 0.0 110.858 -177.931 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' B' B ' 20' ' ' ASP . . . . . . . . . . . . . 50.7 m-20 -60.01 -43.79 94.99 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-O 120.988 0.423 . . . . 0.0 111.017 -177.682 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' B' B ' 21' ' ' VAL . . . . . . . . . . . . . 45.1 t -64.38 -46.6 92.54 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.259 0 CA-C-N 116.401 -0.363 . . . . 0.0 110.573 -177.554 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' B' B ' 22' ' ' ILE . . . . . . . . . . . . . 50.7 mm -56.27 -44.5 79.7 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.206 0 C-N-CA 120.926 -0.31 . . . . 0.0 110.564 178.678 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' B' B ' 23' ' ' ARG . . . . . . . . . . . . . 55.7 ttp180 -53.36 -48.08 68.85 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-O 120.722 0.296 . . . . 0.0 111.396 -179.76 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' B' B ' 24' ' ' ILE . . . . . . . . . . . . . 71.4 mt -58.97 -44.53 91.27 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.251 0 CA-C-N 116.496 -0.32 . . . . 0.0 110.938 -179.228 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' B' B ' 25' ' ' LYS . . . . . . . . . . . . . 53.0 mttm -65.59 -35.27 80.33 Favored 'General case' 0 C--N 1.327 -0.404 0 N-CA-C 112.3 0.482 . . . . 0.0 112.3 -178.051 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' B' B ' 26' ' ' LEU . . . . . . . . . . . . . 56.1 mt -80.01 -46.02 17.36 Favored 'General case' 0 C--N 1.329 -0.31 0 N-CA-C 112.943 0.72 . . . . 0.0 112.943 -172.896 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' B' B ' 27' ' ' GLN . . . . . . . . . . . . . 11.2 pt20 -46.56 138.74 5.63 Favored 'General case' 0 N--CA 1.468 0.464 0 N-CA-C 112.677 0.621 . . . . 0.0 112.677 -174.909 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' B' B ' 28' ' ' GLY . . . . . . . . . . . . . . . 100.09 -24.92 30.24 Favored Glycine 0 CA--C 1.533 1.195 0 CA-C-N 115.599 -0.728 . . . . 0.0 112.412 -177.869 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' B' B ' 29' ' ' LYS . . . . . . . . . . . . . 67.9 mttm -97.72 155.08 17.18 Favored 'General case' 0 C--N 1.331 -0.198 0 CA-C-N 117.402 0.601 . . . . 0.0 111.145 179.656 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' B' B ' 30' ' ' THR . . . . . . . . . . . . . 28.9 m -106.04 133.34 50.9 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 115.861 -0.609 . . . . 0.0 109.778 175.008 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' B' B ' 31' ' ' VAL . . . . . . . . . . . . . 35.2 m -128.63 156.1 40.86 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.214 0 CA-C-N 116.437 -0.347 . . . . 0.0 110.693 -178.619 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' B' B ' 32' ' ' ARG . . . . . . . . . . . . . 72.2 ttt180 -132.73 148.03 52.33 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.036 -0.529 . . . . 0.0 110.351 178.929 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' B' B ' 33' ' ' THR . . . . . . . . . . . . . 19.6 m -52.64 138.09 29.27 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-O 120.858 0.361 . . . . 0.0 111.396 -178.25 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' B' B ' 34' ' ' GLY . . . . . . . . . . . . . . . 102.13 -17.24 54.51 Favored Glycine 0 CA--C 1.534 1.23 0 CA-C-N 116.074 -0.512 . . . . 0.0 113.235 179.286 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' B' B ' 35' ' ' ASP . . . . . . . . . . . . . 78.6 m-20 -66.91 151.17 48.09 Favored 'General case' 0 N--CA 1.462 0.158 0 CA-C-N 117.972 0.886 . . . . 0.0 111.052 178.715 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' B' B ' 36' ' ' VAL . . . . . . . . . . . . . 44.4 t -124.25 132.73 70.91 Favored 'Isoleucine or valine' 0 C--N 1.333 -0.145 0 CA-C-N 115.959 -0.564 . . . . 0.0 109.902 178.234 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' B' B ' 37' ' ' ILE . . . . . . . . . . . . . 68.5 mt -119.66 140.16 44.58 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.189 0 CA-C-N 116.063 -0.517 . . . . 0.0 109.96 -179.258 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' B' B ' 38' ' ' GLY . . . . . . . . . . . . . . . -116.95 128.84 8.07 Favored Glycine 0 CA--C 1.525 0.714 0 N-CA-C 111.043 -0.823 . . . . 0.0 111.043 179.598 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' B' B ' 39' ' ' ILE . . . . . . . . . . . . . 76.9 mt -128.89 139.68 51.26 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.248 0 N-CA-C 110.147 -0.316 . . . . 0.0 110.147 179.245 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' B' B ' 40' ' ' SER . . . . . . . . . . . . . 53.7 p -93.22 126.01 38.12 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.263 -0.426 . . . . 0.0 110.863 175.26 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' B' B ' 41' ' ' ILE . . . . . . . . . . . . . 68.6 mt -134.99 113.94 16.62 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.247 0 CA-C-O 120.826 0.346 . . . . 0.0 110.534 177.702 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' B' B ' 42' ' ' LEU . . . . . . . . . . . . . 1.5 tt 56.33 47.84 18.3 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-O 121.52 0.676 . . . . 0.0 110.358 177.604 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' B' B ' 43' ' ' GLY . . . . . . . . . . . . . . . 72.2 -5.49 14.05 Favored Glycine 0 CA--C 1.536 1.351 0 C-N-CA 121.162 -0.542 . . . . 0.0 113.724 175.118 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' B' B ' 44' ' ' LYS . . . . . . . . . . . . . 80.6 tttt -108.85 135.04 50.71 Favored 'General case' 0 C--N 1.332 -0.181 0 CA-C-N 118.049 0.924 . . . . 0.0 110.19 -179.212 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' B' B ' 45' ' ' GLU . . . . . . . . . . . . . 84.1 tt0 -83.73 130.65 34.95 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-N 116.458 -0.337 . . . . 0.0 111.079 -179.075 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' B' B ' 46' ' ' VAL . . . . . . . . . . . . . 7.3 p -124.04 125.06 70.25 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.189 0 CA-C-O 121.002 0.43 . . . . 0.0 109.875 175.616 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' B' B ' 47' ' ' LYS . . . . . . . . . . . . . 91.9 mttt -100.08 131.46 46.02 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 115.951 -0.568 . . . . 0.0 111.031 176.529 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' B' B ' 48' ' ' PHE . . . . . . . . . . . . . 94.6 m-85 -113.08 131.88 55.64 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.057 -0.52 . . . . 0.0 109.644 175.341 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' B' B ' 49' ' ' LYS . . . . . . . . . . . . . 76.1 tttt -107.22 135.46 48.71 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.605 -0.27 . . . . 0.0 110.302 178.094 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' B' B ' 50' ' ' VAL . . . . . . . . . . . . . 43.9 t -81.16 107.48 13.48 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.315 0 N-CA-C 109.219 -0.66 . . . . 0.0 109.219 176.268 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' B' B ' 51' ' ' VAL . . . . . . . . . . . . . 40.4 t -74.88 -49.65 28.29 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.337 0 CA-C-N 115.982 -0.554 . . . . 0.0 110.14 -172.716 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' B' B ' 52' ' ' GLN . . . . . . . . . . . . . 85.8 mt-30 -154.34 152.98 30.87 Favored 'General case' 0 C--N 1.331 -0.199 0 C-N-CA 120.449 -0.5 . . . . 0.0 111.797 -177.304 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' B' B ' 53' ' ' ALA . . . . . . . . . . . . . . . -130.35 130.5 44.51 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 115.339 -0.846 . . . . 0.0 109.643 175.016 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' B' B ' 54' ' ' TYR . . . . . . . . . . . . . 19.1 t80 -129.13 105.91 17.95 Favored Pre-proline 0 CA--C 1.534 0.357 0 CA-C-O 118.357 -0.83 . . . . 0.0 110.464 -179.572 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' B' B ' 55' ' ' PRO . . . . . . . . . . . . . 73.8 Cg_endo -77.2 170.06 72.49 Favored 'Cis proline' 0 N--CA 1.5 1.912 0 CA-C-N 121.673 1.633 . . . . 0.0 112.474 -5.98 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' B' B ' 56' ' ' SER . . . . . . . . . . . . . 36.0 m -116.42 134.16 22.89 Favored Pre-proline 0 CA--C 1.539 0.524 0 CA-C-O 118.461 -0.781 . . . . 0.0 109.606 175.17 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' B' B ' 57' ' ' PRO . . . . . . . . . . . . . 36.2 Cg_endo -67.07 166.53 62.35 Favored 'Cis proline' 0 N--CA 1.497 1.732 0 CA-C-N 121.856 1.698 . . . . 0.0 111.349 -3.727 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' B' B ' 58' ' ' LEU . . . . . . . . . . . . . 31.4 tp -130.77 138.04 49.75 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.239 -0.437 . . . . 0.0 110.512 -179.324 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' B' B ' 59' ' ' ARG . . . . . . . . . . . . . 59.8 ttm-85 -105.47 127.34 52.95 Favored 'General case' 0 C--N 1.327 -0.37 0 N-CA-C 109.148 -0.686 . . . . 0.0 109.148 175.0 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' B' B ' 60' ' ' VAL . . . . . . . . . . . . . 40.1 t -81.2 123.99 38.33 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.338 0 C-N-CA 120.651 -0.42 . . . . 0.0 110.872 -173.788 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' B' B ' 61' ' ' GLU . . . . . . . . . . . . . 95.7 mt-10 -131.0 162.55 29.52 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 115.691 -0.686 . . . . 0.0 109.666 176.251 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' B' B ' 62' ' ' ASP . . . . . . . . . . . . . 78.7 m-20 -54.85 -33.96 62.35 Favored 'General case' 0 C--N 1.328 -0.329 0 C-N-CA 121.015 -0.274 . . . . 0.0 111.646 -178.86 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' B' B ' 63' ' ' ARG . . . . . . . . . . . . . 7.3 mmm180 -76.18 -10.3 59.3 Favored 'General case' 0 CA--C 1.537 0.446 0 N-CA-C 113.186 0.81 . . . . 0.0 113.186 -176.74 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' B' B ' 64' ' ' THR . . . . . . . . . . . . . 30.0 m -72.27 145.32 47.98 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-O 121.004 0.43 . . . . 0.0 111.246 -175.915 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' B' B ' 65' ' ' LYS . . . . . . . . . . . . . 23.9 mtpp -89.58 127.52 35.9 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 115.878 -0.601 . . . . 0.0 110.265 178.491 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' B' B ' 66' ' ' ILE . . . . . 0.4 HD12 HG21 ' B' ' 66' ' ' ILE . 55.7 mt -114.77 129.93 70.07 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.245 0 N-CA-C 109.779 -0.452 . . . . 0.0 109.779 179.59 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' B' B ' 67' ' ' THR . . . . . . . . . . . . . 25.9 m -127.76 143.63 51.12 Favored 'General case' 0 C--N 1.332 -0.176 0 CA-C-O 121.171 0.51 . . . . 0.0 111.586 -176.842 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' B' B ' 68' ' ' LEU . . . . . . . . . . . . . 16.0 tp . . . . . 0 C--N 1.33 -0.255 0 CA-C-N 115.59 -0.732 . . . . 0.0 109.622 175.666 . . . . . . . . 0 0 . 1 . 016 nuclear orig core ' B' B ' 73' ' ' VAL . . . . . . . . . . . . . 35.4 m . . . . . 0 C--O 1.232 0.146 0 CA-C-O 120.854 0.359 . . . . 0.0 110.697 . . . . . . . . . 0 0 . 1 . 016 nuclear orig core ' B' B ' 74' ' ' ASP . . . . . . . . . . . . . 18.6 t0 -104.09 115.43 30.42 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.001 -0.545 . . . . 0.0 109.893 179.245 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' B' B ' 75' ' ' VAL . . . . . . . . . . . . . 40.8 t -116.69 123.58 71.82 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.291 0 CA-C-O 121.086 0.47 . . . . 0.0 110.738 -176.271 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' B' B ' 76' ' ' LEU . . . . . . . . . . . . . 4.9 mp -125.19 146.63 49.42 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 115.635 -0.712 . . . . 0.0 109.516 176.273 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' B' B ' 77' ' ' GLU . . . . . . . . . . . . . 46.4 mt-10 -134.22 141.11 46.91 Favored 'General case' 0 C--N 1.331 -0.227 0 CA-C-O 120.944 0.402 . . . . 0.0 111.119 -178.513 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' B' B ' 78' ' ' ALA . . . . . . . . . . . . . . . -129.81 135.34 48.3 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 115.879 -0.601 . . . . 0.0 109.925 176.289 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' B' B ' 79' ' ' LYS . . . . . . . . . . . . . 43.3 pttt -80.36 121.59 25.88 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-O 121.123 0.487 . . . . 0.0 111.18 -176.951 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' B' B ' 80' ' ' ILE . . . . . . . . . . . . . 23.7 mm -139.45 112.26 5.87 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.327 0 N-CA-C 109.119 -0.697 . . . . 0.0 109.119 -179.018 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' B' B ' 81' ' ' LYS . . . . . . . . . . . . . 36.2 ttpt -100.45 123.08 44.2 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-O 120.911 0.386 . . . . 0.0 111.148 -178.363 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' B' B ' 82' ' ' GLY . . . . . . . . . . . . . . . 89.17 42.07 5.68 Favored Glycine 0 CA--C 1.527 0.792 0 C-N-CA 120.859 -0.686 . . . . 0.0 112.225 173.732 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' B' B ' 83' ' ' ILE . . . . . . . . . . . . . 69.2 mt -67.46 136.1 27.26 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.321 0 N-CA-C 109.689 -0.486 . . . . 0.0 109.689 175.993 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' B' B ' 84' ' ' LYS . . . . . . . . . . . . . 38.6 ttpt -104.48 -48.21 3.88 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-O 120.873 0.368 . . . . 0.0 110.584 -178.266 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' B' B ' 85' ' ' ASP . . . . . . . . . . . . . 13.8 t70 -143.37 146.64 33.68 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.06 -0.518 . . . . 0.0 110.631 -178.594 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' B' B ' 86' ' ' VAL . . . . . . . . . . . . . 44.7 t -131.08 132.69 63.42 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.268 0 CA-C-O 120.863 0.363 . . . . 0.0 110.389 -179.285 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' B' B ' 87' ' ' ILE . . . . . . . . . . . . . 5.2 mp -123.97 128.09 73.95 Favored 'Isoleucine or valine' 0 C--O 1.233 0.187 0 CA-C-N 115.945 -0.571 . . . . 0.0 109.762 177.527 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' B' B ' 88' ' ' LEU . . . . . . . . . . . . . 18.8 tp -113.62 133.14 55.46 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.284 -0.416 . . . . 0.0 110.953 -177.901 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' B' B ' 89' ' ' ASP . . . . . . . . . . . . . 6.4 t0 -132.33 160.5 36.1 Favored 'General case' 0 C--N 1.331 -0.199 0 CA-C-N 116.171 -0.468 . . . . 0.0 109.848 177.955 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' B' B ' 90' ' ' GLU . . . . . . . . . . . . . 95.7 mt-10 -44.95 -47.29 11.38 Favored 'General case' 0 N--CA 1.465 0.28 0 N-CA-C 113.328 0.862 . . . . 0.0 113.328 -171.785 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' B' B ' 91' ' ' ASN . . . . . . . . . . . . . 77.7 m-20 -124.26 21.48 8.76 Favored 'General case' 0 N--CA 1.468 0.428 0 N-CA-C 112.809 0.67 . . . . 0.0 112.809 -176.237 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' B' B ' 92' ' ' LEU . . . . . . . . . . . . . 26.6 mt -148.23 145.96 28.46 Favored 'General case' 0 C--N 1.331 -0.208 0 CA-C-O 120.757 0.313 . . . . 0.0 110.872 -174.861 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' B' B ' 93' ' ' ILE . . . . . . . . . . . . . 71.7 mt -125.58 115.93 44.86 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.319 0 N-CA-C 108.898 -0.779 . . . . 0.0 108.898 176.683 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' B' B ' 94' ' ' VAL . . . . . . . . . . . . . 43.6 t -116.45 127.06 74.16 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.322 0 N-CA-C 109.95 -0.389 . . . . 0.0 109.95 -177.283 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' B' B ' 95' ' ' VAL . . . . . . . . . . . . . 43.7 t -122.56 134.4 65.86 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.265 0 CA-C-N 116.099 -0.5 . . . . 0.0 109.91 -179.318 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' B' B ' 96' ' ' ILE . . . . . . . . . . . . . 68.8 mt -118.07 126.75 75.15 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.287 0 N-CA-C 109.349 -0.611 . . . . 0.0 109.349 178.981 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' B' B ' 97' ' ' THR . . . . . . . . . . . . . 69.6 p -99.39 157.08 16.66 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-O 121.274 0.559 . . . . 0.0 111.495 -176.029 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' B' B ' 98' ' ' GLU . . . . . . . . . . . . . 12.1 pt-20 -53.82 -25.23 18.45 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 115.966 -0.561 . . . . 0.0 112.489 -179.275 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' B' B ' 99' ' ' GLU . . . . . . . . . . . . . 95.6 mt-10 -81.97 17.85 1.47 Allowed 'General case' 0 CA--C 1.535 0.366 0 N-CA-C 113.021 0.748 . . . . 0.0 113.021 -177.529 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' B' B ' 100' ' ' ASN . . . . . . . . . . . . . 3.2 m-20 61.75 37.96 15.34 Favored 'General case' 0 C--O 1.232 0.175 0 CA-C-O 120.955 0.407 . . . . 0.0 110.98 177.86 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' B' B ' 101' ' ' GLU . . . . . . . . . . . . . 83.9 tt0 -115.2 142.97 45.94 Favored 'General case' 0 C--N 1.331 -0.208 0 N-CA-C 109.709 -0.478 . . . . 0.0 109.709 176.35 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' B' B ' 102' ' ' VAL . . . . . . . . . . . . . 44.4 t -116.04 127.06 73.75 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.34 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.037 -177.247 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' B' B ' 103' ' ' LEU . . . . . . . . . . . . . 45.3 mt -120.44 131.12 54.63 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 115.828 -0.624 . . . . 0.0 110.243 177.081 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' B' B ' 104' ' ' ILE . . . . . . . . . . . . . 67.5 mt -119.68 121.47 66.3 Favored 'Isoleucine or valine' 0 C--O 1.234 0.285 0 CA-C-N 116.471 -0.331 . . . . 0.0 110.182 -178.791 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' B' B ' 105' ' ' PHE . . . . . . . . . . . . . 51.2 m-85 -123.38 163.95 19.81 Favored 'General case' 0 C--N 1.334 -0.089 0 O-C-N 123.838 0.711 . . . . 0.0 109.769 178.7 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' B' B ' 106' ' ' ASN . . . . . . . . . . . . . 43.3 p-10 -97.06 -169.95 1.95 Allowed 'General case' 0 C--N 1.331 -0.221 0 N-CA-C 110.096 -0.335 . . . . 0.0 110.096 174.845 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' B' B ' 107' ' ' GLN . . . . . . . . . . . . . 50.7 tt0 -59.55 -30.0 68.31 Favored 'General case' 0 C--N 1.328 -0.327 0 N-CA-C 111.886 0.328 . . . . 0.0 111.886 179.029 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' B' B ' 108' ' ' ASN . . . . . . . . . . . . . 65.9 t30 -82.56 7.09 15.52 Favored 'General case' 0 CA--C 1.536 0.421 0 N-CA-C 113.283 0.846 . . . . 0.0 113.283 -177.864 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' B' B ' 109' ' ' LEU . . . . . . . . . . . . . 11.9 tp 60.21 37.49 20.57 Favored 'General case' 0 C--N 1.331 -0.2 0 CA-C-O 121.112 0.482 . . . . 0.0 111.218 179.464 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' B' B ' 110' ' ' GLU . . . . . . . . . . . . . 70.9 mm-40 -103.61 148.43 26.01 Favored 'General case' 0 C--N 1.33 -0.264 0 N-CA-C 109.639 -0.504 . . . . 0.0 109.639 175.199 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' B' B ' 111' ' ' GLU . . . . . . . . . . . . . 62.6 tt0 -84.97 122.04 28.64 Favored 'General case' 0 C--N 1.327 -0.396 0 CA-C-O 120.893 0.377 . . . . 0.0 110.586 -176.75 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' B' B ' 112' ' ' LEU . . . . . . . . . . . . . 45.5 mt -109.57 -45.99 3.6 Favored 'General case' 0 C--N 1.332 -0.171 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.722 179.963 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' B' B ' 113' ' ' TYR . . . . . . . . . . . . . 55.5 t80 -133.33 139.12 46.68 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.328 -0.396 . . . . 0.0 110.872 -178.861 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' B' B ' 114' ' ' ARG . . . . . . . . . . . . . 34.7 ptt-85 -145.12 121.01 10.63 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.235 -0.438 . . . . 0.0 110.726 179.624 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' B' B ' 115' ' ' GLY . . . . . . . . . . . . . . . -150.24 159.2 28.01 Favored Glycine 0 CA--C 1.524 0.646 0 C-N-CA 120.871 -0.681 . . . . 0.0 111.439 178.88 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' B' B ' 116' ' ' LYS . . . . . . . . . . . . . 38.6 ttpt -125.59 130.71 52.2 Favored 'General case' 0 C--N 1.33 -0.251 0 N-CA-C 109.525 -0.546 . . . . 0.0 109.525 175.524 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' B' B ' 117' ' ' PHE . . . . . . . . . . . . . 44.5 m-85 -132.43 116.31 16.64 Favored 'General case' 0 C--N 1.331 -0.224 0 CA-C-O 120.934 0.397 . . . . 0.0 110.481 -174.535 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' B' B ' 118' ' ' GLU . . . . . . . . . . . . . 95.8 mt-10 -53.46 -45.03 69.37 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.374 -0.376 . . . . 0.0 111.503 -177.228 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' B' B ' 119' ' ' ASN . . . . . . . . . . . . . 4.6 m120 -97.12 29.72 3.03 Favored 'General case' 0 C--N 1.33 -0.249 0 N-CA-C 112.403 0.52 . . . . 0.0 112.403 -173.958 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' B' B ' 120' ' ' LEU . . . . . . . . . . . . . 17.8 tp -59.07 119.89 8.13 Favored 'General case' 0 C--N 1.331 -0.205 0 N-CA-C 110.067 -0.346 . . . . 0.0 110.067 177.647 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' B' B ' 121' ' ' ASN . . . . . . . . . . . . . 72.8 m-20 -114.07 -44.03 3.18 Favored 'General case' 0 C--N 1.332 -0.167 0 CA-C-N 116.493 -0.321 . . . . 0.0 111.162 -177.521 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' B' B ' 122' ' ' LYS . . . . . . . . . . . . . 97.8 mttt -143.77 151.37 39.9 Favored 'General case' 0 C--N 1.332 -0.162 0 CA-C-O 121.184 0.516 . . . . 0.0 111.748 -176.353 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' B' B ' 123' ' ' VAL . . . . . . . . . . . . . 45.1 t -128.38 126.71 66.19 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.22 0 CA-C-N 115.83 -0.623 . . . . 0.0 109.515 175.225 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' B' B ' 124' ' ' LEU . . . . . . . . . . . . . 7.0 mp -114.36 131.61 56.49 Favored 'General case' 0 C--N 1.332 -0.186 0 CA-C-N 116.373 -0.376 . . . . 0.0 110.772 -178.179 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' B' B ' 125' ' ' VAL . . . . . . . . . . . . . 9.2 p -131.94 131.33 61.68 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.215 0 CA-C-N 116.151 -0.477 . . . . 0.0 109.855 178.024 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' B' B ' 126' ' ' ARG . . . . . . . . . . . . . 48.2 ttt180 -151.44 128.77 11.28 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-O 120.951 0.405 . . . . 0.0 110.772 178.74 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' B' B ' 127' ' ' ASN . . . . . . . . . . . . . 6.9 m120 52.1 -112.73 0.69 Allowed 'General case' 0 CA--C 1.545 0.756 0 CA-C-O 118.837 -0.601 . . . . 0.0 111.029 179.242 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' B' B ' 128' ' ' ASP . . . . . . . . . . . . . 10.9 p-10 -114.17 10.16 17.27 Favored 'General case' 0 N--CA 1.468 0.447 0 CA-C-N 119.934 1.243 . . . . 0.0 113.216 -177.288 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' B' B ' 129' ' ' LEU . . . . . . . . . . . . . 77.9 mt -118.43 149.81 40.62 Favored 'General case' 0 C--O 1.233 0.235 0 CA-C-N 118.212 0.46 . . . . 0.0 110.445 -178.605 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' B' B ' 130' ' ' VAL . . . . . . . . . . . . . 32.9 m -135.43 144.6 33.57 Favored 'Isoleucine or valine' 0 C--O 1.232 0.182 0 CA-C-O 121.326 0.584 . . . . 0.0 111.042 -179.876 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' B' B ' 131' ' ' VAL . . . . . . . . . . . . . 45.7 t -136.03 137.88 48.11 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.324 0 CA-C-N 115.595 -0.73 . . . . 0.0 109.901 179.013 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' B' B ' 132' ' ' ILE . . . . . . . . . . . . . 71.6 mt -112.32 130.35 66.19 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.337 0 N-CA-C 109.317 -0.623 . . . . 0.0 109.317 179.452 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' B' B ' 133' ' ' ILE . . . . . . . . . . . . . 38.9 mm -114.48 120.09 63.22 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.255 0 CA-C-O 120.752 0.31 . . . . 0.0 111.007 -174.513 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' B' B ' 134' ' ' ASP . . . . . . . . . . . . . 6.9 p-10 -130.93 146.3 52.3 Favored 'General case' 0 C--N 1.332 -0.194 0 N-CA-C 109.465 -0.568 . . . . 0.0 109.465 175.048 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' B' B ' 135' ' ' GLU . . . . . . . . . . . . . 33.6 tt0 -49.95 -27.49 5.41 Favored 'General case' 0 C--N 1.329 -0.323 0 N-CA-C 112.731 0.641 . . . . 0.0 112.731 -173.262 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' B' B ' 136' ' ' GLN . . . . . . . . . . . . . 98.7 mt-30 -79.4 -36.2 39.51 Favored 'General case' 0 C--N 1.331 -0.202 0 N-CA-C 112.175 0.435 . . . . 0.0 112.175 -176.86 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' B' B ' 137' ' ' LYS . . . . . . . . . . . . . 45.6 pttt -169.45 175.39 5.51 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-O 121.448 0.642 . . . . 0.0 112.148 -172.137 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' B' B ' 138' ' ' LEU . . . . . . . . . . . . . 7.7 tt -118.18 129.5 55.55 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 115.266 -0.879 . . . . 0.0 110.355 -179.459 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' B' B ' 139' ' ' THR . . . . . . . . . . . . . 32.7 m -107.35 126.45 52.48 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 115.923 -0.58 . . . . 0.0 110.238 178.191 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' B' B ' 140' ' ' LEU . . . . . . . . . . . . . 12.3 tp -111.63 119.11 37.59 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 115.904 -0.589 . . . . 0.0 109.652 -176.602 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' B' B ' 141' ' ' ILE . . . . . . . . . . . . . 27.2 mt -121.71 121.47 64.47 Favored 'Isoleucine or valine' 0 C--O 1.234 0.245 0 CA-C-O 121.351 0.596 . . . . 0.0 110.525 -173.969 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' B' B ' 142' ' ' ARG . . . . . . . . . . . . . 0.5 OUTLIER -108.25 123.99 49.62 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 114.903 -1.044 . . . . 0.0 110.068 -179.794 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' B' B ' 143' ' ' THR . . . . . . . . . . . . . 40.3 p . . . . . 0 C--O 1.219 -0.516 0 CA-C-O 118.002 -0.999 . . . . 0.0 110.574 179.443 . . . . . . . . 0 0 . 1 . 016 nuclear orig core ' C' C ' 2' ' ' SER . . . . . . . . . . . . . 2.9 p . . . . . 0 C--O 1.231 0.094 0 CA-C-O 120.937 0.399 . . . . 0.0 110.691 . . . . . . . . . 0 0 . 1 . 016 nuclear orig core ' C' C ' 3' ' ' GLU . . . . . . . . . . . . . 45.0 mt-10 -140.12 143.1 36.05 Favored 'General case' 0 C--N 1.331 -0.227 0 CA-C-N 116.027 -0.533 . . . . 0.0 110.981 -179.656 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' C' C ' 4' ' ' LEU . . . . . . . . . . . . . 2.4 tt -124.57 124.35 42.05 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 115.65 -0.705 . . . . 0.0 109.535 177.075 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' C' C ' 5' ' ' LYS . . . . . . . . . . . . . 78.6 mttt -103.87 118.77 37.48 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.721 -178.564 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' C' C ' 6' ' ' LEU . . . . . . . . . . . . . 27.3 mt -116.79 147.96 41.61 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 115.566 -0.743 . . . . 0.0 110.317 -179.172 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' C' C ' 7' ' ' LYS . . . . . . . . . . . . . 81.2 tttt -134.87 139.87 33.49 Favored Pre-proline 0 CA--C 1.533 0.308 0 CA-C-O 119.124 -0.465 . . . . 0.0 109.957 175.643 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' C' C ' 8' ' ' PRO . . . . . . . . . . . . . 88.4 Cg_endo -91.34 137.74 2.12 Favored 'Trans proline' 0 N--CA 1.489 1.236 0 C-N-CA 121.722 1.615 . . . . 0.0 111.555 177.813 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' C' C ' 9' ' ' LEU . . . . . . . . . . . . . 68.0 mt -77.73 -47.79 2.3 Favored Pre-proline 0 CA--C 1.535 0.396 0 CA-C-O 118.634 -0.698 . . . . 0.0 112.444 -178.25 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' C' C ' 10' ' ' PRO . . . . . . . . . . . . . 88.9 Cg_endo -80.28 152.84 21.08 Favored 'Trans proline' 0 N--CA 1.497 1.678 0 C-N-CA 121.135 1.223 . . . . 0.0 112.03 177.006 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' C' C ' 11' ' ' LYS . . . . . . . . . . . . . 33.9 mmtp -85.65 97.57 10.19 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.354 -0.384 . . . . 0.0 110.396 177.851 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' C' C ' 12' ' ' VAL . . . . . . . . . . . . . 11.8 p -140.03 145.17 26.76 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.288 0 CA-C-N 116.107 -0.497 . . . . 0.0 110.308 179.778 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' C' C ' 13' ' ' GLU . . . . . . . . . . . . . 70.5 tt0 -84.27 116.16 22.83 Favored 'General case' 0 C--N 1.328 -0.333 0 N-CA-C 109.756 -0.461 . . . . 0.0 109.756 178.179 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' C' C ' 14' ' ' LEU . . . . . . . . . . . . . 19.0 mt -87.21 152.24 52.55 Favored Pre-proline 0 C--N 1.328 -0.33 0 CA-C-N 116.421 -0.354 . . . . 0.0 111.079 -175.131 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' C' C ' 15' ' ' PRO . . . . . . . . . . . . . 26.8 Cg_exo -61.95 161.61 25.2 Favored 'Trans proline' 0 N--CA 1.496 1.65 0 C-N-CA 121.443 1.428 . . . . 0.0 111.698 176.451 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' C' C ' 16' ' ' PRO . . . . . . . . . . . . . 24.0 Cg_exo -62.81 -38.14 50.74 Favored 'Trans proline' 0 N--CA 1.497 1.729 0 C-N-CA 121.485 1.457 . . . . 0.0 112.75 -179.248 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' C' C ' 17' ' ' ASP . . . . . . . . . . . . . 9.4 p-10 -93.88 15.84 15.7 Favored 'General case' 0 C--N 1.327 -0.388 0 N-CA-C 113.154 0.798 . . . . 0.0 113.154 -175.688 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' C' C ' 18' ' ' PHE . . . . . . . . . . . . . 38.2 t80 -57.06 -47.03 81.97 Favored 'General case' 0 C--N 1.334 -0.076 0 O-C-N 122.06 -0.4 . . . . 0.0 110.595 -176.998 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' C' C ' 19' ' ' VAL . . . . . . . . . . . . . 46.3 t -56.33 -46.28 81.69 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.323 0 CA-C-N 116.464 -0.335 . . . . 0.0 110.852 -176.261 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' C' C ' 20' ' ' ASP . . . . . . . . . . . . . 77.2 m-20 -60.08 -41.55 92.7 Favored 'General case' 0 C--N 1.329 -0.298 0 C-N-CA 120.939 -0.304 . . . . 0.0 111.159 -177.066 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' C' C ' 21' ' ' VAL . . . . . . . . . . . . . 44.5 t -64.04 -46.75 92.95 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.29 0 C-N-CA 120.759 -0.376 . . . . 0.0 110.383 -177.968 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' C' C ' 22' ' ' ILE . . . . . . . . . . . . . 51.5 mm -56.36 -46.32 81.8 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.218 0 C-N-CA 120.951 -0.3 . . . . 0.0 110.567 178.352 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' C' C ' 23' ' ' ARG . . . . . . . . . . . . . 56.4 ttp180 -52.88 -49.05 66.64 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-O 120.652 0.263 . . . . 0.0 111.558 -178.798 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' C' C ' 24' ' ' ILE . . . . . . . . . . . . . 71.3 mt -58.32 -47.75 86.84 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.341 0 CA-C-N 116.661 -0.245 . . . . 0.0 110.802 -178.187 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' C' C ' 25' ' ' LYS . . . . . . . . . . . . . 40.4 mmtt -60.76 -43.96 97.34 Favored 'General case' 0 C--N 1.329 -0.315 0 N-CA-C 112.129 0.418 . . . . 0.0 112.129 -177.959 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' C' C ' 26' ' ' LEU . . . . . . . . . . . . . 81.8 mt -80.88 -29.21 35.75 Favored 'General case' 0 C--N 1.33 -0.273 0 N-CA-C 113.392 0.886 . . . . 0.0 113.392 -170.721 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' C' C ' 27' ' ' GLN . . . . . . . . . . . . . 4.4 pt20 -45.87 134.53 7.78 Favored 'General case' 0 N--CA 1.467 0.423 0 N-CA-C 112.856 0.687 . . . . 0.0 112.856 -174.931 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' C' C ' 28' ' ' GLY . . . . . . . . . . . . . . . 101.11 -20.21 48.45 Favored Glycine 0 CA--C 1.533 1.191 0 CA-C-N 115.948 -0.569 . . . . 0.0 112.863 -179.038 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' C' C ' 29' ' ' LYS . . . . . . . . . . . . . 59.9 mtpt -97.53 155.08 17.11 Favored 'General case' 0 C--N 1.332 -0.17 0 CA-C-N 117.78 0.79 . . . . 0.0 111.153 179.84 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' C' C ' 30' ' ' THR . . . . . . . . . . . . . 42.6 m -107.38 138.41 43.63 Favored 'General case' 0 C--N 1.332 -0.164 0 CA-C-N 116.157 -0.474 . . . . 0.0 110.038 176.262 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' C' C ' 31' ' ' VAL . . . . . . . . . . . . . 35.0 m -131.33 160.61 42.19 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.252 0 CA-C-N 116.38 -0.373 . . . . 0.0 110.771 -178.928 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' C' C ' 32' ' ' ARG . . . . . . . . . . . . . 21.1 mtp-105 -132.99 153.3 51.6 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-O 121.37 0.605 . . . . 0.0 110.552 178.236 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' C' C ' 33' ' ' THR . . . . . . . . . . . . . 17.9 m -52.98 139.72 26.97 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.022 -0.536 . . . . 0.0 111.457 -177.817 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' C' C ' 34' ' ' GLY . . . . . . . . . . . . . . . 99.85 -17.06 57.87 Favored Glycine 0 CA--C 1.532 1.108 0 CA-C-O 119.623 -0.543 . . . . 0.0 113.447 177.678 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' C' C ' 35' ' ' ASP . . . . . . . . . . . . . 70.9 m-20 -64.23 148.85 49.19 Favored 'General case' 0 C--O 1.232 0.167 0 CA-C-N 118.004 0.902 . . . . 0.0 111.17 -179.833 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' C' C ' 36' ' ' VAL . . . . . . . . . . . . . 45.9 t -122.63 129.69 75.03 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.241 0 CA-C-N 115.794 -0.639 . . . . 0.0 109.629 178.117 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' C' C ' 37' ' ' ILE . . . . . 0.4 HG23 HD12 ' C' ' 37' ' ' ILE . 67.7 mt -121.82 140.23 46.44 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.278 0 CA-C-N 116.396 -0.365 . . . . 0.0 110.129 -178.146 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' C' C ' 38' ' ' GLY . . . . . . . . . . . . . . . -113.2 128.96 8.62 Favored Glycine 0 CA--C 1.526 0.745 0 N-CA-C 111.082 -0.807 . . . . 0.0 111.082 -179.845 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' C' C ' 39' ' ' ILE . . . . . . . . . . . . . 76.2 mt -124.24 142.64 40.35 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.205 0 N-CA-C 110.025 -0.361 . . . . 0.0 110.025 179.564 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' C' C ' 40' ' ' SER . . . . . . . . . . . . . 89.7 p -91.3 120.47 32.22 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.361 -0.381 . . . . 0.0 111.067 177.888 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' C' C ' 41' ' ' ILE . . . . . . . . . . . . . 46.3 mm -130.16 114.96 30.9 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.242 0 CA-C-N 116.435 -0.348 . . . . 0.0 110.098 177.904 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' C' C ' 42' ' ' LEU . . . . . . . . . . . . . 49.0 mt 58.03 35.16 24.97 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.391 -0.368 . . . . 0.0 111.566 178.248 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' C' C ' 43' ' ' GLY . . . . . . . . . . . . . . . 77.89 -10.08 27.74 Favored Glycine 0 CA--C 1.533 1.203 0 C-N-CA 121.316 -0.469 . . . . 0.0 113.499 177.81 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' C' C ' 44' ' ' LYS . . . . . . . . . . . . . 68.4 mmtt -98.04 139.47 33.81 Favored 'General case' 0 C--N 1.333 -0.11 0 CA-C-N 117.96 0.88 . . . . 0.0 109.869 176.057 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' C' C ' 45' ' ' GLU . . . . . . . . . . . . . 82.2 tt0 -83.3 123.81 29.99 Favored 'General case' 0 C--N 1.329 -0.315 0 C-N-CA 120.936 -0.306 . . . . 0.0 110.713 179.536 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' C' C ' 46' ' ' VAL . . . . . . . . . . . . . 7.7 p -115.5 128.37 72.74 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.167 0 N-CA-C 109.511 -0.552 . . . . 0.0 109.511 177.441 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' C' C ' 47' ' ' LYS . . . . . . . . . . . . . 67.4 mttm -100.24 130.74 46.4 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 115.97 -0.559 . . . . 0.0 111.56 -179.927 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' C' C ' 48' ' ' PHE . . . . . . . . . . . . . 91.1 m-85 -115.31 131.91 56.78 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.079 -0.509 . . . . 0.0 109.714 175.813 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' C' C ' 49' ' ' LYS . . . . . . . . . . . . . 82.8 tttt -107.92 137.18 46.37 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.498 -0.319 . . . . 0.0 110.716 -179.478 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' C' C ' 50' ' ' VAL . . . . . . . . . . . . . 44.3 t -82.29 105.64 12.36 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.262 0 N-CA-C 109.543 -0.54 . . . . 0.0 109.543 176.288 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' C' C ' 51' ' ' VAL . . . . . . . . . . . . . 46.4 t -71.0 -52.89 24.08 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.333 0 CA-C-N 115.926 -0.579 . . . . 0.0 109.75 -174.914 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' C' C ' 52' ' ' GLN . . . . . . . . . . . . . 81.9 mt-30 -154.57 149.92 27.19 Favored 'General case' 0 C--N 1.331 -0.198 0 C-N-CA 120.41 -0.516 . . . . 0.0 111.58 -177.418 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' C' C ' 53' ' ' ALA . . . . . . . . . . . . . . . -122.89 130.69 53.17 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 115.41 -0.813 . . . . 0.0 109.43 174.833 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' C' C ' 54' ' ' TYR . . . . . . . . . . . . . 67.9 t80 -129.0 107.41 18.08 Favored Pre-proline 0 CA--C 1.533 0.318 0 CA-C-O 118.215 -0.898 . . . . 0.0 110.493 -179.416 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' C' C ' 55' ' ' PRO . . . . . . . . . . . . . 73.1 Cg_endo -77.09 170.05 72.67 Favored 'Cis proline' 0 N--CA 1.5 1.907 0 CA-C-N 121.726 1.652 . . . . 0.0 112.583 -5.07 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' C' C ' 56' ' ' SER . . . . . . . . . . . . . 32.5 m -115.71 132.12 23.33 Favored Pre-proline 0 CA--C 1.538 0.516 0 CA-C-O 118.429 -0.796 . . . . 0.0 109.515 175.428 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' C' C ' 57' ' ' PRO . . . . . . . . . . . . . 33.5 Cg_endo -65.76 166.26 55.41 Favored 'Cis proline' 0 N--CA 1.498 1.785 0 CA-C-N 121.971 1.74 . . . . 0.0 111.378 -2.583 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' C' C ' 58' ' ' LEU . . . . . . . . . . . . . 19.4 tp -130.5 138.58 50.31 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-O 121.018 0.437 . . . . 0.0 110.662 -179.919 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' C' C ' 59' ' ' ARG . . . . . . . . . . . . . 78.6 ttt-85 -103.61 128.4 50.9 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 115.579 -0.737 . . . . 0.0 109.47 175.767 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' C' C ' 60' ' ' VAL . . . . . . . . . . . . . 43.2 t -78.86 112.93 17.48 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.344 0 CA-C-O 120.817 0.342 . . . . 0.0 110.378 -177.114 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' C' C ' 61' ' ' GLU . . . . . . . . . . . . . 72.9 tt0 -130.95 157.01 44.11 Favored 'General case' 0 C--N 1.329 -0.314 0 N-CA-C 109.359 -0.608 . . . . 0.0 109.359 177.936 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' C' C ' 62' ' ' ASP . . . . . . . . . . . . . 9.5 t0 -51.7 -30.79 23.51 Favored 'General case' 0 C--N 1.326 -0.414 0 N-CA-C 112.213 0.449 . . . . 0.0 112.213 -177.479 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' C' C ' 63' ' ' ARG . . . . . . . . . . . . . 73.8 mtp180 -72.66 -22.06 60.99 Favored 'General case' 0 CA--C 1.532 0.288 0 N-CA-C 112.966 0.728 . . . . 0.0 112.966 -175.38 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' C' C ' 64' ' ' THR . . . . . . . . . . . . . 32.3 m -73.69 140.58 46.14 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-O 120.895 0.379 . . . . 0.0 110.829 -176.226 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' C' C ' 65' ' ' LYS . . . . . . . . . . . . . 42.1 mtmt -89.22 127.79 35.78 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.099 -0.501 . . . . 0.0 110.12 177.868 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' C' C ' 66' ' ' ILE . . . . . . . . . . . . . 64.8 mt -109.48 125.73 66.62 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.32 0 N-CA-C 109.427 -0.583 . . . . 0.0 109.427 179.152 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' C' C ' 67' ' ' THR . . . . . . . . . . . . . 23.1 m -124.81 142.29 51.53 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-O 121.277 0.56 . . . . 0.0 111.358 -174.9 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' C' C ' 68' ' ' LEU . . . . . . . . . . . . . 43.8 mt . . . . . 0 C--N 1.33 -0.25 0 CA-C-N 115.59 -0.732 . . . . 0.0 109.894 176.123 . . . . . . . . 0 0 . 1 . 016 nuclear orig core ' C' C ' 73' ' ' VAL . . . . . . . . . . . . . 34.8 m . . . . . 0 N--CA 1.462 0.146 0 CA-C-O 120.717 0.294 . . . . 0.0 110.799 . . . . . . . . . 0 0 . 1 . 016 nuclear orig core ' C' C ' 74' ' ' ASP . . . . . . . . . . . . . 35.6 t0 -102.83 118.06 36.0 Favored 'General case' 0 C--N 1.331 -0.199 0 N-CA-C 109.455 -0.572 . . . . 0.0 109.455 177.835 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' C' C ' 75' ' ' VAL . . . . . . . . . . . . . 39.9 t -118.63 123.88 72.25 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.245 0 CA-C-O 121.141 0.496 . . . . 0.0 110.795 -176.634 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' C' C ' 76' ' ' LEU . . . . . . . . . . . . . 6.7 mp -117.62 150.39 39.11 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 115.503 -0.771 . . . . 0.0 109.613 176.184 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' C' C ' 77' ' ' GLU . . . . . . . . . . . . . 47.2 mt-10 -134.62 132.32 38.85 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-O 120.963 0.411 . . . . 0.0 111.019 179.916 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' C' C ' 78' ' ' ALA . . . . . . . . . . . . . . . -124.66 127.76 47.8 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 115.838 -0.619 . . . . 0.0 109.919 177.05 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' C' C ' 79' ' ' LYS . . . . . . . . . . . . . 14.4 ptpt -72.81 119.29 16.85 Favored 'General case' 0 C--N 1.331 -0.239 0 CA-C-O 121.239 0.543 . . . . 0.0 110.589 -178.772 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' C' C ' 80' ' ' ILE . . . . . . . . . . . . . 24.1 mm -139.44 105.59 2.43 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.285 0 N-CA-C 109.213 -0.662 . . . . 0.0 109.213 -177.781 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' C' C ' 81' ' ' LYS . . . . . . . . . . . . . 55.9 pttt -98.91 126.83 44.68 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-O 121.032 0.444 . . . . 0.0 111.26 -177.205 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' C' C ' 82' ' ' GLY . . . . . . . . . . . . . . . 89.16 42.03 5.69 Favored Glycine 0 CA--C 1.526 0.754 0 CA-C-N 115.838 -0.619 . . . . 0.0 111.834 175.05 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' C' C ' 83' ' ' ILE . . . . . . . . . . . . . 67.3 mt -71.99 139.35 19.88 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.391 0 N-CA-C 109.551 -0.537 . . . . 0.0 109.551 176.57 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' C' C ' 84' ' ' LYS . . . . . . . . . . . . . 20.2 ttpp -102.28 -50.21 3.68 Favored 'General case' 0 C--N 1.331 -0.215 0 CA-C-O 120.895 0.378 . . . . 0.0 110.317 -178.857 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' C' C ' 85' ' ' ASP . . . . . . . . . . . . . 11.1 t70 -150.95 150.0 30.29 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.034 -0.53 . . . . 0.0 110.641 -179.184 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' C' C ' 86' ' ' VAL . . . . . . . . . . . . . 44.7 t -132.93 131.12 59.06 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.275 0 CA-C-O 120.89 0.376 . . . . 0.0 110.3 179.779 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' C' C ' 87' ' ' ILE . . . . . . . . . . . . . 40.3 mm -119.5 127.08 75.86 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.233 0 N-CA-C 109.359 -0.608 . . . . 0.0 109.359 177.457 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' C' C ' 88' ' ' LEU . . . . . . . . . . . . . 20.4 tp -113.03 132.15 55.5 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-O 120.973 0.416 . . . . 0.0 111.119 -177.209 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' C' C ' 89' ' ' ASP . . . . . . . . . . . . . 8.6 t70 -125.1 156.5 38.19 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 115.77 -0.65 . . . . 0.0 109.587 176.272 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' C' C ' 90' ' ' GLU . . . . . . . . . . . . . 95.4 mt-10 -47.02 -39.28 12.34 Favored 'General case' 0 C--N 1.329 -0.301 0 N-CA-C 113.007 0.743 . . . . 0.0 113.007 -172.167 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' C' C ' 91' ' ' ASN . . . . . . . . . . . . . 3.7 t-20 -132.09 34.8 3.77 Favored 'General case' 0 N--CA 1.464 0.251 0 N-CA-C 111.832 0.308 . . . . 0.0 111.832 -175.862 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' C' C ' 92' ' ' LEU . . . . . . . . . . . . . 11.4 tp -166.09 146.03 6.27 Favored 'General case' 0 C--N 1.332 -0.187 0 C-N-CA 120.755 -0.378 . . . . 0.0 111.058 -179.335 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' C' C ' 93' ' ' ILE . . . . . . . . . . . . . 64.4 mt -125.3 123.42 65.05 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.18 0 N-CA-C 109.575 -0.528 . . . . 0.0 109.575 178.622 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' C' C ' 94' ' ' VAL . . . . . . . . . . . . . 47.0 t -122.64 125.02 71.92 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.218 0 N-CA-C 109.887 -0.412 . . . . 0.0 109.887 178.806 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' C' C ' 95' ' ' VAL . . . . . . . . . . . . . 44.3 t -121.61 135.8 60.6 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.273 0 CA-C-N 116.068 -0.515 . . . . 0.0 110.049 -178.38 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' C' C ' 96' ' ' ILE . . . . . . . . . . . . . 64.9 mt -117.87 127.31 75.17 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.307 0 N-CA-C 109.647 -0.501 . . . . 0.0 109.647 -179.949 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' C' C ' 97' ' ' THR . . . . . . . . . . . . . 81.2 p -98.94 156.41 16.91 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-O 121.021 0.439 . . . . 0.0 110.984 -178.965 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' C' C ' 98' ' ' GLU . . . . . . . . . . . . . 14.2 pt-20 -55.58 -22.18 20.83 Favored 'General case' 0 CA--C 1.534 0.343 0 N-CA-C 112.603 0.594 . . . . 0.0 112.603 -178.736 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' C' C ' 99' ' ' GLU . . . . . . . . . . . . . 51.0 mp0 -81.22 15.49 1.92 Allowed 'General case' 0 CA--C 1.535 0.399 0 N-CA-C 112.95 0.722 . . . . 0.0 112.95 -178.881 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' C' C ' 100' ' ' ASN . . . . . . . . . . . . . 22.3 m-20 59.66 37.37 22.42 Favored 'General case' 0 C--N 1.332 -0.153 0 CA-C-O 121.026 0.441 . . . . 0.0 111.159 -179.428 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' C' C ' 101' ' ' GLU . . . . . . . . . . . . . 84.4 tt0 -111.91 142.35 44.41 Favored 'General case' 0 C--N 1.333 -0.132 0 N-CA-C 109.575 -0.528 . . . . 0.0 109.575 173.198 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' C' C ' 102' ' ' VAL . . . . . . . . . . . . . 44.3 t -114.95 127.93 72.31 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.249 0 CA-C-N 116.27 -0.423 . . . . 0.0 109.998 -177.025 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' C' C ' 103' ' ' LEU . . . . . . . . . . . . . 39.8 mt -117.01 131.56 56.92 Favored 'General case' 0 C--N 1.331 -0.216 0 CA-C-N 115.604 -0.726 . . . . 0.0 110.224 177.087 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' C' C ' 104' ' ' ILE . . . . . . . . . . . . . 66.8 mt -118.44 122.9 70.66 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.255 0 CA-C-N 116.491 -0.322 . . . . 0.0 110.155 -179.865 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' C' C ' 105' ' ' PHE . . . . . . . . . . . . . 89.7 m-85 -124.85 162.66 23.88 Favored 'General case' 0 N--CA 1.462 0.135 0 O-C-N 123.983 0.802 . . . . 0.0 110.3 -178.3 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' C' C ' 106' ' ' ASN . . . . . . . . . . . . . 41.3 p-10 -100.27 -169.95 1.8 Allowed 'General case' 0 C--N 1.331 -0.21 0 CA-C-N 116.309 -0.405 . . . . 0.0 109.934 174.018 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' C' C ' 107' ' ' GLN . . . . . . . . . . . . . 32.3 tt0 -58.49 -30.01 66.68 Favored 'General case' 0 CA--C 1.532 0.252 0 N-CA-C 111.998 0.37 . . . . 0.0 111.998 179.553 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' C' C ' 108' ' ' ASN . . . . . . . . . . . . . 10.7 t-20 -84.24 9.62 12.46 Favored 'General case' 0 CA--C 1.536 0.407 0 N-CA-C 113.114 0.783 . . . . 0.0 113.114 -176.787 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' C' C ' 109' ' ' LEU . . . . . . . . . . . . . 11.1 tp 56.13 35.85 26.39 Favored 'General case' 0 CA--C 1.531 0.225 0 CA-C-O 120.898 0.38 . . . . 0.0 111.266 -179.97 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' C' C ' 110' ' ' GLU . . . . . . . . . . . . . 42.8 mt-10 -103.17 147.62 26.79 Favored 'General case' 0 C--N 1.331 -0.22 0 N-CA-C 109.522 -0.547 . . . . 0.0 109.522 175.613 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' C' C ' 111' ' ' GLU . . . . . . . . . . . . . 50.9 tt0 -79.68 121.9 25.88 Favored 'General case' 0 C--N 1.327 -0.396 0 CA-C-O 120.822 0.344 . . . . 0.0 110.877 -175.838 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' C' C ' 112' ' ' LEU . . . . . . . . . . . . . 22.9 mt -106.03 -45.89 4.23 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-N 116.029 -0.532 . . . . 0.0 110.42 178.805 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' C' C ' 113' ' ' TYR . . . . . . . . . . . . . 53.4 t80 -136.26 138.79 42.17 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-O 120.905 0.383 . . . . 0.0 111.294 -178.849 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' C' C ' 114' ' ' ARG . . . . . . . . . . . . . 58.8 ttp180 -137.08 121.62 18.37 Favored 'General case' 0 C--N 1.331 -0.197 0 CA-C-N 115.775 -0.648 . . . . 0.0 110.221 178.164 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' C' C ' 115' ' ' GLY . . . . . . . . . . . . . . . -150.0 151.13 23.25 Favored Glycine 0 CA--C 1.523 0.584 0 N-CA-C 111.094 -0.802 . . . . 0.0 111.094 178.033 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' C' C ' 116' ' ' LYS . . . . . . . . . . . . . 72.6 tttt -130.01 133.19 46.6 Favored 'General case' 0 C--N 1.33 -0.261 0 N-CA-C 109.793 -0.447 . . . . 0.0 109.793 178.013 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' C' C ' 117' ' ' PHE . . . . . . . . . . . . . 23.1 m-85 -133.5 113.94 13.04 Favored 'General case' 0 C--N 1.331 -0.226 0 CA-C-O 120.884 0.373 . . . . 0.0 110.339 -174.136 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' C' C ' 118' ' ' GLU . . . . . . . . . . . . . 95.7 mt-10 -54.15 -50.43 66.98 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.396 -0.365 . . . . 0.0 111.179 -177.736 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' C' C ' 119' ' ' ASN . . . . . . . . . . . . . 35.6 m120 -89.67 29.64 1.13 Allowed 'General case' 0 C--N 1.33 -0.278 0 N-CA-C 112.261 0.467 . . . . 0.0 112.261 -174.922 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' C' C ' 120' ' ' LEU . . . . . . . . . . . . . 30.6 tp -57.95 121.22 10.05 Favored 'General case' 0 C--N 1.332 -0.162 0 N-CA-C 110.161 -0.311 . . . . 0.0 110.161 177.313 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' C' C ' 121' ' ' ASN . . . . . . . . . . . . . 32.1 m120 -114.11 -43.41 3.24 Favored 'General case' 0 C--N 1.331 -0.209 0 CA-C-N 116.326 -0.397 . . . . 0.0 111.017 -177.155 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' C' C ' 122' ' ' LYS . . . . . . . . . . . . . 67.9 mttm -138.68 144.34 39.57 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-O 121.152 0.501 . . . . 0.0 111.614 -175.909 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' C' C ' 123' ' ' VAL . . . . . . . . . . . . . 45.7 t -124.55 126.23 71.41 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.21 0 CA-C-N 115.715 -0.675 . . . . 0.0 109.448 176.146 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' C' C ' 124' ' ' LEU . . . . . . . . . . . . . 27.3 mt -123.18 131.0 53.52 Favored 'General case' 0 C--N 1.332 -0.166 0 CA-C-O 120.642 0.258 . . . . 0.0 110.683 -178.212 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' C' C ' 125' ' ' VAL . . . . . . . . . . . . . 35.1 m -136.31 134.41 49.84 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.288 0 CA-C-N 116.321 -0.4 . . . . 0.0 110.752 179.896 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' C' C ' 126' ' ' ARG . . . . . . . . . . . . . 95.7 mtt-85 -146.28 118.17 8.19 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.325 -0.398 . . . . 0.0 110.671 178.053 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' C' C ' 127' ' ' ASN . . . . . . . . . . . . . 34.8 m120 49.84 -104.97 0.16 Allowed 'General case' 0 CA--C 1.544 0.718 0 CA-C-O 119.202 -0.428 . . . . 0.0 111.78 177.599 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' C' C ' 128' ' ' ASP . . . . . . . . . . . . . 13.0 p-10 -114.23 13.5 17.94 Favored 'General case' 0 N--CA 1.467 0.408 0 CA-C-N 119.406 1.003 . . . . 0.0 113.263 -175.112 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' C' C ' 129' ' ' LEU . . . . . . . . . . . . . 24.4 tp -118.32 136.83 53.48 Favored 'General case' 0 C--N 1.332 -0.161 0 O-C-N 122.029 -0.42 . . . . 0.0 110.046 177.592 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' C' C ' 130' ' ' VAL . . . . . . . . . . . . . 42.4 t -125.09 136.56 60.47 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.196 0 CA-C-O 120.926 0.393 . . . . 0.0 110.025 -179.347 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' C' C ' 131' ' ' VAL . . . . . . . . . . . . . 41.8 t -136.02 135.26 50.46 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.291 0 CA-C-O 121.131 0.491 . . . . 0.0 110.167 178.022 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' C' C ' 132' ' ' ILE . . . . . . . . . . . . . 73.1 mt -117.08 129.85 72.95 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.323 0 CA-C-N 115.717 -0.674 . . . . 0.0 109.388 -179.295 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' C' C ' 133' ' ' ILE . . . . . . . . . . . . . 37.6 mm -115.46 120.3 64.31 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.301 0 CA-C-O 120.608 0.242 . . . . 0.0 111.047 -174.494 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' C' C ' 134' ' ' ASP . . . . . . . . . . . . . 7.5 p-10 -130.42 149.87 51.9 Favored 'General case' 0 C--N 1.333 -0.138 0 N-CA-C 109.944 -0.391 . . . . 0.0 109.944 174.655 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' C' C ' 135' ' ' GLU . . . . . . . . . . . . . 58.0 tt0 -49.92 -25.93 3.69 Favored 'General case' 0 C--N 1.327 -0.375 0 N-CA-C 113.088 0.773 . . . . 0.0 113.088 -170.889 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' C' C ' 136' ' ' GLN . . . . . . . . . . . . . 30.1 tt0 -95.38 -26.87 15.71 Favored 'General case' 0 CA--C 1.531 0.221 0 N-CA-C 112.765 0.654 . . . . 0.0 112.765 -172.472 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' C' C ' 137' ' ' LYS . . . . . . . . . . . . . 58.3 pttt -163.86 167.46 20.72 Favored 'General case' 0 C--O 1.233 0.193 0 CA-C-O 121.576 0.703 . . . . 0.0 112.162 -175.114 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' C' C ' 138' ' ' LEU . . . . . . . . . . . . . 6.3 tt -117.12 128.43 55.12 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 115.029 -0.987 . . . . 0.0 109.928 179.712 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' C' C ' 139' ' ' THR . . . . . . . . . . . . . 27.7 m -108.24 124.83 50.9 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.156 -0.474 . . . . 0.0 110.402 179.236 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' C' C ' 140' ' ' LEU . . . . . . . . . . . . . 10.5 tp -111.21 120.47 42.38 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 115.853 -0.612 . . . . 0.0 109.355 -178.977 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' C' C ' 141' ' ' ILE . . . . . . . . . . . . . 18.9 mt -123.21 118.28 54.18 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.269 0 CA-C-O 121.118 0.485 . . . . 0.0 110.081 -174.862 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' C' C ' 142' ' ' ARG . . . . . . . . . . . . . 72.1 mtp180 . . . . . 0 C--N 1.328 -0.349 0 CA-C-N 115.435 -0.802 . . . . 0.0 110.176 176.736 . . . . . . . . 0 0 . 1 . 016 nuclear orig core ' D' D ' 2' ' ' SER . . . . . . . . . . . . . 3.9 p . . . . . 0 N--CA 1.462 0.168 0 CA-C-O 120.951 0.405 . . . . 0.0 110.613 . . . . . . . . . 0 0 . 1 . 016 nuclear orig core ' D' D ' 3' ' ' GLU . . . . . . . . . . . . . 80.7 tt0 -146.6 142.93 28.45 Favored 'General case' 0 C--N 1.327 -0.396 0 CA-C-N 115.987 -0.551 . . . . 0.0 111.019 -178.658 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' D' D ' 4' ' ' LEU . . . . . . . . . . . . . 17.2 tp -124.3 132.27 53.56 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.01 -0.541 . . . . 0.0 110.056 177.171 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' D' D ' 5' ' ' LYS . . . . . . . . . . . . . 66.4 mttm -111.13 121.76 46.14 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 116.331 -0.395 . . . . 0.0 110.513 -179.176 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' D' D ' 6' ' ' LEU . . . . . . . . . . . . . 71.1 mt -117.2 151.43 36.9 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 115.668 -0.696 . . . . 0.0 110.94 -177.384 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' D' D ' 7' ' ' LYS . . . . . . . . . . . . . 74.9 tttt -142.5 141.72 21.47 Favored Pre-proline 0 CA--C 1.532 0.278 0 CA-C-N 116.18 -0.464 . . . . 0.0 109.952 174.005 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' D' D ' 8' ' ' PRO . . . . . . . . . . . . . 84.1 Cg_endo -90.76 144.8 3.7 Favored 'Trans proline' 0 N--CA 1.491 1.325 0 C-N-CA 121.74 1.627 . . . . 0.0 112.081 179.039 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' D' D ' 9' ' ' LEU . . . . . . . . . . . . . 40.9 mt -81.07 -47.18 1.14 Allowed Pre-proline 0 CA--C 1.533 0.292 0 CA-C-O 118.71 -0.662 . . . . 0.0 112.048 179.784 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' D' D ' 10' ' ' PRO . . . . . . . . . . . . . 88.1 Cg_endo -81.34 154.3 18.68 Favored 'Trans proline' 0 N--CA 1.497 1.711 0 C-N-CA 121.149 1.233 . . . . 0.0 111.643 175.223 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' D' D ' 11' ' ' LYS . . . . . . . . . . . . . 61.6 tttm -88.71 100.41 13.1 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.473 -0.331 . . . . 0.0 110.513 179.392 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' D' D ' 12' ' ' VAL . . . . . . . . . . . . . 12.3 p -144.92 146.44 19.98 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.233 0 CA-C-N 116.22 -0.446 . . . . 0.0 110.679 -179.516 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' D' D ' 13' ' ' GLU . . . . . . . . . . . . . 95.1 mt-10 -82.57 130.56 35.14 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 116.28 -0.418 . . . . 0.0 109.97 176.782 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' D' D ' 14' ' ' LEU . . . . . . . . . . . . . 16.8 mt -97.52 146.93 32.25 Favored Pre-proline 0 CA--C 1.533 0.303 0 CA-C-O 119.223 -0.418 . . . . 0.0 110.238 -178.476 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' D' D ' 15' ' ' PRO . . . . . . . . . . . . . 30.5 Cg_exo -60.43 159.36 27.68 Favored 'Trans proline' 0 N--CA 1.497 1.721 0 C-N-CA 121.328 1.352 . . . . 0.0 111.783 177.176 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' D' D ' 16' ' ' PRO . . . . . . . . . . . . . 39.4 Cg_exo -58.4 -41.04 69.67 Favored 'Trans proline' 0 N--CA 1.497 1.683 0 C-N-CA 121.472 1.448 . . . . 0.0 112.676 -178.261 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' D' D ' 17' ' ' ASP . . . . . . . . . . . . . 12.6 p-10 -87.82 13.01 11.55 Favored 'General case' 0 CA--C 1.535 0.404 0 N-CA-C 113.086 0.772 . . . . 0.0 113.086 -178.084 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' D' D ' 18' ' ' PHE . . . . . . . . . . . . . 46.6 t80 -58.26 -45.01 88.61 Favored 'General case' 0 C--N 1.334 -0.079 0 CA-C-O 120.935 0.398 . . . . 0.0 110.078 -178.542 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' D' D ' 19' ' ' VAL . . . . . . . . . . . . . 47.7 t -56.87 -41.2 75.64 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.249 0 CA-C-N 116.142 -0.481 . . . . 0.0 110.438 -178.805 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' D' D ' 20' ' ' ASP . . . . . . . . . . . . . 71.1 m-20 -60.39 -44.0 96.1 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-O 120.811 0.339 . . . . 0.0 111.071 -178.074 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' D' D ' 21' ' ' VAL . . . . . . . . . . . . . 46.1 t -64.22 -48.6 84.89 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 CA-C-N 116.353 -0.385 . . . . 0.0 110.484 -177.844 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' D' D ' 22' ' ' ILE . . . . . . . . . . . . . 50.6 mm -55.09 -47.92 76.62 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.241 0 CA-C-O 120.687 0.279 . . . . 0.0 110.829 179.356 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' D' D ' 23' ' ' ARG . . . . . . . . . . . . . 3.7 tmm_? -53.5 -53.38 52.33 Favored 'General case' 0 C--N 1.329 -0.313 0 N-CA-C 111.605 0.224 . . . . 0.0 111.605 -177.719 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' D' D ' 24' ' ' ILE . . . . . . . . . . . . . 72.2 mt -60.31 -41.86 88.64 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.28 0 N-CA-C 111.659 0.244 . . . . 0.0 111.659 -175.711 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' D' D ' 25' ' ' LYS . . . . . . . . . . . . . 53.0 mttm -67.79 -36.95 81.37 Favored 'General case' 0 C--N 1.328 -0.334 0 N-CA-C 112.147 0.425 . . . . 0.0 112.147 -177.707 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' D' D ' 26' ' ' LEU . . . . . . . . . . . . . 26.5 mt -79.46 -41.94 26.41 Favored 'General case' 0 C--N 1.33 -0.275 0 N-CA-C 112.798 0.666 . . . . 0.0 112.798 -173.617 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' D' D ' 27' ' ' GLN . . . . . . . . . . . . . 8.9 pt20 -46.0 138.57 4.99 Favored 'General case' 0 N--CA 1.47 0.554 0 N-CA-C 112.686 0.625 . . . . 0.0 112.686 -175.669 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' D' D ' 28' ' ' GLY . . . . . . . . . . . . . . . 100.79 -27.86 18.59 Favored Glycine 0 CA--C 1.53 1.02 0 CA-C-N 115.334 -0.848 . . . . 0.0 112.073 -176.086 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' D' D ' 29' ' ' LYS . . . . . . . . . . . . . 94.4 mttt -97.91 155.14 17.22 Favored 'General case' 0 C--O 1.232 0.164 0 CA-C-N 117.186 0.493 . . . . 0.0 111.01 178.796 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' D' D ' 30' ' ' THR . . . . . . . . . . . . . 25.2 m -103.96 139.39 39.18 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.167 -0.47 . . . . 0.0 110.33 176.935 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' D' D ' 31' ' ' VAL . . . . . . . . . . . . . 35.1 m -128.76 151.05 35.0 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.278 0 CA-C-O 121.047 0.451 . . . . 0.0 110.91 -178.922 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' D' D ' 32' ' ' ARG . . . . . . . . . . . . . 26.3 ttm180 -129.05 146.25 51.06 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 115.971 -0.559 . . . . 0.0 110.212 178.895 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' D' D ' 33' ' ' THR . . . . . . . . . . . . . 16.9 m -52.5 139.07 26.2 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.455 -0.339 . . . . 0.0 111.488 -177.301 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' D' D ' 34' ' ' GLY . . . . . . . . . . . . . . . 101.1 -17.21 56.38 Favored Glycine 0 CA--C 1.532 1.151 0 CA-C-O 119.702 -0.499 . . . . 0.0 113.242 179.962 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' D' D ' 35' ' ' ASP . . . . . . . . . . . . . 74.3 m-20 -66.08 149.65 49.94 Favored 'General case' 0 N--CA 1.461 0.095 0 CA-C-N 118.033 0.916 . . . . 0.0 111.15 179.176 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' D' D ' 36' ' ' VAL . . . . . . . . . . . . . 45.9 t -122.12 130.74 74.31 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.193 0 CA-C-N 115.838 -0.619 . . . . 0.0 109.776 177.947 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' D' D ' 37' ' ' ILE . . . . . . . . . . . . . 71.9 mt -121.13 140.13 46.2 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.218 0 CA-C-N 116.299 -0.409 . . . . 0.0 109.994 -179.149 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' D' D ' 38' ' ' GLY . . . . . . . . . . . . . . . -114.26 128.91 8.44 Favored Glycine 0 CA--C 1.526 0.767 0 N-CA-C 111.297 -0.721 . . . . 0.0 111.297 -178.685 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' D' D ' 39' ' ' ILE . . . . . . . . . . . . . 72.2 mt -123.51 135.63 62.69 Favored 'Isoleucine or valine' 0 C--N 1.333 -0.135 0 N-CA-C 109.963 -0.384 . . . . 0.0 109.963 178.268 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' D' D ' 40' ' ' SER . . . . . . . . . . . . . 23.1 t -92.71 123.12 35.76 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-N 116.521 -0.309 . . . . 0.0 111.018 176.786 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' D' D ' 41' ' ' ILE . . . . . . . . . . . . . 73.2 mt -132.21 112.9 20.49 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.167 0 CA-C-O 120.844 0.355 . . . . 0.0 110.315 177.511 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' D' D ' 42' ' ' LEU . . . . . . . . . . . . . 1.4 tt 54.5 47.35 22.97 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-O 121.53 0.681 . . . . 0.0 110.647 178.237 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' D' D ' 43' ' ' GLY . . . . . . . . . . . . . . . 75.23 -10.1 11.51 Favored Glycine 0 CA--C 1.535 1.289 0 CA-C-O 119.692 -0.504 . . . . 0.0 113.796 175.274 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' D' D ' 44' ' ' LYS . . . . . . . . . . . . . 35.8 mmtm -99.79 132.65 45.01 Favored 'General case' 0 C--N 1.332 -0.165 0 CA-C-N 118.066 0.933 . . . . 0.0 110.378 -179.981 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' D' D ' 45' ' ' GLU . . . . . . . . . . . . . 80.3 tt0 -84.45 122.83 29.52 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.22 -0.446 . . . . 0.0 110.806 178.635 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' D' D ' 46' ' ' VAL . . . . . . . . . . . . . 7.7 p -117.19 124.27 72.81 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.199 0 N-CA-C 109.542 -0.54 . . . . 0.0 109.542 176.09 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' D' D ' 47' ' ' LYS . . . . . . . . . . . . . 57.7 mtmt -99.94 129.58 46.03 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 115.812 -0.631 . . . . 0.0 111.18 179.515 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' D' D ' 48' ' ' PHE . . . . . . . . . . . . . 91.3 m-85 -112.34 132.36 55.03 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-N 116.166 -0.47 . . . . 0.0 109.982 177.277 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' D' D ' 49' ' ' LYS . . . . . . . . . . . . . 76.1 tttt -105.84 135.54 47.09 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.348 -0.387 . . . . 0.0 110.41 179.581 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' D' D ' 50' ' ' VAL . . . . . . . . . . . . . 44.1 t -79.47 107.2 11.64 Favored 'Isoleucine or valine' 0 C--O 1.232 0.177 0 N-CA-C 109.324 -0.621 . . . . 0.0 109.324 175.717 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' D' D ' 51' ' ' VAL . . . . . . . . . . . . . 48.2 t -71.21 -51.69 32.54 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.344 0 CA-C-N 115.998 -0.547 . . . . 0.0 109.787 -174.376 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' D' D ' 52' ' ' GLN . . . . . . . . . . . . . 45.1 mt-30 -155.53 150.73 26.83 Favored 'General case' 0 C--N 1.331 -0.221 0 CA-C-O 121.18 0.514 . . . . 0.0 111.74 -177.467 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' D' D ' 53' ' ' ALA . . . . . . . . . . . . . . . -125.19 127.27 46.53 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 115.216 -0.902 . . . . 0.0 109.604 175.907 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' D' D ' 54' ' ' TYR . . . . . . . . . . . . . 62.6 t80 -126.37 107.32 24.02 Favored Pre-proline 0 CA--C 1.535 0.392 0 CA-C-O 118.321 -0.847 . . . . 0.0 110.689 -178.242 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' D' D ' 55' ' ' PRO . . . . . . . . . . . . . 74.1 Cg_endo -77.12 170.02 72.71 Favored 'Cis proline' 0 N--CA 1.499 1.836 0 CA-C-N 121.697 1.642 . . . . 0.0 112.355 -6.022 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' D' D ' 56' ' ' SER . . . . . . . . . . . . . 14.5 m -110.59 128.69 24.93 Favored Pre-proline 0 CA--C 1.539 0.526 0 CA-C-O 118.407 -0.806 . . . . 0.0 109.384 175.739 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' D' D ' 57' ' ' PRO . . . . . . . . . . . . . 61.2 Cg_endo -74.84 149.09 93.3 Favored 'Cis proline' 0 N--CA 1.496 1.639 0 CA-C-N 121.96 1.736 . . . . 0.0 111.716 -0.714 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' D' D ' 58' ' ' LEU . . . . . . . . . . . . . 27.9 tp -108.19 137.52 46.02 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.227 -0.442 . . . . 0.0 110.454 -179.04 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' D' D ' 59' ' ' ARG . . . . . . . . . . . . . 25.5 ttm180 -103.82 126.59 51.06 Favored 'General case' 0 C--N 1.327 -0.383 0 N-CA-C 109.394 -0.595 . . . . 0.0 109.394 176.029 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' D' D ' 60' ' ' VAL . . . . . . . . . . . . . 45.6 t -78.8 116.63 22.96 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.231 0 C-N-CA 120.684 -0.407 . . . . 0.0 110.409 -174.833 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' D' D ' 61' ' ' GLU . . . . . . . . . . . . . 94.7 mt-10 -131.06 163.1 28.36 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 116.0 -0.545 . . . . 0.0 109.849 177.795 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' D' D ' 62' ' ' ASP . . . . . . . . . . . . . 14.2 t0 -52.81 -32.99 47.06 Favored 'General case' 0 C--N 1.329 -0.296 0 N-CA-C 111.864 0.32 . . . . 0.0 111.864 -178.67 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' D' D ' 63' ' ' ARG . . . . . . . . . . . . . 77.2 mtt85 -73.64 -21.97 60.13 Favored 'General case' 0 C--N 1.33 -0.258 0 N-CA-C 113.076 0.769 . . . . 0.0 113.076 -176.061 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' D' D ' 64' ' ' THR . . . . . . . . . . . . . 31.4 m -66.14 138.39 57.69 Favored 'General case' 0 C--N 1.331 -0.211 0 CA-C-O 120.955 0.407 . . . . 0.0 111.14 -175.14 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' D' D ' 65' ' ' LYS . . . . . . . . . . . . . 93.2 mttt -89.01 136.62 32.92 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 115.763 -0.653 . . . . 0.0 109.827 176.969 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' D' D ' 66' ' ' ILE . . . . . . . . . . . . . 58.1 mt -115.8 127.21 73.46 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.294 0 N-CA-C 109.852 -0.425 . . . . 0.0 109.852 -179.181 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' D' D ' 67' ' ' THR . . . . . . . . . . . . . 26.5 m -126.45 147.57 49.78 Favored 'General case' 0 N--CA 1.463 0.215 0 CA-C-O 121.148 0.499 . . . . 0.0 111.362 -175.928 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' D' D ' 68' ' ' LEU . . . . . . . . . . . . . 8.9 mp . . . . . 0 C--N 1.329 -0.292 0 CA-C-N 115.869 -0.605 . . . . 0.0 110.454 177.389 . . . . . . . . 0 0 . 1 . 016 nuclear orig core ' D' D ' 73' ' ' VAL . . . . . . . . . . . . . 3.5 m . . . . . 0 CA--C 1.522 -0.128 0 CA-C-O 121.138 0.494 . . . . 0.0 110.992 . . . . . . . . . 0 0 . 1 . 016 nuclear orig core ' D' D ' 74' ' ' ASP . . . . . . . . . . . . . 6.0 t70 -93.1 118.77 31.59 Favored 'General case' 0 C--N 1.327 -0.409 0 N-CA-C 108.691 -0.855 . . . . 0.0 108.691 173.136 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' D' D ' 75' ' ' VAL . . . . . . . . . . . . . 36.6 t -111.44 126.8 68.86 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.313 0 CA-C-O 121.241 0.543 . . . . 0.0 111.312 -171.754 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' D' D ' 76' ' ' LEU . . . . . . . . . . . . . 5.9 mp -125.97 145.53 50.25 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 115.363 -0.835 . . . . 0.0 109.531 174.672 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' D' D ' 77' ' ' GLU . . . . . . . . . . . . . 97.7 mt-10 -135.26 137.81 42.91 Favored 'General case' 0 N--CA 1.463 0.202 0 CA-C-O 120.982 0.42 . . . . 0.0 111.183 -179.468 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' D' D ' 78' ' ' ALA . . . . . . . . . . . . . . . -131.41 142.12 49.97 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 115.885 -0.598 . . . . 0.0 110.199 177.492 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' D' D ' 79' ' ' LYS . . . . . . . . . . . . . 71.2 mmtt -82.05 122.2 27.52 Favored 'General case' 0 C--N 1.331 -0.239 0 CA-C-O 121.058 0.456 . . . . 0.0 111.276 -178.031 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' D' D ' 80' ' ' ILE . . . . . . . . . . . . . 41.6 mm -139.17 118.94 13.97 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.304 0 N-CA-C 108.926 -0.768 . . . . 0.0 108.926 179.889 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' D' D ' 81' ' ' LYS . . . . . . . . . . . . . 47.5 pttt -112.28 125.56 54.29 Favored 'General case' 0 N--CA 1.464 0.269 0 CA-C-O 121.051 0.453 . . . . 0.0 111.381 -177.051 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' D' D ' 82' ' ' GLY . . . . . . . . . . . . . . . 88.52 42.22 5.86 Favored Glycine 0 CA--C 1.525 0.677 0 C-N-CA 120.825 -0.702 . . . . 0.0 111.689 173.659 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' D' D ' 83' ' ' ILE . . . . . . . . . . . . . 70.1 mt -63.55 138.64 22.63 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.33 0 CA-C-O 121.017 0.437 . . . . 0.0 110.206 179.343 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' D' D ' 84' ' ' LYS . . . . . . . . . . . . . 83.7 tttt -96.96 -50.3 4.68 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 115.792 -0.64 . . . . 0.0 109.718 179.306 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' D' D ' 85' ' ' ASP . . . . . . . . . . . . . 9.8 t70 -158.63 152.52 23.57 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 115.636 -0.711 . . . . 0.0 110.182 179.214 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' D' D ' 86' ' ' VAL . . . . . . . . . . . . . 43.4 t -130.48 130.13 64.93 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.297 0 CA-C-O 120.863 0.364 . . . . 0.0 110.429 -178.991 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' D' D ' 87' ' ' ILE . . . . . . . . . . . . . 5.0 mp -119.6 126.13 75.02 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.261 0 N-CA-C 109.43 -0.582 . . . . 0.0 109.43 176.696 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' D' D ' 88' ' ' LEU . . . . . . . . . . . . . 12.9 tp -113.45 126.19 55.06 Favored 'General case' 0 C--N 1.331 -0.23 0 CA-C-O 120.987 0.422 . . . . 0.0 111.29 -176.636 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' D' D ' 89' ' ' ASP . . . . . . . . . . . . . 9.3 t0 -118.52 151.42 37.88 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 115.871 -0.604 . . . . 0.0 109.524 175.77 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' D' D ' 90' ' ' GLU . . . . . . . . . . . . . 95.4 mt-10 -48.63 -36.85 16.72 Favored 'General case' 0 C--N 1.33 -0.263 0 N-CA-C 112.782 0.66 . . . . 0.0 112.782 -173.054 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' D' D ' 91' ' ' ASN . . . . . . . . . . . . . 36.2 m120 -130.95 31.58 4.45 Favored 'General case' 0 N--CA 1.465 0.307 0 N-CA-C 112.022 0.378 . . . . 0.0 112.022 -176.711 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' D' D ' 92' ' ' LEU . . . . . . . . . . . . . 13.1 tp -166.14 139.38 4.12 Favored 'General case' 0 C--N 1.33 -0.274 0 N-CA-C 110.06 -0.348 . . . . 0.0 110.06 -179.818 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' D' D ' 93' ' ' ILE . . . . . . . . . . . . . 66.2 mt -125.01 124.15 67.02 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.255 0 N-CA-C 109.698 -0.482 . . . . 0.0 109.698 -178.435 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' D' D ' 94' ' ' VAL . . . . . . . . . . . . . 43.0 t -125.72 127.15 71.2 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.256 0 CA-C-O 121.023 0.44 . . . . 0.0 110.169 -179.367 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' D' D ' 95' ' ' VAL . . . . . . . . . . . . . 43.7 t -122.17 135.4 62.39 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.262 0 CA-C-N 115.893 -0.594 . . . . 0.0 109.856 179.845 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' D' D ' 96' ' ' ILE . . . . . . . . . . . . . 58.5 mt -115.43 129.29 71.95 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.323 0 N-CA-C 109.24 -0.652 . . . . 0.0 109.24 179.631 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' D' D ' 97' ' ' THR . . . . . . . . . . . . . 69.7 p -103.92 157.71 16.91 Favored 'General case' 0 C--N 1.331 -0.211 0 CA-C-O 121.381 0.61 . . . . 0.0 111.631 -176.522 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' D' D ' 98' ' ' GLU . . . . . . . . . . . . . 44.6 tp10 -53.77 -29.05 38.31 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 115.832 -0.622 . . . . 0.0 112.16 -178.871 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' D' D ' 99' ' ' GLU . . . . . . . . . . . . . 12.9 pt-20 -80.1 18.07 0.91 Allowed 'General case' 0 CA--C 1.534 0.359 0 N-CA-C 113.12 0.785 . . . . 0.0 113.12 -176.419 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' D' D ' 100' ' ' ASN . . . . . . . . . . . . . 4.6 m-20 62.91 38.13 11.53 Favored 'General case' 0 CA--C 1.529 0.151 0 CA-C-O 121.039 0.447 . . . . 0.0 110.897 177.773 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' D' D ' 101' ' ' GLU . . . . . . . . . . . . . 82.8 tt0 -114.71 142.07 46.99 Favored 'General case' 0 C--N 1.332 -0.173 0 CA-C-N 116.111 -0.495 . . . . 0.0 109.743 176.707 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' D' D ' 102' ' ' VAL . . . . . . . . . . . . . 44.8 t -115.84 125.97 73.18 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.312 0 N-CA-C 109.754 -0.462 . . . . 0.0 109.754 -179.49 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' D' D ' 103' ' ' LEU . . . . . . . . . . . . . 47.7 mt -117.15 130.31 56.53 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 115.746 -0.661 . . . . 0.0 110.295 177.777 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' D' D ' 104' ' ' ILE . . . . . . . . . . . . . 68.9 mt -120.06 121.35 65.64 Favored 'Isoleucine or valine' 0 C--O 1.235 0.316 0 N-CA-C 110.095 -0.335 . . . . 0.0 110.095 -179.139 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' D' D ' 105' ' ' PHE . . . . . . . . . . . . . 62.5 m-85 -122.69 162.65 21.57 Favored 'General case' 0 C--N 1.332 -0.159 0 O-C-N 123.924 0.765 . . . . 0.0 110.099 -178.902 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' D' D ' 106' ' ' ASN . . . . . . . . . . . . . 43.5 p30 -96.03 -171.63 2.37 Favored 'General case' 0 C--N 1.328 -0.348 0 N-CA-C 109.368 -0.604 . . . . 0.0 109.368 172.174 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' D' D ' 107' ' ' GLN . . . . . . . . . . . . . 45.8 tt0 -60.97 -29.9 69.94 Favored 'General case' 0 C--N 1.329 -0.325 0 N-CA-C 112.027 0.38 . . . . 0.0 112.027 -178.634 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' D' D ' 108' ' ' ASN . . . . . . . . . . . . . 6.7 t-20 -82.58 8.59 11.42 Favored 'General case' 0 CA--C 1.537 0.463 0 N-CA-C 113.15 0.796 . . . . 0.0 113.15 -178.069 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' D' D ' 109' ' ' LEU . . . . . . . . . . . . . 11.7 tp 61.67 37.92 15.61 Favored 'General case' 0 CA--C 1.53 0.182 0 CA-C-O 121.089 0.471 . . . . 0.0 111.324 178.122 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' D' D ' 110' ' ' GLU . . . . . . . . . . . . . 70.7 mm-40 -105.72 154.5 20.38 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.272 -0.422 . . . . 0.0 110.058 175.98 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' D' D ' 111' ' ' GLU . . . . . . . . . . . . . 44.4 mt-10 -83.61 122.19 28.25 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-O 120.852 0.358 . . . . 0.0 111.336 -177.88 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' D' D ' 112' ' ' LEU . . . . . . . . . . . . . 95.0 mt -106.25 -45.92 4.18 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.054 -0.521 . . . . 0.0 109.903 175.516 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' D' D ' 113' ' ' TYR . . . . . . . . . . . . . 59.9 t80 -140.0 139.95 36.14 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-N 116.26 -0.427 . . . . 0.0 110.808 179.602 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' D' D ' 114' ' ' ARG . . . . . . . . . . . . . 34.2 ptt180 -145.31 123.01 11.84 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.222 -0.445 . . . . 0.0 110.536 178.579 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' D' D ' 115' ' ' GLY . . . . . . . . . . . . . . . -150.12 156.91 26.97 Favored Glycine 0 CA--C 1.525 0.717 0 C-N-CA 120.694 -0.765 . . . . 0.0 111.641 179.516 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' D' D ' 116' ' ' LYS . . . . . . . . . . . . . 27.1 ttpp -128.44 133.13 48.48 Favored 'General case' 0 C--N 1.33 -0.259 0 N-CA-C 109.826 -0.435 . . . . 0.0 109.826 176.849 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' D' D ' 117' ' ' PHE . . . . . . . . . . . . . 31.4 m-85 -130.41 113.94 14.95 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-O 120.85 0.357 . . . . 0.0 110.237 -175.896 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' D' D ' 118' ' ' GLU . . . . . . . . . . . . . 95.9 mt-10 -52.97 -47.88 67.84 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.477 -0.328 . . . . 0.0 111.491 -176.981 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' D' D ' 119' ' ' ASN . . . . . . . . . . . . . 3.6 m-20 -94.96 31.01 1.95 Allowed 'General case' 0 C--N 1.329 -0.326 0 N-CA-C 112.338 0.496 . . . . 0.0 112.338 -174.131 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' D' D ' 120' ' ' LEU . . . . . . . . . . . . . 18.6 tp -55.96 124.5 17.91 Favored 'General case' 0 C--N 1.333 -0.146 0 CA-C-O 120.565 0.222 . . . . 0.0 110.507 176.86 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' D' D ' 121' ' ' ASN . . . . . . . . . . . . . 35.1 m120 -111.94 -44.0 3.51 Favored 'General case' 0 C--N 1.331 -0.222 0 CA-C-N 116.596 -0.275 . . . . 0.0 110.959 -177.605 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' D' D ' 122' ' ' LYS . . . . . . . . . . . . . 97.9 mttt -144.73 146.1 32.02 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-O 121.001 0.429 . . . . 0.0 111.621 -178.112 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' D' D ' 123' ' ' VAL . . . . . . . . . . . . . 45.6 t -125.69 125.28 68.25 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.26 0 N-CA-C 109.446 -0.575 . . . . 0.0 109.446 175.162 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' D' D ' 124' ' ' LEU . . . . . . . . . . . . . 49.3 mt -124.07 131.05 53.51 Favored 'General case' 0 C--N 1.331 -0.227 0 CA-C-O 120.676 0.274 . . . . 0.0 110.737 -178.169 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' D' D ' 125' ' ' VAL . . . . . . . . . . . . . 34.8 m -132.09 131.48 61.26 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.294 0 CA-C-N 116.274 -0.421 . . . . 0.0 110.389 179.285 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' D' D ' 126' ' ' ARG . . . . . . . . . . . . . 94.3 mtt180 -144.13 125.44 14.71 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-O 121.068 0.461 . . . . 0.0 111.12 -179.555 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' D' D ' 127' ' ' ASN . . . . . . . . . . . . . 6.7 m120 49.98 -109.53 0.38 Allowed 'General case' 0 CA--C 1.545 0.772 0 CA-C-O 118.972 -0.537 . . . . 0.0 111.685 177.334 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' D' D ' 128' ' ' ASP . . . . . . . . . . . . . 11.3 p-10 -114.15 8.72 17.01 Favored 'General case' 0 N--CA 1.469 0.479 0 CA-C-N 119.71 1.141 . . . . 0.0 113.224 -176.194 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' D' D ' 129' ' ' LEU . . . . . . . . . . . . . 58.4 mt -121.98 143.63 49.36 Favored 'General case' 0 C--N 1.333 -0.145 0 N-CA-C 109.483 -0.562 . . . . 0.0 109.483 177.357 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' D' D ' 130' ' ' VAL . . . . . . . . . . . . . 34.9 m -134.8 146.04 31.38 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.288 0 CA-C-O 121.229 0.537 . . . . 0.0 110.644 179.848 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' D' D ' 131' ' ' VAL . . . . . . . . . . . . . 43.1 t -136.03 139.84 45.09 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.396 0 CA-C-N 115.758 -0.655 . . . . 0.0 110.112 -179.789 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' D' D ' 132' ' ' ILE . . . . . . . . . . . . . 71.6 mt -114.59 130.95 68.08 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.322 0 N-CA-C 109.209 -0.663 . . . . 0.0 109.209 178.89 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' D' D ' 133' ' ' ILE . . . . . . . . . . . . . 40.3 mm -112.45 118.94 59.09 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.263 0 CA-C-N 116.438 -0.346 . . . . 0.0 110.763 -174.767 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' D' D ' 134' ' ' ASP . . . . . . . . . . . . . 6.6 p-10 -129.0 145.27 51.29 Favored 'General case' 0 C--N 1.331 -0.214 0 N-CA-C 109.396 -0.594 . . . . 0.0 109.396 175.984 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' D' D ' 135' ' ' GLU . . . . . . . . . . . . . 39.7 tp10 -49.95 -27.32 5.19 Favored 'General case' 0 C--O 1.235 0.315 0 N-CA-C 112.63 0.604 . . . . 0.0 112.63 -174.155 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' D' D ' 136' ' ' GLN . . . . . . . . . . . . . 95.4 mt-30 -76.88 -39.5 50.81 Favored 'General case' 0 C--O 1.235 0.319 0 CA-C-O 120.814 0.34 . . . . 0.0 111.893 -177.884 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' D' D ' 137' ' ' LYS . . . . . . . . . . . . . 55.0 pttt -170.01 176.91 4.51 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-O 121.475 0.655 . . . . 0.0 112.328 -171.825 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' D' D ' 138' ' ' LEU . . . . . . . . . . . . . 6.8 tt -117.23 129.3 55.84 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 115.065 -0.97 . . . . 0.0 110.317 -178.515 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' D' D ' 139' ' ' THR . . . . . . . . . . . . . 35.6 m -109.08 124.88 51.47 Favored 'General case' 0 C--N 1.331 -0.219 0 CA-C-N 116.024 -0.535 . . . . 0.0 110.179 178.577 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' D' D ' 140' ' ' LEU . . . . . . . . . . . . . 5.8 tt -111.29 122.14 47.08 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 115.781 -0.645 . . . . 0.0 109.308 -178.145 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' D' D ' 141' ' ' ILE . . . . . . . . . . . . . 19.6 mt -122.79 118.55 55.37 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.221 0 CA-C-O 121.177 0.513 . . . . 0.0 110.201 -175.993 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' D' D ' 142' ' ' ARG . . . . . . . . . . . . . 92.6 mtt180 -92.77 120.45 33.16 Favored 'General case' 0 C--O 1.234 0.24 0 CA-C-N 115.223 -0.899 . . . . 0.0 109.823 176.865 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' D' D ' 143' ' ' THR . . . . . . . . . . . . . 67.1 p . . . . . 0 C--O 1.221 -0.428 0 CA-C-O 118.006 -0.997 . . . . 0.0 110.464 179.724 . . . . . . . . 0 0 . 1 . 016 nuclear orig core ' E' E ' 2' ' ' SER . . . . . . . . . . . . . 13.1 p . . . . . 0 N--CA 1.462 0.136 0 CA-C-O 121.087 0.47 . . . . 0.0 110.809 . . . . . . . . . 0 0 . 1 . 016 nuclear orig core ' E' E ' 3' ' ' GLU . . . . . . . . . . . . . 46.8 tt0 -152.46 145.63 24.65 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 116.059 -0.519 . . . . 0.0 111.152 -177.227 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' E' E ' 4' ' ' LEU . . . . . . . . . . . . . 18.4 tp -124.04 129.4 50.84 Favored 'General case' 0 C--N 1.331 -0.198 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.281 177.397 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' E' E ' 5' ' ' LYS . . . . . . . . . . . . . 67.6 mttm -108.24 123.1 48.26 Favored 'General case' 0 C--N 1.331 -0.215 0 CA-C-N 116.339 -0.391 . . . . 0.0 110.888 179.047 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' E' E ' 6' ' ' LEU . . . . . . . . . . . . . 33.7 mt -115.83 146.3 42.1 Favored 'General case' 0 N--CA 1.464 0.227 0 CA-C-N 115.641 -0.709 . . . . 0.0 110.155 179.132 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' E' E ' 7' ' ' LYS . . . . . . . . . . . . . 31.2 ttmt -128.32 136.76 29.57 Favored Pre-proline 0 CA--C 1.534 0.329 0 CA-C-O 118.88 -0.581 . . . . 0.0 109.585 174.912 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' E' E ' 8' ' ' PRO . . . . . . . . . . . . . 83.1 Cg_endo -92.0 141.51 2.47 Favored 'Trans proline' 0 N--CA 1.49 1.271 0 C-N-CA 121.719 1.613 . . . . 0.0 112.126 178.53 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' E' E ' 9' ' ' LEU . . . . . . . . . . . . . 20.3 mt -78.95 -46.91 1.72 Allowed Pre-proline 0 CA--C 1.534 0.359 0 CA-C-O 118.628 -0.701 . . . . 0.0 111.712 178.419 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' E' E ' 10' ' ' PRO . . . . . . . . . . . . . 91.5 Cg_endo -81.79 150.79 16.54 Favored 'Trans proline' 0 N--CA 1.495 1.615 0 C-N-CA 121.156 1.237 . . . . 0.0 111.539 174.645 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' E' E ' 11' ' ' LYS . . . . . . . . . . . . . 25.1 pttm -86.91 115.84 24.58 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-O 121.389 0.614 . . . . 0.0 110.742 179.423 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' E' E ' 12' ' ' VAL . . . . . . . . . . . . . 12.4 p -151.16 144.77 16.64 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.295 0 CA-C-N 115.822 -0.627 . . . . 0.0 110.341 177.496 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' E' E ' 13' ' ' GLU . . . . . . . . . . . . . 81.5 tt0 -92.83 114.18 26.67 Favored 'General case' 0 C--N 1.329 -0.32 0 N-CA-C 109.749 -0.463 . . . . 0.0 109.749 176.13 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' E' E ' 14' ' ' LEU . . . . . . . . . . . . . 27.9 mt -86.29 144.22 37.96 Favored Pre-proline 0 CA--C 1.533 0.301 0 CA-C-O 119.075 -0.488 . . . . 0.0 110.238 -176.508 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' E' E ' 15' ' ' PRO . . . . . . . . . . . . . 29.4 Cg_exo -60.34 162.62 16.83 Favored 'Trans proline' 0 N--CA 1.498 1.758 0 C-N-CA 121.271 1.314 . . . . 0.0 111.667 178.221 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' E' E ' 16' ' ' PRO . . . . . . . . . . . . . 33.0 Cg_exo -59.09 -38.86 84.7 Favored 'Trans proline' 0 N--CA 1.497 1.711 0 C-N-CA 121.511 1.474 . . . . 0.0 112.904 -176.892 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' E' E ' 17' ' ' ASP . . . . . . . . . . . . . 14.8 p-10 -83.94 1.67 42.41 Favored 'General case' 0 C--N 1.327 -0.383 0 N-CA-C 113.326 0.861 . . . . 0.0 113.326 -177.376 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' E' E ' 18' ' ' PHE . . . . . . . . . . . . . 61.5 t80 -58.15 -46.4 85.73 Favored 'General case' 0 N--CA 1.457 -0.088 0 O-C-N 121.899 -0.5 . . . . 0.0 110.255 -178.048 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' E' E ' 19' ' ' VAL . . . . . . . . . . . . . 46.6 t -55.45 -43.02 70.39 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.264 0 CA-C-N 116.269 -0.423 . . . . 0.0 110.639 -178.082 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' E' E ' 20' ' ' ASP . . . . . . . . . . . . . 9.5 t0 -60.31 -43.15 96.61 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-O 120.803 0.335 . . . . 0.0 110.844 -178.588 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' E' E ' 21' ' ' VAL . . . . . . . . . . . . . 47.5 t -64.19 -45.88 95.06 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.299 0 C-N-CA 120.882 -0.327 . . . . 0.0 110.603 -177.851 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' E' E ' 22' ' ' ILE . . . . . . . . . . . . . 51.5 mm -55.53 -46.27 78.89 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.251 0 CA-C-O 120.822 0.344 . . . . 0.0 110.521 178.372 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' E' E ' 23' ' ' ARG . . . . . . . . . . . . . 60.0 ttp180 -53.31 -50.88 64.01 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.65 -0.25 . . . . 0.0 111.509 179.744 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' E' E ' 24' ' ' ILE . . . . . . . . . . . . . 73.7 mt -58.81 -42.9 86.87 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.27 0 CA-C-N 116.546 -0.297 . . . . 0.0 111.332 -176.737 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' E' E ' 25' ' ' LYS . . . . . . . . . . . . . 93.1 mttt -68.88 -38.59 79.79 Favored 'General case' 0 C--N 1.328 -0.332 0 N-CA-C 112.379 0.511 . . . . 0.0 112.379 -177.639 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' E' E ' 26' ' ' LEU . . . . . . . . . . . . . 78.3 mt -79.85 -38.81 31.96 Favored 'General case' 0 C--N 1.331 -0.236 0 N-CA-C 113.311 0.856 . . . . 0.0 113.311 -170.947 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' E' E ' 27' ' ' GLN . . . . . . . . . . . . . 10.3 pt20 -46.79 140.03 4.93 Favored 'General case' 0 N--CA 1.47 0.559 0 N-CA-C 112.643 0.609 . . . . 0.0 112.643 -175.376 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' E' E ' 28' ' ' GLY . . . . . . . . . . . . . . . 101.4 -26.02 26.06 Favored Glycine 0 CA--C 1.533 1.201 0 CA-C-N 115.57 -0.741 . . . . 0.0 112.174 -175.811 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' E' E ' 29' ' ' LYS . . . . . . . . . . . . . 88.0 mttt -97.51 155.06 17.11 Favored 'General case' 0 C--O 1.232 0.178 0 CA-C-N 117.374 0.587 . . . . 0.0 111.147 178.713 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' E' E ' 30' ' ' THR . . . . . . . . . . . . . 20.8 m -102.57 140.72 36.48 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 115.947 -0.57 . . . . 0.0 110.28 176.735 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' E' E ' 31' ' ' VAL . . . . . . . . . . . . . 34.9 m -128.4 147.48 32.94 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.25 0 CA-C-O 120.901 0.381 . . . . 0.0 110.64 -179.566 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' E' E ' 32' ' ' ARG . . . . . . . . . . . . . 68.8 ttt-85 -130.12 147.16 51.82 Favored 'General case' 0 C--N 1.331 -0.21 0 CA-C-N 116.07 -0.514 . . . . 0.0 110.415 179.541 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' E' E ' 33' ' ' THR . . . . . . . . . . . . . 22.9 m -52.46 139.36 25.28 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 116.458 -0.337 . . . . 0.0 111.594 -177.958 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' E' E ' 34' ' ' GLY . . . . . . . . . . . . . . . 97.48 -17.13 59.52 Favored Glycine 0 CA--C 1.533 1.179 0 C-N-CA 121.176 -0.535 . . . . 0.0 113.322 178.837 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' E' E ' 35' ' ' ASP . . . . . . . . . . . . . 77.1 m-20 -66.16 151.17 47.53 Favored 'General case' 0 C--O 1.231 0.087 0 CA-C-N 118.032 0.916 . . . . 0.0 111.057 179.838 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' E' E ' 36' ' ' VAL . . . . . . . . . . . . . 44.1 t -123.95 128.05 73.95 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.236 0 N-CA-C 109.678 -0.49 . . . . 0.0 109.678 177.038 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' E' E ' 37' ' ' ILE . . . . . . . . . . . . . 60.7 mt -120.78 137.5 54.31 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.26 0 CA-C-N 116.023 -0.535 . . . . 0.0 109.87 -179.473 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' E' E ' 38' ' ' GLY . . . . . . . . . . . . . . . -113.91 127.35 7.77 Favored Glycine 0 CA--C 1.526 0.748 0 N-CA-C 110.854 -0.898 . . . . 0.0 110.854 178.867 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' E' E ' 39' ' ' ILE . . . . . . . . . . . . . 72.7 mt -126.23 126.53 69.57 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.237 0 N-CA-C 110.005 -0.368 . . . . 0.0 110.005 179.451 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' E' E ' 40' ' ' SER . . . . . . . . . . . . . 80.2 p -93.33 123.1 36.38 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.398 -0.364 . . . . 0.0 111.052 176.423 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' E' E ' 41' ' ' ILE . . . . . . . . . . . . . 71.4 mt -137.3 127.97 39.38 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.215 0 CA-C-O 120.943 0.401 . . . . 0.0 110.21 177.11 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' E' E ' 42' ' ' LEU . . . . . . . . . . . . . 8.7 tp 58.47 35.15 24.5 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.045 -0.525 . . . . 0.0 111.522 179.257 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' E' E ' 43' ' ' GLY . . . . . . . . . . . . . . . 72.48 14.61 77.37 Favored Glycine 0 CA--C 1.535 1.285 0 C-N-CA 121.246 -0.502 . . . . 0.0 113.222 176.933 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' E' E ' 44' ' ' LYS . . . . . . . . . . . . . 72.0 mmtt -124.45 130.28 52.18 Favored 'General case' 0 N--CA 1.462 0.172 0 CA-C-N 117.89 0.845 . . . . 0.0 110.203 178.129 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' E' E ' 45' ' ' GLU . . . . . . . . . . . . . 79.1 tt0 -85.34 122.78 30.0 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 115.954 -0.567 . . . . 0.0 111.11 -179.812 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' E' E ' 46' ' ' VAL . . . . . . . . . . . . . 10.9 p -118.82 123.0 70.79 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.197 0 N-CA-C 109.555 -0.535 . . . . 0.0 109.555 174.376 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' E' E ' 47' ' ' LYS . . . . . . . . . . . . . 68.1 mttm -99.33 126.93 45.28 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 115.984 -0.553 . . . . 0.0 111.014 179.114 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' E' E ' 48' ' ' PHE . . . . . . . . . . . . . 29.1 m-85 -111.09 131.82 54.77 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.116 -0.493 . . . . 0.0 109.944 177.446 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' E' E ' 49' ' ' LYS . . . . . . . . . . . . . 80.9 tttt -107.11 137.19 45.64 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.374 -0.376 . . . . 0.0 110.284 177.557 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' E' E ' 50' ' ' VAL . . . . . . . . . . . . . 42.9 t -74.15 106.72 4.19 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.345 0 N-CA-C 109.812 -0.44 . . . . 0.0 109.812 178.682 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' E' E ' 51' ' ' VAL . . . . . . . . . . . . . 46.1 t -70.75 -50.34 44.73 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.277 0 O-C-N 123.65 0.594 . . . . 0.0 109.704 -176.104 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' E' E ' 52' ' ' GLN . . . . . . . . . . . . . 56.3 tt0 -168.02 138.19 2.66 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 115.908 -0.587 . . . . 0.0 111.145 -179.19 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' E' E ' 53' ' ' ALA . . . . . . . . . . . . . . . -112.15 132.4 54.9 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 115.873 -0.603 . . . . 0.0 110.135 177.04 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' E' E ' 54' ' ' TYR . . . . . . . . . . . . . 22.9 t80 -127.97 107.22 20.1 Favored Pre-proline 0 CA--C 1.534 0.345 0 CA-C-O 118.285 -0.864 . . . . 0.0 110.364 179.778 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' E' E ' 55' ' ' PRO . . . . . . . . . . . . . 73.3 Cg_endo -77.06 170.05 72.7 Favored 'Cis proline' 0 N--CA 1.5 1.888 0 CA-C-N 121.682 1.637 . . . . 0.0 112.488 -5.286 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' E' E ' 56' ' ' SER . . . . . . . . . . . . . 70.5 m -115.54 129.93 24.73 Favored Pre-proline 0 CA--C 1.539 0.538 0 CA-C-O 118.427 -0.796 . . . . 0.0 109.35 175.391 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' E' E ' 57' ' ' PRO . . . . . . . . . . . . . 60.8 Cg_endo -74.34 150.61 95.81 Favored 'Cis proline' 0 N--CA 1.497 1.684 0 CA-C-N 121.952 1.733 . . . . 0.0 111.722 -0.31 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' E' E ' 58' ' ' LEU . . . . . . . . . . . . . 21.4 tp -109.02 138.11 45.88 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 116.299 -0.409 . . . . 0.0 110.85 -177.84 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' E' E ' 59' ' ' ARG . . . . . . . . . . . . . 78.0 ttt180 -101.75 125.88 48.5 Favored 'General case' 0 C--N 1.328 -0.339 0 N-CA-C 109.244 -0.65 . . . . 0.0 109.244 173.537 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' E' E ' 60' ' ' VAL . . . . . . . . . . . . . 46.8 t -77.81 114.64 18.6 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.308 0 C-N-CA 120.72 -0.392 . . . . 0.0 110.378 -176.88 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' E' E ' 61' ' ' GLU . . . . . . . . . . . . . 44.2 mt-10 -131.01 161.19 32.51 Favored 'General case' 0 C--N 1.332 -0.167 0 CA-C-N 115.933 -0.576 . . . . 0.0 110.012 177.663 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' E' E ' 62' ' ' ASP . . . . . . . . . . . . . 77.9 m-20 -54.4 -33.71 59.86 Favored 'General case' 0 C--N 1.328 -0.352 0 N-CA-C 112.088 0.403 . . . . 0.0 112.088 -175.798 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' E' E ' 63' ' ' ARG . . . . . . . . . . . . . 25.0 mmm180 -74.87 -17.21 60.62 Favored 'General case' 0 CA--C 1.535 0.391 0 N-CA-C 113.125 0.787 . . . . 0.0 113.125 -175.427 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' E' E ' 64' ' ' THR . . . . . . . . . . . . . 11.4 m -75.77 142.93 42.24 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-O 120.852 0.358 . . . . 0.0 110.865 -176.131 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' E' E ' 65' ' ' LYS . . . . . . . . . . . . . 95.6 mttt -89.63 139.76 30.23 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.111 -0.495 . . . . 0.0 110.531 179.938 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' E' E ' 66' ' ' ILE . . . . . 0.415 HD13 HG23 ' E' ' 66' ' ' ILE . 55.3 mt -113.81 133.37 59.99 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.287 0 N-CA-C 109.837 -0.431 . . . . 0.0 109.837 178.256 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' E' E ' 67' ' ' THR . . . . . . . . . . . . . 25.3 m -128.34 139.14 52.56 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-O 121.056 0.455 . . . . 0.0 111.166 -178.191 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' E' E ' 68' ' ' LEU . . . . . . . . . . . . . 7.2 mp . . . . . 0 C--N 1.328 -0.336 0 CA-C-N 115.826 -0.625 . . . . 0.0 109.853 176.411 . . . . . . . . 0 0 . 1 . 016 nuclear orig core ' E' E ' 73' ' ' VAL . . . . . . . . . . . . . 34.7 m . . . . . 0 N--CA 1.462 0.138 0 CA-C-O 120.98 0.419 . . . . 0.0 110.616 . . . . . . . . . 0 0 . 1 . 016 nuclear orig core ' E' E ' 74' ' ' ASP . . . . . . . . . . . . . 9.7 t0 -104.33 120.39 41.09 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.025 -0.534 . . . . 0.0 109.822 179.104 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' E' E ' 75' ' ' VAL . . . . . . . . . . . . . 40.5 t -114.39 123.05 69.68 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.18 0 CA-C-O 121.055 0.455 . . . . 0.0 110.955 -175.4 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' E' E ' 76' ' ' LEU . . . . . . . . . . . . . 6.0 mp -123.34 146.71 47.72 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 115.657 -0.701 . . . . 0.0 109.591 175.632 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' E' E ' 77' ' ' GLU . . . . . . . . . . . . . 97.1 mt-10 -134.03 140.84 46.95 Favored 'General case' 0 N--CA 1.463 0.207 0 CA-C-O 121.167 0.508 . . . . 0.0 111.383 -178.418 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' E' E ' 78' ' ' ALA . . . . . . . . . . . . . . . -130.51 129.51 42.98 Favored 'General case' 0 C--N 1.332 -0.193 0 CA-C-N 115.684 -0.689 . . . . 0.0 109.751 175.849 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' E' E ' 79' ' ' LYS . . . . . . . . . . . . . 37.3 mmtm -71.74 119.54 16.04 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-O 120.886 0.374 . . . . 0.0 110.981 -178.234 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' E' E ' 80' ' ' ILE . . . . . . . . . . . . . 32.1 mm -139.31 99.91 1.32 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.259 0 N-CA-C 109.089 -0.708 . . . . 0.0 109.089 -178.213 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' E' E ' 81' ' ' LYS . . . . . . . . . . . . . 53.0 pttt -101.51 128.13 47.89 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-O 121.103 0.478 . . . . 0.0 111.31 -176.639 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' E' E ' 82' ' ' GLY . . . . . . . . . . . . . . . 89.21 41.95 5.7 Favored Glycine 0 CA--C 1.526 0.777 0 CA-C-N 115.799 -0.637 . . . . 0.0 111.66 177.2 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' E' E ' 83' ' ' ILE . . . . . . . . . . . . . 73.7 mt -68.94 144.66 13.95 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 CA-C-O 121.034 0.445 . . . . 0.0 110.234 179.078 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' E' E ' 84' ' ' LYS . . . . . . . . . . . . . 87.6 tttt -100.99 -51.77 3.46 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 115.792 -0.64 . . . . 0.0 109.993 -179.905 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' E' E ' 85' ' ' ASP . . . . . . . . . . . . . 7.9 t70 -160.44 154.69 23.33 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 115.597 -0.729 . . . . 0.0 110.057 179.459 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' E' E ' 86' ' ' VAL . . . . . . . . . . . . . 40.6 t -132.95 131.61 59.04 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.212 0 CA-C-O 121.06 0.457 . . . . 0.0 110.576 -178.588 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' E' E ' 87' ' ' ILE . . . . . . . . . . . . . 44.9 mm -119.45 128.23 75.86 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.208 0 CA-C-N 115.804 -0.634 . . . . 0.0 109.556 176.515 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' E' E ' 88' ' ' LEU . . . . . . . . . . . . . 84.2 mt -110.29 137.82 47.5 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-O 121.111 0.481 . . . . 0.0 111.499 -177.363 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' E' E ' 89' ' ' ASP . . . . . . . . . . . . . 10.9 t70 -127.07 153.23 46.24 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 115.502 -0.772 . . . . 0.0 109.074 174.436 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' E' E ' 90' ' ' GLU . . . . . . . . . . . . . 95.8 mt-10 -48.06 -36.91 13.9 Favored 'General case' 0 C--N 1.33 -0.244 0 N-CA-C 112.903 0.705 . . . . 0.0 112.903 -172.605 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' E' E ' 91' ' ' ASN . . . . . . . . . . . . . 27.6 m120 -132.06 32.03 4.08 Favored 'General case' 0 N--CA 1.465 0.277 0 N-CA-C 112.102 0.408 . . . . 0.0 112.102 -176.848 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' E' E ' 92' ' ' LEU . . . . . . . . . . . . . 8.1 tp -166.09 152.94 9.59 Favored 'General case' 0 C--N 1.33 -0.247 0 C-N-CA 120.897 -0.321 . . . . 0.0 110.81 -179.44 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' E' E ' 93' ' ' ILE . . . . . . . . . . . . . 73.0 mt -130.37 129.91 65.08 Favored 'Isoleucine or valine' 0 N--CA 1.462 0.166 0 N-CA-C 109.971 -0.381 . . . . 0.0 109.971 179.171 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' E' E ' 94' ' ' VAL . . . . . . . . . . . . . 44.7 t -122.56 125.0 71.97 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.246 0 N-CA-C 109.597 -0.52 . . . . 0.0 109.597 176.942 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' E' E ' 95' ' ' VAL . . . . . . . . . . . . . 43.5 t -120.66 134.52 63.82 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.295 0 CA-C-N 116.285 -0.416 . . . . 0.0 110.145 -177.929 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' E' E ' 96' ' ' ILE . . . . . . . . . . . . . 66.9 mt -115.83 129.4 72.25 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 N-CA-C 109.361 -0.607 . . . . 0.0 109.361 178.985 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' E' E ' 97' ' ' THR . . . . . . . . . . . . . 77.8 p -101.28 155.89 17.76 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-O 121.033 0.444 . . . . 0.0 111.111 -178.028 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' E' E ' 98' ' ' GLU . . . . . . . . . . . . . 12.8 pt-20 -54.05 -22.14 10.07 Favored 'General case' 0 CA--C 1.535 0.393 0 N-CA-C 112.613 0.598 . . . . 0.0 112.613 -179.256 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' E' E ' 99' ' ' GLU . . . . . . . . . . . . . 31.2 tt0 -83.38 18.15 1.9 Allowed 'General case' 0 CA--C 1.536 0.417 0 N-CA-C 112.79 0.663 . . . . 0.0 112.79 -177.333 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' E' E ' 100' ' ' ASN . . . . . . . . . . . . . 2.6 m-20 62.16 37.98 14.03 Favored 'General case' 0 CA--C 1.53 0.198 0 CA-C-O 121.011 0.434 . . . . 0.0 110.828 177.961 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' E' E ' 101' ' ' GLU . . . . . . . . . . . . . 81.4 tt0 -119.75 141.55 49.35 Favored 'General case' 0 C--N 1.332 -0.195 0 N-CA-C 109.765 -0.457 . . . . 0.0 109.765 177.684 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' E' E ' 102' ' ' VAL . . . . . . . . . . . . . 41.0 t -115.12 128.69 72.2 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.271 0 N-CA-C 110.216 -0.29 . . . . 0.0 110.216 -178.238 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' E' E ' 103' ' ' LEU . . . . . . . . . . . . . 7.0 mp -116.5 136.69 52.77 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 115.559 -0.746 . . . . 0.0 109.93 176.864 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' E' E ' 104' ' ' ILE . . . . . . . . . . . . . 68.2 mt -116.02 121.82 68.26 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.259 0 N-CA-C 109.766 -0.457 . . . . 0.0 109.766 179.742 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' E' E ' 105' ' ' PHE . . . . . . . . . . . . . 93.0 m-85 -123.33 165.76 16.44 Favored 'General case' 0 C--N 1.332 -0.163 0 O-C-N 124.281 0.988 . . . . 0.0 109.997 -177.713 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' E' E ' 106' ' ' ASN . . . . . . . . . . . . . 46.0 p-10 -104.0 -171.61 1.96 Allowed 'General case' 0 C--N 1.331 -0.197 0 N-CA-C 109.61 -0.515 . . . . 0.0 109.61 171.205 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' E' E ' 107' ' ' GLN . . . . . . . . . . . . . 20.7 tt0 -60.55 -24.37 65.35 Favored 'General case' 0 CA--C 1.534 0.35 0 N-CA-C 112.221 0.452 . . . . 0.0 112.221 179.831 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' E' E ' 108' ' ' ASN . . . . . . . . . . . . . 26.1 t30 -90.19 13.66 14.57 Favored 'General case' 0 CA--C 1.534 0.356 0 N-CA-C 112.978 0.733 . . . . 0.0 112.978 -178.609 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' E' E ' 109' ' ' LEU . . . . . . . . . . . . . 46.0 mt 56.73 35.24 25.91 Favored 'General case' 0 CA--C 1.53 0.206 0 CA-C-N 117.866 0.303 . . . . 0.0 111.557 177.511 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' E' E ' 110' ' ' GLU . . . . . . . . . . . . . 71.0 mm-40 -102.38 146.8 27.53 Favored 'General case' 0 C--N 1.33 -0.269 0 N-CA-C 109.906 -0.405 . . . . 0.0 109.906 176.926 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' E' E ' 111' ' ' GLU . . . . . . . . . . . . . 79.6 tt0 -82.29 124.73 30.23 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-O 120.953 0.406 . . . . 0.0 111.254 -175.993 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' E' E ' 112' ' ' LEU . . . . . . . . . . . . . 15.4 mt -108.38 -46.05 3.78 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 115.915 -0.584 . . . . 0.0 110.061 176.569 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' E' E ' 113' ' ' TYR . . . . . . . . . . . . . 48.3 t80 -142.55 145.06 33.22 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.169 -0.469 . . . . 0.0 111.317 -178.915 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' E' E ' 114' ' ' ARG . . . . . . . . . . . . . 55.1 ttp180 -151.02 125.26 9.38 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-O 121.065 0.459 . . . . 0.0 110.448 174.798 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' E' E ' 115' ' ' GLY . . . . . . . . . . . . . . . -150.13 155.65 26.34 Favored Glycine 0 CA--C 1.524 0.64 0 N-CA-C 110.67 -0.972 . . . . 0.0 110.67 178.374 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' E' E ' 116' ' ' LYS . . . . . . . . . . . . . 38.8 ttpt -114.9 140.29 49.1 Favored 'General case' 0 C--N 1.331 -0.197 0 O-C-N 122.593 -0.357 . . . . 0.0 110.338 179.14 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' E' E ' 117' ' ' PHE . . . . . . . . . . . . . 41.4 m-85 -133.95 114.59 13.43 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.2 -0.455 . . . . 0.0 110.17 -177.778 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' E' E ' 118' ' ' GLU . . . . . . . . . . . . . 70.8 mm-40 -51.28 -53.16 38.34 Favored 'General case' 0 C--N 1.33 -0.27 0 N-CA-C 111.837 0.31 . . . . 0.0 111.837 -175.925 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' E' E ' 119' ' ' ASN . . . . . . . . . . . . . 25.2 m120 -94.22 31.07 1.76 Allowed 'General case' 0 C--N 1.328 -0.334 0 N-CA-C 112.176 0.436 . . . . 0.0 112.176 -174.128 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' E' E ' 120' ' ' LEU . . . . . . . . . . . . . 12.9 tp -54.33 119.82 5.7 Favored 'General case' 0 N--CA 1.464 0.257 0 CA-C-O 120.749 0.309 . . . . 0.0 110.854 179.156 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' E' E ' 121' ' ' ASN . . . . . . . . . . . . . 88.8 m-20 -114.1 -44.03 3.18 Favored 'General case' 0 C--N 1.332 -0.176 0 CA-C-N 116.356 -0.384 . . . . 0.0 111.141 -178.036 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' E' E ' 122' ' ' LYS . . . . . . . . . . . . . 63.2 mtpt -140.63 148.61 41.14 Favored 'General case' 0 C--N 1.331 -0.211 0 CA-C-O 121.137 0.494 . . . . 0.0 111.682 -175.754 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' E' E ' 123' ' ' VAL . . . . . . . . . . . . . 43.5 t -131.27 126.45 58.81 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.261 0 CA-C-N 115.79 -0.641 . . . . 0.0 109.359 174.052 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' E' E ' 124' ' ' LEU . . . . . . . . . . . . . 41.1 mt -121.61 135.61 54.98 Favored 'General case' 0 C--N 1.331 -0.22 0 CA-C-N 116.496 -0.32 . . . . 0.0 110.565 -177.898 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' E' E ' 125' ' ' VAL . . . . . . . . . . . . . 11.6 p -134.0 129.26 54.11 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.277 0 CA-C-N 116.257 -0.429 . . . . 0.0 110.249 179.151 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' E' E ' 126' ' ' ARG . . . . . . . . . . . . . 52.1 mmm-85 -137.33 116.16 12.27 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.348 179.32 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' E' E ' 127' ' ' ASN . . . . . . . . . . . . . 7.1 m-80 52.65 -104.85 0.21 Allowed 'General case' 0 CA--C 1.543 0.689 0 CA-C-O 119.205 -0.426 . . . . 0.0 111.273 178.956 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' E' E ' 128' ' ' ASP . . . . . . . . . . . . . 10.9 p-10 -114.1 2.25 14.86 Favored 'General case' 0 N--CA 1.468 0.468 0 CA-C-N 119.48 1.036 . . . . 0.0 113.464 -176.458 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' E' E ' 129' ' ' LEU . . . . . . . . . . . . . 14.5 tp -105.36 135.1 47.36 Favored 'General case' 0 C--N 1.333 -0.146 0 CA-C-N 118.233 0.469 . . . . 0.0 110.012 179.018 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' E' E ' 130' ' ' VAL . . . . . . . . . . . . . 43.1 t -121.32 135.58 61.03 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.192 0 CA-C-O 120.897 0.379 . . . . 0.0 110.003 -178.288 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' E' E ' 131' ' ' VAL . . . . . . . . . . . . . 43.5 t -135.64 134.14 51.65 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.202 0 CA-C-O 120.991 0.424 . . . . 0.0 110.176 178.541 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' E' E ' 132' ' ' ILE . . . . . 0.404 HD12 HG21 ' E' ' 132' ' ' ILE . 71.5 mt -116.86 132.32 66.94 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.352 0 CA-C-N 115.713 -0.676 . . . . 0.0 109.357 179.748 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' E' E ' 133' ' ' ILE . . . . . . . . . . . . . 39.9 mm -116.0 119.26 61.37 Favored 'Isoleucine or valine' 0 C--O 1.234 0.25 0 CA-C-O 120.79 0.329 . . . . 0.0 111.029 -173.862 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' E' E ' 134' ' ' ASP . . . . . . . . . . . . . 10.4 p-10 -131.11 144.98 51.81 Favored 'General case' 0 C--N 1.332 -0.18 0 N-CA-C 109.454 -0.573 . . . . 0.0 109.454 174.584 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' E' E ' 135' ' ' GLU . . . . . . . . . . . . . 80.0 tt0 -49.8 -26.07 3.62 Favored 'General case' 0 C--N 1.328 -0.334 0 N-CA-C 112.95 0.722 . . . . 0.0 112.95 -171.656 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' E' E ' 136' ' ' GLN . . . . . . . . . . . . . 35.0 tt0 -80.9 -38.33 28.15 Favored 'General case' 0 C--O 1.234 0.256 0 N-CA-C 111.887 0.328 . . . . 0.0 111.887 -176.417 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' E' E ' 137' ' ' LYS . . . . . . . . . . . . . 15.3 pttp -162.02 171.56 17.37 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-O 121.602 0.715 . . . . 0.0 112.119 -172.423 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' E' E ' 138' ' ' LEU . . . . . . . . . . . . . 3.6 tt -114.07 126.51 55.19 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 114.864 -1.062 . . . . 0.0 109.744 179.171 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' E' E ' 139' ' ' THR . . . . . . . . . . . . . 26.2 m -105.32 123.39 47.78 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.338 -0.392 . . . . 0.0 110.529 -179.858 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' E' E ' 140' ' ' LEU . . . . . . . . . . . . . 7.6 tt -110.67 122.28 47.41 Favored 'General case' 0 C--N 1.327 -0.401 0 N-CA-C 109.251 -0.648 . . . . 0.0 109.251 -179.35 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' E' E ' 141' ' ' ILE . . . . . . . . . . . . . 19.7 mt -122.46 113.89 40.28 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.264 0 N-CA-C 109.786 -0.45 . . . . 0.0 109.786 -176.45 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' E' E ' 142' ' ' ARG . . . . . . . . . . . . . 67.8 ttp85 -103.05 129.7 49.94 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 115.416 -0.811 . . . . 0.0 110.831 -177.934 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' E' E ' 143' ' ' THR . . . . . . . . . . . . . 81.3 p . . . . . 0 C--O 1.22 -0.47 0 CA-C-O 117.873 -1.06 . . . . 0.0 110.834 179.463 . . . . . . . . 0 0 . 1 . 016 nuclear orig core ' F' F ' 1' ' ' MET . . . . . . . . . . . . . 23.5 ptp . . . . . 0 C--O 1.232 0.169 0 CA-C-O 120.733 0.301 . . . . 0.0 110.685 . . . . . . . . . 0 0 . 1 . 016 nuclear orig core ' F' F ' 2' ' ' SER . . . . . . . . . . . . . 6.8 p -114.45 132.55 56.22 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.252 -0.431 . . . . 0.0 110.723 -179.566 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' F' F ' 3' ' ' GLU . . . . . . . . . . . . . 81.8 tt0 -141.35 141.06 33.87 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 115.963 -0.562 . . . . 0.0 111.032 -179.07 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' F' F ' 4' ' ' LEU . . . . . . . . . . . . . 15.2 tp -125.58 132.02 52.61 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.049 -0.523 . . . . 0.0 110.01 176.618 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' F' F ' 5' ' ' LYS . . . . . . . . . . . . . 65.1 mttm -111.61 120.18 41.21 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.249 -0.432 . . . . 0.0 110.606 -179.673 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' F' F ' 6' ' ' LEU . . . . . . . . . . . . . 67.1 mt -114.35 150.34 34.72 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 115.477 -0.783 . . . . 0.0 110.279 -178.609 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' F' F ' 7' ' ' LYS . . . . . . . . . . . . . 40.9 tttp -137.65 139.72 27.8 Favored Pre-proline 0 CA--C 1.534 0.353 0 CA-C-O 119.048 -0.501 . . . . 0.0 110.145 176.758 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' F' F ' 8' ' ' PRO . . . . . . . . . . . . . 94.0 Cg_endo -90.21 139.92 3.13 Favored 'Trans proline' 0 N--CA 1.489 1.263 0 C-N-CA 121.746 1.63 . . . . 0.0 111.662 177.575 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' F' F ' 9' ' ' LEU . . . . . . . . . . . . . 46.8 mt -78.7 -47.64 1.81 Allowed Pre-proline 0 CA--C 1.533 0.3 0 CA-C-O 118.652 -0.689 . . . . 0.0 112.181 -178.963 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' F' F ' 10' ' ' PRO . . . . . . . . . . . . . 92.1 Cg_endo -79.47 150.18 21.9 Favored 'Trans proline' 0 N--CA 1.496 1.647 0 C-N-CA 121.139 1.226 . . . . 0.0 111.766 175.95 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' F' F ' 11' ' ' LYS . . . . . . . . . . . . . 82.9 tttt -86.31 101.43 13.07 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.295 -0.411 . . . . 0.0 110.371 179.256 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' F' F ' 12' ' ' VAL . . . . . . . . . . . . . 12.5 p -146.64 149.84 15.55 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.255 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.76 -178.526 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' F' F ' 13' ' ' GLU . . . . . . . . . . . . . 70.7 mm-40 -79.87 126.64 31.25 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.152 -0.477 . . . . 0.0 110.098 177.112 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' F' F ' 14' ' ' LEU . . . . . . . . . . . . . 37.8 mt -97.53 144.48 28.03 Favored Pre-proline 0 CA--C 1.533 0.291 0 CA-C-O 119.012 -0.518 . . . . 0.0 110.038 179.464 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' F' F ' 15' ' ' PRO . . . . . . . . . . . . . 25.7 Cg_exo -62.01 153.97 65.23 Favored 'Trans proline' 0 N--CA 1.497 1.72 0 C-N-CA 121.204 1.27 . . . . 0.0 111.442 177.133 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' F' F ' 16' ' ' PRO . . . . . . . . . . . . . 31.2 Cg_exo -57.2 -38.84 94.14 Favored 'Trans proline' 0 N--CA 1.497 1.715 0 C-N-CA 121.412 1.408 . . . . 0.0 112.856 -179.244 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' F' F ' 17' ' ' ASP . . . . . . . . . . . . . 21.7 p-10 -85.98 9.63 16.45 Favored 'General case' 0 CA--C 1.537 0.444 0 N-CA-C 113.319 0.859 . . . . 0.0 113.319 -177.138 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' F' F ' 18' ' ' PHE . . . . . . . . . . . . . 43.3 t80 -58.47 -48.51 80.51 Favored 'General case' 0 N--CA 1.457 -0.109 0 O-C-N 121.971 -0.455 . . . . 0.0 110.153 -177.239 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' F' F ' 19' ' ' VAL . . . . . . . . . . . . . 14.0 p -54.46 -41.36 53.58 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.256 0 CA-C-N 116.378 -0.374 . . . . 0.0 111.284 -177.611 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' F' F ' 20' ' ' ASP . . . . . . . . . . . . . 73.3 m-20 -60.87 -45.95 92.52 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-O 120.823 0.344 . . . . 0.0 111.039 -177.806 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' F' F ' 21' ' ' VAL . . . . . . . . . . . . . 46.4 t -64.34 -46.92 91.71 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 C-N-CA 120.76 -0.376 . . . . 0.0 110.573 -177.103 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' F' F ' 22' ' ' ILE . . . . . . . . . . . . . 49.1 mm -56.21 -46.72 81.39 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.221 0 C-N-CA 120.917 -0.313 . . . . 0.0 110.647 179.347 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' F' F ' 23' ' ' ARG . . . . . . . . . . . . . 50.9 ttp180 -53.51 -48.42 69.02 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-O 120.639 0.257 . . . . 0.0 111.468 -178.477 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' F' F ' 24' ' ' ILE . . . . . . . . . . . . . 73.1 mt -59.58 -43.38 90.84 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.337 0 C-N-CA 121.072 -0.251 . . . . 0.0 111.05 -178.984 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' F' F ' 25' ' ' LYS . . . . . . . . . . . . . 53.5 mtmt -64.61 -39.1 93.11 Favored 'General case' 0 C--N 1.329 -0.307 0 N-CA-C 112.255 0.465 . . . . 0.0 112.255 -178.409 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' F' F ' 26' ' ' LEU . . . . . . . . . . . . . 63.3 mt -79.8 -40.59 28.27 Favored 'General case' 0 C--N 1.329 -0.298 0 N-CA-C 113.501 0.926 . . . . 0.0 113.501 -170.591 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' F' F ' 27' ' ' GLN . . . . . . . . . . . . . 10.6 pt20 -46.38 138.4 5.66 Favored 'General case' 0 N--CA 1.469 0.506 0 N-CA-C 112.995 0.739 . . . . 0.0 112.995 -173.821 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' F' F ' 28' ' ' GLY . . . . . . . . . . . . . . . 100.92 -26.88 23.05 Favored Glycine 0 CA--C 1.533 1.201 0 CA-C-N 115.611 -0.722 . . . . 0.0 112.185 -177.379 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' F' F ' 29' ' ' LYS . . . . . . . . . . . . . 83.1 mttt -97.98 155.12 17.25 Favored 'General case' 0 C--O 1.233 0.187 0 CA-C-N 117.329 0.564 . . . . 0.0 111.227 179.6 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' F' F ' 30' ' ' THR . . . . . . . . . . . . . 40.9 m -101.19 140.54 35.34 Favored 'General case' 0 C--N 1.33 -0.239 0 CA-C-N 116.01 -0.541 . . . . 0.0 110.375 177.755 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' F' F ' 31' ' ' VAL . . . . . . . . . . . . . 35.4 m -129.79 152.97 38.14 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.164 0 CA-C-N 116.313 -0.403 . . . . 0.0 110.327 178.673 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' F' F ' 32' ' ' ARG . . . . . . . . . . . . . 50.1 ttt180 -132.04 149.08 52.51 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-O 121.185 0.517 . . . . 0.0 110.277 178.529 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' F' F ' 33' ' ' THR . . . . . . . . . . . . . 19.5 m -52.46 137.63 29.34 Favored 'General case' 0 C--N 1.331 -0.212 0 CA-C-N 116.369 -0.378 . . . . 0.0 111.44 -178.218 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' F' F ' 34' ' ' GLY . . . . . . . . . . . . . . . 100.51 -17.15 57.11 Favored Glycine 0 CA--C 1.534 1.238 0 C-N-CA 121.172 -0.537 . . . . 0.0 113.188 179.532 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' F' F ' 35' ' ' ASP . . . . . . . . . . . . . 52.2 m-20 -64.54 151.04 45.59 Favored 'General case' 0 C--N 1.333 -0.115 0 CA-C-N 118.034 0.917 . . . . 0.0 111.19 -179.817 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' F' F ' 36' ' ' VAL . . . . . . . . . . . . . 44.7 t -127.85 130.92 70.12 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.199 0 CA-C-N 115.815 -0.629 . . . . 0.0 109.858 178.685 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' F' F ' 37' ' ' ILE . . . . . . . . . . . . . 66.0 mt -124.37 142.76 40.1 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.231 0 CA-C-N 116.282 -0.417 . . . . 0.0 110.033 -178.73 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' F' F ' 38' ' ' GLY . . . . . . . . . . . . . . . -111.98 128.84 8.77 Favored Glycine 0 CA--C 1.526 0.75 0 N-CA-C 111.036 -0.826 . . . . 0.0 111.036 179.133 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' F' F ' 39' ' ' ILE . . . . . . . . . . . . . 76.2 mt -125.14 135.68 63.26 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.224 0 N-CA-C 110.107 -0.331 . . . . 0.0 110.107 179.469 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' F' F ' 40' ' ' SER . . . . . . . . . . . . . 60.0 p -92.86 116.41 29.01 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.307 -0.406 . . . . 0.0 111.046 176.431 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' F' F ' 41' ' ' ILE . . . . . . . . . . . . . 44.5 mm -121.54 121.52 64.76 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.205 0 CA-C-O 120.86 0.362 . . . . 0.0 110.235 178.865 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' F' F ' 42' ' ' LEU . . . . . . . . . . . . . 60.3 mt 52.28 34.69 15.24 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.166 -0.47 . . . . 0.0 111.819 176.961 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' F' F ' 43' ' ' GLY . . . . . . . . . . . . . . . 72.98 32.56 60.61 Favored Glycine 0 CA--C 1.529 0.939 0 C-N-CA 121.047 -0.597 . . . . 0.0 112.064 177.869 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' F' F ' 44' ' ' LYS . . . . . . . . . . . . . 28.0 ttpp -139.92 132.96 29.51 Favored 'General case' 0 C--N 1.329 -0.322 0 N-CA-C 109.635 -0.506 . . . . 0.0 109.635 177.657 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' F' F ' 45' ' ' GLU . . . . . . . . . . . . . 79.5 tt0 -82.25 121.11 26.23 Favored 'General case' 0 C--N 1.328 -0.326 0 C-N-CA 120.928 -0.309 . . . . 0.0 111.134 -177.025 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' F' F ' 46' ' ' VAL . . . . . . . . . . . . . 7.5 p -120.88 127.03 75.89 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.254 0 N-CA-C 109.454 -0.572 . . . . 0.0 109.454 175.384 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' F' F ' 47' ' ' LYS . . . . . . . . . . . . . 69.0 mttm -100.02 129.93 46.13 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 115.96 -0.564 . . . . 0.0 111.159 179.338 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' F' F ' 48' ' ' PHE . . . . . . . . . . . . . 92.0 m-85 -113.18 131.81 55.73 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.233 -0.439 . . . . 0.0 110.002 177.489 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' F' F ' 49' ' ' LYS . . . . . . . . . . . . . 76.5 tttt -109.52 139.33 44.64 Favored 'General case' 0 C--N 1.331 -0.205 0 CA-C-N 116.409 -0.359 . . . . 0.0 110.581 178.839 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' F' F ' 50' ' ' VAL . . . . . . . . . . . . . 43.6 t -82.59 108.85 15.87 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.212 0 N-CA-C 109.528 -0.545 . . . . 0.0 109.528 176.251 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' F' F ' 51' ' ' VAL . . . . . . . . . . . . . 46.9 t -71.64 -53.68 19.74 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.338 0 CA-C-N 115.91 -0.586 . . . . 0.0 109.536 -175.316 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' F' F ' 52' ' ' GLN . . . . . . . . . . . . . 85.2 mt-30 -154.63 152.55 30.12 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-O 121.114 0.483 . . . . 0.0 111.481 -177.31 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' F' F ' 53' ' ' ALA . . . . . . . . . . . . . . . -129.79 133.3 46.89 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 115.496 -0.774 . . . . 0.0 109.858 175.156 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' F' F ' 54' ' ' TYR . . . . . . . . . . . . . 29.7 t80 -129.08 107.91 18.0 Favored Pre-proline 0 C--N 1.328 -0.331 0 CA-C-O 118.27 -0.871 . . . . 0.0 110.211 179.218 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' F' F ' 55' ' ' PRO . . . . . . . . . . . . . 73.9 Cg_endo -77.2 170.07 72.48 Favored 'Cis proline' 0 N--CA 1.501 1.916 0 CA-C-N 121.881 1.707 . . . . 0.0 112.549 -4.245 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' F' F ' 56' ' ' SER . . . . . . . . . . . . . 60.6 m -117.2 130.74 24.42 Favored Pre-proline 0 CA--C 1.538 0.495 0 CA-C-O 118.413 -0.803 . . . . 0.0 109.602 175.494 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' F' F ' 57' ' ' PRO . . . . . . . . . . . . . 31.3 Cg_endo -65.06 167.32 46.71 Favored 'Cis proline' 0 N--CA 1.498 1.749 0 CA-C-N 121.953 1.733 . . . . 0.0 111.542 -2.848 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' F' F ' 58' ' ' LEU . . . . . . . . . . . . . 18.2 tp -130.77 139.06 50.21 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.081 -0.509 . . . . 0.0 110.203 -179.81 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' F' F ' 59' ' ' ARG . . . . . . . . . . . . . 41.4 ttm180 -101.77 134.35 45.08 Favored 'General case' 0 C--N 1.326 -0.445 0 N-CA-C 109.276 -0.638 . . . . 0.0 109.276 174.523 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' F' F ' 60' ' ' VAL . . . . . . . . . . . . . 42.2 t -84.53 119.29 33.21 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.299 0 C-N-CA 120.569 -0.452 . . . . 0.0 110.161 -178.631 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' F' F ' 61' ' ' GLU . . . . . . . . . . . . . 70.5 tt0 -131.14 155.57 46.77 Favored 'General case' 0 C--N 1.327 -0.373 0 N-CA-C 109.094 -0.706 . . . . 0.0 109.094 176.276 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' F' F ' 62' ' ' ASP . . . . . . . . . . . . . 10.4 p-10 -52.49 -29.78 26.68 Favored 'General case' 0 C--N 1.326 -0.438 0 N-CA-C 112.064 0.394 . . . . 0.0 112.064 -177.72 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' F' F ' 63' ' ' ARG . . . . . . . . . . . . . 84.5 mtt-85 -75.5 -21.97 57.57 Favored 'General case' 0 CA--C 1.532 0.26 0 N-CA-C 113.092 0.775 . . . . 0.0 113.092 -175.902 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' F' F ' 64' ' ' THR . . . . . . . . . . . . . 31.5 m -67.07 146.47 54.28 Favored 'General case' 0 C--N 1.331 -0.227 0 CA-C-O 120.903 0.382 . . . . 0.0 111.195 -174.148 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' F' F ' 65' ' ' LYS . . . . . . . . . . . . . 68.3 mttm -88.63 127.65 35.57 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 115.954 -0.566 . . . . 0.0 110.036 177.691 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' F' F ' 66' ' ' ILE . . . . . . . . . . . . . 60.6 mt -115.02 127.43 72.58 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.322 0 N-CA-C 109.637 -0.505 . . . . 0.0 109.637 179.343 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' F' F ' 67' ' ' THR . . . . . . . . . . . . . 26.0 m -124.73 143.54 50.71 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-O 121.166 0.508 . . . . 0.0 111.357 -176.435 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' F' F ' 68' ' ' LEU . . . . . . . . . . . . . 6.3 tt . . . . . 0 C--N 1.328 -0.333 0 CA-C-N 115.557 -0.747 . . . . 0.0 109.525 175.473 . . . . . . . . 0 0 . 1 . 016 nuclear orig core ' F' F ' 73' ' ' VAL . . . . . . . . . . . . . 33.5 m . . . . . 0 C--O 1.232 0.138 0 CA-C-O 121.044 0.449 . . . . 0.0 110.929 . . . . . . . . . 0 0 . 1 . 016 nuclear orig core ' F' F ' 74' ' ' ASP . . . . . . . . . . . . . 12.9 t70 -98.75 118.35 35.29 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 115.697 -0.683 . . . . 0.0 109.463 176.505 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' F' F ' 75' ' ' VAL . . . . . . . . . . . . . 38.5 t -111.5 125.44 68.81 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.298 0 CA-C-O 121.083 0.468 . . . . 0.0 110.619 -176.351 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' F' F ' 76' ' ' LEU . . . . . . . . . . . . . 21.1 mt -129.5 147.98 51.36 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 115.575 -0.739 . . . . 0.0 109.765 178.793 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' F' F ' 77' ' ' GLU . . . . . . . . . . . . . 43.9 mp0 -135.57 136.49 41.16 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-O 120.981 0.419 . . . . 0.0 111.01 -179.301 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' F' F ' 78' ' ' ALA . . . . . . . . . . . . . . . -123.12 135.25 54.28 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 115.701 -0.681 . . . . 0.0 109.935 176.903 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' F' F ' 79' ' ' LYS . . . . . . . . . . . . . 99.0 mttt -74.93 120.25 20.22 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-O 120.85 0.357 . . . . 0.0 110.801 -177.565 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' F' F ' 80' ' ' ILE . . . . . . . . . . . . . 31.6 mm -139.19 104.6 2.23 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.241 0 N-CA-C 108.956 -0.757 . . . . 0.0 108.956 -178.635 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' F' F ' 81' ' ' LYS . . . . . . . . . . . . . 60.4 tttm -99.11 121.55 41.15 Favored 'General case' 0 C--N 1.327 -0.403 0 CA-C-O 120.881 0.372 . . . . 0.0 111.318 -175.47 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' F' F ' 82' ' ' GLY . . . . . . . . . . . . . . . 89.17 42.17 5.65 Favored Glycine 0 CA--C 1.525 0.681 0 C-N-CA 121.026 -0.607 . . . . 0.0 111.99 174.705 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' F' F ' 83' ' ' ILE . . . . . . . . . . . . . 71.7 mt -66.3 137.38 24.99 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.314 0 N-CA-C 109.65 -0.5 . . . . 0.0 109.65 175.909 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' F' F ' 84' ' ' LYS . . . . . . . . . . . . . 24.1 ttpp -102.38 -50.6 3.56 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-O 120.863 0.363 . . . . 0.0 110.464 -179.758 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' F' F ' 85' ' ' ASP . . . . . . . . . . . . . 8.6 t70 -149.41 151.33 33.86 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 115.976 -0.556 . . . . 0.0 110.648 -179.59 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' F' F ' 86' ' ' VAL . . . . . . . . . . . . . 44.0 t -131.34 132.84 62.76 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.248 0 CA-C-O 120.895 0.379 . . . . 0.0 110.547 -178.645 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' F' F ' 87' ' ' ILE . . . . . . . . . . . . . 5.1 mp -121.94 129.93 75.01 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.289 0 N-CA-C 109.364 -0.606 . . . . 0.0 109.364 176.315 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' F' F ' 88' ' ' LEU . . . . . . . . . . . . . 13.9 tp -115.29 134.58 55.0 Favored 'General case' 0 C--N 1.332 -0.182 0 CA-C-O 121.182 0.515 . . . . 0.0 111.693 -175.366 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' F' F ' 89' ' ' ASP . . . . . . . . . . . . . 7.4 t0 -126.53 148.9 49.66 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 115.465 -0.788 . . . . 0.0 109.0 174.067 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' F' F ' 90' ' ' GLU . . . . . . . . . . . . . 93.5 mt-10 -49.38 -34.08 15.28 Favored 'General case' 0 C--N 1.329 -0.286 0 N-CA-C 112.625 0.602 . . . . 0.0 112.625 -173.769 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' F' F ' 91' ' ' ASN . . . . . . . . . . . . . 21.9 m120 -128.05 30.32 5.26 Favored 'General case' 0 N--CA 1.465 0.323 0 N-CA-C 112.187 0.44 . . . . 0.0 112.187 -176.974 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' F' F ' 92' ' ' LEU . . . . . . . . . . . . . 13.4 tp -166.19 147.57 6.68 Favored 'General case' 0 C--N 1.332 -0.179 0 CA-C-O 120.609 0.242 . . . . 0.0 110.52 -179.993 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' F' F ' 93' ' ' ILE . . . . . . . . . . . . . 70.4 mt -128.83 123.39 59.02 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.254 0 N-CA-C 109.541 -0.54 . . . . 0.0 109.541 179.416 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' F' F ' 94' ' ' VAL . . . . . . . . . . . . . 44.0 t -122.05 129.21 75.57 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.253 0 CA-C-O 120.884 0.373 . . . . 0.0 110.137 -179.424 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' F' F ' 95' ' ' VAL . . . . . . . . . . . . . 43.9 t -124.63 136.1 61.76 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.275 0 CA-C-N 116.04 -0.527 . . . . 0.0 110.054 -179.452 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' F' F ' 96' ' ' ILE . . . . . . . . . . . . . 59.6 mt -116.05 128.48 73.33 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.274 0 N-CA-C 109.255 -0.646 . . . . 0.0 109.255 178.783 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' F' F ' 97' ' ' THR . . . . . . . . . . . . . 82.6 p -102.89 156.63 17.53 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-O 121.156 0.503 . . . . 0.0 111.559 -175.845 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' F' F ' 98' ' ' GLU . . . . . . . . . . . . . 45.0 mt-10 -53.93 -26.04 23.39 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 116.099 -0.5 . . . . 0.0 112.179 179.395 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' F' F ' 99' ' ' GLU . . . . . . . . . . . . . 71.2 mm-40 -79.36 16.32 1.04 Allowed 'General case' 0 CA--C 1.535 0.377 0 N-CA-C 113.158 0.799 . . . . 0.0 113.158 -176.973 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' F' F ' 100' ' ' ASN . . . . . . . . . . . . . 2.1 m-20 62.11 32.78 17.35 Favored 'General case' 0 CA--C 1.531 0.232 0 CA-C-N 117.996 0.362 . . . . 0.0 111.555 178.412 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' F' F ' 101' ' ' GLU . . . . . . . . . . . . . 84.1 tt0 -112.56 144.71 41.59 Favored 'General case' 0 C--O 1.232 0.164 0 N-CA-C 109.735 -0.469 . . . . 0.0 109.735 175.412 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' F' F ' 102' ' ' VAL . . . . . . . . . . . . . 46.5 t -117.21 127.19 74.8 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.367 0 N-CA-C 109.67 -0.493 . . . . 0.0 109.67 -179.087 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' F' F ' 103' ' ' LEU . . . . . . . . . . . . . 27.9 mt -118.99 133.69 55.66 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 115.919 -0.582 . . . . 0.0 110.275 179.561 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' F' F ' 104' ' ' ILE . . . . . . . . . . . . . 70.5 mt -120.2 121.94 67.04 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.205 0 CA-C-N 116.469 -0.332 . . . . 0.0 110.295 -179.791 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' F' F ' 105' ' ' PHE . . . . . . . . . . . . . 81.4 m-85 -120.17 164.03 16.84 Favored 'General case' 0 C--N 1.332 -0.194 0 O-C-N 124.043 0.84 . . . . 0.0 109.681 179.504 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' F' F ' 106' ' ' ASN . . . . . . . . . . . . . 38.8 p-10 -97.41 -171.75 2.27 Favored 'General case' 0 C--N 1.331 -0.216 0 N-CA-C 109.957 -0.386 . . . . 0.0 109.957 174.091 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' F' F ' 107' ' ' GLN . . . . . . . . . . . . . 29.5 tt0 -60.01 -30.07 68.9 Favored 'General case' 0 C--N 1.33 -0.263 0 N-CA-C 111.986 0.365 . . . . 0.0 111.986 179.73 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' F' F ' 108' ' ' ASN . . . . . . . . . . . . . 44.6 t30 -82.71 6.04 19.3 Favored 'General case' 0 CA--C 1.536 0.433 0 N-CA-C 113.246 0.832 . . . . 0.0 113.246 -177.354 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' F' F ' 109' ' ' LEU . . . . . . . . . . . . . 12.6 tp 63.13 40.84 8.61 Favored 'General case' 0 C--O 1.233 0.189 0 CA-C-O 121.229 0.537 . . . . 0.0 111.091 178.107 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' F' F ' 110' ' ' GLU . . . . . . . . . . . . . 43.8 mt-10 -111.67 150.68 29.82 Favored 'General case' 0 C--N 1.33 -0.271 0 N-CA-C 109.814 -0.439 . . . . 0.0 109.814 174.639 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' F' F ' 111' ' ' GLU . . . . . . . . . . . . . 62.8 tt0 -84.75 121.98 28.46 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.389 -0.369 . . . . 0.0 110.956 -176.292 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' F' F ' 112' ' ' LEU . . . . . . . . . . . . . 57.7 mt -109.83 -46.02 3.55 Favored 'General case' 0 C--N 1.333 -0.144 0 CA-C-N 116.277 -0.419 . . . . 0.0 110.796 179.771 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' F' F ' 113' ' ' TYR . . . . . . . . . . . . . 61.0 t80 -132.99 140.56 47.83 Favored 'General case' 0 N--CA 1.464 0.271 0 CA-C-O 120.852 0.358 . . . . 0.0 110.745 -179.551 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' F' F ' 114' ' ' ARG . . . . . . . . . . . . . 36.0 ptt180 -143.99 123.46 13.17 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 115.848 -0.615 . . . . 0.0 110.347 178.384 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' F' F ' 115' ' ' GLY . . . . . . . . . . . . . . . -150.13 160.82 28.69 Favored Glycine 0 CA--C 1.525 0.661 0 N-CA-C 111.196 -0.762 . . . . 0.0 111.196 179.58 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' F' F ' 116' ' ' LYS . . . . . . . . . . . . . 76.8 tttt -130.5 140.6 50.51 Favored 'General case' 0 C--N 1.329 -0.287 0 N-CA-C 109.846 -0.428 . . . . 0.0 109.846 177.597 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' F' F ' 117' ' ' PHE . . . . . . . . . . . . . 30.8 m-85 -139.28 114.02 9.26 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.11 -0.495 . . . . 0.0 109.975 -177.222 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' F' F ' 118' ' ' GLU . . . . . . . . . . . . . 44.9 tp10 -52.05 -45.81 64.86 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.534 -0.303 . . . . 0.0 111.565 -176.927 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' F' F ' 119' ' ' ASN . . . . . . . . . . . . . 86.4 m-20 -98.52 31.14 2.96 Favored 'General case' 0 C--N 1.329 -0.299 0 N-CA-C 112.185 0.439 . . . . 0.0 112.185 -174.608 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' F' F ' 120' ' ' LEU . . . . . . . . . . . . . 17.5 tp -55.33 120.12 6.61 Favored 'General case' 0 N--CA 1.462 0.146 0 O-C-N 122.266 -0.271 . . . . 0.0 110.608 178.067 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' F' F ' 121' ' ' ASN . . . . . . . . . . . . . 89.1 m-20 -112.49 -44.09 3.41 Favored 'General case' 0 C--O 1.232 0.167 0 CA-C-N 116.579 -0.282 . . . . 0.0 111.219 -176.491 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' F' F ' 122' ' ' LYS . . . . . . . . . . . . . 92.4 mttt -146.68 150.24 35.02 Favored 'General case' 0 C--N 1.333 -0.138 0 C-N-CA 120.389 -0.524 . . . . 0.0 111.978 -177.862 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' F' F ' 123' ' ' VAL . . . . . . . . . . . . . 46.1 t -125.62 126.05 69.63 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.224 0 CA-C-N 115.726 -0.67 . . . . 0.0 109.53 175.471 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' F' F ' 124' ' ' LEU . . . . . . . . . . . . . 48.3 mt -115.97 132.99 56.49 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.399 -0.364 . . . . 0.0 110.363 -178.685 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' F' F ' 125' ' ' VAL . . . . . . . . . . . . . 34.9 m -131.73 137.1 55.83 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.211 0 CA-C-O 120.868 0.366 . . . . 0.0 111.074 -177.902 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' F' F ' 126' ' ' ARG . . . . . . . . . . . . . 96.7 mtt-85 -145.43 111.37 5.55 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.151 -0.477 . . . . 0.0 110.575 176.179 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' F' F ' 127' ' ' ASN . . . . . . . . . . . . . 6.2 m120 53.29 -104.91 0.22 Allowed 'General case' 0 CA--C 1.542 0.651 0 CA-C-O 119.07 -0.49 . . . . 0.0 111.193 178.869 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' F' F ' 128' ' ' ASP . . . . . . . . . . . . . 13.3 p-10 -113.66 3.22 15.53 Favored 'General case' 0 N--CA 1.469 0.495 0 CA-C-N 119.454 1.025 . . . . 0.0 113.378 -176.239 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' F' F ' 129' ' ' LEU . . . . . . . . . . . . . 17.2 tp -106.82 139.66 40.89 Favored 'General case' 0 C--N 1.334 -0.104 0 N-CA-C 109.787 -0.449 . . . . 0.0 109.787 177.853 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' F' F ' 130' ' ' VAL . . . . . . . . . . . . . 41.8 t -129.36 139.79 50.85 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.231 0 CA-C-O 121.064 0.459 . . . . 0.0 110.339 -177.565 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' F' F ' 131' ' ' VAL . . . . . . . . . . . . . 44.6 t -136.1 135.61 50.01 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.319 0 CA-C-N 116.015 -0.539 . . . . 0.0 109.838 176.915 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' F' F ' 132' ' ' ILE . . . . . . . . . . . . . 71.3 mt -117.57 134.05 62.4 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.292 0 CA-C-N 116.141 -0.481 . . . . 0.0 109.709 -178.681 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' F' F ' 133' ' ' ILE . . . . . . . . . . . . . 43.0 mm -115.3 123.24 70.67 Favored 'Isoleucine or valine' 0 C--O 1.233 0.217 0 CA-C-N 116.277 -0.42 . . . . 0.0 111.003 -175.054 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' F' F ' 134' ' ' ASP . . . . . . . . . . . . . 8.1 p-10 -134.87 145.48 48.32 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 115.892 -0.595 . . . . 0.0 109.505 173.952 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' F' F ' 135' ' ' GLU . . . . . . . . . . . . . 40.1 tp10 -49.9 -24.83 2.72 Favored 'General case' 0 CA--C 1.534 0.346 0 N-CA-C 112.737 0.643 . . . . 0.0 112.737 -173.901 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' F' F ' 136' ' ' GLN . . . . . . . . . . . . . 60.1 tt0 -81.91 -36.76 27.74 Favored 'General case' 0 C--O 1.234 0.243 0 N-CA-C 111.859 0.318 . . . . 0.0 111.859 -176.533 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' F' F ' 137' ' ' LYS . . . . . . . . . . . . . 20.0 pttp -168.18 175.36 6.59 Favored 'General case' 0 C--N 1.331 -0.201 0 CA-C-O 121.503 0.668 . . . . 0.0 111.984 -173.0 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' F' F ' 138' ' ' LEU . . . . . . . . . . . . . 7.3 tt -118.94 129.79 55.36 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 115.107 -0.951 . . . . 0.0 110.15 179.563 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' F' F ' 139' ' ' THR . . . . . . . . . . . . . 37.7 m -110.39 130.02 55.64 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.104 -0.498 . . . . 0.0 110.508 -179.984 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' F' F ' 140' ' ' LEU . . . . . . . . . . . . . 5.2 tt -115.38 123.98 50.04 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 115.855 -0.611 . . . . 0.0 109.755 -178.091 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' F' F ' 141' ' ' ILE . . . . . . . . . . . . . 18.8 mt -123.4 124.69 70.32 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.184 0 N-CA-C 110.015 -0.365 . . . . 0.0 110.015 -174.379 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' F' F ' 142' ' ' ARG . . . . . . . . . . . . . 77.1 ttt180 -120.91 134.57 55.3 Favored 'General case' 0 C--O 1.234 0.259 0 CA-C-N 116.106 -0.497 . . . . 0.0 110.297 -178.823 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' F' F ' 143' ' ' THR . . . . . . . . . . . . . 21.5 p . . . . . 0 C--O 1.219 -0.533 0 CA-C-O 117.99 -1.005 . . . . 0.0 110.567 -179.607 . . . . . . . . 0 0 . 1 . 017 nuclear orig core ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 7.1 p . . . . . 0 C--O 1.232 0.154 0 CA-C-O 121.084 0.469 . . . . 0.0 110.598 . . . . . . . . . 0 0 . 1 . 017 nuclear orig core ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 95.6 mt-10 -141.23 141.41 34.03 Favored 'General case' 0 C--N 1.327 -0.406 0 CA-C-N 115.861 -0.609 . . . . 0.0 110.876 -179.096 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 4' ' ' LEU . . . . . . . . . . . . . 3.7 tt -128.19 124.95 38.04 Favored 'General case' 0 C--N 1.33 -0.268 0 N-CA-C 109.679 -0.489 . . . . 0.0 109.679 176.887 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 5' ' ' LYS . . . . . . . . . . . . . 63.0 mttp -107.7 122.61 47.08 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-O 120.625 0.25 . . . . 0.0 111.087 -179.189 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 25.2 mt -114.0 144.51 42.97 Favored 'General case' 0 C--O 1.232 0.145 0 CA-C-N 115.542 -0.754 . . . . 0.0 110.525 179.419 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 24.8 ttmt -126.52 139.38 34.56 Favored Pre-proline 0 CA--C 1.531 0.247 0 N-CA-C 109.537 -0.542 . . . . 0.0 109.537 173.224 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 8' ' ' PRO . . . . . . . . . . . . . 98.3 Cg_endo -91.5 141.76 2.76 Favored 'Trans proline' 0 N--CA 1.491 1.335 0 C-N-CA 121.715 1.61 . . . . 0.0 112.156 -179.674 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 56.3 mt -80.07 -47.22 1.39 Allowed Pre-proline 0 CA--C 1.534 0.364 0 CA-C-O 118.64 -0.695 . . . . 0.0 112.222 178.799 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 89.8 Cg_endo -80.98 153.79 19.36 Favored 'Trans proline' 0 N--CA 1.496 1.644 0 C-N-CA 121.168 1.245 . . . . 0.0 111.749 176.142 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 19.4 tptp -88.23 99.09 11.95 Favored 'General case' 0 C--N 1.33 -0.274 0 N-CA-C 110.005 -0.369 . . . . 0.0 110.005 179.303 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 12.7 p -142.34 148.54 20.09 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.258 0 CA-C-N 116.326 -0.397 . . . . 0.0 110.928 -177.766 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 84.2 tt0 -93.69 121.1 34.78 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.05 -0.523 . . . . 0.0 110.04 176.628 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 14' ' ' LEU . . . . . . . . . . . . . 46.6 mt -98.58 152.3 37.84 Favored Pre-proline 0 CA--C 1.533 0.29 0 CA-C-N 116.468 -0.333 . . . . 0.0 110.843 -178.309 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 15' ' ' PRO . . . . . . . . . . . . . 28.6 Cg_exo -61.03 158.65 33.24 Favored 'Trans proline' 0 N--CA 1.498 1.74 0 C-N-CA 121.3 1.333 . . . . 0.0 112.013 177.706 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 16' ' ' PRO . . . . . . . . . . . . . 29.5 Cg_exo -59.99 -36.08 91.04 Favored 'Trans proline' 0 N--CA 1.497 1.677 0 C-N-CA 121.443 1.429 . . . . 0.0 112.689 -179.919 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 17' ' ' ASP . . . . . . . . . . . . . 21.7 p-10 -85.84 8.72 19.02 Favored 'General case' 0 CA--C 1.536 0.406 0 N-CA-C 113.295 0.85 . . . . 0.0 113.295 -177.172 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 18' ' ' PHE . . . . . . . . . . . . . 41.9 t80 -58.09 -44.01 87.36 Favored 'General case' 0 N--CA 1.457 -0.087 0 O-C-N 122.03 -0.419 . . . . 0.0 110.102 -178.713 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 19' ' ' VAL . . . . . . . . . . . . . 48.5 t -56.15 -42.66 73.64 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.291 0 CA-C-N 116.275 -0.42 . . . . 0.0 110.457 -178.81 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 73.0 m-20 -59.89 -43.68 94.67 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-O 120.791 0.329 . . . . 0.0 110.885 -177.907 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 45.8 t -64.35 -45.57 95.61 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.292 0 C-N-CA 120.715 -0.394 . . . . 0.0 110.574 -177.466 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 22' ' ' ILE . . . . . . . . . . . . . 51.1 mm -55.36 -47.61 77.83 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.254 0 C-N-CA 120.921 -0.312 . . . . 0.0 110.73 179.26 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 23' ' ' ARG . . . . . . . . . . . . . 55.6 ttp180 -55.44 -49.1 73.34 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-O 120.704 0.288 . . . . 0.0 111.207 -178.48 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 24' ' ' ILE . . . . . . . . . . . . . 71.6 mt -58.99 -41.72 84.06 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.258 0 CA-C-N 116.529 -0.305 . . . . 0.0 111.351 -176.419 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 83.6 mttt -71.75 -41.1 68.86 Favored 'General case' 0 C--N 1.328 -0.346 0 N-CA-C 112.714 0.635 . . . . 0.0 112.714 -178.02 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 34.2 mt -78.53 -32.58 48.03 Favored 'General case' 0 C--N 1.328 -0.343 0 N-CA-C 113.697 0.999 . . . . 0.0 113.697 -170.332 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 27' ' ' GLN . . . . . . . . . . . . . 10.2 pt20 -47.11 140.76 4.81 Favored 'General case' 0 N--CA 1.468 0.463 0 N-CA-C 112.771 0.656 . . . . 0.0 112.771 -175.873 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 99.62 -24.11 33.49 Favored Glycine 0 CA--C 1.534 1.222 0 CA-C-N 115.696 -0.684 . . . . 0.0 112.399 -178.047 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 57.2 mtpt -97.62 155.06 17.15 Favored 'General case' 0 C--N 1.333 -0.13 0 CA-C-N 117.531 0.666 . . . . 0.0 111.125 179.312 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 30' ' ' THR . . . . . . . . . . . . . 41.0 m -105.18 137.32 43.14 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 115.89 -0.595 . . . . 0.0 110.036 176.273 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 34.7 m -129.08 152.27 36.96 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.213 0 CA-C-O 120.932 0.396 . . . . 0.0 110.932 -178.402 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 32' ' ' ARG . . . . . . . . . . . . . 68.3 ttp85 -130.28 148.51 52.12 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 115.94 -0.573 . . . . 0.0 110.477 179.924 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 33' ' ' THR . . . . . . . . . . . . . 25.0 m -52.99 139.3 28.17 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.308 -0.405 . . . . 0.0 111.435 -178.024 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 100.16 -17.12 57.49 Favored Glycine 0 CA--C 1.532 1.137 0 CA-C-O 119.698 -0.501 . . . . 0.0 113.342 179.437 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 77.8 m-20 -66.43 149.58 50.2 Favored 'General case' 0 C--N 1.334 -0.102 0 CA-C-N 118.055 0.927 . . . . 0.0 111.228 179.122 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 47.4 t -122.35 130.55 74.44 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.199 0 CA-C-N 115.881 -0.6 . . . . 0.0 109.729 177.922 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 37' ' ' ILE . . . . . . . . . . . . . 65.4 mt -122.56 140.24 46.98 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.282 0 CA-C-N 116.063 -0.517 . . . . 0.0 109.998 -178.196 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . -113.89 128.45 8.28 Favored Glycine 0 CA--C 1.525 0.71 0 N-CA-C 110.983 -0.847 . . . . 0.0 110.983 178.343 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 39' ' ' ILE . . . . . . . . . . . . . 73.9 mt -127.95 136.63 59.77 Favored 'Isoleucine or valine' 0 N--CA 1.462 0.175 0 N-CA-C 110.069 -0.345 . . . . 0.0 110.069 178.928 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 40' ' ' SER . . . . . . . . . . . . . 88.3 p -92.69 118.99 31.64 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.481 -0.327 . . . . 0.0 111.15 177.014 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 41' ' ' ILE . . . . . . . . . . . . . 45.2 mm -121.66 121.99 65.84 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.214 0 CA-C-N 116.438 -0.346 . . . . 0.0 110.232 178.327 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 38.1 mt 53.25 34.25 17.27 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.265 -0.425 . . . . 0.0 111.918 176.602 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . 75.72 27.51 62.81 Favored Glycine 0 CA--C 1.53 1.016 0 C-N-CA 121.077 -0.583 . . . . 0.0 112.594 176.646 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 44' ' ' LYS . . . . . . . . . . . . . 24.7 ttpp -140.33 133.44 29.51 Favored 'General case' 0 C--N 1.33 -0.25 0 N-CA-C 109.427 -0.583 . . . . 0.0 109.427 176.582 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 84.3 tt0 -82.85 126.12 32.09 Favored 'General case' 0 C--N 1.329 -0.318 0 C-N-CA 120.796 -0.361 . . . . 0.0 111.327 -176.325 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 46' ' ' VAL . . . . . . . . . . . . . 9.2 p -120.29 125.67 74.44 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.199 0 N-CA-C 109.166 -0.679 . . . . 0.0 109.166 173.975 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 95.5 mttt -99.2 127.67 45.21 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.085 -0.507 . . . . 0.0 110.807 179.076 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 48' ' ' PHE . . . . . . . . . . . . . 37.7 m-85 -111.39 131.89 54.85 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.075 -0.511 . . . . 0.0 109.998 178.486 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 80.4 tttt -106.61 134.86 49.09 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.45 -0.341 . . . . 0.0 110.164 177.469 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 50' ' ' VAL . . . . . . . . . . . . . 44.4 t -78.16 106.14 8.29 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.285 0 N-CA-C 109.559 -0.534 . . . . 0.0 109.559 177.949 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 51' ' ' VAL . . . . . . . . . . . . . 48.7 t -71.25 -49.96 44.61 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.303 0 CA-C-N 115.946 -0.57 . . . . 0.0 109.83 -175.457 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 52' ' ' GLN . . . . . . . . . . . . . 62.0 tt0 -158.55 139.63 13.09 Favored 'General case' 0 C--N 1.33 -0.28 0 C-N-CA 120.278 -0.569 . . . . 0.0 111.764 -177.82 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -115.5 131.52 56.91 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 115.569 -0.741 . . . . 0.0 109.739 174.976 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 54' ' ' TYR . . . . . . . . . . . . . 43.6 t80 -129.03 110.21 18.29 Favored Pre-proline 0 CA--C 1.535 0.397 0 CA-C-O 118.208 -0.901 . . . . 0.0 110.52 -179.334 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 55' ' ' PRO . . . . . . . . . . . . . 72.9 Cg_endo -77.1 169.95 72.9 Favored 'Cis proline' 0 N--CA 1.498 1.781 0 CA-C-N 121.913 1.719 . . . . 0.0 112.228 -5.067 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 56' ' ' SER . . . . . . . . . . . . . 15.0 m -113.64 127.88 26.34 Favored Pre-proline 0 CA--C 1.539 0.529 0 CA-C-O 118.446 -0.788 . . . . 0.0 109.633 176.616 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 57' ' ' PRO . . . . . . . . . . . . . 60.4 Cg_endo -74.11 149.55 94.17 Favored 'Cis proline' 0 N--CA 1.498 1.739 0 CA-C-N 122.002 1.751 . . . . 0.0 111.685 0.063 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 58' ' ' LEU . . . . . . . . . . . . . 32.0 tp -108.16 137.09 46.74 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.229 -0.441 . . . . 0.0 110.606 -178.253 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 59' ' ' ARG . . . . . . . . . . . . . 52.8 ttp180 -104.4 127.94 52.17 Favored 'General case' 0 C--N 1.328 -0.338 0 N-CA-C 109.24 -0.652 . . . . 0.0 109.24 175.345 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 42.2 t -83.5 121.26 36.01 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.259 0 C-N-CA 120.731 -0.388 . . . . 0.0 110.771 -173.758 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 95.8 mt-10 -131.12 165.02 24.18 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 115.667 -0.697 . . . . 0.0 109.627 175.749 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 62' ' ' ASP . . . . . . . . . . . . . 19.0 p-10 -53.78 -32.49 52.69 Favored 'General case' 0 C--N 1.329 -0.322 0 C-N-CA 121.035 -0.266 . . . . 0.0 111.663 179.428 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 63' ' ' ARG . . . . . . . . . . . . . 67.7 mtp180 -72.52 -22.08 61.09 Favored 'General case' 0 CA--C 1.532 0.282 0 N-CA-C 112.963 0.727 . . . . 0.0 112.963 -176.814 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 25.8 m -69.18 138.97 54.54 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-O 120.981 0.42 . . . . 0.0 110.876 -174.982 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 65' ' ' LYS . . . . . . . . . . . . . 90.8 mttt -88.56 127.78 35.55 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 115.964 -0.562 . . . . 0.0 109.854 178.673 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 66' ' ' ILE . . . . . . . . . . . . . 63.4 mt -112.47 129.01 68.79 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.189 0 N-CA-C 109.62 -0.511 . . . . 0.0 109.62 178.718 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 67' ' ' THR . . . . . . . . . . . . . 19.4 m -121.03 136.29 55.02 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.09 -0.504 . . . . 0.0 110.689 -177.311 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 68' ' ' LEU . . . . . . . . . . . . . 17.7 tp . . . . . 0 C--N 1.33 -0.261 0 CA-C-N 115.938 -0.574 . . . . 0.0 110.342 178.753 . . . . . . . . 0 0 . 1 . 017 nuclear orig core ' A' A ' 74' ' ' ASP . . . . . . . . . . . . . 7.2 t70 . . . . . 0 C--O 1.231 0.096 0 N-CA-C 109.71 -0.478 . . . . 0.0 109.71 . . . . . . . . . 0 0 . 1 . 017 nuclear orig core ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 42.7 t -119.19 128.84 75.81 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.322 0 CA-C-O 121.188 0.518 . . . . 0.0 110.899 -176.342 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 76' ' ' LEU . . . . . . . . . . . . . 5.0 mp -124.56 145.63 49.48 Favored 'General case' 0 C--N 1.332 -0.161 0 CA-C-N 115.643 -0.708 . . . . 0.0 109.818 174.679 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 77' ' ' GLU . . . . . . . . . . . . . 97.5 mt-10 -136.15 133.04 36.78 Favored 'General case' 0 C--N 1.331 -0.226 0 CA-C-O 120.927 0.394 . . . . 0.0 111.3 -179.935 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 78' ' ' ALA . . . . . . . . . . . . . . . -121.53 139.62 53.26 Favored 'General case' 0 C--N 1.331 -0.197 0 CA-C-N 115.82 -0.627 . . . . 0.0 109.698 176.105 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 79' ' ' LYS . . . . . . . . . . . . . 32.8 ttpt -76.96 119.85 21.27 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-O 120.889 0.376 . . . . 0.0 110.247 -179.919 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 80' ' ' ILE . . . . . . . . . . . . . 22.9 mm -139.24 111.86 5.86 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.327 0 N-CA-C 109.007 -0.738 . . . . 0.0 109.007 -178.544 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 81' ' ' LYS . . . . . . . . . . . . . 79.0 tttt -115.77 129.09 56.31 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-O 120.902 0.382 . . . . 0.0 110.657 -177.138 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . 89.11 41.98 5.72 Favored Glycine 0 CA--C 1.525 0.704 0 N-CA-C 111.342 -0.703 . . . . 0.0 111.342 178.085 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 83' ' ' ILE . . . . . . . . . . . . . 75.9 mt -67.33 140.21 19.7 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.309 0 CA-C-O 120.902 0.382 . . . . 0.0 109.993 178.593 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 84' ' ' LYS . . . . . . . . . . . . . 71.6 tttt -99.71 -52.03 3.57 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.043 -0.526 . . . . 0.0 110.074 -179.901 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 85' ' ' ASP . . . . . . . . . . . . . 5.0 t70 -159.86 156.73 27.86 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 115.758 -0.656 . . . . 0.0 110.365 179.809 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 86' ' ' VAL . . . . . . . . . . . . . 40.7 t -131.13 132.87 63.22 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.228 0 CA-C-O 120.983 0.42 . . . . 0.0 110.744 -178.94 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 87' ' ' ILE . . . . . . . . . . . . . 43.9 mm -120.07 126.82 75.68 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.268 0 CA-C-N 115.771 -0.649 . . . . 0.0 109.361 177.08 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 88' ' ' LEU . . . . . . . . . . . . . 19.1 tp -114.84 134.33 55.22 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-O 120.944 0.402 . . . . 0.0 111.423 -176.8 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 89' ' ' ASP . . . . . . . . . . . . . 13.5 t70 -129.38 157.17 42.67 Favored 'General case' 0 C--N 1.331 -0.226 0 CA-C-N 115.787 -0.642 . . . . 0.0 109.606 176.719 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 60.2 mp0 -48.51 -35.96 14.24 Favored 'General case' 0 C--N 1.332 -0.192 0 N-CA-C 113.06 0.763 . . . . 0.0 113.06 -171.154 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 91' ' ' ASN . . . . . . . . . . . . . 27.6 t30 -130.65 18.35 5.21 Favored 'General case' 0 N--CA 1.47 0.534 0 N-CA-C 113.15 0.796 . . . . 0.0 113.15 -177.238 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 92' ' ' LEU . . . . . . . . . . . . . 22.6 mt -146.99 142.52 27.59 Favored 'General case' 0 C--N 1.331 -0.216 0 N-CA-C 110.221 -0.288 . . . . 0.0 110.221 -177.595 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 93' ' ' ILE . . . . . . . . . . . . . 71.9 mt -123.21 117.86 52.89 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.354 0 N-CA-C 109.312 -0.625 . . . . 0.0 109.312 177.695 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 94' ' ' VAL . . . . . . . . . . . . . 41.9 t -120.24 128.75 76.0 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.25 0 CA-C-O 120.959 0.409 . . . . 0.0 110.102 -178.987 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 95' ' ' VAL . . . . . . . . . . . . . 42.5 t -123.24 135.56 62.79 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.367 0 CA-C-N 115.933 -0.576 . . . . 0.0 109.77 179.616 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 96' ' ' ILE . . . . . . . . . . . . . 66.9 mt -114.17 130.94 67.53 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.36 0 N-CA-C 109.425 -0.583 . . . . 0.0 109.425 179.259 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 97' ' ' THR . . . . . . . . . . . . . 60.4 p -104.65 158.09 16.73 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-O 121.04 0.447 . . . . 0.0 111.267 -177.825 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 98' ' ' GLU . . . . . . . . . . . . . 97.3 mt-10 -53.98 -26.03 23.89 Favored 'General case' 0 C--N 1.328 -0.355 0 N-CA-C 112.371 0.508 . . . . 0.0 112.371 -179.763 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 99' ' ' GLU . . . . . . . . . . . . . 95.6 mt-10 -78.56 14.62 1.22 Allowed 'General case' 0 CA--C 1.536 0.417 0 N-CA-C 113.171 0.804 . . . . 0.0 113.171 -177.343 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 100' ' ' ASN . . . . . . . . . . . . . 3.6 m-20 62.17 37.94 14.02 Favored 'General case' 0 N--CA 1.462 0.172 0 CA-C-O 121.125 0.488 . . . . 0.0 110.894 178.818 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 101' ' ' GLU . . . . . . . . . . . . . 84.6 tt0 -115.36 144.24 44.07 Favored 'General case' 0 C--O 1.233 0.2 0 CA-C-N 116.047 -0.524 . . . . 0.0 109.807 176.584 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 102' ' ' VAL . . . . . . . . . . . . . 45.1 t -115.03 124.69 71.93 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.338 0 CA-C-N 116.067 -0.515 . . . . 0.0 109.94 -178.339 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 103' ' ' LEU . . . . . . . . . . . . . 23.2 mt -115.13 126.82 55.09 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 115.753 -0.658 . . . . 0.0 110.168 176.449 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 104' ' ' ILE . . . . . . . . . . . . . 72.6 mt -118.21 120.42 64.37 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.232 0 N-CA-C 109.983 -0.377 . . . . 0.0 109.983 179.438 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 105' ' ' PHE . . . . . . . . . . . . . 53.5 m-85 -120.32 162.33 19.63 Favored 'General case' 0 C--N 1.332 -0.178 0 CA-C-N 115.5 -0.773 . . . . 0.0 110.052 179.955 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 106' ' ' ASN . . . . . . . . . . . . . 43.1 p-10 -93.8 -169.83 2.19 Favored 'General case' 0 C--N 1.329 -0.311 0 N-CA-C 109.785 -0.45 . . . . 0.0 109.785 173.375 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 107' ' ' GLN . . . . . . . . . . . . . 48.6 tt0 -57.64 -30.03 65.06 Favored 'General case' 0 CA--C 1.532 0.268 0 N-CA-C 112.061 0.393 . . . . 0.0 112.061 179.37 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 108' ' ' ASN . . . . . . . . . . . . . 49.4 t30 -84.72 9.48 13.87 Favored 'General case' 0 CA--C 1.536 0.412 0 N-CA-C 113.251 0.834 . . . . 0.0 113.251 -177.131 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 109' ' ' LEU . . . . . . . . . . . . . 10.9 tp 58.28 37.03 26.03 Favored 'General case' 0 C--N 1.331 -0.23 0 CA-C-O 120.983 0.421 . . . . 0.0 111.28 179.167 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 110' ' ' GLU . . . . . . . . . . . . . 95.7 mt-10 -106.64 159.48 16.16 Favored 'General case' 0 C--N 1.332 -0.174 0 CA-C-O 120.811 0.338 . . . . 0.0 110.166 176.846 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 111' ' ' GLU . . . . . . . . . . . . . 80.4 tt0 -81.58 121.92 26.93 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.282 -0.417 . . . . 0.0 111.213 -175.646 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 112' ' ' LEU . . . . . . . . . . . . . 15.3 mt -110.29 -46.08 3.48 Favored 'General case' 0 C--N 1.331 -0.227 0 CA-C-N 116.064 -0.516 . . . . 0.0 109.829 175.238 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 113' ' ' TYR . . . . . . . . . . . . . 58.7 t80 -139.24 136.6 35.13 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.145 -0.48 . . . . 0.0 110.931 178.849 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 114' ' ' ARG . . . . . . . . . . . . . 63.3 ttt180 -140.3 122.06 15.4 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 116.095 -0.502 . . . . 0.0 110.187 178.117 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 115' ' ' GLY . . . . . . . . . . . . . . . -150.08 161.66 28.96 Favored Glycine 0 CA--C 1.525 0.703 0 C-N-CA 120.732 -0.747 . . . . 0.0 111.391 179.676 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 116' ' ' LYS . . . . . . . . . . . . . 39.8 ttpt -128.88 136.17 50.07 Favored 'General case' 0 C--N 1.33 -0.27 0 N-CA-C 109.869 -0.419 . . . . 0.0 109.869 177.179 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 117' ' ' PHE . . . . . . . . . . . . . 39.3 m-85 -134.55 113.88 12.23 Favored 'General case' 0 C--N 1.329 -0.285 0 N-CA-C 109.878 -0.416 . . . . 0.0 109.878 -178.012 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 118' ' ' GLU . . . . . . . . . . . . . 12.9 pt-20 -57.06 -39.29 74.64 Favored 'General case' 0 C--N 1.329 -0.313 0 C-N-CA 120.726 -0.39 . . . . 0.0 111.084 -176.415 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 119' ' ' ASN . . . . . . . . . . . . . 32.7 m120 -94.81 26.0 3.79 Favored 'General case' 0 C--N 1.331 -0.207 0 N-CA-C 112.644 0.609 . . . . 0.0 112.644 -174.558 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 120' ' ' LEU . . . . . . . . . . . . . 17.5 tp -58.55 125.01 21.58 Favored 'General case' 0 C--N 1.333 -0.139 0 CA-C-O 120.816 0.341 . . . . 0.0 110.227 178.973 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 121' ' ' ASN . . . . . . . . . . . . . 4.2 m120 -113.96 -44.16 3.19 Favored 'General case' 0 C--N 1.332 -0.186 0 CA-C-N 116.262 -0.426 . . . . 0.0 110.581 -179.141 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 122' ' ' LYS . . . . . . . . . . . . . 56.6 pttt -159.71 157.93 30.41 Favored 'General case' 0 C--N 1.332 -0.186 0 C-N-CA 120.525 -0.47 . . . . 0.0 111.671 -179.624 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 123' ' ' VAL . . . . . . . . . . . . . 43.7 t -129.99 136.78 58.11 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.229 0 CA-C-N 116.022 -0.535 . . . . 0.0 110.09 179.956 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 124' ' ' LEU . . . . . . . . . . . . . 78.4 mt -119.82 133.96 55.41 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.152 -0.476 . . . . 0.0 110.81 -178.93 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 125' ' ' VAL . . . . . . . . . . . . . 48.3 t -126.91 127.25 69.67 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.218 0 N-CA-C 109.482 -0.562 . . . . 0.0 109.482 176.671 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 126' ' ' ARG . . . . . . . . . . . . . 41.7 ttt180 -144.01 124.4 13.89 Favored 'General case' 0 C--N 1.33 -0.242 0 C-N-CA 120.763 -0.375 . . . . 0.0 110.834 -179.192 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 127' ' ' ASN . . . . . . . . . . . . . 3.5 m120 51.2 -106.63 0.26 Allowed 'General case' 0 CA--C 1.544 0.726 0 CA-C-O 118.934 -0.555 . . . . 0.0 111.311 179.916 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 128' ' ' ASP . . . . . . . . . . . . . 10.9 p-10 -114.09 0.4 14.28 Favored 'General case' 0 N--CA 1.467 0.407 0 CA-C-N 119.754 1.161 . . . . 0.0 113.463 -177.883 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 129' ' ' LEU . . . . . . . . . . . . . 30.6 mt -104.91 141.73 36.02 Favored 'General case' 0 C--O 1.232 0.161 0 CA-C-N 118.249 0.477 . . . . 0.0 110.668 -178.429 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 130' ' ' VAL . . . . . . . . . . . . . 46.2 t -123.42 133.59 68.73 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.274 0 CA-C-N 115.973 -0.558 . . . . 0.0 109.574 178.422 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 131' ' ' VAL . . . . . . . . . . . . . 44.4 t -133.86 135.8 54.69 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.27 0 CA-C-O 121.119 0.485 . . . . 0.0 110.162 179.451 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 132' ' ' ILE . . . . . . . . . . . . . 73.8 mt -113.41 130.94 66.5 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.289 0 CA-C-N 115.668 -0.696 . . . . 0.0 109.249 179.423 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 133' ' ' ILE . . . . . . . . . . . . . 42.1 mm -114.2 120.33 63.66 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.277 0 CA-C-O 120.888 0.375 . . . . 0.0 110.727 -176.356 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 134' ' ' ASP . . . . . . . . . . . . . 7.1 p-10 -132.36 145.96 51.62 Favored 'General case' 0 C--N 1.33 -0.255 0 N-CA-C 109.104 -0.702 . . . . 0.0 109.104 174.003 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 135' ' ' GLU . . . . . . . . . . . . . 41.8 tp10 -49.69 -24.66 2.39 Favored 'General case' 0 C--N 1.328 -0.34 0 N-CA-C 112.881 0.697 . . . . 0.0 112.881 -170.961 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 136' ' ' GLN . . . . . . . . . . . . . 54.1 tp60 -96.53 -34.08 11.59 Favored 'General case' 0 CA--C 1.53 0.18 0 N-CA-C 112.223 0.453 . . . . 0.0 112.223 -175.871 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 137' ' ' LYS . . . . . . . . . . . . . 65.3 mttt -141.22 156.57 45.89 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-O 121.31 0.576 . . . . 0.0 111.905 -169.551 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 138' ' ' LEU . . . . . . . . . . . . . 5.1 tt -119.41 122.9 42.81 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 115.392 -0.822 . . . . 0.0 109.042 172.028 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 139' ' ' THR . . . . . . . . . . . . . 24.8 m -107.06 128.11 54.08 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.552 -0.295 . . . . 0.0 110.548 -178.107 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 140' ' ' LEU . . . . . . . . . . . . . 44.4 tp -113.32 119.73 38.69 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 115.74 -0.664 . . . . 0.0 109.417 -179.08 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 141' ' ' ILE . . . . . . . . . . . . . 19.3 mt -119.89 118.11 55.96 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.264 0 CA-C-O 121.006 0.431 . . . . 0.0 109.88 -176.713 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 142' ' ' ARG . . . . . . . . . . . . . 78.1 mtm180 -104.47 129.7 52.45 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 115.285 -0.871 . . . . 0.0 110.549 -178.693 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 143' ' ' THR . . . . . . . . . . . . . 77.1 p . . . . . 0 C--O 1.22 -0.466 0 CA-C-O 117.944 -1.027 . . . . 0.0 110.482 179.501 . . . . . . . . 0 0 . 1 . 017 nuclear orig core ' B' B ' 2' ' ' SER . . . . . . . . . . . . . 12.5 p . . . . . 0 C--O 1.231 0.083 0 CA-C-O 121.009 0.433 . . . . 0.0 110.37 . . . . . . . . . 0 0 . 1 . 017 nuclear orig core ' B' B ' 3' ' ' GLU . . . . . . . . . . . . . 43.6 mt-10 -140.52 145.02 36.28 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-N 115.751 -0.658 . . . . 0.0 110.999 -176.989 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' B' B ' 4' ' ' LEU . . . . . . . . . . . . . 23.1 tp -124.28 128.25 48.87 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.063 -0.517 . . . . 0.0 110.131 174.747 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' B' B ' 5' ' ' LYS . . . . . . . . . . . . . 63.8 mmtt -105.45 113.8 27.58 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 115.988 -0.551 . . . . 0.0 111.121 -179.202 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' B' B ' 6' ' ' LEU . . . . . . . . . . . . . 28.7 mt -113.71 137.48 51.55 Favored 'General case' 0 C--N 1.333 -0.147 0 O-C-N 124.034 0.834 . . . . 0.0 109.659 178.214 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' B' B ' 7' ' ' LYS . . . . . . . . . . . . . 57.7 tttp -123.2 137.95 29.14 Favored Pre-proline 0 CA--C 1.533 0.32 0 CA-C-O 118.853 -0.594 . . . . 0.0 109.862 177.333 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' B' B ' 8' ' ' PRO . . . . . . . . . . . . . 85.0 Cg_endo -90.41 137.2 2.44 Favored 'Trans proline' 0 N--CA 1.491 1.377 0 C-N-CA 121.625 1.55 . . . . 0.0 111.872 179.062 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' B' B ' 9' ' ' LEU . . . . . . . . . . . . . 39.5 mt -80.43 -48.57 1.23 Allowed Pre-proline 0 CA--C 1.535 0.374 0 CA-C-O 118.555 -0.736 . . . . 0.0 112.441 -179.69 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' B' B ' 10' ' ' PRO . . . . . . . . . . . . . 90.0 Cg_endo -78.88 156.21 27.0 Favored 'Trans proline' 0 N--CA 1.497 1.694 0 C-N-CA 121.183 1.256 . . . . 0.0 112.051 178.727 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' B' B ' 11' ' ' LYS . . . . . . . . . . . . . 60.6 mttp -82.71 93.13 7.32 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.353 -0.385 . . . . 0.0 110.333 178.476 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' B' B ' 12' ' ' VAL . . . . . . . . . . . . . 12.7 p -140.16 146.91 24.05 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.303 0 CA-C-N 116.296 -0.411 . . . . 0.0 110.718 -179.262 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' B' B ' 13' ' ' GLU . . . . . . . . . . . . . 84.7 tt0 -97.66 129.04 44.77 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.345 -0.389 . . . . 0.0 110.057 177.823 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' B' B ' 14' ' ' LEU . . . . . . . . . . . . . 27.3 mt -98.37 149.91 36.2 Favored Pre-proline 0 CA--C 1.532 0.282 0 CA-C-O 119.298 -0.382 . . . . 0.0 110.65 -177.12 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' B' B ' 15' ' ' PRO . . . . . . . . . . . . . 24.2 Cg_exo -63.68 160.57 35.87 Favored 'Trans proline' 0 N--CA 1.498 1.737 0 C-N-CA 121.366 1.377 . . . . 0.0 111.733 175.36 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' B' B ' 16' ' ' PRO . . . . . . . . . . . . . 30.4 Cg_exo -59.84 -35.81 92.86 Favored 'Trans proline' 0 N--CA 1.498 1.737 0 C-N-CA 121.47 1.447 . . . . 0.0 112.688 -178.589 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' B' B ' 17' ' ' ASP . . . . . . . . . . . . . 38.1 p30 -90.2 9.6 27.87 Favored 'General case' 0 CA--C 1.535 0.391 0 N-CA-C 113.367 0.877 . . . . 0.0 113.367 -177.553 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' B' B ' 18' ' ' PHE . . . . . . . . . . . . . 37.4 t80 -58.43 -46.38 86.61 Favored 'General case' 0 N--CA 1.458 -0.059 0 O-C-N 121.965 -0.459 . . . . 0.0 110.017 -177.598 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' B' B ' 19' ' ' VAL . . . . . . . . . . . . . 48.5 t -56.86 -41.72 76.63 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.399 0 CA-C-N 116.228 -0.442 . . . . 0.0 110.392 -178.176 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' B' B ' 20' ' ' ASP . . . . . . . . . . . . . 78.3 m-20 -60.14 -44.0 95.29 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-O 120.784 0.326 . . . . 0.0 111.0 -177.399 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' B' B ' 21' ' ' VAL . . . . . . . . . . . . . 48.0 t -64.5 -46.13 93.65 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.294 0 C-N-CA 120.765 -0.374 . . . . 0.0 110.468 -177.648 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' B' B ' 22' ' ' ILE . . . . . . . . . . . . . 50.1 mm -56.31 -44.73 80.48 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.25 0 C-N-CA 120.857 -0.337 . . . . 0.0 110.582 179.083 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' B' B ' 23' ' ' ARG . . . . . . . . . . . . . 59.6 ttp180 -54.49 -48.81 71.4 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-O 120.763 0.316 . . . . 0.0 111.17 -179.549 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' B' B ' 24' ' ' ILE . . . . . . . . . . . . . 74.2 mt -59.52 -41.1 83.69 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.247 0 CA-C-N 116.336 -0.393 . . . . 0.0 111.424 -176.66 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' B' B ' 25' ' ' LYS . . . . . . . . . . . . . 97.7 mttt -70.07 -43.33 71.38 Favored 'General case' 0 C--N 1.33 -0.273 0 N-CA-C 112.719 0.637 . . . . 0.0 112.719 -178.625 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' B' B ' 26' ' ' LEU . . . . . . . . . . . . . 92.2 mt -78.11 -34.23 50.12 Favored 'General case' 0 C--N 1.33 -0.26 0 N-CA-C 113.444 0.905 . . . . 0.0 113.444 -170.336 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' B' B ' 27' ' ' GLN . . . . . . . . . . . . . 6.6 pt20 -46.98 139.38 5.66 Favored 'General case' 0 N--CA 1.468 0.47 0 N-CA-C 112.755 0.65 . . . . 0.0 112.755 -175.95 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' B' B ' 28' ' ' GLY . . . . . . . . . . . . . . . 100.8 -23.95 33.79 Favored Glycine 0 CA--C 1.535 1.283 0 CA-C-N 115.671 -0.695 . . . . 0.0 112.384 -176.232 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' B' B ' 29' ' ' LYS . . . . . . . . . . . . . 45.4 mtmt -97.99 155.16 17.23 Favored 'General case' 0 C--O 1.231 0.1 0 CA-C-N 117.396 0.598 . . . . 0.0 111.037 178.804 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' B' B ' 30' ' ' THR . . . . . . . . . . . . . 32.0 m -105.05 137.7 42.39 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 116.043 -0.526 . . . . 0.0 110.236 177.978 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' B' B ' 31' ' ' VAL . . . . . . . . . . . . . 35.2 m -131.35 158.26 43.29 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.22 0 CA-C-O 120.865 0.364 . . . . 0.0 110.898 -179.153 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' B' B ' 32' ' ' ARG . . . . . . . . . . . . . 98.1 mtt180 -135.63 153.15 51.74 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-O 121.284 0.564 . . . . 0.0 110.77 178.245 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' B' B ' 33' ' ' THR . . . . . . . . . . . . . 19.8 m -53.6 140.67 28.05 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.153 -0.476 . . . . 0.0 111.441 -178.478 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' B' B ' 34' ' ' GLY . . . . . . . . . . . . . . . 99.29 -17.11 58.34 Favored Glycine 0 CA--C 1.532 1.109 0 CA-C-N 116.09 -0.505 . . . . 0.0 113.309 178.996 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' B' B ' 35' ' ' ASP . . . . . . . . . . . . . 78.2 m-20 -67.02 149.14 51.03 Favored 'General case' 0 N--CA 1.462 0.13 0 CA-C-N 118.036 0.918 . . . . 0.0 111.194 178.946 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' B' B ' 36' ' ' VAL . . . . . . . . . . . . . 45.7 t -119.48 129.84 74.8 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.197 0 CA-C-N 115.895 -0.593 . . . . 0.0 109.668 176.768 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' B' B ' 37' ' ' ILE . . . . . . . . . . . . . 65.1 mt -119.08 137.71 52.17 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.275 0 CA-C-N 116.125 -0.489 . . . . 0.0 109.968 -178.93 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' B' B ' 38' ' ' GLY . . . . . . . . . . . . . . . -113.34 127.77 8.04 Favored Glycine 0 CA--C 1.526 0.725 0 N-CA-C 110.873 -0.891 . . . . 0.0 110.873 179.43 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' B' B ' 39' ' ' ILE . . . . . . . . . . . . . 72.2 mt -125.6 131.55 71.94 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.27 0 N-CA-C 110.127 -0.323 . . . . 0.0 110.127 179.254 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' B' B ' 40' ' ' SER . . . . . . . . . . . . . 26.7 p -92.15 114.68 27.28 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.418 -0.356 . . . . 0.0 110.997 176.875 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' B' B ' 41' ' ' ILE . . . . . . . . . . . . . 44.1 mm -121.44 123.43 69.62 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.236 0 CA-C-N 116.483 -0.326 . . . . 0.0 110.33 179.714 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' B' B ' 42' ' ' LEU . . . . . . . . . . . . . 6.7 mp 52.94 34.53 17.02 Favored 'General case' 0 CA--C 1.533 0.29 0 CA-C-N 116.292 -0.413 . . . . 0.0 111.505 177.92 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' B' B ' 43' ' ' GLY . . . . . . . . . . . . . . . 72.67 30.48 63.96 Favored Glycine 0 CA--C 1.53 0.999 0 C-N-CA 121.199 -0.524 . . . . 0.0 112.211 177.888 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' B' B ' 44' ' ' LYS . . . . . . . . . . . . . 61.5 tttm -138.21 128.94 26.69 Favored 'General case' 0 C--N 1.329 -0.288 0 N-CA-C 109.585 -0.524 . . . . 0.0 109.585 178.132 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' B' B ' 45' ' ' GLU . . . . . . . . . . . . . 84.7 tt0 -83.28 122.0 27.85 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-O 120.817 0.342 . . . . 0.0 111.019 -177.153 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' B' B ' 46' ' ' VAL . . . . . . . . . . . . . 10.6 p -119.98 125.03 73.85 Favored 'Isoleucine or valine' 0 C--O 1.232 0.147 0 N-CA-C 109.444 -0.576 . . . . 0.0 109.444 174.651 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' B' B ' 47' ' ' LYS . . . . . . . . . . . . . 99.3 mttt -99.91 128.31 46.01 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.145 -0.479 . . . . 0.0 111.025 179.094 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' B' B ' 48' ' ' PHE . . . . . . . . . . . . . 26.7 m-85 -110.74 131.84 54.7 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 115.946 -0.57 . . . . 0.0 109.588 175.489 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' B' B ' 49' ' ' LYS . . . . . . . . . . . . . 60.8 tttm -105.62 135.42 47.05 Favored 'General case' 0 C--N 1.327 -0.37 0 N-CA-C 109.867 -0.42 . . . . 0.0 109.867 177.047 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' B' B ' 50' ' ' VAL . . . . . . . . . . . . . 47.3 t -79.99 104.99 8.93 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.326 0 N-CA-C 109.563 -0.532 . . . . 0.0 109.563 178.509 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' B' B ' 51' ' ' VAL . . . . . . . . . . . . . 46.4 t -69.88 -51.86 36.49 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.335 0 CA-C-N 115.945 -0.57 . . . . 0.0 109.8 -176.721 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' B' B ' 52' ' ' GLN . . . . . . . . . . . . . 92.4 mt-30 -151.88 151.36 31.18 Favored 'General case' 0 C--N 1.334 -0.105 0 C-N-CA 120.244 -0.582 . . . . 0.0 111.957 -179.456 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' B' B ' 53' ' ' ALA . . . . . . . . . . . . . . . -126.8 131.11 51.34 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 115.092 -0.958 . . . . 0.0 109.555 174.402 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' B' B ' 54' ' ' TYR . . . . . . . . . . . . . 30.2 t80 -129.12 109.67 18.1 Favored Pre-proline 0 C--N 1.328 -0.351 0 CA-C-O 118.201 -0.904 . . . . 0.0 110.31 178.902 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' B' B ' 55' ' ' PRO . . . . . . . . . . . . . 73.7 Cg_endo -77.28 168.3 77.18 Favored 'Cis proline' 0 N--CA 1.5 1.911 0 CA-C-N 121.985 1.745 . . . . 0.0 112.634 -3.558 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' B' B ' 56' ' ' SER . . . . . . . . . . . . . 13.5 m -114.63 125.84 28.64 Favored Pre-proline 0 CA--C 1.538 0.516 0 CA-C-O 118.368 -0.825 . . . . 0.0 109.241 174.907 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' B' B ' 57' ' ' PRO . . . . . . . . . . . . . 44.8 Cg_endo -68.67 168.38 63.03 Favored 'Cis proline' 0 N--CA 1.496 1.66 0 CA-C-N 122.041 1.764 . . . . 0.0 111.573 1.325 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' B' B ' 58' ' ' LEU . . . . . . . . . . . . . 26.9 tp -129.23 135.64 49.07 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.137 179.28 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' B' B ' 59' ' ' ARG . . . . . . . . . . . . . 69.8 ttt180 -104.16 124.27 48.8 Favored 'General case' 0 C--N 1.327 -0.388 0 N-CA-C 109.277 -0.638 . . . . 0.0 109.277 177.413 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' B' B ' 60' ' ' VAL . . . . . . . . . . . . . 46.5 t -73.2 115.45 14.1 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.234 0 C-N-CA 120.61 -0.436 . . . . 0.0 110.078 -175.488 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' B' B ' 61' ' ' GLU . . . . . . . . . . . . . 75.0 tt0 -131.02 155.08 47.46 Favored 'General case' 0 C--N 1.329 -0.314 0 N-CA-C 109.152 -0.685 . . . . 0.0 109.152 177.897 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' B' B ' 62' ' ' ASP . . . . . . . . . . . . . 13.6 t70 -52.0 -32.79 35.37 Favored 'General case' 0 C--N 1.327 -0.405 0 N-CA-C 111.946 0.351 . . . . 0.0 111.946 -177.732 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' B' B ' 63' ' ' ARG . . . . . . . . . . . . . 98.6 mtt180 -74.16 -22.14 59.56 Favored 'General case' 0 C--N 1.33 -0.272 0 N-CA-C 113.04 0.756 . . . . 0.0 113.04 -177.185 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' B' B ' 64' ' ' THR . . . . . . . . . . . . . 31.0 m -64.84 136.85 57.34 Favored 'General case' 0 C--N 1.331 -0.226 0 CA-C-O 120.725 0.298 . . . . 0.0 110.57 -176.843 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' B' B ' 65' ' ' LYS . . . . . . . . . . . . . 40.3 ttpt -88.66 124.6 34.24 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-O 121.079 0.466 . . . . 0.0 110.176 -179.976 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' B' B ' 66' ' ' ILE . . . . . . . . . . . . . 69.9 mt -108.09 126.59 64.66 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.298 0 N-CA-C 109.815 -0.439 . . . . 0.0 109.815 -177.906 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' B' B ' 67' ' ' THR . . . . . . . . . . . . . 42.1 m -120.69 139.93 52.34 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.039 -0.528 . . . . 0.0 110.769 -176.422 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' B' B ' 68' ' ' LEU . . . . . . . . . . . . . 19.8 tp . . . . . 0 C--N 1.329 -0.303 0 CA-C-N 115.796 -0.638 . . . . 0.0 110.463 179.749 . . . . . . . . 0 0 . 1 . 017 nuclear orig core ' B' B ' 73' ' ' VAL . . . . . . . . . . . . . 17.2 m . . . . . 0 C--O 1.231 0.081 0 CA-C-O 121.171 0.51 . . . . 0.0 110.78 . . . . . . . . . 0 0 . 1 . 017 nuclear orig core ' B' B ' 74' ' ' ASP . . . . . . . . . . . . . 18.1 t0 -103.43 121.42 42.76 Favored 'General case' 0 C--N 1.328 -0.36 0 N-CA-C 108.955 -0.757 . . . . 0.0 108.955 175.441 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' B' B ' 75' ' ' VAL . . . . . . . . . . . . . 41.8 t -114.86 124.99 72.05 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.225 0 CA-C-O 121.135 0.493 . . . . 0.0 110.954 -175.017 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' B' B ' 76' ' ' LEU . . . . . . . . . . . . . 5.6 mp -125.13 147.37 49.05 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 115.394 -0.821 . . . . 0.0 109.492 175.069 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' B' B ' 77' ' ' GLU . . . . . . . . . . . . . 97.6 mt-10 -133.35 131.23 39.85 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-O 121.053 0.454 . . . . 0.0 111.165 -178.444 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' B' B ' 78' ' ' ALA . . . . . . . . . . . . . . . -117.67 139.08 51.5 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 115.67 -0.696 . . . . 0.0 109.662 176.822 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' B' B ' 79' ' ' LYS . . . . . . . . . . . . . 9.4 mtpm? -87.34 117.88 26.41 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-O 120.948 0.404 . . . . 0.0 110.707 -178.501 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' B' B ' 80' ' ' ILE . . . . . . . . . . . . . 25.2 mm -139.08 114.29 8.45 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.268 0 N-CA-C 108.979 -0.749 . . . . 0.0 108.979 -177.958 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' B' B ' 81' ' ' LYS . . . . . . . . . . . . . 53.8 tttp -103.92 127.3 51.45 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-O 120.812 0.339 . . . . 0.0 111.402 -175.718 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' B' B ' 82' ' ' GLY . . . . . . . . . . . . . . . 89.19 41.98 5.7 Favored Glycine 0 CA--C 1.527 0.843 0 C-N-CA 120.839 -0.696 . . . . 0.0 112.258 173.271 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' B' B ' 83' ' ' ILE . . . . . . . . . . . . . 69.7 mt -73.57 138.91 20.31 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.347 0 N-CA-C 109.571 -0.529 . . . . 0.0 109.571 176.961 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' B' B ' 84' ' ' LYS . . . . . . . . . . . . . 38.5 ttpt -103.52 -49.08 3.78 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-N 116.294 -0.412 . . . . 0.0 110.606 -177.828 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' B' B ' 85' ' ' ASP . . . . . . . . . . . . . 12.2 t70 -144.49 148.51 34.62 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.091 -0.504 . . . . 0.0 110.603 -178.532 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' B' B ' 86' ' ' VAL . . . . . . . . . . . . . 46.4 t -130.38 133.12 64.33 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.247 0 CA-C-O 120.87 0.367 . . . . 0.0 110.428 -179.189 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' B' B ' 87' ' ' ILE . . . . . . . . . . . . . 5.0 mp -122.64 124.38 70.52 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.195 0 CA-C-N 115.935 -0.575 . . . . 0.0 109.522 176.617 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' B' B ' 88' ' ' LEU . . . . . . . . . . . . . 16.0 tp -109.74 129.61 55.6 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-O 120.866 0.365 . . . . 0.0 110.709 -178.629 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' B' B ' 89' ' ' ASP . . . . . . . . . . . . . 13.4 t70 -128.23 155.68 44.16 Favored 'General case' 0 C--N 1.331 -0.215 0 CA-C-N 116.12 -0.491 . . . . 0.0 110.031 178.122 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' B' B ' 90' ' ' GLU . . . . . . . . . . . . . 96.2 mt-10 -47.5 -36.84 10.84 Favored 'General case' 0 C--N 1.328 -0.357 0 N-CA-C 113.055 0.761 . . . . 0.0 113.055 -171.457 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' B' B ' 91' ' ' ASN . . . . . . . . . . . . . 66.0 m-80 -129.01 16.54 6.22 Favored 'General case' 0 N--CA 1.469 0.502 0 N-CA-C 113.285 0.846 . . . . 0.0 113.285 -176.435 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' B' B ' 92' ' ' LEU . . . . . . . . . . . . . 11.4 mt -148.73 144.89 27.37 Favored 'General case' 0 C--N 1.331 -0.198 0 CA-C-O 120.818 0.342 . . . . 0.0 110.248 -176.265 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' B' B ' 93' ' ' ILE . . . . . . . . . . . . . 72.3 mt -121.59 116.43 49.48 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.224 0 N-CA-C 108.838 -0.801 . . . . 0.0 108.838 174.946 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' B' B ' 94' ' ' VAL . . . . . . . . . . . . . 43.9 t -115.7 125.8 73.0 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.294 0 N-CA-C 109.68 -0.489 . . . . 0.0 109.68 -178.084 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' B' B ' 95' ' ' VAL . . . . . . . . . . . . . 41.9 t -120.8 132.74 69.55 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.315 0 CA-C-N 116.065 -0.516 . . . . 0.0 109.681 -179.636 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' B' B ' 96' ' ' ILE . . . . . . . . . . . . . 70.7 mt -114.31 125.27 71.57 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.353 0 N-CA-C 109.228 -0.656 . . . . 0.0 109.228 178.577 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' B' B ' 97' ' ' THR . . . . . . . . . . . . . 54.6 p -96.2 155.29 16.82 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-O 121.164 0.506 . . . . 0.0 111.115 -177.583 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' B' B ' 98' ' ' GLU . . . . . . . . . . . . . 12.6 pt-20 -55.4 -20.67 12.82 Favored 'General case' 0 C--N 1.328 -0.338 0 N-CA-C 112.707 0.632 . . . . 0.0 112.707 -179.396 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' B' B ' 99' ' ' GLU . . . . . . . . . . . . . 12.8 pt-20 -84.56 17.61 2.62 Favored 'General case' 0 CA--C 1.535 0.377 0 N-CA-C 113.117 0.784 . . . . 0.0 113.117 -178.7 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' B' B ' 100' ' ' ASN . . . . . . . . . . . . . 3.1 m-20 62.86 37.95 11.8 Favored 'General case' 0 N--CA 1.462 0.171 0 CA-C-O 121.084 0.468 . . . . 0.0 111.129 177.29 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' B' B ' 101' ' ' GLU . . . . . . . . . . . . . 84.6 tt0 -117.72 141.01 48.88 Favored 'General case' 0 C--N 1.332 -0.158 0 N-CA-C 109.77 -0.456 . . . . 0.0 109.77 175.358 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' B' B ' 102' ' ' VAL . . . . . . . . . . . . . 45.2 t -114.96 127.67 72.42 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.329 0 N-CA-C 109.991 -0.374 . . . . 0.0 109.991 -178.134 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' B' B ' 103' ' ' LEU . . . . . . . . . . . . . 29.4 mt -119.27 133.99 55.45 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 115.762 -0.653 . . . . 0.0 110.19 177.599 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' B' B ' 104' ' ' ILE . . . . . . . . . . . . . 69.8 mt -118.73 121.48 67.05 Favored 'Isoleucine or valine' 0 C--O 1.233 0.215 0 CA-C-N 116.52 -0.309 . . . . 0.0 110.272 -179.449 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' B' B ' 105' ' ' PHE . . . . . . . . . . . . . 90.1 m-85 -118.57 163.31 16.98 Favored 'General case' 0 C--O 1.232 0.143 0 O-C-N 124.116 0.885 . . . . 0.0 109.692 178.442 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' B' B ' 106' ' ' ASN . . . . . . . . . . . . . 44.6 p-10 -101.21 -170.64 1.87 Allowed 'General case' 0 C--N 1.33 -0.276 0 N-CA-C 110.185 -0.302 . . . . 0.0 110.185 174.1 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' B' B ' 107' ' ' GLN . . . . . . . . . . . . . 42.4 tt0 -57.49 -26.89 61.98 Favored 'General case' 0 C--N 1.328 -0.331 0 N-CA-C 112.325 0.491 . . . . 0.0 112.325 179.526 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' B' B ' 108' ' ' ASN . . . . . . . . . . . . . 21.4 t-20 -92.41 13.53 19.26 Favored 'General case' 0 CA--C 1.535 0.396 0 N-CA-C 113.144 0.794 . . . . 0.0 113.144 -176.43 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' B' B ' 109' ' ' LEU . . . . . . . . . . . . . 38.9 mt 57.26 32.92 22.54 Favored 'General case' 0 C--O 1.233 0.22 0 N-CA-C 112.013 0.375 . . . . 0.0 112.013 178.332 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' B' B ' 110' ' ' GLU . . . . . . . . . . . . . 70.7 mm-40 -103.21 140.19 37.69 Favored 'General case' 0 C--N 1.329 -0.303 0 N-CA-C 109.497 -0.557 . . . . 0.0 109.497 175.203 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' B' B ' 111' ' ' GLU . . . . . . . . . . . . . 52.7 tt0 -76.95 121.72 23.87 Favored 'General case' 0 C--N 1.326 -0.418 0 CA-C-N 116.426 -0.352 . . . . 0.0 110.512 -175.698 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' B' B ' 112' ' ' LEU . . . . . . . . . . . . . 85.6 mt -103.09 -45.77 4.83 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.13 -0.487 . . . . 0.0 110.522 178.841 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' B' B ' 113' ' ' TYR . . . . . . . . . . . . . 65.0 t80 -137.87 144.06 41.21 Favored 'General case' 0 C--N 1.331 -0.2 0 CA-C-N 116.188 -0.46 . . . . 0.0 111.29 -178.105 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' B' B ' 114' ' ' ARG . . . . . . . . . . . . . 37.3 ptt180 -145.59 125.47 13.52 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 115.994 -0.548 . . . . 0.0 110.513 177.429 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' B' B ' 115' ' ' GLY . . . . . . . . . . . . . . . -150.22 149.22 21.07 Favored Glycine 0 CA--C 1.525 0.668 0 N-CA-C 111.12 -0.792 . . . . 0.0 111.12 179.467 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' B' B ' 116' ' ' LYS . . . . . . . . . . . . . 7.4 ttpm? -114.49 137.6 51.65 Favored 'General case' 0 C--N 1.33 -0.265 0 N-CA-C 109.661 -0.496 . . . . 0.0 109.661 176.288 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' B' B ' 117' ' ' PHE . . . . . . . . . . . . . 39.0 m-85 -137.02 113.79 10.37 Favored 'General case' 0 C--N 1.329 -0.305 0 N-CA-C 109.962 -0.384 . . . . 0.0 109.962 -179.036 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' B' B ' 118' ' ' GLU . . . . . . . . . . . . . 96.3 mt-10 -57.91 -42.42 84.69 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.332 -0.395 . . . . 0.0 110.742 -176.371 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' B' B ' 119' ' ' ASN . . . . . . . . . . . . . 69.1 m-80 -97.22 31.1 2.55 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.207 -0.451 . . . . 0.0 112.094 -174.707 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' B' B ' 120' ' ' LEU . . . . . . . . . . . . . 24.2 tp -57.1 121.23 9.54 Favored 'General case' 0 C--N 1.333 -0.136 0 C-N-CA 120.944 -0.302 . . . . 0.0 110.429 177.969 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' B' B ' 121' ' ' ASN . . . . . . . . . . . . . 27.2 m-80 -103.43 -43.56 5.38 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.356 -0.384 . . . . 0.0 110.287 -179.556 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' B' B ' 122' ' ' LYS . . . . . . . . . . . . . 53.6 pttt -165.95 152.98 9.87 Favored 'General case' 0 C--N 1.331 -0.222 0 CA-C-O 121.186 0.517 . . . . 0.0 111.892 179.047 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' B' B ' 123' ' ' VAL . . . . . . . . . . . . . 45.1 t -119.71 132.46 69.39 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.261 0 CA-C-N 115.852 -0.613 . . . . 0.0 109.538 177.911 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' B' B ' 124' ' ' LEU . . . . . . . . . . . . . 6.5 mp -119.36 136.42 54.28 Favored 'General case' 0 C--N 1.332 -0.193 0 CA-C-N 116.156 -0.474 . . . . 0.0 110.673 -177.757 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' B' B ' 125' ' ' VAL . . . . . . . . . . . . . 46.0 t -119.2 131.89 70.62 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.273 0 CA-C-N 116.002 -0.545 . . . . 0.0 109.833 178.36 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' B' B ' 126' ' ' ARG . . . . . . . . . . . . . 40.7 mmt180 -133.27 99.14 4.44 Favored 'General case' 0 C--N 1.331 -0.21 0 CA-C-N 116.25 -0.432 . . . . 0.0 110.278 179.12 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' B' B ' 127' ' ' ASN . . . . . . . . . . . . . 34.3 t-20 53.42 -104.89 0.22 Allowed 'General case' 0 CA--C 1.542 0.65 0 CA-C-O 119.02 -0.514 . . . . 0.0 111.157 178.793 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' B' B ' 128' ' ' ASP . . . . . . . . . . . . . 19.5 p-10 -105.86 -3.09 22.3 Favored 'General case' 0 CA--C 1.537 0.468 0 CA-C-N 119.562 1.074 . . . . 0.0 113.684 -175.971 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' B' B ' 129' ' ' LEU . . . . . . . . . . . . . 60.2 mt -105.09 142.84 34.16 Favored 'General case' 0 C--N 1.332 -0.157 0 O-C-N 122.102 -0.374 . . . . 0.0 110.116 178.571 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' B' B ' 130' ' ' VAL . . . . . . . . . . . . . 42.9 t -121.27 135.88 60.02 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.213 0 N-CA-C 110.016 -0.365 . . . . 0.0 110.016 -178.582 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' B' B ' 131' ' ' VAL . . . . . . . . . . . . . 39.6 t -133.13 133.34 58.47 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.278 0 CA-C-O 120.932 0.396 . . . . 0.0 110.275 179.479 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' B' B ' 132' ' ' ILE . . . . . . . . . . . . . 73.1 mt -114.06 130.17 68.73 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.363 0 N-CA-C 109.263 -0.643 . . . . 0.0 109.263 178.604 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' B' B ' 133' ' ' ILE . . . . . . . . . . . . . 42.3 mm -111.98 119.61 60.46 Favored 'Isoleucine or valine' 0 C--O 1.234 0.247 0 CA-C-O 120.877 0.37 . . . . 0.0 110.878 -176.095 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' B' B ' 134' ' ' ASP . . . . . . . . . . . . . 7.4 p-10 -132.88 143.56 49.59 Favored 'General case' 0 C--N 1.33 -0.246 0 N-CA-C 109.312 -0.625 . . . . 0.0 109.312 175.449 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' B' B ' 135' ' ' GLU . . . . . . . . . . . . . 77.7 tt0 -49.99 -25.77 3.64 Favored 'General case' 0 C--N 1.327 -0.389 0 N-CA-C 112.697 0.629 . . . . 0.0 112.697 -174.599 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' B' B ' 136' ' ' GLN . . . . . . . . . . . . . 47.7 tt0 -85.54 -31.42 22.71 Favored 'General case' 0 C--O 1.233 0.192 0 N-CA-C 112.386 0.513 . . . . 0.0 112.386 -175.388 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' B' B ' 137' ' ' LYS . . . . . . . . . . . . . 18.2 ptpt -164.7 174.06 11.17 Favored 'General case' 0 C--O 1.233 0.205 0 CA-C-O 121.64 0.733 . . . . 0.0 112.193 -175.359 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' B' B ' 138' ' ' LEU . . . . . . . . . . . . . 6.5 tt -119.5 128.87 54.37 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 114.938 -1.028 . . . . 0.0 109.504 176.418 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' B' B ' 139' ' ' THR . . . . . . . . . . . . . 25.4 m -108.1 126.0 52.24 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.315 -0.402 . . . . 0.0 110.467 -179.933 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' B' B ' 140' ' ' LEU . . . . . . . . . . . . . 17.2 tp -112.95 119.9 39.55 Favored 'General case' 0 C--N 1.331 -0.209 0 CA-C-N 115.791 -0.64 . . . . 0.0 109.304 -178.926 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' B' B ' 141' ' ' ILE . . . . . . . . . . . . . 19.2 mt -119.16 123.19 70.93 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.289 0 CA-C-O 120.884 0.373 . . . . 0.0 110.118 -173.845 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' B' B ' 142' ' ' ARG . . . . . . . . . . . . . 72.7 mtt180 -108.79 127.58 54.14 Favored 'General case' 0 C--N 1.331 -0.239 0 CA-C-N 115.439 -0.801 . . . . 0.0 110.027 -176.301 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' B' B ' 143' ' ' THR . . . . . . . . . . . . . 52.9 p . . . . . 0 C--O 1.221 -0.442 0 CA-C-O 117.992 -1.004 . . . . 0.0 110.576 179.804 . . . . . . . . 0 0 . 1 . 017 nuclear orig core ' C' C ' 2' ' ' SER . . . . . . . . . . . . . 55.2 p . . . . . 0 N--CA 1.461 0.112 0 CA-C-O 120.888 0.375 . . . . 0.0 110.554 . . . . . . . . . 0 0 . 1 . 017 nuclear orig core ' C' C ' 3' ' ' GLU . . . . . . . . . . . . . 42.7 mt-10 -140.37 141.07 35.64 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.039 -0.528 . . . . 0.0 111.013 -178.458 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' C' C ' 4' ' ' LEU . . . . . . . . . . . . . 19.0 tp -124.27 128.28 48.92 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 115.808 -0.633 . . . . 0.0 109.976 176.19 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' C' C ' 5' ' ' LYS . . . . . . . . . . . . . 99.1 mttt -110.36 123.43 49.83 Favored 'General case' 0 C--O 1.234 0.254 0 CA-C-O 120.672 0.272 . . . . 0.0 110.929 179.877 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' C' C ' 6' ' ' LEU . . . . . . . . . . . . . 52.4 mt -114.61 145.62 41.77 Favored 'General case' 0 C--N 1.332 -0.185 0 CA-C-N 115.559 -0.746 . . . . 0.0 110.146 178.586 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' C' C ' 7' ' ' LYS . . . . . . . . . . . . . 35.7 ttpt -127.36 141.41 40.78 Favored Pre-proline 0 CA--C 1.533 0.319 0 CA-C-O 119.071 -0.49 . . . . 0.0 109.711 175.286 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' C' C ' 8' ' ' PRO . . . . . . . . . . . . . 91.7 Cg_endo -91.69 138.56 2.1 Favored 'Trans proline' 0 N--CA 1.489 1.211 0 C-N-CA 121.718 1.612 . . . . 0.0 112.129 179.255 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' C' C ' 9' ' ' LEU . . . . . . . . . . . . . 67.8 mt -78.19 -47.16 2.12 Favored Pre-proline 0 C--N 1.329 -0.312 0 CA-C-O 118.714 -0.66 . . . . 0.0 111.826 178.189 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' C' C ' 10' ' ' PRO . . . . . . . . . . . . . 85.5 Cg_endo -81.14 151.61 18.19 Favored 'Trans proline' 0 N--CA 1.495 1.613 0 C-N-CA 121.14 1.226 . . . . 0.0 111.536 174.58 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' C' C ' 11' ' ' LYS . . . . . . . . . . . . . 66.7 tttt -88.33 98.85 11.82 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-O 120.836 0.351 . . . . 0.0 110.194 178.712 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' C' C ' 12' ' ' VAL . . . . . . . . . . . . . 13.2 p -140.03 147.14 23.93 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.285 0 CA-C-N 116.29 -0.414 . . . . 0.0 110.727 -178.463 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' C' C ' 13' ' ' GLU . . . . . . . . . . . . . 84.1 tt0 -88.96 123.82 33.66 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.21 -0.45 . . . . 0.0 109.908 176.978 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' C' C ' 14' ' ' LEU . . . . . . . . . . . . . 22.2 mt -98.14 152.29 37.94 Favored Pre-proline 0 C--N 1.329 -0.299 0 CA-C-N 116.402 -0.363 . . . . 0.0 110.84 -177.189 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' C' C ' 15' ' ' PRO . . . . . . . . . . . . . 25.6 Cg_exo -62.31 157.02 47.6 Favored 'Trans proline' 0 N--CA 1.498 1.761 0 C-N-CA 121.261 1.308 . . . . 0.0 111.713 176.116 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' C' C ' 16' ' ' PRO . . . . . . . . . . . . . 39.5 Cg_exo -58.72 -36.47 97.08 Favored 'Trans proline' 0 N--CA 1.498 1.776 0 C-N-CA 121.389 1.393 . . . . 0.0 112.65 -179.533 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' C' C ' 17' ' ' ASP . . . . . . . . . . . . . 16.6 p-10 -85.66 7.94 21.46 Favored 'General case' 0 CA--C 1.535 0.393 0 N-CA-C 113.23 0.826 . . . . 0.0 113.23 -177.641 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' C' C ' 18' ' ' PHE . . . . . . . . . . . . . 43.9 t80 -58.09 -46.8 84.89 Favored 'General case' 0 N--CA 1.456 -0.126 0 O-C-N 121.983 -0.448 . . . . 0.0 110.285 -176.876 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' C' C ' 19' ' ' VAL . . . . . . . . . . . . . 14.7 p -55.48 -41.76 64.72 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.288 0 CA-C-N 116.523 -0.308 . . . . 0.0 111.029 -178.019 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' C' C ' 20' ' ' ASP . . . . . . . . . . . . . 78.3 m-20 -61.4 -44.44 97.14 Favored 'General case' 0 C--N 1.329 -0.286 0 C-N-CA 120.935 -0.306 . . . . 0.0 111.231 -178.198 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' C' C ' 21' ' ' VAL . . . . . . . . . . . . . 47.6 t -64.11 -45.22 97.12 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.287 0 C-N-CA 120.715 -0.394 . . . . 0.0 110.447 -176.953 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' C' C ' 22' ' ' ILE . . . . . . . . . . . . . 51.0 mm -56.5 -46.25 82.27 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.227 0 C-N-CA 120.872 -0.331 . . . . 0.0 110.55 178.614 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' C' C ' 23' ' ' ARG . . . . . . . . . . . . . 56.1 ttp180 -54.89 -46.75 74.84 Favored 'General case' 0 C--N 1.329 -0.302 0 C-N-CA 121.057 -0.257 . . . . 0.0 111.384 -179.269 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' C' C ' 24' ' ' ILE . . . . . . . . . . . . . 79.7 mt -59.58 -43.87 91.97 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.303 0 C-N-CA 121.075 -0.25 . . . . 0.0 111.246 -177.987 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' C' C ' 25' ' ' LYS . . . . . . . . . . . . . 97.4 mttt -66.01 -42.1 90.12 Favored 'General case' 0 C--N 1.328 -0.361 0 N-CA-C 112.504 0.557 . . . . 0.0 112.504 -178.878 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' C' C ' 26' ' ' LEU . . . . . . . . . . . . . 93.0 mt -77.91 -38.79 44.88 Favored 'General case' 0 C--N 1.33 -0.254 0 N-CA-C 113.216 0.821 . . . . 0.0 113.216 -170.833 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' C' C ' 27' ' ' GLN . . . . . . . . . . . . . 9.9 pt20 -47.19 139.94 5.66 Favored 'General case' 0 N--CA 1.469 0.521 0 N-CA-C 112.709 0.633 . . . . 0.0 112.709 -176.137 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' C' C ' 28' ' ' GLY . . . . . . . . . . . . . . . 100.61 -26.15 25.69 Favored Glycine 0 CA--C 1.534 1.269 0 CA-C-N 115.598 -0.728 . . . . 0.0 112.14 -176.3 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' C' C ' 29' ' ' LYS . . . . . . . . . . . . . 37.9 mtmm -98.79 155.02 17.57 Favored 'General case' 0 C--N 1.332 -0.181 0 CA-C-N 117.295 0.547 . . . . 0.0 111.292 179.115 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' C' C ' 30' ' ' THR . . . . . . . . . . . . . 50.1 m -107.84 136.45 47.55 Favored 'General case' 0 C--N 1.332 -0.19 0 CA-C-N 116.147 -0.479 . . . . 0.0 109.991 176.349 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' C' C ' 31' ' ' VAL . . . . . . . . . . . . . 34.9 m -132.2 162.16 40.16 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.247 0 CA-C-N 116.302 -0.408 . . . . 0.0 111.036 -178.347 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' C' C ' 32' ' ' ARG . . . . . . . . . . . . . 81.6 mtt180 -132.29 152.43 51.38 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 115.989 -0.551 . . . . 0.0 110.591 178.654 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' C' C ' 33' ' ' THR . . . . . . . . . . . . . 28.8 m -53.61 140.18 29.63 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.299 -0.41 . . . . 0.0 111.237 -179.313 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' C' C ' 34' ' ' GLY . . . . . . . . . . . . . . . 100.49 -17.16 57.12 Favored Glycine 0 CA--C 1.532 1.139 0 CA-C-O 119.589 -0.562 . . . . 0.0 113.17 179.755 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' C' C ' 35' ' ' ASP . . . . . . . . . . . . . 72.1 m-20 -65.98 149.69 49.83 Favored 'General case' 0 N--CA 1.461 0.123 0 CA-C-N 118.127 0.963 . . . . 0.0 111.151 178.79 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' C' C ' 36' ' ' VAL . . . . . . . . . . . . . 43.5 t -122.6 130.82 74.23 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.213 0 CA-C-N 115.968 -0.56 . . . . 0.0 109.934 178.9 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' C' C ' 37' ' ' ILE . . . . . . . . . . . . . 69.3 mt -122.53 140.55 45.99 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.205 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.093 -178.928 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' C' C ' 38' ' ' GLY . . . . . . . . . . . . . . . -115.7 128.73 8.17 Favored Glycine 0 CA--C 1.525 0.708 0 N-CA-C 111.177 -0.769 . . . . 0.0 111.177 179.42 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' C' C ' 39' ' ' ILE . . . . . . . . . . . . . 72.9 mt -125.9 135.69 63.12 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.306 0 N-CA-C 110.136 -0.32 . . . . 0.0 110.136 179.245 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' C' C ' 40' ' ' SER . . . . . . . . . . . . . 9.7 t -93.32 114.08 26.43 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.343 -0.389 . . . . 0.0 111.132 177.268 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' C' C ' 41' ' ' ILE . . . . . . . . . . . . . 45.8 mm -122.58 119.55 58.46 Favored 'Isoleucine or valine' 0 CA--C 1.529 0.153 0 N-CA-C 110.07 -0.344 . . . . 0.0 110.07 178.758 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' C' C ' 42' ' ' LEU . . . . . . . . . . . . . 41.3 mt 57.39 34.06 24.15 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.394 -0.366 . . . . 0.0 111.916 177.479 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' C' C ' 43' ' ' GLY . . . . . . . . . . . . . . . 79.32 -10.13 37.37 Favored Glycine 0 CA--C 1.535 1.325 0 C-N-CA 121.271 -0.49 . . . . 0.0 113.485 177.312 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' C' C ' 44' ' ' LYS . . . . . . . . . . . . . 64.0 mmtt -100.46 134.72 42.99 Favored 'General case' 0 C--N 1.332 -0.156 0 CA-C-N 117.887 0.844 . . . . 0.0 110.079 175.878 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' C' C ' 45' ' ' GLU . . . . . . . . . . . . . 84.0 tt0 -85.18 131.57 34.41 Favored 'General case' 0 C--N 1.326 -0.425 0 CA-C-N 116.455 -0.339 . . . . 0.0 111.159 -179.279 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' C' C ' 46' ' ' VAL . . . . . . . . . . . . . 9.5 p -120.97 125.77 74.41 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.189 0 N-CA-C 109.585 -0.524 . . . . 0.0 109.585 174.428 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' C' C ' 47' ' ' LYS . . . . . . . . . . . . . 82.8 mttt -98.8 125.96 44.31 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 115.993 -0.549 . . . . 0.0 110.524 177.83 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' C' C ' 48' ' ' PHE . . . . . . . . . . . . . 31.0 m-85 -110.53 131.91 54.64 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.359 -0.382 . . . . 0.0 110.175 178.293 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' C' C ' 49' ' ' LYS . . . . . . . . . . . . . 58.5 tttt -105.92 132.42 52.05 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.251 -0.431 . . . . 0.0 109.97 177.677 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' C' C ' 50' ' ' VAL . . . . . . . . . . . . . 46.0 t -75.74 104.98 4.29 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.247 0 N-CA-C 109.14 -0.689 . . . . 0.0 109.14 176.552 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' C' C ' 51' ' ' VAL . . . . . . . . . . . . . 47.3 t -69.17 -48.51 68.43 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.324 0 CA-C-N 116.085 -0.507 . . . . 0.0 109.925 -173.418 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' C' C ' 52' ' ' GLN . . . . . . . . . . . . . 46.9 tt0 -168.33 146.83 4.34 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 115.95 -0.568 . . . . 0.0 111.381 -178.706 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' C' C ' 53' ' ' ALA . . . . . . . . . . . . . . . -122.61 136.54 54.91 Favored 'General case' 0 C--N 1.331 -0.209 0 CA-C-N 115.842 -0.617 . . . . 0.0 110.109 177.032 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' C' C ' 54' ' ' TYR . . . . . . . . . . . . . 58.3 t80 -129.12 112.11 18.37 Favored Pre-proline 0 CA--C 1.534 0.329 0 CA-C-O 118.081 -0.961 . . . . 0.0 110.202 177.55 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' C' C ' 55' ' ' PRO . . . . . . . . . . . . . 72.8 Cg_endo -77.31 170.14 72.16 Favored 'Cis proline' 0 N--CA 1.499 1.829 0 CA-C-N 122.015 1.755 . . . . 0.0 112.337 -6.283 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' C' C ' 56' ' ' SER . . . . . . . . . . . . . 25.5 m -122.25 135.65 25.67 Favored Pre-proline 0 CA--C 1.538 0.491 0 CA-C-O 118.513 -0.756 . . . . 0.0 109.537 175.049 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' C' C ' 57' ' ' PRO . . . . . . . . . . . . . 34.9 Cg_endo -66.29 160.85 75.13 Favored 'Cis proline' 0 N--CA 1.499 1.799 0 CA-C-N 121.864 1.701 . . . . 0.0 111.525 -2.839 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' C' C ' 58' ' ' LEU . . . . . . . . . . . . . 30.3 tp -127.57 136.4 51.64 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-O 121.118 0.485 . . . . 0.0 110.713 -178.101 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' C' C ' 59' ' ' ARG . . . . . . . . . . . . . 20.7 ttm180 -103.01 122.52 44.78 Favored 'General case' 0 C--N 1.327 -0.411 0 N-CA-C 108.919 -0.771 . . . . 0.0 108.919 173.936 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' C' C ' 60' ' ' VAL . . . . . . . . . . . . . 39.9 t -77.72 120.81 29.09 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.323 0 C-N-CA 120.561 -0.456 . . . . 0.0 110.349 -173.647 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' C' C ' 61' ' ' GLU . . . . . . . . . . . . . 96.3 mt-10 -131.13 165.5 23.15 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 115.679 -0.691 . . . . 0.0 109.567 176.807 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' C' C ' 62' ' ' ASP . . . . . . . . . . . . . 7.8 p-10 -53.09 -31.25 40.9 Favored 'General case' 0 C--N 1.329 -0.325 0 N-CA-C 111.912 0.338 . . . . 0.0 111.912 179.816 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' C' C ' 63' ' ' ARG . . . . . . . . . . . . . 87.6 mtt180 -71.77 -22.1 61.64 Favored 'General case' 0 CA--C 1.533 0.293 0 N-CA-C 112.962 0.727 . . . . 0.0 112.962 -176.307 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' C' C ' 64' ' ' THR . . . . . . . . . . . . . 32.9 m -74.48 136.6 42.26 Favored 'General case' 0 C--N 1.332 -0.192 0 CA-C-O 120.918 0.389 . . . . 0.0 110.832 -175.956 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' C' C ' 65' ' ' LYS . . . . . . . . . . . . . 96.0 mttt -89.36 133.88 34.31 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.023 -0.535 . . . . 0.0 109.977 179.013 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' C' C ' 66' ' ' ILE . . . . . . . . . . . . . 65.3 mt -115.48 130.56 69.87 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.266 0 N-CA-C 109.976 -0.379 . . . . 0.0 109.976 179.739 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' C' C ' 67' ' ' THR . . . . . . . . . . . . . 23.8 m -122.54 138.42 54.58 Favored 'General case' 0 C--N 1.331 -0.214 0 CA-C-N 115.929 -0.578 . . . . 0.0 110.516 -179.071 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' C' C ' 68' ' ' LEU . . . . . . . . . . . . . 5.8 tt . . . . . 0 C--N 1.33 -0.267 0 CA-C-N 115.959 -0.564 . . . . 0.0 110.173 178.795 . . . . . . . . 0 0 . 1 . 017 nuclear orig core ' C' C ' 73' ' ' VAL . . . . . . . . . . . . . 34.0 m . . . . . 0 C--O 1.231 0.094 0 CA-C-O 120.894 0.378 . . . . 0.0 110.871 . . . . . . . . . 0 0 . 1 . 017 nuclear orig core ' C' C ' 74' ' ' ASP . . . . . . . . . . . . . 8.0 t70 -103.84 126.03 50.68 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.105 -0.498 . . . . 0.0 109.737 179.993 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' C' C ' 75' ' ' VAL . . . . . . . . . . . . . 40.5 t -121.13 127.95 75.95 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.345 0 CA-C-O 121.169 0.509 . . . . 0.0 110.957 -176.633 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' C' C ' 76' ' ' LEU . . . . . . . . . . . . . 5.2 mp -121.47 144.67 48.56 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 115.488 -0.778 . . . . 0.0 109.523 174.244 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' C' C ' 77' ' ' GLU . . . . . . . . . . . . . 47.1 mt-10 -133.92 137.84 45.15 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-O 121.033 0.444 . . . . 0.0 111.127 -177.629 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' C' C ' 78' ' ' ALA . . . . . . . . . . . . . . . -125.79 128.61 47.96 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 115.78 -0.646 . . . . 0.0 109.707 176.477 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' C' C ' 79' ' ' LYS . . . . . . . . . . . . . 54.1 mtmt -77.45 122.72 25.59 Favored 'General case' 0 C--N 1.331 -0.214 0 CA-C-O 121.044 0.449 . . . . 0.0 110.667 -178.327 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' C' C ' 80' ' ' ILE . . . . . . . . . . . . . 39.4 mm -139.05 114.16 8.36 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.356 0 N-CA-C 109.178 -0.675 . . . . 0.0 109.178 -177.779 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' C' C ' 81' ' ' LYS . . . . . . . . . . . . . 31.8 ttpt -101.4 121.99 42.92 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-O 120.821 0.343 . . . . 0.0 111.002 -177.461 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' C' C ' 82' ' ' GLY . . . . . . . . . . . . . . . 89.12 42.23 5.65 Favored Glycine 0 CA--C 1.527 0.786 0 C-N-CA 120.683 -0.77 . . . . 0.0 111.91 174.246 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' C' C ' 83' ' ' ILE . . . . . . . . . . . . . 73.4 mt -67.74 131.91 32.87 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.341 0 N-CA-C 109.468 -0.567 . . . . 0.0 109.468 175.944 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' C' C ' 84' ' ' LYS . . . . . . . . . . . . . 72.8 tttt -88.84 -53.26 4.69 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-O 121.046 0.451 . . . . 0.0 110.181 -178.22 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' C' C ' 85' ' ' ASP . . . . . . . . . . . . . 11.5 t70 -155.85 152.96 29.0 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 115.626 -0.715 . . . . 0.0 110.146 179.201 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' C' C ' 86' ' ' VAL . . . . . . . . . . . . . 46.6 t -128.65 130.59 68.9 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.252 0 CA-C-O 120.961 0.41 . . . . 0.0 110.564 -178.475 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' C' C ' 87' ' ' ILE . . . . . . . . . . . . . 45.0 mm -119.58 126.54 75.42 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.303 0 CA-C-N 115.781 -0.645 . . . . 0.0 109.612 177.453 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' C' C ' 88' ' ' LEU . . . . . . . . . . . . . 86.5 mt -111.15 139.34 46.61 Favored 'General case' 0 C--N 1.331 -0.214 0 CA-C-O 121.152 0.501 . . . . 0.0 111.286 -178.151 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' C' C ' 89' ' ' ASP . . . . . . . . . . . . . 46.8 t0 -130.57 162.94 28.18 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 115.462 -0.79 . . . . 0.0 109.457 176.864 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' C' C ' 90' ' ' GLU . . . . . . . . . . . . . 45.5 tp10 -44.99 -44.51 9.96 Favored 'General case' 0 N--CA 1.465 0.293 0 N-CA-C 113.222 0.823 . . . . 0.0 113.222 -170.874 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' C' C ' 91' ' ' ASN . . . . . . . . . . . . . 31.0 m120 -132.12 26.41 4.55 Favored 'General case' 0 N--CA 1.467 0.381 0 N-CA-C 112.473 0.546 . . . . 0.0 112.473 -178.478 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' C' C ' 92' ' ' LEU . . . . . . . . . . . . . 36.5 mt -146.58 144.87 29.86 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-O 120.736 0.303 . . . . 0.0 110.51 -176.931 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' C' C ' 93' ' ' ILE . . . . . . . . . . . . . 65.3 mt -124.18 115.07 43.75 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.311 0 N-CA-C 109.104 -0.702 . . . . 0.0 109.104 177.505 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' C' C ' 94' ' ' VAL . . . . . . . . . . . . . 46.6 t -115.89 126.4 73.39 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.218 0 N-CA-C 109.763 -0.458 . . . . 0.0 109.763 -179.382 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' C' C ' 95' ' ' VAL . . . . . . . . . . . . . 43.2 t -121.18 133.72 66.86 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.372 0 CA-C-N 116.047 -0.524 . . . . 0.0 109.935 -178.893 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' C' C ' 96' ' ' ILE . . . . . . . . . . . . . 67.8 mt -110.14 124.52 66.95 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.317 0 N-CA-C 108.939 -0.763 . . . . 0.0 108.939 177.637 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' C' C ' 97' ' ' THR . . . . . . . . . . . . . 82.7 p -97.8 155.01 17.23 Favored 'General case' 0 C--N 1.327 -0.395 0 CA-C-O 121.059 0.457 . . . . 0.0 111.025 -177.176 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' C' C ' 98' ' ' GLU . . . . . . . . . . . . . 84.2 tt0 -53.79 -23.22 11.36 Favored 'General case' 0 C--N 1.327 -0.399 0 N-CA-C 112.379 0.511 . . . . 0.0 112.379 -179.835 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' C' C ' 99' ' ' GLU . . . . . . . . . . . . . 68.9 mm-40 -82.26 15.05 2.58 Favored 'General case' 0 CA--C 1.536 0.412 0 N-CA-C 113.2 0.815 . . . . 0.0 113.2 -176.569 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' C' C ' 100' ' ' ASN . . . . . . . . . . . . . 3.0 m-20 62.83 33.5 15.18 Favored 'General case' 0 N--CA 1.465 0.276 0 CA-C-O 120.914 0.387 . . . . 0.0 111.535 179.336 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' C' C ' 101' ' ' GLU . . . . . . . . . . . . . 84.9 tt0 -113.12 145.88 40.17 Favored 'General case' 0 C--N 1.331 -0.225 0 N-CA-C 109.639 -0.504 . . . . 0.0 109.639 174.144 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' C' C ' 102' ' ' VAL . . . . . . . . . . . . . 44.9 t -114.87 123.56 70.68 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.316 0 N-CA-C 109.717 -0.475 . . . . 0.0 109.717 -178.484 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' C' C ' 103' ' ' LEU . . . . . . . . . . . . . 35.5 mt -115.29 132.74 56.52 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 115.804 -0.634 . . . . 0.0 109.82 178.888 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' C' C ' 104' ' ' ILE . . . . . . . . . . . . . 64.6 mt -123.86 121.56 62.54 Favored 'Isoleucine or valine' 0 C--O 1.234 0.248 0 N-CA-C 110.432 -0.21 . . . . 0.0 110.432 -179.241 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' C' C ' 105' ' ' PHE . . . . . . . . . . . . . 61.8 m-85 -118.91 165.29 14.25 Favored 'General case' 0 C--N 1.33 -0.254 0 O-C-N 124.104 0.878 . . . . 0.0 109.617 178.561 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' C' C ' 106' ' ' ASN . . . . . . . . . . . . . 40.9 p-10 -101.21 -169.9 1.76 Allowed 'General case' 0 C--N 1.33 -0.25 0 N-CA-C 109.857 -0.423 . . . . 0.0 109.857 173.627 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' C' C ' 107' ' ' GLN . . . . . . . . . . . . . 49.2 tt0 -56.42 -29.69 61.89 Favored 'General case' 0 CA--C 1.534 0.332 0 N-CA-C 111.823 0.305 . . . . 0.0 111.823 176.744 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' C' C ' 108' ' ' ASN . . . . . . . . . . . . . 8.0 t-20 -84.35 9.57 12.81 Favored 'General case' 0 CA--C 1.536 0.43 0 N-CA-C 113.205 0.816 . . . . 0.0 113.205 -176.684 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' C' C ' 109' ' ' LEU . . . . . . . . . . . . . 8.0 tp 56.05 36.55 27.59 Favored 'General case' 0 C--N 1.332 -0.167 0 CA-C-O 120.923 0.392 . . . . 0.0 111.339 179.442 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' C' C ' 110' ' ' GLU . . . . . . . . . . . . . 70.5 mm-40 -107.79 150.29 27.17 Favored 'General case' 0 C--N 1.333 -0.141 0 N-CA-C 110.07 -0.344 . . . . 0.0 110.07 176.876 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' C' C ' 111' ' ' GLU . . . . . . . . . . . . . 98.0 mt-10 -77.16 122.29 24.8 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-O 120.876 0.37 . . . . 0.0 111.051 -178.296 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' C' C ' 112' ' ' LEU . . . . . . . . . . . . . 17.9 mt -108.62 -46.0 3.75 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 115.988 -0.551 . . . . 0.0 110.388 177.08 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' C' C ' 113' ' ' TYR . . . . . . . . . . . . . 59.6 t80 -136.75 137.68 40.13 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.359 -0.382 . . . . 0.0 111.048 179.943 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' C' C ' 114' ' ' ARG . . . . . . . . . . . . . 72.4 mtm180 -141.44 122.08 14.25 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 115.998 -0.546 . . . . 0.0 110.482 178.111 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' C' C ' 115' ' ' GLY . . . . . . . . . . . . . . . -150.11 160.91 28.73 Favored Glycine 0 CA--C 1.525 0.708 0 N-CA-C 111.03 -0.828 . . . . 0.0 111.03 178.572 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' C' C ' 116' ' ' LYS . . . . . . . . . . . . . 72.5 tttt -134.27 133.43 40.79 Favored 'General case' 0 C--N 1.33 -0.266 0 N-CA-C 110.021 -0.363 . . . . 0.0 110.021 179.27 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' C' C ' 117' ' ' PHE . . . . . . . . . . . . . 31.2 m-85 -133.06 123.15 25.25 Favored 'General case' 0 C--N 1.331 -0.202 0 CA-C-O 120.932 0.396 . . . . 0.0 110.363 -174.457 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' C' C ' 118' ' ' GLU . . . . . . . . . . . . . 43.4 mt-10 -53.77 -48.54 69.65 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.459 -0.337 . . . . 0.0 111.4 -176.49 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' C' C ' 119' ' ' ASN . . . . . . . . . . . . . 67.5 m-80 -98.57 31.03 3.01 Favored 'General case' 0 C--N 1.329 -0.321 0 N-CA-C 112.255 0.465 . . . . 0.0 112.255 -174.098 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' C' C ' 120' ' ' LEU . . . . . . . . . . . . . 18.4 tp -56.6 120.27 7.49 Favored 'General case' 0 N--CA 1.462 0.15 0 C-N-CA 121.04 -0.264 . . . . 0.0 110.325 177.888 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' C' C ' 121' ' ' ASN . . . . . . . . . . . . . 9.8 t-20 -109.42 -44.03 3.98 Favored 'General case' 0 C--N 1.331 -0.219 0 CA-C-N 116.58 -0.282 . . . . 0.0 111.192 -175.646 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' C' C ' 122' ' ' LYS . . . . . . . . . . . . . 15.9 ptpt -154.77 153.54 31.39 Favored 'General case' 0 C--N 1.332 -0.187 0 CA-C-O 121.286 0.565 . . . . 0.0 112.019 -178.291 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' C' C ' 123' ' ' VAL . . . . . . . . . . . . . 45.6 t -121.68 130.89 74.2 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.224 0 CA-C-N 115.698 -0.683 . . . . 0.0 109.474 176.223 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' C' C ' 124' ' ' LEU . . . . . . . . . . . . . 6.2 mp -121.4 140.02 52.69 Favored 'General case' 0 C--N 1.331 -0.215 0 CA-C-N 116.319 -0.401 . . . . 0.0 110.635 -178.05 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' C' C ' 125' ' ' VAL . . . . . . . . . . . . . 35.2 m -134.78 140.12 46.16 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.258 0 CA-C-N 116.334 -0.394 . . . . 0.0 110.453 178.237 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' C' C ' 126' ' ' ARG . . . . . . . . . . . . . 52.5 ttt85 -149.13 118.69 6.95 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-O 120.907 0.384 . . . . 0.0 110.615 178.322 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' C' C ' 127' ' ' ASN . . . . . . . . . . . . . 35.7 t30 50.83 -104.95 0.18 Allowed 'General case' 0 CA--C 1.542 0.668 0 CA-C-N 116.144 -0.48 . . . . 0.0 111.572 179.862 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' C' C ' 128' ' ' ASP . . . . . . . . . . . . . 11.8 p-10 -110.61 -0.17 17.34 Favored 'General case' 0 CA--C 1.536 0.413 0 CA-C-N 119.501 1.046 . . . . 0.0 113.658 -175.043 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' C' C ' 129' ' ' LEU . . . . . . . . . . . . . 88.0 mt -106.35 142.73 35.54 Favored 'General case' 0 C--O 1.232 0.138 0 CA-C-N 118.186 0.448 . . . . 0.0 110.838 -179.451 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' C' C ' 130' ' ' VAL . . . . . . . . . . . . . 47.0 t -122.04 135.91 60.63 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.302 0 N-CA-C 109.619 -0.511 . . . . 0.0 109.619 178.625 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' C' C ' 131' ' ' VAL . . . . . . . . . . . . . 42.9 t -133.48 137.1 53.64 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.269 0 CA-C-O 121.018 0.437 . . . . 0.0 110.624 -178.726 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' C' C ' 132' ' ' ILE . . . . . . . . . . . . . 74.3 mt -115.61 130.46 70.21 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.304 0 CA-C-N 115.642 -0.708 . . . . 0.0 109.262 178.762 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' C' C ' 133' ' ' ILE . . . . . . . . . . . . . 43.7 mm -116.62 121.32 67.4 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.215 0 CA-C-O 120.774 0.321 . . . . 0.0 111.04 -175.447 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' C' C ' 134' ' ' ASP . . . . . . . . . . . . . 8.2 p-10 -136.11 144.3 45.03 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 115.878 -0.601 . . . . 0.0 109.443 173.756 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' C' C ' 135' ' ' GLU . . . . . . . . . . . . . 42.2 tp10 -49.81 -23.85 2.08 Favored 'General case' 0 C--N 1.327 -0.395 0 N-CA-C 112.724 0.639 . . . . 0.0 112.724 -172.226 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' C' C ' 136' ' ' GLN . . . . . . . . . . . . . 50.5 tt0 -93.13 -36.77 12.48 Favored 'General case' 0 C--O 1.233 0.2 0 N-CA-C 112.082 0.401 . . . . 0.0 112.082 -176.468 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' C' C ' 137' ' ' LYS . . . . . . . . . . . . . 89.9 mttt -140.12 155.06 47.15 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-O 121.251 0.548 . . . . 0.0 111.648 -171.185 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' C' C ' 138' ' ' LEU . . . . . . . . . . . . . 5.2 tt -117.8 123.54 46.22 Favored 'General case' 0 C--N 1.329 -0.321 0 N-CA-C 108.881 -0.785 . . . . 0.0 108.881 171.544 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' C' C ' 139' ' ' THR . . . . . . . . . . . . . 31.2 m -113.35 131.11 56.09 Favored 'General case' 0 C--N 1.331 -0.215 0 CA-C-O 120.875 0.369 . . . . 0.0 111.05 -176.353 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' C' C ' 140' ' ' LEU . . . . . . . . . . . . . 6.8 tt -116.61 122.67 45.3 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 115.333 -0.849 . . . . 0.0 108.914 -179.407 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' C' C ' 141' ' ' ILE . . . . . . . . . . . . . 19.5 mt -119.81 120.41 63.21 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.276 0 CA-C-O 120.929 0.395 . . . . 0.0 110.02 -176.239 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' C' C ' 142' ' ' ARG . . . . . . . . . . . . . 57.6 mtp180 . . . . . 0 C--N 1.331 -0.212 0 CA-C-N 115.431 -0.804 . . . . 0.0 110.014 179.319 . . . . . . . . 0 0 . 1 . 017 nuclear orig core ' D' D ' 2' ' ' SER . . . . . . . . . . . . . 2.9 p . . . . . 0 C--O 1.232 0.137 0 CA-C-O 120.833 0.349 . . . . 0.0 110.616 . . . . . . . . . 0 0 . 1 . 017 nuclear orig core ' D' D ' 3' ' ' GLU . . . . . . . . . . . . . 94.3 mt-10 -141.19 139.82 33.91 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.12 -0.491 . . . . 0.0 111.158 -178.798 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' D' D ' 4' ' ' LEU . . . . . . . . . . . . . 21.7 tp -123.27 128.96 50.69 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 115.869 -0.605 . . . . 0.0 109.763 174.799 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' D' D ' 5' ' ' LYS . . . . . . . . . . . . . 94.8 mttt -112.75 121.6 45.2 Favored 'General case' 0 C--O 1.235 0.302 0 CA-C-O 120.897 0.38 . . . . 0.0 111.014 -177.95 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' D' D ' 6' ' ' LEU . . . . . . . . . . . . . 61.9 mt -114.94 142.17 46.97 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-N 115.225 -0.898 . . . . 0.0 110.274 -179.185 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' D' D ' 7' ' ' LYS . . . . . . . . . . . . . 44.7 tttm -122.35 140.48 32.72 Favored Pre-proline 0 CA--C 1.533 0.291 0 CA-C-O 119.017 -0.516 . . . . 0.0 109.993 176.056 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' D' D ' 8' ' ' PRO . . . . . . . . . . . . . 96.9 Cg_endo -91.72 137.76 1.97 Allowed 'Trans proline' 0 N--CA 1.49 1.316 0 C-N-CA 121.83 1.687 . . . . 0.0 111.964 179.45 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' D' D ' 9' ' ' LEU . . . . . . . . . . . . . 26.3 mt -77.54 -48.28 2.34 Favored Pre-proline 0 CA--C 1.535 0.371 0 CA-C-O 118.675 -0.678 . . . . 0.0 112.341 -179.991 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' D' D ' 10' ' ' PRO . . . . . . . . . . . . . 87.0 Cg_endo -80.23 159.35 23.29 Favored 'Trans proline' 0 N--CA 1.497 1.685 0 C-N-CA 121.308 1.339 . . . . 0.0 112.219 177.961 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' D' D ' 11' ' ' LYS . . . . . . . . . . . . . 82.5 mttt -86.54 95.69 9.82 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.51 -0.314 . . . . 0.0 110.318 177.543 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' D' D ' 12' ' ' VAL . . . . . . . . . . . . . 12.4 p -142.2 147.55 21.26 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.324 0 CA-C-N 116.238 -0.437 . . . . 0.0 110.443 179.928 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' D' D ' 13' ' ' GLU . . . . . . . . . . . . . 45.5 tp10 -92.09 121.83 34.01 Favored 'General case' 0 C--N 1.328 -0.336 0 N-CA-C 109.985 -0.376 . . . . 0.0 109.985 177.797 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' D' D ' 14' ' ' LEU . . . . . . . . . . . . . 41.0 mt -93.02 138.15 23.41 Favored Pre-proline 0 C--N 1.329 -0.305 0 CA-C-O 118.88 -0.581 . . . . 0.0 110.073 -178.666 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' D' D ' 15' ' ' PRO . . . . . . . . . . . . . 28.7 Cg_exo -60.47 158.55 31.25 Favored 'Trans proline' 0 N--CA 1.498 1.782 0 C-N-CA 121.268 1.312 . . . . 0.0 111.953 178.995 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' D' D ' 16' ' ' PRO . . . . . . . . . . . . . 39.3 Cg_exo -58.91 -35.52 98.47 Favored 'Trans proline' 0 N--CA 1.498 1.766 0 C-N-CA 121.527 1.485 . . . . 0.0 112.894 -179.469 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' D' D ' 17' ' ' ASP . . . . . . . . . . . . . 15.8 p-10 -82.18 2.65 30.62 Favored 'General case' 0 CA--C 1.537 0.454 0 N-CA-C 113.296 0.85 . . . . 0.0 113.296 -177.682 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' D' D ' 18' ' ' PHE . . . . . . . . . . . . . 36.7 t80 -58.15 -47.08 84.45 Favored 'General case' 0 C--N 1.333 -0.115 0 O-C-N 121.933 -0.48 . . . . 0.0 110.019 -178.242 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' D' D ' 19' ' ' VAL . . . . . . . . . . . . . 12.7 p -55.19 -41.73 62.03 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 CA-C-N 116.353 -0.385 . . . . 0.0 111.197 -178.094 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' D' D ' 20' ' ' ASP . . . . . . . . . . . . . 7.7 t0 -60.91 -44.31 97.36 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-O 120.9 0.381 . . . . 0.0 110.827 -177.811 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' D' D ' 21' ' ' VAL . . . . . . . . . . . . . 45.5 t -64.62 -45.71 94.61 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.324 0 CA-C-N 116.326 -0.397 . . . . 0.0 110.41 -177.486 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' D' D ' 22' ' ' ILE . . . . . . . . . . . . . 49.5 mm -55.55 -47.73 78.31 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.264 0 C-N-CA 121.096 -0.242 . . . . 0.0 110.672 179.533 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' D' D ' 23' ' ' ARG . . . . . . . . . . . . . 47.0 ttp180 -55.15 -49.05 72.8 Favored 'General case' 0 C--N 1.331 -0.219 0 C-N-CA 121.042 -0.263 . . . . 0.0 111.155 -178.33 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' D' D ' 24' ' ' ILE . . . . . 0.426 HG22 HD11 ' D' ' 24' ' ' ILE . 71.4 mt -58.93 -43.97 89.85 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.281 0 C-N-CA 121.05 -0.26 . . . . 0.0 111.251 -176.308 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' D' D ' 25' ' ' LYS . . . . . . . . . . . . . 49.2 mttm -68.18 -41.05 82.05 Favored 'General case' 0 C--N 1.328 -0.332 0 N-CA-C 112.582 0.586 . . . . 0.0 112.582 -177.86 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' D' D ' 26' ' ' LEU . . . . . . . . . . . . . 36.1 mt -79.46 -33.49 42.32 Favored 'General case' 0 C--N 1.329 -0.311 0 N-CA-C 113.837 1.051 . . . . 0.0 113.837 -170.421 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' D' D ' 27' ' ' GLN . . . . . . . . . . . . . 10.6 pt20 -46.84 140.76 4.43 Favored 'General case' 0 N--CA 1.469 0.514 0 N-CA-C 112.956 0.725 . . . . 0.0 112.956 -174.247 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' D' D ' 28' ' ' GLY . . . . . . . . . . . . . . . 98.14 -24.15 33.05 Favored Glycine 0 CA--C 1.532 1.141 0 CA-C-N 115.571 -0.74 . . . . 0.0 112.427 -178.355 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' D' D ' 29' ' ' LYS . . . . . . . . . . . . . 48.9 mtpt -97.45 155.11 17.07 Favored 'General case' 0 C--N 1.333 -0.126 0 CA-C-N 117.425 0.612 . . . . 0.0 110.783 179.101 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' D' D ' 30' ' ' THR . . . . . . . . . . . . . 23.5 m -104.51 139.84 38.83 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.196 -0.456 . . . . 0.0 110.338 178.876 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' D' D ' 31' ' ' VAL . . . . . . . . . . . . . 34.4 m -130.98 150.28 34.44 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.303 0 CA-C-N 116.101 -0.5 . . . . 0.0 110.783 -179.176 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' D' D ' 32' ' ' ARG . . . . . . . . . . . . . 83.0 mtm180 -128.67 150.34 50.29 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 115.913 -0.585 . . . . 0.0 110.475 178.324 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' D' D ' 33' ' ' THR . . . . . . . . . . . . . 15.0 m -53.64 138.53 34.51 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.305 -0.407 . . . . 0.0 111.385 -178.036 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' D' D ' 34' ' ' GLY . . . . . . . . . . . . . . . 100.43 -17.23 57.07 Favored Glycine 0 CA--C 1.532 1.145 0 CA-C-O 119.67 -0.517 . . . . 0.0 113.192 179.589 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' D' D ' 35' ' ' ASP . . . . . . . . . . . . . 75.1 m-20 -66.35 149.8 49.84 Favored 'General case' 0 N--CA 1.461 0.085 0 CA-C-N 118.015 0.907 . . . . 0.0 111.087 178.838 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' D' D ' 36' ' ' VAL . . . . . . . . . . . . . 44.2 t -118.77 130.75 73.17 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.244 0 CA-C-N 115.908 -0.587 . . . . 0.0 109.839 178.08 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' D' D ' 37' ' ' ILE . . . . . . . . . . . . . 64.7 mt -119.72 138.12 51.38 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.233 0 N-CA-C 109.854 -0.425 . . . . 0.0 109.854 -179.723 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' D' D ' 38' ' ' GLY . . . . . . . . . . . . . . . -113.54 127.89 8.07 Favored Glycine 0 CA--C 1.525 0.661 0 N-CA-C 110.782 -0.927 . . . . 0.0 110.782 179.064 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' D' D ' 39' ' ' ILE . . . . . . . . . . . . . 78.0 mt -128.25 137.46 57.39 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.237 0 CA-C-O 120.814 0.34 . . . . 0.0 110.313 179.626 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' D' D ' 40' ' ' SER . . . . . . . . . . . . . 32.4 t -91.54 116.53 28.94 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.248 -0.433 . . . . 0.0 110.598 175.285 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' D' D ' 41' ' ' ILE . . . . . . . . . . . . . 44.0 mm -119.83 114.34 43.86 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.216 0 CA-C-O 120.886 0.374 . . . . 0.0 110.177 178.823 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' D' D ' 42' ' ' LEU . . . . . . . . . . . . . 1.3 tt 52.27 46.23 27.02 Favored 'General case' 0 CA--C 1.532 0.262 0 CA-C-O 121.399 0.618 . . . . 0.0 111.036 177.527 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' D' D ' 43' ' ' GLY . . . . . . . . . . . . . . . 70.9 25.79 75.14 Favored Glycine 0 CA--C 1.532 1.109 0 C-N-CA 121.1 -0.571 . . . . 0.0 112.532 175.398 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' D' D ' 44' ' ' LYS . . . . . . . . . . . . . 85.9 tttt -136.01 129.65 32.35 Favored 'General case' 0 C--N 1.331 -0.221 0 CA-C-N 117.274 0.537 . . . . 0.0 109.975 179.323 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' D' D ' 45' ' ' GLU . . . . . . . . . . . . . 84.7 tt0 -82.47 119.33 24.07 Favored 'General case' 0 C--N 1.328 -0.355 0 C-N-CA 120.816 -0.354 . . . . 0.0 110.842 -179.275 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' D' D ' 46' ' ' VAL . . . . . . . . . . . . . 10.0 p -118.57 125.17 74.16 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.179 0 N-CA-C 109.425 -0.583 . . . . 0.0 109.425 175.391 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' D' D ' 47' ' ' LYS . . . . . . . . . . . . . 39.6 mtmt -98.73 126.77 44.45 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 115.953 -0.567 . . . . 0.0 110.729 177.809 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' D' D ' 48' ' ' PHE . . . . . . . . . . . . . 45.9 m-85 -111.2 131.95 54.71 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 115.747 -0.66 . . . . 0.0 109.928 178.532 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' D' D ' 49' ' ' LYS . . . . . . . . . . . . . 38.2 tttp -104.48 131.78 51.46 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.334 -0.394 . . . . 0.0 110.09 178.531 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' D' D ' 50' ' ' VAL . . . . . . . . . . . . . 45.7 t -77.04 105.33 5.79 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.33 0 N-CA-C 109.204 -0.665 . . . . 0.0 109.204 177.623 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' D' D ' 51' ' ' VAL . . . . . . . . . . . . . 48.8 t -71.27 -52.5 26.37 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.317 0 CA-C-N 116.064 -0.516 . . . . 0.0 109.683 -174.93 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' D' D ' 52' ' ' GLN . . . . . . . . . . . . . 89.4 mt-30 -153.7 151.17 29.33 Favored 'General case' 0 C--N 1.331 -0.239 0 CA-C-N 115.995 -0.548 . . . . 0.0 111.845 -178.308 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' D' D ' 53' ' ' ALA . . . . . . . . . . . . . . . -129.74 133.24 46.91 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 115.145 -0.934 . . . . 0.0 109.561 174.057 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' D' D ' 54' ' ' TYR . . . . . . . . . . . . . 44.0 t80 -129.08 112.04 18.42 Favored Pre-proline 0 CA--C 1.536 0.419 0 CA-C-O 118.107 -0.949 . . . . 0.0 110.124 178.122 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' D' D ' 55' ' ' PRO . . . . . . . . . . . . . 73.3 Cg_endo -77.19 167.56 79.31 Favored 'Cis proline' 0 N--CA 1.5 1.857 0 CA-C-N 121.907 1.717 . . . . 0.0 112.585 -5.875 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' D' D ' 56' ' ' SER . . . . . . . . . . . . . 13.6 m -117.34 134.09 23.14 Favored Pre-proline 0 CA--C 1.539 0.549 0 CA-C-O 118.483 -0.77 . . . . 0.0 109.292 174.204 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' D' D ' 57' ' ' PRO . . . . . . . . . . . . . 56.0 Cg_endo -70.68 147.7 87.16 Favored 'Cis proline' 0 N--CA 1.498 1.785 0 CA-C-N 121.844 1.694 . . . . 0.0 111.415 -1.608 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' D' D ' 58' ' ' LEU . . . . . . . . . . . . . 24.2 tp -107.84 138.14 44.62 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-O 120.896 0.379 . . . . 0.0 110.495 -179.139 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' D' D ' 59' ' ' ARG . . . . . . . . . . . . . 61.2 ttt180 -103.04 120.25 40.32 Favored 'General case' 0 C--N 1.327 -0.397 0 N-CA-C 108.981 -0.748 . . . . 0.0 108.981 174.812 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' D' D ' 60' ' ' VAL . . . . . . . . . . . . . 42.4 t -71.93 119.7 18.93 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.277 0 C-N-CA 120.615 -0.434 . . . . 0.0 110.198 -174.276 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' D' D ' 61' ' ' GLU . . . . . . . . . . . . . 81.3 tt0 -131.14 152.15 50.72 Favored 'General case' 0 C--N 1.328 -0.33 0 N-CA-C 109.268 -0.641 . . . . 0.0 109.268 178.166 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' D' D ' 62' ' ' ASP . . . . . . . . . . . . . 19.3 p-10 -54.48 -31.97 56.89 Favored 'General case' 0 N--CA 1.465 0.301 0 C-N-CA 120.751 -0.38 . . . . 0.0 111.835 -176.405 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' D' D ' 63' ' ' ARG . . . . . . . . . . . . . 77.6 mtp180 -72.32 -21.24 61.36 Favored 'General case' 0 CA--C 1.535 0.38 0 N-CA-C 112.816 0.673 . . . . 0.0 112.816 -177.514 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' D' D ' 64' ' ' THR . . . . . . . . . . . . . 33.1 m -72.26 146.91 46.92 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-O 120.926 0.393 . . . . 0.0 110.905 -176.238 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' D' D ' 65' ' ' LYS . . . . . . . . . . . . . 68.8 mttm -90.14 131.67 35.86 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.018 -0.537 . . . . 0.0 110.819 -179.229 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' D' D ' 66' ' ' ILE . . . . . . . . . . . . . 68.3 mt -118.2 130.52 72.94 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.24 0 N-CA-C 109.655 -0.498 . . . . 0.0 109.655 178.391 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' D' D ' 67' ' ' THR . . . . . . . . . . . . . 29.5 m -126.48 139.65 53.07 Favored 'General case' 0 C--N 1.332 -0.194 0 CA-C-O 121.169 0.509 . . . . 0.0 111.253 -177.537 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' D' D ' 68' ' ' LEU . . . . . . . . . . . . . 51.0 mt . . . . . 0 C--N 1.33 -0.253 0 CA-C-N 115.733 -0.667 . . . . 0.0 110.121 176.62 . . . . . . . . 0 0 . 1 . 017 nuclear orig core ' D' D ' 73' ' ' VAL . . . . . . . . . . . . . 34.8 m . . . . . 0 C--O 1.232 0.176 0 CA-C-O 120.819 0.343 . . . . 0.0 110.716 . . . . . . . . . 0 0 . 1 . 017 nuclear orig core ' D' D ' 74' ' ' ASP . . . . . . . . . . . . . 39.7 t0 -101.77 119.03 38.14 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.309 -0.405 . . . . 0.0 110.126 -179.836 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' D' D ' 75' ' ' VAL . . . . . . . . . . . . . 44.3 t -114.0 123.04 69.27 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.25 0 CA-C-O 121.131 0.491 . . . . 0.0 110.268 -179.451 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' D' D ' 76' ' ' LEU . . . . . . . . . . . . . 33.9 mt -123.4 141.58 51.85 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 115.616 -0.72 . . . . 0.0 109.511 178.535 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' D' D ' 77' ' ' GLU . . . . . . . . . . . . . 96.7 mt-10 -134.75 138.6 44.47 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-O 121.211 0.529 . . . . 0.0 111.375 -177.849 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' D' D ' 78' ' ' ALA . . . . . . . . . . . . . . . -125.11 137.31 54.18 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 115.556 -0.747 . . . . 0.0 109.581 175.809 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' D' D ' 79' ' ' LYS . . . . . . . . . . . . . 65.0 mttp -80.17 117.91 21.39 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-O 120.864 0.364 . . . . 0.0 110.65 -179.017 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' D' D ' 80' ' ' ILE . . . . . . . . . . . . . 40.7 mm -138.96 102.82 1.84 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.32 0 N-CA-C 109.135 -0.691 . . . . 0.0 109.135 -178.052 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' D' D ' 81' ' ' LYS . . . . . . . . . . . . . 78.1 tttt -99.49 128.37 45.6 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-O 120.889 0.376 . . . . 0.0 110.92 -176.195 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' D' D ' 82' ' ' GLY . . . . . . . . . . . . . . . 89.07 42.21 5.67 Favored Glycine 0 CA--C 1.526 0.743 0 C-N-CA 120.987 -0.625 . . . . 0.0 111.862 175.791 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' D' D ' 83' ' ' ILE . . . . . . . . . . . . . 70.1 mt -70.17 137.77 23.36 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.311 0 N-CA-C 109.358 -0.608 . . . . 0.0 109.358 175.874 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' D' D ' 84' ' ' LYS . . . . . . . . . . . . . 38.5 ttpt -99.57 -46.59 5.4 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.343 -0.39 . . . . 0.0 110.243 -178.541 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' D' D ' 85' ' ' ASP . . . . . . . . . . . . . 8.0 t70 -155.11 152.66 29.76 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.072 -0.513 . . . . 0.0 110.663 179.21 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' D' D ' 86' ' ' VAL . . . . . . . . . . . . . 44.0 t -128.57 134.82 63.87 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.19 0 CA-C-O 120.91 0.386 . . . . 0.0 110.347 179.843 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' D' D ' 87' ' ' ILE . . . . . . . . . . . . . 43.7 mm -119.73 125.34 74.23 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.228 0 CA-C-N 115.909 -0.587 . . . . 0.0 109.719 178.152 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' D' D ' 88' ' ' LEU . . . . . . . . . . . . . 14.7 tp -111.05 131.46 55.04 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-O 120.835 0.35 . . . . 0.0 110.96 -177.622 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' D' D ' 89' ' ' ASP . . . . . . . . . . . . . 13.6 t70 -133.1 157.44 45.28 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 116.151 -0.477 . . . . 0.0 110.039 177.737 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' D' D ' 90' ' ' GLU . . . . . . . . . . . . . 82.6 tt0 -46.18 -39.11 9.19 Favored 'General case' 0 C--N 1.331 -0.23 0 N-CA-C 113.127 0.788 . . . . 0.0 113.127 -172.146 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' D' D ' 91' ' ' ASN . . . . . . . . . . . . . 82.8 m-20 -130.75 22.76 5.01 Favored 'General case' 0 N--CA 1.469 0.488 0 N-CA-C 112.762 0.653 . . . . 0.0 112.762 -176.785 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' D' D ' 92' ' ' LEU . . . . . . . . . . . . . 37.6 mt -149.05 141.22 23.97 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-O 120.826 0.346 . . . . 0.0 110.581 -176.931 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' D' D ' 93' ' ' ILE . . . . . . . . . . . . . 69.5 mt -122.08 113.11 37.52 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.255 0 N-CA-C 108.638 -0.875 . . . . 0.0 108.638 174.895 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' D' D ' 94' ' ' VAL . . . . . . . . . . . . . 41.4 t -116.57 128.93 73.79 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.291 0 CA-C-O 120.949 0.404 . . . . 0.0 110.013 -176.955 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' D' D ' 95' ' ' VAL . . . . . . . . . . . . . 46.1 t -121.65 132.58 70.46 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.282 0 CA-C-N 116.021 -0.536 . . . . 0.0 109.808 -179.826 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' D' D ' 96' ' ' ILE . . . . . . . . . . . . . 62.8 mt -113.29 126.41 70.71 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.322 0 N-CA-C 109.074 -0.713 . . . . 0.0 109.074 178.482 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' D' D ' 97' ' ' THR . . . . . . . . . . . . . 81.0 p -101.79 156.91 17.22 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-O 121.085 0.469 . . . . 0.0 111.44 -175.262 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' D' D ' 98' ' ' GLU . . . . . . . . . . . . . 46.1 mt-10 -55.62 -25.35 38.29 Favored 'General case' 0 CA--C 1.533 0.298 0 N-CA-C 112.324 0.49 . . . . 0.0 112.324 178.783 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' D' D ' 99' ' ' GLU . . . . . . . . . . . . . 14.1 mm-40 -76.12 11.92 1.33 Allowed 'General case' 0 CA--C 1.537 0.467 0 N-CA-C 113.161 0.8 . . . . 0.0 113.161 -179.708 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' D' D ' 100' ' ' ASN . . . . . . . . . . . . . 3.2 m-20 62.72 38.0 12.22 Favored 'General case' 0 CA--C 1.529 0.147 0 CA-C-O 121.039 0.447 . . . . 0.0 110.949 179.113 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' D' D ' 101' ' ' GLU . . . . . . . . . . . . . 84.8 tt0 -117.69 145.29 44.51 Favored 'General case' 0 C--N 1.332 -0.155 0 N-CA-C 109.505 -0.554 . . . . 0.0 109.505 176.658 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' D' D ' 102' ' ' VAL . . . . . . . . . . . . . 42.2 t -115.8 124.45 72.22 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.337 0 CA-C-N 116.272 -0.422 . . . . 0.0 109.98 -178.406 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' D' D ' 103' ' ' LEU . . . . . . . . . . . . . 19.3 mt -115.17 127.85 55.8 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 115.69 -0.686 . . . . 0.0 110.129 176.87 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' D' D ' 104' ' ' ILE . . . . . . . . . . . . . 65.6 mt -119.95 120.32 62.83 Favored 'Isoleucine or valine' 0 C--O 1.233 0.223 0 N-CA-C 110.136 -0.32 . . . . 0.0 110.136 -179.496 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' D' D ' 105' ' ' PHE . . . . . . . . . . . . . 46.3 m-85 -120.44 164.2 16.75 Favored 'General case' 0 C--N 1.334 -0.109 0 O-C-N 123.885 0.741 . . . . 0.0 109.977 179.61 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' D' D ' 106' ' ' ASN . . . . . . . . . . . . . 43.4 p-10 -99.24 -169.79 1.81 Allowed 'General case' 0 C--N 1.332 -0.192 0 N-CA-C 110.1 -0.333 . . . . 0.0 110.1 174.883 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' D' D ' 107' ' ' GLN . . . . . . . . . . . . . 62.3 tt0 -57.37 -30.16 64.64 Favored 'General case' 0 C--N 1.33 -0.243 0 N-CA-C 112.121 0.415 . . . . 0.0 112.121 -179.581 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' D' D ' 108' ' ' ASN . . . . . . . . . . . . . 5.4 t30 -88.43 11.24 17.48 Favored 'General case' 0 CA--C 1.536 0.424 0 N-CA-C 113.304 0.853 . . . . 0.0 113.304 -176.405 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' D' D ' 109' ' ' LEU . . . . . . . . . . . . . 9.5 tp 60.63 36.07 19.76 Favored 'General case' 0 CA--C 1.531 0.213 0 O-C-N 122.141 -0.349 . . . . 0.0 111.446 178.452 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' D' D ' 110' ' ' GLU . . . . . . . . . . . . . 95.5 mt-10 -107.84 152.22 24.69 Favored 'General case' 0 C--N 1.331 -0.237 0 N-CA-C 109.836 -0.431 . . . . 0.0 109.836 176.495 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' D' D ' 111' ' ' GLU . . . . . . . . . . . . . 97.3 mt-10 -78.48 126.87 31.36 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-O 121.102 0.477 . . . . 0.0 111.661 -176.359 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' D' D ' 112' ' ' LEU . . . . . . . . . . . . . 30.9 mt -108.93 -46.03 3.69 Favored 'General case' 0 C--N 1.332 -0.181 0 CA-C-N 115.573 -0.74 . . . . 0.0 109.952 174.736 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' D' D ' 113' ' ' TYR . . . . . . . . . . . . . 50.8 t80 -140.45 137.45 33.92 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.095 -0.502 . . . . 0.0 110.91 -179.813 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' D' D ' 114' ' ' ARG . . . . . . . . . . . . . 60.2 ttp180 -142.15 119.09 11.24 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.262 -0.426 . . . . 0.0 110.416 178.701 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' D' D ' 115' ' ' GLY . . . . . . . . . . . . . . . -150.19 162.59 29.27 Favored Glycine 0 CA--C 1.525 0.687 0 N-CA-C 111.021 -0.832 . . . . 0.0 111.021 179.3 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' D' D ' 116' ' ' LYS . . . . . . . . . . . . . 35.0 ttmt -131.66 135.44 46.9 Favored 'General case' 0 C--N 1.33 -0.251 0 N-CA-C 110.024 -0.362 . . . . 0.0 110.024 177.221 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' D' D ' 117' ' ' PHE . . . . . . . . . . . . . 39.8 m-85 -132.2 120.78 22.69 Favored 'General case' 0 C--N 1.331 -0.211 0 CA-C-O 120.86 0.362 . . . . 0.0 110.46 -174.532 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' D' D ' 118' ' ' GLU . . . . . . . . . . . . . 95.9 mt-10 -53.97 -48.53 70.25 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.413 -0.358 . . . . 0.0 111.571 -175.438 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' D' D ' 119' ' ' ASN . . . . . . . . . . . . . 9.4 m120 -99.28 31.11 3.2 Favored 'General case' 0 C--N 1.329 -0.288 0 N-CA-C 112.201 0.445 . . . . 0.0 112.201 -173.771 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' D' D ' 120' ' ' LEU . . . . . . . . . . . . . 23.7 tp -54.88 127.7 29.83 Favored 'General case' 0 C--N 1.332 -0.169 0 CA-C-O 120.805 0.336 . . . . 0.0 110.8 179.544 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' D' D ' 121' ' ' ASN . . . . . . . . . . . . . 95.1 m-20 -111.11 -44.05 3.65 Favored 'General case' 0 C--O 1.233 0.211 0 CA-C-N 116.287 -0.415 . . . . 0.0 111.109 -177.496 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' D' D ' 122' ' ' LYS . . . . . . . . . . . . . 19.0 ptpt -164.34 166.99 20.28 Favored 'General case' 0 N--CA 1.463 0.176 0 CA-C-O 121.277 0.56 . . . . 0.0 112.149 -178.285 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' D' D ' 123' ' ' VAL . . . . . . . . . . . . . 45.5 t -131.49 139.36 50.89 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.207 0 CA-C-N 115.584 -0.735 . . . . 0.0 110.121 179.749 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' D' D ' 124' ' ' LEU . . . . . . . . . . . . . 37.2 mt -121.55 138.9 54.11 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-N 116.313 -0.403 . . . . 0.0 110.737 -179.151 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' D' D ' 125' ' ' VAL . . . . . . . . . . . . . 35.6 m -135.06 134.12 53.23 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.211 0 CA-C-N 116.585 -0.28 . . . . 0.0 110.939 178.922 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' D' D ' 126' ' ' ARG . . . . . . . . . . . . . 22.3 mtp-105 -148.87 118.31 6.92 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 116.523 -0.308 . . . . 0.0 111.048 177.0 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' D' D ' 127' ' ' ASN . . . . . . . . . . . . . 34.6 m120 48.97 -104.89 0.14 Allowed 'General case' 0 CA--C 1.545 0.76 0 CA-C-O 119.193 -0.432 . . . . 0.0 111.976 175.604 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' D' D ' 128' ' ' ASP . . . . . . . . . . . . . 19.2 p-10 -114.05 14.61 18.38 Favored 'General case' 0 N--CA 1.468 0.463 0 CA-C-N 119.407 1.003 . . . . 0.0 113.28 -174.968 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' D' D ' 129' ' ' LEU . . . . . . . . . . . . . 19.1 tp -123.62 139.22 54.22 Favored 'General case' 0 C--N 1.331 -0.233 0 N-CA-C 109.736 -0.468 . . . . 0.0 109.736 177.458 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' D' D ' 130' ' ' VAL . . . . . . . . . . . . . 13.4 p -131.91 140.54 47.78 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.202 0 CA-C-O 121.173 0.511 . . . . 0.0 110.317 179.523 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' D' D ' 131' ' ' VAL . . . . . . . . . . . . . 40.7 t -135.99 140.46 43.98 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.241 0 CA-C-N 115.864 -0.607 . . . . 0.0 110.493 -177.013 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' D' D ' 132' ' ' ILE . . . . . . . . . . . . . 73.4 mt -115.8 131.33 68.52 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.283 0 N-CA-C 109.188 -0.671 . . . . 0.0 109.188 177.501 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' D' D ' 133' ' ' ILE . . . . . . . . . . . . . 43.6 mm -115.12 119.63 62.32 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.191 0 CA-C-O 120.716 0.293 . . . . 0.0 110.752 -175.904 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' D' D ' 134' ' ' ASP . . . . . . . . . . . . . 8.0 p-10 -133.01 144.25 49.96 Favored 'General case' 0 C--N 1.331 -0.233 0 N-CA-C 109.425 -0.583 . . . . 0.0 109.425 175.896 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' D' D ' 135' ' ' GLU . . . . . . . . . . . . . 83.4 tt0 -49.93 -26.86 4.55 Favored 'General case' 0 C--N 1.327 -0.391 0 N-CA-C 112.779 0.659 . . . . 0.0 112.779 -173.63 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' D' D ' 136' ' ' GLN . . . . . . . . . . . . . 97.3 mt-30 -79.01 -36.89 40.44 Favored 'General case' 0 C--O 1.233 0.225 0 N-CA-C 112.448 0.536 . . . . 0.0 112.448 -178.122 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' D' D ' 137' ' ' LYS . . . . . . . . . . . . . 1.2 ptpm? -164.39 174.11 11.41 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-O 121.671 0.748 . . . . 0.0 112.223 -173.206 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' D' D ' 138' ' ' LEU . . . . . . . . . . . . . 5.7 tt -117.89 127.3 53.72 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 114.905 -1.043 . . . . 0.0 109.553 177.637 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' D' D ' 139' ' ' THR . . . . . . . . . . . . . 42.4 m -106.42 123.61 48.34 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.354 -0.385 . . . . 0.0 110.152 179.301 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' D' D ' 140' ' ' LEU . . . . . . . . . . . . . 14.1 tp -110.61 118.41 36.13 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-N 115.723 -0.672 . . . . 0.0 109.33 -177.901 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' D' D ' 141' ' ' ILE . . . . . . . . . . . . . 19.4 mt -120.11 118.25 56.27 Favored 'Isoleucine or valine' 0 C--O 1.234 0.279 0 CA-C-O 121.045 0.45 . . . . 0.0 110.042 -176.632 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' D' D ' 142' ' ' ARG . . . . . . . . . . . . . 81.3 mtp180 -92.03 128.98 38.08 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 115.433 -0.803 . . . . 0.0 110.009 177.459 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' D' D ' 143' ' ' THR . . . . . . . . . . . . . 63.6 p . . . . . 0 C--O 1.221 -0.431 0 CA-C-O 117.965 -1.017 . . . . 0.0 110.424 -179.701 . . . . . . . . 0 0 . 1 . 017 nuclear orig core ' E' E ' 2' ' ' SER . . . . . . . . . . . . . 2.7 p . . . . . 0 N--CA 1.462 0.155 0 CA-C-O 121.138 0.494 . . . . 0.0 110.856 . . . . . . . . . 0 0 . 1 . 017 nuclear orig core ' E' E ' 3' ' ' GLU . . . . . . . . . . . . . 84.2 tt0 -141.53 138.23 32.58 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 115.699 -0.682 . . . . 0.0 110.882 -179.911 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' E' E ' 4' ' ' LEU . . . . . . . . . . . . . 13.6 tp -123.47 127.13 47.95 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.113 -0.494 . . . . 0.0 109.983 176.78 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' E' E ' 5' ' ' LYS . . . . . . . . . . . . . 91.5 mttt -107.2 121.24 44.14 Favored 'General case' 0 C--N 1.331 -0.23 0 CA-C-N 116.442 -0.345 . . . . 0.0 110.627 178.844 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' E' E ' 6' ' ' LEU . . . . . . . . . . . . . 30.6 mt -115.97 147.05 41.59 Favored 'General case' 0 C--N 1.331 -0.222 0 CA-C-N 115.529 -0.76 . . . . 0.0 110.385 -179.147 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' E' E ' 7' ' ' LYS . . . . . . . . . . . . . 36.9 ttmt -133.18 137.93 30.48 Favored Pre-proline 0 CA--C 1.535 0.384 0 CA-C-O 119.028 -0.51 . . . . 0.0 109.928 176.246 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' E' E ' 8' ' ' PRO . . . . . . . . . . . . . 85.9 Cg_endo -90.63 143.97 3.67 Favored 'Trans proline' 0 N--CA 1.49 1.314 0 C-N-CA 121.798 1.665 . . . . 0.0 111.84 178.805 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' E' E ' 9' ' ' LEU . . . . . . . . . . . . . 57.8 mt -81.15 -48.47 1.07 Allowed Pre-proline 0 CA--C 1.534 0.335 0 CA-C-O 118.669 -0.682 . . . . 0.0 112.385 -178.915 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' E' E ' 10' ' ' PRO . . . . . . . . . . . . . 86.0 Cg_endo -80.41 154.24 21.27 Favored 'Trans proline' 0 N--CA 1.496 1.637 0 C-N-CA 121.281 1.321 . . . . 0.0 111.934 177.169 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' E' E ' 11' ' ' LYS . . . . . . . . . . . . . 46.8 pttt -85.06 111.01 19.35 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-O 121.543 0.687 . . . . 0.0 110.426 177.415 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' E' E ' 12' ' ' VAL . . . . . . . . . . . . . 12.7 p -151.09 151.0 12.86 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.276 0 CA-C-N 115.769 -0.65 . . . . 0.0 110.858 -179.196 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' E' E ' 13' ' ' GLU . . . . . . . . . . . . . 95.2 mt-10 -94.26 120.93 35.22 Favored 'General case' 0 C--N 1.329 -0.32 0 N-CA-C 109.827 -0.434 . . . . 0.0 109.827 175.842 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' E' E ' 14' ' ' LEU . . . . . . . . . . . . . 27.4 mt -97.35 150.96 37.37 Favored Pre-proline 0 CA--C 1.532 0.265 0 CA-C-O 119.333 -0.365 . . . . 0.0 110.735 -177.916 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' E' E ' 15' ' ' PRO . . . . . . . . . . . . . 28.0 Cg_exo -60.86 159.5 28.9 Favored 'Trans proline' 0 N--CA 1.497 1.735 0 C-N-CA 121.339 1.359 . . . . 0.0 111.977 178.055 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' E' E ' 16' ' ' PRO . . . . . . . . . . . . . 27.5 Cg_exo -60.14 -37.22 85.2 Favored 'Trans proline' 0 N--CA 1.496 1.661 0 C-N-CA 121.464 1.443 . . . . 0.0 112.497 -179.006 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' E' E ' 17' ' ' ASP . . . . . . . . . . . . . 19.6 p-10 -86.84 10.26 16.61 Favored 'General case' 0 CA--C 1.537 0.455 0 N-CA-C 113.144 0.794 . . . . 0.0 113.144 -177.89 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' E' E ' 18' ' ' PHE . . . . . . . . . . . . . 59.7 t80 -57.56 -45.66 84.89 Favored 'General case' 0 N--CA 1.458 -0.059 0 O-C-N 122.059 -0.401 . . . . 0.0 110.275 -178.075 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' E' E ' 19' ' ' VAL . . . . . . . . . . . . . 14.4 p -56.35 -41.46 71.4 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.307 0 CA-C-N 116.499 -0.318 . . . . 0.0 110.858 -178.832 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' E' E ' 20' ' ' ASP . . . . . . . . . . . . . 67.0 m-20 -60.78 -41.17 94.99 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-O 120.762 0.315 . . . . 0.0 110.7 -179.54 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' E' E ' 21' ' ' VAL . . . . . . . . . . . . . 50.0 t -64.02 -43.91 97.69 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.323 0 CA-C-N 116.346 -0.388 . . . . 0.0 110.148 -178.359 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' E' E ' 22' ' ' ILE . . . . . . . . . . . . . 46.2 mm -55.8 -49.15 76.45 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.227 0 C-N-CA 120.889 -0.324 . . . . 0.0 110.705 178.373 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' E' E ' 23' ' ' ARG . . . . . . . . . . . . . 30.7 ttp180 -54.86 -50.28 69.04 Favored 'General case' 0 C--N 1.33 -0.261 0 C-N-CA 121.013 -0.275 . . . . 0.0 111.466 -178.452 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' E' E ' 24' ' ' ILE . . . . . . . . . . . . . 75.0 mt -58.77 -46.43 90.79 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.293 0 C-N-CA 120.988 -0.285 . . . . 0.0 111.132 -176.308 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' E' E ' 25' ' ' LYS . . . . . . . . . . . . . 8.5 mtpm? -67.17 -42.31 84.5 Favored 'General case' 0 C--N 1.328 -0.366 0 N-CA-C 112.283 0.475 . . . . 0.0 112.283 -176.607 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' E' E ' 26' ' ' LEU . . . . . . . . . . . . . 42.3 mt -80.11 -29.72 39.0 Favored 'General case' 0 C--N 1.33 -0.252 0 N-CA-C 113.326 0.861 . . . . 0.0 113.326 -171.957 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' E' E ' 27' ' ' GLN . . . . . . . . . . . . . 6.0 pt20 -45.99 134.49 8.06 Favored 'General case' 0 N--CA 1.467 0.406 0 N-CA-C 112.78 0.659 . . . . 0.0 112.78 -174.38 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' E' E ' 28' ' ' GLY . . . . . . . . . . . . . . . 99.78 -21.94 42.67 Favored Glycine 0 CA--C 1.535 1.325 0 CA-C-N 115.815 -0.629 . . . . 0.0 112.477 -177.428 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' E' E ' 29' ' ' LYS . . . . . . . . . . . . . 9.1 mtpm? -97.39 155.16 17.03 Favored 'General case' 0 C--N 1.331 -0.2 0 CA-C-N 117.542 0.671 . . . . 0.0 110.875 179.63 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' E' E ' 30' ' ' THR . . . . . . . . . . . . . 37.8 m -102.42 139.03 38.57 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 115.929 -0.578 . . . . 0.0 110.424 177.997 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' E' E ' 31' ' ' VAL . . . . . . . . . . . . . 35.4 m -126.26 150.3 31.76 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.266 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.127 179.028 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' E' E ' 32' ' ' ARG . . . . . . . . . . . . . 66.9 ttt-85 -136.04 148.4 48.34 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-O 121.06 0.457 . . . . 0.0 110.332 179.377 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' E' E ' 33' ' ' THR . . . . . . . . . . . . . 28.0 m -52.84 138.27 29.95 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.35 -0.386 . . . . 0.0 111.515 -177.195 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' E' E ' 34' ' ' GLY . . . . . . . . . . . . . . . 98.44 -17.04 59.06 Favored Glycine 0 CA--C 1.533 1.189 0 CA-C-N 116.141 -0.482 . . . . 0.0 113.316 178.536 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' E' E ' 35' ' ' ASP . . . . . . . . . . . . . 81.2 m-20 -66.66 149.31 50.7 Favored 'General case' 0 C--O 1.231 0.131 0 CA-C-N 117.976 0.888 . . . . 0.0 111.312 179.85 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' E' E ' 36' ' ' VAL . . . . . . . . . . . . . 47.0 t -118.79 129.41 75.04 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.233 0 CA-C-N 115.745 -0.661 . . . . 0.0 109.674 176.679 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' E' E ' 37' ' ' ILE . . . . . . . . . . . . . 70.3 mt -120.17 138.46 50.64 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.26 0 N-CA-C 109.82 -0.437 . . . . 0.0 109.82 179.909 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' E' E ' 38' ' ' GLY . . . . . . . . . . . . . . . -111.9 128.57 8.65 Favored Glycine 0 CA--C 1.525 0.689 0 N-CA-C 111.055 -0.818 . . . . 0.0 111.055 179.384 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' E' E ' 39' ' ' ILE . . . . . . . . . . . . . 73.8 mt -127.59 135.98 61.72 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.189 0 CA-C-O 120.731 0.3 . . . . 0.0 110.267 179.186 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' E' E ' 40' ' ' SER . . . . . . . . . . . . . 91.0 p -92.99 116.24 28.87 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.278 -0.419 . . . . 0.0 110.733 174.429 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' E' E ' 41' ' ' ILE . . . . . . . . . . . . . 44.0 mm -121.1 123.17 69.43 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.216 0 CA-C-N 116.552 -0.294 . . . . 0.0 110.431 179.588 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' E' E ' 42' ' ' LEU . . . . . . . . . . . . . 47.0 mt 52.27 33.27 12.29 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.303 -0.408 . . . . 0.0 111.951 176.919 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' E' E ' 43' ' ' GLY . . . . . . . . . . . . . . . 74.15 31.69 59.27 Favored Glycine 0 CA--C 1.528 0.88 0 C-N-CA 121.135 -0.555 . . . . 0.0 112.159 177.711 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' E' E ' 44' ' ' LYS . . . . . . . . . . . . . 67.6 tttt -139.58 135.54 33.48 Favored 'General case' 0 C--N 1.329 -0.308 0 N-CA-C 109.674 -0.491 . . . . 0.0 109.674 177.747 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' E' E ' 45' ' ' GLU . . . . . . . . . . . . . 83.6 tt0 -82.16 120.92 25.95 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-O 120.861 0.362 . . . . 0.0 110.971 -177.098 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' E' E ' 46' ' ' VAL . . . . . . . . . . . . . 7.6 p -124.58 125.04 69.46 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.179 0 N-CA-C 109.41 -0.589 . . . . 0.0 109.41 176.277 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' E' E ' 47' ' ' LYS . . . . . . . . . . . . . 96.1 mttt -101.08 134.5 43.99 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.019 -0.537 . . . . 0.0 111.31 177.768 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' E' E ' 48' ' ' PHE . . . . . . . . . . . . . 88.5 m-85 -115.19 132.89 56.46 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 115.88 -0.6 . . . . 0.0 109.965 176.553 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' E' E ' 49' ' ' LYS . . . . . . . . . . . . . 83.3 tttt -105.33 136.91 43.99 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 116.347 -0.388 . . . . 0.0 109.987 177.303 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' E' E ' 50' ' ' VAL . . . . . . . . . . . . . 43.1 t -80.42 109.92 15.42 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.277 0 N-CA-C 109.353 -0.61 . . . . 0.0 109.353 176.821 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' E' E ' 51' ' ' VAL . . . . . . . . . . . . . 53.4 t -68.91 -47.33 76.46 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.24 0 CA-C-N 115.898 -0.592 . . . . 0.0 109.889 -174.777 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' E' E ' 52' ' ' GLN . . . . . . . . . . . . . 48.7 tt0 -167.85 141.77 3.46 Favored 'General case' 0 C--N 1.331 -0.219 0 C-N-CA 120.342 -0.543 . . . . 0.0 111.672 -179.688 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' E' E ' 53' ' ' ALA . . . . . . . . . . . . . . . -111.58 131.49 55.22 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 115.55 -0.75 . . . . 0.0 109.675 175.742 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' E' E ' 54' ' ' TYR . . . . . . . . . . . . . 50.6 t80 -127.67 106.48 20.8 Favored Pre-proline 0 CA--C 1.536 0.418 0 CA-C-O 118.319 -0.848 . . . . 0.0 110.438 -179.61 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' E' E ' 55' ' ' PRO . . . . . . . . . . . . . 73.4 Cg_endo -77.02 170.02 72.83 Favored 'Cis proline' 0 N--CA 1.499 1.836 0 CA-C-N 121.696 1.641 . . . . 0.0 112.607 -2.91 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' E' E ' 56' ' ' SER . . . . . . . . . . . . . 13.6 m -109.49 121.19 43.1 Favored Pre-proline 0 CA--C 1.539 0.537 0 CA-C-O 118.381 -0.819 . . . . 0.0 109.563 177.22 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' E' E ' 57' ' ' PRO . . . . . . . . . . . . . 61.1 Cg_endo -74.36 169.3 74.38 Favored 'Cis proline' 0 N--CA 1.497 1.686 0 CA-C-N 122.049 1.767 . . . . 0.0 112.073 0.97 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' E' E ' 58' ' ' LEU . . . . . . . . . . . . . 26.3 tp -128.13 136.16 50.78 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 115.999 -0.546 . . . . 0.0 110.014 179.755 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' E' E ' 59' ' ' ARG . . . . . . . . . . . . . 39.4 ttm180 -101.2 124.99 47.77 Favored 'General case' 0 C--N 1.326 -0.425 0 CA-C-N 115.89 -0.595 . . . . 0.0 109.467 178.512 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' E' E ' 60' ' ' VAL . . . . . . . . . . . . . 42.9 t -80.04 116.56 24.36 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.207 0 C-N-CA 120.57 -0.452 . . . . 0.0 110.353 -175.691 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' E' E ' 61' ' ' GLU . . . . . . . . . . . . . 95.6 mt-10 -131.04 166.07 21.85 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 115.792 -0.64 . . . . 0.0 110.045 178.765 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' E' E ' 62' ' ' ASP . . . . . . . . . . . . . 81.1 m-20 -54.94 -32.6 61.46 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.505 -0.316 . . . . 0.0 111.763 -179.991 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' E' E ' 63' ' ' ARG . . . . . . . . . . . . . 16.8 ptp180 -85.5 7.71 21.88 Favored 'General case' 0 CA--C 1.535 0.402 0 N-CA-C 113.536 0.939 . . . . 0.0 113.536 -175.751 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' E' E ' 64' ' ' THR . . . . . . . . . . . . . 34.0 m -94.35 141.79 28.16 Favored 'General case' 0 C--N 1.332 -0.166 0 CA-C-N 118.156 0.435 . . . . 0.0 110.587 -177.969 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' E' E ' 65' ' ' LYS . . . . . . . . . . . . . 98.3 mttt -88.87 126.8 35.54 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.09 -0.504 . . . . 0.0 110.195 179.234 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' E' E ' 66' ' ' ILE . . . . . . . . . . . . . 59.4 mt -114.23 126.45 71.75 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.292 0 N-CA-C 109.542 -0.54 . . . . 0.0 109.542 178.23 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' E' E ' 67' ' ' THR . . . . . . . . . . . . . 20.6 m -119.46 134.83 55.03 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-O 120.944 0.402 . . . . 0.0 110.481 -178.497 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' E' E ' 68' ' ' LEU . . . . . . . . . . . . . 6.4 tt . . . . . 0 C--N 1.328 -0.345 0 CA-C-N 115.886 -0.597 . . . . 0.0 110.113 179.247 . . . . . . . . 0 0 . 1 . 017 nuclear orig core ' E' E ' 73' ' ' VAL . . . . . . . . . . . . . 26.7 m . . . . . 0 C--O 1.232 0.136 0 CA-C-O 121.06 0.457 . . . . 0.0 110.968 . . . . . . . . . 0 0 . 1 . 017 nuclear orig core ' E' E ' 74' ' ' ASP . . . . . . . . . . . . . 19.6 t0 -112.33 119.13 37.23 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 115.738 -0.665 . . . . 0.0 109.521 177.646 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' E' E ' 75' ' ' VAL . . . . . . . . . . . . . 43.8 t -110.63 126.53 67.96 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.258 0 CA-C-O 121.141 0.496 . . . . 0.0 111.0 -174.983 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' E' E ' 76' ' ' LEU . . . . . . . . . . . . . 23.0 mt -128.76 144.52 51.19 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 115.456 -0.793 . . . . 0.0 109.475 176.379 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' E' E ' 77' ' ' GLU . . . . . . . . . . . . . 98.0 mt-10 -131.72 139.33 48.97 Favored 'General case' 0 C--N 1.332 -0.163 0 CA-C-O 121.117 0.484 . . . . 0.0 111.622 -177.07 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' E' E ' 78' ' ' ALA . . . . . . . . . . . . . . . -126.68 129.41 48.39 Favored 'General case' 0 C--N 1.331 -0.196 0 CA-C-N 115.573 -0.74 . . . . 0.0 109.685 175.693 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' E' E ' 79' ' ' LYS . . . . . . . . . . . . . 51.8 pttt -75.85 121.09 22.11 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-O 121.471 0.653 . . . . 0.0 110.997 -177.996 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' E' E ' 80' ' ' ILE . . . . . . . . . . . . . 41.2 mm -139.28 107.52 3.26 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.224 0 CA-C-N 115.531 -0.759 . . . . 0.0 109.111 -177.131 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' E' E ' 81' ' ' LYS . . . . . . . . . . . . . 31.7 ttpt -103.61 126.94 51.06 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-O 120.838 0.351 . . . . 0.0 111.111 -177.199 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' E' E ' 82' ' ' GLY . . . . . . . . . . . . . . . 89.03 42.01 5.74 Favored Glycine 0 CA--C 1.526 0.722 0 C-N-CA 120.8 -0.714 . . . . 0.0 111.716 174.977 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' E' E ' 83' ' ' ILE . . . . . . . . . . . . . 70.8 mt -65.48 138.97 22.11 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.356 0 CA-C-O 120.931 0.396 . . . . 0.0 110.033 179.194 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' E' E ' 84' ' ' LYS . . . . . . . . . . . . . 57.0 tttp -98.72 -50.27 4.3 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 115.964 -0.562 . . . . 0.0 109.893 179.043 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' E' E ' 85' ' ' ASP . . . . . . . . . . . . . 5.3 t70 -157.92 153.4 26.16 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 115.647 -0.706 . . . . 0.0 110.228 178.696 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' E' E ' 86' ' ' VAL . . . . . . . . . . . . . 44.6 t -128.39 131.77 68.7 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.208 0 CA-C-O 121.014 0.435 . . . . 0.0 110.559 -178.838 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' E' E ' 87' ' ' ILE . . . . . . . . . . . . . 4.9 mp -117.99 123.3 71.46 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.253 0 CA-C-N 115.743 -0.662 . . . . 0.0 109.245 175.149 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' E' E ' 88' ' ' LEU . . . . . . . . . . . . . 13.0 tp -111.08 130.98 55.44 Favored 'General case' 0 C--N 1.331 -0.198 0 CA-C-O 120.99 0.424 . . . . 0.0 111.032 -177.328 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' E' E ' 89' ' ' ASP . . . . . . . . . . . . . 13.2 t70 -126.65 153.12 45.81 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 115.867 -0.606 . . . . 0.0 109.451 176.51 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' E' E ' 90' ' ' GLU . . . . . . . . . . . . . 80.4 tt0 -47.81 -33.42 7.25 Favored 'General case' 0 C--N 1.331 -0.23 0 N-CA-C 112.866 0.691 . . . . 0.0 112.866 -172.271 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' E' E ' 91' ' ' ASN . . . . . . . . . . . . . 3.8 p30 -129.14 14.55 6.22 Favored 'General case' 0 N--CA 1.469 0.509 0 N-CA-C 113.349 0.87 . . . . 0.0 113.349 -175.905 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' E' E ' 92' ' ' LEU . . . . . . . . . . . . . 34.9 mt -149.42 147.17 27.95 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-O 120.796 0.331 . . . . 0.0 110.508 -176.355 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' E' E ' 93' ' ' ILE . . . . . . . . . . . . . 71.7 mt -125.07 117.17 49.25 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.274 0 N-CA-C 109.319 -0.623 . . . . 0.0 109.319 177.696 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' E' E ' 94' ' ' VAL . . . . . . . . . . . . . 46.6 t -116.39 125.85 73.6 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.273 0 N-CA-C 109.753 -0.462 . . . . 0.0 109.753 -179.897 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' E' E ' 95' ' ' VAL . . . . . . . . . . . . . 38.7 t -122.74 132.93 70.32 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.293 0 CA-C-N 116.113 -0.494 . . . . 0.0 109.838 -179.097 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' E' E ' 96' ' ' ILE . . . . . . . . . . . . . 59.4 mt -114.53 129.57 70.37 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.327 0 N-CA-C 109.224 -0.658 . . . . 0.0 109.224 178.451 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' E' E ' 97' ' ' THR . . . . . . . . . . . . . 68.1 p -101.51 157.79 16.56 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-O 121.001 0.429 . . . . 0.0 110.968 -177.762 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' E' E ' 98' ' ' GLU . . . . . . . . . . . . . 44.6 mt-10 -53.81 -25.01 17.34 Favored 'General case' 0 C--N 1.329 -0.298 0 N-CA-C 112.489 0.551 . . . . 0.0 112.489 179.982 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' E' E ' 99' ' ' GLU . . . . . . . . . . . . . 96.4 mt-10 -78.1 14.69 1.08 Allowed 'General case' 0 CA--C 1.536 0.42 0 N-CA-C 113.331 0.863 . . . . 0.0 113.331 -177.052 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' E' E ' 100' ' ' ASN . . . . . . . . . . . . . 2.2 m-20 63.06 34.43 13.82 Favored 'General case' 0 N--CA 1.464 0.264 0 CA-C-N 117.909 0.322 . . . . 0.0 111.352 178.032 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' E' E ' 101' ' ' GLU . . . . . . . . . . . . . 81.4 tt0 -116.49 144.23 44.59 Favored 'General case' 0 C--N 1.332 -0.189 0 N-CA-C 109.582 -0.525 . . . . 0.0 109.582 175.195 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' E' E ' 102' ' ' VAL . . . . . . . . . . . . . 46.2 t -118.94 127.47 75.79 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.257 0 N-CA-C 109.864 -0.421 . . . . 0.0 109.864 -178.269 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' E' E ' 103' ' ' LEU . . . . . . . . . . . . . 6.1 mp -118.39 135.8 54.12 Favored 'General case' 0 C--N 1.332 -0.188 0 CA-C-N 115.829 -0.623 . . . . 0.0 110.112 177.26 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' E' E ' 104' ' ' ILE . . . . . . . . . . . . . 66.2 mt -119.46 122.0 67.84 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.265 0 N-CA-C 110.147 -0.316 . . . . 0.0 110.147 -179.723 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' E' E ' 105' ' ' PHE . . . . . . . . . . . . . 73.7 m-85 -118.84 163.67 16.55 Favored 'General case' 0 C--N 1.33 -0.245 0 O-C-N 123.991 0.807 . . . . 0.0 109.405 179.353 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' E' E ' 106' ' ' ASN . . . . . . . . . . . . . 47.6 p-10 -96.64 -170.93 2.15 Favored 'General case' 0 C--N 1.331 -0.201 0 N-CA-C 109.803 -0.443 . . . . 0.0 109.803 172.714 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' E' E ' 107' ' ' GLN . . . . . . . . . . . . . 42.1 tt0 -59.73 -27.62 66.64 Favored 'General case' 0 C--N 1.327 -0.373 0 N-CA-C 112.104 0.409 . . . . 0.0 112.104 -179.963 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' E' E ' 108' ' ' ASN . . . . . . . . . . . . . 6.9 t-20 -88.14 13.9 10.33 Favored 'General case' 0 CA--C 1.536 0.418 0 N-CA-C 112.874 0.694 . . . . 0.0 112.874 -178.161 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' E' E ' 109' ' ' LEU . . . . . . . . . . . . . 42.0 mt 57.25 32.3 21.51 Favored 'General case' 0 CA--C 1.529 0.172 0 N-CA-C 112.013 0.375 . . . . 0.0 112.013 178.697 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' E' E ' 110' ' ' GLU . . . . . . . . . . . . . 95.1 mt-10 -101.18 140.02 36.05 Favored 'General case' 0 C--N 1.33 -0.261 0 N-CA-C 109.125 -0.694 . . . . 0.0 109.125 174.269 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' E' E ' 111' ' ' GLU . . . . . . . . . . . . . 44.7 tt0 -82.43 121.91 27.34 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-O 120.948 0.404 . . . . 0.0 110.69 -174.605 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' E' E ' 112' ' ' LEU . . . . . . . . . . . . . 14.0 mt -102.12 -45.18 5.23 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 115.909 -0.587 . . . . 0.0 110.547 179.338 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' E' E ' 113' ' ' TYR . . . . . . . . . . . . . 57.4 t80 -134.8 143.51 47.12 Favored 'General case' 0 C--N 1.331 -0.218 0 CA-C-N 116.387 -0.37 . . . . 0.0 111.078 -177.536 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' E' E ' 114' ' ' ARG . . . . . . . . . . . . . 35.1 ptt180 -147.06 125.49 12.36 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.18 -0.463 . . . . 0.0 110.727 177.863 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' E' E ' 115' ' ' GLY . . . . . . . . . . . . . . . -150.15 162.97 29.38 Favored Glycine 0 CA--C 1.523 0.572 0 N-CA-C 110.834 -0.907 . . . . 0.0 110.834 -179.927 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' E' E ' 116' ' ' LYS . . . . . . . . . . . . . 30.7 ttmt -132.06 138.97 48.37 Favored 'General case' 0 C--N 1.329 -0.305 0 O-C-N 122.59 -0.359 . . . . 0.0 110.051 177.922 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' E' E ' 117' ' ' PHE . . . . . . . . . . . . . 28.0 m-85 -137.09 114.78 11.22 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-O 120.875 0.369 . . . . 0.0 110.038 -175.938 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' E' E ' 118' ' ' GLU . . . . . . . . . . . . . 96.8 mt-10 -54.27 -43.03 70.64 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.458 -0.337 . . . . 0.0 111.333 -176.679 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' E' E ' 119' ' ' ASN . . . . . . . . . . . . . 59.2 m-80 -98.9 31.06 3.1 Favored 'General case' 0 C--N 1.331 -0.215 0 CA-C-N 116.222 -0.444 . . . . 0.0 112.159 -174.257 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' E' E ' 120' ' ' LEU . . . . . . . . . . . . . 25.1 tp -57.03 119.82 6.96 Favored 'General case' 0 C--N 1.333 -0.127 0 C-N-CA 121.028 -0.269 . . . . 0.0 110.322 177.937 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' E' E ' 121' ' ' ASN . . . . . . . . . . . . . 9.9 t-20 -114.14 -44.14 3.16 Favored 'General case' 0 C--N 1.332 -0.182 0 CA-C-N 116.545 -0.298 . . . . 0.0 111.192 -177.28 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' E' E ' 122' ' ' LYS . . . . . . . . . . . . . 61.8 mtpt -144.29 152.59 41.0 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-O 121.048 0.451 . . . . 0.0 111.561 -176.814 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' E' E ' 123' ' ' VAL . . . . . . . . . . . . . 43.5 t -132.32 131.89 60.64 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.238 0 CA-C-N 116.01 -0.541 . . . . 0.0 109.808 175.983 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' E' E ' 124' ' ' LEU . . . . . . . . . . . . . 52.6 mt -120.15 133.12 55.58 Favored 'General case' 0 C--N 1.331 -0.213 0 CA-C-N 116.275 -0.421 . . . . 0.0 110.624 -179.339 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' E' E ' 125' ' ' VAL . . . . . . . . . . . . . 43.3 t -127.83 120.34 53.8 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.188 0 N-CA-C 109.788 -0.449 . . . . 0.0 109.788 177.818 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' E' E ' 126' ' ' ARG . . . . . . . . . . . . . 51.2 mtp180 -148.87 138.86 22.16 Favored 'General case' 0 C--N 1.329 -0.323 0 N-CA-C 109.661 -0.496 . . . . 0.0 109.661 179.615 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' E' E ' 127' ' ' ASN . . . . . . . . . . . . . 4.9 p-10 48.67 -151.13 0.14 Allowed 'General case' 0 CA--C 1.54 0.585 0 CA-C-O 119.434 -0.317 . . . . 0.0 111.024 177.353 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' E' E ' 128' ' ' ASP . . . . . . . . . . . . . 13.3 p-10 -84.14 22.84 1.14 Allowed 'General case' 0 CA--C 1.534 0.332 0 CA-C-N 118.541 0.61 . . . . 0.0 112.416 178.653 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' E' E ' 129' ' ' LEU . . . . . . . . . . . . . 15.0 tp -127.08 140.4 52.31 Favored 'General case' 0 C--O 1.233 0.2 0 O-C-N 122.072 -0.393 . . . . 0.0 110.354 -179.398 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' E' E ' 130' ' ' VAL . . . . . . . . . . . . . 30.9 m -129.5 142.81 42.98 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.218 0 CA-C-O 121.001 0.429 . . . . 0.0 110.468 179.297 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' E' E ' 131' ' ' VAL . . . . . . . . . . . . . 39.8 t -136.1 138.92 46.65 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.234 0 CA-C-N 116.118 -0.492 . . . . 0.0 110.545 -177.77 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' E' E ' 132' ' ' ILE . . . . . . . . . . . . . 73.8 mt -117.18 132.22 67.61 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.289 0 N-CA-C 109.347 -0.612 . . . . 0.0 109.347 177.761 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' E' E ' 133' ' ' ILE . . . . . . . . . . . . . 35.2 mm -115.65 122.39 69.32 Favored 'Isoleucine or valine' 0 C--O 1.234 0.278 0 CA-C-O 120.656 0.265 . . . . 0.0 111.06 -174.766 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' E' E ' 134' ' ' ASP . . . . . . . . . . . . . 7.5 p-10 -135.15 146.44 48.78 Favored 'General case' 0 C--N 1.329 -0.31 0 N-CA-C 109.374 -0.602 . . . . 0.0 109.374 174.812 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' E' E ' 135' ' ' GLU . . . . . . . . . . . . . 84.4 tt0 -49.91 -26.37 4.06 Favored 'General case' 0 CA--C 1.532 0.285 0 N-CA-C 112.721 0.637 . . . . 0.0 112.721 -174.242 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' E' E ' 136' ' ' GLN . . . . . . . . . . . . . 24.9 tt0 -77.64 -38.56 47.63 Favored 'General case' 0 C--O 1.234 0.28 0 CA-C-O 120.896 0.379 . . . . 0.0 111.933 -177.01 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' E' E ' 137' ' ' LYS . . . . . . . . . . . . . 17.4 ptpt -166.83 176.47 7.05 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-O 121.496 0.665 . . . . 0.0 111.621 -173.364 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' E' E ' 138' ' ' LEU . . . . . . . . . . . . . 7.4 tt -119.62 128.07 53.53 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 115.243 -0.89 . . . . 0.0 109.954 177.83 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' E' E ' 139' ' ' THR . . . . . . . . . . . . . 36.9 m -105.94 125.85 51.49 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.245 -0.434 . . . . 0.0 110.372 179.869 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' E' E ' 140' ' ' LEU . . . . . . . . . . . . . 21.3 tp -113.08 119.52 38.12 Favored 'General case' 0 C--N 1.329 -0.306 0 N-CA-C 109.018 -0.734 . . . . 0.0 109.018 -179.137 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' E' E ' 141' ' ' ILE . . . . . . . . . . . . . 19.5 mt -119.17 121.64 67.18 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.309 0 CA-C-O 121.042 0.449 . . . . 0.0 110.012 -175.944 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' E' E ' 142' ' ' ARG . . . . . . . . . . . . . 78.9 mtp180 -109.97 115.76 30.38 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 115.126 -0.943 . . . . 0.0 109.901 -177.748 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' E' E ' 143' ' ' THR . . . . . . . . . . . . . 34.9 p . . . . . 0 C--O 1.219 -0.51 0 CA-C-O 118.037 -0.983 . . . . 0.0 110.649 -178.24 . . . . . . . . 0 0 . 1 . 017 nuclear orig core ' F' F ' 1' ' ' MET . . . . . . . . . . . . . 24.6 ptp . . . . . 0 C--O 1.232 0.147 0 CA-C-O 120.686 0.279 . . . . 0.0 110.683 . . . . . . . . . 0 0 . 1 . 017 nuclear orig core ' F' F ' 2' ' ' SER . . . . . . . . . . . . . 50.6 p -123.7 141.06 52.37 Favored 'General case' 0 C--N 1.332 -0.184 0 CA-C-O 120.986 0.422 . . . . 0.0 110.534 178.968 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' F' F ' 3' ' ' GLU . . . . . . . . . . . . . 84.7 tt0 -142.01 140.45 32.67 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.041 -0.527 . . . . 0.0 111.376 -178.777 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' F' F ' 4' ' ' LEU . . . . . . . . . . . . . 67.9 mt -120.16 134.0 55.36 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.042 -0.526 . . . . 0.0 110.2 176.253 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' F' F ' 5' ' ' LYS . . . . . . . . . . . . . 68.1 mttm -109.97 119.85 40.6 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.303 -0.408 . . . . 0.0 110.275 178.194 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' F' F ' 6' ' ' LEU . . . . . . . . . . . . . 57.1 mt -114.51 147.51 39.28 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 115.382 -0.826 . . . . 0.0 110.472 -178.109 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' F' F ' 7' ' ' LYS . . . . . . . . . . . . . 56.4 tttm -136.84 137.14 22.52 Favored Pre-proline 0 CA--C 1.534 0.34 0 CA-C-O 118.901 -0.571 . . . . 0.0 109.962 176.78 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' F' F ' 8' ' ' PRO . . . . . . . . . . . . . 97.3 Cg_endo -91.97 141.98 2.55 Favored 'Trans proline' 0 N--CA 1.488 1.2 0 C-N-CA 121.688 1.592 . . . . 0.0 111.776 177.397 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' F' F ' 9' ' ' LEU . . . . . . . . . . . . . 21.9 mt -79.79 -47.3 1.46 Allowed Pre-proline 0 CA--C 1.532 0.274 0 CA-C-O 118.697 -0.668 . . . . 0.0 111.92 -178.94 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' F' F ' 10' ' ' PRO . . . . . . . . . . . . . 96.0 Cg_endo -81.66 140.61 11.83 Favored 'Trans proline' 0 N--CA 1.494 1.55 0 C-N-CA 121.188 1.258 . . . . 0.0 111.509 175.254 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' F' F ' 11' ' ' LYS . . . . . . . . . . . . . 46.3 tptt -79.94 98.09 7.01 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-O 120.863 0.363 . . . . 0.0 110.184 179.726 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' F' F ' 12' ' ' VAL . . . . . . . . . . . . . 12.7 p -138.16 145.81 27.98 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.245 0 CA-C-N 116.132 -0.485 . . . . 0.0 110.542 -179.357 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' F' F ' 13' ' ' GLU . . . . . . . . . . . . . 84.6 tt0 -83.56 126.13 32.49 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.353 -0.385 . . . . 0.0 110.403 179.515 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' F' F ' 14' ' ' LEU . . . . . . . . . . . . . 15.5 mt -98.13 149.86 36.15 Favored Pre-proline 0 CA--C 1.532 0.284 0 CA-C-N 116.338 -0.392 . . . . 0.0 110.352 -178.593 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' F' F ' 15' ' ' PRO . . . . . . . . . . . . . 25.8 Cg_exo -62.51 164.11 19.03 Favored 'Trans proline' 0 N--CA 1.496 1.628 0 C-N-CA 121.277 1.318 . . . . 0.0 111.916 176.001 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' F' F ' 16' ' ' PRO . . . . . . . . . . . . . 27.6 Cg_exo -60.32 -41.84 46.86 Favored 'Trans proline' 0 N--CA 1.498 1.748 0 C-N-CA 121.439 1.426 . . . . 0.0 112.842 -177.974 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' F' F ' 17' ' ' ASP . . . . . . . . . . . . . 7.9 p-10 -88.67 11.09 18.45 Favored 'General case' 0 C--N 1.327 -0.376 0 N-CA-C 113.249 0.833 . . . . 0.0 113.249 -176.679 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' F' F ' 18' ' ' PHE . . . . . . . . . . . . . 49.2 t80 -57.18 -42.72 81.69 Favored 'General case' 0 C--N 1.334 -0.07 0 O-C-N 121.922 -0.486 . . . . 0.0 110.25 -178.816 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' F' F ' 19' ' ' VAL . . . . . . . . . . . . . 47.7 t -57.52 -43.05 82.3 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.321 0 CA-C-N 116.144 -0.48 . . . . 0.0 110.36 -179.092 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' F' F ' 20' ' ' ASP . . . . . . . . . . . . . 8.6 t70 -59.85 -41.13 90.74 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-O 120.873 0.368 . . . . 0.0 110.726 -178.217 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' F' F ' 21' ' ' VAL . . . . . . . . . . . . . 51.1 t -64.36 -47.2 90.58 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.332 0 CA-C-N 116.323 -0.398 . . . . 0.0 110.392 -178.2 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' F' F ' 22' ' ' ILE . . . . . . . . . . . . . 50.5 mm -55.93 -45.37 80.0 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.202 0 C-N-CA 120.928 -0.309 . . . . 0.0 110.662 179.201 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' F' F ' 23' ' ' ARG . . . . . . . . . . . . . 36.1 ttp180 -53.83 -50.7 65.62 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-O 120.675 0.274 . . . . 0.0 111.428 -178.999 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' F' F ' 24' ' ' ILE . . . . . . . . . . . . . 71.5 mt -60.31 -41.36 86.83 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.264 0 CA-C-N 116.514 -0.312 . . . . 0.0 111.314 -177.18 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' F' F ' 25' ' ' LYS . . . . . . . . . . . . . 82.3 mttt -66.39 -39.02 88.81 Favored 'General case' 0 C--N 1.33 -0.265 0 N-CA-C 112.354 0.502 . . . . 0.0 112.354 -178.674 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' F' F ' 26' ' ' LEU . . . . . . . . . . . . . 75.7 mt -78.42 -41.9 31.64 Favored 'General case' 0 C--N 1.33 -0.278 0 N-CA-C 113.005 0.742 . . . . 0.0 113.005 -173.39 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' F' F ' 27' ' ' GLN . . . . . . . . . . . . . 9.1 pt20 -46.91 142.1 3.66 Favored 'General case' 0 N--CA 1.47 0.538 0 N-CA-C 112.694 0.627 . . . . 0.0 112.694 -175.377 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' F' F ' 28' ' ' GLY . . . . . . . . . . . . . . . 98.94 -29.77 11.09 Favored Glycine 0 CA--C 1.531 1.087 0 CA-C-N 115.514 -0.766 . . . . 0.0 111.96 -177.477 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' F' F ' 29' ' ' LYS . . . . . . . . . . . . . 8.7 mtpm? -98.66 155.14 17.47 Favored 'General case' 0 C--O 1.232 0.167 0 CA-C-O 121.013 0.435 . . . . 0.0 110.955 179.264 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' F' F ' 30' ' ' THR . . . . . . . . . . . . . 29.7 m -97.28 138.4 34.82 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.151 -0.477 . . . . 0.0 109.947 175.682 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' F' F ' 31' ' ' VAL . . . . . . . . . . . . . 35.3 m -124.94 151.45 30.56 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.257 0 CA-C-N 116.289 -0.414 . . . . 0.0 110.82 -178.47 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' F' F ' 32' ' ' ARG . . . . . . . . . . . . . 61.5 mtp180 -135.3 152.19 51.26 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-O 121.398 0.618 . . . . 0.0 110.717 176.82 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' F' F ' 33' ' ' THR . . . . . . . . . . . . . 8.4 m -54.0 138.3 37.48 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 115.973 -0.558 . . . . 0.0 111.18 -179.085 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' F' F ' 34' ' ' GLY . . . . . . . . . . . . . . . 101.57 -17.08 55.79 Favored Glycine 0 CA--C 1.532 1.139 0 CA-C-O 119.539 -0.59 . . . . 0.0 113.293 178.768 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' F' F ' 35' ' ' ASP . . . . . . . . . . . . . 74.2 m-20 -65.27 148.81 51.04 Favored 'General case' 0 N--CA 1.461 0.113 0 CA-C-N 118.134 0.967 . . . . 0.0 111.25 179.869 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' F' F ' 36' ' ' VAL . . . . . . . . . . . . . 44.8 t -122.48 129.84 74.96 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.16 0 CA-C-N 115.741 -0.663 . . . . 0.0 109.793 178.308 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' F' F ' 37' ' ' ILE . . . . . . . . . . . . . 70.4 mt -122.71 140.18 47.28 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.185 0 CA-C-N 116.233 -0.439 . . . . 0.0 109.96 -179.813 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' F' F ' 38' ' ' GLY . . . . . . . . . . . . . . . -114.0 128.78 8.42 Favored Glycine 0 CA--C 1.525 0.679 0 N-CA-C 111.211 -0.756 . . . . 0.0 111.211 -179.973 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' F' F ' 39' ' ' ILE . . . . . . . . . . . . . 72.4 mt -126.25 130.27 72.03 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.214 0 N-CA-C 109.746 -0.465 . . . . 0.0 109.746 178.539 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' F' F ' 40' ' ' SER . . . . . . . . . . . . . 83.7 p -93.45 121.62 35.04 Favored 'General case' 0 C--N 1.331 -0.227 0 C-N-CA 120.945 -0.302 . . . . 0.0 111.456 178.826 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' F' F ' 41' ' ' ILE . . . . . . . . . . . . . 44.5 mm -133.4 129.13 55.99 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.181 0 CA-C-N 116.427 -0.351 . . . . 0.0 110.163 177.813 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' F' F ' 42' ' ' LEU . . . . . . . . . . . . . 70.3 mt 57.6 32.99 22.67 Favored 'General case' 0 C--N 1.33 -0.249 0 N-CA-C 112.023 0.379 . . . . 0.0 112.023 176.93 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' F' F ' 43' ' ' GLY . . . . . . . . . . . . . . . 77.46 -10.12 24.6 Favored Glycine 0 CA--C 1.533 1.205 0 C-N-CA 121.108 -0.568 . . . . 0.0 113.553 177.502 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' F' F ' 44' ' ' LYS . . . . . . . . . . . . . 37.6 mmtm -103.25 136.31 43.26 Favored 'General case' 0 C--O 1.232 0.173 0 CA-C-N 117.988 0.894 . . . . 0.0 110.051 176.638 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' F' F ' 45' ' ' GLU . . . . . . . . . . . . . 35.1 tp10 -84.58 127.56 34.13 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.344 -0.389 . . . . 0.0 110.628 -179.805 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' F' F ' 46' ' ' VAL . . . . . . . . . . . . . 5.8 p -115.22 126.67 72.85 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.223 0 N-CA-C 109.212 -0.662 . . . . 0.0 109.212 176.23 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' F' F ' 47' ' ' LYS . . . . . . . . . . . . . 63.4 mttm -100.14 128.99 46.12 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 115.791 -0.641 . . . . 0.0 110.924 -179.482 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' F' F ' 48' ' ' PHE . . . . . . . . . . . . . 95.6 m-85 -113.73 131.83 56.04 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.358 -0.383 . . . . 0.0 110.324 177.884 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' F' F ' 49' ' ' LYS . . . . . . . . . . . . . 80.0 tttt -108.06 139.01 43.34 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.357 -0.383 . . . . 0.0 110.633 178.214 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' F' F ' 50' ' ' VAL . . . . . . . . . . . . . 45.0 t -82.11 107.33 14.0 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.343 0 N-CA-C 109.224 -0.658 . . . . 0.0 109.224 175.011 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' F' F ' 51' ' ' VAL . . . . . . . . . . . . . 50.3 t -72.25 -51.87 27.42 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.258 0 CA-C-N 116.103 -0.499 . . . . 0.0 109.757 -174.753 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' F' F ' 52' ' ' GLN . . . . . . . . . . . . . 90.7 mt-30 -153.84 153.23 31.73 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-O 121.296 0.57 . . . . 0.0 111.722 -178.564 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' F' F ' 53' ' ' ALA . . . . . . . . . . . . . . . -129.98 132.64 46.37 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 115.252 -0.885 . . . . 0.0 109.635 173.825 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' F' F ' 54' ' ' TYR . . . . . . . . . . . . . 41.1 t80 -129.09 110.58 18.24 Favored Pre-proline 0 CA--C 1.536 0.406 0 CA-C-O 118.231 -0.89 . . . . 0.0 110.555 179.974 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' F' F ' 55' ' ' PRO . . . . . . . . . . . . . 74.4 Cg_endo -77.21 169.37 74.35 Favored 'Cis proline' 0 N--CA 1.5 1.869 0 CA-C-N 121.823 1.687 . . . . 0.0 112.165 -7.971 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' F' F ' 56' ' ' SER . . . . . . . . . . . . . 13.6 m -117.84 135.03 23.22 Favored Pre-proline 0 CA--C 1.538 0.487 0 CA-C-O 118.515 -0.755 . . . . 0.0 109.599 174.809 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' F' F ' 57' ' ' PRO . . . . . . . . . . . . . 58.8 Cg_endo -73.18 162.01 92.69 Favored 'Cis proline' 0 N--CA 1.498 1.736 0 CA-C-N 121.898 1.714 . . . . 0.0 111.412 -2.656 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' F' F ' 58' ' ' LEU . . . . . . . . . . . . . 23.9 tp -130.88 139.64 50.13 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-O 121.003 0.43 . . . . 0.0 110.936 -179.673 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' F' F ' 59' ' ' ARG . . . . . . . . . . . . . 35.7 ttm180 -97.84 125.22 42.59 Favored 'General case' 0 C--N 1.327 -0.399 0 N-CA-C 109.087 -0.708 . . . . 0.0 109.087 173.052 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' F' F ' 60' ' ' VAL . . . . . . . . . . . . . 43.4 t -79.44 119.86 29.59 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.262 0 C-N-CA 120.599 -0.44 . . . . 0.0 110.426 -175.144 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' F' F ' 61' ' ' GLU . . . . . . . . . . . . . 95.2 mt-10 -131.08 169.93 15.21 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 115.792 -0.64 . . . . 0.0 109.742 176.592 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' F' F ' 62' ' ' ASP . . . . . . . . . . . . . 80.1 m-20 -52.8 -32.37 43.66 Favored 'General case' 0 C--N 1.329 -0.305 0 N-CA-C 111.948 0.351 . . . . 0.0 111.948 -178.417 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' F' F ' 63' ' ' ARG . . . . . . . . . . . . . 85.4 mtt180 -72.29 -22.06 61.26 Favored 'General case' 0 CA--C 1.533 0.308 0 N-CA-C 113.019 0.748 . . . . 0.0 113.019 -175.661 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' F' F ' 64' ' ' THR . . . . . . . . . . . . . 33.1 m -68.72 135.43 51.29 Favored 'General case' 0 C--N 1.331 -0.229 0 CA-C-O 120.995 0.426 . . . . 0.0 111.049 -175.099 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' F' F ' 65' ' ' LYS . . . . . . . . . . . . . 63.3 mttm -89.95 136.47 33.02 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 115.912 -0.585 . . . . 0.0 110.064 177.922 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' F' F ' 66' ' ' ILE . . . . . . . . . . . . . 60.1 mt -118.29 129.95 73.86 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.185 0 N-CA-C 109.851 -0.426 . . . . 0.0 109.851 179.06 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' F' F ' 67' ' ' THR . . . . . . . . . . . . . 24.2 m -124.88 142.26 51.57 Favored 'General case' 0 C--N 1.332 -0.186 0 CA-C-O 121.103 0.477 . . . . 0.0 110.9 -178.878 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' F' F ' 68' ' ' LEU . . . . . . . . . . . . . 7.1 tt . . . . . 0 C--N 1.33 -0.24 0 CA-C-N 115.944 -0.571 . . . . 0.0 109.822 177.396 . . . . . . . . 0 0 . 1 . 017 nuclear orig core ' F' F ' 73' ' ' VAL . . . . . . . . . . . . . 33.1 m . . . . . 0 C--O 1.23 0.066 0 N-CA-C 110.112 -0.329 . . . . 0.0 110.112 . . . . . . . . . 0 0 . 1 . 017 nuclear orig core ' F' F ' 74' ' ' ASP . . . . . . . . . . . . . 14.4 t0 -92.85 117.49 30.08 Favored 'General case' 0 C--N 1.331 -0.227 0 C-N-CA 120.735 -0.386 . . . . 0.0 110.3 -173.729 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' F' F ' 75' ' ' VAL . . . . . . . . . . . . . 41.8 t -113.72 120.43 63.56 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.287 0 CA-C-O 121.101 0.477 . . . . 0.0 110.075 -179.785 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' F' F ' 76' ' ' LEU . . . . . . . . . . . . . 15.4 mt -125.17 144.17 50.58 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 115.728 -0.669 . . . . 0.0 109.686 178.129 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' F' F ' 77' ' ' GLU . . . . . . . . . . . . . 97.4 mt-10 -134.6 132.69 39.35 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-O 121.151 0.501 . . . . 0.0 110.981 -176.855 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' F' F ' 78' ' ' ALA . . . . . . . . . . . . . . . -116.33 127.29 54.56 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 115.658 -0.701 . . . . 0.0 109.719 177.309 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' F' F ' 79' ' ' LYS . . . . . . . . . . . . . 52.5 mtmt -78.39 116.31 18.71 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-O 120.85 0.357 . . . . 0.0 110.691 -177.586 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' F' F ' 80' ' ' ILE . . . . . . . . . . . . . 40.1 mm -139.14 106.25 2.83 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.295 0 N-CA-C 109.003 -0.74 . . . . 0.0 109.003 -177.313 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' F' F ' 81' ' ' LYS . . . . . . . . . . . . . 44.3 tptt -98.05 124.17 42.42 Favored 'General case' 0 C--N 1.328 -0.355 0 C-N-CA 120.788 -0.365 . . . . 0.0 110.806 -175.95 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' F' F ' 82' ' ' GLY . . . . . . . . . . . . . . . 89.09 42.24 5.66 Favored Glycine 0 CA--C 1.524 0.648 0 C-N-CA 120.756 -0.735 . . . . 0.0 111.798 175.423 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' F' F ' 83' ' ' ILE . . . . . . . . . . . . . 75.7 mt -66.45 141.09 18.45 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.286 0 N-CA-C 109.815 -0.439 . . . . 0.0 109.815 177.122 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' F' F ' 84' ' ' LYS . . . . . . . . . . . . . 41.6 tttp -95.4 -53.42 3.77 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 115.93 -0.577 . . . . 0.0 110.361 -178.775 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' F' F ' 85' ' ' ASP . . . . . . . . . . . . . 12.9 t70 -153.21 151.98 30.69 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 115.714 -0.675 . . . . 0.0 110.419 -179.711 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' F' F ' 86' ' ' VAL . . . . . . . . . . . . . 44.6 t -127.22 130.68 71.01 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.266 0 CA-C-O 120.951 0.405 . . . . 0.0 110.406 -179.113 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' F' F ' 87' ' ' ILE . . . . . . . . . . . . . 5.0 mp -122.03 129.02 75.74 Favored 'Isoleucine or valine' 0 C--O 1.233 0.206 0 CA-C-N 115.932 -0.576 . . . . 0.0 109.604 176.954 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' F' F ' 88' ' ' LEU . . . . . . . . . . . . . 18.5 tp -112.32 128.36 56.26 Favored 'General case' 0 C--N 1.332 -0.183 0 CA-C-O 121.03 0.443 . . . . 0.0 110.983 -179.0 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' F' F ' 89' ' ' ASP . . . . . . . . . . . . . 6.5 t0 -117.28 152.1 35.56 Favored 'General case' 0 C--N 1.329 -0.3 0 N-CA-C 109.093 -0.706 . . . . 0.0 109.093 175.63 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' F' F ' 90' ' ' GLU . . . . . . . . . . . . . 84.3 tt0 -48.86 -30.57 5.96 Favored 'General case' 0 C--N 1.329 -0.299 0 N-CA-C 112.83 0.678 . . . . 0.0 112.83 -172.534 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' F' F ' 91' ' ' ASN . . . . . . . . . . . . . 7.3 m120 -130.55 15.78 5.43 Favored 'General case' 0 N--CA 1.468 0.468 0 N-CA-C 113.308 0.855 . . . . 0.0 113.308 -177.051 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' F' F ' 92' ' ' LEU . . . . . . . . . . . . . 55.7 mt -149.96 149.59 30.62 Favored 'General case' 0 C--N 1.332 -0.195 0 CA-C-N 117.964 0.347 . . . . 0.0 110.764 -176.396 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' F' F ' 93' ' ' ILE . . . . . . . . . . . . . 68.2 mt -122.16 119.63 59.01 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.244 0 N-CA-C 108.985 -0.746 . . . . 0.0 108.985 176.631 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' F' F ' 94' ' ' VAL . . . . . . . . . . . . . 47.6 t -120.67 127.31 75.91 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.254 0 CA-C-O 121.008 0.432 . . . . 0.0 110.016 -178.785 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' F' F ' 95' ' ' VAL . . . . . . . . . . . . . 40.4 t -122.87 134.84 64.84 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.342 0 CA-C-N 115.809 -0.632 . . . . 0.0 109.876 -179.754 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' F' F ' 96' ' ' ILE . . . . . . . . . . . . . 59.1 mt -114.48 125.65 71.83 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.379 0 N-CA-C 108.947 -0.76 . . . . 0.0 108.947 178.266 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' F' F ' 97' ' ' THR . . . . . . . . . . . . . 73.9 p -98.91 155.23 17.51 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-O 121.221 0.534 . . . . 0.0 111.438 -175.585 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' F' F ' 98' ' ' GLU . . . . . . . . . . . . . 22.1 pt-20 -54.26 -21.76 10.01 Favored 'General case' 0 CA--C 1.534 0.353 0 N-CA-C 112.568 0.581 . . . . 0.0 112.568 179.339 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' F' F ' 99' ' ' GLU . . . . . . . . . . . . . 34.7 tt0 -83.74 18.11 2.07 Favored 'General case' 0 CA--C 1.539 0.542 0 N-CA-C 112.394 0.516 . . . . 0.0 112.394 -177.548 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' F' F ' 100' ' ' ASN . . . . . . . . . . . . . 3.6 m-20 62.04 37.98 14.37 Favored 'General case' 0 C--O 1.232 0.183 0 CA-C-O 121.161 0.505 . . . . 0.0 111.029 177.247 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' F' F ' 101' ' ' GLU . . . . . . . . . . . . . 84.2 tt0 -118.13 143.36 46.55 Favored 'General case' 0 C--N 1.331 -0.219 0 CA-C-N 116.147 -0.479 . . . . 0.0 109.998 176.836 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' F' F ' 102' ' ' VAL . . . . . . . . . . . . . 44.8 t -114.9 125.54 72.25 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.345 0 N-CA-C 109.822 -0.436 . . . . 0.0 109.822 -179.268 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' F' F ' 103' ' ' LEU . . . . . . . . . . . . . 21.2 mt -118.79 129.45 55.25 Favored 'General case' 0 C--N 1.331 -0.223 0 CA-C-N 115.791 -0.64 . . . . 0.0 110.28 178.116 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' F' F ' 104' ' ' ILE . . . . . . . . . . . . . 67.4 mt -118.63 121.56 67.3 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.251 0 N-CA-C 109.974 -0.38 . . . . 0.0 109.974 178.575 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' F' F ' 105' ' ' PHE . . . . . . . . . . . . . 52.7 m-85 -120.74 163.59 17.88 Favored 'General case' 0 C--N 1.332 -0.176 0 O-C-N 123.978 0.799 . . . . 0.0 109.623 179.647 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' F' F ' 106' ' ' ASN . . . . . . . . . . . . . 48.7 p-10 -97.67 -173.45 2.63 Favored 'General case' 0 C--N 1.328 -0.34 0 N-CA-C 109.618 -0.512 . . . . 0.0 109.618 171.887 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' F' F ' 107' ' ' GLN . . . . . . . . . . . . . 47.2 tt0 -58.57 -26.56 63.72 Favored 'General case' 0 C--N 1.329 -0.317 0 N-CA-C 112.349 0.5 . . . . 0.0 112.349 -178.543 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' F' F ' 108' ' ' ASN . . . . . . . . . . . . . 8.3 t-20 -89.63 14.07 12.55 Favored 'General case' 0 CA--C 1.535 0.379 0 N-CA-C 112.96 0.726 . . . . 0.0 112.96 -176.725 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' F' F ' 109' ' ' LEU . . . . . . . . . . . . . 48.9 mt 57.56 38.98 28.08 Favored 'General case' 0 C--N 1.332 -0.154 0 CA-C-O 121.163 0.506 . . . . 0.0 111.504 178.01 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' F' F ' 110' ' ' GLU . . . . . . . . . . . . . 95.9 mt-10 -104.05 161.03 14.34 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.076 -0.511 . . . . 0.0 109.958 176.466 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' F' F ' 111' ' ' GLU . . . . . . . . . . . . . 84.6 tt0 -89.64 122.33 32.67 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-O 120.905 0.383 . . . . 0.0 110.922 -177.869 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' F' F ' 112' ' ' LEU . . . . . . . . . . . . . 14.0 mt -112.1 -46.04 3.24 Favored 'General case' 0 C--N 1.332 -0.195 0 CA-C-N 116.071 -0.513 . . . . 0.0 110.419 178.029 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' F' F ' 113' ' ' TYR . . . . . . . . . . . . . 54.3 t80 -140.84 134.61 30.37 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.286 -0.416 . . . . 0.0 110.921 179.85 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' F' F ' 114' ' ' ARG . . . . . . . . . . . . . 43.4 ttp180 -141.71 122.49 14.37 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.489 -0.323 . . . . 0.0 110.479 177.782 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' F' F ' 115' ' ' GLY . . . . . . . . . . . . . . . -150.16 146.94 16.6 Favored Glycine 0 CA--C 1.526 0.72 0 N-CA-C 111.193 -0.763 . . . . 0.0 111.193 178.998 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' F' F ' 116' ' ' LYS . . . . . . . . . . . . . 33.2 ttpt -115.2 133.76 55.75 Favored 'General case' 0 C--N 1.33 -0.24 0 N-CA-C 109.776 -0.453 . . . . 0.0 109.776 176.228 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' F' F ' 117' ' ' PHE . . . . . . . . . . . . . 52.3 m-85 -131.77 114.59 14.92 Favored 'General case' 0 C--N 1.332 -0.184 0 CA-C-O 120.924 0.392 . . . . 0.0 110.279 -176.298 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' F' F ' 118' ' ' GLU . . . . . . . . . . . . . 84.4 tt0 -54.26 -45.39 72.4 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.443 -0.344 . . . . 0.0 111.539 -176.015 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' F' F ' 119' ' ' ASN . . . . . . . . . . . . . 9.2 m120 -97.54 30.94 2.7 Favored 'General case' 0 C--N 1.33 -0.281 0 N-CA-C 112.178 0.436 . . . . 0.0 112.178 -174.934 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' F' F ' 120' ' ' LEU . . . . . . . . . . . . . 23.9 tp -58.01 126.95 29.68 Favored 'General case' 0 C--N 1.333 -0.148 0 CA-C-O 120.76 0.314 . . . . 0.0 110.304 178.411 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' F' F ' 121' ' ' ASN . . . . . . . . . . . . . 20.8 t-20 -109.77 -44.0 3.92 Favored 'General case' 0 C--N 1.332 -0.181 0 CA-C-N 116.376 -0.374 . . . . 0.0 110.946 -177.987 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' F' F ' 122' ' ' LYS . . . . . . . . . . . . . 18.8 ptpt -161.29 159.72 28.91 Favored 'General case' 0 C--N 1.333 -0.136 0 CA-C-O 121.141 0.496 . . . . 0.0 111.82 -179.33 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' F' F ' 123' ' ' VAL . . . . . . . . . . . . . 45.8 t -127.27 135.59 63.02 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.199 0 CA-C-N 115.867 -0.606 . . . . 0.0 109.749 177.15 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' F' F ' 124' ' ' LEU . . . . . . . . . . . . . 6.5 mp -118.53 130.41 55.9 Favored 'General case' 0 C--N 1.331 -0.22 0 CA-C-N 116.37 -0.377 . . . . 0.0 110.636 -179.22 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' F' F ' 125' ' ' VAL . . . . . . . . . . . . . 44.6 t -131.69 127.71 59.4 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.236 0 CA-C-N 116.331 -0.395 . . . . 0.0 110.17 179.371 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' F' F ' 126' ' ' ARG . . . . . . . . . . . . . 78.7 mtt180 -149.98 133.63 16.72 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-O 120.95 0.405 . . . . 0.0 110.889 177.154 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' F' F ' 127' ' ' ASN . . . . . . . . . . . . . 9.4 m120 52.48 -118.28 1.29 Allowed 'General case' 0 CA--C 1.545 0.77 0 CA-C-O 118.657 -0.687 . . . . 0.0 110.798 178.826 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' F' F ' 128' ' ' ASP . . . . . . . . . . . . . 8.2 p-10 -113.26 13.55 19.17 Favored 'General case' 0 N--CA 1.469 0.477 0 CA-C-N 120.107 1.321 . . . . 0.0 112.838 -179.624 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' F' F ' 129' ' ' LEU . . . . . . . . . . . . . 13.5 tp -116.26 139.2 50.62 Favored 'General case' 0 C--O 1.233 0.187 0 N-CA-C 109.832 -0.433 . . . . 0.0 109.832 179.121 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' F' F ' 130' ' ' VAL . . . . . . . . . . . . . 13.0 p -134.06 141.22 44.44 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.196 0 CA-C-O 121.1 0.476 . . . . 0.0 110.554 -179.326 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' F' F ' 131' ' ' VAL . . . . . . . . . . . . . 35.3 m -136.06 147.45 28.16 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.362 0 CA-C-N 115.963 -0.562 . . . . 0.0 110.801 179.212 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' F' F ' 132' ' ' ILE . . . . . . . . . . . . . 71.0 mt -118.43 131.05 72.33 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.373 0 CA-C-N 115.736 -0.665 . . . . 0.0 109.285 -179.873 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' F' F ' 133' ' ' ILE . . . . . . . . . . . . . 43.4 mm -115.6 121.81 68.08 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.241 0 CA-C-O 120.753 0.311 . . . . 0.0 110.708 -175.979 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' F' F ' 134' ' ' ASP . . . . . . . . . . . . . 7.6 p-10 -133.88 149.15 51.32 Favored 'General case' 0 C--N 1.331 -0.212 0 N-CA-C 109.586 -0.524 . . . . 0.0 109.586 174.562 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' F' F ' 135' ' ' GLU . . . . . . . . . . . . . 84.9 tt0 -49.84 -24.33 2.38 Favored 'General case' 0 C--N 1.326 -0.423 0 N-CA-C 112.949 0.722 . . . . 0.0 112.949 -170.869 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' F' F ' 136' ' ' GLN . . . . . . . . . . . . . 48.5 tt0 -104.68 -25.57 12.65 Favored 'General case' 0 N--CA 1.465 0.297 0 N-CA-C 112.846 0.684 . . . . 0.0 112.846 -174.484 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' F' F ' 137' ' ' LYS . . . . . . . . . . . . . 88.5 mttt -141.62 151.72 43.36 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-O 121.169 0.509 . . . . 0.0 111.777 -171.23 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' F' F ' 138' ' ' LEU . . . . . . . . . . . . . 5.0 tt -120.04 120.27 35.81 Favored 'General case' 0 C--N 1.329 -0.29 0 N-CA-C 109.151 -0.685 . . . . 0.0 109.151 172.502 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' F' F ' 139' ' ' THR . . . . . . . . . . . . . 40.6 m -110.92 131.15 55.29 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.416 -0.356 . . . . 0.0 110.792 -176.956 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' F' F ' 140' ' ' LEU . . . . . . . . . . . . . 8.0 tt -116.26 123.77 48.53 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 115.769 -0.651 . . . . 0.0 109.309 -179.671 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' F' F ' 141' ' ' ILE . . . . . . . . . . . . . 19.2 mt -122.54 121.1 62.77 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.295 0 CA-C-O 121.08 0.467 . . . . 0.0 110.072 -175.811 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' F' F ' 142' ' ' ARG . . . . . . . . . . . . . 65.8 ttt180 -109.98 129.23 55.7 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 115.318 -0.855 . . . . 0.0 110.364 -178.992 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' F' F ' 143' ' ' THR . . . . . . . . . . . . . 81.3 p . . . . . 0 C--O 1.219 -0.505 0 CA-C-O 117.915 -1.04 . . . . 0.0 110.484 178.927 . . . . . . . . 0 0 . 1 . 018 nuclear orig core ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 79.0 p . . . . . 0 N--CA 1.462 0.126 0 CA-C-O 120.936 0.398 . . . . 0.0 110.625 . . . . . . . . . 0 0 . 1 . 018 nuclear orig core ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 44.5 mp0 -138.2 141.26 40.01 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.098 -0.501 . . . . 0.0 110.882 -178.523 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 4' ' ' LEU . . . . . . . . . . . . . 15.1 tp -126.77 131.05 51.38 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 115.939 -0.573 . . . . 0.0 110.077 177.274 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 5' ' ' LYS . . . . . . . . . . . . . 68.9 mttm -114.04 121.52 44.12 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-O 120.901 0.381 . . . . 0.0 110.923 -179.164 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 63.7 mt -115.45 141.05 48.57 Favored 'General case' 0 C--N 1.331 -0.227 0 CA-C-N 115.237 -0.892 . . . . 0.0 110.046 179.686 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 86.3 tttt -121.0 136.87 25.95 Favored Pre-proline 0 CA--C 1.533 0.308 0 CA-C-O 118.867 -0.587 . . . . 0.0 109.751 177.032 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 8' ' ' PRO . . . . . . . . . . . . . 93.0 Cg_endo -89.03 131.91 2.25 Favored 'Trans proline' 0 N--CA 1.491 1.327 0 C-N-CA 121.699 1.599 . . . . 0.0 111.921 179.088 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 57.1 mt -70.95 -47.91 14.57 Favored Pre-proline 0 CA--C 1.533 0.321 0 CA-C-O 118.575 -0.726 . . . . 0.0 112.211 -179.985 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 71.5 Cg_endo -77.77 153.13 29.5 Favored 'Trans proline' 0 N--CA 1.496 1.626 0 C-N-CA 121.14 1.227 . . . . 0.0 111.913 176.528 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 58.7 tttm -87.18 89.71 8.09 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-O 120.842 0.353 . . . . 0.0 110.266 179.634 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 12.1 p -139.34 148.01 23.93 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.245 0 CA-C-N 116.231 -0.441 . . . . 0.0 110.707 -178.072 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 95.6 mt-10 -90.89 128.53 36.79 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.141 -0.481 . . . . 0.0 110.026 177.248 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 14' ' ' LEU . . . . . . . . . . . . . 24.0 mt -98.0 152.55 38.11 Favored Pre-proline 0 CA--C 1.532 0.267 0 CA-C-O 119.512 -0.28 . . . . 0.0 110.801 -178.586 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 15' ' ' PRO . . . . . . . . . . . . . 25.5 Cg_exo -62.09 159.06 36.07 Favored 'Trans proline' 0 N--CA 1.497 1.727 0 C-N-CA 121.281 1.321 . . . . 0.0 112.165 177.513 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 16' ' ' PRO . . . . . . . . . . . . . 37.5 Cg_exo -58.35 -45.02 33.37 Favored 'Trans proline' 0 N--CA 1.498 1.792 0 C-N-CA 121.437 1.425 . . . . 0.0 112.866 -178.863 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 17' ' ' ASP . . . . . . . . . . . . . 19.8 p-10 -85.32 12.9 7.28 Favored 'General case' 0 C--N 1.326 -0.435 0 N-CA-C 113.14 0.793 . . . . 0.0 113.14 -177.016 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 18' ' ' PHE . . . . . . . . . . . . . 42.6 t80 -58.36 -46.79 85.61 Favored 'General case' 0 CA--C 1.523 -0.078 0 O-C-N 122.096 -0.378 . . . . 0.0 110.162 -177.963 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 19' ' ' VAL . . . . . . . . . . . . . 14.0 p -55.92 -40.23 61.43 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.347 0 CA-C-N 116.227 -0.442 . . . . 0.0 111.104 -178.345 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 78.3 m-20 -61.15 -45.18 95.69 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-O 120.783 0.325 . . . . 0.0 111.093 -177.977 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 60.7 t -64.66 -47.02 90.6 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 C-N-CA 120.781 -0.368 . . . . 0.0 110.591 -177.919 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 22' ' ' ILE . . . . . . . . . . . . . 50.5 mm -56.89 -43.35 80.18 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.189 0 C-N-CA 120.829 -0.348 . . . . 0.0 110.483 179.142 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 23' ' ' ARG . . . . . . . . . . . . . 43.2 ttp180 -54.71 -49.38 70.86 Favored 'General case' 0 C--N 1.33 -0.257 0 C-N-CA 121.143 -0.223 . . . . 0.0 111.309 -178.727 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 24' ' ' ILE . . . . . . . . . . . . . 73.2 mt -59.25 -39.84 79.78 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.244 0 C-N-CA 120.869 -0.332 . . . . 0.0 110.751 -178.699 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 8.3 mtpm? -66.05 -41.82 90.33 Favored 'General case' 0 C--N 1.327 -0.385 0 N-CA-C 112.276 0.473 . . . . 0.0 112.276 -179.253 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 67.0 mt -80.75 -36.07 32.46 Favored 'General case' 0 C--N 1.331 -0.228 0 N-CA-C 113.881 1.067 . . . . 0.0 113.881 -171.134 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 27' ' ' GLN . . . . . . . . . . . . . 8.9 pt20 -46.85 141.49 3.97 Favored 'General case' 0 N--CA 1.47 0.527 0 N-CA-C 112.81 0.67 . . . . 0.0 112.81 -175.17 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 98.64 -24.21 33.07 Favored Glycine 0 CA--C 1.533 1.201 0 CA-C-N 115.673 -0.694 . . . . 0.0 112.354 -176.886 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 60.5 mttp -98.07 155.22 17.23 Favored 'General case' 0 C--O 1.232 0.16 0 CA-C-N 117.45 0.625 . . . . 0.0 110.901 179.167 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 30' ' ' THR . . . . . . . . . . . . . 30.9 m -104.51 136.71 43.56 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.161 -0.472 . . . . 0.0 109.88 176.25 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 33.9 m -129.27 152.51 37.35 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.194 0 CA-C-O 120.987 0.423 . . . . 0.0 110.975 -178.683 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 32' ' ' ARG . . . . . . . . . . . . . 94.2 mtt180 -129.34 152.3 49.05 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-O 121.32 0.581 . . . . 0.0 110.614 179.943 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 33' ' ' THR . . . . . . . . . . . . . 21.4 m -53.63 139.75 31.01 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-N 116.162 -0.472 . . . . 0.0 111.202 -179.297 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 98.62 -17.09 58.88 Favored Glycine 0 CA--C 1.534 1.263 0 C-N-CA 121.106 -0.569 . . . . 0.0 113.269 178.844 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 58.7 m-20 -64.14 149.7 47.18 Favored 'General case' 0 C--O 1.231 0.11 0 CA-C-N 117.997 0.898 . . . . 0.0 111.369 -179.609 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 45.6 t -119.46 126.55 75.44 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.288 0 CA-C-N 115.458 -0.792 . . . . 0.0 109.538 177.896 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 37' ' ' ILE . . . . . . . . . . . . . 69.4 mt -120.71 138.34 51.52 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.226 0 CA-C-N 116.397 -0.365 . . . . 0.0 110.05 -179.072 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . -118.67 128.77 7.84 Favored Glycine 0 CA--C 1.525 0.66 0 N-CA-C 110.98 -0.848 . . . . 0.0 110.98 179.467 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 39' ' ' ILE . . . . . . . . . . . . . 70.8 mt -123.21 134.58 65.8 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.184 0 N-CA-C 109.938 -0.393 . . . . 0.0 109.938 178.228 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 40' ' ' SER . . . . . . . . . . . . . 23.2 t -91.49 120.54 32.4 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 116.272 -0.422 . . . . 0.0 111.04 178.72 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 41' ' ' ILE . . . . . . . . . . . . . 71.4 mt -127.5 116.38 43.39 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.234 0 CA-C-N 116.41 -0.359 . . . . 0.0 110.16 177.392 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 1.3 tt 49.58 47.65 22.41 Favored 'General case' 0 CA--C 1.533 0.311 0 CA-C-O 121.468 0.652 . . . . 0.0 111.43 177.166 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . 71.24 21.73 78.51 Favored Glycine 0 CA--C 1.532 1.094 0 C-N-CA 121.102 -0.571 . . . . 0.0 112.862 174.632 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 44' ' ' LYS . . . . . . . . . . . . . 85.3 tttt -135.14 126.43 28.3 Favored 'General case' 0 C--N 1.331 -0.222 0 CA-C-N 117.636 0.718 . . . . 0.0 109.881 178.959 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 84.9 tt0 -84.72 125.82 32.86 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.485 -0.325 . . . . 0.0 111.176 -178.682 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 46' ' ' VAL . . . . . . . . . . . . . 10.3 p -113.34 123.25 68.8 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.252 0 N-CA-C 109.144 -0.687 . . . . 0.0 109.144 174.072 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 88.6 mttt -98.98 122.94 42.9 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 115.92 -0.582 . . . . 0.0 110.857 179.726 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 48' ' ' PHE . . . . . . . . . . . . . 31.0 m-85 -108.76 131.87 54.53 Favored 'General case' 0 C--N 1.329 -0.3 0 N-CA-C 109.71 -0.478 . . . . 0.0 109.71 176.924 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 76.6 tttt -106.57 130.62 54.3 Favored 'General case' 0 C--N 1.328 -0.33 0 N-CA-C 109.964 -0.384 . . . . 0.0 109.964 178.239 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 50' ' ' VAL . . . . . . . . . . . . . 45.5 t -74.82 105.29 3.75 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.305 0 N-CA-C 109.366 -0.605 . . . . 0.0 109.366 178.433 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 51' ' ' VAL . . . . . . . . . . . . . 48.2 t -70.35 -54.01 20.42 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.303 0 N-CA-C 109.475 -0.565 . . . . 0.0 109.475 -175.916 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 52' ' ' GLN . . . . . . . . . . . . . 89.9 mt-30 -153.73 150.15 28.23 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 115.856 -0.611 . . . . 0.0 111.79 -178.129 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -127.21 131.57 50.61 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 115.041 -0.981 . . . . 0.0 109.524 173.5 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 54' ' ' TYR . . . . . . . . . . . . . 14.5 t80 -129.06 110.24 18.25 Favored Pre-proline 0 C--N 1.329 -0.304 0 CA-C-O 118.198 -0.906 . . . . 0.0 110.234 177.453 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 55' ' ' PRO . . . . . . . . . . . . . 75.4 Cg_endo -77.31 170.22 71.94 Favored 'Cis proline' 0 N--CA 1.5 1.861 0 CA-C-N 121.958 1.735 . . . . 0.0 112.492 -5.927 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 56' ' ' SER . . . . . . . . . . . . . 14.1 m -123.91 138.9 31.34 Favored Pre-proline 0 CA--C 1.537 0.462 0 CA-C-O 118.499 -0.762 . . . . 0.0 109.401 173.532 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 57' ' ' PRO . . . . . . . . . . . . . 39.3 Cg_endo -67.67 144.28 71.07 Favored 'Cis proline' 0 N--CA 1.499 1.797 0 CA-C-N 121.695 1.641 . . . . 0.0 111.61 -2.627 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 58' ' ' LEU . . . . . . . . . . . . . 15.7 tp -107.16 136.92 46.17 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-O 120.934 0.397 . . . . 0.0 110.629 -176.841 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 59' ' ' ARG . . . . . . . . . . . . . 56.5 ttp180 -103.73 124.9 49.73 Favored 'General case' 0 C--N 1.327 -0.378 0 N-CA-C 109.272 -0.64 . . . . 0.0 109.272 176.229 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 43.9 t -77.87 116.42 21.39 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 C-N-CA 120.73 -0.388 . . . . 0.0 110.745 -173.306 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 95.2 mt-10 -131.02 161.1 32.72 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 115.699 -0.682 . . . . 0.0 109.531 175.028 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 62' ' ' ASP . . . . . . . . . . . . . 70.0 m-20 -52.36 -31.67 34.77 Favored 'General case' 0 C--N 1.328 -0.349 0 N-CA-C 112.179 0.437 . . . . 0.0 112.179 -178.001 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 63' ' ' ARG . . . . . . . . . . . . . 87.5 mtt180 -70.92 -22.07 62.29 Favored 'General case' 0 CA--C 1.533 0.301 0 N-CA-C 113.038 0.755 . . . . 0.0 113.038 -174.942 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 27.8 m -68.43 137.16 54.28 Favored 'General case' 0 C--N 1.332 -0.188 0 CA-C-O 120.925 0.393 . . . . 0.0 111.061 -175.482 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 65' ' ' LYS . . . . . . . . . . . . . 90.5 mttt -88.92 127.62 35.66 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 115.984 -0.553 . . . . 0.0 109.772 177.832 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 66' ' ' ILE . . . . . . . . . . . . . 65.4 mt -118.06 130.24 73.22 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.278 0 CA-C-O 120.773 0.32 . . . . 0.0 110.236 -177.502 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 67' ' ' THR . . . . . . . . . . . . . 31.4 m -125.55 139.82 53.27 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-O 121.064 0.459 . . . . 0.0 110.967 -178.844 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 68' ' ' LEU . . . . . . . . . . . . . 7.1 mp . . . . . 0 C--N 1.331 -0.211 0 CA-C-N 115.941 -0.572 . . . . 0.0 110.442 177.264 . . . . . . . . 0 0 . 1 . 018 nuclear orig core ' A' A ' 74' ' ' ASP . . . . . . . . . . . . . 31.6 t0 . . . . . 0 C--O 1.23 0.058 0 N-CA-C 109.717 -0.475 . . . . 0.0 109.717 . . . . . . . . . 0 0 . 1 . 018 nuclear orig core ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 40.9 t -114.74 123.87 70.84 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.249 0 CA-C-O 121.083 0.468 . . . . 0.0 110.776 -177.253 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 76' ' ' LEU . . . . . . . . . . . . . 5.5 mp -120.96 144.35 48.53 Favored 'General case' 0 C--N 1.331 -0.226 0 CA-C-N 115.667 -0.697 . . . . 0.0 109.59 175.185 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 77' ' ' GLU . . . . . . . . . . . . . 97.8 mt-10 -133.96 138.01 45.19 Favored 'General case' 0 C--N 1.331 -0.213 0 CA-C-O 121.112 0.482 . . . . 0.0 111.445 -178.95 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 78' ' ' ALA . . . . . . . . . . . . . . . -127.12 142.05 51.61 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 115.579 -0.737 . . . . 0.0 109.745 177.314 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 79' ' ' LYS . . . . . . . . . . . . . 47.3 pttt -85.79 120.78 27.58 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-O 121.23 0.538 . . . . 0.0 110.967 -178.218 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 80' ' ' ILE . . . . . . . . . . . . . 37.0 mm -139.2 114.9 8.9 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.312 0 CA-C-N 115.768 -0.651 . . . . 0.0 109.411 -179.159 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 81' ' ' LYS . . . . . . . . . . . . . 97.7 mttt -107.4 126.96 53.14 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-O 120.804 0.335 . . . . 0.0 111.011 -179.178 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . 89.05 42.17 5.69 Favored Glycine 0 CA--C 1.525 0.683 0 C-N-CA 120.845 -0.693 . . . . 0.0 111.65 175.526 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 83' ' ' ILE . . . . . . . . . . . . . 69.7 mt -69.91 138.2 22.56 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.309 0 CA-C-O 120.901 0.381 . . . . 0.0 110.042 178.514 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 84' ' ' LYS . . . . . . . . . . . . . 63.4 tttm -94.5 -54.05 3.67 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-N 115.945 -0.57 . . . . 0.0 110.07 -179.104 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 85' ' ' ASP . . . . . . . . . . . . . 7.2 t70 -158.01 154.95 28.52 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 115.652 -0.704 . . . . 0.0 110.412 -179.969 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 86' ' ' VAL . . . . . . . . . . . . . 40.0 t -131.94 132.32 61.5 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.259 0 CA-C-O 120.914 0.388 . . . . 0.0 110.576 179.473 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 87' ' ' ILE . . . . . . . . . . . . . 5.1 mp -118.9 128.37 75.73 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.281 0 CA-C-N 115.816 -0.629 . . . . 0.0 109.414 176.044 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 88' ' ' LEU . . . . . . . . . . . . . 16.9 tp -110.95 134.6 52.45 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-O 121.138 0.494 . . . . 0.0 111.414 -176.234 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 89' ' ' ASP . . . . . . . . . . . . . 12.9 t70 -127.14 149.75 49.81 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 115.602 -0.727 . . . . 0.0 109.36 175.129 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 83.6 tt0 -48.89 -32.57 9.15 Favored 'General case' 0 C--N 1.33 -0.264 0 N-CA-C 112.606 0.595 . . . . 0.0 112.606 -173.357 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 91' ' ' ASN . . . . . . . . . . . . . 79.2 m-20 -131.18 29.67 4.62 Favored 'General case' 0 N--CA 1.465 0.316 0 N-CA-C 112.216 0.45 . . . . 0.0 112.216 -176.368 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 92' ' ' LEU . . . . . . . . . . . . . 8.1 tp -166.21 148.83 7.07 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-O 120.784 0.326 . . . . 0.0 110.602 179.299 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 93' ' ' ILE . . . . . . . . . . . . . 69.9 mt -126.74 122.99 61.92 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.277 0 N-CA-C 109.487 -0.56 . . . . 0.0 109.487 178.931 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 94' ' ' VAL . . . . . . . . . . . . . 42.8 t -121.27 127.6 75.81 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.265 0 N-CA-C 110.084 -0.339 . . . . 0.0 110.084 -179.442 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 95' ' ' VAL . . . . . . . . . . . . . 43.4 t -125.66 136.0 62.19 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.239 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.228 -179.294 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 96' ' ' ILE . . . . . . . . . . . . . 51.6 mt -115.86 129.42 72.25 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 N-CA-C 109.112 -0.699 . . . . 0.0 109.112 178.495 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 97' ' ' THR . . . . . . . . . . . . . 81.7 p -101.21 159.06 15.57 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-O 121.105 0.479 . . . . 0.0 111.16 -178.024 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 98' ' ' GLU . . . . . . . . . . . . . 84.8 tt0 -53.85 -28.37 35.47 Favored 'General case' 0 CA--C 1.533 0.312 0 CA-C-N 116.208 -0.451 . . . . 0.0 112.152 -178.797 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 99' ' ' GLU . . . . . . . . . . . . . 96.0 mt-10 -79.04 14.61 1.35 Allowed 'General case' 0 CA--C 1.535 0.375 0 N-CA-C 113.22 0.822 . . . . 0.0 113.22 -176.316 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 100' ' ' ASN . . . . . . . . . . . . . 3.3 m-20 61.54 33.23 18.51 Favored 'General case' 0 N--CA 1.464 0.24 0 CA-C-N 118.067 0.394 . . . . 0.0 111.639 -179.833 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 101' ' ' GLU . . . . . . . . . . . . . 84.9 tt0 -107.61 144.2 34.99 Favored 'General case' 0 C--O 1.232 0.143 0 N-CA-C 109.607 -0.516 . . . . 0.0 109.607 173.08 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 102' ' ' VAL . . . . . . . . . . . . . 42.7 t -114.93 126.07 72.41 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.304 0 CA-C-N 116.294 -0.412 . . . . 0.0 110.009 -177.627 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 103' ' ' LEU . . . . . . . . . . . . . 21.2 mt -115.72 129.7 56.57 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 115.79 -0.641 . . . . 0.0 109.889 177.324 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 104' ' ' ILE . . . . . . . . . . . . . 68.3 mt -118.49 121.51 67.24 Favored 'Isoleucine or valine' 0 C--O 1.235 0.297 0 N-CA-C 110.13 -0.322 . . . . 0.0 110.13 179.274 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 105' ' ' PHE . . . . . . . . . . . . . 78.3 m-85 -118.92 164.47 15.4 Favored 'General case' 0 C--N 1.333 -0.126 0 O-C-N 124.129 0.893 . . . . 0.0 109.757 -179.499 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 106' ' ' ASN . . . . . . . . . . . . . 42.3 p-10 -101.66 -170.83 1.88 Allowed 'General case' 0 C--N 1.331 -0.221 0 N-CA-C 110.039 -0.356 . . . . 0.0 110.039 173.54 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 107' ' ' GLN . . . . . . . . . . . . . 59.4 tt0 -57.67 -28.69 64.0 Favored 'General case' 0 CA--C 1.534 0.341 0 N-CA-C 111.894 0.331 . . . . 0.0 111.894 177.243 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 108' ' ' ASN . . . . . . . . . . . . . 50.1 t30 -82.94 3.28 30.61 Favored 'General case' 0 CA--C 1.536 0.415 0 N-CA-C 113.353 0.872 . . . . 0.0 113.353 -176.447 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 109' ' ' LEU . . . . . . . . . . . . . 11.5 tp 62.66 39.6 11.09 Favored 'General case' 0 CA--C 1.529 0.172 0 CA-C-O 121.115 0.483 . . . . 0.0 111.051 178.378 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 110' ' ' GLU . . . . . . . . . . . . . 95.5 mt-10 -114.28 150.32 34.61 Favored 'General case' 0 C--N 1.331 -0.198 0 CA-C-N 116.366 -0.379 . . . . 0.0 110.278 176.31 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 111' ' ' GLU . . . . . . . . . . . . . 45.6 mt-10 -76.07 123.62 26.08 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 116.359 -0.382 . . . . 0.0 110.894 -179.739 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 112' ' ' LEU . . . . . . . . . . . . . 16.3 mt -110.04 -46.05 3.52 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.142 -0.481 . . . . 0.0 110.178 176.665 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 113' ' ' TYR . . . . . . . . . . . . . 41.0 t80 -134.79 136.73 42.77 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.235 -0.439 . . . . 0.0 110.659 -179.682 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 114' ' ' ARG . . . . . . . . . . . . . 65.8 ttp85 -141.37 123.25 15.36 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.406 -0.361 . . . . 0.0 110.569 178.014 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 115' ' ' GLY . . . . . . . . . . . . . . . -150.14 163.04 29.39 Favored Glycine 0 CA--C 1.523 0.556 0 N-CA-C 111.054 -0.819 . . . . 0.0 111.054 -179.192 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 116' ' ' LYS . . . . . . . . . . . . . 57.1 tttm -131.56 136.63 47.98 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-O 120.781 0.324 . . . . 0.0 110.188 178.656 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 117' ' ' PHE . . . . . . . . . . . . . 36.2 m-85 -136.34 115.58 12.55 Favored 'General case' 0 C--N 1.331 -0.209 0 CA-C-N 116.245 -0.434 . . . . 0.0 110.283 -176.062 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 118' ' ' GLU . . . . . . . . . . . . . 45.4 mp0 -56.48 -44.46 80.64 Favored 'General case' 0 C--N 1.327 -0.381 0 C-N-CA 120.781 -0.368 . . . . 0.0 111.098 -175.194 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 119' ' ' ASN . . . . . . . . . . . . . 11.4 m120 -98.01 30.97 2.85 Favored 'General case' 0 C--N 1.33 -0.259 0 N-CA-C 112.194 0.442 . . . . 0.0 112.194 -174.011 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 120' ' ' LEU . . . . . . . . . . . . . 21.9 tp -57.64 123.29 15.11 Favored 'General case' 0 C--N 1.332 -0.163 0 C-N-CA 120.854 -0.338 . . . . 0.0 110.379 177.941 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 121' ' ' ASN . . . . . . . . . . . . . 34.6 m120 -114.09 -44.08 3.18 Favored 'General case' 0 C--O 1.233 0.191 0 CA-C-N 116.548 -0.296 . . . . 0.0 111.002 -177.561 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 122' ' ' LYS . . . . . . . . . . . . . 98.3 mttt -144.49 149.16 35.49 Favored 'General case' 0 C--N 1.331 -0.198 0 CA-C-O 121.152 0.501 . . . . 0.0 111.621 -176.365 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 123' ' ' VAL . . . . . . . . . . . . . 47.3 t -129.67 128.55 65.77 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.276 0 CA-C-N 115.733 -0.667 . . . . 0.0 109.538 175.952 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 124' ' ' LEU . . . . . . . . . . . . . 75.0 mt -119.72 134.83 55.08 Favored 'General case' 0 C--N 1.331 -0.219 0 CA-C-N 116.48 -0.327 . . . . 0.0 110.443 -178.213 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 125' ' ' VAL . . . . . . . . . . . . . 12.4 p -140.13 130.93 30.6 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.223 0 CA-C-O 120.878 0.37 . . . . 0.0 110.97 -179.76 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 126' ' ' ARG . . . . . . . . . . . . . 72.8 mtt180 -152.55 134.1 14.53 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 115.822 -0.626 . . . . 0.0 109.674 175.848 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 127' ' ' ASN . . . . . . . . . . . . . 31.5 m120 55.74 -147.77 0.51 Allowed 'General case' 0 CA--C 1.542 0.647 0 N-CA-C 109.729 -0.471 . . . . 0.0 109.729 -178.855 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 128' ' ' ASP . . . . . . . . . . . . . 9.3 p-10 -87.23 14.62 7.45 Favored 'General case' 0 CA--C 1.536 0.409 0 CA-C-N 118.809 0.732 . . . . 0.0 112.934 178.641 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 129' ' ' LEU . . . . . . . . . . . . . 80.5 mt -110.89 138.21 47.57 Favored 'General case' 0 C--O 1.233 0.216 0 O-C-N 121.974 -0.454 . . . . 0.0 110.273 179.575 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 130' ' ' VAL . . . . . . . . . . . . . 14.4 p -134.03 142.14 41.97 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.176 0 CA-C-O 121.177 0.513 . . . . 0.0 110.847 -178.937 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 131' ' ' VAL . . . . . . . . . . . . . 44.5 t -135.76 138.51 47.7 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.228 0 CA-C-N 115.876 -0.602 . . . . 0.0 110.243 -178.923 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 132' ' ' ILE . . . . . . . . . . . . . 72.6 mt -115.87 132.39 65.48 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.298 0 CA-C-N 115.948 -0.569 . . . . 0.0 109.488 -179.856 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 133' ' ' ILE . . . . . . . . . . . . . 39.0 mm -116.9 117.37 55.18 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.21 0 CA-C-N 116.5 -0.318 . . . . 0.0 110.624 -176.333 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 134' ' ' ASP . . . . . . . . . . . . . 7.2 p-10 -128.63 151.43 49.5 Favored 'General case' 0 C--N 1.331 -0.204 0 N-CA-C 109.629 -0.508 . . . . 0.0 109.629 175.252 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 135' ' ' GLU . . . . . . . . . . . . . 45.8 tp10 -49.92 -28.16 6.31 Favored 'General case' 0 C--N 1.327 -0.398 0 N-CA-C 112.748 0.647 . . . . 0.0 112.748 -171.056 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 136' ' ' GLN . . . . . . . . . . . . . 76.9 mt-30 -103.45 -22.95 13.58 Favored 'General case' 0 N--CA 1.464 0.254 0 N-CA-C 113.144 0.794 . . . . 0.0 113.144 -173.874 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 137' ' ' LYS . . . . . . . . . . . . . 94.9 mttt -141.93 147.19 36.65 Favored 'General case' 0 C--N 1.331 -0.224 0 CA-C-O 121.376 0.608 . . . . 0.0 112.007 -168.695 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 138' ' ' LEU . . . . . . . . . . . . . 10.5 tp -111.66 118.3 35.29 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 115.193 -0.912 . . . . 0.0 108.863 172.326 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 139' ' ' THR . . . . . . . . . . . . . 24.9 m -111.98 125.61 54.25 Favored 'General case' 0 N--CA 1.463 0.21 0 CA-C-O 120.695 0.283 . . . . 0.0 110.882 -176.819 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 140' ' ' LEU . . . . . . . . . . . . . 11.6 tp -114.03 122.96 48.51 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 115.664 -0.698 . . . . 0.0 109.23 179.534 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 141' ' ' ILE . . . . . . . . . . . . . 20.3 mt -123.15 122.66 66.01 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.243 0 CA-C-O 120.997 0.427 . . . . 0.0 110.3 -175.778 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 142' ' ' ARG . . . . . . . . . . . . . 84.2 mtp180 -106.91 123.22 47.86 Favored 'General case' 0 C--N 1.331 -0.22 0 CA-C-N 115.264 -0.88 . . . . 0.0 110.068 179.252 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 143' ' ' THR . . . . . . . . . . . . . 26.6 p . . . . . 0 C--O 1.221 -0.428 0 CA-C-O 117.939 -1.029 . . . . 0.0 110.58 179.742 . . . . . . . . 0 0 . 1 . 018 nuclear orig core ' B' B ' 2' ' ' SER . . . . . . . . . . . . . 2.8 p . . . . . 0 N--CA 1.462 0.152 0 CA-C-O 120.901 0.382 . . . . 0.0 110.606 . . . . . . . . . 0 0 . 1 . 018 nuclear orig core ' B' B ' 3' ' ' GLU . . . . . . . . . . . . . 84.6 tt0 -142.64 142.55 32.1 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 115.981 -0.554 . . . . 0.0 111.193 -178.297 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' B' B ' 4' ' ' LEU . . . . . . . . . . . . . 13.4 tp -123.05 131.01 53.52 Favored 'General case' 0 C--N 1.331 -0.209 0 CA-C-N 115.757 -0.656 . . . . 0.0 110.143 177.109 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' B' B ' 5' ' ' LYS . . . . . . . . . . . . . 94.6 mttt -107.72 121.8 45.44 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.232 -0.44 . . . . 0.0 110.433 178.727 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' B' B ' 6' ' ' LEU . . . . . . . . . . . . . 44.4 mt -115.88 148.18 40.25 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 115.554 -0.748 . . . . 0.0 110.195 -179.283 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' B' B ' 7' ' ' LYS . . . . . . . . . . . . . 83.4 tttt -135.35 140.31 34.02 Favored Pre-proline 0 CA--C 1.535 0.388 0 CA-C-O 119.092 -0.48 . . . . 0.0 110.118 176.335 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' B' B ' 8' ' ' PRO . . . . . . . . . . . . . 88.8 Cg_endo -92.04 143.71 2.74 Favored 'Trans proline' 0 N--CA 1.491 1.345 0 C-N-CA 121.718 1.612 . . . . 0.0 111.653 177.689 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' B' B ' 9' ' ' LEU . . . . . . . . . . . . . 75.3 mt -81.8 -47.67 1.0 Allowed Pre-proline 0 CA--C 1.535 0.384 0 CA-C-O 118.611 -0.709 . . . . 0.0 112.303 -179.321 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' B' B ' 10' ' ' PRO . . . . . . . . . . . . . 95.1 Cg_endo -79.61 154.48 23.84 Favored 'Trans proline' 0 N--CA 1.496 1.662 0 C-N-CA 121.125 1.217 . . . . 0.0 111.869 176.412 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' B' B ' 11' ' ' LYS . . . . . . . . . . . . . 62.2 tttm -88.46 102.79 15.25 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-N 116.378 -0.374 . . . . 0.0 110.439 179.058 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' B' B ' 12' ' ' VAL . . . . . . . . . . . . . 12.8 p -149.67 144.29 17.82 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.319 0 CA-C-N 116.294 -0.412 . . . . 0.0 110.875 179.945 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' B' B ' 13' ' ' GLU . . . . . . . . . . . . . 95.8 mt-10 -79.62 131.99 36.14 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.14 -0.482 . . . . 0.0 110.062 177.468 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' B' B ' 14' ' ' LEU . . . . . . . . . . . . . 26.6 mt -98.67 147.97 33.91 Favored Pre-proline 0 CA--C 1.534 0.337 0 CA-C-O 119.252 -0.404 . . . . 0.0 110.623 -177.955 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' B' B ' 15' ' ' PRO . . . . . . . . . . . . . 24.7 Cg_exo -62.88 158.26 43.88 Favored 'Trans proline' 0 N--CA 1.498 1.772 0 C-N-CA 121.328 1.352 . . . . 0.0 111.779 176.828 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' B' B ' 16' ' ' PRO . . . . . . . . . . . . . 33.6 Cg_exo -59.2 -39.31 79.87 Favored 'Trans proline' 0 N--CA 1.498 1.748 0 C-N-CA 121.508 1.472 . . . . 0.0 112.714 -177.581 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' B' B ' 17' ' ' ASP . . . . . . . . . . . . . 24.1 p-10 -89.12 11.9 17.25 Favored 'General case' 0 C--N 1.328 -0.358 0 N-CA-C 113.154 0.798 . . . . 0.0 113.154 -177.411 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' B' B ' 18' ' ' PHE . . . . . . . . . . . . . 44.2 t80 -58.09 -45.82 86.53 Favored 'General case' 0 C--N 1.335 -0.056 0 O-C-N 121.993 -0.442 . . . . 0.0 110.081 -178.458 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' B' B ' 19' ' ' VAL . . . . . . . . . . . . . 13.7 p -56.57 -40.52 69.23 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.297 0 CA-C-N 116.15 -0.477 . . . . 0.0 110.878 -179.219 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' B' B ' 20' ' ' ASP . . . . . . . . . . . . . 9.8 t70 -60.53 -44.78 95.71 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-O 120.768 0.318 . . . . 0.0 111.032 -177.766 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' B' B ' 21' ' ' VAL . . . . . . . . . . . . . 46.9 t -64.3 -47.83 88.04 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.282 0 C-N-CA 120.676 -0.41 . . . . 0.0 110.377 -177.891 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' B' B ' 22' ' ' ILE . . . . . . . . . . . . . 51.1 mm -55.92 -46.16 80.23 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.261 0 CA-C-O 120.672 0.273 . . . . 0.0 110.589 179.813 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' B' B ' 23' ' ' ARG . . . . . . . . . . . . . 60.4 ttp180 -54.38 -50.88 66.48 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.779 -0.191 . . . . 0.0 111.39 -178.281 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' B' B ' 24' ' ' ILE . . . . . . . . . . . . . 75.6 mt -59.8 -42.47 89.05 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.298 0 C-N-CA 121.036 -0.266 . . . . 0.0 110.939 -177.686 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' B' B ' 25' ' ' LYS . . . . . . . . . . . . . 60.3 mtpt -64.6 -39.38 93.62 Favored 'General case' 0 C--N 1.328 -0.333 0 N-CA-C 112.232 0.456 . . . . 0.0 112.232 -177.898 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' B' B ' 26' ' ' LEU . . . . . . . . . . . . . 55.7 mt -79.0 -43.5 24.23 Favored 'General case' 0 C--N 1.33 -0.268 0 N-CA-C 113.089 0.774 . . . . 0.0 113.089 -172.454 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' B' B ' 27' ' ' GLN . . . . . . . . . . . . . 10.3 pt20 -46.55 139.31 5.17 Favored 'General case' 0 N--CA 1.469 0.475 0 N-CA-C 112.841 0.682 . . . . 0.0 112.841 -174.084 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' B' B ' 28' ' ' GLY . . . . . . . . . . . . . . . 100.23 -28.06 17.47 Favored Glycine 0 CA--C 1.533 1.192 0 CA-C-N 115.43 -0.805 . . . . 0.0 112.083 -176.215 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' B' B ' 29' ' ' LYS . . . . . . . . . . . . . 55.5 mtmt -98.88 155.16 17.53 Favored 'General case' 0 C--O 1.233 0.226 0 CA-C-N 117.085 0.442 . . . . 0.0 111.248 178.494 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' B' B ' 30' ' ' THR . . . . . . . . . . . . . 35.2 m -104.35 140.39 37.96 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.13 -0.486 . . . . 0.0 110.115 176.305 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' B' B ' 31' ' ' VAL . . . . . . . . . . . . . 35.2 m -129.08 156.61 41.78 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.274 0 CA-C-N 116.321 -0.399 . . . . 0.0 110.627 -179.575 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' B' B ' 32' ' ' ARG . . . . . . . . . . . . . 62.7 ttt180 -133.37 148.64 51.85 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.066 -0.516 . . . . 0.0 110.143 179.076 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' B' B ' 33' ' ' THR . . . . . . . . . . . . . 18.0 m -53.05 139.11 29.14 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.43 -0.35 . . . . 0.0 111.414 -177.248 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' B' B ' 34' ' ' GLY . . . . . . . . . . . . . . . 100.94 -17.19 56.64 Favored Glycine 0 CA--C 1.532 1.142 0 CA-C-O 119.571 -0.572 . . . . 0.0 113.281 179.085 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' B' B ' 35' ' ' ASP . . . . . . . . . . . . . 79.4 m-20 -66.28 149.3 50.56 Favored 'General case' 0 C--N 1.334 -0.09 0 CA-C-N 118.119 0.959 . . . . 0.0 111.077 179.04 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' B' B ' 36' ' ' VAL . . . . . . . . . . . . . 44.3 t -121.71 129.88 75.1 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.204 0 CA-C-N 115.92 -0.582 . . . . 0.0 109.826 178.523 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' B' B ' 37' ' ' ILE . . . . . . . . . . . . . 65.8 mt -120.8 138.69 50.43 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.254 0 N-CA-C 109.982 -0.377 . . . . 0.0 109.982 -179.534 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' B' B ' 38' ' ' GLY . . . . . . . . . . . . . . . -111.61 128.87 8.84 Favored Glycine 0 CA--C 1.526 0.723 0 N-CA-C 111.07 -0.812 . . . . 0.0 111.07 -179.94 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' B' B ' 39' ' ' ILE . . . . . . . . . . . . . 72.3 mt -123.11 138.52 52.82 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.188 0 N-CA-C 110.165 -0.309 . . . . 0.0 110.165 179.161 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' B' B ' 40' ' ' SER . . . . . . . . . . . . . 32.9 t -93.22 117.13 29.71 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.481 -0.327 . . . . 0.0 110.981 175.636 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' B' B ' 41' ' ' ILE . . . . . . . . . . . . . 47.7 mm -125.68 122.96 63.49 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.262 0 CA-C-O 120.844 0.354 . . . . 0.0 110.586 178.694 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' B' B ' 42' ' ' LEU . . . . . . . . . . . . . 65.3 mt 52.61 33.63 14.06 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.185 -0.462 . . . . 0.0 111.881 177.368 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' B' B ' 43' ' ' GLY . . . . . . . . . . . . . . . 73.19 31.19 61.79 Favored Glycine 0 CA--C 1.529 0.963 0 C-N-CA 121.09 -0.576 . . . . 0.0 112.194 177.951 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' B' B ' 44' ' ' LYS . . . . . . . . . . . . . 40.3 ttpt -138.57 133.72 32.91 Favored 'General case' 0 C--N 1.329 -0.303 0 N-CA-C 109.663 -0.495 . . . . 0.0 109.663 178.098 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' B' B ' 45' ' ' GLU . . . . . . . . . . . . . 78.0 tt0 -83.2 118.55 23.68 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-O 120.918 0.39 . . . . 0.0 110.814 -177.598 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' B' B ' 46' ' ' VAL . . . . . . . . . . . . . 7.4 p -117.18 128.08 74.6 Favored 'Isoleucine or valine' 0 N--CA 1.462 0.159 0 N-CA-C 109.611 -0.514 . . . . 0.0 109.611 177.917 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' B' B ' 47' ' ' LYS . . . . . . . . . . . . . 32.3 mmtp -98.93 129.5 45.26 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 115.96 -0.564 . . . . 0.0 111.357 178.721 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' B' B ' 48' ' ' PHE . . . . . . . . . . . . . 90.5 m-85 -114.08 131.83 56.25 Favored 'General case' 0 C--N 1.329 -0.296 0 N-CA-C 109.378 -0.601 . . . . 0.0 109.378 173.966 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' B' B ' 49' ' ' LYS . . . . . . . . . . . . . 59.5 tttm -108.28 138.54 44.39 Favored 'General case' 0 C--N 1.329 -0.308 0 N-CA-C 110.315 -0.254 . . . . 0.0 110.315 179.359 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' B' B ' 50' ' ' VAL . . . . . . . . . . . . . 44.8 t -78.99 107.88 11.96 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.299 0 N-CA-C 109.226 -0.657 . . . . 0.0 109.226 176.529 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' B' B ' 51' ' ' VAL . . . . . . . . . . . . . 52.9 t -73.04 -48.17 45.14 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.271 0 CA-C-N 115.938 -0.574 . . . . 0.0 110.225 -173.573 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' B' B ' 52' ' ' GLN . . . . . . . . . . . . . 45.3 tt0 -162.62 145.17 10.87 Favored 'General case' 0 C--N 1.332 -0.192 0 C-N-CA 120.303 -0.559 . . . . 0.0 111.554 -177.711 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' B' B ' 53' ' ' ALA . . . . . . . . . . . . . . . -121.1 133.89 55.23 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 115.821 -0.627 . . . . 0.0 110.044 176.76 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' B' B ' 54' ' ' TYR . . . . . . . . . . . . . 33.9 t80 -129.01 106.97 18.02 Favored Pre-proline 0 CA--C 1.534 0.342 0 CA-C-O 118.303 -0.856 . . . . 0.0 110.355 179.435 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' B' B ' 55' ' ' PRO . . . . . . . . . . . . . 73.8 Cg_endo -77.13 169.27 74.69 Favored 'Cis proline' 0 N--CA 1.5 1.858 0 CA-C-N 121.812 1.683 . . . . 0.0 112.503 -4.478 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' B' B ' 56' ' ' SER . . . . . . . . . . . . . 67.4 m -115.3 128.07 26.26 Favored Pre-proline 0 CA--C 1.539 0.543 0 CA-C-O 118.454 -0.784 . . . . 0.0 109.466 175.891 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' B' B ' 57' ' ' PRO . . . . . . . . . . . . . 40.0 Cg_endo -67.84 167.38 62.69 Favored 'Cis proline' 0 N--CA 1.496 1.666 0 CA-C-N 121.984 1.744 . . . . 0.0 111.648 -0.845 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' B' B ' 58' ' ' LEU . . . . . . . . . . . . . 31.4 tp -129.85 136.71 49.87 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.187 -0.46 . . . . 0.0 110.334 179.674 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' B' B ' 59' ' ' ARG . . . . . . . . . . . . . 53.6 ttp180 -103.06 128.3 49.98 Favored 'General case' 0 C--N 1.326 -0.417 0 N-CA-C 109.16 -0.682 . . . . 0.0 109.16 176.898 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' B' B ' 60' ' ' VAL . . . . . . . . . . . . . 42.1 t -84.05 127.64 39.6 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.185 0 C-N-CA 120.533 -0.467 . . . . 0.0 110.622 -174.139 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' B' B ' 61' ' ' GLU . . . . . . . . . . . . . 96.0 mt-10 -129.9 159.13 37.55 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 115.558 -0.747 . . . . 0.0 109.611 176.969 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' B' B ' 62' ' ' ASP . . . . . . . . . . . . . 6.8 t0 -53.5 -32.47 50.49 Favored 'General case' 0 C--N 1.328 -0.363 0 N-CA-C 111.88 0.326 . . . . 0.0 111.88 -178.58 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' B' B ' 63' ' ' ARG . . . . . . . . . . . . . 28.7 ptt180 -90.04 6.23 43.24 Favored 'General case' 0 CA--C 1.537 0.476 0 N-CA-C 113.878 1.066 . . . . 0.0 113.878 -175.633 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' B' B ' 64' ' ' THR . . . . . . . . . . . . . 25.7 m -75.11 147.23 40.74 Favored 'General case' 0 C--N 1.331 -0.206 0 CA-C-O 121.006 0.432 . . . . 0.0 111.069 -177.854 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' B' B ' 65' ' ' LYS . . . . . . . . . . . . . 25.2 mtpp -84.94 126.71 33.74 Favored 'General case' 0 C--N 1.331 -0.227 0 CA-C-N 115.893 -0.594 . . . . 0.0 110.208 179.453 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' B' B ' 66' ' ' ILE . . . . . . . . . . . . . 60.4 mt -121.94 132.17 71.51 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.235 0 N-CA-C 110.151 -0.314 . . . . 0.0 110.151 -179.426 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' B' B ' 67' ' ' THR . . . . . . . . . . . . . 29.6 m -130.11 141.55 50.68 Favored 'General case' 0 C--N 1.332 -0.154 0 CA-C-O 121.02 0.438 . . . . 0.0 111.184 -179.458 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' B' B ' 68' ' ' LEU . . . . . . . . . . . . . 7.0 mp . . . . . 0 C--N 1.332 -0.195 0 CA-C-N 115.942 -0.572 . . . . 0.0 110.427 177.013 . . . . . . . . 0 0 . 1 . 018 nuclear orig core ' B' B ' 73' ' ' VAL . . . . . . . . . . . . . 27.1 m . . . . . 0 C--O 1.232 0.135 0 CA-C-O 120.754 0.312 . . . . 0.0 110.365 . . . . . . . . . 0 0 . 1 . 018 nuclear orig core ' B' B ' 74' ' ' ASP . . . . . . . . . . . . . 36.3 t0 -97.78 116.26 29.65 Favored 'General case' 0 C--N 1.329 -0.289 0 N-CA-C 109.732 -0.47 . . . . 0.0 109.732 -179.28 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' B' B ' 75' ' ' VAL . . . . . . . . . . . . . 42.0 t -112.38 122.15 66.07 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.171 0 CA-C-O 121.112 0.482 . . . . 0.0 110.388 -177.97 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' B' B ' 76' ' ' LEU . . . . . . . . . . . . . 14.7 mt -124.82 133.7 53.02 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 115.537 -0.756 . . . . 0.0 109.2 177.422 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' B' B ' 77' ' ' GLU . . . . . . . . . . . . . 35.9 tt0 -131.91 136.89 47.73 Favored 'General case' 0 C--N 1.331 -0.222 0 CA-C-O 121.013 0.435 . . . . 0.0 110.98 -176.25 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' B' B ' 78' ' ' ALA . . . . . . . . . . . . . . . -123.87 139.81 53.6 Favored 'General case' 0 C--N 1.331 -0.219 0 CA-C-N 115.947 -0.57 . . . . 0.0 110.214 178.08 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' B' B ' 79' ' ' LYS . . . . . . . . . . . . . 50.0 pttt -73.37 118.15 15.98 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-O 121.292 0.567 . . . . 0.0 110.453 179.402 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' B' B ' 80' ' ' ILE . . . . . . . . . . . . . 38.0 mm -139.22 109.68 4.4 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.346 0 CA-C-N 115.906 -0.588 . . . . 0.0 109.718 -177.734 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' B' B ' 81' ' ' LYS . . . . . . . . . . . . . 67.6 mttm -110.76 130.6 55.53 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-O 120.948 0.404 . . . . 0.0 110.927 -179.67 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' B' B ' 82' ' ' GLY . . . . . . . . . . . . . . . 89.05 42.22 5.68 Favored Glycine 0 CA--C 1.525 0.698 0 C-N-CA 120.971 -0.633 . . . . 0.0 111.655 175.527 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' B' B ' 83' ' ' ILE . . . . . . . . . . . . . 71.9 mt -66.91 132.35 32.27 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.317 0 N-CA-C 109.672 -0.492 . . . . 0.0 109.672 177.688 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' B' B ' 84' ' ' LYS . . . . . . . . . . . . . 44.9 tttp -96.37 -52.72 3.87 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-O 121.091 0.472 . . . . 0.0 110.227 -178.742 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' B' B ' 85' ' ' ASP . . . . . . . . . . . . . 7.3 t70 -150.98 149.41 29.56 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 115.647 -0.706 . . . . 0.0 110.118 179.422 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' B' B ' 86' ' ' VAL . . . . . . . . . . . . . 43.2 t -128.6 128.77 68.31 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.292 0 CA-C-O 120.887 0.375 . . . . 0.0 110.529 -178.307 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' B' B ' 87' ' ' ILE . . . . . . . . . . . . . 43.7 mm -120.3 125.2 73.93 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.224 0 CA-C-N 116.002 -0.545 . . . . 0.0 109.968 176.251 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' B' B ' 88' ' ' LEU . . . . . . . . . . . . . 19.2 tp -109.64 130.04 55.54 Favored 'General case' 0 C--N 1.331 -0.225 0 CA-C-O 120.967 0.413 . . . . 0.0 111.141 -178.086 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' B' B ' 89' ' ' ASP . . . . . . . . . . . . . 12.7 t70 -123.12 151.6 41.91 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 115.827 -0.624 . . . . 0.0 109.583 176.0 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' B' B ' 90' ' ' GLU . . . . . . . . . . . . . 96.8 mt-10 -47.08 -36.56 8.32 Favored 'General case' 0 C--N 1.33 -0.253 0 N-CA-C 112.993 0.738 . . . . 0.0 112.993 -173.061 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' B' B ' 91' ' ' ASN . . . . . . . . . . . . . 3.4 p-10 -130.47 19.69 5.23 Favored 'General case' 0 N--CA 1.467 0.421 0 N-CA-C 113.051 0.76 . . . . 0.0 113.051 -177.668 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' B' B ' 92' ' ' LEU . . . . . . . . . . . . . 16.5 mt -148.89 143.16 26.05 Favored 'General case' 0 C--N 1.332 -0.169 0 N-CA-C 109.982 -0.377 . . . . 0.0 109.982 -177.336 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' B' B ' 93' ' ' ILE . . . . . . . . . . . . . 70.7 mt -120.09 118.03 55.55 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.328 0 N-CA-C 109.314 -0.624 . . . . 0.0 109.314 178.003 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' B' B ' 94' ' ' VAL . . . . . . . . . . . . . 48.4 t -119.22 123.5 71.44 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.207 0 N-CA-C 109.901 -0.407 . . . . 0.0 109.901 -179.304 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' B' B ' 95' ' ' VAL . . . . . . . . . . . . . 44.3 t -122.4 132.83 70.32 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.397 0 CA-C-N 115.916 -0.584 . . . . 0.0 109.876 -179.439 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' B' B ' 96' ' ' ILE . . . . . . . . . . . . . 67.0 mt -112.78 126.77 70.22 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.287 0 N-CA-C 109.12 -0.696 . . . . 0.0 109.12 178.265 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' B' B ' 97' ' ' THR . . . . . . . . . . . . . 68.2 p -99.6 152.72 19.72 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-O 120.877 0.37 . . . . 0.0 110.929 -178.543 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' B' B ' 98' ' ' GLU . . . . . . . . . . . . . 45.0 mt-10 -53.87 -24.23 15.19 Favored 'General case' 0 CA--C 1.533 0.324 0 N-CA-C 112.346 0.498 . . . . 0.0 112.346 179.927 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' B' B ' 99' ' ' GLU . . . . . . . . . . . . . 31.1 tt0 -79.27 15.54 1.19 Allowed 'General case' 0 CA--C 1.539 0.549 0 N-CA-C 112.697 0.629 . . . . 0.0 112.697 -177.306 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' B' B ' 100' ' ' ASN . . . . . . . . . . . . . 3.8 m-20 63.56 38.0 9.99 Favored 'General case' 0 CA--C 1.531 0.213 0 CA-C-O 121.006 0.432 . . . . 0.0 111.107 177.366 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' B' B ' 101' ' ' GLU . . . . . . . . . . . . . 85.0 tt0 -118.95 143.26 47.13 Favored 'General case' 0 C--N 1.331 -0.202 0 CA-C-N 116.042 -0.526 . . . . 0.0 109.909 176.014 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' B' B ' 102' ' ' VAL . . . . . . . . . . . . . 45.0 t -114.99 126.29 72.53 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.273 0 CA-C-N 116.262 -0.427 . . . . 0.0 109.946 -177.534 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' B' B ' 103' ' ' LEU . . . . . . . . . . . . . 21.2 mt -116.0 129.38 56.35 Favored 'General case' 0 C--N 1.331 -0.201 0 CA-C-N 115.848 -0.614 . . . . 0.0 110.555 178.263 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' B' B ' 104' ' ' ILE . . . . . . . . . . . . . 66.9 mt -118.82 119.55 61.37 Favored 'Isoleucine or valine' 0 C--O 1.233 0.215 0 CA-C-N 116.443 -0.344 . . . . 0.0 110.109 179.216 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' B' B ' 105' ' ' PHE . . . . . . . . . . . . . 66.8 m-85 -120.72 164.69 16.17 Favored 'General case' 0 C--N 1.331 -0.212 0 O-C-N 123.972 0.795 . . . . 0.0 109.878 178.741 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' B' B ' 106' ' ' ASN . . . . . . . . . . . . . 46.0 p-10 -101.08 -171.49 2.01 Favored 'General case' 0 N--CA 1.463 0.215 0 N-CA-C 110.267 -0.272 . . . . 0.0 110.267 174.605 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' B' B ' 107' ' ' GLN . . . . . . . . . . . . . 60.3 tt0 -59.47 -29.37 67.77 Favored 'General case' 0 CA--C 1.531 0.225 0 N-CA-C 112.021 0.378 . . . . 0.0 112.021 -179.347 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' B' B ' 108' ' ' ASN . . . . . . . . . . . . . 17.9 t30 -86.59 10.01 16.78 Favored 'General case' 0 CA--C 1.536 0.426 0 N-CA-C 113.189 0.811 . . . . 0.0 113.189 -177.115 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' B' B ' 109' ' ' LEU . . . . . . . . . . . . . 12.9 tp 59.68 41.65 18.24 Favored 'General case' 0 C--N 1.331 -0.198 0 CA-C-O 121.25 0.548 . . . . 0.0 110.897 178.318 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' B' B ' 110' ' ' GLU . . . . . . . . . . . . . 70.9 mm-40 -108.07 156.79 18.88 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.138 -0.483 . . . . 0.0 109.866 176.133 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' B' B ' 111' ' ' GLU . . . . . . . . . . . . . 84.9 tt0 -84.39 121.96 28.28 Favored 'General case' 0 C--N 1.329 -0.298 0 C-N-CA 120.845 -0.342 . . . . 0.0 110.79 -178.566 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' B' B ' 112' ' ' LEU . . . . . . . . . . . . . 28.4 mt -110.58 -46.18 3.42 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 116.16 -0.473 . . . . 0.0 110.547 178.169 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' B' B ' 113' ' ' TYR . . . . . . . . . . . . . 54.0 t80 -142.17 134.24 27.44 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.357 -0.383 . . . . 0.0 111.249 -179.941 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' B' B ' 114' ' ' ARG . . . . . . . . . . . . . 29.9 ttm180 -135.28 124.27 24.21 Favored 'General case' 0 C--N 1.329 -0.292 0 N-CA-C 109.839 -0.43 . . . . 0.0 109.839 175.44 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' B' B ' 115' ' ' GLY . . . . . . . . . . . . . . . -150.03 151.64 23.67 Favored Glycine 0 CA--C 1.523 0.569 0 C-N-CA 120.754 -0.736 . . . . 0.0 111.325 179.213 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' B' B ' 116' ' ' LYS . . . . . . . . . . . . . 39.1 ttpt -121.94 136.43 54.92 Favored 'General case' 0 C--N 1.328 -0.333 0 N-CA-C 109.662 -0.495 . . . . 0.0 109.662 177.744 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' B' B ' 117' ' ' PHE . . . . . . . . . . . . . 40.6 m-85 -135.2 113.76 11.66 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-O 121.082 0.468 . . . . 0.0 110.074 -176.861 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' B' B ' 118' ' ' GLU . . . . . . . . . . . . . 97.0 mt-10 -53.86 -43.78 69.82 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.073 -0.512 . . . . 0.0 111.662 -174.256 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' B' B ' 119' ' ' ASN . . . . . . . . . . . . . 5.6 p30 -104.63 31.13 4.91 Favored 'General case' 0 C--N 1.33 -0.257 0 N-CA-C 112.244 0.461 . . . . 0.0 112.244 -173.942 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' B' B ' 120' ' ' LEU . . . . . . . . . . . . . 13.7 tp -53.48 126.05 20.14 Favored 'General case' 0 N--CA 1.464 0.238 0 CA-C-O 120.469 0.176 . . . . 0.0 110.8 177.72 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' B' B ' 121' ' ' ASN . . . . . . . . . . . . . 77.3 m-20 -114.1 -44.12 3.17 Favored 'General case' 0 N--CA 1.462 0.173 0 C-N-CA 121.195 -0.202 . . . . 0.0 111.283 -176.843 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' B' B ' 122' ' ' LYS . . . . . . . . . . . . . 62.2 mtpt -142.1 145.69 34.57 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-O 121.121 0.486 . . . . 0.0 111.727 -176.775 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' B' B ' 123' ' ' VAL . . . . . . . . . . . . . 44.0 t -127.24 127.52 69.35 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.264 0 N-CA-C 109.21 -0.663 . . . . 0.0 109.21 174.909 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' B' B ' 124' ' ' LEU . . . . . . . . . . . . . 51.1 mt -128.03 136.38 51.18 Favored 'General case' 0 C--N 1.331 -0.196 0 CA-C-O 120.853 0.358 . . . . 0.0 111.097 -177.216 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' B' B ' 125' ' ' VAL . . . . . . . . . . . . . 11.1 p -133.97 133.65 56.11 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.249 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.027 177.304 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' B' B ' 126' ' ' ARG . . . . . . . . . . . . . 77.0 mtp85 -146.64 126.47 13.52 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-O 120.86 0.362 . . . . 0.0 111.073 -179.275 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' B' B ' 127' ' ' ASN . . . . . . . . . . . . . 7.6 m-80 49.23 -105.21 0.15 Allowed 'General case' 0 CA--C 1.545 0.76 0 CA-C-O 119.036 -0.507 . . . . 0.0 111.784 178.162 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' B' B ' 128' ' ' ASP . . . . . . . . . . . . . 15.9 p-10 -114.09 3.02 15.11 Favored 'General case' 0 CA--C 1.535 0.396 0 CA-C-N 119.552 1.069 . . . . 0.0 113.546 -176.36 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' B' B ' 129' ' ' LEU . . . . . . . . . . . . . 52.8 mt -111.48 140.85 45.73 Favored 'General case' 0 C--N 1.333 -0.114 0 O-C-N 121.972 -0.455 . . . . 0.0 110.522 -179.078 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' B' B ' 130' ' ' VAL . . . . . . . . . . . . . 46.5 t -122.98 134.85 64.9 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.326 0 N-CA-C 109.401 -0.592 . . . . 0.0 109.401 177.839 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' B' B ' 131' ' ' VAL . . . . . . . . . . . . . 39.3 t -134.36 138.06 50.53 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.223 0 CA-C-O 121.187 0.518 . . . . 0.0 110.45 -179.002 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' B' B ' 132' ' ' ILE . . . . . . . . . . . . . 70.7 mt -116.76 130.19 72.04 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.339 0 CA-C-N 115.556 -0.747 . . . . 0.0 109.388 179.508 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' B' B ' 133' ' ' ILE . . . . . . . . . . . . . 40.4 mm -112.2 119.25 59.72 Favored 'Isoleucine or valine' 0 C--O 1.233 0.221 0 CA-C-O 120.855 0.36 . . . . 0.0 110.67 -177.241 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' B' B ' 134' ' ' ASP . . . . . . . . . . . . . 7.2 p-10 -134.13 148.78 51.01 Favored 'General case' 0 C--N 1.331 -0.206 0 CA-C-N 116.103 -0.499 . . . . 0.0 109.76 177.156 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' B' B ' 135' ' ' GLU . . . . . . . . . . . . . 42.8 tp10 -49.9 -30.0 9.33 Favored 'General case' 0 C--N 1.328 -0.36 0 N-CA-C 112.576 0.584 . . . . 0.0 112.576 -173.523 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' B' B ' 136' ' ' GLN . . . . . . . . . . . . . 43.2 tp60 -80.18 -34.91 37.13 Favored 'General case' 0 C--N 1.33 -0.251 0 N-CA-C 112.282 0.475 . . . . 0.0 112.282 -175.046 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' B' B ' 137' ' ' LYS . . . . . . . . . . . . . 40.0 pttt -170.0 174.2 5.64 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-O 121.452 0.644 . . . . 0.0 112.179 -170.512 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' B' B ' 138' ' ' LEU . . . . . . . . . . . . . 6.1 tt -118.0 128.21 54.56 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 115.186 -0.915 . . . . 0.0 109.9 178.969 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' B' B ' 139' ' ' THR . . . . . . . . . . . . . 34.0 m -106.27 127.76 53.48 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.261 -0.427 . . . . 0.0 110.396 -179.87 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' B' B ' 140' ' ' LEU . . . . . . . . . . . . . 5.5 tt -113.88 121.02 42.71 Favored 'General case' 0 C--N 1.328 -0.351 0 N-CA-C 109.149 -0.686 . . . . 0.0 109.149 -178.922 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' B' B ' 141' ' ' ILE . . . . . . . . . . . . . 19.1 mt -119.88 116.81 51.65 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.303 0 N-CA-C 109.814 -0.439 . . . . 0.0 109.814 -176.604 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' B' B ' 142' ' ' ARG . . . . . . . . . . . . . 68.5 ttt180 -108.18 131.97 54.11 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 115.417 -0.81 . . . . 0.0 110.463 -177.092 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' B' B ' 143' ' ' THR . . . . . . . . . . . . . 35.2 p . . . . . 0 C--O 1.22 -0.45 0 CA-C-O 117.936 -1.03 . . . . 0.0 110.522 179.092 . . . . . . . . 0 0 . 1 . 018 nuclear orig core ' C' C ' 2' ' ' SER . . . . . . . . . . . . . 12.6 p . . . . . 0 N--CA 1.463 0.181 0 CA-C-O 121.024 0.44 . . . . 0.0 110.906 . . . . . . . . . 0 0 . 1 . 018 nuclear orig core ' C' C ' 3' ' ' GLU . . . . . . . . . . . . . 95.8 mt-10 -141.0 142.44 34.26 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 115.863 -0.608 . . . . 0.0 110.961 -178.356 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' C' C ' 4' ' ' LEU . . . . . . . . . . . . . 16.2 tp -122.73 127.05 48.7 Favored 'General case' 0 C--N 1.331 -0.207 0 CA-C-N 116.103 -0.499 . . . . 0.0 109.719 175.402 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' C' C ' 5' ' ' LYS . . . . . . . . . . . . . 52.5 mttp -108.07 122.12 46.23 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-O 120.763 0.315 . . . . 0.0 110.995 -179.109 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' C' C ' 6' ' ' LEU . . . . . . . . . . . . . 27.6 mt -116.21 151.81 34.98 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 115.543 -0.753 . . . . 0.0 110.522 179.863 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' C' C ' 7' ' ' LYS . . . . . . . . . . . . . 74.2 tttt -144.02 139.56 16.11 Favored Pre-proline 0 CA--C 1.534 0.331 0 CA-C-O 119.124 -0.465 . . . . 0.0 109.949 173.569 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' C' C ' 8' ' ' PRO . . . . . . . . . . . . . 80.3 Cg_endo -90.65 141.54 3.23 Favored 'Trans proline' 0 N--CA 1.491 1.364 0 C-N-CA 121.66 1.573 . . . . 0.0 111.72 176.764 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' C' C ' 9' ' ' LEU . . . . . . . . . . . . . 54.6 mt -73.78 -47.97 6.66 Favored Pre-proline 0 CA--C 1.535 0.392 0 CA-C-O 118.665 -0.683 . . . . 0.0 112.472 -178.519 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' C' C ' 10' ' ' PRO . . . . . . . . . . . . . 88.1 Cg_endo -80.66 152.3 19.73 Favored 'Trans proline' 0 N--CA 1.497 1.677 0 C-N-CA 121.313 1.342 . . . . 0.0 111.99 177.422 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' C' C ' 11' ' ' LYS . . . . . . . . . . . . . 73.8 mmtt -82.49 102.0 11.06 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-O 120.929 0.395 . . . . 0.0 110.222 177.524 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' C' C ' 12' ' ' VAL . . . . . . . . . . . . . 12.9 p -141.31 146.4 23.53 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 CA-C-N 116.136 -0.483 . . . . 0.0 110.466 -179.225 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' C' C ' 13' ' ' GLU . . . . . . . . . . . . . 85.0 tt0 -85.19 124.44 31.84 Favored 'General case' 0 C--N 1.329 -0.306 0 N-CA-C 109.93 -0.396 . . . . 0.0 109.93 177.429 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' C' C ' 14' ' ' LEU . . . . . . . . . . . . . 48.8 mt -93.12 142.8 25.81 Favored Pre-proline 0 CA--C 1.533 0.314 0 CA-C-O 119.072 -0.49 . . . . 0.0 110.379 -177.453 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' C' C ' 15' ' ' PRO . . . . . . . . . . . . . 35.6 Cg_exo -60.22 162.1 17.94 Favored 'Trans proline' 0 N--CA 1.496 1.665 0 C-N-CA 121.353 1.369 . . . . 0.0 112.034 176.887 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' C' C ' 16' ' ' PRO . . . . . . . . . . . . . 38.3 Cg_exo -58.2 -42.33 57.87 Favored 'Trans proline' 0 N--CA 1.496 1.632 0 C-N-CA 121.507 1.472 . . . . 0.0 112.897 -176.399 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' C' C ' 17' ' ' ASP . . . . . . . . . . . . . 15.2 p-10 -92.87 13.03 21.68 Favored 'General case' 0 C--N 1.327 -0.383 0 N-CA-C 113.239 0.829 . . . . 0.0 113.239 -175.966 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' C' C ' 18' ' ' PHE . . . . . . . . . . . . . 41.8 t80 -57.71 -43.98 85.59 Favored 'General case' 0 C--O 1.231 0.1 0 CA-C-O 121.073 0.463 . . . . 0.0 110.08 -178.188 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' C' C ' 19' ' ' VAL . . . . . . . . . . . . . 44.9 t -59.47 -42.39 87.66 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.346 0 CA-C-N 116.122 -0.49 . . . . 0.0 110.21 -179.259 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' C' C ' 20' ' ' ASP . . . . . . . . . . . . . 78.5 m-20 -59.69 -42.66 93.46 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-O 120.732 0.301 . . . . 0.0 110.951 -177.361 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' C' C ' 21' ' ' VAL . . . . . . . . . . . . . 43.7 t -64.58 -46.8 91.46 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.318 0 C-N-CA 120.79 -0.364 . . . . 0.0 110.315 -177.755 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' C' C ' 22' ' ' ILE . . . . . . . . . . . . . 24.5 mm -59.32 -40.1 80.58 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.276 0 C-N-CA 120.869 -0.332 . . . . 0.0 110.362 -179.017 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' C' C ' 23' ' ' ARG . . . . . . . . . . . . . 55.8 ttp180 -55.36 -50.04 70.72 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-O 121.038 0.447 . . . . 0.0 110.736 178.335 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' C' C ' 24' ' ' ILE . . . . . . . . . . . . . 78.0 mt -60.21 -46.06 95.2 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.327 0 CA-C-N 116.005 -0.543 . . . . 0.0 111.595 -177.379 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' C' C ' 25' ' ' LYS . . . . . . . . . . . . . 17.7 ptpt -67.47 -39.15 85.28 Favored 'General case' 0 CA--C 1.534 0.358 0 C-N-CA 120.584 -0.446 . . . . 0.0 111.94 -173.71 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' C' C ' 26' ' ' LEU . . . . . . . . . . . . . 21.8 mt -79.49 -31.66 42.33 Favored 'General case' 0 C--N 1.33 -0.255 0 N-CA-C 113.045 0.757 . . . . 0.0 113.045 -174.765 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' C' C ' 27' ' ' GLN . . . . . . . . . . . . . 4.5 pt20 -45.9 135.48 7.14 Favored 'General case' 0 CA--C 1.536 0.436 0 N-CA-C 112.78 0.659 . . . . 0.0 112.78 -175.083 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' C' C ' 28' ' ' GLY . . . . . . . . . . . . . . . 97.06 -21.14 47.83 Favored Glycine 0 CA--C 1.534 1.264 0 CA-C-N 115.985 -0.552 . . . . 0.0 112.683 -177.822 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' C' C ' 29' ' ' LYS . . . . . . . . . . . . . 61.7 mttp -97.53 155.14 17.08 Favored 'General case' 0 C--N 1.331 -0.213 0 CA-C-N 117.522 0.661 . . . . 0.0 110.963 -178.984 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' C' C ' 30' ' ' THR . . . . . . . . . . . . . 13.9 m -104.02 139.72 38.74 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.337 177.989 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' C' C ' 31' ' ' VAL . . . . . . . . . . . . . 34.0 m -131.61 157.35 43.15 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.206 0 CA-C-N 116.234 -0.439 . . . . 0.0 110.856 -179.151 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' C' C ' 32' ' ' ARG . . . . . . . . . . . . . 81.7 mtt85 -133.65 150.7 51.57 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-N 115.957 -0.565 . . . . 0.0 110.744 176.828 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' C' C ' 33' ' ' THR . . . . . . . . . . . . . 33.5 m -53.41 139.98 28.95 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.206 -0.452 . . . . 0.0 111.282 -178.944 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' C' C ' 34' ' ' GLY . . . . . . . . . . . . . . . 98.65 -16.98 59.02 Favored Glycine 0 CA--C 1.532 1.125 0 CA-C-O 119.638 -0.535 . . . . 0.0 113.329 178.332 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' C' C ' 35' ' ' ASP . . . . . . . . . . . . . 76.9 m-20 -64.3 149.08 48.86 Favored 'General case' 0 C--O 1.231 0.125 0 CA-C-N 118.054 0.927 . . . . 0.0 111.225 -179.865 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' C' C ' 36' ' ' VAL . . . . . . . . . . . . . 46.2 t -121.07 129.66 75.46 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.211 0 CA-C-N 115.777 -0.647 . . . . 0.0 109.816 178.644 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' C' C ' 37' ' ' ILE . . . . . . . . . . . . . 72.1 mt -123.23 139.98 48.27 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.276 0 CA-C-N 116.182 -0.463 . . . . 0.0 109.994 -179.77 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' C' C ' 38' ' ' GLY . . . . . . . . . . . . . . . -108.91 128.67 9.15 Favored Glycine 0 CA--C 1.526 0.736 0 N-CA-C 111.317 -0.713 . . . . 0.0 111.317 -179.302 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' C' C ' 39' ' ' ILE . . . . . . . . . . . . . 77.7 mt -128.34 135.36 62.82 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.187 0 CA-C-O 120.757 0.313 . . . . 0.0 110.185 178.535 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' C' C ' 40' ' ' SER . . . . . . . . . . . . . 32.6 p -92.78 117.03 29.57 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.324 -0.398 . . . . 0.0 110.822 175.377 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' C' C ' 41' ' ' ILE . . . . . . . . . . . . . 45.7 mm -121.12 112.91 37.66 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.21 0 CA-C-O 120.794 0.331 . . . . 0.0 110.186 178.686 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' C' C ' 42' ' ' LEU . . . . . . . . . . . . . 2.0 tt 55.58 48.56 18.4 Favored 'General case' 0 CA--C 1.533 0.307 0 CA-C-O 121.538 0.685 . . . . 0.0 110.098 178.643 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' C' C ' 43' ' ' GLY . . . . . . . . . . . . . . . 71.77 -5.48 11.92 Favored Glycine 0 CA--C 1.536 1.359 0 C-N-CA 121.125 -0.559 . . . . 0.0 113.766 175.642 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' C' C ' 44' ' ' LYS . . . . . . . . . . . . . 25.6 tptp -103.34 132.97 49.17 Favored 'General case' 0 C--O 1.231 0.126 0 CA-C-N 117.975 0.888 . . . . 0.0 110.031 -178.716 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' C' C ' 45' ' ' GLU . . . . . . . . . . . . . 82.5 tt0 -82.34 119.7 24.48 Favored 'General case' 0 C--N 1.329 -0.32 0 C-N-CA 120.808 -0.357 . . . . 0.0 110.78 -178.476 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' C' C ' 46' ' ' VAL . . . . . . . . . . . . . 7.2 p -122.8 124.52 70.65 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.21 0 N-CA-C 109.42 -0.585 . . . . 0.0 109.42 177.283 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' C' C ' 47' ' ' LYS . . . . . . . . . . . . . 53.7 mtmt -100.88 132.0 46.49 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.073 -0.512 . . . . 0.0 111.124 177.201 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' C' C ' 48' ' ' PHE . . . . . . . . . . . . . 84.3 m-85 -109.42 134.17 52.17 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 115.87 -0.605 . . . . 0.0 110.417 179.741 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' C' C ' 49' ' ' LYS . . . . . . . . . . . . . 87.5 tttt -105.3 134.36 48.54 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 115.844 -0.616 . . . . 0.0 110.05 178.589 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' C' C ' 50' ' ' VAL . . . . . . . . . . . . . 44.6 t -77.87 106.69 8.62 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.243 0 N-CA-C 109.147 -0.686 . . . . 0.0 109.147 174.873 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' C' C ' 51' ' ' VAL . . . . . . . . . . . . . 45.8 t -68.71 -46.63 79.37 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.308 0 CA-C-N 116.107 -0.497 . . . . 0.0 110.018 -172.59 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' C' C ' 52' ' ' GLN . . . . . . . . . . . . . 45.0 tt0 -171.39 145.25 2.09 Favored 'General case' 0 C--N 1.331 -0.207 0 C-N-CA 120.229 -0.588 . . . . 0.0 111.662 -179.361 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' C' C ' 53' ' ' ALA . . . . . . . . . . . . . . . -116.63 132.1 56.77 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 115.766 -0.652 . . . . 0.0 110.013 176.459 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' C' C ' 54' ' ' TYR . . . . . . . . . . . . . 48.2 t80 -129.11 108.87 18.03 Favored Pre-proline 0 CA--C 1.535 0.39 0 CA-C-O 118.264 -0.874 . . . . 0.0 110.242 177.983 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' C' C ' 55' ' ' PRO . . . . . . . . . . . . . 72.4 Cg_endo -77.11 168.5 76.83 Favored 'Cis proline' 0 N--CA 1.498 1.774 0 CA-C-N 121.865 1.702 . . . . 0.0 112.504 -3.823 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' C' C ' 56' ' ' SER . . . . . . . . . . . . . 50.2 m -115.71 130.49 24.31 Favored Pre-proline 0 CA--C 1.538 0.501 0 CA-C-O 118.456 -0.783 . . . . 0.0 109.373 174.446 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' C' C ' 57' ' ' PRO . . . . . . . . . . . . . 54.8 Cg_endo -70.0 165.3 77.7 Favored 'Cis proline' 0 N--CA 1.497 1.732 0 CA-C-N 121.918 1.721 . . . . 0.0 111.432 0.606 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' C' C ' 58' ' ' LEU . . . . . . . . . . . . . 29.3 tp -129.73 137.51 50.61 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-O 120.908 0.385 . . . . 0.0 110.419 -179.957 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' C' C ' 59' ' ' ARG . . . . . . . . . . . . . 64.7 ttp85 -106.98 125.72 51.38 Favored 'General case' 0 C--N 1.328 -0.332 0 N-CA-C 109.328 -0.619 . . . . 0.0 109.328 176.917 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' C' C ' 60' ' ' VAL . . . . . . . . . . . . . 45.0 t -75.48 115.97 17.66 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.288 0 CA-C-O 120.878 0.37 . . . . 0.0 110.656 -173.884 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' C' C ' 61' ' ' GLU . . . . . . . . . . . . . 39.1 tp10 -131.05 154.76 47.89 Favored 'General case' 0 C--N 1.33 -0.263 0 N-CA-C 109.062 -0.718 . . . . 0.0 109.062 176.77 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' C' C ' 62' ' ' ASP . . . . . . . . . . . . . 83.4 m-20 -50.86 -32.33 20.01 Favored 'General case' 0 C--N 1.326 -0.444 0 N-CA-C 112.162 0.43 . . . . 0.0 112.162 -176.612 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' C' C ' 63' ' ' ARG . . . . . . . . . . . . . 75.4 mtt85 -72.37 -22.19 61.18 Favored 'General case' 0 C--N 1.33 -0.261 0 N-CA-C 113.154 0.798 . . . . 0.0 113.154 -175.627 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' C' C ' 64' ' ' THR . . . . . . . . . . . . . 33.3 m -68.81 140.36 55.26 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-O 120.86 0.362 . . . . 0.0 110.697 -176.778 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' C' C ' 65' ' ' LYS . . . . . . . . . . . . . 97.2 mttt -88.08 134.64 33.71 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.045 -0.525 . . . . 0.0 109.989 179.159 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' C' C ' 66' ' ' ILE . . . . . . . . . . . . . 53.7 mt -111.09 129.84 65.64 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.238 0 N-CA-C 109.607 -0.516 . . . . 0.0 109.607 -178.248 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' C' C ' 67' ' ' THR . . . . . . . . . . . . . 34.6 m -123.69 140.24 53.19 Favored 'General case' 0 C--N 1.331 -0.223 0 CA-C-O 121.079 0.466 . . . . 0.0 111.295 -175.724 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' C' C ' 68' ' ' LEU . . . . . . . . . . . . . 8.2 mp . . . . . 0 C--N 1.328 -0.353 0 CA-C-N 115.667 -0.697 . . . . 0.0 110.1 176.077 . . . . . . . . 0 0 . 1 . 018 nuclear orig core ' C' C ' 73' ' ' VAL . . . . . . . . . . . . . 21.1 m . . . . . 0 C--O 1.232 0.134 0 CA-C-O 121.137 0.494 . . . . 0.0 111.038 . . . . . . . . . 0 0 . 1 . 018 nuclear orig core ' C' C ' 74' ' ' ASP . . . . . . . . . . . . . 7.0 t0 -107.95 122.92 47.81 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 115.572 -0.74 . . . . 0.0 109.371 175.251 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' C' C ' 75' ' ' VAL . . . . . . . . . . . . . 40.1 t -112.52 121.32 64.63 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.231 0 CA-C-O 121.128 0.49 . . . . 0.0 110.676 -177.69 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' C' C ' 76' ' ' LEU . . . . . . . . . . . . . 6.4 mp -119.57 148.48 43.26 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 115.573 -0.74 . . . . 0.0 109.621 176.309 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' C' C ' 77' ' ' GLU . . . . . . . . . . . . . 98.0 mt-10 -137.84 133.58 34.1 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-O 121.108 0.48 . . . . 0.0 111.129 -177.988 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' C' C ' 78' ' ' ALA . . . . . . . . . . . . . . . -118.74 128.0 54.08 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 115.674 -0.693 . . . . 0.0 109.672 176.724 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' C' C ' 79' ' ' LYS . . . . . . . . . . . . . 61.7 mttp -83.87 114.94 22.01 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-O 121.05 0.452 . . . . 0.0 110.897 -176.072 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' C' C ' 80' ' ' ILE . . . . . . . . . . . . . 43.7 mm -139.26 107.33 3.19 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.28 0 N-CA-C 109.025 -0.731 . . . . 0.0 109.025 -178.023 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' C' C ' 81' ' ' LYS . . . . . . . . . . . . . 77.4 tttt -95.34 127.41 41.37 Favored 'General case' 0 C--N 1.328 -0.369 0 C-N-CA 120.676 -0.409 . . . . 0.0 110.687 -177.837 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' C' C ' 82' ' ' GLY . . . . . . . . . . . . . . . 89.29 42.03 5.65 Favored Glycine 0 CA--C 1.524 0.645 0 C-N-CA 120.749 -0.738 . . . . 0.0 111.744 176.426 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' C' C ' 83' ' ' ILE . . . . . . . . . . . . . 67.9 mt -68.39 139.28 20.92 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.324 0 N-CA-C 109.47 -0.567 . . . . 0.0 109.47 176.586 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' C' C ' 84' ' ' LYS . . . . . . . . . . . . . 68.5 tttt -98.42 -54.14 3.13 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.112 -0.495 . . . . 0.0 110.704 -176.009 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' C' C ' 85' ' ' ASP . . . . . . . . . . . . . 6.9 t70 -152.14 155.31 37.6 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 115.885 -0.598 . . . . 0.0 110.353 -177.883 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' C' C ' 86' ' ' VAL . . . . . . . . . . . . . 40.3 t -133.17 132.23 58.48 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.254 0 CA-C-O 121.017 0.437 . . . . 0.0 110.729 -178.485 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' C' C ' 87' ' ' ILE . . . . . . . . . . . . . 45.1 mm -117.63 122.28 69.47 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.276 0 CA-C-N 115.776 -0.647 . . . . 0.0 109.325 174.431 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' C' C ' 88' ' ' LEU . . . . . . . . . . . . . 13.4 tp -113.04 130.75 56.04 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-O 120.992 0.425 . . . . 0.0 110.998 -176.219 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' C' C ' 89' ' ' ASP . . . . . . . . . . . . . 11.7 t70 -128.65 160.24 33.06 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 115.888 -0.597 . . . . 0.0 109.863 178.38 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' C' C ' 90' ' ' GLU . . . . . . . . . . . . . 83.3 tt0 -46.23 -41.13 12.45 Favored 'General case' 0 CA--C 1.532 0.282 0 N-CA-C 113.073 0.768 . . . . 0.0 113.073 -172.041 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' C' C ' 91' ' ' ASN . . . . . . . . . . . . . 25.6 m120 -132.05 27.55 4.53 Favored 'General case' 0 N--CA 1.467 0.409 0 N-CA-C 112.44 0.533 . . . . 0.0 112.44 -177.451 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' C' C ' 92' ' ' LEU . . . . . . . . . . . . . 12.2 mt -149.98 141.17 23.11 Favored 'General case' 0 C--N 1.33 -0.265 0 N-CA-C 110.221 -0.288 . . . . 0.0 110.221 -177.43 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' C' C ' 93' ' ' ILE . . . . . 0.411 HD12 HG23 ' C' ' 93' ' ' ILE . 73.0 mt -124.5 113.63 37.22 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.284 0 N-CA-C 109.075 -0.713 . . . . 0.0 109.075 176.887 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' C' C ' 94' ' ' VAL . . . . . . . . . . . . . 45.0 t -116.6 126.49 74.08 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.247 0 N-CA-C 109.806 -0.442 . . . . 0.0 109.806 -179.388 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' C' C ' 95' ' ' VAL . . . . . . . . . . . . . 40.2 t -124.38 136.63 59.89 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.325 0 CA-C-N 116.28 -0.418 . . . . 0.0 110.056 -178.687 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' C' C ' 96' ' ' ILE . . . . . . . . . . . . . 61.4 mt -116.55 130.55 71.19 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.361 0 N-CA-C 109.221 -0.659 . . . . 0.0 109.221 179.112 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' C' C ' 97' ' ' THR . . . . . . . . . . . . . 71.4 p -98.37 159.99 14.58 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-O 120.908 0.385 . . . . 0.0 110.619 -178.346 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' C' C ' 98' ' ' GLU . . . . . . . . . . . . . 12.8 pt-20 -53.99 -19.27 4.45 Favored 'General case' 0 CA--C 1.535 0.367 0 N-CA-C 112.801 0.667 . . . . 0.0 112.801 -179.266 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' C' C ' 99' ' ' GLU . . . . . . . . . . . . . 37.1 tt0 -85.67 16.34 4.02 Favored 'General case' 0 CA--C 1.539 0.545 0 N-CA-C 112.567 0.58 . . . . 0.0 112.567 -177.259 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' C' C ' 100' ' ' ASN . . . . . . . . . . . . . 3.4 m-20 61.14 38.06 17.18 Favored 'General case' 0 CA--C 1.529 0.17 0 O-C-N 121.818 -0.551 . . . . 0.0 110.971 178.564 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' C' C ' 101' ' ' GLU . . . . . . . . . . . . . 82.0 tt0 -116.12 143.24 45.74 Favored 'General case' 0 C--N 1.331 -0.207 0 N-CA-C 109.444 -0.576 . . . . 0.0 109.444 175.831 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' C' C ' 102' ' ' VAL . . . . . . . . . . . . . 44.4 t -117.66 128.41 74.87 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.263 0 CA-C-O 120.972 0.415 . . . . 0.0 110.098 -177.609 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' C' C ' 103' ' ' LEU . . . . . . . . . . . . . 25.0 mt -118.38 136.35 53.8 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 115.564 -0.743 . . . . 0.0 109.752 176.164 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' C' C ' 104' ' ' ILE . . . . . . . . . . . . . 69.2 mt -118.19 121.34 66.99 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.244 0 N-CA-C 109.844 -0.428 . . . . 0.0 109.844 179.725 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' C' C ' 105' ' ' PHE . . . . . . . . . . . . . 53.9 m-85 -118.11 161.31 20.06 Favored 'General case' 0 C--N 1.333 -0.139 0 O-C-N 124.183 0.927 . . . . 0.0 109.836 -179.328 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' C' C ' 106' ' ' ASN . . . . . . . . . . . . . 44.7 p-10 -98.82 -171.04 2.03 Favored 'General case' 0 C--N 1.33 -0.246 0 N-CA-C 110.049 -0.352 . . . . 0.0 110.049 175.427 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' C' C ' 107' ' ' GLN . . . . . . . . . . . . . 41.0 tt0 -58.29 -30.13 66.39 Favored 'General case' 0 C--N 1.329 -0.284 0 N-CA-C 111.968 0.358 . . . . 0.0 111.968 -179.459 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' C' C ' 108' ' ' ASN . . . . . . . . . . . . . 12.9 t30 -86.17 8.78 19.68 Favored 'General case' 0 CA--C 1.535 0.398 0 N-CA-C 113.475 0.917 . . . . 0.0 113.475 -175.954 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' C' C ' 109' ' ' LEU . . . . . . . . . . . . . 11.9 tp 62.96 38.55 11.06 Favored 'General case' 0 CA--C 1.53 0.185 0 CA-C-O 121.073 0.464 . . . . 0.0 111.301 177.752 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' C' C ' 110' ' ' GLU . . . . . . . . . . . . . 70.7 mm-40 -109.16 157.43 18.78 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 116.37 -0.377 . . . . 0.0 110.114 176.211 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' C' C ' 111' ' ' GLU . . . . . . . . . . . . . 98.5 mt-10 -86.35 124.24 32.48 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-O 120.806 0.336 . . . . 0.0 111.263 -178.401 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' C' C ' 112' ' ' LEU . . . . . . . . . . . . . 13.5 mt -111.14 -45.99 3.37 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 115.982 -0.554 . . . . 0.0 110.711 178.479 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' C' C ' 113' ' ' TYR . . . . . . . . . . . . . 61.6 t80 -135.85 142.45 44.79 Favored 'General case' 0 N--CA 1.464 0.256 0 C-N-CA 120.749 -0.381 . . . . 0.0 111.532 -178.224 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' C' C ' 114' ' ' ARG . . . . . . . . . . . . . 51.3 mtt85 -135.75 125.88 26.2 Favored 'General case' 0 C--N 1.331 -0.21 0 CA-C-N 115.996 -0.547 . . . . 0.0 109.937 179.684 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' C' C ' 115' ' ' GLY . . . . . . . . . . . . . . . -150.13 155.06 26.04 Favored Glycine 0 CA--C 1.524 0.65 0 C-N-CA 120.643 -0.789 . . . . 0.0 111.296 177.886 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' C' C ' 116' ' ' LYS . . . . . . . . . . . . . 36.1 ttpt -129.98 136.07 49.02 Favored 'General case' 0 C--N 1.331 -0.224 0 N-CA-C 109.64 -0.504 . . . . 0.0 109.64 175.875 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' C' C ' 117' ' ' PHE . . . . . . . . . . . . . 40.0 m-85 -137.7 113.92 10.08 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-O 120.927 0.394 . . . . 0.0 110.313 -176.033 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' C' C ' 118' ' ' GLU . . . . . . . . . . . . . 95.7 mt-10 -56.0 -46.4 78.74 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.388 -0.369 . . . . 0.0 110.976 -176.321 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' C' C ' 119' ' ' ASN . . . . . . . . . . . . . 71.0 m-80 -95.86 31.03 2.19 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.102 -0.499 . . . . 0.0 112.002 -174.99 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' C' C ' 120' ' ' LEU . . . . . . . . . . . . . 12.2 tp -56.7 119.96 7.02 Favored 'General case' 0 C--N 1.333 -0.144 0 C-N-CA 120.993 -0.283 . . . . 0.0 110.278 178.284 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' C' C ' 121' ' ' ASN . . . . . . . . . . . . . 56.3 m-20 -114.08 -44.2 3.17 Favored 'General case' 0 C--N 1.331 -0.226 0 CA-C-N 116.491 -0.322 . . . . 0.0 110.983 -176.883 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' C' C ' 122' ' ' LYS . . . . . . . . . . . . . 92.5 mttt -143.26 145.21 32.54 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-O 121.126 0.489 . . . . 0.0 111.688 -178.133 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' C' C ' 123' ' ' VAL . . . . . . . . . . . . . 43.8 t -124.75 126.2 71.11 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.262 0 CA-C-N 115.735 -0.666 . . . . 0.0 109.325 174.997 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' C' C ' 124' ' ' LEU . . . . . . . . . . . . . 74.4 mt -115.13 129.45 56.67 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.507 -0.315 . . . . 0.0 110.379 -177.122 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' C' C ' 125' ' ' VAL . . . . . . . . . . . . . 43.6 t -127.9 122.6 58.99 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.225 0 CA-C-N 116.282 -0.417 . . . . 0.0 109.898 178.851 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' C' C ' 126' ' ' ARG . . . . . . . . . . . . . 80.9 mtt85 -151.99 135.6 16.18 Favored 'General case' 0 C--N 1.33 -0.255 0 N-CA-C 109.748 -0.464 . . . . 0.0 109.748 178.267 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' C' C ' 127' ' ' ASN . . . . . . . . . . . . . 3.1 m120 55.99 -154.99 0.3 Allowed 'General case' 0 CA--C 1.539 0.549 0 N-CA-C 109.644 -0.502 . . . . 0.0 109.644 -179.282 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' C' C ' 128' ' ' ASP . . . . . . . . . . . . . 9.3 p-10 -84.88 21.47 1.58 Allowed 'General case' 0 CA--C 1.535 0.384 0 CA-C-N 118.432 0.56 . . . . 0.0 112.199 175.831 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' C' C ' 129' ' ' LEU . . . . . . . . . . . . . 12.8 tp -116.42 137.76 51.9 Favored 'General case' 0 C--O 1.234 0.254 0 CA-C-O 120.91 0.386 . . . . 0.0 110.381 -179.676 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' C' C ' 130' ' ' VAL . . . . . . . . . . . . . 42.8 t -124.33 136.8 59.32 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.204 0 CA-C-N 116.079 -0.509 . . . . 0.0 110.049 -178.864 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' C' C ' 131' ' ' VAL . . . . . . . . . . . . . 44.6 t -136.02 137.79 48.24 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.292 0 CA-C-O 120.946 0.403 . . . . 0.0 110.329 179.181 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' C' C ' 132' ' ' ILE . . . . . . . . . . . . . 72.4 mt -121.26 134.09 65.74 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.247 0 CA-C-N 116.064 -0.516 . . . . 0.0 109.795 -179.027 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' C' C ' 133' ' ' ILE . . . . . . . . . . . . . 42.9 mm -117.2 121.56 67.97 Favored 'Isoleucine or valine' 0 C--O 1.233 0.228 0 CA-C-O 120.834 0.349 . . . . 0.0 111.156 -176.275 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' C' C ' 134' ' ' ASP . . . . . . . . . . . . . 6.9 p-10 -133.47 147.12 51.65 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 115.78 -0.645 . . . . 0.0 109.52 174.003 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' C' C ' 135' ' ' GLU . . . . . . . . . . . . . 83.3 tt0 -50.05 -25.05 3.05 Favored 'General case' 0 C--N 1.327 -0.373 0 N-CA-C 112.96 0.726 . . . . 0.0 112.96 -171.247 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' C' C ' 136' ' ' GLN . . . . . . . . . . . . . 95.6 mm-40 -93.46 -35.03 13.17 Favored 'General case' 0 C--N 1.33 -0.267 0 N-CA-C 112.633 0.605 . . . . 0.0 112.633 -176.379 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' C' C ' 137' ' ' LYS . . . . . . . . . . . . . 50.0 mtmt -146.2 154.74 42.1 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-O 121.303 0.573 . . . . 0.0 112.056 -169.13 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' C' C ' 138' ' ' LEU . . . . . . . . . . . . . 5.5 tt -116.81 123.45 47.15 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 115.349 -0.841 . . . . 0.0 109.16 175.151 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' C' C ' 139' ' ' THR . . . . . . . . . . . . . 30.7 m -111.57 129.71 55.98 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 116.483 -0.326 . . . . 0.0 110.97 -175.939 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' C' C ' 140' ' ' LEU . . . . . . . . . . . . . 7.4 tt -117.77 124.36 48.24 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 115.747 -0.66 . . . . 0.0 109.449 -179.624 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' C' C ' 141' ' ' ILE . . . . . . . . . . . . . 19.0 mt -122.43 120.54 61.35 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.277 0 N-CA-C 109.909 -0.404 . . . . 0.0 109.909 -175.972 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' C' C ' 142' ' ' ARG . . . . . . . . . . . . . 78.3 ttt-85 . . . . . 0 C--N 1.33 -0.248 0 CA-C-N 115.84 -0.618 . . . . 0.0 110.099 -178.086 . . . . . . . . 0 0 . 1 . 018 nuclear orig core ' D' D ' 2' ' ' SER . . . . . . . . . . . . . 79.5 p . . . . . 0 C--O 1.232 0.183 0 CA-C-O 120.92 0.39 . . . . 0.0 110.522 . . . . . . . . . 0 0 . 1 . 018 nuclear orig core ' D' D ' 3' ' ' GLU . . . . . . . . . . . . . 84.9 tt0 -140.22 138.4 35.06 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.063 -0.517 . . . . 0.0 110.987 -178.647 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' D' D ' 4' ' ' LEU . . . . . . . . . . . . . 4.9 tt -124.25 130.23 52.15 Favored 'General case' 0 C--N 1.332 -0.187 0 CA-C-N 115.96 -0.564 . . . . 0.0 110.137 178.309 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' D' D ' 5' ' ' LYS . . . . . . . . . . . . . 67.6 mttm -109.65 122.58 47.78 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.455 -0.339 . . . . 0.0 111.017 -178.739 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' D' D ' 6' ' ' LEU . . . . . . . . . . . . . 79.6 mt -115.38 149.78 37.41 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 115.369 -0.832 . . . . 0.0 110.331 179.793 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' D' D ' 7' ' ' LYS . . . . . . . . . . . . . 64.1 tttm -137.45 137.07 21.29 Favored Pre-proline 0 CA--C 1.534 0.338 0 CA-C-O 119.014 -0.517 . . . . 0.0 110.087 176.587 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' D' D ' 8' ' ' PRO . . . . . . . . . . . . . 93.1 Cg_endo -92.01 141.73 2.49 Favored 'Trans proline' 0 N--CA 1.49 1.3 0 C-N-CA 121.823 1.682 . . . . 0.0 111.491 176.701 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' D' D ' 9' ' ' LEU . . . . . . . . . . . . . 66.7 mt -75.86 -47.48 3.84 Favored Pre-proline 0 CA--C 1.533 0.292 0 CA-C-O 118.74 -0.648 . . . . 0.0 112.219 -178.439 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' D' D ' 10' ' ' PRO . . . . . . . . . . . . . 98.6 Cg_endo -81.74 149.04 16.04 Favored 'Trans proline' 0 N--CA 1.495 1.612 0 C-N-CA 121.184 1.256 . . . . 0.0 111.852 175.542 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' D' D ' 11' ' ' LYS . . . . . . . . . . . . . 24.3 tptp -88.86 100.53 13.24 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-O 120.764 0.316 . . . . 0.0 110.399 179.539 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' D' D ' 12' ' ' VAL . . . . . . . . . . . . . 11.4 p -139.62 142.23 33.19 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.233 0 CA-C-N 116.358 -0.383 . . . . 0.0 110.548 -179.206 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' D' D ' 13' ' ' GLU . . . . . . . . . . . . . 43.1 mp0 -78.17 122.44 25.65 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 116.3 -0.409 . . . . 0.0 110.165 178.041 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' D' D ' 14' ' ' LEU . . . . . . . . . . . . . 35.8 mt -98.4 153.44 38.02 Favored Pre-proline 0 CA--C 1.532 0.285 0 CA-C-N 116.462 -0.336 . . . . 0.0 110.51 -179.283 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' D' D ' 15' ' ' PRO . . . . . . . . . . . . . 33.5 Cg_exo -60.56 157.41 36.92 Favored 'Trans proline' 0 N--CA 1.496 1.653 0 C-N-CA 121.256 1.304 . . . . 0.0 111.792 176.801 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' D' D ' 16' ' ' PRO . . . . . . . . . . . . . 36.2 Cg_exo -58.83 -37.39 94.05 Favored 'Trans proline' 0 N--CA 1.498 1.737 0 C-N-CA 121.376 1.384 . . . . 0.0 112.654 -178.177 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' D' D ' 17' ' ' ASP . . . . . . . . . . . . . 7.1 p-10 -88.46 9.94 21.9 Favored 'General case' 0 CA--C 1.534 0.355 0 N-CA-C 113.284 0.846 . . . . 0.0 113.284 -176.832 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' D' D ' 18' ' ' PHE . . . . . . . . . . . . . 19.8 t80 -57.72 -45.06 86.25 Favored 'General case' 0 C--N 1.334 -0.091 0 O-C-N 121.916 -0.49 . . . . 0.0 110.041 -177.653 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' D' D ' 19' ' ' VAL . . . . . . . . . . . . . 48.0 t -57.61 -43.15 82.82 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.286 0 CA-C-N 116.273 -0.421 . . . . 0.0 110.548 -178.521 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' D' D ' 20' ' ' ASP . . . . . . . . . . . . . 82.5 m-20 -60.15 -42.56 95.15 Favored 'General case' 0 C--N 1.33 -0.258 0 C-N-CA 120.837 -0.345 . . . . 0.0 111.112 -176.789 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' D' D ' 21' ' ' VAL . . . . . . . . . . . . . 45.6 t -64.73 -46.28 92.67 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.33 0 C-N-CA 120.807 -0.357 . . . . 0.0 110.347 -177.863 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' D' D ' 22' ' ' ILE . . . . . . . . . . . . . 50.5 mm -56.91 -42.98 79.61 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.229 0 C-N-CA 120.815 -0.354 . . . . 0.0 110.441 178.379 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' D' D ' 23' ' ' ARG . . . . . . . . . . . . . 54.7 ttp180 -53.5 -47.39 69.9 Favored 'General case' 0 C--N 1.33 -0.266 0 O-C-N 122.32 -0.237 . . . . 0.0 111.339 -179.208 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' D' D ' 24' ' ' ILE . . . . . . . . . . . . . 71.7 mt -60.02 -43.41 92.52 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.342 0 C-N-CA 120.933 -0.307 . . . . 0.0 110.698 179.541 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' D' D ' 25' ' ' LYS . . . . . . . . . . . . . 89.0 mttt -61.73 -38.09 86.62 Favored 'General case' 0 C--N 1.328 -0.343 0 N-CA-C 112.379 0.511 . . . . 0.0 112.379 -179.564 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' D' D ' 26' ' ' LEU . . . . . . . . . . . . . 86.3 mt -77.99 -46.63 20.52 Favored 'General case' 0 C--N 1.329 -0.32 0 N-CA-C 112.702 0.63 . . . . 0.0 112.702 -171.719 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' D' D ' 27' ' ' GLN . . . . . . . . . . . . . 11.2 pt20 -47.03 137.76 7.25 Favored 'General case' 0 N--CA 1.47 0.556 0 N-CA-C 112.75 0.648 . . . . 0.0 112.75 -175.839 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' D' D ' 28' ' ' GLY . . . . . . . . . . . . . . . 101.14 -26.86 23.1 Favored Glycine 0 CA--C 1.531 1.092 0 CA-C-N 115.591 -0.731 . . . . 0.0 112.312 -178.454 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' D' D ' 29' ' ' LYS . . . . . . . . . . . . . 87.4 mttt -99.67 155.14 17.77 Favored 'General case' 0 C--N 1.332 -0.182 0 CA-C-N 117.398 0.599 . . . . 0.0 111.385 179.707 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' D' D ' 30' ' ' THR . . . . . . . . . . . . . 22.2 m -101.07 135.38 42.63 Favored 'General case' 0 C--N 1.33 -0.239 0 CA-C-N 116.099 -0.501 . . . . 0.0 109.662 174.119 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' D' D ' 31' ' ' VAL . . . . . . . . . . . . . 34.3 m -127.48 156.33 39.12 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.226 0 CA-C-O 120.866 0.365 . . . . 0.0 111.14 -177.644 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' D' D ' 32' ' ' ARG . . . . . . . . . . . . . 72.8 mtt85 -132.93 149.35 52.25 Favored 'General case' 0 C--O 1.233 0.186 0 CA-C-N 115.724 -0.671 . . . . 0.0 110.838 178.864 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' D' D ' 33' ' ' THR . . . . . . . . . . . . . 23.7 m -53.8 140.46 29.97 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.07 -0.514 . . . . 0.0 111.146 -179.784 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' D' D ' 34' ' ' GLY . . . . . . . . . . . . . . . 99.7 -17.08 57.99 Favored Glycine 0 CA--C 1.531 1.047 0 C-N-CA 121.105 -0.569 . . . . 0.0 113.31 178.753 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' D' D ' 35' ' ' ASP . . . . . . . . . . . . . 75.8 m-20 -62.15 147.63 47.03 Favored 'General case' 0 N--CA 1.461 0.125 0 CA-C-N 118.054 0.927 . . . . 0.0 111.156 179.683 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' D' D ' 36' ' ' VAL . . . . . . . . . . . . . 46.5 t -124.63 129.12 73.79 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.234 0 CA-C-N 115.659 -0.7 . . . . 0.0 109.721 178.883 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' D' D ' 37' ' ' ILE . . . . . . . . . . . . . 68.0 mt -120.74 137.6 53.95 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.229 0 N-CA-C 109.857 -0.423 . . . . 0.0 109.857 -179.706 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' D' D ' 38' ' ' GLY . . . . . . . . . . . . . . . -111.5 128.74 8.8 Favored Glycine 0 CA--C 1.525 0.666 0 N-CA-C 111.018 -0.833 . . . . 0.0 111.018 179.606 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' D' D ' 39' ' ' ILE . . . . . . . . . . . . . 69.6 mt -125.44 126.64 70.89 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.228 0 N-CA-C 109.849 -0.426 . . . . 0.0 109.849 178.782 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' D' D ' 40' ' ' SER . . . . . . . . . . . . . 46.6 t -93.4 120.45 33.69 Favored 'General case' 0 C--N 1.33 -0.262 0 C-N-CA 120.825 -0.35 . . . . 0.0 110.88 176.158 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' D' D ' 41' ' ' ILE . . . . . . . . . . . . . 71.1 mt -132.88 125.47 52.32 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.186 0 CA-C-O 120.749 0.309 . . . . 0.0 110.316 178.589 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' D' D ' 42' ' ' LEU . . . . . . . . . . . . . 61.4 mt 57.5 34.39 24.54 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.098 -0.501 . . . . 0.0 111.891 177.296 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' D' D ' 43' ' ' GLY . . . . . . . . . . . . . . . 78.52 -10.11 31.88 Favored Glycine 0 CA--C 1.535 1.295 0 C-N-CA 121.192 -0.528 . . . . 0.0 113.463 176.975 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' D' D ' 44' ' ' LYS . . . . . . . . . . . . . 52.7 mtmt -101.76 130.25 48.13 Favored 'General case' 0 C--N 1.333 -0.14 0 CA-C-N 117.884 0.842 . . . . 0.0 110.066 176.65 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' D' D ' 45' ' ' GLU . . . . . . . . . . . . . 38.9 tp10 -85.53 130.33 34.6 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.4 -0.364 . . . . 0.0 110.777 -179.924 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' D' D ' 46' ' ' VAL . . . . . . . . . . . . . 7.2 p -121.61 129.46 75.5 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.235 0 N-CA-C 109.631 -0.507 . . . . 0.0 109.631 176.298 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' D' D ' 47' ' ' LYS . . . . . . . . . . . . . 98.5 mttt -101.03 130.44 47.03 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 115.892 -0.595 . . . . 0.0 111.119 178.387 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' D' D ' 48' ' ' PHE . . . . . . . . . . . . . 95.3 m-85 -113.41 131.83 55.85 Favored 'General case' 0 C--N 1.33 -0.244 0 N-CA-C 109.831 -0.433 . . . . 0.0 109.831 176.211 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' D' D ' 49' ' ' LYS . . . . . . . . . . . . . 81.8 tttt -110.5 139.11 46.05 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.402 -0.363 . . . . 0.0 110.63 179.454 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' D' D ' 50' ' ' VAL . . . . . . . . . . . . . 42.5 t -83.53 108.13 15.76 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.276 0 N-CA-C 109.4 -0.593 . . . . 0.0 109.4 175.59 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' D' D ' 51' ' ' VAL . . . . . . . . . . . . . 48.8 t -70.37 -48.26 61.36 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.314 0 CA-C-N 116.039 -0.528 . . . . 0.0 109.851 -173.816 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' D' D ' 52' ' ' GLN . . . . . . . . . . . . . 14.0 pt20 -167.79 157.6 10.24 Favored 'General case' 0 C--N 1.331 -0.201 0 C-N-CA 120.115 -0.634 . . . . 0.0 112.017 -179.864 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' D' D ' 53' ' ' ALA . . . . . . . . . . . . . . . -133.85 135.28 43.62 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 115.314 -0.857 . . . . 0.0 109.97 177.317 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' D' D ' 54' ' ' TYR . . . . . . . . . . . . . 13.8 t80 -129.01 111.69 18.47 Favored Pre-proline 0 CA--C 1.535 0.39 0 CA-C-O 118.24 -0.886 . . . . 0.0 110.133 179.163 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' D' D ' 55' ' ' PRO . . . . . . . . . . . . . 73.4 Cg_endo -77.12 170.21 72.21 Favored 'Cis proline' 0 N--CA 1.501 1.93 0 CA-C-N 121.899 1.714 . . . . 0.0 112.127 -7.587 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' D' D ' 56' ' ' SER . . . . . . . . . . . . . 66.0 m -129.71 140.64 39.23 Favored Pre-proline 0 CA--C 1.538 0.499 0 CA-C-O 118.71 -0.662 . . . . 0.0 109.489 174.52 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' D' D ' 57' ' ' PRO . . . . . . . . . . . . . 38.3 Cg_endo -68.05 156.31 87.46 Favored 'Cis proline' 0 N--CA 1.499 1.836 0 CA-C-N 121.559 1.592 . . . . 0.0 111.723 -2.018 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' D' D ' 58' ' ' LEU . . . . . . . . . . . . . 32.4 tp -128.75 138.86 52.34 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.252 -0.431 . . . . 0.0 110.778 -176.664 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' D' D ' 59' ' ' ARG . . . . . . . . . . . . . 60.1 ttt180 -100.48 120.36 39.88 Favored 'General case' 0 C--N 1.327 -0.4 0 N-CA-C 108.904 -0.776 . . . . 0.0 108.904 173.413 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' D' D ' 60' ' ' VAL . . . . . . . . . . . . . 43.3 t -72.63 126.38 33.12 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.252 0 C-N-CA 120.67 -0.412 . . . . 0.0 110.279 -174.084 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' D' D ' 61' ' ' GLU . . . . . . . . . . . . . 95.5 mt-10 -130.39 162.88 28.12 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 115.85 -0.613 . . . . 0.0 109.687 178.567 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' D' D ' 62' ' ' ASP . . . . . . . . . . . . . 5.2 t70 -53.34 -32.08 47.44 Favored 'General case' 0 C--N 1.328 -0.353 0 N-CA-C 111.782 0.29 . . . . 0.0 111.782 -179.638 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' D' D ' 63' ' ' ARG . . . . . . . . . . . . . 34.4 ptt180 -84.07 4.26 30.98 Favored 'General case' 0 CA--C 1.537 0.456 0 N-CA-C 113.779 1.029 . . . . 0.0 113.779 -174.926 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' D' D ' 64' ' ' THR . . . . . . . . . . . . . 35.4 m -86.93 139.61 30.45 Favored 'General case' 0 C--N 1.332 -0.186 0 CA-C-N 118.211 0.46 . . . . 0.0 110.713 -178.659 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' D' D ' 65' ' ' LYS . . . . . . . . . . . . . 67.5 mttm -90.14 134.05 34.51 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.252 -0.431 . . . . 0.0 110.581 -179.443 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' D' D ' 66' ' ' ILE . . . . . . . . . . . . . 58.8 mt -116.35 134.32 60.15 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.201 0 CA-C-O 120.897 0.379 . . . . 0.0 110.002 -179.719 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' D' D ' 67' ' ' THR . . . . . . . . . . . . . 34.6 m -125.31 141.46 52.07 Favored 'General case' 0 C--N 1.332 -0.17 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.92 -178.344 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' D' D ' 68' ' ' LEU . . . . . . . . . . . . . 5.3 tt . . . . . 0 C--N 1.33 -0.257 0 CA-C-N 116.002 -0.544 . . . . 0.0 110.128 178.468 . . . . . . . . 0 0 . 1 . 018 nuclear orig core ' D' D ' 73' ' ' VAL . . . . . . . . . . . . . 27.7 m . . . . . 0 C--O 1.232 0.134 0 CA-C-O 120.628 0.251 . . . . 0.0 110.468 . . . . . . . . . 0 0 . 1 . 018 nuclear orig core ' D' D ' 74' ' ' ASP . . . . . . . . . . . . . 10.3 t0 -103.68 117.98 35.66 Favored 'General case' 0 C--N 1.33 -0.242 0 N-CA-C 109.796 -0.446 . . . . 0.0 109.796 179.821 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' D' D ' 75' ' ' VAL . . . . . . . . . . . . . 45.4 t -113.52 122.86 68.46 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.227 0 CA-C-O 121.173 0.511 . . . . 0.0 110.474 -178.756 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' D' D ' 76' ' ' LEU . . . . . . . . . . . . . 24.5 mt -122.71 138.04 54.73 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 115.398 -0.819 . . . . 0.0 109.035 176.451 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' D' D ' 77' ' ' GLU . . . . . . . . . . . . . 58.6 tt0 -136.84 135.34 37.83 Favored 'General case' 0 C--N 1.331 -0.197 0 CA-C-O 121.027 0.441 . . . . 0.0 110.995 -177.133 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' D' D ' 78' ' ' ALA . . . . . . . . . . . . . . . -122.47 137.67 54.8 Favored 'General case' 0 C--N 1.331 -0.203 0 CA-C-N 115.862 -0.608 . . . . 0.0 109.926 178.517 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' D' D ' 79' ' ' LYS . . . . . . . . . . . . . 54.2 mtmt -81.97 120.41 25.21 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-O 120.884 0.374 . . . . 0.0 110.483 179.831 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' D' D ' 80' ' ' ILE . . . . . . . . . . . . . 42.6 mm -138.99 112.55 6.76 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.344 0 N-CA-C 109.254 -0.647 . . . . 0.0 109.254 -177.423 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' D' D ' 81' ' ' LYS . . . . . . . . . . . . . 9.3 mtmp? -103.33 126.88 50.72 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-O 120.91 0.386 . . . . 0.0 111.259 -177.158 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' D' D ' 82' ' ' GLY . . . . . . . . . . . . . . . 89.18 42.06 5.68 Favored Glycine 0 CA--C 1.525 0.712 0 C-N-CA 120.989 -0.624 . . . . 0.0 111.645 174.795 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' D' D ' 83' ' ' ILE . . . . . . . . . . . . . 72.5 mt -69.92 134.71 29.65 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.331 0 N-CA-C 109.501 -0.555 . . . . 0.0 109.501 176.347 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' D' D ' 84' ' ' LYS . . . . . . . . . . . . . 35.7 ttpt -98.65 -54.11 3.12 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-O 121.057 0.456 . . . . 0.0 110.423 -178.811 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' D' D ' 85' ' ' ASP . . . . . . . . . . . . . 10.6 t70 -148.53 149.94 32.5 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 115.758 -0.656 . . . . 0.0 110.387 -178.168 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' D' D ' 86' ' ' VAL . . . . . . . . . . . . . 40.7 t -127.41 129.51 70.58 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.252 0 CA-C-O 120.813 0.339 . . . . 0.0 110.474 -178.906 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' D' D ' 87' ' ' ILE . . . . . . . . . . . . . 43.7 mm -119.49 130.87 73.48 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.255 0 CA-C-N 115.98 -0.554 . . . . 0.0 109.61 177.305 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' D' D ' 88' ' ' LEU . . . . . . . . . . . . . 19.3 tp -115.42 135.79 53.75 Favored 'General case' 0 C--N 1.331 -0.205 0 CA-C-O 120.952 0.406 . . . . 0.0 111.544 -175.797 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' D' D ' 89' ' ' ASP . . . . . . . . . . . . . 13.3 t70 -128.67 156.97 42.6 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-N 115.755 -0.657 . . . . 0.0 109.537 176.091 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' D' D ' 90' ' ' GLU . . . . . . . . . . . . . 70.8 mm-40 -46.96 -38.53 10.79 Favored 'General case' 0 N--CA 1.465 0.305 0 N-CA-C 113.035 0.754 . . . . 0.0 113.035 -171.102 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' D' D ' 91' ' ' ASN . . . . . . . . . . . . . 59.7 m-80 -131.97 20.0 4.54 Favored 'General case' 0 N--CA 1.467 0.413 0 N-CA-C 112.968 0.729 . . . . 0.0 112.968 -177.421 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' D' D ' 92' ' ' LEU . . . . . . . . . . . . . 15.8 mt -147.04 143.93 28.73 Favored 'General case' 0 C--N 1.331 -0.213 0 N-CA-C 110.141 -0.318 . . . . 0.0 110.141 -176.654 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' D' D ' 93' ' ' ILE . . . . . . . . . . . . . 75.2 mt -123.55 119.5 57.44 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.285 0 N-CA-C 109.294 -0.632 . . . . 0.0 109.294 179.035 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' D' D ' 94' ' ' VAL . . . . . . . . . . . . . 46.5 t -118.35 125.09 74.04 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.208 0 CA-C-O 120.988 0.423 . . . . 0.0 109.912 -178.57 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' D' D ' 95' ' ' VAL . . . . . . . . . . . . . 47.0 t -118.72 131.98 69.91 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.344 0 CA-C-N 115.862 -0.608 . . . . 0.0 109.643 -179.564 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' D' D ' 96' ' ' ILE . . . . . . . . . . . . . 68.7 mt -112.61 126.79 70.04 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.328 0 N-CA-C 109.184 -0.672 . . . . 0.0 109.184 178.354 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' D' D ' 97' ' ' THR . . . . . . . . . . . . . 78.4 p -97.63 159.64 14.8 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-O 121.28 0.562 . . . . 0.0 111.214 -176.678 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' D' D ' 98' ' ' GLU . . . . . . . . . . . . . 85.4 tt0 -53.96 -27.48 31.5 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 115.906 -0.588 . . . . 0.0 112.202 -179.061 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' D' D ' 99' ' ' GLU . . . . . . . . . . . . . 95.2 mt-10 -82.32 15.4 2.47 Favored 'General case' 0 CA--C 1.535 0.403 0 N-CA-C 113.14 0.793 . . . . 0.0 113.14 -176.581 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' D' D ' 100' ' ' ASN . . . . . . . . . . . . . 4.1 m-20 62.2 35.63 15.41 Favored 'General case' 0 C--N 1.331 -0.212 0 CA-C-O 120.949 0.404 . . . . 0.0 111.441 179.675 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' D' D ' 101' ' ' GLU . . . . . . . . . . . . . 84.2 tt0 -109.04 143.83 37.84 Favored 'General case' 0 C--N 1.331 -0.203 0 N-CA-C 109.595 -0.521 . . . . 0.0 109.595 173.227 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' D' D ' 102' ' ' VAL . . . . . . . . . . . . . 43.0 t -114.94 125.24 72.21 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.292 0 CA-C-N 116.206 -0.452 . . . . 0.0 109.944 -177.399 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' D' D ' 103' ' ' LEU . . . . . . . . . . . . . 16.8 mt -116.13 130.18 56.68 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 115.877 -0.601 . . . . 0.0 110.256 177.532 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' D' D ' 104' ' ' ILE . . . . . . . . . . . . . 70.9 mt -116.98 121.94 68.92 Favored 'Isoleucine or valine' 0 C--O 1.235 0.299 0 N-CA-C 110.286 -0.265 . . . . 0.0 110.286 179.83 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' D' D ' 105' ' ' PHE . . . . . . . . . . . . . 86.7 m-85 -121.67 163.47 18.95 Favored 'General case' 0 CA--C 1.528 0.134 0 O-C-N 124.052 0.845 . . . . 0.0 109.885 179.0 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' D' D ' 106' ' ' ASN . . . . . . . . . . . . . 40.6 p-10 -96.72 -169.94 1.97 Allowed 'General case' 0 C--N 1.33 -0.274 0 N-CA-C 109.913 -0.403 . . . . 0.0 109.913 173.075 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' D' D ' 107' ' ' GLN . . . . . . . . . . . . . 34.3 tt0 -60.59 -30.09 69.6 Favored 'General case' 0 CA--C 1.532 0.269 0 C-N-CA 121.014 -0.275 . . . . 0.0 111.628 179.565 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' D' D ' 108' ' ' ASN . . . . . . . . . . . . . 4.0 t-20 -82.67 4.79 23.5 Favored 'General case' 0 CA--C 1.536 0.421 0 N-CA-C 113.355 0.872 . . . . 0.0 113.355 -178.454 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' D' D ' 109' ' ' LEU . . . . . . . . . . . . . 7.4 tp 63.87 36.69 10.13 Favored 'General case' 0 CA--C 1.53 0.185 0 O-C-N 122.13 -0.356 . . . . 0.0 111.467 177.492 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' D' D ' 110' ' ' GLU . . . . . . . . . . . . . 95.5 mt-10 -105.13 154.49 20.11 Favored 'General case' 0 C--N 1.331 -0.222 0 N-CA-C 109.887 -0.412 . . . . 0.0 109.887 176.401 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' D' D ' 111' ' ' GLU . . . . . . . . . . . . . 83.6 tt0 -80.46 124.87 29.29 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-O 120.952 0.406 . . . . 0.0 110.928 -176.506 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' D' D ' 112' ' ' LEU . . . . . . . . . . . . . 31.8 mt -111.89 -46.08 3.27 Favored 'General case' 0 C--N 1.331 -0.216 0 CA-C-N 115.995 -0.548 . . . . 0.0 110.511 178.355 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' D' D ' 113' ' ' TYR . . . . . . . . . . . . . 58.1 t80 -142.21 140.35 32.3 Favored 'General case' 0 C--N 1.328 -0.331 0 C-N-CA 120.792 -0.363 . . . . 0.0 111.242 -179.644 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' D' D ' 114' ' ' ARG . . . . . . . . . . . . . 33.6 ttp180 -136.82 126.48 25.4 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.202 -0.454 . . . . 0.0 110.419 176.975 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' D' D ' 115' ' ' GLY . . . . . . . . . . . . . . . -150.05 158.93 27.89 Favored Glycine 0 CA--C 1.524 0.636 0 N-CA-C 110.78 -0.928 . . . . 0.0 110.78 178.164 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' D' D ' 116' ' ' LYS . . . . . . . . . . . . . 79.3 tttt -136.02 131.75 35.38 Favored 'General case' 0 C--N 1.328 -0.331 0 N-CA-C 109.925 -0.398 . . . . 0.0 109.925 178.879 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' D' D ' 117' ' ' PHE . . . . . . . . . . . . . 32.4 m-85 -132.72 117.56 18.0 Favored 'General case' 0 N--CA 1.463 0.214 0 CA-C-O 120.929 0.395 . . . . 0.0 110.599 -173.72 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' D' D ' 118' ' ' GLU . . . . . . . . . . . . . 46.5 tp10 -52.88 -50.96 62.79 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.296 -0.411 . . . . 0.0 111.393 -177.577 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' D' D ' 119' ' ' ASN . . . . . . . . . . . . . 79.4 m-20 -93.61 31.07 1.62 Allowed 'General case' 0 C--N 1.33 -0.27 0 N-CA-C 112.202 0.445 . . . . 0.0 112.202 -173.783 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' D' D ' 120' ' ' LEU . . . . . . . . . . . . . 20.2 tp -58.36 124.58 20.01 Favored 'General case' 0 C--N 1.332 -0.195 0 N-CA-C 110.075 -0.343 . . . . 0.0 110.075 177.474 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' D' D ' 121' ' ' ASN . . . . . . . . . . . . . 4.4 m-20 -114.03 -44.09 3.18 Favored 'General case' 0 C--N 1.331 -0.213 0 CA-C-N 116.56 -0.291 . . . . 0.0 110.963 -178.143 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' D' D ' 122' ' ' LYS . . . . . . . . . . . . . 85.1 mttt -146.45 149.98 34.74 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-O 121.156 0.503 . . . . 0.0 111.902 -176.414 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' D' D ' 123' ' ' VAL . . . . . . . . . . . . . 44.1 t -124.91 128.88 73.47 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.299 0 N-CA-C 109.211 -0.663 . . . . 0.0 109.211 172.873 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' D' D ' 124' ' ' LEU . . . . . . . . . . . . . 6.6 mp -121.89 135.96 54.91 Favored 'General case' 0 C--N 1.332 -0.176 0 CA-C-N 116.609 -0.269 . . . . 0.0 110.732 -176.273 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' D' D ' 125' ' ' VAL . . . . . . . . . . . . . 35.5 m -136.72 130.21 45.96 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.193 0 CA-C-O 120.955 0.407 . . . . 0.0 110.983 178.734 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' D' D ' 126' ' ' ARG . . . . . . . . . . . . . 95.2 mtt180 -151.69 130.19 12.19 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 115.911 -0.586 . . . . 0.0 109.802 176.901 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' D' D ' 127' ' ' ASN . . . . . . . . . . . . . 4.1 m120 56.6 -152.38 0.39 Allowed 'General case' 0 CA--C 1.539 0.536 0 N-CA-C 109.764 -0.458 . . . . 0.0 109.764 179.68 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' D' D ' 128' ' ' ASP . . . . . . . . . . . . . 15.4 p-10 -80.47 14.59 1.96 Allowed 'General case' 0 CA--C 1.536 0.423 0 N-CA-C 112.876 0.695 . . . . 0.0 112.876 178.662 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' D' D ' 129' ' ' LEU . . . . . . . . . . . . . 11.6 tp -114.17 132.63 56.02 Favored 'General case' 0 N--CA 1.46 0.045 0 CA-C-N 118.09 0.404 . . . . 0.0 109.911 179.049 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' D' D ' 130' ' ' VAL . . . . . . . . . . . . . 34.5 m -132.07 142.39 42.97 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.193 0 CA-C-O 121.086 0.469 . . . . 0.0 110.157 176.763 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' D' D ' 131' ' ' VAL . . . . . . . . . . . . . 34.4 m -136.14 148.79 27.41 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 CA-C-O 121.191 0.519 . . . . 0.0 111.21 -179.255 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' D' D ' 132' ' ' ILE . . . . . . . . . . . . . 75.2 mt -115.44 130.66 69.65 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.383 0 CA-C-N 115.4 -0.818 . . . . 0.0 109.024 178.307 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' D' D ' 133' ' ' ILE . . . . . . . . . . . . . 42.3 mm -115.27 115.2 48.66 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.197 0 CA-C-O 120.884 0.373 . . . . 0.0 110.753 -175.993 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' D' D ' 134' ' ' ASP . . . . . . . . . . . . . 6.1 p-10 -125.88 145.51 50.22 Favored 'General case' 0 C--N 1.333 -0.12 0 N-CA-C 109.371 -0.603 . . . . 0.0 109.371 174.95 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' D' D ' 135' ' ' GLU . . . . . . . . . . . . . 46.2 tp10 -49.75 -26.58 3.98 Favored 'General case' 0 C--N 1.327 -0.388 0 N-CA-C 112.761 0.652 . . . . 0.0 112.761 -169.318 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' D' D ' 136' ' ' GLN . . . . . . . . . . . . . 99.1 mm-40 -92.95 -39.74 10.97 Favored 'General case' 0 C--N 1.332 -0.179 0 N-CA-C 112.293 0.479 . . . . 0.0 112.293 -177.126 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' D' D ' 137' ' ' LYS . . . . . . . . . . . . . 28.0 mtpp -137.99 155.02 49.28 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-O 121.277 0.56 . . . . 0.0 111.698 -170.015 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' D' D ' 138' ' ' LEU . . . . . . . . . . . . . 5.3 tt -116.06 125.34 52.29 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 115.547 -0.752 . . . . 0.0 109.286 174.407 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' D' D ' 139' ' ' THR . . . . . . . . . . . . . 39.9 m -110.67 129.65 55.77 Favored 'General case' 0 C--N 1.332 -0.183 0 CA-C-N 116.406 -0.361 . . . . 0.0 110.993 -177.6 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' D' D ' 140' ' ' LEU . . . . . . . . . . . . . 6.5 tt -111.17 123.59 50.5 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 115.499 -0.773 . . . . 0.0 109.322 -179.502 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' D' D ' 141' ' ' ILE . . . . . . . . . . . . . 18.8 mt -125.36 118.38 52.4 Favored 'Isoleucine or valine' 0 C--O 1.234 0.255 0 CA-C-O 120.964 0.411 . . . . 0.0 110.404 -177.199 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' D' D ' 142' ' ' ARG . . . . . . . . . . . . . 15.9 mmt180 -102.91 122.75 45.19 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 115.425 -0.807 . . . . 0.0 109.777 175.079 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' D' D ' 143' ' ' THR . . . . . . . . . . . . . 2.5 p . . . . . 0 C--O 1.22 -0.487 0 CA-C-O 117.983 -1.008 . . . . 0.0 110.568 179.898 . . . . . . . . 0 0 . 1 . 018 nuclear orig core ' E' E ' 2' ' ' SER . . . . . . . . . . . . . 3.9 p . . . . . 0 C--O 1.23 0.06 0 CA-C-O 120.744 0.307 . . . . 0.0 110.287 . . . . . . . . . 0 0 . 1 . 018 nuclear orig core ' E' E ' 3' ' ' GLU . . . . . . . . . . . . . 30.4 tp10 -139.14 139.75 37.71 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.244 -0.435 . . . . 0.0 110.79 -176.215 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' E' E ' 4' ' ' LEU . . . . . . . . . . . . . 18.1 tp -126.01 130.79 51.88 Favored 'General case' 0 C--N 1.332 -0.184 0 N-CA-C 109.881 -0.415 . . . . 0.0 109.881 174.809 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' E' E ' 5' ' ' LYS . . . . . . . . . . . . . 99.3 mttt -116.33 123.98 48.99 Favored 'General case' 0 C--O 1.235 0.297 0 CA-C-O 120.734 0.302 . . . . 0.0 111.192 -178.236 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' E' E ' 6' ' ' LEU . . . . . . . . . . . . . 50.8 mt -113.98 147.11 39.14 Favored 'General case' 0 N--CA 1.461 0.117 0 CA-C-N 115.437 -0.801 . . . . 0.0 110.272 178.837 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' E' E ' 7' ' ' LYS . . . . . . . . . . . . . 82.2 tttt -129.37 141.02 40.36 Favored Pre-proline 0 CA--C 1.533 0.302 0 CA-C-O 119.137 -0.459 . . . . 0.0 109.883 175.031 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' E' E ' 8' ' ' PRO . . . . . . . . . . . . . 90.0 Cg_endo -91.84 146.17 3.13 Favored 'Trans proline' 0 N--CA 1.49 1.272 0 C-N-CA 121.916 1.744 . . . . 0.0 112.163 179.392 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' E' E ' 9' ' ' LEU . . . . . . . . . . . . . 37.1 mt -86.79 -49.23 0.48 Allowed Pre-proline 0 CA--C 1.535 0.376 0 CA-C-O 118.682 -0.675 . . . . 0.0 112.562 178.818 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' E' E ' 10' ' ' PRO . . . . . . . . . . . . . 97.2 Cg_endo -77.93 161.65 29.87 Favored 'Trans proline' 0 N--CA 1.497 1.725 0 C-N-CA 121.256 1.304 . . . . 0.0 112.444 -179.665 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' E' E ' 11' ' ' LYS . . . . . . . . . . . . . 25.1 tptp -86.93 95.44 9.9 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-N 116.231 -0.441 . . . . 0.0 110.085 177.536 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' E' E ' 12' ' ' VAL . . . . . . . . . . . . . 12.5 p -142.18 147.63 21.2 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 CA-C-N 116.313 -0.403 . . . . 0.0 110.838 -179.008 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' E' E ' 13' ' ' GLU . . . . . . . . . . . . . 95.9 mt-10 -93.81 122.6 36.45 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.029 -0.532 . . . . 0.0 110.128 177.507 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' E' E ' 14' ' ' LEU . . . . . . . . . . . . . 22.3 mt -97.65 151.26 37.51 Favored Pre-proline 0 CA--C 1.533 0.301 0 CA-C-O 119.329 -0.367 . . . . 0.0 110.464 -178.714 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' E' E ' 15' ' ' PRO . . . . . . . . . . . . . 37.8 Cg_exo -59.46 156.06 38.25 Favored 'Trans proline' 0 N--CA 1.498 1.775 0 C-N-CA 121.241 1.294 . . . . 0.0 111.835 178.391 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' E' E ' 16' ' ' PRO . . . . . . . . . . . . . 31.4 Cg_exo -56.83 -38.99 94.57 Favored 'Trans proline' 0 N--CA 1.497 1.711 0 C-N-CA 121.333 1.355 . . . . 0.0 112.475 -179.856 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' E' E ' 17' ' ' ASP . . . . . . . . . . . . . 23.1 p-10 -93.48 20.18 7.56 Favored 'General case' 0 C--N 1.329 -0.324 0 N-CA-C 112.665 0.617 . . . . 0.0 112.665 -178.242 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' E' E ' 18' ' ' PHE . . . . . . . . . . . . . 62.5 t80 -57.11 -41.6 79.28 Favored 'General case' 0 C--O 1.227 -0.101 0 O-C-N 122.051 -0.405 . . . . 0.0 110.308 -178.329 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' E' E ' 19' ' ' VAL . . . . . . . . . . . . . 52.2 t -54.91 -45.82 75.84 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.289 0 CA-C-N 116.396 -0.365 . . . . 0.0 110.815 -178.912 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' E' E ' 20' ' ' ASP . . . . . . . . . . . . . 80.8 m-20 -60.28 -41.4 93.25 Favored 'General case' 0 C--N 1.331 -0.222 0 C-N-CA 120.905 -0.318 . . . . 0.0 110.886 -178.165 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' E' E ' 21' ' ' VAL . . . . . . . . . . . . . 47.9 t -63.92 -47.15 91.89 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.306 0 C-N-CA 120.736 -0.386 . . . . 0.0 110.398 -177.931 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' E' E ' 22' ' ' ILE . . . . . . . . . . . . . 51.3 mm -57.18 -43.83 82.4 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.197 0 C-N-CA 120.856 -0.338 . . . . 0.0 110.529 179.158 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' E' E ' 23' ' ' ARG . . . . . . . . . . . . . 28.7 ttp180 -54.56 -48.24 72.3 Favored 'General case' 0 C--N 1.331 -0.201 0 C-N-CA 121.082 -0.247 . . . . 0.0 111.286 -179.472 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' E' E ' 24' ' ' ILE . . . . . . . . . . . . . 72.9 mt -58.52 -44.44 89.18 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.377 0 C-N-CA 120.959 -0.297 . . . . 0.0 110.708 -177.92 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' E' E ' 25' ' ' LYS . . . . . . . . . . . . . 24.5 mtpp -64.68 -44.01 91.71 Favored 'General case' 0 C--N 1.329 -0.291 0 N-CA-C 112.456 0.539 . . . . 0.0 112.456 -178.046 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' E' E ' 26' ' ' LEU . . . . . . . . . . . . . 79.1 mt -84.03 -25.29 30.02 Favored 'General case' 0 C--N 1.329 -0.289 0 N-CA-C 113.388 0.884 . . . . 0.0 113.388 -171.667 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' E' E ' 27' ' ' GLN . . . . . . . . . . . . . 6.1 pt20 -46.13 135.84 7.32 Favored 'General case' 0 N--CA 1.467 0.416 0 N-CA-C 112.757 0.651 . . . . 0.0 112.757 -174.41 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' E' E ' 28' ' ' GLY . . . . . . . . . . . . . . . 98.86 -22.3 41.67 Favored Glycine 0 CA--C 1.535 1.291 0 CA-C-N 115.792 -0.64 . . . . 0.0 112.516 -177.474 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' E' E ' 29' ' ' LYS . . . . . . . . . . . . . 8.2 mtpm? -97.53 155.08 17.11 Favored 'General case' 0 C--N 1.331 -0.2 0 CA-C-N 117.474 0.637 . . . . 0.0 110.925 179.523 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' E' E ' 30' ' ' THR . . . . . . . . . . . . . 22.3 m -109.77 139.27 45.02 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.337 177.115 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' E' E ' 31' ' ' VAL . . . . . . . . . . . . . 35.1 m -128.35 157.7 40.67 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.266 0 CA-C-N 116.254 -0.43 . . . . 0.0 110.505 -179.528 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' E' E ' 32' ' ' ARG . . . . . . . . . . . . . 53.0 ttp180 -132.21 150.92 52.04 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-O 121.198 0.523 . . . . 0.0 110.579 179.139 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' E' E ' 33' ' ' THR . . . . . . . . . . . . . 27.6 m -52.81 138.88 28.37 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.264 -0.425 . . . . 0.0 111.471 -177.812 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' E' E ' 34' ' ' GLY . . . . . . . . . . . . . . . 99.36 -17.23 58.1 Favored Glycine 0 CA--C 1.532 1.142 0 CA-C-N 116.151 -0.477 . . . . 0.0 113.2 179.087 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' E' E ' 35' ' ' ASP . . . . . . . . . . . . . 78.7 m-20 -67.46 149.39 50.27 Favored 'General case' 0 C--N 1.334 -0.085 0 CA-C-N 118.059 0.929 . . . . 0.0 111.204 178.539 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' E' E ' 36' ' ' VAL . . . . . . . . . . . . . 43.4 t -119.27 129.1 75.69 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.216 0 CA-C-N 115.945 -0.57 . . . . 0.0 109.582 176.785 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' E' E ' 37' ' ' ILE . . . . . . . . . . . . . 64.3 mt -118.19 138.35 49.19 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 CA-C-N 116.178 -0.464 . . . . 0.0 109.76 -178.967 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' E' E ' 38' ' ' GLY . . . . . . . . . . . . . . . -116.51 127.64 7.57 Favored Glycine 0 CA--C 1.523 0.567 0 N-CA-C 110.88 -0.888 . . . . 0.0 110.88 179.097 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' E' E ' 39' ' ' ILE . . . . . . . . . . . . . 72.0 mt -127.22 126.78 68.49 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.214 0 N-CA-C 110.136 -0.32 . . . . 0.0 110.136 179.135 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' E' E ' 40' ' ' SER . . . . . . . . . . . . . 53.8 p -92.52 122.41 34.93 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.374 -0.375 . . . . 0.0 110.826 176.632 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' E' E ' 41' ' ' ILE . . . . . . . . . . . . . 70.6 mt -132.22 130.55 60.64 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.228 0 CA-C-O 120.808 0.337 . . . . 0.0 110.22 177.502 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' E' E ' 42' ' ' LEU . . . . . . . . . . . . . 64.7 mt 56.87 32.94 22.32 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 116.144 -0.48 . . . . 0.0 111.959 178.176 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' E' E ' 43' ' ' GLY . . . . . . . . . . . . . . . 72.95 23.69 77.39 Favored Glycine 0 CA--C 1.531 1.039 0 C-N-CA 121.067 -0.587 . . . . 0.0 112.71 177.717 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' E' E ' 44' ' ' LYS . . . . . . . . . . . . . 99.4 mttt -138.66 128.65 25.34 Favored 'General case' 0 C--N 1.331 -0.206 0 CA-C-N 117.404 0.602 . . . . 0.0 109.861 178.051 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' E' E ' 45' ' ' GLU . . . . . . . . . . . . . 44.0 tp10 -85.55 132.36 34.2 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.42 -0.354 . . . . 0.0 111.539 -176.835 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' E' E ' 46' ' ' VAL . . . . . . . . . . . . . 8.8 p -121.92 127.93 75.52 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.186 0 N-CA-C 109.343 -0.614 . . . . 0.0 109.343 172.81 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' E' E ' 47' ' ' LYS . . . . . . . . . . . . . 55.4 mtmt -98.42 127.21 44.25 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.142 -0.481 . . . . 0.0 110.833 177.781 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' E' E ' 48' ' ' PHE . . . . . . . . . . . . . 43.0 m-85 -114.21 131.9 56.3 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 115.925 -0.58 . . . . 0.0 109.683 177.333 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' E' E ' 49' ' ' LYS . . . . . . . . . . . . . 75.8 tttt -105.81 134.81 48.33 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 116.417 -0.356 . . . . 0.0 110.102 178.483 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' E' E ' 50' ' ' VAL . . . . . . . . . . . . . 45.8 t -78.7 107.15 10.64 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.339 0 N-CA-C 109.245 -0.65 . . . . 0.0 109.245 177.752 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' E' E ' 51' ' ' VAL . . . . . . . . . . . . . 48.4 t -73.56 -51.11 26.43 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.316 0 CA-C-N 116.152 -0.476 . . . . 0.0 109.769 -174.567 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' E' E ' 52' ' ' GLN . . . . . . . . . . . . . 90.4 mt-30 -152.77 149.61 28.53 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-O 121.249 0.547 . . . . 0.0 111.963 -177.803 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' E' E ' 53' ' ' ALA . . . . . . . . . . . . . . . -130.46 130.63 44.48 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 114.978 -1.01 . . . . 0.0 109.243 173.143 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' E' E ' 54' ' ' TYR . . . . . . . . . . . . . 6.9 t80 -129.14 109.33 18.03 Favored Pre-proline 0 CA--C 1.534 0.361 0 CA-C-O 118.203 -0.903 . . . . 0.0 110.138 179.011 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' E' E ' 55' ' ' PRO . . . . . . . . . . . . . 74.1 Cg_endo -77.07 170.08 72.61 Favored 'Cis proline' 0 N--CA 1.5 1.895 0 CA-C-N 122.012 1.754 . . . . 0.0 112.593 -4.795 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' E' E ' 56' ' ' SER . . . . . . . . . . . . . 13.6 m -116.39 132.67 23.2 Favored Pre-proline 0 CA--C 1.539 0.546 0 CA-C-O 118.359 -0.829 . . . . 0.0 109.579 176.058 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' E' E ' 57' ' ' PRO . . . . . . . . . . . . . 48.3 Cg_endo -70.57 165.34 79.21 Favored 'Cis proline' 0 N--CA 1.496 1.663 0 CA-C-N 121.975 1.741 . . . . 0.0 111.536 -2.572 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' E' E ' 58' ' ' LEU . . . . . . . . . . . . . 22.5 tp -129.9 138.19 50.79 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.2 -0.455 . . . . 0.0 110.273 -179.563 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' E' E ' 59' ' ' ARG . . . . . . . . . . . . . 53.9 ttp180 -105.83 136.24 45.83 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-N 115.924 -0.58 . . . . 0.0 109.463 176.684 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' E' E ' 60' ' ' VAL . . . . . . . . . . . . . 39.9 t -89.62 116.34 30.88 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.264 0 CA-C-O 121.04 0.448 . . . . 0.0 110.638 -175.172 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' E' E ' 61' ' ' GLU . . . . . . . . . . . . . 95.6 mt-10 -131.05 173.28 11.16 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 115.552 -0.749 . . . . 0.0 109.455 175.501 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' E' E ' 62' ' ' ASP . . . . . . . . . . . . . 58.8 m-20 -53.72 -33.96 57.33 Favored 'General case' 0 C--N 1.328 -0.347 0 N-CA-C 111.778 0.288 . . . . 0.0 111.778 -178.821 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' E' E ' 63' ' ' ARG . . . . . . . . . . . . . 26.2 mmm180 -76.57 -17.81 59.01 Favored 'General case' 0 CA--C 1.533 0.317 0 N-CA-C 113.224 0.824 . . . . 0.0 113.224 -176.28 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' E' E ' 64' ' ' THR . . . . . . . . . . . . . 19.0 m -68.95 136.16 52.11 Favored 'General case' 0 C--N 1.331 -0.208 0 CA-C-O 120.896 0.379 . . . . 0.0 110.707 -174.919 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' E' E ' 65' ' ' LYS . . . . . . . . . . . . . 43.4 mtpt -90.06 122.33 32.95 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.098 -0.501 . . . . 0.0 109.9 179.946 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' E' E ' 66' ' ' ILE . . . . . . . . . . . . . 62.3 mt -113.83 131.95 64.23 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.234 0 CA-C-O 120.896 0.379 . . . . 0.0 110.35 -176.975 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' E' E ' 67' ' ' THR . . . . . . . . . . . . . 41.4 m -126.84 139.42 53.1 Favored 'General case' 0 C--O 1.234 0.24 0 CA-C-N 115.923 -0.58 . . . . 0.0 110.59 179.137 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' E' E ' 68' ' ' LEU . . . . . . . . . . . . . 5.4 tt . . . . . 0 C--N 1.327 -0.397 0 CA-C-N 115.787 -0.642 . . . . 0.0 109.894 177.461 . . . . . . . . 0 0 . 1 . 018 nuclear orig core ' E' E ' 73' ' ' VAL . . . . . . . . . . . . . 35.1 m . . . . . 0 C--O 1.231 0.125 0 N-CA-C 109.882 -0.414 . . . . 0.0 109.882 . . . . . . . . . 0 0 . 1 . 018 nuclear orig core ' E' E ' 74' ' ' ASP . . . . . . . . . . . . . 19.5 t0 -95.41 115.05 26.89 Favored 'General case' 0 C--N 1.332 -0.191 0 N-CA-C 109.764 -0.458 . . . . 0.0 109.764 -178.493 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' E' E ' 75' ' ' VAL . . . . . . . . . . . . . 38.4 t -118.6 126.39 75.14 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.218 0 CA-C-O 121.0 0.428 . . . . 0.0 110.655 -176.547 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' E' E ' 76' ' ' LEU . . . . . . . . . . . . . 5.8 mp -127.32 147.48 50.25 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 115.646 -0.707 . . . . 0.0 109.863 177.125 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' E' E ' 77' ' ' GLU . . . . . . . . . . . . . 96.3 mt-10 -134.21 133.33 40.77 Favored 'General case' 0 C--N 1.332 -0.19 0 CA-C-O 121.078 0.466 . . . . 0.0 111.27 -178.748 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' E' E ' 78' ' ' ALA . . . . . . . . . . . . . . . -122.3 141.29 51.68 Favored 'General case' 0 C--N 1.331 -0.221 0 CA-C-N 115.7 -0.682 . . . . 0.0 109.739 176.347 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' E' E ' 79' ' ' LYS . . . . . . . . . . . . . 82.3 tttt -84.5 117.51 23.73 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-O 120.889 0.376 . . . . 0.0 110.641 -178.262 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' E' E ' 80' ' ' ILE . . . . . . . . . . . . . 42.9 mm -137.95 110.74 7.15 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.381 0 N-CA-C 108.953 -0.758 . . . . 0.0 108.953 -178.858 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' E' E ' 81' ' ' LYS . . . . . . . . . . . . . 55.3 pttt -100.18 125.91 46.38 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-O 120.895 0.378 . . . . 0.0 111.336 -176.589 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' E' E ' 82' ' ' GLY . . . . . . . . . . . . . . . 87.85 42.17 6.11 Favored Glycine 0 CA--C 1.525 0.683 0 C-N-CA 120.825 -0.702 . . . . 0.0 111.714 175.072 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' E' E ' 83' ' ' ILE . . . . . . . . . . . . . 73.4 mt -66.77 127.35 28.07 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.271 0 N-CA-C 109.508 -0.552 . . . . 0.0 109.508 177.548 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' E' E ' 84' ' ' LYS . . . . . . . . . . . . . 59.8 tttt -82.58 -48.44 10.97 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 115.928 -0.578 . . . . 0.0 110.145 -178.25 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' E' E ' 85' ' ' ASP . . . . . . . . . . . . . 33.2 t0 -163.94 159.03 20.4 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 115.851 -0.613 . . . . 0.0 110.653 179.022 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' E' E ' 86' ' ' VAL . . . . . . . . . . . . . 43.2 t -129.33 136.25 59.86 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.27 0 CA-C-O 121.031 0.443 . . . . 0.0 110.55 -179.606 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' E' E ' 87' ' ' ILE . . . . . . . . . . . . . 44.0 mm -123.18 128.55 75.01 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.227 0 CA-C-N 115.821 -0.627 . . . . 0.0 109.685 176.605 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' E' E ' 88' ' ' LEU . . . . . . . . . . . . . 17.4 tp -111.89 133.84 53.83 Favored 'General case' 0 N--CA 1.464 0.227 0 CA-C-O 121.052 0.453 . . . . 0.0 111.43 -175.539 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' E' E ' 89' ' ' ASP . . . . . . . . . . . . . 13.8 t70 -125.66 157.49 37.13 Favored 'General case' 0 C--N 1.331 -0.222 0 CA-C-N 115.688 -0.687 . . . . 0.0 109.679 176.252 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' E' E ' 90' ' ' GLU . . . . . . . . . . . . . 84.1 tt0 -45.56 -42.71 11.31 Favored 'General case' 0 N--CA 1.465 0.314 0 N-CA-C 113.087 0.773 . . . . 0.0 113.087 -171.632 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' E' E ' 91' ' ' ASN . . . . . . . . . . . . . 3.3 t-20 -132.16 25.78 4.55 Favored 'General case' 0 N--CA 1.468 0.446 0 N-CA-C 112.464 0.542 . . . . 0.0 112.464 -178.703 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' E' E ' 92' ' ' LEU . . . . . . . . . . . . . 28.5 mt -149.34 145.22 26.9 Favored 'General case' 0 C--N 1.331 -0.213 0 CA-C-O 120.721 0.296 . . . . 0.0 110.202 -177.376 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' E' E ' 93' ' ' ILE . . . . . . . . . . . . . 66.0 mt -123.71 121.12 61.64 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.292 0 N-CA-C 109.327 -0.62 . . . . 0.0 109.327 178.798 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' E' E ' 94' ' ' VAL . . . . . . . . . . . . . 46.8 t -117.52 126.67 74.82 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.282 0 N-CA-C 109.655 -0.498 . . . . 0.0 109.655 179.956 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' E' E ' 95' ' ' VAL . . . . . . . . . . . . . 38.8 t -121.47 134.15 65.73 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.331 0 CA-C-N 116.102 -0.499 . . . . 0.0 109.731 -178.872 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' E' E ' 96' ' ' ILE . . . . . . . . . . . . . 65.3 mt -113.81 127.07 71.36 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.33 0 N-CA-C 109.267 -0.642 . . . . 0.0 109.267 178.674 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' E' E ' 97' ' ' THR . . . . . . . . . . . . . 68.5 p -98.09 152.38 19.38 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-O 121.108 0.48 . . . . 0.0 111.102 -178.311 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' E' E ' 98' ' ' GLU . . . . . . . . . . . . . 85.0 tt0 -53.95 -23.44 13.08 Favored 'General case' 0 CA--C 1.535 0.377 0 N-CA-C 112.313 0.486 . . . . 0.0 112.313 179.738 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' E' E ' 99' ' ' GLU . . . . . . . . . . . . . 36.6 tt0 -80.94 18.08 1.08 Allowed 'General case' 0 CA--C 1.54 0.571 0 N-CA-C 112.5 0.556 . . . . 0.0 112.5 -177.012 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' E' E ' 100' ' ' ASN . . . . . . . . . . . . . 2.5 m-20 61.54 37.92 16.02 Favored 'General case' 0 CA--C 1.53 0.206 0 O-C-N 121.869 -0.519 . . . . 0.0 110.997 178.365 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' E' E ' 101' ' ' GLU . . . . . . . . . . . . . 85.1 tt0 -119.71 140.71 50.25 Favored 'General case' 0 C--N 1.332 -0.19 0 CA-C-N 116.099 -0.5 . . . . 0.0 109.66 176.703 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' E' E ' 102' ' ' VAL . . . . . . . . . . . . . 41.7 t -115.58 127.86 73.01 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.257 0 N-CA-C 109.732 -0.47 . . . . 0.0 109.732 -177.581 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' E' E ' 103' ' ' LEU . . . . . . . . . . . . . 5.0 mp -124.1 137.94 54.5 Favored 'General case' 0 C--N 1.331 -0.216 0 CA-C-N 116.33 -0.396 . . . . 0.0 110.607 177.506 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' E' E ' 104' ' ' ILE . . . . . . . . . . . . . 64.3 mt -117.63 126.3 74.63 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.274 0 CA-C-N 115.892 -0.594 . . . . 0.0 109.927 -178.893 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' E' E ' 105' ' ' PHE . . . . . . . . . . . . . 98.9 m-85 -120.86 161.35 21.69 Favored 'General case' 0 C--N 1.332 -0.18 0 O-C-N 124.046 0.841 . . . . 0.0 110.275 -179.008 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' E' E ' 106' ' ' ASN . . . . . . . . . . . . . 43.6 p-10 -99.0 -169.8 1.83 Allowed 'General case' 0 CA--C 1.532 0.284 0 CA-C-N 116.351 -0.386 . . . . 0.0 110.123 175.128 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' E' E ' 107' ' ' GLN . . . . . . . . . . . . . 20.4 tt0 -56.33 -30.05 62.1 Favored 'General case' 0 C--N 1.329 -0.303 0 N-CA-C 111.811 0.3 . . . . 0.0 111.811 179.732 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' E' E ' 108' ' ' ASN . . . . . . . . . . . . . 13.1 t30 -90.72 14.1 14.36 Favored 'General case' 0 CA--C 1.535 0.396 0 N-CA-C 113.197 0.814 . . . . 0.0 113.197 -175.889 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' E' E ' 109' ' ' LEU . . . . . . . . . . . . . 11.0 tp 54.88 36.0 25.64 Favored 'General case' 0 C--N 1.332 -0.191 0 CA-C-O 120.829 0.347 . . . . 0.0 111.506 178.501 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' E' E ' 110' ' ' GLU . . . . . . . . . . . . . 70.6 mm-40 -101.29 151.33 22.02 Favored 'General case' 0 C--N 1.33 -0.271 0 N-CA-C 109.808 -0.442 . . . . 0.0 109.808 176.514 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' E' E ' 111' ' ' GLU . . . . . . . . . . . . . 44.0 tp10 -78.52 122.03 25.35 Favored 'General case' 0 C--N 1.329 -0.296 0 C-N-CA 120.698 -0.401 . . . . 0.0 110.825 -176.901 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' E' E ' 112' ' ' LEU . . . . . . . . . . . . . 15.3 mt -110.58 -45.97 3.45 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.115 -0.493 . . . . 0.0 110.428 177.837 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' E' E ' 113' ' ' TYR . . . . . . . . . . . . . 55.7 t80 -137.27 137.22 38.8 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 116.402 -0.363 . . . . 0.0 110.862 -179.585 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' E' E ' 114' ' ' ARG . . . . . . . . . . . . . 56.0 ttp180 -143.45 119.71 10.85 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.422 -0.354 . . . . 0.0 110.413 179.03 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' E' E ' 115' ' ' GLY . . . . . . . . . . . . . . . -150.16 153.75 25.26 Favored Glycine 0 CA--C 1.525 0.704 0 N-CA-C 111.075 -0.81 . . . . 0.0 111.075 178.376 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' E' E ' 116' ' ' LYS . . . . . . . . . . . . . 27.5 ttpp -116.97 143.7 45.42 Favored 'General case' 0 C--N 1.33 -0.262 0 N-CA-C 109.955 -0.387 . . . . 0.0 109.955 177.662 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' E' E ' 117' ' ' PHE . . . . . . . . . . . . . 51.2 m-85 -139.19 114.63 9.78 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-O 120.935 0.397 . . . . 0.0 110.204 -178.24 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' E' E ' 118' ' ' GLU . . . . . . . . . . . . . 95.6 mt-10 -53.61 -50.15 66.28 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.472 -0.331 . . . . 0.0 111.411 -175.558 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' E' E ' 119' ' ' ASN . . . . . . . . . . . . . 2.6 m120 -93.63 31.02 1.63 Allowed 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.192 -0.458 . . . . 0.0 112.158 -175.222 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' E' E ' 120' ' ' LEU . . . . . . . . . . . . . 16.2 tp -57.11 122.89 13.46 Favored 'General case' 0 C--N 1.333 -0.14 0 CA-C-O 120.721 0.296 . . . . 0.0 110.277 178.563 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' E' E ' 121' ' ' ASN . . . . . . . . . . . . . 13.7 m120 -112.13 -44.17 3.45 Favored 'General case' 0 C--N 1.332 -0.185 0 CA-C-N 116.395 -0.366 . . . . 0.0 110.991 -177.183 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' E' E ' 122' ' ' LYS . . . . . . . . . . . . . 80.2 mttt -146.2 145.7 30.53 Favored 'General case' 0 C--N 1.332 -0.194 0 C-N-CA 120.575 -0.45 . . . . 0.0 111.832 -177.282 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' E' E ' 123' ' ' VAL . . . . . . . . . . . . . 46.9 t -127.89 123.83 61.66 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.291 0 N-CA-C 108.883 -0.784 . . . . 0.0 108.883 171.96 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' E' E ' 124' ' ' LEU . . . . . . . . . . . . . 69.0 mt -132.66 145.9 51.44 Favored 'General case' 0 C--N 1.331 -0.2 0 CA-C-O 121.048 0.451 . . . . 0.0 111.492 -175.036 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' E' E ' 125' ' ' VAL . . . . . . . . . . . . . 11.9 p -135.17 137.41 50.33 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.238 0 CA-C-N 115.834 -0.621 . . . . 0.0 110.395 178.915 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' E' E ' 126' ' ' ARG . . . . . . . . . . . . . 25.3 mmt180 -140.35 124.64 17.73 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 115.976 -0.556 . . . . 0.0 110.206 178.605 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' E' E ' 127' ' ' ASN . . . . . . . . . . . . . 14.9 m-80 51.4 -106.67 0.27 Allowed 'General case' 0 CA--C 1.543 0.695 0 CA-C-O 118.976 -0.535 . . . . 0.0 111.36 179.739 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' E' E ' 128' ' ' ASP . . . . . . . . . . . . . 14.8 p-10 -114.07 5.93 16.21 Favored 'General case' 0 N--CA 1.468 0.43 0 CA-C-N 119.723 1.147 . . . . 0.0 113.468 -176.948 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' E' E ' 129' ' ' LEU . . . . . . . . . . . . . 15.8 tp -111.56 134.5 53.09 Favored 'General case' 0 C--N 1.333 -0.138 0 CA-C-N 118.261 0.482 . . . . 0.0 110.472 -179.492 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' E' E ' 130' ' ' VAL . . . . . . . . . . . . . 45.0 t -118.66 134.84 60.99 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.183 0 N-CA-C 109.523 -0.547 . . . . 0.0 109.523 178.657 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' E' E ' 131' ' ' VAL . . . . . . . . . . . . . 39.4 t -136.05 141.01 42.87 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.258 0 CA-C-O 121.119 0.485 . . . . 0.0 110.704 -178.525 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' E' E ' 132' ' ' ILE . . . . . . . . . . . . . 71.5 mt -117.96 132.54 67.5 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.279 0 CA-C-N 115.457 -0.792 . . . . 0.0 109.413 178.669 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' E' E ' 133' ' ' ILE . . . . . . . . . . . . . 44.0 mm -115.8 121.97 68.5 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.246 0 CA-C-O 120.747 0.308 . . . . 0.0 110.675 -176.769 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' E' E ' 134' ' ' ASP . . . . . . . . . . . . . 7.3 p-10 -134.37 149.68 50.84 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.02 -0.536 . . . . 0.0 109.795 175.47 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' E' E ' 135' ' ' GLU . . . . . . . . . . . . . 42.9 tp10 -49.78 -26.71 4.13 Favored 'General case' 0 C--N 1.327 -0.383 0 N-CA-C 112.85 0.685 . . . . 0.0 112.85 -170.442 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' E' E ' 136' ' ' GLN . . . . . . . . . . . . . 55.3 mt-30 -102.78 -25.67 13.43 Favored 'General case' 0 N--CA 1.466 0.367 0 N-CA-C 112.888 0.699 . . . . 0.0 112.888 -174.532 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' E' E ' 137' ' ' LYS . . . . . . . . . . . . . 82.7 mttt -143.21 153.31 42.7 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-O 121.23 0.538 . . . . 0.0 111.714 -170.239 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' E' E ' 138' ' ' LEU . . . . . . . . . . . . . 5.8 tt -118.29 121.15 39.7 Favored 'General case' 0 C--N 1.328 -0.352 0 N-CA-C 108.744 -0.836 . . . . 0.0 108.744 171.667 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' E' E ' 139' ' ' THR . . . . . . . . . . . . . 23.8 m -109.27 128.19 54.88 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.452 -0.34 . . . . 0.0 110.54 -176.344 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' E' E ' 140' ' ' LEU . . . . . . . . . . . . . 7.1 tt -114.37 122.12 45.69 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 115.724 -0.671 . . . . 0.0 109.494 -178.835 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' E' E ' 141' ' ' ILE . . . . . . . . . . . . . 19.1 mt -122.84 116.81 49.9 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.288 0 N-CA-C 109.601 -0.518 . . . . 0.0 109.601 -176.897 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' E' E ' 142' ' ' ARG . . . . . . . . . . . . . 71.5 ttt180 -101.52 120.67 40.67 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 115.671 -0.695 . . . . 0.0 110.458 -179.107 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' E' E ' 143' ' ' THR . . . . . . . . . . . . . 16.4 p . . . . . 0 C--O 1.22 -0.472 0 CA-C-O 118.009 -0.996 . . . . 0.0 110.469 179.678 . . . . . . . . 0 0 . 1 . 018 nuclear orig core ' F' F ' 1' ' ' MET . . . . . . . . . . . . . 25.5 ptp . . . . . 0 CA--C 1.529 0.149 0 CA-C-O 120.644 0.259 . . . . 0.0 110.371 . . . . . . . . . 0 0 . 1 . 018 nuclear orig core ' F' F ' 2' ' ' SER . . . . . . . . . . . . . 4.9 p -124.28 132.8 53.59 Favored 'General case' 0 C--N 1.332 -0.188 0 CA-C-O 120.908 0.385 . . . . 0.0 110.803 179.754 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' F' F ' 3' ' ' GLU . . . . . . . . . . . . . 85.2 tt0 -142.61 140.38 31.64 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.155 -0.475 . . . . 0.0 111.225 -179.119 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' F' F ' 4' ' ' LEU . . . . . . . . . . . . . 14.9 tp -125.55 135.09 51.88 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.03 -0.532 . . . . 0.0 110.049 177.163 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' F' F ' 5' ' ' LYS . . . . . . . . . . . . . 69.0 mttm -112.43 120.73 42.65 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.237 -0.438 . . . . 0.0 110.58 178.764 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' F' F ' 6' ' ' LEU . . . . . . . . . . . . . 73.4 mt -114.93 146.06 41.56 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 115.294 -0.866 . . . . 0.0 110.043 -179.968 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' F' F ' 7' ' ' LYS . . . . . . . . . . . . . 53.4 tttm -133.88 140.2 35.71 Favored Pre-proline 0 CA--C 1.534 0.334 0 CA-C-O 119.115 -0.469 . . . . 0.0 110.245 177.576 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' F' F ' 8' ' ' PRO . . . . . . . . . . . . . 94.4 Cg_endo -91.95 139.07 2.07 Favored 'Trans proline' 0 N--CA 1.489 1.22 0 C-N-CA 121.668 1.578 . . . . 0.0 111.537 176.798 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' F' F ' 9' ' ' LEU . . . . . . . . . . . . . 56.5 mt -71.57 -47.9 12.46 Favored Pre-proline 0 C--N 1.329 -0.315 0 CA-C-O 118.613 -0.708 . . . . 0.0 112.176 -178.889 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' F' F ' 10' ' ' PRO . . . . . . . . . . . . . 97.4 Cg_endo -79.46 157.9 25.55 Favored 'Trans proline' 0 N--CA 1.495 1.616 0 C-N-CA 121.197 1.264 . . . . 0.0 112.291 177.061 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' F' F ' 11' ' ' LYS . . . . . . . . . . . . . 6.6 tmtm? -87.21 97.28 10.68 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.256 178.756 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' F' F ' 12' ' ' VAL . . . . . . . . . . . . . 13.0 p -143.63 146.62 20.93 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.23 0 CA-C-N 116.301 -0.408 . . . . 0.0 110.778 179.607 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' F' F ' 13' ' ' GLU . . . . . . . . . . . . . 94.5 mt-10 -82.71 135.12 35.1 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.079 -0.509 . . . . 0.0 110.256 178.23 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' F' F ' 14' ' ' LEU . . . . . . . . . . . . . 15.2 mt -98.18 141.59 23.21 Favored Pre-proline 0 CA--C 1.534 0.328 0 CA-C-O 118.887 -0.578 . . . . 0.0 110.099 179.536 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' F' F ' 15' ' ' PRO . . . . . . . . . . . . . 26.0 Cg_exo -62.24 159.92 33.09 Favored 'Trans proline' 0 N--CA 1.496 1.658 0 C-N-CA 121.297 1.331 . . . . 0.0 111.711 176.113 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' F' F ' 16' ' ' PRO . . . . . . . . . . . . . 39.6 Cg_exo -58.42 -41.23 67.64 Favored 'Trans proline' 0 N--CA 1.496 1.657 0 C-N-CA 121.499 1.466 . . . . 0.0 112.907 -177.313 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' F' F ' 17' ' ' ASP . . . . . . . . . . . . . 24.2 p-10 -84.71 6.99 22.06 Favored 'General case' 0 CA--C 1.538 0.498 0 N-CA-C 113.261 0.837 . . . . 0.0 113.261 -177.38 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' F' F ' 18' ' ' PHE . . . . . . . . . . . . . 41.2 t80 -57.83 -45.72 85.78 Favored 'General case' 0 C--N 1.334 -0.099 0 O-C-N 122.012 -0.43 . . . . 0.0 110.161 -177.798 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' F' F ' 19' ' ' VAL . . . . . . . . . . . . . 48.7 t -56.71 -44.37 81.28 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.304 0 CA-C-N 116.298 -0.41 . . . . 0.0 110.559 -178.101 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' F' F ' 20' ' ' ASP . . . . . . . . . . . . . 29.2 m-20 -59.67 -42.06 92.01 Favored 'General case' 0 C--N 1.329 -0.296 0 C-N-CA 120.896 -0.322 . . . . 0.0 111.089 -177.711 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' F' F ' 21' ' ' VAL . . . . . . . . . . . . . 46.9 t -63.48 -45.63 97.34 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.285 0 C-N-CA 120.824 -0.35 . . . . 0.0 110.17 -177.738 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' F' F ' 22' ' ' ILE . . . . . . . . . . . . . 51.7 mm -55.56 -48.2 77.73 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 C-N-CA 121.085 -0.246 . . . . 0.0 110.679 178.568 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' F' F ' 23' ' ' ARG . . . . . . . . . . . . . 41.5 ttp180 -54.97 -47.46 74.53 Favored 'General case' 0 C--N 1.328 -0.339 0 C-N-CA 121.074 -0.25 . . . . 0.0 111.395 -177.937 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' F' F ' 24' ' ' ILE . . . . . . . . . . . . . 82.5 mt -58.8 -45.72 91.25 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.29 0 C-N-CA 121.144 -0.222 . . . . 0.0 111.341 -177.442 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' F' F ' 25' ' ' LYS . . . . . . . . . . . . . 93.0 mttt -67.78 -42.68 81.3 Favored 'General case' 0 C--N 1.328 -0.333 0 N-CA-C 112.538 0.57 . . . . 0.0 112.538 -177.56 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' F' F ' 26' ' ' LEU . . . . . . . . . . . . . 94.6 mt -77.68 -37.76 49.0 Favored 'General case' 0 C--N 1.329 -0.287 0 N-CA-C 113.288 0.848 . . . . 0.0 113.288 -170.128 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' F' F ' 27' ' ' GLN . . . . . . . . . . . . . 10.3 pt20 -47.19 137.95 7.49 Favored 'General case' 0 N--CA 1.468 0.451 0 N-CA-C 112.698 0.629 . . . . 0.0 112.698 -174.917 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' F' F ' 28' ' ' GLY . . . . . . . . . . . . . . . 100.77 -26.21 25.47 Favored Glycine 0 CA--C 1.533 1.184 0 CA-C-N 115.533 -0.758 . . . . 0.0 112.26 -177.435 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' F' F ' 29' ' ' LYS . . . . . . . . . . . . . 91.4 mttt -97.79 155.06 17.21 Favored 'General case' 0 C--N 1.332 -0.167 0 CA-C-N 117.375 0.588 . . . . 0.0 110.946 178.101 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' F' F ' 30' ' ' THR . . . . . . . . . . . . . 26.2 m -106.06 138.44 42.25 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.006 -0.543 . . . . 0.0 110.152 177.244 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' F' F ' 31' ' ' VAL . . . . . . . . . . . . . 34.1 m -128.64 157.1 41.34 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.267 0 CA-C-N 116.343 -0.39 . . . . 0.0 110.722 -178.792 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' F' F ' 32' ' ' ARG . . . . . . . . . . . . . 98.6 mtt180 -130.15 150.28 51.48 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-O 121.243 0.544 . . . . 0.0 110.654 177.824 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' F' F ' 33' ' ' THR . . . . . . . . . . . . . 15.2 m -53.66 138.34 35.09 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.217 -0.447 . . . . 0.0 111.187 -178.787 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' F' F ' 34' ' ' GLY . . . . . . . . . . . . . . . 100.88 -17.05 56.91 Favored Glycine 0 CA--C 1.532 1.15 0 CA-C-O 119.614 -0.548 . . . . 0.0 113.287 179.381 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' F' F ' 35' ' ' ASP . . . . . . . . . . . . . 73.5 m-20 -65.25 149.43 49.95 Favored 'General case' 0 C--O 1.231 0.13 0 CA-C-N 118.049 0.924 . . . . 0.0 111.264 179.49 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' F' F ' 36' ' ' VAL . . . . . . . . . . . . . 46.6 t -123.13 131.91 72.36 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.171 0 CA-C-N 115.88 -0.6 . . . . 0.0 110.038 178.884 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' F' F ' 37' ' ' ILE . . . . . . . . . . . . . 67.5 mt -123.67 142.66 39.58 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.28 0 CA-C-N 116.156 -0.475 . . . . 0.0 109.811 -179.959 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' F' F ' 38' ' ' GLY . . . . . . . . . . . . . . . -113.09 128.78 8.56 Favored Glycine 0 CA--C 1.527 0.791 0 N-CA-C 111.335 -0.706 . . . . 0.0 111.335 -179.574 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' F' F ' 39' ' ' ILE . . . . . . . . . . . . . 72.0 mt -126.61 127.3 70.1 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.18 0 N-CA-C 109.829 -0.434 . . . . 0.0 109.829 177.862 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' F' F ' 40' ' ' SER . . . . . . . . . . . . . 42.3 t -93.42 116.43 28.97 Favored 'General case' 0 C--N 1.329 -0.29 0 C-N-CA 120.918 -0.313 . . . . 0.0 110.836 175.815 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' F' F ' 41' ' ' ILE . . . . . . . . . . . . . 44.2 mm -122.78 121.91 64.55 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.188 0 CA-C-O 120.934 0.397 . . . . 0.0 110.362 179.853 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' F' F ' 42' ' ' LEU . . . . . . . . . . . . . 1.3 tt 54.94 46.44 24.37 Favored 'General case' 0 C--N 1.331 -0.211 0 CA-C-O 121.366 0.603 . . . . 0.0 110.686 177.118 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' F' F ' 43' ' ' GLY . . . . . . . . . . . . . . . 70.5 10.05 65.99 Favored Glycine 0 CA--C 1.534 1.259 0 C-N-CA 121.232 -0.509 . . . . 0.0 113.32 174.522 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' F' F ' 44' ' ' LYS . . . . . . . . . . . . . 43.1 tptt -124.83 127.18 46.76 Favored 'General case' 0 C--N 1.333 -0.146 0 CA-C-N 117.986 0.893 . . . . 0.0 109.767 -178.715 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' F' F ' 45' ' ' GLU . . . . . . . . . . . . . 36.9 tp10 -83.43 127.43 33.68 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-O 120.875 0.369 . . . . 0.0 110.943 -177.148 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' F' F ' 46' ' ' VAL . . . . . . . . . . . . . 7.5 p -124.32 130.59 73.59 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.194 0 N-CA-C 109.491 -0.559 . . . . 0.0 109.491 176.191 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' F' F ' 47' ' ' LYS . . . . . . . . . . . . . 30.0 mtpp -100.7 131.21 46.71 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.054 -0.521 . . . . 0.0 111.221 178.292 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' F' F ' 48' ' ' PHE . . . . . . . . . . . . . 89.1 m-85 -113.26 131.91 55.73 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.242 -0.435 . . . . 0.0 110.367 178.118 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' F' F ' 49' ' ' LYS . . . . . . . . . . . . . 82.1 tttt -107.31 137.21 45.78 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.169 -0.469 . . . . 0.0 110.412 178.492 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' F' F ' 50' ' ' VAL . . . . . . . . . . . . . 47.6 t -80.32 106.89 12.08 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.316 0 N-CA-C 109.138 -0.689 . . . . 0.0 109.138 175.061 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' F' F ' 51' ' ' VAL . . . . . . . . . . . . . 55.2 t -70.51 -48.22 60.58 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.286 0 CA-C-N 116.114 -0.494 . . . . 0.0 109.932 -173.373 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' F' F ' 52' ' ' GLN . . . . . . . . . . . . . 21.4 pt20 -164.64 158.92 18.42 Favored 'General case' 0 C--N 1.331 -0.229 0 C-N-CA 120.156 -0.618 . . . . 0.0 111.859 -179.505 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' F' F ' 53' ' ' ALA . . . . . . . . . . . . . . . -135.46 135.86 40.85 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 115.361 -0.836 . . . . 0.0 110.495 179.347 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' F' F ' 54' ' ' TYR . . . . . . . . . . . . . 59.6 t80 -128.98 110.52 18.4 Favored Pre-proline 0 CA--C 1.534 0.345 0 CA-C-O 118.225 -0.893 . . . . 0.0 110.211 177.232 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' F' F ' 55' ' ' PRO . . . . . . . . . . . . . 72.6 Cg_endo -77.15 166.27 82.72 Favored 'Cis proline' 0 N--CA 1.5 1.859 0 CA-C-N 121.988 1.746 . . . . 0.0 112.322 -6.0 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' F' F ' 56' ' ' SER . . . . . . . . . . . . . 43.5 m -116.03 130.09 24.69 Favored Pre-proline 0 CA--C 1.538 0.488 0 CA-C-O 118.387 -0.816 . . . . 0.0 109.293 174.059 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' F' F ' 57' ' ' PRO . . . . . . . . . . . . . 37.6 Cg_endo -66.72 163.64 70.72 Favored 'Cis proline' 0 N--CA 1.498 1.788 0 CA-C-N 122.054 1.769 . . . . 0.0 111.701 -0.172 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' F' F ' 58' ' ' LEU . . . . . . . . . . . . . 24.7 tp -129.37 137.38 50.92 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.349 -179.025 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' F' F ' 59' ' ' ARG . . . . . . . . . . . . . 74.8 ttt180 -105.18 128.59 53.47 Favored 'General case' 0 C--N 1.327 -0.391 0 N-CA-C 109.272 -0.64 . . . . 0.0 109.272 175.657 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' F' F ' 60' ' ' VAL . . . . . . . . . . . . . 45.5 t -79.01 123.09 35.52 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.306 0 C-N-CA 120.686 -0.405 . . . . 0.0 110.347 -175.432 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' F' F ' 61' ' ' GLU . . . . . . . . . . . . . 95.4 mt-10 -131.09 162.75 29.17 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 115.732 -0.667 . . . . 0.0 109.949 177.894 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' F' F ' 62' ' ' ASP . . . . . . . . . . . . . 16.7 p-10 -56.8 -32.84 66.08 Favored 'General case' 0 C--N 1.328 -0.342 0 C-N-CA 120.941 -0.304 . . . . 0.0 111.522 179.329 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' F' F ' 63' ' ' ARG . . . . . . . . . . . . . 17.0 ptm180 -82.9 5.4 21.98 Favored 'General case' 0 CA--C 1.537 0.462 0 N-CA-C 113.558 0.947 . . . . 0.0 113.558 -176.602 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' F' F ' 64' ' ' THR . . . . . . . . . . . . . 19.4 m -88.53 141.97 28.09 Favored 'General case' 0 C--O 1.231 0.126 0 CA-C-N 118.235 0.471 . . . . 0.0 110.753 -177.66 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' F' F ' 65' ' ' LYS . . . . . . . . . . . . . 97.7 mttt -87.4 125.64 34.39 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.264 -0.425 . . . . 0.0 109.918 178.514 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' F' F ' 66' ' ' ILE . . . . . . . . . . . . . 59.0 mt -116.36 124.92 73.11 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.336 0 N-CA-C 109.712 -0.477 . . . . 0.0 109.712 179.708 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' F' F ' 67' ' ' THR . . . . . . . . . . . . . 19.6 m -123.8 146.03 48.64 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-O 121.043 0.449 . . . . 0.0 111.247 -176.231 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' F' F ' 68' ' ' LEU . . . . . . . . . . . . . 49.8 mt . . . . . 0 C--N 1.329 -0.317 0 CA-C-N 115.77 -0.65 . . . . 0.0 110.486 177.637 . . . . . . . . 0 0 . 1 . 018 nuclear orig core ' F' F ' 73' ' ' VAL . . . . . . . . . . . . . 31.0 m . . . . . 0 C--O 1.231 0.122 0 CA-C-O 121.096 0.474 . . . . 0.0 111.213 . . . . . . . . . 0 0 . 1 . 018 nuclear orig core ' F' F ' 74' ' ' ASP . . . . . . . . . . . . . 9.6 t0 -101.9 120.86 41.07 Favored 'General case' 0 C--N 1.327 -0.383 0 N-CA-C 109.042 -0.725 . . . . 0.0 109.042 174.724 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' F' F ' 75' ' ' VAL . . . . . . . . . . . . . 40.5 t -109.39 123.16 65.06 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.288 0 CA-C-O 121.207 0.527 . . . . 0.0 110.779 -175.939 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' F' F ' 76' ' ' LEU . . . . . . . . . . . . . 15.4 mt -129.55 144.25 51.19 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 115.477 -0.783 . . . . 0.0 109.127 177.101 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' F' F ' 77' ' ' GLU . . . . . . . . . . . . . 56.2 tt0 -138.86 139.99 38.31 Favored 'General case' 0 C--N 1.332 -0.184 0 C-N-CA 120.671 -0.411 . . . . 0.0 111.269 -175.148 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' F' F ' 78' ' ' ALA . . . . . . . . . . . . . . . -124.4 140.02 53.35 Favored 'General case' 0 C--N 1.331 -0.229 0 CA-C-N 115.947 -0.57 . . . . 0.0 110.308 178.217 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' F' F ' 79' ' ' LYS . . . . . . . . . . . . . 3.9 mptp? -82.75 116.36 22.07 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-N 116.427 -0.351 . . . . 0.0 110.685 -178.529 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' F' F ' 80' ' ' ILE . . . . . . . . . . . . . 40.0 mm -139.2 107.04 3.08 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.279 0 N-CA-C 109.391 -0.596 . . . . 0.0 109.391 -178.855 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' F' F ' 81' ' ' LYS . . . . . . . . . . . . . 99.3 mttt -105.19 133.61 49.68 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-O 120.902 0.382 . . . . 0.0 110.975 -179.037 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' F' F ' 82' ' ' GLY . . . . . . . . . . . . . . . 88.9 42.23 5.73 Favored Glycine 0 CA--C 1.524 0.63 0 N-CA-C 111.228 -0.749 . . . . 0.0 111.228 176.549 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' F' F ' 83' ' ' ILE . . . . . . . . . . . . . 72.8 mt -72.56 135.91 26.74 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.336 0 N-CA-C 109.964 -0.384 . . . . 0.0 109.964 179.382 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' F' F ' 84' ' ' LYS . . . . . . . . . . . . . 54.7 tttp -98.4 -53.96 3.19 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 115.971 -0.559 . . . . 0.0 110.329 -178.535 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' F' F ' 85' ' ' ASP . . . . . . . . . . . . . 7.4 t0 -149.6 148.31 29.18 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 115.85 -0.613 . . . . 0.0 110.327 -178.808 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' F' F ' 86' ' ' VAL . . . . . . . . . . . . . 42.3 t -129.79 129.39 66.18 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.274 0 CA-C-O 120.906 0.384 . . . . 0.0 110.456 -179.527 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' F' F ' 87' ' ' ILE . . . . . . . . . . . . . 45.6 mm -118.66 125.96 74.82 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.268 0 CA-C-N 116.006 -0.543 . . . . 0.0 109.734 175.809 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' F' F ' 88' ' ' LEU . . . . . . . . . . . . . 38.5 mt -113.02 136.82 52.27 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-O 121.12 0.486 . . . . 0.0 111.303 -177.973 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' F' F ' 89' ' ' ASP . . . . . . . . . . . . . 7.6 t70 -134.85 155.29 50.92 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 115.687 -0.688 . . . . 0.0 109.618 175.538 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' F' F ' 90' ' ' GLU . . . . . . . . . . . . . 95.7 mt-10 -48.78 -33.15 9.82 Favored 'General case' 0 C--N 1.329 -0.324 0 N-CA-C 112.927 0.714 . . . . 0.0 112.927 -172.542 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' F' F ' 91' ' ' ASN . . . . . . . . . . . . . 27.9 t30 -130.44 18.86 5.29 Favored 'General case' 0 N--CA 1.469 0.493 0 N-CA-C 113.063 0.764 . . . . 0.0 113.063 -176.056 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' F' F ' 92' ' ' LEU . . . . . . . . . . . . . 12.0 mt -151.66 143.63 23.83 Favored 'General case' 0 C--N 1.333 -0.151 0 N-CA-C 109.976 -0.379 . . . . 0.0 109.976 -177.225 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' F' F ' 93' ' ' ILE . . . . . . . . . . . . . 71.9 mt -128.82 118.11 46.24 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 N-CA-C 109.278 -0.638 . . . . 0.0 109.278 176.086 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' F' F ' 94' ' ' VAL . . . . . . . . . . . . . 44.5 t -120.84 127.02 75.89 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.344 0 N-CA-C 109.998 -0.371 . . . . 0.0 109.998 -178.538 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' F' F ' 95' ' ' VAL . . . . . . . . . . . . . 44.0 t -123.14 134.11 67.16 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.33 0 CA-C-N 116.064 -0.516 . . . . 0.0 109.95 -179.593 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' F' F ' 96' ' ' ILE . . . . . . . . . . . . . 52.8 mt -113.61 127.54 70.9 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.345 0 N-CA-C 109.006 -0.738 . . . . 0.0 109.006 178.391 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' F' F ' 97' ' ' THR . . . . . . . . . . . . . 66.1 p -99.42 157.15 16.62 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-O 121.204 0.526 . . . . 0.0 111.069 -177.142 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' F' F ' 98' ' ' GLU . . . . . . . . . . . . . 81.9 tt0 -53.98 -27.87 34.22 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 116.127 -0.488 . . . . 0.0 112.056 179.909 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' F' F ' 99' ' ' GLU . . . . . . . . . . . . . 95.9 mt-10 -76.92 12.54 1.32 Allowed 'General case' 0 CA--C 1.536 0.404 0 N-CA-C 113.329 0.863 . . . . 0.0 113.329 -176.737 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' F' F ' 100' ' ' ASN . . . . . . . . . . . . . 3.9 m-20 63.57 34.61 12.37 Favored 'General case' 0 CA--C 1.531 0.248 0 CA-C-O 120.964 0.412 . . . . 0.0 111.369 179.328 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' F' F ' 101' ' ' GLU . . . . . . . . . . . . . 84.0 tt0 -113.96 145.6 41.29 Favored 'General case' 0 C--N 1.333 -0.133 0 N-CA-C 109.52 -0.548 . . . . 0.0 109.52 173.607 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' F' F ' 102' ' ' VAL . . . . . . . . . . . . . 43.9 t -118.12 128.93 75.13 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.253 0 CA-C-O 120.849 0.356 . . . . 0.0 110.096 -177.802 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' F' F ' 103' ' ' LEU . . . . . . . . . . . . . 48.4 mt -115.84 130.43 56.83 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 115.479 -0.782 . . . . 0.0 109.823 178.372 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' F' F ' 104' ' ' ILE . . . . . . . . . . . . . 62.5 mt -119.87 121.59 66.43 Favored 'Isoleucine or valine' 0 C--O 1.233 0.23 0 N-CA-C 110.152 -0.314 . . . . 0.0 110.152 179.597 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' F' F ' 105' ' ' PHE . . . . . . . . . . . . . 30.8 m-85 -124.25 165.78 17.03 Favored 'General case' 0 C--N 1.333 -0.149 0 O-C-N 123.936 0.773 . . . . 0.0 109.521 178.152 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' F' F ' 106' ' ' ASN . . . . . . . . . . . . . 44.1 p-10 -96.99 -170.0 1.96 Allowed 'General case' 0 C--N 1.329 -0.29 0 N-CA-C 109.861 -0.422 . . . . 0.0 109.861 172.858 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' F' F ' 107' ' ' GLN . . . . . . . . . . . . . 47.8 tt0 -60.1 -30.14 69.05 Favored 'General case' 0 CA--C 1.532 0.286 0 N-CA-C 111.873 0.323 . . . . 0.0 111.873 179.532 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' F' F ' 108' ' ' ASN . . . . . . . . . . . . . 7.1 t-20 -82.5 8.19 12.34 Favored 'General case' 0 CA--C 1.537 0.457 0 N-CA-C 113.219 0.822 . . . . 0.0 113.219 -178.31 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' F' F ' 109' ' ' LEU . . . . . . . . . . . . . 11.0 tp 59.76 37.45 22.07 Favored 'General case' 0 CA--C 1.529 0.17 0 CA-C-O 120.977 0.418 . . . . 0.0 111.294 178.255 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' F' F ' 110' ' ' GLU . . . . . . . . . . . . . 70.7 mm-40 -104.04 163.68 12.22 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.416 -0.356 . . . . 0.0 110.109 177.228 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' F' F ' 111' ' ' GLU . . . . . . . . . . . . . 83.6 tt0 -84.86 124.18 31.31 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-N 116.328 -0.397 . . . . 0.0 111.053 -177.215 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' F' F ' 112' ' ' LEU . . . . . . . . . . . . . 15.3 mt -112.64 -46.06 3.18 Favored 'General case' 0 C--N 1.331 -0.197 0 CA-C-N 116.051 -0.522 . . . . 0.0 110.014 175.163 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' F' F ' 113' ' ' TYR . . . . . . . . . . . . . 57.7 t80 -148.25 137.91 22.28 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.228 -0.442 . . . . 0.0 111.036 179.775 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' F' F ' 114' ' ' ARG . . . . . . . . . . . . . 31.1 mtp180 -137.13 123.77 21.05 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.346 -0.388 . . . . 0.0 109.995 174.713 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' F' F ' 115' ' ' GLY . . . . . . . . . . . . . . . -149.46 160.15 28.34 Favored Glycine 0 CA--C 1.523 0.544 0 N-CA-C 110.832 -0.907 . . . . 0.0 110.832 -179.658 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' F' F ' 116' ' ' LYS . . . . . . . . . . . . . 72.5 tttt -133.32 133.64 42.79 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-O 120.844 0.354 . . . . 0.0 110.184 179.622 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' F' F ' 117' ' ' PHE . . . . . . . . . . . . . 23.6 m-85 -132.1 115.64 16.01 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.192 -0.458 . . . . 0.0 109.843 -175.459 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' F' F ' 118' ' ' GLU . . . . . . . . . . . . . 85.2 tt0 -55.4 -40.09 70.99 Favored 'General case' 0 C--N 1.329 -0.324 0 C-N-CA 120.902 -0.319 . . . . 0.0 111.213 -177.152 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' F' F ' 119' ' ' ASN . . . . . . . . . . . . . 4.5 m-80 -97.8 30.99 2.77 Favored 'General case' 0 C--N 1.33 -0.282 0 N-CA-C 112.173 0.434 . . . . 0.0 112.173 -176.084 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' F' F ' 120' ' ' LEU . . . . . . . . . . . . . 11.7 tp -56.54 122.31 11.7 Favored 'General case' 0 C--N 1.333 -0.146 0 C-N-CA 121.065 -0.254 . . . . 0.0 110.641 178.991 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' F' F ' 121' ' ' ASN . . . . . . . . . . . . . 10.5 t-20 -108.16 -44.14 4.22 Favored 'General case' 0 C--O 1.233 0.192 0 CA-C-N 116.578 -0.283 . . . . 0.0 111.05 -177.859 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' F' F ' 122' ' ' LYS . . . . . . . . . . . . . 55.7 pttt -165.94 161.73 17.73 Favored 'General case' 0 C--N 1.332 -0.17 0 C-N-CA 120.398 -0.521 . . . . 0.0 112.218 -179.223 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' F' F ' 123' ' ' VAL . . . . . . . . . . . . . 44.1 t -131.36 137.38 55.61 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.202 0 CA-C-N 115.809 -0.632 . . . . 0.0 109.956 178.959 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' F' F ' 124' ' ' LEU . . . . . . . . . . . . . 88.4 mt -122.38 136.8 54.97 Favored 'General case' 0 C--N 1.331 -0.223 0 CA-C-N 116.498 -0.319 . . . . 0.0 110.944 -179.47 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' F' F ' 125' ' ' VAL . . . . . . . . . . . . . 44.3 t -126.12 129.27 72.19 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.217 0 CA-C-N 116.096 -0.502 . . . . 0.0 109.849 178.576 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' F' F ' 126' ' ' ARG . . . . . . . . . . . . . 27.3 mmt85 -139.85 118.12 12.03 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.408 -0.36 . . . . 0.0 110.701 179.122 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' F' F ' 127' ' ' ASN . . . . . . . . . . . . . 4.9 m-20 49.66 -105.0 0.16 Allowed 'General case' 0 CA--C 1.545 0.759 0 CA-C-O 119.052 -0.499 . . . . 0.0 111.678 178.438 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' F' F ' 128' ' ' ASP . . . . . . . . . . . . . 17.5 p-10 -114.0 1.21 14.6 Favored 'General case' 0 N--CA 1.468 0.429 0 CA-C-N 119.571 1.078 . . . . 0.0 113.401 -178.046 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' F' F ' 129' ' ' LEU . . . . . . . . . . . . . 62.1 mt -107.32 142.86 36.44 Favored 'General case' 0 C--N 1.333 -0.131 0 N-CA-C 109.782 -0.451 . . . . 0.0 109.782 179.508 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' F' F ' 130' ' ' VAL . . . . . . . . . . . . . 41.9 t -129.5 140.31 49.43 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.287 0 CA-C-O 120.911 0.386 . . . . 0.0 110.066 -179.12 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' F' F ' 131' ' ' VAL . . . . . . . . . . . . . 34.8 m -135.93 142.0 40.23 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.267 0 CA-C-O 121.151 0.5 . . . . 0.0 110.838 178.882 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' F' F ' 132' ' ' ILE . . . . . . . . . . . . . 73.7 mt -118.61 134.0 63.64 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.259 0 CA-C-N 115.649 -0.705 . . . . 0.0 109.37 -179.78 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' F' F ' 133' ' ' ILE . . . . . . . . . . . . . 38.7 mm -116.79 122.51 70.11 Favored 'Isoleucine or valine' 0 C--O 1.234 0.278 0 CA-C-O 120.828 0.347 . . . . 0.0 111.077 -175.161 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' F' F ' 134' ' ' ASP . . . . . . . . . . . . . 6.1 p-10 -134.2 147.24 50.7 Favored 'General case' 0 C--N 1.332 -0.183 0 CA-C-N 115.87 -0.605 . . . . 0.0 109.577 172.693 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' F' F ' 135' ' ' GLU . . . . . . . . . . . . . 81.9 tt0 -49.94 -23.91 2.25 Favored 'General case' 0 C--N 1.328 -0.369 0 N-CA-C 113.088 0.773 . . . . 0.0 113.088 -170.147 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' F' F ' 136' ' ' GLN . . . . . . . . . . . . . 47.6 tt0 -104.69 -26.27 12.37 Favored 'General case' 0 CA--C 1.531 0.238 0 N-CA-C 112.748 0.648 . . . . 0.0 112.748 -174.625 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' F' F ' 137' ' ' LYS . . . . . . . . . . . . . 7.2 ttpm? -143.87 150.14 37.99 Favored 'General case' 0 C--N 1.332 -0.167 0 CA-C-O 121.36 0.6 . . . . 0.0 111.781 -170.5 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' F' F ' 138' ' ' LEU . . . . . . . . . . . . . 5.7 tt -116.87 126.62 53.29 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 115.466 -0.788 . . . . 0.0 109.241 175.183 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' F' F ' 139' ' ' THR . . . . . . . . . . . . . 26.4 m -112.44 128.27 56.27 Favored 'General case' 0 C--N 1.331 -0.208 0 CA-C-N 116.592 -0.276 . . . . 0.0 110.82 -178.106 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' F' F ' 140' ' ' LEU . . . . . . . . . . . . . 36.5 tp -112.71 120.24 40.85 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 115.573 -0.739 . . . . 0.0 109.263 179.783 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' F' F ' 141' ' ' ILE . . . . . . . . . . . . . 19.3 mt -119.83 119.73 61.17 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.28 0 N-CA-C 109.863 -0.421 . . . . 0.0 109.863 -175.009 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' F' F ' 142' ' ' ARG . . . . . . . . . . . . . 78.9 mtp180 -108.9 130.11 55.43 Favored 'General case' 0 C--N 1.331 -0.23 0 CA-C-N 115.556 -0.747 . . . . 0.0 110.624 -177.948 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' F' F ' 143' ' ' THR . . . . . . . . . . . . . 26.5 p . . . . . 0 C--O 1.22 -0.485 0 CA-C-O 118.106 -0.95 . . . . 0.0 110.532 -179.238 . . . . . . . . 0 0 . 1 . 019 nuclear orig core ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 3.9 p . . . . . 0 N--CA 1.462 0.152 0 CA-C-O 121.149 0.5 . . . . 0.0 110.692 . . . . . . . . . 0 0 . 1 . 019 nuclear orig core ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 95.7 mt-10 -141.26 144.36 34.63 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 115.593 -0.731 . . . . 0.0 110.996 -176.55 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 4' ' ' LEU . . . . . . . . . . . . . 21.8 tp -122.46 125.6 46.15 Favored 'General case' 0 C--N 1.331 -0.206 0 CA-C-N 115.919 -0.582 . . . . 0.0 109.758 174.431 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 5' ' ' LYS . . . . . . . . . . . . . 90.5 mttt -104.64 120.95 42.52 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.341 -0.391 . . . . 0.0 110.685 -179.51 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 65.9 mt -117.82 147.27 43.19 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 115.575 -0.739 . . . . 0.0 110.7 -178.08 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 56.6 tttt -140.31 139.37 20.66 Favored Pre-proline 0 CA--C 1.533 0.314 0 CA-C-O 119.066 -0.492 . . . . 0.0 109.953 175.103 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 8' ' ' PRO . . . . . . . . . . . . . 94.1 Cg_endo -91.81 146.63 3.18 Favored 'Trans proline' 0 N--CA 1.49 1.319 0 C-N-CA 121.623 1.549 . . . . 0.0 111.834 178.119 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 59.1 mt -78.64 -47.18 1.87 Allowed Pre-proline 0 CA--C 1.534 0.359 0 CA-C-O 118.724 -0.655 . . . . 0.0 112.029 179.96 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 87.8 Cg_endo -81.34 151.37 17.68 Favored 'Trans proline' 0 N--CA 1.495 1.609 0 C-N-CA 121.195 1.264 . . . . 0.0 111.939 175.774 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 34.4 mmtp -84.26 100.43 11.21 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.445 -0.343 . . . . 0.0 110.347 177.703 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 12.5 p -140.28 143.73 29.02 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.275 0 CA-C-N 116.233 -0.439 . . . . 0.0 110.545 -179.794 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 15.0 pt-20 -89.62 130.84 35.86 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.198 -0.455 . . . . 0.0 110.224 177.72 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 14' ' ' LEU . . . . . . . . . . . . . 35.0 mt -98.24 153.72 37.95 Favored Pre-proline 0 C--O 1.234 0.241 0 CA-C-N 116.377 -0.374 . . . . 0.0 111.16 -176.5 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 15' ' ' PRO . . . . . . . . . . . . . 24.8 Cg_exo -63.0 165.44 16.59 Favored 'Trans proline' 0 N--CA 1.496 1.667 0 C-N-CA 121.37 1.38 . . . . 0.0 111.806 174.657 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 16' ' ' PRO . . . . . . . . . . . . . 26.5 Cg_exo -60.71 -46.32 17.36 Favored 'Trans proline' 0 N--CA 1.498 1.763 0 C-N-CA 121.48 1.454 . . . . 0.0 112.912 -177.649 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 17' ' ' ASP . . . . . . . . . . . . . 22.4 p-10 -86.06 11.31 11.96 Favored 'General case' 0 C--N 1.327 -0.412 0 N-CA-C 113.207 0.817 . . . . 0.0 113.207 -176.508 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 18' ' ' PHE . . . . . . . . . . . . . 37.5 t80 -57.03 -40.5 76.86 Favored 'General case' 0 C--N 1.334 -0.091 0 O-C-N 121.877 -0.514 . . . . 0.0 110.461 -179.215 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 19' ' ' VAL . . . . . . . . . . . . . 47.7 t -56.91 -44.06 81.63 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.285 0 CA-C-N 116.344 -0.389 . . . . 0.0 110.412 -179.683 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 18.1 t70 -59.79 -41.55 91.42 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-O 120.892 0.377 . . . . 0.0 110.702 -178.031 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 47.5 t -63.76 -47.74 89.63 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.308 0 CA-C-N 116.422 -0.353 . . . . 0.0 110.487 -178.021 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 22' ' ' ILE . . . . . . . . . . . . . 50.6 mm -56.16 -44.61 79.58 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.201 0 C-N-CA 120.863 -0.335 . . . . 0.0 110.656 179.07 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 23' ' ' ARG . . . . . . . . . . . . . 51.2 ttp180 -53.62 -49.1 68.59 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-O 120.715 0.293 . . . . 0.0 111.462 -179.393 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 24' ' ' ILE . . . . . . . . . . . . . 71.8 mt -59.24 -44.63 92.45 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.268 0 CA-C-N 116.441 -0.345 . . . . 0.0 111.157 -178.329 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 79.3 mttt -64.06 -41.38 97.37 Favored 'General case' 0 C--N 1.329 -0.318 0 N-CA-C 112.377 0.51 . . . . 0.0 112.377 -177.554 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 65.2 mt -79.48 -42.34 25.51 Favored 'General case' 0 C--N 1.329 -0.307 0 N-CA-C 113.147 0.795 . . . . 0.0 113.147 -171.108 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 27' ' ' GLN . . . . . . . . . . . . . 10.2 pt20 -46.58 138.43 5.91 Favored 'General case' 0 N--CA 1.469 0.491 0 N-CA-C 112.816 0.673 . . . . 0.0 112.816 -175.533 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 100.77 -25.65 27.56 Favored Glycine 0 CA--C 1.531 1.086 0 CA-C-N 115.498 -0.774 . . . . 0.0 112.387 -178.515 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 85.6 mttt -98.68 155.22 17.43 Favored 'General case' 0 C--O 1.233 0.197 0 CA-C-N 117.428 0.614 . . . . 0.0 111.467 179.47 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 30' ' ' THR . . . . . . . . . . . . . 29.9 m -100.79 137.14 39.57 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 115.836 -0.62 . . . . 0.0 109.748 175.125 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 34.0 m -128.81 151.77 36.04 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.24 0 CA-C-O 120.829 0.347 . . . . 0.0 111.076 -177.602 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 32' ' ' ARG . . . . . . . . . . . . . 75.5 mtp180 -131.08 150.23 52.24 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-O 121.294 0.569 . . . . 0.0 110.541 177.241 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 33' ' ' THR . . . . . . . . . . . . . 17.6 m -53.17 138.2 32.2 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.163 -0.471 . . . . 0.0 111.471 -178.611 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 102.07 -17.23 54.63 Favored Glycine 0 CA--C 1.531 1.06 0 CA-C-O 119.67 -0.517 . . . . 0.0 113.333 178.06 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 79.7 m-20 -65.82 146.07 55.2 Favored 'General case' 0 C--O 1.231 0.107 0 CA-C-N 118.075 0.938 . . . . 0.0 110.98 179.268 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 46.9 t -121.19 129.19 75.9 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.197 0 CA-C-N 115.943 -0.571 . . . . 0.0 109.806 178.603 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 37' ' ' ILE . . . . . . . . . . . . . 67.7 mt -119.62 138.23 50.92 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.228 0 CA-C-N 116.211 -0.45 . . . . 0.0 109.835 -179.522 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . -112.15 128.68 8.66 Favored Glycine 0 CA--C 1.525 0.682 0 N-CA-C 111.034 -0.826 . . . . 0.0 111.034 179.963 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 39' ' ' ILE . . . . . . . . . . . . . 72.3 mt -127.41 127.18 68.72 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.206 0 N-CA-C 109.848 -0.427 . . . . 0.0 109.848 178.453 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 40' ' ' SER . . . . . . . . . . . . . 45.7 t -92.72 124.88 37.05 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.476 -0.329 . . . . 0.0 110.79 177.0 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 41' ' ' ILE . . . . . . . . . . . . . 73.9 mt -128.67 116.41 41.22 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.158 0 CA-C-O 120.92 0.391 . . . . 0.0 110.186 178.261 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 1.3 tt 54.91 46.71 23.83 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-O 121.441 0.639 . . . . 0.0 110.616 177.835 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . 75.97 -10.05 15.87 Favored Glycine 0 CA--C 1.533 1.194 0 CA-C-N 116.042 -0.526 . . . . 0.0 113.667 174.35 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 44' ' ' LYS . . . . . . . . . . . . . 46.6 mtmt -104.41 126.92 51.94 Favored 'General case' 0 C--N 1.332 -0.175 0 CA-C-N 118.178 0.989 . . . . 0.0 110.328 179.224 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 39.5 tp10 -84.83 134.25 34.3 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-O 120.96 0.409 . . . . 0.0 111.34 -177.699 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 46' ' ' VAL . . . . . . . . . . . . . 7.4 p -127.81 130.65 70.14 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.175 0 CA-C-N 116.085 -0.507 . . . . 0.0 109.851 176.075 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 97.7 mttt -100.89 131.54 46.72 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.146 -0.479 . . . . 0.0 111.452 177.59 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 48' ' ' PHE . . . . . . . . . . . . . 90.4 m-85 -113.9 131.77 56.17 Favored 'General case' 0 C--N 1.33 -0.278 0 N-CA-C 109.535 -0.542 . . . . 0.0 109.535 175.246 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 45.3 tttp -108.07 137.23 46.41 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-O 120.715 0.293 . . . . 0.0 110.736 179.405 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 50' ' ' VAL . . . . . . . . . . . . . 45.0 t -78.91 107.04 10.87 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.236 0 N-CA-C 109.157 -0.683 . . . . 0.0 109.157 175.163 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 51' ' ' VAL . . . . . . . . . . . . . 47.5 t -73.23 -47.68 45.94 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.356 0 CA-C-N 116.263 -0.426 . . . . 0.0 110.053 -173.555 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 52' ' ' GLN . . . . . . . . . . . . . 62.0 tt0 -162.69 141.96 9.04 Favored 'General case' 0 C--N 1.331 -0.201 0 C-N-CA 120.158 -0.617 . . . . 0.0 111.838 -178.129 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -114.92 130.7 56.96 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 115.65 -0.705 . . . . 0.0 109.9 176.057 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 54' ' ' TYR . . . . . . . . . . . . . 37.9 t80 -129.15 107.44 17.85 Favored Pre-proline 0 CA--C 1.534 0.338 0 CA-C-O 118.292 -0.861 . . . . 0.0 110.52 -179.726 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 55' ' ' PRO . . . . . . . . . . . . . 72.4 Cg_endo -77.2 169.98 72.71 Favored 'Cis proline' 0 N--CA 1.499 1.85 0 CA-C-N 121.778 1.671 . . . . 0.0 112.562 -5.145 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 56' ' ' SER . . . . . . . . . . . . . 16.1 m -115.34 133.21 22.76 Favored Pre-proline 0 CA--C 1.538 0.506 0 CA-C-O 118.457 -0.782 . . . . 0.0 109.494 174.764 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 57' ' ' PRO . . . . . . . . . . . . . 56.0 Cg_endo -71.62 147.98 89.3 Favored 'Cis proline' 0 N--CA 1.497 1.71 0 CA-C-N 121.851 1.697 . . . . 0.0 111.502 -2.171 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 58' ' ' LEU . . . . . . . . . . . . . 22.2 tp -108.05 137.11 46.61 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-O 120.926 0.393 . . . . 0.0 110.74 -177.952 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 59' ' ' ARG . . . . . . . . . . . . . 77.2 ttt180 -102.89 122.05 43.76 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-N 115.882 -0.599 . . . . 0.0 109.401 175.714 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 43.3 t -79.31 119.81 29.33 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.254 0 C-N-CA 120.633 -0.427 . . . . 0.0 110.331 -176.3 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 75.3 tt0 -130.88 158.72 39.45 Favored 'General case' 0 C--N 1.328 -0.33 0 N-CA-C 109.059 -0.719 . . . . 0.0 109.059 177.435 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 62' ' ' ASP . . . . . . . . . . . . . 68.4 m-20 -50.98 -31.11 16.93 Favored 'General case' 0 C--N 1.327 -0.381 0 N-CA-C 112.211 0.448 . . . . 0.0 112.211 -178.65 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 63' ' ' ARG . . . . . . . . . . . . . 7.1 ptp180 -86.25 4.63 38.01 Favored 'General case' 0 CA--C 1.535 0.383 0 N-CA-C 113.728 1.01 . . . . 0.0 113.728 -175.579 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 17.9 m -86.65 141.85 28.65 Favored 'General case' 0 C--N 1.332 -0.162 0 CA-C-N 118.188 0.449 . . . . 0.0 110.371 -178.667 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 65' ' ' LYS . . . . . . . . . . . . . 37.3 ttpt -89.08 130.74 35.48 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-O 121.0 0.428 . . . . 0.0 110.607 -177.94 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 66' ' ' ILE . . . . . . . . . . . . . 64.7 mt -111.78 131.52 62.93 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.288 0 N-CA-C 109.857 -0.423 . . . . 0.0 109.857 -179.104 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 67' ' ' THR . . . . . . . . . . . . . 28.5 m -125.7 138.25 53.87 Favored 'General case' 0 C--N 1.332 -0.166 0 CA-C-O 121.059 0.457 . . . . 0.0 110.865 -177.928 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 68' ' ' LEU . . . . . . . . . . . . . 6.8 mp . . . . . 0 C--N 1.33 -0.239 0 CA-C-N 115.889 -0.596 . . . . 0.0 110.332 178.132 . . . . . . . . 0 0 . 1 . 019 nuclear orig core ' A' A ' 74' ' ' ASP . . . . . . . . . . . . . 23.9 t0 . . . . . 0 C--O 1.23 0.064 0 N-CA-C 109.839 -0.43 . . . . 0.0 109.839 . . . . . . . . . 0 0 . 1 . 019 nuclear orig core ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 42.3 t -115.78 124.54 72.29 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.204 0 CA-C-O 121.073 0.463 . . . . 0.0 110.906 -175.712 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 76' ' ' LEU . . . . . . . . . . . . . 5.0 mp -121.08 137.17 54.78 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 115.625 -0.716 . . . . 0.0 109.336 174.162 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 77' ' ' GLU . . . . . . . . . . . . . 96.9 mt-10 -131.75 133.11 44.42 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-O 120.967 0.413 . . . . 0.0 111.141 -178.568 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 78' ' ' ALA . . . . . . . . . . . . . . . -122.39 137.74 54.76 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 115.813 -0.631 . . . . 0.0 109.923 176.971 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 79' ' ' LYS . . . . . . . . . . . . . 99.2 mttt -75.92 117.25 17.45 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-O 120.983 0.421 . . . . 0.0 110.285 179.541 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 80' ' ' ILE . . . . . . . . . . . . . 42.8 mm -139.1 102.6 1.76 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.394 0 N-CA-C 109.382 -0.599 . . . . 0.0 109.382 -176.888 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 81' ' ' LYS . . . . . . . . . . . . . 97.1 mttt -99.7 131.35 45.74 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-O 120.981 0.42 . . . . 0.0 111.198 -177.704 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . 89.02 42.1 5.72 Favored Glycine 0 CA--C 1.526 0.742 0 CA-C-N 115.893 -0.594 . . . . 0.0 111.779 174.866 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 83' ' ' ILE . . . . . . . . . . . . . 70.5 mt -69.3 136.62 25.89 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.354 0 N-CA-C 109.833 -0.432 . . . . 0.0 109.833 178.068 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 84' ' ' LYS . . . . . . . . . . . . . 59.5 tttt -99.11 -53.7 3.18 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.115 -0.493 . . . . 0.0 110.285 -178.395 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 85' ' ' ASP . . . . . . . . . . . . . 8.6 t70 -155.12 154.65 32.69 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 115.857 -0.611 . . . . 0.0 110.4 179.841 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 86' ' ' VAL . . . . . . . . . . . . . 42.2 t -129.41 132.0 66.9 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.225 0 CA-C-O 120.942 0.401 . . . . 0.0 110.642 -178.756 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 87' ' ' ILE . . . . . . . . . . . . . 5.0 mp -119.62 126.81 75.68 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.219 0 CA-C-N 115.975 -0.557 . . . . 0.0 109.566 176.81 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 88' ' ' LEU . . . . . . . . . . . . . 66.8 mt -107.02 135.29 48.83 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-O 121.075 0.464 . . . . 0.0 111.322 -177.949 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 89' ' ' ASP . . . . . . . . . . . . . 13.1 t70 -127.89 152.15 48.2 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 115.758 -0.655 . . . . 0.0 109.536 175.532 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 83.3 tt0 -47.28 -39.68 15.06 Favored 'General case' 0 C--N 1.33 -0.266 0 N-CA-C 112.792 0.664 . . . . 0.0 112.792 -172.978 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 91' ' ' ASN . . . . . . . . . . . . . 29.0 p30 -132.03 34.95 3.77 Favored 'General case' 0 N--CA 1.464 0.245 0 N-CA-C 111.695 0.257 . . . . 0.0 111.695 -177.673 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 92' ' ' LEU . . . . . . . . . . . . . 8.0 tp -166.11 147.0 6.59 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-O 120.73 0.3 . . . . 0.0 110.533 -178.718 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 93' ' ' ILE . . . . . . . . . . . . . 74.6 mt -129.72 122.92 55.99 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.267 0 N-CA-C 109.545 -0.539 . . . . 0.0 109.545 179.881 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 94' ' ' VAL . . . . . . . . . . . . . 40.3 t -121.06 128.06 76.0 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.271 0 CA-C-O 120.854 0.359 . . . . 0.0 110.051 -179.519 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 95' ' ' VAL . . . . . . . . . . . . . 42.0 t -120.12 134.29 64.12 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.314 0 CA-C-N 116.031 -0.531 . . . . 0.0 109.804 179.695 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 96' ' ' ILE . . . . . . . . . . . . . 63.3 mt -111.18 128.77 67.42 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.409 0 N-CA-C 109.166 -0.679 . . . . 0.0 109.166 178.856 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 97' ' ' THR . . . . . . . . . . . . . 75.8 p -100.82 157.63 16.57 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-O 121.343 0.592 . . . . 0.0 111.283 -177.412 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 98' ' ' GLU . . . . . . . . . . . . . 84.7 tt0 -53.92 -28.16 35.12 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.001 -0.545 . . . . 0.0 112.066 -179.478 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 99' ' ' GLU . . . . . . . . . . . . . 44.9 mp0 -80.58 17.73 1.07 Allowed 'General case' 0 CA--C 1.534 0.34 0 N-CA-C 112.984 0.735 . . . . 0.0 112.984 -176.339 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 100' ' ' ASN . . . . . . . . . . . . . 4.1 m-20 61.51 37.97 16.08 Favored 'General case' 0 CA--C 1.529 0.157 0 CA-C-O 121.063 0.459 . . . . 0.0 110.938 178.459 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 101' ' ' GLU . . . . . . . . . . . . . 84.9 tt0 -117.83 144.72 45.13 Favored 'General case' 0 C--N 1.331 -0.232 0 N-CA-C 109.671 -0.492 . . . . 0.0 109.671 176.307 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 102' ' ' VAL . . . . . . . . . . . . . 45.6 t -114.98 126.2 72.51 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.257 0 CA-C-O 120.887 0.375 . . . . 0.0 110.152 -177.483 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 103' ' ' LEU . . . . . . . . . . . . . 42.5 mt -114.3 130.98 56.67 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-N 115.592 -0.731 . . . . 0.0 109.822 176.614 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 104' ' ' ILE . . . . . . . . . . . . . 67.7 mt -122.37 120.96 62.55 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.236 0 N-CA-C 110.436 -0.209 . . . . 0.0 110.436 -177.312 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 105' ' ' PHE . . . . . . . . . . . . . 43.8 m-85 -123.83 166.63 15.28 Favored 'General case' 0 C--N 1.332 -0.193 0 O-C-N 124.041 0.838 . . . . 0.0 109.798 179.64 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 106' ' ' ASN . . . . . . . . . . . . . 41.2 p-10 -96.21 -169.91 2.0 Favored 'General case' 0 C--N 1.329 -0.302 0 N-CA-C 109.377 -0.601 . . . . 0.0 109.377 171.545 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 107' ' ' GLN . . . . . . . . . . . . . 48.0 tt0 -59.61 -30.04 68.42 Favored 'General case' 0 CA--C 1.532 0.256 0 C-N-CA 120.74 -0.384 . . . . 0.0 111.644 177.688 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 108' ' ' ASN . . . . . . . . . . . . . 13.9 t30 -81.89 6.32 16.18 Favored 'General case' 0 CA--C 1.537 0.476 0 N-CA-C 113.178 0.807 . . . . 0.0 113.178 -178.145 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 109' ' ' LEU . . . . . . . . . . . . . 8.9 tp 61.88 36.94 15.65 Favored 'General case' 0 C--O 1.232 0.155 0 O-C-N 122.123 -0.36 . . . . 0.0 111.526 176.567 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 110' ' ' GLU . . . . . . . . . . . . . 96.0 mt-10 -104.99 149.61 25.62 Favored 'General case' 0 C--N 1.33 -0.267 0 N-CA-C 110.032 -0.358 . . . . 0.0 110.032 176.018 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 111' ' ' GLU . . . . . . . . . . . . . 98.8 mt-10 -76.61 122.62 24.9 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-O 120.99 0.424 . . . . 0.0 111.222 -178.101 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 112' ' ' LEU . . . . . . . . . . . . . 16.1 mt -110.78 -45.94 3.42 Favored 'General case' 0 C--N 1.332 -0.177 0 CA-C-N 115.953 -0.567 . . . . 0.0 110.188 176.986 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 113' ' ' TYR . . . . . . . . . . . . . 34.5 t80 -138.65 140.69 38.96 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.859 179.381 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 114' ' ' ARG . . . . . . . . . . . . . 78.3 mtp180 -143.05 122.4 13.07 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.078 -0.51 . . . . 0.0 110.355 179.074 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 115' ' ' GLY . . . . . . . . . . . . . . . -150.12 153.79 25.29 Favored Glycine 0 CA--C 1.525 0.67 0 N-CA-C 111.22 -0.752 . . . . 0.0 111.22 179.73 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 116' ' ' LYS . . . . . . . . . . . . . 40.3 ttpt -126.47 129.46 48.73 Favored 'General case' 0 C--N 1.331 -0.226 0 N-CA-C 109.72 -0.474 . . . . 0.0 109.72 178.778 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 117' ' ' PHE . . . . . . . . . . . . . 41.6 m-85 -130.56 114.96 16.11 Favored 'General case' 0 C--N 1.333 -0.15 0 CA-C-O 120.851 0.358 . . . . 0.0 110.631 -174.155 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 118' ' ' GLU . . . . . . . . . . . . . 84.7 tt0 -53.93 -46.69 71.6 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.418 -0.355 . . . . 0.0 111.379 -177.875 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 119' ' ' ASN . . . . . . . . . . . . . 33.0 m120 -94.77 30.44 2.06 Favored 'General case' 0 C--N 1.329 -0.299 0 N-CA-C 112.241 0.46 . . . . 0.0 112.241 -175.197 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 120' ' ' LEU . . . . . . . . . . . . . 17.1 tp -58.47 123.4 16.06 Favored 'General case' 0 C--N 1.332 -0.153 0 N-CA-C 110.204 -0.295 . . . . 0.0 110.204 177.575 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 121' ' ' ASN . . . . . . . . . . . . . 14.7 m120 -113.77 -44.19 3.21 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-N 116.678 -0.237 . . . . 0.0 110.989 -178.399 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 122' ' ' LYS . . . . . . . . . . . . . 97.3 mttt -148.28 150.31 33.42 Favored 'General case' 0 C--N 1.331 -0.236 0 C-N-CA 120.549 -0.46 . . . . 0.0 111.523 -178.04 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 123' ' ' VAL . . . . . . . . . . . . . 43.9 t -130.13 132.23 65.4 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.185 0 CA-C-N 115.967 -0.561 . . . . 0.0 109.55 175.825 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 124' ' ' LEU . . . . . . . . . . . . . 17.6 tp -127.62 136.9 52.27 Favored 'General case' 0 C--N 1.332 -0.162 0 CA-C-O 120.808 0.337 . . . . 0.0 110.621 -178.188 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 125' ' ' VAL . . . . . . . . . . . . . 11.4 p -125.59 128.05 72.07 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.22 0 CA-C-N 116.112 -0.495 . . . . 0.0 110.252 178.978 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 126' ' ' ARG . . . . . . . . . . . . . 51.8 mmm-85 -140.84 123.9 16.46 Favored 'General case' 0 C--N 1.33 -0.269 0 N-CA-C 109.19 -0.67 . . . . 0.0 109.19 178.909 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 127' ' ' ASN . . . . . . . . . . . . . 37.1 t30 57.25 -150.99 0.43 Allowed 'General case' 0 CA--C 1.539 0.546 0 N-CA-C 109.56 -0.533 . . . . 0.0 109.56 -179.074 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 128' ' ' ASP . . . . . . . . . . . . . 19.5 p-10 -83.57 14.75 3.54 Favored 'General case' 0 CA--C 1.537 0.46 0 CA-C-N 118.637 0.653 . . . . 0.0 112.694 177.024 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 129' ' ' LEU . . . . . . . . . . . . . 40.2 mt -114.1 145.09 42.1 Favored 'General case' 0 C--O 1.231 0.119 0 O-C-N 121.975 -0.453 . . . . 0.0 109.83 179.06 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 130' ' ' VAL . . . . . . . . . . . . . 12.3 p -133.73 144.98 34.24 Favored 'Isoleucine or valine' 0 C--O 1.233 0.206 0 CA-C-O 121.248 0.547 . . . . 0.0 110.756 -176.914 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 131' ' ' VAL . . . . . . . . . . . . . 45.3 t -134.36 137.35 51.74 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.303 0 CA-C-N 115.707 -0.679 . . . . 0.0 110.063 179.695 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 132' ' ' ILE . . . . . . . . . . . . . 72.1 mt -116.53 132.82 65.05 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.367 0 CA-C-N 115.757 -0.656 . . . . 0.0 109.336 179.47 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 133' ' ' ILE . . . . . . . . . . . . . 42.6 mm -114.55 120.18 63.52 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.259 0 CA-C-O 120.693 0.282 . . . . 0.0 110.879 -175.356 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 134' ' ' ASP . . . . . . . . . . . . . 8.4 p-10 -130.62 143.25 50.62 Favored 'General case' 0 C--N 1.33 -0.244 0 N-CA-C 109.351 -0.611 . . . . 0.0 109.351 174.732 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 135' ' ' GLU . . . . . . . . . . . . . 39.6 tp10 -50.0 -26.32 4.18 Favored 'General case' 0 C--N 1.328 -0.328 0 N-CA-C 112.89 0.7 . . . . 0.0 112.89 -171.939 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 136' ' ' GLN . . . . . . . . . . . . . 97.0 mt-30 -80.43 -35.1 35.52 Favored 'General case' 0 C--N 1.331 -0.218 0 N-CA-C 112.022 0.378 . . . . 0.0 112.022 -176.962 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 137' ' ' LYS . . . . . . . . . . . . . 49.7 pttt -167.64 172.61 9.19 Favored 'General case' 0 C--N 1.331 -0.219 0 CA-C-O 121.478 0.656 . . . . 0.0 112.052 -173.828 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 138' ' ' LEU . . . . . . . . . . . . . 6.1 tt -113.99 129.81 56.58 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 115.164 -0.925 . . . . 0.0 110.114 -179.48 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 139' ' ' THR . . . . . . . . . . . . . 24.8 m -108.63 126.41 52.93 Favored 'General case' 0 C--N 1.332 -0.179 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.568 179.964 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 140' ' ' LEU . . . . . . . . . . . . . 11.1 tp -114.26 122.89 48.14 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-N 115.753 -0.658 . . . . 0.0 109.404 -178.846 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 141' ' ' ILE . . . . . . . . . . . . . 19.9 mt -121.48 120.38 61.69 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.273 0 CA-C-O 120.954 0.407 . . . . 0.0 109.94 -176.41 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 142' ' ' ARG . . . . . . . . . . . . . 72.0 mtp180 -110.61 118.03 35.12 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 115.327 -0.851 . . . . 0.0 110.64 -177.405 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 143' ' ' THR . . . . . . . . . . . . . 33.7 p . . . . . 0 C--O 1.219 -0.502 0 CA-C-O 117.891 -1.052 . . . . 0.0 110.533 179.929 . . . . . . . . 0 0 . 1 . 019 nuclear orig core ' B' B ' 2' ' ' SER . . . . . . . . . . . . . 7.3 p . . . . . 0 C--O 1.23 0.074 0 CA-C-O 120.818 0.342 . . . . 0.0 110.358 . . . . . . . . . 0 0 . 1 . 019 nuclear orig core ' B' B ' 3' ' ' GLU . . . . . . . . . . . . . 94.5 mt-10 -140.71 142.96 34.79 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.112 -0.495 . . . . 0.0 111.022 -177.943 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' B' B ' 4' ' ' LEU . . . . . . . . . . . . . 17.7 tp -127.85 127.86 44.2 Favored 'General case' 0 C--N 1.331 -0.205 0 CA-C-N 116.087 -0.506 . . . . 0.0 109.865 175.538 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' B' B ' 5' ' ' LYS . . . . . . . . . . . . . 98.6 mttt -109.02 122.74 47.89 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-O 120.487 0.184 . . . . 0.0 110.87 -179.673 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' B' B ' 6' ' ' LEU . . . . . . . . . . . . . 53.6 mt -114.94 143.89 44.44 Favored 'General case' 0 N--CA 1.463 0.215 0 O-C-N 123.8 0.688 . . . . 0.0 110.946 179.679 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' B' B ' 7' ' ' LYS . . . . . . . . . . . . . 84.3 tttt -129.88 135.47 27.55 Favored Pre-proline 0 CA--C 1.535 0.366 0 CA-C-O 118.811 -0.614 . . . . 0.0 109.643 175.226 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' B' B ' 8' ' ' PRO . . . . . . . . . . . . . 71.8 Cg_endo -90.48 142.85 3.59 Favored 'Trans proline' 0 N--CA 1.492 1.396 0 C-N-CA 121.578 1.519 . . . . 0.0 112.421 179.726 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' B' B ' 9' ' ' LEU . . . . . . . . . . . . . 19.5 mt -87.08 -49.64 0.46 Allowed Pre-proline 0 CA--C 1.535 0.386 0 CA-C-O 118.669 -0.682 . . . . 0.0 112.477 -179.399 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' B' B ' 10' ' ' PRO . . . . . . . . . . . . . 95.7 Cg_endo -79.12 163.03 25.64 Favored 'Trans proline' 0 N--CA 1.496 1.657 0 C-N-CA 121.317 1.344 . . . . 0.0 112.315 -178.995 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' B' B ' 11' ' ' LYS . . . . . . . . . . . . . 26.5 tptp -87.09 104.06 15.98 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.404 178.604 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' B' B ' 12' ' ' VAL . . . . . . . . . . . . . 12.5 p -147.83 147.09 17.57 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.231 0 CA-C-N 116.31 -0.404 . . . . 0.0 110.684 -179.661 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' B' B ' 13' ' ' GLU . . . . . . . . . . . . . 84.7 tt0 -100.34 124.57 45.99 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.158 -0.474 . . . . 0.0 110.079 177.447 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' B' B ' 14' ' ' LEU . . . . . . . . . . . . . 30.3 mt -98.93 151.46 37.4 Favored Pre-proline 0 CA--C 1.533 0.291 0 CA-C-O 119.311 -0.376 . . . . 0.0 111.228 -176.329 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' B' B ' 15' ' ' PRO . . . . . . . . . . . . . 24.2 Cg_exo -63.84 162.25 29.46 Favored 'Trans proline' 0 N--CA 1.498 1.792 0 C-N-CA 121.372 1.382 . . . . 0.0 111.97 175.625 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' B' B ' 16' ' ' PRO . . . . . . . . . . . . . 24.7 Cg_exo -62.41 -37.91 56.82 Favored 'Trans proline' 0 N--CA 1.497 1.694 0 C-N-CA 121.409 1.406 . . . . 0.0 112.469 179.235 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' B' B ' 17' ' ' ASP . . . . . . . . . . . . . 10.0 p-10 -85.25 12.33 8.28 Favored 'General case' 0 CA--C 1.536 0.423 0 N-CA-C 113.012 0.745 . . . . 0.0 113.012 -178.303 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' B' B ' 18' ' ' PHE . . . . . . . . . . . . . 18.7 t80 -56.8 -41.55 77.94 Favored 'General case' 0 C--N 1.334 -0.095 0 O-C-N 121.899 -0.5 . . . . 0.0 110.358 -179.183 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' B' B ' 19' ' ' VAL . . . . . . . . . . . . . 46.8 t -55.63 -41.08 62.99 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.205 0 CA-C-N 116.5 -0.318 . . . . 0.0 110.577 -179.45 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' B' B ' 20' ' ' ASP . . . . . . . . . . . . . 74.6 m-20 -59.33 -41.49 89.26 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-O 121.015 0.436 . . . . 0.0 110.427 179.942 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' B' B ' 21' ' ' VAL . . . . . . . . . . . . . 47.9 t -64.11 -46.0 94.92 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.306 0 CA-C-N 116.136 -0.484 . . . . 0.0 110.386 179.936 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' B' B ' 22' ' ' ILE . . . . . . . . . . . . . 51.2 mm -53.98 -60.02 1.66 Allowed 'Isoleucine or valine' 0 CA--C 1.53 0.191 0 C-N-CA 120.959 -0.296 . . . . 0.0 111.42 -178.324 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' B' B ' 23' ' ' ARG . . . . . . . . . . . . . 6.0 ptm180 -54.84 -44.75 74.2 Favored 'General case' 0 CA--C 1.53 0.184 0 C-N-CA 120.513 -0.475 . . . . 0.0 111.853 -174.244 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' B' B ' 24' ' ' ILE . . . . . . . . . . . . . 81.0 mt -61.03 -45.12 99.18 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.268 0 C-N-CA 120.836 -0.346 . . . . 0.0 111.663 -176.67 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' B' B ' 25' ' ' LYS . . . . . . . . . . . . . 72.1 mmtt -68.78 -42.56 77.22 Favored 'General case' 0 C--N 1.33 -0.267 0 N-CA-C 112.355 0.502 . . . . 0.0 112.355 -177.186 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' B' B ' 26' ' ' LEU . . . . . . . . . . . . . 83.0 mt -79.4 -33.97 42.26 Favored 'General case' 0 C--N 1.33 -0.275 0 N-CA-C 113.679 0.992 . . . . 0.0 113.679 -168.571 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' B' B ' 27' ' ' GLN . . . . . . . . . . . . . 10.6 pt20 -46.7 141.27 3.95 Favored 'General case' 0 N--CA 1.469 0.504 0 N-CA-C 112.785 0.661 . . . . 0.0 112.785 -175.577 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' B' B ' 28' ' ' GLY . . . . . . . . . . . . . . . 101.59 -27.16 21.73 Favored Glycine 0 CA--C 1.531 1.077 0 CA-C-N 115.612 -0.722 . . . . 0.0 112.205 -177.389 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' B' B ' 29' ' ' LYS . . . . . . . . . . . . . 68.0 mttm -97.48 155.09 17.09 Favored 'General case' 0 C--O 1.232 0.155 0 CA-C-N 117.451 0.625 . . . . 0.0 111.07 178.051 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' B' B ' 30' ' ' THR . . . . . . . . . . . . . 29.8 m -107.38 139.63 41.57 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.032 -0.531 . . . . 0.0 110.294 177.719 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' B' B ' 31' ' ' VAL . . . . . . . . . . . . . 34.5 m -129.25 152.97 38.0 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.212 0 CA-C-N 116.211 -0.45 . . . . 0.0 110.658 -179.256 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' B' B ' 32' ' ' ARG . . . . . . . . . . . . . 57.8 ttt180 -130.78 151.11 51.58 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-O 121.119 0.485 . . . . 0.0 110.243 178.798 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' B' B ' 33' ' ' THR . . . . . . . . . . . . . 21.6 m -52.12 137.16 28.39 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.366 -0.379 . . . . 0.0 111.676 -176.705 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' B' B ' 34' ' ' GLY . . . . . . . . . . . . . . . 100.61 -17.21 56.92 Favored Glycine 0 CA--C 1.532 1.154 0 CA-C-N 116.042 -0.526 . . . . 0.0 113.39 178.283 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' B' B ' 35' ' ' ASP . . . . . . . . . . . . . 78.3 m-20 -67.4 151.22 47.8 Favored 'General case' 0 C--O 1.231 0.129 0 CA-C-N 118.002 0.901 . . . . 0.0 111.244 179.141 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' B' B ' 36' ' ' VAL . . . . . . . . . . . . . 45.8 t -120.66 130.12 74.88 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.252 0 CA-C-N 115.996 -0.547 . . . . 0.0 109.806 177.429 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' B' B ' 37' ' ' ILE . . . . . . . . . . . . . 63.0 mt -119.53 138.24 50.81 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.256 0 CA-C-N 116.16 -0.473 . . . . 0.0 109.743 -179.132 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' B' B ' 38' ' ' GLY . . . . . . . . . . . . . . . -116.02 128.72 8.13 Favored Glycine 0 CA--C 1.526 0.724 0 N-CA-C 111.096 -0.802 . . . . 0.0 111.096 -179.765 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' B' B ' 39' ' ' ILE . . . . . . . . . . . . . 74.8 mt -130.58 131.0 65.16 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.237 0 N-CA-C 110.134 -0.321 . . . . 0.0 110.134 178.878 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' B' B ' 40' ' ' SER . . . . . . . . . . . . . 68.2 p -92.79 115.22 27.91 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 116.418 -0.355 . . . . 0.0 110.911 176.47 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' B' B ' 41' ' ' ILE . . . . . . . . . . . . . 44.0 mm -122.07 128.86 75.7 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.232 0 CA-C-N 116.476 -0.329 . . . . 0.0 110.276 -179.934 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' B' B ' 42' ' ' LEU . . . . . . . . . . . . . 49.9 mt 55.32 33.52 20.91 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.24 -0.436 . . . . 0.0 111.825 177.263 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' B' B ' 43' ' ' GLY . . . . . . . . . . . . . . . 72.56 27.62 69.09 Favored Glycine 0 CA--C 1.531 1.052 0 C-N-CA 121.203 -0.522 . . . . 0.0 112.393 177.646 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' B' B ' 44' ' ' LYS . . . . . . . . . . . . . 49.4 tptt -141.9 128.32 20.05 Favored 'General case' 0 C--N 1.331 -0.227 0 N-CA-C 109.65 -0.5 . . . . 0.0 109.65 177.832 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' B' B ' 45' ' ' GLU . . . . . . . . . . . . . 44.1 tp10 -82.93 128.06 34.1 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-O 120.891 0.377 . . . . 0.0 111.323 -176.147 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' B' B ' 46' ' ' VAL . . . . . . . . . . . . . 8.5 p -121.86 128.08 75.59 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.255 0 N-CA-C 109.5 -0.556 . . . . 0.0 109.5 174.765 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' B' B ' 47' ' ' LYS . . . . . . . . . . . . . 52.0 mtpt -98.86 127.26 44.74 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.011 -0.54 . . . . 0.0 110.616 177.41 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' B' B ' 48' ' ' PHE . . . . . . . . . . . . . 46.1 m-85 -111.05 131.84 54.74 Favored 'General case' 0 C--N 1.329 -0.309 0 N-CA-C 109.667 -0.494 . . . . 0.0 109.667 177.082 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' B' B ' 49' ' ' LYS . . . . . . . . . . . . . 77.5 tttt -104.71 133.32 49.75 Favored 'General case' 0 C--N 1.328 -0.327 0 N-CA-C 109.926 -0.398 . . . . 0.0 109.926 178.225 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' B' B ' 50' ' ' VAL . . . . . . . . . . . . . 42.3 t -77.76 105.45 6.8 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.28 0 N-CA-C 109.38 -0.6 . . . . 0.0 109.38 178.169 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' B' B ' 51' ' ' VAL . . . . . . . . . . . . . 49.8 t -73.02 -47.28 48.7 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.372 0 CA-C-N 116.061 -0.518 . . . . 0.0 109.879 -174.693 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' B' B ' 52' ' ' GLN . . . . . . . . . . . . . 62.1 tt0 -158.97 138.43 11.59 Favored 'General case' 0 C--N 1.33 -0.274 0 C-N-CA 120.417 -0.513 . . . . 0.0 111.486 -178.241 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' B' B ' 53' ' ' ALA . . . . . . . . . . . . . . . -117.13 130.7 56.8 Favored 'General case' 0 C--N 1.332 -0.193 0 CA-C-N 115.687 -0.688 . . . . 0.0 109.632 172.058 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' B' B ' 54' ' ' TYR . . . . . . . . . . . . . 57.9 t80 -129.18 112.17 18.29 Favored Pre-proline 0 CA--C 1.536 0.432 0 CA-C-O 118.189 -0.91 . . . . 0.0 110.359 178.933 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' B' B ' 55' ' ' PRO . . . . . . . . . . . . . 74.3 Cg_endo -77.11 168.89 75.76 Favored 'Cis proline' 0 N--CA 1.5 1.9 0 CA-C-N 121.973 1.74 . . . . 0.0 112.156 -6.002 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' B' B ' 56' ' ' SER . . . . . . . . . . . . . 13.5 m -116.6 134.88 22.84 Favored Pre-proline 0 CA--C 1.538 0.492 0 CA-C-O 118.478 -0.772 . . . . 0.0 109.456 175.881 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' B' B ' 57' ' ' PRO . . . . . . . . . . . . . 56.0 Cg_endo -72.11 146.73 86.87 Favored 'Cis proline' 0 N--CA 1.497 1.728 0 CA-C-N 121.842 1.694 . . . . 0.0 111.496 -2.229 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' B' B ' 58' ' ' LEU . . . . . . . . . . . . . 25.0 tp -108.35 136.81 47.36 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.378 -0.374 . . . . 0.0 110.832 -177.667 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' B' B ' 59' ' ' ARG . . . . . . . . . . . . . 29.0 ttm180 -100.51 125.9 46.89 Favored 'General case' 0 C--N 1.328 -0.34 0 N-CA-C 109.371 -0.603 . . . . 0.0 109.371 175.521 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' B' B ' 60' ' ' VAL . . . . . . . . . . . . . 40.8 t -78.04 121.73 31.44 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.247 0 C-N-CA 120.828 -0.349 . . . . 0.0 110.848 -174.798 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' B' B ' 61' ' ' GLU . . . . . . . . . . . . . 42.9 mt-10 -130.96 154.05 48.55 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 115.744 -0.662 . . . . 0.0 109.822 175.308 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' B' B ' 62' ' ' ASP . . . . . . . . . . . . . 19.8 p-10 -53.72 -33.64 56.26 Favored 'General case' 0 C--N 1.327 -0.397 0 N-CA-C 111.843 0.312 . . . . 0.0 111.843 -177.792 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' B' B ' 63' ' ' ARG . . . . . . . . . . . . . 36.5 mmt180 -75.66 -18.61 59.59 Favored 'General case' 0 CA--C 1.535 0.371 0 N-CA-C 113.099 0.778 . . . . 0.0 113.099 -175.969 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' B' B ' 64' ' ' THR . . . . . . . . . . . . . 24.0 m -67.2 147.91 52.46 Favored 'General case' 0 C--N 1.332 -0.172 0 CA-C-N 117.724 0.238 . . . . 0.0 110.48 -177.06 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' B' B ' 65' ' ' LYS . . . . . . . . . . . . . 98.4 mttt -87.61 122.95 31.95 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-O 120.937 0.398 . . . . 0.0 110.116 -179.648 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' B' B ' 66' ' ' ILE . . . . . . . . . . . . . 63.4 mt -108.57 120.27 59.64 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.26 0 N-CA-C 109.581 -0.526 . . . . 0.0 109.581 179.183 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' B' B ' 67' ' ' THR . . . . . . . . . . . . . 4.6 m -109.36 140.69 42.73 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-O 121.338 0.59 . . . . 0.0 111.132 -173.511 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' B' B ' 68' ' ' LEU . . . . . . . . . . . . . 7.0 tt . . . . . 0 C--N 1.329 -0.283 0 CA-C-N 115.202 -0.908 . . . . 0.0 110.121 -178.926 . . . . . . . . 0 0 . 1 . 019 nuclear orig core ' B' B ' 73' ' ' VAL . . . . . . . . . . . . . 34.2 m . . . . . 0 CA--C 1.527 0.065 0 CA-C-O 120.755 0.312 . . . . 0.0 110.377 . . . . . . . . . 0 0 . 1 . 019 nuclear orig core ' B' B ' 74' ' ' ASP . . . . . . . . . . . . . 26.4 t0 -78.85 123.89 27.68 Favored 'General case' 0 C--N 1.331 -0.205 0 CA-C-N 116.259 -0.428 . . . . 0.0 111.156 -165.058 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' B' B ' 75' ' ' VAL . . . . . . . . . . . . . 47.0 t -119.7 118.83 58.5 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.218 0 CA-C-N 116.138 -0.483 . . . . 0.0 110.098 -179.571 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' B' B ' 76' ' ' LEU . . . . . . . . . . . . . 23.8 mt -124.33 145.37 49.46 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 115.63 -0.714 . . . . 0.0 109.688 -179.966 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' B' B ' 77' ' ' GLU . . . . . . . . . . . . . 96.0 mt-10 -136.42 134.94 38.28 Favored 'General case' 0 C--N 1.331 -0.227 0 CA-C-O 121.056 0.455 . . . . 0.0 111.184 -178.606 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' B' B ' 78' ' ' ALA . . . . . . . . . . . . . . . -123.57 131.23 53.57 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 115.611 -0.722 . . . . 0.0 109.701 176.462 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' B' B ' 79' ' ' LYS . . . . . . . . . . . . . 97.3 mttt -77.32 120.33 22.19 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-O 121.043 0.449 . . . . 0.0 111.266 -175.389 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' B' B ' 80' ' ' ILE . . . . . . . . . . . . . 25.9 mm -139.27 101.14 1.49 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.256 0 N-CA-C 109.015 -0.735 . . . . 0.0 109.015 179.11 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' B' B ' 81' ' ' LYS . . . . . . . . . . . . . 68.6 tttt -93.06 124.6 37.15 Favored 'General case' 0 C--N 1.328 -0.332 0 C-N-CA 120.776 -0.37 . . . . 0.0 110.993 -177.01 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' B' B ' 82' ' ' GLY . . . . . . . . . . . . . . . 89.2 42.14 5.65 Favored Glycine 0 CA--C 1.524 0.641 0 C-N-CA 120.738 -0.744 . . . . 0.0 111.416 176.288 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' B' B ' 83' ' ' ILE . . . . . . . . . . . . . 72.1 mt -64.45 137.76 24.31 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.352 0 N-CA-C 109.91 -0.404 . . . . 0.0 109.91 177.884 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' B' B ' 84' ' ' LYS . . . . . . . . . . . . . 80.2 tttt -93.51 -51.38 4.98 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 115.932 -0.576 . . . . 0.0 110.001 -179.426 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' B' B ' 85' ' ' ASP . . . . . . . . . . . . . 9.9 t70 -159.87 153.59 22.78 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 115.514 -0.766 . . . . 0.0 110.062 179.558 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' B' B ' 86' ' ' VAL . . . . . . . . . . . . . 43.9 t -129.94 132.15 65.8 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.212 0 CA-C-O 121.021 0.438 . . . . 0.0 110.479 -179.166 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' B' B ' 87' ' ' ILE . . . . . . . . . . . . . 43.5 mm -120.12 125.38 74.17 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.265 0 CA-C-N 115.665 -0.698 . . . . 0.0 109.221 177.132 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' B' B ' 88' ' ' LEU . . . . . . . . . . . . . 12.0 tp -114.51 127.92 56.06 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-O 121.021 0.439 . . . . 0.0 111.254 -176.788 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' B' B ' 89' ' ' ASP . . . . . . . . . . . . . 11.2 t70 -117.81 153.66 33.1 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 115.702 -0.681 . . . . 0.0 109.407 175.931 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' B' B ' 90' ' ' GLU . . . . . . . . . . . . . 84.6 tt0 -47.78 -35.5 10.12 Favored 'General case' 0 C--N 1.33 -0.282 0 N-CA-C 112.869 0.692 . . . . 0.0 112.869 -172.836 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' B' B ' 91' ' ' ASN . . . . . . . . . . . . . 18.3 p-10 -132.06 31.36 4.16 Favored 'General case' 0 N--CA 1.466 0.326 0 N-CA-C 112.256 0.465 . . . . 0.0 112.256 -175.808 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' B' B ' 92' ' ' LEU . . . . . . . . . . . . . 6.7 tp -166.13 145.1 5.9 Favored 'General case' 0 C--N 1.331 -0.213 0 C-N-CA 120.934 -0.307 . . . . 0.0 110.54 -179.619 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' B' B ' 93' ' ' ILE . . . . . . . . . . . . . 68.8 mt -123.14 123.36 67.67 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.264 0 N-CA-C 109.704 -0.48 . . . . 0.0 109.704 -179.413 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' B' B ' 94' ' ' VAL . . . . . . . . . . . . . 43.5 t -121.38 124.96 73.04 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.239 0 CA-C-O 120.967 0.413 . . . . 0.0 110.024 179.689 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' B' B ' 95' ' ' VAL . . . . . . . . . . . . . 45.9 t -119.68 133.4 66.58 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.283 0 CA-C-N 115.917 -0.583 . . . . 0.0 109.928 -179.071 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' B' B ' 96' ' ' ILE . . . . . . . . . . . . . 61.8 mt -114.59 126.38 72.12 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.366 0 N-CA-C 109.467 -0.568 . . . . 0.0 109.467 178.988 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' B' B ' 97' ' ' THR . . . . . . . . . . . . . 67.4 p -95.94 156.21 16.43 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-O 120.99 0.424 . . . . 0.0 110.812 -179.267 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' B' B ' 98' ' ' GLU . . . . . . . . . . . . . 40.1 tp10 -53.92 -28.66 38.19 Favored 'General case' 0 C--N 1.329 -0.287 0 N-CA-C 112.144 0.424 . . . . 0.0 112.144 -178.401 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' B' B ' 99' ' ' GLU . . . . . . . . . . . . . 14.7 pt-20 -81.54 17.25 1.45 Allowed 'General case' 0 CA--C 1.535 0.373 0 N-CA-C 113.326 0.862 . . . . 0.0 113.326 -176.19 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' B' B ' 100' ' ' ASN . . . . . . . . . . . . . 4.9 m-20 64.89 34.65 9.0 Favored 'General case' 0 N--CA 1.463 0.216 0 CA-C-O 120.793 0.33 . . . . 0.0 111.678 176.959 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' B' B ' 101' ' ' GLU . . . . . . . . . . . . . 84.5 tt0 -108.84 141.78 40.38 Favored 'General case' 0 C--N 1.331 -0.2 0 N-CA-C 109.642 -0.503 . . . . 0.0 109.642 172.226 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' B' B ' 102' ' ' VAL . . . . . . . . . . . . . 46.3 t -114.96 125.9 72.41 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.308 0 N-CA-C 109.967 -0.382 . . . . 0.0 109.967 -177.846 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' B' B ' 103' ' ' LEU . . . . . . . . . . . . . 57.4 mt -117.26 129.79 56.14 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 115.845 -0.616 . . . . 0.0 110.13 177.944 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' B' B ' 104' ' ' ILE . . . . . . . . . . . . . 67.8 mt -118.31 120.84 65.6 Favored 'Isoleucine or valine' 0 C--O 1.234 0.289 0 N-CA-C 110.161 -0.311 . . . . 0.0 110.161 -178.976 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' B' B ' 105' ' ' PHE . . . . . . . . . . . . . 74.6 m-85 -123.53 165.16 17.6 Favored 'General case' 0 C--N 1.333 -0.15 0 O-C-N 123.92 0.763 . . . . 0.0 109.836 -179.252 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' B' B ' 106' ' ' ASN . . . . . . . . . . . . . 46.7 p-10 -99.51 -170.77 1.95 Allowed 'General case' 0 C--N 1.33 -0.274 0 N-CA-C 109.788 -0.449 . . . . 0.0 109.788 171.832 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' B' B ' 107' ' ' GLN . . . . . . . . . . . . . 51.0 tt0 -57.58 -27.64 62.87 Favored 'General case' 0 C--N 1.327 -0.373 0 N-CA-C 112.305 0.483 . . . . 0.0 112.305 -178.944 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' B' B ' 108' ' ' ASN . . . . . . . . . . . . . 14.4 t30 -93.5 14.31 19.11 Favored 'General case' 0 CA--C 1.535 0.379 0 N-CA-C 113.0 0.741 . . . . 0.0 113.0 -175.43 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' B' B ' 109' ' ' LEU . . . . . . . . . . . . . 71.1 mt 59.12 37.7 24.04 Favored 'General case' 0 C--N 1.332 -0.189 0 CA-C-O 121.067 0.461 . . . . 0.0 111.377 177.596 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' B' B ' 110' ' ' GLU . . . . . . . . . . . . . 43.4 mt-10 -103.46 163.43 12.29 Favored 'General case' 0 C--N 1.331 -0.225 0 CA-C-N 116.388 -0.369 . . . . 0.0 110.223 177.331 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' B' B ' 111' ' ' GLU . . . . . . . . . . . . . 82.6 tt0 -84.58 124.9 31.94 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-O 120.94 0.4 . . . . 0.0 111.243 -177.22 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' B' B ' 112' ' ' LEU . . . . . . . . . . . . . 20.0 mt -113.02 -45.99 3.14 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 115.905 -0.589 . . . . 0.0 109.6 172.84 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' B' B ' 113' ' ' TYR . . . . . . . . . . . . . 34.9 t80 -150.64 137.04 18.72 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.02 -0.536 . . . . 0.0 110.821 179.097 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' B' B ' 114' ' ' ARG . . . . . . . . . . . . . 57.0 mtm180 -140.39 124.4 17.46 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-O 120.733 0.302 . . . . 0.0 110.306 175.242 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' B' B ' 115' ' ' GLY . . . . . . . . . . . . . . . -150.15 162.9 29.36 Favored Glycine 0 CA--C 1.523 0.566 0 N-CA-C 110.632 -0.987 . . . . 0.0 110.632 -179.555 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' B' B ' 116' ' ' LYS . . . . . . . . . . . . . 82.7 tttt -133.37 130.83 39.32 Favored 'General case' 0 C--N 1.33 -0.278 0 N-CA-C 109.918 -0.401 . . . . 0.0 109.918 178.553 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' B' B ' 117' ' ' PHE . . . . . . . . . . . . . 46.5 m-85 -125.79 118.43 25.51 Favored 'General case' 0 C--N 1.331 -0.227 0 CA-C-O 121.015 0.436 . . . . 0.0 110.49 -174.862 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' B' B ' 118' ' ' GLU . . . . . . . . . . . . . 44.5 tp10 -52.83 -49.38 65.82 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.397 -0.365 . . . . 0.0 111.572 -176.979 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' B' B ' 119' ' ' ASN . . . . . . . . . . . . . 20.4 m120 -95.76 31.21 2.12 Favored 'General case' 0 C--N 1.33 -0.253 0 N-CA-C 112.11 0.411 . . . . 0.0 112.11 -174.803 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' B' B ' 120' ' ' LEU . . . . . . . . . . . . . 13.7 tp -55.04 123.38 13.4 Favored 'General case' 0 N--CA 1.462 0.134 0 CA-C-O 120.711 0.291 . . . . 0.0 110.769 178.282 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' B' B ' 121' ' ' ASN . . . . . . . . . . . . . 60.5 t30 -113.58 -44.01 3.25 Favored 'General case' 0 C--N 1.332 -0.184 0 CA-C-N 116.337 -0.392 . . . . 0.0 110.822 -177.742 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' B' B ' 122' ' ' LYS . . . . . . . . . . . . . 97.8 mttt -148.53 150.72 33.87 Favored 'General case' 0 C--N 1.331 -0.229 0 CA-C-O 121.119 0.485 . . . . 0.0 111.562 -178.434 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' B' B ' 123' ' ' VAL . . . . . . . . . . . . . 47.4 t -131.74 129.35 61.19 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.224 0 N-CA-C 109.325 -0.62 . . . . 0.0 109.325 174.812 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' B' B ' 124' ' ' LEU . . . . . . . . . . . . . 67.3 mt -130.87 142.65 50.39 Favored 'General case' 0 C--N 1.331 -0.203 0 CA-C-O 120.959 0.409 . . . . 0.0 110.769 -177.438 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' B' B ' 125' ' ' VAL . . . . . . . . . . . . . 12.1 p -135.7 138.32 48.07 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.255 0 CA-C-N 116.005 -0.543 . . . . 0.0 110.555 179.946 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' B' B ' 126' ' ' ARG . . . . . . . . . . . . . 75.3 mtt180 -148.08 121.95 9.35 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 115.838 -0.619 . . . . 0.0 109.393 178.04 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' B' B ' 127' ' ' ASN . . . . . . . . . . . . . 71.6 m-80 57.04 -147.44 0.52 Allowed 'General case' 0 CA--C 1.541 0.614 0 N-CA-C 109.602 -0.518 . . . . 0.0 109.602 -178.278 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' B' B ' 128' ' ' ASP . . . . . . . . . . . . . 23.1 p-10 -83.44 12.62 5.3 Favored 'General case' 0 CA--C 1.537 0.464 0 CA-C-N 118.845 0.748 . . . . 0.0 112.989 179.199 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' B' B ' 129' ' ' LEU . . . . . . . . . . . . . 19.6 tp -109.03 136.45 48.53 Favored 'General case' 0 C--O 1.231 0.084 0 N-CA-C 109.747 -0.464 . . . . 0.0 109.747 178.32 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' B' B ' 130' ' ' VAL . . . . . . . . . . . . . 12.3 p -131.3 141.76 45.12 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.213 0 CA-C-O 120.982 0.42 . . . . 0.0 110.637 -178.806 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' B' B ' 131' ' ' VAL . . . . . . . . . . . . . 41.5 t -136.14 138.37 47.3 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 CA-C-N 116.021 -0.536 . . . . 0.0 110.495 -178.741 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' B' B ' 132' ' ' ILE . . . . . . . . . . . . . 73.1 mt -116.79 133.64 62.82 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.323 0 CA-C-N 115.591 -0.731 . . . . 0.0 109.244 178.448 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' B' B ' 133' ' ' ILE . . . . . . . . . . . . . 41.1 mm -115.94 120.81 65.9 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.268 0 CA-C-O 120.714 0.293 . . . . 0.0 111.018 -175.521 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' B' B ' 134' ' ' ASP . . . . . . . . . . . . . 7.5 p-10 -131.98 144.98 51.19 Favored 'General case' 0 C--N 1.33 -0.262 0 N-CA-C 109.433 -0.58 . . . . 0.0 109.433 175.124 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' B' B ' 135' ' ' GLU . . . . . . . . . . . . . 83.7 tt0 -50.06 -26.23 4.2 Favored 'General case' 0 C--N 1.328 -0.348 0 N-CA-C 112.861 0.689 . . . . 0.0 112.861 -173.682 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' B' B ' 136' ' ' GLN . . . . . . . . . . . . . 97.1 mt-30 -78.51 -35.8 45.81 Favored 'General case' 0 C--O 1.234 0.245 0 N-CA-C 112.058 0.392 . . . . 0.0 112.058 -177.465 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' B' B ' 137' ' ' LYS . . . . . . . . . . . . . 56.2 pttt -170.0 173.66 5.89 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-O 121.426 0.631 . . . . 0.0 111.907 -172.613 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' B' B ' 138' ' ' LEU . . . . . . . . . . . . . 8.2 tt -116.31 130.14 56.63 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 115.415 -0.811 . . . . 0.0 110.136 179.557 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' B' B ' 139' ' ' THR . . . . . . . . . . . . . 25.8 m -108.07 124.35 50.07 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.069 -0.514 . . . . 0.0 110.501 179.995 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' B' B ' 140' ' ' LEU . . . . . . . . . . . . . 49.7 tp -113.08 121.07 43.48 Favored 'General case' 0 C--N 1.328 -0.351 0 N-CA-C 109.094 -0.706 . . . . 0.0 109.094 -179.241 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' B' B ' 141' ' ' ILE . . . . . . . . . . . . . 19.0 mt -121.23 121.1 63.95 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.309 0 CA-C-O 120.985 0.422 . . . . 0.0 110.189 -175.261 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' B' B ' 142' ' ' ARG . . . . . . . . . . . . . 61.4 mtp180 -105.21 120.81 42.45 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 115.15 -0.932 . . . . 0.0 109.985 179.363 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' B' B ' 143' ' ' THR . . . . . . . . . . . . . 35.9 p . . . . . 0 C--O 1.22 -0.486 0 CA-C-O 118.065 -0.969 . . . . 0.0 110.604 -179.697 . . . . . . . . 0 0 . 1 . 019 nuclear orig core ' C' C ' 2' ' ' SER . . . . . . . . . . . . . 3.1 p . . . . . 0 C--O 1.232 0.149 0 CA-C-O 121.043 0.449 . . . . 0.0 110.351 . . . . . . . . . 0 0 . 1 . 019 nuclear orig core ' C' C ' 3' ' ' GLU . . . . . . . . . . . . . 84.8 tt0 -141.24 141.61 33.99 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 115.89 -0.595 . . . . 0.0 110.954 -178.891 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' C' C ' 4' ' ' LEU . . . . . . . . . . . . . 19.2 tp -126.14 129.08 48.35 Favored 'General case' 0 C--N 1.331 -0.216 0 CA-C-N 115.866 -0.606 . . . . 0.0 110.257 177.73 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' C' C ' 5' ' ' LYS . . . . . . . . . . . . . 66.9 mttm -105.35 120.96 42.88 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.255 -0.429 . . . . 0.0 110.543 178.728 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' C' C ' 6' ' ' LEU . . . . . . . . . . . . . 55.1 mt -116.56 146.53 42.57 Favored 'General case' 0 C--N 1.331 -0.23 0 O-C-N 123.831 0.707 . . . . 0.0 110.109 -179.703 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' C' C ' 7' ' ' LYS . . . . . . . . . . . . . 49.8 tttp -126.83 137.67 30.99 Favored Pre-proline 0 CA--C 1.534 0.329 0 CA-C-O 118.901 -0.571 . . . . 0.0 109.912 175.664 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' C' C ' 8' ' ' PRO . . . . . . . . . . . . . 89.8 Cg_endo -92.1 131.72 1.17 Allowed 'Trans proline' 0 N--CA 1.489 1.257 0 C-N-CA 121.661 1.574 . . . . 0.0 111.673 178.016 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' C' C ' 9' ' ' LEU . . . . . . . . . . . . . 64.8 mt -70.98 -46.59 15.0 Favored Pre-proline 0 CA--C 1.533 0.303 0 CA-C-O 118.808 -0.615 . . . . 0.0 112.191 -179.053 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' C' C ' 10' ' ' PRO . . . . . . . . . . . . . 85.8 Cg_endo -81.79 147.89 15.47 Favored 'Trans proline' 0 N--CA 1.495 1.617 0 C-N-CA 121.237 1.291 . . . . 0.0 111.574 174.26 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' C' C ' 11' ' ' LYS . . . . . . . . . . . . . 60.7 tttm -88.14 96.54 10.57 Favored 'General case' 0 C--N 1.33 -0.254 0 C-N-CA 120.862 -0.335 . . . . 0.0 110.455 179.145 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' C' C ' 12' ' ' VAL . . . . . . . . . . . . . 12.5 p -140.06 146.78 24.35 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.321 0 CA-C-N 116.241 -0.436 . . . . 0.0 110.512 -179.79 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' C' C ' 13' ' ' GLU . . . . . . . . . . . . . 81.4 tt0 -85.86 125.8 33.57 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.243 -0.435 . . . . 0.0 110.008 177.949 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' C' C ' 14' ' ' LEU . . . . . . . . . . . . . 17.6 mt -96.94 149.63 35.94 Favored Pre-proline 0 CA--C 1.532 0.263 0 CA-C-O 119.262 -0.399 . . . . 0.0 110.366 -178.708 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' C' C ' 15' ' ' PRO . . . . . . . . . . . . . 26.1 Cg_exo -61.76 160.65 28.01 Favored 'Trans proline' 0 N--CA 1.497 1.732 0 C-N-CA 121.23 1.287 . . . . 0.0 111.852 177.496 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' C' C ' 16' ' ' PRO . . . . . . . . . . . . . 34.0 Cg_exo -59.5 -34.01 97.07 Favored 'Trans proline' 0 N--CA 1.498 1.754 0 C-N-CA 121.437 1.425 . . . . 0.0 112.714 -178.127 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' C' C ' 17' ' ' ASP . . . . . . . . . . . . . 18.5 p-10 -87.88 3.58 47.91 Favored 'General case' 0 CA--C 1.536 0.435 0 N-CA-C 113.409 0.892 . . . . 0.0 113.409 -177.042 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' C' C ' 18' ' ' PHE . . . . . . . . . . . . . 43.3 t80 -58.18 -46.5 85.64 Favored 'General case' 0 C--N 1.334 -0.091 0 O-C-N 122.046 -0.409 . . . . 0.0 110.098 -177.689 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' C' C ' 19' ' ' VAL . . . . . . . . . . . . . 47.8 t -56.75 -43.0 78.59 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.372 0 CA-C-N 116.27 -0.423 . . . . 0.0 110.608 -177.895 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' C' C ' 20' ' ' ASP . . . . . . . . . . . . . 67.7 m-20 -59.66 -43.0 94.11 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-O 120.786 0.327 . . . . 0.0 110.813 -177.549 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' C' C ' 21' ' ' VAL . . . . . . . . . . . . . 46.2 t -64.01 -45.41 96.78 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.32 0 C-N-CA 120.818 -0.353 . . . . 0.0 110.425 -177.848 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' C' C ' 22' ' ' ILE . . . . . . . . . . . . . 51.8 mm -54.96 -48.44 75.26 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.276 0 C-N-CA 120.993 -0.283 . . . . 0.0 110.743 179.032 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' C' C ' 23' ' ' ARG . . . . . . . . . . . . . 54.3 ttp180 -54.65 -47.93 72.93 Favored 'General case' 0 C--N 1.33 -0.258 0 C-N-CA 121.022 -0.271 . . . . 0.0 111.355 -178.328 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' C' C ' 24' ' ' ILE . . . . . . . . . . . . . 74.2 mt -59.11 -42.89 87.98 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.34 0 C-N-CA 121.184 -0.206 . . . . 0.0 111.208 -177.901 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' C' C ' 25' ' ' LYS . . . . . . . . . . . . . 73.9 mmtt -66.68 -41.37 88.21 Favored 'General case' 0 C--N 1.328 -0.335 0 N-CA-C 112.253 0.464 . . . . 0.0 112.253 -178.428 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' C' C ' 26' ' ' LEU . . . . . . . . . . . . . 83.1 mt -79.22 -38.76 34.9 Favored 'General case' 0 C--N 1.328 -0.332 0 N-CA-C 113.283 0.845 . . . . 0.0 113.283 -169.872 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' C' C ' 27' ' ' GLN . . . . . . . . . . . . . 10.4 pt20 -47.06 140.05 5.28 Favored 'General case' 0 N--CA 1.468 0.444 0 N-CA-C 112.78 0.659 . . . . 0.0 112.78 -175.831 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' C' C ' 28' ' ' GLY . . . . . . . . . . . . . . . 99.15 -25.7 27.21 Favored Glycine 0 CA--C 1.533 1.159 0 CA-C-N 115.687 -0.688 . . . . 0.0 112.297 -177.013 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' C' C ' 29' ' ' LYS . . . . . . . . . . . . . 87.5 mttt -97.89 155.11 17.22 Favored 'General case' 0 C--N 1.331 -0.199 0 CA-C-N 117.357 0.579 . . . . 0.0 111.053 179.362 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' C' C ' 30' ' ' THR . . . . . . . . . . . . . 26.2 m -103.79 138.3 40.59 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.133 -0.485 . . . . 0.0 110.1 176.696 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' C' C ' 31' ' ' VAL . . . . . . . . . . . . . 34.4 m -129.85 151.14 35.39 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.201 0 CA-C-O 120.868 0.366 . . . . 0.0 110.986 -178.429 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' C' C ' 32' ' ' ARG . . . . . . . . . . . . . 71.3 mtt85 -127.91 149.19 50.42 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 115.971 -0.558 . . . . 0.0 110.489 178.743 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' C' C ' 33' ' ' THR . . . . . . . . . . . . . 30.3 m -53.18 138.76 30.85 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.43 -0.35 . . . . 0.0 111.375 -179.175 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' C' C ' 34' ' ' GLY . . . . . . . . . . . . . . . 100.23 -17.2 57.32 Favored Glycine 0 CA--C 1.533 1.159 0 C-N-CA 121.307 -0.473 . . . . 0.0 113.223 179.266 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' C' C ' 35' ' ' ASP . . . . . . . . . . . . . 76.2 m-20 -66.63 149.3 50.69 Favored 'General case' 0 N--CA 1.462 0.151 0 CA-C-N 117.967 0.883 . . . . 0.0 111.155 179.361 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' C' C ' 36' ' ' VAL . . . . . . . . . . . . . 44.6 t -119.3 128.99 75.83 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.26 0 CA-C-N 115.845 -0.616 . . . . 0.0 109.674 177.929 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' C' C ' 37' ' ' ILE . . . . . . . . . . . . . 65.6 mt -119.83 138.28 50.95 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.271 0 CA-C-N 116.151 -0.477 . . . . 0.0 109.804 -179.466 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' C' C ' 38' ' ' GLY . . . . . . . . . . . . . . . -116.9 128.71 8.02 Favored Glycine 0 CA--C 1.525 0.667 0 N-CA-C 111.121 -0.792 . . . . 0.0 111.121 -179.653 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' C' C ' 39' ' ' ILE . . . . . . . . . . . . . 70.7 mt -127.0 127.05 69.35 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.256 0 N-CA-C 109.961 -0.385 . . . . 0.0 109.961 178.268 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' C' C ' 40' ' ' SER . . . . . . . . . . . . . 59.6 p -91.41 113.94 26.34 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.561 -0.29 . . . . 0.0 110.988 177.773 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' C' C ' 41' ' ' ILE . . . . . . . . . . . . . 45.5 mm -123.3 128.14 74.69 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.248 0 CA-C-N 116.408 -0.36 . . . . 0.0 110.063 179.694 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' C' C ' 42' ' ' LEU . . . . . . . . . . . . . 69.8 mt 58.02 33.86 23.63 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 116.194 -0.457 . . . . 0.0 111.779 176.934 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' C' C ' 43' ' ' GLY . . . . . . . . . . . . . . . 73.11 21.81 79.5 Favored Glycine 0 CA--C 1.533 1.195 0 C-N-CA 121.227 -0.511 . . . . 0.0 112.89 177.623 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' C' C ' 44' ' ' LYS . . . . . . . . . . . . . 67.6 mttm -138.25 130.54 28.88 Favored 'General case' 0 C--N 1.332 -0.16 0 CA-C-N 117.41 0.605 . . . . 0.0 109.919 177.548 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' C' C ' 45' ' ' GLU . . . . . . . . . . . . . 43.5 tp10 -84.06 127.26 33.78 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.367 -0.379 . . . . 0.0 111.413 -177.545 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' C' C ' 46' ' ' VAL . . . . . . . . . . . . . 8.9 p -116.06 127.3 73.7 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.282 0 N-CA-C 109.249 -0.648 . . . . 0.0 109.249 173.312 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' C' C ' 47' ' ' LYS . . . . . . . . . . . . . 64.8 mttp -98.07 126.16 43.38 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 116.104 -0.498 . . . . 0.0 110.787 178.715 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' C' C ' 48' ' ' PHE . . . . . . . . . . . . . 34.2 m-85 -110.82 131.88 54.67 Favored 'General case' 0 C--N 1.328 -0.345 0 N-CA-C 109.453 -0.573 . . . . 0.0 109.453 177.159 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' C' C ' 49' ' ' LYS . . . . . . . . . . . . . 45.2 tttp -105.65 133.27 50.67 Favored 'General case' 0 C--N 1.328 -0.354 0 N-CA-C 110.085 -0.339 . . . . 0.0 110.085 178.831 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' C' C ' 50' ' ' VAL . . . . . . . . . . . . . 46.2 t -75.79 102.4 2.83 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.324 0 N-CA-C 109.189 -0.671 . . . . 0.0 109.189 176.669 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' C' C ' 51' ' ' VAL . . . . . . . . . . . . . 47.0 t -70.03 -48.18 64.22 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.279 0 CA-C-N 116.005 -0.543 . . . . 0.0 109.895 -174.293 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' C' C ' 52' ' ' GLN . . . . . . . . . . . . . 62.0 tt0 -160.14 138.92 10.54 Favored 'General case' 0 C--N 1.33 -0.252 0 C-N-CA 120.382 -0.527 . . . . 0.0 111.631 -178.8 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' C' C ' 53' ' ' ALA . . . . . . . . . . . . . . . -111.55 130.97 55.57 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 115.665 -0.698 . . . . 0.0 109.806 176.012 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' C' C ' 54' ' ' TYR . . . . . . . . . . . . . 45.7 t80 -128.93 107.32 18.19 Favored Pre-proline 0 CA--C 1.535 0.395 0 CA-C-O 118.335 -0.841 . . . . 0.0 110.54 -179.04 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' C' C ' 55' ' ' PRO . . . . . . . . . . . . . 73.7 Cg_endo -77.12 170.04 72.65 Favored 'Cis proline' 0 N--CA 1.499 1.81 0 CA-C-N 121.784 1.673 . . . . 0.0 112.355 -6.158 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' C' C ' 56' ' ' SER . . . . . . . . . . . . . 69.8 m -117.06 132.33 23.52 Favored Pre-proline 0 CA--C 1.539 0.544 0 CA-C-O 118.492 -0.766 . . . . 0.0 109.476 175.371 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' C' C ' 57' ' ' PRO . . . . . . . . . . . . . 44.2 Cg_endo -69.35 147.4 83.72 Favored 'Cis proline' 0 N--CA 1.498 1.767 0 CA-C-N 121.909 1.718 . . . . 0.0 111.335 -1.46 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' C' C ' 58' ' ' LEU . . . . . . . . . . . . . 27.0 tp -107.06 136.63 46.59 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.372 -0.377 . . . . 0.0 110.68 -178.017 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' C' C ' 59' ' ' ARG . . . . . . . . . . . . . 75.4 ttt180 -102.12 120.79 41.02 Favored 'General case' 0 C--N 1.325 -0.482 0 N-CA-C 109.364 -0.606 . . . . 0.0 109.364 176.27 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' C' C ' 60' ' ' VAL . . . . . . . . . . . . . 40.8 t -74.31 122.09 26.9 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.268 0 C-N-CA 120.633 -0.427 . . . . 0.0 110.09 -176.021 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' C' C ' 61' ' ' GLU . . . . . . . . . . . . . 32.4 tp10 -130.72 157.78 41.87 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 115.994 -0.548 . . . . 0.0 109.759 -178.409 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' C' C ' 62' ' ' ASP . . . . . . . . . . . . . 35.7 m-20 -53.22 -32.5 48.51 Favored 'General case' 0 C--N 1.326 -0.417 0 N-CA-C 111.762 0.282 . . . . 0.0 111.762 179.947 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' C' C ' 63' ' ' ARG . . . . . . . . . . . . . 9.5 ptm180 -86.25 6.56 29.07 Favored 'General case' 0 CA--C 1.535 0.397 0 N-CA-C 113.551 0.945 . . . . 0.0 113.551 -177.522 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' C' C ' 64' ' ' THR . . . . . . . . . . . . . 37.6 m -83.58 137.87 33.64 Favored 'General case' 0 C--N 1.332 -0.166 0 CA-C-N 118.095 0.407 . . . . 0.0 110.569 -178.144 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' C' C ' 65' ' ' LYS . . . . . . . . . . . . . 53.4 mtmt -89.67 127.27 35.9 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 116.016 -0.538 . . . . 0.0 110.279 178.232 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' C' C ' 66' ' ' ILE . . . . . . . . . . . . . 64.1 mt -113.52 125.72 70.84 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.288 0 N-CA-C 109.413 -0.588 . . . . 0.0 109.413 178.957 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' C' C ' 67' ' ' THR . . . . . . . . . . . . . 20.9 m -125.21 143.67 50.83 Favored 'General case' 0 C--N 1.331 -0.208 0 CA-C-O 121.139 0.495 . . . . 0.0 111.221 -175.858 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' C' C ' 68' ' ' LEU . . . . . . . . . . . . . 7.8 mp . . . . . 0 C--N 1.329 -0.295 0 CA-C-N 115.738 -0.665 . . . . 0.0 110.129 176.471 . . . . . . . . 0 0 . 1 . 019 nuclear orig core ' C' C ' 73' ' ' VAL . . . . . . . . . . . . . 35.8 m . . . . . 0 C--O 1.231 0.088 0 CA-C-O 120.828 0.347 . . . . 0.0 110.354 . . . . . . . . . 0 0 . 1 . 019 nuclear orig core ' C' C ' 74' ' ' ASP . . . . . . . . . . . . . 29.4 t0 -101.06 117.53 35.2 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.253 -0.43 . . . . 0.0 110.071 -178.802 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' C' C ' 75' ' ' VAL . . . . . . . . . . . . . 43.5 t -111.48 120.95 63.13 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.241 0 CA-C-O 120.992 0.425 . . . . 0.0 110.315 -179.266 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' C' C ' 76' ' ' LEU . . . . . . . . . . . . . 29.5 mt -123.42 145.41 48.81 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 115.869 -0.605 . . . . 0.0 109.604 179.212 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' C' C ' 77' ' ' GLU . . . . . . . . . . . . . 45.4 mt-10 -136.83 135.47 37.96 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-O 121.035 0.445 . . . . 0.0 111.149 -177.25 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' C' C ' 78' ' ' ALA . . . . . . . . . . . . . . . -122.17 125.84 47.0 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 115.615 -0.721 . . . . 0.0 109.465 176.862 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' C' C ' 79' ' ' LYS . . . . . . . . . . . . . 47.4 pttt -78.63 119.86 22.49 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-O 121.437 0.637 . . . . 0.0 111.208 -175.781 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' C' C ' 80' ' ' ILE . . . . . . . . . . . . . 38.8 mm -139.39 110.25 4.57 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.246 0 CA-C-N 115.478 -0.783 . . . . 0.0 108.993 -179.832 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' C' C ' 81' ' ' LYS . . . . . . . . . . . . . 25.1 mtpp -97.77 123.99 41.94 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-O 120.894 0.378 . . . . 0.0 111.097 -177.977 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' C' C ' 82' ' ' GLY . . . . . . . . . . . . . . . 89.19 42.22 5.63 Favored Glycine 0 CA--C 1.527 0.839 0 C-N-CA 120.85 -0.691 . . . . 0.0 111.604 175.8 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' C' C ' 83' ' ' ILE . . . . . . . . . . . . . 69.2 mt -65.24 136.58 26.45 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.35 0 N-CA-C 109.732 -0.469 . . . . 0.0 109.732 177.477 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' C' C ' 84' ' ' LYS . . . . . . . . . . . . . 26.9 ttmt -88.64 -48.74 7.33 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.136 -0.484 . . . . 0.0 110.114 -179.508 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' C' C ' 85' ' ' ASP . . . . . . . . . . . . . 4.6 t70 -162.97 157.69 21.34 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 115.799 -0.637 . . . . 0.0 110.537 179.311 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' C' C ' 86' ' ' VAL . . . . . . . . . . . . . 41.1 t -130.22 133.81 63.56 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.277 0 CA-C-O 120.984 0.421 . . . . 0.0 110.469 -178.535 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' C' C ' 87' ' ' ILE . . . . . . . . . . . . . 5.0 mp -119.36 125.97 74.91 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.257 0 CA-C-N 115.848 -0.615 . . . . 0.0 109.474 176.993 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' C' C ' 88' ' ' LEU . . . . . . . . . . . . . 54.5 mt -110.52 135.6 50.94 Favored 'General case' 0 C--N 1.332 -0.187 0 CA-C-O 120.998 0.427 . . . . 0.0 111.495 -176.776 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' C' C ' 89' ' ' ASP . . . . . . . . . . . . . 9.0 t70 -131.46 153.16 50.04 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 115.777 -0.647 . . . . 0.0 109.554 174.802 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' C' C ' 90' ' ' GLU . . . . . . . . . . . . . 95.4 mt-10 -48.33 -38.58 19.46 Favored 'General case' 0 C--N 1.33 -0.274 0 N-CA-C 112.666 0.617 . . . . 0.0 112.666 -172.858 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' C' C ' 91' ' ' ASN . . . . . . . . . . . . . 19.0 p30 -132.02 36.82 3.64 Favored 'General case' 0 N--CA 1.463 0.221 0 CA-C-O 120.807 0.336 . . . . 0.0 111.404 -177.294 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' C' C ' 92' ' ' LEU . . . . . . . . . . . . . 13.1 tp -166.07 142.85 5.18 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.578 -0.283 . . . . 0.0 110.626 -179.155 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' C' C ' 93' ' ' ILE . . . . . . . . . . . . . 67.0 mt -127.47 122.16 58.79 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.262 0 N-CA-C 109.461 -0.57 . . . . 0.0 109.461 178.741 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' C' C ' 94' ' ' VAL . . . . . . . . . . . . . 44.9 t -120.8 125.47 74.1 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.228 0 N-CA-C 109.757 -0.46 . . . . 0.0 109.757 179.252 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' C' C ' 95' ' ' VAL . . . . . . . . . . . . . 45.1 t -119.87 132.61 69.13 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.264 0 CA-C-N 116.015 -0.538 . . . . 0.0 109.77 -179.642 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' C' C ' 96' ' ' ILE . . . . . . . . . . . . . 65.9 mt -113.48 125.19 70.71 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.34 0 N-CA-C 109.106 -0.702 . . . . 0.0 109.106 179.025 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' C' C ' 97' ' ' THR . . . . . . . . . . . . . 73.0 p -99.74 151.43 21.24 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-O 121.118 0.485 . . . . 0.0 111.183 -177.185 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' C' C ' 98' ' ' GLU . . . . . . . . . . . . . 85.6 tt0 -53.87 -24.98 17.69 Favored 'General case' 0 C--N 1.33 -0.265 0 N-CA-C 112.343 0.497 . . . . 0.0 112.343 -179.603 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' C' C ' 99' ' ' GLU . . . . . . . . . . . . . 71.1 mm-40 -79.31 16.35 1.02 Allowed 'General case' 0 CA--C 1.534 0.356 0 N-CA-C 113.033 0.753 . . . . 0.0 113.033 -178.102 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' C' C ' 100' ' ' ASN . . . . . . . . . . . . . 4.5 m-20 64.19 37.95 8.49 Favored 'General case' 0 C--O 1.233 0.222 0 CA-C-O 121.0 0.428 . . . . 0.0 111.076 177.326 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' C' C ' 101' ' ' GLU . . . . . . . . . . . . . 84.2 tt0 -118.29 143.65 46.43 Favored 'General case' 0 C--N 1.333 -0.145 0 CA-C-N 116.1 -0.5 . . . . 0.0 109.795 176.711 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' C' C ' 102' ' ' VAL . . . . . . . . . . . . . 42.8 t -115.04 126.11 72.54 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.335 0 CA-C-N 116.434 -0.348 . . . . 0.0 110.063 -178.689 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' C' C ' 103' ' ' LEU . . . . . . . . . . . . . 15.1 mt -115.57 126.87 54.76 Favored 'General case' 0 C--N 1.331 -0.205 0 CA-C-N 115.484 -0.78 . . . . 0.0 110.028 176.873 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' C' C ' 104' ' ' ILE . . . . . . . . . . . . . 68.4 mt -119.22 121.11 65.8 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.275 0 N-CA-C 110.293 -0.262 . . . . 0.0 110.293 -179.973 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' C' C ' 105' ' ' PHE . . . . . . . . . . . . . 35.7 m-85 -125.35 167.05 15.47 Favored 'General case' 0 C--N 1.334 -0.105 0 O-C-N 123.838 0.711 . . . . 0.0 110.166 179.788 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' C' C ' 106' ' ' ASN . . . . . . . . . . . . . 41.3 p-10 -99.95 -169.79 1.79 Allowed 'General case' 0 C--N 1.33 -0.254 0 N-CA-C 110.01 -0.367 . . . . 0.0 110.01 174.399 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' C' C ' 107' ' ' GLN . . . . . . . . . . . . . 46.5 tt0 -58.36 -29.46 66.01 Favored 'General case' 0 C--N 1.329 -0.318 0 N-CA-C 112.006 0.373 . . . . 0.0 112.006 179.421 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' C' C ' 108' ' ' ASN . . . . . . . . . . . . . 10.3 t30 -86.75 13.01 9.51 Favored 'General case' 0 CA--C 1.536 0.435 0 N-CA-C 113.051 0.76 . . . . 0.0 113.051 -177.977 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' C' C ' 109' ' ' LEU . . . . . . . . . . . . . 7.9 tp 55.67 37.83 29.37 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-O 120.947 0.403 . . . . 0.0 111.36 178.277 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' C' C ' 110' ' ' GLU . . . . . . . . . . . . . 96.0 mt-10 -103.04 156.85 17.39 Favored 'General case' 0 C--N 1.33 -0.255 0 N-CA-C 109.832 -0.433 . . . . 0.0 109.832 175.947 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' C' C ' 111' ' ' GLU . . . . . . . . . . . . . 84.6 tt0 -84.31 121.99 28.29 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-O 120.952 0.406 . . . . 0.0 111.127 -176.852 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' C' C ' 112' ' ' LEU . . . . . . . . . . . . . 27.2 mt -105.72 -46.11 4.23 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-N 115.979 -0.555 . . . . 0.0 110.057 176.586 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' C' C ' 113' ' ' TYR . . . . . . . . . . . . . 59.6 t80 -145.49 138.88 26.42 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.048 -0.523 . . . . 0.0 110.856 -179.689 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' C' C ' 114' ' ' ARG . . . . . . . . . . . . . 27.1 ttm180 -141.88 126.29 17.7 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.32 -0.4 . . . . 0.0 110.266 176.965 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' C' C ' 115' ' ' GLY . . . . . . . . . . . . . . . -150.21 160.82 28.7 Favored Glycine 0 CA--C 1.524 0.597 0 N-CA-C 111.101 -0.799 . . . . 0.0 111.101 179.333 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' C' C ' 116' ' ' LYS . . . . . . . . . . . . . 38.9 ttpt -130.39 134.18 46.95 Favored 'General case' 0 C--N 1.33 -0.253 0 N-CA-C 110.035 -0.357 . . . . 0.0 110.035 177.24 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' C' C ' 117' ' ' PHE . . . . . . . . . . . . . 47.5 m-85 -126.99 118.64 24.9 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.333 -0.394 . . . . 0.0 110.464 -176.337 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' C' C ' 118' ' ' GLU . . . . . . . . . . . . . 95.9 mt-10 -51.86 -51.61 55.48 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.39 -0.368 . . . . 0.0 111.697 -175.629 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' C' C ' 119' ' ' ASN . . . . . . . . . . . . . 70.5 m-80 -98.03 31.01 2.84 Favored 'General case' 0 C--N 1.329 -0.294 0 N-CA-C 112.19 0.441 . . . . 0.0 112.19 -173.485 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' C' C ' 120' ' ' LEU . . . . . . . . . . . . . 6.5 tt -56.27 121.3 9.2 Favored 'General case' 0 C--N 1.333 -0.129 0 CA-C-O 120.727 0.299 . . . . 0.0 110.562 178.751 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' C' C ' 121' ' ' ASN . . . . . . . . . . . . . 74.5 m-20 -114.03 -44.12 3.18 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 116.364 -0.38 . . . . 0.0 111.159 -176.44 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' C' C ' 122' ' ' LYS . . . . . . . . . . . . . 55.2 mtmt -142.87 150.73 40.24 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-O 121.149 0.499 . . . . 0.0 111.513 -176.379 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' C' C ' 123' ' ' VAL . . . . . . . . . . . . . 45.8 t -130.38 133.46 63.84 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.228 0 CA-C-N 115.863 -0.608 . . . . 0.0 109.653 177.812 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' C' C ' 124' ' ' LEU . . . . . . . . . . . . . 30.1 mt -125.14 127.78 47.38 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.468 -0.333 . . . . 0.0 110.416 -179.852 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' C' C ' 125' ' ' VAL . . . . . . . . . . . . . 43.0 t -132.57 131.09 60.04 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.262 0 CA-C-N 116.183 -0.462 . . . . 0.0 109.97 -179.829 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' C' C ' 126' ' ' ARG . . . . . . . . . . . . . 78.1 mtt180 -145.95 119.77 9.28 Favored 'General case' 0 C--N 1.331 -0.22 0 CA-C-N 116.348 -0.387 . . . . 0.0 110.79 178.88 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' C' C ' 127' ' ' ASN . . . . . . . . . . . . . 64.1 t30 51.12 -105.75 0.22 Allowed 'General case' 0 CA--C 1.543 0.696 0 CA-C-O 119.023 -0.513 . . . . 0.0 111.476 179.188 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' C' C ' 128' ' ' ASP . . . . . . . . . . . . . 16.1 p-10 -114.08 5.27 15.96 Favored 'General case' 0 N--CA 1.469 0.483 0 CA-C-N 119.602 1.092 . . . . 0.0 113.442 -177.084 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' C' C ' 129' ' ' LEU . . . . . . . . . . . . . 26.1 mt -105.01 133.22 50.17 Favored 'General case' 0 C--N 1.332 -0.184 0 N-CA-C 109.555 -0.535 . . . . 0.0 109.555 177.703 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' C' C ' 130' ' ' VAL . . . . . . . . . . . . . 46.3 t -128.11 132.02 68.85 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.287 0 CA-C-O 120.881 0.372 . . . . 0.0 110.218 -178.508 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' C' C ' 131' ' ' VAL . . . . . . . . . . . . . 35.2 m -136.15 138.69 46.86 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.228 0 CA-C-O 121.15 0.5 . . . . 0.0 111.059 177.246 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' C' C ' 132' ' ' ILE . . . . . . . . . . . . . 71.4 mt -116.4 131.55 68.62 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.303 0 CA-C-N 115.67 -0.695 . . . . 0.0 109.26 179.189 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' C' C ' 133' ' ' ILE . . . . . . . . . . . . . 33.3 mm -115.09 120.66 65.24 Favored 'Isoleucine or valine' 0 C--O 1.234 0.255 0 CA-C-O 120.762 0.315 . . . . 0.0 111.316 -173.958 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' C' C ' 134' ' ' ASP . . . . . . . . . . . . . 10.0 p-10 -132.94 148.43 52.28 Favored 'General case' 0 C--N 1.33 -0.255 0 N-CA-C 109.538 -0.542 . . . . 0.0 109.538 175.066 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' C' C ' 135' ' ' GLU . . . . . . . . . . . . . 85.3 tt0 -49.94 -25.37 3.21 Favored 'General case' 0 C--N 1.328 -0.355 0 N-CA-C 112.864 0.691 . . . . 0.0 112.864 -172.281 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' C' C ' 136' ' ' GLN . . . . . . . . . . . . . 97.5 mt-30 -84.16 -37.83 21.43 Favored 'General case' 0 C--O 1.234 0.245 0 N-CA-C 112.305 0.483 . . . . 0.0 112.305 -176.588 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' C' C ' 137' ' ' LYS . . . . . . . . . . . . . 22.7 pttm -162.16 174.71 12.55 Favored 'General case' 0 C--N 1.331 -0.224 0 CA-C-O 121.507 0.67 . . . . 0.0 112.402 -170.634 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' C' C ' 138' ' ' LEU . . . . . . . . . . . . . 7.0 tt -122.6 128.1 50.25 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 114.903 -1.044 . . . . 0.0 109.918 178.558 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' C' C ' 139' ' ' THR . . . . . . . . . . . . . 30.1 m -104.15 124.05 48.39 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.121 -0.491 . . . . 0.0 110.236 179.012 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' C' C ' 140' ' ' LEU . . . . . . . . . . . . . 19.4 tp -109.25 119.56 39.87 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 115.719 -0.673 . . . . 0.0 109.674 -177.808 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' C' C ' 141' ' ' ILE . . . . . . . . . . . . . 19.0 mt -121.15 120.93 63.55 Favored 'Isoleucine or valine' 0 C--O 1.235 0.297 0 CA-C-O 120.986 0.422 . . . . 0.0 110.235 -175.093 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' C' C ' 142' ' ' ARG . . . . . . . . . . . . . 1.1 mpt_? . . . . . 0 C--N 1.33 -0.272 0 CA-C-N 115.312 -0.858 . . . . 0.0 110.08 -179.296 . . . . . . . . 0 0 . 1 . 019 nuclear orig core ' D' D ' 2' ' ' SER . . . . . . . . . . . . . 7.6 p . . . . . 0 C--O 1.232 0.16 0 CA-C-O 121.124 0.488 . . . . 0.0 110.917 . . . . . . . . . 0 0 . 1 . 019 nuclear orig core ' D' D ' 3' ' ' GLU . . . . . . . . . . . . . 43.6 mp0 -137.85 142.19 40.75 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 115.619 -0.719 . . . . 0.0 110.571 -178.991 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' D' D ' 4' ' ' LEU . . . . . . . . . . . . . 4.2 tt -123.9 123.13 39.74 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 115.753 -0.658 . . . . 0.0 109.78 177.24 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' D' D ' 5' ' ' LYS . . . . . . . . . . . . . 63.6 mttp -102.63 121.51 42.54 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-O 120.77 0.319 . . . . 0.0 110.825 -179.984 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' D' D ' 6' ' ' LEU . . . . . . . . . . . . . 64.7 mt -114.37 148.3 37.84 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 115.553 -0.748 . . . . 0.0 110.614 179.836 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' D' D ' 7' ' ' LYS . . . . . . . . . . . . . 22.7 ttmm -139.82 141.32 27.17 Favored Pre-proline 0 CA--C 1.534 0.339 0 N-CA-C 109.811 -0.44 . . . . 0.0 109.811 174.826 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' D' D ' 8' ' ' PRO . . . . . . . . . . . . . 96.4 Cg_endo -91.22 139.16 2.41 Favored 'Trans proline' 0 N--CA 1.49 1.316 0 C-N-CA 121.694 1.596 . . . . 0.0 111.663 177.988 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' D' D ' 9' ' ' LEU . . . . . . . . . . . . . 49.2 mt -78.28 -45.84 2.13 Favored Pre-proline 0 CA--C 1.533 0.313 0 CA-C-O 118.838 -0.601 . . . . 0.0 111.788 -179.655 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' D' D ' 10' ' ' PRO . . . . . . . . . . . . . 74.7 Cg_endo -84.63 150.75 11.51 Favored 'Trans proline' 0 N--CA 1.495 1.604 0 C-N-CA 121.224 1.283 . . . . 0.0 111.364 171.804 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' D' D ' 11' ' ' LYS . . . . . . . . . . . . . 19.8 pttp -83.47 117.28 22.98 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-O 121.385 0.612 . . . . 0.0 110.423 178.4 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' D' D ' 12' ' ' VAL . . . . . . . . . . . . . 12.3 p -151.05 148.58 14.84 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.271 0 CA-C-N 115.837 -0.62 . . . . 0.0 110.625 -179.965 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' D' D ' 13' ' ' GLU . . . . . . . . . . . . . 44.7 mp0 -91.07 121.59 33.0 Favored 'General case' 0 C--N 1.328 -0.346 0 N-CA-C 109.866 -0.42 . . . . 0.0 109.866 176.663 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' D' D ' 14' ' ' LEU . . . . . . . . . . . . . 15.7 mt -98.09 147.8 33.6 Favored Pre-proline 0 CA--C 1.533 0.3 0 CA-C-O 119.23 -0.414 . . . . 0.0 110.627 -177.801 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' D' D ' 15' ' ' PRO . . . . . . . . . . . . . 24.4 Cg_exo -63.33 162.41 27.11 Favored 'Trans proline' 0 N--CA 1.497 1.685 0 C-N-CA 121.39 1.393 . . . . 0.0 111.813 175.877 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' D' D ' 16' ' ' PRO . . . . . . . . . . . . . 27.8 Cg_exo -60.27 -33.94 94.21 Favored 'Trans proline' 0 N--CA 1.497 1.723 0 C-N-CA 121.495 1.463 . . . . 0.0 112.687 -178.724 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' D' D ' 17' ' ' ASP . . . . . . . . . . . . . 23.1 p-10 -90.07 6.73 41.11 Favored 'General case' 0 CA--C 1.536 0.421 0 N-CA-C 113.447 0.906 . . . . 0.0 113.447 -176.936 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' D' D ' 18' ' ' PHE . . . . . . . . . . . . . 53.4 t80 -58.04 -42.87 86.31 Favored 'General case' 0 C--N 1.335 -0.036 0 O-C-N 122.045 -0.409 . . . . 0.0 110.171 -178.777 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' D' D ' 19' ' ' VAL . . . . . . . . . . . . . 47.3 t -56.6 -43.46 78.74 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 CA-C-N 116.236 -0.438 . . . . 0.0 110.514 -179.27 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' D' D ' 20' ' ' ASP . . . . . . . . . . . . . 79.3 m-20 -60.26 -42.02 94.48 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-O 120.696 0.284 . . . . 0.0 110.923 -178.276 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' D' D ' 21' ' ' VAL . . . . . . . . . . . . . 46.3 t -64.12 -48.38 86.04 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.294 0 C-N-CA 120.854 -0.339 . . . . 0.0 110.517 -177.871 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' D' D ' 22' ' ' ILE . . . . . . . . . . . . . 50.3 mm -55.97 -45.45 80.15 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.218 0 CA-C-O 120.867 0.365 . . . . 0.0 110.577 179.087 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' D' D ' 23' ' ' ARG . . . . . . . . . . . . . 53.7 ttp180 -54.13 -49.93 68.07 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.602 -0.272 . . . . 0.0 111.427 -178.86 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' D' D ' 24' ' ' ILE . . . . . . . . . . . . . 77.5 mt -59.78 -41.5 85.73 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.267 0 C-N-CA 121.172 -0.211 . . . . 0.0 111.253 -178.065 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' D' D ' 25' ' ' LYS . . . . . . . . . . . . . 73.2 mmtt -63.51 -42.56 98.48 Favored 'General case' 0 C--N 1.328 -0.346 0 N-CA-C 112.015 0.376 . . . . 0.0 112.015 -179.695 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' D' D ' 26' ' ' LEU . . . . . . . . . . . . . 74.5 mt -79.87 -40.19 28.88 Favored 'General case' 0 C--N 1.329 -0.311 0 N-CA-C 113.344 0.868 . . . . 0.0 113.344 -170.856 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' D' D ' 27' ' ' GLN . . . . . . . . . . . . . 8.6 pt20 -46.67 140.94 4.12 Favored 'General case' 0 N--CA 1.47 0.526 0 N-CA-C 112.785 0.661 . . . . 0.0 112.785 -174.923 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' D' D ' 28' ' ' GLY . . . . . . . . . . . . . . . 98.57 -27.6 18.84 Favored Glycine 0 CA--C 1.533 1.186 0 CA-C-N 115.527 -0.761 . . . . 0.0 112.123 -177.87 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' D' D ' 29' ' ' LYS . . . . . . . . . . . . . 67.3 mttm -98.39 155.14 17.38 Favored 'General case' 0 C--O 1.232 0.181 0 CA-C-N 117.229 0.515 . . . . 0.0 111.044 179.636 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' D' D ' 30' ' ' THR . . . . . . . . . . . . . 37.9 m -100.7 137.65 38.81 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.075 -0.511 . . . . 0.0 110.062 176.095 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' D' D ' 31' ' ' VAL . . . . . . . . . . . . . 34.6 m -128.4 157.31 40.88 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.282 0 CA-C-O 120.992 0.425 . . . . 0.0 110.716 -178.953 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' D' D ' 32' ' ' ARG . . . . . . . . . . . . . 94.2 mtt180 -133.72 151.26 51.57 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 115.74 -0.664 . . . . 0.0 110.446 177.832 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' D' D ' 33' ' ' THR . . . . . . . . . . . . . 30.0 m -53.12 138.52 31.03 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.496 -0.32 . . . . 0.0 111.317 -179.339 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' D' D ' 34' ' ' GLY . . . . . . . . . . . . . . . 101.28 -17.13 56.19 Favored Glycine 0 CA--C 1.533 1.17 0 CA-C-O 119.593 -0.559 . . . . 0.0 113.305 179.124 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' D' D ' 35' ' ' ASP . . . . . . . . . . . . . 67.9 m-20 -65.26 148.95 50.79 Favored 'General case' 0 N--CA 1.461 0.122 0 CA-C-N 118.039 0.92 . . . . 0.0 110.987 179.332 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' D' D ' 36' ' ' VAL . . . . . . . . . . . . . 44.7 t -124.23 130.86 73.54 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.25 0 CA-C-N 115.858 -0.61 . . . . 0.0 109.916 179.49 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' D' D ' 37' ' ' ILE . . . . . . . . . . . . . 65.4 mt -119.7 138.19 51.12 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.267 0 CA-C-N 116.195 -0.457 . . . . 0.0 109.787 179.396 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' D' D ' 38' ' ' GLY . . . . . . . . . . . . . . . -114.33 128.72 8.34 Favored Glycine 0 CA--C 1.524 0.637 0 N-CA-C 111.096 -0.801 . . . . 0.0 111.096 -179.699 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' D' D ' 39' ' ' ILE . . . . . . . . . . . . . 72.7 mt -127.34 131.03 70.84 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.282 0 N-CA-C 109.863 -0.421 . . . . 0.0 109.863 178.373 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' D' D ' 40' ' ' SER . . . . . . . . . . . . . 51.8 p -91.92 121.1 33.2 Favored 'General case' 0 C--N 1.329 -0.292 0 C-N-CA 120.894 -0.322 . . . . 0.0 110.81 176.348 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' D' D ' 41' ' ' ILE . . . . . . . . . . . . . 71.9 mt -130.02 119.29 46.68 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.201 0 CA-C-O 120.833 0.349 . . . . 0.0 110.295 179.918 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' D' D ' 42' ' ' LEU . . . . . . . . . . . . . 83.5 mt 58.15 33.41 23.14 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.073 -0.512 . . . . 0.0 111.874 177.551 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' D' D ' 43' ' ' GLY . . . . . . . . . . . . . . . 82.57 -10.1 56.8 Favored Glycine 0 CA--C 1.533 1.216 0 C-N-CA 121.22 -0.514 . . . . 0.0 113.468 176.746 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' D' D ' 44' ' ' LYS . . . . . . . . . . . . . 68.2 tttt -103.34 129.51 50.39 Favored 'General case' 0 C--N 1.332 -0.167 0 CA-C-N 117.948 0.874 . . . . 0.0 109.851 176.885 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' D' D ' 45' ' ' GLU . . . . . . . . . . . . . 39.9 tp10 -84.22 131.14 34.78 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-O 120.816 0.341 . . . . 0.0 110.99 -179.47 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' D' D ' 46' ' ' VAL . . . . . . . . . . . . . 7.3 p -120.99 129.03 76.13 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.191 0 N-CA-C 109.69 -0.485 . . . . 0.0 109.69 176.793 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' D' D ' 47' ' ' LYS . . . . . . . . . . . . . 65.2 mmtt -99.59 126.6 45.61 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 115.87 -0.605 . . . . 0.0 110.931 177.075 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' D' D ' 48' ' ' PHE . . . . . . . . . . . . . 95.8 m-85 -108.78 131.74 54.66 Favored 'General case' 0 C--N 1.328 -0.328 0 N-CA-C 109.399 -0.593 . . . . 0.0 109.399 175.193 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' D' D ' 49' ' ' LYS . . . . . . . . . . . . . 74.3 tttt -109.01 135.48 50.11 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.467 -0.333 . . . . 0.0 110.501 179.934 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' D' D ' 50' ' ' VAL . . . . . . . . . . . . . 43.7 t -78.72 106.05 8.95 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.293 0 N-CA-C 109.187 -0.671 . . . . 0.0 109.187 175.73 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' D' D ' 51' ' ' VAL . . . . . . . . . . . . . 52.9 t -68.8 -47.63 75.23 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.315 0 CA-C-N 116.077 -0.511 . . . . 0.0 109.992 -173.251 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' D' D ' 52' ' ' GLN . . . . . . . . . . . . . 62.8 tt0 -170.18 144.2 2.57 Favored 'General case' 0 C--N 1.33 -0.271 0 C-N-CA 120.262 -0.575 . . . . 0.0 111.839 -178.996 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' D' D ' 53' ' ' ALA . . . . . . . . . . . . . . . -116.46 134.32 55.0 Favored 'General case' 0 C--N 1.331 -0.213 0 CA-C-N 115.641 -0.709 . . . . 0.0 109.831 175.948 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' D' D ' 54' ' ' TYR . . . . . . . . . . . . . 48.7 t80 -129.06 112.82 18.52 Favored Pre-proline 0 CA--C 1.534 0.343 0 CA-C-O 118.194 -0.908 . . . . 0.0 110.442 178.578 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' D' D ' 55' ' ' PRO . . . . . . . . . . . . . 74.0 Cg_endo -77.18 167.86 78.5 Favored 'Cis proline' 0 N--CA 1.499 1.84 0 CA-C-N 122.002 1.751 . . . . 0.0 112.14 -7.727 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' D' D ' 56' ' ' SER . . . . . . . . . . . . . 13.6 m -117.11 140.64 27.34 Favored Pre-proline 0 CA--C 1.537 0.454 0 CA-C-O 118.674 -0.679 . . . . 0.0 109.741 174.802 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' D' D ' 57' ' ' PRO . . . . . . . . . . . . . 38.2 Cg_endo -68.0 159.95 82.92 Favored 'Cis proline' 0 N--CA 1.498 1.786 0 CA-C-N 121.596 1.606 . . . . 0.0 111.139 -3.544 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' D' D ' 58' ' ' LEU . . . . . . . . . . . . . 20.7 tp -129.6 137.16 50.55 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-O 120.995 0.426 . . . . 0.0 110.473 -178.136 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' D' D ' 59' ' ' ARG . . . . . . . . . . . . . 41.7 ttp180 -104.57 126.6 51.81 Favored 'General case' 0 C--N 1.327 -0.379 0 N-CA-C 109.24 -0.652 . . . . 0.0 109.24 175.342 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' D' D ' 60' ' ' VAL . . . . . . . . . . . . . 41.4 t -80.06 123.45 36.87 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.291 0 C-N-CA 120.676 -0.409 . . . . 0.0 110.649 -173.411 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' D' D ' 61' ' ' GLU . . . . . . . . . . . . . 95.9 mt-10 -131.05 164.19 25.97 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 115.782 -0.645 . . . . 0.0 109.78 177.34 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' D' D ' 62' ' ' ASP . . . . . . . . . . . . . 76.4 m-20 -53.19 -32.5 48.29 Favored 'General case' 0 C--N 1.328 -0.345 0 N-CA-C 111.81 0.3 . . . . 0.0 111.81 -179.981 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' D' D ' 63' ' ' ARG . . . . . . . . . . . . . 95.7 mtt180 -74.48 -21.99 59.3 Favored 'General case' 0 CA--C 1.533 0.294 0 N-CA-C 112.945 0.72 . . . . 0.0 112.945 -176.986 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' D' D ' 64' ' ' THR . . . . . . . . . . . . . 26.8 m -64.84 137.17 57.61 Favored 'General case' 0 C--N 1.331 -0.223 0 CA-C-O 120.965 0.412 . . . . 0.0 110.572 -175.599 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' D' D ' 65' ' ' LYS . . . . . . . . . . . . . 39.8 ttpt -89.14 123.78 33.72 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 115.903 -0.589 . . . . 0.0 110.317 -179.721 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' D' D ' 66' ' ' ILE . . . . . . . . . . . . . 62.7 mt -111.48 130.2 65.46 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.261 0 N-CA-C 109.94 -0.393 . . . . 0.0 109.94 -178.564 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' D' D ' 67' ' ' THR . . . . . . . . . . . . . 8.1 m -130.1 146.97 51.79 Favored 'General case' 0 C--N 1.332 -0.192 0 CA-C-O 121.068 0.461 . . . . 0.0 111.231 -176.663 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' D' D ' 68' ' ' LEU . . . . . . . . . . . . . 54.0 mt . . . . . 0 C--N 1.33 -0.247 0 CA-C-N 115.836 -0.62 . . . . 0.0 110.266 177.47 . . . . . . . . 0 0 . 1 . 019 nuclear orig core ' D' D ' 73' ' ' VAL . . . . . . . . . . . . . 34.6 m . . . . . 0 C--O 1.231 0.1 0 CA-C-O 120.795 0.331 . . . . 0.0 110.874 . . . . . . . . . 0 0 . 1 . 019 nuclear orig core ' D' D ' 74' ' ' ASP . . . . . . . . . . . . . 23.6 t0 -96.84 124.66 40.88 Favored 'General case' 0 C--N 1.33 -0.264 0 N-CA-C 109.548 -0.538 . . . . 0.0 109.548 178.516 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' D' D ' 75' ' ' VAL . . . . . . . . . . . . . 40.6 t -114.31 122.88 69.31 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.258 0 CA-C-O 121.064 0.459 . . . . 0.0 110.7 -177.524 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' D' D ' 76' ' ' LEU . . . . . . . . . . . . . 5.5 mp -124.76 152.41 43.86 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 115.653 -0.703 . . . . 0.0 109.608 175.951 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' D' D ' 77' ' ' GLU . . . . . . . . . . . . . 98.4 mt-10 -137.35 139.66 40.95 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-O 121.068 0.461 . . . . 0.0 111.34 -177.669 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' D' D ' 78' ' ' ALA . . . . . . . . . . . . . . . -125.58 137.99 53.92 Favored 'General case' 0 C--N 1.331 -0.217 0 CA-C-N 115.711 -0.677 . . . . 0.0 109.841 176.778 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' D' D ' 79' ' ' LYS . . . . . . . . . . . . . 68.8 mttm -88.94 115.82 26.77 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.39 -0.368 . . . . 0.0 110.848 -177.747 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' D' D ' 80' ' ' ILE . . . . . . . . . . . . . 36.2 mm -139.18 111.7 5.8 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.267 0 N-CA-C 109.153 -0.684 . . . . 0.0 109.153 -177.863 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' D' D ' 81' ' ' LYS . . . . . . . . . . . . . 39.7 ttpt -100.7 126.85 47.27 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-O 120.928 0.394 . . . . 0.0 111.279 -176.558 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' D' D ' 82' ' ' GLY . . . . . . . . . . . . . . . 89.18 42.15 5.65 Favored Glycine 0 CA--C 1.526 0.746 0 N-CA-C 111.534 -0.626 . . . . 0.0 111.534 175.548 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' D' D ' 83' ' ' ILE . . . . . . . . . . . . . 67.8 mt -68.26 139.4 20.77 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.348 0 CA-C-O 120.849 0.357 . . . . 0.0 110.111 179.008 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' D' D ' 84' ' ' LYS . . . . . . . . . . . . . 30.3 ttmt -96.66 -53.64 3.49 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.041 -0.527 . . . . 0.0 109.949 179.467 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' D' D ' 85' ' ' ASP . . . . . . . . . . . . . 7.1 t70 -155.41 152.63 29.27 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 115.507 -0.77 . . . . 0.0 110.117 -179.53 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' D' D ' 86' ' ' VAL . . . . . . . . . . . . . 41.6 t -130.13 132.52 65.22 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.215 0 CA-C-O 120.879 0.371 . . . . 0.0 110.533 -179.476 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' D' D ' 87' ' ' ILE . . . . . . . . . . . . . 45.0 mm -119.37 127.61 75.85 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.263 0 CA-C-N 115.902 -0.59 . . . . 0.0 109.643 177.271 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' D' D ' 88' ' ' LEU . . . . . . . . . . . . . 14.7 tp -110.45 131.3 55.17 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.377 -0.374 . . . . 0.0 110.967 -178.16 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' D' D ' 89' ' ' ASP . . . . . . . . . . . . . 13.3 t70 -124.82 152.2 44.22 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.033 -0.531 . . . . 0.0 109.821 177.611 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' D' D ' 90' ' ' GLU . . . . . . . . . . . . . 96.2 mt-10 -48.56 -34.65 11.82 Favored 'General case' 0 C--N 1.328 -0.368 0 N-CA-C 112.605 0.595 . . . . 0.0 112.605 -173.878 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' D' D ' 91' ' ' ASN . . . . . . . . . . . . . 33.6 m120 -132.05 30.99 4.21 Favored 'General case' 0 CA--C 1.531 0.219 0 N-CA-C 112.167 0.432 . . . . 0.0 112.167 -176.179 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' D' D ' 92' ' ' LEU . . . . . . . . . . . . . 10.8 tp -166.06 149.35 7.49 Favored 'General case' 0 C--N 1.331 -0.215 0 CA-C-O 120.795 0.331 . . . . 0.0 111.089 -179.749 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' D' D ' 93' ' ' ILE . . . . . . . . . . . . . 72.6 mt -126.25 120.23 56.13 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.22 0 N-CA-C 109.298 -0.63 . . . . 0.0 109.298 177.426 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' D' D ' 94' ' ' VAL . . . . . . . . . . . . . 45.1 t -120.39 127.19 75.89 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.233 0 CA-C-O 120.818 0.342 . . . . 0.0 110.092 -178.637 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' D' D ' 95' ' ' VAL . . . . . . . . . . . . . 43.9 t -122.91 134.22 66.7 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.341 0 CA-C-N 116.123 -0.489 . . . . 0.0 109.98 -179.062 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' D' D ' 96' ' ' ILE . . . . . . . . . . . . . 60.9 mt -115.97 128.15 73.34 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.317 0 N-CA-C 109.478 -0.564 . . . . 0.0 109.478 179.143 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' D' D ' 97' ' ' THR . . . . . . . . . . . . . 66.9 p -100.98 154.01 19.05 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-O 121.138 0.494 . . . . 0.0 111.011 -178.171 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' D' D ' 98' ' ' GLU . . . . . . . . . . . . . 96.4 mt-10 -56.94 -23.86 48.5 Favored 'General case' 0 CA--C 1.533 0.325 0 N-CA-C 112.469 0.544 . . . . 0.0 112.469 -178.736 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' D' D ' 99' ' ' GLU . . . . . . . . . . . . . 71.1 mm-40 -80.5 18.08 0.99 Allowed 'General case' 0 CA--C 1.533 0.324 0 N-CA-C 112.961 0.726 . . . . 0.0 112.961 -178.699 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' D' D ' 100' ' ' ASN . . . . . . . . . . . . . 3.8 m-20 64.09 38.12 8.62 Favored 'General case' 0 N--CA 1.463 0.191 0 CA-C-O 121.063 0.459 . . . . 0.0 111.049 176.899 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' D' D ' 101' ' ' GLU . . . . . . . . . . . . . 84.5 tt0 -116.68 143.07 46.08 Favored 'General case' 0 C--N 1.332 -0.162 0 CA-C-N 116.068 -0.515 . . . . 0.0 109.884 177.125 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' D' D ' 102' ' ' VAL . . . . . . . . . . . . . 43.5 t -114.99 126.93 72.71 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.287 0 CA-C-N 116.275 -0.42 . . . . 0.0 109.891 -178.801 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' D' D ' 103' ' ' LEU . . . . . . . . . . . . . 44.9 mt -118.16 134.28 55.14 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 115.668 -0.696 . . . . 0.0 109.632 179.532 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' D' D ' 104' ' ' ILE . . . . . . . . . . . . . 73.2 mt -126.11 122.81 62.48 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.266 0 C-N-CA 121.213 -0.195 . . . . 0.0 110.562 -176.819 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' D' D ' 105' ' ' PHE . . . . . . . . . . . . . 49.7 m-85 -127.36 165.94 18.79 Favored 'General case' 0 C--N 1.333 -0.112 0 O-C-N 123.993 0.808 . . . . 0.0 110.075 -179.781 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' D' D ' 106' ' ' ASN . . . . . . . . . . . . . 45.7 p-10 -101.85 -170.01 1.76 Allowed 'General case' 0 C--N 1.331 -0.227 0 N-CA-C 109.94 -0.392 . . . . 0.0 109.94 174.379 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' D' D ' 107' ' ' GLN . . . . . . . . . . . . . 39.0 tt0 -58.72 -30.1 67.19 Favored 'General case' 0 C--N 1.33 -0.269 0 N-CA-C 111.996 0.369 . . . . 0.0 111.996 179.73 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' D' D ' 108' ' ' ASN . . . . . . . . . . . . . 11.3 t-20 -83.55 7.99 15.5 Favored 'General case' 0 CA--C 1.534 0.357 0 N-CA-C 113.238 0.829 . . . . 0.0 113.238 -176.836 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' D' D ' 109' ' ' LEU . . . . . . . . . . . . . 12.8 tp 61.29 38.55 16.35 Favored 'General case' 0 CA--C 1.529 0.154 0 CA-C-O 120.999 0.428 . . . . 0.0 111.028 178.388 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' D' D ' 110' ' ' GLU . . . . . . . . . . . . . 95.5 mt-10 -108.21 152.81 24.09 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 116.396 -0.365 . . . . 0.0 110.373 177.937 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' D' D ' 111' ' ' GLU . . . . . . . . . . . . . 94.9 mt-10 -77.69 125.31 29.14 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-O 120.913 0.387 . . . . 0.0 111.123 -179.543 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' D' D ' 112' ' ' LEU . . . . . . . . . . . . . 83.4 mt -107.99 -45.36 3.99 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 115.975 -0.557 . . . . 0.0 109.664 173.297 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' D' D ' 113' ' ' TYR . . . . . . . . . . . . . 64.6 t80 -147.31 141.55 26.21 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.133 -0.485 . . . . 0.0 111.555 -179.252 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' D' D ' 114' ' ' ARG . . . . . . . . . . . . . 65.3 mtt180 -139.36 124.65 19.07 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 115.874 -0.603 . . . . 0.0 110.3 173.69 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' D' D ' 115' ' ' GLY . . . . . . . . . . . . . . . -150.06 157.43 27.21 Favored Glycine 0 CA--C 1.525 0.683 0 N-CA-C 110.862 -0.895 . . . . 0.0 110.862 178.69 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' D' D ' 116' ' ' LYS . . . . . . . . . . . . . 39.7 ttpt -129.12 139.04 52.12 Favored 'General case' 0 C--N 1.329 -0.322 0 N-CA-C 110.103 -0.332 . . . . 0.0 110.103 178.195 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' D' D ' 117' ' ' PHE . . . . . . . . . . . . . 47.9 m-85 -132.15 116.01 16.46 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.283 -0.417 . . . . 0.0 110.489 -176.196 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' D' D ' 118' ' ' GLU . . . . . . . . . . . . . 84.7 tt0 -51.95 -52.93 46.88 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.407 -0.36 . . . . 0.0 111.659 -176.853 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' D' D ' 119' ' ' ASN . . . . . . . . . . . . . 96.3 m-20 -93.65 31.14 1.62 Allowed 'General case' 0 C--N 1.329 -0.29 0 N-CA-C 112.227 0.454 . . . . 0.0 112.227 -174.525 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' D' D ' 120' ' ' LEU . . . . . . . . . . . . . 15.8 tp -54.08 122.1 9.48 Favored 'General case' 0 N--CA 1.464 0.231 0 O-C-N 122.289 -0.257 . . . . 0.0 110.671 177.562 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' D' D ' 121' ' ' ASN . . . . . . . . . . . . . 26.7 m120 -114.09 -44.02 3.18 Favored 'General case' 0 C--O 1.232 0.166 0 CA-C-N 116.595 -0.275 . . . . 0.0 111.188 -175.977 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' D' D ' 122' ' ' LYS . . . . . . . . . . . . . 44.4 mtmt -145.68 146.52 31.32 Favored 'General case' 0 C--N 1.331 -0.215 0 C-N-CA 120.538 -0.465 . . . . 0.0 111.665 -176.471 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' D' D ' 123' ' ' VAL . . . . . . . . . . . . . 44.0 t -129.02 130.5 68.31 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.275 0 CA-C-N 115.849 -0.614 . . . . 0.0 109.53 176.096 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' D' D ' 124' ' ' LEU . . . . . . . . . . . . . 14.9 tp -128.34 135.34 49.45 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-O 120.78 0.324 . . . . 0.0 110.612 -178.555 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' D' D ' 125' ' ' VAL . . . . . . . . . . . . . 34.9 m -133.61 141.0 45.44 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.195 0 CA-C-N 116.328 -0.396 . . . . 0.0 111.031 -178.719 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' D' D ' 126' ' ' ARG . . . . . . . . . . . . . 78.2 mtt180 -149.41 125.19 10.49 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.554 176.267 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' D' D ' 127' ' ' ASN . . . . . . . . . . . . . 18.8 t-20 52.51 -111.37 0.58 Allowed 'General case' 0 CA--C 1.545 0.755 0 CA-C-O 118.734 -0.65 . . . . 0.0 111.046 178.849 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' D' D ' 128' ' ' ASP . . . . . . . . . . . . . 21.5 p-10 -114.15 10.7 17.4 Favored 'General case' 0 N--CA 1.468 0.454 0 CA-C-N 120.044 1.293 . . . . 0.0 113.081 -179.747 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' D' D ' 129' ' ' LEU . . . . . . . . . . . . . 13.1 tp -107.29 135.77 48.25 Favored 'General case' 0 C--N 1.332 -0.165 0 N-CA-C 109.877 -0.416 . . . . 0.0 109.877 178.914 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' D' D ' 130' ' ' VAL . . . . . . . . . . . . . 44.3 t -123.79 136.16 61.12 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.239 0 CA-C-O 120.869 0.366 . . . . 0.0 110.023 -178.127 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' D' D ' 131' ' ' VAL . . . . . . . . . . . . . 43.4 t -133.87 133.71 56.35 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.258 0 CA-C-O 121.027 0.441 . . . . 0.0 110.059 177.561 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' D' D ' 132' ' ' ILE . . . . . . . . . . . . . 71.6 mt -118.01 131.51 70.55 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.335 0 CA-C-N 115.724 -0.671 . . . . 0.0 109.604 -179.273 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' D' D ' 133' ' ' ILE . . . . . . . . . . . . . 36.8 mm -116.19 124.33 72.35 Favored 'Isoleucine or valine' 0 C--O 1.233 0.197 0 CA-C-O 120.804 0.335 . . . . 0.0 111.106 -175.062 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' D' D ' 134' ' ' ASP . . . . . . . . . . . . . 11.6 p-10 -135.22 151.33 50.52 Favored 'General case' 0 C--N 1.332 -0.18 0 CA-C-N 116.104 -0.498 . . . . 0.0 109.916 174.603 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' D' D ' 135' ' ' GLU . . . . . . . . . . . . . 84.6 tt0 -49.95 -26.24 4.01 Favored 'General case' 0 C--O 1.236 0.354 0 N-CA-C 113.571 0.952 . . . . 0.0 113.571 -168.493 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' D' D ' 136' ' ' GLN . . . . . . . . . . . . . 14.3 pt20 -100.15 -19.55 16.39 Favored 'General case' 0 N--CA 1.466 0.352 0 N-CA-C 113.314 0.857 . . . . 0.0 113.314 -172.491 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' D' D ' 137' ' ' LYS . . . . . . . . . . . . . 56.8 pttt -165.88 170.54 13.69 Favored 'General case' 0 C--O 1.232 0.139 0 CA-C-O 121.645 0.736 . . . . 0.0 112.344 -176.693 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' D' D ' 138' ' ' LEU . . . . . . . . . . . . . 7.2 tt -121.23 127.67 51.67 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 114.919 -1.037 . . . . 0.0 109.827 178.938 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' D' D ' 139' ' ' THR . . . . . . . . . . . . . 42.1 m -106.18 126.71 52.55 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.089 -0.505 . . . . 0.0 110.331 179.895 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' D' D ' 140' ' ' LEU . . . . . . . . . . . . . 5.7 tt -110.74 122.49 47.94 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 115.748 -0.66 . . . . 0.0 109.27 -179.203 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' D' D ' 141' ' ' ILE . . . . . . . . . . . . . 19.1 mt -122.21 116.16 48.32 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.294 0 N-CA-C 109.867 -0.42 . . . . 0.0 109.867 -175.176 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' D' D ' 142' ' ' ARG . . . . . . . . . . . . . 58.9 ttp180 -108.75 129.29 55.37 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 115.64 -0.709 . . . . 0.0 110.507 -178.784 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' D' D ' 143' ' ' THR . . . . . . . . . . . . . 70.2 p . . . . . 0 C--O 1.22 -0.475 0 CA-C-O 118.223 -0.894 . . . . 0.0 110.894 179.695 . . . . . . . . 0 0 . 1 . 019 nuclear orig core ' E' E ' 2' ' ' SER . . . . . . . . . . . . . 2.1 p . . . . . 0 C--O 1.231 0.08 0 N-CA-C 110.026 -0.361 . . . . 0.0 110.026 . . . . . . . . . 0 0 . 1 . 019 nuclear orig core ' E' E ' 3' ' ' GLU . . . . . . . . . . . . . 89.2 mt-10 -139.29 140.75 37.71 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.016 -0.538 . . . . 0.0 111.103 -175.374 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' E' E ' 4' ' ' LEU . . . . . . . . . . . . . 16.0 tp -122.89 124.93 44.35 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 115.785 -0.643 . . . . 0.0 109.506 173.979 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' E' E ' 5' ' ' LYS . . . . . . . . . . . . . 60.7 mttp -108.83 120.26 41.98 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 116.397 -0.365 . . . . 0.0 110.573 -179.265 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' E' E ' 6' ' ' LEU . . . . . . . . . . . . . 54.1 mt -113.91 143.43 44.71 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 115.402 -0.817 . . . . 0.0 110.041 -178.796 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' E' E ' 7' ' ' LYS . . . . . . . . . . . . . 78.4 tttt -122.71 135.77 26.04 Favored Pre-proline 0 CA--C 1.535 0.388 0 CA-C-O 118.84 -0.6 . . . . 0.0 109.542 176.087 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' E' E ' 8' ' ' PRO . . . . . . . . . . . . . 72.4 Cg_endo -88.9 131.54 2.27 Favored 'Trans proline' 0 N--CA 1.49 1.309 0 C-N-CA 121.566 1.511 . . . . 0.0 111.814 178.938 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' E' E ' 9' ' ' LEU . . . . . . . . . . . . . 73.9 mt -70.36 -51.22 13.55 Favored Pre-proline 0 C--N 1.329 -0.313 0 CA-C-O 118.694 -0.67 . . . . 0.0 111.817 -178.703 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' E' E ' 10' ' ' PRO . . . . . . . . . . . . . 70.3 Cg_endo -74.66 151.24 41.08 Favored 'Trans proline' 0 N--CA 1.497 1.713 0 C-N-CA 121.076 1.184 . . . . 0.0 111.891 175.226 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' E' E ' 11' ' ' LYS . . . . . . . . . . . . . 70.6 mmtt -83.92 89.11 7.16 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-O 120.879 0.371 . . . . 0.0 110.42 178.511 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' E' E ' 12' ' ' VAL . . . . . . . . . . . . . 12.2 p -140.06 144.81 27.32 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.276 0 CA-C-N 116.024 -0.535 . . . . 0.0 110.359 179.877 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' E' E ' 13' ' ' GLU . . . . . . . . . . . . . 84.9 tt0 -91.79 130.62 37.53 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.275 -0.42 . . . . 0.0 110.241 178.626 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' E' E ' 14' ' ' LEU . . . . . . . . . . . . . 19.9 mt -97.65 152.98 38.45 Favored Pre-proline 0 C--N 1.33 -0.251 0 CA-C-N 116.258 -0.428 . . . . 0.0 110.796 -177.509 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' E' E ' 15' ' ' PRO . . . . . . . . . . . . . 27.9 Cg_exo -60.81 159.28 29.51 Favored 'Trans proline' 0 N--CA 1.497 1.692 0 C-N-CA 121.334 1.356 . . . . 0.0 111.795 176.833 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' E' E ' 16' ' ' PRO . . . . . . . . . . . . . 38.6 Cg_exo -58.48 -37.04 96.58 Favored 'Trans proline' 0 N--CA 1.497 1.727 0 C-N-CA 121.362 1.374 . . . . 0.0 112.704 -178.211 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' E' E ' 17' ' ' ASP . . . . . . . . . . . . . 10.5 p-10 -94.47 15.43 17.83 Favored 'General case' 0 C--N 1.328 -0.345 0 N-CA-C 113.063 0.764 . . . . 0.0 113.063 -177.088 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' E' E ' 18' ' ' PHE . . . . . . . . . . . . . 51.9 t80 -58.03 -44.34 87.28 Favored 'General case' 0 N--CA 1.46 0.06 0 O-C-N 122.0 -0.437 . . . . 0.0 110.085 -178.788 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' E' E ' 19' ' ' VAL . . . . . . . . . . . . . 47.4 t -56.61 -40.83 71.52 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.344 0 CA-C-N 116.255 -0.43 . . . . 0.0 110.35 -179.764 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' E' E ' 20' ' ' ASP . . . . . . . . . . . . . 70.1 m-20 -60.07 -42.69 95.09 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-O 120.801 0.334 . . . . 0.0 110.85 -178.274 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' E' E ' 21' ' ' VAL . . . . . . . . . . . . . 47.5 t -65.38 -52.02 57.0 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.278 0 C-N-CA 120.828 -0.349 . . . . 0.0 110.613 -178.334 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' E' E ' 22' ' ' ILE . . . . . . . . . . . . . 48.7 mm -54.32 -54.57 20.49 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.231 0 CA-C-O 120.743 0.306 . . . . 0.0 111.24 -177.493 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' E' E ' 23' ' ' ARG . . . . . . . . . . . . . 14.4 ptm180 -61.34 -45.29 95.04 Favored 'General case' 0 CA--C 1.532 0.275 0 N-CA-C 112.166 0.432 . . . . 0.0 112.166 -173.656 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' E' E ' 24' ' ' ILE . . . . . . . . . . . . . 73.0 mt -61.85 -38.53 80.78 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.209 0 O-C-N 122.138 -0.352 . . . . 0.0 111.224 -175.474 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' E' E ' 25' ' ' LYS . . . . . . . . . . . . . 66.6 mttm -72.33 -43.81 63.56 Favored 'General case' 0 C--N 1.331 -0.237 0 N-CA-C 112.077 0.399 . . . . 0.0 112.077 -178.971 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' E' E ' 26' ' ' LEU . . . . . . . . . . . . . 56.4 mt -87.03 -8.19 57.38 Favored 'General case' 0 CA--C 1.533 0.303 0 N-CA-C 113.835 1.05 . . . . 0.0 113.835 -173.627 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' E' E ' 27' ' ' GLN . . . . . . . . . . . . . 3.4 pt20 -46.59 143.13 2.82 Favored 'General case' 0 N--CA 1.467 0.412 0 O-C-N 121.592 -0.692 . . . . 0.0 112.451 -179.706 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' E' E ' 28' ' ' GLY . . . . . . . . . . . . . . . 100.07 -22.49 39.92 Favored Glycine 0 CA--C 1.533 1.212 0 CA-C-N 115.885 -0.598 . . . . 0.0 112.467 -177.953 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' E' E ' 29' ' ' LYS . . . . . . . . . . . . . 34.8 mmtp -89.6 154.98 19.55 Favored 'General case' 0 C--O 1.233 0.186 0 CA-C-N 117.599 0.699 . . . . 0.0 110.632 177.994 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' E' E ' 30' ' ' THR . . . . . . . . . . . . . 9.1 m -107.95 139.77 42.07 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.093 -0.503 . . . . 0.0 110.17 178.269 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' E' E ' 31' ' ' VAL . . . . . . . . . . . . . 35.0 m -127.91 152.87 36.55 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.263 0 CA-C-O 120.929 0.395 . . . . 0.0 110.755 -178.963 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' E' E ' 32' ' ' ARG . . . . . . . . . . . . . 83.5 mtt180 -131.68 150.31 52.19 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.025 -0.534 . . . . 0.0 110.366 177.565 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' E' E ' 33' ' ' THR . . . . . . . . . . . . . 22.0 m -52.8 138.64 28.88 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.366 -0.379 . . . . 0.0 111.457 -178.383 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' E' E ' 34' ' ' GLY . . . . . . . . . . . . . . . 100.16 -17.13 57.47 Favored Glycine 0 CA--C 1.532 1.101 0 CA-C-N 116.18 -0.464 . . . . 0.0 113.28 179.485 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' E' E ' 35' ' ' ASP . . . . . . . . . . . . . 77.0 m-20 -67.97 149.51 49.65 Favored 'General case' 0 N--CA 1.462 0.125 0 CA-C-N 117.989 0.894 . . . . 0.0 111.183 178.683 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' E' E ' 36' ' ' VAL . . . . . . . . . . . . . 44.6 t -120.95 128.81 76.13 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.219 0 CA-C-N 116.063 -0.517 . . . . 0.0 109.688 176.775 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' E' E ' 37' ' ' ILE . . . . . . . . . . . . . 62.9 mt -119.08 138.4 49.93 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 CA-C-N 116.089 -0.505 . . . . 0.0 109.923 -178.539 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' E' E ' 38' ' ' GLY . . . . . . . . . . . . . . . -116.42 128.14 7.81 Favored Glycine 0 CA--C 1.526 0.757 0 N-CA-C 110.937 -0.865 . . . . 0.0 110.937 179.285 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' E' E ' 39' ' ' ILE . . . . . . . . . . . . . 73.5 mt -128.82 131.07 68.7 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.216 0 N-CA-C 110.066 -0.346 . . . . 0.0 110.066 178.893 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' E' E ' 40' ' ' SER . . . . . . . . . . . . . 46.8 t -91.79 113.94 26.34 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.392 -0.367 . . . . 0.0 110.965 177.908 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' E' E ' 41' ' ' ILE . . . . . . . . . . . . . 45.9 mm -123.24 123.45 67.76 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.22 0 N-CA-C 109.835 -0.431 . . . . 0.0 109.835 179.467 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' E' E ' 42' ' ' LEU . . . . . . . . . . . . . 68.7 mt 57.85 34.85 24.84 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.307 -0.406 . . . . 0.0 111.683 177.94 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' E' E ' 43' ' ' GLY . . . . . . . . . . . . . . . 78.94 -10.22 34.22 Favored Glycine 0 CA--C 1.534 1.219 0 C-N-CA 121.248 -0.501 . . . . 0.0 113.43 177.094 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' E' E ' 44' ' ' LYS . . . . . . . . . . . . . 30.4 ttmt -102.83 129.36 49.48 Favored 'General case' 0 N--CA 1.461 0.078 0 CA-C-N 117.982 0.891 . . . . 0.0 110.157 177.103 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' E' E ' 45' ' ' GLU . . . . . . . . . . . . . 39.9 tp10 -84.18 127.54 34.0 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 116.283 -0.417 . . . . 0.0 110.93 -179.662 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' E' E ' 46' ' ' VAL . . . . . . . . . . . . . 9.2 p -119.27 125.9 74.86 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.22 0 N-CA-C 109.675 -0.491 . . . . 0.0 109.675 176.468 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' E' E ' 47' ' ' LYS . . . . . . . . . . . . . 62.8 mttp -99.23 126.81 45.12 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.023 -0.535 . . . . 0.0 110.889 177.266 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' E' E ' 48' ' ' PHE . . . . . . . . . . . . . 41.1 m-85 -110.55 131.87 54.68 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.035 -0.529 . . . . 0.0 109.805 177.138 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' E' E ' 49' ' ' LYS . . . . . . . . . . . . . 78.9 tttt -105.95 132.24 52.29 Favored 'General case' 0 C--N 1.328 -0.351 0 N-CA-C 110.074 -0.343 . . . . 0.0 110.074 177.887 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' E' E ' 50' ' ' VAL . . . . . . . . . . . . . 46.6 t -77.1 107.55 8.68 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.331 0 N-CA-C 109.449 -0.574 . . . . 0.0 109.449 178.023 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' E' E ' 51' ' ' VAL . . . . . . . . . . . . . 46.6 t -71.55 -52.71 24.22 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.339 0 N-CA-C 109.545 -0.539 . . . . 0.0 109.545 -175.943 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' E' E ' 52' ' ' GLN . . . . . . . . . . . . . 83.3 mt-30 -154.74 152.5 29.96 Favored 'General case' 0 C--N 1.331 -0.207 0 CA-C-O 121.252 0.549 . . . . 0.0 111.66 -178.105 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' E' E ' 53' ' ' ALA . . . . . . . . . . . . . . . -130.2 131.96 45.8 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 115.313 -0.858 . . . . 0.0 109.545 174.141 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' E' E ' 54' ' ' TYR . . . . . . . . . . . . . 59.8 t80 -129.04 110.29 18.28 Favored Pre-proline 0 CA--C 1.535 0.374 0 CA-C-O 118.205 -0.902 . . . . 0.0 110.32 179.457 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' E' E ' 55' ' ' PRO . . . . . . . . . . . . . 73.9 Cg_endo -77.16 169.82 73.18 Favored 'Cis proline' 0 N--CA 1.5 1.865 0 CA-C-N 121.987 1.745 . . . . 0.0 112.153 -5.638 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' E' E ' 56' ' ' SER . . . . . . . . . . . . . 13.7 m -115.89 132.44 23.2 Favored Pre-proline 0 CA--C 1.538 0.488 0 CA-C-O 118.458 -0.782 . . . . 0.0 109.155 175.416 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' E' E ' 57' ' ' PRO . . . . . . . . . . . . . 50.9 Cg_endo -69.75 164.12 80.01 Favored 'Cis proline' 0 N--CA 1.498 1.753 0 CA-C-N 121.928 1.724 . . . . 0.0 111.684 0.166 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' E' E ' 58' ' ' LEU . . . . . . . . . . . . . 36.8 tp -129.82 139.4 51.24 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.079 179.821 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' E' E ' 59' ' ' ARG . . . . . . . . . . . . . 26.6 ttm180 -103.83 139.11 39.47 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.246 -0.434 . . . . 0.0 110.05 178.983 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' E' E ' 60' ' ' VAL . . . . . . . . . . . . . 42.9 t -86.64 111.22 21.18 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.196 0 CA-C-O 120.84 0.352 . . . . 0.0 110.34 -177.991 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' E' E ' 61' ' ' GLU . . . . . . . . . . . . . 81.3 tt0 -131.17 154.44 48.37 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 115.845 -0.616 . . . . 0.0 109.58 177.407 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' E' E ' 62' ' ' ASP . . . . . . . . . . . . . 9.4 p-10 -52.82 -23.74 7.55 Favored 'General case' 0 C--N 1.326 -0.433 0 N-CA-C 112.467 0.543 . . . . 0.0 112.467 -179.579 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' E' E ' 63' ' ' ARG . . . . . . . . . . . . . 23.8 mmm180 -84.72 -14.22 49.03 Favored 'General case' 0 CA--C 1.534 0.349 0 N-CA-C 113.443 0.905 . . . . 0.0 113.443 -177.066 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' E' E ' 64' ' ' THR . . . . . . . . . . . . . 14.0 m -76.58 151.84 36.15 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-O 120.937 0.399 . . . . 0.0 111.05 -176.066 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' E' E ' 65' ' ' LYS . . . . . . . . . . . . . 45.7 mtpt -90.49 118.7 30.16 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.134 179.063 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' E' E ' 66' ' ' ILE . . . . . 0.416 HG21 HD13 ' E' ' 66' ' ' ILE . 72.0 mt -117.62 124.67 73.37 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.219 0 N-CA-C 109.741 -0.466 . . . . 0.0 109.741 -178.344 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' E' E ' 67' ' ' THR . . . . . . . . . . . . . 27.4 m -132.1 151.06 51.98 Favored 'General case' 0 C--N 1.332 -0.182 0 CA-C-O 121.269 0.557 . . . . 0.0 111.876 -173.437 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' E' E ' 68' ' ' LEU . . . . . . . . . . . . . 78.9 mt . . . . . 0 C--N 1.331 -0.237 0 CA-C-N 115.548 -0.751 . . . . 0.0 110.126 175.474 . . . . . . . . 0 0 . 1 . 019 nuclear orig core ' E' E ' 73' ' ' VAL . . . . . . . . . . . . . 31.5 m . . . . . 0 C--O 1.233 0.213 0 CA-C-O 121.174 0.511 . . . . 0.0 111.097 . . . . . . . . . 0 0 . 1 . 019 nuclear orig core ' E' E ' 74' ' ' ASP . . . . . . . . . . . . . 16.6 t0 -106.94 122.55 46.64 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 115.496 -0.775 . . . . 0.0 109.232 174.273 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' E' E ' 75' ' ' VAL . . . . . . . . . . . . . 41.2 t -117.83 125.68 74.31 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.294 0 CA-C-O 121.112 0.482 . . . . 0.0 110.809 -176.916 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' E' E ' 76' ' ' LEU . . . . . . . . . . . . . 6.1 mp -127.37 151.11 49.21 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-N 115.566 -0.743 . . . . 0.0 109.62 176.437 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' E' E ' 77' ' ' GLU . . . . . . . . . . . . . 97.0 mt-10 -136.48 136.03 39.1 Favored 'General case' 0 C--N 1.332 -0.171 0 CA-C-O 121.068 0.461 . . . . 0.0 111.26 -177.4 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' E' E ' 78' ' ' ALA . . . . . . . . . . . . . . . -121.05 138.85 53.98 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-N 115.737 -0.665 . . . . 0.0 109.819 176.838 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' E' E ' 79' ' ' LYS . . . . . . . . . . . . . 99.7 mttt -83.59 118.85 24.09 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-O 120.951 0.405 . . . . 0.0 111.0 -176.982 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' E' E ' 80' ' ' ILE . . . . . . . . . . . . . 42.0 mm -139.25 115.43 9.5 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.2 0 N-CA-C 109.346 -0.613 . . . . 0.0 109.346 -178.229 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' E' E ' 81' ' ' LYS . . . . . . . . . . . . . 64.7 mttm -109.44 125.51 52.51 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-O 120.854 0.359 . . . . 0.0 111.09 -177.705 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' E' E ' 82' ' ' GLY . . . . . . . . . . . . . . . 89.09 42.12 5.69 Favored Glycine 0 CA--C 1.523 0.582 0 C-N-CA 120.774 -0.727 . . . . 0.0 111.419 175.994 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' E' E ' 83' ' ' ILE . . . . . . . . . . . . . 72.9 mt -66.06 133.31 31.14 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.297 0 CA-C-O 120.942 0.401 . . . . 0.0 110.01 178.181 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' E' E ' 84' ' ' LYS . . . . . . . . . . . . . 85.9 tttt -91.67 -53.14 4.42 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-N 115.936 -0.574 . . . . 0.0 109.97 -179.633 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' E' E ' 85' ' ' ASP . . . . . . . . . . . . . 13.3 t70 -156.24 151.02 26.03 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 115.553 -0.749 . . . . 0.0 110.059 179.402 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' E' E ' 86' ' ' VAL . . . . . . . . . . . . . 43.3 t -125.87 129.63 72.44 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.287 0 CA-C-O 120.937 0.399 . . . . 0.0 110.439 -178.986 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' E' E ' 87' ' ' ILE . . . . . . . . . . . . . 44.5 mm -118.28 126.15 74.82 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.208 0 CA-C-N 115.979 -0.555 . . . . 0.0 109.714 177.008 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' E' E ' 88' ' ' LEU . . . . . . . . . . . . . 14.2 tp -108.8 131.08 55.32 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-O 120.972 0.415 . . . . 0.0 111.004 -177.591 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' E' E ' 89' ' ' ASP . . . . . . . . . . . . . 7.7 t70 -119.61 154.07 34.52 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 115.787 -0.642 . . . . 0.0 109.5 176.781 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' E' E ' 90' ' ' GLU . . . . . . . . . . . . . 82.4 tt0 -46.28 -43.57 15.8 Favored 'General case' 0 N--CA 1.464 0.263 0 N-CA-C 112.871 0.693 . . . . 0.0 112.871 -173.106 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' E' E ' 91' ' ' ASN . . . . . . . . . . . . . 16.0 t-20 -132.15 39.11 3.44 Favored 'General case' 0 C--N 1.331 -0.217 0 CA-C-O 120.907 0.384 . . . . 0.0 111.195 -178.815 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' E' E ' 92' ' ' LEU . . . . . . . . . . . . . 10.5 tp -166.08 147.26 6.72 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 116.526 -0.307 . . . . 0.0 110.386 -178.708 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' E' E ' 93' ' ' ILE . . . . . . . . . . . . . 65.8 mt -128.78 123.49 59.31 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.214 0 N-CA-C 109.483 -0.562 . . . . 0.0 109.483 -178.972 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' E' E ' 94' ' ' VAL . . . . . . . . . . . . . 44.1 t -124.24 129.36 74.07 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.216 0 CA-C-O 121.021 0.438 . . . . 0.0 110.035 -179.841 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' E' E ' 95' ' ' VAL . . . . . . . . . . . . . 42.5 t -122.04 135.83 60.89 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.328 0 CA-C-N 115.881 -0.599 . . . . 0.0 109.926 -178.906 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' E' E ' 96' ' ' ILE . . . . . . . . . . . . . 62.0 mt -111.92 126.7 69.33 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.355 0 N-CA-C 109.215 -0.661 . . . . 0.0 109.215 178.068 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' E' E ' 97' ' ' THR . . . . . . . . . . . . . 68.3 p -97.16 155.91 16.63 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-O 121.168 0.509 . . . . 0.0 111.134 -178.176 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' E' E ' 98' ' ' GLU . . . . . . . . . . . . . 82.6 tt0 -53.86 -25.88 21.89 Favored 'General case' 0 C--N 1.327 -0.372 0 N-CA-C 112.304 0.483 . . . . 0.0 112.304 -178.941 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' E' E ' 99' ' ' GLU . . . . . . . . . . . . . 71.2 mm-40 -81.56 16.16 1.83 Allowed 'General case' 0 CA--C 1.536 0.413 0 N-CA-C 113.137 0.791 . . . . 0.0 113.137 -176.74 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' E' E ' 100' ' ' ASN . . . . . . . . . . . . . 3.5 m-20 62.89 34.33 14.37 Favored 'General case' 0 CA--C 1.531 0.227 0 CA-C-O 120.909 0.385 . . . . 0.0 111.519 178.644 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' E' E ' 101' ' ' GLU . . . . . . . . . . . . . 84.6 tt0 -112.65 143.63 43.52 Favored 'General case' 0 C--N 1.334 -0.093 0 N-CA-C 109.69 -0.485 . . . . 0.0 109.69 173.422 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' E' E ' 102' ' ' VAL . . . . . . . . . . . . . 45.6 t -115.21 129.43 71.47 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.322 0 CA-C-N 116.49 -0.323 . . . . 0.0 110.297 -177.414 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' E' E ' 103' ' ' LEU . . . . . . . . . . . . . 51.1 mt -117.85 130.75 56.45 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-N 115.7 -0.682 . . . . 0.0 110.415 177.31 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' E' E ' 104' ' ' ILE . . . . . . . . . . . . . 70.7 mt -117.45 122.86 70.88 Favored 'Isoleucine or valine' 0 C--O 1.233 0.226 0 N-CA-C 110.154 -0.313 . . . . 0.0 110.154 178.373 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' E' E ' 105' ' ' PHE . . . . . . . . . . . . . 74.3 m-85 -123.6 164.36 19.19 Favored 'General case' 0 C--O 1.232 0.132 0 O-C-N 123.905 0.753 . . . . 0.0 109.876 -179.781 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' E' E ' 106' ' ' ASN . . . . . . . . . . . . . 43.5 p-10 -99.07 -170.02 1.86 Allowed 'General case' 0 C--N 1.33 -0.254 0 N-CA-C 109.738 -0.467 . . . . 0.0 109.738 172.381 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' E' E ' 107' ' ' GLN . . . . . . . . . . . . . 48.8 tt0 -57.91 -29.8 65.4 Favored 'General case' 0 C--N 1.329 -0.298 0 N-CA-C 112.025 0.38 . . . . 0.0 112.025 179.982 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' E' E ' 108' ' ' ASN . . . . . . . . . . . . . 22.5 t30 -88.69 13.14 12.99 Favored 'General case' 0 CA--C 1.535 0.388 0 N-CA-C 113.094 0.776 . . . . 0.0 113.094 -176.024 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' E' E ' 109' ' ' LEU . . . . . . . . . . . . . 38.4 mt 57.43 36.18 26.77 Favored 'General case' 0 C--N 1.333 -0.149 0 CA-C-O 120.941 0.4 . . . . 0.0 111.566 177.811 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' E' E ' 110' ' ' GLU . . . . . . . . . . . . . 95.6 mt-10 -100.56 155.26 17.95 Favored 'General case' 0 C--N 1.33 -0.258 0 N-CA-C 109.72 -0.474 . . . . 0.0 109.72 176.191 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' E' E ' 111' ' ' GLU . . . . . . . . . . . . . 84.4 tt0 -82.26 121.91 27.25 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-O 120.883 0.373 . . . . 0.0 110.92 -177.707 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' E' E ' 112' ' ' LEU . . . . . . . . . . . . . 75.2 mt -107.9 -45.99 3.87 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.017 -0.538 . . . . 0.0 110.047 176.416 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' E' E ' 113' ' ' TYR . . . . . . . . . . . . . 63.3 t80 -143.28 135.76 27.32 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.153 -0.476 . . . . 0.0 111.52 -179.395 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' E' E ' 114' ' ' ARG . . . . . . . . . . . . . 21.4 ttm180 -131.13 123.88 29.52 Favored 'General case' 0 C--N 1.331 -0.201 0 CA-C-N 115.775 -0.648 . . . . 0.0 109.623 173.529 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' E' E ' 115' ' ' GLY . . . . . . . . . . . . . . . -150.0 156.41 26.73 Favored Glycine 0 CA--C 1.523 0.539 0 N-CA-C 110.85 -0.9 . . . . 0.0 110.85 178.531 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' E' E ' 116' ' ' LYS . . . . . . . . . . . . . 55.6 tttt -132.68 140.31 48.08 Favored 'General case' 0 C--N 1.329 -0.309 0 O-C-N 122.646 -0.326 . . . . 0.0 110.16 179.245 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' E' E ' 117' ' ' PHE . . . . . . . . . . . . . 18.2 m-85 -139.63 113.82 8.95 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-O 120.887 0.375 . . . . 0.0 110.091 -176.194 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' E' E ' 118' ' ' GLU . . . . . . . . . . . . . 83.2 tt0 -53.3 -47.43 69.22 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.453 -0.339 . . . . 0.0 111.573 -175.84 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' E' E ' 119' ' ' ASN . . . . . . . . . . . . . 74.4 m-20 -95.15 31.12 1.98 Allowed 'General case' 0 C--N 1.332 -0.196 0 N-CA-C 112.265 0.468 . . . . 0.0 112.265 -174.45 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' E' E ' 120' ' ' LEU . . . . . . . . . . . . . 22.1 tp -55.85 122.95 12.66 Favored 'General case' 0 C--N 1.333 -0.136 0 CA-C-O 120.724 0.297 . . . . 0.0 110.52 177.146 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' E' E ' 121' ' ' ASN . . . . . . . . . . . . . 62.7 t30 -112.2 -44.08 3.46 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-N 116.362 -0.381 . . . . 0.0 110.718 -177.977 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' E' E ' 122' ' ' LYS . . . . . . . . . . . . . 98.0 mttt -143.45 144.76 32.15 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-O 120.96 0.409 . . . . 0.0 111.661 -177.476 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' E' E ' 123' ' ' VAL . . . . . . . . . . . . . 46.7 t -123.61 122.37 64.77 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.284 0 N-CA-C 109.136 -0.69 . . . . 0.0 109.136 173.826 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' E' E ' 124' ' ' LEU . . . . . . . . . . . . . 5.6 mp -120.59 132.3 55.08 Favored 'General case' 0 C--N 1.331 -0.203 0 CA-C-N 116.483 -0.326 . . . . 0.0 110.389 -177.155 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' E' E ' 125' ' ' VAL . . . . . . . . . . . . . 35.1 m -135.56 138.74 47.7 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.314 0 CA-C-N 116.379 -0.373 . . . . 0.0 110.736 179.279 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' E' E ' 126' ' ' ARG . . . . . . . . . . . . . 32.8 ptt-85 -150.19 125.23 9.95 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 116.088 -0.506 . . . . 0.0 110.178 177.926 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' E' E ' 127' ' ' ASN . . . . . . . . . . . . . 85.5 m-20 55.07 -123.38 2.03 Favored 'General case' 0 CA--C 1.546 0.804 0 CA-C-O 118.529 -0.748 . . . . 0.0 110.209 -178.191 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' E' E ' 128' ' ' ASP . . . . . . . . . . . . . 23.3 p-10 -106.07 12.29 30.51 Favored 'General case' 0 CA--C 1.536 0.431 0 CA-C-N 120.235 1.379 . . . . 0.0 113.088 179.349 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' E' E ' 129' ' ' LEU . . . . . . . . . . . . . 5.0 tt -106.14 132.63 51.98 Favored 'General case' 0 C--O 1.231 0.121 0 N-CA-C 109.653 -0.499 . . . . 0.0 109.653 179.079 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' E' E ' 130' ' ' VAL . . . . . . . . . . . . . 46.4 t -122.05 136.32 59.3 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.248 0 CA-C-O 120.894 0.378 . . . . 0.0 110.185 -177.926 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' E' E ' 131' ' ' VAL . . . . . . . . . . . . . 42.1 t -135.11 135.5 52.46 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.19 0 CA-C-O 121.128 0.49 . . . . 0.0 110.076 177.668 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' E' E ' 132' ' ' ILE . . . . . . . . . . . . . 74.7 mt -118.1 132.34 68.21 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.338 0 CA-C-N 115.746 -0.661 . . . . 0.0 109.532 -178.86 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' E' E ' 133' ' ' ILE . . . . . . . . . . . . . 37.5 mm -116.88 121.9 68.78 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.205 0 CA-C-O 120.78 0.324 . . . . 0.0 111.075 -174.694 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' E' E ' 134' ' ' ASP . . . . . . . . . . . . . 10.2 p-10 -135.23 149.84 49.96 Favored 'General case' 0 C--N 1.331 -0.221 0 CA-C-N 116.03 -0.532 . . . . 0.0 109.767 175.225 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' E' E ' 135' ' ' GLU . . . . . . . . . . . . . 85.1 tt0 -49.92 -26.67 4.36 Favored 'General case' 0 C--N 1.329 -0.318 0 N-CA-C 113.019 0.748 . . . . 0.0 113.019 -172.159 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' E' E ' 136' ' ' GLN . . . . . . . . . . . . . 99.7 mm-40 -85.55 -32.11 22.33 Favored 'General case' 0 C--O 1.235 0.299 0 N-CA-C 112.401 0.519 . . . . 0.0 112.401 -174.935 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' E' E ' 137' ' ' LYS . . . . . . . . . . . . . 55.7 pttt -168.54 174.07 7.04 Favored 'General case' 0 C--N 1.332 -0.186 0 CA-C-O 121.5 0.667 . . . . 0.0 112.257 -171.008 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' E' E ' 138' ' ' LEU . . . . . . . . . . . . . 8.7 tt -121.88 130.1 53.09 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 115.032 -0.985 . . . . 0.0 110.264 179.8 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' E' E ' 139' ' ' THR . . . . . . . . . . . . . 38.0 m -108.3 130.27 55.19 Favored 'General case' 0 C--N 1.331 -0.23 0 CA-C-N 116.163 -0.471 . . . . 0.0 110.653 -179.546 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' E' E ' 140' ' ' LEU . . . . . . . . . . . . . 12.3 tp -116.34 121.8 43.02 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 115.724 -0.671 . . . . 0.0 109.332 -179.271 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' E' E ' 141' ' ' ILE . . . . . . . . . . . . . 18.9 mt -120.57 121.65 65.98 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.288 0 CA-C-O 120.976 0.417 . . . . 0.0 110.296 -175.152 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' E' E ' 142' ' ' ARG . . . . . . . . . . . . . 66.4 mtp180 -108.93 130.86 55.46 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 115.264 -0.88 . . . . 0.0 110.438 179.906 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' E' E ' 143' ' ' THR . . . . . . . . . . . . . 19.1 p . . . . . 0 C--O 1.221 -0.417 0 CA-C-O 117.988 -1.006 . . . . 0.0 110.492 178.782 . . . . . . . . 0 0 . 1 . 019 nuclear orig core ' F' F ' 1' ' ' MET . . . . . . . . . . . . . 16.0 ptm . . . . . 0 CA--C 1.528 0.128 0 CA-C-O 120.679 0.276 . . . . 0.0 110.594 . . . . . . . . . 0 0 . 1 . 019 nuclear orig core ' F' F ' 2' ' ' SER . . . . . . . . . . . . . 11.7 p -118.77 132.77 56.15 Favored 'General case' 0 C--N 1.332 -0.182 0 CA-C-O 121.006 0.431 . . . . 0.0 110.824 -179.335 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' F' F ' 3' ' ' GLU . . . . . . . . . . . . . 95.6 mt-10 -141.3 141.08 33.94 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 115.779 -0.646 . . . . 0.0 110.823 -179.284 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' F' F ' 4' ' ' LEU . . . . . . . . . . . . . 12.5 tp -129.38 131.05 46.74 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.235 -0.439 . . . . 0.0 110.267 177.115 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' F' F ' 5' ' ' LYS . . . . . . . . . . . . . 98.7 mttt -113.77 121.62 44.62 Favored 'General case' 0 C--O 1.234 0.247 0 CA-C-N 116.505 -0.316 . . . . 0.0 110.825 -179.708 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' F' F ' 6' ' ' LEU . . . . . . . . . . . . . 66.7 mt -114.05 145.08 42.08 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-N 115.478 -0.783 . . . . 0.0 110.007 179.372 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' F' F ' 7' ' ' LYS . . . . . . . . . . . . . 27.2 ttpp -126.72 141.22 39.7 Favored Pre-proline 0 CA--C 1.534 0.329 0 CA-C-O 119.059 -0.496 . . . . 0.0 109.804 176.134 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' F' F ' 8' ' ' PRO . . . . . . . . . . . . . 97.8 Cg_endo -92.07 137.2 1.76 Allowed 'Trans proline' 0 N--CA 1.49 1.295 0 C-N-CA 121.799 1.666 . . . . 0.0 111.897 178.801 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' F' F ' 9' ' ' LEU . . . . . . . . . . . . . 63.0 mt -75.64 -46.93 4.15 Favored Pre-proline 0 CA--C 1.535 0.384 0 CA-C-O 118.764 -0.636 . . . . 0.0 112.076 179.255 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' F' F ' 10' ' ' PRO . . . . . . . . . . . . . 71.1 Cg_endo -83.44 158.29 14.64 Favored 'Trans proline' 0 N--CA 1.497 1.691 0 C-N-CA 121.294 1.329 . . . . 0.0 112.179 175.583 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' F' F ' 11' ' ' LYS . . . . . . . . . . . . . 37.0 mmtm -79.19 105.33 10.44 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.396 -0.365 . . . . 0.0 110.167 176.044 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' F' F ' 12' ' ' VAL . . . . . . . . . . . . . 12.7 p -145.58 141.18 22.22 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.312 0 CA-C-O 120.833 0.349 . . . . 0.0 110.863 -179.602 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' F' F ' 13' ' ' GLU . . . . . . . . . . . . . 15.2 mm-40 -95.45 124.82 39.67 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.202 -0.454 . . . . 0.0 109.874 175.378 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' F' F ' 14' ' ' LEU . . . . . . . . . . . . . 44.6 mt -96.79 151.49 37.88 Favored Pre-proline 0 C--N 1.328 -0.332 0 CA-C-N 116.411 -0.359 . . . . 0.0 110.497 -177.131 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' F' F ' 15' ' ' PRO . . . . . . . . . . . . . 35.4 Cg_exo -59.3 158.49 26.37 Favored 'Trans proline' 0 N--CA 1.497 1.716 0 C-N-CA 121.27 1.313 . . . . 0.0 111.795 178.715 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' F' F ' 16' ' ' PRO . . . . . . . . . . . . . 37.1 Cg_exo -59.03 -37.75 91.42 Favored 'Trans proline' 0 N--CA 1.497 1.677 0 C-N-CA 121.472 1.448 . . . . 0.0 112.516 -179.485 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' F' F ' 17' ' ' ASP . . . . . . . . . . . . . 18.2 p-10 -89.04 14.02 11.63 Favored 'General case' 0 CA--C 1.536 0.406 0 N-CA-C 112.984 0.735 . . . . 0.0 112.984 -178.77 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' F' F ' 18' ' ' PHE . . . . . . . . . . . . . 53.0 t80 -58.4 -45.25 88.74 Favored 'General case' 0 N--CA 1.457 -0.082 0 O-C-N 121.975 -0.453 . . . . 0.0 110.122 -177.487 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' F' F ' 19' ' ' VAL . . . . . . . . . . . . . 14.6 p -55.15 -41.39 59.89 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.243 0 CA-C-N 116.512 -0.313 . . . . 0.0 111.066 -177.96 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' F' F ' 20' ' ' ASP . . . . . . . . . . . . . 68.5 m-20 -60.5 -44.47 95.95 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-O 120.83 0.348 . . . . 0.0 110.852 -179.19 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' F' F ' 21' ' ' VAL . . . . . . . . . . . . . 50.4 t -64.07 -48.37 86.2 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.308 0 CA-C-N 116.43 -0.35 . . . . 0.0 110.568 -177.478 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' F' F ' 22' ' ' ILE . . . . . . . . . . . . . 49.0 mm -58.01 -43.55 85.21 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.288 0 C-N-CA 120.926 -0.309 . . . . 0.0 110.754 -178.885 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' F' F ' 23' ' ' ARG . . . . . . . . . . . . . 55.7 ttp180 -55.92 -47.56 77.29 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-O 120.654 0.264 . . . . 0.0 110.832 -179.98 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' F' F ' 24' ' ' ILE . . . . . . . . . . . . . 69.0 mt -60.49 -41.03 86.17 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.29 0 CA-C-N 116.578 -0.283 . . . . 0.0 111.643 -178.473 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' F' F ' 25' ' ' LYS . . . . . . . . . . . . . 14.9 ptpt -74.13 -35.14 64.08 Favored 'General case' 0 CA--C 1.534 0.327 0 N-CA-C 112.317 0.488 . . . . 0.0 112.317 -175.063 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' F' F ' 26' ' ' LEU . . . . . . . . . . . . . 22.7 mt -80.66 -38.89 28.27 Favored 'General case' 0 C--N 1.327 -0.378 0 N-CA-C 113.31 0.855 . . . . 0.0 113.31 -173.662 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' F' F ' 27' ' ' GLN . . . . . . . . . . . . . 10.0 pt20 -46.47 141.23 3.74 Favored 'General case' 0 N--CA 1.47 0.528 0 N-CA-C 112.784 0.661 . . . . 0.0 112.784 -174.411 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' F' F ' 28' ' ' GLY . . . . . . . . . . . . . . . 101.14 -25.92 26.52 Favored Glycine 0 CA--C 1.532 1.122 0 CA-C-N 115.464 -0.789 . . . . 0.0 112.262 -176.477 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' F' F ' 29' ' ' LYS . . . . . . . . . . . . . 55.5 mtpt -98.04 155.04 17.31 Favored 'General case' 0 C--N 1.332 -0.161 0 CA-C-N 117.483 0.642 . . . . 0.0 111.183 178.827 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' F' F ' 30' ' ' THR . . . . . . . . . . . . . 29.9 m -103.63 138.97 39.56 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 115.988 -0.551 . . . . 0.0 109.964 176.127 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' F' F ' 31' ' ' VAL . . . . . . . . . . . . . 35.0 m -129.46 156.25 41.78 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.235 0 CA-C-N 116.382 -0.372 . . . . 0.0 110.972 -178.26 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' F' F ' 32' ' ' ARG . . . . . . . . . . . . . 93.6 mtm-85 -133.31 148.41 51.9 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 115.731 -0.668 . . . . 0.0 110.248 177.439 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' F' F ' 33' ' ' THR . . . . . . . . . . . . . 19.0 m -53.03 140.03 26.35 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.411 -0.359 . . . . 0.0 111.372 -178.442 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' F' F ' 34' ' ' GLY . . . . . . . . . . . . . . . 100.33 -17.14 57.3 Favored Glycine 0 CA--C 1.532 1.144 0 CA-C-O 119.609 -0.55 . . . . 0.0 113.251 179.765 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' F' F ' 35' ' ' ASP . . . . . . . . . . . . . 73.3 m-20 -65.66 149.28 50.36 Favored 'General case' 0 N--CA 1.462 0.151 0 CA-C-N 118.04 0.92 . . . . 0.0 111.094 179.435 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' F' F ' 36' ' ' VAL . . . . . . . . . . . . . 45.6 t -124.83 131.31 72.8 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.174 0 CA-C-N 115.963 -0.562 . . . . 0.0 109.801 178.335 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' F' F ' 37' ' ' ILE . . . . . . . . . . . . . 65.1 mt -122.09 140.0 47.35 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.224 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.027 -178.678 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' F' F ' 38' ' ' GLY . . . . . . . . . . . . . . . -113.76 128.63 8.39 Favored Glycine 0 CA--C 1.524 0.639 0 N-CA-C 110.888 -0.885 . . . . 0.0 110.888 178.329 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' F' F ' 39' ' ' ILE . . . . . . . . . . . . . 71.8 mt -127.52 133.97 66.64 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.197 0 N-CA-C 110.093 -0.336 . . . . 0.0 110.093 179.439 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' F' F ' 40' ' ' SER . . . . . . . . . . . . . 20.4 t -92.35 124.26 36.28 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.376 -0.375 . . . . 0.0 111.298 178.381 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' F' F ' 41' ' ' ILE . . . . . . . . . . . . . 68.9 mt -134.35 121.9 38.46 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.236 0 N-CA-C 110.058 -0.349 . . . . 0.0 110.058 176.436 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' F' F ' 42' ' ' LEU . . . . . . . . . . . . . 45.0 mt 58.84 35.13 24.11 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.087 -0.506 . . . . 0.0 111.694 177.942 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' F' F ' 43' ' ' GLY . . . . . . . . . . . . . . . 74.35 13.13 81.78 Favored Glycine 0 CA--C 1.534 1.231 0 C-N-CA 121.135 -0.555 . . . . 0.0 113.371 176.964 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' F' F ' 44' ' ' LYS . . . . . . . . . . . . . 94.9 mttt -126.21 130.98 52.03 Favored 'General case' 0 C--N 1.332 -0.155 0 CA-C-N 117.847 0.824 . . . . 0.0 109.785 177.191 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' F' F ' 45' ' ' GLU . . . . . . . . . . . . . 83.9 tt0 -84.81 130.5 34.66 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-O 120.887 0.375 . . . . 0.0 111.39 -178.391 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' F' F ' 46' ' ' VAL . . . . . . . . . . . . . 9.8 p -117.96 128.26 75.09 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.236 0 N-CA-C 109.566 -0.531 . . . . 0.0 109.566 174.508 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' F' F ' 47' ' ' LYS . . . . . . . . . . . . . 92.3 mttt -98.13 124.29 42.61 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.157 -0.474 . . . . 0.0 110.693 177.846 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' F' F ' 48' ' ' PHE . . . . . . . . . . . . . 33.5 m-85 -108.43 131.79 54.43 Favored 'General case' 0 C--N 1.329 -0.32 0 N-CA-C 109.571 -0.529 . . . . 0.0 109.571 175.866 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' F' F ' 49' ' ' LYS . . . . . . . . . . . . . 46.6 tttm -108.58 134.2 51.67 Favored 'General case' 0 C--N 1.331 -0.227 0 CA-C-N 116.342 -0.39 . . . . 0.0 110.202 177.678 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' F' F ' 50' ' ' VAL . . . . . . . . . . . . . 45.0 t -78.74 105.68 8.38 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.342 0 N-CA-C 109.368 -0.604 . . . . 0.0 109.368 177.227 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' F' F ' 51' ' ' VAL . . . . . . . . . . . . . 47.8 t -69.68 -52.78 28.65 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.276 0 N-CA-C 109.534 -0.543 . . . . 0.0 109.534 -175.903 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' F' F ' 52' ' ' GLN . . . . . . . . . . . . . 87.8 mt-30 -153.54 151.12 29.42 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 115.889 -0.596 . . . . 0.0 111.544 -178.634 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' F' F ' 53' ' ' ALA . . . . . . . . . . . . . . . -128.82 134.17 48.25 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 115.021 -0.99 . . . . 0.0 109.493 175.089 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' F' F ' 54' ' ' TYR . . . . . . . . . . . . . 84.3 t80 -129.12 111.47 18.31 Favored Pre-proline 0 CA--C 1.535 0.401 0 CA-C-O 118.15 -0.929 . . . . 0.0 110.387 -179.862 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' F' F ' 55' ' ' PRO . . . . . . . . . . . . . 73.4 Cg_endo -77.07 169.18 75.01 Favored 'Cis proline' 0 N--CA 1.5 1.879 0 CA-C-N 121.94 1.729 . . . . 0.0 112.303 -5.952 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' F' F ' 56' ' ' SER . . . . . . . . . . . . . 13.7 m -116.76 128.16 26.21 Favored Pre-proline 0 CA--C 1.538 0.509 0 CA-C-O 118.366 -0.826 . . . . 0.0 109.274 174.686 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' F' F ' 57' ' ' PRO . . . . . . . . . . . . . 37.2 Cg_endo -66.68 165.44 64.93 Favored 'Cis proline' 0 N--CA 1.496 1.647 0 CA-C-N 122.023 1.758 . . . . 0.0 111.78 0.259 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' F' F ' 58' ' ' LEU . . . . . . . . . . . . . 26.6 tp -130.08 135.85 48.69 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.155 -0.475 . . . . 0.0 110.276 179.296 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' F' F ' 59' ' ' ARG . . . . . . . . . . . . . 58.2 ttt-85 -103.82 125.02 49.97 Favored 'General case' 0 C--N 1.327 -0.406 0 N-CA-C 109.278 -0.638 . . . . 0.0 109.278 175.39 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' F' F ' 60' ' ' VAL . . . . . . . . . . . . . 47.6 t -76.86 117.81 22.36 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.318 0 C-N-CA 120.756 -0.378 . . . . 0.0 110.362 -175.127 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' F' F ' 61' ' ' GLU . . . . . . . . . . . . . 95.6 mt-10 -130.95 166.44 20.95 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 115.728 -0.669 . . . . 0.0 109.661 177.917 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' F' F ' 62' ' ' ASP . . . . . . . . . . . . . 82.0 m-20 -53.97 -32.58 54.41 Favored 'General case' 0 C--N 1.329 -0.312 0 C-N-CA 121.012 -0.275 . . . . 0.0 111.688 179.651 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' F' F ' 63' ' ' ARG . . . . . . . . . . . . . 49.8 ptt85 -78.41 -1.0 31.38 Favored 'General case' 0 CA--C 1.537 0.46 0 N-CA-C 113.781 1.03 . . . . 0.0 113.781 -175.838 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' F' F ' 64' ' ' THR . . . . . . . . . . . . . 34.3 m -86.6 134.75 33.61 Favored 'General case' 0 C--O 1.232 0.161 0 CA-C-N 118.164 0.438 . . . . 0.0 110.808 -177.158 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' F' F ' 65' ' ' LYS . . . . . . . . . . . . . 90.9 mttt -90.01 128.11 36.2 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.01 -0.541 . . . . 0.0 110.211 178.208 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' F' F ' 66' ' ' ILE . . . . . . . . . . . . . 63.3 mt -114.04 130.93 67.38 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.252 0 N-CA-C 109.886 -0.412 . . . . 0.0 109.886 -179.682 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' F' F ' 67' ' ' THR . . . . . . . . . . . . . 30.5 m -125.5 143.57 50.94 Favored 'General case' 0 C--N 1.331 -0.227 0 CA-C-N 116.013 -0.54 . . . . 0.0 111.113 -177.977 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' F' F ' 68' ' ' LEU . . . . . . . . . . . . . 20.6 tp . . . . . 0 C--N 1.33 -0.269 0 CA-C-N 115.687 -0.688 . . . . 0.0 110.118 177.431 . . . . . . . . 0 0 . 1 . 019 nuclear orig core ' F' F ' 73' ' ' VAL . . . . . . . . . . . . . 34.3 m . . . . . 0 N--CA 1.462 0.164 0 CA-C-O 120.893 0.378 . . . . 0.0 111.002 . . . . . . . . . 0 0 . 1 . 019 nuclear orig core ' F' F ' 74' ' ' ASP . . . . . . . . . . . . . 33.0 t0 -100.79 124.08 45.92 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 115.842 -0.617 . . . . 0.0 110.233 -178.923 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' F' F ' 75' ' ' VAL . . . . . . . . . . . . . 42.5 t -118.1 123.17 71.25 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.24 0 CA-C-O 121.027 0.441 . . . . 0.0 110.594 -178.294 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' F' F ' 76' ' ' LEU . . . . . . . . . . . . . 5.5 mp -121.94 147.89 45.47 Favored 'General case' 0 C--N 1.331 -0.217 0 CA-C-N 115.744 -0.662 . . . . 0.0 109.686 175.661 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' F' F ' 77' ' ' GLU . . . . . . . . . . . . . 96.4 mt-10 -137.63 132.17 32.61 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-O 121.005 0.431 . . . . 0.0 111.165 -178.712 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' F' F ' 78' ' ' ALA . . . . . . . . . . . . . . . -115.33 131.01 57.07 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 115.744 -0.662 . . . . 0.0 109.859 177.17 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' F' F ' 79' ' ' LYS . . . . . . . . . . . . . 34.3 tptt -85.75 117.42 24.62 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-O 120.798 0.332 . . . . 0.0 110.955 -176.71 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' F' F ' 80' ' ' ILE . . . . . . . . . . . . . 39.1 mm -139.23 107.46 3.26 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.272 0 N-CA-C 109.227 -0.657 . . . . 0.0 109.227 -179.314 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' F' F ' 81' ' ' LYS . . . . . . . . . . . . . 38.8 ttpt -89.08 121.47 31.45 Favored 'General case' 0 C--N 1.328 -0.334 0 C-N-CA 120.865 -0.334 . . . . 0.0 111.084 -177.207 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' F' F ' 82' ' ' GLY . . . . . . . . . . . . . . . 89.21 42.19 5.64 Favored Glycine 0 CA--C 1.525 0.698 0 C-N-CA 120.561 -0.828 . . . . 0.0 111.651 174.239 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' F' F ' 83' ' ' ILE . . . . . . . . . . . . . 73.9 mt -65.45 139.79 20.75 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.306 0 N-CA-C 109.623 -0.51 . . . . 0.0 109.623 176.997 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' F' F ' 84' ' ' LYS . . . . . . . . . . . . . 84.3 tttt -94.72 -53.27 3.93 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.028 -0.533 . . . . 0.0 110.49 -176.773 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' F' F ' 85' ' ' ASP . . . . . . . . . . . . . 9.3 t70 -154.12 153.1 31.25 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 115.787 -0.642 . . . . 0.0 110.313 -179.39 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' F' F ' 86' ' ' VAL . . . . . . . . . . . . . 44.4 t -130.79 131.12 64.66 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.247 0 CA-C-O 120.846 0.355 . . . . 0.0 110.616 -179.009 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' F' F ' 87' ' ' ILE . . . . . . . . . . . . . 5.1 mp -123.13 126.57 73.76 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.249 0 CA-C-N 115.992 -0.549 . . . . 0.0 109.566 176.892 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' F' F ' 88' ' ' LEU . . . . . . . . . . . . . 53.7 mt -113.18 137.76 50.98 Favored 'General case' 0 C--N 1.331 -0.224 0 CA-C-O 121.12 0.486 . . . . 0.0 111.649 -175.963 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' F' F ' 89' ' ' ASP . . . . . . . . . . . . . 12.3 t0 -133.23 150.76 51.93 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 115.592 -0.731 . . . . 0.0 109.279 174.973 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' F' F ' 90' ' ' GLU . . . . . . . . . . . . . 82.9 tt0 -48.18 -38.01 17.15 Favored 'General case' 0 C--N 1.33 -0.258 0 N-CA-C 112.827 0.677 . . . . 0.0 112.827 -173.385 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' F' F ' 91' ' ' ASN . . . . . . . . . . . . . 26.5 m120 -128.44 32.93 4.77 Favored 'General case' 0 N--CA 1.466 0.361 0 N-CA-C 111.794 0.294 . . . . 0.0 111.794 -177.077 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' F' F ' 92' ' ' LEU . . . . . . . . . . . . . 19.3 tp -166.13 138.9 4.01 Favored 'General case' 0 C--N 1.33 -0.259 0 N-CA-C 110.2 -0.296 . . . . 0.0 110.2 -179.438 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' F' F ' 93' ' ' ILE . . . . . . . . . . . . . 71.0 mt -126.36 122.46 61.3 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.279 0 N-CA-C 109.666 -0.494 . . . . 0.0 109.666 178.368 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' F' F ' 94' ' ' VAL . . . . . . . . . . . . . 43.8 t -120.78 126.25 75.01 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.265 0 N-CA-C 109.887 -0.412 . . . . 0.0 109.887 179.995 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' F' F ' 95' ' ' VAL . . . . . . . . . . . . . 42.7 t -121.45 133.77 66.92 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.282 0 CA-C-N 115.939 -0.573 . . . . 0.0 109.665 179.849 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' F' F ' 96' ' ' ILE . . . . . . . . . . . . . 60.9 mt -115.5 126.66 73.12 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.323 0 N-CA-C 109.363 -0.606 . . . . 0.0 109.363 179.039 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' F' F ' 97' ' ' THR . . . . . . . . . . . . . 80.8 p -96.5 156.52 16.31 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-O 120.863 0.363 . . . . 0.0 110.765 -179.191 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' F' F ' 98' ' ' GLU . . . . . . . . . . . . . 40.8 tp10 -53.82 -25.54 19.97 Favored 'General case' 0 CA--C 1.533 0.317 0 N-CA-C 112.111 0.411 . . . . 0.0 112.111 -179.461 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' F' F ' 99' ' ' GLU . . . . . . . . . . . . . 18.1 tp10 -80.05 17.42 1.0 Allowed 'General case' 0 CA--C 1.538 0.503 0 N-CA-C 112.858 0.688 . . . . 0.0 112.858 -177.732 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' F' F ' 100' ' ' ASN . . . . . . . . . . . . . 3.6 m-20 63.1 35.59 12.83 Favored 'General case' 0 CA--C 1.531 0.233 0 CA-C-O 120.882 0.372 . . . . 0.0 111.435 176.39 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' F' F ' 101' ' ' GLU . . . . . . . . . . . . . 83.9 tt0 -113.19 142.06 46.23 Favored 'General case' 0 C--N 1.332 -0.173 0 N-CA-C 109.866 -0.42 . . . . 0.0 109.866 175.355 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' F' F ' 102' ' ' VAL . . . . . . . . . . . . . 45.8 t -115.01 126.17 72.53 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.266 0 N-CA-C 109.896 -0.409 . . . . 0.0 109.896 -178.537 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' F' F ' 103' ' ' LEU . . . . . . . . . . . . . 58.2 mt -116.1 133.85 55.57 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 115.685 -0.689 . . . . 0.0 109.796 177.798 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' F' F ' 104' ' ' ILE . . . . . . . . . . . . . 73.8 mt -121.53 119.41 58.87 Favored 'Isoleucine or valine' 0 C--O 1.233 0.23 0 N-CA-C 110.211 -0.292 . . . . 0.0 110.211 -178.939 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' F' F ' 105' ' ' PHE . . . . . . . . . . . . . 35.5 m-85 -121.79 168.2 12.11 Favored 'General case' 0 C--N 1.332 -0.153 0 O-C-N 124.222 0.951 . . . . 0.0 109.907 -179.968 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' F' F ' 106' ' ' ASN . . . . . . . . . . . . . 45.5 p-10 -102.56 -170.03 1.75 Allowed 'General case' 0 C--N 1.33 -0.273 0 N-CA-C 109.509 -0.552 . . . . 0.0 109.509 171.917 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' F' F ' 107' ' ' GLN . . . . . . . . . . . . . 57.1 tt0 -58.21 -26.1 62.4 Favored 'General case' 0 CA--C 1.534 0.337 0 N-CA-C 112.162 0.43 . . . . 0.0 112.162 179.024 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' F' F ' 108' ' ' ASN . . . . . . . . . . . . . 5.6 t-20 -91.16 13.29 17.43 Favored 'General case' 0 CA--C 1.536 0.426 0 N-CA-C 112.974 0.731 . . . . 0.0 112.974 -176.729 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' F' F ' 109' ' ' LEU . . . . . . . . . . . . . 67.7 mt 57.17 35.44 26.24 Favored 'General case' 0 CA--C 1.53 0.178 0 CA-C-O 120.714 0.292 . . . . 0.0 111.543 177.795 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' F' F ' 110' ' ' GLU . . . . . . . . . . . . . 70.8 mm-40 -102.75 149.27 24.63 Favored 'General case' 0 C--N 1.33 -0.282 0 N-CA-C 109.897 -0.409 . . . . 0.0 109.897 176.249 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' F' F ' 111' ' ' GLU . . . . . . . . . . . . . 98.6 mt-10 -81.47 121.97 26.94 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-O 120.997 0.427 . . . . 0.0 111.38 -176.644 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' F' F ' 112' ' ' LEU . . . . . . . . . . . . . 44.7 mt -105.52 -45.69 4.38 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 115.852 -0.613 . . . . 0.0 109.905 175.94 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' F' F ' 113' ' ' TYR . . . . . . . . . . . . . 61.5 t80 -141.92 140.86 32.91 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 115.976 -0.556 . . . . 0.0 110.761 179.928 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' F' F ' 114' ' ' ARG . . . . . . . . . . . . . 71.7 mtm180 -145.17 121.0 10.59 Favored 'General case' 0 C--N 1.331 -0.226 0 CA-C-N 116.358 -0.383 . . . . 0.0 110.557 177.65 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' F' F ' 115' ' ' GLY . . . . . . . . . . . . . . . -150.13 162.67 29.28 Favored Glycine 0 CA--C 1.525 0.677 0 N-CA-C 110.908 -0.877 . . . . 0.0 110.908 -179.603 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' F' F ' 116' ' ' LYS . . . . . . . . . . . . . 1.9 ttmp? -126.43 136.0 52.1 Favored 'General case' 0 C--N 1.33 -0.267 0 N-CA-C 109.933 -0.395 . . . . 0.0 109.933 176.47 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' F' F ' 117' ' ' PHE . . . . . . . . . . . . . 60.6 m-85 -128.91 115.13 17.38 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.237 -0.438 . . . . 0.0 110.264 -176.519 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' F' F ' 118' ' ' GLU . . . . . . . . . . . . . 84.5 tt0 -51.83 -49.16 63.38 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 116.431 -0.349 . . . . 0.0 111.742 -175.718 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' F' F ' 119' ' ' ASN . . . . . . . . . . . . . 5.2 m120 -98.8 31.08 3.06 Favored 'General case' 0 C--N 1.33 -0.249 0 N-CA-C 112.126 0.417 . . . . 0.0 112.126 -174.053 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' F' F ' 120' ' ' LEU . . . . . . . . . . . . . 19.1 tp -54.5 121.29 8.07 Favored 'General case' 0 N--CA 1.462 0.157 0 CA-C-O 120.671 0.272 . . . . 0.0 110.959 179.056 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' F' F ' 121' ' ' ASN . . . . . . . . . . . . . 6.6 t-20 -113.97 -44.08 3.19 Favored 'General case' 0 C--N 1.333 -0.113 0 CA-C-N 116.536 -0.302 . . . . 0.0 111.008 -177.352 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' F' F ' 122' ' ' LYS . . . . . . . . . . . . . 95.8 mttt -146.9 151.36 36.93 Favored 'General case' 0 C--N 1.331 -0.209 0 CA-C-O 121.064 0.459 . . . . 0.0 111.734 -178.416 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' F' F ' 123' ' ' VAL . . . . . . . . . . . . . 46.1 t -129.52 124.41 59.54 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.325 0 N-CA-C 109.181 -0.674 . . . . 0.0 109.181 173.058 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' F' F ' 124' ' ' LEU . . . . . . . . . . . . . 6.1 mp -117.1 138.79 51.4 Favored 'General case' 0 C--N 1.331 -0.215 0 CA-C-O 120.818 0.342 . . . . 0.0 110.492 -176.699 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' F' F ' 125' ' ' VAL . . . . . . . . . . . . . 35.2 m -135.16 140.06 45.84 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.238 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.996 -179.514 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' F' F ' 126' ' ' ARG . . . . . . . . . . . . . 6.7 ptm85 -139.86 118.98 12.69 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 115.938 -0.574 . . . . 0.0 109.966 176.052 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' F' F ' 127' ' ' ASN . . . . . . . . . . . . . 29.9 m120 52.55 -107.65 0.35 Allowed 'General case' 0 CA--C 1.544 0.747 0 CA-C-O 118.968 -0.539 . . . . 0.0 111.053 -178.221 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' F' F ' 128' ' ' ASP . . . . . . . . . . . . . 9.5 p-10 -114.17 3.9 15.36 Favored 'General case' 0 N--CA 1.467 0.4 0 CA-C-N 119.746 1.157 . . . . 0.0 113.476 -178.378 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' F' F ' 129' ' ' LEU . . . . . . . . . . . . . 10.4 tp -105.04 141.81 35.94 Favored 'General case' 0 C--O 1.232 0.142 0 N-CA-C 109.619 -0.512 . . . . 0.0 109.619 179.413 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' F' F ' 130' ' ' VAL . . . . . . . . . . . . . 14.5 p -133.12 143.4 39.44 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.249 0 CA-C-O 121.312 0.577 . . . . 0.0 111.5 -175.538 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' F' F ' 131' ' ' VAL . . . . . . . . . . . . . 43.8 t -136.06 137.58 48.45 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.232 0 CA-C-N 115.591 -0.732 . . . . 0.0 109.949 177.882 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' F' F ' 132' ' ' ILE . . . . . . . . . . . . . 69.6 mt -114.21 134.08 58.23 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.257 0 CA-C-N 116.075 -0.511 . . . . 0.0 109.628 -179.215 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' F' F ' 133' ' ' ILE . . . . . . . . . . . . . 43.2 mm -117.92 119.53 61.79 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.238 0 CA-C-O 121.007 0.432 . . . . 0.0 110.819 -176.549 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' F' F ' 134' ' ' ASP . . . . . . . . . . . . . 7.3 p-10 -132.84 144.68 50.37 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 115.77 -0.65 . . . . 0.0 109.329 174.834 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' F' F ' 135' ' ' GLU . . . . . . . . . . . . . 85.5 tt0 -49.86 -25.04 2.8 Favored 'General case' 0 C--N 1.328 -0.332 0 N-CA-C 112.942 0.719 . . . . 0.0 112.942 -170.745 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' F' F ' 136' ' ' GLN . . . . . . . . . . . . . 97.4 mt-30 -94.09 -34.47 12.97 Favored 'General case' 0 C--N 1.331 -0.221 0 N-CA-C 112.112 0.412 . . . . 0.0 112.112 -176.953 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' F' F ' 137' ' ' LYS . . . . . . . . . . . . . 78.6 mttt -139.91 153.21 46.91 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-O 121.247 0.546 . . . . 0.0 111.702 -170.149 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' F' F ' 138' ' ' LEU . . . . . . . . . . . . . 6.6 tt -117.56 123.07 45.35 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 115.53 -0.759 . . . . 0.0 108.973 170.94 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' F' F ' 139' ' ' THR . . . . . . . . . . . . . 31.3 m -114.55 128.58 56.4 Favored 'General case' 0 C--N 1.331 -0.218 0 CA-C-N 116.327 -0.397 . . . . 0.0 111.053 -175.537 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' F' F ' 140' ' ' LEU . . . . . . . . . . . . . 7.3 tt -114.18 125.08 53.53 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 115.619 -0.719 . . . . 0.0 109.308 179.634 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' F' F ' 141' ' ' ILE . . . . . . . . . . . . . 19.0 mt -124.72 119.78 57.07 Favored 'Isoleucine or valine' 0 C--O 1.235 0.31 0 CA-C-O 121.005 0.431 . . . . 0.0 110.52 -175.301 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' F' F ' 142' ' ' ARG . . . . . . . . . . . . . 94.1 mtt180 -94.69 125.25 39.22 Favored 'General case' 0 C--N 1.332 -0.182 0 CA-C-N 115.249 -0.887 . . . . 0.0 109.387 174.527 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' F' F ' 143' ' ' THR . . . . . . . . . . . . . 45.1 p . . . . . 0 C--O 1.221 -0.437 0 CA-C-O 117.982 -1.009 . . . . 0.0 110.61 179.58 . . . . . . . . 0 0 . 1 . 020 nuclear orig core ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 59.9 p . . . . . 0 C--O 1.231 0.103 0 N-CA-C 110.063 -0.347 . . . . 0.0 110.063 . . . . . . . . . 0 0 . 1 . 020 nuclear orig core ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 95.6 mt-10 -139.95 142.75 36.36 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-O 121.08 0.467 . . . . 0.0 111.385 -177.423 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 4' ' ' LEU . . . . . . . . . . . . . 39.0 mt -120.86 127.52 51.96 Favored 'General case' 0 C--N 1.331 -0.215 0 CA-C-N 115.603 -0.726 . . . . 0.0 110.043 174.978 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 5' ' ' LYS . . . . . . . . . . . . . 88.8 mttt -108.9 119.43 39.54 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-O 120.862 0.363 . . . . 0.0 110.498 176.364 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 45.6 mt -115.55 146.73 41.47 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 115.297 -0.865 . . . . 0.0 110.234 -179.199 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 75.4 tttt -135.91 136.25 22.93 Favored Pre-proline 0 CA--C 1.534 0.328 0 CA-C-O 118.981 -0.533 . . . . 0.0 110.247 176.125 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 8' ' ' PRO . . . . . . . . . . . . . 89.1 Cg_endo -90.81 141.86 3.17 Favored 'Trans proline' 0 N--CA 1.491 1.361 0 C-N-CA 121.553 1.502 . . . . 0.0 111.526 176.281 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 65.1 mt -73.4 -47.42 7.5 Favored Pre-proline 0 CA--C 1.533 0.313 0 CA-C-O 118.711 -0.661 . . . . 0.0 112.235 -178.266 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 83.2 Cg_endo -80.95 153.11 19.21 Favored 'Trans proline' 0 N--CA 1.495 1.608 0 C-N-CA 121.268 1.312 . . . . 0.0 111.767 175.558 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 24.7 ttpp -86.99 102.57 14.52 Favored 'General case' 0 C--N 1.329 -0.295 0 C-N-CA 120.772 -0.371 . . . . 0.0 110.174 178.588 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 11.8 p -141.33 144.05 26.86 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.291 0 CA-C-N 116.275 -0.42 . . . . 0.0 110.368 -179.412 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 95.3 mt-10 -84.5 129.84 34.81 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.062 178.635 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 14' ' ' LEU . . . . . . . . . . . . . 34.7 mt -98.66 148.54 34.69 Favored Pre-proline 0 CA--C 1.533 0.327 0 CA-C-O 119.229 -0.415 . . . . 0.0 110.629 -177.938 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 15' ' ' PRO . . . . . . . . . . . . . 24.5 Cg_exo -63.51 163.64 23.34 Favored 'Trans proline' 0 N--CA 1.498 1.758 0 C-N-CA 121.382 1.388 . . . . 0.0 111.978 175.992 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 16' ' ' PRO . . . . . . . . . . . . . 25.6 Cg_exo -61.29 -39.91 53.79 Favored 'Trans proline' 0 N--CA 1.496 1.651 0 C-N-CA 121.544 1.496 . . . . 0.0 112.836 -178.511 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 17' ' ' ASP . . . . . . . . . . . . . 7.9 p-10 -83.64 4.57 27.88 Favored 'General case' 0 CA--C 1.535 0.394 0 N-CA-C 113.344 0.868 . . . . 0.0 113.344 -176.973 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 18' ' ' PHE . . . . . . . . . . . . . 39.7 t80 -57.28 -46.66 82.89 Favored 'General case' 0 N--CA 1.457 -0.098 0 O-C-N 121.943 -0.473 . . . . 0.0 110.471 -176.494 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 19' ' ' VAL . . . . . . . . . . . . . 45.9 t -56.05 -47.15 80.71 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.362 0 CA-C-N 116.477 -0.328 . . . . 0.0 110.831 -176.527 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 49.3 m-20 -60.13 -41.09 91.95 Favored 'General case' 0 C--N 1.329 -0.302 0 C-N-CA 120.921 -0.312 . . . . 0.0 111.158 -176.954 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 56.1 t -64.74 -45.3 95.56 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.255 0 C-N-CA 120.746 -0.382 . . . . 0.0 110.504 -177.78 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 22' ' ' ILE . . . . . . . . . . . . . 51.2 mm -56.49 -45.05 81.89 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.235 0 C-N-CA 121.031 -0.268 . . . . 0.0 110.385 178.027 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 23' ' ' ARG . . . . . . . . . . . . . 45.3 ttp180 -53.99 -48.8 70.02 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-O 120.611 0.243 . . . . 0.0 111.375 -179.629 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 24' ' ' ILE . . . . . . . . . . . . . 70.7 mt -60.55 -43.26 94.09 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.349 0 CA-C-O 120.634 0.254 . . . . 0.0 111.025 -178.217 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 74.5 mttt -64.97 -36.48 84.52 Favored 'General case' 0 C--N 1.328 -0.367 0 N-CA-C 112.069 0.396 . . . . 0.0 112.069 -178.804 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 42.6 mt -79.72 -44.19 21.23 Favored 'General case' 0 C--N 1.33 -0.269 0 N-CA-C 113.413 0.894 . . . . 0.0 113.413 -173.396 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 27' ' ' GLN . . . . . . . . . . . . . 11.3 pt20 -46.95 140.08 5.08 Favored 'General case' 0 N--CA 1.469 0.48 0 N-CA-C 112.833 0.679 . . . . 0.0 112.833 -173.619 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 97.55 -26.65 22.18 Favored Glycine 0 CA--C 1.534 1.24 0 CA-C-N 115.525 -0.761 . . . . 0.0 112.169 -176.062 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 65.5 mttm -97.58 155.17 17.09 Favored 'General case' 0 C--O 1.233 0.214 0 CA-C-N 117.108 0.454 . . . . 0.0 110.939 179.009 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 30' ' ' THR . . . . . . . . . . . . . 29.0 m -95.58 136.3 36.15 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.06 -0.518 . . . . 0.0 110.293 176.669 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 35.5 m -121.24 138.87 50.21 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.239 0 CA-C-N 116.352 -0.386 . . . . 0.0 110.612 -179.79 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 32' ' ' ARG . . . . . . . . . . . . . 48.0 tpt85 -134.08 139.11 45.75 Favored 'General case' 0 C--N 1.326 -0.428 0 CA-C-N 115.878 -0.601 . . . . 0.0 110.086 -178.822 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 33' ' ' THR . . . . . . . . . . . . . 19.7 m -51.67 140.58 18.42 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-O 120.922 0.391 . . . . 0.0 111.642 -175.475 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 99.13 -17.34 58.17 Favored Glycine 0 CA--C 1.533 1.181 0 CA-C-N 116.006 -0.543 . . . . 0.0 113.024 -179.372 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 82.0 m-20 -64.95 147.97 52.41 Favored 'General case' 0 C--O 1.231 0.096 0 CA-C-N 118.02 0.91 . . . . 0.0 111.088 179.079 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 46.0 t -120.39 128.18 75.97 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.166 0 CA-C-N 115.712 -0.676 . . . . 0.0 109.66 177.835 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 37' ' ' ILE . . . . . . . . . . . . . 66.9 mt -120.74 138.47 51.09 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.273 0 N-CA-C 109.782 -0.451 . . . . 0.0 109.782 -179.572 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . -114.29 128.68 8.33 Favored Glycine 0 CA--C 1.526 0.762 0 N-CA-C 110.935 -0.866 . . . . 0.0 110.935 179.53 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 39' ' ' ILE . . . . . . . . . . . . . 73.3 mt -126.62 127.01 69.83 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.246 0 N-CA-C 109.936 -0.394 . . . . 0.0 109.936 179.05 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 40' ' ' SER . . . . . . . . . . . . . 45.8 t -93.12 123.24 36.25 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.558 -0.292 . . . . 0.0 110.996 177.31 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 41' ' ' ILE . . . . . . . . . . . . . 73.0 mt -131.16 123.01 52.67 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.21 0 CA-C-O 120.92 0.391 . . . . 0.0 110.059 177.715 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 10.9 tp 56.35 36.8 28.1 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.072 -0.513 . . . . 0.0 111.339 178.847 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . 79.01 -10.08 35.39 Favored Glycine 0 CA--C 1.534 1.227 0 C-N-CA 121.21 -0.519 . . . . 0.0 113.641 175.963 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 44' ' ' LYS . . . . . . . . . . . . . 83.4 tttt -101.15 128.3 47.3 Favored 'General case' 0 C--N 1.334 -0.091 0 CA-C-N 117.968 0.884 . . . . 0.0 109.975 177.699 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 41.2 tp10 -84.94 130.63 34.61 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.373 -0.376 . . . . 0.0 110.921 -178.995 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 46' ' ' VAL . . . . . . . . . . . . . 7.4 p -121.82 132.07 71.69 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.199 0 N-CA-C 109.651 -0.5 . . . . 0.0 109.651 176.419 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 94.1 mttt -100.88 131.1 46.92 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.083 -0.508 . . . . 0.0 111.281 178.982 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 48' ' ' PHE . . . . . . . . . . . . . 92.1 m-85 -115.5 131.88 56.8 Favored 'General case' 0 C--N 1.33 -0.244 0 N-CA-C 109.759 -0.46 . . . . 0.0 109.759 175.598 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 54.4 tttm -108.32 139.32 43.19 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.693 -0.23 . . . . 0.0 110.425 178.022 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 50' ' ' VAL . . . . . . . . . . . . . 44.9 t -79.04 107.84 11.96 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.355 0 N-CA-C 109.262 -0.644 . . . . 0.0 109.262 175.909 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 51' ' ' VAL . . . . . . . . . . . . . 49.2 t -72.06 -48.62 48.82 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.324 0 CA-C-N 116.023 -0.535 . . . . 0.0 109.909 -174.324 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 52' ' ' GLN . . . . . . . . . . . . . 61.8 tt0 -162.95 144.45 9.95 Favored 'General case' 0 C--N 1.331 -0.238 0 C-N-CA 120.345 -0.542 . . . . 0.0 111.917 -178.52 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -121.66 132.61 54.75 Favored 'General case' 0 C--N 1.331 -0.196 0 CA-C-N 115.717 -0.674 . . . . 0.0 109.827 175.913 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 54' ' ' TYR . . . . . . . . . . . . . 22.5 t80 -129.16 110.94 18.2 Favored Pre-proline 0 CA--C 1.535 0.396 0 CA-C-O 118.101 -0.952 . . . . 0.0 110.656 177.787 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 55' ' ' PRO . . . . . . . . . . . . . 71.1 Cg_endo -75.94 170.04 72.86 Favored 'Cis proline' 0 N--CA 1.501 1.929 0 CA-C-N 121.898 1.714 . . . . 0.0 112.578 -7.908 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 56' ' ' SER . . . . . . . . . . . . . 66.3 m -118.36 132.53 23.75 Favored Pre-proline 0 CA--C 1.54 0.58 0 CA-C-O 118.439 -0.791 . . . . 0.0 110.079 178.257 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 57' ' ' PRO . . . . . . . . . . . . . 75.9 Cg_endo -79.22 149.73 84.03 Favored 'Cis proline' 0 N--CA 1.495 1.601 0 CA-C-N 121.932 1.726 . . . . 0.0 111.535 -4.922 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 58' ' ' LEU . . . . . . . . . . . . . 30.6 tp -108.84 140.89 41.66 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.303 -0.408 . . . . 0.0 110.929 -177.817 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 59' ' ' ARG . . . . . . . . . . . . . 78.2 ttt180 -94.06 119.02 32.34 Favored 'General case' 0 C--N 1.328 -0.331 0 N-CA-C 108.809 -0.812 . . . . 0.0 108.809 170.862 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 45.8 t -72.87 120.3 21.28 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.322 0 C-N-CA 120.55 -0.46 . . . . 0.0 110.667 -173.462 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 95.3 mt-10 -131.14 162.68 29.36 Favored 'General case' 0 C--N 1.331 -0.239 0 CA-C-N 115.63 -0.714 . . . . 0.0 109.78 176.945 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 62' ' ' ASP . . . . . . . . . . . . . 12.6 p-10 -54.28 -31.4 53.69 Favored 'General case' 0 C--N 1.329 -0.315 0 N-CA-C 112.185 0.439 . . . . 0.0 112.185 -177.693 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 63' ' ' ARG . . . . . . . . . . . . . 15.2 mmm180 -71.01 -21.81 62.24 Favored 'General case' 0 C--N 1.329 -0.285 0 N-CA-C 113.02 0.748 . . . . 0.0 113.02 -175.787 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 30.3 m -69.76 140.36 53.41 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-O 120.788 0.327 . . . . 0.0 110.997 -175.679 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 65' ' ' LYS . . . . . . . . . . . . . 12.1 mptt -88.91 134.7 33.87 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.154 -0.475 . . . . 0.0 109.836 179.731 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 66' ' ' ILE . . . . . . . . . . . . . 61.1 mt -117.91 131.81 69.57 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.302 0 CA-C-O 120.844 0.354 . . . . 0.0 110.321 -179.067 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 67' ' ' THR . . . . . . . . . . . . . 19.1 m -128.01 135.5 49.98 Favored 'General case' 0 C--N 1.331 -0.23 0 CA-C-N 116.112 -0.495 . . . . 0.0 110.507 178.517 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 68' ' ' LEU . . . . . . . . . . . . . 8.5 mp . . . . . 0 C--N 1.329 -0.293 0 CA-C-N 115.939 -0.573 . . . . 0.0 110.296 177.731 . . . . . . . . 0 0 . 1 . 020 nuclear orig core ' A' A ' 74' ' ' ASP . . . . . . . . . . . . . 36.1 t0 . . . . . 0 N--CA 1.46 0.028 0 N-CA-C 109.998 -0.371 . . . . 0.0 109.998 . . . . . . . . . 0 0 . 1 . 020 nuclear orig core ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 40.2 t -118.26 122.64 70.08 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.262 0 CA-C-O 120.922 0.392 . . . . 0.0 110.791 -176.745 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 76' ' ' LEU . . . . . . . . . . . . . 5.6 mp -122.54 146.43 47.42 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 115.869 -0.605 . . . . 0.0 109.832 175.572 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 77' ' ' GLU . . . . . . . . . . . . . 97.9 mt-10 -134.94 141.59 46.31 Favored 'General case' 0 C--N 1.331 -0.218 0 CA-C-O 121.04 0.448 . . . . 0.0 111.419 -179.241 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 78' ' ' ALA . . . . . . . . . . . . . . . -130.62 140.27 50.41 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-N 115.682 -0.69 . . . . 0.0 109.858 175.581 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 79' ' ' LYS . . . . . . . . . . . . . 53.0 mttm -87.49 122.77 31.64 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-O 120.994 0.426 . . . . 0.0 111.239 -177.606 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 80' ' ' ILE . . . . . . . . . . . . . 39.8 mm -139.2 109.26 4.16 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.298 0 N-CA-C 108.994 -0.743 . . . . 0.0 108.994 179.37 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 81' ' ' LYS . . . . . . . . . . . . . 78.2 tttt -97.8 123.37 41.73 Favored 'General case' 0 C--N 1.329 -0.3 0 C-N-CA 120.788 -0.365 . . . . 0.0 110.935 -176.949 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . 89.17 42.21 5.64 Favored Glycine 0 CA--C 1.526 0.741 0 C-N-CA 120.759 -0.734 . . . . 0.0 111.705 175.292 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 83' ' ' ILE . . . . . . . . . . . . . 71.1 mt -66.12 138.52 22.86 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.218 0 N-CA-C 109.736 -0.468 . . . . 0.0 109.736 177.178 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 84' ' ' LYS . . . . . . . . . . . . . 78.5 tttt -96.17 -52.9 3.83 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.031 -0.531 . . . . 0.0 110.405 -179.192 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 85' ' ' ASP . . . . . . . . . . . . . 7.1 t70 -154.19 153.7 32.23 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 115.906 -0.588 . . . . 0.0 110.567 -178.977 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 86' ' ' VAL . . . . . . . . . . . . . 42.6 t -131.77 131.32 62.13 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.242 0 CA-C-O 120.984 0.421 . . . . 0.0 110.468 -179.821 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 87' ' ' ILE . . . . . . . . . . . . . 5.0 mp -119.06 127.91 75.82 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.224 0 N-CA-C 109.301 -0.629 . . . . 0.0 109.301 176.25 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 88' ' ' LEU . . . . . . . . . . . . . 84.8 mt -117.32 138.82 51.52 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-O 121.149 0.499 . . . . 0.0 111.857 -177.071 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 89' ' ' ASP . . . . . . . . . . . . . 13.7 t70 -134.13 157.75 45.4 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-N 115.375 -0.829 . . . . 0.0 109.19 175.014 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 74.0 tt0 -47.5 -38.13 13.28 Favored 'General case' 0 C--N 1.33 -0.244 0 N-CA-C 112.772 0.656 . . . . 0.0 112.772 -172.785 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 91' ' ' ASN . . . . . . . . . . . . . 13.5 p-10 -132.09 35.97 3.68 Favored 'General case' 0 C--N 1.331 -0.207 0 N-CA-C 111.866 0.321 . . . . 0.0 111.866 -176.604 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 92' ' ' LEU . . . . . . . . . . . . . 13.1 tp -163.73 141.72 7.49 Favored 'General case' 0 C--N 1.332 -0.168 0 C-N-CA 120.85 -0.34 . . . . 0.0 110.934 -179.051 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 93' ' ' ILE . . . . . . . . . . . . . 74.8 mt -126.59 120.83 57.19 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.245 0 N-CA-C 109.461 -0.57 . . . . 0.0 109.461 178.268 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 94' ' ' VAL . . . . . . . . . . . . . 43.7 t -120.96 127.17 75.91 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.271 0 N-CA-C 109.873 -0.418 . . . . 0.0 109.873 179.306 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 95' ' ' VAL . . . . . . . . . . . . . 44.4 t -123.42 134.79 65.29 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.283 0 CA-C-N 116.137 -0.483 . . . . 0.0 109.92 -178.908 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 96' ' ' ILE . . . . . . . . . . . . . 65.3 mt -116.51 128.69 73.79 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.294 0 N-CA-C 109.286 -0.635 . . . . 0.0 109.286 179.157 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 97' ' ' THR . . . . . . . . . . . . . 74.1 p -100.7 156.07 17.54 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-O 121.206 0.527 . . . . 0.0 111.177 -177.606 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 98' ' ' GLU . . . . . . . . . . . . . 79.8 tt0 -54.02 -26.26 25.47 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.166 -0.47 . . . . 0.0 112.129 -178.808 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 99' ' ' GLU . . . . . . . . . . . . . 95.4 mt-10 -81.83 16.62 1.76 Allowed 'General case' 0 CA--C 1.535 0.374 0 N-CA-C 113.232 0.826 . . . . 0.0 113.232 -175.814 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 100' ' ' ASN . . . . . . . . . . . . . 3.7 m-20 62.97 36.03 12.87 Favored 'General case' 0 N--CA 1.464 0.243 0 CA-C-O 120.906 0.384 . . . . 0.0 111.345 178.548 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 101' ' ' GLU . . . . . . . . . . . . . 84.2 tt0 -112.33 144.4 41.82 Favored 'General case' 0 C--N 1.332 -0.188 0 CA-C-N 116.126 -0.488 . . . . 0.0 109.858 173.549 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 102' ' ' VAL . . . . . . . . . . . . . 48.1 t -116.19 128.05 73.61 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.283 0 CA-C-N 116.325 -0.398 . . . . 0.0 110.128 -178.324 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 103' ' ' LEU . . . . . . . . . . . . . 21.3 mt -118.97 131.86 56.04 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 115.693 -0.685 . . . . 0.0 110.094 177.475 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 104' ' ' ILE . . . . . . . . . . . . . 70.1 mt -120.76 123.39 70.17 Favored 'Isoleucine or valine' 0 C--O 1.234 0.248 0 N-CA-C 110.398 -0.223 . . . . 0.0 110.398 -179.735 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 105' ' ' PHE . . . . . . . . . . . . . 66.5 m-85 -122.92 166.15 15.52 Favored 'General case' 0 C--O 1.232 0.162 0 O-C-N 123.915 0.759 . . . . 0.0 109.942 -179.486 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 106' ' ' ASN . . . . . . . . . . . . . 38.0 p-10 -103.71 -171.08 1.88 Allowed 'General case' 0 C--N 1.331 -0.235 0 N-CA-C 109.951 -0.389 . . . . 0.0 109.951 172.662 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 107' ' ' GLN . . . . . . . . . . . . . 62.0 tt0 -59.85 -24.83 64.54 Favored 'General case' 0 CA--C 1.533 0.324 0 N-CA-C 112.156 0.428 . . . . 0.0 112.156 177.199 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 108' ' ' ASN . . . . . . . . . . . . . 28.5 t30 -84.51 4.16 33.18 Favored 'General case' 0 CA--C 1.538 0.498 0 N-CA-C 113.16 0.8 . . . . 0.0 113.16 -178.022 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 109' ' ' LEU . . . . . . . . . . . . . 12.0 tp 60.88 37.68 18.28 Favored 'General case' 0 CA--C 1.531 0.232 0 CA-C-O 120.943 0.401 . . . . 0.0 111.209 179.669 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 110' ' ' GLU . . . . . . . . . . . . . 15.1 mm-40 -106.55 150.14 26.44 Favored 'General case' 0 C--N 1.329 -0.294 0 N-CA-C 109.958 -0.386 . . . . 0.0 109.958 176.598 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 111' ' ' GLU . . . . . . . . . . . . . 43.3 tp10 -80.16 121.91 26.16 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-O 120.889 0.376 . . . . 0.0 110.043 179.776 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 112' ' ' LEU . . . . . . . . . . . . . 14.8 mt -108.34 -45.62 3.87 Favored 'General case' 0 C--N 1.331 -0.201 0 CA-C-N 116.07 -0.514 . . . . 0.0 110.142 178.511 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 113' ' ' TYR . . . . . . . . . . . . . 64.0 t80 -137.29 139.36 40.87 Favored 'General case' 0 C--N 1.331 -0.211 0 CA-C-N 116.248 -0.433 . . . . 0.0 111.221 -179.805 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 114' ' ' ARG . . . . . . . . . . . . . 32.4 ttm180 -140.95 124.26 16.61 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 115.888 -0.596 . . . . 0.0 110.275 177.509 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 115' ' ' GLY . . . . . . . . . . . . . . . -149.98 158.39 27.64 Favored Glycine 0 CA--C 1.524 0.61 0 N-CA-C 110.938 -0.865 . . . . 0.0 110.938 178.967 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 116' ' ' LYS . . . . . . . . . . . . . 77.5 tttt -136.65 133.61 36.42 Favored 'General case' 0 C--N 1.329 -0.311 0 N-CA-C 110.097 -0.335 . . . . 0.0 110.097 178.636 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 117' ' ' PHE . . . . . . . . . . . . . 9.7 m-85 -138.08 118.98 14.23 Favored 'General case' 0 C--N 1.33 -0.25 0 C-N-CA 120.754 -0.379 . . . . 0.0 110.103 -174.208 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 118' ' ' GLU . . . . . . . . . . . . . 70.6 mm-40 -55.18 -43.65 74.53 Favored 'General case' 0 C--N 1.33 -0.279 0 C-N-CA 120.847 -0.341 . . . . 0.0 111.027 -177.935 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 119' ' ' ASN . . . . . . . . . . . . . 65.7 m-80 -93.71 28.41 2.36 Favored 'General case' 0 C--N 1.329 -0.288 0 N-CA-C 112.414 0.524 . . . . 0.0 112.414 -174.248 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 120' ' ' LEU . . . . . . . . . . . . . 19.2 tp -58.65 120.25 8.57 Favored 'General case' 0 C--N 1.333 -0.128 0 N-CA-C 110.028 -0.36 . . . . 0.0 110.028 177.263 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 121' ' ' ASN . . . . . . . . . . . . . 10.4 t-20 -112.46 -44.13 3.41 Favored 'General case' 0 C--O 1.232 0.148 0 CA-C-N 116.655 -0.248 . . . . 0.0 111.058 -176.274 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 122' ' ' LYS . . . . . . . . . . . . . 82.8 mttt -144.52 147.46 33.26 Favored 'General case' 0 C--N 1.332 -0.162 0 CA-C-O 121.177 0.513 . . . . 0.0 111.793 -177.928 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 123' ' ' VAL . . . . . . . . . . . . . 45.8 t -123.24 128.64 74.98 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.193 0 CA-C-N 115.759 -0.655 . . . . 0.0 109.459 175.139 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 124' ' ' LEU . . . . . . . . . . . . . 52.5 mt -123.6 141.09 52.35 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-O 120.798 0.332 . . . . 0.0 110.854 -177.063 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 125' ' ' VAL . . . . . . . . . . . . . 34.8 m -135.11 140.93 44.2 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.259 0 CA-C-N 116.287 -0.415 . . . . 0.0 110.992 179.446 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 126' ' ' ARG . . . . . . . . . . . . . 77.6 mtp85 -144.91 111.01 5.5 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 115.975 -0.557 . . . . 0.0 110.396 176.47 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 127' ' ' ASN . . . . . . . . . . . . . 55.8 t30 52.3 -108.54 0.4 Allowed 'General case' 0 CA--C 1.545 0.765 0 CA-C-O 118.83 -0.605 . . . . 0.0 111.344 179.691 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 128' ' ' ASP . . . . . . . . . . . . . 22.9 p-10 -108.09 5.8 26.34 Favored 'General case' 0 N--CA 1.468 0.464 0 CA-C-N 119.876 1.216 . . . . 0.0 113.485 -177.79 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 129' ' ' LEU . . . . . . . . . . . . . 12.1 tp -104.99 138.33 41.37 Favored 'General case' 0 C--N 1.332 -0.175 0 N-CA-C 109.883 -0.414 . . . . 0.0 109.883 178.692 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 130' ' ' VAL . . . . . . . . . . . . . 41.5 t -121.76 137.99 53.53 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.23 0 N-CA-C 110.081 -0.34 . . . . 0.0 110.081 -178.584 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 131' ' ' VAL . . . . . . . . . . . . . 40.0 t -134.71 136.23 52.58 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.248 0 CA-C-O 121.036 0.446 . . . . 0.0 110.45 -179.476 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 132' ' ' ILE . . . . . . . . . . . . . 75.0 mt -118.21 130.69 72.69 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.273 0 CA-C-N 115.738 -0.665 . . . . 0.0 109.49 179.436 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 133' ' ' ILE . . . . . . . . . . . . . 43.0 mm -117.75 123.33 71.55 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.261 0 CA-C-O 120.985 0.422 . . . . 0.0 111.063 -175.907 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 134' ' ' ASP . . . . . . . . . . . . . 7.7 p-10 -135.01 148.18 49.88 Favored 'General case' 0 C--N 1.331 -0.223 0 CA-C-N 115.849 -0.614 . . . . 0.0 109.517 173.92 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 135' ' ' GLU . . . . . . . . . . . . . 43.6 tp10 -49.89 -24.71 2.64 Favored 'General case' 0 C--N 1.326 -0.416 0 N-CA-C 112.797 0.665 . . . . 0.0 112.797 -172.01 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 136' ' ' GLN . . . . . . . . . . . . . 59.7 tp60 -101.11 -27.49 13.22 Favored 'General case' 0 CA--C 1.53 0.211 0 N-CA-C 112.668 0.618 . . . . 0.0 112.668 -174.863 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 137' ' ' LYS . . . . . . . . . . . . . 81.5 mttt -142.36 152.99 43.43 Favored 'General case' 0 C--N 1.332 -0.188 0 CA-C-O 121.17 0.51 . . . . 0.0 111.685 -171.661 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 138' ' ' LEU . . . . . . . . . . . . . 4.7 tt -120.22 122.27 40.56 Favored 'General case' 0 C--N 1.328 -0.346 0 N-CA-C 109.011 -0.737 . . . . 0.0 109.011 171.675 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 139' ' ' THR . . . . . . . . . . . . . 32.8 m -112.62 128.6 56.42 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 116.376 -0.374 . . . . 0.0 110.787 -176.835 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 140' ' ' LEU . . . . . . . . . . . . . 15.0 tp -115.85 121.63 42.96 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 115.522 -0.763 . . . . 0.0 109.264 -179.292 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 141' ' ' ILE . . . . . . . . . . . . . 19.3 mt -119.29 120.15 62.87 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.266 0 CA-C-O 120.888 0.375 . . . . 0.0 110.354 -174.613 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 142' ' ' ARG . . . . . . . . . . . . . 73.1 mtm180 -106.48 127.51 53.36 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-N 115.498 -0.774 . . . . 0.0 110.166 179.629 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 143' ' ' THR . . . . . . . . . . . . . 77.3 p . . . . . 0 C--O 1.221 -0.398 0 CA-C-O 117.922 -1.037 . . . . 0.0 110.577 -179.419 . . . . . . . . 0 0 . 1 . 020 nuclear orig core ' B' B ' 2' ' ' SER . . . . . . . . . . . . . 36.4 p . . . . . 0 C--O 1.231 0.125 0 CA-C-O 120.896 0.379 . . . . 0.0 110.687 . . . . . . . . . 0 0 . 1 . 020 nuclear orig core ' B' B ' 3' ' ' GLU . . . . . . . . . . . . . 95.2 mt-10 -140.52 145.96 37.52 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-O 121.026 0.441 . . . . 0.0 111.484 -177.106 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' B' B ' 4' ' ' LEU . . . . . . . . . . . . . 17.2 tp -125.47 131.03 52.93 Favored 'General case' 0 C--N 1.332 -0.191 0 CA-C-N 115.82 -0.627 . . . . 0.0 109.859 175.264 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' B' B ' 5' ' ' LYS . . . . . . . . . . . . . 98.6 mttt -108.55 120.86 43.67 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.42 -0.354 . . . . 0.0 110.837 -179.256 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' B' B ' 6' ' ' LEU . . . . . . . . . . . . . 55.2 mt -114.64 148.71 37.76 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 115.35 -0.841 . . . . 0.0 110.225 -179.728 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' B' B ' 7' ' ' LYS . . . . . . . . . . . . . 58.9 tttp -138.47 140.86 29.38 Favored Pre-proline 0 CA--C 1.535 0.379 0 CA-C-O 119.132 -0.461 . . . . 0.0 110.015 175.139 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' B' B ' 8' ' ' PRO . . . . . . . . . . . . . 90.1 Cg_endo -91.98 142.27 2.58 Favored 'Trans proline' 0 N--CA 1.489 1.247 0 C-N-CA 121.76 1.64 . . . . 0.0 111.922 178.229 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' B' B ' 9' ' ' LEU . . . . . . . . . . . . . 68.8 mt -74.22 -47.35 6.09 Favored Pre-proline 0 CA--C 1.533 0.316 0 CA-C-O 118.64 -0.695 . . . . 0.0 112.105 179.244 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' B' B ' 10' ' ' PRO . . . . . . . . . . . . . 84.0 Cg_endo -80.77 150.39 18.61 Favored 'Trans proline' 0 N--CA 1.495 1.6 0 C-N-CA 121.242 1.295 . . . . 0.0 111.816 175.49 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' B' B ' 11' ' ' LYS . . . . . . . . . . . . . 62.3 mtpt -86.67 97.46 10.58 Favored 'General case' 0 C--N 1.331 -0.229 0 CA-C-O 120.82 0.343 . . . . 0.0 110.362 178.74 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' B' B ' 12' ' ' VAL . . . . . . . . . . . . . 12.6 p -142.67 148.91 19.36 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.259 0 CA-C-N 116.102 -0.499 . . . . 0.0 110.568 -179.186 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' B' B ' 13' ' ' GLU . . . . . . . . . . . . . 82.3 tt0 -87.29 131.5 34.22 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 116.307 -0.406 . . . . 0.0 110.09 178.144 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' B' B ' 14' ' ' LEU . . . . . . . . . . . . . 28.0 mt -96.23 150.9 37.76 Favored Pre-proline 0 CA--C 1.532 0.263 0 CA-C-O 119.376 -0.345 . . . . 0.0 110.62 -178.225 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' B' B ' 15' ' ' PRO . . . . . . . . . . . . . 28.4 Cg_exo -60.75 159.43 28.71 Favored 'Trans proline' 0 N--CA 1.497 1.702 0 C-N-CA 121.307 1.338 . . . . 0.0 111.832 177.228 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' B' B ' 16' ' ' PRO . . . . . . . . . . . . . 38.5 Cg_exo -57.94 -45.0 35.2 Favored 'Trans proline' 0 N--CA 1.498 1.776 0 C-N-CA 121.452 1.435 . . . . 0.0 113.061 -176.73 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' B' B ' 17' ' ' ASP . . . . . . . . . . . . . 22.7 p-10 -87.64 12.47 12.54 Favored 'General case' 0 CA--C 1.536 0.413 0 N-CA-C 113.138 0.792 . . . . 0.0 113.138 -177.303 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' B' B ' 18' ' ' PHE . . . . . . . . . . . . . 48.2 t80 -58.26 -42.69 86.99 Favored 'General case' 0 N--CA 1.457 -0.092 0 O-C-N 122.054 -0.404 . . . . 0.0 110.178 -178.297 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' B' B ' 19' ' ' VAL . . . . . . . . . . . . . 46.3 t -56.94 -43.83 81.33 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 CA-C-N 116.308 -0.405 . . . . 0.0 110.533 -178.384 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' B' B ' 20' ' ' ASP . . . . . . . . . . . . . 36.8 m-20 -59.94 -41.95 92.94 Favored 'General case' 0 C--N 1.33 -0.276 0 C-N-CA 120.924 -0.31 . . . . 0.0 110.908 -177.964 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' B' B ' 21' ' ' VAL . . . . . . . . . . . . . 48.9 t -64.29 -46.65 92.63 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.27 0 C-N-CA 120.661 -0.416 . . . . 0.0 110.376 -177.78 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' B' B ' 22' ' ' ILE . . . . . . . . . . . . . 51.3 mm -56.32 -45.28 81.37 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.275 0 C-N-CA 120.955 -0.298 . . . . 0.0 110.577 179.036 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' B' B ' 23' ' ' ARG . . . . . . . . . . . . . 51.7 ttp180 -54.65 -48.58 72.14 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-O 120.584 0.23 . . . . 0.0 111.224 -178.472 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' B' B ' 24' ' ' ILE . . . . . . . . . . . . . 72.0 mt -59.96 -44.38 94.43 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.268 0 CA-C-N 116.599 -0.273 . . . . 0.0 111.293 -177.675 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' B' B ' 25' ' ' LYS . . . . . . . . . . . . . 35.9 mttm -63.99 -42.16 97.27 Favored 'General case' 0 C--N 1.33 -0.277 0 N-CA-C 112.341 0.496 . . . . 0.0 112.341 -178.82 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' B' B ' 26' ' ' LEU . . . . . . . . . . . . . 92.0 mt -78.42 -42.2 30.82 Favored 'General case' 0 C--N 1.328 -0.35 0 N-CA-C 113.162 0.801 . . . . 0.0 113.162 -170.911 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' B' B ' 27' ' ' GLN . . . . . . . . . . . . . 4.1 pt20 -47.51 140.93 5.45 Favored 'General case' 0 N--CA 1.468 0.459 0 N-CA-C 112.708 0.633 . . . . 0.0 112.708 -174.726 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' B' B ' 28' ' ' GLY . . . . . . . . . . . . . . . 100.7 -26.93 22.8 Favored Glycine 0 CA--C 1.533 1.168 0 CA-C-N 115.564 -0.744 . . . . 0.0 112.205 -177.521 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' B' B ' 29' ' ' LYS . . . . . . . . . . . . . 99.5 mttt -98.71 155.08 17.51 Favored 'General case' 0 C--N 1.332 -0.168 0 CA-C-N 117.379 0.59 . . . . 0.0 111.269 179.32 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' B' B ' 30' ' ' THR . . . . . . . . . . . . . 34.6 m -103.57 135.65 44.77 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 115.75 -0.659 . . . . 0.0 109.763 174.925 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' B' B ' 31' ' ' VAL . . . . . . . . . . . . . 35.4 m -130.86 161.21 41.25 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.245 0 CA-C-N 116.379 -0.373 . . . . 0.0 110.775 -178.805 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' B' B ' 32' ' ' ARG . . . . . . . . . . . . . 70.5 mtm180 -133.75 151.98 51.75 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 115.848 -0.615 . . . . 0.0 110.981 179.748 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' B' B ' 33' ' ' THR . . . . . . . . . . . . . 20.7 m -53.5 139.53 30.87 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.199 -0.455 . . . . 0.0 111.29 -178.758 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' B' B ' 34' ' ' GLY . . . . . . . . . . . . . . . 100.5 -17.01 57.34 Favored Glycine 0 CA--C 1.531 1.086 0 CA-C-O 119.584 -0.565 . . . . 0.0 113.224 178.9 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' B' B ' 35' ' ' ASP . . . . . . . . . . . . . 71.9 m-20 -64.78 148.29 51.5 Favored 'General case' 0 C--O 1.232 0.147 0 CA-C-N 118.183 0.992 . . . . 0.0 111.251 179.639 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' B' B ' 36' ' ' VAL . . . . . . . . . . . . . 46.3 t -117.92 128.41 75.05 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.22 0 CA-C-N 115.527 -0.76 . . . . 0.0 109.739 178.52 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' B' B ' 37' ' ' ILE . . . . . . . . . . . . . 69.8 mt -121.91 138.99 50.32 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.26 0 CA-C-N 116.259 -0.428 . . . . 0.0 109.977 -179.306 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' B' B ' 38' ' ' GLY . . . . . . . . . . . . . . . -114.22 128.97 8.48 Favored Glycine 0 CA--C 1.526 0.742 0 N-CA-C 111.176 -0.769 . . . . 0.0 111.176 -179.203 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' B' B ' 39' ' ' ILE . . . . . . . . . . . . . 75.6 mt -124.06 134.54 66.29 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.253 0 CA-C-O 120.765 0.317 . . . . 0.0 110.164 179.077 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' B' B ' 40' ' ' SER . . . . . . . . . . . . . 53.3 p -92.88 115.95 28.59 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 116.39 -0.368 . . . . 0.0 111.052 176.345 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' B' B ' 41' ' ' ILE . . . . . . . . . . . . . 44.7 mm -121.42 120.78 62.91 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.257 0 CA-C-O 120.775 0.321 . . . . 0.0 110.305 178.461 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' B' B ' 42' ' ' LEU . . . . . . . . . . . . . 62.6 mt 51.75 35.39 15.13 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-N 116.252 -0.431 . . . . 0.0 111.799 176.688 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' B' B ' 43' ' ' GLY . . . . . . . . . . . . . . . 73.88 31.79 59.7 Favored Glycine 0 CA--C 1.528 0.872 0 C-N-CA 121.073 -0.584 . . . . 0.0 112.141 177.706 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' B' B ' 44' ' ' LYS . . . . . . . . . . . . . 23.6 tptm -136.85 128.0 27.9 Favored 'General case' 0 C--N 1.329 -0.293 0 N-CA-C 109.397 -0.594 . . . . 0.0 109.397 177.736 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' B' B ' 45' ' ' GLU . . . . . . . . . . . . . 81.8 tt0 -82.73 117.42 22.64 Favored 'General case' 0 C--N 1.327 -0.373 0 C-N-CA 120.917 -0.313 . . . . 0.0 110.702 -178.356 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' B' B ' 46' ' ' VAL . . . . . . . . . . . . . 7.3 p -115.84 128.58 73.06 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.192 0 N-CA-C 109.412 -0.588 . . . . 0.0 109.412 176.284 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' B' B ' 47' ' ' LYS . . . . . . . . . . . . . 68.6 mttm -99.55 126.93 45.6 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 115.788 -0.642 . . . . 0.0 110.991 179.451 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' B' B ' 48' ' ' PHE . . . . . . . . . . . . . 91.1 m-85 -111.3 131.93 54.77 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-N 116.078 -0.51 . . . . 0.0 109.816 176.996 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' B' B ' 49' ' ' LYS . . . . . . . . . . . . . 83.5 tttt -106.56 134.97 48.88 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-N 116.365 -0.379 . . . . 0.0 110.269 178.6 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' B' B ' 50' ' ' VAL . . . . . . . . . . . . . 45.3 t -78.92 105.59 8.45 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.329 0 N-CA-C 108.993 -0.743 . . . . 0.0 108.993 175.328 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' B' B ' 51' ' ' VAL . . . . . . . . . . . . . 49.0 t -70.1 -53.42 23.58 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.387 0 N-CA-C 109.479 -0.563 . . . . 0.0 109.479 -174.208 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' B' B ' 52' ' ' GLN . . . . . . . . . . . . . 91.7 mt-30 -153.88 152.51 30.72 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 115.947 -0.57 . . . . 0.0 111.695 -177.617 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' B' B ' 53' ' ' ALA . . . . . . . . . . . . . . . -128.2 132.93 48.81 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 115.313 -0.858 . . . . 0.0 109.62 174.87 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' B' B ' 54' ' ' TYR . . . . . . . . . . . . . 58.2 t80 -129.05 107.61 18.01 Favored Pre-proline 0 CA--C 1.534 0.33 0 CA-C-O 118.219 -0.896 . . . . 0.0 110.354 179.767 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' B' B ' 55' ' ' PRO . . . . . . . . . . . . . 73.8 Cg_endo -77.22 169.75 73.32 Favored 'Cis proline' 0 N--CA 1.501 1.926 0 CA-C-N 121.839 1.692 . . . . 0.0 112.863 -4.419 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' B' B ' 56' ' ' SER . . . . . . . . . . . . . 50.6 m -117.59 132.0 23.81 Favored Pre-proline 0 CA--C 1.539 0.537 0 CA-C-O 118.352 -0.832 . . . . 0.0 109.548 174.361 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' B' B ' 57' ' ' PRO . . . . . . . . . . . . . 32.4 Cg_endo -65.21 164.99 57.4 Favored 'Cis proline' 0 N--CA 1.498 1.769 0 CA-C-N 122.027 1.76 . . . . 0.0 111.554 -2.615 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' B' B ' 58' ' ' LEU . . . . . . . . . . . . . 25.0 tp -129.4 137.51 50.96 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-O 120.997 0.427 . . . . 0.0 110.518 -178.284 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' B' B ' 59' ' ' ARG . . . . . . . . . . . . . 75.0 ttt180 -103.4 127.71 50.7 Favored 'General case' 0 C--N 1.326 -0.443 0 CA-C-N 115.731 -0.668 . . . . 0.0 109.225 175.169 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' B' B ' 60' ' ' VAL . . . . . . . . . . . . . 45.6 t -82.07 116.77 26.9 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.232 0 C-N-CA 120.553 -0.459 . . . . 0.0 110.39 -175.928 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' B' B ' 61' ' ' GLU . . . . . . . . . . . . . 70.6 mm-40 -131.14 162.14 30.57 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 115.905 -0.589 . . . . 0.0 109.877 176.618 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' B' B ' 62' ' ' ASP . . . . . . . . . . . . . 43.7 m-20 -53.15 -32.36 47.22 Favored 'General case' 0 C--N 1.328 -0.331 0 N-CA-C 111.807 0.299 . . . . 0.0 111.807 -179.694 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' B' B ' 63' ' ' ARG . . . . . . . . . . . . . 23.7 mmt180 -71.14 -21.94 62.13 Favored 'General case' 0 CA--C 1.532 0.282 0 N-CA-C 112.858 0.688 . . . . 0.0 112.858 -175.99 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' B' B ' 64' ' ' THR . . . . . . . . . . . . . 26.1 m -77.4 140.95 40.01 Favored 'General case' 0 C--N 1.331 -0.226 0 CA-C-O 121.0 0.429 . . . . 0.0 110.877 -175.315 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' B' B ' 65' ' ' LYS . . . . . . . . . . . . . 3.0 mptp? -89.75 134.67 34.05 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 115.976 -0.556 . . . . 0.0 110.233 179.753 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' B' B ' 66' ' ' ILE . . . . . . . . . . . . . 58.9 mt -114.28 129.0 71.04 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.229 0 N-CA-C 109.649 -0.5 . . . . 0.0 109.649 178.083 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' B' B ' 67' ' ' THR . . . . . . . . . . . . . 32.6 m -124.79 139.65 53.65 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-O 121.001 0.429 . . . . 0.0 111.014 -177.128 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' B' B ' 68' ' ' LEU . . . . . . . . . . . . . 6.8 mp . . . . . 0 C--N 1.329 -0.285 0 CA-C-N 115.886 -0.597 . . . . 0.0 110.171 176.196 . . . . . . . . 0 0 . 1 . 020 nuclear orig core ' B' B ' 73' ' ' VAL . . . . . . . . . . . . . 30.4 m . . . . . 0 C--O 1.231 0.112 0 N-CA-C 110.06 -0.348 . . . . 0.0 110.06 . . . . . . . . . 0 0 . 1 . 020 nuclear orig core ' B' B ' 74' ' ' ASP . . . . . . . . . . . . . 25.2 t0 -103.44 116.42 32.36 Favored 'General case' 0 C--N 1.33 -0.273 0 N-CA-C 109.819 -0.438 . . . . 0.0 109.819 -178.691 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' B' B ' 75' ' ' VAL . . . . . . . . . . . . . 41.7 t -111.34 122.23 65.39 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.243 0 CA-C-O 121.042 0.448 . . . . 0.0 110.355 -178.354 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' B' B ' 76' ' ' LEU . . . . . . . . . . . . . 35.8 mt -119.09 138.69 52.7 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 115.665 -0.698 . . . . 0.0 109.39 177.341 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' B' B ' 77' ' ' GLU . . . . . . . . . . . . . 46.3 mt-10 -134.32 136.37 43.43 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-O 121.14 0.495 . . . . 0.0 111.265 -176.914 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' B' B ' 78' ' ' ALA . . . . . . . . . . . . . . . -125.87 137.55 53.75 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 115.602 -0.726 . . . . 0.0 109.768 176.258 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' B' B ' 79' ' ' LYS . . . . . . . . . . . . . 93.5 mttt -81.73 119.1 23.43 Favored 'General case' 0 C--N 1.329 -0.311 0 C-N-CA 120.811 -0.356 . . . . 0.0 110.438 -179.16 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' B' B ' 80' ' ' ILE . . . . . . . . . . . . . 29.5 mm -134.65 118.46 26.04 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.292 0 CA-C-N 115.721 -0.672 . . . . 0.0 109.234 -176.652 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' B' B ' 81' ' ' LYS . . . . . . . . . . . . . 17.8 ttpt -108.67 123.92 49.73 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-O 120.818 0.342 . . . . 0.0 111.13 -177.073 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' B' B ' 82' ' ' GLY . . . . . . . . . . . . . . . 89.08 42.19 5.68 Favored Glycine 0 CA--C 1.526 0.779 0 C-N-CA 120.838 -0.696 . . . . 0.0 111.816 173.88 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' B' B ' 83' ' ' ILE . . . . . . . . . . . . . 69.9 mt -67.55 138.41 22.78 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.369 0 N-CA-C 109.883 -0.414 . . . . 0.0 109.883 177.969 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' B' B ' 84' ' ' LYS . . . . . . . . . . . . . 39.8 ttpt -100.39 -52.09 3.46 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-O 121.103 0.477 . . . . 0.0 110.046 179.643 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' B' B ' 85' ' ' ASP . . . . . . . . . . . . . 6.5 t70 -153.04 152.35 31.26 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 115.69 -0.687 . . . . 0.0 110.393 -179.955 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' B' B ' 86' ' ' VAL . . . . . . . . . . . . . 41.2 t -129.07 131.73 67.75 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.207 0 CA-C-O 120.871 0.367 . . . . 0.0 110.426 -179.61 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' B' B ' 87' ' ' ILE . . . . . . . . . . . . . 44.3 mm -119.28 126.37 75.28 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.238 0 N-CA-C 109.301 -0.629 . . . . 0.0 109.301 176.251 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' B' B ' 88' ' ' LEU . . . . . . . . . . . . . 81.3 mt -120.95 137.22 54.72 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-O 121.236 0.541 . . . . 0.0 111.706 -176.23 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' B' B ' 89' ' ' ASP . . . . . . . . . . . . . 5.2 t0 -133.09 154.83 50.2 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 115.452 -0.795 . . . . 0.0 109.054 174.823 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' B' B ' 90' ' ' GLU . . . . . . . . . . . . . 84.2 tt0 -48.84 -30.92 6.33 Favored 'General case' 0 C--N 1.33 -0.273 0 N-CA-C 112.804 0.668 . . . . 0.0 112.804 -172.891 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' B' B ' 91' ' ' ASN . . . . . . . . . . . . . 78.2 m-20 -131.54 28.78 4.6 Favored 'General case' 0 N--CA 1.466 0.343 0 N-CA-C 112.521 0.563 . . . . 0.0 112.521 -174.46 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' B' B ' 92' ' ' LEU . . . . . . . . . . . . . 16.9 tp -166.11 143.07 5.22 Favored 'General case' 0 C--N 1.331 -0.217 0 C-N-CA 120.765 -0.374 . . . . 0.0 110.923 179.794 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' B' B ' 93' ' ' ILE . . . . . . . . . . . . . 72.3 mt -125.13 123.83 66.17 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.242 0 N-CA-C 109.633 -0.506 . . . . 0.0 109.633 178.548 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' B' B ' 94' ' ' VAL . . . . . . . . . . . . . 44.1 t -125.41 127.54 71.92 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.238 0 CA-C-O 121.016 0.436 . . . . 0.0 109.996 178.126 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' B' B ' 95' ' ' VAL . . . . . . . . . . . . . 46.1 t -120.7 134.87 62.76 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.312 0 CA-C-N 115.944 -0.571 . . . . 0.0 109.765 179.872 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' B' B ' 96' ' ' ILE . . . . . . . . . . . . . 67.9 mt -115.46 128.46 72.67 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.273 0 N-CA-C 109.416 -0.587 . . . . 0.0 109.416 178.898 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' B' B ' 97' ' ' THR . . . . . . . . . . . . . 74.5 p -102.7 159.11 15.75 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-O 121.283 0.563 . . . . 0.0 111.308 -177.103 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' B' B ' 98' ' ' GLU . . . . . . . . . . . . . 45.0 mt-10 -53.95 -25.01 18.53 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.049 -0.523 . . . . 0.0 112.276 179.736 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' B' B ' 99' ' ' GLU . . . . . . . . . . . . . 33.7 tt0 -80.69 17.37 1.15 Allowed 'General case' 0 CA--C 1.538 0.494 0 N-CA-C 112.519 0.563 . . . . 0.0 112.519 -176.485 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' B' B ' 100' ' ' ASN . . . . . . . . . . . . . 2.4 m-20 60.72 37.97 18.61 Favored 'General case' 0 N--CA 1.463 0.181 0 O-C-N 121.801 -0.562 . . . . 0.0 110.883 179.392 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' B' B ' 101' ' ' GLU . . . . . . . . . . . . . 84.7 tt0 -116.19 144.13 44.59 Favored 'General case' 0 C--N 1.332 -0.169 0 CA-C-N 116.215 -0.448 . . . . 0.0 109.895 178.133 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' B' B ' 102' ' ' VAL . . . . . . . . . . . . . 44.8 t -116.51 127.07 74.22 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.234 0 CA-C-O 120.963 0.411 . . . . 0.0 109.907 -178.724 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' B' B ' 103' ' ' LEU . . . . . . . . . . . . . 51.1 mt -113.33 129.95 56.4 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 115.431 -0.804 . . . . 0.0 110.063 178.2 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' B' B ' 104' ' ' ILE . . . . . . . . . . . . . 67.7 mt -118.82 120.08 62.99 Favored 'Isoleucine or valine' 0 C--O 1.234 0.249 0 N-CA-C 110.213 -0.291 . . . . 0.0 110.213 -179.418 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' B' B ' 105' ' ' PHE . . . . . . . . . . . . . 38.6 m-85 -124.04 163.69 20.91 Favored 'General case' 0 C--N 1.332 -0.168 0 CA-C-N 115.537 -0.756 . . . . 0.0 109.55 178.404 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' B' B ' 106' ' ' ASN . . . . . . . . . . . . . 41.5 p-10 -95.92 -171.68 2.4 Favored 'General case' 0 C--N 1.33 -0.262 0 N-CA-C 109.955 -0.387 . . . . 0.0 109.955 173.949 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' B' B ' 107' ' ' GLN . . . . . . . . . . . . . 39.3 tt0 -59.86 -30.05 68.71 Favored 'General case' 0 C--N 1.328 -0.341 0 N-CA-C 111.806 0.299 . . . . 0.0 111.806 179.782 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' B' B ' 108' ' ' ASN . . . . . . . . . . . . . 3.7 t-20 -83.66 7.54 17.15 Favored 'General case' 0 CA--C 1.535 0.398 0 N-CA-C 113.275 0.843 . . . . 0.0 113.275 -177.366 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' B' B ' 109' ' ' LEU . . . . . . . . . . . . . 12.2 tp 63.01 39.88 9.75 Favored 'General case' 0 C--O 1.232 0.179 0 CA-C-O 121.116 0.484 . . . . 0.0 111.371 176.971 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' B' B ' 110' ' ' GLU . . . . . . . . . . . . . 95.9 mt-10 -108.88 163.44 13.28 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.28 -0.418 . . . . 0.0 110.381 177.064 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' B' B ' 111' ' ' GLU . . . . . . . . . . . . . 82.6 tt0 -84.65 123.63 30.57 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.193 -0.458 . . . . 0.0 111.037 -178.552 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' B' B ' 112' ' ' LEU . . . . . . . . . . . . . 22.7 mt -113.08 -46.02 3.13 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.094 -0.503 . . . . 0.0 110.257 174.374 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' B' B ' 113' ' ' TYR . . . . . . . . . . . . . 53.7 t80 -146.72 140.22 25.74 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.333 -0.394 . . . . 0.0 111.199 -179.998 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' B' B ' 114' ' ' ARG . . . . . . . . . . . . . 33.6 mtp180 -141.7 123.25 15.03 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.381 -0.372 . . . . 0.0 110.276 175.483 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' B' B ' 115' ' ' GLY . . . . . . . . . . . . . . . -150.08 161.08 28.79 Favored Glycine 0 CA--C 1.523 0.576 0 C-N-CA 120.7 -0.762 . . . . 0.0 111.364 179.922 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' B' B ' 116' ' ' LYS . . . . . . . . . . . . . 38.6 ttpt -126.9 138.08 53.25 Favored 'General case' 0 C--N 1.33 -0.25 0 N-CA-C 109.929 -0.397 . . . . 0.0 109.929 177.661 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' B' B ' 117' ' ' PHE . . . . . . . . . . . . . 35.7 m-85 -136.35 113.81 10.86 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-O 120.752 0.311 . . . . 0.0 110.347 -176.556 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' B' B ' 118' ' ' GLU . . . . . . . . . . . . . 44.2 mt-10 -54.83 -45.63 74.49 Favored 'General case' 0 C--N 1.329 -0.29 0 C-N-CA 120.942 -0.303 . . . . 0.0 111.27 -176.986 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' B' B ' 119' ' ' ASN . . . . . . . . . . . . . 34.7 m120 -93.78 28.78 2.25 Favored 'General case' 0 C--N 1.329 -0.287 0 O-C-N 123.554 0.534 . . . . 0.0 112.381 -173.688 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' B' B ' 120' ' ' LEU . . . . . . . . . . . . . 17.9 tp -57.37 119.9 7.26 Favored 'General case' 0 C--N 1.333 -0.141 0 C-N-CA 120.957 -0.297 . . . . 0.0 110.317 177.82 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' B' B ' 121' ' ' ASN . . . . . . . . . . . . . 45.8 t-20 -113.32 -44.06 3.28 Favored 'General case' 0 C--N 1.332 -0.19 0 CA-C-N 116.651 -0.25 . . . . 0.0 111.191 -177.164 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' B' B ' 122' ' ' LYS . . . . . . . . . . . . . 98.7 mttt -143.89 146.37 32.95 Favored 'General case' 0 C--N 1.332 -0.182 0 CA-C-O 121.087 0.47 . . . . 0.0 111.698 -178.351 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' B' B ' 123' ' ' VAL . . . . . . . . . . . . . 47.4 t -127.85 126.08 66.1 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.234 0 CA-C-N 115.756 -0.657 . . . . 0.0 109.375 175.075 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' B' B ' 124' ' ' LEU . . . . . . . . . . . . . 31.2 mt -125.6 134.7 51.83 Favored 'General case' 0 C--N 1.331 -0.212 0 CA-C-O 120.799 0.333 . . . . 0.0 110.675 -178.604 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' B' B ' 125' ' ' VAL . . . . . . . . . . . . . 35.1 m -132.15 144.22 37.74 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.244 0 CA-C-N 116.075 -0.511 . . . . 0.0 110.801 -179.213 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' B' B ' 126' ' ' ARG . . . . . . . . . . . . . 34.3 ptt-85 -152.51 120.49 6.18 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-O 121.328 0.585 . . . . 0.0 111.147 176.0 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' B' B ' 127' ' ' ASN . . . . . . . . . . . . . 82.3 m-20 52.82 -106.24 0.28 Allowed 'General case' 0 CA--C 1.542 0.637 0 CA-C-N 115.457 -0.792 . . . . 0.0 111.284 -179.439 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' B' B ' 128' ' ' ASP . . . . . . . . . . . . . 16.3 p-10 -114.1 0.87 14.42 Favored 'General case' 0 N--CA 1.468 0.445 0 CA-C-N 119.585 1.084 . . . . 0.0 113.372 -176.239 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' B' B ' 129' ' ' LEU . . . . . . . . . . . . . 18.0 tp -109.71 139.8 44.32 Favored 'General case' 0 C--N 1.332 -0.159 0 N-CA-C 109.699 -0.482 . . . . 0.0 109.699 -179.513 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' B' B ' 130' ' ' VAL . . . . . . . . . . . . . 13.2 p -134.39 143.1 38.94 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.2 0 CA-C-O 121.229 0.537 . . . . 0.0 110.9 -177.958 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' B' B ' 131' ' ' VAL . . . . . . . . . . . . . 42.9 t -135.97 139.79 45.27 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.246 0 CA-C-N 115.753 -0.658 . . . . 0.0 110.319 179.024 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' B' B ' 132' ' ' ILE . . . . . . . . . . . . . 72.9 mt -117.29 133.85 62.74 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.264 0 CA-C-N 115.599 -0.728 . . . . 0.0 109.481 179.7 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' B' B ' 133' ' ' ILE . . . . . . . . . . . . . 37.3 mm -115.47 124.21 71.74 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.224 0 CA-C-O 120.681 0.277 . . . . 0.0 110.965 -175.877 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' B' B ' 134' ' ' ASP . . . . . . . . . . . . . 9.6 p-10 -136.13 150.68 49.18 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-N 115.996 -0.547 . . . . 0.0 109.837 174.975 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' B' B ' 135' ' ' GLU . . . . . . . . . . . . . 46.7 tp10 -49.88 -28.95 7.26 Favored 'General case' 0 C--N 1.327 -0.393 0 N-CA-C 112.675 0.62 . . . . 0.0 112.675 -172.111 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' B' B ' 136' ' ' GLN . . . . . . . . . . . . . 58.7 tt0 -86.74 -31.55 20.89 Favored 'General case' 0 C--N 1.331 -0.233 0 N-CA-C 112.562 0.579 . . . . 0.0 112.562 -173.394 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' B' B ' 137' ' ' LYS . . . . . . . . . . . . . 56.9 pttt -166.09 174.66 9.12 Favored 'General case' 0 C--O 1.232 0.143 0 CA-C-O 121.545 0.688 . . . . 0.0 112.498 -172.649 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' B' B ' 138' ' ' LEU . . . . . . . . . . . . . 5.9 tt -120.54 129.84 53.98 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 114.932 -1.031 . . . . 0.0 109.811 179.048 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' B' B ' 139' ' ' THR . . . . . . . . . . . . . 28.2 m -108.51 125.85 52.27 Favored 'General case' 0 C--N 1.331 -0.22 0 CA-C-N 116.272 -0.422 . . . . 0.0 110.357 179.446 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' B' B ' 140' ' ' LEU . . . . . . . . . . . . . 8.0 tt -113.94 121.7 44.72 Favored 'General case' 0 C--N 1.329 -0.315 0 N-CA-C 109.156 -0.683 . . . . 0.0 109.156 -179.171 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' B' B ' 141' ' ' ILE . . . . . . . . . . . . . 19.0 mt -121.64 119.66 59.5 Favored 'Isoleucine or valine' 0 C--O 1.234 0.26 0 CA-C-O 120.949 0.404 . . . . 0.0 110.074 -176.193 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' B' B ' 142' ' ' ARG . . . . . . . . . . . . . 46.2 ttp180 -107.48 129.79 54.91 Favored 'General case' 0 C--N 1.332 -0.163 0 CA-C-N 115.198 -0.91 . . . . 0.0 110.772 -178.779 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' B' B ' 143' ' ' THR . . . . . . . . . . . . . 38.1 p . . . . . 0 C--O 1.22 -0.468 0 CA-C-O 118.044 -0.979 . . . . 0.0 110.516 178.969 . . . . . . . . 0 0 . 1 . 020 nuclear orig core ' C' C ' 2' ' ' SER . . . . . . . . . . . . . 16.6 p . . . . . 0 N--CA 1.461 0.089 0 CA-C-O 121.014 0.435 . . . . 0.0 110.52 . . . . . . . . . 0 0 . 1 . 020 nuclear orig core ' C' C ' 3' ' ' GLU . . . . . . . . . . . . . 95.5 mt-10 -141.48 141.29 33.65 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 115.978 -0.555 . . . . 0.0 111.089 -179.078 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' C' C ' 4' ' ' LEU . . . . . . . . . . . . . 15.3 tp -126.0 127.53 46.04 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 115.931 -0.577 . . . . 0.0 110.032 176.892 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' C' C ' 5' ' ' LYS . . . . . . . . . . . . . 86.8 mttt -106.5 120.57 42.26 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 116.438 -0.347 . . . . 0.0 110.776 178.162 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' C' C ' 6' ' ' LEU . . . . . . . . . . . . . 27.9 mt -115.05 148.82 38.4 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-N 115.295 -0.866 . . . . 0.0 110.381 179.772 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' C' C ' 7' ' ' LYS . . . . . . . . . . . . . 25.7 ttpp -134.62 133.18 21.13 Favored Pre-proline 0 CA--C 1.534 0.331 0 CA-C-O 118.791 -0.623 . . . . 0.0 110.04 176.875 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' C' C ' 8' ' ' PRO . . . . . . . . . . . . . 59.1 Cg_endo -89.7 135.81 2.53 Favored 'Trans proline' 0 N--CA 1.489 1.229 0 C-N-CA 121.69 1.593 . . . . 0.0 111.586 176.656 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' C' C ' 9' ' ' LEU . . . . . . . . . . . . . 34.2 mt -75.36 -47.47 4.33 Favored Pre-proline 0 CA--C 1.534 0.345 0 CA-C-O 118.581 -0.724 . . . . 0.0 112.085 -177.234 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' C' C ' 10' ' ' PRO . . . . . . . . . . . . . 71.8 Cg_endo -78.65 146.82 21.58 Favored 'Trans proline' 0 N--CA 1.495 1.609 0 C-N-CA 121.052 1.168 . . . . 0.0 111.684 175.143 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' C' C ' 11' ' ' LYS . . . . . . . . . . . . . 21.3 tptm -85.92 99.62 11.54 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-O 120.84 0.352 . . . . 0.0 110.349 -178.625 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' C' C ' 12' ' ' VAL . . . . . . . . . . . . . 12.6 p -143.65 150.12 17.5 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.264 0 CA-C-N 116.207 -0.451 . . . . 0.0 110.665 -179.172 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' C' C ' 13' ' ' GLU . . . . . . . . . . . . . 81.2 tt0 -84.55 127.67 34.18 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.281 -0.418 . . . . 0.0 110.13 178.582 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' C' C ' 14' ' ' LEU . . . . . . . . . . . . . 43.7 mt -96.63 150.03 36.51 Favored Pre-proline 0 CA--C 1.532 0.284 0 CA-C-O 119.368 -0.349 . . . . 0.0 110.627 -178.136 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' C' C ' 15' ' ' PRO . . . . . . . . . . . . . 28.0 Cg_exo -61.23 158.95 32.7 Favored 'Trans proline' 0 N--CA 1.497 1.701 0 C-N-CA 121.26 1.307 . . . . 0.0 111.97 177.754 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' C' C ' 16' ' ' PRO . . . . . . . . . . . . . 26.4 Cg_exo -60.79 -39.34 63.47 Favored 'Trans proline' 0 N--CA 1.496 1.671 0 C-N-CA 121.433 1.422 . . . . 0.0 112.732 -179.128 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' C' C ' 17' ' ' ASP . . . . . . . . . . . . . 19.3 p-10 -87.84 12.76 12.22 Favored 'General case' 0 CA--C 1.535 0.385 0 N-CA-C 113.171 0.804 . . . . 0.0 113.171 -177.006 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' C' C ' 18' ' ' PHE . . . . . . . . . . . . . 42.7 t80 -58.29 -45.39 88.05 Favored 'General case' 0 C--N 1.333 -0.117 0 O-C-N 122.135 -0.353 . . . . 0.0 110.089 -177.754 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' C' C ' 19' ' ' VAL . . . . . . . . . . . . . 47.8 t -55.87 -43.25 73.84 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.355 0 CA-C-N 116.523 -0.308 . . . . 0.0 110.779 -177.356 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' C' C ' 20' ' ' ASP . . . . . . . . . . . . . 7.5 t70 -60.09 -47.29 86.5 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-O 120.799 0.333 . . . . 0.0 111.009 -176.676 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' C' C ' 21' ' ' VAL . . . . . . . . . . . . . 46.4 t -64.4 -43.06 96.99 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.259 0 C-N-CA 120.663 -0.415 . . . . 0.0 110.408 -177.1 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' C' C ' 22' ' ' ILE . . . . . . . . . . . . . 43.9 mm -55.76 -48.31 78.2 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.346 0 N-CA-C 110.438 -0.208 . . . . 0.0 110.438 178.488 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' C' C ' 23' ' ' ARG . . . . . . . . . . . . . 53.8 ttp180 -54.97 -44.48 74.43 Favored 'General case' 0 C--N 1.332 -0.175 0 C-N-CA 120.911 -0.316 . . . . 0.0 111.221 -177.988 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' C' C ' 24' ' ' ILE . . . . . . . . . . . . . 75.0 mt -59.23 -46.9 91.89 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.253 0 CA-C-O 120.721 0.296 . . . . 0.0 110.938 -179.658 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' C' C ' 25' ' ' LYS . . . . . . . . . . . . . 44.2 mtmt -64.63 -38.62 91.63 Favored 'General case' 0 C--N 1.328 -0.331 0 N-CA-C 112.483 0.549 . . . . 0.0 112.483 -177.61 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' C' C ' 26' ' ' LEU . . . . . . . . . . . . . 81.1 mt -79.02 -44.74 21.62 Favored 'General case' 0 C--N 1.33 -0.259 0 N-CA-C 113.268 0.84 . . . . 0.0 113.268 -172.282 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' C' C ' 27' ' ' GLN . . . . . . . . . . . . . 11.6 pt20 -47.01 140.39 4.92 Favored 'General case' 0 N--CA 1.467 0.423 0 N-CA-C 112.812 0.671 . . . . 0.0 112.812 -173.548 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' C' C ' 28' ' ' GLY . . . . . . . . . . . . . . . 98.21 -27.09 20.91 Favored Glycine 0 CA--C 1.533 1.199 0 CA-C-N 115.513 -0.767 . . . . 0.0 112.103 -176.774 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' C' C ' 29' ' ' LYS . . . . . . . . . . . . . 29.2 mtpp -98.0 155.18 17.22 Favored 'General case' 0 C--O 1.232 0.154 0 CA-C-N 117.149 0.474 . . . . 0.0 111.072 179.246 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' C' C ' 30' ' ' THR . . . . . . . . . . . . . 28.7 m -100.37 139.59 35.82 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 115.991 -0.55 . . . . 0.0 110.361 177.307 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' C' C ' 31' ' ' VAL . . . . . . . . . . . . . 35.0 m -130.41 149.84 33.99 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.285 0 CA-C-N 116.319 -0.401 . . . . 0.0 110.759 -179.619 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' C' C ' 32' ' ' ARG . . . . . . . . . . . . . 72.2 mtp180 -132.68 154.09 50.48 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-O 121.198 0.523 . . . . 0.0 110.821 177.07 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' C' C ' 33' ' ' THR . . . . . . . . . . . . . 15.3 m -53.5 136.96 37.32 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-N 116.022 -0.536 . . . . 0.0 111.239 -179.026 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' C' C ' 34' ' ' GLY . . . . . . . . . . . . . . . 101.15 -16.99 56.63 Favored Glycine 0 CA--C 1.532 1.142 0 CA-C-O 119.641 -0.533 . . . . 0.0 113.346 178.24 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' C' C ' 35' ' ' ASP . . . . . . . . . . . . . 61.5 m-20 -64.53 149.61 48.35 Favored 'General case' 0 N--CA 1.461 0.116 0 CA-C-N 118.081 0.941 . . . . 0.0 111.1 179.599 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' C' C ' 36' ' ' VAL . . . . . . . . . . . . . 46.0 t -126.34 130.69 71.93 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.277 0 CA-C-N 115.82 -0.627 . . . . 0.0 109.812 178.682 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' C' C ' 37' ' ' ILE . . . . . . . . . . . . . 68.3 mt -122.2 139.39 49.3 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.259 0 CA-C-N 116.137 -0.483 . . . . 0.0 109.952 -179.458 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' C' C ' 38' ' ' GLY . . . . . . . . . . . . . . . -113.34 128.84 8.55 Favored Glycine 0 CA--C 1.527 0.782 0 N-CA-C 110.908 -0.877 . . . . 0.0 110.908 179.294 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' C' C ' 39' ' ' ILE . . . . . . . . . . . . . 72.7 mt -125.07 129.56 73.3 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.212 0 N-CA-C 109.828 -0.434 . . . . 0.0 109.828 179.091 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' C' C ' 40' ' ' SER . . . . . . . . . . . . . 85.7 p -92.97 121.13 33.99 Favored 'General case' 0 C--N 1.329 -0.294 0 C-N-CA 120.915 -0.314 . . . . 0.0 110.946 176.803 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' C' C ' 41' ' ' ILE . . . . . . . . . . . . . 74.5 mt -131.78 122.47 49.73 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.19 0 CA-C-O 120.756 0.312 . . . . 0.0 110.179 178.363 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' C' C ' 42' ' ' LEU . . . . . . . . . . . . . 82.2 mt 57.5 34.18 24.25 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.146 -0.479 . . . . 0.0 111.756 178.59 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' C' C ' 43' ' ' GLY . . . . . . . . . . . . . . . 80.39 -10.14 45.11 Favored Glycine 0 CA--C 1.534 1.264 0 C-N-CA 121.262 -0.494 . . . . 0.0 113.447 176.879 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' C' C ' 44' ' ' LYS . . . . . . . . . . . . . 96.6 mttt -99.19 129.16 45.41 Favored 'General case' 0 C--N 1.333 -0.127 0 CA-C-N 117.917 0.858 . . . . 0.0 110.052 177.327 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' C' C ' 45' ' ' GLU . . . . . . . . . . . . . 37.7 tp10 -85.18 126.92 34.04 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.414 -0.357 . . . . 0.0 110.481 179.321 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' C' C ' 46' ' ' VAL . . . . . . . . . . . . . 7.4 p -119.23 130.69 73.59 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.227 0 CA-C-O 121.203 0.525 . . . . 0.0 109.824 177.484 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' C' C ' 47' ' ' LYS . . . . . . . . . . . . . 44.6 mmtm -99.09 128.4 45.22 Favored 'General case' 0 C--N 1.331 -0.23 0 CA-C-N 115.719 -0.673 . . . . 0.0 111.281 177.746 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' C' C ' 48' ' ' PHE . . . . . . . . . . . . . 95.5 m-85 -112.3 131.8 55.31 Favored 'General case' 0 C--N 1.33 -0.251 0 N-CA-C 109.634 -0.506 . . . . 0.0 109.634 174.676 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' C' C ' 49' ' ' LYS . . . . . . . . . . . . . 79.7 tttt -107.94 137.53 45.77 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.417 -0.356 . . . . 0.0 110.222 179.103 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' C' C ' 50' ' ' VAL . . . . . . . . . . . . . 44.8 t -82.04 107.72 14.35 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.289 0 N-CA-C 109.389 -0.597 . . . . 0.0 109.389 177.065 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' C' C ' 51' ' ' VAL . . . . . . . . . . . . . 51.8 t -69.58 -47.45 71.51 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.335 0 CA-C-N 116.029 -0.532 . . . . 0.0 109.893 -174.335 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' C' C ' 52' ' ' GLN . . . . . . . . . . . . . 61.3 tt0 -169.74 144.43 2.86 Favored 'General case' 0 C--N 1.331 -0.217 0 C-N-CA 120.288 -0.565 . . . . 0.0 111.648 -179.978 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' C' C ' 53' ' ' ALA . . . . . . . . . . . . . . . -114.51 134.85 54.71 Favored 'General case' 0 C--N 1.331 -0.227 0 CA-C-N 115.627 -0.715 . . . . 0.0 110.117 176.429 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' C' C ' 54' ' ' TYR . . . . . . . . . . . . . 51.0 t80 -128.99 112.08 18.55 Favored Pre-proline 0 CA--C 1.536 0.408 0 CA-C-O 118.189 -0.91 . . . . 0.0 110.453 178.809 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' C' C ' 55' ' ' PRO . . . . . . . . . . . . . 72.7 Cg_endo -77.15 169.36 74.43 Favored 'Cis proline' 0 N--CA 1.5 1.9 0 CA-C-N 122.053 1.769 . . . . 0.0 112.2 -6.336 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' C' C ' 56' ' ' SER . . . . . . . . . . . . . 14.7 m -117.23 135.87 23.25 Favored Pre-proline 0 CA--C 1.538 0.509 0 CA-C-O 118.591 -0.718 . . . . 0.0 109.605 175.272 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' C' C ' 57' ' ' PRO . . . . . . . . . . . . . 49.1 Cg_endo -70.17 146.76 83.92 Favored 'Cis proline' 0 N--CA 1.496 1.653 0 CA-C-N 121.724 1.651 . . . . 0.0 111.355 -3.484 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' C' C ' 58' ' ' LEU . . . . . . . . . . . . . 17.2 tp -107.81 135.87 48.49 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-O 120.847 0.356 . . . . 0.0 110.798 -177.329 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' C' C ' 59' ' ' ARG . . . . . . . . . . . . . 42.4 ttp180 -102.44 119.85 39.51 Favored 'General case' 0 C--N 1.328 -0.349 0 N-CA-C 108.971 -0.752 . . . . 0.0 108.971 174.418 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' C' C ' 60' ' ' VAL . . . . . . . . . . . . . 41.2 t -76.2 122.73 30.97 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.238 0 C-N-CA 120.661 -0.415 . . . . 0.0 110.674 -173.289 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' C' C ' 61' ' ' GLU . . . . . . . . . . . . . 88.3 mt-10 -131.09 163.13 28.32 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 115.938 -0.573 . . . . 0.0 109.749 175.962 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' C' C ' 62' ' ' ASP . . . . . . . . . . . . . 11.4 p-10 -53.87 -30.4 45.59 Favored 'General case' 0 C--N 1.328 -0.339 0 N-CA-C 111.85 0.315 . . . . 0.0 111.85 178.751 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' C' C ' 63' ' ' ARG . . . . . . . . . . . . . 77.8 mtp180 -71.58 -22.08 61.78 Favored 'General case' 0 CA--C 1.533 0.308 0 N-CA-C 112.952 0.723 . . . . 0.0 112.952 -175.958 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' C' C ' 64' ' ' THR . . . . . . . . . . . . . 31.0 m -71.46 141.79 50.22 Favored 'General case' 0 C--N 1.331 -0.213 0 CA-C-O 120.859 0.362 . . . . 0.0 111.381 -174.173 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' C' C ' 65' ' ' LYS . . . . . . . . . . . . . 2.4 mptp? -88.96 129.66 35.59 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 115.925 -0.579 . . . . 0.0 109.849 177.416 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' C' C ' 66' ' ' ILE . . . . . . . . . . . . . 66.8 mt -116.68 127.84 74.2 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.268 0 N-CA-C 109.913 -0.402 . . . . 0.0 109.913 179.615 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' C' C ' 67' ' ' THR . . . . . . . . . . . . . 32.2 m -127.89 143.69 51.1 Favored 'General case' 0 C--N 1.332 -0.164 0 CA-C-N 116.16 -0.473 . . . . 0.0 111.0 -177.25 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' C' C ' 68' ' ' LEU . . . . . . . . . . . . . 28.2 mt . . . . . 0 C--N 1.33 -0.246 0 CA-C-N 115.877 -0.602 . . . . 0.0 110.404 177.435 . . . . . . . . 0 0 . 1 . 020 nuclear orig core ' C' C ' 73' ' ' VAL . . . . . . . . . . . . . 31.5 m . . . . . 0 C--O 1.231 0.127 0 CA-C-O 121.069 0.462 . . . . 0.0 110.741 . . . . . . . . . 0 0 . 1 . 020 nuclear orig core ' C' C ' 74' ' ' ASP . . . . . . . . . . . . . 13.7 t0 -97.46 119.64 36.37 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 115.58 -0.736 . . . . 0.0 109.437 178.436 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' C' C ' 75' ' ' VAL . . . . . . . . . . . . . 43.0 t -109.75 122.52 64.49 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.221 0 CA-C-O 121.036 0.446 . . . . 0.0 110.402 -177.906 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' C' C ' 76' ' ' LEU . . . . . . . . . . . . . 28.7 mt -123.1 140.53 52.93 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 115.612 -0.722 . . . . 0.0 109.678 178.568 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' C' C ' 77' ' ' GLU . . . . . . . . . . . . . 97.2 mt-10 -132.83 135.67 45.78 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-O 121.082 0.468 . . . . 0.0 111.12 -179.267 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' C' C ' 78' ' ' ALA . . . . . . . . . . . . . . . -124.55 133.92 53.15 Favored 'General case' 0 C--O 1.233 0.221 0 CA-C-N 115.807 -0.633 . . . . 0.0 109.903 177.013 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' C' C ' 79' ' ' LYS . . . . . . . . . . . . . 61.3 mtpt -79.15 118.31 20.98 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-O 120.874 0.369 . . . . 0.0 110.747 -178.068 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' C' C ' 80' ' ' ILE . . . . . . . . . . . . . 34.7 mm -139.18 105.98 2.7 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.285 0 N-CA-C 108.886 -0.783 . . . . 0.0 108.886 -178.462 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' C' C ' 81' ' ' LYS . . . . . . . . . . . . . 23.2 tptm -98.99 126.52 44.71 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-O 120.849 0.357 . . . . 0.0 111.137 -175.715 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' C' C ' 82' ' ' GLY . . . . . . . . . . . . . . . 89.17 42.07 5.68 Favored Glycine 0 CA--C 1.526 0.758 0 C-N-CA 120.755 -0.736 . . . . 0.0 111.798 174.816 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' C' C ' 83' ' ' ILE . . . . . . . . . . . . . 72.5 mt -69.73 136.22 26.62 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.338 0 N-CA-C 109.648 -0.501 . . . . 0.0 109.648 177.182 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' C' C ' 84' ' ' LYS . . . . . . . . . . . . . 22.9 ttmt -94.7 -54.1 3.62 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-O 121.123 0.487 . . . . 0.0 110.121 -179.759 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' C' C ' 85' ' ' ASP . . . . . . . . . . . . . 7.6 t70 -152.31 148.09 27.11 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 115.604 -0.725 . . . . 0.0 110.352 -179.005 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' C' C ' 86' ' ' VAL . . . . . . . . . . . . . 45.3 t -126.9 129.32 71.34 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.275 0 CA-C-O 120.976 0.417 . . . . 0.0 110.225 179.999 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' C' C ' 87' ' ' ILE . . . . . . . . . . . . . 5.1 mp -118.32 129.41 74.67 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.239 0 CA-C-N 115.898 -0.592 . . . . 0.0 109.524 177.403 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' C' C ' 88' ' ' LEU . . . . . . . . . . . . . 26.9 mt -111.14 140.15 45.92 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-O 120.96 0.409 . . . . 0.0 111.312 -177.277 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' C' C ' 89' ' ' ASP . . . . . . . . . . . . . 36.0 t0 -132.16 157.39 44.4 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 115.811 -0.631 . . . . 0.0 109.542 177.314 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' C' C ' 90' ' ' GLU . . . . . . . . . . . . . 40.5 mp0 -49.66 -34.09 17.45 Favored 'General case' 0 C--N 1.331 -0.222 0 N-CA-C 112.914 0.709 . . . . 0.0 112.914 -171.448 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' C' C ' 91' ' ' ASN . . . . . . . . . . . . . 26.2 m120 -130.23 16.22 5.58 Favored 'General case' 0 N--CA 1.469 0.492 0 N-CA-C 113.256 0.836 . . . . 0.0 113.256 -177.225 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' C' C ' 92' ' ' LEU . . . . . . . . . . . . . 28.9 mt -148.12 149.76 32.61 Favored 'General case' 0 C--N 1.332 -0.188 0 CA-C-O 120.798 0.332 . . . . 0.0 110.763 -175.568 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' C' C ' 93' ' ' ILE . . . . . . . . . . . . . 68.1 mt -126.01 118.25 51.18 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.292 0 N-CA-C 109.041 -0.725 . . . . 0.0 109.041 175.648 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' C' C ' 94' ' ' VAL . . . . . . . . . . . . . 44.5 t -117.61 125.54 74.15 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.255 0 CA-C-O 121.034 0.445 . . . . 0.0 109.956 -178.727 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' C' C ' 95' ' ' VAL . . . . . . . . . . . . . 42.3 t -120.1 134.64 62.93 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.307 0 CA-C-N 115.859 -0.61 . . . . 0.0 109.852 -178.94 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' C' C ' 96' ' ' ILE . . . . . . . . . . . . . 64.9 mt -114.17 126.03 71.59 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.279 0 N-CA-C 109.016 -0.735 . . . . 0.0 109.016 177.432 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' C' C ' 97' ' ' THR . . . . . . . . . . . . . 76.2 p -100.87 157.49 16.68 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-O 120.908 0.385 . . . . 0.0 111.093 -176.317 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' C' C ' 98' ' ' GLU . . . . . . . . . . . . . 13.0 pt-20 -53.96 -22.57 10.61 Favored 'General case' 0 CA--C 1.535 0.366 0 N-CA-C 112.279 0.474 . . . . 0.0 112.279 178.019 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' C' C ' 99' ' ' GLU . . . . . . . . . . . . . 95.3 mt-10 -78.18 12.51 1.83 Allowed 'General case' 0 CA--C 1.536 0.434 0 N-CA-C 113.022 0.749 . . . . 0.0 113.022 179.605 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' C' C ' 100' ' ' ASN . . . . . . . . . . . . . 2.1 m-20 61.87 38.07 14.86 Favored 'General case' 0 CA--C 1.53 0.207 0 CA-C-O 121.028 0.442 . . . . 0.0 110.923 179.48 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' C' C ' 101' ' ' GLU . . . . . . . . . . . . . 42.0 mt-10 -111.17 148.71 32.17 Favored 'General case' 0 CA--C 1.521 -0.17 0 CA-C-N 115.988 -0.551 . . . . 0.0 110.494 176.019 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' C' C ' 102' ' ' VAL . . . . . . . . . . . . . 46.6 t -114.85 120.9 65.76 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.293 0 CA-C-N 115.487 -0.779 . . . . 0.0 109.126 177.114 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' C' C ' 103' ' ' LEU . . . . . . . . . . . . . 22.1 mt -111.56 126.12 54.65 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 115.68 -0.691 . . . . 0.0 109.994 177.851 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' C' C ' 104' ' ' ILE . . . . . . . . . . . . . 68.4 mt -111.94 114.21 46.39 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.325 0 N-CA-C 109.58 -0.526 . . . . 0.0 109.58 179.318 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' C' C ' 105' ' ' PHE . . . . . . . . . . . . . 95.6 m-85 -117.23 163.12 16.78 Favored 'General case' 0 C--N 1.332 -0.169 0 O-C-N 124.056 0.847 . . . . 0.0 109.956 -179.796 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' C' C ' 106' ' ' ASN . . . . . . . . . . . . . 51.1 p-10 -104.05 -170.73 1.82 Allowed 'General case' 0 C--N 1.328 -0.362 0 N-CA-C 109.661 -0.496 . . . . 0.0 109.661 171.805 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' C' C ' 107' ' ' GLN . . . . . . . . . . . . . 45.4 tt0 -58.39 -28.9 65.6 Favored 'General case' 0 C--N 1.328 -0.35 0 N-CA-C 112.071 0.397 . . . . 0.0 112.071 178.513 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' C' C ' 108' ' ' ASN . . . . . . . . . . . . . 48.6 t30 -89.49 6.86 39.01 Favored 'General case' 0 CA--C 1.536 0.427 0 N-CA-C 113.202 0.815 . . . . 0.0 113.202 -175.857 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' C' C ' 109' ' ' LEU . . . . . . . . . . . . . 89.0 mt 59.09 31.94 21.74 Favored 'General case' 0 C--N 1.332 -0.157 0 N-CA-C 112.034 0.383 . . . . 0.0 112.034 175.968 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' C' C ' 110' ' ' GLU . . . . . . . . . . . . . 14.0 pt-20 -106.09 144.22 33.11 Favored 'General case' 0 C--N 1.332 -0.165 0 N-CA-C 109.616 -0.513 . . . . 0.0 109.616 173.867 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' C' C ' 111' ' ' GLU . . . . . . . . . . . . . 54.5 tt0 -66.79 121.95 16.59 Favored 'General case' 0 C--N 1.327 -0.412 0 CA-C-N 116.12 -0.491 . . . . 0.0 111.528 -172.281 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' C' C ' 112' ' ' LEU . . . . . . . . . . . . . 10.7 mt -101.41 -46.16 5.09 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.039 -0.528 . . . . 0.0 109.653 174.009 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' C' C ' 113' ' ' TYR . . . . . . . . . . . . . 64.0 t80 -148.48 140.55 23.98 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.059 -0.519 . . . . 0.0 111.133 178.023 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' C' C ' 114' ' ' ARG . . . . . . . . . . . . . 29.6 ttm180 -137.61 126.12 23.54 Favored 'General case' 0 C--N 1.329 -0.289 0 N-CA-C 109.819 -0.438 . . . . 0.0 109.819 175.803 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' C' C ' 115' ' ' GLY . . . . . . . . . . . . . . . -150.12 161.56 28.94 Favored Glycine 0 CA--C 1.522 0.505 0 N-CA-C 110.753 -0.939 . . . . 0.0 110.753 -179.089 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' C' C ' 116' ' ' LYS . . . . . . . . . . . . . 26.4 ttpp -127.84 134.35 49.42 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-O 120.755 0.312 . . . . 0.0 110.363 -179.614 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' C' C ' 117' ' ' PHE . . . . . . . . . . . . . 59.2 m-85 -134.37 113.91 12.39 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.249 -0.432 . . . . 0.0 109.982 -178.932 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' C' C ' 118' ' ' GLU . . . . . . . . . . . . . 44.4 mp0 -58.06 -39.47 78.56 Favored 'General case' 0 C--N 1.328 -0.332 0 C-N-CA 120.629 -0.429 . . . . 0.0 110.745 -175.649 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' C' C ' 119' ' ' ASN . . . . . . . . . . . . . 3.5 m120 -100.06 30.73 3.62 Favored 'General case' 0 C--N 1.329 -0.286 0 N-CA-C 112.169 0.433 . . . . 0.0 112.169 -175.341 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' C' C ' 120' ' ' LEU . . . . . . . . . . . . . 18.5 tp -58.85 119.85 7.94 Favored 'General case' 0 C--N 1.332 -0.157 0 N-CA-C 110.029 -0.36 . . . . 0.0 110.029 178.279 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' C' C ' 121' ' ' ASN . . . . . . . . . . . . . 87.0 m-20 -114.16 -44.16 3.16 Favored 'General case' 0 C--N 1.333 -0.137 0 CA-C-N 116.493 -0.322 . . . . 0.0 111.302 -178.272 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' C' C ' 122' ' ' LYS . . . . . . . . . . . . . 62.1 mtpt -143.51 151.27 40.07 Favored 'General case' 0 C--N 1.33 -0.239 0 CA-C-O 120.973 0.416 . . . . 0.0 111.532 -175.258 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' C' C ' 123' ' ' VAL . . . . . . . . . . . . . 43.6 t -135.2 135.16 52.55 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.245 0 CA-C-N 116.143 -0.48 . . . . 0.0 109.866 176.059 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' C' C ' 124' ' ' LEU . . . . . . . . . . . . . 55.8 mt -126.0 141.88 51.77 Favored 'General case' 0 C--N 1.331 -0.221 0 CA-C-O 120.897 0.38 . . . . 0.0 110.839 -177.962 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' C' C ' 125' ' ' VAL . . . . . . . . . . . . . 34.9 m -135.93 138.72 47.17 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.201 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.74 179.039 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' C' C ' 126' ' ' ARG . . . . . . . . . . . . . 46.6 ptt85 -152.53 131.08 12.23 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-O 120.849 0.357 . . . . 0.0 110.774 175.873 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' C' C ' 127' ' ' ASN . . . . . . . . . . . . . 89.7 m-20 50.71 -115.43 0.86 Allowed 'General case' 0 CA--C 1.546 0.797 0 CA-C-O 118.67 -0.681 . . . . 0.0 111.177 -179.77 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' C' C ' 128' ' ' ASP . . . . . . . . . . . . . 8.7 p-10 -114.11 16.06 18.19 Favored 'General case' 0 CA--C 1.536 0.433 0 CA-C-N 120.17 1.35 . . . . 0.0 112.848 -179.884 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' C' C ' 129' ' ' LEU . . . . . . . . . . . . . 5.7 tt -111.96 136.75 50.89 Favored 'General case' 0 C--O 1.234 0.252 0 N-CA-C 110.024 -0.361 . . . . 0.0 110.024 -179.617 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' C' C ' 130' ' ' VAL . . . . . . . . . . . . . 43.2 t -117.99 135.88 56.97 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.185 0 CA-C-N 116.39 -0.368 . . . . 0.0 110.109 -177.442 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' C' C ' 131' ' ' VAL . . . . . . . . . . . . . 43.4 t -133.79 133.78 56.51 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.214 0 CA-C-O 120.938 0.399 . . . . 0.0 110.289 178.513 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' C' C ' 132' ' ' ILE . . . . . . . . . . . . . 70.6 mt -119.82 133.31 66.99 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.233 0 N-CA-C 109.513 -0.551 . . . . 0.0 109.513 -179.567 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' C' C ' 133' ' ' ILE . . . . . . . . . . . . . 40.9 mm -117.77 120.78 65.7 Favored 'Isoleucine or valine' 0 C--O 1.234 0.266 0 CA-C-O 120.801 0.334 . . . . 0.0 111.102 -175.301 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' C' C ' 134' ' ' ASP . . . . . . . . . . . . . 6.9 p-10 -132.43 148.0 52.39 Favored 'General case' 0 C--N 1.33 -0.251 0 N-CA-C 109.708 -0.478 . . . . 0.0 109.708 176.322 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' C' C ' 135' ' ' GLU . . . . . . . . . . . . . 41.6 tp10 -49.98 -29.42 8.5 Favored 'General case' 0 C--N 1.327 -0.387 0 N-CA-C 112.648 0.61 . . . . 0.0 112.648 -173.667 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' C' C ' 136' ' ' GLN . . . . . . . . . . . . . 93.9 mt-30 -79.96 -33.32 39.63 Favored 'General case' 0 C--O 1.234 0.268 0 N-CA-C 112.321 0.489 . . . . 0.0 112.321 -175.302 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' C' C ' 137' ' ' LYS . . . . . . . . . . . . . 46.8 pttt -169.93 174.65 5.49 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-O 121.403 0.621 . . . . 0.0 112.31 -172.451 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' C' C ' 138' ' ' LEU . . . . . . . . . . . . . 5.2 tt -116.12 129.88 56.54 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 115.116 -0.947 . . . . 0.0 109.951 179.499 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' C' C ' 139' ' ' THR . . . . . . . . . . . . . 27.0 m -108.39 126.61 53.07 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-N 116.318 -0.401 . . . . 0.0 110.366 179.855 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' C' C ' 140' ' ' LEU . . . . . . . . . . . . . 14.3 tp -114.44 121.37 43.33 Favored 'General case' 0 C--N 1.33 -0.273 0 N-CA-C 109.048 -0.723 . . . . 0.0 109.048 -179.463 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' C' C ' 141' ' ' ILE . . . . . . . . . . . . . 19.5 mt -119.91 115.6 47.91 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.279 0 CA-C-O 120.978 0.418 . . . . 0.0 109.906 -175.888 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' C' C ' 142' ' ' ARG . . . . . . . . . . . . . 84.2 mtm180 . . . . . 0 C--N 1.33 -0.25 0 CA-C-N 115.243 -0.889 . . . . 0.0 110.841 -175.933 . . . . . . . . 0 0 . 1 . 020 nuclear orig core ' D' D ' 2' ' ' SER . . . . . . . . . . . . . 6.8 p . . . . . 0 C--O 1.231 0.119 0 CA-C-O 120.859 0.362 . . . . 0.0 110.718 . . . . . . . . . 0 0 . 1 . 020 nuclear orig core ' D' D ' 3' ' ' GLU . . . . . . . . . . . . . 95.6 mt-10 -140.22 138.23 34.92 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.03 -0.532 . . . . 0.0 110.897 179.236 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' D' D ' 4' ' ' LEU . . . . . . . . . . . . . 17.2 tp -122.86 128.33 50.21 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 115.911 -0.586 . . . . 0.0 110.249 178.095 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' D' D ' 5' ' ' LYS . . . . . . . . . . . . . 67.6 mttm -105.54 121.4 43.88 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.382 -0.372 . . . . 0.0 110.468 178.219 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' D' D ' 6' ' ' LEU . . . . . . . . . . . . . 73.8 mt -117.65 149.46 40.68 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 115.622 -0.717 . . . . 0.0 110.778 -178.78 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' D' D ' 7' ' ' LYS . . . . . . . . . . . . . 35.5 ttpt -139.55 139.41 22.29 Favored Pre-proline 0 CA--C 1.535 0.376 0 CA-C-O 119.136 -0.459 . . . . 0.0 110.135 175.704 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' D' D ' 8' ' ' PRO . . . . . . . . . . . . . 94.0 Cg_endo -92.09 144.06 2.76 Favored 'Trans proline' 0 N--CA 1.49 1.267 0 C-N-CA 121.778 1.652 . . . . 0.0 111.659 177.053 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' D' D ' 9' ' ' LEU . . . . . . . . . . . . . 45.1 mt -80.25 -48.23 1.29 Allowed Pre-proline 0 CA--C 1.534 0.349 0 CA-C-O 118.665 -0.683 . . . . 0.0 112.445 -178.602 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' D' D ' 10' ' ' PRO . . . . . . . . . . . . . 86.1 Cg_endo -79.75 152.61 22.52 Favored 'Trans proline' 0 N--CA 1.496 1.632 0 C-N-CA 121.213 1.276 . . . . 0.0 112.055 177.318 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' D' D ' 11' ' ' LYS . . . . . . . . . . . . . 90.2 mttt -85.38 97.85 10.22 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.483 -0.326 . . . . 0.0 110.534 178.374 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' D' D ' 12' ' ' VAL . . . . . . . . . . . . . 12.1 p -144.32 143.12 23.57 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.288 0 CA-C-N 116.222 -0.445 . . . . 0.0 110.524 179.743 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' D' D ' 13' ' ' GLU . . . . . . . . . . . . . 45.8 mp0 -81.89 127.01 32.57 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.342 -0.39 . . . . 0.0 110.037 176.956 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' D' D ' 14' ' ' LEU . . . . . . . . . . . . . 22.5 mt -97.28 144.79 28.53 Favored Pre-proline 0 CA--C 1.533 0.311 0 CA-C-O 119.019 -0.515 . . . . 0.0 110.11 -179.688 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' D' D ' 15' ' ' PRO . . . . . . . . . . . . . 29.8 Cg_exo -59.95 160.32 22.38 Favored 'Trans proline' 0 N--CA 1.497 1.709 0 C-N-CA 121.241 1.294 . . . . 0.0 112.085 179.079 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' D' D ' 16' ' ' PRO . . . . . . . . . . . . . 31.6 Cg_exo -59.3 -37.83 88.56 Favored 'Trans proline' 0 N--CA 1.497 1.691 0 C-N-CA 121.452 1.434 . . . . 0.0 112.905 -177.424 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' D' D ' 17' ' ' ASP . . . . . . . . . . . . . 13.7 p-10 -85.33 4.17 36.34 Favored 'General case' 0 CA--C 1.537 0.46 0 N-CA-C 113.301 0.852 . . . . 0.0 113.301 -177.204 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' D' D ' 18' ' ' PHE . . . . . . . . . . . . . 48.2 t80 -58.29 -47.17 84.52 Favored 'General case' 0 C--N 1.334 -0.102 0 O-C-N 122.03 -0.419 . . . . 0.0 110.151 -177.275 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' D' D ' 19' ' ' VAL . . . . . . . . . . . . . 47.5 t -56.72 -42.94 78.26 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.356 0 CA-C-N 116.335 -0.393 . . . . 0.0 110.504 -177.789 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' D' D ' 20' ' ' ASP . . . . . . . . . . . . . 53.4 m-20 -59.82 -41.79 92.07 Favored 'General case' 0 C--N 1.328 -0.333 0 C-N-CA 120.913 -0.315 . . . . 0.0 110.896 -177.851 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' D' D ' 21' ' ' VAL . . . . . . . . . . . . . 47.7 t -64.63 -46.26 92.97 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.275 0 C-N-CA 120.811 -0.356 . . . . 0.0 110.491 -178.06 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' D' D ' 22' ' ' ILE . . . . . . . . . . . . . 46.8 mm -57.75 -40.44 75.69 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.317 0 C-N-CA 120.745 -0.382 . . . . 0.0 110.615 179.726 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' D' D ' 23' ' ' ARG . . . . . . . . . . . . . 59.1 ttp180 -55.69 -49.97 71.55 Favored 'General case' 0 C--N 1.331 -0.219 0 CA-C-O 120.969 0.414 . . . . 0.0 110.843 178.11 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' D' D ' 24' ' ' ILE . . . . . . . . . . . . . 74.1 mt -61.36 -40.26 85.57 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.324 0 CA-C-N 115.918 -0.583 . . . . 0.0 111.925 -176.666 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' D' D ' 25' ' ' LYS . . . . . . . . . . . . . 7.7 ptmm? -72.19 -36.46 69.23 Favored 'General case' 0 CA--C 1.531 0.239 0 C-N-CA 120.534 -0.466 . . . . 0.0 111.882 -176.145 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' D' D ' 26' ' ' LEU . . . . . . . . . . . . . 77.0 mt -77.7 -40.25 41.96 Favored 'General case' 0 C--N 1.33 -0.243 0 N-CA-C 113.194 0.813 . . . . 0.0 113.194 -173.23 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' D' D ' 27' ' ' GLN . . . . . . . . . . . . . 10.5 pt20 -47.53 137.12 9.26 Favored 'General case' 0 N--CA 1.471 0.58 0 N-CA-C 112.661 0.615 . . . . 0.0 112.661 -175.901 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' D' D ' 28' ' ' GLY . . . . . . . . . . . . . . . 99.63 -24.84 30.58 Favored Glycine 0 CA--C 1.533 1.21 0 CA-C-N 115.545 -0.752 . . . . 0.0 112.304 -176.345 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' D' D ' 29' ' ' LYS . . . . . . . . . . . . . 72.9 mmtt -98.11 155.18 17.26 Favored 'General case' 0 C--N 1.331 -0.218 0 CA-C-N 117.318 0.559 . . . . 0.0 111.232 179.352 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' D' D ' 30' ' ' THR . . . . . . . . . . . . . 24.4 m -105.79 135.85 46.47 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 115.784 -0.643 . . . . 0.0 109.859 175.342 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' D' D ' 31' ' ' VAL . . . . . . . . . . . . . 34.8 m -130.83 155.52 41.96 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.276 0 CA-C-O 120.994 0.426 . . . . 0.0 110.926 -178.225 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' D' D ' 32' ' ' ARG . . . . . . . . . . . . . 84.8 mtm180 -131.65 150.78 52.03 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.012 -0.54 . . . . 0.0 110.863 179.143 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' D' D ' 33' ' ' THR . . . . . . . . . . . . . 20.8 m -53.5 140.37 28.36 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.111 -0.495 . . . . 0.0 111.293 -179.09 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' D' D ' 34' ' ' GLY . . . . . . . . . . . . . . . 98.99 -17.17 58.55 Favored Glycine 0 CA--C 1.533 1.189 0 C-N-CA 121.103 -0.57 . . . . 0.0 113.207 179.699 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' D' D ' 35' ' ' ASP . . . . . . . . . . . . . 69.1 m-20 -65.47 148.87 50.99 Favored 'General case' 0 C--O 1.232 0.138 0 CA-C-N 118.013 0.907 . . . . 0.0 111.122 178.99 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' D' D ' 36' ' ' VAL . . . . . . . . . . . . . 45.7 t -122.97 130.03 74.72 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.251 0 CA-C-N 115.774 -0.648 . . . . 0.0 109.704 178.594 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' D' D ' 37' ' ' ILE . . . . . . . . . . . . . 69.7 mt -120.12 137.93 52.33 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.276 0 N-CA-C 109.767 -0.457 . . . . 0.0 109.767 179.442 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' D' D ' 38' ' ' GLY . . . . . . . . . . . . . . . -112.52 128.79 8.65 Favored Glycine 0 CA--C 1.526 0.724 0 N-CA-C 111.11 -0.796 . . . . 0.0 111.11 -179.078 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' D' D ' 39' ' ' ILE . . . . . . . . . . . . . 75.8 mt -124.23 135.55 63.33 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.261 0 CA-C-O 120.795 0.331 . . . . 0.0 110.164 178.999 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' D' D ' 40' ' ' SER . . . . . . . . . . . . . 23.0 t -92.71 120.74 33.41 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.321 -0.399 . . . . 0.0 110.723 176.142 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' D' D ' 41' ' ' ILE . . . . . . . . . . . . . 70.3 mt -132.09 118.16 35.89 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.23 0 N-CA-C 110.107 -0.331 . . . . 0.0 110.107 178.272 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' D' D ' 42' ' ' LEU . . . . . . . . . . . . . 5.4 mp 56.11 36.96 28.32 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.179 -0.464 . . . . 0.0 111.326 179.315 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' D' D ' 43' ' ' GLY . . . . . . . . . . . . . . . 77.48 -10.07 24.99 Favored Glycine 0 CA--C 1.533 1.209 0 C-N-CA 121.279 -0.486 . . . . 0.0 113.531 176.54 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' D' D ' 44' ' ' LYS . . . . . . . . . . . . . 61.9 mttp -97.19 135.96 38.39 Favored 'General case' 0 C--N 1.333 -0.123 0 CA-C-N 117.993 0.897 . . . . 0.0 110.151 177.398 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' D' D ' 45' ' ' GLU . . . . . . . . . . . . . 80.8 tt0 -85.2 126.9 34.03 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.282 -0.417 . . . . 0.0 110.758 179.817 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' D' D ' 46' ' ' VAL . . . . . . . . . . . . . 7.1 p -121.15 127.13 75.81 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.224 0 N-CA-C 109.597 -0.52 . . . . 0.0 109.597 175.895 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' D' D ' 47' ' ' LYS . . . . . . . . . . . . . 58.4 mttm -100.63 129.48 46.56 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 115.862 -0.608 . . . . 0.0 111.139 178.051 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' D' D ' 48' ' ' PHE . . . . . . . . . . . . . 92.5 m-85 -111.12 131.75 54.84 Favored 'General case' 0 C--N 1.329 -0.319 0 N-CA-C 109.61 -0.515 . . . . 0.0 109.61 174.807 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' D' D ' 49' ' ' LYS . . . . . . . . . . . . . 83.3 tttt -108.82 138.15 45.62 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.414 -0.357 . . . . 0.0 110.486 179.76 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' D' D ' 50' ' ' VAL . . . . . . . . . . . . . 44.9 t -80.3 109.56 14.93 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.285 0 N-CA-C 109.292 -0.632 . . . . 0.0 109.292 176.141 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' D' D ' 51' ' ' VAL . . . . . . . . . . . . . 51.2 t -71.81 -47.14 57.94 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.273 0 CA-C-N 115.988 -0.551 . . . . 0.0 109.97 -174.084 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' D' D ' 52' ' ' GLN . . . . . . . . . . . . . 47.6 tt0 -170.93 145.09 2.29 Favored 'General case' 0 C--N 1.33 -0.28 0 C-N-CA 120.433 -0.507 . . . . 0.0 111.439 -179.8 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' D' D ' 53' ' ' ALA . . . . . . . . . . . . . . . -121.14 136.18 55.02 Favored 'General case' 0 C--N 1.331 -0.227 0 CA-C-N 115.903 -0.589 . . . . 0.0 110.474 178.499 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' D' D ' 54' ' ' TYR . . . . . . . . . . . . . 35.6 t80 -129.16 113.59 18.49 Favored Pre-proline 0 CA--C 1.536 0.406 0 CA-C-O 118.24 -0.886 . . . . 0.0 110.117 176.142 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' D' D ' 55' ' ' PRO . . . . . . . . . . . . . 72.8 Cg_endo -77.29 170.08 72.35 Favored 'Cis proline' 0 N--CA 1.499 1.825 0 CA-C-N 122.037 1.763 . . . . 0.0 112.057 -6.089 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' D' D ' 56' ' ' SER . . . . . . . . . . . . . 17.5 m -122.51 134.1 24.74 Favored Pre-proline 0 CA--C 1.538 0.508 0 CA-C-O 118.519 -0.753 . . . . 0.0 109.496 175.204 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' D' D ' 57' ' ' PRO . . . . . . . . . . . . . 38.4 Cg_endo -67.2 145.54 73.63 Favored 'Cis proline' 0 N--CA 1.498 1.777 0 CA-C-N 121.834 1.691 . . . . 0.0 111.562 -1.67 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' D' D ' 58' ' ' LEU . . . . . . . . . . . . . 23.7 tp -106.25 136.05 46.65 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.263 -0.426 . . . . 0.0 110.736 -177.626 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' D' D ' 59' ' ' ARG . . . . . . . . . . . . . 42.1 ttm180 -103.28 127.83 50.5 Favored 'General case' 0 C--N 1.328 -0.367 0 N-CA-C 109.247 -0.649 . . . . 0.0 109.247 174.945 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' D' D ' 60' ' ' VAL . . . . . . . . . . . . . 45.5 t -84.18 120.28 34.73 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.242 0 C-N-CA 120.689 -0.404 . . . . 0.0 110.37 -175.916 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' D' D ' 61' ' ' GLU . . . . . . . . . . . . . 43.9 mt-10 -131.11 167.19 19.53 Favored 'General case' 0 C--N 1.331 -0.214 0 CA-C-N 115.735 -0.666 . . . . 0.0 109.858 177.391 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' D' D ' 62' ' ' ASP . . . . . . . . . . . . . 13.3 t70 -53.81 -32.57 53.19 Favored 'General case' 0 C--N 1.327 -0.377 0 N-CA-C 111.776 0.287 . . . . 0.0 111.776 -179.879 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' D' D ' 63' ' ' ARG . . . . . . . . . . . . . 26.5 ptt180 -82.99 3.79 28.65 Favored 'General case' 0 CA--C 1.536 0.434 0 N-CA-C 113.793 1.034 . . . . 0.0 113.793 -175.629 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' D' D ' 64' ' ' THR . . . . . . . . . . . . . 38.0 m -86.98 135.12 33.4 Favored 'General case' 0 C--N 1.333 -0.148 0 CA-C-N 118.117 0.417 . . . . 0.0 110.584 -178.343 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' D' D ' 65' ' ' LYS . . . . . . . . . . . . . 93.4 mttt -90.24 129.54 36.48 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.066 -0.515 . . . . 0.0 110.237 178.917 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' D' D ' 66' ' ' ILE . . . . . . . . . . . . . 63.4 mt -112.67 129.52 68.12 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.314 0 N-CA-C 109.725 -0.472 . . . . 0.0 109.725 179.641 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' D' D ' 67' ' ' THR . . . . . . . . . . . . . 29.3 m -124.02 138.11 54.5 Favored 'General case' 0 C--N 1.331 -0.204 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.807 -178.267 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' D' D ' 68' ' ' LEU . . . . . . . . . . . . . 7.8 mp . . . . . 0 C--N 1.327 -0.386 0 CA-C-N 115.845 -0.616 . . . . 0.0 110.219 178.2 . . . . . . . . 0 0 . 1 . 020 nuclear orig core ' D' D ' 73' ' ' VAL . . . . . . . . . . . . . 30.7 m . . . . . 0 C--O 1.231 0.088 0 CA-C-O 121.067 0.46 . . . . 0.0 111.253 . . . . . . . . . 0 0 . 1 . 020 nuclear orig core ' D' D ' 74' ' ' ASP . . . . . . . . . . . . . 8.3 t0 -101.54 118.42 36.91 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 115.696 -0.684 . . . . 0.0 109.598 178.539 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' D' D ' 75' ' ' VAL . . . . . . . . . . . . . 40.8 t -110.2 123.71 66.33 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.244 0 CA-C-O 120.99 0.424 . . . . 0.0 110.481 -177.179 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' D' D ' 76' ' ' LEU . . . . . . . . . . . . . 30.0 mt -128.49 147.41 50.68 Favored 'General case' 0 C--N 1.331 -0.22 0 CA-C-N 115.794 -0.639 . . . . 0.0 110.066 178.854 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' D' D ' 77' ' ' GLU . . . . . . . . . . . . . 97.1 mt-10 -136.75 140.65 42.73 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-O 120.98 0.419 . . . . 0.0 110.99 -177.95 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' D' D ' 78' ' ' ALA . . . . . . . . . . . . . . . -125.67 127.39 46.19 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 115.799 -0.637 . . . . 0.0 109.748 176.878 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' D' D ' 79' ' ' LYS . . . . . . . . . . . . . 48.8 mmtm -71.59 119.37 15.66 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-O 120.849 0.357 . . . . 0.0 110.848 -178.096 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' D' D ' 80' ' ' ILE . . . . . . . . . . . . . 41.3 mm -139.09 112.73 6.75 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.289 0 N-CA-C 108.885 -0.783 . . . . 0.0 108.885 -179.298 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' D' D ' 81' ' ' LYS . . . . . . . . . . . . . 83.2 tttt -102.65 123.67 46.79 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-O 120.833 0.349 . . . . 0.0 111.205 -174.534 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' D' D ' 82' ' ' GLY . . . . . . . . . . . . . . . 89.22 41.99 5.68 Favored Glycine 0 CA--C 1.526 0.747 0 C-N-CA 120.824 -0.703 . . . . 0.0 112.064 173.702 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' D' D ' 83' ' ' ILE . . . . . . . . . . . . . 67.6 mt -68.25 139.63 20.39 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.311 0 N-CA-C 109.802 -0.444 . . . . 0.0 109.802 177.249 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' D' D ' 84' ' ' LYS . . . . . . . . . . . . . 39.7 ttpt -102.62 -47.9 4.29 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.165 -0.47 . . . . 0.0 110.295 -179.081 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' D' D ' 85' ' ' ASP . . . . . . . . . . . . . 7.5 t70 -152.31 151.04 30.4 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.068 -0.515 . . . . 0.0 110.552 179.903 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' D' D ' 86' ' ' VAL . . . . . . . . . . . . . 42.0 t -129.04 131.5 68.02 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.241 0 CA-C-O 120.917 0.389 . . . . 0.0 110.394 179.513 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' D' D ' 87' ' ' ILE . . . . . . . . . . . . . 5.1 mp -118.64 127.35 75.62 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.245 0 N-CA-C 109.472 -0.566 . . . . 0.0 109.472 177.506 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' D' D ' 88' ' ' LEU . . . . . . . . . . . . . 20.6 tp -111.66 123.45 50.26 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.382 -0.372 . . . . 0.0 110.691 -176.963 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' D' D ' 89' ' ' ASP . . . . . . . . . . . . . 12.8 t70 -121.23 156.14 33.1 Favored 'General case' 0 C--N 1.332 -0.184 0 CA-C-N 116.419 -0.355 . . . . 0.0 110.235 -179.983 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' D' D ' 90' ' ' GLU . . . . . . . . . . . . . 68.1 tt0 -46.04 -45.7 16.22 Favored 'General case' 0 N--CA 1.465 0.291 0 N-CA-C 112.972 0.73 . . . . 0.0 112.972 -171.832 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' D' D ' 91' ' ' ASN . . . . . . . . . . . . . 8.4 t-20 -129.59 34.76 4.29 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-O 120.709 0.29 . . . . 0.0 111.665 -176.039 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' D' D ' 92' ' ' LEU . . . . . . . . . . . . . 7.0 tp -166.14 146.38 6.33 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-O 120.944 0.402 . . . . 0.0 110.554 179.68 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' D' D ' 93' ' ' ILE . . . . . . . . . . . . . 66.7 mt -122.26 123.0 67.8 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.366 0 N-CA-C 109.13 -0.693 . . . . 0.0 109.13 179.146 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' D' D ' 94' ' ' VAL . . . . . . . . . . . . . 43.1 t -119.33 128.19 75.84 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.246 0 CA-C-O 120.839 0.352 . . . . 0.0 110.053 -178.122 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' D' D ' 95' ' ' VAL . . . . . . . . . . . . . 42.4 t -123.12 132.59 71.11 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.302 0 CA-C-N 116.043 -0.526 . . . . 0.0 109.882 179.474 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' D' D ' 96' ' ' ILE . . . . . . . . . . . . . 67.5 mt -116.2 127.87 73.67 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.312 0 N-CA-C 109.268 -0.642 . . . . 0.0 109.268 179.077 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' D' D ' 97' ' ' THR . . . . . . . . . . . . . 70.0 p -99.76 158.27 15.91 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-O 121.029 0.442 . . . . 0.0 111.026 -177.664 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' D' D ' 98' ' ' GLU . . . . . . . . . . . . . 44.8 tp10 -54.03 -26.13 24.89 Favored 'General case' 0 CA--C 1.534 0.34 0 CA-C-N 116.224 -0.444 . . . . 0.0 111.916 179.058 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' D' D ' 99' ' ' GLU . . . . . . . . . . . . . 34.5 tt0 -76.3 11.47 1.54 Allowed 'General case' 0 CA--C 1.539 0.533 0 N-CA-C 112.765 0.654 . . . . 0.0 112.765 -177.512 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' D' D ' 100' ' ' ASN . . . . . . . . . . . . . 2.1 m-20 62.81 32.15 16.07 Favored 'General case' 0 CA--C 1.532 0.277 0 O-C-N 121.705 -0.622 . . . . 0.0 111.555 178.983 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' D' D ' 101' ' ' GLU . . . . . . . . . . . . . 78.5 tt0 -109.75 144.66 37.85 Favored 'General case' 0 C--O 1.234 0.241 0 N-CA-C 109.631 -0.507 . . . . 0.0 109.631 172.887 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' D' D ' 102' ' ' VAL . . . . . . . . . . . . . 44.6 t -116.13 128.2 73.5 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.248 0 CA-C-N 116.432 -0.349 . . . . 0.0 110.134 -178.592 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' D' D ' 103' ' ' LEU . . . . . . . . . . . . . 21.1 mt -116.2 130.52 56.83 Favored 'General case' 0 C--N 1.331 -0.208 0 CA-C-N 115.717 -0.674 . . . . 0.0 110.163 176.973 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' D' D ' 104' ' ' ILE . . . . . . . . . . . . . 66.9 mt -116.82 120.5 65.22 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.299 0 N-CA-C 110.018 -0.364 . . . . 0.0 110.018 179.621 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' D' D ' 105' ' ' PHE . . . . . . . . . . . . . 62.8 m-85 -120.8 165.12 15.59 Favored 'General case' 0 C--N 1.333 -0.123 0 O-C-N 123.893 0.746 . . . . 0.0 109.807 178.777 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' D' D ' 106' ' ' ASN . . . . . . . . . . . . . 42.9 p-10 -98.94 -170.05 1.87 Allowed 'General case' 0 C--N 1.331 -0.229 0 N-CA-C 109.936 -0.394 . . . . 0.0 109.936 173.549 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' D' D ' 107' ' ' GLN . . . . . . . . . . . . . 48.7 tt0 -60.5 -30.03 69.46 Favored 'General case' 0 C--N 1.329 -0.289 0 N-CA-C 111.955 0.354 . . . . 0.0 111.955 179.946 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' D' D ' 108' ' ' ASN . . . . . . . . . . . . . 6.6 t-20 -83.27 6.78 18.46 Favored 'General case' 0 CA--C 1.536 0.425 0 N-CA-C 113.223 0.824 . . . . 0.0 113.223 -178.371 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' D' D ' 109' ' ' LEU . . . . . . . . . . . . . 10.2 tp 62.41 37.69 13.41 Favored 'General case' 0 CA--C 1.529 0.167 0 O-C-N 122.087 -0.383 . . . . 0.0 111.377 178.244 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' D' D ' 110' ' ' GLU . . . . . . . . . . . . . 70.7 mm-40 -105.89 162.24 13.75 Favored 'General case' 0 C--N 1.33 -0.255 0 N-CA-C 109.765 -0.457 . . . . 0.0 109.765 176.014 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' D' D ' 111' ' ' GLU . . . . . . . . . . . . . 83.9 tt0 -86.67 127.45 34.95 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-O 120.938 0.399 . . . . 0.0 111.208 -176.357 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' D' D ' 112' ' ' LEU . . . . . . . . . . . . . 15.6 mt -113.03 -46.09 3.13 Favored 'General case' 0 C--N 1.331 -0.197 0 CA-C-N 115.953 -0.567 . . . . 0.0 110.418 176.579 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' D' D ' 113' ' ' TYR . . . . . . . . . . . . . 38.2 t80 -143.06 138.73 30.13 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.269 -0.423 . . . . 0.0 111.26 -179.295 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' D' D ' 114' ' ' ARG . . . . . . . . . . . . . 27.4 ttm180 -137.42 122.61 19.24 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.338 -0.392 . . . . 0.0 109.968 174.908 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' D' D ' 115' ' ' GLY . . . . . . . . . . . . . . . -150.07 163.1 29.38 Favored Glycine 0 CA--C 1.526 0.775 0 N-CA-C 111.115 -0.794 . . . . 0.0 111.115 179.031 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' D' D ' 116' ' ' LYS . . . . . . . . . . . . . 88.2 tttt -131.69 138.19 48.59 Favored 'General case' 0 C--N 1.33 -0.241 0 N-CA-C 110.046 -0.353 . . . . 0.0 110.046 178.628 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' D' D ' 117' ' ' PHE . . . . . . . . . . . . . 27.6 m-85 -139.05 113.96 9.32 Favored 'General case' 0 C--N 1.331 -0.205 0 CA-C-N 116.26 -0.427 . . . . 0.0 109.963 -176.657 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' D' D ' 118' ' ' GLU . . . . . . . . . . . . . 70.7 mm-40 -54.5 -47.78 72.65 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.564 -0.289 . . . . 0.0 111.542 -174.982 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' D' D ' 119' ' ' ASN . . . . . . . . . . . . . 29.5 m120 -93.59 31.06 1.61 Allowed 'General case' 0 C--N 1.329 -0.315 0 N-CA-C 112.15 0.426 . . . . 0.0 112.15 -174.319 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' D' D ' 120' ' ' LEU . . . . . . . . . . . . . 10.3 tp -56.06 120.69 7.89 Favored 'General case' 0 C--N 1.333 -0.139 0 C-N-CA 121.078 -0.249 . . . . 0.0 110.584 177.864 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' D' D ' 121' ' ' ASN . . . . . . . . . . . . . 36.2 m120 -113.78 -44.05 3.22 Favored 'General case' 0 C--O 1.233 0.204 0 CA-C-N 116.575 -0.284 . . . . 0.0 111.178 -177.582 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' D' D ' 122' ' ' LYS . . . . . . . . . . . . . 98.3 mttt -145.72 150.11 35.65 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-O 121.081 0.467 . . . . 0.0 111.945 -177.978 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' D' D ' 123' ' ' VAL . . . . . . . . . . . . . 44.0 t -127.67 127.56 68.6 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.166 0 CA-C-N 115.811 -0.631 . . . . 0.0 109.485 175.292 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' D' D ' 124' ' ' LEU . . . . . . . . . . . . . 35.6 mt -118.02 136.59 53.44 Favored 'General case' 0 C--N 1.332 -0.161 0 CA-C-N 116.426 -0.352 . . . . 0.0 110.606 -179.231 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' D' D ' 125' ' ' VAL . . . . . . . . . . . . . 34.9 m -121.82 141.95 40.16 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.223 0 CA-C-N 116.128 -0.487 . . . . 0.0 110.608 -179.293 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' D' D ' 126' ' ' ARG . . . . . . . . . . . . . 36.5 ptt180 -148.05 114.78 6.04 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-O 121.292 0.567 . . . . 0.0 110.462 177.725 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' D' D ' 127' ' ' ASN . . . . . . . . . . . . . 60.6 t30 49.48 -107.74 0.26 Allowed 'General case' 0 CA--C 1.546 0.823 0 CA-C-O 118.967 -0.539 . . . . 0.0 111.432 -178.516 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' D' D ' 128' ' ' ASP . . . . . . . . . . . . . 20.4 p-10 -114.08 4.98 15.85 Favored 'General case' 0 N--CA 1.469 0.482 0 CA-C-N 119.813 1.188 . . . . 0.0 113.264 179.726 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' D' D ' 129' ' ' LEU . . . . . . . . . . . . . 25.1 mt -108.82 152.75 24.46 Favored 'General case' 0 C--O 1.233 0.222 0 N-CA-C 109.349 -0.612 . . . . 0.0 109.349 178.332 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' D' D ' 130' ' ' VAL . . . . . . . . . . . . . 33.3 m -139.34 150.17 22.84 Favored 'Isoleucine or valine' 0 N--CA 1.462 0.153 0 CA-C-O 121.462 0.649 . . . . 0.0 111.804 -177.756 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' D' D ' 131' ' ' VAL . . . . . . . . . . . . . 43.4 t -136.09 138.49 47.21 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.267 0 CA-C-N 115.321 -0.854 . . . . 0.0 109.891 177.277 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' D' D ' 132' ' ' ILE . . . . . . . . . . . . . 70.6 mt -118.03 133.97 63.14 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.305 0 CA-C-N 116.086 -0.506 . . . . 0.0 109.702 -178.538 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' D' D ' 133' ' ' ILE . . . . . . . . . . . . . 42.9 mm -115.07 124.06 71.34 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.287 0 CA-C-N 116.399 -0.364 . . . . 0.0 110.846 -175.643 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' D' D ' 134' ' ' ASP . . . . . . . . . . . . . 8.9 p-10 -136.6 146.58 46.23 Favored 'General case' 0 C--N 1.332 -0.166 0 N-CA-C 109.651 -0.5 . . . . 0.0 109.651 174.227 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' D' D ' 135' ' ' GLU . . . . . . . . . . . . . 45.7 tp10 -49.9 -28.4 6.58 Favored 'General case' 0 C--N 1.328 -0.346 0 N-CA-C 112.874 0.694 . . . . 0.0 112.874 -172.05 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' D' D ' 136' ' ' GLN . . . . . . . . . . . . . 36.5 tt0 -80.48 -35.6 34.56 Favored 'General case' 0 C--N 1.331 -0.21 0 N-CA-C 112.236 0.458 . . . . 0.0 112.236 -176.048 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' D' D ' 137' ' ' LYS . . . . . . . . . . . . . 58.5 pttt -167.05 172.59 9.98 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-O 121.61 0.719 . . . . 0.0 112.193 -171.994 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' D' D ' 138' ' ' LEU . . . . . . . . . . . . . 5.0 tt -115.8 128.39 55.8 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 115.046 -0.979 . . . . 0.0 109.847 179.749 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' D' D ' 139' ' ' THR . . . . . . . . . . . . . 38.5 m -109.62 130.25 55.53 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.303 -0.408 . . . . 0.0 110.377 -179.459 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' D' D ' 140' ' ' LEU . . . . . . . . . . . . . 10.0 tp -118.46 127.54 53.75 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.025 -0.534 . . . . 0.0 109.914 -178.26 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' D' D ' 141' ' ' ILE . . . . . . . . . . . . . 19.0 mt -125.71 121.64 60.41 Favored 'Isoleucine or valine' 0 C--O 1.234 0.28 0 N-CA-C 109.898 -0.408 . . . . 0.0 109.898 -176.043 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' D' D ' 142' ' ' ARG . . . . . . . . . . . . . 73.9 mtm180 -115.42 123.48 48.73 Favored 'General case' 0 N--CA 1.463 0.179 0 CA-C-N 116.132 -0.485 . . . . 0.0 109.872 -179.463 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' D' D ' 143' ' ' THR . . . . . . . . . . . . . 25.2 p . . . . . 0 C--O 1.219 -0.526 0 CA-C-O 118.047 -0.977 . . . . 0.0 110.57 -179.263 . . . . . . . . 0 0 . 1 . 020 nuclear orig core ' E' E ' 2' ' ' SER . . . . . . . . . . . . . 87.3 p . . . . . 0 N--CA 1.463 0.2 0 CA-C-O 121.042 0.449 . . . . 0.0 111.173 . . . . . . . . . 0 0 . 1 . 020 nuclear orig core ' E' E ' 3' ' ' GLU . . . . . . . . . . . . . 47.6 mp0 -138.74 144.7 39.6 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 115.855 -0.611 . . . . 0.0 110.986 -178.468 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' E' E ' 4' ' ' LEU . . . . . . . . . . . . . 16.8 tp -125.02 125.13 43.38 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 115.809 -0.632 . . . . 0.0 109.931 176.298 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' E' E ' 5' ' ' LYS . . . . . . . . . . . . . 69.2 mttm -106.39 121.71 44.79 Favored 'General case' 0 C--N 1.331 -0.224 0 CA-C-N 116.362 -0.381 . . . . 0.0 110.634 179.078 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' E' E ' 6' ' ' LEU . . . . . . . . . . . . . 77.1 mt -118.65 147.87 43.32 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 115.492 -0.776 . . . . 0.0 110.522 179.768 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' E' E ' 7' ' ' LYS . . . . . . . . . . . . . 84.9 tttt -140.25 142.46 29.93 Favored Pre-proline 0 C--N 1.329 -0.316 0 N-CA-C 109.666 -0.494 . . . . 0.0 109.666 175.687 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' E' E ' 8' ' ' PRO . . . . . . . . . . . . . 85.1 Cg_endo -90.86 147.45 3.87 Favored 'Trans proline' 0 N--CA 1.492 1.391 0 C-N-CA 121.779 1.653 . . . . 0.0 112.081 179.584 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' E' E ' 9' ' ' LEU . . . . . . . . . . . . . 37.4 mt -84.03 -47.69 0.72 Allowed Pre-proline 0 C--N 1.329 -0.301 0 CA-C-O 118.598 -0.715 . . . . 0.0 112.012 178.929 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' E' E ' 10' ' ' PRO . . . . . . . . . . . . . 97.3 Cg_endo -80.76 154.42 20.27 Favored 'Trans proline' 0 N--CA 1.495 1.602 0 C-N-CA 121.124 1.216 . . . . 0.0 111.667 176.052 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' E' E ' 11' ' ' LYS . . . . . . . . . . . . . 58.2 mtpt -88.71 100.99 13.56 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-O 120.804 0.335 . . . . 0.0 110.471 -179.969 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' E' E ' 12' ' ' VAL . . . . . . . . . . . . . 12.3 p -139.6 143.94 29.67 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.224 0 CA-C-N 116.18 -0.464 . . . . 0.0 110.62 -179.225 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' E' E ' 13' ' ' GLU . . . . . . . . . . . . . 45.5 mp0 -90.98 117.41 29.55 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.31 -0.405 . . . . 0.0 110.018 177.254 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' E' E ' 14' ' ' LEU . . . . . . . . . . . . . 25.3 mt -97.93 155.3 37.23 Favored Pre-proline 0 C--N 1.329 -0.283 0 CA-C-N 116.334 -0.394 . . . . 0.0 111.03 -176.832 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' E' E ' 15' ' ' PRO . . . . . . . . . . . . . 32.9 Cg_exo -60.46 161.27 21.0 Favored 'Trans proline' 0 N--CA 1.496 1.676 0 C-N-CA 121.316 1.344 . . . . 0.0 112.048 177.067 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' E' E ' 16' ' ' PRO . . . . . . . . . . . . . 24.6 Cg_exo -61.82 -34.88 81.45 Favored 'Trans proline' 0 N--CA 1.497 1.725 0 C-N-CA 121.472 1.448 . . . . 0.0 112.753 -178.954 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' E' E ' 17' ' ' ASP . . . . . . . . . . . . . 15.7 p-10 -88.38 11.65 16.27 Favored 'General case' 0 CA--C 1.534 0.336 0 N-CA-C 113.24 0.829 . . . . 0.0 113.24 -176.408 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' E' E ' 18' ' ' PHE . . . . . . . . . . . . . 37.3 t80 -56.91 -45.53 82.57 Favored 'General case' 0 C--O 1.231 0.118 0 O-C-N 122.024 -0.423 . . . . 0.0 110.334 -178.377 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' E' E ' 19' ' ' VAL . . . . . . . . . . . . . 13.2 p -56.55 -41.57 73.58 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.317 0 CA-C-N 116.544 -0.298 . . . . 0.0 110.898 -179.013 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' E' E ' 20' ' ' ASP . . . . . . . . . . . . . 78.1 m-20 -61.05 -43.12 99.37 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-O 120.837 0.351 . . . . 0.0 110.889 -178.545 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' E' E ' 21' ' ' VAL . . . . . . . . . . . . . 48.8 t -64.3 -44.86 97.34 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.319 0 C-N-CA 120.797 -0.361 . . . . 0.0 110.448 -176.952 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' E' E ' 22' ' ' ILE . . . . . . . . . . . . . 49.8 mm -55.2 -50.62 62.74 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.247 0 C-N-CA 121.151 -0.22 . . . . 0.0 110.716 178.72 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' E' E ' 23' ' ' ARG . . . . . . . . . . . . . 37.8 ttp180 -55.21 -48.65 73.57 Favored 'General case' 0 C--N 1.329 -0.311 0 C-N-CA 120.949 -0.3 . . . . 0.0 111.567 -177.778 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' E' E ' 24' ' ' ILE . . . . . . . . . . . . . 75.4 mt -58.91 -43.72 89.21 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 C-N-CA 121.054 -0.258 . . . . 0.0 111.368 -176.126 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' E' E ' 25' ' ' LYS . . . . . . . . . . . . . 93.1 mttt -69.34 -39.62 78.04 Favored 'General case' 0 C--N 1.33 -0.268 0 N-CA-C 112.556 0.576 . . . . 0.0 112.556 -178.302 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' E' E ' 26' ' ' LEU . . . . . . . . . . . . . 79.2 mt -78.98 -33.49 45.07 Favored 'General case' 0 C--N 1.331 -0.219 0 N-CA-C 113.673 0.99 . . . . 0.0 113.673 -170.745 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' E' E ' 27' ' ' GLN . . . . . . . . . . . . . 6.3 pt20 -46.4 137.42 6.5 Favored 'General case' 0 N--CA 1.469 0.5 0 N-CA-C 112.861 0.689 . . . . 0.0 112.861 -174.406 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' E' E ' 28' ' ' GLY . . . . . . . . . . . . . . . 99.99 -23.73 34.89 Favored Glycine 0 CA--C 1.533 1.198 0 CA-C-N 115.68 -0.691 . . . . 0.0 112.53 -177.448 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' E' E ' 29' ' ' LYS . . . . . . . . . . . . . 97.7 mttt -97.59 155.13 17.11 Favored 'General case' 0 C--O 1.233 0.235 0 CA-C-N 117.459 0.63 . . . . 0.0 111.132 179.512 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' E' E ' 30' ' ' THR . . . . . . . . . . . . . 27.0 m -103.28 138.52 39.95 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.085 -0.507 . . . . 0.0 110.272 177.545 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' E' E ' 31' ' ' VAL . . . . . . . . . . . . . 34.9 m -130.23 156.73 42.54 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.239 0 CA-C-N 116.385 -0.371 . . . . 0.0 110.879 -178.923 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' E' E ' 32' ' ' ARG . . . . . . . . . . . . . 79.0 mtm180 -136.1 150.4 49.1 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-O 121.32 0.581 . . . . 0.0 110.819 178.112 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' E' E ' 33' ' ' THR . . . . . . . . . . . . . 17.6 m -53.55 141.43 25.54 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.128 -0.487 . . . . 0.0 111.27 -178.625 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' E' E ' 34' ' ' GLY . . . . . . . . . . . . . . . 99.64 -17.08 58.06 Favored Glycine 0 CA--C 1.532 1.149 0 CA-C-O 119.699 -0.501 . . . . 0.0 113.275 179.609 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' E' E ' 35' ' ' ASP . . . . . . . . . . . . . 76.6 m-20 -66.03 147.69 52.95 Favored 'General case' 0 C--O 1.23 0.071 0 CA-C-N 118.054 0.927 . . . . 0.0 111.152 179.054 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' E' E ' 36' ' ' VAL . . . . . . . . . . . . . 46.4 t -122.54 127.97 75.2 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.204 0 CA-C-N 115.83 -0.623 . . . . 0.0 109.649 177.803 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' E' E ' 37' ' ' ILE . . . . . . . . . . . . . 68.2 mt -119.31 138.66 49.28 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.239 0 CA-C-N 116.247 -0.433 . . . . 0.0 109.928 -179.499 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' E' E ' 38' ' ' GLY . . . . . . . . . . . . . . . -110.34 128.58 8.9 Favored Glycine 0 CA--C 1.525 0.7 0 N-CA-C 111.025 -0.83 . . . . 0.0 111.025 179.891 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' E' E ' 39' ' ' ILE . . . . . . . . . . . . . 75.4 mt -126.13 139.34 51.83 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.2 0 N-CA-C 110.027 -0.36 . . . . 0.0 110.027 178.835 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' E' E ' 40' ' ' SER . . . . . . . . . . . . . 31.0 t -92.28 116.66 29.16 Favored 'General case' 0 C--N 1.329 -0.297 0 C-N-CA 120.935 -0.306 . . . . 0.0 110.936 176.107 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' E' E ' 41' ' ' ILE . . . . . . . . . . . . . 46.0 mm -124.59 115.96 46.06 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.157 0 N-CA-C 110.112 -0.329 . . . . 0.0 110.112 178.584 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' E' E ' 42' ' ' LEU . . . . . . . . . . . . . 70.4 mt 57.58 33.43 23.24 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-N 116.196 -0.457 . . . . 0.0 111.793 179.437 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' E' E ' 43' ' ' GLY . . . . . . . . . . . . . . . 81.78 -10.05 53.44 Favored Glycine 0 CA--C 1.534 1.261 0 C-N-CA 121.26 -0.495 . . . . 0.0 113.435 177.043 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' E' E ' 44' ' ' LYS . . . . . . . . . . . . . 53.1 mtpt -100.45 140.45 34.68 Favored 'General case' 0 C--N 1.333 -0.134 0 CA-C-N 117.892 0.846 . . . . 0.0 110.198 178.321 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' E' E ' 45' ' ' GLU . . . . . . . . . . . . . 80.7 tt0 -83.98 126.05 32.65 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.464 -0.334 . . . . 0.0 110.985 -178.752 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' E' E ' 46' ' ' VAL . . . . . . . . . . . . . 7.6 p -120.68 124.37 72.27 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.224 0 N-CA-C 109.409 -0.589 . . . . 0.0 109.409 175.836 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' E' E ' 47' ' ' LYS . . . . . . . . . . . . . 93.1 mttt -100.51 128.5 46.55 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.011 -0.54 . . . . 0.0 111.132 178.027 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' E' E ' 48' ' ' PHE . . . . . . . . . . . . . 93.5 m-85 -109.56 131.96 54.58 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.249 -0.432 . . . . 0.0 110.015 176.499 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' E' E ' 49' ' ' LYS . . . . . . . . . . . . . 80.0 tttt -107.49 134.59 50.3 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.312 -0.403 . . . . 0.0 110.293 179.53 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' E' E ' 50' ' ' VAL . . . . . . . . . . . . . 46.2 t -77.13 110.01 12.31 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.304 0 N-CA-C 109.287 -0.635 . . . . 0.0 109.287 176.393 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' E' E ' 51' ' ' VAL . . . . . . . . . . . . . 48.4 t -74.28 -47.08 42.29 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.278 0 CA-C-N 116.073 -0.512 . . . . 0.0 110.233 -173.852 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' E' E ' 52' ' ' GLN . . . . . . . . . . . . . 61.9 tt0 -168.01 140.08 3.0 Favored 'General case' 0 C--N 1.331 -0.228 0 C-N-CA 120.409 -0.516 . . . . 0.0 111.351 -177.942 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' E' E ' 53' ' ' ALA . . . . . . . . . . . . . . . -117.18 134.46 54.75 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 115.798 -0.637 . . . . 0.0 110.179 175.62 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' E' E ' 54' ' ' TYR . . . . . . . . . . . . . 55.5 t80 -129.05 112.69 18.53 Favored Pre-proline 0 CA--C 1.535 0.375 0 CA-C-O 118.146 -0.93 . . . . 0.0 110.378 177.877 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' E' E ' 55' ' ' PRO . . . . . . . . . . . . . 74.0 Cg_endo -77.09 168.13 77.89 Favored 'Cis proline' 0 N--CA 1.5 1.902 0 CA-C-N 122.14 1.8 . . . . 0.0 112.273 -6.925 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' E' E ' 56' ' ' SER . . . . . . . . . . . . . 15.5 m -116.89 133.79 23.04 Favored Pre-proline 0 CA--C 1.538 0.506 0 CA-C-O 118.414 -0.803 . . . . 0.0 109.572 175.198 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' E' E ' 57' ' ' PRO . . . . . . . . . . . . . 39.4 Cg_endo -67.54 161.11 79.13 Favored 'Cis proline' 0 N--CA 1.497 1.716 0 CA-C-N 121.864 1.701 . . . . 0.0 111.29 -1.695 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' E' E ' 58' ' ' LEU . . . . . . . . . . . . . 21.3 tp -125.99 138.39 53.74 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-O 120.969 0.414 . . . . 0.0 110.46 -178.967 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' E' E ' 59' ' ' ARG . . . . . . . . . . . . . 74.6 ttt180 -103.25 127.0 50.7 Favored 'General case' 0 C--N 1.327 -0.4 0 CA-C-N 115.737 -0.665 . . . . 0.0 109.355 176.249 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' E' E ' 60' ' ' VAL . . . . . . . . . . . . . 41.8 t -77.35 116.74 21.21 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.26 0 C-N-CA 120.672 -0.411 . . . . 0.0 110.156 -176.441 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' E' E ' 61' ' ' GLU . . . . . . . . . . . . . 95.7 mt-10 -131.15 162.17 30.5 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 115.907 -0.588 . . . . 0.0 110.145 178.423 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' E' E ' 62' ' ' ASP . . . . . . . . . . . . . 79.3 m-20 -54.79 -32.67 60.5 Favored 'General case' 0 C--N 1.328 -0.346 0 C-N-CA 121.065 -0.254 . . . . 0.0 111.667 -179.851 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' E' E ' 63' ' ' ARG . . . . . . . . . . . . . 10.8 ptm180 -82.6 6.82 16.47 Favored 'General case' 0 CA--C 1.534 0.354 0 N-CA-C 113.744 1.016 . . . . 0.0 113.744 -175.887 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' E' E ' 64' ' ' THR . . . . . . . . . . . . . 27.6 m -93.43 140.14 29.91 Favored 'General case' 0 C--O 1.232 0.133 0 CA-C-N 118.16 0.436 . . . . 0.0 110.486 -179.62 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' E' E ' 65' ' ' LYS . . . . . . . . . . . . . 68.3 mttm -88.62 124.2 33.83 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.277 -0.42 . . . . 0.0 110.008 179.558 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' E' E ' 66' ' ' ILE . . . . . . . . . . . . . 56.5 mt -113.58 129.8 68.74 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.253 0 N-CA-C 109.815 -0.439 . . . . 0.0 109.815 -179.814 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' E' E ' 67' ' ' THR . . . . . . . . . . . . . 19.0 m -127.21 133.97 50.18 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-O 121.245 0.545 . . . . 0.0 110.767 179.949 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' E' E ' 68' ' ' LEU . . . . . . . . . . . . . 21.7 tp . . . . . 0 C--N 1.33 -0.269 0 CA-C-N 115.737 -0.665 . . . . 0.0 109.72 176.55 . . . . . . . . 0 0 . 1 . 020 nuclear orig core ' E' E ' 73' ' ' VAL . . . . . . . . . . . . . 34.3 m . . . . . 0 C--O 1.232 0.132 0 N-CA-C 110.293 -0.262 . . . . 0.0 110.293 . . . . . . . . . 0 0 . 1 . 020 nuclear orig core ' E' E ' 74' ' ' ASP . . . . . . . . . . . . . 13.9 t70 -77.35 114.98 16.73 Favored 'General case' 0 C--N 1.328 -0.338 0 C-N-CA 120.362 -0.535 . . . . 0.0 110.274 -168.414 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' E' E ' 75' ' ' VAL . . . . . . . . . . . . . 46.8 t -119.38 117.91 55.63 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.273 0 CA-C-O 121.16 0.505 . . . . 0.0 109.733 -179.654 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' E' E ' 76' ' ' LEU . . . . . . . . . . . . . 15.2 mt -124.59 148.57 47.78 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 115.459 -0.791 . . . . 0.0 109.613 -178.329 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' E' E ' 77' ' ' GLU . . . . . . . . . . . . . 45.3 mt-10 -138.77 135.46 34.7 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-O 121.15 0.5 . . . . 0.0 111.266 -177.604 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' E' E ' 78' ' ' ALA . . . . . . . . . . . . . . . -121.78 129.24 52.52 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 115.562 -0.745 . . . . 0.0 109.622 175.708 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' E' E ' 79' ' ' LYS . . . . . . . . . . . . . 48.7 mttm -75.83 117.84 18.0 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-O 121.008 0.433 . . . . 0.0 110.875 -178.55 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' E' E ' 80' ' ' ILE . . . . . . . . . . . . . 38.4 mm -139.14 102.5 1.73 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.261 0 N-CA-C 108.908 -0.775 . . . . 0.0 108.908 -177.95 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' E' E ' 81' ' ' LYS . . . . . . . . . . . . . 53.5 mttp -96.31 127.82 42.66 Favored 'General case' 0 C--N 1.327 -0.397 0 C-N-CA 120.783 -0.367 . . . . 0.0 111.305 -176.489 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' E' E ' 82' ' ' GLY . . . . . . . . . . . . . . . 89.14 42.18 5.66 Favored Glycine 0 CA--C 1.525 0.703 0 C-N-CA 120.714 -0.755 . . . . 0.0 111.867 173.588 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' E' E ' 83' ' ' ILE . . . . . . . . . . . . . 70.7 mt -70.95 135.0 28.98 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.358 0 N-CA-C 109.477 -0.564 . . . . 0.0 109.477 177.186 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' E' E ' 84' ' ' LYS . . . . . . . . . . . . . 31.1 ttpt -94.34 -51.64 4.7 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-O 121.023 0.44 . . . . 0.0 110.212 -177.521 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' E' E ' 85' ' ' ASP . . . . . . . . . . . . . 8.9 t70 -149.49 149.31 30.57 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 115.696 -0.684 . . . . 0.0 110.068 -179.383 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' E' E ' 86' ' ' VAL . . . . . . . . . . . . . 39.6 t -132.3 133.65 59.99 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.244 0 CA-C-O 120.959 0.409 . . . . 0.0 110.502 -179.671 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' E' E ' 87' ' ' ILE . . . . . . . . . . . . . 5.0 mp -118.94 123.48 71.56 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 N-CA-C 109.206 -0.665 . . . . 0.0 109.206 176.717 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' E' E ' 88' ' ' LEU . . . . . . . . . . . . . 14.0 tp -109.43 119.52 39.72 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.401 -0.363 . . . . 0.0 110.475 -179.068 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' E' E ' 89' ' ' ASP . . . . . . . . . . . . . 6.6 t70 -112.28 153.92 26.43 Favored 'General case' 0 C--N 1.33 -0.28 0 N-CA-C 109.628 -0.508 . . . . 0.0 109.628 178.249 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' E' E ' 90' ' ' GLU . . . . . . . . . . . . . 82.0 tt0 -47.76 -36.86 12.22 Favored 'General case' 0 C--N 1.329 -0.296 0 N-CA-C 112.685 0.624 . . . . 0.0 112.685 -173.364 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' E' E ' 91' ' ' ASN . . . . . . . . . . . . . 13.2 p30 -131.97 32.19 4.08 Favored 'General case' 0 N--CA 1.465 0.285 0 N-CA-C 112.29 0.478 . . . . 0.0 112.29 -175.79 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' E' E ' 92' ' ' LEU . . . . . . . . . . . . . 6.4 tp -166.02 144.68 5.87 Favored 'General case' 0 C--N 1.332 -0.183 0 C-N-CA 120.686 -0.406 . . . . 0.0 111.016 -179.656 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' E' E ' 93' ' ' ILE . . . . . . . . . . . . . 62.3 mt -119.82 119.87 61.59 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.24 0 N-CA-C 109.346 -0.613 . . . . 0.0 109.346 -179.787 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' E' E ' 94' ' ' VAL . . . . . . . . . . . . . 45.5 t -122.22 126.44 74.3 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.293 0 CA-C-O 120.849 0.357 . . . . 0.0 110.212 -178.984 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' E' E ' 95' ' ' VAL . . . . . . . . . . . . . 42.9 t -123.65 134.23 66.99 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.209 0 CA-C-N 116.109 -0.496 . . . . 0.0 110.093 -179.356 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' E' E ' 96' ' ' ILE . . . . . . . . . . . . . 66.6 mt -117.13 127.54 74.69 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.257 0 N-CA-C 109.509 -0.552 . . . . 0.0 109.509 178.634 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' E' E ' 97' ' ' THR . . . . . . . . . . . . . 82.0 p -99.28 157.33 16.46 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-O 121.13 0.491 . . . . 0.0 111.282 -177.433 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' E' E ' 98' ' ' GLU . . . . . . . . . . . . . 96.7 mt-10 -54.62 -26.45 32.89 Favored 'General case' 0 C--N 1.328 -0.328 0 N-CA-C 112.236 0.458 . . . . 0.0 112.236 -179.829 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' E' E ' 99' ' ' GLU . . . . . . . . . . . . . 95.7 mt-10 -78.22 14.7 1.11 Allowed 'General case' 0 CA--C 1.536 0.43 0 N-CA-C 113.1 0.778 . . . . 0.0 113.1 -177.425 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' E' E ' 100' ' ' ASN . . . . . . . . . . . . . 4.5 m-20 63.47 38.03 10.19 Favored 'General case' 0 C--O 1.232 0.149 0 CA-C-O 121.055 0.455 . . . . 0.0 110.951 178.11 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' E' E ' 101' ' ' GLU . . . . . . . . . . . . . 83.3 tt0 -119.24 141.31 49.03 Favored 'General case' 0 C--N 1.332 -0.192 0 N-CA-C 109.601 -0.518 . . . . 0.0 109.601 176.178 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' E' E ' 102' ' ' VAL . . . . . . . . . . . . . 41.8 t -115.03 130.9 68.76 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.271 0 CA-C-O 120.812 0.339 . . . . 0.0 110.407 -177.527 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' E' E ' 103' ' ' LEU . . . . . . . . . . . . . 27.1 mt -119.29 130.89 55.64 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 115.454 -0.794 . . . . 0.0 109.992 176.725 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' E' E ' 104' ' ' ILE . . . . . . . . . . . . . 72.4 mt -119.65 123.56 71.26 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.252 0 N-CA-C 110.096 -0.335 . . . . 0.0 110.096 179.506 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' E' E ' 105' ' ' PHE . . . . . . . . . . . . . 66.9 m-85 -124.86 162.99 23.16 Favored 'General case' 0 C--N 1.332 -0.159 0 O-C-N 123.735 0.647 . . . . 0.0 110.482 -177.792 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' E' E ' 106' ' ' ASN . . . . . . . . . . . . . 40.6 p-10 -100.7 -169.98 1.79 Allowed 'General case' 0 CA--C 1.531 0.218 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.263 175.592 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' E' E ' 107' ' ' GLN . . . . . . . . . . . . . 47.2 tt0 -59.09 -29.97 67.74 Favored 'General case' 0 CA--C 1.531 0.232 0 N-CA-C 112.017 0.377 . . . . 0.0 112.017 179.917 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' E' E ' 108' ' ' ASN . . . . . . . . . . . . . 12.2 t-20 -86.01 9.62 16.57 Favored 'General case' 0 CA--C 1.534 0.348 0 N-CA-C 113.275 0.842 . . . . 0.0 113.275 -177.087 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' E' E ' 109' ' ' LEU . . . . . . . . . . . . . 12.1 tp 57.76 40.11 26.55 Favored 'General case' 0 CA--C 1.529 0.169 0 CA-C-O 121.206 0.527 . . . . 0.0 111.012 178.33 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' E' E ' 110' ' ' GLU . . . . . . . . . . . . . 95.5 mt-10 -108.32 156.93 18.83 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.202 -0.454 . . . . 0.0 109.99 175.953 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' E' E ' 111' ' ' GLU . . . . . . . . . . . . . 35.5 tt0 -81.61 122.08 27.15 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-O 120.892 0.377 . . . . 0.0 110.744 -177.304 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' E' E ' 112' ' ' LEU . . . . . . . . . . . . . 16.8 mt -107.74 -45.94 3.91 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 115.991 -0.549 . . . . 0.0 110.219 175.996 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' E' E ' 113' ' ' TYR . . . . . . . . . . . . . 63.2 t80 -139.5 135.08 33.13 Favored 'General case' 0 C--N 1.332 -0.19 0 C-N-CA 120.814 -0.355 . . . . 0.0 111.456 179.624 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' E' E ' 114' ' ' ARG . . . . . . . . . . . . . 19.4 ttm180 -133.76 123.85 25.61 Favored 'General case' 0 C--N 1.331 -0.224 0 CA-C-N 115.811 -0.631 . . . . 0.0 109.72 175.58 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' E' E ' 115' ' ' GLY . . . . . . . . . . . . . . . -150.11 141.36 8.72 Favored Glycine 0 CA--C 1.524 0.655 0 N-CA-C 111.272 -0.731 . . . . 0.0 111.272 178.906 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' E' E ' 116' ' ' LYS . . . . . . . . . . . . . 17.1 ttpp -116.57 130.72 56.9 Favored 'General case' 0 C--N 1.332 -0.194 0 N-CA-C 109.748 -0.464 . . . . 0.0 109.748 177.443 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' E' E ' 117' ' ' PHE . . . . . . . . . . . . . 38.6 m-85 -130.58 114.04 14.96 Favored 'General case' 0 C--N 1.331 -0.213 0 CA-C-O 120.782 0.325 . . . . 0.0 110.211 -175.696 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' E' E ' 118' ' ' GLU . . . . . . . . . . . . . 96.0 mt-10 -55.54 -41.49 73.29 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.406 -0.361 . . . . 0.0 111.102 -176.695 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' E' E ' 119' ' ' ASN . . . . . . . . . . . . . 34.7 m-80 -99.57 30.96 3.36 Favored 'General case' 0 C--N 1.33 -0.268 0 N-CA-C 112.121 0.415 . . . . 0.0 112.121 -174.123 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' E' E ' 120' ' ' LEU . . . . . . . . . . . . . 13.7 tp -55.33 121.3 8.61 Favored 'General case' 0 C--N 1.333 -0.115 0 CA-C-O 120.747 0.308 . . . . 0.0 110.736 178.382 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' E' E ' 121' ' ' ASN . . . . . . . . . . . . . 72.0 m-80 -112.51 -44.13 3.4 Favored 'General case' 0 C--N 1.332 -0.175 0 CA-C-N 116.316 -0.402 . . . . 0.0 110.841 -178.145 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' E' E ' 122' ' ' LYS . . . . . . . . . . . . . 35.4 mtmm -147.47 147.05 29.78 Favored 'General case' 0 C--N 1.331 -0.231 0 C-N-CA 120.6 -0.44 . . . . 0.0 111.783 -177.985 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' E' E ' 123' ' ' VAL . . . . . . . . . . . . . 45.5 t -123.94 127.27 73.54 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.233 0 CA-C-N 115.88 -0.6 . . . . 0.0 109.562 176.133 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' E' E ' 124' ' ' LEU . . . . . . . . . . . . . 51.5 mt -119.73 136.36 54.46 Favored 'General case' 0 C--N 1.331 -0.23 0 CA-C-N 116.355 -0.384 . . . . 0.0 110.673 -177.743 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' E' E ' 125' ' ' VAL . . . . . . . . . . . . . 12.1 p -133.31 135.25 56.58 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.265 0 CA-C-O 120.749 0.309 . . . . 0.0 110.392 178.505 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' E' E ' 126' ' ' ARG . . . . . . . . . . . . . 95.8 mtt-85 -144.5 120.9 10.97 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-N 116.093 -0.503 . . . . 0.0 110.566 179.139 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' E' E ' 127' ' ' ASN . . . . . . . . . . . . . 94.9 m-20 50.4 -108.02 0.31 Allowed 'General case' 0 CA--C 1.544 0.721 0 CA-C-O 118.854 -0.593 . . . . 0.0 111.428 179.662 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' E' E ' 128' ' ' ASP . . . . . . . . . . . . . 11.0 p-10 -114.08 6.85 16.54 Favored 'General case' 0 CA--C 1.536 0.436 0 CA-C-N 119.796 1.18 . . . . 0.0 113.417 -177.776 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' E' E ' 129' ' ' LEU . . . . . . . . . . . . . 6.1 mp -110.75 150.04 29.66 Favored 'General case' 0 C--O 1.233 0.189 0 CA-C-N 118.206 0.457 . . . . 0.0 110.435 178.666 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' E' E ' 130' ' ' VAL . . . . . . . . . . . . . 40.6 t -130.86 140.98 47.35 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.237 0 CA-C-N 116.271 -0.422 . . . . 0.0 110.406 -178.213 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' E' E ' 131' ' ' VAL . . . . . . . . . . . . . 41.3 t -134.92 135.88 52.51 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 CA-C-N 116.096 -0.502 . . . . 0.0 109.806 177.835 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' E' E ' 132' ' ' ILE . . . . . . . . . . . . . 71.3 mt -119.29 133.68 65.32 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.25 0 N-CA-C 109.737 -0.468 . . . . 0.0 109.737 -179.842 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' E' E ' 133' ' ' ILE . . . . . . . . . . . . . 41.8 mm -115.9 123.58 71.35 Favored 'Isoleucine or valine' 0 C--O 1.233 0.223 0 CA-C-N 116.39 -0.368 . . . . 0.0 110.663 -176.867 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' E' E ' 134' ' ' ASP . . . . . . . . . . . . . 10.1 p-10 -134.88 150.14 50.4 Favored 'General case' 0 C--N 1.331 -0.237 0 N-CA-C 109.75 -0.463 . . . . 0.0 109.75 175.332 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' E' E ' 135' ' ' GLU . . . . . . . . . . . . . 40.6 tp10 -49.95 -27.29 5.14 Favored 'General case' 0 C--N 1.328 -0.347 0 N-CA-C 112.809 0.67 . . . . 0.0 112.809 -171.581 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' E' E ' 136' ' ' GLN . . . . . . . . . . . . . 43.4 tt0 -89.99 -29.97 18.09 Favored 'General case' 0 C--O 1.234 0.266 0 N-CA-C 112.619 0.6 . . . . 0.0 112.619 -173.388 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' E' E ' 137' ' ' LYS . . . . . . . . . . . . . 52.2 pttt -163.86 173.02 13.23 Favored 'General case' 0 C--N 1.332 -0.179 0 CA-C-O 121.528 0.68 . . . . 0.0 112.448 -173.238 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' E' E ' 138' ' ' LEU . . . . . . . . . . . . . 6.4 tt -121.15 129.94 53.49 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 115.03 -0.986 . . . . 0.0 109.928 178.579 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' E' E ' 139' ' ' THR . . . . . . . . . . . . . 27.9 m -111.78 129.49 56.11 Favored 'General case' 0 C--N 1.331 -0.211 0 CA-C-N 116.315 -0.402 . . . . 0.0 110.676 -178.856 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' E' E ' 140' ' ' LEU . . . . . . . . . . . . . 8.7 tp -117.14 120.7 39.1 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 115.748 -0.66 . . . . 0.0 109.363 -177.989 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' E' E ' 141' ' ' ILE . . . . . . . . . . . . . 19.4 mt -119.49 121.42 66.33 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.239 0 CA-C-O 120.818 0.342 . . . . 0.0 110.219 -175.701 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' E' E ' 142' ' ' ARG . . . . . . . . . . . . . 75.1 mtp180 -111.85 130.4 55.83 Favored 'General case' 0 C--N 1.331 -0.222 0 CA-C-N 115.556 -0.747 . . . . 0.0 110.185 -178.666 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' E' E ' 143' ' ' THR . . . . . . . . . . . . . 39.9 p . . . . . 0 C--O 1.219 -0.506 0 CA-C-O 118.011 -0.995 . . . . 0.0 110.598 179.953 . . . . . . . . 0 0 . 1 . 020 nuclear orig core ' F' F ' 1' ' ' MET . . . . . . . . . . . . . 26.1 ptt? . . . . . 0 CA--C 1.527 0.094 0 CA-C-O 120.849 0.356 . . . . 0.0 110.441 . . . . . . . . . 0 0 . 1 . 020 nuclear orig core ' F' F ' 2' ' ' SER . . . . . . . . . . . . . 6.2 p -108.34 139.38 43.13 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-N 116.1 -0.5 . . . . 0.0 110.805 -178.536 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' F' F ' 3' ' ' GLU . . . . . . . . . . . . . 33.1 tp10 -139.18 133.58 31.6 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 115.723 -0.671 . . . . 0.0 110.194 -178.102 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' F' F ' 4' ' ' LEU . . . . . . . . . . . . . 19.7 tp -125.15 127.59 47.08 Favored 'General case' 0 C--N 1.331 -0.196 0 N-CA-C 110.071 -0.344 . . . . 0.0 110.071 175.23 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' F' F ' 5' ' ' LYS . . . . . . . . . . . . . 98.7 mttt -111.14 121.39 45.18 Favored 'General case' 0 C--O 1.235 0.302 0 CA-C-O 120.831 0.348 . . . . 0.0 110.827 179.378 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' F' F ' 6' ' ' LEU . . . . . . . . . . . . . 60.4 mt -114.46 143.31 45.15 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 115.369 -0.832 . . . . 0.0 109.898 179.549 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' F' F ' 7' ' ' LYS . . . . . . . . . . . . . 80.6 tttt -123.43 134.23 25.08 Favored Pre-proline 0 CA--C 1.534 0.339 0 CA-C-O 118.893 -0.575 . . . . 0.0 109.812 175.96 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' F' F ' 8' ' ' PRO . . . . . . . . . . . . . 94.4 Cg_endo -92.03 136.57 1.69 Allowed 'Trans proline' 0 N--CA 1.489 1.261 0 C-N-CA 121.607 1.538 . . . . 0.0 111.703 177.722 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' F' F ' 9' ' ' LEU . . . . . . . . . . . . . 63.0 mt -79.32 -47.53 1.57 Allowed Pre-proline 0 CA--C 1.533 0.301 0 CA-C-O 118.61 -0.71 . . . . 0.0 112.1 -179.486 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' F' F ' 10' ' ' PRO . . . . . . . . . . . . . 90.1 Cg_endo -80.9 149.82 18.04 Favored 'Trans proline' 0 N--CA 1.496 1.63 0 C-N-CA 121.207 1.271 . . . . 0.0 111.87 176.502 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' F' F ' 11' ' ' LYS . . . . . . . . . . . . . 45.3 tttp -88.25 111.2 21.39 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-O 120.753 0.311 . . . . 0.0 110.371 178.99 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' F' F ' 12' ' ' VAL . . . . . . . . . . . . . 12.4 p -145.52 146.78 19.24 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.299 0 CA-C-O 120.898 0.38 . . . . 0.0 110.801 -178.645 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' F' F ' 13' ' ' GLU . . . . . . . . . . . . . 70.3 mm-40 -88.22 108.95 19.55 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.084 -0.507 . . . . 0.0 110.382 175.384 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' F' F ' 14' ' ' LEU . . . . . . . . . . . . . 38.9 mt -91.75 147.04 34.23 Favored Pre-proline 0 C--N 1.328 -0.361 0 CA-C-N 116.125 -0.489 . . . . 0.0 110.012 -179.439 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' F' F ' 15' ' ' PRO . . . . . . . . . . . . . 36.3 Cg_exo -58.37 157.42 26.51 Favored 'Trans proline' 0 N--CA 1.497 1.705 0 C-N-CA 121.237 1.291 . . . . 0.0 111.823 179.024 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' F' F ' 16' ' ' PRO . . . . . . . . . . . . . 36.9 Cg_exo -58.22 -36.79 97.45 Favored 'Trans proline' 0 N--CA 1.497 1.73 0 C-N-CA 121.384 1.389 . . . . 0.0 112.876 -178.505 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' F' F ' 17' ' ' ASP . . . . . . . . . . . . . 8.7 p-10 -83.51 12.19 5.98 Favored 'General case' 0 CA--C 1.536 0.412 0 N-CA-C 113.146 0.795 . . . . 0.0 113.146 -177.803 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' F' F ' 18' ' ' PHE . . . . . . . . . . . . . 45.6 t80 -56.78 -45.86 81.88 Favored 'General case' 0 N--CA 1.457 -0.096 0 O-C-N 122.007 -0.433 . . . . 0.0 110.424 -178.566 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' F' F ' 19' ' ' VAL . . . . . . . . . . . . . 15.0 p -54.85 -41.04 55.24 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.273 0 CA-C-N 116.549 -0.296 . . . . 0.0 111.175 -178.176 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' F' F ' 20' ' ' ASP . . . . . . . . . . . . . 73.7 m-20 -60.72 -45.25 94.99 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-O 120.814 0.34 . . . . 0.0 111.075 -178.429 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' F' F ' 21' ' ' VAL . . . . . . . . . . . . . 47.6 t -64.64 -46.97 90.83 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.328 0 C-N-CA 120.65 -0.42 . . . . 0.0 110.574 -177.273 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' F' F ' 22' ' ' ILE . . . . . . . . . . . . . 50.8 mm -56.46 -45.73 81.97 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.271 0 CA-C-O 120.875 0.369 . . . . 0.0 110.462 179.443 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' F' F ' 23' ' ' ARG . . . . . . . . . . . . . 32.3 ttp180 -53.64 -49.03 68.78 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.655 -0.248 . . . . 0.0 111.369 -179.076 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' F' F ' 24' ' ' ILE . . . . . . . . . . . . . 67.8 mt -59.27 -48.27 87.55 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.336 0 C-N-CA 121.039 -0.265 . . . . 0.0 111.193 -177.361 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' F' F ' 25' ' ' LYS . . . . . . . . . . . . . 98.8 mttt -64.35 -36.23 83.45 Favored 'General case' 0 C--N 1.329 -0.286 0 N-CA-C 112.538 0.57 . . . . 0.0 112.538 -177.029 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' F' F ' 26' ' ' LEU . . . . . . . . . . . . . 53.4 mt -77.47 -43.77 31.19 Favored 'General case' 0 C--N 1.33 -0.259 0 N-CA-C 112.869 0.692 . . . . 0.0 112.869 -173.169 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' F' F ' 27' ' ' GLN . . . . . . . . . . . . . 10.9 pt20 -47.4 137.91 8.1 Favored 'General case' 0 N--CA 1.468 0.439 0 N-CA-C 112.714 0.635 . . . . 0.0 112.714 -175.424 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' F' F ' 28' ' ' GLY . . . . . . . . . . . . . . . 101.02 -26.45 24.63 Favored Glycine 0 CA--C 1.533 1.165 0 CA-C-N 115.587 -0.733 . . . . 0.0 112.235 -176.998 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' F' F ' 29' ' ' LYS . . . . . . . . . . . . . 66.7 mmtt -98.14 155.1 17.31 Favored 'General case' 0 C--O 1.233 0.217 0 CA-C-N 117.311 0.556 . . . . 0.0 111.26 178.792 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' F' F ' 30' ' ' THR . . . . . . . . . . . . . 26.9 m -107.95 139.8 42.04 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 115.882 -0.599 . . . . 0.0 110.152 176.741 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' F' F ' 31' ' ' VAL . . . . . . . . . . . . . 34.7 m -129.5 157.67 42.19 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.267 0 CA-C-N 116.373 -0.376 . . . . 0.0 111.08 -178.121 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' F' F ' 32' ' ' ARG . . . . . . . . . . . . . 88.7 mtt180 -131.03 149.02 52.8 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 115.7 -0.682 . . . . 0.0 110.34 177.01 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' F' F ' 33' ' ' THR . . . . . . . . . . . . . 14.1 m -53.5 138.47 33.72 Favored 'General case' 0 C--N 1.332 -0.189 0 CA-C-N 116.489 -0.323 . . . . 0.0 111.271 -177.949 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' F' F ' 34' ' ' GLY . . . . . . . . . . . . . . . 100.72 -17.04 57.06 Favored Glycine 0 CA--C 1.532 1.139 0 CA-C-O 119.632 -0.538 . . . . 0.0 113.298 179.326 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' F' F ' 35' ' ' ASP . . . . . . . . . . . . . 54.1 m-20 -63.0 150.63 41.93 Favored 'General case' 0 C--O 1.233 0.206 0 CA-C-N 118.121 0.961 . . . . 0.0 111.316 -179.926 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' F' F ' 36' ' ' VAL . . . . . . . . . . . . . 45.3 t -123.33 129.48 74.79 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.232 0 CA-C-N 115.76 -0.655 . . . . 0.0 109.822 178.582 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' F' F ' 37' ' ' ILE . . . . . . . . . . . . . 67.5 mt -124.84 140.41 48.08 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.257 0 CA-C-N 116.304 -0.407 . . . . 0.0 110.183 -179.096 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' F' F ' 38' ' ' GLY . . . . . . . . . . . . . . . -118.65 128.71 7.81 Favored Glycine 0 CA--C 1.525 0.689 0 N-CA-C 111.181 -0.768 . . . . 0.0 111.181 179.322 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' F' F ' 39' ' ' ILE . . . . . . . . . . . . . 77.4 mt -127.36 141.25 46.83 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.276 0 N-CA-C 110.234 -0.284 . . . . 0.0 110.234 179.218 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' F' F ' 40' ' ' SER . . . . . . . . . . . . . 76.8 p -92.48 119.11 31.66 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.445 -0.343 . . . . 0.0 110.995 176.068 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' F' F ' 41' ' ' ILE . . . . . . . . . . . . . 43.8 mm -121.05 118.74 57.22 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.195 0 CA-C-N 116.463 -0.335 . . . . 0.0 110.141 178.125 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' F' F ' 42' ' ' LEU . . . . . . . . . . . . . 64.5 mt 52.05 34.42 13.97 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.308 -0.405 . . . . 0.0 111.907 177.194 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' F' F ' 43' ' ' GLY . . . . . . . . . . . . . . . 76.74 28.8 58.52 Favored Glycine 0 CA--C 1.53 1.028 0 C-N-CA 121.185 -0.531 . . . . 0.0 112.523 176.693 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' F' F ' 44' ' ' LYS . . . . . . . . . . . . . 7.8 ttpm? -140.52 131.28 25.79 Favored 'General case' 0 C--N 1.33 -0.242 0 N-CA-C 109.289 -0.634 . . . . 0.0 109.289 176.316 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' F' F ' 45' ' ' GLU . . . . . . . . . . . . . 81.3 tt0 -82.4 126.71 32.5 Favored 'General case' 0 C--N 1.328 -0.332 0 C-N-CA 120.865 -0.334 . . . . 0.0 111.263 -175.806 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' F' F ' 46' ' ' VAL . . . . . . . . . . . . . 10.4 p -118.2 124.96 73.88 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.2 0 N-CA-C 109.532 -0.544 . . . . 0.0 109.532 175.091 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' F' F ' 47' ' ' LYS . . . . . . . . . . . . . 62.0 mttp -99.14 125.53 44.71 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 115.866 -0.606 . . . . 0.0 110.942 178.105 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' F' F ' 48' ' ' PHE . . . . . . . . . . . . . 33.7 m-85 -110.26 131.91 54.64 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.037 -0.529 . . . . 0.0 109.921 177.384 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' F' F ' 49' ' ' LYS . . . . . . . . . . . . . 43.0 tttp -107.67 132.99 52.74 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 116.31 -0.404 . . . . 0.0 109.975 176.402 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' F' F ' 50' ' ' VAL . . . . . . . . . . . . . 44.0 t -76.81 107.82 8.71 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.312 0 N-CA-C 109.483 -0.562 . . . . 0.0 109.483 178.701 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' F' F ' 51' ' ' VAL . . . . . . . . . . . . . 44.7 t -72.43 -50.42 35.31 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.289 0 CA-C-N 116.022 -0.535 . . . . 0.0 109.825 -174.747 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' F' F ' 52' ' ' GLN . . . . . . . . . . . . . 62.8 tt0 -159.06 144.61 16.25 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 115.836 -0.62 . . . . 0.0 111.501 -176.908 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' F' F ' 53' ' ' ALA . . . . . . . . . . . . . . . -123.25 132.43 54.02 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 115.524 -0.762 . . . . 0.0 109.931 175.971 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' F' F ' 54' ' ' TYR . . . . . . . . . . . . . 67.7 t80 -129.13 112.81 18.43 Favored Pre-proline 0 CA--C 1.536 0.407 0 CA-C-O 118.154 -0.927 . . . . 0.0 110.261 177.351 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' F' F ' 55' ' ' PRO . . . . . . . . . . . . . 74.4 Cg_endo -77.05 166.97 81.17 Favored 'Cis proline' 0 N--CA 1.501 1.919 0 CA-C-N 122.09 1.782 . . . . 0.0 112.467 -5.4 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' F' F ' 56' ' ' SER . . . . . . . . . . . . . 13.7 m -114.05 124.99 29.96 Favored Pre-proline 0 CA--C 1.539 0.535 0 CA-C-O 118.369 -0.824 . . . . 0.0 109.381 176.506 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' F' F ' 57' ' ' PRO . . . . . . . . . . . . . 39.5 Cg_endo -67.16 166.24 64.07 Favored 'Cis proline' 0 N--CA 1.498 1.751 0 CA-C-N 122.065 1.773 . . . . 0.0 111.556 0.939 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' F' F ' 58' ' ' LEU . . . . . . . . . . . . . 24.0 tp -127.46 135.0 49.81 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.227 -0.442 . . . . 0.0 110.365 179.958 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' F' F ' 59' ' ' ARG . . . . . . . . . . . . . 57.4 ttp180 -106.63 123.1 47.61 Favored 'General case' 0 C--N 1.328 -0.358 0 N-CA-C 109.244 -0.65 . . . . 0.0 109.244 177.129 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' F' F ' 60' ' ' VAL . . . . . . . . . . . . . 44.5 t -78.12 122.22 32.57 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.347 0 C-N-CA 120.753 -0.379 . . . . 0.0 110.546 -174.049 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' F' F ' 61' ' ' GLU . . . . . . . . . . . . . 95.5 mt-10 -131.06 164.92 24.36 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-N 115.804 -0.635 . . . . 0.0 109.784 176.293 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' F' F ' 62' ' ' ASP . . . . . . . . . . . . . 80.5 m-20 -53.94 -32.66 54.4 Favored 'General case' 0 C--N 1.328 -0.342 0 C-N-CA 121.027 -0.269 . . . . 0.0 111.646 -179.663 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' F' F ' 63' ' ' ARG . . . . . . . . . . . . . 24.4 mmt180 -73.07 -21.39 60.79 Favored 'General case' 0 CA--C 1.533 0.32 0 N-CA-C 113.034 0.753 . . . . 0.0 113.034 -177.519 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' F' F ' 64' ' ' THR . . . . . . . . . . . . . 30.9 m -68.08 137.35 54.91 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-O 120.882 0.373 . . . . 0.0 111.009 -174.201 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' F' F ' 65' ' ' LYS . . . . . . . . . . . . . 97.9 mttt -90.36 132.17 35.73 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.038 -0.528 . . . . 0.0 109.992 178.525 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' F' F ' 66' ' ' ILE . . . . . . . . . . . . . 64.2 mt -119.51 131.39 72.25 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.264 0 CA-C-O 120.934 0.397 . . . . 0.0 110.071 -179.822 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' F' F ' 67' ' ' THR . . . . . . . . . . . . . 22.9 m -123.39 139.03 54.45 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 115.96 -0.563 . . . . 0.0 110.651 -179.412 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' F' F ' 68' ' ' LEU . . . . . . . . . . . . . 6.3 tt . . . . . 0 C--N 1.331 -0.225 0 CA-C-N 116.108 -0.496 . . . . 0.0 110.506 179.673 . . . . . . . . 0 0 . 1 . 020 nuclear orig core ' F' F ' 73' ' ' VAL . . . . . . . . . . . . . 35.6 m . . . . . 0 N--CA 1.462 0.15 0 N-CA-C 109.747 -0.464 . . . . 0.0 109.747 . . . . . . . . . 0 0 . 1 . 020 nuclear orig core ' F' F ' 74' ' ' ASP . . . . . . . . . . . . . 12.0 t0 -96.43 117.19 30.37 Favored 'General case' 0 C--N 1.332 -0.192 0 C-N-CA 120.743 -0.383 . . . . 0.0 110.065 -176.284 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' F' F ' 75' ' ' VAL . . . . . . . . . . . . . 41.9 t -116.99 122.21 69.54 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.253 0 CA-C-O 120.985 0.421 . . . . 0.0 110.522 -178.043 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' F' F ' 76' ' ' LEU . . . . . . . . . . . . . 6.2 mp -119.85 144.96 47.08 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 115.675 -0.693 . . . . 0.0 109.782 176.51 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' F' F ' 77' ' ' GLU . . . . . . . . . . . . . 46.3 mt-10 -136.11 136.75 40.38 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-O 121.082 0.468 . . . . 0.0 111.351 -179.278 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' F' F ' 78' ' ' ALA . . . . . . . . . . . . . . . -123.97 132.27 53.68 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-N 115.68 -0.691 . . . . 0.0 109.7 175.873 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' F' F ' 79' ' ' LYS . . . . . . . . . . . . . 62.1 mttp -81.17 117.37 21.66 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-O 120.925 0.393 . . . . 0.0 110.669 -178.814 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' F' F ' 80' ' ' ILE . . . . . . . . . . . . . 40.3 mm -139.04 112.25 6.44 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.37 0 N-CA-C 109.13 -0.693 . . . . 0.0 109.13 -177.002 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' F' F ' 81' ' ' LYS . . . . . . . . . . . . . 79.0 tttt -102.08 127.49 48.96 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-O 120.852 0.358 . . . . 0.0 111.071 -177.668 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' F' F ' 82' ' ' GLY . . . . . . . . . . . . . . . 89.07 42.15 5.69 Favored Glycine 0 CA--C 1.525 0.691 0 C-N-CA 120.872 -0.68 . . . . 0.0 112.037 174.481 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' F' F ' 83' ' ' ILE . . . . . . . . . . . . . 68.7 mt -71.6 136.93 24.73 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.351 0 N-CA-C 109.281 -0.637 . . . . 0.0 109.281 175.684 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' F' F ' 84' ' ' LYS . . . . . . . . . . . . . 27.7 ttpp -94.94 -48.92 5.79 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-O 121.03 0.443 . . . . 0.0 110.047 -178.717 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' F' F ' 85' ' ' ASP . . . . . . . . . . . . . 10.0 t70 -154.57 153.38 31.32 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 115.756 -0.656 . . . . 0.0 110.562 -179.682 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' F' F ' 86' ' ' VAL . . . . . . . . . . . . . 41.9 t -128.98 133.47 66.01 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.202 0 CA-C-O 121.043 0.449 . . . . 0.0 110.243 179.201 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' F' F ' 87' ' ' ILE . . . . . . . . . . . . . 43.9 mm -117.77 123.69 72.04 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.263 0 CA-C-N 115.777 -0.647 . . . . 0.0 109.277 177.21 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' F' F ' 88' ' ' LEU . . . . . . . . . . . . . 14.7 tp -115.02 125.28 53.4 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-O 121.147 0.498 . . . . 0.0 111.44 -175.701 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' F' F ' 89' ' ' ASP . . . . . . . . . . . . . 13.2 t70 -118.4 154.78 31.86 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 115.525 -0.761 . . . . 0.0 109.147 174.185 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' F' F ' 90' ' ' GLU . . . . . . . . . . . . . 96.0 mt-10 -48.7 -39.92 26.35 Favored 'General case' 0 C--N 1.329 -0.302 0 N-CA-C 112.717 0.636 . . . . 0.0 112.717 -172.187 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' F' F ' 91' ' ' ASN . . . . . . . . . . . . . 21.8 p30 -132.15 38.09 3.52 Favored 'General case' 0 N--CA 1.464 0.259 0 CA-C-O 120.815 0.341 . . . . 0.0 111.477 -178.291 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' F' F ' 92' ' ' LEU . . . . . . . . . . . . . 18.4 tp -165.64 137.99 4.15 Favored 'General case' 0 C--N 1.329 -0.298 0 N-CA-C 110.25 -0.278 . . . . 0.0 110.25 -179.996 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' F' F ' 93' ' ' ILE . . . . . . . . . . . . . 71.5 mt -125.02 126.49 71.24 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.23 0 N-CA-C 109.91 -0.404 . . . . 0.0 109.91 -176.956 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' F' F ' 94' ' ' VAL . . . . . . . . . . . . . 44.0 t -125.05 128.47 73.04 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.207 0 N-CA-C 109.915 -0.402 . . . . 0.0 109.915 178.212 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' F' F ' 95' ' ' VAL . . . . . . . . . . . . . 44.0 t -120.14 133.4 67.0 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.302 0 CA-C-N 116.096 -0.502 . . . . 0.0 109.749 179.001 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' F' F ' 96' ' ' ILE . . . . . . . . . . . . . 64.3 mt -115.66 128.11 73.02 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.293 0 N-CA-C 109.462 -0.57 . . . . 0.0 109.462 179.545 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' F' F ' 97' ' ' THR . . . . . . . . . . . . . 72.7 p -103.74 157.76 16.85 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-O 121.331 0.586 . . . . 0.0 111.516 -176.392 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' F' F ' 98' ' ' GLU . . . . . . . . . . . . . 70.8 mm-40 -53.9 -26.02 23.04 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 115.994 -0.548 . . . . 0.0 112.397 179.709 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' F' F ' 99' ' ' GLU . . . . . . . . . . . . . 36.1 tt0 -79.99 16.99 1.05 Allowed 'General case' 0 CA--C 1.538 0.51 0 N-CA-C 112.588 0.588 . . . . 0.0 112.588 -176.441 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' F' F ' 100' ' ' ASN . . . . . . . . . . . . . 2.6 m-20 60.85 37.76 18.34 Favored 'General case' 0 C--O 1.232 0.165 0 O-C-N 121.761 -0.587 . . . . 0.0 110.95 178.454 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' F' F ' 101' ' ' GLU . . . . . . . . . . . . . 84.2 tt0 -116.37 144.38 44.34 Favored 'General case' 0 C--N 1.331 -0.225 0 CA-C-N 115.99 -0.55 . . . . 0.0 109.679 176.852 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' F' F ' 102' ' ' VAL . . . . . . . . . . . . . 44.6 t -117.63 126.37 74.68 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.357 0 CA-C-N 116.24 -0.436 . . . . 0.0 109.839 -178.257 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' F' F ' 103' ' ' LEU . . . . . . . . . . . . . 40.7 mt -116.39 129.22 56.13 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 115.717 -0.674 . . . . 0.0 110.121 176.692 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' F' F ' 104' ' ' ILE . . . . . . . . . . . . . 72.2 mt -116.62 122.08 69.09 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.257 0 N-CA-C 110.136 -0.32 . . . . 0.0 110.136 -179.596 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' F' F ' 105' ' ' PHE . . . . . . . . . . . . . 58.6 m-85 -121.21 166.38 14.07 Favored 'General case' 0 C--N 1.332 -0.162 0 O-C-N 124.087 0.867 . . . . 0.0 109.837 -178.968 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' F' F ' 106' ' ' ASN . . . . . . . . . . . . . 42.1 p-10 -102.79 -170.83 1.85 Allowed 'General case' 0 C--N 1.331 -0.231 0 N-CA-C 110.011 -0.366 . . . . 0.0 110.011 172.501 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' F' F ' 107' ' ' GLN . . . . . . . . . . . . . 45.4 tt0 -59.58 -30.16 68.46 Favored 'General case' 0 C--N 1.328 -0.358 0 N-CA-C 111.903 0.335 . . . . 0.0 111.903 179.106 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' F' F ' 108' ' ' ASN . . . . . . . . . . . . . 12.3 t-20 -81.84 6.19 16.45 Favored 'General case' 0 CA--C 1.537 0.467 0 N-CA-C 113.221 0.822 . . . . 0.0 113.221 -177.768 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' F' F ' 109' ' ' LEU . . . . . . . . . . . . . 9.7 tp 61.6 36.82 16.59 Favored 'General case' 0 CA--C 1.53 0.178 0 CA-C-O 120.905 0.383 . . . . 0.0 111.369 178.816 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' F' F ' 110' ' ' GLU . . . . . . . . . . . . . 43.0 mt-10 -106.36 158.44 16.88 Favored 'General case' 0 C--N 1.33 -0.264 0 N-CA-C 109.623 -0.51 . . . . 0.0 109.623 175.805 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' F' F ' 111' ' ' GLU . . . . . . . . . . . . . 44.1 mp0 -87.07 121.97 30.26 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-O 121.106 0.479 . . . . 0.0 111.212 -177.985 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' F' F ' 112' ' ' LEU . . . . . . . . . . . . . 42.9 mt -101.19 -45.95 5.2 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 115.611 -0.722 . . . . 0.0 110.095 175.768 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' F' F ' 113' ' ' TYR . . . . . . . . . . . . . 64.3 t80 -141.79 137.28 31.44 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.049 -0.523 . . . . 0.0 111.613 -178.054 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' F' F ' 114' ' ' ARG . . . . . . . . . . . . . 92.3 mtt180 -129.06 123.65 32.84 Favored 'General case' 0 C--N 1.331 -0.23 0 N-CA-C 109.3 -0.63 . . . . 0.0 109.3 175.245 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' F' F ' 115' ' ' GLY . . . . . . . . . . . . . . . -150.06 157.68 27.33 Favored Glycine 0 CA--C 1.525 0.661 0 C-N-CA 120.447 -0.882 . . . . 0.0 111.807 -179.835 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' F' F ' 116' ' ' LYS . . . . . . . . . . . . . 39.7 ttpt -128.72 140.7 51.61 Favored 'General case' 0 C--N 1.33 -0.263 0 N-CA-C 109.848 -0.427 . . . . 0.0 109.848 176.695 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' F' F ' 117' ' ' PHE . . . . . . . . . . . . . 47.2 m-85 -139.56 114.28 9.33 Favored 'General case' 0 C--N 1.329 -0.283 0 C-N-CA 120.836 -0.346 . . . . 0.0 110.334 -178.257 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' F' F ' 118' ' ' GLU . . . . . . . . . . . . . 84.4 tt0 -53.58 -45.87 70.13 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.523 -0.308 . . . . 0.0 111.405 -176.489 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' F' F ' 119' ' ' ASN . . . . . . . . . . . . . 85.4 m-20 -97.51 31.03 2.66 Favored 'General case' 0 C--N 1.331 -0.22 0 N-CA-C 112.182 0.438 . . . . 0.0 112.182 -174.86 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' F' F ' 120' ' ' LEU . . . . . . . . . . . . . 22.8 tp -57.51 120.44 8.28 Favored 'General case' 0 C--N 1.332 -0.174 0 CA-C-O 120.638 0.256 . . . . 0.0 110.326 178.146 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' F' F ' 121' ' ' ASN . . . . . . . . . . . . . 35.1 m120 -114.13 -44.13 3.17 Favored 'General case' 0 C--N 1.332 -0.188 0 CA-C-N 116.62 -0.263 . . . . 0.0 111.159 -177.521 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' F' F ' 122' ' ' LYS . . . . . . . . . . . . . 92.8 mttt -144.43 150.16 37.23 Favored 'General case' 0 C--N 1.332 -0.189 0 C-N-CA 120.598 -0.441 . . . . 0.0 111.646 -177.448 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' F' F ' 123' ' ' VAL . . . . . . . . . . . . . 42.5 t -132.91 129.32 57.76 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.267 0 N-CA-C 109.526 -0.546 . . . . 0.0 109.526 174.044 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' F' F ' 124' ' ' LEU . . . . . . . . . . . . . 80.4 mt -127.92 144.28 51.1 Favored 'General case' 0 C--N 1.331 -0.209 0 CA-C-O 120.754 0.311 . . . . 0.0 111.23 -176.87 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' F' F ' 125' ' ' VAL . . . . . . . . . . . . . 34.6 m -132.49 143.95 38.3 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.182 0 CA-C-N 116.173 -0.467 . . . . 0.0 111.18 -179.584 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' F' F ' 126' ' ' ARG . . . . . . . . . . . . . 76.7 mtp85 -145.58 116.49 7.78 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 116.006 -0.543 . . . . 0.0 110.408 176.406 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' F' F ' 127' ' ' ASN . . . . . . . . . . . . . 88.2 m-20 51.52 -104.84 0.19 Allowed 'General case' 0 CA--C 1.544 0.729 0 CA-C-O 119.087 -0.483 . . . . 0.0 111.283 179.824 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' F' F ' 128' ' ' ASP . . . . . . . . . . . . . 11.7 p-10 -114.03 0.19 14.25 Favored 'General case' 0 N--CA 1.468 0.463 0 CA-C-N 119.619 1.1 . . . . 0.0 113.318 -178.079 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' F' F ' 129' ' ' LEU . . . . . . . . . . . . . 17.2 tp -104.93 140.32 38.34 Favored 'General case' 0 C--N 1.332 -0.187 0 N-CA-C 109.565 -0.531 . . . . 0.0 109.565 178.463 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' F' F ' 130' ' ' VAL . . . . . . . . . . . . . 13.1 p -133.71 143.37 38.91 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.236 0 CA-C-O 121.257 0.551 . . . . 0.0 110.663 -179.357 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' F' F ' 131' ' ' VAL . . . . . . . . . . . . . 43.4 t -134.67 138.86 48.76 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.259 0 CA-C-N 115.766 -0.652 . . . . 0.0 110.162 -179.372 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' F' F ' 132' ' ' ILE . . . . . . . . . . . . . 69.5 mt -115.26 133.02 62.83 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.345 0 CA-C-N 115.625 -0.716 . . . . 0.0 109.078 179.003 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' F' F ' 133' ' ' ILE . . . . . . . . . . . . . 41.5 mm -117.13 123.55 71.95 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.211 0 CA-C-O 120.727 0.299 . . . . 0.0 110.949 -174.664 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' F' F ' 134' ' ' ASP . . . . . . . . . . . . . 8.1 p-10 -136.68 147.24 46.71 Favored 'General case' 0 C--N 1.331 -0.202 0 N-CA-C 109.654 -0.498 . . . . 0.0 109.654 174.13 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' F' F ' 135' ' ' GLU . . . . . . . . . . . . . 38.6 tp10 -49.89 -26.42 4.08 Favored 'General case' 0 C--N 1.328 -0.334 0 N-CA-C 112.709 0.633 . . . . 0.0 112.709 -172.348 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' F' F ' 136' ' ' GLN . . . . . . . . . . . . . 65.5 tp60 -81.9 -39.07 24.36 Favored 'General case' 0 C--O 1.233 0.21 0 N-CA-C 112.077 0.399 . . . . 0.0 112.077 -176.764 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' F' F ' 137' ' ' LYS . . . . . . . . . . . . . 50.4 pttt -161.48 172.24 16.78 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-O 121.484 0.659 . . . . 0.0 112.2 -171.303 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' F' F ' 138' ' ' LEU . . . . . . . . . . . . . 7.2 tt -119.58 129.82 54.83 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 115.111 -0.949 . . . . 0.0 109.664 178.584 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' F' F ' 139' ' ' THR . . . . . . . . . . . . . 21.6 m -109.34 126.64 53.6 Favored 'General case' 0 C--N 1.331 -0.21 0 CA-C-N 116.24 -0.436 . . . . 0.0 110.4 -179.677 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' F' F ' 140' ' ' LEU . . . . . . . . . . . . . 25.6 tp -112.09 120.06 40.56 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 115.73 -0.668 . . . . 0.0 109.417 -178.665 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' F' F ' 141' ' ' ILE . . . . . . . . . . . . . 19.5 mt -120.91 122.95 69.11 Favored 'Isoleucine or valine' 0 C--O 1.235 0.307 0 CA-C-O 121.022 0.439 . . . . 0.0 110.108 -175.591 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' F' F ' 142' ' ' ARG . . . . . . . . . . . . . 76.9 mtt180 -113.24 131.96 55.7 Favored 'General case' 0 C--O 1.233 0.206 0 CA-C-N 115.302 -0.863 . . . . 0.0 109.961 -175.969 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' F' F ' 143' ' ' THR . . . . . . . . . . . . . 52.0 p . . . . . 0 C--O 1.221 -0.418 0 CA-C-O 118.024 -0.989 . . . . 0.0 110.408 178.275 . . . . . . . . 0 0 . 1 . 001 nuclear orig full ' A' A ' -3' ' ' GLU . . . . . . . . . . . . . 48.2 mt-10 . . . . . 0 N--CA 1.491 1.581 0 N-CA-C 109.567 -0.531 . . . . 32.380000000000003 109.567 . . . . . . . . . 0 0 . 1 . 001 nuclear orig full ' A' A ' -2' ' ' GLY . . . . . . . . . . . . . . . -69.3 141.34 35.4 Favored Glycine 0 CA--C 1.525 0.671 0 N-CA-C 110.484 -1.046 . . . . 29.41 110.484 177.692 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' -1' ' ' VAL . . . . . . . . . . . . . 43.2 t -96.01 136.32 27.3 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.315 0 CA-C-O 120.815 0.341 . . . . 26.449999999999999 110.246 -178.457 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 0' ' ' ILE . . . . . . . . . . . . . 75.1 mt -107.64 130.62 59.65 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.266 0 CA-C-N 116.141 -0.481 . . . . 24.920000000000002 109.751 178.537 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 26.1 ptt? -79.17 169.78 17.64 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.25 -0.432 . . . . 21.329999999999998 111.111 -177.219 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 1.9 p -120.37 125.95 49.26 Favored 'General case' 0 C--N 1.331 -0.22 0 CA-C-N 115.963 -0.562 . . . . 18.41 110.564 178.464 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 84.7 tt0 -143.85 141.64 30.43 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 116.023 -0.535 . . . . 16.050000000000001 111.114 -179.308 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 4' ' ' LEU . . . . . . . . . . . . . 19.0 tp -122.62 127.84 49.89 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-N 116.019 -0.537 . . . . 13.859999999999999 110.087 177.485 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 5' ' ' LYS . . . . . . . . . . . . . 72.6 mttt -109.81 121.44 45.23 Favored 'General case' 0 C--O 1.234 0.246 0 CA-C-O 120.916 0.389 . . . . 12.23 110.709 178.94 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 31.1 mt -114.33 149.18 36.41 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 115.205 -0.907 . . . . 11.34 110.371 -178.719 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 19.5 ttmm -133.85 139.41 33.35 Favored Pre-proline 0 CA--C 1.536 0.418 0 CA-C-O 119.095 -0.479 . . . . 9.3100000000000005 109.799 175.17 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 8' ' ' PRO . . . . . . . . . . . . . 90.3 Cg_endo -91.82 134.47 1.49 Allowed 'Trans proline' 0 N--CA 1.49 1.293 0 C-N-CA 121.718 1.612 . . . . 9.7699999999999996 111.649 177.427 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 59.0 mt -71.78 -46.54 12.3 Favored Pre-proline 0 C--N 1.329 -0.295 0 CA-C-O 118.723 -0.656 . . . . 13.94 111.838 -179.703 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 92.4 Cg_endo -80.47 146.85 17.5 Favored 'Trans proline' 0 N--CA 1.494 1.556 0 C-N-CA 121.077 1.185 . . . . 14.0 111.582 173.071 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 93.4 mttt -87.09 92.21 8.97 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-O 120.872 0.367 . . . . 12.710000000000001 110.561 -179.942 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 12.4 p -138.63 143.74 31.6 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.292 0 CA-C-N 116.111 -0.495 . . . . 14.199999999999999 110.414 179.672 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 94.8 mt-10 -82.24 131.35 35.23 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.298 -0.41 . . . . 13.84 110.126 178.055 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 14' ' ' LEU . . . . . . . . . . . . . 30.8 mt -93.92 150.32 38.38 Favored Pre-proline 0 C--N 1.328 -0.328 0 CA-C-N 116.358 -0.383 . . . . 13.0 110.164 -179.483 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 15' ' ' PRO . . . . . . . . . . . . . 39.2 Cg_exo -57.9 159.92 16.59 Favored 'Trans proline' 0 N--CA 1.497 1.684 0 C-N-CA 121.213 1.275 . . . . 16.25 111.624 179.515 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 16' ' ' PRO . . . . . . . . . . . . . 39.7 Cg_exo -58.54 -39.78 80.12 Favored 'Trans proline' 0 N--CA 1.497 1.698 0 C-N-CA 121.479 1.453 . . . . 16.989999999999998 112.866 -177.39 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 17' ' ' ASP . . . . . . . . . . . . . 19.5 p-10 -88.4 9.11 24.61 Favored 'General case' 0 C--N 1.326 -0.415 0 N-CA-C 113.22 0.822 . . . . 16.690000000000001 113.22 -178.168 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 18' ' ' PHE . . . . . . . . . . . . . 50.3 t80 -58.27 -48.05 81.68 Favored 'General case' 0 N--CA 1.457 -0.103 0 O-C-N 121.91 -0.494 . . . . 13.779999999999999 110.19 -176.316 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 19' ' ' VAL . . . . . . . . . . . . . 46.4 t -54.8 -47.95 73.93 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.345 0 CA-C-N 116.446 -0.343 . . . . 12.65 111.167 -175.077 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 2.6 p30 -62.71 -38.24 89.65 Favored 'General case' 0 C--N 1.332 -0.175 0 C-N-CA 120.572 -0.451 . . . . 15.76 111.336 -176.245 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 54.7 t -64.34 -46.79 92.09 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.181 0 C-N-CA 120.582 -0.447 . . . . 15.73 110.213 -179.775 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 22' ' ' ILE . . . . . . . . . . . . . 51.6 mm -56.71 -45.26 82.72 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.248 0 C-N-CA 121.036 -0.266 . . . . 13.869999999999999 110.454 178.96 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 23' ' ' ARG . . . . . . . . . . . . . 59.5 ttp180 -53.98 -48.43 70.36 Favored 'General case' 0 C--N 1.329 -0.295 0 C-N-CA 121.179 -0.208 . . . . 16.760000000000002 111.32 -179.273 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 24' ' ' ILE . . . . . . . . . . . . . 76.1 mt -58.97 -46.58 91.47 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.339 0 C-N-CA 120.877 -0.329 . . . . 17.460000000000001 110.86 -177.965 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 99.6 mttt -64.25 -38.08 89.77 Favored 'General case' 0 C--N 1.329 -0.324 0 N-CA-C 112.546 0.572 . . . . 16.82 112.546 -177.948 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 49.7 mt -77.89 -41.6 36.09 Favored 'General case' 0 C--N 1.33 -0.247 0 N-CA-C 113.093 0.775 . . . . 16.620000000000001 113.093 -172.015 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 27' ' ' GLN . . . . . . . . . . . . . 14.3 pt20 -47.69 139.35 7.33 Favored 'General case' 0 N--CA 1.468 0.462 0 N-CA-C 112.77 0.656 . . . . 18.079999999999998 112.77 -174.426 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 100.29 -24.11 33.35 Favored Glycine 0 CA--C 1.535 1.287 0 CA-C-N 115.532 -0.758 . . . . 19.920000000000002 112.259 -175.698 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 98.0 mttt -97.78 155.19 17.14 Favored 'General case' 0 C--O 1.233 0.228 0 CA-C-N 117.369 0.585 . . . . 19.600000000000001 110.993 178.568 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 30' ' ' THR . . . . . . . . . . . . . 29.5 m -104.01 139.2 39.46 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 115.907 -0.588 . . . . 20.68 110.034 176.141 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 34.8 m -126.34 150.58 32.06 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.221 0 CA-C-N 116.408 -0.36 . . . . 17.93 110.719 -178.997 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 32' ' ' ARG . . . . . . . . . . . . . 32.4 ttm105 -134.94 147.33 49.75 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-O 121.16 0.505 . . . . 23.690000000000001 110.31 177.519 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 33' ' ' THR . . . . . . . . . . . . . 15.9 m -52.18 137.93 27.07 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.214 -0.448 . . . . 17.899999999999999 111.534 -177.355 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 100.71 -17.0 57.13 Favored Glycine 0 CA--C 1.532 1.147 0 CA-C-O 119.663 -0.52 . . . . 17.48 113.301 178.819 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 78.6 m-20 -65.8 147.8 52.8 Favored 'General case' 0 N--CA 1.462 0.146 0 CA-C-N 118.022 0.911 . . . . 18.859999999999999 111.125 179.135 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 44.8 t -123.25 129.76 74.7 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.173 0 CA-C-N 115.927 -0.579 . . . . 17.5 109.852 177.888 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 37' ' ' ILE . . . . . . . . . . . . . 65.0 mt -122.57 139.02 50.74 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.279 0 CA-C-N 116.345 -0.389 . . . . 16.620000000000001 109.961 -179.749 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . -112.9 128.79 8.59 Favored Glycine 0 CA--C 1.527 0.787 0 N-CA-C 111.013 -0.835 . . . . 17.550000000000001 111.013 179.281 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 39' ' ' ILE . . . . . . . . . . . . . 76.7 mt -123.9 136.25 60.89 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.22 0 N-CA-C 109.994 -0.373 . . . . 17.100000000000001 109.994 179.046 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 40' ' ' SER . . . . . . . . . . . . . 34.5 t -91.91 118.16 30.48 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-O 120.696 0.284 . . . . 20.75 111.09 178.181 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 41' ' ' ILE . . . . . . . . . . . . . 45.2 mm -120.93 116.71 50.67 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.237 0 CA-C-N 116.283 -0.417 . . . . 18.940000000000001 110.23 178.881 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 7.5 mp 50.92 35.62 12.95 Favored 'General case' 0 N--CA 1.464 0.228 0 CA-C-N 116.345 -0.389 . . . . 21.68 111.751 177.708 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . 76.05 31.13 56.2 Favored Glycine 0 CA--C 1.529 0.946 0 C-N-CA 121.082 -0.58 . . . . 23.0 112.274 177.57 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 44' ' ' LYS . . . . . . . . . . . . . 59.6 tttp -136.64 129.11 30.22 Favored 'General case' 0 C--N 1.33 -0.262 0 N-CA-C 109.484 -0.561 . . . . 20.379999999999999 109.484 176.862 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 82.1 tt0 -81.73 115.08 20.8 Favored 'General case' 0 C--N 1.329 -0.324 0 C-N-CA 120.75 -0.38 . . . . 20.210000000000001 110.663 -178.22 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 46' ' ' VAL . . . . . . . . . . . . . 6.8 p -110.86 125.17 68.16 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.24 0 N-CA-C 109.061 -0.718 . . . . 16.350000000000001 109.061 175.967 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 9.5 mtmp? -99.9 125.61 45.91 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 115.702 -0.681 . . . . 19.030000000000001 111.282 -178.568 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 48' ' ' PHE . . . . . . . . . . . . . 96.0 m-85 -111.26 131.9 54.78 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-N 116.188 -0.46 . . . . 13.44 109.899 177.268 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 49.1 tttm -108.31 139.07 43.55 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.357 -0.383 . . . . 14.85 110.513 178.941 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 50' ' ' VAL . . . . . . . . . . . . . 44.2 t -82.46 111.47 18.9 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.298 0 N-CA-C 109.505 -0.554 . . . . 14.17 109.505 176.683 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 51' ' ' VAL . . . . . . . . . . . . . 45.9 t -77.74 -46.54 26.98 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.321 0 CA-C-N 116.129 -0.487 . . . . 13.24 110.27 -174.014 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 52' ' ' GLN . . . . . . . . . . . . . 59.9 tt0 -157.82 135.35 10.43 Favored 'General case' 0 C--N 1.33 -0.276 0 C-N-CA 120.413 -0.515 . . . . 15.82 111.526 -177.0 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -113.2 118.78 35.63 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 115.401 -0.818 . . . . 16.949999999999999 109.596 173.497 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 54' ' ' TYR . . . . . . . . . . . . . 16.9 t80 -116.91 107.14 46.53 Favored Pre-proline 0 CA--C 1.534 0.351 0 CA-C-O 118.246 -0.883 . . . . 21.390000000000001 110.613 -177.757 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 55' ' ' PRO . . . . . . . . . . . . . 73.0 Cg_endo -76.98 169.98 72.96 Favored 'Cis proline' 0 N--CA 1.499 1.828 0 CA-C-N 121.758 1.664 . . . . 21.239999999999998 112.605 -3.775 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 56' ' ' SER . . . . . . . . . . . . . 13.6 m -105.2 117.73 57.7 Favored Pre-proline 0 CA--C 1.538 0.513 0 CA-C-O 118.41 -0.805 . . . . 21.829999999999998 109.546 176.92 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 57' ' ' PRO . . . . . . . . . . . . . 72.1 Cg_endo -77.84 171.05 68.85 Favored 'Cis proline' 0 N--CA 1.495 1.604 0 CA-C-N 121.968 1.738 . . . . 22.940000000000001 112.422 2.164 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 58' ' ' LEU . . . . . . . . . . . . . 25.6 tp -128.18 138.14 52.35 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 115.789 -0.641 . . . . 18.829999999999998 110.348 -178.735 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 59' ' ' ARG . . . . . . . . . . . . . 59.9 ttt85 -101.12 129.74 47.06 Favored 'General case' 0 C--N 1.326 -0.419 0 CA-C-N 115.949 -0.569 . . . . 22.98 109.549 176.441 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 42.1 t -88.79 116.7 30.86 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.229 0 C-N-CA 120.572 -0.451 . . . . 17.399999999999999 110.496 -176.631 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 94.8 mt-10 -131.14 168.76 16.9 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 115.967 -0.56 . . . . 20.440000000000001 109.581 174.953 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 62' ' ' ASP . . . . . . . . . . . . . 2.1 m-20 -53.91 -34.34 59.25 Favored 'General case' 0 C--N 1.329 -0.312 0 C-N-CA 121.046 -0.262 . . . . 18.68 111.693 -177.783 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 63' ' ' ARG . . . . . . . . . . . . . 28.2 mmm180 -73.87 -17.65 61.02 Favored 'General case' 0 CA--C 1.533 0.313 0 N-CA-C 113.234 0.827 . . . . 22.920000000000002 113.234 -176.169 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 18.0 m -69.94 141.72 53.02 Favored 'General case' 0 C--N 1.332 -0.191 0 CA-C-O 120.838 0.351 . . . . 16.77 111.014 -174.887 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 65' ' ' LYS . . . . . . . . . . . . . 93.8 mttt -88.5 132.66 34.41 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.098 -0.501 . . . . 17.359999999999999 109.988 178.732 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 66' ' ' ILE . . . . . . . . . . . . . 53.7 mt -117.56 131.91 68.9 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.233 0 N-CA-C 110.012 -0.366 . . . . 12.83 110.012 179.921 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 67' ' ' THR . . . . . . . . . . . . . 18.8 m -130.96 135.86 48.03 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-O 121.011 0.434 . . . . 11.24 110.788 178.796 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 68' ' ' LEU . . . . . . . . . . . . . 6.7 mp -108.0 129.58 55.11 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.124 -0.489 . . . . 8.5 110.43 176.685 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 69' ' ' VAL . . . . . . . . . . . . . 43.2 t -102.22 131.77 49.6 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.312 0 CA-C-N 116.225 -0.443 . . . . 7.5300000000000002 110.37 -179.046 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 70' ' ' THR . . . . . . . . . . . . . 3.4 m -99.09 -55.1 2.79 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.107 -0.497 . . . . 6.0800000000000001 110.552 178.101 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 71' ' ' HIS . . . . . . . . . . . . . 62.2 m80 -140.02 155.78 70.65 Favored Pre-proline 0 C--N 1.331 -0.221 0 CA-C-N 116.213 -0.449 . . . . 7.4400000000000004 110.763 -179.6 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 72' ' ' PRO . . . . . . . . . . . . . 91.0 Cg_endo -85.01 -29.3 0.7 Allowed 'Trans proline' 0 N--CA 1.493 1.446 0 C-N-CA 121.649 1.566 . . . . 3.8799999999999999 112.644 178.843 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 73' ' ' VAL . . . . . . . . . . . . . 35.3 m -127.17 166.32 24.12 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.202 0 CA-C-N 116.474 -0.33 . . . . 1.3400000000000001 110.303 -179.837 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 74' ' ' ASP . . . . . . . . . . . . . 29.6 t70 -99.33 119.52 38.07 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.471 -0.332 . . . . 0.95999999999999996 110.217 -177.849 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 44.7 t -112.72 122.7 67.39 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.228 0 CA-C-O 121.148 0.499 . . . . 1.3700000000000001 110.243 -179.551 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 76' ' ' LEU . . . . . . . . . . . . . 36.0 mt -124.12 139.24 54.13 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 115.56 -0.745 . . . . 1.75 109.403 177.802 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 77' ' ' GLU . . . . . . . . . . . . . 96.8 mt-10 -129.99 142.24 50.66 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-O 121.136 0.493 . . . . 1.4199999999999999 111.142 -177.224 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 78' ' ' ALA . . . . . . . . . . . . . . . -131.64 136.56 47.83 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 115.479 -0.782 . . . . 1.1699999999999999 109.937 177.334 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 79' ' ' LYS . . . . . . . . . . . . . 38.0 tttp -81.23 119.57 23.79 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-O 120.91 0.386 . . . . 3.4100000000000001 110.939 -176.537 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 80' ' ' ILE . . . . . . . . . . . . . 42.0 mm -139.13 108.45 3.8 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.324 0 N-CA-C 109.089 -0.708 . . . . 1.21 109.089 -178.347 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 81' ' ' LYS . . . . . . . . . . . . . 37.9 tttp -102.78 125.44 49.52 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-O 120.95 0.405 . . . . 3.21 111.114 -176.818 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . 89.01 42.13 5.71 Favored Glycine 0 CA--C 1.526 0.757 0 C-N-CA 121.057 -0.592 . . . . 0.62 111.93 174.993 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 83' ' ' ILE . . . . . . . . . . . . . 72.2 mt -68.14 136.35 26.68 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 N-CA-C 109.641 -0.503 . . . . 1.1899999999999999 109.641 177.01 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 84' ' ' LYS . . . . . . . . . . . . . 40.2 ttpt -104.93 -46.94 4.15 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.35 -0.387 . . . . 1.95 110.306 -178.432 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 85' ' ' ASP . . . . . . . . . . . . . 20.7 t70 -149.49 148.48 29.46 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.068 -0.514 . . . . 0.79000000000000004 110.455 179.319 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 86' ' ' VAL . . . . . . . . . . . . . 43.2 t -130.89 133.31 63.24 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.227 0 CA-C-O 120.955 0.407 . . . . 1.1899999999999999 110.375 -179.887 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 87' ' ' ILE . . . . . . . . . . . . . 45.1 mm -120.55 127.74 75.95 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.231 0 CA-C-N 115.821 -0.627 . . . . 2.0600000000000001 109.781 178.537 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 88' ' ' LEU . . . . . . . . . . . . . 54.5 mt -107.82 135.49 49.14 Favored 'General case' 0 C--N 1.331 -0.221 0 CA-C-N 116.276 -0.42 . . . . 2.1000000000000001 110.974 -179.659 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 89' ' ' ASP . . . . . . . . . . . . . 12.2 t70 -130.78 155.48 46.6 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.005 -0.543 . . . . 0.96999999999999997 109.655 176.988 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 96.8 mt-10 -48.69 -36.35 15.95 Favored 'General case' 0 C--N 1.329 -0.3 0 N-CA-C 112.818 0.673 . . . . 2.4900000000000002 112.818 -171.478 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 91' ' ' ASN . . . . . . . . . . . . . 12.6 t-20 -131.99 22.2 4.54 Favored 'General case' 0 N--CA 1.468 0.452 0 N-CA-C 112.781 0.659 . . . . 2.96 112.781 -177.572 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 92' ' ' LEU . . . . . . . . . . . . . 23.1 mt -150.06 147.1 27.4 Favored 'General case' 0 C--N 1.332 -0.153 0 CA-C-O 120.799 0.333 . . . . 1.95 110.395 -177.348 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 93' ' ' ILE . . . . . . . . . . . . . 70.6 mt -124.24 117.94 52.24 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.272 0 N-CA-C 109.104 -0.702 . . . . 1.2 109.104 175.964 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 94' ' ' VAL . . . . . . . . . . . . . 46.4 t -118.96 127.08 75.82 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.268 0 CA-C-O 120.91 0.386 . . . . 1.1699999999999999 110.028 -178.427 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 95' ' ' VAL . . . . . . . . . . . . . 43.7 t -120.88 132.7 69.72 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.308 0 CA-C-N 115.945 -0.571 . . . . 1.1200000000000001 109.733 179.912 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 96' ' ' ILE . . . . . . . . . . . . . 67.5 mt -114.21 126.94 71.83 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.24 0 N-CA-C 109.215 -0.661 . . . . 1.1799999999999999 109.215 178.859 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 97' ' ' THR . . . . . . . . . . . . . 69.6 p -102.6 155.64 18.15 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-O 121.241 0.543 . . . . 1.1799999999999999 111.228 -176.41 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 98' ' ' GLU . . . . . . . . . . . . . 48.6 mt-10 -54.27 -23.54 15.32 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.017 -0.538 . . . . 2.4199999999999999 112.275 178.279 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 99' ' ' GLU . . . . . . . . . . . . . 95.0 mt-10 -76.82 13.28 1.07 Allowed 'General case' 0 CA--C 1.536 0.406 0 N-CA-C 113.24 0.829 . . . . 2.3399999999999999 113.24 -178.278 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 100' ' ' ASN . . . . . . . . . . . . . 1.7 m120 64.35 36.28 9.2 Favored 'General case' 0 CA--C 1.53 0.19 0 CA-C-O 120.944 0.402 . . . . 0.59999999999999998 110.922 177.545 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 101' ' ' GLU . . . . . . . . . . . . . 84.3 tt0 -122.43 143.93 49.37 Favored 'General case' 0 C--N 1.333 -0.139 0 CA-C-N 116.239 -0.437 . . . . 0.54000000000000004 109.916 178.586 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 102' ' ' VAL . . . . . . . . . . . . . 45.4 t -115.09 126.79 72.77 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.231 0 N-CA-C 109.811 -0.441 . . . . 1.1399999999999999 109.811 -179.713 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 103' ' ' LEU . . . . . . . . . . . . . 27.6 mt -114.69 130.11 56.77 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 115.723 -0.671 . . . . 1.4299999999999999 110.051 177.308 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 104' ' ' ILE . . . . . . . . . . . . . 72.4 mt -116.63 121.44 67.67 Favored 'Isoleucine or valine' 0 C--O 1.234 0.279 0 CA-C-N 116.552 -0.295 . . . . 1.1599999999999999 110.321 -179.193 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 105' ' ' PHE . . . . . . . . . . . . . 88.3 m-85 -120.9 161.26 21.86 Favored 'General case' 0 C--N 1.333 -0.134 0 O-C-N 123.953 0.783 . . . . 0.52000000000000002 109.884 -179.856 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 106' ' ' ASN . . . . . . . . . . . . . 39.0 p30 -95.87 -173.19 2.77 Favored 'General case' 0 C--N 1.33 -0.276 0 N-CA-C 110.065 -0.346 . . . . 0.65000000000000002 110.065 175.314 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 107' ' ' GLN . . . . . . . . . . . . . 61.1 tt0 -60.17 -30.06 69.09 Favored 'General case' 0 C--N 1.329 -0.29 0 N-CA-C 111.936 0.347 . . . . 1.98 111.936 -179.98 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 108' ' ' ASN . . . . . . . . . . . . . 50.7 t30 -82.33 8.66 10.71 Favored 'General case' 0 CA--C 1.537 0.446 0 N-CA-C 113.043 0.757 . . . . 1.8999999999999999 113.043 -177.831 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 109' ' ' LEU . . . . . . . . . . . . . 13.0 tp 61.47 39.83 14.53 Favored 'General case' 0 C--O 1.233 0.193 0 CA-C-O 121.324 0.583 . . . . 1.71 110.975 179.229 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 110' ' ' GLU . . . . . . . . . . . . . 95.2 mt-10 -109.97 152.2 26.17 Favored 'General case' 0 C--N 1.33 -0.244 0 N-CA-C 109.532 -0.544 . . . . 1.9199999999999999 109.532 175.535 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 111' ' ' GLU . . . . . . . . . . . . . 81.2 tt0 -88.02 122.3 31.45 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-O 120.828 0.347 . . . . 1.78 110.941 -175.555 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 112' ' ' LEU . . . . . . . . . . . . . 51.8 mt -106.09 -46.1 4.17 Favored 'General case' 0 C--N 1.332 -0.186 0 CA-C-N 116.14 -0.482 . . . . 1.24 111.139 179.539 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 113' ' ' TYR . . . . . . . . . . . . . 61.4 t80 -136.76 138.23 40.71 Favored 'General case' 0 C--N 1.331 -0.213 0 CA-C-O 120.912 0.386 . . . . 0.82999999999999996 111.545 -176.148 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 114' ' ' ARG . . . . . . . . . . . . . 38.9 ttm180 -132.54 122.89 25.52 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 115.878 -0.601 . . . . 3.1099999999999999 109.773 175.612 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 115' ' ' GLY . . . . . . . . . . . . . . . -150.1 138.62 6.84 Favored Glycine 0 CA--C 1.523 0.543 0 N-CA-C 111.07 -0.812 . . . . 0.47999999999999998 111.07 178.779 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 116' ' ' LYS . . . . . . . . . . . . . 34.0 ttmt -114.95 140.22 49.19 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-O 120.818 0.342 . . . . 2.02 110.079 177.256 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 117' ' ' PHE . . . . . . . . . . . . . 32.4 m-85 -136.89 114.93 11.49 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.147 -0.479 . . . . 0.54000000000000004 109.892 -176.724 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 118' ' ' GLU . . . . . . . . . . . . . 84.2 tt0 -51.39 -49.4 61.61 Favored 'General case' 0 C--N 1.328 -0.358 0 N-CA-C 111.869 0.322 . . . . 2.77 111.869 -176.221 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 119' ' ' ASN . . . . . . . . . . . . . 97.7 m-20 -98.07 31.29 2.77 Favored 'General case' 0 C--N 1.328 -0.335 0 N-CA-C 112.221 0.452 . . . . 2.0800000000000001 112.221 -174.321 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 120' ' ' LEU . . . . . . . . . . . . . 21.8 tp -54.57 120.74 7.12 Favored 'General case' 0 N--CA 1.463 0.19 0 O-C-N 122.243 -0.286 . . . . 1.2 110.71 178.727 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 121' ' ' ASN . . . . . . . . . . . . . 85.9 m-20 -113.81 -44.0 3.22 Favored 'General case' 0 C--N 1.332 -0.181 0 CA-C-N 116.459 -0.337 . . . . 2.21 111.07 -176.465 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 122' ' ' LYS . . . . . . . . . . . . . 84.9 mttt -142.93 145.3 32.9 Favored 'General case' 0 C--N 1.331 -0.227 0 CA-C-O 121.148 0.499 . . . . 2.4399999999999999 111.705 -178.129 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 123' ' ' VAL . . . . . . . . . . . . . 46.4 t -121.8 122.57 67.21 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.249 0 N-CA-C 108.978 -0.749 . . . . 1.1799999999999999 108.978 173.363 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 124' ' ' LEU . . . . . . . . . . . . . 6.8 mp -108.9 122.97 48.32 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 116.272 -0.422 . . . . 2.23 110.349 -177.301 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 125' ' ' VAL . . . . . . . . . . . . . 44.2 t -126.16 125.37 67.69 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.307 0 N-CA-C 109.608 -0.516 . . . . 2.25 109.608 178.825 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 126' ' ' ARG . . . . . . . . . . . . . 81.2 mtt-85 -143.94 123.84 13.5 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-O 121.045 0.45 . . . . 3.6499999999999999 110.774 -179.535 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 127' ' ' ASN . . . . . . . . . . . . . 18.9 t-20 50.91 -105.23 0.19 Allowed 'General case' 0 CA--C 1.543 0.709 0 CA-C-O 118.965 -0.54 . . . . 2.8199999999999998 111.398 179.764 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 128' ' ' ASP . . . . . . . . . . . . . 9.1 p-10 -114.16 -1.51 13.65 Favored 'General case' 0 CA--C 1.537 0.452 0 CA-C-N 119.697 1.135 . . . . 1.1699999999999999 113.522 -177.425 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 129' ' ' LEU . . . . . . . . . . . . . 79.3 mt -105.58 144.24 32.62 Favored 'General case' 0 C--O 1.232 0.162 0 CA-C-N 118.207 0.458 . . . . 2.54 110.876 -177.398 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 130' ' ' VAL . . . . . . . . . . . . . 45.1 t -127.35 134.99 64.6 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.169 0 CA-C-O 121.075 0.464 . . . . 2.0800000000000001 110.251 -179.354 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 131' ' ' VAL . . . . . . . . . . . . . 45.5 t -133.02 135.35 57.04 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.287 0 CA-C-N 116.088 -0.505 . . . . 1.6899999999999999 109.906 177.517 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 132' ' ' ILE . . . . . . . . . . . . . 68.5 mt -113.46 131.17 65.97 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.304 0 N-CA-C 109.381 -0.6 . . . . 1.2 109.381 -179.976 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 133' ' ' ILE . . . . . . . . . . . . . 41.9 mm -118.55 120.77 65.26 Favored 'Isoleucine or valine' 0 C--O 1.233 0.22 0 CA-C-O 120.954 0.407 . . . . 1.25 111.111 -175.384 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 134' ' ' ASP . . . . . . . . . . . . . 3.6 p30 -135.59 146.73 48.26 Favored 'General case' 0 C--N 1.332 -0.196 0 N-CA-C 109.362 -0.607 . . . . 0.55000000000000004 109.362 173.19 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 135' ' ' GLU . . . . . . . . . . . . . 85.9 tt0 -49.88 -23.76 2.1 Favored 'General case' 0 C--N 1.326 -0.454 0 N-CA-C 112.85 0.685 . . . . 2.04 112.85 -172.658 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 136' ' ' GLN . . . . . . . . . . . . . 52.0 mt-30 -87.57 -36.27 17.65 Favored 'General case' 0 C--O 1.234 0.251 0 N-CA-C 112.586 0.587 . . . . 2.54 112.586 -176.203 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 137' ' ' LYS . . . . . . . . . . . . . 40.7 pttt -157.44 167.45 30.18 Favored 'General case' 0 C--N 1.331 -0.197 0 CA-C-O 121.514 0.673 . . . . 2.0 112.277 -172.87 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 138' ' ' LEU . . . . . . . . . . . . . 6.1 tt -121.31 128.74 52.62 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 115.084 -0.962 . . . . 1.5600000000000001 109.701 178.006 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 139' ' ' THR . . . . . . . . . . . . . 28.6 m -111.78 129.9 55.98 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.41 -0.359 . . . . 1.1399999999999999 110.46 -179.411 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 140' ' ' LEU . . . . . . . . . . . . . 21.6 tp -111.75 118.82 36.64 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 115.679 -0.691 . . . . 1.6799999999999999 109.165 179.734 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 141' ' ' ILE . . . . . . . . . . . . . 19.5 mt -119.09 118.02 56.22 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.314 0 N-CA-C 109.569 -0.53 . . . . 1.1399999999999999 109.569 -176.794 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 142' ' ' ARG . . . . . . . . . . . . . 49.5 ttp180 -110.84 124.81 52.78 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 115.354 -0.839 . . . . 3.2599999999999998 110.174 -176.6 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 143' ' ' THR . . . . . . . . . . . . . 27.6 p . . . . . 0 C--O 1.219 -0.525 0 CA-C-O 117.977 -1.011 . . . . 1.54 110.6 -179.242 . . . . . . . . 0 0 . 1 . 001 nuclear orig full ' B' B ' -3' ' ' GLU . . . . . . . . . . . . . 47.3 mt-10 . . . . . 0 N--CA 1.491 1.587 0 N-CA-C 109.31 -0.626 . . . . 33.380000000000003 109.31 . . . . . . . . . 0 0 . 1 . 001 nuclear orig full ' B' B ' -2' ' ' GLY . . . . . . . . . . . . . . . -65.61 138.63 38.22 Favored Glycine 0 CA--C 1.525 0.676 0 N-CA-C 110.874 -0.89 . . . . 29.5 110.874 179.9 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' -1' ' ' VAL . . . . . . . . . . . . . 42.9 t -96.96 126.5 49.69 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.294 0 N-CA-C 110.081 -0.34 . . . . 26.949999999999999 110.081 -179.857 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 0' ' ' ILE . . . . . . . . . . . . . 44.8 mm -124.53 118.7 54.28 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.235 0 CA-C-N 116.354 -0.385 . . . . 24.940000000000001 110.117 179.489 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 1' ' ' MET . . . . . . . . . . . . . 24.6 ptt? -95.94 156.39 16.35 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.12 -0.491 . . . . 21.859999999999999 110.57 179.57 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 2' ' ' SER . . . . . . . . . . . . . 2.0 p -114.68 123.14 48.53 Favored 'General case' 0 C--O 1.232 0.183 0 CA-C-O 121.125 0.488 . . . . 19.25 110.598 178.492 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 3' ' ' GLU . . . . . . . . . . . . . 93.2 mt-10 -140.71 141.86 34.9 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-N 115.781 -0.645 . . . . 16.68 110.956 -178.157 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 4' ' ' LEU . . . . . . . . . . . . . 12.7 tp -125.6 130.05 50.87 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 115.986 -0.552 . . . . 14.6 109.874 176.336 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 5' ' ' LYS . . . . . . . . . . . . . 94.8 mttt -106.73 119.77 40.22 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.37 -0.377 . . . . 12.4 110.285 179.839 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 6' ' ' LEU . . . . . . . . . . . . . 75.7 mt -117.13 148.68 41.34 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 115.477 -0.783 . . . . 12.300000000000001 110.257 -176.982 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 7' ' ' LYS . . . . . . . . . . . . . 34.1 ttmt -132.76 134.83 25.08 Favored Pre-proline 0 CA--C 1.535 0.385 0 CA-C-O 118.853 -0.594 . . . . 9.8100000000000005 110.118 177.578 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 8' ' ' PRO . . . . . . . . . . . . . 74.3 Cg_endo -91.61 131.87 1.33 Allowed 'Trans proline' 0 N--CA 1.491 1.329 0 C-N-CA 121.668 1.578 . . . . 10.369999999999999 111.606 176.537 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 9' ' ' LEU . . . . . . . . . . . . . 72.8 mt -70.95 -52.12 10.1 Favored Pre-proline 0 CA--C 1.533 0.295 0 CA-C-O 118.591 -0.718 . . . . 13.619999999999999 112.106 -177.526 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 10' ' ' PRO . . . . . . . . . . . . . 38.4 Cg_endo -68.59 141.8 51.45 Favored 'Trans proline' 0 N--CA 1.498 1.78 0 CA-C-N 120.287 1.138 . . . . 13.99 111.613 175.072 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 11' ' ' LYS . . . . . . . . . . . . . 69.1 mttm -87.04 97.38 10.69 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.408 -0.36 . . . . 12.9 110.645 -179.921 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 12' ' ' VAL . . . . . . . . . . . . . 11.8 p -139.38 142.08 34.05 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.325 0 CA-C-N 116.021 -0.536 . . . . 14.99 110.385 -179.902 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 13' ' ' GLU . . . . . . . . . . . . . 47.7 mt-10 -73.48 120.44 19.08 Favored 'General case' 0 C--N 1.329 -0.317 0 N-CA-C 110.007 -0.368 . . . . 14.92 110.007 177.64 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 14' ' ' LEU . . . . . . . . . . . . . 26.3 mt -95.84 143.16 25.65 Favored Pre-proline 0 CA--C 1.533 0.303 0 CA-C-O 118.928 -0.558 . . . . 14.869999999999999 109.752 179.953 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 15' ' ' PRO . . . . . . . . . . . . . 29.6 Cg_exo -59.82 159.82 23.63 Favored 'Trans proline' 0 N--CA 1.497 1.682 0 C-N-CA 121.253 1.302 . . . . 18.52 111.545 178.764 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 16' ' ' PRO . . . . . . . . . . . . . 37.4 Cg_exo -58.88 -40.11 75.04 Favored 'Trans proline' 0 N--CA 1.498 1.791 0 C-N-CA 121.429 1.419 . . . . 19.219999999999999 112.799 -177.813 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 17' ' ' ASP . . . . . . . . . . . . . 3.1 p30 -87.5 10.88 16.26 Favored 'General case' 0 CA--C 1.536 0.409 0 N-CA-C 113.05 0.759 . . . . 19.809999999999999 113.05 -178.61 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 18' ' ' PHE . . . . . . . . . . . . . 50.2 t80 -58.62 -44.97 90.13 Favored 'General case' 0 CA--C 1.523 -0.095 0 O-C-N 121.902 -0.499 . . . . 16.350000000000001 109.883 -178.348 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 19' ' ' VAL . . . . . . . . . . . . . 13.7 p -56.0 -39.04 55.58 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.283 0 CA-C-N 116.121 -0.491 . . . . 15.529999999999999 110.827 179.838 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 20' ' ' ASP . . . . . . . . . . . . . 31.0 t0 -60.11 -44.91 94.51 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-O 120.767 0.318 . . . . 19.219999999999999 110.717 -179.032 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 21' ' ' VAL . . . . . . . . . . . . . 47.7 t -64.24 -45.82 95.14 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.293 0 C-N-CA 120.757 -0.377 . . . . 18.960000000000001 110.43 -177.813 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 22' ' ' ILE . . . . . . . . . . . . . 51.0 mm -55.82 -47.3 79.75 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.224 0 C-N-CA 121.002 -0.279 . . . . 16.420000000000002 110.651 179.525 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 23' ' ' ARG . . . . . . . . . . . . . 43.7 ttp180 -55.25 -48.11 74.46 Favored 'General case' 0 C--N 1.329 -0.291 0 C-N-CA 121.064 -0.254 . . . . 20.329999999999998 111.346 -178.354 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 24' ' ' ILE . . . . . . . . . . . . . 72.9 mt -59.26 -41.28 83.52 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.297 0 C-N-CA 121.076 -0.25 . . . . 20.949999999999999 110.96 -177.964 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 25' ' ' LYS . . . . . . . . . . . . . 8.3 mtpm? -69.45 -38.91 78.01 Favored 'General case' 0 C--N 1.328 -0.356 0 N-CA-C 112.274 0.472 . . . . 19.640000000000001 112.274 -178.122 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 26' ' ' LEU . . . . . . . . . . . . . 37.9 mt -79.35 -38.08 35.94 Favored 'General case' 0 C--N 1.329 -0.291 0 N-CA-C 113.587 0.958 . . . . 18.5 113.587 -171.457 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 27' ' ' GLN . . . . . . . . . . . . . 9.7 pt20 -46.77 141.08 4.13 Favored 'General case' 0 N--CA 1.47 0.554 0 N-CA-C 112.747 0.647 . . . . 21.329999999999998 112.747 -175.189 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 28' ' ' GLY . . . . . . . . . . . . . . . 100.26 -23.68 34.97 Favored Glycine 0 CA--C 1.533 1.17 0 CA-C-N 115.481 -0.781 . . . . 21.399999999999999 112.289 -176.152 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 29' ' ' LYS . . . . . . . . . . . . . 68.5 mttm -98.06 155.11 17.27 Favored 'General case' 0 C--O 1.233 0.194 0 CA-C-N 117.559 0.679 . . . . 20.77 111.212 178.986 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 30' ' ' THR . . . . . . . . . . . . . 30.7 m -104.93 139.46 39.62 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 115.953 -0.567 . . . . 21.359999999999999 109.936 176.303 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 31' ' ' VAL . . . . . . . . . . . . . 34.8 m -129.78 149.09 33.28 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.252 0 CA-C-O 120.954 0.407 . . . . 18.25 111.167 -177.957 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 32' ' ' ARG . . . . . . . . . . . . . 75.2 mtt85 -124.69 149.15 47.52 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 115.823 -0.626 . . . . 22.77 110.166 177.427 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 33' ' ' THR . . . . . . . . . . . . . 23.6 m -53.83 136.7 39.94 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.369 -0.378 . . . . 17.280000000000001 111.356 -179.053 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 34' ' ' GLY . . . . . . . . . . . . . . . 100.0 -17.11 57.65 Favored Glycine 0 CA--C 1.531 1.053 0 CA-C-O 119.585 -0.564 . . . . 16.84 113.386 177.457 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 35' ' ' ASP . . . . . . . . . . . . . 81.8 m-20 -66.0 146.93 54.11 Favored 'General case' 0 C--O 1.231 0.117 0 CA-C-N 118.111 0.956 . . . . 18.379999999999999 111.17 -179.366 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 36' ' ' VAL . . . . . . . . . . . . . 44.5 t -121.17 128.83 76.07 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.235 0 CA-C-N 115.999 -0.546 . . . . 17.190000000000001 109.698 176.982 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 37' ' ' ILE . . . . . . . . . . . . . 64.6 mt -120.57 138.81 49.84 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.305 0 CA-C-N 116.238 -0.437 . . . . 16.91 110.019 -178.138 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 38' ' ' GLY . . . . . . . . . . . . . . . -106.63 127.24 8.79 Favored Glycine 0 CA--C 1.524 0.615 0 N-CA-C 110.927 -0.869 . . . . 18.219999999999999 110.927 178.424 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 39' ' ' ILE . . . . . . . . . . . . . 76.8 mt -127.72 141.48 46.29 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.264 0 N-CA-C 110.048 -0.353 . . . . 18.239999999999998 110.048 179.583 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 40' ' ' SER . . . . . . . . . . . . . 40.6 t -91.8 118.83 31.06 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-O 120.813 0.34 . . . . 22.140000000000001 110.96 177.189 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 41' ' ' ILE . . . . . . . . . . . . . 47.3 mm -124.7 120.0 57.65 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.213 0 CA-C-N 116.149 -0.478 . . . . 20.260000000000002 110.487 178.989 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 42' ' ' LEU . . . . . . . . . . . . . 7.8 mp 52.06 35.87 17.37 Favored 'General case' 0 C--N 1.331 -0.2 0 CA-C-N 116.301 -0.409 . . . . 22.93 111.638 177.848 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 43' ' ' GLY . . . . . . . . . . . . . . . 72.8 31.5 62.31 Favored Glycine 0 CA--C 1.529 0.956 0 C-N-CA 121.131 -0.557 . . . . 23.789999999999999 112.101 178.375 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 44' ' ' LYS . . . . . . . . . . . . . 85.1 tttt -137.71 131.46 31.39 Favored 'General case' 0 C--N 1.329 -0.311 0 N-CA-C 109.57 -0.53 . . . . 21.050000000000001 109.57 178.416 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 45' ' ' GLU . . . . . . . . . . . . . 81.7 tt0 -80.17 111.0 16.12 Favored 'General case' 0 C--N 1.328 -0.337 0 C-N-CA 120.657 -0.417 . . . . 20.120000000000001 110.238 -179.222 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 46' ' ' VAL . . . . . . . . . . . . . 7.0 p -109.86 128.2 66.16 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.188 0 N-CA-C 109.332 -0.618 . . . . 16.989999999999998 109.332 178.954 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 47' ' ' LYS . . . . . . . . . . . . . 44.0 mttm -98.54 124.28 43.2 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 115.781 -0.645 . . . . 18.579999999999998 110.666 178.409 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 48' ' ' PHE . . . . . . . . . . . . . 96.4 m-85 -108.99 131.79 54.73 Favored 'General case' 0 C--N 1.328 -0.351 0 N-CA-C 109.679 -0.489 . . . . 13.9 109.679 176.013 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 49' ' ' LYS . . . . . . . . . . . . . 42.6 tttp -109.18 137.97 46.26 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.484 -0.326 . . . . 14.449999999999999 110.593 178.246 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 50' ' ' VAL . . . . . . . . . . . . . 48.1 t -82.41 106.85 13.73 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.369 0 N-CA-C 109.156 -0.683 . . . . 14.109999999999999 109.156 175.527 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 51' ' ' VAL . . . . . . . . . . . . . 48.2 t -69.92 -52.35 31.85 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.354 0 N-CA-C 109.476 -0.564 . . . . 12.960000000000001 109.476 -176.113 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 52' ' ' GLN . . . . . . . . . . . . . 46.6 mt-30 -155.14 152.72 29.8 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 115.914 -0.584 . . . . 15.279999999999999 111.61 -179.401 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 53' ' ' ALA . . . . . . . . . . . . . . . -127.27 131.31 50.56 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 115.327 -0.851 . . . . 16.719999999999999 109.847 176.473 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 54' ' ' TYR . . . . . . . . . . . . . 9.8 t80 -129.1 107.5 17.93 Favored Pre-proline 0 CA--C 1.535 0.367 0 CA-C-O 118.337 -0.839 . . . . 21.030000000000001 110.496 -179.829 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 55' ' ' PRO . . . . . . . . . . . . . 73.2 Cg_endo -77.11 170.0 72.77 Favored 'Cis proline' 0 N--CA 1.5 1.882 0 CA-C-N 121.781 1.672 . . . . 21.239999999999998 112.397 -5.952 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 56' ' ' SER . . . . . . . . . . . . . 18.7 m -116.54 133.21 23.03 Favored Pre-proline 0 CA--C 1.538 0.494 0 CA-C-O 118.445 -0.788 . . . . 21.170000000000002 109.433 174.37 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 57' ' ' PRO . . . . . . . . . . . . . 55.4 Cg_endo -71.72 149.04 91.86 Favored 'Cis proline' 0 N--CA 1.497 1.728 0 CA-C-N 121.967 1.738 . . . . 22.289999999999999 111.566 -1.057 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 58' ' ' LEU . . . . . . . . . . . . . 26.7 tp -107.63 136.24 47.73 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.438 -0.347 . . . . 19.170000000000002 110.467 -178.873 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 59' ' ' ARG . . . . . . . . . . . . . 71.3 ttt-85 -106.64 119.23 38.74 Favored 'General case' 0 C--N 1.327 -0.371 0 N-CA-C 109.131 -0.692 . . . . 24.09 109.131 177.239 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 60' ' ' VAL . . . . . . . . . . . . . 44.7 t -78.05 122.27 32.6 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.286 0 C-N-CA 120.753 -0.379 . . . . 19.329999999999998 110.428 -173.96 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 61' ' ' GLU . . . . . . . . . . . . . 46.9 mt-10 -131.0 174.31 10.13 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.065 -0.516 . . . . 21.739999999999998 109.882 176.923 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 62' ' ' ASP . . . . . . . . . . . . . 10.9 t70 -54.29 -32.71 57.06 Favored 'General case' 0 C--N 1.327 -0.381 0 C-N-CA 121.037 -0.265 . . . . 21.649999999999999 111.668 -178.812 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 63' ' ' ARG . . . . . . . . . . . . . 39.9 ptt180 -89.49 5.14 46.75 Favored 'General case' 0 CA--C 1.537 0.452 0 N-CA-C 113.715 1.006 . . . . 24.690000000000001 113.715 -176.152 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 64' ' ' THR . . . . . . . . . . . . . 38.7 m -81.1 130.7 35.14 Favored 'General case' 0 C--N 1.331 -0.2 0 CA-C-N 118.134 0.425 . . . . 18.760000000000002 110.386 -179.717 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 65' ' ' LYS . . . . . . . . . . . . . 91.0 mttt -90.47 130.37 36.54 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.353 -0.385 . . . . 18.940000000000001 110.469 -179.715 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 66' ' ' ILE . . . . . . . . . . . . . 65.1 mt -116.48 132.35 66.37 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.232 0 CA-C-O 120.923 0.392 . . . . 15.210000000000001 110.006 179.456 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 67' ' ' THR . . . . . . . . . . . . . 30.4 m -120.4 139.37 52.91 Favored 'General case' 0 C--N 1.331 -0.22 0 CA-C-N 116.04 -0.527 . . . . 12.77 110.637 -178.938 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 68' ' ' LEU . . . . . . . . . . . . . 6.8 mp -101.24 116.32 32.53 Favored 'General case' 0 C--N 1.332 -0.193 0 CA-C-N 116.209 -0.45 . . . . 10.5 110.781 179.692 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 69' ' ' VAL . . . . . . . . . . . . . 44.1 t -103.57 139.29 24.92 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.322 0 CA-C-N 115.926 -0.579 . . . . 8.1400000000000006 109.933 178.5 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 70' ' ' THR . . . . . . . . . . . . . 3.2 p -136.88 45.46 2.27 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-O 121.325 0.583 . . . . 6.9199999999999999 110.619 179.983 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 71' ' ' HIS . . . . . . . . . . . . . 18.5 t60 -125.71 80.62 66.38 Favored Pre-proline 0 CA--C 1.535 0.371 0 CA-C-N 116.063 -0.517 . . . . 7.3899999999999997 110.595 -179.372 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 72' ' ' PRO . . . . . . . . . . . . . 16.8 Cg_exo -65.0 -30.04 56.94 Favored 'Trans proline' 0 N--CA 1.496 1.656 0 C-N-CA 121.429 1.42 . . . . 3.52 112.443 -179.436 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 73' ' ' VAL . . . . . . . . . . . . . 34.5 m -147.93 172.12 2.5 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.36 0 CA-C-N 116.515 -0.311 . . . . 1.3500000000000001 110.53 -179.831 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 74' ' ' ASP . . . . . . . . . . . . . 29.8 t0 -94.01 120.23 33.98 Favored 'General case' 0 C--N 1.331 -0.229 0 CA-C-N 116.446 -0.343 . . . . 0.93000000000000005 110.159 -179.631 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 75' ' ' VAL . . . . . . . . . . . . . 43.4 t -118.76 121.77 67.75 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.212 0 CA-C-O 121.046 0.45 . . . . 1.26 110.688 -177.86 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 76' ' ' LEU . . . . . . . . . . . . . 6.0 mp -123.66 146.49 48.18 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-N 115.82 -0.627 . . . . 1.77 109.672 175.284 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 77' ' ' GLU . . . . . . . . . . . . . 98.1 mt-10 -135.54 139.74 44.18 Favored 'General case' 0 N--CA 1.462 0.161 0 CA-C-O 121.015 0.436 . . . . 1.3300000000000001 111.582 -177.642 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 78' ' ' ALA . . . . . . . . . . . . . . . -127.73 137.79 52.56 Favored 'General case' 0 C--N 1.331 -0.223 0 CA-C-N 115.639 -0.71 . . . . 1.3 109.69 175.474 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 79' ' ' LYS . . . . . . . . . . . . . 49.8 pttt -84.64 123.15 30.03 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-O 121.073 0.464 . . . . 3.4900000000000002 110.937 -179.019 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 80' ' ' ILE . . . . . . . . . . . . . 40.0 mm -139.16 117.54 12.51 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.28 0 N-CA-C 109.421 -0.585 . . . . 1.25 109.421 -177.659 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 81' ' ' LYS . . . . . . . . . . . . . 85.4 tttt -104.14 121.79 43.97 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-O 120.795 0.331 . . . . 3.3900000000000001 111.122 -177.292 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 82' ' ' GLY . . . . . . . . . . . . . . . 89.11 42.2 5.67 Favored Glycine 0 CA--C 1.526 0.733 0 C-N-CA 120.648 -0.786 . . . . 0.70999999999999996 112.069 173.618 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 83' ' ' ILE . . . . . . . . . . . . . 69.3 mt -67.43 137.92 23.78 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.282 0 N-CA-C 109.669 -0.493 . . . . 1.1499999999999999 109.669 176.625 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 84' ' ' LYS . . . . . . . . . . . . . 80.5 tttt -93.46 -54.07 3.82 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.078 -0.51 . . . . 2.1600000000000001 110.379 -178.388 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 85' ' ' ASP . . . . . . . . . . . . . 19.5 t70 -156.43 152.92 28.07 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 115.63 -0.714 . . . . 0.69999999999999996 110.138 -179.085 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 86' ' ' VAL . . . . . . . . . . . . . 45.1 t -127.5 131.07 70.57 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.25 0 CA-C-O 121.096 0.474 . . . . 1.26 110.543 -179.092 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 87' ' ' ILE . . . . . . . . . . . . . 5.1 mp -118.94 125.13 74.23 Favored 'Isoleucine or valine' 0 C--O 1.233 0.23 0 CA-C-N 115.668 -0.696 . . . . 2.02 109.276 176.64 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 88' ' ' LEU . . . . . . . . . . . . . 16.6 tp -110.05 127.28 54.75 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-O 120.926 0.393 . . . . 2.29 110.958 -177.415 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 89' ' ' ASP . . . . . . . . . . . . . 14.6 t70 -118.89 158.17 26.21 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 115.813 -0.631 . . . . 0.84999999999999998 109.408 177.09 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 90' ' ' GLU . . . . . . . . . . . . . 95.1 mt-10 -47.31 -40.35 16.83 Favored 'General case' 0 C--N 1.33 -0.265 0 N-CA-C 113.0 0.741 . . . . 2.5099999999999998 113.0 -171.33 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 91' ' ' ASN . . . . . . . . . . . . . 69.9 m-80 -132.09 26.51 4.56 Favored 'General case' 0 N--CA 1.466 0.373 0 N-CA-C 112.469 0.544 . . . . 2.5899999999999999 112.469 -178.023 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 92' ' ' LEU . . . . . . . . . . . . . 84.9 mt -150.51 143.22 24.57 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-O 120.748 0.308 . . . . 2.04 110.448 -178.731 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 93' ' ' ILE . . . . . . . . . . . . . 74.5 mt -118.53 113.37 41.63 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.346 0 N-CA-C 109.257 -0.646 . . . . 1.21 109.257 178.181 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 94' ' ' VAL . . . . . . . . . . . . . 46.1 t -115.35 124.95 72.41 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.201 0 CA-C-O 120.939 0.4 . . . . 1.1399999999999999 109.99 -178.43 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 95' ' ' VAL . . . . . . . . . . . . . 42.7 t -121.91 134.34 65.49 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.285 0 CA-C-N 116.07 -0.514 . . . . 1.1699999999999999 109.881 -179.122 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 96' ' ' ILE . . . . . . . . . . . . . 64.6 mt -112.89 128.71 69.48 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.365 0 N-CA-C 109.075 -0.713 . . . . 1.1799999999999999 109.075 177.831 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 97' ' ' THR . . . . . . . . . . . . . 69.6 p -98.37 158.72 15.4 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-O 121.153 0.501 . . . . 1.1499999999999999 111.082 -178.043 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 98' ' ' GLU . . . . . . . . . . . . . 83.6 tt0 -53.93 -27.66 32.18 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.148 -0.478 . . . . 3.0499999999999998 112.081 -179.819 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 99' ' ' GLU . . . . . . . . . . . . . 95.5 mt-10 -81.31 16.78 1.49 Allowed 'General case' 0 CA--C 1.534 0.363 0 N-CA-C 113.152 0.797 . . . . 2.29 113.152 -176.588 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 100' ' ' ASN . . . . . . . . . . . . . 4.3 m-20 62.89 38.05 11.65 Favored 'General case' 0 N--CA 1.462 0.158 0 CA-C-O 121.073 0.464 . . . . 0.66000000000000003 111.158 177.265 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 101' ' ' GLU . . . . . . . . . . . . . 84.6 tt0 -115.18 144.46 43.65 Favored 'General case' 0 C--N 1.333 -0.132 0 CA-C-N 116.1 -0.5 . . . . 0.68999999999999995 109.738 174.937 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 102' ' ' VAL . . . . . . . . . . . . . 45.0 t -115.5 126.23 72.98 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 CA-C-N 116.257 -0.429 . . . . 1.1899999999999999 110.083 -177.812 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 103' ' ' LEU . . . . . . . . . . . . . 55.6 mt -119.23 132.48 55.93 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 115.789 -0.641 . . . . 1.8600000000000001 110.014 177.15 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 104' ' ' ILE . . . . . . . . . . . . . 66.7 mt -121.34 121.61 65.18 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.236 0 N-CA-C 110.369 -0.234 . . . . 1.22 110.369 179.047 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 105' ' ' PHE . . . . . . . . . . . . . 76.0 m-85 -115.81 166.32 12.09 Favored 'General case' 0 C--N 1.332 -0.175 0 O-C-N 124.205 0.941 . . . . 0.58999999999999997 109.643 177.911 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 106' ' ' ASN . . . . . . . . . . . . . 52.0 p-10 -100.08 -171.57 2.07 Favored 'General case' 0 C--N 1.331 -0.213 0 N-CA-C 110.086 -0.338 . . . . 0.73999999999999999 110.086 173.546 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 107' ' ' GLN . . . . . . . . . . . . . 50.2 tt0 -58.37 -30.15 66.56 Favored 'General case' 0 CA--C 1.532 0.286 0 N-CA-C 111.901 0.334 . . . . 1.8400000000000001 111.901 178.574 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 108' ' ' ASN . . . . . . . . . . . . . 63.6 t30 -83.03 8.16 13.63 Favored 'General case' 0 CA--C 1.535 0.388 0 N-CA-C 113.212 0.819 . . . . 1.9399999999999999 113.212 -177.147 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 109' ' ' LEU . . . . . . . . . . . . . 11.9 tp 60.92 37.43 18.33 Favored 'General case' 0 CA--C 1.53 0.186 0 CA-C-O 120.99 0.424 . . . . 1.75 111.197 179.028 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 110' ' ' GLU . . . . . . . . . . . . . 47.6 mt-10 -110.09 153.09 25.16 Favored 'General case' 0 C--N 1.33 -0.24 0 N-CA-C 109.751 -0.463 . . . . 1.97 109.751 176.436 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 111' ' ' GLU . . . . . . . . . . . . . 73.7 tt0 -86.76 123.17 31.61 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-O 120.855 0.359 . . . . 1.8400000000000001 110.926 -174.931 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 112' ' ' LEU . . . . . . . . . . . . . 32.9 mt -108.9 -46.06 3.69 Favored 'General case' 0 C--N 1.332 -0.186 0 CA-C-N 116.198 -0.455 . . . . 1.3100000000000001 111.27 -179.55 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 113' ' ' TYR . . . . . . . . . . . . . 71.6 t80 -136.83 142.3 42.87 Favored 'General case' 0 N--CA 1.464 0.244 0 CA-C-O 120.778 0.323 . . . . 0.94999999999999996 111.064 -178.202 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 114' ' ' ARG . . . . . . . . . . . . . 25.0 ptt180 -144.52 127.25 16.21 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.05 -0.523 . . . . 3.3700000000000001 110.927 -179.989 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 115' ' ' GLY . . . . . . . . . . . . . . . -150.19 160.46 28.55 Favored Glycine 0 CA--C 1.525 0.659 0 N-CA-C 111.242 -0.743 . . . . 0.56999999999999995 111.242 178.614 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 116' ' ' LYS . . . . . . . . . . . . . 7.9 ttpm? -129.65 134.45 47.69 Favored 'General case' 0 C--N 1.33 -0.267 0 N-CA-C 109.782 -0.451 . . . . 2.21 109.782 175.911 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 117' ' ' PHE . . . . . . . . . . . . . 38.3 m-85 -134.46 113.97 12.39 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-O 120.815 0.34 . . . . 0.56999999999999995 110.258 -176.939 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 118' ' ' GLU . . . . . . . . . . . . . 95.9 mt-10 -55.29 -40.94 71.66 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.424 -0.353 . . . . 2.5600000000000001 111.129 -176.371 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 119' ' ' ASN . . . . . . . . . . . . . 7.2 m120 -102.84 31.12 4.33 Favored 'General case' 0 C--N 1.331 -0.227 0 CA-C-N 116.272 -0.422 . . . . 2.0499999999999998 112.136 -174.431 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 120' ' ' LEU . . . . . . . . . . . . . 18.8 tp -56.23 120.46 7.6 Favored 'General case' 0 N--CA 1.462 0.156 0 C-N-CA 120.971 -0.292 . . . . 1.1899999999999999 110.403 178.418 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 121' ' ' ASN . . . . . . . . . . . . . 64.2 t30 -114.08 -44.1 3.18 Favored 'General case' 0 C--O 1.233 0.186 0 CA-C-N 116.504 -0.316 . . . . 2.4199999999999999 111.239 -175.891 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 122' ' ' LYS . . . . . . . . . . . . . 91.0 mttt -146.22 150.32 35.61 Favored 'General case' 0 C--N 1.331 -0.197 0 CA-C-O 121.192 0.52 . . . . 2.1600000000000001 111.981 -176.339 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 123' ' ' VAL . . . . . . . . . . . . . 45.4 t -124.73 128.86 73.64 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.245 0 CA-C-N 115.651 -0.704 . . . . 1.2 109.391 174.723 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 124' ' ' LEU . . . . . . . . . . . . . 72.5 mt -120.8 132.43 55.02 Favored 'General case' 0 C--N 1.33 -0.273 0 N-CA-C 110.181 -0.303 . . . . 2.1600000000000001 110.181 -178.194 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 125' ' ' VAL . . . . . . . . . . . . . 35.1 m -138.43 132.44 41.61 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.25 0 CA-C-O 120.971 0.415 . . . . 2.3500000000000001 111.085 -179.754 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 126' ' ' ARG . . . . . . . . . . . . . 89.3 mtt-85 -151.58 132.92 14.57 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 115.777 -0.647 . . . . 3.0600000000000001 109.714 176.605 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 127' ' ' ASN . . . . . . . . . . . . . 32.0 t30 56.67 -147.82 0.51 Allowed 'General case' 0 CA--C 1.541 0.623 0 N-CA-C 109.686 -0.487 . . . . 2.71 109.686 -179.415 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 128' ' ' ASP . . . . . . . . . . . . . 4.5 p30 -88.04 16.89 5.46 Favored 'General case' 0 CA--C 1.536 0.433 0 CA-C-N 118.75 0.705 . . . . 1.02 112.725 178.446 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 129' ' ' LEU . . . . . . . . . . . . . 15.0 tp -115.37 136.08 53.46 Favored 'General case' 0 C--O 1.232 0.167 0 O-C-N 122.118 -0.364 . . . . 2.3399999999999999 110.073 179.389 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 130' ' ' VAL . . . . . . . . . . . . . 32.6 m -131.53 144.0 38.81 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.27 0 CA-C-O 120.995 0.426 . . . . 2.1099999999999999 111.0 -178.546 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 131' ' ' VAL . . . . . . . . . . . . . 42.8 t -136.04 140.07 44.65 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 CA-C-N 116.022 -0.536 . . . . 1.3400000000000001 110.34 179.796 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 132' ' ' ILE . . . . . . . . . . . . . 72.4 mt -112.95 133.88 57.37 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.323 0 N-CA-C 109.422 -0.584 . . . . 1.1399999999999999 109.422 178.256 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 133' ' ' ILE . . . . . . . . . . . . . 38.5 mm -114.68 116.97 54.18 Favored 'Isoleucine or valine' 0 C--O 1.233 0.232 0 CA-C-N 116.534 -0.303 . . . . 1.24 110.767 -176.118 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 134' ' ' ASP . . . . . . . . . . . . . 7.6 p-10 -129.61 149.79 51.22 Favored 'General case' 0 C--N 1.331 -0.215 0 N-CA-C 109.594 -0.521 . . . . 0.56000000000000005 109.594 174.963 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 135' ' ' GLU . . . . . . . . . . . . . 85.0 tt0 -49.9 -25.94 3.65 Favored 'General case' 0 C--N 1.327 -0.372 0 N-CA-C 112.719 0.637 . . . . 1.6399999999999999 112.719 -172.113 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 136' ' ' GLN . . . . . . . . . . . . . 53.0 mt-30 -101.82 -25.68 13.73 Favored 'General case' 0 C--O 1.233 0.218 0 N-CA-C 112.892 0.701 . . . . 2.46 112.892 -173.939 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 137' ' ' LYS . . . . . . . . . . . . . 86.5 mttt -144.84 150.67 37.52 Favored 'General case' 0 C--N 1.331 -0.227 0 CA-C-O 121.482 0.658 . . . . 2.3900000000000001 112.559 -168.503 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 138' ' ' LEU . . . . . . . . . . . . . 12.5 tp -112.65 117.6 32.71 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 114.888 -1.051 . . . . 1.3999999999999999 108.78 172.64 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 139' ' ' THR . . . . . . . . . . . . . 22.1 m -110.54 124.97 52.83 Favored 'General case' 0 C--N 1.332 -0.182 0 CA-C-O 120.596 0.236 . . . . 1.1799999999999999 110.753 -177.266 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 140' ' ' LEU . . . . . . . . . . . . . 6.5 tt -116.1 122.73 45.99 Favored 'General case' 0 C--N 1.33 -0.249 0 N-CA-C 109.484 -0.561 . . . . 1.5700000000000001 109.484 -178.261 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 141' ' ' ILE . . . . . . . . . . . . . 19.8 mt -120.71 122.95 69.26 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.298 0 CA-C-O 120.949 0.404 . . . . 1.22 110.015 -175.397 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 142' ' ' ARG . . . . . . . . . . . . . 67.5 mtm180 -104.4 126.38 51.45 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 115.281 -0.872 . . . . 4.0899999999999999 109.938 179.78 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 143' ' ' THR . . . . . . . . . . . . . 23.0 p . . . . . 0 C--O 1.22 -0.497 0 CA-C-O 117.963 -1.018 . . . . 1.46 110.645 -179.576 . . . . . . . . 0 0 . 1 . 001 nuclear orig full ' C' C ' -3' ' ' GLU . . . . . . . . . . . . . 21.9 pt-20 . . . . . 0 N--CA 1.492 1.643 0 N-CA-C 110.322 -0.251 . . . . 36.630000000000003 110.322 . . . . . . . . . 0 0 . 1 . 001 nuclear orig full ' C' C ' -2' ' ' GLY . . . . . . . . . . . . . . . -73.3 94.0 0.71 Allowed Glycine 0 CA--C 1.524 0.603 0 N-CA-C 111.245 -0.742 . . . . 32.57 111.245 -178.441 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' C' C ' -1' ' ' VAL . . . . . . . . . . . . . 45.1 t -93.84 126.69 46.23 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.337 0 N-CA-C 109.018 -0.734 . . . . 29.239999999999998 109.018 175.43 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' C' C ' 0' ' ' ILE . . . . . . . . . . . . . 44.6 mm -99.44 117.86 45.2 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.316 0 CA-C-O 120.944 0.402 . . . . 27.960000000000001 110.588 -175.998 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' C' C ' 1' ' ' MET . . . . . . . . . . . . . 24.9 ptm -90.72 141.11 29.13 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-N 115.815 -0.63 . . . . 24.050000000000001 110.079 178.21 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' C' C ' 2' ' ' SER . . . . . . . . . . . . . 51.0 p -104.93 140.09 38.68 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-O 120.996 0.427 . . . . 21.68 110.875 -178.159 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' C' C ' 3' ' ' GLU . . . . . . . . . . . . . 95.2 mt-10 -140.02 142.57 36.22 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 115.832 -0.622 . . . . 19.0 110.711 -179.463 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' C' C ' 4' ' ' LEU . . . . . . . . . . . . . 4.0 tt -123.78 124.02 41.78 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.083 -0.508 . . . . 16.859999999999999 109.788 176.63 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' C' C ' 5' ' ' LYS . . . . . . . . . . . . . 57.3 mttm -100.12 121.7 41.81 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.298 -0.41 . . . . 14.550000000000001 110.866 -179.314 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' C' C ' 6' ' ' LEU . . . . . . . . . . . . . 60.6 mt -117.59 146.3 43.72 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 115.557 -0.747 . . . . 14.02 110.67 -179.437 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' C' C ' 7' ' ' LYS . . . . . . . . . . . . . 38.5 ttmt -138.89 139.14 22.8 Favored Pre-proline 0 CA--C 1.533 0.318 0 CA-C-O 119.115 -0.469 . . . . 11.369999999999999 109.998 174.779 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' C' C ' 8' ' ' PRO . . . . . . . . . . . . . 94.1 Cg_endo -91.95 146.12 3.05 Favored 'Trans proline' 0 N--CA 1.489 1.258 0 C-N-CA 121.82 1.68 . . . . 11.15 112.098 178.817 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' C' C ' 9' ' ' LEU . . . . . . . . . . . . . 70.2 mt -75.89 -46.34 3.93 Favored Pre-proline 0 CA--C 1.533 0.31 0 CA-C-O 118.742 -0.647 . . . . 14.81 111.596 178.035 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' C' C ' 10' ' ' PRO . . . . . . . . . . . . . 84.6 Cg_endo -81.76 142.68 12.85 Favored 'Trans proline' 0 N--CA 1.495 1.574 0 C-N-CA 121.024 1.15 . . . . 14.039999999999999 111.227 172.308 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' C' C ' 11' ' ' LYS . . . . . . . . . . . . . 53.7 tttm -86.33 109.94 19.33 Favored 'General case' 0 C--N 1.331 -0.223 0 C-N-CA 120.68 -0.408 . . . . 12.199999999999999 110.524 -179.254 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' C' C ' 12' ' ' VAL . . . . . . . . . . . . . 11.6 p -147.38 145.62 18.95 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.299 0 CA-C-N 116.003 -0.544 . . . . 13.76 110.402 -179.294 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' C' C ' 13' ' ' GLU . . . . . . . . . . . . . 46.1 mt-10 -81.15 130.28 34.95 Favored 'General case' 0 C--N 1.329 -0.286 0 N-CA-C 110.096 -0.335 . . . . 13.26 110.096 177.91 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' C' C ' 14' ' ' LEU . . . . . . . . . . . . . 17.3 mt -98.78 143.94 27.27 Favored Pre-proline 0 CA--C 1.533 0.326 0 CA-C-O 118.987 -0.53 . . . . 13.07 110.336 -178.215 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' C' C ' 15' ' ' PRO . . . . . . . . . . . . . 23.2 Cg_exo -64.49 161.09 36.49 Favored 'Trans proline' 0 N--CA 1.498 1.754 0 C-N-CA 121.36 1.373 . . . . 16.109999999999999 111.733 176.333 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' C' C ' 16' ' ' PRO . . . . . . . . . . . . . 35.7 Cg_exo -59.12 -35.32 98.18 Favored 'Trans proline' 0 N--CA 1.498 1.748 0 C-N-CA 121.508 1.472 . . . . 16.780000000000001 112.979 -178.545 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' C' C ' 17' ' ' ASP . . . . . . . . . . . . . 11.6 p-10 -83.3 -0.71 50.9 Favored 'General case' 0 CA--C 1.537 0.452 0 N-CA-C 113.35 0.87 . . . . 17.370000000000001 113.35 -177.397 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' C' C ' 18' ' ' PHE . . . . . . . . . . . . . 29.2 t80 -58.34 -44.26 88.65 Favored 'General case' 0 C--N 1.334 -0.107 0 O-C-N 121.972 -0.455 . . . . 14.82 110.082 -177.343 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' C' C ' 19' ' ' VAL . . . . . . . . . . . . . 49.7 t -57.14 -43.96 82.47 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.288 0 CA-C-N 116.132 -0.485 . . . . 15.029999999999999 110.423 -177.737 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' C' C ' 20' ' ' ASP . . . . . . . . . . . . . 2.0 m-20 -60.07 -43.31 95.54 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.551 -0.295 . . . . 17.449999999999999 111.029 -177.653 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' C' C ' 21' ' ' VAL . . . . . . . . . . . . . 46.4 t -63.84 -45.49 96.94 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.289 0 C-N-CA 120.707 -0.397 . . . . 17.609999999999999 110.545 -176.94 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' C' C ' 22' ' ' ILE . . . . . . . . . . . . . 50.6 mm -55.9 -48.58 78.25 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.226 0 C-N-CA 121.038 -0.265 . . . . 16.84 110.71 179.014 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' C' C ' 23' ' ' ARG . . . . . . . . . . . . . 49.3 ttp180 -54.84 -45.76 74.55 Favored 'General case' 0 C--N 1.331 -0.234 0 C-N-CA 120.92 -0.312 . . . . 19.43 111.347 -178.245 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' C' C ' 24' ' ' ILE . . . . . . . . . . . . . 75.5 mt -58.94 -45.33 92.03 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.253 0 C-N-CA 121.013 -0.275 . . . . 20.399999999999999 111.073 -178.696 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' C' C ' 25' ' ' LYS . . . . . . . . . . . . . 53.6 mttm -65.81 -38.1 88.04 Favored 'General case' 0 C--N 1.328 -0.349 0 N-CA-C 112.418 0.525 . . . . 20.059999999999999 112.418 -178.325 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' C' C ' 26' ' ' LEU . . . . . . . . . . . . . 62.8 mt -78.51 -39.82 36.99 Favored 'General case' 0 C--N 1.33 -0.25 0 N-CA-C 113.697 0.999 . . . . 20.370000000000001 113.697 -170.443 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' C' C ' 27' ' ' GLN . . . . . . . . . . . . . 12.1 pt20 -47.39 138.66 7.29 Favored 'General case' 0 N--CA 1.469 0.478 0 N-CA-C 112.827 0.677 . . . . 21.899999999999999 112.827 -174.772 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' C' C ' 28' ' ' GLY . . . . . . . . . . . . . . . 98.62 -22.05 42.86 Favored Glycine 0 CA--C 1.534 1.234 0 CA-C-N 115.772 -0.649 . . . . 24.109999999999999 112.683 -177.737 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' C' C ' 29' ' ' LYS . . . . . . . . . . . . . 63.3 mttp -98.26 155.07 17.37 Favored 'General case' 0 C--N 1.333 -0.129 0 CA-C-N 117.521 0.661 . . . . 23.399999999999999 111.02 -179.964 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' C' C ' 30' ' ' THR . . . . . . . . . . . . . 41.7 m -105.73 135.25 47.49 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.165 -0.47 . . . . 24.760000000000002 109.826 175.33 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' C' C ' 31' ' ' VAL . . . . . . . . . . . . . 34.9 m -130.56 150.5 34.68 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.289 0 CA-C-O 120.979 0.419 . . . . 21.440000000000001 111.171 -177.815 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' C' C ' 32' ' ' ARG . . . . . . . . . . . . . 56.0 ttp180 -131.71 151.0 51.97 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 115.772 -0.649 . . . . 26.43 110.182 177.674 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' C' C ' 33' ' ' THR . . . . . . . . . . . . . 23.5 m -52.92 138.82 29.09 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.423 -0.353 . . . . 20.32 111.436 -177.761 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' C' C ' 34' ' ' GLY . . . . . . . . . . . . . . . 101.25 -17.23 56.08 Favored Glycine 0 CA--C 1.533 1.177 0 CA-C-O 119.695 -0.503 . . . . 19.649999999999999 113.276 179.24 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' C' C ' 35' ' ' ASP . . . . . . . . . . . . . 75.1 m-20 -67.0 152.48 45.7 Favored 'General case' 0 N--CA 1.461 0.103 0 CA-C-N 118.046 0.923 . . . . 21.469999999999999 111.417 178.984 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' C' C ' 36' ' ' VAL . . . . . . . . . . . . . 44.9 t -121.03 130.98 74.12 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.227 0 CA-C-N 115.969 -0.56 . . . . 19.550000000000001 109.99 178.423 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' C' C ' 37' ' ' ILE . . . . . . . . . . . . . 71.9 mt -123.61 140.87 45.83 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.23 0 CA-C-N 116.158 -0.474 . . . . 18.649999999999999 109.858 179.972 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' C' C ' 38' ' ' GLY . . . . . . . . . . . . . . . -113.42 128.93 8.58 Favored Glycine 0 CA--C 1.528 0.851 0 N-CA-C 111.272 -0.731 . . . . 18.91 111.272 -179.548 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' C' C ' 39' ' ' ILE . . . . . . . . . . . . . 68.7 mt -124.83 132.37 71.41 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.199 0 N-CA-C 109.911 -0.403 . . . . 18.359999999999999 109.911 178.395 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' C' C ' 40' ' ' SER . . . . . . . . . . . . . 15.7 t -92.78 117.92 30.53 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-N 116.546 -0.297 . . . . 21.23 111.009 177.093 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' C' C ' 41' ' ' ILE . . . . . . . . . . . . . 47.4 mm -130.89 128.2 62.36 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.217 0 CA-C-O 120.711 0.291 . . . . 18.73 110.223 178.847 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' C' C ' 42' ' ' LEU . . . . . . . . . . . . . 23.1 mt 57.33 33.53 23.42 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.196 -0.456 . . . . 20.859999999999999 111.873 177.985 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' C' C ' 43' ' ' GLY . . . . . . . . . . . . . . . 77.64 -10.1 25.89 Favored Glycine 0 CA--C 1.535 1.311 0 C-N-CA 121.188 -0.529 . . . . 22.32 113.421 177.341 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' C' C ' 44' ' ' LYS . . . . . . . . . . . . . 65.6 tttt -104.87 135.46 46.19 Favored 'General case' 0 C--N 1.332 -0.162 0 CA-C-N 117.938 0.869 . . . . 19.989999999999998 110.105 177.58 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' C' C ' 45' ' ' GLU . . . . . . . . . . . . . 84.6 tt0 -83.72 131.14 34.95 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.36 -0.382 . . . . 20.5 110.91 -179.734 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' C' C ' 46' ' ' VAL . . . . . . . . . . . . . 7.3 p -120.76 130.64 74.36 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.229 0 N-CA-C 109.369 -0.604 . . . . 16.82 109.369 175.99 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' C' C ' 47' ' ' LYS . . . . . . . . . . . . . 66.8 mttm -99.26 126.89 45.17 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 115.877 -0.601 . . . . 19.600000000000001 110.709 178.949 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' C' C ' 48' ' ' PHE . . . . . . . . . . . . . 85.2 m-85 -111.27 131.96 54.74 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.366 -0.379 . . . . 15.050000000000001 110.085 177.921 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' C' C ' 49' ' ' LYS . . . . . . . . . . . . . 78.9 tttt -105.16 136.09 45.3 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.228 -0.442 . . . . 16.59 109.913 178.156 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' C' C ' 50' ' ' VAL . . . . . . . . . . . . . 46.6 t -78.22 107.85 10.81 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.312 0 N-CA-C 109.161 -0.681 . . . . 16.710000000000001 109.161 177.174 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' C' C ' 51' ' ' VAL . . . . . . . . . . . . . 48.9 t -70.22 -47.87 64.71 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.304 0 CA-C-N 115.964 -0.562 . . . . 15.449999999999999 109.956 -174.298 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' C' C ' 52' ' ' GLN . . . . . . . . . . . . . 48.4 tt0 -168.99 140.1 2.43 Favored 'General case' 0 C--N 1.33 -0.255 0 C-N-CA 120.389 -0.524 . . . . 17.390000000000001 111.581 -179.004 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' C' C ' 53' ' ' ALA . . . . . . . . . . . . . . . -109.65 133.3 53.28 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 115.85 -0.614 . . . . 19.600000000000001 109.799 174.922 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' C' C ' 54' ' ' TYR . . . . . . . . . . . . . 10.0 t80 -129.03 107.39 18.03 Favored Pre-proline 0 CA--C 1.534 0.35 0 CA-C-O 118.27 -0.871 . . . . 23.510000000000002 110.389 -179.942 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' C' C ' 55' ' ' PRO . . . . . . . . . . . . . 72.7 Cg_endo -77.21 170.03 72.59 Favored 'Cis proline' 0 N--CA 1.501 1.932 0 CA-C-N 121.798 1.678 . . . . 24.34 112.558 -6.009 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' C' C ' 56' ' ' SER . . . . . . . . . . . . . 20.0 m -116.59 140.21 26.44 Favored Pre-proline 0 CA--C 1.539 0.524 0 CA-C-O 118.616 -0.707 . . . . 24.73 109.737 174.763 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' C' C ' 57' ' ' PRO . . . . . . . . . . . . . 57.0 Cg_endo -73.36 148.01 91.04 Favored 'Cis proline' 0 N--CA 1.499 1.809 0 CA-C-N 121.621 1.615 . . . . 26.280000000000001 111.161 -6.123 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' C' C ' 58' ' ' LEU . . . . . . . . . . . . . 25.1 tp -107.47 139.3 42.18 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-O 120.986 0.422 . . . . 22.27 110.759 -177.487 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' C' C ' 59' ' ' ARG . . . . . . . . . . . . . 54.3 ttp180 -103.91 119.42 38.89 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 115.543 -0.753 . . . . 27.23 109.016 174.598 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' C' C ' 60' ' ' VAL . . . . . . . . . . . . . 40.9 t -72.58 120.18 20.67 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.286 0 C-N-CA 120.872 -0.331 . . . . 21.449999999999999 110.726 -173.092 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' C' C ' 61' ' ' GLU . . . . . . . . . . . . . 94.8 mt-10 -131.03 164.9 24.39 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 115.774 -0.648 . . . . 24.699999999999999 109.764 175.979 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' C' C ' 62' ' ' ASP . . . . . . . . . . . . . 39.4 m-20 -53.87 -32.49 53.32 Favored 'General case' 0 C--N 1.328 -0.349 0 C-N-CA 120.982 -0.287 . . . . 22.780000000000001 111.763 -179.865 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' C' C ' 63' ' ' ARG . . . . . . . . . . . . . 28.5 ptt180 -78.77 0.23 27.73 Favored 'General case' 0 CA--C 1.537 0.468 0 N-CA-C 113.799 1.037 . . . . 26.199999999999999 113.799 -175.445 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' C' C ' 64' ' ' THR . . . . . . . . . . . . . 32.5 m -86.28 136.4 33.17 Favored 'General case' 0 C--N 1.333 -0.148 0 CA-C-N 118.146 0.43 . . . . 20.399999999999999 110.797 -177.926 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' C' C ' 65' ' ' LYS . . . . . . . . . . . . . 62.8 mttm -89.67 131.08 35.83 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.166 -0.47 . . . . 19.690000000000001 110.192 178.924 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' C' C ' 66' ' ' ILE . . . . . . . . . . . . . 58.2 mt -112.2 130.18 66.35 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.254 0 N-CA-C 109.631 -0.507 . . . . 15.960000000000001 109.631 -179.808 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' C' C ' 67' ' ' THR . . . . . . . . . . . . . 26.5 m -124.78 137.34 54.33 Favored 'General case' 0 C--N 1.332 -0.167 0 CA-C-O 121.01 0.433 . . . . 13.69 111.022 -177.307 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' C' C ' 68' ' ' LEU . . . . . . . . . . . . . 53.9 mt -105.02 127.45 52.88 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 115.859 -0.61 . . . . 10.69 110.209 177.806 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' C' C ' 69' ' ' VAL . . . . . . . . . . . . . 44.1 t -102.4 117.25 47.47 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.275 0 CA-C-O 120.836 0.35 . . . . 9.9000000000000004 110.245 179.434 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' C' C ' 70' ' ' THR . . . . . . . . . . . . . 27.3 p -150.07 161.68 41.89 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.045 -0.525 . . . . 6.9699999999999998 110.425 178.391 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' C' C ' 71' ' ' HIS . . . . . . . . . . . . . 15.8 t60 -135.81 68.33 65.05 Favored Pre-proline 0 CA--C 1.535 0.396 0 CA-C-N 116.352 -0.386 . . . . 8.5800000000000001 110.38 177.924 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' C' C ' 72' ' ' PRO . . . . . . . . . . . . . 93.8 Cg_endo -90.89 160.04 4.03 Favored 'Trans proline' 0 N--CA 1.489 1.211 0 C-N-CA 121.936 1.758 . . . . 3.9399999999999999 112.222 179.049 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' C' C ' 73' ' ' VAL . . . . . . . . . . . . . 33.8 m -111.61 154.59 13.14 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.214 0 CA-C-O 120.87 0.367 . . . . 1.4199999999999999 110.48 179.322 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' C' C ' 74' ' ' ASP . . . . . . . . . . . . . 6.7 t70 -103.36 128.33 50.48 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 115.978 -0.555 . . . . 0.81000000000000005 109.778 -179.514 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' C' C ' 75' ' ' VAL . . . . . . . . . . . . . 41.0 t -114.63 122.9 69.67 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.209 0 CA-C-O 121.063 0.458 . . . . 1.24 110.745 -176.878 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' C' C ' 76' ' ' LEU . . . . . . . . . . . . . 6.8 mp -119.88 139.56 52.2 Favored 'General case' 0 C--N 1.33 -0.277 0 N-CA-C 108.875 -0.787 . . . . 1.6499999999999999 108.875 173.831 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' C' C ' 77' ' ' GLU . . . . . . . . . . . . . 59.6 tt0 -137.29 136.25 37.86 Favored 'General case' 0 C--N 1.333 -0.14 0 C-N-CA 120.496 -0.482 . . . . 1.1799999999999999 111.416 -174.237 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' C' C ' 78' ' ' ALA . . . . . . . . . . . . . . . -124.07 137.43 54.57 Favored 'General case' 0 C--N 1.331 -0.199 0 CA-C-N 115.771 -0.65 . . . . 1.24 109.835 177.45 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' C' C ' 79' ' ' LYS . . . . . . . . . . . . . 68.1 mttm -79.84 120.27 23.85 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-O 120.976 0.417 . . . . 3.6299999999999999 110.621 -179.542 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' C' C ' 80' ' ' ILE . . . . . . . . . . . . . 43.4 mm -139.11 114.05 8.13 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.311 0 N-CA-C 109.13 -0.693 . . . . 1.25 109.13 -176.95 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' C' C ' 81' ' ' LYS . . . . . . . . . . . . . 41.6 tttp -110.22 130.42 55.55 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-O 120.974 0.416 . . . . 3.3799999999999999 111.247 -176.362 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' C' C ' 82' ' ' GLY . . . . . . . . . . . . . . . 89.13 42.08 5.69 Favored Glycine 0 CA--C 1.526 0.722 0 CA-C-N 115.857 -0.61 . . . . 0.55000000000000004 111.692 175.694 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' C' C ' 83' ' ' ILE . . . . . . . . . . . . . 67.7 mt -69.95 138.34 22.26 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.279 0 N-CA-C 109.833 -0.432 . . . . 1.1699999999999999 109.833 178.54 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' C' C ' 84' ' ' LYS . . . . . . . . . . . . . 35.3 tttp -101.01 -54.03 2.9 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.068 -0.515 . . . . 2.29 110.366 -178.658 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' C' C ' 85' ' ' ASP . . . . . . . . . . . . . 13.3 t70 -151.97 151.33 31.06 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 115.862 -0.608 . . . . 0.76000000000000001 110.353 -179.7 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' C' C ' 86' ' ' VAL . . . . . . . . . . . . . 44.6 t -131.06 130.43 63.77 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.235 0 CA-C-O 120.93 0.395 . . . . 1.1699999999999999 110.596 -178.657 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' C' C ' 87' ' ' ILE . . . . . . . . . . . . . 46.1 mm -119.88 127.29 75.88 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.221 0 CA-C-N 115.883 -0.599 . . . . 1.98 109.71 176.297 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' C' C ' 88' ' ' LEU . . . . . . . . . . . . . 14.1 tp -110.02 131.5 55.0 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-O 120.869 0.366 . . . . 2.2400000000000002 110.969 -178.228 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' C' C ' 89' ' ' ASP . . . . . . . . . . . . . 21.8 t70 -123.42 156.68 35.01 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-N 116.087 -0.506 . . . . 0.94999999999999996 109.939 178.389 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' C' C ' 90' ' ' GLU . . . . . . . . . . . . . 81.2 tt0 -46.33 -40.17 11.38 Favored 'General case' 0 C--N 1.33 -0.255 0 N-CA-C 113.048 0.758 . . . . 2.4300000000000002 113.048 -171.738 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' C' C ' 91' ' ' ASN . . . . . . . . . . . . . 6.3 p-10 -132.1 23.03 4.51 Favored 'General case' 0 N--CA 1.468 0.434 0 N-CA-C 112.779 0.659 . . . . 2.7200000000000002 112.779 -178.546 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' C' C ' 92' ' ' LEU . . . . . . . . . . . . . 15.1 mt -149.26 148.79 29.98 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-O 120.734 0.302 . . . . 2.0499999999999998 110.262 -176.504 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' C' C ' 93' ' ' ILE . . . . . . . . . . . . . 75.7 mt -125.84 120.23 56.75 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.262 0 N-CA-C 109.41 -0.589 . . . . 1.1699999999999999 109.41 177.005 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' C' C ' 94' ' ' VAL . . . . . . . . . . . . . 46.4 t -118.65 124.97 74.01 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.244 0 N-CA-C 109.765 -0.457 . . . . 1.1899999999999999 109.765 -179.603 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' C' C ' 95' ' ' VAL . . . . . . . . . . . . . 41.6 t -122.02 134.49 65.13 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.328 0 CA-C-N 116.038 -0.528 . . . . 1.1699999999999999 109.946 -178.226 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' C' C ' 96' ' ' ILE . . . . . . . . . . . . . 62.6 mt -115.85 127.73 73.35 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.341 0 N-CA-C 109.004 -0.739 . . . . 1.1200000000000001 109.004 178.039 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' C' C ' 97' ' ' THR . . . . . . . . . . . . . 81.4 p -99.56 157.45 16.44 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-O 121.199 0.523 . . . . 1.0900000000000001 111.1 -178.262 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' C' C ' 98' ' ' GLU . . . . . . . . . . . . . 85.0 tt0 -54.01 -27.82 34.23 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.065 -0.516 . . . . 2.3300000000000001 112.043 179.771 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' C' C ' 99' ' ' GLU . . . . . . . . . . . . . 94.6 mt-10 -77.49 12.14 1.71 Allowed 'General case' 0 CA--C 1.537 0.458 0 N-CA-C 113.162 0.801 . . . . 2.1000000000000001 113.162 -177.676 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' C' C ' 100' ' ' ASN . . . . . . . . . . . . . 3.4 m-20 63.57 33.59 13.22 Favored 'General case' 0 CA--C 1.532 0.262 0 CA-C-O 120.904 0.383 . . . . 0.51000000000000001 111.565 179.174 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' C' C ' 101' ' ' GLU . . . . . . . . . . . . . 85.1 tt0 -107.71 144.74 34.4 Favored 'General case' 0 C--N 1.333 -0.15 0 N-CA-C 109.715 -0.476 . . . . 0.45000000000000001 109.715 172.833 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' C' C ' 102' ' ' VAL . . . . . . . . . . . . . 45.7 t -115.35 127.08 73.05 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.317 0 CA-C-N 116.255 -0.429 . . . . 1.1699999999999999 109.851 -177.876 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' C' C ' 103' ' ' LEU . . . . . . . . . . . . . 27.0 mt -117.78 131.41 56.59 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-N 115.883 -0.599 . . . . 1.28 110.407 178.526 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' C' C ' 104' ' ' ILE . . . . . . . . . . . . . 68.9 mt -117.34 119.79 62.92 Favored 'Isoleucine or valine' 0 C--O 1.233 0.219 0 N-CA-C 110.132 -0.321 . . . . 1.1799999999999999 110.132 178.308 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' C' C ' 105' ' ' PHE . . . . . . . . . . . . . 95.8 m-85 -120.65 166.9 13.04 Favored 'General case' 0 C--N 1.332 -0.158 0 O-C-N 124.136 0.897 . . . . 0.46000000000000002 110.038 179.676 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' C' C ' 106' ' ' ASN . . . . . . . . . . . . . 35.5 p30 -101.11 -171.94 2.08 Favored 'General case' 0 C--N 1.33 -0.265 0 N-CA-C 110.17 -0.307 . . . . 0.58999999999999997 110.17 173.073 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' C' C ' 107' ' ' GLN . . . . . . . . . . . . . 63.0 tt0 -60.56 -30.29 69.7 Favored 'General case' 0 CA--C 1.531 0.236 0 N-CA-C 111.803 0.298 . . . . 1.6699999999999999 111.803 179.633 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' C' C ' 108' ' ' ASN . . . . . . . . . . . . . 6.6 t30 -82.94 9.28 10.39 Favored 'General case' 0 CA--C 1.536 0.426 0 N-CA-C 112.976 0.732 . . . . 1.76 112.976 -178.375 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' C' C ' 109' ' ' LEU . . . . . . . . . . . . . 7.6 tp 61.24 32.99 19.33 Favored 'General case' 0 CA--C 1.53 0.193 0 O-C-N 122.228 -0.295 . . . . 1.6000000000000001 111.741 179.14 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' C' C ' 110' ' ' GLU . . . . . . . . . . . . . 94.9 mt-10 -100.89 142.3 32.55 Favored 'General case' 0 C--N 1.33 -0.265 0 N-CA-C 109.319 -0.623 . . . . 1.8999999999999999 109.319 174.724 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' C' C ' 111' ' ' GLU . . . . . . . . . . . . . 60.6 tt0 -85.05 121.99 28.61 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-O 120.893 0.378 . . . . 1.8600000000000001 110.807 -175.14 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' C' C ' 112' ' ' LEU . . . . . . . . . . . . . 60.3 mt -99.71 -46.13 5.52 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 115.94 -0.573 . . . . 1.3100000000000001 110.877 179.256 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' C' C ' 113' ' ' TYR . . . . . . . . . . . . . 85.5 t80 -137.15 140.0 41.55 Favored 'General case' 0 N--CA 1.464 0.242 0 CA-C-O 121.078 0.466 . . . . 1.1200000000000001 111.59 -178.1 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' C' C ' 114' ' ' ARG . . . . . . . . . . . . . 41.1 ttm180 -130.5 124.57 32.24 Favored 'General case' 0 C--N 1.331 -0.23 0 CA-C-N 115.361 -0.836 . . . . 3.0699999999999998 109.862 175.993 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' C' C ' 115' ' ' GLY . . . . . . . . . . . . . . . -147.18 159.02 27.91 Favored Glycine 0 CA--C 1.523 0.572 0 N-CA-C 110.56 -1.016 . . . . 0.47999999999999998 110.56 178.474 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' C' C ' 116' ' ' LYS . . . . . . . . . . . . . 77.3 tttt -137.49 133.12 34.25 Favored 'General case' 0 C--N 1.329 -0.305 0 N-CA-C 109.996 -0.372 . . . . 2.1099999999999999 109.996 179.385 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' C' C ' 117' ' ' PHE . . . . . . . . . . . . . 35.6 m-85 -134.18 115.75 14.56 Favored 'General case' 0 C--N 1.331 -0.223 0 CA-C-N 116.386 -0.37 . . . . 0.63 110.226 -174.82 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' C' C ' 118' ' ' GLU . . . . . . . . . . . . . 95.2 mt-10 -54.64 -40.88 69.43 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.472 -0.331 . . . . 2.1099999999999999 111.498 -175.623 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' C' C ' 119' ' ' ASN . . . . . . . . . . . . . 30.6 m120 -100.53 31.16 3.58 Favored 'General case' 0 C--N 1.33 -0.244 0 N-CA-C 112.266 0.469 . . . . 2.1200000000000001 112.266 -173.187 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' C' C ' 120' ' ' LEU . . . . . . . . . . . . . 14.2 tp -53.79 120.03 5.73 Favored 'General case' 0 N--CA 1.464 0.267 0 CA-C-O 120.676 0.274 . . . . 1.1200000000000001 110.907 178.048 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' C' C ' 121' ' ' ASN . . . . . . . . . . . . . 59.9 m-80 -113.92 -44.15 3.19 Favored 'General case' 0 C--N 1.331 -0.2 0 CA-C-N 116.441 -0.345 . . . . 2.27 110.992 -177.699 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' C' C ' 122' ' ' LYS . . . . . . . . . . . . . 97.9 mttt -146.44 150.31 35.38 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-O 121.059 0.457 . . . . 2.3799999999999999 111.644 -178.022 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' C' C ' 123' ' ' VAL . . . . . . . . . . . . . 44.7 t -129.78 127.58 64.31 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.303 0 N-CA-C 109.383 -0.599 . . . . 1.25 109.383 174.536 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' C' C ' 124' ' ' LEU . . . . . . . . . . . . . 71.0 mt -117.18 132.34 56.67 Favored 'General case' 0 N--CA 1.463 0.223 0 CA-C-N 116.547 -0.297 . . . . 2.2599999999999998 110.663 -178.066 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' C' C ' 125' ' ' VAL . . . . . . . . . . . . . 43.7 t -132.63 121.8 45.81 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.206 0 CA-C-N 116.234 -0.439 . . . . 2.2400000000000002 110.283 -179.411 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' C' C ' 126' ' ' ARG . . . . . . . . . . . . . 80.5 mtt85 -152.69 137.31 16.89 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.287 -0.415 . . . . 3.73 110.152 176.647 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' C' C ' 127' ' ' ASN . . . . . . . . . . . . . 20.1 m120 54.82 -154.44 0.28 Allowed 'General case' 0 CA--C 1.539 0.53 0 N-CA-C 110.102 -0.332 . . . . 2.8100000000000001 110.102 178.562 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' C' C ' 128' ' ' ASP . . . . . . . . . . . . . 4.2 p30 -82.9 19.71 1.32 Allowed 'General case' 0 CA--C 1.534 0.332 0 N-CA-C 112.483 0.549 . . . . 1.1100000000000001 112.483 178.543 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' C' C ' 129' ' ' LEU . . . . . . . . . . . . . 15.5 tp -122.75 137.09 55.02 Favored 'General case' 0 C--O 1.233 0.193 0 O-C-N 122.019 -0.426 . . . . 2.54 110.381 179.935 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' C' C ' 130' ' ' VAL . . . . . . . . . . . . . 32.1 m -132.8 143.68 38.89 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.215 0 CA-C-O 120.957 0.408 . . . . 2.0800000000000001 110.379 178.527 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' C' C ' 131' ' ' VAL . . . . . . . . . . . . . 14.1 p -136.05 141.15 42.48 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.283 0 CA-C-N 116.349 -0.387 . . . . 1.52 110.683 179.9 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' C' C ' 132' ' ' ILE . . . . . . . . . . . . . 74.1 mt -114.64 131.84 65.57 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.354 0 N-CA-C 109.196 -0.668 . . . . 1.1299999999999999 109.196 178.751 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' C' C ' 133' ' ' ILE . . . . . . . . . . . . . 42.7 mm -117.37 120.14 63.98 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.232 0 CA-C-O 120.946 0.403 . . . . 1.1299999999999999 110.901 -175.659 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' C' C ' 134' ' ' ASP . . . . . . . . . . . . . 7.2 p-10 -130.79 144.29 51.34 Favored 'General case' 0 C--N 1.33 -0.257 0 N-CA-C 109.072 -0.714 . . . . 0.53000000000000003 109.072 173.689 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' C' C ' 135' ' ' GLU . . . . . . . . . . . . . 84.4 tt0 -49.78 -25.35 2.97 Favored 'General case' 0 C--N 1.327 -0.379 0 N-CA-C 112.852 0.686 . . . . 2.0 112.852 -170.559 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' C' C ' 136' ' ' GLN . . . . . . . . . . . . . 94.7 mt-30 -92.78 -36.97 12.59 Favored 'General case' 0 C--N 1.332 -0.183 0 N-CA-C 112.105 0.409 . . . . 2.7400000000000002 112.105 -177.499 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' C' C ' 137' ' ' LYS . . . . . . . . . . . . . 41.6 mttp -136.83 151.53 49.24 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-O 121.03 0.443 . . . . 1.98 111.1 -168.453 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' C' C ' 138' ' ' LEU . . . . . . . . . . . . . 5.2 tt -118.91 121.47 40.05 Favored 'General case' 0 C--N 1.332 -0.19 0 N-CA-C 109.047 -0.723 . . . . 1.3799999999999999 109.047 173.133 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' C' C ' 139' ' ' THR . . . . . . . . . . . . . 33.1 m -114.19 127.38 55.87 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-O 120.711 0.291 . . . . 1.2 111.066 -176.565 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' C' C ' 140' ' ' LEU . . . . . . . . . . . . . 21.6 tp -111.03 123.84 50.98 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 115.599 -0.728 . . . . 1.8200000000000001 109.158 179.922 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' C' C ' 141' ' ' ILE . . . . . . . . . . . . . 19.5 mt -122.19 121.61 64.38 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.298 0 CA-C-O 120.981 0.419 . . . . 1.21 110.073 -173.906 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' C' C ' 142' ' ' ARG . . . . . . . . . . . . . 59.3 mtp180 -100.88 122.29 43.19 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 115.419 -0.809 . . . . 4.5599999999999996 110.001 178.762 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' C' C ' 143' ' ' THR . . . . . . . . . . . . . 37.4 p . . . . . 0 C--O 1.219 -0.505 0 CA-C-O 117.871 -1.061 . . . . 1.6699999999999999 110.599 -179.28 . . . . . . . . 0 0 . 1 . 001 nuclear orig full ' D' D ' -3' ' ' GLU . . . . . . . . . . . . . 95.2 mt-10 . . . . . 0 N--CA 1.49 1.544 0 N-CA-C 109.439 -0.578 . . . . 32.649999999999999 109.439 . . . . . . . . . 0 0 . 1 . 001 nuclear orig full ' D' D ' -2' ' ' GLY . . . . . . . . . . . . . . . -111.62 128.36 8.59 Favored Glycine 0 CA--C 1.526 0.721 0 N-CA-C 111.015 -0.834 . . . . 30.629999999999999 111.015 179.987 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' D' D ' -1' ' ' VAL . . . . . . . . . . . . . 44.2 t -97.2 134.12 36.22 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.323 0 CA-C-O 120.767 0.318 . . . . 27.780000000000001 110.148 179.313 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' D' D ' 0' ' ' ILE . . . . . . . . . . . . . 68.7 mt -115.45 143.98 24.08 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.26 0 CA-C-N 116.18 -0.464 . . . . 25.809999999999999 109.959 -179.462 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' D' D ' 1' ' ' MET . . . . . . . . . . . . . 25.6 ptm -143.16 149.93 38.72 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.196 -0.456 . . . . 22.289999999999999 110.903 -179.53 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' D' D ' 2' ' ' SER . . . . . . . . . . . . . 3.6 p -125.02 134.76 52.44 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 116.153 -0.476 . . . . 20.190000000000001 110.477 178.286 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' D' D ' 3' ' ' GLU . . . . . . . . . . . . . 84.7 tt0 -139.71 139.57 36.6 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.137 -0.483 . . . . 17.239999999999998 110.807 -179.434 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' D' D ' 4' ' ' LEU . . . . . . . . . . . . . 15.3 tp -124.42 126.09 45.36 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 115.912 -0.585 . . . . 15.27 110.117 177.695 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' D' D ' 5' ' ' LYS . . . . . . . . . . . . . 46.5 mttm -102.49 120.48 40.59 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.328 -0.396 . . . . 12.65 110.389 177.795 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' D' D ' 6' ' ' LEU . . . . . . . . . . . . . 78.4 mt -117.63 149.25 41.01 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 115.564 -0.744 . . . . 13.039999999999999 110.663 -179.145 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' D' D ' 7' ' ' LYS . . . . . . . . . . . . . 77.5 tttt -136.77 135.68 20.54 Favored Pre-proline 0 CA--C 1.534 0.359 0 CA-C-O 118.764 -0.636 . . . . 10.07 109.792 176.266 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' D' D ' 8' ' ' PRO . . . . . . . . . . . . . 86.9 Cg_endo -87.83 143.91 6.17 Favored 'Trans proline' 0 N--CA 1.492 1.395 0 C-N-CA 121.546 1.497 . . . . 10.67 111.635 178.43 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' D' D ' 9' ' ' LEU . . . . . . . . . . . . . 21.7 mt -79.86 -46.99 1.46 Allowed Pre-proline 0 CA--C 1.533 0.305 0 CA-C-O 118.746 -0.645 . . . . 13.82 111.91 -178.884 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' D' D ' 10' ' ' PRO . . . . . . . . . . . . . 92.3 Cg_endo -80.69 148.9 18.14 Favored 'Trans proline' 0 N--CA 1.495 1.603 0 C-N-CA 121.194 1.263 . . . . 14.25 111.646 174.127 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' D' D ' 11' ' ' LYS . . . . . . . . . . . . . 96.0 mttt -88.71 102.1 14.65 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-O 120.886 0.374 . . . . 13.050000000000001 110.767 179.961 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' D' D ' 12' ' ' VAL . . . . . . . . . . . . . 12.2 p -141.03 143.85 27.61 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 CA-C-N 116.108 -0.496 . . . . 15.210000000000001 110.391 179.145 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' D' D ' 13' ' ' GLU . . . . . . . . . . . . . 45.9 mt-10 -79.72 124.65 28.78 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.408 -0.36 . . . . 15.06 110.38 179.245 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' D' D ' 14' ' ' LEU . . . . . . . . . . . . . 22.7 mt -99.52 147.78 33.81 Favored Pre-proline 0 CA--C 1.534 0.332 0 CA-C-O 119.185 -0.436 . . . . 15.039999999999999 110.534 -178.139 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' D' D ' 15' ' ' PRO . . . . . . . . . . . . . 23.8 Cg_exo -64.1 160.82 36.28 Favored 'Trans proline' 0 N--CA 1.499 1.821 0 C-N-CA 121.298 1.332 . . . . 18.609999999999999 111.816 175.018 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' D' D ' 16' ' ' PRO . . . . . . . . . . . . . 28.1 Cg_exo -60.02 -36.76 88.53 Favored 'Trans proline' 0 N--CA 1.496 1.64 0 C-N-CA 121.486 1.457 . . . . 19.289999999999999 112.795 -178.408 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' D' D ' 17' ' ' ASP . . . . . . . . . . . . . 2.9 p30 -88.27 9.22 23.85 Favored 'General case' 0 CA--C 1.535 0.402 0 N-CA-C 113.189 0.811 . . . . 20.129999999999999 113.189 -177.775 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' D' D ' 18' ' ' PHE . . . . . . . . . . . . . 61.8 t80 -57.53 -42.44 82.87 Favored 'General case' 0 N--CA 1.46 0.042 0 O-C-N 121.983 -0.448 . . . . 16.760000000000002 110.172 -179.443 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' D' D ' 19' ' ' VAL . . . . . . . . . . . . . 48.0 t -56.91 -42.53 78.67 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.321 0 CA-C-N 116.264 -0.426 . . . . 16.27 110.428 -179.353 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' D' D ' 20' ' ' ASP . . . . . . . . . . . . . 18.4 t70 -59.98 -42.16 93.57 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-O 120.8 0.333 . . . . 19.600000000000001 110.89 -178.12 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' D' D ' 21' ' ' VAL . . . . . . . . . . . . . 46.2 t -64.26 -46.61 92.82 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.269 0 C-N-CA 120.793 -0.363 . . . . 19.539999999999999 110.452 -177.938 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' D' D ' 22' ' ' ILE . . . . . . . . . . . . . 49.0 mm -56.23 -44.41 79.25 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.211 0 C-N-CA 120.962 -0.295 . . . . 17.48 110.565 178.651 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' D' D ' 23' ' ' ARG . . . . . . . . . . . . . 55.9 ttp180 -54.15 -49.38 69.39 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-O 120.673 0.273 . . . . 21.219999999999999 111.444 -179.689 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' D' D ' 24' ' ' ILE . . . . . . . . . . . . . 76.9 mt -58.88 -43.01 87.45 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.308 0 CA-C-N 116.48 -0.327 . . . . 22.359999999999999 111.135 -177.474 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' D' D ' 25' ' ' LYS . . . . . . . . . . . . . 63.4 mttm -66.39 -43.25 86.36 Favored 'General case' 0 C--N 1.328 -0.355 0 N-CA-C 112.619 0.6 . . . . 20.969999999999999 112.619 -178.438 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' D' D ' 26' ' ' LEU . . . . . . . . . . . . . 92.8 mt -78.71 -37.54 41.29 Favored 'General case' 0 C--N 1.331 -0.228 0 N-CA-C 113.55 0.944 . . . . 19.879999999999999 113.55 -170.385 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' D' D ' 27' ' ' GLN . . . . . . . . . . . . . 9.7 pt20 -46.75 138.99 5.67 Favored 'General case' 0 N--CA 1.469 0.488 0 N-CA-C 112.765 0.654 . . . . 22.91 112.765 -175.305 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' D' D ' 28' ' ' GLY . . . . . . . . . . . . . . . 100.3 -23.42 35.94 Favored Glycine 0 CA--C 1.534 1.263 0 CA-C-N 115.606 -0.725 . . . . 23.129999999999999 112.393 -176.572 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' D' D ' 29' ' ' LYS . . . . . . . . . . . . . 68.8 mttm -98.44 155.11 17.41 Favored 'General case' 0 C--O 1.233 0.2 0 CA-C-N 117.441 0.621 . . . . 22.27 111.253 179.436 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' D' D ' 30' ' ' THR . . . . . . . . . . . . . 40.8 m -102.98 137.88 40.58 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.034 -0.53 . . . . 22.780000000000001 109.938 175.362 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' D' D ' 31' ' ' VAL . . . . . . . . . . . . . 34.8 m -128.19 154.38 38.79 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.249 0 CA-C-O 120.911 0.386 . . . . 19.359999999999999 110.854 -178.708 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' D' D ' 32' ' ' ARG . . . . . . . . . . . . . 43.6 mtm180 -133.46 151.53 51.8 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 115.742 -0.663 . . . . 23.66 110.307 177.908 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' D' D ' 33' ' ' THR . . . . . . . . . . . . . 31.9 m -53.2 137.77 33.47 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.498 -0.319 . . . . 17.539999999999999 111.458 -178.155 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' D' D ' 34' ' ' GLY . . . . . . . . . . . . . . . 98.91 -17.02 58.8 Favored Glycine 0 CA--C 1.532 1.147 0 CA-C-O 119.65 -0.528 . . . . 16.98 113.365 177.927 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' D' D ' 35' ' ' ASP . . . . . . . . . . . . . 75.2 m-20 -65.72 149.69 49.72 Favored 'General case' 0 C--O 1.231 0.108 0 CA-C-N 118.012 0.906 . . . . 19.02 111.198 179.96 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' D' D ' 36' ' ' VAL . . . . . . . . . . . . . 46.3 t -118.66 130.11 73.96 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.251 0 CA-C-N 115.847 -0.615 . . . . 17.789999999999999 109.682 177.304 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' D' D ' 37' ' ' ILE . . . . . . . . . . . . . 64.1 mt -115.55 136.98 50.62 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.298 0 CA-C-N 116.11 -0.496 . . . . 17.59 109.764 179.912 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' D' D ' 38' ' ' GLY . . . . . . . . . . . . . . . -109.53 127.61 8.55 Favored Glycine 0 CA--C 1.524 0.635 0 N-CA-C 110.73 -0.948 . . . . 18.84 110.73 178.945 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' D' D ' 39' ' ' ILE . . . . . . . . . . . . . 72.2 mt -121.19 130.73 74.37 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.206 0 N-CA-C 109.911 -0.403 . . . . 18.780000000000001 109.911 179.222 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' D' D ' 40' ' ' SER . . . . . . . . . . . . . 78.0 p -92.24 119.18 31.6 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.233 -0.44 . . . . 22.210000000000001 110.74 176.506 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' D' D ' 41' ' ' ILE . . . . . . . . . . . . . 72.6 mt -129.59 116.91 40.53 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.244 0 N-CA-C 109.954 -0.387 . . . . 20.469999999999999 109.954 177.938 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' D' D ' 42' ' ' LEU . . . . . . . . . . . . . 69.8 mt 58.08 33.23 22.96 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.269 -0.423 . . . . 23.100000000000001 111.698 179.173 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' D' D ' 43' ' ' GLY . . . . . . . . . . . . . . . 80.9 -10.13 48.82 Favored Glycine 0 CA--C 1.535 1.293 0 C-N-CA 121.188 -0.53 . . . . 23.870000000000001 113.433 177.303 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' D' D ' 44' ' ' LYS . . . . . . . . . . . . . 94.6 mttt -99.05 137.33 37.73 Favored 'General case' 0 C--N 1.332 -0.173 0 CA-C-N 117.966 0.883 . . . . 21.23 110.285 178.622 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' D' D ' 45' ' ' GLU . . . . . . . . . . . . . 84.7 tt0 -85.21 130.61 34.57 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.257 -0.429 . . . . 20.640000000000001 111.474 -178.686 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' D' D ' 46' ' ' VAL . . . . . . . . . . . . . 7.4 p -125.37 126.2 70.26 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.22 0 N-CA-C 109.275 -0.639 . . . . 17.309999999999999 109.275 173.333 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' D' D ' 47' ' ' LYS . . . . . . . . . . . . . 9.7 mtmp? -101.46 131.27 47.67 Favored 'General case' 0 C--N 1.331 -0.23 0 CA-C-N 116.165 -0.47 . . . . 18.559999999999999 111.688 179.204 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' D' D ' 48' ' ' PHE . . . . . . . . . . . . . 92.2 m-85 -114.58 133.63 55.67 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 115.893 -0.594 . . . . 14.359999999999999 109.985 176.32 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' D' D ' 49' ' ' LYS . . . . . . . . . . . . . 60.7 tttm -105.33 137.61 42.86 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.743 -0.208 . . . . 14.4 110.559 179.065 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' D' D ' 50' ' ' VAL . . . . . . . . . . . . . 44.2 t -81.04 108.35 14.28 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.268 0 N-CA-C 109.275 -0.639 . . . . 14.82 109.275 175.862 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' D' D ' 51' ' ' VAL . . . . . . . . . . . . . 48.4 t -73.23 -47.35 47.23 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.351 0 CA-C-N 116.224 -0.443 . . . . 12.84 110.107 -173.821 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' D' D ' 52' ' ' GLN . . . . . . . . . . . . . 48.4 tt0 -162.54 136.82 6.5 Favored 'General case' 0 C--N 1.331 -0.234 0 C-N-CA 120.354 -0.538 . . . . 14.890000000000001 111.648 -178.378 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' D' D ' 53' ' ' ALA . . . . . . . . . . . . . . . -110.06 131.3 55.18 Favored 'General case' 0 C--N 1.332 -0.19 0 CA-C-N 115.852 -0.613 . . . . 16.93 109.891 175.482 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' D' D ' 54' ' ' TYR . . . . . . . . . . . . . 8.9 t80 -129.02 108.34 18.12 Favored Pre-proline 0 CA--C 1.534 0.361 0 CA-C-O 118.333 -0.842 . . . . 20.91 110.47 179.8 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' D' D ' 55' ' ' PRO . . . . . . . . . . . . . 74.2 Cg_endo -77.14 170.05 72.6 Favored 'Cis proline' 0 N--CA 1.5 1.858 0 CA-C-N 121.831 1.689 . . . . 21.899999999999999 112.481 -5.288 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' D' D ' 56' ' ' SER . . . . . . . . . . . . . 50.1 m -117.29 133.62 23.17 Favored Pre-proline 0 CA--C 1.538 0.515 0 CA-C-O 118.511 -0.757 . . . . 21.68 109.714 175.307 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' D' D ' 57' ' ' PRO . . . . . . . . . . . . . 38.0 Cg_endo -68.09 165.15 72.06 Favored 'Cis proline' 0 N--CA 1.496 1.666 0 CA-C-N 121.828 1.689 . . . . 23.309999999999999 111.217 -3.535 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' D' D ' 58' ' ' LEU . . . . . . . . . . . . . 25.0 tp -130.2 136.29 49.08 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-O 120.937 0.399 . . . . 20.079999999999998 110.891 -179.001 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' D' D ' 59' ' ' ARG . . . . . . . . . . . . . 55.8 ttp180 -101.73 124.39 47.3 Favored 'General case' 0 C--N 1.327 -0.377 0 N-CA-C 109.08 -0.711 . . . . 25.989999999999998 109.08 174.383 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' D' D ' 60' ' ' VAL . . . . . . . . . . . . . 41.3 t -82.12 122.49 36.96 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.304 0 C-N-CA 120.677 -0.409 . . . . 20.84 110.491 -174.538 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' D' D ' 61' ' ' GLU . . . . . . . . . . . . . 45.2 mt-10 -131.13 169.72 15.51 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 115.972 -0.558 . . . . 23.879999999999999 109.74 177.415 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' D' D ' 62' ' ' ASP . . . . . . . . . . . . . 6.9 p-10 -55.3 -32.32 62.34 Favored 'General case' 0 C--N 1.328 -0.366 0 N-CA-C 111.743 0.275 . . . . 23.34 111.743 -179.123 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' D' D ' 63' ' ' ARG . . . . . . . . . . . . . 40.2 ptt180 -77.63 -8.44 57.88 Favored 'General case' 0 CA--C 1.537 0.451 0 N-CA-C 113.669 0.988 . . . . 26.329999999999998 113.669 -176.415 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' D' D ' 64' ' ' THR . . . . . . . . . . . . . 36.9 m -77.29 136.68 38.51 Favored 'General case' 0 C--N 1.333 -0.116 0 CA-C-O 120.902 0.382 . . . . 19.899999999999999 110.73 -176.149 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' D' D ' 65' ' ' LYS . . . . . . . . . . . . . 61.2 mttm -89.51 127.6 35.88 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.026 -0.534 . . . . 19.120000000000001 110.031 178.043 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' D' D ' 66' ' ' ILE . . . . . . . . . . . . . 62.5 mt -113.31 127.78 70.44 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.284 0 N-CA-C 109.66 -0.496 . . . . 15.94 109.66 179.376 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' D' D ' 67' ' ' THR . . . . . . . . . . . . . 18.3 m -124.37 141.74 51.83 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.226 -0.443 . . . . 12.93 110.825 -176.925 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' D' D ' 68' ' ' LEU . . . . . . . . . . . . . 16.6 tp -102.08 130.16 48.6 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 115.938 -0.574 . . . . 11.09 110.038 178.545 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' D' D ' 69' ' ' VAL . . . . . . . . . . . . . 40.9 t -96.3 136.51 26.93 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.317 0 CA-C-N 116.321 -0.399 . . . . 8.3599999999999994 110.507 -177.822 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' D' D ' 70' ' ' THR . . . . . . . . . . . . . 29.6 p -139.23 -47.89 0.48 Allowed 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 115.93 -0.577 . . . . 7.3799999999999999 110.558 179.299 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' D' D ' 71' ' ' HIS . . . . . . . . . . . . . 32.3 m-70 -127.05 99.08 29.15 Favored Pre-proline 0 CA--C 1.533 0.305 0 CA-C-N 116.044 -0.526 . . . . 7.8200000000000003 110.324 -178.833 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' D' D ' 72' ' ' PRO . . . . . . . . . . . . . 19.3 Cg_exo -64.93 -29.93 57.7 Favored 'Trans proline' 0 N--CA 1.497 1.691 0 C-N-CA 121.277 1.318 . . . . 3.3799999999999999 112.328 -177.689 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' D' D ' 73' ' ' VAL . . . . . . . . . . . . . 34.9 m -136.38 158.56 38.05 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.232 0 CA-C-O 120.841 0.353 . . . . 1.46 110.578 177.377 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' D' D ' 74' ' ' ASP . . . . . . . . . . . . . 21.5 t70 -100.57 118.49 36.85 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.088 -0.506 . . . . 0.93000000000000005 109.947 179.648 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' D' D ' 75' ' ' VAL . . . . . . . . . . . . . 43.9 t -113.97 122.38 67.97 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.213 0 CA-C-O 121.118 0.485 . . . . 1.3100000000000001 110.555 -177.654 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' D' D ' 76' ' ' LEU . . . . . . . . . . . . . 14.1 mt -125.92 138.26 53.76 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 115.52 -0.764 . . . . 1.8799999999999999 109.059 175.77 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' D' D ' 77' ' ' GLU . . . . . . . . . . . . . 73.3 tt0 -136.43 141.93 43.62 Favored 'General case' 0 C--N 1.332 -0.17 0 CA-C-O 121.118 0.485 . . . . 1.29 111.591 -173.762 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' D' D ' 78' ' ' ALA . . . . . . . . . . . . . . . -127.88 145.12 51.05 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 115.52 -0.764 . . . . 1.23 109.94 177.476 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' D' D ' 79' ' ' LYS . . . . . . . . . . . . . 45.8 mttm -81.48 123.86 28.97 Favored 'General case' 0 C--N 1.331 -0.234 0 C-N-CA 120.753 -0.379 . . . . 3.5600000000000001 110.688 178.913 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' D' D ' 80' ' ' ILE . . . . . . . . . . . . . 42.8 mm -138.46 113.7 9.23 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.343 0 N-CA-C 109.212 -0.662 . . . . 1.24 109.212 -179.15 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' D' D ' 81' ' ' LYS . . . . . . . . . . . . . 58.6 mttp -102.04 121.94 43.14 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-O 120.784 0.326 . . . . 3.6099999999999999 111.243 -176.536 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' D' D ' 82' ' ' GLY . . . . . . . . . . . . . . . 89.07 42.14 5.69 Favored Glycine 0 CA--C 1.525 0.702 0 C-N-CA 120.935 -0.65 . . . . 0.5 112.006 173.702 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' D' D ' 83' ' ' ILE . . . . . . . . . . . . . 76.3 mt -65.69 136.93 25.88 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.257 0 N-CA-C 109.765 -0.457 . . . . 1.2 109.765 177.113 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' D' D ' 84' ' ' LYS . . . . . . . . . . . . . 55.2 tttp -98.66 -53.63 3.25 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.21 -0.45 . . . . 2.1299999999999999 110.275 -178.757 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' D' D ' 85' ' ' ASP . . . . . . . . . . . . . 20.9 t0 -152.86 149.72 28.57 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 115.755 -0.657 . . . . 0.82999999999999996 110.28 -179.756 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' D' D ' 86' ' ' VAL . . . . . . . . . . . . . 40.5 t -133.79 131.16 56.42 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.286 0 CA-C-O 120.973 0.416 . . . . 1.1299999999999999 110.56 -179.702 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' D' D ' 87' ' ' ILE . . . . . . . . . . . . . 45.3 mm -119.85 129.54 75.27 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.243 0 CA-C-N 115.795 -0.639 . . . . 1.8700000000000001 109.695 176.857 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' D' D ' 88' ' ' LEU . . . . . . . . . . . . . 17.0 tp -112.6 135.75 52.96 Favored 'General case' 0 C--N 1.331 -0.203 0 CA-C-O 121.083 0.468 . . . . 2.23 111.289 -177.354 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' D' D ' 89' ' ' ASP . . . . . . . . . . . . . 20.6 t70 -128.62 155.11 45.48 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 115.545 -0.752 . . . . 0.88 109.253 174.587 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' D' D ' 90' ' ' GLU . . . . . . . . . . . . . 82.6 tt0 -46.97 -39.95 13.43 Favored 'General case' 0 C--N 1.33 -0.243 0 N-CA-C 112.964 0.727 . . . . 2.54 112.964 -171.887 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' D' D ' 91' ' ' ASN . . . . . . . . . . . . . 7.4 t-20 -132.07 37.85 3.55 Favored 'General case' 0 N--CA 1.463 0.189 0 CA-C-O 120.836 0.351 . . . . 2.8500000000000001 111.437 -177.223 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' D' D ' 92' ' ' LEU . . . . . . . . . . . . . 11.7 tp -166.09 140.37 4.43 Favored 'General case' 0 C--N 1.33 -0.246 0 C-N-CA 121.01 -0.276 . . . . 2.0499999999999998 110.602 -179.038 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' D' D ' 93' ' ' ILE . . . . . . . . . . . . . 71.3 mt -124.14 122.62 64.75 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.188 0 N-CA-C 109.653 -0.499 . . . . 1.1299999999999999 109.653 178.679 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' D' D ' 94' ' ' VAL . . . . . . . . . . . . . 42.9 t -120.77 125.07 73.64 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.214 0 N-CA-C 109.901 -0.407 . . . . 1.1499999999999999 109.901 179.52 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' D' D ' 95' ' ' VAL . . . . . . . . . . . . . 42.9 t -123.88 135.16 64.42 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.25 0 CA-C-N 116.097 -0.502 . . . . 1.1399999999999999 110.109 -178.448 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' D' D ' 96' ' ' ILE . . . . . . . . . . . . . 58.3 mt -116.59 128.49 73.94 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.28 0 N-CA-C 109.256 -0.646 . . . . 1.1499999999999999 109.256 178.37 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' D' D ' 97' ' ' THR . . . . . . . . . . . . . 81.2 p -103.7 155.79 18.3 Favored 'General case' 0 C--N 1.331 -0.222 0 CA-C-O 121.356 0.598 . . . . 1.1100000000000001 111.561 -176.74 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' D' D ' 98' ' ' GLU . . . . . . . . . . . . . 84.8 tt0 -54.0 -27.26 30.6 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 115.836 -0.62 . . . . 2.6699999999999999 112.191 179.504 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' D' D ' 99' ' ' GLU . . . . . . . . . . . . . 46.0 mp0 -78.93 16.2 0.94 Allowed 'General case' 0 CA--C 1.536 0.406 0 N-CA-C 113.123 0.786 . . . . 2.2999999999999998 113.123 -177.474 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' D' D ' 100' ' ' ASN . . . . . . . . . . . . . 1.8 m-20 63.59 37.34 10.37 Favored 'General case' 0 CA--C 1.529 0.147 0 CA-C-O 121.007 0.432 . . . . 0.62 110.945 176.757 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' D' D ' 101' ' ' GLU . . . . . . . . . . . . . 84.9 tt0 -116.52 144.69 44.03 Favored 'General case' 0 C--N 1.332 -0.157 0 CA-C-N 116.187 -0.461 . . . . 1.1000000000000001 109.892 176.88 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' D' D ' 102' ' ' VAL . . . . . . . . . . . . . 46.7 t -114.98 125.36 72.28 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.32 0 CA-C-N 116.116 -0.493 . . . . 1.1399999999999999 109.815 -179.206 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' D' D ' 103' ' ' LEU . . . . . . . . . . . . . 19.2 mt -117.36 128.93 55.52 Favored 'General case' 0 C--N 1.331 -0.219 0 CA-C-N 115.789 -0.642 . . . . 1.53 110.19 178.08 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' D' D ' 104' ' ' ILE . . . . . . . . . . . . . 71.9 mt -119.09 120.69 64.68 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.278 0 N-CA-C 110.042 -0.355 . . . . 1.1599999999999999 110.042 177.807 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' D' D ' 105' ' ' PHE . . . . . . . . . . . . . 97.4 m-85 -118.47 161.23 20.34 Favored 'General case' 0 C--N 1.332 -0.187 0 O-C-N 124.084 0.865 . . . . 0.45000000000000001 110.129 -178.627 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' D' D ' 106' ' ' ASN . . . . . . . . . . . . . 18.4 p-10 -93.26 -170.63 2.44 Favored 'General case' 0 C--N 1.329 -0.315 0 N-CA-C 109.805 -0.443 . . . . 0.56000000000000005 109.805 172.278 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' D' D ' 107' ' ' GLN . . . . . . . . . . . . . 48.8 tt0 -59.63 -30.2 68.54 Favored 'General case' 0 C--N 1.328 -0.336 0 N-CA-C 112.0 0.37 . . . . 2.23 112.0 -179.849 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' D' D ' 108' ' ' ASN . . . . . . . . . . . . . 13.1 t30 -85.55 8.29 19.86 Favored 'General case' 0 CA--C 1.536 0.428 0 N-CA-C 113.293 0.849 . . . . 1.8400000000000001 113.293 -177.292 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' D' D ' 109' ' ' LEU . . . . . . . . . . . . . 13.6 tp 61.97 43.76 8.84 Favored 'General case' 0 C--N 1.332 -0.18 0 CA-C-O 121.377 0.608 . . . . 1.9099999999999999 110.854 178.797 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' D' D ' 110' ' ' GLU . . . . . . . . . . . . . 77.7 mm-40 -114.23 143.66 44.48 Favored 'General case' 0 C--N 1.331 -0.224 0 CA-C-N 116.035 -0.53 . . . . 2.0800000000000001 109.998 176.557 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' D' D ' 111' ' ' GLU . . . . . . . . . . . . . 96.3 mt-10 -72.03 123.02 21.9 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-O 120.908 0.385 . . . . 1.9199999999999999 111.197 -177.392 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' D' D ' 112' ' ' LEU . . . . . . . . . . . . . 12.3 mt -108.09 -44.89 4.06 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 115.932 -0.576 . . . . 1.23 109.795 175.0 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' D' D ' 113' ' ' TYR . . . . . . . . . . . . . 71.9 t80 -136.62 132.32 34.9 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 115.969 -0.56 . . . . 1.1100000000000001 110.549 178.785 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' D' D ' 114' ' ' ARG . . . . . . . . . . . . . 56.3 ttp180 -139.74 121.75 15.66 Favored 'General case' 0 C--N 1.331 -0.225 0 CA-C-O 120.823 0.344 . . . . 4.0099999999999998 110.498 178.662 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' D' D ' 115' ' ' GLY . . . . . . . . . . . . . . . -150.12 163.07 29.39 Favored Glycine 0 CA--C 1.524 0.604 0 N-CA-C 110.949 -0.86 . . . . 0.56999999999999995 110.949 179.779 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' D' D ' 116' ' ' LYS . . . . . . . . . . . . . 40.2 ttpt -128.84 138.1 51.86 Favored 'General case' 0 C--N 1.331 -0.237 0 N-CA-C 110.098 -0.334 . . . . 2.1099999999999999 110.098 177.84 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' D' D ' 117' ' ' PHE . . . . . . . . . . . . . 42.6 m-85 -135.81 113.89 11.34 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-N 116.334 -0.394 . . . . 0.62 110.148 -177.757 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' D' D ' 118' ' ' GLU . . . . . . . . . . . . . 96.9 mt-10 -56.97 -43.74 81.93 Favored 'General case' 0 C--N 1.328 -0.338 0 C-N-CA 120.883 -0.327 . . . . 2.5899999999999999 110.832 -177.0 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' D' D ' 119' ' ' ASN . . . . . . . . . . . . . 10.1 m120 -96.44 30.98 2.36 Favored 'General case' 0 C--N 1.328 -0.349 0 N-CA-C 112.116 0.413 . . . . 2.2400000000000002 112.116 -174.765 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' D' D ' 120' ' ' LEU . . . . . . . . . . . . . 20.2 tp -57.7 120.0 7.61 Favored 'General case' 0 N--CA 1.461 0.104 0 N-CA-C 110.009 -0.367 . . . . 1.1899999999999999 110.009 176.854 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' D' D ' 121' ' ' ASN . . . . . . . . . . . . . 8.4 t-20 -111.95 -44.1 3.5 Favored 'General case' 0 C--N 1.332 -0.156 0 CA-C-N 116.597 -0.274 . . . . 2.0600000000000001 111.132 -175.423 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' D' D ' 122' ' ' LYS . . . . . . . . . . . . . 98.4 mttt -143.82 145.17 32.15 Favored 'General case' 0 C--N 1.33 -0.274 0 C-N-CA 120.691 -0.404 . . . . 2.3399999999999999 111.728 -177.316 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' D' D ' 123' ' ' VAL . . . . . . . . . . . . . 45.0 t -127.92 128.73 69.41 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.295 0 N-CA-C 109.383 -0.599 . . . . 1.24 109.383 175.318 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' D' D ' 124' ' ' LEU . . . . . . . . . . . . . 8.2 tp -130.81 134.73 47.09 Favored 'General case' 0 C--N 1.332 -0.179 0 CA-C-O 120.932 0.396 . . . . 2.2000000000000002 110.367 -178.292 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' D' D ' 125' ' ' VAL . . . . . . . . . . . . . 35.1 m -130.66 137.53 55.87 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.208 0 CA-C-N 116.251 -0.431 . . . . 2.3100000000000001 110.991 -178.551 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' D' D ' 126' ' ' ARG . . . . . . . . . . . . . 96.7 mtt-85 -148.71 119.21 7.4 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 115.947 -0.57 . . . . 3.8500000000000001 109.934 176.097 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' D' D ' 127' ' ' ASN . . . . . . . . . . . . . 2.0 t30 56.29 -149.06 0.47 Allowed 'General case' 0 CA--C 1.541 0.632 0 N-CA-C 109.723 -0.473 . . . . 2.9500000000000002 109.723 179.669 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' D' D ' 128' ' ' ASP . . . . . . . . . . . . . 11.8 p-10 -80.43 13.06 2.61 Favored 'General case' 0 CA--C 1.537 0.444 0 CA-C-N 118.78 0.718 . . . . 1.1799999999999999 112.93 -179.993 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' D' D ' 129' ' ' LEU . . . . . . . . . . . . . 15.7 tp -110.02 133.15 53.5 Favored 'General case' 0 C--O 1.232 0.175 0 CA-C-N 118.217 0.462 . . . . 2.4100000000000001 110.085 178.423 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' D' D ' 130' ' ' VAL . . . . . . . . . . . . . 41.4 t -122.65 139.81 48.37 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.308 0 CA-C-N 116.578 -0.283 . . . . 1.96 110.498 -176.987 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' D' D ' 131' ' ' VAL . . . . . . . . . . . . . 40.7 t -133.93 134.86 55.62 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.192 0 CA-C-O 121.087 0.47 . . . . 1.29 110.484 177.536 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' D' D ' 132' ' ' ILE . . . . . . . . . . . . . 72.3 mt -117.95 134.07 62.74 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.269 0 CA-C-N 115.61 -0.723 . . . . 1.1399999999999999 109.424 179.294 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' D' D ' 133' ' ' ILE . . . . . . . . . . . . . 29.7 mm -115.35 120.57 65.06 Favored 'Isoleucine or valine' 0 C--O 1.234 0.262 0 CA-C-N 116.5 -0.318 . . . . 1.25 110.763 -175.254 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' D' D ' 134' ' ' ASP . . . . . . . . . . . . . 5.6 p-10 -136.41 148.14 47.63 Favored 'General case' 0 C--N 1.331 -0.203 0 CA-C-N 116.327 -0.397 . . . . 0.59999999999999998 109.946 176.331 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' D' D ' 135' ' ' GLU . . . . . . . . . . . . . 84.6 tt0 -49.85 -28.46 6.51 Favored 'General case' 0 C--O 1.236 0.352 0 N-CA-C 112.582 0.586 . . . . 1.6799999999999999 112.582 -175.277 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' D' D ' 136' ' ' GLN . . . . . . . . . . . . . 94.8 mt-30 -78.26 -36.12 47.29 Favored 'General case' 0 C--N 1.331 -0.223 0 N-CA-C 112.414 0.524 . . . . 2.9399999999999999 112.414 -176.458 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' D' D ' 137' ' ' LYS . . . . . . . . . . . . . 35.3 pttt -170.06 177.0 4.44 Favored 'General case' 0 C--O 1.233 0.217 0 CA-C-O 121.827 0.822 . . . . 1.9399999999999999 113.117 -170.821 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' D' D ' 138' ' ' LEU . . . . . . . . . . . . . 9.5 tp -113.18 129.2 56.59 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 114.233 -1.348 . . . . 1.49 109.797 178.311 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' D' D ' 139' ' ' THR . . . . . . . . . . . . . 36.9 m -112.09 126.02 54.73 Favored 'General case' 0 C--N 1.331 -0.22 0 CA-C-O 120.673 0.273 . . . . 1.1699999999999999 110.616 179.197 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' D' D ' 140' ' ' LEU . . . . . . . . . . . . . 17.1 tp -115.01 124.28 51.23 Favored 'General case' 0 C--N 1.329 -0.299 0 N-CA-C 108.905 -0.776 . . . . 1.71 108.905 179.261 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' D' D ' 141' ' ' ILE . . . . . . . . . . . . . 20.0 mt -119.91 118.54 57.37 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.375 0 N-CA-C 109.808 -0.441 . . . . 1.2 109.808 -175.796 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' D' D ' 142' ' ' ARG . . . . . . . . . . . . . 74.3 ttt180 -109.75 124.02 50.53 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-N 115.141 -0.936 . . . . 3.3799999999999999 110.453 -175.472 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' D' D ' 143' ' ' THR . . . . . . . . . . . . . 22.6 p . . . . . 0 C--O 1.22 -0.485 0 CA-C-O 118.015 -0.993 . . . . 1.8600000000000001 110.601 -179.75 . . . . . . . . 0 0 . 1 . 001 nuclear orig full ' E' E ' -3' ' ' GLU . . . . . . . . . . . . . 95.1 mt-10 . . . . . 0 N--CA 1.491 1.592 0 N-CA-C 109.16 -0.682 . . . . 32.090000000000003 109.16 . . . . . . . . . 0 0 . 1 . 001 nuclear orig full ' E' E ' -2' ' ' GLY . . . . . . . . . . . . . . . -72.83 133.67 19.28 Favored Glycine 0 CA--C 1.523 0.58 0 N-CA-C 110.641 -0.984 . . . . 28.579999999999998 110.641 178.247 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' E' E ' -1' ' ' VAL . . . . . . . . . . . . . 46.3 t -90.46 130.88 38.98 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.363 0 CA-C-O 120.916 0.389 . . . . 25.559999999999999 110.088 -178.953 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' E' E ' 0' ' ' ILE . . . . . . . . . . . . . 72.7 mt -115.85 127.19 73.53 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.278 0 CA-C-N 115.959 -0.564 . . . . 24.449999999999999 109.511 178.588 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' E' E ' 1' ' ' MET . . . . . . . . . . . . . 16.3 ptt? -84.01 153.5 23.82 Favored 'General case' 0 C--N 1.329 -0.305 0 C-N-CA 120.818 -0.353 . . . . 20.57 110.586 -178.3 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' E' E ' 2' ' ' SER . . . . . . . . . . . . . 2.0 p -113.04 122.96 49.17 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-O 121.075 0.464 . . . . 18.629999999999999 110.299 177.715 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' E' E ' 3' ' ' GLU . . . . . . . . . . . . . 85.0 tt0 -140.33 139.14 35.37 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-N 115.711 -0.677 . . . . 15.99 110.869 -178.485 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' E' E ' 4' ' ' LEU . . . . . . . . . . . . . 18.8 tp -122.56 126.34 47.55 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 115.987 -0.551 . . . . 14.779999999999999 110.154 177.248 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' E' E ' 5' ' ' LYS . . . . . . . . . . . . . 91.4 mttt -103.43 120.31 40.58 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.238 -0.437 . . . . 12.050000000000001 110.319 178.028 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' E' E ' 6' ' ' LEU . . . . . . . . . . . . . 69.6 mt -118.32 149.9 40.4 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 115.565 -0.743 . . . . 12.51 110.437 -178.68 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' E' E ' 7' ' ' LYS . . . . . . . . . . . . . 59.8 tttm -135.67 141.69 38.06 Favored Pre-proline 0 CA--C 1.534 0.351 0 CA-C-O 119.192 -0.432 . . . . 10.039999999999999 110.039 176.976 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' E' E ' 8' ' ' PRO . . . . . . . . . . . . . 75.1 Cg_endo -88.52 136.97 3.39 Favored 'Trans proline' 0 N--CA 1.49 1.295 0 C-N-CA 121.643 1.562 . . . . 10.59 111.568 178.924 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' E' E ' 9' ' ' LEU . . . . . . . . . . . . . 81.8 mt -77.72 -52.17 1.7 Allowed Pre-proline 0 C--N 1.33 -0.258 0 CA-C-O 119.057 -0.497 . . . . 14.26 111.587 -177.95 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' E' E ' 10' ' ' PRO . . . . . . . . . . . . . 57.2 Cg_endo -73.19 148.3 43.9 Favored 'Trans proline' 0 N--CA 1.496 1.67 0 C-N-CA 121.049 1.166 . . . . 14.41 111.439 172.399 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' E' E ' 11' ' ' LYS . . . . . . . . . . . . . 63.9 mttp -82.91 97.34 8.63 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-O 120.84 0.352 . . . . 12.82 110.853 -179.124 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' E' E ' 12' ' ' VAL . . . . . . . . . . . . . 12.3 p -142.72 144.25 24.6 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.334 0 CA-C-N 116.09 -0.505 . . . . 14.699999999999999 110.422 178.802 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' E' E ' 13' ' ' GLU . . . . . . . . . . . . . 85.0 tt0 -87.0 129.39 34.9 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.312 -0.403 . . . . 14.369999999999999 109.947 177.539 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' E' E ' 14' ' ' LEU . . . . . . . . . . . . . 21.3 mt -91.36 148.19 37.07 Favored Pre-proline 0 CA--C 1.533 0.309 0 C-N-CA 120.804 -0.358 . . . . 13.59 110.51 -176.701 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' E' E ' 15' ' ' PRO . . . . . . . . . . . . . 26.5 Cg_exo -62.22 161.2 27.62 Favored 'Trans proline' 0 N--CA 1.496 1.632 0 C-N-CA 121.321 1.348 . . . . 16.550000000000001 111.84 175.497 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' E' E ' 16' ' ' PRO . . . . . . . . . . . . . 35.7 Cg_exo -59.08 -31.88 96.38 Favored 'Trans proline' 0 N--CA 1.496 1.673 0 C-N-CA 121.45 1.433 . . . . 16.629999999999999 112.704 -178.779 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' E' E ' 17' ' ' ASP . . . . . . . . . . . . . 3.0 p30 -93.58 8.5 40.54 Favored 'General case' 0 CA--C 1.535 0.403 0 N-CA-C 113.302 0.853 . . . . 17.129999999999999 113.302 -176.847 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' E' E ' 18' ' ' PHE . . . . . . . . . . . . . 47.4 t80 -57.93 -44.47 86.93 Favored 'General case' 0 C--N 1.334 -0.105 0 CA-C-N 118.098 0.408 . . . . 15.15 110.184 -178.074 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' E' E ' 19' ' ' VAL . . . . . . . . . . . . . 47.8 t -57.35 -42.95 81.44 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 CA-C-N 116.311 -0.404 . . . . 13.57 110.345 -178.624 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' E' E ' 20' ' ' ASP . . . . . . . . . . . . . 8.5 m-20 -59.2 -41.98 89.86 Favored 'General case' 0 C--N 1.329 -0.32 0 C-N-CA 120.85 -0.34 . . . . 16.079999999999998 110.554 -178.268 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' E' E ' 21' ' ' VAL . . . . . . . . . . . . . 47.1 t -64.78 -46.78 91.03 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.347 0 C-N-CA 120.829 -0.348 . . . . 17.34 110.612 -178.079 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' E' E ' 22' ' ' ILE . . . . . . . . . . . . . 48.3 mm -61.22 -34.65 61.48 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 C-N-CA 120.981 -0.287 . . . . 15.74 111.253 -178.303 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' E' E ' 23' ' ' ARG . . . . . . . . . . . . . 58.3 ttp180 -60.52 -51.58 68.82 Favored 'General case' 0 C--N 1.331 -0.235 0 C-N-CA 120.537 -0.465 . . . . 17.039999999999999 110.164 176.135 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' E' E ' 24' ' ' ILE . . . . . . . . . . . . . 78.5 mt -60.76 -39.3 81.3 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.323 0 CA-C-N 115.968 -0.56 . . . . 19.190000000000001 111.985 -176.467 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' E' E ' 25' ' ' LYS . . . . . . . . . . . . . 11.7 ptmm? -76.67 -39.39 52.28 Favored 'General case' 0 CA--C 1.535 0.37 0 N-CA-C 112.003 0.371 . . . . 19.210000000000001 112.003 -174.615 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' E' E ' 26' ' ' LEU . . . . . . . . . . . . . 30.6 mt -78.82 -32.34 46.19 Favored 'General case' 0 C--N 1.332 -0.183 0 N-CA-C 113.51 0.93 . . . . 18.899999999999999 113.51 -172.267 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' E' E ' 27' ' ' GLN . . . . . . . . . . . . . 10.6 pt20 -46.69 139.02 5.57 Favored 'General case' 0 N--CA 1.471 0.593 0 N-CA-C 112.862 0.689 . . . . 20.23 112.862 -175.481 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' E' E ' 28' ' ' GLY . . . . . . . . . . . . . . . 97.17 -22.17 42.2 Favored Glycine 0 CA--C 1.534 1.245 0 CA-C-N 115.554 -0.748 . . . . 22.390000000000001 112.554 -177.284 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' E' E ' 29' ' ' LYS . . . . . . . . . . . . . 93.1 mttt -98.29 155.14 17.34 Favored 'General case' 0 C--O 1.232 0.176 0 CA-C-N 117.419 0.609 . . . . 22.77 111.136 -179.469 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' E' E ' 30' ' ' THR . . . . . . . . . . . . . 30.5 m -105.68 139.33 40.44 Favored 'General case' 0 C--N 1.332 -0.191 0 CA-C-N 116.029 -0.532 . . . . 22.879999999999999 110.341 177.659 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' E' E ' 31' ' ' VAL . . . . . . . . . . . . . 34.8 m -131.15 154.11 40.15 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.21 0 CA-C-N 116.33 -0.395 . . . . 19.559999999999999 110.821 -179.766 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' E' E ' 32' ' ' ARG . . . . . . . . . . . . . 22.2 ttp180 -136.15 151.32 49.63 Favored 'General case' 0 C--N 1.331 -0.219 0 CA-C-O 121.225 0.535 . . . . 25.210000000000001 110.439 177.004 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' E' E ' 33' ' ' THR . . . . . . . . . . . . . 41.9 m -52.78 138.64 28.75 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 116.258 -0.428 . . . . 18.579999999999998 111.417 -179.228 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' E' E ' 34' ' ' GLY . . . . . . . . . . . . . . . 98.68 -17.1 58.84 Favored Glycine 0 CA--C 1.531 1.092 0 CA-C-N 116.048 -0.524 . . . . 18.030000000000001 113.369 177.312 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' E' E ' 35' ' ' ASP . . . . . . . . . . . . . 80.9 m-20 -66.6 147.39 53.34 Favored 'General case' 0 C--O 1.231 0.129 0 CA-C-N 118.015 0.907 . . . . 20.260000000000002 111.232 179.488 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' E' E ' 36' ' ' VAL . . . . . . . . . . . . . 44.1 t -121.13 128.2 75.99 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.264 0 N-CA-C 109.443 -0.577 . . . . 18.850000000000001 109.443 175.96 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' E' E ' 37' ' ' ILE . . . . . . . . . . . . . 66.4 mt -120.32 139.72 46.71 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.271 0 CA-C-N 116.328 -0.396 . . . . 18.440000000000001 110.156 -177.96 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' E' E ' 38' ' ' GLY . . . . . . . . . . . . . . . -108.22 128.57 9.18 Favored Glycine 0 CA--C 1.524 0.653 0 N-CA-C 110.884 -0.887 . . . . 19.379999999999999 110.884 177.739 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' E' E ' 39' ' ' ILE . . . . . . . . . . . . . 74.4 mt -124.48 135.31 64.22 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.193 0 N-CA-C 110.085 -0.339 . . . . 19.010000000000002 110.085 179.479 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' E' E ' 40' ' ' SER . . . . . . . . . . . . . 34.6 t -92.56 116.96 29.46 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.433 -0.349 . . . . 22.530000000000001 110.86 176.241 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' E' E ' 41' ' ' ILE . . . . . . . . . . . . . 48.5 mm -128.94 128.16 67.03 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.19 0 CA-C-O 120.778 0.323 . . . . 20.190000000000001 110.407 179.37 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' E' E ' 42' ' ' LEU . . . . . . . . . . . . . 56.7 mt 54.59 33.03 18.24 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.194 -0.457 . . . . 22.670000000000002 111.856 177.824 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' E' E ' 43' ' ' GLY . . . . . . . . . . . . . . . 71.16 28.74 69.68 Favored Glycine 0 CA--C 1.532 1.106 0 C-N-CA 121.109 -0.567 . . . . 24.109999999999999 112.176 177.872 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' E' E ' 44' ' ' LYS . . . . . . . . . . . . . 45.9 tttp -141.75 137.7 31.81 Favored 'General case' 0 C--N 1.33 -0.263 0 N-CA-C 109.773 -0.454 . . . . 21.449999999999999 109.773 179.464 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' E' E ' 45' ' ' GLU . . . . . . . . . . . . . 83.7 tt0 -82.36 126.64 32.4 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-O 120.934 0.397 . . . . 21.32 111.18 -176.993 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' E' E ' 46' ' ' VAL . . . . . . . . . . . . . 7.6 p -124.32 129.83 73.84 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.222 0 N-CA-C 109.367 -0.605 . . . . 17.640000000000001 109.367 175.822 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' E' E ' 47' ' ' LYS . . . . . . . . . . . . . 98.7 mttt -101.07 132.61 46.43 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.087 -0.506 . . . . 19.539999999999999 111.364 179.799 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' E' E ' 48' ' ' PHE . . . . . . . . . . . . . 92.3 m-85 -117.01 132.02 56.8 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.267 -0.424 . . . . 14.77 110.364 176.952 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' E' E ' 49' ' ' LYS . . . . . . . . . . . . . 84.6 tttt -106.78 137.28 45.11 Favored 'General case' 0 C--N 1.331 -0.23 0 CA-C-N 116.503 -0.317 . . . . 14.890000000000001 110.45 178.045 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' E' E ' 50' ' ' VAL . . . . . . . . . . . . . 44.7 t -84.29 111.13 19.68 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.258 0 N-CA-C 109.245 -0.65 . . . . 15.1 109.245 175.701 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' E' E ' 51' ' ' VAL . . . . . . . . . . . . . 46.8 t -72.66 -46.72 53.37 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.317 0 CA-C-N 116.265 -0.425 . . . . 13.279999999999999 110.053 -174.269 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' E' E ' 52' ' ' GLN . . . . . . . . . . . . . 46.9 tt0 -169.04 142.6 2.87 Favored 'General case' 0 C--N 1.331 -0.205 0 C-N-CA 120.295 -0.562 . . . . 15.119999999999999 111.776 -178.922 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' E' E ' 53' ' ' ALA . . . . . . . . . . . . . . . -116.13 135.41 53.95 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-N 115.714 -0.675 . . . . 17.09 110.106 176.589 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' E' E ' 54' ' ' TYR . . . . . . . . . . . . . 62.5 t80 -128.94 109.23 18.34 Favored Pre-proline 0 CA--C 1.536 0.427 0 CA-C-O 118.26 -0.876 . . . . 20.390000000000001 110.181 178.688 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' E' E ' 55' ' ' PRO . . . . . . . . . . . . . 74.0 Cg_endo -77.09 170.06 72.65 Favored 'Cis proline' 0 N--CA 1.499 1.826 0 CA-C-N 121.81 1.682 . . . . 21.440000000000001 112.445 -4.544 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' E' E ' 56' ' ' SER . . . . . . . . . . . . . 13.6 m -113.99 126.96 27.34 Favored Pre-proline 0 CA--C 1.538 0.498 0 CA-C-O 118.405 -0.807 . . . . 22.329999999999998 109.476 176.28 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' E' E ' 57' ' ' PRO . . . . . . . . . . . . . 56.9 Cg_endo -72.64 169.04 73.39 Favored 'Cis proline' 0 N--CA 1.497 1.704 0 CA-C-N 122.083 1.78 . . . . 24.07 111.848 -0.096 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' E' E ' 58' ' ' LEU . . . . . . . . . . . . . 28.9 tp -130.0 137.7 50.42 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.139 -0.482 . . . . 19.780000000000001 110.294 179.95 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' E' E ' 59' ' ' ARG . . . . . . . . . . . . . 52.2 ttp180 -105.19 128.75 53.55 Favored 'General case' 0 C--N 1.328 -0.35 0 N-CA-C 109.239 -0.652 . . . . 24.93 109.239 176.106 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' E' E ' 60' ' ' VAL . . . . . . . . . . . . . 41.9 t -85.39 119.08 33.38 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.272 0 C-N-CA 120.607 -0.437 . . . . 18.940000000000001 110.919 -173.992 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' E' E ' 61' ' ' GLU . . . . . . . . . . . . . 47.2 mt-10 -131.03 170.11 14.94 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 115.703 -0.68 . . . . 21.280000000000001 109.492 174.29 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' E' E ' 62' ' ' ASP . . . . . . . . . . . . . 4.5 m-20 -53.23 -32.67 49.46 Favored 'General case' 0 C--N 1.329 -0.308 0 N-CA-C 111.925 0.343 . . . . 19.550000000000001 111.925 -177.609 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' E' E ' 63' ' ' ARG . . . . . . . . . . . . . 98.2 mtt180 -73.13 -22.0 60.62 Favored 'General case' 0 CA--C 1.533 0.289 0 N-CA-C 113.038 0.755 . . . . 22.420000000000002 113.038 -176.188 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' E' E ' 64' ' ' THR . . . . . . . . . . . . . 26.7 m -66.42 137.24 56.71 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-O 120.983 0.42 . . . . 17.350000000000001 111.061 -174.692 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' E' E ' 65' ' ' LYS . . . . . . . . . . . . . 67.5 mttm -89.71 129.79 36.08 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 115.927 -0.579 . . . . 16.41 109.967 177.207 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' E' E ' 66' ' ' ILE . . . . . . . . . . . . . 63.2 mt -118.83 129.57 74.86 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.287 0 N-CA-C 109.849 -0.426 . . . . 13.67 109.849 -179.775 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' E' E ' 67' ' ' THR . . . . . . . . . . . . . 25.9 m -127.38 139.82 52.59 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-O 120.95 0.405 . . . . 10.800000000000001 110.994 -178.165 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' E' E ' 68' ' ' LEU . . . . . . . . . . . . . 65.4 mt -104.95 131.32 52.6 Favored 'General case' 0 C--N 1.331 -0.226 0 CA-C-N 116.056 -0.52 . . . . 9.0999999999999996 110.528 177.912 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' E' E ' 69' ' ' VAL . . . . . . . . . . . . . 42.0 t -102.83 125.64 57.16 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.334 0 CA-C-N 116.33 -0.396 . . . . 7.4400000000000004 110.205 179.024 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' E' E ' 70' ' ' THR . . . . . . . . . . . . . 10.2 t -150.05 149.78 30.81 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.042 -0.527 . . . . 6.2199999999999998 110.319 177.711 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' E' E ' 71' ' ' HIS . . . . . . . . . . . . . 83.1 t60 -141.88 69.79 24.22 Favored Pre-proline 0 CA--C 1.535 0.4 0 C-N-CA 120.858 -0.337 . . . . 7.1299999999999999 111.135 -179.447 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' E' E ' 72' ' ' PRO . . . . . . . . . . . . . 64.8 Cg_endo -91.38 160.04 3.68 Favored 'Trans proline' 0 N--CA 1.488 1.194 0 C-N-CA 121.861 1.707 . . . . 3.5299999999999998 111.606 174.16 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' E' E ' 73' ' ' VAL . . . . . . . . . . . . . 26.9 m -105.0 154.59 6.43 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.163 0 CA-C-O 120.972 0.415 . . . . 1.3600000000000001 110.452 179.161 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' E' E ' 74' ' ' ASP . . . . . . . . . . . . . 21.6 t0 -96.08 119.91 35.42 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 115.907 -0.588 . . . . 0.95999999999999996 109.544 179.853 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' E' E ' 75' ' ' VAL . . . . . . . . . . . . . 41.8 t -107.54 119.32 56.93 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.268 0 CA-C-O 121.071 0.462 . . . . 1.28 110.233 -178.973 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' E' E ' 76' ' ' LEU . . . . . . . . . . . . . 34.8 mt -115.11 137.86 51.54 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 115.592 -0.731 . . . . 1.8200000000000001 109.435 177.232 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' E' E ' 77' ' ' GLU . . . . . . . . . . . . . 98.0 mt-10 -134.06 131.45 38.84 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-O 121.064 0.459 . . . . 1.1699999999999999 111.061 -177.769 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' E' E ' 78' ' ' ALA . . . . . . . . . . . . . . . -119.1 124.07 45.99 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 115.654 -0.703 . . . . 1.25 109.625 176.419 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' E' E ' 79' ' ' LYS . . . . . . . . . . . . . 7.8 ttpm? -74.58 122.82 23.73 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-O 120.876 0.369 . . . . 3.4300000000000002 110.615 -177.162 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' E' E ' 80' ' ' ILE . . . . . . . . . . . . . 39.6 mm -139.06 113.72 7.84 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.298 0 N-CA-C 109.009 -0.737 . . . . 1.22 109.009 -178.443 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' E' E ' 81' ' ' LYS . . . . . . . . . . . . . 29.2 tttp -98.94 118.12 35.0 Favored 'General case' 0 C--N 1.327 -0.397 0 CA-C-N 116.524 -0.307 . . . . 3.4300000000000002 110.646 -175.381 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' E' E ' 82' ' ' GLY . . . . . . . . . . . . . . . 89.16 42.32 5.62 Favored Glycine 0 CA--C 1.527 0.818 0 C-N-CA 120.421 -0.895 . . . . 0.64000000000000001 112.058 175.282 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' E' E ' 83' ' ' ILE . . . . . . . . . . . . . 77.1 mt -61.67 142.37 16.37 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.293 0 N-CA-C 109.704 -0.48 . . . . 1.22 109.704 175.994 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' E' E ' 84' ' ' LYS . . . . . . . . . . . . . 84.9 tttt -98.68 -54.02 3.14 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.11 -0.495 . . . . 2.1400000000000001 110.536 -178.293 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' E' E ' 85' ' ' ASP . . . . . . . . . . . . . 11.6 t70 -156.37 155.67 32.58 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 115.769 -0.651 . . . . 0.82999999999999996 110.254 -178.912 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' E' E ' 86' ' ' VAL . . . . . . . . . . . . . 43.5 t -129.28 130.86 67.86 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.268 0 CA-C-O 121.048 0.451 . . . . 1.1599999999999999 110.622 -178.308 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' E' E ' 87' ' ' ILE . . . . . . . . . . . . . 44.1 mm -118.74 122.81 70.34 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.281 0 CA-C-N 115.651 -0.704 . . . . 2.1000000000000001 109.249 175.653 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' E' E ' 88' ' ' LEU . . . . . . . . . . . . . 14.4 tp -115.03 131.7 56.84 Favored 'General case' 0 C--N 1.331 -0.217 0 CA-C-O 121.014 0.435 . . . . 2.1899999999999999 111.256 -176.072 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' E' E ' 89' ' ' ASP . . . . . . . . . . . . . 21.3 t70 -125.5 154.41 42.12 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 115.788 -0.642 . . . . 0.91000000000000003 109.472 175.427 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' E' E ' 90' ' ' GLU . . . . . . . . . . . . . 48.1 mt-10 -49.46 -34.43 16.79 Favored 'General case' 0 C--N 1.328 -0.336 0 N-CA-C 112.845 0.683 . . . . 2.25 112.845 -171.653 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' E' E ' 91' ' ' ASN . . . . . . . . . . . . . 37.6 p-10 -132.0 32.2 4.07 Favored 'General case' 0 N--CA 1.466 0.33 0 N-CA-C 112.17 0.433 . . . . 2.8999999999999999 112.17 -176.096 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' E' E ' 92' ' ' LEU . . . . . . . . . . . . . 16.0 tp -166.04 141.75 4.87 Favored 'General case' 0 C--N 1.329 -0.292 0 C-N-CA 120.886 -0.326 . . . . 2.02 110.668 179.56 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' E' E ' 93' ' ' ILE . . . . . . . . . . . . . 69.1 mt -121.45 121.75 65.43 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.217 0 N-CA-C 109.722 -0.473 . . . . 1.21 109.722 -179.583 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' E' E ' 94' ' ' VAL . . . . . . . . . . . . . 45.1 t -122.74 126.64 74.21 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.202 0 N-CA-C 109.969 -0.382 . . . . 1.1799999999999999 109.969 179.212 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' E' E ' 95' ' ' VAL . . . . . . . . . . . . . 42.2 t -124.0 135.88 62.15 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.307 0 CA-C-N 116.276 -0.42 . . . . 1.3899999999999999 110.01 -179.377 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' E' E ' 96' ' ' ILE . . . . . . . . . . . . . 59.2 mt -115.38 132.46 64.66 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.248 0 N-CA-C 109.429 -0.582 . . . . 1.1799999999999999 109.429 179.408 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' E' E ' 97' ' ' THR . . . . . . . . . . . . . 68.9 p -103.56 158.92 16.03 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-O 120.906 0.384 . . . . 1.24 110.782 -179.579 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' E' E ' 98' ' ' GLU . . . . . . . . . . . . . 96.9 mt-10 -53.85 -24.21 15.04 Favored 'General case' 0 CA--C 1.533 0.327 0 N-CA-C 112.413 0.523 . . . . 2.6299999999999999 112.413 -179.983 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' E' E ' 99' ' ' GLU . . . . . . . . . . . . . 95.3 mt-10 -78.43 14.36 1.27 Allowed 'General case' 0 CA--C 1.535 0.385 0 N-CA-C 113.218 0.821 . . . . 2.6200000000000001 113.218 -176.7 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' E' E ' 100' ' ' ASN . . . . . . . . . . . . . 2.7 m-20 61.8 38.03 15.11 Favored 'General case' 0 N--CA 1.463 0.193 0 CA-C-O 121.148 0.499 . . . . 0.76000000000000001 110.922 179.221 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' E' E ' 101' ' ' GLU . . . . . . . . . . . . . 61.2 tt0 -119.98 142.35 48.86 Favored 'General case' 0 C--N 1.331 -0.217 0 CA-C-N 116.093 -0.503 . . . . 0.84999999999999998 109.673 176.404 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' E' E ' 102' ' ' VAL . . . . . . . . . . . . . 46.3 t -115.25 130.19 70.22 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.291 0 CA-C-N 116.227 -0.442 . . . . 1.21 110.162 -178.521 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' E' E ' 103' ' ' LEU . . . . . . . . . . . . . 20.0 mt -117.35 133.93 55.41 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 115.502 -0.772 . . . . 1.75 110.066 176.221 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' E' E ' 104' ' ' ILE . . . . . . . . . . . . . 67.0 mt -119.48 124.91 73.81 Favored 'Isoleucine or valine' 0 C--O 1.234 0.284 0 N-CA-C 110.192 -0.299 . . . . 1.1799999999999999 110.192 179.912 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' E' E ' 105' ' ' PHE . . . . . . . . . . . . . 67.4 m-85 -123.92 163.4 21.39 Favored 'General case' 0 C--O 1.232 0.151 0 O-C-N 124.013 0.821 . . . . 0.58999999999999997 110.182 -179.444 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' E' E ' 106' ' ' ASN . . . . . . . . . . . . . 40.1 p30 -98.39 -171.94 2.23 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.421 -0.354 . . . . 0.72999999999999998 110.327 175.651 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' E' E ' 107' ' ' GLN . . . . . . . . . . . . . 59.5 tt0 -58.37 -29.53 66.08 Favored 'General case' 0 CA--C 1.534 0.329 0 N-CA-C 111.858 0.318 . . . . 1.77 111.858 178.774 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' E' E ' 108' ' ' ASN . . . . . . . . . . . . . 7.5 t-20 -83.24 10.95 7.29 Favored 'General case' 0 CA--C 1.536 0.422 0 N-CA-C 112.933 0.716 . . . . 2.1200000000000001 112.933 -177.729 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' E' E ' 109' ' ' LEU . . . . . . . . . . . . . 12.5 tp 54.82 37.66 28.91 Favored 'General case' 0 C--N 1.332 -0.169 0 CA-C-O 121.023 0.44 . . . . 2.02 111.08 -179.509 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' E' E ' 110' ' ' GLU . . . . . . . . . . . . . 95.4 mt-10 -104.78 145.91 29.7 Favored 'General case' 0 C--N 1.331 -0.224 0 N-CA-C 109.704 -0.48 . . . . 1.8899999999999999 109.704 175.275 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' E' E ' 111' ' ' GLU . . . . . . . . . . . . . 80.2 tt0 -83.69 122.15 28.24 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.401 -0.363 . . . . 1.3200000000000001 110.747 -175.783 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' E' E ' 112' ' ' LEU . . . . . . . . . . . . . 49.4 mt -109.14 -45.26 3.79 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-N 116.095 -0.502 . . . . 1.3400000000000001 111.128 -179.275 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' E' E ' 113' ' ' TYR . . . . . . . . . . . . . 58.0 t80 -132.96 137.58 46.62 Favored 'General case' 0 N--CA 1.464 0.238 0 CA-C-O 120.839 0.352 . . . . 1.0600000000000001 111.36 -176.828 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' E' E ' 114' ' ' ARG . . . . . . . . . . . . . 47.5 ttp180 -138.73 123.66 18.88 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 115.831 -0.622 . . . . 3.1800000000000002 110.123 177.361 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' E' E ' 115' ' ' GLY . . . . . . . . . . . . . . . -150.14 140.09 7.78 Favored Glycine 0 CA--C 1.526 0.719 0 C-N-CA 120.737 -0.744 . . . . 0.5 111.356 178.732 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' E' E ' 116' ' ' LYS . . . . . . . . . . . . . 27.5 ttpp -110.37 134.59 52.15 Favored 'General case' 0 C--N 1.33 -0.24 0 N-CA-C 109.748 -0.464 . . . . 2.3100000000000001 109.748 176.618 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' E' E ' 117' ' ' PHE . . . . . . . . . . . . . 31.7 m-85 -135.57 113.9 11.52 Favored 'General case' 0 C--N 1.332 -0.191 0 C-N-CA 120.871 -0.331 . . . . 0.65000000000000002 110.158 -176.817 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' E' E ' 118' ' ' GLU . . . . . . . . . . . . . 96.3 mt-10 -55.59 -45.71 77.36 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.519 -0.31 . . . . 2.4500000000000002 111.176 -176.191 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' E' E ' 119' ' ' ASN . . . . . . . . . . . . . 68.3 m-80 -95.99 30.0 2.56 Favored 'General case' 0 C--N 1.329 -0.287 0 N-CA-C 112.22 0.452 . . . . 2.1200000000000001 112.22 -174.172 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' E' E ' 120' ' ' LEU . . . . . . . . . . . . . 22.0 tp -58.39 122.13 12.54 Favored 'General case' 0 C--N 1.333 -0.149 0 N-CA-C 110.027 -0.36 . . . . 1.26 110.027 177.509 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' E' E ' 121' ' ' ASN . . . . . . . . . . . . . 68.2 m-20 -113.99 -44.07 3.19 Favored 'General case' 0 C--O 1.232 0.147 0 CA-C-N 116.534 -0.303 . . . . 2.2999999999999998 111.094 -178.081 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' E' E ' 122' ' ' LYS . . . . . . . . . . . . . 60.7 mttm -145.1 149.51 35.16 Favored 'General case' 0 C--N 1.332 -0.18 0 CA-C-O 121.28 0.562 . . . . 2.3500000000000001 112.064 -177.028 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' E' E ' 123' ' ' VAL . . . . . . . . . . . . . 47.3 t -126.68 129.66 71.59 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.239 0 CA-C-N 115.627 -0.715 . . . . 1.1599999999999999 109.461 175.536 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' E' E ' 124' ' ' LEU . . . . . . . . . . . . . 57.6 mt -121.98 139.56 53.53 Favored 'General case' 0 N--CA 1.463 0.212 0 CA-C-N 116.551 -0.295 . . . . 1.8799999999999999 110.792 -178.114 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' E' E ' 125' ' ' VAL . . . . . . . . . . . . . 34.3 m -137.23 139.87 43.25 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.239 0 CA-C-O 121.042 0.448 . . . . 2.1600000000000001 111.603 -178.723 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' E' E ' 126' ' ' ARG . . . . . . . . . . . . . 93.4 mtt-85 -147.77 115.57 6.41 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 115.687 -0.688 . . . . 3.9700000000000002 110.19 174.207 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' E' E ' 127' ' ' ASN . . . . . . . . . . . . . 93.4 m-20 53.79 -129.92 2.21 Favored 'General case' 0 CA--C 1.545 0.786 0 CA-C-O 118.557 -0.735 . . . . 2.79 110.552 179.578 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' E' E ' 128' ' ' ASP . . . . . . . . . . . . . 5.1 p30 -91.82 5.78 48.6 Favored 'General case' 0 CA--C 1.536 0.42 0 CA-C-N 120.078 1.308 . . . . 1.0 113.457 -178.216 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' E' E ' 129' ' ' LEU . . . . . . . . . . . . . 15.3 tp -105.41 134.51 48.41 Favored 'General case' 0 C--N 1.333 -0.115 0 CA-C-N 118.17 0.441 . . . . 2.3100000000000001 109.834 178.555 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' E' E ' 130' ' ' VAL . . . . . . . . . . . . . 12.4 p -132.17 143.32 40.37 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.165 0 CA-C-O 121.019 0.438 . . . . 1.9099999999999999 110.705 -177.943 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' E' E ' 131' ' ' VAL . . . . . . . . . . . . . 38.9 t -136.0 140.09 44.66 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.278 0 CA-C-N 116.034 -0.53 . . . . 1.54 110.437 -179.086 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' E' E ' 132' ' ' ILE . . . . . . . . . . . . . 76.3 mt -114.98 133.88 59.78 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.288 0 CA-C-N 115.67 -0.695 . . . . 1.25 109.472 179.515 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' E' E ' 133' ' ' ILE . . . . . . . . . . . . . 38.0 mm -116.57 119.16 61.14 Favored 'Isoleucine or valine' 0 C--O 1.236 0.345 0 CA-C-N 116.537 -0.301 . . . . 1.1399999999999999 110.989 -175.58 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' E' E ' 134' ' ' ASP . . . . . . . . . . . . . 5.8 p-10 -135.21 148.5 49.65 Favored 'General case' 0 C--N 1.332 -0.167 0 N-CA-C 109.809 -0.441 . . . . 0.56000000000000005 109.809 174.753 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' E' E ' 135' ' ' GLU . . . . . . . . . . . . . 44.6 tp10 -50.01 -28.06 6.41 Favored 'General case' 0 C--N 1.329 -0.323 0 N-CA-C 112.702 0.63 . . . . 2.0099999999999998 112.702 -172.222 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' E' E ' 136' ' ' GLN . . . . . . . . . . . . . 95.9 mt-30 -81.98 -37.63 26.33 Favored 'General case' 0 C--O 1.234 0.272 0 N-CA-C 112.683 0.623 . . . . 2.8799999999999999 112.683 -175.694 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' E' E ' 137' ' ' LYS . . . . . . . . . . . . . 20.3 pttp -160.47 169.52 22.85 Favored 'General case' 0 C--O 1.234 0.251 0 CA-C-O 121.825 0.821 . . . . 2.27 113.192 -169.801 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' E' E ' 138' ' ' LEU . . . . . . . . . . . . . 7.7 tp -111.96 127.83 55.98 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 114.085 -1.416 . . . . 1.28 109.459 177.859 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' E' E ' 139' ' ' THR . . . . . . . . . . . . . 27.3 m -113.59 123.59 50.33 Favored 'General case' 0 C--N 1.331 -0.221 0 CA-C-O 120.614 0.245 . . . . 1.1200000000000001 110.39 178.699 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' E' E ' 140' ' ' LEU . . . . . . . . . . . . . 8.1 tp -113.36 121.39 44.21 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 115.884 -0.598 . . . . 1.5900000000000001 109.44 -179.439 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' E' E ' 141' ' ' ILE . . . . . . . . . . . . . 19.4 mt -121.14 122.79 68.46 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.307 0 CA-C-O 121.053 0.454 . . . . 1.1899999999999999 109.791 -176.218 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' E' E ' 142' ' ' ARG . . . . . . . . . . . . . 50.6 ttp180 -117.35 129.46 55.89 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 115.382 -0.826 . . . . 3.54 110.587 -175.51 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' E' E ' 143' ' ' THR . . . . . . . . . . . . . 11.6 p . . . . . 0 C--O 1.22 -0.458 0 CA-C-O 117.938 -1.03 . . . . 1.5700000000000001 110.603 179.642 . . . . . . . . 0 0 . 1 . 001 nuclear orig full ' F' F ' -3' ' ' GLU . . . . . . . . . . . . . 13.8 pt-20 . . . . . 0 N--CA 1.49 1.543 0 N-CA-C 109.502 -0.555 . . . . 33.380000000000003 109.502 . . . . . . . . . 0 0 . 1 . 001 nuclear orig full ' F' F ' -2' ' ' GLY . . . . . . . . . . . . . . . -99.3 135.17 11.99 Favored Glycine 0 CA--C 1.525 0.669 0 N-CA-C 110.715 -0.954 . . . . 31.620000000000001 110.715 178.438 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' F' F ' -1' ' ' VAL . . . . . . . . . . . . . 44.1 t -96.07 132.83 39.32 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.333 0 CA-C-O 120.868 0.366 . . . . 28.460000000000001 110.117 -179.099 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' F' F ' 0' ' ' ILE . . . . . . . . . . . . . 73.8 mt -117.61 136.65 54.08 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.215 0 CA-C-N 116.076 -0.511 . . . . 26.809999999999999 109.941 -179.942 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' F' F ' 1' ' ' MET . . . . . . . . . . . . . 26.2 ptt? -80.82 137.41 36.2 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.083 -0.508 . . . . 23.050000000000001 111.283 -177.55 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' F' F ' 2' ' ' SER . . . . . . . . . . . . . 4.4 p -121.85 135.71 54.91 Favored 'General case' 0 C--N 1.332 -0.187 0 CA-C-N 116.001 -0.545 . . . . 20.539999999999999 110.4 177.243 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' F' F ' 3' ' ' GLU . . . . . . . . . . . . . 46.0 mt-10 -141.25 142.74 33.9 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.218 -0.446 . . . . 17.77 111.133 -178.055 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' F' F ' 4' ' ' LEU . . . . . . . . . . . . . 13.5 tp -127.24 133.25 50.24 Favored 'General case' 0 C--N 1.331 -0.202 0 CA-C-N 115.886 -0.597 . . . . 15.619999999999999 109.989 176.813 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' F' F ' 5' ' ' LYS . . . . . . . . . . . . . 92.6 mttt -112.99 120.68 42.22 Favored 'General case' 0 C--O 1.234 0.273 0 CA-C-N 116.409 -0.359 . . . . 13.210000000000001 110.952 -179.573 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' F' F ' 6' ' ' LEU . . . . . . . . . . . . . 35.6 mt -113.91 149.06 35.73 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 115.289 -0.869 . . . . 12.93 110.23 179.713 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' F' F ' 7' ' ' LYS . . . . . . . . . . . . . 42.6 tttt -139.71 142.01 29.9 Favored Pre-proline 0 CA--C 1.533 0.307 0 CA-C-O 119.176 -0.44 . . . . 10.09 110.248 174.553 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' F' F ' 8' ' ' PRO . . . . . . . . . . . . . 85.5 Cg_endo -91.62 139.58 2.32 Favored 'Trans proline' 0 N--CA 1.489 1.241 0 C-N-CA 121.838 1.692 . . . . 10.43 111.782 177.997 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' F' F ' 9' ' ' LEU . . . . . . . . . . . . . 83.6 mt -70.1 -47.57 21.38 Favored Pre-proline 0 CA--C 1.533 0.293 0 CA-C-O 118.656 -0.688 . . . . 14.039999999999999 111.975 179.612 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' F' F ' 10' ' ' PRO . . . . . . . . . . . . . 84.4 Cg_endo -80.52 151.52 19.79 Favored 'Trans proline' 0 N--CA 1.495 1.586 0 C-N-CA 121.172 1.248 . . . . 14.01 111.859 175.615 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' F' F ' 11' ' ' LYS . . . . . . . . . . . . . 28.0 ttpt -83.69 103.75 13.25 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-O 120.81 0.338 . . . . 12.33 110.183 178.286 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' F' F ' 12' ' ' VAL . . . . . . . . . . . . . 12.7 p -141.02 147.41 22.59 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.258 0 CA-C-N 116.164 -0.471 . . . . 14.52 110.574 -178.589 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' F' F ' 13' ' ' GLU . . . . . . . . . . . . . 95.2 mt-10 -85.92 124.89 32.89 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 116.349 -0.387 . . . . 14.23 110.376 179.152 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' F' F ' 14' ' ' LEU . . . . . . . . . . . . . 30.9 mt -99.48 147.37 33.25 Favored Pre-proline 0 CA--C 1.532 0.284 0 CA-C-O 119.163 -0.446 . . . . 14.0 110.471 -179.186 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' F' F ' 15' ' ' PRO . . . . . . . . . . . . . 24.0 Cg_exo -63.85 154.65 68.55 Favored 'Trans proline' 0 N--CA 1.499 1.836 0 C-N-CA 121.354 1.369 . . . . 17.510000000000002 112.07 176.964 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' F' F ' 16' ' ' PRO . . . . . . . . . . . . . 39.8 Cg_exo -59.45 -35.58 95.78 Favored 'Trans proline' 0 N--CA 1.498 1.738 0 C-N-CA 121.368 1.379 . . . . 18.039999999999999 112.381 177.836 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' F' F ' 17' ' ' ASP . . . . . . . . . . . . . 6.1 p-10 -82.92 11.87 5.59 Favored 'General case' 0 C--N 1.327 -0.398 0 N-CA-C 112.95 0.722 . . . . 18.760000000000002 112.95 -179.341 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' F' F ' 18' ' ' PHE . . . . . . . . . . . . . 36.7 t80 -57.34 -44.17 84.05 Favored 'General case' 0 C--O 1.227 -0.11 0 O-C-N 121.914 -0.491 . . . . 15.65 110.196 -178.523 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' F' F ' 19' ' ' VAL . . . . . . . . . . . . . 47.4 t -55.55 -42.1 66.84 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.29 0 CA-C-N 116.417 -0.356 . . . . 15.15 110.786 -177.825 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' F' F ' 20' ' ' ASP . . . . . . . . . . . . . 5.2 t70 -60.14 -44.1 95.2 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-O 120.9 0.381 . . . . 18.079999999999998 110.969 -177.498 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' F' F ' 21' ' ' VAL . . . . . . . . . . . . . 47.5 t -65.6 -47.91 84.58 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.307 0 C-N-CA 120.576 -0.449 . . . . 18.440000000000001 110.593 -178.625 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' F' F ' 22' ' ' ILE . . . . . . . . . . . . . 49.1 mm -55.45 -58.46 4.53 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.315 0 C-N-CA 121.119 -0.232 . . . . 16.719999999999999 111.151 -177.976 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' F' F ' 23' ' ' ARG . . . . . . . . . . . . . 6.1 ptm180 -54.99 -44.0 74.06 Favored 'General case' 0 CA--C 1.53 0.189 0 C-N-CA 120.54 -0.464 . . . . 19.530000000000001 111.632 -173.696 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' F' F ' 24' ' ' ILE . . . . . . . . . . . . . 85.0 mt -60.06 -43.46 92.76 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.223 0 C-N-CA 120.796 -0.361 . . . . 20.960000000000001 111.404 -177.362 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' F' F ' 25' ' ' LYS . . . . . . . . . . . . . 93.3 mttt -71.55 -43.85 65.63 Favored 'General case' 0 C--N 1.33 -0.281 0 N-CA-C 112.823 0.675 . . . . 19.960000000000001 112.823 -177.933 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' F' F ' 26' ' ' LEU . . . . . . . . . . . . . 79.0 mt -79.04 -27.36 43.16 Favored 'General case' 0 C--N 1.329 -0.289 0 N-CA-C 113.777 1.029 . . . . 19.690000000000001 113.777 -169.301 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' F' F ' 27' ' ' GLN . . . . . . . . . . . . . 10.4 pt20 -46.78 139.83 5.07 Favored 'General case' 0 N--CA 1.469 0.523 0 N-CA-C 112.894 0.702 . . . . 21.809999999999999 112.894 -175.741 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' F' F ' 28' ' ' GLY . . . . . . . . . . . . . . . 100.66 -20.41 48.28 Favored Glycine 0 CA--C 1.534 1.221 0 CA-C-N 115.501 -0.772 . . . . 23.210000000000001 112.744 -179.0 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' F' F ' 29' ' ' LYS . . . . . . . . . . . . . 62.0 mttp -96.34 155.08 16.91 Favored 'General case' 0 C--O 1.231 0.101 0 CA-C-N 117.843 0.821 . . . . 22.59 110.99 177.726 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' F' F ' 30' ' ' THR . . . . . . . . . . . . . 30.1 m -107.02 138.97 42.17 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 115.96 -0.564 . . . . 23.59 109.948 177.584 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' F' F ' 31' ' ' VAL . . . . . . . . . . . . . 35.1 m -128.33 152.61 36.68 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.172 0 CA-C-N 116.352 -0.386 . . . . 20.100000000000001 110.779 -179.045 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' F' F ' 32' ' ' ARG . . . . . . . . . . . . . 2.8 mpt_? -131.37 150.72 52.04 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.009 -0.541 . . . . 25.530000000000001 109.976 177.195 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' F' F ' 33' ' ' THR . . . . . . . . . . . . . 14.6 m -53.68 137.39 37.53 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.426 -0.352 . . . . 18.77 111.394 -177.953 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' F' F ' 34' ' ' GLY . . . . . . . . . . . . . . . 99.88 -17.08 57.81 Favored Glycine 0 CA--C 1.533 1.198 0 C-N-CA 121.186 -0.531 . . . . 18.140000000000001 113.348 178.869 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' F' F ' 35' ' ' ASP . . . . . . . . . . . . . 60.1 m-20 -64.92 150.71 47.37 Favored 'General case' 0 C--O 1.231 0.091 0 CA-C-N 117.977 0.888 . . . . 20.129999999999999 111.487 -179.253 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' F' F ' 36' ' ' VAL . . . . . . . . . . . . . 47.7 t -121.91 129.14 75.68 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.205 0 CA-C-N 115.641 -0.709 . . . . 18.530000000000001 109.844 178.037 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' F' F ' 37' ' ' ILE . . . . . . . . . . . . . 73.9 mt -122.09 140.48 45.89 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.245 0 CA-C-N 116.299 -0.41 . . . . 18.129999999999999 110.068 -179.731 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' F' F ' 38' ' ' GLY . . . . . . . . . . . . . . . -110.52 128.68 8.92 Favored Glycine 0 CA--C 1.526 0.761 0 N-CA-C 111.092 -0.803 . . . . 19.07 111.092 179.476 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' F' F ' 39' ' ' ILE . . . . . . . . . . . . . 74.7 mt -123.47 133.35 69.43 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.262 0 N-CA-C 110.087 -0.338 . . . . 18.800000000000001 110.087 178.845 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' F' F ' 40' ' ' SER . . . . . . . . . . . . . 25.0 t -93.46 123.03 36.49 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.509 -0.314 . . . . 22.350000000000001 111.352 177.584 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' F' F ' 41' ' ' ILE . . . . . . . . . . . . . 73.2 mt -123.79 116.41 48.03 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.214 0 CA-C-N 116.348 -0.387 . . . . 20.059999999999999 110.136 176.667 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' F' F ' 42' ' ' LEU . . . . . . . . . . . . . 8.7 mp 51.06 37.08 16.98 Favored 'General case' 0 N--CA 1.465 0.313 0 CA-C-O 121.174 0.511 . . . . 22.579999999999998 111.507 178.694 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' F' F ' 43' ' ' GLY . . . . . . . . . . . . . . . 74.06 32.21 58.82 Favored Glycine 0 CA--C 1.529 0.948 0 C-N-CA 121.163 -0.541 . . . . 23.829999999999998 112.016 178.95 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' F' F ' 44' ' ' LYS . . . . . . . . . . . . . 87.6 tttt -130.62 125.9 35.27 Favored 'General case' 0 C--N 1.331 -0.232 0 N-CA-C 109.535 -0.543 . . . . 21.120000000000001 109.535 177.227 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' F' F ' 45' ' ' GLU . . . . . . . . . . . . . 82.1 tt0 -84.39 115.6 22.61 Favored 'General case' 0 C--N 1.328 -0.369 0 C-N-CA 120.811 -0.356 . . . . 20.710000000000001 110.966 -178.891 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' F' F ' 46' ' ' VAL . . . . . . . . . . . . . 7.3 p -115.25 130.36 69.93 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.243 0 N-CA-C 109.191 -0.67 . . . . 17.239999999999998 109.191 175.38 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' F' F ' 47' ' ' LYS . . . . . . . . . . . . . 63.5 mttp -99.48 125.81 45.3 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 115.97 -0.559 . . . . 19.140000000000001 111.119 179.089 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' F' F ' 48' ' ' PHE . . . . . . . . . . . . . 87.6 m-85 -108.9 131.95 54.53 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.078 -0.51 . . . . 14.5 109.899 176.735 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' F' F ' 49' ' ' LYS . . . . . . . . . . . . . 46.8 tttm -106.31 137.34 44.44 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.222 -0.445 . . . . 15.119999999999999 110.326 179.483 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' F' F ' 50' ' ' VAL . . . . . . . . . . . . . 47.6 t -81.04 107.09 13.0 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.333 0 N-CA-C 109.324 -0.621 . . . . 15.35 109.324 175.769 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' F' F ' 51' ' ' VAL . . . . . . . . . . . . . 56.6 t -70.57 -53.49 22.22 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.312 0 CA-C-N 115.864 -0.607 . . . . 13.92 109.452 -175.282 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' F' F ' 52' ' ' GLN . . . . . . . . . . . . . 88.1 mt-30 -154.34 151.96 29.68 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 115.99 -0.55 . . . . 16.129999999999999 111.822 -178.31 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' F' F ' 53' ' ' ALA . . . . . . . . . . . . . . . -129.68 130.79 45.98 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 115.21 -0.905 . . . . 18.149999999999999 109.552 174.06 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' F' F ' 54' ' ' TYR . . . . . . . . . . . . . 8.3 t80 -129.18 110.55 18.12 Favored Pre-proline 0 CA--C 1.535 0.383 0 CA-C-O 118.214 -0.898 . . . . 22.390000000000001 110.038 177.652 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' F' F ' 55' ' ' PRO . . . . . . . . . . . . . 74.0 Cg_endo -77.16 169.75 73.37 Favored 'Cis proline' 0 N--CA 1.5 1.857 0 CA-C-N 121.999 1.75 . . . . 22.949999999999999 112.666 -2.796 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' F' F ' 56' ' ' SER . . . . . . . . . . . . . 13.6 m -116.82 127.95 26.37 Favored Pre-proline 0 CA--C 1.539 0.554 0 CA-C-O 118.383 -0.818 . . . . 23.18 109.474 176.643 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' F' F ' 57' ' ' PRO . . . . . . . . . . . . . 37.6 Cg_endo -66.95 167.94 55.24 Favored 'Cis proline' 0 N--CA 1.497 1.726 0 CA-C-N 121.994 1.748 . . . . 24.699999999999999 111.466 -1.103 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' F' F ' 58' ' ' LEU . . . . . . . . . . . . . 33.5 tp -129.43 135.82 49.15 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-O 120.935 0.398 . . . . 20.82 110.507 -179.834 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' F' F ' 59' ' ' ARG . . . . . . . . . . . . . 52.5 ttt85 -97.56 127.23 43.35 Favored 'General case' 0 C--N 1.326 -0.417 0 N-CA-C 109.259 -0.645 . . . . 25.879999999999999 109.259 177.237 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' F' F ' 60' ' ' VAL . . . . . . . . . . . . . 42.6 t -82.52 114.68 23.77 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.208 0 C-N-CA 120.564 -0.454 . . . . 20.510000000000002 110.2 -176.169 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' F' F ' 61' ' ' GLU . . . . . . . . . . . . . 95.7 mt-10 -131.14 158.15 41.24 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 115.806 -0.634 . . . . 23.66 110.117 177.844 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' F' F ' 62' ' ' ASP . . . . . . . . . . . . . 4.6 p-10 -55.51 -32.46 62.91 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-N 116.511 -0.313 . . . . 21.75 111.513 177.951 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' F' F ' 63' ' ' ARG . . . . . . . . . . . . . 14.4 ptp180 -75.59 -4.94 42.84 Favored 'General case' 0 CA--C 1.535 0.389 0 N-CA-C 113.578 0.955 . . . . 25.579999999999998 113.578 -177.177 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' F' F ' 64' ' ' THR . . . . . . . . . . . . . 30.5 m -91.76 145.97 24.14 Favored 'General case' 0 C--N 1.332 -0.156 0 CA-C-N 118.271 0.487 . . . . 19.280000000000001 110.376 -178.036 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' F' F ' 65' ' ' LYS . . . . . . . . . . . . . 51.9 mtmt -87.55 124.9 33.97 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-O 121.109 0.481 . . . . 19.390000000000001 110.328 179.998 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' F' F ' 66' ' ' ILE . . . . . . . . . . . . . 71.5 mt -116.29 124.38 72.46 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.289 0 N-CA-C 109.704 -0.48 . . . . 15.44 109.704 -179.555 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' F' F ' 67' ' ' THR . . . . . . . . . . . . . 25.3 m -123.59 146.27 48.28 Favored 'General case' 0 C--N 1.331 -0.223 0 CA-C-O 121.054 0.455 . . . . 12.710000000000001 111.201 -175.776 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' F' F ' 68' ' ' LEU . . . . . . . . . . . . . 8.2 mp -106.46 130.29 54.28 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 115.902 -0.59 . . . . 10.039999999999999 110.664 178.796 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' F' F ' 69' ' ' VAL . . . . . . . . . . . . . 45.8 t -101.75 138.26 26.6 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.287 0 CA-C-N 115.977 -0.556 . . . . 8.5999999999999996 109.896 178.574 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' F' F ' 70' ' ' THR . . . . . . . . . . . . . 21.7 p -131.69 -46.3 0.96 Allowed 'General case' 0 C--N 1.331 -0.231 0 CA-C-N 116.503 -0.317 . . . . 6.6500000000000004 110.966 -178.272 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' F' F ' 71' ' ' HIS . . . . . . . . . . . . . 51.3 m-70 -134.42 154.65 79.92 Favored Pre-proline 0 C--N 1.33 -0.258 0 CA-C-N 116.686 -0.234 . . . . 8.0500000000000007 110.802 -179.157 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' F' F ' 72' ' ' PRO . . . . . . . . . . . . . 59.5 Cg_endo -74.99 -29.97 7.66 Favored 'Trans proline' 0 N--CA 1.495 1.577 0 C-N-CA 121.356 1.371 . . . . 3.9399999999999999 112.608 -179.888 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' F' F ' 73' ' ' VAL . . . . . . . . . . . . . 33.4 m -132.99 168.62 23.82 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.192 0 CA-C-O 120.88 0.371 . . . . 1.3999999999999999 110.737 179.815 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' F' F ' 74' ' ' ASP . . . . . . . . . . . . . 2.5 t70 -101.35 127.96 47.74 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 115.954 -0.567 . . . . 1.0600000000000001 109.947 179.825 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' F' F ' 75' ' ' VAL . . . . . . . . . . . . . 42.2 t -119.59 124.31 72.68 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.277 0 CA-C-O 120.935 0.398 . . . . 1.25 110.607 -178.273 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' F' F ' 76' ' ' LEU . . . . . . . . . . . . . 5.8 mp -122.48 140.72 52.42 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 115.825 -0.625 . . . . 1.6000000000000001 109.79 175.689 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' F' F ' 77' ' ' GLU . . . . . . . . . . . . . 98.2 mt-10 -133.69 140.75 47.23 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-O 121.075 0.464 . . . . 1.24 111.324 -178.442 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' F' F ' 78' ' ' ALA . . . . . . . . . . . . . . . -130.9 130.2 43.21 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 115.8 -0.636 . . . . 1.22 109.971 176.326 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' F' F ' 79' ' ' LYS . . . . . . . . . . . . . 35.5 mmtt -76.55 119.43 20.37 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-O 121.05 0.452 . . . . 3.3999999999999999 110.847 179.334 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' F' F ' 80' ' ' ILE . . . . . . . . . . . . . 41.1 mm -139.26 100.86 1.45 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.285 0 N-CA-C 108.814 -0.81 . . . . 1.3200000000000001 108.814 -179.093 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' F' F ' 81' ' ' LYS . . . . . . . . . . . . . 81.3 tttt -91.41 127.5 36.88 Favored 'General case' 0 C--N 1.327 -0.388 0 C-N-CA 120.804 -0.358 . . . . 3.6000000000000001 111.085 -174.967 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' F' F ' 82' ' ' GLY . . . . . . . . . . . . . . . 89.16 42.16 5.66 Favored Glycine 0 CA--C 1.525 0.715 0 C-N-CA 120.772 -0.728 . . . . 0.68000000000000005 111.974 174.961 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' F' F ' 83' ' ' ILE . . . . . . . . . . . . . 70.4 mt -72.78 138.02 22.28 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.241 0 N-CA-C 109.611 -0.514 . . . . 1.1899999999999999 109.611 175.802 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' F' F ' 84' ' ' LYS . . . . . . . . . . . . . 55.7 tttp -97.89 -53.99 3.23 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.13 -0.486 . . . . 2.1099999999999999 110.377 -178.325 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' F' F ' 85' ' ' ASP . . . . . . . . . . . . . 22.5 t70 -148.88 148.5 29.93 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 115.92 -0.582 . . . . 0.75 110.54 -177.381 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' F' F ' 86' ' ' VAL . . . . . . . . . . . . . 43.8 t -129.77 130.25 66.58 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.259 0 CA-C-O 120.924 0.393 . . . . 1.1699999999999999 110.49 -179.518 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' F' F ' 87' ' ' ILE . . . . . . . . . . . . . 5.1 mp -115.59 125.66 72.86 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.283 0 CA-C-N 115.8 -0.636 . . . . 2.0 109.352 176.51 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' F' F ' 88' ' ' LEU . . . . . . . . . . . . . 18.1 tp -111.49 131.2 55.39 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-O 121.056 0.455 . . . . 2.3100000000000001 111.297 -176.465 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' F' F ' 89' ' ' ASP . . . . . . . . . . . . . 31.4 t0 -130.99 153.97 48.66 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 115.718 -0.674 . . . . 0.82999999999999996 109.546 176.225 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' F' F ' 90' ' ' GLU . . . . . . . . . . . . . 95.9 mt-10 -49.34 -37.98 26.49 Favored 'General case' 0 C--N 1.328 -0.331 0 N-CA-C 112.749 0.648 . . . . 2.21 112.749 -171.959 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' F' F ' 91' ' ' ASN . . . . . . . . . . . . . 25.6 m120 -122.57 14.54 10.23 Favored 'General case' 0 N--CA 1.469 0.5 0 N-CA-C 113.193 0.812 . . . . 2.8300000000000001 113.193 -176.84 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' F' F ' 92' ' ' LEU . . . . . . . . . . . . . 49.0 mt -148.74 141.52 24.6 Favored 'General case' 0 C--N 1.332 -0.195 0 CA-C-O 120.838 0.351 . . . . 2.1000000000000001 110.516 -175.919 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' F' F ' 93' ' ' ILE . . . . . . . . . . . . . 73.2 mt -124.65 116.17 46.63 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.37 0 N-CA-C 109.063 -0.717 . . . . 1.1299999999999999 109.063 176.256 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' F' F ' 94' ' ' VAL . . . . . . . . . . . . . 45.0 t -117.36 125.16 73.84 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.249 0 N-CA-C 109.907 -0.405 . . . . 1.1299999999999999 109.907 -178.439 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' F' F ' 95' ' ' VAL . . . . . . . . . . . . . 42.2 t -120.84 133.41 67.6 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.344 0 CA-C-N 116.055 -0.52 . . . . 1.1499999999999999 109.766 -179.739 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' F' F ' 96' ' ' ILE . . . . . . . . . . . . . 59.1 mt -114.01 128.11 71.12 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.297 0 N-CA-C 109.124 -0.695 . . . . 1.2 109.124 178.353 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' F' F ' 97' ' ' THR . . . . . . . . . . . . . 62.7 p -101.1 161.37 13.65 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-O 121.034 0.445 . . . . 1.1599999999999999 110.999 -177.65 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' F' F ' 98' ' ' GLU . . . . . . . . . . . . . 97.3 mt-10 -54.03 -26.09 24.71 Favored 'General case' 0 CA--C 1.532 0.284 0 N-CA-C 112.345 0.498 . . . . 2.4700000000000002 112.345 179.958 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' F' F ' 99' ' ' GLU . . . . . . . . . . . . . 95.1 mt-10 -77.69 13.08 1.4 Allowed 'General case' 0 CA--C 1.535 0.384 0 N-CA-C 113.24 0.829 . . . . 2.0600000000000001 113.24 -177.748 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' F' F ' 100' ' ' ASN . . . . . . . . . . . . . 2.9 m-20 61.23 37.61 17.22 Favored 'General case' 0 CA--C 1.529 0.169 0 CA-C-O 121.106 0.479 . . . . 0.73999999999999999 110.955 179.442 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' F' F ' 101' ' ' GLU . . . . . . . . . . . . . 84.0 tt0 -115.93 144.72 43.67 Favored 'General case' 0 C--N 1.334 -0.108 0 CA-C-N 116.062 -0.517 . . . . 0.54000000000000004 109.606 176.182 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' F' F ' 102' ' ' VAL . . . . . . . . . . . . . 45.5 t -114.97 125.35 72.27 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.261 0 CA-C-N 116.291 -0.413 . . . . 1.1599999999999999 109.963 -178.092 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' F' F ' 103' ' ' LEU . . . . . . . . . . . . . 26.4 mt -113.44 128.84 56.59 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 115.621 -0.718 . . . . 1.55 109.909 175.883 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' F' F ' 104' ' ' ILE . . . . . . . . . . . . . 65.3 mt -118.42 119.16 60.37 Favored 'Isoleucine or valine' 0 C--O 1.233 0.229 0 N-CA-C 110.308 -0.256 . . . . 1.2 110.308 -179.25 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' F' F ' 105' ' ' PHE . . . . . . . . . . . . . 49.0 m-85 -118.99 169.45 9.89 Favored 'General case' 0 C--N 1.332 -0.157 0 CA-C-N 115.423 -0.808 . . . . 0.54000000000000004 109.71 177.152 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' F' F ' 106' ' ' ASN . . . . . . . . . . . . . 51.2 p-10 -102.03 -170.15 1.78 Allowed 'General case' 0 C--N 1.33 -0.277 0 N-CA-C 109.886 -0.413 . . . . 0.64000000000000001 109.886 172.987 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' F' F ' 107' ' ' GLN . . . . . . . . . . . . . 48.5 tt0 -59.79 -29.96 68.58 Favored 'General case' 0 C--N 1.33 -0.264 0 N-CA-C 111.766 0.284 . . . . 1.6899999999999999 111.766 178.535 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' F' F ' 108' ' ' ASN . . . . . . . . . . . . . 3.6 t-20 -81.9 9.88 7.39 Favored 'General case' 0 CA--C 1.537 0.459 0 N-CA-C 112.976 0.732 . . . . 1.9399999999999999 112.976 -178.496 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' F' F ' 109' ' ' LEU . . . . . . . . . . . . . 8.1 tp 58.12 36.38 25.85 Favored 'General case' 0 CA--C 1.529 0.164 0 CA-C-O 120.874 0.369 . . . . 1.98 111.461 177.9 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' F' F ' 110' ' ' GLU . . . . . . . . . . . . . 47.2 mt-10 -105.1 151.22 24.28 Favored 'General case' 0 C--N 1.33 -0.241 0 N-CA-C 109.781 -0.451 . . . . 1.71 109.781 176.67 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' F' F ' 111' ' ' GLU . . . . . . . . . . . . . 83.1 tt0 -83.92 121.92 28.03 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-O 120.858 0.361 . . . . 1.71 110.73 -176.634 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' F' F ' 112' ' ' LEU . . . . . . . . . . . . . 37.4 mt -107.77 -46.2 3.85 Favored 'General case' 0 C--N 1.332 -0.181 0 CA-C-N 116.112 -0.494 . . . . 1.27 110.809 179.241 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' F' F ' 113' ' ' TYR . . . . . . . . . . . . . 42.9 t80 -138.82 139.66 38.27 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-N 116.385 -0.37 . . . . 1.03 111.377 -178.249 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' F' F ' 114' ' ' ARG . . . . . . . . . . . . . 23.7 ttp-105 -136.15 123.75 22.29 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 115.913 -0.585 . . . . 2.9300000000000002 110.167 176.234 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' F' F ' 115' ' ' GLY . . . . . . . . . . . . . . . -150.06 155.4 26.22 Favored Glycine 0 CA--C 1.521 0.446 0 N-CA-C 110.855 -0.898 . . . . 0.56000000000000005 110.855 178.677 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' F' F ' 116' ' ' LYS . . . . . . . . . . . . . 33.9 ttmt -127.44 137.78 52.8 Favored 'General case' 0 C--N 1.329 -0.284 0 N-CA-C 109.925 -0.398 . . . . 2.1000000000000001 109.925 177.009 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' F' F ' 117' ' ' PHE . . . . . . . . . . . . . 31.9 m-85 -137.42 114.51 10.77 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.254 -0.43 . . . . 0.58999999999999997 109.932 -176.002 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' F' F ' 118' ' ' GLU . . . . . . . . . . . . . 84.4 tt0 -53.77 -42.36 68.16 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.557 -0.292 . . . . 2.71 111.349 -177.134 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' F' F ' 119' ' ' ASN . . . . . . . . . . . . . 30.8 m-80 -99.51 31.14 3.26 Favored 'General case' 0 C--N 1.33 -0.272 0 N-CA-C 112.075 0.398 . . . . 1.9199999999999999 112.075 -175.062 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' F' F ' 120' ' ' LEU . . . . . . . . . . . . . 25.8 tp -58.53 119.94 7.94 Favored 'General case' 0 C--N 1.332 -0.171 0 N-CA-C 110.033 -0.358 . . . . 1.1299999999999999 110.033 178.34 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' F' F ' 121' ' ' ASN . . . . . . . . . . . . . 48.3 t30 -114.16 -43.98 3.18 Favored 'General case' 0 C--N 1.332 -0.173 0 CA-C-N 116.372 -0.376 . . . . 1.96 110.909 -178.146 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' F' F ' 122' ' ' LYS . . . . . . . . . . . . . 57.1 mttm -141.62 146.81 36.66 Favored 'General case' 0 C--N 1.331 -0.227 0 CA-C-O 121.111 0.481 . . . . 2.4700000000000002 111.577 -176.011 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' F' F ' 123' ' ' VAL . . . . . . . . . . . . . 46.7 t -130.12 129.53 65.47 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.307 0 N-CA-C 109.177 -0.675 . . . . 1.1599999999999999 109.177 173.82 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' F' F ' 124' ' ' LEU . . . . . . . . . . . . . 81.8 mt -130.95 139.81 50.09 Favored 'General case' 0 C--N 1.332 -0.192 0 CA-C-O 121.086 0.469 . . . . 2.1299999999999999 111.322 -175.613 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' F' F ' 125' ' ' VAL . . . . . . . . . . . . . 35.8 m -128.0 131.54 69.43 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.216 0 CA-C-N 115.696 -0.683 . . . . 2.23 110.213 177.689 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' F' F ' 126' ' ' ARG . . . . . . . . . . . . . 77.6 mtt180 -147.39 124.29 11.3 Favored 'General case' 0 C--N 1.327 -0.372 0 N-CA-C 109.656 -0.498 . . . . 3.7799999999999998 109.656 178.639 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' F' F ' 127' ' ' ASN . . . . . . . . . . . . . 18.4 t30 56.85 -152.3 0.39 Allowed 'General case' 0 CA--C 1.54 0.565 0 N-CA-C 109.57 -0.53 . . . . 2.7400000000000002 109.57 -178.828 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' F' F ' 128' ' ' ASP . . . . . . . . . . . . . 20.7 p-10 -81.13 14.65 2.22 Favored 'General case' 0 CA--C 1.537 0.46 0 N-CA-C 112.772 0.656 . . . . 1.0700000000000001 112.772 178.235 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' F' F ' 129' ' ' LEU . . . . . . . . . . . . . 16.5 tp -114.33 137.24 52.06 Favored 'General case' 0 C--O 1.232 0.166 0 O-C-N 122.027 -0.42 . . . . 2.3500000000000001 109.953 179.315 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' F' F ' 130' ' ' VAL . . . . . . . . . . . . . 12.3 p -130.22 141.81 45.39 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.268 0 CA-C-O 120.842 0.353 . . . . 1.9199999999999999 110.528 -178.18 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' F' F ' 131' ' ' VAL . . . . . . . . . . . . . 14.7 p -136.17 143.01 37.1 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.207 0 CA-C-O 121.063 0.458 . . . . 1.54 111.386 -179.584 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' F' F ' 132' ' ' ILE . . . . . . . . . . . . . 70.2 mt -116.15 132.68 64.97 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.32 0 CA-C-N 115.577 -0.738 . . . . 1.1399999999999999 109.044 176.188 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' F' F ' 133' ' ' ILE . . . . . . . . . . . . . 37.3 mm -116.05 121.75 68.12 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.296 0 CA-C-O 120.785 0.326 . . . . 1.1499999999999999 111.386 -173.601 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' F' F ' 134' ' ' ASP . . . . . . . . . . . . . 2.8 p30 -130.68 148.64 52.49 Favored 'General case' 0 C--N 1.331 -0.219 0 N-CA-C 109.534 -0.543 . . . . 0.51000000000000001 109.534 174.294 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' F' F ' 135' ' ' GLU . . . . . . . . . . . . . 84.4 tt0 -50.96 -27.53 7.86 Favored 'General case' 0 C--N 1.326 -0.424 0 N-CA-C 112.955 0.724 . . . . 1.8300000000000001 112.955 -171.939 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' F' F ' 136' ' ' GLN . . . . . . . . . . . . . 98.1 mt-30 -86.18 -27.82 24.31 Favored 'General case' 0 C--O 1.234 0.24 0 N-CA-C 112.845 0.683 . . . . 2.21 112.845 -175.251 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' F' F ' 137' ' ' LYS . . . . . . . . . . . . . 33.2 pttt -170.01 172.72 6.35 Favored 'General case' 0 C--N 1.331 -0.208 0 CA-C-O 121.588 0.708 . . . . 2.2599999999999998 112.378 -173.178 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' F' F ' 138' ' ' LEU . . . . . . . . . . . . . 7.1 tt -120.06 130.17 54.56 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 114.998 -1.001 . . . . 1.4199999999999999 110.048 -179.428 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' F' F ' 139' ' ' THR . . . . . . . . . . . . . 46.5 m -108.51 120.59 42.88 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 116.207 -0.451 . . . . 1.1499999999999999 109.92 177.786 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' F' F ' 140' ' ' LEU . . . . . . . . . . . . . 17.6 tp -109.71 125.85 53.08 Favored 'General case' 0 C--N 1.329 -0.291 0 N-CA-C 109.31 -0.626 . . . . 1.8300000000000001 109.31 -178.015 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' F' F ' 141' ' ' ILE . . . . . . . . . . . . . 19.4 mt -123.46 122.76 65.89 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.275 0 CA-C-O 120.843 0.354 . . . . 1.1799999999999999 110.19 -172.918 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' F' F ' 142' ' ' ARG . . . . . . . . . . . . . 80.6 mtp180 -108.04 126.64 52.97 Favored 'General case' 0 C--N 1.331 -0.219 0 CA-C-N 115.491 -0.777 . . . . 4.4199999999999999 110.269 -179.466 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' F' F ' 143' ' ' THR . . . . . . . . . . . . . 66.5 p . . . . . 0 C--O 1.22 -0.472 0 CA-C-O 118.09 -0.957 . . . . 1.6100000000000001 110.493 179.749 . . . . . . . . 0 0 . 1 . 002 nuclear orig full ' A' A ' -3' ' ' GLU . . . . . . . . . . . . . 84.8 tt0 . . . . . 0 N--CA 1.49 1.551 0 N-CA-C 109.297 -0.631 . . . . 0.0 109.297 . . . . . . . . . 0 0 . 1 . 002 nuclear orig full ' A' A ' -2' ' ' GLY . . . . . . . . . . . . . . . -81.47 135.23 14.13 Favored Glycine 0 CA--C 1.525 0.664 0 N-CA-C 111.102 -0.799 . . . . 0.0 111.102 -179.437 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' -1' ' ' VAL . . . . . . . . . . . . . 46.7 t -96.01 129.43 46.1 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.285 0 N-CA-C 109.898 -0.408 . . . . 0.0 109.898 178.938 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 0' ' ' ILE . . . . . . . . . . . . . 73.7 mt -114.28 128.17 71.41 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.243 0 CA-C-N 116.241 -0.436 . . . . 0.0 109.995 -179.137 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 25.5 ptp -85.36 140.3 30.88 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.142 -0.481 . . . . 0.0 110.924 -178.679 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 2.8 p -117.6 139.24 51.24 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-N 116.047 -0.524 . . . . 0.0 110.479 179.359 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 84.4 tt0 -140.17 143.36 36.08 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.187 -0.46 . . . . 0.0 110.988 -178.721 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 4' ' ' LEU . . . . . . . . . . . . . 4.9 tt -127.88 127.24 43.06 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 115.864 -0.607 . . . . 0.0 109.997 177.964 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 5' ' ' LYS . . . . . . . . . . . . . 98.0 mttt -108.7 122.8 47.87 Favored 'General case' 0 C--O 1.234 0.249 0 CA-C-O 120.771 0.32 . . . . 0.0 110.909 -179.586 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 22.4 mt -113.99 150.06 34.4 Favored 'General case' 0 C--N 1.332 -0.177 0 CA-C-N 115.393 -0.821 . . . . 0.0 110.065 179.552 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 61.0 tttt -137.95 137.2 20.8 Favored Pre-proline 0 CA--C 1.535 0.377 0 CA-C-O 118.942 -0.552 . . . . 0.0 110.007 175.852 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 8' ' ' PRO . . . . . . . . . . . . . 85.9 Cg_endo -87.61 141.7 5.66 Favored 'Trans proline' 0 N--CA 1.492 1.386 0 C-N-CA 121.541 1.494 . . . . 0.0 111.792 177.575 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 46.7 mt -78.23 -47.07 2.11 Favored Pre-proline 0 CA--C 1.533 0.305 0 CA-C-O 118.745 -0.645 . . . . 0.0 112.275 -179.118 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 92.4 Cg_endo -81.98 153.9 17.05 Favored 'Trans proline' 0 N--CA 1.496 1.655 0 C-N-CA 121.269 1.313 . . . . 0.0 111.901 175.353 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 59.8 mttp -89.38 99.93 12.83 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.458 -0.337 . . . . 0.0 110.82 179.513 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 12.0 p -145.76 143.08 21.78 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.268 0 CA-C-N 116.236 -0.438 . . . . 0.0 110.493 179.198 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 43.9 mp0 -79.88 125.87 30.27 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.379 -0.373 . . . . 0.0 110.148 177.687 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 14' ' ' LEU . . . . . . . . . . . . . 29.5 mt -97.89 154.59 37.75 Favored Pre-proline 0 C--N 1.329 -0.284 0 CA-C-N 116.487 -0.324 . . . . 0.0 111.02 -177.651 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 15' ' ' PRO . . . . . . . . . . . . . 35.4 Cg_exo -59.88 160.6 21.17 Favored 'Trans proline' 0 N--CA 1.497 1.686 0 C-N-CA 121.364 1.376 . . . . 0.0 111.872 177.957 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 16' ' ' PRO . . . . . . . . . . . . . 25.7 Cg_exo -61.33 -43.19 29.74 Favored 'Trans proline' 0 N--CA 1.497 1.686 0 C-N-CA 121.571 1.514 . . . . 0.0 112.571 -179.031 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 17' ' ' ASP . . . . . . . . . . . . . 17.9 p-10 -88.34 17.0 5.57 Favored 'General case' 0 CA--C 1.535 0.371 0 N-CA-C 112.953 0.723 . . . . 0.0 112.953 -177.219 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 18' ' ' PHE . . . . . . . . . . . . . 42.7 t80 -58.27 -45.87 87.07 Favored 'General case' 0 C--N 1.334 -0.087 0 O-C-N 122.142 -0.349 . . . . 0.0 110.081 -178.489 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 19' ' ' VAL . . . . . . . . . . . . . 13.3 p -55.59 -39.69 55.72 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 CA-C-N 116.423 -0.353 . . . . 0.0 110.937 -179.532 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 77.5 m-20 -60.42 -46.65 89.27 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-O 120.926 0.393 . . . . 0.0 110.876 -178.378 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 46.4 t -64.27 -47.25 90.59 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.347 0 CA-C-N 116.365 -0.38 . . . . 0.0 110.561 -177.229 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 22' ' ' ILE . . . . . . . . . . . . . 50.9 mm -56.36 -45.33 81.5 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.218 0 C-N-CA 120.947 -0.301 . . . . 0.0 110.58 179.335 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 23' ' ' ARG . . . . . . . . . . . . . 59.2 ttp180 -54.24 -46.5 72.57 Favored 'General case' 0 C--N 1.33 -0.27 0 C-N-CA 121.164 -0.215 . . . . 0.0 111.366 -179.062 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 24' ' ' ILE . . . . . . . . . . . . . 74.7 mt -58.91 -45.09 92.03 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 C-N-CA 121.137 -0.225 . . . . 0.0 111.057 -179.467 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 93.8 mttt -65.22 -40.66 94.39 Favored 'General case' 0 C--N 1.329 -0.302 0 N-CA-C 112.352 0.501 . . . . 0.0 112.352 -177.89 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 80.1 mt -79.64 -42.19 25.37 Favored 'General case' 0 C--N 1.33 -0.274 0 N-CA-C 112.898 0.703 . . . . 0.0 112.898 -171.575 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 27' ' ' GLN . . . . . . . . . . . . . 9.8 pt20 -46.05 139.51 4.41 Favored 'General case' 0 N--CA 1.469 0.49 0 N-CA-C 112.79 0.663 . . . . 0.0 112.79 -175.292 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 101.33 -28.61 15.21 Favored Glycine 0 CA--C 1.531 1.058 0 CA-C-N 115.483 -0.781 . . . . 0.0 111.973 -176.779 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 90.4 mttt -98.16 155.23 17.26 Favored 'General case' 0 C--O 1.233 0.203 0 CA-C-N 117.267 0.533 . . . . 0.0 111.055 178.452 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 30' ' ' THR . . . . . . . . . . . . . 38.0 m -101.6 138.36 38.69 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.235 -0.438 . . . . 0.0 109.831 175.026 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 34.5 m -126.31 156.45 36.8 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.191 0 CA-C-N 116.45 -0.341 . . . . 0.0 110.675 -178.822 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 32' ' ' ARG . . . . . . . . . . . . . 90.4 mtt180 -132.93 150.39 52.16 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.0 -0.545 . . . . 0.0 110.683 178.858 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 33' ' ' THR . . . . . . . . . . . . . 24.5 m -52.5 139.07 26.24 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.177 -0.465 . . . . 0.0 111.453 -178.643 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 99.47 -17.14 58.13 Favored Glycine 0 CA--C 1.533 1.175 0 CA-C-O 119.631 -0.538 . . . . 0.0 113.29 178.598 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 74.7 m-20 -65.6 148.72 51.27 Favored 'General case' 0 C--N 1.334 -0.073 0 CA-C-N 118.081 0.941 . . . . 0.0 110.954 179.463 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 46.9 t -123.13 130.1 74.58 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.249 0 CA-C-N 115.87 -0.605 . . . . 0.0 109.797 178.241 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 37' ' ' ILE . . . . . . . . . . . . . 63.3 mt -117.57 137.97 49.76 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.275 0 N-CA-C 109.844 -0.428 . . . . 0.0 109.844 -179.742 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . -108.3 128.75 9.25 Favored Glycine 0 CA--C 1.525 0.701 0 N-CA-C 110.957 -0.857 . . . . 0.0 110.957 179.885 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 39' ' ' ILE . . . . . . . . . . . . . 75.8 mt -127.02 135.51 63.41 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.244 0 N-CA-C 110.12 -0.326 . . . . 0.0 110.12 179.4 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 40' ' ' SER . . . . . . . . . . . . . 11.1 p -92.04 115.15 27.82 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.218 -0.447 . . . . 0.0 110.751 176.085 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 41' ' ' ILE . . . . . . . . . . . . . 43.7 mm -120.82 116.78 50.98 Favored 'Isoleucine or valine' 0 N--CA 1.462 0.171 0 CA-C-O 120.772 0.32 . . . . 0.0 110.498 -179.81 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 6.8 mp 50.9 37.12 16.51 Favored 'General case' 0 C--N 1.331 -0.219 0 CA-C-O 121.081 0.467 . . . . 0.0 111.656 177.301 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . 75.16 30.71 58.52 Favored Glycine 0 CA--C 1.528 0.886 0 C-N-CA 121.072 -0.585 . . . . 0.0 112.345 176.67 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 44' ' ' LYS . . . . . . . . . . . . . 16.5 ttmm -136.04 132.69 36.56 Favored 'General case' 0 C--N 1.33 -0.274 0 N-CA-C 109.861 -0.422 . . . . 0.0 109.861 176.652 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 79.0 tt0 -81.79 113.34 19.68 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.408 -0.36 . . . . 0.0 110.747 -178.844 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 46' ' ' VAL . . . . . . . . . . . . . 7.3 p -116.01 125.92 73.31 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.195 0 N-CA-C 109.628 -0.508 . . . . 0.0 109.628 177.936 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 97.1 mttt -100.48 130.0 46.5 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 115.965 -0.561 . . . . 0.0 111.287 178.445 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 48' ' ' PHE . . . . . . . . . . . . . 80.7 m-85 -111.2 131.95 54.71 Favored 'General case' 0 C--N 1.329 -0.296 0 N-CA-C 109.749 -0.463 . . . . 0.0 109.749 175.902 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 85.5 tttt -107.04 137.01 45.92 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.288 -0.415 . . . . 0.0 110.674 -179.172 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 50' ' ' VAL . . . . . . . . . . . . . 42.9 t -81.26 108.78 14.86 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.262 0 N-CA-C 109.462 -0.57 . . . . 0.0 109.462 176.094 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 51' ' ' VAL . . . . . . . . . . . . . 45.2 t -70.2 -49.29 55.97 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.288 0 CA-C-N 115.971 -0.559 . . . . 0.0 109.924 -174.116 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 52' ' ' GLN . . . . . . . . . . . . . 46.6 tt0 -168.13 142.5 3.45 Favored 'General case' 0 C--N 1.33 -0.273 0 C-N-CA 120.082 -0.647 . . . . 0.0 112.009 -177.378 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -113.08 133.39 55.02 Favored 'General case' 0 C--N 1.331 -0.215 0 CA-C-N 115.395 -0.82 . . . . 0.0 109.81 175.496 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 54' ' ' TYR . . . . . . . . . . . . . 50.5 t80 -129.03 107.29 18.02 Favored Pre-proline 0 CA--C 1.534 0.351 0 CA-C-O 118.314 -0.85 . . . . 0.0 110.41 179.709 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 55' ' ' PRO . . . . . . . . . . . . . 72.6 Cg_endo -77.14 169.19 74.92 Favored 'Cis proline' 0 N--CA 1.5 1.884 0 CA-C-N 121.764 1.666 . . . . 0.0 112.291 -4.827 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 56' ' ' SER . . . . . . . . . . . . . 74.7 m -117.3 137.31 23.9 Favored Pre-proline 0 CA--C 1.538 0.49 0 CA-C-O 118.494 -0.765 . . . . 0.0 109.691 175.114 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 57' ' ' PRO . . . . . . . . . . . . . 36.5 Cg_endo -66.72 161.66 75.03 Favored 'Cis proline' 0 N--CA 1.499 1.797 0 CA-C-N 121.746 1.659 . . . . 0.0 111.388 -3.385 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 58' ' ' LEU . . . . . . . . . . . . . 28.8 tp -130.03 137.29 50.18 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-O 120.945 0.403 . . . . 0.0 110.676 -178.785 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 59' ' ' ARG . . . . . . . . . . . . . 73.8 ttt180 -99.11 135.4 40.56 Favored 'General case' 0 C--N 1.327 -0.394 0 N-CA-C 109.513 -0.551 . . . . 0.0 109.513 175.395 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 40.3 t -84.93 116.33 28.28 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.287 0 C-N-CA 120.652 -0.419 . . . . 0.0 110.453 -177.398 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 34.6 tp10 -131.03 155.49 46.78 Favored 'General case' 0 C--N 1.329 -0.288 0 N-CA-C 109.088 -0.708 . . . . 0.0 109.088 177.138 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 62' ' ' ASP . . . . . . . . . . . . . 77.4 m-20 -51.68 -32.26 29.15 Favored 'General case' 0 C--N 1.326 -0.438 0 N-CA-C 112.134 0.42 . . . . 0.0 112.134 -175.787 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 63' ' ' ARG . . . . . . . . . . . . . 34.5 mmt180 -74.48 -21.61 59.49 Favored 'General case' 0 C--N 1.33 -0.281 0 N-CA-C 113.022 0.749 . . . . 0.0 113.022 -175.447 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 20.8 m -63.29 141.44 58.76 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-O 120.849 0.357 . . . . 0.0 110.824 -176.148 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 65' ' ' LYS . . . . . . . . . . . . . 94.4 mttt -84.06 123.96 30.59 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.191 -0.459 . . . . 0.0 109.796 178.013 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 66' ' ' ILE . . . . . . . . . . . . . 54.9 mt -113.83 129.7 69.25 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.247 0 N-CA-C 109.994 -0.373 . . . . 0.0 109.994 -178.803 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 67' ' ' THR . . . . . . . . . . . . . 12.0 m -125.16 136.63 53.78 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-N 116.234 -0.439 . . . . 0.0 110.736 -179.058 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 68' ' ' LEU . . . . . . . . . . . . . 7.4 mp -108.27 123.1 48.27 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-N 116.04 -0.527 . . . . 0.0 110.906 179.397 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 69' ' ' VAL . . . . . . . . . . . . . 45.5 t -101.67 139.06 23.79 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.344 0 N-CA-C 109.394 -0.595 . . . . 0.0 109.394 176.959 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 70' ' ' THR . . . . . . . . . . . . . 4.5 t -133.4 -53.24 0.89 Allowed 'General case' 0 N--CA 1.463 0.213 0 N-CA-C 112.062 0.393 . . . . 0.0 112.062 -176.248 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 71' ' ' HIS . . . . . . . . . . . . . 32.0 m80 -150.03 93.39 3.92 Favored Pre-proline 0 CA--C 1.531 0.244 0 C-N-CA 120.562 -0.455 . . . . 0.0 111.993 -174.571 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 72' ' ' PRO . . . . . . . . . . . . . 57.1 Cg_endo -75.19 -30.06 7.29 Favored 'Trans proline' 0 N--CA 1.495 1.583 0 C-N-CA 121.154 1.236 . . . . 0.0 111.869 170.039 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 73' ' ' VAL . . . . . . . . . . . . . 32.0 m -144.36 179.7 1.31 Allowed 'Isoleucine or valine' 0 C--N 1.332 -0.182 0 N-CA-C 109.322 -0.621 . . . . 0.0 109.322 174.483 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 74' ' ' ASP . . . . . . . . . . . . . 15.9 t0 -99.08 115.34 28.78 Favored 'General case' 0 C--N 1.331 -0.215 0 N-CA-C 109.93 -0.396 . . . . 0.0 109.93 179.929 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 40.9 t -112.98 122.52 67.28 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.271 0 CA-C-O 121.164 0.507 . . . . 0.0 110.432 -178.877 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 76' ' ' LEU . . . . . . . . . . . . . 23.4 mt -119.77 140.52 50.61 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 115.507 -0.77 . . . . 0.0 109.242 178.44 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 77' ' ' GLU . . . . . . . . . . . . . 98.4 mt-10 -136.18 136.96 40.42 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-O 121.102 0.477 . . . . 0.0 111.492 -177.204 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 78' ' ' ALA . . . . . . . . . . . . . . . -125.76 136.15 52.84 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 115.554 -0.748 . . . . 0.0 109.947 176.842 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 79' ' ' LYS . . . . . . . . . . . . . 43.3 mmtm -81.52 113.62 19.69 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.405 -0.361 . . . . 0.0 110.562 -179.48 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 80' ' ' ILE . . . . . . . . . . . . . 28.5 mm -139.22 104.12 2.09 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.355 0 N-CA-C 109.26 -0.644 . . . . 0.0 109.26 -179.633 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 81' ' ' LYS . . . . . . . . . . . . . 60.4 mtpt -99.71 131.42 45.71 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-O 120.851 0.357 . . . . 0.0 110.81 -177.307 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . 89.2 42.07 5.67 Favored Glycine 0 CA--C 1.525 0.707 0 N-CA-C 111.194 -0.762 . . . . 0.0 111.194 178.34 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 83' ' ' ILE . . . . . . . . . . . . . 70.1 mt -71.08 137.54 23.59 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.308 0 N-CA-C 109.486 -0.561 . . . . 0.0 109.486 176.801 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 84' ' ' LYS . . . . . . . . . . . . . 38.1 ttpt -98.91 -52.62 3.51 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-O 120.843 0.354 . . . . 0.0 110.379 -178.687 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 85' ' ' ASP . . . . . . . . . . . . . 12.6 t70 -151.76 153.16 33.77 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.039 -0.528 . . . . 0.0 110.692 -179.167 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 86' ' ' VAL . . . . . . . . . . . . . 41.9 t -131.4 132.97 62.59 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.248 0 CA-C-O 120.964 0.412 . . . . 0.0 110.421 -178.763 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 87' ' ' ILE . . . . . . . . . . . . . 5.1 mp -122.31 129.66 75.13 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.225 0 CA-C-N 115.819 -0.628 . . . . 0.0 109.358 177.351 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 88' ' ' LEU . . . . . . . . . . . . . 25.5 tp -116.28 132.52 56.64 Favored 'General case' 0 C--N 1.331 -0.219 0 CA-C-O 120.995 0.426 . . . . 0.0 111.433 -176.4 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 89' ' ' ASP . . . . . . . . . . . . . 13.4 t70 -127.04 154.84 44.14 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 115.764 -0.653 . . . . 0.0 109.511 175.668 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 96.1 mt-10 -46.72 -39.36 11.42 Favored 'General case' 0 C--N 1.329 -0.288 0 N-CA-C 113.222 0.823 . . . . 0.0 113.222 -171.735 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 91' ' ' ASN . . . . . . . . . . . . . 12.8 m120 -129.56 22.25 5.52 Favored 'General case' 0 N--CA 1.469 0.496 0 N-CA-C 112.802 0.667 . . . . 0.0 112.802 -177.409 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 92' ' ' LEU . . . . . . . . . . . . . 10.1 mt -150.09 141.91 23.74 Favored 'General case' 0 C--N 1.331 -0.209 0 N-CA-C 109.564 -0.532 . . . . 0.0 109.564 -178.094 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 93' ' ' ILE . . . . . . . . . . . . . 72.2 mt -123.99 121.28 61.73 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 N-CA-C 109.412 -0.588 . . . . 0.0 109.412 178.382 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 94' ' ' VAL . . . . . . . . . . . . . 46.3 t -120.3 126.86 75.72 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.264 0 CA-C-O 120.853 0.359 . . . . 0.0 110.145 -178.215 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 95' ' ' VAL . . . . . . . . . . . . . 41.5 t -122.48 134.3 66.1 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.316 0 CA-C-N 116.001 -0.545 . . . . 0.0 109.801 -179.731 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 96' ' ' ILE . . . . . . . . . . . . . 64.4 mt -115.9 126.73 73.53 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.255 0 N-CA-C 109.405 -0.591 . . . . 0.0 109.405 179.221 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 97' ' ' THR . . . . . . . . . . . . . 70.9 p -103.26 157.34 17.08 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-O 121.356 0.598 . . . . 0.0 111.639 -175.505 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 98' ' ' GLU . . . . . . . . . . . . . 81.5 tt0 -53.96 -26.83 27.63 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 115.893 -0.594 . . . . 0.0 112.303 -178.832 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 99' ' ' GLU . . . . . . . . . . . . . 43.2 mt-10 -80.33 17.62 1.03 Allowed 'General case' 0 CA--C 1.533 0.317 0 N-CA-C 113.069 0.766 . . . . 0.0 113.069 -177.096 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 100' ' ' ASN . . . . . . . . . . . . . 3.2 m-20 61.65 37.37 16.08 Favored 'General case' 0 CA--C 1.53 0.174 0 CA-C-O 121.09 0.472 . . . . 0.0 111.014 178.292 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 101' ' ' GLU . . . . . . . . . . . . . 84.2 tt0 -113.12 143.5 44.25 Favored 'General case' 0 C--O 1.232 0.139 0 CA-C-N 116.083 -0.508 . . . . 0.0 109.966 176.52 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 102' ' ' VAL . . . . . . . . . . . . . 46.2 t -114.98 123.8 71.03 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.27 0 N-CA-C 109.658 -0.497 . . . . 0.0 109.658 -179.653 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 103' ' ' LEU . . . . . . . . . . . . . 22.4 mt -115.98 129.51 56.41 Favored 'General case' 0 C--N 1.331 -0.199 0 CA-C-N 115.696 -0.684 . . . . 0.0 110.355 178.36 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 104' ' ' ILE . . . . . . . . . . . . . 70.5 mt -118.29 120.27 63.87 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.246 0 CA-C-N 116.446 -0.343 . . . . 0.0 110.189 179.081 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 105' ' ' PHE . . . . . . . . . . . . . 57.9 m-85 -121.3 165.4 15.55 Favored 'General case' 0 C--N 1.332 -0.168 0 O-C-N 123.932 0.77 . . . . 0.0 110.155 179.478 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 106' ' ' ASN . . . . . . . . . . . . . 40.9 p-10 -96.88 -169.93 1.96 Allowed 'General case' 0 C--N 1.331 -0.205 0 N-CA-C 109.913 -0.403 . . . . 0.0 109.913 173.636 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 107' ' ' GLN . . . . . . . . . . . . . 63.3 tt0 -58.96 -30.1 67.66 Favored 'General case' 0 C--N 1.329 -0.306 0 N-CA-C 111.781 0.289 . . . . 0.0 111.781 178.38 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 108' ' ' ASN . . . . . . . . . . . . . 52.2 t30 -83.47 7.22 17.59 Favored 'General case' 0 CA--C 1.536 0.437 0 N-CA-C 113.304 0.853 . . . . 0.0 113.304 -177.698 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 109' ' ' LEU . . . . . . . . . . . . . 11.4 tp 59.6 37.24 22.65 Favored 'General case' 0 C--N 1.332 -0.165 0 CA-C-O 121.017 0.437 . . . . 0.0 111.349 178.409 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 110' ' ' GLU . . . . . . . . . . . . . 70.7 mm-40 -103.55 152.12 22.09 Favored 'General case' 0 C--N 1.331 -0.216 0 N-CA-C 109.886 -0.413 . . . . 0.0 109.886 176.019 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 111' ' ' GLU . . . . . . . . . . . . . 83.4 tt0 -79.35 121.98 25.8 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-O 120.944 0.402 . . . . 0.0 110.73 -177.598 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 112' ' ' LEU . . . . . . . . . . . . . 28.8 mt -111.32 -46.04 3.34 Favored 'General case' 0 C--N 1.331 -0.229 0 CA-C-N 116.063 -0.517 . . . . 0.0 110.145 178.1 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 113' ' ' TYR . . . . . . . . . . . . . 59.8 t80 -138.99 133.43 31.73 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-N 116.115 -0.493 . . . . 0.0 111.009 179.59 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 114' ' ' ARG . . . . . . . . . . . . . 60.1 ttp180 -137.19 122.91 19.9 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.167 -0.469 . . . . 0.0 110.179 176.692 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 115' ' ' GLY . . . . . . . . . . . . . . . -150.07 146.66 16.06 Favored Glycine 0 CA--C 1.524 0.618 0 N-CA-C 110.91 -0.876 . . . . 0.0 110.91 178.974 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 116' ' ' LYS . . . . . . . . . . . . . 14.1 ttmm -116.42 134.93 54.3 Favored 'General case' 0 C--N 1.33 -0.271 0 N-CA-C 109.932 -0.396 . . . . 0.0 109.932 178.663 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 117' ' ' PHE . . . . . . . . . . . . . 48.8 m-85 -132.55 116.92 17.32 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-O 121.01 0.433 . . . . 0.0 110.331 -176.123 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 118' ' ' GLU . . . . . . . . . . . . . 43.8 mp0 -55.22 -45.06 75.96 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 116.246 -0.434 . . . . 0.0 111.133 -175.529 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 119' ' ' ASN . . . . . . . . . . . . . 35.1 m120 -98.71 31.0 3.06 Favored 'General case' 0 C--N 1.33 -0.24 0 N-CA-C 112.208 0.447 . . . . 0.0 112.208 -174.331 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 120' ' ' LEU . . . . . . . . . . . . . 31.5 tp -56.79 121.4 9.76 Favored 'General case' 0 C--N 1.333 -0.14 0 CA-C-O 120.752 0.31 . . . . 0.0 110.471 178.028 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 121' ' ' ASN . . . . . . . . . . . . . 20.3 m120 -114.05 -44.12 3.18 Favored 'General case' 0 C--N 1.333 -0.146 0 CA-C-N 116.414 -0.357 . . . . 0.0 111.204 -177.328 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 122' ' ' LYS . . . . . . . . . . . . . 96.1 mttt -144.1 149.85 37.2 Favored 'General case' 0 C--N 1.331 -0.205 0 CA-C-O 121.01 0.433 . . . . 0.0 111.72 -175.609 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 123' ' ' VAL . . . . . . . . . . . . . 47.1 t -129.69 130.4 66.81 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.27 0 N-CA-C 109.399 -0.593 . . . . 0.0 109.399 174.658 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 124' ' ' LEU . . . . . . . . . . . . . 69.9 mt -125.07 140.04 53.25 Favored 'General case' 0 N--CA 1.464 0.267 0 CA-C-O 120.782 0.325 . . . . 0.0 111.094 -177.237 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 125' ' ' VAL . . . . . . . . . . . . . 10.4 p -132.22 131.21 60.97 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.19 0 CA-C-N 116.009 -0.541 . . . . 0.0 110.332 -179.928 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 126' ' ' ARG . . . . . . . . . . . . . 35.3 mmt180 -142.3 118.03 10.45 Favored 'General case' 0 C--N 1.332 -0.192 0 CA-C-O 120.841 0.353 . . . . 0.0 110.733 178.44 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 127' ' ' ASN . . . . . . . . . . . . . 18.3 t-20 50.07 -104.89 0.16 Allowed 'General case' 0 CA--C 1.543 0.702 0 CA-C-O 119.098 -0.477 . . . . 0.0 111.664 178.017 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 128' ' ' ASP . . . . . . . . . . . . . 22.6 p-10 -114.08 3.8 15.41 Favored 'General case' 0 CA--C 1.537 0.478 0 CA-C-N 119.562 1.074 . . . . 0.0 113.451 -176.689 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 129' ' ' LEU . . . . . . . . . . . . . 14.4 tp -110.91 139.76 45.96 Favored 'General case' 0 C--N 1.332 -0.191 0 N-CA-C 109.673 -0.491 . . . . 0.0 109.673 178.374 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 130' ' ' VAL . . . . . . . . . . . . . 30.1 m -128.64 140.75 48.4 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.226 0 CA-C-O 120.892 0.377 . . . . 0.0 110.176 178.792 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 131' ' ' VAL . . . . . . . . . . . . . 43.8 t -136.06 140.52 43.78 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 CA-C-O 121.257 0.551 . . . . 0.0 110.458 -178.754 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 132' ' ' ILE . . . . . . . . . . . . . 71.8 mt -114.87 132.17 64.88 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.336 0 CA-C-N 115.415 -0.811 . . . . 0.0 109.302 179.28 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 133' ' ' ILE . . . . . . . . . . . . . 39.0 mm -114.25 118.76 59.44 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.236 0 CA-C-N 116.53 -0.304 . . . . 0.0 110.74 -175.604 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 134' ' ' ASP . . . . . . . . . . . . . 8.1 p-10 -133.63 146.31 50.79 Favored 'General case' 0 C--N 1.33 -0.254 0 N-CA-C 109.587 -0.523 . . . . 0.0 109.587 174.95 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 135' ' ' GLU . . . . . . . . . . . . . 80.1 tt0 -49.85 -24.21 2.32 Favored 'General case' 0 C--N 1.328 -0.359 0 N-CA-C 112.782 0.66 . . . . 0.0 112.782 -172.644 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 136' ' ' GLN . . . . . . . . . . . . . 98.7 mt-30 -93.73 -35.35 12.83 Favored 'General case' 0 C--N 1.333 -0.126 0 N-CA-C 112.294 0.479 . . . . 0.0 112.294 -176.243 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 137' ' ' LYS . . . . . . . . . . . . . 88.6 mttt -142.32 153.62 44.02 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-O 121.59 0.709 . . . . 0.0 112.622 -167.788 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 138' ' ' LEU . . . . . . . . . . . . . 14.3 tp -110.7 116.87 32.06 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 114.725 -1.125 . . . . 0.0 108.76 170.725 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 139' ' ' THR . . . . . . . . . . . . . 31.7 m -107.68 121.14 44.09 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-O 120.558 0.218 . . . . 0.0 110.775 -178.165 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 140' ' ' LEU . . . . . . . . . . . . . 7.4 tt -112.85 122.83 48.82 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 115.885 -0.598 . . . . 0.0 109.426 -179.372 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 141' ' ' ILE . . . . . . . . . . . . . 18.9 mt -124.09 122.57 64.7 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.254 0 CA-C-O 121.007 0.432 . . . . 0.0 109.891 -175.863 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 142' ' ' ARG . . . . . . . . . . . . . 71.4 ttt180 -108.86 125.24 51.78 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 115.443 -0.799 . . . . 0.0 110.468 -179.196 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 143' ' ' THR . . . . . . . . . . . . . 5.6 p . . . . . 0 C--O 1.219 -0.536 0 CA-C-O 118.028 -0.986 . . . . 0.0 110.457 179.799 . . . . . . . . 0 0 . 1 . 002 nuclear orig full ' B' B ' -3' ' ' GLU . . . . . . . . . . . . . 84.8 tt0 . . . . . 0 N--CA 1.49 1.574 0 N-CA-C 109.362 -0.606 . . . . 0.0 109.362 . . . . . . . . . 0 0 . 1 . 002 nuclear orig full ' B' B ' -2' ' ' GLY . . . . . . . . . . . . . . . -71.21 144.26 37.34 Favored Glycine 0 CA--C 1.526 0.722 0 N-CA-C 111.031 -0.828 . . . . 0.0 111.031 -179.975 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' -1' ' ' VAL . . . . . . . . . . . . . 43.3 t -96.5 138.79 20.78 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.332 0 CA-C-O 120.789 0.328 . . . . 0.0 110.272 179.922 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 0' ' ' ILE . . . . . . . . . . . . . 72.3 mt -110.04 131.15 61.82 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.236 0 CA-C-N 116.214 -0.448 . . . . 0.0 109.941 179.074 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 1' ' ' MET . . . . . . . . . . . . . 25.6 ptm -80.81 136.22 36.08 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.229 -0.442 . . . . 0.0 110.626 179.62 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 2' ' ' SER . . . . . . . . . . . . . 90.2 p -126.56 153.72 44.84 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 116.155 -0.475 . . . . 0.0 110.269 179.341 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 3' ' ' GLU . . . . . . . . . . . . . 95.2 mt-10 -140.41 143.74 35.8 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.274 -0.421 . . . . 0.0 111.147 -177.712 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 4' ' ' LEU . . . . . . . . . . . . . 38.9 mt -121.32 127.01 50.88 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 115.811 -0.631 . . . . 0.0 110.037 175.939 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 5' ' ' LYS . . . . . . . . . . . . . 91.8 mttt -104.64 120.46 41.37 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.29 -0.414 . . . . 0.0 110.468 178.843 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 6' ' ' LEU . . . . . . . . . . . . . 57.8 mt -115.46 148.03 39.91 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 115.564 -0.744 . . . . 0.0 110.406 -179.171 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 7' ' ' LYS . . . . . . . . . . . . . 82.2 tttt -139.95 137.85 18.84 Favored Pre-proline 0 CA--C 1.534 0.357 0 CA-C-O 119.046 -0.502 . . . . 0.0 109.976 176.86 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 8' ' ' PRO . . . . . . . . . . . . . 98.0 Cg_endo -91.44 142.48 2.9 Favored 'Trans proline' 0 N--CA 1.49 1.295 0 C-N-CA 121.734 1.623 . . . . 0.0 111.718 177.719 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 9' ' ' LEU . . . . . . . . . . . . . 52.8 mt -79.23 -46.71 1.64 Allowed Pre-proline 0 CA--C 1.532 0.278 0 CA-C-O 118.847 -0.597 . . . . 0.0 112.105 -179.055 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 10' ' ' PRO . . . . . . . . . . . . . 65.7 Cg_endo -84.36 156.57 12.63 Favored 'Trans proline' 0 N--CA 1.496 1.663 0 C-N-CA 121.309 1.339 . . . . 0.0 111.631 174.488 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 11' ' ' LYS . . . . . . . . . . . . . 20.0 pttm -86.16 120.85 27.97 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-O 120.998 0.428 . . . . 0.0 110.045 176.494 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 12' ' ' VAL . . . . . . . . . . . . . 12.0 p -151.02 148.79 14.7 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.327 0 CA-C-N 116.081 -0.509 . . . . 0.0 110.637 -178.26 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 13' ' ' GLU . . . . . . . . . . . . . 84.7 tt0 -91.62 116.58 28.99 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.279 -0.419 . . . . 0.0 110.132 177.464 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 14' ' ' LEU . . . . . . . . . . . . . 29.5 mt -98.15 146.52 31.66 Favored Pre-proline 0 CA--C 1.532 0.287 0 CA-C-O 119.171 -0.442 . . . . 0.0 110.425 -177.491 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 15' ' ' PRO . . . . . . . . . . . . . 24.0 Cg_exo -64.01 162.18 30.3 Favored 'Trans proline' 0 N--CA 1.498 1.769 0 C-N-CA 121.335 1.357 . . . . 0.0 111.86 176.409 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 16' ' ' PRO . . . . . . . . . . . . . 27.0 Cg_exo -61.14 -35.34 86.64 Favored 'Trans proline' 0 N--CA 1.497 1.699 0 C-N-CA 121.484 1.456 . . . . 0.0 112.511 -179.585 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 17' ' ' ASP . . . . . . . . . . . . . 7.1 p-10 -85.86 6.27 28.98 Favored 'General case' 0 CA--C 1.535 0.388 0 N-CA-C 113.302 0.852 . . . . 0.0 113.302 -177.226 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 18' ' ' PHE . . . . . . . . . . . . . 51.5 t80 -57.48 -43.41 84.07 Favored 'General case' 0 C--N 1.334 -0.105 0 O-C-N 121.891 -0.506 . . . . 0.0 110.152 -179.038 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 19' ' ' VAL . . . . . . . . . . . . . 12.3 p -56.85 -41.76 76.62 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.345 0 CA-C-N 116.304 -0.407 . . . . 0.0 110.763 -179.509 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 20' ' ' ASP . . . . . . . . . . . . . 71.5 m-20 -60.68 -42.04 96.32 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-O 120.893 0.378 . . . . 0.0 110.881 -178.203 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 21' ' ' VAL . . . . . . . . . . . . . 50.6 t -64.42 -47.17 90.56 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.332 0 CA-C-N 116.314 -0.403 . . . . 0.0 110.512 -178.488 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 22' ' ' ILE . . . . . . . . . . . . . 50.5 mm -57.5 -40.21 73.43 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.281 0 C-N-CA 120.916 -0.313 . . . . 0.0 110.675 179.95 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 23' ' ' ARG . . . . . . . . . . . . . 46.4 ttp180 -55.95 -50.75 69.92 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-O 120.927 0.394 . . . . 0.0 110.774 177.571 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 24' ' ' ILE . . . . . . . . . . . . . 67.7 mt -62.17 -41.23 90.52 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.278 0 CA-C-N 116.047 -0.524 . . . . 0.0 112.078 -176.667 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 25' ' ' LYS . . . . . . . . . . . . . 14.9 pttp -73.32 -34.88 65.93 Favored 'General case' 0 CA--C 1.533 0.324 0 C-N-CA 120.687 -0.405 . . . . 0.0 111.79 -174.125 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 26' ' ' LEU . . . . . . . . . . . . . 75.6 mt -79.86 -43.09 22.94 Favored 'General case' 0 C--N 1.33 -0.255 0 N-CA-C 112.426 0.528 . . . . 0.0 112.426 -174.912 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 27' ' ' GLN . . . . . . . . . . . . . 9.6 pt20 -46.36 139.21 5.0 Favored 'General case' 0 N--CA 1.469 0.478 0 N-CA-C 112.838 0.681 . . . . 0.0 112.838 -175.554 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 28' ' ' GLY . . . . . . . . . . . . . . . 101.35 -29.53 12.32 Favored Glycine 0 CA--C 1.531 1.078 0 CA-C-N 115.355 -0.838 . . . . 0.0 112.031 -177.289 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 29' ' ' LYS . . . . . . . . . . . . . 73.7 mmtt -98.16 155.17 17.29 Favored 'General case' 0 C--N 1.332 -0.196 0 CA-C-N 117.194 0.497 . . . . 0.0 110.964 178.466 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 30' ' ' THR . . . . . . . . . . . . . 27.9 m -92.2 135.43 34.01 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.081 -0.509 . . . . 0.0 109.906 175.107 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 31' ' ' VAL . . . . . . . . . . . . . 34.9 m -122.51 145.09 29.84 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.227 0 CA-C-O 120.896 0.379 . . . . 0.0 110.57 -179.152 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 32' ' ' ARG . . . . . . . . . . . . . 73.1 ttt-85 -136.0 148.86 48.61 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 115.863 -0.608 . . . . 0.0 110.383 178.436 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 33' ' ' THR . . . . . . . . . . . . . 26.8 m -52.62 140.7 22.5 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.357 -0.383 . . . . 0.0 111.493 -178.543 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 34' ' ' GLY . . . . . . . . . . . . . . . 100.17 -17.3 57.23 Favored Glycine 0 CA--C 1.533 1.187 0 CA-C-O 119.675 -0.514 . . . . 0.0 113.159 179.678 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 35' ' ' ASP . . . . . . . . . . . . . 75.5 m-20 -65.96 148.87 51.12 Favored 'General case' 0 C--O 1.231 0.092 0 CA-C-N 118.091 0.946 . . . . 0.0 111.054 178.648 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 36' ' ' VAL . . . . . . . . . . . . . 43.4 t -126.44 130.92 71.85 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.2 0 CA-C-N 116.199 -0.455 . . . . 0.0 109.91 178.414 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 37' ' ' ILE . . . . . . . . . . . . . 65.5 mt -122.73 139.69 48.79 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.237 0 CA-C-N 116.174 -0.466 . . . . 0.0 109.984 -179.758 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 38' ' ' GLY . . . . . . . . . . . . . . . -109.31 128.76 9.13 Favored Glycine 0 CA--C 1.526 0.738 0 N-CA-C 111.086 -0.805 . . . . 0.0 111.086 179.518 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 39' ' ' ILE . . . . . . . . . . . . . 65.5 mt -125.69 126.82 70.82 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.249 0 N-CA-C 109.802 -0.444 . . . . 0.0 109.802 178.621 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 40' ' ' SER . . . . . . . . . . . . . 41.2 t -92.44 117.32 29.81 Favored 'General case' 0 C--N 1.329 -0.307 0 C-N-CA 120.961 -0.296 . . . . 0.0 110.914 177.075 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 41' ' ' ILE . . . . . . . . . . . . . 45.3 mm -130.32 124.64 58.08 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.227 0 CA-C-O 120.722 0.296 . . . . 0.0 110.288 179.45 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 42' ' ' LEU . . . . . . . . . . . . . 77.9 mt 58.54 35.1 24.4 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.19 -0.459 . . . . 0.0 111.678 177.307 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 43' ' ' GLY . . . . . . . . . . . . . . . 77.54 -10.12 25.09 Favored Glycine 0 CA--C 1.534 1.261 0 C-N-CA 121.212 -0.518 . . . . 0.0 113.479 177.586 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 44' ' ' LYS . . . . . . . . . . . . . 60.3 mttp -102.49 130.13 49.21 Favored 'General case' 0 C--O 1.232 0.154 0 CA-C-N 117.977 0.888 . . . . 0.0 110.175 177.505 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 45' ' ' GLU . . . . . . . . . . . . . 38.1 tp10 -84.48 128.14 34.42 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-O 120.797 0.332 . . . . 0.0 110.887 179.552 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 46' ' ' VAL . . . . . . . . . . . . . 7.3 p -119.56 129.44 75.32 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.235 0 N-CA-C 109.617 -0.512 . . . . 0.0 109.617 176.741 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 47' ' ' LYS . . . . . . . . . . . . . 35.0 mmtp -99.78 126.91 45.93 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.074 -0.512 . . . . 0.0 110.885 177.833 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 48' ' ' PHE . . . . . . . . . . . . . 91.2 m-85 -108.68 131.81 54.54 Favored 'General case' 0 C--N 1.33 -0.247 0 N-CA-C 109.824 -0.435 . . . . 0.0 109.824 176.461 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 49' ' ' LYS . . . . . . . . . . . . . 85.0 tttt -108.29 136.83 47.29 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.274 -0.421 . . . . 0.0 110.276 178.698 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 50' ' ' VAL . . . . . . . . . . . . . 44.2 t -78.37 108.47 11.83 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.368 0 N-CA-C 109.318 -0.623 . . . . 0.0 109.318 176.304 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 51' ' ' VAL . . . . . . . . . . . . . 48.0 t -69.68 -48.32 65.9 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.298 0 CA-C-N 116.044 -0.525 . . . . 0.0 109.898 -174.27 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 52' ' ' GLN . . . . . . . . . . . . . 47.5 tt0 -169.2 142.56 2.78 Favored 'General case' 0 C--N 1.33 -0.266 0 C-N-CA 120.256 -0.578 . . . . 0.0 111.774 -178.551 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 53' ' ' ALA . . . . . . . . . . . . . . . -111.83 134.17 53.57 Favored 'General case' 0 C--N 1.332 -0.191 0 CA-C-N 115.594 -0.73 . . . . 0.0 109.867 175.572 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 54' ' ' TYR . . . . . . . . . . . . . 41.8 t80 -129.04 108.01 18.07 Favored Pre-proline 0 CA--C 1.534 0.36 0 CA-C-O 118.279 -0.867 . . . . 0.0 110.387 179.823 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 55' ' ' PRO . . . . . . . . . . . . . 73.7 Cg_endo -77.16 170.11 72.4 Favored 'Cis proline' 0 N--CA 1.5 1.863 0 CA-C-N 121.826 1.688 . . . . 0.0 112.396 -6.059 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 56' ' ' SER . . . . . . . . . . . . . 20.9 m -116.1 135.19 22.74 Favored Pre-proline 0 CA--C 1.539 0.544 0 CA-C-O 118.489 -0.767 . . . . 0.0 109.709 175.874 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 57' ' ' PRO . . . . . . . . . . . . . 60.8 Cg_endo -75.15 161.62 94.38 Favored 'Cis proline' 0 N--CA 1.497 1.714 0 CA-C-N 121.792 1.676 . . . . 0.0 111.346 -4.982 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 58' ' ' LEU . . . . . . . . . . . . . 40.4 tp -129.98 138.54 50.88 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-O 120.922 0.392 . . . . 0.0 110.335 -179.791 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 59' ' ' ARG . . . . . . . . . . . . . 74.3 ttt180 -95.52 125.99 40.5 Favored 'General case' 0 C--N 1.326 -0.456 0 N-CA-C 109.229 -0.656 . . . . 0.0 109.229 175.235 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 60' ' ' VAL . . . . . . . . . . . . . 49.9 t -74.76 114.49 14.76 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.331 0 C-N-CA 120.709 -0.396 . . . . 0.0 110.392 -174.587 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 61' ' ' GLU . . . . . . . . . . . . . 70.9 mm-40 -131.1 164.53 25.26 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 115.901 -0.59 . . . . 0.0 110.021 176.542 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 62' ' ' ASP . . . . . . . . . . . . . 13.4 t70 -52.34 -30.32 27.97 Favored 'General case' 0 C--N 1.328 -0.345 0 N-CA-C 112.149 0.426 . . . . 0.0 112.149 -179.408 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 63' ' ' ARG . . . . . . . . . . . . . 39.9 mmt180 -72.05 -20.8 61.62 Favored 'General case' 0 CA--C 1.533 0.301 0 N-CA-C 112.968 0.729 . . . . 0.0 112.968 -174.837 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 64' ' ' THR . . . . . . . . . . . . . 32.9 m -75.66 139.44 41.98 Favored 'General case' 0 C--N 1.331 -0.207 0 CA-C-O 120.947 0.403 . . . . 0.0 111.0 -175.896 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 65' ' ' LYS . . . . . . . . . . . . . 2.3 mptm? -89.4 137.56 32.22 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 115.882 -0.599 . . . . 0.0 109.994 177.457 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 66' ' ' ILE . . . . . . . . . . . . . 60.3 mt -116.51 130.88 70.59 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.29 0 N-CA-C 110.047 -0.353 . . . . 0.0 110.047 179.602 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 67' ' ' THR . . . . . . . . . . . . . 25.5 m -125.06 137.76 54.2 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 116.241 -0.436 . . . . 0.0 110.932 -178.631 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 68' ' ' LEU . . . . . . . . . . . . . 8.4 mp -103.65 121.16 42.37 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 115.99 -0.55 . . . . 0.0 110.588 178.835 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 69' ' ' VAL . . . . . . . . . . . . . 44.8 t -102.28 129.16 54.17 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.323 0 CA-C-N 116.146 -0.479 . . . . 0.0 109.878 178.007 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 70' ' ' THR . . . . . . . . . . . . . 8.5 t -139.37 135.12 33.36 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-O 120.849 0.357 . . . . 0.0 110.597 179.448 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 71' ' ' HIS . . . . . . . . . . . . . 94.6 m-70 -147.71 80.73 8.82 Favored Pre-proline 0 C--N 1.329 -0.318 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.456 179.72 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 72' ' ' PRO . . . . . . . . . . . . . 72.9 Cg_endo -86.69 150.14 8.67 Favored 'Trans proline' 0 N--CA 1.489 1.248 0 C-N-CA 121.665 1.577 . . . . 0.0 112.272 179.721 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 73' ' ' VAL . . . . . . . . . . . . . 28.9 m -103.19 171.4 1.6 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.262 0 CA-C-N 116.166 -0.47 . . . . 0.0 109.909 177.445 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 74' ' ' ASP . . . . . . . . . . . . . 8.8 t70 -97.28 115.01 26.86 Favored 'General case' 0 C--N 1.329 -0.292 0 N-CA-C 109.803 -0.443 . . . . 0.0 109.803 -178.924 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 75' ' ' VAL . . . . . . . . . . . . . 46.3 t -113.08 120.29 62.71 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.242 0 CA-C-O 121.059 0.457 . . . . 0.0 110.223 -178.164 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 76' ' ' LEU . . . . . . . . . . . . . 26.9 mt -123.45 139.74 53.72 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 115.586 -0.734 . . . . 0.0 109.588 178.739 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 77' ' ' GLU . . . . . . . . . . . . . 97.5 mt-10 -134.61 130.97 37.25 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-O 121.101 0.477 . . . . 0.0 111.18 -178.134 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 78' ' ' ALA . . . . . . . . . . . . . . . -120.97 130.46 53.83 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 115.582 -0.736 . . . . 0.0 109.702 177.005 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 79' ' ' LYS . . . . . . . . . . . . . 9.1 ptpp? -73.7 120.97 20.04 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-O 121.201 0.524 . . . . 0.0 110.381 -179.306 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 80' ' ' ILE . . . . . . . . . . . . . 36.8 mm -139.12 108.66 3.9 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.288 0 N-CA-C 109.133 -0.691 . . . . 0.0 109.133 -177.648 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 81' ' ' LYS . . . . . . . . . . . . . 45.6 tttm -107.52 125.93 51.89 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-O 120.877 0.37 . . . . 0.0 111.205 -175.827 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 82' ' ' GLY . . . . . . . . . . . . . . . 89.18 42.0 5.69 Favored Glycine 0 CA--C 1.525 0.665 0 C-N-CA 120.773 -0.727 . . . . 0.0 111.811 175.005 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 83' ' ' ILE . . . . . . . . . . . . . 69.7 mt -69.15 139.94 19.64 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.315 0 N-CA-C 109.936 -0.394 . . . . 0.0 109.936 178.206 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 84' ' ' LYS . . . . . . . . . . . . . 53.1 tttp -96.74 -51.98 4.09 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.158 -0.474 . . . . 0.0 110.221 -179.199 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 85' ' ' ASP . . . . . . . . . . . . . 3.8 t70 -155.62 155.13 32.73 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 115.784 -0.644 . . . . 0.0 110.386 -179.902 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 86' ' ' VAL . . . . . . . . . . . . . 44.2 t -133.51 132.33 57.53 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.198 0 CA-C-O 121.05 0.452 . . . . 0.0 110.715 -177.957 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 87' ' ' ILE . . . . . . . . . . . . . 46.5 mm -121.26 128.12 75.91 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.194 0 CA-C-N 115.693 -0.685 . . . . 0.0 109.439 175.361 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 88' ' ' LEU . . . . . . . . . . . . . 12.8 tp -113.84 133.17 55.58 Favored 'General case' 0 C--N 1.331 -0.212 0 CA-C-O 120.997 0.427 . . . . 0.0 111.298 -176.793 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 89' ' ' ASP . . . . . . . . . . . . . 6.8 t70 -124.96 157.88 34.99 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-N 115.863 -0.608 . . . . 0.0 109.684 176.375 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 90' ' ' GLU . . . . . . . . . . . . . 44.3 mt-10 -44.99 -45.87 10.83 Favored 'General case' 0 N--CA 1.465 0.285 0 N-CA-C 113.272 0.841 . . . . 0.0 113.272 -172.025 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 91' ' ' ASN . . . . . . . . . . . . . 7.7 p-10 -131.97 37.7 3.58 Favored 'General case' 0 N--CA 1.463 0.22 0 CA-C-O 120.801 0.334 . . . . 0.0 111.373 -176.836 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 92' ' ' LEU . . . . . . . . . . . . . 4.3 tp -166.0 144.09 5.68 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-O 120.812 0.339 . . . . 0.0 110.33 179.916 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 93' ' ' ILE . . . . . . . . . . . . . 62.9 mt -125.42 124.74 67.65 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.279 0 N-CA-C 109.709 -0.478 . . . . 0.0 109.709 -177.658 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 94' ' ' VAL . . . . . . . . . . . . . 46.5 t -122.4 125.92 73.43 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.242 0 N-CA-C 109.917 -0.401 . . . . 0.0 109.917 179.527 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 95' ' ' VAL . . . . . . . . . . . . . 45.4 t -124.01 138.09 54.84 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.32 0 CA-C-N 116.131 -0.486 . . . . 0.0 110.113 -178.749 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 96' ' ' ILE . . . . . . . . . . . . . 61.8 mt -116.44 128.51 73.76 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.315 0 N-CA-C 109.255 -0.646 . . . . 0.0 109.255 178.556 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 97' ' ' THR . . . . . . . . . . . . . 71.8 p -102.9 159.61 15.34 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-O 121.265 0.555 . . . . 0.0 111.436 -175.888 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 98' ' ' GLU . . . . . . . . . . . . . 84.9 tt0 -53.91 -25.73 21.64 Favored 'General case' 0 CA--C 1.532 0.272 0 CA-C-N 116.083 -0.508 . . . . 0.0 112.161 179.327 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 99' ' ' GLU . . . . . . . . . . . . . 41.2 mt-10 -78.66 14.93 1.14 Allowed 'General case' 0 CA--C 1.535 0.39 0 N-CA-C 113.097 0.777 . . . . 0.0 113.097 -177.773 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 100' ' ' ASN . . . . . . . . . . . . . 2.4 m-20 60.63 38.01 18.89 Favored 'General case' 0 CA--C 1.529 0.167 0 CA-C-O 121.018 0.437 . . . . 0.0 110.713 179.481 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 101' ' ' GLU . . . . . . . . . . . . . 84.9 tt0 -117.29 146.31 43.41 Favored 'General case' 0 C--N 1.332 -0.173 0 CA-C-N 116.078 -0.51 . . . . 0.0 109.795 178.189 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 102' ' ' VAL . . . . . . . . . . . . . 44.9 t -114.95 124.74 71.91 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.275 0 CA-C-N 116.258 -0.428 . . . . 0.0 109.85 -178.158 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 103' ' ' LEU . . . . . . . . . . . . . 50.9 mt -115.15 132.69 56.52 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 115.715 -0.675 . . . . 0.0 109.996 178.594 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 104' ' ' ILE . . . . . 0.412 HD11 HG22 ' B' ' 104' ' ' ILE . 66.6 mt -123.22 119.59 58.02 Favored 'Isoleucine or valine' 0 C--O 1.233 0.2 0 N-CA-C 110.375 -0.231 . . . . 0.0 110.375 -178.334 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' B' B ' 105' ' ' PHE . . . . . . . . . . . . . 47.1 m-85 -121.17 164.61 16.62 Favored 'General case' 0 C--N 1.331 -0.211 0 CA-C-N 115.471 -0.786 . . . . 0.0 109.809 178.841 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 106' ' ' ASN . . . . . . . . . . . . . 47.4 p-10 -97.67 -169.98 1.92 Allowed 'General case' 0 C--N 1.33 -0.282 0 N-CA-C 109.652 -0.499 . . . . 0.0 109.652 172.851 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 107' ' ' GLN . . . . . . . . . . . . . 62.6 tt0 -59.67 -30.07 68.5 Favored 'General case' 0 C--N 1.33 -0.27 0 N-CA-C 111.879 0.325 . . . . 0.0 111.879 179.81 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 108' ' ' ASN . . . . . . . . . . . . . 7.0 t30 -83.24 8.76 12.39 Favored 'General case' 0 CA--C 1.536 0.432 0 N-CA-C 113.148 0.796 . . . . 0.0 113.148 -177.535 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 109' ' ' LEU . . . . . . . . . . . . . 11.1 tp 60.99 36.21 18.71 Favored 'General case' 0 CA--C 1.53 0.198 0 CA-C-O 120.838 0.351 . . . . 0.0 111.434 178.845 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 110' ' ' GLU . . . . . . . . . . . . . 95.3 mt-10 -105.9 151.2 24.86 Favored 'General case' 0 C--N 1.33 -0.264 0 N-CA-C 109.898 -0.408 . . . . 0.0 109.898 176.884 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 111' ' ' GLU . . . . . . . . . . . . . 99.4 mt-10 -79.77 121.97 26.03 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-O 120.961 0.41 . . . . 0.0 111.34 -177.107 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 112' ' ' LEU . . . . . . . . . . . . . 16.3 mt -106.6 -45.74 4.16 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 115.894 -0.593 . . . . 0.0 110.086 176.418 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 113' ' ' TYR . . . . . . . . . . . . . 61.1 t80 -141.16 142.92 34.0 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 116.104 -0.498 . . . . 0.0 111.006 -179.488 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 114' ' ' ARG . . . . . . . . . . . . . 83.7 mtp180 -144.86 122.12 11.55 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.097 -0.502 . . . . 0.0 110.285 177.388 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 115' ' ' GLY . . . . . . . . . . . . . . . -150.05 162.59 29.23 Favored Glycine 0 CA--C 1.524 0.646 0 N-CA-C 111.006 -0.837 . . . . 0.0 111.006 179.881 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 116' ' ' LYS . . . . . . . . . . . . . 21.6 ttpt -129.1 140.8 51.42 Favored 'General case' 0 C--N 1.33 -0.267 0 N-CA-C 110.204 -0.295 . . . . 0.0 110.204 179.376 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 117' ' ' PHE . . . . . . . . . . . . . 29.1 m-85 -140.8 113.91 8.48 Favored 'General case' 0 C--N 1.331 -0.215 0 N-CA-C 109.927 -0.397 . . . . 0.0 109.927 -178.919 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 118' ' ' GLU . . . . . . . . . . . . . 70.8 mm-40 -56.19 -40.1 73.44 Favored 'General case' 0 C--N 1.329 -0.304 0 C-N-CA 120.912 -0.315 . . . . 0.0 110.944 -177.164 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 119' ' ' ASN . . . . . . . . . . . . . 80.7 m-20 -98.02 30.73 2.95 Favored 'General case' 0 C--N 1.33 -0.261 0 N-CA-C 112.168 0.432 . . . . 0.0 112.168 -175.502 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 120' ' ' LEU . . . . . . . . . . . . . 15.3 tp -58.29 123.69 16.92 Favored 'General case' 0 C--N 1.332 -0.184 0 N-CA-C 110.177 -0.305 . . . . 0.0 110.177 177.051 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 121' ' ' ASN . . . . . . . . . . . . . 77.7 m-20 -114.09 -44.08 3.18 Favored 'General case' 0 C--N 1.332 -0.195 0 CA-C-N 116.545 -0.298 . . . . 0.0 110.866 -178.475 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 122' ' ' LYS . . . . . . . . . . . . . 97.2 mttt -148.58 153.69 38.71 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-O 121.052 0.453 . . . . 0.0 111.569 -178.288 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 123' ' ' VAL . . . . . . . . . . . . . 46.1 t -133.91 130.87 55.9 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.228 0 CA-C-N 115.95 -0.568 . . . . 0.0 109.658 175.13 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 124' ' ' LEU . . . . . . . . . . . . . 64.5 mt -120.56 138.67 53.74 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.176 -0.465 . . . . 0.0 110.476 -178.206 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 125' ' ' VAL . . . . . . . . . . . . . 11.9 p -133.19 127.35 54.36 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.254 0 CA-C-N 116.463 -0.335 . . . . 0.0 110.266 178.413 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 126' ' ' ARG . . . . . . . . . . . . . 40.8 mmt180 -136.84 116.11 12.61 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.3 -0.409 . . . . 0.0 110.339 -179.707 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 127' ' ' ASN . . . . . . . . . . . . . 47.8 t30 52.67 -106.27 0.28 Allowed 'General case' 0 CA--C 1.543 0.71 0 CA-C-O 119.039 -0.505 . . . . 0.0 111.058 -179.986 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 128' ' ' ASP . . . . . . . . . . . . . 19.0 p-10 -114.09 2.92 15.07 Favored 'General case' 0 CA--C 1.536 0.426 0 CA-C-N 119.665 1.12 . . . . 0.0 113.422 -178.449 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 129' ' ' LEU . . . . . . . . . . . . . 2.5 tt -104.86 135.72 45.7 Favored 'General case' 0 C--N 1.332 -0.17 0 N-CA-C 109.583 -0.525 . . . . 0.0 109.583 179.324 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 130' ' ' VAL . . . . . . . . . . . . . 42.0 t -123.13 139.64 49.25 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.298 0 CA-C-O 120.799 0.333 . . . . 0.0 110.176 -177.678 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 131' ' ' VAL . . . . . . . . . . . . . 39.9 t -135.8 135.17 51.07 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.284 0 CA-C-N 116.235 -0.438 . . . . 0.0 110.162 179.561 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 132' ' ' ILE . . . . . . . . . . . . . 71.1 mt -117.52 132.45 67.3 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 N-CA-C 109.37 -0.604 . . . . 0.0 109.37 178.493 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 133' ' ' ILE . . . . . . . . . . . . . 37.7 mm -117.79 122.31 69.46 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.268 0 CA-C-O 120.617 0.246 . . . . 0.0 111.09 -174.272 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 134' ' ' ASP . . . . . . . . . . . . . 9.1 p-10 -137.38 147.82 45.76 Favored 'General case' 0 C--N 1.331 -0.207 0 CA-C-N 116.179 -0.464 . . . . 0.0 109.794 174.862 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 135' ' ' GLU . . . . . . . . . . . . . 85.5 tt0 -49.78 -24.67 2.5 Favored 'General case' 0 C--N 1.328 -0.333 0 N-CA-C 112.875 0.695 . . . . 0.0 112.875 -173.239 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 136' ' ' GLN . . . . . . . . . . . . . 56.1 tp60 -83.91 -37.64 22.11 Favored 'General case' 0 C--O 1.235 0.316 0 N-CA-C 111.959 0.355 . . . . 0.0 111.959 -175.762 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 137' ' ' LYS . . . . . . . . . . . . . 54.0 pttt -161.28 171.92 17.53 Favored 'General case' 0 C--N 1.331 -0.239 0 CA-C-O 121.558 0.694 . . . . 0.0 112.072 -172.394 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 138' ' ' LEU . . . . . . . . . . . . . 4.7 tt -118.36 126.21 51.62 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 114.962 -1.017 . . . . 0.0 109.649 177.425 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 139' ' ' THR . . . . . . . . . . . . . 16.9 m -106.88 126.19 51.99 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-N 116.24 -0.436 . . . . 0.0 110.616 -178.735 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 140' ' ' LEU . . . . . . . . . . . . . 30.8 tp -114.98 122.51 46.46 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 115.655 -0.702 . . . . 0.0 109.456 -178.405 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 141' ' ' ILE . . . . . . . . . . . . . 19.3 mt -121.86 119.79 59.71 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.282 0 N-CA-C 110.142 -0.318 . . . . 0.0 110.142 -175.039 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 142' ' ' ARG . . . . . . . . . . . . . 82.0 mtm180 -110.18 127.45 54.94 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 115.661 -0.699 . . . . 0.0 110.286 -179.585 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 143' ' ' THR . . . . . . . . . . . . . 41.6 p . . . . . 0 C--O 1.22 -0.467 0 CA-C-O 118.037 -0.982 . . . . 0.0 110.68 -179.436 . . . . . . . . 0 0 . 1 . 002 nuclear orig full ' C' C ' -3' ' ' GLU . . . . . . . . . . . . . 95.7 mt-10 . . . . . 0 N--CA 1.49 1.557 0 N-CA-C 109.441 -0.577 . . . . 0.0 109.441 . . . . . . . . . 0 0 . 1 . 002 nuclear orig full ' C' C ' -2' ' ' GLY . . . . . . . . . . . . . . . -72.98 113.2 4.23 Favored Glycine 0 CA--C 1.526 0.771 0 N-CA-C 110.783 -0.927 . . . . 0.0 110.783 178.899 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' C' C ' -1' ' ' VAL . . . . . . . . . . . . . 43.1 t -95.68 139.82 18.23 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 CA-C-O 120.822 0.344 . . . . 0.0 110.11 -179.322 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' C' C ' 0' ' ' ILE . . . . . . . . . . . . . 43.9 mm -100.92 139.32 22.52 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.293 0 CA-C-N 116.15 -0.477 . . . . 0.0 110.205 -179.59 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' C' C ' 1' ' ' MET . . . . . . . . . . . . . 21.5 ptm -77.69 136.84 38.24 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.088 -0.506 . . . . 0.0 110.661 179.939 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' C' C ' 2' ' ' SER . . . . . . . . . . . . . 2.6 p -123.44 127.07 47.89 Favored 'General case' 0 C--N 1.331 -0.239 0 CA-C-N 116.123 -0.489 . . . . 0.0 110.336 178.778 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' C' C ' 3' ' ' GLU . . . . . . . . . . . . . 95.5 mt-10 -140.99 140.34 34.33 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 116.049 -0.523 . . . . 0.0 111.063 -177.9 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' C' C ' 4' ' ' LEU . . . . . . . . . . . . . 16.1 tp -126.62 128.52 46.91 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 115.996 -0.547 . . . . 0.0 110.098 176.508 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' C' C ' 5' ' ' LYS . . . . . . . . . . . . . 97.4 mttt -109.27 121.5 45.31 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.4 -0.363 . . . . 0.0 110.478 179.531 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' C' C ' 6' ' ' LEU . . . . . . . . . . . . . 62.1 mt -116.21 148.8 40.05 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 115.616 -0.72 . . . . 0.0 110.293 -178.398 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' C' C ' 7' ' ' LYS . . . . . . . . . . . . . 75.6 tttt -136.4 138.54 27.16 Favored Pre-proline 0 CA--C 1.535 0.374 0 CA-C-O 118.996 -0.526 . . . . 0.0 110.2 176.774 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' C' C ' 8' ' ' PRO . . . . . . . . . . . . . 94.2 Cg_endo -91.81 142.76 2.74 Favored 'Trans proline' 0 N--CA 1.489 1.263 0 C-N-CA 121.725 1.617 . . . . 0.0 111.664 176.959 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' C' C ' 9' ' ' LEU . . . . . . . . . . . . . 36.9 mt -82.52 -47.83 0.88 Allowed Pre-proline 0 CA--C 1.534 0.343 0 CA-C-O 118.74 -0.647 . . . . 0.0 112.495 -177.681 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' C' C ' 10' ' ' PRO . . . . . . . . . . . . . 94.5 Cg_endo -81.65 161.13 19.2 Favored 'Trans proline' 0 N--CA 1.497 1.694 0 C-N-CA 121.24 1.293 . . . . 0.0 111.969 177.101 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' C' C ' 11' ' ' LYS . . . . . . . . . . . . . 91.0 mttt -86.52 103.11 14.73 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.389 -0.368 . . . . 0.0 110.38 177.825 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' C' C ' 12' ' ' VAL . . . . . . . . . . . . . 11.9 p -141.71 143.61 26.93 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.276 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.371 179.847 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' C' C ' 13' ' ' GLU . . . . . . . . . . . . . 82.5 tt0 -90.82 122.81 33.86 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 116.323 -0.399 . . . . 0.0 109.987 177.967 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' C' C ' 14' ' ' LEU . . . . . . . . . . . . . 25.3 mt -96.9 152.38 38.36 Favored Pre-proline 0 C--N 1.329 -0.311 0 CA-C-N 116.458 -0.337 . . . . 0.0 111.03 -175.973 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' C' C ' 15' ' ' PRO . . . . . . . . . . . . . 26.6 Cg_exo -61.72 163.11 19.48 Favored 'Trans proline' 0 N--CA 1.497 1.711 0 C-N-CA 121.255 1.303 . . . . 0.0 111.892 176.634 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' C' C ' 16' ' ' PRO . . . . . . . . . . . . . 25.2 Cg_exo -61.64 -44.44 21.77 Favored 'Trans proline' 0 N--CA 1.497 1.713 0 C-N-CA 121.516 1.478 . . . . 0.0 112.668 -178.472 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' C' C ' 17' ' ' ASP . . . . . . . . . . . . . 22.3 p-10 -88.72 16.23 7.07 Favored 'General case' 0 C--N 1.327 -0.385 0 N-CA-C 112.994 0.738 . . . . 0.0 112.994 -177.13 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' C' C ' 18' ' ' PHE . . . . . . . . . . . . . 63.4 t80 -57.6 -41.53 81.43 Favored 'General case' 0 C--N 1.335 -0.064 0 O-C-N 122.053 -0.404 . . . . 0.0 110.315 -178.59 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' C' C ' 19' ' ' VAL . . . . . . . . . . . . . 44.3 t -56.26 -45.56 81.22 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.338 0 CA-C-N 116.47 -0.332 . . . . 0.0 110.624 -178.173 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' C' C ' 20' ' ' ASP . . . . . . . . . . . . . 51.4 m-20 -60.6 -40.43 91.77 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-O 120.763 0.316 . . . . 0.0 111.021 -178.295 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' C' C ' 21' ' ' VAL . . . . . . . . . . . . . 48.2 t -64.0 -48.46 85.91 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.328 0 C-N-CA 120.769 -0.373 . . . . 0.0 110.421 -178.373 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' C' C ' 22' ' ' ILE . . . . . . . . . . . . . 51.5 mm -55.61 -44.37 76.41 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.299 0 CA-C-O 120.895 0.379 . . . . 0.0 110.461 178.29 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' C' C ' 23' ' ' ARG . . . . . . . . . . . . . 56.6 ttp180 -52.51 -52.26 55.44 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-O 120.717 0.294 . . . . 0.0 111.609 -179.955 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' C' C ' 24' ' ' ILE . . . . . . . . . . . . . 71.1 mt -59.4 -40.63 82.12 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.294 0 CA-C-N 116.407 -0.361 . . . . 0.0 111.389 -176.338 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' C' C ' 25' ' ' LYS . . . . . . . . . . . . . 91.3 mttt -67.2 -37.83 84.31 Favored 'General case' 0 C--N 1.329 -0.288 0 N-CA-C 112.179 0.437 . . . . 0.0 112.179 -179.53 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' C' C ' 26' ' ' LEU . . . . . . . . . . . . . 68.2 mt -79.13 -41.18 29.15 Favored 'General case' 0 C--N 1.329 -0.295 0 N-CA-C 113.125 0.787 . . . . 0.0 113.125 -171.297 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' C' C ' 27' ' ' GLN . . . . . . . . . . . . . 9.9 pt20 -46.68 139.0 5.57 Favored 'General case' 0 N--CA 1.47 0.558 0 N-CA-C 112.659 0.614 . . . . 0.0 112.659 -176.151 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' C' C ' 28' ' ' GLY . . . . . . . . . . . . . . . 101.13 -26.87 23.07 Favored Glycine 0 CA--C 1.532 1.114 0 CA-C-N 115.536 -0.756 . . . . 0.0 112.213 -177.441 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' C' C ' 29' ' ' LYS . . . . . . . . . . . . . 61.7 mtpt -98.22 155.2 17.29 Favored 'General case' 0 C--N 1.333 -0.138 0 CA-C-N 117.32 0.56 . . . . 0.0 111.2 179.595 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' C' C ' 30' ' ' THR . . . . . . . . . . . . . 36.0 m -105.91 135.63 47.0 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 115.962 -0.563 . . . . 0.0 109.939 175.705 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' C' C ' 31' ' ' VAL . . . . . . . . . . . . . 34.5 m -132.87 158.32 43.24 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.271 0 CA-C-O 120.947 0.403 . . . . 0.0 111.019 -177.587 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' C' C ' 32' ' ' ARG . . . . . . . . . . . . . 50.7 mtp180 -134.89 152.71 51.97 Favored 'General case' 0 C--N 1.331 -0.219 0 CA-C-O 121.353 0.597 . . . . 0.0 110.706 178.736 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' C' C ' 33' ' ' THR . . . . . . . . . . . . . 22.1 m -52.57 140.17 23.68 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 115.997 -0.547 . . . . 0.0 111.509 -178.347 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' C' C ' 34' ' ' GLY . . . . . . . . . . . . . . . 100.0 -17.22 57.51 Favored Glycine 0 CA--C 1.532 1.117 0 CA-C-O 119.553 -0.582 . . . . 0.0 113.258 178.092 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' C' C ' 35' ' ' ASP . . . . . . . . . . . . . 77.5 m-20 -66.06 148.08 52.36 Favored 'General case' 0 N--CA 1.461 0.109 0 CA-C-N 118.148 0.974 . . . . 0.0 110.897 178.836 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' C' C ' 36' ' ' VAL . . . . . . . . . . . . . 44.2 t -124.92 132.8 70.85 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.238 0 CA-C-N 116.169 -0.468 . . . . 0.0 109.955 178.648 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' C' C ' 37' ' ' ILE . . . . . . . . . . . . . 67.8 mt -123.43 141.64 42.97 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.286 0 CA-C-N 116.072 -0.513 . . . . 0.0 110.04 -178.714 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' C' C ' 38' ' ' GLY . . . . . . . . . . . . . . . -111.56 129.0 8.91 Favored Glycine 0 CA--C 1.525 0.673 0 N-CA-C 111.021 -0.832 . . . . 0.0 111.021 179.667 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' C' C ' 39' ' ' ILE . . . . . . . . . . . . . 76.3 mt -125.39 137.34 57.96 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.193 0 CA-C-O 120.731 0.3 . . . . 0.0 110.205 179.805 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' C' C ' 40' ' ' SER . . . . . . . . . . . . . 35.8 t -93.4 124.6 37.5 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.273 -0.421 . . . . 0.0 110.903 175.643 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' C' C ' 41' ' ' ILE . . . . . . . . . . . . . 73.1 mt -130.56 119.59 46.21 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.181 0 CA-C-O 120.845 0.355 . . . . 0.0 110.336 177.757 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' C' C ' 42' ' ' LEU . . . . . . . . . . . . . 7.3 mp 51.71 37.24 19.66 Favored 'General case' 0 C--N 1.331 -0.221 0 CA-C-N 116.06 -0.518 . . . . 0.0 111.489 177.306 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' C' C ' 43' ' ' GLY . . . . . . . . . . . . . . . 72.58 30.88 63.58 Favored Glycine 0 CA--C 1.528 0.892 0 C-N-CA 121.07 -0.586 . . . . 0.0 112.309 176.837 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' C' C ' 44' ' ' LYS . . . . . . . . . . . . . 82.4 tttt -137.75 131.62 31.56 Favored 'General case' 0 C--N 1.33 -0.265 0 N-CA-C 109.692 -0.484 . . . . 0.0 109.692 177.085 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' C' C ' 45' ' ' GLU . . . . . . . . . . . . . 81.2 tt0 -82.91 123.08 29.07 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-O 120.725 0.298 . . . . 0.0 111.179 -177.345 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' C' C ' 46' ' ' VAL . . . . . . . . . . . . . 7.3 p -121.58 128.24 75.77 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.223 0 N-CA-C 109.624 -0.51 . . . . 0.0 109.624 176.212 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' C' C ' 47' ' ' LYS . . . . . . . . . . . . . 66.8 mttm -99.45 129.99 45.68 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.008 -0.542 . . . . 0.0 111.138 178.668 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' C' C ' 48' ' ' PHE . . . . . . . . . . . . . 91.6 m-85 -113.82 131.86 56.09 Favored 'General case' 0 C--N 1.33 -0.269 0 N-CA-C 109.873 -0.418 . . . . 0.0 109.873 176.255 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' C' C ' 49' ' ' LYS . . . . . . . . . . . . . 63.6 tttm -109.28 139.23 44.48 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.528 -0.305 . . . . 0.0 110.7 178.323 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' C' C ' 50' ' ' VAL . . . . . . . . . . . . . 45.7 t -81.17 108.54 14.56 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.352 0 N-CA-C 109.327 -0.62 . . . . 0.0 109.327 175.614 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' C' C ' 51' ' ' VAL . . . . . . . . . . . . . 46.7 t -70.04 -48.66 61.37 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.316 0 CA-C-N 116.131 -0.486 . . . . 0.0 109.8 -174.494 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' C' C ' 52' ' ' GLN . . . . . . . . . . . . . 61.6 tt0 -165.72 148.21 7.51 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.063 -0.517 . . . . 0.0 111.691 -178.964 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' C' C ' 53' ' ' ALA . . . . . . . . . . . . . . . -123.35 133.55 54.11 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 115.655 -0.702 . . . . 0.0 110.01 177.928 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' C' C ' 54' ' ' TYR . . . . . . . . . . . . . 10.3 t80 -129.02 111.98 18.5 Favored Pre-proline 0 CA--C 1.536 0.409 0 CA-C-O 118.179 -0.915 . . . . 0.0 110.483 178.977 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' C' C ' 55' ' ' PRO . . . . . . . . . . . . . 73.2 Cg_endo -77.23 168.27 77.32 Favored 'Cis proline' 0 N--CA 1.501 1.918 0 CA-C-N 122.028 1.76 . . . . 0.0 112.278 -6.782 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' C' C ' 56' ' ' SER . . . . . . . . . . . . . 13.5 m -117.35 132.33 23.59 Favored Pre-proline 0 CA--C 1.539 0.533 0 CA-C-O 118.453 -0.784 . . . . 0.0 109.292 174.21 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' C' C ' 57' ' ' PRO . . . . . . . . . . . . . 54.2 Cg_endo -70.08 147.15 84.72 Favored 'Cis proline' 0 N--CA 1.497 1.735 0 CA-C-N 121.834 1.691 . . . . 0.0 111.573 -0.109 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' C' C ' 58' ' ' LEU . . . . . . . . . . . . . 24.6 tp -108.51 136.51 48.0 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.409 -0.359 . . . . 0.0 110.843 -178.427 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' C' C ' 59' ' ' ARG . . . . . . . . . . . . . 59.2 ttt85 -102.95 121.11 41.86 Favored 'General case' 0 C--N 1.326 -0.421 0 N-CA-C 109.288 -0.634 . . . . 0.0 109.288 175.15 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' C' C ' 60' ' ' VAL . . . . . . . . . . . . . 42.5 t -76.42 118.42 22.78 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.28 0 C-N-CA 120.728 -0.389 . . . . 0.0 110.559 -174.881 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' C' C ' 61' ' ' GLU . . . . . . . . . . . . . 71.0 mm-40 -130.99 162.7 29.18 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 115.984 -0.553 . . . . 0.0 109.779 176.377 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' C' C ' 62' ' ' ASP . . . . . . . . . . . . . 80.3 m-20 -52.41 -30.5 29.66 Favored 'General case' 0 C--N 1.329 -0.302 0 N-CA-C 112.05 0.389 . . . . 0.0 112.05 179.758 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' C' C ' 63' ' ' ARG . . . . . . . . . . . . . 77.1 mtp85 -72.61 -21.85 61.05 Favored 'General case' 0 CA--C 1.533 0.294 0 N-CA-C 112.894 0.702 . . . . 0.0 112.894 -175.956 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' C' C ' 64' ' ' THR . . . . . . . . . . . . . 26.4 m -69.52 137.7 52.72 Favored 'General case' 0 C--N 1.331 -0.215 0 CA-C-O 120.993 0.425 . . . . 0.0 111.292 -174.683 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' C' C ' 65' ' ' LYS . . . . . . . . . . . . . 98.7 mttt -90.08 135.61 33.55 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 115.832 -0.622 . . . . 0.0 110.111 177.561 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' C' C ' 66' ' ' ILE . . . . . . . . . . . . . 64.4 mt -117.66 132.89 66.14 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.224 0 CA-C-O 120.868 0.366 . . . . 0.0 110.166 -179.787 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' C' C ' 67' ' ' THR . . . . . . . . . . . . . 30.1 m -122.39 139.61 53.64 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 115.988 -0.551 . . . . 0.0 110.813 -179.188 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' C' C ' 68' ' ' LEU . . . . . . . . . . . . . 4.1 tt -103.63 121.74 43.56 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 115.982 -0.554 . . . . 0.0 110.29 178.971 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' C' C ' 69' ' ' VAL . . . . . . . . . . . . . 42.0 t -101.63 129.13 53.29 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.257 0 CA-C-N 116.363 -0.381 . . . . 0.0 110.581 -178.031 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' C' C ' 70' ' ' THR . . . . . . . . . . . . . 12.0 m -144.76 132.7 21.35 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 115.992 -0.549 . . . . 0.0 110.128 177.114 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' C' C ' 71' ' ' HIS . . . . . . . . . . . . . 61.0 m-70 -129.4 84.79 60.97 Favored Pre-proline 0 CA--C 1.533 0.31 0 CA-C-N 116.5 -0.318 . . . . 0.0 110.577 -178.585 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' C' C ' 72' ' ' PRO . . . . . . . . . . . . . 74.1 Cg_endo -81.88 160.05 18.58 Favored 'Trans proline' 0 N--CA 1.493 1.465 0 C-N-CA 121.474 1.45 . . . . 0.0 112.429 -179.551 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' C' C ' 73' ' ' VAL . . . . . . . . . . . . . 30.2 m -116.53 171.22 5.48 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.229 0 CA-C-N 115.981 -0.554 . . . . 0.0 110.382 -179.973 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' C' C ' 74' ' ' ASP . . . . . . . . . . . . . 25.8 t0 -98.59 119.91 38.13 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.463 -0.335 . . . . 0.0 110.243 -177.552 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' C' C ' 75' ' ' VAL . . . . . . . . . . . . . 44.2 t -114.84 121.79 67.64 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.222 0 CA-C-O 121.176 0.513 . . . . 0.0 110.379 -179.277 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' C' C ' 76' ' ' LEU . . . . . . . . . . . . . 24.3 mt -118.92 146.58 44.83 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 115.553 -0.749 . . . . 0.0 109.628 178.119 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' C' C ' 77' ' ' GLU . . . . . . . . . . . . . 97.6 mt-10 -138.62 129.35 26.39 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-O 121.051 0.453 . . . . 0.0 111.204 -179.214 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' C' C ' 78' ' ' ALA . . . . . . . . . . . . . . . -116.94 136.5 52.9 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 115.797 -0.638 . . . . 0.0 109.787 177.345 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' C' C ' 79' ' ' LYS . . . . . . . . . . . . . 52.2 pttt -84.79 119.4 25.26 Favored 'General case' 0 C--N 1.331 -0.218 0 CA-C-O 121.237 0.541 . . . . 0.0 111.006 -177.247 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' C' C ' 80' ' ' ILE . . . . . . . . . . . . . 36.0 mm -139.43 117.98 12.26 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.212 0 N-CA-C 109.277 -0.638 . . . . 0.0 109.277 179.946 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' C' C ' 81' ' ' LYS . . . . . . . . . . . . . 57.2 tttm -103.36 122.54 45.05 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-O 120.777 0.322 . . . . 0.0 111.031 -178.037 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' C' C ' 82' ' ' GLY . . . . . . . . . . . . . . . 89.24 42.13 5.64 Favored Glycine 0 CA--C 1.526 0.719 0 C-N-CA 120.819 -0.705 . . . . 0.0 111.831 175.044 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' C' C ' 83' ' ' ILE . . . . . . . . . . . . . 75.3 mt -66.97 137.42 24.87 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.312 0 N-CA-C 109.858 -0.423 . . . . 0.0 109.858 177.318 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' C' C ' 84' ' ' LYS . . . . . . . . . . . . . 80.0 tttt -96.74 -54.02 3.36 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 115.971 -0.558 . . . . 0.0 110.326 -177.727 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' C' C ' 85' ' ' ASP . . . . . . . . . . . . . 8.1 t70 -151.14 150.01 30.15 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 115.748 -0.66 . . . . 0.0 110.407 -177.648 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' C' C ' 86' ' ' VAL . . . . . . . . . . . . . 44.6 t -129.04 129.18 67.87 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.266 0 CA-C-O 120.896 0.379 . . . . 0.0 110.435 -179.483 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' C' C ' 87' ' ' ILE . . . . . . . . . . . . . 5.0 mp -117.45 125.56 74.11 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.288 0 CA-C-N 115.909 -0.587 . . . . 0.0 109.481 176.872 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' C' C ' 88' ' ' LEU . . . . . . . . . . . . . 16.7 tp -110.5 129.68 55.73 Favored 'General case' 0 C--N 1.331 -0.221 0 CA-C-N 116.373 -0.376 . . . . 0.0 110.719 -179.025 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' C' C ' 89' ' ' ASP . . . . . . . . . . . . . 11.9 t70 -126.63 154.75 43.58 Favored 'General case' 0 C--N 1.331 -0.222 0 CA-C-N 116.119 -0.491 . . . . 0.0 109.945 178.0 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' C' C ' 90' ' ' GLU . . . . . . . . . . . . . 77.8 tt0 -45.73 -35.14 4.04 Favored 'General case' 0 C--N 1.329 -0.299 0 N-CA-C 113.332 0.864 . . . . 0.0 113.332 -172.218 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' C' C ' 91' ' ' ASN . . . . . . . . . . . . . 56.7 m-80 -130.87 15.27 5.28 Favored 'General case' 0 N--CA 1.469 0.488 0 N-CA-C 113.309 0.855 . . . . 0.0 113.309 -175.587 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' C' C ' 92' ' ' LEU . . . . . . . . . . . . . 8.5 mt -150.34 151.97 33.71 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 118.131 0.423 . . . . 0.0 110.33 -176.414 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' C' C ' 93' ' ' ILE . . . . . . . . . . . . . 70.1 mt -129.15 119.29 48.63 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.316 0 N-CA-C 109.172 -0.677 . . . . 0.0 109.172 177.342 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' C' C ' 94' ' ' VAL . . . . . . . . . . . . . 45.7 t -119.91 127.98 75.91 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.252 0 CA-C-O 120.875 0.369 . . . . 0.0 110.08 -178.364 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' C' C ' 95' ' ' VAL . . . . . . . . . . . . . 42.5 t -122.46 134.02 66.93 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.25 0 CA-C-N 116.045 -0.525 . . . . 0.0 109.899 -179.984 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' C' C ' 96' ' ' ILE . . . . . . . . . . . . . 64.9 mt -114.54 127.65 71.93 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.386 0 N-CA-C 109.384 -0.599 . . . . 0.0 109.384 179.435 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' C' C ' 97' ' ' THR . . . . . . . . . . . . . 68.1 p -97.8 156.46 16.57 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-O 120.92 0.391 . . . . 0.0 110.732 -179.495 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' C' C ' 98' ' ' GLU . . . . . . . . . . . . . 45.6 tp10 -53.82 -26.5 24.44 Favored 'General case' 0 CA--C 1.534 0.336 0 N-CA-C 112.1 0.407 . . . . 0.0 112.1 -179.531 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' C' C ' 99' ' ' GLU . . . . . . . . . . . . . 28.3 tt0 -79.74 17.26 0.95 Allowed 'General case' 0 CA--C 1.536 0.417 0 N-CA-C 113.004 0.742 . . . . 0.0 113.004 -176.467 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' C' C ' 100' ' ' ASN . . . . . . . . . . . . . 3.0 m-20 62.74 31.39 16.6 Favored 'General case' 0 CA--C 1.532 0.272 0 O-C-N 122.11 -0.369 . . . . 0.0 111.908 176.765 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' C' C ' 101' ' ' GLU . . . . . . . . . . . . . 84.8 tt0 -111.92 142.55 44.18 Favored 'General case' 0 C--N 1.332 -0.165 0 N-CA-C 109.594 -0.521 . . . . 0.0 109.594 173.762 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' C' C ' 102' ' ' VAL . . . . . . . . . . . . . 43.3 t -115.42 129.33 71.87 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.306 0 CA-C-N 116.368 -0.378 . . . . 0.0 110.213 -177.449 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' C' C ' 103' ' ' LEU . . . . . . . . . . . . . 39.9 mt -115.96 129.7 56.5 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 115.601 -0.727 . . . . 0.0 109.822 176.9 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' C' C ' 104' ' ' ILE . . . . . . . . . . . . . 67.4 mt -117.97 121.19 66.73 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.228 0 N-CA-C 110.343 -0.243 . . . . 0.0 110.343 -178.784 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' C' C ' 105' ' ' PHE . . . . . . . . . . . . . 52.7 m-85 -122.66 166.95 14.06 Favored 'General case' 0 C--N 1.333 -0.139 0 O-C-N 123.872 0.732 . . . . 0.0 109.948 179.625 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' C' C ' 106' ' ' ASN . . . . . . . . . . . . . 43.9 p-10 -102.23 -169.97 1.75 Allowed 'General case' 0 C--N 1.33 -0.245 0 N-CA-C 109.972 -0.381 . . . . 0.0 109.972 174.883 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' C' C ' 107' ' ' GLN . . . . . . . . . . . . . 43.2 tt0 -57.19 -29.52 63.75 Favored 'General case' 0 C--N 1.33 -0.274 0 N-CA-C 111.915 0.339 . . . . 0.0 111.915 178.19 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' C' C ' 108' ' ' ASN . . . . . . . . . . . . . 4.0 t-20 -84.67 11.5 8.85 Favored 'General case' 0 CA--C 1.535 0.384 0 N-CA-C 113.009 0.744 . . . . 0.0 113.009 -176.96 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' C' C ' 109' ' ' LEU . . . . . . . . . . . . . 9.7 tp 53.65 37.23 25.56 Favored 'General case' 0 C--O 1.233 0.19 0 CA-C-O 121.064 0.459 . . . . 0.0 111.254 -179.809 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' C' C ' 110' ' ' GLU . . . . . . . . . . . . . 95.8 mt-10 -104.8 145.36 30.48 Favored 'General case' 0 C--N 1.33 -0.25 0 N-CA-C 109.566 -0.531 . . . . 0.0 109.566 175.499 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' C' C ' 111' ' ' GLU . . . . . . . . . . . . . 71.0 tt0 -80.01 121.93 26.1 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-O 120.893 0.377 . . . . 0.0 110.576 -176.738 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' C' C ' 112' ' ' LEU . . . . . . . . . . . . . 10.8 mt -107.66 -46.05 3.9 Favored 'General case' 0 C--N 1.331 -0.218 0 CA-C-N 116.066 -0.515 . . . . 0.0 110.386 -179.54 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' C' C ' 113' ' ' TYR . . . . . . . . . . . . . 55.6 t80 -136.79 142.2 42.94 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-N 116.336 -0.393 . . . . 0.0 111.085 -178.784 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' C' C ' 114' ' ' ARG . . . . . . . . . . . . . 35.9 ptt-85 -142.52 124.59 15.34 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.063 -0.517 . . . . 0.0 110.363 177.507 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' C' C ' 115' ' ' GLY . . . . . . . . . . . . . . . -150.11 162.6 29.25 Favored Glycine 0 CA--C 1.524 0.629 0 N-CA-C 111.123 -0.791 . . . . 0.0 111.123 -179.765 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' C' C ' 116' ' ' LYS . . . . . . . . . . . . . 69.2 tttt -132.09 136.73 47.38 Favored 'General case' 0 C--N 1.329 -0.319 0 N-CA-C 109.797 -0.445 . . . . 0.0 109.797 177.266 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' C' C ' 117' ' ' PHE . . . . . . . . . . . . . 38.2 m-85 -133.67 114.8 13.88 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-O 120.905 0.383 . . . . 0.0 110.179 -175.595 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' C' C ' 118' ' ' GLU . . . . . . . . . . . . . 71.0 mm-40 -51.07 -52.42 43.59 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.454 -0.339 . . . . 0.0 111.792 -176.042 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' C' C ' 119' ' ' ASN . . . . . . . . . . . . . 1.8 m-80 -95.63 31.18 2.09 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.274 -0.421 . . . . 0.0 112.024 -174.193 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' C' C ' 120' ' ' LEU . . . . . . . . . . . . . 18.3 tp -53.57 121.24 7.36 Favored 'General case' 0 N--CA 1.463 0.22 0 O-C-N 122.234 -0.291 . . . . 0.0 110.929 178.704 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' C' C ' 121' ' ' ASN . . . . . . . . . . . . . 69.2 m-20 -113.75 -43.85 3.25 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.341 -0.391 . . . . 0.0 110.929 -177.096 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' C' C ' 122' ' ' LYS . . . . . . . . . . . . . 97.1 mttt -144.69 147.47 33.05 Favored 'General case' 0 C--N 1.332 -0.177 0 CA-C-O 121.154 0.502 . . . . 0.0 111.946 -176.993 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' C' C ' 123' ' ' VAL . . . . . . . . . . . . . 45.6 t -125.82 125.43 68.31 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.259 0 N-CA-C 109.079 -0.711 . . . . 0.0 109.079 173.351 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' C' C ' 124' ' ' LEU . . . . . . . . . . . . . 59.9 mt -123.9 138.76 54.43 Favored 'General case' 0 C--N 1.331 -0.216 0 CA-C-O 120.877 0.37 . . . . 0.0 110.99 -176.232 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' C' C ' 125' ' ' VAL . . . . . . . . . . . . . 35.7 m -133.97 140.51 46.16 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.28 0 CA-C-N 116.018 -0.537 . . . . 0.0 110.365 178.399 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' C' C ' 126' ' ' ARG . . . . . . . . . . . . . 38.9 ttt180 -151.09 122.66 7.95 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-O 120.98 0.419 . . . . 0.0 110.67 177.634 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' C' C ' 127' ' ' ASN . . . . . . . . . . . . . 20.3 t-20 52.08 -107.29 0.32 Allowed 'General case' 0 CA--C 1.543 0.687 0 CA-C-O 118.968 -0.539 . . . . 0.0 111.177 -179.048 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' C' C ' 128' ' ' ASP . . . . . . . . . . . . . 17.7 p-10 -114.17 5.07 15.78 Favored 'General case' 0 N--CA 1.467 0.413 0 CA-C-N 119.654 1.116 . . . . 0.0 113.468 -177.223 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' C' C ' 129' ' ' LEU . . . . . . . . . . . . . 18.3 tp -106.66 138.62 42.49 Favored 'General case' 0 C--O 1.232 0.147 0 O-C-N 122.008 -0.432 . . . . 0.0 110.362 -179.419 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' C' C ' 130' ' ' VAL . . . . . . . . . . . . . 40.4 t -121.33 135.36 61.75 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.227 0 N-CA-C 109.724 -0.472 . . . . 0.0 109.724 179.938 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' C' C ' 131' ' ' VAL . . . . . . . . . . . . . 43.0 t -136.01 136.82 49.42 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.24 0 CA-C-O 120.997 0.427 . . . . 0.0 110.419 179.985 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' C' C ' 132' ' ' ILE . . . . . . . . . . . . . 68.5 mt -118.42 133.87 63.86 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.314 0 CA-C-N 115.853 -0.612 . . . . 0.0 109.491 179.058 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' C' C ' 133' ' ' ILE . . . . . . . . . . . . . 37.6 mm -116.78 119.31 61.62 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.231 0 CA-C-N 116.52 -0.309 . . . . 0.0 110.941 -175.361 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' C' C ' 134' ' ' ASP . . . . . . . . . . . . . 7.4 p-10 -130.13 148.95 52.03 Favored 'General case' 0 C--N 1.332 -0.182 0 N-CA-C 109.727 -0.471 . . . . 0.0 109.727 174.258 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' C' C ' 135' ' ' GLU . . . . . . . . . . . . . 39.2 tp10 -49.95 -24.57 2.63 Favored 'General case' 0 C--N 1.329 -0.302 0 N-CA-C 112.996 0.739 . . . . 0.0 112.996 -170.471 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' C' C ' 136' ' ' GLN . . . . . . . . . . . . . 52.8 mt-30 -104.76 -26.63 12.19 Favored 'General case' 0 N--CA 1.464 0.248 0 N-CA-C 112.773 0.657 . . . . 0.0 112.773 -174.113 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' C' C ' 137' ' ' LYS . . . . . . . . . . . . . 56.6 mtpt -141.15 150.0 42.23 Favored 'General case' 0 C--N 1.332 -0.194 0 CA-C-O 121.404 0.621 . . . . 0.0 112.099 -169.038 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' C' C ' 138' ' ' LEU . . . . . . . . . . . . . 18.1 tp -111.12 120.6 42.86 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 115.054 -0.975 . . . . 0.0 109.045 173.259 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' C' C ' 139' ' ' THR . . . . . . . . . . . . . 27.0 m -109.82 126.02 53.36 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-O 120.82 0.343 . . . . 0.0 110.973 -178.23 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' C' C ' 140' ' ' LEU . . . . . . . . . . . . . 17.7 tp -115.61 122.71 46.42 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 115.471 -0.786 . . . . 0.0 109.309 -179.361 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' C' C ' 141' ' ' ILE . . . . . . . . . . . . . 19.5 mt -121.76 119.42 58.74 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 N-CA-C 109.763 -0.458 . . . . 0.0 109.763 -176.37 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' C' C ' 142' ' ' ARG . . . . . . . . . . . . . 82.6 mtm180 -111.92 122.93 49.14 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 115.691 -0.686 . . . . 0.0 110.721 -177.769 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' C' C ' 143' ' ' THR . . . . . . . . . . . . . 41.1 p . . . . . 0 C--O 1.22 -0.477 0 CA-C-O 118.06 -0.971 . . . . 0.0 110.606 -179.52 . . . . . . . . 0 0 . 1 . 002 nuclear orig full ' D' D ' -3' ' ' GLU . . . . . . . . . . . . . 44.3 mp0 . . . . . 0 N--CA 1.489 1.524 0 N-CA-C 109.317 -0.623 . . . . 0.0 109.317 . . . . . . . . . 0 0 . 1 . 002 nuclear orig full ' D' D ' -2' ' ' GLY . . . . . . . . . . . . . . . -69.92 140.14 32.44 Favored Glycine 0 CA--C 1.525 0.692 0 N-CA-C 111.123 -0.791 . . . . 0.0 111.123 -179.54 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' D' D ' -1' ' ' VAL . . . . . . . . . . . . . 46.9 t -141.47 131.61 25.57 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.348 0 N-CA-C 109.607 -0.516 . . . . 0.0 109.607 178.451 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' D' D ' 0' ' ' ILE . . . . . . . . . . . . . 69.9 mt -111.77 126.92 69.2 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.266 0 CA-C-N 116.249 -0.432 . . . . 0.0 110.227 -178.173 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' D' D ' 1' ' ' MET . . . . . . . . . . . . . 18.2 ptp -80.39 119.82 23.6 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.049 -0.523 . . . . 0.0 110.134 177.655 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' D' D ' 2' ' ' SER . . . . . . . . . . . . . 92.7 p -113.95 154.55 27.39 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-O 121.01 0.433 . . . . 0.0 110.742 -177.836 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' D' D ' 3' ' ' GLU . . . . . . . . . . . . . 47.1 mp0 -139.41 144.58 38.17 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 115.933 -0.576 . . . . 0.0 111.227 -176.669 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' D' D ' 4' ' ' LEU . . . . . . . . . . . . . 16.4 tp -123.32 126.8 47.54 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 115.777 -0.647 . . . . 0.0 109.685 175.187 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' D' D ' 5' ' ' LYS . . . . . . . . . . . . . 88.3 mttt -109.02 121.0 44.21 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.384 -0.371 . . . . 0.0 110.642 -178.542 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' D' D ' 6' ' ' LEU . . . . . . . . . . . . . 47.8 mt -115.48 144.5 43.75 Favored 'General case' 0 C--N 1.331 -0.21 0 CA-C-N 115.87 -0.605 . . . . 0.0 110.256 -179.844 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' D' D ' 7' ' ' LYS . . . . . . . . . . . . . 45.4 tttp -127.37 136.89 29.59 Favored Pre-proline 0 CA--C 1.532 0.278 0 CA-C-O 118.886 -0.578 . . . . 0.0 109.465 175.17 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' D' D ' 8' ' ' PRO . . . . . . . . . . . . . 71.9 Cg_endo -90.41 132.99 1.82 Allowed 'Trans proline' 0 N--CA 1.49 1.319 0 C-N-CA 121.619 1.546 . . . . 0.0 111.858 178.548 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' D' D ' 9' ' ' LEU . . . . . . . . . . . . . 43.0 mt -72.26 -46.99 10.77 Favored Pre-proline 0 C--N 1.329 -0.313 0 CA-C-O 118.69 -0.671 . . . . 0.0 111.963 -179.956 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' D' D ' 10' ' ' PRO . . . . . . . . . . . . . 93.2 Cg_endo -82.37 146.63 13.94 Favored 'Trans proline' 0 N--CA 1.496 1.62 0 C-N-CA 121.178 1.252 . . . . 0.0 111.635 174.978 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' D' D ' 11' ' ' LYS . . . . . . . . . . . . . 25.1 pttm -71.67 119.2 15.49 Favored 'General case' 0 C--N 1.331 -0.203 0 N-CA-C 109.692 -0.484 . . . . 0.0 109.692 177.19 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' D' D ' 12' ' ' VAL . . . . . . . . . . . . . 12.2 p -151.17 149.51 14.07 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.288 0 CA-C-N 116.094 -0.503 . . . . 0.0 111.127 -176.414 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' D' D ' 13' ' ' GLU . . . . . . . . . . . . . 42.5 mt-10 -108.46 109.98 21.38 Favored 'General case' 0 C--N 1.331 -0.227 0 CA-C-N 115.985 -0.552 . . . . 0.0 109.81 175.466 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' D' D ' 14' ' ' LEU . . . . . . . . . . . . . 16.1 mt -97.6 152.1 37.98 Favored Pre-proline 0 CA--C 1.532 0.282 0 CA-C-O 119.398 -0.334 . . . . 0.0 110.915 -176.724 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' D' D ' 15' ' ' PRO . . . . . . . . . . . . . 25.5 Cg_exo -62.36 160.41 31.39 Favored 'Trans proline' 0 N--CA 1.498 1.769 0 C-N-CA 121.337 1.358 . . . . 0.0 111.894 176.999 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' D' D ' 16' ' ' PRO . . . . . . . . . . . . . 27.2 Cg_exo -60.98 -37.79 73.91 Favored 'Trans proline' 0 N--CA 1.498 1.758 0 C-N-CA 121.479 1.453 . . . . 0.0 112.643 -179.7 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' D' D ' 17' ' ' ASP . . . . . . . . . . . . . 11.1 p-10 -81.63 4.9 19.93 Favored 'General case' 0 CA--C 1.536 0.429 0 N-CA-C 113.303 0.853 . . . . 0.0 113.303 -177.501 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' D' D ' 18' ' ' PHE . . . . . . . . . . . . . 52.4 t80 -57.5 -44.26 84.85 Favored 'General case' 0 C--N 1.335 -0.059 0 O-C-N 121.929 -0.482 . . . . 0.0 110.272 -178.286 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' D' D ' 19' ' ' VAL . . . . . . . . . . . . . 44.0 t -55.52 -44.16 75.17 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.289 0 CA-C-N 116.396 -0.365 . . . . 0.0 110.804 -178.144 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' D' D ' 20' ' ' ASP . . . . . . . . . . . . . 13.4 t70 -59.8 -42.2 92.93 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-O 120.888 0.375 . . . . 0.0 110.809 -177.761 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' D' D ' 21' ' ' VAL . . . . . . . . . . . . . 45.2 t -64.31 -46.48 93.08 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.28 0 C-N-CA 120.742 -0.383 . . . . 0.0 110.534 -178.3 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' D' D ' 22' ' ' ILE . . . . . . . . . . . . . 51.4 mm -55.12 -47.38 77.32 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.232 0 C-N-CA 121.087 -0.245 . . . . 0.0 110.662 178.931 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' D' D ' 23' ' ' ARG . . . . . . . . . . . . . 52.6 ttp180 -53.74 -51.92 61.81 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-O 120.659 0.266 . . . . 0.0 111.418 -178.792 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' D' D ' 24' ' ' ILE . . . . . . . . . . . . . 71.2 mt -58.54 -43.15 86.45 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.344 0 C-N-CA 121.034 -0.266 . . . . 0.0 111.451 -175.705 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' D' D ' 25' ' ' LYS . . . . . . . . . . . . . 60.1 mttm -66.67 -43.68 83.82 Favored 'General case' 0 C--N 1.33 -0.269 0 N-CA-C 112.183 0.438 . . . . 0.0 112.183 -177.768 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' D' D ' 26' ' ' LEU . . . . . . . . . . . . . 27.1 mt -81.73 -25.95 34.98 Favored 'General case' 0 C--N 1.329 -0.298 0 N-CA-C 113.1 0.778 . . . . 0.0 113.1 -172.825 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' D' D ' 27' ' ' GLN . . . . . . . . . . . . . 5.8 pt20 -45.76 139.28 4.19 Favored 'General case' 0 N--CA 1.467 0.412 0 N-CA-C 112.819 0.674 . . . . 0.0 112.819 -174.666 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' D' D ' 28' ' ' GLY . . . . . . . . . . . . . . . 100.43 -26.95 22.63 Favored Glycine 0 CA--C 1.532 1.14 0 CA-C-N 115.755 -0.657 . . . . 0.0 112.116 -177.671 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' D' D ' 29' ' ' LYS . . . . . . . . . . . . . 64.0 mttp -96.72 155.09 16.92 Favored 'General case' 0 C--N 1.332 -0.175 0 CA-C-N 117.376 0.588 . . . . 0.0 110.788 178.525 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' D' D ' 30' ' ' THR . . . . . . . . . . . . . 35.3 m -108.11 141.24 40.11 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.196 -0.456 . . . . 0.0 110.489 178.993 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' D' D ' 31' ' ' VAL . . . . . . . . . . . . . 35.4 m -127.96 156.5 39.99 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.234 0 CA-C-N 116.097 -0.501 . . . . 0.0 110.32 179.147 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' D' D ' 32' ' ' ARG . . . . . . . . . . . . . 72.9 ttt-85 -130.17 150.28 51.49 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-O 121.116 0.484 . . . . 0.0 110.456 179.703 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' D' D ' 33' ' ' THR . . . . . . . . . . . . . 14.9 m -52.39 137.15 30.03 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.376 -0.375 . . . . 0.0 111.478 -178.148 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' D' D ' 34' ' ' GLY . . . . . . . . . . . . . . . 100.84 -17.17 56.77 Favored Glycine 0 CA--C 1.533 1.175 0 CA-C-O 119.691 -0.505 . . . . 0.0 113.241 179.021 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' D' D ' 35' ' ' ASP . . . . . . . . . . . . . 73.4 m-20 -66.58 150.96 48.24 Favored 'General case' 0 C--O 1.231 0.124 0 CA-C-N 118.083 0.941 . . . . 0.0 111.364 179.992 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' D' D ' 36' ' ' VAL . . . . . . . . . . . . . 41.9 t -122.01 127.81 75.44 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.228 0 CA-C-N 115.934 -0.575 . . . . 0.0 109.684 177.652 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' D' D ' 37' ' ' ILE . . . . . . . . . . . . . 61.8 mt -121.33 138.53 51.39 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.256 0 N-CA-C 109.882 -0.414 . . . . 0.0 109.882 -179.253 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' D' D ' 38' ' ' GLY . . . . . . . . . . . . . . . -117.52 128.85 8.01 Favored Glycine 0 CA--C 1.526 0.764 0 N-CA-C 111.123 -0.791 . . . . 0.0 111.123 -179.892 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' D' D ' 39' ' ' ILE . . . . . . . . . . . . . 74.5 mt -126.21 136.62 60.29 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.176 0 CA-C-O 120.785 0.326 . . . . 0.0 110.179 178.903 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' D' D ' 40' ' ' SER . . . . . . . . . . . . . 63.7 p -91.59 122.44 34.16 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.219 -0.446 . . . . 0.0 110.816 176.216 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' D' D ' 41' ' ' ILE . . . . . . . . . . . . . 68.3 mt -130.46 117.55 39.78 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.231 0 CA-C-O 120.89 0.376 . . . . 0.0 110.244 178.262 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' D' D ' 42' ' ' LEU . . . . . . . . . . . . . 1.3 tt 54.62 43.73 29.75 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-O 121.419 0.628 . . . . 0.0 110.401 177.603 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' D' D ' 43' ' ' GLY . . . . . . . . . . . . . . . 71.12 19.0 76.96 Favored Glycine 0 CA--C 1.533 1.157 0 C-N-CA 121.211 -0.519 . . . . 0.0 113.089 175.411 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' D' D ' 44' ' ' LYS . . . . . . . . . . . . . 53.1 mttm -131.05 130.5 43.33 Favored 'General case' 0 C--N 1.333 -0.137 0 CA-C-N 117.774 0.787 . . . . 0.0 110.342 178.836 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' D' D ' 45' ' ' GLU . . . . . . . . . . . . . 84.8 tt0 -84.1 124.93 31.63 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 116.499 -0.319 . . . . 0.0 111.258 -178.917 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' D' D ' 46' ' ' VAL . . . . . . . . . . . . . 10.1 p -117.84 124.71 73.46 Favored 'Isoleucine or valine' 0 N--CA 1.462 0.172 0 N-CA-C 109.577 -0.527 . . . . 0.0 109.577 174.549 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' D' D ' 47' ' ' LYS . . . . . . . . . . . . . 64.7 mttp -98.52 124.11 43.07 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.076 -0.511 . . . . 0.0 110.859 178.529 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' D' D ' 48' ' ' PHE . . . . . . . . . . . . . 34.3 m-85 -108.49 131.87 54.39 Favored 'General case' 0 C--N 1.329 -0.324 0 N-CA-C 109.563 -0.532 . . . . 0.0 109.563 176.545 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' D' D ' 49' ' ' LYS . . . . . . . . . . . . . 46.6 tttp -107.48 133.65 51.66 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.367 -0.379 . . . . 0.0 110.137 178.202 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' D' D ' 50' ' ' VAL . . . . . . . . . . . . . 44.1 t -76.63 104.4 4.64 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.325 0 N-CA-C 109.414 -0.587 . . . . 0.0 109.414 177.802 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' D' D ' 51' ' ' VAL . . . . . . . . . . . . . 52.5 t -69.83 -53.38 24.38 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.324 0 CA-C-N 115.985 -0.552 . . . . 0.0 109.646 -175.732 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' D' D ' 52' ' ' GLN . . . . . . . . . . . . . 87.9 mt-30 -153.73 152.2 30.49 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 115.949 -0.569 . . . . 0.0 111.377 -177.752 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' D' D ' 53' ' ' ALA . . . . . . . . . . . . . . . -131.04 129.9 42.58 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 115.231 -0.895 . . . . 0.0 109.55 175.198 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' D' D ' 54' ' ' TYR . . . . . . . . . . . . . 54.3 t80 -128.35 108.01 19.36 Favored Pre-proline 0 CA--C 1.534 0.339 0 CA-C-O 118.179 -0.915 . . . . 0.0 110.276 -179.536 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' D' D ' 55' ' ' PRO . . . . . . . . . . . . . 74.0 Cg_endo -77.09 170.08 72.59 Favored 'Cis proline' 0 N--CA 1.5 1.859 0 CA-C-N 121.754 1.662 . . . . 0.0 112.608 -3.981 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' D' D ' 56' ' ' SER . . . . . . . . . . . . . 13.6 m -112.88 131.72 22.64 Favored Pre-proline 0 CA--C 1.539 0.53 0 CA-C-O 118.438 -0.791 . . . . 0.0 109.666 176.17 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' D' D ' 57' ' ' PRO . . . . . . . . . . . . . 42.2 Cg_endo -69.42 168.17 67.25 Favored 'Cis proline' 0 N--CA 1.496 1.66 0 CA-C-N 121.929 1.725 . . . . 0.0 111.374 -3.732 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' D' D ' 58' ' ' LEU . . . . . . . . . . . . . 44.9 tp -130.24 137.67 50.15 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-O 120.955 0.407 . . . . 0.0 110.256 -179.804 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' D' D ' 59' ' ' ARG . . . . . . . . . . . . . 74.0 ttt180 -104.2 134.47 47.38 Favored 'General case' 0 C--N 1.327 -0.396 0 CA-C-N 115.918 -0.583 . . . . 0.0 109.767 178.033 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' D' D ' 60' ' ' VAL . . . . . . . . . . . . . 42.6 t -76.98 112.91 15.43 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.316 0 C-N-CA 120.821 -0.351 . . . . 0.0 110.183 -177.545 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' D' D ' 61' ' ' GLU . . . . . . . . . . . . . 96.0 mt-10 -131.08 162.05 30.69 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.001 -0.545 . . . . 0.0 110.077 178.944 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' D' D ' 62' ' ' ASP . . . . . . . . . . . . . 6.4 t70 -53.63 -31.86 48.98 Favored 'General case' 0 C--N 1.327 -0.375 0 N-CA-C 111.862 0.319 . . . . 0.0 111.862 -179.092 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' D' D ' 63' ' ' ARG . . . . . . . . . . . . . 39.4 ptt180 -84.66 3.91 34.9 Favored 'General case' 0 CA--C 1.537 0.449 0 N-CA-C 113.774 1.027 . . . . 0.0 113.774 -174.555 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' D' D ' 64' ' ' THR . . . . . . . . . . . . . 25.7 m -92.02 138.84 31.21 Favored 'General case' 0 C--N 1.333 -0.152 0 CA-C-N 118.155 0.434 . . . . 0.0 110.854 -177.805 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' D' D ' 65' ' ' LYS . . . . . . . . . . . . . 68.0 mttm -88.62 127.84 35.57 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.069 -0.514 . . . . 0.0 109.894 177.834 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' D' D ' 66' ' ' ILE . . . . . . . . . . . . . 59.8 mt -115.65 126.43 73.18 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.228 0 N-CA-C 109.684 -0.487 . . . . 0.0 109.684 179.314 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' D' D ' 67' ' ' THR . . . . . . . . . . . . . 28.4 m -126.8 145.04 50.78 Favored 'General case' 0 C--O 1.233 0.216 0 CA-C-O 121.271 0.558 . . . . 0.0 111.637 -175.448 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' D' D ' 68' ' ' LEU . . . . . . . . . . . . . 6.1 tt -97.18 124.07 41.14 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 115.435 -0.802 . . . . 0.0 109.528 175.366 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' D' D ' 69' ' ' VAL . . . . . . . . . . . . . 44.7 t -100.14 137.22 28.33 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.315 0 CA-C-O 121.102 0.477 . . . . 0.0 110.902 -175.008 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' D' D ' 70' ' ' THR . . . . . . . . . . . . . 3.6 t -137.27 63.0 1.57 Allowed 'General case' 0 C--N 1.33 -0.244 0 CA-C-O 121.625 0.726 . . . . 0.0 110.129 178.134 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' D' D ' 71' ' ' HIS . . . . . . . . . . . . . 6.1 m-70 -109.82 175.34 1.97 Allowed Pre-proline 0 CA--C 1.534 0.362 0 CA-C-N 115.688 -0.687 . . . . 0.0 110.476 -176.705 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' D' D ' 72' ' ' PRO . . . . . . . . . . . . . 21.7 Cg_exo -64.92 160.03 43.22 Favored 'Trans proline' 0 N--CA 1.496 1.63 0 C-N-CA 121.569 1.512 . . . . 0.0 112.148 179.836 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' D' D ' 73' ' ' VAL . . . . . . . . . . . . . 35.1 m -69.82 172.32 0.89 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.298 0 CA-C-N 115.881 -0.6 . . . . 0.0 111.18 -174.557 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' D' D ' 74' ' ' ASP . . . . . . . . . . . . . 12.5 t0 -94.89 123.24 38.24 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 115.893 -0.594 . . . . 0.0 110.294 -176.873 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' D' D ' 75' ' ' VAL . . . . . . . . . . . . . 47.1 t -116.33 121.9 68.57 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.209 0 CA-C-O 121.143 0.496 . . . . 0.0 110.204 -179.323 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' D' D ' 76' ' ' LEU . . . . . . . . . . . . . 36.8 mt -123.67 144.6 49.54 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 115.547 -0.751 . . . . 0.0 109.68 -179.54 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' D' D ' 77' ' ' GLU . . . . . . . . . . . . . 97.2 mt-10 -137.74 131.29 31.09 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-O 121.096 0.474 . . . . 0.0 111.274 -178.946 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' D' D ' 78' ' ' ALA . . . . . . . . . . . . . . . -118.94 139.82 51.02 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 115.693 -0.685 . . . . 0.0 109.974 177.183 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' D' D ' 79' ' ' LYS . . . . . . . . . . . . . 35.2 tptt -80.47 116.43 20.51 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.513 -0.312 . . . . 0.0 110.818 -177.586 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' D' D ' 80' ' ' ILE . . . . . . . . . . . . . 40.7 mm -139.11 108.18 3.69 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.237 0 CA-C-N 116.325 -0.398 . . . . 0.0 109.971 -176.542 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' D' D ' 81' ' ' LYS . . . . . . . . . . . . . 51.1 mttm -103.56 129.09 50.71 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-O 120.761 0.315 . . . . 0.0 111.18 -179.088 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' D' D ' 82' ' ' GLY . . . . . . . . . . . . . . . 89.05 42.16 5.69 Favored Glycine 0 CA--C 1.524 0.656 0 C-N-CA 120.828 -0.701 . . . . 0.0 111.545 173.64 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' D' D ' 83' ' ' ILE . . . . . . . . . . . . . 72.7 mt -67.15 131.1 32.93 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.365 0 N-CA-C 109.915 -0.402 . . . . 0.0 109.915 178.646 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' D' D ' 84' ' ' LYS . . . . . . . . . . . . . 76.3 tttt -91.15 -50.45 5.83 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-O 121.198 0.523 . . . . 0.0 109.665 179.619 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' D' D ' 85' ' ' ASP . . . . . . . . . . . . . 5.1 t70 -160.43 155.3 24.25 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 115.448 -0.796 . . . . 0.0 110.193 178.939 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' D' D ' 86' ' ' VAL . . . . . . . . . . . . . 40.1 t -131.54 133.31 61.91 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.285 0 CA-C-O 121.039 0.447 . . . . 0.0 110.175 179.699 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' D' D ' 87' ' ' ILE . . . . . . . . . . . . . 44.7 mm -119.05 128.46 75.8 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.294 0 CA-C-N 115.79 -0.641 . . . . 0.0 109.584 178.659 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' D' D ' 88' ' ' LEU . . . . . . . . . . . . . 21.8 tp -108.53 130.14 55.29 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-N 116.282 -0.417 . . . . 0.0 111.117 -177.638 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' D' D ' 89' ' ' ASP . . . . . . . . . . . . . 13.6 t70 -121.68 150.89 41.1 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 115.846 -0.616 . . . . 0.0 109.352 175.691 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' D' D ' 90' ' ' GLU . . . . . . . . . . . . . 43.8 tp10 -47.29 -36.34 9.07 Favored 'General case' 0 C--N 1.331 -0.206 0 N-CA-C 112.868 0.692 . . . . 0.0 112.868 -173.327 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' D' D ' 91' ' ' ASN . . . . . . . . . . . . . 86.9 m-20 -132.14 32.4 4.01 Favored 'General case' 0 N--CA 1.463 0.209 0 N-CA-C 112.097 0.406 . . . . 0.0 112.097 -176.332 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' D' D ' 92' ' ' LEU . . . . . . . . . . . . . 9.0 tp -166.15 151.23 8.32 Favored 'General case' 0 C--N 1.331 -0.223 0 C-N-CA 120.871 -0.332 . . . . 0.0 111.016 179.929 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' D' D ' 93' ' ' ILE . . . . . . . . . . . . . 71.2 mt -125.84 122.7 62.64 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.234 0 N-CA-C 109.429 -0.582 . . . . 0.0 109.429 179.707 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' D' D ' 94' ' ' VAL . . . . . . . . . . . . . 41.9 t -120.1 127.59 75.9 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.186 0 N-CA-C 110.09 -0.337 . . . . 0.0 110.09 -179.201 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' D' D ' 95' ' ' VAL . . . . . . . . . . . . . 44.4 t -123.27 133.47 69.02 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.275 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.042 -179.797 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' D' D ' 96' ' ' ILE . . . . . . . . . . . . . 65.5 mt -115.61 127.52 73.16 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.225 0 N-CA-C 109.559 -0.534 . . . . 0.0 109.559 179.231 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' D' D ' 97' ' ' THR . . . . . . . . . . . . . 66.4 p -100.47 153.58 19.24 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-O 121.081 0.467 . . . . 0.0 110.882 -178.656 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' D' D ' 98' ' ' GLU . . . . . . . . . . . . . 12.7 pt-20 -53.96 -21.71 8.65 Favored 'General case' 0 CA--C 1.534 0.362 0 N-CA-C 112.532 0.567 . . . . 0.0 112.532 -179.409 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' D' D ' 99' ' ' GLU . . . . . . . . . . . . . 96.2 mt-10 -81.34 14.99 2.16 Favored 'General case' 0 CA--C 1.534 0.364 0 N-CA-C 113.077 0.769 . . . . 0.0 113.077 -177.071 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' D' D ' 100' ' ' ASN . . . . . . . . . . . . . 4.7 m-20 62.18 34.86 15.91 Favored 'General case' 0 CA--C 1.53 0.203 0 CA-C-N 118.085 0.402 . . . . 0.0 111.182 -179.904 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' D' D ' 101' ' ' GLU . . . . . . . . . . . . . 83.5 tt0 -112.37 142.04 45.38 Favored 'General case' 0 C--N 1.333 -0.148 0 N-CA-C 109.534 -0.543 . . . . 0.0 109.534 174.552 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' D' D ' 102' ' ' VAL . . . . . . . . . . . . . 46.7 t -115.0 126.57 72.62 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.277 0 N-CA-C 109.847 -0.427 . . . . 0.0 109.847 -178.239 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' D' D ' 103' ' ' LEU . . . . . . . . . . . . . 26.0 mt -116.64 127.87 54.84 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 115.658 -0.701 . . . . 0.0 110.022 177.703 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' D' D ' 104' ' ' ILE . . . . . . . . . . . . . 67.9 mt -117.61 122.68 70.39 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.262 0 CA-C-N 116.408 -0.36 . . . . 0.0 110.219 -179.336 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' D' D ' 105' ' ' PHE . . . . . . . . . . . . . 66.2 m-85 -124.5 163.16 22.45 Favored 'General case' 0 C--N 1.331 -0.202 0 O-C-N 123.804 0.69 . . . . 0.0 109.757 179.521 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' D' D ' 106' ' ' ASN . . . . . . . . . . . . . 45.8 p-10 -96.83 -173.11 2.62 Favored 'General case' 0 C--N 1.329 -0.308 0 N-CA-C 109.59 -0.522 . . . . 0.0 109.59 173.889 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' D' D ' 107' ' ' GLN . . . . . . . . . . . . . 28.6 tt0 -60.85 -23.99 65.55 Favored 'General case' 0 CA--C 1.534 0.337 0 N-CA-C 112.312 0.486 . . . . 0.0 112.312 179.862 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' D' D ' 108' ' ' ASN . . . . . . . . . . . . . 60.6 t30 -86.53 10.22 16.0 Favored 'General case' 0 CA--C 1.536 0.43 0 N-CA-C 113.037 0.754 . . . . 0.0 113.037 -178.737 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' D' D ' 109' ' ' LEU . . . . . . . . . . . . . 12.3 tp 57.04 38.94 29.54 Favored 'General case' 0 C--N 1.332 -0.194 0 CA-C-O 121.152 0.501 . . . . 0.0 111.206 178.885 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' D' D ' 110' ' ' GLU . . . . . . . . . . . . . 70.9 mm-40 -107.1 148.82 28.32 Favored 'General case' 0 C--N 1.33 -0.265 0 N-CA-C 109.832 -0.432 . . . . 0.0 109.832 175.566 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' D' D ' 111' ' ' GLU . . . . . . . . . . . . . 83.1 tt0 -78.16 121.89 24.92 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.27 -0.423 . . . . 0.0 110.821 -177.683 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' D' D ' 112' ' ' LEU . . . . . . . . . . . . . 31.4 mt -109.6 -46.05 3.58 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-N 116.256 -0.429 . . . . 0.0 110.686 179.564 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' D' D ' 113' ' ' TYR . . . . . . . . . . . . . 58.0 t80 -140.71 135.31 31.45 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 116.264 -0.425 . . . . 0.0 110.927 -179.2 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' D' D ' 114' ' ' ARG . . . . . . . . . . . . . 69.6 ttp85 -136.42 122.03 19.65 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.138 -0.483 . . . . 0.0 110.117 178.035 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' D' D ' 115' ' ' GLY . . . . . . . . . . . . . . . -150.03 153.14 24.91 Favored Glycine 0 CA--C 1.524 0.652 0 N-CA-C 110.996 -0.842 . . . . 0.0 110.996 179.015 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' D' D ' 116' ' ' LYS . . . . . . . . . . . . . 63.4 tttt -129.5 132.13 46.82 Favored 'General case' 0 C--N 1.329 -0.321 0 N-CA-C 109.825 -0.435 . . . . 0.0 109.825 177.941 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' D' D ' 117' ' ' PHE . . . . . . . . . . . . . 37.3 m-85 -128.13 117.25 21.27 Favored 'General case' 0 C--N 1.332 -0.187 0 CA-C-O 120.963 0.411 . . . . 0.0 110.232 -175.11 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' D' D ' 118' ' ' GLU . . . . . . . . . . . . . 44.9 tp10 -51.67 -51.21 57.68 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.403 -0.362 . . . . 0.0 111.61 -177.078 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' D' D ' 119' ' ' ASN . . . . . . . . . . . . . 3.6 m120 -94.48 30.95 1.85 Allowed 'General case' 0 C--N 1.329 -0.287 0 N-CA-C 112.249 0.463 . . . . 0.0 112.249 -174.927 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' D' D ' 120' ' ' LEU . . . . . . . . . . . . . 15.6 tp -56.7 121.09 8.97 Favored 'General case' 0 C--N 1.332 -0.167 0 CA-C-O 120.597 0.237 . . . . 0.0 110.41 178.032 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' D' D ' 121' ' ' ASN . . . . . . . . . . . . . 33.1 m120 -114.08 -44.0 3.19 Favored 'General case' 0 C--O 1.232 0.171 0 CA-C-N 116.723 -0.217 . . . . 0.0 111.147 -176.649 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' D' D ' 122' ' ' LYS . . . . . . . . . . . . . 61.4 mtpt -139.13 138.58 37.13 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-O 120.92 0.391 . . . . 0.0 111.314 -176.674 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' D' D ' 123' ' ' VAL . . . . . . . . . . . . . 45.1 t -126.93 126.2 67.98 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.326 0 N-CA-C 109.375 -0.602 . . . . 0.0 109.375 175.26 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' D' D ' 124' ' ' LEU . . . . . . . . . . . . . 59.5 mt -131.21 136.43 48.24 Favored 'General case' 0 C--N 1.332 -0.194 0 CA-C-O 120.95 0.405 . . . . 0.0 110.781 -177.444 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' D' D ' 125' ' ' VAL . . . . . . . . . . . . . 11.6 p -133.95 138.57 50.17 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.284 0 CA-C-N 116.113 -0.494 . . . . 0.0 110.355 178.863 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' D' D ' 126' ' ' ARG . . . . . . . . . . . . . 96.7 mtt180 -149.1 126.82 11.74 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 115.769 -0.65 . . . . 0.0 109.425 177.778 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' D' D ' 127' ' ' ASN . . . . . . . . . . . . . 1.8 t-20 57.63 -147.47 0.51 Allowed 'General case' 0 CA--C 1.541 0.62 0 N-CA-C 109.418 -0.586 . . . . 0.0 109.418 -178.352 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' D' D ' 128' ' ' ASP . . . . . . . . . . . . . 8.7 p-10 -87.32 17.38 4.44 Favored 'General case' 0 CA--C 1.534 0.36 0 CA-C-N 118.892 0.769 . . . . 0.0 112.657 178.03 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' D' D ' 129' ' ' LEU . . . . . . . . . . . . . 13.3 tp -112.5 136.16 52.35 Favored 'General case' 0 C--O 1.231 0.098 0 O-C-N 122.003 -0.435 . . . . 0.0 109.988 179.001 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' D' D ' 130' ' ' VAL . . . . . . . . . . . . . 39.0 t -124.89 140.05 49.19 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.338 0 CA-C-O 120.768 0.318 . . . . 0.0 110.354 -176.646 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' D' D ' 131' ' ' VAL . . . . . . . . . . . . . 44.2 t -136.07 136.48 49.52 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.206 0 CA-C-O 121.144 0.497 . . . . 0.0 110.309 177.459 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' D' D ' 132' ' ' ILE . . . . . . . . . . . . . 71.3 mt -120.41 134.16 64.78 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.229 0 CA-C-N 115.69 -0.686 . . . . 0.0 109.645 -179.105 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' D' D ' 133' ' ' ILE . . . . . . . . . . . . . 43.5 mm -117.44 120.96 66.44 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.215 0 CA-C-O 121.142 0.496 . . . . 0.0 111.045 -175.915 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' D' D ' 134' ' ' ASP . . . . . . . . . . . . . 6.7 p-10 -131.71 145.82 51.84 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 115.671 -0.695 . . . . 0.0 109.449 174.216 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' D' D ' 135' ' ' GLU . . . . . . . . . . . . . 41.2 tp10 -49.74 -24.63 2.43 Favored 'General case' 0 C--N 1.328 -0.361 0 N-CA-C 112.872 0.693 . . . . 0.0 112.872 -171.584 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' D' D ' 136' ' ' GLN . . . . . . . . . . . . . 96.9 mt-30 -94.25 -33.23 13.33 Favored 'General case' 0 C--O 1.232 0.166 0 N-CA-C 112.356 0.502 . . . . 0.0 112.356 -175.932 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' D' D ' 137' ' ' LYS . . . . . . . . . . . . . 54.4 mtmt -148.17 158.11 43.89 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-O 121.388 0.613 . . . . 0.0 112.114 -170.445 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' D' D ' 138' ' ' LEU . . . . . . . . . . . . . 5.6 tt -116.6 124.77 50.62 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 115.219 -0.9 . . . . 0.0 109.323 174.783 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' D' D ' 139' ' ' THR . . . . . . . . . . . . . 34.5 m -110.12 131.1 55.36 Favored 'General case' 0 C--N 1.331 -0.208 0 CA-C-N 116.366 -0.379 . . . . 0.0 110.863 -176.735 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' D' D ' 140' ' ' LEU . . . . . . . . . . . . . 6.1 tt -119.79 124.02 45.12 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 115.543 -0.753 . . . . 0.0 109.303 -178.735 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' D' D ' 141' ' ' ILE . . . . . . . . . . . . . 19.1 mt -121.28 120.25 61.49 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.314 0 CA-C-O 120.779 0.323 . . . . 0.0 110.131 -174.723 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' D' D ' 142' ' ' ARG . . . . . . . . . . . . . 82.8 mtp180 -110.32 127.66 55.15 Favored 'General case' 0 C--N 1.331 -0.226 0 CA-C-N 115.613 -0.722 . . . . 0.0 110.426 -179.039 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' D' D ' 143' ' ' THR . . . . . . . . . . . . . 59.8 p . . . . . 0 C--O 1.22 -0.463 0 CA-C-O 117.942 -1.028 . . . . 0.0 110.575 179.73 . . . . . . . . 0 0 . 1 . 002 nuclear orig full ' E' E ' -3' ' ' GLU . . . . . . . . . . . . . 95.6 mt-10 . . . . . 0 N--CA 1.489 1.525 0 N-CA-C 109.281 -0.637 . . . . 0.0 109.281 . . . . . . . . . 0 0 . 1 . 002 nuclear orig full ' E' E ' -2' ' ' GLY . . . . . . . . . . . . . . . -76.79 149.61 36.67 Favored Glycine 0 CA--C 1.525 0.702 0 N-CA-C 110.958 -0.857 . . . . 0.0 110.958 179.828 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' E' E ' -1' ' ' VAL . . . . . . . . . . . . . 46.5 t -95.71 133.1 38.03 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.368 0 N-CA-C 109.992 -0.373 . . . . 0.0 109.992 179.505 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' E' E ' 0' ' ' ILE . . . . . . . . . . . . . 70.0 mt -119.32 134.18 63.76 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.191 0 CA-C-N 116.207 -0.451 . . . . 0.0 110.105 -179.204 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' E' E ' 1' ' ' MET . . . . . . . . . . . . . 25.6 ptm -78.08 132.83 37.89 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.078 -0.51 . . . . 0.0 110.464 178.398 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' E' E ' 2' ' ' SER . . . . . . . . . . . . . 3.6 p -129.11 127.13 40.83 Favored 'General case' 0 C--N 1.331 -0.218 0 CA-C-O 120.955 0.407 . . . . 0.0 110.46 -179.617 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' E' E ' 3' ' ' GLU . . . . . . . . . . . . . 28.6 tp10 -139.44 137.55 35.71 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 115.745 -0.661 . . . . 0.0 110.503 -176.511 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' E' E ' 4' ' ' LEU . . . . . . . . . . . . . 17.8 tp -124.12 126.15 45.71 Favored 'General case' 0 C--N 1.33 -0.244 0 N-CA-C 109.564 -0.532 . . . . 0.0 109.564 174.525 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' E' E ' 5' ' ' LYS . . . . . . . . . . . . . 66.4 mttm -112.85 122.13 46.75 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-O 120.948 0.404 . . . . 0.0 110.87 -177.668 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' E' E ' 6' ' ' LEU . . . . . . . . . . . . . 59.2 mt -113.89 143.87 43.97 Favored 'General case' 0 C--N 1.331 -0.23 0 CA-C-N 115.199 -0.909 . . . . 0.0 110.161 -179.421 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' E' E ' 7' ' ' LYS . . . . . . . . . . . . . 84.8 tttt -121.05 135.22 24.68 Favored Pre-proline 0 CA--C 1.535 0.398 0 CA-C-O 118.858 -0.591 . . . . 0.0 109.529 176.167 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' E' E ' 8' ' ' PRO . . . . . . . . . . . . . 97.6 Cg_endo -91.19 132.65 1.5 Allowed 'Trans proline' 0 N--CA 1.49 1.275 0 C-N-CA 121.683 1.589 . . . . 0.0 111.765 178.484 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' E' E ' 9' ' ' LEU . . . . . . . . . . . . . 46.9 mt -74.31 -47.02 6.02 Favored Pre-proline 0 CA--C 1.533 0.32 0 CA-C-O 118.709 -0.662 . . . . 0.0 112.176 -177.55 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' E' E ' 10' ' ' PRO . . . . . . . . . . . . . 84.4 Cg_endo -81.41 153.37 18.2 Favored 'Trans proline' 0 N--CA 1.496 1.671 0 C-N-CA 121.158 1.239 . . . . 0.0 111.726 174.95 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' E' E ' 11' ' ' LYS . . . . . . . . . . . . . 57.1 tttm -86.77 99.44 11.8 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.418 -0.356 . . . . 0.0 110.3 178.747 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' E' E ' 12' ' ' VAL . . . . . . . . . . . . . 12.0 p -141.5 147.54 21.98 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.254 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.571 -178.59 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' E' E ' 13' ' ' GLU . . . . . . . . . . . . . 43.1 tp10 -93.76 122.36 36.15 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.059 -0.519 . . . . 0.0 110.045 177.61 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' E' E ' 14' ' ' LEU . . . . . . . . . . . . . 20.7 mt -95.94 148.94 35.33 Favored Pre-proline 0 C--N 1.329 -0.292 0 CA-C-O 119.328 -0.368 . . . . 0.0 110.465 -178.161 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' E' E ' 15' ' ' PRO . . . . . . . . . . . . . 24.8 Cg_exo -62.46 160.25 32.54 Favored 'Trans proline' 0 N--CA 1.497 1.731 0 C-N-CA 121.214 1.276 . . . . 0.0 111.722 177.404 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' E' E ' 16' ' ' PRO . . . . . . . . . . . . . 29.9 Cg_exo -60.06 -32.37 94.7 Favored 'Trans proline' 0 N--CA 1.497 1.685 0 C-N-CA 121.385 1.39 . . . . 0.0 112.718 -178.659 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' E' E ' 17' ' ' ASP . . . . . . . . . . . . . 18.1 p-10 -88.39 4.73 45.25 Favored 'General case' 0 CA--C 1.536 0.422 0 N-CA-C 113.326 0.861 . . . . 0.0 113.326 -177.414 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' E' E ' 18' ' ' PHE . . . . . . . . . . . . . 52.4 t80 -58.23 -43.2 87.64 Favored 'General case' 0 C--N 1.334 -0.077 0 O-C-N 121.998 -0.439 . . . . 0.0 110.042 -178.606 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' E' E ' 19' ' ' VAL . . . . . . . . . . . . . 47.2 t -55.54 -42.81 69.99 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.28 0 CA-C-N 116.33 -0.395 . . . . 0.0 110.585 -179.425 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' E' E ' 20' ' ' ASP . . . . . . . . . . . . . 76.7 m-20 -60.57 -42.99 97.76 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-O 120.801 0.334 . . . . 0.0 110.926 -178.485 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' E' E ' 21' ' ' VAL . . . . . . . . . . . . . 45.7 t -64.01 -46.32 94.24 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.265 0 C-N-CA 120.792 -0.363 . . . . 0.0 110.463 -177.757 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' E' E ' 22' ' ' ILE . . . . . . . . . . . . . 51.5 mm -55.67 -46.29 79.4 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.234 0 CA-C-O 120.788 0.328 . . . . 0.0 110.548 178.45 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' E' E ' 23' ' ' ARG . . . . . . . . . . . . . 54.6 ttp180 -53.1 -50.97 63.35 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-O 120.669 0.271 . . . . 0.0 111.569 -179.887 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' E' E ' 24' ' ' ILE . . . . . . . . . . . . . 74.6 mt -58.35 -47.28 88.22 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.312 0 CA-C-N 116.505 -0.316 . . . . 0.0 111.452 -176.3 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' E' E ' 25' ' ' LYS . . . . . . . . . . . . . 76.0 mttt -65.49 -40.59 93.26 Favored 'General case' 0 C--N 1.329 -0.298 0 N-CA-C 112.428 0.529 . . . . 0.0 112.428 -176.613 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' E' E ' 26' ' ' LEU . . . . . . . . . . . . . 40.6 mt -79.65 -38.6 33.35 Favored 'General case' 0 C--N 1.33 -0.245 0 N-CA-C 113.19 0.811 . . . . 0.0 113.19 -171.143 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' E' E ' 27' ' ' GLN . . . . . . . . . . . . . 13.1 pt20 -46.88 139.46 5.47 Favored 'General case' 0 N--CA 1.468 0.443 0 N-CA-C 112.785 0.661 . . . . 0.0 112.785 -174.976 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' E' E ' 28' ' ' GLY . . . . . . . . . . . . . . . 99.61 -25.54 27.86 Favored Glycine 0 CA--C 1.534 1.229 0 CA-C-N 115.559 -0.746 . . . . 0.0 112.178 -176.209 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' E' E ' 29' ' ' LYS . . . . . . . . . . . . . 95.6 mttt -97.21 155.19 16.95 Favored 'General case' 0 C--O 1.233 0.186 0 CA-C-N 117.324 0.562 . . . . 0.0 110.918 178.935 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' E' E ' 30' ' ' THR . . . . . . . . . . . . . 23.6 m -104.68 137.66 42.16 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 115.922 -0.581 . . . . 0.0 110.035 175.83 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' E' E ' 31' ' ' VAL . . . . . . . . . . . . . 35.2 m -127.82 155.69 39.36 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.235 0 CA-C-N 116.381 -0.372 . . . . 0.0 110.685 -179.235 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' E' E ' 32' ' ' ARG . . . . . . . . . . . . . 78.2 mtt85 -132.6 150.49 52.15 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.079 -0.51 . . . . 0.0 110.402 177.821 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' E' E ' 33' ' ' THR . . . . . . . . . . . . . 22.3 m -52.8 139.1 27.71 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.302 -0.408 . . . . 0.0 111.419 -179.194 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' E' E ' 34' ' ' GLY . . . . . . . . . . . . . . . 101.03 -17.21 56.49 Favored Glycine 0 CA--C 1.532 1.141 0 CA-C-O 119.69 -0.505 . . . . 0.0 113.165 179.751 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' E' E ' 35' ' ' ASP . . . . . . . . . . . . . 73.5 m-20 -66.95 149.64 50.33 Favored 'General case' 0 C--O 1.231 0.104 0 CA-C-N 118.08 0.94 . . . . 0.0 111.147 178.859 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' E' E ' 36' ' ' VAL . . . . . . . . . . . . . 43.1 t -121.83 130.89 74.19 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.24 0 CA-C-N 116.107 -0.497 . . . . 0.0 109.843 178.188 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' E' E ' 37' ' ' ILE . . . . . . . . . . . . . 65.1 mt -121.32 139.18 49.28 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.194 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.0 -178.971 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' E' E ' 38' ' ' GLY . . . . . . . . . . . . . . . -116.66 129.0 8.18 Favored Glycine 0 CA--C 1.525 0.676 0 N-CA-C 111.137 -0.785 . . . . 0.0 111.137 -179.873 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' E' E ' 39' ' ' ILE . . . . . . . . . . . . . 76.5 mt -127.26 139.96 50.44 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.224 0 CA-C-O 120.755 0.312 . . . . 0.0 110.243 179.351 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' E' E ' 40' ' ' SER . . . . . . . . . . . . . 13.3 t -92.6 126.02 37.5 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.288 -0.414 . . . . 0.0 111.059 177.0 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' E' E ' 41' ' ' ILE . . . . . . . . . . . . . 65.5 mt -129.53 117.0 41.12 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.193 0 CA-C-O 120.863 0.363 . . . . 0.0 110.126 177.088 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' E' E ' 42' ' ' LEU . . . . . . . . . . . . . 7.2 mp 51.78 38.18 22.44 Favored 'General case' 0 CA--C 1.53 0.195 0 CA-C-N 116.101 -0.499 . . . . 0.0 111.598 176.747 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' E' E ' 43' ' ' GLY . . . . . . . . . . . . . . . 74.17 29.1 62.96 Favored Glycine 0 CA--C 1.529 0.969 0 C-N-CA 121.156 -0.545 . . . . 0.0 112.51 176.663 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' E' E ' 44' ' ' LYS . . . . . . . . . . . . . 30.0 ttpt -139.13 128.39 24.07 Favored 'General case' 0 C--N 1.33 -0.281 0 N-CA-C 109.523 -0.547 . . . . 0.0 109.523 176.578 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' E' E ' 45' ' ' GLU . . . . . . . . . . . . . 84.3 tt0 -83.1 125.66 31.73 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-O 120.799 0.333 . . . . 0.0 111.305 -177.111 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' E' E ' 46' ' ' VAL . . . . . . . . . . . . . 9.2 p -117.38 124.96 73.7 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.183 0 N-CA-C 109.558 -0.534 . . . . 0.0 109.558 174.852 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' E' E ' 47' ' ' LYS . . . . . . . . . . . . . 62.5 mttp -98.16 126.46 43.64 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.06 -0.518 . . . . 0.0 110.904 177.973 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' E' E ' 48' ' ' PHE . . . . . . . . . . . . . 33.0 m-85 -110.13 131.86 54.68 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.025 -0.534 . . . . 0.0 109.679 176.568 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' E' E ' 49' ' ' LYS . . . . . . . . . . . . . 70.2 tttt -106.53 130.55 54.29 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.378 -0.373 . . . . 0.0 110.159 178.581 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' E' E ' 50' ' ' VAL . . . . . . . . . . . . . 46.4 t -74.73 103.16 2.52 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.258 0 N-CA-C 109.151 -0.685 . . . . 0.0 109.151 176.821 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' E' E ' 51' ' ' VAL . . . . . . . . . . . . . 47.3 t -69.58 -52.97 27.12 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.289 0 N-CA-C 109.478 -0.564 . . . . 0.0 109.478 -174.687 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' E' E ' 52' ' ' GLN . . . . . . . . . . . . . 81.3 mt-30 -154.49 149.93 27.27 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 115.986 -0.552 . . . . 0.0 111.624 -178.101 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' E' E ' 53' ' ' ALA . . . . . . . . . . . . . . . -128.26 133.21 48.75 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 115.305 -0.861 . . . . 0.0 109.542 175.046 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' E' E ' 54' ' ' TYR . . . . . . . . . . . . . 58.8 t80 -129.03 110.44 18.32 Favored Pre-proline 0 C--N 1.327 -0.372 0 CA-C-O 118.202 -0.904 . . . . 0.0 110.191 179.123 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' E' E ' 55' ' ' PRO . . . . . . . . . . . . . 73.7 Cg_endo -77.21 168.36 77.08 Favored 'Cis proline' 0 N--CA 1.5 1.865 0 CA-C-N 121.828 1.689 . . . . 0.0 112.511 -5.453 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' E' E ' 56' ' ' SER . . . . . . . . . . . . . 17.7 m -116.76 131.36 23.96 Favored Pre-proline 0 CA--C 1.537 0.479 0 CA-C-O 118.392 -0.813 . . . . 0.0 109.361 174.104 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' E' E ' 57' ' ' PRO . . . . . . . . . . . . . 38.6 Cg_endo -67.13 164.98 69.45 Favored 'Cis proline' 0 N--CA 1.497 1.72 0 CA-C-N 121.96 1.736 . . . . 0.0 111.522 -0.919 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' E' E ' 58' ' ' LEU . . . . . . . . . . . . . 27.0 tp -130.44 137.0 49.59 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.218 -0.447 . . . . 0.0 110.316 -179.535 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' E' E ' 59' ' ' ARG . . . . . . . . . . . . . 41.1 ttm180 -103.05 132.67 49.14 Favored 'General case' 0 C--N 1.327 -0.373 0 N-CA-C 109.525 -0.546 . . . . 0.0 109.525 176.65 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' E' E ' 60' ' ' VAL . . . . . . . . . . . . . 45.8 t -83.24 115.44 25.65 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.284 0 C-N-CA 120.751 -0.379 . . . . 0.0 110.532 -176.9 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' E' E ' 61' ' ' GLU . . . . . . . . . . . . . 15.6 mm-40 -131.06 163.54 27.41 Favored 'General case' 0 C--N 1.331 -0.23 0 CA-C-N 115.75 -0.659 . . . . 0.0 109.714 175.165 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' E' E ' 62' ' ' ASP . . . . . . . . . . . . . 78.4 m-20 -53.13 -32.35 47.1 Favored 'General case' 0 C--N 1.328 -0.35 0 N-CA-C 111.917 0.34 . . . . 0.0 111.917 -178.95 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' E' E ' 63' ' ' ARG . . . . . . . . . . . . . 84.0 mtt180 -74.03 -22.02 59.72 Favored 'General case' 0 C--N 1.33 -0.26 0 N-CA-C 112.992 0.738 . . . . 0.0 112.992 -176.619 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' E' E ' 64' ' ' THR . . . . . . . . . . . . . 37.8 m -64.78 140.07 58.83 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-O 120.913 0.387 . . . . 0.0 110.835 -175.947 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' E' E ' 65' ' ' LYS . . . . . . . . . . . . . 25.0 mtpp -90.05 123.17 33.7 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.061 -0.518 . . . . 0.0 109.995 179.567 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' E' E ' 66' ' ' ILE . . . . . . . . . . . . . 57.3 mt -113.79 131.13 66.53 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.241 0 CA-C-O 120.85 0.357 . . . . 0.0 110.351 -177.623 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' E' E ' 67' ' ' THR . . . . . . . . . . . . . 30.9 m -132.49 139.84 48.12 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.127 -0.488 . . . . 0.0 111.012 -179.122 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' E' E ' 68' ' ' LEU . . . . . . . . . . . . . 8.1 mp -107.36 135.48 48.78 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.039 -0.528 . . . . 0.0 110.203 176.836 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' E' E ' 69' ' ' VAL . . . . . . . . . . . . . 43.8 t -98.32 132.62 43.0 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.346 0 CA-C-N 116.064 -0.516 . . . . 0.0 110.197 -179.036 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' E' E ' 70' ' ' THR . . . . . . . . . . . . . 19.8 m -135.0 -50.89 0.77 Allowed 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.491 -179.916 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' E' E ' 71' ' ' HIS . . . . . . . . . . . . . 81.2 m-70 -108.53 153.17 42.28 Favored Pre-proline 0 CA--C 1.532 0.279 0 CA-C-N 116.282 -0.417 . . . . 0.0 110.419 -179.913 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' E' E ' 72' ' ' PRO . . . . . . . . . . . . . 97.7 Cg_endo -85.01 -21.34 3.17 Favored 'Trans proline' 0 N--CA 1.493 1.475 0 C-N-CA 121.589 1.526 . . . . 0.0 113.238 179.744 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' E' E ' 73' ' ' VAL . . . . . . . . . . . . . 34.6 m -126.11 167.48 20.52 Favored 'Isoleucine or valine' 0 C--O 1.232 0.155 0 CA-C-O 120.804 0.335 . . . . 0.0 110.663 -178.464 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' E' E ' 74' ' ' ASP . . . . . . . . . . . . . 26.4 t0 -99.33 120.57 39.78 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.222 -0.445 . . . . 0.0 109.998 -178.901 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' E' E ' 75' ' ' VAL . . . . . . . . . . . . . 46.8 t -112.61 121.3 64.66 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.19 0 CA-C-O 121.031 0.443 . . . . 0.0 110.358 -178.477 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' E' E ' 76' ' ' LEU . . . . . . . . . . . . . 41.2 mt -118.42 144.75 45.72 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 115.626 -0.716 . . . . 0.0 109.737 178.713 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' E' E ' 77' ' ' GLU . . . . . . . . . . . . . 97.3 mt-10 -139.43 130.2 26.07 Favored 'General case' 0 C--N 1.331 -0.205 0 CA-C-O 120.999 0.428 . . . . 0.0 111.327 -179.416 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' E' E ' 78' ' ' ALA . . . . . . . . . . . . . . . -119.16 135.28 54.74 Favored 'General case' 0 C--N 1.331 -0.212 0 CA-C-N 115.797 -0.638 . . . . 0.0 109.775 176.689 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' E' E ' 79' ' ' LYS . . . . . . . . . . . . . 91.0 mttt -77.13 118.62 19.85 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-O 120.882 0.373 . . . . 0.0 110.711 -179.452 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' E' E ' 80' ' ' ILE . . . . . . . . . . . . . 41.1 mm -139.13 106.04 2.75 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.39 0 N-CA-C 109.138 -0.69 . . . . 0.0 109.138 -178.077 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' E' E ' 81' ' ' LYS . . . . . . . . . . . . . 76.0 tttt -105.24 127.34 52.88 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-O 120.895 0.379 . . . . 0.0 111.164 -176.0 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' E' E ' 82' ' ' GLY . . . . . . . . . . . . . . . 89.13 42.09 5.69 Favored Glycine 0 CA--C 1.524 0.638 0 N-CA-C 111.615 -0.594 . . . . 0.0 111.615 176.346 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' E' E ' 83' ' ' ILE . . . . . . . . . . . . . 72.4 mt -69.64 140.18 19.1 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.294 0 N-CA-C 109.836 -0.431 . . . . 0.0 109.836 177.446 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' E' E ' 84' ' ' LYS . . . . . . . . . . . . . 49.4 tttp -98.17 -51.06 4.14 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 115.9 -0.591 . . . . 0.0 110.263 -178.733 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' E' E ' 85' ' ' ASP . . . . . . . . . . . . . 6.5 t70 -155.27 151.72 28.39 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 115.764 -0.653 . . . . 0.0 110.316 179.67 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' E' E ' 86' ' ' VAL . . . . . . . . . . . . . 44.2 t -130.44 131.41 65.24 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.221 0 CA-C-O 120.931 0.395 . . . . 0.0 110.553 -178.719 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' E' E ' 87' ' ' ILE . . . . . . . . . . . . . 5.0 mp -120.6 126.65 75.49 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.22 0 CA-C-N 115.889 -0.596 . . . . 0.0 109.494 176.382 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' E' E ' 88' ' ' LEU . . . . . . . . . . . . . 47.2 mt -116.0 137.76 51.82 Favored 'General case' 0 N--CA 1.462 0.167 0 CA-C-O 121.045 0.45 . . . . 0.0 111.468 -176.88 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' E' E ' 89' ' ' ASP . . . . . . . . . . . . . 8.7 t70 -136.14 156.73 48.27 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 115.655 -0.702 . . . . 0.0 109.584 175.202 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' E' E ' 90' ' ' GLU . . . . . . . . . . . . . 40.8 mp0 -51.23 -34.01 30.45 Favored 'General case' 0 C--N 1.328 -0.326 0 N-CA-C 112.507 0.558 . . . . 0.0 112.507 -171.919 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' E' E ' 91' ' ' ASN . . . . . . . . . . . . . 7.8 m120 -130.28 32.01 4.54 Favored 'General case' 0 N--CA 1.465 0.313 0 N-CA-C 112.062 0.393 . . . . 0.0 112.062 -175.897 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' E' E ' 92' ' ' LEU . . . . . . . . . . . . . 13.8 tp -166.11 141.77 4.82 Favored 'General case' 0 C--N 1.331 -0.239 0 C-N-CA 120.945 -0.302 . . . . 0.0 110.526 179.242 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' E' E ' 93' ' ' ILE . . . . . . . . . . . . . 71.9 mt -128.73 119.48 49.94 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.207 0 N-CA-C 109.121 -0.696 . . . . 0.0 109.121 176.686 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' E' E ' 94' ' ' VAL . . . . . . . . . . . . . 47.6 t -123.53 128.27 74.52 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.286 0 CA-C-O 121.037 0.446 . . . . 0.0 110.019 -178.898 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' E' E ' 95' ' ' VAL . . . . . . . . . . . . . 41.6 t -121.04 135.5 61.02 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.347 0 CA-C-N 115.807 -0.633 . . . . 0.0 109.821 -179.831 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' E' E ' 96' ' ' ILE . . . . . . . . . . . . . 49.9 mt -111.18 126.31 68.56 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.36 0 N-CA-C 108.959 -0.756 . . . . 0.0 108.959 178.041 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' E' E ' 97' ' ' THR . . . . . . . . . . . . . 74.7 p -96.27 155.73 16.64 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-O 121.114 0.483 . . . . 0.0 111.005 -177.747 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' E' E ' 98' ' ' GLU . . . . . . . . . . . . . 79.2 tt0 -53.84 -27.37 29.29 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.153 -0.476 . . . . 0.0 112.1 -179.143 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' E' E ' 99' ' ' GLU . . . . . . . . . . . . . 12.7 pt-20 -81.08 18.01 1.14 Allowed 'General case' 0 CA--C 1.535 0.374 0 N-CA-C 113.181 0.808 . . . . 0.0 113.181 -176.946 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' E' E ' 100' ' ' ASN . . . . . . . . . . . . . 3.4 m-20 63.52 37.43 10.49 Favored 'General case' 0 N--CA 1.463 0.179 0 CA-C-O 121.063 0.459 . . . . 0.0 111.204 176.831 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' E' E ' 101' ' ' GLU . . . . . . . . . . . . . 84.6 tt0 -116.22 146.02 42.67 Favored 'General case' 0 C--N 1.333 -0.131 0 CA-C-N 116.202 -0.454 . . . . 0.0 109.982 175.981 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' E' E ' 102' ' ' VAL . . . . . . . . . . . . . 46.8 t -115.08 126.1 72.57 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.346 0 CA-C-N 116.34 -0.391 . . . . 0.0 110.144 -177.668 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' E' E ' 103' ' ' LEU . . . . . . . . . . . . . 35.1 mt -117.82 128.54 54.95 Favored 'General case' 0 C--N 1.332 -0.169 0 CA-C-N 115.777 -0.647 . . . . 0.0 110.083 176.832 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' E' E ' 104' ' ' ILE . . . . . . . . . . . . . 68.9 mt -119.13 122.71 69.9 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.225 0 CA-C-N 116.722 -0.217 . . . . 0.0 110.422 -179.072 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' E' E ' 105' ' ' PHE . . . . . . . . . . . . . 55.5 m-85 -122.8 166.8 14.39 Favored 'General case' 0 C--O 1.232 0.137 0 O-C-N 123.917 0.76 . . . . 0.0 109.753 179.494 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' E' E ' 106' ' ' ASN . . . . . . . . . . . . . 45.9 p-10 -99.11 -170.04 1.86 Allowed 'General case' 0 C--N 1.33 -0.276 0 N-CA-C 109.758 -0.46 . . . . 0.0 109.758 173.079 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' E' E ' 107' ' ' GLN . . . . . . . . . . . . . 46.9 tt0 -60.61 -30.0 69.57 Favored 'General case' 0 C--N 1.329 -0.289 0 N-CA-C 111.932 0.345 . . . . 0.0 111.932 -179.675 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' E' E ' 108' ' ' ASN . . . . . . . . . . . . . 5.3 t30 -81.96 7.84 12.05 Favored 'General case' 0 CA--C 1.536 0.416 0 N-CA-C 113.108 0.781 . . . . 0.0 113.108 -177.891 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' E' E ' 109' ' ' LEU . . . . . . . . . . . . . 11.4 tp 61.42 35.97 17.53 Favored 'General case' 0 CA--C 1.53 0.19 0 O-C-N 122.106 -0.371 . . . . 0.0 111.442 178.724 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' E' E ' 110' ' ' GLU . . . . . . . . . . . . . 42.8 mt-10 -104.9 143.15 33.55 Favored 'General case' 0 C--N 1.33 -0.256 0 N-CA-C 109.586 -0.524 . . . . 0.0 109.586 175.288 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' E' E ' 111' ' ' GLU . . . . . . . . . . . . . 61.0 tt0 -79.72 121.98 26.01 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-O 120.877 0.37 . . . . 0.0 110.727 -176.661 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' E' E ' 112' ' ' LEU . . . . . . . . . . . . . 20.3 mt -105.98 -46.13 4.18 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 116.123 -0.489 . . . . 0.0 110.665 179.864 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' E' E ' 113' ' ' TYR . . . . . . . . . . . . . 57.1 t80 -134.31 138.26 44.83 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-O 120.901 0.382 . . . . 0.0 111.26 -178.077 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' E' E ' 114' ' ' ARG . . . . . . . . . . . . . 52.7 ttp180 -136.09 123.49 22.0 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 115.842 -0.617 . . . . 0.0 110.325 177.494 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' E' E ' 115' ' ' GLY . . . . . . . . . . . . . . . -150.0 157.98 27.46 Favored Glycine 0 CA--C 1.524 0.601 0 N-CA-C 110.915 -0.874 . . . . 0.0 110.915 179.0 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' E' E ' 116' ' ' LYS . . . . . . . . . . . . . 31.9 ttmt -131.83 138.95 48.7 Favored 'General case' 0 C--N 1.329 -0.303 0 N-CA-C 109.886 -0.413 . . . . 0.0 109.886 177.317 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' E' E ' 117' ' ' PHE . . . . . . . . . . . . . 39.1 m-85 -137.74 114.61 10.65 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-O 120.867 0.365 . . . . 0.0 110.208 -175.769 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' E' E ' 118' ' ' GLU . . . . . . . . . . . . . 81.2 tt0 -52.81 -44.51 66.7 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.493 -0.321 . . . . 0.0 111.503 -177.078 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' E' E ' 119' ' ' ASN . . . . . . . . . . . . . 36.5 m120 -95.77 30.69 2.27 Favored 'General case' 0 C--N 1.33 -0.248 0 N-CA-C 112.262 0.467 . . . . 0.0 112.262 -174.938 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' E' E ' 120' ' ' LEU . . . . . . . . . . . . . 13.9 tp -57.35 121.02 9.19 Favored 'General case' 0 C--N 1.332 -0.169 0 CA-C-O 120.631 0.253 . . . . 0.0 110.385 178.068 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' E' E ' 121' ' ' ASN . . . . . . . . . . . . . 66.7 m-20 -114.09 -44.12 3.17 Favored 'General case' 0 C--N 1.332 -0.188 0 CA-C-N 116.471 -0.331 . . . . 0.0 111.101 -178.794 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' E' E ' 122' ' ' LYS . . . . . . . . . . . . . 63.2 mtpt -145.5 152.12 39.27 Favored 'General case' 0 C--N 1.332 -0.171 0 CA-C-O 121.041 0.448 . . . . 0.0 111.714 -176.447 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' E' E ' 123' ' ' VAL . . . . . . . . . . . . . 47.2 t -130.85 131.95 64.19 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.252 0 CA-C-N 115.943 -0.571 . . . . 0.0 109.482 174.461 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' E' E ' 124' ' ' LEU . . . . . . . . . . . . . 83.0 mt -125.72 140.48 52.66 Favored 'General case' 0 C--N 1.332 -0.181 0 CA-C-O 120.827 0.346 . . . . 0.0 110.911 -177.549 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' E' E ' 125' ' ' VAL . . . . . . . . . . . . . 34.5 m -132.89 142.79 41.37 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.182 0 CA-C-N 116.127 -0.488 . . . . 0.0 110.764 179.878 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' E' E ' 126' ' ' ARG . . . . . . . . . . . . . 96.2 mtt-85 -148.05 112.15 5.18 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.443 177.105 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' E' E ' 127' ' ' ASN . . . . . . . . . . . . . 17.1 m120 53.85 -104.93 0.23 Allowed 'General case' 0 CA--C 1.543 0.699 0 CA-C-O 119.078 -0.487 . . . . 0.0 111.017 179.542 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' E' E ' 128' ' ' ASP . . . . . . . . . . . . . 18.7 p-10 -113.98 3.5 15.38 Favored 'General case' 0 N--CA 1.468 0.453 0 CA-C-N 119.508 1.049 . . . . 0.0 113.473 -177.487 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' E' E ' 129' ' ' LEU . . . . . . . . . . . . . 12.4 tp -104.92 140.47 38.1 Favored 'General case' 0 C--N 1.331 -0.215 0 N-CA-C 109.609 -0.515 . . . . 0.0 109.609 178.034 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' E' E ' 130' ' ' VAL . . . . . . . . . . . . . 13.4 p -132.92 139.2 50.14 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.184 0 CA-C-O 121.132 0.491 . . . . 0.0 110.742 -178.28 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' E' E ' 131' ' ' VAL . . . . . . . . . . . . . 38.4 t -136.11 140.85 43.11 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.267 0 CA-C-N 115.96 -0.564 . . . . 0.0 110.565 -179.792 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' E' E ' 132' ' ' ILE . . . . . . . . . . . . . 70.0 mt -116.17 133.08 63.8 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.27 0 CA-C-N 115.747 -0.66 . . . . 0.0 109.433 178.957 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' E' E ' 133' ' ' ILE . . . . . . . . . . . . . 39.0 mm -116.1 123.26 71.13 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.228 0 CA-C-O 120.678 0.275 . . . . 0.0 111.1 -174.898 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' E' E ' 134' ' ' ASP . . . . . . . . . . . . . 9.3 p-10 -136.18 149.73 48.72 Favored 'General case' 0 C--N 1.331 -0.226 0 CA-C-N 116.253 -0.431 . . . . 0.0 110.101 175.428 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' E' E ' 135' ' ' GLU . . . . . . . . . . . . . 81.5 tt0 -49.96 -27.33 5.22 Favored 'General case' 0 C--N 1.329 -0.299 0 N-CA-C 112.878 0.696 . . . . 0.0 112.878 -173.753 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' E' E ' 136' ' ' GLN . . . . . . . . . . . . . 94.8 mt-30 -83.24 -34.48 25.83 Favored 'General case' 0 C--O 1.233 0.232 0 N-CA-C 112.304 0.483 . . . . 0.0 112.304 -175.621 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' E' E ' 137' ' ' LYS . . . . . . . . . . . . . 15.2 pttp -167.51 174.23 8.04 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-O 121.597 0.713 . . . . 0.0 112.194 -170.941 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' E' E ' 138' ' ' LEU . . . . . . . . . . . . . 6.3 tt -119.42 126.65 51.86 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 114.951 -1.022 . . . . 0.0 109.923 178.652 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' E' E ' 139' ' ' THR . . . . . . . . . . . . . 25.9 m -105.82 122.91 47.06 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.139 -0.482 . . . . 0.0 110.217 179.367 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' E' E ' 140' ' ' LEU . . . . . . . . . . . . . 10.6 tp -111.91 121.48 45.14 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 115.94 -0.573 . . . . 0.0 109.619 -177.428 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' E' E ' 141' ' ' ILE . . . . . . . . . . . . . 19.4 mt -122.0 118.68 56.31 Favored 'Isoleucine or valine' 0 C--O 1.234 0.265 0 CA-C-O 121.168 0.509 . . . . 0.0 110.121 -176.799 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' E' E ' 142' ' ' ARG . . . . . . . . . . . . . 78.6 mtp180 -102.75 110.13 21.96 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 115.058 -0.973 . . . . 0.0 110.114 178.985 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' E' E ' 143' ' ' THR . . . . . . . . . . . . . 69.6 p . . . . . 0 C--O 1.219 -0.538 0 CA-C-O 118.041 -0.98 . . . . 0.0 110.558 -178.561 . . . . . . . . 0 0 . 1 . 002 nuclear orig full ' F' F ' -3' ' ' GLU . . . . . . . . . . . . . 95.9 mt-10 . . . . . 0 N--CA 1.49 1.528 0 N-CA-C 109.458 -0.571 . . . . 0.0 109.458 . . . . . . . . . 0 0 . 1 . 002 nuclear orig full ' F' F ' -2' ' ' GLY . . . . . . . . . . . . . . . -75.58 150.0 39.31 Favored Glycine 0 CA--C 1.525 0.676 0 N-CA-C 110.906 -0.878 . . . . 0.0 110.906 179.86 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' F' F ' -1' ' ' VAL . . . . . . . . . . . . . 44.4 t -90.68 131.43 37.87 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.261 0 CA-C-O 120.842 0.353 . . . . 0.0 110.055 179.98 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' F' F ' 0' ' ' ILE . . . . . . . . . . . . . 44.1 mm -116.65 130.59 71.23 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.224 0 CA-C-N 116.121 -0.49 . . . . 0.0 109.996 179.224 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' F' F ' 1' ' ' MET . . . . . . . . . . . . . 25.3 ptp -83.05 134.8 35.01 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.246 -0.434 . . . . 0.0 110.778 -179.509 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' F' F ' 2' ' ' SER . . . . . . . . . . . . . 10.1 p -112.22 134.47 53.75 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.562 179.319 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' F' F ' 3' ' ' GLU . . . . . . . . . . . . . 40.6 mt-10 -139.61 141.6 37.11 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 115.991 -0.55 . . . . 0.0 110.653 -179.544 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' F' F ' 4' ' ' LEU . . . . . . . . . . . . . 3.1 tt -128.01 125.63 39.77 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-N 115.896 -0.593 . . . . 0.0 109.945 179.11 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' F' F ' 5' ' ' LYS . . . . . . . . . . . . . 97.9 mttt -106.28 120.05 40.84 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.297 -0.411 . . . . 0.0 110.655 -179.811 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' F' F ' 6' ' ' LEU . . . . . . . . . . . . . 64.1 mt -114.01 150.06 34.46 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 115.538 -0.756 . . . . 0.0 110.485 -178.88 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' F' F ' 7' ' ' LYS . . . . . . . . . . . . . 82.3 tttt -137.15 134.74 19.03 Favored Pre-proline 0 CA--C 1.534 0.365 0 CA-C-O 118.806 -0.616 . . . . 0.0 109.676 175.021 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' F' F ' 8' ' ' PRO . . . . . . . . . . . . . 71.8 Cg_endo -89.6 135.97 2.61 Favored 'Trans proline' 0 N--CA 1.49 1.319 0 C-N-CA 121.615 1.544 . . . . 0.0 111.483 177.838 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' F' F ' 9' ' ' LEU . . . . . . . . . . . . . 37.9 mt -72.93 -47.1 8.54 Favored Pre-proline 0 CA--C 1.533 0.325 0 CA-C-O 118.689 -0.672 . . . . 0.0 112.318 -177.538 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' F' F ' 10' ' ' PRO . . . . . . . . . . . . . 92.5 Cg_endo -80.68 149.87 18.61 Favored 'Trans proline' 0 N--CA 1.495 1.576 0 C-N-CA 121.104 1.203 . . . . 0.0 111.757 175.586 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' F' F ' 11' ' ' LYS . . . . . . . . . . . . . 83.6 tttt -84.1 96.9 9.06 Favored 'General case' 0 C--N 1.33 -0.275 0 C-N-CA 120.836 -0.346 . . . . 0.0 110.49 179.358 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' F' F ' 12' ' ' VAL . . . . . . . . . . . . . 12.1 p -142.77 144.39 24.36 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.364 0 CA-C-N 116.123 -0.49 . . . . 0.0 110.434 179.678 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' F' F ' 13' ' ' GLU . . . . . . . . . . . . . 43.7 mp0 -85.67 125.37 33.12 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.224 -0.444 . . . . 0.0 110.045 177.666 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' F' F ' 14' ' ' LEU . . . . . . . . . . . . . 45.7 mt -95.15 153.52 39.73 Favored Pre-proline 0 C--N 1.329 -0.303 0 CA-C-N 116.444 -0.344 . . . . 0.0 110.81 -177.8 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' F' F ' 15' ' ' PRO . . . . . . . . . . . . . 36.8 Cg_exo -59.33 160.14 20.67 Favored 'Trans proline' 0 N--CA 1.497 1.7 0 C-N-CA 121.296 1.331 . . . . 0.0 111.704 177.743 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' F' F ' 16' ' ' PRO . . . . . . . . . . . . . 27.5 Cg_exo -60.25 -43.13 36.98 Favored 'Trans proline' 0 N--CA 1.498 1.737 0 C-N-CA 121.381 1.388 . . . . 0.0 112.802 -177.628 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' F' F ' 17' ' ' ASP . . . . . . . . . . . . . 16.3 p-10 -87.72 12.5 12.65 Favored 'General case' 0 C--N 1.326 -0.422 0 N-CA-C 113.182 0.808 . . . . 0.0 113.182 -176.377 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' F' F ' 18' ' ' PHE . . . . . . . . . . . . . 48.1 t80 -58.0 -44.64 87.33 Favored 'General case' 0 C--N 1.334 -0.074 0 O-C-N 122.04 -0.413 . . . . 0.0 110.151 -178.241 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' F' F ' 19' ' ' VAL . . . . . . . . . . . . . 14.6 p -56.46 -42.08 74.18 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.333 0 CA-C-N 116.36 -0.382 . . . . 0.0 110.941 -178.474 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' F' F ' 20' ' ' ASP . . . . . . . . . . . . . 79.9 m-20 -60.98 -42.12 97.77 Favored 'General case' 0 C--O 1.233 0.234 0 CA-C-O 120.884 0.373 . . . . 0.0 110.957 -178.051 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' F' F ' 21' ' ' VAL . . . . . . . . . . . . . 46.9 t -64.0 -47.37 90.74 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 CA-C-N 116.343 -0.39 . . . . 0.0 110.406 -178.395 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' F' F ' 22' ' ' ILE . . . . . . . . . . . . . 50.1 mm -55.96 -43.96 76.67 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.182 0 CA-C-O 120.774 0.321 . . . . 0.0 110.66 178.769 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' F' F ' 23' ' ' ARG . . . . . . . . . . . . . 56.0 ttp180 -52.86 -52.36 57.57 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-O 120.709 0.29 . . . . 0.0 111.519 179.986 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' F' F ' 24' ' ' ILE . . . . . . . . . . . . . 69.3 mt -59.63 -40.62 82.68 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.268 0 CA-C-N 116.414 -0.357 . . . . 0.0 111.273 -177.051 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' F' F ' 25' ' ' LYS . . . . . . . . . . . . . 46.4 mttm -65.46 -42.06 92.7 Favored 'General case' 0 C--N 1.327 -0.377 0 N-CA-C 112.192 0.442 . . . . 0.0 112.192 -178.626 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' F' F ' 26' ' ' LEU . . . . . . . . . . . . . 74.4 mt -80.58 -38.03 30.21 Favored 'General case' 0 C--N 1.33 -0.261 0 N-CA-C 113.39 0.885 . . . . 0.0 113.39 -170.841 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' F' F ' 27' ' ' GLN . . . . . . . . . . . . . 8.6 pt20 -46.48 139.78 4.74 Favored 'General case' 0 N--CA 1.469 0.479 0 N-CA-C 112.871 0.693 . . . . 0.0 112.871 -174.946 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' F' F ' 28' ' ' GLY . . . . . . . . . . . . . . . 99.29 -25.4 28.37 Favored Glycine 0 CA--C 1.533 1.193 0 CA-C-N 115.507 -0.77 . . . . 0.0 112.264 -177.035 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' F' F ' 29' ' ' LYS . . . . . . . . . . . . . 33.5 mmtp -97.61 155.15 17.1 Favored 'General case' 0 C--O 1.233 0.198 0 CA-C-N 117.335 0.568 . . . . 0.0 110.771 178.982 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' F' F ' 30' ' ' THR . . . . . . . . . . . . . 25.2 m -107.21 136.65 46.68 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 115.928 -0.578 . . . . 0.0 109.827 175.428 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' F' F ' 31' ' ' VAL . . . . . . . . . . . . . 35.0 m -129.78 161.15 39.94 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.267 0 CA-C-N 116.473 -0.33 . . . . 0.0 110.814 -177.959 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' F' F ' 32' ' ' ARG . . . . . . . . . . . . . 92.7 mtt180 -132.56 151.22 52.0 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-O 121.307 0.575 . . . . 0.0 110.595 178.88 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' F' F ' 33' ' ' THR . . . . . . . . . . . . . 24.1 m -52.45 140.54 22.18 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.112 -0.494 . . . . 0.0 111.396 -178.467 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' F' F ' 34' ' ' GLY . . . . . . . . . . . . . . . 99.28 -17.09 58.39 Favored Glycine 0 CA--C 1.532 1.135 0 CA-C-O 119.596 -0.558 . . . . 0.0 113.218 178.977 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' F' F ' 35' ' ' ASP . . . . . . . . . . . . . 54.3 m-20 -63.3 150.48 43.18 Favored 'General case' 0 C--O 1.232 0.142 0 CA-C-N 118.09 0.945 . . . . 0.0 111.0 179.365 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' F' F ' 36' ' ' VAL . . . . . . . . . . . . . 42.4 t -125.72 130.44 72.53 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.293 0 CA-C-N 115.801 -0.636 . . . . 0.0 109.706 178.763 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' F' F ' 37' ' ' ILE . . . . . . . . . . . . . 65.2 mt -120.66 138.92 49.57 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.294 0 CA-C-N 116.336 -0.393 . . . . 0.0 110.098 -178.921 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' F' F ' 38' ' ' GLY . . . . . . . . . . . . . . . -109.13 128.86 9.21 Favored Glycine 0 CA--C 1.525 0.689 0 N-CA-C 110.872 -0.891 . . . . 0.0 110.872 179.02 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' F' F ' 39' ' ' ILE . . . . . . . . . . . . . 74.4 mt -123.57 134.91 65.03 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.256 0 N-CA-C 110.176 -0.305 . . . . 0.0 110.176 179.828 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' F' F ' 40' ' ' SER . . . . . . . . . . . . . 88.0 p -92.65 118.63 31.24 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.895 176.383 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' F' F ' 41' ' ' ILE . . . . . . . . . . . . . 44.5 mm -120.48 113.01 38.68 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.263 0 CA-C-O 120.751 0.31 . . . . 0.0 110.247 178.799 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' F' F ' 42' ' ' LEU . . . . . . . . . . . . . 7.9 mp 51.21 37.4 18.37 Favored 'General case' 0 C--N 1.331 -0.223 0 CA-C-N 116.151 -0.477 . . . . 0.0 111.748 177.006 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' F' F ' 43' ' ' GLY . . . . . . . . . . . . . . . 75.95 29.84 58.4 Favored Glycine 0 CA--C 1.53 1.03 0 C-N-CA 121.151 -0.547 . . . . 0.0 112.33 177.606 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' F' F ' 44' ' ' LYS . . . . . . . . . . . . . 60.0 mtpt -135.29 127.88 30.76 Favored 'General case' 0 C--N 1.329 -0.295 0 N-CA-C 109.65 -0.5 . . . . 0.0 109.65 177.062 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' F' F ' 45' ' ' GLU . . . . . . . . . . . . . 84.2 tt0 -82.73 123.42 29.29 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-O 120.822 0.344 . . . . 0.0 111.322 -176.738 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' F' F ' 46' ' ' VAL . . . . . . . . . . . . . 7.1 p -123.23 128.4 74.89 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.202 0 N-CA-C 109.592 -0.521 . . . . 0.0 109.592 175.386 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' F' F ' 47' ' ' LYS . . . . . . . . . . . . . 63.6 mttp -99.53 128.79 45.65 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.125 -0.489 . . . . 0.0 111.229 178.099 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' F' F ' 48' ' ' PHE . . . . . . . . . . . . . 91.5 m-85 -111.64 131.9 54.96 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.023 -0.535 . . . . 0.0 109.746 176.196 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' F' F ' 49' ' ' LYS . . . . . . . . . . . . . 71.9 tttt -106.6 136.18 46.83 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.4 -0.364 . . . . 0.0 110.455 -179.654 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' F' F ' 50' ' ' VAL . . . . . . . . . . . . . 45.4 t -81.11 105.62 11.25 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.292 0 N-CA-C 109.53 -0.544 . . . . 0.0 109.53 176.691 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' F' F ' 51' ' ' VAL . . . . . . . . . . . . . 47.6 t -70.21 -51.96 34.34 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.33 0 CA-C-N 115.879 -0.6 . . . . 0.0 109.73 -174.387 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' F' F ' 52' ' ' GLN . . . . . . . . . . . . . 77.8 mt-30 -154.62 147.67 24.68 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-O 121.175 0.512 . . . . 0.0 111.756 -177.261 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' F' F ' 53' ' ' ALA . . . . . . . . . . . . . . . -122.39 128.84 51.46 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 115.19 -0.914 . . . . 0.0 109.317 175.282 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' F' F ' 54' ' ' TYR . . . . . . . . . . . . . 45.7 t80 -126.77 109.53 22.51 Favored Pre-proline 0 CA--C 1.534 0.335 0 CA-C-O 118.383 -0.817 . . . . 0.0 110.443 -178.479 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' F' F ' 55' ' ' PRO . . . . . . . . . . . . . 74.4 Cg_endo -77.09 170.04 72.69 Favored 'Cis proline' 0 N--CA 1.5 1.902 0 CA-C-N 121.768 1.667 . . . . 0.0 112.536 -5.091 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' F' F ' 56' ' ' SER . . . . . . . . . . . . . 13.7 m -112.27 126.91 27.6 Favored Pre-proline 0 CA--C 1.539 0.542 0 CA-C-O 118.409 -0.805 . . . . 0.0 109.642 176.52 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' F' F ' 57' ' ' PRO . . . . . . . . . . . . . 33.7 Cg_endo -65.27 169.15 41.16 Favored 'Cis proline' 0 N--CA 1.498 1.791 0 CA-C-N 122.083 1.78 . . . . 0.0 111.475 -1.543 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' F' F ' 58' ' ' LEU . . . . . . . . . . . . . 34.0 tp -130.61 137.05 49.45 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-O 120.971 0.415 . . . . 0.0 110.574 -179.313 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' F' F ' 59' ' ' ARG . . . . . . . . . . . . . 71.1 ttt180 -104.68 129.24 52.88 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 115.773 -0.648 . . . . 0.0 109.575 177.695 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' F' F ' 60' ' ' VAL . . . . . . . . . . . . . 42.3 t -86.74 119.17 34.23 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.272 0 C-N-CA 120.744 -0.382 . . . . 0.0 110.353 -176.131 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' F' F ' 61' ' ' GLU . . . . . . . . . . . . . 95.3 mt-10 -131.08 168.04 18.07 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.329 178.28 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' F' F ' 62' ' ' ASP . . . . . . . . . . . . . 55.8 m-20 -54.01 -32.51 54.43 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.641 -0.254 . . . . 0.0 111.641 179.259 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' F' F ' 63' ' ' ARG . . . . . . . . . . . . . 6.8 ptp180 -85.5 9.08 16.85 Favored 'General case' 0 CA--C 1.537 0.447 0 N-CA-C 113.508 0.929 . . . . 0.0 113.508 -175.892 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' F' F ' 64' ' ' THR . . . . . . . . . . . . . 30.1 m -85.43 134.81 34.05 Favored 'General case' 0 C--N 1.333 -0.124 0 CA-C-N 118.085 0.402 . . . . 0.0 110.813 -178.749 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' F' F ' 65' ' ' LYS . . . . . . . . . . . . . 52.4 mtmt -88.74 124.6 34.28 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.234 -0.439 . . . . 0.0 109.932 177.426 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' F' F ' 66' ' ' ILE . . . . . . . . . . . . . 62.3 mt -112.51 128.54 69.12 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.325 0 N-CA-C 109.835 -0.431 . . . . 0.0 109.835 -178.572 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' F' F ' 67' ' ' THR . . . . . . . . . . . . . 28.5 m -126.15 141.82 51.78 Favored 'General case' 0 C--N 1.331 -0.222 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.972 -177.05 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' F' F ' 68' ' ' LEU . . . . . . . . . . . . . 8.5 mp -104.46 122.95 46.59 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 115.966 -0.561 . . . . 0.0 110.104 178.061 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' F' F ' 69' ' ' VAL . . . . . . . . . . . . . 46.8 t -101.12 102.84 14.02 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.262 0 CA-C-O 120.852 0.358 . . . . 0.0 110.206 -179.119 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' F' F ' 70' ' ' THR . . . . . . . . . . . . . 10.0 t -150.07 157.62 43.32 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.129 -0.487 . . . . 0.0 110.513 177.511 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' F' F ' 71' ' ' HIS . . . . . . . . . . . . . 83.3 m-70 -137.92 65.76 45.91 Favored Pre-proline 0 CA--C 1.536 0.426 0 C-N-CA 121.048 -0.261 . . . . 0.0 110.626 176.4 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' F' F ' 72' ' ' PRO . . . . . . . . . . . . . 69.5 Cg_endo -95.0 158.58 1.73 Allowed 'Trans proline' 0 N--CA 1.489 1.253 0 C-N-CA 121.989 1.793 . . . . 0.0 111.996 177.781 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' F' F ' 73' ' ' VAL . . . . . . . . . . . . . 35.6 m -96.19 145.19 8.97 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.305 0 N-CA-C 109.681 -0.489 . . . . 0.0 109.681 174.812 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' F' F ' 74' ' ' ASP . . . . . . . . . . . . . 39.7 t0 -88.85 114.91 25.98 Favored 'General case' 0 C--N 1.328 -0.343 0 N-CA-C 109.982 -0.377 . . . . 0.0 109.982 -177.596 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' F' F ' 75' ' ' VAL . . . . . . . . . . . . . 41.4 t -111.05 120.79 62.47 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.287 0 CA-C-O 121.07 0.462 . . . . 0.0 110.242 -178.784 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' F' F ' 76' ' ' LEU . . . . . . . . . . . . . 15.3 mt -128.55 143.81 51.03 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 115.732 -0.667 . . . . 0.0 109.692 179.097 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' F' F ' 77' ' ' GLU . . . . . . . . . . . . . 97.3 mt-10 -131.94 131.26 42.5 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-O 120.989 0.424 . . . . 0.0 111.093 -177.153 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' F' F ' 78' ' ' ALA . . . . . . . . . . . . . . . -117.94 128.38 54.75 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 115.747 -0.661 . . . . 0.0 109.621 177.148 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' F' F ' 79' ' ' LYS . . . . . . . . . . . . . 95.2 mttt -79.93 120.63 24.41 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-O 120.904 0.383 . . . . 0.0 110.857 -177.085 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' F' F ' 80' ' ' ILE . . . . . . . . . . . . . 41.4 mm -139.1 108.68 3.93 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.309 0 N-CA-C 109.072 -0.714 . . . . 0.0 109.072 -177.322 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' F' F ' 81' ' ' LYS . . . . . . . . . . . . . 82.7 tttt -97.53 123.79 41.54 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-O 120.868 0.366 . . . . 0.0 111.239 -175.913 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' F' F ' 82' ' ' GLY . . . . . . . . . . . . . . . 89.22 42.02 5.68 Favored Glycine 0 CA--C 1.526 0.724 0 C-N-CA 120.884 -0.674 . . . . 0.0 111.907 174.647 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' F' F ' 83' ' ' ILE . . . . . . . . . . . . . 71.4 mt -68.7 136.71 25.85 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.304 0 N-CA-C 109.661 -0.496 . . . . 0.0 109.661 176.571 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' F' F ' 84' ' ' LYS . . . . . . . . . . . . . 36.7 ttpt -101.36 -51.31 3.52 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-O 120.868 0.366 . . . . 0.0 110.262 -178.908 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' F' F ' 85' ' ' ASP . . . . . . . . . . . . . 11.9 t70 -148.22 148.65 30.74 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 115.874 -0.603 . . . . 0.0 110.385 -179.752 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' F' F ' 86' ' ' VAL . . . . . . . . . . . . . 46.3 t -133.56 132.95 57.52 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.269 0 CA-C-O 121.0 0.429 . . . . 0.0 110.494 -178.98 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' F' F ' 87' ' ' ILE . . . . . . . . . . . . . 5.0 mp -119.82 127.25 75.87 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.202 0 CA-C-N 115.859 -0.61 . . . . 0.0 109.474 175.901 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' F' F ' 88' ' ' LEU . . . . . . . . . . . . . 12.8 tp -112.6 129.94 56.2 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.3 -0.409 . . . . 0.0 111.022 -177.453 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' F' F ' 89' ' ' ASP . . . . . . . . . . . . . 6.2 t70 -123.94 156.36 36.49 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 115.868 -0.606 . . . . 0.0 109.747 176.794 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' F' F ' 90' ' ' GLU . . . . . . . . . . . . . 96.3 mt-10 -46.15 -41.93 13.21 Favored 'General case' 0 C--N 1.332 -0.192 0 N-CA-C 113.15 0.796 . . . . 0.0 113.15 -172.58 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' F' F ' 91' ' ' ASN . . . . . . . . . . . . . 54.0 m-80 -132.09 36.6 3.64 Favored 'General case' 0 N--CA 1.464 0.259 0 CA-C-O 120.732 0.301 . . . . 0.0 111.569 -176.575 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' F' F ' 92' ' ' LEU . . . . . . . . . . . . . 12.6 tp -166.07 144.98 5.91 Favored 'General case' 0 C--N 1.331 -0.232 0 C-N-CA 120.927 -0.309 . . . . 0.0 110.746 -179.752 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' F' F ' 93' ' ' ILE . . . . . . . . . . . . . 68.7 mt -127.3 123.63 62.31 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.253 0 N-CA-C 109.584 -0.524 . . . . 0.0 109.584 179.795 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' F' F ' 94' ' ' VAL . . . . . . . . . . . . . 47.2 t -123.09 125.4 72.02 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.27 0 N-CA-C 109.907 -0.405 . . . . 0.0 109.907 -179.92 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' F' F ' 95' ' ' VAL . . . . . . . . . . . . . 43.4 t -121.16 135.81 60.13 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.325 0 CA-C-N 115.902 -0.59 . . . . 0.0 109.97 -177.877 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' F' F ' 96' ' ' ILE . . . . . . . . . . . . . 60.3 mt -117.62 126.51 74.76 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.286 0 N-CA-C 109.258 -0.645 . . . . 0.0 109.258 178.58 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' F' F ' 97' ' ' THR . . . . . . . . . . . . . 64.0 p -102.6 157.61 16.81 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-O 121.081 0.467 . . . . 0.0 111.36 -176.432 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' F' F ' 98' ' ' GLU . . . . . . . . . . . . . 12.5 pt-20 -53.88 -22.17 9.33 Favored 'General case' 0 CA--C 1.534 0.345 0 N-CA-C 112.51 0.559 . . . . 0.0 112.51 -179.936 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' F' F ' 99' ' ' GLU . . . . . . . . . . . . . 16.9 tt0 -78.94 14.56 1.34 Allowed 'General case' 0 CA--C 1.537 0.444 0 N-CA-C 112.855 0.687 . . . . 0.0 112.855 -178.061 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' F' F ' 100' ' ' ASN . . . . . . . . . . . . . 3.6 m-20 59.92 38.09 21.23 Favored 'General case' 0 CA--C 1.531 0.214 0 CA-C-O 121.027 0.441 . . . . 0.0 110.599 -179.536 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' F' F ' 101' ' ' GLU . . . . . . . . . . . . . 84.7 tt0 -118.24 143.49 46.51 Favored 'General case' 0 C--N 1.332 -0.163 0 CA-C-N 116.014 -0.539 . . . . 0.0 109.776 178.429 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' F' F ' 102' ' ' VAL . . . . . . . . . . . . . 43.6 t -114.95 126.75 72.61 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.269 0 CA-C-N 116.182 -0.463 . . . . 0.0 109.946 -177.862 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' F' F ' 103' ' ' LEU . . . . . . . . . . . . . 27.0 mt -116.53 130.78 56.94 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 115.665 -0.698 . . . . 0.0 110.267 177.704 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' F' F ' 104' ' ' ILE . . . . . . . . . . . . . 66.5 mt -118.38 120.75 65.28 Favored 'Isoleucine or valine' 0 C--O 1.234 0.25 0 N-CA-C 110.053 -0.351 . . . . 0.0 110.053 179.669 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' F' F ' 105' ' ' PHE . . . . . . . . . . . . . 84.3 m-85 -123.47 164.87 18.08 Favored 'General case' 0 C--N 1.333 -0.15 0 O-C-N 123.928 0.768 . . . . 0.0 109.91 179.742 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' F' F ' 106' ' ' ASN . . . . . . . . . . . . . 45.4 p-10 -100.07 -171.31 2.02 Favored 'General case' 0 C--N 1.331 -0.229 0 N-CA-C 109.88 -0.415 . . . . 0.0 109.88 172.934 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' F' F ' 107' ' ' GLN . . . . . . . . . . . . . 48.7 tt0 -58.67 -28.23 65.54 Favored 'General case' 0 C--N 1.328 -0.365 0 N-CA-C 112.278 0.473 . . . . 0.0 112.278 -178.693 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' F' F ' 108' ' ' ASN . . . . . . . . . . . . . 14.0 t30 -91.4 14.11 15.59 Favored 'General case' 0 CA--C 1.534 0.359 0 N-CA-C 113.177 0.806 . . . . 0.0 113.177 -176.336 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' F' F ' 109' ' ' LEU . . . . . . . . . . . . . 28.2 mt 59.15 37.2 24.09 Favored 'General case' 0 CA--C 1.529 0.144 0 CA-C-O 121.03 0.443 . . . . 0.0 111.551 177.122 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' F' F ' 110' ' ' GLU . . . . . . . . . . . . . 95.7 mt-10 -100.6 150.15 23.01 Favored 'General case' 0 C--N 1.329 -0.285 0 N-CA-C 109.818 -0.438 . . . . 0.0 109.818 176.058 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' F' F ' 111' ' ' GLU . . . . . . . . . . . . . 84.9 tt0 -82.38 122.01 27.45 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-O 120.918 0.389 . . . . 0.0 110.713 -178.255 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' F' F ' 112' ' ' LEU . . . . . . . . . . . . . 60.6 mt -110.91 -46.02 3.39 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.029 -0.532 . . . . 0.0 110.334 178.872 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' F' F ' 113' ' ' TYR . . . . . . . . . . . . . 52.6 t80 -140.96 138.58 33.87 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-O 120.874 0.368 . . . . 0.0 111.393 -179.791 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' F' F ' 114' ' ' ARG . . . . . . . . . . . . . 31.4 ttp180 -138.61 123.02 18.34 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 115.863 -0.608 . . . . 0.0 109.955 176.29 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' F' F ' 115' ' ' GLY . . . . . . . . . . . . . . . -150.08 157.78 27.37 Favored Glycine 0 CA--C 1.523 0.581 0 C-N-CA 120.794 -0.717 . . . . 0.0 111.35 179.002 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' F' F ' 116' ' ' LYS . . . . . . . . . . . . . 39.8 ttpt -127.7 140.74 51.88 Favored 'General case' 0 C--N 1.331 -0.228 0 N-CA-C 110.139 -0.319 . . . . 0.0 110.139 178.446 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' F' F ' 117' ' ' PHE . . . . . . . . . . . . . 44.2 m-85 -136.16 115.01 12.13 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-O 120.865 0.364 . . . . 0.0 110.292 -178.331 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' F' F ' 118' ' ' GLU . . . . . . . . . . . . . 84.9 tt0 -52.23 -46.9 65.89 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.43 -0.35 . . . . 0.0 111.561 -177.515 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' F' F ' 119' ' ' ASN . . . . . . . . . . . . . 18.0 m120 -97.01 31.02 2.51 Favored 'General case' 0 C--N 1.329 -0.285 0 N-CA-C 112.105 0.409 . . . . 0.0 112.105 -175.213 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' F' F ' 120' ' ' LEU . . . . . . . . . . . . . 15.5 tp -56.29 120.11 7.07 Favored 'General case' 0 C--N 1.331 -0.202 0 CA-C-O 120.694 0.283 . . . . 0.0 110.543 178.392 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' F' F ' 121' ' ' ASN . . . . . . . . . . . . . 12.5 m120 -114.06 -44.02 3.19 Favored 'General case' 0 C--N 1.332 -0.181 0 CA-C-N 116.499 -0.319 . . . . 0.0 111.225 -177.53 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' F' F ' 122' ' ' LYS . . . . . . . . . . . . . 88.4 mttt -144.7 153.84 42.14 Favored 'General case' 0 C--N 1.332 -0.195 0 CA-C-O 121.096 0.474 . . . . 0.0 111.912 -176.104 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' F' F ' 123' ' ' VAL . . . . . . . . . . . . . 44.3 t -129.29 129.04 67.23 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.261 0 CA-C-N 115.735 -0.666 . . . . 0.0 109.621 175.428 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' F' F ' 124' ' ' LEU . . . . . . . . . . . . . 34.0 mt -116.69 133.25 56.24 Favored 'General case' 0 C--N 1.331 -0.208 0 CA-C-N 116.305 -0.407 . . . . 0.0 110.275 -179.251 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' F' F ' 125' ' ' VAL . . . . . . . . . . . . . 34.3 m -136.21 139.03 46.33 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.298 0 CA-C-N 116.506 -0.315 . . . . 0.0 110.831 -179.032 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' F' F ' 126' ' ' ARG . . . . . . . . . . . . . 19.2 ttm180 -157.63 127.46 6.11 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-O 120.974 0.416 . . . . 0.0 110.88 175.913 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' F' F ' 127' ' ' ASN . . . . . . . . . . . . . 78.8 m-20 52.9 -113.09 0.74 Allowed 'General case' 0 CA--C 1.544 0.73 0 CA-C-O 118.748 -0.644 . . . . 0.0 110.858 -179.77 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' F' F ' 128' ' ' ASP . . . . . . . . . . . . . 18.9 p-10 -114.17 9.84 17.21 Favored 'General case' 0 CA--C 1.536 0.42 0 CA-C-N 119.978 1.263 . . . . 0.0 113.074 -178.233 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' F' F ' 129' ' ' LEU . . . . . . . . . . . . . 15.1 tp -109.02 138.69 44.97 Favored 'General case' 0 C--O 1.233 0.211 0 O-C-N 122.056 -0.403 . . . . 0.0 109.93 179.123 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' F' F ' 130' ' ' VAL . . . . . . . . . . . . . 43.0 t -125.36 139.49 51.1 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.24 0 CA-C-N 116.311 -0.404 . . . . 0.0 110.002 -178.968 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' F' F ' 131' ' ' VAL . . . . . . . . . . . . . 43.6 t -135.62 135.62 51.14 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.338 0 CA-C-N 116.239 -0.437 . . . . 0.0 109.959 178.287 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' F' F ' 132' ' ' ILE . . . . . . . . . . . . . 69.3 mt -114.41 134.13 58.31 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.323 0 N-CA-C 109.41 -0.589 . . . . 0.0 109.41 -179.926 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' F' F ' 133' ' ' ILE . . . . . . . . . . . . . 39.2 mm -116.22 117.88 56.97 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.211 0 CA-C-N 116.295 -0.411 . . . . 0.0 111.006 -174.594 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' F' F ' 134' ' ' ASP . . . . . . . . . . . . . 7.0 p-10 -129.81 149.64 51.47 Favored 'General case' 0 C--N 1.332 -0.177 0 N-CA-C 109.582 -0.525 . . . . 0.0 109.582 174.085 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' F' F ' 135' ' ' GLU . . . . . . . . . . . . . 39.7 tp10 -49.87 -26.17 3.83 Favored 'General case' 0 C--N 1.327 -0.39 0 N-CA-C 112.988 0.736 . . . . 0.0 112.988 -169.676 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' F' F ' 136' ' ' GLN . . . . . . . . . . . . . 96.9 mt-30 -105.09 -24.27 12.8 Favored 'General case' 0 N--CA 1.466 0.353 0 N-CA-C 113.178 0.807 . . . . 0.0 113.178 -174.654 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' F' F ' 137' ' ' LYS . . . . . . . . . . . . . 38.6 ttpt -140.86 147.75 39.44 Favored 'General case' 0 C--N 1.331 -0.21 0 CA-C-O 121.515 0.674 . . . . 0.0 112.35 -168.32 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' F' F ' 138' ' ' LEU . . . . . . . . . . . . . 16.3 tp -111.67 121.19 44.46 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 114.863 -1.062 . . . . 0.0 109.069 173.567 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' F' F ' 139' ' ' THR . . . . . . . . . . . . . 21.7 m -110.88 126.39 54.64 Favored 'General case' 0 C--N 1.332 -0.179 0 CA-C-O 120.689 0.28 . . . . 0.0 110.963 -178.328 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' F' F ' 140' ' ' LEU . . . . . . . . . . . . . 7.8 tt -114.56 123.45 49.38 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 115.592 -0.731 . . . . 0.0 109.247 179.701 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' F' F ' 141' ' ' ILE . . . . . . . . . . . . . 19.5 mt -122.09 121.42 63.99 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.326 0 CA-C-O 120.988 0.423 . . . . 0.0 109.929 -175.545 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' F' F ' 142' ' ' ARG . . . . . . . . . . . . . 72.3 ttt-85 -113.91 131.43 56.3 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 115.268 -0.878 . . . . 0.0 110.452 -176.917 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' F' F ' 143' ' ' THR . . . . . . . . . . . . . 20.1 p . . . . . 0 C--O 1.221 -0.422 0 CA-C-O 117.991 -1.005 . . . . 0.0 110.522 179.458 . . . . . . . . 0 0 . 1 . 003 nuclear orig full ' A' A ' -3' ' ' GLU . . . . . . . . . . . . . 95.7 mt-10 . . . . . 0 N--CA 1.49 1.539 0 N-CA-C 109.281 -0.637 . . . . 0.0 109.281 . . . . . . . . . 0 0 . 1 . 003 nuclear orig full ' A' A ' -2' ' ' GLY . . . . . . . . . . . . . . . -61.18 150.01 44.44 Favored Glycine 0 CA--C 1.525 0.66 0 N-CA-C 110.764 -0.934 . . . . 0.0 110.764 179.694 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' -1' ' ' VAL . . . . . . . . . . . . . 45.6 t -95.22 125.23 47.94 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.273 0 CA-C-O 120.939 0.4 . . . . 0.0 110.108 -179.546 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 0' ' ' ILE . . . . . . . . . . . . . 74.2 mt -124.03 131.15 73.36 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.235 0 CA-C-N 116.037 -0.529 . . . . 0.0 109.675 178.844 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 24.6 ptp -90.57 131.86 36.05 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.241 -0.436 . . . . 0.0 110.604 -178.905 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 6.7 p -112.07 135.3 52.9 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.287 -0.415 . . . . 0.0 110.96 -179.254 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 53.7 mp0 -140.96 141.48 34.45 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.065 -0.516 . . . . 0.0 111.005 179.04 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 4' ' ' LEU . . . . . . . . . . . . . 15.8 tp -128.22 130.44 47.97 Favored 'General case' 0 C--N 1.331 -0.206 0 CA-C-N 116.067 -0.515 . . . . 0.0 110.106 175.833 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 5' ' ' LYS . . . . . . . . . . . . . 66.8 mttm -113.71 121.58 44.54 Favored 'General case' 0 C--O 1.235 0.308 0 CA-C-N 116.356 -0.384 . . . . 0.0 110.845 -179.765 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 45.1 mt -114.17 145.46 41.64 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 115.413 -0.812 . . . . 0.0 110.3 -179.271 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 78.6 tttt -131.75 136.96 29.27 Favored Pre-proline 0 CA--C 1.535 0.374 0 CA-C-O 119.011 -0.519 . . . . 0.0 109.934 176.573 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 8' ' ' PRO . . . . . . . . . . . . . 85.5 Cg_endo -91.9 143.32 2.77 Favored 'Trans proline' 0 N--CA 1.491 1.358 0 C-N-CA 121.786 1.657 . . . . 0.0 111.864 178.623 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 43.4 mt -77.94 -47.79 2.19 Favored Pre-proline 0 CA--C 1.534 0.349 0 CA-C-O 118.657 -0.687 . . . . 0.0 112.22 179.787 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 95.0 Cg_endo -81.19 156.21 19.66 Favored 'Trans proline' 0 N--CA 1.496 1.649 0 C-N-CA 121.253 1.302 . . . . 0.0 112.128 177.075 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 62.9 tttm -88.96 107.33 18.96 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.358 -0.383 . . . . 0.0 110.435 177.908 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 12.7 p -147.83 146.29 18.16 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.336 0 CA-C-O 120.814 0.34 . . . . 0.0 110.763 -179.855 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 70.7 mm-40 -84.47 130.28 34.78 Favored 'General case' 0 C--N 1.33 -0.275 0 N-CA-C 109.874 -0.417 . . . . 0.0 109.874 177.033 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 14' ' ' LEU . . . . . . . . . . . . . 32.9 mt -98.56 145.04 29.21 Favored Pre-proline 0 CA--C 1.534 0.357 0 CA-C-O 119.042 -0.504 . . . . 0.0 110.472 -178.653 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 15' ' ' PRO . . . . . . . . . . . . . 24.7 Cg_exo -62.85 160.37 33.61 Favored 'Trans proline' 0 N--CA 1.497 1.722 0 C-N-CA 121.359 1.373 . . . . 0.0 112.053 176.749 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 16' ' ' PRO . . . . . . . . . . . . . 27.8 Cg_exo -60.4 -33.04 94.58 Favored 'Trans proline' 0 N--CA 1.497 1.7 0 C-N-CA 121.556 1.504 . . . . 0.0 112.693 -179.637 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 17' ' ' ASP . . . . . . . . . . . . . 11.0 p-10 -86.16 4.42 38.54 Favored 'General case' 0 CA--C 1.536 0.42 0 N-CA-C 113.264 0.839 . . . . 0.0 113.264 -177.583 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 18' ' ' PHE . . . . . . . . . . . . . 23.0 t80 -57.45 -44.79 85.05 Favored 'General case' 0 N--CA 1.457 -0.093 0 O-C-N 121.878 -0.514 . . . . 0.0 110.252 -177.374 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 19' ' ' VAL . . . . . . . . . . . . . 48.4 t -55.9 -46.07 80.12 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.36 0 CA-C-N 116.449 -0.342 . . . . 0.0 110.823 -177.532 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 79.8 m-20 -59.59 -42.01 91.57 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-O 120.771 0.319 . . . . 0.0 110.951 -176.855 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 48.0 t -64.13 -47.48 89.93 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.25 0 C-N-CA 120.645 -0.422 . . . . 0.0 110.495 -177.701 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 22' ' ' ILE . . . . . . . . . . . . . 51.6 mm -55.82 -47.05 80.1 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.237 0 C-N-CA 120.978 -0.289 . . . . 0.0 110.684 179.631 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 23' ' ' ARG . . . . . . . . . . . . . 50.9 ttp180 -54.35 -49.39 69.89 Favored 'General case' 0 C--N 1.329 -0.286 0 C-N-CA 121.005 -0.278 . . . . 0.0 111.419 -177.626 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 24' ' ' ILE . . . . . . . . . . . . . 74.0 mt -60.32 -45.12 96.87 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.235 0 C-N-CA 121.117 -0.233 . . . . 0.0 111.26 -177.197 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 56.2 mmtt -64.67 -38.7 91.91 Favored 'General case' 0 C--N 1.328 -0.334 0 N-CA-C 112.259 0.466 . . . . 0.0 112.259 -177.571 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 91.2 mt -78.33 -44.8 24.25 Favored 'General case' 0 C--N 1.33 -0.273 0 N-CA-C 112.983 0.734 . . . . 0.0 112.983 -172.27 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 27' ' ' GLN . . . . . . . . . . . . . 11.1 pt20 -47.23 139.41 6.2 Favored 'General case' 0 N--CA 1.469 0.492 0 N-CA-C 112.714 0.635 . . . . 0.0 112.714 -175.495 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 99.37 -26.34 24.74 Favored Glycine 0 CA--C 1.533 1.17 0 CA-C-N 115.613 -0.721 . . . . 0.0 112.245 -177.744 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 89.9 mttt -98.5 155.1 17.43 Favored 'General case' 0 C--O 1.233 0.191 0 CA-C-N 117.248 0.524 . . . . 0.0 111.439 179.756 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 30' ' ' THR . . . . . . . . . . . . . 24.2 m -105.78 135.17 47.68 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 115.717 -0.674 . . . . 0.0 109.774 174.906 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 34.8 m -131.73 157.13 43.1 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.276 0 CA-C-N 116.353 -0.385 . . . . 0.0 111.006 -177.739 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 32' ' ' ARG . . . . . . . . . . . . . 91.6 mtm-85 -130.61 150.42 51.82 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-O 121.289 0.566 . . . . 0.0 110.902 179.43 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 33' ' ' THR . . . . . . . . . . . . . 20.3 m -53.47 140.63 27.43 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.076 -0.511 . . . . 0.0 111.299 -178.634 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 99.63 -17.08 58.06 Favored Glycine 0 CA--C 1.534 1.278 0 C-N-CA 121.116 -0.564 . . . . 0.0 113.155 179.252 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 73.0 m-20 -64.68 148.46 50.96 Favored 'General case' 0 C--O 1.232 0.136 0 CA-C-N 118.081 0.941 . . . . 0.0 111.127 179.278 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 46.5 t -118.94 129.43 75.14 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.208 0 CA-C-N 115.721 -0.672 . . . . 0.0 109.686 178.529 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 37' ' ' ILE . . . . . . . . . . . . . 69.0 mt -121.22 138.73 50.63 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.265 0 CA-C-N 116.14 -0.482 . . . . 0.0 109.907 -179.158 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . -113.53 128.94 8.57 Favored Glycine 0 CA--C 1.526 0.758 0 N-CA-C 110.989 -0.844 . . . . 0.0 110.989 -179.976 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 39' ' ' ILE . . . . . . . . . . . . . 70.7 mt -123.43 136.99 58.22 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.218 0 N-CA-C 110.041 -0.355 . . . . 0.0 110.041 179.478 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 40' ' ' SER . . . . . . . . . . . . . 13.4 p -92.83 121.68 34.45 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.344 -0.389 . . . . 0.0 110.961 176.406 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 41' ' ' ILE . . . . . . . . . . . . . 70.6 mt -129.42 114.1 30.19 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.218 0 N-CA-C 109.756 -0.461 . . . . 0.0 109.756 177.136 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 8.6 mp 57.22 35.29 25.98 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-O 120.954 0.407 . . . . 0.0 111.337 -178.973 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . 77.79 -10.13 26.77 Favored Glycine 0 CA--C 1.536 1.359 0 C-N-CA 121.275 -0.488 . . . . 0.0 113.414 178.218 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 44' ' ' LYS . . . . . . . . . . . . . 25.5 ttpt -91.77 129.97 37.64 Favored 'General case' 0 C--N 1.331 -0.226 0 CA-C-N 117.915 0.858 . . . . 0.0 109.811 176.693 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 84.4 tt0 -84.05 125.97 32.61 Favored 'General case' 0 C--N 1.327 -0.392 0 C-N-CA 120.874 -0.33 . . . . 0.0 110.805 -179.731 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 46' ' ' VAL . . . . . . . . . . . . . 7.5 p -119.4 129.25 75.52 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.187 0 N-CA-C 109.553 -0.536 . . . . 0.0 109.553 176.147 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 59.0 mtpt -100.34 126.39 46.68 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 115.704 -0.68 . . . . 0.0 111.059 179.238 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 48' ' ' PHE . . . . . . . . . . . . . 94.0 m-85 -111.33 131.9 54.81 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.198 -0.456 . . . . 0.0 109.918 176.361 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 78.4 tttt -107.28 135.61 48.5 Favored 'General case' 0 C--N 1.329 -0.322 0 N-CA-C 110.155 -0.313 . . . . 0.0 110.155 178.265 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 50' ' ' VAL . . . . . . . . . . . . . 45.0 t -79.7 109.56 14.41 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.285 0 N-CA-C 109.333 -0.617 . . . . 0.0 109.333 177.047 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 51' ' ' VAL . . . . . . . . . . . . . 49.1 t -72.4 -52.37 24.18 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.321 0 CA-C-N 115.993 -0.548 . . . . 0.0 109.626 -174.885 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 52' ' ' GLN . . . . . . . . . . . . . 90.8 mt-30 -153.42 150.27 28.64 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.061 -0.518 . . . . 0.0 111.769 -177.821 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -130.16 132.81 46.22 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 115.208 -0.905 . . . . 0.0 109.611 174.725 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 54' ' ' TYR . . . . . . . . . . . . . 37.4 t80 -129.07 113.02 18.53 Favored Pre-proline 0 CA--C 1.535 0.392 0 CA-C-O 118.144 -0.931 . . . . 0.0 110.496 179.092 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 55' ' ' PRO . . . . . . . . . . . . . 74.4 Cg_endo -77.11 167.37 79.96 Favored 'Cis proline' 0 N--CA 1.5 1.854 0 CA-C-N 121.97 1.739 . . . . 0.0 112.475 -6.872 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 56' ' ' SER . . . . . . . . . . . . . 13.6 m -116.09 127.02 27.09 Favored Pre-proline 0 CA--C 1.538 0.502 0 CA-C-O 118.427 -0.797 . . . . 0.0 109.239 175.859 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 57' ' ' PRO . . . . . . . . . . . . . 46.7 Cg_endo -69.7 148.65 87.03 Favored 'Cis proline' 0 N--CA 1.498 1.741 0 CA-C-N 122.067 1.774 . . . . 0.0 111.862 0.497 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 58' ' ' LEU . . . . . . . . . . . . . 23.2 tp -107.52 137.18 46.02 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.014 -0.539 . . . . 0.0 110.742 -178.898 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 59' ' ' ARG . . . . . . . . . . . . . 56.9 ttp180 -104.04 120.12 40.39 Favored 'General case' 0 C--N 1.327 -0.383 0 N-CA-C 109.205 -0.665 . . . . 0.0 109.205 174.513 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 40.3 t -81.37 122.35 36.28 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.232 0 C-N-CA 120.626 -0.429 . . . . 0.0 110.74 -173.453 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 91.1 mt-10 -131.07 164.15 26.06 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 115.96 -0.564 . . . . 0.0 109.675 176.567 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 62' ' ' ASP . . . . . . . . . . . . . 44.5 m-20 -53.04 -32.8 48.79 Favored 'General case' 0 C--N 1.328 -0.347 0 N-CA-C 111.852 0.316 . . . . 0.0 111.852 -179.739 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 63' ' ' ARG . . . . . . . . . . . . . 68.4 mtp180 -72.47 -21.79 61.16 Favored 'General case' 0 CA--C 1.534 0.335 0 N-CA-C 112.907 0.706 . . . . 0.0 112.907 -176.354 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 31.1 m -68.77 140.14 55.32 Favored 'General case' 0 C--N 1.331 -0.2 0 CA-C-O 120.86 0.362 . . . . 0.0 111.057 -175.675 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 65' ' ' LYS . . . . . . . . . . . . . 50.3 mtmt -89.5 134.24 34.2 Favored 'General case' 0 C--N 1.331 -0.23 0 CA-C-N 116.11 -0.496 . . . . 0.0 110.444 178.316 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 66' ' ' ILE . . . . . . . . . . . . . 61.0 mt -118.27 132.59 67.67 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.254 0 N-CA-C 109.98 -0.378 . . . . 0.0 109.98 179.917 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 67' ' ' THR . . . . . . . . . . . . . 20.5 m -124.18 136.81 54.46 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-O 121.028 0.442 . . . . 0.0 110.918 -179.362 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 68' ' ' LEU . . . . . . . . . . . . . 30.6 mt -106.16 123.02 47.37 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 115.881 -0.599 . . . . 0.0 110.431 177.498 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 69' ' ' VAL . . . . . . . . . . . . . 46.3 t -102.68 130.64 52.37 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.245 0 CA-C-N 116.159 -0.473 . . . . 0.0 109.928 178.337 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 70' ' ' THR . . . . . . . . . . . . . 24.1 m -145.28 -57.74 0.33 Allowed 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.308 -0.405 . . . . 0.0 110.466 179.685 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 71' ' ' HIS . . . . . . . . . . . . . 32.4 m80 -110.12 153.79 43.08 Favored Pre-proline 0 C--N 1.329 -0.302 0 CA-C-N 116.259 -0.428 . . . . 0.0 110.366 179.623 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 72' ' ' PRO . . . . . . . . . . . . . 38.0 Cg_endo -66.17 -15.78 49.61 Favored 'Trans proline' 0 N--CA 1.499 1.821 0 C-N-CA 121.298 1.332 . . . . 0.0 113.218 178.379 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 73' ' ' VAL . . . . . . . . . . . . . 35.6 m -120.25 161.5 19.76 Favored 'Isoleucine or valine' 0 N--CA 1.462 0.133 0 CA-C-O 120.913 0.387 . . . . 0.0 110.545 -178.802 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 74' ' ' ASP . . . . . . . . . . . . . 4.9 t70 -98.57 124.07 43.11 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.082 -0.508 . . . . 0.0 110.275 -178.243 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 42.8 t -117.8 123.65 71.98 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.26 0 CA-C-O 120.931 0.396 . . . . 0.0 110.646 -177.937 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 76' ' ' LEU . . . . . . . . . . . . . 5.8 mp -121.81 148.48 44.63 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 115.848 -0.615 . . . . 0.0 109.679 175.537 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 77' ' ' GLU . . . . . . . . . . . . . 96.6 mt-10 -137.68 134.93 35.99 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-O 120.991 0.424 . . . . 0.0 111.354 -178.308 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 78' ' ' ALA . . . . . . . . . . . . . . . -119.95 135.44 54.9 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 115.718 -0.674 . . . . 0.0 109.679 176.266 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 79' ' ' LYS . . . . . . . . . . . . . 62.0 mttp -84.78 115.56 22.79 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-O 120.816 0.341 . . . . 0.0 111.078 -176.578 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 80' ' ' ILE . . . . . . . . . . . . . 39.6 mm -139.3 108.56 3.71 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.27 0 N-CA-C 109.301 -0.629 . . . . 0.0 109.301 -178.082 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 81' ' ' LYS . . . . . . . . . . . . . 63.6 mttp -94.53 126.25 39.69 Favored 'General case' 0 C--N 1.33 -0.249 0 C-N-CA 120.629 -0.428 . . . . 0.0 111.175 -179.734 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . 89.08 42.1 5.7 Favored Glycine 0 CA--C 1.527 0.821 0 C-N-CA 120.679 -0.772 . . . . 0.0 112.119 173.798 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 83' ' ' ILE . . . . . . . . . . . . . 72.9 mt -68.84 137.91 23.42 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.291 0 N-CA-C 109.597 -0.52 . . . . 0.0 109.597 176.19 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 84' ' ' LYS . . . . . . . . . . . . . 14.2 ttmm -93.08 -54.05 3.88 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-O 121.104 0.478 . . . . 0.0 110.216 -178.029 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 85' ' ' ASP . . . . . . . . . . . . . 13.1 t70 -151.22 151.41 31.83 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 115.611 -0.722 . . . . 0.0 110.55 -178.725 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 86' ' ' VAL . . . . . . . . . . . . . 44.1 t -128.58 129.43 68.72 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.255 0 CA-C-O 121.016 0.436 . . . . 0.0 110.083 178.914 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 87' ' ' ILE . . . . . . . . . . . . . 5.1 mp -119.33 124.04 72.31 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.207 0 N-CA-C 109.229 -0.656 . . . . 0.0 109.229 178.22 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 88' ' ' LEU . . . . . . . . . . . . . 15.9 tp -113.79 126.74 55.54 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-O 121.077 0.465 . . . . 0.0 111.259 -175.758 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 89' ' ' ASP . . . . . . . . . . . . . 13.0 t70 -121.87 152.45 39.57 Favored 'General case' 0 C--N 1.331 -0.223 0 N-CA-C 109.232 -0.655 . . . . 0.0 109.232 174.994 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 44.4 mt-10 -49.83 -35.18 22.08 Favored 'General case' 0 C--N 1.328 -0.348 0 N-CA-C 112.812 0.671 . . . . 0.0 112.812 -172.179 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 91' ' ' ASN . . . . . . . . . . . . . 87.9 m-20 -126.87 26.77 6.11 Favored 'General case' 0 N--CA 1.467 0.391 0 N-CA-C 112.596 0.591 . . . . 0.0 112.596 -175.272 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 92' ' ' LEU . . . . . . . . . . . . . 7.2 tp -166.2 141.39 4.61 Favored 'General case' 0 C--N 1.33 -0.239 0 CA-C-O 120.728 0.299 . . . . 0.0 110.387 178.233 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 93' ' ' ILE . . . . . . . . . . . . . 68.1 mt -120.61 122.4 67.9 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.267 0 N-CA-C 109.407 -0.59 . . . . 0.0 109.407 179.327 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 94' ' ' VAL . . . . . . . . . . . . . 48.0 t -120.92 125.81 74.47 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.267 0 CA-C-O 120.981 0.419 . . . . 0.0 109.993 -179.864 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 95' ' ' VAL . . . . . . . . . . . . . 44.9 t -119.81 132.25 70.04 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.249 0 CA-C-N 115.867 -0.606 . . . . 0.0 109.543 178.872 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 96' ' ' ILE . . . . . . . . . . . . . 63.3 mt -114.0 125.56 71.31 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.293 0 N-CA-C 109.077 -0.712 . . . . 0.0 109.077 179.069 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 97' ' ' THR . . . . . . . . . . . . . 80.3 p -97.66 156.46 16.53 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-O 121.011 0.434 . . . . 0.0 110.864 -177.78 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 98' ' ' GLU . . . . . . . . . . . . . 84.4 tt0 -53.88 -24.32 15.61 Favored 'General case' 0 CA--C 1.534 0.343 0 N-CA-C 112.163 0.431 . . . . 0.0 112.163 179.348 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 99' ' ' GLU . . . . . . . . . . . . . 96.0 mt-10 -76.4 11.69 1.49 Allowed 'General case' 0 CA--C 1.537 0.451 0 N-CA-C 113.227 0.825 . . . . 0.0 113.227 -178.597 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 100' ' ' ASN . . . . . . . . . . . . . 2.1 m-20 63.2 37.16 11.45 Favored 'General case' 0 CA--C 1.53 0.203 0 CA-C-O 121.005 0.431 . . . . 0.0 111.093 178.601 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 101' ' ' GLU . . . . . . . . . . . . . 68.5 tt0 -117.08 145.41 43.76 Favored 'General case' 0 C--N 1.332 -0.173 0 N-CA-C 109.386 -0.598 . . . . 0.0 109.386 175.654 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 102' ' ' VAL . . . . . . . . . . . . . 43.6 t -117.19 126.2 74.38 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.249 0 N-CA-C 109.869 -0.419 . . . . 0.0 109.869 -178.308 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 103' ' ' LEU . . . . . . . . . . . . . 28.7 mt -115.68 130.53 56.89 Favored 'General case' 0 C--N 1.331 -0.225 0 CA-C-N 115.552 -0.749 . . . . 0.0 110.157 176.409 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 104' ' ' ILE . . . . . . . . . . . . . 67.2 mt -116.78 120.45 65.08 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.294 0 N-CA-C 109.972 -0.381 . . . . 0.0 109.972 179.606 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 105' ' ' PHE . . . . . . . . . . . . . 66.3 m-85 -120.03 166.34 13.51 Favored 'General case' 0 C--N 1.333 -0.143 0 CA-C-N 115.323 -0.853 . . . . 0.0 109.622 179.754 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 106' ' ' ASN . . . . . . . . . . . . . 51.9 p-10 -101.49 -170.96 1.9 Allowed 'General case' 0 C--N 1.33 -0.257 0 N-CA-C 109.976 -0.379 . . . . 0.0 109.976 174.159 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 107' ' ' GLN . . . . . . . . . . . . . 50.4 tt0 -59.6 -28.02 66.81 Favored 'General case' 0 CA--C 1.533 0.301 0 N-CA-C 112.131 0.419 . . . . 0.0 112.131 179.997 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 108' ' ' ASN . . . . . . . . . . . . . 6.0 t-20 -85.22 13.37 6.46 Favored 'General case' 0 CA--C 1.536 0.418 0 N-CA-C 112.81 0.671 . . . . 0.0 112.81 -178.891 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 109' ' ' LEU . . . . . . . . . . . . . 7.1 tp 54.64 37.03 27.42 Favored 'General case' 0 CA--C 1.529 0.161 0 CA-C-O 120.935 0.398 . . . . 0.0 111.385 179.212 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 110' ' ' GLU . . . . . . . . . . . . . 95.6 mt-10 -104.33 148.6 26.2 Favored 'General case' 0 C--N 1.331 -0.216 0 N-CA-C 109.742 -0.466 . . . . 0.0 109.742 175.717 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 111' ' ' GLU . . . . . . . . . . . . . 61.3 tt0 -85.06 121.86 28.45 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-O 120.798 0.332 . . . . 0.0 110.611 -176.434 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 112' ' ' LEU . . . . . . . . . . . . . 15.0 mt -107.48 -46.13 3.91 Favored 'General case' 0 C--N 1.331 -0.225 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.699 179.886 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 113' ' ' TYR . . . . . . . . . . . . . 57.5 t80 -133.05 139.28 47.1 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.399 -0.364 . . . . 0.0 110.802 -178.101 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 114' ' ' ARG . . . . . . . . . . . . . 26.4 ptt180 -141.36 123.07 15.21 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.769 -179.923 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 115' ' ' GLY . . . . . . . . . . . . . . . -150.13 158.81 27.84 Favored Glycine 0 CA--C 1.522 0.471 0 N-CA-C 110.931 -0.868 . . . . 0.0 110.931 179.892 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 116' ' ' LYS . . . . . . . . . . . . . 33.0 ttmt -131.44 135.85 47.48 Favored 'General case' 0 C--N 1.327 -0.379 0 N-CA-C 109.868 -0.419 . . . . 0.0 109.868 177.464 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 117' ' ' PHE . . . . . . . . . . . . . 25.2 m-85 -137.91 113.86 9.9 Favored 'General case' 0 C--N 1.329 -0.319 0 N-CA-C 109.8 -0.444 . . . . 0.0 109.8 -175.805 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 118' ' ' GLU . . . . . . . . . . . . . 84.7 tt0 -56.31 -40.5 74.47 Favored 'General case' 0 C--N 1.33 -0.272 0 C-N-CA 120.787 -0.365 . . . . 0.0 110.959 -177.362 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 119' ' ' ASN . . . . . . . . . . . . . 5.4 m120 -97.5 30.62 2.82 Favored 'General case' 0 C--N 1.33 -0.263 0 N-CA-C 112.251 0.463 . . . . 0.0 112.251 -175.034 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 120' ' ' LEU . . . . . . . . . . . . . 23.9 tp -59.21 120.26 8.89 Favored 'General case' 0 C--N 1.332 -0.167 0 N-CA-C 109.859 -0.422 . . . . 0.0 109.859 176.545 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 121' ' ' ASN . . . . . . . . . . . . . 31.8 m120 -113.49 -44.18 3.24 Favored 'General case' 0 C--N 1.331 -0.223 0 CA-C-N 116.609 -0.268 . . . . 0.0 111.032 -177.162 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 122' ' ' LYS . . . . . . . . . . . . . 60.6 mtpt -143.52 144.42 31.96 Favored 'General case' 0 C--N 1.331 -0.22 0 CA-C-O 121.015 0.435 . . . . 0.0 111.383 -178.46 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 123' ' ' VAL . . . . . . . . . . . . . 47.7 t -128.9 127.53 66.35 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.297 0 N-CA-C 109.298 -0.63 . . . . 0.0 109.298 174.897 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 124' ' ' LEU . . . . . . . . . . . . . 51.8 mt -126.23 132.58 51.71 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-O 120.791 0.329 . . . . 0.0 110.654 -178.636 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 125' ' ' VAL . . . . . . . . . . . . . 11.6 p -134.45 136.0 53.3 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.34 0 CA-C-N 116.111 -0.495 . . . . 0.0 110.375 179.32 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 126' ' ' ARG . . . . . . . . . . . . . 76.2 mtt180 -143.91 127.79 17.35 Favored 'General case' 0 C--N 1.327 -0.395 0 CA-C-N 115.846 -0.615 . . . . 0.0 109.365 178.158 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 127' ' ' ASN . . . . . . . . . . . . . 79.9 m-20 56.83 -134.72 1.24 Allowed 'General case' 0 CA--C 1.544 0.743 0 CA-C-O 118.679 -0.677 . . . . 0.0 109.65 -178.285 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 128' ' ' ASP . . . . . . . . . . . . . 8.4 p-10 -99.06 15.81 24.64 Favored 'General case' 0 CA--C 1.535 0.389 0 CA-C-N 119.923 1.238 . . . . 0.0 113.057 178.641 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 129' ' ' LEU . . . . . . . . . . . . . 7.0 mp -114.27 141.23 47.84 Favored 'General case' 0 N--CA 1.463 0.224 0 N-CA-C 109.874 -0.417 . . . . 0.0 109.874 178.346 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 130' ' ' VAL . . . . . . . . . . . . . 14.6 p -140.06 146.47 24.81 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.234 0 CA-C-O 121.312 0.577 . . . . 0.0 111.682 -176.432 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 131' ' ' VAL . . . . . . . . . . . . . 44.2 t -136.02 139.52 45.7 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.264 0 CA-C-N 115.712 -0.677 . . . . 0.0 110.196 177.105 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 132' ' ' ILE . . . . . . . . . . . . . 70.9 mt -115.58 132.68 64.25 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.335 0 CA-C-N 115.998 -0.547 . . . . 0.0 109.673 -179.82 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 133' ' ' ILE . . . . . . . . . . . . . 41.1 mm -116.94 123.43 71.79 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.241 0 CA-C-O 120.781 0.324 . . . . 0.0 111.078 -175.127 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 134' ' ' ASP . . . . . . . . . . . . . 10.3 p-10 -136.61 149.4 48.0 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-N 116.227 -0.442 . . . . 0.0 109.981 175.255 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 135' ' ' GLU . . . . . . . . . . . . . 41.8 tp10 -49.95 -28.36 6.66 Favored 'General case' 0 C--N 1.327 -0.385 0 N-CA-C 112.673 0.62 . . . . 0.0 112.673 -171.986 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 136' ' ' GLN . . . . . . . . . . . . . 97.6 mt-30 -83.47 -34.96 25.27 Favored 'General case' 0 C--O 1.234 0.242 0 N-CA-C 112.707 0.632 . . . . 0.0 112.707 -175.96 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 137' ' ' LYS . . . . . . . . . . . . . 56.3 pttt -164.08 174.51 11.24 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-O 121.6 0.714 . . . . 0.0 112.529 -171.055 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 138' ' ' LEU . . . . . . . . . . . . . 6.9 tt -121.33 128.43 52.28 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 114.889 -1.05 . . . . 0.0 109.881 177.716 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 139' ' ' THR . . . . . . . . . . . . . 47.0 m -109.26 127.98 54.7 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-N 116.117 -0.492 . . . . 0.0 109.882 178.282 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 140' ' ' LEU . . . . . . . . . . . . . 6.9 tp -114.56 121.36 43.24 Favored 'General case' 0 C--N 1.327 -0.395 0 CA-C-N 115.983 -0.553 . . . . 0.0 109.608 -176.574 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 141' ' ' ILE . . . . . . . . . . . . . 18.9 mt -121.75 118.49 55.91 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.245 0 N-CA-C 109.885 -0.413 . . . . 0.0 109.885 -175.817 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 142' ' ' ARG . . . . . . . . . . . . . 34.4 mmt180 -116.21 134.81 54.51 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 115.557 -0.747 . . . . 0.0 110.054 -178.248 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 143' ' ' THR . . . . . . . . . . . . . 48.8 p . . . . . 0 C--O 1.221 -0.444 0 CA-C-O 118.041 -0.98 . . . . 0.0 110.775 179.363 . . . . . . . . 0 0 . 1 . 003 nuclear orig full ' B' B ' -3' ' ' GLU . . . . . . . . . . . . . 95.6 mt-10 . . . . . 0 N--CA 1.49 1.55 0 N-CA-C 109.3 -0.629 . . . . 0.0 109.3 . . . . . . . . . 0 0 . 1 . 003 nuclear orig full ' B' B ' -2' ' ' GLY . . . . . . . . . . . . . . . -60.4 146.17 46.42 Favored Glycine 0 CA--C 1.524 0.617 0 N-CA-C 110.771 -0.931 . . . . 0.0 110.771 179.635 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' -1' ' ' VAL . . . . . . . . . . . . . 42.7 t -95.56 133.92 34.87 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.349 0 CA-C-O 120.829 0.347 . . . . 0.0 110.149 -179.908 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 0' ' ' ILE . . . . . . . . . . . . . 42.9 mm -113.47 143.31 23.43 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.249 0 CA-C-N 116.118 -0.492 . . . . 0.0 109.916 -179.977 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 1' ' ' MET . . . . . . . . . . . . . 24.0 ptm -141.94 138.98 32.35 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.233 -0.44 . . . . 0.0 110.523 -178.748 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 2' ' ' SER . . . . . . . . . . . . . 96.8 p -129.27 151.18 50.21 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.238 -0.437 . . . . 0.0 110.627 -179.089 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 3' ' ' GLU . . . . . . . . . . . . . 95.3 mt-10 -139.4 141.27 37.54 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 115.879 -0.6 . . . . 0.0 110.804 -179.223 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 4' ' ' LEU . . . . . . . . . . . . . 5.2 tt -126.14 128.01 46.64 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.131 -0.486 . . . . 0.0 109.803 177.342 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 5' ' ' LYS . . . . . . . . . . . . . 92.5 mttt -110.19 122.28 47.27 Favored 'General case' 0 C--O 1.235 0.315 0 CA-C-O 120.873 0.368 . . . . 0.0 111.034 -178.313 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 6' ' ' LEU . . . . . . . . . . . . . 48.9 mt -114.02 148.42 37.02 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 115.296 -0.866 . . . . 0.0 110.536 -179.5 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 7' ' ' LYS . . . . . . . . . . . . . 35.8 ttpt -134.63 139.5 32.7 Favored Pre-proline 0 CA--C 1.534 0.356 0 CA-C-O 119.023 -0.513 . . . . 0.0 110.022 175.683 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 8' ' ' PRO . . . . . . . . . . . . . 84.9 Cg_endo -91.76 141.72 2.62 Favored 'Trans proline' 0 N--CA 1.489 1.257 0 C-N-CA 121.754 1.636 . . . . 0.0 111.61 177.731 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 9' ' ' LEU . . . . . . . . . . . . . 24.1 mt -79.35 -47.62 1.56 Allowed Pre-proline 0 CA--C 1.534 0.343 0 CA-C-O 118.696 -0.669 . . . . 0.0 112.203 -178.397 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 10' ' ' PRO . . . . . . . . . . . . . 89.6 Cg_endo -81.22 155.53 19.37 Favored 'Trans proline' 0 N--CA 1.495 1.581 0 C-N-CA 121.213 1.275 . . . . 0.0 111.95 176.059 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 11' ' ' LYS . . . . . . . . . . . . . 85.5 tttt -83.71 96.02 8.58 Favored 'General case' 0 C--N 1.33 -0.282 0 C-N-CA 120.832 -0.347 . . . . 0.0 110.099 177.465 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 12' ' ' VAL . . . . . . . . . . . . . 12.1 p -136.28 145.64 30.39 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.276 0 CA-C-N 116.1 -0.5 . . . . 0.0 110.411 -178.64 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 13' ' ' GLU . . . . . . . . . . . . . 81.9 tt0 -91.72 126.32 36.76 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.152 -0.476 . . . . 0.0 110.109 178.562 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 14' ' ' LEU . . . . . . . . . . . . . 27.5 mt -98.1 145.25 29.47 Favored Pre-proline 0 CA--C 1.532 0.281 0 CA-C-O 119.167 -0.444 . . . . 0.0 110.365 -177.932 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 15' ' ' PRO . . . . . . . . . . . . . 24.0 Cg_exo -63.71 160.0 38.68 Favored 'Trans proline' 0 N--CA 1.497 1.695 0 C-N-CA 121.331 1.354 . . . . 0.0 111.694 176.144 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 16' ' ' PRO . . . . . . . . . . . . . 37.5 Cg_exo -59.22 -31.6 95.53 Favored 'Trans proline' 0 N--CA 1.495 1.613 0 C-N-CA 121.474 1.45 . . . . 0.0 112.737 -179.747 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 17' ' ' ASP . . . . . . . . . . . . . 10.0 p-10 -88.1 3.97 47.11 Favored 'General case' 0 CA--C 1.536 0.404 0 N-CA-C 113.319 0.859 . . . . 0.0 113.319 -177.323 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 18' ' ' PHE . . . . . . . . . . . . . 39.2 t80 -58.26 -47.03 84.86 Favored 'General case' 0 C--N 1.334 -0.107 0 O-C-N 121.931 -0.481 . . . . 0.0 110.121 -177.64 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 19' ' ' VAL . . . . . . . . . . . . . 47.3 t -56.6 -40.83 71.5 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 CA-C-N 116.249 -0.432 . . . . 0.0 110.54 -178.236 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 20' ' ' ASP . . . . . . . . . . . . . 74.3 m-20 -59.63 -44.79 93.35 Favored 'General case' 0 C--N 1.33 -0.269 0 C-N-CA 120.919 -0.312 . . . . 0.0 110.797 -177.398 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 21' ' ' VAL . . . . . . . . . . . . . 46.9 t -64.69 -45.48 95.14 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.255 0 C-N-CA 120.702 -0.399 . . . . 0.0 110.522 -177.61 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 22' ' ' ILE . . . . . . . . . . . . . 50.7 mm -58.71 -40.59 79.96 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.299 0 C-N-CA 120.98 -0.288 . . . . 0.0 110.826 -179.803 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 23' ' ' ARG . . . . . . . . . . . . . 52.2 ttp180 -56.73 -47.07 80.82 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-O 120.891 0.377 . . . . 0.0 110.515 178.713 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 24' ' ' ILE . . . . . . . . . . . . . 77.3 mt -60.87 -44.8 98.51 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.261 0 CA-C-N 115.979 -0.555 . . . . 0.0 111.822 -178.852 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 25' ' ' LYS . . . . . . . . . . . . . 12.5 pttp -71.69 -36.56 70.63 Favored 'General case' 0 CA--C 1.533 0.309 0 C-N-CA 120.372 -0.531 . . . . 0.0 111.851 -173.042 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 26' ' ' LEU . . . . . . . . . . . . . 24.8 mt -78.94 -42.68 26.33 Favored 'General case' 0 C--N 1.331 -0.228 0 N-CA-C 113.186 0.81 . . . . 0.0 113.186 -173.435 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 27' ' ' GLN . . . . . . . . . . . . . 11.2 pt20 -47.17 138.24 7.16 Favored 'General case' 0 N--CA 1.47 0.553 0 N-CA-C 112.696 0.628 . . . . 0.0 112.696 -175.356 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 28' ' ' GLY . . . . . . . . . . . . . . . 101.5 -25.95 26.26 Favored Glycine 0 CA--C 1.532 1.122 0 CA-C-N 115.669 -0.696 . . . . 0.0 112.295 -176.391 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 29' ' ' LYS . . . . . . . . . . . . . 63.8 mttp -98.14 155.15 17.28 Favored 'General case' 0 C--O 1.232 0.175 0 CA-C-N 117.5 0.65 . . . . 0.0 111.256 178.219 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 30' ' ' THR . . . . . . . . . . . . . 41.3 m -100.49 136.23 40.68 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.015 -0.539 . . . . 0.0 109.83 175.157 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 31' ' ' VAL . . . . . . . . . . . . . 35.2 m -125.78 153.72 33.98 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.314 0 CA-C-O 120.902 0.382 . . . . 0.0 110.622 -178.738 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 32' ' ' ARG . . . . . . . . . . . . . 34.2 ttp180 -132.39 147.55 52.39 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 115.897 -0.592 . . . . 0.0 110.242 178.118 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 33' ' ' THR . . . . . . . . . . . . . 17.0 m -53.42 139.37 30.8 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.394 -0.366 . . . . 0.0 111.355 -178.342 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 34' ' ' GLY . . . . . . . . . . . . . . . 101.1 -17.18 56.42 Favored Glycine 0 CA--C 1.534 1.219 0 CA-C-O 119.69 -0.505 . . . . 0.0 113.274 179.842 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 35' ' ' ASP . . . . . . . . . . . . . 70.5 m-20 -64.46 149.34 48.71 Favored 'General case' 0 C--O 1.232 0.148 0 CA-C-N 118.017 0.908 . . . . 0.0 111.478 179.506 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 36' ' ' VAL . . . . . . . . . . . . . 44.9 t -121.4 130.25 74.82 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.216 0 CA-C-N 115.752 -0.658 . . . . 0.0 109.791 178.148 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 37' ' ' ILE . . . . . . . . . . . . . 69.7 mt -121.7 139.59 48.3 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.267 0 CA-C-N 116.294 -0.412 . . . . 0.0 110.095 -179.548 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 38' ' ' GLY . . . . . . . . . . . . . . . -111.52 128.85 8.85 Favored Glycine 0 CA--C 1.525 0.712 0 N-CA-C 111.017 -0.833 . . . . 0.0 111.017 179.634 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 39' ' ' ILE . . . . . . . . . . . . . 73.9 mt -123.3 137.12 57.71 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.201 0 N-CA-C 110.072 -0.344 . . . . 0.0 110.072 179.521 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 40' ' ' SER . . . . . . . . . . . . . 59.6 p -91.78 115.91 28.45 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.559 -0.291 . . . . 0.0 111.117 177.612 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 41' ' ' ILE . . . . . . . . . . . . . 44.7 mm -121.39 114.2 42.27 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.231 0 N-CA-C 109.772 -0.455 . . . . 0.0 109.772 178.159 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 42' ' ' LEU . . . . . . . . . . . . . 6.4 mp 56.9 35.5 26.44 Favored 'General case' 0 CA--C 1.532 0.26 0 CA-C-O 120.973 0.416 . . . . 0.0 111.342 -179.378 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 43' ' ' GLY . . . . . . . . . . . . . . . 77.91 -10.06 27.93 Favored Glycine 0 CA--C 1.534 1.276 0 C-N-CA 121.249 -0.5 . . . . 0.0 113.472 177.725 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 44' ' ' LYS . . . . . . . . . . . . . 61.1 tttm -96.32 134.33 39.6 Favored 'General case' 0 C--N 1.331 -0.197 0 CA-C-N 117.901 0.851 . . . . 0.0 109.819 176.651 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 45' ' ' GLU . . . . . . . . . . . . . 82.9 tt0 -83.5 127.94 34.11 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-O 120.867 0.365 . . . . 0.0 111.084 -177.863 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 46' ' ' VAL . . . . . . . . . . . . . 7.3 p -120.53 130.07 74.89 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.265 0 N-CA-C 109.315 -0.624 . . . . 0.0 109.315 175.541 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 47' ' ' LYS . . . . . . . . . . . . . 79.8 mttt -100.4 128.64 46.41 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.076 -0.511 . . . . 0.0 111.366 179.317 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 48' ' ' PHE . . . . . . . . . . . . . 92.1 m-85 -112.89 131.91 55.53 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 115.88 -0.6 . . . . 0.0 109.78 176.705 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 49' ' ' LYS . . . . . . . . . . . . . 66.8 tttt -107.19 137.45 45.22 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.48 -0.327 . . . . 0.0 110.64 179.68 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 50' ' ' VAL . . . . . . . . . . . . . 45.0 t -80.71 107.22 12.82 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.241 0 N-CA-C 109.17 -0.678 . . . . 0.0 109.17 175.613 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 51' ' ' VAL . . . . . . . . . . . . . 49.4 t -71.47 -54.14 18.29 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.292 0 N-CA-C 109.493 -0.558 . . . . 0.0 109.493 -174.516 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 52' ' ' GLN . . . . . . . . . . . . . 90.8 mt-30 -154.7 154.07 32.31 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 115.93 -0.577 . . . . 0.0 112.097 -176.74 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 53' ' ' ALA . . . . . . . . . . . . . . . -132.6 134.37 44.83 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 115.191 -0.913 . . . . 0.0 109.784 174.421 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 54' ' ' TYR . . . . . . . . . . . . . 58.6 t80 -129.21 111.31 18.16 Favored Pre-proline 0 CA--C 1.533 0.309 0 CA-C-O 118.147 -0.93 . . . . 0.0 110.344 178.007 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 55' ' ' PRO . . . . . . . . . . . . . 74.4 Cg_endo -77.14 170.15 72.34 Favored 'Cis proline' 0 N--CA 1.5 1.907 0 CA-C-N 121.996 1.749 . . . . 0.0 111.957 -6.859 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 56' ' ' SER . . . . . . . . . . . . . 68.8 m -125.02 136.24 27.85 Favored Pre-proline 0 CA--C 1.538 0.491 0 CA-C-O 118.556 -0.735 . . . . 0.0 109.457 175.969 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 57' ' ' PRO . . . . . . . . . . . . . 37.2 Cg_endo -67.32 160.67 79.1 Favored 'Cis proline' 0 N--CA 1.499 1.852 0 CA-C-N 121.771 1.668 . . . . 0.0 111.689 -2.129 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 58' ' ' LEU . . . . . . . . . . . . . 29.4 tp -129.27 138.07 51.42 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-O 120.993 0.425 . . . . 0.0 110.593 -178.558 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 59' ' ' ARG . . . . . . . . . . . . . 57.2 ttp180 -101.02 121.22 41.39 Favored 'General case' 0 C--N 1.327 -0.38 0 N-CA-C 109.12 -0.696 . . . . 0.0 109.12 174.325 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 60' ' ' VAL . . . . . . . . . . . . . 47.4 t -72.14 122.07 23.77 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.361 0 C-N-CA 120.848 -0.341 . . . . 0.0 110.365 -173.969 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 61' ' ' GLU . . . . . . . . . . . . . 95.4 mt-10 -131.04 165.73 22.57 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.0 -0.546 . . . . 0.0 110.206 179.213 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 62' ' ' ASP . . . . . . . . . . . . . 48.2 m-20 -55.01 -32.61 61.94 Favored 'General case' 0 C--N 1.329 -0.324 0 N-CA-C 111.766 0.284 . . . . 0.0 111.766 -179.25 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 63' ' ' ARG . . . . . . . . . . . . . 32.5 ptt180 -83.35 3.36 31.95 Favored 'General case' 0 CA--C 1.538 0.487 0 N-CA-C 113.583 0.957 . . . . 0.0 113.583 -175.36 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 64' ' ' THR . . . . . . . . . . . . . 40.1 m -85.01 135.29 34.08 Favored 'General case' 0 C--N 1.331 -0.217 0 CA-C-N 118.137 0.426 . . . . 0.0 110.258 -178.997 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 65' ' ' LYS . . . . . . . . . . . . . 99.1 mttt -88.97 127.36 35.66 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.012 179.245 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 66' ' ' ILE . . . . . . . . . . . . . 58.4 mt -112.74 129.48 68.27 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.328 0 N-CA-C 109.859 -0.422 . . . . 0.0 109.859 -178.531 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 67' ' ' THR . . . . . . . . . . . . . 23.9 m -124.46 138.7 54.33 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-O 121.045 0.45 . . . . 0.0 110.801 -177.527 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 68' ' ' LEU . . . . . . . . . . . . . 7.6 mp -107.28 131.15 54.52 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 115.972 -0.558 . . . . 0.0 110.242 177.025 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 69' ' ' VAL . . . . . . . . . . . . . 43.2 t -87.37 130.53 37.03 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.294 0 CA-C-N 116.424 -0.353 . . . . 0.0 110.067 179.132 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 70' ' ' THR . . . . . . . . . . . . . 5.7 p -99.52 -60.02 1.61 Allowed 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 116.11 -0.495 . . . . 0.0 111.092 -178.253 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 71' ' ' HIS . . . . . . . . . . . . . 83.3 m-70 -69.57 131.4 89.85 Favored Pre-proline 0 CA--C 1.536 0.412 0 CA-C-O 118.563 -0.732 . . . . 0.0 110.237 -177.768 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 72' ' ' PRO . . . . . . . . . . . . . 13.2 Cg_exo -66.37 -30.0 45.17 Favored 'Trans proline' 0 N--CA 1.498 1.759 0 C-N-CA 121.161 1.241 . . . . 0.0 112.252 177.785 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 73' ' ' VAL . . . . . . . . . . . . . 33.1 m -137.25 169.88 18.78 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.218 0 CA-C-O 121.018 0.437 . . . . 0.0 110.983 -177.711 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 74' ' ' ASP . . . . . . . . . . . . . 4.8 t0 -98.93 125.59 44.39 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 115.828 -0.623 . . . . 0.0 110.101 -179.601 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 75' ' ' VAL . . . . . . . . . . . . . 42.9 t -119.14 123.35 71.23 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.286 0 CA-C-O 121.084 0.468 . . . . 0.0 110.509 -179.402 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 76' ' ' LEU . . . . . . . . . . . . . 6.6 mp -120.39 148.38 43.84 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-N 115.691 -0.686 . . . . 0.0 109.741 176.043 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 77' ' ' GLU . . . . . . . . . . . . . 98.5 mt-10 -137.86 138.3 38.97 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-O 121.015 0.436 . . . . 0.0 111.577 -179.024 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 78' ' ' ALA . . . . . . . . . . . . . . . -130.47 134.29 46.97 Favored 'General case' 0 C--N 1.331 -0.227 0 CA-C-N 115.755 -0.657 . . . . 0.0 109.728 175.541 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 79' ' ' LYS . . . . . . . . . . . . . 30.0 ttmt -81.2 119.53 23.72 Favored 'General case' 0 C--N 1.331 -0.204 0 CA-C-O 120.925 0.393 . . . . 0.0 110.603 -179.38 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 80' ' ' ILE . . . . . . . . . . . . . 41.7 mm -139.15 108.43 3.77 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.367 0 N-CA-C 109.201 -0.666 . . . . 0.0 109.201 -177.439 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 81' ' ' LYS . . . . . . . . . . . . . 55.6 mtpt -100.49 129.16 46.4 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-O 120.941 0.4 . . . . 0.0 111.257 -176.642 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 82' ' ' GLY . . . . . . . . . . . . . . . 89.16 42.11 5.67 Favored Glycine 0 CA--C 1.526 0.725 0 C-N-CA 120.956 -0.64 . . . . 0.0 111.726 174.344 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 83' ' ' ILE . . . . . . . . . . . . . 68.2 mt -69.13 136.02 27.16 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.407 0 N-CA-C 109.563 -0.532 . . . . 0.0 109.563 177.625 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 84' ' ' LYS . . . . . . . . . . . . . 25.2 ttpp -100.5 -51.66 3.56 Favored 'General case' 0 C--N 1.332 -0.195 0 CA-C-O 121.002 0.429 . . . . 0.0 110.082 179.938 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 85' ' ' ASP . . . . . . . . . . . . . 13.4 t70 -149.16 147.16 28.11 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 115.812 -0.631 . . . . 0.0 110.358 179.754 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 86' ' ' VAL . . . . . . . . . . . . . 42.7 t -129.34 130.29 67.53 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.24 0 CA-C-O 120.969 0.414 . . . . 0.0 110.251 179.427 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 87' ' ' ILE . . . . . . . . . . . . . 44.6 mm -118.25 125.04 73.99 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.28 0 CA-C-N 115.847 -0.615 . . . . 0.0 109.555 177.347 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 88' ' ' LEU . . . . . . . . . . . . . 44.5 mt -116.84 135.56 53.64 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-O 121.292 0.568 . . . . 0.0 111.688 -177.025 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 89' ' ' ASP . . . . . . . . . . . . . 7.3 t0 -128.58 155.96 44.1 Favored 'General case' 0 C--N 1.327 -0.403 0 CA-C-N 115.156 -0.929 . . . . 0.0 108.642 174.78 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 90' ' ' GLU . . . . . . . . . . . . . 76.9 tt0 -48.67 -36.09 15.27 Favored 'General case' 0 C--N 1.329 -0.285 0 N-CA-C 112.562 0.578 . . . . 0.0 112.562 -172.749 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 91' ' ' ASN . . . . . . . . . . . . . 26.3 m120 -132.07 37.23 3.6 Favored 'General case' 0 CA--C 1.531 0.248 0 N-CA-C 111.757 0.281 . . . . 0.0 111.757 -176.953 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 92' ' ' LEU . . . . . . . . . . . . . 26.3 tp -166.06 139.72 4.28 Favored 'General case' 0 C--N 1.33 -0.265 0 C-N-CA 121.005 -0.278 . . . . 0.0 110.801 -179.377 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 93' ' ' ILE . . . . . . . . . . . . . 72.3 mt -126.39 122.48 61.31 Favored 'Isoleucine or valine' 0 N--CA 1.462 0.157 0 N-CA-C 109.648 -0.501 . . . . 0.0 109.648 178.605 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 94' ' ' VAL . . . . . . . . . . . . . 43.8 t -124.61 126.19 71.28 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.239 0 N-CA-C 109.774 -0.454 . . . . 0.0 109.774 177.994 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 95' ' ' VAL . . . . . . . . . . . . . 44.6 t -120.73 133.59 66.9 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.336 0 CA-C-N 116.009 -0.541 . . . . 0.0 109.806 -179.165 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 96' ' ' ILE . . . . . . . . . . . . . 61.1 mt -115.4 128.29 72.66 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.25 0 N-CA-C 109.257 -0.646 . . . . 0.0 109.257 178.788 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 97' ' ' THR . . . . . . . . . . . . . 82.1 p -102.96 155.62 18.23 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-O 121.279 0.561 . . . . 0.0 111.343 -176.368 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 98' ' ' GLU . . . . . . . . . . . . . 13.2 pt-20 -55.08 -17.02 3.43 Favored 'General case' 0 CA--C 1.535 0.382 0 N-CA-C 112.814 0.672 . . . . 0.0 112.814 179.277 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 99' ' ' GLU . . . . . . . . . . . . . 41.7 mt-10 -85.36 16.29 3.81 Favored 'General case' 0 CA--C 1.535 0.402 0 N-CA-C 112.952 0.723 . . . . 0.0 112.952 -178.674 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 100' ' ' ASN . . . . . . . . . . . . . 3.6 m-20 62.36 38.02 13.34 Favored 'General case' 0 CA--C 1.529 0.166 0 CA-C-O 121.046 0.451 . . . . 0.0 110.869 178.505 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 101' ' ' GLU . . . . . . . . . . . . . 84.3 tt0 -121.26 143.63 49.05 Favored 'General case' 0 C--N 1.332 -0.187 0 CA-C-N 116.2 -0.455 . . . . 0.0 110.045 177.955 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 102' ' ' VAL . . . . . . . . . . . . . 43.9 t -116.73 127.59 74.31 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.28 0 CA-C-N 116.341 -0.39 . . . . 0.0 110.102 -178.671 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 103' ' ' LEU . . . . . . . . . . . . . 6.2 mp -116.86 134.31 54.93 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 115.747 -0.66 . . . . 0.0 110.285 176.745 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 104' ' ' ILE . . . . . . . . . . . . . 71.3 mt -120.87 123.24 69.78 Favored 'Isoleucine or valine' 0 C--O 1.234 0.285 0 CA-C-N 116.612 -0.267 . . . . 0.0 110.56 -178.885 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 105' ' ' PHE . . . . . . . . . . . . . 60.0 m-85 -124.98 167.24 14.99 Favored 'General case' 0 C--O 1.232 0.178 0 O-C-N 124.07 0.856 . . . . 0.0 109.736 -179.665 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 106' ' ' ASN . . . . . . . . . . . . . 44.8 p-10 -104.11 -170.23 1.74 Allowed 'General case' 0 C--N 1.331 -0.237 0 N-CA-C 110.15 -0.315 . . . . 0.0 110.15 174.218 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 107' ' ' GLN . . . . . . . . . . . . . 37.9 tt0 -58.64 -30.11 67.04 Favored 'General case' 0 C--N 1.33 -0.278 0 N-CA-C 112.047 0.388 . . . . 0.0 112.047 -179.603 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 108' ' ' ASN . . . . . . . . . . . . . 5.4 t30 -86.02 10.6 13.74 Favored 'General case' 0 CA--C 1.536 0.43 0 N-CA-C 113.116 0.784 . . . . 0.0 113.116 -176.699 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 109' ' ' LEU . . . . . . . . . . . . . 8.5 tp 59.38 37.63 23.21 Favored 'General case' 0 C--N 1.332 -0.173 0 CA-C-O 121.034 0.445 . . . . 0.0 111.315 178.69 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 110' ' ' GLU . . . . . . . . . . . . . 94.9 mt-10 -105.18 138.5 41.28 Favored 'General case' 0 C--N 1.329 -0.3 0 N-CA-C 109.222 -0.659 . . . . 0.0 109.222 173.718 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 111' ' ' GLU . . . . . . . . . . . . . 47.8 tt0 -85.54 121.77 28.7 Favored 'General case' 0 C--N 1.329 -0.308 0 C-N-CA 120.708 -0.397 . . . . 0.0 110.249 -176.492 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 112' ' ' LEU . . . . . . . . . . . . . 58.2 mt -103.06 -42.89 5.65 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.074 -0.512 . . . . 0.0 110.527 179.687 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 113' ' ' TYR . . . . . . . . . . . . . 64.3 t80 -133.02 141.23 48.16 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.297 -0.411 . . . . 0.0 111.254 -177.1 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 114' ' ' ARG . . . . . . . . . . . . . 36.5 ptt180 -149.27 124.09 9.91 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.092 -0.504 . . . . 0.0 110.541 177.407 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 115' ' ' GLY . . . . . . . . . . . . . . . -150.02 158.9 27.87 Favored Glycine 0 CA--C 1.524 0.601 0 N-CA-C 111.254 -0.739 . . . . 0.0 111.254 179.933 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 116' ' ' LYS . . . . . . . . . . . . . 34.4 ttpt -125.07 134.92 52.32 Favored 'General case' 0 C--N 1.33 -0.257 0 N-CA-C 110.02 -0.363 . . . . 0.0 110.02 178.491 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 117' ' ' PHE . . . . . . . . . . . . . 51.5 m-85 -129.08 115.21 17.38 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-O 120.97 0.414 . . . . 0.0 110.155 -177.064 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 118' ' ' GLU . . . . . . . . . . . . . 95.8 mt-10 -53.6 -49.79 67.03 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.387 -0.37 . . . . 0.0 111.526 -175.633 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 119' ' ' ASN . . . . . . . . . . . . . 87.2 m-20 -96.7 31.13 2.4 Favored 'General case' 0 C--N 1.328 -0.342 0 N-CA-C 112.207 0.447 . . . . 0.0 112.207 -174.169 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 120' ' ' LEU . . . . . . . . . . . . . 17.1 tp -53.44 121.84 8.48 Favored 'General case' 0 N--CA 1.464 0.271 0 CA-C-O 120.599 0.238 . . . . 0.0 110.88 178.062 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 121' ' ' ASN . . . . . . . . . . . . . 34.4 m120 -114.07 -44.17 3.17 Favored 'General case' 0 N--CA 1.463 0.203 0 CA-C-N 116.547 -0.297 . . . . 0.0 111.213 -176.289 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 122' ' ' LYS . . . . . . . . . . . . . 97.2 mttt -144.61 150.7 37.88 Favored 'General case' 0 C--N 1.331 -0.206 0 CA-C-O 120.982 0.42 . . . . 0.0 111.591 -177.386 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 123' ' ' VAL . . . . . . . . . . . . . 45.9 t -130.44 127.94 63.13 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.298 0 N-CA-C 109.437 -0.579 . . . . 0.0 109.437 174.929 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 124' ' ' LEU . . . . . . . . . . . . . 52.7 mt -127.35 138.09 52.94 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-O 120.871 0.367 . . . . 0.0 110.633 -178.067 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 125' ' ' VAL . . . . . . . . . . . . . 34.7 m -135.73 140.09 45.01 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.24 0 CA-C-N 116.221 -0.445 . . . . 0.0 110.885 -179.53 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 126' ' ' ARG . . . . . . . . . . . . . 90.5 mtt-85 -140.69 112.12 7.36 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 115.889 -0.596 . . . . 0.0 110.199 177.117 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 127' ' ' ASN . . . . . . . . . . . . . 26.2 m-20 48.96 -105.01 0.14 Allowed 'General case' 0 CA--C 1.541 0.618 0 CA-C-O 119.299 -0.381 . . . . 0.0 111.79 -179.964 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 128' ' ' ASP . . . . . . . . . . . . . 13.0 p-10 -106.08 1.02 26.01 Favored 'General case' 0 CA--C 1.536 0.414 0 N-CA-C 113.692 0.997 . . . . 0.0 113.692 -174.957 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 129' ' ' LEU . . . . . . . . . . . . . 14.5 tp -104.94 131.82 51.96 Favored 'General case' 0 C--N 1.332 -0.188 0 CA-C-N 118.125 0.421 . . . . 0.0 109.996 178.479 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 130' ' ' VAL . . . . . . . . . . . . . 46.8 t -118.95 132.97 67.3 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.252 0 N-CA-C 109.828 -0.434 . . . . 0.0 109.828 -179.618 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 131' ' ' VAL . . . . . . . . . . . . . 42.1 t -134.96 134.37 53.44 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.196 0 CA-C-O 121.042 0.449 . . . . 0.0 110.416 179.396 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 132' ' ' ILE . . . . . . . . . . . . . 74.0 mt -117.25 133.78 62.91 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 CA-C-N 115.773 -0.649 . . . . 0.0 109.294 -179.799 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 133' ' ' ILE . . . . . . . . . . . . . 43.0 mm -117.62 123.86 72.29 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.224 0 CA-C-O 121.031 0.443 . . . . 0.0 111.086 -173.931 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 134' ' ' ASP . . . . . . . . . . . . . 9.1 p-10 -135.03 144.67 47.43 Favored 'General case' 0 C--N 1.33 -0.242 0 N-CA-C 109.228 -0.656 . . . . 0.0 109.228 173.777 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 135' ' ' GLU . . . . . . . . . . . . . 38.0 tp10 -49.93 -25.56 3.36 Favored 'General case' 0 C--N 1.326 -0.439 0 N-CA-C 112.719 0.637 . . . . 0.0 112.719 -174.553 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 136' ' ' GLN . . . . . . . . . . . . . 47.6 tt0 -80.43 -33.77 36.62 Favored 'General case' 0 C--O 1.233 0.212 0 N-CA-C 112.364 0.505 . . . . 0.0 112.364 -176.705 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 137' ' ' LYS . . . . . . . . . . . . . 57.7 pttt -169.98 175.3 5.16 Favored 'General case' 0 C--N 1.332 -0.182 0 CA-C-O 121.461 0.648 . . . . 0.0 112.182 -174.901 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 138' ' ' LEU . . . . . . . . . . . . . 6.1 tt -120.28 129.47 54.04 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-N 115.221 -0.9 . . . . 0.0 110.188 -179.96 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 139' ' ' THR . . . . . . . . . . . . . 36.2 m -110.19 128.21 55.36 Favored 'General case' 0 C--N 1.332 -0.181 0 CA-C-N 116.341 -0.391 . . . . 0.0 110.656 179.995 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 140' ' ' LEU . . . . . . . . . . . . . 7.4 tt -112.27 124.36 52.29 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 115.656 -0.702 . . . . 0.0 109.2 -179.428 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 141' ' ' ILE . . . . . . . . . . . . . 19.5 mt -124.08 117.46 50.92 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.36 0 CA-C-O 121.053 0.454 . . . . 0.0 109.959 -176.439 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 142' ' ' ARG . . . . . . . . . . . . . 60.0 ttt-85 -107.54 126.51 52.62 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 115.594 -0.73 . . . . 0.0 110.698 -179.195 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 143' ' ' THR . . . . . . . . . . . . . 25.3 p . . . . . 0 C--O 1.221 -0.409 0 CA-C-O 118.248 -0.882 . . . . 0.0 110.938 179.138 . . . . . . . . 0 0 . 1 . 003 nuclear orig full ' C' C ' -3' ' ' GLU . . . . . . . . . . . . . 83.6 tt0 . . . . . 0 N--CA 1.491 1.596 0 N-CA-C 109.25 -0.648 . . . . 0.0 109.25 . . . . . . . . . 0 0 . 1 . 003 nuclear orig full ' C' C ' -2' ' ' GLY . . . . . . . . . . . . . . . -71.58 150.04 46.03 Favored Glycine 0 CA--C 1.525 0.659 0 N-CA-C 111.019 -0.832 . . . . 0.0 111.019 179.627 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' C' C ' -1' ' ' VAL . . . . . . . . . . . . . 44.0 t -94.28 140.95 15.69 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.359 0 N-CA-C 110.086 -0.338 . . . . 0.0 110.086 179.883 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' C' C ' 0' ' ' ILE . . . . . . . . . . . . . 43.8 mm -98.57 141.87 15.63 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.38 0 CA-C-N 116.228 -0.442 . . . . 0.0 110.256 -178.272 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' C' C ' 1' ' ' MET . . . . . . . . . . . . . 24.8 ptp -83.59 142.16 31.04 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.067 -0.515 . . . . 0.0 110.789 -179.684 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' C' C ' 2' ' ' SER . . . . . . . . . . . . . 6.9 p -116.61 132.96 56.55 Favored 'General case' 0 C--N 1.331 -0.211 0 CA-C-N 116.128 -0.487 . . . . 0.0 110.054 176.88 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' C' C ' 3' ' ' GLU . . . . . . . . . . . . . 95.6 mt-10 -140.77 141.14 34.85 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.107 -0.497 . . . . 0.0 111.134 -177.388 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' C' C ' 4' ' ' LEU . . . . . . . . . . . . . 19.7 tp -125.38 130.38 51.8 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 115.713 -0.676 . . . . 0.0 110.122 176.799 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' C' C ' 5' ' ' LYS . . . . . . . . . . . . . 61.4 mttp -108.4 120.16 41.6 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.483 -0.326 . . . . 0.0 110.66 179.534 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' C' C ' 6' ' ' LEU . . . . . . . . . . . . . 46.6 mt -114.36 147.17 39.57 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 115.499 -0.773 . . . . 0.0 110.459 -178.642 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' C' C ' 7' ' ' LYS . . . . . . . . . . . . . 83.2 tttt -135.15 135.97 23.82 Favored Pre-proline 0 CA--C 1.535 0.402 0 CA-C-O 118.87 -0.586 . . . . 0.0 109.88 175.901 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' C' C ' 8' ' ' PRO . . . . . . . . . . . . . 79.1 Cg_endo -90.5 143.25 3.65 Favored 'Trans proline' 0 N--CA 1.49 1.313 0 C-N-CA 121.745 1.63 . . . . 0.0 111.794 178.255 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' C' C ' 9' ' ' LEU . . . . . . . . . . . . . 41.2 mt -81.59 -48.75 0.99 Allowed Pre-proline 0 CA--C 1.534 0.359 0 CA-C-O 118.706 -0.664 . . . . 0.0 112.527 -178.601 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' C' C ' 10' ' ' PRO . . . . . . . . . . . . . 91.5 Cg_endo -78.97 154.68 25.96 Favored 'Trans proline' 0 N--CA 1.498 1.755 0 C-N-CA 121.113 1.209 . . . . 0.0 111.983 178.161 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' C' C ' 11' ' ' LYS . . . . . . . . . . . . . 72.4 tttt -88.46 94.26 9.81 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-N 116.345 -0.389 . . . . 0.0 110.499 179.47 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' C' C ' 12' ' ' VAL . . . . . . . . . . . . . 13.0 p -141.96 147.99 21.05 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.282 0 CA-C-N 116.236 -0.438 . . . . 0.0 110.533 -179.989 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' C' C ' 13' ' ' GLU . . . . . . . . . . . . . 84.3 tt0 -87.98 128.76 35.39 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.246 -0.434 . . . . 0.0 110.403 179.151 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' C' C ' 14' ' ' LEU . . . . . . . . . . . . . 19.2 mt -98.5 151.39 37.45 Favored Pre-proline 0 CA--C 1.533 0.296 0 CA-C-N 116.467 -0.333 . . . . 0.0 110.677 -178.438 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' C' C ' 15' ' ' PRO . . . . . . . . . . . . . 27.4 Cg_exo -61.84 161.25 26.02 Favored 'Trans proline' 0 N--CA 1.497 1.714 0 C-N-CA 121.395 1.397 . . . . 0.0 112.042 177.298 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' C' C ' 16' ' ' PRO . . . . . . . . . . . . . 26.0 Cg_exo -61.51 -38.55 62.13 Favored 'Trans proline' 0 N--CA 1.497 1.705 0 C-N-CA 121.412 1.408 . . . . 0.0 112.699 179.97 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' C' C ' 17' ' ' ASP . . . . . . . . . . . . . 21.3 p-10 -84.84 9.26 14.71 Favored 'General case' 0 CA--C 1.535 0.403 0 N-CA-C 113.232 0.827 . . . . 0.0 113.232 -176.951 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' C' C ' 18' ' ' PHE . . . . . . . . . . . . . 45.1 t80 -56.83 -48.06 78.89 Favored 'General case' 0 N--CA 1.456 -0.14 0 O-C-N 121.978 -0.451 . . . . 0.0 110.662 -177.287 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' C' C ' 19' ' ' VAL . . . . . . . . . . . . . 14.9 p -54.82 -43.15 66.19 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.259 0 C-N-CA 121.007 -0.277 . . . . 0.0 111.441 -176.404 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' C' C ' 20' ' ' ASP . . . . . . . . . . . . . 42.1 m-20 -62.37 -43.28 99.19 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-O 120.759 0.314 . . . . 0.0 111.217 -177.637 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' C' C ' 21' ' ' VAL . . . . . . . . . . . . . 47.9 t -64.63 -44.38 96.7 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.288 0 C-N-CA 120.637 -0.425 . . . . 0.0 110.534 -177.199 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' C' C ' 22' ' ' ILE . . . . . . . . . . . . . 50.8 mm -56.16 -46.7 81.23 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.21 0 C-N-CA 121.029 -0.268 . . . . 0.0 110.477 178.313 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' C' C ' 23' ' ' ARG . . . . . . . . . . . . . 55.3 ttp180 -54.21 -48.45 71.02 Favored 'General case' 0 C--N 1.33 -0.28 0 C-N-CA 121.06 -0.256 . . . . 0.0 111.336 -178.754 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' C' C ' 24' ' ' ILE . . . . . . . . . . . . . 73.8 mt -59.89 -43.93 93.21 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.331 0 CA-C-N 116.685 -0.234 . . . . 0.0 111.249 -177.815 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' C' C ' 25' ' ' LYS . . . . . . . . . . . . . 80.6 mttt -67.66 -40.43 84.49 Favored 'General case' 0 C--N 1.328 -0.352 0 N-CA-C 112.666 0.617 . . . . 0.0 112.666 -177.164 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' C' C ' 26' ' ' LEU . . . . . . . . . . . . . 36.8 mt -79.19 -39.43 33.38 Favored 'General case' 0 C--N 1.33 -0.274 0 N-CA-C 113.303 0.853 . . . . 0.0 113.303 -171.849 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' C' C ' 27' ' ' GLN . . . . . . . . . . . . . 9.8 pt20 -46.62 140.76 4.2 Favored 'General case' 0 N--CA 1.47 0.533 0 N-CA-C 112.732 0.641 . . . . 0.0 112.732 -175.088 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' C' C ' 28' ' ' GLY . . . . . . . . . . . . . . . 100.97 -24.82 30.61 Favored Glycine 0 CA--C 1.532 1.136 0 CA-C-N 115.388 -0.824 . . . . 0.0 112.31 -177.2 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' C' C ' 29' ' ' LYS . . . . . . . . . . . . . 69.0 mttm -97.42 155.07 17.08 Favored 'General case' 0 C--N 1.331 -0.202 0 CA-C-N 117.609 0.705 . . . . 0.0 110.904 177.317 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' C' C ' 30' ' ' THR . . . . . . . . . . . . . 13.8 m -106.6 133.69 50.9 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.07 -0.514 . . . . 0.0 109.624 175.257 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' C' C ' 31' ' ' VAL . . . . . . . . . . . . . 34.4 m -130.2 156.63 42.45 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.278 0 CA-C-O 120.982 0.42 . . . . 0.0 110.94 -176.823 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' C' C ' 32' ' ' ARG . . . . . . . . . . . . . 36.0 mtp180 -129.77 153.59 48.07 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-O 121.433 0.635 . . . . 0.0 110.84 179.476 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' C' C ' 33' ' ' THR . . . . . . . . . . . . . 24.5 m -53.84 138.85 35.09 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-N 115.907 -0.588 . . . . 0.0 111.231 -179.664 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' C' C ' 34' ' ' GLY . . . . . . . . . . . . . . . 100.95 -17.04 56.85 Favored Glycine 0 CA--C 1.532 1.136 0 CA-C-O 119.678 -0.512 . . . . 0.0 113.307 179.411 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' C' C ' 35' ' ' ASP . . . . . . . . . . . . . 62.7 m-20 -65.58 149.9 49.32 Favored 'General case' 0 C--O 1.232 0.155 0 CA-C-N 118.036 0.918 . . . . 0.0 111.315 179.496 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' C' C ' 36' ' ' VAL . . . . . . . . . . . . . 46.3 t -119.01 128.97 75.78 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.232 0 CA-C-N 115.779 -0.646 . . . . 0.0 109.686 177.836 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' C' C ' 37' ' ' ILE . . . . . . . . . . . . . 70.1 mt -120.35 139.42 47.7 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.255 0 CA-C-N 116.274 -0.421 . . . . 0.0 109.939 -178.568 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' C' C ' 38' ' ' GLY . . . . . . . . . . . . . . . -113.03 128.88 8.61 Favored Glycine 0 CA--C 1.526 0.763 0 N-CA-C 110.977 -0.849 . . . . 0.0 110.977 -179.924 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' C' C ' 39' ' ' ILE . . . . . . . . . . . . . 75.1 mt -123.24 136.97 58.18 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.243 0 N-CA-C 110.085 -0.339 . . . . 0.0 110.085 179.16 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' C' C ' 40' ' ' SER . . . . . . . . . . . . . 84.0 p -93.13 124.24 36.97 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.359 -0.382 . . . . 0.0 110.95 175.883 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' C' C ' 41' ' ' ILE . . . . . . . . . . . . . 72.7 mt -127.5 113.1 30.25 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.225 0 CA-C-O 120.925 0.393 . . . . 0.0 110.213 177.262 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' C' C ' 42' ' ' LEU . . . . . . . . . . . . . 1.3 tt 49.4 47.46 22.38 Favored 'General case' 0 CA--C 1.533 0.318 0 CA-C-O 121.529 0.68 . . . . 0.0 111.357 177.73 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' C' C ' 43' ' ' GLY . . . . . . . . . . . . . . . 70.68 24.16 77.16 Favored Glycine 0 CA--C 1.53 1.01 0 C-N-CA 121.116 -0.564 . . . . 0.0 112.563 175.946 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' C' C ' 44' ' ' LYS . . . . . . . . . . . . . 17.0 ttmm -132.14 129.5 39.93 Favored 'General case' 0 C--N 1.331 -0.215 0 CA-C-N 117.515 0.658 . . . . 0.0 109.956 179.049 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' C' C ' 45' ' ' GLU . . . . . . . . . . . . . 81.6 tt0 -84.07 125.79 32.45 Favored 'General case' 0 C--N 1.327 -0.381 0 C-N-CA 120.856 -0.338 . . . . 0.0 111.148 -177.787 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' C' C ' 46' ' ' VAL . . . . . . . . . . . . . 7.4 p -123.22 129.68 74.76 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.19 0 N-CA-C 109.614 -0.513 . . . . 0.0 109.614 174.773 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' C' C ' 47' ' ' LYS . . . . . . . . . . . . . 64.1 mttp -99.67 129.98 45.85 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.117 -0.492 . . . . 0.0 111.157 177.757 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' C' C ' 48' ' ' PHE . . . . . . . . . . . . . 92.8 m-85 -113.04 132.05 55.55 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 115.792 -0.64 . . . . 0.0 109.769 175.276 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' C' C ' 49' ' ' LYS . . . . . . . . . . . . . 84.1 tttt -106.13 135.43 47.61 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.412 -0.358 . . . . 0.0 110.142 179.359 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' C' C ' 50' ' ' VAL . . . . . . . . . . . . . 44.9 t -81.41 108.13 14.31 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.321 0 N-CA-C 109.304 -0.628 . . . . 0.0 109.304 176.749 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' C' C ' 51' ' ' VAL . . . . . . . . . . . . . 44.0 t -73.31 -51.23 26.6 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.333 0 CA-C-N 116.079 -0.51 . . . . 0.0 109.843 -174.302 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' C' C ' 52' ' ' GLN . . . . . . . . . . . . . 91.3 mt-30 -152.9 151.84 30.83 Favored 'General case' 0 C--N 1.333 -0.148 0 CA-C-O 121.095 0.474 . . . . 0.0 111.743 -178.104 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' C' C ' 53' ' ' ALA . . . . . . . . . . . . . . . -130.05 131.95 46.0 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 115.374 -0.83 . . . . 0.0 109.841 174.525 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' C' C ' 54' ' ' TYR . . . . . . . . . . . . . 15.5 t80 -129.16 111.34 18.24 Favored Pre-proline 0 CA--C 1.536 0.41 0 CA-C-O 118.159 -0.924 . . . . 0.0 110.33 177.423 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' C' C ' 55' ' ' PRO . . . . . . . . . . . . . 73.4 Cg_endo -77.26 167.0 80.73 Favored 'Cis proline' 0 N--CA 1.501 1.92 0 CA-C-N 122.03 1.761 . . . . 0.0 112.356 -6.056 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' C' C ' 56' ' ' SER . . . . . . . . . . . . . 13.6 m -116.89 130.73 24.37 Favored Pre-proline 0 CA--C 1.538 0.503 0 CA-C-O 118.384 -0.817 . . . . 0.0 109.158 174.086 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' C' C ' 57' ' ' PRO . . . . . . . . . . . . . 42.7 Cg_endo -68.42 146.99 80.38 Favored 'Cis proline' 0 N--CA 1.497 1.706 0 CA-C-N 122.011 1.754 . . . . 0.0 111.527 -0.353 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' C' C ' 58' ' ' LEU . . . . . . . . . . . . . 22.7 tp -107.36 135.44 48.84 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.145 -0.479 . . . . 0.0 110.403 -178.876 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' C' C ' 59' ' ' ARG . . . . . . . . . . . . . 48.6 ttt180 -102.08 122.92 45.05 Favored 'General case' 0 C--N 1.326 -0.433 0 N-CA-C 109.134 -0.691 . . . . 0.0 109.134 176.707 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' C' C ' 60' ' ' VAL . . . . . . . . . . . . . 43.8 t -78.26 117.53 23.77 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.207 0 C-N-CA 120.633 -0.427 . . . . 0.0 110.084 -175.565 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' C' C ' 61' ' ' GLU . . . . . . . . . . . . . 95.8 mt-10 -131.06 162.92 28.77 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.025 -0.534 . . . . 0.0 109.992 178.355 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' C' C ' 62' ' ' ASP . . . . . . . . . . . . . 10.0 t0 -53.55 -32.16 49.58 Favored 'General case' 0 C--N 1.327 -0.402 0 N-CA-C 111.834 0.309 . . . . 0.0 111.834 -179.117 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' C' C ' 63' ' ' ARG . . . . . . . . . . . . . 33.6 ptt180 -84.11 3.43 34.81 Favored 'General case' 0 CA--C 1.536 0.424 0 N-CA-C 113.762 1.023 . . . . 0.0 113.762 -174.972 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' C' C ' 64' ' ' THR . . . . . . . . . . . . . 34.8 m -86.53 139.26 31.03 Favored 'General case' 0 C--O 1.232 0.144 0 CA-C-N 118.171 0.442 . . . . 0.0 110.742 -178.003 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' C' C ' 65' ' ' LYS . . . . . . . . . . . . . 98.7 mttt -89.35 127.67 35.83 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.157 -0.474 . . . . 0.0 110.205 178.918 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' C' C ' 66' ' ' ILE . . . . . . . . . . . . . 63.8 mt -114.06 127.46 71.46 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.269 0 N-CA-C 109.638 -0.505 . . . . 0.0 109.638 179.995 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' C' C ' 67' ' ' THR . . . . . . . . . . . . . 22.6 m -123.5 139.24 54.22 Favored 'General case' 0 C--N 1.331 -0.216 0 CA-C-N 116.223 -0.444 . . . . 0.0 110.818 -177.459 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' C' C ' 68' ' ' LEU . . . . . . . . . . . . . 30.4 mt -102.22 126.68 49.27 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 115.881 -0.6 . . . . 0.0 110.124 178.126 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' C' C ' 69' ' ' VAL . . . . . . . . . . . . . 43.8 t -101.27 104.11 15.82 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.334 0 N-CA-C 109.765 -0.458 . . . . 0.0 109.765 179.253 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' C' C ' 70' ' ' THR . . . . . . . . . . . . . 9.9 t -149.98 123.86 9.3 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 116.055 -0.52 . . . . 0.0 110.586 179.402 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' C' C ' 71' ' ' HIS . . . . . . . . . . . . . 91.0 m-70 -147.21 67.17 10.65 Favored Pre-proline 0 C--N 1.328 -0.348 0 C-N-CA 120.848 -0.341 . . . . 0.0 110.855 178.164 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' C' C ' 72' ' ' PRO . . . . . . . . . . . . . 82.0 Cg_endo -93.46 156.91 2.47 Favored 'Trans proline' 0 N--CA 1.487 1.116 0 C-N-CA 121.955 1.77 . . . . 0.0 111.731 176.751 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' C' C ' 73' ' ' VAL . . . . . . . . . . . . . 27.6 m -80.73 140.25 16.93 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.258 0 CA-C-O 121.118 0.485 . . . . 0.0 110.348 178.577 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' C' C ' 74' ' ' ASP . . . . . . . . . . . . . 13.6 t70 -89.76 119.85 30.51 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 115.743 -0.662 . . . . 0.0 109.717 179.854 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' C' C ' 75' ' ' VAL . . . . . . . . . . . . . 45.1 t -110.43 121.15 62.72 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.203 0 CA-C-O 121.204 0.526 . . . . 0.0 110.327 -178.56 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' C' C ' 76' ' ' LEU . . . . . . . . . . . . . 18.6 mt -121.08 141.69 50.54 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 115.377 -0.829 . . . . 0.0 109.192 177.468 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' C' C ' 77' ' ' GLU . . . . . . . . . . . . . 97.9 mt-10 -134.14 134.02 41.71 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-O 121.204 0.526 . . . . 0.0 111.338 -177.425 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' C' C ' 78' ' ' ALA . . . . . . . . . . . . . . . -122.9 129.51 51.7 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 115.455 -0.793 . . . . 0.0 109.654 176.593 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' C' C ' 79' ' ' LYS . . . . . . . . . . . . . 80.6 tttt -73.98 119.7 18.55 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.477 -0.328 . . . . 0.0 110.241 -179.013 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' C' C ' 80' ' ' ILE . . . . . . . . . . . . . 35.7 mm -139.13 116.21 10.86 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.304 0 N-CA-C 109.403 -0.591 . . . . 0.0 109.403 -176.279 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' C' C ' 81' ' ' LYS . . . . . . . . . . . . . 21.1 pttp -110.73 124.18 51.47 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-O 121.246 0.546 . . . . 0.0 111.284 -177.033 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' C' C ' 82' ' ' GLY . . . . . . . . . . . . . . . 89.2 42.09 5.67 Favored Glycine 0 CA--C 1.528 0.854 0 CA-C-N 115.675 -0.693 . . . . 0.0 112.053 175.677 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' C' C ' 83' ' ' ILE . . . . . . . . . . . . . 68.2 mt -69.56 137.09 24.87 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.248 0 N-CA-C 109.487 -0.56 . . . . 0.0 109.487 176.498 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' C' C ' 84' ' ' LYS . . . . . . . . . . . . . 28.1 ttpp -103.68 -52.13 3.04 Favored 'General case' 0 C--N 1.331 -0.201 0 CA-C-O 120.852 0.358 . . . . 0.0 110.524 -179.104 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' C' C ' 85' ' ' ASP . . . . . . . . . . . . . 13.3 t70 -143.54 145.31 32.44 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.077 -0.511 . . . . 0.0 110.653 -178.597 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' C' C ' 86' ' ' VAL . . . . . . . . . . . . . 44.4 t -127.66 129.2 70.15 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.234 0 CA-C-O 120.871 0.367 . . . . 0.0 110.382 179.89 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' C' C ' 87' ' ' ILE . . . . . . . . . . . . . 43.9 mm -118.5 123.98 72.41 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.26 0 CA-C-N 116.041 -0.527 . . . . 0.0 109.604 176.598 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' C' C ' 88' ' ' LEU . . . . . . . . . . . . . 68.2 mt -113.66 137.22 51.91 Favored 'General case' 0 C--N 1.331 -0.201 0 CA-C-O 121.081 0.467 . . . . 0.0 111.687 -176.347 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' C' C ' 89' ' ' ASP . . . . . . . . . . . . . 10.2 t70 -132.62 156.35 47.08 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 115.631 -0.713 . . . . 0.0 109.204 174.352 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' C' C ' 90' ' ' GLU . . . . . . . . . . . . . 82.0 tt0 -47.4 -41.62 20.35 Favored 'General case' 0 N--CA 1.464 0.228 0 N-CA-C 112.95 0.722 . . . . 0.0 112.95 -171.633 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' C' C ' 91' ' ' ASN . . . . . . . . . . . . . 15.7 p-10 -132.14 38.49 3.49 Favored 'General case' 0 N--CA 1.465 0.298 0 CA-C-O 120.821 0.343 . . . . 0.0 111.345 -177.934 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' C' C ' 92' ' ' LEU . . . . . . . . . . . . . 20.7 tp -164.74 139.88 5.5 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.59 -0.277 . . . . 0.0 110.258 -178.872 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' C' C ' 93' ' ' ILE . . . . . . . . . . . . . 66.3 mt -130.18 124.2 57.53 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.221 0 N-CA-C 109.576 -0.527 . . . . 0.0 109.576 -177.886 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' C' C ' 94' ' ' VAL . . . . . . . . . . . . . 46.7 t -125.81 127.91 71.69 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.265 0 N-CA-C 109.848 -0.427 . . . . 0.0 109.848 178.551 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' C' C ' 95' ' ' VAL . . . . . . . . . . . . . 42.4 t -122.08 136.09 60.06 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.283 0 CA-C-N 115.979 -0.555 . . . . 0.0 109.852 -179.089 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' C' C ' 96' ' ' ILE . . . . . . . . . . . . . 60.4 mt -116.12 127.61 73.66 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.328 0 N-CA-C 109.348 -0.612 . . . . 0.0 109.348 179.51 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' C' C ' 97' ' ' THR . . . . . . . . . . . . . 80.6 p -99.3 157.7 16.22 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-O 120.983 0.42 . . . . 0.0 110.952 -177.81 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' C' C ' 98' ' ' GLU . . . . . . . . . . . . . 96.2 mt-10 -53.98 -25.54 21.41 Favored 'General case' 0 CA--C 1.534 0.336 0 N-CA-C 112.306 0.484 . . . . 0.0 112.306 -179.03 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' C' C ' 99' ' ' GLU . . . . . . . . . . . . . 95.7 mt-10 -79.39 15.79 1.17 Allowed 'General case' 0 CA--C 1.535 0.379 0 N-CA-C 113.197 0.814 . . . . 0.0 113.197 -177.541 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' C' C ' 100' ' ' ASN . . . . . . . . . . . . . 2.6 m-20 62.05 37.27 14.87 Favored 'General case' 0 C--O 1.233 0.216 0 CA-C-O 121.076 0.465 . . . . 0.0 111.064 178.948 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' C' C ' 101' ' ' GLU . . . . . . . . . . . . . 83.6 tt0 -111.96 143.04 43.6 Favored 'General case' 0 C--N 1.333 -0.147 0 N-CA-C 109.611 -0.514 . . . . 0.0 109.611 176.436 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' C' C ' 102' ' ' VAL . . . . . . . . . . . . . 43.7 t -114.97 123.76 70.97 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.275 0 CA-C-N 116.123 -0.489 . . . . 0.0 109.833 -178.753 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' C' C ' 103' ' ' LEU . . . . . . . . . . . . . 69.1 mt -116.58 127.53 54.58 Favored 'General case' 0 C--N 1.331 -0.207 0 CA-C-N 115.76 -0.654 . . . . 0.0 109.902 176.086 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' C' C ' 104' ' ' ILE . . . . . . . . . . . . . 65.2 mt -114.84 123.41 70.49 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.289 0 N-CA-C 109.855 -0.424 . . . . 0.0 109.855 -179.665 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' C' C ' 105' ' ' PHE . . . . . . . . . . . . . 81.9 m-85 -123.53 162.1 23.58 Favored 'General case' 0 C--N 1.331 -0.226 0 O-C-N 123.864 0.728 . . . . 0.0 109.788 -178.333 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' C' C ' 106' ' ' ASN . . . . . . . . . . . . . 38.9 p30 -98.03 -173.98 2.74 Favored 'General case' 0 C--N 1.328 -0.334 0 N-CA-C 109.553 -0.536 . . . . 0.0 109.553 173.942 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' C' C ' 107' ' ' GLN . . . . . . . . . . . . . 45.7 tt0 -59.37 -29.06 67.42 Favored 'General case' 0 CA--C 1.532 0.264 0 N-CA-C 112.004 0.372 . . . . 0.0 112.004 -179.836 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' C' C ' 108' ' ' ASN . . . . . . . . . . . . . 52.9 t30 -81.94 8.59 10.07 Favored 'General case' 0 CA--C 1.537 0.472 0 N-CA-C 113.14 0.792 . . . . 0.0 113.14 -177.485 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' C' C ' 109' ' ' LEU . . . . . . . . . . . . . 13.2 tp 58.9 40.45 22.63 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-O 121.293 0.568 . . . . 0.0 110.981 178.425 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' C' C ' 110' ' ' GLU . . . . . . . . . . . . . 95.9 mt-10 -110.26 147.39 33.92 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.05 -0.523 . . . . 0.0 109.711 174.089 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' C' C ' 111' ' ' GLU . . . . . . . . . . . . . 55.5 tt0 -82.58 121.96 27.48 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.402 -0.363 . . . . 0.0 110.497 -176.043 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' C' C ' 112' ' ' LEU . . . . . . . . . . . . . 24.3 mt -105.37 -46.09 4.3 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.079 -0.51 . . . . 0.0 110.892 -179.549 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' C' C ' 113' ' ' TYR . . . . . . . . . . . . . 55.3 t80 -135.54 140.45 44.73 Favored 'General case' 0 C--N 1.331 -0.239 0 CA-C-N 116.221 -0.445 . . . . 0.0 110.805 -178.881 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' C' C ' 114' ' ' ARG . . . . . . . . . . . . . 36.1 ptt180 -143.61 120.88 11.56 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-O 121.183 0.516 . . . . 0.0 110.902 178.327 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' C' C ' 115' ' ' GLY . . . . . . . . . . . . . . . -150.19 163.04 29.4 Favored Glycine 0 CA--C 1.524 0.631 0 N-CA-C 110.866 -0.894 . . . . 0.0 110.866 -179.328 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' C' C ' 116' ' ' LYS . . . . . . . . . . . . . 40.0 ttpt -128.75 136.13 50.15 Favored 'General case' 0 C--N 1.33 -0.266 0 O-C-N 122.616 -0.343 . . . . 0.0 110.082 177.439 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' C' C ' 117' ' ' PHE . . . . . . . . . . . . . 61.9 m-85 -132.2 114.24 14.24 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-O 120.902 0.382 . . . . 0.0 110.448 -176.263 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' C' C ' 118' ' ' GLU . . . . . . . . . . . . . 70.8 mm-40 -53.47 -50.88 64.38 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.447 -0.342 . . . . 0.0 111.499 -176.205 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' C' C ' 119' ' ' ASN . . . . . . . . . . . . . 83.1 m-20 -94.73 31.06 1.88 Allowed 'General case' 0 C--N 1.329 -0.31 0 N-CA-C 112.187 0.44 . . . . 0.0 112.187 -174.083 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' C' C ' 120' ' ' LEU . . . . . . . . . . . . . 16.7 tp -56.46 124.71 19.1 Favored 'General case' 0 C--O 1.232 0.161 0 CA-C-O 120.659 0.266 . . . . 0.0 110.556 178.484 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' C' C ' 121' ' ' ASN . . . . . . . . . . . . . 35.5 m120 -114.03 -43.97 3.2 Favored 'General case' 0 C--N 1.332 -0.167 0 CA-C-N 116.483 -0.326 . . . . 0.0 111.044 -177.871 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' C' C ' 122' ' ' LYS . . . . . . . . . . . . . 55.5 mttm -145.3 148.09 33.06 Favored 'General case' 0 C--N 1.33 -0.239 0 CA-C-O 121.071 0.463 . . . . 0.0 111.815 -176.937 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' C' C ' 123' ' ' VAL . . . . . . . . . . . . . 45.4 t -128.0 124.23 62.29 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 N-CA-C 108.909 -0.774 . . . . 0.0 108.909 171.965 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' C' C ' 124' ' ' LEU . . . . . . . . . . . . . 11.3 tp -123.29 135.66 54.33 Favored 'General case' 0 C--N 1.332 -0.185 0 CA-C-O 120.765 0.317 . . . . 0.0 110.914 -174.941 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' C' C ' 125' ' ' VAL . . . . . . . . . . . . . 35.7 m -131.34 139.18 51.46 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.229 0 CA-C-N 116.225 -0.443 . . . . 0.0 110.886 -179.507 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' C' C ' 126' ' ' ARG . . . . . . . . . . . . . 89.0 mtt180 -146.6 125.07 12.37 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.167 -0.469 . . . . 0.0 110.51 175.83 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' C' C ' 127' ' ' ASN . . . . . . . . . . . . . 13.4 t-20 51.62 -109.31 0.43 Allowed 'General case' 0 CA--C 1.545 0.753 0 CA-C-O 118.824 -0.608 . . . . 0.0 111.199 -179.989 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' C' C ' 128' ' ' ASP . . . . . . . . . . . . . 14.3 p-10 -114.01 5.76 16.22 Favored 'General case' 0 N--CA 1.468 0.438 0 CA-C-N 119.818 1.19 . . . . 0.0 113.413 -177.918 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' C' C ' 129' ' ' LEU . . . . . . . . . . . . . 13.2 tp -109.89 136.6 48.93 Favored 'General case' 0 C--N 1.334 -0.108 0 N-CA-C 109.718 -0.475 . . . . 0.0 109.718 179.445 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' C' C ' 130' ' ' VAL . . . . . . . . . . . . . 12.9 p -129.54 140.7 48.42 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.205 0 CA-C-O 121.047 0.451 . . . . 0.0 110.46 -179.521 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' C' C ' 131' ' ' VAL . . . . . . . . . . . . . 43.0 t -135.72 138.29 48.07 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.314 0 CA-C-O 121.125 0.488 . . . . 0.0 110.18 179.689 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' C' C ' 132' ' ' ILE . . . . . . . . . . . . . 69.2 mt -110.64 131.23 62.34 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.328 0 CA-C-N 115.527 -0.76 . . . . 0.0 109.11 179.335 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' C' C ' 133' ' ' ILE . . . . . . . . . . . . . 42.4 mm -115.22 119.75 62.69 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.222 0 CA-C-O 120.859 0.361 . . . . 0.0 110.893 -174.716 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' C' C ' 134' ' ' ASP . . . . . . . . . . . . . 8.0 p-10 -132.17 144.24 50.53 Favored 'General case' 0 C--N 1.33 -0.253 0 N-CA-C 109.271 -0.64 . . . . 0.0 109.271 174.7 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' C' C ' 135' ' ' GLU . . . . . . . . . . . . . 84.2 tt0 -49.97 -26.41 4.2 Favored 'General case' 0 C--N 1.327 -0.395 0 N-CA-C 112.774 0.657 . . . . 0.0 112.774 -173.643 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' C' C ' 136' ' ' GLN . . . . . . . . . . . . . 62.8 tt0 -78.95 -36.59 41.39 Favored 'General case' 0 CA--C 1.531 0.217 0 N-CA-C 112.196 0.443 . . . . 0.0 112.196 -177.237 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' C' C ' 137' ' ' LYS . . . . . . . . . . . . . 34.5 pttt -167.27 172.29 9.96 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-O 121.482 0.658 . . . . 0.0 112.025 -173.258 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' C' C ' 138' ' ' LEU . . . . . . . . . . . . . 7.1 tt -117.01 128.78 55.52 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 115.223 -0.899 . . . . 0.0 109.953 179.213 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' C' C ' 139' ' ' THR . . . . . . . . . . . . . 32.7 m -110.46 123.47 49.97 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.164 178.885 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' C' C ' 140' ' ' LEU . . . . . . . . . . . . . 7.0 tt -107.95 123.11 48.13 Favored 'General case' 0 C--N 1.327 -0.408 0 N-CA-C 108.947 -0.76 . . . . 0.0 108.947 -179.49 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' C' C ' 141' ' ' ILE . . . . . . . . . . . . . 20.0 mt -124.96 118.64 53.71 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.248 0 CA-C-O 121.205 0.526 . . . . 0.0 109.944 -176.448 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' C' C ' 142' ' ' ARG . . . . . . . . . . . . . 67.1 ttt-85 -103.7 118.46 36.77 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 115.221 -0.9 . . . . 0.0 109.929 178.919 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' C' C ' 143' ' ' THR . . . . . . . . . . . . . 70.7 p . . . . . 0 C--O 1.22 -0.493 0 CA-C-O 117.975 -1.012 . . . . 0.0 110.565 -179.19 . . . . . . . . 0 0 . 1 . 003 nuclear orig full ' D' D ' -3' ' ' GLU . . . . . . . . . . . . . 84.7 tt0 . . . . . 0 N--CA 1.49 1.571 0 N-CA-C 109.35 -0.611 . . . . 0.0 109.35 . . . . . . . . . 0 0 . 1 . 003 nuclear orig full ' D' D ' -2' ' ' GLY . . . . . . . . . . . . . . . -67.21 134.92 31.49 Favored Glycine 0 CA--C 1.525 0.716 0 N-CA-C 110.999 -0.841 . . . . 0.0 110.999 -179.935 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' D' D ' -1' ' ' VAL . . . . . . . . . . . . . 42.8 t -96.82 139.79 18.77 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.358 0 N-CA-C 110.063 -0.347 . . . . 0.0 110.063 179.556 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' D' D ' 0' ' ' ILE . . . . . . . . . . . . . 45.0 mm -103.17 133.34 47.27 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.251 0 CA-C-N 116.334 -0.394 . . . . 0.0 110.197 -179.817 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' D' D ' 1' ' ' MET . . . . . . . . . . . . . 25.4 ptm -94.89 156.35 16.39 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.055 -0.52 . . . . 0.0 110.747 -178.922 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' D' D ' 2' ' ' SER . . . . . . . . . . . . . 2.3 p -130.13 124.46 32.74 Favored 'General case' 0 C--N 1.331 -0.22 0 CA-C-N 116.124 -0.489 . . . . 0.0 110.271 178.217 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' D' D ' 3' ' ' GLU . . . . . . . . . . . . . 84.3 tt0 -140.03 141.24 36.3 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 115.778 -0.646 . . . . 0.0 110.983 -176.666 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' D' D ' 4' ' ' LEU . . . . . . . . . . . . . 12.6 tp -125.38 127.64 46.9 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-N 115.927 -0.579 . . . . 0.0 110.18 176.568 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' D' D ' 5' ' ' LYS . . . . . . . . . . . . . 98.8 mttt -108.8 121.58 45.38 Favored 'General case' 0 C--O 1.235 0.322 0 CA-C-N 116.532 -0.304 . . . . 0.0 110.905 179.931 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' D' D ' 6' ' ' LEU . . . . . . . . . . . . . 40.5 mt -114.02 148.32 37.19 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-N 115.352 -0.84 . . . . 0.0 110.289 179.989 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' D' D ' 7' ' ' LYS . . . . . . . . . . . . . 57.8 tttm -128.72 137.04 30.1 Favored Pre-proline 0 CA--C 1.535 0.383 0 CA-C-O 118.831 -0.604 . . . . 0.0 109.703 173.62 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' D' D ' 8' ' ' PRO . . . . . . . . . . . . . 90.8 Cg_endo -90.84 134.05 1.77 Allowed 'Trans proline' 0 N--CA 1.491 1.344 0 C-N-CA 121.7 1.6 . . . . 0.0 111.694 178.081 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' D' D ' 9' ' ' LEU . . . . . . . . . . . . . 35.5 mt -73.38 -46.98 7.69 Favored Pre-proline 0 CA--C 1.532 0.277 0 CA-C-O 118.701 -0.666 . . . . 0.0 112.056 -178.845 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' D' D ' 10' ' ' PRO . . . . . . . . . . . . . 91.7 Cg_endo -81.78 150.38 16.42 Favored 'Trans proline' 0 N--CA 1.495 1.614 0 C-N-CA 121.267 1.311 . . . . 0.0 111.64 174.61 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' D' D ' 11' ' ' LYS . . . . . . . . . . . . . 49.9 pttt -85.38 111.29 19.79 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-O 121.626 0.727 . . . . 0.0 110.606 178.367 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' D' D ' 12' ' ' VAL . . . . . . . . . . . . . 12.3 p -151.12 148.28 15.01 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.309 0 CA-C-N 115.57 -0.741 . . . . 0.0 110.348 179.339 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' D' D ' 13' ' ' GLU . . . . . . . . . . . . . 45.5 tp10 -94.0 122.16 36.23 Favored 'General case' 0 C--N 1.33 -0.282 0 N-CA-C 110.002 -0.37 . . . . 0.0 110.002 177.584 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' D' D ' 14' ' ' LEU . . . . . . . . . . . . . 46.4 mt -98.02 152.44 38.05 Favored Pre-proline 0 CA--C 1.532 0.272 0 CA-C-O 119.439 -0.315 . . . . 0.0 110.758 -177.558 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' D' D ' 15' ' ' PRO . . . . . . . . . . . . . 27.8 Cg_exo -61.13 159.84 28.69 Favored 'Trans proline' 0 N--CA 1.497 1.684 0 C-N-CA 121.315 1.343 . . . . 0.0 111.977 177.499 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' D' D ' 16' ' ' PRO . . . . . . . . . . . . . 29.8 Cg_exo -59.96 -36.36 90.31 Favored 'Trans proline' 0 N--CA 1.497 1.692 0 C-N-CA 121.434 1.423 . . . . 0.0 112.742 -178.536 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' D' D ' 17' ' ' ASP . . . . . . . . . . . . . 8.2 p-10 -88.18 8.88 24.95 Favored 'General case' 0 CA--C 1.536 0.404 0 N-CA-C 113.24 0.829 . . . . 0.0 113.24 -177.388 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' D' D ' 18' ' ' PHE . . . . . . . . . . . . . 43.6 t80 -58.16 -46.13 86.22 Favored 'General case' 0 CA--C 1.524 -0.031 0 O-C-N 121.887 -0.508 . . . . 0.0 109.973 -178.391 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' D' D ' 19' ' ' VAL . . . . . . . . . . . . . 13.8 p -57.47 -40.6 75.58 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.34 0 CA-C-N 116.121 -0.49 . . . . 0.0 110.723 -179.519 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' D' D ' 20' ' ' ASP . . . . . . . . . . . . . 22.2 m-20 -59.49 -43.14 93.39 Favored 'General case' 0 C--N 1.331 -0.228 0 C-N-CA 120.88 -0.328 . . . . 0.0 110.846 -178.143 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' D' D ' 21' ' ' VAL . . . . . . . . . . . . . 47.7 t -64.92 -46.3 92.14 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.246 0 C-N-CA 120.717 -0.393 . . . . 0.0 110.472 -178.192 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' D' D ' 22' ' ' ILE . . . . . . . . . . . . . 45.2 mm -59.33 -35.82 60.4 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.256 0 C-N-CA 120.843 -0.343 . . . . 0.0 110.98 -179.872 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' D' D ' 23' ' ' ARG . . . . . . . . . . . . . 33.1 ttp180 -59.45 -49.74 76.63 Favored 'General case' 0 C--N 1.33 -0.242 0 C-N-CA 120.621 -0.432 . . . . 0.0 110.19 176.789 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' D' D ' 24' ' ' ILE . . . . . . . . . . . . . 75.6 mt -61.34 -39.8 83.94 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.322 0 CA-C-N 116.155 -0.475 . . . . 0.0 112.085 -177.034 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' D' D ' 25' ' ' LYS . . . . . . . . . . . . . 10.2 ptmt -75.06 -40.43 60.29 Favored 'General case' 0 CA--C 1.535 0.38 0 C-N-CA 120.537 -0.465 . . . . 0.0 111.98 -175.144 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' D' D ' 26' ' ' LEU . . . . . . . . . . . . . 24.2 mt -79.04 -33.92 44.32 Favored 'General case' 0 C--N 1.331 -0.225 0 N-CA-C 113.337 0.866 . . . . 0.0 113.337 -172.978 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' D' D ' 27' ' ' GLN . . . . . . . . . . . . . 8.7 pt20 -46.55 139.66 4.91 Favored 'General case' 0 N--CA 1.47 0.527 0 N-CA-C 112.726 0.639 . . . . 0.0 112.726 -176.3 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' D' D ' 28' ' ' GLY . . . . . . . . . . . . . . . 100.24 -24.59 31.53 Favored Glycine 0 CA--C 1.534 1.231 0 CA-C-N 115.688 -0.687 . . . . 0.0 112.134 -174.287 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' D' D ' 29' ' ' LYS . . . . . . . . . . . . . 99.4 mttt -97.83 155.22 17.15 Favored 'General case' 0 C--N 1.333 -0.113 0 CA-C-N 117.334 0.567 . . . . 0.0 110.985 178.791 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' D' D ' 30' ' ' THR . . . . . . . . . . . . . 17.8 m -105.56 140.52 38.52 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 115.949 -0.569 . . . . 0.0 110.179 176.447 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' D' D ' 31' ' ' VAL . . . . . . . . . . . . . 35.1 m -126.66 149.51 31.73 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.224 0 CA-C-N 116.398 -0.365 . . . . 0.0 110.793 -179.393 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' D' D ' 32' ' ' ARG . . . . . . . . . . . . . 93.1 mtt180 -129.91 149.18 51.75 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-O 121.29 0.567 . . . . 0.0 110.431 179.348 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' D' D ' 33' ' ' THR . . . . . . . . . . . . . 21.2 m -53.24 137.49 34.37 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.169 -0.468 . . . . 0.0 111.546 -176.671 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' D' D ' 34' ' ' GLY . . . . . . . . . . . . . . . 99.31 -16.98 58.5 Favored Glycine 0 CA--C 1.531 1.067 0 C-N-CA 121.243 -0.503 . . . . 0.0 113.358 177.278 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' D' D ' 35' ' ' ASP . . . . . . . . . . . . . 81.3 m-20 -65.89 147.98 52.51 Favored 'General case' 0 C--O 1.231 0.117 0 CA-C-N 118.045 0.923 . . . . 0.0 111.127 -179.879 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' D' D ' 36' ' ' VAL . . . . . . . . . . . . . 46.4 t -119.95 129.5 75.36 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.266 0 CA-C-N 115.971 -0.559 . . . . 0.0 109.646 176.891 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' D' D ' 37' ' ' ILE . . . . . . . . . . . . . 63.0 mt -119.33 138.02 51.38 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.267 0 N-CA-C 109.864 -0.421 . . . . 0.0 109.864 -178.306 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' D' D ' 38' ' ' GLY . . . . . . . . . . . . . . . -115.77 128.2 7.92 Favored Glycine 0 CA--C 1.526 0.763 0 N-CA-C 110.881 -0.888 . . . . 0.0 110.881 179.04 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' D' D ' 39' ' ' ILE . . . . . . . . . . . . . 68.7 mt -126.15 127.42 70.85 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.223 0 N-CA-C 110.011 -0.366 . . . . 0.0 110.011 179.036 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' D' D ' 40' ' ' SER . . . . . . . . . . . . . 42.5 t -93.12 119.92 32.85 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.509 -0.314 . . . . 0.0 111.03 176.935 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' D' D ' 41' ' ' ILE . . . . . . . . . . . . . 71.6 mt -132.93 129.96 58.21 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.206 0 CA-C-O 120.795 0.331 . . . . 0.0 110.441 178.144 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' D' D ' 42' ' ' LEU . . . . . . . . . . . . . 74.0 mt 56.74 33.01 22.24 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.204 -0.453 . . . . 0.0 111.853 177.401 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' D' D ' 43' ' ' GLY . . . . . . . . . . . . . . . 72.85 24.81 75.34 Favored Glycine 0 CA--C 1.532 1.129 0 C-N-CA 121.149 -0.548 . . . . 0.0 112.55 177.712 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' D' D ' 44' ' ' LYS . . . . . . . . . . . . . 67.3 mttm -136.85 127.01 26.2 Favored 'General case' 0 C--N 1.331 -0.214 0 CA-C-N 117.162 0.481 . . . . 0.0 109.899 178.001 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' D' D ' 45' ' ' GLU . . . . . . . . . . . . . 39.2 tp10 -85.53 126.29 33.74 Favored 'General case' 0 C--N 1.328 -0.349 0 C-N-CA 120.776 -0.369 . . . . 0.0 110.968 -178.979 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' D' D ' 46' ' ' VAL . . . . . . . . . . . . . 9.0 p -118.14 126.43 74.96 Favored 'Isoleucine or valine' 0 C--O 1.233 0.224 0 N-CA-C 109.417 -0.586 . . . . 0.0 109.417 174.778 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' D' D ' 47' ' ' LYS . . . . . . . . . . . . . 62.0 mttp -98.89 125.62 44.35 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 116.111 -0.495 . . . . 0.0 110.886 177.762 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' D' D ' 48' ' ' PHE . . . . . . . . . . . . . 38.4 m-85 -111.22 131.86 54.79 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 115.79 -0.641 . . . . 0.0 109.458 177.166 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' D' D ' 49' ' ' LYS . . . . . . . . . . . . . 46.0 tttp -105.44 133.33 50.37 Favored 'General case' 0 C--N 1.328 -0.355 0 N-CA-C 110.174 -0.306 . . . . 0.0 110.174 178.823 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' D' D ' 50' ' ' VAL . . . . . . . . . . . . . 44.0 t -77.94 103.44 5.01 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.299 0 N-CA-C 109.243 -0.651 . . . . 0.0 109.243 177.894 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' D' D ' 51' ' ' VAL . . . . . . . . . . . . . 48.1 t -72.21 -48.36 49.19 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.324 0 CA-C-N 116.105 -0.498 . . . . 0.0 110.068 -173.664 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' D' D ' 52' ' ' GLN . . . . . . . . . . . . . 62.6 tt0 -159.13 141.44 13.86 Favored 'General case' 0 C--N 1.33 -0.27 0 C-N-CA 120.298 -0.561 . . . . 0.0 111.749 -178.542 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' D' D ' 53' ' ' ALA . . . . . . . . . . . . . . . -120.66 132.41 55.09 Favored 'General case' 0 C--N 1.331 -0.2 0 CA-C-N 115.96 -0.564 . . . . 0.0 109.889 175.172 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' D' D ' 54' ' ' TYR . . . . . . . . . . . . . 71.5 t80 -129.05 111.17 18.37 Favored Pre-proline 0 CA--C 1.534 0.355 0 CA-C-O 118.231 -0.89 . . . . 0.0 110.522 179.522 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' D' D ' 55' ' ' PRO . . . . . . . . . . . . . 72.7 Cg_endo -77.24 169.9 72.89 Favored 'Cis proline' 0 N--CA 1.5 1.872 0 CA-C-N 121.945 1.73 . . . . 0.0 112.086 -7.417 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' D' D ' 56' ' ' SER . . . . . . . . . . . . . 13.7 m -119.27 134.32 23.73 Favored Pre-proline 0 CA--C 1.538 0.507 0 CA-C-O 118.51 -0.757 . . . . 0.0 109.403 174.219 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' D' D ' 57' ' ' PRO . . . . . . . . . . . . . 48.7 Cg_endo -69.85 144.7 77.56 Favored 'Cis proline' 0 N--CA 1.498 1.745 0 CA-C-N 121.857 1.699 . . . . 0.0 111.496 -0.695 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' D' D ' 58' ' ' LEU . . . . . . . . . . . . . 19.6 tp -106.75 134.55 49.72 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.369 -0.378 . . . . 0.0 110.57 -178.756 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' D' D ' 59' ' ' ARG . . . . . . . . . . . . . 19.9 ttm180 -103.59 125.52 50.17 Favored 'General case' 0 C--N 1.327 -0.395 0 N-CA-C 109.158 -0.682 . . . . 0.0 109.158 175.823 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' D' D ' 60' ' ' VAL . . . . . . . . . . . . . 43.1 t -82.23 123.51 38.29 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.25 0 C-N-CA 120.557 -0.457 . . . . 0.0 110.491 -175.659 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' D' D ' 61' ' ' GLU . . . . . . . . . . . . . 95.3 mt-10 -129.71 172.3 11.77 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 115.721 -0.672 . . . . 0.0 109.36 176.689 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' D' D ' 62' ' ' ASP . . . . . . . . . . . . . 69.2 m-20 -53.89 -32.37 53.11 Favored 'General case' 0 C--N 1.328 -0.332 0 C-N-CA 121.068 -0.253 . . . . 0.0 111.636 178.595 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' D' D ' 63' ' ' ARG . . . . . . . . . . . . . 40.7 ptt180 -83.86 -0.38 50.97 Favored 'General case' 0 CA--C 1.537 0.475 0 N-CA-C 113.754 1.02 . . . . 0.0 113.754 -176.037 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' D' D ' 64' ' ' THR . . . . . . . . . . . . . 25.3 m -76.31 132.11 39.61 Favored 'General case' 0 C--N 1.333 -0.127 0 CA-C-N 118.158 0.435 . . . . 0.0 110.733 -176.234 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' D' D ' 65' ' ' LYS . . . . . . . . . . . . . 36.5 ttpt -89.78 122.62 33.03 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.191 -0.459 . . . . 0.0 110.136 179.249 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' D' D ' 66' ' ' ILE . . . . . . . . . . . . . 61.9 mt -112.8 131.98 62.85 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.268 0 N-CA-C 109.918 -0.401 . . . . 0.0 109.918 -178.229 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' D' D ' 67' ' ' THR . . . . . . . . . . . . . 24.4 m -130.05 143.82 51.0 Favored 'General case' 0 C--O 1.234 0.268 0 CA-C-O 121.172 0.51 . . . . 0.0 111.496 -177.835 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' D' D ' 68' ' ' LEU . . . . . . . . . . . . . 8.2 tt -101.09 127.02 47.82 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 115.656 -0.702 . . . . 0.0 109.553 175.908 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' D' D ' 69' ' ' VAL . . . . . . . . . . . . . 41.5 t -89.05 116.71 31.05 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.294 0 CA-C-O 121.124 0.488 . . . . 0.0 110.639 -177.036 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' D' D ' 70' ' ' THR . . . . . . . . . . . . . 10.0 t -150.1 143.83 25.34 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 115.643 -0.708 . . . . 0.0 109.833 175.565 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' D' D ' 71' ' ' HIS . . . . . . . . . . . . . 68.1 m-70 -144.44 73.22 15.76 Favored Pre-proline 0 CA--C 1.535 0.391 0 C-N-CA 120.85 -0.34 . . . . 0.0 111.132 -178.326 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' D' D ' 72' ' ' PRO . . . . . . . . . . . . . 91.2 Cg_endo -88.21 146.93 6.48 Favored 'Trans proline' 0 N--CA 1.491 1.367 0 C-N-CA 121.635 1.557 . . . . 0.0 111.625 175.575 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' D' D ' 73' ' ' VAL . . . . . . . . . . . . . 27.4 m -69.92 147.6 11.64 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.209 0 CA-C-O 120.85 0.357 . . . . 0.0 110.41 179.278 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' D' D ' 74' ' ' ASP . . . . . . . . . . . . . 42.6 t0 -90.87 115.08 27.64 Favored 'General case' 0 C--N 1.326 -0.44 0 CA-C-N 115.981 -0.554 . . . . 0.0 109.719 179.471 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' D' D ' 75' ' ' VAL . . . . . . . . . . . . . 46.0 t -112.27 120.11 61.77 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.264 0 CA-C-O 121.238 0.542 . . . . 0.0 110.279 -178.943 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' D' D ' 76' ' ' LEU . . . . . . . . . . . . . 23.4 mt -122.67 144.33 49.21 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 115.408 -0.815 . . . . 0.0 109.446 179.53 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' D' D ' 77' ' ' GLU . . . . . . . . . . . . . 45.9 mt-10 -135.64 137.31 41.74 Favored 'General case' 0 N--CA 1.463 0.212 0 CA-C-O 121.219 0.533 . . . . 0.0 111.688 -176.914 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' D' D ' 78' ' ' ALA . . . . . . . . . . . . . . . -126.52 131.6 51.56 Favored 'General case' 0 C--N 1.332 -0.184 0 CA-C-N 115.507 -0.77 . . . . 0.0 109.725 175.558 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' D' D ' 79' ' ' LYS . . . . . . . . . . . . . 64.7 mttp -81.32 118.46 22.66 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-O 120.832 0.349 . . . . 0.0 110.718 -177.913 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' D' D ' 80' ' ' ILE . . . . . . . . . . . . . 24.8 mm -139.26 114.71 8.57 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.306 0 N-CA-C 109.57 -0.53 . . . . 0.0 109.57 -177.91 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' D' D ' 81' ' ' LYS . . . . . . . . . . . . . 97.9 mttt -98.64 123.71 43.0 Favored 'General case' 0 C--N 1.33 -0.28 0 C-N-CA 120.907 -0.317 . . . . 0.0 110.993 -179.938 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' D' D ' 82' ' ' GLY . . . . . . . . . . . . . . . 89.21 42.18 5.64 Favored Glycine 0 CA--C 1.524 0.654 0 C-N-CA 120.676 -0.773 . . . . 0.0 112.168 173.057 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' D' D ' 83' ' ' ILE . . . . . . . . . . . . . 73.5 mt -65.4 133.23 30.85 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.279 0 N-CA-C 109.314 -0.625 . . . . 0.0 109.314 175.194 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' D' D ' 84' ' ' LYS . . . . . . . . . . . . . 28.2 ttpp -97.71 -53.14 3.51 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-O 120.981 0.42 . . . . 0.0 110.51 -176.734 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' D' D ' 85' ' ' ASP . . . . . . . . . . . . . 13.9 t70 -147.54 146.67 29.53 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 115.868 -0.606 . . . . 0.0 110.396 -179.475 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' D' D ' 86' ' ' VAL . . . . . . . . . . . . . 45.0 t -128.91 129.39 68.17 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.299 0 CA-C-O 121.01 0.433 . . . . 0.0 110.545 -179.53 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' D' D ' 87' ' ' ILE . . . . . . . . . . . . . 43.6 mm -116.46 121.87 68.55 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.274 0 N-CA-C 109.087 -0.709 . . . . 0.0 109.087 175.451 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' D' D ' 88' ' ' LEU . . . . . . . . . . . . . 10.0 tp -114.93 131.58 56.84 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-O 121.047 0.451 . . . . 0.0 111.327 -174.907 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' D' D ' 89' ' ' ASP . . . . . . . . . . . . . 12.8 t70 -129.62 152.28 49.3 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 115.697 -0.683 . . . . 0.0 109.358 175.359 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' D' D ' 90' ' ' GLU . . . . . . . . . . . . . 95.9 mt-10 -50.65 -31.61 16.72 Favored 'General case' 0 C--N 1.328 -0.366 0 N-CA-C 112.477 0.547 . . . . 0.0 112.477 -173.115 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' D' D ' 91' ' ' ASN . . . . . . . . . . . . . 23.6 p30 -128.54 27.69 5.51 Favored 'General case' 0 N--CA 1.465 0.32 0 N-CA-C 112.607 0.595 . . . . 0.0 112.607 -175.779 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' D' D ' 92' ' ' LEU . . . . . . . . . . . . . 15.1 tp -166.11 143.11 5.24 Favored 'General case' 0 C--N 1.331 -0.196 0 C-N-CA 121.074 -0.25 . . . . 0.0 110.662 179.445 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' D' D ' 93' ' ' ILE . . . . . . . . . . . . . 75.6 mt -126.17 119.66 54.78 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.263 0 N-CA-C 109.552 -0.536 . . . . 0.0 109.552 178.082 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' D' D ' 94' ' ' VAL . . . . . . . . . . . . . 43.8 t -118.3 124.16 72.69 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.255 0 N-CA-C 109.627 -0.509 . . . . 0.0 109.627 178.954 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' D' D ' 95' ' ' VAL . . . . . . . . . . . . . 44.7 t -121.38 132.65 70.15 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.275 0 CA-C-N 116.233 -0.44 . . . . 0.0 109.934 -178.586 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' D' D ' 96' ' ' ILE . . . . . . . . . . . . . 67.7 mt -115.58 127.36 73.18 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 N-CA-C 109.244 -0.65 . . . . 0.0 109.244 179.128 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' D' D ' 97' ' ' THR . . . . . . . . . . . . . 80.5 p -101.47 159.68 15.08 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-O 121.364 0.602 . . . . 0.0 111.48 -176.18 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' D' D ' 98' ' ' GLU . . . . . . . . . . . . . 84.4 tt0 -53.95 -26.46 25.75 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 115.836 -0.62 . . . . 0.0 112.264 179.965 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' D' D ' 99' ' ' GLU . . . . . . . . . . . . . 43.3 mt-10 -79.49 15.64 1.24 Allowed 'General case' 0 CA--C 1.534 0.35 0 N-CA-C 113.115 0.783 . . . . 0.0 113.115 -177.169 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' D' D ' 100' ' ' ASN . . . . . . . . . . . . . 3.2 m-20 61.3 38.02 16.7 Favored 'General case' 0 N--CA 1.463 0.183 0 CA-C-O 121.16 0.505 . . . . 0.0 110.962 178.948 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' D' D ' 101' ' ' GLU . . . . . . . . . . . . . 84.1 tt0 -117.47 142.1 47.55 Favored 'General case' 0 C--N 1.333 -0.14 0 N-CA-C 109.636 -0.505 . . . . 0.0 109.636 176.308 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' D' D ' 102' ' ' VAL . . . . . . . . . . . . . 43.0 t -114.94 126.15 72.44 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.351 0 N-CA-C 109.947 -0.39 . . . . 0.0 109.947 -179.149 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' D' D ' 103' ' ' LEU . . . . . . . . . . . . . 45.7 mt -115.95 133.34 56.13 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 115.728 -0.669 . . . . 0.0 109.948 177.179 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' D' D ' 104' ' ' ILE . . . . . . . . . . . . . 68.2 mt -118.35 120.71 65.18 Favored 'Isoleucine or valine' 0 C--O 1.233 0.221 0 N-CA-C 110.112 -0.329 . . . . 0.0 110.112 -179.475 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' D' D ' 105' ' ' PHE . . . . . . . . . . . . . 55.8 m-85 -122.8 167.35 13.62 Favored 'General case' 0 C--N 1.332 -0.158 0 O-C-N 124.011 0.82 . . . . 0.0 109.933 -179.694 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' D' D ' 106' ' ' ASN . . . . . . . . . . . . . 41.2 p-10 -101.48 -170.84 1.89 Allowed 'General case' 0 C--N 1.331 -0.205 0 N-CA-C 109.95 -0.389 . . . . 0.0 109.95 172.922 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' D' D ' 107' ' ' GLN . . . . . . . . . . . . . 47.4 tt0 -60.57 -29.99 69.51 Favored 'General case' 0 C--N 1.33 -0.273 0 N-CA-C 111.904 0.335 . . . . 0.0 111.904 179.754 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' D' D ' 108' ' ' ASN . . . . . . . . . . . . . 10.8 t30 -82.18 7.41 13.7 Favored 'General case' 0 CA--C 1.537 0.443 0 N-CA-C 113.143 0.794 . . . . 0.0 113.143 -178.026 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' D' D ' 109' ' ' LEU . . . . . . . . . . . . . 10.0 tp 62.31 36.67 14.45 Favored 'General case' 0 CA--C 1.53 0.204 0 CA-C-O 120.881 0.372 . . . . 0.0 111.393 178.082 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' D' D ' 110' ' ' GLU . . . . . . . . . . . . . 70.7 mm-40 -104.57 155.55 18.73 Favored 'General case' 0 C--N 1.33 -0.243 0 N-CA-C 109.503 -0.554 . . . . 0.0 109.503 175.348 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' D' D ' 111' ' ' GLU . . . . . . . . . . . . . 66.2 tt0 -91.07 124.68 35.48 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-O 120.982 0.42 . . . . 0.0 111.0 -176.003 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' D' D ' 112' ' ' LEU . . . . . . . . . . . . . 23.8 mt -108.77 -45.93 3.73 Favored 'General case' 0 C--N 1.331 -0.204 0 CA-C-N 116.097 -0.501 . . . . 0.0 110.861 179.264 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' D' D ' 113' ' ' TYR . . . . . . . . . . . . . 51.1 t80 -138.32 143.18 39.83 Favored 'General case' 0 N--CA 1.462 0.174 0 C-N-CA 120.835 -0.346 . . . . 0.0 111.074 -178.027 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' D' D ' 114' ' ' ARG . . . . . . . . . . . . . 36.2 ptt-85 -142.57 127.8 18.7 Favored 'General case' 0 C--N 1.331 -0.217 0 CA-C-N 116.274 -0.421 . . . . 0.0 110.85 177.094 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' D' D ' 115' ' ' GLY . . . . . . . . . . . . . . . -150.15 141.72 9.04 Favored Glycine 0 CA--C 1.524 0.621 0 N-CA-C 111.439 -0.665 . . . . 0.0 111.439 178.559 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' D' D ' 116' ' ' LYS . . . . . . . . . . . . . 39.5 ttpt -111.74 134.38 53.34 Favored 'General case' 0 C--N 1.331 -0.198 0 N-CA-C 109.485 -0.561 . . . . 0.0 109.485 175.101 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' D' D ' 117' ' ' PHE . . . . . . . . . . . . . 42.1 m-85 -135.79 113.95 11.4 Favored 'General case' 0 C--N 1.331 -0.225 0 CA-C-O 120.967 0.413 . . . . 0.0 110.394 -175.912 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' D' D ' 118' ' ' GLU . . . . . . . . . . . . . 70.7 mm-40 -55.13 -48.76 73.2 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.313 -0.403 . . . . 0.0 111.257 -175.811 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' D' D ' 119' ' ' ASN . . . . . . . . . . . . . 11.7 m-80 -96.01 31.05 2.23 Favored 'General case' 0 C--N 1.328 -0.344 0 N-CA-C 112.149 0.426 . . . . 0.0 112.149 -174.04 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' D' D ' 120' ' ' LEU . . . . . . . . . . . . . 15.7 tp -56.48 122.23 11.48 Favored 'General case' 0 C--N 1.332 -0.175 0 CA-C-O 120.686 0.279 . . . . 0.0 110.391 177.538 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' D' D ' 121' ' ' ASN . . . . . . . . . . . . . 12.5 t-20 -112.17 -44.12 3.46 Favored 'General case' 0 C--N 1.332 -0.18 0 CA-C-N 116.488 -0.323 . . . . 0.0 110.846 -176.027 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' D' D ' 122' ' ' LYS . . . . . . . . . . . . . 98.3 mttt -146.37 149.61 34.1 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-O 121.112 0.482 . . . . 0.0 111.51 -178.489 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' D' D ' 123' ' ' VAL . . . . . . . . . . . . . 46.4 t -130.31 126.33 61.14 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.289 0 N-CA-C 109.25 -0.648 . . . . 0.0 109.25 172.928 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' D' D ' 124' ' ' LEU . . . . . . . . . . . . . 6.2 mp -114.71 137.09 52.34 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-O 120.824 0.345 . . . . 0.0 111.0 -176.52 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' D' D ' 125' ' ' VAL . . . . . . . . . . . . . 44.3 t -122.83 132.15 71.88 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.179 0 CA-C-N 115.911 -0.586 . . . . 0.0 109.939 179.861 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' D' D ' 126' ' ' ARG . . . . . . . . . . . . . 25.7 mmt180 -134.86 104.66 6.08 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 116.124 -0.489 . . . . 0.0 110.215 178.021 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' D' D ' 127' ' ' ASN . . . . . . . . . . . . . 35.0 m120 53.98 -104.98 0.23 Allowed 'General case' 0 CA--C 1.544 0.733 0 CA-C-O 119.053 -0.499 . . . . 0.0 110.922 179.75 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' D' D ' 128' ' ' ASP . . . . . . . . . . . . . 13.8 p-10 -112.33 2.65 16.6 Favored 'General case' 0 CA--C 1.536 0.431 0 CA-C-N 119.579 1.081 . . . . 0.0 113.498 -177.574 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' D' D ' 129' ' ' LEU . . . . . . . . . . . . . 26.1 mt -105.01 148.66 26.51 Favored 'General case' 0 C--O 1.231 0.124 0 N-CA-C 109.726 -0.472 . . . . 0.0 109.726 177.263 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' D' D ' 130' ' ' VAL . . . . . . . . . . . . . 12.7 p -133.04 141.03 45.87 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.233 0 CA-C-O 121.301 0.572 . . . . 0.0 110.784 -177.682 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' D' D ' 131' ' ' VAL . . . . . . . . . . . . . 38.9 t -134.43 135.96 53.4 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 CA-C-N 115.716 -0.675 . . . . 0.0 109.924 178.909 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' D' D ' 132' ' ' ILE . . . . . . . . . . . . . 70.6 mt -113.87 132.21 63.53 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.366 0 N-CA-C 109.394 -0.595 . . . . 0.0 109.394 -178.717 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' D' D ' 133' ' ' ILE . . . . . . . . . . . . . 35.4 mm -117.31 120.39 64.78 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.261 0 CA-C-O 120.837 0.351 . . . . 0.0 110.78 -176.06 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' D' D ' 134' ' ' ASP . . . . . . . . . . . . . 9.3 p-10 -129.89 148.95 51.81 Favored 'General case' 0 C--N 1.329 -0.284 0 N-CA-C 109.419 -0.586 . . . . 0.0 109.419 175.179 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' D' D ' 135' ' ' GLU . . . . . . . . . . . . . 54.6 tt0 -50.03 -25.43 3.38 Favored 'General case' 0 C--N 1.327 -0.39 0 N-CA-C 112.746 0.647 . . . . 0.0 112.746 -172.414 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' D' D ' 136' ' ' GLN . . . . . . . . . . . . . 43.0 tt0 -89.86 -31.1 17.49 Favored 'General case' 0 C--O 1.233 0.208 0 N-CA-C 112.542 0.571 . . . . 0.0 112.542 -174.058 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' D' D ' 137' ' ' LYS . . . . . . . . . . . . . 25.1 pttm -164.07 174.09 11.74 Favored 'General case' 0 C--O 1.232 0.176 0 CA-C-O 121.434 0.635 . . . . 0.0 112.57 -174.373 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' D' D ' 138' ' ' LEU . . . . . . . . . . . . . 7.4 tt -122.44 130.33 52.98 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 115.197 -0.91 . . . . 0.0 110.109 179.564 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' D' D ' 139' ' ' THR . . . . . . . . . . . . . 34.9 m -112.68 129.77 56.28 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-N 116.341 -0.39 . . . . 0.0 110.677 179.914 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' D' D ' 140' ' ' LEU . . . . . . . . . . . . . 19.5 tp -113.98 120.41 40.55 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 115.567 -0.742 . . . . 0.0 109.462 -178.241 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' D' D ' 141' ' ' ILE . . . . . . . . . . . . . 20.1 mt -120.3 119.49 60.07 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.281 0 CA-C-O 121.193 0.52 . . . . 0.0 109.93 -177.589 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' D' D ' 142' ' ' ARG . . . . . . . . . . . . . 84.6 mtm180 -111.17 133.29 53.64 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 114.941 -1.027 . . . . 0.0 110.689 -174.699 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' D' D ' 143' ' ' THR . . . . . . . . . . . . . 48.7 p . . . . . 0 C--O 1.22 -0.465 0 CA-C-O 118.03 -0.986 . . . . 0.0 110.371 179.588 . . . . . . . . 0 0 . 1 . 003 nuclear orig full ' E' E ' -3' ' ' GLU . . . . . . . . . . . . . 84.5 tt0 . . . . . 0 N--CA 1.49 1.538 0 N-CA-C 109.515 -0.55 . . . . 0.0 109.515 . . . . . . . . . 0 0 . 1 . 003 nuclear orig full ' E' E ' -2' ' ' GLY . . . . . . . . . . . . . . . -76.4 121.68 6.19 Favored Glycine 0 CA--C 1.525 0.712 0 N-CA-C 111.117 -0.793 . . . . 0.0 111.117 -179.432 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' E' E ' -1' ' ' VAL . . . . . . . . . . . . . 45.1 t -97.07 134.78 33.53 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.283 0 N-CA-C 110.053 -0.351 . . . . 0.0 110.053 178.684 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' E' E ' 0' ' ' ILE . . . . . . . . . . . . . 73.4 mt -115.14 132.44 64.4 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.203 0 CA-C-N 116.244 -0.435 . . . . 0.0 109.998 -179.683 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' E' E ' 1' ' ' MET . . . . . . . . . . . . . 25.6 ptt? -81.13 150.68 28.61 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.433 179.277 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' E' E ' 2' ' ' SER . . . . . . . . . . . . . 15.9 p -130.33 148.87 52.2 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.338 -0.392 . . . . 0.0 110.949 -178.997 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' E' E ' 3' ' ' GLU . . . . . . . . . . . . . 95.7 mt-10 -140.61 139.33 34.88 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 115.992 -0.549 . . . . 0.0 110.927 -179.864 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' E' E ' 4' ' ' LEU . . . . . . . . . . . . . 17.4 tp -122.94 126.76 47.84 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-N 116.071 -0.513 . . . . 0.0 110.155 176.533 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' E' E ' 5' ' ' LYS . . . . . . . . . . . . . 86.4 mttt -106.96 121.6 44.76 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.3 -0.409 . . . . 0.0 110.711 179.024 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' E' E ' 6' ' ' LEU . . . . . . . . . . . . . 75.9 mt -116.78 151.3 36.74 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 115.46 -0.791 . . . . 0.0 110.58 -179.394 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' E' E ' 7' ' ' LYS . . . . . . . . . . . . . 33.9 ttpt -140.32 142.14 28.58 Favored Pre-proline 0 CA--C 1.534 0.338 0 N-CA-C 109.764 -0.458 . . . . 0.0 109.764 175.088 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' E' E ' 8' ' ' PRO . . . . . . . . . . . . . 92.2 Cg_endo -89.03 147.91 5.6 Favored 'Trans proline' 0 N--CA 1.491 1.372 0 C-N-CA 121.654 1.569 . . . . 0.0 112.024 -179.896 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' E' E ' 9' ' ' LEU . . . . . . . . . . . . . 84.3 mt -84.23 -52.07 0.56 Allowed Pre-proline 0 C--N 1.329 -0.284 0 CA-C-O 118.855 -0.593 . . . . 0.0 111.551 -179.94 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' E' E ' 10' ' ' PRO . . . . . . . . . . . . . 61.6 Cg_endo -73.43 155.66 50.56 Favored 'Trans proline' 0 N--CA 1.498 1.762 0 C-N-CA 121.093 1.196 . . . . 0.0 111.898 173.469 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' E' E ' 11' ' ' LYS . . . . . . . . . . . . . 62.1 mtpt -89.07 98.93 12.04 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.433 -0.349 . . . . 0.0 110.749 179.207 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' E' E ' 12' ' ' VAL . . . . . . . . . . . . . 12.6 p -142.68 142.58 26.5 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.288 0 CA-C-N 116.335 -0.393 . . . . 0.0 110.667 179.809 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' E' E ' 13' ' ' GLU . . . . . . . . . . . . . 45.1 mp0 -84.74 128.28 34.53 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 116.267 -0.424 . . . . 0.0 109.86 176.754 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' E' E ' 14' ' ' LEU . . . . . . . . . . . . . 32.3 mt -98.5 148.99 35.29 Favored Pre-proline 0 CA--C 1.533 0.293 0 CA-C-O 119.197 -0.43 . . . . 0.0 110.499 -177.585 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' E' E ' 15' ' ' PRO . . . . . . . . . . . . . 26.3 Cg_exo -62.37 159.96 33.44 Favored 'Trans proline' 0 N--CA 1.497 1.71 0 C-N-CA 121.245 1.296 . . . . 0.0 111.478 174.869 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' E' E ' 16' ' ' PRO . . . . . . . . . . . . . 38.6 Cg_exo -58.68 -34.34 98.86 Favored 'Trans proline' 0 N--CA 1.496 1.666 0 C-N-CA 121.413 1.409 . . . . 0.0 112.899 -178.32 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' E' E ' 17' ' ' ASP . . . . . . . . . . . . . 22.9 p-10 -91.4 8.43 36.3 Favored 'General case' 0 CA--C 1.534 0.362 0 N-CA-C 113.341 0.867 . . . . 0.0 113.341 -177.193 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' E' E ' 18' ' ' PHE . . . . . . . . . . . . . 52.3 t80 -58.19 -43.85 87.77 Favored 'General case' 0 N--CA 1.457 -0.093 0 O-C-N 121.944 -0.472 . . . . 0.0 110.058 -178.162 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' E' E ' 19' ' ' VAL . . . . . . . . . . . . . 48.7 t -58.17 -42.52 83.51 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.304 0 CA-C-N 116.207 -0.452 . . . . 0.0 110.234 -178.909 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' E' E ' 20' ' ' ASP . . . . . . . . . . . . . 7.5 t70 -59.92 -42.09 93.15 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-O 120.833 0.349 . . . . 0.0 110.83 -177.92 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' E' E ' 21' ' ' VAL . . . . . . . . . . . . . 48.3 t -64.73 -46.18 92.94 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.332 0 CA-C-N 116.405 -0.361 . . . . 0.0 110.483 -177.723 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' E' E ' 22' ' ' ILE . . . . . . . . . . . . . 29.3 mm -57.0 -45.13 83.74 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.257 0 N-CA-C 110.172 -0.307 . . . . 0.0 110.172 179.266 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' E' E ' 23' ' ' ARG . . . . . . . . . . . . . 2.3 tmm_? -54.39 -48.77 71.18 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-O 120.573 0.225 . . . . 0.0 111.246 -178.935 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' E' E ' 24' ' ' ILE . . . . . . . . . . . . . 72.8 mt -59.02 -42.98 87.91 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.316 0 C-N-CA 120.943 -0.303 . . . . 0.0 110.963 -177.828 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' E' E ' 25' ' ' LYS . . . . . . . . . . . . . 96.2 mttt -66.34 -41.7 89.21 Favored 'General case' 0 C--N 1.329 -0.293 0 N-CA-C 112.759 0.652 . . . . 0.0 112.759 -178.874 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' E' E ' 26' ' ' LEU . . . . . . . . . . . . . 48.6 mt -78.48 -37.31 43.65 Favored 'General case' 0 C--N 1.327 -0.372 0 N-CA-C 113.689 0.996 . . . . 0.0 113.689 -169.812 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' E' E ' 27' ' ' GLN . . . . . . . . . . . . . 10.4 pt20 -47.23 138.85 6.7 Favored 'General case' 0 N--CA 1.467 0.422 0 N-CA-C 112.765 0.654 . . . . 0.0 112.765 -175.261 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' E' E ' 28' ' ' GLY . . . . . . . . . . . . . . . 101.17 -24.53 31.52 Favored Glycine 0 CA--C 1.532 1.139 0 CA-C-N 115.552 -0.749 . . . . 0.0 112.405 -177.182 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' E' E ' 29' ' ' LYS . . . . . . . . . . . . . 86.5 mttt -98.4 155.06 17.42 Favored 'General case' 0 C--O 1.233 0.198 0 CA-C-N 117.594 0.697 . . . . 0.0 111.381 179.376 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' E' E ' 30' ' ' THR . . . . . . . . . . . . . 30.5 m -104.39 136.7 43.49 Favored 'General case' 0 C--N 1.331 -0.226 0 CA-C-N 116.011 -0.54 . . . . 0.0 110.268 177.42 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' E' E ' 31' ' ' VAL . . . . . . . . . . . . . 35.0 m -132.29 157.06 43.0 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.329 0 CA-C-N 116.327 -0.397 . . . . 0.0 110.831 -179.123 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' E' E ' 32' ' ' ARG . . . . . . . . . . . . . 96.9 mtt180 -132.12 154.84 49.08 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 115.954 -0.566 . . . . 0.0 110.44 176.673 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' E' E ' 33' ' ' THR . . . . . . . . . . . . . 29.1 m -53.53 138.13 34.71 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.307 -0.406 . . . . 0.0 111.279 -178.978 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' E' E ' 34' ' ' GLY . . . . . . . . . . . . . . . 100.16 -17.11 57.51 Favored Glycine 0 CA--C 1.532 1.107 0 CA-C-O 119.616 -0.547 . . . . 0.0 113.295 178.744 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' E' E ' 35' ' ' ASP . . . . . . . . . . . . . 54.1 m-20 -65.37 150.18 48.73 Favored 'General case' 0 C--N 1.334 -0.077 0 CA-C-N 118.019 0.909 . . . . 0.0 111.137 179.818 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' E' E ' 36' ' ' VAL . . . . . . . . . . . . . 44.6 t -121.56 130.0 75.02 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.233 0 CA-C-N 115.67 -0.696 . . . . 0.0 109.76 178.536 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' E' E ' 37' ' ' ILE . . . . . . . . . . . . . 69.7 mt -119.31 138.66 49.27 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.29 0 CA-C-N 116.275 -0.421 . . . . 0.0 109.923 -179.636 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' E' E ' 38' ' ' GLY . . . . . . . . . . . . . . . -112.27 128.95 8.77 Favored Glycine 0 CA--C 1.526 0.77 0 N-CA-C 111.086 -0.806 . . . . 0.0 111.086 -179.505 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' E' E ' 39' ' ' ILE . . . . . . . . . . . . . 71.1 mt -122.03 134.14 66.21 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.275 0 N-CA-C 109.899 -0.408 . . . . 0.0 109.899 178.895 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' E' E ' 40' ' ' SER . . . . . . . . . . . . . 53.8 p -93.39 122.71 36.08 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.323 -0.398 . . . . 0.0 110.857 175.509 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' E' E ' 41' ' ' ILE . . . . . . . . . . . . . 71.4 mt -131.85 114.37 24.57 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.225 0 N-CA-C 110.021 -0.363 . . . . 0.0 110.021 177.678 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' E' E ' 42' ' ' LEU . . . . . . . . . . . . . 7.9 mp 56.6 37.57 28.92 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-O 121.086 0.47 . . . . 0.0 111.074 -179.707 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' E' E ' 43' ' ' GLY . . . . . . . . . . . . . . . 77.42 -10.08 24.53 Favored Glycine 0 CA--C 1.534 1.219 0 C-N-CA 121.296 -0.478 . . . . 0.0 113.473 177.043 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' E' E ' 44' ' ' LYS . . . . . . . . . . . . . 68.7 mttm -93.99 132.97 37.93 Favored 'General case' 0 C--N 1.333 -0.121 0 CA-C-N 118.005 0.903 . . . . 0.0 110.069 178.093 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' E' E ' 45' ' ' GLU . . . . . . . . . . . . . 69.3 tt0 -86.46 127.28 34.83 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.172 -0.467 . . . . 0.0 111.04 -177.816 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' E' E ' 46' ' ' VAL . . . . . . . . . . . . . 7.2 p -124.84 128.13 73.04 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.198 0 CA-C-O 120.943 0.401 . . . . 0.0 109.98 176.627 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' E' E ' 47' ' ' LYS . . . . . . . . . . . . . 72.6 mmtt -100.08 133.91 43.78 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-N 115.972 -0.558 . . . . 0.0 111.525 177.631 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' E' E ' 48' ' ' PHE . . . . . . . . . . . . . 91.1 m-85 -116.34 131.98 56.79 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 115.907 -0.588 . . . . 0.0 109.782 174.046 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' E' E ' 49' ' ' LYS . . . . . . . . . . . . . 82.4 tttt -105.73 136.34 45.53 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.488 -0.324 . . . . 0.0 110.527 -179.927 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' E' E ' 50' ' ' VAL . . . . . . . . . . . . . 45.0 t -80.53 108.67 14.16 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.331 0 N-CA-C 109.196 -0.668 . . . . 0.0 109.196 176.089 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' E' E ' 51' ' ' VAL . . . . . . . . . . . . . 47.5 t -74.63 -47.21 39.75 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.289 0 CA-C-N 116.139 -0.482 . . . . 0.0 110.174 -172.968 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' E' E ' 52' ' ' GLN . . . . . . . . . . . . . 48.2 tt0 -164.85 138.49 4.9 Favored 'General case' 0 C--N 1.331 -0.236 0 C-N-CA 120.155 -0.618 . . . . 0.0 111.749 -177.954 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' E' E ' 53' ' ' ALA . . . . . . . . . . . . . . . -116.46 133.6 55.82 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 115.9 -0.591 . . . . 0.0 110.169 176.835 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' E' E ' 54' ' ' TYR . . . . . . . . . . . . . 38.5 t80 -129.13 112.47 18.4 Favored Pre-proline 0 CA--C 1.535 0.398 0 CA-C-O 118.154 -0.927 . . . . 0.0 110.171 177.607 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' E' E ' 55' ' ' PRO . . . . . . . . . . . . . 72.2 Cg_endo -77.09 168.72 76.23 Favored 'Cis proline' 0 N--CA 1.5 1.904 0 CA-C-N 122.082 1.779 . . . . 0.0 112.426 -5.346 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' E' E ' 56' ' ' SER . . . . . . . . . . . . . 13.6 m -117.57 134.08 23.21 Favored Pre-proline 0 CA--C 1.54 0.562 0 CA-C-O 118.455 -0.783 . . . . 0.0 109.595 174.764 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' E' E ' 57' ' ' PRO . . . . . . . . . . . . . 36.0 Cg_endo -66.36 164.7 65.68 Favored 'Cis proline' 0 N--CA 1.498 1.751 0 CA-C-N 121.862 1.701 . . . . 0.0 111.299 -3.177 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' E' E ' 58' ' ' LEU . . . . . . . . . . . . . 23.4 tp -129.96 138.82 51.06 Favored 'General case' 0 C--N 1.331 -0.222 0 CA-C-O 121.081 0.467 . . . . 0.0 110.584 179.61 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' E' E ' 59' ' ' ARG . . . . . . . . . . . . . 75.1 ttt180 -106.06 123.31 47.8 Favored 'General case' 0 C--N 1.329 -0.295 0 N-CA-C 109.084 -0.71 . . . . 0.0 109.084 174.115 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' E' E ' 60' ' ' VAL . . . . . . . . . . . . . 44.3 t -73.52 118.95 19.69 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.351 0 C-N-CA 120.735 -0.386 . . . . 0.0 110.166 -175.198 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' E' E ' 61' ' ' GLU . . . . . . . . . . . . . 95.0 mt-10 -131.05 162.43 29.84 Favored 'General case' 0 C--N 1.331 -0.222 0 CA-C-N 116.107 -0.497 . . . . 0.0 110.109 178.455 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' E' E ' 62' ' ' ASP . . . . . . . . . . . . . 65.2 m-20 -53.57 -32.84 52.58 Favored 'General case' 0 C--N 1.326 -0.427 0 N-CA-C 111.751 0.278 . . . . 0.0 111.751 -178.898 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' E' E ' 63' ' ' ARG . . . . . . . . . . . . . 27.6 mmm180 -72.69 -21.35 61.07 Favored 'General case' 0 C--N 1.33 -0.267 0 N-CA-C 113.054 0.761 . . . . 0.0 113.054 -176.159 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' E' E ' 64' ' ' THR . . . . . . . . . . . . . 29.6 m -72.56 139.37 47.47 Favored 'General case' 0 C--N 1.331 -0.21 0 CA-C-O 120.869 0.366 . . . . 0.0 111.183 -174.409 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' E' E ' 65' ' ' LYS . . . . . . . . . . . . . 13.1 mptt -89.04 134.34 34.03 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.009 -0.541 . . . . 0.0 109.982 178.68 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' E' E ' 66' ' ' ILE . . . . . . . . . . . . . 64.4 mt -116.96 131.75 68.72 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.326 0 CA-C-O 120.885 0.374 . . . . 0.0 110.076 -179.772 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' E' E ' 67' ' ' THR . . . . . . . . . . . . . 32.5 m -127.6 140.44 52.1 Favored 'General case' 0 C--N 1.332 -0.19 0 CA-C-N 116.047 -0.524 . . . . 0.0 110.821 -178.559 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' E' E ' 68' ' ' LEU . . . . . . . . . . . . . 5.0 tt -102.85 120.97 41.54 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 115.994 -0.548 . . . . 0.0 109.649 177.044 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' E' E ' 69' ' ' VAL . . . . . . . . . . . . . 42.3 t -102.0 135.14 40.24 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.29 0 CA-C-O 120.982 0.42 . . . . 0.0 110.635 -176.091 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' E' E ' 70' ' ' THR . . . . . . . . . . . . . 11.4 m -147.18 92.42 2.11 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 115.857 -0.61 . . . . 0.0 109.976 177.934 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' E' E ' 71' ' ' HIS . . . . . . . . . . . . . 86.1 m-70 -145.8 153.0 49.78 Favored Pre-proline 0 CA--C 1.534 0.327 0 C-N-CA 120.746 -0.382 . . . . 0.0 111.029 -178.268 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' E' E ' 72' ' ' PRO . . . . . . . . . . . . . 93.8 Cg_endo -93.03 160.12 2.64 Favored 'Trans proline' 0 N--CA 1.488 1.187 0 C-N-CA 121.988 1.792 . . . . 0.0 111.511 173.483 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' E' E ' 73' ' ' VAL . . . . . . . . . . . . . 33.9 m -69.87 154.05 8.36 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.224 0 C-N-CA 120.739 -0.384 . . . . 0.0 110.41 -179.477 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' E' E ' 74' ' ' ASP . . . . . . . . . . . . . 7.3 t0 -95.34 126.44 40.65 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.009 -0.542 . . . . 0.0 110.228 -176.924 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' E' E ' 75' ' ' VAL . . . . . . . . . . . . . 40.4 t -119.17 123.79 71.96 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.205 0 CA-C-O 121.025 0.44 . . . . 0.0 110.583 -178.514 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' E' E ' 76' ' ' LEU . . . . . . . . . . . . . 6.3 mp -123.94 146.24 48.6 Favored 'General case' 0 C--N 1.331 -0.224 0 CA-C-N 115.828 -0.624 . . . . 0.0 109.908 176.195 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' E' E ' 77' ' ' GLU . . . . . . . . . . . . . 45.9 mt-10 -135.69 136.86 41.22 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-O 121.011 0.434 . . . . 0.0 111.22 -178.883 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' E' E ' 78' ' ' ALA . . . . . . . . . . . . . . . -125.95 133.44 51.83 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 115.816 -0.629 . . . . 0.0 109.674 176.145 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' E' E ' 79' ' ' LYS . . . . . . . . . . . . . 84.0 mttt -80.51 120.3 24.31 Favored 'General case' 0 C--N 1.331 -0.215 0 CA-C-O 121.091 0.472 . . . . 0.0 110.754 -178.199 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' E' E ' 80' ' ' ILE . . . . . . . . . . . . . 43.1 mm -139.18 108.68 3.86 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.335 0 N-CA-C 108.961 -0.755 . . . . 0.0 108.961 -176.991 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' E' E ' 81' ' ' LYS . . . . . . . . . . . . . 68.8 mttm -97.84 126.73 43.36 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-O 120.877 0.37 . . . . 0.0 111.199 -176.265 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' E' E ' 82' ' ' GLY . . . . . . . . . . . . . . . 89.08 42.14 5.69 Favored Glycine 0 CA--C 1.527 0.791 0 C-N-CA 120.911 -0.662 . . . . 0.0 111.725 174.992 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' E' E ' 83' ' ' ILE . . . . . . . . . . . . . 75.5 mt -66.83 138.52 22.75 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.314 0 CA-C-O 120.945 0.402 . . . . 0.0 109.94 178.34 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' E' E ' 84' ' ' LYS . . . . . . . . . . . . . 83.8 tttt -99.22 -53.97 3.09 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 115.989 -0.55 . . . . 0.0 110.34 -178.815 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' E' E ' 85' ' ' ASP . . . . . . . . . . . . . 5.9 t0 -154.69 151.4 28.71 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-N 115.746 -0.661 . . . . 0.0 110.044 -178.943 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' E' E ' 86' ' ' VAL . . . . . . . . . . . . . 42.8 t -131.9 130.77 61.7 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.233 0 CA-C-O 120.961 0.41 . . . . 0.0 110.537 -179.181 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' E' E ' 87' ' ' ILE . . . . . . . . . . . . . 44.5 mm -119.04 128.89 75.78 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.221 0 CA-C-N 115.863 -0.608 . . . . 0.0 109.705 177.011 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' E' E ' 88' ' ' LEU . . . . . . . . . . . . . 27.5 mt -114.54 139.33 49.67 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-O 121.151 0.501 . . . . 0.0 111.463 -177.635 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' E' E ' 89' ' ' ASP . . . . . . . . . . . . . 11.6 t70 -132.96 156.83 46.56 Favored 'General case' 0 C--N 1.331 -0.23 0 CA-C-N 115.517 -0.765 . . . . 0.0 109.388 175.39 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' E' E ' 90' ' ' GLU . . . . . . . . . . . . . 96.0 mt-10 -48.44 -38.52 20.0 Favored 'General case' 0 C--N 1.327 -0.371 0 N-CA-C 112.796 0.665 . . . . 0.0 112.796 -171.507 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' E' E ' 91' ' ' ASN . . . . . . . . . . . . . 33.5 m120 -132.11 34.73 3.77 Favored 'General case' 0 N--CA 1.465 0.278 0 C-N-CA 120.961 -0.296 . . . . 0.0 111.703 -176.494 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' E' E ' 92' ' ' LEU . . . . . . . . . . . . . 9.7 tp -166.16 145.55 6.02 Favored 'General case' 0 C--N 1.33 -0.258 0 C-N-CA 120.885 -0.326 . . . . 0.0 110.717 -179.66 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' E' E ' 93' ' ' ILE . . . . . . . . . . . . . 67.7 mt -127.79 125.96 65.98 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.222 0 N-CA-C 109.711 -0.477 . . . . 0.0 109.711 178.989 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' E' E ' 94' ' ' VAL . . . . . . . . . . . . . 47.1 t -122.99 127.14 74.62 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.267 0 N-CA-C 109.797 -0.446 . . . . 0.0 109.797 178.868 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' E' E ' 95' ' ' VAL . . . . . . . . . . . . . 44.2 t -122.93 135.38 63.18 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.294 0 CA-C-N 116.328 -0.396 . . . . 0.0 110.061 -179.252 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' E' E ' 96' ' ' ILE . . . . . . . . . . . . . 61.9 mt -116.31 128.75 73.54 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.326 0 N-CA-C 109.304 -0.628 . . . . 0.0 109.304 179.341 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' E' E ' 97' ' ' THR . . . . . . . . . . . . . 75.7 p -101.67 157.09 17.08 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-O 121.191 0.52 . . . . 0.0 111.371 -177.353 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' E' E ' 98' ' ' GLU . . . . . . . . . . . . . 84.6 tt0 -53.99 -26.66 27.14 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-N 116.008 -0.542 . . . . 0.0 112.133 -179.793 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' E' E ' 99' ' ' GLU . . . . . . . . . . . . . 45.7 mp0 -79.14 16.25 0.99 Allowed 'General case' 0 CA--C 1.536 0.426 0 N-CA-C 113.013 0.746 . . . . 0.0 113.013 -177.931 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' E' E ' 100' ' ' ASN . . . . . . . . . . . . . 3.8 m-20 62.95 38.08 11.44 Favored 'General case' 0 C--O 1.233 0.186 0 CA-C-O 120.952 0.406 . . . . 0.0 110.939 177.397 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' E' E ' 101' ' ' GLU . . . . . . . . . . . . . 84.5 tt0 -116.49 142.5 46.78 Favored 'General case' 0 C--N 1.331 -0.221 0 CA-C-N 116.078 -0.51 . . . . 0.0 109.801 177.124 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' E' E ' 102' ' ' VAL . . . . . . . . . . . . . 46.4 t -115.12 126.46 72.71 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.22 0 N-CA-C 109.87 -0.419 . . . . 0.0 109.87 -178.615 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' E' E ' 103' ' ' LEU . . . . . . . . . . . . . 42.5 mt -118.29 133.43 55.9 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-N 115.692 -0.685 . . . . 0.0 110.249 177.098 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' E' E ' 104' ' ' ILE . . . . . . . . . . . . . 68.5 mt -118.1 123.36 71.53 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.316 0 N-CA-C 109.986 -0.375 . . . . 0.0 109.986 179.632 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' E' E ' 105' ' ' PHE . . . . . . . . . . . . . 75.4 m-85 -122.43 165.69 15.94 Favored 'General case' 0 C--N 1.332 -0.157 0 O-C-N 124.047 0.842 . . . . 0.0 109.607 -179.964 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' E' E ' 106' ' ' ASN . . . . . . . . . . . . . 50.5 p-10 -101.54 -171.23 1.95 Allowed 'General case' 0 C--N 1.331 -0.204 0 N-CA-C 110.002 -0.37 . . . . 0.0 110.002 174.996 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' E' E ' 107' ' ' GLN . . . . . . . . . . . . . 45.8 tt0 -59.13 -29.3 67.29 Favored 'General case' 0 C--N 1.329 -0.3 0 N-CA-C 112.003 0.372 . . . . 0.0 112.003 -179.733 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' E' E ' 108' ' ' ASN . . . . . . . . . . . . . 14.4 t-20 -84.55 10.48 10.89 Favored 'General case' 0 CA--C 1.536 0.42 0 N-CA-C 113.035 0.754 . . . . 0.0 113.035 -177.508 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' E' E ' 109' ' ' LEU . . . . . . . . . . . . . 8.7 tp 58.33 36.77 25.79 Favored 'General case' 0 CA--C 1.531 0.226 0 CA-C-O 121.046 0.45 . . . . 0.0 111.373 179.711 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' E' E ' 110' ' ' GLU . . . . . . . . . . . . . 43.4 mt-10 -103.65 152.84 21.31 Favored 'General case' 0 C--N 1.33 -0.244 0 N-CA-C 109.662 -0.496 . . . . 0.0 109.662 175.676 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' E' E ' 111' ' ' GLU . . . . . . . . . . . . . 58.9 tt0 -87.29 121.91 30.36 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-O 120.914 0.387 . . . . 0.0 110.763 -176.315 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' E' E ' 112' ' ' LEU . . . . . . . . . . . . . 13.8 mt -105.18 -46.06 4.34 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 115.978 -0.556 . . . . 0.0 110.834 -179.895 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' E' E ' 113' ' ' TYR . . . . . . . . . . . . . 65.3 t80 -139.91 143.75 36.79 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.299 -0.41 . . . . 0.0 111.221 -178.431 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' E' E ' 114' ' ' ARG . . . . . . . . . . . . . 38.8 ptt180 -144.55 123.28 12.59 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.096 -0.502 . . . . 0.0 110.796 178.128 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' E' E ' 115' ' ' GLY . . . . . . . . . . . . . . . -150.13 158.81 27.84 Favored Glycine 0 CA--C 1.525 0.703 0 N-CA-C 110.934 -0.866 . . . . 0.0 110.934 178.205 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' E' E ' 116' ' ' LYS . . . . . . . . . . . . . 37.4 ttpt -127.87 139.01 52.88 Favored 'General case' 0 C--N 1.331 -0.224 0 O-C-N 122.634 -0.333 . . . . 0.0 110.29 178.118 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' E' E ' 117' ' ' PHE . . . . . . . . . . . . . 39.8 m-85 -133.75 114.96 13.99 Favored 'General case' 0 C--N 1.329 -0.296 0 N-CA-C 110.0 -0.37 . . . . 0.0 110.0 -178.153 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' E' E ' 118' ' ' GLU . . . . . . . . . . . . . 84.3 tt0 -53.57 -43.2 68.33 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.64 -0.255 . . . . 0.0 111.542 -175.97 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' E' E ' 119' ' ' ASN . . . . . . . . . . . . . 82.3 m-20 -100.17 31.0 3.53 Favored 'General case' 0 C--N 1.33 -0.24 0 N-CA-C 112.154 0.428 . . . . 0.0 112.154 -174.185 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' E' E ' 120' ' ' LEU . . . . . . . . . . . . . 13.9 tp -54.97 121.04 7.82 Favored 'General case' 0 C--N 1.331 -0.207 0 CA-C-O 120.663 0.268 . . . . 0.0 110.745 178.716 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' E' E ' 121' ' ' ASN . . . . . . . . . . . . . 46.1 t30 -114.03 -43.93 3.2 Favored 'General case' 0 C--O 1.232 0.167 0 CA-C-N 116.598 -0.273 . . . . 0.0 111.516 -176.184 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' E' E ' 122' ' ' LYS . . . . . . . . . . . . . 57.9 mtpt -140.08 144.55 36.88 Favored 'General case' 0 C--N 1.332 -0.159 0 CA-C-O 120.938 0.399 . . . . 0.0 111.741 -176.084 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' E' E ' 123' ' ' VAL . . . . . . . . . . . . . 46.7 t -127.1 124.9 65.34 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 N-CA-C 109.381 -0.6 . . . . 0.0 109.381 174.078 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' E' E ' 124' ' ' LEU . . . . . . . . . . . . . 51.6 mt -126.73 139.32 53.23 Favored 'General case' 0 C--N 1.331 -0.201 0 CA-C-O 120.95 0.405 . . . . 0.0 110.967 -177.186 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' E' E ' 125' ' ' VAL . . . . . . . . . . . . . 34.9 m -132.01 139.03 51.28 Favored 'Isoleucine or valine' 0 C--N 1.333 -0.145 0 CA-C-N 116.017 -0.538 . . . . 0.0 110.911 -179.871 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' E' E ' 126' ' ' ARG . . . . . . . . . . . . . 77.1 mtp85 -140.52 109.41 6.04 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 115.958 -0.565 . . . . 0.0 110.29 175.422 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' E' E ' 127' ' ' ASN . . . . . . . . . . . . . 94.5 m-20 53.32 -104.9 0.22 Allowed 'General case' 0 CA--C 1.542 0.663 0 CA-C-O 119.067 -0.492 . . . . 0.0 111.136 -179.897 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' E' E ' 128' ' ' ASP . . . . . . . . . . . . . 14.6 p-10 -113.69 5.41 16.44 Favored 'General case' 0 CA--C 1.537 0.447 0 CA-C-N 119.496 1.044 . . . . 0.0 113.393 -177.334 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' E' E ' 129' ' ' LEU . . . . . . . . . . . . . 3.9 tt -105.11 131.51 52.51 Favored 'General case' 0 C--N 1.332 -0.154 0 N-CA-C 109.367 -0.605 . . . . 0.0 109.367 177.809 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' E' E ' 130' ' ' VAL . . . . . . . . . . . . . 44.2 t -120.6 137.05 55.64 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.218 0 CA-C-O 120.765 0.317 . . . . 0.0 110.165 -177.236 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' E' E ' 131' ' ' VAL . . . . . . . . . . . . . 41.8 t -135.95 138.07 48.0 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.249 0 CA-C-O 121.203 0.525 . . . . 0.0 110.459 178.926 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' E' E ' 132' ' ' ILE . . . . . . . . . . . . . 76.4 mt -119.93 134.0 64.87 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.324 0 CA-C-N 115.513 -0.767 . . . . 0.0 109.51 -179.739 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' E' E ' 133' ' ' ILE . . . . . . . . . . . . . 42.8 mm -117.21 125.32 73.89 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.23 0 CA-C-O 120.798 0.332 . . . . 0.0 110.865 -176.142 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' E' E ' 134' ' ' ASP . . . . . . . . . . . . . 7.7 p-10 -137.03 148.72 47.0 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.0 -0.545 . . . . 0.0 109.568 174.187 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' E' E ' 135' ' ' GLU . . . . . . . . . . . . . 43.5 tp10 -49.81 -25.88 3.48 Favored 'General case' 0 C--N 1.327 -0.377 0 N-CA-C 112.792 0.664 . . . . 0.0 112.792 -171.585 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' E' E ' 136' ' ' GLN . . . . . . . . . . . . . 97.3 mt-30 -96.5 -33.06 11.98 Favored 'General case' 0 CA--C 1.53 0.178 0 N-CA-C 112.476 0.547 . . . . 0.0 112.476 -175.995 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' E' E ' 137' ' ' LYS . . . . . . . . . . . . . 84.5 mttt -141.37 154.56 45.72 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-O 121.233 0.54 . . . . 0.0 111.697 -168.427 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' E' E ' 138' ' ' LEU . . . . . . . . . . . . . 4.5 tt -117.56 119.68 35.74 Favored 'General case' 0 C--N 1.33 -0.246 0 N-CA-C 108.965 -0.754 . . . . 0.0 108.965 171.071 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' E' E ' 139' ' ' THR . . . . . . . . . . . . . 25.3 m -106.05 128.8 54.1 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.454 -0.339 . . . . 0.0 110.712 -176.53 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' E' E ' 140' ' ' LEU . . . . . . . . . . . . . 5.4 tt -116.56 122.85 45.88 Favored 'General case' 0 C--N 1.329 -0.322 0 N-CA-C 109.068 -0.716 . . . . 0.0 109.068 -179.221 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' E' E ' 141' ' ' ILE . . . . . . . . . . . . . 18.9 mt -121.99 118.79 56.69 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.288 0 CA-C-O 121.025 0.44 . . . . 0.0 109.981 -176.757 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' E' E ' 142' ' ' ARG . . . . . . . . . . . . . 84.4 mtp180 -103.7 125.27 50.08 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 115.285 -0.871 . . . . 0.0 110.341 -179.576 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' E' E ' 143' ' ' THR . . . . . . . . . . . . . 43.2 p . . . . . 0 C--O 1.22 -0.472 0 CA-C-O 118.015 -0.993 . . . . 0.0 110.527 -179.781 . . . . . . . . 0 0 . 1 . 003 nuclear orig full ' F' F ' -3' ' ' GLU . . . . . . . . . . . . . 95.6 mt-10 . . . . . 0 N--CA 1.49 1.554 0 N-CA-C 109.466 -0.568 . . . . 0.0 109.466 . . . . . . . . . 0 0 . 1 . 003 nuclear orig full ' F' F ' -2' ' ' GLY . . . . . . . . . . . . . . . -105.79 149.29 16.67 Favored Glycine 0 CA--C 1.525 0.659 0 N-CA-C 110.641 -0.984 . . . . 0.0 110.641 178.279 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' F' F ' -1' ' ' VAL . . . . . . . . . . . . . 46.6 t -95.1 134.16 33.45 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.347 0 N-CA-C 109.776 -0.453 . . . . 0.0 109.776 179.289 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' F' F ' 0' ' ' ILE . . . . . . . . . . . . . 70.7 mt -101.85 130.91 50.8 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.286 0 CA-C-N 116.211 -0.45 . . . . 0.0 110.073 -178.03 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' F' F ' 1' ' ' MET . . . . . . . . . . . . . 27.3 ptm -81.86 133.87 35.36 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 115.872 -0.604 . . . . 0.0 110.564 178.876 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' F' F ' 2' ' ' SER . . . . . . . . . . . . . 4.5 p -117.78 130.1 56.09 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.135 177.686 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' F' F ' 3' ' ' GLU . . . . . . . . . . . . . 83.3 tt0 -142.08 137.74 31.23 Favored 'General case' 0 C--N 1.327 -0.4 0 CA-C-N 115.988 -0.551 . . . . 0.0 111.062 -177.928 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' F' F ' 4' ' ' LEU . . . . . . . . . . . . . 17.1 tp -124.54 131.1 53.49 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.059 176.816 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' F' F ' 5' ' ' LYS . . . . . . . . . . . . . 69.0 mttm -110.28 122.29 47.3 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.305 -0.407 . . . . 0.0 110.602 179.962 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' F' F ' 6' ' ' LEU . . . . . . . . . . . . . 30.3 mt -113.88 149.44 35.12 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 115.234 -0.893 . . . . 0.0 109.954 -178.895 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' F' F ' 7' ' ' LYS . . . . . . . . . . . . . 52.4 tttp -137.11 137.15 22.03 Favored Pre-proline 0 CA--C 1.534 0.34 0 CA-C-O 118.857 -0.592 . . . . 0.0 109.994 175.569 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' F' F ' 8' ' ' PRO . . . . . . . . . . . . . 74.3 Cg_endo -91.45 138.41 2.18 Favored 'Trans proline' 0 N--CA 1.49 1.276 0 C-N-CA 121.675 1.583 . . . . 0.0 111.708 177.259 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' F' F ' 9' ' ' LEU . . . . . . . . . . . . . 58.1 mt -74.78 -48.18 4.92 Favored Pre-proline 0 CA--C 1.534 0.336 0 CA-C-O 118.629 -0.7 . . . . 0.0 112.277 -178.881 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' F' F ' 10' ' ' PRO . . . . . . . . . . . . . 95.3 Cg_endo -78.79 156.8 27.6 Favored 'Trans proline' 0 N--CA 1.496 1.653 0 C-N-CA 121.081 1.187 . . . . 0.0 112.008 177.381 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' F' F ' 11' ' ' LYS . . . . . . . . . . . . . 81.8 tttt -87.92 101.76 14.06 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.396 -0.365 . . . . 0.0 110.266 179.32 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' F' F ' 12' ' ' VAL . . . . . . . . . . . . . 12.3 p -143.57 149.3 18.2 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.295 0 CA-C-N 116.2 -0.454 . . . . 0.0 110.744 -178.313 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' F' F ' 13' ' ' GLU . . . . . . . . . . . . . 84.0 tt0 -91.43 127.6 36.94 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.302 -0.408 . . . . 0.0 109.989 177.598 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' F' F ' 14' ' ' LEU . . . . . . . . . . . . . 29.9 mt -98.83 146.04 30.97 Favored Pre-proline 0 CA--C 1.534 0.333 0 CA-C-O 119.183 -0.437 . . . . 0.0 110.632 -177.711 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' F' F ' 15' ' ' PRO . . . . . . . . . . . . . 23.8 Cg_exo -64.44 158.61 48.44 Favored 'Trans proline' 0 N--CA 1.497 1.707 0 C-N-CA 121.401 1.4 . . . . 0.0 111.777 174.309 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' F' F ' 16' ' ' PRO . . . . . . . . . . . . . 37.8 Cg_exo -57.98 -43.51 47.93 Favored 'Trans proline' 0 N--CA 1.496 1.648 0 C-N-CA 121.477 1.451 . . . . 0.0 112.97 -177.834 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' F' F ' 17' ' ' ASP . . . . . . . . . . . . . 23.2 p-10 -82.42 7.73 13.41 Favored 'General case' 0 CA--C 1.536 0.429 0 N-CA-C 113.252 0.834 . . . . 0.0 113.252 -177.615 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' F' F ' 18' ' ' PHE . . . . . . . . . . . . . 45.7 t80 -58.05 -45.11 87.57 Favored 'General case' 0 N--CA 1.458 -0.069 0 O-C-N 121.996 -0.44 . . . . 0.0 110.183 -178.179 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' F' F ' 19' ' ' VAL . . . . . . . . . . . . . 14.4 p -56.98 -41.96 78.12 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.35 0 CA-C-N 116.34 -0.391 . . . . 0.0 110.935 -178.585 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' F' F ' 20' ' ' ASP . . . . . . . . . . . . . 67.6 m-20 -60.85 -42.13 97.23 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-O 120.884 0.373 . . . . 0.0 110.9 -178.125 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' F' F ' 21' ' ' VAL . . . . . . . . . . . . . 52.9 t -64.36 -47.37 89.84 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.32 0 CA-C-N 116.374 -0.376 . . . . 0.0 110.353 -178.107 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' F' F ' 22' ' ' ILE . . . . . . . . . . . . . 51.0 mm -56.72 -43.49 79.47 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.283 0 CA-C-O 120.773 0.32 . . . . 0.0 110.479 178.764 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' F' F ' 23' ' ' ARG . . . . . . . . . . . . . 42.2 ttp180 -54.4 -49.12 70.66 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.632 -0.258 . . . . 0.0 111.432 -179.003 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' F' F ' 24' ' ' ILE . . . . . . . . . . . . . 73.4 mt -59.37 -43.72 90.88 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.284 0 C-N-CA 121.072 -0.251 . . . . 0.0 111.019 -178.071 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' F' F ' 25' ' ' LYS . . . . . . . . . . . . . 99.0 mttt -63.79 -41.8 97.87 Favored 'General case' 0 C--N 1.327 -0.382 0 N-CA-C 112.526 0.565 . . . . 0.0 112.526 -178.255 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' F' F ' 26' ' ' LEU . . . . . . . . . . . . . 93.3 mt -79.49 -41.64 26.98 Favored 'General case' 0 C--N 1.329 -0.318 0 N-CA-C 113.14 0.793 . . . . 0.0 113.14 -172.511 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' F' F ' 27' ' ' GLN . . . . . . . . . . . . . 9.5 pt20 -46.41 142.16 3.19 Favored 'General case' 0 N--CA 1.469 0.482 0 N-CA-C 112.9 0.704 . . . . 0.0 112.9 -173.581 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' F' F ' 28' ' ' GLY . . . . . . . . . . . . . . . 101.26 -29.85 11.64 Favored Glycine 0 CA--C 1.529 0.953 0 CA-C-N 115.15 -0.932 . . . . 0.0 111.941 -177.182 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' F' F ' 29' ' ' LYS . . . . . . . . . . . . . 93.3 mttt -98.62 155.18 17.43 Favored 'General case' 0 C--N 1.332 -0.173 0 CA-C-N 117.329 0.564 . . . . 0.0 111.129 177.981 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' F' F ' 30' ' ' THR . . . . . . . . . . . . . 34.8 m -102.58 138.91 38.86 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.163 -0.471 . . . . 0.0 110.063 176.657 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' F' F ' 31' ' ' VAL . . . . . . . . . . . . . 34.9 m -128.91 158.6 41.47 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.186 0 CA-C-N 116.413 -0.358 . . . . 0.0 110.808 -178.8 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' F' F ' 32' ' ' ARG . . . . . . . . . . . . . 96.9 mtt180 -130.79 151.74 50.89 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 115.922 -0.581 . . . . 0.0 110.5 178.735 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' F' F ' 33' ' ' THR . . . . . . . . . . . . . 18.4 m -53.97 138.78 36.13 Favored 'General case' 0 C--N 1.331 -0.239 0 CA-C-N 116.19 -0.459 . . . . 0.0 111.153 -179.519 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' F' F ' 34' ' ' GLY . . . . . . . . . . . . . . . 101.82 -17.12 55.29 Favored Glycine 0 CA--C 1.534 1.225 0 CA-C-O 119.618 -0.546 . . . . 0.0 113.191 -179.915 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' F' F ' 35' ' ' ASP . . . . . . . . . . . . . 56.7 m-20 -64.71 149.57 48.89 Favored 'General case' 0 C--O 1.232 0.14 0 CA-C-N 118.146 0.973 . . . . 0.0 111.29 179.434 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' F' F ' 36' ' ' VAL . . . . . . . . . . . . . 46.3 t -124.32 130.07 73.76 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.303 0 CA-C-N 115.698 -0.683 . . . . 0.0 109.845 179.565 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' F' F ' 37' ' ' ILE . . . . . . . . . . . . . 69.1 mt -121.97 139.42 49.05 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.219 0 CA-C-N 116.216 -0.447 . . . . 0.0 109.835 179.95 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' F' F ' 38' ' ' GLY . . . . . . . . . . . . . . . -114.41 128.88 8.41 Favored Glycine 0 CA--C 1.526 0.75 0 N-CA-C 110.943 -0.863 . . . . 0.0 110.943 -179.974 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' F' F ' 39' ' ' ILE . . . . . . . . . . . . . 70.8 mt -119.37 129.89 74.69 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.245 0 N-CA-C 109.929 -0.397 . . . . 0.0 109.929 179.059 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' F' F ' 40' ' ' SER . . . . . . . . . . . . . 22.8 t -93.74 118.9 32.03 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.437 -0.347 . . . . 0.0 110.788 175.732 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' F' F ' 41' ' ' ILE . . . . . . . . . . . . . 71.4 mt -124.76 117.06 49.2 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.269 0 CA-C-O 120.787 0.327 . . . . 0.0 110.315 178.808 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' F' F ' 42' ' ' LEU . . . . . . . . . . . . . 6.9 mp 51.04 36.93 16.52 Favored 'General case' 0 N--CA 1.463 0.21 0 CA-C-O 121.143 0.497 . . . . 0.0 111.548 178.17 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' F' F ' 43' ' ' GLY . . . . . . . . . . . . . . . 73.88 30.79 60.95 Favored Glycine 0 CA--C 1.529 0.941 0 C-N-CA 121.184 -0.531 . . . . 0.0 112.324 177.636 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' F' F ' 44' ' ' LYS . . . . . . . . . . . . . 64.1 mttp -132.5 127.21 34.71 Favored 'General case' 0 C--N 1.331 -0.233 0 N-CA-C 109.679 -0.489 . . . . 0.0 109.679 177.231 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' F' F ' 45' ' ' GLU . . . . . . . . . . . . . 80.2 tt0 -84.79 122.77 29.61 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-O 120.843 0.354 . . . . 0.0 111.215 -177.535 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' F' F ' 46' ' ' VAL . . . . . . . . . . . . . 7.6 p -122.2 126.45 74.34 Favored 'Isoleucine or valine' 0 C--O 1.233 0.186 0 N-CA-C 109.329 -0.619 . . . . 0.0 109.329 174.625 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' F' F ' 47' ' ' LYS . . . . . . . . . . . . . 93.7 mttt -100.33 130.48 46.44 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.123 -0.49 . . . . 0.0 111.342 179.871 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' F' F ' 48' ' ' PHE . . . . . . . . . . . . . 91.7 m-85 -114.21 131.79 56.34 Favored 'General case' 0 C--N 1.33 -0.267 0 N-CA-C 109.637 -0.505 . . . . 0.0 109.637 175.095 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' F' F ' 49' ' ' LYS . . . . . . . . . . . . . 37.2 tttp -109.38 139.9 43.76 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.452 -0.34 . . . . 0.0 110.542 179.846 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' F' F ' 50' ' ' VAL . . . . . . . . . . . . . 43.4 t -82.96 108.22 15.5 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.225 0 N-CA-C 109.267 -0.642 . . . . 0.0 109.267 175.513 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' F' F ' 51' ' ' VAL . . . . . . . . . . . . . 48.0 t -73.08 -53.08 19.48 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.32 0 CA-C-N 115.926 -0.579 . . . . 0.0 109.615 -174.404 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' F' F ' 52' ' ' GLN . . . . . . . . . . . . . 88.7 mt-30 -154.09 151.44 29.29 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.022 -0.535 . . . . 0.0 111.972 -177.493 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' F' F ' 53' ' ' ALA . . . . . . . . . . . . . . . -128.18 132.96 48.84 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 115.214 -0.903 . . . . 0.0 109.683 174.975 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' F' F ' 54' ' ' TYR . . . . . . . . . . . . . 25.7 t80 -129.07 108.41 18.06 Favored Pre-proline 0 CA--C 1.535 0.4 0 CA-C-O 118.327 -0.844 . . . . 0.0 110.256 179.07 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' F' F ' 55' ' ' PRO . . . . . . . . . . . . . 73.2 Cg_endo -77.16 169.0 75.4 Favored 'Cis proline' 0 N--CA 1.501 1.919 0 CA-C-N 121.853 1.698 . . . . 0.0 112.453 -5.205 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' F' F ' 56' ' ' SER . . . . . . . . . . . . . 54.3 m -116.72 130.42 24.56 Favored Pre-proline 0 CA--C 1.539 0.536 0 CA-C-O 118.413 -0.803 . . . . 0.0 109.229 174.819 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' F' F ' 57' ' ' PRO . . . . . . . . . . . . . 38.1 Cg_endo -67.15 164.65 70.31 Favored 'Cis proline' 0 N--CA 1.498 1.741 0 CA-C-N 121.991 1.747 . . . . 0.0 111.584 -0.282 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' F' F ' 58' ' ' LEU . . . . . . . . . . . . . 29.7 tp -129.75 136.2 49.35 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-N 116.26 -0.427 . . . . 0.0 110.297 179.702 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' F' F ' 59' ' ' ARG . . . . . . . . . . . . . 70.5 ttt180 -100.42 128.57 46.44 Favored 'General case' 0 C--N 1.326 -0.423 0 N-CA-C 109.188 -0.671 . . . . 0.0 109.188 176.244 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' F' F ' 60' ' ' VAL . . . . . . . . . . . . . 46.9 t -80.65 115.01 22.45 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.254 0 C-N-CA 120.588 -0.445 . . . . 0.0 110.096 -175.075 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' F' F ' 61' ' ' GLU . . . . . . . . . . . . . 95.3 mt-10 -130.99 160.53 34.29 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 115.841 -0.618 . . . . 0.0 109.758 178.221 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' F' F ' 62' ' ' ASP . . . . . . . . . . . . . 15.0 p-10 -53.25 -31.45 43.56 Favored 'General case' 0 C--N 1.327 -0.387 0 N-CA-C 111.925 0.343 . . . . 0.0 111.925 179.944 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' F' F ' 63' ' ' ARG . . . . . . . . . . . . . 39.7 mtp180 -71.86 -22.11 61.57 Favored 'General case' 0 CA--C 1.532 0.27 0 N-CA-C 112.894 0.701 . . . . 0.0 112.894 -176.095 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' F' F ' 64' ' ' THR . . . . . . . . . . . . . 34.2 m -72.73 141.13 48.16 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-O 121.013 0.435 . . . . 0.0 111.013 -175.612 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' F' F ' 65' ' ' LYS . . . . . . . . . . . . . 97.5 mttt -89.18 131.2 35.42 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 115.851 -0.613 . . . . 0.0 109.84 177.635 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' F' F ' 66' ' ' ILE . . . . . . . . . . . . . 59.9 mt -116.01 129.03 73.06 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.228 0 N-CA-C 109.798 -0.445 . . . . 0.0 109.798 179.37 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' F' F ' 67' ' ' THR . . . . . . . . . . . . . 23.8 m -127.05 142.63 51.49 Favored 'General case' 0 C--N 1.331 -0.227 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.892 -178.148 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' F' F ' 68' ' ' LEU . . . . . . . . . . . . . 6.7 mp -102.3 125.72 49.09 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.023 -0.535 . . . . 0.0 110.321 176.948 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' F' F ' 69' ' ' VAL . . . . . . . . . . . . . 44.2 t -102.07 123.73 55.48 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 CA-C-N 116.11 -0.496 . . . . 0.0 110.111 -179.889 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' F' F ' 70' ' ' THR . . . . . . . . . . . . . 78.0 p -150.07 120.34 7.32 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 115.944 -0.571 . . . . 0.0 110.088 178.401 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' F' F ' 71' ' ' HIS . . . . . . . . . . . . . 54.6 m-70 -132.43 60.04 47.88 Favored Pre-proline 0 CA--C 1.538 0.517 0 C-N-CA 120.945 -0.302 . . . . 0.0 111.449 179.711 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' F' F ' 72' ' ' PRO . . . . . . . . . . . . . 77.9 Cg_endo -88.36 144.93 5.92 Favored 'Trans proline' 0 N--CA 1.491 1.379 0 C-N-CA 121.569 1.513 . . . . 0.0 110.839 170.363 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' F' F ' 73' ' ' VAL . . . . . . . . . . . . . 24.5 m -83.51 130.55 35.62 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.231 0 CA-C-O 121.356 0.598 . . . . 0.0 110.933 -179.323 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' F' F ' 74' ' ' ASP . . . . . . . . . . . . . 12.3 t0 -99.41 124.1 44.25 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 115.404 -0.816 . . . . 0.0 108.981 176.053 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' F' F ' 75' ' ' VAL . . . . . . . . . . . . . 41.8 t -112.83 124.08 69.13 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.245 0 CA-C-O 121.072 0.463 . . . . 0.0 110.839 -174.35 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' F' F ' 76' ' ' LEU . . . . . . . . . . . . . 5.8 mp -125.76 146.87 49.59 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 115.549 -0.75 . . . . 0.0 109.638 175.394 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' F' F ' 77' ' ' GLU . . . . . . . . . . . . . 97.7 mt-10 -134.22 130.88 37.84 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-O 120.977 0.418 . . . . 0.0 110.889 -178.075 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' F' F ' 78' ' ' ALA . . . . . . . . . . . . . . . -114.47 134.21 55.18 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 115.709 -0.678 . . . . 0.0 109.502 176.806 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' F' F ' 79' ' ' LYS . . . . . . . . . . . . . 25.7 pttm -77.55 119.31 20.95 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-O 121.472 0.653 . . . . 0.0 110.792 -178.644 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' F' F ' 80' ' ' ILE . . . . . . . . . . . . . 36.6 mm -139.26 113.87 7.66 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.282 0 CA-C-N 115.546 -0.752 . . . . 0.0 109.103 -178.795 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' F' F ' 81' ' ' LYS . . . . . . . . . . . . . 24.5 pttm -114.32 128.01 56.14 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-O 120.991 0.424 . . . . 0.0 111.269 -177.252 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' F' F ' 82' ' ' GLY . . . . . . . . . . . . . . . 88.89 42.21 5.73 Favored Glycine 0 CA--C 1.527 0.794 0 N-CA-C 111.483 -0.647 . . . . 0.0 111.483 177.078 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' F' F ' 83' ' ' ILE . . . . . . . . . . . . . 72.9 mt -69.88 140.95 17.79 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 CA-C-O 120.871 0.367 . . . . 0.0 110.197 179.633 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' F' F ' 84' ' ' LYS . . . . . . . . . . . . . 54.7 tttp -101.6 -50.88 3.59 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-N 115.951 -0.568 . . . . 0.0 109.984 178.746 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' F' F ' 85' ' ' ASP . . . . . . . . . . . . . 6.5 t0 -153.71 149.26 27.31 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 115.792 -0.64 . . . . 0.0 110.402 -179.543 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' F' F ' 86' ' ' VAL . . . . . . . . . . . . . 42.1 t -132.2 129.73 60.13 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.185 0 CA-C-O 120.882 0.372 . . . . 0.0 110.319 -179.852 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' F' F ' 87' ' ' ILE . . . . . . . . . . . . . 4.9 mp -120.1 126.65 75.5 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.245 0 N-CA-C 109.548 -0.538 . . . . 0.0 109.548 176.321 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' F' F ' 88' ' ' LEU . . . . . . . . . . . . . 59.0 mt -111.59 136.9 50.17 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-O 121.103 0.478 . . . . 0.0 111.263 -177.798 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' F' F ' 89' ' ' ASP . . . . . . . . . . . . . 12.6 t70 -129.49 153.66 47.77 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 115.646 -0.706 . . . . 0.0 109.285 175.742 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' F' F ' 90' ' ' GLU . . . . . . . . . . . . . 43.6 tp10 -48.47 -33.99 10.33 Favored 'General case' 0 C--N 1.329 -0.326 0 N-CA-C 112.918 0.71 . . . . 0.0 112.918 -172.011 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' F' F ' 91' ' ' ASN . . . . . . . . . . . . . 83.3 m-20 -131.25 27.54 4.79 Favored 'General case' 0 N--CA 1.466 0.343 0 N-CA-C 112.514 0.561 . . . . 0.0 112.514 -175.381 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' F' F ' 92' ' ' LEU . . . . . . . . . . . . . 6.6 tp -166.13 150.46 7.94 Favored 'General case' 0 C--N 1.331 -0.199 0 C-N-CA 120.83 -0.348 . . . . 0.0 110.752 -179.981 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' F' F ' 93' ' ' ILE . . . . . . . . . . . . . 71.8 mt -129.03 126.14 63.95 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.216 0 N-CA-C 109.693 -0.484 . . . . 0.0 109.693 178.927 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' F' F ' 94' ' ' VAL . . . . . . . . . . . . . 44.8 t -121.8 127.16 75.39 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.258 0 N-CA-C 109.735 -0.468 . . . . 0.0 109.735 178.8 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' F' F ' 95' ' ' VAL . . . . . . . . . . . . . 42.4 t -124.16 136.3 60.86 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.25 0 CA-C-N 116.091 -0.504 . . . . 0.0 110.054 -178.361 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' F' F ' 96' ' ' ILE . . . . . . . . . . . . . 47.3 mt -118.27 130.93 72.41 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.235 0 N-CA-C 109.37 -0.604 . . . . 0.0 109.37 179.306 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' F' F ' 97' ' ' THR . . . . . . . . . . . . . 67.3 p -103.16 157.21 17.16 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-O 121.1 0.476 . . . . 0.0 111.101 -178.586 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' F' F ' 98' ' ' GLU . . . . . . . . . . . . . 96.5 mt-10 -53.84 -26.01 22.35 Favored 'General case' 0 C--N 1.328 -0.354 0 N-CA-C 112.424 0.527 . . . . 0.0 112.424 -178.79 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' F' F ' 99' ' ' GLU . . . . . . . . . . . . . 95.7 mt-10 -79.62 16.8 1.0 Allowed 'General case' 0 CA--C 1.534 0.352 0 N-CA-C 113.213 0.82 . . . . 0.0 113.213 -176.126 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' F' F ' 100' ' ' ASN . . . . . . . . . . . . . 3.6 m-20 62.72 37.4 12.68 Favored 'General case' 0 C--O 1.234 0.24 0 CA-C-O 121.212 0.53 . . . . 0.0 111.038 178.136 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' F' F ' 101' ' ' GLU . . . . . . . . . . . . . 84.5 tt0 -117.65 139.85 50.44 Favored 'General case' 0 C--N 1.333 -0.142 0 N-CA-C 109.378 -0.601 . . . . 0.0 109.378 176.217 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' F' F ' 102' ' ' VAL . . . . . . . . . . . . . 45.0 t -117.57 129.89 73.32 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 N-CA-C 109.847 -0.427 . . . . 0.0 109.847 -177.377 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' F' F ' 103' ' ' LEU . . . . . . . . . . . . . 4.7 mp -123.09 137.99 54.78 Favored 'General case' 0 C--N 1.331 -0.219 0 CA-C-N 116.144 -0.48 . . . . 0.0 110.715 178.288 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' F' F ' 104' ' ' ILE . . . . . . . . . . . . . 65.5 mt -117.8 124.7 73.44 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.255 0 CA-C-N 115.802 -0.635 . . . . 0.0 109.882 179.989 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' F' F ' 105' ' ' PHE . . . . . . . . . . . . . 89.9 m-85 -122.43 161.47 23.45 Favored 'General case' 0 C--N 1.332 -0.187 0 O-C-N 123.969 0.793 . . . . 0.0 109.817 179.458 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' F' F ' 106' ' ' ASN . . . . . . . . . . . . . 47.2 p-10 -97.5 -171.35 2.17 Favored 'General case' 0 C--N 1.331 -0.209 0 N-CA-C 109.932 -0.396 . . . . 0.0 109.932 173.132 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' F' F ' 107' ' ' GLN . . . . . . . . . . . . . 48.4 tt0 -57.3 -30.12 64.47 Favored 'General case' 0 C--N 1.328 -0.348 0 N-CA-C 112.043 0.386 . . . . 0.0 112.043 -179.188 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' F' F ' 108' ' ' ASN . . . . . . . . . . . . . 13.0 t-20 -88.73 14.02 11.09 Favored 'General case' 0 CA--C 1.534 0.349 0 N-CA-C 112.973 0.731 . . . . 0.0 112.973 -175.612 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' F' F ' 109' ' ' LEU . . . . . . . . . . . . . 33.5 mt 57.97 33.4 23.15 Favored 'General case' 0 C--O 1.233 0.19 0 N-CA-C 111.756 0.28 . . . . 0.0 111.756 179.247 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' F' F ' 110' ' ' GLU . . . . . . . . . . . . . 43.3 mt-10 -98.05 145.24 26.73 Favored 'General case' 0 C--N 1.33 -0.277 0 N-CA-C 109.594 -0.521 . . . . 0.0 109.594 175.924 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' F' F ' 111' ' ' GLU . . . . . . . . . . . . . 53.7 tt0 -81.24 122.02 26.89 Favored 'General case' 0 C--N 1.328 -0.351 0 C-N-CA 120.725 -0.39 . . . . 0.0 110.487 -176.992 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' F' F ' 112' ' ' LEU . . . . . . . . . . . . . 58.2 mt -106.53 -46.09 4.09 Favored 'General case' 0 C--N 1.331 -0.226 0 CA-C-N 116.135 -0.484 . . . . 0.0 110.42 178.178 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' F' F ' 113' ' ' TYR . . . . . . . . . . . . . 64.6 t80 -138.36 137.08 36.98 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.134 -0.485 . . . . 0.0 111.169 -179.017 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' F' F ' 114' ' ' ARG . . . . . . . . . . . . . 56.1 ttp180 -141.45 121.29 13.55 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.277 -0.419 . . . . 0.0 109.949 174.848 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' F' F ' 115' ' ' GLY . . . . . . . . . . . . . . . -148.52 160.96 28.54 Favored Glycine 0 CA--C 1.524 0.595 0 N-CA-C 111.069 -0.812 . . . . 0.0 111.069 179.826 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' F' F ' 116' ' ' LYS . . . . . . . . . . . . . 40.2 ttpt -124.36 141.93 51.69 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-O 120.64 0.257 . . . . 0.0 110.385 -179.901 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' F' F ' 117' ' ' PHE . . . . . . . . . . . . . 47.4 m-85 -135.24 113.9 11.76 Favored 'General case' 0 C--N 1.332 -0.184 0 CA-C-O 120.907 0.384 . . . . 0.0 110.019 179.459 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' F' F ' 118' ' ' GLU . . . . . . . . . . . . . 82.1 tt0 -53.95 -51.69 63.03 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.457 -0.338 . . . . 0.0 111.376 -176.348 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' F' F ' 119' ' ' ASN . . . . . . . . . . . . . 87.6 m-20 -93.84 31.19 1.65 Allowed 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.052 -0.522 . . . . 0.0 112.19 -174.712 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' F' F ' 120' ' ' LEU . . . . . . . . . . . . . 12.9 tp -54.2 124.08 14.69 Favored 'General case' 0 N--CA 1.462 0.153 0 CA-C-O 120.624 0.249 . . . . 0.0 110.738 178.348 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' F' F ' 121' ' ' ASN . . . . . . . . . . . . . 12.4 m120 -112.15 -44.06 3.47 Favored 'General case' 0 C--O 1.232 0.137 0 CA-C-N 116.62 -0.264 . . . . 0.0 110.944 -176.679 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' F' F ' 122' ' ' LYS . . . . . . . . . . . . . 98.2 mttt -146.66 143.16 28.57 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-O 120.917 0.389 . . . . 0.0 111.387 -178.875 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' F' F ' 123' ' ' VAL . . . . . . . . . . . . . 46.5 t -126.77 127.43 70.01 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.314 0 N-CA-C 109.19 -0.67 . . . . 0.0 109.19 175.049 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' F' F ' 124' ' ' LEU . . . . . . . . . . . . . 13.9 tp -134.05 140.05 46.41 Favored 'General case' 0 C--N 1.331 -0.227 0 CA-C-O 120.947 0.403 . . . . 0.0 110.805 -176.797 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' F' F ' 125' ' ' VAL . . . . . . . . . . . . . 12.2 p -131.51 140.03 49.26 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.215 0 CA-C-N 116.239 -0.437 . . . . 0.0 110.335 178.492 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' F' F ' 126' ' ' ARG . . . . . . . . . . . . . 96.6 mtt-85 -136.97 124.24 21.85 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.064 -0.516 . . . . 0.0 110.402 179.297 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' F' F ' 127' ' ' ASN . . . . . . . . . . . . . 67.7 m-80 52.02 -106.46 0.27 Allowed 'General case' 0 CA--C 1.544 0.73 0 CA-C-O 119.044 -0.503 . . . . 0.0 111.104 179.997 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' F' F ' 128' ' ' ASP . . . . . . . . . . . . . 8.1 p-10 -114.09 1.67 14.68 Favored 'General case' 0 CA--C 1.536 0.414 0 CA-C-N 119.629 1.104 . . . . 0.0 113.459 -177.86 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' F' F ' 129' ' ' LEU . . . . . . . . . . . . . 29.3 mt -107.35 145.12 33.26 Favored 'General case' 0 C--N 1.333 -0.11 0 O-C-N 121.962 -0.461 . . . . 0.0 110.383 -178.571 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' F' F ' 130' ' ' VAL . . . . . . . . . . . . . 43.3 t -122.18 136.31 59.44 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.231 0 CA-C-O 120.909 0.385 . . . . 0.0 110.072 -178.109 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' F' F ' 131' ' ' VAL . . . . . . . . . . . . . 42.4 t -131.69 133.61 61.27 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.247 0 CA-C-N 116.209 -0.451 . . . . 0.0 109.812 177.651 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' F' F ' 132' ' ' ILE . . . . . . . . . . . . . 71.0 mt -119.68 132.14 70.25 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.317 0 CA-C-N 115.966 -0.561 . . . . 0.0 109.536 -179.143 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' F' F ' 133' ' ' ILE . . . . . . . . . . . . . 37.4 mm -116.84 123.39 71.69 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.331 0 CA-C-O 120.916 0.388 . . . . 0.0 110.855 -175.274 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' F' F ' 134' ' ' ASP . . . . . . . . . . . . . 9.3 p-10 -134.07 149.12 51.12 Favored 'General case' 0 C--N 1.329 -0.298 0 N-CA-C 109.606 -0.516 . . . . 0.0 109.606 174.661 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' F' F ' 135' ' ' GLU . . . . . . . . . . . . . 84.3 tt0 -49.87 -26.58 4.19 Favored 'General case' 0 C--N 1.327 -0.386 0 N-CA-C 112.71 0.633 . . . . 0.0 112.71 -173.283 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' F' F ' 136' ' ' GLN . . . . . . . . . . . . . 36.3 tt0 -84.72 -36.47 21.8 Favored 'General case' 0 C--O 1.234 0.289 0 N-CA-C 112.19 0.441 . . . . 0.0 112.19 -174.729 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' F' F ' 137' ' ' LYS . . . . . . . . . . . . . 20.4 pttp -163.08 171.7 16.02 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-O 121.539 0.685 . . . . 0.0 112.375 -171.32 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' F' F ' 138' ' ' LEU . . . . . . . . . . . . . 3.9 tt -116.33 127.64 54.86 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 114.995 -1.002 . . . . 0.0 109.661 178.808 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' F' F ' 139' ' ' THR . . . . . . . . . . . . . 28.4 m -108.46 127.82 54.25 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-O 120.772 0.32 . . . . 0.0 110.676 -179.88 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' F' F ' 140' ' ' LEU . . . . . . . . . . . . . 10.0 tp -113.57 120.48 41.11 Favored 'General case' 0 C--N 1.328 -0.339 0 N-CA-C 109.175 -0.676 . . . . 0.0 109.175 -179.367 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' F' F ' 141' ' ' ILE . . . . . . . . . . . . . 18.9 mt -120.56 118.36 56.29 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.299 0 CA-C-O 120.986 0.422 . . . . 0.0 109.966 -174.76 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' F' F ' 142' ' ' ARG . . . . . . . . . . . . . 83.9 mtm180 -108.86 128.18 54.69 Favored 'General case' 0 C--N 1.332 -0.19 0 CA-C-N 115.543 -0.753 . . . . 0.0 110.318 -179.255 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' F' F ' 143' ' ' THR . . . . . . . . . . . . . 22.6 p . . . . . 0 C--O 1.22 -0.462 0 CA-C-O 117.94 -1.028 . . . . 0.0 110.669 -179.42 . . . . . . . . 0 0 . 1 . 004 nuclear orig full ' A' A ' -3' ' ' GLU . . . . . . . . . . . . . 42.4 mp0 . . . . . 0 N--CA 1.489 1.52 0 N-CA-C 109.361 -0.607 . . . . 0.0 109.361 . . . . . . . . . 0 0 . 1 . 004 nuclear orig full ' A' A ' -2' ' ' GLY . . . . . . . . . . . . . . . -97.81 142.01 15.91 Favored Glycine 0 CA--C 1.525 0.715 0 N-CA-C 111.099 -0.801 . . . . 0.0 111.099 -179.616 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' -1' ' ' VAL . . . . . . . . . . . . . 42.7 t -142.32 147.8 20.88 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.4 0 N-CA-C 109.929 -0.397 . . . . 0.0 109.929 179.652 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 0' ' ' ILE . . . . . . . . . . . . . 42.9 mm -96.67 131.93 42.27 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.284 0 CA-C-N 116.256 -0.429 . . . . 0.0 110.282 -179.604 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 24.9 ptp -80.27 146.85 31.44 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.136 -0.484 . . . . 0.0 110.636 -179.953 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 3.8 p -122.93 130.14 52.46 Favored 'General case' 0 N--CA 1.463 0.206 0 CA-C-O 121.065 0.459 . . . . 0.0 110.875 -179.202 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 95.6 mt-10 -140.32 139.57 35.46 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 115.737 -0.665 . . . . 0.0 110.904 -179.974 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 4' ' ' LEU . . . . . . . . . . . . . 18.6 tp -125.91 129.54 49.52 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 115.922 -0.581 . . . . 0.0 110.19 177.641 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 5' ' ' LYS . . . . . . . . . . . . . 64.0 mttp -111.65 121.12 44.29 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.393 -0.367 . . . . 0.0 110.784 179.892 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 18.8 mt -114.09 148.17 37.55 Favored 'General case' 0 C--N 1.332 -0.193 0 CA-C-N 115.52 -0.764 . . . . 0.0 109.771 179.449 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 48.4 tttp -126.09 137.88 31.06 Favored Pre-proline 0 CA--C 1.533 0.3 0 CA-C-O 118.863 -0.589 . . . . 0.0 109.842 174.954 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 8' ' ' PRO . . . . . . . . . . . . . 91.6 Cg_endo -90.51 134.93 2.02 Favored 'Trans proline' 0 N--CA 1.489 1.219 0 C-N-CA 121.729 1.619 . . . . 0.0 111.791 179.182 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 22.1 mt -80.16 -47.92 1.33 Allowed Pre-proline 0 CA--C 1.533 0.307 0 CA-C-O 118.654 -0.688 . . . . 0.0 112.238 -178.844 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 90.8 Cg_endo -79.53 152.26 22.98 Favored 'Trans proline' 0 N--CA 1.497 1.677 0 C-N-CA 121.065 1.176 . . . . 0.0 111.914 176.977 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 22.9 tptm -84.35 92.38 8.01 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.39 -0.368 . . . . 0.0 110.312 178.841 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 12.0 p -139.97 144.11 28.77 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.339 0 CA-C-N 116.151 -0.477 . . . . 0.0 110.441 179.957 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 95.5 mt-10 -89.18 122.23 32.26 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.339 -0.391 . . . . 0.0 110.194 178.063 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 14' ' ' LEU . . . . . . . . . . . . . 28.5 mt -93.91 144.77 28.67 Favored Pre-proline 0 C--N 1.329 -0.29 0 CA-C-O 118.971 -0.538 . . . . 0.0 109.99 -179.354 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 15' ' ' PRO . . . . . . . . . . . . . 31.0 Cg_exo -59.53 159.92 22.19 Favored 'Trans proline' 0 N--CA 1.498 1.757 0 C-N-CA 121.256 1.304 . . . . 0.0 111.713 179.095 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 16' ' ' PRO . . . . . . . . . . . . . 37.0 Cg_exo -58.59 -41.21 66.64 Favored 'Trans proline' 0 N--CA 1.496 1.648 0 C-N-CA 121.477 1.451 . . . . 0.0 112.757 -178.226 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 17' ' ' ASP . . . . . . . . . . . . . 19.1 p-10 -82.34 6.14 18.0 Favored 'General case' 0 CA--C 1.536 0.434 0 N-CA-C 113.274 0.842 . . . . 0.0 113.274 -178.008 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 18' ' ' PHE . . . . . . . . . . . . . 58.1 t80 -57.99 -45.18 87.22 Favored 'General case' 0 C--N 1.334 -0.084 0 O-C-N 121.938 -0.476 . . . . 0.0 110.119 -178.389 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 19' ' ' VAL . . . . . . . . . . . . . 48.3 t -56.33 -43.77 77.98 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.297 0 CA-C-N 116.291 -0.413 . . . . 0.0 110.628 -177.959 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 80.6 m-20 -60.31 -42.61 95.93 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.497 -0.32 . . . . 0.0 110.964 -178.068 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 45.6 t -64.01 -46.48 93.79 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.282 0 C-N-CA 120.846 -0.342 . . . . 0.0 110.56 -177.711 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 22' ' ' ILE . . . . . . . . . . . . . 50.8 mm -55.54 -46.02 78.85 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.241 0 CA-C-O 120.727 0.299 . . . . 0.0 110.549 178.649 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 23' ' ' ARG . . . . . . . . . . . . . 53.7 ttp180 -53.36 -49.15 67.74 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-O 120.711 0.291 . . . . 0.0 111.412 179.959 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 24' ' ' ILE . . . . . . . . . . . . . 73.9 mt -58.81 -40.54 80.18 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.306 0 CA-C-N 116.483 -0.326 . . . . 0.0 111.133 -178.345 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 51.4 mttm -70.91 -37.54 72.94 Favored 'General case' 0 C--N 1.329 -0.308 0 N-CA-C 112.511 0.56 . . . . 0.0 112.511 -178.272 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 67.6 mt -78.73 -35.85 44.14 Favored 'General case' 0 C--N 1.33 -0.265 0 N-CA-C 113.199 0.814 . . . . 0.0 113.199 -170.062 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 27' ' ' GLN . . . . . . . . . . . . . 7.3 pt20 -46.57 135.98 8.07 Favored 'General case' 0 N--CA 1.468 0.426 0 N-CA-C 112.822 0.675 . . . . 0.0 112.822 -176.319 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 101.15 -20.69 46.35 Favored Glycine 0 CA--C 1.535 1.294 0 CA-C-N 115.759 -0.655 . . . . 0.0 112.644 -177.84 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 56.5 mtpt -97.12 155.11 16.96 Favored 'General case' 0 C--O 1.233 0.196 0 CA-C-N 117.695 0.747 . . . . 0.0 111.061 178.84 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 30' ' ' THR . . . . . . . . . . . . . 44.5 m -106.96 133.76 51.13 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 115.95 -0.568 . . . . 0.0 109.613 174.356 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 34.7 m -128.81 153.19 38.02 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.241 0 CA-C-O 121.017 0.437 . . . . 0.0 110.961 -177.43 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 32' ' ' ARG . . . . . . . . . . . . . 96.9 mtt180 -132.81 150.92 52.11 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 115.897 -0.592 . . . . 0.0 110.623 179.365 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 33' ' ' THR . . . . . . . . . . . . . 12.5 m -53.03 139.01 29.23 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.232 -0.44 . . . . 0.0 111.295 -178.638 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 100.65 -17.14 56.99 Favored Glycine 0 CA--C 1.532 1.109 0 C-N-CA 121.205 -0.521 . . . . 0.0 113.232 179.275 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 54.4 m-20 -64.48 151.07 45.3 Favored 'General case' 0 C--O 1.232 0.136 0 CA-C-N 118.099 0.949 . . . . 0.0 111.308 -179.621 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 47.5 t -125.04 128.33 72.96 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.258 0 CA-C-N 115.767 -0.651 . . . . 0.0 109.621 178.223 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 37' ' ' ILE . . . . . . . . . . . . . 64.1 mt -123.41 140.43 47.03 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.173 0 CA-C-N 116.29 -0.414 . . . . 0.0 110.039 -178.656 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . -115.07 128.77 8.26 Favored Glycine 0 CA--C 1.526 0.752 0 N-CA-C 110.815 -0.914 . . . . 0.0 110.815 178.179 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 39' ' ' ILE . . . . . . . . . . . . . 74.5 mt -126.42 138.08 55.79 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.221 0 CA-C-O 120.75 0.31 . . . . 0.0 110.205 -179.907 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 40' ' ' SER . . . . . . . . . . . . . 35.1 t -91.51 113.94 26.34 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.616 175.491 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 41' ' ' ILE . . . . . . . . . . . . . 45.3 mm -119.66 119.99 62.08 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.214 0 CA-C-O 120.76 0.314 . . . . 0.0 110.415 -179.852 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 37.3 mt 52.74 35.08 17.62 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.192 -0.458 . . . . 0.0 111.744 177.007 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . 73.25 31.0 61.91 Favored Glycine 0 CA--C 1.529 0.947 0 C-N-CA 121.106 -0.569 . . . . 0.0 112.264 177.976 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 44' ' ' LYS . . . . . . . . . . . . . 21.0 tptp -141.36 130.8 23.79 Favored 'General case' 0 C--N 1.329 -0.315 0 N-CA-C 109.548 -0.538 . . . . 0.0 109.548 178.142 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 82.7 tt0 -81.53 121.62 26.53 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-O 120.883 0.373 . . . . 0.0 111.277 -176.397 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 46' ' ' VAL . . . . . . . . . . . . . 9.0 p -119.61 124.5 73.02 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.175 0 N-CA-C 109.564 -0.532 . . . . 0.0 109.564 175.754 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 97.7 mttt -98.83 128.71 45.11 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 116.09 -0.505 . . . . 0.0 110.843 178.326 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 48' ' ' PHE . . . . . . . . . . . . . 30.1 m-85 -113.63 131.81 55.99 Favored 'General case' 0 C--N 1.33 -0.267 0 N-CA-C 109.86 -0.422 . . . . 0.0 109.86 177.862 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 83.1 tttt -107.24 135.79 48.16 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 116.39 -0.368 . . . . 0.0 110.193 177.629 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 50' ' ' VAL . . . . . . . . . . . . . 43.9 t -79.52 107.64 12.17 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.33 0 N-CA-C 109.682 -0.488 . . . . 0.0 109.682 178.228 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 51' ' ' VAL . . . . . . . . . . . . . 47.5 t -72.51 -51.95 26.07 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.354 0 CA-C-N 115.872 -0.604 . . . . 0.0 109.619 -176.046 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 52' ' ' GLN . . . . . . . . . . . . . 63.0 mt-30 -155.59 147.62 23.44 Favored 'General case' 0 C--N 1.331 -0.225 0 C-N-CA 120.346 -0.541 . . . . 0.0 111.698 -177.672 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -124.38 132.08 53.52 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 115.231 -0.895 . . . . 0.0 109.419 174.512 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 54' ' ' TYR . . . . . . . . . . . . . 38.3 t80 -129.03 110.69 18.34 Favored Pre-proline 0 CA--C 1.535 0.368 0 CA-C-O 118.181 -0.914 . . . . 0.0 110.353 179.836 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 55' ' ' PRO . . . . . . . . . . . . . 73.8 Cg_endo -77.15 170.01 72.71 Favored 'Cis proline' 0 N--CA 1.501 1.914 0 CA-C-N 121.947 1.731 . . . . 0.0 112.335 -6.405 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 56' ' ' SER . . . . . . . . . . . . . 13.6 m -117.48 132.73 23.43 Favored Pre-proline 0 CA--C 1.539 0.555 0 CA-C-O 118.476 -0.773 . . . . 0.0 109.487 175.185 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 57' ' ' PRO . . . . . . . . . . . . . 43.5 Cg_endo -69.53 148.59 86.52 Favored 'Cis proline' 0 N--CA 1.498 1.785 0 CA-C-N 121.823 1.687 . . . . 0.0 111.348 -2.082 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 58' ' ' LEU . . . . . . . . . . . . . 19.0 tp -107.65 135.83 48.44 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.327 -0.397 . . . . 0.0 110.591 -178.168 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 59' ' ' ARG . . . . . . . . . . . . . 23.0 ttm180 -102.83 123.54 46.68 Favored 'General case' 0 C--N 1.327 -0.4 0 N-CA-C 109.293 -0.632 . . . . 0.0 109.293 175.751 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 40.5 t -82.14 119.8 32.38 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.359 0 CA-C-O 120.933 0.396 . . . . 0.0 110.807 -174.067 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 95.6 mt-10 -130.98 165.33 23.41 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 115.817 -0.629 . . . . 0.0 109.417 175.12 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 62' ' ' ASP . . . . . . . . . . . . . 64.1 m-20 -52.37 -32.01 36.44 Favored 'General case' 0 C--N 1.328 -0.332 0 N-CA-C 111.948 0.351 . . . . 0.0 111.948 -178.548 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 63' ' ' ARG . . . . . . . . . . . . . 74.4 mtt180 -73.41 -21.96 60.35 Favored 'General case' 0 CA--C 1.533 0.291 0 N-CA-C 112.84 0.682 . . . . 0.0 112.84 -175.719 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 30.6 m -69.52 134.58 49.04 Favored 'General case' 0 C--N 1.331 -0.208 0 CA-C-O 120.787 0.327 . . . . 0.0 110.952 -175.823 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 65' ' ' LYS . . . . . . . . . . . . . 57.6 mtmt -90.55 133.77 34.85 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.52 179.206 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 66' ' ' ILE . . . . . . . . . . . . . 65.4 mt -117.12 131.14 70.7 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.234 0 N-CA-C 109.995 -0.372 . . . . 0.0 109.995 -179.84 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 67' ' ' THR . . . . . . . . . . . . . 31.6 m -127.19 143.55 51.23 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.876 -178.645 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 68' ' ' LEU . . . . . . . . . . . . . 15.4 tp -105.71 131.36 53.16 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 116.119 -0.491 . . . . 0.0 110.127 177.596 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 69' ' ' VAL . . . . . . . . . . . . . 42.3 t -86.01 135.18 25.56 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.364 0 CA-C-N 116.128 -0.487 . . . . 0.0 110.488 -178.109 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 70' ' ' THR . . . . . . . . . . . . . 4.0 m -87.86 167.42 13.8 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 115.833 -0.621 . . . . 0.0 109.943 177.316 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 71' ' ' HIS . . . . . . . . . . . . . 44.3 m80 -64.93 145.63 98.98 Favored Pre-proline 0 CA--C 1.534 0.328 0 N-CA-C 109.814 -0.439 . . . . 0.0 109.814 -179.959 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 72' ' ' PRO . . . . . . . . . . . . . 72.9 Cg_endo -77.39 -27.63 6.27 Favored 'Trans proline' 0 N--CA 1.493 1.498 0 C-N-CA 121.326 1.35 . . . . 0.0 112.707 -178.644 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 73' ' ' VAL . . . . . . . . . . . . . 35.7 m -130.27 162.89 37.27 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.184 0 CA-C-O 121.046 0.45 . . . . 0.0 110.887 -178.68 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 74' ' ' ASP . . . . . . . . . . . . . 7.1 t70 -101.64 125.87 48.38 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 115.741 -0.663 . . . . 0.0 109.806 178.939 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 42.7 t -113.94 125.04 71.15 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.268 0 CA-C-O 121.154 0.502 . . . . 0.0 110.508 -177.424 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 76' ' ' LEU . . . . . . . . . . . . . 37.7 mt -125.77 140.08 52.98 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 115.578 -0.737 . . . . 0.0 109.73 177.787 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 77' ' ' GLU . . . . . . . . . . . . . 45.9 mt-10 -132.75 136.41 46.34 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-O 120.983 0.42 . . . . 0.0 111.193 -178.751 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 78' ' ' ALA . . . . . . . . . . . . . . . -124.92 136.96 54.25 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-N 115.76 -0.654 . . . . 0.0 110.01 177.128 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 79' ' ' LYS . . . . . . . . . . . . . 74.6 mmtt -78.86 119.55 22.22 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-O 120.808 0.337 . . . . 0.0 110.516 -178.54 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 80' ' ' ILE . . . . . . . . . . . . . 24.2 mm -139.27 113.33 7.05 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.267 0 N-CA-C 109.303 -0.629 . . . . 0.0 109.303 -177.237 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 81' ' ' LYS . . . . . . . . . . . . . 38.5 ttpt -105.86 124.24 49.26 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-O 120.855 0.36 . . . . 0.0 111.226 -177.809 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . 89.12 42.16 5.67 Favored Glycine 0 CA--C 1.525 0.663 0 C-N-CA 120.758 -0.734 . . . . 0.0 111.886 173.655 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 83' ' ' ILE . . . . . . . . . . . . . 72.1 mt -65.64 132.79 31.26 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 CA-C-O 120.973 0.416 . . . . 0.0 110.019 178.185 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 84' ' ' LYS . . . . . . . . . . . . . 30.3 ttmt -91.87 -50.67 5.6 Favored 'General case' 0 C--N 1.331 -0.204 0 CA-C-N 116.067 -0.515 . . . . 0.0 109.883 179.493 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 85' ' ' ASP . . . . . . . . . . . . . 5.7 t70 -159.75 157.0 28.6 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 115.715 -0.675 . . . . 0.0 110.474 179.73 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 86' ' ' VAL . . . . . . . . . . . . . 42.1 t -127.86 132.46 68.78 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.221 0 CA-C-O 121.049 0.452 . . . . 0.0 110.457 -179.038 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 87' ' ' ILE . . . . . . . . . . . . . 43.2 mm -119.64 124.4 72.82 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.216 0 CA-C-N 115.863 -0.608 . . . . 0.0 109.731 177.463 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 88' ' ' LEU . . . . . . . . . . . . . 50.5 mt -108.42 136.68 47.64 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-O 120.986 0.422 . . . . 0.0 111.286 -178.521 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 89' ' ' ASP . . . . . . . . . . . . . 6.5 t70 -130.41 155.36 46.53 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 115.72 -0.673 . . . . 0.0 109.546 176.177 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 96.2 mt-10 -47.29 -36.66 9.51 Favored 'General case' 0 C--N 1.33 -0.253 0 N-CA-C 113.099 0.777 . . . . 0.0 113.099 -172.148 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 91' ' ' ASN . . . . . . . . . . . . . 35.9 t30 -132.1 21.24 4.48 Favored 'General case' 0 N--CA 1.467 0.417 0 N-CA-C 112.95 0.722 . . . . 0.0 112.95 -177.429 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 92' ' ' LEU . . . . . . . . . . . . . 20.2 mt -151.25 150.43 30.56 Favored 'General case' 0 C--N 1.333 -0.152 0 N-CA-C 110.138 -0.319 . . . . 0.0 110.138 -176.597 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 93' ' ' ILE . . . . . . . . . . . . . 76.2 mt -129.09 120.41 51.57 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.186 0 N-CA-C 109.325 -0.62 . . . . 0.0 109.325 176.159 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 94' ' ' VAL . . . . . . . . . . . . . 43.2 t -118.02 127.01 75.3 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.282 0 N-CA-C 109.68 -0.489 . . . . 0.0 109.68 -179.863 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 95' ' ' VAL . . . . . . . . . . . . . 42.8 t -120.78 135.08 62.11 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.36 0 CA-C-N 116.171 -0.468 . . . . 0.0 109.819 -179.258 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 96' ' ' ILE . . . . . . . . . . . . . 58.6 mt -113.99 128.23 71.03 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.338 0 N-CA-C 109.258 -0.645 . . . . 0.0 109.258 179.594 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 97' ' ' THR . . . . . . . . . . . . . 70.6 p -99.67 154.12 18.54 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-O 120.856 0.36 . . . . 0.0 110.686 -179.09 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 98' ' ' GLU . . . . . . . . . . . . . 96.0 mt-10 -54.76 -23.21 16.86 Favored 'General case' 0 CA--C 1.533 0.319 0 N-CA-C 112.451 0.537 . . . . 0.0 112.451 -179.701 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 99' ' ' GLU . . . . . . . . . . . . . 43.0 mt-10 -79.6 16.14 1.16 Allowed 'General case' 0 CA--C 1.535 0.379 0 N-CA-C 113.05 0.759 . . . . 0.0 113.05 -179.458 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 100' ' ' ASN . . . . . . . . . . . . . 3.6 m-20 63.57 37.97 9.97 Favored 'General case' 0 CA--C 1.529 0.144 0 CA-C-O 121.05 0.452 . . . . 0.0 110.967 177.694 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 101' ' ' GLU . . . . . . . . . . . . . 83.0 tt0 -114.38 142.36 46.45 Favored 'General case' 0 C--N 1.332 -0.162 0 CA-C-N 116.118 -0.492 . . . . 0.0 109.731 176.618 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 102' ' ' VAL . . . . . . . . . . . . . 43.6 t -115.14 123.72 71.04 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 N-CA-C 109.693 -0.484 . . . . 0.0 109.693 -179.731 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 103' ' ' LEU . . . . . . . . . . . . . 36.4 mt -116.57 130.6 56.84 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 115.877 -0.601 . . . . 0.0 110.05 178.294 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 104' ' ' ILE . . . . . . . . . . . . . 65.5 mt -115.35 118.95 60.41 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.324 0 N-CA-C 109.934 -0.395 . . . . 0.0 109.934 -179.591 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 105' ' ' PHE . . . . . . . . . . . . . 96.9 m-85 -118.29 162.86 17.57 Favored 'General case' 0 C--O 1.233 0.192 0 O-C-N 124.061 0.851 . . . . 0.0 110.079 -178.643 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 106' ' ' ASN . . . . . . . . . . . . . 53.2 p-10 -96.36 -169.95 2.0 Favored 'General case' 0 C--N 1.329 -0.285 0 N-CA-C 109.297 -0.631 . . . . 0.0 109.297 170.664 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 107' ' ' GLN . . . . . . . . . . . . . 44.1 tt0 -57.82 -27.53 63.25 Favored 'General case' 0 C--N 1.328 -0.335 0 N-CA-C 112.405 0.52 . . . . 0.0 112.405 -178.067 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 108' ' ' ASN . . . . . . . . . . . . . 19.6 t30 -94.63 14.25 21.65 Favored 'General case' 0 CA--C 1.534 0.333 0 N-CA-C 113.033 0.753 . . . . 0.0 113.033 -175.149 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 109' ' ' LEU . . . . . . . . . . . . . 91.4 mt 60.4 34.65 20.6 Favored 'General case' 0 CA--C 1.529 0.162 0 CA-C-O 120.756 0.312 . . . . 0.0 111.679 178.169 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 110' ' ' GLU . . . . . . . . . . . . . 96.2 mt-10 -101.47 141.16 34.75 Favored 'General case' 0 C--N 1.33 -0.265 0 N-CA-C 109.717 -0.475 . . . . 0.0 109.717 175.973 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 111' ' ' GLU . . . . . . . . . . . . . 96.4 mt-10 -73.13 121.86 20.91 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-O 120.945 0.402 . . . . 0.0 111.242 -176.719 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 112' ' ' LEU . . . . . . . . . . . . . 17.3 mt -103.43 -45.04 4.98 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 115.861 -0.608 . . . . 0.0 109.737 173.718 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 113' ' ' TYR . . . . . . . . . . . . . 61.8 t80 -142.03 142.48 32.89 Favored 'General case' 0 C--N 1.331 -0.224 0 CA-C-N 115.8 -0.636 . . . . 0.0 110.158 178.251 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 114' ' ' ARG . . . . . . . . . . . . . 33.6 ptt180 -150.65 123.59 8.71 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-O 120.957 0.408 . . . . 0.0 110.966 178.699 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 115' ' ' GLY . . . . . . . . . . . . . . . -150.2 163.03 29.4 Favored Glycine 0 CA--C 1.524 0.624 0 N-CA-C 110.664 -0.974 . . . . 0.0 110.664 -179.385 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 116' ' ' LYS . . . . . . . . . . . . . 29.8 ttmt -127.51 136.23 51.46 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-O 120.883 0.373 . . . . 0.0 110.185 178.604 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 117' ' ' PHE . . . . . . . . . . . . . 43.0 m-85 -131.44 115.15 15.81 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.12 -0.491 . . . . 0.0 110.161 -177.051 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 118' ' ' GLU . . . . . . . . . . . . . 96.2 mt-10 -54.0 -42.08 68.65 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.564 -0.289 . . . . 0.0 111.356 -176.895 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 119' ' ' ASN . . . . . . . . . . . . . 33.6 m120 -99.75 31.02 3.38 Favored 'General case' 0 CA--C 1.531 0.215 0 N-CA-C 112.132 0.419 . . . . 0.0 112.132 -174.809 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 120' ' ' LEU . . . . . . . . . . . . . 13.4 tp -56.83 121.19 9.28 Favored 'General case' 0 C--N 1.332 -0.177 0 CA-C-O 120.756 0.312 . . . . 0.0 110.562 178.41 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 121' ' ' ASN . . . . . . . . . . . . . 6.2 m120 -113.97 -44.01 3.2 Favored 'General case' 0 C--N 1.331 -0.204 0 CA-C-N 116.324 -0.398 . . . . 0.0 110.876 -178.981 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 122' ' ' LYS . . . . . . . . . . . . . 63.9 mtpt -139.68 144.54 37.64 Favored 'General case' 0 C--N 1.331 -0.211 0 CA-C-O 120.972 0.415 . . . . 0.0 111.631 -175.989 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 123' ' ' VAL . . . . . . . . . . . . . 45.2 t -131.36 122.52 51.02 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.305 0 N-CA-C 109.126 -0.694 . . . . 0.0 109.126 172.788 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 124' ' ' LEU . . . . . . . . . . . . . 14.3 tp -127.87 136.04 50.85 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-O 120.82 0.343 . . . . 0.0 110.813 -176.057 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 125' ' ' VAL . . . . . . . . . . . . . 12.6 p -134.03 137.01 52.88 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.205 0 CA-C-N 116.288 -0.414 . . . . 0.0 110.412 178.938 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 126' ' ' ARG . . . . . . . . . . . . . 26.3 mmt180 -141.77 124.99 16.39 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.118 -0.492 . . . . 0.0 110.368 179.43 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 127' ' ' ASN . . . . . . . . . . . . . 81.8 m-20 51.87 -105.02 0.2 Allowed 'General case' 0 CA--C 1.543 0.691 0 CA-C-N 115.982 -0.554 . . . . 0.0 111.356 178.949 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 128' ' ' ASP . . . . . . . . . . . . . 10.3 p-10 -114.21 0.45 14.22 Favored 'General case' 0 N--CA 1.466 0.368 0 CA-C-N 119.506 1.048 . . . . 0.0 113.656 -175.77 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 129' ' ' LEU . . . . . . . . . . . . . 47.4 mt -111.85 145.71 38.99 Favored 'General case' 0 C--O 1.231 0.117 0 CA-C-N 118.166 0.439 . . . . 0.0 110.344 -179.417 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 130' ' ' VAL . . . . . . . . . . . . . 12.5 p -134.16 141.21 44.38 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.217 0 CA-C-O 121.15 0.5 . . . . 0.0 110.559 -179.843 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 131' ' ' VAL . . . . . . . . . . . . . 44.3 t -135.84 139.6 45.78 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.271 0 CA-C-N 115.985 -0.552 . . . . 0.0 110.109 -179.784 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 132' ' ' ILE . . . . . . . . . . . . . 74.4 mt -118.65 133.42 65.54 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.268 0 CA-C-N 115.708 -0.678 . . . . 0.0 109.49 179.883 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 133' ' ' ILE . . . . . . . . . . . . . 38.1 mm -116.2 121.37 67.35 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.256 0 CA-C-N 116.39 -0.368 . . . . 0.0 110.78 -175.156 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 134' ' ' ASP . . . . . . . . . . . . . 8.4 p-10 -131.94 147.93 52.49 Favored 'General case' 0 C--N 1.332 -0.183 0 N-CA-C 109.871 -0.418 . . . . 0.0 109.871 175.33 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 135' ' ' GLU . . . . . . . . . . . . . 78.8 tt0 -49.86 -26.64 4.22 Favored 'General case' 0 C--N 1.328 -0.336 0 N-CA-C 113.02 0.748 . . . . 0.0 113.02 -172.742 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 136' ' ' GLN . . . . . . . . . . . . . 98.5 mt-30 -85.43 -32.04 22.54 Favored 'General case' 0 C--O 1.234 0.243 0 N-CA-C 112.425 0.528 . . . . 0.0 112.425 -175.428 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 137' ' ' LYS . . . . . . . . . . . . . 48.3 pttt -168.31 173.24 7.86 Favored 'General case' 0 C--N 1.332 -0.161 0 CA-C-O 121.646 0.736 . . . . 0.0 112.417 -173.226 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 138' ' ' LEU . . . . . . . . . . . . . 3.6 tt -115.7 129.11 56.35 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 114.831 -1.077 . . . . 0.0 109.996 -179.572 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 139' ' ' THR . . . . . . . . . . . . . 39.0 m -110.67 123.51 50.16 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 116.221 -0.445 . . . . 0.0 110.223 179.358 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 140' ' ' LEU . . . . . . . . . . . . . 6.1 tt -113.28 122.33 47.09 Favored 'General case' 0 C--N 1.328 -0.351 0 N-CA-C 109.567 -0.531 . . . . 0.0 109.567 -178.961 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 141' ' ' ILE . . . . . . . . . . . . . 19.6 mt -121.67 118.5 55.98 Favored 'Isoleucine or valine' 0 C--O 1.235 0.303 0 CA-C-O 121.104 0.478 . . . . 0.0 109.899 -175.938 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 142' ' ' ARG . . . . . . . . . . . . . 58.9 ttt180 -108.31 132.28 53.87 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 115.298 -0.864 . . . . 0.0 110.734 -177.198 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 143' ' ' THR . . . . . . . . . . . . . 56.0 p . . . . . 0 C--O 1.22 -0.483 0 CA-C-O 118.026 -0.988 . . . . 0.0 110.601 178.934 . . . . . . . . 0 0 . 1 . 004 nuclear orig full ' B' B ' -3' ' ' GLU . . . . . . . . . . . . . 95.8 mt-10 . . . . . 0 N--CA 1.491 1.606 0 N-CA-C 109.385 -0.598 . . . . 0.0 109.385 . . . . . . . . . 0 0 . 1 . 004 nuclear orig full ' B' B ' -2' ' ' GLY . . . . . . . . . . . . . . . -66.62 140.26 38.43 Favored Glycine 0 CA--C 1.525 0.714 0 N-CA-C 111.062 -0.815 . . . . 0.0 111.062 -179.901 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' -1' ' ' VAL . . . . . . . . . . . . . 44.5 t -96.1 132.28 40.75 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.372 0 CA-C-O 120.845 0.355 . . . . 0.0 110.07 179.454 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 0' ' ' ILE . . . . . . . . . . . . . 70.6 mt -117.68 134.48 61.13 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.178 0 CA-C-N 116.301 -0.409 . . . . 0.0 110.129 -179.759 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 1' ' ' MET . . . . . . . . . . . . . 26.6 ptt? -91.59 139.64 30.5 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.032 -0.531 . . . . 0.0 110.315 178.222 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 2' ' ' SER . . . . . . . . . . . . . 6.7 p -114.32 131.72 56.43 Favored 'General case' 0 C--N 1.331 -0.23 0 CA-C-O 121.072 0.463 . . . . 0.0 110.88 -178.519 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 3' ' ' GLU . . . . . . . . . . . . . 95.5 mt-10 -141.15 141.56 34.14 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 115.79 -0.641 . . . . 0.0 110.897 -179.226 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 4' ' ' LEU . . . . . . . . . . . . . 18.8 tp -127.15 128.33 45.99 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 115.955 -0.566 . . . . 0.0 110.12 177.056 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 5' ' ' LYS . . . . . . . . . . . . . 83.1 mttt -104.93 119.62 39.45 Favored 'General case' 0 C--O 1.234 0.267 0 CA-C-N 116.084 -0.507 . . . . 0.0 110.462 178.828 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 6' ' ' LEU . . . . . . . . . . . . . 45.1 mt -116.57 144.38 44.44 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 115.458 -0.792 . . . . 0.0 110.313 -178.967 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 7' ' ' LYS . . . . . . . . . . . . . 82.9 tttt -133.05 138.36 31.59 Favored Pre-proline 0 CA--C 1.534 0.328 0 CA-C-O 119.007 -0.521 . . . . 0.0 109.988 177.247 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 8' ' ' PRO . . . . . . . . . . . . . 89.7 Cg_endo -92.09 144.19 2.78 Favored 'Trans proline' 0 N--CA 1.489 1.223 0 C-N-CA 121.717 1.611 . . . . 0.0 111.97 178.155 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 9' ' ' LEU . . . . . . . . . . . . . 62.4 mt -81.09 -47.65 1.11 Allowed Pre-proline 0 CA--C 1.534 0.36 0 CA-C-O 118.637 -0.697 . . . . 0.0 112.319 -179.946 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 10' ' ' PRO . . . . . . . . . . . . . 86.8 Cg_endo -80.3 151.43 20.36 Favored 'Trans proline' 0 N--CA 1.496 1.656 0 C-N-CA 121.125 1.217 . . . . 0.0 111.888 176.999 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 11' ' ' LYS . . . . . . . . . . . . . 96.5 mttt -87.47 96.98 10.58 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.432 -0.349 . . . . 0.0 110.492 178.79 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 12' ' ' VAL . . . . . . . . . . . . . 12.6 p -142.06 147.07 21.9 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.328 0 CA-C-N 116.237 -0.438 . . . . 0.0 110.5 -179.932 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 13' ' ' GLU . . . . . . . . . . . . . 84.4 tt0 -84.92 127.9 34.37 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.253 -0.43 . . . . 0.0 110.055 178.069 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 14' ' ' LEU . . . . . . . . . . . . . 36.5 mt -96.41 149.96 36.51 Favored Pre-proline 0 CA--C 1.533 0.309 0 CA-C-O 119.311 -0.376 . . . . 0.0 110.713 -177.154 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 15' ' ' PRO . . . . . . . . . . . . . 27.8 Cg_exo -60.99 158.39 34.27 Favored 'Trans proline' 0 N--CA 1.499 1.797 0 C-N-CA 121.269 1.313 . . . . 0.0 111.964 178.272 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 16' ' ' PRO . . . . . . . . . . . . . 35.7 Cg_exo -59.09 -41.02 64.85 Favored 'Trans proline' 0 N--CA 1.497 1.692 0 C-N-CA 121.439 1.426 . . . . 0.0 112.714 -179.218 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 17' ' ' ASP . . . . . . . . . . . . . 15.8 p-10 -84.73 11.59 8.79 Favored 'General case' 0 CA--C 1.535 0.388 0 N-CA-C 113.155 0.798 . . . . 0.0 113.155 -178.183 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 18' ' ' PHE . . . . . . . . . . . . . 44.9 t80 -57.6 -45.73 84.94 Favored 'General case' 0 C--N 1.335 -0.064 0 O-C-N 121.949 -0.47 . . . . 0.0 110.305 -177.833 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 19' ' ' VAL . . . . . . . . . . . . . 15.0 p -55.88 -42.21 69.98 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.326 0 CA-C-N 116.475 -0.329 . . . . 0.0 111.075 -177.599 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 20' ' ' ASP . . . . . . . . . . . . . 32.8 m-20 -60.76 -42.85 98.27 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-O 120.9 0.381 . . . . 0.0 110.923 -178.397 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 21' ' ' VAL . . . . . . . . . . . . . 46.9 t -63.8 -45.41 97.25 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.264 0 C-N-CA 120.735 -0.386 . . . . 0.0 110.4 -178.52 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 22' ' ' ILE . . . . . . . . . . . . . 50.7 mm -55.7 -47.13 79.57 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.262 0 C-N-CA 121.001 -0.28 . . . . 0.0 110.592 178.366 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 23' ' ' ARG . . . . . . . . . . . . . 47.0 ttp180 -53.41 -51.66 61.87 Favored 'General case' 0 C--N 1.329 -0.292 0 C-N-CA 121.13 -0.228 . . . . 0.0 111.534 -178.615 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 24' ' ' ILE . . . . . . . . . . . . . 71.9 mt -59.52 -44.24 92.56 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.319 0 C-N-CA 121.112 -0.235 . . . . 0.0 111.163 -177.293 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 25' ' ' LYS . . . . . . . . . . . . . 8.7 mtpm? -64.94 -40.1 94.51 Favored 'General case' 0 C--N 1.328 -0.357 0 N-CA-C 112.178 0.436 . . . . 0.0 112.178 -176.946 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 26' ' ' LEU . . . . . . . . . . . . . 74.6 mt -80.09 -43.41 21.8 Favored 'General case' 0 C--N 1.33 -0.276 0 N-CA-C 112.945 0.72 . . . . 0.0 112.945 -172.106 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 27' ' ' GLN . . . . . . . . . . . . . 10.3 pt20 -46.39 137.67 6.27 Favored 'General case' 0 N--CA 1.469 0.487 0 N-CA-C 112.81 0.67 . . . . 0.0 112.81 -174.996 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 28' ' ' GLY . . . . . . . . . . . . . . . 100.85 -26.31 25.11 Favored Glycine 0 CA--C 1.533 1.196 0 CA-C-N 115.518 -0.765 . . . . 0.0 112.216 -176.575 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 29' ' ' LYS . . . . . . . . . . . . . 35.2 mmtp -97.79 155.08 17.2 Favored 'General case' 0 C--N 1.332 -0.159 0 CA-C-N 117.251 0.526 . . . . 0.0 111.012 179.28 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 30' ' ' THR . . . . . . . . . . . . . 43.5 m -108.01 134.4 50.97 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 115.934 -0.576 . . . . 0.0 109.869 175.202 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 31' ' ' VAL . . . . . . . . . . . . . 34.5 m -129.39 155.56 41.31 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.251 0 CA-C-O 120.9 0.381 . . . . 0.0 111.049 -177.363 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 32' ' ' ARG . . . . . . . . . . . . . 92.5 mtt180 -129.9 152.9 48.87 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-O 121.291 0.567 . . . . 0.0 110.604 179.16 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 33' ' ' THR . . . . . . . . . . . . . 18.2 m -52.82 139.02 28.03 Favored 'General case' 0 C--N 1.331 -0.225 0 CA-C-N 116.228 -0.442 . . . . 0.0 111.39 -179.001 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 34' ' ' GLY . . . . . . . . . . . . . . . 100.31 -17.12 57.34 Favored Glycine 0 CA--C 1.533 1.172 0 C-N-CA 121.219 -0.515 . . . . 0.0 113.224 179.346 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 35' ' ' ASP . . . . . . . . . . . . . 56.1 m-20 -66.04 150.5 48.59 Favored 'General case' 0 C--O 1.23 0.041 0 CA-C-N 118.043 0.922 . . . . 0.0 111.055 179.443 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 36' ' ' VAL . . . . . . . . . . . . . 46.5 t -123.06 129.72 74.86 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.207 0 CA-C-N 115.748 -0.66 . . . . 0.0 109.677 178.39 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 37' ' ' ILE . . . . . . . . . . . . . 64.8 mt -120.1 138.34 50.98 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.297 0 N-CA-C 109.755 -0.461 . . . . 0.0 109.755 179.816 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 38' ' ' GLY . . . . . . . . . . . . . . . -112.36 128.86 8.71 Favored Glycine 0 CA--C 1.525 0.716 0 N-CA-C 110.731 -0.948 . . . . 0.0 110.731 179.552 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 39' ' ' ILE . . . . . . . . . . . . . 73.4 mt -121.12 136.18 58.91 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.277 0 N-CA-C 110.043 -0.354 . . . . 0.0 110.043 179.831 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 40' ' ' SER . . . . . . . . . . . . . 74.6 p -91.65 116.16 28.64 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.246 -0.434 . . . . 0.0 110.78 176.185 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 41' ' ' ILE . . . . . . . . . . . . . 48.1 mm -128.74 118.13 46.42 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.165 0 N-CA-C 110.063 -0.347 . . . . 0.0 110.063 178.711 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 42' ' ' LEU . . . . . . . . . . . . . 38.7 mt 58.1 34.53 24.29 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.212 -0.449 . . . . 0.0 111.52 179.325 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 43' ' ' GLY . . . . . . . . . . . . . . . 77.47 -10.14 24.54 Favored Glycine 0 CA--C 1.535 1.286 0 C-N-CA 121.315 -0.469 . . . . 0.0 113.424 178.047 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 44' ' ' LYS . . . . . . . . . . . . . 47.7 mtmt -98.85 137.47 37.38 Favored 'General case' 0 C--N 1.333 -0.144 0 CA-C-N 117.897 0.848 . . . . 0.0 110.198 177.965 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 45' ' ' GLU . . . . . . . . . . . . . 83.8 tt0 -84.46 128.18 34.44 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.293 -0.412 . . . . 0.0 111.287 -179.409 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 46' ' ' VAL . . . . . . . . . . . . . 7.2 p -120.61 129.14 75.93 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.197 0 N-CA-C 109.508 -0.553 . . . . 0.0 109.508 175.465 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 47' ' ' LYS . . . . . . . . . . . . . 98.8 mttt -99.4 128.32 45.51 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.009 -0.541 . . . . 0.0 111.007 179.001 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 48' ' ' PHE . . . . . . . . . . . . . 93.2 m-85 -113.08 131.85 55.65 Favored 'General case' 0 C--N 1.331 -0.232 0 N-CA-C 109.67 -0.493 . . . . 0.0 109.67 175.041 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 49' ' ' LYS . . . . . . . . . . . . . 79.2 tttt -106.98 136.14 47.35 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.304 -0.407 . . . . 0.0 110.426 -179.777 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 50' ' ' VAL . . . . . . . . . . . . . 42.2 t -80.08 106.99 11.99 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 N-CA-C 109.433 -0.58 . . . . 0.0 109.433 176.799 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 51' ' ' VAL . . . . . . . . . . . . . 46.7 t -75.15 -48.21 32.83 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.286 0 CA-C-N 116.064 -0.516 . . . . 0.0 110.077 -174.044 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 52' ' ' GLN . . . . . . . . . . . . . 62.6 tt0 -159.46 137.05 9.96 Favored 'General case' 0 C--N 1.33 -0.251 0 C-N-CA 120.475 -0.49 . . . . 0.0 111.397 -177.692 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 53' ' ' ALA . . . . . . . . . . . . . . . -114.23 130.76 56.63 Favored 'General case' 0 C--N 1.331 -0.23 0 CA-C-N 115.783 -0.644 . . . . 0.0 109.755 174.561 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 54' ' ' TYR . . . . . . . . . . . . . 30.2 t80 -129.08 110.76 18.29 Favored Pre-proline 0 CA--C 1.535 0.399 0 CA-C-O 118.334 -0.841 . . . . 0.0 110.329 179.495 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 55' ' ' PRO . . . . . . . . . . . . . 73.9 Cg_endo -77.11 170.08 72.56 Favored 'Cis proline' 0 N--CA 1.499 1.823 0 CA-C-N 121.918 1.721 . . . . 0.0 112.44 -4.554 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 56' ' ' SER . . . . . . . . . . . . . 13.7 m -116.18 129.46 25.2 Favored Pre-proline 0 CA--C 1.539 0.548 0 CA-C-O 118.347 -0.835 . . . . 0.0 109.37 175.96 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 57' ' ' PRO . . . . . . . . . . . . . 50.8 Cg_endo -69.99 148.18 86.7 Favored 'Cis proline' 0 N--CA 1.497 1.735 0 CA-C-N 122.053 1.769 . . . . 0.0 111.561 -0.771 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 58' ' ' LEU . . . . . . . . . . . . . 22.4 tp -106.48 135.44 47.97 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-O 120.851 0.357 . . . . 0.0 110.454 -178.994 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 59' ' ' ARG . . . . . . . . . . . . . 52.9 ttp180 -105.82 121.85 44.9 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-N 115.873 -0.603 . . . . 0.0 109.377 177.307 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 60' ' ' VAL . . . . . . . . . . . . . 42.6 t -79.09 122.92 35.31 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.287 0 C-N-CA 120.807 -0.357 . . . . 0.0 110.591 -173.848 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 61' ' ' GLU . . . . . . . . . . . . . 95.5 mt-10 -131.03 165.62 22.8 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.021 -0.536 . . . . 0.0 110.149 178.195 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 62' ' ' ASP . . . . . . . . . . . . . 14.9 p-10 -55.87 -32.59 63.8 Favored 'General case' 0 C--N 1.329 -0.324 0 N-CA-C 111.781 0.289 . . . . 0.0 111.781 -179.147 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 63' ' ' ARG . . . . . . . . . . . . . 11.0 ptm180 -86.41 4.58 38.87 Favored 'General case' 0 CA--C 1.537 0.47 0 N-CA-C 113.527 0.936 . . . . 0.0 113.527 -176.15 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 64' ' ' THR . . . . . . . . . . . . . 31.5 m -83.54 137.86 33.66 Favored 'General case' 0 C--N 1.332 -0.166 0 CA-C-N 118.231 0.469 . . . . 0.0 110.443 -178.22 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 65' ' ' LYS . . . . . . . . . . . . . 67.7 mttm -88.24 123.72 33.15 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.219 -179.911 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 66' ' ' ILE . . . . . . . . . . . . . 62.6 mt -111.94 126.59 69.35 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.283 0 N-CA-C 109.574 -0.528 . . . . 0.0 109.574 179.63 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 67' ' ' THR . . . . . . . . . . . . . 18.4 m -122.08 139.32 53.86 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 116.176 -0.465 . . . . 0.0 110.908 -177.119 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 68' ' ' LEU . . . . . . . . . . . . . 15.7 tp -103.77 129.9 51.23 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 115.841 -0.618 . . . . 0.0 110.236 178.624 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 69' ' ' VAL . . . . . . . . . . . . . 43.0 t -96.25 135.06 31.59 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.286 0 CA-C-N 116.252 -0.431 . . . . 0.0 110.45 -179.101 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 70' ' ' THR . . . . . . . . . . . . . 74.9 p -107.25 -174.33 2.51 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.117 -0.492 . . . . 0.0 110.597 -179.932 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 71' ' ' HIS . . . . . . . . . . . . . 48.7 m-70 -112.03 87.51 8.88 Favored Pre-proline 0 CA--C 1.533 0.304 0 CA-C-N 116.276 -0.42 . . . . 0.0 110.911 -178.557 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 72' ' ' PRO . . . . . . . . . . . . . 90.5 Cg_endo -85.28 159.98 11.26 Favored 'Trans proline' 0 N--CA 1.492 1.435 0 C-N-CA 121.566 1.511 . . . . 0.0 112.105 178.072 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 73' ' ' VAL . . . . . . . . . . . . . 34.2 m -87.19 164.45 2.32 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.335 0 CA-C-N 116.303 -0.408 . . . . 0.0 110.703 179.741 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 74' ' ' ASP . . . . . . . . . . . . . 13.8 t0 -99.53 123.52 43.87 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.152 -0.476 . . . . 0.0 110.051 -179.444 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 75' ' ' VAL . . . . . . . . . . . . . 41.5 t -115.24 123.89 71.28 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.261 0 CA-C-O 120.905 0.383 . . . . 0.0 110.617 -177.788 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 76' ' ' LEU . . . . . . . . . . . . . 4.4 mp -124.84 144.99 50.01 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 115.934 -0.576 . . . . 0.0 109.697 176.261 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 77' ' ' GLU . . . . . . . . . . . . . 97.4 mt-10 -134.96 138.53 44.13 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-O 121.0 0.429 . . . . 0.0 111.243 -178.068 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 78' ' ' ALA . . . . . . . . . . . . . . . -125.76 130.5 51.61 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 115.697 -0.683 . . . . 0.0 109.674 176.229 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 79' ' ' LYS . . . . . . . . . . . . . 62.1 mtpt -79.02 119.44 22.17 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-O 120.865 0.364 . . . . 0.0 110.898 -177.481 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 80' ' ' ILE . . . . . . . . . . . . . 41.6 mm -139.19 109.31 4.2 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.311 0 N-CA-C 109.138 -0.69 . . . . 0.0 109.138 -177.721 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 81' ' ' LYS . . . . . . . . . . . . . 60.6 tttm -101.81 126.55 48.71 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-O 120.842 0.353 . . . . 0.0 111.223 -176.642 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 82' ' ' GLY . . . . . . . . . . . . . . . 89.2 42.11 5.66 Favored Glycine 0 CA--C 1.527 0.784 0 C-N-CA 120.885 -0.674 . . . . 0.0 112.017 174.193 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 83' ' ' ILE . . . . . . . . . . . . . 72.5 mt -70.13 136.34 26.29 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.269 0 N-CA-C 109.676 -0.49 . . . . 0.0 109.676 176.407 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 84' ' ' LYS . . . . . . . . . . . . . 19.7 ttpp -101.0 -50.14 3.9 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-O 120.9 0.381 . . . . 0.0 110.461 -178.176 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 85' ' ' ASP . . . . . . . . . . . . . 10.8 t70 -147.1 148.13 31.29 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 115.987 -0.551 . . . . 0.0 110.348 -179.729 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 86' ' ' VAL . . . . . . . . . . . . . 42.2 t -130.71 132.62 64.12 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.232 0 CA-C-O 121.05 0.452 . . . . 0.0 110.578 -178.365 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 87' ' ' ILE . . . . . . . . . . . . . 5.1 mp -122.62 123.02 67.47 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.217 0 N-CA-C 109.208 -0.664 . . . . 0.0 109.208 176.102 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 88' ' ' LEU . . . . . . . . . . . . . 33.8 mt -111.66 136.29 51.08 Favored 'General case' 0 C--N 1.332 -0.182 0 CA-C-O 121.223 0.535 . . . . 0.0 111.352 -176.129 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 89' ' ' ASP . . . . . . . . . . . . . 11.3 t70 -129.19 146.25 51.15 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 115.511 -0.768 . . . . 0.0 109.296 175.333 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 90' ' ' GLU . . . . . . . . . . . . . 12.8 pt-20 -51.09 -28.8 11.42 Favored 'General case' 0 C--N 1.328 -0.347 0 N-CA-C 112.522 0.564 . . . . 0.0 112.522 -174.017 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 91' ' ' ASN . . . . . . . . . . . . . 92.1 m-20 -127.26 22.67 6.54 Favored 'General case' 0 N--CA 1.469 0.486 0 N-CA-C 112.8 0.667 . . . . 0.0 112.8 -176.558 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 92' ' ' LEU . . . . . . . . . . . . . 7.4 tp -166.24 148.54 6.94 Favored 'General case' 0 C--N 1.331 -0.237 0 N-CA-C 110.302 -0.258 . . . . 0.0 110.302 179.471 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 93' ' ' ILE . . . . . . . . . . . . . 71.0 mt -128.18 123.97 61.42 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.285 0 N-CA-C 109.848 -0.427 . . . . 0.0 109.848 179.145 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 94' ' ' VAL . . . . . . . . . . . . . 40.8 t -122.13 125.88 73.61 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.182 0 N-CA-C 109.98 -0.378 . . . . 0.0 109.98 179.038 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 95' ' ' VAL . . . . . . . . . . . . . 41.8 t -120.82 134.66 63.54 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.329 0 CA-C-N 116.026 -0.533 . . . . 0.0 109.815 -179.959 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 96' ' ' ILE . . . . . . . . . . . . . 67.4 mt -115.76 126.15 73.18 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.209 0 N-CA-C 109.381 -0.6 . . . . 0.0 109.381 179.071 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 97' ' ' THR . . . . . . . . . . . . . 73.5 p -99.89 158.36 15.86 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-O 121.307 0.575 . . . . 0.0 111.326 -176.404 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 98' ' ' GLU . . . . . . . . . . . . . 43.7 tp10 -53.83 -26.62 25.21 Favored 'General case' 0 CA--C 1.533 0.311 0 CA-C-N 116.052 -0.522 . . . . 0.0 112.267 -179.174 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 99' ' ' GLU . . . . . . . . . . . . . 95.7 mt-10 -79.91 17.6 0.94 Allowed 'General case' 0 CA--C 1.535 0.377 0 N-CA-C 113.151 0.797 . . . . 0.0 113.151 -176.212 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 100' ' ' ASN . . . . . . . . . . . . . 4.2 m-20 62.42 38.1 13.1 Favored 'General case' 0 N--CA 1.463 0.175 0 CA-C-O 121.115 0.484 . . . . 0.0 110.894 177.954 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 101' ' ' GLU . . . . . . . . . . . . . 84.4 tt0 -119.04 141.86 48.34 Favored 'General case' 0 C--N 1.332 -0.184 0 CA-C-N 116.208 -0.451 . . . . 0.0 109.869 177.562 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 102' ' ' VAL . . . . . . . . . . . . . 46.2 t -115.08 127.54 72.6 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.264 0 N-CA-C 109.895 -0.409 . . . . 0.0 109.895 -178.915 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 103' ' ' LEU . . . . . . . . . . . . . 28.8 mt -118.58 131.9 56.2 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-N 115.78 -0.646 . . . . 0.0 110.306 177.845 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 104' ' ' ILE . . . . . . . . . . . . . 71.4 mt -119.52 121.85 67.39 Favored 'Isoleucine or valine' 0 C--O 1.234 0.283 0 CA-C-N 116.606 -0.27 . . . . 0.0 110.426 -179.106 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 105' ' ' PHE . . . . . . . . . . . . . 53.2 m-85 -123.18 168.44 12.42 Favored 'General case' 0 C--N 1.333 -0.122 0 O-C-N 124.115 0.885 . . . . 0.0 109.901 179.499 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 106' ' ' ASN . . . . . . . . . . . . . 44.0 p-10 -100.38 -170.61 1.89 Allowed 'General case' 0 CA--C 1.531 0.217 0 N-CA-C 109.789 -0.448 . . . . 0.0 109.789 171.754 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 107' ' ' GLN . . . . . . . . . . . . . 63.3 tt0 -58.55 -30.06 66.83 Favored 'General case' 0 C--N 1.328 -0.339 0 N-CA-C 111.858 0.318 . . . . 0.0 111.858 179.567 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 108' ' ' ASN . . . . . . . . . . . . . 59.8 t30 -86.85 14.06 7.88 Favored 'General case' 0 CA--C 1.534 0.343 0 N-CA-C 112.923 0.712 . . . . 0.0 112.923 -176.757 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 109' ' ' LEU . . . . . . . . . . . . . 34.5 mt 58.35 33.19 22.91 Favored 'General case' 0 C--N 1.332 -0.188 0 N-CA-C 111.877 0.325 . . . . 0.0 111.877 177.262 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 110' ' ' GLU . . . . . . . . . . . . . 70.5 mm-40 -98.97 138.82 35.52 Favored 'General case' 0 C--N 1.331 -0.226 0 N-CA-C 109.21 -0.663 . . . . 0.0 109.21 174.426 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 111' ' ' GLU . . . . . . . . . . . . . 42.2 tt0 -85.72 121.81 28.91 Favored 'General case' 0 C--N 1.327 -0.408 0 CA-C-O 120.942 0.401 . . . . 0.0 110.574 -176.243 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 112' ' ' LEU . . . . . . . . . . . . . 38.6 mt -105.73 -42.4 5.18 Favored 'General case' 0 C--N 1.331 -0.227 0 CA-C-N 116.007 -0.542 . . . . 0.0 110.466 179.745 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 113' ' ' TYR . . . . . . . . . . . . . 63.9 t80 -132.89 138.7 47.07 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-N 116.274 -0.421 . . . . 0.0 110.883 -178.452 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 114' ' ' ARG . . . . . . . . . . . . . 24.6 ptt180 -147.89 122.22 9.65 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.3 -0.409 . . . . 0.0 110.619 179.126 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 115' ' ' GLY . . . . . . . . . . . . . . . -150.13 148.15 19.1 Favored Glycine 0 CA--C 1.525 0.701 0 C-N-CA 120.682 -0.77 . . . . 0.0 111.451 179.761 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 116' ' ' LYS . . . . . . . . . . . . . 21.3 ttpp -116.44 131.93 56.81 Favored 'General case' 0 C--N 1.33 -0.26 0 N-CA-C 109.717 -0.475 . . . . 0.0 109.717 176.517 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 117' ' ' PHE . . . . . . . . . . . . . 47.5 m-85 -127.12 116.85 21.29 Favored 'General case' 0 C--N 1.331 -0.216 0 CA-C-O 120.945 0.403 . . . . 0.0 110.243 -176.47 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 118' ' ' GLU . . . . . . . . . . . . . 95.8 mt-10 -52.97 -47.03 68.47 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.309 -0.405 . . . . 0.0 111.476 -176.293 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 119' ' ' ASN . . . . . . . . . . . . . 82.6 m-20 -98.16 31.02 2.88 Favored 'General case' 0 C--N 1.33 -0.256 0 N-CA-C 112.173 0.435 . . . . 0.0 112.173 -173.805 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 120' ' ' LEU . . . . . . . . . . . . . 21.4 tp -56.72 121.82 10.69 Favored 'General case' 0 C--N 1.332 -0.184 0 CA-C-O 120.677 0.275 . . . . 0.0 110.466 177.778 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 121' ' ' ASN . . . . . . . . . . . . . 31.4 m120 -113.98 -44.14 3.19 Favored 'General case' 0 N--CA 1.462 0.155 0 CA-C-N 116.554 -0.294 . . . . 0.0 111.323 -176.684 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 122' ' ' LYS . . . . . . . . . . . . . 55.4 mtmt -147.67 152.7 38.28 Favored 'General case' 0 C--N 1.332 -0.172 0 C-N-CA 120.651 -0.42 . . . . 0.0 111.62 -177.701 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 123' ' ' VAL . . . . . . . . . . . . . 46.2 t -132.77 132.18 59.52 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.243 0 CA-C-N 115.919 -0.582 . . . . 0.0 109.862 177.715 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 124' ' ' LEU . . . . . . . . . . . . . 23.9 mt -121.15 136.13 55.03 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.231 -0.44 . . . . 0.0 110.548 -179.059 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 125' ' ' VAL . . . . . . . . . . . . . 43.5 t -130.46 130.73 65.28 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.262 0 CA-C-N 116.335 -0.393 . . . . 0.0 110.019 179.078 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 126' ' ' ARG . . . . . . . . . . . . . 89.8 mtt-85 -142.05 121.14 12.93 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-O 120.935 0.398 . . . . 0.0 110.642 178.578 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 127' ' ' ASN . . . . . . . . . . . . . 58.4 m-80 51.46 -107.75 0.33 Allowed 'General case' 0 CA--C 1.545 0.761 0 CA-C-O 118.881 -0.581 . . . . 0.0 111.146 179.404 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 128' ' ' ASP . . . . . . . . . . . . . 14.7 p-10 -114.19 4.26 15.47 Favored 'General case' 0 CA--C 1.537 0.445 0 CA-C-N 119.802 1.183 . . . . 0.0 113.257 -178.111 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 129' ' ' LEU . . . . . . . . . . . . . 72.6 mt -107.75 144.93 34.21 Favored 'General case' 0 C--O 1.231 0.109 0 CA-C-N 118.142 0.428 . . . . 0.0 110.09 -179.916 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 130' ' ' VAL . . . . . . . . . . . . . 41.4 t -127.67 140.22 49.73 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.185 0 CA-C-O 120.98 0.419 . . . . 0.0 110.156 -177.739 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 131' ' ' VAL . . . . . . . . . . . . . 41.0 t -135.01 134.84 53.23 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.277 0 CA-C-N 116.15 -0.477 . . . . 0.0 110.025 178.317 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 132' ' ' ILE . . . . . . . . . . . . . 69.9 mt -118.07 132.84 66.72 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.274 0 CA-C-N 115.984 -0.553 . . . . 0.0 109.606 -179.468 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 133' ' ' ILE . . . . . . . . . . . . . 34.0 mm -116.0 123.49 71.32 Favored 'Isoleucine or valine' 0 C--O 1.234 0.262 0 CA-C-N 116.511 -0.313 . . . . 0.0 110.894 -175.598 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 134' ' ' ASP . . . . . . . . . . . . . 7.9 p-10 -132.61 155.11 49.31 Favored 'General case' 0 C--N 1.332 -0.196 0 CA-C-N 116.434 -0.348 . . . . 0.0 110.089 174.371 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 135' ' ' GLU . . . . . . . . . . . . . 80.7 tt0 -49.83 -28.66 6.71 Favored 'General case' 0 C--N 1.328 -0.364 0 N-CA-C 113.17 0.804 . . . . 0.0 113.17 -169.951 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 136' ' ' GLN . . . . . . . . . . . . . 97.5 mt-30 -99.22 -24.78 14.73 Favored 'General case' 0 C--O 1.233 0.227 0 N-CA-C 113.096 0.776 . . . . 0.0 113.096 -171.761 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 137' ' ' LYS . . . . . . . . . . . . . 57.0 pttt -161.01 168.25 24.89 Favored 'General case' 0 C--O 1.232 0.163 0 CA-C-O 121.619 0.723 . . . . 0.0 112.56 -173.23 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 138' ' ' LEU . . . . . . . . . . . . . 6.9 tt -120.07 128.36 53.41 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 114.848 -1.069 . . . . 0.0 110.009 178.219 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 139' ' ' THR . . . . . . . . . . . . . 43.1 m -106.49 127.82 53.6 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.068 -0.515 . . . . 0.0 110.28 179.562 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 140' ' ' LEU . . . . . . . . . . . . . 19.3 tp -114.92 119.26 35.95 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 115.795 -0.639 . . . . 0.0 109.674 -177.969 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 141' ' ' ILE . . . . . . . . . . . . . 19.3 mt -119.35 119.91 62.07 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.221 0 CA-C-O 120.95 0.405 . . . . 0.0 110.015 -174.516 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 142' ' ' ARG . . . . . . . . . . . . . 76.2 mtm180 -113.77 126.21 54.96 Favored 'General case' 0 C--N 1.332 -0.166 0 CA-C-N 115.44 -0.8 . . . . 0.0 110.369 -177.97 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 143' ' ' THR . . . . . . . . . . . . . 52.0 p . . . . . 0 C--O 1.22 -0.493 0 CA-C-O 118.123 -0.942 . . . . 0.0 110.527 -179.564 . . . . . . . . 0 0 . 1 . 004 nuclear orig full ' C' C ' -3' ' ' GLU . . . . . . . . . . . . . 96.0 mt-10 . . . . . 0 N--CA 1.49 1.54 0 N-CA-C 109.437 -0.579 . . . . 0.0 109.437 . . . . . . . . . 0 0 . 1 . 004 nuclear orig full ' C' C ' -2' ' ' GLY . . . . . . . . . . . . . . . -71.11 131.54 20.5 Favored Glycine 0 CA--C 1.524 0.638 0 N-CA-C 110.676 -0.969 . . . . 0.0 110.676 178.7 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' C' C ' -1' ' ' VAL . . . . . . . . . . . . . 43.7 t -95.51 139.38 19.01 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.323 0 CA-C-O 120.948 0.404 . . . . 0.0 110.14 -179.04 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' C' C ' 0' ' ' ILE . . . . . . . . . . . . . 69.4 mt -103.52 131.76 51.34 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.208 0 CA-C-N 116.051 -0.522 . . . . 0.0 110.127 -179.108 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' C' C ' 1' ' ' MET . . . . . . . . . . . . . 25.2 ptp -82.88 141.05 32.51 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.309 -0.405 . . . . 0.0 110.608 179.82 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' C' C ' 2' ' ' SER . . . . . . . . . . . . . 3.9 p -124.14 133.53 53.56 Favored 'General case' 0 C--N 1.331 -0.212 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.597 179.925 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' C' C ' 3' ' ' GLU . . . . . . . . . . . . . 93.6 mt-10 -141.04 140.9 34.33 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 115.974 -0.557 . . . . 0.0 110.879 -179.292 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' C' C ' 4' ' ' LEU . . . . . . . . . . . . . 15.5 tp -125.21 130.29 51.8 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 116.151 -0.477 . . . . 0.0 110.01 175.629 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' C' C ' 5' ' ' LYS . . . . . . . . . . . . . 96.5 mttt -111.77 121.85 46.21 Favored 'General case' 0 C--N 1.332 -0.192 0 CA-C-N 116.686 -0.234 . . . . 0.0 110.939 -178.512 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' C' C ' 6' ' ' LEU . . . . . . . . . . . . . 27.7 mt -114.3 140.91 48.23 Favored 'General case' 0 C--O 1.234 0.27 0 CA-C-N 115.504 -0.771 . . . . 0.0 110.591 -179.506 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' C' C ' 7' ' ' LYS . . . . . . . . . . . . . 41.1 tttp -121.54 137.88 27.6 Favored Pre-proline 0 CA--C 1.534 0.351 0 CA-C-O 118.935 -0.555 . . . . 0.0 109.592 174.934 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' C' C ' 8' ' ' PRO . . . . . . . . . . . . . 86.9 Cg_endo -91.93 134.68 1.49 Allowed 'Trans proline' 0 N--CA 1.488 1.193 0 C-N-CA 121.682 1.588 . . . . 0.0 111.831 178.858 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' C' C ' 9' ' ' LEU . . . . . . . . . . . . . 49.0 mt -76.66 -46.26 3.15 Favored Pre-proline 0 CA--C 1.533 0.319 0 CA-C-O 118.791 -0.623 . . . . 0.0 111.764 -179.908 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' C' C ' 10' ' ' PRO . . . . . . . . . . . . . 79.2 Cg_endo -83.78 140.46 9.19 Favored 'Trans proline' 0 N--CA 1.495 1.575 0 C-N-CA 121.288 1.325 . . . . 0.0 111.408 173.259 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' C' C ' 11' ' ' LYS . . . . . . . . . . . . . 48.8 pttt -78.96 111.34 15.05 Favored 'General case' 0 C--N 1.331 -0.214 0 CA-C-O 121.449 0.642 . . . . 0.0 110.174 178.414 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' C' C ' 12' ' ' VAL . . . . . . . . . . . . . 11.6 p -151.1 151.99 11.79 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.373 0 CA-C-N 115.711 -0.677 . . . . 0.0 110.589 -178.553 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' C' C ' 13' ' ' GLU . . . . . . . . . . . . . 80.6 tt0 -91.04 124.51 35.33 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.303 -0.408 . . . . 0.0 110.082 177.241 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' C' C ' 14' ' ' LEU . . . . . . . . . . . . . 23.8 mt -95.16 150.87 38.29 Favored Pre-proline 0 C--N 1.329 -0.284 0 CA-C-O 119.332 -0.366 . . . . 0.0 110.511 -179.141 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' C' C ' 15' ' ' PRO . . . . . . . . . . . . . 28.2 Cg_exo -60.51 157.86 34.56 Favored 'Trans proline' 0 N--CA 1.496 1.673 0 C-N-CA 121.257 1.305 . . . . 0.0 111.65 177.623 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' C' C ' 16' ' ' PRO . . . . . . . . . . . . . 38.4 Cg_exo -58.27 -39.79 81.52 Favored 'Trans proline' 0 N--CA 1.497 1.722 0 C-N-CA 121.428 1.419 . . . . 0.0 112.634 -178.718 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' C' C ' 17' ' ' ASP . . . . . . . . . . . . . 19.5 p-10 -87.79 12.76 12.13 Favored 'General case' 0 CA--C 1.536 0.421 0 N-CA-C 113.027 0.751 . . . . 0.0 113.027 -177.896 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' C' C ' 18' ' ' PHE . . . . . . . . . . . . . 45.9 t80 -57.85 -41.29 82.05 Favored 'General case' 0 C--O 1.228 -0.046 0 O-C-N 122.008 -0.432 . . . . 0.0 110.271 -178.664 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' C' C ' 19' ' ' VAL . . . . . . . . . . . . . 48.5 t -56.49 -43.83 79.0 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.271 0 CA-C-N 116.529 -0.305 . . . . 0.0 110.429 -179.484 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' C' C ' 20' ' ' ASP . . . . . . . . . . . . . 35.3 m-20 -60.31 -41.18 92.95 Favored 'General case' 0 C--N 1.33 -0.282 0 C-N-CA 120.872 -0.331 . . . . 0.0 110.719 -178.935 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' C' C ' 21' ' ' VAL . . . . . . . . . . . . . 47.9 t -63.33 -49.23 83.77 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 C-N-CA 120.836 -0.346 . . . . 0.0 110.344 -178.232 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' C' C ' 22' ' ' ILE . . . . . . . . . . . . . 50.6 mm -55.63 -47.57 78.79 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.268 0 CA-C-O 120.696 0.284 . . . . 0.0 110.828 179.482 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' C' C ' 23' ' ' ARG . . . . . . . . . . . . . 50.8 ttp180 -53.97 -50.65 66.06 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-O 120.619 0.247 . . . . 0.0 111.444 -177.832 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' C' C ' 24' ' ' ILE . . . . . . . . . . . . . 75.5 mt -58.66 -43.0 86.58 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.286 0 CA-C-N 116.688 -0.233 . . . . 0.0 111.139 -177.454 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' C' C ' 25' ' ' LYS . . . . . . . . . . . . . 42.8 mttm -65.37 -40.88 94.08 Favored 'General case' 0 C--N 1.328 -0.348 0 N-CA-C 112.223 0.453 . . . . 0.0 112.223 -178.264 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' C' C ' 26' ' ' LEU . . . . . . . . . . . . . 91.9 mt -79.98 -39.4 30.16 Favored 'General case' 0 C--N 1.33 -0.253 0 N-CA-C 113.546 0.943 . . . . 0.0 113.546 -170.061 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' C' C ' 27' ' ' GLN . . . . . . . . . . . . . 10.4 pt20 -46.35 138.71 5.36 Favored 'General case' 0 N--CA 1.47 0.527 0 N-CA-C 112.922 0.712 . . . . 0.0 112.922 -174.162 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' C' C ' 28' ' ' GLY . . . . . . . . . . . . . . . 99.95 -27.27 21.06 Favored Glycine 0 CA--C 1.534 1.263 0 CA-C-N 115.47 -0.786 . . . . 0.0 112.175 -177.074 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' C' C ' 29' ' ' LYS . . . . . . . . . . . . . 99.0 mttt -97.83 155.15 17.18 Favored 'General case' 0 C--O 1.234 0.272 0 CA-C-O 121.107 0.48 . . . . 0.0 111.26 179.457 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' C' C ' 30' ' ' THR . . . . . . . . . . . . . 36.2 m -104.82 138.93 40.33 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 115.903 -0.59 . . . . 0.0 110.057 176.14 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' C' C ' 31' ' ' VAL . . . . . . . . . . . . . 35.3 m -126.76 149.94 32.2 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.197 0 CA-C-O 120.878 0.37 . . . . 0.0 110.814 -178.702 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' C' C ' 32' ' ' ARG . . . . . . . . . . . . . 73.8 mtt85 -128.28 148.1 50.63 Favored 'General case' 0 C--N 1.331 -0.239 0 CA-C-N 116.041 -0.527 . . . . 0.0 110.481 178.788 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' C' C ' 33' ' ' THR . . . . . . . . . . . . . 11.2 m -52.68 137.89 29.96 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.292 -0.413 . . . . 0.0 111.497 -177.763 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' C' C ' 34' ' ' GLY . . . . . . . . . . . . . . . 101.31 -17.16 56.09 Favored Glycine 0 CA--C 1.532 1.134 0 CA-C-O 119.643 -0.532 . . . . 0.0 113.241 179.221 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' C' C ' 35' ' ' ASP . . . . . . . . . . . . . 77.9 m-20 -66.47 150.49 48.87 Favored 'General case' 0 N--CA 1.462 0.168 0 CA-C-N 118.062 0.931 . . . . 0.0 110.912 178.917 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' C' C ' 36' ' ' VAL . . . . . . . . . . . . . 43.9 t -124.49 132.57 71.15 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.264 0 CA-C-N 116.107 -0.497 . . . . 0.0 109.908 178.503 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' C' C ' 37' ' ' ILE . . . . . . . . . . . . . 64.3 mt -120.82 139.21 48.79 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.187 0 CA-C-N 116.065 -0.516 . . . . 0.0 109.863 -179.53 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' C' C ' 38' ' ' GLY . . . . . . . . . . . . . . . -116.16 128.7 8.1 Favored Glycine 0 CA--C 1.526 0.752 0 N-CA-C 110.922 -0.871 . . . . 0.0 110.922 178.826 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' C' C ' 39' ' ' ILE . . . . . . . . . . . . . 71.2 mt -124.53 135.27 64.4 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.215 0 CA-C-O 120.733 0.302 . . . . 0.0 110.209 179.806 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' C' C ' 40' ' ' SER . . . . . . . . . . . . . 78.9 p -92.05 121.99 34.12 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.2 -0.455 . . . . 0.0 110.885 176.942 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' C' C ' 41' ' ' ILE . . . . . . . . . . . . . 71.0 mt -130.68 120.69 48.62 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.166 0 CA-C-O 120.772 0.32 . . . . 0.0 110.461 178.07 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' C' C ' 42' ' ' LEU . . . . . . . . . . . . . 76.4 mt 53.21 35.32 19.66 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.141 -0.481 . . . . 0.0 111.703 177.349 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' C' C ' 43' ' ' GLY . . . . . . . . . . . . . . . 72.47 30.44 64.49 Favored Glycine 0 CA--C 1.53 0.994 0 C-N-CA 121.051 -0.595 . . . . 0.0 112.173 178.015 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' C' C ' 44' ' ' LYS . . . . . . . . . . . . . 29.5 ttmt -138.78 128.7 25.16 Favored 'General case' 0 C--N 1.33 -0.258 0 N-CA-C 109.616 -0.513 . . . . 0.0 109.616 178.195 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' C' C ' 45' ' ' GLU . . . . . . . . . . . . . 83.1 tt0 -83.8 124.25 30.73 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-O 120.705 0.288 . . . . 0.0 111.41 -177.566 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' C' C ' 46' ' ' VAL . . . . . . . . . . . . . 10.2 p -115.89 123.1 70.84 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.245 0 N-CA-C 109.485 -0.561 . . . . 0.0 109.485 173.618 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' C' C ' 47' ' ' LYS . . . . . . . . . . . . . 61.9 mtpt -98.3 124.35 42.88 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.03 -0.532 . . . . 0.0 110.76 179.016 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' C' C ' 48' ' ' PHE . . . . . . . . . . . . . 32.7 m-85 -110.78 131.84 54.71 Favored 'General case' 0 C--N 1.33 -0.247 0 N-CA-C 109.659 -0.497 . . . . 0.0 109.659 177.178 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' C' C ' 49' ' ' LYS . . . . . . . . . . . . . 82.8 tttt -106.51 132.36 52.61 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.224 179.068 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' C' C ' 50' ' ' VAL . . . . . . . . . . . . . 42.7 t -75.92 103.54 3.52 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.335 0 N-CA-C 109.432 -0.581 . . . . 0.0 109.432 178.021 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' C' C ' 51' ' ' VAL . . . . . . . . . . . . . 44.9 t -69.47 -54.07 21.56 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 CA-C-N 115.898 -0.592 . . . . 0.0 109.449 -175.437 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' C' C ' 52' ' ' GLN . . . . . . . . . . . . . 89.1 mt-30 -153.27 150.73 29.26 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.007 -0.542 . . . . 0.0 111.531 -177.961 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' C' C ' 53' ' ' ALA . . . . . . . . . . . . . . . -126.92 131.65 51.06 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 115.157 -0.929 . . . . 0.0 109.478 174.637 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' C' C ' 54' ' ' TYR . . . . . . . . . . . . . 78.0 t80 -129.1 109.62 18.13 Favored Pre-proline 0 CA--C 1.534 0.359 0 CA-C-O 118.281 -0.866 . . . . 0.0 110.464 -179.17 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' C' C ' 55' ' ' PRO . . . . . . . . . . . . . 73.6 Cg_endo -77.15 170.02 72.68 Favored 'Cis proline' 0 N--CA 1.501 1.936 0 CA-C-N 121.895 1.713 . . . . 0.0 112.269 -6.057 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' C' C ' 56' ' ' SER . . . . . . . . . . . . . 13.6 m -116.28 131.15 23.96 Favored Pre-proline 0 CA--C 1.538 0.487 0 CA-C-O 118.46 -0.781 . . . . 0.0 109.36 174.972 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' C' C ' 57' ' ' PRO . . . . . . . . . . . . . 55.3 Cg_endo -71.38 146.83 86.3 Favored 'Cis proline' 0 N--CA 1.497 1.73 0 CA-C-N 121.996 1.749 . . . . 0.0 111.531 -1.055 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' C' C ' 58' ' ' LEU . . . . . . . . . . . . . 14.4 tp -105.97 136.59 45.36 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.286 -0.416 . . . . 0.0 110.651 -178.422 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' C' C ' 59' ' ' ARG . . . . . . . . . . . . . 78.6 ttt180 -103.58 122.46 45.02 Favored 'General case' 0 C--N 1.327 -0.394 0 N-CA-C 109.308 -0.627 . . . . 0.0 109.308 175.788 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' C' C ' 60' ' ' VAL . . . . . . . . . . . . . 42.2 t -80.09 123.71 37.21 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.315 0 C-N-CA 120.704 -0.398 . . . . 0.0 110.48 -175.346 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' C' C ' 61' ' ' GLU . . . . . . . . . . . . . 95.6 mt-10 -130.84 164.25 25.62 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 115.705 -0.679 . . . . 0.0 109.745 177.645 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' C' C ' 62' ' ' ASP . . . . . . . . . . . . . 48.1 m-20 -53.37 -32.1 47.76 Favored 'General case' 0 C--N 1.327 -0.371 0 N-CA-C 111.895 0.331 . . . . 0.0 111.895 -179.178 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' C' C ' 63' ' ' ARG . . . . . . . . . . . . . 35.9 ptt180 -88.5 5.17 43.86 Favored 'General case' 0 CA--C 1.537 0.46 0 N-CA-C 113.676 0.991 . . . . 0.0 113.676 -174.929 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' C' C ' 64' ' ' THR . . . . . . . . . . . . . 26.0 m -84.59 141.66 30.52 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-N 118.19 0.45 . . . . 0.0 110.653 -178.7 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' C' C ' 65' ' ' LYS . . . . . . . . . . . . . 98.8 mttt -89.52 133.53 34.54 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-O 121.092 0.473 . . . . 0.0 110.646 -179.195 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' C' C ' 66' ' ' ILE . . . . . . . . . . . . . 60.4 mt -114.15 127.26 71.66 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.237 0 N-CA-C 109.579 -0.526 . . . . 0.0 109.579 179.482 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' C' C ' 67' ' ' THR . . . . . . . . . . . . . 15.1 m -120.5 142.66 49.1 Favored 'General case' 0 C--N 1.331 -0.214 0 CA-C-O 121.176 0.512 . . . . 0.0 111.149 -175.597 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' C' C ' 68' ' ' LEU . . . . . . . . . . . . . 34.2 mt -104.82 145.75 29.94 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 115.761 -0.654 . . . . 0.0 110.534 179.605 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' C' C ' 69' ' ' VAL . . . . . . . . . . . . . 46.9 t -82.97 155.02 3.84 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.351 0 N-CA-C 109.757 -0.46 . . . . 0.0 109.757 176.394 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' C' C ' 70' ' ' THR . . . . . . . . . . . . . 66.1 p -83.16 171.0 14.14 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-O 121.226 0.536 . . . . 0.0 111.701 -172.502 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' C' C ' 71' ' ' HIS . . . . . . . . . . . . . 69.5 m80 -69.57 161.14 76.21 Favored Pre-proline 0 CA--C 1.533 0.308 0 CA-C-N 115.343 -0.844 . . . . 0.0 111.561 -176.464 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' C' C ' 72' ' ' PRO . . . . . . . . . . . . . 28.6 Cg_endo -64.98 160.23 42.46 Favored 'Trans proline' 0 N--CA 1.495 1.601 0 C-N-CA 121.537 1.492 . . . . 0.0 111.97 175.909 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' C' C ' 73' ' ' VAL . . . . . . . . . . . . . 34.6 m -69.91 -178.72 0.26 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.25 0 CA-C-N 116.174 -0.466 . . . . 0.0 110.618 -176.128 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' C' C ' 74' ' ' ASP . . . . . . . . . . . . . 15.7 t0 -96.06 122.75 39.22 Favored 'General case' 0 C--N 1.333 -0.147 0 C-N-CA 120.753 -0.379 . . . . 0.0 110.489 -174.094 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' C' C ' 75' ' ' VAL . . . . . . . . . . . . . 41.2 t -121.07 121.17 64.28 Favored 'Isoleucine or valine' 0 N--CA 1.462 0.166 0 CA-C-O 121.119 0.485 . . . . 0.0 110.498 -179.364 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' C' C ' 76' ' ' LEU . . . . . . . . . . . . . 5.4 mp -118.01 150.78 38.71 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 115.651 -0.704 . . . . 0.0 109.501 175.833 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' C' C ' 77' ' ' GLU . . . . . . . . . . . . . 97.7 mt-10 -136.87 136.59 38.84 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-O 121.042 0.449 . . . . 0.0 111.214 -177.769 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' C' C ' 78' ' ' ALA . . . . . . . . . . . . . . . -124.77 135.91 53.39 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 115.669 -0.696 . . . . 0.0 109.712 176.353 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' C' C ' 79' ' ' LYS . . . . . . . . . . . . . 99.0 mttt -81.73 119.04 23.35 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-O 120.913 0.387 . . . . 0.0 110.757 -178.498 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' C' C ' 80' ' ' ILE . . . . . . . . . . . . . 35.5 mm -139.1 105.6 2.61 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.334 0 N-CA-C 109.22 -0.659 . . . . 0.0 109.22 -178.013 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' C' C ' 81' ' ' LYS . . . . . . . . . . . . . 53.4 mtmt -98.12 125.24 43.04 Favored 'General case' 0 C--N 1.329 -0.314 0 C-N-CA 120.95 -0.3 . . . . 0.0 111.167 -176.934 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' C' C ' 82' ' ' GLY . . . . . . . . . . . . . . . 89.17 42.04 5.69 Favored Glycine 0 CA--C 1.526 0.728 0 C-N-CA 120.786 -0.721 . . . . 0.0 112.048 174.816 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' C' C ' 83' ' ' ILE . . . . . . . . . . . . . 76.5 mt -69.8 138.3 22.38 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.336 0 N-CA-C 109.676 -0.491 . . . . 0.0 109.676 176.749 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' C' C ' 84' ' ' LYS . . . . . . . . . . . . . 38.0 ttpt -101.58 -50.56 3.69 Favored 'General case' 0 C--N 1.331 -0.23 0 CA-C-O 120.942 0.401 . . . . 0.0 110.381 -178.77 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' C' C ' 85' ' ' ASP . . . . . . . . . . . . . 6.6 t0 -149.65 147.51 28.19 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 115.938 -0.574 . . . . 0.0 110.509 -178.572 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' C' C ' 86' ' ' VAL . . . . . . . . . . . . . 43.7 t -129.35 133.64 65.12 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.215 0 CA-C-O 120.925 0.393 . . . . 0.0 110.414 -179.043 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' C' C ' 87' ' ' ILE . . . . . . . . . . . . . 4.9 mp -121.94 127.6 75.42 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.215 0 CA-C-N 115.854 -0.612 . . . . 0.0 109.449 176.62 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' C' C ' 88' ' ' LEU . . . . . . . . . . . . . 22.3 tp -118.07 131.52 56.44 Favored 'General case' 0 C--N 1.331 -0.221 0 CA-C-O 121.078 0.466 . . . . 0.0 111.339 -177.279 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' C' C ' 89' ' ' ASP . . . . . . . . . . . . . 14.0 t70 -130.84 152.02 50.63 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 115.616 -0.72 . . . . 0.0 109.293 174.987 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' C' C ' 90' ' ' GLU . . . . . . . . . . . . . 84.9 tt0 -47.81 -35.73 10.62 Favored 'General case' 0 C--N 1.329 -0.286 0 N-CA-C 113.079 0.77 . . . . 0.0 113.079 -172.299 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' C' C ' 91' ' ' ASN . . . . . . . . . . . . . 35.9 m120 -115.4 2.88 14.03 Favored 'General case' 0 N--CA 1.468 0.462 0 N-CA-C 113.734 1.012 . . . . 0.0 113.734 -174.664 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' C' C ' 92' ' ' LEU . . . . . . . . . . . . . 40.7 mt -148.77 147.31 28.66 Favored 'General case' 0 C--N 1.332 -0.196 0 CA-C-N 118.305 0.502 . . . . 0.0 110.972 -175.228 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' C' C ' 93' ' ' ILE . . . . . . . . . . . . . 69.4 mt -125.18 122.05 62.16 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.278 0 N-CA-C 109.383 -0.599 . . . . 0.0 109.383 176.998 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' C' C ' 94' ' ' VAL . . . . . . . . . . . . . 42.9 t -121.87 127.12 75.34 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.267 0 CA-C-O 120.802 0.334 . . . . 0.0 110.155 -179.448 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' C' C ' 95' ' ' VAL . . . . . . . . . . . . . 45.8 t -122.7 132.64 70.86 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.249 0 CA-C-N 116.094 -0.503 . . . . 0.0 109.786 179.151 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' C' C ' 96' ' ' ILE . . . . . . . . . . . . . 62.7 mt -115.77 128.37 73.05 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.247 0 N-CA-C 109.433 -0.581 . . . . 0.0 109.433 179.75 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' C' C ' 97' ' ' THR . . . . . . . . . . . . . 64.9 p -105.3 163.16 12.82 Favored 'General case' 0 N--CA 1.464 0.233 0 CA-C-O 121.244 0.545 . . . . 0.0 111.68 -174.636 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' C' C ' 98' ' ' GLU . . . . . . . . . . . . . 14.9 mm-40 -53.78 -27.29 28.11 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 115.933 -0.576 . . . . 0.0 112.203 177.676 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' C' C ' 99' ' ' GLU . . . . . . . . . . . . . 71.1 mm-40 -75.26 9.74 1.93 Allowed 'General case' 0 CA--C 1.535 0.395 0 N-CA-C 113.284 0.846 . . . . 0.0 113.284 -177.681 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' C' C ' 100' ' ' ASN . . . . . . . . . . . . . 3.1 m-20 61.03 31.63 19.86 Favored 'General case' 0 CA--C 1.534 0.342 0 CA-C-N 118.268 0.485 . . . . 0.0 111.302 -178.611 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' C' C ' 101' ' ' GLU . . . . . . . . . . . . . 84.5 tt0 -109.63 145.14 36.95 Favored 'General case' 0 C--O 1.233 0.199 0 N-CA-C 109.729 -0.471 . . . . 0.0 109.729 174.569 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' C' C ' 102' ' ' VAL . . . . . . . . . . . . . 45.2 t -114.99 124.12 71.34 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.302 0 CA-C-N 116.137 -0.483 . . . . 0.0 109.783 -179.834 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' C' C ' 103' ' ' LEU . . . . . . . . . . . . . 21.5 mt -112.26 127.69 56.05 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 115.845 -0.616 . . . . 0.0 109.982 176.902 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' C' C ' 104' ' ' ILE . . . . . . . . . . . . . 66.3 mt -116.88 119.74 62.92 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.261 0 N-CA-C 110.268 -0.271 . . . . 0.0 110.268 -179.728 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' C' C ' 105' ' ' PHE . . . . . . . . . . . . . 44.7 m-85 -119.83 168.87 10.66 Favored 'General case' 0 C--N 1.332 -0.158 0 CA-C-N 115.421 -0.809 . . . . 0.0 110.078 179.183 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' C' C ' 106' ' ' ASN . . . . . . . . . . . . . 46.9 p-10 -103.02 -170.48 1.8 Allowed 'General case' 0 CA--C 1.53 0.187 0 N-CA-C 110.018 -0.364 . . . . 0.0 110.018 174.46 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' C' C ' 107' ' ' GLN . . . . . . . . . . . . . 57.0 tt0 -60.94 -23.2 65.12 Favored 'General case' 0 CA--C 1.532 0.272 0 N-CA-C 112.52 0.563 . . . . 0.0 112.52 -179.803 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' C' C ' 108' ' ' ASN . . . . . . . . . . . . . 37.5 t30 -89.88 14.02 13.12 Favored 'General case' 0 CA--C 1.536 0.406 0 N-CA-C 112.89 0.7 . . . . 0.0 112.89 -179.413 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' C' C ' 109' ' ' LEU . . . . . . . . . . . . . 10.4 tp 54.96 37.95 29.68 Favored 'General case' 0 C--O 1.232 0.144 0 CA-C-O 121.036 0.446 . . . . 0.0 111.225 178.732 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' C' C ' 110' ' ' GLU . . . . . . . . . . . . . 70.7 mm-40 -107.98 155.93 19.79 Favored 'General case' 0 C--N 1.331 -0.237 0 N-CA-C 109.921 -0.4 . . . . 0.0 109.921 175.423 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' C' C ' 111' ' ' GLU . . . . . . . . . . . . . 65.8 tt0 -84.56 122.02 28.43 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-N 116.278 -0.419 . . . . 0.0 111.053 -176.245 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' C' C ' 112' ' ' LEU . . . . . . . . . . . . . 36.2 mt -105.44 -46.04 4.3 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.343 -0.39 . . . . 0.0 110.376 177.58 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' C' C ' 113' ' ' TYR . . . . . . . . . . . . . 56.8 t80 -143.68 141.35 30.5 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.301 -0.409 . . . . 0.0 110.966 -179.487 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' C' C ' 114' ' ' ARG . . . . . . . . . . . . . 58.2 ttp180 -139.45 125.27 19.6 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.248 -0.433 . . . . 0.0 110.332 177.642 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' C' C ' 115' ' ' GLY . . . . . . . . . . . . . . . -149.97 151.11 23.23 Favored Glycine 0 CA--C 1.524 0.624 0 N-CA-C 110.905 -0.878 . . . . 0.0 110.905 -179.963 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' C' C ' 116' ' ' LYS . . . . . . . . . . . . . 53.3 tttt -122.09 134.85 54.76 Favored 'General case' 0 C--N 1.328 -0.355 0 N-CA-C 110.021 -0.363 . . . . 0.0 110.021 179.03 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' C' C ' 117' ' ' PHE . . . . . . . . . . . . . 40.9 m-85 -132.31 114.95 15.01 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-N 116.256 -0.429 . . . . 0.0 110.2 -175.921 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' C' C ' 118' ' ' GLU . . . . . . . . . . . . . 43.2 mt-10 -53.32 -44.95 68.8 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.478 -0.328 . . . . 0.0 111.599 -176.625 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' C' C ' 119' ' ' ASN . . . . . . . . . . . . . 30.4 m120 -100.06 31.07 3.46 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.238 -0.437 . . . . 0.0 112.098 -174.271 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' C' C ' 120' ' ' LEU . . . . . . . . . . . . . 13.2 tp -55.39 119.83 6.19 Favored 'General case' 0 N--CA 1.462 0.174 0 C-N-CA 120.984 -0.286 . . . . 0.0 110.696 178.456 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' C' C ' 121' ' ' ASN . . . . . . . . . . . . . 8.2 t-20 -113.98 -44.07 3.19 Favored 'General case' 0 C--N 1.331 -0.209 0 CA-C-N 116.477 -0.329 . . . . 0.0 111.257 -175.884 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' C' C ' 122' ' ' LYS . . . . . . . . . . . . . 95.1 mttt -142.13 148.74 38.8 Favored 'General case' 0 C--N 1.331 -0.216 0 CA-C-O 121.055 0.455 . . . . 0.0 111.602 -176.255 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' C' C ' 123' ' ' VAL . . . . . . . . . . . . . 47.1 t -132.04 124.58 53.21 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.267 0 CA-C-N 115.846 -0.616 . . . . 0.0 109.418 174.222 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' C' C ' 124' ' ' LEU . . . . . . . . . . . . . 6.3 mp -119.71 134.72 55.12 Favored 'General case' 0 N--CA 1.463 0.191 0 CA-C-N 116.453 -0.34 . . . . 0.0 110.711 -178.118 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' C' C ' 125' ' ' VAL . . . . . . . . . . . . . 43.5 t -132.58 124.23 50.95 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.254 0 CA-C-N 116.144 -0.48 . . . . 0.0 110.183 -179.82 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' C' C ' 126' ' ' ARG . . . . . . . . . . . . . 59.9 mtm180 -151.86 135.74 16.42 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.32 -0.4 . . . . 0.0 109.95 176.7 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' C' C ' 127' ' ' ASN . . . . . . . . . . . . . 5.5 m120 55.0 -154.22 0.3 Allowed 'General case' 0 CA--C 1.54 0.559 0 N-CA-C 110.073 -0.343 . . . . 0.0 110.073 177.852 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' C' C ' 128' ' ' ASP . . . . . . . . . . . . . 15.1 p-10 -83.05 20.74 1.16 Allowed 'General case' 0 CA--C 1.533 0.309 0 N-CA-C 112.509 0.559 . . . . 0.0 112.509 178.13 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' C' C ' 129' ' ' LEU . . . . . . . . . . . . . 14.5 tp -123.15 137.1 54.99 Favored 'General case' 0 C--O 1.234 0.269 0 O-C-N 122.052 -0.405 . . . . 0.0 110.311 179.091 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' C' C ' 130' ' ' VAL . . . . . . . . . . . . . 12.3 p -132.74 143.29 40.07 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.255 0 CA-C-O 120.999 0.428 . . . . 0.0 110.2 179.412 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' C' C ' 131' ' ' VAL . . . . . . . . . . . . . 41.5 t -136.04 138.93 46.72 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.37 0 CA-C-N 116.032 -0.531 . . . . 0.0 110.339 -178.436 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' C' C ' 132' ' ' ILE . . . . . . . . . . . . . 71.3 mt -116.09 132.45 65.59 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.323 0 CA-C-N 115.614 -0.721 . . . . 0.0 109.141 177.683 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' C' C ' 133' ' ' ILE . . . . . . . . . . . . . 41.4 mm -116.8 121.61 68.12 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.237 0 CA-C-O 120.753 0.311 . . . . 0.0 110.927 -174.464 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' C' C ' 134' ' ' ASP . . . . . . . . . . . . . 8.1 p-10 -135.42 146.48 48.31 Favored 'General case' 0 C--N 1.332 -0.18 0 CA-C-N 116.006 -0.543 . . . . 0.0 109.589 175.316 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' C' C ' 135' ' ' GLU . . . . . . . . . . . . . 83.2 tt0 -50.53 -27.67 7.09 Favored 'General case' 0 C--N 1.329 -0.321 0 N-CA-C 112.827 0.677 . . . . 0.0 112.827 -172.967 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' C' C ' 136' ' ' GLN . . . . . . . . . . . . . 98.4 mt-30 -79.7 -33.24 41.19 Favored 'General case' 0 C--N 1.331 -0.203 0 N-CA-C 112.263 0.468 . . . . 0.0 112.263 -176.226 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' C' C ' 137' ' ' LYS . . . . . . . . . . . . . 56.1 pttt -169.74 174.7 5.61 Favored 'General case' 0 C--N 1.331 -0.21 0 CA-C-O 121.524 0.678 . . . . 0.0 112.257 -172.894 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' C' C ' 138' ' ' LEU . . . . . . . . . . . . . 6.0 tt -119.14 130.38 55.51 Favored 'General case' 0 C--N 1.331 -0.226 0 CA-C-N 114.973 -1.012 . . . . 0.0 110.236 -179.109 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' C' C ' 139' ' ' THR . . . . . . . . . . . . . 21.7 m -108.52 121.76 45.65 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.141 -0.482 . . . . 0.0 110.755 179.551 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' C' C ' 140' ' ' LEU . . . . . . . . . . . . . 33.3 tp -109.59 118.9 37.8 Favored 'General case' 0 C--N 1.329 -0.283 0 N-CA-C 109.058 -0.719 . . . . 0.0 109.058 -179.975 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' C' C ' 141' ' ' ILE . . . . . . . . . . . . . 22.1 mt -121.82 121.61 64.72 Favored 'Isoleucine or valine' 0 C--O 1.234 0.259 0 CA-C-O 121.089 0.471 . . . . 0.0 110.225 -175.627 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' C' C ' 142' ' ' ARG . . . . . . . . . . . . . 80.6 mtp180 -103.6 116.56 32.58 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 115.273 -0.876 . . . . 0.0 110.111 178.265 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' C' C ' 143' ' ' THR . . . . . . . . . . . . . 71.4 p . . . . . 0 C--O 1.219 -0.519 0 CA-C-O 117.992 -1.004 . . . . 0.0 110.528 -179.453 . . . . . . . . 0 0 . 1 . 004 nuclear orig full ' D' D ' -3' ' ' GLU . . . . . . . . . . . . . 96.0 mt-10 . . . . . 0 N--CA 1.489 1.524 0 N-CA-C 109.446 -0.576 . . . . 0.0 109.446 . . . . . . . . . 0 0 . 1 . 004 nuclear orig full ' D' D ' -2' ' ' GLY . . . . . . . . . . . . . . . -97.81 121.76 7.23 Favored Glycine 0 CA--C 1.526 0.767 0 N-CA-C 110.733 -0.947 . . . . 0.0 110.733 179.271 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' D' D ' -1' ' ' VAL . . . . . . . . . . . . . 43.7 t -95.85 134.33 33.74 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.317 0 CA-C-O 120.78 0.324 . . . . 0.0 110.163 -179.642 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' D' D ' 0' ' ' ILE . . . . . . . . . . . . . 43.9 mm -113.66 138.19 44.22 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.237 0 CA-C-N 116.265 -0.425 . . . . 0.0 110.15 -179.529 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' D' D ' 1' ' ' MET . . . . . . . . . . . . . 24.9 ptp -84.04 132.24 34.74 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.701 179.974 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' D' D ' 2' ' ' SER . . . . . . . . . . . . . 18.2 p -125.83 136.97 53.7 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.125 -0.489 . . . . 0.0 110.274 178.582 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' D' D ' 3' ' ' GLU . . . . . . . . . . . . . 75.4 tt0 -148.0 139.23 23.46 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.235 -0.439 . . . . 0.0 111.305 -176.816 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' D' D ' 4' ' ' LEU . . . . . . . . . . . . . 16.1 tp -124.01 130.2 52.18 Favored 'General case' 0 C--N 1.331 -0.214 0 CA-C-N 116.051 -0.522 . . . . 0.0 110.031 176.477 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' D' D ' 5' ' ' LYS . . . . . . . . . . . . . 65.3 mttm -112.66 123.22 49.81 Favored 'General case' 0 C--O 1.233 0.215 0 CA-C-N 116.516 -0.311 . . . . 0.0 110.944 -179.734 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' D' D ' 6' ' ' LEU . . . . . . . . . . . . . 55.0 mt -115.72 143.19 45.72 Favored 'General case' 0 N--CA 1.463 0.206 0 CA-C-N 115.609 -0.723 . . . . 0.0 110.63 -179.299 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' D' D ' 7' ' ' LYS . . . . . . . . . . . . . 52.1 tttm -124.36 139.37 32.77 Favored Pre-proline 0 CA--C 1.536 0.409 0 CA-C-O 118.88 -0.581 . . . . 0.0 109.434 175.474 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' D' D ' 8' ' ' PRO . . . . . . . . . . . . . 86.4 Cg_endo -91.72 143.07 2.84 Favored 'Trans proline' 0 N--CA 1.491 1.363 0 C-N-CA 121.707 1.605 . . . . 0.0 112.026 179.647 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' D' D ' 9' ' ' LEU . . . . . . . . . . . . . 48.9 mt -81.98 -46.59 1.01 Allowed Pre-proline 0 CA--C 1.533 0.302 0 CA-C-O 118.757 -0.64 . . . . 0.0 112.113 178.595 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' D' D ' 10' ' ' PRO . . . . . . . . . . . . . 83.6 Cg_endo -83.46 151.5 13.43 Favored 'Trans proline' 0 N--CA 1.495 1.57 0 C-N-CA 121.316 1.344 . . . . 0.0 111.693 174.928 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' D' D ' 11' ' ' LYS . . . . . . . . . . . . . 53.4 pttt -84.98 116.68 23.51 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-O 121.234 0.54 . . . . 0.0 110.144 177.41 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' D' D ' 12' ' ' VAL . . . . . . . . . . . . . 12.1 p -151.06 149.63 14.01 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.223 0 CA-C-N 116.023 -0.535 . . . . 0.0 110.777 -178.457 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' D' D ' 13' ' ' GLU . . . . . . . . . . . . . 84.7 tt0 -99.16 111.69 24.02 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.262 -0.426 . . . . 0.0 110.225 177.164 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' D' D ' 14' ' ' LEU . . . . . . . . . . . . . 20.0 mt -98.37 158.05 33.32 Favored Pre-proline 0 C--N 1.33 -0.274 0 CA-C-N 116.513 -0.312 . . . . 0.0 111.27 -177.469 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' D' D ' 15' ' ' PRO . . . . . . . . . . . . . 23.1 Cg_exo -64.72 161.53 35.48 Favored 'Trans proline' 0 N--CA 1.496 1.671 0 C-N-CA 121.424 1.416 . . . . 0.0 111.876 176.973 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' D' D ' 16' ' ' PRO . . . . . . . . . . . . . 24.6 Cg_exo -62.2 -39.8 45.81 Favored 'Trans proline' 0 N--CA 1.496 1.667 0 C-N-CA 121.53 1.487 . . . . 0.0 112.622 -179.182 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' D' D ' 17' ' ' ASP . . . . . . . . . . . . . 16.2 p-10 -84.66 9.58 13.46 Favored 'General case' 0 CA--C 1.537 0.446 0 N-CA-C 113.175 0.805 . . . . 0.0 113.175 -177.109 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' D' D ' 18' ' ' PHE . . . . . . . . . . . . . 48.0 t80 -56.64 -46.47 81.0 Favored 'General case' 0 C--N 1.334 -0.097 0 O-C-N 121.983 -0.448 . . . . 0.0 110.465 -178.397 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' D' D ' 19' ' ' VAL . . . . . . . . . . . . . 48.0 t -56.65 -42.7 77.22 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.338 0 CA-C-N 116.354 -0.385 . . . . 0.0 110.595 -178.006 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' D' D ' 20' ' ' ASP . . . . . . . . . . . . . 9.9 t0 -59.63 -42.46 92.76 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-O 120.79 0.329 . . . . 0.0 110.839 -177.82 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' D' D ' 21' ' ' VAL . . . . . . . . . . . . . 46.5 t -64.02 -45.96 95.21 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.257 0 C-N-CA 120.806 -0.358 . . . . 0.0 110.479 -178.524 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' D' D ' 22' ' ' ILE . . . . . . . . . . . . . 51.4 mm -54.33 -48.49 67.86 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.258 0 O-C-N 122.289 -0.257 . . . . 0.0 110.812 178.812 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' D' D ' 23' ' ' ARG . . . . . . . . . . . . . 54.1 ttp180 -54.24 -52.12 62.35 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-O 120.793 0.33 . . . . 0.0 111.43 -178.905 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' D' D ' 24' ' ' ILE . . . . . . . . . . . . . 71.4 mt -56.85 -44.2 81.58 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.315 0 CA-C-N 116.541 -0.299 . . . . 0.0 111.271 -174.703 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' D' D ' 25' ' ' LYS . . . . . . . . . . . . . 80.9 mttt -69.34 -43.95 72.64 Favored 'General case' 0 C--N 1.329 -0.311 0 N-CA-C 112.428 0.529 . . . . 0.0 112.428 -177.466 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' D' D ' 26' ' ' LEU . . . . . . . . . . . . . 59.3 mt -83.35 -16.15 47.17 Favored 'General case' 0 C--N 1.329 -0.307 0 N-CA-C 113.786 1.032 . . . . 0.0 113.786 -170.12 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' D' D ' 27' ' ' GLN . . . . . . . . . . . . . 11.0 pt20 -46.65 151.44 0.58 Allowed 'General case' 0 N--CA 1.468 0.439 0 N-CA-C 112.837 0.68 . . . . 0.0 112.837 -177.013 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' D' D ' 28' ' ' GLY . . . . . . . . . . . . . . . 84.74 -18.18 27.07 Favored Glycine 0 CA--C 1.537 1.438 0 CA-C-N 114.937 -1.029 . . . . 0.0 113.055 -173.636 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' D' D ' 29' ' ' LYS . . . . . . . . . . . . . 51.7 mttm -86.5 134.81 33.64 Favored 'General case' 0 CA--C 1.535 0.371 0 CA-C-N 118.273 1.037 . . . . 0.0 112.596 179.343 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' D' D ' 30' ' ' THR . . . . . . . . . . . . . 26.7 m -88.73 132.77 34.46 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 115.531 -0.759 . . . . 0.0 109.593 175.791 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' D' D ' 31' ' ' VAL . . . . . . . . . . . . . 35.0 m -126.46 148.8 31.14 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.29 0 CA-C-O 120.767 0.318 . . . . 0.0 111.066 -177.532 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' D' D ' 32' ' ' ARG . . . . . . . . . . . . . 75.6 mtt180 -131.29 151.07 51.85 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 116.056 -0.52 . . . . 0.0 110.381 177.764 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' D' D ' 33' ' ' THR . . . . . . . . . . . . . 12.6 m -52.93 137.63 32.02 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.243 -0.435 . . . . 0.0 111.43 -178.49 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' D' D ' 34' ' ' GLY . . . . . . . . . . . . . . . 100.74 -17.1 56.97 Favored Glycine 0 CA--C 1.533 1.177 0 CA-C-O 119.642 -0.532 . . . . 0.0 113.228 178.779 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' D' D ' 35' ' ' ASP . . . . . . . . . . . . . 62.1 m-20 -65.34 150.32 48.48 Favored 'General case' 0 C--O 1.232 0.156 0 CA-C-N 118.038 0.919 . . . . 0.0 111.224 -179.733 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' D' D ' 36' ' ' VAL . . . . . . . . . . . . . 46.8 t -121.22 128.27 75.95 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.272 0 CA-C-N 115.776 -0.647 . . . . 0.0 109.682 178.031 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' D' D ' 37' ' ' ILE . . . . . . . . . . . . . 65.2 mt -122.25 139.24 49.8 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.243 0 CA-C-N 116.159 -0.473 . . . . 0.0 109.807 -179.29 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' D' D ' 38' ' ' GLY . . . . . . . . . . . . . . . -118.47 128.9 7.92 Favored Glycine 0 CA--C 1.526 0.721 0 N-CA-C 111.2 -0.76 . . . . 0.0 111.2 -179.613 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' D' D ' 39' ' ' ILE . . . . . . . . . . . . . 70.3 mt -124.7 130.51 73.39 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.179 0 N-CA-C 109.881 -0.414 . . . . 0.0 109.881 178.196 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' D' D ' 40' ' ' SER . . . . . . . . . . . . . 18.4 m -92.47 124.83 36.8 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.301 -0.409 . . . . 0.0 111.116 177.634 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' D' D ' 41' ' ' ILE . . . . . . . . . . . . . 66.8 mt -135.65 122.84 34.97 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.204 0 N-CA-C 110.02 -0.363 . . . . 0.0 110.02 177.749 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' D' D ' 42' ' ' LEU . . . . . . . . . . . . . 68.2 mt 58.2 35.2 24.83 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.176 -0.465 . . . . 0.0 111.522 178.124 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' D' D ' 43' ' ' GLY . . . . . . . . . . . . . . . 77.88 -10.19 27.05 Favored Glycine 0 CA--C 1.534 1.261 0 C-N-CA 121.235 -0.507 . . . . 0.0 113.418 177.278 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' D' D ' 44' ' ' LYS . . . . . . . . . . . . . 57.7 tttm -102.91 131.52 49.78 Favored 'General case' 0 C--N 1.334 -0.071 0 CA-C-N 118.007 0.903 . . . . 0.0 110.144 177.857 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' D' D ' 45' ' ' GLU . . . . . . . . . . . . . 83.6 tt0 -85.77 133.23 34.01 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.328 -0.396 . . . . 0.0 111.539 -179.318 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' D' D ' 46' ' ' VAL . . . . . . . . . . . . . 9.6 p -120.24 123.96 71.67 Favored 'Isoleucine or valine' 0 C--O 1.233 0.208 0 N-CA-C 109.42 -0.585 . . . . 0.0 109.42 173.206 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' D' D ' 47' ' ' LYS . . . . . . . . . . . . . 98.2 mttt -98.72 127.73 44.74 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.092 -0.504 . . . . 0.0 110.79 178.594 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' D' D ' 48' ' ' PHE . . . . . . . . . . . . . 35.9 m-85 -112.17 131.92 55.19 Favored 'General case' 0 C--N 1.33 -0.263 0 N-CA-C 109.714 -0.476 . . . . 0.0 109.714 177.362 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' D' D ' 49' ' ' LYS . . . . . . . . . . . . . 79.5 tttt -107.07 133.04 52.29 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.325 -0.398 . . . . 0.0 109.967 177.531 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' D' D ' 50' ' ' VAL . . . . . . . . . . . . . 43.2 t -76.71 109.83 11.49 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.339 0 N-CA-C 109.631 -0.507 . . . . 0.0 109.631 179.001 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' D' D ' 51' ' ' VAL . . . . . . . . . . . . . 47.3 t -74.17 -48.37 37.65 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.35 0 CA-C-N 116.057 -0.52 . . . . 0.0 109.918 -175.179 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' D' D ' 52' ' ' GLN . . . . . . . . . . . . . 48.4 tt0 -160.72 137.75 9.03 Favored 'General case' 0 C--N 1.33 -0.266 0 C-N-CA 120.299 -0.56 . . . . 0.0 111.595 -178.121 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' D' D ' 53' ' ' ALA . . . . . . . . . . . . . . . -116.64 132.12 56.77 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 115.975 -0.557 . . . . 0.0 109.744 174.619 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' D' D ' 54' ' ' TYR . . . . . . . . . . . . . 50.7 t80 -129.01 112.02 18.51 Favored Pre-proline 0 CA--C 1.535 0.385 0 CA-C-O 118.166 -0.921 . . . . 0.0 110.346 179.12 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' D' D ' 55' ' ' PRO . . . . . . . . . . . . . 73.8 Cg_endo -77.18 168.73 76.1 Favored 'Cis proline' 0 N--CA 1.499 1.822 0 CA-C-N 122.061 1.772 . . . . 0.0 112.368 -6.223 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' D' D ' 56' ' ' SER . . . . . . . . . . . . . 13.5 m -117.11 126.57 27.34 Favored Pre-proline 0 CA--C 1.538 0.505 0 CA-C-O 118.347 -0.835 . . . . 0.0 109.108 174.732 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' D' D ' 57' ' ' PRO . . . . . . . . . . . . . 49.6 Cg_endo -69.55 146.66 82.37 Favored 'Cis proline' 0 N--CA 1.497 1.683 0 CA-C-N 122.063 1.772 . . . . 0.0 112.044 1.934 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' D' D ' 58' ' ' LEU . . . . . . . . . . . . . 17.5 tp -106.28 135.09 48.38 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 115.99 -0.55 . . . . 0.0 110.641 179.745 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' D' D ' 59' ' ' ARG . . . . . . . . . . . . . 1.5 tpm_? -104.58 107.59 18.6 Favored 'General case' 0 C--N 1.327 -0.401 0 N-CA-C 109.01 -0.737 . . . . 0.0 109.01 178.473 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' D' D ' 60' ' ' VAL . . . . . . . . . . . . . 43.1 t -72.69 108.72 4.25 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.378 0 CA-C-O 121.449 0.642 . . . . 0.0 112.005 -174.643 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' D' D ' 61' ' ' GLU . . . . . . . . . . . . . 95.7 mt-10 -125.16 167.21 15.13 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.269 -0.423 . . . . 0.0 109.892 175.624 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' D' D ' 62' ' ' ASP . . . . . . . . . . . . . 7.6 t0 -52.85 -32.36 44.12 Favored 'General case' 0 C--N 1.328 -0.36 0 N-CA-C 112.066 0.395 . . . . 0.0 112.066 -177.035 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' D' D ' 63' ' ' ARG . . . . . . . . . . . . . 34.5 ptt180 -73.66 -17.32 61.16 Favored 'General case' 0 CA--C 1.535 0.38 0 N-CA-C 113.282 0.845 . . . . 0.0 113.282 -175.743 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' D' D ' 64' ' ' THR . . . . . . . . . . . . . 32.6 m -77.54 143.75 38.16 Favored 'General case' 0 C--N 1.331 -0.229 0 CA-C-O 120.872 0.368 . . . . 0.0 111.048 -175.511 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' D' D ' 65' ' ' LYS . . . . . . . . . . . . . 99.1 mttt -89.17 134.62 33.95 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 115.977 -0.556 . . . . 0.0 110.313 178.591 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' D' D ' 66' ' ' ILE . . . . . . . . . . . . . 69.2 mt -118.7 127.66 75.64 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.228 0 N-CA-C 109.733 -0.469 . . . . 0.0 109.733 178.625 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' D' D ' 67' ' ' THR . . . . . . . . . . . . . 20.2 m -116.02 135.87 53.56 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.113 -0.494 . . . . 0.0 110.948 -176.72 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' D' D ' 68' ' ' LEU . . . . . . . . . . . . . 16.7 tp -106.33 121.53 44.42 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 115.726 -0.67 . . . . 0.0 110.319 178.553 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' D' D ' 69' ' ' VAL . . . . . . . . . . . . . 44.1 t -100.24 135.14 37.36 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.321 0 N-CA-C 109.904 -0.406 . . . . 0.0 109.904 179.334 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' D' D ' 70' ' ' THR . . . . . . . . . . . . . 19.9 m -132.32 107.12 8.33 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-N 116.281 -0.418 . . . . 0.0 110.601 -178.668 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' D' D ' 71' ' ' HIS . . . . . . . . . . . . . 31.7 m80 -150.01 65.56 7.52 Favored Pre-proline 0 CA--C 1.536 0.436 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.549 177.89 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' D' D ' 72' ' ' PRO . . . . . . . . . . . . . 98.5 Cg_endo -89.92 159.05 4.98 Favored 'Trans proline' 0 N--CA 1.49 1.269 0 C-N-CA 121.896 1.73 . . . . 0.0 112.052 178.106 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' D' D ' 73' ' ' VAL . . . . . . . . . . . . . 36.0 m -102.7 151.34 6.09 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.241 0 CA-C-O 120.743 0.306 . . . . 0.0 110.182 177.686 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' D' D ' 74' ' ' ASP . . . . . . . . . . . . . 18.5 t0 -95.21 116.66 29.04 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.152 -0.477 . . . . 0.0 109.831 -178.45 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' D' D ' 75' ' ' VAL . . . . . . . . . . . . . 44.6 t -111.68 121.95 65.15 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.227 0 CA-C-O 121.164 0.507 . . . . 0.0 110.547 -177.02 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' D' D ' 76' ' ' LEU . . . . . . . . . . . . . 21.7 mt -122.13 140.47 52.5 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 115.563 -0.744 . . . . 0.0 109.514 177.543 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' D' D ' 77' ' ' GLU . . . . . . . . . . . . . 46.7 mt-10 -133.77 135.88 44.19 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-O 120.92 0.39 . . . . 0.0 111.126 -178.136 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' D' D ' 78' ' ' ALA . . . . . . . . . . . . . . . -124.59 127.18 46.98 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 115.729 -0.669 . . . . 0.0 109.998 177.771 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' D' D ' 79' ' ' LYS . . . . . . . . . . . . . 37.0 tptt -75.9 115.72 15.88 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-O 120.864 0.364 . . . . 0.0 110.535 -177.89 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' D' D ' 80' ' ' ILE . . . . . . . . . . . . . 40.4 mm -139.26 111.59 5.62 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.287 0 N-CA-C 109.493 -0.558 . . . . 0.0 109.493 -176.355 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' D' D ' 81' ' ' LYS . . . . . . . . . . . . . 99.1 mttt -101.14 123.82 45.89 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-O 120.855 0.36 . . . . 0.0 110.96 -178.091 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' D' D ' 82' ' ' GLY . . . . . . . . . . . . . . . 89.0 42.35 5.66 Favored Glycine 0 CA--C 1.524 0.647 0 C-N-CA 120.791 -0.718 . . . . 0.0 111.826 175.05 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' D' D ' 83' ' ' ILE . . . . . . . . . . . . . 71.8 mt -63.77 136.73 25.89 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.33 0 N-CA-C 109.607 -0.516 . . . . 0.0 109.607 176.338 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' D' D ' 84' ' ' LYS . . . . . . . . . . . . . 76.7 tttt -95.78 -53.95 3.52 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.107 -0.497 . . . . 0.0 110.412 -177.567 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' D' D ' 85' ' ' ASP . . . . . . . . . . . . . 12.9 t70 -151.43 148.87 28.62 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 115.878 -0.601 . . . . 0.0 110.379 -179.21 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' D' D ' 86' ' ' VAL . . . . . . . . . . . . . 42.2 t -127.84 128.17 68.96 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.28 0 CA-C-O 120.886 0.374 . . . . 0.0 110.379 -179.078 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' D' D ' 87' ' ' ILE . . . . . . . . . . . . . 4.9 mp -122.36 127.39 75.11 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.153 0 CA-C-N 115.994 -0.548 . . . . 0.0 109.634 176.993 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' D' D ' 88' ' ' LEU . . . . . . . . . . . . . 58.5 mt -110.22 134.96 51.7 Favored 'General case' 0 C--N 1.331 -0.204 0 CA-C-O 121.025 0.441 . . . . 0.0 110.802 -179.784 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' D' D ' 89' ' ' ASP . . . . . . . . . . . . . 4.4 t70 -123.82 163.12 21.85 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 115.775 -0.648 . . . . 0.0 109.526 178.265 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' D' D ' 90' ' ' GLU . . . . . . . . . . . . . 43.6 tp10 -44.92 -46.02 10.72 Favored 'General case' 0 N--CA 1.464 0.255 0 N-CA-C 113.158 0.799 . . . . 0.0 113.158 -171.495 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' D' D ' 91' ' ' ASN . . . . . . . . . . . . . 25.5 p30 -132.1 26.93 4.55 Favored 'General case' 0 N--CA 1.465 0.276 0 N-CA-C 112.408 0.521 . . . . 0.0 112.408 -178.837 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' D' D ' 92' ' ' LEU . . . . . . . . . . . . . 15.3 mt -147.72 150.44 34.32 Favored 'General case' 0 C--N 1.332 -0.164 0 CA-C-O 120.738 0.304 . . . . 0.0 110.493 -176.352 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' D' D ' 93' ' ' ILE . . . . . 0.41 HG22 HD12 ' D' ' 93' ' ' ILE . 69.0 mt -126.38 119.55 54.2 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.272 0 N-CA-C 109.363 -0.606 . . . . 0.0 109.363 177.785 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' D' D ' 94' ' ' VAL . . . . . . . . . . . . . 45.2 t -119.69 126.28 75.16 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.282 0 CA-C-O 120.99 0.424 . . . . 0.0 109.892 -179.743 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' D' D ' 95' ' ' VAL . . . . . . . . . . . . . 45.6 t -124.15 136.22 61.1 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.265 0 CA-C-N 116.003 -0.544 . . . . 0.0 110.046 -179.392 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' D' D ' 96' ' ' ILE . . . . . . . . . . . . . 54.4 mt -114.75 128.52 71.82 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.343 0 N-CA-C 108.979 -0.749 . . . . 0.0 108.979 178.539 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' D' D ' 97' ' ' THR . . . . . . . . . . . . . 55.1 p -101.11 160.53 14.31 Favored 'General case' 0 C--N 1.331 -0.216 0 CA-C-O 121.115 0.484 . . . . 0.0 111.416 -175.824 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' D' D ' 98' ' ' GLU . . . . . . . . . . . . . 84.2 tt0 -53.86 -26.97 27.12 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.192 -0.458 . . . . 0.0 112.094 178.399 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' D' D ' 99' ' ' GLU . . . . . . . . . . . . . 43.6 mt-10 -77.83 14.34 1.11 Allowed 'General case' 0 CA--C 1.536 0.409 0 N-CA-C 113.01 0.744 . . . . 0.0 113.01 -178.921 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' D' D ' 100' ' ' ASN . . . . . . . . . . . . . 1.9 m120 63.58 37.87 10.03 Favored 'General case' 0 CA--C 1.529 0.155 0 CA-C-N 118.103 0.411 . . . . 0.0 110.731 177.288 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' D' D ' 101' ' ' GLU . . . . . . . . . . . . . 96.7 mt-10 -113.12 148.21 35.76 Favored 'General case' 0 C--O 1.232 0.152 0 CA-C-N 116.268 -0.424 . . . . 0.0 110.377 177.356 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' D' D ' 102' ' ' VAL . . . . . . . . . . . . . 45.5 t -114.88 121.73 67.55 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.367 0 CA-C-N 115.662 -0.699 . . . . 0.0 109.412 177.811 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' D' D ' 103' ' ' LEU . . . . . . . . . . . . . 21.1 mt -115.0 125.66 53.85 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 115.811 -0.631 . . . . 0.0 109.889 177.531 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' D' D ' 104' ' ' ILE . . . . . . . . . . . . . 69.5 mt -114.77 118.77 59.7 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 N-CA-C 110.038 -0.356 . . . . 0.0 110.038 -179.648 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' D' D ' 105' ' ' PHE . . . . . . . . . . . . . 27.9 m-85 -119.88 166.1 13.74 Favored 'General case' 0 C--N 1.331 -0.216 0 O-C-N 123.972 0.795 . . . . 0.0 109.929 178.513 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' D' D ' 106' ' ' ASN . . . . . . . . . . . . . 41.3 p-10 -98.27 -170.33 1.95 Allowed 'General case' 0 C--N 1.329 -0.313 0 N-CA-C 109.791 -0.448 . . . . 0.0 109.791 174.614 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' D' D ' 107' ' ' GLN . . . . . . . . . . . . . 58.1 tt0 -59.77 -29.79 68.42 Favored 'General case' 0 CA--C 1.532 0.285 0 N-CA-C 111.827 0.306 . . . . 0.0 111.827 178.675 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' D' D ' 108' ' ' ASN . . . . . . . . . . . . . 5.1 t-20 -81.99 3.19 27.49 Favored 'General case' 0 CA--C 1.536 0.442 0 N-CA-C 113.283 0.846 . . . . 0.0 113.283 -177.443 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' D' D ' 109' ' ' LEU . . . . . . . . . . . . . 9.5 tp 64.48 40.94 5.91 Favored 'General case' 0 CA--C 1.53 0.182 0 CA-C-O 121.13 0.491 . . . . 0.0 111.364 177.543 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' D' D ' 110' ' ' GLU . . . . . . . . . . . . . 70.7 mm-40 -111.11 160.97 16.4 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-N 116.226 -0.443 . . . . 0.0 109.954 175.243 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' D' D ' 111' ' ' GLU . . . . . . . . . . . . . 45.1 tp10 -84.55 127.14 33.89 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-O 120.881 0.372 . . . . 0.0 111.065 -177.113 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' D' D ' 112' ' ' LEU . . . . . . . . . . . . . 18.9 mt -113.05 -46.11 3.12 Favored 'General case' 0 C--O 1.233 0.213 0 CA-C-N 116.017 -0.538 . . . . 0.0 110.388 176.825 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' D' D ' 113' ' ' TYR . . . . . . . . . . . . . 59.3 t80 -141.13 140.32 34.1 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.303 -0.408 . . . . 0.0 111.003 -179.939 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' D' D ' 114' ' ' ARG . . . . . . . . . . . . . 36.5 ttp180 -141.83 125.1 16.46 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 116.443 -0.344 . . . . 0.0 110.543 177.95 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' D' D ' 115' ' ' GLY . . . . . . . . . . . . . . . -150.1 160.95 28.75 Favored Glycine 0 CA--C 1.523 0.56 0 N-CA-C 111.124 -0.79 . . . . 0.0 111.124 178.867 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' D' D ' 116' ' ' LYS . . . . . . . . . . . . . 39.4 ttpt -127.25 134.34 50.09 Favored 'General case' 0 C--N 1.33 -0.281 0 N-CA-C 110.119 -0.326 . . . . 0.0 110.119 177.287 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' D' D ' 117' ' ' PHE . . . . . . . . . . . . . 31.5 m-85 -138.32 113.89 9.69 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.241 -0.436 . . . . 0.0 110.059 -176.739 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' D' D ' 118' ' ' GLU . . . . . . . . . . . . . 41.6 mp0 -55.18 -49.22 72.43 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-N 116.45 -0.341 . . . . 0.0 111.436 -174.504 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' D' D ' 119' ' ' ASN . . . . . . . . . . . . . 2.7 p30 -94.5 31.16 1.81 Allowed 'General case' 0 C--N 1.331 -0.216 0 N-CA-C 112.168 0.433 . . . . 0.0 112.168 -175.337 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' D' D ' 120' ' ' LEU . . . . . . . . . . . . . 26.8 tp -55.7 119.91 6.46 Favored 'General case' 0 C--N 1.332 -0.175 0 N-CA-C 110.344 -0.243 . . . . 0.0 110.344 175.831 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' D' D ' 121' ' ' ASN . . . . . . . . . . . . . 86.6 m-20 -114.19 -44.0 3.17 Favored 'General case' 0 N--CA 1.463 0.202 0 N-CA-C 111.569 0.211 . . . . 0.0 111.569 -175.37 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' D' D ' 122' ' ' LYS . . . . . . . . . . . . . 53.4 mtpt -138.59 149.02 44.83 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-O 121.11 0.481 . . . . 0.0 111.534 -175.419 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' D' D ' 123' ' ' VAL . . . . . . . . . . . . . 46.4 t -133.92 126.49 50.55 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.268 0 CA-C-N 116.0 -0.545 . . . . 0.0 109.588 174.108 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' D' D ' 124' ' ' LEU . . . . . . . . . . . . . 7.2 mp -116.99 134.44 54.73 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.311 -0.404 . . . . 0.0 110.571 -177.48 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' D' D ' 125' ' ' VAL . . . . . . . . . . . . . 34.8 m -131.32 125.85 57.65 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.283 0 CA-C-N 116.389 -0.368 . . . . 0.0 110.36 178.492 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' D' D ' 126' ' ' ARG . . . . . . . . . . . . . 91.2 mtt-85 -150.42 126.44 10.51 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.258 -0.428 . . . . 0.0 110.003 179.468 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' D' D ' 127' ' ' ASN . . . . . . . . . . . . . 10.9 t30 55.57 -148.94 0.47 Allowed 'General case' 0 CA--C 1.54 0.575 0 N-CA-C 110.001 -0.37 . . . . 0.0 110.001 179.502 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' D' D ' 128' ' ' ASP . . . . . . . . . . . . . 17.3 p-10 -82.84 15.35 2.73 Favored 'General case' 0 CA--C 1.535 0.388 0 CA-C-N 118.782 0.719 . . . . 0.0 112.931 179.459 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' D' D ' 129' ' ' LEU . . . . . . . . . . . . . 58.6 mt -112.49 138.2 49.59 Favored 'General case' 0 C--O 1.233 0.216 0 CA-C-N 118.171 0.441 . . . . 0.0 110.7 -179.991 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' D' D ' 130' ' ' VAL . . . . . . . . . . . . . 44.7 t -124.16 136.18 61.25 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.217 0 CA-C-N 115.924 -0.58 . . . . 0.0 109.744 179.638 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' D' D ' 131' ' ' VAL . . . . . . . . . . . . . 42.6 t -134.71 134.21 54.09 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.215 0 CA-C-O 120.964 0.411 . . . . 0.0 110.339 179.645 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' D' D ' 132' ' ' ILE . . . . . . . . . . . . . 73.6 mt -115.86 132.83 64.15 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.321 0 CA-C-N 115.963 -0.562 . . . . 0.0 109.509 -179.805 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' D' D ' 133' ' ' ILE . . . . . . . . . . . . . 35.7 mm -118.46 120.04 63.05 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.247 0 CA-C-O 120.847 0.356 . . . . 0.0 110.943 -174.043 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' D' D ' 134' ' ' ASP . . . . . . . . . . . . . 8.1 p-10 -133.11 147.95 52.14 Favored 'General case' 0 C--N 1.332 -0.185 0 N-CA-C 109.801 -0.444 . . . . 0.0 109.801 174.789 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' D' D ' 135' ' ' GLU . . . . . . . . . . . . . 84.1 tt0 -49.76 -23.86 2.04 Favored 'General case' 0 C--N 1.329 -0.32 0 N-CA-C 113.049 0.759 . . . . 0.0 113.049 -170.962 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' D' D ' 136' ' ' GLN . . . . . . . . . . . . . 39.3 tp60 -89.4 -37.68 14.66 Favored 'General case' 0 C--N 1.33 -0.241 0 N-CA-C 112.146 0.425 . . . . 0.0 112.146 -175.366 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' D' D ' 137' ' ' LYS . . . . . . . . . . . . . 57.0 pttt -156.41 166.0 34.69 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-O 121.525 0.679 . . . . 0.0 112.077 -171.185 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' D' D ' 138' ' ' LEU . . . . . . . . . . . . . 4.8 tt -117.7 128.4 54.86 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 115.065 -0.97 . . . . 0.0 109.793 178.115 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' D' D ' 139' ' ' THR . . . . . . . . . . . . . 29.8 m -110.43 127.4 55.1 Favored 'General case' 0 C--N 1.331 -0.224 0 CA-C-N 116.421 -0.354 . . . . 0.0 110.809 -179.59 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' D' D ' 140' ' ' LEU . . . . . . . . . . . . . 9.9 tp -112.61 120.12 40.47 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 115.567 -0.742 . . . . 0.0 109.056 -179.912 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' D' D ' 141' ' ' ILE . . . . . . . . . . . . . 19.6 mt -119.66 117.12 52.77 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.283 0 CA-C-O 121.077 0.465 . . . . 0.0 109.933 -175.823 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' D' D ' 142' ' ' ARG . . . . . . . . . . . . . 58.8 ttp180 -108.85 119.1 38.55 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 115.28 -0.873 . . . . 0.0 110.13 -178.344 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' D' D ' 143' ' ' THR . . . . . . . . . . . . . 54.6 p . . . . . 0 C--O 1.22 -0.465 0 CA-C-O 117.983 -1.008 . . . . 0.0 110.749 -178.596 . . . . . . . . 0 0 . 1 . 004 nuclear orig full ' E' E ' -3' ' ' GLU . . . . . . . . . . . . . 96.0 mt-10 . . . . . 0 N--CA 1.49 1.57 0 N-CA-C 109.387 -0.597 . . . . 0.0 109.387 . . . . . . . . . 0 0 . 1 . 004 nuclear orig full ' E' E ' -2' ' ' GLY . . . . . . . . . . . . . . . -63.12 145.04 49.93 Favored Glycine 0 CA--C 1.525 0.681 0 N-CA-C 111.139 -0.785 . . . . 0.0 111.139 -179.305 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' E' E ' -1' ' ' VAL . . . . . . . . . . . . . 45.0 t -96.41 136.72 26.34 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.269 0 N-CA-C 110.1 -0.333 . . . . 0.0 110.1 179.703 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' E' E ' 0' ' ' ILE . . . . . . . . . . . . . 70.2 mt -112.27 135.52 51.35 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.202 0 CA-C-N 116.294 -0.412 . . . . 0.0 109.994 179.935 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' E' E ' 1' ' ' MET . . . . . . . . . . . . . 25.0 ptm -78.44 144.12 36.11 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 115.956 -0.565 . . . . 0.0 111.129 -178.519 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' E' E ' 2' ' ' SER . . . . . . . . . . . . . 3.0 p -126.79 129.01 47.49 Favored 'General case' 0 C--N 1.331 -0.207 0 CA-C-N 116.249 -0.432 . . . . 0.0 110.629 178.933 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' E' E ' 3' ' ' GLU . . . . . . . . . . . . . 83.4 tt0 -142.27 142.35 32.57 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.034 -0.53 . . . . 0.0 111.203 -178.579 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' E' E ' 4' ' ' LEU . . . . . . . . . . . . . 14.4 tp -123.24 128.58 50.19 Favored 'General case' 0 C--N 1.332 -0.187 0 CA-C-N 115.958 -0.565 . . . . 0.0 110.281 176.85 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' E' E ' 5' ' ' LYS . . . . . . . . . . . . . 75.1 mttt -105.86 121.4 44.0 Favored 'General case' 0 C--O 1.235 0.293 0 CA-C-N 116.306 -0.406 . . . . 0.0 110.57 178.065 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' E' E ' 6' ' ' LEU . . . . . . . . . . . . . 29.3 mt -115.3 149.82 37.22 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 115.531 -0.759 . . . . 0.0 110.251 -179.735 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' E' E ' 7' ' ' LYS . . . . . . . . . . . . . 58.4 tttm -139.6 138.08 19.66 Favored Pre-proline 0 CA--C 1.533 0.305 0 CA-C-O 119.031 -0.509 . . . . 0.0 110.086 175.088 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' E' E ' 8' ' ' PRO . . . . . . . . . . . . . 98.7 Cg_endo -91.44 139.28 2.34 Favored 'Trans proline' 0 N--CA 1.489 1.258 0 C-N-CA 121.716 1.611 . . . . 0.0 111.728 177.396 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' E' E ' 9' ' ' LEU . . . . . . . . . . . . . 57.5 mt -71.46 -46.65 13.36 Favored Pre-proline 0 CA--C 1.533 0.312 0 CA-C-O 118.644 -0.693 . . . . 0.0 112.033 -179.026 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' E' E ' 10' ' ' PRO . . . . . . . . . . . . . 89.9 Cg_endo -82.31 147.36 14.35 Favored 'Trans proline' 0 N--CA 1.495 1.596 0 C-N-CA 121.147 1.231 . . . . 0.0 111.509 174.419 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' E' E ' 11' ' ' LYS . . . . . . . . . . . . . 50.3 pttt -86.51 115.06 23.76 Favored 'General case' 0 C--N 1.331 -0.222 0 CA-C-O 121.383 0.611 . . . . 0.0 110.217 178.122 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' E' E ' 12' ' ' VAL . . . . . . . . . . . . . 11.6 p -151.11 146.59 16.06 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 CA-C-N 115.879 -0.6 . . . . 0.0 110.544 -178.89 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' E' E ' 13' ' ' GLU . . . . . . . . . . . . . 95.8 mt-10 -83.23 118.03 23.35 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.347 -0.388 . . . . 0.0 110.042 177.126 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' E' E ' 14' ' ' LEU . . . . . . . . . . . . . 48.6 mt -96.53 148.8 35.01 Favored Pre-proline 0 C--N 1.33 -0.265 0 CA-C-O 119.282 -0.39 . . . . 0.0 110.665 -177.881 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' E' E ' 15' ' ' PRO . . . . . . . . . . . . . 27.9 Cg_exo -61.31 163.61 16.98 Favored 'Trans proline' 0 N--CA 1.497 1.704 0 C-N-CA 121.339 1.36 . . . . 0.0 112.093 177.015 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' E' E ' 16' ' ' PRO . . . . . . . . . . . . . 24.4 Cg_exo -62.25 -39.58 46.82 Favored 'Trans proline' 0 N--CA 1.497 1.69 0 C-N-CA 121.561 1.508 . . . . 0.0 112.987 -178.296 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' E' E ' 17' ' ' ASP . . . . . . . . . . . . . 22.1 p-10 -85.39 8.42 18.94 Favored 'General case' 0 CA--C 1.535 0.396 0 N-CA-C 113.302 0.853 . . . . 0.0 113.302 -176.304 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' E' E ' 18' ' ' PHE . . . . . . . . . . . . . 32.4 t80 -55.97 -47.87 76.86 Favored 'General case' 0 C--N 1.334 -0.107 0 O-C-N 121.904 -0.498 . . . . 0.0 110.506 -179.359 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' E' E ' 19' ' ' VAL . . . . . . . . . . . . . 14.0 p -56.3 -40.77 68.13 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.272 0 CA-C-N 116.227 -0.442 . . . . 0.0 111.037 -178.985 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' E' E ' 20' ' ' ASP . . . . . . . . . . . . . 20.2 t0 -60.54 -43.78 96.81 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-O 120.793 0.33 . . . . 0.0 111.15 -177.312 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' E' E ' 21' ' ' VAL . . . . . . . . . . . . . 49.1 t -63.67 -46.33 95.0 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.332 0 C-N-CA 120.834 -0.346 . . . . 0.0 110.296 -178.488 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' E' E ' 22' ' ' ILE . . . . . . . . . . . . . 49.3 mm -55.54 -45.79 78.77 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.227 0 C-N-CA 120.956 -0.298 . . . . 0.0 110.707 178.377 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' E' E ' 23' ' ' ARG . . . . . . . . . . . . . 54.7 ttp180 -53.33 -51.0 63.79 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-O 120.584 0.23 . . . . 0.0 111.538 -178.544 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' E' E ' 24' ' ' ILE . . . . . 0.402 HG23 HD11 ' E' ' 24' ' ' ILE . 68.5 mt -59.64 -43.71 91.82 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.287 0 C-N-CA 121.138 -0.225 . . . . 0.0 111.349 -177.221 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' E' E ' 25' ' ' LYS . . . . . . . . . . . . . 97.9 mttt -64.85 -38.45 91.02 Favored 'General case' 0 C--N 1.329 -0.314 0 N-CA-C 112.208 0.447 . . . . 0.0 112.208 -178.247 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' E' E ' 26' ' ' LEU . . . . . . . . . . . . . 37.5 mt -80.47 -41.77 23.79 Favored 'General case' 0 C--N 1.329 -0.302 0 N-CA-C 113.258 0.836 . . . . 0.0 113.258 -171.675 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' E' E ' 27' ' ' GLN . . . . . . . . . . . . . 11.0 pt20 -46.42 142.68 2.91 Favored 'General case' 0 N--CA 1.469 0.486 0 N-CA-C 112.869 0.692 . . . . 0.0 112.869 -174.325 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' E' E ' 28' ' ' GLY . . . . . . . . . . . . . . . 98.75 -28.68 13.98 Favored Glycine 0 CA--C 1.531 1.066 0 CA-C-N 115.479 -0.782 . . . . 0.0 112.02 -177.467 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' E' E ' 29' ' ' LYS . . . . . . . . . . . . . 87.7 mttt -98.07 155.08 17.29 Favored 'General case' 0 C--N 1.331 -0.224 0 CA-C-N 117.235 0.517 . . . . 0.0 111.08 178.808 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' E' E ' 30' ' ' THR . . . . . . . . . . . . . 40.1 m -102.4 137.39 40.71 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.002 -0.544 . . . . 0.0 109.949 175.679 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' E' E ' 31' ' ' VAL . . . . . . . . . . . . . 34.6 m -127.92 152.81 36.48 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.256 0 CA-C-O 120.939 0.4 . . . . 0.0 110.729 -178.23 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' E' E ' 32' ' ' ARG . . . . . . . . . . . . . 61.1 ttt180 -131.09 147.82 52.66 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-O 121.215 0.531 . . . . 0.0 110.628 -179.527 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' E' E ' 33' ' ' THR . . . . . . . . . . . . . 31.4 m -52.56 140.7 22.25 Favored 'General case' 0 C--N 1.331 -0.23 0 CA-C-N 116.293 -0.412 . . . . 0.0 111.453 -178.552 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' E' E ' 34' ' ' GLY . . . . . . . . . . . . . . . 99.51 -17.2 58.01 Favored Glycine 0 CA--C 1.531 1.087 0 CA-C-O 119.681 -0.511 . . . . 0.0 113.247 179.502 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' E' E ' 35' ' ' ASP . . . . . . . . . . . . . 80.0 m-20 -66.88 147.52 53.13 Favored 'General case' 0 C--O 1.232 0.138 0 CA-C-N 118.013 0.906 . . . . 0.0 111.028 178.531 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' E' E ' 36' ' ' VAL . . . . . . . . . . . . . 44.2 t -120.9 129.31 75.81 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.208 0 CA-C-N 116.082 -0.508 . . . . 0.0 109.713 177.527 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' E' E ' 37' ' ' ILE . . . . . . . . . . . . . 67.2 mt -121.01 138.83 50.16 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.289 0 CA-C-N 116.246 -0.434 . . . . 0.0 109.937 -178.951 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' E' E ' 38' ' ' GLY . . . . . . . . . . . . . . . -109.78 128.86 9.11 Favored Glycine 0 CA--C 1.524 0.656 0 N-CA-C 111.159 -0.776 . . . . 0.0 111.159 -179.64 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' E' E ' 39' ' ' ILE . . . . . . . . . . . . . 74.4 mt -123.61 133.73 68.38 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.203 0 N-CA-C 109.976 -0.379 . . . . 0.0 109.976 179.017 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' E' E ' 40' ' ' SER . . . . . . . . . . . . . 59.7 p -92.87 117.4 30.0 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.284 -0.417 . . . . 0.0 110.797 175.465 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' E' E ' 41' ' ' ILE . . . . . . . . . . . . . 43.8 mm -121.05 118.0 54.76 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.224 0 CA-C-O 120.802 0.334 . . . . 0.0 110.379 -179.864 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' E' E ' 42' ' ' LEU . . . . . . . . . . . . . 61.1 mt 52.65 36.3 20.51 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 116.194 -0.457 . . . . 0.0 111.604 176.646 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' E' E ' 43' ' ' GLY . . . . . . . . . . . . . . . 73.04 30.51 63.08 Favored Glycine 0 CA--C 1.529 0.911 0 C-N-CA 121.135 -0.555 . . . . 0.0 112.275 177.816 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' E' E ' 44' ' ' LYS . . . . . . . . . . . . . 68.7 mttm -138.31 134.27 34.08 Favored 'General case' 0 C--N 1.331 -0.234 0 N-CA-C 109.759 -0.46 . . . . 0.0 109.759 177.757 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' E' E ' 45' ' ' GLU . . . . . . . . . . . . . 80.6 tt0 -83.02 124.46 30.44 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-O 120.839 0.352 . . . . 0.0 111.6 -176.192 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' E' E ' 46' ' ' VAL . . . . . . . . . . . . . 7.2 p -124.61 126.44 71.68 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.19 0 N-CA-C 109.478 -0.564 . . . . 0.0 109.478 173.863 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' E' E ' 47' ' ' LYS . . . . . . . . . . . . . 98.9 mttt -99.91 129.66 46.01 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.064 -0.516 . . . . 0.0 111.081 178.994 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' E' E ' 48' ' ' PHE . . . . . . . . . . . . . 91.1 m-85 -112.69 131.9 55.44 Favored 'General case' 0 C--N 1.33 -0.271 0 N-CA-C 109.872 -0.418 . . . . 0.0 109.872 177.035 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' E' E ' 49' ' ' LYS . . . . . . . . . . . . . 80.0 tttt -106.96 135.99 47.57 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.294 -0.412 . . . . 0.0 110.279 179.067 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' E' E ' 50' ' ' VAL . . . . . . . . . . . . . 46.0 t -77.14 105.02 5.56 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.218 0 N-CA-C 109.192 -0.67 . . . . 0.0 109.192 175.585 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' E' E ' 51' ' ' VAL . . . . . . . . . . . . . 48.6 t -68.71 -47.97 73.75 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.362 0 O-C-N 123.563 0.539 . . . . 0.0 109.744 -173.179 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' E' E ' 52' ' ' GLN . . . . . . . . . . . . . 43.2 tt0 -171.03 142.12 1.78 Allowed 'General case' 0 C--N 1.329 -0.318 0 C-N-CA 120.313 -0.555 . . . . 0.0 111.423 -179.709 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' E' E ' 53' ' ' ALA . . . . . . . . . . . . . . . -114.41 136.03 53.45 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 115.697 -0.683 . . . . 0.0 110.14 177.517 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' E' E ' 54' ' ' TYR . . . . . . . . . . . . . 37.0 t80 -128.99 108.6 18.18 Favored Pre-proline 0 CA--C 1.535 0.374 0 CA-C-O 118.245 -0.883 . . . . 0.0 110.206 178.558 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' E' E ' 55' ' ' PRO . . . . . . . . . . . . . 73.4 Cg_endo -77.15 170.01 72.71 Favored 'Cis proline' 0 N--CA 1.499 1.841 0 CA-C-N 121.769 1.667 . . . . 0.0 112.486 -5.025 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' E' E ' 56' ' ' SER . . . . . . . . . . . . . 41.2 m -117.21 131.39 24.03 Favored Pre-proline 0 CA--C 1.539 0.524 0 CA-C-O 118.399 -0.81 . . . . 0.0 109.509 174.768 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' E' E ' 57' ' ' PRO . . . . . . . . . . . . . 57.0 Cg_endo -72.36 148.26 90.9 Favored 'Cis proline' 0 N--CA 1.497 1.719 0 CA-C-N 121.917 1.72 . . . . 0.0 111.54 -1.173 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' E' E ' 58' ' ' LEU . . . . . . . . . . . . . 23.8 tp -108.26 137.11 46.79 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.561 -178.622 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' E' E ' 59' ' ' ARG . . . . . . . . . . . . . 54.0 ttp180 -99.92 126.06 46.01 Favored 'General case' 0 C--N 1.328 -0.341 0 N-CA-C 109.334 -0.617 . . . . 0.0 109.334 174.92 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' E' E ' 60' ' ' VAL . . . . . . . . . . . . . 40.5 t -83.03 120.43 34.36 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.269 0 C-N-CA 120.599 -0.44 . . . . 0.0 110.578 -174.955 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' E' E ' 61' ' ' GLU . . . . . . . . . . . . . 74.7 tt0 -130.8 156.01 45.72 Favored 'General case' 0 C--N 1.329 -0.326 0 N-CA-C 108.989 -0.745 . . . . 0.0 108.989 176.252 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' E' E ' 62' ' ' ASP . . . . . . . . . . . . . 9.8 p-10 -51.01 -30.62 15.78 Favored 'General case' 0 C--N 1.327 -0.385 0 N-CA-C 112.369 0.507 . . . . 0.0 112.369 -175.312 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' E' E ' 63' ' ' ARG . . . . . . . . . . . . . 76.0 mtt180 -77.89 -22.07 50.3 Favored 'General case' 0 CA--C 1.533 0.322 0 N-CA-C 113.149 0.796 . . . . 0.0 113.149 -174.987 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' E' E ' 64' ' ' THR . . . . . . . . . . . . . 28.3 m -63.37 146.16 54.1 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-O 120.872 0.367 . . . . 0.0 110.964 -175.841 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' E' E ' 65' ' ' LYS . . . . . . . . . . . . . 67.5 mttm -89.2 134.37 34.06 Favored 'General case' 0 C--N 1.331 -0.212 0 CA-C-N 116.121 -0.49 . . . . 0.0 110.662 -179.733 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' E' E ' 66' ' ' ILE . . . . . . . . . . . . . 62.4 mt -120.9 130.97 74.08 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.238 0 N-CA-C 109.993 -0.373 . . . . 0.0 109.993 179.224 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' E' E ' 67' ' ' THR . . . . . . . . . . . . . 19.1 m -129.72 142.82 50.64 Favored 'General case' 0 C--N 1.332 -0.175 0 CA-C-O 120.979 0.418 . . . . 0.0 111.042 -178.403 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' E' E ' 68' ' ' LEU . . . . . . . . . . . . . 6.7 mp -105.98 128.69 53.99 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 116.106 -0.497 . . . . 0.0 110.601 177.702 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' E' E ' 69' ' ' VAL . . . . . . . . . . . . . 43.7 t -102.39 137.44 30.37 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.314 0 CA-C-N 116.163 -0.471 . . . . 0.0 110.09 179.306 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' E' E ' 70' ' ' THR . . . . . . . . . . . . . 28.8 m -134.23 114.95 13.59 Favored 'General case' 0 C--N 1.331 -0.213 0 CA-C-O 120.87 0.367 . . . . 0.0 110.875 179.598 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' E' E ' 71' ' ' HIS . . . . . . . . . . . . . 64.5 t60 -150.03 79.46 7.65 Favored Pre-proline 0 C--N 1.328 -0.347 0 CA-C-N 116.077 -0.51 . . . . 0.0 110.156 177.167 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' E' E ' 72' ' ' PRO . . . . . . . . . . . . . 55.5 Cg_endo -89.17 160.01 5.73 Favored 'Trans proline' 0 N--CA 1.489 1.213 0 C-N-CA 121.769 1.646 . . . . 0.0 112.42 -177.733 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' E' E ' 73' ' ' VAL . . . . . . . . . . . . . 36.0 m -116.32 168.87 7.39 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.216 0 CA-C-N 115.855 -0.611 . . . . 0.0 110.008 178.355 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' E' E ' 74' ' ' ASP . . . . . . . . . . . . . 18.9 t0 -93.85 118.78 31.91 Favored 'General case' 0 C--N 1.328 -0.331 0 N-CA-C 109.978 -0.378 . . . . 0.0 109.978 -177.84 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' E' E ' 75' ' ' VAL . . . . . . . . . . . . . 42.2 t -116.57 121.0 66.66 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.224 0 CA-C-O 121.055 0.455 . . . . 0.0 110.468 -178.445 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' E' E ' 76' ' ' LEU . . . . . . . . . . . . . 7.0 mp -119.01 149.06 42.28 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 115.778 -0.646 . . . . 0.0 109.788 176.961 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' E' E ' 77' ' ' GLU . . . . . . . . . . . . . 96.3 mt-10 -136.97 134.63 36.89 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-O 121.006 0.432 . . . . 0.0 111.333 -178.975 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' E' E ' 78' ' ' ALA . . . . . . . . . . . . . . . -121.28 136.63 54.94 Favored 'General case' 0 C--N 1.331 -0.225 0 CA-C-N 115.671 -0.695 . . . . 0.0 109.85 176.959 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' E' E ' 79' ' ' LYS . . . . . . . . . . . . . 46.3 mmtm -78.48 119.25 21.51 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-O 120.798 0.332 . . . . 0.0 110.611 179.859 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' E' E ' 80' ' ' ILE . . . . . . . . . . . . . 26.4 mm -139.25 110.45 4.85 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.28 0 N-CA-C 108.967 -0.753 . . . . 0.0 108.967 -179.351 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' E' E ' 81' ' ' LYS . . . . . . . . . . . . . 54.8 pttt -103.24 124.56 48.85 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-O 120.948 0.404 . . . . 0.0 111.194 -176.753 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' E' E ' 82' ' ' GLY . . . . . . . . . . . . . . . 88.94 42.2 5.72 Favored Glycine 0 CA--C 1.525 0.695 0 C-N-CA 120.713 -0.756 . . . . 0.0 111.616 174.622 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' E' E ' 83' ' ' ILE . . . . . . . . . . . . . 68.2 mt -66.35 139.7 20.74 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.362 0 N-CA-C 109.779 -0.452 . . . . 0.0 109.779 178.247 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' E' E ' 84' ' ' LYS . . . . . . . . . . . . . 87.6 tttt -101.05 -53.96 2.91 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-N 116.011 -0.54 . . . . 0.0 110.311 -178.217 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' E' E ' 85' ' ' ASP . . . . . . . . . . . . . 9.6 t70 -149.97 146.98 27.33 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 115.754 -0.657 . . . . 0.0 110.187 -178.373 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' E' E ' 86' ' ' VAL . . . . . . . . . . . . . 43.0 t -131.69 129.78 61.61 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.228 0 CA-C-O 121.006 0.431 . . . . 0.0 110.476 -178.495 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' E' E ' 87' ' ' ILE . . . . . . . . . . . . . 4.9 mp -119.94 125.05 73.88 Favored 'Isoleucine or valine' 0 C--O 1.233 0.198 0 CA-C-N 115.943 -0.571 . . . . 0.0 109.481 176.2 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' E' E ' 88' ' ' LEU . . . . . . . . . . . . . 16.8 tp -110.54 129.19 55.85 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-O 120.911 0.386 . . . . 0.0 110.737 -179.185 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' E' E ' 89' ' ' ASP . . . . . . . . . . . . . 9.5 t70 -123.79 154.18 39.92 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-N 116.01 -0.541 . . . . 0.0 109.815 178.709 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' E' E ' 90' ' ' GLU . . . . . . . . . . . . . 43.1 mt-10 -47.82 -38.43 15.89 Favored 'General case' 0 C--N 1.33 -0.241 0 N-CA-C 112.71 0.633 . . . . 0.0 112.71 -172.643 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' E' E ' 91' ' ' ASN . . . . . . . . . . . . . 6.6 t-20 -132.1 34.58 3.79 Favored 'General case' 0 N--CA 1.463 0.217 0 N-CA-C 111.738 0.273 . . . . 0.0 111.738 -176.455 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' E' E ' 92' ' ' LEU . . . . . . . . . . . . . 12.5 tp -166.16 148.76 7.11 Favored 'General case' 0 C--N 1.329 -0.286 0 C-N-CA 120.937 -0.305 . . . . 0.0 110.906 -178.991 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' E' E ' 93' ' ' ILE . . . . . . . . . . . . . 72.9 mt -128.18 123.28 59.98 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.178 0 N-CA-C 109.491 -0.559 . . . . 0.0 109.491 178.222 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' E' E ' 94' ' ' VAL . . . . . . . . . . . . . 44.8 t -123.96 126.12 72.0 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.277 0 CA-C-O 120.875 0.369 . . . . 0.0 110.035 -179.66 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' E' E ' 95' ' ' VAL . . . . . . . . . . . . . 41.8 t -123.77 134.73 65.64 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.252 0 CA-C-N 116.104 -0.498 . . . . 0.0 110.21 -178.419 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' E' E ' 96' ' ' ILE . . . . . . . . . . . . . 58.1 mt -115.51 130.06 70.75 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 N-CA-C 109.287 -0.634 . . . . 0.0 109.287 178.359 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' E' E ' 97' ' ' THR . . . . . . . . . . . . . 80.3 p -102.09 158.44 16.16 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-O 121.257 0.551 . . . . 0.0 111.324 -177.034 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' E' E ' 98' ' ' GLU . . . . . . . . . . . . . 83.5 tt0 -53.86 -27.05 27.61 Favored 'General case' 0 CA--C 1.533 0.313 0 N-CA-C 112.3 0.481 . . . . 0.0 112.3 -179.529 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' E' E ' 99' ' ' GLU . . . . . . . . . . . . . 34.7 tt0 -80.77 18.06 1.05 Allowed 'General case' 0 CA--C 1.536 0.418 0 N-CA-C 112.728 0.64 . . . . 0.0 112.728 -176.619 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' E' E ' 100' ' ' ASN . . . . . . . . . . . . . 3.2 m-20 61.06 37.96 17.52 Favored 'General case' 0 N--CA 1.463 0.176 0 O-C-N 121.955 -0.466 . . . . 0.0 110.819 178.366 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' E' E ' 101' ' ' GLU . . . . . . . . . . . . . 84.2 tt0 -116.74 143.11 46.05 Favored 'General case' 0 C--N 1.331 -0.203 0 CA-C-N 116.159 -0.473 . . . . 0.0 109.75 177.379 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' E' E ' 102' ' ' VAL . . . . . . . . . . . . . 44.0 t -115.52 127.55 73.05 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.367 0 CA-C-N 116.419 -0.355 . . . . 0.0 110.132 -177.804 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' E' E ' 103' ' ' LEU . . . . . . . . . . . . . 28.9 mt -117.96 131.14 56.53 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-N 115.677 -0.692 . . . . 0.0 109.889 177.123 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' E' E ' 104' ' ' ILE . . . . . 0.402 HG21 HD12 ' E' ' 104' ' ' ILE . 67.4 mt -117.66 122.17 69.19 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.26 0 N-CA-C 110.107 -0.331 . . . . 0.0 110.107 -178.336 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' E' E ' 105' ' ' PHE . . . . . . . . . . . . . 91.5 m-85 -124.11 166.4 15.86 Favored 'General case' 0 C--O 1.232 0.151 0 O-C-N 123.985 0.803 . . . . 0.0 110.131 -178.52 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' E' E ' 106' ' ' ASN . . . . . . . . . . . . . 45.6 p-10 -104.04 -172.51 2.12 Favored 'General case' 0 C--N 1.332 -0.172 0 N-CA-C 109.755 -0.461 . . . . 0.0 109.755 171.131 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' E' E ' 107' ' ' GLN . . . . . . . . . . . . . 49.4 tt0 -58.76 -29.99 67.18 Favored 'General case' 0 CA--C 1.532 0.255 0 N-CA-C 112.065 0.394 . . . . 0.0 112.065 -179.72 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' E' E ' 108' ' ' ASN . . . . . . . . . . . . . 48.4 t30 -86.72 12.7 10.15 Favored 'General case' 0 CA--C 1.534 0.34 0 N-CA-C 113.001 0.741 . . . . 0.0 113.001 -176.384 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' E' E ' 109' ' ' LEU . . . . . . . . . . . . . 34.4 mt 58.2 33.34 23.06 Favored 'General case' 0 C--O 1.232 0.168 0 N-CA-C 111.998 0.37 . . . . 0.0 111.998 176.912 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' E' E ' 110' ' ' GLU . . . . . . . . . . . . . 95.5 mt-10 -101.86 129.94 48.21 Favored 'General case' 0 C--N 1.33 -0.25 0 N-CA-C 109.182 -0.673 . . . . 0.0 109.182 174.582 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' E' E ' 111' ' ' GLU . . . . . . . . . . . . . 45.5 tt0 -74.11 121.99 22.02 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-O 121.073 0.463 . . . . 0.0 110.352 -176.108 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' E' E ' 112' ' ' LEU . . . . . . . . . . . . . 35.4 mt -99.62 -46.07 5.57 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 115.795 -0.639 . . . . 0.0 110.461 -179.612 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' E' E ' 113' ' ' TYR . . . . . . . . . . . . . 57.8 t80 -139.22 145.66 39.53 Favored 'General case' 0 C--N 1.331 -0.208 0 CA-C-N 116.317 -0.402 . . . . 0.0 111.197 -178.166 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' E' E ' 114' ' ' ARG . . . . . . . . . . . . . 45.3 ptt85 -147.35 125.27 11.98 Favored 'General case' 0 C--N 1.33 -0.239 0 CA-C-N 116.07 -0.514 . . . . 0.0 110.663 179.062 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' E' E ' 115' ' ' GLY . . . . . . . . . . . . . . . -150.07 159.11 27.96 Favored Glycine 0 CA--C 1.523 0.538 0 N-CA-C 111.105 -0.798 . . . . 0.0 111.105 178.96 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' E' E ' 116' ' ' LYS . . . . . . . . . . . . . 38.4 ttpt -127.07 132.46 50.66 Favored 'General case' 0 C--N 1.33 -0.268 0 N-CA-C 109.809 -0.441 . . . . 0.0 109.809 178.077 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' E' E ' 117' ' ' PHE . . . . . . . . . . . . . 36.6 m-85 -132.14 113.82 13.77 Favored 'General case' 0 C--N 1.331 -0.213 0 CA-C-O 121.014 0.435 . . . . 0.0 110.376 -175.582 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' E' E ' 118' ' ' GLU . . . . . . . . . . . . . 96.3 mt-10 -54.77 -46.93 74.45 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 116.268 -0.424 . . . . 0.0 111.254 -176.728 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' E' E ' 119' ' ' ASN . . . . . . . . . . . . . 24.4 m120 -95.62 31.01 2.13 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.165 -0.471 . . . . 0.0 112.139 -173.523 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' E' E ' 120' ' ' LEU . . . . . . . . . . . . . 14.7 tp -54.92 119.94 6.14 Favored 'General case' 0 N--CA 1.463 0.191 0 C-N-CA 121.019 -0.272 . . . . 0.0 110.752 177.449 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' E' E ' 121' ' ' ASN . . . . . . . . . . . . . 33.3 t-20 -114.09 -43.97 3.19 Favored 'General case' 0 C--N 1.331 -0.22 0 CA-C-N 116.599 -0.273 . . . . 0.0 111.359 -175.181 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' E' E ' 122' ' ' LYS . . . . . . . . . . . . . 36.5 mtmm -143.3 145.22 32.53 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-O 121.121 0.486 . . . . 0.0 111.63 -176.628 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' E' E ' 123' ' ' VAL . . . . . . . . . . . . . 46.8 t -126.67 127.54 70.25 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.22 0 CA-C-N 115.873 -0.603 . . . . 0.0 109.63 176.525 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' E' E ' 124' ' ' LEU . . . . . . . . . . . . . 50.2 mt -130.33 123.56 30.27 Favored 'General case' 0 C--N 1.331 -0.222 0 CA-C-N 116.441 -0.345 . . . . 0.0 110.186 179.751 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' E' E ' 125' ' ' VAL . . . . . . . . . . . . . 33.0 m -143.14 136.43 25.58 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.305 0 CA-C-O 120.816 0.341 . . . . 0.0 111.125 -178.937 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' E' E ' 126' ' ' ARG . . . . . . . . . . . . . 63.3 mtm180 -151.02 131.15 13.49 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-O 121.152 0.501 . . . . 0.0 110.876 177.82 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' E' E ' 127' ' ' ASN . . . . . . . . . . . . . 3.7 m120 52.01 -105.05 0.2 Allowed 'General case' 0 CA--C 1.543 0.677 0 CA-C-N 115.827 -0.624 . . . . 0.0 111.489 178.629 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' E' E ' 128' ' ' ASP . . . . . . . . . . . . . 22.8 p-10 -114.13 1.45 14.59 Favored 'General case' 0 N--CA 1.467 0.409 0 CA-C-N 119.345 0.975 . . . . 0.0 113.461 -174.895 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' E' E ' 129' ' ' LEU . . . . . . . . . . . . . 68.7 mt -105.55 128.91 53.86 Favored 'General case' 0 C--N 1.333 -0.126 0 CA-C-N 118.28 0.491 . . . . 0.0 110.301 179.215 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' E' E ' 130' ' ' VAL . . . . . . . . . . . . . 60.3 t -122.06 128.75 75.67 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.273 0 CA-C-N 115.95 -0.568 . . . . 0.0 109.544 -179.571 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' E' E ' 131' ' ' VAL . . . . . . . . . . . . . 41.8 t -136.03 132.38 50.13 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.227 0 CA-C-O 121.186 0.517 . . . . 0.0 110.288 177.493 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' E' E ' 132' ' ' ILE . . . . . . . . . . . . . 73.5 mt -117.25 131.78 68.96 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.316 0 CA-C-N 115.625 -0.716 . . . . 0.0 109.393 179.784 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' E' E ' 133' ' ' ILE . . . . . . . . . . . . . 36.9 mm -113.04 121.07 64.56 Favored 'Isoleucine or valine' 0 C--O 1.233 0.206 0 CA-C-O 120.741 0.305 . . . . 0.0 111.009 -174.935 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' E' E ' 134' ' ' ASP . . . . . . . . . . . . . 9.7 p-10 -131.73 148.23 52.56 Favored 'General case' 0 C--N 1.332 -0.18 0 N-CA-C 109.727 -0.472 . . . . 0.0 109.727 175.2 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' E' E ' 135' ' ' GLU . . . . . . . . . . . . . 78.2 tt0 -49.9 -26.61 4.27 Favored 'General case' 0 C--N 1.328 -0.331 0 N-CA-C 113.019 0.748 . . . . 0.0 113.019 -171.515 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' E' E ' 136' ' ' GLN . . . . . . . . . . . . . 99.4 mm-40 -86.26 -32.07 21.32 Favored 'General case' 0 C--N 1.331 -0.234 0 N-CA-C 112.411 0.522 . . . . 0.0 112.411 -174.932 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' E' E ' 137' ' ' LYS . . . . . . . . . . . . . 23.8 pttm -167.21 174.04 8.51 Favored 'General case' 0 C--O 1.233 0.191 0 CA-C-O 121.472 0.653 . . . . 0.0 112.429 -172.488 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' E' E ' 138' ' ' LEU . . . . . . . . . . . . . 5.6 tt -118.52 127.32 53.51 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 114.925 -1.034 . . . . 0.0 110.033 179.867 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' E' E ' 139' ' ' THR . . . . . . . . . . . . . 28.4 m -104.51 120.39 41.15 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.042 -0.526 . . . . 0.0 110.257 179.439 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' E' E ' 140' ' ' LEU . . . . . . . . . . . . . 7.7 tt -108.65 120.65 43.08 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 115.824 -0.626 . . . . 0.0 109.427 -179.974 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' E' E ' 141' ' ' ILE . . . . . . . . . . . . . 18.4 mt -123.84 121.2 61.69 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.265 0 CA-C-O 121.012 0.434 . . . . 0.0 109.833 -175.041 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' E' E ' 142' ' ' ARG . . . . . . . . . . . . . 64.5 ttt180 -109.11 124.12 50.29 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 115.689 -0.687 . . . . 0.0 110.22 179.218 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' E' E ' 143' ' ' THR . . . . . . . . . . . . . 55.9 p . . . . . 0 C--O 1.22 -0.467 0 CA-C-O 118.19 -0.909 . . . . 0.0 110.822 -179.542 . . . . . . . . 0 0 . 1 . 004 nuclear orig full ' F' F ' -3' ' ' GLU . . . . . . . . . . . . . 82.8 tt0 . . . . . 0 N--CA 1.491 1.61 0 N-CA-C 109.252 -0.647 . . . . 0.0 109.252 . . . . . . . . . 0 0 . 1 . 004 nuclear orig full ' F' F ' -2' ' ' GLY . . . . . . . . . . . . . . . -71.33 136.55 25.12 Favored Glycine 0 CA--C 1.526 0.767 0 N-CA-C 111.281 -0.728 . . . . 0.0 111.281 -178.178 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' F' F ' -1' ' ' VAL . . . . . . . . . . . . . 43.5 t -142.38 138.3 29.32 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.292 0 N-CA-C 110.03 -0.359 . . . . 0.0 110.03 178.94 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' F' F ' 0' ' ' ILE . . . . . . . . . . . . . 72.3 mt -112.27 135.73 50.71 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.273 0 CA-C-N 116.209 -0.45 . . . . 0.0 109.884 179.69 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' F' F ' 1' ' ' MET . . . . . . . . . . . . . 27.6 ptm -92.11 147.73 22.72 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.084 -0.507 . . . . 0.0 110.638 -179.31 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' F' F ' 2' ' ' SER . . . . . . . . . . . . . 2.5 p -129.32 128.1 42.45 Favored 'General case' 0 C--N 1.331 -0.198 0 CA-C-N 116.113 -0.494 . . . . 0.0 110.596 179.59 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' F' F ' 3' ' ' GLU . . . . . . . . . . . . . 83.8 tt0 -142.29 141.24 32.41 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.151 -0.477 . . . . 0.0 111.293 -179.984 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' F' F ' 4' ' ' LEU . . . . . . . . . . . . . 17.5 tp -127.31 133.23 50.14 Favored 'General case' 0 C--N 1.331 -0.201 0 CA-C-N 116.04 -0.527 . . . . 0.0 110.272 177.782 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' F' F ' 5' ' ' LYS . . . . . . . . . . . . . 98.5 mttt -112.06 121.32 44.66 Favored 'General case' 0 C--N 1.331 -0.212 0 CA-C-N 116.241 -0.436 . . . . 0.0 110.638 179.829 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' F' F ' 6' ' ' LEU . . . . . . . . . . . . . 69.8 mt -115.02 145.86 41.85 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 115.446 -0.797 . . . . 0.0 110.058 179.948 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' F' F ' 7' ' ' LYS . . . . . . . . . . . . . 40.2 ttmt -128.45 138.58 33.36 Favored Pre-proline 0 CA--C 1.533 0.295 0 CA-C-O 119.052 -0.499 . . . . 0.0 109.879 176.166 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' F' F ' 8' ' ' PRO . . . . . . . . . . . . . 94.4 Cg_endo -92.03 139.38 2.09 Favored 'Trans proline' 0 N--CA 1.488 1.197 0 C-N-CA 121.786 1.658 . . . . 0.0 111.963 178.694 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' F' F ' 9' ' ' LEU . . . . . . . . . . . . . 66.3 mt -74.46 -46.6 5.77 Favored Pre-proline 0 CA--C 1.533 0.314 0 CA-C-O 118.691 -0.671 . . . . 0.0 111.967 178.942 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' F' F ' 10' ' ' PRO . . . . . . . . . . . . . 90.0 Cg_endo -81.04 142.29 13.6 Favored 'Trans proline' 0 N--CA 1.496 1.635 0 C-N-CA 121.076 1.184 . . . . 0.0 111.561 174.035 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' F' F ' 11' ' ' LYS . . . . . . . . . . . . . 80.6 tttt -80.98 101.95 9.84 Favored 'General case' 0 C--N 1.329 -0.295 0 C-N-CA 120.802 -0.359 . . . . 0.0 110.441 179.317 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' F' F ' 12' ' ' VAL . . . . . . . . . . . . . 11.9 p -145.35 147.57 18.55 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.291 0 CA-C-N 116.233 -0.439 . . . . 0.0 110.715 -178.592 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' F' F ' 13' ' ' GLU . . . . . . . . . . . . . 70.7 mm-40 -92.9 123.74 36.38 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.033 176.687 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' F' F ' 14' ' ' LEU . . . . . . . . . . . . . 26.1 mt -96.81 154.48 38.32 Favored Pre-proline 0 C--N 1.329 -0.322 0 CA-C-N 116.426 -0.352 . . . . 0.0 110.69 -178.689 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' F' F ' 15' ' ' PRO . . . . . . . . . . . . . 31.3 Cg_exo -57.04 156.2 25.33 Favored 'Trans proline' 0 N--CA 1.496 1.659 0 C-N-CA 121.335 1.356 . . . . 0.0 111.777 179.636 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' F' F ' 16' ' ' PRO . . . . . . . . . . . . . 35.0 Cg_exo -57.81 -37.76 95.24 Favored 'Trans proline' 0 N--CA 1.497 1.677 0 C-N-CA 121.46 1.44 . . . . 0.0 112.802 -178.627 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' F' F ' 17' ' ' ASP . . . . . . . . . . . . . 19.1 p-10 -90.29 13.36 15.54 Favored 'General case' 0 CA--C 1.537 0.445 0 N-CA-C 113.116 0.784 . . . . 0.0 113.116 -177.38 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' F' F ' 18' ' ' PHE . . . . . . . . . . . . . 46.1 t80 -58.11 -45.32 87.46 Favored 'General case' 0 C--N 1.333 -0.126 0 CA-C-O 120.876 0.37 . . . . 0.0 110.089 -178.512 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' F' F ' 19' ' ' VAL . . . . . . . . . . . . . 48.4 t -57.18 -39.67 68.54 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.322 0 CA-C-N 116.25 -0.432 . . . . 0.0 110.505 -178.131 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' F' F ' 20' ' ' ASP . . . . . . . . . . . . . 10.2 t70 -59.85 -46.46 89.2 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-O 121.095 0.474 . . . . 0.0 110.875 -178.315 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' F' F ' 21' ' ' VAL . . . . . . . . . . . . . 49.5 t -64.19 -48.74 84.34 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.305 0 CA-C-N 116.207 -0.451 . . . . 0.0 110.624 -177.925 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' F' F ' 22' ' ' ILE . . . . . . . . . . . . . 51.0 mm -56.36 -43.45 77.35 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.297 0 CA-C-O 120.888 0.375 . . . . 0.0 110.51 179.135 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' F' F ' 23' ' ' ARG . . . . . . . . . . . . . 41.0 ttp180 -54.2 -47.52 72.0 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.545 -0.298 . . . . 0.0 111.337 -178.535 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' F' F ' 24' ' ' ILE . . . . . . . . . . . . . 73.8 mt -58.68 -44.17 89.26 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.307 0 CA-C-N 116.578 -0.283 . . . . 0.0 111.082 -179.068 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' F' F ' 25' ' ' LYS . . . . . . . . . . . . . 55.8 mttp -64.81 -39.33 93.41 Favored 'General case' 0 N--CA 1.464 0.24 0 N-CA-C 112.461 0.541 . . . . 0.0 112.461 -179.632 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' F' F ' 26' ' ' LEU . . . . . . . . . . . . . 49.7 mt -78.9 -41.72 29.0 Favored 'General case' 0 C--N 1.33 -0.28 0 N-CA-C 113.299 0.851 . . . . 0.0 113.299 -170.114 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' F' F ' 27' ' ' GLN . . . . . . . . . . . . . 10.9 pt20 -46.66 139.65 5.05 Favored 'General case' 0 N--CA 1.469 0.508 0 N-CA-C 112.817 0.673 . . . . 0.0 112.817 -175.11 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' F' F ' 28' ' ' GLY . . . . . . . . . . . . . . . 100.63 -27.97 18.04 Favored Glycine 0 CA--C 1.53 0.995 0 CA-C-N 115.494 -0.775 . . . . 0.0 112.218 -177.382 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' F' F ' 29' ' ' LYS . . . . . . . . . . . . . 98.2 mttt -97.9 155.07 17.24 Favored 'General case' 0 C--O 1.232 0.18 0 CA-C-N 117.33 0.565 . . . . 0.0 111.247 179.056 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' F' F ' 30' ' ' THR . . . . . . . . . . . . . 42.0 m -103.67 140.28 37.8 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 115.892 -0.594 . . . . 0.0 110.162 176.839 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' F' F ' 31' ' ' VAL . . . . . . . . . . . . . 35.5 m -127.48 155.06 38.53 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.303 0 CA-C-N 116.272 -0.422 . . . . 0.0 110.374 179.429 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' F' F ' 32' ' ' ARG . . . . . . . . . . . . . 35.9 ttp180 -134.03 149.31 51.17 Favored 'General case' 0 C--N 1.331 -0.207 0 CA-C-O 121.305 0.574 . . . . 0.0 110.603 178.678 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' F' F ' 33' ' ' THR . . . . . . . . . . . . . 16.3 m -52.51 139.61 24.85 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-N 116.073 -0.512 . . . . 0.0 111.544 -177.939 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' F' F ' 34' ' ' GLY . . . . . . . . . . . . . . . 98.75 -17.23 58.61 Favored Glycine 0 CA--C 1.533 1.175 0 C-N-CA 121.236 -0.507 . . . . 0.0 113.366 178.947 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' F' F ' 35' ' ' ASP . . . . . . . . . . . . . 76.3 m-20 -65.79 150.17 48.97 Favored 'General case' 0 N--CA 1.462 0.161 0 CA-C-N 117.942 0.871 . . . . 0.0 111.291 -179.891 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' F' F ' 36' ' ' VAL . . . . . . . . . . . . . 44.3 t -119.73 128.93 75.91 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.222 0 CA-C-N 115.798 -0.637 . . . . 0.0 109.725 177.882 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' F' F ' 37' ' ' ILE . . . . . . . . . . . . . 68.8 mt -122.22 139.19 49.94 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.248 0 CA-C-N 116.261 -0.427 . . . . 0.0 109.928 -179.275 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' F' F ' 38' ' ' GLY . . . . . . . . . . . . . . . -115.3 128.35 8.04 Favored Glycine 0 CA--C 1.525 0.693 0 N-CA-C 110.859 -0.896 . . . . 0.0 110.859 178.853 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' F' F ' 39' ' ' ILE . . . . . . . . . . . . . 76.3 mt -127.44 138.6 54.29 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.217 0 CA-C-O 120.74 0.305 . . . . 0.0 110.197 179.921 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' F' F ' 40' ' ' SER . . . . . . . . . . . . . 42.6 t -91.96 114.05 26.48 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.274 -0.421 . . . . 0.0 110.981 176.849 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' F' F ' 41' ' ' ILE . . . . . . . . . . . . . 44.3 mm -122.94 121.06 62.3 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.234 0 N-CA-C 109.665 -0.494 . . . . 0.0 109.665 178.645 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' F' F ' 42' ' ' LEU . . . . . . . . . . . . . 84.2 mt 57.71 33.67 23.51 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 116.454 -0.339 . . . . 0.0 111.662 179.606 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' F' F ' 43' ' ' GLY . . . . . . . . . . . . . . . 77.64 -10.2 25.37 Favored Glycine 0 CA--C 1.535 1.288 0 C-N-CA 121.311 -0.471 . . . . 0.0 113.47 178.114 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' F' F ' 44' ' ' LYS . . . . . . . . . . . . . 98.3 mttt -101.05 138.76 37.66 Favored 'General case' 0 C--N 1.334 -0.108 0 CA-C-N 117.898 0.849 . . . . 0.0 110.05 177.436 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' F' F ' 45' ' ' GLU . . . . . . . . . . . . . 80.9 tt0 -83.75 130.08 34.95 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.431 -0.35 . . . . 0.0 111.263 -178.945 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' F' F ' 46' ' ' VAL . . . . . . . . . . . . . 10.4 p -120.55 125.87 74.61 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.209 0 N-CA-C 109.653 -0.499 . . . . 0.0 109.653 174.512 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' F' F ' 47' ' ' LYS . . . . . . . . . . . . . 29.2 mtpp -98.0 124.98 42.74 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 115.984 -0.553 . . . . 0.0 110.622 177.979 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' F' F ' 48' ' ' PHE . . . . . . . . . . . . . 40.8 m-85 -110.15 131.89 54.65 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.251 -0.431 . . . . 0.0 109.893 177.534 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' F' F ' 49' ' ' LYS . . . . . . . . . . . . . 85.6 tttt -106.34 131.39 53.61 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.209 -0.451 . . . . 0.0 109.811 177.158 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' F' F ' 50' ' ' VAL . . . . . . . . . . . . . 43.8 t -75.59 105.92 4.95 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.335 0 N-CA-C 109.384 -0.598 . . . . 0.0 109.384 177.911 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' F' F ' 51' ' ' VAL . . . . . . . . . . . . . 48.1 t -69.17 -48.01 71.23 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.27 0 CA-C-N 116.062 -0.517 . . . . 0.0 109.761 -174.354 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' F' F ' 52' ' ' GLN . . . . . . . . . . . . . 21.4 pt20 -167.01 158.56 12.47 Favored 'General case' 0 C--N 1.331 -0.199 0 C-N-CA 120.249 -0.58 . . . . 0.0 111.79 179.167 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' F' F ' 53' ' ' ALA . . . . . . . . . . . . . . . -133.5 137.04 45.44 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 115.485 -0.779 . . . . 0.0 110.243 179.07 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' F' F ' 54' ' ' TYR . . . . . . . . . . . . . 38.4 t80 -128.98 109.43 18.29 Favored Pre-proline 0 CA--C 1.535 0.372 0 CA-C-O 118.274 -0.87 . . . . 0.0 110.359 -179.425 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' F' F ' 55' ' ' PRO . . . . . . . . . . . . . 74.0 Cg_endo -77.17 169.97 72.77 Favored 'Cis proline' 0 N--CA 1.502 2.002 0 CA-C-N 121.855 1.698 . . . . 0.0 112.145 -7.375 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' F' F ' 56' ' ' SER . . . . . . . . . . . . . 49.0 m -117.82 132.8 23.48 Favored Pre-proline 0 CA--C 1.538 0.483 0 CA-C-O 118.492 -0.766 . . . . 0.0 109.616 175.057 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' F' F ' 57' ' ' PRO . . . . . . . . . . . . . 40.4 Cg_endo -68.56 165.45 72.8 Favored 'Cis proline' 0 N--CA 1.497 1.731 0 CA-C-N 121.88 1.707 . . . . 0.0 111.328 -1.657 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' F' F ' 58' ' ' LEU . . . . . . . . . . . . . 23.4 tp -130.62 137.45 49.63 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-O 120.871 0.367 . . . . 0.0 110.691 -178.049 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' F' F ' 59' ' ' ARG . . . . . . . . . . . . . 57.6 ttt85 -104.05 128.4 51.65 Favored 'General case' 0 C--N 1.328 -0.35 0 N-CA-C 109.464 -0.569 . . . . 0.0 109.464 176.35 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' F' F ' 60' ' ' VAL . . . . . . . . . . . . . 41.1 t -81.48 122.61 36.77 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.267 0 C-N-CA 120.769 -0.372 . . . . 0.0 110.69 -175.159 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' F' F ' 61' ' ' GLU . . . . . . . . . . . . . 44.3 mt-10 -131.12 168.0 18.18 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 115.842 -0.617 . . . . 0.0 109.77 176.892 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' F' F ' 62' ' ' ASP . . . . . . . . . . . . . 10.0 p-10 -55.91 -32.67 63.97 Favored 'General case' 0 C--N 1.329 -0.316 0 N-CA-C 111.803 0.297 . . . . 0.0 111.803 -178.484 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' F' F ' 63' ' ' ARG . . . . . . . . . . . . . 24.5 mmt180 -78.77 -9.33 59.4 Favored 'General case' 0 N--CA 1.467 0.383 0 N-CA-C 113.347 0.869 . . . . 0.0 113.347 -176.772 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' F' F ' 64' ' ' THR . . . . . . . . . . . . . 31.4 m -70.85 138.93 50.67 Favored 'General case' 0 C--N 1.332 -0.165 0 CA-C-O 121.007 0.432 . . . . 0.0 111.148 -175.356 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' F' F ' 65' ' ' LYS . . . . . . . . . . . . . 62.2 mttm -88.95 123.12 32.99 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 115.862 -0.608 . . . . 0.0 109.881 176.425 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' F' F ' 66' ' ' ILE . . . . . . . . . . . . . 61.7 mt -115.2 126.61 72.82 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 N-CA-C 109.779 -0.452 . . . . 0.0 109.779 179.758 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' F' F ' 67' ' ' THR . . . . . . . . . . . . . 28.4 m -125.38 138.76 54.04 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-O 121.126 0.488 . . . . 0.0 111.175 -177.351 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' F' F ' 68' ' ' LEU . . . . . . . . . . . . . 46.3 mt -103.24 127.89 50.42 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 115.753 -0.658 . . . . 0.0 109.959 176.161 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' F' F ' 69' ' ' VAL . . . . . . . . . . . . . 42.8 t -100.59 133.49 43.57 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.345 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.189 -178.69 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' F' F ' 70' ' ' THR . . . . . . . . . . . . . 21.6 p -103.69 152.22 22.06 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.488 179.616 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' F' F ' 71' ' ' HIS . . . . . . . . . . . . . 6.8 t60 -94.79 145.22 29.2 Favored Pre-proline 0 CA--C 1.534 0.353 0 CA-C-O 119.075 -0.488 . . . . 0.0 109.846 -179.904 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' F' F ' 72' ' ' PRO . . . . . . . . . . . . . 59.2 Cg_endo -75.24 -23.95 12.92 Favored 'Trans proline' 0 N--CA 1.495 1.606 0 C-N-CA 121.284 1.323 . . . . 0.0 112.867 -179.85 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' F' F ' 73' ' ' VAL . . . . . . . . . . . . . 35.9 m -130.95 167.85 25.12 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.161 0 CA-C-O 121.027 0.441 . . . . 0.0 110.814 -179.862 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' F' F ' 74' ' ' ASP . . . . . . . . . . . . . 13.5 t0 -105.11 117.9 35.18 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 115.849 -0.614 . . . . 0.0 109.741 177.748 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' F' F ' 75' ' ' VAL . . . . . . . . . . . . . 40.1 t -118.06 125.61 74.34 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.267 0 CA-C-O 121.048 0.451 . . . . 0.0 110.61 -178.08 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' F' F ' 76' ' ' LEU . . . . . . . . . . . . . 5.7 mp -126.3 145.42 50.43 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 115.672 -0.695 . . . . 0.0 109.559 176.206 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' F' F ' 77' ' ' GLU . . . . . . . . . . . . . 96.7 mt-10 -132.04 129.11 39.62 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-O 121.02 0.438 . . . . 0.0 110.715 -178.064 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' F' F ' 78' ' ' ALA . . . . . . . . . . . . . . . -115.4 132.62 56.56 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 115.75 -0.659 . . . . 0.0 109.999 178.869 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' F' F ' 79' ' ' LYS . . . . . . . . . . . . . 20.2 tptm -76.91 116.38 17.52 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-O 120.916 0.389 . . . . 0.0 110.791 -177.424 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' F' F ' 80' ' ' ILE . . . . . . . . . . . . . 42.3 mm -139.28 98.45 1.16 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.282 0 N-CA-C 109.152 -0.684 . . . . 0.0 109.152 -176.938 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' F' F ' 81' ' ' LYS . . . . . . . . . . . . . 17.8 pttp -98.4 131.26 44.82 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-O 120.956 0.408 . . . . 0.0 111.454 -175.72 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' F' F ' 82' ' ' GLY . . . . . . . . . . . . . . . 89.12 41.98 5.72 Favored Glycine 0 CA--C 1.524 0.643 0 CA-C-N 115.82 -0.627 . . . . 0.0 111.57 176.076 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' F' F ' 83' ' ' ILE . . . . . . . . . . . . . 65.8 mt -74.59 135.5 27.24 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 N-CA-C 109.453 -0.573 . . . . 0.0 109.453 176.719 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' F' F ' 84' ' ' LYS . . . . . . . . . . . . . 38.0 ttpt -106.94 -42.48 4.91 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-O 120.782 0.325 . . . . 0.0 110.634 -177.805 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' F' F ' 85' ' ' ASP . . . . . . . . . . . . . 9.2 t70 -149.23 149.83 31.6 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.311 -0.404 . . . . 0.0 110.433 179.336 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' F' F ' 86' ' ' VAL . . . . . . . . . . . . . 41.9 t -137.64 136.76 45.9 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.231 0 CA-C-O 120.936 0.398 . . . . 0.0 110.74 -178.915 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' F' F ' 87' ' ' ILE . . . . . . . . . . . . . 4.9 mp -123.83 126.86 73.32 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.251 0 CA-C-N 115.828 -0.624 . . . . 0.0 109.522 176.171 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' F' F ' 88' ' ' LEU . . . . . . . . . . . . . 19.2 tp -114.89 130.26 56.86 Favored 'General case' 0 N--CA 1.463 0.184 0 CA-C-O 121.088 0.47 . . . . 0.0 111.187 -177.525 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' F' F ' 89' ' ' ASP . . . . . . . . . . . . . 4.2 t0 -125.42 156.58 38.6 Favored 'General case' 0 C--N 1.331 -0.207 0 CA-C-N 115.638 -0.71 . . . . 0.0 109.388 175.399 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' F' F ' 90' ' ' GLU . . . . . . . . . . . . . 81.9 tt0 -46.53 -40.89 13.39 Favored 'General case' 0 N--CA 1.463 0.211 0 N-CA-C 113.11 0.781 . . . . 0.0 113.11 -172.445 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' F' F ' 91' ' ' ASN . . . . . . . . . . . . . 71.1 m-80 -132.14 37.75 3.55 Favored 'General case' 0 N--CA 1.465 0.28 0 CA-C-O 120.785 0.326 . . . . 0.0 111.554 -176.479 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' F' F ' 92' ' ' LEU . . . . . . . . . . . . . 17.3 tp -166.08 138.85 4.04 Favored 'General case' 0 C--N 1.33 -0.281 0 C-N-CA 120.931 -0.308 . . . . 0.0 110.589 -179.563 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' F' F ' 93' ' ' ILE . . . . . . . . . . . . . 67.0 mt -124.02 122.42 64.42 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.187 0 N-CA-C 109.769 -0.456 . . . . 0.0 109.769 179.724 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' F' F ' 94' ' ' VAL . . . . . . . . . . . . . 44.8 t -120.92 125.18 73.73 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.222 0 N-CA-C 109.789 -0.448 . . . . 0.0 109.789 178.59 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' F' F ' 95' ' ' VAL . . . . . . . . . . . . . 43.1 t -120.11 134.04 64.88 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.379 0 CA-C-N 116.071 -0.513 . . . . 0.0 109.746 -179.422 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' F' F ' 96' ' ' ILE . . . . . . . . . . . . . 68.4 mt -116.6 127.88 74.1 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.232 0 N-CA-C 109.458 -0.571 . . . . 0.0 109.458 179.31 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' F' F ' 97' ' ' THR . . . . . . . . . . . . . 77.8 p -101.92 162.23 13.06 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-O 121.5 0.667 . . . . 0.0 111.704 -175.362 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' F' F ' 98' ' ' GLU . . . . . . . . . . . . . 82.1 tt0 -53.82 -28.51 35.92 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 115.442 -0.799 . . . . 0.0 112.361 -178.947 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' F' F ' 99' ' ' GLU . . . . . . . . . . . . . 96.0 mt-10 -81.97 18.04 1.42 Allowed 'General case' 0 CA--C 1.534 0.354 0 N-CA-C 113.116 0.784 . . . . 0.0 113.116 -176.356 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' F' F ' 100' ' ' ASN . . . . . . . . . . . . . 2.7 m-20 62.22 37.65 14.07 Favored 'General case' 0 CA--C 1.53 0.185 0 CA-C-O 121.036 0.446 . . . . 0.0 111.047 177.591 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' F' F ' 101' ' ' GLU . . . . . . . . . . . . . 84.7 tt0 -117.1 144.61 44.48 Favored 'General case' 0 C--N 1.332 -0.193 0 N-CA-C 109.719 -0.475 . . . . 0.0 109.719 177.342 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' F' F ' 102' ' ' VAL . . . . . . . . . . . . . 42.4 t -117.47 127.29 74.94 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.23 0 N-CA-C 109.962 -0.385 . . . . 0.0 109.962 -178.446 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' F' F ' 103' ' ' LEU . . . . . . . . . . . . . 31.5 mt -116.33 132.07 56.77 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 115.572 -0.74 . . . . 0.0 110.036 176.699 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' F' F ' 104' ' ' ILE . . . . . . . . . . . . . 66.4 mt -117.73 122.21 69.26 Favored 'Isoleucine or valine' 0 C--O 1.234 0.265 0 N-CA-C 110.238 -0.282 . . . . 0.0 110.238 -178.939 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' F' F ' 105' ' ' PHE . . . . . . . . . . . . . 86.5 m-85 -123.48 164.27 19.27 Favored 'General case' 0 C--N 1.332 -0.165 0 O-C-N 123.936 0.773 . . . . 0.0 110.3 -178.857 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' F' F ' 106' ' ' ASN . . . . . . . . . . . . . 46.0 p-10 -99.73 -169.92 1.82 Allowed 'General case' 0 CA--C 1.53 0.2 0 N-CA-C 109.655 -0.498 . . . . 0.0 109.655 171.849 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' F' F ' 107' ' ' GLN . . . . . . . . . . . . . 41.4 tt0 -57.86 -30.06 65.49 Favored 'General case' 0 C--N 1.327 -0.379 0 N-CA-C 112.117 0.414 . . . . 0.0 112.117 -178.767 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' F' F ' 108' ' ' ASN . . . . . . . . . . . . . 8.8 t30 -91.24 14.11 15.29 Favored 'General case' 0 CA--C 1.535 0.398 0 N-CA-C 113.106 0.78 . . . . 0.0 113.106 -175.558 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' F' F ' 109' ' ' LEU . . . . . . . . . . . . . 40.8 mt 58.12 34.01 23.75 Favored 'General case' 0 CA--C 1.53 0.204 0 CA-C-O 120.718 0.294 . . . . 0.0 111.723 177.914 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' F' F ' 110' ' ' GLU . . . . . . . . . . . . . 96.0 mt-10 -98.92 134.75 41.33 Favored 'General case' 0 C--N 1.329 -0.288 0 N-CA-C 109.408 -0.59 . . . . 0.0 109.408 175.434 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' F' F ' 111' ' ' GLU . . . . . . . . . . . . . 48.4 tt0 -71.7 121.97 19.8 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-O 121.009 0.433 . . . . 0.0 110.729 -175.751 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' F' F ' 112' ' ' LEU . . . . . . . . . . . . . 25.6 mt -105.87 -46.04 4.22 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-N 115.898 -0.592 . . . . 0.0 110.327 178.994 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' F' F ' 113' ' ' TYR . . . . . . . . . . . . . 31.2 t80 -137.95 141.54 40.53 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.11 -0.495 . . . . 0.0 111.05 -179.036 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' F' F ' 114' ' ' ARG . . . . . . . . . . . . . 32.7 ptt180 -141.69 123.58 15.31 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.247 -0.433 . . . . 0.0 110.392 177.206 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' F' F ' 115' ' ' GLY . . . . . . . . . . . . . . . -150.14 160.08 28.38 Favored Glycine 0 CA--C 1.524 0.601 0 N-CA-C 111.16 -0.776 . . . . 0.0 111.16 179.821 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' F' F ' 116' ' ' LYS . . . . . . . . . . . . . 33.4 ttpt -128.96 136.91 50.99 Favored 'General case' 0 C--N 1.33 -0.276 0 N-CA-C 109.908 -0.405 . . . . 0.0 109.908 177.333 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' F' F ' 117' ' ' PHE . . . . . . . . . . . . . 43.4 m-85 -134.1 113.79 12.45 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-O 120.971 0.415 . . . . 0.0 110.238 -177.124 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' F' F ' 118' ' ' GLU . . . . . . . . . . . . . 45.7 tp10 -54.69 -48.88 71.89 Favored 'General case' 0 C--N 1.326 -0.449 0 CA-C-N 116.289 -0.414 . . . . 0.0 111.277 -176.188 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' F' F ' 119' ' ' ASN . . . . . . . . . . . . . 73.3 m-20 -95.17 31.1 1.99 Allowed 'General case' 0 C--N 1.33 -0.275 0 N-CA-C 112.155 0.428 . . . . 0.0 112.155 -173.836 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' F' F ' 120' ' ' LEU . . . . . . . . . . . . . 20.0 tp -54.18 119.91 5.76 Favored 'General case' 0 N--CA 1.464 0.233 0 O-C-N 122.207 -0.308 . . . . 0.0 110.738 177.29 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' F' F ' 121' ' ' ASN . . . . . . . . . . . . . 13.6 t-20 -114.11 -44.03 3.18 Favored 'General case' 0 C--N 1.331 -0.214 0 CA-C-N 116.455 -0.339 . . . . 0.0 110.962 -177.009 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' F' F ' 122' ' ' LYS . . . . . . . . . . . . . 61.9 mtpt -142.0 147.29 36.67 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-O 121.168 0.509 . . . . 0.0 111.233 -177.059 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' F' F ' 123' ' ' VAL . . . . . . . . . . . . . 44.2 t -128.66 125.98 64.39 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.191 0 N-CA-C 109.312 -0.625 . . . . 0.0 109.312 174.679 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' F' F ' 124' ' ' LEU . . . . . . . . . . . . . 6.0 mp -118.17 132.82 56.3 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-O 120.766 0.317 . . . . 0.0 110.696 -177.019 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' F' F ' 125' ' ' VAL . . . . . . . . . . . . . 43.9 t -125.57 127.51 71.69 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.241 0 CA-C-N 116.051 -0.522 . . . . 0.0 110.178 179.918 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' F' F ' 126' ' ' ARG . . . . . . . . . . . . . 40.8 mmt180 -145.22 119.88 9.8 Favored 'General case' 0 C--N 1.328 -0.336 0 N-CA-C 109.478 -0.564 . . . . 0.0 109.478 177.193 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' F' F ' 127' ' ' ASN . . . . . . . . . . . . . 13.8 m120 56.38 -152.73 0.37 Allowed 'General case' 0 CA--C 1.54 0.564 0 N-CA-C 109.737 -0.468 . . . . 0.0 109.737 -179.164 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' F' F ' 128' ' ' ASP . . . . . . . . . . . . . 23.3 p-10 -79.95 14.29 1.87 Allowed 'General case' 0 CA--C 1.537 0.448 0 N-CA-C 112.759 0.652 . . . . 0.0 112.759 177.799 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' F' F ' 129' ' ' LEU . . . . . . . . . . . . . 60.9 mt -109.37 139.75 43.93 Favored 'General case' 0 C--O 1.232 0.181 0 O-C-N 121.955 -0.465 . . . . 0.0 109.747 178.254 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' F' F ' 130' ' ' VAL . . . . . . . . . . . . . 12.1 p -132.34 141.75 44.45 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.235 0 CA-C-O 121.202 0.525 . . . . 0.0 110.562 -177.746 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' F' F ' 131' ' ' VAL . . . . . . . . . . . . . 42.8 t -135.99 135.2 50.58 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.299 0 CA-C-N 115.794 -0.639 . . . . 0.0 110.035 178.63 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' F' F ' 132' ' ' ILE . . . . . . . . . . . . . 69.0 mt -113.52 130.76 66.98 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.332 0 CA-C-N 115.815 -0.629 . . . . 0.0 109.348 -179.784 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' F' F ' 133' ' ' ILE . . . . . . . . . . . . . 36.8 mm -114.59 120.41 64.19 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.216 0 CA-C-O 120.989 0.423 . . . . 0.0 110.914 -175.044 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' F' F ' 134' ' ' ASP . . . . . . . . . . . . . 6.9 p-10 -132.56 147.45 52.35 Favored 'General case' 0 C--N 1.332 -0.181 0 N-CA-C 109.519 -0.549 . . . . 0.0 109.519 176.007 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' F' F ' 135' ' ' GLU . . . . . . . . . . . . . 84.5 tt0 -49.94 -27.57 5.51 Favored 'General case' 0 C--N 1.329 -0.298 0 N-CA-C 112.703 0.631 . . . . 0.0 112.703 -173.008 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' F' F ' 136' ' ' GLN . . . . . . . . . . . . . 98.5 mt-30 -81.36 -34.48 31.71 Favored 'General case' 0 C--O 1.232 0.183 0 N-CA-C 112.181 0.438 . . . . 0.0 112.181 -176.158 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' F' F ' 137' ' ' LYS . . . . . . . . . . . . . 56.3 pttt -168.01 175.04 6.92 Favored 'General case' 0 C--N 1.332 -0.188 0 CA-C-O 121.506 0.669 . . . . 0.0 112.14 -172.482 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' F' F ' 138' ' ' LEU . . . . . . . . . . . . . 8.5 tt -120.13 128.59 53.58 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 115.174 -0.921 . . . . 0.0 110.135 179.205 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' F' F ' 139' ' ' THR . . . . . . . . . . . . . 33.2 m -107.64 122.41 46.65 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-N 116.116 -0.493 . . . . 0.0 110.239 178.906 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' F' F ' 140' ' ' LEU . . . . . . . . . . . . . 6.2 tt -111.03 122.27 47.47 Favored 'General case' 0 C--N 1.329 -0.326 0 N-CA-C 109.189 -0.671 . . . . 0.0 109.189 -179.432 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' F' F ' 141' ' ' ILE . . . . . . . . . . . . . 19.8 mt -121.63 116.36 49.25 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.275 0 CA-C-O 121.086 0.47 . . . . 0.0 109.927 -176.113 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' F' F ' 142' ' ' ARG . . . . . . . . . . . . . 61.6 ttt180 -106.07 127.46 53.2 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 114.921 -1.036 . . . . 0.0 110.619 -176.259 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' F' F ' 143' ' ' THR . . . . . . . . . . . . . 75.8 p . . . . . 0 C--O 1.22 -0.46 0 CA-C-O 118.001 -1.0 . . . . 0.0 110.589 179.192 . . . . . . . . 0 0 . 1 . 005 nuclear orig full ' A' A ' -3' ' ' GLU . . . . . . . . . . . . . 11.8 pt-20 . . . . . 0 N--CA 1.49 1.557 0 N-CA-C 109.501 -0.555 . . . . 0.0 109.501 . . . . . . . . . 0 0 . 1 . 005 nuclear orig full ' A' A ' -2' ' ' GLY . . . . . . . . . . . . . . . -62.93 115.13 7.63 Favored Glycine 0 CA--C 1.525 0.695 0 N-CA-C 110.843 -0.903 . . . . 0.0 110.843 -179.86 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' -1' ' ' VAL . . . . . . . . . . . . . 41.0 t -97.35 128.64 48.43 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 CA-C-O 120.83 0.348 . . . . 0.0 110.233 -179.518 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 0' ' ' ILE . . . . . . . . . . . . . 74.8 mt -122.58 133.51 68.54 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.234 0 N-CA-C 109.741 -0.466 . . . . 0.0 109.741 177.773 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 26.8 ptm -143.66 166.83 23.75 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.264 -0.426 . . . . 0.0 110.909 -178.52 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 13.7 p -114.74 135.41 54.2 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.01 -0.541 . . . . 0.0 110.618 177.934 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 84.9 tt0 -140.02 138.94 35.84 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-N 115.724 -0.671 . . . . 0.0 110.676 179.64 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 4' ' ' LEU . . . . . . . . . . . . . 3.0 tt -125.7 126.51 44.76 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 115.734 -0.666 . . . . 0.0 109.698 178.579 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 5' ' ' LYS . . . . . . . . . . . . . 87.8 mttt -108.99 124.34 50.56 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-O 120.655 0.265 . . . . 0.0 110.864 -179.119 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 18.3 mt -122.01 150.29 42.28 Favored 'General case' 0 C--O 1.232 0.163 0 CA-C-N 115.811 -0.631 . . . . 0.0 111.254 -178.879 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 49.3 tttm -138.27 143.47 39.1 Favored Pre-proline 0 C--N 1.329 -0.304 0 CA-C-N 115.757 -0.656 . . . . 0.0 109.792 175.199 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 8' ' ' PRO . . . . . . . . . . . . . 97.5 Cg_endo -89.8 136.72 2.65 Favored 'Trans proline' 0 N--CA 1.489 1.234 0 C-N-CA 121.741 1.628 . . . . 0.0 111.766 178.537 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 40.9 mt -75.9 -45.68 3.93 Favored Pre-proline 0 CA--C 1.532 0.285 0 CA-C-O 119.064 -0.493 . . . . 0.0 111.524 -179.253 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 71.1 Cg_endo -85.1 152.12 10.93 Favored 'Trans proline' 0 N--CA 1.494 1.519 0 C-N-CA 121.234 1.289 . . . . 0.0 111.31 170.534 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 27.5 ttpp -86.23 109.78 19.16 Favored 'General case' 0 C--N 1.33 -0.271 0 C-N-CA 120.702 -0.399 . . . . 0.0 110.235 178.692 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 11.8 p -142.77 145.09 23.55 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.291 0 CA-C-N 116.092 -0.504 . . . . 0.0 110.62 -178.576 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 84.8 tt0 -88.47 121.32 30.72 Favored 'General case' 0 C--N 1.328 -0.344 0 N-CA-C 109.913 -0.403 . . . . 0.0 109.913 176.886 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 14' ' ' LEU . . . . . . . . . . . . . 29.6 mt -98.01 151.56 37.61 Favored Pre-proline 0 C--N 1.33 -0.268 0 CA-C-N 116.354 -0.384 . . . . 0.0 110.976 -176.277 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 15' ' ' PRO . . . . . . . . . . . . . 24.5 Cg_exo -63.31 161.13 31.95 Favored 'Trans proline' 0 N--CA 1.497 1.723 0 C-N-CA 121.322 1.348 . . . . 0.0 111.666 175.436 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 16' ' ' PRO . . . . . . . . . . . . . 26.6 Cg_exo -60.73 -34.0 92.39 Favored 'Trans proline' 0 N--CA 1.496 1.646 0 C-N-CA 121.478 1.452 . . . . 0.0 112.966 -177.722 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 17' ' ' ASP . . . . . . . . . . . . . 18.8 p-10 -90.62 6.6 43.17 Favored 'General case' 0 CA--C 1.537 0.465 0 N-CA-C 113.402 0.89 . . . . 0.0 113.402 -176.833 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 18' ' ' PHE . . . . . . . . . . . . . 49.6 t80 -57.59 -42.93 84.18 Favored 'General case' 0 C--N 1.334 -0.105 0 CA-C-O 120.952 0.406 . . . . 0.0 110.291 -178.021 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 19' ' ' VAL . . . . . . . . . . . . . 47.8 t -57.16 -43.57 81.84 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.346 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.358 -178.827 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 4.2 m-20 -60.15 -41.33 92.54 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.525 -0.307 . . . . 0.0 110.882 -178.381 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 47.0 t -63.58 -46.17 95.66 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 C-N-CA 120.85 -0.34 . . . . 0.0 110.296 -177.385 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 22' ' ' ILE . . . . . . . . . . . . . 51.0 mm -55.54 -48.63 77.13 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.237 0 CA-C-O 120.81 0.338 . . . . 0.0 110.714 178.778 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 23' ' ' ARG . . . . . . . . . . . . . 55.9 ttp180 -54.31 -48.77 70.93 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.629 -0.26 . . . . 0.0 111.568 -178.057 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 24' ' ' ILE . . . . . . . . . . . . . 78.5 mt -60.11 -42.7 90.92 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.269 0 C-N-CA 121.052 -0.259 . . . . 0.0 111.54 -176.791 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 51.1 mttm -65.13 -40.49 94.52 Favored 'General case' 0 C--N 1.328 -0.327 0 N-CA-C 112.21 0.448 . . . . 0.0 112.21 -179.12 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 37.6 mt -78.96 -40.06 32.83 Favored 'General case' 0 C--N 1.33 -0.271 0 N-CA-C 113.526 0.935 . . . . 0.0 113.526 -171.366 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 27' ' ' GLN . . . . . . . . . . . . . 9.8 pt20 -46.88 141.91 3.75 Favored 'General case' 0 N--CA 1.47 0.545 0 N-CA-C 112.82 0.674 . . . . 0.0 112.82 -175.207 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 97.72 -30.0 10.06 Favored Glycine 0 CA--C 1.531 1.044 0 CA-C-N 115.652 -0.703 . . . . 0.0 111.984 -177.529 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 48.8 mtmt -99.3 155.3 17.58 Favored 'General case' 0 C--O 1.233 0.227 0 CA-C-O 120.993 0.425 . . . . 0.0 111.324 179.304 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 30' ' ' THR . . . . . . . . . . . . . 20.8 m -105.57 140.55 38.49 Favored 'General case' 0 C--N 1.331 -0.212 0 CA-C-N 115.91 -0.586 . . . . 0.0 110.166 176.657 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 35.5 m -129.54 161.43 39.08 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.187 0 CA-C-N 116.41 -0.359 . . . . 0.0 110.848 -179.138 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 32' ' ' ARG . . . . . . . . . . . . . 79.7 mtt85 -127.28 147.37 50.23 Favored 'General case' 0 C--N 1.331 -0.212 0 CA-C-O 121.291 0.567 . . . . 0.0 110.776 179.093 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 33' ' ' THR . . . . . . . . . . . . . 29.2 m -53.91 140.69 29.98 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.248 -0.433 . . . . 0.0 111.146 -179.879 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 98.83 -17.13 58.69 Favored Glycine 0 CA--C 1.532 1.144 0 C-N-CA 121.131 -0.557 . . . . 0.0 113.232 179.33 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 76.1 m-20 -64.63 150.26 47.37 Favored 'General case' 0 C--O 1.232 0.147 0 CA-C-N 118.096 0.948 . . . . 0.0 111.241 179.813 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 45.0 t -119.07 129.65 74.91 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.247 0 CA-C-N 115.713 -0.676 . . . . 0.0 109.81 178.85 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 37' ' ' ILE . . . . . . . . . . . . . 69.2 mt -119.94 138.28 51.03 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.273 0 CA-C-N 116.171 -0.468 . . . . 0.0 109.759 179.414 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . -113.74 128.98 8.56 Favored Glycine 0 CA--C 1.525 0.707 0 N-CA-C 111.029 -0.828 . . . . 0.0 111.029 -179.255 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 39' ' ' ILE . . . . . . . . . . . . . 72.4 mt -123.55 133.97 67.69 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.231 0 N-CA-C 110.188 -0.301 . . . . 0.0 110.188 179.079 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 40' ' ' SER . . . . . . . . . . . . . 45.2 t -93.0 113.93 26.34 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.455 -0.338 . . . . 0.0 110.776 175.597 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 41' ' ' ILE . . . . . . . . . . . . . 44.9 mm -121.51 123.44 69.59 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.265 0 CA-C-O 120.778 0.323 . . . . 0.0 110.45 179.997 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 34.5 mt 52.57 34.09 14.91 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.235 -0.438 . . . . 0.0 111.791 177.292 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . 72.52 32.16 62.28 Favored Glycine 0 CA--C 1.53 0.988 0 C-N-CA 121.113 -0.565 . . . . 0.0 111.889 178.747 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 44' ' ' LYS . . . . . . . . . . . . . 33.7 ttmt -139.21 130.48 26.82 Favored 'General case' 0 C--N 1.329 -0.314 0 N-CA-C 109.767 -0.457 . . . . 0.0 109.767 179.188 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 84.0 tt0 -82.62 122.38 28.03 Favored 'General case' 0 C--N 1.329 -0.29 0 C-N-CA 120.755 -0.378 . . . . 0.0 111.003 -177.848 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 46' ' ' VAL . . . . . . . . . . . . . 7.1 p -120.64 129.1 75.98 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.227 0 N-CA-C 109.338 -0.616 . . . . 0.0 109.338 174.682 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 59.7 mtpt -100.32 127.05 46.71 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 115.748 -0.66 . . . . 0.0 110.858 179.624 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 48' ' ' PHE . . . . . . . . . . . . . 89.5 m-85 -110.44 131.87 54.68 Favored 'General case' 0 C--N 1.33 -0.275 0 N-CA-C 110.017 -0.364 . . . . 0.0 110.017 176.919 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 86.2 tttt -106.33 133.94 50.24 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.258 -0.428 . . . . 0.0 110.415 179.892 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 50' ' ' VAL . . . . . . . . . . . . . 42.1 t -77.76 105.38 6.7 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.236 0 N-CA-C 109.165 -0.68 . . . . 0.0 109.165 176.177 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 51' ' ' VAL . . . . . . . . . . . . . 48.9 t -69.79 -48.52 63.97 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.295 0 CA-C-N 116.022 -0.535 . . . . 0.0 110.146 -173.16 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 52' ' ' GLN . . . . . . . . . . . . . 61.8 tt0 -163.96 144.62 8.51 Favored 'General case' 0 C--N 1.329 -0.296 0 C-N-CA 120.288 -0.565 . . . . 0.0 111.811 -177.911 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -115.18 133.04 56.39 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 115.559 -0.746 . . . . 0.0 109.79 176.016 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 54' ' ' TYR . . . . . . . . . . . . . 9.5 t80 -129.04 108.41 18.09 Favored Pre-proline 0 CA--C 1.535 0.379 0 CA-C-O 118.182 -0.914 . . . . 0.0 110.464 178.499 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 55' ' ' PRO . . . . . . . . . . . . . 72.0 Cg_endo -76.96 168.89 75.87 Favored 'Cis proline' 0 N--CA 1.501 1.952 0 CA-C-N 121.941 1.729 . . . . 0.0 112.408 -4.945 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 56' ' ' SER . . . . . . . . . . . . . 14.4 m -112.33 128.0 26.1 Favored Pre-proline 0 CA--C 1.539 0.535 0 CA-C-O 118.366 -0.826 . . . . 0.0 109.673 176.961 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 57' ' ' PRO . . . . . . . . . . . . . 35.2 Cg_endo -65.72 168.86 44.6 Favored 'Cis proline' 0 N--CA 1.497 1.715 0 CA-C-N 122.029 1.76 . . . . 0.0 111.45 -2.862 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 58' ' ' LEU . . . . . . . . . . . . . 30.0 tp -129.95 135.71 48.63 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-O 120.887 0.375 . . . . 0.0 110.707 -179.41 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 59' ' ' ARG . . . . . . . . . . . . . 52.9 ttt180 -106.99 129.12 54.83 Favored 'General case' 0 C--N 1.328 -0.335 0 N-CA-C 108.688 -0.856 . . . . 0.0 108.688 176.521 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 40.6 t -89.85 126.23 42.75 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.183 0 C-N-CA 120.385 -0.526 . . . . 0.0 111.36 -172.607 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 49.8 mp0 -131.07 168.55 17.21 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 115.58 -0.737 . . . . 0.0 109.077 171.917 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 62' ' ' ASP . . . . . . . . . . . . . 18.2 p-10 -53.87 -32.6 53.72 Favored 'General case' 0 C--N 1.329 -0.323 0 C-N-CA 120.931 -0.308 . . . . 0.0 111.815 -178.449 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 63' ' ' ARG . . . . . . . . . . . . . 98.4 mtt180 -71.97 -22.14 61.49 Favored 'General case' 0 CA--C 1.532 0.273 0 N-CA-C 112.896 0.702 . . . . 0.0 112.896 -177.299 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 50.9 m -67.37 130.24 42.43 Favored 'General case' 0 C--N 1.332 -0.193 0 N-CA-C 110.125 -0.324 . . . . 0.0 110.125 -178.275 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 65' ' ' LYS . . . . . . . . . . . . . 50.3 mtmt -89.23 135.79 33.38 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.222 -0.445 . . . . 0.0 110.538 179.825 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 66' ' ' ILE . . . . . 0.404 HD11 HG23 ' A' ' 66' ' ' ILE . 65.1 mt -114.8 130.95 68.36 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.229 0 N-CA-C 109.736 -0.468 . . . . 0.0 109.736 -178.408 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 67' ' ' THR . . . . . . . . . . . . . 23.4 m -117.63 134.73 54.57 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.123 -0.49 . . . . 0.0 110.608 -178.524 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 68' ' ' LEU . . . . . . . . . . . . . 15.4 tp -108.4 127.72 54.14 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 115.891 -0.595 . . . . 0.0 110.472 179.585 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 69' ' ' VAL . . . . . . . . . . . . . 43.0 t -97.61 136.2 29.31 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.272 0 CA-C-O 120.877 0.37 . . . . 0.0 110.284 178.318 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 70' ' ' THR . . . . . . . . . . . . . 69.7 p -92.2 173.65 7.71 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.031 -0.531 . . . . 0.0 110.748 179.927 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 71' ' ' HIS . . . . . . . . . . . . . 14.4 t60 -65.07 141.14 98.25 Favored Pre-proline 0 CA--C 1.533 0.321 0 CA-C-N 116.239 -0.437 . . . . 0.0 110.365 -178.462 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 72' ' ' PRO . . . . . . . . . . . . . 64.1 Cg_endo -94.49 159.91 1.95 Allowed 'Trans proline' 0 N--CA 1.491 1.362 0 C-N-CA 121.891 1.727 . . . . 0.0 112.903 179.771 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 73' ' ' VAL . . . . . . . . . . . . . 35.4 m -79.68 -170.26 0.11 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.271 0 CA-C-N 115.934 -0.575 . . . . 0.0 109.773 175.255 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 74' ' ' ASP . . . . . . . . . . . . . 13.6 t70 -86.18 114.97 23.45 Favored 'General case' 0 C--N 1.33 -0.247 0 N-CA-C 109.557 -0.535 . . . . 0.0 109.557 -179.088 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 41.4 t -122.59 124.26 70.28 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.203 0 CA-C-O 121.077 0.465 . . . . 0.0 110.909 -175.203 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 76' ' ' LEU . . . . . . . . . . . . . 5.1 mp -126.38 147.05 49.83 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 115.664 -0.698 . . . . 0.0 109.603 174.852 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 77' ' ' GLU . . . . . . . . . . . . . 45.9 mt-10 -135.1 140.52 45.55 Favored 'General case' 0 C--N 1.331 -0.207 0 CA-C-O 121.015 0.436 . . . . 0.0 111.425 -178.443 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 78' ' ' ALA . . . . . . . . . . . . . . . -129.92 131.33 45.96 Favored 'General case' 0 C--N 1.331 -0.22 0 CA-C-N 115.774 -0.648 . . . . 0.0 109.842 176.513 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 79' ' ' LYS . . . . . . . . . . . . . 16.3 ptpt -74.94 122.57 23.65 Favored 'General case' 0 C--N 1.331 -0.222 0 CA-C-O 121.281 0.562 . . . . 0.0 111.087 -176.801 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 80' ' ' ILE . . . . . . . . . . . . . 41.2 mm -139.22 110.57 4.95 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.318 0 CA-C-N 115.779 -0.646 . . . . 0.0 109.289 -177.875 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 81' ' ' LYS . . . . . . . . . . . . . 60.6 mttp -101.37 125.56 48.03 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-O 120.914 0.388 . . . . 0.0 111.293 -178.234 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . 89.15 42.07 5.69 Favored Glycine 0 CA--C 1.525 0.702 0 C-N-CA 121.105 -0.569 . . . . 0.0 111.894 174.254 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 83' ' ' ILE . . . . . . . . . . . . . 71.4 mt -69.55 133.3 32.09 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.33 0 N-CA-C 109.489 -0.56 . . . . 0.0 109.489 175.999 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 84' ' ' LYS . . . . . . . . . . . . . 35.7 ttpt -101.58 -49.58 3.97 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-O 120.742 0.306 . . . . 0.0 110.398 -177.881 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 85' ' ' ASP . . . . . . . . . . . . . 5.6 t70 -150.87 151.26 31.97 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.242 -0.435 . . . . 0.0 110.483 -179.972 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 86' ' ' VAL . . . . . . . . . . . . . 41.0 t -133.89 137.62 52.0 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.261 0 CA-C-O 121.014 0.435 . . . . 0.0 110.537 -179.061 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 87' ' ' ILE . . . . . . . . . . . . . 5.0 mp -121.0 130.69 74.42 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.21 0 CA-C-N 115.701 -0.681 . . . . 0.0 109.699 178.134 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 88' ' ' LEU . . . . . . . . . . . . . 15.9 tp -111.79 132.83 54.4 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-O 120.858 0.361 . . . . 0.0 110.743 -178.893 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 89' ' ' ASP . . . . . . . . . . . . . 46.4 t0 -130.6 160.31 34.58 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.161 178.584 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 84.6 tt0 -45.77 -43.1 12.83 Favored 'General case' 0 CA--C 1.532 0.257 0 N-CA-C 113.06 0.763 . . . . 0.0 113.06 -171.392 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 91' ' ' ASN . . . . . . . . . . . . . 3.0 m120 -131.96 26.49 4.6 Favored 'General case' 0 N--CA 1.467 0.394 0 N-CA-C 112.471 0.545 . . . . 0.0 112.471 -178.286 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 92' ' ' LEU . . . . . . . . . . . . . 18.6 mt -148.58 144.47 27.28 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-O 120.759 0.314 . . . . 0.0 110.508 -176.693 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 93' ' ' ILE . . . . . . . . . . . . . 69.3 mt -125.23 116.69 47.65 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.306 0 N-CA-C 108.822 -0.807 . . . . 0.0 108.822 175.694 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 94' ' ' VAL . . . . . . . . . . . . . 44.3 t -117.62 127.85 74.93 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.286 0 N-CA-C 109.904 -0.406 . . . . 0.0 109.904 -177.807 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 95' ' ' VAL . . . . . . . . . . . . . 43.1 t -121.38 133.94 66.31 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.339 0 CA-C-N 116.027 -0.533 . . . . 0.0 109.813 -179.822 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 96' ' ' ILE . . . . . . . . . . . . . 66.8 mt -114.57 125.17 71.82 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.355 0 N-CA-C 109.254 -0.647 . . . . 0.0 109.254 178.63 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 97' ' ' THR . . . . . . . . . . . . . 74.7 p -97.37 156.29 16.52 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-O 121.401 0.62 . . . . 0.0 111.091 -177.388 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 98' ' ' GLU . . . . . . . . . . . . . 84.9 tt0 -53.86 -27.25 28.84 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 115.831 -0.622 . . . . 0.0 112.242 -179.163 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 99' ' ' GLU . . . . . . . . . . . . . 18.8 tp10 -80.8 16.71 1.34 Allowed 'General case' 0 CA--C 1.538 0.491 0 N-CA-C 112.741 0.645 . . . . 0.0 112.741 -176.538 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 100' ' ' ASN . . . . . . . . . . . . . 4.5 m-20 63.43 33.33 13.79 Favored 'General case' 0 C--O 1.233 0.233 0 O-C-N 122.013 -0.43 . . . . 0.0 111.694 177.478 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 101' ' ' GLU . . . . . . . . . . . . . 84.6 tt0 -111.3 142.72 43.16 Favored 'General case' 0 C--N 1.333 -0.147 0 N-CA-C 109.654 -0.498 . . . . 0.0 109.654 173.754 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 102' ' ' VAL . . . . . . . . . . . . . 46.7 t -115.06 127.3 72.67 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.294 0 CA-C-N 116.167 -0.47 . . . . 0.0 109.942 -177.711 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 103' ' ' LEU . . . . . . . . . . . . . 30.5 mt -117.8 129.55 55.74 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 115.809 -0.632 . . . . 0.0 110.279 177.267 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 104' ' ' ILE . . . . . . . . . . . . . 70.9 mt -118.35 120.86 65.65 Favored 'Isoleucine or valine' 0 C--O 1.234 0.244 0 N-CA-C 110.198 -0.297 . . . . 0.0 110.198 179.927 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 105' ' ' PHE . . . . . . . . . . . . . 54.3 m-85 -121.99 164.8 17.03 Favored 'General case' 0 C--N 1.333 -0.15 0 O-C-N 123.87 0.731 . . . . 0.0 109.781 179.377 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 106' ' ' ASN . . . . . . . . . . . . . 45.9 p-10 -99.04 -169.95 1.85 Allowed 'General case' 0 C--N 1.331 -0.219 0 N-CA-C 110.021 -0.363 . . . . 0.0 110.021 174.563 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 107' ' ' GLN . . . . . . . . . . . . . 40.0 tt0 -59.73 -30.1 68.59 Favored 'General case' 0 C--N 1.33 -0.268 0 N-CA-C 111.988 0.366 . . . . 0.0 111.988 -179.744 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 108' ' ' ASN . . . . . . . . . . . . . 51.7 t30 -82.85 8.83 11.29 Favored 'General case' 0 CA--C 1.536 0.425 0 N-CA-C 113.19 0.811 . . . . 0.0 113.19 -178.0 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 109' ' ' LEU . . . . . . . . . . . . . 12.2 tp 58.98 39.02 24.06 Favored 'General case' 0 C--N 1.332 -0.184 0 CA-C-O 121.162 0.506 . . . . 0.0 111.009 178.966 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 110' ' ' GLU . . . . . . . . . . . . . 70.7 mm-40 -106.91 155.41 19.79 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 116.299 -0.41 . . . . 0.0 109.998 176.595 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 111' ' ' GLU . . . . . . . . . . . . . 84.4 tt0 -83.54 121.92 27.87 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-O 120.835 0.35 . . . . 0.0 110.787 -177.364 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 112' ' ' LEU . . . . . . . . . . . . . 38.5 mt -109.02 -46.0 3.68 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 116.178 -0.465 . . . . 0.0 110.495 177.949 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 113' ' ' TYR . . . . . . . . . . . . . 63.0 t80 -140.29 138.01 34.63 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-O 120.804 0.335 . . . . 0.0 111.388 -179.383 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 114' ' ' ARG . . . . . . . . . . . . . 68.9 ttp85 -136.37 124.82 23.46 Favored 'General case' 0 C--N 1.331 -0.239 0 CA-C-N 115.946 -0.57 . . . . 0.0 110.274 177.535 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 115' ' ' GLY . . . . . . . . . . . . . . . -150.03 157.12 27.08 Favored Glycine 0 CA--C 1.522 0.524 0 N-CA-C 110.784 -0.926 . . . . 0.0 110.784 179.099 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 116' ' ' LYS . . . . . . . . . . . . . 69.8 tttt -134.68 132.23 38.65 Favored 'General case' 0 C--N 1.329 -0.305 0 N-CA-C 109.958 -0.386 . . . . 0.0 109.958 177.641 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 117' ' ' PHE . . . . . . . . . . . . . 39.9 m-85 -127.41 120.6 28.8 Favored 'General case' 0 N--CA 1.463 0.2 0 CA-C-N 116.308 -0.406 . . . . 0.0 110.073 -174.761 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 118' ' ' GLU . . . . . . . . . . . . . 95.6 mt-10 -54.35 -45.89 72.82 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 116.421 -0.354 . . . . 0.0 111.314 -175.851 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 119' ' ' ASN . . . . . . . . . . . . . 88.3 m-20 -101.31 31.11 3.84 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.137 -0.483 . . . . 0.0 112.076 -174.285 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 120' ' ' LEU . . . . . . . . . . . . . 15.0 tp -54.98 119.97 6.21 Favored 'General case' 0 N--CA 1.463 0.214 0 O-C-N 122.264 -0.272 . . . . 0.0 110.615 179.724 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 121' ' ' ASN . . . . . . . . . . . . . 23.9 t-20 -114.18 -44.07 3.17 Favored 'General case' 0 C--O 1.232 0.143 0 CA-C-N 116.487 -0.324 . . . . 0.0 111.151 -177.072 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 122' ' ' LYS . . . . . . . . . . . . . 63.6 mtpt -139.26 142.16 37.78 Favored 'General case' 0 C--N 1.331 -0.225 0 CA-C-O 120.99 0.424 . . . . 0.0 111.594 -175.59 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 123' ' ' VAL . . . . . . . . . . . . . 48.0 t -126.17 125.75 68.32 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 N-CA-C 109.01 -0.737 . . . . 0.0 109.01 173.001 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 124' ' ' LEU . . . . . . . . . . . . . 78.5 mt -121.42 131.13 53.99 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-O 120.843 0.354 . . . . 0.0 110.77 -175.853 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 125' ' ' VAL . . . . . . . . . . . . . 44.5 t -126.15 126.29 69.27 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.239 0 CA-C-N 115.98 -0.555 . . . . 0.0 109.742 178.52 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 126' ' ' ARG . . . . . . . . . . . . . 82.4 mtt85 -150.9 129.24 12.03 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.299 -0.41 . . . . 0.0 110.045 177.729 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 127' ' ' ASN . . . . . . . . . . . . . 8.8 t-20 56.21 -152.42 0.38 Allowed 'General case' 0 CA--C 1.54 0.581 0 N-CA-C 109.736 -0.468 . . . . 0.0 109.736 179.755 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 128' ' ' ASP . . . . . . . . . . . . . 23.4 p-10 -83.06 18.13 1.76 Allowed 'General case' 0 CA--C 1.536 0.414 0 N-CA-C 112.628 0.603 . . . . 0.0 112.628 178.303 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 129' ' ' LEU . . . . . . . . . . . . . 11.7 tp -117.35 137.2 52.61 Favored 'General case' 0 C--O 1.234 0.241 0 O-C-N 122.079 -0.388 . . . . 0.0 110.472 179.765 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 130' ' ' VAL . . . . . . . . . . . . . 42.0 t -125.84 138.73 53.59 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.188 0 CA-C-N 116.276 -0.42 . . . . 0.0 109.963 -179.424 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 131' ' ' VAL . . . . . . . . . . . . . 35.1 m -136.1 143.98 34.49 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.282 0 CA-C-O 121.152 0.501 . . . . 0.0 111.163 178.143 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 132' ' ' ILE . . . . . . . . . . . . . 69.9 mt -120.9 134.03 65.63 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 CA-C-N 115.657 -0.702 . . . . 0.0 109.606 179.966 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 133' ' ' ILE . . . . . . . . . . . . . 40.8 mm -116.68 117.83 56.75 Favored 'Isoleucine or valine' 0 C--O 1.233 0.224 0 CA-C-O 120.965 0.412 . . . . 0.0 110.711 -176.684 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 134' ' ' ASP . . . . . . . . . . . . . 8.0 p-10 -131.49 148.47 52.64 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 115.844 -0.616 . . . . 0.0 109.408 174.717 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 135' ' ' GLU . . . . . . . . . . . . . 84.8 tt0 -49.76 -24.44 2.35 Favored 'General case' 0 C--N 1.327 -0.399 0 N-CA-C 112.835 0.68 . . . . 0.0 112.835 -171.947 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 136' ' ' GLN . . . . . . . . . . . . . 51.2 tt0 -101.67 -27.72 12.9 Favored 'General case' 0 C--O 1.233 0.212 0 N-CA-C 112.58 0.585 . . . . 0.0 112.58 -173.789 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 137' ' ' LYS . . . . . . . . . . . . . 49.6 mttm -142.13 149.23 39.53 Favored 'General case' 0 C--N 1.332 -0.17 0 N-CA-C 112.766 0.654 . . . . 0.0 112.766 -170.51 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 138' ' ' LEU . . . . . . . . . . . . . 9.9 tp -110.4 118.66 36.87 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 114.891 -1.049 . . . . 0.0 108.732 170.973 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 139' ' ' THR . . . . . . . . . . . . . 31.5 m -111.05 127.47 55.55 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-O 120.67 0.271 . . . . 0.0 110.86 -177.283 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 140' ' ' LEU . . . . . . . . . . . . . 7.3 tt -116.05 122.66 45.84 Favored 'General case' 0 C--N 1.329 -0.292 0 N-CA-C 109.251 -0.648 . . . . 0.0 109.251 179.913 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 141' ' ' ILE . . . . . . . . . . . . . 19.0 mt -120.6 123.45 70.41 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.273 0 CA-C-O 120.87 0.367 . . . . 0.0 110.112 -174.378 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 142' ' ' ARG . . . . . . . . . . . . . 76.4 mtp180 -110.94 127.61 55.54 Favored 'General case' 0 C--N 1.331 -0.229 0 CA-C-N 115.521 -0.763 . . . . 0.0 110.164 -178.507 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 143' ' ' THR . . . . . . . . . . . . . 42.0 p . . . . . 0 C--O 1.219 -0.505 0 CA-C-O 118.024 -0.988 . . . . 0.0 110.593 -179.524 . . . . . . . . 0 0 . 1 . 005 nuclear orig full ' B' B ' -3' ' ' GLU . . . . . . . . . . . . . 70.3 mm-40 . . . . . 0 N--CA 1.489 1.518 0 N-CA-C 109.32 -0.622 . . . . 0.0 109.32 . . . . . . . . . 0 0 . 1 . 005 nuclear orig full ' B' B ' -2' ' ' GLY . . . . . . . . . . . . . . . -109.36 125.42 7.66 Favored Glycine 0 CA--C 1.526 0.76 0 N-CA-C 110.889 -0.885 . . . . 0.0 110.889 -179.886 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' -1' ' ' VAL . . . . . . . . . . . . . 44.4 t -141.21 135.28 31.99 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.299 0 N-CA-C 109.988 -0.375 . . . . 0.0 109.988 179.696 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 0' ' ' ILE . . . . . . . . . . . . . 69.3 mt -113.5 133.64 58.77 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.21 0 CA-C-N 116.395 -0.366 . . . . 0.0 110.026 179.622 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 1' ' ' MET . . . . . . . . . . . . . 25.9 ptt? -78.55 137.98 38.16 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.092 -0.504 . . . . 0.0 110.677 -179.611 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 2' ' ' SER . . . . . . . . . . . . . 5.2 p -111.78 139.87 46.9 Favored 'General case' 0 C--O 1.233 0.191 0 CA-C-N 116.187 -0.46 . . . . 0.0 111.03 -178.769 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 3' ' ' GLU . . . . . . . . . . . . . 33.8 tp10 -139.55 136.4 34.43 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 115.786 -0.643 . . . . 0.0 110.402 -178.52 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 4' ' ' LEU . . . . . . . . . . . . . 21.3 tp -124.49 128.77 49.48 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-O 120.714 0.292 . . . . 0.0 110.355 176.028 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 5' ' ' LYS . . . . . . . . . . . . . 98.3 mttt -105.5 120.94 42.89 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.344 -0.389 . . . . 0.0 110.539 179.074 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 6' ' ' LEU . . . . . . . . . . . . . 79.8 mt -118.21 147.62 43.2 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 115.587 -0.733 . . . . 0.0 110.549 -179.474 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 7' ' ' LYS . . . . . . . . . . . . . 73.5 tttt -134.79 140.11 34.3 Favored Pre-proline 0 CA--C 1.534 0.332 0 CA-C-O 118.985 -0.531 . . . . 0.0 110.038 176.193 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 8' ' ' PRO . . . . . . . . . . . . . 88.1 Cg_endo -91.79 137.17 1.86 Allowed 'Trans proline' 0 N--CA 1.489 1.25 0 C-N-CA 121.649 1.566 . . . . 0.0 111.559 177.804 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 9' ' ' LEU . . . . . . . . . . . . . 68.3 mt -72.32 -46.21 10.55 Favored Pre-proline 0 CA--C 1.533 0.32 0 CA-C-O 118.937 -0.554 . . . . 0.0 111.905 -178.682 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 10' ' ' PRO . . . . . . . . . . . . . 78.1 Cg_endo -84.37 152.09 12.08 Favored 'Trans proline' 0 N--CA 1.495 1.575 0 C-N-CA 121.318 1.345 . . . . 0.0 111.734 172.597 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 11' ' ' LYS . . . . . . . . . . . . . 67.5 mttm -88.91 99.9 12.76 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-O 120.81 0.338 . . . . 0.0 110.614 178.104 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 12' ' ' VAL . . . . . . . . . . . . . 12.6 p -140.91 142.42 30.09 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.28 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.362 179.239 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 13' ' ' GLU . . . . . . . . . . . . . 96.1 mt-10 -78.62 129.26 34.56 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.365 -0.379 . . . . 0.0 110.168 178.166 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 14' ' ' LEU . . . . . . . . . . . . . 29.9 mt -98.03 148.66 34.8 Favored Pre-proline 0 C--N 1.329 -0.301 0 CA-C-O 119.223 -0.417 . . . . 0.0 110.282 -179.016 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 15' ' ' PRO . . . . . . . . . . . . . 30.0 Cg_exo -60.67 160.46 24.55 Favored 'Trans proline' 0 N--CA 1.497 1.681 0 C-N-CA 121.322 1.348 . . . . 0.0 111.492 176.117 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 16' ' ' PRO . . . . . . . . . . . . . 38.8 Cg_exo -58.72 -33.81 98.57 Favored 'Trans proline' 0 N--CA 1.497 1.704 0 C-N-CA 121.375 1.384 . . . . 0.0 112.795 -177.993 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 17' ' ' ASP . . . . . . . . . . . . . 11.6 p-10 -93.76 9.83 35.5 Favored 'General case' 0 CA--C 1.535 0.381 0 N-CA-C 113.287 0.847 . . . . 0.0 113.287 -177.147 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 18' ' ' PHE . . . . . . . . . . . . . 44.4 t80 -58.49 -47.21 84.82 Favored 'General case' 0 C--N 1.334 -0.082 0 CA-C-O 120.963 0.411 . . . . 0.0 110.084 -177.961 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 19' ' ' VAL . . . . . . . . . . . . . 49.0 t -57.41 -40.65 75.66 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.339 0 CA-C-N 116.277 -0.42 . . . . 0.0 110.361 -178.737 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 20' ' ' ASP . . . . . . . . . . . . . 79.8 m-20 -60.4 -43.73 96.38 Favored 'General case' 0 C--N 1.331 -0.205 0 C-N-CA 120.936 -0.306 . . . . 0.0 110.968 -178.272 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 21' ' ' VAL . . . . . . . . . . . . . 49.1 t -64.4 -47.35 89.88 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.262 0 C-N-CA 120.753 -0.379 . . . . 0.0 110.359 -177.448 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 22' ' ' ILE . . . . . . . . . . . . . 48.9 mm -56.29 -46.53 81.61 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.258 0 CA-C-O 120.813 0.34 . . . . 0.0 110.598 179.501 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 23' ' ' ARG . . . . . . . . . . . . . 47.9 ttp180 -54.64 -50.61 67.74 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.532 -0.304 . . . . 0.0 111.391 -178.6 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 24' ' ' ILE . . . . . . . . . . . . . 76.1 mt -60.06 -40.5 83.43 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.268 0 C-N-CA 121.073 -0.251 . . . . 0.0 111.432 -176.78 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 25' ' ' LYS . . . . . . . . . . . . . 52.2 mtmt -66.9 -38.93 87.17 Favored 'General case' 0 C--N 1.328 -0.329 0 N-CA-C 112.114 0.413 . . . . 0.0 112.114 -179.833 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 26' ' ' LEU . . . . . . . . . . . . . 93.3 mt -78.49 -40.49 35.22 Favored 'General case' 0 C--N 1.331 -0.21 0 N-CA-C 113.175 0.806 . . . . 0.0 113.175 -172.441 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 27' ' ' GLN . . . . . . . . . . . . . 9.5 pt20 -46.83 139.06 5.71 Favored 'General case' 0 N--CA 1.471 0.591 0 N-CA-C 112.635 0.605 . . . . 0.0 112.635 -175.467 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 28' ' ' GLY . . . . . . . . . . . . . . . 97.68 -23.08 37.48 Favored Glycine 0 CA--C 1.535 1.283 0 CA-C-N 115.573 -0.74 . . . . 0.0 112.319 -175.931 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 29' ' ' LYS . . . . . . . . . . . . . 96.3 mttt -98.41 155.08 17.41 Favored 'General case' 0 C--O 1.233 0.234 0 CA-C-N 117.486 0.643 . . . . 0.0 111.143 179.135 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 30' ' ' THR . . . . . . . . . . . . . 38.6 m -98.38 137.88 36.44 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-N 116.073 -0.512 . . . . 0.0 110.07 176.091 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 31' ' ' VAL . . . . . . . . . . . . . 34.7 m -128.04 148.48 32.6 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.267 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.902 -178.349 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 32' ' ' ARG . . . . . . . . . . . . . 80.3 mtt180 -133.4 150.72 51.79 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-O 121.326 0.584 . . . . 0.0 110.627 177.83 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 33' ' ' THR . . . . . . . . . . . . . 23.1 m -53.39 138.57 32.77 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.034 -0.53 . . . . 0.0 111.279 -178.369 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 34' ' ' GLY . . . . . . . . . . . . . . . 100.35 -17.22 57.17 Favored Glycine 0 CA--C 1.533 1.178 0 CA-C-O 119.537 -0.591 . . . . 0.0 113.243 178.252 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 35' ' ' ASP . . . . . . . . . . . . . 77.7 m-20 -65.33 148.26 52.0 Favored 'General case' 0 C--N 1.333 -0.132 0 CA-C-N 118.131 0.965 . . . . 0.0 111.043 179.808 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 36' ' ' VAL . . . . . . . . . . . . . 44.5 t -121.06 129.72 75.41 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.228 0 CA-C-N 115.852 -0.613 . . . . 0.0 109.842 178.387 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 37' ' ' ILE . . . . . . . . . . . . . 65.3 mt -117.82 137.84 50.44 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.261 0 CA-C-N 116.19 -0.459 . . . . 0.0 109.843 -179.83 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 38' ' ' GLY . . . . . . . . . . . . . . . -110.6 128.58 8.86 Favored Glycine 0 CA--C 1.526 0.764 0 N-CA-C 110.986 -0.845 . . . . 0.0 110.986 179.561 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 39' ' ' ILE . . . . . . . . . . . . . 73.6 mt -124.34 134.66 66.06 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.178 0 N-CA-C 110.015 -0.365 . . . . 0.0 110.015 179.039 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 40' ' ' SER . . . . . . . . . . . . . 43.0 t -92.62 117.56 30.1 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.535 -0.302 . . . . 0.0 110.873 176.201 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 41' ' ' ILE . . . . . . . . . . . . . 45.3 mm -122.75 114.38 42.06 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.159 0 CA-C-O 120.897 0.38 . . . . 0.0 110.546 179.261 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 42' ' ' LEU . . . . . . . . . . . . . 9.2 tp 53.58 37.84 26.82 Favored 'General case' 0 C--N 1.331 -0.216 0 CA-C-N 116.094 -0.503 . . . . 0.0 111.399 176.862 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 43' ' ' GLY . . . . . . . . . . . . . . . 74.62 25.28 70.38 Favored Glycine 0 CA--C 1.531 1.075 0 C-N-CA 121.126 -0.559 . . . . 0.0 112.725 177.563 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 44' ' ' LYS . . . . . . . . . . . . . 34.6 mmtp -130.18 129.31 43.28 Favored 'General case' 0 C--N 1.331 -0.207 0 N-CA-C 109.546 -0.538 . . . . 0.0 109.546 177.682 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 45' ' ' GLU . . . . . . . . . . . . . 81.1 tt0 -83.1 118.98 23.93 Favored 'General case' 0 C--N 1.329 -0.295 0 C-N-CA 120.762 -0.375 . . . . 0.0 110.762 -179.173 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 46' ' ' VAL . . . . . . . . . . . . . 7.4 p -118.6 126.75 75.42 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.216 0 N-CA-C 109.288 -0.634 . . . . 0.0 109.288 176.489 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 47' ' ' LYS . . . . . . . . . . . . . 56.3 mtmt -100.67 128.73 46.61 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 115.84 -0.618 . . . . 0.0 111.304 178.85 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 48' ' ' PHE . . . . . . . . . . . . . 94.3 m-85 -110.73 131.87 54.68 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 115.999 -0.546 . . . . 0.0 109.774 176.089 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 49' ' ' LYS . . . . . . . . . . . . . 36.1 tttp -106.58 135.64 47.75 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.407 -0.36 . . . . 0.0 110.407 -179.498 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 50' ' ' VAL . . . . . . . . . . . . . 43.7 t -80.18 108.76 13.96 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.207 0 N-CA-C 109.257 -0.646 . . . . 0.0 109.257 176.488 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 51' ' ' VAL . . . . . . . . . . . . . 46.0 t -73.39 -47.94 43.93 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.273 0 CA-C-N 116.141 -0.481 . . . . 0.0 110.11 -174.125 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 52' ' ' GLN . . . . . . . . . . . . . 59.8 tt0 -162.6 140.84 8.57 Favored 'General case' 0 C--N 1.33 -0.262 0 C-N-CA 120.401 -0.52 . . . . 0.0 111.343 -177.37 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 53' ' ' ALA . . . . . . . . . . . . . . . -114.82 131.67 56.74 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 115.45 -0.795 . . . . 0.0 109.971 175.56 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 54' ' ' TYR . . . . . . . . . . . . . 30.9 t80 -129.12 111.54 18.31 Favored Pre-proline 0 CA--C 1.535 0.386 0 CA-C-O 118.302 -0.856 . . . . 0.0 110.232 177.598 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 55' ' ' PRO . . . . . . . . . . . . . 73.5 Cg_endo -77.18 167.94 78.3 Favored 'Cis proline' 0 N--CA 1.499 1.835 0 CA-C-N 121.985 1.745 . . . . 0.0 112.373 -5.955 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 56' ' ' SER . . . . . . . . . . . . . 13.6 m -117.34 134.87 23.06 Favored Pre-proline 0 CA--C 1.538 0.51 0 CA-C-O 118.574 -0.727 . . . . 0.0 109.493 174.049 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 57' ' ' PRO . . . . . . . . . . . . . 39.8 Cg_endo -68.11 146.66 78.64 Favored 'Cis proline' 0 N--CA 1.498 1.744 0 CA-C-N 121.87 1.704 . . . . 0.0 111.329 -3.06 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 58' ' ' LEU . . . . . . . . . . . . . 16.3 tp -107.2 136.8 46.41 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.282 -0.417 . . . . 0.0 110.584 -177.599 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 59' ' ' ARG . . . . . . . . . . . . . 51.2 ttp180 -104.64 119.9 40.07 Favored 'General case' 0 C--N 1.328 -0.342 0 N-CA-C 109.315 -0.624 . . . . 0.0 109.315 175.975 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 60' ' ' VAL . . . . . . . . . . . . . 48.7 t -73.37 122.53 26.47 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.252 0 C-N-CA 120.662 -0.415 . . . . 0.0 110.154 -175.214 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 61' ' ' GLU . . . . . . . . . . . . . 95.8 mt-10 -131.05 163.39 27.71 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 115.934 -0.575 . . . . 0.0 110.422 -179.21 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 62' ' ' ASP . . . . . . . . . . . . . 12.5 t70 -55.15 -32.73 62.34 Favored 'General case' 0 C--N 1.327 -0.401 0 CA-C-N 116.426 -0.352 . . . . 0.0 111.523 178.59 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 63' ' ' ARG . . . . . . . . . . . . . 13.1 ptp180 -89.84 9.6 26.86 Favored 'General case' 0 CA--C 1.534 0.337 0 N-CA-C 113.522 0.934 . . . . 0.0 113.522 -176.016 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 64' ' ' THR . . . . . . . . . . . . . 39.4 m -91.41 133.41 35.49 Favored 'General case' 0 C--N 1.332 -0.16 0 CA-C-N 118.198 0.454 . . . . 0.0 110.087 179.667 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 65' ' ' LYS . . . . . . . . . . . . . 57.6 mtmt -90.0 132.55 35.3 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-O 120.987 0.422 . . . . 0.0 110.648 -177.664 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 66' ' ' ILE . . . . . . . . . . . . . 60.7 mt -114.84 127.84 72.21 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.358 0 N-CA-C 109.755 -0.461 . . . . 0.0 109.755 -179.269 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 67' ' ' THR . . . . . . . . . . . . . 30.6 m -119.12 138.84 52.63 Favored 'General case' 0 C--N 1.332 -0.186 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.941 -176.91 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 68' ' ' LEU . . . . . . . . . . . . . 14.8 tp -103.14 125.57 49.9 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 115.913 -0.585 . . . . 0.0 110.065 178.223 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 69' ' ' VAL . . . . . . . . . . . . . 44.1 t -96.82 117.94 42.27 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.344 0 CA-C-O 120.968 0.413 . . . . 0.0 110.324 -178.774 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 70' ' ' THR . . . . . . . . . . . . . 17.4 p -150.04 75.22 1.24 Allowed 'General case' 0 C--N 1.331 -0.238 0 CA-C-N 116.007 -0.542 . . . . 0.0 110.496 178.317 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 71' ' ' HIS . . . . . . . . . . . . . 81.5 m-70 -135.71 84.41 33.09 Favored Pre-proline 0 CA--C 1.534 0.332 0 CA-C-N 116.335 -0.393 . . . . 0.0 110.59 -179.203 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 72' ' ' PRO . . . . . . . . . . . . . 61.8 Cg_endo -74.97 -26.35 11.07 Favored 'Trans proline' 0 N--CA 1.496 1.637 0 C-N-CA 121.472 1.448 . . . . 0.0 113.075 -178.069 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 73' ' ' VAL . . . . . . . . . . . . . 35.1 m -130.5 168.65 22.94 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.214 0 CA-C-O 120.859 0.361 . . . . 0.0 111.091 -176.893 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 74' ' ' ASP . . . . . . . . . . . . . 38.7 t0 -99.11 122.95 43.02 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 115.963 -0.562 . . . . 0.0 109.94 -178.975 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 75' ' ' VAL . . . . . . . . . . . . . 40.0 t -119.9 124.13 72.18 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.264 0 CA-C-O 121.063 0.459 . . . . 0.0 110.802 -177.609 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 76' ' ' LEU . . . . . . . . . . . . . 5.7 mp -119.65 142.12 48.74 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 115.687 -0.688 . . . . 0.0 109.426 174.696 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 77' ' ' GLU . . . . . . . . . . . . . 97.4 mt-10 -135.6 130.75 34.93 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-O 121.117 0.484 . . . . 0.0 111.011 -177.789 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 78' ' ' ALA . . . . . . . . . . . . . . . -117.46 134.93 54.29 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 115.619 -0.718 . . . . 0.0 109.725 177.007 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 79' ' ' LYS . . . . . . . . . . . . . 90.0 mttt -75.49 115.87 15.61 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-O 120.903 0.382 . . . . 0.0 110.236 -179.041 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 80' ' ' ILE . . . . . . . . . . . . . 44.0 mm -139.09 119.35 14.69 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.328 0 N-CA-C 109.346 -0.613 . . . . 0.0 109.346 -176.836 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 81' ' ' LYS . . . . . . . . . . . . . 60.0 tttm -117.92 129.67 55.76 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-O 120.924 0.392 . . . . 0.0 111.088 -176.964 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 82' ' ' GLY . . . . . . . . . . . . . . . 88.96 42.13 5.73 Favored Glycine 0 CA--C 1.524 0.651 0 CA-C-N 115.883 -0.599 . . . . 0.0 112.089 175.687 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 83' ' ' ILE . . . . . . . . . . . . . 73.9 mt -73.72 133.01 32.52 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.249 0 N-CA-C 109.229 -0.656 . . . . 0.0 109.229 175.398 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 84' ' ' LYS . . . . . . . . . . . . . 38.4 ttpt -102.47 -45.1 5.17 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.567 -0.288 . . . . 0.0 110.567 -176.94 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 85' ' ' ASP . . . . . . . . . . . . . 9.1 t70 -147.68 149.44 32.46 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.293 -0.412 . . . . 0.0 110.518 -179.914 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 86' ' ' VAL . . . . . . . . . . . . . 40.3 t -130.79 134.55 61.71 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.251 0 CA-C-O 121.002 0.429 . . . . 0.0 110.485 -179.208 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 87' ' ' ILE . . . . . . . . . . . . . 5.0 mp -121.8 125.89 73.89 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.214 0 CA-C-N 115.841 -0.618 . . . . 0.0 109.385 176.51 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 88' ' ' LEU . . . . . . . . . . . . . 8.3 tp -117.91 134.19 55.18 Favored 'General case' 0 C--N 1.331 -0.224 0 CA-C-O 120.9 0.381 . . . . 0.0 111.088 -176.058 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 89' ' ' ASP . . . . . . . . . . . . . 12.4 t70 -134.84 160.12 39.24 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 115.948 -0.569 . . . . 0.0 109.859 177.943 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 90' ' ' GLU . . . . . . . . . . . . . 95.6 mt-10 -48.14 -37.75 16.25 Favored 'General case' 0 C--N 1.331 -0.226 0 N-CA-C 112.991 0.737 . . . . 0.0 112.991 -171.637 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 91' ' ' ASN . . . . . . . . . . . . . 12.2 m120 -130.01 22.35 5.33 Favored 'General case' 0 N--CA 1.468 0.468 0 N-CA-C 112.813 0.672 . . . . 0.0 112.813 -176.621 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 92' ' ' LEU . . . . . . . . . . . . . 51.0 mt -148.45 141.23 24.63 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-O 120.773 0.32 . . . . 0.0 110.599 -178.237 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 93' ' ' ILE . . . . . . . . . . . . . 73.2 mt -124.42 112.78 33.65 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.322 0 N-CA-C 108.858 -0.793 . . . . 0.0 108.858 176.195 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 94' ' ' VAL . . . . . . . . . . . . . 46.1 t -116.58 127.85 74.09 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.284 0 CA-C-O 120.923 0.392 . . . . 0.0 110.038 -177.681 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 95' ' ' VAL . . . . . . . . . . . . . 42.3 t -121.08 132.7 69.86 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.388 0 CA-C-N 115.885 -0.598 . . . . 0.0 109.595 -179.556 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 96' ' ' ILE . . . . . . . . . . . . . 72.4 mt -115.11 125.16 72.33 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.251 0 N-CA-C 109.192 -0.67 . . . . 0.0 109.192 178.259 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 97' ' ' THR . . . . . . . . . . . . . 80.7 p -98.67 160.42 14.29 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-O 121.33 0.586 . . . . 0.0 111.302 -175.868 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 98' ' ' GLU . . . . . . . . . . . . . 84.3 tt0 -53.84 -26.72 25.77 Favored 'General case' 0 C--N 1.327 -0.385 0 CA-C-N 115.683 -0.69 . . . . 0.0 112.249 179.843 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 99' ' ' GLU . . . . . . . . . . . . . 69.4 mm-40 -79.04 11.59 2.67 Favored 'General case' 0 CA--C 1.536 0.432 0 N-CA-C 113.227 0.825 . . . . 0.0 113.227 -177.36 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 100' ' ' ASN . . . . . . . . . . . . . 3.3 m-20 62.71 32.31 16.2 Favored 'General case' 0 CA--C 1.533 0.29 0 CA-C-N 118.233 0.469 . . . . 0.0 111.756 -179.796 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 101' ' ' GLU . . . . . . . . . . . . . 84.2 tt0 -107.79 144.18 35.31 Favored 'General case' 0 C--N 1.332 -0.187 0 N-CA-C 109.714 -0.476 . . . . 0.0 109.714 171.559 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 102' ' ' VAL . . . . . . . . . . . . . 44.5 t -116.28 126.49 73.78 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.246 0 N-CA-C 110.055 -0.35 . . . . 0.0 110.055 -178.957 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 103' ' ' LEU . . . . . . . . . . . . . 63.7 mt -114.48 131.77 56.51 Favored 'General case' 0 C--N 1.331 -0.23 0 CA-C-N 115.641 -0.709 . . . . 0.0 109.58 178.112 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 104' ' ' ILE . . . . . . . . . . . . . 62.3 mt -122.17 118.64 56.07 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.242 0 N-CA-C 110.293 -0.262 . . . . 0.0 110.293 -178.857 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 105' ' ' PHE . . . . . . . . . . . . . 41.3 m-85 -119.84 165.31 14.76 Favored 'General case' 0 C--N 1.331 -0.196 0 O-C-N 123.986 0.804 . . . . 0.0 109.717 178.032 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 106' ' ' ASN . . . . . . . . . . . . . 46.8 p-10 -98.07 -169.89 1.89 Allowed 'General case' 0 C--N 1.329 -0.313 0 N-CA-C 109.664 -0.495 . . . . 0.0 109.664 172.591 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 107' ' ' GLN . . . . . . . . . . . . . 28.0 tt0 -59.83 -30.21 68.78 Favored 'General case' 0 C--N 1.329 -0.29 0 N-CA-C 111.938 0.347 . . . . 0.0 111.938 -179.905 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 108' ' ' ASN . . . . . . . . . . . . . 14.8 t-20 -83.59 9.32 11.74 Favored 'General case' 0 CA--C 1.538 0.515 0 N-CA-C 113.09 0.774 . . . . 0.0 113.09 -178.354 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 109' ' ' LEU . . . . . . . . . . . . . 9.2 tp 60.38 36.32 20.41 Favored 'General case' 0 C--N 1.332 -0.179 0 CA-C-O 120.918 0.39 . . . . 0.0 111.495 178.921 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 110' ' ' GLU . . . . . . . . . . . . . 70.7 mm-40 -105.65 149.82 26.0 Favored 'General case' 0 C--N 1.33 -0.24 0 N-CA-C 109.978 -0.378 . . . . 0.0 109.978 177.094 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 111' ' ' GLU . . . . . . . . . . . . . 47.2 mp0 -76.86 126.41 30.93 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-O 121.035 0.445 . . . . 0.0 111.357 -177.249 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 112' ' ' LEU . . . . . . . . . . . . . 39.5 mt -110.07 -46.05 3.51 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 115.821 -0.627 . . . . 0.0 109.967 174.974 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 113' ' ' TYR . . . . . . . . . . . . . 65.5 t80 -143.62 140.52 30.17 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 115.975 -0.557 . . . . 0.0 111.134 179.752 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 114' ' ' ARG . . . . . . . . . . . . . 93.2 mtt180 -139.51 125.66 19.98 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.54 173.665 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 115' ' ' GLY . . . . . . . . . . . . . . . -150.16 162.92 29.36 Favored Glycine 0 CA--C 1.524 0.623 0 N-CA-C 111.083 -0.807 . . . . 0.0 111.083 179.491 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 116' ' ' LYS . . . . . . . . . . . . . 87.6 tttt -131.22 135.14 47.12 Favored 'General case' 0 C--N 1.33 -0.277 0 N-CA-C 109.832 -0.432 . . . . 0.0 109.832 177.412 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 117' ' ' PHE . . . . . . . . . . . . . 33.4 m-85 -136.46 114.16 11.12 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.327 -0.397 . . . . 0.0 110.393 -174.789 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 118' ' ' GLU . . . . . . . . . . . . . 83.4 tt0 -52.3 -47.68 65.8 Favored 'General case' 0 C--N 1.327 -0.408 0 CA-C-N 116.475 -0.33 . . . . 0.0 111.618 -176.999 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 119' ' ' ASN . . . . . . . . . . . . . 50.3 m-80 -97.4 30.94 2.66 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.192 -0.458 . . . . 0.0 112.175 -173.826 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 120' ' ' LEU . . . . . . . . . . . . . 12.8 tp -57.15 122.31 12.11 Favored 'General case' 0 C--N 1.332 -0.19 0 C-N-CA 120.987 -0.285 . . . . 0.0 110.318 177.98 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 121' ' ' ASN . . . . . . . . . . . . . 26.3 m120 -113.29 -44.2 3.27 Favored 'General case' 0 C--O 1.232 0.162 0 CA-C-N 116.652 -0.249 . . . . 0.0 111.101 -176.965 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 122' ' ' LYS . . . . . . . . . . . . . 97.1 mttt -148.22 150.65 34.11 Favored 'General case' 0 C--N 1.331 -0.208 0 CA-C-O 121.061 0.458 . . . . 0.0 111.701 -178.684 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 123' ' ' VAL . . . . . . . . . . . . . 43.9 t -127.38 129.09 70.58 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.233 0 N-CA-C 109.447 -0.575 . . . . 0.0 109.447 174.716 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 124' ' ' LEU . . . . . . . . . . . . . 6.1 mp -122.06 134.57 54.78 Favored 'General case' 0 C--N 1.332 -0.184 0 CA-C-O 120.863 0.363 . . . . 0.0 110.757 -178.538 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 125' ' ' VAL . . . . . . . . . . . . . 43.2 t -125.28 128.23 72.59 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.283 0 CA-C-N 115.933 -0.576 . . . . 0.0 109.765 178.21 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 126' ' ' ARG . . . . . . . . . . . . . 30.5 ttm180 -149.15 122.01 8.74 Favored 'General case' 0 C--N 1.33 -0.276 0 N-CA-C 109.809 -0.441 . . . . 0.0 109.809 178.368 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 127' ' ' ASN . . . . . . . . . . . . . 76.9 m-20 56.37 -151.55 0.4 Allowed 'General case' 0 CA--C 1.541 0.609 0 N-CA-C 109.771 -0.455 . . . . 0.0 109.771 179.742 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 128' ' ' ASP . . . . . . . . . . . . . 19.7 p-10 -80.18 15.43 1.54 Allowed 'General case' 0 CA--C 1.535 0.383 0 N-CA-C 112.861 0.689 . . . . 0.0 112.861 178.797 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 129' ' ' LEU . . . . . . . . . . . . . 15.6 tp -111.84 133.66 53.9 Favored 'General case' 0 C--O 1.232 0.133 0 O-C-N 122.0 -0.438 . . . . 0.0 110.287 179.158 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 130' ' ' VAL . . . . . . . . . . . . . 47.7 t -121.91 135.3 62.47 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.222 0 N-CA-C 109.759 -0.46 . . . . 0.0 109.759 -179.953 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 131' ' ' VAL . . . . . . . . . . . . . 42.8 t -134.83 135.62 52.95 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.253 0 CA-C-O 121.029 0.442 . . . . 0.0 110.594 -179.533 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 132' ' ' ILE . . . . . . . . . . . . . 73.1 mt -117.51 132.69 66.57 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.26 0 CA-C-N 115.676 -0.693 . . . . 0.0 109.392 178.84 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 133' ' ' ILE . . . . . . . . . . . . . 44.6 mm -116.34 122.32 69.49 Favored 'Isoleucine or valine' 0 C--O 1.234 0.251 0 CA-C-N 116.55 -0.296 . . . . 0.0 110.931 -176.014 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 134' ' ' ASP . . . . . . . . . . . . . 7.2 p-10 -133.0 146.7 52.01 Favored 'General case' 0 C--N 1.33 -0.258 0 N-CA-C 109.714 -0.476 . . . . 0.0 109.714 174.628 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 135' ' ' GLU . . . . . . . . . . . . . 84.7 tt0 -49.87 -26.27 3.91 Favored 'General case' 0 C--N 1.326 -0.445 0 N-CA-C 112.916 0.71 . . . . 0.0 112.916 -173.321 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 136' ' ' GLN . . . . . . . . . . . . . 61.4 tt0 -84.55 -32.4 23.86 Favored 'General case' 0 C--N 1.331 -0.231 0 N-CA-C 112.42 0.526 . . . . 0.0 112.42 -175.488 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 137' ' ' LYS . . . . . . . . . . . . . 18.1 pttp -168.64 172.74 7.81 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-O 121.436 0.636 . . . . 0.0 112.245 -172.536 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 138' ' ' LEU . . . . . . . . . . . . . 5.3 tt -117.72 130.1 56.11 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 115.113 -0.948 . . . . 0.0 110.025 -179.217 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 139' ' ' THR . . . . . . . . . . . . . 42.2 m -111.53 126.74 55.3 Favored 'General case' 0 C--N 1.331 -0.223 0 CA-C-N 116.147 -0.479 . . . . 0.0 110.384 179.833 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 140' ' ' LEU . . . . . . . . . . . . . 5.6 tt -114.18 124.02 51.03 Favored 'General case' 0 C--N 1.329 -0.322 0 N-CA-C 109.261 -0.644 . . . . 0.0 109.261 -179.65 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 141' ' ' ILE . . . . . . . . . . . . . 19.1 mt -121.94 125.71 73.53 Favored 'Isoleucine or valine' 0 C--O 1.234 0.266 0 CA-C-O 120.818 0.342 . . . . 0.0 110.15 -173.783 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 142' ' ' ARG . . . . . . . . . . . . . 72.0 mtm180 -114.23 133.94 55.27 Favored 'General case' 0 C--O 1.233 0.233 0 CA-C-N 115.66 -0.7 . . . . 0.0 109.82 -179.267 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 143' ' ' THR . . . . . . . . . . . . . 60.6 p . . . . . 0 C--O 1.219 -0.514 0 CA-C-O 117.957 -1.02 . . . . 0.0 110.449 179.207 . . . . . . . . 0 0 . 1 . 005 nuclear orig full ' C' C ' -3' ' ' GLU . . . . . . . . . . . . . 95.7 mt-10 . . . . . 0 N--CA 1.49 1.568 0 N-CA-C 109.376 -0.602 . . . . 0.0 109.376 . . . . . . . . . 0 0 . 1 . 005 nuclear orig full ' C' C ' -2' ' ' GLY . . . . . . . . . . . . . . . -61.7 149.74 46.1 Favored Glycine 0 CA--C 1.524 0.627 0 N-CA-C 110.871 -0.891 . . . . 0.0 110.871 179.75 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' C' C ' -1' ' ' VAL . . . . . . . . . . . . . 43.5 t -95.88 137.8 23.0 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.317 0 N-CA-C 110.022 -0.362 . . . . 0.0 110.022 -179.895 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' C' C ' 0' ' ' ILE . . . . . . . . . . . . . 43.4 mm -107.63 129.02 62.31 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.27 0 CA-C-N 116.258 -0.428 . . . . 0.0 110.166 -178.93 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' C' C ' 1' ' ' MET . . . . . . . . . . . . . 25.0 ptp -79.85 142.87 34.85 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.072 -0.513 . . . . 0.0 110.413 178.956 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' C' C ' 2' ' ' SER . . . . . . . . . . . . . 2.9 p -127.61 126.53 42.23 Favored 'General case' 0 C--N 1.331 -0.203 0 CA-C-N 116.356 -0.384 . . . . 0.0 110.329 -179.71 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' C' C ' 3' ' ' GLU . . . . . . . . . . . . . 94.2 mt-10 -138.51 141.54 39.36 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 115.902 -0.59 . . . . 0.0 110.721 -176.769 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' C' C ' 4' ' ' LEU . . . . . . . . . . . . . 25.2 tp -126.37 126.73 44.36 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.054 -0.521 . . . . 0.0 110.039 176.198 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' C' C ' 5' ' ' LYS . . . . . . . . . . . . . 62.7 mttp -103.83 120.96 42.07 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.508 -0.315 . . . . 0.0 110.647 179.354 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' C' C ' 6' ' ' LEU . . . . . . . . . . . . . 43.1 mt -116.79 143.03 46.16 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 115.536 -0.756 . . . . 0.0 110.556 -178.598 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' C' C ' 7' ' ' LYS . . . . . . . . . . . . . 54.8 tttm -134.3 139.58 33.31 Favored Pre-proline 0 CA--C 1.534 0.349 0 CA-C-O 119.117 -0.468 . . . . 0.0 109.997 176.164 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' C' C ' 8' ' ' PRO . . . . . . . . . . . . . 88.7 Cg_endo -91.94 143.79 2.81 Favored 'Trans proline' 0 N--CA 1.491 1.35 0 C-N-CA 121.721 1.614 . . . . 0.0 111.888 177.812 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' C' C ' 9' ' ' LEU . . . . . . . . . . . . . 63.9 mt -79.2 -48.28 1.55 Allowed Pre-proline 0 CA--C 1.535 0.385 0 CA-C-O 118.638 -0.696 . . . . 0.0 112.242 -179.93 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' C' C ' 10' ' ' PRO . . . . . . . . . . . . . 94.0 Cg_endo -79.51 153.78 23.82 Favored 'Trans proline' 0 N--CA 1.497 1.697 0 C-N-CA 121.149 1.232 . . . . 0.0 111.819 176.949 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' C' C ' 11' ' ' LYS . . . . . . . . . . . . . 51.6 tptt -87.19 96.64 10.39 Favored 'General case' 0 C--N 1.331 -0.226 0 CA-C-N 116.373 -0.376 . . . . 0.0 110.315 178.861 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' C' C ' 12' ' ' VAL . . . . . . . . . . . . . 12.0 p -143.86 143.44 23.93 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.284 0 CA-C-N 116.219 -0.446 . . . . 0.0 110.462 179.019 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' C' C ' 13' ' ' GLU . . . . . . . . . . . . . 12.8 pt-20 -88.09 128.15 35.42 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.351 -0.386 . . . . 0.0 110.296 177.751 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' C' C ' 14' ' ' LEU . . . . . . . . . . . . . 24.4 mt -98.22 153.01 38.26 Favored Pre-proline 0 C--N 1.329 -0.291 0 CA-C-N 116.232 -0.44 . . . . 0.0 110.369 -178.473 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' C' C ' 15' ' ' PRO . . . . . . . . . . . . . 33.6 Cg_exo -59.66 159.97 22.52 Favored 'Trans proline' 0 N--CA 1.495 1.616 0 C-N-CA 121.31 1.34 . . . . 0.0 111.621 178.082 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' C' C ' 16' ' ' PRO . . . . . . . . . . . . . 32.2 Cg_exo -59.42 -32.56 96.68 Favored 'Trans proline' 0 N--CA 1.498 1.743 0 C-N-CA 121.435 1.423 . . . . 0.0 112.714 -177.855 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' C' C ' 17' ' ' ASP . . . . . . . . . . . . . 9.5 p-10 -94.13 9.96 35.7 Favored 'General case' 0 CA--C 1.535 0.388 0 N-CA-C 113.211 0.819 . . . . 0.0 113.211 -177.301 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' C' C ' 18' ' ' PHE . . . . . . . . . . . . . 48.9 t80 -58.13 -42.67 86.33 Favored 'General case' 0 C--O 1.231 0.091 0 O-C-N 121.987 -0.446 . . . . 0.0 110.111 -178.511 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' C' C ' 19' ' ' VAL . . . . . . . . . . . . . 48.7 t -57.7 -42.13 80.96 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.352 0 CA-C-N 116.332 -0.395 . . . . 0.0 110.311 -179.311 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' C' C ' 20' ' ' ASP . . . . . . . . . . . . . 13.6 t70 -60.64 -42.09 96.22 Favored 'General case' 0 C--N 1.329 -0.304 0 C-N-CA 120.988 -0.285 . . . . 0.0 110.99 -178.642 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' C' C ' 21' ' ' VAL . . . . . . . . . . . . . 47.5 t -64.04 -47.56 89.8 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.284 0 C-N-CA 120.713 -0.395 . . . . 0.0 110.38 -177.973 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' C' C ' 22' ' ' ILE . . . . . . . . . . . . . 51.0 mm -56.67 -43.99 80.28 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.279 0 CA-C-O 120.668 0.27 . . . . 0.0 110.456 178.689 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' C' C ' 23' ' ' ARG . . . . . . . . . . . . . 60.3 ttp180 -54.11 -49.03 70.08 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-O 120.627 0.251 . . . . 0.0 111.419 -179.373 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' C' C ' 24' ' ' ILE . . . . . . . . . . . . . 75.7 mt -59.96 -42.35 89.2 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.295 0 CA-C-N 116.592 -0.276 . . . . 0.0 111.003 -178.348 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' C' C ' 25' ' ' LYS . . . . . . . . . . . . . 54.9 mtmt -67.2 -36.49 81.85 Favored 'General case' 0 C--N 1.328 -0.355 0 N-CA-C 112.299 0.481 . . . . 0.0 112.299 -179.088 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' C' C ' 26' ' ' LEU . . . . . . . . . . . . . 46.9 mt -77.74 -43.62 30.33 Favored 'General case' 0 C--N 1.33 -0.26 0 N-CA-C 112.899 0.703 . . . . 0.0 112.899 -172.373 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' C' C ' 27' ' ' GLN . . . . . . . . . . . . . 10.6 pt20 -46.91 138.13 6.68 Favored 'General case' 0 N--CA 1.47 0.539 0 N-CA-C 112.564 0.579 . . . . 0.0 112.564 -175.673 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' C' C ' 28' ' ' GLY . . . . . . . . . . . . . . . 100.6 -26.12 25.79 Favored Glycine 0 CA--C 1.533 1.172 0 CA-C-N 115.645 -0.707 . . . . 0.0 112.174 -176.652 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' C' C ' 29' ' ' LYS . . . . . . . . . . . . . 60.3 mmtt -98.06 155.17 17.25 Favored 'General case' 0 C--O 1.232 0.145 0 CA-C-N 117.257 0.529 . . . . 0.0 111.174 178.327 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' C' C ' 30' ' ' THR . . . . . . . . . . . . . 37.7 m -105.94 136.4 45.66 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 115.807 -0.633 . . . . 0.0 109.561 174.26 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' C' C ' 31' ' ' VAL . . . . . . . . . . . . . 34.9 m -127.4 153.75 36.97 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.234 0 CA-C-O 121.172 0.51 . . . . 0.0 111.169 -176.442 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' C' C ' 32' ' ' ARG . . . . . . . . . . . . . 78.2 mtm180 -130.53 150.07 51.91 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 115.537 -0.756 . . . . 0.0 110.26 178.663 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' C' C ' 33' ' ' THR . . . . . . . . . . . . . 24.3 m -53.68 138.95 33.74 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-N 116.453 -0.34 . . . . 0.0 111.285 -178.863 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' C' C ' 34' ' ' GLY . . . . . . . . . . . . . . . 101.0 -17.14 56.66 Favored Glycine 0 CA--C 1.532 1.154 0 CA-C-O 119.621 -0.544 . . . . 0.0 113.306 179.209 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' C' C ' 35' ' ' ASP . . . . . . . . . . . . . 72.5 m-20 -65.25 148.41 51.73 Favored 'General case' 0 C--O 1.232 0.166 0 CA-C-N 118.054 0.927 . . . . 0.0 111.069 179.421 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' C' C ' 36' ' ' VAL . . . . . . . . . . . . . 43.8 t -122.42 131.68 72.69 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.237 0 CA-C-N 115.933 -0.576 . . . . 0.0 109.871 179.111 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' C' C ' 37' ' ' ILE . . . . . . . . . . . . . 67.1 mt -121.06 138.16 52.4 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 CA-C-N 116.114 -0.494 . . . . 0.0 109.902 179.794 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' C' C ' 38' ' ' GLY . . . . . . . . . . . . . . . -112.42 128.63 8.59 Favored Glycine 0 CA--C 1.525 0.692 0 N-CA-C 111.071 -0.812 . . . . 0.0 111.071 179.562 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' C' C ' 39' ' ' ILE . . . . . . . . . . . . . 74.7 mt -124.85 137.13 58.53 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.184 0 N-CA-C 110.128 -0.323 . . . . 0.0 110.128 179.449 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' C' C ' 40' ' ' SER . . . . . . . . . . . . . 41.4 t -92.44 114.06 26.51 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 116.445 -0.343 . . . . 0.0 110.755 176.213 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' C' C ' 41' ' ' ILE . . . . . . . . . . . . . 42.7 mm -119.99 120.67 63.84 Favored 'Isoleucine or valine' 0 N--CA 1.462 0.167 0 CA-C-O 120.737 0.304 . . . . 0.0 110.59 179.879 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' C' C ' 42' ' ' LEU . . . . . . . . . . . . . 47.3 mt 51.85 34.84 14.17 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-N 116.308 -0.405 . . . . 0.0 111.856 176.435 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' C' C ' 43' ' ' GLY . . . . . . . . . . . . . . . 72.88 33.24 60.17 Favored Glycine 0 CA--C 1.529 0.907 0 C-N-CA 121.017 -0.611 . . . . 0.0 111.961 178.665 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' C' C ' 44' ' ' LYS . . . . . . . . . . . . . 55.6 tptt -140.7 129.61 23.2 Favored 'General case' 0 C--N 1.33 -0.268 0 N-CA-C 109.4 -0.593 . . . . 0.0 109.4 178.622 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' C' C ' 45' ' ' GLU . . . . . . . . . . . . . 83.6 tt0 -81.71 119.39 23.78 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-O 120.928 0.394 . . . . 0.0 110.658 -177.782 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' C' C ' 46' ' ' VAL . . . . . . . . . . . . . 7.4 p -117.56 127.06 75.03 Favored 'Isoleucine or valine' 0 C--N 1.333 -0.12 0 N-CA-C 109.303 -0.629 . . . . 0.0 109.303 176.765 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' C' C ' 47' ' ' LYS . . . . . . . . . . . . . 68.0 mttm -100.37 127.36 46.7 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 115.827 -0.624 . . . . 0.0 111.001 179.312 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' C' C ' 48' ' ' PHE . . . . . . . . . . . . . 93.8 m-85 -109.94 131.92 54.62 Favored 'General case' 0 C--N 1.328 -0.347 0 N-CA-C 109.81 -0.441 . . . . 0.0 109.81 175.632 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' C' C ' 49' ' ' LYS . . . . . . . . . . . . . 85.6 tttt -107.75 135.63 48.84 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.437 -0.347 . . . . 0.0 110.385 178.857 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' C' C ' 50' ' ' VAL . . . . . . . . . . . . . 44.6 t -79.76 107.25 11.97 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 N-CA-C 109.198 -0.668 . . . . 0.0 109.198 176.261 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' C' C ' 51' ' ' VAL . . . . . . . . . . . . . 48.4 t -70.36 -46.96 68.97 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.316 0 N-CA-C 109.856 -0.424 . . . . 0.0 109.856 -174.339 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' C' C ' 52' ' ' GLN . . . . . . . . . . . . . 37.4 tt0 -167.14 142.44 4.09 Favored 'General case' 0 C--N 1.33 -0.241 0 C-N-CA 120.314 -0.554 . . . . 0.0 111.711 -179.887 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' C' C ' 53' ' ' ALA . . . . . . . . . . . . . . . -114.69 133.79 55.6 Favored 'General case' 0 C--N 1.331 -0.227 0 CA-C-N 115.761 -0.654 . . . . 0.0 109.745 175.113 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' C' C ' 54' ' ' TYR . . . . . . . . . . . . . 64.2 t80 -129.08 112.81 18.5 Favored Pre-proline 0 CA--C 1.534 0.348 0 CA-C-O 118.259 -0.877 . . . . 0.0 110.52 -179.963 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' C' C ' 55' ' ' PRO . . . . . . . . . . . . . 73.4 Cg_endo -77.18 168.19 77.58 Favored 'Cis proline' 0 N--CA 1.501 1.964 0 CA-C-N 122.05 1.768 . . . . 0.0 112.083 -7.607 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' C' C ' 56' ' ' SER . . . . . . . . . . . . . 14.0 m -117.22 140.42 27.16 Favored Pre-proline 0 CA--C 1.539 0.52 0 CA-C-O 118.599 -0.715 . . . . 0.0 109.828 174.518 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' C' C ' 57' ' ' PRO . . . . . . . . . . . . . 51.5 Cg_endo -70.82 144.2 78.18 Favored 'Cis proline' 0 N--CA 1.498 1.742 0 CA-C-N 121.575 1.598 . . . . 0.0 111.2 -3.742 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' C' C ' 58' ' ' LEU . . . . . . . . . . . . . 16.9 tp -107.49 135.88 48.22 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-O 120.796 0.331 . . . . 0.0 110.981 -176.199 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' C' C ' 59' ' ' ARG . . . . . . . . . . . . . 55.7 ttt180 -101.68 126.06 48.45 Favored 'General case' 0 C--N 1.327 -0.405 0 N-CA-C 109.15 -0.685 . . . . 0.0 109.15 174.254 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' C' C ' 60' ' ' VAL . . . . . . . . . . . . . 42.5 t -83.65 124.48 39.69 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.264 0 C-N-CA 120.64 -0.424 . . . . 0.0 110.549 -175.426 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' C' C ' 61' ' ' GLU . . . . . . . . . . . . . 95.6 mt-10 -129.02 170.74 13.1 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 115.68 -0.691 . . . . 0.0 109.881 177.238 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' C' C ' 62' ' ' ASP . . . . . . . . . . . . . 81.6 m-20 -54.81 -32.51 60.45 Favored 'General case' 0 C--N 1.327 -0.372 0 C-N-CA 121.048 -0.261 . . . . 0.0 111.695 -178.877 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' C' C ' 63' ' ' ARG . . . . . . . . . . . . . 9.2 ptm180 -86.73 6.21 32.47 Favored 'General case' 0 CA--C 1.536 0.415 0 N-CA-C 113.623 0.972 . . . . 0.0 113.623 -175.474 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' C' C ' 64' ' ' THR . . . . . . . . . . . . . 19.8 m -73.36 135.91 44.34 Favored 'General case' 0 C--N 1.332 -0.186 0 CA-C-N 118.138 0.427 . . . . 0.0 110.799 -177.814 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' C' C ' 65' ' ' LYS . . . . . . . . . . . . . 25.3 mtpp -89.94 119.21 30.11 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.098 -0.501 . . . . 0.0 110.001 178.062 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' C' C ' 66' ' ' ILE . . . . . . . . . . . . . 65.6 mt -114.56 131.18 67.41 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.277 0 CA-C-O 120.83 0.348 . . . . 0.0 110.07 -178.681 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' C' C ' 67' ' ' THR . . . . . . . . . . . . . 21.3 m -123.01 134.65 54.3 Favored 'General case' 0 C--N 1.331 -0.224 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.478 -179.253 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' C' C ' 68' ' ' LEU . . . . . . . . . . . . . 21.5 tp -108.63 130.48 55.32 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 115.876 -0.602 . . . . 0.0 110.802 -179.809 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' C' C ' 69' ' ' VAL . . . . . . . . . . . . . 45.8 t -89.45 133.41 31.6 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.292 0 N-CA-C 109.768 -0.456 . . . . 0.0 109.768 177.476 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' C' C ' 70' ' ' THR . . . . . . . . . . . . . 3.3 m -144.44 32.28 1.19 Allowed 'General case' 0 C--N 1.331 -0.236 0 N-CA-C 111.95 0.352 . . . . 0.0 111.95 -177.944 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' C' C ' 71' ' ' HIS . . . . . . . . . . . . . 27.2 t-80 -134.18 81.8 49.45 Favored Pre-proline 0 C--O 1.234 0.238 0 N-CA-C 110.364 -0.236 . . . . 0.0 110.364 178.458 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' C' C ' 72' ' ' PRO . . . . . . . . . . . . . 90.2 Cg_endo -90.17 154.64 4.7 Favored 'Trans proline' 0 N--CA 1.49 1.274 0 C-N-CA 121.837 1.691 . . . . 0.0 113.254 -176.657 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' C' C ' 73' ' ' VAL . . . . . . . . . . . . . 33.0 m -120.52 -171.37 0.62 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 CA-C-N 115.365 -0.834 . . . . 0.0 109.243 174.896 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' C' C ' 74' ' ' ASP . . . . . . . . . . . . . 7.4 t0 -89.13 114.88 26.2 Favored 'General case' 0 C--N 1.331 -0.211 0 N-CA-C 109.09 -0.707 . . . . 0.0 109.09 -178.753 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' C' C ' 75' ' ' VAL . . . . . . . . . . . . . 42.3 t -124.52 122.0 62.85 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.266 0 CA-C-O 121.054 0.454 . . . . 0.0 110.652 -175.109 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' C' C ' 76' ' ' LEU . . . . . . . . . . . . . 6.4 mp -118.92 144.54 46.37 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 115.584 -0.735 . . . . 0.0 109.378 175.332 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' C' C ' 77' ' ' GLU . . . . . . . . . . . . . 96.3 mt-10 -134.07 137.49 44.68 Favored 'General case' 0 C--N 1.331 -0.219 0 CA-C-O 120.998 0.428 . . . . 0.0 111.081 -177.653 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' C' C ' 78' ' ' ALA . . . . . . . . . . . . . . . -125.1 135.69 52.93 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 115.738 -0.665 . . . . 0.0 109.79 176.568 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' C' C ' 79' ' ' LYS . . . . . . . . . . . . . 61.6 mmtt -78.0 118.5 20.35 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-O 121.002 0.43 . . . . 0.0 110.949 -177.815 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' C' C ' 80' ' ' ILE . . . . . . . . . . . . . 41.5 mm -139.1 106.55 2.96 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.327 0 N-CA-C 109.107 -0.701 . . . . 0.0 109.107 -178.951 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' C' C ' 81' ' ' LYS . . . . . . . . . . . . . 99.4 mttt -100.2 127.34 46.48 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-O 120.928 0.394 . . . . 0.0 110.949 -178.145 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' C' C ' 82' ' ' GLY . . . . . . . . . . . . . . . 89.04 42.1 5.71 Favored Glycine 0 CA--C 1.524 0.634 0 C-N-CA 120.968 -0.634 . . . . 0.0 111.722 176.057 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' C' C ' 83' ' ' ILE . . . . . . . . . . . . . 72.5 mt -66.47 137.26 25.21 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.321 0 N-CA-C 109.634 -0.506 . . . . 0.0 109.634 176.339 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' C' C ' 84' ' ' LYS . . . . . . . . . . . . . 39.6 ttpt -101.02 -50.66 3.74 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-O 120.894 0.378 . . . . 0.0 110.389 -179.066 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' C' C ' 85' ' ' ASP . . . . . . . . . . . . . 12.7 t70 -152.44 151.1 30.37 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.078 -0.51 . . . . 0.0 110.783 -179.894 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' C' C ' 86' ' ' VAL . . . . . . . . . . . . . 42.4 t -128.15 131.19 69.54 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.222 0 CA-C-O 120.895 0.379 . . . . 0.0 110.261 179.362 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' C' C ' 87' ' ' ILE . . . . . . . . . . . . . 5.0 mp -122.98 131.58 73.01 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.251 0 CA-C-N 116.178 -0.464 . . . . 0.0 109.781 178.884 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' C' C ' 88' ' ' LEU . . . . . . . . . . . . . 80.8 mt -109.31 139.61 44.04 Favored 'General case' 0 C--N 1.331 -0.212 0 CA-C-O 121.03 0.443 . . . . 0.0 111.181 -179.354 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' C' C ' 89' ' ' ASP . . . . . . . . . . . . . 13.6 t70 -129.23 156.25 44.26 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 115.667 -0.697 . . . . 0.0 109.624 177.562 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' C' C ' 90' ' ' GLU . . . . . . . . . . . . . 85.3 tt0 -45.93 -38.77 7.93 Favored 'General case' 0 CA--C 1.532 0.265 0 N-CA-C 113.101 0.778 . . . . 0.0 113.101 -172.151 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' C' C ' 91' ' ' ASN . . . . . . . . . . . . . 78.9 m-20 -132.07 21.48 4.49 Favored 'General case' 0 N--CA 1.469 0.485 0 N-CA-C 112.799 0.666 . . . . 0.0 112.799 -178.035 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' C' C ' 92' ' ' LEU . . . . . . . . . . . . . 40.4 mt -150.59 152.26 33.81 Favored 'General case' 0 C--N 1.331 -0.217 0 CA-C-O 120.997 0.427 . . . . 0.0 110.678 -176.423 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' C' C ' 93' ' ' ILE . . . . . . . . . . . . . 69.8 mt -125.35 123.33 64.79 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.335 0 N-CA-C 109.141 -0.689 . . . . 0.0 109.141 175.727 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' C' C ' 94' ' ' VAL . . . . . . . . . . . . . 42.3 t -119.74 128.78 75.91 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.284 0 CA-C-O 120.964 0.411 . . . . 0.0 110.079 -179.192 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' C' C ' 95' ' ' VAL . . . . . . . . . . . . . 45.5 t -120.48 134.18 64.78 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.322 0 CA-C-N 115.94 -0.573 . . . . 0.0 109.655 179.89 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' C' C ' 96' ' ' ILE . . . . . . . . . . . . . 66.9 mt -115.59 127.05 73.3 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.309 0 N-CA-C 109.283 -0.636 . . . . 0.0 109.283 178.845 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' C' C ' 97' ' ' THR . . . . . . . . . . . . . 68.6 p -100.87 158.22 16.14 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-O 121.139 0.495 . . . . 0.0 111.115 -176.819 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' C' C ' 98' ' ' GLU . . . . . . . . . . . . . 84.6 tt0 -53.85 -26.31 23.87 Favored 'General case' 0 CA--C 1.534 0.335 0 CA-C-N 116.22 -0.445 . . . . 0.0 112.172 179.861 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' C' C ' 99' ' ' GLU . . . . . . . . . . . . . 18.2 tp10 -76.8 9.97 2.52 Favored 'General case' 0 CA--C 1.538 0.517 0 N-CA-C 113.007 0.743 . . . . 0.0 113.007 -177.929 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' C' C ' 100' ' ' ASN . . . . . . . . . . . . . 3.6 m-20 63.32 33.48 13.96 Favored 'General case' 0 N--CA 1.464 0.258 0 O-C-N 121.984 -0.447 . . . . 0.0 111.57 -179.812 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' C' C ' 101' ' ' GLU . . . . . . . . . . . . . 84.7 tt0 -108.64 143.99 36.97 Favored 'General case' 0 C--N 1.332 -0.167 0 N-CA-C 109.666 -0.494 . . . . 0.0 109.666 172.038 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' C' C ' 102' ' ' VAL . . . . . . . . . . . . . 46.9 t -115.61 126.1 73.03 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.27 0 N-CA-C 109.72 -0.474 . . . . 0.0 109.72 -177.958 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' C' C ' 103' ' ' LEU . . . . . . . . . . . . . 30.9 mt -117.3 130.77 56.76 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-N 115.856 -0.611 . . . . 0.0 110.334 177.845 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' C' C ' 104' ' ' ILE . . . . . . . . . . . . . 64.0 mt -118.28 121.29 66.82 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.207 0 N-CA-C 110.07 -0.345 . . . . 0.0 110.07 179.383 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' C' C ' 105' ' ' PHE . . . . . . . . . . . . . 45.4 m-85 -121.63 167.55 12.78 Favored 'General case' 0 C--N 1.332 -0.182 0 O-C-N 123.851 0.719 . . . . 0.0 109.883 177.993 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' C' C ' 106' ' ' ASN . . . . . . . . . . . . . 45.2 p-10 -97.29 -169.93 1.93 Allowed 'General case' 0 C--N 1.331 -0.209 0 N-CA-C 109.879 -0.415 . . . . 0.0 109.879 173.677 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' C' C ' 107' ' ' GLN . . . . . . . . . . . . . 48.9 tt0 -59.57 -30.13 68.43 Favored 'General case' 0 CA--C 1.532 0.251 0 N-CA-C 111.9 0.333 . . . . 0.0 111.9 179.84 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' C' C ' 108' ' ' ASN . . . . . . . . . . . . . 51.6 t30 -83.78 9.85 10.91 Favored 'General case' 0 CA--C 1.536 0.424 0 N-CA-C 113.062 0.764 . . . . 0.0 113.062 -178.195 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' C' C ' 109' ' ' LEU . . . . . . . . . . . . . 8.0 tp 59.85 36.29 21.93 Favored 'General case' 0 C--N 1.331 -0.223 0 CA-C-O 120.853 0.359 . . . . 0.0 111.366 179.085 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' C' C ' 110' ' ' GLU . . . . . . . . . . . . . 96.0 mt-10 -103.38 150.1 24.13 Favored 'General case' 0 C--N 1.33 -0.26 0 N-CA-C 109.957 -0.386 . . . . 0.0 109.957 176.06 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' C' C ' 111' ' ' GLU . . . . . . . . . . . . . 71.6 tt0 -81.98 121.99 27.21 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-O 120.886 0.374 . . . . 0.0 111.111 -174.713 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' C' C ' 112' ' ' LEU . . . . . . . . . . . . . 34.1 mt -107.08 -46.09 3.99 Favored 'General case' 0 C--N 1.331 -0.21 0 CA-C-N 116.16 -0.473 . . . . 0.0 110.76 178.049 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' C' C ' 113' ' ' TYR . . . . . . . . . . . . . 60.7 t80 -139.34 139.72 37.33 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.201 -0.454 . . . . 0.0 111.14 -178.047 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' C' C ' 114' ' ' ARG . . . . . . . . . . . . . 59.1 ttp180 -137.6 125.53 22.69 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 115.956 -0.565 . . . . 0.0 110.224 177.321 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' C' C ' 115' ' ' GLY . . . . . . . . . . . . . . . -149.98 153.25 24.98 Favored Glycine 0 CA--C 1.523 0.573 0 N-CA-C 110.262 -1.135 . . . . 0.0 110.262 178.505 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' C' C ' 116' ' ' LYS . . . . . . . . . . . . . 59.0 tttm -131.5 128.98 40.48 Favored 'General case' 0 C--N 1.329 -0.325 0 N-CA-C 109.65 -0.5 . . . . 0.0 109.65 179.388 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' C' C ' 117' ' ' PHE . . . . . . . . . . . . . 26.1 m-85 -132.91 117.64 17.94 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.329 -0.396 . . . . 0.0 110.029 -173.153 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' C' C ' 118' ' ' GLU . . . . . . . . . . . . . 95.8 mt-10 -55.18 -39.46 69.58 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.521 -0.308 . . . . 0.0 111.043 -177.774 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' C' C ' 119' ' ' ASN . . . . . . . . . . . . . 29.5 m120 -100.7 30.98 3.7 Favored 'General case' 0 C--N 1.33 -0.271 0 N-CA-C 112.229 0.455 . . . . 0.0 112.229 -173.896 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' C' C ' 120' ' ' LEU . . . . . . . . . . . . . 17.1 tp -57.76 122.56 13.14 Favored 'General case' 0 N--CA 1.462 0.16 0 C-N-CA 120.845 -0.342 . . . . 0.0 110.121 177.462 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' C' C ' 121' ' ' ASN . . . . . . . . . . . . . 21.9 t-20 -112.79 -44.03 3.36 Favored 'General case' 0 C--N 1.332 -0.183 0 CA-C-N 116.554 -0.294 . . . . 0.0 111.41 -175.968 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' C' C ' 122' ' ' LYS . . . . . . . . . . . . . 31.4 ttmt -158.57 151.04 21.84 Favored 'General case' 0 C--N 1.332 -0.188 0 C-N-CA 120.546 -0.462 . . . . 0.0 111.156 -176.721 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' C' C ' 123' ' ' VAL . . . . . . . . . . . . . 41.9 t -122.42 131.91 72.22 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.218 0 CA-C-N 116.19 -0.459 . . . . 0.0 109.957 177.687 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' C' C ' 124' ' ' LEU . . . . . . . . . . . . . 7.2 mp -116.76 133.67 55.74 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-N 116.147 -0.479 . . . . 0.0 109.999 179.28 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' C' C ' 125' ' ' VAL . . . . . . . . . . . . . 35.2 m -135.25 139.68 46.46 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.289 0 CA-C-O 120.843 0.354 . . . . 0.0 110.922 -179.479 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' C' C ' 126' ' ' ARG . . . . . . . . . . . . . 38.8 ttt180 -163.32 133.63 4.44 Favored 'General case' 0 C--N 1.329 -0.298 0 N-CA-C 109.525 -0.546 . . . . 0.0 109.525 177.015 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' C' C ' 127' ' ' ASN . . . . . . . . . . . . . 33.4 m120 56.85 -155.13 0.32 Allowed 'General case' 0 CA--C 1.538 0.503 0 N-CA-C 109.627 -0.508 . . . . 0.0 109.627 -177.843 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' C' C ' 128' ' ' ASP . . . . . . . . . . . . . 11.6 p-10 -82.31 16.92 1.84 Allowed 'General case' 0 CA--C 1.536 0.421 0 N-CA-C 112.642 0.608 . . . . 0.0 112.642 177.705 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' C' C ' 129' ' ' LEU . . . . . . . . . . . . . 49.3 mt -115.74 142.45 46.73 Favored 'General case' 0 C--O 1.231 0.116 0 O-C-N 122.077 -0.39 . . . . 0.0 110.279 179.723 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' C' C ' 130' ' ' VAL . . . . . . . . . . . . . 32.5 m -134.77 146.8 30.12 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.249 0 CA-C-O 120.986 0.422 . . . . 0.0 110.947 -179.333 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' C' C ' 131' ' ' VAL . . . . . . . . . . . . . 39.1 t -135.99 137.86 48.2 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.299 0 CA-C-N 116.087 -0.506 . . . . 0.0 110.157 178.43 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' C' C ' 132' ' ' ILE . . . . . . . . . . . . . 70.2 mt -112.96 131.75 63.68 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.357 0 N-CA-C 109.341 -0.614 . . . . 0.0 109.341 179.933 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' C' C ' 133' ' ' ILE . . . . . . . . . . . . . 36.6 mm -113.64 122.33 67.57 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.256 0 CA-C-O 120.837 0.351 . . . . 0.0 110.79 -176.15 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' C' C ' 134' ' ' ASP . . . . . . . . . . . . . 9.4 p-10 -132.97 150.06 52.19 Favored 'General case' 0 C--N 1.331 -0.222 0 CA-C-N 116.107 -0.497 . . . . 0.0 109.66 174.741 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' C' C ' 135' ' ' GLU . . . . . . . . . . . . . 40.3 tp10 -50.0 -29.02 7.79 Favored 'General case' 0 C--N 1.327 -0.398 0 N-CA-C 112.715 0.635 . . . . 0.0 112.715 -171.873 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' C' C ' 136' ' ' GLN . . . . . . . . . . . . . 99.6 mm-40 -85.87 -29.52 23.62 Favored 'General case' 0 C--N 1.33 -0.247 0 N-CA-C 112.896 0.702 . . . . 0.0 112.896 -174.086 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' C' C ' 137' ' ' LYS . . . . . . . . . . . . . 21.0 pttm -168.97 173.16 7.12 Favored 'General case' 0 C--O 1.234 0.242 0 CA-C-O 121.496 0.665 . . . . 0.0 112.477 -171.975 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' C' C ' 138' ' ' LEU . . . . . . . . . . . . . 7.3 tt -120.71 129.38 53.63 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 115.088 -0.96 . . . . 0.0 109.869 179.594 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' C' C ' 139' ' ' THR . . . . . . . . . . . . . 38.0 m -109.76 128.5 55.33 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 116.112 -0.495 . . . . 0.0 110.444 179.703 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' C' C ' 140' ' ' LEU . . . . . . . . . . . . . 5.9 tt -112.01 122.64 48.33 Favored 'General case' 0 C--N 1.329 -0.305 0 N-CA-C 109.039 -0.726 . . . . 0.0 109.039 -179.39 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' C' C ' 141' ' ' ILE . . . . . . . . . . . . . 19.5 mt -121.86 121.39 64.13 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.333 0 CA-C-O 120.98 0.419 . . . . 0.0 109.93 -176.298 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' C' C ' 142' ' ' ARG . . . . . . . . . . . . . 78.9 mtm180 -111.14 125.13 53.46 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 115.463 -0.79 . . . . 0.0 110.169 -178.379 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' C' C ' 143' ' ' THR . . . . . . . . . . . . . 41.9 p . . . . . 0 C--O 1.221 -0.447 0 CA-C-O 117.905 -1.045 . . . . 0.0 110.618 -179.436 . . . . . . . . 0 0 . 1 . 005 nuclear orig full ' D' D ' -3' ' ' GLU . . . . . . . . . . . . . 95.6 mt-10 . . . . . 0 N--CA 1.489 1.52 0 N-CA-C 109.34 -0.615 . . . . 0.0 109.34 . . . . . . . . . 0 0 . 1 . 005 nuclear orig full ' D' D ' -2' ' ' GLY . . . . . . . . . . . . . . . -91.56 115.57 4.77 Favored Glycine 0 CA--C 1.525 0.697 0 N-CA-C 111.065 -0.814 . . . . 0.0 111.065 -179.804 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' D' D ' -1' ' ' VAL . . . . . . . . . . . . . 41.5 t -140.98 140.48 32.66 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.351 0 N-CA-C 110.138 -0.319 . . . . 0.0 110.138 179.483 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' D' D ' 0' ' ' ILE . . . . . . . . . . . . . 73.3 mt -105.58 136.38 39.94 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.223 0 CA-C-N 116.25 -0.432 . . . . 0.0 109.977 -179.849 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' D' D ' 1' ' ' MET . . . . . . . . . . . . . 26.3 ptt? -88.2 151.78 22.44 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 115.982 -0.554 . . . . 0.0 110.796 -179.059 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' D' D ' 2' ' ' SER . . . . . . . . . . . . . 6.5 p -121.1 134.0 55.24 Favored 'General case' 0 C--N 1.332 -0.187 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.752 179.703 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' D' D ' 3' ' ' GLU . . . . . . . . . . . . . 94.9 mt-10 -140.54 140.14 35.15 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.14 -0.482 . . . . 0.0 110.986 -179.044 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' D' D ' 4' ' ' LEU . . . . . . . . . . . . . 21.0 tp -126.31 128.01 46.46 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 116.129 -0.487 . . . . 0.0 110.223 176.912 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' D' D ' 5' ' ' LYS . . . . . . . . . . . . . 64.1 mttp -107.39 122.19 46.11 Favored 'General case' 0 C--O 1.234 0.274 0 CA-C-N 116.456 -0.338 . . . . 0.0 110.696 178.726 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' D' D ' 6' ' ' LEU . . . . . . . . . . . . . 73.3 mt -118.32 144.12 46.1 Favored 'General case' 0 C--N 1.331 -0.223 0 CA-C-N 115.683 -0.69 . . . . 0.0 110.778 -178.947 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' D' D ' 7' ' ' LYS . . . . . . . . . . . . . 59.3 tttm -133.95 141.76 40.91 Favored Pre-proline 0 CA--C 1.535 0.382 0 CA-C-O 119.12 -0.466 . . . . 0.0 110.158 176.727 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' D' D ' 8' ' ' PRO . . . . . . . . . . . . . 87.5 Cg_endo -91.52 140.64 2.57 Favored 'Trans proline' 0 N--CA 1.49 1.273 0 C-N-CA 121.748 1.632 . . . . 0.0 111.711 177.759 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' D' D ' 9' ' ' LEU . . . . . . . . . . . . . 53.5 mt -77.08 -48.06 2.6 Favored Pre-proline 0 CA--C 1.533 0.301 0 CA-C-O 118.799 -0.619 . . . . 0.0 112.464 -178.707 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' D' D ' 10' ' ' PRO . . . . . . . . . . . . . 85.2 Cg_endo -80.3 160.54 23.03 Favored 'Trans proline' 0 N--CA 1.495 1.605 0 C-N-CA 121.187 1.258 . . . . 0.0 112.071 176.92 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' D' D ' 11' ' ' LYS . . . . . . . . . . . . . 52.6 mttm -88.69 100.62 13.26 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.317 -0.402 . . . . 0.0 110.151 178.241 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' D' D ' 12' ' ' VAL . . . . . . . . . . . . . 12.9 p -145.77 147.34 18.53 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.263 0 CA-C-N 116.363 -0.38 . . . . 0.0 110.882 -178.888 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' D' D ' 13' ' ' GLU . . . . . . . . . . . . . 70.7 mm-40 -92.12 124.0 35.88 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.069 177.526 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' D' D ' 14' ' ' LEU . . . . . . . . . . . . . 36.4 mt -98.02 154.73 37.63 Favored Pre-proline 0 C--N 1.33 -0.258 0 CA-C-N 116.426 -0.352 . . . . 0.0 110.958 -177.88 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' D' D ' 15' ' ' PRO . . . . . . . . . . . . . 28.7 Cg_exo -60.6 154.82 51.74 Favored 'Trans proline' 0 N--CA 1.496 1.661 0 C-N-CA 121.405 1.403 . . . . 0.0 111.857 177.941 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' D' D ' 16' ' ' PRO . . . . . . . . . . . . . 36.4 Cg_exo -58.21 -37.13 96.72 Favored 'Trans proline' 0 N--CA 1.496 1.65 0 C-N-CA 121.4 1.4 . . . . 0.0 112.703 179.749 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' D' D ' 17' ' ' ASP . . . . . . . . . . . . . 15.0 p-10 -87.38 13.46 9.84 Favored 'General case' 0 CA--C 1.536 0.414 0 N-CA-C 112.981 0.734 . . . . 0.0 112.981 -178.384 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' D' D ' 18' ' ' PHE . . . . . . . . . . . . . 48.3 t80 -58.24 -45.09 88.39 Favored 'General case' 0 C--N 1.334 -0.104 0 O-C-N 122.145 -0.347 . . . . 0.0 110.14 -177.997 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' D' D ' 19' ' ' VAL . . . . . . . . . . . . . 14.6 p -55.7 -41.38 64.99 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.305 0 CA-C-N 116.478 -0.328 . . . . 0.0 111.073 -178.364 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' D' D ' 20' ' ' ASP . . . . . . . . . . . . . 71.5 m-20 -61.09 -43.76 98.4 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-O 120.818 0.342 . . . . 0.0 111.06 -178.329 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' D' D ' 21' ' ' VAL . . . . . . . . . . . . . 46.8 t -65.04 -46.78 90.36 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.318 0 C-N-CA 120.71 -0.396 . . . . 0.0 110.565 -177.285 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' D' D ' 22' ' ' ILE . . . . . . . . . . . . . 50.1 mm -56.7 -43.69 79.77 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.207 0 C-N-CA 120.959 -0.297 . . . . 0.0 110.493 179.378 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' D' D ' 23' ' ' ARG . . . . . . . . . . . . . 26.8 ttm-85 -52.93 -53.96 41.84 Favored 'General case' 0 C--N 1.331 -0.213 0 CA-C-O 121.413 0.625 . . . . 0.0 111.393 179.293 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' D' D ' 24' ' ' ILE . . . . . . . . . . . . . 78.8 mt -59.34 -41.06 83.06 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.356 0 CA-C-N 115.282 -0.872 . . . . 0.0 111.368 -173.524 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' D' D ' 25' ' ' LYS . . . . . . . . . . . . . 68.0 mttm -69.55 -41.63 75.66 Favored 'General case' 0 C--N 1.33 -0.278 0 N-CA-C 112.651 0.611 . . . . 0.0 112.651 -179.434 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' D' D ' 26' ' ' LEU . . . . . . . . . . . . . 60.4 mt -78.62 -33.86 47.05 Favored 'General case' 0 C--N 1.33 -0.262 0 N-CA-C 113.674 0.99 . . . . 0.0 113.674 -170.323 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' D' D ' 27' ' ' GLN . . . . . . . . . . . . . 10.4 pt20 -46.74 139.95 4.93 Favored 'General case' 0 N--CA 1.469 0.505 0 N-CA-C 112.863 0.69 . . . . 0.0 112.863 -174.884 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' D' D ' 28' ' ' GLY . . . . . . . . . . . . . . . 96.82 -21.39 46.27 Favored Glycine 0 CA--C 1.534 1.239 0 CA-C-N 115.728 -0.669 . . . . 0.0 112.531 -177.458 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' D' D ' 29' ' ' LYS . . . . . . . . . . . . . 35.1 mmtp -97.34 155.07 17.05 Favored 'General case' 0 C--O 1.232 0.16 0 CA-C-N 117.605 0.703 . . . . 0.0 110.783 179.407 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' D' D ' 30' ' ' THR . . . . . . . . . . . . . 32.0 m -106.0 137.1 44.49 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.043 -0.526 . . . . 0.0 109.868 176.165 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' D' D ' 31' ' ' VAL . . . . . . . . . . . . . 35.1 m -128.5 152.78 37.11 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.243 0 CA-C-O 121.026 0.441 . . . . 0.0 111.057 -178.088 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' D' D ' 32' ' ' ARG . . . . . . . . . . . . . 76.5 mtm180 -130.6 149.37 52.29 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 115.767 -0.652 . . . . 0.0 110.44 178.084 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' D' D ' 33' ' ' THR . . . . . . . . . . . . . 19.4 m -53.44 139.16 31.53 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.449 -0.342 . . . . 0.0 111.392 -178.238 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' D' D ' 34' ' ' GLY . . . . . . . . . . . . . . . 99.58 -17.02 58.2 Favored Glycine 0 CA--C 1.531 1.084 0 CA-C-O 119.684 -0.509 . . . . 0.0 113.296 179.378 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' D' D ' 35' ' ' ASP . . . . . . . . . . . . . 76.7 m-20 -66.17 148.74 51.38 Favored 'General case' 0 N--CA 1.461 0.107 0 CA-C-N 118.056 0.928 . . . . 0.0 111.074 179.145 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' D' D ' 36' ' ' VAL . . . . . . . . . . . . . 44.4 t -120.19 130.56 74.19 Favored 'Isoleucine or valine' 0 C--N 1.333 -0.133 0 CA-C-N 115.811 -0.631 . . . . 0.0 109.981 179.042 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' D' D ' 37' ' ' ILE . . . . . . . . . . . . . 68.3 mt -119.75 137.76 52.56 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.262 0 N-CA-C 109.721 -0.474 . . . . 0.0 109.721 179.103 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' D' D ' 38' ' ' GLY . . . . . . . . . . . . . . . -111.05 128.57 8.79 Favored Glycine 0 CA--C 1.524 0.633 0 N-CA-C 111.394 -0.682 . . . . 0.0 111.394 -178.955 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' D' D ' 39' ' ' ILE . . . . . . . . . . . . . 73.9 mt -129.99 130.47 66.18 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.217 0 N-CA-C 109.817 -0.438 . . . . 0.0 109.817 177.838 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' D' D ' 40' ' ' SER . . . . . . . . . . . . . 59.6 p -92.28 115.19 27.86 Favored 'General case' 0 C--N 1.33 -0.281 0 C-N-CA 120.912 -0.315 . . . . 0.0 110.875 176.968 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' D' D ' 41' ' ' ILE . . . . . . . . . . . . . 44.1 mm -123.39 124.48 69.85 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.223 0 N-CA-C 109.996 -0.372 . . . . 0.0 109.996 -179.754 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' D' D ' 42' ' ' LEU . . . . . . . . . . . . . 56.1 mt 57.67 34.16 24.14 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.362 -0.381 . . . . 0.0 111.729 178.274 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' D' D ' 43' ' ' GLY . . . . . . . . . . . . . . . 77.94 -10.05 28.25 Favored Glycine 0 CA--C 1.535 1.308 0 C-N-CA 121.28 -0.486 . . . . 0.0 113.407 177.713 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' D' D ' 44' ' ' LYS . . . . . . . . . . . . . 61.0 tttm -101.31 130.99 47.57 Favored 'General case' 0 C--N 1.331 -0.211 0 CA-C-N 117.914 0.857 . . . . 0.0 109.846 176.869 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' D' D ' 45' ' ' GLU . . . . . . . . . . . . . 43.3 tp10 -83.23 128.17 34.26 Favored 'General case' 0 C--N 1.329 -0.293 0 C-N-CA 120.817 -0.353 . . . . 0.0 110.727 -179.113 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' D' D ' 46' ' ' VAL . . . . . . . . . . . . . 7.3 p -121.67 131.2 73.63 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.227 0 CA-C-O 121.11 0.481 . . . . 0.0 109.704 177.363 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' D' D ' 47' ' ' LYS . . . . . . . . . . . . . 37.1 mtmm -100.47 128.06 46.64 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 115.879 -0.601 . . . . 0.0 111.069 176.349 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' D' D ' 48' ' ' PHE . . . . . . . . . . . . . 89.9 m-85 -107.97 131.96 54.0 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.077 -0.51 . . . . 0.0 109.75 176.125 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' D' D ' 49' ' ' LYS . . . . . . . . . . . . . 82.8 tttt -107.17 134.57 50.09 Favored 'General case' 0 C--N 1.327 -0.385 0 CA-C-N 116.289 -0.414 . . . . 0.0 110.379 179.856 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' D' D ' 50' ' ' VAL . . . . . . . . . . . . . 46.8 t -76.95 108.68 10.39 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.297 0 N-CA-C 109.037 -0.727 . . . . 0.0 109.037 175.709 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' D' D ' 51' ' ' VAL . . . . . . . . . . . . . 51.0 t -70.67 -47.16 65.82 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.329 0 CA-C-N 116.131 -0.486 . . . . 0.0 109.868 -174.338 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' D' D ' 52' ' ' GLN . . . . . . . . . . . . . 49.6 tt0 -167.94 142.08 3.47 Favored 'General case' 0 C--N 1.33 -0.275 0 C-N-CA 120.308 -0.557 . . . . 0.0 111.567 -179.907 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' D' D ' 53' ' ' ALA . . . . . . . . . . . . . . . -115.76 132.87 56.51 Favored 'General case' 0 C--N 1.331 -0.196 0 CA-C-N 115.745 -0.661 . . . . 0.0 110.024 176.255 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' D' D ' 54' ' ' TYR . . . . . . . . . . . . . 75.4 t80 -129.14 112.19 18.35 Favored Pre-proline 0 CA--C 1.536 0.413 0 CA-C-O 118.291 -0.861 . . . . 0.0 110.319 178.503 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' D' D ' 55' ' ' PRO . . . . . . . . . . . . . 73.0 Cg_endo -77.21 170.01 72.62 Favored 'Cis proline' 0 N--CA 1.499 1.836 0 CA-C-N 121.995 1.748 . . . . 0.0 112.119 -5.61 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' D' D ' 56' ' ' SER . . . . . . . . . . . . . 13.5 m -117.2 132.05 23.7 Favored Pre-proline 0 CA--C 1.538 0.502 0 CA-C-O 118.464 -0.779 . . . . 0.0 109.454 175.666 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' D' D ' 57' ' ' PRO . . . . . . . . . . . . . 45.3 Cg_endo -69.37 146.86 82.54 Favored 'Cis proline' 0 N--CA 1.496 1.667 0 CA-C-N 121.902 1.715 . . . . 0.0 111.532 -0.835 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' D' D ' 58' ' ' LEU . . . . . . . . . . . . . 27.2 tp -107.61 135.23 49.4 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.275 -0.421 . . . . 0.0 110.527 -179.035 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' D' D ' 59' ' ' ARG . . . . . . . . . . . . . 52.7 ttp180 -102.43 125.28 49.09 Favored 'General case' 0 C--N 1.328 -0.356 0 N-CA-C 109.482 -0.562 . . . . 0.0 109.482 177.101 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' D' D ' 60' ' ' VAL . . . . . . . . . . . . . 41.2 t -81.44 121.37 34.74 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.2 0 C-N-CA 120.745 -0.382 . . . . 0.0 110.505 -174.917 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' D' D ' 61' ' ' GLU . . . . . . . . . . . . . 96.1 mt-10 -131.13 159.92 36.25 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 115.73 -0.668 . . . . 0.0 109.929 177.213 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' D' D ' 62' ' ' ASP . . . . . . . . . . . . . 10.8 t70 -53.66 -32.3 51.02 Favored 'General case' 0 C--N 1.327 -0.376 0 N-CA-C 111.722 0.268 . . . . 0.0 111.722 179.648 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' D' D ' 63' ' ' ARG . . . . . . . . . . . . . 27.8 ptt180 -85.78 5.05 34.19 Favored 'General case' 0 CA--C 1.537 0.459 0 N-CA-C 113.771 1.026 . . . . 0.0 113.771 -175.634 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' D' D ' 64' ' ' THR . . . . . . . . . . . . . 39.9 m -86.19 143.67 27.86 Favored 'General case' 0 C--N 1.332 -0.184 0 CA-C-N 118.002 0.365 . . . . 0.0 110.411 -179.728 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' D' D ' 65' ' ' LYS . . . . . . . . . . . . . 98.7 mttt -87.21 126.08 34.58 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.438 -0.346 . . . . 0.0 110.104 179.968 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' D' D ' 66' ' ' ILE . . . . . . . . . . . . . 65.5 mt -117.71 128.33 74.91 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.295 0 N-CA-C 109.862 -0.422 . . . . 0.0 109.862 -178.969 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' D' D ' 67' ' ' THR . . . . . . . . . . . . . 25.4 m -121.86 136.8 54.94 Favored 'General case' 0 C--N 1.331 -0.202 0 CA-C-O 121.05 0.452 . . . . 0.0 110.981 -177.65 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' D' D ' 68' ' ' LEU . . . . . . . . . . . . . 19.0 tp -107.77 134.09 51.23 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-N 115.914 -0.585 . . . . 0.0 110.635 179.593 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' D' D ' 69' ' ' VAL . . . . . . . . . . . . . 43.1 t -83.77 138.02 19.95 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.29 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.238 178.326 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' D' D ' 70' ' ' THR . . . . . . . . . . . . . 9.1 t -96.4 177.87 5.55 Favored 'General case' 0 C--N 1.331 -0.2 0 CA-C-N 116.198 -0.456 . . . . 0.0 110.749 -179.424 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' D' D ' 71' ' ' HIS . . . . . . . . . . . . . 95.9 m-70 -65.1 151.13 94.34 Favored Pre-proline 0 C--N 1.331 -0.23 0 CA-C-N 116.238 -0.437 . . . . 0.0 110.882 -178.282 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' D' D ' 72' ' ' PRO . . . . . . . . . . . . . 93.2 Cg_endo -92.2 160.01 3.16 Favored 'Trans proline' 0 N--CA 1.489 1.221 0 C-N-CA 121.864 1.709 . . . . 0.0 112.38 178.774 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' D' D ' 73' ' ' VAL . . . . . . . . . . . . . 35.4 m -87.51 -176.85 0.33 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.246 0 CA-C-N 116.206 -0.452 . . . . 0.0 109.984 177.229 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' D' D ' 74' ' ' ASP . . . . . . . . . . . . . 12.8 t70 -91.47 118.56 30.67 Favored 'General case' 0 C--N 1.331 -0.217 0 N-CA-C 109.953 -0.388 . . . . 0.0 109.953 -178.832 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' D' D ' 75' ' ' VAL . . . . . . . . . . . . . 45.8 t -117.36 123.67 72.06 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.239 0 CA-C-O 121.184 0.516 . . . . 0.0 110.507 -177.328 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' D' D ' 76' ' ' LEU . . . . . . . . . . . . . 14.6 mt -125.85 144.61 50.59 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-N 115.463 -0.79 . . . . 0.0 109.347 177.726 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' D' D ' 77' ' ' GLU . . . . . . . . . . . . . 97.0 mt-10 -135.67 138.33 42.7 Favored 'General case' 0 C--N 1.332 -0.183 0 CA-C-O 121.029 0.443 . . . . 0.0 111.583 -176.739 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' D' D ' 78' ' ' ALA . . . . . . . . . . . . . . . -127.14 135.28 50.49 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 115.627 -0.715 . . . . 0.0 109.675 175.772 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' D' D ' 79' ' ' LYS . . . . . . . . . . . . . 22.7 tptm -78.08 121.83 24.8 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-O 120.914 0.388 . . . . 0.0 110.647 -177.604 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' D' D ' 80' ' ' ILE . . . . . . . . . . . . . 43.2 mm -139.22 113.21 7.0 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.325 0 N-CA-C 108.995 -0.743 . . . . 0.0 108.995 -178.358 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' D' D ' 81' ' ' LYS . . . . . . . . . . . . . 76.2 tttt -103.09 123.24 46.27 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-O 120.749 0.309 . . . . 0.0 111.134 -175.809 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' D' D ' 82' ' ' GLY . . . . . . . . . . . . . . . 89.15 42.19 5.65 Favored Glycine 0 CA--C 1.528 0.871 0 C-N-CA 120.925 -0.655 . . . . 0.0 112.356 173.422 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' D' D ' 83' ' ' ILE . . . . . . . . . . . . . 71.4 mt -70.84 139.43 19.99 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.245 0 N-CA-C 109.706 -0.479 . . . . 0.0 109.706 176.359 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' D' D ' 84' ' ' LYS . . . . . . . . . . . . . 38.9 ttpt -107.16 -47.28 3.71 Favored 'General case' 0 C--N 1.331 -0.197 0 CA-C-N 116.451 -0.34 . . . . 0.0 110.631 -178.316 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' D' D ' 85' ' ' ASP . . . . . . . . . . . . . 9.9 t70 -148.35 148.13 30.02 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.253 -0.43 . . . . 0.0 110.489 -179.439 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' D' D ' 86' ' ' VAL . . . . . . . . . . . . . 42.4 t -133.25 134.48 57.39 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.252 0 CA-C-O 121.032 0.444 . . . . 0.0 110.425 179.442 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' D' D ' 87' ' ' ILE . . . . . . . . . . . . . 46.0 mm -120.09 127.52 75.9 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.29 0 CA-C-N 115.799 -0.637 . . . . 0.0 109.658 178.403 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' D' D ' 88' ' ' LEU . . . . . . . . . . . . . 18.2 tp -109.66 127.06 54.3 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-O 120.937 0.398 . . . . 0.0 110.898 -178.612 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' D' D ' 89' ' ' ASP . . . . . . . . . . . . . 13.7 t70 -117.96 154.68 31.54 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 115.926 -0.579 . . . . 0.0 109.559 177.124 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' D' D ' 90' ' ' GLU . . . . . . . . . . . . . 96.3 mt-10 -49.0 -38.63 23.95 Favored 'General case' 0 C--N 1.329 -0.311 0 N-CA-C 112.748 0.648 . . . . 0.0 112.748 -172.195 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' D' D ' 91' ' ' ASN . . . . . . . . . . . . . 37.5 t30 -132.06 35.64 3.71 Favored 'General case' 0 N--CA 1.464 0.258 0 C-N-CA 120.91 -0.316 . . . . 0.0 111.654 -177.797 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' D' D ' 92' ' ' LEU . . . . . . . . . . . . . 9.2 tp -166.06 146.66 6.53 Favored 'General case' 0 C--N 1.33 -0.244 0 C-N-CA 120.8 -0.36 . . . . 0.0 110.815 -179.304 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' D' D ' 93' ' ' ILE . . . . . . . . . . . . . 71.2 mt -125.71 123.66 64.93 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.262 0 N-CA-C 109.501 -0.555 . . . . 0.0 109.501 179.975 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' D' D ' 94' ' ' VAL . . . . . . . . . . . . . 46.4 t -124.41 129.69 73.82 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.24 0 CA-C-O 121.011 0.434 . . . . 0.0 110.236 179.893 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' D' D ' 95' ' ' VAL . . . . . . . . . . . . . 42.8 t -121.8 135.68 61.14 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.294 0 CA-C-N 115.86 -0.609 . . . . 0.0 109.821 -179.255 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' D' D ' 96' ' ' ILE . . . . . . . . . . . . . 67.8 mt -117.93 128.03 75.11 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.239 0 N-CA-C 109.561 -0.533 . . . . 0.0 109.561 179.043 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' D' D ' 97' ' ' THR . . . . . . . . . . . . . 65.8 p -100.12 159.53 15.03 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-O 121.102 0.477 . . . . 0.0 111.067 -178.16 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' D' D ' 98' ' ' GLU . . . . . . . . . . . . . 44.4 mt-10 -54.49 -26.32 30.71 Favored 'General case' 0 C--N 1.329 -0.319 0 N-CA-C 112.296 0.48 . . . . 0.0 112.296 -179.89 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' D' D ' 99' ' ' GLU . . . . . . . . . . . . . 95.4 mt-10 -76.08 10.77 1.74 Allowed 'General case' 0 CA--C 1.536 0.427 0 N-CA-C 113.326 0.862 . . . . 0.0 113.326 -177.557 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' D' D ' 100' ' ' ASN . . . . . . . . . . . . . 4.4 m-20 64.16 34.64 10.86 Favored 'General case' 0 N--CA 1.463 0.22 0 CA-C-O 120.971 0.415 . . . . 0.0 111.418 179.836 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' D' D ' 101' ' ' GLU . . . . . . . . . . . . . 84.7 tt0 -112.38 141.8 45.67 Favored 'General case' 0 C--N 1.334 -0.102 0 N-CA-C 109.778 -0.453 . . . . 0.0 109.778 173.72 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' D' D ' 102' ' ' VAL . . . . . . . . . . . . . 44.1 t -116.62 128.95 73.85 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.336 0 N-CA-C 109.988 -0.375 . . . . 0.0 109.988 -178.643 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' D' D ' 103' ' ' LEU . . . . . . . . . . . . . 52.9 mt -117.7 134.43 54.91 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 115.747 -0.661 . . . . 0.0 110.202 177.509 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' D' D ' 104' ' ' ILE . . . . . . . . . . . . . 67.9 mt -119.67 123.41 70.96 Favored 'Isoleucine or valine' 0 C--O 1.234 0.288 0 N-CA-C 110.35 -0.241 . . . . 0.0 110.35 -179.39 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' D' D ' 105' ' ' PHE . . . . . . . . . . . . . 63.9 m-85 -123.69 166.56 15.32 Favored 'General case' 0 C--N 1.333 -0.133 0 O-C-N 123.913 0.758 . . . . 0.0 109.666 179.577 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' D' D ' 106' ' ' ASN . . . . . . . . . . . . . 44.7 p-10 -101.45 -169.97 1.77 Allowed 'General case' 0 C--N 1.331 -0.235 0 N-CA-C 109.82 -0.437 . . . . 0.0 109.82 174.474 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' D' D ' 107' ' ' GLN . . . . . . . . . . . . . 62.2 tt0 -59.73 -30.14 68.63 Favored 'General case' 0 C--N 1.33 -0.273 0 N-CA-C 111.887 0.329 . . . . 0.0 111.887 179.82 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' D' D ' 108' ' ' ASN . . . . . . . . . . . . . 13.1 t-20 -82.05 7.02 14.41 Favored 'General case' 0 CA--C 1.537 0.46 0 N-CA-C 113.067 0.766 . . . . 0.0 113.067 -177.723 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' D' D ' 109' ' ' LEU . . . . . . . . . . . . . 8.0 tp 60.29 36.28 20.67 Favored 'General case' 0 C--N 1.332 -0.163 0 CA-C-O 120.878 0.371 . . . . 0.0 111.488 179.246 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' D' D ' 110' ' ' GLU . . . . . . . . . . . . . 43.1 mt-10 -104.83 150.77 24.54 Favored 'General case' 0 C--N 1.332 -0.176 0 N-CA-C 109.603 -0.517 . . . . 0.0 109.603 175.424 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' D' D ' 111' ' ' GLU . . . . . . . . . . . . . 67.8 tt0 -84.68 121.87 28.28 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-O 120.907 0.384 . . . . 0.0 110.722 -175.774 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' D' D ' 112' ' ' LEU . . . . . . . . . . . . . 11.4 mt -104.29 -46.07 4.51 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.016 -0.538 . . . . 0.0 110.489 179.36 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' D' D ' 113' ' ' TYR . . . . . . . . . . . . . 64.9 t80 -140.95 145.01 35.47 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.189 -0.46 . . . . 0.0 111.319 -178.236 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' D' D ' 114' ' ' ARG . . . . . . . . . . . . . 39.0 ptt85 -142.5 127.75 18.71 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 115.994 -0.548 . . . . 0.0 110.615 177.134 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' D' D ' 115' ' ' GLY . . . . . . . . . . . . . . . -150.06 151.79 23.8 Favored Glycine 0 CA--C 1.522 0.48 0 N-CA-C 110.724 -0.95 . . . . 0.0 110.724 178.788 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' D' D ' 116' ' ' LYS . . . . . . . . . . . . . 79.1 tttt -128.37 128.82 45.24 Favored 'General case' 0 C--N 1.328 -0.335 0 N-CA-C 109.842 -0.429 . . . . 0.0 109.842 178.531 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' D' D ' 117' ' ' PHE . . . . . . . . . . . . . 33.3 m-85 -125.86 117.97 24.48 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.283 -0.417 . . . . 0.0 110.154 -174.302 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' D' D ' 118' ' ' GLU . . . . . . . . . . . . . 96.0 mt-10 -55.02 -43.01 73.3 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.558 -0.292 . . . . 0.0 111.144 -176.615 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' D' D ' 119' ' ' ASN . . . . . . . . . . . . . 26.7 m120 -99.93 30.98 3.46 Favored 'General case' 0 C--N 1.331 -0.235 0 N-CA-C 112.176 0.435 . . . . 0.0 112.176 -174.273 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' D' D ' 120' ' ' LEU . . . . . . . . . . . . . 17.3 tp -56.11 119.87 6.6 Favored 'General case' 0 C--O 1.232 0.136 0 C-N-CA 120.925 -0.31 . . . . 0.0 110.613 178.539 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' D' D ' 121' ' ' ASN . . . . . . . . . . . . . 15.8 t-20 -114.16 -44.09 3.17 Favored 'General case' 0 C--N 1.332 -0.183 0 CA-C-N 116.592 -0.276 . . . . 0.0 111.416 -177.648 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' D' D ' 122' ' ' LYS . . . . . . . . . . . . . 96.5 mttt -145.23 150.38 36.59 Favored 'General case' 0 C--N 1.332 -0.153 0 C-N-CA 120.54 -0.464 . . . . 0.0 111.828 -176.671 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' D' D ' 123' ' ' VAL . . . . . . . . . . . . . 43.8 t -130.59 130.46 64.86 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.275 0 CA-C-N 115.951 -0.568 . . . . 0.0 109.753 176.318 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' D' D ' 124' ' ' LEU . . . . . . . . . . . . . 75.5 mt -131.1 135.61 47.65 Favored 'General case' 0 C--N 1.331 -0.208 0 CA-C-N 116.628 -0.26 . . . . 0.0 110.536 -179.643 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' D' D ' 125' ' ' VAL . . . . . . . . . . . . . 34.2 m -141.66 151.32 19.18 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.306 0 CA-C-O 121.007 0.432 . . . . 0.0 111.337 -179.09 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' D' D ' 126' ' ' ARG . . . . . . . . . . . . . 35.8 ptt-85 -154.15 129.75 9.97 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 115.873 -0.603 . . . . 0.0 110.549 175.965 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' D' D ' 127' ' ' ASN . . . . . . . . . . . . . 6.8 m120 51.91 -109.39 0.44 Allowed 'General case' 0 CA--C 1.546 0.809 0 CA-C-O 118.925 -0.559 . . . . 0.0 111.154 -179.927 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' D' D ' 128' ' ' ASP . . . . . . . . . . . . . 18.5 p-10 -114.13 2.92 15.04 Favored 'General case' 0 N--CA 1.468 0.438 0 CA-C-N 119.755 1.161 . . . . 0.0 113.443 -177.998 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' D' D ' 129' ' ' LEU . . . . . . . . . . . . . 48.7 mt -106.82 139.26 41.52 Favored 'General case' 0 C--N 1.333 -0.115 0 N-CA-C 109.558 -0.534 . . . . 0.0 109.558 179.12 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' D' D ' 130' ' ' VAL . . . . . . . . . . . . . 32.7 m -137.25 144.26 32.29 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.246 0 CA-C-O 121.167 0.508 . . . . 0.0 111.263 -178.322 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' D' D ' 131' ' ' VAL . . . . . . . . . . . . . 41.7 t -136.04 139.69 45.34 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.286 0 CA-C-N 115.878 -0.601 . . . . 0.0 110.243 178.199 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' D' D ' 132' ' ' ILE . . . . . . . . . . . . . 73.7 mt -117.14 133.31 64.28 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 CA-C-N 115.496 -0.774 . . . . 0.0 109.28 179.997 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' D' D ' 133' ' ' ILE . . . . . . . . . . . . . 40.8 mm -115.73 124.27 71.98 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.236 0 CA-C-O 120.72 0.295 . . . . 0.0 110.966 -175.034 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' D' D ' 134' ' ' ASP . . . . . . . . . . . . . 9.5 p-10 -136.46 146.4 46.29 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 115.972 -0.558 . . . . 0.0 109.719 175.548 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' D' D ' 135' ' ' GLU . . . . . . . . . . . . . 86.2 tt0 -50.27 -24.63 3.03 Favored 'General case' 0 C--N 1.327 -0.379 0 N-CA-C 112.85 0.685 . . . . 0.0 112.85 -175.014 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' D' D ' 136' ' ' GLN . . . . . . . . . . . . . 53.1 mt-30 -82.89 -32.48 27.32 Favored 'General case' 0 C--O 1.234 0.241 0 N-CA-C 112.384 0.512 . . . . 0.0 112.384 -177.15 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' D' D ' 137' ' ' LYS . . . . . . . . . . . . . 52.5 pttt -170.09 175.63 4.95 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-O 121.474 0.654 . . . . 0.0 112.295 -173.567 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' D' D ' 138' ' ' LEU . . . . . . . . . . . . . 7.5 tt -119.68 127.5 52.95 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 115.184 -0.916 . . . . 0.0 109.944 177.65 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' D' D ' 139' ' ' THR . . . . . . . . . . . . . 44.6 m -110.16 127.3 54.84 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 116.243 -0.435 . . . . 0.0 110.129 -179.896 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' D' D ' 140' ' ' LEU . . . . . . . . . . . . . 8.1 tt -117.07 126.23 52.53 Favored 'General case' 0 C--N 1.329 -0.311 0 N-CA-C 109.498 -0.556 . . . . 0.0 109.498 -178.708 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' D' D ' 141' ' ' ILE . . . . . . . . . . . . . 19.1 mt -123.37 121.4 62.67 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.281 0 N-CA-C 109.733 -0.469 . . . . 0.0 109.733 -175.627 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' D' D ' 142' ' ' ARG . . . . . . . . . . . . . 29.5 ttp180 -115.66 128.07 55.64 Favored 'General case' 0 C--N 1.331 -0.212 0 CA-C-N 115.696 -0.683 . . . . 0.0 110.331 -177.205 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' D' D ' 143' ' ' THR . . . . . . . . . . . . . 35.4 p . . . . . 0 C--O 1.22 -0.487 0 CA-C-O 117.976 -1.011 . . . . 0.0 110.53 -179.7 . . . . . . . . 0 0 . 1 . 005 nuclear orig full ' E' E ' -3' ' ' GLU . . . . . . . . . . . . . 83.5 tt0 . . . . . 0 N--CA 1.491 1.599 0 N-CA-C 109.387 -0.597 . . . . 0.0 109.387 . . . . . . . . . 0 0 . 1 . 005 nuclear orig full ' E' E ' -2' ' ' GLY . . . . . . . . . . . . . . . -105.18 146.25 16.04 Favored Glycine 0 CA--C 1.525 0.708 0 N-CA-C 111.038 -0.825 . . . . 0.0 111.038 -179.639 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' E' E ' -1' ' ' VAL . . . . . . . . . . . . . 41.0 t -141.12 139.23 33.56 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.35 0 CA-C-O 120.854 0.359 . . . . 0.0 110.118 179.475 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' E' E ' 0' ' ' ILE . . . . . . . . . . . . . 69.4 mt -111.03 135.62 49.62 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.262 0 CA-C-N 116.09 -0.505 . . . . 0.0 109.779 -179.947 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' E' E ' 1' ' ' MET . . . . . . . . . . . . . 25.4 ptp -78.81 134.97 36.95 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-O 120.892 0.377 . . . . 0.0 110.909 -178.969 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' E' E ' 2' ' ' SER . . . . . . . . . . . . . 5.3 p -123.09 132.22 54.01 Favored 'General case' 0 C--N 1.331 -0.2 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.129 176.721 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' E' E ' 3' ' ' GLU . . . . . . . . . . . . . 84.9 tt0 -144.41 141.35 29.58 Favored 'General case' 0 C--N 1.327 -0.409 0 CA-C-N 116.198 -0.456 . . . . 0.0 111.182 -178.63 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' E' E ' 4' ' ' LEU . . . . . . . . . . . . . 20.1 tp -122.73 132.07 54.07 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-N 116.04 -0.527 . . . . 0.0 110.102 176.235 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' E' E ' 5' ' ' LYS . . . . . . . . . . . . . 50.2 mtmt -108.27 119.02 38.28 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 116.353 -0.385 . . . . 0.0 110.69 -179.604 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' E' E ' 6' ' ' LEU . . . . . . . . . . . . . 54.8 mt -114.15 142.19 46.55 Favored 'General case' 0 C--N 1.331 -0.229 0 O-C-N 123.86 0.725 . . . . 0.0 111.169 -178.165 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' E' E ' 7' ' ' LYS . . . . . . . . . . . . . 65.5 tttt -132.97 138.48 31.94 Favored Pre-proline 0 CA--C 1.534 0.356 0 CA-C-O 118.922 -0.561 . . . . 0.0 109.672 176.152 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' E' E ' 8' ' ' PRO . . . . . . . . . . . . . 78.1 Cg_endo -90.99 146.55 3.68 Favored 'Trans proline' 0 N--CA 1.49 1.317 0 C-N-CA 121.691 1.594 . . . . 0.0 112.083 178.671 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' E' E ' 9' ' ' LEU . . . . . . . . . . . . . 54.8 mt -86.0 -48.55 0.55 Allowed Pre-proline 0 CA--C 1.535 0.392 0 CA-C-O 118.518 -0.753 . . . . 0.0 112.499 -179.845 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' E' E ' 10' ' ' PRO . . . . . . . . . . . . . 95.6 Cg_endo -78.41 157.13 29.14 Favored 'Trans proline' 0 N--CA 1.496 1.645 0 C-N-CA 121.22 1.28 . . . . 0.0 112.002 178.651 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' E' E ' 11' ' ' LYS . . . . . . . . . . . . . 92.5 mttt -85.18 92.2 8.34 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.311 -0.404 . . . . 0.0 110.539 179.383 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' E' E ' 12' ' ' VAL . . . . . . . . . . . . . 12.6 p -142.5 143.42 25.93 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.281 0 CA-C-N 116.372 -0.376 . . . . 0.0 110.61 179.819 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' E' E ' 13' ' ' GLU . . . . . . . . . . . . . 41.7 mt-10 -93.28 132.49 37.42 Favored 'General case' 0 C--N 1.329 -0.307 0 N-CA-C 109.926 -0.398 . . . . 0.0 109.926 177.349 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' E' E ' 14' ' ' LEU . . . . . . . . . . . . . 21.2 mt -98.5 149.76 36.05 Favored Pre-proline 0 CA--C 1.534 0.342 0 CA-C-O 119.318 -0.373 . . . . 0.0 110.737 -176.351 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' E' E ' 15' ' ' PRO . . . . . . . . . . . . . 23.5 Cg_exo -64.26 161.21 35.16 Favored 'Trans proline' 0 N--CA 1.498 1.791 0 C-N-CA 121.291 1.328 . . . . 0.0 111.971 175.841 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' E' E ' 16' ' ' PRO . . . . . . . . . . . . . 29.7 Cg_exo -59.9 -34.81 95.16 Favored 'Trans proline' 0 N--CA 1.498 1.774 0 C-N-CA 121.451 1.434 . . . . 0.0 112.938 -178.536 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' E' E ' 17' ' ' ASP . . . . . . . . . . . . . 16.5 p-10 -83.91 0.99 45.53 Favored 'General case' 0 CA--C 1.538 0.488 0 N-CA-C 113.375 0.88 . . . . 0.0 113.375 -177.738 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' E' E ' 18' ' ' PHE . . . . . . . . . . . . . 45.9 t80 -57.92 -42.27 84.46 Favored 'General case' 0 C--N 1.333 -0.124 0 O-C-N 121.938 -0.476 . . . . 0.0 110.228 -177.426 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' E' E ' 19' ' ' VAL . . . . . . . . . . . . . 46.7 t -56.19 -45.74 81.05 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.244 0 CA-C-N 116.44 -0.346 . . . . 0.0 110.62 -178.003 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' E' E ' 20' ' ' ASP . . . . . . . . . . . . . 81.3 m-20 -60.14 -40.18 88.92 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-O 120.833 0.349 . . . . 0.0 110.936 -178.217 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' E' E ' 21' ' ' VAL . . . . . . . . . . . . . 46.2 t -63.78 -47.02 92.8 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.265 0 C-N-CA 120.675 -0.41 . . . . 0.0 110.381 -178.262 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' E' E ' 22' ' ' ILE . . . . . . . . . . . . . 51.7 mm -55.28 -46.74 78.22 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.274 0 C-N-CA 121.131 -0.228 . . . . 0.0 110.771 179.304 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' E' E ' 23' ' ' ARG . . . . . . . . . . . . . 34.6 ttp180 -54.42 -49.36 70.14 Favored 'General case' 0 C--N 1.33 -0.267 0 C-N-CA 121.023 -0.271 . . . . 0.0 111.454 -178.841 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' E' E ' 24' ' ' ILE . . . . . . . . . . . . . 70.3 mt -59.88 -44.13 93.6 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.257 0 CA-C-N 116.549 -0.296 . . . . 0.0 111.223 -177.172 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' E' E ' 25' ' ' LYS . . . . . . . . . . . . . 50.9 mmtt -64.46 -41.85 96.28 Favored 'General case' 0 C--N 1.328 -0.336 0 N-CA-C 112.406 0.521 . . . . 0.0 112.406 -178.027 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' E' E ' 26' ' ' LEU . . . . . . . . . . . . . 28.8 mt -78.54 -41.59 31.76 Favored 'General case' 0 C--N 1.33 -0.269 0 N-CA-C 113.252 0.834 . . . . 0.0 113.252 -171.181 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' E' E ' 27' ' ' GLN . . . . . . . . . . . . . 10.2 pt20 -46.58 139.03 5.4 Favored 'General case' 0 N--CA 1.469 0.502 0 N-CA-C 112.787 0.662 . . . . 0.0 112.787 -175.056 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' E' E ' 28' ' ' GLY . . . . . . . . . . . . . . . 98.77 -27.04 21.61 Favored Glycine 0 CA--C 1.533 1.174 0 CA-C-N 115.528 -0.76 . . . . 0.0 112.226 -177.247 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' E' E ' 29' ' ' LYS . . . . . . . . . . . . . 46.0 mtmt -98.12 155.16 17.28 Favored 'General case' 0 C--N 1.331 -0.203 0 CA-C-N 117.168 0.484 . . . . 0.0 111.182 179.35 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' E' E ' 30' ' ' THR . . . . . . . . . . . . . 28.8 m -104.15 137.71 41.7 Favored 'General case' 0 C--N 1.331 -0.222 0 CA-C-N 115.908 -0.587 . . . . 0.0 110.149 175.957 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' E' E ' 31' ' ' VAL . . . . . . . . . . . . . 35.2 m -130.6 153.51 39.18 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 CA-C-N 116.361 -0.381 . . . . 0.0 110.94 -178.709 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' E' E ' 32' ' ' ARG . . . . . . . . . . . . . 87.8 mtm-85 -128.1 149.21 50.51 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.138 -0.483 . . . . 0.0 110.653 179.432 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' E' E ' 33' ' ' THR . . . . . . . . . . . . . 29.9 m -53.46 139.22 31.51 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.372 -0.376 . . . . 0.0 111.376 -178.524 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' E' E ' 34' ' ' GLY . . . . . . . . . . . . . . . 99.35 -17.14 58.24 Favored Glycine 0 CA--C 1.532 1.111 0 CA-C-O 119.707 -0.496 . . . . 0.0 113.312 179.217 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' E' E ' 35' ' ' ASP . . . . . . . . . . . . . 77.8 m-20 -66.3 148.62 51.58 Favored 'General case' 0 C--O 1.231 0.129 0 CA-C-N 118.02 0.91 . . . . 0.0 111.078 179.189 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' E' E ' 36' ' ' VAL . . . . . . . . . . . . . 43.9 t -119.91 129.68 75.13 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.2 0 CA-C-N 115.78 -0.645 . . . . 0.0 109.822 178.267 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' E' E ' 37' ' ' ILE . . . . . . . . . . . . . 67.5 mt -116.88 137.51 50.53 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.272 0 N-CA-C 109.739 -0.467 . . . . 0.0 109.739 179.437 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' E' E ' 38' ' ' GLY . . . . . . . . . . . . . . . -114.72 128.67 8.26 Favored Glycine 0 CA--C 1.525 0.672 0 N-CA-C 111.143 -0.783 . . . . 0.0 111.143 -179.164 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' E' E ' 39' ' ' ILE . . . . . . . . . . . . . 77.2 mt -122.41 134.4 65.73 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.249 0 N-CA-C 109.974 -0.38 . . . . 0.0 109.974 178.787 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' E' E ' 40' ' ' SER . . . . . . . . . . . . . 59.8 p -92.74 119.04 31.72 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.441 -0.345 . . . . 0.0 110.829 175.7 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' E' E ' 41' ' ' ILE . . . . . . . . . . . . . 72.3 mt -126.37 122.23 60.76 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.215 0 CA-C-N 116.553 -0.294 . . . . 0.0 110.32 178.652 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' E' E ' 42' ' ' LEU . . . . . . . . . . . . . 44.4 mt 52.11 34.25 13.8 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.251 -0.431 . . . . 0.0 111.853 177.675 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' E' E ' 43' ' ' GLY . . . . . . . . . . . . . . . 72.23 33.2 62.05 Favored Glycine 0 CA--C 1.529 0.935 0 C-N-CA 121.053 -0.594 . . . . 0.0 111.796 179.002 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' E' E ' 44' ' ' LYS . . . . . . . . . . . . . 44.2 tttp -138.35 128.76 26.13 Favored 'General case' 0 C--N 1.328 -0.33 0 N-CA-C 109.696 -0.483 . . . . 0.0 109.696 179.711 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' E' E ' 45' ' ' GLU . . . . . . . . . . . . . 83.7 tt0 -83.03 121.78 27.46 Favored 'General case' 0 C--N 1.328 -0.347 0 C-N-CA 120.786 -0.366 . . . . 0.0 111.127 -177.639 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' E' E ' 46' ' ' VAL . . . . . . . . . . . . . 7.5 p -119.94 125.88 74.73 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.194 0 N-CA-C 109.298 -0.63 . . . . 0.0 109.298 175.087 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' E' E ' 47' ' ' LYS . . . . . . . . . . . . . 96.5 mttt -100.87 129.78 46.78 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 115.964 -0.562 . . . . 0.0 111.437 179.442 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' E' E ' 48' ' ' PHE . . . . . . . . . . . . . 91.7 m-85 -112.73 131.81 55.5 Favored 'General case' 0 C--N 1.33 -0.253 0 N-CA-C 109.612 -0.514 . . . . 0.0 109.612 174.507 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' E' E ' 49' ' ' LYS . . . . . . . . . . . . . 68.5 tttt -107.87 137.42 45.91 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.643 -0.253 . . . . 0.0 110.715 179.817 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' E' E ' 50' ' ' VAL . . . . . . . . . . . . . 46.7 t -81.04 106.57 12.37 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.281 0 N-CA-C 109.175 -0.676 . . . . 0.0 109.175 175.148 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' E' E ' 51' ' ' VAL . . . . . . . . . . . . . 48.0 t -69.68 -53.99 21.64 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.324 0 N-CA-C 109.479 -0.563 . . . . 0.0 109.479 -176.302 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' E' E ' 52' ' ' GLN . . . . . . . . . . . . . 93.7 mt-30 -152.53 154.55 35.67 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.097 -0.501 . . . . 0.0 111.714 -179.226 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' E' E ' 53' ' ' ALA . . . . . . . . . . . . . . . -130.49 132.33 45.59 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 115.168 -0.924 . . . . 0.0 109.764 176.056 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' E' E ' 54' ' ' TYR . . . . . . . . . . . . . 57.9 t80 -129.1 108.82 18.04 Favored Pre-proline 0 CA--C 1.534 0.351 0 CA-C-O 118.312 -0.851 . . . . 0.0 110.368 -179.767 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' E' E ' 55' ' ' PRO . . . . . . . . . . . . . 73.8 Cg_endo -77.21 170.03 72.57 Favored 'Cis proline' 0 N--CA 1.499 1.813 0 CA-C-N 121.808 1.682 . . . . 0.0 112.583 -5.154 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' E' E ' 56' ' ' SER . . . . . . . . . . . . . 13.8 m -116.12 128.97 25.57 Favored Pre-proline 0 CA--C 1.539 0.53 0 CA-C-O 118.356 -0.83 . . . . 0.0 109.139 174.425 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' E' E ' 57' ' ' PRO . . . . . . . . . . . . . 54.3 Cg_endo -70.7 149.63 91.18 Favored 'Cis proline' 0 N--CA 1.497 1.684 0 CA-C-N 121.993 1.747 . . . . 0.0 111.733 0.454 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' E' E ' 58' ' ' LEU . . . . . . . . . . . . . 25.3 tp -108.39 136.53 47.86 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.572 -179.426 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' E' E ' 59' ' ' ARG . . . . . . . . . . . . . 72.8 ttt180 -104.55 125.96 51.19 Favored 'General case' 0 C--N 1.326 -0.438 0 N-CA-C 109.14 -0.689 . . . . 0.0 109.14 176.0 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' E' E ' 60' ' ' VAL . . . . . . . . . . . . . 45.8 t -80.44 118.07 27.48 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.213 0 C-N-CA 120.521 -0.471 . . . . 0.0 110.48 -174.765 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' E' E ' 61' ' ' GLU . . . . . . . . . . . . . 95.0 mt-10 -131.02 162.81 28.97 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 115.786 -0.643 . . . . 0.0 109.563 176.326 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' E' E ' 62' ' ' ASP . . . . . . . . . . . . . 21.1 p-10 -56.27 -33.12 65.17 Favored 'General case' 0 C--N 1.328 -0.328 0 N-CA-C 111.854 0.316 . . . . 0.0 111.854 -177.15 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' E' E ' 63' ' ' ARG . . . . . . . . . . . . . 27.1 mmm180 -73.31 -17.36 61.32 Favored 'General case' 0 CA--C 1.533 0.317 0 N-CA-C 113.178 0.807 . . . . 0.0 113.178 -177.08 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' E' E ' 64' ' ' THR . . . . . . . . . . . . . 25.7 m -70.07 139.25 52.56 Favored 'General case' 0 C--N 1.332 -0.156 0 CA-C-O 120.865 0.364 . . . . 0.0 110.987 -175.235 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' E' E ' 65' ' ' LYS . . . . . . . . . . . . . 64.4 mttm -86.06 133.94 33.86 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.041 -0.527 . . . . 0.0 109.922 178.167 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' E' E ' 66' ' ' ILE . . . . . . . . . . . . . 64.3 mt -114.31 125.59 71.65 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.29 0 N-CA-C 109.57 -0.53 . . . . 0.0 109.57 178.839 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' E' E ' 67' ' ' THR . . . . . . . . . . . . . 29.5 m -118.12 137.53 52.89 Favored 'General case' 0 C--N 1.331 -0.213 0 CA-C-N 116.06 -0.518 . . . . 0.0 110.555 -178.013 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' E' E ' 68' ' ' LEU . . . . . . . . . . . . . 19.6 tp -107.29 143.47 35.51 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 115.79 -0.641 . . . . 0.0 110.466 -179.222 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' E' E ' 69' ' ' VAL . . . . . . . . . . . . . 48.3 t -82.77 155.15 3.88 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.359 0 N-CA-C 109.027 -0.731 . . . . 0.0 109.027 175.322 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' E' E ' 70' ' ' THR . . . . . . . . . . . . . 73.8 p -76.05 153.47 36.39 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-O 121.347 0.594 . . . . 0.0 110.909 -169.892 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' E' E ' 71' ' ' HIS . . . . . . . . . . . . . 46.9 m-70 -96.49 172.24 5.33 Favored Pre-proline 0 C--N 1.329 -0.283 0 CA-C-N 115.09 -0.959 . . . . 0.0 111.159 -174.084 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' E' E ' 72' ' ' PRO . . . . . . . . . . . . . 22.7 Cg_exo -64.85 160.16 42.31 Favored 'Trans proline' 0 N--CA 1.493 1.498 0 C-N-CA 121.543 1.495 . . . . 0.0 111.226 174.399 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' E' E ' 73' ' ' VAL . . . . . . . . . . . . . 34.2 m -69.88 -179.74 0.31 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.331 0 CA-C-N 116.316 -0.402 . . . . 0.0 110.597 -174.565 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' E' E ' 74' ' ' ASP . . . . . . . . . . . . . 33.7 t0 -86.46 117.59 25.35 Favored 'General case' 0 C--N 1.33 -0.259 0 C-N-CA 120.933 -0.307 . . . . 0.0 110.187 -173.862 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' E' E ' 75' ' ' VAL . . . . . . . . . . . . . 46.4 t -117.28 120.78 65.99 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.235 0 CA-C-O 121.126 0.489 . . . . 0.0 110.191 -178.439 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' E' E ' 76' ' ' LEU . . . . . . . . . . . . . 15.7 mt -123.32 142.22 51.17 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 115.559 -0.746 . . . . 0.0 109.502 178.688 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' E' E ' 77' ' ' GLU . . . . . . . . . . . . . 97.1 mt-10 -135.4 129.58 33.53 Favored 'General case' 0 C--N 1.331 -0.227 0 CA-C-O 121.064 0.459 . . . . 0.0 111.058 -177.221 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' E' E ' 78' ' ' ALA . . . . . . . . . . . . . . . -116.25 126.54 53.73 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 115.649 -0.705 . . . . 0.0 109.586 177.24 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' E' E ' 79' ' ' LYS . . . . . . . . . . . . . 48.0 pttt -76.72 119.18 20.16 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-O 121.284 0.564 . . . . 0.0 110.962 -177.386 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' E' E ' 80' ' ' ILE . . . . . . . . . . . . . 26.8 mm -139.25 106.11 2.71 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.244 0 CA-C-N 115.563 -0.744 . . . . 0.0 109.09 -178.932 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' E' E ' 81' ' ' LYS . . . . . . . . . . . . . 53.1 mtmt -99.5 129.19 45.65 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-O 120.925 0.393 . . . . 0.0 110.865 -178.678 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' E' E ' 82' ' ' GLY . . . . . . . . . . . . . . . 89.16 42.18 5.65 Favored Glycine 0 CA--C 1.525 0.666 0 C-N-CA 120.915 -0.66 . . . . 0.0 111.701 175.423 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' E' E ' 83' ' ' ILE . . . . . . . . . . . . . 75.2 mt -67.95 138.16 23.16 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.302 0 N-CA-C 109.771 -0.455 . . . . 0.0 109.771 176.48 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' E' E ' 84' ' ' LYS . . . . . . . . . . . . . 58.6 tttp -95.06 -52.76 4.08 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.122 -0.49 . . . . 0.0 109.956 -179.702 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' E' E ' 85' ' ' ASP . . . . . . . . . . . . . 6.5 t70 -155.72 153.58 30.15 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 115.792 -0.64 . . . . 0.0 110.371 -179.458 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' E' E ' 86' ' ' VAL . . . . . . . . . . . . . 43.0 t -130.29 132.67 64.86 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.258 0 CA-C-O 120.991 0.424 . . . . 0.0 110.498 -179.628 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' E' E ' 87' ' ' ILE . . . . . . . . . . . . . 45.2 mm -116.95 125.72 74.0 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.252 0 CA-C-N 115.722 -0.672 . . . . 0.0 109.55 176.745 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' E' E ' 88' ' ' LEU . . . . . . . . . . . . . 16.8 tp -110.11 129.87 55.63 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-O 120.852 0.358 . . . . 0.0 110.946 -177.436 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' E' E ' 89' ' ' ASP . . . . . . . . . . . . . 13.9 t70 -125.47 155.7 40.08 Favored 'General case' 0 C--N 1.331 -0.221 0 CA-C-N 116.085 -0.507 . . . . 0.0 109.936 177.637 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' E' E ' 90' ' ' GLU . . . . . . . . . . . . . 45.3 tp10 -45.84 -38.84 7.75 Favored 'General case' 0 C--N 1.33 -0.282 0 N-CA-C 113.132 0.79 . . . . 0.0 113.132 -172.167 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' E' E ' 91' ' ' ASN . . . . . . . . . . . . . 20.9 t30 -132.04 22.37 4.52 Favored 'General case' 0 N--CA 1.468 0.462 0 N-CA-C 112.87 0.692 . . . . 0.0 112.87 -177.147 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' E' E ' 92' ' ' LEU . . . . . . . . . . . . . 10.2 mt -149.48 147.14 27.87 Favored 'General case' 0 C--N 1.332 -0.167 0 N-CA-C 110.191 -0.3 . . . . 0.0 110.191 -177.025 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' E' E ' 93' ' ' ILE . . . . . . . . . . . . . 67.6 mt -124.34 119.57 56.88 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.203 0 N-CA-C 109.199 -0.667 . . . . 0.0 109.199 176.213 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' E' E ' 94' ' ' VAL . . . . . . . . . . . . . 45.7 t -118.84 127.44 75.74 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.252 0 N-CA-C 109.849 -0.426 . . . . 0.0 109.849 -179.482 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' E' E ' 95' ' ' VAL . . . . . . . . . . . . . 44.0 t -123.99 135.8 62.38 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.324 0 CA-C-N 116.135 -0.484 . . . . 0.0 110.177 -178.404 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' E' E ' 96' ' ' ILE . . . . . . . . . . . . . 57.7 mt -117.19 129.19 74.12 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.287 0 N-CA-C 109.269 -0.641 . . . . 0.0 109.269 178.117 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' E' E ' 97' ' ' THR . . . . . . . . . . . . . 78.5 p -103.63 158.16 16.56 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-O 121.185 0.517 . . . . 0.0 111.282 -177.431 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' E' E ' 98' ' ' GLU . . . . . . . . . . . . . 70.6 mm-40 -54.23 -25.62 24.12 Favored 'General case' 0 C--N 1.33 -0.247 0 N-CA-C 112.408 0.521 . . . . 0.0 112.408 -179.754 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' E' E ' 99' ' ' GLU . . . . . . . . . . . . . 47.2 mp0 -78.19 14.33 1.21 Allowed 'General case' 0 CA--C 1.535 0.402 0 N-CA-C 113.136 0.791 . . . . 0.0 113.136 -178.032 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' E' E ' 100' ' ' ASN . . . . . . . . . . . . . 3.6 m-20 62.21 37.33 14.32 Favored 'General case' 0 CA--C 1.53 0.201 0 CA-C-O 120.994 0.426 . . . . 0.0 110.997 178.741 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' E' E ' 101' ' ' GLU . . . . . . . . . . . . . 84.7 tt0 -113.99 144.14 43.58 Favored 'General case' 0 C--N 1.331 -0.198 0 CA-C-N 116.02 -0.536 . . . . 0.0 109.735 176.244 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' E' E ' 102' ' ' VAL . . . . . . . . . . . . . 44.3 t -114.98 126.0 72.45 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.299 0 CA-C-N 116.225 -0.443 . . . . 0.0 109.914 -178.803 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' E' E ' 103' ' ' LEU . . . . . . . . . . . . . 21.5 mt -118.29 132.08 56.31 Favored 'General case' 0 C--N 1.331 -0.217 0 CA-C-N 115.662 -0.699 . . . . 0.0 110.31 178.778 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' E' E ' 104' ' ' ILE . . . . . . . . . . . . . 69.7 mt -120.14 123.57 70.96 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.266 0 N-CA-C 110.063 -0.347 . . . . 0.0 110.063 178.601 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' E' E ' 105' ' ' PHE . . . . . . . . . . . . . 70.8 m-85 -124.88 162.43 24.41 Favored 'General case' 0 C--N 1.333 -0.15 0 O-C-N 123.848 0.718 . . . . 0.0 109.89 179.336 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' E' E ' 106' ' ' ASN . . . . . . . . . . . . . 46.0 p-10 -97.22 -170.46 2.03 Favored 'General case' 0 C--N 1.33 -0.266 0 N-CA-C 109.981 -0.377 . . . . 0.0 109.981 174.143 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' E' E ' 107' ' ' GLN . . . . . . . . . . . . . 55.6 tp60 -59.71 -30.07 68.55 Favored 'General case' 0 CA--C 1.531 0.214 0 N-CA-C 111.911 0.337 . . . . 0.0 111.911 179.911 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' E' E ' 108' ' ' ASN . . . . . . . . . . . . . 52.0 t30 -81.92 8.21 11.01 Favored 'General case' 0 CA--C 1.535 0.384 0 N-CA-C 113.109 0.781 . . . . 0.0 113.109 -177.601 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' E' E ' 109' ' ' LEU . . . . . . . . . . . . . 12.7 tp 58.39 38.79 25.75 Favored 'General case' 0 C--N 1.332 -0.183 0 CA-C-O 121.105 0.479 . . . . 0.0 110.901 179.339 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' E' E ' 110' ' ' GLU . . . . . . . . . . . . . 70.8 mm-40 -105.23 149.14 26.22 Favored 'General case' 0 C--N 1.332 -0.192 0 N-CA-C 109.925 -0.398 . . . . 0.0 109.925 176.798 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' E' E ' 111' ' ' GLU . . . . . . . . . . . . . 84.5 tt0 -78.39 121.83 25.01 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 116.419 -0.355 . . . . 0.0 110.616 -177.402 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' E' E ' 112' ' ' LEU . . . . . . . . . . . . . 18.4 mt -110.17 -46.11 3.49 Favored 'General case' 0 C--N 1.331 -0.21 0 CA-C-N 116.283 -0.417 . . . . 0.0 110.697 179.174 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' E' E ' 113' ' ' TYR . . . . . . . . . . . . . 64.3 t80 -138.89 136.27 35.35 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.262 -0.426 . . . . 0.0 111.045 -179.147 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' E' E ' 114' ' ' ARG . . . . . . . . . . . . . 70.1 ttp85 -138.53 120.37 15.37 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-N 116.025 -0.534 . . . . 0.0 110.277 176.695 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' E' E ' 115' ' ' GLY . . . . . . . . . . . . . . . -150.14 145.65 13.95 Favored Glycine 0 CA--C 1.524 0.641 0 N-CA-C 110.842 -0.903 . . . . 0.0 110.842 178.118 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' E' E ' 116' ' ' LYS . . . . . . . . . . . . . 28.4 ttmt -115.26 136.59 52.95 Favored 'General case' 0 C--N 1.331 -0.23 0 O-C-N 122.565 -0.374 . . . . 0.0 110.171 177.94 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' E' E ' 117' ' ' PHE . . . . . . . . . . . . . 58.5 m-85 -131.46 117.37 18.74 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 116.15 -0.477 . . . . 0.0 110.129 -177.018 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' E' E ' 118' ' ' GLU . . . . . . . . . . . . . 96.2 mt-10 -54.43 -41.64 69.6 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.507 -0.315 . . . . 0.0 111.486 -175.31 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' E' E ' 119' ' ' ASN . . . . . . . . . . . . . 19.0 m120 -104.05 31.1 4.73 Favored 'General case' 0 C--N 1.33 -0.249 0 N-CA-C 112.129 0.418 . . . . 0.0 112.129 -173.885 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' E' E ' 120' ' ' LEU . . . . . . . . . . . . . 21.3 tp -56.65 123.29 14.36 Favored 'General case' 0 C--N 1.332 -0.16 0 C-N-CA 121.118 -0.233 . . . . 0.0 110.412 178.555 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' E' E ' 121' ' ' ASN . . . . . . . . . . . . . 27.2 m120 -114.13 -44.28 3.15 Favored 'General case' 0 N--CA 1.462 0.165 0 CA-C-N 116.759 -0.201 . . . . 0.0 111.353 -176.829 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' E' E ' 122' ' ' LYS . . . . . . . . . . . . . 94.4 mttt -147.73 151.52 36.23 Favored 'General case' 0 C--N 1.332 -0.191 0 CA-C-O 121.03 0.443 . . . . 0.0 111.715 -176.963 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' E' E ' 123' ' ' VAL . . . . . . . . . . . . . 42.7 t -132.91 133.13 59.14 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.181 0 N-CA-C 109.633 -0.506 . . . . 0.0 109.633 175.249 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' E' E ' 124' ' ' LEU . . . . . . . . . . . . . 69.9 mt -130.09 137.72 50.33 Favored 'General case' 0 C--N 1.331 -0.197 0 CA-C-N 116.452 -0.34 . . . . 0.0 110.842 -178.772 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' E' E ' 125' ' ' VAL . . . . . . . . . . . . . 11.8 p -136.95 137.17 47.24 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.262 0 CA-C-N 116.385 -0.37 . . . . 0.0 110.651 179.669 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' E' E ' 126' ' ' ARG . . . . . . . . . . . . . 83.3 mtt180 -146.06 130.28 17.54 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.679 177.226 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' E' E ' 127' ' ' ASN . . . . . . . . . . . . . 36.3 t30 50.64 -112.22 0.59 Allowed 'General case' 0 CA--C 1.545 0.761 0 CA-C-O 118.64 -0.695 . . . . 0.0 111.46 178.751 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' E' E ' 128' ' ' ASP . . . . . . . . . . . . . 17.3 p-10 -112.59 8.16 19.07 Favored 'General case' 0 N--CA 1.468 0.435 0 CA-C-N 120.157 1.344 . . . . 0.0 113.317 -177.317 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' E' E ' 129' ' ' LEU . . . . . . . . . . . . . 15.5 tp -116.38 137.49 52.11 Favored 'General case' 0 C--N 1.333 -0.139 0 N-CA-C 109.745 -0.465 . . . . 0.0 109.745 178.89 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' E' E ' 130' ' ' VAL . . . . . . . . . . . . . 12.7 p -132.62 143.39 39.86 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.198 0 CA-C-O 121.143 0.497 . . . . 0.0 110.563 -179.556 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' E' E ' 131' ' ' VAL . . . . . . . . . . . . . 39.3 t -135.53 140.72 44.08 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.246 0 CA-C-N 115.969 -0.559 . . . . 0.0 110.383 -178.941 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' E' E ' 132' ' ' ILE . . . . . . . . . . . . . 70.3 mt -115.93 132.86 64.17 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.316 0 CA-C-N 115.752 -0.658 . . . . 0.0 109.355 179.292 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' E' E ' 133' ' ' ILE . . . . . . . . . . . . . 41.9 mm -116.24 124.15 72.18 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.238 0 CA-C-O 120.896 0.379 . . . . 0.0 111.064 -175.061 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' E' E ' 134' ' ' ASP . . . . . . . . . . . . . 7.8 p-10 -135.35 149.76 49.79 Favored 'General case' 0 C--N 1.331 -0.205 0 CA-C-N 116.075 -0.511 . . . . 0.0 109.677 174.574 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' E' E ' 135' ' ' GLU . . . . . . . . . . . . . 40.2 tp10 -50.76 -28.38 9.09 Favored 'General case' 0 C--N 1.327 -0.377 0 N-CA-C 112.709 0.633 . . . . 0.0 112.709 -173.088 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' E' E ' 136' ' ' GLN . . . . . . . . . . . . . 98.3 mt-30 -84.55 -29.82 25.58 Favored 'General case' 0 C--O 1.233 0.229 0 N-CA-C 112.882 0.697 . . . . 0.0 112.882 -175.432 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' E' E ' 137' ' ' LYS . . . . . . . . . . . . . 58.9 pttt -168.86 175.35 5.98 Favored 'General case' 0 C--N 1.332 -0.171 0 CA-C-O 121.609 0.719 . . . . 0.0 112.449 -172.879 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' E' E ' 138' ' ' LEU . . . . . . . . . . . . . 8.6 tt -121.62 129.42 52.81 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 114.997 -1.001 . . . . 0.0 109.958 178.475 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' E' E ' 139' ' ' THR . . . . . . . . . . . . . 43.7 m -109.1 128.22 54.82 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.188 179.316 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' E' E ' 140' ' ' LEU . . . . . . . . . . . . . 7.2 tt -112.81 125.25 54.14 Favored 'General case' 0 C--N 1.328 -0.35 0 N-CA-C 109.174 -0.676 . . . . 0.0 109.174 -178.828 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' E' E ' 141' ' ' ILE . . . . . . . . . . . . . 19.4 mt -123.57 119.29 56.86 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.277 0 CA-C-O 121.132 0.492 . . . . 0.0 110.09 -176.469 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' E' E ' 142' ' ' ARG . . . . . . . . . . . . . 77.6 ttt-85 -106.39 130.0 54.28 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 115.001 -1.0 . . . . 0.0 110.226 -179.882 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' E' E ' 143' ' ' THR . . . . . . . . . . . . . 44.6 p . . . . . 0 C--O 1.219 -0.514 0 CA-C-O 117.959 -1.02 . . . . 0.0 110.547 179.112 . . . . . . . . 0 0 . 1 . 005 nuclear orig full ' F' F ' -3' ' ' GLU . . . . . . . . . . . . . 45.8 tp10 . . . . . 0 N--CA 1.489 1.505 0 N-CA-C 109.332 -0.618 . . . . 0.0 109.332 . . . . . . . . . 0 0 . 1 . 005 nuclear orig full ' F' F ' -2' ' ' GLY . . . . . . . . . . . . . . . -67.57 140.2 36.52 Favored Glycine 0 CA--C 1.524 0.63 0 N-CA-C 111.223 -0.751 . . . . 0.0 111.223 -178.651 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' F' F ' -1' ' ' VAL . . . . . . . . . . . . . 44.7 t -141.57 140.34 31.16 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.292 0 N-CA-C 110.079 -0.341 . . . . 0.0 110.079 179.603 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' F' F ' 0' ' ' ILE . . . . . . . . . . . . . 43.7 mm -110.64 136.11 47.68 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.295 0 CA-C-N 116.236 -0.438 . . . . 0.0 110.186 -179.742 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' F' F ' 1' ' ' MET . . . . . . . . . . . . . 26.2 ptt? -82.39 137.12 34.82 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.276 -0.42 . . . . 0.0 110.957 -179.212 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' F' F ' 2' ' ' SER . . . . . . . . . . . . . 14.3 p -130.8 135.33 47.65 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.083 -0.508 . . . . 0.0 110.082 178.419 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' F' F ' 3' ' ' GLU . . . . . . . . . . . . . 46.8 mp0 -139.45 141.15 37.45 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.146 -0.479 . . . . 0.0 111.321 -176.615 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' F' F ' 4' ' ' LEU . . . . . . . . . . . . . 57.6 mt -118.94 124.97 48.35 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 115.606 -0.725 . . . . 0.0 109.85 173.96 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' F' F ' 5' ' ' LYS . . . . . . . . . . . . . 98.3 mttt -102.36 119.81 39.44 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.459 -0.337 . . . . 0.0 110.144 177.646 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' F' F ' 6' ' ' LEU . . . . . . . . . . . . . 70.5 mt -119.45 144.32 47.03 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 115.416 -0.811 . . . . 0.0 110.421 -177.9 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' F' F ' 7' ' ' LYS . . . . . . . . . . . . . 47.4 tttm -134.64 142.78 43.86 Favored Pre-proline 0 CA--C 1.534 0.354 0 CA-C-O 119.2 -0.428 . . . . 0.0 110.142 177.331 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' F' F ' 8' ' ' PRO . . . . . . . . . . . . . 85.0 Cg_endo -92.16 143.35 2.63 Favored 'Trans proline' 0 N--CA 1.49 1.319 0 C-N-CA 121.749 1.633 . . . . 0.0 111.714 176.997 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' F' F ' 9' ' ' LEU . . . . . . . . . . . . . 62.0 mt -76.74 -47.02 3.04 Favored Pre-proline 0 CA--C 1.535 0.367 0 CA-C-O 118.691 -0.671 . . . . 0.0 112.041 179.735 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' F' F ' 10' ' ' PRO . . . . . . . . . . . . . 85.4 Cg_endo -81.71 150.2 16.5 Favored 'Trans proline' 0 N--CA 1.495 1.59 0 C-N-CA 121.185 1.257 . . . . 0.0 111.54 174.604 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' F' F ' 11' ' ' LYS . . . . . . . . . . . . . 54.0 pttt -86.95 113.12 22.45 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-O 121.552 0.692 . . . . 0.0 110.949 179.981 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' F' F ' 12' ' ' VAL . . . . . . . . . . . . . 13.3 p -151.09 148.34 14.99 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.194 0 CA-C-N 115.736 -0.666 . . . . 0.0 110.458 178.901 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' F' F ' 13' ' ' GLU . . . . . . . . . . . . . 45.3 mt-10 -88.0 124.19 33.48 Favored 'General case' 0 C--N 1.331 -0.224 0 CA-C-O 120.759 0.314 . . . . 0.0 110.595 177.836 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' F' F ' 14' ' ' LEU . . . . . . . . . . . . . 22.8 mt -99.77 154.61 37.16 Favored Pre-proline 0 CA--C 1.532 0.285 0 CA-C-N 116.276 -0.42 . . . . 0.0 111.012 -178.282 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' F' F ' 15' ' ' PRO . . . . . . . . . . . . . 27.7 Cg_exo -62.05 162.99 20.83 Favored 'Trans proline' 0 N--CA 1.498 1.736 0 C-N-CA 121.423 1.415 . . . . 0.0 111.963 176.07 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' F' F ' 16' ' ' PRO . . . . . . . . . . . . . 21.5 Cg_exo -64.61 -37.07 39.07 Favored 'Trans proline' 0 N--CA 1.497 1.705 0 C-N-CA 121.592 1.528 . . . . 0.0 112.724 -179.512 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' F' F ' 17' ' ' ASP . . . . . . . . . . . . . 12.7 p-10 -87.09 12.11 12.25 Favored 'General case' 0 CA--C 1.535 0.391 0 N-CA-C 113.142 0.793 . . . . 0.0 113.142 -177.149 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' F' F ' 18' ' ' PHE . . . . . . . . . . . . . 41.1 t80 -56.44 -41.85 77.15 Favored 'General case' 0 CA--C 1.526 0.047 0 O-C-N 121.939 -0.476 . . . . 0.0 110.375 -179.56 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' F' F ' 19' ' ' VAL . . . . . . . . . . . . . 44.3 t -55.98 -43.51 75.28 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.285 0 CA-C-N 116.399 -0.364 . . . . 0.0 110.579 -178.627 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' F' F ' 20' ' ' ASP . . . . . . . . . . . . . 29.8 t0 -59.88 -43.09 94.95 Favored 'General case' 0 C--N 1.33 -0.274 0 C-N-CA 120.915 -0.314 . . . . 0.0 110.784 -177.811 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' F' F ' 21' ' ' VAL . . . . . . . . . . . . . 45.4 t -63.33 -46.44 95.51 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.277 0 C-N-CA 120.63 -0.428 . . . . 0.0 110.437 -177.748 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' F' F ' 22' ' ' ILE . . . . . . . . . . . . . 51.4 mm -55.98 -47.11 80.54 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.275 0 C-N-CA 120.905 -0.318 . . . . 0.0 110.808 179.793 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' F' F ' 23' ' ' ARG . . . . . . . . . . . . . 55.4 ttp180 -55.02 -47.19 75.03 Favored 'General case' 0 C--N 1.331 -0.239 0 C-N-CA 120.932 -0.307 . . . . 0.0 111.303 -178.194 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' F' F ' 24' ' ' ILE . . . . . . . . . . . . . 75.5 mt -59.17 -42.58 87.23 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.268 0 C-N-CA 120.939 -0.304 . . . . 0.0 111.212 -177.672 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' F' F ' 25' ' ' LYS . . . . . . . . . . . . . 50.3 mttm -67.74 -39.57 84.23 Favored 'General case' 0 C--N 1.33 -0.266 0 N-CA-C 112.67 0.619 . . . . 0.0 112.67 -179.51 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' F' F ' 26' ' ' LEU . . . . . . . . . . . . . 95.8 mt -77.37 -39.85 45.96 Favored 'General case' 0 C--N 1.329 -0.307 0 N-CA-C 113.17 0.804 . . . . 0.0 113.17 -170.486 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' F' F ' 27' ' ' GLN . . . . . . . . . . . . . 10.4 pt20 -46.7 139.99 4.86 Favored 'General case' 0 N--CA 1.469 0.476 0 N-CA-C 112.785 0.661 . . . . 0.0 112.785 -174.501 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' F' F ' 28' ' ' GLY . . . . . . . . . . . . . . . 100.56 -29.29 12.67 Favored Glycine 0 CA--C 1.531 1.045 0 CA-C-N 115.592 -0.731 . . . . 0.0 112.016 -177.642 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' F' F ' 29' ' ' LYS . . . . . . . . . . . . . 72.8 mttt -97.92 155.08 17.25 Favored 'General case' 0 C--O 1.233 0.199 0 CA-C-N 117.203 0.501 . . . . 0.0 111.163 178.236 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' F' F ' 30' ' ' THR . . . . . . . . . . . . . 29.6 m -100.67 139.16 36.74 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 115.899 -0.591 . . . . 0.0 109.822 175.272 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' F' F ' 31' ' ' VAL . . . . . . . . . . . . . 35.0 m -122.08 149.55 25.45 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.259 0 CA-C-O 120.926 0.393 . . . . 0.0 110.823 -178.105 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' F' F ' 32' ' ' ARG . . . . . . . . . . . . . 39.1 ttp180 -132.95 147.86 52.28 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-N 115.669 -0.696 . . . . 0.0 110.314 177.582 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' F' F ' 33' ' ' THR . . . . . . . . . . . . . 27.4 m -53.61 137.34 37.16 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.418 -0.355 . . . . 0.0 111.281 -179.348 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' F' F ' 34' ' ' GLY . . . . . . . . . . . . . . . 101.76 -17.22 55.2 Favored Glycine 0 CA--C 1.532 1.108 0 CA-C-O 119.7 -0.5 . . . . 0.0 113.348 178.813 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' F' F ' 35' ' ' ASP . . . . . . . . . . . . . 78.8 m-20 -65.79 147.73 52.91 Favored 'General case' 0 N--CA 1.462 0.147 0 CA-C-N 118.015 0.907 . . . . 0.0 111.058 179.472 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' F' F ' 36' ' ' VAL . . . . . . . . . . . . . 44.3 t -122.97 129.62 74.99 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.267 0 CA-C-N 116.115 -0.493 . . . . 0.0 109.815 178.431 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' F' F ' 37' ' ' ILE . . . . . . . . . . . . . 68.0 mt -119.62 138.64 49.58 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.184 0 CA-C-N 116.123 -0.489 . . . . 0.0 109.846 -179.972 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' F' F ' 38' ' ' GLY . . . . . . . . . . . . . . . -110.58 128.65 8.9 Favored Glycine 0 CA--C 1.525 0.683 0 N-CA-C 111.19 -0.764 . . . . 0.0 111.19 -179.653 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' F' F ' 39' ' ' ILE . . . . . . . . . . . . . 72.5 mt -127.13 128.07 70.09 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.233 0 N-CA-C 109.922 -0.399 . . . . 0.0 109.922 178.537 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' F' F ' 40' ' ' SER . . . . . . . . . . . . . 30.8 t -92.42 121.19 33.65 Favored 'General case' 0 C--N 1.329 -0.305 0 C-N-CA 120.823 -0.351 . . . . 0.0 110.677 175.967 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' F' F ' 41' ' ' ILE . . . . . . . . . . . . . 71.1 mt -127.45 123.99 62.81 Favored 'Isoleucine or valine' 0 N--CA 1.462 0.159 0 CA-C-O 120.935 0.398 . . . . 0.0 110.582 -179.226 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' F' F ' 42' ' ' LEU . . . . . . . . . . . . . 7.0 tp 52.58 37.65 23.78 Favored 'General case' 0 C--N 1.331 -0.219 0 CA-C-N 116.062 -0.517 . . . . 0.0 111.671 175.661 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' F' F ' 43' ' ' GLY . . . . . . . . . . . . . . . 73.18 28.16 66.84 Favored Glycine 0 CA--C 1.53 1.025 0 C-N-CA 121.073 -0.584 . . . . 0.0 112.567 176.569 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' F' F ' 44' ' ' LYS . . . . . . . . . . . . . 62.8 tttm -140.59 126.38 19.28 Favored 'General case' 0 C--N 1.33 -0.272 0 N-CA-C 109.474 -0.565 . . . . 0.0 109.474 177.234 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' F' F ' 45' ' ' GLU . . . . . . . . . . . . . 34.7 tp10 -82.82 124.31 30.18 Favored 'General case' 0 C--N 1.328 -0.331 0 C-N-CA 120.718 -0.393 . . . . 0.0 110.836 -176.876 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' F' F ' 46' ' ' VAL . . . . . . . . . . . . . 7.6 p -120.8 129.45 75.64 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.204 0 N-CA-C 109.561 -0.533 . . . . 0.0 109.561 177.285 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' F' F ' 47' ' ' LYS . . . . . . . . . . . . . 61.3 mmtt -100.23 130.09 46.32 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 115.935 -0.575 . . . . 0.0 111.104 178.572 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' F' F ' 48' ' ' PHE . . . . . . . . . . . . . 94.2 m-85 -112.61 131.86 55.42 Favored 'General case' 0 C--N 1.331 -0.233 0 N-CA-C 109.638 -0.504 . . . . 0.0 109.638 175.795 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' F' F ' 49' ' ' LYS . . . . . . . . . . . . . 48.9 tttp -108.7 136.71 47.83 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.314 -0.403 . . . . 0.0 110.612 179.936 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' F' F ' 50' ' ' VAL . . . . . . . . . . . . . 46.8 t -78.92 106.46 9.92 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.333 0 N-CA-C 108.91 -0.774 . . . . 0.0 108.91 175.155 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' F' F ' 51' ' ' VAL . . . . . . . . . . . . . 47.3 t -74.81 -47.43 37.8 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.327 0 CA-C-N 116.075 -0.511 . . . . 0.0 110.139 -172.957 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' F' F ' 52' ' ' GLN . . . . . . . . . . . . . 57.5 tt0 -160.72 137.84 9.1 Favored 'General case' 0 C--N 1.33 -0.281 0 C-N-CA 120.465 -0.494 . . . . 0.0 111.351 -177.466 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' F' F ' 53' ' ' ALA . . . . . . . . . . . . . . . -114.75 131.79 56.66 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 115.964 -0.562 . . . . 0.0 109.983 174.494 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' F' F ' 54' ' ' TYR . . . . . . . . . . . . . 33.7 t80 -129.01 109.16 18.2 Favored Pre-proline 0 C--N 1.328 -0.334 0 CA-C-O 118.302 -0.856 . . . . 0.0 110.492 179.271 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' F' F ' 55' ' ' PRO . . . . . . . . . . . . . 74.0 Cg_endo -77.14 168.51 76.76 Favored 'Cis proline' 0 N--CA 1.499 1.841 0 CA-C-N 121.951 1.733 . . . . 0.0 112.292 -5.819 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' F' F ' 56' ' ' SER . . . . . . . . . . . . . 69.2 m -117.5 134.78 23.12 Favored Pre-proline 0 CA--C 1.539 0.524 0 CA-C-O 118.466 -0.778 . . . . 0.0 109.704 175.126 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' F' F ' 57' ' ' PRO . . . . . . . . . . . . . 57.6 Cg_endo -73.14 162.82 90.92 Favored 'Cis proline' 0 N--CA 1.496 1.619 0 CA-C-N 121.806 1.681 . . . . 0.0 111.375 -3.501 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' F' F ' 58' ' ' LEU . . . . . . . . . . . . . 33.6 tp -130.0 137.84 50.5 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-O 120.851 0.357 . . . . 0.0 110.793 -178.658 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' F' F ' 59' ' ' ARG . . . . . . . . . . . . . 32.2 ttp180 -99.65 127.52 45.76 Favored 'General case' 0 C--N 1.327 -0.374 0 N-CA-C 109.335 -0.617 . . . . 0.0 109.335 175.459 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' F' F ' 60' ' ' VAL . . . . . . . . . . . . . 41.2 t -80.96 123.15 37.27 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.266 0 C-N-CA 120.598 -0.441 . . . . 0.0 110.506 -175.073 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' F' F ' 61' ' ' GLU . . . . . . . . . . . . . 42.9 mt-10 -131.13 171.38 13.34 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 115.608 -0.724 . . . . 0.0 109.674 176.483 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' F' F ' 62' ' ' ASP . . . . . . . . . . . . . 83.8 m-20 -54.27 -32.59 56.58 Favored 'General case' 0 C--N 1.329 -0.308 0 C-N-CA 120.968 -0.293 . . . . 0.0 111.752 -179.279 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' F' F ' 63' ' ' ARG . . . . . . . . . . . . . 25.0 ptt180 -83.9 2.25 39.46 Favored 'General case' 0 CA--C 1.537 0.455 0 N-CA-C 113.727 1.01 . . . . 0.0 113.727 -175.263 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' F' F ' 64' ' ' THR . . . . . . . . . . . . . 28.4 m -78.44 136.8 37.71 Favored 'General case' 0 C--N 1.333 -0.133 0 CA-C-N 118.119 0.418 . . . . 0.0 110.705 -177.621 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' F' F ' 65' ' ' LYS . . . . . . . . . . . . . 24.6 mtpp -90.35 127.04 36.07 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.037 -0.529 . . . . 0.0 110.218 179.275 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' F' F ' 66' ' ' ILE . . . . . . . . . . . . . 4.3 mp -113.87 131.47 65.65 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.262 0 N-CA-C 110.012 -0.366 . . . . 0.0 110.012 179.628 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' F' F ' 67' ' ' THR . . . . . . . . . . . . . 20.9 m -122.19 132.62 54.54 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-O 121.069 0.462 . . . . 0.0 110.331 178.525 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' F' F ' 68' ' ' LEU . . . . . . . . . . . . . 6.2 tt -106.91 124.79 50.14 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 115.825 -0.625 . . . . 0.0 110.002 -179.982 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' F' F ' 69' ' ' VAL . . . . . . . . . . . . . 43.4 t -95.22 135.95 27.76 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.315 0 CA-C-O 121.061 0.458 . . . . 0.0 110.412 -178.008 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' F' F ' 70' ' ' THR . . . . . . . . . . . . . 9.0 t -130.91 175.14 9.31 Favored 'General case' 0 C--N 1.331 -0.219 0 CA-C-N 115.882 -0.599 . . . . 0.0 110.304 -178.999 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' F' F ' 71' ' ' HIS . . . . . . . . . . . . . 96.1 m-70 -64.95 149.68 96.25 Favored Pre-proline 0 C--N 1.329 -0.324 0 CA-C-N 116.269 -0.423 . . . . 0.0 110.396 -178.367 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' F' F ' 72' ' ' PRO . . . . . . . . . . . . . 71.8 Cg_endo -77.58 -24.38 8.98 Favored 'Trans proline' 0 N--CA 1.495 1.592 0 C-N-CA 121.375 1.383 . . . . 0.0 113.038 -177.238 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' F' F ' 73' ' ' VAL . . . . . . . . . . . . . 34.8 m -129.11 154.24 39.78 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.158 0 CA-C-O 121.109 0.481 . . . . 0.0 111.154 -178.201 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' F' F ' 74' ' ' ASP . . . . . . . . . . . . . 12.8 t70 -101.82 123.72 46.24 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 115.542 -0.754 . . . . 0.0 109.594 177.464 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' F' F ' 75' ' ' VAL . . . . . . . . . . . . . 45.1 t -111.86 123.92 68.1 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.253 0 CA-C-O 121.145 0.498 . . . . 0.0 110.527 -178.105 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' F' F ' 76' ' ' LEU . . . . . . . . . . . . . 29.1 mt -123.86 142.23 51.31 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 115.533 -0.758 . . . . 0.0 109.418 177.661 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' F' F ' 77' ' ' GLU . . . . . . . . . . . . . 97.8 mt-10 -133.92 137.98 45.24 Favored 'General case' 0 C--N 1.331 -0.227 0 CA-C-O 121.018 0.437 . . . . 0.0 111.312 -178.145 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' F' F ' 78' ' ' ALA . . . . . . . . . . . . . . . -128.11 136.36 51.06 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 115.718 -0.673 . . . . 0.0 109.722 176.35 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' F' F ' 79' ' ' LYS . . . . . . . . . . . . . 19.8 pttp -79.46 123.76 27.83 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-O 121.187 0.518 . . . . 0.0 111.142 -177.893 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' F' F ' 80' ' ' ILE . . . . . . . . . . . . . 40.6 mm -139.21 112.73 6.57 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.279 0 CA-C-N 115.725 -0.671 . . . . 0.0 109.278 -178.199 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' F' F ' 81' ' ' LYS . . . . . . . . . . . . . 47.0 tptt -102.1 123.43 45.96 Favored 'General case' 0 C--N 1.329 -0.287 0 C-N-CA 120.921 -0.312 . . . . 0.0 111.072 -177.474 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' F' F ' 82' ' ' GLY . . . . . . . . . . . . . . . 89.07 42.15 5.69 Favored Glycine 0 CA--C 1.525 0.657 0 C-N-CA 120.722 -0.752 . . . . 0.0 111.954 173.551 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' F' F ' 83' ' ' ILE . . . . . . . . . . . . . 72.4 mt -64.04 137.47 24.75 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.29 0 N-CA-C 109.915 -0.402 . . . . 0.0 109.915 178.139 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' F' F ' 84' ' ' LYS . . . . . . . . . . . . . 82.2 tttt -99.43 -53.8 3.12 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 115.999 -0.546 . . . . 0.0 110.42 -178.975 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' F' F ' 85' ' ' ASP . . . . . . . . . . . . . 8.6 t0 -154.96 153.01 30.39 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 115.748 -0.66 . . . . 0.0 109.972 -179.706 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' F' F ' 86' ' ' VAL . . . . . . . . . . . . . 43.2 t -128.85 131.59 68.22 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.24 0 CA-C-O 120.9 0.381 . . . . 0.0 110.767 -178.016 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' F' F ' 87' ' ' ILE . . . . . . . . . . . . . 42.4 mm -118.22 124.26 72.84 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.245 0 CA-C-N 115.782 -0.644 . . . . 0.0 109.503 175.164 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' F' F ' 88' ' ' LEU . . . . . . . . . . . . . 14.8 tp -112.96 131.9 55.56 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-O 120.938 0.399 . . . . 0.0 111.36 -176.185 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' F' F ' 89' ' ' ASP . . . . . . . . . . . . . 13.5 t70 -131.08 151.52 51.35 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 115.861 -0.609 . . . . 0.0 109.442 175.932 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' F' F ' 90' ' ' GLU . . . . . . . . . . . . . 46.6 tp10 -48.96 -35.05 14.19 Favored 'General case' 0 C--N 1.329 -0.32 0 N-CA-C 112.712 0.634 . . . . 0.0 112.712 -172.49 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' F' F ' 91' ' ' ASN . . . . . . . . . . . . . 12.7 p30 -123.36 14.58 9.64 Favored 'General case' 0 N--CA 1.47 0.534 0 N-CA-C 113.452 0.908 . . . . 0.0 113.452 -175.883 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' F' F ' 92' ' ' LEU . . . . . . . . . . . . . 8.1 mt -151.66 143.17 23.53 Favored 'General case' 0 C--N 1.332 -0.171 0 N-CA-C 109.797 -0.446 . . . . 0.0 109.797 -177.101 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' F' F ' 93' ' ' ILE . . . . . . . . . . . . . 71.0 mt -127.26 117.13 46.39 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.346 0 N-CA-C 108.892 -0.781 . . . . 0.0 108.892 176.186 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' F' F ' 94' ' ' VAL . . . . . . . . . . . . . 48.4 t -121.71 128.11 75.67 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.257 0 CA-C-O 121.147 0.498 . . . . 0.0 110.189 -178.174 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' F' F ' 95' ' ' VAL . . . . . . . . . . . . . 45.2 t -120.78 135.08 62.12 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.358 0 CA-C-N 115.524 -0.762 . . . . 0.0 109.644 -179.168 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' F' F ' 96' ' ' ILE . . . . . . . . . . . . . 62.0 mt -111.66 129.03 67.8 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.358 0 N-CA-C 108.789 -0.819 . . . . 0.0 108.789 178.137 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' F' F ' 97' ' ' THR . . . . . . . . . . . . . 58.1 p -103.93 157.08 17.34 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-O 121.335 0.588 . . . . 0.0 111.235 -176.77 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' F' F ' 98' ' ' GLU . . . . . . . . . . . . . 85.4 tt0 -53.93 -24.03 14.97 Favored 'General case' 0 CA--C 1.534 0.36 0 CA-C-N 115.866 -0.606 . . . . 0.0 112.314 179.581 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' F' F ' 99' ' ' GLU . . . . . . . . . . . . . 41.3 tt0 -79.74 16.69 1.06 Allowed 'General case' 0 CA--C 1.54 0.561 0 N-CA-C 112.401 0.519 . . . . 0.0 112.401 -178.354 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' F' F ' 100' ' ' ASN . . . . . . . . . . . . . 2.2 m-20 60.05 37.39 21.14 Favored 'General case' 0 CA--C 1.53 0.209 0 O-C-N 121.675 -0.64 . . . . 0.0 110.818 178.367 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' F' F ' 101' ' ' GLU . . . . . . . . . . . . . 85.1 tt0 -117.1 145.38 43.81 Favored 'General case' 0 C--N 1.332 -0.186 0 CA-C-N 116.018 -0.537 . . . . 0.0 109.876 178.075 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' F' F ' 102' ' ' VAL . . . . . . . . . . . . . 46.2 t -115.51 124.79 72.36 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.372 0 N-CA-C 109.776 -0.453 . . . . 0.0 109.776 -178.83 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' F' F ' 103' ' ' LEU . . . . . . . . . . . . . 56.3 mt -114.47 129.92 56.69 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 115.83 -0.623 . . . . 0.0 110.016 176.961 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' F' F ' 104' ' ' ILE . . . . . 0.418 HD12 HG22 ' F' ' 104' ' ' ILE . 68.9 mt -117.93 118.43 58.25 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.27 0 N-CA-C 109.909 -0.404 . . . . 0.0 109.909 -179.811 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' F' F ' 105' ' ' PHE . . . . . . . . . . . . . 36.0 m-85 -119.36 164.18 16.08 Favored 'General case' 0 C--N 1.332 -0.163 0 O-C-N 123.898 0.749 . . . . 0.0 109.647 179.715 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' F' F ' 106' ' ' ASN . . . . . . . . . . . . . 44.3 p-10 -100.03 -170.65 1.91 Allowed 'General case' 0 C--N 1.33 -0.259 0 N-CA-C 109.808 -0.441 . . . . 0.0 109.808 173.575 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' F' F ' 107' ' ' GLN . . . . . . . . . . . . . 27.7 tt0 -59.75 -29.88 68.47 Favored 'General case' 0 C--N 1.329 -0.29 0 N-CA-C 111.944 0.35 . . . . 0.0 111.944 179.201 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' F' F ' 108' ' ' ASN . . . . . . . . . . . . . 16.6 t-20 -81.88 6.92 14.28 Favored 'General case' 0 CA--C 1.537 0.445 0 N-CA-C 113.232 0.827 . . . . 0.0 113.232 -177.948 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' F' F ' 109' ' ' LEU . . . . . . . . . . . . . 11.1 tp 62.4 36.68 14.18 Favored 'General case' 0 C--O 1.233 0.186 0 O-C-N 122.054 -0.404 . . . . 0.0 111.436 177.248 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' F' F ' 110' ' ' GLU . . . . . . . . . . . . . 70.9 mm-40 -109.58 156.96 19.53 Favored 'General case' 0 C--N 1.331 -0.237 0 N-CA-C 110.107 -0.331 . . . . 0.0 110.107 177.127 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' F' F ' 111' ' ' GLU . . . . . . . . . . . . . 46.4 mp0 -83.69 122.03 28.07 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-O 120.941 0.401 . . . . 0.0 111.053 -178.501 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' F' F ' 112' ' ' LEU . . . . . . . . . . . . . 29.5 mt -104.87 -45.97 4.42 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 115.987 -0.552 . . . . 0.0 109.941 175.117 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' F' F ' 113' ' ' TYR . . . . . . . . . . . . . 64.5 t80 -138.6 137.42 36.93 Favored 'General case' 0 C--N 1.33 -0.239 0 CA-C-N 115.988 -0.551 . . . . 0.0 110.842 -179.7 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' F' F ' 114' ' ' ARG . . . . . . . . . . . . . 83.4 mtm180 -139.61 122.66 16.77 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.448 -0.342 . . . . 0.0 110.315 176.254 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' F' F ' 115' ' ' GLY . . . . . . . . . . . . . . . -150.05 163.0 29.36 Favored Glycine 0 CA--C 1.526 0.722 0 N-CA-C 111.211 -0.756 . . . . 0.0 111.211 -179.937 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' F' F ' 116' ' ' LYS . . . . . . . . . . . . . 8.0 ttpm? -127.47 139.76 52.6 Favored 'General case' 0 C--N 1.33 -0.248 0 N-CA-C 110.074 -0.343 . . . . 0.0 110.074 178.368 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' F' F ' 117' ' ' PHE . . . . . . . . . . . . . 51.8 m-85 -136.44 113.96 10.95 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 116.397 -0.365 . . . . 0.0 110.054 -178.679 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' F' F ' 118' ' ' GLU . . . . . . . . . . . . . 96.1 mt-10 -55.1 -42.9 73.5 Favored 'General case' 0 C--N 1.33 -0.268 0 C-N-CA 121.0 -0.28 . . . . 0.0 111.13 -176.35 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' F' F ' 119' ' ' ASN . . . . . . . . . . . . . 2.4 m120 -97.97 31.0 2.83 Favored 'General case' 0 C--N 1.33 -0.258 0 N-CA-C 112.096 0.406 . . . . 0.0 112.096 -175.107 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' F' F ' 120' ' ' LEU . . . . . . . . . . . . . 14.8 tp -57.6 119.99 7.54 Favored 'General case' 0 C--N 1.333 -0.139 0 N-CA-C 110.264 -0.273 . . . . 0.0 110.264 178.166 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' F' F ' 121' ' ' ASN . . . . . . . . . . . . . 26.5 m120 -114.0 -43.95 3.2 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-N 116.487 -0.324 . . . . 0.0 110.832 -178.376 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' F' F ' 122' ' ' LYS . . . . . . . . . . . . . 38.3 ttpt -144.76 141.5 29.27 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-O 120.87 0.367 . . . . 0.0 111.28 -176.773 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' F' F ' 123' ' ' VAL . . . . . . . . . . . . . 46.1 t -126.69 127.19 69.9 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.315 0 N-CA-C 109.21 -0.663 . . . . 0.0 109.21 173.255 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' F' F ' 124' ' ' LEU . . . . . . . . . . . . . 16.2 tp -129.08 137.67 51.4 Favored 'General case' 0 C--N 1.331 -0.225 0 CA-C-O 121.034 0.445 . . . . 0.0 111.013 -176.344 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' F' F ' 125' ' ' VAL . . . . . . . . . . . . . 42.3 t -125.14 131.26 72.67 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.259 0 CA-C-N 115.844 -0.616 . . . . 0.0 109.624 177.864 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' F' F ' 126' ' ' ARG . . . . . . . . . . . . . 57.9 ttt180 -147.45 126.79 13.08 Favored 'General case' 0 C--N 1.329 -0.284 0 N-CA-C 109.46 -0.571 . . . . 0.0 109.46 178.858 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' F' F ' 127' ' ' ASN . . . . . . . . . . . . . 79.7 m-20 56.49 -147.13 0.53 Allowed 'General case' 0 CA--C 1.541 0.61 0 N-CA-C 109.682 -0.488 . . . . 0.0 109.682 -178.033 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' F' F ' 128' ' ' ASP . . . . . . . . . . . . . 24.1 p-10 -87.91 18.15 4.38 Favored 'General case' 0 CA--C 1.537 0.46 0 CA-C-N 118.901 0.773 . . . . 0.0 112.605 178.639 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' F' F ' 129' ' ' LEU . . . . . . . . . . . . . 15.6 tp -113.63 137.35 51.71 Favored 'General case' 0 N--CA 1.461 0.116 0 CA-C-N 117.99 0.359 . . . . 0.0 110.315 178.65 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' F' F ' 130' ' ' VAL . . . . . . . . . . . . . 46.1 t -121.89 135.9 60.53 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.215 0 CA-C-N 116.086 -0.506 . . . . 0.0 109.732 -179.963 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' F' F ' 131' ' ' VAL . . . . . . . . . . . . . 41.4 t -134.8 136.35 52.28 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.264 0 CA-C-O 121.104 0.478 . . . . 0.0 110.697 -179.454 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' F' F ' 132' ' ' ILE . . . . . . . . . . . . . 72.2 mt -116.62 132.93 64.84 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.234 0 CA-C-N 115.667 -0.697 . . . . 0.0 109.49 178.598 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' F' F ' 133' ' ' ILE . . . . . . . . . . . . . 42.7 mm -116.83 122.01 69.02 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.242 0 CA-C-O 120.764 0.316 . . . . 0.0 110.802 -176.629 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' F' F ' 134' ' ' ASP . . . . . . . . . . . . . 7.8 p-10 -133.42 146.23 51.0 Favored 'General case' 0 C--N 1.329 -0.29 0 N-CA-C 109.297 -0.631 . . . . 0.0 109.297 174.338 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' F' F ' 135' ' ' GLU . . . . . . . . . . . . . 84.6 tt0 -50.07 -27.79 6.15 Favored 'General case' 0 C--N 1.328 -0.333 0 N-CA-C 112.645 0.609 . . . . 0.0 112.645 -174.212 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' F' F ' 136' ' ' GLN . . . . . . . . . . . . . 95.7 mt-30 -79.09 -34.65 43.39 Favored 'General case' 0 C--O 1.232 0.174 0 N-CA-C 112.35 0.5 . . . . 0.0 112.35 -176.847 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' F' F ' 137' ' ' LYS . . . . . . . . . . . . . 49.8 pttt -170.06 176.2 4.75 Favored 'General case' 0 C--N 1.331 -0.227 0 CA-C-O 121.489 0.661 . . . . 0.0 112.577 -173.143 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' F' F ' 138' ' ' LEU . . . . . . . . . . . . . 6.7 tt -119.36 130.99 55.63 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 115.107 -0.951 . . . . 0.0 110.111 179.875 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' F' F ' 139' ' ' THR . . . . . . . . . . . . . 39.7 m -111.42 129.67 55.95 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.198 -0.455 . . . . 0.0 110.359 179.412 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' F' F ' 140' ' ' LEU . . . . . . . . . . . . . 8.5 tt -113.73 125.42 54.1 Favored 'General case' 0 C--N 1.328 -0.365 0 N-CA-C 109.515 -0.55 . . . . 0.0 109.515 -178.867 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' F' F ' 141' ' ' ILE . . . . . . . . . . . . . 19.0 mt -124.55 125.91 70.91 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.371 0 N-CA-C 109.873 -0.417 . . . . 0.0 109.873 -175.64 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' F' F ' 142' ' ' ARG . . . . . . . . . . . . . 23.4 tpt180 -120.37 135.42 55.03 Favored 'General case' 0 C--N 1.332 -0.193 0 CA-C-N 115.973 -0.558 . . . . 0.0 109.936 -178.458 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' F' F ' 143' ' ' THR . . . . . . . . . . . . . 23.9 p . . . . . 0 C--O 1.22 -0.49 0 CA-C-O 118.025 -0.988 . . . . 0.0 110.485 179.776 . . . . . . . . 0 0 . 1 . 006 nuclear orig full ' A' A ' -3' ' ' GLU . . . . . . . . . . . . . 40.5 mp0 . . . . . 0 N--CA 1.491 1.609 0 N-CA-C 109.73 -0.471 . . . . 0.0 109.73 . . . . . . . . . 0 0 . 1 . 006 nuclear orig full ' A' A ' -2' ' ' GLY . . . . . . . . . . . . . . . -109.24 123.54 6.93 Favored Glycine 0 CA--C 1.525 0.688 0 N-CA-C 111.318 -0.713 . . . . 0.0 111.318 -178.935 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' -1' ' ' VAL . . . . . . . . . . . . . 45.3 t -97.07 139.63 19.22 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.325 0 CA-C-O 120.789 0.328 . . . . 0.0 110.16 178.892 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 0' ' ' ILE . . . . . . . . . . . . . 69.5 mt -103.14 126.92 57.41 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.288 0 N-CA-C 109.558 -0.534 . . . . 0.0 109.558 178.111 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 26.7 ptm -78.05 157.38 29.59 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.247 -0.433 . . . . 0.0 110.763 -178.546 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 2.9 p -113.91 138.42 50.35 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 116.044 -0.526 . . . . 0.0 110.677 -179.407 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 85.4 tt0 -139.71 139.97 36.7 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.092 -0.503 . . . . 0.0 110.909 -179.333 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 4' ' ' LEU . . . . . . . . . . . . . 22.1 tp -121.74 125.7 47.18 Favored 'General case' 0 C--N 1.332 -0.185 0 CA-C-N 115.781 -0.645 . . . . 0.0 110.065 178.256 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 5' ' ' LYS . . . . . . . . . . . . . 64.7 mttp -101.73 121.24 41.7 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.437 -0.347 . . . . 0.0 110.656 178.923 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 85.8 mt -116.34 145.96 42.8 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 115.622 -0.717 . . . . 0.0 110.574 -179.76 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 82.6 tttt -139.34 135.31 17.05 Favored Pre-proline 0 CA--C 1.533 0.326 0 CA-C-O 118.905 -0.569 . . . . 0.0 109.723 177.01 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 8' ' ' PRO . . . . . . . . . . . . . 96.1 Cg_endo -89.49 142.87 4.35 Favored 'Trans proline' 0 N--CA 1.491 1.333 0 C-N-CA 121.621 1.547 . . . . 0.0 111.728 177.954 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 46.3 mt -77.07 -46.44 2.77 Favored Pre-proline 0 C--N 1.329 -0.317 0 CA-C-O 118.889 -0.577 . . . . 0.0 111.644 -179.374 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 94.8 Cg_endo -82.67 144.87 12.71 Favored 'Trans proline' 0 N--CA 1.493 1.497 0 C-N-CA 121.174 1.249 . . . . 0.0 111.361 172.159 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 64.4 mttp -86.58 100.63 12.55 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-O 121.037 0.446 . . . . 0.0 110.596 178.967 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 11.6 p -137.52 145.36 29.42 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.26 0 CA-C-N 115.762 -0.654 . . . . 0.0 110.022 179.765 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 84.1 tt0 -82.13 116.42 21.69 Favored 'General case' 0 C--N 1.329 -0.299 0 N-CA-C 109.973 -0.38 . . . . 0.0 109.973 178.938 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 14' ' ' LEU . . . . . . . . . . . . . 17.9 mt -92.82 153.18 42.12 Favored Pre-proline 0 C--N 1.33 -0.25 0 CA-C-N 116.224 -0.443 . . . . 0.0 110.864 -176.387 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 15' ' ' PRO . . . . . . . . . . . . . 31.1 Cg_exo -60.22 156.58 39.46 Favored 'Trans proline' 0 N--CA 1.495 1.578 0 C-N-CA 121.314 1.343 . . . . 0.0 111.876 177.744 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 16' ' ' PRO . . . . . . . . . . . . . 38.0 Cg_exo -58.02 -38.07 93.38 Favored 'Trans proline' 0 N--CA 1.497 1.714 0 C-N-CA 121.441 1.427 . . . . 0.0 112.777 -177.681 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 17' ' ' ASP . . . . . . . . . . . . . 18.7 p-10 -89.72 10.51 23.08 Favored 'General case' 0 CA--C 1.535 0.393 0 N-CA-C 113.313 0.857 . . . . 0.0 113.313 -176.482 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 18' ' ' PHE . . . . . . . . . . . . . 44.1 t80 -58.09 -44.58 87.68 Favored 'General case' 0 C--N 1.334 -0.068 0 O-C-N 122.047 -0.408 . . . . 0.0 110.121 -177.624 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 19' ' ' VAL . . . . . . . . . . . . . 47.2 t -57.96 -44.6 87.13 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.318 0 CA-C-N 116.251 -0.431 . . . . 0.0 110.4 -178.647 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 14.7 t70 -59.52 -40.23 86.46 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-O 120.829 0.347 . . . . 0.0 110.75 -177.462 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 47.2 t -64.53 -48.61 84.27 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.304 0 CA-C-N 116.382 -0.372 . . . . 0.0 110.251 -178.514 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 22' ' ' ILE . . . . . . . . . . . . . 51.5 mm -55.18 -42.26 64.69 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.242 0 CA-C-O 120.833 0.349 . . . . 0.0 110.605 179.441 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 23' ' ' ARG . . . . . . . . . . . . . 54.5 ttp180 -53.89 -53.58 50.6 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.464 -0.335 . . . . 0.0 111.49 179.577 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 24' ' ' ILE . . . . . . . . . . . . . 71.9 mt -61.24 -38.76 80.52 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.335 0 CA-C-N 116.56 -0.291 . . . . 0.0 111.508 -177.18 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 59.9 mmtt -65.88 -40.94 92.07 Favored 'General case' 0 C--N 1.329 -0.311 0 N-CA-C 112.104 0.409 . . . . 0.0 112.104 179.884 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 75.7 mt -78.41 -38.18 42.15 Favored 'General case' 0 C--N 1.33 -0.266 0 N-CA-C 113.312 0.856 . . . . 0.0 113.312 -171.205 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 27' ' ' GLN . . . . . . . . . . . . . 9.4 pt20 -46.99 140.22 5.01 Favored 'General case' 0 N--CA 1.47 0.552 0 N-CA-C 112.732 0.641 . . . . 0.0 112.732 -175.541 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 98.22 -26.08 25.09 Favored Glycine 0 CA--C 1.533 1.18 0 CA-C-N 115.58 -0.737 . . . . 0.0 112.242 -176.194 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 58.6 mtpt -98.07 155.12 17.28 Favored 'General case' 0 C--O 1.232 0.177 0 CA-C-N 117.117 0.458 . . . . 0.0 110.764 179.358 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 30' ' ' THR . . . . . . . . . . . . . 25.9 m -103.3 138.35 40.2 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.293 -0.412 . . . . 0.0 110.021 176.63 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 34.3 m -129.19 150.9 35.06 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.215 0 CA-C-O 121.066 0.46 . . . . 0.0 111.145 -178.179 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 32' ' ' ARG . . . . . . . . . . . . . 83.7 mtt180 -132.64 152.85 51.55 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 115.589 -0.732 . . . . 0.0 110.168 177.492 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 33' ' ' THR . . . . . . . . . . . . . 20.9 m -53.35 137.23 35.73 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.3 -0.409 . . . . 0.0 111.359 -177.685 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 102.06 -16.94 55.21 Favored Glycine 0 CA--C 1.532 1.122 0 CA-C-O 119.655 -0.525 . . . . 0.0 113.386 177.619 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 72.3 m-20 -64.26 148.31 50.48 Favored 'General case' 0 N--CA 1.461 0.112 0 CA-C-N 118.125 0.963 . . . . 0.0 110.987 179.494 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 44.7 t -125.83 133.23 69.54 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.19 0 CA-C-N 116.017 -0.538 . . . . 0.0 110.001 179.52 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 37' ' ' ILE . . . . . . . . . . . . . 68.6 mt -122.43 140.18 47.07 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.255 0 CA-C-N 116.081 -0.509 . . . . 0.0 109.981 179.849 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . -113.17 128.91 8.61 Favored Glycine 0 CA--C 1.527 0.815 0 N-CA-C 110.978 -0.849 . . . . 0.0 110.978 179.485 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 39' ' ' ILE . . . . . . . . . . . . . 71.9 mt -122.97 130.14 74.65 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.2 0 N-CA-C 110.091 -0.337 . . . . 0.0 110.091 179.793 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 40' ' ' SER . . . . . . . . . . . . . 35.8 t -94.58 124.79 38.82 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.483 -0.326 . . . . 0.0 111.007 175.377 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 41' ' ' ILE . . . . . . . . . . . . . 71.9 mt -133.42 123.79 47.34 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.247 0 CA-C-O 120.907 0.384 . . . . 0.0 110.567 177.183 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 10.9 tp 52.51 35.93 19.06 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 115.994 -0.548 . . . . 0.0 111.695 177.319 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . 73.23 28.38 66.31 Favored Glycine 0 CA--C 1.53 1.007 0 C-N-CA 121.169 -0.539 . . . . 0.0 112.46 176.6 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 44' ' ' LYS . . . . . . . . . . . . . 94.5 mttt -134.9 129.98 35.19 Favored 'General case' 0 C--N 1.332 -0.189 0 CA-C-N 117.044 0.422 . . . . 0.0 110.01 177.268 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 68.0 tt0 -86.96 125.78 34.29 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 116.067 -0.515 . . . . 0.0 111.371 -175.8 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 46' ' ' VAL . . . . . . . . . . . . . 7.1 p -125.17 129.77 73.16 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.19 0 CA-C-O 120.926 0.393 . . . . 0.0 110.02 175.744 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 56.5 mmtt -100.53 130.91 46.66 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 115.865 -0.607 . . . . 0.0 111.768 177.896 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 48' ' ' PHE . . . . . . . . . . . . . 93.8 m-85 -113.86 131.89 56.1 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.071 -0.513 . . . . 0.0 109.929 175.022 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 83.1 tttt -106.62 137.76 44.03 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.382 -0.372 . . . . 0.0 110.492 179.357 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 50' ' ' VAL . . . . . . . . . . . . . 44.5 t -81.3 105.98 11.86 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.297 0 N-CA-C 108.991 -0.744 . . . . 0.0 108.991 174.735 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 51' ' ' VAL . . . . . . . . . . . . . 45.6 t -69.54 -48.13 67.95 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.349 0 CA-C-N 116.05 -0.523 . . . . 0.0 110.016 -173.075 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 52' ' ' GLN . . . . . . . . . . . . . 48.0 tt0 -167.89 139.9 3.04 Favored 'General case' 0 C--N 1.328 -0.348 0 C-N-CA 120.362 -0.535 . . . . 0.0 111.651 -177.816 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -110.47 131.93 54.62 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 115.839 -0.619 . . . . 0.0 109.882 174.776 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 54' ' ' TYR . . . . . . . . . . . . . 40.7 t80 -129.07 110.66 18.28 Favored Pre-proline 0 CA--C 1.535 0.381 0 CA-C-O 118.292 -0.861 . . . . 0.0 110.546 179.769 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 55' ' ' PRO . . . . . . . . . . . . . 71.7 Cg_endo -77.22 166.96 80.91 Favored 'Cis proline' 0 N--CA 1.5 1.866 0 CA-C-N 121.874 1.705 . . . . 0.0 111.978 -7.102 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 56' ' ' SER . . . . . . . . . . . . . 51.3 m -118.02 141.97 30.18 Favored Pre-proline 0 CA--C 1.538 0.519 0 CA-C-O 118.699 -0.667 . . . . 0.0 109.596 174.132 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 57' ' ' PRO . . . . . . . . . . . . . 43.9 Cg_endo -68.96 142.87 70.55 Favored 'Cis proline' 0 N--CA 1.499 1.807 0 CA-C-N 121.484 1.566 . . . . 0.0 111.205 -3.006 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 58' ' ' LEU . . . . . . . . . . . . . 29.7 tp -107.75 136.05 48.14 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-O 120.729 0.3 . . . . 0.0 110.877 -177.849 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 59' ' ' ARG . . . . . . . . . . . . . 66.5 ttt180 -101.79 122.2 43.51 Favored 'General case' 0 C--N 1.326 -0.426 0 N-CA-C 109.099 -0.704 . . . . 0.0 109.099 175.919 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 43.9 t -76.18 120.88 27.03 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.263 0 C-N-CA 120.68 -0.408 . . . . 0.0 110.639 -173.964 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 43.7 mt-10 -131.04 165.38 23.34 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 115.954 -0.566 . . . . 0.0 109.838 175.181 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 62' ' ' ASP . . . . . . . . . . . . . 9.5 p-10 -55.51 -32.55 62.97 Favored 'General case' 0 C--N 1.329 -0.311 0 N-CA-C 111.89 0.33 . . . . 0.0 111.89 -177.289 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 63' ' ' ARG . . . . . . . . . . . . . 24.3 ptt180 -79.76 -4.4 51.79 Favored 'General case' 0 CA--C 1.536 0.441 0 N-CA-C 113.753 1.02 . . . . 0.0 113.753 -174.945 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 24.6 m -75.08 136.07 41.18 Favored 'General case' 0 C--N 1.333 -0.118 0 CA-C-N 118.118 0.417 . . . . 0.0 110.453 -177.943 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 65' ' ' LYS . . . . . . . . . . . . . 3.0 mptp? -88.35 128.12 35.5 Favored 'General case' 0 C--N 1.328 -0.329 0 N-CA-C 109.689 -0.486 . . . . 0.0 109.689 -179.86 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 66' ' ' ILE . . . . . 0.409 HG22 HD13 ' A' ' 66' ' ' ILE . 59.2 mt -112.03 131.96 62.01 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.244 0 N-CA-C 109.807 -0.442 . . . . 0.0 109.807 -179.223 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 67' ' ' THR . . . . . . . . . . . . . 27.5 m -123.95 137.15 54.66 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.138 -0.483 . . . . 0.0 110.744 -179.142 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 68' ' ' LEU . . . . . . . . . . . . . 3.6 tt -103.89 120.28 40.68 Favored 'General case' 0 C--N 1.329 -0.302 0 N-CA-C 109.37 -0.604 . . . . 0.0 109.37 178.072 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 69' ' ' VAL . . . . . . . . . . . . . 41.0 t -100.13 130.83 48.71 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.273 0 CA-C-O 120.98 0.419 . . . . 0.0 111.021 -174.683 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 70' ' ' THR . . . . . . . . . . . . . 10.1 p -146.88 178.63 8.18 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 115.746 -0.661 . . . . 0.0 110.387 177.514 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 71' ' ' HIS . . . . . . . . . . . . . 91.7 m-70 -122.52 85.68 48.48 Favored Pre-proline 0 CA--C 1.532 0.274 0 CA-C-N 116.42 -0.355 . . . . 0.0 110.589 -179.741 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 72' ' ' PRO . . . . . . . . . . . . . 84.0 Cg_endo -87.35 160.09 8.23 Favored 'Trans proline' 0 N--CA 1.492 1.405 0 C-N-CA 121.762 1.642 . . . . 0.0 112.717 -179.366 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 73' ' ' VAL . . . . . . . . . . . . . 28.7 m -114.95 170.28 5.25 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.245 0 CA-C-N 116.095 -0.502 . . . . 0.0 110.101 177.469 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 74' ' ' ASP . . . . . . . . . . . . . 40.5 t0 -95.22 116.58 28.94 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 116.359 -0.382 . . . . 0.0 110.11 -178.192 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 44.8 t -112.52 121.64 65.24 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.211 0 CA-C-O 121.081 0.467 . . . . 0.0 110.259 179.961 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 76' ' ' LEU . . . . . . . . . . . . . 35.1 mt -125.42 140.59 52.66 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 115.571 -0.74 . . . . 0.0 109.539 179.381 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 77' ' ' GLU . . . . . . . . . . . . . 96.8 mt-10 -133.94 143.96 48.52 Favored 'General case' 0 C--N 1.332 -0.185 0 CA-C-O 121.153 0.501 . . . . 0.0 111.622 -177.166 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 78' ' ' ALA . . . . . . . . . . . . . . . -130.62 133.64 46.32 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 115.435 -0.802 . . . . 0.0 109.886 175.574 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 79' ' ' LYS . . . . . . . . . . . . . 36.6 ttpt -82.26 117.83 22.66 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.358 -0.383 . . . . 0.0 110.634 -178.019 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 80' ' ' ILE . . . . . . . . . . . . . 42.7 mm -139.06 113.07 7.1 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.285 0 N-CA-C 109.156 -0.683 . . . . 0.0 109.156 -178.142 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 81' ' ' LYS . . . . . . . . . . . . . 6.3 mtmp? -100.5 124.69 46.37 Favored 'General case' 0 C--N 1.327 -0.409 0 CA-C-O 120.913 0.387 . . . . 0.0 111.116 -176.637 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . 89.25 42.05 5.66 Favored Glycine 0 CA--C 1.525 0.691 0 C-N-CA 120.961 -0.638 . . . . 0.0 111.642 176.259 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 83' ' ' ILE . . . . . . . . . . . . . 74.9 mt -68.06 132.58 32.6 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.309 0 N-CA-C 109.575 -0.528 . . . . 0.0 109.575 176.694 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 84' ' ' LYS . . . . . . . . . . . . . 39.6 ttpt -95.05 -53.41 3.82 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-O 120.986 0.422 . . . . 0.0 110.365 -177.96 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 85' ' ' ASP . . . . . . . . . . . . . 7.9 t70 -149.69 151.87 34.39 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 115.944 -0.571 . . . . 0.0 110.696 -179.131 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 86' ' ' VAL . . . . . . . . . . . . . 44.1 t -130.67 131.65 64.66 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.267 0 CA-C-N 116.339 -0.392 . . . . 0.0 110.305 179.444 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 87' ' ' ILE . . . . . . . . . . . . . 5.1 mp -118.47 126.1 74.86 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.273 0 N-CA-C 109.564 -0.532 . . . . 0.0 109.564 177.027 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 88' ' ' LEU . . . . . . . . . . . . . 15.7 tp -109.79 130.41 55.52 Favored 'General case' 0 C--N 1.332 -0.191 0 CA-C-N 116.34 -0.391 . . . . 0.0 110.687 -178.534 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 89' ' ' ASP . . . . . . . . . . . . . 9.8 t70 -125.88 156.94 38.86 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 116.107 -0.497 . . . . 0.0 109.964 179.091 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 84.8 tt0 -46.48 -38.24 8.94 Favored 'General case' 0 C--N 1.33 -0.248 0 N-CA-C 113.088 0.773 . . . . 0.0 113.088 -172.068 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 91' ' ' ASN . . . . . . . . . . . . . 2.7 t-20 -132.06 20.99 4.49 Favored 'General case' 0 N--CA 1.47 0.532 0 N-CA-C 112.925 0.713 . . . . 0.0 112.925 -177.518 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 92' ' ' LEU . . . . . . . . . . . . . 28.4 mt -149.55 147.71 28.5 Favored 'General case' 0 C--N 1.331 -0.225 0 CA-C-O 120.78 0.324 . . . . 0.0 110.617 -175.938 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 93' ' ' ILE . . . . . . . . . . . . . 70.1 mt -126.22 119.47 54.21 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.264 0 N-CA-C 109.197 -0.668 . . . . 0.0 109.197 176.538 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 94' ' ' VAL . . . . . . . . . . . . . 44.1 t -120.11 127.77 75.91 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.253 0 N-CA-C 109.957 -0.386 . . . . 0.0 109.957 -179.275 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 95' ' ' VAL . . . . . . . . . . . . . 45.9 t -123.32 134.58 65.86 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.208 0 CA-C-N 116.082 -0.508 . . . . 0.0 109.939 -179.433 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 96' ' ' ILE . . . . . . . . . . . . . 63.4 mt -116.86 128.03 74.34 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.284 0 N-CA-C 109.434 -0.58 . . . . 0.0 109.434 -179.726 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 97' ' ' THR . . . . . . . . . . . . . 75.3 p -100.36 155.57 17.73 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-O 121.214 0.531 . . . . 0.0 111.286 -177.501 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 98' ' ' GLU . . . . . . . . . . . . . 84.9 tt0 -53.94 -25.84 22.48 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-N 115.954 -0.566 . . . . 0.0 112.34 179.851 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 99' ' ' GLU . . . . . . . . . . . . . 34.4 tt0 -80.41 17.95 0.99 Allowed 'General case' 0 CA--C 1.54 0.594 0 N-CA-C 112.553 0.575 . . . . 0.0 112.553 -177.164 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 100' ' ' ASN . . . . . . . . . . . . . 3.5 m-20 63.11 36.44 12.2 Favored 'General case' 0 CA--C 1.53 0.174 0 O-C-N 121.931 -0.481 . . . . 0.0 111.221 176.077 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 101' ' ' GLU . . . . . . . . . . . . . 84.8 tt0 -116.72 142.88 46.33 Favored 'General case' 0 C--N 1.332 -0.189 0 CA-C-N 116.318 -0.401 . . . . 0.0 109.942 175.788 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 102' ' ' VAL . . . . . . . . . . . . . 45.0 t -117.11 126.55 74.53 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.262 0 CA-C-N 116.193 -0.458 . . . . 0.0 109.947 -178.06 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 103' ' ' LEU . . . . . . . . . . . . . 6.3 mp -118.43 133.73 55.64 Favored 'General case' 0 C--N 1.331 -0.227 0 CA-C-N 116.045 -0.525 . . . . 0.0 110.283 176.759 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 104' ' ' ILE . . . . . . . . . . . . . 70.4 mt -121.27 122.6 67.82 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.235 0 CA-C-N 116.542 -0.299 . . . . 0.0 110.21 -179.045 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 105' ' ' PHE . . . . . . . . . . . . . 39.0 m-85 -123.41 164.52 18.72 Favored 'General case' 0 C--N 1.332 -0.173 0 O-C-N 123.839 0.712 . . . . 0.0 109.809 179.754 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 106' ' ' ASN . . . . . . . . . . . . . 41.7 p-10 -97.55 -169.9 1.92 Allowed 'General case' 0 C--N 1.33 -0.254 0 N-CA-C 109.989 -0.374 . . . . 0.0 109.989 174.315 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 107' ' ' GLN . . . . . . . . . . . . . 27.5 tt0 -60.2 -27.29 67.04 Favored 'General case' 0 CA--C 1.533 0.308 0 N-CA-C 112.002 0.371 . . . . 0.0 112.002 177.925 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 108' ' ' ASN . . . . . . . . . . . . . 10.2 t-20 -81.87 4.21 23.23 Favored 'General case' 0 CA--C 1.536 0.419 0 N-CA-C 113.232 0.827 . . . . 0.0 113.232 -178.95 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 109' ' ' LEU . . . . . . . . . . . . . 12.5 tp 61.03 38.26 17.38 Favored 'General case' 0 C--O 1.234 0.26 0 CA-C-O 120.973 0.415 . . . . 0.0 111.072 179.109 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 110' ' ' GLU . . . . . . . . . . . . . 95.2 mt-10 -111.16 149.89 30.26 Favored 'General case' 0 C--N 1.332 -0.189 0 CA-C-N 116.539 -0.3 . . . . 0.0 110.332 177.086 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 111' ' ' GLU . . . . . . . . . . . . . 98.4 mt-10 -73.12 125.04 26.78 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-O 120.977 0.418 . . . . 0.0 111.48 -178.823 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 112' ' ' LEU . . . . . . . . . . . . . 21.7 mt -109.95 -45.95 3.55 Favored 'General case' 0 C--N 1.331 -0.221 0 CA-C-N 115.819 -0.628 . . . . 0.0 109.917 174.669 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 113' ' ' TYR . . . . . . . . . . . . . 63.7 t80 -141.55 142.55 33.52 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 115.877 -0.601 . . . . 0.0 110.608 178.782 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 114' ' ' ARG . . . . . . . . . . . . . 33.8 ptt-85 -149.14 124.07 9.99 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-O 121.059 0.457 . . . . 0.0 110.789 177.325 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 115' ' ' GLY . . . . . . . . . . . . . . . -150.11 163.03 29.38 Favored Glycine 0 CA--C 1.524 0.636 0 N-CA-C 110.964 -0.854 . . . . 0.0 110.964 -179.12 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 116' ' ' LYS . . . . . . . . . . . . . 34.5 ttmt -130.07 134.98 47.74 Favored 'General case' 0 C--N 1.33 -0.244 0 N-CA-C 110.088 -0.338 . . . . 0.0 110.088 177.928 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 117' ' ' PHE . . . . . . . . . . . . . 33.4 m-85 -130.93 117.39 19.17 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.403 -0.362 . . . . 0.0 110.297 -175.711 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 118' ' ' GLU . . . . . . . . . . . . . 48.9 mp0 -56.08 -43.37 77.95 Favored 'General case' 0 C--N 1.328 -0.352 0 C-N-CA 120.759 -0.376 . . . . 0.0 111.104 -175.025 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 119' ' ' ASN . . . . . . . . . . . . . 71.1 m-80 -100.26 31.08 3.52 Favored 'General case' 0 C--N 1.329 -0.299 0 N-CA-C 112.259 0.466 . . . . 0.0 112.259 -172.737 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 120' ' ' LEU . . . . . . . . . . . . . 11.1 tp -55.82 120.76 7.86 Favored 'General case' 0 C--O 1.232 0.138 0 C-N-CA 121.078 -0.249 . . . . 0.0 110.491 177.199 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 121' ' ' ASN . . . . . . . . . . . . . 33.1 m120 -114.02 -44.06 3.19 Favored 'General case' 0 N--CA 1.463 0.205 0 CA-C-N 116.654 -0.248 . . . . 0.0 111.035 -176.793 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 122' ' ' LYS . . . . . . . . . . . . . 89.0 mttt -143.58 144.89 32.12 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-O 120.942 0.401 . . . . 0.0 111.352 -177.628 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 123' ' ' VAL . . . . . . . . . . . . . 45.7 t -130.53 131.17 65.18 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.27 0 N-CA-C 109.387 -0.597 . . . . 0.0 109.387 175.27 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 124' ' ' LEU . . . . . . . . . . . . . 10.1 tp -131.43 136.27 47.84 Favored 'General case' 0 C--N 1.331 -0.199 0 CA-C-O 120.824 0.345 . . . . 0.0 111.151 -176.857 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 125' ' ' VAL . . . . . . . . . . . . . 45.0 t -127.58 129.96 70.38 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.232 0 CA-C-N 116.059 -0.519 . . . . 0.0 109.751 177.061 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 126' ' ' ARG . . . . . . . . . . . . . 63.0 ttm-85 -141.63 124.73 16.32 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-O 120.944 0.402 . . . . 0.0 110.603 179.851 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 127' ' ' ASN . . . . . . . . . . . . . 23.1 m120 50.58 -109.79 0.42 Allowed 'General case' 0 CA--C 1.545 0.754 0 CA-C-O 118.832 -0.604 . . . . 0.0 111.293 179.738 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 128' ' ' ASP . . . . . . . . . . . . . 9.9 p-10 -114.08 8.67 17.09 Favored 'General case' 0 N--CA 1.469 0.516 0 CA-C-N 119.875 1.216 . . . . 0.0 113.158 -179.124 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 129' ' ' LEU . . . . . . . . . . . . . 18.1 tp -107.75 134.99 49.92 Favored 'General case' 0 C--N 1.332 -0.166 0 CA-C-N 117.956 0.344 . . . . 0.0 110.123 179.643 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 130' ' ' VAL . . . . . . . . . . . . . 44.0 t -116.69 132.69 65.64 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.253 0 N-CA-C 109.583 -0.525 . . . . 0.0 109.583 179.617 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 131' ' ' VAL . . . . . . . . . . . . . 40.7 t -132.89 133.99 58.55 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.253 0 CA-C-O 121.034 0.445 . . . . 0.0 110.474 -179.258 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 132' ' ' ILE . . . . . . . . . . . . . 74.6 mt -118.45 130.66 72.99 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 CA-C-N 115.72 -0.673 . . . . 0.0 109.204 177.718 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 133' ' ' ILE . . . . . . . . . . . . . 40.0 mm -116.68 123.39 71.6 Favored 'Isoleucine or valine' 0 C--O 1.234 0.262 0 CA-C-O 120.933 0.397 . . . . 0.0 111.071 -174.228 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 134' ' ' ASP . . . . . . . . . . . . . 6.8 p-10 -136.45 146.33 46.23 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-N 116.006 -0.543 . . . . 0.0 109.557 175.227 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 135' ' ' GLU . . . . . . . . . . . . . 38.9 tp10 -50.32 -27.94 7.04 Favored 'General case' 0 C--N 1.328 -0.36 0 N-CA-C 112.598 0.592 . . . . 0.0 112.598 -173.592 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 136' ' ' GLN . . . . . . . . . . . . . 97.8 mt-30 -76.04 -37.23 58.59 Favored 'General case' 0 C--O 1.234 0.246 0 N-CA-C 112.34 0.496 . . . . 0.0 112.34 -177.903 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 137' ' ' LYS . . . . . . . . . . . . . 47.5 pttt -168.02 175.0 6.93 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-O 121.607 0.718 . . . . 0.0 112.19 -171.593 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 138' ' ' LEU . . . . . . . . . . . . . 6.3 tt -118.94 128.57 54.54 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 115.13 -0.941 . . . . 0.0 110.039 179.247 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 139' ' ' THR . . . . . . . . . . . . . 31.5 m -108.03 126.02 52.24 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.285 -0.416 . . . . 0.0 110.291 179.885 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 140' ' ' LEU . . . . . . . . . . . . . 36.5 tp -113.04 122.95 49.13 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 115.722 -0.672 . . . . 0.0 109.305 -179.364 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 141' ' ' ILE . . . . . . . . . . . . . 19.0 mt -121.84 119.82 59.81 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 CA-C-O 120.955 0.407 . . . . 0.0 110.052 -174.411 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 142' ' ' ARG . . . . . . . . . . . . . 54.8 mtp180 -105.09 123.22 47.44 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 115.583 -0.735 . . . . 0.0 110.165 178.856 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 143' ' ' THR . . . . . . . . . . . . . 31.8 p . . . . . 0 C--O 1.221 -0.446 0 CA-C-O 117.98 -1.01 . . . . 0.0 110.515 -179.672 . . . . . . . . 0 0 . 1 . 006 nuclear orig full ' B' B ' -3' ' ' GLU . . . . . . . . . . . . . 70.5 mm-40 . . . . . 0 N--CA 1.49 1.526 0 N-CA-C 109.428 -0.582 . . . . 0.0 109.428 . . . . . . . . . 0 0 . 1 . 006 nuclear orig full ' B' B ' -2' ' ' GLY . . . . . . . . . . . . . . . -72.27 146.26 38.98 Favored Glycine 0 CA--C 1.526 0.774 0 N-CA-C 110.912 -0.875 . . . . 0.0 110.912 179.825 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' -1' ' ' VAL . . . . . . . . . . . . . 43.3 t -141.41 137.15 32.8 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.299 0 N-CA-C 110.095 -0.335 . . . . 0.0 110.095 179.381 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 0' ' ' ILE . . . . . . . . . . . . . 44.7 mm -113.92 136.25 50.99 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.273 0 CA-C-N 116.258 -0.428 . . . . 0.0 110.088 179.376 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 1' ' ' MET . . . . . . . . . . . . . 23.7 ptm -81.14 133.04 35.39 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.065 -0.516 . . . . 0.0 110.916 -178.46 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 2' ' ' SER . . . . . . . . . . . . . 13.5 p -118.97 136.26 54.19 Favored 'General case' 0 C--O 1.233 0.197 0 CA-C-N 116.308 -0.405 . . . . 0.0 110.9 -179.668 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 3' ' ' GLU . . . . . . . . . . . . . 46.9 mp0 -140.65 147.37 39.21 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.181 -0.463 . . . . 0.0 111.33 -178.746 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 4' ' ' LEU . . . . . . . . . . . . . 17.8 tp -127.02 127.71 45.19 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 115.702 -0.681 . . . . 0.0 109.947 174.718 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 5' ' ' LYS . . . . . . . . . . . . . 92.5 mttt -109.51 121.23 44.72 Favored 'General case' 0 C--O 1.234 0.27 0 CA-C-O 120.815 0.34 . . . . 0.0 110.855 178.919 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 6' ' ' LEU . . . . . . . . . . . . . 58.1 mt -115.08 147.24 40.44 Favored 'General case' 0 C--N 1.331 -0.211 0 CA-C-N 115.375 -0.83 . . . . 0.0 110.716 -179.097 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 7' ' ' LYS . . . . . . . . . . . . . 69.5 tttt -134.89 138.02 28.63 Favored Pre-proline 0 CA--C 1.534 0.355 0 CA-C-O 118.955 -0.545 . . . . 0.0 109.989 175.78 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 8' ' ' PRO . . . . . . . . . . . . . 75.1 Cg_endo -90.06 139.67 3.16 Favored 'Trans proline' 0 N--CA 1.489 1.249 0 C-N-CA 121.7 1.6 . . . . 0.0 111.574 178.213 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 9' ' ' LEU . . . . . . . . . . . . . 26.8 mt -77.27 -51.91 1.91 Allowed Pre-proline 0 CA--C 1.531 0.239 0 CA-C-O 119.138 -0.458 . . . . 0.0 111.313 -177.488 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 10' ' ' PRO . . . . . . . . . . . . . 71.7 Cg_endo -76.56 149.86 31.03 Favored 'Trans proline' 0 N--CA 1.497 1.682 0 C-N-CA 121.156 1.238 . . . . 0.0 111.399 170.671 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 11' ' ' LYS . . . . . . . . . . . . . 25.1 pttm -84.91 117.02 23.66 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-O 121.45 0.643 . . . . 0.0 110.61 178.254 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 12' ' ' VAL . . . . . . . . . . . . . 12.8 p -151.06 148.04 15.2 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 CA-C-N 115.653 -0.703 . . . . 0.0 110.493 -179.44 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 13' ' ' GLU . . . . . . . . . . . . . 84.7 tt0 -91.03 125.5 35.84 Favored 'General case' 0 C--N 1.329 -0.321 0 N-CA-C 110.034 -0.358 . . . . 0.0 110.034 177.827 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 14' ' ' LEU . . . . . . . . . . . . . 28.2 mt -97.87 149.86 36.17 Favored Pre-proline 0 CA--C 1.533 0.291 0 CA-C-N 116.357 -0.383 . . . . 0.0 110.718 -176.583 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 15' ' ' PRO . . . . . . . . . . . . . 24.0 Cg_exo -63.69 161.28 32.75 Favored 'Trans proline' 0 N--CA 1.497 1.689 0 C-N-CA 121.402 1.401 . . . . 0.0 111.866 175.648 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 16' ' ' PRO . . . . . . . . . . . . . 27.4 Cg_exo -60.35 -35.64 90.42 Favored 'Trans proline' 0 N--CA 1.498 1.745 0 C-N-CA 121.451 1.434 . . . . 0.0 112.789 -178.535 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 17' ' ' ASP . . . . . . . . . . . . . 9.4 p-10 -89.13 8.07 31.85 Favored 'General case' 0 CA--C 1.536 0.426 0 N-CA-C 113.245 0.831 . . . . 0.0 113.245 -177.428 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 18' ' ' PHE . . . . . . . . . . . . . 47.5 t80 -58.27 -44.97 88.67 Favored 'General case' 0 C--N 1.334 -0.108 0 O-C-N 122.041 -0.412 . . . . 0.0 110.031 -178.017 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 19' ' ' VAL . . . . . . . . . . . . . 13.8 p -55.66 -41.27 64.19 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.36 0 CA-C-N 116.283 -0.417 . . . . 0.0 111.058 -178.984 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 20' ' ' ASP . . . . . . . . . . . . . 75.6 m-20 -60.9 -43.49 98.44 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-O 120.951 0.405 . . . . 0.0 110.888 -178.154 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 21' ' ' VAL . . . . . . . . . . . . . 47.4 t -65.07 -46.39 91.46 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.281 0 CA-C-N 116.331 -0.395 . . . . 0.0 110.555 -177.556 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 22' ' ' ILE . . . . . . . . . . . . . 50.9 mm -55.15 -46.52 77.68 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.259 0 CA-C-O 120.817 0.341 . . . . 0.0 110.645 179.483 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 23' ' ' ARG . . . . . . . . . . . . . 26.8 ttm-85 -53.65 -54.08 42.87 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-O 121.16 0.505 . . . . 0.0 111.385 -179.727 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 24' ' ' ILE . . . . . . . . . . . . . 77.3 mt -60.66 -36.72 72.47 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.373 0 CA-C-N 115.61 -0.723 . . . . 0.0 111.581 -173.675 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 25' ' ' LYS . . . . . . . . . . . . . 57.5 mttm -70.71 -42.86 70.07 Favored 'General case' 0 C--N 1.33 -0.281 0 N-CA-C 112.551 0.574 . . . . 0.0 112.551 179.781 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 26' ' ' LEU . . . . . . . . . . . . . 34.3 mt -77.75 -35.84 51.34 Favored 'General case' 0 C--N 1.331 -0.23 0 N-CA-C 113.15 0.796 . . . . 0.0 113.15 -170.748 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 27' ' ' GLN . . . . . . . . . . . . . 5.3 pt20 -46.97 140.91 4.44 Favored 'General case' 0 N--CA 1.468 0.462 0 N-CA-C 112.747 0.647 . . . . 0.0 112.747 -175.808 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 28' ' ' GLY . . . . . . . . . . . . . . . 99.96 -24.79 30.76 Favored Glycine 0 CA--C 1.534 1.223 0 CA-C-N 115.624 -0.716 . . . . 0.0 112.261 -176.733 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 29' ' ' LYS . . . . . . . . . . . . . 47.2 mtmt -98.24 155.15 17.32 Favored 'General case' 0 C--N 1.332 -0.187 0 CA-C-N 117.339 0.57 . . . . 0.0 111.269 179.64 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 30' ' ' THR . . . . . . . . . . . . . 38.9 m -107.19 138.48 43.3 Favored 'General case' 0 C--N 1.331 -0.209 0 CA-C-N 115.914 -0.585 . . . . 0.0 109.901 176.62 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 31' ' ' VAL . . . . . . . . . . . . . 34.1 m -131.72 155.89 42.09 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.206 0 CA-C-O 120.99 0.424 . . . . 0.0 111.551 -176.866 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 32' ' ' ARG . . . . . . . . . . . . . 36.3 mtp180 -129.28 152.69 48.57 Favored 'General case' 0 C--O 1.233 0.236 0 CA-C-N 115.667 -0.697 . . . . 0.0 110.688 176.802 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 33' ' ' THR . . . . . . . . . . . . . 24.6 m -53.57 139.71 30.77 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.203 -0.453 . . . . 0.0 111.253 -179.075 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 34' ' ' GLY . . . . . . . . . . . . . . . 99.43 -17.13 58.18 Favored Glycine 0 CA--C 1.532 1.109 0 CA-C-O 119.486 -0.619 . . . . 0.0 113.304 177.69 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 35' ' ' ASP . . . . . . . . . . . . . 76.1 m-20 -65.09 148.25 52.0 Favored 'General case' 0 C--O 1.232 0.178 0 CA-C-N 118.116 0.958 . . . . 0.0 110.97 179.346 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 36' ' ' VAL . . . . . . . . . . . . . 45.7 t -122.52 131.52 73.05 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.241 0 CA-C-N 115.969 -0.559 . . . . 0.0 109.85 178.58 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 37' ' ' ILE . . . . . . . . . . . . . 66.7 mt -118.68 138.52 49.12 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 CA-C-N 116.128 -0.487 . . . . 0.0 109.89 -179.462 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 38' ' ' GLY . . . . . . . . . . . . . . . -109.83 128.69 9.02 Favored Glycine 0 CA--C 1.526 0.757 0 N-CA-C 110.871 -0.892 . . . . 0.0 110.871 179.5 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 39' ' ' ILE . . . . . . . . . . . . . 71.7 mt -124.62 131.46 72.67 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.246 0 N-CA-C 110.047 -0.353 . . . . 0.0 110.047 179.437 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 40' ' ' SER . . . . . . . . . . . . . 31.5 t -92.86 119.99 32.75 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.332 -0.395 . . . . 0.0 110.675 175.819 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 41' ' ' ILE . . . . . . . . . . . . . 70.4 mt -131.54 119.99 44.23 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.202 0 N-CA-C 110.223 -0.288 . . . . 0.0 110.223 178.418 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 42' ' ' LEU . . . . . . . . . . . . . 30.1 mt 56.87 33.83 23.8 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.227 -0.442 . . . . 0.0 111.84 178.729 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 43' ' ' GLY . . . . . . . . . . . . . . . 81.05 -10.13 49.78 Favored Glycine 0 CA--C 1.535 1.302 0 C-N-CA 121.24 -0.505 . . . . 0.0 113.584 176.482 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 44' ' ' LYS . . . . . . . . . . . . . 93.4 mttt -100.03 134.43 42.96 Favored 'General case' 0 C--N 1.333 -0.126 0 CA-C-N 117.821 0.81 . . . . 0.0 110.188 177.563 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 45' ' ' GLU . . . . . . . . . . . . . 85.0 tt0 -85.71 130.5 34.55 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 116.213 -0.449 . . . . 0.0 111.217 -179.815 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 46' ' ' VAL . . . . . . . . . . . . . 7.3 p -124.46 129.85 73.73 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.211 0 N-CA-C 109.605 -0.517 . . . . 0.0 109.605 175.714 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 47' ' ' LYS . . . . . . . . . . . . . 79.9 mttt -101.08 130.75 47.16 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.006 -0.543 . . . . 0.0 111.171 177.674 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 48' ' ' PHE . . . . . . . . . . . . . 93.5 m-85 -112.46 132.0 55.28 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 116.478 -0.328 . . . . 0.0 110.131 176.102 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 49' ' ' LYS . . . . . . . . . . . . . 68.5 tttt -106.04 135.54 47.3 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.352 -0.386 . . . . 0.0 110.398 179.123 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 50' ' ' VAL . . . . . . . . . . . . . 43.4 t -81.96 110.18 16.92 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.243 0 N-CA-C 109.435 -0.58 . . . . 0.0 109.435 177.001 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 51' ' ' VAL . . . . . . . . . . . . . 47.5 t -75.53 -47.04 35.63 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.295 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.092 -173.964 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 52' ' ' GLN . . . . . . . . . . . . . 62.8 tt0 -160.83 137.26 8.57 Favored 'General case' 0 C--N 1.332 -0.186 0 C-N-CA 120.165 -0.614 . . . . 0.0 112.193 -177.917 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 53' ' ' ALA . . . . . . . . . . . . . . . -112.51 130.35 56.03 Favored 'General case' 0 C--N 1.331 -0.211 0 CA-C-N 115.741 -0.663 . . . . 0.0 109.312 172.295 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 54' ' ' TYR . . . . . . . . . . . . . 47.4 t80 -129.05 110.22 18.26 Favored Pre-proline 0 C--N 1.328 -0.341 0 CA-C-O 118.22 -0.895 . . . . 0.0 110.689 -178.342 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 55' ' ' PRO . . . . . . . . . . . . . 72.8 Cg_endo -77.31 170.11 72.23 Favored 'Cis proline' 0 N--CA 1.5 1.909 0 CA-C-N 121.949 1.732 . . . . 0.0 112.22 -6.177 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 56' ' ' SER . . . . . . . . . . . . . 13.7 m -116.24 135.88 22.91 Favored Pre-proline 0 CA--C 1.539 0.536 0 CA-C-O 118.491 -0.766 . . . . 0.0 109.329 175.143 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 57' ' ' PRO . . . . . . . . . . . . . 53.1 Cg_endo -70.34 145.57 81.06 Favored 'Cis proline' 0 N--CA 1.498 1.755 0 CA-C-N 121.795 1.677 . . . . 0.0 111.452 -1.546 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 58' ' ' LEU . . . . . . . . . . . . . 29.2 tp -108.34 138.3 44.85 Favored 'General case' 0 C--N 1.331 -0.225 0 CA-C-N 116.271 -0.422 . . . . 0.0 110.866 -177.865 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 59' ' ' ARG . . . . . . . . . . . . . 55.7 ttt180 -103.52 127.05 50.99 Favored 'General case' 0 C--N 1.328 -0.333 0 N-CA-C 109.341 -0.614 . . . . 0.0 109.341 174.543 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 60' ' ' VAL . . . . . . . . . . . . . 42.2 t -82.2 117.27 27.88 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.285 0 C-N-CA 120.74 -0.384 . . . . 0.0 110.327 -176.486 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 61' ' ' GLU . . . . . . . . . . . . . 77.5 tt0 -131.2 156.83 44.68 Favored 'General case' 0 C--N 1.329 -0.302 0 N-CA-C 109.12 -0.696 . . . . 0.0 109.12 176.158 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 62' ' ' ASP . . . . . . . . . . . . . 5.6 t70 -50.11 -30.99 12.24 Favored 'General case' 0 C--N 1.328 -0.363 0 N-CA-C 112.223 0.453 . . . . 0.0 112.223 -178.987 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 63' ' ' ARG . . . . . . . . . . . . . 20.5 mtp-105 -72.12 -22.08 61.38 Favored 'General case' 0 CA--C 1.533 0.311 0 N-CA-C 113.063 0.764 . . . . 0.0 113.063 -176.398 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 64' ' ' THR . . . . . . . . . . . . . 27.1 m -69.55 144.05 53.21 Favored 'General case' 0 C--N 1.331 -0.209 0 CA-C-O 120.92 0.39 . . . . 0.0 111.122 -174.989 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 65' ' ' LYS . . . . . . . . . . . . . 85.1 mttt -89.18 130.08 35.66 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.062 -0.517 . . . . 0.0 110.126 178.739 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 66' ' ' ILE . . . . . . . . . . . . . 67.6 mt -115.53 131.94 66.4 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.223 0 N-CA-C 109.886 -0.413 . . . . 0.0 109.886 -179.762 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 67' ' ' THR . . . . . . . . . . . . . 32.7 m -127.54 140.44 52.13 Favored 'General case' 0 C--N 1.331 -0.225 0 CA-C-O 121.232 0.539 . . . . 0.0 110.999 -178.235 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 68' ' ' LEU . . . . . . . . . . . . . 41.5 mt -101.51 130.25 47.74 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 115.768 -0.651 . . . . 0.0 109.978 177.349 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 69' ' ' VAL . . . . . . . . . . . . . 43.5 t -99.42 130.54 48.26 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.319 0 CA-C-N 116.359 -0.382 . . . . 0.0 110.1 -179.829 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 70' ' ' THR . . . . . . . . . . . . . 7.1 m -134.82 118.03 16.56 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.429 178.84 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 71' ' ' HIS . . . . . . . . . . . . . 39.9 m80 -148.72 151.51 35.66 Favored Pre-proline 0 C--N 1.329 -0.3 0 CA-C-N 116.052 -0.522 . . . . 0.0 109.957 178.848 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 72' ' ' PRO . . . . . . . . . . . . . 90.0 Cg_endo -81.26 -30.03 1.73 Allowed 'Trans proline' 0 N--CA 1.493 1.492 0 C-N-CA 121.254 1.303 . . . . 0.0 112.465 -179.198 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 73' ' ' VAL . . . . . . . . . . . . . 27.7 m -151.43 161.94 3.15 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.282 0 CA-C-O 120.874 0.368 . . . . 0.0 110.488 177.923 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 74' ' ' ASP . . . . . . . . . . . . . 31.9 t0 -102.88 116.96 33.57 Favored 'General case' 0 C--N 1.33 -0.27 0 N-CA-C 109.467 -0.568 . . . . 0.0 109.467 176.867 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 75' ' ' VAL . . . . . . . . . . . . . 42.1 t -114.04 124.41 70.67 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.26 0 CA-C-O 121.057 0.456 . . . . 0.0 110.704 -176.148 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 76' ' ' LEU . . . . . . . . . . . . . 7.3 mp -122.39 144.25 49.15 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 115.71 -0.677 . . . . 0.0 109.841 175.864 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 77' ' ' GLU . . . . . . . . . . . . . 97.7 mt-10 -134.6 130.28 36.24 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-O 121.07 0.462 . . . . 0.0 110.837 -178.887 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 78' ' ' ALA . . . . . . . . . . . . . . . -117.68 128.24 54.72 Favored 'General case' 0 C--N 1.331 -0.221 0 CA-C-N 115.8 -0.636 . . . . 0.0 109.938 177.966 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 79' ' ' LYS . . . . . . . . . . . . . 49.0 tptt -75.65 118.75 18.81 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.306 -0.406 . . . . 0.0 110.62 -177.37 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 80' ' ' ILE . . . . . . . . . . . . . 38.1 mm -139.11 106.24 2.84 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.325 0 N-CA-C 109.278 -0.638 . . . . 0.0 109.278 -177.588 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 81' ' ' LYS . . . . . . . . . . . . . 86.1 mttt -93.56 126.85 38.94 Favored 'General case' 0 C--N 1.328 -0.368 0 C-N-CA 120.709 -0.397 . . . . 0.0 111.086 -178.636 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 82' ' ' GLY . . . . . . . . . . . . . . . 89.04 42.14 5.7 Favored Glycine 0 CA--C 1.525 0.71 0 C-N-CA 120.811 -0.709 . . . . 0.0 111.839 174.092 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 83' ' ' ILE . . . . . . . . . . . . . 71.6 mt -70.28 131.46 34.22 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.312 0 N-CA-C 109.339 -0.615 . . . . 0.0 109.339 176.128 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 84' ' ' LYS . . . . . . . . . . . . . 38.5 ttpt -99.05 -43.99 6.47 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.568 -0.287 . . . . 0.0 110.389 -178.272 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 85' ' ' ASP . . . . . . . . . . . . . 9.7 t70 -155.48 154.26 31.56 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.356 -0.384 . . . . 0.0 110.792 179.348 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 86' ' ' VAL . . . . . . . . . . . . . 44.5 t -132.93 134.36 58.2 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.183 0 CA-C-O 120.959 0.409 . . . . 0.0 110.502 -179.476 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 87' ' ' ILE . . . . . . . . . . . . . 44.3 mm -121.03 128.47 76.07 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.274 0 CA-C-N 115.798 -0.637 . . . . 0.0 109.593 178.7 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 88' ' ' LEU . . . . . . . . . . . . . 17.4 tp -115.17 133.19 56.26 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-O 120.985 0.421 . . . . 0.0 111.116 -178.04 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 89' ' ' ASP . . . . . . . . . . . . . 7.0 t70 -127.42 159.9 33.08 Favored 'General case' 0 C--N 1.332 -0.17 0 CA-C-N 115.898 -0.592 . . . . 0.0 109.574 176.822 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 90' ' ' GLU . . . . . . . . . . . . . 96.3 mt-10 -47.15 -38.07 11.04 Favored 'General case' 0 C--N 1.33 -0.272 0 N-CA-C 113.2 0.815 . . . . 0.0 113.2 -171.009 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 91' ' ' ASN . . . . . . . . . . . . . 1.2 p30 -132.04 20.69 4.5 Favored 'General case' 0 N--CA 1.468 0.442 0 N-CA-C 113.038 0.755 . . . . 0.0 113.038 -176.736 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 92' ' ' LEU . . . . . . . . . . . . . 57.5 mt -149.01 146.93 28.0 Favored 'General case' 0 C--N 1.331 -0.204 0 CA-C-O 120.767 0.318 . . . . 0.0 110.64 -177.038 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 93' ' ' ILE . . . . . 0.403 HD12 HG23 ' B' ' 93' ' ' ILE . 67.1 mt -123.89 119.86 58.08 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.291 0 N-CA-C 109.236 -0.653 . . . . 0.0 109.236 178.231 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' B' B ' 94' ' ' VAL . . . . . . . . . . . . . 44.7 t -118.76 128.28 75.64 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.257 0 N-CA-C 109.829 -0.434 . . . . 0.0 109.829 -179.076 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 95' ' ' VAL . . . . . . . . . . . . . 42.6 t -121.73 134.1 66.08 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.304 0 CA-C-N 116.138 -0.483 . . . . 0.0 109.829 -179.882 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 96' ' ' ILE . . . . . . . . . . . . . 63.7 mt -115.13 127.1 72.82 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.21 0 N-CA-C 109.411 -0.589 . . . . 0.0 109.411 179.95 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 97' ' ' THR . . . . . . . . . . . . . 66.4 p -102.6 157.71 16.75 Favored 'General case' 0 C--N 1.331 -0.222 0 CA-C-O 121.394 0.616 . . . . 0.0 111.376 -176.74 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 98' ' ' GLU . . . . . . . . . . . . . 84.0 tt0 -53.9 -25.54 20.61 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 115.867 -0.606 . . . . 0.0 112.317 179.834 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 99' ' ' GLU . . . . . . . . . . . . . 45.8 mp0 -77.69 14.37 1.06 Allowed 'General case' 0 CA--C 1.535 0.403 0 N-CA-C 113.161 0.8 . . . . 0.0 113.161 -177.206 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 100' ' ' ASN . . . . . . . . . . . . . 3.2 m-20 62.32 38.04 13.45 Favored 'General case' 0 CA--C 1.529 0.169 0 CA-C-O 121.05 0.453 . . . . 0.0 110.747 178.699 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 101' ' ' GLU . . . . . . . . . . . . . 84.7 tt0 -120.61 141.76 50.03 Favored 'General case' 0 C--N 1.332 -0.163 0 CA-C-N 116.098 -0.501 . . . . 0.0 109.75 177.214 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 102' ' ' VAL . . . . . . . . . . . . . 44.9 t -114.97 127.63 72.45 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.297 0 CA-C-N 116.331 -0.395 . . . . 0.0 109.972 -178.297 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 103' ' ' LEU . . . . . . . . . . . . . 6.7 mp -117.25 132.83 56.54 Favored 'General case' 0 C--N 1.331 -0.227 0 CA-C-N 115.763 -0.653 . . . . 0.0 110.273 176.988 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 104' ' ' ILE . . . . . . . . . . . . . 67.3 mt -118.24 121.69 67.79 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.24 0 CA-C-N 116.037 -0.529 . . . . 0.0 110.031 179.662 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 105' ' ' PHE . . . . . . . . . . . . . 56.7 m-85 -120.37 161.72 20.71 Favored 'General case' 0 C--N 1.331 -0.219 0 O-C-N 123.98 0.8 . . . . 0.0 109.651 178.64 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 106' ' ' ASN . . . . . . . . . . . . . 44.2 p-10 -93.97 -169.95 2.2 Favored 'General case' 0 C--N 1.33 -0.249 0 N-CA-C 110.053 -0.351 . . . . 0.0 110.053 175.019 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 107' ' ' GLN . . . . . . . . . . . . . 61.4 tt0 -58.91 -30.03 67.51 Favored 'General case' 0 C--N 1.33 -0.258 0 N-CA-C 111.876 0.324 . . . . 0.0 111.876 179.333 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 108' ' ' ASN . . . . . . . . . . . . . 6.8 t30 -83.66 7.94 15.96 Favored 'General case' 0 CA--C 1.536 0.406 0 N-CA-C 113.193 0.812 . . . . 0.0 113.193 -177.274 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 109' ' ' LEU . . . . . . . . . . . . . 12.0 tp 60.78 37.66 18.64 Favored 'General case' 0 C--O 1.232 0.181 0 CA-C-O 120.962 0.41 . . . . 0.0 111.211 179.074 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 110' ' ' GLU . . . . . . . . . . . . . 95.4 mt-10 -107.34 151.24 25.76 Favored 'General case' 0 C--N 1.331 -0.238 0 N-CA-C 109.925 -0.398 . . . . 0.0 109.925 176.174 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 111' ' ' GLU . . . . . . . . . . . . . 84.8 tt0 -82.01 123.24 28.73 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-O 120.939 0.399 . . . . 0.0 111.175 -175.626 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 112' ' ' LEU . . . . . . . . . . . . . 33.7 mt -108.36 -46.0 3.79 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 115.933 -0.576 . . . . 0.0 110.481 177.443 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 113' ' ' TYR . . . . . . . . . . . . . 60.5 t80 -140.61 137.68 33.84 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.163 -0.471 . . . . 0.0 110.921 -179.053 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 114' ' ' ARG . . . . . . . . . . . . . 56.9 ttp180 -147.0 124.98 12.0 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-O 120.991 0.424 . . . . 0.0 110.386 175.866 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 115' ' ' GLY . . . . . . . . . . . . . . . -150.15 156.53 26.78 Favored Glycine 0 CA--C 1.526 0.737 0 N-CA-C 110.95 -0.86 . . . . 0.0 110.95 179.164 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 116' ' ' LYS . . . . . . . . . . . . . 35.0 ttpt -118.69 138.45 52.62 Favored 'General case' 0 C--O 1.233 0.189 0 CA-C-O 120.73 0.3 . . . . 0.0 110.288 179.18 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 117' ' ' PHE . . . . . . . . . . . . . 24.0 m-85 -135.78 114.07 11.53 Favored 'General case' 0 C--N 1.329 -0.299 0 N-CA-C 109.733 -0.469 . . . . 0.0 109.733 -178.973 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 118' ' ' GLU . . . . . . . . . . . . . 96.3 mt-10 -54.97 -42.22 72.12 Favored 'General case' 0 C--N 1.329 -0.29 0 C-N-CA 120.874 -0.33 . . . . 0.0 111.223 -176.234 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 119' ' ' ASN . . . . . . . . . . . . . 2.5 m120 -97.32 31.13 2.58 Favored 'General case' 0 C--N 1.33 -0.257 0 N-CA-C 112.148 0.425 . . . . 0.0 112.148 -174.97 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 120' ' ' LEU . . . . . . . . . . . . . 18.7 tp -57.13 121.85 11.03 Favored 'General case' 0 C--N 1.332 -0.174 0 N-CA-C 110.278 -0.268 . . . . 0.0 110.278 177.253 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 121' ' ' ASN . . . . . . . . . . . . . 57.9 m-20 -113.98 -44.17 3.18 Favored 'General case' 0 C--N 1.332 -0.186 0 CA-C-N 116.667 -0.242 . . . . 0.0 111.309 -176.766 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 122' ' ' LYS . . . . . . . . . . . . . 98.3 mttt -146.67 149.76 34.09 Favored 'General case' 0 C--O 1.232 0.171 0 C-N-CA 120.442 -0.503 . . . . 0.0 112.008 -177.951 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 123' ' ' VAL . . . . . . . . . . . . . 48.8 t -119.41 127.78 75.85 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.218 0 CA-C-N 115.697 -0.683 . . . . 0.0 109.163 174.326 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 124' ' ' LEU . . . . . . . . . . . . . 31.6 mt -120.89 136.01 55.04 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 116.531 -0.304 . . . . 0.0 110.633 -176.255 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 125' ' ' VAL . . . . . . . . . . . . . 42.6 t -131.1 131.45 63.84 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.264 0 CA-C-N 116.306 -0.406 . . . . 0.0 110.266 179.121 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 126' ' ' ARG . . . . . . . . . . . . . 27.7 mtp180 -151.55 129.73 11.93 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.113 -0.494 . . . . 0.0 109.842 176.619 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 127' ' ' ASN . . . . . . . . . . . . . 32.5 t30 56.2 -152.45 0.38 Allowed 'General case' 0 CA--C 1.54 0.565 0 N-CA-C 109.7 -0.481 . . . . 0.0 109.7 -179.119 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 128' ' ' ASP . . . . . . . . . . . . . 15.9 p-10 -83.6 18.04 2.03 Favored 'General case' 0 CA--C 1.537 0.45 0 CA-C-N 118.526 0.603 . . . . 0.0 112.562 177.558 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 129' ' ' LEU . . . . . . . . . . . . . 41.1 mt -115.24 144.92 42.99 Favored 'General case' 0 C--O 1.232 0.179 0 CA-C-N 117.956 0.344 . . . . 0.0 110.24 179.69 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 130' ' ' VAL . . . . . . . . . . . . . 32.3 m -129.31 143.21 41.89 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.232 0 CA-C-O 120.93 0.395 . . . . 0.0 110.6 -178.512 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 131' ' ' VAL . . . . . . . . . . . . . 38.0 t -136.1 141.34 41.87 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.254 0 CA-C-O 121.079 0.466 . . . . 0.0 110.551 -178.844 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 132' ' ' ILE . . . . . . . . . . . . . 74.1 mt -118.39 131.38 71.34 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.262 0 CA-C-N 115.805 -0.634 . . . . 0.0 109.396 178.726 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 133' ' ' ILE . . . . . . . . . . . . . 41.8 mm -117.11 125.12 73.75 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.235 0 CA-C-O 120.785 0.326 . . . . 0.0 111.158 -174.035 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 134' ' ' ASP . . . . . . . . . . . . . 9.7 p-10 -136.09 148.01 48.09 Favored 'General case' 0 C--N 1.332 -0.167 0 N-CA-C 109.514 -0.55 . . . . 0.0 109.514 172.89 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 135' ' ' GLU . . . . . . . . . . . . . 44.3 tp10 -49.92 -27.26 5.02 Favored 'General case' 0 C--N 1.326 -0.45 0 N-CA-C 112.873 0.694 . . . . 0.0 112.873 -172.668 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 136' ' ' GLN . . . . . . . . . . . . . 53.8 mt-30 -85.23 -30.46 23.82 Favored 'General case' 0 C--N 1.33 -0.24 0 N-CA-C 112.694 0.627 . . . . 0.0 112.694 -175.113 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 137' ' ' LYS . . . . . . . . . . . . . 22.9 pttm -167.62 171.18 10.44 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-O 121.518 0.675 . . . . 0.0 112.483 -173.024 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 138' ' ' LEU . . . . . . . . . . . . . 6.4 tt -121.11 130.02 53.56 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 115.059 -0.973 . . . . 0.0 110.164 -178.521 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 139' ' ' THR . . . . . . . . . . . . . 29.2 m -109.57 125.38 52.47 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-N 116.26 -0.427 . . . . 0.0 110.291 178.593 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 140' ' ' LEU . . . . . . . . . . . . . 15.0 tp -114.24 119.24 36.35 Favored 'General case' 0 C--N 1.328 -0.328 0 N-CA-C 109.412 -0.588 . . . . 0.0 109.412 -178.015 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 141' ' ' ILE . . . . . . . . . . . . . 22.1 mt -120.08 121.18 65.2 Favored 'Isoleucine or valine' 0 C--O 1.234 0.248 0 CA-C-O 121.067 0.461 . . . . 0.0 110.217 -175.731 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 142' ' ' ARG . . . . . . . . . . . . . 85.3 mtm180 -107.13 127.23 53.31 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 115.219 -0.9 . . . . 0.0 110.435 -178.748 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 143' ' ' THR . . . . . . . . . . . . . 76.5 p . . . . . 0 C--O 1.22 -0.472 0 CA-C-O 117.976 -1.011 . . . . 0.0 110.537 179.778 . . . . . . . . 0 0 . 1 . 006 nuclear orig full ' C' C ' -3' ' ' GLU . . . . . . . . . . . . . 70.5 mm-40 . . . . . 0 N--CA 1.49 1.537 0 N-CA-C 109.408 -0.59 . . . . 0.0 109.408 . . . . . . . . . 0 0 . 1 . 006 nuclear orig full ' C' C ' -2' ' ' GLY . . . . . . . . . . . . . . . -67.31 147.61 49.12 Favored Glycine 0 CA--C 1.524 0.654 0 N-CA-C 110.875 -0.89 . . . . 0.0 110.875 179.984 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' C' C ' -1' ' ' VAL . . . . . . . . . . . . . 44.8 t -96.43 131.85 42.2 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.248 0 CA-C-O 120.868 0.366 . . . . 0.0 110.093 -179.925 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' C' C ' 0' ' ' ILE . . . . . . . . . . . . . 70.8 mt -119.02 127.88 75.82 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.265 0 CA-C-N 116.123 -0.49 . . . . 0.0 109.892 179.379 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' C' C ' 1' ' ' MET . . . . . . . . . . . . . 26.6 ptt? -93.36 133.61 36.44 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.241 -0.436 . . . . 0.0 110.325 179.156 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' C' C ' 2' ' ' SER . . . . . . . . . . . . . 5.7 p -110.41 132.32 54.28 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-O 121.071 0.463 . . . . 0.0 110.818 -178.297 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' C' C ' 3' ' ' GLU . . . . . . . . . . . . . 85.1 tt0 -142.12 140.44 32.48 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 115.801 -0.636 . . . . 0.0 111.001 -179.832 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' C' C ' 4' ' ' LEU . . . . . . . . . . . . . 15.9 tp -121.89 126.53 48.9 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 115.887 -0.597 . . . . 0.0 110.093 177.171 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' C' C ' 5' ' ' LYS . . . . . . . . . . . . . 99.0 mttt -104.64 121.0 42.65 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.414 -0.357 . . . . 0.0 110.572 178.577 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' C' C ' 6' ' ' LEU . . . . . . . . . . . . . 75.7 mt -116.63 148.71 40.71 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 115.43 -0.804 . . . . 0.0 110.284 -178.959 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' C' C ' 7' ' ' LYS . . . . . . . . . . . . . 64.2 tttm -133.18 136.04 26.68 Favored Pre-proline 0 CA--C 1.534 0.365 0 CA-C-O 118.929 -0.558 . . . . 0.0 109.91 177.084 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' C' C ' 8' ' ' PRO . . . . . . . . . . . . . 84.7 Cg_endo -90.61 140.64 3.07 Favored 'Trans proline' 0 N--CA 1.491 1.365 0 C-N-CA 121.716 1.611 . . . . 0.0 111.571 178.063 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' C' C ' 9' ' ' LEU . . . . . . . . . . . . . 68.6 mt -75.13 -47.53 4.55 Favored Pre-proline 0 CA--C 1.534 0.345 0 CA-C-O 118.712 -0.661 . . . . 0.0 112.311 -178.689 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' C' C ' 10' ' ' PRO . . . . . . . . . . . . . 91.4 Cg_endo -81.49 152.57 17.76 Favored 'Trans proline' 0 N--CA 1.497 1.715 0 C-N-CA 121.312 1.341 . . . . 0.0 111.987 176.038 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' C' C ' 11' ' ' LYS . . . . . . . . . . . . . 50.0 tttm -89.23 102.2 14.86 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.426 -0.352 . . . . 0.0 110.373 178.282 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' C' C ' 12' ' ' VAL . . . . . . . . . . . . . 12.8 p -147.36 145.7 18.89 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.359 0 CA-C-N 116.313 -0.403 . . . . 0.0 110.802 -179.461 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' C' C ' 13' ' ' GLU . . . . . . . . . . . . . 39.6 mt-10 -83.72 122.15 28.25 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.324 -0.398 . . . . 0.0 109.99 175.613 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' C' C ' 14' ' ' LEU . . . . . . . . . . . . . 27.4 mt -94.68 153.92 40.08 Favored Pre-proline 0 C--N 1.329 -0.288 0 CA-C-N 116.456 -0.338 . . . . 0.0 110.83 -177.699 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' C' C ' 15' ' ' PRO . . . . . . . . . . . . . 36.0 Cg_exo -58.35 154.96 37.84 Favored 'Trans proline' 0 N--CA 1.495 1.588 0 C-N-CA 121.268 1.312 . . . . 0.0 111.724 178.576 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' C' C ' 16' ' ' PRO . . . . . . . . . . . . . 34.2 Cg_exo -57.85 -33.61 97.21 Favored 'Trans proline' 0 N--CA 1.497 1.701 0 C-N-CA 121.483 1.455 . . . . 0.0 112.817 -179.098 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' C' C ' 17' ' ' ASP . . . . . . . . . . . . . 20.8 p-10 -90.1 8.79 30.98 Favored 'General case' 0 CA--C 1.536 0.41 0 N-CA-C 113.45 0.907 . . . . 0.0 113.45 -176.671 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' C' C ' 18' ' ' PHE . . . . . . . . . . . . . 35.4 t80 -58.4 -45.8 87.65 Favored 'General case' 0 N--CA 1.457 -0.094 0 O-C-N 121.972 -0.455 . . . . 0.0 110.122 -177.212 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' C' C ' 19' ' ' VAL . . . . . . . . . . . . . 14.2 p -56.51 -41.33 72.47 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.411 0 CA-C-N 116.269 -0.423 . . . . 0.0 110.889 -178.916 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' C' C ' 20' ' ' ASP . . . . . . . . . . . . . 68.8 m-20 -60.73 -42.83 98.09 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-O 120.83 0.348 . . . . 0.0 111.076 -178.191 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' C' C ' 21' ' ' VAL . . . . . . . . . . . . . 48.7 t -64.44 -48.52 84.78 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.32 0 CA-C-N 116.311 -0.404 . . . . 0.0 110.403 -177.566 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' C' C ' 22' ' ' ILE . . . . . . . . . . . . . 48.8 mm -55.73 -46.37 79.64 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.221 0 CA-C-O 120.869 0.366 . . . . 0.0 110.738 -179.742 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' C' C ' 23' ' ' ARG . . . . . . . . . . . . . 59.9 ttp180 -53.48 -51.7 61.91 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-O 120.777 0.323 . . . . 0.0 111.566 -178.719 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' C' C ' 24' ' ' ILE . . . . . . . . . . . . . 74.9 mt -60.12 -41.42 86.49 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.269 0 CA-C-N 116.6 -0.273 . . . . 0.0 111.214 -176.631 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' C' C ' 25' ' ' LYS . . . . . . . . . . . . . 53.6 mmtt -63.78 -39.97 95.54 Favored 'General case' 0 C--N 1.328 -0.33 0 N-CA-C 112.107 0.41 . . . . 0.0 112.107 -179.948 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' C' C ' 26' ' ' LEU . . . . . . . . . . . . . 87.7 mt -78.48 -41.12 33.47 Favored 'General case' 0 C--N 1.33 -0.252 0 N-CA-C 113.539 0.94 . . . . 0.0 113.539 -170.715 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' C' C ' 27' ' ' GLN . . . . . . . . . . . . . 11.3 pt20 -47.24 139.85 5.85 Favored 'General case' 0 N--CA 1.469 0.509 0 N-CA-C 112.75 0.648 . . . . 0.0 112.75 -174.237 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' C' C ' 28' ' ' GLY . . . . . . . . . . . . . . . 99.33 -26.75 23.12 Favored Glycine 0 CA--C 1.532 1.127 0 CA-C-N 115.633 -0.712 . . . . 0.0 112.217 -177.723 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' C' C ' 29' ' ' LYS . . . . . . . . . . . . . 98.9 mttt -98.51 155.06 17.45 Favored 'General case' 0 C--O 1.232 0.181 0 CA-C-N 117.273 0.536 . . . . 0.0 111.254 179.662 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' C' C ' 30' ' ' THR . . . . . . . . . . . . . 23.5 m -103.88 137.3 42.08 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-N 115.957 -0.565 . . . . 0.0 110.092 176.392 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' C' C ' 31' ' ' VAL . . . . . . . . . . . . . 34.8 m -130.51 154.07 40.01 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.245 0 CA-C-O 120.947 0.403 . . . . 0.0 110.971 -178.523 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' C' C ' 32' ' ' ARG . . . . . . . . . . . . . 95.6 mtt180 -130.11 151.58 50.49 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 116.013 -0.539 . . . . 0.0 110.466 178.502 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' C' C ' 33' ' ' THR . . . . . . . . . . . . . 29.3 m -53.4 139.25 31.07 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-O 120.851 0.358 . . . . 0.0 111.225 -178.314 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' C' C ' 34' ' ' GLY . . . . . . . . . . . . . . . 100.63 -17.05 57.14 Favored Glycine 0 CA--C 1.532 1.136 0 CA-C-O 119.671 -0.516 . . . . 0.0 113.244 179.732 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' C' C ' 35' ' ' ASP . . . . . . . . . . . . . 64.4 m-20 -65.65 150.81 47.85 Favored 'General case' 0 C--O 1.231 0.089 0 CA-C-N 118.028 0.914 . . . . 0.0 110.891 178.461 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' C' C ' 36' ' ' VAL . . . . . . . . . . . . . 43.7 t -124.38 133.61 68.89 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.188 0 CA-C-N 116.044 -0.526 . . . . 0.0 110.027 179.056 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' C' C ' 37' ' ' ILE . . . . . . . . . . . . . 69.9 mt -119.98 139.73 46.35 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.25 0 CA-C-N 116.087 -0.506 . . . . 0.0 109.842 179.882 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' C' C ' 38' ' ' GLY . . . . . . . . . . . . . . . -114.22 128.73 8.37 Favored Glycine 0 CA--C 1.526 0.727 0 N-CA-C 111.214 -0.754 . . . . 0.0 111.214 -179.82 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' C' C ' 39' ' ' ILE . . . . . . . . . . . . . 70.8 mt -125.34 130.84 72.84 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.267 0 N-CA-C 109.791 -0.448 . . . . 0.0 109.791 178.371 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' C' C ' 40' ' ' SER . . . . . . . . . . . . . 31.3 t -93.18 113.95 26.32 Favored 'General case' 0 C--N 1.33 -0.24 0 C-N-CA 120.747 -0.381 . . . . 0.0 110.817 176.185 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' C' C ' 41' ' ' ILE . . . . . . . . . . . . . 43.9 mm -123.82 121.79 63.12 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.204 0 CA-C-N 116.484 -0.326 . . . . 0.0 110.237 -179.413 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' C' C ' 42' ' ' LEU . . . . . . . . . . . . . 72.4 mt 57.68 35.33 25.51 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-N 116.349 -0.387 . . . . 0.0 111.8 177.118 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' C' C ' 43' ' ' GLY . . . . . . . . . . . . . . . 78.3 -10.18 30.01 Favored Glycine 0 CA--C 1.533 1.169 0 C-N-CA 121.178 -0.534 . . . . 0.0 113.449 177.248 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' C' C ' 44' ' ' LYS . . . . . . . . . . . . . 68.7 mttm -100.24 131.71 46.02 Favored 'General case' 0 C--N 1.333 -0.125 0 CA-C-N 118.016 0.908 . . . . 0.0 110.078 176.51 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' C' C ' 45' ' ' GLU . . . . . . . . . . . . . 31.5 tp10 -84.37 127.02 33.75 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.396 -0.366 . . . . 0.0 110.459 -179.905 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' C' C ' 46' ' ' VAL . . . . . . . . . . . . . 7.6 p -121.09 128.15 76.0 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.243 0 CA-C-O 121.116 0.484 . . . . 0.0 109.807 178.36 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' C' C ' 47' ' ' LYS . . . . . . . . . . . . . 62.8 mttp -100.57 130.66 46.66 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 115.903 -0.59 . . . . 0.0 111.459 178.058 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' C' C ' 48' ' ' PHE . . . . . . . . . . . . . 94.9 m-85 -113.95 131.95 56.13 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 115.915 -0.584 . . . . 0.0 109.873 176.023 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' C' C ' 49' ' ' LYS . . . . . . . . . . . . . 84.4 tttt -106.53 136.53 46.14 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.471 -0.331 . . . . 0.0 110.518 179.975 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' C' C ' 50' ' ' VAL . . . . . . . . . . . . . 43.6 t -80.99 109.3 15.21 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.302 0 N-CA-C 109.311 -0.626 . . . . 0.0 109.311 177.252 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' C' C ' 51' ' ' VAL . . . . . . . . . . . . . 47.9 t -73.96 -47.55 42.24 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.39 0 CA-C-N 116.148 -0.478 . . . . 0.0 110.11 -173.781 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' C' C ' 52' ' ' GLN . . . . . . . . . . . . . 61.9 tt0 -163.86 139.43 6.31 Favored 'General case' 0 C--N 1.331 -0.222 0 C-N-CA 120.218 -0.593 . . . . 0.0 111.912 -177.724 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' C' C ' 53' ' ' ALA . . . . . . . . . . . . . . . -112.94 133.67 54.8 Favored 'General case' 0 C--N 1.332 -0.195 0 CA-C-N 115.66 -0.7 . . . . 0.0 109.853 175.445 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' C' C ' 54' ' ' TYR . . . . . . . . . . . . . 48.9 t80 -129.08 111.14 18.33 Favored Pre-proline 0 CA--C 1.536 0.415 0 CA-C-O 118.172 -0.918 . . . . 0.0 110.456 179.263 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' C' C ' 55' ' ' PRO . . . . . . . . . . . . . 72.5 Cg_endo -77.17 168.09 77.89 Favored 'Cis proline' 0 N--CA 1.497 1.726 0 CA-C-N 121.883 1.708 . . . . 0.0 112.213 -6.24 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' C' C ' 56' ' ' SER . . . . . . . . . . . . . 48.1 m -117.32 136.5 23.48 Favored Pre-proline 0 CA--C 1.539 0.525 0 CA-C-O 118.518 -0.754 . . . . 0.0 109.683 174.652 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' C' C ' 57' ' ' PRO . . . . . . . . . . . . . 36.8 Cg_endo -66.95 145.99 73.87 Favored 'Cis proline' 0 N--CA 1.499 1.795 0 CA-C-N 121.822 1.687 . . . . 0.0 111.383 -3.473 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' C' C ' 58' ' ' LEU . . . . . . . . . . . . . 20.6 tp -107.76 136.17 47.95 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.505 -0.316 . . . . 0.0 110.699 -177.796 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' C' C ' 59' ' ' ARG . . . . . . . . . . . . . 71.3 ttt180 -104.58 124.42 49.29 Favored 'General case' 0 C--N 1.328 -0.355 0 N-CA-C 109.247 -0.649 . . . . 0.0 109.247 175.462 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' C' C ' 60' ' ' VAL . . . . . . . . . . . . . 42.3 t -79.73 126.23 39.14 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.251 0 C-N-CA 120.663 -0.415 . . . . 0.0 110.492 -174.459 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' C' C ' 61' ' ' GLU . . . . . . . . . . . . . 96.4 mt-10 -131.05 160.97 33.07 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 115.712 -0.676 . . . . 0.0 109.967 178.507 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' C' C ' 62' ' ' ASP . . . . . . . . . . . . . 11.7 t70 -53.76 -32.49 52.49 Favored 'General case' 0 C--N 1.328 -0.363 0 N-CA-C 111.822 0.304 . . . . 0.0 111.822 -179.154 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' C' C ' 63' ' ' ARG . . . . . . . . . . . . . 38.0 ptt180 -88.38 6.19 38.55 Favored 'General case' 0 CA--C 1.537 0.447 0 N-CA-C 113.688 0.996 . . . . 0.0 113.688 -175.616 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' C' C ' 64' ' ' THR . . . . . . . . . . . . . 38.2 m -81.12 142.51 33.22 Favored 'General case' 0 C--N 1.331 -0.2 0 CA-C-N 118.03 0.377 . . . . 0.0 110.549 -179.404 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' C' C ' 65' ' ' LYS . . . . . . . . . . . . . 68.4 mttm -89.26 129.9 35.75 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.237 179.543 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' C' C ' 66' ' ' ILE . . . . . . . . . . . . . 64.7 mt -116.93 130.1 72.4 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.217 0 N-CA-C 109.758 -0.46 . . . . 0.0 109.758 178.86 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' C' C ' 67' ' ' THR . . . . . . . . . . . . . 36.0 m -126.47 140.23 52.63 Favored 'General case' 0 C--N 1.331 -0.22 0 CA-C-O 121.069 0.461 . . . . 0.0 111.065 -177.119 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' C' C ' 68' ' ' LEU . . . . . . . . . . . . . 6.4 tt -101.72 123.03 45.02 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 115.763 -0.653 . . . . 0.0 109.446 176.562 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' C' C ' 69' ' ' VAL . . . . . . . . . . . . . 40.4 t -96.22 106.05 17.85 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.309 0 CA-C-O 121.009 0.433 . . . . 0.0 110.944 -175.365 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' C' C ' 70' ' ' THR . . . . . . . . . . . . . 5.9 p -141.55 169.61 17.29 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 115.559 -0.746 . . . . 0.0 109.63 175.806 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' C' C ' 71' ' ' HIS . . . . . . . . . . . . . 21.6 m80 -127.45 64.19 61.78 Favored Pre-proline 0 CA--C 1.537 0.472 0 CA-C-O 120.653 0.263 . . . . 0.0 111.241 179.016 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' C' C ' 72' ' ' PRO . . . . . . . . . . . . . 63.6 Cg_endo -92.74 153.97 2.82 Favored 'Trans proline' 0 N--CA 1.49 1.305 0 C-N-CA 121.875 1.716 . . . . 0.0 111.289 172.447 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' C' C ' 73' ' ' VAL . . . . . . . . . . . . . 18.7 m -92.79 132.51 36.86 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.26 0 CA-C-O 121.201 0.524 . . . . 0.0 110.541 177.706 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' C' C ' 74' ' ' ASP . . . . . . . . . . . . . 13.7 t0 -97.52 123.72 41.49 Favored 'General case' 0 C--N 1.326 -0.417 0 CA-C-N 115.508 -0.769 . . . . 0.0 109.34 178.262 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' C' C ' 75' ' ' VAL . . . . . . . . . . . . . 42.1 t -112.65 121.23 64.56 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.257 0 CA-C-O 121.187 0.518 . . . . 0.0 110.621 -176.221 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' C' C ' 76' ' ' LEU . . . . . . . . . . . . . 7.6 mp -119.09 141.32 48.87 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 115.58 -0.737 . . . . 0.0 109.496 175.673 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' C' C ' 77' ' ' GLU . . . . . . . . . . . . . 46.3 mt-10 -132.23 137.0 47.38 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-O 121.059 0.457 . . . . 0.0 110.994 -178.515 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' C' C ' 78' ' ' ALA . . . . . . . . . . . . . . . -127.39 135.68 50.81 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 115.727 -0.67 . . . . 0.0 109.889 177.152 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' C' C ' 79' ' ' LYS . . . . . . . . . . . . . 54.9 pttt -83.85 120.87 26.58 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-O 121.31 0.576 . . . . 0.0 110.932 -178.516 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' C' C ' 80' ' ' ILE . . . . . . . . . . . . . 39.6 mm -139.18 115.92 10.34 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.274 0 CA-C-N 115.738 -0.665 . . . . 0.0 109.359 -177.769 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' C' C ' 81' ' ' LYS . . . . . . . . . . . . . 99.3 mttt -101.09 125.48 47.71 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-O 120.828 0.347 . . . . 0.0 111.156 -178.172 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' C' C ' 82' ' ' GLY . . . . . . . . . . . . . . . 89.13 42.2 5.66 Favored Glycine 0 CA--C 1.524 0.624 0 C-N-CA 120.714 -0.755 . . . . 0.0 111.772 173.117 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' C' C ' 83' ' ' ILE . . . . . . . . . . . . . 74.8 mt -65.61 134.91 29.18 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.374 0 N-CA-C 109.606 -0.516 . . . . 0.0 109.606 176.841 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' C' C ' 84' ' ' LYS . . . . . . . . . . . . . 51.0 tttp -99.09 -53.96 3.11 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-O 121.061 0.458 . . . . 0.0 110.375 -179.148 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' C' C ' 85' ' ' ASP . . . . . . . . . . . . . 10.1 t70 -148.78 146.37 28.0 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 115.786 -0.643 . . . . 0.0 110.284 -179.082 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' C' C ' 86' ' ' VAL . . . . . . . . . . . . . 43.7 t -127.14 127.61 69.63 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.196 0 CA-C-O 120.783 0.325 . . . . 0.0 110.414 -179.558 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' C' C ' 87' ' ' ILE . . . . . . . . . . . . . 44.6 mm -120.53 126.71 75.55 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.27 0 CA-C-N 115.996 -0.547 . . . . 0.0 109.766 177.935 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' C' C ' 88' ' ' LEU . . . . . . . . . . . . . 74.6 mt -107.25 139.61 41.44 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-O 121.006 0.432 . . . . 0.0 111.037 -179.314 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' C' C ' 89' ' ' ASP . . . . . . . . . . . . . 6.0 t70 -130.3 154.06 48.01 Favored 'General case' 0 C--N 1.328 -0.328 0 N-CA-C 109.302 -0.629 . . . . 0.0 109.302 176.253 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' C' C ' 90' ' ' GLU . . . . . . . . . . . . . 84.9 tt0 -47.91 -34.79 9.53 Favored 'General case' 0 C--N 1.33 -0.253 0 N-CA-C 112.972 0.73 . . . . 0.0 112.972 -172.07 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' C' C ' 91' ' ' ASN . . . . . . . . . . . . . 86.9 m-20 -132.03 19.51 4.53 Favored 'General case' 0 N--CA 1.468 0.464 0 N-CA-C 113.124 0.787 . . . . 0.0 113.124 -178.437 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' C' C ' 92' ' ' LEU . . . . . . . . . . . . . 48.5 mt -148.66 148.55 30.21 Favored 'General case' 0 C--N 1.331 -0.218 0 CA-C-O 120.644 0.259 . . . . 0.0 110.35 -177.702 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' C' C ' 93' ' ' ILE . . . . . . . . . . . . . 70.5 mt -126.94 118.39 50.33 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.345 0 N-CA-C 109.148 -0.686 . . . . 0.0 109.148 176.42 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' C' C ' 94' ' ' VAL . . . . . . . . . . . . . 46.3 t -118.89 126.29 75.19 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.281 0 CA-C-O 121.028 0.442 . . . . 0.0 110.022 -179.035 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' C' C ' 95' ' ' VAL . . . . . . . . . . . . . 44.7 t -119.91 133.1 67.77 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.382 0 CA-C-N 115.788 -0.642 . . . . 0.0 109.648 179.386 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' C' C ' 96' ' ' ILE . . . . . . . . . . . . . 63.9 mt -111.77 127.74 68.76 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.349 0 N-CA-C 109.089 -0.708 . . . . 0.0 109.089 178.016 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' C' C ' 97' ' ' THR . . . . . . . . . . . . . 80.9 p -97.83 157.91 15.82 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-O 121.159 0.504 . . . . 0.0 110.979 -178.071 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' C' C ' 98' ' ' GLU . . . . . . . . . . . . . 82.1 tt0 -53.73 -25.53 19.02 Favored 'General case' 0 CA--C 1.533 0.323 0 CA-C-N 116.105 -0.498 . . . . 0.0 112.145 179.509 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' C' C ' 99' ' ' GLU . . . . . . . . . . . . . 95.4 mt-10 -80.12 15.34 1.54 Allowed 'General case' 0 CA--C 1.535 0.398 0 N-CA-C 113.191 0.811 . . . . 0.0 113.191 -176.714 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' C' C ' 100' ' ' ASN . . . . . . . . . . . . . 3.3 m-20 61.96 37.89 14.71 Favored 'General case' 0 N--CA 1.463 0.198 0 CA-C-O 121.105 0.479 . . . . 0.0 110.939 179.001 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' C' C ' 101' ' ' GLU . . . . . . . . . . . . . 84.5 tt0 -117.99 144.43 45.54 Favored 'General case' 0 C--N 1.332 -0.172 0 CA-C-N 116.074 -0.512 . . . . 0.0 109.755 176.764 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' C' C ' 102' ' ' VAL . . . . . . . . . . . . . 44.7 t -115.14 126.26 72.67 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.253 0 CA-C-N 116.284 -0.416 . . . . 0.0 110.14 -176.75 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' C' C ' 103' ' ' LEU . . . . . . . . . . . . . 29.5 mt -115.25 127.14 55.29 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-N 115.686 -0.688 . . . . 0.0 109.932 175.905 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' C' C ' 104' ' ' ILE . . . . . . . . . . . . . 66.7 mt -116.33 120.32 64.57 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.225 0 N-CA-C 110.15 -0.315 . . . . 0.0 110.15 179.737 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' C' C ' 105' ' ' PHE . . . . . . . . . . . . . 47.8 m-85 -119.8 166.41 13.3 Favored 'General case' 0 C--N 1.332 -0.178 0 CA-C-N 115.415 -0.812 . . . . 0.0 109.535 178.364 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' C' C ' 106' ' ' ASN . . . . . . . . . . . . . 43.0 p-10 -99.5 -170.07 1.85 Allowed 'General case' 0 C--N 1.33 -0.261 0 N-CA-C 109.993 -0.373 . . . . 0.0 109.993 174.988 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' C' C ' 107' ' ' GLN . . . . . . . . . . . . . 29.7 tt0 -58.51 -30.07 66.77 Favored 'General case' 0 C--N 1.329 -0.313 0 N-CA-C 111.984 0.365 . . . . 0.0 111.984 179.287 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' C' C ' 108' ' ' ASN . . . . . . . . . . . . . 13.5 t-20 -84.05 7.57 18.16 Favored 'General case' 0 CA--C 1.536 0.439 0 N-CA-C 113.204 0.816 . . . . 0.0 113.204 -176.903 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' C' C ' 109' ' ' LEU . . . . . . . . . . . . . 10.6 tp 61.39 38.39 16.15 Favored 'General case' 0 C--N 1.332 -0.189 0 CA-C-O 121.131 0.491 . . . . 0.0 111.19 179.192 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' C' C ' 110' ' ' GLU . . . . . . . . . . . . . 96.8 mt-10 -105.38 153.29 21.86 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.219 -0.446 . . . . 0.0 109.928 176.85 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' C' C ' 111' ' ' GLU . . . . . . . . . . . . . 83.2 tt0 -85.67 121.9 29.01 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-O 120.768 0.318 . . . . 0.0 110.587 -178.508 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' C' C ' 112' ' ' LEU . . . . . . . . . . . . . 61.6 mt -111.61 -46.14 3.29 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.258 -0.428 . . . . 0.0 110.741 179.623 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' C' C ' 113' ' ' TYR . . . . . . . . . . . . . 55.8 t80 -137.17 134.72 36.64 Favored 'General case' 0 C--N 1.331 -0.223 0 CA-C-N 116.434 -0.348 . . . . 0.0 110.966 -179.094 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' C' C ' 114' ' ' ARG . . . . . . . . . . . . . 31.6 ttp180 -135.62 124.03 23.39 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.34 -0.391 . . . . 0.0 110.164 176.604 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' C' C ' 115' ' ' GLY . . . . . . . . . . . . . . . -150.05 162.68 29.26 Favored Glycine 0 CA--C 1.523 0.567 0 N-CA-C 111.038 -0.825 . . . . 0.0 111.038 179.334 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' C' C ' 116' ' ' LYS . . . . . . . . . . . . . 30.0 ttpt -131.28 137.85 49.02 Favored 'General case' 0 C--N 1.33 -0.248 0 N-CA-C 109.941 -0.392 . . . . 0.0 109.941 178.42 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' C' C ' 117' ' ' PHE . . . . . . . . . . . . . 39.2 m-85 -135.11 113.93 11.89 Favored 'General case' 0 C--N 1.331 -0.23 0 N-CA-C 109.919 -0.4 . . . . 0.0 109.919 -178.55 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' C' C ' 118' ' ' GLU . . . . . . . . . . . . . 44.1 mt-10 -57.07 -42.12 80.07 Favored 'General case' 0 C--N 1.328 -0.34 0 C-N-CA 120.774 -0.37 . . . . 0.0 110.886 -176.324 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' C' C ' 119' ' ' ASN . . . . . . . . . . . . . 3.9 p30 -100.51 31.19 3.56 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.232 -0.44 . . . . 0.0 111.964 -175.674 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' C' C ' 120' ' ' LEU . . . . . . . . . . . . . 14.2 tp -54.03 125.9 20.6 Favored 'General case' 0 N--CA 1.463 0.195 0 CA-C-O 120.487 0.184 . . . . 0.0 110.776 177.996 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' C' C ' 121' ' ' ASN . . . . . . . . . . . . . 16.6 m120 -112.72 -44.14 3.36 Favored 'General case' 0 C--O 1.231 0.12 0 C-N-CA 121.125 -0.23 . . . . 0.0 111.415 -176.422 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' C' C ' 122' ' ' LYS . . . . . . . . . . . . . 97.7 mttt -148.3 149.38 31.75 Favored 'General case' 0 C--N 1.332 -0.189 0 C-N-CA 120.557 -0.457 . . . . 0.0 111.879 -177.593 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' C' C ' 123' ' ' VAL . . . . . . . . . . . . . 44.3 t -130.18 126.92 62.47 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.325 0 N-CA-C 109.117 -0.697 . . . . 0.0 109.117 172.908 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' C' C ' 124' ' ' LEU . . . . . . . . . . . . . 12.1 tp -127.97 138.38 52.6 Favored 'General case' 0 N--CA 1.463 0.208 0 CA-C-O 120.859 0.362 . . . . 0.0 111.371 -175.661 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' C' C ' 125' ' ' VAL . . . . . . . . . . . . . 35.6 m -126.19 133.02 69.82 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.241 0 CA-C-N 115.942 -0.572 . . . . 0.0 110.436 177.715 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' C' C ' 126' ' ' ARG . . . . . . . . . . . . . 24.4 mmt180 -139.38 116.48 11.05 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.312 -0.404 . . . . 0.0 110.537 178.367 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' C' C ' 127' ' ' ASN . . . . . . . . . . . . . 17.8 m-80 52.1 -105.03 0.2 Allowed 'General case' 0 CA--C 1.543 0.68 0 CA-C-O 119.173 -0.441 . . . . 0.0 111.255 178.578 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' C' C ' 128' ' ' ASP . . . . . . . . . . . . . 21.2 p-10 -113.95 1.19 14.63 Favored 'General case' 0 N--CA 1.469 0.487 0 CA-C-N 119.501 1.046 . . . . 0.0 113.423 -176.916 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' C' C ' 129' ' ' LEU . . . . . . . . . . . . . 12.1 tp -108.13 137.77 45.54 Favored 'General case' 0 C--N 1.332 -0.166 0 N-CA-C 109.728 -0.471 . . . . 0.0 109.728 179.155 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' C' C ' 130' ' ' VAL . . . . . . . . . . . . . 13.0 p -126.74 137.97 56.21 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.235 0 CA-C-O 121.035 0.445 . . . . 0.0 110.131 179.906 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' C' C ' 131' ' ' VAL . . . . . . . . . . . . . 42.3 t -135.73 141.14 42.9 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.274 0 CA-C-O 121.16 0.505 . . . . 0.0 110.495 -177.358 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' C' C ' 132' ' ' ILE . . . . . . . . . . . . . 73.6 mt -115.92 132.1 66.4 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.345 0 CA-C-N 115.477 -0.783 . . . . 0.0 109.051 177.838 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' C' C ' 133' ' ' ILE . . . . . . . . . . . . . 43.3 mm -113.36 122.21 67.04 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.242 0 CA-C-O 120.9 0.381 . . . . 0.0 110.494 -175.715 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' C' C ' 134' ' ' ASP . . . . . . . . . . . . . 7.4 p-10 -135.17 146.98 49.26 Favored 'General case' 0 C--N 1.331 -0.209 0 CA-C-N 116.045 -0.525 . . . . 0.0 109.892 178.063 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' C' C ' 135' ' ' GLU . . . . . . . . . . . . . 85.2 tt0 -50.01 -27.9 6.16 Favored 'General case' 0 C--N 1.326 -0.417 0 N-CA-C 112.738 0.644 . . . . 0.0 112.738 -174.536 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' C' C ' 136' ' ' GLN . . . . . . . . . . . . . 97.3 mt-30 -79.81 -34.23 39.71 Favored 'General case' 0 C--O 1.233 0.232 0 N-CA-C 112.456 0.539 . . . . 0.0 112.456 -176.818 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' C' C ' 137' ' ' LYS . . . . . . . . . . . . . 53.1 pttt -169.99 177.06 4.46 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-O 121.551 0.691 . . . . 0.0 112.31 -172.289 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' C' C ' 138' ' ' LEU . . . . . . . . . . . . . 5.7 tt -116.32 126.38 53.44 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 115.126 -0.943 . . . . 0.0 109.634 176.547 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' C' C ' 139' ' ' THR . . . . . . . . . . . . . 28.4 m -106.65 123.24 47.82 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.305 -0.407 . . . . 0.0 110.158 -179.638 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' C' C ' 140' ' ' LEU . . . . . . . . . . . . . 5.7 tt -108.78 120.77 43.46 Favored 'General case' 0 C--N 1.329 -0.321 0 N-CA-C 109.114 -0.699 . . . . 0.0 109.114 -178.311 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' C' C ' 141' ' ' ILE . . . . . . . . . . . . . 21.1 mt -123.38 118.91 55.98 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.286 0 CA-C-O 121.211 0.529 . . . . 0.0 109.833 -177.153 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' C' C ' 142' ' ' ARG . . . . . . . . . . . . . 47.0 ttt180 -101.27 120.15 39.82 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 115.207 -0.906 . . . . 0.0 110.002 179.838 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' C' C ' 143' ' ' THR . . . . . . . . . . . . . 76.5 p . . . . . 0 C--O 1.22 -0.476 0 CA-C-O 117.988 -1.006 . . . . 0.0 110.474 -179.104 . . . . . . . . 0 0 . 1 . 006 nuclear orig full ' D' D ' -3' ' ' GLU . . . . . . . . . . . . . 84.6 tt0 . . . . . 0 N--CA 1.49 1.543 0 N-CA-C 109.427 -0.582 . . . . 0.0 109.427 . . . . . . . . . 0 0 . 1 . 006 nuclear orig full ' D' D ' -2' ' ' GLY . . . . . . . . . . . . . . . -67.88 143.56 41.92 Favored Glycine 0 CA--C 1.524 0.638 0 N-CA-C 110.963 -0.855 . . . . 0.0 110.963 179.882 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' D' D ' -1' ' ' VAL . . . . . . . . . . . . . 43.7 t -96.27 136.73 26.19 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.326 0 N-CA-C 110.067 -0.346 . . . . 0.0 110.067 -179.583 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' D' D ' 0' ' ' ILE . . . . . . . . . . . . . 69.6 mt -107.29 134.97 47.43 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.318 0 CA-C-N 116.157 -0.474 . . . . 0.0 109.982 -179.401 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' D' D ' 1' ' ' MET . . . . . . . . . . . . . 25.4 ptp -86.48 147.05 26.15 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.156 -0.475 . . . . 0.0 110.63 -179.874 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' D' D ' 2' ' ' SER . . . . . . . . . . . . . 3.2 p -114.73 134.13 55.34 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-N 116.096 -0.502 . . . . 0.0 110.219 178.848 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' D' D ' 3' ' ' GLU . . . . . . . . . . . . . 95.6 mt-10 -141.02 139.67 34.17 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-O 120.971 0.415 . . . . 0.0 111.074 -178.985 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' D' D ' 4' ' ' LEU . . . . . . . . . . . . . 20.1 tp -123.55 125.21 44.46 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 115.889 -0.596 . . . . 0.0 110.108 176.402 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' D' D ' 5' ' ' LYS . . . . . . . . . . . . . 54.2 mtmt -104.22 118.06 35.72 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.156 -0.474 . . . . 0.0 110.725 179.493 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' D' D ' 6' ' ' LEU . . . . . . . . . . . . . 26.3 mt -115.15 146.0 41.81 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 115.632 -0.713 . . . . 0.0 110.087 179.877 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' D' D ' 7' ' ' LYS . . . . . . . . . . . . . 74.2 tttt -131.93 139.56 35.44 Favored Pre-proline 0 CA--C 1.534 0.347 0 CA-C-O 119.164 -0.446 . . . . 0.0 109.841 176.763 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' D' D ' 8' ' ' PRO . . . . . . . . . . . . . 84.4 Cg_endo -91.96 139.23 2.1 Favored 'Trans proline' 0 N--CA 1.49 1.306 0 C-N-CA 121.776 1.651 . . . . 0.0 111.802 177.782 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' D' D ' 9' ' ' LEU . . . . . . . . . . . . . 59.0 mt -76.14 -46.93 3.65 Favored Pre-proline 0 CA--C 1.533 0.313 0 CA-C-O 118.818 -0.611 . . . . 0.0 112.146 -179.59 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' D' D ' 10' ' ' PRO . . . . . . . . . . . . . 89.1 Cg_endo -81.88 147.06 14.98 Favored 'Trans proline' 0 N--CA 1.495 1.582 0 C-N-CA 121.269 1.313 . . . . 0.0 111.614 174.175 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' D' D ' 11' ' ' LYS . . . . . . . . . . . . . 83.9 tttt -85.07 99.81 11.28 Favored 'General case' 0 C--N 1.33 -0.263 0 C-N-CA 120.801 -0.36 . . . . 0.0 110.136 178.84 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' D' D ' 12' ' ' VAL . . . . . . . . . . . . . 12.2 p -140.84 144.38 27.03 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.257 0 CA-C-N 116.219 -0.446 . . . . 0.0 110.65 -177.788 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' D' D ' 13' ' ' GLU . . . . . . . . . . . . . 43.4 mt-10 -77.69 130.32 36.65 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.253 -0.43 . . . . 0.0 110.02 176.687 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' D' D ' 14' ' ' LEU . . . . . . . . . . . . . 27.3 mt -97.88 146.1 30.89 Favored Pre-proline 0 C--N 1.329 -0.286 0 CA-C-O 119.096 -0.478 . . . . 0.0 109.996 -179.717 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' D' D ' 15' ' ' PRO . . . . . . . . . . . . . 26.9 Cg_exo -61.83 158.69 36.73 Favored 'Trans proline' 0 N--CA 1.498 1.741 0 C-N-CA 121.261 1.307 . . . . 0.0 111.693 177.144 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' D' D ' 16' ' ' PRO . . . . . . . . . . . . . 38.7 Cg_exo -58.79 -34.06 98.79 Favored 'Trans proline' 0 N--CA 1.497 1.711 0 C-N-CA 121.516 1.477 . . . . 0.0 112.898 -178.196 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' D' D ' 17' ' ' ASP . . . . . . . . . . . . . 17.3 p-10 -92.45 9.65 33.43 Favored 'General case' 0 CA--C 1.535 0.389 0 N-CA-C 113.322 0.86 . . . . 0.0 113.322 -177.348 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' D' D ' 18' ' ' PHE . . . . . . . . . . . . . 50.7 t80 -58.15 -45.71 86.93 Favored 'General case' 0 N--CA 1.457 -0.115 0 CA-C-O 121.04 0.448 . . . . 0.0 110.219 -177.709 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' D' D ' 19' ' ' VAL . . . . . . . . . . . . . 47.3 t -56.24 -44.01 78.17 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.337 0 CA-C-N 116.085 -0.507 . . . . 0.0 110.557 -177.493 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' D' D ' 20' ' ' ASP . . . . . . . . . . . . . 44.4 t0 -59.86 -43.41 94.7 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-O 120.729 0.3 . . . . 0.0 110.95 -177.338 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' D' D ' 21' ' ' VAL . . . . . . . . . . . . . 47.5 t -63.93 -46.65 93.49 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.305 0 C-N-CA 120.702 -0.399 . . . . 0.0 110.506 -177.086 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' D' D ' 22' ' ' ILE . . . . . . . . . . . . . 51.4 mm -55.87 -47.95 79.01 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.275 0 C-N-CA 120.946 -0.301 . . . . 0.0 110.774 179.937 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' D' D ' 23' ' ' ARG . . . . . . . . . . . . . 60.8 ttp180 -54.93 -48.76 72.7 Favored 'General case' 0 C--N 1.331 -0.233 0 C-N-CA 121.06 -0.256 . . . . 0.0 111.347 -178.143 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' D' D ' 24' ' ' ILE . . . . . . . . . . . . . 77.0 mt -59.33 -41.96 85.85 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.357 0 C-N-CA 121.027 -0.269 . . . . 0.0 111.21 -177.126 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' D' D ' 25' ' ' LYS . . . . . . . . . . . . . 73.5 mmtt -65.49 -43.58 89.75 Favored 'General case' 0 C--N 1.329 -0.312 0 N-CA-C 112.445 0.535 . . . . 0.0 112.445 -179.54 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' D' D ' 26' ' ' LEU . . . . . . . . . . . . . 83.8 mt -78.26 -36.15 47.19 Favored 'General case' 0 C--N 1.329 -0.308 0 N-CA-C 113.287 0.847 . . . . 0.0 113.287 -170.181 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' D' D ' 27' ' ' GLN . . . . . . . . . . . . . 4.6 pt20 -46.3 137.08 6.61 Favored 'General case' 0 N--CA 1.467 0.391 0 N-CA-C 112.871 0.693 . . . . 0.0 112.871 -174.709 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' D' D ' 28' ' ' GLY . . . . . . . . . . . . . . . 99.43 -25.37 28.52 Favored Glycine 0 CA--C 1.533 1.186 0 CA-C-N 115.883 -0.598 . . . . 0.0 112.374 -178.383 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' D' D ' 29' ' ' LYS . . . . . . . . . . . . . 54.7 mtmt -97.88 155.2 17.18 Favored 'General case' 0 C--N 1.332 -0.187 0 CA-C-N 117.341 0.57 . . . . 0.0 111.253 179.76 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' D' D ' 30' ' ' THR . . . . . . . . . . . . . 25.0 m -106.46 138.39 42.72 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 115.908 -0.587 . . . . 0.0 109.992 176.654 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' D' D ' 31' ' ' VAL . . . . . . . . . . . . . 35.8 m -128.85 155.96 41.12 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.239 0 CA-C-N 116.303 -0.408 . . . . 0.0 110.876 -178.486 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' D' D ' 32' ' ' ARG . . . . . . . . . . . . . 77.5 mtt85 -129.46 148.09 51.34 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-N 116.06 -0.518 . . . . 0.0 110.697 178.811 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' D' D ' 33' ' ' THR . . . . . . . . . . . . . 26.7 m -53.87 140.15 31.38 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.34 -0.391 . . . . 0.0 111.27 -179.703 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' D' D ' 34' ' ' GLY . . . . . . . . . . . . . . . 100.71 -17.1 56.99 Favored Glycine 0 CA--C 1.532 1.118 0 CA-C-O 119.618 -0.545 . . . . 0.0 113.306 179.541 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' D' D ' 35' ' ' ASP . . . . . . . . . . . . . 78.7 m-20 -66.51 147.87 52.68 Favored 'General case' 0 C--O 1.232 0.167 0 CA-C-N 118.017 0.909 . . . . 0.0 111.179 178.881 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' D' D ' 36' ' ' VAL . . . . . . . . . . . . . 45.1 t -121.63 129.81 75.18 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.206 0 CA-C-N 116.003 -0.544 . . . . 0.0 109.728 177.317 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' D' D ' 37' ' ' ILE . . . . . . . . . . . . . 68.0 mt -122.64 140.14 47.35 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.264 0 CA-C-N 116.293 -0.412 . . . . 0.0 110.109 -178.332 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' D' D ' 38' ' ' GLY . . . . . . . . . . . . . . . -108.96 128.74 9.18 Favored Glycine 0 CA--C 1.526 0.719 0 N-CA-C 111.086 -0.806 . . . . 0.0 111.086 179.166 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' D' D ' 39' ' ' ILE . . . . . . . . . . . . . 74.6 mt -125.54 140.81 47.29 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.258 0 N-CA-C 110.104 -0.332 . . . . 0.0 110.104 179.445 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' D' D ' 40' ' ' SER . . . . . . . . . . . . . 36.3 t -92.13 117.57 29.98 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.41 -0.359 . . . . 0.0 110.828 175.998 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' D' D ' 41' ' ' ILE . . . . . . . . . . . . . 48.1 mm -130.03 123.35 56.13 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.243 0 N-CA-C 110.174 -0.306 . . . . 0.0 110.174 178.852 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' D' D ' 42' ' ' LEU . . . . . . . . . . . . . 9.0 tp 58.09 33.45 23.18 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.241 -0.436 . . . . 0.0 111.68 178.674 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' D' D ' 43' ' ' GLY . . . . . . . . . . . . . . . 77.02 -10.04 21.96 Favored Glycine 0 CA--C 1.534 1.262 0 C-N-CA 121.258 -0.496 . . . . 0.0 113.517 178.152 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' D' D ' 44' ' ' LYS . . . . . . . . . . . . . 99.2 mttt -103.06 146.26 28.64 Favored 'General case' 0 C--N 1.334 -0.081 0 CA-C-N 117.884 0.842 . . . . 0.0 110.081 178.443 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' D' D ' 45' ' ' GLU . . . . . . . . . . . . . 81.8 tt0 -83.85 127.42 33.82 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.377 -0.374 . . . . 0.0 110.797 -179.51 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' D' D ' 46' ' ' VAL . . . . . . . . . . . . . 7.4 p -122.11 128.8 75.66 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.183 0 N-CA-C 109.521 -0.548 . . . . 0.0 109.521 176.393 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' D' D ' 47' ' ' LYS . . . . . . . . . . . . . 89.8 mttt -100.1 130.0 46.2 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 115.993 -0.549 . . . . 0.0 111.28 178.969 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' D' D ' 48' ' ' PHE . . . . . . . . . . . . . 92.0 m-85 -113.43 131.77 55.89 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.01 176.541 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' D' D ' 49' ' ' LYS . . . . . . . . . . . . . 80.7 tttt -108.34 137.6 46.04 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 116.309 -0.405 . . . . 0.0 110.337 178.797 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' D' D ' 50' ' ' VAL . . . . . . . . . . . . . 44.1 t -82.39 109.71 16.7 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.288 0 N-CA-C 109.521 -0.548 . . . . 0.0 109.521 176.81 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' D' D ' 51' ' ' VAL . . . . . . . . . . . . . 47.8 t -72.82 -48.79 43.91 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.326 0 CA-C-N 115.794 -0.639 . . . . 0.0 110.043 -175.228 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' D' D ' 52' ' ' GLN . . . . . . . . . . . . . 49.7 tt0 -162.96 142.09 8.7 Favored 'General case' 0 C--N 1.332 -0.168 0 C-N-CA 120.037 -0.665 . . . . 0.0 111.941 -178.663 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' D' D ' 53' ' ' ALA . . . . . . . . . . . . . . . -116.83 132.63 56.65 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 115.766 -0.652 . . . . 0.0 109.998 175.577 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' D' D ' 54' ' ' TYR . . . . . . . . . . . . . 67.1 t80 -129.01 111.97 18.51 Favored Pre-proline 0 CA--C 1.535 0.379 0 CA-C-O 118.204 -0.903 . . . . 0.0 110.487 179.384 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' D' D ' 55' ' ' PRO . . . . . . . . . . . . . 74.4 Cg_endo -77.2 169.32 74.5 Favored 'Cis proline' 0 N--CA 1.499 1.848 0 CA-C-N 122.027 1.76 . . . . 0.0 112.198 -5.979 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' D' D ' 56' ' ' SER . . . . . . . . . . . . . 13.6 m -115.24 128.96 25.49 Favored Pre-proline 0 CA--C 1.539 0.525 0 CA-C-O 118.388 -0.815 . . . . 0.0 109.424 176.521 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' D' D ' 57' ' ' PRO . . . . . . . . . . . . . 56.7 Cg_endo -71.77 148.13 89.82 Favored 'Cis proline' 0 N--CA 1.497 1.688 0 CA-C-N 121.958 1.735 . . . . 0.0 111.62 0.19 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' D' D ' 58' ' ' LEU . . . . . . . . . . . . . 14.2 tp -107.69 135.73 48.63 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 116.296 -0.411 . . . . 0.0 110.559 -178.567 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' D' D ' 59' ' ' ARG . . . . . . . . . . . . . 43.6 ttp180 -106.19 124.47 49.64 Favored 'General case' 0 C--N 1.327 -0.41 0 N-CA-C 109.324 -0.621 . . . . 0.0 109.324 175.891 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' D' D ' 60' ' ' VAL . . . . . . . . . . . . . 41.4 t -79.98 120.99 32.47 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.299 0 C-N-CA 120.741 -0.384 . . . . 0.0 110.352 -175.46 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' D' D ' 61' ' ' GLU . . . . . . . . . . . . . 42.6 mt-10 -130.97 170.22 14.77 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.066 -0.515 . . . . 0.0 110.129 178.425 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' D' D ' 62' ' ' ASP . . . . . . . . . . . . . 45.1 m-20 -54.31 -32.54 56.79 Favored 'General case' 0 C--N 1.327 -0.379 0 N-CA-C 111.847 0.314 . . . . 0.0 111.847 -178.151 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' D' D ' 63' ' ' ARG . . . . . . . . . . . . . 30.7 ptt180 -88.47 4.41 46.64 Favored 'General case' 0 CA--C 1.537 0.446 0 N-CA-C 113.751 1.019 . . . . 0.0 113.751 -175.011 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' D' D ' 64' ' ' THR . . . . . . . . . . . . . 32.3 m -85.4 136.97 33.23 Favored 'General case' 0 C--N 1.332 -0.163 0 CA-C-O 120.934 0.397 . . . . 0.0 110.628 -178.609 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' D' D ' 65' ' ' LYS . . . . . . . . . . . . . 90.5 mttt -89.61 129.79 36.01 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.096 -0.502 . . . . 0.0 110.223 179.306 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' D' D ' 66' ' ' ILE . . . . . . . . . . . . . 62.5 mt -113.55 128.6 70.33 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.26 0 N-CA-C 109.575 -0.528 . . . . 0.0 109.575 178.684 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' D' D ' 67' ' ' THR . . . . . . . . . . . . . 27.0 m -122.3 138.73 54.41 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-O 120.991 0.424 . . . . 0.0 111.118 -176.31 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' D' D ' 68' ' ' LEU . . . . . . . . . . . . . 7.3 mp -100.56 111.18 23.4 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 115.863 -0.608 . . . . 0.0 110.282 177.706 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' D' D ' 69' ' ' VAL . . . . . . . . . . . . . 43.3 t -103.06 140.2 21.94 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.364 0 CA-C-N 115.867 -0.606 . . . . 0.0 110.081 -179.145 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' D' D ' 70' ' ' THR . . . . . . . . . . . . . 23.6 m -146.11 -60.05 0.32 Allowed 'General case' 0 C--N 1.328 -0.345 0 CA-C-O 120.844 0.354 . . . . 0.0 110.363 177.287 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' D' D ' 71' ' ' HIS . . . . . . . . . . . . . 2.5 t60 -150.06 80.99 7.04 Favored Pre-proline 0 C--N 1.329 -0.302 0 CA-C-N 116.021 -0.536 . . . . 0.0 110.121 177.865 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' D' D ' 72' ' ' PRO . . . . . . . . . . . . . 59.4 Cg_endo -73.27 -30.18 10.67 Favored 'Trans proline' 0 N--CA 1.496 1.619 0 C-N-CA 121.152 1.235 . . . . 0.0 112.515 -175.96 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' D' D ' 73' ' ' VAL . . . . . . . . . . . . . 15.6 m -155.16 151.51 10.35 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.299 0 CA-C-O 120.993 0.425 . . . . 0.0 110.667 178.435 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' D' D ' 74' ' ' ASP . . . . . . . . . . . . . 5.0 t70 -108.77 118.87 37.92 Favored 'General case' 0 C--N 1.328 -0.362 0 N-CA-C 109.288 -0.634 . . . . 0.0 109.288 174.541 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' D' D ' 75' ' ' VAL . . . . . . . . . . . . . 41.9 t -113.74 125.68 71.06 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.214 0 CA-C-O 121.059 0.457 . . . . 0.0 110.898 -175.854 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' D' D ' 76' ' ' LEU . . . . . . . . . . . . . 5.6 mp -125.56 146.42 49.69 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 115.581 -0.736 . . . . 0.0 109.538 174.953 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' D' D ' 77' ' ' GLU . . . . . . . . . . . . . 99.2 mt-10 -134.23 131.23 38.27 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-O 121.134 0.492 . . . . 0.0 111.291 -176.95 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' D' D ' 78' ' ' ALA . . . . . . . . . . . . . . . -118.38 121.72 41.06 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 115.69 -0.686 . . . . 0.0 109.558 176.647 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' D' D ' 79' ' ' LYS . . . . . . . . . . . . . 19.2 pttp -71.77 122.65 21.04 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-O 121.134 0.492 . . . . 0.0 110.96 -178.091 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' D' D ' 80' ' ' ILE . . . . . . . . . . . . . 37.4 mm -139.19 108.87 3.94 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.355 0 N-CA-C 109.023 -0.732 . . . . 0.0 109.023 -178.122 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' D' D ' 81' ' ' LYS . . . . . . . . . . . . . 50.7 pttt -97.59 123.7 41.58 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-O 120.941 0.401 . . . . 0.0 111.152 -177.617 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' D' D ' 82' ' ' GLY . . . . . . . . . . . . . . . 88.97 42.26 5.69 Favored Glycine 0 CA--C 1.525 0.699 0 C-N-CA 120.718 -0.753 . . . . 0.0 111.533 174.649 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' D' D ' 83' ' ' ILE . . . . . . . . . . . . . 75.3 mt -65.91 137.17 25.41 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.332 0 N-CA-C 109.809 -0.441 . . . . 0.0 109.809 178.106 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' D' D ' 84' ' ' LYS . . . . . . . . . . . . . 50.9 tttp -98.59 -54.18 3.1 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.246 -0.434 . . . . 0.0 110.283 -179.469 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' D' D ' 85' ' ' ASP . . . . . . . . . . . . . 13.4 t70 -151.77 150.89 30.67 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 115.902 -0.59 . . . . 0.0 110.456 -179.474 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' D' D ' 86' ' ' VAL . . . . . . . . . . . . . 42.5 t -129.86 129.79 66.18 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.248 0 CA-C-O 120.974 0.416 . . . . 0.0 110.598 -179.058 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' D' D ' 87' ' ' ILE . . . . . . . . . . . . . 45.2 mm -118.83 125.79 74.75 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.286 0 CA-C-N 115.826 -0.625 . . . . 0.0 109.373 175.31 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' D' D ' 88' ' ' LEU . . . . . . . . . . . . . 30.8 mt -118.65 138.84 52.33 Favored 'General case' 0 C--N 1.332 -0.188 0 CA-C-O 121.316 0.579 . . . . 0.0 111.941 -175.427 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' D' D ' 89' ' ' ASP . . . . . . . . . . . . . 12.2 t0 -136.09 151.72 50.11 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 115.171 -0.922 . . . . 0.0 108.764 174.725 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' D' D ' 90' ' ' GLU . . . . . . . . . . . . . 83.5 tt0 -49.0 -31.8 8.13 Favored 'General case' 0 C--N 1.329 -0.32 0 N-CA-C 112.876 0.695 . . . . 0.0 112.876 -172.829 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' D' D ' 91' ' ' ASN . . . . . . . . . . . . . 12.4 p30 -117.24 3.07 12.62 Favored 'General case' 0 N--CA 1.469 0.513 0 N-CA-C 113.815 1.043 . . . . 0.0 113.815 -174.867 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' D' D ' 92' ' ' LEU . . . . . . . . . . . . . 17.7 mt -148.47 148.45 30.29 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 118.241 0.473 . . . . 0.0 110.647 -175.421 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' D' D ' 93' ' ' ILE . . . . . . . . . . . . . 75.9 mt -129.65 118.36 44.84 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.285 0 N-CA-C 109.233 -0.654 . . . . 0.0 109.233 176.949 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' D' D ' 94' ' ' VAL . . . . . . . . . . . . . 44.7 t -118.29 125.12 74.05 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.288 0 N-CA-C 109.884 -0.413 . . . . 0.0 109.884 -178.786 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' D' D ' 95' ' ' VAL . . . . . . . . . . . . . 43.5 t -120.91 134.09 65.45 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.343 0 CA-C-N 116.133 -0.485 . . . . 0.0 109.841 -179.703 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' D' D ' 96' ' ' ILE . . . . . . . . . . . . . 68.6 mt -114.42 126.71 72.01 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.339 0 N-CA-C 109.042 -0.725 . . . . 0.0 109.042 178.439 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' D' D ' 97' ' ' THR . . . . . . . . . . . . . 79.7 p -98.82 158.15 15.82 Favored 'General case' 0 C--N 1.331 -0.239 0 CA-C-O 121.176 0.512 . . . . 0.0 111.124 -176.965 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' D' D ' 98' ' ' GLU . . . . . . . . . . . . . 83.1 tt0 -53.98 -27.3 30.61 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-N 116.093 -0.503 . . . . 0.0 112.065 179.843 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' D' D ' 99' ' ' GLU . . . . . . . . . . . . . 96.6 mt-10 -78.07 13.48 1.43 Allowed 'General case' 0 CA--C 1.536 0.421 0 N-CA-C 113.294 0.85 . . . . 0.0 113.294 -176.852 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' D' D ' 100' ' ' ASN . . . . . . . . . . . . . 3.2 m-20 62.49 32.93 16.4 Favored 'General case' 0 N--CA 1.464 0.266 0 CA-C-O 120.898 0.38 . . . . 0.0 111.637 179.155 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' D' D ' 101' ' ' GLU . . . . . . . . . . . . . 84.6 tt0 -109.59 144.4 37.95 Favored 'General case' 0 C--N 1.334 -0.105 0 N-CA-C 109.709 -0.478 . . . . 0.0 109.709 173.247 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' D' D ' 102' ' ' VAL . . . . . . . . . . . . . 45.9 t -114.94 125.88 72.37 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.331 0 CA-C-N 116.113 -0.494 . . . . 0.0 109.858 -178.181 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' D' D ' 103' ' ' LEU . . . . . . . . . . . . . 53.1 mt -117.71 129.77 55.92 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 115.998 -0.546 . . . . 0.0 110.331 177.553 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' D' D ' 104' ' ' ILE . . . . . . . . . . . . . 70.3 mt -118.15 119.58 61.83 Favored 'Isoleucine or valine' 0 C--O 1.234 0.256 0 CA-C-N 116.393 -0.367 . . . . 0.0 110.173 -179.692 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' D' D ' 105' ' ' PHE . . . . . . . . . . . . . 46.6 m-85 -121.55 168.15 12.07 Favored 'General case' 0 C--N 1.332 -0.194 0 O-C-N 123.879 0.737 . . . . 0.0 109.738 179.794 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' D' D ' 106' ' ' ASN . . . . . . . . . . . . . 44.0 p-10 -99.42 -170.2 1.87 Allowed 'General case' 0 C--N 1.331 -0.217 0 N-CA-C 109.734 -0.469 . . . . 0.0 109.734 172.036 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' D' D ' 107' ' ' GLN . . . . . . . . . . . . . 59.3 tt0 -59.37 -30.03 68.12 Favored 'General case' 0 C--N 1.329 -0.31 0 N-CA-C 111.824 0.305 . . . . 0.0 111.824 -179.724 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' D' D ' 108' ' ' ASN . . . . . . . . . . . . . 11.8 t-20 -86.56 13.53 8.34 Favored 'General case' 0 CA--C 1.535 0.399 0 N-CA-C 112.904 0.705 . . . . 0.0 112.904 -177.152 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' D' D ' 109' ' ' LEU . . . . . . . . . . . . . 21.7 mt 58.51 34.03 23.58 Favored 'General case' 0 C--O 1.233 0.198 0 CA-C-O 120.73 0.3 . . . . 0.0 111.747 177.563 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' D' D ' 110' ' ' GLU . . . . . . . . . . . . . 96.1 mt-10 -99.73 138.8 36.31 Favored 'General case' 0 C--N 1.33 -0.28 0 N-CA-C 109.455 -0.572 . . . . 0.0 109.455 175.222 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' D' D ' 111' ' ' GLU . . . . . . . . . . . . . 48.3 tt0 -79.67 121.86 25.83 Favored 'General case' 0 C--N 1.327 -0.373 0 C-N-CA 120.759 -0.376 . . . . 0.0 110.293 -176.402 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' D' D ' 112' ' ' LEU . . . . . . . . . . . . . 26.6 mt -105.79 -46.01 4.24 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.019 -0.537 . . . . 0.0 110.432 179.656 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' D' D ' 113' ' ' TYR . . . . . . . . . . . . . 61.3 t80 -135.91 138.85 42.83 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.089 -0.505 . . . . 0.0 110.838 -179.041 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' D' D ' 114' ' ' ARG . . . . . . . . . . . . . 39.6 ptt180 -141.6 126.38 18.07 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-O 120.941 0.401 . . . . 0.0 110.681 176.913 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' D' D ' 115' ' ' GLY . . . . . . . . . . . . . . . -150.06 163.08 29.38 Favored Glycine 0 CA--C 1.522 0.515 0 N-CA-C 110.604 -0.999 . . . . 0.0 110.604 -179.723 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' D' D ' 116' ' ' LYS . . . . . . . . . . . . . 72.4 tttt -134.35 134.07 41.35 Favored 'General case' 0 C--N 1.33 -0.257 0 N-CA-C 110.093 -0.336 . . . . 0.0 110.093 179.192 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' D' D ' 117' ' ' PHE . . . . . . . . . . . . . 39.2 m-85 -134.03 114.01 12.74 Favored 'General case' 0 C--N 1.331 -0.209 0 CA-C-N 116.328 -0.396 . . . . 0.0 110.124 -175.18 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' D' D ' 118' ' ' GLU . . . . . . . . . . . . . 45.0 tp10 -53.49 -43.82 68.54 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.467 -0.333 . . . . 0.0 111.526 -175.665 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' D' D ' 119' ' ' ASN . . . . . . . . . . . . . 80.4 m-20 -99.69 31.04 3.36 Favored 'General case' 0 C--N 1.332 -0.175 0 N-CA-C 112.319 0.489 . . . . 0.0 112.319 -173.875 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' D' D ' 120' ' ' LEU . . . . . . . . . . . . . 15.0 tp -57.44 122.72 13.31 Favored 'General case' 0 C--N 1.331 -0.213 0 N-CA-C 110.162 -0.31 . . . . 0.0 110.162 177.386 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' D' D ' 121' ' ' ASN . . . . . . . . . . . . . 73.8 m-20 -114.02 -44.15 3.18 Favored 'General case' 0 C--O 1.232 0.153 0 CA-C-N 116.689 -0.232 . . . . 0.0 111.378 -176.883 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' D' D ' 122' ' ' LYS . . . . . . . . . . . . . 98.0 mttt -143.83 147.02 33.5 Favored 'General case' 0 C--N 1.333 -0.15 0 CA-C-O 121.072 0.463 . . . . 0.0 111.657 -178.36 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' D' D ' 123' ' ' VAL . . . . . . . . . . . . . 45.4 t -127.21 124.33 63.96 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.256 0 N-CA-C 109.302 -0.629 . . . . 0.0 109.302 174.158 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' D' D ' 124' ' ' LEU . . . . . . . . . . . . . 7.2 mp -115.39 131.49 56.91 Favored 'General case' 0 C--N 1.331 -0.229 0 CA-C-N 116.306 -0.406 . . . . 0.0 110.617 -177.898 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' D' D ' 125' ' ' VAL . . . . . . . . . . . . . 45.9 t -126.72 126.83 69.39 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.243 0 CA-C-N 116.128 -0.487 . . . . 0.0 109.999 179.49 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' D' D ' 126' ' ' ARG . . . . . . . . . . . . . 69.6 ttt180 -155.22 141.13 18.22 Favored 'General case' 0 C--N 1.328 -0.356 0 N-CA-C 109.527 -0.545 . . . . 0.0 109.527 177.542 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' D' D ' 127' ' ' ASN . . . . . . . . . . . . . 9.7 p30 48.73 -151.84 0.13 Allowed 'General case' 0 CA--C 1.54 0.593 0 CA-C-O 119.299 -0.381 . . . . 0.0 110.897 178.989 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' D' D ' 128' ' ' ASP . . . . . . . . . . . . . 12.7 p-10 -84.49 22.71 1.23 Allowed 'General case' 0 CA--C 1.535 0.385 0 CA-C-N 118.61 0.641 . . . . 0.0 112.264 177.705 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' D' D ' 129' ' ' LEU . . . . . . . . . . . . . 13.4 tp -120.72 137.02 54.7 Favored 'General case' 0 C--O 1.233 0.216 0 CA-C-O 121.061 0.458 . . . . 0.0 110.508 -179.605 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' D' D ' 130' ' ' VAL . . . . . . . . . . . . . 45.0 t -123.24 136.01 61.32 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.218 0 CA-C-N 115.949 -0.569 . . . . 0.0 109.61 178.26 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' D' D ' 131' ' ' VAL . . . . . . . . . . . . . 42.2 t -134.9 136.82 51.63 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.238 0 CA-C-O 121.186 0.517 . . . . 0.0 110.516 179.957 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' D' D ' 132' ' ' ILE . . . . . . . . . . . . . 72.1 mt -117.55 133.89 62.87 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.295 0 CA-C-N 115.639 -0.71 . . . . 0.0 109.63 -179.579 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' D' D ' 133' ' ' ILE . . . . . . . . . . . . . 43.1 mm -118.55 122.21 68.92 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.19 0 CA-C-O 120.961 0.41 . . . . 0.0 110.947 -176.221 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' D' D ' 134' ' ' ASP . . . . . . . . . . . . . 8.0 p-10 -135.11 148.04 49.69 Favored 'General case' 0 C--N 1.329 -0.299 0 N-CA-C 109.3 -0.63 . . . . 0.0 109.3 173.029 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' D' D ' 135' ' ' GLU . . . . . . . . . . . . . 43.5 tp10 -49.83 -24.74 2.59 Favored 'General case' 0 C--N 1.327 -0.386 0 N-CA-C 112.768 0.655 . . . . 0.0 112.768 -171.671 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' D' D ' 136' ' ' GLN . . . . . . . . . . . . . 46.5 tt0 -102.83 -24.65 13.69 Favored 'General case' 0 CA--C 1.533 0.298 0 N-CA-C 112.96 0.726 . . . . 0.0 112.96 -173.995 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' D' D ' 137' ' ' LYS . . . . . . . . . . . . . 97.3 mttt -143.65 152.77 41.77 Favored 'General case' 0 C--N 1.331 -0.201 0 CA-C-O 121.168 0.508 . . . . 0.0 111.821 -172.574 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' D' D ' 138' ' ' LEU . . . . . . . . . . . . . 4.4 tt -120.41 121.8 39.32 Favored 'General case' 0 C--N 1.33 -0.262 0 N-CA-C 109.079 -0.712 . . . . 0.0 109.079 172.434 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' D' D ' 139' ' ' THR . . . . . . . . . . . . . 34.3 m -111.23 130.4 55.66 Favored 'General case' 0 C--N 1.332 -0.193 0 CA-C-O 120.734 0.302 . . . . 0.0 111.036 -175.683 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' D' D ' 140' ' ' LEU . . . . . . . . . . . . . 5.6 tt -116.98 122.54 44.53 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 115.618 -0.719 . . . . 0.0 109.238 -179.683 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' D' D ' 141' ' ' ILE . . . . . . . . . . . . . 18.8 mt -121.6 122.74 67.83 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.248 0 CA-C-O 120.888 0.375 . . . . 0.0 110.085 -175.663 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' D' D ' 142' ' ' ARG . . . . . . . . . . . . . 73.4 mtp180 -110.9 125.95 54.2 Favored 'General case' 0 C--N 1.331 -0.22 0 CA-C-N 115.682 -0.69 . . . . 0.0 110.16 -179.534 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' D' D ' 143' ' ' THR . . . . . . . . . . . . . 66.6 p . . . . . 0 C--O 1.219 -0.503 0 CA-C-O 118.074 -0.965 . . . . 0.0 110.492 -179.796 . . . . . . . . 0 0 . 1 . 006 nuclear orig full ' E' E ' -3' ' ' GLU . . . . . . . . . . . . . 95.9 mt-10 . . . . . 0 N--CA 1.49 1.559 0 N-CA-C 109.404 -0.591 . . . . 0.0 109.404 . . . . . . . . . 0 0 . 1 . 006 nuclear orig full ' E' E ' -2' ' ' GLY . . . . . . . . . . . . . . . -74.65 145.73 34.53 Favored Glycine 0 CA--C 1.524 0.638 0 N-CA-C 111.261 -0.735 . . . . 0.0 111.261 -179.325 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' E' E ' -1' ' ' VAL . . . . . . . . . . . . . 44.9 t -141.05 134.38 31.43 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.278 0 N-CA-C 109.748 -0.464 . . . . 0.0 109.748 178.719 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' E' E ' 0' ' ' ILE . . . . . . . . . . . . . 74.2 mt -116.01 138.59 45.97 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.255 0 CA-C-O 120.899 0.381 . . . . 0.0 110.148 -178.677 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' E' E ' 1' ' ' MET . . . . . . . . . . . . . 22.6 ptm -91.71 140.04 30.1 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.014 -0.539 . . . . 0.0 110.876 -178.306 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' E' E ' 2' ' ' SER . . . . . . . . . . . . . 6.4 p -122.88 132.97 54.42 Favored 'General case' 0 C--N 1.331 -0.22 0 CA-C-O 121.033 0.444 . . . . 0.0 110.994 -178.973 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' E' E ' 3' ' ' GLU . . . . . . . . . . . . . 95.1 mt-10 -140.91 141.95 34.49 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 115.876 -0.602 . . . . 0.0 110.961 -179.238 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' E' E ' 4' ' ' LEU . . . . . . . . . . . . . 15.0 tp -126.77 126.16 42.95 Favored 'General case' 0 C--N 1.331 -0.206 0 CA-C-N 116.091 -0.504 . . . . 0.0 109.97 176.516 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' E' E ' 5' ' ' LYS . . . . . . . . . . . . . 68.6 mttm -106.11 122.2 45.7 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-O 120.844 0.355 . . . . 0.0 110.826 178.426 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' E' E ' 6' ' ' LEU . . . . . . . . . . . . . 74.6 mt -118.59 146.56 44.52 Favored 'General case' 0 C--N 1.331 -0.209 0 CA-C-N 115.535 -0.757 . . . . 0.0 110.311 179.765 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' E' E ' 7' ' ' LYS . . . . . . . . . . . . . 80.0 tttt -135.66 140.24 33.26 Favored Pre-proline 0 CA--C 1.534 0.335 0 CA-C-O 119.093 -0.479 . . . . 0.0 110.254 176.985 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' E' E ' 8' ' ' PRO . . . . . . . . . . . . . 88.8 Cg_endo -91.98 143.39 2.74 Favored 'Trans proline' 0 N--CA 1.49 1.311 0 C-N-CA 121.827 1.685 . . . . 0.0 111.934 177.773 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' E' E ' 9' ' ' LEU . . . . . . . . . . . . . 60.8 mt -77.37 -47.51 2.52 Favored Pre-proline 0 CA--C 1.533 0.317 0 CA-C-O 118.688 -0.673 . . . . 0.0 112.226 179.533 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' E' E ' 10' ' ' PRO . . . . . . . . . . . . . 94.8 Cg_endo -80.26 142.82 15.31 Favored 'Trans proline' 0 N--CA 1.495 1.582 0 C-N-CA 121.133 1.222 . . . . 0.0 111.518 175.905 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' E' E ' 11' ' ' LYS . . . . . . . . . . . . . 46.0 pttt -83.76 113.38 20.86 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-O 121.496 0.665 . . . . 0.0 110.879 -179.74 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' E' E ' 12' ' ' VAL . . . . . . . . . . . . . 12.2 p -151.18 148.54 14.8 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.284 0 CA-C-N 115.649 -0.705 . . . . 0.0 110.377 179.873 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' E' E ' 13' ' ' GLU . . . . . . . . . . . . . 43.0 mt-10 -83.78 116.03 22.51 Favored 'General case' 0 C--N 1.329 -0.313 0 N-CA-C 110.144 -0.317 . . . . 0.0 110.144 177.658 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' E' E ' 14' ' ' LEU . . . . . . . . . . . . . 31.1 mt -99.33 143.53 26.59 Favored Pre-proline 0 CA--C 1.533 0.309 0 CA-C-O 119.09 -0.481 . . . . 0.0 110.279 -179.439 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' E' E ' 15' ' ' PRO . . . . . . . . . . . . . 25.7 Cg_exo -62.55 157.34 47.11 Favored 'Trans proline' 0 N--CA 1.498 1.774 0 C-N-CA 121.342 1.361 . . . . 0.0 112.013 177.682 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' E' E ' 16' ' ' PRO . . . . . . . . . . . . . 31.4 Cg_exo -59.76 -34.43 95.93 Favored 'Trans proline' 0 N--CA 1.498 1.752 0 C-N-CA 121.452 1.435 . . . . 0.0 112.782 179.969 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' E' E ' 17' ' ' ASP . . . . . . . . . . . . . 9.1 p-10 -83.32 4.43 27.24 Favored 'General case' 0 CA--C 1.537 0.465 0 N-CA-C 113.26 0.837 . . . . 0.0 113.26 -177.462 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' E' E ' 18' ' ' PHE . . . . . . . . . . . . . 33.8 t80 -58.06 -44.69 87.63 Favored 'General case' 0 C--N 1.334 -0.07 0 O-C-N 121.884 -0.51 . . . . 0.0 109.898 -178.574 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' E' E ' 19' ' ' VAL . . . . . . . . . . . . . 48.5 t -58.3 -40.33 77.45 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.361 0 CA-C-N 116.037 -0.529 . . . . 0.0 110.525 -178.725 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' E' E ' 20' ' ' ASP . . . . . . . . . . . . . 11.8 t70 -58.85 -43.74 90.86 Favored 'General case' 0 C--O 1.234 0.268 0 CA-C-O 120.947 0.403 . . . . 0.0 110.772 -177.223 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' E' E ' 21' ' ' VAL . . . . . . . . . . . . . 48.4 t -65.8 -51.98 55.24 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.291 0 C-N-CA 120.662 -0.415 . . . . 0.0 110.517 -179.011 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' E' E ' 22' ' ' ILE . . . . . . . . . . . . . 50.4 mm -55.24 -54.09 28.29 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.295 0 C-N-CA 120.901 -0.32 . . . . 0.0 111.168 -176.665 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' E' E ' 23' ' ' ARG . . . . . . . . . . . . . 13.8 ptm180 -58.52 -44.45 89.52 Favored 'General case' 0 C--N 1.33 -0.249 0 C-N-CA 120.773 -0.371 . . . . 0.0 111.721 -172.973 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' E' E ' 24' ' ' ILE . . . . . . . . . . . . . 86.9 mt -64.18 -34.97 72.29 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.303 0 C-N-CA 120.767 -0.373 . . . . 0.0 111.355 -177.714 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' E' E ' 25' ' ' LYS . . . . . . . . . . . . . 34.4 mmtp -67.87 -44.07 77.93 Favored 'General case' 0 C--N 1.33 -0.27 0 N-CA-C 112.09 0.404 . . . . 0.0 112.09 177.365 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' E' E ' 26' ' ' LEU . . . . . . . . . . . . . 75.8 mt -85.49 -23.79 27.63 Favored 'General case' 0 C--N 1.329 -0.294 0 N-CA-C 114.065 1.135 . . . . 0.0 114.065 -170.266 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' E' E ' 27' ' ' GLN . . . . . . . . . . . . . 8.3 pt20 -47.63 145.66 2.58 Favored 'General case' 0 N--CA 1.47 0.535 0 N-CA-C 112.553 0.575 . . . . 0.0 112.553 -176.152 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' E' E ' 28' ' ' GLY . . . . . . . . . . . . . . . 99.77 -23.82 34.58 Favored Glycine 0 CA--C 1.532 1.121 0 CA-C-N 115.512 -0.767 . . . . 0.0 112.2 -175.28 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' E' E ' 29' ' ' LYS . . . . . . . . . . . . . 79.9 mttt -94.54 155.06 17.09 Favored 'General case' 0 C--O 1.233 0.212 0 CA-C-N 117.577 0.689 . . . . 0.0 110.518 177.153 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' E' E ' 30' ' ' THR . . . . . . . . . . . . . 26.9 m -107.48 138.5 43.57 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 116.116 -0.493 . . . . 0.0 110.128 178.056 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' E' E ' 31' ' ' VAL . . . . . . . . . . . . . 34.7 m -127.24 151.66 34.36 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.199 0 CA-C-O 121.005 0.431 . . . . 0.0 110.893 -179.161 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' E' E ' 32' ' ' ARG . . . . . . . . . . . . . 55.0 ttt180 -128.32 150.09 50.23 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 115.893 -0.594 . . . . 0.0 110.073 179.389 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' E' E ' 33' ' ' THR . . . . . . . . . . . . . 23.2 m -52.59 137.62 30.08 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-O 120.733 0.302 . . . . 0.0 111.528 -177.357 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' E' E ' 34' ' ' GLY . . . . . . . . . . . . . . . 100.03 -17.04 57.73 Favored Glycine 0 CA--C 1.533 1.183 0 CA-C-O 119.671 -0.516 . . . . 0.0 113.313 178.763 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' E' E ' 35' ' ' ASP . . . . . . . . . . . . . 76.7 m-20 -67.22 149.88 49.83 Favored 'General case' 0 N--CA 1.462 0.144 0 CA-C-N 117.983 0.891 . . . . 0.0 111.266 179.043 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' E' E ' 36' ' ' VAL . . . . . . . . . . . . . 44.8 t -121.23 130.5 74.59 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.186 0 CA-C-N 115.966 -0.561 . . . . 0.0 109.956 178.464 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' E' E ' 37' ' ' ILE . . . . . . . . . . . . . 69.9 mt -121.27 139.09 49.52 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.279 0 CA-C-N 116.139 -0.482 . . . . 0.0 109.85 179.839 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' E' E ' 38' ' ' GLY . . . . . . . . . . . . . . . -114.33 129.38 8.68 Favored Glycine 0 CA--C 1.527 0.784 0 N-CA-C 111.53 -0.628 . . . . 0.0 111.53 -177.791 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' E' E ' 39' ' ' ILE . . . . . . . . . . . . . 69.9 mt -121.85 136.76 57.71 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.189 0 N-CA-C 109.829 -0.434 . . . . 0.0 109.829 177.765 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' E' E ' 40' ' ' SER . . . . . . . . . . . . . 39.7 t -92.88 113.98 26.41 Favored 'General case' 0 C--N 1.33 -0.264 0 C-N-CA 120.935 -0.306 . . . . 0.0 110.895 176.167 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' E' E ' 41' ' ' ILE . . . . . . . . . . . . . 47.9 mm -120.87 113.2 39.01 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.167 0 N-CA-C 110.157 -0.312 . . . . 0.0 110.157 179.196 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' E' E ' 42' ' ' LEU . . . . . . . . . . . . . 7.0 mp 57.01 36.17 27.41 Favored 'General case' 0 CA--C 1.533 0.298 0 CA-C-O 120.84 0.352 . . . . 0.0 111.232 179.681 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' E' E ' 43' ' ' GLY . . . . . . . . . . . . . . . 77.74 -10.17 26.21 Favored Glycine 0 CA--C 1.535 1.29 0 C-N-CA 121.245 -0.502 . . . . 0.0 113.566 177.708 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' E' E ' 44' ' ' LYS . . . . . . . . . . . . . 49.4 tptt -94.95 132.91 39.27 Favored 'General case' 0 C--N 1.332 -0.19 0 CA-C-N 117.763 0.781 . . . . 0.0 109.695 176.821 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' E' E ' 45' ' ' GLU . . . . . . . . . . . . . 84.5 tt0 -83.49 125.82 32.14 Favored 'General case' 0 C--N 1.328 -0.359 0 C-N-CA 120.838 -0.345 . . . . 0.0 111.003 -178.796 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' E' E ' 46' ' ' VAL . . . . . . . . . . . . . 7.2 p -119.44 124.68 73.42 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.231 0 N-CA-C 109.311 -0.626 . . . . 0.0 109.311 175.268 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' E' E ' 47' ' ' LYS . . . . . . . . . . . . . 60.6 mttp -99.36 128.34 45.47 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 115.976 -0.557 . . . . 0.0 111.11 178.486 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' E' E ' 48' ' ' PHE . . . . . . . . . . . . . 95.7 m-85 -110.2 131.87 54.67 Favored 'General case' 0 C--N 1.329 -0.321 0 N-CA-C 109.687 -0.486 . . . . 0.0 109.687 175.44 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' E' E ' 49' ' ' LYS . . . . . . . . . . . . . 61.9 tttm -106.99 136.6 46.58 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.485 -0.325 . . . . 0.0 110.283 178.984 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' E' E ' 50' ' ' VAL . . . . . . . . . . . . . 45.7 t -75.4 107.29 5.98 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.34 0 N-CA-C 109.023 -0.732 . . . . 0.0 109.023 175.715 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' E' E ' 51' ' ' VAL . . . . . . . . . . . . . 47.0 t -71.34 -48.07 55.98 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.261 0 O-C-N 123.511 0.507 . . . . 0.0 109.856 -174.063 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' E' E ' 52' ' ' GLN . . . . . . . . . . . . . 48.2 tt0 -168.11 135.65 2.19 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 116.051 -0.522 . . . . 0.0 111.445 -179.142 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' E' E ' 53' ' ' ALA . . . . . . . . . . . . . . . -110.34 131.44 55.05 Favored 'General case' 0 C--N 1.331 -0.23 0 CA-C-N 115.943 -0.571 . . . . 0.0 109.865 176.114 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' E' E ' 54' ' ' TYR . . . . . . . . . . . . . 34.0 t80 -129.07 108.0 18.01 Favored Pre-proline 0 CA--C 1.535 0.389 0 CA-C-O 118.28 -0.867 . . . . 0.0 110.379 -179.735 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' E' E ' 55' ' ' PRO . . . . . . . . . . . . . 73.9 Cg_endo -77.09 170.02 72.74 Favored 'Cis proline' 0 N--CA 1.499 1.833 0 CA-C-N 121.85 1.697 . . . . 0.0 112.369 -5.351 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' E' E ' 56' ' ' SER . . . . . . . . . . . . . 48.9 m -115.9 137.12 23.1 Favored Pre-proline 0 CA--C 1.538 0.518 0 CA-C-O 118.51 -0.757 . . . . 0.0 109.565 175.547 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' E' E ' 57' ' ' PRO . . . . . . . . . . . . . 59.7 Cg_endo -73.76 146.79 87.89 Favored 'Cis proline' 0 N--CA 1.497 1.712 0 CA-C-N 121.705 1.644 . . . . 0.0 111.553 -2.481 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' E' E ' 58' ' ' LEU . . . . . . . . . . . . . 31.1 tp -108.38 138.3 44.91 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.375 -0.375 . . . . 0.0 110.762 -177.509 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' E' E ' 59' ' ' ARG . . . . . . . . . . . . . 55.8 ttp180 -102.04 128.71 48.37 Favored 'General case' 0 C--N 1.327 -0.387 0 N-CA-C 109.266 -0.642 . . . . 0.0 109.266 175.837 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' E' E ' 60' ' ' VAL . . . . . . . . . . . . . 42.3 t -84.88 116.36 28.31 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.233 0 C-N-CA 120.743 -0.383 . . . . 0.0 110.815 -173.235 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' E' E ' 61' ' ' GLU . . . . . . . . . . . . . 95.8 mt-10 -131.25 159.47 37.72 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 115.909 -0.587 . . . . 0.0 110.139 175.095 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' E' E ' 62' ' ' ASP . . . . . . . . . . . . . 81.4 m-20 -54.43 -30.79 53.75 Favored 'General case' 0 C--N 1.329 -0.319 0 N-CA-C 111.893 0.331 . . . . 0.0 111.893 179.507 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' E' E ' 63' ' ' ARG . . . . . . . . . . . . . 39.0 ptt180 -78.4 -1.18 32.2 Favored 'General case' 0 CA--C 1.538 0.487 0 N-CA-C 113.72 1.007 . . . . 0.0 113.72 -175.8 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' E' E ' 64' ' ' THR . . . . . . . . . . . . . 31.6 m -93.4 148.25 22.23 Favored 'General case' 0 C--N 1.331 -0.199 0 CA-C-N 118.168 0.44 . . . . 0.0 110.305 -179.134 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' E' E ' 65' ' ' LYS . . . . . . . . . . . . . 43.7 mtmt -86.31 122.44 30.29 Favored 'General case' 0 C--N 1.329 -0.287 0 C-N-CA 120.654 -0.419 . . . . 0.0 110.213 179.413 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' E' E ' 66' ' ' ILE . . . . . . . . . . . . . 61.0 mt -112.26 125.71 69.57 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.246 0 N-CA-C 109.393 -0.595 . . . . 0.0 109.393 179.91 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' E' E ' 67' ' ' THR . . . . . . . . . . . . . 27.8 m -119.33 138.12 53.25 Favored 'General case' 0 C--N 1.331 -0.202 0 CA-C-N 116.235 -0.439 . . . . 0.0 110.891 -175.749 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' E' E ' 68' ' ' LEU . . . . . . . . . . . . . 4.4 tt -106.21 124.39 49.52 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 115.788 -0.642 . . . . 0.0 109.725 178.191 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' E' E ' 69' ' ' VAL . . . . . . . . . . . . . 41.8 t -95.32 139.17 19.35 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.281 0 CA-C-O 120.963 0.411 . . . . 0.0 110.59 -177.002 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' E' E ' 70' ' ' THR . . . . . . . . . . . . . 23.7 p -132.16 -37.95 1.1 Allowed 'General case' 0 C--N 1.332 -0.162 0 CA-C-N 115.865 -0.607 . . . . 0.0 111.037 179.799 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' E' E ' 71' ' ' HIS . . . . . . . . . . . . . 18.2 m80 -71.11 113.45 19.19 Favored Pre-proline 0 CA--C 1.536 0.416 0 CA-C-O 118.631 -0.699 . . . . 0.0 110.574 -178.887 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' E' E ' 72' ' ' PRO . . . . . . . . . . . . . 95.6 Cg_endo -82.33 -24.35 3.78 Favored 'Trans proline' 0 N--CA 1.496 1.645 0 C-N-CA 121.407 1.405 . . . . 0.0 112.989 178.966 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' E' E ' 73' ' ' VAL . . . . . . . . . . . . . 35.9 m -126.15 166.45 22.32 Favored 'Isoleucine or valine' 0 C--O 1.233 0.187 0 CA-C-O 120.8 0.333 . . . . 0.0 110.667 -179.046 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' E' E ' 74' ' ' ASP . . . . . . . . . . . . . 6.0 t70 -103.04 122.3 44.35 Favored 'General case' 0 C--N 1.329 -0.296 0 N-CA-C 109.614 -0.513 . . . . 0.0 109.614 -178.937 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' E' E ' 75' ' ' VAL . . . . . . . . . . . . . 40.5 t -119.37 125.73 74.68 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.241 0 CA-C-O 121.095 0.474 . . . . 0.0 110.808 -176.699 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' E' E ' 76' ' ' LEU . . . . . . . . . . . . . 6.0 mp -120.51 143.37 48.59 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 115.659 -0.7 . . . . 0.0 109.586 174.701 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' E' E ' 77' ' ' GLU . . . . . . . . . . . . . 47.1 mt-10 -134.99 129.05 33.57 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-O 121.022 0.439 . . . . 0.0 110.768 -178.563 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' E' E ' 78' ' ' ALA . . . . . . . . . . . . . . . -114.47 133.6 55.63 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 115.802 -0.635 . . . . 0.0 109.865 177.854 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' E' E ' 79' ' ' LYS . . . . . . . . . . . . . 83.3 tttt -78.8 114.87 18.09 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.332 -0.395 . . . . 0.0 109.981 -179.792 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' E' E ' 80' ' ' ILE . . . . . . . . . . . . . 41.9 mm -138.14 121.16 19.77 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.255 0 N-CA-C 109.864 -0.421 . . . . 0.0 109.864 -175.551 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' E' E ' 81' ' ' LYS . . . . . . . . . . . . . 9.6 mtmp? -110.92 126.9 55.22 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-O 120.962 0.41 . . . . 0.0 111.02 -178.426 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' E' E ' 82' ' ' GLY . . . . . . . . . . . . . . . 89.06 42.12 5.7 Favored Glycine 0 CA--C 1.525 0.679 0 C-N-CA 121.003 -0.618 . . . . 0.0 112.025 174.403 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' E' E ' 83' ' ' ILE . . . . . . . . . . . . . 74.7 mt -67.78 133.26 31.88 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.246 0 N-CA-C 109.719 -0.474 . . . . 0.0 109.719 177.329 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' E' E ' 84' ' ' LYS . . . . . . . . . . . . . 83.0 tttt -97.21 -54.15 3.25 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 115.999 -0.546 . . . . 0.0 110.465 -176.979 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' E' E ' 85' ' ' ASP . . . . . . . . . . . . . 13.8 t70 -152.15 149.87 29.24 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 115.604 -0.726 . . . . 0.0 110.163 -179.226 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' E' E ' 86' ' ' VAL . . . . . . . . . . . . . 44.0 t -133.5 131.08 57.31 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.297 0 CA-C-O 120.97 0.414 . . . . 0.0 110.523 -179.66 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' E' E ' 87' ' ' ILE . . . . . . . . . . . . . 46.9 mm -120.07 126.53 75.38 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.254 0 CA-C-N 115.846 -0.616 . . . . 0.0 109.585 176.241 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' E' E ' 88' ' ' LEU . . . . . . . . . . . . . 53.6 mt -110.96 135.75 51.0 Favored 'General case' 0 C--N 1.331 -0.218 0 CA-C-O 121.153 0.501 . . . . 0.0 111.375 -176.243 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' E' E ' 89' ' ' ASP . . . . . . . . . . . . . 7.8 t0 -128.84 150.52 50.3 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 115.596 -0.729 . . . . 0.0 109.034 175.045 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' E' E ' 90' ' ' GLU . . . . . . . . . . . . . 44.1 mt-10 -49.12 -32.82 10.65 Favored 'General case' 0 C--N 1.329 -0.31 0 N-CA-C 112.864 0.69 . . . . 0.0 112.864 -172.339 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' E' E ' 91' ' ' ASN . . . . . . . . . . . . . 65.7 m-80 -131.86 28.68 4.51 Favored 'General case' 0 N--CA 1.467 0.388 0 N-CA-C 112.412 0.523 . . . . 0.0 112.412 -176.208 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' E' E ' 92' ' ' LEU . . . . . . . . . . . . . 9.0 tp -166.2 145.7 6.02 Favored 'General case' 0 C--N 1.33 -0.258 0 N-CA-C 110.207 -0.294 . . . . 0.0 110.207 179.623 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' E' E ' 93' ' ' ILE . . . . . 0.4 HG23 HD12 ' E' ' 93' ' ' ILE . 69.2 mt -127.72 125.17 64.72 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.202 0 N-CA-C 109.795 -0.446 . . . . 0.0 109.795 179.857 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' E' E ' 94' ' ' VAL . . . . . . . . . . . . . 45.8 t -120.88 125.91 74.6 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.22 0 N-CA-C 109.688 -0.486 . . . . 0.0 109.688 179.255 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' E' E ' 95' ' ' VAL . . . . . . . . . . . . . 43.3 t -122.52 135.18 63.44 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.236 0 CA-C-N 116.205 -0.452 . . . . 0.0 109.979 -178.471 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' E' E ' 96' ' ' ILE . . . . . . . . . . . . . 57.1 mt -116.27 130.11 71.57 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 N-CA-C 109.372 -0.603 . . . . 0.0 109.372 179.224 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' E' E ' 97' ' ' THR . . . . . . . . . . . . . 72.9 p -102.23 154.85 18.64 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-O 121.184 0.516 . . . . 0.0 111.056 -178.778 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' E' E ' 98' ' ' GLU . . . . . . . . . . . . . 96.8 mt-10 -54.23 -23.26 14.07 Favored 'General case' 0 CA--C 1.533 0.318 0 N-CA-C 112.366 0.506 . . . . 0.0 112.366 178.932 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' E' E ' 99' ' ' GLU . . . . . . . . . . . . . 32.5 tt0 -79.09 14.69 1.35 Allowed 'General case' 0 CA--C 1.539 0.523 0 N-CA-C 112.688 0.625 . . . . 0.0 112.688 -177.97 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' E' E ' 100' ' ' ASN . . . . . . . . . . . . . 4.4 m-20 62.35 38.06 13.35 Favored 'General case' 0 C--O 1.231 0.117 0 O-C-N 121.801 -0.562 . . . . 0.0 111.002 178.817 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' E' E ' 101' ' ' GLU . . . . . . . . . . . . . 84.9 tt0 -118.01 142.64 47.16 Favored 'General case' 0 C--N 1.331 -0.212 0 CA-C-N 115.996 -0.547 . . . . 0.0 109.845 176.263 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' E' E ' 102' ' ' VAL . . . . . . . . . . . . . 45.5 t -114.97 128.51 72.09 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.306 0 N-CA-C 109.811 -0.44 . . . . 0.0 109.811 -178.688 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' E' E ' 103' ' ' LEU . . . . . . . . . . . . . 51.0 mt -120.29 134.85 55.18 Favored 'General case' 0 C--N 1.331 -0.219 0 CA-C-N 115.865 -0.607 . . . . 0.0 110.382 178.222 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' E' E ' 104' ' ' ILE . . . . . . . . . . . . . 67.8 mt -118.78 124.36 73.03 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.304 0 N-CA-C 110.077 -0.342 . . . . 0.0 110.077 -179.745 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' E' E ' 105' ' ' PHE . . . . . . . . . . . . . 92.2 m-85 -124.07 162.77 22.84 Favored 'General case' 0 C--N 1.332 -0.194 0 O-C-N 123.912 0.758 . . . . 0.0 109.984 -179.981 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' E' E ' 106' ' ' ASN . . . . . . . . . . . . . 47.7 p-10 -98.59 -170.5 1.95 Allowed 'General case' 0 C--N 1.33 -0.279 0 N-CA-C 109.871 -0.418 . . . . 0.0 109.871 174.551 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' E' E ' 107' ' ' GLN . . . . . . . . . . . . . 46.0 tt0 -60.18 -30.07 69.1 Favored 'General case' 0 C--N 1.329 -0.297 0 N-CA-C 111.987 0.366 . . . . 0.0 111.987 -178.827 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' E' E ' 108' ' ' ASN . . . . . . . . . . . . . 59.9 t30 -84.86 10.16 12.34 Favored 'General case' 0 CA--C 1.536 0.439 0 N-CA-C 113.154 0.798 . . . . 0.0 113.154 -177.632 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' E' E ' 109' ' ' LEU . . . . . . . . . . . . . 8.4 tp 58.6 37.18 25.4 Favored 'General case' 0 C--N 1.331 -0.198 0 CA-C-O 121.065 0.459 . . . . 0.0 111.232 179.476 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' E' E ' 110' ' ' GLU . . . . . . . . . . . . . 70.5 mm-40 -103.4 142.16 34.71 Favored 'General case' 0 C--N 1.329 -0.303 0 N-CA-C 109.358 -0.608 . . . . 0.0 109.358 174.908 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' E' E ' 111' ' ' GLU . . . . . . . . . . . . . 71.6 tt0 -78.36 121.77 24.9 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-O 120.94 0.4 . . . . 0.0 110.387 -175.199 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' E' E ' 112' ' ' LEU . . . . . . . . . . . . . 15.3 mt -106.21 -46.02 4.16 Favored 'General case' 0 C--N 1.331 -0.196 0 CA-C-N 116.08 -0.509 . . . . 0.0 110.778 -178.913 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' E' E ' 113' ' ' TYR . . . . . . . . . . . . . 59.0 t80 -137.31 144.38 42.58 Favored 'General case' 0 C--N 1.331 -0.223 0 CA-C-N 116.204 -0.453 . . . . 0.0 111.012 -178.4 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' E' E ' 114' ' ' ARG . . . . . . . . . . . . . 48.1 ptt85 -147.12 125.75 12.53 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.271 -0.422 . . . . 0.0 111.003 179.073 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' E' E ' 115' ' ' GLY . . . . . . . . . . . . . . . -149.98 153.95 25.4 Favored Glycine 0 CA--C 1.525 0.678 0 N-CA-C 111.231 -0.748 . . . . 0.0 111.231 178.206 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' E' E ' 116' ' ' LYS . . . . . . . . . . . . . 25.9 ttpp -124.83 132.49 53.33 Favored 'General case' 0 C--N 1.331 -0.212 0 N-CA-C 109.942 -0.392 . . . . 0.0 109.942 178.352 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' E' E ' 117' ' ' PHE . . . . . . . . . . . . . 48.5 m-85 -130.68 115.9 17.32 Favored 'General case' 0 C--N 1.331 -0.206 0 CA-C-O 120.928 0.394 . . . . 0.0 110.373 -175.568 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' E' E ' 118' ' ' GLU . . . . . . . . . . . . . 46.1 tp10 -52.84 -51.11 62.2 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.36 -0.382 . . . . 0.0 111.784 -174.734 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' E' E ' 119' ' ' ASN . . . . . . . . . . . . . 3.2 p30 -98.45 31.31 2.88 Favored 'General case' 0 C--N 1.33 -0.274 0 N-CA-C 112.197 0.443 . . . . 0.0 112.197 -174.418 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' E' E ' 120' ' ' LEU . . . . . . . . . . . . . 14.5 tp -51.71 124.81 13.24 Favored 'General case' 0 N--CA 1.464 0.237 0 CA-C-O 120.535 0.207 . . . . 0.0 111.057 178.025 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' E' E ' 121' ' ' ASN . . . . . . . . . . . . . 15.6 m120 -113.55 -44.06 3.25 Favored 'General case' 0 C--O 1.232 0.183 0 CA-C-N 116.727 -0.215 . . . . 0.0 111.285 -176.495 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' E' E ' 122' ' ' LYS . . . . . . . . . . . . . 98.8 mttt -145.36 148.53 33.48 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-O 121.049 0.452 . . . . 0.0 111.826 -176.737 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' E' E ' 123' ' ' VAL . . . . . . . . . . . . . 45.6 t -129.41 130.93 67.6 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.293 0 N-CA-C 109.396 -0.594 . . . . 0.0 109.396 175.462 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' E' E ' 124' ' ' LEU . . . . . . . . . . . . . 19.7 tp -130.26 133.97 46.9 Favored 'General case' 0 C--N 1.332 -0.163 0 CA-C-O 120.791 0.329 . . . . 0.0 110.748 -177.179 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' E' E ' 125' ' ' VAL . . . . . . . . . . . . . 11.1 p -133.67 135.49 55.49 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.25 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.303 179.776 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' E' E ' 126' ' ' ARG . . . . . . . . . . . . . 20.8 ttm180 -144.39 121.86 11.71 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.307 -0.406 . . . . 0.0 110.626 178.331 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' E' E ' 127' ' ' ASN . . . . . . . . . . . . . 4.3 m120 49.41 -106.39 0.2 Allowed 'General case' 0 CA--C 1.545 0.77 0 CA-C-O 118.957 -0.544 . . . . 0.0 111.639 178.994 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' E' E ' 128' ' ' ASP . . . . . . . . . . . . . 11.6 p-10 -114.09 4.0 15.47 Favored 'General case' 0 N--CA 1.468 0.468 0 CA-C-N 119.693 1.133 . . . . 0.0 113.408 -177.21 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' E' E ' 129' ' ' LEU . . . . . . . . . . . . . 15.5 tp -107.13 132.67 52.75 Favored 'General case' 0 C--N 1.333 -0.147 0 N-CA-C 109.561 -0.533 . . . . 0.0 109.561 178.617 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' E' E ' 130' ' ' VAL . . . . . . . . . . . . . 41.5 t -122.92 136.55 59.35 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.243 0 CA-C-O 120.668 0.271 . . . . 0.0 110.349 -177.309 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' E' E ' 131' ' ' VAL . . . . . . . . . . . . . 27.1 m -136.07 140.81 43.23 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.236 0 CA-C-O 121.166 0.508 . . . . 0.0 111.274 177.579 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' E' E ' 132' ' ' ILE . . . . . . . . . . . . . 75.5 mt -121.22 132.4 70.67 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.384 0 CA-C-N 115.39 -0.823 . . . . 0.0 109.171 178.125 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' E' E ' 133' ' ' ILE . . . . . . . . . . . . . 33.2 mm -115.37 121.17 66.65 Favored 'Isoleucine or valine' 0 C--O 1.234 0.251 0 CA-C-O 120.898 0.38 . . . . 0.0 111.237 -173.464 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' E' E ' 134' ' ' ASP . . . . . . . . . . . . . 7.3 p-10 -133.59 146.53 51.05 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 115.904 -0.589 . . . . 0.0 109.584 175.724 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' E' E ' 135' ' ' GLU . . . . . . . . . . . . . 39.2 tp10 -49.93 -26.8 4.49 Favored 'General case' 0 C--N 1.326 -0.422 0 N-CA-C 112.815 0.672 . . . . 0.0 112.815 -173.407 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' E' E ' 136' ' ' GLN . . . . . . . . . . . . . 49.7 tt0 -81.91 -32.99 30.66 Favored 'General case' 0 C--O 1.234 0.274 0 N-CA-C 112.328 0.492 . . . . 0.0 112.328 -175.968 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' E' E ' 137' ' ' LYS . . . . . . . . . . . . . 50.7 pttt -170.06 173.04 6.14 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-O 121.451 0.643 . . . . 0.0 112.27 -172.967 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' E' E ' 138' ' ' LEU . . . . . . . . . . . . . 6.6 tt -118.33 129.13 55.26 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 115.212 -0.904 . . . . 0.0 110.055 179.521 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' E' E ' 139' ' ' THR . . . . . . . . . . . . . 24.4 m -106.87 130.25 54.58 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.439 -0.346 . . . . 0.0 110.516 -179.803 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' E' E ' 140' ' ' LEU . . . . . . . . . . . . . 51.2 tp -118.34 127.21 53.48 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 115.784 -0.644 . . . . 0.0 109.413 -177.766 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' E' E ' 141' ' ' ILE . . . . . . . . . . . . . 19.1 mt -123.49 122.38 64.92 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 CA-C-N 116.397 -0.365 . . . . 0.0 110.143 -174.996 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' E' E ' 142' ' ' ARG . . . . . . . . . . . . . 84.4 mtp180 -108.77 129.41 55.38 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-N 115.523 -0.762 . . . . 0.0 110.455 179.46 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' E' E ' 143' ' ' THR . . . . . . . . . . . . . 40.0 p . . . . . 0 C--O 1.221 -0.442 0 CA-C-O 117.961 -1.018 . . . . 0.0 110.605 179.145 . . . . . . . . 0 0 . 1 . 006 nuclear orig full ' F' F ' -3' ' ' GLU . . . . . . . . . . . . . 95.7 mt-10 . . . . . 0 N--CA 1.49 1.56 0 N-CA-C 109.36 -0.607 . . . . 0.0 109.36 . . . . . . . . . 0 0 . 1 . 006 nuclear orig full ' F' F ' -2' ' ' GLY . . . . . . . . . . . . . . . -69.48 136.37 27.99 Favored Glycine 0 CA--C 1.524 0.655 0 N-CA-C 110.918 -0.873 . . . . 0.0 110.918 179.699 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' F' F ' -1' ' ' VAL . . . . . . . . . . . . . 42.6 t -141.0 142.07 30.42 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.27 0 N-CA-C 109.907 -0.405 . . . . 0.0 109.907 179.306 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' F' F ' 0' ' ' ILE . . . . . . . . . . . . . 43.4 mm -102.3 135.05 41.16 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.285 0 CA-C-N 116.263 -0.426 . . . . 0.0 110.157 -179.355 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' F' F ' 1' ' ' MET . . . . . . . . . . . . . 24.2 ptp -90.63 144.48 25.71 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.228 -0.442 . . . . 0.0 110.728 -178.899 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' F' F ' 2' ' ' SER . . . . . . . . . . . . . 4.5 p -115.79 131.19 57.01 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.107 -0.497 . . . . 0.0 110.098 177.249 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' F' F ' 3' ' ' GLU . . . . . . . . . . . . . 84.8 tt0 -142.75 141.07 31.67 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.054 -0.521 . . . . 0.0 111.08 -178.304 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' F' F ' 4' ' ' LEU . . . . . . . . . . . . . 18.0 tp -127.41 132.52 50.1 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 115.883 -0.599 . . . . 0.0 110.216 178.097 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' F' F ' 5' ' ' LYS . . . . . . . . . . . . . 68.6 mttm -112.03 121.06 43.95 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-N 116.338 -0.392 . . . . 0.0 110.665 179.477 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' F' F ' 6' ' ' LEU . . . . . . . . . . . . . 68.4 mt -116.61 144.76 44.0 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 115.451 -0.795 . . . . 0.0 110.158 -178.394 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' F' F ' 7' ' ' LYS . . . . . . . . . . . . . 1.7 ttmp? -130.56 135.25 27.1 Favored Pre-proline 0 CA--C 1.534 0.351 0 CA-C-O 118.848 -0.596 . . . . 0.0 110.293 177.627 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' F' F ' 8' ' ' PRO . . . . . . . . . . . . . 62.9 Cg_endo -91.03 137.91 2.26 Favored 'Trans proline' 0 N--CA 1.49 1.265 0 C-N-CA 121.715 1.61 . . . . 0.0 111.348 175.75 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' F' F ' 9' ' ' LEU . . . . . . . . . . . . . 50.6 mt -77.01 -47.45 2.72 Favored Pre-proline 0 CA--C 1.532 0.274 0 CA-C-O 118.762 -0.637 . . . . 0.0 112.241 -176.693 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' F' F ' 10' ' ' PRO . . . . . . . . . . . . . 93.0 Cg_endo -82.03 151.21 16.17 Favored 'Trans proline' 0 N--CA 1.498 1.744 0 C-N-CA 121.178 1.252 . . . . 0.0 111.607 174.956 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' F' F ' 11' ' ' LYS . . . . . . . . . . . . . 19.5 pttp -84.6 114.02 21.68 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-O 121.623 0.725 . . . . 0.0 110.682 178.166 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' F' F ' 12' ' ' VAL . . . . . . . . . . . . . 11.5 p -151.05 148.79 14.69 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.241 0 CA-C-N 115.534 -0.757 . . . . 0.0 110.059 179.918 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' F' F ' 13' ' ' GLU . . . . . . . . . . . . . 84.8 tt0 -89.58 122.87 33.15 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-O 120.822 0.344 . . . . 0.0 110.246 178.458 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' F' F ' 14' ' ' LEU . . . . . . . . . . . . . 21.1 mt -97.61 151.48 37.64 Favored Pre-proline 0 C--N 1.33 -0.266 0 CA-C-N 116.293 -0.412 . . . . 0.0 110.431 -178.342 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' F' F ' 15' ' ' PRO . . . . . . . . . . . . . 27.0 Cg_exo -61.17 156.58 44.38 Favored 'Trans proline' 0 N--CA 1.496 1.676 0 C-N-CA 121.21 1.273 . . . . 0.0 111.577 177.381 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' F' F ' 16' ' ' PRO . . . . . . . . . . . . . 39.5 Cg_exo -58.78 -35.66 98.27 Favored 'Trans proline' 0 N--CA 1.496 1.621 0 C-N-CA 121.436 1.424 . . . . 0.0 112.708 -179.62 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' F' F ' 17' ' ' ASP . . . . . . . . . . . . . 12.4 p-10 -88.24 11.17 17.2 Favored 'General case' 0 CA--C 1.536 0.427 0 N-CA-C 113.12 0.785 . . . . 0.0 113.12 -178.211 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' F' F ' 18' ' ' PHE . . . . . . . . . . . . . 61.6 t80 -58.06 -43.52 86.95 Favored 'General case' 0 C--N 1.333 -0.111 0 O-C-N 121.994 -0.441 . . . . 0.0 110.131 -178.232 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' F' F ' 19' ' ' VAL . . . . . . . . . . . . . 48.5 t -57.01 -42.06 78.54 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.308 0 CA-C-N 116.256 -0.429 . . . . 0.0 110.416 -178.568 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' F' F ' 20' ' ' ASP . . . . . . . . . . . . . 17.0 t0 -59.95 -42.59 94.36 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-O 120.872 0.368 . . . . 0.0 110.882 -178.303 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' F' F ' 21' ' ' VAL . . . . . . . . . . . . . 48.0 t -64.55 -46.23 93.23 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.285 0 C-N-CA 120.84 -0.344 . . . . 0.0 110.518 -177.988 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' F' F ' 22' ' ' ILE . . . . . . . . . . . . . 48.5 mm -56.34 -45.04 81.35 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.177 0 C-N-CA 120.92 -0.312 . . . . 0.0 110.583 178.968 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' F' F ' 23' ' ' ARG . . . . . . . . . . . . . 56.6 ttp180 -54.39 -48.55 71.42 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-O 120.738 0.304 . . . . 0.0 111.305 -179.27 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' F' F ' 24' ' ' ILE . . . . . . . . . . . . . 72.4 mt -59.19 -44.3 91.54 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.21 0 CA-C-N 116.493 -0.321 . . . . 0.0 110.935 -178.047 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' F' F ' 25' ' ' LYS . . . . . . . . . . . . . 44.8 mtpt -63.91 -43.31 96.33 Favored 'General case' 0 C--N 1.328 -0.347 0 N-CA-C 112.357 0.502 . . . . 0.0 112.357 -177.997 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' F' F ' 26' ' ' LEU . . . . . . . . . . . . . 67.7 mt -79.18 -40.95 29.55 Favored 'General case' 0 C--N 1.33 -0.273 0 N-CA-C 113.428 0.899 . . . . 0.0 113.428 -170.551 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' F' F ' 27' ' ' GLN . . . . . . . . . . . . . 9.9 pt20 -46.67 137.66 6.73 Favored 'General case' 0 N--CA 1.468 0.449 0 N-CA-C 112.871 0.693 . . . . 0.0 112.871 -174.607 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' F' F ' 28' ' ' GLY . . . . . . . . . . . . . . . 100.47 -25.85 26.76 Favored Glycine 0 CA--C 1.533 1.181 0 CA-C-N 115.571 -0.741 . . . . 0.0 112.312 -177.589 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' F' F ' 29' ' ' LYS . . . . . . . . . . . . . 55.1 mmtt -97.4 155.17 17.03 Favored 'General case' 0 C--O 1.232 0.169 0 CA-C-N 117.272 0.536 . . . . 0.0 111.304 178.253 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' F' F ' 30' ' ' THR . . . . . . . . . . . . . 26.6 m -107.09 134.28 50.45 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 115.517 -0.765 . . . . 0.0 109.577 174.802 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' F' F ' 31' ' ' VAL . . . . . . . . . . . . . 35.0 m -130.1 158.94 42.54 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.226 0 CA-C-O 120.926 0.393 . . . . 0.0 110.918 -177.086 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' F' F ' 32' ' ' ARG . . . . . . . . . . . . . 34.9 mtp180 -131.46 152.82 50.36 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-O 121.458 0.647 . . . . 0.0 110.94 179.095 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' F' F ' 33' ' ' THR . . . . . . . . . . . . . 16.8 m -53.53 139.67 30.64 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 115.786 -0.643 . . . . 0.0 111.22 -179.417 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' F' F ' 34' ' ' GLY . . . . . . . . . . . . . . . 101.81 -17.05 55.45 Favored Glycine 0 CA--C 1.533 1.181 0 CA-C-O 119.635 -0.536 . . . . 0.0 113.287 179.261 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' F' F ' 35' ' ' ASP . . . . . . . . . . . . . 72.0 m-20 -64.9 148.4 51.53 Favored 'General case' 0 N--CA 1.461 0.106 0 CA-C-N 118.073 0.936 . . . . 0.0 111.19 178.98 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' F' F ' 36' ' ' VAL . . . . . . . . . . . . . 44.3 t -124.01 131.82 72.32 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.179 0 CA-C-N 115.929 -0.578 . . . . 0.0 109.906 179.844 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' F' F ' 37' ' ' ILE . . . . . . . . . . . . . 68.4 mt -122.93 139.9 48.32 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.195 0 CA-C-N 116.076 -0.511 . . . . 0.0 109.777 179.702 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' F' F ' 38' ' ' GLY . . . . . . . . . . . . . . . -115.2 128.99 8.35 Favored Glycine 0 CA--C 1.526 0.742 0 N-CA-C 110.904 -0.878 . . . . 0.0 110.904 179.508 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' F' F ' 39' ' ' ILE . . . . . . . . . . . . . 72.6 mt -123.69 136.21 60.91 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.229 0 CA-C-O 120.722 0.296 . . . . 0.0 110.359 -179.18 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' F' F ' 40' ' ' SER . . . . . . . . . . . . . 48.0 t -93.77 120.3 33.86 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.326 -0.397 . . . . 0.0 110.654 173.833 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' F' F ' 41' ' ' ILE . . . . . . . . . . . . . 72.3 mt -125.84 121.07 58.91 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.243 0 CA-C-O 120.817 0.341 . . . . 0.0 110.343 178.337 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' F' F ' 42' ' ' LEU . . . . . . . . . . . . . 7.0 mp 50.94 35.09 11.72 Favored 'General case' 0 CA--C 1.532 0.256 0 CA-C-O 121.131 0.491 . . . . 0.0 111.636 178.326 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' F' F ' 43' ' ' GLY . . . . . . . . . . . . . . . 73.03 32.84 60.18 Favored Glycine 0 CA--C 1.527 0.839 0 C-N-CA 121.132 -0.556 . . . . 0.0 112.076 177.842 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' F' F ' 44' ' ' LYS . . . . . . . . . . . . . 44.7 tttp -137.54 130.01 29.65 Favored 'General case' 0 C--N 1.329 -0.288 0 N-CA-C 109.539 -0.541 . . . . 0.0 109.539 178.318 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' F' F ' 45' ' ' GLU . . . . . . . . . . . . . 77.5 tt0 -84.15 123.59 30.25 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.529 -0.305 . . . . 0.0 111.336 -175.462 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' F' F ' 46' ' ' VAL . . . . . . . . . . . . . 7.2 p -124.7 130.31 73.44 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.207 0 CA-C-O 120.918 0.389 . . . . 0.0 109.994 176.876 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' F' F ' 47' ' ' LYS . . . . . . . . . . . . . 33.8 mmtp -99.75 132.22 45.23 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 115.906 -0.588 . . . . 0.0 111.298 177.647 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' F' F ' 48' ' ' PHE . . . . . . . . . . . . . 95.4 m-85 -115.8 131.87 56.81 Favored 'General case' 0 C--N 1.331 -0.208 0 N-CA-C 109.603 -0.517 . . . . 0.0 109.603 174.449 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' F' F ' 49' ' ' LYS . . . . . . . . . . . . . 82.4 tttt -108.92 135.88 49.38 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.338 -0.392 . . . . 0.0 110.51 179.553 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' F' F ' 50' ' ' VAL . . . . . . . . . . . . . 47.1 t -79.03 105.82 8.98 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.253 0 N-CA-C 109.127 -0.694 . . . . 0.0 109.127 176.061 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' F' F ' 51' ' ' VAL . . . . . . . . . . . . . 46.3 t -70.54 -53.48 22.33 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.298 0 CA-C-N 115.887 -0.597 . . . . 0.0 109.579 -174.271 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' F' F ' 52' ' ' GLN . . . . . . . . . . . . . 90.9 mt-30 -153.75 152.05 30.3 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 115.974 -0.557 . . . . 0.0 111.742 -178.114 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' F' F ' 53' ' ' ALA . . . . . . . . . . . . . . . -128.42 132.92 48.47 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 115.317 -0.856 . . . . 0.0 109.765 174.547 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' F' F ' 54' ' ' TYR . . . . . . . . . . . . . 82.3 t80 -129.13 111.67 18.31 Favored Pre-proline 0 CA--C 1.535 0.368 0 CA-C-O 118.298 -0.858 . . . . 0.0 110.402 179.473 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' F' F ' 55' ' ' PRO . . . . . . . . . . . . . 73.6 Cg_endo -77.05 169.6 73.93 Favored 'Cis proline' 0 N--CA 1.5 1.854 0 CA-C-N 122.023 1.758 . . . . 0.0 112.226 -6.227 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' F' F ' 56' ' ' SER . . . . . . . . . . . . . 13.6 m -116.43 124.66 29.26 Favored Pre-proline 0 CA--C 1.539 0.554 0 CA-C-O 118.37 -0.824 . . . . 0.0 109.219 176.102 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' F' F ' 57' ' ' PRO . . . . . . . . . . . . . 53.9 Cg_endo -69.55 149.32 87.88 Favored 'Cis proline' 0 N--CA 1.498 1.754 0 CA-C-N 122.063 1.773 . . . . 0.0 112.086 2.128 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' F' F ' 58' ' ' LEU . . . . . . . . . . . . . 21.4 tp -108.63 136.3 48.45 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.111 -0.495 . . . . 0.0 110.619 -179.569 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' F' F ' 59' ' ' ARG . . . . . . . . . . . . . 40.9 ttm180 -103.75 123.4 46.98 Favored 'General case' 0 C--N 1.329 -0.291 0 N-CA-C 109.346 -0.613 . . . . 0.0 109.346 175.867 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' F' F ' 60' ' ' VAL . . . . . . . . . . . . . 42.1 t -81.91 124.09 38.73 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.269 0 C-N-CA 120.638 -0.425 . . . . 0.0 110.362 -175.581 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' F' F ' 61' ' ' GLU . . . . . . . . . . . . . 79.3 tt0 -131.09 157.47 43.0 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 115.74 -0.664 . . . . 0.0 109.27 179.367 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' F' F ' 62' ' ' ASP . . . . . . . . . . . . . 10.5 t0 -51.56 -32.48 28.39 Favored 'General case' 0 C--N 1.328 -0.368 0 N-CA-C 112.138 0.422 . . . . 0.0 112.138 -176.692 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' F' F ' 63' ' ' ARG . . . . . . . . . . . . . 16.7 ptp180 -89.4 10.05 23.98 Favored 'General case' 0 N--CA 1.466 0.36 0 N-CA-C 113.613 0.968 . . . . 0.0 113.613 -176.157 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' F' F ' 64' ' ' THR . . . . . . . . . . . . . 22.4 m -80.15 143.34 33.95 Favored 'General case' 0 C--N 1.331 -0.21 0 CA-C-N 118.001 0.364 . . . . 0.0 110.63 -178.508 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' F' F ' 65' ' ' LYS . . . . . . . . . . . . . 95.9 mttt -87.47 126.69 35.05 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.169 -0.468 . . . . 0.0 110.008 179.372 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' F' F ' 66' ' ' ILE . . . . . . . . . . . . . 66.6 mt -118.2 129.52 74.41 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.288 0 N-CA-C 109.903 -0.406 . . . . 0.0 109.903 -179.404 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' F' F ' 67' ' ' THR . . . . . . . . . . . . . 24.4 m -121.0 138.97 53.91 Favored 'General case' 0 C--N 1.331 -0.207 0 CA-C-N 116.248 -0.433 . . . . 0.0 110.856 -178.189 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' F' F ' 68' ' ' LEU . . . . . . . . . . . . . 15.2 tp -107.42 126.18 52.16 Favored 'General case' 0 C--N 1.332 -0.172 0 CA-C-N 115.929 -0.578 . . . . 0.0 110.347 179.155 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' F' F ' 69' ' ' VAL . . . . . . . . . . . . . 44.8 t -102.86 138.81 25.69 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.26 0 CA-C-N 116.068 -0.515 . . . . 0.0 110.17 178.873 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' F' F ' 70' ' ' THR . . . . . . . . . . . . . 6.6 t -132.7 -39.46 0.99 Allowed 'General case' 0 C--N 1.332 -0.181 0 CA-C-N 116.138 -0.483 . . . . 0.0 110.726 179.549 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' F' F ' 71' ' ' HIS . . . . . . . . . . . . . 71.5 t60 -149.82 105.65 3.23 Favored Pre-proline 0 CA--C 1.535 0.366 0 CA-C-O 118.71 -0.662 . . . . 0.0 110.267 -179.649 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' F' F ' 72' ' ' PRO . . . . . . . . . . . . . 57.2 Cg_endo -70.3 160.04 50.92 Favored 'Trans proline' 0 N--CA 1.496 1.665 0 C-N-CA 121.274 1.316 . . . . 0.0 112.247 -177.984 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' F' F ' 73' ' ' VAL . . . . . . . . . . . . . 34.6 m -110.53 154.9 12.0 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.204 0 CA-C-N 116.18 -0.463 . . . . 0.0 110.193 178.541 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' F' F ' 74' ' ' ASP . . . . . . . . . . . . . 7.5 t0 -97.6 124.77 42.0 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.138 -0.483 . . . . 0.0 110.157 -177.769 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' F' F ' 75' ' ' VAL . . . . . . . . . . . . . 42.7 t -113.42 125.93 70.77 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.247 0 CA-C-O 121.078 0.466 . . . . 0.0 110.446 -178.745 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' F' F ' 76' ' ' LEU . . . . . . . . . . . . . 27.0 mt -128.78 149.54 50.68 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 115.671 -0.695 . . . . 0.0 109.727 178.737 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' F' F ' 77' ' ' GLU . . . . . . . . . . . . . 47.2 mt-10 -136.05 140.31 43.73 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-O 121.004 0.43 . . . . 0.0 111.44 -176.526 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' F' F ' 78' ' ' ALA . . . . . . . . . . . . . . . -124.03 126.62 46.58 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 115.663 -0.698 . . . . 0.0 109.56 175.906 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' F' F ' 79' ' ' LYS . . . . . . . . . . . . . 53.7 pttt -80.06 123.93 28.29 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-O 121.133 0.492 . . . . 0.0 111.341 -176.714 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' F' F ' 80' ' ' ILE . . . . . . . . . . . . . 39.5 mm -139.14 118.49 13.58 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.238 0 CA-C-N 115.901 -0.591 . . . . 0.0 109.692 -178.287 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' F' F ' 81' ' ' LYS . . . . . . . . . . . . . 40.2 mmtt -96.1 118.87 33.55 Favored 'General case' 0 C--N 1.327 -0.374 0 C-N-CA 120.905 -0.318 . . . . 0.0 111.205 179.667 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' F' F ' 82' ' ' GLY . . . . . . . . . . . . . . . 89.19 42.17 5.65 Favored Glycine 0 CA--C 1.526 0.747 0 C-N-CA 120.654 -0.784 . . . . 0.0 112.027 172.202 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' F' F ' 83' ' ' ILE . . . . . . . . . . . . . 73.1 mt -64.47 134.21 29.35 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.294 0 N-CA-C 109.505 -0.554 . . . . 0.0 109.505 175.835 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' F' F ' 84' ' ' LYS . . . . . . . . . . . . . 36.5 ttpt -97.73 -53.97 3.26 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-O 120.992 0.425 . . . . 0.0 110.14 -179.346 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' F' F ' 85' ' ' ASP . . . . . . . . . . . . . 9.1 t70 -149.35 151.56 34.33 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 115.745 -0.661 . . . . 0.0 110.503 -179.472 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' F' F ' 86' ' ' VAL . . . . . . . . . . . . . 44.6 t -126.67 130.58 71.63 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.218 0 CA-C-O 120.952 0.406 . . . . 0.0 110.321 -178.986 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' F' F ' 87' ' ' ILE . . . . . . . . . . . . . 43.4 mm -119.2 126.2 75.14 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.304 0 CA-C-N 115.84 -0.618 . . . . 0.0 109.388 177.961 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' F' F ' 88' ' ' LEU . . . . . . . . . . . . . 13.0 tp -116.94 135.32 53.8 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-O 120.976 0.417 . . . . 0.0 111.394 -175.943 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' F' F ' 89' ' ' ASP . . . . . . . . . . . . . 6.1 t70 -132.17 156.31 46.65 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 115.812 -0.631 . . . . 0.0 109.457 175.228 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' F' F ' 90' ' ' GLU . . . . . . . . . . . . . 96.6 mt-10 -48.03 -36.95 13.78 Favored 'General case' 0 C--N 1.33 -0.28 0 N-CA-C 113.176 0.806 . . . . 0.0 113.176 -171.123 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' F' F ' 91' ' ' ASN . . . . . . . . . . . . . 35.3 m120 -123.44 13.14 9.45 Favored 'General case' 0 N--CA 1.468 0.466 0 N-CA-C 113.555 0.946 . . . . 0.0 113.555 -174.763 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' F' F ' 92' ' ' LEU . . . . . . . . . . . . . 44.3 mt -149.73 147.98 28.69 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-N 117.925 0.33 . . . . 0.0 110.721 -176.577 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' F' F ' 93' ' ' ILE . . . . . . . . . . . . . 74.0 mt -122.71 118.3 54.62 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.268 0 N-CA-C 109.102 -0.703 . . . . 0.0 109.102 175.736 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' F' F ' 94' ' ' VAL . . . . . . . . . . . . . 45.5 t -117.42 127.28 74.91 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.249 0 N-CA-C 109.743 -0.466 . . . . 0.0 109.743 -179.054 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' F' F ' 95' ' ' VAL . . . . . . . . . . . . . 43.0 t -123.21 134.94 64.77 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.364 0 CA-C-N 116.1 -0.5 . . . . 0.0 109.964 -178.958 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' F' F ' 96' ' ' ILE . . . . . . . . . . . . . 65.8 mt -115.45 126.28 72.95 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.308 0 N-CA-C 109.259 -0.645 . . . . 0.0 109.259 178.718 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' F' F ' 97' ' ' THR . . . . . . . . . . . . . 69.4 p -99.75 155.93 17.37 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-O 121.228 0.537 . . . . 0.0 110.957 -177.341 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' F' F ' 98' ' ' GLU . . . . . . . . . . . . . 84.9 tt0 -53.87 -24.91 17.45 Favored 'General case' 0 CA--C 1.536 0.422 0 CA-C-N 116.057 -0.519 . . . . 0.0 112.267 179.658 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' F' F ' 99' ' ' GLU . . . . . . . . . . . . . 96.8 mt-10 -77.55 12.89 1.42 Allowed 'General case' 0 CA--C 1.537 0.45 0 N-CA-C 113.301 0.852 . . . . 0.0 113.301 -177.924 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' F' F ' 100' ' ' ASN . . . . . . . . . . . . . 2.2 m-20 61.84 33.62 17.55 Favored 'General case' 0 N--CA 1.464 0.262 0 CA-C-N 118.099 0.409 . . . . 0.0 111.315 -179.74 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' F' F ' 101' ' ' GLU . . . . . . . . . . . . . 54.4 tt0 -110.27 143.69 40.07 Favored 'General case' 0 C--N 1.333 -0.137 0 N-CA-C 109.571 -0.529 . . . . 0.0 109.571 174.189 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' F' F ' 102' ' ' VAL . . . . . . . . . . . . . 46.7 t -115.39 127.16 73.06 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.295 0 N-CA-C 109.84 -0.429 . . . . 0.0 109.84 -178.39 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' F' F ' 103' ' ' LEU . . . . . . . . . . . . . 19.7 mt -118.64 132.58 56.18 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 115.864 -0.607 . . . . 0.0 110.715 178.711 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' F' F ' 104' ' ' ILE . . . . . . . . . . . . . 63.8 mt -116.85 120.65 65.68 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.277 0 N-CA-C 109.81 -0.441 . . . . 0.0 109.81 177.921 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' F' F ' 105' ' ' PHE . . . . . . . . . . . . . 92.3 m-85 -120.43 162.78 18.95 Favored 'General case' 0 C--N 1.332 -0.157 0 O-C-N 123.859 0.724 . . . . 0.0 109.91 -179.906 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' F' F ' 106' ' ' ASN . . . . . . . . . . . . . 45.6 p-10 -97.62 -174.09 2.81 Favored 'General case' 0 C--N 1.33 -0.268 0 N-CA-C 109.593 -0.521 . . . . 0.0 109.593 172.214 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' F' F ' 107' ' ' GLN . . . . . . . . . . . . . 21.6 tt0 -62.21 -19.24 62.95 Favored 'General case' 0 CA--C 1.536 0.429 0 N-CA-C 112.586 0.588 . . . . 0.0 112.586 -178.725 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' F' F ' 108' ' ' ASN . . . . . . . . . . . . . 17.2 t30 -95.68 14.09 24.23 Favored 'General case' 0 CA--C 1.535 0.393 0 N-CA-C 113.124 0.787 . . . . 0.0 113.124 -178.259 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' F' F ' 109' ' ' LEU . . . . . . . . . . . . . 52.5 mt 58.98 38.92 24.1 Favored 'General case' 0 C--O 1.232 0.155 0 CA-C-O 121.139 0.495 . . . . 0.0 111.395 178.095 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' F' F ' 110' ' ' GLU . . . . . . . . . . . . . 96.5 mt-10 -106.14 156.9 17.97 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.15 -0.477 . . . . 0.0 109.95 176.055 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' F' F ' 111' ' ' GLU . . . . . . . . . . . . . 84.5 tt0 -86.98 121.91 30.1 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-O 120.884 0.374 . . . . 0.0 111.107 -177.258 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' F' F ' 112' ' ' LEU . . . . . . . . . . . . . 31.4 mt -108.43 -45.95 3.79 Favored 'General case' 0 C--N 1.332 -0.189 0 CA-C-N 116.054 -0.521 . . . . 0.0 110.448 176.735 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' F' F ' 113' ' ' TYR . . . . . . . . . . . . . 55.5 t80 -141.86 138.55 32.21 Favored 'General case' 0 C--N 1.331 -0.229 0 C-N-CA 120.614 -0.434 . . . . 0.0 111.319 179.947 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' F' F ' 114' ' ' ARG . . . . . . . . . . . . . 23.7 ttm180 -138.1 124.2 20.28 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.232 -0.44 . . . . 0.0 110.195 176.539 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' F' F ' 115' ' ' GLY . . . . . . . . . . . . . . . -150.17 159.64 28.2 Favored Glycine 0 CA--C 1.525 0.676 0 N-CA-C 110.798 -0.921 . . . . 0.0 110.798 178.283 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' F' F ' 116' ' ' LYS . . . . . . . . . . . . . 55.4 tttt -132.6 135.33 45.83 Favored 'General case' 0 C--N 1.329 -0.305 0 N-CA-C 110.098 -0.334 . . . . 0.0 110.098 178.714 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' F' F ' 117' ' ' PHE . . . . . . . . . . . . . 26.3 m-85 -137.72 116.31 12.11 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-O 120.799 0.333 . . . . 0.0 110.309 -174.611 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' F' F ' 118' ' ' GLU . . . . . . . . . . . . . 46.0 tp10 -53.96 -44.58 70.85 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.594 -0.276 . . . . 0.0 111.309 -177.621 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' F' F ' 119' ' ' ASN . . . . . . . . . . . . . 11.7 m120 -97.09 31.1 2.51 Favored 'General case' 0 C--N 1.329 -0.309 0 N-CA-C 112.202 0.445 . . . . 0.0 112.202 -174.497 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' F' F ' 120' ' ' LEU . . . . . . . . . . . . . 15.5 tp -57.76 122.53 13.06 Favored 'General case' 0 C--N 1.333 -0.126 0 N-CA-C 110.225 -0.287 . . . . 0.0 110.225 177.744 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' F' F ' 121' ' ' ASN . . . . . . . . . . . . . 88.6 m-20 -113.75 -43.95 3.23 Favored 'General case' 0 C--N 1.333 -0.124 0 CA-C-N 116.66 -0.246 . . . . 0.0 111.232 -176.729 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' F' F ' 122' ' ' LYS . . . . . . . . . . . . . 51.2 mttm -143.74 144.73 31.96 Favored 'General case' 0 C--N 1.33 -0.25 0 C-N-CA 120.629 -0.428 . . . . 0.0 111.669 -177.408 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' F' F ' 123' ' ' VAL . . . . . . . . . . . . . 43.9 t -127.18 127.84 69.77 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.249 0 N-CA-C 109.328 -0.619 . . . . 0.0 109.328 174.795 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' F' F ' 124' ' ' LEU . . . . . . . . . . . . . 56.5 mt -128.78 139.2 52.3 Favored 'General case' 0 C--N 1.331 -0.211 0 CA-C-O 120.792 0.33 . . . . 0.0 110.933 -176.653 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' F' F ' 125' ' ' VAL . . . . . . . . . . . . . 12.8 p -137.88 137.72 44.63 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.249 0 CA-C-N 116.344 -0.389 . . . . 0.0 110.569 178.487 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' F' F ' 126' ' ' ARG . . . . . . . . . . . . . 55.2 ttt180 -163.87 135.31 4.68 Favored 'General case' 0 C--N 1.33 -0.243 0 N-CA-C 109.803 -0.443 . . . . 0.0 109.803 177.775 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' F' F ' 127' ' ' ASN . . . . . . . . . . . . . 77.7 m-20 55.39 -153.34 0.33 Allowed 'General case' 0 CA--C 1.541 0.607 0 N-CA-C 109.974 -0.38 . . . . 0.0 109.974 -179.791 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' F' F ' 128' ' ' ASP . . . . . . . . . . . . . 10.4 p-10 -80.76 16.06 1.54 Allowed 'General case' 0 CA--C 1.535 0.386 0 N-CA-C 112.815 0.672 . . . . 0.0 112.815 179.439 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' F' F ' 129' ' ' LEU . . . . . . . . . . . . . 38.5 mt -117.51 138.32 51.97 Favored 'General case' 0 C--O 1.231 0.106 0 CA-C-N 118.131 0.423 . . . . 0.0 110.371 179.778 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' F' F ' 130' ' ' VAL . . . . . . . . . . . . . 12.9 p -132.07 141.0 46.59 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.217 0 N-CA-C 109.919 -0.4 . . . . 0.0 109.919 175.983 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' F' F ' 131' ' ' VAL . . . . . . . . . . . . . 39.4 t -134.58 140.77 45.03 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.218 0 CA-C-O 121.13 0.491 . . . . 0.0 110.636 -175.24 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' F' F ' 132' ' ' ILE . . . . . . . . . . . . . 71.4 mt -119.28 130.75 73.53 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.316 0 CA-C-N 115.526 -0.761 . . . . 0.0 109.133 177.451 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' F' F ' 133' ' ' ILE . . . . . . . . . . . . . 41.4 mm -117.87 123.49 71.75 Favored 'Isoleucine or valine' 0 C--O 1.233 0.221 0 CA-C-O 120.773 0.321 . . . . 0.0 111.041 -175.184 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' F' F ' 134' ' ' ASP . . . . . . . . . . . . . 8.5 p-10 -135.63 146.51 47.94 Favored 'General case' 0 C--N 1.33 -0.25 0 N-CA-C 109.57 -0.53 . . . . 0.0 109.57 173.268 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' F' F ' 135' ' ' GLU . . . . . . . . . . . . . 40.6 tp10 -49.87 -25.83 3.51 Favored 'General case' 0 C--N 1.327 -0.387 0 N-CA-C 112.725 0.639 . . . . 0.0 112.725 -173.259 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' F' F ' 136' ' ' GLN . . . . . . . . . . . . . 61.7 tt0 -82.39 -35.7 27.44 Favored 'General case' 0 C--O 1.233 0.236 0 N-CA-C 112.269 0.47 . . . . 0.0 112.269 -176.333 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' F' F ' 137' ' ' LYS . . . . . . . . . . . . . 45.6 pttt -165.12 167.98 17.68 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-O 121.486 0.66 . . . . 0.0 112.12 -172.315 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' F' F ' 138' ' ' LEU . . . . . . . . . . . . . 7.3 tt -118.34 130.79 56.22 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 115.169 -0.923 . . . . 0.0 109.866 -179.526 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' F' F ' 139' ' ' THR . . . . . . . . . . . . . 38.0 m -113.1 126.22 55.23 Favored 'General case' 0 C--N 1.331 -0.21 0 CA-C-N 116.328 -0.396 . . . . 0.0 110.773 179.92 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' F' F ' 140' ' ' LEU . . . . . . . . . . . . . 18.7 tp -109.85 122.77 48.28 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 115.526 -0.761 . . . . 0.0 108.973 178.745 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' F' F ' 141' ' ' ILE . . . . . . . . . . . . . 19.6 mt -122.04 119.48 58.69 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.32 0 N-CA-C 109.594 -0.521 . . . . 0.0 109.594 -177.158 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' F' F ' 142' ' ' ARG . . . . . . . . . . . . . 66.4 ttp85 -110.92 128.85 55.96 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 115.488 -0.778 . . . . 0.0 110.57 -176.415 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' F' F ' 143' ' ' THR . . . . . . . . . . . . . 39.4 p . . . . . 0 C--O 1.222 -0.37 0 CA-C-O 117.952 -1.023 . . . . 0.0 110.558 -179.983 . . . . . . . . 0 0 . 1 . 007 nuclear orig full ' A' A ' -3' ' ' GLU . . . . . . . . . . . . . 95.9 mt-10 . . . . . 0 N--CA 1.491 1.622 0 N-CA-C 109.46 -0.571 . . . . 0.0 109.46 . . . . . . . . . 0 0 . 1 . 007 nuclear orig full ' A' A ' -2' ' ' GLY . . . . . . . . . . . . . . . -70.5 140.22 31.69 Favored Glycine 0 CA--C 1.525 0.697 0 N-CA-C 111.035 -0.826 . . . . 0.0 111.035 -179.377 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' -1' ' ' VAL . . . . . . . . . . . . . 42.9 t -141.51 144.37 26.12 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.358 0 N-CA-C 109.895 -0.409 . . . . 0.0 109.895 179.216 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 0' ' ' ILE . . . . . . . . . . . . . 44.1 mm -102.06 134.68 41.96 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.22 0 CA-C-N 116.221 -0.445 . . . . 0.0 110.381 -178.757 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 27.6 ptm -77.92 136.57 38.04 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.076 -0.511 . . . . 0.0 110.48 178.779 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 88.8 p -131.0 160.54 34.26 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.48 179.809 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 85.2 tt0 -140.5 142.53 35.25 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-N 116.149 -0.478 . . . . 0.0 111.057 -177.527 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 4' ' ' LEU . . . . . . . . . . . . . 19.0 tp -122.99 127.57 49.0 Favored 'General case' 0 C--N 1.331 -0.198 0 CA-C-N 115.964 -0.562 . . . . 0.0 110.148 177.046 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 5' ' ' LYS . . . . . . . . . . . . . 98.8 mttt -106.71 122.88 47.24 Favored 'General case' 0 C--O 1.234 0.244 0 CA-C-N 116.543 -0.299 . . . . 0.0 110.641 179.275 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 63.5 mt -116.08 144.65 43.85 Favored 'General case' 0 N--CA 1.464 0.235 0 CA-C-N 115.859 -0.609 . . . . 0.0 110.692 -179.241 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 85.0 tttt -125.81 131.22 23.94 Favored Pre-proline 0 CA--C 1.536 0.433 0 CA-C-O 118.583 -0.722 . . . . 0.0 109.523 175.758 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 8' ' ' PRO . . . . . . . . . . . . . 96.1 Cg_endo -83.56 137.79 8.12 Favored 'Trans proline' 0 N--CA 1.494 1.529 0 C-N-CA 121.295 1.33 . . . . 0.0 112.078 177.851 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 67.4 mt -77.95 -47.87 2.18 Favored Pre-proline 0 CA--C 1.534 0.352 0 CA-C-O 118.548 -0.739 . . . . 0.0 112.084 179.165 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 72.2 Cg_endo -77.8 151.34 27.99 Favored 'Trans proline' 0 N--CA 1.497 1.679 0 CA-C-N 120.28 1.136 . . . . 0.0 111.642 176.36 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 23.2 tptm -85.67 95.15 9.27 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.421 -0.354 . . . . 0.0 110.55 -179.336 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 12.1 p -143.7 144.33 23.29 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.319 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.552 -179.92 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 45.6 mp0 -90.4 127.23 36.14 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.334 -0.393 . . . . 0.0 109.963 177.58 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 14' ' ' LEU . . . . . . . . . . . . . 37.2 mt -97.87 146.89 32.24 Favored Pre-proline 0 CA--C 1.533 0.29 0 CA-C-O 119.19 -0.433 . . . . 0.0 110.371 -177.44 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 15' ' ' PRO . . . . . . . . . . . . . 26.2 Cg_exo -61.29 162.32 20.55 Favored 'Trans proline' 0 N--CA 1.498 1.759 0 C-N-CA 121.345 1.363 . . . . 0.0 111.939 178.148 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 16' ' ' PRO . . . . . . . . . . . . . 34.8 Cg_exo -59.34 -38.64 83.42 Favored 'Trans proline' 0 N--CA 1.496 1.629 0 C-N-CA 121.541 1.494 . . . . 0.0 112.907 -177.699 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 17' ' ' ASP . . . . . . . . . . . . . 18.9 p-10 -86.52 6.34 31.09 Favored 'General case' 0 CA--C 1.537 0.443 0 N-CA-C 113.303 0.853 . . . . 0.0 113.303 -178.161 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 18' ' ' PHE . . . . . . . . . . . . . 39.2 t80 -58.33 -43.09 88.07 Favored 'General case' 0 C--N 1.334 -0.108 0 O-C-N 121.982 -0.449 . . . . 0.0 110.103 -178.212 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 19' ' ' VAL . . . . . . . . . . . . . 47.5 t -56.69 -41.14 73.79 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.282 0 CA-C-N 116.243 -0.435 . . . . 0.0 110.468 -179.405 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 5.7 t70 -59.77 -42.0 92.33 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-O 120.873 0.368 . . . . 0.0 110.534 -179.002 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 47.9 t -63.86 -46.18 94.97 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.325 0 CA-C-N 116.242 -0.435 . . . . 0.0 110.301 -178.971 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 22' ' ' ILE . . . . . . . . . . . . . 51.6 mm -55.03 -47.93 76.41 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.282 0 CA-C-O 120.572 0.225 . . . . 0.0 110.819 179.241 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 23' ' ' ARG . . . . . . . . . . . . . 30.8 ttp180 -54.53 -51.5 64.97 Favored 'General case' 0 C--N 1.329 -0.307 0 C-N-CA 121.121 -0.232 . . . . 0.0 111.332 -177.813 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 24' ' ' ILE . . . . . . . . . . . . . 72.9 mt -59.53 -41.3 84.37 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.277 0 C-N-CA 121.031 -0.267 . . . . 0.0 111.232 -176.881 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 60.7 mtpt -68.67 -41.9 78.64 Favored 'General case' 0 C--N 1.328 -0.333 0 N-CA-C 112.45 0.537 . . . . 0.0 112.45 -177.324 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 95.3 mt -79.57 -37.46 36.32 Favored 'General case' 0 C--N 1.33 -0.266 0 N-CA-C 113.152 0.797 . . . . 0.0 113.152 -171.365 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 27' ' ' GLN . . . . . . . . . . . . . 9.1 pt20 -46.33 140.48 4.09 Favored 'General case' 0 N--CA 1.47 0.544 0 N-CA-C 112.802 0.667 . . . . 0.0 112.802 -175.273 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 100.97 -25.44 28.33 Favored Glycine 0 CA--C 1.532 1.14 0 CA-C-N 115.575 -0.739 . . . . 0.0 112.229 -176.089 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 96.9 mttt -98.18 155.1 17.33 Favored 'General case' 0 C--O 1.233 0.185 0 CA-C-N 117.451 0.625 . . . . 0.0 111.192 179.267 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 30' ' ' THR . . . . . . . . . . . . . 41.5 m -100.96 138.73 37.62 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.138 -0.483 . . . . 0.0 110.273 177.154 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 34.7 m -131.3 148.52 32.81 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.247 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.79 -178.971 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 32' ' ' ARG . . . . . . . . . . . . . 23.0 ttm180 -130.06 146.69 51.74 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.163 -0.471 . . . . 0.0 110.26 178.166 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 33' ' ' THR . . . . . . . . . . . . . 29.6 m -52.39 139.18 25.36 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-O 120.777 0.323 . . . . 0.0 111.469 -178.285 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 98.91 -17.25 58.48 Favored Glycine 0 CA--C 1.534 1.23 0 CA-C-O 119.737 -0.479 . . . . 0.0 113.135 -179.907 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 78.1 m-20 -67.67 149.19 50.35 Favored 'General case' 0 C--N 1.334 -0.09 0 CA-C-N 117.948 0.874 . . . . 0.0 111.346 179.065 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 46.3 t -117.01 126.45 74.44 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.179 0 CA-C-N 115.652 -0.703 . . . . 0.0 109.441 176.513 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 37' ' ' ILE . . . . . . . . . . . . . 64.0 mt -118.36 137.15 53.25 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.297 0 N-CA-C 109.866 -0.42 . . . . 0.0 109.866 -179.118 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . -114.74 128.51 8.19 Favored Glycine 0 CA--C 1.524 0.656 0 N-CA-C 110.876 -0.889 . . . . 0.0 110.876 179.304 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 39' ' ' ILE . . . . . . . . . . . . . 70.4 mt -124.45 127.36 72.99 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.224 0 N-CA-C 110.08 -0.341 . . . . 0.0 110.08 179.223 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 40' ' ' SER . . . . . . . . . . . . . 27.5 t -92.84 119.04 31.76 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.312 -0.403 . . . . 0.0 110.931 176.727 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 41' ' ' ILE . . . . . 0.4 HD11 HG23 ' A' ' 41' ' ' ILE . 71.7 mt -134.02 129.13 53.92 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.211 0 CA-C-O 121.017 0.436 . . . . 0.0 110.462 178.491 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 8.3 tp 54.75 33.4 19.5 Favored 'General case' 0 CA--C 1.531 0.244 0 CA-C-N 115.958 -0.565 . . . . 0.0 111.737 177.523 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . 71.52 29.02 68.48 Favored Glycine 0 CA--C 1.53 0.996 0 C-N-CA 121.046 -0.597 . . . . 0.0 112.253 177.794 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 44' ' ' LYS . . . . . . . . . . . . . 81.3 tttt -139.1 127.4 22.75 Favored 'General case' 0 C--N 1.33 -0.255 0 N-CA-C 109.739 -0.467 . . . . 0.0 109.739 178.833 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 84.8 tt0 -85.24 125.78 33.15 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-N 116.375 -0.375 . . . . 0.0 111.423 -178.395 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 46' ' ' VAL . . . . . . . . . . . . . 9.6 p -118.69 124.41 73.1 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.172 0 N-CA-C 109.434 -0.58 . . . . 0.0 109.434 173.587 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 61.9 mtpt -98.49 124.27 43.12 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 116.046 -0.525 . . . . 0.0 110.523 177.726 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 48' ' ' PHE . . . . . . . . . . . . . 38.9 m-85 -111.1 131.81 54.78 Favored 'General case' 0 C--N 1.328 -0.344 0 N-CA-C 109.555 -0.535 . . . . 0.0 109.555 177.573 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 43.0 tttp -106.42 131.92 53.06 Favored 'General case' 0 C--N 1.328 -0.345 0 N-CA-C 109.936 -0.394 . . . . 0.0 109.936 178.638 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 50' ' ' VAL . . . . . . . . . . . . . 46.0 t -75.38 106.58 5.27 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.332 0 N-CA-C 109.336 -0.616 . . . . 0.0 109.336 178.068 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 51' ' ' VAL . . . . . . . . . . . . . 44.6 t -71.17 -49.65 47.12 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.288 0 CA-C-N 116.165 -0.471 . . . . 0.0 109.79 -174.789 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 52' ' ' GLN . . . . . . . . . . . . . 43.3 tt0 -162.73 136.88 6.33 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 115.88 -0.6 . . . . 0.0 111.289 -178.102 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -115.9 132.84 56.53 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 115.968 -0.56 . . . . 0.0 109.999 176.119 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 54' ' ' TYR . . . . . . . . . . . . . 11.6 t80 -129.06 110.64 18.3 Favored Pre-proline 0 CA--C 1.534 0.346 0 CA-C-O 118.157 -0.925 . . . . 0.0 110.192 178.466 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 55' ' ' PRO . . . . . . . . . . . . . 72.7 Cg_endo -77.22 170.13 72.29 Favored 'Cis proline' 0 N--CA 1.501 1.931 0 CA-C-N 122.024 1.758 . . . . 0.0 112.49 -6.054 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 56' ' ' SER . . . . . . . . . . . . . 48.9 m -124.01 137.55 29.11 Favored Pre-proline 0 CA--C 1.538 0.514 0 CA-C-O 118.532 -0.747 . . . . 0.0 109.546 174.904 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 57' ' ' PRO . . . . . . . . . . . . . 37.8 Cg_endo -67.52 145.52 74.37 Favored 'Cis proline' 0 N--CA 1.498 1.778 0 CA-C-N 121.687 1.638 . . . . 0.0 111.487 -2.894 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 58' ' ' LEU . . . . . . . . . . . . . 20.7 tp -107.99 137.95 45.09 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.256 -0.429 . . . . 0.0 110.47 -178.768 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 59' ' ' ARG . . . . . . . . . . . . . 56.7 ttp180 -103.31 120.61 41.1 Favored 'General case' 0 C--N 1.328 -0.366 0 N-CA-C 109.133 -0.691 . . . . 0.0 109.133 174.917 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 42.2 t -72.95 118.53 18.29 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.276 0 C-N-CA 120.766 -0.374 . . . . 0.0 110.647 -173.8 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 70.6 mm-40 -131.02 159.12 38.45 Favored 'General case' 0 C--N 1.331 -0.216 0 CA-C-N 115.951 -0.568 . . . . 0.0 109.734 176.909 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 62' ' ' ASP . . . . . . . . . . . . . 11.0 p-10 -53.34 -31.43 44.3 Favored 'General case' 0 C--N 1.328 -0.343 0 N-CA-C 112.034 0.383 . . . . 0.0 112.034 -178.27 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 63' ' ' ARG . . . . . . . . . . . . . 86.2 mtt-85 -72.02 -21.94 61.48 Favored 'General case' 0 CA--C 1.533 0.324 0 N-CA-C 112.888 0.699 . . . . 0.0 112.888 -175.444 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 33.3 m -70.1 143.75 52.31 Favored 'General case' 0 C--N 1.332 -0.191 0 CA-C-O 120.988 0.423 . . . . 0.0 111.209 -174.479 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 65' ' ' LYS . . . . . . . . . . . . . 1.1 mptm? -89.54 134.8 33.95 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 115.839 -0.619 . . . . 0.0 110.013 177.827 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 66' ' ' ILE . . . . . . . . . . . . . 58.9 mt -114.82 130.36 69.39 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.27 0 N-CA-C 109.771 -0.455 . . . . 0.0 109.771 178.394 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 67' ' ' THR . . . . . . . . . . . . . 30.8 m -124.47 142.1 51.58 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-O 121.247 0.546 . . . . 0.0 111.136 -177.253 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 68' ' ' LEU . . . . . . . . . . . . . 2.6 tt -100.88 134.49 43.79 Favored 'General case' 0 C--N 1.331 -0.224 0 CA-C-N 115.544 -0.753 . . . . 0.0 109.68 178.485 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 69' ' ' VAL . . . . . . . . . . . . . 43.3 t -82.86 148.7 4.98 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.25 0 CA-C-O 120.919 0.39 . . . . 0.0 110.196 -179.25 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 70' ' ' THR . . . . . . . . . . . . . 6.9 m -82.6 149.19 27.58 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.087 -0.506 . . . . 0.0 110.673 -175.832 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 71' ' ' HIS . . . . . . . . . . . . . 1.3 m-70 -123.91 171.91 6.41 Favored Pre-proline 0 CA--C 1.535 0.393 0 CA-C-N 115.82 -0.627 . . . . 0.0 110.581 -175.073 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 72' ' ' PRO . . . . . . . . . . . . . 19.8 Cg_endo -64.82 160.35 41.27 Favored 'Trans proline' 0 N--CA 1.496 1.67 0 C-N-CA 121.43 1.42 . . . . 0.0 111.719 175.869 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 73' ' ' VAL . . . . . . . . . . . . . 35.1 m -69.62 -176.43 0.16 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.287 0 CA-C-N 116.255 -0.43 . . . . 0.0 110.438 -171.782 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 74' ' ' ASP . . . . . . . . . . . . . 13.0 t70 -81.99 114.98 20.93 Favored 'General case' 0 C--N 1.331 -0.199 0 C-N-CA 120.388 -0.525 . . . . 0.0 110.229 -168.937 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 45.7 t -117.37 117.92 56.82 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 CA-C-O 121.192 0.52 . . . . 0.0 109.919 -179.439 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 76' ' ' LEU . . . . . . . . . . . . . 14.9 mt -120.9 142.92 49.25 Favored 'General case' 0 C--N 1.327 -0.403 0 CA-C-N 115.453 -0.794 . . . . 0.0 109.3 178.552 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 77' ' ' GLU . . . . . . . . . . . . . 96.8 mt-10 -135.31 128.91 32.66 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-O 121.16 0.505 . . . . 0.0 110.527 -177.548 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 78' ' ' ALA . . . . . . . . . . . . . . . -113.0 130.71 56.04 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 115.582 -0.735 . . . . 0.0 109.478 177.353 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 79' ' ' LYS . . . . . . . . . . . . . 84.2 tttt -76.07 112.7 12.79 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-O 120.963 0.411 . . . . 0.0 110.532 -177.193 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 80' ' ' ILE . . . . . . . . . . . . . 42.4 mm -139.08 109.95 4.7 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.346 0 CA-C-N 115.768 -0.651 . . . . 0.0 109.316 -177.727 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 81' ' ' LYS . . . . . . . . . . . . . 48.5 mtmt -108.64 130.76 55.32 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-O 120.875 0.369 . . . . 0.0 110.728 -178.321 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . 89.06 42.18 5.68 Favored Glycine 0 CA--C 1.525 0.708 0 C-N-CA 120.794 -0.717 . . . . 0.0 111.434 176.806 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 83' ' ' ILE . . . . . . . . . . . . . 73.5 mt -68.49 136.16 26.99 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.297 0 N-CA-C 109.872 -0.418 . . . . 0.0 109.872 177.423 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 84' ' ' LYS . . . . . . . . . . . . . 50.0 tttp -93.05 -50.45 5.52 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.213 -0.448 . . . . 0.0 110.18 -179.341 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 85' ' ' ASP . . . . . . . . . . . . . 6.6 t0 -157.22 154.97 30.05 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 115.908 -0.587 . . . . 0.0 110.517 179.734 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 86' ' ' VAL . . . . . . . . . . . . . 42.7 t -129.81 132.34 65.91 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.201 0 CA-C-O 120.974 0.416 . . . . 0.0 110.552 -178.862 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 87' ' ' ILE . . . . . . . . . . . . . 5.0 mp -121.84 128.83 75.79 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.193 0 CA-C-N 115.957 -0.565 . . . . 0.0 109.629 176.887 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 88' ' ' LEU . . . . . . . . . . . . . 75.2 mt -112.6 135.96 52.7 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-O 120.997 0.427 . . . . 0.0 111.268 -177.826 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 89' ' ' ASP . . . . . . . . . . . . . 13.6 t70 -133.02 152.4 51.97 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 115.754 -0.657 . . . . 0.0 109.532 175.613 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 97.4 mt-10 -48.56 -36.27 15.14 Favored 'General case' 0 C--N 1.329 -0.319 0 N-CA-C 113.036 0.754 . . . . 0.0 113.036 -172.678 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 91' ' ' ASN . . . . . . . . . . . . . 81.8 m-20 -121.96 12.19 10.42 Favored 'General case' 0 N--CA 1.468 0.473 0 N-CA-C 113.379 0.881 . . . . 0.0 113.379 -176.268 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 92' ' ' LEU . . . . . . . . . . . . . 11.8 mt -148.68 145.3 27.64 Favored 'General case' 0 C--N 1.332 -0.185 0 CA-C-N 118.101 0.41 . . . . 0.0 110.455 -175.701 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 93' ' ' ILE . . . . . . . . . . . . . 66.8 mt -120.95 117.81 54.21 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.294 0 N-CA-C 108.942 -0.762 . . . . 0.0 108.942 174.499 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 94' ' ' VAL . . . . . . . . . . . . . 46.2 t -118.83 128.2 75.69 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.24 0 CA-C-O 120.82 0.343 . . . . 0.0 110.224 -177.097 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 95' ' ' VAL . . . . . . . . . . . . . 44.2 t -125.63 137.25 58.28 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.334 0 CA-C-N 116.115 -0.493 . . . . 0.0 109.916 179.977 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 96' ' ' ILE . . . . . . . . . . . . . 57.0 mt -116.6 128.45 73.95 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.325 0 N-CA-C 109.098 -0.705 . . . . 0.0 109.098 178.575 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 97' ' ' THR . . . . . . . . . . . . . 81.7 p -102.59 159.96 14.99 Favored 'General case' 0 C--N 1.331 -0.223 0 CA-C-O 121.099 0.476 . . . . 0.0 111.471 -175.202 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 98' ' ' GLU . . . . . . . . . . . . . 84.8 tt0 -53.86 -27.5 30.37 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.168 -0.469 . . . . 0.0 112.037 179.443 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 99' ' ' GLU . . . . . . . . . . . . . 42.8 mt-10 -79.62 15.83 1.24 Allowed 'General case' 0 CA--C 1.535 0.398 0 N-CA-C 113.07 0.767 . . . . 0.0 113.07 -178.393 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 100' ' ' ASN . . . . . . . . . . . . . 3.3 m-20 62.37 30.97 17.46 Favored 'General case' 0 CA--C 1.532 0.279 0 N-CA-C 111.832 0.308 . . . . 0.0 111.832 177.663 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 101' ' ' GLU . . . . . . . . . . . . . 98.5 mt-10 -101.28 150.58 22.84 Favored 'General case' 0 C--N 1.333 -0.128 0 CA-C-O 120.78 0.324 . . . . 0.0 110.851 171.687 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 102' ' ' VAL . . . . . . . . . . . . . 47.3 t -117.83 124.44 73.08 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.379 0 CA-C-N 115.469 -0.787 . . . . 0.0 109.208 176.442 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 103' ' ' LEU . . . . . . . . . . . . . 40.2 mt -116.44 130.06 56.56 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 115.925 -0.58 . . . . 0.0 110.261 178.602 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 104' ' ' ILE . . . . . . . . . . . . . 68.0 mt -118.76 117.94 56.13 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.291 0 N-CA-C 109.948 -0.39 . . . . 0.0 109.948 179.194 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 105' ' ' PHE . . . . . . . . . . . . . 40.1 m-85 -118.5 163.96 16.0 Favored 'General case' 0 C--N 1.332 -0.19 0 O-C-N 124.086 0.866 . . . . 0.0 110.255 179.282 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 106' ' ' ASN . . . . . . . . . . . . . 43.6 p-10 -98.69 -169.91 1.86 Allowed 'General case' 0 C--N 1.33 -0.263 0 N-CA-C 109.898 -0.408 . . . . 0.0 109.898 173.506 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 107' ' ' GLN . . . . . . . . . . . . . 41.2 tt0 -58.67 -29.89 66.93 Favored 'General case' 0 C--N 1.329 -0.322 0 N-CA-C 112.01 0.374 . . . . 0.0 112.01 179.242 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 108' ' ' ASN . . . . . . . . . . . . . 8.3 t-20 -83.55 6.61 19.91 Favored 'General case' 0 CA--C 1.537 0.458 0 N-CA-C 113.298 0.851 . . . . 0.0 113.298 -177.509 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 109' ' ' LEU . . . . . . . . . . . . . 9.1 tp 61.98 36.24 15.72 Favored 'General case' 0 CA--C 1.53 0.2 0 CA-C-O 120.877 0.37 . . . . 0.0 111.536 178.595 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 110' ' ' GLU . . . . . . . . . . . . . 70.8 mm-40 -105.6 152.27 23.31 Favored 'General case' 0 C--N 1.332 -0.189 0 CA-C-N 116.516 -0.311 . . . . 0.0 110.196 177.443 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 111' ' ' GLU . . . . . . . . . . . . . 98.6 mt-10 -80.9 122.06 26.76 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-O 120.878 0.371 . . . . 0.0 111.193 -178.486 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 112' ' ' LEU . . . . . . . . . . . . . 19.2 mt -108.55 -46.01 3.76 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 115.969 -0.56 . . . . 0.0 110.054 176.165 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 113' ' ' TYR . . . . . . . . . . . . . 57.7 t80 -134.74 133.06 39.52 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 116.284 -0.416 . . . . 0.0 110.735 179.184 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 114' ' ' ARG . . . . . . . . . . . . . 55.1 ttp180 -138.11 123.44 19.42 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.262 -0.426 . . . . 0.0 110.006 178.089 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 115' ' ' GLY . . . . . . . . . . . . . . . -150.12 162.84 29.33 Favored Glycine 0 CA--C 1.523 0.553 0 N-CA-C 110.902 -0.879 . . . . 0.0 110.902 -178.522 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 116' ' ' LYS . . . . . . . . . . . . . 76.3 tttt -131.9 131.02 42.36 Favored 'General case' 0 C--N 1.33 -0.278 0 N-CA-C 110.082 -0.34 . . . . 0.0 110.082 178.184 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 117' ' ' PHE . . . . . . . . . . . . . 47.9 m-85 -130.03 117.34 19.88 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 116.238 -0.437 . . . . 0.0 110.25 -177.196 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 118' ' ' GLU . . . . . . . . . . . . . 97.5 mt-10 -53.81 -43.69 69.57 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 116.433 -0.349 . . . . 0.0 111.363 -176.803 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 119' ' ' ASN . . . . . . . . . . . . . 2.8 m-20 -101.98 31.09 4.06 Favored 'General case' 0 C--N 1.331 -0.214 0 N-CA-C 112.089 0.403 . . . . 0.0 112.089 -174.786 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 120' ' ' LEU . . . . . . . . . . . . . 13.8 tp -55.04 120.07 6.38 Favored 'General case' 0 N--CA 1.462 0.169 0 CA-C-O 120.62 0.248 . . . . 0.0 110.666 178.65 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 121' ' ' ASN . . . . . . . . . . . . . 32.7 t-20 -110.77 -44.11 3.7 Favored 'General case' 0 C--N 1.332 -0.189 0 CA-C-N 116.565 -0.288 . . . . 0.0 111.137 -176.543 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 122' ' ' LYS . . . . . . . . . . . . . 90.6 mttt -148.23 152.03 36.49 Favored 'General case' 0 C--N 1.331 -0.204 0 CA-C-O 121.129 0.49 . . . . 0.0 111.955 -177.996 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 123' ' ' VAL . . . . . . . . . . . . . 42.2 t -129.45 124.66 60.24 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.268 0 CA-C-N 115.685 -0.689 . . . . 0.0 109.158 172.407 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 124' ' ' LEU . . . . . . . . . . . . . 6.2 mp -118.1 141.67 48.23 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-O 120.765 0.316 . . . . 0.0 111.004 -175.65 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 125' ' ' VAL . . . . . . . . . . . . . 41.2 t -129.17 135.66 61.39 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.209 0 CA-C-N 116.24 -0.436 . . . . 0.0 110.427 -179.901 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 126' ' ' ARG . . . . . . . . . . . . . 26.3 mmt85 -139.48 109.92 6.6 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.081 -0.509 . . . . 0.0 110.215 176.712 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 127' ' ' ASN . . . . . . . . . . . . . 79.1 m-20 51.96 -104.83 0.19 Allowed 'General case' 0 CA--C 1.543 0.691 0 CA-C-O 119.1 -0.476 . . . . 0.0 111.341 179.521 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 128' ' ' ASP . . . . . . . . . . . . . 18.7 p-10 -110.3 -2.13 16.88 Favored 'General case' 0 CA--C 1.536 0.439 0 CA-C-N 119.513 1.051 . . . . 0.0 113.459 -176.105 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 129' ' ' LEU . . . . . . . . . . . . . 27.5 mt -104.99 143.89 32.56 Favored 'General case' 0 C--N 1.332 -0.17 0 N-CA-C 109.721 -0.474 . . . . 0.0 109.721 178.557 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 130' ' ' VAL . . . . . . . . . . . . . 12.2 p -132.23 142.06 43.72 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.212 0 CA-C-O 121.147 0.499 . . . . 0.0 110.507 -178.92 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 131' ' ' VAL . . . . . . . . . . . . . 40.9 t -134.39 138.09 50.43 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.252 0 CA-C-N 115.917 -0.583 . . . . 0.0 110.315 -178.236 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 132' ' ' ILE . . . . . . . . . . . . . 70.7 mt -113.98 131.52 65.67 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.341 0 N-CA-C 109.137 -0.69 . . . . 0.0 109.137 178.308 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 133' ' ' ILE . . . . . . . . . . . . . 40.2 mm -115.65 121.02 66.43 Favored 'Isoleucine or valine' 0 C--O 1.234 0.257 0 CA-C-O 120.665 0.269 . . . . 0.0 110.993 -174.501 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 134' ' ' ASP . . . . . . . . . . . . . 9.7 p-10 -134.72 146.39 49.39 Favored 'General case' 0 C--N 1.331 -0.215 0 CA-C-N 115.984 -0.553 . . . . 0.0 109.66 174.509 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 135' ' ' GLU . . . . . . . . . . . . . 85.2 tt0 -49.89 -26.49 4.13 Favored 'General case' 0 C--N 1.328 -0.33 0 N-CA-C 112.792 0.664 . . . . 0.0 112.792 -173.946 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 136' ' ' GLN . . . . . . . . . . . . . 43.2 tt0 -80.03 -35.19 37.58 Favored 'General case' 0 C--O 1.233 0.205 0 N-CA-C 112.124 0.416 . . . . 0.0 112.124 -176.644 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 137' ' ' LYS . . . . . . . . . . . . . 50.3 pttt -167.61 171.47 10.21 Favored 'General case' 0 C--N 1.331 -0.208 0 CA-C-O 121.527 0.68 . . . . 0.0 112.244 -172.5 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 138' ' ' LEU . . . . . . . . . . . . . 4.3 tt -114.83 127.34 55.66 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 115.053 -0.976 . . . . 0.0 109.821 178.269 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 139' ' ' THR . . . . . . . . . . . . . 22.8 m -107.08 125.41 51.01 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.323 -0.399 . . . . 0.0 110.458 179.609 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 140' ' ' LEU . . . . . . . . . . . . . 14.9 tp -113.49 119.64 38.25 Favored 'General case' 0 C--N 1.328 -0.365 0 N-CA-C 109.252 -0.647 . . . . 0.0 109.252 -178.371 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 141' ' ' ILE . . . . . . . . . . . . . 19.4 mt -119.65 120.91 64.86 Favored 'Isoleucine or valine' 0 C--O 1.234 0.269 0 CA-C-O 120.949 0.404 . . . . 0.0 110.046 -175.977 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 142' ' ' ARG . . . . . . . . . . . . . 73.3 mtm180 -107.32 129.48 54.89 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 115.38 -0.827 . . . . 0.0 110.258 179.575 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 143' ' ' THR . . . . . . . . . . . . . 32.1 p . . . . . 0 C--O 1.22 -0.448 0 CA-C-O 118.045 -0.979 . . . . 0.0 110.618 179.691 . . . . . . . . 0 0 . 1 . 007 nuclear orig full ' B' B ' -3' ' ' GLU . . . . . . . . . . . . . 85.0 tt0 . . . . . 0 N--CA 1.49 1.563 0 N-CA-C 109.438 -0.579 . . . . 0.0 109.438 . . . . . . . . . 0 0 . 1 . 007 nuclear orig full ' B' B ' -2' ' ' GLY . . . . . . . . . . . . . . . -65.9 138.45 37.38 Favored Glycine 0 CA--C 1.525 0.673 0 N-CA-C 110.981 -0.848 . . . . 0.0 110.981 -179.939 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' -1' ' ' VAL . . . . . . . . . . . . . 44.5 t -96.65 133.19 38.96 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.283 0 CA-C-O 120.775 0.321 . . . . 0.0 110.156 179.42 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 0' ' ' ILE . . . . . . . . . . . . . 71.8 mt -115.94 129.44 72.31 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.248 0 N-CA-C 109.725 -0.472 . . . . 0.0 109.725 179.124 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 1' ' ' MET . . . . . . . . . . . . . 23.6 ptm -144.55 139.96 28.51 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.125 -0.489 . . . . 0.0 110.781 -179.222 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 2' ' ' SER . . . . . . . . . . . . . 3.6 p -121.78 129.45 52.68 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 116.319 -0.401 . . . . 0.0 110.411 178.514 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 3' ' ' GLU . . . . . . . . . . . . . 95.1 mt-10 -140.62 140.63 35.1 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-N 116.094 -0.503 . . . . 0.0 110.882 -178.445 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 4' ' ' LEU . . . . . . . . . . . . . 16.5 tp -126.21 127.5 45.76 Favored 'General case' 0 C--N 1.331 -0.216 0 CA-C-N 115.971 -0.559 . . . . 0.0 110.36 177.441 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 5' ' ' LYS . . . . . . . . . . . . . 98.1 mttt -104.37 120.95 42.37 Favored 'General case' 0 C--O 1.234 0.237 0 CA-C-N 116.287 -0.415 . . . . 0.0 110.336 177.727 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 6' ' ' LEU . . . . . . . . . . . . . 54.3 mt -117.14 148.0 41.94 Favored 'General case' 0 C--N 1.331 -0.227 0 CA-C-N 115.499 -0.773 . . . . 0.0 110.613 -178.501 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 7' ' ' LYS . . . . . . . . . . . . . 79.4 tttt -138.84 141.04 29.14 Favored Pre-proline 0 CA--C 1.534 0.344 0 CA-C-O 119.135 -0.46 . . . . 0.0 110.163 175.505 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 8' ' ' PRO . . . . . . . . . . . . . 88.0 Cg_endo -92.04 142.11 2.53 Favored 'Trans proline' 0 N--CA 1.49 1.287 0 C-N-CA 121.792 1.661 . . . . 0.0 111.723 177.438 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 9' ' ' LEU . . . . . . . . . . . . . 57.8 mt -77.36 -46.78 2.6 Favored Pre-proline 0 CA--C 1.534 0.348 0 CA-C-O 118.671 -0.68 . . . . 0.0 112.175 -179.736 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 10' ' ' PRO . . . . . . . . . . . . . 86.5 Cg_endo -81.75 150.47 16.51 Favored 'Trans proline' 0 N--CA 1.495 1.612 0 C-N-CA 121.266 1.311 . . . . 0.0 111.79 175.232 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 11' ' ' LYS . . . . . . . . . . . . . 28.2 ttpp -88.87 99.72 12.61 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-O 120.778 0.323 . . . . 0.0 110.541 179.742 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 12' ' ' VAL . . . . . . . . . . . . . 12.6 p -143.68 148.02 19.39 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.29 0 CA-C-N 116.261 -0.427 . . . . 0.0 110.559 -179.398 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 13' ' ' GLU . . . . . . . . . . . . . 44.5 mp0 -84.51 126.09 32.98 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.315 -0.402 . . . . 0.0 110.298 178.676 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 14' ' ' LEU . . . . . . . . . . . . . 47.9 mt -98.63 148.27 34.32 Favored Pre-proline 0 CA--C 1.532 0.284 0 CA-C-O 119.168 -0.444 . . . . 0.0 110.498 -179.415 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 15' ' ' PRO . . . . . . . . . . . . . 24.7 Cg_exo -63.16 159.62 38.24 Favored 'Trans proline' 0 N--CA 1.497 1.73 0 C-N-CA 121.301 1.334 . . . . 0.0 111.831 176.518 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 16' ' ' PRO . . . . . . . . . . . . . 28.8 Cg_exo -60.18 -33.69 94.73 Favored 'Trans proline' 0 N--CA 1.497 1.722 0 C-N-CA 121.52 1.48 . . . . 0.0 112.677 -178.998 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 17' ' ' ASP . . . . . . . . . . . . . 10.6 p-10 -82.79 1.07 40.86 Favored 'General case' 0 CA--C 1.537 0.458 0 N-CA-C 113.281 0.845 . . . . 0.0 113.281 -177.617 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 18' ' ' PHE . . . . . . . . . . . . . 36.2 t80 -57.61 -45.04 85.84 Favored 'General case' 0 C--N 1.334 -0.106 0 O-C-N 121.962 -0.461 . . . . 0.0 110.23 -178.182 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 19' ' ' VAL . . . . . . . . . . . . . 46.9 t -57.08 -43.99 82.24 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.349 0 CA-C-N 116.263 -0.426 . . . . 0.0 110.492 -178.407 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 20' ' ' ASP . . . . . . . . . . . . . 40.8 m-20 -59.76 -42.54 93.5 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-O 120.742 0.306 . . . . 0.0 110.948 -177.467 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 21' ' ' VAL . . . . . . . . . . . . . 46.8 t -63.85 -48.31 86.86 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.241 0 C-N-CA 120.724 -0.391 . . . . 0.0 110.515 -177.792 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 22' ' ' ILE . . . . . . . . . . . . . 50.4 mm -55.57 -46.92 79.25 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.258 0 C-N-CA 120.997 -0.281 . . . . 0.0 110.798 179.639 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 23' ' ' ARG . . . . . . . . . . . . . 57.8 ttp180 -53.8 -50.39 66.23 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-O 120.594 0.235 . . . . 0.0 111.449 -178.152 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 24' ' ' ILE . . . . . . . . . . . . . 74.8 mt -60.13 -42.96 91.89 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.317 0 CA-C-N 116.57 -0.286 . . . . 0.0 111.304 -177.462 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 25' ' ' LYS . . . . . . . . . . . . . 70.7 mmtt -65.13 -38.44 90.65 Favored 'General case' 0 C--N 1.33 -0.265 0 N-CA-C 112.127 0.417 . . . . 0.0 112.127 -178.73 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 26' ' ' LEU . . . . . . . . . . . . . 83.4 mt -77.9 -44.77 26.02 Favored 'General case' 0 C--N 1.329 -0.307 0 N-CA-C 112.747 0.647 . . . . 0.0 112.747 -172.119 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 27' ' ' GLN . . . . . . . . . . . . . 10.7 pt20 -46.98 137.88 7.01 Favored 'General case' 0 N--CA 1.469 0.489 0 N-CA-C 112.751 0.648 . . . . 0.0 112.751 -176.168 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 28' ' ' GLY . . . . . . . . . . . . . . . 100.66 -28.82 14.15 Favored Glycine 0 CA--C 1.533 1.195 0 CA-C-N 115.619 -0.718 . . . . 0.0 111.978 -177.066 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 29' ' ' LYS . . . . . . . . . . . . . 93.3 mttt -98.84 155.19 17.5 Favored 'General case' 0 C--O 1.233 0.216 0 CA-C-O 121.053 0.454 . . . . 0.0 111.133 179.285 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 30' ' ' THR . . . . . . . . . . . . . 27.3 m -104.28 137.39 42.26 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.136 -0.484 . . . . 0.0 110.065 175.884 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 31' ' ' VAL . . . . . . . . . . . . . 34.9 m -130.56 155.84 42.07 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.308 0 CA-C-N 116.375 -0.375 . . . . 0.0 110.927 -178.133 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 32' ' ' ARG . . . . . . . . . . . . . 66.2 mtp180 -132.29 152.9 51.16 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-O 121.334 0.588 . . . . 0.0 110.835 179.084 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 33' ' ' THR . . . . . . . . . . . . . 23.9 m -53.27 140.06 27.77 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 115.985 -0.552 . . . . 0.0 111.378 -178.245 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 34' ' ' GLY . . . . . . . . . . . . . . . 99.28 -17.02 58.48 Favored Glycine 0 CA--C 1.532 1.121 0 CA-C-O 119.611 -0.549 . . . . 0.0 113.279 178.273 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 35' ' ' ASP . . . . . . . . . . . . . 77.0 m-20 -66.1 147.71 52.92 Favored 'General case' 0 C--O 1.231 0.109 0 CA-C-N 118.06 0.93 . . . . 0.0 110.888 178.6 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 36' ' ' VAL . . . . . . . . . . . . . 44.3 t -124.58 131.06 73.24 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.271 0 CA-C-N 116.07 -0.514 . . . . 0.0 109.927 178.853 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 37' ' ' ILE . . . . . . . . . . . . . 64.8 mt -120.47 138.97 49.22 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.277 0 CA-C-N 116.197 -0.456 . . . . 0.0 109.951 -179.69 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 38' ' ' GLY . . . . . . . . . . . . . . . -109.22 128.7 9.12 Favored Glycine 0 CA--C 1.526 0.729 0 N-CA-C 111.171 -0.772 . . . . 0.0 111.171 179.969 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 39' ' ' ILE . . . . . . . . . . . . . 72.1 mt -124.38 130.12 73.7 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.256 0 N-CA-C 109.779 -0.452 . . . . 0.0 109.779 178.422 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 40' ' ' SER . . . . . . . . . . . . . 78.6 p -91.42 117.02 29.32 Favored 'General case' 0 C--N 1.329 -0.294 0 C-N-CA 120.973 -0.291 . . . . 0.0 111.02 178.512 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 41' ' ' ILE . . . . . . . . . . . . . 47.1 mm -130.32 125.07 58.94 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.23 0 CA-C-O 120.778 0.323 . . . . 0.0 110.191 179.512 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 42' ' ' LEU . . . . . . . . . . . . . 52.8 mt 57.8 34.23 24.16 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.246 -0.433 . . . . 0.0 111.782 177.802 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 43' ' ' GLY . . . . . . . . . . . . . . . 77.7 -10.08 26.42 Favored Glycine 0 CA--C 1.534 1.279 0 C-N-CA 121.265 -0.493 . . . . 0.0 113.456 177.525 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 44' ' ' LYS . . . . . . . . . . . . . 39.1 mtpt -104.83 133.93 48.81 Favored 'General case' 0 C--N 1.333 -0.121 0 CA-C-N 117.952 0.876 . . . . 0.0 109.855 177.086 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 45' ' ' GLU . . . . . . . . . . . . . 36.3 tp10 -84.6 129.25 34.87 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.425 -0.352 . . . . 0.0 110.864 -179.475 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 46' ' ' VAL . . . . . . . . . . . . . 7.5 p -116.79 129.62 73.0 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.224 0 N-CA-C 109.312 -0.625 . . . . 0.0 109.312 176.599 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 47' ' ' LYS . . . . . . . . . . . . . 58.9 mtpt -99.99 126.8 46.22 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 115.912 -0.585 . . . . 0.0 111.032 179.134 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 48' ' ' PHE . . . . . . . . . . . . . 92.4 m-85 -109.86 131.88 54.66 Favored 'General case' 0 C--N 1.331 -0.213 0 CA-C-N 116.318 -0.401 . . . . 0.0 110.047 176.454 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 49' ' ' LYS . . . . . . . . . . . . . 62.4 tttm -107.64 137.42 45.7 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 116.276 -0.42 . . . . 0.0 110.509 179.2 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 50' ' ' VAL . . . . . . . . . . . . . 45.5 t -80.29 107.42 12.65 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.286 0 N-CA-C 109.135 -0.691 . . . . 0.0 109.135 174.615 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 51' ' ' VAL . . . . . . . . . . . . . 47.8 t -73.5 -47.3 45.9 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.374 0 CA-C-N 116.35 -0.386 . . . . 0.0 110.024 -173.773 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 52' ' ' GLN . . . . . . . . . . . . . 43.3 tt0 -162.17 137.07 7.02 Favored 'General case' 0 C--N 1.33 -0.279 0 C-N-CA 120.418 -0.513 . . . . 0.0 111.606 -178.964 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 53' ' ' ALA . . . . . . . . . . . . . . . -113.47 133.01 55.44 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 115.782 -0.645 . . . . 0.0 109.987 175.35 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 54' ' ' TYR . . . . . . . . . . . . . 12.5 t80 -129.11 112.65 18.44 Favored Pre-proline 0 CA--C 1.534 0.358 0 CA-C-O 118.32 -0.848 . . . . 0.0 110.469 179.208 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 55' ' ' PRO . . . . . . . . . . . . . 73.9 Cg_endo -77.07 169.61 73.87 Favored 'Cis proline' 0 N--CA 1.499 1.8 0 CA-C-N 121.934 1.726 . . . . 0.0 112.195 -6.412 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 56' ' ' SER . . . . . . . . . . . . . 13.6 m -116.83 131.02 24.15 Favored Pre-proline 0 CA--C 1.54 0.559 0 CA-C-O 118.37 -0.824 . . . . 0.0 109.474 176.097 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 57' ' ' PRO . . . . . . . . . . . . . 48.4 Cg_endo -69.99 148.2 86.74 Favored 'Cis proline' 0 N--CA 1.497 1.683 0 CA-C-N 121.937 1.728 . . . . 0.0 111.573 -1.349 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 58' ' ' LEU . . . . . . . . . . . . . 25.8 tp -107.74 135.38 49.25 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.384 -0.371 . . . . 0.0 110.744 -178.399 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 59' ' ' ARG . . . . . . . . . . . . . 55.0 ttt180 -101.96 121.15 41.6 Favored 'General case' 0 C--N 1.327 -0.382 0 N-CA-C 109.297 -0.631 . . . . 0.0 109.297 176.14 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 60' ' ' VAL . . . . . . . . . . . . . 44.4 t -78.97 123.19 35.62 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.263 0 C-N-CA 120.694 -0.402 . . . . 0.0 110.36 -174.987 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 61' ' ' GLU . . . . . . . . . . . . . 95.7 mt-10 -131.03 165.57 22.93 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.062 -0.517 . . . . 0.0 110.057 178.269 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 62' ' ' ASP . . . . . . . . . . . . . 18.0 p-10 -54.61 -32.64 59.19 Favored 'General case' 0 C--N 1.328 -0.329 0 C-N-CA 120.975 -0.29 . . . . 0.0 111.675 179.872 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 63' ' ' ARG . . . . . . . . . . . . . 10.8 ptm180 -85.21 7.29 22.52 Favored 'General case' 0 CA--C 1.537 0.452 0 N-CA-C 113.523 0.934 . . . . 0.0 113.523 -176.273 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 64' ' ' THR . . . . . . . . . . . . . 33.0 m -83.84 138.48 33.19 Favored 'General case' 0 C--N 1.332 -0.17 0 CA-C-N 118.135 0.425 . . . . 0.0 110.76 -178.319 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 65' ' ' LYS . . . . . . . . . . . . . 69.2 mttm -89.99 129.27 36.34 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.106 -0.497 . . . . 0.0 110.281 178.541 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 66' ' ' ILE . . . . . . . . . . . . . 63.0 mt -116.84 130.37 71.83 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.292 0 N-CA-C 109.935 -0.395 . . . . 0.0 109.935 179.454 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 67' ' ' THR . . . . . . . . . . . . . 25.5 m -123.3 136.69 54.81 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.596 -179.513 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 68' ' ' LEU . . . . . . . . . . . . . 17.7 tp -107.86 126.06 52.21 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.039 -0.528 . . . . 0.0 110.551 179.515 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 69' ' ' VAL . . . . . . . . . . . . . 43.2 t -101.29 146.72 9.2 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.308 0 CA-C-N 116.243 -0.435 . . . . 0.0 110.059 179.256 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 70' ' ' THR . . . . . . . . . . . . . 4.8 m -130.49 -49.33 1.07 Allowed 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 116.261 -0.427 . . . . 0.0 110.59 -178.522 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 71' ' ' HIS . . . . . . . . . . . . . 82.6 m-70 -72.49 154.08 91.73 Favored Pre-proline 0 C--N 1.329 -0.321 0 CA-C-N 116.336 -0.393 . . . . 0.0 110.601 -179.464 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 72' ' ' PRO . . . . . . . . . . . . . 87.3 Cg_endo -86.08 24.54 0.74 Allowed 'Trans proline' 0 N--CA 1.492 1.384 0 C-N-CA 121.692 1.595 . . . . 0.0 113.131 -178.188 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 73' ' ' VAL . . . . . . . . . . . . . 31.0 m -130.94 163.13 37.7 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.17 0 CA-C-O 120.902 0.382 . . . . 0.0 110.668 179.148 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 74' ' ' ASP . . . . . . . . . . . . . 7.5 t70 -102.84 120.69 41.05 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.041 -0.527 . . . . 0.0 109.731 179.695 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 75' ' ' VAL . . . . . . . . . . . . . 42.5 t -113.74 122.21 67.42 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.219 0 CA-C-O 121.087 0.47 . . . . 0.0 110.531 -177.76 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 76' ' ' LEU . . . . . . . . . . . . . 32.6 mt -119.85 145.57 46.53 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 115.575 -0.739 . . . . 0.0 109.434 177.471 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 77' ' ' GLU . . . . . . . . . . . . . 98.0 mt-10 -136.46 134.24 37.46 Favored 'General case' 0 C--N 1.332 -0.187 0 CA-C-O 121.189 0.518 . . . . 0.0 111.18 -178.095 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 78' ' ' ALA . . . . . . . . . . . . . . . -122.22 123.76 42.22 Favored 'General case' 0 C--N 1.331 -0.224 0 CA-C-N 115.62 -0.718 . . . . 0.0 109.666 176.471 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 79' ' ' LYS . . . . . . . . . . . . . 45.9 pttt -73.6 121.04 20.03 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-O 121.295 0.569 . . . . 0.0 110.811 -177.832 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 80' ' ' ILE . . . . . . . . . . . . . 40.4 mm -139.33 112.49 6.22 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.267 0 CA-C-N 115.658 -0.701 . . . . 0.0 109.267 -177.799 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 81' ' ' LYS . . . . . . . . . . . . . 28.9 mtpt -99.46 122.31 42.38 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-O 120.845 0.355 . . . . 0.0 111.113 -177.789 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 82' ' ' GLY . . . . . . . . . . . . . . . 89.22 42.2 5.63 Favored Glycine 0 CA--C 1.525 0.694 0 C-N-CA 120.738 -0.744 . . . . 0.0 111.808 174.362 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 83' ' ' ILE . . . . . . . . . . . . . 68.5 mt -61.92 135.39 26.55 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.33 0 N-CA-C 109.727 -0.472 . . . . 0.0 109.727 176.938 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 84' ' ' LYS . . . . . . . . . . . . . 75.6 tttt -94.39 -51.6 4.71 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.129 -0.487 . . . . 0.0 109.988 -179.312 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 85' ' ' ASP . . . . . . . . . . . . . 11.6 t70 -157.86 152.14 24.57 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 115.666 -0.697 . . . . 0.0 110.347 178.979 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 86' ' ' VAL . . . . . . . . . . . . . 42.6 t -127.41 129.46 70.58 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.275 0 CA-C-O 120.897 0.38 . . . . 0.0 110.313 -179.541 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 87' ' ' ILE . . . . . . . . . . . . . 44.7 mm -119.55 128.95 75.88 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.312 0 CA-C-N 115.985 -0.552 . . . . 0.0 109.755 177.984 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 88' ' ' LEU . . . . . . . . . . . . . 47.7 mt -111.85 138.12 48.88 Favored 'General case' 0 C--N 1.332 -0.185 0 CA-C-O 121.057 0.456 . . . . 0.0 111.791 -176.645 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 89' ' ' ASP . . . . . . . . . . . . . 13.4 t70 -132.87 155.34 49.2 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 115.401 -0.818 . . . . 0.0 109.226 174.876 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 90' ' ' GLU . . . . . . . . . . . . . 35.0 tt0 -47.54 -37.21 11.72 Favored 'General case' 0 N--CA 1.465 0.301 0 N-CA-C 113.005 0.743 . . . . 0.0 113.005 -171.409 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 91' ' ' ASN . . . . . . . . . . . . . 4.1 t-20 -129.59 20.3 5.63 Favored 'General case' 0 N--CA 1.469 0.507 0 N-CA-C 112.823 0.675 . . . . 0.0 112.823 -177.005 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 92' ' ' LEU . . . . . . . . . . . . . 19.6 mt -148.73 143.25 26.29 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-O 120.822 0.344 . . . . 0.0 110.288 -177.427 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 93' ' ' ILE . . . . . . . . . . . . . 71.3 mt -121.54 117.0 51.2 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.331 0 N-CA-C 108.947 -0.76 . . . . 0.0 108.947 175.755 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 94' ' ' VAL . . . . . . . . . . . . . 46.8 t -114.37 123.51 70.12 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.292 0 N-CA-C 109.728 -0.471 . . . . 0.0 109.728 -179.102 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 95' ' ' VAL . . . . . . . . . . . . . 44.1 t -119.95 132.0 70.83 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.321 0 CA-C-N 116.032 -0.531 . . . . 0.0 109.767 -179.447 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 96' ' ' ILE . . . . . . . . . . . . . 66.1 mt -114.48 127.93 71.76 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.33 0 N-CA-C 109.073 -0.714 . . . . 0.0 109.073 178.471 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 97' ' ' THR . . . . . . . . . . . . . 61.3 p -102.31 154.9 18.61 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-O 121.061 0.457 . . . . 0.0 111.094 -177.644 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 98' ' ' GLU . . . . . . . . . . . . . 98.0 mt-10 -53.96 -22.2 9.77 Favored 'General case' 0 CA--C 1.533 0.302 0 N-CA-C 112.355 0.502 . . . . 0.0 112.355 178.177 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 99' ' ' GLU . . . . . . . . . . . . . 95.9 mt-10 -76.54 11.67 1.54 Allowed 'General case' 0 CA--C 1.537 0.468 0 N-CA-C 113.149 0.796 . . . . 0.0 113.149 -178.939 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 100' ' ' ASN . . . . . . . . . . . . . 2.4 m-20 61.96 37.94 14.66 Favored 'General case' 0 CA--C 1.529 0.172 0 CA-C-O 121.077 0.465 . . . . 0.0 110.836 179.785 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 101' ' ' GLU . . . . . . . . . . . . . 84.6 tt0 -120.39 142.02 49.57 Favored 'General case' 0 C--N 1.332 -0.193 0 N-CA-C 109.564 -0.532 . . . . 0.0 109.564 176.215 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 102' ' ' VAL . . . . . . . . . . . . . 45.9 t -114.92 127.57 72.41 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.238 0 N-CA-C 109.976 -0.379 . . . . 0.0 109.976 -178.362 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 103' ' ' LEU . . . . . . . . . . . . . 55.6 mt -116.77 131.89 56.84 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 115.641 -0.709 . . . . 0.0 110.335 177.771 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 104' ' ' ILE . . . . . . . . . . . . . 66.2 mt -115.97 119.35 61.63 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.256 0 CA-C-N 116.375 -0.375 . . . . 0.0 110.03 178.511 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 105' ' ' PHE . . . . . . . . . . . . . 34.7 m-85 -119.59 167.1 12.33 Favored 'General case' 0 C--N 1.333 -0.142 0 O-C-N 123.995 0.809 . . . . 0.0 109.994 178.657 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 106' ' ' ASN . . . . . . . . . . . . . 44.3 p-10 -104.02 -169.98 1.71 Allowed 'General case' 0 C--N 1.331 -0.232 0 N-CA-C 110.078 -0.341 . . . . 0.0 110.078 174.631 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 107' ' ' GLN . . . . . . . . . . . . . 41.0 tt0 -59.64 -29.9 68.35 Favored 'General case' 0 CA--C 1.531 0.244 0 N-CA-C 111.963 0.357 . . . . 0.0 111.963 179.612 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 108' ' ' ASN . . . . . . . . . . . . . 4.9 t-20 -82.87 6.77 17.34 Favored 'General case' 0 CA--C 1.537 0.45 0 N-CA-C 113.171 0.804 . . . . 0.0 113.171 -177.749 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 109' ' ' LEU . . . . . . . . . . . . . 12.0 tp 61.85 37.76 15.15 Favored 'General case' 0 CA--C 1.53 0.18 0 CA-C-O 120.948 0.404 . . . . 0.0 111.294 178.188 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 110' ' ' GLU . . . . . . . . . . . . . 96.0 mt-10 -107.66 165.59 11.32 Favored 'General case' 0 C--N 1.331 -0.218 0 CA-C-N 116.342 -0.39 . . . . 0.0 110.123 176.9 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 111' ' ' GLU . . . . . . . . . . . . . 45.4 tp10 -89.1 125.51 35.06 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-O 120.928 0.394 . . . . 0.0 111.0 -177.452 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 112' ' ' LEU . . . . . . . . . . . . . 17.4 mt -109.62 -46.05 3.58 Favored 'General case' 0 C--N 1.332 -0.19 0 CA-C-N 115.991 -0.55 . . . . 0.0 110.404 177.201 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 113' ' ' TYR . . . . . . . . . . . . . 64.4 t80 -145.42 140.31 27.53 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.226 -0.443 . . . . 0.0 111.382 -179.398 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 114' ' ' ARG . . . . . . . . . . . . . 21.3 ttm180 -132.39 127.8 36.21 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-N 116.006 -0.543 . . . . 0.0 109.842 175.627 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 115' ' ' GLY . . . . . . . . . . . . . . . -150.1 131.35 3.58 Favored Glycine 0 CA--C 1.523 0.573 0 N-CA-C 111.137 -0.785 . . . . 0.0 111.137 178.334 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 116' ' ' LYS . . . . . . . . . . . . . 28.4 ttpp -106.68 133.24 51.65 Favored 'General case' 0 C--N 1.331 -0.235 0 N-CA-C 109.664 -0.495 . . . . 0.0 109.664 176.85 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 117' ' ' PHE . . . . . . . . . . . . . 39.4 m-85 -136.01 113.92 11.23 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-O 120.903 0.382 . . . . 0.0 110.246 -175.591 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 118' ' ' GLU . . . . . . . . . . . . . 97.0 mt-10 -54.34 -44.01 71.73 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.485 -0.325 . . . . 0.0 111.279 -177.628 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 119' ' ' ASN . . . . . . . . . . . . . 83.9 m-20 -96.67 31.03 2.41 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 116.182 -0.463 . . . . 0.0 112.146 -174.661 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 120' ' ' LEU . . . . . . . . . . . . . 14.9 tp -57.04 120.25 7.68 Favored 'General case' 0 C--N 1.333 -0.137 0 CA-C-O 120.641 0.258 . . . . 0.0 110.33 177.447 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 121' ' ' ASN . . . . . . . . . . . . . 61.1 m-80 -113.6 -44.0 3.25 Favored 'General case' 0 C--N 1.332 -0.156 0 CA-C-N 116.627 -0.26 . . . . 0.0 111.084 -177.357 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 122' ' ' LYS . . . . . . . . . . . . . 88.6 mttt -147.4 149.8 33.43 Favored 'General case' 0 C--N 1.331 -0.197 0 CA-C-O 121.221 0.534 . . . . 0.0 111.744 -178.035 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 123' ' ' VAL . . . . . . . . . . . . . 44.6 t -128.19 129.2 69.29 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.263 0 CA-C-N 115.71 -0.677 . . . . 0.0 109.589 175.506 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 124' ' ' LEU . . . . . . . . . . . . . 83.8 mt -123.63 131.93 53.74 Favored 'General case' 0 C--N 1.331 -0.224 0 CA-C-N 116.396 -0.366 . . . . 0.0 110.573 -179.041 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 125' ' ' VAL . . . . . . . . . . . . . 11.2 p -131.12 122.86 52.46 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.232 0 CA-C-N 116.163 -0.471 . . . . 0.0 109.835 177.161 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 126' ' ' ARG . . . . . . . . . . . . . 88.8 mtt180 -147.45 128.82 14.86 Favored 'General case' 0 C--N 1.33 -0.252 0 N-CA-C 109.62 -0.511 . . . . 0.0 109.62 -179.802 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 127' ' ' ASN . . . . . . . . . . . . . 32.0 m120 55.95 -151.94 0.39 Allowed 'General case' 0 CA--C 1.541 0.616 0 N-CA-C 109.784 -0.451 . . . . 0.0 109.784 -178.749 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 128' ' ' ASP . . . . . . . . . . . . . 19.4 p-10 -83.69 19.73 1.59 Allowed 'General case' 0 CA--C 1.536 0.412 0 CA-C-N 118.67 0.668 . . . . 0.0 112.49 177.337 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 129' ' ' LEU . . . . . . . . . . . . . 2.0 tt -116.41 131.81 56.85 Favored 'General case' 0 C--O 1.232 0.156 0 N-CA-C 109.96 -0.385 . . . . 0.0 109.96 -179.92 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 130' ' ' VAL . . . . . . . . . . . . . 44.7 t -124.19 138.26 54.38 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.228 0 CA-C-O 120.765 0.317 . . . . 0.0 110.146 -178.826 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 131' ' ' VAL . . . . . . . . . . . . . 41.2 t -136.1 137.75 48.14 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.261 0 CA-C-O 121.037 0.446 . . . . 0.0 110.444 179.851 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 132' ' ' ILE . . . . . . . . . . . . . 73.5 mt -119.84 133.39 66.76 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.254 0 N-CA-C 109.342 -0.614 . . . . 0.0 109.342 178.68 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 133' ' ' ILE . . . . . . . . . . . . . 40.1 mm -117.44 121.71 68.22 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.29 0 CA-C-O 120.824 0.345 . . . . 0.0 111.205 -174.498 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 134' ' ' ASP . . . . . . . . . . . . . 6.8 p-10 -132.07 147.25 52.43 Favored 'General case' 0 C--N 1.332 -0.178 0 CA-C-N 115.852 -0.613 . . . . 0.0 109.521 173.831 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 135' ' ' GLU . . . . . . . . . . . . . 43.7 tp10 -49.9 -26.72 4.37 Favored 'General case' 0 C--N 1.328 -0.33 0 N-CA-C 112.904 0.705 . . . . 0.0 112.904 -170.756 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 136' ' ' GLN . . . . . . . . . . . . . 96.9 mt-30 -92.88 -34.76 13.69 Favored 'General case' 0 C--N 1.331 -0.232 0 N-CA-C 112.381 0.511 . . . . 0.0 112.381 -175.475 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 137' ' ' LYS . . . . . . . . . . . . . 55.4 mtmt -145.49 154.98 42.81 Favored 'General case' 0 C--N 1.33 -0.239 0 CA-C-O 121.474 0.654 . . . . 0.0 111.856 -170.141 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 138' ' ' LEU . . . . . . . . . . . . . 4.2 tt -113.31 123.05 49.22 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 115.144 -0.935 . . . . 0.0 108.981 174.403 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 139' ' ' THR . . . . . . . . . . . . . 33.1 m -107.61 128.48 54.58 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-O 120.848 0.356 . . . . 0.0 110.852 -177.218 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 140' ' ' LEU . . . . . . . . . . . . . 18.8 tp -114.08 121.53 44.09 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 115.45 -0.796 . . . . 0.0 109.355 -179.28 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 141' ' ' ILE . . . . . . . . . . . . . 19.5 mt -120.86 120.13 61.5 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.342 0 N-CA-C 109.855 -0.424 . . . . 0.0 109.855 -175.733 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 142' ' ' ARG . . . . . . . . . . . . . 73.5 mtm180 -111.01 129.23 55.96 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 115.55 -0.75 . . . . 0.0 110.547 -179.401 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 143' ' ' THR . . . . . . . . . . . . . 39.9 p . . . . . 0 C--O 1.222 -0.373 0 CA-C-O 117.959 -1.02 . . . . 0.0 110.56 179.939 . . . . . . . . 0 0 . 1 . 007 nuclear orig full ' C' C ' -3' ' ' GLU . . . . . . . . . . . . . 84.9 tt0 . . . . . 0 N--CA 1.489 1.508 0 N-CA-C 109.345 -0.613 . . . . 0.0 109.345 . . . . . . . . . 0 0 . 1 . 007 nuclear orig full ' C' C ' -2' ' ' GLY . . . . . . . . . . . . . . . -84.03 110.34 3.31 Favored Glycine 0 CA--C 1.525 0.706 0 N-CA-C 110.784 -0.927 . . . . 0.0 110.784 179.599 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' C' C ' -1' ' ' VAL . . . . . . . . . . . . . 46.2 t -84.99 123.93 39.57 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.321 0 N-CA-C 109.547 -0.538 . . . . 0.0 109.547 179.112 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' C' C ' 0' ' ' ILE . . . . . . . . . . . . . 71.3 mt -120.29 137.19 54.91 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.262 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.254 -177.506 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' C' C ' 1' ' ' MET . . . . . . . . . . . . . 26.4 ptm -90.15 131.96 35.72 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.017 -0.538 . . . . 0.0 110.489 178.511 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' C' C ' 2' ' ' SER . . . . . . . . . . . . . 25.9 p -117.71 150.13 39.6 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.312 179.179 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' C' C ' 3' ' ' GLU . . . . . . . . . . . . . 95.7 mt-10 -139.42 141.8 37.48 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.191 -0.459 . . . . 0.0 111.014 -178.021 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' C' C ' 4' ' ' LEU . . . . . . . . . . . . . 16.9 tp -125.11 125.83 44.37 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 115.724 -0.671 . . . . 0.0 110.197 177.165 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' C' C ' 5' ' ' LYS . . . . . . . . . . . . . 60.5 mttp -105.23 121.53 44.04 Favored 'General case' 0 C--O 1.234 0.25 0 CA-C-N 116.505 -0.316 . . . . 0.0 110.282 177.632 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' C' C ' 6' ' ' LEU . . . . . . . . . . . . . 53.2 mt -114.46 145.71 41.55 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-N 115.623 -0.717 . . . . 0.0 110.917 -178.058 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' C' C ' 7' ' ' LYS . . . . . . . . . . . . . 25.9 ttpt -132.7 134.53 24.77 Favored Pre-proline 0 CA--C 1.536 0.412 0 CA-C-O 118.884 -0.579 . . . . 0.0 109.64 176.449 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' C' C ' 8' ' ' PRO . . . . . . . . . . . . . 86.5 Cg_endo -90.67 133.3 1.75 Allowed 'Trans proline' 0 N--CA 1.489 1.228 0 C-N-CA 121.624 1.55 . . . . 0.0 111.343 174.095 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' C' C ' 9' ' ' LEU . . . . . . . . . . . . . 62.1 mt -69.13 -48.21 27.59 Favored Pre-proline 0 CA--C 1.533 0.325 0 CA-C-O 118.608 -0.711 . . . . 0.0 112.48 -177.085 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' C' C ' 10' ' ' PRO . . . . . . . . . . . . . 90.0 Cg_endo -78.81 146.83 21.17 Favored 'Trans proline' 0 N--CA 1.495 1.59 0 C-N-CA 121.109 1.206 . . . . 0.0 111.817 177.367 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' C' C ' 11' ' ' LYS . . . . . . . . . . . . . 62.0 tttm -78.55 91.39 4.57 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.436 -0.347 . . . . 0.0 110.424 179.185 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' C' C ' 12' ' ' VAL . . . . . . . . . . . . . 12.4 p -139.63 146.15 25.77 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.308 0 CA-C-N 116.297 -0.41 . . . . 0.0 110.485 -179.705 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' C' C ' 13' ' ' GLU . . . . . . . . . . . . . 44.7 tp10 -90.26 129.37 36.51 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.33 -0.396 . . . . 0.0 110.298 179.351 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' C' C ' 14' ' ' LEU . . . . . . . . . . . . . 27.3 mt -97.99 152.36 38.02 Favored Pre-proline 0 CA--C 1.531 0.246 0 CA-C-N 116.33 -0.395 . . . . 0.0 110.653 -178.323 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' C' C ' 15' ' ' PRO . . . . . . . . . . . . . 27.2 Cg_exo -61.31 159.01 32.77 Favored 'Trans proline' 0 N--CA 1.499 1.795 0 C-N-CA 121.307 1.338 . . . . 0.0 111.815 177.265 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' C' C ' 16' ' ' PRO . . . . . . . . . . . . . 39.8 Cg_exo -58.63 -39.37 83.27 Favored 'Trans proline' 0 N--CA 1.498 1.74 0 C-N-CA 121.483 1.455 . . . . 0.0 112.871 -178.481 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' C' C ' 17' ' ' ASP . . . . . . . . . . . . . 12.9 p-10 -85.81 8.51 19.73 Favored 'General case' 0 CA--C 1.536 0.44 0 N-CA-C 113.176 0.806 . . . . 0.0 113.176 -177.738 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' C' C ' 18' ' ' PHE . . . . . . . . . . . . . 55.0 t80 -58.1 -45.53 87.06 Favored 'General case' 0 C--N 1.333 -0.118 0 O-C-N 122.077 -0.389 . . . . 0.0 110.178 -177.925 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' C' C ' 19' ' ' VAL . . . . . . . . . . . . . 13.8 p -55.88 -41.69 67.9 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.371 0 CA-C-N 116.336 -0.393 . . . . 0.0 111.006 -178.244 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' C' C ' 20' ' ' ASP . . . . . . . . . . . . . 11.3 t70 -60.82 -42.03 96.91 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-O 120.977 0.418 . . . . 0.0 110.655 -178.831 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' C' C ' 21' ' ' VAL . . . . . . . . . . . . . 47.3 t -64.04 -45.47 96.58 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.248 0 CA-C-N 116.244 -0.434 . . . . 0.0 110.442 -178.138 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' C' C ' 22' ' ' ILE . . . . . . . . . . . . . 51.5 mm -55.4 -47.25 78.41 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.265 0 C-N-CA 121.056 -0.258 . . . . 0.0 110.661 179.037 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' C' C ' 23' ' ' ARG . . . . . . . . . . . . . 54.0 ttp180 -54.35 -49.83 68.86 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-O 120.671 0.272 . . . . 0.0 111.411 -179.068 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' C' C ' 24' ' ' ILE . . . . . . . . . . . . . 73.1 mt -59.34 -41.76 85.26 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.314 0 CA-C-N 116.566 -0.288 . . . . 0.0 111.422 -176.889 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' C' C ' 25' ' ' LYS . . . . . . . . . . . . . 49.6 mttm -67.28 -42.64 83.46 Favored 'General case' 0 C--N 1.329 -0.32 0 N-CA-C 112.351 0.5 . . . . 0.0 112.351 -178.791 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' C' C ' 26' ' ' LEU . . . . . . . . . . . . . 92.6 mt -78.34 -37.91 43.38 Favored 'General case' 0 C--N 1.33 -0.272 0 N-CA-C 113.116 0.784 . . . . 0.0 113.116 -170.651 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' C' C ' 27' ' ' GLN . . . . . . . . . . . . . 9.3 pt20 -46.87 139.12 5.72 Favored 'General case' 0 N--CA 1.47 0.531 0 N-CA-C 112.918 0.71 . . . . 0.0 112.918 -175.016 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' C' C ' 28' ' ' GLY . . . . . . . . . . . . . . . 100.01 -26.69 23.51 Favored Glycine 0 CA--C 1.533 1.17 0 CA-C-N 115.493 -0.776 . . . . 0.0 112.207 -177.505 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' C' C ' 29' ' ' LYS . . . . . . . . . . . . . 60.8 mttp -98.24 155.12 17.34 Favored 'General case' 0 C--O 1.232 0.169 0 CA-C-N 117.264 0.532 . . . . 0.0 111.071 179.555 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' C' C ' 30' ' ' THR . . . . . . . . . . . . . 32.8 m -110.0 133.52 53.1 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-N 116.048 -0.523 . . . . 0.0 110.186 176.823 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' C' C ' 31' ' ' VAL . . . . . . . . . . . . . 35.0 m -133.45 164.3 35.32 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.267 0 CA-C-N 116.265 -0.425 . . . . 0.0 110.364 -179.641 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' C' C ' 32' ' ' ARG . . . . . . . . . . . . . 29.9 ttp180 -132.53 153.59 50.8 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-O 121.294 0.569 . . . . 0.0 110.605 179.232 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' C' C ' 33' ' ' THR . . . . . . . . . . . . . 28.8 m -52.41 140.35 22.46 Favored 'General case' 0 C--N 1.331 -0.227 0 CA-C-N 116.127 -0.488 . . . . 0.0 111.561 -178.327 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' C' C ' 34' ' ' GLY . . . . . . . . . . . . . . . 100.02 -17.2 57.52 Favored Glycine 0 CA--C 1.533 1.181 0 CA-C-O 119.713 -0.493 . . . . 0.0 113.199 179.875 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' C' C ' 35' ' ' ASP . . . . . . . . . . . . . 60.7 m-20 -66.77 149.73 50.12 Favored 'General case' 0 C--O 1.232 0.164 0 CA-C-N 118.074 0.937 . . . . 0.0 111.2 178.918 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' C' C ' 36' ' ' VAL . . . . . . . . . . . . . 45.2 t -123.65 130.44 74.05 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.261 0 CA-C-N 115.897 -0.592 . . . . 0.0 109.825 178.905 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' C' C ' 37' ' ' ILE . . . . . . . . . . . . . 62.1 mt -122.15 139.2 49.84 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.265 0 CA-C-N 116.259 -0.428 . . . . 0.0 109.898 -178.84 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' C' C ' 38' ' ' GLY . . . . . . . . . . . . . . . -109.83 128.74 9.05 Favored Glycine 0 CA--C 1.525 0.696 0 N-CA-C 111.192 -0.763 . . . . 0.0 111.192 179.744 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' C' C ' 39' ' ' ILE . . . . . . . . . . . . . 68.8 mt -120.76 130.96 74.02 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.19 0 N-CA-C 109.944 -0.391 . . . . 0.0 109.944 178.406 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' C' C ' 40' ' ' SER . . . . . . . . . . . . . 32.8 t -93.12 122.58 35.65 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.423 -0.353 . . . . 0.0 111.099 177.324 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' C' C ' 41' ' ' ILE . . . . . . . . . . . . . 70.3 mt -129.75 120.24 49.66 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.206 0 CA-C-O 120.881 0.372 . . . . 0.0 110.325 177.405 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' C' C ' 42' ' ' LEU . . . . . . . . . . . . . 62.6 mt 52.84 36.13 20.67 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 116.02 -0.536 . . . . 0.0 111.677 177.163 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' C' C ' 43' ' ' GLY . . . . . . . . . . . . . . . 72.64 30.0 64.74 Favored Glycine 0 CA--C 1.529 0.967 0 C-N-CA 121.108 -0.567 . . . . 0.0 112.284 177.615 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' C' C ' 44' ' ' LYS . . . . . . . . . . . . . 62.3 mtpt -134.65 129.06 34.27 Favored 'General case' 0 C--N 1.331 -0.222 0 N-CA-C 109.645 -0.502 . . . . 0.0 109.645 177.809 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' C' C ' 45' ' ' GLU . . . . . . . . . . . . . 84.5 tt0 -84.23 122.2 28.55 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-O 120.871 0.367 . . . . 0.0 111.304 -178.255 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' C' C ' 46' ' ' VAL . . . . . . . . . . . . . 7.6 p -119.03 125.6 74.64 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.168 0 N-CA-C 109.06 -0.718 . . . . 0.0 109.06 173.643 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' C' C ' 47' ' ' LYS . . . . . . . . . . . . . 97.9 mttt -99.62 126.87 45.7 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.099 -0.5 . . . . 0.0 111.151 -179.843 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' C' C ' 48' ' ' PHE . . . . . . . . . . . . . 93.6 m-85 -110.39 131.78 54.75 Favored 'General case' 0 C--N 1.329 -0.289 0 N-CA-C 109.624 -0.51 . . . . 0.0 109.624 176.76 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' C' C ' 49' ' ' LYS . . . . . . . . . . . . . 71.4 tttt -108.79 136.83 47.71 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.388 -0.369 . . . . 0.0 110.459 179.075 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' C' C ' 50' ' ' VAL . . . . . . . . . . . . . 48.0 t -78.87 105.36 8.0 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.278 0 N-CA-C 109.087 -0.709 . . . . 0.0 109.087 175.899 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' C' C ' 51' ' ' VAL . . . . . . . . . . . . . 46.8 t -69.19 -48.96 65.75 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.291 0 CA-C-N 116.07 -0.514 . . . . 0.0 109.843 -173.922 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' C' C ' 52' ' ' GLN . . . . . . . . . . . . . 32.3 tt0 -162.43 143.23 10.12 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-N 115.949 -0.569 . . . . 0.0 111.522 -179.1 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' C' C ' 53' ' ' ALA . . . . . . . . . . . . . . . -122.58 133.85 54.54 Favored 'General case' 0 C--N 1.331 -0.212 0 CA-C-N 115.786 -0.643 . . . . 0.0 109.718 176.714 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' C' C ' 54' ' ' TYR . . . . . . . . . . . . . 14.9 t80 -129.08 113.08 18.52 Favored Pre-proline 0 CA--C 1.535 0.397 0 CA-C-O 118.041 -0.981 . . . . 0.0 110.345 179.265 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' C' C ' 55' ' ' PRO . . . . . . . . . . . . . 73.7 Cg_endo -77.08 169.15 75.09 Favored 'Cis proline' 0 N--CA 1.501 1.967 0 CA-C-N 122.017 1.756 . . . . 0.0 112.214 -6.95 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' C' C ' 56' ' ' SER . . . . . . . . . . . . . 13.5 m -117.74 135.95 23.51 Favored Pre-proline 0 CA--C 1.539 0.533 0 CA-C-O 118.549 -0.738 . . . . 0.0 109.825 175.681 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' C' C ' 57' ' ' PRO . . . . . . . . . . . . . 36.5 Cg_endo -67.22 164.68 70.47 Favored 'Cis proline' 0 N--CA 1.496 1.665 0 CA-C-N 121.743 1.658 . . . . 0.0 111.231 -4.318 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' C' C ' 58' ' ' LEU . . . . . . . . . . . . . 42.4 tp -130.71 138.4 49.99 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-O 121.126 0.489 . . . . 0.0 110.777 -178.737 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' C' C ' 59' ' ' ARG . . . . . . . . . . . . . 51.1 ttt180 -104.1 125.81 50.72 Favored 'General case' 0 C--N 1.327 -0.395 0 N-CA-C 108.939 -0.763 . . . . 0.0 108.939 173.297 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' C' C ' 60' ' ' VAL . . . . . . . . . . . . . 44.1 t -78.94 122.46 34.2 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.319 0 CA-C-O 120.937 0.398 . . . . 0.0 110.609 -174.135 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' C' C ' 61' ' ' GLU . . . . . . . . . . . . . 43.1 mt-10 -131.03 166.04 21.89 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 115.79 -0.641 . . . . 0.0 109.697 174.739 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' C' C ' 62' ' ' ASP . . . . . . . . . . . . . 81.0 m-20 -52.87 -31.85 41.69 Favored 'General case' 0 C--N 1.328 -0.369 0 N-CA-C 111.971 0.36 . . . . 0.0 111.971 -179.883 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' C' C ' 63' ' ' ARG . . . . . . . . . . . . . 21.0 mmm180 -71.17 -21.88 62.11 Favored 'General case' 0 CA--C 1.534 0.351 0 N-CA-C 112.76 0.652 . . . . 0.0 112.76 -176.128 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' C' C ' 64' ' ' THR . . . . . . . . . . . . . 25.3 m -72.12 136.3 46.49 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-O 120.933 0.397 . . . . 0.0 110.947 -175.829 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' C' C ' 65' ' ' LYS . . . . . . . . . . . . . 96.9 mttt -89.8 131.45 35.74 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.011 -0.54 . . . . 0.0 110.144 179.221 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' C' C ' 66' ' ' ILE . . . . . . . . . . . . . 64.0 mt -116.67 130.52 71.38 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.256 0 CA-C-O 120.89 0.376 . . . . 0.0 110.121 -179.892 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' C' C ' 67' ' ' THR . . . . . . . . . . . . . 21.7 m -129.19 142.5 50.85 Favored 'General case' 0 C--N 1.332 -0.185 0 CA-C-N 116.084 -0.507 . . . . 0.0 110.787 -178.846 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' C' C ' 68' ' ' LEU . . . . . . . . . . . . . 7.1 mp -105.09 138.46 41.26 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 116.081 -0.509 . . . . 0.0 110.417 178.631 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' C' C ' 69' ' ' VAL . . . . . . . . . . . . . 38.6 t -82.9 138.62 19.04 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.265 0 N-CA-C 109.869 -0.419 . . . . 0.0 109.869 178.18 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' C' C ' 70' ' ' THR . . . . . . . . . . . . . 42.9 p -86.17 -60.04 2.12 Favored 'General case' 0 C--N 1.33 -0.258 0 N-CA-C 112.247 0.462 . . . . 0.0 112.247 -172.557 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' C' C ' 71' ' ' HIS . . . . . . . . . . . . . 91.3 m-70 -129.3 67.85 79.28 Favored Pre-proline 0 CA--C 1.536 0.442 0 CA-C-O 120.662 0.268 . . . . 0.0 111.262 -174.793 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' C' C ' 72' ' ' PRO . . . . . . . . . . . . . 72.7 Cg_endo -94.94 160.13 1.74 Allowed 'Trans proline' 0 N--CA 1.488 1.156 0 C-N-CA 122.034 1.823 . . . . 0.0 112.297 175.925 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' C' C ' 73' ' ' VAL . . . . . . . . . . . . . 26.8 m -103.59 161.63 4.32 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.299 0 N-CA-C 109.802 -0.444 . . . . 0.0 109.802 175.347 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' C' C ' 74' ' ' ASP . . . . . . . . . . . . . 14.0 t70 -91.35 115.24 27.87 Favored 'General case' 0 C--N 1.328 -0.33 0 N-CA-C 109.921 -0.4 . . . . 0.0 109.921 -178.351 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' C' C ' 75' ' ' VAL . . . . . . . . . . . . . 45.6 t -113.1 120.29 62.72 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.268 0 CA-C-O 121.094 0.473 . . . . 0.0 110.216 -178.446 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' C' C ' 76' ' ' LEU . . . . . . . . . . . . . 19.8 mt -123.18 144.94 49.02 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 115.605 -0.725 . . . . 0.0 109.585 179.452 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' C' C ' 77' ' ' GLU . . . . . . . . . . . . . 46.2 mt-10 -134.31 133.5 40.78 Favored 'General case' 0 C--N 1.332 -0.188 0 CA-C-O 121.042 0.449 . . . . 0.0 111.149 -178.804 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' C' C ' 78' ' ' ALA . . . . . . . . . . . . . . . -118.94 135.75 54.43 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 115.713 -0.676 . . . . 0.0 109.808 176.461 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' C' C ' 79' ' ' LYS . . . . . . . . . . . . . 62.5 mtpt -80.7 115.3 20.13 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-O 120.813 0.34 . . . . 0.0 110.869 -177.627 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' C' C ' 80' ' ' ILE . . . . . . . . . . . . . 37.2 mm -139.23 104.61 2.22 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.281 0 N-CA-C 109.284 -0.636 . . . . 0.0 109.284 -178.527 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' C' C ' 81' ' ' LYS . . . . . . . . . . . . . 93.1 mttt -97.65 128.48 44.38 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-O 120.782 0.325 . . . . 0.0 110.839 -178.766 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' C' C ' 82' ' ' GLY . . . . . . . . . . . . . . . 89.08 42.25 5.66 Favored Glycine 0 CA--C 1.524 0.655 0 N-CA-C 111.176 -0.77 . . . . 0.0 111.176 176.685 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' C' C ' 83' ' ' ILE . . . . . . . . . . . . . 73.6 mt -67.37 132.3 32.5 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.306 0 N-CA-C 109.771 -0.455 . . . . 0.0 109.771 177.689 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' C' C ' 84' ' ' LYS . . . . . . . . . . . . . 76.4 tttt -95.42 -54.06 3.53 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.22 -0.445 . . . . 0.0 110.311 -178.736 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' C' C ' 85' ' ' ASP . . . . . . . . . . . . . 7.4 t0 -149.81 146.3 27.07 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 115.806 -0.634 . . . . 0.0 110.39 -178.652 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' C' C ' 86' ' ' VAL . . . . . . . . . . . . . 42.6 t -124.31 129.5 73.96 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.216 0 CA-C-O 120.858 0.361 . . . . 0.0 110.291 -179.597 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' C' C ' 87' ' ' ILE . . . . . . . . . . . . . 45.1 mm -120.18 126.15 74.97 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.268 0 CA-C-N 115.957 -0.565 . . . . 0.0 109.738 177.637 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' C' C ' 88' ' ' LEU . . . . . . . . . . . . . 19.9 tp -115.15 134.72 54.91 Favored 'General case' 0 C--N 1.332 -0.171 0 CA-C-O 120.992 0.425 . . . . 0.0 111.222 -177.736 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' C' C ' 89' ' ' ASP . . . . . . . . . . . . . 5.6 t70 -131.53 162.23 30.77 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 115.861 -0.609 . . . . 0.0 109.562 176.43 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' C' C ' 90' ' ' GLU . . . . . . . . . . . . . 43.2 mt-10 -46.94 -41.9 16.83 Favored 'General case' 0 N--CA 1.464 0.26 0 N-CA-C 113.015 0.746 . . . . 0.0 113.015 -171.224 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' C' C ' 91' ' ' ASN . . . . . . . . . . . . . 1.8 p30 -132.04 28.29 4.48 Favored 'General case' 0 N--CA 1.466 0.329 0 N-CA-C 112.301 0.482 . . . . 0.0 112.301 -177.773 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' C' C ' 92' ' ' LEU . . . . . . . . . . . . . 16.1 mt -148.62 142.33 25.57 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-O 120.689 0.281 . . . . 0.0 110.35 -177.38 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' C' C ' 93' ' ' ILE . . . . . . . . . . . . . 72.9 mt -125.25 116.58 47.27 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.286 0 N-CA-C 109.143 -0.688 . . . . 0.0 109.143 176.11 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' C' C ' 94' ' ' VAL . . . . . . . . . . . . . 45.2 t -118.54 127.73 75.53 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.29 0 CA-C-O 120.959 0.409 . . . . 0.0 109.939 -178.795 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' C' C ' 95' ' ' VAL . . . . . . . . . . . . . 44.0 t -122.59 132.78 70.53 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.373 0 CA-C-N 115.96 -0.564 . . . . 0.0 109.854 -179.524 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' C' C ' 96' ' ' ILE . . . . . . . . . . . . . 58.6 mt -113.12 125.58 70.4 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.327 0 N-CA-C 109.058 -0.719 . . . . 0.0 109.058 178.066 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' C' C ' 97' ' ' THR . . . . . . . . . . . . . 71.5 p -98.95 154.53 17.99 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-O 121.197 0.522 . . . . 0.0 111.108 -177.758 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' C' C ' 98' ' ' GLU . . . . . . . . . . . . . 85.1 tt0 -53.82 -25.48 19.62 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 115.959 -0.564 . . . . 0.0 112.341 179.771 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' C' C ' 99' ' ' GLU . . . . . . . . . . . . . 37.0 tt0 -81.07 17.96 1.14 Allowed 'General case' 0 CA--C 1.539 0.525 0 N-CA-C 112.625 0.602 . . . . 0.0 112.625 -177.436 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' C' C ' 100' ' ' ASN . . . . . . . . . . . . . 2.7 m-20 62.39 32.77 16.72 Favored 'General case' 0 N--CA 1.464 0.259 0 O-C-N 121.85 -0.531 . . . . 0.0 111.836 176.276 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' C' C ' 101' ' ' GLU . . . . . . . . . . . . . 84.8 tt0 -113.06 144.82 41.96 Favored 'General case' 0 C--N 1.332 -0.155 0 N-CA-C 109.812 -0.44 . . . . 0.0 109.812 174.14 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' C' C ' 102' ' ' VAL . . . . . . . . . . . . . 45.7 t -115.09 127.43 72.65 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.293 0 CA-C-N 116.244 -0.435 . . . . 0.0 109.926 -177.695 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' C' C ' 103' ' ' LEU . . . . . . . . . . . . . 50.6 mt -117.38 131.53 56.76 Favored 'General case' 0 C--N 1.331 -0.215 0 CA-C-N 115.881 -0.6 . . . . 0.0 110.132 178.531 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' C' C ' 104' ' ' ILE . . . . . . . . . . . . . 65.1 mt -122.56 122.65 66.61 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.227 0 CA-C-O 120.568 0.223 . . . . 0.0 110.46 -179.657 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' C' C ' 105' ' ' PHE . . . . . . . . . . . . . 47.7 m-85 -124.07 164.64 19.0 Favored 'General case' 0 C--N 1.331 -0.225 0 CA-C-N 115.596 -0.729 . . . . 0.0 109.843 178.432 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' C' C ' 106' ' ' ASN . . . . . . . . . . . . . 42.9 p-10 -96.29 -171.41 2.29 Favored 'General case' 0 C--N 1.331 -0.212 0 N-CA-C 109.992 -0.373 . . . . 0.0 109.992 174.929 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' C' C ' 107' ' ' GLN . . . . . . . . . . . . . 40.1 tt0 -60.23 -29.46 68.77 Favored 'General case' 0 C--N 1.329 -0.32 0 N-CA-C 111.96 0.355 . . . . 0.0 111.96 -179.659 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' C' C ' 108' ' ' ASN . . . . . . . . . . . . . 12.1 t30 -83.95 6.16 22.83 Favored 'General case' 0 CA--C 1.536 0.441 0 N-CA-C 113.277 0.843 . . . . 0.0 113.277 -177.468 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' C' C ' 109' ' ' LEU . . . . . . . . . . . . . 12.0 tp 62.09 41.67 10.64 Favored 'General case' 0 C--N 1.332 -0.164 0 CA-C-O 121.383 0.611 . . . . 0.0 110.98 178.657 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' C' C ' 110' ' ' GLU . . . . . . . . . . . . . 96.2 mt-10 -108.55 155.97 20.04 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.139 -0.482 . . . . 0.0 110.014 176.094 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' C' C ' 111' ' ' GLU . . . . . . . . . . . . . 83.7 tt0 -79.97 121.93 26.09 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.394 -0.366 . . . . 0.0 110.683 -179.121 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' C' C ' 112' ' ' LEU . . . . . . . . . . . . . 17.9 mt -112.44 -46.03 3.2 Favored 'General case' 0 C--N 1.331 -0.212 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.306 177.026 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' C' C ' 113' ' ' TYR . . . . . . . . . . . . . 62.7 t80 -147.07 137.2 23.35 Favored 'General case' 0 C--N 1.33 -0.243 0 C-N-CA 120.606 -0.438 . . . . 0.0 111.462 179.991 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' C' C ' 114' ' ' ARG . . . . . . . . . . . . . 93.2 mtt180 -137.67 127.83 26.05 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.131 -0.486 . . . . 0.0 110.096 173.876 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' C' C ' 115' ' ' GLY . . . . . . . . . . . . . . . -149.99 162.89 29.31 Favored Glycine 0 CA--C 1.524 0.596 0 N-CA-C 110.682 -0.967 . . . . 0.0 110.682 179.337 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' C' C ' 116' ' ' LYS . . . . . . . . . . . . . 75.2 tttt -132.31 138.5 47.84 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-O 120.856 0.36 . . . . 0.0 110.143 179.287 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' C' C ' 117' ' ' PHE . . . . . . . . . . . . . 33.4 m-85 -136.28 116.72 13.71 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.158 -0.474 . . . . 0.0 109.812 -177.113 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' C' C ' 118' ' ' GLU . . . . . . . . . . . . . 45.7 mp0 -56.01 -40.62 73.65 Favored 'General case' 0 C--N 1.329 -0.304 0 C-N-CA 120.803 -0.359 . . . . 0.0 110.92 -175.758 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' C' C ' 119' ' ' ASN . . . . . . . . . . . . . 30.5 m120 -100.07 31.19 3.42 Favored 'General case' 0 CA--C 1.53 0.21 0 N-CA-C 112.103 0.408 . . . . 0.0 112.103 -174.912 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' C' C ' 120' ' ' LEU . . . . . . . . . . . . . 15.0 tp -57.34 119.9 7.25 Favored 'General case' 0 C--N 1.333 -0.148 0 C-N-CA 121.005 -0.278 . . . . 0.0 110.352 178.087 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' C' C ' 121' ' ' ASN . . . . . . . . . . . . . 46.8 m-80 -114.15 -44.1 3.17 Favored 'General case' 0 C--N 1.332 -0.195 0 CA-C-N 116.571 -0.286 . . . . 0.0 111.245 -177.705 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' C' C ' 122' ' ' LYS . . . . . . . . . . . . . 75.7 mttt -143.35 149.22 37.44 Favored 'General case' 0 C--N 1.331 -0.222 0 CA-C-O 121.066 0.46 . . . . 0.0 111.834 -176.312 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' C' C ' 123' ' ' VAL . . . . . . . . . . . . . 43.1 t -128.62 130.96 69.03 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.227 0 N-CA-C 109.266 -0.642 . . . . 0.0 109.266 174.847 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' C' C ' 124' ' ' LEU . . . . . . . . . . . . . 13.3 tp -130.27 138.3 50.43 Favored 'General case' 0 C--N 1.332 -0.184 0 CA-C-O 120.837 0.351 . . . . 0.0 110.916 -177.484 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' C' C ' 125' ' ' VAL . . . . . . . . . . . . . 34.9 m -129.74 138.82 53.19 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.229 0 CA-C-N 116.127 -0.488 . . . . 0.0 110.603 179.939 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' C' C ' 126' ' ' ARG . . . . . . . . . . . . . 77.9 mtp85 -147.17 121.88 9.87 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-O 120.868 0.366 . . . . 0.0 110.938 178.162 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' C' C ' 127' ' ' ASN . . . . . . . . . . . . . 9.5 m120 51.02 -105.11 0.19 Allowed 'General case' 0 CA--C 1.544 0.739 0 CA-C-N 116.113 -0.494 . . . . 0.0 111.437 178.684 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' C' C ' 128' ' ' ASP . . . . . . . . . . . . . 12.6 p-10 -114.13 -0.32 14.02 Favored 'General case' 0 CA--C 1.537 0.461 0 CA-C-N 119.504 1.047 . . . . 0.0 113.372 -177.37 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' C' C ' 129' ' ' LEU . . . . . . . . . . . . . 58.3 mt -105.01 143.65 32.89 Favored 'General case' 0 C--O 1.232 0.166 0 CA-C-N 118.135 0.425 . . . . 0.0 110.373 -179.465 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' C' C ' 130' ' ' VAL . . . . . . . . . . . . . 44.9 t -124.4 136.97 58.81 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.284 0 N-CA-C 109.642 -0.503 . . . . 0.0 109.642 -179.956 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' C' C ' 131' ' ' VAL . . . . . . . . . . . . . 41.3 t -134.55 137.62 51.0 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.248 0 CA-C-O 121.194 0.521 . . . . 0.0 110.376 179.974 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' C' C ' 132' ' ' ILE . . . . . . . . . . . . . 73.3 mt -118.85 133.71 64.82 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.29 0 CA-C-N 115.54 -0.755 . . . . 0.0 109.366 179.565 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' C' C ' 133' ' ' ILE . . . . . . . . . . . . . 37.7 mm -117.02 121.62 68.21 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.229 0 CA-C-N 116.462 -0.336 . . . . 0.0 110.889 -175.035 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' C' C ' 134' ' ' ASP . . . . . . . . . . . . . 7.9 p-10 -133.57 145.86 50.46 Favored 'General case' 0 C--N 1.332 -0.163 0 N-CA-C 109.652 -0.499 . . . . 0.0 109.652 174.067 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' C' C ' 135' ' ' GLU . . . . . . . . . . . . . 80.4 tt0 -49.75 -23.0 1.58 Allowed 'General case' 0 C--N 1.327 -0.403 0 N-CA-C 113.055 0.761 . . . . 0.0 113.055 -171.356 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' C' C ' 136' ' ' GLN . . . . . . . . . . . . . 44.6 tt0 -105.0 -22.56 13.1 Favored 'General case' 0 N--CA 1.465 0.294 0 N-CA-C 113.075 0.769 . . . . 0.0 113.075 -174.976 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' C' C ' 137' ' ' LYS . . . . . . . . . . . . . 78.4 mttt -145.37 153.09 40.85 Favored 'General case' 0 C--N 1.333 -0.143 0 CA-C-O 121.538 0.685 . . . . 0.0 112.22 -172.342 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' C' C ' 138' ' ' LEU . . . . . . . . . . . . . 14.6 tp -115.2 122.16 45.18 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 115.064 -0.971 . . . . 0.0 109.237 173.743 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' C' C ' 139' ' ' THR . . . . . . . . . . . . . 24.4 m -111.79 126.5 55.14 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-O 120.584 0.23 . . . . 0.0 111.011 -177.817 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' C' C ' 140' ' ' LEU . . . . . . . . . . . . . 15.0 tp -117.84 122.5 43.54 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 115.796 -0.638 . . . . 0.0 109.387 -178.976 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' C' C ' 141' ' ' ILE . . . . . . . . . . . . . 19.1 mt -121.7 123.05 68.51 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.252 0 CA-C-O 120.853 0.359 . . . . 0.0 110.127 -176.317 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' C' C ' 142' ' ' ARG . . . . . . . . . . . . . 84.2 mtp180 -109.62 129.61 55.58 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 115.521 -0.763 . . . . 0.0 110.536 -178.696 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' C' C ' 143' ' ' THR . . . . . . . . . . . . . 61.2 p . . . . . 0 C--O 1.219 -0.5 0 CA-C-O 117.963 -1.018 . . . . 0.0 110.497 179.78 . . . . . . . . 0 0 . 1 . 007 nuclear orig full ' D' D ' -3' ' ' GLU . . . . . . . . . . . . . 70.4 mm-40 . . . . . 0 N--CA 1.49 1.537 0 N-CA-C 109.351 -0.611 . . . . 0.0 109.351 . . . . . . . . . 0 0 . 1 . 007 nuclear orig full ' D' D ' -2' ' ' GLY . . . . . . . . . . . . . . . -76.36 141.61 27.04 Favored Glycine 0 CA--C 1.524 0.654 0 N-CA-C 110.76 -0.936 . . . . 0.0 110.76 178.977 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' D' D ' -1' ' ' VAL . . . . . . . . . . . . . 43.5 t -96.39 126.87 48.94 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.334 0 CA-C-O 120.813 0.339 . . . . 0.0 110.187 -179.872 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' D' D ' 0' ' ' ILE . . . . . . . . . . . . . 71.3 mt -124.72 140.48 47.81 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.196 0 CA-C-N 116.192 -0.458 . . . . 0.0 109.924 -179.865 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' D' D ' 1' ' ' MET . . . . . . . . . . . . . 25.6 ptp -78.52 143.58 36.44 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.224 -0.444 . . . . 0.0 111.044 -178.704 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' D' D ' 2' ' ' SER . . . . . . . . . . . . . 1.8 p -131.05 121.99 25.98 Favored 'General case' 0 C--N 1.331 -0.216 0 CA-C-N 116.097 -0.501 . . . . 0.0 110.178 177.706 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' D' D ' 3' ' ' GLU . . . . . . . . . . . . . 93.3 mt-10 -139.99 143.17 36.34 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-N 116.042 -0.526 . . . . 0.0 111.403 -175.819 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' D' D ' 4' ' ' LEU . . . . . . . . . . . . . 20.9 tp -126.53 129.52 48.77 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 115.776 -0.647 . . . . 0.0 109.751 175.49 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' D' D ' 5' ' ' LYS . . . . . . . . . . . . . 99.7 mttt -113.43 122.43 47.3 Favored 'General case' 0 C--O 1.235 0.336 0 CA-C-N 116.581 -0.281 . . . . 0.0 111.069 -178.624 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' D' D ' 6' ' ' LEU . . . . . . . . . . . . . 43.7 mt -114.0 143.34 44.91 Favored 'General case' 0 C--N 1.332 -0.19 0 CA-C-N 115.49 -0.777 . . . . 0.0 110.202 -179.958 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' D' D ' 7' ' ' LYS . . . . . . . . . . . . . 31.3 ttpt -125.88 138.57 32.32 Favored Pre-proline 0 CA--C 1.534 0.346 0 CA-C-O 118.917 -0.564 . . . . 0.0 109.637 175.601 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' D' D ' 8' ' ' PRO . . . . . . . . . . . . . 85.9 Cg_endo -91.14 135.22 1.8 Allowed 'Trans proline' 0 N--CA 1.489 1.23 0 C-N-CA 121.71 1.607 . . . . 0.0 112.049 179.537 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' D' D ' 9' ' ' LEU . . . . . . . . . . . . . 35.3 mt -73.81 -46.78 6.91 Favored Pre-proline 0 C--N 1.329 -0.313 0 CA-C-O 118.715 -0.66 . . . . 0.0 111.865 179.527 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' D' D ' 10' ' ' PRO . . . . . . . . . . . . . 89.4 Cg_endo -81.77 153.17 17.32 Favored 'Trans proline' 0 N--CA 1.495 1.588 0 C-N-CA 121.179 1.253 . . . . 0.0 111.574 174.71 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' D' D ' 11' ' ' LYS . . . . . . . . . . . . . 62.7 tttm -87.6 99.08 11.78 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-O 120.893 0.378 . . . . 0.0 110.443 178.863 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' D' D ' 12' ' ' VAL . . . . . . . . . . . . . 12.2 p -140.47 145.46 25.8 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.293 0 CA-C-N 116.108 -0.496 . . . . 0.0 110.352 179.971 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' D' D ' 13' ' ' GLU . . . . . . . . . . . . . 84.6 tt0 -90.1 125.45 35.43 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.317 -0.401 . . . . 0.0 110.029 178.588 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' D' D ' 14' ' ' LEU . . . . . . . . . . . . . 21.1 mt -96.77 151.17 37.7 Favored Pre-proline 0 C--N 1.329 -0.309 0 CA-C-N 116.404 -0.362 . . . . 0.0 110.692 -177.669 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' D' D ' 15' ' ' PRO . . . . . . . . . . . . . 26.7 Cg_exo -61.61 157.38 42.29 Favored 'Trans proline' 0 N--CA 1.497 1.697 0 C-N-CA 121.225 1.283 . . . . 0.0 111.669 176.812 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' D' D ' 16' ' ' PRO . . . . . . . . . . . . . 37.2 Cg_exo -57.59 -36.21 98.63 Favored 'Trans proline' 0 N--CA 1.496 1.66 0 C-N-CA 121.461 1.441 . . . . 0.0 112.981 -177.466 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' D' D ' 17' ' ' ASP . . . . . . . . . . . . . 22.4 p-10 -92.03 9.06 34.86 Favored 'General case' 0 CA--C 1.535 0.403 0 N-CA-C 113.418 0.896 . . . . 0.0 113.418 -175.988 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' D' D ' 18' ' ' PHE . . . . . . . . . . . . . 62.4 t80 -57.09 -47.61 80.63 Favored 'General case' 0 C--N 1.333 -0.145 0 O-C-N 121.837 -0.539 . . . . 0.0 110.483 -177.585 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' D' D ' 19' ' ' VAL . . . . . . . . . . . . . 44.3 t -55.57 -51.0 62.7 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.382 0 CA-C-N 116.281 -0.418 . . . . 0.0 111.235 -174.429 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' D' D ' 20' ' ' ASP . . . . . . . . . . . . . 2.3 p-10 -59.33 -37.27 77.39 Favored 'General case' 0 N--CA 1.464 0.228 0 C-N-CA 120.381 -0.527 . . . . 0.0 111.252 -176.32 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' D' D ' 21' ' ' VAL . . . . . . . . . . . . . 59.7 t -63.0 -45.15 99.61 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.266 0 C-N-CA 120.314 -0.555 . . . . 0.0 110.191 179.885 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' D' D ' 22' ' ' ILE . . . . . . . . . . . . . 46.1 mm -57.39 -39.46 68.45 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.317 0 C-N-CA 120.961 -0.296 . . . . 0.0 110.475 178.36 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' D' D ' 23' ' ' ARG . . . . . . . . . . . . . 55.5 ttp180 -57.26 -49.97 74.38 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-O 121.057 0.456 . . . . 0.0 110.437 176.751 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' D' D ' 24' ' ' ILE . . . . . . . . . . . . . 76.6 mt -60.0 -38.89 78.56 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.34 0 CA-C-N 116.028 -0.533 . . . . 0.0 111.858 -176.884 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' D' D ' 25' ' ' LYS . . . . . . . . . . . . . 25.9 pttt -76.64 -40.82 47.97 Favored 'General case' 0 CA--C 1.534 0.36 0 C-N-CA 120.343 -0.543 . . . . 0.0 112.112 -174.426 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' D' D ' 26' ' ' LEU . . . . . . . . . . . . . 14.7 mt -79.35 -28.39 42.0 Favored 'General case' 0 CA--C 1.53 0.211 0 N-CA-C 113.172 0.804 . . . . 0.0 113.172 -171.828 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' D' D ' 27' ' ' GLN . . . . . . . . . . . . . 10.2 pt20 -46.37 141.68 3.4 Favored 'General case' 0 N--CA 1.471 0.589 0 N-CA-C 112.931 0.715 . . . . 0.0 112.931 -175.518 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' D' D ' 28' ' ' GLY . . . . . . . . . . . . . . . 100.36 -25.85 26.74 Favored Glycine 0 CA--C 1.532 1.117 0 CA-C-N 115.58 -0.736 . . . . 0.0 112.189 -176.55 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' D' D ' 29' ' ' LYS . . . . . . . . . . . . . 53.2 mttm -97.65 155.13 17.13 Favored 'General case' 0 C--N 1.332 -0.162 0 CA-C-N 117.422 0.611 . . . . 0.0 110.854 178.45 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' D' D ' 30' ' ' THR . . . . . . . . . . . . . 33.4 m -106.19 140.64 38.83 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.235 -0.438 . . . . 0.0 110.24 176.946 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' D' D ' 31' ' ' VAL . . . . . . . . . . . . . 35.0 m -127.82 155.03 39.03 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.198 0 CA-C-O 120.819 0.342 . . . . 0.0 110.875 -178.581 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' D' D ' 32' ' ' ARG . . . . . . . . . . . . . 43.6 mtp180 -133.31 152.57 51.93 Favored 'General case' 0 C--N 1.331 -0.203 0 CA-C-N 115.854 -0.612 . . . . 0.0 110.675 177.719 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' D' D ' 33' ' ' THR . . . . . . . . . . . . . 18.8 m -53.46 139.14 31.72 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.034 -0.53 . . . . 0.0 111.387 -179.256 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' D' D ' 34' ' ' GLY . . . . . . . . . . . . . . . 99.84 -17.2 57.69 Favored Glycine 0 CA--C 1.533 1.202 0 C-N-CA 121.123 -0.56 . . . . 0.0 113.284 178.13 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' D' D ' 35' ' ' ASP . . . . . . . . . . . . . 77.3 m-20 -66.12 147.79 52.8 Favored 'General case' 0 C--O 1.231 0.112 0 CA-C-N 118.053 0.927 . . . . 0.0 111.064 179.444 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' D' D ' 36' ' ' VAL . . . . . . . . . . . . . 45.0 t -122.23 129.61 75.19 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.241 0 CA-C-N 115.933 -0.576 . . . . 0.0 109.751 177.775 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' D' D ' 37' ' ' ILE . . . . . . . . . . . . . 63.9 mt -120.14 137.91 52.44 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.254 0 CA-C-N 116.289 -0.414 . . . . 0.0 110.031 -179.381 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' D' D ' 38' ' ' GLY . . . . . . . . . . . . . . . -112.65 127.72 8.12 Favored Glycine 0 CA--C 1.526 0.746 0 N-CA-C 110.828 -0.909 . . . . 0.0 110.828 178.557 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' D' D ' 39' ' ' ILE . . . . . . . . . . . . . 70.8 mt -124.76 131.0 73.24 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.282 0 N-CA-C 110.113 -0.329 . . . . 0.0 110.113 179.58 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' D' D ' 40' ' ' SER . . . . . . . . . . . . . 53.1 p -91.94 123.05 35.02 Favored 'General case' 0 C--N 1.331 -0.2 0 CA-C-N 116.292 -0.413 . . . . 0.0 110.928 177.555 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' D' D ' 41' ' ' ILE . . . . . . . . . . . . . 72.9 mt -132.34 122.43 48.03 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.229 0 CA-C-N 116.469 -0.332 . . . . 0.0 110.344 177.756 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' D' D ' 42' ' ' LEU . . . . . . . . . . . . . 52.9 mt 53.87 35.9 22.84 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.161 -0.472 . . . . 0.0 111.742 176.821 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' D' D ' 43' ' ' GLY . . . . . . . . . . . . . . . 72.85 28.03 67.75 Favored Glycine 0 CA--C 1.53 1.031 0 C-N-CA 121.171 -0.537 . . . . 0.0 112.457 177.241 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' D' D ' 44' ' ' LYS . . . . . . . . . . . . . 48.7 mtmt -138.12 128.24 25.8 Favored 'General case' 0 C--N 1.331 -0.206 0 N-CA-C 109.778 -0.453 . . . . 0.0 109.778 177.77 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' D' D ' 45' ' ' GLU . . . . . . . . . . . . . 84.5 tt0 -84.62 125.92 32.89 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.515 -0.311 . . . . 0.0 111.444 -177.939 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' D' D ' 46' ' ' VAL . . . . . . . . . . . . . 8.9 p -118.58 124.39 73.06 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.23 0 N-CA-C 109.22 -0.659 . . . . 0.0 109.22 173.553 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' D' D ' 47' ' ' LYS . . . . . . . . . . . . . 91.8 mttt -98.96 124.86 44.21 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 116.087 -0.506 . . . . 0.0 110.845 178.362 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' D' D ' 48' ' ' PHE . . . . . . . . . . . . . 31.7 m-85 -108.03 131.86 54.15 Favored 'General case' 0 C--N 1.329 -0.32 0 N-CA-C 109.626 -0.509 . . . . 0.0 109.626 176.812 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' D' D ' 49' ' ' LYS . . . . . . . . . . . . . 82.2 tttt -106.79 132.08 53.17 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.246 -0.434 . . . . 0.0 110.123 178.718 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' D' D ' 50' ' ' VAL . . . . . . . . . . . . . 45.7 t -75.65 105.02 4.24 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.323 0 N-CA-C 109.257 -0.645 . . . . 0.0 109.257 177.5 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' D' D ' 51' ' ' VAL . . . . . . . . . . . . . 47.7 t -71.61 -51.43 32.7 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.273 0 CA-C-N 116.04 -0.527 . . . . 0.0 109.774 -174.687 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' D' D ' 52' ' ' GLN . . . . . . . . . . . . . 55.0 mt-30 -155.35 147.48 23.62 Favored 'General case' 0 C--N 1.33 -0.256 0 C-N-CA 120.343 -0.543 . . . . 0.0 111.789 -177.862 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' D' D ' 53' ' ' ALA . . . . . . . . . . . . . . . -124.47 130.8 53.14 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 115.291 -0.868 . . . . 0.0 109.51 173.909 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' D' D ' 54' ' ' TYR . . . . . . . . . . . . . 16.0 t80 -128.97 108.19 18.19 Favored Pre-proline 0 CA--C 1.534 0.341 0 CA-C-O 118.272 -0.871 . . . . 0.0 110.458 -179.465 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' D' D ' 55' ' ' PRO . . . . . . . . . . . . . 74.2 Cg_endo -77.16 170.0 72.71 Favored 'Cis proline' 0 N--CA 1.499 1.845 0 CA-C-N 121.86 1.7 . . . . 0.0 112.422 -5.915 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' D' D ' 56' ' ' SER . . . . . . . . . . . . . 19.6 m -116.85 133.19 23.1 Favored Pre-proline 0 CA--C 1.539 0.533 0 CA-C-O 118.465 -0.778 . . . . 0.0 109.487 174.826 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' D' D ' 57' ' ' PRO . . . . . . . . . . . . . 49.0 Cg_endo -69.91 164.18 80.32 Favored 'Cis proline' 0 N--CA 1.497 1.726 0 CA-C-N 121.848 1.696 . . . . 0.0 111.485 -1.898 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' D' D ' 58' ' ' LEU . . . . . . . . . . . . . 37.4 tp -130.23 138.05 50.35 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-O 120.886 0.374 . . . . 0.0 110.589 -179.355 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' D' D ' 59' ' ' ARG . . . . . . . . . . . . . 30.1 ttm180 -99.66 132.51 44.96 Favored 'General case' 0 C--N 1.327 -0.396 0 CA-C-N 115.85 -0.614 . . . . 0.0 109.617 176.236 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' D' D ' 60' ' ' VAL . . . . . . . . . . . . . 42.9 t -82.34 114.79 23.78 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.259 0 C-N-CA 120.787 -0.365 . . . . 0.0 110.238 -178.092 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' D' D ' 61' ' ' GLU . . . . . . . . . . . . . 96.0 mt-10 -131.19 169.43 15.93 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.079 -0.51 . . . . 0.0 109.928 176.709 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' D' D ' 62' ' ' ASP . . . . . . . . . . . . . 10.1 p-10 -55.26 -32.58 62.45 Favored 'General case' 0 C--N 1.329 -0.3 0 C-N-CA 120.904 -0.319 . . . . 0.0 111.572 178.716 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' D' D ' 63' ' ' ARG . . . . . . . . . . . . . 16.8 ptp180 -82.51 7.66 13.82 Favored 'General case' 0 CA--C 1.536 0.407 0 N-CA-C 113.504 0.927 . . . . 0.0 113.504 -176.743 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' D' D ' 64' ' ' THR . . . . . . . . . . . . . 28.5 m -91.65 134.31 34.81 Favored 'General case' 0 C--N 1.333 -0.133 0 CA-C-N 118.167 0.439 . . . . 0.0 110.618 -179.385 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' D' D ' 65' ' ' LYS . . . . . . . . . . . . . 23.0 mtpp -89.86 127.6 36.03 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.034 -0.53 . . . . 0.0 110.268 179.589 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' D' D ' 66' ' ' ILE . . . . . . . . . . . . . 65.0 mt -117.35 132.84 65.97 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.25 0 CA-C-O 120.805 0.336 . . . . 0.0 110.291 -178.327 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' D' D ' 67' ' ' THR . . . . . . . . . . . . . 23.1 m -128.7 144.19 51.1 Favored 'General case' 0 N--CA 1.463 0.217 0 CA-C-N 116.094 -0.503 . . . . 0.0 110.941 -179.139 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' D' D ' 68' ' ' LEU . . . . . . . . . . . . . 15.8 tp -107.7 134.4 50.73 Favored 'General case' 0 C--N 1.331 -0.225 0 CA-C-N 115.916 -0.584 . . . . 0.0 110.622 179.348 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' D' D ' 69' ' ' VAL . . . . . . . . . . . . . 43.6 t -99.67 140.43 18.98 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.295 0 CA-C-N 116.057 -0.52 . . . . 0.0 110.043 178.358 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' D' D ' 70' ' ' THR . . . . . . . . . . . . . 3.1 m -136.24 40.62 2.65 Favored 'General case' 0 C--N 1.331 -0.213 0 CA-C-O 121.131 0.491 . . . . 0.0 110.975 -178.263 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' D' D ' 71' ' ' HIS . . . . . . . . . . . . . 5.9 t60 -130.8 75.99 77.88 Favored Pre-proline 0 CA--C 1.535 0.382 0 CA-C-N 116.36 -0.382 . . . . 0.0 110.523 179.569 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' D' D ' 72' ' ' PRO . . . . . . . . . . . . . 90.1 Cg_endo -91.62 160.07 3.53 Favored 'Trans proline' 0 N--CA 1.491 1.364 0 C-N-CA 121.936 1.757 . . . . 0.0 112.851 -178.448 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' D' D ' 73' ' ' VAL . . . . . . . . . . . . . 34.7 m -117.31 168.29 9.22 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.205 0 CA-C-N 116.076 -0.511 . . . . 0.0 109.801 176.576 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' D' D ' 74' ' ' ASP . . . . . . . . . . . . . 13.7 t70 -97.75 116.88 30.83 Favored 'General case' 0 C--N 1.33 -0.259 0 C-N-CA 120.86 -0.336 . . . . 0.0 110.149 -177.257 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' D' D ' 75' ' ' VAL . . . . . . . . . . . . . 45.3 t -112.76 122.09 66.27 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.212 0 CA-C-O 121.086 0.469 . . . . 0.0 110.218 -178.617 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' D' D ' 76' ' ' LEU . . . . . . . . . . . . . 29.7 mt -126.78 143.2 51.32 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 115.623 -0.717 . . . . 0.0 109.433 179.28 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' D' D ' 77' ' ' GLU . . . . . . . . . . . . . 39.4 tt0 -138.44 138.97 38.67 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-O 121.052 0.453 . . . . 0.0 111.228 -177.156 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' D' D ' 78' ' ' ALA . . . . . . . . . . . . . . . -122.94 142.01 51.29 Favored 'General case' 0 C--N 1.331 -0.239 0 CA-C-N 115.881 -0.6 . . . . 0.0 110.063 177.613 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' D' D ' 79' ' ' LYS . . . . . . . . . . . . . 84.4 tttt -84.7 119.2 24.98 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-O 120.743 0.306 . . . . 0.0 110.741 -178.263 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' D' D ' 80' ' ' ILE . . . . . . . . . . . . . 38.2 mm -139.13 113.33 7.27 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.283 0 N-CA-C 109.763 -0.458 . . . . 0.0 109.763 -178.302 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' D' D ' 81' ' ' LYS . . . . . . . . . . . . . 39.2 tptt -105.12 125.56 51.11 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-O 120.734 0.302 . . . . 0.0 110.814 -178.275 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' D' D ' 82' ' ' GLY . . . . . . . . . . . . . . . 89.16 42.16 5.66 Favored Glycine 0 CA--C 1.526 0.726 0 C-N-CA 120.83 -0.7 . . . . 0.0 111.473 174.986 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' D' D ' 83' ' ' ILE . . . . . . . . . . . . . 71.5 mt -67.92 137.02 25.41 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.286 0 N-CA-C 109.897 -0.408 . . . . 0.0 109.897 177.78 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' D' D ' 84' ' ' LYS . . . . . . . . . . . . . 42.8 tttp -95.11 -52.31 4.26 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 116.139 -0.482 . . . . 0.0 110.075 -179.63 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' D' D ' 85' ' ' ASP . . . . . . . . . . . . . 10.9 t70 -158.48 154.32 26.6 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 115.694 -0.685 . . . . 0.0 110.252 178.632 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' D' D ' 86' ' ' VAL . . . . . . . . . . . . . 43.3 t -130.11 132.86 65.05 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.223 0 CA-C-O 120.935 0.398 . . . . 0.0 110.563 -178.939 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' D' D ' 87' ' ' ILE . . . . . . . . . . . . . 5.0 mp -120.48 128.37 76.0 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.272 0 CA-C-N 115.851 -0.613 . . . . 0.0 109.516 176.752 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' D' D ' 88' ' ' LEU . . . . . . . . . . . . . 16.6 tp -114.17 134.46 54.89 Favored 'General case' 0 C--N 1.331 -0.218 0 CA-C-O 121.066 0.46 . . . . 0.0 110.949 -177.652 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' D' D ' 89' ' ' ASP . . . . . . . . . . . . . 7.6 t70 -130.49 160.93 32.62 Favored 'General case' 0 C--N 1.332 -0.187 0 CA-C-N 115.849 -0.614 . . . . 0.0 109.734 177.046 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' D' D ' 90' ' ' GLU . . . . . . . . . . . . . 71.0 mm-40 -46.63 -40.11 12.45 Favored 'General case' 0 C--N 1.329 -0.289 0 N-CA-C 113.117 0.784 . . . . 0.0 113.117 -171.517 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' D' D ' 91' ' ' ASN . . . . . . . . . . . . . 82.4 m-20 -132.04 25.44 4.59 Favored 'General case' 0 N--CA 1.467 0.403 0 N-CA-C 112.665 0.617 . . . . 0.0 112.665 -177.015 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' D' D ' 92' ' ' LEU . . . . . . . . . . . . . 18.1 mt -149.76 143.36 25.36 Favored 'General case' 0 C--N 1.331 -0.223 0 CA-C-O 120.622 0.249 . . . . 0.0 110.382 -177.361 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' D' D ' 93' ' ' ILE . . . . . . . . . . . . . 73.4 mt -126.19 115.1 41.39 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.345 0 N-CA-C 109.19 -0.67 . . . . 0.0 109.19 176.022 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' D' D ' 94' ' ' VAL . . . . . . . . . . . . . 45.1 t -117.82 126.4 74.79 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.267 0 CA-C-O 120.878 0.371 . . . . 0.0 110.049 -177.857 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' D' D ' 95' ' ' VAL . . . . . . . . . . . . . 43.4 t -120.63 134.01 65.46 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 CA-C-N 115.918 -0.583 . . . . 0.0 109.824 179.978 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' D' D ' 96' ' ' ILE . . . . . . . . . . . . . 63.3 mt -112.58 126.88 70.03 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 N-CA-C 108.951 -0.759 . . . . 0.0 108.951 178.466 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' D' D ' 97' ' ' THR . . . . . . . . . . . . . 81.7 p -99.34 156.95 16.73 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-O 121.21 0.529 . . . . 0.0 111.154 -177.036 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' D' D ' 98' ' ' GLU . . . . . . . . . . . . . 45.9 tp10 -53.85 -27.61 30.9 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.193 -0.458 . . . . 0.0 112.182 -179.529 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' D' D ' 99' ' ' GLU . . . . . . . . . . . . . 40.8 tt0 -79.78 16.31 1.17 Allowed 'General case' 0 CA--C 1.538 0.517 0 N-CA-C 112.666 0.617 . . . . 0.0 112.666 -176.808 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' D' D ' 100' ' ' ASN . . . . . . . . . . . . . 4.2 m-20 61.24 34.37 18.74 Favored 'General case' 0 CA--C 1.531 0.245 0 O-C-N 121.749 -0.595 . . . . 0.0 111.399 177.828 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' D' D ' 101' ' ' GLU . . . . . . . . . . . . . 84.9 tt0 -111.79 145.65 39.02 Favored 'General case' 0 C--N 1.331 -0.2 0 N-CA-C 109.594 -0.521 . . . . 0.0 109.594 173.604 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' D' D ' 102' ' ' VAL . . . . . . . . . . . . . 45.5 t -114.93 125.98 72.39 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.356 0 CA-C-N 116.275 -0.421 . . . . 0.0 110.125 -177.502 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' D' D ' 103' ' ' LEU . . . . . . . . . . . . . 29.8 mt -117.55 128.28 54.81 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 115.794 -0.639 . . . . 0.0 110.232 177.441 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' D' D ' 104' ' ' ILE . . . . . . . . . . . . . 67.3 mt -119.45 122.18 68.3 Favored 'Isoleucine or valine' 0 C--O 1.235 0.299 0 N-CA-C 110.403 -0.221 . . . . 0.0 110.403 -179.612 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' D' D ' 105' ' ' PHE . . . . . . . . . . . . . 62.4 m-85 -120.78 165.16 15.53 Favored 'General case' 0 C--O 1.232 0.147 0 O-C-N 123.95 0.781 . . . . 0.0 109.804 179.126 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' D' D ' 106' ' ' ASN . . . . . . . . . . . . . 43.3 p-10 -99.56 -170.1 1.85 Allowed 'General case' 0 C--N 1.33 -0.249 0 N-CA-C 109.78 -0.452 . . . . 0.0 109.78 172.708 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' D' D ' 107' ' ' GLN . . . . . . . . . . . . . 50.9 tt0 -57.65 -29.79 64.88 Favored 'General case' 0 C--N 1.328 -0.337 0 N-CA-C 112.033 0.383 . . . . 0.0 112.033 179.707 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' D' D ' 108' ' ' ASN . . . . . . . . . . . . . 15.1 t-20 -88.07 13.43 11.18 Favored 'General case' 0 CA--C 1.535 0.386 0 N-CA-C 112.917 0.71 . . . . 0.0 112.917 -176.215 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' D' D ' 109' ' ' LEU . . . . . . . . . . . . . 29.4 mt 57.64 34.81 24.97 Favored 'General case' 0 CA--C 1.53 0.182 0 O-C-N 122.108 -0.37 . . . . 0.0 111.661 177.98 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' D' D ' 110' ' ' GLU . . . . . . . . . . . . . 43.3 mt-10 -101.3 153.99 19.17 Favored 'General case' 0 C--N 1.331 -0.235 0 N-CA-C 109.984 -0.376 . . . . 0.0 109.984 176.991 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' D' D ' 111' ' ' GLU . . . . . . . . . . . . . 80.6 tt0 -82.7 121.96 27.54 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.383 -0.371 . . . . 0.0 110.589 -178.246 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' D' D ' 112' ' ' LEU . . . . . . . . . . . . . 25.5 mt -110.92 -46.05 3.39 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 116.293 -0.412 . . . . 0.0 110.444 178.354 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' D' D ' 113' ' ' TYR . . . . . . . . . . . . . 46.8 t80 -137.93 136.3 36.89 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-O 120.839 0.352 . . . . 0.0 111.061 -179.679 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' D' D ' 114' ' ' ARG . . . . . . . . . . . . . 60.1 ttt180 -138.01 121.45 17.17 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 115.931 -0.577 . . . . 0.0 110.257 177.034 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' D' D ' 115' ' ' GLY . . . . . . . . . . . . . . . -150.07 162.44 29.19 Favored Glycine 0 CA--C 1.525 0.677 0 N-CA-C 110.977 -0.849 . . . . 0.0 110.977 179.506 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' D' D ' 116' ' ' LYS . . . . . . . . . . . . . 70.3 tttt -136.72 137.5 40.0 Favored 'General case' 0 C--N 1.328 -0.36 0 N-CA-C 110.124 -0.324 . . . . 0.0 110.124 178.762 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' D' D ' 117' ' ' PHE . . . . . . . . . . . . . 26.3 m-85 -135.61 117.59 15.29 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 116.403 -0.362 . . . . 0.0 110.198 -176.135 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' D' D ' 118' ' ' GLU . . . . . . . . . . . . . 96.0 mt-10 -54.17 -44.96 71.94 Favored 'General case' 0 C--N 1.33 -0.27 0 C-N-CA 120.937 -0.305 . . . . 0.0 111.392 -176.316 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' D' D ' 119' ' ' ASN . . . . . . . . . . . . . 3.2 m-20 -97.78 31.04 2.75 Favored 'General case' 0 C--N 1.329 -0.317 0 N-CA-C 112.143 0.423 . . . . 0.0 112.143 -174.838 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' D' D ' 120' ' ' LEU . . . . . . . . . . . . . 20.3 tp -56.48 122.61 12.35 Favored 'General case' 0 C--O 1.233 0.197 0 CA-C-O 120.587 0.232 . . . . 0.0 110.407 178.01 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' D' D ' 121' ' ' ASN . . . . . . . . . . . . . 53.4 m-20 -114.11 -44.13 3.17 Favored 'General case' 0 C--N 1.332 -0.18 0 CA-C-N 116.707 -0.224 . . . . 0.0 111.394 -176.325 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' D' D ' 122' ' ' LYS . . . . . . . . . . . . . 26.1 ttmt -149.97 147.52 27.97 Favored 'General case' 0 C--N 1.332 -0.177 0 C-N-CA 120.417 -0.513 . . . . 0.0 111.563 -176.312 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' D' D ' 123' ' ' VAL . . . . . . . . . . . . . 43.9 t -126.73 134.35 66.45 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.181 0 CA-C-N 116.038 -0.528 . . . . 0.0 109.731 177.742 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' D' D ' 124' ' ' LEU . . . . . . . . . . . . . 65.7 mt -130.08 142.7 50.58 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-O 120.809 0.338 . . . . 0.0 110.986 -178.275 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' D' D ' 125' ' ' VAL . . . . . . . . . . . . . 35.1 m -132.79 140.25 47.84 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.243 0 CA-C-N 116.26 -0.427 . . . . 0.0 110.569 178.416 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' D' D ' 126' ' ' ARG . . . . . . . . . . . . . 95.3 mtt-85 -144.26 119.09 9.89 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.443 -0.344 . . . . 0.0 110.617 178.74 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' D' D ' 127' ' ' ASN . . . . . . . . . . . . . 84.9 m-20 51.36 -104.98 0.19 Allowed 'General case' 0 CA--C 1.543 0.697 0 CA-C-O 119.095 -0.479 . . . . 0.0 111.334 179.707 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' D' D ' 128' ' ' ASP . . . . . . . . . . . . . 18.9 p-10 -114.19 1.35 14.51 Favored 'General case' 0 N--CA 1.468 0.442 0 CA-C-N 119.548 1.067 . . . . 0.0 113.371 -177.794 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' D' D ' 129' ' ' LEU . . . . . . . . . . . . . 58.8 mt -104.96 144.84 31.24 Favored 'General case' 0 C--N 1.334 -0.108 0 O-C-N 121.961 -0.462 . . . . 0.0 110.246 179.881 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' D' D ' 130' ' ' VAL . . . . . . . . . . . . . 42.4 t -124.48 139.56 50.38 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.214 0 CA-C-N 116.375 -0.375 . . . . 0.0 110.009 -178.107 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' D' D ' 131' ' ' VAL . . . . . . . . . . . . . 42.6 t -134.55 135.37 53.8 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.24 0 CA-C-O 121.065 0.459 . . . . 0.0 110.271 179.275 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' D' D ' 132' ' ' ILE . . . . . . . . . . . . . 73.2 mt -118.47 130.82 72.77 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.282 0 CA-C-N 115.657 -0.701 . . . . 0.0 109.354 179.068 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' D' D ' 133' ' ' ILE . . . . . . . . . . . . . 43.1 mm -115.83 121.95 68.45 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.249 0 CA-C-O 120.975 0.417 . . . . 0.0 110.912 -175.992 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' D' D ' 134' ' ' ASP . . . . . . . . . . . . . 7.2 p-10 -133.43 146.08 50.86 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 115.826 -0.625 . . . . 0.0 109.507 174.615 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' D' D ' 135' ' ' GLU . . . . . . . . . . . . . 85.9 tt0 -49.8 -23.02 1.64 Allowed 'General case' 0 C--N 1.328 -0.36 0 N-CA-C 113.022 0.749 . . . . 0.0 113.022 -171.573 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' D' D ' 136' ' ' GLN . . . . . . . . . . . . . 50.2 tt0 -100.18 -31.57 11.33 Favored 'General case' 0 N--CA 1.462 0.175 0 N-CA-C 112.342 0.497 . . . . 0.0 112.342 -176.07 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' D' D ' 137' ' ' LYS . . . . . . . . . . . . . 88.4 mttt -140.45 153.11 46.16 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-O 121.288 0.566 . . . . 0.0 111.644 -171.057 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' D' D ' 138' ' ' LEU . . . . . . . . . . . . . 5.5 tt -116.87 120.52 38.72 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 115.488 -0.778 . . . . 0.0 109.017 171.733 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' D' D ' 139' ' ' THR . . . . . . . . . . . . . 30.5 m -108.38 128.11 54.48 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 116.322 -0.399 . . . . 0.0 110.744 -176.451 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' D' D ' 140' ' ' LEU . . . . . . . . . . . . . 14.0 tp -117.54 122.6 44.1 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 115.619 -0.719 . . . . 0.0 109.354 -178.811 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' D' D ' 141' ' ' ILE . . . . . . . . . . . . . 19.1 mt -120.92 119.64 60.02 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.274 0 N-CA-C 109.964 -0.384 . . . . 0.0 109.964 -175.404 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' D' D ' 142' ' ' ARG . . . . . . . . . . . . . 74.3 mtm180 -106.93 131.31 54.15 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 115.782 -0.645 . . . . 0.0 110.481 -178.318 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' D' D ' 143' ' ' THR . . . . . . . . . . . . . 44.6 p . . . . . 0 C--O 1.22 -0.466 0 CA-C-O 117.984 -1.008 . . . . 0.0 110.591 179.798 . . . . . . . . 0 0 . 1 . 007 nuclear orig full ' E' E ' -3' ' ' GLU . . . . . . . . . . . . . 96.0 mt-10 . . . . . 0 N--CA 1.49 1.529 0 N-CA-C 109.464 -0.569 . . . . 0.0 109.464 . . . . . . . . . 0 0 . 1 . 007 nuclear orig full ' E' E ' -2' ' ' GLY . . . . . . . . . . . . . . . -69.58 102.29 0.94 Allowed Glycine 0 CA--C 1.524 0.649 0 N-CA-C 111.182 -0.767 . . . . 0.0 111.182 -179.337 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' E' E ' -1' ' ' VAL . . . . . . . . . . . . . 44.1 t -141.91 142.35 28.22 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.262 0 N-CA-C 109.908 -0.404 . . . . 0.0 109.908 179.198 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' E' E ' 0' ' ' ILE . . . . . . . . . . . . . 70.4 mt -88.39 142.54 12.77 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.236 0 CA-C-N 116.31 -0.405 . . . . 0.0 110.265 -178.572 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' E' E ' 1' ' ' MET . . . . . . . . . . . . . 24.8 ptp -82.4 153.27 25.8 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.077 -0.511 . . . . 0.0 110.639 179.89 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' E' E ' 2' ' ' SER . . . . . . . . . . . . . 98.5 p -124.57 152.56 43.36 Favored 'General case' 0 C--O 1.232 0.155 0 CA-C-N 116.227 -0.442 . . . . 0.0 110.664 -179.516 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' E' E ' 3' ' ' GLU . . . . . . . . . . . . . 85.0 tt0 -140.33 144.73 36.48 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.107 -0.497 . . . . 0.0 111.109 -178.025 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' E' E ' 4' ' ' LEU . . . . . . . . . . . . . 16.3 tp -127.56 134.59 49.72 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 115.852 -0.613 . . . . 0.0 110.131 177.426 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' E' E ' 5' ' ' LYS . . . . . . . . . . . . . 68.9 mttm -115.23 122.67 46.7 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.635 -0.257 . . . . 0.0 110.997 -178.808 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' E' E ' 6' ' ' LEU . . . . . . . . . . . . . 58.5 mt -114.34 142.52 46.21 Favored 'General case' 0 N--CA 1.462 0.163 0 CA-C-N 115.564 -0.744 . . . . 0.0 110.095 178.601 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' E' E ' 7' ' ' LYS . . . . . . . . . . . . . 79.3 tttt -122.49 136.19 26.33 Favored Pre-proline 0 CA--C 1.534 0.348 0 CA-C-O 118.775 -0.631 . . . . 0.0 109.781 176.634 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' E' E ' 8' ' ' PRO . . . . . . . . . . . . . 89.4 Cg_endo -91.36 131.49 1.38 Allowed 'Trans proline' 0 N--CA 1.49 1.279 0 C-N-CA 121.741 1.627 . . . . 0.0 111.705 178.089 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' E' E ' 9' ' ' LEU . . . . . . . . . . . . . 59.4 mt -72.01 -47.86 11.11 Favored Pre-proline 0 CA--C 1.534 0.335 0 CA-C-O 118.563 -0.732 . . . . 0.0 112.286 -178.642 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' E' E ' 10' ' ' PRO . . . . . . . . . . . . . 95.1 Cg_endo -79.61 152.37 22.81 Favored 'Trans proline' 0 N--CA 1.497 1.713 0 C-N-CA 121.166 1.244 . . . . 0.0 111.916 177.145 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' E' E ' 11' ' ' LYS . . . . . . . . . . . . . 97.7 mttt -83.86 91.92 7.67 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.366 -0.379 . . . . 0.0 110.262 178.34 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' E' E ' 12' ' ' VAL . . . . . . . . . . . . . 12.2 p -139.0 145.15 28.05 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.257 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.476 -178.931 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' E' E ' 13' ' ' GLU . . . . . . . . . . . . . 44.6 mp0 -91.6 125.93 36.51 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.235 -0.439 . . . . 0.0 110.179 178.671 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' E' E ' 14' ' ' LEU . . . . . . . . . . . . . 20.8 mt -97.93 149.99 36.29 Favored Pre-proline 0 CA--C 1.532 0.287 0 CA-C-O 119.331 -0.366 . . . . 0.0 110.562 -178.843 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' E' E ' 15' ' ' PRO . . . . . . . . . . . . . 27.4 Cg_exo -61.02 158.74 32.76 Favored 'Trans proline' 0 N--CA 1.496 1.675 0 C-N-CA 121.317 1.345 . . . . 0.0 111.943 177.979 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' E' E ' 16' ' ' PRO . . . . . . . . . . . . . 29.8 Cg_exo -59.68 -34.85 96.15 Favored 'Trans proline' 0 N--CA 1.496 1.675 0 C-N-CA 121.403 1.402 . . . . 0.0 112.76 -178.938 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' E' E ' 17' ' ' ASP . . . . . . . . . . . . . 8.3 p-10 -85.03 4.73 32.49 Favored 'General case' 0 C--N 1.327 -0.401 0 N-CA-C 113.322 0.86 . . . . 0.0 113.322 -177.497 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' E' E ' 18' ' ' PHE . . . . . . . . . . . . . 44.0 t80 -57.95 -44.85 87.24 Favored 'General case' 0 N--CA 1.457 -0.091 0 O-C-N 121.836 -0.54 . . . . 0.0 110.187 -178.315 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' E' E ' 19' ' ' VAL . . . . . . . . . . . . . 46.6 t -56.78 -44.99 82.88 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 CA-C-N 116.152 -0.476 . . . . 0.0 110.544 -178.304 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' E' E ' 20' ' ' ASP . . . . . . . . . . . . . 80.1 m-20 -59.54 -41.9 91.12 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-O 120.772 0.32 . . . . 0.0 110.808 -177.233 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' E' E ' 21' ' ' VAL . . . . . . . . . . . . . 46.9 t -64.55 -46.79 91.6 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.284 0 C-N-CA 120.809 -0.356 . . . . 0.0 110.621 -177.801 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' E' E ' 22' ' ' ILE . . . . . . . . . . . . . 51.4 mm -57.26 -39.98 70.97 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.217 0 C-N-CA 120.902 -0.319 . . . . 0.0 110.774 -179.562 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' E' E ' 23' ' ' ARG . . . . . . . . . . . . . 34.2 ttp180 -56.91 -50.28 73.02 Favored 'General case' 0 N--CA 1.464 0.255 0 CA-C-O 121.08 0.466 . . . . 0.0 110.443 177.326 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' E' E ' 24' ' ' ILE . . . . . . . . . . . . . 70.6 mt -61.16 -38.65 80.17 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.327 0 CA-C-N 115.807 -0.633 . . . . 0.0 112.072 -176.739 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' E' E ' 25' ' ' LYS . . . . . . . . . . . . . 14.7 pttp -78.34 -36.42 46.29 Favored 'General case' 0 CA--C 1.534 0.348 0 C-N-CA 120.606 -0.437 . . . . 0.0 112.007 -174.049 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' E' E ' 26' ' ' LEU . . . . . . . . . . . . . 47.6 mt -79.74 -35.06 39.38 Favored 'General case' 0 C--N 1.33 -0.266 0 N-CA-C 113.046 0.758 . . . . 0.0 113.046 -173.022 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' E' E ' 27' ' ' GLN . . . . . . . . . . . . . 9.6 pt20 -46.82 139.75 5.18 Favored 'General case' 0 N--CA 1.468 0.465 0 N-CA-C 112.906 0.706 . . . . 0.0 112.906 -175.49 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' E' E ' 28' ' ' GLY . . . . . . . . . . . . . . . 100.54 -25.94 26.44 Favored Glycine 0 CA--C 1.533 1.166 0 CA-C-N 115.511 -0.768 . . . . 0.0 112.304 -177.991 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' E' E ' 29' ' ' LYS . . . . . . . . . . . . . 98.9 mttt -98.3 155.12 17.36 Favored 'General case' 0 C--N 1.332 -0.167 0 CA-C-N 117.423 0.611 . . . . 0.0 111.175 179.439 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' E' E ' 30' ' ' THR . . . . . . . . . . . . . 31.2 m -102.72 137.14 41.33 Favored 'General case' 0 C--N 1.331 -0.199 0 CA-C-N 116.105 -0.498 . . . . 0.0 110.204 177.069 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' E' E ' 31' ' ' VAL . . . . . . . . . . . . . 34.9 m -128.98 154.27 39.74 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.26 0 CA-C-N 116.444 -0.344 . . . . 0.0 110.816 -179.226 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' E' E ' 32' ' ' ARG . . . . . . . . . . . . . 94.8 mtt180 -131.67 149.08 52.61 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-O 121.179 0.514 . . . . 0.0 110.611 178.332 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' E' E ' 33' ' ' THR . . . . . . . . . . . . . 22.3 m -53.44 139.74 29.84 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.22 -0.446 . . . . 0.0 111.357 -179.382 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' E' E ' 34' ' ' GLY . . . . . . . . . . . . . . . 99.69 -17.12 57.94 Favored Glycine 0 CA--C 1.532 1.126 0 CA-C-O 119.62 -0.545 . . . . 0.0 113.263 179.36 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' E' E ' 35' ' ' ASP . . . . . . . . . . . . . 78.3 m-20 -66.67 148.5 51.82 Favored 'General case' 0 C--N 1.333 -0.152 0 CA-C-N 118.041 0.921 . . . . 0.0 111.078 178.934 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' E' E ' 36' ' ' VAL . . . . . . . . . . . . . 44.3 t -120.97 129.91 75.21 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.262 0 CA-C-N 115.933 -0.576 . . . . 0.0 109.785 178.236 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' E' E ' 37' ' ' ILE . . . . . . . . . . . . . 63.8 mt -119.79 136.96 55.23 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.257 0 N-CA-C 109.751 -0.463 . . . . 0.0 109.751 -179.636 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' E' E ' 38' ' ' GLY . . . . . . . . . . . . . . . -114.97 128.72 8.25 Favored Glycine 0 CA--C 1.524 0.644 0 N-CA-C 111.006 -0.838 . . . . 0.0 111.006 -179.77 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' E' E ' 39' ' ' ILE . . . . . . . . . . . . . 72.5 mt -126.47 127.67 70.63 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.232 0 N-CA-C 110.143 -0.317 . . . . 0.0 110.143 179.142 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' E' E ' 40' ' ' SER . . . . . . . . . . . . . 7.4 m -92.7 119.35 32.01 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.295 -0.411 . . . . 0.0 110.595 175.423 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' E' E ' 41' ' ' ILE . . . . . . . . . . . . . 69.3 mt -129.73 126.57 62.98 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.175 0 CA-C-O 120.951 0.405 . . . . 0.0 110.49 179.769 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' E' E ' 42' ' ' LEU . . . . . . . . . . . . . 30.7 mt 54.1 33.8 18.57 Favored 'General case' 0 C--N 1.331 -0.223 0 CA-C-N 116.033 -0.53 . . . . 0.0 111.781 177.395 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' E' E ' 43' ' ' GLY . . . . . . . . . . . . . . . 72.36 29.54 66.04 Favored Glycine 0 CA--C 1.529 0.936 0 C-N-CA 121.127 -0.559 . . . . 0.0 112.296 177.811 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' E' E ' 44' ' ' LYS . . . . . . . . . . . . . 83.6 tttt -139.43 126.92 21.61 Favored 'General case' 0 C--N 1.331 -0.225 0 N-CA-C 109.637 -0.505 . . . . 0.0 109.637 178.217 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' E' E ' 45' ' ' GLU . . . . . . . . . . . . . 47.1 tt0 -85.65 126.59 34.05 Favored 'General case' 0 C--N 1.327 -0.397 0 CA-C-N 116.229 -0.441 . . . . 0.0 111.539 -175.483 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' E' E ' 46' ' ' VAL . . . . . . . . . . . . . 9.9 p -123.21 126.08 72.9 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.198 0 N-CA-C 109.966 -0.383 . . . . 0.0 109.966 174.457 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' E' E ' 47' ' ' LYS . . . . . . . . . . . . . 33.8 mmtp -99.48 127.44 45.54 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 115.967 -0.561 . . . . 0.0 110.877 176.223 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' E' E ' 48' ' ' PHE . . . . . . . . . . . . . 34.6 m-85 -109.78 131.7 54.82 Favored 'General case' 0 C--N 1.329 -0.289 0 N-CA-C 109.444 -0.576 . . . . 0.0 109.444 175.506 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' E' E ' 49' ' ' LYS . . . . . . . . . . . . . 46.2 tttp -107.67 132.12 53.67 Favored 'General case' 0 C--N 1.327 -0.38 0 N-CA-C 110.08 -0.341 . . . . 0.0 110.08 178.081 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' E' E ' 50' ' ' VAL . . . . . . . . . . . . . 46.7 t -76.58 104.42 4.61 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.268 0 N-CA-C 109.188 -0.671 . . . . 0.0 109.188 177.022 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' E' E ' 51' ' ' VAL . . . . . . . . . . . . . 48.3 t -69.74 -52.94 27.02 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.363 0 N-CA-C 109.609 -0.515 . . . . 0.0 109.609 -174.959 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' E' E ' 52' ' ' GLN . . . . . . . . . . . . . 91.1 mt-30 -153.64 153.69 32.79 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-O 121.253 0.549 . . . . 0.0 111.783 -178.08 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' E' E ' 53' ' ' ALA . . . . . . . . . . . . . . . -130.57 132.69 45.68 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 115.02 -0.991 . . . . 0.0 109.621 174.978 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' E' E ' 54' ' ' TYR . . . . . . . . . . . . . 40.4 t80 -129.0 107.65 18.1 Favored Pre-proline 0 CA--C 1.535 0.397 0 CA-C-O 118.138 -0.934 . . . . 0.0 110.36 179.893 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' E' E ' 55' ' ' PRO . . . . . . . . . . . . . 72.8 Cg_endo -77.17 168.07 77.94 Favored 'Cis proline' 0 N--CA 1.5 1.891 0 CA-C-N 121.783 1.672 . . . . 0.0 112.713 -5.278 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' E' E ' 56' ' ' SER . . . . . . . . . . . . . 68.4 m -118.2 132.89 23.54 Favored Pre-proline 0 CA--C 1.539 0.553 0 CA-C-O 118.377 -0.821 . . . . 0.0 109.463 173.77 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' E' E ' 57' ' ' PRO . . . . . . . . . . . . . 34.4 Cg_endo -66.19 163.97 66.91 Favored 'Cis proline' 0 N--CA 1.496 1.675 0 CA-C-N 121.95 1.732 . . . . 0.0 111.66 -1.788 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' E' E ' 58' ' ' LEU . . . . . . . . . . . . . 33.5 tp -130.07 136.83 49.79 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.104 -0.498 . . . . 0.0 110.281 -179.537 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' E' E ' 59' ' ' ARG . . . . . . . . . . . . . 41.8 ttm180 -102.72 123.58 46.67 Favored 'General case' 0 C--N 1.327 -0.403 0 CA-C-N 115.791 -0.64 . . . . 0.0 109.31 176.349 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' E' E ' 60' ' ' VAL . . . . . . . . . . . . . 45.8 t -71.99 116.97 14.7 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.294 0 C-N-CA 120.803 -0.359 . . . . 0.0 110.331 -174.584 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' E' E ' 61' ' ' GLU . . . . . . . . . . . . . 95.7 mt-10 -131.05 159.5 37.36 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 115.816 -0.629 . . . . 0.0 109.761 176.475 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' E' E ' 62' ' ' ASP . . . . . . . . . . . . . 13.8 t70 -52.48 -31.94 37.57 Favored 'General case' 0 C--N 1.328 -0.357 0 N-CA-C 111.953 0.353 . . . . 0.0 111.953 -179.209 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' E' E ' 63' ' ' ARG . . . . . . . . . . . . . 37.3 mtp180 -72.22 -21.89 61.34 Favored 'General case' 0 C--N 1.33 -0.281 0 N-CA-C 112.954 0.724 . . . . 0.0 112.954 -175.935 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' E' E ' 64' ' ' THR . . . . . . . . . . . . . 28.4 m -69.33 136.77 52.25 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-O 120.93 0.395 . . . . 0.0 110.865 -175.988 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' E' E ' 65' ' ' LYS . . . . . . . . . . . . . 92.1 mttt -89.31 127.91 35.83 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-N 115.97 -0.559 . . . . 0.0 109.917 177.987 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' E' E ' 66' ' ' ILE . . . . . . . . . . . . . 64.4 mt -114.49 129.33 70.73 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 N-CA-C 110.008 -0.368 . . . . 0.0 110.008 -179.705 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' E' E ' 67' ' ' THR . . . . . . . . . . . . . 30.2 m -122.74 142.27 50.89 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-O 121.16 0.505 . . . . 0.0 111.11 -177.644 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' E' E ' 68' ' ' LEU . . . . . . . . . . . . . 17.6 tp -101.56 125.84 48.28 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 115.563 -0.744 . . . . 0.0 109.898 177.491 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' E' E ' 69' ' ' VAL . . . . . . . . . . . . . 43.3 t -101.38 127.98 54.16 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.298 0 CA-C-N 116.333 -0.394 . . . . 0.0 110.174 -179.445 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' E' E ' 70' ' ' THR . . . . . . . . . . . . . 21.6 p -101.7 -52.26 3.24 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.137 -0.483 . . . . 0.0 110.602 179.689 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' E' E ' 71' ' ' HIS . . . . . . . . . . . . . 66.2 m80 -91.09 164.93 23.27 Favored Pre-proline 0 C--N 1.33 -0.257 0 CA-C-N 116.25 -0.432 . . . . 0.0 110.712 -179.471 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' E' E ' 72' ' ' PRO . . . . . . . . . . . . . 16.9 Cg_exo -64.91 -21.81 63.65 Favored 'Trans proline' 0 N--CA 1.497 1.696 0 C-N-CA 121.521 1.481 . . . . 0.0 113.081 -179.012 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' E' E ' 73' ' ' VAL . . . . . . . . . . . . . 27.0 m -99.89 163.63 2.82 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.222 0 CA-C-O 120.893 0.378 . . . . 0.0 110.752 -179.162 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' E' E ' 74' ' ' ASP . . . . . . . . . . . . . 28.2 t0 -98.77 119.6 37.78 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.028 -0.533 . . . . 0.0 110.023 -178.762 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' E' E ' 75' ' ' VAL . . . . . . . . . . . . . 42.7 t -112.64 123.43 68.32 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.256 0 CA-C-O 120.987 0.422 . . . . 0.0 110.427 -178.263 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' E' E ' 76' ' ' LEU . . . . . . . . . . . . . 27.0 mt -125.02 142.64 51.36 Favored 'General case' 0 C--N 1.331 -0.239 0 CA-C-N 115.842 -0.617 . . . . 0.0 109.772 177.492 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' E' E ' 77' ' ' GLU . . . . . . . . . . . . . 97.6 mt-10 -135.22 131.24 36.42 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-O 121.005 0.431 . . . . 0.0 111.123 -177.747 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' E' E ' 78' ' ' ALA . . . . . . . . . . . . . . . -118.06 135.86 53.92 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 115.814 -0.63 . . . . 0.0 109.67 176.588 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' E' E ' 79' ' ' LYS . . . . . . . . . . . . . 90.0 mttt -79.65 118.46 21.5 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-O 121.003 0.43 . . . . 0.0 110.677 -178.864 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' E' E ' 80' ' ' ILE . . . . . . . . . . . . . 41.1 mm -139.12 114.09 8.15 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.376 0 N-CA-C 108.944 -0.761 . . . . 0.0 108.944 -178.502 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' E' E ' 81' ' ' LYS . . . . . . . . . . . . . 56.2 pttt -111.06 129.46 55.91 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-O 121.009 0.433 . . . . 0.0 111.628 -174.253 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' E' E ' 82' ' ' GLY . . . . . . . . . . . . . . . 89.13 42.04 5.7 Favored Glycine 0 CA--C 1.526 0.728 0 N-CA-C 111.524 -0.63 . . . . 0.0 111.524 175.974 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' E' E ' 83' ' ' ILE . . . . . 0.413 HG23 HD12 ' E' ' 83' ' ' ILE . 69.1 mt -74.23 138.62 20.76 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.342 0 N-CA-C 109.833 -0.432 . . . . 0.0 109.833 178.145 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' E' E ' 84' ' ' LYS . . . . . . . . . . . . . 39.4 ttpt -102.49 -47.4 4.47 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.302 -0.408 . . . . 0.0 110.163 -179.756 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' E' E ' 85' ' ' ASP . . . . . . . . . . . . . 45.5 t0 -148.91 147.06 28.21 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 115.987 -0.551 . . . . 0.0 110.608 179.876 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' E' E ' 86' ' ' VAL . . . . . . . . . . . . . 42.4 t -127.84 131.46 69.73 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.266 0 CA-C-O 120.902 0.382 . . . . 0.0 110.404 -179.208 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' E' E ' 87' ' ' ILE . . . . . . . . . . . . . 46.7 mm -121.4 125.12 73.26 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.271 0 CA-C-N 115.955 -0.566 . . . . 0.0 109.686 176.772 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' E' E ' 88' ' ' LEU . . . . . . . . . . . . . 18.3 tp -114.26 130.49 56.65 Favored 'General case' 0 C--N 1.332 -0.163 0 CA-C-O 120.924 0.392 . . . . 0.0 111.074 -177.445 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' E' E ' 89' ' ' ASP . . . . . . . . . . . . . 13.0 t70 -127.33 154.79 44.52 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 115.957 -0.565 . . . . 0.0 109.896 177.16 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' E' E ' 90' ' ' GLU . . . . . . . . . . . . . 96.8 mt-10 -48.1 -36.93 14.15 Favored 'General case' 0 C--N 1.329 -0.313 0 N-CA-C 112.923 0.712 . . . . 0.0 112.923 -172.722 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' E' E ' 91' ' ' ASN . . . . . . . . . . . . . 87.6 m-20 -132.0 33.76 3.89 Favored 'General case' 0 N--CA 1.465 0.31 0 N-CA-C 111.939 0.348 . . . . 0.0 111.939 -175.942 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' E' E ' 92' ' ' LEU . . . . . . . . . . . . . 17.3 tp -166.12 141.66 4.77 Favored 'General case' 0 C--N 1.329 -0.308 0 C-N-CA 121.027 -0.269 . . . . 0.0 110.719 179.46 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' E' E ' 93' ' ' ILE . . . . . . . . . . . . . 72.8 mt -121.86 120.42 61.48 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.27 0 N-CA-C 109.138 -0.69 . . . . 0.0 109.138 178.017 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' E' E ' 94' ' ' VAL . . . . . . . . . . . . . 47.1 t -121.4 125.74 74.03 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.261 0 CA-C-O 121.052 0.453 . . . . 0.0 109.986 -177.763 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' E' E ' 95' ' ' VAL . . . . . . . . . . . . . 43.0 t -121.27 132.81 69.7 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.245 0 CA-C-N 115.873 -0.603 . . . . 0.0 109.847 -179.257 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' E' E ' 96' ' ' ILE . . . . . . . . . . . . . 66.7 mt -115.48 124.19 71.72 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.273 0 N-CA-C 109.147 -0.686 . . . . 0.0 109.147 178.395 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' E' E ' 97' ' ' THR . . . . . . . . . . . . . 77.1 p -99.9 155.02 17.9 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-O 121.523 0.678 . . . . 0.0 111.595 -174.657 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' E' E ' 98' ' ' GLU . . . . . . . . . . . . . 84.7 tt0 -54.03 -26.72 27.87 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 115.548 -0.751 . . . . 0.0 112.141 179.726 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' E' E ' 99' ' ' GLU . . . . . . . . . . . . . 96.3 mt-10 -79.76 16.72 1.06 Allowed 'General case' 0 CA--C 1.537 0.454 0 N-CA-C 113.126 0.788 . . . . 0.0 113.126 -177.369 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' E' E ' 100' ' ' ASN . . . . . . . . . . . . . 4.2 m-20 62.81 37.38 12.39 Favored 'General case' 0 CA--C 1.53 0.198 0 CA-C-O 121.073 0.463 . . . . 0.0 111.048 178.168 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' E' E ' 101' ' ' GLU . . . . . . . . . . . . . 84.7 tt0 -116.46 143.98 44.89 Favored 'General case' 0 C--N 1.333 -0.139 0 CA-C-N 116.159 -0.473 . . . . 0.0 109.909 176.939 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' E' E ' 102' ' ' VAL . . . . . . . . . . . . . 46.4 t -115.0 125.68 72.38 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.27 0 N-CA-C 109.803 -0.443 . . . . 0.0 109.803 -179.468 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' E' E ' 103' ' ' LEU . . . . . . . . . . . . . 27.7 mt -118.94 128.69 54.65 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-N 115.732 -0.667 . . . . 0.0 110.251 177.783 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' E' E ' 104' ' ' ILE . . . . . . . . . . . . . 66.4 mt -117.66 122.67 70.36 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.2 0 N-CA-C 110.028 -0.36 . . . . 0.0 110.028 179.787 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' E' E ' 105' ' ' PHE . . . . . . . . . . . . . 91.6 m-85 -122.75 166.08 15.53 Favored 'General case' 0 N--CA 1.462 0.129 0 O-C-N 123.999 0.812 . . . . 0.0 110.131 -179.464 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' E' E ' 106' ' ' ASN . . . . . . . . . . . . . 48.7 p-10 -102.94 -172.59 2.14 Favored 'General case' 0 C--N 1.331 -0.196 0 N-CA-C 109.888 -0.412 . . . . 0.0 109.888 172.378 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' E' E ' 107' ' ' GLN . . . . . . . . . . . . . 53.3 tp60 -59.16 -27.9 66.1 Favored 'General case' 0 C--N 1.329 -0.294 0 N-CA-C 112.239 0.459 . . . . 0.0 112.239 -178.586 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' E' E ' 108' ' ' ASN . . . . . . . . . . . . . 8.4 t-20 -88.24 14.06 10.17 Favored 'General case' 0 CA--C 1.533 0.306 0 N-CA-C 112.92 0.711 . . . . 0.0 112.92 -176.918 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' E' E ' 109' ' ' LEU . . . . . . . . . . . . . 41.4 mt 57.99 34.53 24.36 Favored 'General case' 0 CA--C 1.531 0.224 0 CA-C-O 120.718 0.294 . . . . 0.0 111.643 178.514 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' E' E ' 110' ' ' GLU . . . . . . . . . . . . . 43.5 mt-10 -101.49 154.51 18.76 Favored 'General case' 0 C--N 1.33 -0.272 0 N-CA-C 109.28 -0.637 . . . . 0.0 109.28 174.968 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' E' E ' 111' ' ' GLU . . . . . . . . . . . . . 41.6 tt0 -90.96 121.83 33.12 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-O 121.048 0.451 . . . . 0.0 110.987 -175.444 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' E' E ' 112' ' ' LEU . . . . . . . . . . . . . 90.4 mt -101.23 -46.15 5.13 Favored 'General case' 0 C--N 1.332 -0.195 0 CA-C-N 115.803 -0.635 . . . . 0.0 110.388 178.675 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' E' E ' 113' ' ' TYR . . . . . . . . . . . . . 59.8 t80 -139.17 136.56 35.2 Favored 'General case' 0 C--N 1.331 -0.211 0 CA-C-N 116.174 -0.467 . . . . 0.0 111.355 -177.475 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' E' E ' 114' ' ' ARG . . . . . . . . . . . . . 57.3 ttp180 -135.05 120.15 18.75 Favored 'General case' 0 C--N 1.331 -0.22 0 CA-C-N 115.943 -0.572 . . . . 0.0 110.107 177.239 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' E' E ' 115' ' ' GLY . . . . . . . . . . . . . . . -150.07 149.39 21.29 Favored Glycine 0 CA--C 1.524 0.617 0 N-CA-C 111.073 -0.811 . . . . 0.0 111.073 178.281 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' E' E ' 116' ' ' LYS . . . . . . . . . . . . . 34.3 ttmt -125.8 136.45 53.13 Favored 'General case' 0 C--N 1.33 -0.266 0 N-CA-C 109.977 -0.379 . . . . 0.0 109.977 176.042 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' E' E ' 117' ' ' PHE . . . . . . . . . . . . . 40.1 m-85 -129.65 115.97 18.14 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.167 -0.47 . . . . 0.0 110.136 -176.584 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' E' E ' 118' ' ' GLU . . . . . . . . . . . . . 85.4 tt0 -53.7 -46.18 70.63 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.493 -0.322 . . . . 0.0 111.451 -177.133 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' E' E ' 119' ' ' ASN . . . . . . . . . . . . . 86.7 m-20 -96.99 31.07 2.49 Favored 'General case' 0 C--N 1.331 -0.2 0 N-CA-C 112.11 0.411 . . . . 0.0 112.11 -175.8 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' E' E ' 120' ' ' LEU . . . . . . . . . . . . . 10.4 tp -56.12 121.06 8.55 Favored 'General case' 0 C--N 1.332 -0.161 0 O-C-N 122.313 -0.242 . . . . 0.0 110.449 178.343 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' E' E ' 121' ' ' ASN . . . . . . . . . . . . . 31.1 m120 -113.82 -44.07 3.21 Favored 'General case' 0 C--N 1.331 -0.217 0 CA-C-N 116.734 -0.212 . . . . 0.0 111.245 -175.765 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' E' E ' 122' ' ' LYS . . . . . . . . . . . . . 97.9 mttt -146.5 147.3 31.04 Favored 'General case' 0 C--N 1.332 -0.194 0 C-N-CA 120.488 -0.485 . . . . 0.0 111.389 -177.705 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' E' E ' 123' ' ' VAL . . . . . . . . . . . . . 44.6 t -130.61 129.11 64.11 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.252 0 CA-C-N 115.982 -0.554 . . . . 0.0 109.678 176.759 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' E' E ' 124' ' ' LEU . . . . . . . . . . . . . 6.5 mp -126.49 131.06 51.71 Favored 'General case' 0 C--N 1.331 -0.205 0 N-CA-C 109.999 -0.371 . . . . 0.0 109.999 -179.513 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' E' E ' 125' ' ' VAL . . . . . . . . . . . . . 33.7 m -139.7 137.02 39.8 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.342 0 CA-C-O 120.766 0.317 . . . . 0.0 110.792 -179.071 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' E' E ' 126' ' ' ARG . . . . . . . . . . . . . 74.5 ttt-85 -143.91 127.73 17.28 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.708 -179.683 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' E' E ' 127' ' ' ASN . . . . . . . . . . . . . 4.6 m120 51.24 -106.62 0.26 Allowed 'General case' 0 CA--C 1.544 0.713 0 CA-C-O 118.982 -0.532 . . . . 0.0 111.594 179.064 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' E' E ' 128' ' ' ASP . . . . . . . . . . . . . 23.7 p-10 -114.16 1.86 14.69 Favored 'General case' 0 CA--C 1.536 0.406 0 CA-C-N 119.675 1.125 . . . . 0.0 113.582 -175.854 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' E' E ' 129' ' ' LEU . . . . . . . . . . . . . 13.5 tp -112.79 136.43 52.41 Favored 'General case' 0 C--N 1.333 -0.135 0 N-CA-C 109.771 -0.455 . . . . 0.0 109.771 179.605 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' E' E ' 130' ' ' VAL . . . . . . . . . . . . . 32.4 m -132.74 142.89 41.22 Favored 'Isoleucine or valine' 0 C--O 1.233 0.198 0 CA-C-O 121.115 0.484 . . . . 0.0 110.976 -179.18 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' E' E ' 131' ' ' VAL . . . . . . . . . . . . . 41.4 t -136.12 138.63 46.98 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.338 0 CA-C-N 115.986 -0.552 . . . . 0.0 109.981 178.37 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' E' E ' 132' ' ' ILE . . . . . . . . . . . . . 74.1 mt -113.57 133.75 58.52 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.312 0 CA-C-N 115.665 -0.698 . . . . 0.0 109.508 -179.568 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' E' E ' 133' ' ' ILE . . . . . . . . . . . . . 42.6 mm -116.04 122.62 69.99 Favored 'Isoleucine or valine' 0 C--O 1.233 0.225 0 CA-C-O 120.991 0.424 . . . . 0.0 110.928 -176.18 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' E' E ' 134' ' ' ASP . . . . . . . . . . . . . 10.5 p-10 -134.86 147.59 49.92 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 115.84 -0.618 . . . . 0.0 109.537 174.625 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' E' E ' 135' ' ' GLU . . . . . . . . . . . . . 84.6 tt0 -49.76 -26.64 4.04 Favored 'General case' 0 C--N 1.325 -0.463 0 N-CA-C 112.811 0.671 . . . . 0.0 112.811 -171.627 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' E' E ' 136' ' ' GLN . . . . . . . . . . . . . 96.8 mt-30 -83.6 -37.88 22.34 Favored 'General case' 0 C--O 1.234 0.243 0 N-CA-C 112.332 0.493 . . . . 0.0 112.332 -176.243 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' E' E ' 137' ' ' LYS . . . . . . . . . . . . . 19.5 pttp -159.91 174.09 14.93 Favored 'General case' 0 C--N 1.331 -0.209 0 CA-C-O 121.51 0.671 . . . . 0.0 112.296 -171.834 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' E' E ' 138' ' ' LEU . . . . . . . . . . . . . 8.1 tt -121.91 130.5 53.39 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 114.926 -1.034 . . . . 0.0 109.732 177.599 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' E' E ' 139' ' ' THR . . . . . . . . . . . . . 40.8 m -113.07 125.51 54.46 Favored 'General case' 0 C--N 1.331 -0.23 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.716 -178.558 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' E' E ' 140' ' ' LEU . . . . . . . . . . . . . 8.7 tt -107.65 122.57 46.98 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 115.636 -0.711 . . . . 0.0 109.288 -179.502 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' E' E ' 141' ' ' ILE . . . . . . . . . . . . . 19.2 mt -125.07 118.87 54.25 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.288 0 CA-C-O 121.066 0.46 . . . . 0.0 109.886 -177.692 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' E' E ' 142' ' ' ARG . . . . . . . . . . . . . 77.4 ttt-85 -110.94 119.3 38.62 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 115.474 -0.785 . . . . 0.0 109.822 -179.428 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' E' E ' 143' ' ' THR . . . . . . . . . . . . . 71.4 p . . . . . 0 C--O 1.221 -0.442 0 CA-C-O 117.951 -1.023 . . . . 0.0 110.623 -178.14 . . . . . . . . 0 0 . 1 . 007 nuclear orig full ' F' F ' -3' ' ' GLU . . . . . . . . . . . . . 70.5 mm-40 . . . . . 0 N--CA 1.49 1.531 0 N-CA-C 109.388 -0.597 . . . . 0.0 109.388 . . . . . . . . . 0 0 . 1 . 007 nuclear orig full ' F' F ' -2' ' ' GLY . . . . . . . . . . . . . . . -77.62 130.85 10.58 Favored Glycine 0 CA--C 1.525 0.71 0 N-CA-C 110.875 -0.89 . . . . 0.0 110.875 179.448 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' F' F ' -1' ' ' VAL . . . . . . . . . . . . . 43.0 t -96.61 129.45 46.65 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.34 0 CA-C-O 120.789 0.328 . . . . 0.0 110.335 -179.786 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' F' F ' 0' ' ' ILE . . . . . . . . . . . . . 71.3 mt -124.57 143.01 39.53 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.164 0 CA-C-N 116.302 -0.408 . . . . 0.0 109.931 -179.888 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' F' F ' 1' ' ' MET . . . . . . . . . . . . . 25.3 ptp -91.02 146.28 23.99 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.312 -0.404 . . . . 0.0 110.691 179.826 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' F' F ' 2' ' ' SER . . . . . . . . . . . . . 2.2 p -122.52 125.24 45.35 Favored 'General case' 0 C--N 1.331 -0.227 0 CA-C-O 121.096 0.474 . . . . 0.0 110.564 178.426 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' F' F ' 3' ' ' GLU . . . . . . . . . . . . . 85.1 tt0 -144.49 144.56 31.41 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-N 115.942 -0.572 . . . . 0.0 111.184 -178.973 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' F' F ' 4' ' ' LEU . . . . . . . . . . . . . 12.1 tp -126.11 135.32 51.57 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 115.782 -0.645 . . . . 0.0 110.292 178.092 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' F' F ' 5' ' ' LYS . . . . . . . . . . . . . 98.9 mttt -111.37 121.57 45.59 Favored 'General case' 0 C--O 1.235 0.316 0 CA-C-N 116.345 -0.389 . . . . 0.0 110.505 179.764 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' F' F ' 6' ' ' LEU . . . . . . . . . . . . . 78.7 mt -116.93 147.24 42.4 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 115.735 -0.666 . . . . 0.0 110.538 -178.981 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' F' F ' 7' ' ' LYS . . . . . . . . . . . . . 55.0 tttt -137.45 140.38 30.27 Favored Pre-proline 0 CA--C 1.534 0.328 0 CA-C-O 119.201 -0.428 . . . . 0.0 110.1 177.035 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' F' F ' 8' ' ' PRO . . . . . . . . . . . . . 93.5 Cg_endo -91.55 143.2 2.95 Favored 'Trans proline' 0 N--CA 1.49 1.303 0 C-N-CA 121.764 1.643 . . . . 0.0 111.717 177.781 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' F' F ' 9' ' ' LEU . . . . . . . . . . . . . 41.6 mt -79.81 -47.41 1.45 Allowed Pre-proline 0 CA--C 1.535 0.373 0 CA-C-O 118.686 -0.673 . . . . 0.0 112.42 -178.594 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' F' F ' 10' ' ' PRO . . . . . . . . . . . . . 86.1 Cg_endo -80.67 155.98 21.11 Favored 'Trans proline' 0 N--CA 1.496 1.638 0 C-N-CA 121.243 1.296 . . . . 0.0 111.951 176.252 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' F' F ' 11' ' ' LYS . . . . . . . . . . . . . 53.9 tptt -88.01 99.32 12.07 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.393 -0.367 . . . . 0.0 110.39 179.094 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' F' F ' 12' ' ' VAL . . . . . . . . . . . . . 11.9 p -145.94 143.21 21.51 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.305 0 CA-C-N 116.118 -0.492 . . . . 0.0 110.378 179.03 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' F' F ' 13' ' ' GLU . . . . . . . . . . . . . 43.8 mt-10 -85.91 124.27 32.19 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.373 -0.376 . . . . 0.0 110.219 177.677 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' F' F ' 14' ' ' LEU . . . . . . . . . . . . . 18.7 mt -94.76 152.19 39.59 Favored Pre-proline 0 C--N 1.329 -0.298 0 CA-C-N 116.315 -0.402 . . . . 0.0 110.544 -178.695 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' F' F ' 15' ' ' PRO . . . . . . . . . . . . . 39.7 Cg_exo -58.43 157.31 27.19 Favored 'Trans proline' 0 N--CA 1.498 1.752 0 C-N-CA 121.235 1.29 . . . . 0.0 111.796 179.586 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' F' F ' 16' ' ' PRO . . . . . . . . . . . . . 32.1 Cg_exo -59.5 -37.92 86.21 Favored 'Trans proline' 0 N--CA 1.497 1.729 0 C-N-CA 121.42 1.414 . . . . 0.0 112.672 -178.182 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' F' F ' 17' ' ' ASP . . . . . . . . . . . . . 15.2 p-10 -87.59 11.25 15.48 Favored 'General case' 0 CA--C 1.535 0.387 0 N-CA-C 113.074 0.768 . . . . 0.0 113.074 -178.149 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' F' F ' 18' ' ' PHE . . . . . . . . . . . . . 45.2 t80 -58.28 -43.33 87.92 Favored 'General case' 0 CA--C 1.522 -0.114 0 O-C-N 121.863 -0.523 . . . . 0.0 110.089 -178.524 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' F' F ' 19' ' ' VAL . . . . . . . . . . . . . 46.8 t -55.54 -42.77 69.81 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.323 0 CA-C-N 116.354 -0.384 . . . . 0.0 110.675 -178.583 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' F' F ' 20' ' ' ASP . . . . . . . . . . . . . 81.2 m-20 -60.2 -44.94 94.71 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-O 120.859 0.362 . . . . 0.0 110.857 -177.97 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' F' F ' 21' ' ' VAL . . . . . . . . . . . . . 48.7 t -64.13 -46.71 92.83 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.309 0 C-N-CA 120.788 -0.365 . . . . 0.0 110.547 -177.52 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' F' F ' 22' ' ' ILE . . . . . . . . . . . . . 49.4 mm -55.88 -46.63 80.25 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.257 0 CA-C-O 120.633 0.254 . . . . 0.0 110.597 179.375 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' F' F ' 23' ' ' ARG . . . . . . . . . . . . . 53.9 ttp180 -54.11 -47.91 71.32 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-O 120.607 0.242 . . . . 0.0 111.349 -178.502 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' F' F ' 24' ' ' ILE . . . . . . . . . . . . . 72.2 mt -59.12 -44.51 91.76 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.285 0 CA-C-N 116.677 -0.238 . . . . 0.0 111.098 -178.405 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' F' F ' 25' ' ' LYS . . . . . . . . . . . . . 67.6 mttm -65.05 -39.75 93.75 Favored 'General case' 0 C--N 1.328 -0.339 0 N-CA-C 112.429 0.529 . . . . 0.0 112.429 -177.977 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' F' F ' 26' ' ' LEU . . . . . . . . . . . . . 63.6 mt -78.62 -43.27 26.71 Favored 'General case' 0 C--N 1.331 -0.229 0 N-CA-C 112.882 0.697 . . . . 0.0 112.882 -171.824 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' F' F ' 27' ' ' GLN . . . . . . . . . . . . . 10.5 pt20 -46.73 139.4 5.33 Favored 'General case' 0 N--CA 1.467 0.41 0 N-CA-C 112.883 0.697 . . . . 0.0 112.883 -174.641 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' F' F ' 28' ' ' GLY . . . . . . . . . . . . . . . 99.82 -25.57 27.76 Favored Glycine 0 CA--C 1.533 1.199 0 CA-C-N 115.472 -0.786 . . . . 0.0 112.197 -176.154 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' F' F ' 29' ' ' LYS . . . . . . . . . . . . . 91.4 mttt -98.0 155.22 17.21 Favored 'General case' 0 C--O 1.233 0.197 0 CA-C-N 117.242 0.521 . . . . 0.0 110.929 178.091 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' F' F ' 30' ' ' THR . . . . . . . . . . . . . 26.0 m -107.28 134.57 50.16 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 115.894 -0.594 . . . . 0.0 109.565 173.9 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' F' F ' 31' ' ' VAL . . . . . . . . . . . . . 34.9 m -125.98 153.5 34.18 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.214 0 CA-C-O 120.924 0.393 . . . . 0.0 110.938 -176.978 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' F' F ' 32' ' ' ARG . . . . . . . . . . . . . 47.8 ttp180 -126.46 147.07 49.86 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 116.044 -0.525 . . . . 0.0 110.334 179.421 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' F' F ' 33' ' ' THR . . . . . . . . . . . . . 15.8 m -52.84 138.74 28.86 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.323 -0.399 . . . . 0.0 111.46 -177.514 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' F' F ' 34' ' ' GLY . . . . . . . . . . . . . . . 101.17 -17.22 56.23 Favored Glycine 0 CA--C 1.535 1.287 0 CA-C-O 119.662 -0.521 . . . . 0.0 113.253 179.248 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' F' F ' 35' ' ' ASP . . . . . . . . . . . . . 78.5 m-20 -66.06 149.06 50.85 Favored 'General case' 0 N--CA 1.461 0.11 0 CA-C-N 117.947 0.873 . . . . 0.0 110.938 178.645 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' F' F ' 36' ' ' VAL . . . . . . . . . . . . . 44.1 t -122.25 131.99 72.01 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.219 0 CA-C-N 116.034 -0.53 . . . . 0.0 109.967 179.178 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' F' F ' 37' ' ' ILE . . . . . . . . . . . . . 66.0 mt -120.76 139.3 48.43 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.247 0 CA-C-N 115.973 -0.558 . . . . 0.0 109.667 179.7 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' F' F ' 38' ' ' GLY . . . . . . . . . . . . . . . -114.49 128.9 8.41 Favored Glycine 0 CA--C 1.525 0.686 0 N-CA-C 111.371 -0.692 . . . . 0.0 111.371 -178.536 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' F' F ' 39' ' ' ILE . . . . . . . . . . . . . 72.1 mt -125.19 129.41 73.2 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.188 0 N-CA-C 109.896 -0.409 . . . . 0.0 109.896 178.014 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' F' F ' 40' ' ' SER . . . . . . . . . . . . . 28.8 t -92.47 121.82 34.31 Favored 'General case' 0 C--N 1.329 -0.301 0 C-N-CA 120.997 -0.281 . . . . 0.0 110.834 176.935 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' F' F ' 41' ' ' ILE . . . . . . . . . . . . . 72.9 mt -133.98 124.96 47.84 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.224 0 CA-C-O 120.774 0.321 . . . . 0.0 110.253 179.304 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' F' F ' 42' ' ' LEU . . . . . . . . . . . . . 60.6 mt 58.29 33.65 23.33 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-N 116.145 -0.48 . . . . 0.0 111.798 178.082 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' F' F ' 43' ' ' GLY . . . . . . . . . . . . . . . 77.66 -10.23 25.37 Favored Glycine 0 CA--C 1.536 1.361 0 C-N-CA 121.268 -0.492 . . . . 0.0 113.456 178.203 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' F' F ' 44' ' ' LYS . . . . . . . . . . . . . 27.1 mtpp -100.52 130.58 46.61 Favored 'General case' 0 C--N 1.332 -0.171 0 CA-C-N 117.852 0.826 . . . . 0.0 109.891 176.937 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' F' F ' 45' ' ' GLU . . . . . . . . . . . . . 38.2 tp10 -84.53 128.46 34.61 Favored 'General case' 0 C--N 1.33 -0.271 0 C-N-CA 120.884 -0.326 . . . . 0.0 110.808 179.877 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' F' F ' 46' ' ' VAL . . . . . . . . . . . . . 7.6 p -119.89 128.57 75.93 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.242 0 N-CA-C 109.702 -0.481 . . . . 0.0 109.702 177.543 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' F' F ' 47' ' ' LYS . . . . . . . . . . . . . 64.9 mttp -100.25 130.17 46.34 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 115.948 -0.569 . . . . 0.0 111.214 178.975 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' F' F ' 48' ' ' PHE . . . . . . . . . . . . . 92.2 m-85 -113.46 131.87 55.87 Favored 'General case' 0 C--N 1.33 -0.267 0 N-CA-C 109.721 -0.474 . . . . 0.0 109.721 176.024 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' F' F ' 49' ' ' LYS . . . . . . . . . . . . . 54.1 tttm -107.83 137.79 45.22 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.545 -0.298 . . . . 0.0 110.622 179.197 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' F' F ' 50' ' ' VAL . . . . . . . . . . . . . 44.5 t -79.17 107.23 11.39 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.282 0 N-CA-C 109.179 -0.674 . . . . 0.0 109.179 175.22 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' F' F ' 51' ' ' VAL . . . . . . . . . . . . . 46.0 t -70.52 -52.78 26.24 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.339 0 CA-C-N 115.934 -0.576 . . . . 0.0 109.585 -174.664 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' F' F ' 52' ' ' GLN . . . . . . . . . . . . . 46.9 mt-30 -155.73 153.6 30.18 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.058 -0.519 . . . . 0.0 111.669 -177.527 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' F' F ' 53' ' ' ALA . . . . . . . . . . . . . . . -128.97 132.44 47.57 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 115.292 -0.867 . . . . 0.0 109.889 175.546 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' F' F ' 54' ' ' TYR . . . . . . . . . . . . . 27.1 t80 -129.01 107.71 18.08 Favored Pre-proline 0 CA--C 1.535 0.378 0 CA-C-O 118.238 -0.887 . . . . 0.0 110.43 -179.849 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' F' F ' 55' ' ' PRO . . . . . . . . . . . . . 73.7 Cg_endo -77.1 170.1 72.53 Favored 'Cis proline' 0 N--CA 1.5 1.862 0 CA-C-N 121.787 1.674 . . . . 0.0 112.364 -5.812 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' F' F ' 56' ' ' SER . . . . . . . . . . . . . 45.5 m -115.61 131.44 23.65 Favored Pre-proline 0 CA--C 1.538 0.507 0 CA-C-O 118.499 -0.763 . . . . 0.0 109.448 175.74 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' F' F ' 57' ' ' PRO . . . . . . . . . . . . . 53.7 Cg_endo -70.88 149.04 90.61 Favored 'Cis proline' 0 N--CA 1.496 1.675 0 CA-C-N 121.955 1.734 . . . . 0.0 111.577 -1.899 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' F' F ' 58' ' ' LEU . . . . . . . . . . . . . 23.8 tp -108.29 136.43 47.95 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.219 -0.446 . . . . 0.0 110.725 -177.449 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' F' F ' 59' ' ' ARG . . . . . . . . . . . . . 70.7 ttt180 -103.02 126.12 50.06 Favored 'General case' 0 C--N 1.327 -0.384 0 N-CA-C 109.117 -0.697 . . . . 0.0 109.117 175.744 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' F' F ' 60' ' ' VAL . . . . . . . . . . . . . 41.2 t -91.07 123.21 43.12 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.303 0 C-N-CA 120.663 -0.415 . . . . 0.0 111.014 -174.059 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' F' F ' 61' ' ' GLU . . . . . . . . . . . . . 96.1 mt-10 -131.13 172.06 12.55 Favored 'General case' 0 C--N 1.329 -0.317 0 N-CA-C 109.407 -0.59 . . . . 0.0 109.407 173.055 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' F' F ' 62' ' ' ASP . . . . . . . . . . . . . 73.3 m-20 -54.22 -32.67 56.47 Favored 'General case' 0 C--N 1.328 -0.334 0 C-N-CA 121.029 -0.268 . . . . 0.0 111.583 179.299 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' F' F ' 63' ' ' ARG . . . . . . . . . . . . . 13.5 ptm180 -74.56 -11.91 60.33 Favored 'General case' 0 CA--C 1.535 0.394 0 N-CA-C 113.409 0.892 . . . . 0.0 113.409 -177.298 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' F' F ' 64' ' ' THR . . . . . . . . . . . . . 37.6 m -74.67 138.72 43.04 Favored 'General case' 0 C--O 1.233 0.193 0 O-C-N 122.096 -0.377 . . . . 0.0 110.75 -176.09 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' F' F ' 65' ' ' LYS . . . . . . . . . . . . . 55.5 mtmt -89.24 129.12 35.86 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.149 -0.478 . . . . 0.0 110.141 177.863 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' F' F ' 66' ' ' ILE . . . . . . . . . . . . . 65.3 mt -114.75 129.84 70.19 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.295 0 N-CA-C 109.899 -0.408 . . . . 0.0 109.899 -179.835 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' F' F ' 67' ' ' THR . . . . . . . . . . . . . 24.8 m -118.82 135.51 54.5 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-N 116.076 -0.511 . . . . 0.0 110.464 179.862 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' F' F ' 68' ' ' LEU . . . . . . . . . . . . . 6.5 tt -106.75 122.97 47.44 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 115.912 -0.586 . . . . 0.0 110.01 179.062 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' F' F ' 69' ' ' VAL . . . . . . . . . . . . . 43.4 t -99.58 129.98 49.32 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.291 0 CA-C-N 116.31 -0.404 . . . . 0.0 110.043 179.83 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' F' F ' 70' ' ' THR . . . . . . . . . . . . . 74.7 p -101.31 162.48 12.86 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.246 -0.434 . . . . 0.0 110.585 -179.681 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' F' F ' 71' ' ' HIS . . . . . . . . . . . . . 20.3 m-70 -82.93 119.07 73.64 Favored Pre-proline 0 CA--C 1.535 0.372 0 CA-C-O 118.74 -0.648 . . . . 0.0 110.842 -177.328 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' F' F ' 72' ' ' PRO . . . . . . . . . . . . . 7.3 Cg_exo -70.74 -27.43 21.8 Favored 'Trans proline' 0 N--CA 1.498 1.776 0 C-N-CA 121.274 1.316 . . . . 0.0 112.18 174.448 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' F' F ' 73' ' ' VAL . . . . . . . . . . . . . 34.4 m -124.84 178.91 3.36 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.228 0 N-CA-C 110.118 -0.327 . . . . 0.0 110.118 -179.44 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' F' F ' 74' ' ' ASP . . . . . . . . . . . . . 24.1 t0 -96.37 121.9 38.67 Favored 'General case' 0 C--N 1.33 -0.263 0 C-N-CA 120.941 -0.304 . . . . 0.0 110.186 -177.302 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' F' F ' 75' ' ' VAL . . . . . . . . . . . . . 41.0 t -121.29 124.68 72.52 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.214 0 CA-C-O 121.039 0.447 . . . . 0.0 110.913 -177.781 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' F' F ' 76' ' ' LEU . . . . . . . . . . . . . 7.5 mp -121.57 143.73 49.13 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 115.61 -0.723 . . . . 0.0 109.512 176.473 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' F' F ' 77' ' ' GLU . . . . . . . . . . . . . 98.3 mt-10 -134.78 140.83 46.2 Favored 'General case' 0 N--CA 1.463 0.186 0 CA-C-O 121.091 0.472 . . . . 0.0 111.617 -178.16 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' F' F ' 78' ' ' ALA . . . . . . . . . . . . . . . -133.95 141.2 47.21 Favored 'General case' 0 C--N 1.331 -0.223 0 CA-C-N 115.706 -0.679 . . . . 0.0 110.229 176.248 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' F' F ' 79' ' ' LYS . . . . . . . . . . . . . 10.0 mtpm? -82.19 119.96 24.74 Favored 'General case' 0 C--N 1.331 -0.225 0 CA-C-O 120.934 0.397 . . . . 0.0 110.801 -178.868 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' F' F ' 80' ' ' ILE . . . . . . . . . . . . . 42.2 mm -139.23 102.09 1.65 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 N-CA-C 109.165 -0.679 . . . . 0.0 109.165 -178.705 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' F' F ' 81' ' ' LYS . . . . . . . . . . . . . 54.6 mtpt -97.21 127.71 43.42 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-O 120.957 0.408 . . . . 0.0 111.133 -176.92 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' F' F ' 82' ' ' GLY . . . . . . . . . . . . . . . 89.16 42.12 5.67 Favored Glycine 0 CA--C 1.525 0.695 0 C-N-CA 120.937 -0.649 . . . . 0.0 111.522 175.793 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' F' F ' 83' ' ' ILE . . . . . . . . . . . . . 71.9 mt -67.49 138.03 23.55 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.297 0 N-CA-C 109.89 -0.411 . . . . 0.0 109.89 178.407 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' F' F ' 84' ' ' LYS . . . . . . . . . . . . . 56.3 tttp -99.63 -51.91 3.62 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.02 -0.536 . . . . 0.0 110.173 -179.726 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' F' F ' 85' ' ' ASP . . . . . . . . . . . . . 7.9 t70 -156.85 153.31 28.02 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 115.811 -0.632 . . . . 0.0 110.293 -179.914 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' F' F ' 86' ' ' VAL . . . . . . . . . . . . . 41.9 t -133.36 134.75 56.96 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.246 0 CA-C-O 121.083 0.468 . . . . 0.0 110.548 -179.128 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' F' F ' 87' ' ' ILE . . . . . . . . . . . . . 45.1 mm -119.36 128.16 75.85 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.25 0 CA-C-N 115.666 -0.697 . . . . 0.0 109.733 176.892 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' F' F ' 88' ' ' LEU . . . . . . . . . . . . . 63.9 mt -114.54 133.62 55.65 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-O 121.078 0.466 . . . . 0.0 111.173 -178.754 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' F' F ' 89' ' ' ASP . . . . . . . . . . . . . 8.8 t70 -131.89 154.62 49.03 Favored 'General case' 0 C--N 1.327 -0.385 0 CA-C-N 115.667 -0.697 . . . . 0.0 109.425 177.094 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' F' F ' 90' ' ' GLU . . . . . . . . . . . . . 83.9 tt0 -47.49 -32.98 5.73 Favored 'General case' 0 C--N 1.328 -0.33 0 N-CA-C 113.031 0.752 . . . . 0.0 113.031 -172.483 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' F' F ' 91' ' ' ASN . . . . . . . . . . . . . 35.0 m120 -124.47 7.82 8.34 Favored 'General case' 0 N--CA 1.469 0.489 0 N-CA-C 113.613 0.968 . . . . 0.0 113.613 -175.128 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' F' F ' 92' ' ' LEU . . . . . . . . . . . . . 27.5 mt -147.15 148.57 31.69 Favored 'General case' 0 C--N 1.333 -0.14 0 CA-C-N 118.247 0.476 . . . . 0.0 110.965 -175.464 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' F' F ' 93' ' ' ILE . . . . . . . . . . . . . 74.0 mt -126.52 116.45 45.26 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.286 0 N-CA-C 109.105 -0.702 . . . . 0.0 109.105 175.846 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' F' F ' 94' ' ' VAL . . . . . . . . . . . . . 46.1 t -118.79 128.59 75.64 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.193 0 CA-C-O 120.827 0.346 . . . . 0.0 110.101 -177.967 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' F' F ' 95' ' ' VAL . . . . . . . . . . . . . 42.1 t -123.27 134.98 64.68 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.317 0 CA-C-N 116.079 -0.509 . . . . 0.0 109.871 -179.853 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' F' F ' 96' ' ' ILE . . . . . . . . . . . . . 59.8 mt -115.25 129.22 71.85 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.282 0 N-CA-C 109.324 -0.621 . . . . 0.0 109.324 178.822 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' F' F ' 97' ' ' THR . . . . . . . . . . . . . 82.5 p -100.72 158.83 15.66 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-O 121.298 0.571 . . . . 0.0 111.157 -177.95 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' F' F ' 98' ' ' GLU . . . . . . . . . . . . . 46.4 tp10 -53.74 -27.2 27.02 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.011 -0.541 . . . . 0.0 112.259 -179.436 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' F' F ' 99' ' ' GLU . . . . . . . . . . . . . 39.4 tt0 -80.25 17.87 0.97 Allowed 'General case' 0 CA--C 1.539 0.555 0 N-CA-C 112.679 0.622 . . . . 0.0 112.679 -176.822 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' F' F ' 100' ' ' ASN . . . . . . . . . . . . . 4.1 m-20 61.05 38.0 17.52 Favored 'General case' 0 N--CA 1.462 0.166 0 O-C-N 121.857 -0.527 . . . . 0.0 111.017 176.792 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' F' F ' 101' ' ' GLU . . . . . . . . . . . . . 84.8 tt0 -117.66 143.08 46.51 Favored 'General case' 0 C--N 1.331 -0.226 0 N-CA-C 109.574 -0.528 . . . . 0.0 109.574 175.838 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' F' F ' 102' ' ' VAL . . . . . . . . . . . . . 44.9 t -116.73 126.59 74.25 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.353 0 CA-C-N 116.319 -0.4 . . . . 0.0 110.107 -176.986 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' F' F ' 103' ' ' LEU . . . . . . . . . . . . . 6.8 mp -118.42 135.31 54.42 Favored 'General case' 0 C--N 1.331 -0.215 0 CA-C-N 115.752 -0.658 . . . . 0.0 110.01 176.446 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' F' F ' 104' ' ' ILE . . . . . . . . . . . . . 72.4 mt -123.67 122.24 64.39 Favored 'Isoleucine or valine' 0 C--O 1.234 0.246 0 CA-C-N 116.503 -0.317 . . . . 0.0 110.29 -178.525 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' F' F ' 105' ' ' PHE . . . . . . . . . . . . . 47.5 m-85 -121.16 166.5 13.85 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 115.314 -0.857 . . . . 0.0 109.92 179.778 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' F' F ' 106' ' ' ASN . . . . . . . . . . . . . 42.3 p-10 -99.7 -169.89 1.81 Allowed 'General case' 0 C--N 1.33 -0.25 0 N-CA-C 109.821 -0.437 . . . . 0.0 109.821 172.992 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' F' F ' 107' ' ' GLN . . . . . . . . . . . . . 29.5 tt0 -60.44 -30.07 69.42 Favored 'General case' 0 C--N 1.329 -0.317 0 N-CA-C 111.734 0.272 . . . . 0.0 111.734 178.857 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' F' F ' 108' ' ' ASN . . . . . . . . . . . . . 10.1 t-20 -81.96 4.93 20.79 Favored 'General case' 0 CA--C 1.537 0.458 0 N-CA-C 113.305 0.854 . . . . 0.0 113.305 -178.833 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' F' F ' 109' ' ' LEU . . . . . . . . . . . . . 6.0 tp 63.4 38.51 10.02 Favored 'General case' 0 C--O 1.232 0.167 0 CA-C-O 121.107 0.479 . . . . 0.0 111.377 177.158 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' F' F ' 110' ' ' GLU . . . . . . . . . . . . . 70.7 mm-40 -107.76 152.44 24.36 Favored 'General case' 0 C--N 1.331 -0.23 0 CA-C-N 116.256 -0.429 . . . . 0.0 110.12 176.03 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' F' F ' 111' ' ' GLU . . . . . . . . . . . . . 98.6 mt-10 -78.58 125.83 29.91 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-O 120.944 0.402 . . . . 0.0 111.188 -178.542 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' F' F ' 112' ' ' LEU . . . . . . . . . . . . . 8.4 mt -111.97 -46.04 3.26 Favored 'General case' 0 C--N 1.332 -0.159 0 CA-C-N 116.012 -0.54 . . . . 0.0 109.905 176.336 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' F' F ' 113' ' ' TYR . . . . . . . . . . . . . 49.5 t80 -139.69 140.94 36.97 Favored 'General case' 0 C--N 1.332 -0.19 0 CA-C-N 116.128 -0.487 . . . . 0.0 110.773 -179.637 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' F' F ' 114' ' ' ARG . . . . . . . . . . . . . 42.4 ptt85 -150.96 118.75 6.16 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-O 121.043 0.449 . . . . 0.0 110.959 179.731 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' F' F ' 115' ' ' GLY . . . . . . . . . . . . . . . -150.28 162.98 29.41 Favored Glycine 0 CA--C 1.527 0.786 0 N-CA-C 111.177 -0.769 . . . . 0.0 111.177 -178.846 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' F' F ' 116' ' ' LYS . . . . . . . . . . . . . 26.6 ttpp -122.41 144.84 48.79 Favored 'General case' 0 C--N 1.33 -0.245 0 O-C-N 122.644 -0.327 . . . . 0.0 110.172 176.457 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' F' F ' 117' ' ' PHE . . . . . . . . . . . . . 45.4 m-85 -138.22 113.9 9.76 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-O 121.035 0.445 . . . . 0.0 110.278 179.771 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' F' F ' 118' ' ' GLU . . . . . . . . . . . . . 84.7 tt0 -52.53 -50.17 63.39 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-N 116.385 -0.371 . . . . 0.0 111.702 -176.016 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' F' F ' 119' ' ' ASN . . . . . . . . . . . . . 72.2 m-80 -95.78 30.98 2.18 Favored 'General case' 0 C--N 1.329 -0.285 0 N-CA-C 112.246 0.462 . . . . 0.0 112.246 -174.458 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' F' F ' 120' ' ' LEU . . . . . . . . . . . . . 17.3 tp -55.29 120.75 7.54 Favored 'General case' 0 C--N 1.332 -0.163 0 CA-C-O 120.703 0.287 . . . . 0.0 110.77 178.392 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' F' F ' 121' ' ' ASN . . . . . . . . . . . . . 37.2 t30 -114.16 -44.05 3.17 Favored 'General case' 0 C--N 1.333 -0.125 0 CA-C-N 116.6 -0.273 . . . . 0.0 111.039 -177.995 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' F' F ' 122' ' ' LYS . . . . . . . . . . . . . 61.2 mtpt -140.6 148.54 41.1 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-O 121.045 0.45 . . . . 0.0 111.584 -175.461 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' F' F ' 123' ' ' VAL . . . . . . . . . . . . . 45.0 t -132.6 133.19 59.76 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.274 0 N-CA-C 109.374 -0.602 . . . . 0.0 109.374 174.761 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' F' F ' 124' ' ' LEU . . . . . . . . . . . . . 66.8 mt -131.74 136.05 47.3 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-O 120.988 0.423 . . . . 0.0 111.201 -176.415 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' F' F ' 125' ' ' VAL . . . . . . . . . . . . . 38.7 t -129.2 135.19 62.48 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.207 0 CA-C-N 115.73 -0.668 . . . . 0.0 110.067 -179.582 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' F' F ' 126' ' ' ARG . . . . . . . . . . . . . 17.1 ptp180 -165.18 142.78 6.02 Favored 'General case' 0 C--N 1.331 -0.202 0 CA-C-O 121.004 0.431 . . . . 0.0 110.414 176.31 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' F' F ' 127' ' ' ASN . . . . . . . . . . . . . 1.3 t-20 54.74 -155.13 0.26 Allowed 'General case' 0 CA--C 1.538 0.517 0 N-CA-C 110.104 -0.332 . . . . 0.0 110.104 -179.656 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' F' F ' 128' ' ' ASP . . . . . . . . . . . . . 23.1 p-10 -84.12 20.71 1.51 Allowed 'General case' 0 CA--C 1.534 0.35 0 CA-C-N 118.325 0.511 . . . . 0.0 112.347 176.481 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' F' F ' 129' ' ' LEU . . . . . . . . . . . . . 46.2 mt -121.09 144.47 48.54 Favored 'General case' 0 C--O 1.234 0.246 0 O-C-N 122.053 -0.405 . . . . 0.0 110.438 -179.376 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' F' F ' 130' ' ' VAL . . . . . . . . . . . . . 11.1 p -134.19 139.76 47.51 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.268 0 CA-C-N 116.286 -0.415 . . . . 0.0 110.016 178.832 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' F' F ' 131' ' ' VAL . . . . . . . . . . . . . 34.6 m -136.06 146.49 29.23 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.254 0 CA-C-O 121.268 0.556 . . . . 0.0 111.286 -178.265 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' F' F ' 132' ' ' ILE . . . . . . . . . . . . . 68.2 mt -121.91 133.97 66.64 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.299 0 CA-C-N 115.389 -0.823 . . . . 0.0 109.497 179.645 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' F' F ' 133' ' ' ILE . . . . . . . . . . . . . 37.3 mm -115.57 117.52 55.85 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.267 0 CA-C-N 116.463 -0.335 . . . . 0.0 110.828 -175.984 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' F' F ' 134' ' ' ASP . . . . . . . . . . . . . 8.0 p-10 -129.92 146.65 51.63 Favored 'General case' 0 C--N 1.33 -0.245 0 N-CA-C 109.649 -0.501 . . . . 0.0 109.649 175.526 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' F' F ' 135' ' ' GLU . . . . . . . . . . . . . 41.5 tp10 -49.93 -23.04 1.75 Allowed 'General case' 0 C--N 1.327 -0.371 0 N-CA-C 112.799 0.666 . . . . 0.0 112.799 -172.207 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' F' F ' 136' ' ' GLN . . . . . . . . . . . . . 48.1 tt0 -101.38 -28.73 12.43 Favored 'General case' 0 CA--C 1.531 0.215 0 N-CA-C 112.481 0.549 . . . . 0.0 112.481 -174.801 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' F' F ' 137' ' ' LYS . . . . . . . . . . . . . 76.6 mttt -141.95 151.74 42.85 Favored 'General case' 0 C--O 1.233 0.22 0 CA-C-O 121.363 0.601 . . . . 0.0 112.378 -170.714 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' F' F ' 138' ' ' LEU . . . . . . . . . . . . . 24.3 tp -109.14 119.14 38.63 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 115.011 -0.995 . . . . 0.0 108.941 170.251 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' F' F ' 139' ' ' THR . . . . . . . . . . . . . 33.0 m -108.19 123.73 49.2 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-O 120.751 0.31 . . . . 0.0 110.914 -177.263 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' F' F ' 140' ' ' LEU . . . . . . . . . . . . . 12.4 tp -115.82 120.61 39.81 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 115.601 -0.727 . . . . 0.0 109.503 -179.219 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' F' F ' 141' ' ' ILE . . . . . . . . . . . . . 19.7 mt -118.97 121.18 66.19 Favored 'Isoleucine or valine' 0 C--O 1.235 0.302 0 N-CA-C 109.801 -0.444 . . . . 0.0 109.801 -176.676 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' F' F ' 142' ' ' ARG . . . . . . . . . . . . . 73.8 mtm180 -111.56 126.82 55.4 Favored 'General case' 0 C--N 1.332 -0.175 0 CA-C-N 115.798 -0.637 . . . . 0.0 110.125 -178.348 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' F' F ' 143' ' ' THR . . . . . . . . . . . . . 25.8 p . . . . . 0 C--O 1.221 -0.443 0 CA-C-O 118.235 -0.888 . . . . 0.0 110.998 -179.368 . . . . . . . . 0 0 . 1 . 008 nuclear orig full ' A' A ' -3' ' ' GLU . . . . . . . . . . . . . 85.1 tt0 . . . . . 0 N--CA 1.49 1.556 0 N-CA-C 109.432 -0.581 . . . . 0.0 109.432 . . . . . . . . . 0 0 . 1 . 008 nuclear orig full ' A' A ' -2' ' ' GLY . . . . . . . . . . . . . . . -75.5 99.67 1.23 Allowed Glycine 0 CA--C 1.525 0.702 0 N-CA-C 111.066 -0.813 . . . . 0.0 111.066 179.866 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' -1' ' ' VAL . . . . . . . . . . . . . 45.3 t -141.46 139.54 32.17 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.311 0 N-CA-C 109.989 -0.374 . . . . 0.0 109.989 179.488 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 0' ' ' ILE . . . . . . . . . . . . . 44.3 mm -109.0 128.49 64.83 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.243 0 CA-C-N 116.23 -0.441 . . . . 0.0 110.138 179.925 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 25.8 ptt? -81.03 145.09 31.32 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.131 -0.486 . . . . 0.0 110.783 -179.537 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 5.0 p -119.65 137.49 53.86 Favored 'General case' 0 C--N 1.332 -0.181 0 CA-C-N 116.211 -0.45 . . . . 0.0 110.781 179.989 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 41.2 mt-10 -140.4 140.74 35.53 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 115.985 -0.552 . . . . 0.0 111.029 -179.332 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 4' ' ' LEU . . . . . . . . . . . . . 3.0 tt -124.2 126.3 45.89 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 115.918 -0.583 . . . . 0.0 109.707 177.338 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 5' ' ' LYS . . . . . . . . . . . . . 63.9 mttp -106.91 120.24 41.51 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-O 120.69 0.281 . . . . 0.0 110.807 -179.791 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 37.2 mt -114.66 145.64 41.79 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 115.502 -0.772 . . . . 0.0 110.742 -178.573 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 53.6 tttm -137.78 140.56 30.05 Favored Pre-proline 0 CA--C 1.534 0.35 0 CA-C-O 119.104 -0.474 . . . . 0.0 109.791 174.36 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 8' ' ' PRO . . . . . . . . . . . . . 88.4 Cg_endo -91.81 144.71 3.01 Favored 'Trans proline' 0 N--CA 1.489 1.23 0 C-N-CA 121.775 1.65 . . . . 0.0 111.83 177.931 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 62.7 mt -78.64 -46.51 1.91 Allowed Pre-proline 0 CA--C 1.532 0.277 0 CA-C-O 118.859 -0.591 . . . . 0.0 111.906 179.663 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 75.5 Cg_endo -83.93 144.98 11.11 Favored 'Trans proline' 0 N--CA 1.494 1.543 0 C-N-CA 121.219 1.28 . . . . 0.0 111.516 173.362 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 22.3 pttm -74.53 116.44 15.22 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-O 121.319 0.58 . . . . 0.0 110.437 177.639 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 12.3 p -150.41 147.32 16.04 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.359 0 CA-C-N 115.682 -0.69 . . . . 0.0 110.56 -177.966 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 84.6 tt0 -95.73 121.98 38.02 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.394 -0.366 . . . . 0.0 110.099 177.881 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 14' ' ' LEU . . . . . . . . . . . . . 21.9 mt -99.14 144.03 27.48 Favored Pre-proline 0 CA--C 1.533 0.324 0 CA-C-O 119.093 -0.48 . . . . 0.0 110.521 -176.718 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 15' ' ' PRO . . . . . . . . . . . . . 23.6 Cg_exo -64.76 161.66 35.08 Favored 'Trans proline' 0 N--CA 1.498 1.754 0 C-N-CA 121.292 1.328 . . . . 0.0 111.933 175.209 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 16' ' ' PRO . . . . . . . . . . . . . 27.1 Cg_exo -60.67 -31.97 92.67 Favored 'Trans proline' 0 N--CA 1.496 1.643 0 C-N-CA 121.538 1.492 . . . . 0.0 112.79 -178.96 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 17' ' ' ASP . . . . . . . . . . . . . 10.0 p-10 -83.16 -2.41 55.42 Favored 'General case' 0 CA--C 1.535 0.386 0 N-CA-C 113.351 0.871 . . . . 0.0 113.351 -176.556 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 18' ' ' PHE . . . . . . . . . . . . . 45.5 t80 -57.45 -43.76 84.2 Favored 'General case' 0 C--O 1.23 0.035 0 O-C-N 121.913 -0.492 . . . . 0.0 110.236 -178.478 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 19' ' ' VAL . . . . . . . . . . . . . 48.5 t -57.02 -44.1 82.18 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.314 0 CA-C-N 116.269 -0.423 . . . . 0.0 110.485 -178.497 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 18.2 t70 -59.69 -41.81 91.55 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-O 120.757 0.313 . . . . 0.0 110.902 -177.651 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 43.8 t -64.32 -47.28 90.32 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.274 0 C-N-CA 120.692 -0.403 . . . . 0.0 110.459 -177.948 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 22' ' ' ILE . . . . . . . . . . . . . 50.2 mm -57.3 -42.05 79.48 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.244 0 C-N-CA 120.801 -0.359 . . . . 0.0 110.591 179.942 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 23' ' ' ARG . . . . . . . . . . . . . 56.5 ttp180 -55.8 -50.31 70.85 Favored 'General case' 0 C--N 1.331 -0.211 0 CA-C-O 120.928 0.394 . . . . 0.0 110.899 179.73 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 24' ' ' ILE . . . . . . . . . . . . . 77.5 mt -60.44 -41.02 86.01 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.251 0 CA-C-N 116.09 -0.505 . . . . 0.0 111.67 -176.961 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 16.5 ptpt -72.49 -37.57 68.41 Favored 'General case' 0 CA--C 1.535 0.376 0 C-N-CA 120.622 -0.431 . . . . 0.0 112.115 -175.15 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 43.9 mt -79.84 -39.5 30.52 Favored 'General case' 0 C--N 1.331 -0.209 0 N-CA-C 113.383 0.883 . . . . 0.0 113.383 -173.406 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 27' ' ' GLN . . . . . . . . . . . . . 9.9 pt20 -46.49 141.24 3.76 Favored 'General case' 0 N--CA 1.469 0.503 0 N-CA-C 112.958 0.725 . . . . 0.0 112.958 -173.492 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 97.26 -25.97 24.82 Favored Glycine 0 CA--C 1.534 1.262 0 CA-C-N 115.553 -0.749 . . . . 0.0 112.164 -177.304 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 84.0 mttt -97.94 155.14 17.22 Favored 'General case' 0 C--O 1.233 0.21 0 CA-C-N 117.232 0.516 . . . . 0.0 110.943 179.812 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 30' ' ' THR . . . . . . . . . . . . . 29.1 m -106.86 137.62 44.57 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.142 -0.481 . . . . 0.0 110.101 177.168 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 34.8 m -130.2 159.45 42.21 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.202 0 CA-C-N 116.321 -0.4 . . . . 0.0 110.84 -178.8 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 32' ' ' ARG . . . . . . . . . . . . . 82.2 mtm180 -132.82 150.93 52.11 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-O 121.31 0.576 . . . . 0.0 110.682 178.357 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 33' ' ' THR . . . . . . . . . . . . . 22.0 m -53.4 139.82 29.34 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.074 -0.512 . . . . 0.0 111.312 -178.764 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 100.11 -17.15 57.49 Favored Glycine 0 CA--C 1.532 1.119 0 CA-C-O 119.591 -0.561 . . . . 0.0 113.226 178.881 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 76.6 m-20 -66.08 147.98 52.52 Favored 'General case' 0 C--O 1.233 0.187 0 CA-C-N 118.078 0.939 . . . . 0.0 111.155 178.857 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 44.0 t -122.79 131.53 73.08 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.224 0 CA-C-N 115.937 -0.574 . . . . 0.0 109.906 178.871 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 37' ' ' ILE . . . . . . . . . . . . . 69.0 mt -120.95 139.01 49.5 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.253 0 CA-C-N 116.167 -0.469 . . . . 0.0 110.008 -179.683 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . -109.43 128.85 9.16 Favored Glycine 0 CA--C 1.527 0.785 0 N-CA-C 110.975 -0.85 . . . . 0.0 110.975 179.663 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 39' ' ' ILE . . . . . . . . . . . . . 77.6 mt -126.06 135.9 62.46 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.229 0 CA-C-O 120.765 0.317 . . . . 0.0 110.181 179.612 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 40' ' ' SER . . . . . . . . . . . . . 36.6 t -93.87 122.28 36.19 Favored 'General case' 0 C--N 1.331 -0.239 0 CA-C-N 116.309 -0.405 . . . . 0.0 110.902 175.149 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 41' ' ' ILE . . . . . . . . . . . . . 70.6 mt -133.36 127.43 53.89 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.202 0 CA-C-O 120.841 0.353 . . . . 0.0 110.376 178.662 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 83.4 mt 53.66 33.04 15.71 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 116.203 -0.453 . . . . 0.0 111.959 177.788 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . 72.39 29.37 66.22 Favored Glycine 0 CA--C 1.529 0.952 0 C-N-CA 121.112 -0.566 . . . . 0.0 112.313 177.839 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 44' ' ' LYS . . . . . . . . . . . . . 60.3 mttm -137.36 136.5 37.98 Favored 'General case' 0 C--N 1.331 -0.215 0 N-CA-C 109.862 -0.422 . . . . 0.0 109.862 178.723 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 84.4 tt0 -83.81 122.02 28.11 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.459 -0.337 . . . . 0.0 110.899 -179.688 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 46' ' ' VAL . . . . . . . . . . . . . 7.3 p -122.07 130.06 74.87 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.212 0 N-CA-C 109.547 -0.538 . . . . 0.0 109.547 176.221 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 64.3 mttp -100.66 128.4 46.72 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.011 -0.541 . . . . 0.0 110.994 178.935 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 48' ' ' PHE . . . . . . . . . . . . . 91.0 m-85 -111.12 131.89 54.72 Favored 'General case' 0 C--N 1.33 -0.272 0 N-CA-C 109.698 -0.482 . . . . 0.0 109.698 176.035 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 84.5 tttt -109.12 136.89 47.87 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.356 -0.383 . . . . 0.0 110.729 -179.558 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 50' ' ' VAL . . . . . . . . . . . . . 44.0 t -80.49 106.22 11.33 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.317 0 N-CA-C 109.178 -0.675 . . . . 0.0 109.178 175.159 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 51' ' ' VAL . . . . . . . . . . . . . 47.0 t -70.55 -53.21 23.47 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.354 0 N-CA-C 109.493 -0.558 . . . . 0.0 109.493 -175.035 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 52' ' ' GLN . . . . . . . . . . . . . 90.5 mt-30 -153.85 153.55 32.31 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-O 121.258 0.552 . . . . 0.0 111.796 -178.575 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -129.06 132.11 47.4 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 115.072 -0.967 . . . . 0.0 109.552 175.041 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 54' ' ' TYR . . . . . . . . . . . . . 25.1 t80 -129.03 110.1 18.28 Favored Pre-proline 0 CA--C 1.536 0.41 0 CA-C-O 118.197 -0.906 . . . . 0.0 110.048 179.391 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 55' ' ' PRO . . . . . . . . . . . . . 74.2 Cg_endo -77.17 170.01 72.67 Favored 'Cis proline' 0 N--CA 1.499 1.851 0 CA-C-N 121.877 1.706 . . . . 0.0 112.542 -4.103 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 56' ' ' SER . . . . . . . . . . . . . 13.6 m -115.55 127.61 26.65 Favored Pre-proline 0 CA--C 1.538 0.485 0 CA-C-O 118.344 -0.836 . . . . 0.0 109.506 176.214 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 57' ' ' PRO . . . . . . . . . . . . . 38.0 Cg_endo -66.6 168.5 50.82 Favored 'Cis proline' 0 N--CA 1.498 1.739 0 CA-C-N 122.081 1.779 . . . . 0.0 111.41 -0.657 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 58' ' ' LEU . . . . . . . . . . . . . 32.7 tp -130.55 136.15 48.63 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-O 120.926 0.393 . . . . 0.0 110.622 -178.997 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 59' ' ' ARG . . . . . . . . . . . . . 49.3 ttp180 -103.69 127.65 51.12 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 115.974 -0.557 . . . . 0.0 109.554 177.303 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 41.7 t -79.67 120.89 31.89 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.181 0 C-N-CA 120.57 -0.452 . . . . 0.0 110.143 -176.247 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 90.7 mt-10 -131.05 161.16 32.63 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 115.86 -0.609 . . . . 0.0 109.88 179.956 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 62' ' ' ASP . . . . . . . . . . . . . 12.7 t70 -54.34 -32.26 56.37 Favored 'General case' 0 C--N 1.328 -0.345 0 C-N-CA 120.926 -0.309 . . . . 0.0 111.714 177.728 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 63' ' ' ARG . . . . . . . . . . . . . 8.1 ptp180 -87.79 9.86 20.35 Favored 'General case' 0 CA--C 1.535 0.391 0 N-CA-C 113.568 0.951 . . . . 0.0 113.568 -175.405 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 39.5 m -92.2 141.0 29.06 Favored 'General case' 0 C--N 1.334 -0.085 0 CA-C-N 118.199 0.454 . . . . 0.0 110.437 -179.426 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 65' ' ' LYS . . . . . . . . . . . . . 67.0 mttm -88.82 127.16 35.61 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.151 -0.477 . . . . 0.0 110.258 179.915 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 66' ' ' ILE . . . . . . . . . . . . . 67.2 mt -115.18 129.13 71.93 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.236 0 N-CA-C 109.87 -0.419 . . . . 0.0 109.87 179.741 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 67' ' ' THR . . . . . . . . . . . . . 31.0 m -126.7 139.4 53.18 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-O 121.076 0.465 . . . . 0.0 111.107 -177.404 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 68' ' ' LEU . . . . . . . . . . . . . 33.8 mt -102.32 131.67 48.77 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 115.825 -0.625 . . . . 0.0 110.229 176.481 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 69' ' ' VAL . . . . . . . . . . . . . 42.5 t -97.31 133.18 39.97 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.369 0 CA-C-N 116.137 -0.483 . . . . 0.0 109.855 179.322 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 70' ' ' THR . . . . . . . . . . . . . 19.8 p -131.81 -38.1 1.14 Allowed 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.187 -0.46 . . . . 0.0 110.974 -178.906 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 71' ' ' HIS . . . . . . . . . . . . . 48.7 m80 -65.11 128.65 93.98 Favored Pre-proline 0 CA--C 1.535 0.367 0 CA-C-O 118.824 -0.608 . . . . 0.0 109.939 -179.617 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 72' ' ' PRO . . . . . . . . . . . . . 96.5 Cg_endo -90.71 -22.46 0.66 Allowed 'Trans proline' 0 N--CA 1.493 1.471 0 C-N-CA 121.628 1.552 . . . . 0.0 113.286 179.338 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 73' ' ' VAL . . . . . . . . . . . . . 34.5 m -127.01 162.3 32.15 Favored 'Isoleucine or valine' 0 C--N 1.333 -0.151 0 CA-C-O 120.939 0.4 . . . . 0.0 110.72 -177.459 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 74' ' ' ASP . . . . . . . . . . . . . 12.1 t70 -99.14 120.25 39.18 Favored 'General case' 0 C--N 1.331 -0.225 0 CA-C-N 116.088 -0.506 . . . . 0.0 109.713 179.399 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 42.4 t -110.98 121.06 62.99 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.263 0 CA-C-O 121.17 0.509 . . . . 0.0 110.534 -177.671 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 76' ' ' LEU . . . . . . . . . . . . . 29.7 mt -123.9 137.48 54.63 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 115.483 -0.781 . . . . 0.0 109.083 177.149 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 77' ' ' GLU . . . . . . . . . . . . . 33.5 tt0 -136.7 135.84 38.53 Favored 'General case' 0 C--N 1.33 -0.257 0 C-N-CA 120.745 -0.382 . . . . 0.0 111.111 -175.727 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 78' ' ' ALA . . . . . . . . . . . . . . . -124.72 140.77 52.63 Favored 'General case' 0 N--CA 1.463 0.211 0 CA-C-N 116.059 -0.518 . . . . 0.0 110.281 179.064 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 79' ' ' LYS . . . . . . . . . . . . . 63.6 mttp -83.25 123.66 29.81 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.358 -0.383 . . . . 0.0 110.546 -179.501 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 80' ' ' ILE . . . . . . . . . . . . . 23.3 mm -139.23 114.1 7.96 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.247 0 N-CA-C 108.967 -0.753 . . . . 0.0 108.967 -178.822 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 81' ' ' LYS . . . . . . . . . . . . . 84.2 tttt -103.16 123.92 47.62 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-O 120.92 0.39 . . . . 0.0 111.35 -175.696 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . 89.1 42.17 5.68 Favored Glycine 0 CA--C 1.525 0.707 0 C-N-CA 120.95 -0.643 . . . . 0.0 111.933 173.185 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 83' ' ' ILE . . . . . . . . . . . . . 71.2 mt -68.33 136.9 25.54 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.287 0 N-CA-C 109.847 -0.427 . . . . 0.0 109.847 177.925 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 84' ' ' LYS . . . . . . . . . . . . . 28.6 ttpp -99.66 -48.29 4.78 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.086 -0.506 . . . . 0.0 109.999 179.858 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 85' ' ' ASP . . . . . . . . . . . . . 8.9 t70 -153.36 149.09 27.48 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 115.842 -0.617 . . . . 0.0 110.542 179.303 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 86' ' ' VAL . . . . . . . . . . . . . 45.0 t -128.16 130.51 69.6 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.218 0 CA-C-O 120.917 0.389 . . . . 0.0 110.245 179.558 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 87' ' ' ILE . . . . . . . . . . . . . 5.1 mp -122.1 126.18 74.03 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.23 0 CA-C-N 116.007 -0.542 . . . . 0.0 109.58 177.721 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 88' ' ' LEU . . . . . . . . . . . . . 39.0 mt -113.21 137.99 50.64 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-O 121.207 0.527 . . . . 0.0 111.294 -178.104 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 89' ' ' ASP . . . . . . . . . . . . . 13.0 t70 -128.8 157.75 40.59 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 115.376 -0.829 . . . . 0.0 109.008 175.781 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 85.0 tt0 -46.79 -37.9 9.32 Favored 'General case' 0 C--N 1.33 -0.271 0 N-CA-C 112.97 0.73 . . . . 0.0 112.97 -172.07 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 91' ' ' ASN . . . . . . . . . . . . . 28.7 p30 -132.06 23.91 4.56 Favored 'General case' 0 N--CA 1.465 0.306 0 N-CA-C 112.863 0.69 . . . . 0.0 112.863 -177.89 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 92' ' ' LEU . . . . . . . . . . . . . 9.8 mt -149.24 144.45 26.54 Favored 'General case' 0 C--N 1.331 -0.206 0 N-CA-C 110.131 -0.322 . . . . 0.0 110.131 -177.547 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 93' ' ' ILE . . . . . . . . . . . . . 75.8 mt -127.69 119.0 50.63 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.247 0 N-CA-C 109.428 -0.582 . . . . 0.0 109.428 177.757 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 94' ' ' VAL . . . . . . . . . . . . . 45.5 t -121.39 128.3 75.87 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.261 0 CA-C-O 120.925 0.393 . . . . 0.0 110.133 179.984 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 95' ' ' VAL . . . . . . . . . . . . . 47.2 t -122.63 134.1 66.82 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.298 0 CA-C-N 115.863 -0.608 . . . . 0.0 109.754 -179.307 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 96' ' ' ILE . . . . . . . . . . . . . 60.0 mt -115.21 130.02 70.45 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.294 0 N-CA-C 109.273 -0.64 . . . . 0.0 109.273 179.127 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 97' ' ' THR . . . . . . . . . . . . . 73.1 p -103.81 156.28 17.94 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-O 121.253 0.549 . . . . 0.0 111.243 -178.107 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 98' ' ' GLU . . . . . . . . . . . . . 96.2 mt-10 -54.95 -26.89 39.45 Favored 'General case' 0 CA--C 1.532 0.276 0 CA-C-N 116.091 -0.504 . . . . 0.0 112.325 -179.041 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 99' ' ' GLU . . . . . . . . . . . . . 12.7 pt-20 -78.9 16.67 0.85 Allowed 'General case' 0 CA--C 1.535 0.382 0 N-CA-C 113.261 0.838 . . . . 0.0 113.261 -177.638 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 100' ' ' ASN . . . . . . . . . . . . . 3.1 m-20 63.53 37.59 10.35 Favored 'General case' 0 C--O 1.232 0.147 0 CA-C-O 121.072 0.463 . . . . 0.0 111.106 176.992 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 101' ' ' GLU . . . . . . . . . . . . . 85.0 tt0 -116.36 142.63 46.59 Favored 'General case' 0 C--N 1.331 -0.238 0 N-CA-C 109.709 -0.478 . . . . 0.0 109.709 175.819 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 102' ' ' VAL . . . . . . . . . . . . . 46.6 t -117.4 125.79 74.23 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.29 0 CA-C-N 116.179 -0.464 . . . . 0.0 109.908 -178.057 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 103' ' ' LEU . . . . . . . . . . . . . 6.3 mp -116.5 134.57 54.7 Favored 'General case' 0 N--CA 1.463 0.185 0 CA-C-N 115.813 -0.631 . . . . 0.0 110.287 177.311 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 104' ' ' ILE . . . . . . . . . . . . . 66.0 mt -121.39 120.94 63.37 Favored 'Isoleucine or valine' 0 C--O 1.234 0.261 0 N-CA-C 110.051 -0.352 . . . . 0.0 110.051 -179.065 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 105' ' ' PHE . . . . . . . . . . . . . 66.3 m-85 -120.89 164.7 16.28 Favored 'General case' 0 C--N 1.331 -0.234 0 O-C-N 124.012 0.82 . . . . 0.0 109.688 179.593 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 106' ' ' ASN . . . . . . . . . . . . . 44.2 p-10 -100.88 -171.13 1.95 Allowed 'General case' 0 C--N 1.33 -0.276 0 N-CA-C 109.737 -0.468 . . . . 0.0 109.737 172.842 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 107' ' ' GLN . . . . . . . . . . . . . 29.7 tt0 -60.83 -27.59 68.19 Favored 'General case' 0 CA--C 1.533 0.31 0 N-CA-C 111.96 0.355 . . . . 0.0 111.96 178.785 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 108' ' ' ASN . . . . . . . . . . . . . 6.3 t-20 -81.97 6.0 17.4 Favored 'General case' 0 CA--C 1.538 0.501 0 N-CA-C 113.06 0.763 . . . . 0.0 113.06 -178.693 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 109' ' ' LEU . . . . . . . . . . . . . 11.2 tp 61.58 37.52 16.17 Favored 'General case' 0 C--O 1.233 0.204 0 CA-C-O 120.952 0.406 . . . . 0.0 111.3 178.319 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 110' ' ' GLU . . . . . . . . . . . . . 43.2 mt-10 -109.02 153.97 22.87 Favored 'General case' 0 C--N 1.33 -0.245 0 N-CA-C 110.091 -0.337 . . . . 0.0 110.091 177.375 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 111' ' ' GLU . . . . . . . . . . . . . 98.3 mt-10 -81.7 121.94 27.02 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-O 120.974 0.416 . . . . 0.0 111.098 -179.814 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 112' ' ' LEU . . . . . . . . . . . . . 21.3 mt -107.45 -45.47 4.07 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 115.887 -0.597 . . . . 0.0 109.963 175.835 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 113' ' ' TYR . . . . . . . . . . . . . 50.4 t80 -139.37 140.51 37.48 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 115.944 -0.571 . . . . 0.0 110.502 179.678 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 114' ' ' ARG . . . . . . . . . . . . . 32.0 ptt180 -150.92 120.74 7.06 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-O 120.917 0.389 . . . . 0.0 110.818 178.476 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 115' ' ' GLY . . . . . . . . . . . . . . . -150.24 163.04 29.42 Favored Glycine 0 CA--C 1.525 0.7 0 N-CA-C 111.314 -0.714 . . . . 0.0 111.314 -179.309 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 116' ' ' LYS . . . . . . . . . . . . . 36.2 ttpt -122.87 136.63 54.93 Favored 'General case' 0 C--N 1.33 -0.261 0 N-CA-C 109.671 -0.492 . . . . 0.0 109.671 175.988 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 117' ' ' PHE . . . . . . . . . . . . . 43.9 m-85 -134.21 115.55 14.3 Favored 'General case' 0 C--N 1.331 -0.22 0 CA-C-O 121.006 0.431 . . . . 0.0 110.343 -176.791 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 118' ' ' GLU . . . . . . . . . . . . . 84.2 tt0 -52.31 -49.16 64.75 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.271 -0.422 . . . . 0.0 111.785 -175.574 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 119' ' ' ASN . . . . . . . . . . . . . 86.2 m-20 -97.57 31.02 2.69 Favored 'General case' 0 C--N 1.33 -0.273 0 N-CA-C 112.284 0.475 . . . . 0.0 112.284 -173.791 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 120' ' ' LEU . . . . . . . . . . . . . 14.7 tp -58.24 121.8 11.63 Favored 'General case' 0 C--N 1.332 -0.177 0 N-CA-C 110.039 -0.356 . . . . 0.0 110.039 177.354 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 121' ' ' ASN . . . . . . . . . . . . . 72.7 m-20 -113.47 -44.05 3.26 Favored 'General case' 0 C--N 1.331 -0.203 0 CA-C-N 116.537 -0.301 . . . . 0.0 111.044 -177.176 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 122' ' ' LYS . . . . . . . . . . . . . 98.9 mttt -144.62 149.07 35.12 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-O 121.068 0.461 . . . . 0.0 111.689 -177.409 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 123' ' ' VAL . . . . . . . . . . . . . 40.3 t -128.81 129.63 68.4 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.305 0 N-CA-C 109.124 -0.695 . . . . 0.0 109.124 173.723 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 124' ' ' LEU . . . . . . . . . . . . . 66.2 mt -124.6 133.68 53.19 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-O 120.892 0.377 . . . . 0.0 111.017 -176.162 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 125' ' ' VAL . . . . . . . . . . . . . 42.0 t -124.92 125.07 69.08 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.239 0 CA-C-N 115.866 -0.606 . . . . 0.0 109.619 177.257 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 126' ' ' ARG . . . . . . . . . . . . . 84.7 mtt180 -149.08 130.35 14.62 Favored 'General case' 0 C--N 1.328 -0.35 0 N-CA-C 110.034 -0.358 . . . . 0.0 110.034 179.058 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 127' ' ' ASN . . . . . . . . . . . . . 3.4 t-20 55.75 -151.72 0.39 Allowed 'General case' 0 CA--C 1.54 0.57 0 N-CA-C 109.841 -0.429 . . . . 0.0 109.841 -179.514 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 128' ' ' ASP . . . . . . . . . . . . . 18.8 p-10 -83.64 17.27 2.31 Favored 'General case' 0 CA--C 1.535 0.37 0 N-CA-C 112.695 0.628 . . . . 0.0 112.695 178.44 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 129' ' ' LEU . . . . . . . . . . . . . 47.4 mt -116.96 138.87 51.27 Favored 'General case' 0 C--O 1.232 0.133 0 CA-C-N 118.1 0.409 . . . . 0.0 110.697 179.563 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 130' ' ' VAL . . . . . . . . . . . . . 45.6 t -124.66 138.64 53.39 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.215 0 CA-C-N 116.127 -0.488 . . . . 0.0 109.814 179.419 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 131' ' ' VAL . . . . . . . . . . . . . 35.3 m -136.0 144.36 33.56 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.24 0 CA-C-O 121.236 0.541 . . . . 0.0 111.359 -179.738 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 132' ' ' ILE . . . . . . . . . . . . . 73.9 mt -117.36 133.64 63.49 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.297 0 CA-C-N 115.326 -0.852 . . . . 0.0 109.269 179.202 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 133' ' ' ILE . . . . . . . . . . . . . 40.9 mm -116.03 119.09 60.87 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.255 0 CA-C-O 120.806 0.336 . . . . 0.0 111.159 -175.204 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 134' ' ' ASP . . . . . . . . . . . . . 8.0 p-10 -133.85 145.59 49.83 Favored 'General case' 0 C--N 1.331 -0.212 0 N-CA-C 109.365 -0.605 . . . . 0.0 109.365 174.181 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 135' ' ' GLU . . . . . . . . . . . . . 43.3 tp10 -50.03 -28.01 6.38 Favored 'General case' 0 C--N 1.327 -0.375 0 N-CA-C 112.616 0.598 . . . . 0.0 112.616 -172.755 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 136' ' ' GLN . . . . . . . . . . . . . 97.4 mt-30 -78.11 -37.19 46.88 Favored 'General case' 0 C--N 1.331 -0.221 0 N-CA-C 112.35 0.5 . . . . 0.0 112.35 -177.188 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 137' ' ' LYS . . . . . . . . . . . . . 53.4 pttt -165.85 172.87 11.17 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-O 121.683 0.754 . . . . 0.0 112.271 -171.964 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 138' ' ' LEU . . . . . . . . . . . . . 6.5 tt -118.14 130.93 56.4 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 114.902 -1.045 . . . . 0.0 109.787 178.359 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 139' ' ' THR . . . . . . . . . . . . . 37.2 m -108.16 129.93 55.15 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.353 179.727 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 140' ' ' LEU . . . . . . . . . . . . . 36.7 tp -113.46 121.83 45.47 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 115.478 -0.783 . . . . 0.0 109.254 -178.298 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 141' ' ' ILE . . . . . . . . . . . . . 19.8 mt -119.65 116.26 50.11 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.292 0 N-CA-C 109.797 -0.446 . . . . 0.0 109.797 -176.42 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 142' ' ' ARG . . . . . . . . . . . . . 84.3 mtp180 -104.88 124.17 49.0 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 115.329 -0.851 . . . . 0.0 110.537 -178.832 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 143' ' ' THR . . . . . . . . . . . . . 37.0 p . . . . . 0 C--O 1.221 -0.412 0 CA-C-O 117.972 -1.013 . . . . 0.0 110.595 -179.912 . . . . . . . . 0 0 . 1 . 008 nuclear orig full ' B' B ' -3' ' ' GLU . . . . . . . . . . . . . 95.8 mt-10 . . . . . 0 N--CA 1.491 1.591 0 N-CA-C 109.354 -0.61 . . . . 0.0 109.354 . . . . . . . . . 0 0 . 1 . 008 nuclear orig full ' B' B ' -2' ' ' GLY . . . . . . . . . . . . . . . -61.45 149.98 45.17 Favored Glycine 0 CA--C 1.526 0.728 0 N-CA-C 110.775 -0.93 . . . . 0.0 110.775 179.804 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' -1' ' ' VAL . . . . . . . . . . . . . 45.2 t -95.77 134.21 34.11 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.332 0 N-CA-C 110.021 -0.363 . . . . 0.0 110.021 -179.796 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 0' ' ' ILE . . . . . . . . . . . . . 43.2 mm -114.51 128.96 71.35 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.236 0 CA-C-N 116.104 -0.498 . . . . 0.0 109.953 179.935 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 1' ' ' MET . . . . . . . . . . . . . 25.4 ptp -81.64 144.37 31.26 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.168 -0.469 . . . . 0.0 110.406 179.534 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 2' ' ' SER . . . . . . . . . . . . . 6.1 p -108.1 132.41 53.61 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-O 121.026 0.441 . . . . 0.0 110.481 -179.879 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 3' ' ' GLU . . . . . . . . . . . . . 84.6 tt0 -141.24 139.35 33.74 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 115.901 -0.591 . . . . 0.0 111.188 -179.108 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 4' ' ' LEU . . . . . . . . . . . . . 48.4 mt -119.75 129.77 54.65 Favored 'General case' 0 C--N 1.331 -0.212 0 CA-C-N 115.791 -0.64 . . . . 0.0 110.37 176.814 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 5' ' ' LYS . . . . . . . . . . . . . 59.9 mttp -104.75 119.22 38.48 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.167 -0.47 . . . . 0.0 110.257 177.187 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 6' ' ' LEU . . . . . . . . . . . . . 62.4 mt -117.46 144.16 45.3 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 115.516 -0.766 . . . . 0.0 110.075 -178.395 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 7' ' ' LYS . . . . . . . . . . . . . 33.7 ttpt -132.71 140.26 37.2 Favored Pre-proline 0 CA--C 1.532 0.279 0 CA-C-O 119.176 -0.44 . . . . 0.0 110.231 176.549 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 8' ' ' PRO . . . . . . . . . . . . . 91.5 Cg_endo -91.98 134.74 1.47 Allowed 'Trans proline' 0 N--CA 1.488 1.191 0 C-N-CA 121.795 1.663 . . . . 0.0 111.543 176.864 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 9' ' ' LEU . . . . . . . . . . . . . 26.8 mt -70.19 -46.99 21.33 Favored Pre-proline 0 CA--C 1.533 0.308 0 CA-C-O 118.683 -0.675 . . . . 0.0 112.026 -178.855 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 10' ' ' PRO . . . . . . . . . . . . . 94.6 Cg_endo -81.89 155.26 17.66 Favored 'Trans proline' 0 N--CA 1.496 1.631 0 C-N-CA 121.29 1.327 . . . . 0.0 111.883 175.372 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 11' ' ' LYS . . . . . . . . . . . . . 38.6 mmtm -88.18 102.6 14.96 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-O 120.793 0.33 . . . . 0.0 110.65 178.105 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 12' ' ' VAL . . . . . . . . . . . . . 12.2 p -146.45 146.47 18.89 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.26 0 CA-C-N 116.207 -0.451 . . . . 0.0 110.267 178.946 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 13' ' ' GLU . . . . . . . . . . . . . 80.6 tt0 -86.54 131.32 34.2 Favored 'General case' 0 C--N 1.33 -0.269 0 N-CA-C 109.941 -0.392 . . . . 0.0 109.941 178.312 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 14' ' ' LEU . . . . . . . . . . . . . 29.5 mt -96.57 151.67 38.11 Favored Pre-proline 0 CA--C 1.533 0.32 0 CA-C-N 116.402 -0.363 . . . . 0.0 110.814 -176.703 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 15' ' ' PRO . . . . . . . . . . . . . 25.8 Cg_exo -62.03 158.64 37.93 Favored 'Trans proline' 0 N--CA 1.497 1.735 0 C-N-CA 121.273 1.315 . . . . 0.0 111.93 176.793 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 16' ' ' PRO . . . . . . . . . . . . . 37.9 Cg_exo -58.71 -38.99 86.29 Favored 'Trans proline' 0 N--CA 1.498 1.741 0 C-N-CA 121.388 1.392 . . . . 0.0 112.835 -178.899 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 17' ' ' ASP . . . . . . . . . . . . . 10.7 p-10 -87.67 10.26 18.71 Favored 'General case' 0 CA--C 1.535 0.371 0 N-CA-C 113.279 0.844 . . . . 0.0 113.279 -176.951 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 18' ' ' PHE . . . . . . . . . . . . . 42.7 t80 -58.0 -44.95 87.5 Favored 'General case' 0 N--CA 1.457 -0.087 0 O-C-N 121.973 -0.454 . . . . 0.0 110.26 -177.489 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 19' ' ' VAL . . . . . . . . . . . . . 13.6 p -56.15 -41.68 70.27 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.327 0 CA-C-N 116.62 -0.263 . . . . 0.0 110.958 -178.589 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 20' ' ' ASP . . . . . . . . . . . . . 82.5 m-20 -60.83 -43.53 98.14 Favored 'General case' 0 C--N 1.331 -0.21 0 CA-C-O 120.799 0.333 . . . . 0.0 110.82 -178.278 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 21' ' ' VAL . . . . . . . . . . . . . 49.1 t -63.94 -48.46 86.05 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.285 0 C-N-CA 120.744 -0.383 . . . . 0.0 110.509 -177.347 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 22' ' ' ILE . . . . . . . . . . . . . 49.8 mm -55.61 -47.06 79.35 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.274 0 C-N-CA 120.978 -0.289 . . . . 0.0 110.892 -179.34 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 23' ' ' ARG . . . . . . . . . . . . . 45.7 ttp180 -55.69 -48.94 74.25 Favored 'General case' 0 C--N 1.33 -0.255 0 C-N-CA 120.83 -0.348 . . . . 0.0 111.234 -177.841 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 24' ' ' ILE . . . . . . . . . . . . . 76.3 mt -59.85 -41.63 86.39 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.215 0 C-N-CA 121.081 -0.248 . . . . 0.0 111.203 -177.407 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 25' ' ' LYS . . . . . . . . . . . . . 40.3 mmtm -64.08 -43.03 96.67 Favored 'General case' 0 C--N 1.329 -0.3 0 N-CA-C 112.216 0.451 . . . . 0.0 112.216 -179.593 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 26' ' ' LEU . . . . . . . . . . . . . 71.4 mt -78.69 -38.51 39.05 Favored 'General case' 0 C--N 1.328 -0.327 0 N-CA-C 113.502 0.927 . . . . 0.0 113.502 -169.888 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 27' ' ' GLN . . . . . . . . . . . . . 10.3 pt20 -47.52 140.13 6.21 Favored 'General case' 0 N--CA 1.469 0.51 0 N-CA-C 112.704 0.631 . . . . 0.0 112.704 -174.788 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 28' ' ' GLY . . . . . . . . . . . . . . . 98.73 -27.46 19.64 Favored Glycine 0 CA--C 1.532 1.137 0 CA-C-N 115.53 -0.759 . . . . 0.0 112.179 -178.438 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 29' ' ' LYS . . . . . . . . . . . . . 61.3 mtpt -98.25 155.03 17.38 Favored 'General case' 0 C--N 1.332 -0.181 0 CA-C-N 117.314 0.557 . . . . 0.0 111.06 179.602 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 30' ' ' THR . . . . . . . . . . . . . 30.1 m -94.54 136.73 34.51 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.032 -0.531 . . . . 0.0 110.003 176.321 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 31' ' ' VAL . . . . . . . . . . . . . 35.1 m -124.87 148.4 29.28 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.228 0 CA-C-N 116.308 -0.406 . . . . 0.0 110.549 -179.798 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 32' ' ' ARG . . . . . . . . . . . . . 33.6 ttm180 -136.02 146.52 47.24 Favored 'General case' 0 C--N 1.331 -0.219 0 CA-C-O 121.267 0.555 . . . . 0.0 110.583 178.501 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 33' ' ' THR . . . . . . . . . . . . . 22.8 m -53.04 139.93 26.72 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.206 -0.452 . . . . 0.0 111.317 -178.56 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 34' ' ' GLY . . . . . . . . . . . . . . . 101.23 -17.18 56.19 Favored Glycine 0 CA--C 1.534 1.254 0 CA-C-O 119.669 -0.517 . . . . 0.0 113.172 -179.989 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 35' ' ' ASP . . . . . . . . . . . . . 80.2 m-20 -66.57 146.99 53.9 Favored 'General case' 0 N--CA 1.461 0.108 0 CA-C-N 118.024 0.912 . . . . 0.0 111.086 178.421 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 36' ' ' VAL . . . . . . . . . . . . . 43.6 t -123.1 130.99 74.06 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.258 0 CA-C-N 116.009 -0.541 . . . . 0.0 109.781 177.898 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 37' ' ' ILE . . . . . . . . . . . . . 66.7 mt -122.17 138.84 51.02 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.289 0 CA-C-N 116.285 -0.416 . . . . 0.0 110.093 -179.401 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 38' ' ' GLY . . . . . . . . . . . . . . . -108.76 128.63 9.15 Favored Glycine 0 CA--C 1.526 0.746 0 N-CA-C 110.995 -0.842 . . . . 0.0 110.995 178.878 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 39' ' ' ILE . . . . . . . . . . . . . 74.6 mt -125.77 136.84 59.61 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.21 0 N-CA-C 110.16 -0.311 . . . . 0.0 110.16 179.766 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 40' ' ' SER . . . . . . . . . . . . . 38.0 t -92.59 115.33 28.0 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.363 -0.38 . . . . 0.0 110.832 175.822 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 41' ' ' ILE . . . . . . . . . . . . . 44.3 mm -121.48 119.1 58.03 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.198 0 CA-C-N 116.509 -0.314 . . . . 0.0 110.412 -179.905 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 42' ' ' LEU . . . . . . . . . . . . . 9.6 tp 53.27 36.88 23.86 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.194 -0.457 . . . . 0.0 111.576 176.964 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 43' ' ' GLY . . . . . . . . . . . . . . . 72.99 27.26 69.06 Favored Glycine 0 CA--C 1.53 0.993 0 C-N-CA 121.145 -0.55 . . . . 0.0 112.591 177.02 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 44' ' ' LYS . . . . . . . . . . . . . 97.8 mttt -136.67 134.91 37.76 Favored 'General case' 0 C--N 1.331 -0.212 0 N-CA-C 109.58 -0.526 . . . . 0.0 109.58 177.47 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 45' ' ' GLU . . . . . . . . . . . . . 84.3 tt0 -82.82 122.55 28.36 Favored 'General case' 0 C--N 1.329 -0.321 0 C-N-CA 120.701 -0.4 . . . . 0.0 111.066 -177.726 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 46' ' ' VAL . . . . . . . . . . . . . 7.1 p -121.04 128.53 76.08 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.206 0 N-CA-C 109.391 -0.596 . . . . 0.0 109.391 175.768 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 47' ' ' LYS . . . . . . . . . . . . . 68.5 mttm -100.31 126.87 46.69 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 115.979 -0.555 . . . . 0.0 110.971 178.335 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 48' ' ' PHE . . . . . . . . . . . . . 90.3 m-85 -109.14 131.95 54.58 Favored 'General case' 0 C--N 1.331 -0.228 0 N-CA-C 109.697 -0.483 . . . . 0.0 109.697 176.661 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 49' ' ' LYS . . . . . . . . . . . . . 83.1 tttt -108.54 135.5 49.7 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.282 -0.417 . . . . 0.0 110.371 179.037 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 50' ' ' VAL . . . . . . . . . . . . . 47.4 t -79.8 106.84 11.49 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.273 0 N-CA-C 109.164 -0.68 . . . . 0.0 109.164 175.906 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 51' ' ' VAL . . . . . . . . . . . . . 47.9 t -72.65 -48.62 45.55 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.273 0 CA-C-N 115.961 -0.563 . . . . 0.0 110.098 -173.547 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 52' ' ' GLN . . . . . . . . . . . . . 62.5 tt0 -161.83 145.58 12.4 Favored 'General case' 0 C--N 1.33 -0.246 0 C-N-CA 120.207 -0.597 . . . . 0.0 111.597 -177.341 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 53' ' ' ALA . . . . . . . . . . . . . . . -122.71 134.73 54.45 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 115.877 -0.602 . . . . 0.0 109.852 175.852 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 54' ' ' TYR . . . . . . . . . . . . . 31.2 t80 -129.07 111.71 18.4 Favored Pre-proline 0 CA--C 1.534 0.361 0 CA-C-O 118.331 -0.842 . . . . 0.0 110.506 -179.716 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 55' ' ' PRO . . . . . . . . . . . . . 74.3 Cg_endo -77.18 168.28 77.37 Favored 'Cis proline' 0 N--CA 1.5 1.882 0 CA-C-N 121.832 1.69 . . . . 0.0 112.005 -8.089 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 56' ' ' SER . . . . . . . . . . . . . 49.8 m -117.03 136.38 23.3 Favored Pre-proline 0 CA--C 1.537 0.468 0 CA-C-O 118.525 -0.75 . . . . 0.0 109.796 175.952 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 57' ' ' PRO . . . . . . . . . . . . . 43.1 Cg_endo -69.61 163.52 81.22 Favored 'Cis proline' 0 N--CA 1.497 1.714 0 CA-C-N 121.794 1.677 . . . . 0.0 111.259 -4.277 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 58' ' ' LEU . . . . . . . . . . . . . 20.8 tp -130.4 138.95 50.61 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-O 120.811 0.338 . . . . 0.0 110.829 -178.583 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 59' ' ' ARG . . . . . . . . . . . . . 55.9 ttp180 -99.18 124.17 44.02 Favored 'General case' 0 C--N 1.328 -0.352 0 N-CA-C 109.2 -0.667 . . . . 0.0 109.2 174.035 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 60' ' ' VAL . . . . . . . . . . . . . 40.7 t -73.77 125.35 32.77 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.289 0 C-N-CA 120.595 -0.442 . . . . 0.0 110.341 -175.113 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 61' ' ' GLU . . . . . . . . . . . . . 95.9 mt-10 -130.26 160.9 32.48 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 115.837 -0.619 . . . . 0.0 110.092 179.699 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 62' ' ' ASP . . . . . . . . . . . . . 7.3 p-10 -56.08 -32.9 64.56 Favored 'General case' 0 C--N 1.328 -0.349 0 C-N-CA 120.852 -0.339 . . . . 0.0 111.435 178.69 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 63' ' ' ARG . . . . . . . . . . . . . 15.5 ptm180 -82.59 6.7 16.82 Favored 'General case' 0 CA--C 1.537 0.473 0 N-CA-C 113.52 0.933 . . . . 0.0 113.52 -177.361 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 64' ' ' THR . . . . . . . . . . . . . 21.3 m -87.2 139.39 30.61 Favored 'General case' 0 C--N 1.333 -0.13 0 CA-C-N 118.119 0.418 . . . . 0.0 110.611 -178.262 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 65' ' ' LYS . . . . . . . . . . . . . 48.7 mtmt -88.89 128.71 35.68 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.082 -0.508 . . . . 0.0 110.373 179.291 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 66' ' ' ILE . . . . . . . . . . . . . 66.9 mt -117.73 128.31 74.94 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.261 0 N-CA-C 109.783 -0.451 . . . . 0.0 109.783 179.928 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 67' ' ' THR . . . . . . . . . . . . . 25.2 m -122.2 135.88 54.83 Favored 'General case' 0 C--N 1.332 -0.172 0 CA-C-O 121.074 0.464 . . . . 0.0 110.727 -179.096 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 68' ' ' LEU . . . . . . . . . . . . . 8.0 mp -106.48 126.98 52.94 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 115.815 -0.63 . . . . 0.0 110.344 178.781 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 69' ' ' VAL . . . . . . . . . . . . . 44.1 t -98.17 130.91 46.25 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.247 0 CA-C-N 116.037 -0.529 . . . . 0.0 109.717 178.487 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 70' ' ' THR . . . . . . . . . . . . . 36.7 p -139.35 -54.63 0.57 Allowed 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.295 -0.411 . . . . 0.0 110.723 -178.389 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 71' ' ' HIS . . . . . . . . . . . . . 77.7 m80 -121.03 155.27 58.03 Favored Pre-proline 0 C--N 1.33 -0.261 0 CA-C-N 116.335 -0.393 . . . . 0.0 110.591 -179.504 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 72' ' ' PRO . . . . . . . . . . . . . 42.3 Cg_endo -67.94 -29.23 34.74 Favored 'Trans proline' 0 N--CA 1.496 1.622 0 C-N-CA 121.331 1.354 . . . . 0.0 112.481 178.931 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 73' ' ' VAL . . . . . . . . . . . . . 34.9 m -73.08 142.86 14.49 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.236 0 CA-C-O 121.052 0.453 . . . . 0.0 110.828 -179.19 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 74' ' ' ASP . . . . . . . . . . . . . 12.8 t70 -94.07 121.33 35.45 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 115.679 -0.691 . . . . 0.0 109.686 178.067 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 75' ' ' VAL . . . . . . . . . . . . . 45.8 t -110.29 122.57 65.06 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.236 0 CA-C-O 121.246 0.545 . . . . 0.0 110.42 -178.378 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 76' ' ' LEU . . . . . . . . . . . . . 26.7 mt -126.93 146.56 50.27 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 115.39 -0.823 . . . . 0.0 109.422 178.687 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 77' ' ' GLU . . . . . . . . . . . . . 97.6 mt-10 -134.35 138.8 45.18 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-O 121.089 0.471 . . . . 0.0 111.193 -177.346 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 78' ' ' ALA . . . . . . . . . . . . . . . -125.29 130.54 52.22 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 115.636 -0.711 . . . . 0.0 109.607 176.203 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 79' ' ' LYS . . . . . . . . . . . . . 79.4 tttt -78.45 119.48 21.81 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-O 120.906 0.384 . . . . 0.0 110.636 -176.508 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 80' ' ' ILE . . . . . . . . . . . . . 37.6 mm -139.24 105.02 2.32 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.325 0 N-CA-C 108.926 -0.768 . . . . 0.0 108.926 -178.807 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 81' ' ' LYS . . . . . . . . . . . . . 56.1 pttt -98.54 127.98 44.68 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-O 120.936 0.398 . . . . 0.0 111.557 -176.71 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 82' ' ' GLY . . . . . . . . . . . . . . . 89.14 42.12 5.67 Favored Glycine 0 CA--C 1.526 0.766 0 C-N-CA 121.036 -0.602 . . . . 0.0 111.975 175.148 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 83' ' ' ILE . . . . . . . . . . . . . 74.2 mt -71.81 138.88 20.72 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 N-CA-C 109.646 -0.502 . . . . 0.0 109.646 176.478 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 84' ' ' LYS . . . . . . . . . . . . . 33.1 ttpt -99.88 -52.94 3.3 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-O 120.938 0.399 . . . . 0.0 110.177 -179.802 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 85' ' ' ASP . . . . . . . . . . . . . 11.1 t70 -145.88 147.43 31.77 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 115.915 -0.584 . . . . 0.0 110.518 -178.813 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 86' ' ' VAL . . . . . . . . . . . . . 44.9 t -128.06 131.88 69.04 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.254 0 CA-C-O 120.81 0.338 . . . . 0.0 110.496 -179.105 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 87' ' ' ILE . . . . . . . . . . . . . 5.1 mp -122.26 127.15 75.1 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.168 0 N-CA-C 109.692 -0.485 . . . . 0.0 109.692 177.434 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 88' ' ' LEU . . . . . . . . . . . . . 17.4 tp -111.22 131.63 54.97 Favored 'General case' 0 C--N 1.331 -0.201 0 CA-C-O 120.954 0.407 . . . . 0.0 110.934 -178.471 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 89' ' ' ASP . . . . . . . . . . . . . 5.9 t70 -126.09 155.33 41.77 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.014 -0.539 . . . . 0.0 109.73 178.039 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 90' ' ' GLU . . . . . . . . . . . . . 84.2 tt0 -47.12 -38.52 11.68 Favored 'General case' 0 CA--C 1.531 0.248 0 N-CA-C 112.888 0.699 . . . . 0.0 112.888 -172.181 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 91' ' ' ASN . . . . . . . . . . . . . 14.7 m120 -128.09 17.42 6.66 Favored 'General case' 0 N--CA 1.469 0.482 0 N-CA-C 113.007 0.743 . . . . 0.0 113.007 -177.085 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 92' ' ' LEU . . . . . . . . . . . . . 35.6 mt -147.91 144.46 28.09 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-O 120.801 0.334 . . . . 0.0 110.433 -176.171 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 93' ' ' ILE . . . . . . . . . . . . . 70.5 mt -122.84 115.32 45.49 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.373 0 N-CA-C 109.056 -0.72 . . . . 0.0 109.056 177.376 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 94' ' ' VAL . . . . . . . . . . . . . 42.6 t -117.32 126.84 74.81 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.283 0 CA-C-O 120.901 0.381 . . . . 0.0 110.178 -177.111 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 95' ' ' VAL . . . . . . . . . . . . . 46.5 t -122.39 133.18 69.41 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.337 0 CA-C-N 115.933 -0.576 . . . . 0.0 109.773 179.874 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 96' ' ' ILE . . . . . . . . . . . . . 66.0 mt -115.21 125.22 72.43 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.329 0 N-CA-C 109.315 -0.624 . . . . 0.0 109.315 179.097 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 97' ' ' THR . . . . . . . . . . . . . 80.4 p -99.75 158.0 16.09 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-O 121.202 0.525 . . . . 0.0 111.191 -176.127 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 98' ' ' GLU . . . . . . . . . . . . . 44.9 mt-10 -53.95 -26.12 24.03 Favored 'General case' 0 C--N 1.329 -0.319 0 N-CA-C 112.308 0.485 . . . . 0.0 112.308 -179.268 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 99' ' ' GLU . . . . . . . . . . . . . 70.0 mm-40 -78.84 15.73 1.02 Allowed 'General case' 0 CA--C 1.535 0.371 0 N-CA-C 113.203 0.816 . . . . 0.0 113.203 -176.829 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 100' ' ' ASN . . . . . . . . . . . . . 2.4 m-20 62.24 38.01 13.74 Favored 'General case' 0 N--CA 1.463 0.2 0 CA-C-O 121.118 0.485 . . . . 0.0 110.996 178.647 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 101' ' ' GLU . . . . . . . . . . . . . 84.6 tt0 -116.77 142.79 46.46 Favored 'General case' 0 C--N 1.331 -0.224 0 CA-C-N 116.021 -0.536 . . . . 0.0 109.917 176.486 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 102' ' ' VAL . . . . . . . . . . . . . 43.2 t -114.96 125.0 72.17 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.327 0 N-CA-C 109.738 -0.467 . . . . 0.0 109.738 -178.957 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 103' ' ' LEU . . . . . . . . . . . . . 57.5 mt -115.23 131.52 56.9 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 115.637 -0.71 . . . . 0.0 109.906 177.819 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 104' ' ' ILE . . . . . . . . . . . . . 67.4 mt -118.82 118.39 57.61 Favored 'Isoleucine or valine' 0 C--O 1.234 0.271 0 N-CA-C 110.096 -0.335 . . . . 0.0 110.096 -178.831 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 105' ' ' PHE . . . . . . . . . . . . . 68.8 m-85 -115.07 162.95 16.31 Favored 'General case' 0 C--N 1.332 -0.191 0 O-C-N 124.196 0.935 . . . . 0.0 109.893 179.265 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 106' ' ' ASN . . . . . . . . . . . . . 45.0 p-10 -102.62 -170.11 1.76 Allowed 'General case' 0 C--N 1.329 -0.3 0 N-CA-C 109.801 -0.444 . . . . 0.0 109.801 174.392 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 107' ' ' GLN . . . . . . . . . . . . . 60.3 tt0 -58.52 -28.27 65.28 Favored 'General case' 0 C--N 1.33 -0.248 0 N-CA-C 111.968 0.359 . . . . 0.0 111.968 177.682 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 108' ' ' ASN . . . . . . . . . . . . . 10.6 t-20 -84.11 7.09 19.9 Favored 'General case' 0 CA--C 1.536 0.439 0 N-CA-C 113.235 0.828 . . . . 0.0 113.235 -177.625 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 109' ' ' LEU . . . . . . . . . . . . . 6.5 tp 60.52 36.61 19.97 Favored 'General case' 0 C--O 1.233 0.197 0 CA-C-O 120.891 0.377 . . . . 0.0 111.414 178.745 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 110' ' ' GLU . . . . . . . . . . . . . 70.8 mm-40 -115.45 150.64 36.14 Favored 'General case' 0 C--N 1.331 -0.215 0 CA-C-O 120.723 0.297 . . . . 0.0 110.321 177.117 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 111' ' ' GLU . . . . . . . . . . . . . 24.7 mm-40 -78.14 122.69 25.97 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-O 121.188 0.518 . . . . 0.0 111.762 -177.752 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 112' ' ' LEU . . . . . . . . . . . . . 57.7 mt -102.94 -42.63 5.76 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 115.449 -0.796 . . . . 0.0 110.137 173.622 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 113' ' ' TYR . . . . . . . . . . . . . 56.3 t80 -139.12 140.81 38.05 Favored 'General case' 0 N--CA 1.463 0.205 0 CA-C-O 120.978 0.418 . . . . 0.0 111.329 -179.677 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 114' ' ' ARG . . . . . . . . . . . . . 66.4 mtm180 -139.85 125.27 19.06 Favored 'General case' 0 C--N 1.331 -0.22 0 CA-C-N 115.794 -0.639 . . . . 0.0 110.247 177.515 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 115' ' ' GLY . . . . . . . . . . . . . . . -150.03 153.12 24.9 Favored Glycine 0 CA--C 1.524 0.604 0 C-N-CA 120.697 -0.763 . . . . 0.0 111.581 179.46 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 116' ' ' LYS . . . . . . . . . . . . . 39.8 ttpt -122.16 135.15 54.75 Favored 'General case' 0 C--N 1.33 -0.258 0 N-CA-C 109.602 -0.518 . . . . 0.0 109.602 176.104 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 117' ' ' PHE . . . . . . . . . . . . . 47.1 m-85 -134.92 113.96 12.06 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-O 121.037 0.446 . . . . 0.0 110.335 -176.611 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 118' ' ' GLU . . . . . . . . . . . . . 84.8 tt0 -53.41 -49.87 66.38 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.384 -0.371 . . . . 0.0 111.485 -176.771 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 119' ' ' ASN . . . . . . . . . . . . . 19.6 m-80 -94.21 30.99 1.77 Allowed 'General case' 0 C--N 1.329 -0.284 0 N-CA-C 112.111 0.412 . . . . 0.0 112.111 -174.591 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 120' ' ' LEU . . . . . . . . . . . . . 14.9 tp -57.42 122.88 13.65 Favored 'General case' 0 C--N 1.332 -0.188 0 N-CA-C 110.28 -0.267 . . . . 0.0 110.28 178.289 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 121' ' ' ASN . . . . . . . . . . . . . 80.9 m-20 -114.01 -44.07 3.19 Favored 'General case' 0 C--N 1.331 -0.204 0 CA-C-N 116.628 -0.26 . . . . 0.0 111.215 -176.617 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 122' ' ' LYS . . . . . . . . . . . . . 54.0 mttm -143.34 145.71 32.92 Favored 'General case' 0 C--N 1.331 -0.199 0 C-N-CA 120.593 -0.443 . . . . 0.0 111.478 -177.406 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 123' ' ' VAL . . . . . . . . . . . . . 46.3 t -126.31 128.54 71.59 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.259 0 N-CA-C 109.38 -0.6 . . . . 0.0 109.38 175.522 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 124' ' ' LEU . . . . . . . . . . . . . 40.4 mt -126.84 136.45 52.37 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-O 120.812 0.339 . . . . 0.0 110.773 -177.292 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 125' ' ' VAL . . . . . . . . . . . . . 11.4 p -136.23 130.39 47.83 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.298 0 CA-C-N 116.338 -0.392 . . . . 0.0 110.134 177.244 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 126' ' ' ARG . . . . . . . . . . . . . 29.5 mmm180 -138.17 119.91 15.2 Favored 'General case' 0 C--N 1.331 -0.201 0 CA-C-N 116.281 -0.418 . . . . 0.0 110.417 -178.977 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 127' ' ' ASN . . . . . . . . . . . . . 78.3 m-20 50.14 -104.85 0.16 Allowed 'General case' 0 CA--C 1.544 0.713 0 CA-C-O 119.176 -0.44 . . . . 0.0 111.794 176.622 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 128' ' ' ASP . . . . . . . . . . . . . 18.1 p-10 -110.54 -0.43 17.34 Favored 'General case' 0 CA--C 1.536 0.415 0 N-CA-C 113.752 1.019 . . . . 0.0 113.752 -174.759 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 129' ' ' LEU . . . . . . . . . . . . . 83.7 mt -111.01 144.22 40.47 Favored 'General case' 0 C--N 1.332 -0.175 0 O-C-N 121.972 -0.455 . . . . 0.0 110.273 179.349 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 130' ' ' VAL . . . . . . . . . . . . . 13.6 p -130.81 138.58 53.25 Favored 'Isoleucine or valine' 0 C--O 1.233 0.214 0 CA-C-O 121.188 0.518 . . . . 0.0 110.423 178.706 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 131' ' ' VAL . . . . . . . . . . . . . 37.5 t -135.11 138.95 48.06 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.263 0 CA-C-N 115.858 -0.61 . . . . 0.0 110.47 -175.773 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 132' ' ' ILE . . . . . . . . . . . . . 70.1 mt -117.22 129.77 73.21 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.283 0 CA-C-N 115.866 -0.606 . . . . 0.0 109.409 178.869 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 133' ' ' ILE . . . . . . . . . . . . . 43.5 mm -114.0 119.46 61.22 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.244 0 CA-C-O 120.815 0.34 . . . . 0.0 110.652 -176.183 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 134' ' ' ASP . . . . . . . . . . . . . 9.0 p-10 -134.43 143.04 47.33 Favored 'General case' 0 C--N 1.33 -0.27 0 N-CA-C 109.586 -0.524 . . . . 0.0 109.586 177.05 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 135' ' ' GLU . . . . . . . . . . . . . 85.7 tt0 -49.93 -25.84 3.63 Favored 'General case' 0 C--N 1.328 -0.347 0 N-CA-C 112.594 0.59 . . . . 0.0 112.594 -174.316 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 136' ' ' GLN . . . . . . . . . . . . . 53.2 mt-30 -78.95 -38.28 37.48 Favored 'General case' 0 CA--C 1.531 0.216 0 N-CA-C 112.138 0.422 . . . . 0.0 112.138 -178.016 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 137' ' ' LYS . . . . . . . . . . . . . 19.6 ptpt -162.77 174.46 12.44 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-O 121.49 0.662 . . . . 0.0 111.958 -173.458 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 138' ' ' LEU . . . . . . . . . . . . . 6.1 tt -117.88 126.77 53.0 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 115.098 -0.956 . . . . 0.0 109.568 177.007 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 139' ' ' THR . . . . . . . . . . . . . 28.6 m -108.78 124.86 51.26 Favored 'General case' 0 C--N 1.331 -0.204 0 CA-C-N 116.372 -0.376 . . . . 0.0 110.619 -178.882 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 140' ' ' LEU . . . . . . . . . . . . . 17.9 tp -112.17 119.02 36.95 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 115.579 -0.737 . . . . 0.0 109.124 -179.449 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 141' ' ' ILE . . . . . . . . . . . . . 19.9 mt -119.29 121.11 65.74 Favored 'Isoleucine or valine' 0 C--O 1.235 0.309 0 CA-C-O 121.236 0.541 . . . . 0.0 110.375 -176.209 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 142' ' ' ARG . . . . . . . . . . . . . 7.8 mmm180 -94.75 117.34 29.97 Favored 'General case' 0 C--N 1.331 -0.224 0 CA-C-N 114.861 -1.063 . . . . 0.0 109.718 177.86 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 143' ' ' THR . . . . . . . . . . . . . 6.0 p . . . . . 0 C--O 1.221 -0.444 0 CA-C-O 117.929 -1.034 . . . . 0.0 110.523 -177.914 . . . . . . . . 0 0 . 1 . 008 nuclear orig full ' C' C ' -3' ' ' GLU . . . . . . . . . . . . . 95.9 mt-10 . . . . . 0 N--CA 1.49 1.541 0 N-CA-C 109.442 -0.577 . . . . 0.0 109.442 . . . . . . . . . 0 0 . 1 . 008 nuclear orig full ' C' C ' -2' ' ' GLY . . . . . . . . . . . . . . . -76.62 150.02 37.55 Favored Glycine 0 CA--C 1.525 0.68 0 N-CA-C 110.945 -0.862 . . . . 0.0 110.945 179.665 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' C' C ' -1' ' ' VAL . . . . . . . . . . . . . 47.5 t -88.9 133.85 29.97 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.325 0 CA-C-O 120.892 0.377 . . . . 0.0 110.007 179.792 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' C' C ' 0' ' ' ILE . . . . . . . . . . . . . 73.6 mt -112.27 133.92 56.45 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.242 0 CA-C-N 116.142 -0.481 . . . . 0.0 109.943 -179.606 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' C' C ' 1' ' ' MET . . . . . . . . . . . . . 26.0 ptm -79.67 132.18 36.16 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.224 -0.443 . . . . 0.0 110.246 178.181 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' C' C ' 2' ' ' SER . . . . . . . . . . . . . 3.1 p -130.58 125.96 35.5 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-O 121.041 0.448 . . . . 0.0 110.41 -179.63 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' C' C ' 3' ' ' GLU . . . . . . . . . . . . . 96.0 mt-10 -140.35 141.1 35.68 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 115.72 -0.673 . . . . 0.0 110.951 -177.886 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' C' C ' 4' ' ' LEU . . . . . . . . . . . . . 18.3 tp -123.19 127.06 48.12 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 115.771 -0.65 . . . . 0.0 109.799 175.795 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' C' C ' 5' ' ' LYS . . . . . . . . . . . . . 98.8 mttt -110.41 119.77 40.28 Favored 'General case' 0 C--O 1.234 0.26 0 CA-C-N 116.427 -0.352 . . . . 0.0 110.789 -179.257 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' C' C ' 6' ' ' LEU . . . . . . . . . . . . . 70.9 mt -114.8 143.98 44.23 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 115.302 -0.863 . . . . 0.0 110.277 -179.187 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' C' C ' 7' ' ' LYS . . . . . . . . . . . . . 51.3 tttm -128.26 133.29 24.99 Favored Pre-proline 0 CA--C 1.535 0.39 0 CA-C-O 118.777 -0.63 . . . . 0.0 110.102 177.442 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' C' C ' 8' ' ' PRO . . . . . . . . . . . . . 73.4 Cg_endo -89.01 136.32 2.95 Favored 'Trans proline' 0 N--CA 1.491 1.378 0 C-N-CA 121.61 1.54 . . . . 0.0 111.501 176.699 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' C' C ' 9' ' ' LEU . . . . . . . . . . . . . 75.8 mt -75.29 -52.08 3.16 Favored Pre-proline 0 CA--C 1.533 0.32 0 CA-C-O 118.712 -0.661 . . . . 0.0 112.02 -177.312 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' C' C ' 10' ' ' PRO . . . . . . . . . . . . . 60.4 Cg_endo -72.95 150.23 48.54 Favored 'Trans proline' 0 N--CA 1.5 1.866 0 C-N-CA 121.085 1.19 . . . . 0.0 111.948 174.375 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' C' C ' 11' ' ' LYS . . . . . . . . . . . . . 41.0 mtpt -89.13 100.78 13.49 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.502 -0.317 . . . . 0.0 110.825 179.391 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' C' C ' 12' ' ' VAL . . . . . . . . . . . . . 12.4 p -146.24 143.39 21.09 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.336 0 CA-C-N 116.265 -0.425 . . . . 0.0 110.579 179.223 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' C' C ' 13' ' ' GLU . . . . . . . . . . . . . 95.0 mt-10 -81.09 123.99 28.85 Favored 'General case' 0 C--N 1.33 -0.274 0 N-CA-C 109.98 -0.378 . . . . 0.0 109.98 177.916 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' C' C ' 14' ' ' LEU . . . . . . . . . . . . . 28.2 mt -98.27 152.31 37.92 Favored Pre-proline 0 CA--C 1.532 0.287 0 CA-C-N 116.425 -0.352 . . . . 0.0 110.601 -179.046 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' C' C ' 15' ' ' PRO . . . . . . . . . . . . . 34.3 Cg_exo -58.41 156.07 32.74 Favored 'Trans proline' 0 N--CA 1.497 1.693 0 C-N-CA 121.323 1.348 . . . . 0.0 111.854 178.088 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' C' C ' 16' ' ' PRO . . . . . . . . . . . . . 39.3 Cg_exo -58.85 -34.36 99.01 Favored 'Trans proline' 0 N--CA 1.496 1.64 0 C-N-CA 121.475 1.45 . . . . 0.0 112.677 -179.821 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' C' C ' 17' ' ' ASP . . . . . . . . . . . . . 19.4 p-10 -85.3 9.78 14.37 Favored 'General case' 0 CA--C 1.535 0.375 0 N-CA-C 113.081 0.771 . . . . 0.0 113.081 -177.545 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' C' C ' 18' ' ' PHE . . . . . . . . . . . . . 34.7 t80 -56.79 -42.15 78.96 Favored 'General case' 0 C--N 1.333 -0.118 0 O-C-N 121.939 -0.476 . . . . 0.0 110.365 -179.378 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' C' C ' 19' ' ' VAL . . . . . . . . . . . . . 53.1 t -56.43 -44.47 80.34 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 CA-C-N 116.361 -0.381 . . . . 0.0 110.469 -179.335 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' C' C ' 20' ' ' ASP . . . . . . . . . . . . . 82.8 m-20 -59.8 -42.5 93.55 Favored 'General case' 0 C--N 1.329 -0.308 0 C-N-CA 120.817 -0.353 . . . . 0.0 110.785 -178.271 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' C' C ' 21' ' ' VAL . . . . . . . . . . . . . 56.2 t -63.37 -47.75 90.45 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.303 0 C-N-CA 120.736 -0.385 . . . . 0.0 110.464 -177.294 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' C' C ' 22' ' ' ILE . . . . . . . . . . . . . 51.3 mm -55.42 -48.75 76.64 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.326 0 C-N-CA 121.077 -0.249 . . . . 0.0 110.8 -179.976 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' C' C ' 23' ' ' ARG . . . . . . . . . . . . . 55.4 ttp180 -55.66 -47.8 76.09 Favored 'General case' 0 C--N 1.33 -0.276 0 C-N-CA 120.806 -0.358 . . . . 0.0 111.415 -177.314 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' C' C ' 24' ' ' ILE . . . . . . . . . . . . . 75.8 mt -59.29 -42.01 85.87 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.311 0 C-N-CA 121.089 -0.244 . . . . 0.0 111.315 -177.284 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' C' C ' 25' ' ' LYS . . . . . . . . . . . . . 93.3 mttt -67.82 -43.79 78.78 Favored 'General case' 0 C--N 1.331 -0.219 0 N-CA-C 112.6 0.592 . . . . 0.0 112.6 -178.903 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' C' C ' 26' ' ' LEU . . . . . . . . . . . . . 70.6 mt -78.31 -33.96 48.98 Favored 'General case' 0 C--N 1.329 -0.313 0 N-CA-C 113.548 0.944 . . . . 0.0 113.548 -169.967 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' C' C ' 27' ' ' GLN . . . . . . . . . . . . . 6.2 pt20 -46.76 138.79 5.86 Favored 'General case' 0 N--CA 1.467 0.385 0 N-CA-C 112.971 0.73 . . . . 0.0 112.971 -173.925 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' C' C ' 28' ' ' GLY . . . . . . . . . . . . . . . 100.05 -27.18 21.51 Favored Glycine 0 CA--C 1.532 1.116 0 CA-C-N 115.614 -0.721 . . . . 0.0 112.214 -178.906 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' C' C ' 29' ' ' LYS . . . . . . . . . . . . . 61.8 mttp -97.96 155.21 17.2 Favored 'General case' 0 C--O 1.232 0.159 0 CA-C-N 117.341 0.571 . . . . 0.0 111.301 179.475 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' C' C ' 30' ' ' THR . . . . . . . . . . . . . 37.3 m -104.92 139.95 38.89 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-N 115.954 -0.566 . . . . 0.0 109.898 175.817 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' C' C ' 31' ' ' VAL . . . . . . . . . . . . . 34.7 m -127.31 152.26 35.13 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.218 0 CA-C-O 120.947 0.403 . . . . 0.0 111.077 -178.048 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' C' C ' 32' ' ' ARG . . . . . . . . . . . . . 97.1 mtt180 -126.35 149.47 49.17 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 115.834 -0.621 . . . . 0.0 110.622 177.912 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' C' C ' 33' ' ' THR . . . . . . . . . . . . . 17.6 m -53.65 138.81 33.93 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-N 116.118 -0.492 . . . . 0.0 111.308 -178.658 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' C' C ' 34' ' ' GLY . . . . . . . . . . . . . . . 100.2 -17.15 57.4 Favored Glycine 0 CA--C 1.533 1.194 0 CA-C-O 119.672 -0.515 . . . . 0.0 113.333 178.967 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' C' C ' 35' ' ' ASP . . . . . . . . . . . . . 77.5 m-20 -65.53 148.35 51.88 Favored 'General case' 0 N--CA 1.462 0.142 0 CA-C-N 117.965 0.883 . . . . 0.0 110.922 178.869 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' C' C ' 36' ' ' VAL . . . . . . . . . . . . . 41.4 t -120.53 131.52 72.49 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.258 0 CA-C-N 116.007 -0.542 . . . . 0.0 109.858 178.943 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' C' C ' 37' ' ' ILE . . . . . . . . . . . . . 67.1 mt -118.68 138.11 50.46 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.225 0 CA-C-N 116.082 -0.508 . . . . 0.0 109.682 179.276 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' C' C ' 38' ' ' GLY . . . . . . . . . . . . . . . -114.85 128.75 8.28 Favored Glycine 0 CA--C 1.525 0.67 0 N-CA-C 111.006 -0.838 . . . . 0.0 111.006 -179.878 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' C' C ' 39' ' ' ILE . . . . . . . . . . . . . 73.0 mt -123.21 137.35 56.89 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.186 0 N-CA-C 110.252 -0.277 . . . . 0.0 110.252 179.585 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' C' C ' 40' ' ' SER . . . . . . . . . . . . . 99.5 p -91.69 117.71 30.0 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.329 -0.396 . . . . 0.0 110.713 175.767 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' C' C ' 41' ' ' ILE . . . . . . . . . . . . . 72.0 mt -127.79 121.48 56.64 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.202 0 CA-C-O 120.902 0.382 . . . . 0.0 110.397 178.82 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' C' C ' 42' ' ' LEU . . . . . . . . . . . . . 10.8 tp 52.3 35.61 17.5 Favored 'General case' 0 CA--C 1.531 0.23 0 CA-C-N 116.036 -0.529 . . . . 0.0 111.614 177.087 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' C' C ' 43' ' ' GLY . . . . . . . . . . . . . . . 72.07 31.88 63.73 Favored Glycine 0 CA--C 1.529 0.92 0 C-N-CA 121.183 -0.532 . . . . 0.0 111.972 178.047 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' C' C ' 44' ' ' LYS . . . . . . . . . . . . . 40.7 ttpt -138.79 129.75 26.58 Favored 'General case' 0 C--N 1.329 -0.313 0 N-CA-C 109.609 -0.515 . . . . 0.0 109.609 178.743 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' C' C ' 45' ' ' GLU . . . . . . . . . . . . . 84.6 tt0 -82.6 118.23 23.14 Favored 'General case' 0 C--N 1.328 -0.335 0 C-N-CA 120.753 -0.379 . . . . 0.0 110.673 -178.768 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' C' C ' 46' ' ' VAL . . . . . . . . . . . . . 7.5 p -114.94 127.36 72.52 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.153 0 N-CA-C 109.285 -0.635 . . . . 0.0 109.285 176.795 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' C' C ' 47' ' ' LYS . . . . . . . . . . . . . 64.2 mttp -100.45 128.15 46.59 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 115.817 -0.629 . . . . 0.0 111.306 179.724 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' C' C ' 48' ' ' PHE . . . . . . . . . . . . . 94.9 m-85 -111.83 131.86 55.07 Favored 'General case' 0 C--N 1.329 -0.283 0 N-CA-C 109.652 -0.499 . . . . 0.0 109.652 174.956 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' C' C ' 49' ' ' LYS . . . . . . . . . . . . . 41.8 tttp -107.57 136.57 47.12 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.619 -0.264 . . . . 0.0 110.427 179.287 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' C' C ' 50' ' ' VAL . . . . . . . . . . . . . 46.4 t -79.87 108.75 13.69 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.305 0 N-CA-C 109.164 -0.68 . . . . 0.0 109.164 176.273 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' C' C ' 51' ' ' VAL . . . . . . . . . . . . . 46.8 t -73.24 -51.63 25.13 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.293 0 CA-C-N 116.153 -0.476 . . . . 0.0 109.737 -175.336 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' C' C ' 52' ' ' GLN . . . . . . . . . . . . . 86.2 mt-30 -154.03 149.17 26.91 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-O 121.334 0.587 . . . . 0.0 112.077 -178.007 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' C' C ' 53' ' ' ALA . . . . . . . . . . . . . . . -124.25 130.31 52.3 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 115.091 -0.958 . . . . 0.0 109.5 172.885 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' C' C ' 54' ' ' TYR . . . . . . . . . . . . . 45.5 t80 -128.97 107.08 18.1 Favored Pre-proline 0 CA--C 1.535 0.386 0 CA-C-O 118.24 -0.886 . . . . 0.0 110.593 -179.383 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' C' C ' 55' ' ' PRO . . . . . . . . . . . . . 73.3 Cg_endo -77.1 168.68 76.34 Favored 'Cis proline' 0 N--CA 1.499 1.827 0 CA-C-N 121.821 1.686 . . . . 0.0 112.243 -5.413 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' C' C ' 56' ' ' SER . . . . . . . . . . . . . 71.1 m -116.57 133.26 23.03 Favored Pre-proline 0 CA--C 1.537 0.472 0 CA-C-O 118.544 -0.741 . . . . 0.0 109.342 174.989 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' C' C ' 57' ' ' PRO . . . . . . . . . . . . . 55.3 Cg_endo -70.79 146.27 83.94 Favored 'Cis proline' 0 N--CA 1.498 1.745 0 CA-C-N 121.844 1.694 . . . . 0.0 111.688 -0.561 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' C' C ' 58' ' ' LEU . . . . . . . . . . . . . 31.4 tp -108.03 137.63 45.7 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.085 -0.507 . . . . 0.0 110.605 -178.7 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' C' C ' 59' ' ' ARG . . . . . . . . . . . . . 37.1 ttm180 -98.91 133.56 43.02 Favored 'General case' 0 C--N 1.328 -0.355 0 N-CA-C 109.453 -0.573 . . . . 0.0 109.453 175.273 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' C' C ' 60' ' ' VAL . . . . . . . . . . . . . 40.1 t -87.01 113.8 25.16 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.236 0 C-N-CA 120.616 -0.434 . . . . 0.0 110.386 -178.112 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' C' C ' 61' ' ' GLU . . . . . . . . . . . . . 15.7 mm-40 -131.1 163.66 27.17 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 115.944 -0.571 . . . . 0.0 109.769 174.246 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' C' C ' 62' ' ' ASP . . . . . . . . . . . . . 81.8 m-20 -52.32 -32.21 36.79 Favored 'General case' 0 C--N 1.329 -0.309 0 N-CA-C 111.802 0.297 . . . . 0.0 111.802 177.743 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' C' C ' 63' ' ' ARG . . . . . . . . . . . . . 41.4 mtp180 -72.07 -22.07 61.42 Favored 'General case' 0 CA--C 1.533 0.299 0 N-CA-C 112.884 0.698 . . . . 0.0 112.884 -176.484 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' C' C ' 64' ' ' THR . . . . . . . . . . . . . 40.5 m -72.27 138.12 47.22 Favored 'General case' 0 C--N 1.332 -0.186 0 CA-C-O 120.918 0.39 . . . . 0.0 110.657 -176.467 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' C' C ' 65' ' ' LYS . . . . . . . . . . . . . 38.8 ttpt -88.63 127.11 35.56 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 115.989 -0.551 . . . . 0.0 110.239 179.549 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' C' C ' 66' ' ' ILE . . . . . . . . . . . . . 72.5 mt -112.96 132.09 62.72 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.28 0 CA-C-O 120.892 0.377 . . . . 0.0 110.064 -178.053 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' C' C ' 67' ' ' THR . . . . . . . . . . . . . 23.4 m -125.29 137.26 54.07 Favored 'General case' 0 C--N 1.331 -0.212 0 CA-C-N 116.091 -0.504 . . . . 0.0 110.655 -179.239 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' C' C ' 68' ' ' LEU . . . . . . . . . . . . . 13.8 tp -104.74 124.82 50.06 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 115.887 -0.597 . . . . 0.0 110.527 179.841 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' C' C ' 69' ' ' VAL . . . . . . . . . . . . . 44.5 t -102.09 129.52 53.33 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.284 0 CA-C-N 116.02 -0.536 . . . . 0.0 109.695 178.589 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' C' C ' 70' ' ' THR . . . . . . . . . . . . . 40.5 p -144.71 -44.74 0.24 Allowed 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.299 -0.41 . . . . 0.0 110.574 -178.997 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' C' C ' 71' ' ' HIS . . . . . . . . . . . . . 31.7 m80 -124.52 166.43 19.84 Favored Pre-proline 0 C--N 1.329 -0.295 0 CA-C-N 115.909 -0.587 . . . . 0.0 110.297 -179.661 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' C' C ' 72' ' ' PRO . . . . . . . . . . . . . 17.3 Cg_exo -64.82 -23.16 62.81 Favored 'Trans proline' 0 N--CA 1.497 1.703 0 C-N-CA 121.356 1.371 . . . . 0.0 112.838 179.924 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' C' C ' 73' ' ' VAL . . . . . . . . . . . . . 34.6 m -126.3 157.57 36.64 Favored 'Isoleucine or valine' 0 N--CA 1.462 0.159 0 CA-C-O 120.752 0.31 . . . . 0.0 110.369 179.134 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' C' C ' 74' ' ' ASP . . . . . . . . . . . . . 42.3 t0 -104.55 121.52 43.66 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-N 116.332 -0.394 . . . . 0.0 110.183 -177.966 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' C' C ' 75' ' ' VAL . . . . . . . . . . . . . 40.6 t -118.24 125.91 74.62 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.326 0 CA-C-O 121.107 0.479 . . . . 0.0 111.005 -176.462 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' C' C ' 76' ' ' LEU . . . . . . . . . . . . . 6.8 mp -121.53 143.99 48.96 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 115.601 -0.727 . . . . 0.0 109.732 174.681 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' C' C ' 77' ' ' GLU . . . . . . . . . . . . . 97.0 mt-10 -134.47 130.67 37.06 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-O 120.988 0.423 . . . . 0.0 111.016 -177.995 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' C' C ' 78' ' ' ALA . . . . . . . . . . . . . . . -117.98 134.09 55.29 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 115.663 -0.699 . . . . 0.0 109.766 176.933 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' C' C ' 79' ' ' LYS . . . . . . . . . . . . . 49.2 mtmt -77.47 120.71 22.85 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-O 120.967 0.413 . . . . 0.0 110.967 -177.956 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' C' C ' 80' ' ' ILE . . . . . . . . . . . . . 42.1 mm -139.09 108.54 3.87 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.322 0 N-CA-C 108.933 -0.765 . . . . 0.0 108.933 -179.009 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' C' C ' 81' ' ' LYS . . . . . . . . . . . . . 44.0 mtmt -101.44 123.34 45.34 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-O 120.723 0.297 . . . . 0.0 111.257 -176.382 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' C' C ' 82' ' ' GLY . . . . . . . . . . . . . . . 89.07 42.43 5.62 Favored Glycine 0 CA--C 1.526 0.738 0 C-N-CA 120.652 -0.785 . . . . 0.0 111.794 174.674 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' C' C ' 83' ' ' ILE . . . . . . . . . . . . . 68.0 mt -65.29 137.03 25.73 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 CA-C-O 121.001 0.429 . . . . 0.0 109.862 177.733 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' C' C ' 84' ' ' LYS . . . . . . . . . . . . . 46.3 tttp -92.94 -52.52 4.55 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 115.942 -0.572 . . . . 0.0 109.94 179.891 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' C' C ' 85' ' ' ASP . . . . . . . . . . . . . 7.0 t70 -154.33 151.98 29.71 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 115.478 -0.783 . . . . 0.0 110.321 -179.225 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' C' C ' 86' ' ' VAL . . . . . . . . . . . . . 43.4 t -130.46 129.76 64.8 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.287 0 CA-C-N 116.47 -0.332 . . . . 0.0 110.495 -179.485 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' C' C ' 87' ' ' ILE . . . . . . . . . . . . . 5.1 mp -119.37 128.78 75.85 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.285 0 N-CA-C 109.405 -0.591 . . . . 0.0 109.405 176.184 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' C' C ' 88' ' ' LEU . . . . . . . . . . . . . 23.7 tp -117.58 135.96 53.61 Favored 'General case' 0 C--N 1.331 -0.216 0 CA-C-O 121.014 0.435 . . . . 0.0 111.556 -176.126 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' C' C ' 89' ' ' ASP . . . . . . . . . . . . . 10.9 t70 -130.01 154.31 47.53 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 115.665 -0.698 . . . . 0.0 109.19 174.537 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' C' C ' 90' ' ' GLU . . . . . . . . . . . . . 96.6 mt-10 -49.81 -35.0 21.26 Favored 'General case' 0 C--N 1.33 -0.261 0 N-CA-C 112.718 0.636 . . . . 0.0 112.718 -172.277 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' C' C ' 91' ' ' ASN . . . . . . . . . . . . . 86.2 m-20 -130.29 32.61 4.44 Favored 'General case' 0 N--CA 1.465 0.294 0 N-CA-C 111.99 0.367 . . . . 0.0 111.99 -175.902 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' C' C ' 92' ' ' LEU . . . . . . . . . . . . . 8.7 tp -166.1 145.75 6.15 Favored 'General case' 0 C--N 1.331 -0.228 0 C-N-CA 120.933 -0.307 . . . . 0.0 110.782 178.67 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' C' C ' 93' ' ' ILE . . . . . . . . . . . . . 68.0 mt -125.93 124.08 65.47 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.181 0 N-CA-C 109.586 -0.524 . . . . 0.0 109.586 179.391 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' C' C ' 94' ' ' VAL . . . . . . . . . . . . . 43.3 t -122.64 125.21 72.21 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.223 0 N-CA-C 109.937 -0.394 . . . . 0.0 109.937 179.344 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' C' C ' 95' ' ' VAL . . . . . . . . . . . . . 43.8 t -124.08 134.67 65.94 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.299 0 CA-C-N 116.305 -0.407 . . . . 0.0 110.168 -179.461 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' C' C ' 96' ' ' ILE . . . . . . . . . . . . . 61.1 mt -118.99 130.52 73.7 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.238 0 N-CA-C 109.457 -0.571 . . . . 0.0 109.457 179.54 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' C' C ' 97' ' ' THR . . . . . . . . . . . . . 81.1 p -103.46 158.44 16.35 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-O 121.088 0.47 . . . . 0.0 111.44 -177.295 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' C' C ' 98' ' ' GLU . . . . . . . . . . . . . 98.1 mt-10 -53.97 -26.5 26.09 Favored 'General case' 0 CA--C 1.532 0.257 0 N-CA-C 112.392 0.516 . . . . 0.0 112.392 179.998 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' C' C ' 99' ' ' GLU . . . . . . . . . . . . . 95.8 mt-10 -77.78 14.05 1.18 Allowed 'General case' 0 CA--C 1.535 0.391 0 N-CA-C 113.302 0.853 . . . . 0.0 113.302 -177.23 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' C' C ' 100' ' ' ASN . . . . . . . . . . . . . 4.6 m-20 63.01 37.95 11.35 Favored 'General case' 0 C--O 1.232 0.142 0 CA-C-O 121.08 0.467 . . . . 0.0 111.033 178.489 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' C' C ' 101' ' ' GLU . . . . . . . . . . . . . 84.9 tt0 -117.65 140.11 50.1 Favored 'General case' 0 C--N 1.333 -0.151 0 CA-C-N 116.083 -0.508 . . . . 0.0 109.646 175.697 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' C' C ' 102' ' ' VAL . . . . . . . . . . . . . 45.7 t -115.16 128.83 72.18 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.263 0 CA-C-N 116.311 -0.404 . . . . 0.0 110.063 -178.667 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' C' C ' 103' ' ' LEU . . . . . . . . . . . . . 6.1 mp -118.4 132.94 56.24 Favored 'General case' 0 C--N 1.331 -0.201 0 CA-C-N 115.695 -0.684 . . . . 0.0 110.131 176.904 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' C' C ' 104' ' ' ILE . . . . . . . . . . . . . 67.9 mt -117.92 122.48 69.82 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.228 0 CA-C-N 116.328 -0.397 . . . . 0.0 109.972 -179.766 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' C' C ' 105' ' ' PHE . . . . . . . . . . . . . 67.1 m-85 -123.16 164.67 18.24 Favored 'General case' 0 C--N 1.333 -0.132 0 O-C-N 123.916 0.76 . . . . 0.0 109.777 -179.972 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' C' C ' 106' ' ' ASN . . . . . . . . . . . . . 47.3 p-10 -102.42 -172.08 2.07 Favored 'General case' 0 C--N 1.33 -0.246 0 N-CA-C 110.151 -0.315 . . . . 0.0 110.151 174.688 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' C' C ' 107' ' ' GLN . . . . . . . . . . . . . 29.1 tt0 -58.81 -28.07 65.67 Favored 'General case' 0 C--N 1.329 -0.311 0 N-CA-C 112.086 0.402 . . . . 0.0 112.086 179.166 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' C' C ' 108' ' ' ASN . . . . . . . . . . . . . 7.9 t-20 -84.75 12.12 7.85 Favored 'General case' 0 CA--C 1.537 0.453 0 N-CA-C 112.89 0.7 . . . . 0.0 112.89 -177.956 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' C' C ' 109' ' ' LEU . . . . . . . . . . . . . 10.7 tp 53.8 37.22 25.89 Favored 'General case' 0 C--N 1.333 -0.148 0 CA-C-O 121.089 0.471 . . . . 0.0 111.315 179.409 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' C' C ' 110' ' ' GLU . . . . . . . . . . . . . 96.0 mt-10 -105.98 141.88 36.64 Favored 'General case' 0 C--N 1.33 -0.272 0 N-CA-C 109.325 -0.62 . . . . 0.0 109.325 174.528 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' C' C ' 111' ' ' GLU . . . . . . . . . . . . . 51.4 tt0 -79.61 121.92 25.87 Favored 'General case' 0 C--N 1.328 -0.332 0 C-N-CA 120.693 -0.403 . . . . 0.0 110.286 -176.478 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' C' C ' 112' ' ' LEU . . . . . . . . . . . . . 34.3 mt -102.85 -46.11 4.79 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.034 -0.53 . . . . 0.0 110.72 -179.668 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' C' C ' 113' ' ' TYR . . . . . . . . . . . . . 59.1 t80 -137.45 140.8 41.46 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.034 -0.53 . . . . 0.0 110.927 -177.824 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' C' C ' 114' ' ' ARG . . . . . . . . . . . . . 28.5 ptt180 -144.83 126.08 14.75 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-O 120.93 0.395 . . . . 0.0 110.664 176.56 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' C' C ' 115' ' ' GLY . . . . . . . . . . . . . . . -150.01 151.8 23.82 Favored Glycine 0 CA--C 1.524 0.61 0 N-CA-C 111.131 -0.788 . . . . 0.0 111.131 179.297 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' C' C ' 116' ' ' LYS . . . . . . . . . . . . . 39.7 ttpt -119.53 132.55 55.78 Favored 'General case' 0 C--N 1.329 -0.296 0 N-CA-C 110.006 -0.368 . . . . 0.0 110.006 178.185 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' C' C ' 117' ' ' PHE . . . . . . . . . . . . . 37.5 m-85 -128.93 113.8 15.66 Favored 'General case' 0 C--N 1.329 -0.286 0 N-CA-C 109.878 -0.416 . . . . 0.0 109.878 -178.257 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' C' C ' 118' ' ' GLU . . . . . . . . . . . . . 85.1 tt0 -55.54 -38.49 69.35 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-N 116.398 -0.364 . . . . 0.0 111.339 -175.308 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' C' C ' 119' ' ' ASN . . . . . . . . . . . . . 10.5 p-10 -108.73 31.14 5.87 Favored 'General case' 0 N--CA 1.463 0.196 0 N-CA-C 112.237 0.458 . . . . 0.0 112.237 -173.106 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' C' C ' 120' ' ' LEU . . . . . . . . . . . . . 15.0 tp -54.36 126.81 24.71 Favored 'General case' 0 N--CA 1.463 0.21 0 O-C-N 122.358 -0.213 . . . . 0.0 110.683 177.024 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' C' C ' 121' ' ' ASN . . . . . . . . . . . . . 27.1 m120 -110.56 -44.22 3.72 Favored 'General case' 0 C--N 1.332 -0.187 0 C-N-CA 121.169 -0.212 . . . . 0.0 111.173 -177.06 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' C' C ' 122' ' ' LYS . . . . . . . . . . . . . 95.2 mttt -148.36 148.15 30.05 Favored 'General case' 0 C--N 1.331 -0.229 0 CA-C-O 121.028 0.442 . . . . 0.0 111.44 -178.266 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' C' C ' 123' ' ' VAL . . . . . . . . . . . . . 47.0 t -127.42 128.33 69.83 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.223 0 N-CA-C 109.569 -0.53 . . . . 0.0 109.569 174.769 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' C' C ' 124' ' ' LEU . . . . . . . . . . . . . 67.9 mt -126.45 135.22 51.1 Favored 'General case' 0 C--N 1.331 -0.217 0 CA-C-N 116.494 -0.321 . . . . 0.0 110.626 -178.785 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' C' C ' 125' ' ' VAL . . . . . . . . . . . . . 12.4 p -138.05 137.45 44.5 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.284 0 CA-C-N 116.442 -0.345 . . . . 0.0 110.524 179.141 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' C' C ' 126' ' ' ARG . . . . . . . . . . . . . 90.6 mtt180 -143.96 123.32 13.08 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.565 178.676 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' C' C ' 127' ' ' ASN . . . . . . . . . . . . . 1.9 m-80 51.67 -105.02 0.19 Allowed 'General case' 0 CA--C 1.544 0.723 0 CA-C-O 119.134 -0.46 . . . . 0.0 111.279 -179.814 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' C' C ' 128' ' ' ASP . . . . . . . . . . . . . 8.9 p-10 -114.11 1.99 14.77 Favored 'General case' 0 CA--C 1.536 0.406 0 CA-C-N 119.538 1.063 . . . . 0.0 113.49 -176.53 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' C' C ' 129' ' ' LEU . . . . . . . . . . . . . 54.4 mt -104.97 135.49 46.21 Favored 'General case' 0 C--N 1.332 -0.185 0 CA-C-N 118.193 0.451 . . . . 0.0 110.401 179.618 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' C' C ' 130' ' ' VAL . . . . . . . . . . . . . 47.2 t -123.35 135.16 64.15 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.22 0 N-CA-C 109.913 -0.403 . . . . 0.0 109.913 179.991 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' C' C ' 131' ' ' VAL . . . . . . . . . . . . . 42.0 t -134.32 135.37 54.29 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.344 0 CA-C-O 121.125 0.488 . . . . 0.0 110.103 178.257 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' C' C ' 132' ' ' ILE . . . . . . . . . . . . . 72.5 mt -115.35 130.2 70.31 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.361 0 CA-C-N 115.498 -0.774 . . . . 0.0 109.179 -179.682 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' C' C ' 133' ' ' ILE . . . . . . . . . . . . . 44.6 mm -114.06 120.03 62.78 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.248 0 CA-C-O 120.981 0.419 . . . . 0.0 110.631 -176.226 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' C' C ' 134' ' ' ASP . . . . . . . . . . . . . 6.7 p-10 -129.58 149.51 51.31 Favored 'General case' 0 C--N 1.331 -0.23 0 CA-C-N 115.97 -0.559 . . . . 0.0 109.539 176.117 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' C' C ' 135' ' ' GLU . . . . . . . . . . . . . 41.4 tp10 -49.96 -27.05 4.81 Favored 'General case' 0 C--N 1.327 -0.378 0 N-CA-C 112.806 0.669 . . . . 0.0 112.806 -169.927 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' C' C ' 136' ' ' GLN . . . . . . . . . . . . . 30.7 tt0 -103.67 -22.82 13.51 Favored 'General case' 0 N--CA 1.465 0.282 0 N-CA-C 113.093 0.775 . . . . 0.0 113.093 -173.402 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' C' C ' 137' ' ' LYS . . . . . . . . . . . . . 54.0 mtmt -148.77 157.16 43.24 Favored 'General case' 0 C--N 1.332 -0.153 0 CA-C-O 121.212 0.529 . . . . 0.0 112.008 -170.649 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' C' C ' 138' ' ' LEU . . . . . . . . . . . . . 5.5 tt -120.18 125.48 48.29 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 115.568 -0.742 . . . . 0.0 109.444 175.312 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' C' C ' 139' ' ' THR . . . . . . . . . . . . . 37.6 m -111.57 131.57 55.15 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-O 120.762 0.315 . . . . 0.0 111.126 -176.463 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' C' C ' 140' ' ' LEU . . . . . . . . . . . . . 14.3 tp -116.35 122.5 45.06 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 115.527 -0.761 . . . . 0.0 109.428 -179.67 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' C' C ' 141' ' ' ILE . . . . . . . . . . . . . 19.5 mt -120.77 119.45 59.59 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.29 0 N-CA-C 109.687 -0.486 . . . . 0.0 109.687 -177.258 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' C' C ' 142' ' ' ARG . . . . . . . . . . . . . 53.2 ttt180 -108.96 125.28 51.87 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 115.301 -0.863 . . . . 0.0 110.501 -176.341 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' C' C ' 143' ' ' THR . . . . . . . . . . . . . 81.0 p . . . . . 0 C--O 1.219 -0.503 0 CA-C-O 117.945 -1.026 . . . . 0.0 110.522 179.33 . . . . . . . . 0 0 . 1 . 008 nuclear orig full ' D' D ' -3' ' ' GLU . . . . . . . . . . . . . 84.6 tt0 . . . . . 0 N--CA 1.491 1.61 0 N-CA-C 109.505 -0.554 . . . . 0.0 109.505 . . . . . . . . . 0 0 . 1 . 008 nuclear orig full ' D' D ' -2' ' ' GLY . . . . . . . . . . . . . . . -60.69 146.28 47.07 Favored Glycine 0 CA--C 1.525 0.683 0 N-CA-C 110.501 -1.04 . . . . 0.0 110.501 178.607 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' D' D ' -1' ' ' VAL . . . . . . . . . . . . . 43.0 t -95.08 129.8 44.73 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.28 0 CA-C-O 120.818 0.342 . . . . 0.0 110.143 -178.933 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' D' D ' 0' ' ' ILE . . . . . . . . . . . . . 70.8 mt -118.56 143.43 29.54 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.28 0 CA-C-N 116.066 -0.515 . . . . 0.0 109.78 -179.975 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' D' D ' 1' ' ' MET . . . . . . . . . . . . . 22.2 ptm -142.91 125.53 15.86 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.043 -0.526 . . . . 0.0 110.382 -179.62 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' D' D ' 2' ' ' SER . . . . . . . . . . . . . 4.2 p -107.28 127.81 53.87 Favored 'General case' 0 C--N 1.331 -0.206 0 CA-C-O 121.167 0.508 . . . . 0.0 110.698 -179.343 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' D' D ' 3' ' ' GLU . . . . . . . . . . . . . 84.8 tt0 -141.28 141.97 33.92 Favored 'General case' 0 C--N 1.326 -0.423 0 CA-C-N 115.578 -0.737 . . . . 0.0 111.121 -178.25 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' D' D ' 4' ' ' LEU . . . . . . . . . . . . . 65.2 mt -119.9 128.98 54.14 Favored 'General case' 0 C--N 1.331 -0.224 0 CA-C-N 115.739 -0.664 . . . . 0.0 110.436 176.303 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' D' D ' 5' ' ' LYS . . . . . . . . . . . . . 61.1 mttp -106.02 119.55 39.49 Favored 'General case' 0 C--O 1.235 0.322 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.303 176.62 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' D' D ' 6' ' ' LEU . . . . . . . . . . . . . 73.2 mt -118.18 152.08 36.36 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-N 115.457 -0.792 . . . . 0.0 110.726 -177.72 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' D' D ' 7' ' ' LYS . . . . . . . . . . . . . 29.2 ttpt -143.27 140.92 18.28 Favored Pre-proline 0 CA--C 1.534 0.354 0 CA-C-O 119.19 -0.434 . . . . 0.0 110.067 174.33 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' D' D ' 8' ' ' PRO . . . . . . . . . . . . . 93.9 Cg_endo -89.27 138.23 3.25 Favored 'Trans proline' 0 N--CA 1.489 1.23 0 C-N-CA 121.752 1.635 . . . . 0.0 111.555 177.875 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' D' D ' 9' ' ' LEU . . . . . . . . . . . . . 84.9 mt -70.85 -48.81 14.59 Favored Pre-proline 0 C--N 1.329 -0.306 0 CA-C-O 119.143 -0.456 . . . . 0.0 111.045 -178.824 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' D' D ' 10' ' ' PRO . . . . . . . . . . . . . 95.6 Cg_endo -79.75 138.44 13.36 Favored 'Trans proline' 0 N--CA 1.495 1.57 0 C-N-CA 121.098 1.198 . . . . 0.0 111.228 169.398 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' D' D ' 11' ' ' LYS . . . . . . . . . . . . . 82.3 tttt -87.88 102.86 15.11 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-O 120.886 0.375 . . . . 0.0 110.472 -178.923 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' D' D ' 12' ' ' VAL . . . . . . . . . . . . . 12.1 p -140.77 147.86 22.43 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.248 0 CA-C-N 116.127 -0.488 . . . . 0.0 110.518 -179.391 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' D' D ' 13' ' ' GLU . . . . . . . . . . . . . 95.2 mt-10 -78.93 123.36 27.19 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 116.3 -0.409 . . . . 0.0 110.041 178.392 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' D' D ' 14' ' ' LEU . . . . . . . . . . . . . 21.8 mt -98.55 153.88 37.76 Favored Pre-proline 0 C--N 1.33 -0.24 0 CA-C-N 116.427 -0.351 . . . . 0.0 111.103 -178.072 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' D' D ' 15' ' ' PRO . . . . . . . . . . . . . 37.9 Cg_exo -59.72 158.8 26.85 Favored 'Trans proline' 0 N--CA 1.497 1.717 0 C-N-CA 121.359 1.373 . . . . 0.0 111.83 178.295 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' D' D ' 16' ' ' PRO . . . . . . . . . . . . . 26.4 Cg_exo -60.47 -37.96 77.21 Favored 'Trans proline' 0 N--CA 1.498 1.787 0 C-N-CA 121.424 1.416 . . . . 0.0 112.911 -177.347 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' D' D ' 17' ' ' ASP . . . . . . . . . . . . . 22.6 p-10 -89.93 11.01 21.71 Favored 'General case' 0 CA--C 1.537 0.464 0 N-CA-C 113.303 0.853 . . . . 0.0 113.303 -176.47 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' D' D ' 18' ' ' PHE . . . . . . . . . . . . . 51.2 t80 -57.97 -42.81 85.83 Favored 'General case' 0 C--O 1.227 -0.081 0 O-C-N 121.996 -0.44 . . . . 0.0 110.113 -178.933 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' D' D ' 19' ' ' VAL . . . . . . . . . . . . . 48.2 t -57.34 -41.22 77.93 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.306 0 CA-C-N 116.234 -0.439 . . . . 0.0 110.391 -178.624 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' D' D ' 20' ' ' ASP . . . . . . . . . . . . . 79.7 m-20 -59.9 -43.53 94.77 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-O 120.798 0.333 . . . . 0.0 110.876 -177.916 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' D' D ' 21' ' ' VAL . . . . . . . . . . . . . 45.4 t -64.63 -46.46 92.37 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.312 0 C-N-CA 120.719 -0.392 . . . . 0.0 110.527 -177.801 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' D' D ' 22' ' ' ILE . . . . . . . . . . . . . 50.3 mm -56.44 -45.6 81.86 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.276 0 CA-C-O 120.727 0.299 . . . . 0.0 110.571 179.215 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' D' D ' 23' ' ' ARG . . . . . . . . . . . . . 59.4 ttp180 -53.34 -49.7 66.56 Favored 'General case' 0 C--N 1.331 -0.224 0 CA-C-O 120.835 0.35 . . . . 0.0 111.412 -178.704 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' D' D ' 24' ' ' ILE . . . . . . . . . . . . . 72.9 mt -59.61 -45.76 93.83 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.262 0 CA-C-N 116.281 -0.418 . . . . 0.0 111.136 -177.32 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' D' D ' 25' ' ' LYS . . . . . . . . . . . . . 59.4 mtpt -65.32 -37.35 86.83 Favored 'General case' 0 C--N 1.33 -0.263 0 N-CA-C 112.354 0.502 . . . . 0.0 112.354 -177.121 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' D' D ' 26' ' ' LEU . . . . . . . . . . . . . 25.9 mt -78.25 -45.68 22.26 Favored 'General case' 0 C--N 1.329 -0.296 0 N-CA-C 112.979 0.733 . . . . 0.0 112.979 -172.781 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' D' D ' 27' ' ' GLN . . . . . . . . . . . . . 11.3 pt20 -46.89 138.52 6.29 Favored 'General case' 0 N--CA 1.468 0.452 0 N-CA-C 112.728 0.64 . . . . 0.0 112.728 -175.68 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' D' D ' 28' ' ' GLY . . . . . . . . . . . . . . . 100.89 -26.6 24.04 Favored Glycine 0 CA--C 1.534 1.223 0 CA-C-N 115.542 -0.754 . . . . 0.0 112.274 -176.596 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' D' D ' 29' ' ' LYS . . . . . . . . . . . . . 65.8 mttm -98.74 155.12 17.51 Favored 'General case' 0 C--N 1.332 -0.154 0 CA-C-N 117.261 0.53 . . . . 0.0 111.217 179.259 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' D' D ' 30' ' ' THR . . . . . . . . . . . . . 17.7 m -102.73 137.13 41.35 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.185 -0.461 . . . . 0.0 110.084 176.128 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' D' D ' 31' ' ' VAL . . . . . . . . . . . . . 33.8 m -130.87 156.88 43.04 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.263 0 CA-C-O 120.816 0.341 . . . . 0.0 110.857 -179.158 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' D' D ' 32' ' ' ARG . . . . . . . . . . . . . 60.9 ttt180 -134.62 150.0 50.63 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 115.992 -0.549 . . . . 0.0 110.218 178.283 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' D' D ' 33' ' ' THR . . . . . . . . . . . . . 31.7 m -52.38 140.17 22.79 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-O 120.826 0.346 . . . . 0.0 111.421 -177.737 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' D' D ' 34' ' ' GLY . . . . . . . . . . . . . . . 99.68 -17.1 57.99 Favored Glycine 0 CA--C 1.531 1.053 0 C-N-CA 121.199 -0.524 . . . . 0.0 113.286 179.105 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' D' D ' 35' ' ' ASP . . . . . . . . . . . . . 72.5 m-20 -65.16 149.1 50.49 Favored 'General case' 0 C--O 1.231 0.101 0 CA-C-N 118.086 0.943 . . . . 0.0 111.141 179.427 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' D' D ' 36' ' ' VAL . . . . . . . . . . . . . 46.1 t -123.1 131.13 73.81 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.223 0 CA-C-N 115.683 -0.69 . . . . 0.0 109.798 178.409 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' D' D ' 37' ' ' ILE . . . . . . . . . . . . . 71.5 mt -119.59 139.79 45.75 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.251 0 CA-C-N 116.166 -0.47 . . . . 0.0 109.958 -179.709 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' D' D ' 38' ' ' GLY . . . . . . . . . . . . . . . -113.01 128.74 8.55 Favored Glycine 0 CA--C 1.526 0.721 0 N-CA-C 111.051 -0.82 . . . . 0.0 111.051 179.492 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' D' D ' 39' ' ' ILE . . . . . . . . . . . . . 68.3 mt -123.28 133.65 68.53 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.185 0 N-CA-C 110.103 -0.332 . . . . 0.0 110.103 179.241 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' D' D ' 40' ' ' SER . . . . . . . . . . . . . 93.4 p -92.69 122.67 35.32 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.394 -0.366 . . . . 0.0 110.729 175.859 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' D' D ' 41' ' ' ILE . . . . . . . . . . . . . 68.2 mt -129.04 119.64 49.76 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.219 0 CA-C-O 120.754 0.312 . . . . 0.0 110.482 178.218 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' D' D ' 42' ' ' LEU . . . . . . . . . . . . . 10.4 tp 51.94 37.21 20.4 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.143 -0.48 . . . . 0.0 111.594 176.907 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' D' D ' 43' ' ' GLY . . . . . . . . . . . . . . . 72.96 30.13 63.84 Favored Glycine 0 CA--C 1.528 0.886 0 C-N-CA 121.007 -0.616 . . . . 0.0 112.34 177.512 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' D' D ' 44' ' ' LYS . . . . . . . . . . . . . 81.9 mttt -136.57 129.39 30.78 Favored 'General case' 0 C--N 1.329 -0.313 0 N-CA-C 109.667 -0.494 . . . . 0.0 109.667 177.925 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' D' D ' 45' ' ' GLU . . . . . . . . . . . . . 85.2 tt0 -83.56 123.42 29.74 Favored 'General case' 0 C--N 1.329 -0.3 0 C-N-CA 120.812 -0.355 . . . . 0.0 111.141 -177.854 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' D' D ' 46' ' ' VAL . . . . . . . . . . . . . 7.7 p -120.97 128.3 76.06 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.231 0 N-CA-C 109.481 -0.563 . . . . 0.0 109.481 175.972 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' D' D ' 47' ' ' LYS . . . . . . . . . . . . . 35.3 mtmm -102.11 129.72 48.52 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 115.809 -0.632 . . . . 0.0 111.645 -179.892 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' D' D ' 48' ' ' PHE . . . . . . . . . . . . . 88.3 m-85 -112.8 131.97 55.46 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.368 -0.378 . . . . 0.0 110.37 177.224 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' D' D ' 49' ' ' LYS . . . . . . . . . . . . . 60.5 tttt -106.01 137.39 44.0 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.517 -0.31 . . . . 0.0 110.576 178.796 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' D' D ' 50' ' ' VAL . . . . . . . . . . . . . 45.5 t -84.82 107.84 16.24 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.241 0 N-CA-C 109.198 -0.667 . . . . 0.0 109.198 174.735 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' D' D ' 51' ' ' VAL . . . . . . . . . . . . . 47.2 t -73.07 -47.61 47.1 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.302 0 CA-C-N 116.153 -0.476 . . . . 0.0 110.159 -173.099 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' D' D ' 52' ' ' GLN . . . . . . . . . . . . . 62.8 tt0 -161.4 139.18 9.16 Favored 'General case' 0 C--N 1.331 -0.226 0 C-N-CA 120.231 -0.588 . . . . 0.0 111.884 -177.321 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' D' D ' 53' ' ' ALA . . . . . . . . . . . . . . . -115.96 133.61 55.85 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 115.655 -0.702 . . . . 0.0 109.609 174.144 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' D' D ' 54' ' ' TYR . . . . . . . . . . . . . 44.3 t80 -128.94 110.77 18.49 Favored Pre-proline 0 CA--C 1.537 0.449 0 CA-C-O 118.112 -0.947 . . . . 0.0 110.489 -179.531 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' D' D ' 55' ' ' PRO . . . . . . . . . . . . . 73.6 Cg_endo -77.13 169.9 73.03 Favored 'Cis proline' 0 N--CA 1.5 1.869 0 CA-C-N 121.853 1.698 . . . . 0.0 112.155 -6.987 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' D' D ' 56' ' ' SER . . . . . . . . . . . . . 49.1 m -117.79 135.01 23.19 Favored Pre-proline 0 CA--C 1.54 0.574 0 CA-C-O 118.42 -0.8 . . . . 0.0 109.949 175.901 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' D' D ' 57' ' ' PRO . . . . . . . . . . . . . 38.3 Cg_endo -68.45 163.73 77.04 Favored 'Cis proline' 0 N--CA 1.498 1.773 0 CA-C-N 121.875 1.705 . . . . 0.0 111.361 -3.754 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' D' D ' 58' ' ' LEU . . . . . . . . . . . . . 37.4 tp -129.78 137.94 50.79 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-O 120.877 0.37 . . . . 0.0 110.595 -179.866 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' D' D ' 59' ' ' ARG . . . . . . . . . . . . . 62.0 ttm-85 -100.62 121.28 41.35 Favored 'General case' 0 C--N 1.326 -0.414 0 N-CA-C 109.142 -0.688 . . . . 0.0 109.142 174.593 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' D' D ' 60' ' ' VAL . . . . . . . . . . . . . 42.3 t -74.54 124.81 32.92 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 C-N-CA 120.778 -0.369 . . . . 0.0 110.391 -173.786 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' D' D ' 61' ' ' GLU . . . . . . . . . . . . . 70.5 mm-40 -131.01 163.39 27.68 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 115.913 -0.585 . . . . 0.0 109.868 177.569 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' D' D ' 62' ' ' ASP . . . . . . . . . . . . . 14.9 p-10 -55.67 -31.64 62.56 Favored 'General case' 0 C--N 1.328 -0.346 0 N-CA-C 111.749 0.278 . . . . 0.0 111.749 -178.898 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' D' D ' 63' ' ' ARG . . . . . . . . . . . . . 10.0 ptm180 -83.68 6.75 19.81 Favored 'General case' 0 CA--C 1.536 0.438 0 N-CA-C 113.553 0.946 . . . . 0.0 113.553 -176.121 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' D' D ' 64' ' ' THR . . . . . . . . . . . . . 29.3 m -85.64 139.68 31.2 Favored 'General case' 0 C--N 1.332 -0.184 0 CA-C-N 118.192 0.451 . . . . 0.0 110.651 -179.074 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' D' D ' 65' ' ' LYS . . . . . . . . . . . . . 38.1 mtmt -89.07 132.6 34.7 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.273 -0.421 . . . . 0.0 110.419 179.657 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' D' D ' 66' ' ' ILE . . . . . 0.404 HG21 HD12 ' D' ' 66' ' ' ILE . 61.6 mt -120.38 128.16 75.97 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.221 0 CA-C-N 116.366 -0.379 . . . . 0.0 110.046 -177.244 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' D' D ' 67' ' ' THR . . . . . . . . . . . . . 27.8 m -130.21 142.65 50.55 Favored 'General case' 0 C--N 1.332 -0.177 0 CA-C-O 120.978 0.418 . . . . 0.0 111.234 -178.638 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' D' D ' 68' ' ' LEU . . . . . . . . . . . . . 7.2 mp -107.09 140.53 39.77 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.049 -0.523 . . . . 0.0 110.65 177.827 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' D' D ' 69' ' ' VAL . . . . . . . . . . . . . 43.2 t -100.18 126.53 53.68 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.263 0 CA-C-N 116.209 -0.451 . . . . 0.0 109.976 177.129 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' D' D ' 70' ' ' THR . . . . . . . . . . . . . 81.8 p -148.41 169.17 20.78 Favored 'General case' 0 C--N 1.332 -0.195 0 CA-C-O 120.91 0.386 . . . . 0.0 111.192 -179.585 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' D' D ' 71' ' ' HIS . . . . . . . . . . . . . 6.1 m-70 -136.77 157.13 75.52 Favored Pre-proline 0 C--N 1.329 -0.301 0 CA-C-N 115.882 -0.599 . . . . 0.0 109.952 177.591 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' D' D ' 72' ' ' PRO . . . . . . . . . . . . . 56.0 Cg_endo -71.07 -30.24 16.62 Favored 'Trans proline' 0 N--CA 1.497 1.688 0 C-N-CA 121.128 1.219 . . . . 0.0 112.397 -179.38 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' D' D ' 73' ' ' VAL . . . . . . . . . . . . . 2.5 m -158.97 132.83 1.32 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.214 0 CA-C-N 116.224 -0.444 . . . . 0.0 110.262 176.242 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' D' D ' 74' ' ' ASP . . . . . . . . . . . . . 15.3 t0 -99.06 118.81 36.67 Favored 'General case' 0 C--N 1.325 -0.497 0 N-CA-C 108.829 -0.804 . . . . 0.0 108.829 173.894 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' D' D ' 75' ' ' VAL . . . . . . . . . . . . . 47.8 t -110.19 122.04 64.07 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.218 0 CA-C-O 121.132 0.491 . . . . 0.0 110.671 -176.325 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' D' D ' 76' ' ' LEU . . . . . . . . . . . . . 5.1 mp -124.08 138.66 54.41 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 115.657 -0.701 . . . . 0.0 109.28 174.5 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' D' D ' 77' ' ' GLU . . . . . . . . . . . . . 69.3 tt0 -134.37 136.9 43.71 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-O 120.955 0.407 . . . . 0.0 110.803 -177.801 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' D' D ' 78' ' ' ALA . . . . . . . . . . . . . . . -121.52 138.59 54.23 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 115.959 -0.564 . . . . 0.0 110.434 178.774 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' D' D ' 79' ' ' LYS . . . . . . . . . . . . . 7.6 ttpm? -77.75 115.38 17.46 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 116.438 -0.346 . . . . 0.0 110.419 179.582 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' D' D ' 80' ' ' ILE . . . . . . . . . . . . . 42.1 mm -139.06 108.09 3.68 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.273 0 N-CA-C 109.328 -0.619 . . . . 0.0 109.328 -178.369 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' D' D ' 81' ' ' LYS . . . . . . . . . . . . . 55.1 pttt -106.76 129.82 54.57 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-O 120.921 0.391 . . . . 0.0 111.518 -176.33 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' D' D ' 82' ' ' GLY . . . . . . . . . . . . . . . 88.95 42.19 5.72 Favored Glycine 0 CA--C 1.526 0.778 0 N-CA-C 111.529 -0.628 . . . . 0.0 111.529 176.752 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' D' D ' 83' ' ' ILE . . . . . . . . . . . . . 73.3 mt -71.92 138.76 20.95 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.32 0 N-CA-C 109.718 -0.475 . . . . 0.0 109.718 178.064 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' D' D ' 84' ' ' LYS . . . . . . . . . . . . . 50.4 tttp -95.7 -53.87 3.56 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 116.023 -0.535 . . . . 0.0 110.207 -178.136 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' D' D ' 85' ' ' ASP . . . . . . . . . . . . . 8.3 t70 -152.55 152.26 31.66 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 115.795 -0.639 . . . . 0.0 110.14 -179.594 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' D' D ' 86' ' ' VAL . . . . . . . . . . . . . 46.6 t -127.74 129.07 70.01 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.224 0 CA-C-O 120.883 0.373 . . . . 0.0 110.44 -179.041 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' D' D ' 87' ' ' ILE . . . . . . . . . . . . . 44.5 mm -117.97 127.5 75.2 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.217 0 CA-C-N 115.941 -0.572 . . . . 0.0 109.461 176.682 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' D' D ' 88' ' ' LEU . . . . . . . . . . . . . 12.5 tp -113.98 131.63 56.26 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-O 120.998 0.427 . . . . 0.0 111.154 -176.861 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' D' D ' 89' ' ' ASP . . . . . . . . . . . . . 13.8 t70 -123.88 152.08 42.76 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 115.78 -0.646 . . . . 0.0 109.432 176.837 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' D' D ' 90' ' ' GLU . . . . . . . . . . . . . 46.2 tp10 -47.84 -36.85 12.65 Favored 'General case' 0 CA--C 1.531 0.242 0 N-CA-C 112.735 0.643 . . . . 0.0 112.735 -172.967 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' D' D ' 91' ' ' ASN . . . . . . . . . . . . . 28.7 m120 -132.02 32.39 4.04 Favored 'General case' 0 N--CA 1.466 0.338 0 C-N-CA 120.846 -0.342 . . . . 0.0 111.916 -176.508 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' D' D ' 92' ' ' LEU . . . . . . . . . . . . . 9.7 tp -166.11 148.14 6.97 Favored 'General case' 0 C--N 1.329 -0.291 0 C-N-CA 121.008 -0.277 . . . . 0.0 110.591 -179.839 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' D' D ' 93' ' ' ILE . . . . . . . . . . . . . 64.1 mt -127.06 124.54 64.68 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.284 0 N-CA-C 109.58 -0.526 . . . . 0.0 109.58 -179.356 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' D' D ' 94' ' ' VAL . . . . . . . . . . . . . 46.7 t -124.08 127.74 73.64 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.234 0 CA-C-O 121.004 0.431 . . . . 0.0 110.181 179.99 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' D' D ' 95' ' ' VAL . . . . . . . . . . . . . 44.6 t -121.88 135.47 61.9 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.261 0 CA-C-N 116.054 -0.521 . . . . 0.0 109.931 179.984 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' D' D ' 96' ' ' ILE . . . . . . . . . . . . . 66.2 mt -116.3 129.49 72.64 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 N-CA-C 109.356 -0.609 . . . . 0.0 109.356 178.82 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' D' D ' 97' ' ' THR . . . . . . . . . . . . . 79.6 p -100.0 158.48 15.8 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-O 121.02 0.438 . . . . 0.0 111.105 -177.334 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' D' D ' 98' ' ' GLU . . . . . . . . . . . . . 97.1 mt-10 -54.06 -26.36 26.43 Favored 'General case' 0 C--N 1.329 -0.288 0 N-CA-C 112.219 0.451 . . . . 0.0 112.219 -179.795 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' D' D ' 99' ' ' GLU . . . . . . . . . . . . . 41.0 mt-10 -80.04 16.85 1.1 Allowed 'General case' 0 CA--C 1.536 0.412 0 N-CA-C 112.99 0.737 . . . . 0.0 112.99 -177.759 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' D' D ' 100' ' ' ASN . . . . . . . . . . . . . 3.3 m-20 63.16 37.94 10.99 Favored 'General case' 0 N--CA 1.463 0.197 0 CA-C-O 121.05 0.452 . . . . 0.0 111.085 177.453 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' D' D ' 101' ' ' GLU . . . . . . . . . . . . . 98.2 mt-10 -112.18 146.0 38.87 Favored 'General case' 0 C--N 1.332 -0.162 0 CA-C-N 116.2 -0.455 . . . . 0.0 110.419 174.981 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' D' D ' 102' ' ' VAL . . . . . . . . . . . . . 45.3 t -117.01 127.18 74.69 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.363 0 CA-C-N 115.762 -0.654 . . . . 0.0 109.606 179.134 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' D' D ' 103' ' ' LEU . . . . . . . . . . . . . 7.4 mp -119.45 129.76 54.92 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 115.883 -0.599 . . . . 0.0 110.207 175.716 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' D' D ' 104' ' ' ILE . . . . . . . . . . . . . 73.8 mt -114.13 122.22 67.81 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.335 0 CA-C-N 116.024 -0.534 . . . . 0.0 109.885 -179.341 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' D' D ' 105' ' ' PHE . . . . . . . . . . . . . 85.8 m-85 -119.23 160.03 22.94 Favored 'General case' 0 C--N 1.331 -0.229 0 O-C-N 124.17 0.919 . . . . 0.0 109.894 179.96 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' D' D ' 106' ' ' ASN . . . . . . . . . . . . . 42.8 p-10 -95.04 -170.22 2.15 Favored 'General case' 0 C--N 1.329 -0.321 0 N-CA-C 109.557 -0.534 . . . . 0.0 109.557 172.799 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' D' D ' 107' ' ' GLN . . . . . . . . . . . . . 58.2 tt0 -61.07 -25.57 67.03 Favored 'General case' 0 C--N 1.329 -0.314 0 N-CA-C 112.123 0.416 . . . . 0.0 112.123 178.54 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' D' D ' 108' ' ' ASN . . . . . . . . . . . . . 5.7 t-20 -83.66 3.2 33.93 Favored 'General case' 0 CA--C 1.538 0.518 0 N-CA-C 113.133 0.79 . . . . 0.0 113.133 -178.703 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' D' D ' 109' ' ' LEU . . . . . . . . . . . . . 9.1 tp 62.86 37.23 12.35 Favored 'General case' 0 C--O 1.232 0.151 0 CA-C-O 120.945 0.402 . . . . 0.0 111.36 179.39 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' D' D ' 110' ' ' GLU . . . . . . . . . . . . . 96.3 mt-10 -106.82 149.95 26.86 Favored 'General case' 0 C--N 1.331 -0.216 0 N-CA-C 110.025 -0.361 . . . . 0.0 110.025 176.458 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' D' D ' 111' ' ' GLU . . . . . . . . . . . . . 43.0 tp10 -79.67 121.98 25.98 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-O 121.114 0.483 . . . . 0.0 110.803 -176.889 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' D' D ' 112' ' ' LEU . . . . . . . . . . . . . 28.4 mt -103.93 -46.08 4.58 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 115.747 -0.661 . . . . 0.0 110.119 176.541 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' D' D ' 113' ' ' TYR . . . . . . . . . . . . . 65.2 t80 -142.53 135.5 28.37 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.226 -0.443 . . . . 0.0 111.33 -179.614 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' D' D ' 114' ' ' ARG . . . . . . . . . . . . . 79.0 ttt-85 -139.98 121.94 15.62 Favored 'General case' 0 C--N 1.331 -0.229 0 CA-C-N 116.321 -0.399 . . . . 0.0 110.121 177.17 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' D' D ' 115' ' ' GLY . . . . . . . . . . . . . . . -150.15 161.98 29.07 Favored Glycine 0 CA--C 1.525 0.656 0 N-CA-C 110.982 -0.847 . . . . 0.0 110.982 -178.761 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' D' D ' 116' ' ' LYS . . . . . . . . . . . . . 39.0 ttpt -120.08 137.32 54.2 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-O 120.741 0.305 . . . . 0.0 110.307 178.622 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' D' D ' 117' ' ' PHE . . . . . . . . . . . . . 31.6 m-85 -133.39 113.95 13.13 Favored 'General case' 0 C--N 1.33 -0.244 0 N-CA-C 109.859 -0.423 . . . . 0.0 109.859 179.224 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' D' D ' 118' ' ' GLU . . . . . . . . . . . . . 95.9 mt-10 -55.72 -44.8 77.83 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.33 -0.396 . . . . 0.0 111.228 -174.898 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' D' D ' 119' ' ' ASN . . . . . . . . . . . . . 20.2 m120 -95.89 30.93 2.23 Favored 'General case' 0 C--N 1.33 -0.275 0 N-CA-C 112.132 0.419 . . . . 0.0 112.132 -174.11 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' D' D ' 120' ' ' LEU . . . . . . . . . . . . . 13.3 tp -57.35 119.74 6.99 Favored 'General case' 0 C--N 1.334 -0.083 0 C-N-CA 120.984 -0.287 . . . . 0.0 110.259 178.078 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' D' D ' 121' ' ' ASN . . . . . . . . . . . . . 73.4 m-20 -114.12 -44.06 3.17 Favored 'General case' 0 C--N 1.332 -0.156 0 CA-C-N 116.409 -0.359 . . . . 0.0 111.118 -178.405 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' D' D ' 122' ' ' LYS . . . . . . . . . . . . . 63.1 mtpt -141.96 148.73 39.09 Favored 'General case' 0 C--N 1.331 -0.219 0 CA-C-O 121.079 0.466 . . . . 0.0 111.607 -176.611 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' D' D ' 123' ' ' VAL . . . . . . . . . . . . . 43.9 t -131.53 125.9 57.1 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.252 0 CA-C-N 115.854 -0.612 . . . . 0.0 109.512 174.565 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' D' D ' 124' ' ' LEU . . . . . . . . . . . . . 49.7 mt -122.79 137.46 54.92 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-O 120.74 0.305 . . . . 0.0 110.697 -178.157 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' D' D ' 125' ' ' VAL . . . . . . . . . . . . . 34.8 m -129.69 130.1 66.69 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.25 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.789 179.735 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' D' D ' 126' ' ' ARG . . . . . . . . . . . . . 83.0 mtt180 -144.94 118.96 9.37 Favored 'General case' 0 C--N 1.328 -0.348 0 N-CA-C 109.56 -0.533 . . . . 0.0 109.56 177.164 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' D' D ' 127' ' ' ASN . . . . . . . . . . . . . 30.8 m120 56.73 -149.05 0.47 Allowed 'General case' 0 CA--C 1.54 0.596 0 N-CA-C 109.648 -0.501 . . . . 0.0 109.648 -178.229 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' D' D ' 128' ' ' ASP . . . . . . . . . . . . . 23.3 p-10 -82.41 12.96 3.92 Favored 'General case' 0 CA--C 1.536 0.429 0 CA-C-N 118.773 0.715 . . . . 0.0 112.88 178.364 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' D' D ' 129' ' ' LEU . . . . . . . . . . . . . 16.1 tp -108.64 134.98 50.64 Favored 'General case' 0 C--O 1.233 0.196 0 CA-C-N 118.261 0.482 . . . . 0.0 110.088 178.637 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' D' D ' 130' ' ' VAL . . . . . . . . . . . . . 44.0 t -126.26 141.36 46.05 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.303 0 CA-C-O 120.929 0.395 . . . . 0.0 110.623 -177.539 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' D' D ' 131' ' ' VAL . . . . . . . . . . . . . 42.6 t -133.63 133.99 56.8 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.305 0 CA-C-N 116.049 -0.523 . . . . 0.0 110.126 177.994 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' D' D ' 132' ' ' ILE . . . . . . . . . . . . . 65.8 mt -118.41 134.0 63.42 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.343 0 N-CA-C 109.364 -0.606 . . . . 0.0 109.364 178.834 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' D' D ' 133' ' ' ILE . . . . . . . . . . . . . 37.6 mm -117.14 123.56 71.96 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.254 0 CA-C-O 120.619 0.247 . . . . 0.0 111.122 -174.367 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' D' D ' 134' ' ' ASP . . . . . . . . . . . . . 9.8 p-10 -135.82 147.62 48.36 Favored 'General case' 0 C--N 1.331 -0.202 0 N-CA-C 109.537 -0.542 . . . . 0.0 109.537 173.295 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' D' D ' 135' ' ' GLU . . . . . . . . . . . . . 85.2 tt0 -49.9 -27.7 5.58 Favored 'General case' 0 C--N 1.328 -0.356 0 N-CA-C 112.89 0.7 . . . . 0.0 112.89 -170.184 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' D' D ' 136' ' ' GLN . . . . . . . . . . . . . 98.0 mt-30 -82.21 -40.03 22.26 Favored 'General case' 0 C--O 1.235 0.297 0 N-CA-C 112.185 0.439 . . . . 0.0 112.185 -176.92 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' D' D ' 137' ' ' LYS . . . . . . . . . . . . . 56.6 pttt -156.73 167.04 31.66 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-O 121.523 0.678 . . . . 0.0 112.294 -169.745 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' D' D ' 138' ' ' LEU . . . . . . . . . . . . . 6.0 tt -116.24 127.74 55.01 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 115.06 -0.973 . . . . 0.0 109.664 178.156 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' D' D ' 139' ' ' THR . . . . . . . . . . . . . 29.0 m -106.71 126.62 52.52 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-N 116.281 -0.418 . . . . 0.0 110.712 -178.313 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' D' D ' 140' ' ' LEU . . . . . . . . . . . . . 21.1 tp -111.51 122.83 48.86 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 115.664 -0.698 . . . . 0.0 109.191 179.553 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' D' D ' 141' ' ' ILE . . . . . . . . . . . . . 19.5 mt -121.16 118.89 57.61 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.279 0 N-CA-C 109.87 -0.419 . . . . 0.0 109.87 -174.664 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' D' D ' 142' ' ' ARG . . . . . . . . . . . . . 48.5 mtm180 -109.0 127.97 54.55 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 115.481 -0.781 . . . . 0.0 110.098 -178.527 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' D' D ' 143' ' ' THR . . . . . . . . . . . . . 6.9 p . . . . . 0 C--O 1.22 -0.497 0 CA-C-O 117.989 -1.005 . . . . 0.0 110.61 -179.472 . . . . . . . . 0 0 . 1 . 008 nuclear orig full ' E' E ' -3' ' ' GLU . . . . . . . . . . . . . 95.9 mt-10 . . . . . 0 N--CA 1.489 1.523 0 N-CA-C 109.432 -0.581 . . . . 0.0 109.432 . . . . . . . . . 0 0 . 1 . 008 nuclear orig full ' E' E ' -2' ' ' GLY . . . . . . . . . . . . . . . -69.71 130.89 23.34 Favored Glycine 0 CA--C 1.526 0.737 0 N-CA-C 111.065 -0.814 . . . . 0.0 111.065 -179.444 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' E' E ' -1' ' ' VAL . . . . . . . . . . . . . 45.4 t -141.4 140.85 31.19 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.285 0 N-CA-C 109.806 -0.442 . . . . 0.0 109.806 179.271 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' E' E ' 0' ' ' ILE . . . . . . . . . . . . . 71.6 mt -107.72 135.95 44.67 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.288 0 CA-C-O 120.89 0.376 . . . . 0.0 110.078 -178.748 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' E' E ' 1' ' ' MET . . . . . . . . . . . . . 26.1 ptm -78.67 138.41 38.28 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 116.011 -0.541 . . . . 0.0 110.549 179.397 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' E' E ' 2' ' ' SER . . . . . . . . . . . . . 2.9 p -128.59 130.56 47.52 Favored 'General case' 0 C--N 1.331 -0.201 0 CA-C-N 116.24 -0.436 . . . . 0.0 110.449 179.101 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' E' E ' 3' ' ' GLU . . . . . . . . . . . . . 84.7 tt0 -141.99 141.59 32.88 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.089 -0.505 . . . . 0.0 111.06 -179.302 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' E' E ' 4' ' ' LEU . . . . . . . . . . . . . 17.0 tp -126.12 126.86 44.85 Favored 'General case' 0 C--N 1.332 -0.195 0 CA-C-N 116.136 -0.483 . . . . 0.0 110.257 177.664 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' E' E ' 5' ' ' LYS . . . . . . . . . . . . . 61.6 mttp -107.06 121.39 44.39 Favored 'General case' 0 C--O 1.235 0.319 0 CA-C-N 116.251 -0.431 . . . . 0.0 110.7 178.5 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' E' E ' 6' ' ' LEU . . . . . . . . . . . . . 72.6 mt -116.84 146.25 43.02 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 115.326 -0.852 . . . . 0.0 110.46 -178.784 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' E' E ' 7' ' ' LYS . . . . . . . . . . . . . 55.6 tttm -135.24 139.75 32.55 Favored Pre-proline 0 CA--C 1.534 0.351 0 CA-C-O 119.135 -0.459 . . . . 0.0 110.361 176.927 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' E' E ' 8' ' ' PRO . . . . . . . . . . . . . 84.7 Cg_endo -91.85 139.46 2.19 Favored 'Trans proline' 0 N--CA 1.489 1.262 0 C-N-CA 121.694 1.596 . . . . 0.0 111.632 176.602 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' E' E ' 9' ' ' LEU . . . . . . . . . . . . . 38.7 mt -76.03 -48.4 3.52 Favored Pre-proline 0 CA--C 1.534 0.363 0 CA-C-O 118.631 -0.7 . . . . 0.0 112.569 -178.036 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' E' E ' 10' ' ' PRO . . . . . . . . . . . . . 91.3 Cg_endo -80.06 157.13 23.49 Favored 'Trans proline' 0 N--CA 1.497 1.723 0 C-N-CA 121.315 1.343 . . . . 0.0 111.912 178.126 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' E' E ' 11' ' ' LYS . . . . . . . . . . . . . 17.4 pttp -83.17 112.54 19.93 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-O 121.55 0.691 . . . . 0.0 110.428 176.84 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' E' E ' 12' ' ' VAL . . . . . . . . . . . . . 12.5 p -151.13 151.19 12.65 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.248 0 CA-C-N 115.629 -0.714 . . . . 0.0 110.58 -178.769 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' E' E ' 13' ' ' GLU . . . . . . . . . . . . . 96.5 mt-10 -97.71 121.68 39.9 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.3 -0.409 . . . . 0.0 110.351 177.679 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' E' E ' 14' ' ' LEU . . . . . . . . . . . . . 39.4 mt -98.45 137.65 20.72 Favored Pre-proline 0 CA--C 1.534 0.351 0 CA-C-O 118.808 -0.615 . . . . 0.0 110.213 -179.377 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' E' E ' 15' ' ' PRO . . . . . . . . . . . . . 25.3 Cg_exo -62.59 162.24 25.25 Favored 'Trans proline' 0 N--CA 1.498 1.765 0 C-N-CA 121.299 1.333 . . . . 0.0 112.013 176.942 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' E' E ' 16' ' ' PRO . . . . . . . . . . . . . 28.1 Cg_exo -59.95 -32.71 95.48 Favored 'Trans proline' 0 N--CA 1.497 1.691 0 C-N-CA 121.568 1.512 . . . . 0.0 112.931 -178.219 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' E' E ' 17' ' ' ASP . . . . . . . . . . . . . 10.1 p-10 -81.52 -3.93 54.54 Favored 'General case' 0 CA--C 1.535 0.383 0 N-CA-C 113.357 0.873 . . . . 0.0 113.357 -177.451 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' E' E ' 18' ' ' PHE . . . . . . . . . . . . . 30.0 t80 -56.62 -44.49 81.24 Favored 'General case' 0 C--N 1.334 -0.09 0 O-C-N 121.885 -0.509 . . . . 0.0 110.242 -179.182 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' E' E ' 19' ' ' VAL . . . . . . . . . . . . . 14.4 p -57.38 -40.67 75.66 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.329 0 CA-C-N 116.346 -0.388 . . . . 0.0 110.698 -179.707 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' E' E ' 20' ' ' ASP . . . . . . . . . . . . . 8.2 t70 -60.33 -42.74 96.29 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-O 120.921 0.391 . . . . 0.0 110.781 -177.827 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' E' E ' 21' ' ' VAL . . . . . . . . . . . . . 46.4 t -64.46 -47.33 89.78 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.297 0 CA-C-N 116.331 -0.395 . . . . 0.0 110.476 -177.751 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' E' E ' 22' ' ' ILE . . . . . . . . . . . . . 49.1 mm -57.5 -42.04 80.11 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.362 0 C-N-CA 120.934 -0.306 . . . . 0.0 110.673 -179.633 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' E' E ' 23' ' ' ARG . . . . . . . . . . . . . 61.9 ttp180 -54.8 -51.09 66.87 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-O 120.981 0.42 . . . . 0.0 110.9 178.935 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' E' E ' 24' ' ' ILE . . . . . . . . . . . . . 73.0 mt -60.85 -41.64 89.47 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.355 0 CA-C-N 115.92 -0.582 . . . . 0.0 111.764 -176.564 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' E' E ' 25' ' ' LYS . . . . . . . . . . . . . 15.1 ptpt -70.39 -39.64 74.4 Favored 'General case' 0 CA--C 1.535 0.373 0 N-CA-C 112.174 0.435 . . . . 0.0 112.174 -174.804 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' E' E ' 26' ' ' LEU . . . . . . . . . . . . . 15.4 mt -78.87 -39.27 35.61 Favored 'General case' 0 C--N 1.33 -0.278 0 N-CA-C 113.268 0.84 . . . . 0.0 113.268 -171.291 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' E' E ' 27' ' ' GLN . . . . . . . . . . . . . 10.5 pt20 -47.0 135.69 9.21 Favored 'General case' 0 N--CA 1.469 0.499 0 N-CA-C 112.763 0.653 . . . . 0.0 112.763 -175.13 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' E' E ' 28' ' ' GLY . . . . . . . . . . . . . . . 101.05 -24.02 33.44 Favored Glycine 0 CA--C 1.534 1.259 0 CA-C-N 115.606 -0.725 . . . . 0.0 112.378 -176.784 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' E' E ' 29' ' ' LYS . . . . . . . . . . . . . 91.8 mttt -98.82 155.17 17.51 Favored 'General case' 0 C--O 1.233 0.208 0 CA-C-N 117.443 0.622 . . . . 0.0 111.311 179.534 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' E' E ' 30' ' ' THR . . . . . . . . . . . . . 28.8 m -109.39 138.57 45.55 Favored 'General case' 0 C--N 1.331 -0.209 0 CA-C-N 116.27 -0.423 . . . . 0.0 110.005 175.841 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' E' E ' 31' ' ' VAL . . . . . . . . . . . . . 34.5 m -132.13 160.92 42.16 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.22 0 CA-C-N 116.392 -0.367 . . . . 0.0 110.857 -178.95 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' E' E ' 32' ' ' ARG . . . . . . . . . . . . . 63.5 mtt85 -130.44 149.04 52.3 Favored 'General case' 0 C--N 1.332 -0.19 0 CA-C-O 121.199 0.523 . . . . 0.0 110.667 177.303 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' E' E ' 33' ' ' THR . . . . . . . . . . . . . 31.5 m -53.59 141.38 25.91 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.129 -0.487 . . . . 0.0 111.259 -179.581 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' E' E ' 34' ' ' GLY . . . . . . . . . . . . . . . 99.28 -17.16 58.27 Favored Glycine 0 CA--C 1.533 1.2 0 CA-C-O 119.643 -0.532 . . . . 0.0 113.156 179.874 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' E' E ' 35' ' ' ASP . . . . . . . . . . . . . 78.8 m-20 -66.5 147.72 52.9 Favored 'General case' 0 C--O 1.232 0.145 0 CA-C-N 118.026 0.913 . . . . 0.0 110.999 178.163 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' E' E ' 36' ' ' VAL . . . . . . . . . . . . . 46.9 t -119.85 129.78 74.99 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.212 0 CA-C-N 115.829 -0.623 . . . . 0.0 109.829 178.611 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' E' E ' 37' ' ' ILE . . . . . . . . . . . . . 66.7 mt -120.13 138.18 51.55 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.269 0 N-CA-C 109.748 -0.464 . . . . 0.0 109.748 179.833 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' E' E ' 38' ' ' GLY . . . . . . . . . . . . . . . -113.77 128.78 8.46 Favored Glycine 0 CA--C 1.524 0.624 0 N-CA-C 111.389 -0.684 . . . . 0.0 111.389 -179.024 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' E' E ' 39' ' ' ILE . . . . . . . . . . . . . 71.2 mt -122.51 126.74 74.52 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.24 0 N-CA-C 109.747 -0.464 . . . . 0.0 109.747 177.336 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' E' E ' 40' ' ' SER . . . . . . . . . . . . . 43.1 t -92.16 119.51 31.88 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.442 -0.344 . . . . 0.0 110.786 177.162 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' E' E ' 41' ' ' ILE . . . . . . . . . . . . . 71.8 mt -131.47 123.9 53.55 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.225 0 N-CA-C 110.052 -0.351 . . . . 0.0 110.052 178.594 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' E' E ' 42' ' ' LEU . . . . . . . . . . . . . 82.6 mt 57.8 33.74 23.58 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.2 -0.455 . . . . 0.0 111.87 178.485 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' E' E ' 43' ' ' GLY . . . . . . . . . . . . . . . 77.87 -10.15 27.25 Favored Glycine 0 CA--C 1.535 1.306 0 C-N-CA 121.274 -0.489 . . . . 0.0 113.431 177.79 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' E' E ' 44' ' ' LYS . . . . . . . . . . . . . 62.8 tttm -98.78 127.24 44.65 Favored 'General case' 0 C--O 1.232 0.138 0 CA-C-N 117.808 0.804 . . . . 0.0 109.696 176.723 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' E' E ' 45' ' ' GLU . . . . . . . . . . . . . 39.2 tp10 -84.76 126.84 33.77 Favored 'General case' 0 C--N 1.328 -0.336 0 C-N-CA 120.811 -0.356 . . . . 0.0 110.662 -179.935 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' E' E ' 46' ' ' VAL . . . . . . . . . . . . . 7.6 p -117.09 128.71 74.41 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.199 0 N-CA-C 109.368 -0.604 . . . . 0.0 109.368 176.585 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' E' E ' 47' ' ' LYS . . . . . . . . . . . . . 64.6 mttp -100.32 129.35 46.29 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 115.884 -0.598 . . . . 0.0 111.142 179.052 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' E' E ' 48' ' ' PHE . . . . . . . . . . . . . 93.5 m-85 -112.19 131.86 55.23 Favored 'General case' 0 C--N 1.33 -0.27 0 N-CA-C 109.604 -0.517 . . . . 0.0 109.604 175.889 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' E' E ' 49' ' ' LYS . . . . . . . . . . . . . 52.5 tttp -108.05 135.46 49.37 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 116.434 -0.348 . . . . 0.0 110.332 179.244 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' E' E ' 50' ' ' VAL . . . . . . . . . . . . . 46.2 t -78.43 106.53 9.29 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.281 0 N-CA-C 108.954 -0.758 . . . . 0.0 108.954 175.317 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' E' E ' 51' ' ' VAL . . . . . . . . . . . . . 51.5 t -71.74 -47.05 58.89 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.319 0 CA-C-N 116.18 -0.464 . . . . 0.0 110.106 -172.98 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' E' E ' 52' ' ' GLN . . . . . . . . . . . . . 46.9 tt0 -163.5 136.86 5.6 Favored 'General case' 0 C--N 1.329 -0.297 0 C-N-CA 120.175 -0.61 . . . . 0.0 111.834 -178.281 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' E' E ' 53' ' ' ALA . . . . . . . . . . . . . . . -113.01 134.36 54.55 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 115.721 -0.672 . . . . 0.0 109.699 174.566 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' E' E ' 54' ' ' TYR . . . . . . . . . . . . . 24.8 t80 -129.03 111.28 18.4 Favored Pre-proline 0 CA--C 1.536 0.419 0 CA-C-O 118.17 -0.919 . . . . 0.0 110.555 -179.889 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' E' E ' 55' ' ' PRO . . . . . . . . . . . . . 73.6 Cg_endo -77.08 168.8 76.03 Favored 'Cis proline' 0 N--CA 1.501 1.946 0 CA-C-N 121.899 1.714 . . . . 0.0 112.068 -7.245 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' E' E ' 56' ' ' SER . . . . . . . . . . . . . 27.0 m -115.04 131.27 23.61 Favored Pre-proline 0 CA--C 1.539 0.525 0 CA-C-O 118.456 -0.783 . . . . 0.0 109.533 176.24 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' E' E ' 57' ' ' PRO . . . . . . . . . . . . . 36.5 Cg_endo -66.6 164.17 68.67 Favored 'Cis proline' 0 N--CA 1.496 1.671 0 CA-C-N 121.957 1.734 . . . . 0.0 111.503 -1.501 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' E' E ' 58' ' ' LEU . . . . . . . . . . . . . 28.7 tp -129.45 135.47 48.7 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.436 -0.347 . . . . 0.0 110.623 -179.693 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' E' E ' 59' ' ' ARG . . . . . . . . . . . . . 73.5 ttt-85 -103.21 127.2 50.59 Favored 'General case' 0 C--N 1.327 -0.4 0 N-CA-C 109.028 -0.73 . . . . 0.0 109.028 175.504 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' E' E ' 60' ' ' VAL . . . . . . . . . . . . . 40.1 t -87.41 124.39 40.75 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.305 0 C-N-CA 120.767 -0.373 . . . . 0.0 110.878 -173.071 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' E' E ' 61' ' ' GLU . . . . . . . . . . . . . 40.6 mt-10 -131.01 166.52 20.82 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.01 -0.541 . . . . 0.0 109.703 176.002 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' E' E ' 62' ' ' ASP . . . . . . . . . . . . . 5.5 t70 -53.57 -32.92 52.87 Favored 'General case' 0 C--N 1.329 -0.318 0 N-CA-C 111.746 0.276 . . . . 0.0 111.746 -179.166 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' E' E ' 63' ' ' ARG . . . . . . . . . . . . . 35.2 mmt180 -73.51 -19.07 61.02 Favored 'General case' 0 N--CA 1.465 0.318 0 N-CA-C 113.023 0.749 . . . . 0.0 113.023 -176.863 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' E' E ' 64' ' ' THR . . . . . . . . . . . . . 25.0 m -66.23 141.9 57.89 Favored 'General case' 0 C--N 1.331 -0.2 0 CA-C-O 120.862 0.363 . . . . 0.0 110.876 -174.935 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' E' E ' 65' ' ' LYS . . . . . . . . . . . . . 92.1 mttt -87.83 128.71 35.34 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 115.995 -0.548 . . . . 0.0 109.893 178.285 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' E' E ' 66' ' ' ILE . . . . . . . . . . . . . 51.7 mt -116.18 131.24 69.27 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 N-CA-C 110.036 -0.357 . . . . 0.0 110.036 179.82 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' E' E ' 67' ' ' THR . . . . . . . . . . . . . 22.5 m -127.26 135.82 51.13 Favored 'General case' 0 C--N 1.332 -0.157 0 CA-C-O 121.036 0.446 . . . . 0.0 110.948 -179.89 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' E' E ' 68' ' ' LEU . . . . . . . . . . . . . 32.8 mt -107.93 133.33 52.43 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 115.938 -0.574 . . . . 0.0 110.337 176.918 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' E' E ' 69' ' ' VAL . . . . . . . . . . . . . 43.2 t -97.31 138.66 21.63 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.307 0 CA-C-N 116.356 -0.384 . . . . 0.0 110.328 179.579 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' E' E ' 70' ' ' THR . . . . . . . . . . . . . 7.9 t -146.02 -33.42 0.33 Allowed 'General case' 0 C--N 1.331 -0.224 0 N-CA-C 111.913 0.338 . . . . 0.0 111.913 -178.067 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' E' E ' 71' ' ' HIS . . . . . . . . . . . . . 15.4 m80 -117.92 90.4 36.68 Favored Pre-proline 0 CA--C 1.534 0.359 0 CA-C-O 119.5 -0.286 . . . . 0.0 110.952 -176.484 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' E' E ' 72' ' ' PRO . . . . . . . . . . . . . 58.4 Cg_endo -71.32 -15.22 31.46 Favored 'Trans proline' 0 N--CA 1.498 1.744 0 C-N-CA 121.402 1.401 . . . . 0.0 113.737 -178.433 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' E' E ' 73' ' ' VAL . . . . . . . . . . . . . 33.5 m -114.59 163.69 11.61 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.281 0 CA-C-O 121.019 0.438 . . . . 0.0 110.784 -178.174 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' E' E ' 74' ' ' ASP . . . . . . . . . . . . . 5.0 t70 -100.13 120.12 39.38 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 115.859 -0.609 . . . . 0.0 109.795 -178.613 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' E' E ' 75' ' ' VAL . . . . . . . . . . . . . 44.0 t -119.75 126.4 75.27 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.246 0 CA-C-O 121.014 0.435 . . . . 0.0 110.749 -176.262 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' E' E ' 76' ' ' LEU . . . . . . . . . . . . . 5.9 mp -124.03 149.65 45.83 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 115.671 -0.695 . . . . 0.0 109.683 175.503 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' E' E ' 77' ' ' GLU . . . . . . . . . . . . . 96.2 mt-10 -136.01 131.54 35.14 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-O 121.022 0.439 . . . . 0.0 110.989 -178.646 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' E' E ' 78' ' ' ALA . . . . . . . . . . . . . . . -115.12 140.8 48.77 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 115.71 -0.677 . . . . 0.0 109.822 177.367 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' E' E ' 79' ' ' LYS . . . . . . . . . . . . . 69.4 mttm -87.99 116.73 26.36 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-O 120.846 0.355 . . . . 0.0 111.223 -176.442 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' E' E ' 80' ' ' ILE . . . . . . . . . . . . . 40.1 mm -139.19 102.32 1.69 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.312 0 N-CA-C 109.074 -0.713 . . . . 0.0 109.074 179.438 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' E' E ' 81' ' ' LYS . . . . . . . . . . . . . 41.0 tttp -91.3 126.15 36.29 Favored 'General case' 0 C--N 1.328 -0.351 0 C-N-CA 120.695 -0.402 . . . . 0.0 110.892 -177.171 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' E' E ' 82' ' ' GLY . . . . . . . . . . . . . . . 89.12 42.08 5.69 Favored Glycine 0 CA--C 1.524 0.629 0 C-N-CA 120.885 -0.674 . . . . 0.0 111.721 176.038 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' E' E ' 83' ' ' ILE . . . . . . . . . . . . . 72.6 mt -69.61 137.95 23.12 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.37 0 N-CA-C 109.711 -0.478 . . . . 0.0 109.711 177.027 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' E' E ' 84' ' ' LYS . . . . . . . . . . . . . 38.9 ttpt -100.87 -49.27 4.19 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-O 120.752 0.31 . . . . 0.0 110.234 -179.378 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' E' E ' 85' ' ' ASP . . . . . . . . . . . . . 9.0 t70 -151.85 154.06 35.42 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.243 -0.435 . . . . 0.0 110.7 -178.771 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' E' E ' 86' ' ' VAL . . . . . . . . . . . . . 44.6 t -132.57 136.36 56.14 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.22 0 CA-C-O 121.003 0.43 . . . . 0.0 110.392 -179.812 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' E' E ' 87' ' ' ILE . . . . . . . . . . . . . 47.4 mm -122.74 128.14 75.15 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.289 0 CA-C-N 115.71 -0.677 . . . . 0.0 109.674 178.919 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' E' E ' 88' ' ' LEU . . . . . . . . . . . . . 70.3 mt -111.99 136.52 51.22 Favored 'General case' 0 C--N 1.332 -0.185 0 CA-C-O 121.094 0.473 . . . . 0.0 111.396 -177.759 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' E' E ' 89' ' ' ASP . . . . . . . . . . . . . 9.5 t70 -127.2 154.87 44.28 Favored 'General case' 0 C--N 1.33 -0.274 0 N-CA-C 109.067 -0.716 . . . . 0.0 109.067 175.576 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' E' E ' 90' ' ' GLU . . . . . . . . . . . . . 82.9 tt0 -48.04 -34.32 9.34 Favored 'General case' 0 C--N 1.331 -0.235 0 N-CA-C 112.933 0.716 . . . . 0.0 112.933 -171.74 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' E' E ' 91' ' ' ASN . . . . . . . . . . . . . 13.6 p30 -131.99 18.25 4.59 Favored 'General case' 0 N--CA 1.468 0.454 0 N-CA-C 113.207 0.818 . . . . 0.0 113.207 -177.717 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' E' E ' 92' ' ' LEU . . . . . . . . . . . . . 25.3 mt -146.98 151.08 36.39 Favored 'General case' 0 C--N 1.332 -0.175 0 CA-C-N 117.861 0.301 . . . . 0.0 110.404 -177.069 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' E' E ' 93' ' ' ILE . . . . . . . . . . . . . 67.1 mt -127.1 121.73 58.49 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.213 0 N-CA-C 109.43 -0.582 . . . . 0.0 109.43 178.189 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' E' E ' 94' ' ' VAL . . . . . . . . . . . . . 45.9 t -120.62 129.91 75.1 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.291 0 CA-C-O 120.889 0.376 . . . . 0.0 110.013 -179.816 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' E' E ' 95' ' ' VAL . . . . . . . . . . . . . 44.3 t -122.7 136.0 60.94 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 CA-C-N 116.015 -0.539 . . . . 0.0 109.867 -179.562 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' E' E ' 96' ' ' ILE . . . . . . . . . . . . . 63.1 mt -118.26 127.18 75.41 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.232 0 N-CA-C 109.402 -0.592 . . . . 0.0 109.402 178.896 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' E' E ' 97' ' ' THR . . . . . . . . . . . . . 77.8 p -100.75 158.52 15.9 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-O 121.083 0.468 . . . . 0.0 111.106 -177.464 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' E' E ' 98' ' ' GLU . . . . . . . . . . . . . 47.1 tp10 -53.85 -26.32 23.93 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.279 -0.419 . . . . 0.0 112.105 -179.861 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' E' E ' 99' ' ' GLU . . . . . . . . . . . . . 96.0 mt-10 -76.1 11.61 1.42 Allowed 'General case' 0 CA--C 1.535 0.381 0 N-CA-C 113.404 0.89 . . . . 0.0 113.404 -177.204 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' E' E ' 100' ' ' ASN . . . . . . . . . . . . . 4.0 m-20 63.42 37.67 10.55 Favored 'General case' 0 CA--C 1.529 0.156 0 CA-C-O 121.143 0.497 . . . . 0.0 111.023 179.792 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' E' E ' 101' ' ' GLU . . . . . . . . . . . . . 85.0 tt0 -114.97 140.07 49.32 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.025 -0.534 . . . . 0.0 109.6 175.559 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' E' E ' 102' ' ' VAL . . . . . . . . . . . . . 47.5 t -114.88 126.1 72.37 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.243 0 N-CA-C 109.795 -0.446 . . . . 0.0 109.795 -178.508 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' E' E ' 103' ' ' LEU . . . . . . . . . . . . . 45.7 mt -119.15 133.15 55.95 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 115.768 -0.651 . . . . 0.0 110.483 178.233 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' E' E ' 104' ' ' ILE . . . . . . . . . . . . . 69.4 mt -119.0 122.42 69.28 Favored 'Isoleucine or valine' 0 C--O 1.235 0.296 0 CA-C-N 116.399 -0.364 . . . . 0.0 110.41 -179.618 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' E' E ' 105' ' ' PHE . . . . . . . . . . . . . 61.9 m-85 -121.72 167.1 13.34 Favored 'General case' 0 C--N 1.333 -0.142 0 O-C-N 124.013 0.821 . . . . 0.0 109.498 178.208 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' E' E ' 106' ' ' ASN . . . . . . . . . . . . . 46.3 p-10 -101.05 -170.36 1.83 Allowed 'General case' 0 C--N 1.33 -0.261 0 N-CA-C 109.95 -0.389 . . . . 0.0 109.95 172.99 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' E' E ' 107' ' ' GLN . . . . . . . . . . . . . 58.6 tt0 -58.99 -29.82 67.5 Favored 'General case' 0 C--N 1.328 -0.327 0 N-CA-C 111.902 0.334 . . . . 0.0 111.902 -179.998 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' E' E ' 108' ' ' ASN . . . . . . . . . . . . . 51.3 t30 -84.77 11.32 9.35 Favored 'General case' 0 CA--C 1.535 0.4 0 N-CA-C 112.838 0.681 . . . . 0.0 112.838 -177.307 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' E' E ' 109' ' ' LEU . . . . . . . . . . . . . 17.8 mt 57.58 36.46 26.82 Favored 'General case' 0 CA--C 1.53 0.185 0 CA-C-O 120.898 0.38 . . . . 0.0 111.342 178.63 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' E' E ' 110' ' ' GLU . . . . . . . . . . . . . 70.4 mm-40 -101.87 138.18 39.18 Favored 'General case' 0 C--N 1.33 -0.281 0 N-CA-C 109.172 -0.677 . . . . 0.0 109.172 174.909 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' E' E ' 111' ' ' GLU . . . . . . . . . . . . . 73.1 tt0 -82.55 121.81 27.27 Favored 'General case' 0 C--N 1.33 -0.28 0 C-N-CA 120.665 -0.414 . . . . 0.0 110.029 -176.655 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' E' E ' 112' ' ' LEU . . . . . . . . . . . . . 22.5 mt -108.95 -44.76 3.92 Favored 'General case' 0 C--N 1.332 -0.195 0 CA-C-N 116.129 -0.487 . . . . 0.0 110.789 -177.655 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' E' E ' 113' ' ' TYR . . . . . . . . . . . . . 50.9 t80 -132.91 137.07 46.51 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.365 -0.38 . . . . 0.0 110.911 -177.739 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' E' E ' 114' ' ' ARG . . . . . . . . . . . . . 16.3 ptm180 -143.31 126.95 17.0 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-O 121.034 0.445 . . . . 0.0 110.664 176.57 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' E' E ' 115' ' ' GLY . . . . . . . . . . . . . . . -150.11 140.27 7.9 Favored Glycine 0 CA--C 1.524 0.64 0 N-CA-C 111.147 -0.781 . . . . 0.0 111.147 178.599 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' E' E ' 116' ' ' LYS . . . . . . . . . . . . . 39.6 ttpt -104.89 128.98 53.33 Favored 'General case' 0 C--N 1.33 -0.269 0 N-CA-C 109.721 -0.474 . . . . 0.0 109.721 175.67 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' E' E ' 117' ' ' PHE . . . . . . . . . . . . . 69.8 m-85 -125.68 114.96 19.36 Favored 'General case' 0 C--N 1.331 -0.22 0 CA-C-O 121.019 0.438 . . . . 0.0 110.129 -177.268 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' E' E ' 118' ' ' GLU . . . . . . . . . . . . . 96.0 mt-10 -54.55 -41.35 69.68 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.462 -0.336 . . . . 0.0 111.265 -175.825 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' E' E ' 119' ' ' ASN . . . . . . . . . . . . . 69.9 m-80 -104.07 31.07 4.76 Favored 'General case' 0 C--O 1.234 0.246 0 CA-C-N 116.229 -0.441 . . . . 0.0 112.111 -173.92 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' E' E ' 120' ' ' LEU . . . . . . . . . . . . . 11.7 tp -56.24 120.05 6.95 Favored 'General case' 0 N--CA 1.462 0.147 0 CA-C-O 120.715 0.293 . . . . 0.0 110.311 178.884 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' E' E ' 121' ' ' ASN . . . . . . . . . . . . . 45.7 m-80 -114.34 -44.03 3.15 Favored 'General case' 0 C--O 1.232 0.153 0 CA-C-N 116.385 -0.37 . . . . 0.0 111.169 -176.655 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' E' E ' 122' ' ' LYS . . . . . . . . . . . . . 97.8 mttt -142.59 147.62 36.16 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-O 121.021 0.439 . . . . 0.0 111.596 -175.915 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' E' E ' 123' ' ' VAL . . . . . . . . . . . . . 44.1 t -127.09 129.16 71.07 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.275 0 N-CA-C 109.278 -0.638 . . . . 0.0 109.278 174.126 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' E' E ' 124' ' ' LEU . . . . . . . . . . . . . 38.1 mt -129.52 137.06 50.58 Favored 'General case' 0 C--N 1.331 -0.202 0 CA-C-O 120.838 0.352 . . . . 0.0 110.948 -178.394 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' E' E ' 125' ' ' VAL . . . . . . . . . . . . . 12.8 p -137.55 138.22 44.88 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.255 0 CA-C-N 116.282 -0.417 . . . . 0.0 110.329 177.908 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' E' E ' 126' ' ' ARG . . . . . . . . . . . . . 37.8 mtp180 -146.2 127.67 15.01 Favored 'General case' 0 C--N 1.331 -0.229 0 CA-C-O 120.954 0.406 . . . . 0.0 110.839 179.159 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' E' E ' 127' ' ' ASN . . . . . . . . . . . . . 62.1 t30 49.55 -104.93 0.15 Allowed 'General case' 0 CA--C 1.543 0.684 0 CA-C-O 118.953 -0.546 . . . . 0.0 111.826 179.157 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' E' E ' 128' ' ' ASP . . . . . . . . . . . . . 12.0 p-10 -114.19 0.61 14.28 Favored 'General case' 0 CA--C 1.537 0.445 0 CA-C-N 119.612 1.096 . . . . 0.0 113.591 -175.148 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' E' E ' 129' ' ' LEU . . . . . . . . . . . . . 84.3 mt -112.32 145.16 40.52 Favored 'General case' 0 C--N 1.333 -0.133 0 CA-C-N 118.203 0.456 . . . . 0.0 110.03 179.839 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' E' E ' 130' ' ' VAL . . . . . . . . . . . . . 12.0 p -131.95 141.93 44.26 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.175 0 CA-C-O 121.059 0.457 . . . . 0.0 110.25 179.954 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' E' E ' 131' ' ' VAL . . . . . . . . . . . . . 27.0 t -135.42 139.32 46.92 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.315 0 CA-C-N 115.961 -0.563 . . . . 0.0 110.397 -177.348 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' E' E ' 132' ' ' ILE . . . . . . . . . . . . . 74.6 mt -115.97 130.45 70.65 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.332 0 N-CA-C 109.215 -0.661 . . . . 0.0 109.215 178.582 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' E' E ' 133' ' ' ILE . . . . . . . . . . . . . 39.5 mm -116.47 123.08 71.14 Favored 'Isoleucine or valine' 0 N--CA 1.462 0.159 0 CA-C-O 120.727 0.299 . . . . 0.0 110.923 -174.662 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' E' E ' 134' ' ' ASP . . . . . . . . . . . . . 12.1 p-10 -136.47 151.71 49.76 Favored 'General case' 0 C--N 1.332 -0.173 0 N-CA-C 109.883 -0.414 . . . . 0.0 109.883 174.422 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' E' E ' 135' ' ' GLU . . . . . . . . . . . . . 41.2 tp10 -50.05 -26.42 4.35 Favored 'General case' 0 C--N 1.328 -0.343 0 N-CA-C 113.025 0.75 . . . . 0.0 113.025 -171.781 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' E' E ' 136' ' ' GLN . . . . . . . . . . . . . 47.1 tt0 -91.47 -25.11 19.46 Favored 'General case' 0 C--O 1.234 0.264 0 N-CA-C 112.977 0.732 . . . . 0.0 112.977 -173.121 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' E' E ' 137' ' ' LYS . . . . . . . . . . . . . 22.6 pttm -170.06 171.36 7.02 Favored 'General case' 0 C--O 1.232 0.148 0 CA-C-O 121.501 0.667 . . . . 0.0 112.659 -172.522 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' E' E ' 138' ' ' LEU . . . . . . . . . . . . . 5.1 tt -122.28 129.01 51.78 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 115.009 -0.996 . . . . 0.0 109.817 179.727 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' E' E ' 139' ' ' THR . . . . . . . . . . . . . 43.5 m -111.46 127.61 55.74 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.528 -0.306 . . . . 0.0 110.354 179.288 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' E' E ' 140' ' ' LEU . . . . . . . . . . . . . 11.9 tp -114.27 123.34 49.3 Favored 'General case' 0 C--N 1.33 -0.268 0 N-CA-C 109.554 -0.535 . . . . 0.0 109.554 -178.976 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' E' E ' 141' ' ' ILE . . . . . . . . . . . . . 19.6 mt -121.5 124.79 72.54 Favored 'Isoleucine or valine' 0 C--O 1.234 0.253 0 CA-C-O 120.943 0.401 . . . . 0.0 110.261 -174.648 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' E' E ' 142' ' ' ARG . . . . . . . . . . . . . 82.2 mtp180 -108.68 128.13 54.59 Favored 'General case' 0 C--N 1.331 -0.222 0 CA-C-N 115.229 -0.896 . . . . 0.0 110.181 -178.654 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' E' E ' 143' ' ' THR . . . . . . . . . . . . . 24.9 p . . . . . 0 C--O 1.221 -0.412 0 CA-C-O 117.964 -1.017 . . . . 0.0 110.52 -179.754 . . . . . . . . 0 0 . 1 . 008 nuclear orig full ' F' F ' -3' ' ' GLU . . . . . . . . . . . . . 45.3 tp10 . . . . . 0 N--CA 1.49 1.553 0 N-CA-C 109.215 -0.661 . . . . 0.0 109.215 . . . . . . . . . 0 0 . 1 . 008 nuclear orig full ' F' F ' -2' ' ' GLY . . . . . . . . . . . . . . . -62.26 150.04 47.23 Favored Glycine 0 CA--C 1.525 0.714 0 N-CA-C 110.925 -0.87 . . . . 0.0 110.925 -179.434 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' F' F ' -1' ' ' VAL . . . . . . . . . . . . . 43.5 t -95.47 137.06 24.59 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.316 0 N-CA-C 109.944 -0.391 . . . . 0.0 109.944 -179.86 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' F' F ' 0' ' ' ILE . . . . . . . . . . . . . 42.9 mm -112.77 141.04 29.64 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.263 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.321 -177.662 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' F' F ' 1' ' ' MET . . . . . . . . . . . . . 25.2 ptp -81.59 137.63 35.48 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.061 -0.518 . . . . 0.0 110.789 179.929 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' F' F ' 2' ' ' SER . . . . . . . . . . . . . 2.5 p -131.03 125.44 33.28 Favored 'General case' 0 C--N 1.331 -0.224 0 CA-C-N 116.461 -0.336 . . . . 0.0 110.358 178.738 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' F' F ' 3' ' ' GLU . . . . . . . . . . . . . 93.9 mt-10 -139.47 139.66 37.07 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 116.144 -0.48 . . . . 0.0 111.056 -176.439 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' F' F ' 4' ' ' LEU . . . . . . . . . . . . . 20.6 tp -123.24 127.66 48.9 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 115.805 -0.634 . . . . 0.0 109.91 175.387 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' F' F ' 5' ' ' LYS . . . . . . . . . . . . . 90.9 mttt -109.76 122.25 47.07 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 116.466 -0.334 . . . . 0.0 110.829 179.891 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' F' F ' 6' ' ' LEU . . . . . . . . . . . . . 71.7 mt -116.69 147.2 42.2 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 115.551 -0.75 . . . . 0.0 110.094 179.274 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' F' F ' 7' ' ' LYS . . . . . . . . . . . . . 39.4 ttmt -137.44 142.29 36.8 Favored Pre-proline 0 CA--C 1.533 0.319 0 CA-C-O 119.298 -0.382 . . . . 0.0 110.043 175.845 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' F' F ' 8' ' ' PRO . . . . . . . . . . . . . 87.7 Cg_endo -90.51 143.89 3.75 Favored 'Trans proline' 0 N--CA 1.489 1.244 0 C-N-CA 121.761 1.641 . . . . 0.0 111.846 178.376 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' F' F ' 9' ' ' LEU . . . . . . . . . . . . . 50.4 mt -76.84 -47.97 2.81 Favored Pre-proline 0 CA--C 1.534 0.347 0 CA-C-O 118.709 -0.663 . . . . 0.0 112.27 -179.652 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' F' F ' 10' ' ' PRO . . . . . . . . . . . . . 84.5 Cg_endo -80.41 157.76 22.48 Favored 'Trans proline' 0 N--CA 1.497 1.702 0 C-N-CA 121.237 1.291 . . . . 0.0 111.967 176.561 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' F' F ' 11' ' ' LYS . . . . . . . . . . . . . 53.3 mttm -87.48 100.54 12.84 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-O 120.817 0.341 . . . . 0.0 110.539 178.049 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' F' F ' 12' ' ' VAL . . . . . . . . . . . . . 11.4 p -139.97 144.2 28.62 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.275 0 CA-C-N 116.05 -0.523 . . . . 0.0 110.071 179.281 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' F' F ' 13' ' ' GLU . . . . . . . . . . . . . 41.6 tp10 -91.01 116.67 28.97 Favored 'General case' 0 C--N 1.329 -0.325 0 N-CA-C 109.989 -0.374 . . . . 0.0 109.989 178.611 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' F' F ' 14' ' ' LEU . . . . . . . . . . . . . 23.0 mt -98.24 153.67 37.98 Favored Pre-proline 0 C--N 1.33 -0.269 0 CA-C-N 116.251 -0.431 . . . . 0.0 111.177 -176.124 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' F' F ' 15' ' ' PRO . . . . . . . . . . . . . 37.4 Cg_exo -59.7 156.88 35.11 Favored 'Trans proline' 0 N--CA 1.497 1.733 0 C-N-CA 121.332 1.355 . . . . 0.0 112.132 179.065 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' F' F ' 16' ' ' PRO . . . . . . . . . . . . . 28.1 Cg_exo -60.68 -34.34 92.17 Favored 'Trans proline' 0 N--CA 1.497 1.701 0 C-N-CA 121.404 1.403 . . . . 0.0 112.187 178.043 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' F' F ' 17' ' ' ASP . . . . . . . . . . . . . 15.1 p-10 -85.11 12.29 8.07 Favored 'General case' 0 CA--C 1.536 0.427 0 N-CA-C 113.113 0.783 . . . . 0.0 113.113 -177.939 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' F' F ' 18' ' ' PHE . . . . . . . . . . . . . 33.4 t80 -57.83 -42.36 84.2 Favored 'General case' 0 C--N 1.333 -0.115 0 O-C-N 121.988 -0.445 . . . . 0.0 110.142 -179.678 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' F' F ' 19' ' ' VAL . . . . . . . . . . . . . 49.8 t -55.89 -52.98 43.18 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.316 0 CA-C-N 116.352 -0.385 . . . . 0.0 111.102 -176.675 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' F' F ' 20' ' ' ASP . . . . . . . . . . . . . 2.5 p-10 -59.82 -36.25 76.38 Favored 'General case' 0 N--CA 1.464 0.268 0 C-N-CA 120.582 -0.447 . . . . 0.0 111.342 -176.452 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' F' F ' 21' ' ' VAL . . . . . . . . . . . . . 51.7 t -63.93 -47.13 91.96 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.239 0 C-N-CA 120.575 -0.45 . . . . 0.0 110.34 -179.853 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' F' F ' 22' ' ' ILE . . . . . . . . . . . . . 49.2 mm -55.54 -48.35 77.48 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.219 0 CA-C-O 120.736 0.303 . . . . 0.0 110.505 178.129 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' F' F ' 23' ' ' ARG . . . . . . . . . . . . . 53.2 ttp180 -54.41 -49.54 69.7 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.521 -0.309 . . . . 0.0 111.572 -177.109 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' F' F ' 24' ' ' ILE . . . . . . . . . . . . . 78.0 mt -59.16 -46.15 92.24 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.316 0 C-N-CA 120.971 -0.291 . . . . 0.0 111.166 -176.7 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' F' F ' 25' ' ' LYS . . . . . . . . . . . . . 90.8 mttt -64.76 -44.05 91.34 Favored 'General case' 0 C--N 1.33 -0.275 0 N-CA-C 112.54 0.57 . . . . 0.0 112.54 -177.25 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' F' F ' 26' ' ' LEU . . . . . . . . . . . . . 61.4 mt -83.67 -24.16 31.44 Favored 'General case' 0 C--N 1.329 -0.302 0 N-CA-C 113.467 0.914 . . . . 0.0 113.467 -171.508 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' F' F ' 27' ' ' GLN . . . . . . . . . . . . . 6.4 pt20 -46.15 136.58 6.76 Favored 'General case' 0 CA--C 1.534 0.351 0 N-CA-C 112.813 0.671 . . . . 0.0 112.813 -174.633 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' F' F ' 28' ' ' GLY . . . . . . . . . . . . . . . 100.53 -21.56 43.58 Favored Glycine 0 CA--C 1.533 1.214 0 CA-C-N 115.701 -0.681 . . . . 0.0 112.786 -178.623 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' F' F ' 29' ' ' LYS . . . . . . . . . . . . . 63.2 mttp -97.79 155.08 17.2 Favored 'General case' 0 C--N 1.331 -0.199 0 CA-C-N 117.604 0.702 . . . . 0.0 111.144 179.125 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' F' F ' 30' ' ' THR . . . . . . . . . . . . . 24.2 m -104.7 139.23 39.82 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.196 177.366 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' F' F ' 31' ' ' VAL . . . . . . . . . . . . . 34.3 m -129.33 157.45 42.1 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.19 0 CA-C-O 120.856 0.36 . . . . 0.0 110.915 -178.741 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' F' F ' 32' ' ' ARG . . . . . . . . . . . . . 93.4 mtt180 -133.74 152.33 51.85 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 115.959 -0.564 . . . . 0.0 110.779 177.934 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' F' F ' 33' ' ' THR . . . . . . . . . . . . . 28.5 m -53.31 139.97 28.33 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.133 -0.485 . . . . 0.0 111.399 -178.852 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' F' F ' 34' ' ' GLY . . . . . . . . . . . . . . . 99.21 -17.17 58.33 Favored Glycine 0 CA--C 1.532 1.118 0 C-N-CA 121.16 -0.543 . . . . 0.0 113.222 178.81 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' F' F ' 35' ' ' ASP . . . . . . . . . . . . . 76.0 m-20 -65.83 148.66 51.42 Favored 'General case' 0 C--O 1.232 0.176 0 CA-C-N 118.065 0.933 . . . . 0.0 111.188 179.092 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' F' F ' 36' ' ' VAL . . . . . . . . . . . . . 45.0 t -122.3 129.76 75.06 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.243 0 CA-C-N 115.981 -0.554 . . . . 0.0 109.874 178.468 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' F' F ' 37' ' ' ILE . . . . . . . . . . . . . 66.1 mt -119.77 138.79 49.24 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.201 0 CA-C-N 116.21 -0.45 . . . . 0.0 109.933 -179.776 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' F' F ' 38' ' ' GLY . . . . . . . . . . . . . . . -110.76 128.78 8.93 Favored Glycine 0 CA--C 1.525 0.691 0 N-CA-C 111.193 -0.763 . . . . 0.0 111.193 -179.331 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' F' F ' 39' ' ' ILE . . . . . . . . . . . . . 72.9 mt -123.85 132.69 70.96 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.216 0 N-CA-C 110.137 -0.32 . . . . 0.0 110.137 178.89 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' F' F ' 40' ' ' SER . . . . . . . . . . . . . 23.0 t -92.7 118.86 31.51 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.332 -0.394 . . . . 0.0 110.685 175.34 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' F' F ' 41' ' ' ILE . . . . . . . . . . . . . 70.5 mt -130.69 125.33 58.47 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.229 0 CA-C-O 120.884 0.374 . . . . 0.0 110.469 179.219 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' F' F ' 42' ' ' LEU . . . . . . . . . . . . . 48.3 mt 51.94 34.46 13.69 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 115.994 -0.548 . . . . 0.0 111.913 176.833 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' F' F ' 43' ' ' GLY . . . . . . . . . . . . . . . 72.92 31.36 62.18 Favored Glycine 0 CA--C 1.53 0.993 0 C-N-CA 121.076 -0.583 . . . . 0.0 112.187 177.089 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' F' F ' 44' ' ' LYS . . . . . . . . . . . . . 40.6 ttpt -138.31 130.89 29.23 Favored 'General case' 0 C--N 1.329 -0.314 0 N-CA-C 109.613 -0.514 . . . . 0.0 109.613 178.081 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' F' F ' 45' ' ' GLU . . . . . . . . . . . . . 84.6 tt0 -83.06 118.91 23.86 Favored 'General case' 0 C--N 1.328 -0.351 0 C-N-CA 120.815 -0.354 . . . . 0.0 110.847 -179.66 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' F' F ' 46' ' ' VAL . . . . . . . . . . . . . 7.6 p -119.13 126.74 75.62 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.27 0 N-CA-C 109.375 -0.602 . . . . 0.0 109.375 176.623 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' F' F ' 47' ' ' LYS . . . . . . . . . . . . . 61.0 mttm -100.12 130.61 46.28 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.033 -0.53 . . . . 0.0 111.342 177.813 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' F' F ' 48' ' ' PHE . . . . . . . . . . . . . 90.0 m-85 -111.03 131.91 54.67 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 115.969 -0.559 . . . . 0.0 109.777 175.589 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' F' F ' 49' ' ' LYS . . . . . . . . . . . . . 83.6 tttt -106.81 134.68 49.6 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 116.213 -0.448 . . . . 0.0 110.379 -179.559 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' F' F ' 50' ' ' VAL . . . . . . . . . . . . . 46.8 t -77.07 106.98 7.68 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.283 0 N-CA-C 109.142 -0.688 . . . . 0.0 109.142 176.368 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' F' F ' 51' ' ' VAL . . . . . . . . . . . . . 47.9 t -69.57 -47.95 68.76 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.325 0 CA-C-N 115.932 -0.577 . . . . 0.0 109.979 -173.278 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' F' F ' 52' ' ' GLN . . . . . . . . . . . . . 61.1 tt0 -168.22 148.39 4.8 Favored 'General case' 0 C--N 1.331 -0.22 0 C-N-CA 120.228 -0.589 . . . . 0.0 111.678 -178.838 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' F' F ' 53' ' ' ALA . . . . . . . . . . . . . . . -123.25 132.07 53.9 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 115.651 -0.704 . . . . 0.0 109.86 176.492 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' F' F ' 54' ' ' TYR . . . . . . . . . . . . . 54.3 t80 -129.04 110.11 18.27 Favored Pre-proline 0 CA--C 1.535 0.385 0 CA-C-O 118.317 -0.849 . . . . 0.0 110.166 179.92 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' F' F ' 55' ' ' PRO . . . . . . . . . . . . . 73.9 Cg_endo -77.07 170.03 72.74 Favored 'Cis proline' 0 N--CA 1.497 1.713 0 CA-C-N 121.861 1.7 . . . . 0.0 112.27 -4.661 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' F' F ' 56' ' ' SER . . . . . . . . . . . . . 13.5 m -113.93 131.91 22.91 Favored Pre-proline 0 CA--C 1.538 0.484 0 CA-C-O 118.513 -0.756 . . . . 0.0 109.326 175.652 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' F' F ' 57' ' ' PRO . . . . . . . . . . . . . 55.6 Cg_endo -71.33 166.88 76.79 Favored 'Cis proline' 0 N--CA 1.498 1.757 0 CA-C-N 121.923 1.722 . . . . 0.0 111.643 -0.321 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' F' F ' 58' ' ' LEU . . . . . . . . . . . . . 35.3 tp -129.54 137.34 50.72 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.271 -0.422 . . . . 0.0 110.152 179.491 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' F' F ' 59' ' ' ARG . . . . . . . . . . . . . 38.5 ttm180 -103.71 133.89 47.95 Favored 'General case' 0 C--N 1.327 -0.381 0 N-CA-C 109.706 -0.479 . . . . 0.0 109.706 177.836 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' F' F ' 60' ' ' VAL . . . . . . . . . . . . . 44.1 t -85.28 111.38 20.65 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.264 0 C-N-CA 120.761 -0.376 . . . . 0.0 110.36 -176.428 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' F' F ' 61' ' ' GLU . . . . . . . . . . . . . 95.5 mt-10 -131.06 165.26 23.63 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 115.835 -0.621 . . . . 0.0 109.677 176.043 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' F' F ' 62' ' ' ASP . . . . . . . . . . . . . 19.9 p-10 -53.7 -32.47 51.98 Favored 'General case' 0 C--N 1.328 -0.365 0 N-CA-C 111.85 0.315 . . . . 0.0 111.85 -179.42 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' F' F ' 63' ' ' ARG . . . . . . . . . . . . . 81.3 mtp180 -72.97 -21.93 60.78 Favored 'General case' 0 CA--C 1.533 0.299 0 N-CA-C 113.041 0.756 . . . . 0.0 113.041 -176.313 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' F' F ' 64' ' ' THR . . . . . . . . . . . . . 17.8 m -71.17 142.01 50.7 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-O 120.952 0.406 . . . . 0.0 111.09 -174.568 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' F' F ' 65' ' ' LYS . . . . . . . . . . . . . 39.7 mtpt -89.48 125.46 35.19 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 115.883 -0.599 . . . . 0.0 109.925 178.784 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' F' F ' 66' ' ' ILE . . . . . . . . . . . . . 68.1 mt -119.07 131.64 71.25 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.339 0 CA-C-O 120.874 0.368 . . . . 0.0 110.277 -178.15 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' F' F ' 67' ' ' THR . . . . . . . . . . . . . 26.1 m -123.98 136.89 54.6 Favored 'General case' 0 C--N 1.331 -0.215 0 CA-C-N 116.015 -0.539 . . . . 0.0 110.742 -179.048 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' F' F ' 68' ' ' LEU . . . . . . . . . . . . . 5.7 tt -108.39 119.15 38.67 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 115.968 -0.56 . . . . 0.0 110.515 179.485 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' F' F ' 69' ' ' VAL . . . . . . . . . . . . . 44.7 t -104.36 137.01 35.16 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.238 0 CA-C-N 116.139 -0.482 . . . . 0.0 110.069 179.138 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' F' F ' 70' ' ' THR . . . . . . . . . . . . . 7.2 t -132.21 -39.58 1.05 Allowed 'General case' 0 C--N 1.331 -0.203 0 CA-C-O 120.75 0.31 . . . . 0.0 110.789 179.156 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' F' F ' 71' ' ' HIS . . . . . . . . . . . . . 39.1 m80 -128.32 154.95 79.1 Favored Pre-proline 0 CA--C 1.531 0.234 0 CA-C-N 116.503 -0.317 . . . . 0.0 110.452 179.944 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' F' F ' 72' ' ' PRO . . . . . . . . . . . . . 59.6 Cg_endo -73.95 -30.16 9.42 Favored 'Trans proline' 0 N--CA 1.494 1.554 0 C-N-CA 121.335 1.357 . . . . 0.0 112.462 -179.31 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' F' F ' 73' ' ' VAL . . . . . . . . . . . . . 35.9 m -137.34 163.41 31.6 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.262 0 CA-C-O 120.837 0.351 . . . . 0.0 110.686 179.005 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' F' F ' 74' ' ' ASP . . . . . . . . . . . . . 19.5 t0 -107.05 123.04 47.64 Favored 'General case' 0 C--N 1.328 -0.329 0 N-CA-C 109.584 -0.525 . . . . 0.0 109.584 179.156 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' F' F ' 75' ' ' VAL . . . . . . . . . . . . . 46.2 t -117.34 126.26 74.48 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.233 0 CA-C-O 121.173 0.511 . . . . 0.0 110.771 -177.43 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' F' F ' 76' ' ' LEU . . . . . . . . . . . . . 6.5 mp -122.82 143.66 49.7 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 115.463 -0.79 . . . . 0.0 109.128 174.546 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' F' F ' 77' ' ' GLU . . . . . . . . . . . . . 30.1 tt0 -135.85 140.76 44.42 Favored 'General case' 0 C--N 1.331 -0.225 0 C-N-CA 120.734 -0.386 . . . . 0.0 111.273 -174.73 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' F' F ' 78' ' ' ALA . . . . . . . . . . . . . . . -130.16 134.96 47.68 Favored 'General case' 0 C--N 1.331 -0.239 0 CA-C-N 115.933 -0.576 . . . . 0.0 110.013 176.762 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' F' F ' 79' ' ' LYS . . . . . . . . . . . . . 31.1 ttmt -82.4 125.71 31.36 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-O 120.74 0.305 . . . . 0.0 110.822 -178.607 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' F' F ' 80' ' ' ILE . . . . . . . . . . . . . 28.0 mm -139.12 114.81 8.98 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.265 0 N-CA-C 109.062 -0.718 . . . . 0.0 109.062 -177.8 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' F' F ' 81' ' ' LYS . . . . . . . . . . . . . 70.1 tttt -103.69 122.11 44.36 Favored 'General case' 0 C--N 1.328 -0.334 0 C-N-CA 121.027 -0.269 . . . . 0.0 111.116 -175.884 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' F' F ' 82' ' ' GLY . . . . . . . . . . . . . . . 89.09 42.18 5.68 Favored Glycine 0 CA--C 1.525 0.66 0 C-N-CA 120.715 -0.755 . . . . 0.0 111.892 174.789 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' F' F ' 83' ' ' ILE . . . . . . . . . . . . . 69.0 mt -65.27 136.49 26.6 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.243 0 N-CA-C 109.91 -0.404 . . . . 0.0 109.91 178.044 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' F' F ' 84' ' ' LYS . . . . . . . . . . . . . 29.0 ttmt -94.32 -51.78 4.64 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.088 -0.506 . . . . 0.0 109.93 179.482 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' F' F ' 85' ' ' ASP . . . . . . . . . . . . . 4.3 t70 -157.29 153.59 27.7 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 115.621 -0.718 . . . . 0.0 110.504 -179.659 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' F' F ' 86' ' ' VAL . . . . . . . . . . . . . 43.8 t -131.52 133.41 61.85 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.232 0 CA-C-O 120.98 0.419 . . . . 0.0 110.356 -179.181 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' F' F ' 87' ' ' ILE . . . . . . . . . . . . . 5.0 mp -120.37 126.29 75.1 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.241 0 CA-C-N 115.943 -0.572 . . . . 0.0 109.528 177.765 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' F' F ' 88' ' ' LEU . . . . . . . . . . . . . 10.7 tp -109.5 128.2 55.0 Favored 'General case' 0 C--N 1.331 -0.226 0 CA-C-O 120.902 0.382 . . . . 0.0 110.895 -177.929 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' F' F ' 89' ' ' ASP . . . . . . . . . . . . . 4.2 t0 -120.69 158.14 28.1 Favored 'General case' 0 C--N 1.329 -0.286 0 N-CA-C 109.497 -0.557 . . . . 0.0 109.497 177.441 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' F' F ' 90' ' ' GLU . . . . . . . . . . . . . 84.0 tt0 -45.12 -46.19 11.68 Favored 'General case' 0 N--CA 1.465 0.291 0 N-CA-C 112.985 0.735 . . . . 0.0 112.985 -172.484 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' F' F ' 91' ' ' ASN . . . . . . . . . . . . . 79.4 m-20 -132.05 30.84 4.22 Favored 'General case' 0 N--CA 1.465 0.29 0 N-CA-C 112.189 0.44 . . . . 0.0 112.189 -179.608 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' F' F ' 92' ' ' LEU . . . . . . . . . . . . . 7.2 mt -150.35 140.94 22.56 Favored 'General case' 0 C--N 1.331 -0.204 0 N-CA-C 109.564 -0.532 . . . . 0.0 109.564 -178.088 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' F' F ' 93' ' ' ILE . . . . . . . . . . . . . 73.5 mt -124.01 119.45 56.87 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.289 0 N-CA-C 109.338 -0.616 . . . . 0.0 109.338 178.997 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' F' F ' 94' ' ' VAL . . . . . . . . . . . . . 44.0 t -119.55 126.59 75.46 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.198 0 CA-C-O 120.892 0.377 . . . . 0.0 109.998 -179.648 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' F' F ' 95' ' ' VAL . . . . . . . . . . . . . 44.1 t -121.58 133.14 69.01 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.298 0 CA-C-N 116.101 -0.5 . . . . 0.0 109.738 179.623 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' F' F ' 96' ' ' ILE . . . . . . . . . . . . . 64.3 mt -114.26 126.15 71.71 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.326 0 N-CA-C 109.234 -0.654 . . . . 0.0 109.234 178.88 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' F' F ' 97' ' ' THR . . . . . . . . . . . . . 64.6 p -98.62 154.8 17.67 Favored 'General case' 0 C--N 1.327 -0.385 0 CA-C-O 121.109 0.48 . . . . 0.0 110.952 -178.311 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' F' F ' 98' ' ' GLU . . . . . . . . . . . . . 83.4 tt0 -53.89 -23.5 12.91 Favored 'General case' 0 CA--C 1.535 0.371 0 N-CA-C 112.419 0.525 . . . . 0.0 112.419 179.966 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' F' F ' 99' ' ' GLU . . . . . . . . . . . . . 13.8 mm-40 -77.54 13.92 1.14 Allowed 'General case' 0 CA--C 1.536 0.431 0 N-CA-C 113.272 0.841 . . . . 0.0 113.272 -178.444 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' F' F ' 100' ' ' ASN . . . . . . . . . . . . . 2.2 m-20 63.65 37.73 9.95 Favored 'General case' 0 N--CA 1.463 0.212 0 CA-C-O 121.111 0.481 . . . . 0.0 110.948 178.322 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' F' F ' 101' ' ' GLU . . . . . . . . . . . . . 84.9 tt0 -120.09 140.93 50.3 Favored 'General case' 0 C--N 1.333 -0.151 0 CA-C-N 116.203 -0.453 . . . . 0.0 109.853 176.68 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' F' F ' 102' ' ' VAL . . . . . . . . . . . . . 43.2 t -115.03 126.74 72.7 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 CA-C-N 116.197 -0.456 . . . . 0.0 109.881 -178.32 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' F' F ' 103' ' ' LEU . . . . . . . . . . . . . 6.2 mp -117.29 134.89 54.27 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 115.994 -0.548 . . . . 0.0 110.294 177.784 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' F' F ' 104' ' ' ILE . . . . . . . . . . . . . 66.3 mt -119.0 122.22 68.78 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.218 0 CA-C-N 116.422 -0.354 . . . . 0.0 110.217 -179.147 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' F' F ' 105' ' ' PHE . . . . . . . . . . . . . 79.3 m-85 -120.54 161.46 21.27 Favored 'General case' 0 C--N 1.331 -0.235 0 O-C-N 124.046 0.841 . . . . 0.0 109.987 179.614 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' F' F ' 106' ' ' ASN . . . . . . . . . . . . . 46.8 p-10 -97.4 -169.85 1.92 Allowed 'General case' 0 CA--C 1.531 0.228 0 N-CA-C 110.19 -0.3 . . . . 0.0 110.19 175.559 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' F' F ' 107' ' ' GLN . . . . . . . . . . . . . 63.0 tt0 -59.0 -30.09 67.72 Favored 'General case' 0 C--N 1.33 -0.271 0 N-CA-C 111.954 0.353 . . . . 0.0 111.954 179.618 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' F' F ' 108' ' ' ASN . . . . . . . . . . . . . 8.5 t-20 -83.98 11.76 7.32 Favored 'General case' 0 CA--C 1.536 0.428 0 N-CA-C 112.877 0.695 . . . . 0.0 112.877 -178.124 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' F' F ' 109' ' ' LEU . . . . . . . . . . . . . 10.5 tp 54.96 35.41 24.49 Favored 'General case' 0 C--N 1.331 -0.201 0 CA-C-O 120.902 0.382 . . . . 0.0 111.431 -179.602 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' F' F ' 110' ' ' GLU . . . . . . . . . . . . . 94.9 mt-10 -104.46 147.06 28.0 Favored 'General case' 0 C--N 1.331 -0.233 0 N-CA-C 109.335 -0.617 . . . . 0.0 109.335 175.38 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' F' F ' 111' ' ' GLU . . . . . . . . . . . . . 64.8 tt0 -81.47 121.95 26.92 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-O 120.913 0.387 . . . . 0.0 110.639 -174.97 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' F' F ' 112' ' ' LEU . . . . . . . . . . . . . 16.9 mt -104.7 -46.04 4.44 Favored 'General case' 0 C--N 1.331 -0.227 0 CA-C-N 116.04 -0.527 . . . . 0.0 110.623 179.513 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' F' F ' 113' ' ' TYR . . . . . . . . . . . . . 49.5 t80 -137.25 146.04 44.28 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.166 -0.47 . . . . 0.0 111.026 -177.919 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' F' F ' 114' ' ' ARG . . . . . . . . . . . . . 37.6 ptt180 -148.58 126.58 12.0 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.141 -0.481 . . . . 0.0 110.779 178.505 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' F' F ' 115' ' ' GLY . . . . . . . . . . . . . . . -150.16 142.78 9.98 Favored Glycine 0 CA--C 1.524 0.641 0 N-CA-C 111.062 -0.815 . . . . 0.0 111.062 179.159 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' F' F ' 116' ' ' LYS . . . . . . . . . . . . . 39.1 ttpt -112.37 134.09 54.09 Favored 'General case' 0 C--N 1.331 -0.236 0 N-CA-C 109.694 -0.484 . . . . 0.0 109.694 176.908 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' F' F ' 117' ' ' PHE . . . . . . . . . . . . . 28.1 m-85 -136.54 114.38 11.25 Favored 'General case' 0 C--N 1.329 -0.313 0 N-CA-C 110.055 -0.35 . . . . 0.0 110.055 -175.351 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' F' F ' 118' ' ' GLU . . . . . . . . . . . . . 43.7 mt-10 -54.94 -44.1 74.0 Favored 'General case' 0 C--N 1.33 -0.274 0 C-N-CA 120.883 -0.327 . . . . 0.0 111.348 -176.618 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' F' F ' 119' ' ' ASN . . . . . . . . . . . . . 30.6 m120 -94.87 30.49 2.07 Favored 'General case' 0 C--N 1.33 -0.263 0 N-CA-C 112.161 0.43 . . . . 0.0 112.161 -174.659 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' F' F ' 120' ' ' LEU . . . . . . . . . . . . . 22.0 tp -57.5 120.08 7.65 Favored 'General case' 0 C--N 1.331 -0.211 0 C-N-CA 120.925 -0.31 . . . . 0.0 110.293 177.577 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' F' F ' 121' ' ' ASN . . . . . . . . . . . . . 76.2 m-20 -111.63 -44.1 3.55 Favored 'General case' 0 C--N 1.331 -0.221 0 CA-C-N 116.425 -0.352 . . . . 0.0 110.711 -179.273 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' F' F ' 122' ' ' LYS . . . . . . . . . . . . . 97.0 mttt -146.93 145.08 29.67 Favored 'General case' 0 C--N 1.331 -0.216 0 C-N-CA 120.536 -0.466 . . . . 0.0 111.899 -179.316 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' F' F ' 123' ' ' VAL . . . . . . . . . . . . . 45.1 t -122.95 125.86 72.89 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.234 0 N-CA-C 108.998 -0.742 . . . . 0.0 108.998 171.531 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' F' F ' 124' ' ' LEU . . . . . . . . . . . . . 3.3 tt -125.26 131.86 53.03 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.461 -0.336 . . . . 0.0 110.482 -175.28 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' F' F ' 125' ' ' VAL . . . . . . . . . . . . . 11.7 p -131.14 135.95 58.78 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.224 0 CA-C-N 116.377 -0.374 . . . . 0.0 110.502 178.961 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' F' F ' 126' ' ' ARG . . . . . . . . . . . . . 96.6 mtt180 -149.43 128.37 12.63 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 116.109 -0.496 . . . . 0.0 110.873 177.333 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' F' F ' 127' ' ' ASN . . . . . . . . . . . . . 17.3 t-20 50.46 -106.77 0.24 Allowed 'General case' 0 CA--C 1.543 0.677 0 CA-C-O 118.975 -0.536 . . . . 0.0 111.543 178.85 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' F' F ' 128' ' ' ASP . . . . . . . . . . . . . 18.7 p-10 -114.14 5.17 15.85 Favored 'General case' 0 N--CA 1.469 0.476 0 CA-C-N 119.667 1.121 . . . . 0.0 113.531 -176.332 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' F' F ' 129' ' ' LEU . . . . . . . . . . . . . 61.9 mt -109.39 137.52 47.12 Favored 'General case' 0 C--O 1.232 0.159 0 CA-C-N 118.155 0.434 . . . . 0.0 110.702 -179.428 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' F' F ' 130' ' ' VAL . . . . . . . . . . . . . 44.4 t -124.02 132.0 72.05 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.194 0 N-CA-C 109.609 -0.515 . . . . 0.0 109.609 177.596 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' F' F ' 131' ' ' VAL . . . . . . . . . . . . . 41.4 t -135.56 137.08 50.06 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.208 0 CA-C-O 121.091 0.472 . . . . 0.0 110.511 -179.452 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' F' F ' 132' ' ' ILE . . . . . . . . . . . . . 71.0 mt -118.26 132.82 66.99 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.239 0 CA-C-N 115.815 -0.629 . . . . 0.0 109.542 178.717 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' F' F ' 133' ' ' ILE . . . . . . . . . . . . . 43.1 mm -118.31 124.6 73.37 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.238 0 CA-C-N 116.519 -0.31 . . . . 0.0 111.205 -174.758 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' F' F ' 134' ' ' ASP . . . . . . . . . . . . . 13.9 p-10 -140.52 151.42 44.76 Favored 'General case' 0 C--N 1.332 -0.19 0 N-CA-C 109.737 -0.468 . . . . 0.0 109.737 172.655 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' F' F ' 135' ' ' GLU . . . . . . . . . . . . . 42.5 tp10 -50.89 -27.44 7.5 Favored 'General case' 0 C--N 1.328 -0.357 0 N-CA-C 112.971 0.73 . . . . 0.0 112.971 -171.028 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' F' F ' 136' ' ' GLN . . . . . . . . . . . . . 99.3 mm-40 -86.28 -29.62 22.93 Favored 'General case' 0 C--O 1.233 0.23 0 N-CA-C 112.705 0.631 . . . . 0.0 112.705 -174.332 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' F' F ' 137' ' ' LYS . . . . . . . . . . . . . 55.7 pttt -164.95 169.11 16.84 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-O 121.524 0.678 . . . . 0.0 112.545 -170.605 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' F' F ' 138' ' ' LEU . . . . . . . . . . . . . 5.3 tt -122.26 127.52 50.01 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 114.986 -1.006 . . . . 0.0 109.598 178.565 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' F' F ' 139' ' ' THR . . . . . . . . . . . . . 35.0 m -108.07 124.59 50.43 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.423 -0.353 . . . . 0.0 110.333 -179.299 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' F' F ' 140' ' ' LEU . . . . . . . . . . . . . 14.5 tp -113.0 120.2 40.56 Favored 'General case' 0 C--N 1.329 -0.284 0 N-CA-C 109.337 -0.616 . . . . 0.0 109.337 -179.069 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' F' F ' 141' ' ' ILE . . . . . . . . . . . . . 18.9 mt -120.94 121.96 66.48 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.28 0 CA-C-O 120.961 0.41 . . . . 0.0 110.052 -175.364 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' F' F ' 142' ' ' ARG . . . . . . . . . . . . . 75.3 mtp180 -105.84 117.18 33.37 Favored 'General case' 0 C--O 1.232 0.163 0 CA-C-N 115.548 -0.751 . . . . 0.0 109.945 179.113 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' F' F ' 143' ' ' THR . . . . . . . . . . . . . 18.8 p . . . . . 0 C--O 1.219 -0.505 0 CA-C-O 118.029 -0.986 . . . . 0.0 110.663 -179.015 . . . . . . . . 0 0 . 1 . 009 nuclear orig full ' A' A ' -3' ' ' GLU . . . . . . . . . . . . . 70.8 mm-40 . . . . . 0 N--CA 1.49 1.557 0 N-CA-C 109.343 -0.614 . . . . 0.0 109.343 . . . . . . . . . 0 0 . 1 . 009 nuclear orig full ' A' A ' -2' ' ' GLY . . . . . . . . . . . . . . . -69.81 145.28 41.49 Favored Glycine 0 CA--C 1.525 0.702 0 N-CA-C 111.049 -0.82 . . . . 0.0 111.049 -179.55 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' -1' ' ' VAL . . . . . . . . . . . . . 44.7 t -141.86 135.67 29.77 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.34 0 N-CA-C 109.938 -0.393 . . . . 0.0 109.938 179.361 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 0' ' ' ILE . . . . . . . . . . . . . 71.2 mt -107.13 133.0 53.08 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.322 0 N-CA-C 109.779 -0.452 . . . . 0.0 109.779 179.574 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 25.7 ptm -77.69 140.55 39.57 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.198 -0.455 . . . . 0.0 111.17 -177.264 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 5.3 p -115.97 132.99 56.49 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 115.967 -0.56 . . . . 0.0 110.013 177.29 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 84.9 tt0 -146.14 143.85 29.59 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.27 -0.423 . . . . 0.0 111.371 -178.232 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 4' ' ' LEU . . . . . . . . . . . . . 16.8 tp -127.54 132.84 49.84 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 115.937 -0.574 . . . . 0.0 110.079 176.934 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 5' ' ' LYS . . . . . . . . . . . . . 91.6 mttt -112.05 120.64 42.55 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.589 -179.555 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 71.5 mt -115.95 142.67 46.47 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 115.471 -0.786 . . . . 0.0 110.305 -178.685 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 39.4 ttmt -122.71 138.42 29.42 Favored Pre-proline 0 CA--C 1.532 0.286 0 CA-C-O 118.991 -0.528 . . . . 0.0 109.807 176.013 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 8' ' ' PRO . . . . . . . . . . . . . 91.3 Cg_endo -91.44 131.76 1.37 Allowed 'Trans proline' 0 N--CA 1.489 1.229 0 C-N-CA 121.702 1.602 . . . . 0.0 111.803 178.688 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 41.2 mt -71.91 -46.98 11.88 Favored Pre-proline 0 C--N 1.327 -0.376 0 CA-C-O 118.648 -0.691 . . . . 0.0 112.004 -179.388 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 83.6 Cg_endo -81.05 150.42 17.93 Favored 'Trans proline' 0 N--CA 1.495 1.581 0 C-N-CA 121.213 1.276 . . . . 0.0 111.878 175.412 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 68.8 mttm -88.85 99.33 12.3 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.401 -0.363 . . . . 0.0 110.496 178.932 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 12.4 p -144.52 149.16 17.52 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.282 0 CA-C-N 116.239 -0.437 . . . . 0.0 110.522 -179.494 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 44.2 mp0 -90.48 120.61 31.72 Favored 'General case' 0 C--N 1.331 -0.208 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.436 179.064 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 14' ' ' LEU . . . . . . . . . . . . . 24.2 mt -98.24 154.23 37.74 Favored Pre-proline 0 C--N 1.329 -0.291 0 CA-C-N 116.351 -0.386 . . . . 0.0 110.867 -179.744 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 15' ' ' PRO . . . . . . . . . . . . . 37.5 Cg_exo -59.63 155.93 39.84 Favored 'Trans proline' 0 N--CA 1.497 1.729 0 C-N-CA 121.272 1.315 . . . . 0.0 111.615 177.742 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 16' ' ' PRO . . . . . . . . . . . . . 35.8 Cg_exo -58.18 -38.29 91.84 Favored 'Trans proline' 0 N--CA 1.496 1.643 0 C-N-CA 121.491 1.461 . . . . 0.0 112.697 -179.514 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 17' ' ' ASP . . . . . . . . . . . . . 15.9 p-10 -85.18 10.69 11.59 Favored 'General case' 0 CA--C 1.534 0.363 0 N-CA-C 113.215 0.82 . . . . 0.0 113.215 -177.816 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 18' ' ' PHE . . . . . . . . . . . . . 42.1 t80 -58.2 -42.3 85.86 Favored 'General case' 0 N--CA 1.458 -0.046 0 O-C-N 121.95 -0.469 . . . . 0.0 110.116 -179.158 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 19' ' ' VAL . . . . . . . . . . . . . 12.6 p -55.9 -40.51 62.74 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.287 0 CA-C-N 116.436 -0.347 . . . . 0.0 110.709 179.65 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 53.9 m-20 -60.59 -44.0 96.74 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-O 120.83 0.348 . . . . 0.0 110.722 -179.394 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 47.0 t -63.64 -47.13 92.67 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.324 0 CA-C-N 116.358 -0.383 . . . . 0.0 110.587 -177.643 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 22' ' ' ILE . . . . . . . . . . . . . 50.7 mm -54.97 -49.51 70.52 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.204 0 O-C-N 122.227 -0.296 . . . . 0.0 110.835 179.3 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 23' ' ' ARG . . . . . . . . . . . . . 34.8 ttp180 -54.04 -49.32 69.21 Favored 'General case' 0 C--N 1.33 -0.247 0 C-N-CA 121.043 -0.263 . . . . 0.0 111.53 -178.339 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 24' ' ' ILE . . . . . . . . . . . . . 79.1 mt -58.85 -42.0 84.45 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.281 0 C-N-CA 121.181 -0.208 . . . . 0.0 111.428 -177.147 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 45.2 mttm -67.97 -42.13 81.33 Favored 'General case' 0 C--N 1.328 -0.347 0 N-CA-C 112.212 0.449 . . . . 0.0 112.212 -178.442 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 81.6 mt -80.19 -34.72 37.22 Favored 'General case' 0 C--N 1.328 -0.34 0 N-CA-C 113.501 0.926 . . . . 0.0 113.501 -169.64 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 27' ' ' GLN . . . . . . . . . . . . . 9.7 pt20 -46.64 141.52 3.75 Favored 'General case' 0 N--CA 1.467 0.412 0 N-CA-C 112.876 0.695 . . . . 0.0 112.876 -174.84 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 100.25 -26.89 22.83 Favored Glycine 0 CA--C 1.534 1.225 0 CA-C-N 115.644 -0.707 . . . . 0.0 112.166 -177.485 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 49.2 mtpt -97.52 155.04 17.13 Favored 'General case' 0 C--O 1.233 0.205 0 CA-C-N 117.322 0.561 . . . . 0.0 110.976 178.802 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 30' ' ' THR . . . . . . . . . . . . . 25.6 m -106.21 137.71 43.67 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.189 -0.459 . . . . 0.0 110.007 176.436 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 34.9 m -129.14 159.21 41.43 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.275 0 CA-C-N 116.409 -0.359 . . . . 0.0 110.866 -178.286 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 32' ' ' ARG . . . . . . . . . . . . . 76.7 mtm180 -133.46 150.82 51.73 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-O 121.209 0.528 . . . . 0.0 110.564 178.391 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 33' ' ' THR . . . . . . . . . . . . . 13.6 m -52.69 140.23 24.12 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.203 -0.453 . . . . 0.0 111.416 -178.148 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 100.53 -17.16 57.08 Favored Glycine 0 CA--C 1.532 1.111 0 CA-C-O 119.805 -0.442 . . . . 0.0 113.315 179.673 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 74.1 m-20 -66.82 149.31 50.76 Favored 'General case' 0 N--CA 1.461 0.098 0 CA-C-N 118.021 0.91 . . . . 0.0 111.205 178.931 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 45.3 t -119.42 129.87 74.74 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.2 0 CA-C-N 115.915 -0.584 . . . . 0.0 109.737 178.007 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 37' ' ' ILE . . . . . . . . . . . . . 64.1 mt -120.48 138.71 50.1 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.238 0 CA-C-N 116.091 -0.504 . . . . 0.0 109.854 -179.332 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . -116.52 128.8 8.11 Favored Glycine 0 CA--C 1.525 0.701 0 N-CA-C 111.052 -0.819 . . . . 0.0 111.052 179.953 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 39' ' ' ILE . . . . . . . . . . . . . 71.1 mt -126.72 134.24 66.71 Favored 'Isoleucine or valine' 0 C--N 1.333 -0.138 0 CA-C-O 120.822 0.344 . . . . 0.0 110.219 178.988 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 40' ' ' SER . . . . . . . . . . . . . 8.6 t -92.79 114.52 27.1 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.224 -0.444 . . . . 0.0 110.938 175.139 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 41' ' ' ILE . . . . . . . . . . . . . 44.3 mm -121.79 119.37 58.57 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.232 0 CA-C-O 120.87 0.367 . . . . 0.0 110.353 179.912 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 9.4 tp 55.45 36.63 27.52 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.182 -0.463 . . . . 0.0 111.483 177.254 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . 72.43 24.9 75.53 Favored Glycine 0 CA--C 1.532 1.111 0 C-N-CA 121.14 -0.553 . . . . 0.0 112.659 177.929 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 44' ' ' LYS . . . . . . . . . . . . . 43.4 mmtm -132.02 130.9 41.98 Favored 'General case' 0 C--N 1.332 -0.174 0 CA-C-N 117.28 0.54 . . . . 0.0 109.748 178.609 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 84.0 tt0 -83.32 121.22 26.84 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.479 -0.328 . . . . 0.0 111.154 -178.286 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 46' ' ' VAL . . . . . . . . . . . . . 11.2 p -119.73 121.41 66.09 Favored 'Isoleucine or valine' 0 C--O 1.232 0.166 0 N-CA-C 109.6 -0.518 . . . . 0.0 109.6 173.935 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 51.9 mtmt -98.72 126.48 44.35 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 115.968 -0.56 . . . . 0.0 110.657 178.243 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 48' ' ' PHE . . . . . . . . . . . . . 46.2 m-85 -110.99 131.85 54.7 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.201 -0.454 . . . . 0.0 109.816 178.631 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 80.9 tttt -106.43 130.89 54.16 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.362 -0.381 . . . . 0.0 110.044 178.329 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 50' ' ' VAL . . . . . . . . . . . . . 43.3 t -75.04 105.54 4.1 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.322 0 N-CA-C 109.414 -0.587 . . . . 0.0 109.414 177.785 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 51' ' ' VAL . . . . . . . . . . . . . 45.8 t -71.24 -51.95 30.54 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.363 0 CA-C-N 116.053 -0.521 . . . . 0.0 109.713 -175.015 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 52' ' ' GLN . . . . . . . . . . . . . 87.1 mt-30 -153.74 151.91 30.16 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-O 121.146 0.498 . . . . 0.0 111.44 -178.313 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -128.08 133.69 49.08 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 115.253 -0.885 . . . . 0.0 109.828 175.819 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 54' ' ' TYR . . . . . . . . . . . . . 58.1 t80 -129.03 108.81 18.15 Favored Pre-proline 0 CA--C 1.535 0.373 0 CA-C-O 118.363 -0.827 . . . . 0.0 110.324 -179.421 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 55' ' ' PRO . . . . . . . . . . . . . 73.5 Cg_endo -77.14 170.13 72.39 Favored 'Cis proline' 0 N--CA 1.499 1.845 0 CA-C-N 121.766 1.666 . . . . 0.0 112.372 -5.47 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 56' ' ' SER . . . . . . . . . . . . . 32.3 m -115.54 127.2 26.99 Favored Pre-proline 0 CA--C 1.538 0.494 0 CA-C-O 118.384 -0.817 . . . . 0.0 109.322 175.495 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 57' ' ' PRO . . . . . . . . . . . . . 36.9 Cg_endo -66.28 167.43 53.59 Favored 'Cis proline' 0 N--CA 1.497 1.682 0 CA-C-N 121.977 1.742 . . . . 0.0 111.708 0.063 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 58' ' ' LEU . . . . . . . . . . . . . 28.5 tp -130.98 137.26 49.16 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.136 -0.484 . . . . 0.0 110.447 -179.912 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 59' ' ' ARG . . . . . . . . . . . . . 70.8 ttt180 -102.44 130.94 49.38 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 116.149 -0.478 . . . . 0.0 109.791 177.163 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 40.8 t -80.43 112.39 18.39 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 CA-C-O 120.878 0.37 . . . . 0.0 110.397 -177.101 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 83.0 tt0 -131.0 155.41 46.87 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 115.84 -0.618 . . . . 0.0 109.461 177.433 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 62' ' ' ASP . . . . . . . . . . . . . 76.3 m-20 -50.5 -30.38 12.72 Favored 'General case' 0 C--N 1.328 -0.356 0 N-CA-C 112.208 0.447 . . . . 0.0 112.208 179.733 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 63' ' ' ARG . . . . . . . . . . . . . 77.2 mtp180 -71.99 -21.6 61.55 Favored 'General case' 0 CA--C 1.534 0.352 0 N-CA-C 112.843 0.682 . . . . 0.0 112.843 -176.768 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 27.5 m -71.59 139.3 49.33 Favored 'General case' 0 C--N 1.332 -0.159 0 CA-C-O 120.971 0.415 . . . . 0.0 111.0 -176.687 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 65' ' ' LYS . . . . . . . . . . . . . 55.0 mtmt -89.09 134.51 33.97 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-N 115.902 -0.59 . . . . 0.0 109.896 176.714 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 66' ' ' ILE . . . . . . . . . . . . . 63.3 mt -115.55 129.83 71.18 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.259 0 N-CA-C 109.925 -0.398 . . . . 0.0 109.925 -178.643 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 67' ' ' THR . . . . . . . . . . . . . 24.5 m -120.02 135.78 54.8 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.851 -179.148 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 68' ' ' LEU . . . . . . . . . . . . . 6.6 tt -106.16 123.54 48.18 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 115.701 -0.681 . . . . 0.0 110.039 178.168 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 69' ' ' VAL . . . . . . . . . . . . . 42.3 t -98.46 127.19 51.23 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.293 0 CA-C-N 116.185 -0.461 . . . . 0.0 110.191 -179.259 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 70' ' ' THR . . . . . . . . . . . . . 9.1 m -93.19 -59.97 1.9 Allowed 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.747 -179.69 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 71' ' ' HIS . . . . . . . . . . . . . 46.1 m80 -79.27 161.09 69.07 Favored Pre-proline 0 C--N 1.33 -0.264 0 CA-C-N 116.299 -0.409 . . . . 0.0 110.618 -178.927 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 72' ' ' PRO . . . . . . . . . . . . . 15.6 Cg_endo -84.19 -25.45 2.19 Favored 'Trans proline' 0 N--CA 1.49 1.32 0 C-N-CA 121.605 1.537 . . . . 0.0 112.94 -179.103 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 73' ' ' VAL . . . . . . . . . . . . . 35.6 m -89.52 172.9 0.93 Allowed 'Isoleucine or valine' 0 C--N 1.332 -0.183 0 CA-C-O 120.984 0.421 . . . . 0.0 110.895 -178.544 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 74' ' ' ASP . . . . . . . . . . . . . 9.0 t0 -102.86 124.82 49.1 Favored 'General case' 0 C--N 1.331 -0.22 0 CA-C-N 115.979 -0.555 . . . . 0.0 109.904 -179.285 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 41.0 t -114.26 121.98 67.46 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.255 0 CA-C-O 121.213 0.53 . . . . 0.0 110.521 -178.321 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 76' ' ' LEU . . . . . . . . . . . . . 29.9 mt -117.74 141.29 48.57 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 115.446 -0.797 . . . . 0.0 109.165 176.28 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 77' ' ' GLU . . . . . . . . . . . . . 16.8 tt0 -137.31 133.53 35.05 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-O 120.851 0.358 . . . . 0.0 111.135 -176.11 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 78' ' ' ALA . . . . . . . . . . . . . . . -125.99 141.06 52.13 Favored 'General case' 0 C--N 1.331 -0.202 0 CA-C-N 116.058 -0.519 . . . . 0.0 110.457 178.913 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 79' ' ' LYS . . . . . . . . . . . . . 45.0 mmtt -79.63 121.89 25.85 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.382 -0.372 . . . . 0.0 110.38 177.992 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 80' ' ' ILE . . . . . . . . . . . . . 38.5 mm -138.9 107.41 3.5 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.343 0 N-CA-C 109.386 -0.598 . . . . 0.0 109.386 -179.413 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 81' ' ' LYS . . . . . . . . . . . . . 28.7 ttpp -103.25 125.22 49.8 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-O 120.811 0.339 . . . . 0.0 111.64 -175.321 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . 89.19 42.05 5.68 Favored Glycine 0 CA--C 1.524 0.646 0 C-N-CA 121.102 -0.57 . . . . 0.0 112.012 172.48 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 83' ' ' ILE . . . . . . . . . . . . . 71.3 mt -72.85 136.75 24.87 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 N-CA-C 109.851 -0.426 . . . . 0.0 109.851 176.965 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 84' ' ' LYS . . . . . . . . . . . . . 39.6 ttpt -100.54 -48.14 4.64 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-O 120.966 0.412 . . . . 0.0 110.105 -179.438 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 85' ' ' ASP . . . . . . . . . . . . . 6.3 t70 -151.41 152.51 33.17 Favored 'General case' 0 C--N 1.331 -0.23 0 CA-C-N 115.891 -0.595 . . . . 0.0 110.548 179.1 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 86' ' ' VAL . . . . . . . . . . . . . 41.5 t -131.16 133.64 62.3 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.266 0 CA-C-O 121.034 0.445 . . . . 0.0 110.664 -178.461 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 87' ' ' ILE . . . . . . . . . . . . . 44.2 mm -119.75 125.48 74.36 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.247 0 CA-C-N 115.757 -0.656 . . . . 0.0 109.434 175.924 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 88' ' ' LEU . . . . . . . . . . . . . 14.5 tp -110.74 134.2 52.68 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-O 121.018 0.437 . . . . 0.0 111.309 -176.069 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 89' ' ' ASP . . . . . . . . . . . . . 12.9 t70 -127.5 155.1 44.28 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 115.875 -0.602 . . . . 0.0 109.829 177.497 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 43.1 tp10 -45.61 -44.09 12.78 Favored 'General case' 0 N--CA 1.465 0.308 0 N-CA-C 113.105 0.78 . . . . 0.0 113.105 -172.432 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 91' ' ' ASN . . . . . . . . . . . . . 66.0 m-80 -128.3 24.42 5.9 Favored 'General case' 0 N--CA 1.467 0.42 0 N-CA-C 112.547 0.573 . . . . 0.0 112.547 -178.421 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 92' ' ' LEU . . . . . . . . . . . . . 13.8 mt -149.78 145.68 26.76 Favored 'General case' 0 C--N 1.332 -0.169 0 N-CA-C 109.689 -0.486 . . . . 0.0 109.689 -176.832 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 93' ' ' ILE . . . . . . . . . . . . . 68.2 mt -128.47 118.54 48.0 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.306 0 N-CA-C 109.491 -0.559 . . . . 0.0 109.491 179.003 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 94' ' ' VAL . . . . . . . . . . . . . 46.4 t -118.53 126.14 74.91 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.252 0 N-CA-C 109.92 -0.4 . . . . 0.0 109.92 -179.6 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 95' ' ' VAL . . . . . . . . . . . . . 42.1 t -122.21 135.15 63.25 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.317 0 CA-C-N 116.054 -0.521 . . . . 0.0 109.988 -179.336 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 96' ' ' ILE . . . . . . . . . . . . . 67.1 mt -114.07 127.1 71.64 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.291 0 N-CA-C 109.366 -0.605 . . . . 0.0 109.366 179.075 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 97' ' ' THR . . . . . . . . . . . . . 68.0 p -100.08 156.73 17.02 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-O 121.397 0.617 . . . . 0.0 111.442 -176.879 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 98' ' ' GLU . . . . . . . . . . . . . 97.5 mt-10 -53.93 -25.79 22.13 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 115.822 -0.626 . . . . 0.0 112.312 -179.983 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 99' ' ' GLU . . . . . . . . . . . . . 41.5 mt-10 -80.4 18.11 0.96 Allowed 'General case' 0 CA--C 1.534 0.353 0 N-CA-C 113.003 0.742 . . . . 0.0 113.003 -177.148 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 100' ' ' ASN . . . . . . . . . . . . . 1.8 m120 63.87 35.48 10.95 Favored 'General case' 0 CA--C 1.531 0.222 0 CA-C-O 120.93 0.395 . . . . 0.0 111.145 176.634 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 101' ' ' GLU . . . . . . . . . . . . . 85.0 tt0 -118.47 142.33 47.68 Favored 'General case' 0 C--N 1.333 -0.14 0 N-CA-C 110.018 -0.364 . . . . 0.0 110.018 178.369 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 102' ' ' VAL . . . . . . . . . . . . . 45.6 t -116.39 126.67 73.97 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.297 0 N-CA-C 109.851 -0.425 . . . . 0.0 109.851 -178.686 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 103' ' ' LEU . . . . . . . . . . . . . 6.1 mp -118.37 133.48 55.84 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-N 115.807 -0.633 . . . . 0.0 110.458 177.95 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 104' ' ' ILE . . . . . . . . . . . . . 64.5 mt -117.88 119.54 61.85 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.22 0 CA-C-N 116.441 -0.345 . . . . 0.0 110.216 -179.761 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 105' ' ' PHE . . . . . . . . . . . . . 85.3 m-85 -114.87 165.26 13.04 Favored 'General case' 0 C--N 1.333 -0.146 0 O-C-N 124.042 0.839 . . . . 0.0 109.873 178.194 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 106' ' ' ASN . . . . . . . . . . . . . 49.3 p-10 -100.93 -170.27 1.82 Allowed 'General case' 0 C--N 1.331 -0.236 0 N-CA-C 109.636 -0.505 . . . . 0.0 109.636 171.727 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 107' ' ' GLN . . . . . . . . . . . . . 28.8 tt0 -58.06 -28.63 64.71 Favored 'General case' 0 C--N 1.328 -0.347 0 N-CA-C 112.261 0.467 . . . . 0.0 112.261 -179.201 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 108' ' ' ASN . . . . . . . . . . . . . 12.1 t-20 -90.88 14.19 14.4 Favored 'General case' 0 CA--C 1.533 0.314 0 N-CA-C 112.942 0.719 . . . . 0.0 112.942 -176.059 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 109' ' ' LEU . . . . . . . . . . . . . 63.4 mt 57.68 33.76 23.63 Favored 'General case' 0 CA--C 1.53 0.176 0 O-C-N 122.211 -0.306 . . . . 0.0 111.738 179.193 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 110' ' ' GLU . . . . . . . . . . . . . 70.6 mm-40 -99.66 140.83 33.29 Favored 'General case' 0 C--N 1.331 -0.225 0 N-CA-C 109.334 -0.617 . . . . 0.0 109.334 174.527 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 111' ' ' GLU . . . . . . . . . . . . . 47.5 tt0 -81.06 121.89 26.63 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-O 120.889 0.376 . . . . 0.0 110.714 -176.04 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 112' ' ' LEU . . . . . . . . . . . . . 30.9 mt -104.72 -46.02 4.44 Favored 'General case' 0 C--N 1.331 -0.219 0 CA-C-N 115.992 -0.549 . . . . 0.0 110.588 -179.857 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 113' ' ' TYR . . . . . . . . . . . . . 59.4 t80 -135.31 141.12 45.58 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.235 -0.439 . . . . 0.0 110.813 -178.682 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 114' ' ' ARG . . . . . . . . . . . . . 44.5 ptt85 -146.54 121.18 9.8 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.396 -0.366 . . . . 0.0 110.7 178.962 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 115' ' ' GLY . . . . . . . . . . . . . . . -150.15 160.4 28.52 Favored Glycine 0 CA--C 1.525 0.665 0 N-CA-C 111.008 -0.837 . . . . 0.0 111.008 179.296 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 116' ' ' LYS . . . . . . . . . . . . . 27.8 ttmt -125.59 137.41 53.9 Favored 'General case' 0 C--N 1.33 -0.248 0 N-CA-C 109.883 -0.414 . . . . 0.0 109.883 176.966 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 117' ' ' PHE . . . . . . . . . . . . . 44.1 m-85 -134.34 114.93 13.48 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.265 -0.425 . . . . 0.0 110.351 -175.513 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 118' ' ' GLU . . . . . . . . . . . . . 84.1 tt0 -50.62 -53.07 33.73 Favored 'General case' 0 C--N 1.329 -0.305 0 N-CA-C 111.98 0.363 . . . . 0.0 111.98 -176.019 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 119' ' ' ASN . . . . . . . . . . . . . 73.5 m-20 -94.94 31.01 1.94 Allowed 'General case' 0 C--N 1.33 -0.246 0 N-CA-C 112.308 0.484 . . . . 0.0 112.308 -173.505 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 120' ' ' LEU . . . . . . . . . . . . . 16.9 tp -56.4 123.07 13.42 Favored 'General case' 0 C--N 1.332 -0.178 0 C-N-CA 120.87 -0.332 . . . . 0.0 110.528 177.281 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 121' ' ' ASN . . . . . . . . . . . . . 9.9 m120 -114.09 -44.12 3.17 Favored 'General case' 0 C--N 1.331 -0.212 0 CA-C-N 116.55 -0.296 . . . . 0.0 110.985 -177.494 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 122' ' ' LYS . . . . . . . . . . . . . 91.4 mttt -145.15 148.78 33.97 Favored 'General case' 0 C--N 1.331 -0.209 0 CA-C-O 121.028 0.442 . . . . 0.0 111.728 -177.362 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 123' ' ' VAL . . . . . . . . . . . . . 44.6 t -128.63 125.73 64.0 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 N-CA-C 109.071 -0.714 . . . . 0.0 109.071 173.403 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 124' ' ' LEU . . . . . . . . . . . . . 5.8 mp -122.65 142.83 50.24 Favored 'General case' 0 C--N 1.332 -0.188 0 CA-C-O 120.836 0.351 . . . . 0.0 111.014 -175.68 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 125' ' ' VAL . . . . . . . . . . . . . 35.5 m -137.37 140.58 41.7 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.265 0 CA-C-N 115.999 -0.546 . . . . 0.0 110.581 179.053 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 126' ' ' ARG . . . . . . . . . . . . . 7.2 ptm85 -153.18 131.1 11.73 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-O 120.906 0.384 . . . . 0.0 110.577 176.068 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 127' ' ' ASN . . . . . . . . . . . . . 30.5 m120 50.6 -110.54 0.47 Allowed 'General case' 0 CA--C 1.545 0.763 0 CA-C-O 118.86 -0.591 . . . . 0.0 111.229 -179.691 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 128' ' ' ASP . . . . . . . . . . . . . 8.9 p-10 -114.11 7.79 16.8 Favored 'General case' 0 N--CA 1.468 0.428 0 CA-C-N 119.878 1.217 . . . . 0.0 113.314 -178.081 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 129' ' ' LEU . . . . . . . . . . . . . 11.8 tp -108.92 138.5 45.16 Favored 'General case' 0 C--N 1.332 -0.167 0 CA-C-N 118.153 0.433 . . . . 0.0 110.423 -178.825 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 130' ' ' VAL . . . . . . . . . . . . . 44.5 t -121.56 136.29 58.96 Favored 'Isoleucine or valine' 0 N--CA 1.462 0.169 0 N-CA-C 109.691 -0.485 . . . . 0.0 109.691 179.843 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 131' ' ' VAL . . . . . . . . . . . . . 39.0 t -134.46 136.31 52.95 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.235 0 CA-C-O 120.974 0.416 . . . . 0.0 110.504 -178.84 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 132' ' ' ILE . . . . . . . . . . . . . 71.0 mt -116.77 131.39 69.56 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 CA-C-N 115.746 -0.661 . . . . 0.0 109.267 178.722 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 133' ' ' ILE . . . . . . . . . . . . . 42.7 mm -119.36 122.3 68.69 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.223 0 CA-C-O 120.746 0.308 . . . . 0.0 110.987 -174.793 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 134' ' ' ASP . . . . . . . . . . . . . 16.6 p-10 -138.82 146.86 41.8 Favored 'General case' 0 C--N 1.332 -0.163 0 CA-C-N 116.272 -0.422 . . . . 0.0 109.872 173.744 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 135' ' ' GLU . . . . . . . . . . . . . 77.8 tt0 -49.9 -23.05 1.73 Allowed 'General case' 0 C--N 1.329 -0.305 0 N-CA-C 113.606 0.965 . . . . 0.0 113.606 -168.013 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 136' ' ' GLN . . . . . . . . . . . . . 22.3 pt20 -96.69 -27.21 14.88 Favored 'General case' 0 C--O 1.235 0.293 0 N-CA-C 112.551 0.574 . . . . 0.0 112.551 -174.011 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 137' ' ' LYS . . . . . . . . . . . . . 53.7 pttt -156.01 165.32 36.8 Favored 'General case' 0 C--O 1.233 0.205 0 CA-C-O 121.599 0.714 . . . . 0.0 112.125 -176.95 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 138' ' ' LEU . . . . . . . . . . . . . 6.0 tt -119.58 127.04 52.6 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 115.02 -0.991 . . . . 0.0 109.416 176.375 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 139' ' ' THR . . . . . . . . . . . . . 34.1 m -111.78 131.08 55.57 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.368 -0.378 . . . . 0.0 110.572 -178.458 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 140' ' ' LEU . . . . . . . . . . . . . 12.7 tp -117.31 123.81 47.44 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 115.657 -0.701 . . . . 0.0 109.273 -178.328 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 141' ' ' ILE . . . . . . . . . . . . . 19.5 mt -120.28 118.76 57.84 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.332 0 CA-C-O 120.983 0.42 . . . . 0.0 109.88 -174.859 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 142' ' ' ARG . . . . . . . . . . . . . 29.6 tpt85 -105.3 122.08 45.2 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 115.302 -0.863 . . . . 0.0 109.932 -178.251 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 143' ' ' THR . . . . . . . . . . . . . 57.2 p . . . . . 0 C--O 1.221 -0.445 0 CA-C-O 117.949 -1.024 . . . . 0.0 110.632 -178.721 . . . . . . . . 0 0 . 1 . 009 nuclear orig full ' B' B ' -3' ' ' GLU . . . . . . . . . . . . . 84.6 tt0 . . . . . 0 N--CA 1.49 1.569 0 N-CA-C 109.445 -0.576 . . . . 0.0 109.445 . . . . . . . . . 0 0 . 1 . 009 nuclear orig full ' B' B ' -2' ' ' GLY . . . . . . . . . . . . . . . -82.31 150.01 28.24 Favored Glycine 0 CA--C 1.525 0.675 0 N-CA-C 111.191 -0.764 . . . . 0.0 111.191 -179.716 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' -1' ' ' VAL . . . . . . . . . . . . . 45.0 t -95.57 135.06 30.85 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.284 0 N-CA-C 109.998 -0.371 . . . . 0.0 109.998 179.257 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 0' ' ' ILE . . . . . . . . . . . . . 71.5 mt -117.07 136.88 52.8 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.241 0 CA-C-N 116.346 -0.388 . . . . 0.0 110.202 -179.247 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 1' ' ' MET . . . . . . . . . . . . . 23.9 ptp -86.97 148.76 25.19 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 116.128 -0.487 . . . . 0.0 110.608 179.553 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 2' ' ' SER . . . . . . . . . . . . . 2.9 p -120.88 131.09 54.19 Favored 'General case' 0 C--N 1.332 -0.192 0 CA-C-N 116.302 -0.408 . . . . 0.0 110.913 -178.236 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 3' ' ' GLU . . . . . . . . . . . . . 84.9 tt0 -144.21 143.15 30.92 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.14 -0.482 . . . . 0.0 111.206 179.998 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 4' ' ' LEU . . . . . . . . . . . . . 15.5 tp -127.04 132.88 50.61 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 115.892 -0.595 . . . . 0.0 110.187 177.264 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 5' ' ' LYS . . . . . . . . . . . . . 95.8 mttt -112.61 122.25 47.13 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.326 -0.397 . . . . 0.0 110.799 -179.279 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 6' ' ' LEU . . . . . . . . . . . . . 38.7 mt -114.05 141.0 47.99 Favored 'General case' 0 C--N 1.332 -0.19 0 CA-C-N 115.506 -0.77 . . . . 0.0 110.266 -179.452 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 7' ' ' LYS . . . . . . . . . . . . . 74.6 tttt -121.97 136.26 26.08 Favored Pre-proline 0 CA--C 1.535 0.385 0 CA-C-O 118.839 -0.601 . . . . 0.0 109.697 176.304 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 8' ' ' PRO . . . . . . . . . . . . . 84.4 Cg_endo -90.47 135.31 2.1 Favored 'Trans proline' 0 N--CA 1.491 1.349 0 C-N-CA 121.656 1.57 . . . . 0.0 112.011 178.357 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 9' ' ' LEU . . . . . . . . . . . . . 53.9 mt -74.2 -47.93 5.96 Favored Pre-proline 0 CA--C 1.535 0.366 0 CA-C-O 118.628 -0.701 . . . . 0.0 112.336 -179.738 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 10' ' ' PRO . . . . . . . . . . . . . 97.4 Cg_endo -79.11 151.98 24.01 Favored 'Trans proline' 0 N--CA 1.497 1.677 0 C-N-CA 121.092 1.195 . . . . 0.0 111.882 177.563 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 11' ' ' LYS . . . . . . . . . . . . . 62.1 tttm -81.27 95.7 7.05 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.333 -0.394 . . . . 0.0 110.167 178.341 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 12' ' ' VAL . . . . . . . . . . . . . 12.3 p -141.69 146.43 23.09 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.321 0 CA-C-N 116.273 -0.421 . . . . 0.0 110.752 -177.629 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 13' ' ' GLU . . . . . . . . . . . . . 85.2 tt0 -99.5 114.61 27.69 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.067 -0.515 . . . . 0.0 109.895 176.581 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 14' ' ' LEU . . . . . . . . . . . . . 32.2 mt -92.46 160.6 34.48 Favored Pre-proline 0 C--N 1.328 -0.33 0 CA-C-N 116.328 -0.396 . . . . 0.0 111.115 -176.341 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 15' ' ' PRO . . . . . . . . . . . . . 35.3 Cg_exo -57.64 155.26 32.51 Favored 'Trans proline' 0 N--CA 1.496 1.62 0 C-N-CA 121.341 1.361 . . . . 0.0 111.874 -179.464 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 16' ' ' PRO . . . . . . . . . . . . . 33.7 Cg_exo -57.19 -40.91 79.22 Favored 'Trans proline' 0 N--CA 1.498 1.74 0 C-N-CA 121.347 1.364 . . . . 0.0 112.734 -178.262 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 17' ' ' ASP . . . . . . . . . . . . . 16.9 p-10 -89.46 15.69 8.85 Favored 'General case' 0 CA--C 1.534 0.362 0 N-CA-C 112.929 0.714 . . . . 0.0 112.929 -177.239 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 18' ' ' PHE . . . . . . . . . . . . . 27.3 t80 -57.14 -39.9 76.11 Favored 'General case' 0 C--O 1.227 -0.089 0 O-C-N 122.052 -0.405 . . . . 0.0 110.438 -179.07 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 19' ' ' VAL . . . . . . . . . . . . . 46.0 t -54.91 -44.59 73.57 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.201 0 CA-C-O 120.762 0.315 . . . . 0.0 110.584 -179.96 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 20' ' ' ASP . . . . . . . . . . . . . 74.8 m-20 -59.92 -40.99 90.76 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.482 -0.326 . . . . 0.0 110.631 -179.738 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 21' ' ' VAL . . . . . . . . . . . . . 47.5 t -62.69 -45.08 99.7 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.305 0 CA-C-N 116.448 -0.342 . . . . 0.0 110.265 -178.526 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 22' ' ' ILE . . . . . . . . . . . . . 51.0 mm -55.14 -49.74 69.52 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.332 0 C-N-CA 121.136 -0.226 . . . . 0.0 110.649 178.224 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 23' ' ' ARG . . . . . . . . . . . . . 58.7 ttp180 -53.83 -47.05 71.29 Favored 'General case' 0 C--N 1.33 -0.281 0 C-N-CA 121.079 -0.248 . . . . 0.0 111.538 -179.019 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 24' ' ' ILE . . . . . . . . . . . . . 70.9 mt -57.88 -45.42 87.53 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.322 0 C-N-CA 121.065 -0.254 . . . . 0.0 111.067 -177.224 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 25' ' ' LYS . . . . . . . . . . . . . 46.1 mtmt -70.21 -34.19 72.61 Favored 'General case' 0 C--N 1.328 -0.34 0 N-CA-C 112.378 0.51 . . . . 0.0 112.378 -177.607 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 26' ' ' LEU . . . . . . . . . . . . . 31.2 mt -80.87 -38.17 28.59 Favored 'General case' 0 C--N 1.331 -0.232 0 N-CA-C 113.579 0.955 . . . . 0.0 113.579 -171.514 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 27' ' ' GLN . . . . . . . . . . . . . 11.3 pt20 -45.39 139.42 3.64 Favored 'General case' 0 N--CA 1.47 0.557 0 N-CA-C 113.071 0.767 . . . . 0.0 113.071 -173.2 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 28' ' ' GLY . . . . . . . . . . . . . . . 98.27 -27.17 20.58 Favored Glycine 0 CA--C 1.532 1.124 0 CA-C-N 115.53 -0.759 . . . . 0.0 112.257 -178.003 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 29' ' ' LYS . . . . . . . . . . . . . 99.1 mttt -97.46 155.18 17.05 Favored 'General case' 0 C--O 1.233 0.22 0 CA-C-N 117.257 0.529 . . . . 0.0 111.066 179.159 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 30' ' ' THR . . . . . . . . . . . . . 34.7 m -105.26 138.57 41.25 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 115.879 -0.601 . . . . 0.0 110.035 176.108 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 31' ' ' VAL . . . . . . . . . . . . . 34.6 m -127.52 151.38 34.29 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.225 0 CA-C-O 120.925 0.393 . . . . 0.0 110.855 -178.634 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 32' ' ' ARG . . . . . . . . . . . . . 58.3 ttp180 -127.18 148.8 50.18 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.042 -0.526 . . . . 0.0 110.551 179.43 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 33' ' ' THR . . . . . . . . . . . . . 25.4 m -52.93 137.43 32.56 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.339 -0.391 . . . . 0.0 111.289 179.985 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 34' ' ' GLY . . . . . . . . . . . . . . . 100.96 -17.17 56.64 Favored Glycine 0 CA--C 1.533 1.175 0 C-N-CA 121.191 -0.528 . . . . 0.0 113.202 179.764 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 35' ' ' ASP . . . . . . . . . . . . . 57.3 m-20 -65.75 151.26 47.0 Favored 'General case' 0 C--O 1.232 0.168 0 CA-C-N 118.007 0.903 . . . . 0.0 111.089 179.86 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 36' ' ' VAL . . . . . . . . . . . . . 45.1 t -123.93 130.36 73.91 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.245 0 CA-C-N 116.048 -0.524 . . . . 0.0 109.868 178.717 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 37' ' ' ILE . . . . . . . . . . . . . 62.1 mt -120.09 137.63 53.29 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.206 0 CA-C-N 116.136 -0.484 . . . . 0.0 109.919 -179.969 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 38' ' ' GLY . . . . . . . . . . . . . . . -118.72 128.78 7.84 Favored Glycine 0 CA--C 1.525 0.712 0 N-CA-C 111.028 -0.829 . . . . 0.0 111.028 179.597 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 39' ' ' ILE . . . . . . . . . . . . . 70.8 mt -126.7 131.85 70.74 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.245 0 CA-C-O 120.825 0.345 . . . . 0.0 110.158 178.87 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 40' ' ' SER . . . . . . . . . . . . . 33.6 t -91.66 120.9 32.84 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.28 -0.418 . . . . 0.0 110.797 177.039 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 41' ' ' ILE . . . . . . . . . . . . . 72.7 mt -133.84 126.49 50.83 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.18 0 CA-C-O 120.884 0.373 . . . . 0.0 110.539 178.772 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 42' ' ' LEU . . . . . . . . . . . . . 42.7 mt 54.79 34.64 22.31 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-N 116.018 -0.537 . . . . 0.0 111.79 176.15 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 43' ' ' GLY . . . . . . . . . . . . . . . 71.89 29.36 67.28 Favored Glycine 0 CA--C 1.531 1.053 0 C-N-CA 121.027 -0.606 . . . . 0.0 112.311 177.683 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 44' ' ' LYS . . . . . . . . . . . . . 53.6 tttm -141.53 127.11 18.95 Favored 'General case' 0 C--N 1.33 -0.259 0 N-CA-C 109.754 -0.461 . . . . 0.0 109.754 178.144 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 45' ' ' GLU . . . . . . . . . . . . . 80.4 tt0 -84.07 123.36 29.95 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 116.441 -0.345 . . . . 0.0 111.133 -178.386 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 46' ' ' VAL . . . . . . . . . . . . . 10.6 p -115.59 120.83 65.86 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.195 0 N-CA-C 109.473 -0.566 . . . . 0.0 109.473 175.034 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 47' ' ' LYS . . . . . . . . . . . . . 52.2 mtpt -99.2 126.98 45.11 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.047 -0.524 . . . . 0.0 110.968 178.248 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 48' ' ' PHE . . . . . . . . . . . . . 37.7 m-85 -110.12 132.0 54.55 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.049 -0.523 . . . . 0.0 109.746 176.7 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 49' ' ' LYS . . . . . . . . . . . . . 85.6 tttt -106.21 132.05 52.73 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.319 -0.401 . . . . 0.0 110.002 178.407 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 50' ' ' VAL . . . . . . . . . . . . . 44.4 t -76.19 105.46 5.12 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.392 0 N-CA-C 109.471 -0.566 . . . . 0.0 109.471 178.252 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 51' ' ' VAL . . . . . . . . . . . . . 50.6 t -73.41 -46.42 49.27 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.261 0 CA-C-N 116.042 -0.526 . . . . 0.0 110.089 -174.05 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 52' ' ' GLN . . . . . . . . . . . . . 30.6 tt0 -157.87 144.4 17.72 Favored 'General case' 0 C--N 1.332 -0.166 0 C-N-CA 120.09 -0.644 . . . . 0.0 111.894 -178.085 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 53' ' ' ALA . . . . . . . . . . . . . . . -123.5 130.91 53.38 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 115.442 -0.799 . . . . 0.0 109.775 176.364 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 54' ' ' TYR . . . . . . . . . . . . . 64.8 t80 -128.95 109.84 18.37 Favored Pre-proline 0 CA--C 1.535 0.377 0 CA-C-O 118.15 -0.928 . . . . 0.0 110.449 179.99 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 55' ' ' PRO . . . . . . . . . . . . . 74.1 Cg_endo -77.05 169.94 73.01 Favored 'Cis proline' 0 N--CA 1.499 1.841 0 CA-C-N 121.993 1.748 . . . . 0.0 112.436 -5.299 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 56' ' ' SER . . . . . . . . . . . . . 13.6 m -114.95 126.14 28.19 Favored Pre-proline 0 CA--C 1.537 0.463 0 CA-C-O 118.416 -0.802 . . . . 0.0 109.241 175.824 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 57' ' ' PRO . . . . . . . . . . . . . 61.3 Cg_endo -74.18 152.65 98.5 Favored 'Cis proline' 0 N--CA 1.495 1.61 0 CA-C-N 121.976 1.741 . . . . 0.0 111.873 1.36 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 58' ' ' LEU . . . . . . . . . . . . . 17.8 tp -109.44 136.09 49.41 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.165 -0.471 . . . . 0.0 110.819 -178.292 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 59' ' ' ARG . . . . . . . . . . . . . 57.4 ttp180 -105.2 126.2 51.82 Favored 'General case' 0 C--N 1.329 -0.319 0 N-CA-C 109.509 -0.552 . . . . 0.0 109.509 176.076 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 60' ' ' VAL . . . . . . . . . . . . . 40.4 t -83.23 121.03 35.58 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.315 0 C-N-CA 120.694 -0.402 . . . . 0.0 111.046 -174.498 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 61' ' ' GLU . . . . . . . . . . . . . 95.4 mt-10 -131.01 165.68 22.65 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 115.674 -0.694 . . . . 0.0 109.424 175.243 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 62' ' ' ASP . . . . . . . . . . . . . 79.8 m-20 -52.47 -33.45 44.6 Favored 'General case' 0 C--N 1.329 -0.324 0 N-CA-C 112.056 0.391 . . . . 0.0 112.056 -175.64 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 63' ' ' ARG . . . . . . . . . . . . . 65.8 mtp180 -76.58 -21.97 54.89 Favored 'General case' 0 C--N 1.329 -0.297 0 N-CA-C 113.088 0.773 . . . . 0.0 113.088 -175.512 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 64' ' ' THR . . . . . . . . . . . . . 29.8 m -61.1 138.28 58.21 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-O 120.915 0.388 . . . . 0.0 111.164 -175.137 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 65' ' ' LYS . . . . . . . . . . . . . 55.6 mttm -89.99 133.32 34.87 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 115.913 -0.585 . . . . 0.0 110.38 179.129 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 66' ' ' ILE . . . . . . . . . . . . . 66.8 mt -120.05 129.84 74.98 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.202 0 N-CA-C 109.93 -0.396 . . . . 0.0 109.93 178.0 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 67' ' ' THR . . . . . . . . . . . . . 31.4 m -121.33 140.13 52.5 Favored 'General case' 0 C--N 1.331 -0.213 0 CA-C-N 116.062 -0.517 . . . . 0.0 111.002 -178.352 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 68' ' ' LEU . . . . . . . . . . . . . 6.1 tt -104.05 123.6 47.53 Favored 'General case' 0 C--N 1.331 -0.225 0 CA-C-N 115.863 -0.608 . . . . 0.0 110.238 178.882 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 69' ' ' VAL . . . . . . . . . . . . . 45.0 t -101.44 136.84 31.39 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.327 0 CA-C-N 116.069 -0.514 . . . . 0.0 109.888 179.704 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 70' ' ' THR . . . . . . . . . . . . . 5.6 t -85.44 161.7 19.3 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.329 -0.396 . . . . 0.0 110.924 -178.643 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 71' ' ' HIS . . . . . . . . . . . . . 4.0 t60 -73.58 112.52 16.49 Favored Pre-proline 0 CA--C 1.534 0.357 0 CA-C-O 118.845 -0.598 . . . . 0.0 110.754 -178.788 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 72' ' ' PRO . . . . . . . . . . . . . 97.7 Cg_endo -94.19 156.96 2.13 Favored 'Trans proline' 0 N--CA 1.491 1.347 0 C-N-CA 121.758 1.639 . . . . 0.0 112.255 179.054 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 73' ' ' VAL . . . . . . . . . . . . . 35.5 m -70.1 178.01 0.44 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.325 0 CA-C-N 116.283 -0.417 . . . . 0.0 109.882 177.288 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 74' ' ' ASP . . . . . . . . . . . . . 27.6 t0 -99.86 116.46 31.98 Favored 'General case' 0 C--N 1.331 -0.217 0 C-N-CA 120.794 -0.363 . . . . 0.0 110.041 -178.804 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 75' ' ' VAL . . . . . . . . . . . . . 44.4 t -114.97 123.13 70.36 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.217 0 CA-C-O 120.96 0.41 . . . . 0.0 110.401 -177.658 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 76' ' ' LEU . . . . . . . . . . . . . 26.0 mt -125.31 146.95 49.33 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 115.775 -0.648 . . . . 0.0 109.65 178.806 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 77' ' ' GLU . . . . . . . . . . . . . 96.8 mt-10 -138.48 141.95 39.42 Favored 'General case' 0 C--N 1.332 -0.188 0 CA-C-O 121.016 0.436 . . . . 0.0 111.57 -177.656 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 78' ' ' ALA . . . . . . . . . . . . . . . -129.81 139.41 51.24 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 115.801 -0.636 . . . . 0.0 110.003 175.827 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 79' ' ' LYS . . . . . . . . . . . . . 98.2 mttt -79.4 119.54 22.56 Favored 'General case' 0 C--N 1.331 -0.198 0 CA-C-O 120.78 0.324 . . . . 0.0 110.937 -178.128 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 80' ' ' ILE . . . . . . . . . . . . . 25.9 mm -139.19 113.08 6.91 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 N-CA-C 109.171 -0.678 . . . . 0.0 109.171 -178.673 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 81' ' ' LYS . . . . . . . . . . . . . 62.4 mttm -108.99 127.27 53.93 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-O 121.04 0.448 . . . . 0.0 111.376 -177.173 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 82' ' ' GLY . . . . . . . . . . . . . . . 89.15 41.99 5.71 Favored Glycine 0 CA--C 1.526 0.747 0 CA-C-N 115.833 -0.621 . . . . 0.0 111.823 174.199 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 83' ' ' ILE . . . . . . . . . . . . . 71.0 mt -72.95 140.44 17.88 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.318 0 N-CA-C 110.099 -0.334 . . . . 0.0 110.099 178.329 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 84' ' ' LYS . . . . . . . . . . . . . 28.5 ttmt -97.53 -53.22 3.51 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.174 -0.466 . . . . 0.0 109.94 179.175 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 85' ' ' ASP . . . . . . . . . . . . . 7.0 t70 -152.38 151.51 30.92 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 115.76 -0.655 . . . . 0.0 110.556 -179.535 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 86' ' ' VAL . . . . . . . . . . . . . 42.8 t -128.82 130.11 68.52 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.24 0 CA-C-O 120.912 0.387 . . . . 0.0 110.289 -179.238 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 87' ' ' ILE . . . . . . . . . . . . . 5.1 mp -119.44 128.26 75.86 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.178 0 N-CA-C 109.531 -0.544 . . . . 0.0 109.531 177.134 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 88' ' ' LEU . . . . . . . . . . . . . 57.0 mt -114.34 140.89 48.26 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-O 121.204 0.526 . . . . 0.0 111.263 -177.764 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 89' ' ' ASP . . . . . . . . . . . . . 5.0 t70 -132.27 158.94 40.53 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 115.376 -0.829 . . . . 0.0 109.457 176.517 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 90' ' ' GLU . . . . . . . . . . . . . 83.0 tt0 -46.33 -41.68 13.7 Favored 'General case' 0 C--N 1.331 -0.238 0 N-CA-C 112.975 0.731 . . . . 0.0 112.975 -173.19 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 91' ' ' ASN . . . . . . . . . . . . . 9.5 p-10 -132.19 38.01 3.52 Favored 'General case' 0 N--CA 1.464 0.231 0 CA-C-O 120.704 0.288 . . . . 0.0 111.391 -177.696 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 92' ' ' LEU . . . . . . . . . . . . . 11.6 tp -163.45 142.23 8.11 Favored 'General case' 0 C--N 1.331 -0.226 0 C-N-CA 120.865 -0.334 . . . . 0.0 110.89 -177.978 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 93' ' ' ILE . . . . . . . . . . . . . 76.9 mt -127.65 119.08 50.92 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 N-CA-C 109.284 -0.635 . . . . 0.0 109.284 177.715 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 94' ' ' VAL . . . . . . . . . . . . . 47.3 t -123.44 127.11 74.07 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.234 0 CA-C-O 120.978 0.418 . . . . 0.0 110.123 -179.8 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 95' ' ' VAL . . . . . . . . . . . . . 41.9 t -121.97 137.18 56.43 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.337 0 CA-C-N 115.741 -0.663 . . . . 0.0 109.91 -178.377 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 96' ' ' ILE . . . . . . . . . . . . . 58.0 mt -114.75 127.8 72.12 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.263 0 N-CA-C 109.362 -0.607 . . . . 0.0 109.362 179.126 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 97' ' ' THR . . . . . . . . . . . . . 67.6 p -102.5 154.34 19.19 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-O 121.199 0.524 . . . . 0.0 111.383 -177.626 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 98' ' ' GLU . . . . . . . . . . . . . 46.5 tp10 -53.95 -25.56 21.24 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 115.984 -0.553 . . . . 0.0 112.207 179.751 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 99' ' ' GLU . . . . . . . . . . . . . 32.6 tt0 -78.82 16.74 0.82 Allowed 'General case' 0 CA--C 1.537 0.469 0 N-CA-C 112.812 0.671 . . . . 0.0 112.812 -177.82 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 100' ' ' ASN . . . . . . . . . . . . . 4.1 m-20 61.67 37.94 15.59 Favored 'General case' 0 CA--C 1.53 0.181 0 O-C-N 121.894 -0.503 . . . . 0.0 110.855 178.066 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 101' ' ' GLU . . . . . . . . . . . . . 84.5 tt0 -116.54 143.35 45.71 Favored 'General case' 0 C--N 1.333 -0.149 0 CA-C-N 115.935 -0.575 . . . . 0.0 109.724 177.603 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 102' ' ' VAL . . . . . . . . . . . . . 44.7 t -114.98 125.05 72.2 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.331 0 CA-C-N 116.206 -0.452 . . . . 0.0 109.857 -178.822 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 103' ' ' LEU . . . . . . . . . . . . . 24.2 mt -116.84 128.26 55.09 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 115.807 -0.633 . . . . 0.0 110.348 177.84 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 104' ' ' ILE . . . . . . . . . . . . . 68.1 mt -120.39 121.04 64.57 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.26 0 CA-C-N 116.64 -0.254 . . . . 0.0 110.428 179.688 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 105' ' ' PHE . . . . . . . . . . . . . 52.5 m-85 -121.85 166.77 13.88 Favored 'General case' 0 C--N 1.333 -0.139 0 CA-C-N 115.674 -0.693 . . . . 0.0 109.678 178.611 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 106' ' ' ASN . . . . . . . . . . . . . 45.1 p-10 -99.57 -171.02 1.99 Allowed 'General case' 0 C--N 1.329 -0.285 0 N-CA-C 109.876 -0.416 . . . . 0.0 109.876 173.318 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 107' ' ' GLN . . . . . . . . . . . . . 45.4 tt0 -60.23 -29.63 68.87 Favored 'General case' 0 C--N 1.329 -0.293 0 N-CA-C 112.001 0.371 . . . . 0.0 112.001 179.979 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 108' ' ' ASN . . . . . . . . . . . . . 4.5 t-20 -82.49 7.34 14.64 Favored 'General case' 0 CA--C 1.536 0.431 0 N-CA-C 113.163 0.801 . . . . 0.0 113.163 -177.633 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 109' ' ' LEU . . . . . . . . . . . . . 12.5 tp 61.63 38.18 15.53 Favored 'General case' 0 C--N 1.333 -0.139 0 CA-C-O 121.165 0.507 . . . . 0.0 111.205 179.073 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 110' ' ' GLU . . . . . . . . . . . . . 95.7 mt-10 -108.07 148.13 30.21 Favored 'General case' 0 C--N 1.33 -0.281 0 N-CA-C 109.539 -0.541 . . . . 0.0 109.539 174.871 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 111' ' ' GLU . . . . . . . . . . . . . 49.3 tt0 -83.21 122.03 27.87 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-O 120.896 0.379 . . . . 0.0 111.023 -175.624 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 112' ' ' LEU . . . . . . . . . . . . . 84.8 mt -104.83 -46.03 4.41 Favored 'General case' 0 C--N 1.331 -0.203 0 CA-C-N 116.025 -0.534 . . . . 0.0 110.591 178.844 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 113' ' ' TYR . . . . . . . . . . . . . 42.3 t80 -137.15 136.71 38.48 Favored 'General case' 0 C--N 1.331 -0.223 0 CA-C-N 116.357 -0.383 . . . . 0.0 111.363 -177.823 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 114' ' ' ARG . . . . . . . . . . . . . 46.2 ttp180 -137.17 125.64 23.51 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 115.913 -0.585 . . . . 0.0 110.039 176.474 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 115' ' ' GLY . . . . . . . . . . . . . . . -150.03 154.71 25.85 Favored Glycine 0 CA--C 1.525 0.667 0 C-N-CA 120.756 -0.735 . . . . 0.0 111.271 178.932 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 116' ' ' LYS . . . . . . . . . . . . . 30.8 ttpt -128.62 130.67 47.62 Favored 'General case' 0 C--N 1.329 -0.304 0 N-CA-C 109.797 -0.446 . . . . 0.0 109.797 177.778 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 117' ' ' PHE . . . . . . . . . . . . . 46.1 m-85 -128.79 116.21 19.13 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-O 120.926 0.393 . . . . 0.0 110.464 -175.987 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 118' ' ' GLU . . . . . . . . . . . . . 95.9 mt-10 -52.65 -46.76 67.29 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.361 -0.381 . . . . 0.0 111.573 -176.942 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 119' ' ' ASN . . . . . . . . . . . . . 9.8 m120 -99.57 30.97 3.35 Favored 'General case' 0 C--N 1.33 -0.272 0 N-CA-C 112.22 0.452 . . . . 0.0 112.22 -174.35 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 120' ' ' LEU . . . . . . . . . . . . . 15.8 tp -54.21 125.78 20.47 Favored 'General case' 0 N--CA 1.462 0.17 0 CA-C-O 120.718 0.294 . . . . 0.0 110.984 179.22 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 121' ' ' ASN . . . . . . . . . . . . . 31.3 m120 -107.92 -44.1 4.28 Favored 'General case' 0 C--N 1.331 -0.212 0 CA-C-N 116.367 -0.379 . . . . 0.0 110.806 -177.98 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 122' ' ' LYS . . . . . . . . . . . . . 1.2 ptpm? -160.29 157.35 27.9 Favored 'General case' 0 C--N 1.332 -0.19 0 CA-C-O 121.231 0.538 . . . . 0.0 112.056 -179.348 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 123' ' ' VAL . . . . . . . . . . . . . 46.8 t -127.23 131.51 70.53 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.224 0 CA-C-N 115.587 -0.733 . . . . 0.0 109.526 176.707 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 124' ' ' LEU . . . . . . . . . . . . . 14.4 tp -126.8 138.81 53.41 Favored 'General case' 0 N--CA 1.463 0.19 0 CA-C-N 116.496 -0.32 . . . . 0.0 110.541 -177.988 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 125' ' ' VAL . . . . . . . . . . . . . 34.7 m -132.68 141.99 43.6 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.182 0 CA-C-O 120.835 0.35 . . . . 0.0 111.328 -177.654 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 126' ' ' ARG . . . . . . . . . . . . . 88.9 mtt180 -146.57 118.07 7.97 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.658 175.128 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 127' ' ' ASN . . . . . . . . . . . . . 75.2 m-80 52.0 -106.43 0.27 Allowed 'General case' 0 CA--C 1.544 0.715 0 CA-C-O 118.97 -0.538 . . . . 0.0 111.256 178.996 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 128' ' ' ASP . . . . . . . . . . . . . 15.5 p-10 -114.07 3.16 15.18 Favored 'General case' 0 N--CA 1.469 0.484 0 CA-C-N 119.649 1.113 . . . . 0.0 113.295 -177.893 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 129' ' ' LEU . . . . . . . . . . . . . 15.6 tp -105.34 135.48 46.65 Favored 'General case' 0 C--N 1.332 -0.184 0 N-CA-C 109.553 -0.536 . . . . 0.0 109.553 178.084 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 130' ' ' VAL . . . . . . . . . . . . . 41.1 t -124.63 140.46 47.79 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.235 0 N-CA-C 110.136 -0.32 . . . . 0.0 110.136 -177.751 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 131' ' ' VAL . . . . . . . . . . . . . 41.5 t -133.51 135.07 56.39 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 CA-C-O 120.963 0.411 . . . . 0.0 110.145 178.788 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 132' ' ' ILE . . . . . . . . . . . . . 70.1 mt -116.92 131.41 69.68 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.314 0 N-CA-C 109.197 -0.668 . . . . 0.0 109.197 178.297 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 133' ' ' ILE . . . . . . . . . . . . . 43.3 mm -115.94 120.94 66.3 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.316 0 CA-C-N 116.406 -0.361 . . . . 0.0 110.819 -174.901 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 134' ' ' ASP . . . . . . . . . . . . . 8.6 p-10 -134.37 147.48 50.52 Favored 'General case' 0 C--N 1.331 -0.2 0 N-CA-C 109.545 -0.539 . . . . 0.0 109.545 174.346 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 135' ' ' GLU . . . . . . . . . . . . . 84.9 tt0 -49.84 -24.36 2.39 Favored 'General case' 0 C--N 1.328 -0.357 0 N-CA-C 112.894 0.702 . . . . 0.0 112.894 -172.537 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 136' ' ' GLN . . . . . . . . . . . . . 96.1 mt-30 -99.81 -27.93 13.39 Favored 'General case' 0 N--CA 1.463 0.182 0 N-CA-C 112.727 0.64 . . . . 0.0 112.727 -174.672 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 137' ' ' LYS . . . . . . . . . . . . . 94.4 mttt -141.94 150.66 41.73 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-O 121.467 0.651 . . . . 0.0 112.296 -169.531 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 138' ' ' LEU . . . . . . . . . . . . . 11.3 tp -112.06 118.48 35.53 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 114.988 -1.005 . . . . 0.0 108.987 170.945 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 139' ' ' THR . . . . . . . . . . . . . 25.6 m -110.38 125.22 52.98 Favored 'General case' 0 C--N 1.331 -0.216 0 CA-C-O 120.644 0.259 . . . . 0.0 111.127 -177.014 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 140' ' ' LEU . . . . . . . . . . . . . 23.3 tp -114.56 122.8 47.65 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 115.652 -0.704 . . . . 0.0 109.354 179.586 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 141' ' ' ILE . . . . . . . . . . . . . 19.3 mt -121.87 125.16 72.86 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.247 0 CA-C-O 120.856 0.36 . . . . 0.0 110.199 -174.094 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 142' ' ' ARG . . . . . . . . . . . . . 79.0 mtp180 -114.53 129.38 56.66 Favored 'General case' 0 C--N 1.331 -0.212 0 CA-C-N 115.67 -0.695 . . . . 0.0 110.351 -179.34 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 143' ' ' THR . . . . . . . . . . . . . 26.0 p . . . . . 0 C--O 1.221 -0.424 0 CA-C-O 118.015 -0.993 . . . . 0.0 110.525 179.749 . . . . . . . . 0 0 . 1 . 009 nuclear orig full ' C' C ' -3' ' ' GLU . . . . . . . . . . . . . 95.8 mt-10 . . . . . 0 N--CA 1.49 1.557 0 N-CA-C 109.368 -0.604 . . . . 0.0 109.368 . . . . . . . . . 0 0 . 1 . 009 nuclear orig full ' C' C ' -2' ' ' GLY . . . . . . . . . . . . . . . -88.18 135.44 13.09 Favored Glycine 0 CA--C 1.525 0.689 0 N-CA-C 110.916 -0.873 . . . . 0.0 110.916 179.751 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' C' C ' -1' ' ' VAL . . . . . . . . . . . . . 43.3 t -142.21 139.55 29.83 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.284 0 CA-C-O 120.773 0.321 . . . . 0.0 110.144 -179.996 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' C' C ' 0' ' ' ILE . . . . . . . . . . . . . 72.1 mt -109.78 136.52 45.45 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.257 0 CA-C-N 116.141 -0.481 . . . . 0.0 109.772 179.357 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' C' C ' 1' ' ' MET . . . . . . . . . . . . . 25.6 ptp -77.92 157.61 29.7 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.104 -0.498 . . . . 0.0 110.935 -178.541 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' C' C ' 2' ' ' SER . . . . . . . . . . . . . 2.3 p -126.99 123.93 38.26 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.095 -0.502 . . . . 0.0 110.36 178.287 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' C' C ' 3' ' ' GLU . . . . . . . . . . . . . 85.3 tt0 -140.12 141.6 36.09 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 115.795 -0.639 . . . . 0.0 111.088 -177.001 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' C' C ' 4' ' ' LEU . . . . . . . . . . . . . 13.2 tp -124.11 130.39 52.46 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 115.765 -0.652 . . . . 0.0 110.116 177.497 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' C' C ' 5' ' ' LYS . . . . . . . . . . . . . 53.5 mttp -108.65 120.35 42.21 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.185 -0.462 . . . . 0.0 110.541 179.817 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' C' C ' 6' ' ' LEU . . . . . . . . . . . . . 55.4 mt -114.48 147.93 38.6 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 115.427 -0.806 . . . . 0.0 110.45 -178.827 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' C' C ' 7' ' ' LYS . . . . . . . . . . . . . 78.7 tttt -139.85 138.87 20.4 Favored Pre-proline 0 CA--C 1.534 0.328 0 CA-C-O 119.081 -0.485 . . . . 0.0 110.162 176.249 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' C' C ' 8' ' ' PRO . . . . . . . . . . . . . 98.2 Cg_endo -92.08 144.43 2.81 Favored 'Trans proline' 0 N--CA 1.49 1.267 0 C-N-CA 121.69 1.593 . . . . 0.0 111.812 177.482 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' C' C ' 9' ' ' LEU . . . . . . . . . . . . . 53.0 mt -74.94 -47.1 4.88 Favored Pre-proline 0 CA--C 1.534 0.353 0 CA-C-O 118.699 -0.667 . . . . 0.0 112.051 -179.524 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' C' C ' 10' ' ' PRO . . . . . . . . . . . . . 96.5 Cg_endo -82.28 156.56 17.04 Favored 'Trans proline' 0 N--CA 1.496 1.64 0 C-N-CA 121.221 1.281 . . . . 0.0 111.808 175.27 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' C' C ' 11' ' ' LYS . . . . . . . . . . . . . 59.3 tttm -88.7 106.57 18.42 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.428 -0.351 . . . . 0.0 110.24 178.32 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' C' C ' 12' ' ' VAL . . . . . . . . . . . . . 12.4 p -140.46 148.47 22.19 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.243 0 CA-C-N 116.248 -0.433 . . . . 0.0 110.632 -178.659 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' C' C ' 13' ' ' GLU . . . . . . . . . . . . . 83.2 tt0 -90.91 122.0 33.23 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 116.131 -0.486 . . . . 0.0 110.21 178.522 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' C' C ' 14' ' ' LEU . . . . . . . . . . . . . 35.5 mt -98.55 151.84 37.64 Favored Pre-proline 0 CA--C 1.532 0.282 0 CA-C-N 116.383 -0.371 . . . . 0.0 110.948 -176.706 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' C' C ' 15' ' ' PRO . . . . . . . . . . . . . 24.2 Cg_exo -63.96 158.01 49.75 Favored 'Trans proline' 0 N--CA 1.497 1.722 0 C-N-CA 121.266 1.311 . . . . 0.0 111.721 174.871 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' C' C ' 16' ' ' PRO . . . . . . . . . . . . . 39.4 Cg_exo -58.72 -38.87 86.86 Favored 'Trans proline' 0 N--CA 1.496 1.665 0 C-N-CA 121.409 1.406 . . . . 0.0 112.776 -178.965 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' C' C ' 17' ' ' ASP . . . . . . . . . . . . . 12.7 p-10 -87.95 11.94 14.54 Favored 'General case' 0 CA--C 1.536 0.424 0 N-CA-C 113.148 0.796 . . . . 0.0 113.148 -177.402 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' C' C ' 18' ' ' PHE . . . . . . . . . . . . . 44.9 t80 -57.95 -44.74 87.17 Favored 'General case' 0 C--N 1.335 -0.065 0 O-C-N 122.007 -0.433 . . . . 0.0 110.113 -178.826 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' C' C ' 19' ' ' VAL . . . . . . . . . . . . . 12.7 p -56.94 -41.61 77.15 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.357 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.726 -179.145 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' C' C ' 20' ' ' ASP . . . . . . . . . . . . . 79.6 m-20 -60.65 -42.93 97.97 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-O 120.843 0.354 . . . . 0.0 111.015 -177.709 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' C' C ' 21' ' ' VAL . . . . . . . . . . . . . 47.1 t -63.94 -47.98 88.18 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.338 0 C-N-CA 120.782 -0.367 . . . . 0.0 110.383 -178.076 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' C' C ' 22' ' ' ILE . . . . . . . . . . . . . 46.4 mm -58.11 -38.49 67.96 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.298 0 CA-C-O 120.841 0.353 . . . . 0.0 110.56 179.407 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' C' C ' 23' ' ' ARG . . . . . . . . . . . . . 56.3 ttp180 -55.53 -48.24 75.01 Favored 'General case' 0 C--N 1.33 -0.253 0 O-C-N 122.094 -0.379 . . . . 0.0 110.845 177.429 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' C' C ' 24' ' ' ILE . . . . . . . . . . . . . 67.2 mt -60.24 -41.9 88.54 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.358 0 CA-C-N 116.148 -0.478 . . . . 0.0 111.75 -177.776 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' C' C ' 25' ' ' LYS . . . . . . . . . . . . . 16.1 ptmt -72.33 -36.08 68.76 Favored 'General case' 0 CA--C 1.534 0.328 0 C-N-CA 120.561 -0.455 . . . . 0.0 112.077 -176.044 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' C' C ' 26' ' ' LEU . . . . . . . . . . . . . 78.3 mt -78.54 -41.78 31.19 Favored 'General case' 0 C--N 1.33 -0.247 0 N-CA-C 112.887 0.699 . . . . 0.0 112.887 -172.952 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' C' C ' 27' ' ' GLN . . . . . . . . . . . . . 9.9 pt20 -46.38 138.53 5.56 Favored 'General case' 0 N--CA 1.468 0.466 0 N-CA-C 112.812 0.671 . . . . 0.0 112.812 -175.338 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' C' C ' 28' ' ' GLY . . . . . . . . . . . . . . . 100.62 -26.65 23.82 Favored Glycine 0 CA--C 1.532 1.119 0 CA-C-N 115.55 -0.75 . . . . 0.0 112.135 -177.891 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' C' C ' 29' ' ' LYS . . . . . . . . . . . . . 59.7 mmtt -97.82 155.23 17.14 Favored 'General case' 0 C--O 1.233 0.217 0 CA-C-N 117.445 0.623 . . . . 0.0 111.019 178.699 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' C' C ' 30' ' ' THR . . . . . . . . . . . . . 40.5 m -100.08 135.79 40.97 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 115.883 -0.599 . . . . 0.0 109.688 174.24 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' C' C ' 31' ' ' VAL . . . . . . . . . . . . . 34.9 m -125.91 154.8 35.23 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.211 0 CA-C-N 116.5 -0.318 . . . . 0.0 110.602 -178.367 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' C' C ' 32' ' ' ARG . . . . . . . . . . . . . 46.3 ttt180 -135.71 149.13 49.13 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-O 121.225 0.536 . . . . 0.0 110.667 179.624 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' C' C ' 33' ' ' THR . . . . . . . . . . . . . 18.2 m -52.48 140.51 22.35 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.286 -0.415 . . . . 0.0 111.426 -178.339 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' C' C ' 34' ' ' GLY . . . . . . . . . . . . . . . 99.71 -17.04 58.03 Favored Glycine 0 CA--C 1.532 1.11 0 CA-C-O 119.656 -0.524 . . . . 0.0 113.224 179.073 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' C' C ' 35' ' ' ASP . . . . . . . . . . . . . 72.6 m-20 -64.59 149.19 49.33 Favored 'General case' 0 C--O 1.231 0.1 0 CA-C-N 118.13 0.965 . . . . 0.0 111.081 179.426 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' C' C ' 36' ' ' VAL . . . . . . . . . . . . . 45.6 t -126.01 130.69 72.24 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.249 0 CA-C-N 115.995 -0.548 . . . . 0.0 109.838 178.477 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' C' C ' 37' ' ' ILE . . . . . . . . . . . . . 66.6 mt -121.93 139.69 48.2 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.299 0 CA-C-N 116.292 -0.413 . . . . 0.0 110.194 -178.953 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' C' C ' 38' ' ' GLY . . . . . . . . . . . . . . . -108.7 128.85 9.25 Favored Glycine 0 CA--C 1.526 0.748 0 N-CA-C 110.96 -0.856 . . . . 0.0 110.96 179.285 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' C' C ' 39' ' ' ILE . . . . . . . . . . . . . 72.6 mt -125.78 132.22 71.02 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.181 0 N-CA-C 110.191 -0.3 . . . . 0.0 110.191 179.829 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' C' C ' 40' ' ' SER . . . . . . . . . . . . . 27.6 t -92.78 122.16 34.9 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.418 -0.356 . . . . 0.0 110.886 175.581 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' C' C ' 41' ' ' ILE . . . . . . . . . . . . . 72.3 mt -131.01 116.89 35.43 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.223 0 CA-C-O 121.031 0.443 . . . . 0.0 110.55 178.699 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' C' C ' 42' ' ' LEU . . . . . . . . . . . . . 1.3 tt 51.46 47.4 24.89 Favored 'General case' 0 CA--C 1.531 0.217 0 CA-C-N 115.768 -0.651 . . . . 0.0 111.208 175.996 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' C' C ' 43' ' ' GLY . . . . . . . . . . . . . . . 70.17 21.38 77.09 Favored Glycine 0 CA--C 1.531 1.075 0 C-N-CA 121.081 -0.58 . . . . 0.0 112.79 175.016 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' C' C ' 44' ' ' LYS . . . . . . . . . . . . . 59.4 mtpt -131.65 128.35 38.88 Favored 'General case' 0 C--N 1.331 -0.212 0 CA-C-N 117.692 0.746 . . . . 0.0 110.098 179.068 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' C' C ' 45' ' ' GLU . . . . . . . . . . . . . 83.2 tt0 -83.8 123.14 29.58 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 116.441 -0.345 . . . . 0.0 110.997 -179.68 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' C' C ' 46' ' ' VAL . . . . . . . . . . . . . 7.2 p -123.15 128.26 74.92 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.204 0 N-CA-C 109.722 -0.473 . . . . 0.0 109.722 176.669 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' C' C ' 47' ' ' LYS . . . . . . . . . . . . . 63.2 mttp -100.19 128.65 46.23 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.085 -0.507 . . . . 0.0 111.089 177.664 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' C' C ' 48' ' ' PHE . . . . . . . . . . . . . 91.1 m-85 -110.5 131.83 54.71 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.206 -0.452 . . . . 0.0 109.863 176.346 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' C' C ' 49' ' ' LYS . . . . . . . . . . . . . 79.2 tttt -108.61 137.99 45.66 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.377 -0.374 . . . . 0.0 110.424 178.978 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' C' C ' 50' ' ' VAL . . . . . . . . . . . . . 44.9 t -79.73 106.28 10.55 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.335 0 N-CA-C 109.335 -0.617 . . . . 0.0 109.335 175.828 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' C' C ' 51' ' ' VAL . . . . . . . . . . . . . 48.2 t -69.81 -47.67 68.69 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.284 0 CA-C-N 116.052 -0.522 . . . . 0.0 109.863 -173.486 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' C' C ' 52' ' ' GLN . . . . . . . . . . . . . 21.4 pt20 -167.85 158.88 11.11 Favored 'General case' 0 C--N 1.332 -0.192 0 C-N-CA 120.165 -0.614 . . . . 0.0 111.643 179.482 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' C' C ' 53' ' ' ALA . . . . . . . . . . . . . . . -135.56 138.68 43.24 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 115.564 -0.743 . . . . 0.0 110.229 178.94 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' C' C ' 54' ' ' TYR . . . . . . . . . . . . . 63.6 t80 -128.9 110.31 18.52 Favored Pre-proline 0 CA--C 1.534 0.36 0 CA-C-O 118.156 -0.926 . . . . 0.0 110.259 179.772 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' C' C ' 55' ' ' PRO . . . . . . . . . . . . . 73.4 Cg_endo -77.17 170.06 72.55 Favored 'Cis proline' 0 N--CA 1.501 1.926 0 CA-C-N 121.908 1.717 . . . . 0.0 112.236 -7.91 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' C' C ' 56' ' ' SER . . . . . . . . . . . . . 51.1 m -121.24 134.6 24.49 Favored Pre-proline 0 CA--C 1.537 0.457 0 CA-C-O 118.582 -0.723 . . . . 0.0 109.619 175.09 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' C' C ' 57' ' ' PRO . . . . . . . . . . . . . 36.3 Cg_endo -66.41 164.68 66.05 Favored 'Cis proline' 0 N--CA 1.499 1.799 0 CA-C-N 121.841 1.693 . . . . 0.0 111.521 -2.944 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' C' C ' 58' ' ' LEU . . . . . . . . . . . . . 32.8 tp -130.77 139.68 50.25 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-O 120.947 0.403 . . . . 0.0 110.663 -178.338 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' C' C ' 59' ' ' ARG . . . . . . . . . . . . . 55.2 ttm-85 -96.1 129.5 43.37 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-N 115.762 -0.654 . . . . 0.0 109.338 174.367 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' C' C ' 60' ' ' VAL . . . . . . . . . . . . . 40.9 t -86.14 121.11 37.02 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.268 0 C-N-CA 120.624 -0.431 . . . . 0.0 110.4 -177.917 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' C' C ' 61' ' ' GLU . . . . . . . . . . . . . 71.6 tt0 -130.57 157.66 42.1 Favored 'General case' 0 C--N 1.329 -0.31 0 N-CA-C 109.113 -0.699 . . . . 0.0 109.113 177.523 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' C' C ' 62' ' ' ASP . . . . . . . . . . . . . 12.8 t70 -51.22 -32.28 23.45 Favored 'General case' 0 C--N 1.327 -0.404 0 N-CA-C 112.07 0.396 . . . . 0.0 112.07 -178.282 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' C' C ' 63' ' ' ARG . . . . . . . . . . . . . 98.2 mtt180 -77.18 -21.94 53.21 Favored 'General case' 0 CA--C 1.533 0.29 0 N-CA-C 112.857 0.688 . . . . 0.0 112.857 -177.812 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' C' C ' 64' ' ' THR . . . . . . . . . . . . . 20.0 m -57.46 141.8 46.27 Favored 'General case' 0 C--N 1.331 -0.207 0 CA-C-O 120.842 0.353 . . . . 0.0 110.642 -176.478 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' C' C ' 65' ' ' LYS . . . . . . . . . . . . . 40.2 ttpt -89.13 121.44 31.45 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.1 -0.5 . . . . 0.0 110.279 -179.63 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' C' C ' 66' ' ' ILE . . . . . . . . . . . . . 63.1 mt -113.5 129.15 69.82 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.241 0 N-CA-C 109.87 -0.418 . . . . 0.0 109.87 -179.718 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' C' C ' 67' ' ' THR . . . . . . . . . . . . . 18.8 m -129.08 143.86 51.0 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-O 121.142 0.496 . . . . 0.0 111.236 -177.433 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' C' C ' 68' ' ' LEU . . . . . . . . . . . . . 17.1 tp -101.39 132.28 47.04 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 115.827 -0.624 . . . . 0.0 110.092 177.58 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' C' C ' 69' ' ' VAL . . . . . . . . . . . . . 41.1 t -92.5 136.05 25.82 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.346 0 CA-C-N 116.281 -0.418 . . . . 0.0 110.529 -177.7 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' C' C ' 70' ' ' THR . . . . . . . . . . . . . 40.2 p -91.12 -172.45 3.32 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 115.955 -0.566 . . . . 0.0 110.265 178.616 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' C' C ' 71' ' ' HIS . . . . . . . . . . . . . 66.1 t-80 -121.31 76.19 32.93 Favored Pre-proline 0 CA--C 1.533 0.31 0 CA-C-N 116.758 -0.201 . . . . 0.0 111.12 -178.561 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' C' C ' 72' ' ' PRO . . . . . . . . . . . . . 92.0 Cg_endo -93.48 160.08 2.43 Favored 'Trans proline' 0 N--CA 1.489 1.24 0 C-N-CA 122.079 1.853 . . . . 0.0 111.932 175.493 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' C' C ' 73' ' ' VAL . . . . . . . . . . . . . 35.5 m -69.92 178.88 0.39 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.286 0 N-CA-C 109.598 -0.519 . . . . 0.0 109.598 177.508 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' C' C ' 74' ' ' ASP . . . . . . . . . . . . . 27.6 t0 -98.71 119.81 38.08 Favored 'General case' 0 C--N 1.331 -0.203 0 C-N-CA 120.805 -0.358 . . . . 0.0 110.193 -176.185 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' C' C ' 75' ' ' VAL . . . . . . . . . . . . . 40.6 t -119.13 121.9 67.87 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.237 0 CA-C-O 121.094 0.473 . . . . 0.0 110.63 -178.009 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' C' C ' 76' ' ' LEU . . . . . . . . . . . . . 7.1 mp -117.25 139.78 50.37 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 115.669 -0.696 . . . . 0.0 109.402 175.437 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' C' C ' 77' ' ' GLU . . . . . . . . . . . . . 98.0 mt-10 -135.47 129.08 32.6 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-O 121.072 0.463 . . . . 0.0 111.007 -178.401 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' C' C ' 78' ' ' ALA . . . . . . . . . . . . . . . -117.66 136.69 53.15 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 115.638 -0.71 . . . . 0.0 109.957 177.778 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' C' C ' 79' ' ' LYS . . . . . . . . . . . . . 68.4 mmtt -73.37 116.01 13.42 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.512 -0.313 . . . . 0.0 110.16 -179.107 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' C' C ' 80' ' ' ILE . . . . . . . . . . . . . 39.7 mm -139.09 110.63 5.13 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.303 0 N-CA-C 109.56 -0.533 . . . . 0.0 109.56 -177.433 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' C' C ' 81' ' ' LYS . . . . . . . . . . . . . 99.5 mttt -112.56 128.73 56.44 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-O 120.95 0.405 . . . . 0.0 110.775 -178.852 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' C' C ' 82' ' ' GLY . . . . . . . . . . . . . . . 89.08 42.16 5.68 Favored Glycine 0 CA--C 1.525 0.679 0 C-N-CA 121.024 -0.608 . . . . 0.0 111.649 176.835 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' C' C ' 83' ' ' ILE . . . . . . . . . . . . . 72.0 mt -69.51 136.17 26.78 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.22 0 N-CA-C 109.718 -0.475 . . . . 0.0 109.718 177.23 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' C' C ' 84' ' ' LYS . . . . . . . . . . . . . 60.2 tttp -97.81 -53.56 3.37 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.054 -0.521 . . . . 0.0 110.195 -178.187 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' C' C ' 85' ' ' ASP . . . . . . . . . . . . . 13.1 t70 -151.17 148.67 28.54 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 115.746 -0.661 . . . . 0.0 110.232 -179.342 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' C' C ' 86' ' ' VAL . . . . . . . . . . . . . 41.4 t -129.2 129.62 67.63 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.264 0 CA-C-O 120.944 0.402 . . . . 0.0 110.397 -179.294 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' C' C ' 87' ' ' ILE . . . . . . . . . . . . . 44.6 mm -119.14 126.0 74.97 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.263 0 CA-C-N 115.923 -0.58 . . . . 0.0 109.657 177.097 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' C' C ' 88' ' ' LEU . . . . . . . . . . . . . 19.4 tp -109.82 123.4 49.49 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-O 121.005 0.431 . . . . 0.0 110.826 -178.333 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' C' C ' 89' ' ' ASP . . . . . . . . . . . . . 13.6 t70 -113.61 156.86 22.92 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 115.81 -0.632 . . . . 0.0 109.336 176.325 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' C' C ' 90' ' ' GLU . . . . . . . . . . . . . 81.8 tt0 -45.14 -42.28 8.82 Favored 'General case' 0 N--CA 1.465 0.282 0 N-CA-C 113.266 0.839 . . . . 0.0 113.266 -171.694 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' C' C ' 91' ' ' ASN . . . . . . . . . . . . . 73.1 m-20 -132.02 25.19 4.6 Favored 'General case' 0 N--CA 1.467 0.377 0 N-CA-C 112.652 0.612 . . . . 0.0 112.652 -178.539 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' C' C ' 92' ' ' LEU . . . . . . . . . . . . . 38.1 mt -148.17 142.02 25.74 Favored 'General case' 0 C--N 1.332 -0.19 0 N-CA-C 110.171 -0.307 . . . . 0.0 110.171 -177.635 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' C' C ' 93' ' ' ILE . . . . . . . . . . . . . 62.7 mt -118.62 116.9 52.72 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.266 0 N-CA-C 109.425 -0.583 . . . . 0.0 109.425 179.986 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' C' C ' 94' ' ' VAL . . . . . . . . . . . . . 44.2 t -119.39 124.13 72.45 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.2 0 CA-C-O 121.026 0.441 . . . . 0.0 110.075 -179.671 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' C' C ' 95' ' ' VAL . . . . . . . . . . . . . 42.7 t -121.23 135.35 61.68 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.297 0 CA-C-N 115.803 -0.635 . . . . 0.0 109.96 -179.258 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' C' C ' 96' ' ' ILE . . . . . . . . . . . . . 60.4 mt -115.9 128.86 73.04 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.288 0 N-CA-C 109.411 -0.588 . . . . 0.0 109.411 178.264 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' C' C ' 97' ' ' THR . . . . . . . . . . . . . 80.5 p -98.67 160.08 14.51 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-O 121.08 0.467 . . . . 0.0 110.828 -179.184 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' C' C ' 98' ' ' GLU . . . . . . . . . . . . . 97.6 mt-10 -53.82 -25.73 20.86 Favored 'General case' 0 CA--C 1.532 0.265 0 N-CA-C 112.257 0.465 . . . . 0.0 112.257 -179.927 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' C' C ' 99' ' ' GLU . . . . . . . . . . . . . 43.2 mt-10 -79.86 16.37 1.18 Allowed 'General case' 0 CA--C 1.535 0.375 0 N-CA-C 113.071 0.767 . . . . 0.0 113.071 -177.732 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' C' C ' 100' ' ' ASN . . . . . . . . . . . . . 3.9 m-20 61.83 38.07 15.0 Favored 'General case' 0 CA--C 1.529 0.155 0 CA-C-O 121.12 0.486 . . . . 0.0 110.91 178.27 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' C' C ' 101' ' ' GLU . . . . . . . . . . . . . 84.7 tt0 -113.18 141.42 46.96 Favored 'General case' 0 C--N 1.331 -0.199 0 CA-C-N 116.159 -0.473 . . . . 0.0 109.854 176.55 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' C' C ' 102' ' ' VAL . . . . . . . . . . . . . 46.1 t -114.86 125.08 72.09 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.272 0 CA-C-N 116.221 -0.445 . . . . 0.0 109.917 -178.55 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' C' C ' 103' ' ' LEU . . . . . . . . . . . . . 16.8 mt -116.65 129.83 56.38 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 115.616 -0.72 . . . . 0.0 110.182 177.763 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' C' C ' 104' ' ' ILE . . . . . . . . . . . . . 61.5 mt -117.7 120.71 65.53 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.286 0 N-CA-C 110.296 -0.261 . . . . 0.0 110.296 179.028 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' C' C ' 105' ' ' PHE . . . . . . . . . . . . . 46.0 m-85 -120.75 163.28 18.35 Favored 'General case' 0 C--N 1.332 -0.171 0 O-C-N 123.97 0.794 . . . . 0.0 109.654 177.86 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' C' C ' 106' ' ' ASN . . . . . . . . . . . . . 45.8 p-10 -97.42 -171.02 2.11 Favored 'General case' 0 C--N 1.331 -0.219 0 N-CA-C 109.783 -0.451 . . . . 0.0 109.783 173.719 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' C' C ' 107' ' ' GLN . . . . . . . . . . . . . 51.1 tt0 -59.67 -28.69 67.49 Favored 'General case' 0 C--N 1.329 -0.309 0 N-CA-C 112.043 0.386 . . . . 0.0 112.043 179.687 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' C' C ' 108' ' ' ASN . . . . . . . . . . . . . 24.6 t30 -84.88 11.94 8.37 Favored 'General case' 0 CA--C 1.537 0.447 0 N-CA-C 112.955 0.724 . . . . 0.0 112.955 -178.012 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' C' C ' 109' ' ' LEU . . . . . . . . . . . . . 11.6 tp 55.76 38.19 29.79 Favored 'General case' 0 C--O 1.232 0.154 0 CA-C-O 121.099 0.476 . . . . 0.0 111.338 178.722 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' C' C ' 110' ' ' GLU . . . . . . . . . . . . . 70.7 mm-40 -101.97 148.91 24.78 Favored 'General case' 0 C--N 1.328 -0.336 0 N-CA-C 109.636 -0.505 . . . . 0.0 109.636 175.707 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' C' C ' 111' ' ' GLU . . . . . . . . . . . . . 82.8 tt0 -81.85 121.91 27.05 Favored 'General case' 0 C--N 1.326 -0.415 0 CA-C-O 120.834 0.349 . . . . 0.0 110.357 -179.45 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' C' C ' 112' ' ' LEU . . . . . . . . . . . . . 34.1 mt -111.56 -46.04 3.31 Favored 'General case' 0 C--N 1.331 -0.203 0 CA-C-N 116.107 -0.497 . . . . 0.0 110.595 -179.689 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' C' C ' 113' ' ' TYR . . . . . . . . . . . . . 56.9 t80 -138.58 135.29 34.83 Favored 'General case' 0 C--N 1.33 -0.259 0 C-N-CA 120.772 -0.371 . . . . 0.0 111.332 -179.154 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' C' C ' 114' ' ' ARG . . . . . . . . . . . . . 63.8 ttp85 -137.88 122.08 18.07 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 115.949 -0.569 . . . . 0.0 110.026 178.956 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' C' C ' 115' ' ' GLY . . . . . . . . . . . . . . . -150.12 142.81 10.02 Favored Glycine 0 CA--C 1.525 0.671 0 C-N-CA 120.79 -0.719 . . . . 0.0 111.336 178.826 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' C' C ' 116' ' ' LYS . . . . . . . . . . . . . 38.8 ttpt -111.49 132.94 54.13 Favored 'General case' 0 C--N 1.33 -0.25 0 N-CA-C 109.782 -0.451 . . . . 0.0 109.782 176.379 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' C' C ' 117' ' ' PHE . . . . . . . . . . . . . 57.8 m-85 -130.69 113.97 14.82 Favored 'General case' 0 C--N 1.332 -0.193 0 CA-C-O 120.983 0.421 . . . . 0.0 110.385 -176.631 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' C' C ' 118' ' ' GLU . . . . . . . . . . . . . 71.0 mm-40 -54.28 -47.52 72.27 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.284 -0.416 . . . . 0.0 111.283 -177.276 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' C' C ' 119' ' ' ASN . . . . . . . . . . . . . 33.3 m120 -94.63 30.99 1.87 Allowed 'General case' 0 C--N 1.33 -0.251 0 N-CA-C 112.194 0.442 . . . . 0.0 112.194 -175.043 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' C' C ' 120' ' ' LEU . . . . . . . . . . . . . 13.7 tp -57.64 121.21 9.82 Favored 'General case' 0 C--N 1.332 -0.165 0 N-CA-C 110.204 -0.295 . . . . 0.0 110.204 177.163 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' C' C ' 121' ' ' ASN . . . . . . . . . . . . . 94.2 m-20 -114.01 -43.91 3.2 Favored 'General case' 0 C--O 1.232 0.171 0 CA-C-N 116.484 -0.326 . . . . 0.0 111.338 -176.113 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' C' C ' 122' ' ' LYS . . . . . . . . . . . . . 39.5 ttpt -150.97 148.88 28.93 Favored 'General case' 0 C--N 1.331 -0.227 0 CA-C-O 121.04 0.448 . . . . 0.0 111.637 -176.617 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' C' C ' 123' ' ' VAL . . . . . . . . . . . . . 44.9 t -128.65 133.87 65.62 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.227 0 CA-C-N 116.007 -0.542 . . . . 0.0 109.737 177.417 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' C' C ' 124' ' ' LEU . . . . . . . . . . . . . 79.5 mt -128.93 139.35 52.16 Favored 'General case' 0 C--N 1.331 -0.201 0 CA-C-O 120.759 0.314 . . . . 0.0 110.942 -178.595 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' C' C ' 125' ' ' VAL . . . . . . . . . . . . . 35.6 m -133.17 128.93 56.58 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.206 0 CA-C-N 116.254 -0.43 . . . . 0.0 110.53 178.242 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' C' C ' 126' ' ' ARG . . . . . . . . . . . . . 91.0 mtt180 -150.78 128.33 11.48 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.419 -0.355 . . . . 0.0 110.177 178.199 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' C' C ' 127' ' ' ASN . . . . . . . . . . . . . 77.5 m-20 54.52 -151.58 0.36 Allowed 'General case' 0 CA--C 1.541 0.6 0 CA-C-O 119.449 -0.31 . . . . 0.0 110.228 178.017 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' C' C ' 128' ' ' ASP . . . . . . . . . . . . . 23.5 p-10 -81.03 18.14 1.09 Allowed 'General case' 0 CA--C 1.536 0.405 0 N-CA-C 112.881 0.697 . . . . 0.0 112.881 -179.62 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' C' C ' 129' ' ' LEU . . . . . . . . . . . . . 15.9 tp -123.92 137.02 54.69 Favored 'General case' 0 C--O 1.232 0.165 0 CA-C-N 117.983 0.356 . . . . 0.0 110.185 178.715 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' C' C ' 130' ' ' VAL . . . . . . . . . . . . . 32.1 m -131.78 145.81 34.4 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.197 0 CA-C-O 120.905 0.383 . . . . 0.0 110.327 178.575 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' C' C ' 131' ' ' VAL . . . . . . . . . . . . . 40.7 t -136.1 140.49 43.8 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.325 0 CA-C-O 121.058 0.456 . . . . 0.0 110.553 -177.704 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' C' C ' 132' ' ' ILE . . . . . . . . . . . . . 73.9 mt -116.8 129.68 72.92 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 CA-C-N 115.585 -0.734 . . . . 0.0 109.032 177.45 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' C' C ' 133' ' ' ILE . . . . . . . . . . . . . 40.3 mm -114.06 121.84 66.99 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.275 0 CA-C-O 120.698 0.285 . . . . 0.0 110.942 -174.428 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' C' C ' 134' ' ' ASP . . . . . . . . . . . . . 9.0 p-10 -135.23 146.54 48.72 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.116 -0.493 . . . . 0.0 109.786 175.501 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' C' C ' 135' ' ' GLU . . . . . . . . . . . . . 81.2 tt0 -49.92 -25.41 3.21 Favored 'General case' 0 CA--C 1.533 0.325 0 N-CA-C 112.77 0.656 . . . . 0.0 112.77 -175.465 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' C' C ' 136' ' ' GLN . . . . . . . . . . . . . 58.3 tp60 -80.88 -34.28 33.7 Favored 'General case' 0 C--O 1.233 0.2 0 N-CA-C 112.036 0.384 . . . . 0.0 112.036 -176.032 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' C' C ' 137' ' ' LYS . . . . . . . . . . . . . 40.3 pttt -169.57 175.49 5.38 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-O 121.522 0.677 . . . . 0.0 112.085 -173.597 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' C' C ' 138' ' ' LEU . . . . . . . . . . . . . 4.8 tt -117.74 125.34 50.47 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 115.05 -0.977 . . . . 0.0 109.81 177.931 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' C' C ' 139' ' ' THR . . . . . . . . . . . . . 28.6 m -105.18 124.01 48.81 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.312 -0.404 . . . . 0.0 110.497 179.701 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' C' C ' 140' ' ' LEU . . . . . . . . . . . . . 19.6 tp -110.68 117.89 34.71 Favored 'General case' 0 C--N 1.329 -0.302 0 N-CA-C 109.046 -0.724 . . . . 0.0 109.046 -179.496 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' C' C ' 141' ' ' ILE . . . . . . . . . . . . . 19.9 mt -118.63 121.29 66.63 Favored 'Isoleucine or valine' 0 C--O 1.234 0.25 0 CA-C-O 121.24 0.543 . . . . 0.0 109.877 -175.496 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' C' C ' 142' ' ' ARG . . . . . . . . . . . . . 70.5 mtt180 -104.11 113.31 26.77 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 115.042 -0.981 . . . . 0.0 110.112 -177.952 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' C' C ' 143' ' ' THR . . . . . . . . . . . . . 80.3 p . . . . . 0 C--O 1.219 -0.514 0 CA-C-O 117.921 -1.037 . . . . 0.0 110.636 -179.406 . . . . . . . . 0 0 . 1 . 009 nuclear orig full ' D' D ' -3' ' ' GLU . . . . . . . . . . . . . 84.1 tt0 . . . . . 0 N--CA 1.489 1.508 0 N-CA-C 109.315 -0.624 . . . . 0.0 109.315 . . . . . . . . . 0 0 . 1 . 009 nuclear orig full ' D' D ' -2' ' ' GLY . . . . . . . . . . . . . . . -62.2 145.52 49.38 Favored Glycine 0 CA--C 1.525 0.685 0 N-CA-C 111.24 -0.744 . . . . 0.0 111.24 -178.325 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' D' D ' -1' ' ' VAL . . . . . . . . . . . . . 44.8 t -95.92 129.61 45.77 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.262 0 N-CA-C 109.93 -0.396 . . . . 0.0 109.93 179.216 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' D' D ' 0' ' ' ILE . . . . . . . . . . . . . 73.6 mt -121.28 143.49 33.46 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.242 0 CA-C-N 116.293 -0.412 . . . . 0.0 110.181 -178.573 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' D' D ' 1' ' ' MET . . . . . . . . . . . . . 23.2 ptp -144.07 148.33 35.01 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 115.954 -0.566 . . . . 0.0 110.568 -179.63 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' D' D ' 2' ' ' SER . . . . . . . . . . . . . 12.7 p -117.44 133.32 56.1 Favored 'General case' 0 C--N 1.331 -0.227 0 CA-C-O 121.164 0.507 . . . . 0.0 110.677 -179.868 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' D' D ' 3' ' ' GLU . . . . . . . . . . . . . 84.9 tt0 -143.99 140.87 29.85 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 115.748 -0.66 . . . . 0.0 111.161 -178.709 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' D' D ' 4' ' ' LEU . . . . . . . . . . . . . 19.2 tp -124.56 131.74 53.47 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.014 -0.539 . . . . 0.0 110.06 177.093 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' D' D ' 5' ' ' LYS . . . . . . . . . . . . . 77.9 mttt -111.93 120.91 43.51 Favored 'General case' 0 C--O 1.234 0.259 0 CA-C-N 116.365 -0.379 . . . . 0.0 110.767 -179.406 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' D' D ' 6' ' ' LEU . . . . . . . . . . . . . 54.5 mt -114.57 142.47 46.39 Favored 'General case' 0 C--N 1.332 -0.174 0 CA-C-N 115.553 -0.749 . . . . 0.0 110.163 -179.563 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' D' D ' 7' ' ' LYS . . . . . . . . . . . . . 31.0 ttpt -122.3 136.87 26.86 Favored Pre-proline 0 CA--C 1.534 0.351 0 CA-C-O 118.84 -0.6 . . . . 0.0 109.602 175.794 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' D' D ' 8' ' ' PRO . . . . . . . . . . . . . 98.8 Cg_endo -91.22 131.78 1.44 Allowed 'Trans proline' 0 N--CA 1.489 1.255 0 C-N-CA 121.687 1.591 . . . . 0.0 111.799 178.215 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' D' D ' 9' ' ' LEU . . . . . . . . . . . . . 36.1 mt -72.8 -47.48 8.83 Favored Pre-proline 0 CA--C 1.535 0.38 0 CA-C-O 118.49 -0.767 . . . . 0.0 112.128 -178.593 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' D' D ' 10' ' ' PRO . . . . . . . . . . . . . 75.8 Cg_endo -78.62 149.1 23.53 Favored 'Trans proline' 0 N--CA 1.496 1.623 0 CA-C-N 120.347 1.159 . . . . 0.0 111.794 176.397 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' D' D ' 11' ' ' LYS . . . . . . . . . . . . . 53.7 mttp -85.51 95.85 9.43 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.481 -0.327 . . . . 0.0 110.693 -179.721 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' D' D ' 12' ' ' VAL . . . . . . . . . . . . . 12.1 p -144.35 145.19 21.79 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.278 0 CA-C-N 116.285 -0.416 . . . . 0.0 110.43 179.361 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' D' D ' 13' ' ' GLU . . . . . . . . . . . . . 95.7 mt-10 -90.11 122.09 32.76 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.254 -0.43 . . . . 0.0 110.271 178.681 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' D' D ' 14' ' ' LEU . . . . . . . . . . . . . 23.1 mt -98.07 154.34 37.77 Favored Pre-proline 0 CA--C 1.532 0.265 0 CA-C-N 116.283 -0.417 . . . . 0.0 111.174 -177.874 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' D' D ' 15' ' ' PRO . . . . . . . . . . . . . 36.6 Cg_exo -59.35 162.29 14.88 Favored 'Trans proline' 0 N--CA 1.496 1.669 0 C-N-CA 121.4 1.4 . . . . 0.0 112.079 178.581 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' D' D ' 16' ' ' PRO . . . . . . . . . . . . . 23.7 Cg_exo -63.01 -41.42 28.83 Favored 'Trans proline' 0 N--CA 1.497 1.703 0 C-N-CA 121.493 1.462 . . . . 0.0 112.815 -179.175 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' D' D ' 17' ' ' ASP . . . . . . . . . . . . . 22.8 p-10 -82.91 9.53 9.81 Favored 'General case' 0 CA--C 1.537 0.47 0 N-CA-C 113.241 0.83 . . . . 0.0 113.241 -176.859 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' D' D ' 18' ' ' PHE . . . . . . . . . . . . . 29.3 t80 -56.98 -41.81 79.09 Favored 'General case' 0 C--N 1.334 -0.09 0 O-C-N 121.986 -0.446 . . . . 0.0 110.369 -179.562 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' D' D ' 19' ' ' VAL . . . . . . . . . . . . . 46.5 t -56.23 -44.44 79.35 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.252 0 CA-C-N 116.327 -0.397 . . . . 0.0 110.599 -179.379 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' D' D ' 20' ' ' ASP . . . . . . . . . . . . . 41.6 m-20 -59.81 -41.26 90.87 Favored 'General case' 0 C--N 1.33 -0.247 0 C-N-CA 120.84 -0.344 . . . . 0.0 110.943 -178.091 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' D' D ' 21' ' ' VAL . . . . . . . . . . . . . 47.2 t -63.66 -47.54 90.78 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 C-N-CA 120.759 -0.377 . . . . 0.0 110.494 -178.357 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' D' D ' 22' ' ' ILE . . . . . . . . . . . . . 49.8 mm -54.78 -47.28 74.55 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.273 0 C-N-CA 120.97 -0.292 . . . . 0.0 110.798 178.907 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' D' D ' 23' ' ' ARG . . . . . . . . . . . . . 53.2 ttp180 -53.74 -52.0 61.55 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-O 120.609 0.242 . . . . 0.0 111.533 -178.953 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' D' D ' 24' ' ' ILE . . . . . . . . . . . . . 76.7 mt -58.61 -41.26 81.6 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.377 0 CA-C-N 116.749 -0.205 . . . . 0.0 111.367 -176.339 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' D' D ' 25' ' ' LYS . . . . . . . . . . . . . 73.0 mmtt -68.4 -42.29 79.23 Favored 'General case' 0 C--N 1.329 -0.292 0 N-CA-C 112.277 0.473 . . . . 0.0 112.277 -178.338 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' D' D ' 26' ' ' LEU . . . . . . . . . . . . . 33.1 mt -80.47 -34.31 35.99 Favored 'General case' 0 C--N 1.33 -0.258 0 N-CA-C 113.661 0.986 . . . . 0.0 113.661 -169.41 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' D' D ' 27' ' ' GLN . . . . . . . . . . . . . 9.1 pt20 -46.1 139.71 4.34 Favored 'General case' 0 N--CA 1.469 0.489 0 N-CA-C 112.853 0.686 . . . . 0.0 112.853 -175.17 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' D' D ' 28' ' ' GLY . . . . . . . . . . . . . . . 101.05 -27.01 22.54 Favored Glycine 0 CA--C 1.532 1.144 0 CA-C-N 115.657 -0.701 . . . . 0.0 112.163 -175.99 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' D' D ' 29' ' ' LYS . . . . . . . . . . . . . 64.9 mttp -97.65 155.09 17.15 Favored 'General case' 0 C--O 1.233 0.226 0 CA-C-N 117.336 0.568 . . . . 0.0 110.986 178.751 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' D' D ' 30' ' ' THR . . . . . . . . . . . . . 40.1 m -106.77 140.63 39.32 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.232 -0.44 . . . . 0.0 110.151 177.251 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' D' D ' 31' ' ' VAL . . . . . . . . . . . . . 34.9 m -128.22 156.12 40.21 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.19 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.851 -179.125 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' D' D ' 32' ' ' ARG . . . . . . . . . . . . . 67.3 ttt180 -131.65 147.0 52.48 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 115.974 -0.557 . . . . 0.0 110.314 178.285 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' D' D ' 33' ' ' THR . . . . . . . . . . . . . 22.8 m -52.52 139.22 25.94 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-O 120.762 0.315 . . . . 0.0 111.502 -178.329 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' D' D ' 34' ' ' GLY . . . . . . . . . . . . . . . 99.67 -17.05 58.07 Favored Glycine 0 CA--C 1.533 1.159 0 CA-C-O 119.762 -0.466 . . . . 0.0 113.32 179.26 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' D' D ' 35' ' ' ASP . . . . . . . . . . . . . 76.7 m-20 -66.44 149.24 50.72 Favored 'General case' 0 N--CA 1.46 0.074 0 CA-C-N 117.992 0.896 . . . . 0.0 111.17 179.787 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' D' D ' 36' ' ' VAL . . . . . . . . . . . . . 45.6 t -120.18 128.9 76.0 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.202 0 CA-C-N 115.749 -0.66 . . . . 0.0 109.687 177.439 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' D' D ' 37' ' ' ILE . . . . . . . . . . . . . 64.1 mt -121.37 138.85 50.38 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.229 0 CA-C-N 116.194 -0.457 . . . . 0.0 109.889 -179.145 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' D' D ' 38' ' ' GLY . . . . . . . . . . . . . . . -117.97 128.87 7.97 Favored Glycine 0 CA--C 1.526 0.749 0 N-CA-C 110.97 -0.852 . . . . 0.0 110.97 -179.943 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' D' D ' 39' ' ' ILE . . . . . . . . . . . . . 71.5 mt -128.05 129.83 69.64 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.198 0 N-CA-C 110.036 -0.357 . . . . 0.0 110.036 178.815 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' D' D ' 40' ' ' SER . . . . . . . . . . . . . 87.2 p -92.16 123.73 35.72 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.267 -0.424 . . . . 0.0 110.861 176.804 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' D' D ' 41' ' ' ILE . . . . . . . . . . . . . 71.9 mt -134.14 121.04 36.83 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.263 0 CA-C-O 120.993 0.425 . . . . 0.0 110.278 177.82 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' D' D ' 42' ' ' LEU . . . . . . . . . . . . . 1.3 tt 57.81 44.78 19.66 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-O 121.42 0.629 . . . . 0.0 110.187 178.46 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' D' D ' 43' ' ' GLY . . . . . . . . . . . . . . . 72.36 -5.75 13.89 Favored Glycine 0 CA--C 1.534 1.276 0 C-N-CA 121.146 -0.549 . . . . 0.0 113.644 175.897 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' D' D ' 44' ' ' LYS . . . . . . . . . . . . . 22.9 tptm -109.27 126.05 52.93 Favored 'General case' 0 N--CA 1.462 0.129 0 CA-C-N 118.141 0.971 . . . . 0.0 110.183 -178.908 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' D' D ' 45' ' ' GLU . . . . . . . . . . . . . 43.6 tp10 -84.69 130.31 34.72 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-O 120.816 0.341 . . . . 0.0 111.124 -179.482 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' D' D ' 46' ' ' VAL . . . . . . . . . . . . . 10.3 p -120.3 126.99 75.86 Favored 'Isoleucine or valine' 0 N--CA 1.462 0.167 0 N-CA-C 109.818 -0.438 . . . . 0.0 109.818 175.25 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' D' D ' 47' ' ' LYS . . . . . . . . . . . . . 86.4 mttt -99.09 126.16 44.77 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 115.912 -0.585 . . . . 0.0 110.931 178.248 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' D' D ' 48' ' ' PHE . . . . . . . . . . . . . 34.2 m-85 -111.43 131.97 54.8 Favored 'General case' 0 C--N 1.331 -0.207 0 N-CA-C 109.812 -0.44 . . . . 0.0 109.812 177.665 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' D' D ' 49' ' ' LYS . . . . . . . . . . . . . 38.4 tttp -107.71 132.15 53.66 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.362 -0.381 . . . . 0.0 110.274 177.655 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' D' D ' 50' ' ' VAL . . . . . . . . . . . . . 45.5 t -76.56 104.11 4.38 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.332 0 N-CA-C 109.361 -0.607 . . . . 0.0 109.361 177.06 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' D' D ' 51' ' ' VAL . . . . . . . . . . . . . 47.5 t -69.48 -53.2 26.11 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.341 0 N-CA-C 109.554 -0.536 . . . . 0.0 109.554 -175.692 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' D' D ' 52' ' ' GLN . . . . . . . . . . . . . 81.8 mt-30 -154.86 152.45 29.79 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.053 -0.522 . . . . 0.0 111.677 -178.381 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' D' D ' 53' ' ' ALA . . . . . . . . . . . . . . . -129.29 133.29 47.4 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 115.361 -0.836 . . . . 0.0 109.703 175.539 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' D' D ' 54' ' ' TYR . . . . . . . . . . . . . 45.8 t80 -129.0 109.69 18.28 Favored Pre-proline 0 CA--C 1.535 0.397 0 CA-C-O 118.162 -0.923 . . . . 0.0 110.463 179.217 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' D' D ' 55' ' ' PRO . . . . . . . . . . . . . 73.7 Cg_endo -77.17 167.47 79.58 Favored 'Cis proline' 0 N--CA 1.5 1.871 0 CA-C-N 121.808 1.681 . . . . 0.0 112.103 -6.676 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' D' D ' 56' ' ' SER . . . . . . . . . . . . . 62.7 m -117.41 133.04 23.27 Favored Pre-proline 0 CA--C 1.54 0.567 0 CA-C-O 118.437 -0.792 . . . . 0.0 109.458 174.803 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' D' D ' 57' ' ' PRO . . . . . . . . . . . . . 38.4 Cg_endo -67.7 164.5 72.51 Favored 'Cis proline' 0 N--CA 1.498 1.774 0 CA-C-N 121.881 1.707 . . . . 0.0 111.433 -1.407 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' D' D ' 58' ' ' LEU . . . . . . . . . . . . . 24.0 tp -130.73 138.05 49.8 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 116.321 -0.399 . . . . 0.0 110.612 -179.478 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' D' D ' 59' ' ' ARG . . . . . . . . . . . . . 56.7 ttp180 -103.24 127.96 50.4 Favored 'General case' 0 C--N 1.328 -0.342 0 N-CA-C 109.362 -0.607 . . . . 0.0 109.362 174.882 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' D' D ' 60' ' ' VAL . . . . . . . . . . . . . 43.5 t -78.48 119.47 27.57 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.28 0 C-N-CA 120.75 -0.38 . . . . 0.0 110.836 -174.591 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' D' D ' 61' ' ' GLU . . . . . . . . . . . . . 15.6 mm-40 -131.09 161.33 32.31 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 115.729 -0.669 . . . . 0.0 109.666 175.378 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' D' D ' 62' ' ' ASP . . . . . . . . . . . . . 54.0 m-20 -52.6 -31.65 37.51 Favored 'General case' 0 C--N 1.328 -0.343 0 N-CA-C 112.085 0.402 . . . . 0.0 112.085 -178.252 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' D' D ' 63' ' ' ARG . . . . . . . . . . . . . 79.7 mtp180 -73.2 -21.91 60.57 Favored 'General case' 0 CA--C 1.532 0.256 0 N-CA-C 112.949 0.722 . . . . 0.0 112.949 -175.41 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' D' D ' 64' ' ' THR . . . . . . . . . . . . . 25.7 m -69.31 139.96 54.33 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-O 120.951 0.405 . . . . 0.0 110.965 -175.752 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' D' D ' 65' ' ' LYS . . . . . . . . . . . . . 67.5 mttm -89.34 132.14 35.09 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 115.945 -0.57 . . . . 0.0 110.134 178.341 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' D' D ' 66' ' ' ILE . . . . . . . . . . . . . 62.7 mt -117.51 129.52 73.85 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.261 0 N-CA-C 109.893 -0.41 . . . . 0.0 109.893 179.446 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' D' D ' 67' ' ' THR . . . . . . . . . . . . . 25.5 m -122.86 137.47 54.93 Favored 'General case' 0 C--N 1.332 -0.181 0 CA-C-N 116.128 -0.487 . . . . 0.0 110.769 -178.872 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' D' D ' 68' ' ' LEU . . . . . . . . . . . . . 14.9 tp -107.33 129.36 54.91 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 115.964 -0.562 . . . . 0.0 110.348 178.805 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' D' D ' 69' ' ' VAL . . . . . . . . . . . . . 43.3 t -92.72 134.12 31.74 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.352 0 CA-C-N 116.033 -0.531 . . . . 0.0 110.005 178.495 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' D' D ' 70' ' ' THR . . . . . . . . . . . . . 21.5 p -84.85 -54.36 4.73 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.36 -0.382 . . . . 0.0 110.422 -179.455 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' D' D ' 71' ' ' HIS . . . . . . . . . . . . . 96.7 m-70 -149.98 151.61 32.49 Favored Pre-proline 0 C--N 1.329 -0.296 0 CA-C-N 116.314 -0.403 . . . . 0.0 110.561 178.671 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' D' D ' 72' ' ' PRO . . . . . . . . . . . . . 86.5 Cg_endo -89.88 158.25 5.01 Favored 'Trans proline' 0 N--CA 1.49 1.266 0 C-N-CA 121.762 1.641 . . . . 0.0 111.988 178.859 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' D' D ' 73' ' ' VAL . . . . . . . . . . . . . 30.3 m -77.97 143.51 12.66 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.238 0 CA-C-O 120.936 0.398 . . . . 0.0 110.404 178.906 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' D' D ' 74' ' ' ASP . . . . . . . . . . . . . 15.2 t0 -97.04 124.46 41.04 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 115.997 -0.547 . . . . 0.0 109.59 178.905 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' D' D ' 75' ' ' VAL . . . . . . . . . . . . . 41.9 t -116.75 125.29 73.62 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.211 0 CA-C-O 121.091 0.472 . . . . 0.0 110.891 -175.29 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' D' D ' 76' ' ' LEU . . . . . . . . . . . . . 5.7 mp -125.73 144.71 50.5 Favored 'General case' 0 C--N 1.331 -0.205 0 CA-C-N 115.704 -0.68 . . . . 0.0 109.55 173.896 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' D' D ' 77' ' ' GLU . . . . . . . . . . . . . 98.0 mt-10 -133.52 131.03 39.31 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-O 120.961 0.41 . . . . 0.0 111.007 -177.666 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' D' D ' 78' ' ' ALA . . . . . . . . . . . . . . . -116.13 130.95 57.04 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 115.833 -0.621 . . . . 0.0 109.697 177.516 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' D' D ' 79' ' ' LYS . . . . . . . . . . . . . 88.1 mttt -77.34 123.85 27.07 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-O 120.854 0.359 . . . . 0.0 110.906 -177.059 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' D' D ' 80' ' ' ILE . . . . . . . . . . . . . 39.5 mm -139.1 114.4 8.56 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.277 0 N-CA-C 109.309 -0.626 . . . . 0.0 109.309 -177.858 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' D' D ' 81' ' ' LYS . . . . . . . . . . . . . 69.3 mttm -100.48 118.93 37.68 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-O 120.793 0.33 . . . . 0.0 111.245 -177.234 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' D' D ' 82' ' ' GLY . . . . . . . . . . . . . . . 89.17 42.22 5.64 Favored Glycine 0 CA--C 1.526 0.738 0 C-N-CA 120.668 -0.777 . . . . 0.0 111.989 172.888 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' D' D ' 83' ' ' ILE . . . . . . . . . . . . . 72.3 mt -61.99 135.92 25.97 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.341 0 N-CA-C 109.835 -0.431 . . . . 0.0 109.835 176.434 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' D' D ' 84' ' ' LYS . . . . . . . . . . . . . 15.5 ttmm -95.21 -51.45 4.61 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-O 121.118 0.485 . . . . 0.0 109.744 179.115 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' D' D ' 85' ' ' ASP . . . . . . . . . . . . . 7.5 t70 -158.38 154.9 27.73 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 115.548 -0.751 . . . . 0.0 110.145 179.105 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' D' D ' 86' ' ' VAL . . . . . . . . . . . . . 44.4 t -130.56 133.98 62.81 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.176 0 CA-C-O 121.055 0.455 . . . . 0.0 110.459 -179.436 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' D' D ' 87' ' ' ILE . . . . . . . . . . . . . 44.3 mm -119.25 125.72 74.7 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.253 0 CA-C-N 115.653 -0.703 . . . . 0.0 109.664 177.657 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' D' D ' 88' ' ' LEU . . . . . . . . . . . . . 14.2 tp -108.14 127.17 53.58 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.299 -0.409 . . . . 0.0 110.848 -178.331 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' D' D ' 89' ' ' ASP . . . . . . . . . . . . . 13.6 t70 -121.22 154.41 36.32 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.002 -0.545 . . . . 0.0 109.843 178.23 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' D' D ' 90' ' ' GLU . . . . . . . . . . . . . 82.3 tt0 -46.32 -37.58 7.61 Favored 'General case' 0 C--N 1.33 -0.271 0 N-CA-C 113.079 0.77 . . . . 0.0 113.079 -172.754 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' D' D ' 91' ' ' ASN . . . . . . . . . . . . . 13.4 t-20 -132.0 22.02 4.53 Favored 'General case' 0 N--CA 1.469 0.477 0 N-CA-C 112.779 0.659 . . . . 0.0 112.779 -177.446 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' D' D ' 92' ' ' LEU . . . . . . . . . . . . . 19.9 mt -150.49 144.15 25.19 Favored 'General case' 0 C--N 1.331 -0.204 0 CA-C-O 120.773 0.321 . . . . 0.0 110.269 -176.59 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' D' D ' 93' ' ' ILE . . . . . . . . . . . . . 74.6 mt -121.78 115.08 45.33 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.276 0 N-CA-C 109.168 -0.678 . . . . 0.0 109.168 176.944 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' D' D ' 94' ' ' VAL . . . . . . . . . . . . . 46.8 t -118.06 127.04 75.32 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.217 0 CA-C-O 121.071 0.462 . . . . 0.0 110.111 -177.883 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' D' D ' 95' ' ' VAL . . . . . . . . . . . . . 41.1 t -121.42 134.55 64.41 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.277 0 CA-C-N 115.769 -0.651 . . . . 0.0 109.772 -179.678 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' D' D ' 96' ' ' ILE . . . . . . . . . . . . . 63.4 mt -113.57 127.58 70.84 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.287 0 N-CA-C 109.209 -0.663 . . . . 0.0 109.209 178.381 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' D' D ' 97' ' ' THR . . . . . . . . . . . . . 59.9 p -101.44 156.15 17.63 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-O 121.289 0.566 . . . . 0.0 111.379 -177.106 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' D' D ' 98' ' ' GLU . . . . . . . . . . . . . 45.5 tp10 -53.81 -26.65 25.1 Favored 'General case' 0 CA--C 1.533 0.32 0 CA-C-N 116.009 -0.542 . . . . 0.0 112.075 179.309 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' D' D ' 99' ' ' GLU . . . . . . . . . . . . . 96.7 mt-10 -79.97 17.49 0.96 Allowed 'General case' 0 CA--C 1.534 0.357 0 N-CA-C 113.084 0.772 . . . . 0.0 113.084 -177.217 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' D' D ' 100' ' ' ASN . . . . . . . . . . . . . 2.7 m-20 62.41 37.65 13.45 Favored 'General case' 0 C--O 1.233 0.19 0 CA-C-O 121.004 0.43 . . . . 0.0 110.959 177.456 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' D' D ' 101' ' ' GLU . . . . . . . . . . . . . 84.5 tt0 -116.27 143.64 45.26 Favored 'General case' 0 C--N 1.332 -0.173 0 CA-C-N 116.22 -0.445 . . . . 0.0 109.864 177.356 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' D' D ' 102' ' ' VAL . . . . . . . . . . . . . 45.3 t -114.93 124.37 71.52 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.267 0 CA-C-N 116.103 -0.499 . . . . 0.0 109.842 -179.122 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' D' D ' 103' ' ' LEU . . . . . . . . . . . . . 30.9 mt -115.88 131.31 56.98 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-N 115.815 -0.63 . . . . 0.0 110.464 178.075 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' D' D ' 104' ' ' ILE . . . . . 0.404 HG23 HD12 ' D' ' 104' ' ' ILE . 68.9 mt -120.77 120.1 61.49 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.302 0 N-CA-C 110.268 -0.271 . . . . 0.0 110.268 179.425 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' D' D ' 105' ' ' PHE . . . . . . . . . . . . . 59.1 m-85 -121.64 166.95 13.49 Favored 'General case' 0 C--N 1.333 -0.149 0 O-C-N 123.886 0.741 . . . . 0.0 110.043 178.494 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' D' D ' 106' ' ' ASN . . . . . . . . . . . . . 45.2 p-10 -104.1 -170.63 1.8 Allowed 'General case' 0 CA--C 1.531 0.227 0 N-CA-C 110.088 -0.338 . . . . 0.0 110.088 173.187 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' D' D ' 107' ' ' GLN . . . . . . . . . . . . . 63.3 tt0 -57.56 -29.77 64.69 Favored 'General case' 0 C--N 1.33 -0.255 0 N-CA-C 112.071 0.396 . . . . 0.0 112.071 179.338 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' D' D ' 108' ' ' ASN . . . . . . . . . . . . . 10.8 t30 -87.3 12.62 11.46 Favored 'General case' 0 CA--C 1.536 0.415 0 N-CA-C 113.045 0.757 . . . . 0.0 113.045 -176.295 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' D' D ' 109' ' ' LEU . . . . . . . . . . . . . 24.9 mt 55.1 36.75 27.66 Favored 'General case' 0 CA--C 1.528 0.132 0 CA-C-O 120.943 0.401 . . . . 0.0 111.43 178.665 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' D' D ' 110' ' ' GLU . . . . . . . . . . . . . 95.8 mt-10 -102.28 148.86 24.93 Favored 'General case' 0 C--N 1.33 -0.251 0 N-CA-C 109.689 -0.485 . . . . 0.0 109.689 175.917 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' D' D ' 111' ' ' GLU . . . . . . . . . . . . . 79.9 tt0 -79.34 122.0 25.82 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.339 -0.392 . . . . 0.0 110.565 -178.027 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' D' D ' 112' ' ' LEU . . . . . . . . . . . . . 43.4 mt -109.05 -46.01 3.67 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-N 116.128 -0.487 . . . . 0.0 110.245 178.677 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' D' D ' 113' ' ' TYR . . . . . . . . . . . . . 60.3 t80 -140.94 137.49 33.14 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.32 -0.4 . . . . 0.0 111.147 -179.959 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' D' D ' 114' ' ' ARG . . . . . . . . . . . . . 68.5 ttp85 -140.72 119.25 12.3 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 115.881 -0.6 . . . . 0.0 109.98 177.377 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' D' D ' 115' ' ' GLY . . . . . . . . . . . . . . . -150.08 151.13 23.24 Favored Glycine 0 CA--C 1.523 0.588 0 N-CA-C 110.919 -0.872 . . . . 0.0 110.919 179.554 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' D' D ' 116' ' ' LYS . . . . . . . . . . . . . 35.2 ttmt -124.29 140.0 53.38 Favored 'General case' 0 C--N 1.329 -0.298 0 N-CA-C 109.968 -0.382 . . . . 0.0 109.968 177.449 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' D' D ' 117' ' ' PHE . . . . . . . . . . . . . 28.9 m-85 -136.16 118.89 16.08 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.04 -176.232 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' D' D ' 118' ' ' GLU . . . . . . . . . . . . . 96.1 mt-10 -53.45 -46.55 69.91 Favored 'General case' 0 C--N 1.33 -0.278 0 C-N-CA 121.041 -0.264 . . . . 0.0 111.307 -177.88 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' D' D ' 119' ' ' ASN . . . . . . . . . . . . . 24.3 m120 -95.87 31.04 2.19 Favored 'General case' 0 C--N 1.331 -0.216 0 CA-C-N 116.149 -0.478 . . . . 0.0 112.198 -175.891 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' D' D ' 120' ' ' LEU . . . . . . . . . . . . . 19.4 tp -57.59 122.04 11.78 Favored 'General case' 0 C--O 1.231 0.123 0 N-CA-C 110.077 -0.342 . . . . 0.0 110.077 177.271 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' D' D ' 121' ' ' ASN . . . . . . . . . . . . . 29.2 t-20 -113.56 -44.0 3.26 Favored 'General case' 0 C--O 1.233 0.199 0 CA-C-N 116.683 -0.235 . . . . 0.0 111.329 -175.37 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' D' D ' 122' ' ' LYS . . . . . . . . . . . . . 34.7 ttmt -150.98 141.81 22.85 Favored 'General case' 0 C--N 1.331 -0.201 0 C-N-CA 120.513 -0.475 . . . . 0.0 111.703 -177.457 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' D' D ' 123' ' ' VAL . . . . . . . . . . . . . 46.5 t -119.57 127.87 75.87 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.231 0 N-CA-C 108.972 -0.751 . . . . 0.0 108.972 173.539 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' D' D ' 124' ' ' LEU . . . . . . . . . . . . . 17.7 tp -127.16 140.72 52.05 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-O 120.867 0.365 . . . . 0.0 110.924 -175.506 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' D' D ' 125' ' ' VAL . . . . . . . . . . . . . 35.6 m -126.82 140.91 47.65 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.276 0 CA-C-N 116.065 -0.516 . . . . 0.0 110.629 179.787 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' D' D ' 126' ' ' ARG . . . . . . . . . . . . . 47.7 ttt180 -159.34 134.08 7.98 Favored 'General case' 0 C--N 1.329 -0.318 0 N-CA-C 109.53 -0.544 . . . . 0.0 109.53 178.287 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' D' D ' 127' ' ' ASN . . . . . . . . . . . . . 1.6 t-20 56.68 -154.0 0.35 Allowed 'General case' 0 CA--C 1.537 0.47 0 N-CA-C 109.588 -0.523 . . . . 0.0 109.588 -178.333 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' D' D ' 128' ' ' ASP . . . . . . . . . . . . . 13.7 p-10 -84.99 20.7 1.79 Allowed 'General case' 0 CA--C 1.535 0.381 0 CA-C-N 118.433 0.561 . . . . 0.0 112.346 177.178 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' D' D ' 129' ' ' LEU . . . . . . . . . . . . . 59.1 mt -122.87 150.3 43.07 Favored 'General case' 0 C--O 1.233 0.228 0 O-C-N 122.119 -0.363 . . . . 0.0 110.307 -179.699 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' D' D ' 130' ' ' VAL . . . . . . . . . . . . . 12.9 p -134.46 147.15 30.07 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.205 0 CA-C-O 120.891 0.377 . . . . 0.0 110.412 -179.16 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' D' D ' 131' ' ' VAL . . . . . . . . . . . . . 14.9 p -136.23 142.84 37.48 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.211 0 CA-C-O 121.121 0.486 . . . . 0.0 110.904 -179.528 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' D' D ' 132' ' ' ILE . . . . . . . . . . . . . 72.4 mt -115.63 131.41 68.09 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.231 0 CA-C-N 115.689 -0.687 . . . . 0.0 109.374 178.333 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' D' D ' 133' ' ' ILE . . . . . . . . . . . . . 42.5 mm -115.61 124.23 71.85 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.307 0 CA-C-O 120.878 0.371 . . . . 0.0 110.911 -175.597 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' D' D ' 134' ' ' ASP . . . . . . . . . . . . . 10.3 p-10 -137.46 146.33 44.17 Favored 'General case' 0 C--N 1.331 -0.201 0 CA-C-N 116.103 -0.499 . . . . 0.0 109.762 174.294 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' D' D ' 135' ' ' GLU . . . . . . . . . . . . . 84.9 tt0 -49.87 -25.95 3.63 Favored 'General case' 0 C--N 1.329 -0.309 0 N-CA-C 112.776 0.658 . . . . 0.0 112.776 -173.798 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' D' D ' 136' ' ' GLN . . . . . . . . . . . . . 48.0 tt0 -81.91 -34.04 30.12 Favored 'General case' 0 C--N 1.331 -0.231 0 N-CA-C 111.939 0.348 . . . . 0.0 111.939 -175.828 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' D' D ' 137' ' ' LYS . . . . . . . . . . . . . 53.7 pttt -167.78 175.3 6.99 Favored 'General case' 0 C--N 1.331 -0.223 0 CA-C-O 121.561 0.696 . . . . 0.0 112.079 -173.396 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' D' D ' 138' ' ' LEU . . . . . . . . . . . . . 5.5 tt -119.2 129.6 55.05 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 115.095 -0.957 . . . . 0.0 109.853 179.07 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' D' D ' 139' ' ' THR . . . . . . . . . . . . . 39.1 m -112.49 124.22 52.02 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.289 -0.414 . . . . 0.0 110.353 178.829 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' D' D ' 140' ' ' LEU . . . . . . . . . . . . . 31.7 tp -112.07 124.97 53.57 Favored 'General case' 0 C--N 1.327 -0.378 0 N-CA-C 109.186 -0.672 . . . . 0.0 109.186 -178.663 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' D' D ' 141' ' ' ILE . . . . . . . . . . . . . 19.7 mt -121.99 117.16 51.44 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.292 0 CA-C-O 120.954 0.406 . . . . 0.0 109.983 -173.071 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' D' D ' 142' ' ' ARG . . . . . . . . . . . . . 78.6 mtp180 -107.11 125.26 50.83 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-N 115.382 -0.826 . . . . 0.0 110.445 -177.35 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' D' D ' 143' ' ' THR . . . . . . . . . . . . . 25.4 p . . . . . 0 C--O 1.219 -0.544 0 CA-C-O 118.004 -0.998 . . . . 0.0 110.61 -179.748 . . . . . . . . 0 0 . 1 . 009 nuclear orig full ' E' E ' -3' ' ' GLU . . . . . . . . . . . . . 45.1 tp10 . . . . . 0 N--CA 1.49 1.558 0 N-CA-C 109.378 -0.601 . . . . 0.0 109.378 . . . . . . . . . 0 0 . 1 . 009 nuclear orig full ' E' E ' -2' ' ' GLY . . . . . . . . . . . . . . . -77.88 138.34 21.32 Favored Glycine 0 CA--C 1.524 0.646 0 N-CA-C 110.893 -0.883 . . . . 0.0 110.893 179.647 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' E' E ' -1' ' ' VAL . . . . . . . . . . . . . 43.9 t -96.04 130.07 45.24 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.289 0 N-CA-C 110.065 -0.346 . . . . 0.0 110.065 179.733 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' E' E ' 0' ' ' ILE . . . . . . . . . . . . . 44.0 mm -117.67 140.09 42.16 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.222 0 CA-C-O 120.901 0.382 . . . . 0.0 110.46 -178.649 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' E' E ' 1' ' ' MET . . . . . . . . . . . . . 20.1 ptt? -144.4 140.47 29.05 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 115.924 -0.58 . . . . 0.0 110.503 -179.832 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' E' E ' 2' ' ' SER . . . . . . . . . . . . . 2.0 p -128.3 122.27 31.22 Favored 'General case' 0 C--O 1.233 0.207 0 CA-C-O 121.014 0.435 . . . . 0.0 110.67 -178.6 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' E' E ' 3' ' ' GLU . . . . . . . . . . . . . 66.3 tt0 -144.87 142.52 29.98 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-N 115.794 -0.639 . . . . 0.0 111.251 -175.29 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' E' E ' 4' ' ' LEU . . . . . . . . . . . . . 15.9 tp -123.37 135.0 53.94 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 115.918 -0.583 . . . . 0.0 110.001 175.583 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' E' E ' 5' ' ' LYS . . . . . . . . . . . . . 89.9 mttt -115.42 121.98 44.41 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.581 -0.281 . . . . 0.0 110.89 -179.125 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' E' E ' 6' ' ' LEU . . . . . . . . . . . . . 69.4 mt -114.48 145.93 41.3 Favored 'General case' 0 C--N 1.331 -0.225 0 CA-C-N 115.808 -0.633 . . . . 0.0 110.19 178.227 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' E' E ' 7' ' ' LYS . . . . . . . . . . . . . 26.3 ttpp -127.76 142.58 44.69 Favored Pre-proline 0 CA--C 1.533 0.323 0 CA-C-O 119.129 -0.462 . . . . 0.0 109.826 175.928 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' E' E ' 8' ' ' PRO . . . . . . . . . . . . . 87.2 Cg_endo -91.04 132.49 1.54 Allowed 'Trans proline' 0 N--CA 1.489 1.234 0 C-N-CA 121.652 1.568 . . . . 0.0 111.843 178.769 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' E' E ' 9' ' ' LEU . . . . . . . . . . . . . 71.6 mt -71.0 -47.17 14.73 Favored Pre-proline 0 CA--C 1.534 0.331 0 CA-C-O 118.663 -0.684 . . . . 0.0 112.111 -179.696 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' E' E ' 10' ' ' PRO . . . . . . . . . . . . . 98.3 Cg_endo -79.96 155.95 23.37 Favored 'Trans proline' 0 N--CA 1.495 1.614 0 C-N-CA 121.106 1.204 . . . . 0.0 111.878 175.573 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' E' E ' 11' ' ' LYS . . . . . . . . . . . . . 62.4 mttp -88.14 96.03 10.38 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-O 120.774 0.321 . . . . 0.0 110.695 179.696 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' E' E ' 12' ' ' VAL . . . . . . . . . . . . . 12.5 p -143.35 147.01 20.74 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.248 0 CA-C-N 116.231 -0.44 . . . . 0.0 110.37 179.228 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' E' E ' 13' ' ' GLU . . . . . . . . . . . . . 84.8 tt0 -92.06 123.59 35.53 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.321 -0.399 . . . . 0.0 110.276 179.175 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' E' E ' 14' ' ' LEU . . . . . . . . . . . . . 41.7 mt -97.9 149.01 35.28 Favored Pre-proline 0 CA--C 1.533 0.307 0 CA-C-O 119.352 -0.356 . . . . 0.0 110.6 -178.099 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' E' E ' 15' ' ' PRO . . . . . . . . . . . . . 26.1 Cg_exo -62.08 157.57 43.58 Favored 'Trans proline' 0 N--CA 1.498 1.751 0 C-N-CA 121.349 1.366 . . . . 0.0 111.906 177.412 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' E' E ' 16' ' ' PRO . . . . . . . . . . . . . 34.0 Cg_exo -59.36 -37.85 87.89 Favored 'Trans proline' 0 N--CA 1.498 1.758 0 C-N-CA 121.49 1.46 . . . . 0.0 112.875 -179.228 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' E' E ' 17' ' ' ASP . . . . . . . . . . . . . 18.2 p-10 -79.43 1.86 23.95 Favored 'General case' 0 CA--C 1.538 0.499 0 N-CA-C 113.327 0.862 . . . . 0.0 113.327 -177.34 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' E' E ' 18' ' ' PHE . . . . . . . . . . . . . 46.9 t80 -57.61 -47.18 82.88 Favored 'General case' 0 N--CA 1.458 -0.074 0 O-C-N 121.97 -0.456 . . . . 0.0 110.142 -178.605 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' E' E ' 19' ' ' VAL . . . . . . . . . . . . . 13.8 p -55.34 -41.49 62.11 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.319 0 CA-C-N 116.26 -0.427 . . . . 0.0 111.095 -178.553 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' E' E ' 20' ' ' ASP . . . . . . . . . . . . . 9.5 t0 -60.44 -43.16 97.11 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-O 120.925 0.393 . . . . 0.0 110.899 -177.977 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' E' E ' 21' ' ' VAL . . . . . . . . . . . . . 47.2 t -64.34 -45.98 94.45 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.287 0 CA-C-N 116.272 -0.422 . . . . 0.0 110.496 -178.177 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' E' E ' 22' ' ' ILE . . . . . . . . . . . . . 50.2 mm -54.63 -47.09 73.05 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.287 0 CA-C-O 120.676 0.275 . . . . 0.0 110.753 178.809 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' E' E ' 23' ' ' ARG . . . . . . . . . . . . . 25.1 ttm-85 -53.3 -54.17 40.28 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-O 121.258 0.551 . . . . 0.0 111.677 179.963 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' E' E ' 24' ' ' ILE . . . . . . . . . . . . . 76.4 mt -61.0 -36.52 72.94 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.38 0 CA-C-N 115.67 -0.696 . . . . 0.0 111.59 -172.857 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' E' E ' 25' ' ' LYS . . . . . . . . . . . . . 64.1 mttm -75.22 -40.66 58.91 Favored 'General case' 0 C--N 1.33 -0.267 0 N-CA-C 112.349 0.5 . . . . 0.0 112.349 -178.855 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' E' E ' 26' ' ' LEU . . . . . . . . . . . . . 75.9 mt -80.22 -25.64 39.52 Favored 'General case' 0 C--N 1.331 -0.201 0 N-CA-C 113.195 0.813 . . . . 0.0 113.195 -171.112 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' E' E ' 27' ' ' GLN . . . . . . . . . . . . . 4.2 pt20 -46.38 136.67 7.1 Favored 'General case' 0 N--CA 1.469 0.495 0 N-CA-C 112.594 0.59 . . . . 0.0 112.594 -177.368 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' E' E ' 28' ' ' GLY . . . . . . . . . . . . . . . 99.8 -21.06 46.67 Favored Glycine 0 CA--C 1.535 1.305 0 CA-C-N 115.824 -0.626 . . . . 0.0 112.661 -177.162 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' E' E ' 29' ' ' LYS . . . . . . . . . . . . . 61.1 mttp -97.02 155.14 16.91 Favored 'General case' 0 C--O 1.233 0.218 0 CA-C-N 117.471 0.636 . . . . 0.0 110.935 179.492 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' E' E ' 30' ' ' THR . . . . . . . . . . . . . 28.5 m -108.65 137.45 46.57 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.042 -0.526 . . . . 0.0 110.031 176.748 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' E' E ' 31' ' ' VAL . . . . . . . . . . . . . 35.3 m -130.35 152.77 37.98 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.223 0 CA-C-O 120.919 0.39 . . . . 0.0 110.778 -178.751 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' E' E ' 32' ' ' ARG . . . . . . . . . . . . . 37.9 ttm180 -133.23 148.23 51.99 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-O 121.246 0.546 . . . . 0.0 110.398 179.568 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' E' E ' 33' ' ' THR . . . . . . . . . . . . . 16.4 m -52.11 139.33 23.49 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.244 -0.434 . . . . 0.0 111.624 -177.145 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' E' E ' 34' ' ' GLY . . . . . . . . . . . . . . . 101.03 -17.24 56.45 Favored Glycine 0 CA--C 1.534 1.235 0 CA-C-O 119.667 -0.519 . . . . 0.0 113.201 179.051 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' E' E ' 35' ' ' ASP . . . . . . . . . . . . . 79.2 m-20 -66.78 147.3 53.43 Favored 'General case' 0 N--CA 1.462 0.163 0 CA-C-N 118.026 0.913 . . . . 0.0 111.229 179.25 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' E' E ' 36' ' ' VAL . . . . . . . . . . . . . 45.8 t -122.51 129.1 75.49 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.204 0 CA-C-N 115.779 -0.646 . . . . 0.0 109.737 177.802 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' E' E ' 37' ' ' ILE . . . . . . . . . . . . . 63.2 mt -123.16 139.23 50.53 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.256 0 CA-C-N 116.286 -0.416 . . . . 0.0 109.953 -179.011 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' E' E ' 38' ' ' GLY . . . . . . . . . . . . . . . -115.46 128.65 8.16 Favored Glycine 0 CA--C 1.524 0.605 0 N-CA-C 110.982 -0.847 . . . . 0.0 110.982 178.661 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' E' E ' 39' ' ' ILE . . . . . . . . . . . . . 68.7 mt -126.98 125.71 67.05 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.271 0 N-CA-C 110.019 -0.363 . . . . 0.0 110.019 179.501 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' E' E ' 40' ' ' SER . . . . . . . . . . . . . 24.0 t -91.99 118.66 30.99 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.388 -0.369 . . . . 0.0 110.794 176.545 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' E' E ' 41' ' ' ILE . . . . . . . . . . . . . 70.9 mt -130.35 131.05 65.63 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.227 0 CA-C-O 120.927 0.394 . . . . 0.0 110.299 179.283 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' E' E ' 42' ' ' LEU . . . . . . . . . . . . . 47.3 mt 54.94 33.47 20.15 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-N 116.039 -0.528 . . . . 0.0 111.817 177.954 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' E' E ' 43' ' ' GLY . . . . . . . . . . . . . . . 71.77 28.99 68.03 Favored Glycine 0 CA--C 1.53 0.983 0 C-N-CA 121.075 -0.583 . . . . 0.0 112.299 178.094 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' E' E ' 44' ' ' LYS . . . . . . . . . . . . . 20.0 tptm -142.43 125.92 16.75 Favored 'General case' 0 C--N 1.331 -0.205 0 N-CA-C 109.748 -0.464 . . . . 0.0 109.748 178.46 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' E' E ' 45' ' ' GLU . . . . . . . . . . . . . 41.0 tp10 -85.21 128.6 34.74 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-O 120.843 0.354 . . . . 0.0 111.589 -177.413 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' E' E ' 46' ' ' VAL . . . . . . . . . . . . . 8.9 p -120.15 127.74 75.92 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.188 0 N-CA-C 109.525 -0.546 . . . . 0.0 109.525 174.261 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' E' E ' 47' ' ' LYS . . . . . . . . . . . . . 52.7 mtpt -98.55 124.41 43.28 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.035 -0.529 . . . . 0.0 110.792 178.01 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' E' E ' 48' ' ' PHE . . . . . . . . . . . . . 37.6 m-85 -109.27 131.82 54.7 Favored 'General case' 0 C--N 1.33 -0.265 0 N-CA-C 109.782 -0.451 . . . . 0.0 109.782 178.069 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' E' E ' 49' ' ' LYS . . . . . . . . . . . . . 76.8 tttt -108.63 132.58 53.75 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.417 -0.356 . . . . 0.0 110.344 178.009 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' E' E ' 50' ' ' VAL . . . . . . . . . . . . . 45.6 t -76.29 105.07 4.83 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.367 0 N-CA-C 109.249 -0.649 . . . . 0.0 109.249 176.087 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' E' E ' 51' ' ' VAL . . . . . . . . . . . . . 47.0 t -68.64 -53.92 24.32 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.351 0 N-CA-C 109.401 -0.592 . . . . 0.0 109.401 -175.64 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' E' E ' 52' ' ' GLN . . . . . . . . . . . . . 80.8 mt-30 -155.7 154.61 31.78 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 115.967 -0.561 . . . . 0.0 111.584 -178.163 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' E' E ' 53' ' ' ALA . . . . . . . . . . . . . . . -130.9 132.17 44.97 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 115.371 -0.831 . . . . 0.0 109.667 174.91 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' E' E ' 54' ' ' TYR . . . . . . . . . . . . . 39.7 t80 -129.07 108.92 18.1 Favored Pre-proline 0 CA--C 1.534 0.353 0 CA-C-O 118.273 -0.87 . . . . 0.0 110.421 179.892 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' E' E ' 55' ' ' PRO . . . . . . . . . . . . . 73.2 Cg_endo -77.21 169.89 72.94 Favored 'Cis proline' 0 N--CA 1.5 1.866 0 CA-C-N 121.84 1.693 . . . . 0.0 112.32 -6.428 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' E' E ' 56' ' ' SER . . . . . . . . . . . . . 13.6 m -117.22 134.71 23.03 Favored Pre-proline 0 CA--C 1.539 0.528 0 CA-C-O 118.401 -0.809 . . . . 0.0 109.45 174.031 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' E' E ' 57' ' ' PRO . . . . . . . . . . . . . 50.8 Cg_endo -70.07 146.79 83.81 Favored 'Cis proline' 0 N--CA 1.496 1.672 0 CA-C-N 121.85 1.696 . . . . 0.0 111.519 -1.379 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' E' E ' 58' ' ' LEU . . . . . . . . . . . . . 33.6 tp -107.89 138.76 43.57 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-O 120.87 0.367 . . . . 0.0 110.689 -177.838 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' E' E ' 59' ' ' ARG . . . . . . . . . . . . . 72.7 ttt180 -102.66 131.59 49.34 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 115.813 -0.63 . . . . 0.0 109.679 176.952 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' E' E ' 60' ' ' VAL . . . . . . . . . . . . . 41.7 t -86.29 118.65 33.08 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.213 0 C-N-CA 120.775 -0.37 . . . . 0.0 110.602 -177.167 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' E' E ' 61' ' ' GLU . . . . . . . . . . . . . 96.6 mt-10 -131.11 158.17 41.13 Favored 'General case' 0 C--N 1.331 -0.229 0 CA-C-N 115.874 -0.603 . . . . 0.0 109.748 177.302 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' E' E ' 62' ' ' ASP . . . . . . . . . . . . . 48.5 m-20 -52.44 -32.94 41.92 Favored 'General case' 0 C--N 1.329 -0.324 0 N-CA-C 111.816 0.302 . . . . 0.0 111.816 -178.663 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' E' E ' 63' ' ' ARG . . . . . . . . . . . . . 75.5 mtp180 -78.91 -19.96 50.53 Favored 'General case' 0 CA--C 1.533 0.301 0 N-CA-C 113.153 0.797 . . . . 0.0 113.153 -176.258 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' E' E ' 64' ' ' THR . . . . . . . . . . . . . 24.9 m -66.34 149.2 50.74 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-O 120.993 0.425 . . . . 0.0 111.117 -174.739 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' E' E ' 65' ' ' LYS . . . . . . . . . . . . . 24.6 mtpp -89.67 127.26 35.9 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 115.964 -0.562 . . . . 0.0 110.651 179.997 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' E' E ' 66' ' ' ILE . . . . . . . . . . . . . 64.1 mt -117.64 128.52 74.84 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.272 0 N-CA-C 109.842 -0.429 . . . . 0.0 109.842 177.476 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' E' E ' 67' ' ' THR . . . . . . . . . . . . . 28.8 m -120.56 137.76 54.23 Favored 'General case' 0 C--N 1.331 -0.229 0 CA-C-O 121.123 0.487 . . . . 0.0 110.928 -178.587 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' E' E ' 68' ' ' LEU . . . . . . . . . . . . . 13.3 tp -106.03 122.37 46.01 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 115.706 -0.679 . . . . 0.0 110.254 178.44 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' E' E ' 69' ' ' VAL . . . . . . . . . . . . . 43.4 t -99.6 123.84 52.6 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.271 0 CA-C-N 116.219 -0.446 . . . . 0.0 109.922 179.881 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' E' E ' 70' ' ' THR . . . . . . . . . . . . . 8.8 t -96.11 -42.28 8.31 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.185 -0.461 . . . . 0.0 110.764 -179.552 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' E' E ' 71' ' ' HIS . . . . . . . . . . . . . 92.4 m-70 -149.96 156.78 38.15 Favored Pre-proline 0 C--N 1.328 -0.336 0 CA-C-O 119.519 -0.276 . . . . 0.0 110.653 178.936 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' E' E ' 72' ' ' PRO . . . . . . . . . . . . . 16.6 Cg_exo -65.02 -26.24 58.53 Favored 'Trans proline' 0 N--CA 1.497 1.679 0 C-N-CA 121.258 1.306 . . . . 0.0 112.447 176.264 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' E' E ' 73' ' ' VAL . . . . . . . . . . . . . 35.2 m -123.15 170.62 13.21 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.198 0 CA-C-O 120.709 0.29 . . . . 0.0 110.466 -178.664 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' E' E ' 74' ' ' ASP . . . . . . . . . . . . . 10.8 t70 -98.04 118.04 33.74 Favored 'General case' 0 C--N 1.33 -0.274 0 N-CA-C 109.935 -0.394 . . . . 0.0 109.935 -178.471 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' E' E ' 75' ' ' VAL . . . . . . . . . . . . . 42.0 t -112.32 122.65 66.97 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.2 0 CA-C-O 121.09 0.471 . . . . 0.0 110.369 -178.31 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' E' E ' 76' ' ' LEU . . . . . . . . . . . . . 29.9 mt -122.79 137.62 54.87 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 115.63 -0.713 . . . . 0.0 109.432 178.398 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' E' E ' 77' ' ' GLU . . . . . . . . . . . . . 96.4 mt-10 -133.27 140.3 47.39 Favored 'General case' 0 C--N 1.331 -0.217 0 CA-C-O 121.035 0.445 . . . . 0.0 111.301 -177.29 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' E' E ' 78' ' ' ALA . . . . . . . . . . . . . . . -130.12 129.62 43.76 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 115.678 -0.692 . . . . 0.0 109.957 176.377 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' E' E ' 79' ' ' LYS . . . . . . . . . . . . . 32.7 mmtp -75.24 119.09 18.9 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-O 120.949 0.404 . . . . 0.0 110.58 -179.428 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' E' E ' 80' ' ' ILE . . . . . . . . . . . . . 22.7 mm -139.25 112.53 6.36 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.269 0 N-CA-C 108.947 -0.76 . . . . 0.0 108.947 -178.578 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' E' E ' 81' ' ' LYS . . . . . . . . . . . . . 40.6 mttp -99.72 126.75 45.82 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-O 120.875 0.369 . . . . 0.0 111.293 -176.07 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' E' E ' 82' ' ' GLY . . . . . . . . . . . . . . . 89.11 42.21 5.66 Favored Glycine 0 CA--C 1.526 0.744 0 C-N-CA 120.989 -0.624 . . . . 0.0 111.892 174.119 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' E' E ' 83' ' ' ILE . . . . . . . . . . . . . 69.8 mt -67.93 137.99 23.5 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.34 0 N-CA-C 109.793 -0.447 . . . . 0.0 109.793 177.099 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' E' E ' 84' ' ' LYS . . . . . . . . . . . . . 70.4 tttt -100.24 -53.63 3.08 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.165 -0.471 . . . . 0.0 110.226 -178.58 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' E' E ' 85' ' ' ASP . . . . . . . . . . . . . 8.5 t70 -151.23 148.45 28.23 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 115.837 -0.619 . . . . 0.0 110.387 -178.985 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' E' E ' 86' ' ' VAL . . . . . . . . . . . . . 43.7 t -129.47 129.42 66.93 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.269 0 CA-C-O 120.928 0.394 . . . . 0.0 110.377 -179.648 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' E' E ' 87' ' ' ILE . . . . . . . . . . . . . 4.6 mp -122.19 134.28 65.93 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.255 0 CA-C-N 115.972 -0.558 . . . . 0.0 109.709 178.593 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' E' E ' 88' ' ' LEU . . . . . . . . . . . . . 10.2 tp -111.59 134.89 52.85 Favored 'General case' 0 C--N 1.331 -0.205 0 CA-C-O 121.105 0.479 . . . . 0.0 111.059 -178.206 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' E' E ' 89' ' ' ASP . . . . . . . . . . . . . 4.7 t70 -121.53 159.12 27.01 Favored 'General case' 0 C--N 1.331 -0.205 0 CA-C-N 115.651 -0.704 . . . . 0.0 109.634 177.515 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' E' E ' 90' ' ' GLU . . . . . . . . . . . . . 84.3 tt0 -44.97 -44.37 9.8 Favored 'General case' 0 N--CA 1.465 0.301 0 N-CA-C 113.094 0.775 . . . . 0.0 113.094 -172.224 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' E' E ' 91' ' ' ASN . . . . . . . . . . . . . 23.8 m120 -132.02 26.34 4.59 Favored 'General case' 0 N--CA 1.467 0.419 0 N-CA-C 112.401 0.519 . . . . 0.0 112.401 -179.427 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' E' E ' 92' ' ' LEU . . . . . . . . . . . . . 12.8 mt -149.24 151.88 35.02 Favored 'General case' 0 C--N 1.333 -0.143 0 N-CA-C 110.105 -0.332 . . . . 0.0 110.105 -176.159 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' E' E ' 93' ' ' ILE . . . . . . . . . . . . . 72.2 mt -127.71 121.98 57.93 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.28 0 N-CA-C 109.349 -0.612 . . . . 0.0 109.349 177.812 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' E' E ' 94' ' ' VAL . . . . . . . . . . . . . 44.6 t -118.07 128.1 75.19 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.294 0 CA-C-O 120.813 0.34 . . . . 0.0 110.119 -178.343 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' E' E ' 95' ' ' VAL . . . . . . . . . . . . . 43.6 t -122.19 135.11 63.37 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.381 0 CA-C-N 115.986 -0.552 . . . . 0.0 109.996 -179.238 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' E' E ' 96' ' ' ILE . . . . . . . . . . . . . 62.2 mt -115.3 128.04 72.65 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.346 0 N-CA-C 109.241 -0.652 . . . . 0.0 109.241 178.392 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' E' E ' 97' ' ' THR . . . . . . . . . . . . . 66.5 p -101.32 155.74 17.86 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-O 121.056 0.455 . . . . 0.0 111.04 -177.521 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' E' E ' 98' ' ' GLU . . . . . . . . . . . . . 97.1 mt-10 -53.91 -26.22 24.08 Favored 'General case' 0 CA--C 1.532 0.265 0 N-CA-C 112.194 0.442 . . . . 0.0 112.194 179.874 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' E' E ' 99' ' ' GLU . . . . . . . . . . . . . 97.0 mt-10 -78.86 15.53 1.06 Allowed 'General case' 0 CA--C 1.535 0.37 0 N-CA-C 113.167 0.803 . . . . 0.0 113.167 -177.383 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' E' E ' 100' ' ' ASN . . . . . . . . . . . . . 3.6 m-20 61.54 37.41 16.4 Favored 'General case' 0 CA--C 1.529 0.17 0 CA-C-O 120.974 0.416 . . . . 0.0 111.124 178.728 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' E' E ' 101' ' ' GLU . . . . . . . . . . . . . 80.9 tt0 -115.23 145.45 42.41 Favored 'General case' 0 C--N 1.332 -0.173 0 CA-C-N 115.951 -0.568 . . . . 0.0 109.616 175.803 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' E' E ' 102' ' ' VAL . . . . . . . . . . . . . 43.4 t -115.59 125.98 72.97 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.335 0 CA-C-N 116.318 -0.401 . . . . 0.0 110.143 -177.043 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' E' E ' 103' ' ' LEU . . . . . . . . . . . . . 23.4 mt -117.92 130.5 56.26 Favored 'General case' 0 C--N 1.331 -0.226 0 CA-C-N 115.888 -0.596 . . . . 0.0 110.15 177.747 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' E' E ' 104' ' ' ILE . . . . . . . . . . . . . 68.8 mt -119.9 120.85 64.45 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.189 0 CA-C-O 120.646 0.26 . . . . 0.0 110.308 179.02 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' E' E ' 105' ' ' PHE . . . . . . . . . . . . . 55.6 m-85 -119.86 166.5 13.21 Favored 'General case' 0 C--N 1.332 -0.18 0 CA-C-N 115.352 -0.84 . . . . 0.0 109.796 178.618 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' E' E ' 106' ' ' ASN . . . . . . . . . . . . . 47.1 p-10 -97.87 -169.94 1.91 Allowed 'General case' 0 C--N 1.331 -0.231 0 N-CA-C 109.708 -0.478 . . . . 0.0 109.708 172.972 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' E' E ' 107' ' ' GLN . . . . . . . . . . . . . 39.0 tp60 -60.89 -28.17 68.69 Favored 'General case' 0 CA--C 1.533 0.295 0 N-CA-C 112.012 0.375 . . . . 0.0 112.012 179.564 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' E' E ' 108' ' ' ASN . . . . . . . . . . . . . 15.6 t-20 -82.94 9.43 10.07 Favored 'General case' 0 CA--C 1.536 0.42 0 N-CA-C 112.94 0.718 . . . . 0.0 112.94 -179.125 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' E' E ' 109' ' ' LEU . . . . . . . . . . . . . 9.4 tp 57.78 36.92 26.94 Favored 'General case' 0 C--O 1.232 0.164 0 CA-C-O 120.877 0.37 . . . . 0.0 111.278 179.973 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' E' E ' 110' ' ' GLU . . . . . . . . . . . . . 96.6 mt-10 -102.14 150.07 23.64 Favored 'General case' 0 C--N 1.331 -0.23 0 N-CA-C 109.788 -0.449 . . . . 0.0 109.788 176.364 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' E' E ' 111' ' ' GLU . . . . . . . . . . . . . 68.0 tt0 -83.24 121.93 27.75 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 116.47 -0.332 . . . . 0.0 110.846 -176.509 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' E' E ' 112' ' ' LEU . . . . . . . . . . . . . 13.4 mt -110.47 -45.99 3.46 Favored 'General case' 0 C--N 1.332 -0.182 0 CA-C-N 116.228 -0.442 . . . . 0.0 110.553 179.685 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' E' E ' 113' ' ' TYR . . . . . . . . . . . . . 57.3 t80 -135.77 133.74 38.26 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.341 -0.391 . . . . 0.0 110.936 -178.346 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' E' E ' 114' ' ' ARG . . . . . . . . . . . . . 76.7 ttt180 -134.57 120.18 19.32 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.14 -0.482 . . . . 0.0 110.054 176.938 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' E' E ' 115' ' ' GLY . . . . . . . . . . . . . . . -148.32 162.46 28.82 Favored Glycine 0 CA--C 1.524 0.635 0 N-CA-C 110.694 -0.962 . . . . 0.0 110.694 -179.773 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' E' E ' 116' ' ' LYS . . . . . . . . . . . . . 33.6 ttmt -136.81 139.09 41.5 Favored 'General case' 0 C--N 1.327 -0.371 0 N-CA-C 110.224 -0.287 . . . . 0.0 110.224 -179.623 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' E' E ' 117' ' ' PHE . . . . . . . . . . . . . 32.9 m-85 -137.51 113.94 10.21 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-O 121.047 0.451 . . . . 0.0 110.272 -176.487 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' E' E ' 118' ' ' GLU . . . . . . . . . . . . . 96.5 mt-10 -53.59 -45.6 70.07 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.142 -0.481 . . . . 0.0 111.514 -176.425 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' E' E ' 119' ' ' ASN . . . . . . . . . . . . . 32.7 m120 -96.55 30.93 2.41 Favored 'General case' 0 C--N 1.329 -0.299 0 N-CA-C 112.306 0.484 . . . . 0.0 112.306 -174.316 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' E' E ' 120' ' ' LEU . . . . . . . . . . . . . 12.9 tp -56.24 122.94 12.94 Favored 'General case' 0 C--N 1.332 -0.191 0 C-N-CA 121.139 -0.224 . . . . 0.0 110.559 177.645 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' E' E ' 121' ' ' ASN . . . . . . . . . . . . . 44.7 t30 -114.07 -44.01 3.19 Favored 'General case' 0 C--N 1.333 -0.131 0 CA-C-N 116.684 -0.235 . . . . 0.0 111.559 -176.641 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' E' E ' 122' ' ' LYS . . . . . . . . . . . . . 33.6 ttpt -149.1 149.16 30.61 Favored 'General case' 0 C--N 1.332 -0.158 0 CA-C-O 121.077 0.465 . . . . 0.0 111.431 -174.647 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' E' E ' 123' ' ' VAL . . . . . . . . . . . . . 45.7 t -126.52 136.49 60.67 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.265 0 CA-C-N 116.11 -0.495 . . . . 0.0 109.935 179.126 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' E' E ' 124' ' ' LEU . . . . . . . . . . . . . 57.3 mt -129.86 138.32 50.91 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-O 120.714 0.292 . . . . 0.0 110.655 -178.926 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' E' E ' 125' ' ' VAL . . . . . . . . . . . . . 35.7 m -135.9 143.67 35.58 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.269 0 CA-C-N 116.341 -0.391 . . . . 0.0 110.644 178.509 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' E' E ' 126' ' ' ARG . . . . . . . . . . . . . 67.6 ttt180 -162.02 122.09 2.51 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 116.128 -0.487 . . . . 0.0 110.103 177.921 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' E' E ' 127' ' ' ASN . . . . . . . . . . . . . 3.7 t-20 56.02 -149.58 0.45 Allowed 'General case' 0 CA--C 1.54 0.591 0 N-CA-C 109.973 -0.38 . . . . 0.0 109.973 179.822 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' E' E ' 128' ' ' ASP . . . . . . . . . . . . . 14.2 p-10 -80.01 13.54 2.21 Favored 'General case' 0 CA--C 1.536 0.441 0 N-CA-C 112.879 0.696 . . . . 0.0 112.879 -179.792 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' E' E ' 129' ' ' LEU . . . . . . . . . . . . . 39.6 mt -110.82 138.58 47.03 Favored 'General case' 0 C--O 1.231 0.129 0 CA-C-N 118.143 0.429 . . . . 0.0 109.981 178.053 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' E' E ' 130' ' ' VAL . . . . . . . . . . . . . 30.6 m -132.63 140.76 46.78 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.185 0 CA-C-O 120.957 0.408 . . . . 0.0 110.377 178.478 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' E' E ' 131' ' ' VAL . . . . . . . . . . . . . 39.7 t -136.06 139.31 46.02 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.256 0 CA-C-O 121.166 0.507 . . . . 0.0 110.392 -178.419 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' E' E ' 132' ' ' ILE . . . . . . . . . . . . . 68.1 mt -116.63 130.95 70.62 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.325 0 CA-C-N 115.552 -0.749 . . . . 0.0 109.379 179.932 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' E' E ' 133' ' ' ILE . . . . . . . . . . . . . 41.8 mm -114.47 119.12 60.59 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.214 0 CA-C-O 121.026 0.441 . . . . 0.0 110.797 -176.07 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' E' E ' 134' ' ' ASP . . . . . . . . . . . . . 7.0 p-10 -128.18 147.44 50.57 Favored 'General case' 0 C--N 1.33 -0.259 0 N-CA-C 109.649 -0.5 . . . . 0.0 109.649 175.684 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' E' E ' 135' ' ' GLU . . . . . . . . . . . . . 85.6 tt0 -49.81 -24.21 2.28 Favored 'General case' 0 C--N 1.327 -0.371 0 N-CA-C 112.971 0.73 . . . . 0.0 112.971 -171.084 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' E' E ' 136' ' ' GLN . . . . . . . . . . . . . 63.0 tt0 -100.03 -31.16 11.58 Favored 'General case' 0 CA--C 1.529 0.165 0 N-CA-C 112.145 0.424 . . . . 0.0 112.145 -175.318 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' E' E ' 137' ' ' LYS . . . . . . . . . . . . . 74.5 mttt -142.23 155.52 45.26 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-O 121.384 0.612 . . . . 0.0 111.818 -169.66 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' E' E ' 138' ' ' LEU . . . . . . . . . . . . . 4.4 tt -116.47 120.98 40.51 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 115.323 -0.853 . . . . 0.0 109.054 171.772 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' E' E ' 139' ' ' THR . . . . . . . . . . . . . 26.3 m -108.39 126.39 52.82 Favored 'General case' 0 C--N 1.331 -0.204 0 CA-C-N 116.381 -0.372 . . . . 0.0 110.974 -176.764 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' E' E ' 140' ' ' LEU . . . . . . . . . . . . . 15.4 tp -112.34 122.43 47.71 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 115.486 -0.779 . . . . 0.0 109.418 -179.618 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' E' E ' 141' ' ' ILE . . . . . . . . . . . . . 19.2 mt -123.14 121.36 62.83 Favored 'Isoleucine or valine' 0 C--O 1.234 0.259 0 N-CA-C 109.778 -0.452 . . . . 0.0 109.778 -177.339 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' E' E ' 142' ' ' ARG . . . . . . . . . . . . . 29.2 ttp180 -118.68 127.06 53.22 Favored 'General case' 0 C--N 1.331 -0.22 0 CA-C-N 115.437 -0.801 . . . . 0.0 110.276 -177.7 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' E' E ' 143' ' ' THR . . . . . . . . . . . . . 72.9 p . . . . . 0 C--O 1.221 -0.432 0 CA-C-O 118.108 -0.948 . . . . 0.0 110.677 -179.265 . . . . . . . . 0 0 . 1 . 009 nuclear orig full ' F' F ' -3' ' ' GLU . . . . . . . . . . . . . 95.8 mt-10 . . . . . 0 N--CA 1.49 1.567 0 N-CA-C 109.291 -0.633 . . . . 0.0 109.291 . . . . . . . . . 0 0 . 1 . 009 nuclear orig full ' F' F ' -2' ' ' GLY . . . . . . . . . . . . . . . -66.72 149.09 51.13 Favored Glycine 0 CA--C 1.525 0.705 0 N-CA-C 111.221 -0.751 . . . . 0.0 111.221 -179.096 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' F' F ' -1' ' ' VAL . . . . . . . . . . . . . 44.5 t -96.3 134.79 32.58 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.367 0 N-CA-C 110.123 -0.325 . . . . 0.0 110.123 179.616 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' F' F ' 0' ' ' ILE . . . . . . . . . . . . . 69.1 mt -116.59 137.96 48.72 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.251 0 CA-C-N 116.29 -0.413 . . . . 0.0 110.095 -179.576 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' F' F ' 1' ' ' MET . . . . . . . . . . . . . 26.2 ptt? -89.35 134.06 34.23 Favored 'General case' 0 C--N 1.331 -0.211 0 CA-C-N 116.151 -0.477 . . . . 0.0 110.7 179.768 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' F' F ' 2' ' ' SER . . . . . . . . . . . . . 9.1 p -126.83 147.62 50.01 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-N 116.261 -0.427 . . . . 0.0 110.684 179.985 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' F' F ' 3' ' ' GLU . . . . . . . . . . . . . 81.9 tt0 -140.78 140.13 34.71 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.068 -0.515 . . . . 0.0 111.132 -178.424 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' F' F ' 4' ' ' LEU . . . . . . . . . . . . . 18.1 tp -122.1 131.11 53.8 Favored 'General case' 0 C--N 1.332 -0.185 0 CA-C-N 115.971 -0.559 . . . . 0.0 109.907 176.418 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' F' F ' 5' ' ' LYS . . . . . . . . . . . . . 64.1 mttp -109.72 121.14 44.54 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.238 -0.437 . . . . 0.0 110.576 -179.041 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' F' F ' 6' ' ' LEU . . . . . . . . . . . . . 63.0 mt -114.0 149.33 35.51 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 115.467 -0.788 . . . . 0.0 110.811 -177.878 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' F' F ' 7' ' ' LYS . . . . . . . . . . . . . 29.6 ttpt -135.0 134.87 22.07 Favored Pre-proline 0 CA--C 1.534 0.357 0 CA-C-O 118.929 -0.558 . . . . 0.0 109.728 176.72 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' F' F ' 8' ' ' PRO . . . . . . . . . . . . . 97.1 Cg_endo -91.05 131.2 1.46 Allowed 'Trans proline' 0 N--CA 1.49 1.265 0 C-N-CA 121.73 1.62 . . . . 0.0 111.396 175.331 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' F' F ' 9' ' ' LEU . . . . . . . . . . . . . 27.9 mt -68.63 -46.84 35.11 Favored Pre-proline 0 CA--C 1.532 0.28 0 CA-C-O 118.791 -0.623 . . . . 0.0 111.509 -177.067 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' F' F ' 10' ' ' PRO . . . . . . . . . . . . . 98.4 Cg_endo -80.71 140.96 13.37 Favored 'Trans proline' 0 N--CA 1.496 1.643 0 C-N-CA 121.012 1.141 . . . . 0.0 111.25 171.542 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' F' F ' 11' ' ' LYS . . . . . . . . . . . . . 54.0 tttp -84.82 106.47 16.38 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-O 120.86 0.362 . . . . 0.0 110.586 -179.433 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' F' F ' 12' ' ' VAL . . . . . . . . . . . . . 12.2 p -142.98 148.72 19.23 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.344 0 CA-C-N 116.101 -0.5 . . . . 0.0 110.497 -179.758 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' F' F ' 13' ' ' GLU . . . . . . . . . . . . . 43.8 tp10 -82.18 117.07 22.04 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.211 -0.449 . . . . 0.0 109.984 177.74 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' F' F ' 14' ' ' LEU . . . . . . . . . . . . . 32.3 mt -89.61 149.79 43.0 Favored Pre-proline 0 C--N 1.33 -0.263 0 CA-C-O 119.326 -0.369 . . . . 0.0 110.618 -177.62 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' F' F ' 15' ' ' PRO . . . . . . . . . . . . . 26.0 Cg_exo -61.67 159.12 33.94 Favored 'Trans proline' 0 N--CA 1.496 1.631 0 C-N-CA 121.186 1.257 . . . . 0.0 111.627 176.756 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' F' F ' 16' ' ' PRO . . . . . . . . . . . . . 38.5 Cg_exo -58.52 -36.17 97.73 Favored 'Trans proline' 0 N--CA 1.497 1.712 0 C-N-CA 121.386 1.391 . . . . 0.0 112.931 -177.499 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' F' F ' 17' ' ' ASP . . . . . . . . . . . . . 7.2 p-10 -90.77 8.42 34.76 Favored 'General case' 0 CA--C 1.535 0.372 0 N-CA-C 113.393 0.886 . . . . 0.0 113.393 -176.867 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' F' F ' 18' ' ' PHE . . . . . . . . . . . . . 34.9 t80 -58.42 -45.45 88.42 Favored 'General case' 0 C--O 1.231 0.102 0 O-C-N 121.983 -0.448 . . . . 0.0 110.018 -178.187 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' F' F ' 19' ' ' VAL . . . . . . . . . . . . . 13.2 p -57.22 -40.66 75.04 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.372 0 CA-C-N 116.156 -0.475 . . . . 0.0 110.571 179.939 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' F' F ' 20' ' ' ASP . . . . . . . . . . . . . 65.8 m-20 -60.02 -43.12 95.48 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-O 120.798 0.333 . . . . 0.0 110.84 -178.013 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' F' F ' 21' ' ' VAL . . . . . . . . . . . . . 46.6 t -64.06 -47.33 90.76 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.284 0 CA-C-N 116.398 -0.365 . . . . 0.0 110.377 -178.183 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' F' F ' 22' ' ' ILE . . . . . . . . . . . . . 49.9 mm -57.73 -39.24 69.43 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.353 0 CA-C-O 120.793 0.33 . . . . 0.0 110.896 -179.941 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' F' F ' 23' ' ' ARG . . . . . . . . . . . . . 54.6 ttp180 -57.13 -50.55 72.45 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-O 120.904 0.383 . . . . 0.0 110.562 177.243 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' F' F ' 24' ' ' ILE . . . . . . . . . . . . . 72.8 mt -61.0 -40.1 84.44 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.287 0 CA-C-N 115.986 -0.552 . . . . 0.0 111.968 -176.979 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' F' F ' 25' ' ' LYS . . . . . . . . . . . . . 13.8 pttp -75.48 -35.18 60.9 Favored 'General case' 0 CA--C 1.534 0.348 0 C-N-CA 120.671 -0.412 . . . . 0.0 112.046 -174.03 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' F' F ' 26' ' ' LEU . . . . . . . . . . . . . 34.3 mt -80.32 -41.42 24.89 Favored 'General case' 0 C--N 1.33 -0.256 0 N-CA-C 112.841 0.682 . . . . 0.0 112.841 -174.762 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' F' F ' 27' ' ' GLN . . . . . . . . . . . . . 9.0 pt20 -46.3 139.63 4.63 Favored 'General case' 0 N--CA 1.467 0.392 0 N-CA-C 113.006 0.743 . . . . 0.0 113.006 -174.551 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' F' F ' 28' ' ' GLY . . . . . . . . . . . . . . . 99.61 -25.85 26.66 Favored Glycine 0 CA--C 1.534 1.243 0 CA-C-N 115.539 -0.755 . . . . 0.0 112.199 -175.362 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' F' F ' 29' ' ' LYS . . . . . . . . . . . . . 25.7 mtpp -98.43 155.18 17.37 Favored 'General case' 0 C--N 1.333 -0.146 0 CA-C-N 117.18 0.49 . . . . 0.0 111.167 179.648 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' F' F ' 30' ' ' THR . . . . . . . . . . . . . 29.8 m -101.17 137.73 39.14 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.036 -0.529 . . . . 0.0 109.96 175.657 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' F' F ' 31' ' ' VAL . . . . . . . . . . . . . 35.3 m -129.26 154.24 39.82 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.254 0 CA-C-O 120.94 0.4 . . . . 0.0 110.742 -179.754 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' F' F ' 32' ' ' ARG . . . . . . . . . . . . . 80.8 mtm180 -132.53 148.29 52.38 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 115.849 -0.614 . . . . 0.0 110.335 178.395 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' F' F ' 33' ' ' THR . . . . . . . . . . . . . 25.3 m -52.79 138.01 30.33 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.344 -0.389 . . . . 0.0 111.418 -178.688 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' F' F ' 34' ' ' GLY . . . . . . . . . . . . . . . 101.64 -17.14 55.56 Favored Glycine 0 CA--C 1.532 1.155 0 CA-C-O 119.697 -0.501 . . . . 0.0 113.28 179.369 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' F' F ' 35' ' ' ASP . . . . . . . . . . . . . 73.3 m-20 -65.84 149.17 50.61 Favored 'General case' 0 C--O 1.232 0.136 0 CA-C-N 117.981 0.89 . . . . 0.0 110.952 179.23 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' F' F ' 36' ' ' VAL . . . . . . . . . . . . . 45.8 t -126.0 131.61 71.54 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.289 0 CA-C-N 116.049 -0.523 . . . . 0.0 109.854 178.302 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' F' F ' 37' ' ' ILE . . . . . . . . . . . . . 65.2 mt -121.06 139.15 49.18 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.233 0 CA-C-N 116.162 -0.472 . . . . 0.0 109.891 -178.995 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' F' F ' 38' ' ' GLY . . . . . . . . . . . . . . . -110.36 128.8 9.0 Favored Glycine 0 CA--C 1.525 0.662 0 N-CA-C 111.059 -0.816 . . . . 0.0 111.059 179.916 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' F' F ' 39' ' ' ILE . . . . . . . . . . . . . 73.7 mt -123.9 133.68 68.59 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.185 0 N-CA-C 110.049 -0.352 . . . . 0.0 110.049 179.347 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' F' F ' 40' ' ' SER . . . . . . . . . . . . . 99.8 p -93.23 123.66 36.66 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.398 -0.364 . . . . 0.0 111.0 176.298 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' F' F ' 41' ' ' ILE . . . . . . . . . . . . . 70.9 mt -131.21 120.69 47.28 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.209 0 CA-C-O 120.918 0.39 . . . . 0.0 110.345 177.869 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' F' F ' 42' ' ' LEU . . . . . . . . . . . . . 48.9 mt 52.76 35.45 18.64 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.011 -0.54 . . . . 0.0 111.699 177.166 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' F' F ' 43' ' ' GLY . . . . . . . . . . . . . . . 72.31 31.48 63.55 Favored Glycine 0 CA--C 1.53 1.027 0 C-N-CA 121.139 -0.553 . . . . 0.0 112.142 178.064 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' F' F ' 44' ' ' LYS . . . . . . . . . . . . . 58.8 mtpt -135.91 131.49 35.28 Favored 'General case' 0 C--N 1.33 -0.278 0 N-CA-C 109.714 -0.476 . . . . 0.0 109.714 177.783 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' F' F ' 45' ' ' GLU . . . . . . . . . . . . . 83.8 tt0 -83.6 119.39 24.68 Favored 'General case' 0 C--N 1.328 -0.343 0 C-N-CA 120.844 -0.342 . . . . 0.0 111.219 -178.631 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' F' F ' 46' ' ' VAL . . . . . . . . . . . . . 7.7 p -118.66 122.75 70.21 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.198 0 N-CA-C 109.195 -0.669 . . . . 0.0 109.195 174.824 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' F' F ' 47' ' ' LYS . . . . . . . . . . . . . 55.5 mtmt -100.22 128.64 46.25 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 115.999 -0.546 . . . . 0.0 111.303 -179.815 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' F' F ' 48' ' ' PHE . . . . . . . . . . . . . 93.6 m-85 -110.55 131.92 54.64 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-N 116.099 -0.501 . . . . 0.0 109.872 177.529 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' F' F ' 49' ' ' LYS . . . . . . . . . . . . . 84.3 tttt -107.77 137.09 46.4 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.281 -0.418 . . . . 0.0 110.683 179.339 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' F' F ' 50' ' ' VAL . . . . . . . . . . . . . 43.5 t -82.32 106.29 13.07 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.24 0 N-CA-C 109.279 -0.637 . . . . 0.0 109.279 175.389 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' F' F ' 51' ' ' VAL . . . . . . . . . . . . . 47.7 t -71.06 -52.58 26.32 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.373 0 N-CA-C 109.707 -0.479 . . . . 0.0 109.707 -174.475 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' F' F ' 52' ' ' GLN . . . . . . . . . . . . . 88.5 mt-30 -154.81 153.67 31.56 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-O 121.206 0.527 . . . . 0.0 111.748 -176.64 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' F' F ' 53' ' ' ALA . . . . . . . . . . . . . . . -132.17 133.01 43.72 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 115.333 -0.849 . . . . 0.0 109.526 174.42 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' F' F ' 54' ' ' TYR . . . . . . . . . . . . . 17.2 t80 -129.13 111.47 18.29 Favored Pre-proline 0 CA--C 1.535 0.385 0 CA-C-O 118.16 -0.924 . . . . 0.0 110.204 179.088 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' F' F ' 55' ' ' PRO . . . . . . . . . . . . . 73.9 Cg_endo -77.14 168.88 75.76 Favored 'Cis proline' 0 N--CA 1.5 1.876 0 CA-C-N 121.872 1.704 . . . . 0.0 112.321 -6.644 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' F' F ' 56' ' ' SER . . . . . . . . . . . . . 13.4 m -117.32 135.04 23.05 Favored Pre-proline 0 CA--C 1.539 0.531 0 CA-C-O 118.477 -0.773 . . . . 0.0 109.627 175.243 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' F' F ' 57' ' ' PRO . . . . . . . . . . . . . 35.4 Cg_endo -66.38 164.68 65.91 Favored 'Cis proline' 0 N--CA 1.498 1.774 0 CA-C-N 121.809 1.682 . . . . 0.0 111.338 -3.225 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' F' F ' 58' ' ' LEU . . . . . . . . . . . . . 16.4 tp -130.77 139.08 50.21 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-O 120.996 0.427 . . . . 0.0 110.38 179.738 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' F' F ' 59' ' ' ARG . . . . . . . . . . . . . 60.3 ttm-85 -104.48 127.93 52.29 Favored 'General case' 0 C--N 1.327 -0.397 0 N-CA-C 109.152 -0.685 . . . . 0.0 109.152 174.986 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' F' F ' 60' ' ' VAL . . . . . . . . . . . . . 41.6 t -81.0 119.38 30.55 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.271 0 C-N-CA 120.732 -0.387 . . . . 0.0 110.604 -174.941 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' F' F ' 61' ' ' GLU . . . . . . . . . . . . . 95.5 mt-10 -131.05 163.07 28.43 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 115.853 -0.612 . . . . 0.0 109.689 175.301 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' F' F ' 62' ' ' ASP . . . . . . . . . . . . . 41.2 m-20 -52.51 -31.64 36.35 Favored 'General case' 0 C--N 1.328 -0.354 0 N-CA-C 112.045 0.387 . . . . 0.0 112.045 -178.942 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' F' F ' 63' ' ' ARG . . . . . . . . . . . . . 79.3 mtt85 -72.94 -22.03 60.79 Favored 'General case' 0 CA--C 1.533 0.324 0 N-CA-C 112.896 0.702 . . . . 0.0 112.896 -176.205 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' F' F ' 64' ' ' THR . . . . . . . . . . . . . 20.3 m -72.54 141.48 48.47 Favored 'General case' 0 C--N 1.331 -0.206 0 CA-C-O 120.833 0.349 . . . . 0.0 110.999 -175.755 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' F' F ' 65' ' ' LYS . . . . . . . . . . . . . 67.1 mttm -90.01 137.09 32.63 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.009 -0.541 . . . . 0.0 110.49 179.578 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' F' F ' 66' ' ' ILE . . . . . . . . . . . . . 60.4 mt -119.33 130.03 74.5 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.268 0 N-CA-C 109.68 -0.489 . . . . 0.0 109.68 177.856 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' F' F ' 67' ' ' THR . . . . . . . . . . . . . 31.9 m -125.97 145.33 50.33 Favored 'General case' 0 C--N 1.331 -0.21 0 CA-C-O 121.089 0.471 . . . . 0.0 111.37 -176.81 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' F' F ' 68' ' ' LEU . . . . . . . . . . . . . 4.8 tt -100.56 124.7 46.48 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 115.721 -0.672 . . . . 0.0 109.786 176.553 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' F' F ' 69' ' ' VAL . . . . . . . . . . . . . 41.2 t -96.68 142.43 14.0 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.298 0 CA-C-O 120.929 0.395 . . . . 0.0 111.0 -175.804 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' F' F ' 70' ' ' THR . . . . . . . . . . . . . 27.7 m -85.2 146.05 27.28 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 115.976 -0.556 . . . . 0.0 109.792 176.985 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' F' F ' 71' ' ' HIS . . . . . . . . . . . . . 10.6 m-70 -149.91 175.86 2.58 Favored Pre-proline 0 C--N 1.328 -0.337 0 C-N-CA 120.846 -0.342 . . . . 0.0 111.233 -174.046 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' F' F ' 72' ' ' PRO . . . . . . . . . . . . . 24.2 Cg_exo -64.93 160.28 42.02 Favored 'Trans proline' 0 N--CA 1.495 1.61 0 C-N-CA 121.695 1.597 . . . . 0.0 111.474 176.56 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' F' F ' 73' ' ' VAL . . . . . . . . . . . . . 34.9 m -69.6 -178.31 0.23 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.276 0 CA-C-N 116.368 -0.378 . . . . 0.0 110.305 -172.054 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' F' F ' 74' ' ' ASP . . . . . . . . . . . . . 47.4 t0 -84.98 114.92 22.51 Favored 'General case' 0 C--N 1.33 -0.264 0 C-N-CA 120.524 -0.47 . . . . 0.0 110.381 -171.112 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' F' F ' 75' ' ' VAL . . . . . . . . . . . . . 46.5 t -118.16 117.89 56.28 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.27 0 CA-C-O 121.178 0.513 . . . . 0.0 109.74 178.643 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' F' F ' 76' ' ' LEU . . . . . . . . . . . . . 13.9 mt -120.86 142.44 49.66 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 115.453 -0.794 . . . . 0.0 109.216 179.385 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' F' F ' 77' ' ' GLU . . . . . . . . . . . . . 97.7 mt-10 -135.49 130.05 34.08 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-O 121.225 0.536 . . . . 0.0 111.343 -176.713 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' F' F ' 78' ' ' ALA . . . . . . . . . . . . . . . -118.7 134.46 55.11 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-N 115.47 -0.786 . . . . 0.0 109.649 176.373 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' F' F ' 79' ' ' LYS . . . . . . . . . . . . . 39.7 mtmt -83.81 115.44 22.24 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-O 120.958 0.408 . . . . 0.0 110.751 -178.784 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' F' F ' 80' ' ' ILE . . . . . . . . . . . . . 24.0 mm -139.19 114.73 8.74 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.323 0 CA-C-N 115.722 -0.672 . . . . 0.0 109.266 -177.93 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' F' F ' 81' ' ' LYS . . . . . . . . . . . . . 75.6 mttt -101.65 126.49 48.5 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-O 120.802 0.334 . . . . 0.0 111.029 -178.086 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' F' F ' 82' ' ' GLY . . . . . . . . . . . . . . . 89.04 42.14 5.7 Favored Glycine 0 CA--C 1.525 0.718 0 C-N-CA 120.905 -0.665 . . . . 0.0 111.933 175.423 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' F' F ' 83' ' ' ILE . . . . . . . . . . . . . 74.1 mt -66.69 138.41 22.98 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 N-CA-C 109.634 -0.506 . . . . 0.0 109.634 176.461 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' F' F ' 84' ' ' LYS . . . . . . . . . . . . . 53.8 tttp -99.34 -51.85 3.68 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.597 -176.729 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' F' F ' 85' ' ' ASP . . . . . . . . . . . . . 7.3 t70 -154.7 154.81 33.49 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.024 -0.534 . . . . 0.0 110.633 -179.807 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' F' F ' 86' ' ' VAL . . . . . . . . . . . . . 41.4 t -130.68 132.6 64.2 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.258 0 CA-C-O 121.032 0.444 . . . . 0.0 110.535 -179.516 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' F' F ' 87' ' ' ILE . . . . . . . . . . . . . 45.1 mm -120.76 128.37 76.04 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.229 0 CA-C-N 115.72 -0.673 . . . . 0.0 109.582 177.738 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' F' F ' 88' ' ' LEU . . . . . . . . . . . . . 37.4 mt -109.39 138.72 45.33 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-O 121.159 0.504 . . . . 0.0 111.312 -178.389 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' F' F ' 89' ' ' ASP . . . . . . . . . . . . . 11.7 t70 -130.07 154.89 47.0 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 115.485 -0.78 . . . . 0.0 109.197 175.319 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' F' F ' 90' ' ' GLU . . . . . . . . . . . . . 84.8 tt0 -46.12 -39.1 8.98 Favored 'General case' 0 N--CA 1.465 0.276 0 N-CA-C 113.175 0.806 . . . . 0.0 113.175 -172.315 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' F' F ' 91' ' ' ASN . . . . . . . . . . . . . 14.5 p30 -132.09 25.03 4.58 Favored 'General case' 0 N--CA 1.467 0.393 0 N-CA-C 112.71 0.633 . . . . 0.0 112.71 -178.391 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' F' F ' 92' ' ' LEU . . . . . . . . . . . . . 13.6 mt -150.38 147.22 27.32 Favored 'General case' 0 C--N 1.331 -0.218 0 N-CA-C 109.963 -0.384 . . . . 0.0 109.963 -177.398 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' F' F ' 93' ' ' ILE . . . . . . . . . . . . . 71.3 mt -126.98 117.79 48.66 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.269 0 N-CA-C 109.294 -0.632 . . . . 0.0 109.294 178.705 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' F' F ' 94' ' ' VAL . . . . . . . . . . . . . 44.3 t -118.09 127.98 75.22 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.217 0 N-CA-C 109.955 -0.387 . . . . 0.0 109.955 -178.584 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' F' F ' 95' ' ' VAL . . . . . . . . . . . . . 42.7 t -124.31 134.35 66.9 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.293 0 CA-C-N 116.18 -0.463 . . . . 0.0 109.992 -179.409 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' F' F ' 96' ' ' ILE . . . . . . . . . . . . . 57.5 mt -113.27 129.9 68.18 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.284 0 N-CA-C 109.423 -0.584 . . . . 0.0 109.423 178.722 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' F' F ' 97' ' ' THR . . . . . . . . . . . . . 59.7 p -102.1 156.92 17.24 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-O 120.946 0.403 . . . . 0.0 110.782 179.958 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' F' F ' 98' ' ' GLU . . . . . . . . . . . . . 97.8 mt-10 -53.95 -24.42 16.45 Favored 'General case' 0 CA--C 1.533 0.304 0 N-CA-C 112.344 0.498 . . . . 0.0 112.344 179.854 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' F' F ' 99' ' ' GLU . . . . . . . . . . . . . 97.1 mt-10 -75.49 9.07 2.38 Favored 'General case' 0 CA--C 1.536 0.435 0 N-CA-C 113.402 0.889 . . . . 0.0 113.402 -178.22 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' F' F ' 100' ' ' ASN . . . . . . . . . . . . . 4.2 m-20 63.07 33.94 14.2 Favored 'General case' 0 CA--C 1.532 0.263 0 CA-C-N 118.131 0.423 . . . . 0.0 111.332 -178.512 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' F' F ' 101' ' ' GLU . . . . . . . . . . . . . 84.0 tt0 -110.1 142.29 41.77 Favored 'General case' 0 C--N 1.333 -0.146 0 N-CA-C 109.475 -0.565 . . . . 0.0 109.475 172.39 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' F' F ' 102' ' ' VAL . . . . . . . . . . . . . 45.6 t -114.9 124.57 71.68 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.319 0 CA-C-N 116.226 -0.443 . . . . 0.0 109.814 -179.242 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' F' F ' 103' ' ' LEU . . . . . . . . . . . . . 26.1 mt -112.27 132.55 54.89 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 115.508 -0.769 . . . . 0.0 109.798 177.245 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' F' F ' 104' ' ' ILE . . . . . . . . . . . . . 69.9 mt -123.02 117.8 52.84 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.286 0 N-CA-C 109.983 -0.377 . . . . 0.0 109.983 -178.84 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' F' F ' 105' ' ' PHE . . . . . . . . . . . . . 20.8 m-85 -120.3 165.68 14.53 Favored 'General case' 0 C--N 1.331 -0.221 0 CA-C-N 115.568 -0.742 . . . . 0.0 109.892 179.838 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' F' F ' 106' ' ' ASN . . . . . . . . . . . . . 45.8 p-10 -98.67 -169.96 1.87 Allowed 'General case' 0 C--N 1.329 -0.288 0 N-CA-C 109.702 -0.481 . . . . 0.0 109.702 173.993 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' F' F ' 107' ' ' GLN . . . . . . . . . . . . . 45.4 tt0 -58.85 -28.09 65.75 Favored 'General case' 0 C--N 1.327 -0.379 0 N-CA-C 112.168 0.433 . . . . 0.0 112.168 179.272 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' F' F ' 108' ' ' ASN . . . . . . . . . . . . . 14.1 t30 -86.22 10.24 15.23 Favored 'General case' 0 CA--C 1.535 0.377 0 N-CA-C 113.136 0.791 . . . . 0.0 113.136 -177.72 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' F' F ' 109' ' ' LEU . . . . . . . . . . . . . 9.9 tp 59.7 35.89 22.34 Favored 'General case' 0 C--O 1.233 0.187 0 O-C-N 122.106 -0.371 . . . . 0.0 111.426 178.612 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' F' F ' 110' ' ' GLU . . . . . . . . . . . . . 70.9 mm-40 -106.79 149.9 26.88 Favored 'General case' 0 C--N 1.33 -0.275 0 N-CA-C 110.207 -0.294 . . . . 0.0 110.207 177.168 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' F' F ' 111' ' ' GLU . . . . . . . . . . . . . 98.5 mt-10 -77.85 122.11 25.01 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.264 -0.426 . . . . 0.0 111.389 -176.944 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' F' F ' 112' ' ' LEU . . . . . . . . . . . . . 17.8 mt -107.45 -44.71 4.24 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 115.928 -0.578 . . . . 0.0 109.954 176.21 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' F' F ' 113' ' ' TYR . . . . . . . . . . . . . 42.1 t80 -141.59 137.44 31.91 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.054 -0.521 . . . . 0.0 110.987 -179.3 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' F' F ' 114' ' ' ARG . . . . . . . . . . . . . 23.9 ttm180 -138.13 125.76 22.19 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.109 -0.496 . . . . 0.0 109.869 175.823 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' F' F ' 115' ' ' GLY . . . . . . . . . . . . . . . -150.12 142.07 9.36 Favored Glycine 0 CA--C 1.524 0.597 0 N-CA-C 110.756 -0.938 . . . . 0.0 110.756 178.454 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' F' F ' 116' ' ' LYS . . . . . . . . . . . . . 84.8 tttt -118.76 128.06 54.13 Favored 'General case' 0 C--N 1.33 -0.25 0 N-CA-C 109.693 -0.484 . . . . 0.0 109.693 177.754 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' F' F ' 117' ' ' PHE . . . . . . . . . . . . . 22.7 m-85 -129.57 117.48 20.49 Favored 'General case' 0 C--N 1.332 -0.166 0 CA-C-O 120.921 0.391 . . . . 0.0 110.32 -172.954 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' F' F ' 118' ' ' GLU . . . . . . . . . . . . . 43.4 mt-10 -52.35 -49.27 64.66 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.349 -0.387 . . . . 0.0 111.765 -176.242 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' F' F ' 119' ' ' ASN . . . . . . . . . . . . . 90.3 m-20 -97.32 31.06 2.6 Favored 'General case' 0 C--N 1.33 -0.24 0 N-CA-C 112.164 0.431 . . . . 0.0 112.164 -174.293 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' F' F ' 120' ' ' LEU . . . . . . . . . . . . . 12.5 tp -56.33 124.32 17.64 Favored 'General case' 0 C--N 1.331 -0.21 0 CA-C-O 120.588 0.233 . . . . 0.0 110.604 178.273 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' F' F ' 121' ' ' ASN . . . . . . . . . . . . . 31.4 m120 -114.08 -44.04 3.18 Favored 'General case' 0 C--N 1.331 -0.198 0 CA-C-N 116.524 -0.307 . . . . 0.0 111.149 -177.327 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' F' F ' 122' ' ' LYS . . . . . . . . . . . . . 98.6 mttt -144.35 148.79 35.18 Favored 'General case' 0 C--N 1.332 -0.194 0 CA-C-O 121.198 0.523 . . . . 0.0 112.028 -175.921 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' F' F ' 123' ' ' VAL . . . . . . . . . . . . . 45.6 t -127.42 124.5 63.92 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.239 0 CA-C-N 115.624 -0.716 . . . . 0.0 109.078 172.711 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' F' F ' 124' ' ' LEU . . . . . . . . . . . . . 57.9 mt -118.93 138.8 52.53 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-O 120.837 0.351 . . . . 0.0 111.078 -175.567 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' F' F ' 125' ' ' VAL . . . . . . . . . . . . . 34.3 m -130.34 129.58 64.99 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.273 0 CA-C-N 115.961 -0.563 . . . . 0.0 110.284 177.888 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' F' F ' 126' ' ' ARG . . . . . . . . . . . . . 31.1 mmt180 -135.9 108.11 7.26 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.224 -0.444 . . . . 0.0 110.29 179.074 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' F' F ' 127' ' ' ASN . . . . . . . . . . . . . 42.1 m-80 54.26 -104.81 0.23 Allowed 'General case' 0 CA--C 1.541 0.628 0 CA-C-O 119.163 -0.446 . . . . 0.0 110.934 179.403 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' F' F ' 128' ' ' ASP . . . . . . . . . . . . . 7.5 p-10 -111.41 1.6 17.1 Favored 'General case' 0 N--CA 1.468 0.437 0 CA-C-N 119.45 1.023 . . . . 0.0 113.447 -176.053 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' F' F ' 129' ' ' LEU . . . . . . . . . . . . . 38.2 mt -104.97 141.82 35.88 Favored 'General case' 0 C--O 1.231 0.131 0 CA-C-N 118.195 0.452 . . . . 0.0 110.257 178.915 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' F' F ' 130' ' ' VAL . . . . . . . . . . . . . 44.0 t -123.37 137.08 57.9 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.224 0 CA-C-N 116.268 -0.424 . . . . 0.0 109.916 -179.275 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' F' F ' 131' ' ' VAL . . . . . . . . . . . . . 42.7 t -135.69 136.44 50.35 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.29 0 CA-C-O 121.041 0.448 . . . . 0.0 110.408 179.326 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' F' F ' 132' ' ' ILE . . . . . . . . . . . . . 67.7 mt -117.71 130.2 72.96 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.232 0 CA-C-N 115.74 -0.664 . . . . 0.0 109.286 179.567 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' F' F ' 133' ' ' ILE . . . . . . . . . . . . . 41.9 mm -118.06 120.02 63.22 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.227 0 CA-C-O 120.831 0.348 . . . . 0.0 111.221 -174.329 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' F' F ' 134' ' ' ASP . . . . . . . . . . . . . 7.1 p-10 -131.58 145.59 51.78 Favored 'General case' 0 C--N 1.332 -0.173 0 N-CA-C 109.422 -0.584 . . . . 0.0 109.422 173.403 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' F' F ' 135' ' ' GLU . . . . . . . . . . . . . 73.6 tt0 -49.92 -22.97 1.71 Allowed 'General case' 0 C--N 1.329 -0.322 0 N-CA-C 113.286 0.847 . . . . 0.0 113.286 -170.615 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' F' F ' 136' ' ' GLN . . . . . . . . . . . . . 57.1 tp60 -99.04 -34.08 10.55 Favored 'General case' 0 C--N 1.331 -0.225 0 N-CA-C 111.94 0.348 . . . . 0.0 111.94 -176.135 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' F' F ' 137' ' ' LYS . . . . . . . . . . . . . 57.5 mtpt -138.77 151.84 47.43 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-O 121.13 0.491 . . . . 0.0 111.128 -169.612 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' F' F ' 138' ' ' LEU . . . . . . . . . . . . . 5.2 tt -119.29 122.76 42.63 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 115.809 -0.632 . . . . 0.0 109.437 174.445 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' F' F ' 139' ' ' THR . . . . . . . . . . . . . 19.8 m -110.36 130.39 55.56 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-N 116.323 -0.399 . . . . 0.0 110.838 -177.27 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' F' F ' 140' ' ' LEU . . . . . . . . . . . . . 8.9 tt -118.75 123.58 45.2 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 115.821 -0.627 . . . . 0.0 109.404 -179.232 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' F' F ' 141' ' ' ILE . . . . . . . . . . . . . 19.8 mt -120.47 120.72 63.56 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.309 0 CA-C-O 121.039 0.447 . . . . 0.0 109.887 -175.698 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' F' F ' 142' ' ' ARG . . . . . . . . . . . . . 68.9 ttt180 -110.69 130.77 55.48 Favored 'General case' 0 C--N 1.331 -0.22 0 CA-C-N 115.2 -0.909 . . . . 0.0 110.717 -175.494 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' F' F ' 143' ' ' THR . . . . . . . . . . . . . 41.2 p . . . . . 0 C--O 1.22 -0.475 0 CA-C-O 118.158 -0.925 . . . . 0.0 110.958 179.469 . . . . . . . . 0 0 . 1 . 010 nuclear orig full ' A' A ' -3' ' ' GLU . . . . . . . . . . . . . 95.6 mt-10 . . . . . 0 N--CA 1.491 1.588 0 N-CA-C 109.371 -0.603 . . . . 0.0 109.371 . . . . . . . . . 0 0 . 1 . 010 nuclear orig full ' A' A ' -2' ' ' GLY . . . . . . . . . . . . . . . -62.75 141.78 47.11 Favored Glycine 0 CA--C 1.524 0.654 0 N-CA-C 110.944 -0.862 . . . . 0.0 110.944 179.767 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' -1' ' ' VAL . . . . . . . . . . . . . 47.6 t -96.06 138.92 20.22 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.297 0 CA-C-O 120.853 0.358 . . . . 0.0 110.109 179.723 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 0' ' ' ILE . . . . . . . . . . . . . 66.8 mt -110.43 133.76 54.82 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.267 0 CA-C-N 116.146 -0.479 . . . . 0.0 110.056 179.941 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 24.8 ptp -85.35 143.29 28.74 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.29 -0.414 . . . . 0.0 110.538 179.662 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 10.5 p -121.96 135.28 54.85 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.196 -0.457 . . . . 0.0 110.588 179.265 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 95.7 mt-10 -141.06 136.8 32.37 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.111 -0.495 . . . . 0.0 110.746 179.836 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 4' ' ' LEU . . . . . . . . . . . . . 14.5 tp -125.42 132.05 52.81 Favored 'General case' 0 C--N 1.332 -0.176 0 CA-C-N 116.114 -0.494 . . . . 0.0 110.218 177.616 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 5' ' ' LYS . . . . . . . . . . . . . 97.9 mttt -110.26 120.88 43.87 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.145 -0.479 . . . . 0.0 110.403 179.342 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 66.3 mt -117.44 145.81 43.89 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 115.535 -0.757 . . . . 0.0 110.157 -178.864 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 25.8 ttpp -135.69 139.78 31.86 Favored Pre-proline 0 CA--C 1.534 0.334 0 CA-C-O 119.087 -0.483 . . . . 0.0 110.156 176.929 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 8' ' ' PRO . . . . . . . . . . . . . 92.7 Cg_endo -91.84 141.12 2.49 Favored 'Trans proline' 0 N--CA 1.489 1.227 0 C-N-CA 121.806 1.67 . . . . 0.0 111.766 177.157 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 58.8 mt -75.8 -49.65 3.46 Favored Pre-proline 0 CA--C 1.533 0.324 0 CA-C-O 118.507 -0.759 . . . . 0.0 112.588 -178.588 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 74.2 Cg_endo -76.33 155.56 36.94 Favored 'Trans proline' 0 N--CA 1.498 1.751 0 C-N-CA 121.062 1.175 . . . . 0.0 112.171 -179.436 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 27.0 tptp -87.74 92.47 9.12 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.117 -0.492 . . . . 0.0 110.468 179.42 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 12.6 p -143.63 148.75 18.66 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.32 0 CA-C-O 120.889 0.376 . . . . 0.0 110.837 -179.181 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 42.4 mp0 -87.68 129.6 35.09 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.1 -0.5 . . . . 0.0 110.332 178.47 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 14' ' ' LEU . . . . . . . . . . . . . 34.5 mt -99.24 151.66 37.49 Favored Pre-proline 0 C--N 1.33 -0.281 0 CA-C-N 116.41 -0.359 . . . . 0.0 110.813 -179.38 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 15' ' ' PRO . . . . . . . . . . . . . 27.4 Cg_exo -61.24 155.67 50.13 Favored 'Trans proline' 0 N--CA 1.497 1.717 0 C-N-CA 121.348 1.365 . . . . 0.0 111.624 177.051 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 16' ' ' PRO . . . . . . . . . . . . . 39.4 Cg_exo -58.58 -38.0 91.71 Favored 'Trans proline' 0 N--CA 1.498 1.74 0 C-N-CA 121.347 1.365 . . . . 0.0 112.798 -178.398 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 17' ' ' ASP . . . . . . . . . . . . . 12.3 p-10 -87.12 10.56 16.33 Favored 'General case' 0 CA--C 1.535 0.402 0 N-CA-C 113.231 0.826 . . . . 0.0 113.231 -177.476 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 18' ' ' PHE . . . . . . . . . . . . . 44.1 t80 -57.76 -43.14 85.26 Favored 'General case' 0 C--N 1.334 -0.085 0 O-C-N 121.942 -0.474 . . . . 0.0 110.229 -178.327 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 19' ' ' VAL . . . . . . . . . . . . . 48.1 t -56.32 -43.97 78.5 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.325 0 CA-C-N 116.291 -0.413 . . . . 0.0 110.64 -178.399 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 66.4 m-20 -59.57 -42.99 93.72 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-O 121.059 0.457 . . . . 0.0 110.815 -177.681 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 46.0 t -64.21 -48.79 84.09 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.253 0 CA-C-N 116.349 -0.387 . . . . 0.0 110.669 -177.856 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 22' ' ' ILE . . . . . . . . . . . . . 50.1 mm -55.65 -43.66 73.99 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.211 0 C-N-CA 120.911 -0.316 . . . . 0.0 110.689 179.861 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 23' ' ' ARG . . . . . . . . . . . . . 53.8 ttp180 -52.92 -51.92 59.62 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-O 120.55 0.214 . . . . 0.0 111.554 -179.367 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 24' ' ' ILE . . . . . . . . . . . . . 73.1 mt -60.01 -41.47 86.32 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.37 0 C-N-CA 121.095 -0.242 . . . . 0.0 111.295 -178.218 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 69.6 mmtt -64.19 -40.76 96.78 Favored 'General case' 0 C--N 1.328 -0.345 0 N-CA-C 112.187 0.44 . . . . 0.0 112.187 -178.516 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 36.1 mt -79.61 -42.45 24.89 Favored 'General case' 0 C--N 1.329 -0.307 0 N-CA-C 113.025 0.75 . . . . 0.0 113.025 -171.289 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 27' ' ' GLN . . . . . . . . . . . . . 9.6 pt20 -46.4 140.08 4.45 Favored 'General case' 0 N--CA 1.469 0.492 0 N-CA-C 112.808 0.67 . . . . 0.0 112.808 -175.447 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 101.19 -27.93 18.35 Favored Glycine 0 CA--C 1.531 1.05 0 CA-C-N 115.591 -0.731 . . . . 0.0 112.214 -177.67 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 99.2 mttt -98.57 155.06 17.48 Favored 'General case' 0 C--O 1.232 0.18 0 CA-C-N 117.338 0.569 . . . . 0.0 111.228 179.095 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 30' ' ' THR . . . . . . . . . . . . . 49.3 m -105.29 135.54 46.48 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.117 -0.492 . . . . 0.0 109.709 174.994 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 34.4 m -129.26 159.99 40.67 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.206 0 CA-C-O 120.803 0.335 . . . . 0.0 110.996 -177.768 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 32' ' ' ARG . . . . . . . . . . . . . 38.2 ttm180 -130.66 147.88 52.39 Favored 'General case' 0 C--N 1.331 -0.217 0 CA-C-N 116.008 -0.542 . . . . 0.0 110.357 179.17 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 33' ' ' THR . . . . . . . . . . . . . 30.6 m -52.2 140.73 20.51 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-O 120.849 0.357 . . . . 0.0 111.386 -179.099 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 99.65 -17.13 57.96 Favored Glycine 0 CA--C 1.533 1.207 0 C-N-CA 121.156 -0.545 . . . . 0.0 113.202 -179.455 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 60.7 m-20 -64.92 150.1 48.47 Favored 'General case' 0 C--O 1.231 0.129 0 CA-C-N 118.059 0.93 . . . . 0.0 111.205 179.686 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 45.8 t -124.44 130.88 73.43 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.221 0 CA-C-N 115.762 -0.654 . . . . 0.0 109.838 178.963 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 37' ' ' ILE . . . . . . . . . . . . . 66.9 mt -122.89 139.86 48.4 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.221 0 CA-C-N 116.181 -0.463 . . . . 0.0 109.929 -179.647 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . -108.93 128.87 9.24 Favored Glycine 0 CA--C 1.525 0.668 0 N-CA-C 111.034 -0.826 . . . . 0.0 111.034 179.456 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 39' ' ' ILE . . . . . . . . . . . . . 70.3 mt -124.93 137.67 56.79 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.282 0 N-CA-C 110.008 -0.367 . . . . 0.0 110.008 179.59 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 40' ' ' SER . . . . . . . . . . . . . 53.6 p -91.37 114.28 26.76 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.443 -0.344 . . . . 0.0 110.789 176.697 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 41' ' ' ILE . . . . . . . . . . . . . 43.3 mm -121.69 113.44 39.17 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.185 0 N-CA-C 109.939 -0.393 . . . . 0.0 109.939 179.075 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 85.6 mt 58.83 35.46 24.26 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.36 -0.382 . . . . 0.0 111.475 178.61 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . 77.57 -10.14 25.24 Favored Glycine 0 CA--C 1.534 1.264 0 C-N-CA 121.283 -0.484 . . . . 0.0 113.434 178.419 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 44' ' ' LYS . . . . . . . . . . . . . 18.7 tptm -97.13 135.17 39.48 Favored 'General case' 0 C--N 1.333 -0.149 0 CA-C-N 117.941 0.87 . . . . 0.0 109.767 176.918 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 85.9 tt0 -82.38 123.96 29.58 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-O 120.802 0.334 . . . . 0.0 110.959 -178.977 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 46' ' ' VAL . . . . . . . . . . . . . 7.4 p -118.64 127.44 75.62 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.217 0 N-CA-C 109.465 -0.568 . . . . 0.0 109.465 176.765 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 62.3 mtpt -99.57 127.73 45.66 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.027 -0.533 . . . . 0.0 110.981 179.318 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 48' ' ' PHE . . . . . . . . . . . . . 86.8 m-85 -110.65 131.85 54.7 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.41 -0.359 . . . . 0.0 110.132 177.425 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 77.7 tttt -108.93 136.59 48.23 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.115 -0.493 . . . . 0.0 110.464 179.117 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 50' ' ' VAL . . . . . . . . . . . . . 44.6 t -81.0 106.19 11.86 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.288 0 N-CA-C 109.357 -0.609 . . . . 0.0 109.357 175.612 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 51' ' ' VAL . . . . . . . . . . . . . 55.3 t -69.38 -48.29 68.15 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.255 0 CA-C-N 116.065 -0.516 . . . . 0.0 109.89 -173.896 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 52' ' ' GLN . . . . . . . . . . . . . 21.5 pt20 -164.34 158.21 18.44 Favored 'General case' 0 C--N 1.331 -0.215 0 C-N-CA 120.198 -0.601 . . . . 0.0 111.786 179.549 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -135.87 136.4 40.53 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-N 115.292 -0.867 . . . . 0.0 110.062 179.126 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 54' ' ' TYR . . . . . . . . . . . . . 41.5 t80 -129.15 113.23 18.45 Favored Pre-proline 0 CA--C 1.535 0.368 0 CA-C-O 118.164 -0.922 . . . . 0.0 110.126 177.5 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 55' ' ' PRO . . . . . . . . . . . . . 74.3 Cg_endo -77.11 167.82 78.7 Favored 'Cis proline' 0 N--CA 1.499 1.804 0 CA-C-N 122.01 1.754 . . . . 0.0 112.343 -6.878 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 56' ' ' SER . . . . . . . . . . . . . 13.7 m -117.6 131.53 24.04 Favored Pre-proline 0 CA--C 1.539 0.531 0 CA-C-O 118.389 -0.815 . . . . 0.0 109.609 175.526 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 57' ' ' PRO . . . . . . . . . . . . . 36.6 Cg_endo -66.73 167.28 56.98 Favored 'Cis proline' 0 N--CA 1.498 1.756 0 CA-C-N 121.937 1.727 . . . . 0.0 111.253 -2.472 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 58' ' ' LEU . . . . . . . . . . . . . 34.5 tp -130.47 136.48 49.04 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.348 -0.387 . . . . 0.0 110.525 -179.831 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 59' ' ' ARG . . . . . . . . . . . . . 58.2 ttp180 -101.67 121.0 41.22 Favored 'General case' 0 C--N 1.326 -0.422 0 N-CA-C 109.164 -0.68 . . . . 0.0 109.164 175.721 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 43.7 t -76.28 120.29 26.05 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.308 0 C-N-CA 120.723 -0.391 . . . . 0.0 110.637 -173.049 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 95.0 mt-10 -131.02 163.21 28.09 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 115.78 -0.646 . . . . 0.0 109.726 176.891 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 62' ' ' ASP . . . . . . . . . . . . . 77.8 m-20 -53.99 -32.27 53.57 Favored 'General case' 0 C--N 1.329 -0.318 0 C-N-CA 120.981 -0.288 . . . . 0.0 111.695 -179.793 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 63' ' ' ARG . . . . . . . . . . . . . 39.7 ptt180 -78.47 2.35 19.25 Favored 'General case' 0 CA--C 1.537 0.465 0 N-CA-C 113.682 0.993 . . . . 0.0 113.682 -175.738 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 29.0 m -89.55 139.49 30.48 Favored 'General case' 0 C--N 1.333 -0.121 0 CA-C-N 118.131 0.423 . . . . 0.0 110.91 -178.446 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 65' ' ' LYS . . . . . . . . . . . . . 98.2 mttt -88.83 129.71 35.53 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.076 -0.511 . . . . 0.0 110.2 178.579 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 66' ' ' ILE . . . . . . . . . . . . . 60.6 mt -115.27 129.75 70.99 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.275 0 N-CA-C 109.903 -0.406 . . . . 0.0 109.903 179.296 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 67' ' ' THR . . . . . . . . . . . . . 25.7 m -120.25 136.97 54.48 Favored 'General case' 0 C--N 1.331 -0.224 0 CA-C-N 116.061 -0.518 . . . . 0.0 110.674 -179.587 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 68' ' ' LEU . . . . . . . . . . . . . 6.6 tt -103.92 124.28 48.68 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 115.863 -0.608 . . . . 0.0 110.158 178.778 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 69' ' ' VAL . . . . . . . . . . . . . 46.3 t -96.58 127.74 48.44 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 CA-C-N 116.218 -0.446 . . . . 0.0 110.162 -179.379 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 70' ' ' THR . . . . . . . . . . . . . 67.6 p -106.88 -176.04 2.97 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.049 -0.523 . . . . 0.0 110.26 179.028 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 71' ' ' HIS . . . . . . . . . . . . . 1.8 t-80 -65.13 145.66 99.06 Favored Pre-proline 0 CA--C 1.534 0.353 0 N-CA-C 109.665 -0.494 . . . . 0.0 109.665 179.907 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 72' ' ' PRO . . . . . . . . . . . . . 71.5 Cg_endo -80.0 -23.63 6.45 Favored 'Trans proline' 0 N--CA 1.493 1.469 0 C-N-CA 121.395 1.397 . . . . 0.0 113.161 -176.905 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 73' ' ' VAL . . . . . . . . . . . . . 35.5 m -129.03 160.55 39.77 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.196 0 CA-C-O 121.144 0.497 . . . . 0.0 111.198 -178.988 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 74' ' ' ASP . . . . . . . . . . . . . 30.7 t0 -104.9 122.42 45.77 Favored 'General case' 0 C--N 1.327 -0.385 0 CA-C-N 115.308 -0.86 . . . . 0.0 109.617 177.327 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 39.4 t -112.71 122.76 67.51 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.207 0 CA-C-O 120.953 0.406 . . . . 0.0 110.481 -177.897 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 76' ' ' LEU . . . . . . . . . . . . . 25.0 mt -125.64 149.27 48.57 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 115.844 -0.616 . . . . 0.0 109.829 178.195 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 77' ' ' GLU . . . . . . . . . . . . . 96.8 mt-10 -137.03 138.04 40.04 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-O 121.015 0.436 . . . . 0.0 111.213 -177.986 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 78' ' ' ALA . . . . . . . . . . . . . . . -123.1 136.61 54.87 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 115.642 -0.708 . . . . 0.0 109.813 177.076 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 79' ' ' LYS . . . . . . . . . . . . . 24.9 pttm -79.3 119.82 22.9 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-O 121.262 0.553 . . . . 0.0 111.018 -177.479 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 80' ' ' ILE . . . . . . . . . . . . . 35.7 mm -139.28 104.67 2.21 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.252 0 CA-C-N 115.75 -0.659 . . . . 0.0 109.33 179.822 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 81' ' ' LYS . . . . . . . . . . . . . 99.3 mttt -102.21 127.03 49.33 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-O 120.958 0.409 . . . . 0.0 111.211 -176.726 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . 89.29 42.03 5.65 Favored Glycine 0 CA--C 1.525 0.673 0 N-CA-C 111.504 -0.638 . . . . 0.0 111.504 175.883 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 83' ' ' ILE . . . . . . . . . . . . . 71.0 mt -69.66 137.49 24.04 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.298 0 N-CA-C 109.77 -0.455 . . . . 0.0 109.77 176.749 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 84' ' ' LYS . . . . . . . . . . . . . 6.9 ttpm? -101.96 -48.56 4.21 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.102 179.362 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 85' ' ' ASP . . . . . . . . . . . . . 11.1 t70 -150.44 151.39 32.69 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 115.85 -0.614 . . . . 0.0 110.38 -179.721 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 86' ' ' VAL . . . . . . . . . . . . . 45.1 t -131.33 132.88 62.78 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.283 0 CA-C-O 120.958 0.409 . . . . 0.0 110.447 -179.134 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 87' ' ' ILE . . . . . . . . . . . . . 5.1 mp -119.31 123.64 71.62 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.206 0 N-CA-C 109.169 -0.678 . . . . 0.0 109.169 175.891 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 88' ' ' LEU . . . . . . . . . . . . . 23.2 mt -114.0 129.71 56.59 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.164 -0.471 . . . . 0.0 111.148 -176.089 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 89' ' ' ASP . . . . . . . . . . . . . 13.6 t70 -124.02 154.6 39.64 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 115.83 -0.623 . . . . 0.0 109.677 176.709 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 41.6 mp0 -50.69 -37.33 40.66 Favored 'General case' 0 C--N 1.329 -0.316 0 N-CA-C 112.396 0.517 . . . . 0.0 112.396 -171.789 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 91' ' ' ASN . . . . . . . . . . . . . 20.2 p-10 -132.23 35.64 3.68 Favored 'General case' 0 N--CA 1.464 0.268 0 CA-C-O 120.679 0.276 . . . . 0.0 111.727 -177.112 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 92' ' ' LEU . . . . . . . . . . . . . 7.1 tp -166.12 139.76 4.24 Favored 'General case' 0 C--N 1.33 -0.282 0 N-CA-C 110.08 -0.341 . . . . 0.0 110.08 179.792 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 93' ' ' ILE . . . . . . . . . . . . . 66.7 mt -124.93 122.96 64.63 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.178 0 N-CA-C 109.749 -0.463 . . . . 0.0 109.749 -178.758 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 94' ' ' VAL . . . . . . . . . . . . . 41.8 t -125.6 127.84 71.9 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.181 0 CA-C-O 120.958 0.408 . . . . 0.0 110.142 179.44 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 95' ' ' VAL . . . . . . . . . . . . . 47.7 t -120.58 135.41 60.9 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.343 0 CA-C-N 115.909 -0.587 . . . . 0.0 109.875 -179.951 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 96' ' ' ILE . . . . . . . . . . . . . 65.7 mt -114.08 127.04 71.68 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.279 0 N-CA-C 109.341 -0.615 . . . . 0.0 109.341 178.388 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 97' ' ' THR . . . . . . . . . . . . . 67.8 p -97.72 162.8 13.1 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-O 121.331 0.586 . . . . 0.0 111.316 -176.918 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 98' ' ' GLU . . . . . . . . . . . . . 79.7 tt0 -53.84 -29.05 39.36 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 115.86 -0.609 . . . . 0.0 112.1 -178.993 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 99' ' ' GLU . . . . . . . . . . . . . 95.6 mt-10 -79.2 13.38 1.88 Allowed 'General case' 0 CA--C 1.534 0.365 0 N-CA-C 113.224 0.824 . . . . 0.0 113.224 -176.936 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 100' ' ' ASN . . . . . . . . . . . . . 4.0 m-20 61.18 34.41 18.88 Favored 'General case' 0 CA--C 1.53 0.179 0 CA-C-N 118.058 0.39 . . . . 0.0 111.414 -179.388 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 101' ' ' GLU . . . . . . . . . . . . . 84.0 tt0 -107.74 143.99 35.5 Favored 'General case' 0 C--N 1.333 -0.138 0 N-CA-C 109.537 -0.542 . . . . 0.0 109.537 172.993 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 102' ' ' VAL . . . . . . . . . . . . . 42.6 t -115.52 125.98 72.91 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.302 0 CA-C-N 116.273 -0.421 . . . . 0.0 110.007 -177.195 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 103' ' ' LEU . . . . . . . . . . . . . 66.2 mt -116.72 130.77 56.93 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 115.767 -0.651 . . . . 0.0 110.189 176.749 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 104' ' ' ILE . . . . . . . . . . . . . 68.6 mt -118.63 123.33 71.38 Favored 'Isoleucine or valine' 0 C--O 1.234 0.247 0 N-CA-C 110.26 -0.274 . . . . 0.0 110.26 -178.854 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 105' ' ' PHE . . . . . . . . . . . . . 67.6 m-85 -122.99 163.7 19.94 Favored 'General case' 0 C--O 1.232 0.148 0 O-C-N 124.003 0.815 . . . . 0.0 110.136 -178.176 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 106' ' ' ASN . . . . . . . . . . . . . 43.5 p-10 -97.77 -169.9 1.9 Allowed 'General case' 0 C--N 1.329 -0.283 0 N-CA-C 109.566 -0.531 . . . . 0.0 109.566 171.93 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 107' ' ' GLN . . . . . . . . . . . . . 31.7 tt0 -57.38 -29.68 64.26 Favored 'General case' 0 C--N 1.328 -0.348 0 N-CA-C 111.988 0.366 . . . . 0.0 111.988 178.983 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 108' ' ' ASN . . . . . . . . . . . . . 6.1 t-20 -86.98 11.57 13.29 Favored 'General case' 0 CA--C 1.536 0.421 0 N-CA-C 113.09 0.774 . . . . 0.0 113.09 -175.792 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 109' ' ' LEU . . . . . . . . . . . . . 41.6 mt 57.69 37.03 27.21 Favored 'General case' 0 C--N 1.332 -0.181 0 CA-C-O 120.88 0.372 . . . . 0.0 111.475 177.303 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 110' ' ' GLU . . . . . . . . . . . . . 43.5 mt-10 -104.73 146.72 28.56 Favored 'General case' 0 C--N 1.331 -0.228 0 N-CA-C 110.108 -0.33 . . . . 0.0 110.108 176.475 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 111' ' ' GLU . . . . . . . . . . . . . 99.3 mt-10 -76.89 121.98 24.19 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-O 120.92 0.39 . . . . 0.0 110.928 -178.57 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 112' ' ' LEU . . . . . . . . . . . . . 49.0 mt -110.12 -45.69 3.56 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 115.941 -0.572 . . . . 0.0 110.158 177.575 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 113' ' ' TYR . . . . . . . . . . . . . 64.8 t80 -134.15 135.86 43.4 Favored 'General case' 0 C--N 1.332 -0.187 0 CA-C-N 116.119 -0.491 . . . . 0.0 110.99 179.845 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 114' ' ' ARG . . . . . . . . . . . . . 83.3 mtp180 -135.17 123.25 22.81 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 116.043 -0.526 . . . . 0.0 110.248 177.937 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 115' ' ' GLY . . . . . . . . . . . . . . . -150.08 158.8 27.83 Favored Glycine 0 CA--C 1.524 0.625 0 N-CA-C 110.854 -0.898 . . . . 0.0 110.854 178.761 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 116' ' ' LYS . . . . . . . . . . . . . 79.8 tttt -134.18 131.76 38.99 Favored 'General case' 0 C--N 1.329 -0.32 0 N-CA-C 110.016 -0.365 . . . . 0.0 110.016 178.199 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 117' ' ' PHE . . . . . . . . . . . . . 20.0 m-85 -136.36 114.07 11.1 Favored 'General case' 0 C--N 1.331 -0.216 0 CA-C-N 116.362 -0.381 . . . . 0.0 110.066 -174.65 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 118' ' ' GLU . . . . . . . . . . . . . 96.1 mt-10 -54.5 -38.57 66.63 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.557 -0.292 . . . . 0.0 111.283 -177.945 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 119' ' ' ASN . . . . . . . . . . . . . 7.9 m-80 -100.44 30.53 3.85 Favored 'General case' 0 C--N 1.331 -0.232 0 N-CA-C 112.142 0.423 . . . . 0.0 112.142 -175.24 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 120' ' ' LEU . . . . . . . . . . . . . 16.3 tp -58.33 122.27 12.83 Favored 'General case' 0 C--N 1.331 -0.196 0 N-CA-C 110.084 -0.339 . . . . 0.0 110.084 177.322 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 121' ' ' ASN . . . . . . . . . . . . . 60.8 t30 -114.13 -44.09 3.17 Favored 'General case' 0 N--CA 1.462 0.169 0 CA-C-N 116.712 -0.222 . . . . 0.0 111.426 -176.986 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 122' ' ' LYS . . . . . . . . . . . . . 98.5 mttt -147.02 150.69 35.6 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-O 121.016 0.436 . . . . 0.0 111.665 -176.39 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 123' ' ' VAL . . . . . . . . . . . . . 40.9 t -128.79 129.16 68.31 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.319 0 CA-C-N 115.89 -0.596 . . . . 0.0 109.414 174.691 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 124' ' ' LEU . . . . . . . . . . . . . 52.6 mt -117.2 132.94 56.53 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-O 120.723 0.297 . . . . 0.0 110.372 -178.787 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 125' ' ' VAL . . . . . . . . . . . . . 34.9 m -134.32 133.75 55.19 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.252 0 CA-C-N 116.152 -0.477 . . . . 0.0 111.045 -178.092 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 126' ' ' ARG . . . . . . . . . . . . . 14.9 ptm180 -163.4 137.19 5.82 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.185 -0.461 . . . . 0.0 109.85 175.291 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 127' ' ' ASN . . . . . . . . . . . . . 69.4 m-20 55.56 -154.82 0.29 Allowed 'General case' 0 CA--C 1.539 0.531 0 N-CA-C 109.818 -0.438 . . . . 0.0 109.818 -178.77 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 128' ' ' ASP . . . . . . . . . . . . . 23.8 p-10 -84.65 22.25 1.36 Allowed 'General case' 0 CA--C 1.534 0.334 0 CA-C-N 118.383 0.538 . . . . 0.0 112.339 177.419 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 129' ' ' LEU . . . . . . . . . . . . . 16.5 tp -118.58 138.92 52.23 Favored 'General case' 0 C--O 1.234 0.249 0 O-C-N 122.112 -0.367 . . . . 0.0 110.178 178.764 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 130' ' ' VAL . . . . . . . . . . . . . 12.3 p -135.37 140.35 44.99 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.2 0 CA-C-O 120.96 0.41 . . . . 0.0 110.396 -178.773 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 131' ' ' VAL . . . . . . . . . . . . . 14.6 p -136.17 141.12 42.42 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.233 0 CA-C-O 120.981 0.42 . . . . 0.0 110.891 179.29 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 132' ' ' ILE . . . . . . . . . . . . . 73.4 mt -112.96 134.02 56.93 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.292 0 CA-C-N 115.859 -0.61 . . . . 0.0 109.637 179.756 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 133' ' ' ILE . . . . . . . . . . . . . 41.7 mm -117.66 124.35 72.94 Favored 'Isoleucine or valine' 0 C--O 1.233 0.198 0 CA-C-O 120.806 0.336 . . . . 0.0 110.976 -176.192 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 134' ' ' ASP . . . . . . . . . . . . . 7.1 p-10 -136.61 148.46 47.49 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.253 -0.43 . . . . 0.0 109.85 175.747 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 135' ' ' GLU . . . . . . . . . . . . . 83.0 tt0 -50.02 -26.9 4.76 Favored 'General case' 0 C--N 1.328 -0.341 0 N-CA-C 112.67 0.619 . . . . 0.0 112.67 -174.66 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 136' ' ' GLN . . . . . . . . . . . . . 94.3 mt-30 -82.67 -32.44 28.14 Favored 'General case' 0 C--N 1.33 -0.251 0 N-CA-C 112.344 0.498 . . . . 0.0 112.344 -175.596 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 137' ' ' LYS . . . . . . . . . . . . . 56.5 pttt -170.01 176.63 4.62 Favored 'General case' 0 C--N 1.333 -0.133 0 CA-C-O 121.592 0.71 . . . . 0.0 112.29 -172.795 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 138' ' ' LEU . . . . . . . . . . . . . 7.5 tt -122.18 130.17 52.96 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-N 115.006 -0.997 . . . . 0.0 110.045 179.201 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 139' ' ' THR . . . . . . . . . . . . . 85.2 m -115.42 124.54 51.43 Favored 'General case' 0 C--N 1.331 -0.224 0 CA-C-N 116.253 -0.431 . . . . 0.0 110.212 179.206 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 140' ' ' LEU . . . . . . . . . . . . . 21.0 tp -111.86 125.93 54.55 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.005 -0.543 . . . . 0.0 109.606 -178.979 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 141' ' ' ILE . . . . . . . . . . . . . 19.6 mt -123.31 124.56 70.14 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.252 0 CA-C-O 120.996 0.427 . . . . 0.0 110.234 -172.814 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 142' ' ' ARG . . . . . . . . . . . . . 81.1 mtp180 -111.84 125.78 54.38 Favored 'General case' 0 C--O 1.233 0.22 0 CA-C-N 115.429 -0.805 . . . . 0.0 109.843 -178.895 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 143' ' ' THR . . . . . . . . . . . . . 40.0 p . . . . . 0 C--O 1.22 -0.452 0 CA-C-O 118.014 -0.994 . . . . 0.0 110.555 -179.226 . . . . . . . . 0 0 . 1 . 010 nuclear orig full ' B' B ' -3' ' ' GLU . . . . . . . . . . . . . 95.7 mt-10 . . . . . 0 N--CA 1.488 1.463 0 N-CA-C 109.326 -0.62 . . . . 0.0 109.326 . . . . . . . . . 0 0 . 1 . 010 nuclear orig full ' B' B ' -2' ' ' GLY . . . . . . . . . . . . . . . -70.5 129.49 19.7 Favored Glycine 0 CA--C 1.525 0.663 0 N-CA-C 110.956 -0.858 . . . . 0.0 110.956 179.537 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' -1' ' ' VAL . . . . . . . . . . . . . 43.4 t -96.46 138.43 21.73 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.305 0 N-CA-C 110.098 -0.334 . . . . 0.0 110.098 179.76 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 0' ' ' ILE . . . . . . . . . . . . . 72.0 mt -88.33 129.58 39.28 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.222 0 CA-C-N 116.346 -0.388 . . . . 0.0 110.275 -178.695 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 1' ' ' MET . . . . . . . . . . . . . 26.2 ptt? -78.3 131.58 37.11 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.044 -0.526 . . . . 0.0 110.764 179.743 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 2' ' ' SER . . . . . . . . . . . . . 4.9 p -113.05 135.14 54.11 Favored 'General case' 0 C--N 1.331 -0.201 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.585 -179.687 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 3' ' ' GLU . . . . . . . . . . . . . 40.7 mt-10 -141.08 141.44 34.25 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.243 -0.435 . . . . 0.0 111.09 -178.962 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 4' ' ' LEU . . . . . . . . . . . . . 16.4 tp -125.9 129.82 50.09 Favored 'General case' 0 C--N 1.333 -0.143 0 CA-C-N 116.011 -0.541 . . . . 0.0 109.912 176.047 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 5' ' ' LYS . . . . . . . . . . . . . 57.1 mttp -108.79 123.24 48.71 Favored 'General case' 0 C--O 1.236 0.359 0 CA-C-N 116.625 -0.262 . . . . 0.0 110.891 -179.394 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 6' ' ' LEU . . . . . . . . . . . . . 66.6 mt -114.62 145.88 41.48 Favored 'General case' 0 C--N 1.331 -0.223 0 CA-C-N 115.71 -0.677 . . . . 0.0 110.557 179.646 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 7' ' ' LYS . . . . . . . . . . . . . 83.7 tttt -128.12 142.0 43.08 Favored Pre-proline 0 CA--C 1.533 0.303 0 CA-C-O 119.057 -0.497 . . . . 0.0 109.787 175.569 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 8' ' ' PRO . . . . . . . . . . . . . 93.7 Cg_endo -90.37 136.06 2.26 Favored 'Trans proline' 0 N--CA 1.49 1.318 0 C-N-CA 121.717 1.611 . . . . 0.0 111.832 179.131 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 9' ' ' LEU . . . . . . . . . . . . . 28.0 mt -82.96 -47.2 0.84 Allowed Pre-proline 0 CA--C 1.535 0.401 0 CA-C-O 118.631 -0.699 . . . . 0.0 112.061 -179.358 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 10' ' ' PRO . . . . . . . . . . . . . 83.8 Cg_endo -82.53 157.03 16.52 Favored 'Trans proline' 0 N--CA 1.495 1.592 0 C-N-CA 121.29 1.326 . . . . 0.0 111.802 175.688 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 11' ' ' LYS . . . . . . . . . . . . . 18.2 pttp -86.03 110.38 19.46 Favored 'General case' 0 C--N 1.331 -0.216 0 CA-C-O 121.523 0.677 . . . . 0.0 110.329 177.42 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 12' ' ' VAL . . . . . . . . . . . . . 12.0 p -151.07 149.53 14.09 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.359 0 CA-C-N 115.72 -0.673 . . . . 0.0 110.329 -179.978 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 13' ' ' GLU . . . . . . . . . . . . . 42.0 tp10 -95.73 120.6 36.28 Favored 'General case' 0 C--N 1.329 -0.293 0 C-N-CA 120.853 -0.339 . . . . 0.0 110.217 177.714 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 14' ' ' LEU . . . . . . . . . . . . . 37.2 mt -97.94 149.05 35.32 Favored Pre-proline 0 CA--C 1.533 0.316 0 CA-C-O 119.318 -0.372 . . . . 0.0 110.592 -177.736 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 15' ' ' PRO . . . . . . . . . . . . . 26.7 Cg_exo -61.8 157.11 44.55 Favored 'Trans proline' 0 N--CA 1.499 1.83 0 C-N-CA 121.286 1.324 . . . . 0.0 111.663 176.998 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 16' ' ' PRO . . . . . . . . . . . . . 39.1 Cg_exo -58.97 -33.95 98.94 Favored 'Trans proline' 0 N--CA 1.497 1.685 0 C-N-CA 121.416 1.411 . . . . 0.0 112.498 179.584 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 17' ' ' ASP . . . . . . . . . . . . . 18.7 p-10 -88.02 9.69 21.54 Favored 'General case' 0 CA--C 1.536 0.413 0 N-CA-C 113.234 0.828 . . . . 0.0 113.234 -177.791 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 18' ' ' PHE . . . . . . . . . . . . . 43.5 t80 -58.32 -46.49 86.08 Favored 'General case' 0 CA--C 1.523 -0.06 0 O-C-N 121.965 -0.459 . . . . 0.0 109.996 -177.983 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 19' ' ' VAL . . . . . . . . . . . . . 12.9 p -53.91 -41.4 48.95 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.328 0 CA-C-N 116.501 -0.318 . . . . 0.0 111.188 -178.422 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 20' ' ' ASP . . . . . . . . . . . . . 81.2 m-20 -60.82 -45.15 95.57 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-O 120.935 0.398 . . . . 0.0 110.83 -178.841 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 21' ' ' VAL . . . . . . . . . . . . . 40.7 t -64.16 -44.32 97.54 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.287 0 CA-C-N 116.272 -0.422 . . . . 0.0 110.654 -177.614 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 22' ' ' ILE . . . . . . . . . . . . . 50.3 mm -59.68 -40.01 81.16 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.199 0 C-N-CA 120.816 -0.354 . . . . 0.0 110.829 -179.65 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 23' ' ' ARG . . . . . . . . . . . . . 57.7 ttp180 -55.16 -49.14 72.6 Favored 'General case' 0 N--CA 1.463 0.219 0 CA-C-O 121.103 0.478 . . . . 0.0 110.692 177.736 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 24' ' ' ILE . . . . . . . . . . . . . 72.4 mt -60.39 -42.85 92.43 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 CA-C-N 115.729 -0.668 . . . . 0.0 111.845 -177.047 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 25' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -72.01 -37.43 69.79 Favored 'General case' 0 CA--C 1.535 0.37 0 N-CA-C 112.103 0.409 . . . . 0.0 112.103 -175.157 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' B' B ' 26' ' ' LEU . . . . . . . . . . . . . 40.4 mt -79.54 -39.7 31.25 Favored 'General case' 0 C--N 1.331 -0.231 0 N-CA-C 112.91 0.707 . . . . 0.0 112.91 -172.569 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 27' ' ' GLN . . . . . . . . . . . . . 9.6 pt20 -45.78 139.03 4.36 Favored 'General case' 0 N--CA 1.469 0.523 0 N-CA-C 112.84 0.682 . . . . 0.0 112.84 -175.095 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 28' ' ' GLY . . . . . . . . . . . . . . . 102.01 -26.65 23.57 Favored Glycine 0 CA--C 1.531 1.066 0 CA-C-N 115.367 -0.833 . . . . 0.0 112.191 -176.737 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 29' ' ' LYS . . . . . . . . . . . . . 54.8 mtpt -98.59 155.18 17.42 Favored 'General case' 0 C--O 1.233 0.198 0 CA-C-N 117.523 0.661 . . . . 0.0 111.237 179.058 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 30' ' ' THR . . . . . . . . . . . . . 53.7 m -101.03 139.43 36.73 Favored 'General case' 0 C--N 1.331 -0.216 0 CA-C-N 116.045 -0.525 . . . . 0.0 110.1 176.03 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 31' ' ' VAL . . . . . . . . . . . . . 34.5 m -130.47 155.4 41.7 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.305 0 CA-C-N 116.142 -0.481 . . . . 0.0 110.413 179.394 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 32' ' ' ARG . . . . . . . . . . . . . 71.5 ttt-85 -135.41 150.25 49.84 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-O 121.048 0.451 . . . . 0.0 110.24 178.211 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 33' ' ' THR . . . . . . . . . . . . . 19.8 m -52.28 137.67 28.2 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-O 120.894 0.378 . . . . 0.0 111.634 -177.068 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 34' ' ' GLY . . . . . . . . . . . . . . . 101.97 -17.2 54.86 Favored Glycine 0 CA--C 1.533 1.179 0 CA-C-O 119.622 -0.543 . . . . 0.0 113.21 179.087 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 35' ' ' ASP . . . . . . . . . . . . . 76.3 m-20 -67.28 148.58 51.51 Favored 'General case' 0 N--CA 1.462 0.128 0 CA-C-N 118.087 0.943 . . . . 0.0 111.299 179.514 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 36' ' ' VAL . . . . . . . . . . . . . 46.3 t -121.44 131.15 73.74 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.198 0 CA-C-N 115.935 -0.575 . . . . 0.0 109.873 177.737 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 37' ' ' ILE . . . . . . . . . . . . . 63.8 mt -121.27 138.57 51.21 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.299 0 CA-C-N 116.26 -0.427 . . . . 0.0 109.957 -179.921 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 38' ' ' GLY . . . . . . . . . . . . . . . -114.42 127.52 7.78 Favored Glycine 0 CA--C 1.524 0.636 0 N-CA-C 111.01 -0.836 . . . . 0.0 111.01 179.126 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 39' ' ' ILE . . . . . . . . . . . . . 70.8 mt -128.94 130.92 68.57 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.213 0 N-CA-C 110.003 -0.369 . . . . 0.0 110.003 178.685 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 40' ' ' SER . . . . . . . . . . . . . 59.7 p -90.93 118.19 30.12 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.422 -0.354 . . . . 0.0 110.693 176.959 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 41' ' ' ILE . . . . . . . . . . . . . 48.2 mm -125.08 116.95 48.58 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.19 0 CA-C-O 120.974 0.416 . . . . 0.0 110.237 179.686 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 42' ' ' LEU . . . . . . . . . . . . . 1.3 tt 56.65 45.58 21.8 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-O 121.414 0.626 . . . . 0.0 110.366 178.217 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 43' ' ' GLY . . . . . . . . . . . . . . . 75.16 -9.65 12.21 Favored Glycine 0 CA--C 1.534 1.238 0 CA-C-N 116.062 -0.517 . . . . 0.0 113.726 175.378 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 44' ' ' LYS . . . . . . . . . . . . . 46.8 tttp -107.29 126.9 53.03 Favored 'General case' 0 C--N 1.333 -0.121 0 CA-C-N 118.064 0.932 . . . . 0.0 110.189 -179.216 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 45' ' ' GLU . . . . . . . . . . . . . 42.6 tp10 -83.51 128.84 34.83 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-O 120.829 0.347 . . . . 0.0 111.222 -178.781 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 46' ' ' VAL . . . . . . . . . . . . . 8.7 p -120.18 127.08 75.88 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.198 0 N-CA-C 109.574 -0.528 . . . . 0.0 109.574 176.004 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 47' ' ' LYS . . . . . . . . . . . . . 87.0 mttt -98.94 124.82 44.16 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.03 -0.532 . . . . 0.0 110.603 177.092 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 48' ' ' PHE . . . . . . . . . . . . . 40.5 m-85 -108.96 131.8 54.71 Favored 'General case' 0 C--N 1.327 -0.379 0 N-CA-C 109.698 -0.482 . . . . 0.0 109.698 177.145 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 49' ' ' LYS . . . . . . . . . . . . . 84.3 tttt -107.89 134.71 50.44 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.452 -0.34 . . . . 0.0 110.406 178.21 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 50' ' ' VAL . . . . . . . . . . . . . 43.4 t -76.34 104.86 4.72 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.303 0 N-CA-C 109.25 -0.648 . . . . 0.0 109.25 176.729 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 51' ' ' VAL . . . . . . . . . . . . . 47.0 t -69.6 -49.79 55.87 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.275 0 CA-C-N 116.088 -0.505 . . . . 0.0 109.799 -174.428 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 52' ' ' GLN . . . . . . . . . . . . . 34.2 tt0 -161.91 145.05 11.99 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 115.928 -0.578 . . . . 0.0 111.569 -178.458 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 53' ' ' ALA . . . . . . . . . . . . . . . -120.71 133.57 55.34 Favored 'General case' 0 C--N 1.331 -0.219 0 CA-C-N 115.792 -0.64 . . . . 0.0 110.051 176.963 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 54' ' ' TYR . . . . . . . . . . . . . 45.9 t80 -129.06 109.63 18.19 Favored Pre-proline 0 CA--C 1.534 0.362 0 CA-C-O 118.27 -0.871 . . . . 0.0 110.243 178.276 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 55' ' ' PRO . . . . . . . . . . . . . 73.6 Cg_endo -77.11 168.24 77.54 Favored 'Cis proline' 0 N--CA 1.5 1.862 0 CA-C-N 121.818 1.685 . . . . 0.0 112.518 -5.921 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 56' ' ' SER . . . . . . . . . . . . . 50.5 m -117.3 134.02 23.13 Favored Pre-proline 0 CA--C 1.539 0.532 0 CA-C-O 118.418 -0.801 . . . . 0.0 109.557 174.851 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 57' ' ' PRO . . . . . . . . . . . . . 35.2 Cg_endo -66.27 164.37 66.14 Favored 'Cis proline' 0 N--CA 1.497 1.713 0 CA-C-N 121.838 1.692 . . . . 0.0 111.341 -2.547 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 58' ' ' LEU . . . . . . . . . . . . . 20.7 tp -129.78 136.05 49.16 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-O 120.966 0.413 . . . . 0.0 110.321 -179.061 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 59' ' ' ARG . . . . . . . . . . . . . 36.4 ttm180 -104.47 126.89 51.98 Favored 'General case' 0 C--N 1.326 -0.455 0 N-CA-C 109.169 -0.678 . . . . 0.0 109.169 175.69 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 60' ' ' VAL . . . . . . . . . . . . . 49.3 t -77.3 117.51 22.43 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.243 0 C-N-CA 120.638 -0.425 . . . . 0.0 109.933 -176.159 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 61' ' ' GLU . . . . . . . . . . . . . 94.9 mt-10 -130.99 167.9 18.27 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.088 -0.505 . . . . 0.0 110.247 -179.789 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 62' ' ' ASP . . . . . . . . . . . . . 24.6 t0 -54.26 -32.5 56.28 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-N 116.506 -0.315 . . . . 0.0 111.799 -178.816 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 63' ' ' ARG . . . . . . . . . . . . . 5.0 ptp180 -88.9 10.14 22.35 Favored 'General case' 0 CA--C 1.534 0.353 0 N-CA-C 113.499 0.926 . . . . 0.0 113.499 -175.147 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 64' ' ' THR . . . . . . . . . . . . . 27.2 m -94.02 134.4 36.46 Favored 'General case' 0 C--N 1.333 -0.122 0 CA-C-N 118.199 0.454 . . . . 0.0 110.507 -179.557 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 65' ' ' LYS . . . . . . . . . . . . . 67.2 mttm -90.7 133.31 35.24 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.011 -0.54 . . . . 0.0 110.616 179.706 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 66' ' ' ILE . . . . . . . . . . . . . 61.5 mt -110.75 129.6 65.64 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.21 0 N-CA-C 109.737 -0.468 . . . . 0.0 109.737 178.959 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 67' ' ' THR . . . . . . . . . . . . . 27.5 m -123.47 145.52 48.76 Favored 'General case' 0 C--N 1.331 -0.23 0 CA-C-N 116.055 -0.52 . . . . 0.0 110.644 -178.277 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 68' ' ' LEU . . . . . . . . . . . . . 52.9 mt -107.84 147.22 31.2 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-N 115.931 -0.577 . . . . 0.0 111.135 -178.442 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 69' ' ' VAL . . . . . . . . . . . . . 48.5 t -82.81 155.28 3.87 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.293 0 CA-C-N 115.664 -0.698 . . . . 0.0 109.122 175.602 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 70' ' ' THR . . . . . . . . . . . . . 9.9 t -73.69 166.49 23.18 Favored 'General case' 0 C--N 1.331 -0.208 0 CA-C-O 121.257 0.551 . . . . 0.0 110.996 -169.921 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 71' ' ' HIS . . . . . . . . . . . . . 64.6 m-70 -64.99 156.38 80.56 Favored Pre-proline 0 CA--C 1.533 0.32 0 CA-C-N 115.399 -0.819 . . . . 0.0 112.341 -170.562 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 72' ' ' PRO . . . . . . . . . . . . . 38.8 Cg_endo -67.5 160.28 48.65 Favored 'Trans proline' 0 N--CA 1.497 1.678 0 C-N-CA 121.729 1.62 . . . . 0.0 111.856 175.706 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 73' ' ' VAL . . . . . . . . . . . . . 34.5 m -69.68 -174.27 0.11 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.235 0 N-CA-C 109.629 -0.508 . . . . 0.0 109.629 -179.163 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 74' ' ' ASP . . . . . . . . . . . . . 28.9 t0 -84.85 115.35 22.7 Favored 'General case' 0 C--N 1.329 -0.323 0 C-N-CA 120.474 -0.49 . . . . 0.0 110.242 -170.972 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 75' ' ' VAL . . . . . . . . . . . . . 40.8 t -120.26 122.19 67.66 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.211 0 CA-C-O 121.099 0.476 . . . . 0.0 110.55 -177.842 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 76' ' ' LEU . . . . . . . . . . . . . 5.9 mp -119.25 137.64 53.53 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 115.609 -0.723 . . . . 0.0 109.288 174.627 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 77' ' ' GLU . . . . . . . . . . . . . 96.8 mt-10 -129.6 138.11 51.08 Favored 'General case' 0 C--N 1.331 -0.208 0 CA-C-O 121.159 0.504 . . . . 0.0 111.106 -176.405 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 78' ' ' ALA . . . . . . . . . . . . . . . -127.35 129.19 47.17 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 115.591 -0.731 . . . . 0.0 109.681 176.785 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 79' ' ' LYS . . . . . . . . . . . . . 79.9 tttt -76.35 119.34 20.09 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.413 -0.358 . . . . 0.0 110.304 -178.294 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 80' ' ' ILE . . . . . . . . . . . . . 40.6 mm -139.2 113.86 7.75 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.306 0 N-CA-C 109.469 -0.567 . . . . 0.0 109.469 -175.027 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 81' ' ' LYS . . . . . . . . . . . . . 86.9 tttt -99.33 122.89 43.1 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-O 120.82 0.343 . . . . 0.0 111.214 -177.219 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 82' ' ' GLY . . . . . . . . . . . . . . . 89.15 42.18 5.66 Favored Glycine 0 CA--C 1.526 0.752 0 C-N-CA 120.683 -0.77 . . . . 0.0 112.413 171.715 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 83' ' ' ILE . . . . . . . . . . . . . 71.3 mt -63.83 137.93 23.9 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.283 0 N-CA-C 109.484 -0.562 . . . . 0.0 109.484 174.818 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 84' ' ' LYS . . . . . . . . . . . . . 36.7 ttpt -106.58 -51.22 2.98 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-O 120.878 0.37 . . . . 0.0 110.352 -178.152 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 85' ' ' ASP . . . . . . . . . . . . . 13.1 t70 -145.25 146.16 31.58 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 115.969 -0.559 . . . . 0.0 110.54 -178.108 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 86' ' ' VAL . . . . . . . . . . . . . 46.2 t -129.97 131.89 65.89 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.263 0 CA-C-O 120.996 0.427 . . . . 0.0 110.448 -179.098 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 87' ' ' ILE . . . . . . . . . . . . . 5.0 mp -120.47 127.29 75.9 Favored 'Isoleucine or valine' 0 C--O 1.233 0.22 0 CA-C-N 115.86 -0.609 . . . . 0.0 109.494 176.846 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 88' ' ' LEU . . . . . . . . . . . . . 13.7 tp -113.68 132.93 55.61 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-O 120.963 0.411 . . . . 0.0 111.284 -177.036 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 89' ' ' ASP . . . . . . . . . . . . . 11.4 t70 -130.38 155.25 46.69 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 115.745 -0.661 . . . . 0.0 109.675 176.602 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 90' ' ' GLU . . . . . . . . . . . . . 84.4 tt0 -45.74 -48.56 15.27 Favored 'General case' 0 N--CA 1.466 0.34 0 N-CA-C 112.798 0.666 . . . . 0.0 112.798 -173.194 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 91' ' ' ASN . . . . . . . . . . . . . 2.6 p30 -126.04 39.33 3.97 Favored 'General case' 0 N--CA 1.465 0.294 0 CA-C-O 120.958 0.409 . . . . 0.0 110.966 -177.904 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 92' ' ' LEU . . . . . . . . . . . . . 10.8 tp -165.5 140.17 4.87 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.312 -0.404 . . . . 0.0 110.383 -179.376 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 93' ' ' ILE . . . . . . . . . . . . . 69.6 mt -128.77 122.56 57.3 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.289 0 N-CA-C 109.294 -0.632 . . . . 0.0 109.294 179.55 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 94' ' ' VAL . . . . . . . . . . . . . 46.4 t -122.54 128.62 75.42 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.229 0 CA-C-O 120.947 0.403 . . . . 0.0 110.147 -178.838 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 95' ' ' VAL . . . . . . . . . . . . . 42.1 t -123.16 134.28 66.67 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.283 0 CA-C-N 116.017 -0.538 . . . . 0.0 109.834 -179.785 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 96' ' ' ILE . . . . . . . . . . . . . 62.1 mt -117.8 129.92 73.47 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.237 0 N-CA-C 109.464 -0.569 . . . . 0.0 109.464 179.845 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 97' ' ' THR . . . . . . . . . . . . . 70.8 p -103.38 161.2 14.04 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-O 121.23 0.538 . . . . 0.0 111.547 -176.522 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 98' ' ' GLU . . . . . . . . . . . . . 71.0 mm-40 -53.79 -27.42 29.06 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 115.97 -0.559 . . . . 0.0 112.149 178.679 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 99' ' ' GLU . . . . . . . . . . . . . 95.5 mt-10 -76.6 11.8 1.51 Allowed 'General case' 0 CA--C 1.536 0.433 0 N-CA-C 113.235 0.828 . . . . 0.0 113.235 -178.113 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 100' ' ' ASN . . . . . . . . . . . . . 6.2 m-20 61.24 37.61 17.19 Favored 'General case' 0 CA--C 1.528 0.116 0 CA-C-O 120.912 0.387 . . . . 0.0 110.984 179.524 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 101' ' ' GLU . . . . . . . . . . . . . 85.0 tt0 -113.44 142.89 45.36 Favored 'General case' 0 C--N 1.331 -0.197 0 N-CA-C 109.606 -0.516 . . . . 0.0 109.606 174.321 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 102' ' ' VAL . . . . . . . . . . . . . 40.3 t -115.69 125.67 72.95 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.312 0 CA-C-N 116.158 -0.474 . . . . 0.0 109.968 -178.173 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 103' ' ' LEU . . . . . . . . . . . . . 23.5 mt -115.87 126.97 54.64 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 115.736 -0.665 . . . . 0.0 109.959 176.296 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 104' ' ' ILE . . . . . . . . . . . . . 66.2 mt -117.38 120.26 64.32 Favored 'Isoleucine or valine' 0 C--O 1.235 0.29 0 CA-C-N 116.612 -0.267 . . . . 0.0 110.355 -179.429 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 105' ' ' PHE . . . . . . . . . . . . . 17.7 m-85 -122.97 168.4 12.37 Favored 'General case' 0 C--N 1.332 -0.188 0 O-C-N 123.797 0.686 . . . . 0.0 109.949 178.686 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 106' ' ' ASN . . . . . . . . . . . . . 41.7 p-10 -96.93 -169.86 1.94 Allowed 'General case' 0 C--N 1.329 -0.316 0 N-CA-C 109.627 -0.508 . . . . 0.0 109.627 173.485 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 107' ' ' GLN . . . . . . . . . . . . . 60.4 tt0 -59.5 -30.04 68.28 Favored 'General case' 0 CA--C 1.532 0.274 0 C-N-CA 120.968 -0.293 . . . . 0.0 111.775 178.438 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 108' ' ' ASN . . . . . . . . . . . . . 4.8 t-20 -82.0 5.76 18.22 Favored 'General case' 0 CA--C 1.537 0.47 0 N-CA-C 113.167 0.803 . . . . 0.0 113.167 -178.053 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 109' ' ' LEU . . . . . . . . . . . . . 10.2 tp 61.97 37.8 14.73 Favored 'General case' 0 C--N 1.332 -0.166 0 O-C-N 122.047 -0.408 . . . . 0.0 111.377 178.106 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 110' ' ' GLU . . . . . . . . . . . . . 70.9 mm-40 -103.17 159.41 15.56 Favored 'General case' 0 C--N 1.33 -0.277 0 N-CA-C 109.749 -0.463 . . . . 0.0 109.749 175.688 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 111' ' ' GLU . . . . . . . . . . . . . 84.0 tt0 -85.17 123.31 30.53 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-O 120.974 0.416 . . . . 0.0 111.053 -177.397 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 112' ' ' LEU . . . . . . . . . . . . . 12.7 mt -110.04 -45.96 3.53 Favored 'General case' 0 C--N 1.331 -0.216 0 CA-C-N 115.884 -0.598 . . . . 0.0 110.144 176.776 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 113' ' ' TYR . . . . . . . . . . . . . 63.8 t80 -141.46 138.23 32.71 Favored 'General case' 0 C--N 1.331 -0.217 0 CA-C-N 116.212 -0.449 . . . . 0.0 111.152 179.977 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 114' ' ' ARG . . . . . . . . . . . . . 67.0 ttt180 -138.62 119.58 14.37 Favored 'General case' 0 C--N 1.332 -0.191 0 CA-C-N 116.015 -0.539 . . . . 0.0 110.132 178.41 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 115' ' ' GLY . . . . . . . . . . . . . . . -150.15 158.04 27.49 Favored Glycine 0 CA--C 1.525 0.696 0 C-N-CA 120.666 -0.778 . . . . 0.0 111.367 179.342 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 116' ' ' LYS . . . . . . . . . . . . . 29.8 ttmt -130.81 139.31 50.17 Favored 'General case' 0 C--N 1.331 -0.231 0 N-CA-C 109.898 -0.408 . . . . 0.0 109.898 176.643 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 117' ' ' PHE . . . . . . . . . . . . . 30.7 m-85 -135.84 114.5 11.9 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.329 -0.396 . . . . 0.0 110.372 -176.047 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 118' ' ' GLU . . . . . . . . . . . . . 96.0 mt-10 -52.82 -47.63 67.52 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.351 -0.386 . . . . 0.0 111.579 -176.473 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 119' ' ' ASN . . . . . . . . . . . . . 32.4 m120 -94.91 31.03 1.93 Allowed 'General case' 0 C--N 1.331 -0.238 0 N-CA-C 112.199 0.444 . . . . 0.0 112.199 -174.553 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 120' ' ' LEU . . . . . . . . . . . . . 11.8 tp -56.48 120.46 7.75 Favored 'General case' 0 C--N 1.332 -0.156 0 CA-C-O 120.728 0.299 . . . . 0.0 110.504 177.68 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 121' ' ' ASN . . . . . . . . . . . . . 64.3 t30 -112.53 -44.09 3.4 Favored 'General case' 0 C--N 1.331 -0.23 0 CA-C-N 116.317 -0.401 . . . . 0.0 110.874 -176.502 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 122' ' ' LYS . . . . . . . . . . . . . 34.2 mtmm -147.45 145.97 29.37 Favored 'General case' 0 C--N 1.331 -0.217 0 CA-C-O 121.08 0.467 . . . . 0.0 111.445 -178.191 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 123' ' ' VAL . . . . . . . . . . . . . 46.6 t -125.92 129.64 72.39 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.24 0 CA-C-N 115.831 -0.622 . . . . 0.0 109.409 176.395 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 124' ' ' LEU . . . . . . . . . . . . . 44.9 mt -118.88 128.33 54.34 Favored 'General case' 0 C--N 1.331 -0.239 0 CA-C-N 116.308 -0.405 . . . . 0.0 110.431 -179.204 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 125' ' ' VAL . . . . . . . . . . . . . 47.7 t -130.61 124.35 56.78 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.324 0 CA-C-N 116.141 -0.481 . . . . 0.0 109.824 179.105 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 126' ' ' ARG . . . . . . . . . . . . . 37.0 mtm105 -145.0 119.72 9.83 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-O 120.973 0.416 . . . . 0.0 110.195 178.248 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 127' ' ' ASN . . . . . . . . . . . . . 89.8 m-20 55.44 -130.17 1.99 Allowed 'General case' 0 CA--C 1.545 0.759 0 CA-C-O 118.516 -0.754 . . . . 0.0 110.196 -179.398 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 128' ' ' ASP . . . . . . . . . . . . . 11.5 p-10 -97.23 10.05 40.55 Favored 'General case' 0 CA--C 1.536 0.417 0 CA-C-N 120.04 1.291 . . . . 0.0 113.237 -178.1 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 129' ' ' LEU . . . . . . . . . . . . . 6.2 tt -109.05 133.57 52.82 Favored 'General case' 0 C--O 1.232 0.178 0 CA-C-N 118.28 0.491 . . . . 0.0 110.065 -179.923 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 130' ' ' VAL . . . . . . . . . . . . . 46.4 t -125.89 137.35 57.99 Favored 'Isoleucine or valine' 0 N--CA 1.462 0.175 0 CA-C-O 120.953 0.406 . . . . 0.0 110.453 -176.947 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 131' ' ' VAL . . . . . . . . . . . . . 46.9 t -136.1 135.4 50.15 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.277 0 CA-C-N 116.137 -0.483 . . . . 0.0 110.187 178.414 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 132' ' ' ILE . . . . . . . . . . . . . 74.1 mt -120.28 131.65 71.99 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.271 0 N-CA-C 109.708 -0.479 . . . . 0.0 109.708 -179.833 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 133' ' ' ILE . . . . . . . . . . . . . 39.0 mm -117.83 121.47 67.46 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.271 0 CA-C-N 116.493 -0.321 . . . . 0.0 110.868 -176.989 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 134' ' ' ASP . . . . . . . . . . . . . 8.8 p-10 -132.69 149.43 52.29 Favored 'General case' 0 CA--C 1.528 0.128 0 N-CA-C 109.898 -0.408 . . . . 0.0 109.898 173.837 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 135' ' ' GLU . . . . . . . . . . . . . 85.4 tt0 -49.89 -25.5 3.25 Favored 'General case' 0 C--N 1.328 -0.357 0 N-CA-C 113.083 0.771 . . . . 0.0 113.083 -170.315 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 136' ' ' GLN . . . . . . . . . . . . . 97.5 mt-30 -92.86 -29.95 15.68 Favored 'General case' 0 C--N 1.33 -0.269 0 N-CA-C 112.581 0.585 . . . . 0.0 112.581 -173.932 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 137' ' ' LYS . . . . . . . . . . . . . 43.8 pttt -161.11 165.69 29.22 Favored 'General case' 0 C--O 1.233 0.212 0 CA-C-O 121.475 0.655 . . . . 0.0 112.19 -173.221 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 138' ' ' LEU . . . . . . . . . . . . . 7.0 tt -117.44 129.92 56.14 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 115.103 -0.953 . . . . 0.0 110.01 178.798 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 139' ' ' THR . . . . . . . . . . . . . 31.0 m -112.57 128.18 56.29 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.157 -0.474 . . . . 0.0 110.51 -179.888 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 140' ' ' LEU . . . . . . . . . . . . . 11.5 tp -117.1 120.82 39.51 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 115.814 -0.63 . . . . 0.0 109.352 -178.761 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 141' ' ' ILE . . . . . . . . . . . . . 19.9 mt -116.96 119.69 62.78 Favored 'Isoleucine or valine' 0 C--O 1.233 0.193 0 CA-C-O 121.037 0.446 . . . . 0.0 110.417 -173.657 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 142' ' ' ARG . . . . . . . . . . . . . 84.2 mtp180 -108.06 133.77 51.89 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 115.009 -0.996 . . . . 0.0 110.507 -177.565 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 143' ' ' THR . . . . . . . . . . . . . 15.1 p . . . . . 0 C--O 1.219 -0.503 0 CA-C-O 117.907 -1.044 . . . . 0.0 110.984 179.886 . . . . . . . . 0 0 . 1 . 010 nuclear orig full ' C' C ' -3' ' ' GLU . . . . . . . . . . . . . 70.8 mm-40 . . . . . 0 N--CA 1.49 1.529 0 N-CA-C 109.394 -0.595 . . . . 0.0 109.394 . . . . . . . . . 0 0 . 1 . 010 nuclear orig full ' C' C ' -2' ' ' GLY . . . . . . . . . . . . . . . -82.09 140.82 21.06 Favored Glycine 0 CA--C 1.524 0.654 0 N-CA-C 110.85 -0.9 . . . . 0.0 110.85 179.398 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' C' C ' -1' ' ' VAL . . . . . . . . . . . . . 46.1 t -95.58 140.61 16.66 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.302 0 CA-C-O 120.785 0.326 . . . . 0.0 110.192 -179.732 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' C' C ' 0' ' ' ILE . . . . . . . . . . . . . 71.1 mt -95.23 131.01 43.19 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.332 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.248 -179.879 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' C' C ' 1' ' ' MET . . . . . . . . . . . . . 25.1 ptp -79.2 148.83 32.12 Favored 'General case' 0 C--N 1.327 -0.395 0 CA-C-N 116.023 -0.535 . . . . 0.0 110.471 178.247 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' C' C ' 2' ' ' SER . . . . . . . . . . . . . 3.3 p -113.73 129.97 56.5 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.315 -0.402 . . . . 0.0 110.487 -179.988 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' C' C ' 3' ' ' GLU . . . . . . . . . . . . . 95.3 mt-10 -140.29 139.34 35.47 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.057 -0.52 . . . . 0.0 110.953 -178.34 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' C' C ' 4' ' ' LEU . . . . . . . . . . . . . 20.2 tp -127.05 128.48 46.35 Favored 'General case' 0 C--N 1.331 -0.221 0 CA-C-N 115.891 -0.595 . . . . 0.0 109.838 176.067 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' C' C ' 5' ' ' LYS . . . . . . . . . . . . . 96.3 mttt -112.48 122.8 48.73 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-O 120.769 0.318 . . . . 0.0 110.872 -178.581 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' C' C ' 6' ' ' LEU . . . . . . . . . . . . . 47.8 mt -114.24 142.61 46.05 Favored 'General case' 0 N--CA 1.462 0.143 0 CA-C-N 115.404 -0.817 . . . . 0.0 110.271 -179.451 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' C' C ' 7' ' ' LYS . . . . . . . . . . . . . 40.1 ttmt -123.45 137.16 28.05 Favored Pre-proline 0 CA--C 1.533 0.305 0 CA-C-O 119.001 -0.523 . . . . 0.0 109.622 175.545 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' C' C ' 8' ' ' PRO . . . . . . . . . . . . . 85.4 Cg_endo -91.83 136.01 1.69 Allowed 'Trans proline' 0 N--CA 1.489 1.231 0 C-N-CA 121.692 1.595 . . . . 0.0 111.895 179.314 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' C' C ' 9' ' ' LEU . . . . . . . . . . . . . 71.1 mt -74.62 -47.65 5.3 Favored Pre-proline 0 CA--C 1.534 0.35 0 CA-C-O 118.578 -0.725 . . . . 0.0 112.283 -179.744 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' C' C ' 10' ' ' PRO . . . . . . . . . . . . . 85.4 Cg_endo -80.15 151.49 20.81 Favored 'Trans proline' 0 N--CA 1.496 1.623 0 C-N-CA 121.162 1.241 . . . . 0.0 111.898 176.82 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' C' C ' 11' ' ' LYS . . . . . . . . . . . . . 50.5 tttp -87.21 98.25 11.22 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-O 120.752 0.311 . . . . 0.0 110.444 178.813 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' C' C ' 12' ' ' VAL . . . . . . . . . . . . . 11.9 p -144.55 144.88 21.86 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.289 0 CA-C-N 116.198 -0.455 . . . . 0.0 110.433 179.954 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' C' C ' 13' ' ' GLU . . . . . . . . . . . . . 95.2 mt-10 -82.05 126.76 32.37 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-N 116.352 -0.385 . . . . 0.0 110.041 177.846 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' C' C ' 14' ' ' LEU . . . . . . . . . . . . . 46.3 mt -95.48 148.48 34.68 Favored Pre-proline 0 C--N 1.329 -0.29 0 CA-C-O 119.235 -0.412 . . . . 0.0 110.4 -179.11 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' C' C ' 15' ' ' PRO . . . . . . . . . . . . . 38.8 Cg_exo -58.65 156.86 30.03 Favored 'Trans proline' 0 N--CA 1.496 1.651 0 C-N-CA 121.187 1.258 . . . . 0.0 111.772 178.97 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' C' C ' 16' ' ' PRO . . . . . . . . . . . . . 35.5 Cg_exo -58.49 -42.84 50.97 Favored 'Trans proline' 0 N--CA 1.498 1.762 0 C-N-CA 121.315 1.344 . . . . 0.0 112.703 -177.206 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' C' C ' 17' ' ' ASP . . . . . . . . . . . . . 12.8 p-10 -86.86 13.21 9.35 Favored 'General case' 0 C--N 1.327 -0.402 0 N-CA-C 112.999 0.741 . . . . 0.0 112.999 -177.961 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' C' C ' 18' ' ' PHE . . . . . . . . . . . . . 44.2 t80 -57.63 -50.52 72.87 Favored 'General case' 0 N--CA 1.456 -0.166 0 O-C-N 121.991 -0.443 . . . . 0.0 110.459 -176.958 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' C' C ' 19' ' ' VAL . . . . . . . . . . . . . 13.9 p -54.25 -40.46 47.62 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.285 0 CA-C-N 116.493 -0.321 . . . . 0.0 111.209 -177.911 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' C' C ' 20' ' ' ASP . . . . . . . . . . . . . 82.5 m-20 -60.53 -44.75 95.75 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-O 120.969 0.414 . . . . 0.0 110.86 -178.566 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' C' C ' 21' ' ' VAL . . . . . . . . . . . . . 46.4 t -64.16 -44.48 97.56 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.319 0 CA-C-N 116.291 -0.413 . . . . 0.0 110.396 -178.141 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' C' C ' 22' ' ' ILE . . . . . . . . . . . . . 50.6 mm -55.9 -44.71 78.8 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.248 0 C-N-CA 121.026 -0.269 . . . . 0.0 110.712 179.019 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' C' C ' 23' ' ' ARG . . . . . . . . . . . . . 55.5 ttp180 -53.8 -50.61 65.74 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-O 120.674 0.274 . . . . 0.0 111.439 179.727 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' C' C ' 24' ' ' ILE . . . . . . . . . . . . . 66.9 mt -58.34 -42.18 83.24 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.274 0 CA-C-N 116.558 -0.292 . . . . 0.0 110.884 -178.183 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' C' C ' 25' ' ' LYS . . . . . . . . . . . . . 53.1 mtpt -66.71 -43.82 83.29 Favored 'General case' 0 C--N 1.328 -0.367 0 N-CA-C 112.531 0.567 . . . . 0.0 112.531 -177.481 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' C' C ' 26' ' ' LEU . . . . . . . . . . . . . 62.9 mt -80.47 -36.23 33.74 Favored 'General case' 0 C--N 1.33 -0.256 0 N-CA-C 113.542 0.941 . . . . 0.0 113.542 -169.117 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' C' C ' 27' ' ' GLN . . . . . . . . . . . . . 10.0 pt20 -46.81 141.01 4.21 Favored 'General case' 0 N--CA 1.47 0.573 0 N-CA-C 112.674 0.62 . . . . 0.0 112.674 -176.006 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' C' C ' 28' ' ' GLY . . . . . . . . . . . . . . . 101.23 -25.77 27.02 Favored Glycine 0 CA--C 1.532 1.107 0 CA-C-N 115.752 -0.658 . . . . 0.0 112.235 -175.959 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' C' C ' 29' ' ' LYS . . . . . . . . . . . . . 73.3 mmtt -97.24 155.11 17.0 Favored 'General case' 0 C--O 1.234 0.247 0 CA-C-N 117.462 0.631 . . . . 0.0 111.191 178.46 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' C' C ' 30' ' ' THR . . . . . . . . . . . . . 23.7 m -104.8 136.01 45.11 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 115.807 -0.633 . . . . 0.0 109.785 174.841 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' C' C ' 31' ' ' VAL . . . . . . . . . . . . . 34.3 m -128.34 154.79 39.53 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.254 0 CA-C-O 120.918 0.39 . . . . 0.0 111.022 -176.916 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' C' C ' 32' ' ' ARG . . . . . . . . . . . . . 94.3 mtm-85 -133.32 150.37 51.87 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-O 121.249 0.547 . . . . 0.0 110.625 178.351 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' C' C ' 33' ' ' THR . . . . . . . . . . . . . 25.9 m -52.45 139.89 23.8 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 116.188 -0.46 . . . . 0.0 111.513 -178.327 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' C' C ' 34' ' ' GLY . . . . . . . . . . . . . . . 99.29 -17.06 58.4 Favored Glycine 0 CA--C 1.532 1.143 0 CA-C-O 119.533 -0.593 . . . . 0.0 113.214 179.228 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' C' C ' 35' ' ' ASP . . . . . . . . . . . . . 59.6 m-20 -63.15 149.76 44.48 Favored 'General case' 0 C--O 1.231 0.126 0 CA-C-N 118.138 0.969 . . . . 0.0 110.911 179.205 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' C' C ' 36' ' ' VAL . . . . . . . . . . . . . 42.0 t -122.45 129.33 75.34 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.251 0 CA-C-N 115.897 -0.592 . . . . 0.0 109.766 179.068 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' C' C ' 37' ' ' ILE . . . . . . . . . . . . . 66.2 mt -122.93 138.65 52.28 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.226 0 CA-C-N 116.265 -0.425 . . . . 0.0 109.968 179.815 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' C' C ' 38' ' ' GLY . . . . . . . . . . . . . . . -118.93 129.0 7.91 Favored Glycine 0 CA--C 1.525 0.683 0 N-CA-C 110.891 -0.884 . . . . 0.0 110.891 178.978 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' C' C ' 39' ' ' ILE . . . . . . . . . . . . . 70.2 mt -125.07 134.53 66.66 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.241 0 CA-C-O 120.764 0.316 . . . . 0.0 110.297 179.269 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' C' C ' 40' ' ' SER . . . . . . . . . . . . . 36.3 t -91.3 117.87 30.02 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.078 -0.51 . . . . 0.0 110.723 176.196 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' C' C ' 41' ' ' ILE . . . . . . . . . . . . . 65.7 mt -126.5 122.25 60.63 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.164 0 CA-C-O 120.816 0.341 . . . . 0.0 110.209 179.506 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' C' C ' 42' ' ' LEU . . . . . . . . . . . . . 5.5 mp 52.9 35.88 20.25 Favored 'General case' 0 CA--C 1.532 0.279 0 CA-C-N 116.186 -0.461 . . . . 0.0 111.399 178.099 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' C' C ' 43' ' ' GLY . . . . . . . . . . . . . . . 73.87 27.99 65.73 Favored Glycine 0 CA--C 1.531 1.087 0 C-N-CA 121.15 -0.548 . . . . 0.0 112.542 176.528 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' C' C ' 44' ' ' LYS . . . . . . . . . . . . . 95.7 mttt -139.52 128.71 23.9 Favored 'General case' 0 C--N 1.33 -0.282 0 N-CA-C 109.744 -0.465 . . . . 0.0 109.744 176.971 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' C' C ' 45' ' ' GLU . . . . . . . . . . . . . 85.2 tt0 -84.08 127.75 34.11 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-O 120.882 0.372 . . . . 0.0 111.533 -177.473 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' C' C ' 46' ' ' VAL . . . . . . . . . . . . . 9.3 p -118.41 126.76 75.34 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.21 0 N-CA-C 109.569 -0.53 . . . . 0.0 109.569 174.342 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' C' C ' 47' ' ' LYS . . . . . . . . . . . . . 75.9 mttt -98.28 123.89 42.61 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.044 -0.526 . . . . 0.0 110.808 178.315 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' C' C ' 48' ' ' PHE . . . . . . . . . . . . . 34.5 m-85 -109.18 131.77 54.75 Favored 'General case' 0 C--N 1.329 -0.299 0 N-CA-C 109.691 -0.485 . . . . 0.0 109.691 176.75 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' C' C ' 49' ' ' LYS . . . . . . . . . . . . . 49.1 tttp -107.37 132.54 53.04 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.432 -0.349 . . . . 0.0 110.164 177.638 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' C' C ' 50' ' ' VAL . . . . . . . . . . . . . 44.5 t -75.6 107.25 6.19 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.327 0 N-CA-C 109.594 -0.521 . . . . 0.0 109.594 178.314 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' C' C ' 51' ' ' VAL . . . . . . . . . . . . . 47.1 t -68.94 -49.12 66.12 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.305 0 CA-C-N 116.116 -0.493 . . . . 0.0 109.721 -175.594 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' C' C ' 52' ' ' GLN . . . . . . . . . . . . . 49.1 tt0 -162.84 143.03 9.38 Favored 'General case' 0 C--N 1.329 -0.291 0 C-N-CA 120.211 -0.596 . . . . 0.0 111.773 -178.836 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' C' C ' 53' ' ' ALA . . . . . . . . . . . . . . . -114.86 130.92 56.97 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 115.32 -0.855 . . . . 0.0 109.456 174.096 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' C' C ' 54' ' ' TYR . . . . . . . . . . . . . 22.2 t80 -128.62 110.27 19.0 Favored Pre-proline 0 CA--C 1.534 0.363 0 CA-C-O 118.34 -0.838 . . . . 0.0 110.306 -178.891 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' C' C ' 55' ' ' PRO . . . . . . . . . . . . . 74.5 Cg_endo -77.23 170.06 72.46 Favored 'Cis proline' 0 N--CA 1.499 1.831 0 CA-C-N 121.827 1.688 . . . . 0.0 112.367 -5.623 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' C' C ' 56' ' ' SER . . . . . . . . . . . . . 13.8 m -114.73 129.13 25.25 Favored Pre-proline 0 CA--C 1.538 0.496 0 CA-C-O 118.451 -0.785 . . . . 0.0 109.451 175.855 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' C' C ' 57' ' ' PRO . . . . . . . . . . . . . 59.6 Cg_endo -73.61 148.95 93.29 Favored 'Cis proline' 0 N--CA 1.497 1.689 0 CA-C-N 121.99 1.747 . . . . 0.0 111.759 -0.352 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' C' C ' 58' ' ' LEU . . . . . . . . . . . . . 23.8 tp -108.3 136.6 47.68 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.376 -0.374 . . . . 0.0 110.836 -178.174 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' C' C ' 59' ' ' ARG . . . . . . . . . . . . . 60.1 ttm-85 -103.13 123.21 46.25 Favored 'General case' 0 C--N 1.329 -0.323 0 N-CA-C 109.242 -0.651 . . . . 0.0 109.242 174.779 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' C' C ' 60' ' ' VAL . . . . . . . . . . . . . 44.1 t -80.56 121.6 34.28 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.264 0 C-N-CA 120.712 -0.395 . . . . 0.0 110.246 -176.94 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' C' C ' 61' ' ' GLU . . . . . . . . . . . . . 40.3 mt-10 -130.72 172.37 12.05 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 115.958 -0.565 . . . . 0.0 109.863 178.821 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' C' C ' 62' ' ' ASP . . . . . . . . . . . . . 60.1 m-20 -54.92 -32.52 61.28 Favored 'General case' 0 C--N 1.328 -0.365 0 N-CA-C 111.773 0.286 . . . . 0.0 111.773 -178.978 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' C' C ' 63' ' ' ARG . . . . . . . . . . . . . 17.5 ptm180 -88.92 6.31 39.94 Favored 'General case' 0 CA--C 1.536 0.437 0 N-CA-C 113.507 0.929 . . . . 0.0 113.507 -176.226 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' C' C ' 64' ' ' THR . . . . . . . . . . . . . 32.8 m -82.39 131.53 35.22 Favored 'General case' 0 C--N 1.331 -0.203 0 CA-C-N 118.143 0.429 . . . . 0.0 110.559 -178.874 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' C' C ' 65' ' ' LYS . . . . . . . . . . . . . 96.6 mttt -88.77 129.34 35.58 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.155 -0.475 . . . . 0.0 110.104 179.744 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' C' C ' 66' ' ' ILE . . . . . . . . . . . . . 64.2 mt -114.17 130.36 68.52 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.252 0 N-CA-C 109.82 -0.437 . . . . 0.0 109.82 179.305 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' C' C ' 67' ' ' THR . . . . . . . . . . . . . 22.4 m -121.53 140.09 52.66 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-N 116.118 -0.492 . . . . 0.0 111.0 -177.732 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' C' C ' 68' ' ' LEU . . . . . . . . . . . . . 44.1 mt -103.71 132.31 50.08 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 115.832 -0.622 . . . . 0.0 110.415 178.173 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' C' C ' 69' ' ' VAL . . . . . . . . . . . . . 42.0 t -96.95 144.44 10.59 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.367 0 CA-C-N 116.164 -0.471 . . . . 0.0 109.891 178.461 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' C' C ' 70' ' ' THR . . . . . . . . . . . . . 68.6 p -130.54 45.34 2.83 Favored 'General case' 0 C--N 1.331 -0.203 0 CA-C-O 121.408 0.623 . . . . 0.0 110.866 -176.675 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' C' C ' 71' ' ' HIS . . . . . . . . . . . . . 58.5 t-80 -131.07 66.23 78.54 Favored Pre-proline 0 CA--C 1.536 0.421 0 CA-C-N 116.097 -0.502 . . . . 0.0 110.277 178.196 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' C' C ' 72' ' ' PRO . . . . . . . . . . . . . 97.7 Cg_endo -91.97 160.04 3.31 Favored 'Trans proline' 0 N--CA 1.49 1.277 0 C-N-CA 121.999 1.799 . . . . 0.0 112.412 179.263 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' C' C ' 73' ' ' VAL . . . . . . . . . . . . . 27.6 m -103.0 165.07 3.15 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.232 0 CA-C-N 116.314 -0.403 . . . . 0.0 110.191 177.326 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' C' C ' 74' ' ' ASP . . . . . . . . . . . . . 3.1 t70 -105.53 121.68 44.44 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.273 -0.421 . . . . 0.0 109.964 -178.563 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' C' C ' 75' ' ' VAL . . . . . . . . . . . . . 40.4 t -117.47 123.77 72.19 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.229 0 CA-C-O 121.095 0.474 . . . . 0.0 110.566 -177.41 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' C' C ' 76' ' ' LEU . . . . . . . . . . . . . 7.0 mp -117.86 142.0 47.8 Favored 'General case' 0 C--N 1.332 -0.189 0 CA-C-N 115.683 -0.689 . . . . 0.0 109.468 176.147 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' C' C ' 77' ' ' GLU . . . . . . . . . . . . . 96.5 mt-10 -133.02 136.94 46.3 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-O 121.022 0.439 . . . . 0.0 111.259 -178.261 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' C' C ' 78' ' ' ALA . . . . . . . . . . . . . . . -126.84 135.44 51.0 Favored 'General case' 0 C--N 1.331 -0.225 0 CA-C-N 115.8 -0.636 . . . . 0.0 109.877 176.428 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' C' C ' 79' ' ' LYS . . . . . . . . . . . . . 90.6 mttt -74.72 122.82 23.85 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-O 120.802 0.334 . . . . 0.0 110.553 -179.678 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' C' C ' 80' ' ' ILE . . . . . . . . . . . . . 26.0 mm -139.16 113.36 7.27 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.306 0 N-CA-C 109.059 -0.719 . . . . 0.0 109.059 -178.47 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' C' C ' 81' ' ' LYS . . . . . . . . . . . . . 19.5 pttp -105.88 124.69 49.97 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-O 121.02 0.438 . . . . 0.0 111.363 -176.225 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' C' C ' 82' ' ' GLY . . . . . . . . . . . . . . . 88.99 42.09 5.73 Favored Glycine 0 CA--C 1.525 0.702 0 C-N-CA 120.73 -0.748 . . . . 0.0 111.75 173.152 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' C' C ' 83' ' ' ILE . . . . . . . . . . . . . 72.9 mt -65.75 136.14 27.2 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.311 0 CA-C-O 121.001 0.429 . . . . 0.0 110.081 178.668 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' C' C ' 84' ' ' LYS . . . . . . . . . . . . . 33.8 tttp -97.42 -53.54 3.43 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 115.824 -0.625 . . . . 0.0 110.128 -178.988 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' C' C ' 85' ' ' ASP . . . . . . . . . . . . . 12.7 t70 -153.99 153.16 31.48 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 115.596 -0.729 . . . . 0.0 110.251 179.569 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' C' C ' 86' ' ' VAL . . . . . . . . . . . . . 47.2 t -129.75 131.32 66.69 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.258 0 CA-C-O 121.003 0.43 . . . . 0.0 110.552 -179.312 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' C' C ' 87' ' ' ILE . . . . . . . . . . . . . 4.8 mp -119.92 127.28 75.88 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.236 0 CA-C-N 115.738 -0.664 . . . . 0.0 109.509 175.529 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' C' C ' 88' ' ' LEU . . . . . . . . . . . . . 11.0 tp -112.66 130.19 56.13 Favored 'General case' 0 C--N 1.331 -0.198 0 CA-C-O 120.994 0.425 . . . . 0.0 111.083 -177.144 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' C' C ' 89' ' ' ASP . . . . . . . . . . . . . 6.3 t70 -128.64 154.25 46.45 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 115.884 -0.598 . . . . 0.0 109.749 177.087 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' C' C ' 90' ' ' GLU . . . . . . . . . . . . . 81.4 tt0 -47.52 -41.41 20.95 Favored 'General case' 0 N--CA 1.464 0.229 0 N-CA-C 112.915 0.709 . . . . 0.0 112.915 -172.952 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' C' C ' 91' ' ' ASN . . . . . . . . . . . . . 19.7 m120 -121.54 16.79 11.25 Favored 'General case' 0 N--CA 1.467 0.401 0 N-CA-C 113.255 0.835 . . . . 0.0 113.255 -175.938 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' C' C ' 92' ' ' LEU . . . . . . . . . . . . . 55.2 mt -150.97 142.78 23.8 Favored 'General case' 0 C--N 1.332 -0.193 0 CA-C-O 120.818 0.342 . . . . 0.0 110.33 -177.096 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' C' C ' 93' ' ' ILE . . . . . . . . . . . . . 69.1 mt -123.28 115.41 45.45 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.32 0 N-CA-C 108.904 -0.776 . . . . 0.0 108.904 175.767 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' C' C ' 94' ' ' VAL . . . . . . . . . . . . . 45.2 t -116.58 123.9 72.11 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.308 0 CA-C-O 120.886 0.374 . . . . 0.0 110.085 -176.765 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' C' C ' 95' ' ' VAL . . . . . . . . . . . . . 42.2 t -121.04 131.92 71.79 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 CA-C-N 116.001 -0.545 . . . . 0.0 109.788 -179.815 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' C' C ' 96' ' ' ILE . . . . . . . . . . . . . 62.9 mt -112.94 127.16 70.33 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.284 0 N-CA-C 109.366 -0.605 . . . . 0.0 109.366 179.439 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' C' C ' 97' ' ' THR . . . . . . . . . . . . . 81.0 p -96.89 154.36 17.34 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-O 120.896 0.379 . . . . 0.0 110.733 -178.965 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' C' C ' 98' ' ' GLU . . . . . . . . . . . . . 97.3 mt-10 -53.91 -25.85 22.27 Favored 'General case' 0 C--N 1.328 -0.329 0 N-CA-C 112.335 0.495 . . . . 0.0 112.335 -179.722 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' C' C ' 99' ' ' GLU . . . . . . . . . . . . . 94.3 mt-10 -77.11 12.27 1.5 Allowed 'General case' 0 CA--C 1.537 0.466 0 N-CA-C 113.218 0.822 . . . . 0.0 113.218 -178.147 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' C' C ' 100' ' ' ASN . . . . . . . . . . . . . 4.0 m-20 65.08 32.81 10.03 Favored 'General case' 0 CA--C 1.531 0.248 0 CA-C-N 117.998 0.363 . . . . 0.0 111.68 178.242 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' C' C ' 101' ' ' GLU . . . . . . . . . . . . . 84.6 tt0 -112.26 143.48 43.27 Favored 'General case' 0 C--O 1.232 0.162 0 N-CA-C 109.457 -0.572 . . . . 0.0 109.457 173.149 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' C' C ' 102' ' ' VAL . . . . . . . . . . . . . 45.3 t -115.52 127.76 72.99 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.336 0 CA-C-O 120.886 0.374 . . . . 0.0 110.165 -177.591 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' C' C ' 103' ' ' LEU . . . . . . . . . . . . . 42.0 mt -114.8 127.42 55.72 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 115.489 -0.778 . . . . 0.0 109.874 176.518 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' C' C ' 104' ' ' ILE . . . . . . . . . . . . . 66.7 mt -116.48 118.52 59.05 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.292 0 N-CA-C 110.054 -0.351 . . . . 0.0 110.054 179.955 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' C' C ' 105' ' ' PHE . . . . . . . . . . . . . 63.8 m-85 -118.37 164.85 14.63 Favored 'General case' 0 C--N 1.333 -0.146 0 O-C-N 123.952 0.782 . . . . 0.0 110.523 179.613 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' C' C ' 106' ' ' ASN . . . . . . . . . . . . . 45.8 p-10 -97.96 -169.97 1.91 Allowed 'General case' 0 C--N 1.33 -0.28 0 N-CA-C 109.699 -0.482 . . . . 0.0 109.699 171.868 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' C' C ' 107' ' ' GLN . . . . . . . . . . . . . 58.7 tt0 -57.66 -29.11 64.35 Favored 'General case' 0 C--N 1.329 -0.291 0 N-CA-C 112.044 0.387 . . . . 0.0 112.044 -179.682 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' C' C ' 108' ' ' ASN . . . . . . . . . . . . . 50.8 t30 -90.4 14.08 13.85 Favored 'General case' 0 CA--C 1.534 0.329 0 N-CA-C 113.103 0.779 . . . . 0.0 113.103 -175.661 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' C' C ' 109' ' ' LEU . . . . . . . . . . . . . 59.9 mt 58.43 35.69 24.89 Favored 'General case' 0 CA--C 1.529 0.165 0 CA-C-O 120.775 0.321 . . . . 0.0 111.651 176.783 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' C' C ' 110' ' ' GLU . . . . . . . . . . . . . 95.4 mt-10 -101.78 152.85 20.38 Favored 'General case' 0 C--N 1.33 -0.254 0 N-CA-C 109.566 -0.531 . . . . 0.0 109.566 175.313 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' C' C ' 111' ' ' GLU . . . . . . . . . . . . . 44.0 tp10 -82.21 121.93 27.25 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-O 120.903 0.382 . . . . 0.0 110.954 -177.673 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' C' C ' 112' ' ' LEU . . . . . . . . . . . . . 17.6 mt -106.53 -45.94 4.12 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.006 -0.543 . . . . 0.0 110.147 177.319 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' C' C ' 113' ' ' TYR . . . . . . . . . . . . . 59.6 t80 -137.88 135.56 36.26 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.079 -0.51 . . . . 0.0 110.929 179.153 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' C' C ' 114' ' ' ARG . . . . . . . . . . . . . 41.1 ttm180 -135.7 119.82 17.67 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.027 -0.533 . . . . 0.0 110.038 177.474 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' C' C ' 115' ' ' GLY . . . . . . . . . . . . . . . -150.03 159.14 27.98 Favored Glycine 0 CA--C 1.525 0.664 0 N-CA-C 111.016 -0.834 . . . . 0.0 111.016 179.168 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' C' C ' 116' ' ' LYS . . . . . . . . . . . . . 69.4 tttt -131.15 130.32 42.91 Favored 'General case' 0 C--N 1.329 -0.316 0 N-CA-C 109.963 -0.384 . . . . 0.0 109.963 178.122 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' C' C ' 117' ' ' PHE . . . . . . . . . . . . . 41.7 m-85 -125.83 117.3 23.09 Favored 'General case' 0 C--N 1.331 -0.215 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.228 -175.271 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' C' C ' 118' ' ' GLU . . . . . . . . . . . . . 81.9 tt0 -51.94 -46.68 64.82 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.428 -0.351 . . . . 0.0 111.702 -176.422 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' C' C ' 119' ' ' ASN . . . . . . . . . . . . . 83.6 m-20 -101.47 31.26 3.82 Favored 'General case' 0 C--N 1.33 -0.239 0 N-CA-C 112.174 0.435 . . . . 0.0 112.174 -173.971 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' C' C ' 120' ' ' LEU . . . . . . . . . . . . . 13.8 tp -53.53 122.97 10.83 Favored 'General case' 0 N--CA 1.464 0.254 0 CA-C-O 120.832 0.349 . . . . 0.0 111.078 179.506 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' C' C ' 121' ' ' ASN . . . . . . . . . . . . . 9.9 t-20 -112.86 -44.07 3.35 Favored 'General case' 0 C--N 1.331 -0.199 0 CA-C-N 116.257 -0.429 . . . . 0.0 110.746 -177.507 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' C' C ' 122' ' ' LYS . . . . . . . . . . . . . 98.4 mttt -147.98 148.53 30.84 Favored 'General case' 0 C--N 1.332 -0.181 0 CA-C-O 121.061 0.458 . . . . 0.0 111.855 -178.593 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' C' C ' 123' ' ' VAL . . . . . . . . . . . . . 45.1 t -129.41 124.58 60.17 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.316 0 N-CA-C 109.175 -0.676 . . . . 0.0 109.175 173.278 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' C' C ' 124' ' ' LEU . . . . . . . . . . . . . 48.0 mt -129.55 143.79 50.98 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-O 120.946 0.403 . . . . 0.0 110.988 -176.175 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' C' C ' 125' ' ' VAL . . . . . . . . . . . . . 11.4 p -135.95 138.64 47.23 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.249 0 CA-C-N 115.881 -0.599 . . . . 0.0 110.235 178.752 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' C' C ' 126' ' ' ARG . . . . . . . . . . . . . 26.8 ttm180 -144.46 127.64 16.66 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-N 116.209 -0.45 . . . . 0.0 110.224 178.557 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' C' C ' 127' ' ' ASN . . . . . . . . . . . . . 80.7 m-20 53.16 -110.4 0.53 Allowed 'General case' 0 CA--C 1.545 0.772 0 CA-C-O 118.843 -0.599 . . . . 0.0 110.927 -179.402 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' C' C ' 128' ' ' ASP . . . . . . . . . . . . . 19.0 p-10 -114.2 5.64 15.96 Favored 'General case' 0 CA--C 1.536 0.416 0 CA-C-N 119.893 1.224 . . . . 0.0 113.384 -177.819 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' C' C ' 129' ' ' LEU . . . . . . . . . . . . . 58.4 mt -108.6 141.11 41.01 Favored 'General case' 0 C--N 1.334 -0.093 0 CA-C-N 118.133 0.424 . . . . 0.0 110.351 -179.185 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' C' C ' 130' ' ' VAL . . . . . . . . . . . . . 42.5 t -122.69 136.73 58.54 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.246 0 N-CA-C 109.884 -0.413 . . . . 0.0 109.884 -179.806 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' C' C ' 131' ' ' VAL . . . . . . . . . . . . . 44.3 t -134.63 135.14 53.88 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.214 0 CA-C-O 121.066 0.46 . . . . 0.0 110.342 -179.591 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' C' C ' 132' ' ' ILE . . . . . . . . . . . . . 68.9 mt -118.43 131.21 71.86 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.264 0 CA-C-N 115.753 -0.658 . . . . 0.0 109.371 178.854 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' C' C ' 133' ' ' ILE . . . . . . . . . . . . . 40.4 mm -116.07 122.77 70.33 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.237 0 CA-C-N 116.515 -0.311 . . . . 0.0 110.913 -175.301 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' C' C ' 134' ' ' ASP . . . . . . . . . . . . . 7.1 p-10 -133.62 148.74 51.58 Favored 'General case' 0 C--N 1.331 -0.224 0 N-CA-C 110.043 -0.354 . . . . 0.0 110.043 174.934 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' C' C ' 135' ' ' GLU . . . . . . . . . . . . . 81.3 tt0 -49.72 -25.11 2.69 Favored 'General case' 0 C--N 1.327 -0.384 0 N-CA-C 112.99 0.737 . . . . 0.0 112.99 -172.206 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' C' C ' 136' ' ' GLN . . . . . . . . . . . . . 63.1 tt0 -88.51 -37.52 15.69 Favored 'General case' 0 C--O 1.234 0.24 0 N-CA-C 112.111 0.411 . . . . 0.0 112.111 -175.656 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' C' C ' 137' ' ' LYS . . . . . . . . . . . . . 45.0 pttt -159.44 169.08 24.7 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-O 121.568 0.699 . . . . 0.0 112.252 -171.34 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' C' C ' 138' ' ' LEU . . . . . . . . . . . . . 6.4 tt -116.33 126.43 53.51 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 114.942 -1.027 . . . . 0.0 109.829 178.362 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' C' C ' 139' ' ' THR . . . . . . . . . . . . . 49.8 m -107.73 128.4 54.54 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.178 -0.464 . . . . 0.0 110.357 179.928 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' C' C ' 140' ' ' LEU . . . . . . . . . . . . . 9.5 tp -114.36 122.65 47.34 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 115.736 -0.665 . . . . 0.0 109.368 -178.748 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' C' C ' 141' ' ' ILE . . . . . . . . . . . . . 19.6 mt -120.18 124.57 72.9 Favored 'Isoleucine or valine' 0 C--O 1.234 0.238 0 CA-C-O 120.912 0.387 . . . . 0.0 110.034 -173.402 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' C' C ' 142' ' ' ARG . . . . . . . . . . . . . 64.9 mtt180 -114.05 130.43 56.56 Favored 'General case' 0 C--O 1.233 0.19 0 CA-C-N 115.574 -0.739 . . . . 0.0 110.05 -175.77 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' C' C ' 143' ' ' THR . . . . . . . . . . . . . 22.5 p . . . . . 0 C--O 1.219 -0.507 0 CA-C-O 118.014 -0.993 . . . . 0.0 110.542 -179.634 . . . . . . . . 0 0 . 1 . 010 nuclear orig full ' D' D ' -3' ' ' GLU . . . . . . . . . . . . . 85.6 tt0 . . . . . 0 N--CA 1.49 1.547 0 N-CA-C 109.303 -0.629 . . . . 0.0 109.303 . . . . . . . . . 0 0 . 1 . 010 nuclear orig full ' D' D ' -2' ' ' GLY . . . . . . . . . . . . . . . -72.12 137.0 24.58 Favored Glycine 0 CA--C 1.524 0.62 0 N-CA-C 111.256 -0.738 . . . . 0.0 111.256 -178.644 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' D' D ' -1' ' ' VAL . . . . . . . . . . . . . 41.7 t -96.45 135.35 30.86 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.337 0 N-CA-C 110.179 -0.304 . . . . 0.0 110.179 179.424 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' D' D ' 0' ' ' ILE . . . . . . . . . . . . . 45.9 mm -115.36 138.01 47.09 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.201 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.115 179.761 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' D' D ' 1' ' ' MET . . . . . . . . . . . . . 24.5 ptp -143.89 163.23 34.02 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.313 -0.403 . . . . 0.0 110.789 -179.435 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' D' D ' 2' ' ' SER . . . . . . . . . . . . . 99.1 p -114.71 157.06 23.67 Favored 'General case' 0 N--CA 1.462 0.149 0 CA-C-N 116.247 -0.433 . . . . 0.0 110.761 -178.357 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' D' D ' 3' ' ' GLU . . . . . . . . . . . . . 95.7 mt-10 -141.65 145.28 34.77 Favored 'General case' 0 C--N 1.331 -0.223 0 CA-C-N 116.031 -0.531 . . . . 0.0 111.246 -177.56 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' D' D ' 4' ' ' LEU . . . . . . . . . . . . . 15.4 tp -125.58 129.45 49.71 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-N 116.047 -0.524 . . . . 0.0 109.936 174.828 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' D' D ' 5' ' ' LYS . . . . . . . . . . . . . 52.4 mttm -110.63 123.63 50.37 Favored 'General case' 0 C--O 1.233 0.235 0 CA-C-O 120.71 0.291 . . . . 0.0 110.857 -179.248 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' D' D ' 6' ' ' LEU . . . . . . . . . . . . . 68.9 mt -116.63 144.57 44.24 Favored 'General case' 0 C--N 1.333 -0.148 0 CA-C-N 115.739 -0.664 . . . . 0.0 110.554 179.838 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' D' D ' 7' ' ' LYS . . . . . . . . . . . . . 55.3 tttm -126.93 141.84 41.79 Favored Pre-proline 0 CA--C 1.533 0.305 0 N-CA-C 109.704 -0.48 . . . . 0.0 109.704 175.293 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' D' D ' 8' ' ' PRO . . . . . . . . . . . . . 87.5 Cg_endo -91.4 144.15 3.17 Favored 'Trans proline' 0 N--CA 1.49 1.308 0 C-N-CA 121.645 1.563 . . . . 0.0 112.271 179.577 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' D' D ' 9' ' ' LEU . . . . . . . . . . . . . 49.6 mt -85.46 -47.17 0.61 Allowed Pre-proline 0 C--N 1.328 -0.334 0 CA-C-O 118.645 -0.693 . . . . 0.0 112.024 178.131 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' D' D ' 10' ' ' PRO . . . . . . . . . . . . . 86.4 Cg_endo -81.03 154.88 19.62 Favored 'Trans proline' 0 N--CA 1.495 1.605 0 C-N-CA 121.244 1.296 . . . . 0.0 111.8 175.956 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' D' D ' 11' ' ' LYS . . . . . . . . . . . . . 60.3 mttp -87.79 95.16 9.98 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-O 120.846 0.355 . . . . 0.0 110.654 178.824 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' D' D ' 12' ' ' VAL . . . . . . . . . . . . . 11.3 p -142.08 139.07 30.51 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.268 0 CA-C-N 116.133 -0.485 . . . . 0.0 110.303 178.691 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' D' D ' 13' ' ' GLU . . . . . . . . . . . . . 42.2 mp0 -82.5 127.15 33.04 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.311 -0.404 . . . . 0.0 110.06 178.313 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' D' D ' 14' ' ' LEU . . . . . . . . . . . . . 47.0 mt -93.68 149.69 37.53 Favored Pre-proline 0 C--N 1.329 -0.288 0 CA-C-O 119.207 -0.425 . . . . 0.0 110.27 -178.917 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' D' D ' 15' ' ' PRO . . . . . . . . . . . . . 25.6 Cg_exo -61.74 159.41 33.05 Favored 'Trans proline' 0 N--CA 1.497 1.7 0 C-N-CA 121.158 1.238 . . . . 0.0 111.381 177.007 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' D' D ' 16' ' ' PRO . . . . . . . . . . . . . 26.5 Cg_exo -60.78 -31.98 92.42 Favored 'Trans proline' 0 N--CA 1.497 1.731 0 C-N-CA 121.368 1.378 . . . . 0.0 112.362 -179.343 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' D' D ' 17' ' ' ASP . . . . . . . . . . . . . 10.2 p-10 -90.38 9.19 29.94 Favored 'General case' 0 CA--C 1.536 0.423 0 N-CA-C 113.166 0.802 . . . . 0.0 113.166 -178.506 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' D' D ' 18' ' ' PHE . . . . . . . . . . . . . 41.2 t80 -57.86 -46.73 84.38 Favored 'General case' 0 CA--C 1.522 -0.108 0 O-C-N 122.006 -0.434 . . . . 0.0 110.298 -176.915 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' D' D ' 19' ' ' VAL . . . . . . . . . . . . . 45.9 t -55.33 -44.25 74.67 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.259 0 CA-C-N 116.379 -0.373 . . . . 0.0 110.8 -177.555 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' D' D ' 20' ' ' ASP . . . . . . . . . . . . . 75.6 m-20 -59.87 -43.63 94.61 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-O 120.86 0.362 . . . . 0.0 110.965 -176.918 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' D' D ' 21' ' ' VAL . . . . . . . . . . . . . 48.9 t -64.62 -47.68 87.93 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.251 0 C-N-CA 120.817 -0.353 . . . . 0.0 110.54 -177.861 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' D' D ' 22' ' ' ILE . . . . . . . . . . . . . 47.1 mm -56.05 -44.4 78.47 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.282 0 CA-C-O 120.796 0.332 . . . . 0.0 110.557 179.3 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' D' D ' 23' ' ' ARG . . . . . . . . . . . . . 54.6 ttp180 -53.22 -52.29 59.4 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-O 120.848 0.356 . . . . 0.0 111.378 -179.662 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' D' D ' 24' ' ' ILE . . . . . . . . . . . . . 71.8 mt -59.08 -40.94 82.02 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.268 0 CA-C-N 116.232 -0.44 . . . . 0.0 111.404 -176.561 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' D' D ' 25' ' ' LYS . . . . . . . . . . . . . 55.8 mmtt -67.89 -39.88 83.57 Favored 'General case' 0 C--N 1.33 -0.279 0 N-CA-C 112.462 0.541 . . . . 0.0 112.462 -178.796 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' D' D ' 26' ' ' LEU . . . . . . . . . . . . . 76.2 mt -78.29 -39.29 40.31 Favored 'General case' 0 C--N 1.329 -0.284 0 N-CA-C 113.255 0.835 . . . . 0.0 113.255 -169.825 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' D' D ' 27' ' ' GLN . . . . . . . . . . . . . 10.1 pt20 -46.6 138.67 5.74 Favored 'General case' 0 N--CA 1.47 0.559 0 N-CA-C 112.742 0.645 . . . . 0.0 112.742 -175.81 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' D' D ' 28' ' ' GLY . . . . . . . . . . . . . . . 102.34 -26.3 24.71 Favored Glycine 0 CA--C 1.533 1.174 0 CA-C-N 115.638 -0.71 . . . . 0.0 112.297 -176.767 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' D' D ' 29' ' ' LYS . . . . . . . . . . . . . 61.5 mttm -98.45 155.19 17.37 Favored 'General case' 0 CA--C 1.528 0.105 0 CA-C-N 117.364 0.582 . . . . 0.0 111.045 178.191 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' D' D ' 30' ' ' THR . . . . . . . . . . . . . 55.5 m -107.2 138.72 42.87 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-N 116.155 -0.475 . . . . 0.0 109.906 175.937 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' D' D ' 31' ' ' VAL . . . . . . . . . . . . . 34.7 m -130.43 159.07 42.78 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.232 0 CA-C-O 120.817 0.341 . . . . 0.0 111.019 -178.016 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' D' D ' 32' ' ' ARG . . . . . . . . . . . . . 96.8 mtt180 -132.58 149.07 52.37 Favored 'General case' 0 C--N 1.332 -0.176 0 CA-C-N 115.934 -0.576 . . . . 0.0 110.662 178.65 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' D' D ' 33' ' ' THR . . . . . . . . . . . . . 18.7 m -52.96 140.4 24.93 Favored 'General case' 0 C--N 1.331 -0.23 0 CA-C-N 116.33 -0.396 . . . . 0.0 111.412 -179.387 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' D' D ' 34' ' ' GLY . . . . . . . . . . . . . . . 99.17 -17.1 58.48 Favored Glycine 0 CA--C 1.532 1.13 0 CA-C-O 119.62 -0.545 . . . . 0.0 113.274 179.335 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' D' D ' 35' ' ' ASP . . . . . . . . . . . . . 77.9 m-20 -66.61 148.9 51.26 Favored 'General case' 0 C--O 1.231 0.112 0 CA-C-N 118.037 0.919 . . . . 0.0 111.131 179.076 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' D' D ' 36' ' ' VAL . . . . . . . . . . . . . 45.5 t -119.56 128.7 75.88 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.213 0 CA-C-N 115.931 -0.577 . . . . 0.0 109.734 177.962 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' D' D ' 37' ' ' ILE . . . . . . . . . . . . . 63.3 mt -120.1 138.25 51.29 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.271 0 CA-C-N 116.158 -0.474 . . . . 0.0 109.83 -179.179 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' D' D ' 38' ' ' GLY . . . . . . . . . . . . . . . -118.38 128.86 7.91 Favored Glycine 0 CA--C 1.524 0.638 0 N-CA-C 111.058 -0.817 . . . . 0.0 111.058 -179.859 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' D' D ' 39' ' ' ILE . . . . . . . . . . . . . 68.0 mt -123.88 129.78 74.2 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.196 0 N-CA-C 110.026 -0.361 . . . . 0.0 110.026 178.808 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' D' D ' 40' ' ' SER . . . . . . . . . . . . . 20.3 t -92.09 117.42 29.82 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.142 -0.481 . . . . 0.0 110.734 176.453 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' D' D ' 41' ' ' ILE . . . . . . . . . . . . . 72.6 mt -131.95 122.56 49.43 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.232 0 CA-C-O 120.813 0.34 . . . . 0.0 110.095 178.376 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' D' D ' 42' ' ' LEU . . . . . . . . . . . . . 76.3 mt 58.3 34.9 24.48 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.023 -0.535 . . . . 0.0 111.506 179.012 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' D' D ' 43' ' ' GLY . . . . . . . . . . . . . . . 77.23 -10.15 22.8 Favored Glycine 0 CA--C 1.535 1.342 0 CA-C-O 119.785 -0.453 . . . . 0.0 113.427 178.123 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' D' D ' 44' ' ' LYS . . . . . . . . . . . . . 21.4 tptm -99.86 128.21 45.97 Favored 'General case' 0 C--N 1.332 -0.175 0 CA-C-N 117.915 0.858 . . . . 0.0 110.064 178.452 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' D' D ' 45' ' ' GLU . . . . . . . . . . . . . 85.0 tt0 -85.25 129.65 34.76 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.393 -0.367 . . . . 0.0 111.239 179.911 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' D' D ' 46' ' ' VAL . . . . . . . . . . . . . 10.3 p -119.14 124.19 72.69 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.16 0 N-CA-C 109.654 -0.499 . . . . 0.0 109.654 174.82 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' D' D ' 47' ' ' LYS . . . . . . . . . . . . . 63.6 mttp -98.19 125.07 43.08 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.072 -0.513 . . . . 0.0 110.614 177.24 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' D' D ' 48' ' ' PHE . . . . . . . . . . . . . 40.0 m-85 -111.4 131.83 54.9 Favored 'General case' 0 C--N 1.329 -0.29 0 N-CA-C 109.481 -0.562 . . . . 0.0 109.481 176.985 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' D' D ' 49' ' ' LYS . . . . . . . . . . . . . 42.2 tttp -107.36 132.1 53.52 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.29 -0.413 . . . . 0.0 110.206 179.08 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' D' D ' 50' ' ' VAL . . . . . . . . . . . . . 41.9 t -74.86 105.03 3.59 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.289 0 N-CA-C 109.34 -0.615 . . . . 0.0 109.34 177.495 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' D' D ' 51' ' ' VAL . . . . . . . . . . . . . 51.4 t -72.3 -48.6 47.55 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.331 0 CA-C-N 116.182 -0.463 . . . . 0.0 109.996 -174.038 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' D' D ' 52' ' ' GLN . . . . . . . . . . . . . 60.2 tt0 -162.21 148.21 13.13 Favored 'General case' 0 C--N 1.329 -0.29 0 C-N-CA 120.242 -0.583 . . . . 0.0 111.757 -179.21 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' D' D ' 53' ' ' ALA . . . . . . . . . . . . . . . -126.33 134.47 51.09 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 115.597 -0.729 . . . . 0.0 110.117 177.892 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' D' D ' 54' ' ' TYR . . . . . . . . . . . . . 59.9 t80 -129.09 111.06 18.3 Favored Pre-proline 0 CA--C 1.535 0.376 0 CA-C-O 118.198 -0.906 . . . . 0.0 110.086 177.879 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' D' D ' 55' ' ' PRO . . . . . . . . . . . . . 72.5 Cg_endo -77.19 169.93 72.86 Favored 'Cis proline' 0 N--CA 1.5 1.887 0 CA-C-N 121.932 1.726 . . . . 0.0 112.643 -4.822 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' D' D ' 56' ' ' SER . . . . . . . . . . . . . 13.6 m -118.49 130.82 24.55 Favored Pre-proline 0 CA--C 1.539 0.545 0 CA-C-O 118.431 -0.795 . . . . 0.0 109.743 174.737 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' D' D ' 57' ' ' PRO . . . . . . . . . . . . . 32.9 Cg_endo -65.16 167.65 46.12 Favored 'Cis proline' 0 N--CA 1.498 1.753 0 CA-C-N 121.953 1.733 . . . . 0.0 111.147 -2.952 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' D' D ' 58' ' ' LEU . . . . . . . . . . . . . 14.9 tp -128.38 134.79 48.9 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-O 121.069 0.461 . . . . 0.0 110.255 -179.812 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' D' D ' 59' ' ' ARG . . . . . . . . . . . . . 58.6 ttt-85 -103.05 119.58 39.11 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 115.406 -0.815 . . . . 0.0 109.133 176.817 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' D' D ' 60' ' ' VAL . . . . . . . . . . . . . 40.6 t -74.17 117.07 17.57 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.315 0 C-N-CA 120.867 -0.333 . . . . 0.0 110.731 -172.939 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' D' D ' 61' ' ' GLU . . . . . . . . . . . . . 40.5 mt-10 -131.08 161.18 32.62 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 115.982 -0.554 . . . . 0.0 109.952 175.977 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' D' D ' 62' ' ' ASP . . . . . . . . . . . . . 61.6 m-20 -52.09 -31.43 30.44 Favored 'General case' 0 C--N 1.328 -0.33 0 N-CA-C 112.157 0.428 . . . . 0.0 112.157 -177.664 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' D' D ' 63' ' ' ARG . . . . . . . . . . . . . 78.3 mtp180 -72.58 -22.04 61.05 Favored 'General case' 0 CA--C 1.532 0.268 0 N-CA-C 113.091 0.775 . . . . 0.0 113.091 -174.607 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' D' D ' 64' ' ' THR . . . . . . . . . . . . . 34.5 m -71.2 140.39 50.45 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-O 120.888 0.375 . . . . 0.0 111.244 -175.118 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' D' D ' 65' ' ' LYS . . . . . . . . . . . . . 3.9 mptp? -90.06 138.76 31.24 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 115.85 -0.614 . . . . 0.0 110.261 178.196 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' D' D ' 66' ' ' ILE . . . . . . . . . . . . . 60.6 mt -114.1 128.25 71.15 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.231 0 N-CA-C 109.658 -0.497 . . . . 0.0 109.658 178.754 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' D' D ' 67' ' ' THR . . . . . . . . . . . . . 15.5 m -122.35 146.71 47.07 Favored 'General case' 0 C--N 1.332 -0.159 0 CA-C-O 121.233 0.54 . . . . 0.0 111.133 -176.253 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' D' D ' 68' ' ' LEU . . . . . . . . . . . . . 15.1 tp -102.38 140.46 36.63 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 115.647 -0.706 . . . . 0.0 110.765 -179.467 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' D' D ' 69' ' ' VAL . . . . . . . . . . . . . 46.6 t -82.93 155.3 3.85 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 CA-C-N 116.078 -0.51 . . . . 0.0 109.848 177.851 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' D' D ' 70' ' ' THR . . . . . . . . . . . . . 7.6 m -79.62 158.82 26.99 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-O 121.116 0.484 . . . . 0.0 110.942 -174.01 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' D' D ' 71' ' ' HIS . . . . . . . . . . . . . 79.9 m80 -65.14 156.96 79.25 Favored Pre-proline 0 CA--C 1.534 0.352 0 CA-C-N 115.563 -0.744 . . . . 0.0 112.055 -173.578 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' D' D ' 72' ' ' PRO . . . . . . . . . . . . . 57.2 Cg_endo -71.97 160.17 48.35 Favored 'Trans proline' 0 N--CA 1.496 1.647 0 C-N-CA 121.704 1.603 . . . . 0.0 112.673 178.175 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' D' D ' 73' ' ' VAL . . . . . . . . . . . . . 33.5 m -69.82 -171.59 0.08 OUTLIER 'Isoleucine or valine' 0 C--N 1.33 -0.27 0 CA-C-N 116.122 -0.49 . . . . 0.0 110.124 179.898 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' D' D ' 74' ' ' ASP . . . . . . . . . . . . . 22.4 t0 -84.56 118.36 24.29 Favored 'General case' 0 C--N 1.33 -0.258 0 C-N-CA 120.601 -0.44 . . . . 0.0 110.295 -172.538 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' D' D ' 75' ' ' VAL . . . . . . . . . . . . . 39.4 t -122.22 121.93 65.15 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.271 0 CA-C-O 120.961 0.41 . . . . 0.0 110.659 -176.948 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' D' D ' 76' ' ' LEU . . . . . . . . . . . . . 5.8 mp -122.03 149.13 43.94 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 115.735 -0.666 . . . . 0.0 109.39 174.861 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' D' D ' 77' ' ' GLU . . . . . . . . . . . . . 96.5 mt-10 -136.68 137.12 39.67 Favored 'General case' 0 C--N 1.332 -0.189 0 CA-C-O 121.16 0.505 . . . . 0.0 111.516 -176.644 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' D' D ' 78' ' ' ALA . . . . . . . . . . . . . . . -123.58 135.37 53.94 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 115.587 -0.733 . . . . 0.0 109.414 175.156 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' D' D ' 79' ' ' LYS . . . . . . . . . . . . . 59.4 mtpt -82.73 120.63 25.84 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-O 120.907 0.384 . . . . 0.0 111.129 -176.42 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' D' D ' 80' ' ' ILE . . . . . . . . . . . . . 40.2 mm -139.19 105.8 2.63 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.305 0 N-CA-C 109.103 -0.703 . . . . 0.0 109.103 -178.769 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' D' D ' 81' ' ' LYS . . . . . . . . . . . . . 19.2 pttp -98.14 128.69 44.77 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-O 120.869 0.366 . . . . 0.0 111.225 -176.544 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' D' D ' 82' ' ' GLY . . . . . . . . . . . . . . . 89.21 41.99 5.69 Favored Glycine 0 CA--C 1.524 0.651 0 C-N-CA 120.685 -0.769 . . . . 0.0 111.52 176.2 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' D' D ' 83' ' ' ILE . . . . . . . . . . . . . 71.7 mt -65.3 139.25 21.67 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.328 0 CA-C-O 121.009 0.433 . . . . 0.0 110.046 178.86 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' D' D ' 84' ' ' LYS . . . . . . . . . . . . . 59.5 tttm -99.17 -53.93 3.11 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 115.89 -0.595 . . . . 0.0 109.906 -179.609 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' D' D ' 85' ' ' ASP . . . . . . . . . . . . . 13.4 t70 -156.7 150.11 24.37 Favored 'General case' 0 C--N 1.326 -0.42 0 CA-C-N 115.646 -0.706 . . . . 0.0 110.187 -179.991 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' D' D ' 86' ' ' VAL . . . . . . . . . . . . . 42.8 t -128.41 128.74 68.6 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.279 0 CA-C-O 120.93 0.395 . . . . 0.0 110.41 -179.227 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' D' D ' 87' ' ' ILE . . . . . . . . . . . . . 44.1 mm -118.08 127.63 75.26 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.284 0 CA-C-N 115.824 -0.626 . . . . 0.0 109.488 176.679 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' D' D ' 88' ' ' LEU . . . . . . . . . . . . . 18.7 tp -112.74 133.65 54.65 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-O 121.137 0.494 . . . . 0.0 111.123 -177.64 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' D' D ' 89' ' ' ASP . . . . . . . . . . . . . 10.7 t70 -125.35 158.51 34.07 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 115.587 -0.733 . . . . 0.0 109.431 176.256 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' D' D ' 90' ' ' GLU . . . . . . . . . . . . . 96.0 mt-10 -46.74 -37.74 8.96 Favored 'General case' 0 C--N 1.331 -0.237 0 N-CA-C 113.17 0.804 . . . . 0.0 113.17 -172.138 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' D' D ' 91' ' ' ASN . . . . . . . . . . . . . 4.7 p-10 -132.04 23.35 4.54 Favored 'General case' 0 N--CA 1.467 0.413 0 N-CA-C 112.815 0.672 . . . . 0.0 112.815 -177.747 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' D' D ' 92' ' ' LEU . . . . . . . . . . . . . 16.5 mt -148.97 144.45 26.79 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-O 120.858 0.361 . . . . 0.0 110.56 -176.522 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' D' D ' 93' ' ' ILE . . . . . . . . . . . . . 71.4 mt -122.6 115.31 45.61 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.316 0 N-CA-C 109.224 -0.658 . . . . 0.0 109.224 176.728 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' D' D ' 94' ' ' VAL . . . . . . . . . . . . . 44.9 t -117.06 123.0 71.31 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.267 0 N-CA-C 109.867 -0.42 . . . . 0.0 109.867 -178.932 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' D' D ' 95' ' ' VAL . . . . . . . . . . . . . 42.0 t -120.18 133.75 65.89 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.236 0 CA-C-N 116.021 -0.536 . . . . 0.0 110.025 -178.039 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' D' D ' 96' ' ' ILE . . . . . . . . . . . . . 56.1 mt -113.88 130.76 67.46 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 N-CA-C 109.124 -0.695 . . . . 0.0 109.124 177.145 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' D' D ' 97' ' ' THR . . . . . . . . . . . . . 68.6 p -103.48 157.18 17.21 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-O 120.872 0.368 . . . . 0.0 110.988 -178.638 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' D' D ' 98' ' ' GLU . . . . . . . . . . . . . 97.4 mt-10 -53.89 -22.89 10.96 Favored 'General case' 0 CA--C 1.535 0.375 0 N-CA-C 112.307 0.484 . . . . 0.0 112.307 179.121 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' D' D ' 99' ' ' GLU . . . . . . . . . . . . . 95.6 mt-10 -77.49 12.55 1.54 Allowed 'General case' 0 CA--C 1.536 0.441 0 N-CA-C 113.208 0.818 . . . . 0.0 113.208 -178.714 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' D' D ' 100' ' ' ASN . . . . . . . . . . . . . 3.0 m-20 61.85 37.46 15.36 Favored 'General case' 0 CA--C 1.531 0.217 0 CA-C-O 121.023 0.439 . . . . 0.0 110.979 179.833 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' D' D ' 101' ' ' GLU . . . . . . . . . . . . . 85.4 tt0 -116.84 145.63 43.43 Favored 'General case' 0 C--N 1.333 -0.137 0 CA-C-N 116.086 -0.506 . . . . 0.0 109.886 176.239 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' D' D ' 102' ' ' VAL . . . . . . . . . . . . . 42.9 t -117.64 127.1 75.07 Favored 'Isoleucine or valine' 0 C--O 1.233 0.224 0 CA-C-N 116.277 -0.42 . . . . 0.0 109.929 -178.284 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' D' D ' 103' ' ' LEU . . . . . . . . . . . . . 63.0 mt -119.57 134.61 55.15 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 115.991 -0.549 . . . . 0.0 110.511 178.058 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' D' D ' 104' ' ' ILE . . . . . . . . . . . . . 66.1 mt -120.99 120.18 61.52 Favored 'Isoleucine or valine' 0 C--O 1.234 0.252 0 CA-C-N 116.567 -0.288 . . . . 0.0 110.513 -179.09 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' D' D ' 105' ' ' PHE . . . . . . . . . . . . . 54.2 m-85 -120.53 167.71 12.11 Favored 'General case' 0 N--CA 1.462 0.146 0 O-C-N 124.066 0.854 . . . . 0.0 109.829 177.707 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' D' D ' 106' ' ' ASN . . . . . . . . . . . . . 47.5 p-10 -104.04 -170.39 1.77 Allowed 'General case' 0 CA--C 1.532 0.264 0 N-CA-C 110.221 -0.288 . . . . 0.0 110.221 173.091 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' D' D ' 107' ' ' GLN . . . . . . . . . . . . . 61.7 tt0 -57.75 -29.85 65.12 Favored 'General case' 0 CA--C 1.532 0.286 0 N-CA-C 111.97 0.359 . . . . 0.0 111.97 178.987 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' D' D ' 108' ' ' ASN . . . . . . . . . . . . . 10.2 t-20 -86.52 12.7 9.81 Favored 'General case' 0 CA--C 1.535 0.367 0 N-CA-C 112.922 0.712 . . . . 0.0 112.922 -176.681 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' D' D ' 109' ' ' LEU . . . . . . . . . . . . . 26.4 mt 56.76 32.34 21.06 Favored 'General case' 0 CA--C 1.53 0.211 0 N-CA-C 111.75 0.278 . . . . 0.0 111.75 179.356 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' D' D ' 110' ' ' GLU . . . . . . . . . . . . . 69.3 mm-40 -98.27 143.38 28.81 Favored 'General case' 0 C--N 1.33 -0.28 0 N-CA-C 109.258 -0.645 . . . . 0.0 109.258 175.372 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' D' D ' 111' ' ' GLU . . . . . . . . . . . . . 58.9 tt0 -83.33 121.88 27.72 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-O 121.082 0.467 . . . . 0.0 110.344 -177.162 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' D' D ' 112' ' ' LEU . . . . . . . . . . . . . 23.7 mt -104.31 -45.83 4.57 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 115.816 -0.629 . . . . 0.0 110.413 -178.759 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' D' D ' 113' ' ' TYR . . . . . . . . . . . . . 61.1 t80 -140.39 140.75 35.56 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.096 -0.502 . . . . 0.0 111.008 -178.361 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' D' D ' 114' ' ' ARG . . . . . . . . . . . . . 35.6 ptt-85 -142.21 125.41 16.41 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.305 -0.407 . . . . 0.0 110.489 176.427 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' D' D ' 115' ' ' GLY . . . . . . . . . . . . . . . -150.14 159.79 28.26 Favored Glycine 0 CA--C 1.522 0.522 0 N-CA-C 110.691 -0.964 . . . . 0.0 110.691 179.203 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' D' D ' 116' ' ' LYS . . . . . . . . . . . . . 2.1 ttmp? -127.84 138.95 52.88 Favored 'General case' 0 C--N 1.329 -0.312 0 N-CA-C 110.027 -0.361 . . . . 0.0 110.027 177.566 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' D' D ' 117' ' ' PHE . . . . . . . . . . . . . 43.8 m-85 -135.68 113.89 11.43 Favored 'General case' 0 C--N 1.331 -0.23 0 CA-C-N 116.207 -0.451 . . . . 0.0 109.895 -177.032 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' D' D ' 118' ' ' GLU . . . . . . . . . . . . . 70.8 mm-40 -54.69 -42.66 71.68 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.448 -0.342 . . . . 0.0 111.294 -176.3 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' D' D ' 119' ' ' ASN . . . . . . . . . . . . . 19.9 m120 -100.94 31.03 3.75 Favored 'General case' 0 C--N 1.331 -0.227 0 N-CA-C 112.188 0.44 . . . . 0.0 112.188 -174.287 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' D' D ' 120' ' ' LEU . . . . . . . . . . . . . 16.3 tp -56.96 121.1 9.14 Favored 'General case' 0 N--CA 1.462 0.167 0 C-N-CA 121.009 -0.276 . . . . 0.0 110.345 177.727 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' D' D ' 121' ' ' ASN . . . . . . . . . . . . . 60.5 m-20 -114.2 -44.06 3.16 Favored 'General case' 0 C--N 1.332 -0.154 0 CA-C-N 116.678 -0.237 . . . . 0.0 111.26 -176.898 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' D' D ' 122' ' ' LYS . . . . . . . . . . . . . 39.0 ttpt -144.82 143.12 30.47 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-O 120.953 0.406 . . . . 0.0 111.343 -175.976 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' D' D ' 123' ' ' VAL . . . . . . . . . . . . . 43.6 t -128.77 134.23 64.8 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.219 0 CA-C-N 116.172 -0.467 . . . . 0.0 109.762 177.18 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' D' D ' 124' ' ' LEU . . . . . . . . . . . . . 59.0 mt -129.51 135.27 48.41 Favored 'General case' 0 C--N 1.331 -0.196 0 CA-C-O 120.815 0.341 . . . . 0.0 110.949 -179.048 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' D' D ' 125' ' ' VAL . . . . . . . . . . . . . 10.6 p -132.33 131.12 60.67 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.274 0 CA-C-N 116.11 -0.496 . . . . 0.0 109.958 177.526 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' D' D ' 126' ' ' ARG . . . . . . . . . . . . . 53.8 ttm-85 -143.08 116.04 8.83 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.462 -0.335 . . . . 0.0 110.815 -178.72 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' D' D ' 127' ' ' ASN . . . . . . . . . . . . . 3.1 m120 51.97 -105.0 0.2 Allowed 'General case' 0 CA--C 1.544 0.721 0 CA-C-O 119.172 -0.442 . . . . 0.0 111.323 178.214 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' D' D ' 128' ' ' ASP . . . . . . . . . . . . . 19.1 p-10 -113.9 3.95 15.62 Favored 'General case' 0 CA--C 1.538 0.496 0 CA-C-N 119.42 1.009 . . . . 0.0 113.426 -176.208 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' D' D ' 129' ' ' LEU . . . . . . . . . . . . . 21.6 tp -110.43 137.01 48.71 Favored 'General case' 0 C--N 1.331 -0.222 0 CA-C-N 118.047 0.385 . . . . 0.0 110.05 178.857 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' D' D ' 130' ' ' VAL . . . . . . . . . . . . . 54.6 t -124.99 137.25 58.2 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.284 0 CA-C-O 120.833 0.349 . . . . 0.0 110.15 -179.475 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' D' D ' 131' ' ' VAL . . . . . . . . . . . . . 42.9 t -135.98 136.27 49.84 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.274 0 CA-C-N 116.271 -0.422 . . . . 0.0 110.363 179.698 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' D' D ' 132' ' ' ILE . . . . . . . . . . . . . 74.1 mt -119.33 133.37 66.35 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.298 0 N-CA-C 109.52 -0.548 . . . . 0.0 109.52 178.784 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' D' D ' 133' ' ' ILE . . . . . . . . . . . . . 40.4 mm -119.12 124.3 72.88 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.223 0 CA-C-O 120.829 0.347 . . . . 0.0 111.315 -174.831 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' D' D ' 134' ' ' ASP . . . . . . . . . . . . . 9.7 p-10 -137.68 150.1 47.07 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-N 116.307 -0.406 . . . . 0.0 109.932 173.637 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' D' D ' 135' ' ' GLU . . . . . . . . . . . . . 86.0 tt0 -49.77 -22.93 1.57 Allowed 'General case' 0 C--N 1.328 -0.359 0 N-CA-C 113.067 0.765 . . . . 0.0 113.067 -174.21 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' D' D ' 136' ' ' GLN . . . . . . . . . . . . . 63.1 tt0 -93.16 -28.76 16.11 Favored 'General case' 0 C--O 1.234 0.265 0 N-CA-C 112.384 0.512 . . . . 0.0 112.384 -174.004 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' D' D ' 137' ' ' LYS . . . . . . . . . . . . . 47.7 pttt -166.04 170.58 13.4 Favored 'General case' 0 C--N 1.332 -0.185 0 CA-C-O 121.55 0.69 . . . . 0.0 112.317 -172.849 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' D' D ' 138' ' ' LEU . . . . . . . . . . . . . 5.6 tt -121.96 128.61 51.7 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 114.882 -1.053 . . . . 0.0 109.836 178.797 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' D' D ' 139' ' ' THR . . . . . . . . . . . . . 26.4 m -109.69 132.65 53.95 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-N 116.198 -0.455 . . . . 0.0 110.629 -179.254 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' D' D ' 140' ' ' LEU . . . . . . . . . . . . . 12.1 tp -118.58 124.14 46.74 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 115.583 -0.735 . . . . 0.0 109.381 -178.425 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' D' D ' 141' ' ' ILE . . . . . . . . . . . . . 19.6 mt -120.48 119.62 60.32 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.344 0 N-CA-C 109.87 -0.418 . . . . 0.0 109.87 -175.795 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' D' D ' 142' ' ' ARG . . . . . . . . . . . . . 7.8 mmm180 -109.03 126.13 52.81 Favored 'General case' 0 C--N 1.331 -0.227 0 CA-C-N 115.496 -0.775 . . . . 0.0 110.508 -177.857 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' D' D ' 143' ' ' THR . . . . . . . . . . . . . 49.5 p . . . . . 0 C--O 1.219 -0.501 0 CA-C-O 117.998 -1.001 . . . . 0.0 110.627 -179.864 . . . . . . . . 0 0 . 1 . 010 nuclear orig full ' E' E ' -3' ' ' GLU . . . . . . . . . . . . . 95.7 mt-10 . . . . . 0 N--CA 1.491 1.578 0 N-CA-C 109.289 -0.634 . . . . 0.0 109.289 . . . . . . . . . 0 0 . 1 . 010 nuclear orig full ' E' E ' -2' ' ' GLY . . . . . . . . . . . . . . . -73.35 120.82 7.24 Favored Glycine 0 CA--C 1.524 0.654 0 N-CA-C 110.894 -0.882 . . . . 0.0 110.894 179.463 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' E' E ' -1' ' ' VAL . . . . . . . . . . . . . 40.8 t -96.41 136.15 28.19 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.273 0 N-CA-C 110.17 -0.307 . . . . 0.0 110.17 179.849 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' E' E ' 0' ' ' ILE . . . . . . . . . . . . . 70.5 mt -104.35 135.87 40.22 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.321 0 N-CA-C 109.936 -0.394 . . . . 0.0 109.936 -179.588 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' E' E ' 1' ' ' MET . . . . . . . . . . . . . 24.3 ptp -143.46 154.0 43.21 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.044 -0.526 . . . . 0.0 110.66 -178.342 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' E' E ' 2' ' ' SER . . . . . . . . . . . . . 94.5 p -116.97 152.12 35.25 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-O 121.106 0.479 . . . . 0.0 110.637 -179.771 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' E' E ' 3' ' ' GLU . . . . . . . . . . . . . 82.4 tt0 -140.63 143.99 35.49 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 115.935 -0.575 . . . . 0.0 110.851 -177.842 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' E' E ' 4' ' ' LEU . . . . . . . . . . . . . 20.6 tp -124.86 130.87 53.24 Favored 'General case' 0 C--N 1.331 -0.216 0 CA-C-N 116.016 -0.538 . . . . 0.0 110.176 177.673 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' E' E ' 5' ' ' LYS . . . . . . . . . . . . . 61.3 mttp -108.44 121.84 45.78 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-O 120.876 0.37 . . . . 0.0 110.616 178.856 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' E' E ' 6' ' ' LEU . . . . . . . . . . . . . 67.2 mt -114.05 150.21 34.31 Favored 'General case' 0 C--N 1.331 -0.217 0 CA-C-N 115.548 -0.751 . . . . 0.0 110.702 -179.982 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' E' E ' 7' ' ' LYS . . . . . . . . . . . . . 84.6 tttt -140.46 140.11 22.06 Favored Pre-proline 0 CA--C 1.534 0.354 0 CA-C-O 119.09 -0.481 . . . . 0.0 110.02 175.189 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' E' E ' 8' ' ' PRO . . . . . . . . . . . . . 95.2 Cg_endo -92.01 143.7 2.76 Favored 'Trans proline' 0 N--CA 1.49 1.315 0 C-N-CA 121.765 1.643 . . . . 0.0 111.73 177.593 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' E' E ' 9' ' ' LEU . . . . . . . . . . . . . 60.7 mt -78.36 -47.51 1.99 Allowed Pre-proline 0 CA--C 1.533 0.298 0 CA-C-O 118.715 -0.66 . . . . 0.0 112.242 -179.257 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' E' E ' 10' ' ' PRO . . . . . . . . . . . . . 92.9 Cg_endo -80.36 153.84 21.26 Favored 'Trans proline' 0 N--CA 1.496 1.63 0 C-N-CA 121.067 1.178 . . . . 0.0 111.904 176.129 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' E' E ' 11' ' ' LYS . . . . . . . . . . . . . 55.7 mtmt -88.35 98.95 11.89 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.376 -0.374 . . . . 0.0 110.604 179.312 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' E' E ' 12' ' ' VAL . . . . . . . . . . . . . 11.2 p -145.06 144.04 21.91 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.294 0 CA-C-N 116.111 -0.495 . . . . 0.0 110.357 -179.718 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' E' E ' 13' ' ' GLU . . . . . . . . . . . . . 95.4 mt-10 -85.02 121.51 27.9 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.176 -0.465 . . . . 0.0 109.972 177.774 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' E' E ' 14' ' ' LEU . . . . . . . . . . . . . 20.0 mt -93.62 156.5 39.58 Favored Pre-proline 0 C--N 1.329 -0.323 0 CA-C-N 116.349 -0.387 . . . . 0.0 110.784 -177.188 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' E' E ' 15' ' ' PRO . . . . . . . . . . . . . 27.0 Cg_exo -60.73 155.07 50.8 Favored 'Trans proline' 0 N--CA 1.496 1.625 0 C-N-CA 121.354 1.369 . . . . 0.0 111.764 179.614 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' E' E ' 16' ' ' PRO . . . . . . . . . . . . . 32.3 Cg_exo -57.63 -36.48 98.51 Favored 'Trans proline' 0 N--CA 1.497 1.689 0 C-N-CA 121.328 1.352 . . . . 0.0 112.572 179.598 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' E' E ' 17' ' ' ASP . . . . . . . . . . . . . 8.8 p-10 -88.74 13.78 11.65 Favored 'General case' 0 CA--C 1.535 0.389 0 N-CA-C 113.027 0.751 . . . . 0.0 113.027 -177.74 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' E' E ' 18' ' ' PHE . . . . . . . . . . . . . 40.8 t80 -58.43 -44.37 89.08 Favored 'General case' 0 C--N 1.333 -0.134 0 O-C-N 121.968 -0.457 . . . . 0.0 110.198 -178.599 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' E' E ' 19' ' ' VAL . . . . . . . . . . . . . 14.4 p -58.42 -46.42 89.46 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.354 0 CA-C-N 116.459 -0.337 . . . . 0.0 111.807 -174.83 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' E' E ' 20' ' ' ASP . . . . . . . . . . . . . 2.7 p-10 -64.75 -36.17 83.44 Favored 'General case' 0 N--CA 1.463 0.224 0 C-N-CA 120.655 -0.418 . . . . 0.0 111.169 -177.383 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' E' E ' 21' ' ' VAL . . . . . . . . . . . . . 48.2 t -63.95 -48.19 87.2 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.217 0 C-N-CA 120.632 -0.427 . . . . 0.0 110.193 179.374 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' E' E ' 22' ' ' ILE . . . . . . . . . . . . . 51.0 mm -56.17 -43.09 75.15 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.216 0 C-N-CA 121.019 -0.272 . . . . 0.0 110.416 177.321 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' E' E ' 23' ' ' ARG . . . . . . . . . . . . . 43.2 ttp180 -52.1 -51.11 59.84 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-O 120.723 0.297 . . . . 0.0 111.498 -179.457 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' E' E ' 24' ' ' ILE . . . . . . . . . . . . . 70.3 mt -59.78 -41.69 86.4 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.256 0 CA-C-N 116.471 -0.331 . . . . 0.0 110.963 -179.047 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' E' E ' 25' ' ' LYS . . . . . . . . . . . . . 60.6 mtpt -62.98 -41.85 99.68 Favored 'General case' 0 C--N 1.327 -0.388 0 N-CA-C 112.076 0.399 . . . . 0.0 112.076 -178.598 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' E' E ' 26' ' ' LEU . . . . . . . . . . . . . 72.4 mt -80.42 -39.65 27.88 Favored 'General case' 0 C--N 1.33 -0.256 0 N-CA-C 113.27 0.841 . . . . 0.0 113.27 -170.916 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' E' E ' 27' ' ' GLN . . . . . . . . . . . . . 9.1 pt20 -46.59 135.08 8.93 Favored 'General case' 0 N--CA 1.468 0.462 0 N-CA-C 113.003 0.742 . . . . 0.0 113.003 -174.768 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' E' E ' 28' ' ' GLY . . . . . . . . . . . . . . . 100.44 -21.79 42.68 Favored Glycine 0 CA--C 1.534 1.251 0 CA-C-N 115.523 -0.762 . . . . 0.0 112.719 -178.416 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' E' E ' 29' ' ' LYS . . . . . . . . . . . . . 65.6 mttm -98.79 155.12 17.52 Favored 'General case' 0 C--O 1.232 0.177 0 CA-C-N 117.512 0.656 . . . . 0.0 111.29 -179.767 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' E' E ' 30' ' ' THR . . . . . . . . . . . . . 38.1 m -104.07 133.64 48.66 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 115.901 -0.591 . . . . 0.0 109.73 175.223 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' E' E ' 31' ' ' VAL . . . . . . . . . . . . . 33.6 m -131.72 154.91 41.14 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.211 0 CA-C-O 121.03 0.443 . . . . 0.0 111.343 -176.984 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' E' E ' 32' ' ' ARG . . . . . . . . . . . . . 55.7 mtp180 -132.25 152.33 51.4 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 115.771 -0.65 . . . . 0.0 110.436 177.553 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' E' E ' 33' ' ' THR . . . . . . . . . . . . . 20.5 m -53.18 139.68 28.36 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.271 -0.422 . . . . 0.0 111.322 -179.121 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' E' E ' 34' ' ' GLY . . . . . . . . . . . . . . . 100.82 -17.28 56.61 Favored Glycine 0 CA--C 1.532 1.126 0 CA-C-O 119.608 -0.551 . . . . 0.0 113.279 179.709 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' E' E ' 35' ' ' ASP . . . . . . . . . . . . . 66.7 m-20 -65.93 149.58 49.99 Favored 'General case' 0 C--O 1.231 0.131 0 CA-C-N 118.036 0.918 . . . . 0.0 110.998 179.059 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' E' E ' 36' ' ' VAL . . . . . . . . . . . . . 46.4 t -122.1 131.75 72.48 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.196 0 CA-C-N 115.911 -0.586 . . . . 0.0 110.134 179.825 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' E' E ' 37' ' ' ILE . . . . . . . . . . . . . 67.7 mt -119.92 139.02 48.62 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.245 0 CA-C-N 116.086 -0.506 . . . . 0.0 109.797 178.637 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' E' E ' 38' ' ' GLY . . . . . . . . . . . . . . . -113.48 128.99 8.6 Favored Glycine 0 CA--C 1.526 0.741 0 N-CA-C 111.139 -0.784 . . . . 0.0 111.139 -179.614 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' E' E ' 39' ' ' ILE . . . . . . . . . . . . . 72.1 mt -123.43 135.78 62.15 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.186 0 N-CA-C 110.015 -0.365 . . . . 0.0 110.015 178.656 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' E' E ' 40' ' ' SER . . . . . . . . . . . . . 30.0 t -92.67 123.02 35.65 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.225 -0.443 . . . . 0.0 110.835 175.8 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' E' E ' 41' ' ' ILE . . . . . . . . . . . . . 71.4 mt -131.34 114.57 26.36 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.214 0 N-CA-C 110.08 -0.341 . . . . 0.0 110.08 177.69 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' E' E ' 42' ' ' LEU . . . . . . . . . . . . . 84.4 mt 58.11 33.28 23.01 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.038 -0.528 . . . . 0.0 111.797 178.893 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' E' E ' 43' ' ' GLY . . . . . . . . . . . . . . . 83.24 -10.18 59.18 Favored Glycine 0 CA--C 1.535 1.283 0 C-N-CA 121.156 -0.545 . . . . 0.0 113.497 177.018 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' E' E ' 44' ' ' LYS . . . . . . . . . . . . . 64.6 mttp -98.46 136.18 38.96 Favored 'General case' 0 C--N 1.333 -0.115 0 CA-C-N 117.892 0.846 . . . . 0.0 110.271 177.785 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' E' E ' 45' ' ' GLU . . . . . . . . . . . . . 84.3 tt0 -85.26 128.87 34.85 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-N 116.464 -0.334 . . . . 0.0 111.373 179.946 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' E' E ' 46' ' ' VAL . . . . . . . . . . . . . 7.4 p -121.8 126.33 74.47 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.18 0 N-CA-C 109.457 -0.571 . . . . 0.0 109.457 174.697 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' E' E ' 47' ' ' LYS . . . . . . . . . . . . . 61.6 mttm -100.06 129.18 46.08 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-N 116.052 -0.522 . . . . 0.0 111.162 179.004 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' E' E ' 48' ' ' PHE . . . . . . . . . . . . . 92.6 m-85 -111.43 131.93 54.83 Favored 'General case' 0 C--N 1.332 -0.182 0 CA-C-N 116.28 -0.418 . . . . 0.0 109.954 176.28 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' E' E ' 49' ' ' LYS . . . . . . . . . . . . . 54.8 tttp -107.68 137.17 46.17 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.464 -0.335 . . . . 0.0 110.564 179.368 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' E' E ' 50' ' ' VAL . . . . . . . . . . . . . 45.6 t -79.92 108.25 13.2 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.25 0 N-CA-C 109.258 -0.645 . . . . 0.0 109.258 174.894 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' E' E ' 51' ' ' VAL . . . . . . . . . . . . . 48.7 t -71.46 -47.62 57.74 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.326 0 CA-C-N 116.223 -0.444 . . . . 0.0 110.004 -173.795 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' E' E ' 52' ' ' GLN . . . . . . . . . . . . . 62.3 tt0 -166.13 143.83 5.45 Favored 'General case' 0 C--N 1.329 -0.307 0 C-N-CA 120.441 -0.504 . . . . 0.0 111.847 -178.952 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' E' E ' 53' ' ' ALA . . . . . . . . . . . . . . . -119.66 134.11 55.36 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 115.915 -0.584 . . . . 0.0 109.774 175.599 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' E' E ' 54' ' ' TYR . . . . . . . . . . . . . 10.9 t80 -129.1 112.33 18.42 Favored Pre-proline 0 CA--C 1.534 0.348 0 CA-C-O 118.191 -0.909 . . . . 0.0 110.028 177.917 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' E' E ' 55' ' ' PRO . . . . . . . . . . . . . 71.7 Cg_endo -77.2 170.17 72.2 Favored 'Cis proline' 0 N--CA 1.5 1.911 0 CA-C-N 122.002 1.751 . . . . 0.0 112.527 -5.94 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' E' E ' 56' ' ' SER . . . . . . . . . . . . . 15.8 m -123.47 139.02 31.12 Favored Pre-proline 0 CA--C 1.539 0.545 0 CA-C-O 118.553 -0.737 . . . . 0.0 109.443 174.06 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' E' E ' 57' ' ' PRO . . . . . . . . . . . . . 37.6 Cg_endo -67.45 145.2 73.48 Favored 'Cis proline' 0 N--CA 1.498 1.773 0 CA-C-N 121.616 1.613 . . . . 0.0 111.53 -3.128 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' E' E ' 58' ' ' LEU . . . . . . . . . . . . . 16.2 tp -107.99 139.05 43.19 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-O 120.999 0.428 . . . . 0.0 110.837 -177.331 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' E' E ' 59' ' ' ARG . . . . . . . . . . . . . 21.3 ttm180 -102.45 122.54 44.52 Favored 'General case' 0 C--N 1.327 -0.389 0 N-CA-C 108.985 -0.746 . . . . 0.0 108.985 173.393 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' E' E ' 60' ' ' VAL . . . . . . . . . . . . . 45.6 t -81.55 119.17 30.62 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.35 0 C-N-CA 120.689 -0.404 . . . . 0.0 110.634 -174.281 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' E' E ' 61' ' ' GLU . . . . . . . . . . . . . 95.5 mt-10 -131.19 160.96 33.3 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 115.765 -0.652 . . . . 0.0 109.71 175.422 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' E' E ' 62' ' ' ASP . . . . . . . . . . . . . 10.9 p-10 -52.77 -29.93 30.08 Favored 'General case' 0 C--N 1.328 -0.363 0 N-CA-C 112.067 0.395 . . . . 0.0 112.067 -179.302 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' E' E ' 63' ' ' ARG . . . . . . . . . . . . . 60.0 mtp180 -72.35 -22.06 61.22 Favored 'General case' 0 CA--C 1.533 0.295 0 N-CA-C 113.002 0.742 . . . . 0.0 113.002 -175.616 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' E' E ' 64' ' ' THR . . . . . . . . . . . . . 36.8 m -66.7 142.27 57.48 Favored 'General case' 0 C--N 1.331 -0.225 0 CA-C-O 120.983 0.421 . . . . 0.0 110.913 -176.444 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' E' E ' 65' ' ' LYS . . . . . . . . . . . . . 46.6 mtmt -88.4 129.52 35.4 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 115.938 -0.574 . . . . 0.0 109.912 177.684 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' E' E ' 66' ' ' ILE . . . . . . . . . . . . . 60.7 mt -113.54 126.65 71.03 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.347 0 N-CA-C 109.976 -0.379 . . . . 0.0 109.976 -178.089 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' E' E ' 67' ' ' THR . . . . . . . . . . . . . 25.8 m -127.14 149.73 49.82 Favored 'General case' 0 C--N 1.331 -0.226 0 CA-C-O 121.147 0.498 . . . . 0.0 111.112 -176.896 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' E' E ' 68' ' ' LEU . . . . . . . . . . . . . 72.3 mt -106.46 147.15 29.67 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 115.909 -0.587 . . . . 0.0 110.791 179.543 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' E' E ' 69' ' ' VAL . . . . . . . . . . . . . 45.9 t -82.83 155.23 3.87 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.281 0 CA-C-N 115.906 -0.588 . . . . 0.0 109.731 177.208 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' E' E ' 70' ' ' THR . . . . . . . . . . . . . 69.8 p -79.49 162.85 25.16 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-O 121.108 0.48 . . . . 0.0 111.033 -172.959 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' E' E ' 71' ' ' HIS . . . . . . . . . . . . . 48.4 m80 -75.84 168.47 27.48 Favored Pre-proline 0 CA--C 1.533 0.311 0 CA-C-N 115.544 -0.753 . . . . 0.0 111.676 -174.982 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' E' E ' 72' ' ' PRO . . . . . . . . . . . . . 18.6 Cg_exo -65.04 160.16 43.02 Favored 'Trans proline' 0 N--CA 1.495 1.594 0 C-N-CA 121.7 1.6 . . . . 0.0 112.132 177.513 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' E' E ' 73' ' ' VAL . . . . . . . . . . . . . 32.6 m -69.77 165.12 2.67 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.279 0 CA-C-N 116.124 -0.489 . . . . 0.0 110.634 -176.894 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' E' E ' 74' ' ' ASP . . . . . . . . . . . . . 42.1 t0 -93.3 122.54 35.8 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-N 116.348 -0.387 . . . . 0.0 110.264 -175.607 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' E' E ' 75' ' ' VAL . . . . . . . . . . . . . 41.3 t -116.97 123.34 71.71 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.237 0 CA-C-O 121.051 0.453 . . . . 0.0 110.345 -178.845 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' E' E ' 76' ' ' LEU . . . . . . . . . . . . . 20.4 mt -123.82 148.73 46.47 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 115.659 -0.701 . . . . 0.0 109.64 178.518 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' E' E ' 77' ' ' GLU . . . . . . . . . . . . . 46.0 mt-10 -139.1 136.39 35.14 Favored 'General case' 0 C--N 1.331 -0.208 0 CA-C-O 121.052 0.453 . . . . 0.0 111.334 -177.946 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' E' E ' 78' ' ' ALA . . . . . . . . . . . . . . . -123.42 134.82 53.91 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 115.707 -0.678 . . . . 0.0 109.724 176.28 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' E' E ' 79' ' ' LYS . . . . . . . . . . . . . 77.8 mttt -77.98 121.51 24.3 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-O 120.791 0.329 . . . . 0.0 110.837 -177.065 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' E' E ' 80' ' ' ILE . . . . . . . . . . . . . 38.2 mm -139.21 109.95 4.57 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.327 0 N-CA-C 109.538 -0.541 . . . . 0.0 109.538 -178.571 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' E' E ' 81' ' ' LYS . . . . . . . . . . . . . 15.4 ptpt -103.85 126.84 51.26 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-O 121.114 0.483 . . . . 0.0 111.102 -177.808 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' E' E ' 82' ' ' GLY . . . . . . . . . . . . . . . 89.13 42.11 5.68 Favored Glycine 0 CA--C 1.524 0.624 0 N-CA-C 111.512 -0.635 . . . . 0.0 111.512 175.047 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' E' E ' 83' ' ' ILE . . . . . . . . . . . . . 72.0 mt -67.63 140.24 19.57 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.293 0 CA-C-O 120.889 0.376 . . . . 0.0 110.132 179.252 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' E' E ' 84' ' ' LYS . . . . . . . . . . . . . 82.6 tttt -100.82 -53.85 2.96 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 115.895 -0.593 . . . . 0.0 110.089 -179.403 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' E' E ' 85' ' ' ASP . . . . . . . . . . . . . 5.8 t70 -157.57 155.66 30.58 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 115.731 -0.668 . . . . 0.0 110.477 -178.577 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' E' E ' 86' ' ' VAL . . . . . . . . . . . . . 42.9 t -133.27 132.67 58.26 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.258 0 CA-C-O 121.02 0.438 . . . . 0.0 110.533 -178.662 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' E' E ' 87' ' ' ILE . . . . . . . . . . . . . 43.3 mm -117.63 130.5 72.42 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.259 0 CA-C-N 115.813 -0.631 . . . . 0.0 109.503 174.714 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' E' E ' 88' ' ' LEU . . . . . . . . . . . . . 18.6 tp -114.7 134.61 54.95 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-O 121.127 0.489 . . . . 0.0 111.493 -175.995 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' E' E ' 89' ' ' ASP . . . . . . . . . . . . . 7.0 t70 -127.39 155.37 43.74 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 115.605 -0.725 . . . . 0.0 109.426 174.931 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' E' E ' 90' ' ' GLU . . . . . . . . . . . . . 96.0 mt-10 -47.49 -42.07 22.16 Favored 'General case' 0 N--CA 1.463 0.217 0 N-CA-C 112.781 0.659 . . . . 0.0 112.781 -172.862 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' E' E ' 91' ' ' ASN . . . . . . . . . . . . . 87.2 m-20 -132.02 39.9 3.39 Favored 'General case' 0 C--O 1.233 0.227 0 CA-C-O 120.871 0.367 . . . . 0.0 111.161 -178.279 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' E' E ' 92' ' ' LEU . . . . . . . . . . . . . 10.5 tp -166.11 141.77 4.82 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.517 -0.311 . . . . 0.0 110.521 -179.579 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' E' E ' 93' ' ' ILE . . . . . . . . . . . . . 65.1 mt -126.98 124.34 64.4 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.283 0 N-CA-C 109.695 -0.483 . . . . 0.0 109.695 -178.965 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' E' E ' 94' ' ' VAL . . . . . . . . . . . . . 41.9 t -121.64 124.7 72.2 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.28 0 N-CA-C 109.794 -0.447 . . . . 0.0 109.794 179.71 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' E' E ' 95' ' ' VAL . . . . . . . . . . . . . 45.6 t -122.53 135.5 62.43 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.237 0 CA-C-N 116.443 -0.344 . . . . 0.0 110.147 -178.952 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' E' E ' 96' ' ' ILE . . . . . . . . . . . . . 60.0 mt -117.54 130.99 71.56 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.294 0 CA-C-N 115.954 -0.566 . . . . 0.0 109.476 179.155 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' E' E ' 97' ' ' THR . . . . . . . . . . . . . 40.7 p -101.01 157.37 16.8 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-O 121.095 0.474 . . . . 0.0 111.127 -179.403 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' E' E ' 98' ' ' GLU . . . . . . . . . . . . . 46.0 mt-10 -54.85 -29.49 55.4 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.231 -0.44 . . . . 0.0 112.138 -179.216 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' E' E ' 99' ' ' GLU . . . . . . . . . . . . . 71.2 mm-40 -78.64 14.18 1.39 Allowed 'General case' 0 CA--C 1.536 0.409 0 N-CA-C 113.124 0.787 . . . . 0.0 113.124 -177.361 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' E' E ' 100' ' ' ASN . . . . . . . . . . . . . 38.1 m-20 63.46 36.23 11.46 Favored 'General case' 0 N--CA 1.462 0.141 0 CA-C-O 120.947 0.403 . . . . 0.0 111.585 178.728 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' E' E ' 101' ' ' GLU . . . . . . . . . . . . . 84.8 tt0 -107.38 140.21 40.67 Favored 'General case' 0 C--N 1.331 -0.201 0 N-CA-C 109.372 -0.603 . . . . 0.0 109.372 170.989 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' E' E ' 102' ' ' VAL . . . . . . . . . . . . . 47.9 t -115.1 128.53 72.24 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.269 0 CA-C-N 116.256 -0.429 . . . . 0.0 109.9 -178.187 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' E' E ' 103' ' ' LEU . . . . . . . . . . . . . 31.0 mt -120.42 131.31 54.73 Favored 'General case' 0 C--N 1.331 -0.215 0 CA-C-N 115.757 -0.656 . . . . 0.0 110.368 177.43 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' E' E ' 104' ' ' ILE . . . . . . . . . . . . . 65.8 mt -117.64 121.61 67.87 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.241 0 CA-C-N 116.346 -0.388 . . . . 0.0 110.007 179.038 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' E' E ' 105' ' ' PHE . . . . . . . . . . . . . 75.6 m-85 -121.87 165.24 16.21 Favored 'General case' 0 C--N 1.332 -0.158 0 O-C-N 123.885 0.741 . . . . 0.0 109.823 179.819 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' E' E ' 106' ' ' ASN . . . . . . . . . . . . . 46.6 p-10 -100.21 -169.99 1.81 Allowed 'General case' 0 C--N 1.329 -0.291 0 N-CA-C 109.716 -0.476 . . . . 0.0 109.716 173.437 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' E' E ' 107' ' ' GLN . . . . . . . . . . . . . 46.7 tt0 -59.27 -30.06 68.02 Favored 'General case' 0 C--N 1.329 -0.301 0 N-CA-C 111.89 0.33 . . . . 0.0 111.89 179.2 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' E' E ' 108' ' ' ASN . . . . . . . . . . . . . 58.6 t30 -82.19 6.94 15.01 Favored 'General case' 0 CA--C 1.536 0.429 0 N-CA-C 113.161 0.8 . . . . 0.0 113.161 -177.536 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' E' E ' 109' ' ' LEU . . . . . . . . . . . . . 7.4 tp 59.69 34.79 22.21 Favored 'General case' 0 C--O 1.232 0.167 0 O-C-N 122.07 -0.394 . . . . 0.0 111.602 179.42 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' E' E ' 110' ' ' GLU . . . . . . . . . . . . . 42.7 mt-10 -101.9 148.67 25.05 Favored 'General case' 0 C--N 1.33 -0.282 0 N-CA-C 109.52 -0.548 . . . . 0.0 109.52 175.118 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' E' E ' 111' ' ' GLU . . . . . . . . . . . . . 53.0 tt0 -81.98 121.97 27.2 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-O 120.849 0.357 . . . . 0.0 110.759 -176.288 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' E' E ' 112' ' ' LEU . . . . . . . . . . . . . 14.5 mt -106.91 -45.89 4.07 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.071 -0.513 . . . . 0.0 110.594 -179.958 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' E' E ' 113' ' ' TYR . . . . . . . . . . . . . 49.4 t80 -134.88 134.85 41.13 Favored 'General case' 0 C--N 1.331 -0.209 0 CA-C-N 116.28 -0.418 . . . . 0.0 111.026 -178.489 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' E' E ' 114' ' ' ARG . . . . . . . . . . . . . 78.7 ttt-85 -134.06 121.74 21.97 Favored 'General case' 0 C--N 1.331 -0.2 0 CA-C-N 116.04 -0.527 . . . . 0.0 110.262 179.655 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' E' E ' 115' ' ' GLY . . . . . . . . . . . . . . . -150.11 146.67 16.06 Favored Glycine 0 CA--C 1.523 0.553 0 N-CA-C 111.114 -0.794 . . . . 0.0 111.114 179.007 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' E' E ' 116' ' ' LYS . . . . . . . . . . . . . 61.8 tttm -128.04 126.88 42.13 Favored 'General case' 0 C--N 1.33 -0.267 0 N-CA-C 109.734 -0.469 . . . . 0.0 109.734 177.087 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' E' E ' 117' ' ' PHE . . . . . . . . . . . . . 33.6 m-85 -125.22 117.28 23.5 Favored 'General case' 0 N--CA 1.463 0.203 0 CA-C-O 121.037 0.446 . . . . 0.0 110.455 -174.47 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' E' E ' 118' ' ' GLU . . . . . . . . . . . . . 84.0 tt0 -52.08 -50.76 60.93 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.367 -0.379 . . . . 0.0 111.537 -177.891 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' E' E ' 119' ' ' ASN . . . . . . . . . . . . . 23.9 m120 -94.53 31.17 1.82 Allowed 'General case' 0 C--N 1.33 -0.243 0 N-CA-C 112.2 0.444 . . . . 0.0 112.2 -174.735 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' E' E ' 120' ' ' LEU . . . . . . . . . . . . . 20.5 tp -56.4 124.51 18.34 Favored 'General case' 0 N--CA 1.462 0.136 0 C-N-CA 120.992 -0.283 . . . . 0.0 110.448 177.789 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' E' E ' 121' ' ' ASN . . . . . . . . . . . . . 33.6 m120 -113.58 -43.97 3.26 Favored 'General case' 0 C--N 1.331 -0.217 0 CA-C-N 116.588 -0.278 . . . . 0.0 111.137 -175.948 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' E' E ' 122' ' ' LYS . . . . . . . . . . . . . 39.6 ttpt -148.59 147.29 28.83 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-O 121.016 0.436 . . . . 0.0 111.419 -176.888 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' E' E ' 123' ' ' VAL . . . . . . . . . . . . . 46.2 t -132.41 135.71 57.41 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.281 0 CA-C-N 116.021 -0.536 . . . . 0.0 109.644 176.06 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' E' E ' 124' ' ' LEU . . . . . . . . . . . . . 37.8 mt -132.8 141.63 48.58 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-O 120.791 0.329 . . . . 0.0 110.973 -178.567 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' E' E ' 125' ' ' VAL . . . . . . . . . . . . . 10.6 p -139.26 141.54 35.55 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.23 0 CA-C-N 116.258 -0.428 . . . . 0.0 110.309 177.964 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' E' E ' 126' ' ' ARG . . . . . . . . . . . . . 35.0 ptt-85 -150.88 126.77 10.36 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.09 -0.505 . . . . 0.0 110.579 178.486 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' E' E ' 127' ' ' ASN . . . . . . . . . . . . . 39.2 m-20 49.17 -107.37 0.23 Allowed 'General case' 0 CA--C 1.546 0.807 0 CA-C-O 119.033 -0.508 . . . . 0.0 111.792 178.715 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' E' E ' 128' ' ' ASP . . . . . . . . . . . . . 11.2 p-10 -114.06 11.88 17.78 Favored 'General case' 0 N--CA 1.467 0.408 0 CA-C-N 119.627 1.103 . . . . 0.0 113.416 -175.33 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' E' E ' 129' ' ' LEU . . . . . . . . . . . . . 81.9 mt -120.04 140.74 50.53 Favored 'General case' 0 C--N 1.333 -0.143 0 CA-C-N 118.058 0.39 . . . . 0.0 110.274 178.978 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' E' E ' 130' ' ' VAL . . . . . . . . . . . . . 46.2 t -128.25 138.91 53.35 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.212 0 N-CA-C 109.741 -0.466 . . . . 0.0 109.741 -179.988 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' E' E ' 131' ' ' VAL . . . . . . . . . . . . . 41.6 t -134.53 138.03 50.34 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.321 0 CA-C-N 116.287 -0.415 . . . . 0.0 110.242 -179.725 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' E' E ' 132' ' ' ILE . . . . . . . . . . . . . 72.9 mt -119.55 132.61 68.85 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.306 0 N-CA-C 109.374 -0.602 . . . . 0.0 109.374 179.942 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' E' E ' 133' ' ' ILE . . . . . . . . . . . . . 39.7 mm -117.64 119.23 61.02 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.253 0 CA-C-N 116.307 -0.406 . . . . 0.0 110.883 -175.991 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' E' E ' 134' ' ' ASP . . . . . . . . . . . . . 8.1 p-10 -131.68 146.46 52.19 Favored 'General case' 0 C--N 1.331 -0.217 0 N-CA-C 109.536 -0.542 . . . . 0.0 109.536 174.504 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' E' E ' 135' ' ' GLU . . . . . . . . . . . . . 43.5 tp10 -49.88 -23.66 2.05 Favored 'General case' 0 C--N 1.328 -0.344 0 N-CA-C 112.941 0.719 . . . . 0.0 112.941 -172.061 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' E' E ' 136' ' ' GLN . . . . . . . . . . . . . 55.6 tp60 -100.97 -27.91 13.03 Favored 'General case' 0 C--O 1.233 0.237 0 N-CA-C 112.46 0.541 . . . . 0.0 112.46 -174.838 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' E' E ' 137' ' ' LYS . . . . . . . . . . . . . 86.6 mttt -142.39 151.35 41.76 Favored 'General case' 0 C--N 1.332 -0.193 0 CA-C-O 121.464 0.649 . . . . 0.0 112.188 -170.396 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' E' E ' 138' ' ' LEU . . . . . . . . . . . . . 14.3 tp -112.49 122.21 47.05 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 115.11 -0.95 . . . . 0.0 108.925 171.977 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' E' E ' 139' ' ' THR . . . . . . . . . . . . . 24.0 m -114.61 124.08 50.95 Favored 'General case' 0 C--N 1.331 -0.212 0 CA-C-O 120.82 0.343 . . . . 0.0 110.868 -177.92 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' E' E ' 140' ' ' LEU . . . . . . . . . . . . . 13.2 tp -111.48 118.48 35.88 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 115.5 -0.773 . . . . 0.0 108.926 178.73 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' E' E ' 141' ' ' ILE . . . . . . . . . . . . . 19.6 mt -119.77 114.31 43.8 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.193 0 N-CA-C 109.726 -0.472 . . . . 0.0 109.726 -176.009 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' E' E ' 142' ' ' ARG . . . . . . . . . . . . . 79.5 mtm180 -90.98 113.67 25.98 Favored 'General case' 0 C--N 1.326 -0.43 0 CA-C-N 115.882 -0.599 . . . . 0.0 110.621 178.039 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' E' E ' 143' ' ' THR . . . . . . . . . . . . . 2.4 p . . . . . 0 C--O 1.221 -0.447 0 CA-C-O 117.951 -1.023 . . . . 0.0 110.559 -179.229 . . . . . . . . 0 0 . 1 . 010 nuclear orig full ' F' F ' -3' ' ' GLU . . . . . . . . . . . . . 84.9 tt0 . . . . . 0 N--CA 1.49 1.545 0 N-CA-C 109.298 -0.63 . . . . 0.0 109.298 . . . . . . . . . 0 0 . 1 . 010 nuclear orig full ' F' F ' -2' ' ' GLY . . . . . . . . . . . . . . . -73.79 149.95 42.21 Favored Glycine 0 CA--C 1.526 0.739 0 N-CA-C 110.804 -0.918 . . . . 0.0 110.804 179.193 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' F' F ' -1' ' ' VAL . . . . . . . . . . . . . 42.3 t -93.84 134.87 30.03 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 CA-C-O 120.874 0.369 . . . . 0.0 110.068 -179.894 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' F' F ' 0' ' ' ILE . . . . . . . . . . . . . 70.9 mt -111.76 133.63 56.8 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.185 0 CA-C-N 116.16 -0.473 . . . . 0.0 109.877 179.685 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' F' F ' 1' ' ' MET . . . . . . . . . . . . . 25.1 ptt? -82.86 139.28 33.55 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.18 -0.463 . . . . 0.0 110.772 -179.347 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' F' F ' 2' ' ' SER . . . . . . . . . . . . . 6.3 p -116.12 132.9 56.53 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 116.255 -0.429 . . . . 0.0 110.142 178.42 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' F' F ' 3' ' ' GLU . . . . . . . . . . . . . 95.7 mt-10 -140.8 138.04 33.78 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.095 -0.502 . . . . 0.0 110.829 -178.351 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' F' F ' 4' ' ' LEU . . . . . . . . . . . . . 23.4 tp -123.92 125.31 44.4 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 115.994 -0.548 . . . . 0.0 109.971 175.956 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' F' F ' 5' ' ' LYS . . . . . . . . . . . . . 62.2 mttp -103.78 119.14 38.31 Favored 'General case' 0 C--O 1.234 0.281 0 CA-C-N 116.32 -0.4 . . . . 0.0 110.457 178.395 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' F' F ' 6' ' ' LEU . . . . . . . . . . . . . 58.1 mt -115.08 141.6 47.79 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 115.398 -0.819 . . . . 0.0 110.223 -178.488 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' F' F ' 7' ' ' LYS . . . . . . . . . . . . . 35.3 ttpt -121.45 136.24 25.73 Favored Pre-proline 0 CA--C 1.534 0.359 0 CA-C-O 118.784 -0.627 . . . . 0.0 109.896 176.627 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' F' F ' 8' ' ' PRO . . . . . . . . . . . . . 95.8 Cg_endo -91.92 133.23 1.32 Allowed 'Trans proline' 0 N--CA 1.489 1.25 0 C-N-CA 121.698 1.599 . . . . 0.0 111.901 178.048 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' F' F ' 9' ' ' LEU . . . . . . . . . . . . . 57.6 mt -73.31 -47.2 7.74 Favored Pre-proline 0 CA--C 1.534 0.336 0 CA-C-O 118.616 -0.707 . . . . 0.0 112.13 -179.117 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' F' F ' 10' ' ' PRO . . . . . . . . . . . . . 97.2 Cg_endo -81.54 147.6 15.78 Favored 'Trans proline' 0 N--CA 1.496 1.622 0 C-N-CA 121.226 1.284 . . . . 0.0 111.504 175.817 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' F' F ' 11' ' ' LYS . . . . . . . . . . . . . 32.3 ttmt -86.51 90.7 8.31 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-O 120.941 0.401 . . . . 0.0 110.498 179.469 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' F' F ' 12' ' ' VAL . . . . . . . . . . . . . 12.6 p -136.11 147.57 28.04 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.252 0 CA-C-N 116.064 -0.517 . . . . 0.0 110.29 179.562 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' F' F ' 13' ' ' GLU . . . . . . . . . . . . . 84.9 tt0 -85.55 130.08 34.66 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.391 -0.368 . . . . 0.0 110.464 179.685 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' F' F ' 14' ' ' LEU . . . . . . . . . . . . . 22.9 mt -97.72 150.7 37.05 Favored Pre-proline 0 C--N 1.33 -0.252 0 CA-C-N 116.207 -0.451 . . . . 0.0 110.354 -179.506 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' F' F ' 15' ' ' PRO . . . . . . . . . . . . . 29.9 Cg_exo -60.36 158.56 30.71 Favored 'Trans proline' 0 N--CA 1.496 1.653 0 C-N-CA 121.199 1.266 . . . . 0.0 111.9 178.096 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' F' F ' 16' ' ' PRO . . . . . . . . . . . . . 39.0 Cg_exo -58.54 -44.37 37.77 Favored 'Trans proline' 0 N--CA 1.497 1.713 0 C-N-CA 121.445 1.43 . . . . 0.0 112.662 -178.373 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' F' F ' 17' ' ' ASP . . . . . . . . . . . . . 12.3 p-10 -83.29 12.89 4.74 Favored 'General case' 0 CA--C 1.536 0.426 0 N-CA-C 112.973 0.731 . . . . 0.0 112.973 -178.718 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' F' F ' 18' ' ' PHE . . . . . . . . . . . . . 51.4 t80 -56.98 -41.18 77.93 Favored 'General case' 0 C--O 1.227 -0.108 0 O-C-N 122.016 -0.427 . . . . 0.0 110.477 -178.537 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' F' F ' 19' ' ' VAL . . . . . . . . . . . . . 47.0 t -55.78 -44.95 79.17 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.244 0 CA-C-N 116.57 -0.287 . . . . 0.0 110.649 -178.726 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' F' F ' 20' ' ' ASP . . . . . . . . . . . . . 83.1 m-20 -59.95 -41.91 92.92 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-O 120.847 0.356 . . . . 0.0 110.723 -178.851 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' F' F ' 21' ' ' VAL . . . . . . . . . . . . . 57.6 t -63.86 -46.91 92.94 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.303 0 CA-C-N 116.377 -0.374 . . . . 0.0 110.727 -177.809 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' F' F ' 22' ' ' ILE . . . . . . . . . . . . . 51.6 mm -55.59 -46.37 79.15 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.206 0 CA-C-O 120.694 0.283 . . . . 0.0 110.566 178.628 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' F' F ' 23' ' ' ARG . . . . . . . . . . . . . 41.6 ttp180 -54.39 -51.62 64.27 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.71 -0.223 . . . . 0.0 111.489 -179.502 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' F' F ' 24' ' ' ILE . . . . . . . . . . . . . 75.9 mt -58.65 -44.36 89.52 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.323 0 CA-C-N 116.652 -0.249 . . . . 0.0 111.433 -175.861 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' F' F ' 25' ' ' LYS . . . . . . . . . . . . . 95.3 mttt -68.14 -42.7 79.74 Favored 'General case' 0 C--N 1.328 -0.337 0 N-CA-C 112.331 0.493 . . . . 0.0 112.331 -176.928 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' F' F ' 26' ' ' LEU . . . . . . . . . . . . . 80.0 mt -78.81 -38.19 38.86 Favored 'General case' 0 C--N 1.329 -0.326 0 N-CA-C 112.984 0.735 . . . . 0.0 112.984 -170.636 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' F' F ' 27' ' ' GLN . . . . . . . . . . . . . 9.7 pt20 -46.97 139.42 5.62 Favored 'General case' 0 N--CA 1.47 0.547 0 N-CA-C 112.633 0.605 . . . . 0.0 112.633 -176.431 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' F' F ' 28' ' ' GLY . . . . . . . . . . . . . . . 101.05 -25.36 28.62 Favored Glycine 0 CA--C 1.533 1.202 0 CA-C-N 115.437 -0.801 . . . . 0.0 112.197 -176.058 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' F' F ' 29' ' ' LYS . . . . . . . . . . . . . 95.1 mttt -97.98 155.2 17.21 Favored 'General case' 0 C--O 1.233 0.192 0 CA-C-N 117.427 0.614 . . . . 0.0 111.01 178.5 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' F' F ' 30' ' ' THR . . . . . . . . . . . . . 21.7 m -107.13 135.93 47.83 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 115.882 -0.599 . . . . 0.0 109.913 175.41 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' F' F ' 31' ' ' VAL . . . . . . . . . . . . . 34.5 m -132.12 156.73 42.76 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.207 0 CA-C-O 120.876 0.369 . . . . 0.0 111.159 -177.107 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' F' F ' 32' ' ' ARG . . . . . . . . . . . . . 82.8 mtt180 -132.18 152.53 51.24 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-O 121.333 0.587 . . . . 0.0 110.673 179.214 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' F' F ' 33' ' ' THR . . . . . . . . . . . . . 18.3 m -52.87 139.95 25.72 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.096 -0.502 . . . . 0.0 111.311 -178.758 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' F' F ' 34' ' ' GLY . . . . . . . . . . . . . . . 100.18 -17.3 57.21 Favored Glycine 0 CA--C 1.533 1.172 0 CA-C-O 119.619 -0.545 . . . . 0.0 113.242 179.274 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' F' F ' 35' ' ' ASP . . . . . . . . . . . . . 74.3 m-20 -67.15 150.03 49.69 Favored 'General case' 0 N--CA 1.46 0.07 0 CA-C-N 118.086 0.943 . . . . 0.0 110.991 178.774 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' F' F ' 36' ' ' VAL . . . . . . . . . . . . . 44.3 t -122.47 130.3 74.62 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.205 0 CA-C-N 116.055 -0.52 . . . . 0.0 109.909 178.44 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' F' F ' 37' ' ' ILE . . . . . . . . . . . . . 69.6 mt -122.34 140.87 44.88 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.218 0 CA-C-N 116.105 -0.498 . . . . 0.0 110.017 -178.527 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' F' F ' 38' ' ' GLY . . . . . . . . . . . . . . . -115.82 128.85 8.21 Favored Glycine 0 CA--C 1.526 0.744 0 N-CA-C 111.179 -0.768 . . . . 0.0 111.179 179.736 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' F' F ' 39' ' ' ILE . . . . . . . . . . . . . 76.3 mt -127.63 140.23 49.7 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.228 0 CA-C-O 120.746 0.308 . . . . 0.0 110.218 179.247 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' F' F ' 40' ' ' SER . . . . . . . . . . . . . 52.8 p -93.32 115.85 28.42 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 116.298 -0.41 . . . . 0.0 111.19 176.229 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' F' F ' 41' ' ' ILE . . . . . . . . . . . . . 44.8 mm -122.58 118.99 56.91 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.214 0 N-CA-C 110.19 -0.3 . . . . 0.0 110.19 178.72 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' F' F ' 42' ' ' LEU . . . . . . . . . . . . . 69.2 mt 55.89 35.64 25.82 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.191 -0.458 . . . . 0.0 111.63 177.412 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' F' F ' 43' ' ' GLY . . . . . . . . . . . . . . . 73.22 23.75 76.88 Favored Glycine 0 CA--C 1.532 1.144 0 C-N-CA 121.151 -0.547 . . . . 0.0 112.795 177.818 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' F' F ' 44' ' ' LYS . . . . . . . . . . . . . 34.7 mmtp -131.5 133.81 45.49 Favored 'General case' 0 C--N 1.331 -0.206 0 CA-C-N 117.264 0.532 . . . . 0.0 109.572 177.538 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' F' F ' 45' ' ' GLU . . . . . . . . . . . . . 85.9 tt0 -82.7 120.21 25.3 Favored 'General case' 0 C--N 1.329 -0.322 0 C-N-CA 120.745 -0.382 . . . . 0.0 110.89 -179.331 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' F' F ' 46' ' ' VAL . . . . . . . . . . . . . 11.2 p -116.83 124.28 72.71 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.154 0 N-CA-C 109.647 -0.501 . . . . 0.0 109.647 175.724 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' F' F ' 47' ' ' LYS . . . . . . . . . . . . . 55.3 mttp -98.58 126.5 44.18 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-N 116.101 -0.5 . . . . 0.0 110.955 179.208 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' F' F ' 48' ' ' PHE . . . . . . . . . . . . . 29.1 m-85 -109.3 131.82 54.71 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.168 -0.469 . . . . 0.0 109.971 177.056 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' F' F ' 49' ' ' LYS . . . . . . . . . . . . . 37.5 tttp -107.66 132.31 53.46 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-N 116.24 -0.436 . . . . 0.0 110.091 177.751 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' F' F ' 50' ' ' VAL . . . . . . . . . . . . . 42.4 t -75.53 107.05 5.86 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.345 0 N-CA-C 109.453 -0.573 . . . . 0.0 109.453 178.151 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' F' F ' 51' ' ' VAL . . . . . . . . . . . . . 47.4 t -74.5 -48.75 34.09 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.309 0 N-CA-C 109.759 -0.46 . . . . 0.0 109.759 -175.661 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' F' F ' 52' ' ' GLN . . . . . . . . . . . . . 49.4 tt0 -160.11 137.15 9.3 Favored 'General case' 0 C--N 1.33 -0.28 0 C-N-CA 120.316 -0.553 . . . . 0.0 111.568 -179.262 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' F' F ' 53' ' ' ALA . . . . . . . . . . . . . . . -113.46 133.06 55.41 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 115.708 -0.678 . . . . 0.0 109.81 175.94 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' F' F ' 54' ' ' TYR . . . . . . . . . . . . . 65.3 t80 -129.18 112.63 18.35 Favored Pre-proline 0 CA--C 1.535 0.386 0 CA-C-O 118.292 -0.861 . . . . 0.0 110.294 178.219 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' F' F ' 55' ' ' PRO . . . . . . . . . . . . . 73.2 Cg_endo -77.18 168.08 77.89 Favored 'Cis proline' 0 N--CA 1.499 1.822 0 CA-C-N 121.935 1.727 . . . . 0.0 112.238 -5.903 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' F' F ' 56' ' ' SER . . . . . . . . . . . . . 13.9 m -116.66 130.51 24.49 Favored Pre-proline 0 CA--C 1.538 0.484 0 CA-C-O 118.536 -0.745 . . . . 0.0 109.413 174.906 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' F' F ' 57' ' ' PRO . . . . . . . . . . . . . 39.3 Cg_endo -67.46 146.74 76.93 Favored 'Cis proline' 0 N--CA 1.498 1.76 0 CA-C-N 121.898 1.713 . . . . 0.0 111.434 -0.786 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' F' F ' 58' ' ' LEU . . . . . . . . . . . . . 20.6 tp -106.12 135.82 46.91 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.409 -0.359 . . . . 0.0 110.492 -178.634 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' F' F ' 59' ' ' ARG . . . . . . . . . . . . . 39.3 ttm180 -105.76 126.55 52.29 Favored 'General case' 0 C--N 1.326 -0.438 0 N-CA-C 109.211 -0.663 . . . . 0.0 109.211 175.889 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' F' F ' 60' ' ' VAL . . . . . . . . . . . . . 46.6 t -83.58 119.6 33.15 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.27 0 C-N-CA 120.665 -0.414 . . . . 0.0 110.514 -175.624 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' F' F ' 61' ' ' GLU . . . . . . . . . . . . . 91.6 mt-10 -130.98 165.72 22.55 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 115.926 -0.579 . . . . 0.0 109.775 177.507 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' F' F ' 62' ' ' ASP . . . . . . . . . . . . . 59.7 m-20 -53.34 -32.46 49.25 Favored 'General case' 0 C--N 1.329 -0.303 0 N-CA-C 111.858 0.318 . . . . 0.0 111.858 -178.563 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' F' F ' 63' ' ' ARG . . . . . . . . . . . . . 92.7 mtt180 -74.72 -22.06 59.03 Favored 'General case' 0 C--N 1.33 -0.25 0 N-CA-C 113.02 0.748 . . . . 0.0 113.02 -176.796 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' F' F ' 64' ' ' THR . . . . . . . . . . . . . 39.5 m -65.89 136.52 56.24 Favored 'General case' 0 C--N 1.331 -0.197 0 CA-C-O 120.894 0.378 . . . . 0.0 110.95 -174.547 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' F' F ' 65' ' ' LYS . . . . . . . . . . . . . 96.8 mttt -89.75 133.01 34.92 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 115.912 -0.586 . . . . 0.0 110.153 177.512 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' F' F ' 66' ' ' ILE . . . . . . . . . . . . . 4.7 mp -113.29 125.54 70.57 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.284 0 N-CA-C 109.596 -0.52 . . . . 0.0 109.596 178.65 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' F' F ' 67' ' ' THR . . . . . . . . . . . . . 25.6 m -120.59 141.89 49.89 Favored 'General case' 0 C--N 1.331 -0.204 0 CA-C-N 116.111 -0.495 . . . . 0.0 110.997 -176.235 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' F' F ' 68' ' ' LEU . . . . . . . . . . . . . 25.4 tp -100.76 135.26 42.49 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 115.823 -0.626 . . . . 0.0 110.344 179.021 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' F' F ' 69' ' ' VAL . . . . . . . . . . . . . 39.2 t -82.86 130.36 35.86 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.315 0 CA-C-N 116.175 -0.466 . . . . 0.0 109.97 179.285 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' F' F ' 70' ' ' THR . . . . . . . . . . . . . 71.3 p -103.57 -175.31 2.76 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 115.962 -0.563 . . . . 0.0 109.741 -177.801 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' F' F ' 71' ' ' HIS . . . . . . . . . . . . . 5.8 m-70 -64.95 173.12 1.83 Allowed Pre-proline 0 C--N 1.329 -0.324 0 N-CA-C 109.576 -0.527 . . . . 0.0 109.576 177.876 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' F' F ' 72' ' ' PRO . . . . . . . . . . . . . 20.2 Cg_exo -64.81 -29.28 59.06 Favored 'Trans proline' 0 N--CA 1.497 1.731 0 C-N-CA 121.15 1.233 . . . . 0.0 111.974 -179.905 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' F' F ' 73' ' ' VAL . . . . . . . . . . . . . 3.1 m -150.82 102.64 0.28 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.227 0 CA-C-O 121.227 0.537 . . . . 0.0 111.25 174.143 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' F' F ' 74' ' ' ASP . . . . . . . . . . . . . 13.2 t0 -96.42 115.81 28.03 Favored 'General case' 0 C--N 1.325 -0.469 0 N-CA-C 108.271 -1.011 . . . . 0.0 108.271 171.175 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' F' F ' 75' ' ' VAL . . . . . . . . . . . . . 42.9 t -107.39 124.77 63.53 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.268 0 CA-C-O 121.156 0.503 . . . . 0.0 111.064 -171.235 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' F' F ' 76' ' ' LEU . . . . . . . . . . . . . 24.3 mt -125.24 133.59 52.65 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 115.399 -0.819 . . . . 0.0 109.442 176.452 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' F' F ' 77' ' ' GLU . . . . . . . . . . . . . 98.3 mt-10 -129.35 136.41 49.96 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-O 121.046 0.451 . . . . 0.0 111.126 -178.147 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' F' F ' 78' ' ' ALA . . . . . . . . . . . . . . . -128.2 138.14 52.34 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 115.748 -0.66 . . . . 0.0 109.868 177.124 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' F' F ' 79' ' ' LYS . . . . . . . . . . . . . 19.9 pttp -76.07 121.9 23.47 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-O 121.193 0.52 . . . . 0.0 110.599 -179.025 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' F' F ' 80' ' ' ILE . . . . . . . . . . . . . 39.1 mm -139.22 116.58 11.18 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.282 0 N-CA-C 109.25 -0.648 . . . . 0.0 109.25 -178.242 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' F' F ' 81' ' ' LYS . . . . . . . . . . . . . 83.7 tttt -112.56 126.39 55.29 Favored 'General case' 0 C--N 1.331 -0.215 0 CA-C-O 120.958 0.408 . . . . 0.0 111.206 -176.139 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' F' F ' 82' ' ' GLY . . . . . . . . . . . . . . . 89.0 42.24 5.69 Favored Glycine 0 CA--C 1.525 0.714 0 C-N-CA 120.86 -0.686 . . . . 0.0 111.569 174.652 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' F' F ' 83' ' ' ILE . . . . . . . . . . . . . 72.8 mt -69.15 141.81 16.89 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.342 0 CA-C-O 120.975 0.417 . . . . 0.0 110.001 178.446 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' F' F ' 84' ' ' LYS . . . . . . . . . . . . . 57.0 tttp -103.59 -52.57 2.96 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 115.884 -0.598 . . . . 0.0 110.356 -178.663 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' F' F ' 85' ' ' ASP . . . . . . . . . . . . . 11.1 t70 -153.55 155.56 36.4 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 115.988 -0.551 . . . . 0.0 110.587 -178.904 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' F' F ' 86' ' ' VAL . . . . . . . . . . . . . 45.1 t -130.72 133.39 63.41 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.236 0 CA-C-O 120.976 0.417 . . . . 0.0 110.682 -177.765 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' F' F ' 87' ' ' ILE . . . . . . . . . . . . . 46.1 mm -124.76 126.61 71.77 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.221 0 CA-C-N 115.883 -0.599 . . . . 0.0 109.748 176.432 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' F' F ' 88' ' ' LEU . . . . . . . . . . . . . 36.4 mt -116.22 136.54 52.92 Favored 'General case' 0 N--CA 1.464 0.239 0 CA-C-O 121.129 0.49 . . . . 0.0 111.504 -177.02 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' F' F ' 89' ' ' ASP . . . . . . . . . . . . . 10.6 t70 -130.01 159.33 37.04 Favored 'General case' 0 C--N 1.331 -0.221 0 CA-C-N 115.566 -0.743 . . . . 0.0 109.605 175.439 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' F' F ' 90' ' ' GLU . . . . . . . . . . . . . 95.4 mt-10 -46.7 -39.34 11.32 Favored 'General case' 0 CA--C 1.531 0.237 0 N-CA-C 113.118 0.784 . . . . 0.0 113.118 -171.68 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' F' F ' 91' ' ' ASN . . . . . . . . . . . . . 23.9 p30 -131.73 23.55 4.66 Favored 'General case' 0 N--CA 1.466 0.35 0 N-CA-C 112.725 0.639 . . . . 0.0 112.725 -177.383 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' F' F ' 92' ' ' LEU . . . . . . . . . . . . . 16.3 mt -148.7 141.13 24.24 Favored 'General case' 0 C--N 1.33 -0.243 0 N-CA-C 110.137 -0.32 . . . . 0.0 110.137 -176.691 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' F' F ' 93' ' ' ILE . . . . . . . . . . . . . 69.6 mt -124.93 117.39 50.02 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.362 0 N-CA-C 109.604 -0.517 . . . . 0.0 109.604 179.029 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' F' F ' 94' ' ' VAL . . . . . . . . . . . . . 46.7 t -117.13 127.07 74.78 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.242 0 CA-C-O 120.959 0.409 . . . . 0.0 110.106 179.844 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' F' F ' 95' ' ' VAL . . . . . . . . . . . . . 47.7 t -121.59 132.51 70.58 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.322 0 CA-C-N 115.844 -0.616 . . . . 0.0 109.626 178.799 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' F' F ' 96' ' ' ILE . . . . . . . . . . . . . 63.0 mt -113.71 129.09 70.18 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.269 0 N-CA-C 109.351 -0.611 . . . . 0.0 109.351 179.476 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' F' F ' 97' ' ' THR . . . . . . . . . . . . . 72.8 p -101.21 158.34 16.11 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-O 121.136 0.493 . . . . 0.0 111.121 -178.299 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' F' F ' 98' ' ' GLU . . . . . . . . . . . . . 96.9 mt-10 -54.0 -25.79 22.8 Favored 'General case' 0 CA--C 1.532 0.274 0 N-CA-C 112.316 0.487 . . . . 0.0 112.316 -179.037 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' F' F ' 99' ' ' GLU . . . . . . . . . . . . . 71.4 mm-40 -80.7 16.68 1.32 Allowed 'General case' 0 CA--C 1.535 0.385 0 N-CA-C 113.031 0.752 . . . . 0.0 113.031 -177.298 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' F' F ' 100' ' ' ASN . . . . . . . . . . . . . 3.8 m-20 62.11 37.57 14.48 Favored 'General case' 0 C--N 1.332 -0.156 0 CA-C-O 121.076 0.465 . . . . 0.0 111.088 177.847 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' F' F ' 101' ' ' GLU . . . . . . . . . . . . . 84.0 tt0 -114.79 143.12 45.59 Favored 'General case' 0 C--N 1.333 -0.111 0 N-CA-C 109.704 -0.48 . . . . 0.0 109.704 175.922 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' F' F ' 102' ' ' VAL . . . . . . . . . . . . . 43.0 t -115.22 125.02 72.37 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 CA-C-N 116.146 -0.479 . . . . 0.0 110.055 -178.184 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' F' F ' 103' ' ' LEU . . . . . . . . . . . . . 20.2 mt -114.1 128.64 56.47 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 115.695 -0.684 . . . . 0.0 109.973 176.251 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' F' F ' 104' ' ' ILE . . . . . . . . . . . . . 71.2 mt -117.49 118.97 60.31 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.253 0 N-CA-C 110.371 -0.233 . . . . 0.0 110.371 179.999 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' F' F ' 105' ' ' PHE . . . . . . . . . . . . . 66.0 m-85 -117.54 166.3 12.53 Favored 'General case' 0 C--N 1.333 -0.152 0 CA-C-N 115.455 -0.793 . . . . 0.0 109.898 178.401 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' F' F ' 106' ' ' ASN . . . . . . . . . . . . . 44.4 p-10 -100.4 -169.98 1.8 Allowed 'General case' 0 C--N 1.33 -0.275 0 N-CA-C 109.91 -0.404 . . . . 0.0 109.91 173.988 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' F' F ' 107' ' ' GLN . . . . . . . . . . . . . 30.1 tt0 -59.38 -29.99 68.1 Favored 'General case' 0 C--N 1.329 -0.298 0 N-CA-C 111.855 0.317 . . . . 0.0 111.855 178.221 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' F' F ' 108' ' ' ASN . . . . . . . . . . . . . 14.1 t-20 -81.98 5.17 20.05 Favored 'General case' 0 CA--C 1.537 0.448 0 N-CA-C 113.276 0.843 . . . . 0.0 113.276 -177.796 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' F' F ' 109' ' ' LEU . . . . . . . . . . . . . 9.9 tp 62.61 36.28 13.77 Favored 'General case' 0 CA--C 1.53 0.2 0 O-C-N 122.073 -0.392 . . . . 0.0 111.476 178.119 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' F' F ' 110' ' ' GLU . . . . . . . . . . . . . 96.0 mt-10 -108.1 156.24 19.5 Favored 'General case' 0 C--N 1.332 -0.193 0 N-CA-C 109.894 -0.41 . . . . 0.0 109.894 176.304 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' F' F ' 111' ' ' GLU . . . . . . . . . . . . . 46.2 tp10 -82.91 123.05 29.03 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-O 121.02 0.438 . . . . 0.0 110.852 -177.479 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' F' F ' 112' ' ' LEU . . . . . . . . . . . . . 12.5 mt -108.3 -46.01 3.8 Favored 'General case' 0 C--N 1.332 -0.184 0 CA-C-N 115.93 -0.577 . . . . 0.0 110.136 177.577 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' F' F ' 113' ' ' TYR . . . . . . . . . . . . . 62.3 t80 -140.67 136.54 32.75 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.443 -0.344 . . . . 0.0 110.981 179.863 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' F' F ' 114' ' ' ARG . . . . . . . . . . . . . 59.6 ttp180 -137.97 125.25 21.74 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.28 -0.418 . . . . 0.0 110.169 177.536 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' F' F ' 115' ' ' GLY . . . . . . . . . . . . . . . -150.2 161.87 29.05 Favored Glycine 0 CA--C 1.524 0.613 0 N-CA-C 111.167 -0.773 . . . . 0.0 111.167 179.94 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' F' F ' 116' ' ' LYS . . . . . . . . . . . . . 36.3 ttpt -128.27 134.55 48.97 Favored 'General case' 0 C--N 1.33 -0.273 0 N-CA-C 109.855 -0.424 . . . . 0.0 109.855 178.09 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' F' F ' 117' ' ' PHE . . . . . . . . . . . . . 39.9 m-85 -133.33 113.84 13.04 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-O 120.968 0.414 . . . . 0.0 110.404 -176.412 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' F' F ' 118' ' ' GLU . . . . . . . . . . . . . 44.0 mp0 -57.55 -44.1 84.93 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.088 -0.505 . . . . 0.0 110.71 -175.011 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' F' F ' 119' ' ' ASN . . . . . . . . . . . . . 14.8 m120 -99.12 30.99 3.2 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.201 -0.454 . . . . 0.0 112.192 -173.722 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' F' F ' 120' ' ' LEU . . . . . . . . . . . . . 14.2 tp -55.49 121.6 9.38 Favored 'General case' 0 C--O 1.232 0.16 0 O-C-N 122.235 -0.29 . . . . 0.0 110.671 177.78 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' F' F ' 121' ' ' ASN . . . . . . . . . . . . . 38.6 m-80 -113.9 -44.14 3.2 Favored 'General case' 0 C--N 1.332 -0.183 0 CA-C-N 116.544 -0.298 . . . . 0.0 111.301 -177.756 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' F' F ' 122' ' ' LYS . . . . . . . . . . . . . 33.6 ttpt -145.27 143.5 30.26 Favored 'General case' 0 C--N 1.331 -0.21 0 C-N-CA 120.66 -0.416 . . . . 0.0 111.639 -176.514 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' F' F ' 123' ' ' VAL . . . . . . . . . . . . . 42.1 t -124.86 131.65 72.34 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.237 0 N-CA-C 109.385 -0.598 . . . . 0.0 109.385 175.15 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' F' F ' 124' ' ' LEU . . . . . . . . . . . . . 9.6 tt -133.9 130.75 38.22 Favored 'General case' 0 C--N 1.332 -0.194 0 CA-C-O 121.073 0.464 . . . . 0.0 111.105 -178.402 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' F' F ' 125' ' ' VAL . . . . . . . . . . . . . 43.3 t -121.16 133.54 67.44 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.233 0 CA-C-N 115.783 -0.644 . . . . 0.0 109.543 176.867 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' F' F ' 126' ' ' ARG . . . . . . . . . . . . . 36.6 ptt-85 -142.83 125.03 15.4 Favored 'General case' 0 C--N 1.331 -0.226 0 CA-C-O 121.021 0.438 . . . . 0.0 111.087 179.759 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' F' F ' 127' ' ' ASN . . . . . . . . . . . . . 58.8 m-80 49.21 -105.06 0.15 Allowed 'General case' 0 CA--C 1.544 0.738 0 CA-C-N 116.126 -0.488 . . . . 0.0 111.748 177.42 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' F' F ' 128' ' ' ASP . . . . . . . . . . . . . 8.8 p-10 -114.15 1.79 14.67 Favored 'General case' 0 CA--C 1.534 0.359 0 CA-C-N 119.524 1.057 . . . . 0.0 113.57 -176.366 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' F' F ' 129' ' ' LEU . . . . . . . . . . . . . 82.9 mt -113.7 145.7 40.94 Favored 'General case' 0 C--N 1.333 -0.131 0 O-C-N 121.92 -0.488 . . . . 0.0 110.5 -178.805 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' F' F ' 130' ' ' VAL . . . . . . . . . . . . . 45.7 t -125.41 135.78 62.91 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.22 0 CA-C-N 116.123 -0.49 . . . . 0.0 109.769 179.955 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' F' F ' 131' ' ' VAL . . . . . . . . . . . . . 27.5 m -136.03 143.1 37.01 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.251 0 CA-C-O 121.356 0.598 . . . . 0.0 111.126 178.774 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' F' F ' 132' ' ' ILE . . . . . . . . . . . . . 70.7 mt -123.6 133.95 67.74 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.288 0 CA-C-N 115.219 -0.9 . . . . 0.0 109.502 -179.336 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' F' F ' 133' ' ' ILE . . . . . . . . . . . . . 39.6 mm -115.57 122.01 68.48 Favored 'Isoleucine or valine' 0 C--O 1.233 0.225 0 CA-C-O 120.735 0.302 . . . . 0.0 110.89 -176.165 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' F' F ' 134' ' ' ASP . . . . . . . . . . . . . 6.7 p-10 -131.98 146.39 52.06 Favored 'General case' 0 C--N 1.331 -0.216 0 N-CA-C 109.457 -0.571 . . . . 0.0 109.457 174.098 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' F' F ' 135' ' ' GLU . . . . . . . . . . . . . 42.7 tp10 -49.82 -23.9 2.12 Favored 'General case' 0 C--N 1.328 -0.348 0 N-CA-C 112.883 0.697 . . . . 0.0 112.883 -171.406 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' F' F ' 136' ' ' GLN . . . . . . . . . . . . . 94.3 mt-30 -92.73 -37.21 12.49 Favored 'General case' 0 C--N 1.332 -0.185 0 N-CA-C 112.115 0.413 . . . . 0.0 112.115 -176.284 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' F' F ' 137' ' ' LYS . . . . . . . . . . . . . 45.9 mtmt -148.48 159.17 44.31 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-O 121.512 0.672 . . . . 0.0 111.819 -168.968 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' F' F ' 138' ' ' LEU . . . . . . . . . . . . . 5.0 tt -115.43 124.74 51.93 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 115.173 -0.921 . . . . 0.0 109.365 175.737 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' F' F ' 139' ' ' THR . . . . . . . . . . . . . 27.5 m -108.27 129.52 55.21 Favored 'General case' 0 C--N 1.331 -0.22 0 CA-C-N 116.437 -0.347 . . . . 0.0 110.878 -177.523 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' F' F ' 140' ' ' LEU . . . . . . . . . . . . . 5.9 tt -117.31 122.56 44.25 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 115.607 -0.724 . . . . 0.0 109.109 -178.427 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' F' F ' 141' ' ' ILE . . . . . . . . . . . . . 19.3 mt -120.06 116.97 52.02 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.345 0 N-CA-C 109.815 -0.439 . . . . 0.0 109.815 -175.969 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' F' F ' 142' ' ' ARG . . . . . . . . . . . . . 56.4 ttp180 -104.67 129.04 52.9 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 115.445 -0.798 . . . . 0.0 110.638 -178.829 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' F' F ' 143' ' ' THR . . . . . . . . . . . . . 55.8 p . . . . . 0 C--O 1.221 -0.427 0 CA-C-O 117.962 -1.018 . . . . 0.0 110.467 178.603 . . . . . . . . 0 0 . 1 . 011 nuclear orig full ' A' A ' -3' ' ' GLU . . . . . . . . . . . . . 95.6 mt-10 . . . . . 0 N--CA 1.49 1.53 0 N-CA-C 109.346 -0.613 . . . . 0.0 109.346 . . . . . . . . . 0 0 . 1 . 011 nuclear orig full ' A' A ' -2' ' ' GLY . . . . . . . . . . . . . . . -67.31 141.83 39.9 Favored Glycine 0 CA--C 1.525 0.663 0 N-CA-C 111.057 -0.817 . . . . 0.0 111.057 -179.609 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' -1' ' ' VAL . . . . . . . . . . . . . 42.9 t -141.12 144.29 26.78 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.308 0 N-CA-C 110.023 -0.362 . . . . 0.0 110.023 179.804 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 0' ' ' ILE . . . . . . . . . . . . . 72.4 mt -99.9 137.16 28.26 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.343 0 CA-C-O 120.931 0.396 . . . . 0.0 110.162 -179.407 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 25.4 ptp -91.46 153.55 19.75 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 115.966 -0.561 . . . . 0.0 110.563 -179.827 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 2.8 p -126.49 129.92 49.6 Favored 'General case' 0 C--N 1.331 -0.223 0 CA-C-N 116.296 -0.411 . . . . 0.0 110.609 179.537 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 84.9 tt0 -141.74 138.14 32.15 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.097 -0.501 . . . . 0.0 110.856 179.501 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 4' ' ' LEU . . . . . . . . . . . . . 12.7 tp -123.27 133.19 54.2 Favored 'General case' 0 C--N 1.332 -0.155 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.166 177.157 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 5' ' ' LYS . . . . . . . . . . . . . 95.6 mttt -108.48 120.62 42.94 Favored 'General case' 0 C--O 1.234 0.271 0 CA-C-N 116.421 -0.354 . . . . 0.0 110.417 179.737 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 56.2 mt -115.89 148.23 40.22 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 115.457 -0.792 . . . . 0.0 110.715 -177.755 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 31.9 ttpt -138.57 140.59 28.29 Favored Pre-proline 0 CA--C 1.534 0.357 0 CA-C-O 119.164 -0.446 . . . . 0.0 110.075 175.421 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 8' ' ' PRO . . . . . . . . . . . . . 85.5 Cg_endo -92.02 141.96 2.52 Favored 'Trans proline' 0 N--CA 1.491 1.332 0 C-N-CA 121.734 1.622 . . . . 0.0 111.802 177.794 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 51.2 mt -77.4 -48.19 2.42 Favored Pre-proline 0 CA--C 1.534 0.338 0 CA-C-O 118.649 -0.691 . . . . 0.0 112.435 -179.459 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 90.1 Cg_endo -79.82 156.66 24.1 Favored 'Trans proline' 0 N--CA 1.496 1.636 0 C-N-CA 121.15 1.233 . . . . 0.0 111.812 177.292 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 61.6 tttm -87.97 95.66 10.21 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.378 -0.374 . . . . 0.0 110.281 178.292 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 12.4 p -140.14 144.57 27.68 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.263 0 CA-C-N 116.145 -0.479 . . . . 0.0 110.532 -179.43 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 95.6 mt-10 -82.18 127.13 32.85 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.234 -0.439 . . . . 0.0 110.07 177.392 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 14' ' ' LEU . . . . . . . . . . . . . 23.9 mt -97.94 139.42 21.28 Favored Pre-proline 0 CA--C 1.533 0.318 0 CA-C-O 118.796 -0.621 . . . . 0.0 109.767 179.871 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 15' ' ' PRO . . . . . . . . . . . . . 26.6 Cg_exo -60.99 160.57 25.27 Favored 'Trans proline' 0 N--CA 1.498 1.758 0 C-N-CA 121.161 1.241 . . . . 0.0 111.713 178.348 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 16' ' ' PRO . . . . . . . . . . . . . 30.7 Cg_exo -59.66 -32.71 96.29 Favored 'Trans proline' 0 N--CA 1.499 1.794 0 C-N-CA 121.396 1.397 . . . . 0.0 112.863 -177.618 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 17' ' ' ASP . . . . . . . . . . . . . 9.6 p-10 -91.56 6.1 47.0 Favored 'General case' 0 CA--C 1.538 0.498 0 N-CA-C 113.254 0.835 . . . . 0.0 113.254 -177.275 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 18' ' ' PHE . . . . . . . . . . . . . 47.1 t80 -58.54 -46.08 87.55 Favored 'General case' 0 C--N 1.333 -0.122 0 CA-C-O 120.985 0.421 . . . . 0.0 109.975 -178.356 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 19' ' ' VAL . . . . . . . . . . . . . 48.5 t -57.37 -40.9 76.95 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.328 0 CA-C-N 116.074 -0.512 . . . . 0.0 110.41 -178.784 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 9.2 t70 -60.07 -44.11 94.98 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-O 120.743 0.306 . . . . 0.0 111.099 -177.613 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 49.0 t -64.66 -46.71 91.53 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.248 0 C-N-CA 120.694 -0.402 . . . . 0.0 110.512 -177.893 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 22' ' ' ILE . . . . . . . . . . . . . 50.7 mm -56.19 -45.19 80.85 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.246 0 C-N-CA 120.915 -0.314 . . . . 0.0 110.626 178.912 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 23' ' ' ARG . . . . . . . . . . . . . 55.7 ttp180 -54.76 -49.82 69.92 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-O 120.658 0.266 . . . . 0.0 111.296 -178.626 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 24' ' ' ILE . . . . . . . . . . . . . 75.9 mt -59.72 -42.22 87.92 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.249 0 CA-C-N 116.574 -0.285 . . . . 0.0 111.178 -177.522 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 99.4 mttt -67.6 -38.16 83.6 Favored 'General case' 0 C--N 1.328 -0.362 0 N-CA-C 112.604 0.594 . . . . 0.0 112.604 -178.686 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 83.1 mt -78.13 -41.27 35.55 Favored 'General case' 0 C--N 1.33 -0.261 0 N-CA-C 113.144 0.794 . . . . 0.0 113.144 -172.168 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 27' ' ' GLN . . . . . . . . . . . . . 10.5 pt20 -46.98 138.06 6.85 Favored 'General case' 0 N--CA 1.47 0.551 0 N-CA-C 112.704 0.631 . . . . 0.0 112.704 -175.675 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 101.63 -26.43 24.48 Favored Glycine 0 CA--C 1.532 1.115 0 CA-C-N 115.571 -0.74 . . . . 0.0 112.306 -177.331 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 71.6 mmtt -98.17 155.14 17.3 Favored 'General case' 0 C--N 1.331 -0.209 0 CA-C-N 117.51 0.655 . . . . 0.0 111.097 177.802 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 30' ' ' THR . . . . . . . . . . . . . 41.4 m -105.33 137.52 43.01 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 115.895 -0.593 . . . . 0.0 109.862 176.068 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 34.8 m -129.51 157.38 42.24 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.245 0 CA-C-N 116.354 -0.385 . . . . 0.0 110.798 -178.468 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 32' ' ' ARG . . . . . . . . . . . . . 73.5 mtt85 -131.37 153.13 49.97 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-O 121.282 0.563 . . . . 0.0 110.701 177.899 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 33' ' ' THR . . . . . . . . . . . . . 22.7 m -53.02 139.66 27.32 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.051 -0.522 . . . . 0.0 111.397 -177.84 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 99.13 -16.99 58.66 Favored Glycine 0 CA--C 1.533 1.17 0 CA-C-O 119.593 -0.56 . . . . 0.0 113.327 178.345 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 61.3 m-20 -62.81 148.82 45.81 Favored 'General case' 0 C--O 1.231 0.11 0 CA-C-N 118.044 0.922 . . . . 0.0 111.084 179.696 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 45.1 t -123.66 130.69 73.93 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.257 0 CA-C-N 115.585 -0.734 . . . . 0.0 109.853 179.343 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 37' ' ' ILE . . . . . . . . . . . . . 69.6 mt -122.71 139.19 50.32 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.237 0 CA-C-N 116.248 -0.433 . . . . 0.0 110.04 -179.773 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . -110.72 128.78 8.94 Favored Glycine 0 CA--C 1.525 0.665 0 N-CA-C 111.037 -0.825 . . . . 0.0 111.037 179.556 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 39' ' ' ILE . . . . . . . . . . . . . 72.1 mt -123.06 135.62 62.51 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.257 0 N-CA-C 110.109 -0.33 . . . . 0.0 110.109 179.33 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 40' ' ' SER . . . . . . . . . . . . . 41.5 t -93.6 116.91 29.44 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.394 -0.366 . . . . 0.0 111.039 176.01 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 41' ' ' ILE . . . . . . . . . . . . . 44.2 mm -121.53 115.26 45.99 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.241 0 CA-C-N 116.476 -0.329 . . . . 0.0 110.333 179.34 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 78.5 mt 54.38 37.07 26.89 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-O 120.93 0.395 . . . . 0.0 111.548 176.942 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . 74.13 24.46 73.54 Favored Glycine 0 CA--C 1.532 1.123 0 C-N-CA 121.061 -0.59 . . . . 0.0 112.797 177.622 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 44' ' ' LYS . . . . . . . . . . . . . 70.0 mmtt -130.36 132.54 45.85 Favored 'General case' 0 C--N 1.331 -0.223 0 N-CA-C 109.57 -0.529 . . . . 0.0 109.57 177.74 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 81.3 tt0 -84.02 122.5 28.87 Favored 'General case' 0 C--N 1.329 -0.308 0 C-N-CA 120.74 -0.384 . . . . 0.0 111.099 -178.142 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 46' ' ' VAL . . . . . . . . . . . . . 7.1 p -120.86 128.15 76.03 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.194 0 N-CA-C 109.356 -0.609 . . . . 0.0 109.356 175.241 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 60.3 mttp -100.48 127.78 46.73 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 115.988 -0.551 . . . . 0.0 111.015 179.277 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 48' ' ' PHE . . . . . . . . . . . . . 92.2 m-85 -110.48 131.83 54.71 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.368 -0.378 . . . . 0.0 110.099 176.44 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 45.5 tttp -108.46 136.96 47.21 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.246 -0.433 . . . . 0.0 110.598 179.158 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 50' ' ' VAL . . . . . . . . . . . . . 47.0 t -82.33 107.35 14.18 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.33 0 N-CA-C 109.161 -0.681 . . . . 0.0 109.161 175.416 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 51' ' ' VAL . . . . . . . . . . . . . 47.8 t -71.68 -52.26 26.96 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.364 0 CA-C-N 115.952 -0.567 . . . . 0.0 109.668 -174.295 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 52' ' ' GLN . . . . . . . . . . . . . 90.8 mt-30 -152.94 151.09 29.93 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-O 121.182 0.515 . . . . 0.0 111.572 -177.755 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -126.46 131.88 51.57 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 115.214 -0.903 . . . . 0.0 109.639 175.087 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 54' ' ' TYR . . . . . . . . . . . . . 51.7 t80 -128.93 108.43 18.29 Favored Pre-proline 0 CA--C 1.533 0.323 0 CA-C-O 118.294 -0.86 . . . . 0.0 110.421 -179.826 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 55' ' ' PRO . . . . . . . . . . . . . 73.4 Cg_endo -77.12 170.0 72.77 Favored 'Cis proline' 0 N--CA 1.499 1.837 0 CA-C-N 121.809 1.682 . . . . 0.0 112.501 -5.54 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 56' ' ' SER . . . . . . . . . . . . . 15.2 m -115.27 129.05 25.41 Favored Pre-proline 0 CA--C 1.539 0.554 0 CA-C-O 118.448 -0.787 . . . . 0.0 109.462 174.994 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 57' ' ' PRO . . . . . . . . . . . . . 38.4 Cg_endo -67.48 165.73 67.61 Favored 'Cis proline' 0 N--CA 1.498 1.741 0 CA-C-N 121.979 1.742 . . . . 0.0 111.517 -0.601 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 58' ' ' LEU . . . . . . . . . . . . . 27.9 tp -129.28 135.89 49.35 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.268 179.646 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 59' ' ' ARG . . . . . . . . . . . . . 74.0 ttt180 -104.72 128.69 52.89 Favored 'General case' 0 C--N 1.326 -0.421 0 N-CA-C 109.188 -0.671 . . . . 0.0 109.188 176.562 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 46.2 t -79.92 122.4 35.06 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.212 0 C-N-CA 120.566 -0.453 . . . . 0.0 109.982 -175.945 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 78.9 tt0 -130.75 157.82 41.78 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 115.713 -0.676 . . . . 0.0 109.264 -179.511 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 62' ' ' ASP . . . . . . . . . . . . . 79.9 m-20 -51.58 -32.21 27.62 Favored 'General case' 0 C--N 1.328 -0.339 0 N-CA-C 112.125 0.417 . . . . 0.0 112.125 -177.642 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 63' ' ' ARG . . . . . . . . . . . . . 46.8 ptt85 -88.97 5.11 45.69 Favored 'General case' 0 CA--C 1.538 0.518 0 N-CA-C 113.767 1.025 . . . . 0.0 113.767 -175.598 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 30.4 m -80.14 141.03 36.12 Favored 'General case' 0 C--N 1.331 -0.206 0 CA-C-N 117.981 0.355 . . . . 0.0 110.742 -178.483 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 65' ' ' LYS . . . . . . . . . . . . . 97.0 mttt -88.67 131.36 35.03 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.237 -0.438 . . . . 0.0 110.262 178.895 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 66' ' ' ILE . . . . . . . . . . . . . 59.1 mt -115.26 126.45 72.83 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.297 0 N-CA-C 109.502 -0.555 . . . . 0.0 109.502 179.061 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 67' ' ' THR . . . . . . . . . . . . . 26.4 m -117.56 136.61 53.15 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-O 121.05 0.452 . . . . 0.0 110.731 -177.756 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 68' ' ' LEU . . . . . . . . . . . . . 6.3 tt -104.71 123.96 48.53 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 115.782 -0.645 . . . . 0.0 109.69 178.277 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 69' ' ' VAL . . . . . . . . . . . . . 45.6 t -92.55 131.27 40.08 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.269 0 CA-C-O 120.974 0.416 . . . . 0.0 110.131 -178.474 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 70' ' ' THR . . . . . . . . . . . . . 6.5 m -90.03 145.67 24.91 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 115.924 -0.58 . . . . 0.0 110.566 -179.216 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 71' ' ' HIS . . . . . . . . . . . . . 65.3 m80 -64.87 160.3 56.12 Favored Pre-proline 0 C--N 1.329 -0.318 0 CA-C-N 116.254 -0.43 . . . . 0.0 110.458 -179.976 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 72' ' ' PRO . . . . . . . . . . . . . 47.7 Cg_endo -85.67 155.74 10.38 Favored 'Trans proline' 0 N--CA 1.49 1.314 0 C-N-CA 121.697 1.598 . . . . 0.0 112.384 -178.697 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 73' ' ' VAL . . . . . . . . . . . . . 35.4 m -80.63 167.1 2.24 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.246 0 CA-C-N 116.168 -0.469 . . . . 0.0 110.622 -179.709 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 74' ' ' ASP . . . . . . . . . . . . . 30.2 t0 -101.45 121.42 41.92 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.227 -0.442 . . . . 0.0 109.845 -179.623 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 43.5 t -115.7 124.27 71.95 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.215 0 CA-C-O 121.071 0.462 . . . . 0.0 110.467 -178.62 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 76' ' ' LEU . . . . . . . . . . . . . 6.3 mp -118.35 138.52 52.36 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 115.692 -0.685 . . . . 0.0 109.501 175.569 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 77' ' ' GLU . . . . . . . . . . . . . 96.8 mt-10 -134.15 136.3 43.71 Favored 'General case' 0 C--N 1.331 -0.204 0 CA-C-O 121.079 0.466 . . . . 0.0 111.017 -179.222 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 78' ' ' ALA . . . . . . . . . . . . . . . -124.81 141.68 51.95 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 115.632 -0.713 . . . . 0.0 110.077 177.704 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 79' ' ' LYS . . . . . . . . . . . . . 11.4 mptt -81.52 109.83 16.35 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-O 120.858 0.361 . . . . 0.0 110.379 -179.922 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 80' ' ' ILE . . . . . . . . . . . . . 41.5 mm -139.09 103.77 2.04 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.356 0 N-CA-C 109.2 -0.667 . . . . 0.0 109.2 -178.122 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 81' ' ' LYS . . . . . . . . . . . . . 19.7 pttp -112.38 140.39 47.15 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-O 121.002 0.429 . . . . 0.0 111.335 -176.857 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . 89.2 42.07 5.67 Favored Glycine 0 CA--C 1.526 0.724 0 N-CA-C 110.865 -0.894 . . . . 0.0 110.865 178.599 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 83' ' ' ILE . . . . . . . . . . . . . 70.7 mt -75.79 140.94 16.5 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.333 0 CA-C-O 120.88 0.372 . . . . 0.0 110.205 -179.139 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 84' ' ' LYS . . . . . . . . . . . . . 58.0 tttp -95.13 -53.4 3.82 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 115.904 -0.589 . . . . 0.0 109.991 179.597 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 85' ' ' ASP . . . . . . . . . . . . . 10.2 t70 -155.04 154.16 32.06 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 115.629 -0.714 . . . . 0.0 110.349 -179.627 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 86' ' ' VAL . . . . . . . . . . . . . 41.6 t -126.01 131.09 72.12 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.205 0 CA-C-O 120.925 0.393 . . . . 0.0 110.422 -179.197 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 87' ' ' ILE . . . . . . . . . . . . . 46.0 mm -120.33 124.75 73.19 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.285 0 CA-C-N 115.849 -0.614 . . . . 0.0 109.39 177.423 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 88' ' ' LEU . . . . . . . . . . . . . 30.1 mt -118.66 136.1 54.1 Favored 'General case' 0 C--N 1.331 -0.22 0 CA-C-O 121.209 0.528 . . . . 0.0 111.29 -176.147 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 89' ' ' ASP . . . . . . . . . . . . . 6.6 t0 -131.13 157.91 41.87 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 115.448 -0.796 . . . . 0.0 109.533 177.759 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 14.2 pt-20 -46.4 -36.93 6.96 Favored 'General case' 0 C--N 1.33 -0.272 0 N-CA-C 113.218 0.822 . . . . 0.0 113.218 -172.326 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 91' ' ' ASN . . . . . . . . . . . . . 11.9 t-20 -131.99 20.81 4.52 Favored 'General case' 0 N--CA 1.468 0.467 0 N-CA-C 112.93 0.715 . . . . 0.0 112.93 -177.083 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 92' ' ' LEU . . . . . . . . . . . . . 35.2 mt -147.52 142.61 27.09 Favored 'General case' 0 C--N 1.33 -0.267 0 N-CA-C 110.323 -0.251 . . . . 0.0 110.323 -177.625 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 93' ' ' ILE . . . . . . . . . . . . . 71.5 mt -125.34 116.02 45.48 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.336 0 N-CA-C 109.416 -0.587 . . . . 0.0 109.416 179.09 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 94' ' ' VAL . . . . . . . . . . . . . 46.7 t -119.13 126.79 75.67 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.295 0 CA-C-O 121.001 0.429 . . . . 0.0 110.114 -178.814 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 95' ' ' VAL . . . . . . . . . . . . . 47.3 t -118.66 131.16 72.26 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.376 0 CA-C-N 115.704 -0.68 . . . . 0.0 109.455 178.982 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 96' ' ' ILE . . . . . . . . . . . . . 65.6 mt -112.04 125.82 69.37 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.299 0 N-CA-C 109.127 -0.694 . . . . 0.0 109.127 178.699 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 97' ' ' THR . . . . . . . . . . . . . 71.2 p -98.25 157.1 16.37 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-O 121.216 0.532 . . . . 0.0 111.06 -177.22 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 98' ' ' GLU . . . . . . . . . . . . . 97.1 mt-10 -54.34 -24.25 18.61 Favored 'General case' 0 C--N 1.329 -0.322 0 N-CA-C 112.434 0.531 . . . . 0.0 112.434 -179.571 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 99' ' ' GLU . . . . . . . . . . . . . 35.3 tt0 -80.78 16.74 1.33 Allowed 'General case' 0 CA--C 1.538 0.51 0 N-CA-C 112.642 0.608 . . . . 0.0 112.642 -177.551 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 100' ' ' ASN . . . . . . . . . . . . . 3.4 m-20 61.83 37.91 15.1 Favored 'General case' 0 C--O 1.232 0.153 0 O-C-N 121.91 -0.494 . . . . 0.0 111.151 178.129 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 101' ' ' GLU . . . . . . . . . . . . . 84.7 tt0 -116.31 144.55 44.1 Favored 'General case' 0 C--N 1.331 -0.214 0 CA-C-N 116.165 -0.471 . . . . 0.0 109.858 176.501 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 102' ' ' VAL . . . . . . . . . . . . . 41.3 t -115.8 125.54 72.99 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.26 0 CA-C-N 116.207 -0.451 . . . . 0.0 110.177 -178.299 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 103' ' ' LEU . . . . . . . . . . . . . 22.6 mt -116.25 127.86 55.1 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 115.782 -0.645 . . . . 0.0 109.867 175.811 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 104' ' ' ILE . . . . . . . . . . . . . 62.4 mt -118.15 122.55 69.91 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.295 0 N-CA-C 110.342 -0.244 . . . . 0.0 110.342 179.639 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 105' ' ' PHE . . . . . . . . . . . . . 62.4 m-85 -120.18 163.58 17.52 Favored 'General case' 0 C--N 1.332 -0.182 0 O-C-N 124.136 0.897 . . . . 0.0 109.679 178.689 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 106' ' ' ASN . . . . . . . . . . . . . 46.8 p-10 -95.24 -170.69 2.23 Favored 'General case' 0 C--N 1.331 -0.232 0 N-CA-C 109.752 -0.462 . . . . 0.0 109.752 173.23 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 107' ' ' GLN . . . . . . . . . . . . . 49.3 tt0 -59.32 -30.1 68.12 Favored 'General case' 0 C--N 1.33 -0.278 0 N-CA-C 111.879 0.326 . . . . 0.0 111.879 179.144 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 108' ' ' ASN . . . . . . . . . . . . . 6.8 t-20 -82.23 9.68 8.31 Favored 'General case' 0 CA--C 1.536 0.438 0 N-CA-C 113.052 0.76 . . . . 0.0 113.052 -177.809 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 109' ' ' LEU . . . . . . . . . . . . . 11.1 tp 58.03 35.71 25.43 Favored 'General case' 0 CA--C 1.531 0.215 0 CA-C-O 120.965 0.412 . . . . 0.0 111.409 179.203 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 110' ' ' GLU . . . . . . . . . . . . . 70.7 mm-40 -104.98 143.53 33.05 Favored 'General case' 0 C--N 1.331 -0.222 0 N-CA-C 109.264 -0.643 . . . . 0.0 109.264 174.812 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 111' ' ' GLU . . . . . . . . . . . . . 62.6 tt0 -81.64 121.97 27.02 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-O 121.058 0.456 . . . . 0.0 110.678 -175.144 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 112' ' ' LEU . . . . . . . . . . . . . 29.5 mt -104.58 -45.62 4.57 Favored 'General case' 0 C--N 1.331 -0.211 0 CA-C-N 115.935 -0.575 . . . . 0.0 110.736 179.716 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 113' ' ' TYR . . . . . . . . . . . . . 63.6 t80 -133.02 135.69 45.57 Favored 'General case' 0 C--N 1.331 -0.218 0 CA-C-N 116.376 -0.375 . . . . 0.0 111.277 -177.604 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 114' ' ' ARG . . . . . . . . . . . . . 55.6 ttp180 -133.98 121.22 21.31 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 115.868 -0.605 . . . . 0.0 110.109 177.333 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 115' ' ' GLY . . . . . . . . . . . . . . . -150.12 160.8 28.68 Favored Glycine 0 CA--C 1.524 0.642 0 N-CA-C 111.013 -0.835 . . . . 0.0 111.013 -179.987 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 116' ' ' LYS . . . . . . . . . . . . . 33.4 ttmt -135.97 139.43 43.2 Favored 'General case' 0 C--N 1.328 -0.368 0 N-CA-C 109.971 -0.381 . . . . 0.0 109.971 177.312 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 117' ' ' PHE . . . . . . . . . . . . . 39.9 m-85 -136.88 114.68 11.28 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-O 121.053 0.454 . . . . 0.0 110.312 -175.127 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 118' ' ' GLU . . . . . . . . . . . . . 96.6 mt-10 -53.38 -45.06 69.1 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 116.287 -0.415 . . . . 0.0 111.664 -175.413 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 119' ' ' ASN . . . . . . . . . . . . . 69.5 m-80 -98.66 31.08 3.02 Favored 'General case' 0 C--N 1.33 -0.271 0 N-CA-C 112.255 0.465 . . . . 0.0 112.255 -173.035 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 120' ' ' LEU . . . . . . . . . . . . . 26.8 tp -56.44 122.53 12.15 Favored 'General case' 0 C--N 1.332 -0.171 0 C-N-CA 121.059 -0.256 . . . . 0.0 110.494 177.638 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 121' ' ' ASN . . . . . . . . . . . . . 34.9 m120 -114.0 -44.15 3.18 Favored 'General case' 0 C--O 1.232 0.149 0 CA-C-N 116.687 -0.233 . . . . 0.0 111.181 -178.373 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 122' ' ' LYS . . . . . . . . . . . . . 97.3 mttt -148.31 152.92 37.92 Favored 'General case' 0 C--N 1.332 -0.156 0 CA-C-O 121.126 0.489 . . . . 0.0 111.468 -177.896 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 123' ' ' VAL . . . . . . . . . . . . . 45.0 t -127.19 132.41 69.72 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.217 0 CA-C-N 115.897 -0.592 . . . . 0.0 109.679 176.931 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 124' ' ' LEU . . . . . . . . . . . . . 75.8 mt -126.67 131.04 51.5 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.455 -0.339 . . . . 0.0 110.307 -179.993 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 125' ' ' VAL . . . . . . . . . . . . . 35.3 m -136.59 138.85 46.02 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.258 0 CA-C-O 120.844 0.354 . . . . 0.0 110.829 -179.748 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 126' ' ' ARG . . . . . . . . . . . . . 14.5 ptm180 -165.96 143.55 5.53 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.066 -0.515 . . . . 0.0 110.081 177.216 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 127' ' ' ASN . . . . . . . . . . . . . 4.3 t30 55.24 -153.82 0.31 Allowed 'General case' 0 CA--C 1.539 0.539 0 N-CA-C 110.017 -0.364 . . . . 0.0 110.017 -179.844 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 128' ' ' ASP . . . . . . . . . . . . . 8.2 p-10 -83.66 18.53 1.89 Allowed 'General case' 0 CA--C 1.535 0.37 0 N-CA-C 112.679 0.622 . . . . 0.0 112.679 179.269 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 129' ' ' LEU . . . . . . . . . . . . . 15.5 tp -122.94 138.25 54.72 Favored 'General case' 0 C--O 1.232 0.157 0 O-C-N 121.983 -0.448 . . . . 0.0 110.503 -179.608 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 130' ' ' VAL . . . . . . . . . . . . . 32.7 m -131.23 141.75 45.19 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.184 0 CA-C-O 120.805 0.336 . . . . 0.0 110.449 177.578 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 131' ' ' VAL . . . . . . . . . . . . . 47.9 t -136.14 138.61 46.99 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.285 0 CA-C-O 121.274 0.559 . . . . 0.0 110.682 -179.526 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 132' ' ' ILE . . . . . . . . . . . . . 72.1 mt -111.74 133.27 57.92 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.329 0 CA-C-N 115.41 -0.814 . . . . 0.0 109.135 178.089 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 133' ' ' ILE . . . . . . . . . . . . . 43.4 mm -114.82 120.04 63.35 Favored 'Isoleucine or valine' 0 C--O 1.233 0.229 0 CA-C-O 120.884 0.373 . . . . 0.0 110.964 -175.294 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 134' ' ' ASP . . . . . . . . . . . . . 6.2 p-10 -130.46 144.83 51.65 Favored 'General case' 0 C--N 1.331 -0.227 0 N-CA-C 109.366 -0.605 . . . . 0.0 109.366 173.83 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 135' ' ' GLU . . . . . . . . . . . . . 43.4 tp10 -49.78 -24.97 2.65 Favored 'General case' 0 C--N 1.328 -0.334 0 N-CA-C 112.793 0.664 . . . . 0.0 112.793 -170.799 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 136' ' ' GLN . . . . . . . . . . . . . 96.0 mt-30 -91.53 -40.08 11.57 Favored 'General case' 0 C--N 1.331 -0.231 0 N-CA-C 112.305 0.483 . . . . 0.0 112.305 -177.389 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 137' ' ' LYS . . . . . . . . . . . . . 61.2 mtpt -141.96 155.81 45.47 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-O 121.34 0.59 . . . . 0.0 111.718 -167.989 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 138' ' ' LEU . . . . . . . . . . . . . 5.9 tt -116.0 124.69 51.13 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 115.519 -0.764 . . . . 0.0 109.177 173.832 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 139' ' ' THR . . . . . . . . . . . . . 31.1 m -111.12 124.38 52.08 Favored 'General case' 0 C--N 1.331 -0.196 0 CA-C-N 116.438 -0.346 . . . . 0.0 110.794 -176.993 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 140' ' ' LEU . . . . . . . . . . . . . 9.9 tt -112.07 126.85 55.62 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 115.762 -0.653 . . . . 0.0 109.591 -178.468 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 141' ' ' ILE . . . . . . . . . . . . . 19.5 mt -125.21 123.88 66.15 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.302 0 CA-C-O 121.008 0.432 . . . . 0.0 109.873 -176.543 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 142' ' ' ARG . . . . . . . . . . . . . 61.5 ttt180 -110.06 124.88 52.27 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 115.119 -0.946 . . . . 0.0 110.459 -177.794 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 143' ' ' THR . . . . . . . . . . . . . 9.3 p . . . . . 0 C--O 1.22 -0.49 0 CA-C-O 117.979 -1.01 . . . . 0.0 110.592 179.959 . . . . . . . . 0 0 . 1 . 011 nuclear orig full ' B' B ' -3' ' ' GLU . . . . . . . . . . . . . 95.2 mt-10 . . . . . 0 N--CA 1.49 1.553 0 N-CA-C 109.319 -0.623 . . . . 0.0 109.319 . . . . . . . . . 0 0 . 1 . 011 nuclear orig full ' B' B ' -2' ' ' GLY . . . . . . . . . . . . . . . -72.55 135.2 21.78 Favored Glycine 0 CA--C 1.524 0.652 0 N-CA-C 111.059 -0.816 . . . . 0.0 111.059 -179.668 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' B' B ' -1' ' ' VAL . . . . . . . . . . . . . 46.4 t -96.52 136.08 28.52 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.284 0 N-CA-C 109.871 -0.418 . . . . 0.0 109.871 179.072 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' B' B ' 0' ' ' ILE . . . . . . . . . . . . . 71.9 mt -109.66 132.01 59.02 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.234 0 CA-C-N 116.27 -0.423 . . . . 0.0 110.053 -179.058 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' B' B ' 1' ' ' MET . . . . . . . . . . . . . 25.0 ptp -88.04 134.08 33.82 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.05 -0.523 . . . . 0.0 110.429 178.938 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' B' B ' 2' ' ' SER . . . . . . . . . . . . . 11.6 p -112.89 134.45 54.4 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-O 120.953 0.406 . . . . 0.0 110.549 179.976 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' B' B ' 3' ' ' GLU . . . . . . . . . . . . . 95.0 mt-10 -140.91 140.48 34.5 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 115.941 -0.572 . . . . 0.0 111.0 -178.762 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' B' B ' 4' ' ' LEU . . . . . . . . . . . . . 18.2 tp -125.23 130.73 52.68 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 115.915 -0.584 . . . . 0.0 110.119 176.558 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' B' B ' 5' ' ' LYS . . . . . . . . . . . . . 93.6 mttt -112.19 121.43 44.9 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-O 120.843 0.354 . . . . 0.0 110.569 179.588 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' B' B ' 6' ' ' LEU . . . . . . . . . . . . . 62.7 mt -114.1 147.16 39.22 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 115.388 -0.823 . . . . 0.0 111.157 -177.869 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' B' B ' 7' ' ' LYS . . . . . . . . . . . . . 79.4 tttt -137.0 140.26 31.0 Favored Pre-proline 0 CA--C 1.534 0.333 0 CA-C-N 116.07 -0.514 . . . . 0.0 109.724 175.715 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' B' B ' 8' ' ' PRO . . . . . . . . . . . . . 89.4 Cg_endo -91.58 146.45 3.31 Favored 'Trans proline' 0 N--CA 1.491 1.333 0 C-N-CA 121.735 1.624 . . . . 0.0 111.972 178.968 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' B' B ' 9' ' ' LEU . . . . . . . . . . . . . 41.4 mt -82.57 -46.84 0.91 Allowed Pre-proline 0 CA--C 1.534 0.353 0 CA-C-O 118.78 -0.628 . . . . 0.0 111.909 179.317 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' B' B ' 10' ' ' PRO . . . . . . . . . . . . . 94.3 Cg_endo -82.05 155.84 17.42 Favored 'Trans proline' 0 N--CA 1.495 1.56 0 C-N-CA 121.253 1.302 . . . . 0.0 111.767 174.433 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' B' B ' 11' ' ' LYS . . . . . . . . . . . . . 92.2 mttt -88.53 98.43 11.64 Favored 'General case' 0 C--N 1.329 -0.316 0 C-N-CA 120.883 -0.327 . . . . 0.0 110.513 178.725 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' B' B ' 12' ' ' VAL . . . . . . . . . . . . . 12.2 p -140.34 147.4 23.34 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.302 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.433 -179.976 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' B' B ' 13' ' ' GLU . . . . . . . . . . . . . 43.0 tp10 -89.21 129.93 35.7 Favored 'General case' 0 C--N 1.329 -0.298 0 N-CA-C 109.862 -0.421 . . . . 0.0 109.862 178.298 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' B' B ' 14' ' ' LEU . . . . . . . . . . . . . 53.8 mt -97.33 147.58 33.16 Favored Pre-proline 0 CA--C 1.532 0.286 0 CA-C-O 119.196 -0.43 . . . . 0.0 110.727 -176.94 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' B' B ' 15' ' ' PRO . . . . . . . . . . . . . 24.4 Cg_exo -63.31 161.11 32.03 Favored 'Trans proline' 0 N--CA 1.498 1.738 0 C-N-CA 121.248 1.299 . . . . 0.0 111.762 175.881 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' B' B ' 16' ' ' PRO . . . . . . . . . . . . . 31.2 Cg_exo -59.24 -38.15 87.22 Favored 'Trans proline' 0 N--CA 1.497 1.721 0 C-N-CA 121.471 1.447 . . . . 0.0 112.78 -177.706 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' B' B ' 17' ' ' ASP . . . . . . . . . . . . . 18.2 p-10 -88.79 9.44 24.58 Favored 'General case' 0 CA--C 1.536 0.419 0 N-CA-C 113.243 0.831 . . . . 0.0 113.243 -177.735 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' B' B ' 18' ' ' PHE . . . . . . . . . . . . . 34.2 t80 -58.25 -43.74 88.01 Favored 'General case' 0 C--N 1.334 -0.081 0 O-C-N 122.023 -0.423 . . . . 0.0 109.9 -178.446 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' B' B ' 19' ' ' VAL . . . . . . . . . . . . . 53.9 t -56.92 -42.91 79.54 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.369 0 CA-C-N 116.18 -0.464 . . . . 0.0 110.494 -179.479 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' B' B ' 20' ' ' ASP . . . . . . . . . . . . . 10.4 t0 -60.04 -42.6 94.77 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-O 120.847 0.356 . . . . 0.0 111.049 -177.796 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' B' B ' 21' ' ' VAL . . . . . . . . . . . . . 51.3 t -64.25 -47.01 91.67 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.335 0 CA-C-N 116.448 -0.342 . . . . 0.0 110.515 -177.685 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' B' B ' 22' ' ' ILE . . . . . . . . . . . . . 49.7 mm -56.48 -45.42 81.97 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.252 0 C-N-CA 120.982 -0.287 . . . . 0.0 110.572 178.819 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' B' B ' 23' ' ' ARG . . . . . . . . . . . . . 24.8 ttp180 -53.8 -50.16 66.75 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-O 120.58 0.229 . . . . 0.0 111.48 -178.446 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' B' B ' 24' ' ' ILE . . . . . . . . . . . . . 73.9 mt -59.86 -45.15 95.27 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.316 0 CA-C-N 116.574 -0.284 . . . . 0.0 111.281 -176.536 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' B' B ' 25' ' ' LYS . . . . . . . . . . . . . 50.2 mttm -65.44 -39.28 91.86 Favored 'General case' 0 C--N 1.329 -0.289 0 N-CA-C 112.607 0.595 . . . . 0.0 112.607 -177.629 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' B' B ' 26' ' ' LEU . . . . . . . . . . . . . 26.8 mt -77.55 -43.19 32.69 Favored 'General case' 0 C--N 1.33 -0.272 0 N-CA-C 112.763 0.653 . . . . 0.0 112.763 -172.838 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' B' B ' 27' ' ' GLN . . . . . . . . . . . . . 10.6 pt20 -47.0 137.49 7.42 Favored 'General case' 0 N--CA 1.469 0.51 0 N-CA-C 112.629 0.603 . . . . 0.0 112.629 -177.071 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' B' B ' 28' ' ' GLY . . . . . . . . . . . . . . . 100.72 -26.84 23.13 Favored Glycine 0 CA--C 1.533 1.183 0 CA-C-N 115.565 -0.743 . . . . 0.0 112.209 -176.477 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' B' B ' 29' ' ' LYS . . . . . . . . . . . . . 94.8 mttt -98.38 155.13 17.38 Favored 'General case' 0 C--O 1.232 0.166 0 CA-C-N 117.219 0.509 . . . . 0.0 110.842 178.555 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' B' B ' 30' ' ' THR . . . . . . . . . . . . . 28.5 m -103.04 136.45 42.82 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.279 -0.419 . . . . 0.0 109.962 175.269 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' B' B ' 31' ' ' VAL . . . . . . . . . . . . . 35.5 m -128.99 153.39 38.52 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.216 0 CA-C-O 121.047 0.451 . . . . 0.0 111.019 -177.856 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' B' B ' 32' ' ' ARG . . . . . . . . . . . . . 90.0 mtm-85 -128.81 148.98 50.92 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 115.905 -0.589 . . . . 0.0 110.457 178.877 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' B' B ' 33' ' ' THR . . . . . . . . . . . . . 18.7 m -53.42 138.6 32.86 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.326 -0.397 . . . . 0.0 111.279 -177.978 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' B' B ' 34' ' ' GLY . . . . . . . . . . . . . . . 101.06 -17.1 56.62 Favored Glycine 0 CA--C 1.533 1.167 0 CA-C-O 119.609 -0.55 . . . . 0.0 113.284 179.574 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' B' B ' 35' ' ' ASP . . . . . . . . . . . . . 69.0 m-20 -64.26 148.88 49.18 Favored 'General case' 0 C--N 1.334 -0.106 0 CA-C-N 118.07 0.935 . . . . 0.0 111.029 179.537 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' B' B ' 36' ' ' VAL . . . . . . . . . . . . . 45.6 t -123.8 131.58 72.77 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.215 0 CA-C-N 115.774 -0.648 . . . . 0.0 109.8 178.899 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' B' B ' 37' ' ' ILE . . . . . . . . . . . . . 65.6 mt -121.2 139.23 49.04 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.217 0 CA-C-N 116.197 -0.456 . . . . 0.0 109.973 -179.925 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' B' B ' 38' ' ' GLY . . . . . . . . . . . . . . . -112.31 128.78 8.68 Favored Glycine 0 CA--C 1.526 0.767 0 N-CA-C 111.033 -0.827 . . . . 0.0 111.033 179.799 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' B' B ' 39' ' ' ILE . . . . . . . . . . . . . 71.6 mt -124.12 134.81 65.56 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.21 0 N-CA-C 110.091 -0.337 . . . . 0.0 110.091 179.199 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' B' B ' 40' ' ' SER . . . . . . . . . . . . . 95.0 p -93.64 124.49 37.66 Favored 'General case' 0 C--N 1.331 -0.225 0 CA-C-N 116.338 -0.392 . . . . 0.0 111.096 176.24 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' B' B ' 41' ' ' ILE . . . . . . . . . . . . . 75.0 mt -130.63 122.5 52.87 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.254 0 CA-C-N 116.488 -0.324 . . . . 0.0 110.331 176.749 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' B' B ' 42' ' ' LEU . . . . . . . . . . . . . 6.6 tp 52.16 36.03 18.11 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 116.279 -0.419 . . . . 0.0 111.652 176.823 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' B' B ' 43' ' ' GLY . . . . . . . . . . . . . . . 71.84 32.56 63.7 Favored Glycine 0 CA--C 1.529 0.964 0 C-N-CA 121.085 -0.578 . . . . 0.0 112.033 178.543 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' B' B ' 44' ' ' LYS . . . . . . . . . . . . . 84.8 tttt -137.19 127.18 25.87 Favored 'General case' 0 C--N 1.328 -0.356 0 N-CA-C 109.74 -0.467 . . . . 0.0 109.74 178.915 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' B' B ' 45' ' ' GLU . . . . . . . . . . . . . 84.7 tt0 -83.01 122.84 28.83 Favored 'General case' 0 C--N 1.327 -0.409 0 CA-C-O 120.802 0.334 . . . . 0.0 110.923 -178.874 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' B' B ' 46' ' ' VAL . . . . . . . . . . . . . 7.6 p -120.16 127.74 75.92 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.229 0 N-CA-C 109.35 -0.611 . . . . 0.0 109.35 175.35 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' B' B ' 47' ' ' LYS . . . . . . . . . . . . . 58.2 mtpt -101.26 128.14 47.53 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 115.798 -0.637 . . . . 0.0 111.148 -179.658 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' B' B ' 48' ' ' PHE . . . . . . . . . . . . . 95.6 m-85 -112.44 131.94 55.3 Favored 'General case' 0 C--N 1.331 -0.223 0 CA-C-N 116.335 -0.393 . . . . 0.0 110.196 176.946 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' B' B ' 49' ' ' LYS . . . . . . . . . . . . . 74.4 tttt -108.39 137.45 46.33 Favored 'General case' 0 C--N 1.331 -0.229 0 CA-C-N 116.449 -0.342 . . . . 0.0 110.664 179.022 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' B' B ' 50' ' ' VAL . . . . . . . . . . . . . 47.1 t -82.88 110.59 18.1 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.254 0 N-CA-C 109.434 -0.58 . . . . 0.0 109.434 176.265 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' B' B ' 51' ' ' VAL . . . . . . . . . . . . . 47.5 t -73.78 -51.53 24.27 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.231 0 CA-C-N 116.108 -0.496 . . . . 0.0 109.754 -174.774 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' B' B ' 52' ' ' GLN . . . . . . . . . . . . . 92.6 mt-30 -153.26 152.82 31.61 Favored 'General case' 0 C--N 1.331 -0.211 0 CA-C-O 121.176 0.513 . . . . 0.0 111.82 -177.739 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' B' B ' 53' ' ' ALA . . . . . . . . . . . . . . . -132.27 133.59 44.28 Favored 'General case' 0 C--N 1.327 -0.404 0 CA-C-N 115.113 -0.949 . . . . 0.0 109.677 174.9 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' B' B ' 54' ' ' TYR . . . . . . . . . . . . . 63.1 t80 -129.2 113.6 18.43 Favored Pre-proline 0 CA--C 1.536 0.411 0 CA-C-O 118.077 -0.963 . . . . 0.0 110.569 179.07 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' B' B ' 55' ' ' PRO . . . . . . . . . . . . . 71.8 Cg_endo -77.25 164.11 87.57 Favored 'Cis proline' 0 N--CA 1.5 1.879 0 CA-C-N 121.993 1.748 . . . . 0.0 112.123 -8.831 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' B' B ' 56' ' ' SER . . . . . . . . . . . . . 13.7 m -114.03 132.82 22.51 Favored Pre-proline 0 CA--C 1.539 0.52 0 CA-C-O 118.495 -0.764 . . . . 0.0 109.388 175.173 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' B' B ' 57' ' ' PRO . . . . . . . . . . . . . 43.5 Cg_endo -69.02 143.81 73.45 Favored 'Cis proline' 0 N--CA 1.498 1.763 0 CA-C-N 121.865 1.702 . . . . 0.0 111.439 -0.713 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' B' B ' 58' ' ' LEU . . . . . . . . . . . . . 24.2 tp -105.68 135.51 46.96 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.382 -0.372 . . . . 0.0 110.667 -178.282 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' B' B ' 59' ' ' ARG . . . . . . . . . . . . . 41.7 ttm180 -99.98 121.54 41.51 Favored 'General case' 0 C--N 1.326 -0.438 0 N-CA-C 108.983 -0.747 . . . . 0.0 108.983 174.133 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' B' B ' 60' ' ' VAL . . . . . . . . . . . . . 39.9 t -79.53 122.57 35.02 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.225 0 C-N-CA 120.587 -0.445 . . . . 0.0 110.205 -174.107 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' B' B ' 61' ' ' GLU . . . . . . . . . . . . . 34.9 tp10 -130.89 156.7 44.61 Favored 'General case' 0 C--N 1.329 -0.32 0 N-CA-C 109.071 -0.715 . . . . 0.0 109.071 179.131 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' B' B ' 62' ' ' ASP . . . . . . . . . . . . . 5.5 t70 -51.42 -32.53 26.83 Favored 'General case' 0 C--N 1.326 -0.454 0 N-CA-C 111.946 0.35 . . . . 0.0 111.946 -178.945 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' B' B ' 63' ' ' ARG . . . . . . . . . . . . . 48.0 mmm-85 -73.91 -19.17 60.78 Favored 'General case' 0 CA--C 1.536 0.431 0 N-CA-C 113.095 0.776 . . . . 0.0 113.095 -176.928 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' B' B ' 64' ' ' THR . . . . . . . . . . . . . 32.0 m -67.9 141.69 56.3 Favored 'General case' 0 C--N 1.331 -0.209 0 CA-C-O 120.978 0.418 . . . . 0.0 111.114 -175.307 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' B' B ' 65' ' ' LYS . . . . . . . . . . . . . 68.4 mttm -90.23 132.88 35.26 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 115.833 -0.621 . . . . 0.0 110.322 179.639 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' B' B ' 66' ' ' ILE . . . . . . . . . . . . . 66.4 mt -112.56 131.2 64.75 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.239 0 N-CA-C 109.865 -0.42 . . . . 0.0 109.865 179.574 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' B' B ' 67' ' ' THR . . . . . . . . . . . . . 22.6 m -126.05 142.84 51.35 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-N 115.989 -0.551 . . . . 0.0 110.917 -177.723 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' B' B ' 68' ' ' LEU . . . . . . . . . . . . . 16.5 tp -98.69 141.21 31.8 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 115.845 -0.616 . . . . 0.0 109.829 177.282 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' B' B ' 69' ' ' VAL . . . . . . . . . . . . . 42.5 t -82.9 136.93 21.86 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.292 0 CA-C-O 121.3 0.572 . . . . 0.0 110.231 -178.231 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' B' B ' 70' ' ' THR . . . . . . . . . . . . . 12.2 t -89.61 -169.89 2.63 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 115.34 -0.845 . . . . 0.0 111.058 -176.328 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' B' B ' 71' ' ' HIS . . . . . . . . . . . . . 2.0 m-70 -64.82 172.94 1.87 Allowed Pre-proline 0 CA--C 1.533 0.305 0 CA-C-N 116.284 -0.416 . . . . 0.0 110.028 -177.975 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' B' B ' 72' ' ' PRO . . . . . . . . . . . . . 23.6 Cg_exo -64.74 1.06 1.99 Allowed 'Trans proline' 0 N--CA 1.498 1.784 0 C-N-CA 121.309 1.339 . . . . 0.0 113.985 -174.469 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' B' B ' 73' ' ' VAL . . . . . . . . . . . . . 27.6 m -104.64 145.17 13.53 Favored 'Isoleucine or valine' 0 C--O 1.232 0.164 0 N-CA-C 109.422 -0.584 . . . . 0.0 109.422 170.841 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' B' B ' 74' ' ' ASP . . . . . . . . . . . . . 36.2 t0 -92.62 123.71 36.12 Favored 'General case' 0 C--N 1.327 -0.397 0 CA-C-N 116.252 -0.431 . . . . 0.0 110.195 -176.764 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' B' B ' 75' ' ' VAL . . . . . . . . . . . . . 43.0 t -118.23 123.64 71.92 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.267 0 CA-C-O 121.16 0.505 . . . . 0.0 110.455 -178.592 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' B' B ' 76' ' ' LEU . . . . . . . . . . . . . 5.7 mp -123.48 146.04 48.36 Favored 'General case' 0 C--N 1.331 -0.22 0 CA-C-N 115.572 -0.74 . . . . 0.0 109.554 175.812 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' B' B ' 77' ' ' GLU . . . . . . . . . . . . . 96.9 mt-10 -134.5 132.29 39.05 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-O 121.085 0.469 . . . . 0.0 111.106 -178.267 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' B' B ' 78' ' ' ALA . . . . . . . . . . . . . . . -117.18 136.81 52.77 Favored 'General case' 0 C--N 1.331 -0.229 0 CA-C-N 115.657 -0.701 . . . . 0.0 109.91 176.898 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' B' B ' 79' ' ' LYS . . . . . . . . . . . . . 55.6 mtmt -85.37 112.8 21.16 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.501 -0.318 . . . . 0.0 110.721 -178.359 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' B' B ' 80' ' ' ILE . . . . . . . . . . . . . 41.0 mm -139.04 104.2 2.18 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.302 0 N-CA-C 109.33 -0.619 . . . . 0.0 109.33 -178.164 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' B' B ' 81' ' ' LYS . . . . . . . . . . . . . 52.9 pttt -98.99 130.87 45.36 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-O 120.923 0.392 . . . . 0.0 111.123 -178.497 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' B' B ' 82' ' ' GLY . . . . . . . . . . . . . . . 89.22 42.1 5.66 Favored Glycine 0 CA--C 1.524 0.649 0 N-CA-C 111.191 -0.764 . . . . 0.0 111.191 178.087 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' B' B ' 83' ' ' ILE . . . . . . . . . . . . . 66.6 mt -70.23 135.55 27.94 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.342 0 N-CA-C 109.539 -0.541 . . . . 0.0 109.539 177.676 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' B' B ' 84' ' ' LYS . . . . . . . . . . . . . 16.4 ttmm -89.37 -52.24 5.14 Favored 'General case' 0 C--N 1.328 -0.36 0 N-CA-C 109.734 -0.469 . . . . 0.0 109.734 179.687 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' B' B ' 85' ' ' ASP . . . . . . . . . . . . . 8.5 t70 -160.46 154.39 22.84 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 115.615 -0.72 . . . . 0.0 110.476 178.845 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' B' B ' 86' ' ' VAL . . . . . . . . . . . . . 40.5 t -128.34 131.47 69.03 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.259 0 CA-C-O 120.89 0.376 . . . . 0.0 110.194 179.985 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' B' B ' 87' ' ' ILE . . . . . . . . . . . . . 5.0 mp -120.54 127.12 75.89 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.238 0 CA-C-N 116.021 -0.536 . . . . 0.0 109.755 177.855 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' B' B ' 88' ' ' LEU . . . . . . . . . . . . . 42.4 mt -104.75 139.78 39.04 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 116.248 -0.433 . . . . 0.0 111.0 -179.842 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' B' B ' 89' ' ' ASP . . . . . . . . . . . . . 9.5 t70 -132.98 158.4 42.77 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 115.922 -0.581 . . . . 0.0 109.672 176.917 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' B' B ' 90' ' ' GLU . . . . . . . . . . . . . 43.0 mt-10 -46.83 -39.69 12.43 Favored 'General case' 0 C--N 1.329 -0.306 0 N-CA-C 113.139 0.792 . . . . 0.0 113.139 -170.469 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' B' B ' 91' ' ' ASN . . . . . . . . . . . . . 29.2 m-80 -131.99 21.33 4.52 Favored 'General case' 0 N--CA 1.468 0.444 0 N-CA-C 113.044 0.757 . . . . 0.0 113.044 -177.591 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' B' B ' 92' ' ' LEU . . . . . . . . . . . . . 34.1 mt -150.37 150.34 31.28 Favored 'General case' 0 C--N 1.331 -0.222 0 CA-C-O 120.766 0.317 . . . . 0.0 110.451 -176.923 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' B' B ' 93' ' ' ILE . . . . . . . . . . . . . 73.3 mt -127.07 121.48 57.97 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.251 0 N-CA-C 109.133 -0.691 . . . . 0.0 109.133 175.361 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' B' B ' 94' ' ' VAL . . . . . . . . . . . . . 46.9 t -118.64 126.25 75.05 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.215 0 N-CA-C 109.814 -0.439 . . . . 0.0 109.814 -179.192 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' B' B ' 95' ' ' VAL . . . . . . . . . . . . . 46.5 t -118.91 133.19 66.56 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.316 0 CA-C-N 115.901 -0.591 . . . . 0.0 109.643 -179.951 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' B' B ' 96' ' ' ILE . . . . . . . . . . . . . 64.4 mt -111.91 126.22 69.28 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.317 0 N-CA-C 109.081 -0.711 . . . . 0.0 109.081 178.982 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' B' B ' 97' ' ' THR . . . . . . . . . . . . . 74.3 p -99.34 154.12 18.44 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-O 121.192 0.52 . . . . 0.0 111.117 -176.877 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' B' B ' 98' ' ' GLU . . . . . . . . . . . . . 84.9 tt0 -53.88 -25.51 20.34 Favored 'General case' 0 CA--C 1.535 0.372 0 CA-C-N 116.069 -0.514 . . . . 0.0 112.231 -179.513 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' B' B ' 99' ' ' GLU . . . . . . . . . . . . . 45.5 mp0 -80.91 18.08 1.08 Allowed 'General case' 0 CA--C 1.535 0.386 0 N-CA-C 112.989 0.737 . . . . 0.0 112.989 -176.619 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' B' B ' 100' ' ' ASN . . . . . . . . . . . . . 3.1 m-20 62.4 37.97 13.24 Favored 'General case' 0 C--O 1.232 0.171 0 CA-C-O 121.193 0.52 . . . . 0.0 110.997 178.121 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' B' B ' 101' ' ' GLU . . . . . . . . . . . . . 84.8 tt0 -118.77 144.77 46.08 Favored 'General case' 0 C--N 1.332 -0.175 0 CA-C-N 116.211 -0.449 . . . . 0.0 109.954 177.136 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' B' B ' 102' ' ' VAL . . . . . . . . . . . . . 44.1 t -115.09 125.34 72.37 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.29 0 N-CA-C 109.797 -0.445 . . . . 0.0 109.797 -178.034 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' B' B ' 103' ' ' LEU . . . . . . . . . . . . . 34.6 mt -117.07 130.23 56.52 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-N 115.814 -0.63 . . . . 0.0 110.006 177.874 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' B' B ' 104' ' ' ILE . . . . . . . . . . . . . 69.7 mt -118.05 122.73 70.37 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.249 0 N-CA-C 110.222 -0.288 . . . . 0.0 110.222 -179.115 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' B' B ' 105' ' ' PHE . . . . . . . . . . . . . 90.9 m-85 -122.77 164.31 18.59 Favored 'General case' 0 C--N 1.332 -0.168 0 O-C-N 123.783 0.677 . . . . 0.0 110.236 -178.496 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' B' B ' 106' ' ' ASN . . . . . . . . . . . . . 49.6 p-10 -98.14 -170.74 2.02 Favored 'General case' 0 C--N 1.33 -0.28 0 N-CA-C 109.866 -0.42 . . . . 0.0 109.866 174.933 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' B' B ' 107' ' ' GLN . . . . . . . . . . . . . 58.9 tt0 -58.24 -30.01 66.2 Favored 'General case' 0 C--N 1.328 -0.332 0 N-CA-C 112.038 0.384 . . . . 0.0 112.038 -178.407 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' B' B ' 108' ' ' ASN . . . . . . . . . . . . . 10.6 t-20 -89.88 14.02 13.11 Favored 'General case' 0 CA--C 1.534 0.348 0 N-CA-C 113.098 0.777 . . . . 0.0 113.098 -176.033 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' B' B ' 109' ' ' LEU . . . . . . . . . . . . . 14.5 mt 58.61 35.38 24.49 Favored 'General case' 0 C--N 1.331 -0.201 0 CA-C-O 120.924 0.392 . . . . 0.0 111.502 179.628 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' B' B ' 110' ' ' GLU . . . . . . . . . . . . . 96.5 mt-10 -101.92 143.3 31.97 Favored 'General case' 0 C--N 1.328 -0.34 0 N-CA-C 109.189 -0.671 . . . . 0.0 109.189 174.392 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' B' B ' 111' ' ' GLU . . . . . . . . . . . . . 51.1 tt0 -81.23 121.83 26.65 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-O 120.97 0.414 . . . . 0.0 110.653 -175.299 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' B' B ' 112' ' ' LEU . . . . . . . . . . . . . 23.2 mt -103.67 -46.09 4.63 Favored 'General case' 0 C--N 1.331 -0.212 0 CA-C-N 115.88 -0.6 . . . . 0.0 110.691 179.668 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' B' B ' 113' ' ' TYR . . . . . . . . . . . . . 58.7 t80 -137.67 146.73 44.19 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.961 -178.929 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' B' B ' 114' ' ' ARG . . . . . . . . . . . . . 30.4 ptt180 -149.69 124.58 9.92 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-N 116.158 -0.473 . . . . 0.0 111.051 -178.527 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' B' B ' 115' ' ' GLY . . . . . . . . . . . . . . . -150.16 162.42 29.21 Favored Glycine 0 CA--C 1.525 0.692 0 N-CA-C 110.928 -0.869 . . . . 0.0 110.928 178.806 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' B' B ' 116' ' ' LYS . . . . . . . . . . . . . 38.3 ttpt -131.95 138.67 48.42 Favored 'General case' 0 C--N 1.33 -0.259 0 N-CA-C 109.979 -0.378 . . . . 0.0 109.979 177.13 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' B' B ' 117' ' ' PHE . . . . . . . . . . . . . 41.8 m-85 -136.37 117.31 14.23 Favored 'General case' 0 C--N 1.331 -0.227 0 C-N-CA 120.874 -0.331 . . . . 0.0 110.362 -175.716 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' B' B ' 118' ' ' GLU . . . . . . . . . . . . . 70.6 mm-40 -54.11 -45.23 71.82 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.616 -0.265 . . . . 0.0 111.246 -177.515 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' B' B ' 119' ' ' ASN . . . . . . . . . . . . . 84.1 m-20 -98.87 31.06 3.09 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.181 -0.463 . . . . 0.0 112.171 -174.479 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' B' B ' 120' ' ' LEU . . . . . . . . . . . . . 23.0 tp -56.23 120.78 8.13 Favored 'General case' 0 C--N 1.332 -0.17 0 CA-C-O 120.626 0.25 . . . . 0.0 110.393 178.512 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' B' B ' 121' ' ' ASN . . . . . . . . . . . . . 34.3 m120 -109.66 -44.21 3.9 Favored 'General case' 0 N--CA 1.462 0.152 0 CA-C-N 116.649 -0.251 . . . . 0.0 111.211 -176.118 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' B' B ' 122' ' ' LYS . . . . . . . . . . . . . 94.3 mttt -147.94 148.14 30.47 Favored 'General case' 0 C--N 1.333 -0.139 0 C-N-CA 120.392 -0.523 . . . . 0.0 111.966 -177.918 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' B' B ' 123' ' ' VAL . . . . . . . . . . . . . 48.0 t -124.09 128.17 73.88 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.255 0 N-CA-C 109.251 -0.648 . . . . 0.0 109.251 173.792 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' B' B ' 124' ' ' LEU . . . . . . . . . . . . . 12.9 tp -129.07 132.42 47.43 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-O 120.651 0.262 . . . . 0.0 110.729 -177.092 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' B' B ' 125' ' ' VAL . . . . . . . . . . . . . 12.3 p -135.45 136.08 51.17 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.23 0 CA-C-O 120.735 0.302 . . . . 0.0 110.393 179.095 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' B' B ' 126' ' ' ARG . . . . . . . . . . . . . 96.4 mtt180 -148.72 134.16 18.58 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-O 120.977 0.418 . . . . 0.0 111.052 179.583 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' B' B ' 127' ' ' ASN . . . . . . . . . . . . . 86.3 m-20 50.32 -111.52 0.52 Allowed 'General case' 0 CA--C 1.545 0.778 0 CA-C-O 118.786 -0.626 . . . . 0.0 111.398 178.827 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' B' B ' 128' ' ' ASP . . . . . . . . . . . . . 8.2 p-10 -114.12 8.62 17.01 Favored 'General case' 0 CA--C 1.536 0.423 0 CA-C-N 119.908 1.231 . . . . 0.0 113.322 -176.934 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' B' B ' 129' ' ' LEU . . . . . . . . . . . . . 42.3 mt -117.72 144.75 44.99 Favored 'General case' 0 C--O 1.232 0.134 0 CA-C-N 118.028 0.376 . . . . 0.0 110.197 179.73 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' B' B ' 130' ' ' VAL . . . . . . . . . . . . . 12.1 p -132.97 140.31 47.58 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.212 0 CA-C-O 120.967 0.413 . . . . 0.0 110.366 -179.572 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' B' B ' 131' ' ' VAL . . . . . . . . . . . . . 44.1 t -136.01 139.95 44.9 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.287 0 CA-C-N 116.046 -0.524 . . . . 0.0 110.337 -178.531 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' B' B ' 132' ' ' ILE . . . . . . . . . . . . . 74.4 mt -115.92 131.43 68.39 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.364 0 CA-C-N 115.548 -0.751 . . . . 0.0 109.05 177.735 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' B' B ' 133' ' ' ILE . . . . . . . . . . . . . 42.9 mm -114.86 121.07 66.2 Favored 'Isoleucine or valine' 0 C--O 1.234 0.252 0 CA-C-O 120.867 0.365 . . . . 0.0 111.027 -174.744 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' B' B ' 134' ' ' ASP . . . . . . . . . . . . . 6.3 p-10 -129.74 146.41 51.5 Favored 'General case' 0 C--N 1.332 -0.191 0 CA-C-N 115.834 -0.621 . . . . 0.0 109.485 174.605 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' B' B ' 135' ' ' GLU . . . . . . . . . . . . . 41.7 tp10 -49.9 -24.25 2.4 Favored 'General case' 0 C--N 1.328 -0.369 0 N-CA-C 112.976 0.732 . . . . 0.0 112.976 -169.808 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' B' B ' 136' ' ' GLN . . . . . . . . . . . . . 21.3 pt20 -102.4 -30.45 11.02 Favored 'General case' 0 CA--C 1.532 0.255 0 N-CA-C 112.709 0.633 . . . . 0.0 112.709 -174.603 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' B' B ' 137' ' ' LYS . . . . . . . . . . . . . 27.4 mtpp -141.48 153.86 45.2 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-O 121.278 0.561 . . . . 0.0 111.519 -172.044 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' B' B ' 138' ' ' LEU . . . . . . . . . . . . . 5.0 tt -114.94 124.43 51.66 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 115.615 -0.72 . . . . 0.0 109.382 174.72 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' B' B ' 139' ' ' THR . . . . . . . . . . . . . 44.0 m -108.04 122.97 47.96 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.471 -0.331 . . . . 0.0 110.727 -177.994 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' B' B ' 140' ' ' LEU . . . . . . . . . . . . . 38.8 tp -112.97 121.56 45.0 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 115.665 -0.698 . . . . 0.0 109.322 -179.294 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' B' B ' 141' ' ' ILE . . . . . . . . . . . . . 19.2 mt -123.91 125.84 71.63 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.268 0 CA-C-O 121.012 0.434 . . . . 0.0 109.937 -176.991 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' B' B ' 142' ' ' ARG . . . . . . . . . . . . . 72.7 mtp180 -108.53 124.01 49.8 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 115.304 -0.862 . . . . 0.0 110.344 179.716 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' B' B ' 143' ' ' THR . . . . . . . . . . . . . 77.2 p . . . . . 0 C--O 1.219 -0.501 0 CA-C-O 118.016 -0.992 . . . . 0.0 110.522 -179.316 . . . . . . . . 0 0 . 1 . 011 nuclear orig full ' C' C ' -3' ' ' GLU . . . . . . . . . . . . . 70.5 mm-40 . . . . . 0 N--CA 1.489 1.513 0 N-CA-C 109.278 -0.638 . . . . 0.0 109.278 . . . . . . . . . 0 0 . 1 . 011 nuclear orig full ' C' C ' -2' ' ' GLY . . . . . . . . . . . . . . . -62.31 127.86 40.67 Favored Glycine 0 CA--C 1.526 0.743 0 N-CA-C 110.676 -0.97 . . . . 0.0 110.676 179.548 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' C' C ' -1' ' ' VAL . . . . . . . . . . . . . 46.2 t -96.58 135.85 29.33 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.321 0 CA-C-O 120.848 0.356 . . . . 0.0 110.069 -179.215 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' C' C ' 0' ' ' ILE . . . . . . . . . . . . . 71.2 mt -107.91 127.14 64.26 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.256 0 CA-C-N 116.154 -0.476 . . . . 0.0 109.845 178.675 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' C' C ' 1' ' ' MET . . . . . . . . . . . . . 25.8 ptt? -82.54 149.23 27.62 Favored 'General case' 0 C--N 1.326 -0.429 0 CA-C-N 115.935 -0.575 . . . . 0.0 110.487 179.747 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' C' C ' 2' ' ' SER . . . . . . . . . . . . . 5.5 p -107.75 132.06 53.78 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.361 -0.381 . . . . 0.0 110.128 177.143 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' C' C ' 3' ' ' GLU . . . . . . . . . . . . . 94.7 mt-10 -141.28 136.6 31.78 Favored 'General case' 0 C--N 1.327 -0.407 0 CA-C-N 116.129 -0.487 . . . . 0.0 111.066 -178.681 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' C' C ' 4' ' ' LEU . . . . . . . . . . . . . 15.2 tp -123.04 126.38 46.99 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 115.983 -0.553 . . . . 0.0 109.806 175.554 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' C' C ' 5' ' ' LYS . . . . . . . . . . . . . 69.2 mttm -113.49 121.49 44.41 Favored 'General case' 0 C--N 1.331 -0.221 0 CA-C-N 116.371 -0.377 . . . . 0.0 110.669 -179.267 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' C' C ' 6' ' ' LEU . . . . . . . . . . . . . 58.2 mt -115.83 143.57 45.22 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 115.415 -0.812 . . . . 0.0 110.264 -178.726 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' C' C ' 7' ' ' LYS . . . . . . . . . . . . . 82.8 tttt -124.19 135.17 26.09 Favored Pre-proline 0 CA--C 1.534 0.359 0 CA-C-O 118.792 -0.623 . . . . 0.0 109.575 175.098 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' C' C ' 8' ' ' PRO . . . . . . . . . . . . . 88.3 Cg_endo -91.27 137.99 2.18 Favored 'Trans proline' 0 N--CA 1.49 1.317 0 C-N-CA 121.665 1.577 . . . . 0.0 111.901 179.357 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' C' C ' 9' ' ' LEU . . . . . . . . . . . . . 65.1 mt -71.8 -47.44 12.02 Favored Pre-proline 0 CA--C 1.533 0.312 0 CA-C-O 118.725 -0.655 . . . . 0.0 112.071 179.628 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' C' C ' 10' ' ' PRO . . . . . . . . . . . . . 98.7 Cg_endo -79.53 151.95 22.78 Favored 'Trans proline' 0 N--CA 1.495 1.57 0 C-N-CA 121.156 1.237 . . . . 0.0 111.779 175.696 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' C' C ' 11' ' ' LYS . . . . . . . . . . . . . 64.3 mttp -88.32 91.83 8.93 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-O 120.783 0.325 . . . . 0.0 110.69 179.807 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' C' C ' 12' ' ' VAL . . . . . . . . . . . . . 12.6 p -140.47 145.93 25.13 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.325 0 CA-C-N 116.16 -0.473 . . . . 0.0 110.34 178.684 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' C' C ' 13' ' ' GLU . . . . . . . . . . . . . 13.9 pt-20 -86.81 134.07 33.59 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.784 179.828 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' C' C ' 14' ' ' LEU . . . . . . . . . . . . . 50.0 mt -97.65 149.33 35.6 Favored Pre-proline 0 CA--C 1.532 0.28 0 CA-C-O 119.244 -0.407 . . . . 0.0 110.27 179.492 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' C' C ' 15' ' ' PRO . . . . . . . . . . . . . 26.8 Cg_exo -60.7 160.23 25.49 Favored 'Trans proline' 0 N--CA 1.498 1.786 0 C-N-CA 121.321 1.347 . . . . 0.0 111.834 178.584 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' C' C ' 16' ' ' PRO . . . . . . . . . . . . . 33.7 Cg_exo -59.17 -41.99 54.81 Favored 'Trans proline' 0 N--CA 1.497 1.705 0 C-N-CA 121.5 1.467 . . . . 0.0 112.587 -178.16 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' C' C ' 17' ' ' ASP . . . . . . . . . . . . . 8.7 p-10 -85.27 11.07 10.78 Favored 'General case' 0 CA--C 1.537 0.456 0 N-CA-C 113.065 0.765 . . . . 0.0 113.065 -178.816 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' C' C ' 18' ' ' PHE . . . . . . . . . . . . . 51.3 t80 -58.21 -42.96 87.36 Favored 'General case' 0 C--N 1.333 -0.109 0 O-C-N 122.06 -0.4 . . . . 0.0 110.082 -177.54 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' C' C ' 19' ' ' VAL . . . . . . . . . . . . . 48.3 t -57.54 -42.09 80.34 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.319 0 CA-C-N 116.385 -0.37 . . . . 0.0 110.522 -177.919 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' C' C ' 20' ' ' ASP . . . . . . . . . . . . . 83.4 m-20 -59.86 -43.52 94.65 Favored 'General case' 0 C--O 1.234 0.261 0 CA-C-O 120.96 0.409 . . . . 0.0 110.848 -178.493 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' C' C ' 21' ' ' VAL . . . . . . . . . . . . . 49.1 t -64.39 -48.54 84.81 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.251 0 CA-C-N 116.376 -0.374 . . . . 0.0 110.433 -178.097 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' C' C ' 22' ' ' ILE . . . . . . . . . . . . . 51.7 mm -56.68 -43.05 78.31 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.254 0 C-N-CA 121.079 -0.248 . . . . 0.0 110.574 179.175 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' C' C ' 23' ' ' ARG . . . . . . . . . . . . . 47.3 ttp180 -55.06 -46.64 75.38 Favored 'General case' 0 C--N 1.33 -0.255 0 C-N-CA 121.065 -0.254 . . . . 0.0 111.212 -178.495 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' C' C ' 24' ' ' ILE . . . . . . . . . . . . . 72.4 mt -59.57 -42.95 89.8 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.229 0 C-N-CA 120.869 -0.333 . . . . 0.0 110.758 179.571 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' C' C ' 25' ' ' LYS . . . . . . . . . . . . . 45.9 mmtt -62.0 -43.35 99.03 Favored 'General case' 0 C--N 1.328 -0.36 0 N-CA-C 112.037 0.384 . . . . 0.0 112.037 -179.425 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' C' C ' 26' ' ' LEU . . . . . . . . . . . . . 92.8 mt -79.67 -39.28 31.73 Favored 'General case' 0 C--N 1.329 -0.288 0 N-CA-C 113.646 0.98 . . . . 0.0 113.646 -169.899 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' C' C ' 27' ' ' GLN . . . . . . . . . . . . . 9.9 pt20 -46.77 137.51 7.02 Favored 'General case' 0 N--CA 1.469 0.502 0 N-CA-C 112.925 0.713 . . . . 0.0 112.925 -173.627 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' C' C ' 28' ' ' GLY . . . . . . . . . . . . . . . 99.47 -25.53 27.9 Favored Glycine 0 CA--C 1.533 1.179 0 CA-C-N 115.45 -0.796 . . . . 0.0 112.367 -176.934 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' C' C ' 29' ' ' LYS . . . . . . . . . . . . . 68.5 mttm -98.38 155.16 17.36 Favored 'General case' 0 C--O 1.233 0.187 0 CA-C-N 117.256 0.528 . . . . 0.0 111.061 179.537 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' C' C ' 30' ' ' THR . . . . . . . . . . . . . 25.9 m -108.59 139.92 42.69 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.149 176.267 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' C' C ' 31' ' ' VAL . . . . . . . . . . . . . 34.6 m -130.06 153.92 39.63 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.277 0 CA-C-N 116.292 -0.413 . . . . 0.0 110.9 -178.738 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' C' C ' 32' ' ' ARG . . . . . . . . . . . . . 84.3 mtm180 -128.82 147.55 50.81 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-O 121.325 0.583 . . . . 0.0 110.702 179.436 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' C' C ' 33' ' ' THR . . . . . . . . . . . . . 19.0 m -53.58 139.8 30.57 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.133 -0.485 . . . . 0.0 111.329 -178.902 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' C' C ' 34' ' ' GLY . . . . . . . . . . . . . . . 98.45 -17.13 58.92 Favored Glycine 0 CA--C 1.533 1.207 0 CA-C-O 119.706 -0.496 . . . . 0.0 113.266 178.969 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' C' C ' 35' ' ' ASP . . . . . . . . . . . . . 81.9 m-20 -66.75 149.34 50.69 Favored 'General case' 0 N--CA 1.461 0.109 0 CA-C-N 118.017 0.908 . . . . 0.0 111.044 178.978 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' C' C ' 36' ' ' VAL . . . . . . . . . . . . . 43.6 t -118.71 128.27 75.6 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.211 0 CA-C-N 116.154 -0.475 . . . . 0.0 109.725 176.832 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' C' C ' 37' ' ' ILE . . . . . . . . . . . . . 61.6 mt -119.46 137.47 53.27 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.251 0 CA-C-N 116.105 -0.498 . . . . 0.0 109.867 -179.515 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' C' C ' 38' ' ' GLY . . . . . . . . . . . . . . . -115.45 127.9 7.82 Favored Glycine 0 CA--C 1.525 0.668 0 N-CA-C 110.95 -0.86 . . . . 0.0 110.95 178.971 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' C' C ' 39' ' ' ILE . . . . . . . . . . . . . 70.5 mt -126.72 127.78 70.41 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.232 0 N-CA-C 109.905 -0.405 . . . . 0.0 109.905 178.493 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' C' C ' 40' ' ' SER . . . . . . . . . . . . . 60.4 p -91.97 119.63 31.88 Favored 'General case' 0 C--N 1.33 -0.264 0 C-N-CA 120.968 -0.293 . . . . 0.0 110.667 176.463 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' C' C ' 41' ' ' ILE . . . . . . . . . . . . . 73.3 mt -131.45 130.33 62.62 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.215 0 CA-C-O 120.868 0.366 . . . . 0.0 110.367 179.708 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' C' C ' 42' ' ' LEU . . . . . . . . . . . . . 72.8 mt 57.38 33.06 22.76 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 116.105 -0.498 . . . . 0.0 111.895 177.589 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' C' C ' 43' ' ' GLY . . . . . . . . . . . . . . . 72.55 23.06 78.57 Favored Glycine 0 CA--C 1.532 1.138 0 C-N-CA 121.132 -0.556 . . . . 0.0 112.727 177.882 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' C' C ' 44' ' ' LYS . . . . . . . . . . . . . 33.4 ttmt -139.09 129.56 25.73 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 117.315 0.557 . . . . 0.0 109.746 178.379 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' C' C ' 45' ' ' GLU . . . . . . . . . . . . . 45.9 tp10 -84.14 129.66 34.89 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-O 120.836 0.35 . . . . 0.0 111.279 -177.172 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' C' C ' 46' ' ' VAL . . . . . . . . . . . . . 9.1 p -122.75 126.12 73.43 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.246 0 N-CA-C 109.409 -0.589 . . . . 0.0 109.409 174.578 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' C' C ' 47' ' ' LYS . . . . . . . . . . . . . 64.3 mttm -100.03 128.76 46.07 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.03 -0.532 . . . . 0.0 111.339 179.068 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' C' C ' 48' ' ' PHE . . . . . . . . . . . . . 28.4 m-85 -112.51 131.97 55.32 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 116.015 -0.539 . . . . 0.0 109.795 177.549 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' C' C ' 49' ' ' LYS . . . . . . . . . . . . . 46.2 tttp -105.45 132.21 51.91 Favored 'General case' 0 C--N 1.329 -0.315 0 N-CA-C 109.812 -0.44 . . . . 0.0 109.812 177.741 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' C' C ' 50' ' ' VAL . . . . . . . . . . . . . 46.2 t -72.86 106.03 2.74 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.324 0 N-CA-C 109.454 -0.573 . . . . 0.0 109.454 178.454 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' C' C ' 51' ' ' VAL . . . . . . . . . . . . . 49.0 t -68.5 -50.61 54.8 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.279 0 N-CA-C 109.5 -0.556 . . . . 0.0 109.5 -176.357 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' C' C ' 52' ' ' GLN . . . . . . . . . . . . . 21.5 pt20 -162.67 157.81 22.31 Favored 'General case' 0 C--N 1.331 -0.201 0 CA-C-N 115.908 -0.587 . . . . 0.0 111.649 179.239 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' C' C ' 53' ' ' ALA . . . . . . . . . . . . . . . -130.97 132.61 45.16 Favored 'General case' 0 C--N 1.326 -0.422 0 CA-C-N 115.176 -0.92 . . . . 0.0 109.817 178.165 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' C' C ' 54' ' ' TYR . . . . . . . . . . . . . 29.3 t80 -128.98 108.37 18.19 Favored Pre-proline 0 CA--C 1.534 0.358 0 CA-C-O 118.204 -0.903 . . . . 0.0 110.413 -179.008 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' C' C ' 55' ' ' PRO . . . . . . . . . . . . . 73.1 Cg_endo -77.16 170.03 72.63 Favored 'Cis proline' 0 N--CA 1.501 1.916 0 CA-C-N 121.833 1.69 . . . . 0.0 112.451 -5.776 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' C' C ' 56' ' ' SER . . . . . . . . . . . . . 14.5 m -114.23 128.34 25.91 Favored Pre-proline 0 CA--C 1.54 0.568 0 CA-C-O 118.368 -0.825 . . . . 0.0 109.348 175.356 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' C' C ' 57' ' ' PRO . . . . . . . . . . . . . 57.0 Cg_endo -71.97 149.5 92.95 Favored 'Cis proline' 0 N--CA 1.497 1.689 0 CA-C-N 121.98 1.743 . . . . 0.0 111.857 -0.556 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' C' C ' 58' ' ' LEU . . . . . . . . . . . . . 24.9 tp -108.64 137.03 47.26 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.294 -0.412 . . . . 0.0 110.643 -178.622 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' C' C ' 59' ' ' ARG . . . . . . . . . . . . . 57.0 ttm-85 -107.11 127.53 53.57 Favored 'General case' 0 C--N 1.329 -0.321 0 N-CA-C 109.322 -0.621 . . . . 0.0 109.322 175.95 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' C' C ' 60' ' ' VAL . . . . . . . . . . . . . 40.9 t -81.71 120.69 33.75 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.231 0 CA-C-O 121.074 0.464 . . . . 0.0 110.968 -173.733 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' C' C ' 61' ' ' GLU . . . . . . . . . . . . . 80.4 tt0 -131.15 158.21 41.08 Favored 'General case' 0 C--N 1.33 -0.275 0 N-CA-C 108.73 -0.841 . . . . 0.0 108.73 174.729 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' C' C ' 62' ' ' ASP . . . . . . . . . . . . . 52.8 m-20 -49.82 -32.2 13.56 Favored 'General case' 0 C--N 1.329 -0.294 0 N-CA-C 112.352 0.501 . . . . 0.0 112.352 -178.146 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' C' C ' 63' ' ' ARG . . . . . . . . . . . . . 26.7 mmm180 -71.25 -20.79 62.19 Favored 'General case' 0 CA--C 1.536 0.415 0 N-CA-C 112.999 0.741 . . . . 0.0 112.999 -176.357 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' C' C ' 64' ' ' THR . . . . . . . . . . . . . 36.8 m -67.87 141.76 56.31 Favored 'General case' 0 C--N 1.331 -0.239 0 CA-C-O 121.051 0.453 . . . . 0.0 111.222 -175.592 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' C' C ' 65' ' ' LYS . . . . . . . . . . . . . 63.6 mttm -89.65 132.94 34.89 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 115.749 -0.66 . . . . 0.0 109.86 177.35 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' C' C ' 66' ' ' ILE . . . . . . . . . . . . . 63.1 mt -118.59 132.04 69.61 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.22 0 N-CA-C 110.055 -0.35 . . . . 0.0 110.055 -179.276 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' C' C ' 67' ' ' THR . . . . . . . . . . . . . 25.9 m -129.24 139.08 51.97 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-O 121.048 0.451 . . . . 0.0 111.26 -178.348 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' C' C ' 68' ' ' LEU . . . . . . . . . . . . . 39.3 mt -102.38 122.9 45.19 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 115.891 -0.595 . . . . 0.0 110.165 176.066 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' C' C ' 69' ' ' VAL . . . . . . . . . . . . . 43.3 t -102.99 136.02 37.59 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.338 0 CA-C-N 116.088 -0.505 . . . . 0.0 110.31 -178.922 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' C' C ' 70' ' ' THR . . . . . . . . . . . . . 17.2 p -136.55 97.61 3.6 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.266 -0.425 . . . . 0.0 110.4 178.454 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' C' C ' 71' ' ' HIS . . . . . . . . . . . . . 83.7 m-70 -142.5 154.25 63.19 Favored Pre-proline 0 C--N 1.33 -0.241 0 CA-C-N 116.131 -0.486 . . . . 0.0 110.468 179.692 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' C' C ' 72' ' ' PRO . . . . . . . . . . . . . 70.3 Cg_endo -76.1 -28.04 7.77 Favored 'Trans proline' 0 N--CA 1.495 1.561 0 C-N-CA 121.304 1.336 . . . . 0.0 112.562 178.266 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' C' C ' 73' ' ' VAL . . . . . . . . . . . . . 32.9 m -77.99 156.57 5.15 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.203 0 CA-C-O 120.888 0.375 . . . . 0.0 110.782 -179.175 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' C' C ' 74' ' ' ASP . . . . . . . . . . . . . 10.8 t70 -97.04 122.29 39.87 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.109 -0.496 . . . . 0.0 109.734 179.222 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' C' C ' 75' ' ' VAL . . . . . . . . . . . . . 46.0 t -116.98 125.54 73.93 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.196 0 CA-C-O 120.879 0.371 . . . . 0.0 110.698 -175.27 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' C' C ' 76' ' ' LEU . . . . . . . . . . . . . 19.4 mt -131.51 145.57 51.82 Favored 'General case' 0 C--N 1.333 -0.148 0 CA-C-N 116.012 -0.54 . . . . 0.0 110.488 179.559 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' C' C ' 77' ' ' GLU . . . . . . . . . . . . . 33.1 mp0 -135.48 141.92 45.42 Favored 'General case' 0 C--N 1.331 -0.225 0 CA-C-O 121.136 0.493 . . . . 0.0 111.046 178.345 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' C' C ' 78' ' ' ALA . . . . . . . . . . . . . . . -126.57 135.03 50.73 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 115.677 -0.692 . . . . 0.0 109.86 176.184 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' C' C ' 79' ' ' LYS . . . . . . . . . . . . . 76.5 tttt -81.73 111.19 17.76 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.315 -0.402 . . . . 0.0 110.57 -177.57 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' C' C ' 80' ' ' ILE . . . . . . . . . . . . . 42.8 mm -139.14 105.92 2.7 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.341 0 N-CA-C 109.15 -0.685 . . . . 0.0 109.15 -177.45 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' C' C ' 81' ' ' LYS . . . . . . . . . . . . . 32.1 ttpt -102.24 132.29 48.27 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-O 120.921 0.391 . . . . 0.0 110.845 -176.213 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' C' C ' 82' ' ' GLY . . . . . . . . . . . . . . . 89.19 42.09 5.67 Favored Glycine 0 CA--C 1.526 0.78 0 N-CA-C 111.563 -0.615 . . . . 0.0 111.563 177.623 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' C' C ' 83' ' ' ILE . . . . . . . . . . . . . 69.1 mt -79.26 141.87 14.78 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.284 0 N-CA-C 109.717 -0.475 . . . . 0.0 109.717 177.562 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' C' C ' 84' ' ' LYS . . . . . . . . . . . . . 38.8 ttpt -101.08 -54.02 2.89 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.309 -0.405 . . . . 0.0 110.464 -178.454 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' C' C ' 85' ' ' ASP . . . . . . . . . . . . . 7.2 t0 -146.46 150.61 35.94 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.097 -0.501 . . . . 0.0 110.781 -176.949 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' C' C ' 86' ' ' VAL . . . . . . . . . . . . . 44.1 t -128.12 131.2 69.58 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.259 0 CA-C-N 116.34 -0.391 . . . . 0.0 110.275 -179.065 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' C' C ' 87' ' ' ILE . . . . . . . . . . . . . 44.9 mm -118.61 126.84 75.5 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.254 0 N-CA-C 109.696 -0.483 . . . . 0.0 109.696 176.827 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' C' C ' 88' ' ' LEU . . . . . . . . . . . . . 13.7 tp -115.61 130.21 56.78 Favored 'General case' 0 C--N 1.331 -0.227 0 CA-C-O 120.964 0.411 . . . . 0.0 111.067 -177.014 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' C' C ' 89' ' ' ASP . . . . . . . . . . . . . 6.1 t0 -126.1 152.57 45.71 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 115.836 -0.62 . . . . 0.0 109.449 176.829 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' C' C ' 90' ' ' GLU . . . . . . . . . . . . . 84.8 tt0 -48.23 -35.72 12.5 Favored 'General case' 0 C--N 1.329 -0.312 0 N-CA-C 112.751 0.648 . . . . 0.0 112.751 -173.219 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' C' C ' 91' ' ' ASN . . . . . . . . . . . . . 85.1 m-20 -131.97 33.59 3.92 Favored 'General case' 0 N--CA 1.465 0.314 0 N-CA-C 111.877 0.325 . . . . 0.0 111.877 -176.804 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' C' C ' 92' ' ' LEU . . . . . . . . . . . . . 8.2 tp -166.07 142.6 5.11 Favored 'General case' 0 C--N 1.331 -0.215 0 C-N-CA 121.014 -0.274 . . . . 0.0 110.566 -179.002 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' C' C ' 93' ' ' ILE . . . . . . . . . . . . . 74.0 mt -127.14 125.17 65.8 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.26 0 N-CA-C 109.493 -0.558 . . . . 0.0 109.493 178.227 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' C' C ' 94' ' ' VAL . . . . . . . . . . . . . 45.2 t -127.1 129.83 71.11 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.259 0 CA-C-O 120.968 0.414 . . . . 0.0 110.197 179.914 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' C' C ' 95' ' ' VAL . . . . . . . . . . . . . 42.3 t -121.35 134.4 64.84 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.339 0 CA-C-N 115.936 -0.574 . . . . 0.0 109.76 179.324 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' C' C ' 96' ' ' ILE . . . . . . . . . . . . . 64.1 mt -116.15 128.71 73.37 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 N-CA-C 109.371 -0.604 . . . . 0.0 109.371 179.64 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' C' C ' 97' ' ' THR . . . . . . . . . . . . . 73.3 p -101.82 160.56 14.37 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-O 121.185 0.517 . . . . 0.0 111.13 -177.577 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' C' C ' 98' ' ' GLU . . . . . . . . . . . . . 12.5 pt-20 -54.04 -25.94 24.0 Favored 'General case' 0 C--N 1.328 -0.337 0 N-CA-C 112.39 0.515 . . . . 0.0 112.39 -178.108 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' C' C ' 99' ' ' GLU . . . . . . . . . . . . . 95.5 mt-10 -79.87 15.44 1.43 Allowed 'General case' 0 CA--C 1.536 0.404 0 N-CA-C 113.131 0.789 . . . . 0.0 113.131 -176.164 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' C' C ' 100' ' ' ASN . . . . . . . . . . . . . 3.5 m-20 61.82 37.35 15.54 Favored 'General case' 0 CA--C 1.531 0.245 0 CA-C-O 121.047 0.451 . . . . 0.0 110.995 179.499 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' C' C ' 101' ' ' GLU . . . . . . . . . . . . . 84.9 tt0 -114.82 141.27 48.12 Favored 'General case' 0 C--N 1.332 -0.159 0 CA-C-N 116.071 -0.513 . . . . 0.0 109.62 175.98 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' C' C ' 102' ' ' VAL . . . . . . . . . . . . . 43.7 t -116.46 127.01 74.19 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.341 0 CA-C-N 116.298 -0.41 . . . . 0.0 110.047 -178.122 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' C' C ' 103' ' ' LEU . . . . . . . . . . . . . 40.6 mt -114.85 130.14 56.83 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 115.719 -0.673 . . . . 0.0 110.071 176.496 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' C' C ' 104' ' ' ILE . . . . . . . . . . . . . 66.4 mt -114.95 122.22 68.62 Favored 'Isoleucine or valine' 0 C--O 1.234 0.254 0 N-CA-C 110.161 -0.311 . . . . 0.0 110.161 -178.693 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' C' C ' 105' ' ' PHE . . . . . . . . . . . . . 81.2 m-85 -123.24 163.57 20.41 Favored 'General case' 0 C--O 1.231 0.121 0 O-C-N 124.02 0.825 . . . . 0.0 109.591 -179.17 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' C' C ' 106' ' ' ASN . . . . . . . . . . . . . 47.4 p-10 -98.32 -170.61 1.99 Allowed 'General case' 0 C--N 1.33 -0.265 0 N-CA-C 109.828 -0.434 . . . . 0.0 109.828 173.525 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' C' C ' 107' ' ' GLN . . . . . . . . . . . . . 49.0 tt0 -59.44 -30.1 68.25 Favored 'General case' 0 C--N 1.33 -0.273 0 N-CA-C 112.128 0.418 . . . . 0.0 112.128 -179.252 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' C' C ' 108' ' ' ASN . . . . . . . . . . . . . 30.7 t30 -84.75 9.2 14.67 Favored 'General case' 0 CA--C 1.536 0.419 0 N-CA-C 113.181 0.808 . . . . 0.0 113.181 -177.009 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' C' C ' 109' ' ' LEU . . . . . . . . . . . . . 12.4 tp 61.56 37.51 16.24 Favored 'General case' 0 CA--C 1.53 0.188 0 CA-C-O 120.993 0.425 . . . . 0.0 111.249 178.573 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' C' C ' 110' ' ' GLU . . . . . . . . . . . . . 95.3 mt-10 -105.12 149.55 25.78 Favored 'General case' 0 C--N 1.33 -0.254 0 N-CA-C 109.687 -0.486 . . . . 0.0 109.687 175.584 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' C' C ' 111' ' ' GLU . . . . . . . . . . . . . 74.1 tt0 -87.45 121.92 30.52 Favored 'General case' 0 C--N 1.33 -0.272 0 C-N-CA 120.77 -0.372 . . . . 0.0 110.583 -175.31 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' C' C ' 112' ' ' LEU . . . . . . . . . . . . . 17.8 mt -108.01 -45.98 3.86 Favored 'General case' 0 C--N 1.332 -0.176 0 CA-C-N 115.992 -0.549 . . . . 0.0 110.78 -179.856 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' C' C ' 113' ' ' TYR . . . . . . . . . . . . . 46.8 t80 -135.55 141.89 45.27 Favored 'General case' 0 C--N 1.331 -0.23 0 CA-C-N 116.361 -0.381 . . . . 0.0 111.213 -178.179 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' C' C ' 114' ' ' ARG . . . . . . . . . . . . . 38.8 ptt180 -142.48 125.26 15.99 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.254 -0.43 . . . . 0.0 110.475 176.757 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' C' C ' 115' ' ' GLY . . . . . . . . . . . . . . . -150.09 162.25 29.14 Favored Glycine 0 CA--C 1.524 0.628 0 C-N-CA 120.693 -0.765 . . . . 0.0 111.55 -179.92 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' C' C ' 116' ' ' LYS . . . . . . . . . . . . . 39.1 ttpt -125.83 135.52 52.07 Favored 'General case' 0 C--N 1.332 -0.185 0 N-CA-C 109.866 -0.42 . . . . 0.0 109.866 176.994 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' C' C ' 117' ' ' PHE . . . . . . . . . . . . . 64.3 m-85 -130.65 113.81 14.64 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-O 120.856 0.36 . . . . 0.0 110.365 -178.256 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' C' C ' 118' ' ' GLU . . . . . . . . . . . . . 14.3 mm-40 -55.76 -48.19 75.71 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 116.397 -0.365 . . . . 0.0 111.056 -175.916 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' C' C ' 119' ' ' ASN . . . . . . . . . . . . . 68.1 m-80 -97.19 31.11 2.54 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.005 -0.543 . . . . 0.0 112.12 -174.185 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' C' C ' 120' ' ' LEU . . . . . . . . . . . . . 13.8 tp -52.63 119.88 5.04 Favored 'General case' 0 N--CA 1.466 0.325 0 O-C-N 122.238 -0.289 . . . . 0.0 111.029 178.999 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' C' C ' 121' ' ' ASN . . . . . . . . . . . . . 90.9 m-20 -113.93 -44.05 3.2 Favored 'General case' 0 C--N 1.331 -0.226 0 CA-C-N 116.317 -0.401 . . . . 0.0 111.242 -177.959 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' C' C ' 122' ' ' LYS . . . . . . . . . . . . . 38.4 ttpt -143.9 143.44 31.28 Favored 'General case' 0 C--N 1.333 -0.113 0 C-N-CA 120.507 -0.477 . . . . 0.0 111.577 -177.163 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' C' C ' 123' ' ' VAL . . . . . . . . . . . . . 43.9 t -126.41 127.44 70.5 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.285 0 N-CA-C 109.148 -0.686 . . . . 0.0 109.148 173.773 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' C' C ' 124' ' ' LEU . . . . . . . . . . . . . 8.7 tt -131.39 133.03 44.84 Favored 'General case' 0 N--CA 1.463 0.219 0 CA-C-O 120.961 0.41 . . . . 0.0 111.142 -176.377 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' C' C ' 125' ' ' VAL . . . . . . . . . . . . . 35.8 m -126.68 144.96 35.11 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.238 0 CA-C-N 115.798 -0.637 . . . . 0.0 110.441 179.607 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' C' C ' 126' ' ' ARG . . . . . . . . . . . . . 34.8 ttm180 -150.0 117.04 5.95 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-O 120.996 0.427 . . . . 0.0 110.412 177.819 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' C' C ' 127' ' ' ASN . . . . . . . . . . . . . 96.2 m-20 53.77 -107.6 0.37 Allowed 'General case' 0 CA--C 1.542 0.651 0 CA-C-N 116.0 -0.546 . . . . 0.0 110.859 -178.268 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' C' C ' 128' ' ' ASP . . . . . . . . . . . . . 8.4 p-10 -114.13 1.9 14.73 Favored 'General case' 0 CA--C 1.537 0.447 0 CA-C-N 119.742 1.156 . . . . 0.0 113.271 -177.994 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' C' C ' 129' ' ' LEU . . . . . . . . . . . . . 12.7 tp -105.15 139.59 39.58 Favored 'General case' 0 C--O 1.232 0.156 0 N-CA-C 109.429 -0.582 . . . . 0.0 109.429 178.789 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' C' C ' 130' ' ' VAL . . . . . . . . . . . . . 12.2 p -135.81 140.29 44.54 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.21 0 CA-C-O 121.295 0.569 . . . . 0.0 110.869 -177.564 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' C' C ' 131' ' ' VAL . . . . . . . . . . . . . 35.6 m -136.11 146.43 29.26 Favored 'Isoleucine or valine' 0 C--O 1.234 0.251 0 CA-C-N 115.793 -0.64 . . . . 0.0 110.935 178.782 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' C' C ' 132' ' ' ILE . . . . . . . . . . . . . 68.1 mt -122.88 134.0 67.32 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.293 0 CA-C-N 115.596 -0.729 . . . . 0.0 109.521 179.69 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' C' C ' 133' ' ' ILE . . . . . . . . . . . . . 42.7 mm -116.26 120.43 64.89 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.212 0 CA-C-N 116.548 -0.297 . . . . 0.0 110.733 -176.996 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' C' C ' 134' ' ' ASP . . . . . . . . . . . . . 6.1 p-10 -131.83 146.56 52.21 Favored 'General case' 0 C--N 1.331 -0.214 0 CA-C-N 116.21 -0.45 . . . . 0.0 109.806 176.379 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' C' C ' 135' ' ' GLU . . . . . . . . . . . . . 84.2 tt0 -50.0 -26.31 4.17 Favored 'General case' 0 C--N 1.328 -0.359 0 N-CA-C 112.937 0.718 . . . . 0.0 112.937 -170.779 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' C' C ' 136' ' ' GLN . . . . . . . . . . . . . 97.4 mt-30 -92.6 -35.47 13.53 Favored 'General case' 0 C--N 1.331 -0.196 0 N-CA-C 112.461 0.541 . . . . 0.0 112.461 -176.819 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' C' C ' 137' ' ' LYS . . . . . . . . . . . . . 54.4 mtmt -147.14 157.97 43.79 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-O 121.501 0.667 . . . . 0.0 112.048 -169.543 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' C' C ' 138' ' ' LEU . . . . . . . . . . . . . 6.9 tt -116.08 126.26 53.5 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 115.203 -0.908 . . . . 0.0 109.317 174.621 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' C' C ' 139' ' ' THR . . . . . . . . . . . . . 33.8 m -111.47 127.98 55.86 Favored 'General case' 0 C--N 1.331 -0.212 0 CA-C-N 116.401 -0.363 . . . . 0.0 110.713 -177.831 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' C' C ' 140' ' ' LEU . . . . . . . . . . . . . 9.0 tt -115.39 122.84 47.06 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 115.48 -0.782 . . . . 0.0 109.203 -179.781 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' C' C ' 141' ' ' ILE . . . . . . . . . . . . . 20.2 mt -120.5 117.72 54.24 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.27 0 CA-C-O 120.973 0.416 . . . . 0.0 110.046 -176.309 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' C' C ' 142' ' ' ARG . . . . . . . . . . . . . 62.6 ttp85 -106.64 130.83 54.32 Favored 'General case' 0 C--N 1.331 -0.205 0 CA-C-N 115.096 -0.956 . . . . 0.0 110.621 -177.72 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' C' C ' 143' ' ' THR . . . . . . . . . . . . . 63.6 p . . . . . 0 C--O 1.22 -0.473 0 CA-C-O 118.047 -0.978 . . . . 0.0 110.527 179.162 . . . . . . . . 0 0 . 1 . 011 nuclear orig full ' D' D ' -3' ' ' GLU . . . . . . . . . . . . . 45.2 tp10 . . . . . 0 N--CA 1.488 1.46 0 N-CA-C 109.408 -0.59 . . . . 0.0 109.408 . . . . . . . . . 0 0 . 1 . 011 nuclear orig full ' D' D ' -2' ' ' GLY . . . . . . . . . . . . . . . -64.67 141.97 44.72 Favored Glycine 0 CA--C 1.525 0.705 0 N-CA-C 110.938 -0.865 . . . . 0.0 110.938 -179.541 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' D' D ' -1' ' ' VAL . . . . . . . . . . . . . 45.5 t -141.08 134.18 31.02 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.282 0 CA-C-O 120.817 0.342 . . . . 0.0 110.109 -179.981 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' D' D ' 0' ' ' ILE . . . . . . . . . . . . . 71.2 mt -118.94 137.12 53.93 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.234 0 CA-C-N 116.059 -0.519 . . . . 0.0 109.943 179.529 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' D' D ' 1' ' ' MET . . . . . . . . . . . . . 24.9 ptp -143.24 150.15 38.91 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.252 -0.431 . . . . 0.0 110.691 -179.862 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' D' D ' 2' ' ' SER . . . . . . . . . . . . . 5.8 p -111.74 133.37 54.01 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.236 -0.438 . . . . 0.0 110.354 178.779 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' D' D ' 3' ' ' GLU . . . . . . . . . . . . . 94.2 mt-10 -141.28 137.92 32.82 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-N 116.072 -0.513 . . . . 0.0 111.014 -178.376 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' D' D ' 4' ' ' LEU . . . . . . . . . . . . . 15.5 tp -122.49 128.69 51.15 Favored 'General case' 0 C--N 1.33 -0.282 0 N-CA-C 109.86 -0.422 . . . . 0.0 109.86 175.695 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' D' D ' 5' ' ' LYS . . . . . . . . . . . . . 55.7 mttp -107.93 119.13 38.6 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.432 -0.349 . . . . 0.0 110.48 179.699 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' D' D ' 6' ' ' LEU . . . . . . . . . . . . . 71.3 mt -114.8 145.7 41.84 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 115.464 -0.789 . . . . 0.0 110.386 -177.698 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' D' D ' 7' ' ' LYS . . . . . . . . . . . . . 52.3 tttm -135.0 137.66 27.64 Favored Pre-proline 0 CA--C 1.534 0.329 0 CA-C-O 118.966 -0.54 . . . . 0.0 109.818 176.757 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' D' D ' 8' ' ' PRO . . . . . . . . . . . . . 94.0 Cg_endo -91.48 143.92 3.09 Favored 'Trans proline' 0 N--CA 1.49 1.322 0 C-N-CA 121.652 1.568 . . . . 0.0 111.877 178.495 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' D' D ' 9' ' ' LEU . . . . . . . . . . . . . 69.5 mt -80.31 -48.46 1.26 Allowed Pre-proline 0 C--N 1.328 -0.331 0 CA-C-O 118.467 -0.778 . . . . 0.0 112.372 -179.488 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' D' D ' 10' ' ' PRO . . . . . . . . . . . . . 77.7 Cg_endo -77.64 151.73 28.85 Favored 'Trans proline' 0 N--CA 1.496 1.635 0 C-N-CA 121.09 1.193 . . . . 0.0 112.009 177.618 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' D' D ' 11' ' ' LYS . . . . . . . . . . . . . 24.8 mtmt -88.29 92.32 9.12 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.311 -0.404 . . . . 0.0 110.616 179.965 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' D' D ' 12' ' ' VAL . . . . . . . . . . . . . 12.4 p -139.61 148.67 23.02 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.242 0 CA-C-N 116.073 -0.512 . . . . 0.0 110.454 -179.972 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' D' D ' 13' ' ' GLU . . . . . . . . . . . . . 84.6 tt0 -88.38 125.34 34.66 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.251 -0.431 . . . . 0.0 109.962 177.321 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' D' D ' 14' ' ' LEU . . . . . . . . . . . . . 38.2 mt -97.94 150.79 37.12 Favored Pre-proline 0 CA--C 1.531 0.249 0 CA-C-N 116.297 -0.41 . . . . 0.0 110.719 -176.328 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' D' D ' 15' ' ' PRO . . . . . . . . . . . . . 25.3 Cg_exo -62.66 155.61 57.88 Favored 'Trans proline' 0 N--CA 1.497 1.722 0 C-N-CA 121.347 1.365 . . . . 0.0 111.939 176.732 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' D' D ' 16' ' ' PRO . . . . . . . . . . . . . 35.4 Cg_exo -59.8 -30.65 92.47 Favored 'Trans proline' 0 N--CA 1.498 1.736 0 C-N-CA 121.345 1.363 . . . . 0.0 112.57 179.331 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' D' D ' 17' ' ' ASP . . . . . . . . . . . . . 7.9 p-10 -84.09 3.26 35.51 Favored 'General case' 0 C--N 1.327 -0.384 0 N-CA-C 113.329 0.862 . . . . 0.0 113.329 -177.448 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' D' D ' 18' ' ' PHE . . . . . . . . . . . . . 10.8 t80 -57.99 -45.98 85.93 Favored 'General case' 0 C--O 1.227 -0.118 0 O-C-N 121.871 -0.518 . . . . 0.0 110.058 -177.819 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' D' D ' 19' ' ' VAL . . . . . . . . . . . . . 48.6 t -56.23 -42.82 74.71 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.273 0 CA-C-N 116.168 -0.469 . . . . 0.0 110.61 -178.075 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' D' D ' 20' ' ' ASP . . . . . . . . . . . . . 83.3 m-20 -60.05 -44.05 94.94 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-O 120.782 0.325 . . . . 0.0 111.231 -177.338 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' D' D ' 21' ' ' VAL . . . . . . . . . . . . . 46.7 t -64.8 -45.6 94.55 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 C-N-CA 120.72 -0.392 . . . . 0.0 110.528 -177.532 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' D' D ' 22' ' ' ILE . . . . . . . . . . . . . 51.3 mm -56.63 -45.83 82.62 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.168 0 C-N-CA 120.87 -0.332 . . . . 0.0 110.547 179.386 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' D' D ' 23' ' ' ARG . . . . . . . . . . . . . 54.8 ttp180 -54.2 -49.52 69.18 Favored 'General case' 0 C--N 1.33 -0.258 0 C-N-CA 121.09 -0.244 . . . . 0.0 111.315 -178.165 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' D' D ' 24' ' ' ILE . . . . . 0.407 HD13 HG21 ' D' ' 24' ' ' ILE . 71.8 mt -60.32 -43.1 92.92 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.216 0 C-N-CA 121.059 -0.256 . . . . 0.0 111.32 -178.478 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' D' D ' 25' ' ' LYS . . . . . . . . . . . . . 62.4 mtpt -65.13 -40.99 95.22 Favored 'General case' 0 C--N 1.329 -0.323 0 N-CA-C 112.32 0.489 . . . . 0.0 112.32 -177.499 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' D' D ' 26' ' ' LEU . . . . . . . . . . . . . 45.2 mt -79.15 -41.61 28.09 Favored 'General case' 0 C--N 1.329 -0.324 0 N-CA-C 113.354 0.872 . . . . 0.0 113.354 -171.202 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' D' D ' 27' ' ' GLN . . . . . . . . . . . . . 10.2 pt20 -46.43 137.52 6.47 Favored 'General case' 0 N--CA 1.469 0.512 0 N-CA-C 112.823 0.675 . . . . 0.0 112.823 -174.882 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' D' D ' 28' ' ' GLY . . . . . . . . . . . . . . . 100.17 -27.27 21.12 Favored Glycine 0 CA--C 1.532 1.146 0 CA-C-N 115.591 -0.731 . . . . 0.0 112.249 -177.765 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' D' D ' 29' ' ' LYS . . . . . . . . . . . . . 97.2 mttt -98.21 155.24 17.27 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 117.142 0.471 . . . . 0.0 111.123 179.218 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' D' D ' 30' ' ' THR . . . . . . . . . . . . . 28.2 m -101.0 138.52 37.94 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 115.953 -0.567 . . . . 0.0 110.172 176.044 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' D' D ' 31' ' ' VAL . . . . . . . . . . . . . 34.9 m -131.07 152.57 37.76 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.255 0 CA-C-N 116.32 -0.4 . . . . 0.0 110.759 -179.586 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' D' D ' 32' ' ' ARG . . . . . . . . . . . . . 58.5 ttp180 -129.28 148.98 51.26 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-O 121.202 0.525 . . . . 0.0 110.673 179.676 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' D' D ' 33' ' ' THR . . . . . . . . . . . . . 27.4 m -53.52 138.96 32.65 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 116.276 -0.42 . . . . 0.0 111.24 179.964 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' D' D ' 34' ' ' GLY . . . . . . . . . . . . . . . 100.51 -17.11 57.17 Favored Glycine 0 CA--C 1.531 1.077 0 C-N-CA 121.272 -0.489 . . . . 0.0 113.225 -179.871 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' D' D ' 35' ' ' ASP . . . . . . . . . . . . . 69.3 m-20 -65.67 149.76 49.58 Favored 'General case' 0 C--O 1.232 0.147 0 CA-C-N 118.014 0.907 . . . . 0.0 111.314 179.564 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' D' D ' 36' ' ' VAL . . . . . . . . . . . . . 45.6 t -121.72 129.58 75.36 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.23 0 CA-C-N 115.774 -0.648 . . . . 0.0 109.771 177.511 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' D' D ' 37' ' ' ILE . . . . . . . . . . . . . 69.2 mt -121.41 138.98 49.97 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.282 0 CA-C-N 116.3 -0.409 . . . . 0.0 109.956 -179.504 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' D' D ' 38' ' ' GLY . . . . . . . . . . . . . . . -109.08 128.79 9.18 Favored Glycine 0 CA--C 1.526 0.762 0 N-CA-C 111.073 -0.811 . . . . 0.0 111.073 179.914 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' D' D ' 39' ' ' ILE . . . . . . . . . . . . . 71.7 mt -123.83 136.08 61.39 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.234 0 CA-C-O 120.842 0.353 . . . . 0.0 110.091 179.728 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' D' D ' 40' ' ' SER . . . . . . . . . . . . . 59.9 p -92.88 114.23 26.73 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.245 -0.434 . . . . 0.0 110.641 174.335 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' D' D ' 41' ' ' ILE . . . . . . . . . . . . . 47.0 mm -122.91 112.85 35.65 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.211 0 CA-C-O 120.724 0.297 . . . . 0.0 110.379 179.473 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' D' D ' 42' ' ' LEU . . . . . . . . . . . . . 1.3 tt 55.23 45.79 25.05 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-O 121.443 0.639 . . . . 0.0 110.521 178.111 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' D' D ' 43' ' ' GLY . . . . . . . . . . . . . . . 74.99 -9.67 11.15 Favored Glycine 0 CA--C 1.535 1.324 0 C-N-CA 121.342 -0.456 . . . . 0.0 113.712 175.687 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' D' D ' 44' ' ' LYS . . . . . . . . . . . . . 22.0 tptp -100.37 134.19 43.68 Favored 'General case' 0 C--N 1.331 -0.206 0 CA-C-N 117.927 0.863 . . . . 0.0 110.153 -178.998 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' D' D ' 45' ' ' GLU . . . . . . . . . . . . . 84.8 tt0 -83.29 123.03 29.21 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 116.458 -0.337 . . . . 0.0 110.732 -179.869 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' D' D ' 46' ' ' VAL . . . . . . . . . . . . . 7.1 p -123.49 127.64 74.26 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.182 0 N-CA-C 109.715 -0.476 . . . . 0.0 109.715 177.643 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' D' D ' 47' ' ' LYS . . . . . . . . . . . . . 63.7 mttp -100.23 129.98 46.3 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 115.954 -0.566 . . . . 0.0 111.172 178.59 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' D' D ' 48' ' ' PHE . . . . . . . . . . . . . 90.7 m-85 -113.19 131.89 55.7 Favored 'General case' 0 C--N 1.331 -0.213 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.09 177.054 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' D' D ' 49' ' ' LYS . . . . . . . . . . . . . 82.5 tttt -107.92 137.14 46.44 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.489 179.262 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' D' D ' 50' ' ' VAL . . . . . . . . . . . . . 46.4 t -83.04 108.79 16.13 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.312 0 N-CA-C 109.311 -0.625 . . . . 0.0 109.311 176.219 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' D' D ' 51' ' ' VAL . . . . . . . . . . . . . 46.1 t -73.4 -50.76 28.78 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.328 0 CA-C-N 116.142 -0.481 . . . . 0.0 109.907 -174.573 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' D' D ' 52' ' ' GLN . . . . . . . . . . . . . 92.4 mt-30 -152.72 154.22 34.81 Favored 'General case' 0 C--N 1.332 -0.18 0 CA-C-O 121.285 0.564 . . . . 0.0 111.552 -178.167 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' D' D ' 53' ' ' ALA . . . . . . . . . . . . . . . -132.56 132.59 42.74 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 115.212 -0.904 . . . . 0.0 109.788 175.832 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' D' D ' 54' ' ' TYR . . . . . . . . . . . . . 41.7 t80 -129.08 109.23 18.11 Favored Pre-proline 0 CA--C 1.534 0.364 0 CA-C-O 118.251 -0.88 . . . . 0.0 110.355 179.509 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' D' D ' 55' ' ' PRO . . . . . . . . . . . . . 73.2 Cg_endo -77.18 168.91 75.62 Favored 'Cis proline' 0 N--CA 1.5 1.873 0 CA-C-N 121.839 1.692 . . . . 0.0 112.43 -6.826 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' D' D ' 56' ' ' SER . . . . . . . . . . . . . 13.6 m -116.98 129.49 25.28 Favored Pre-proline 0 CA--C 1.538 0.49 0 CA-C-O 118.459 -0.781 . . . . 0.0 109.262 173.911 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' D' D ' 57' ' ' PRO . . . . . . . . . . . . . 56.1 Cg_endo -71.65 149.4 92.36 Favored 'Cis proline' 0 N--CA 1.498 1.768 0 CA-C-N 122.002 1.751 . . . . 0.0 111.691 0.37 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' D' D ' 58' ' ' LEU . . . . . . . . . . . . . 23.7 tp -108.98 137.99 46.03 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.176 -0.466 . . . . 0.0 110.843 -177.723 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' D' D ' 59' ' ' ARG . . . . . . . . . . . . . 31.7 ttp180 -102.23 122.87 45.03 Favored 'General case' 0 C--N 1.329 -0.315 0 N-CA-C 109.158 -0.682 . . . . 0.0 109.158 175.111 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' D' D ' 60' ' ' VAL . . . . . . . . . . . . . 43.3 t -79.84 122.37 34.93 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.262 0 C-N-CA 120.703 -0.399 . . . . 0.0 110.802 -173.36 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' D' D ' 61' ' ' GLU . . . . . . . . . . . . . 84.1 mt-10 -131.1 161.18 32.66 Favored 'General case' 0 C--N 1.332 -0.184 0 CA-C-N 115.91 -0.586 . . . . 0.0 109.562 177.214 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' D' D ' 62' ' ' ASP . . . . . . . . . . . . . 79.0 m-20 -53.3 -33.16 52.15 Favored 'General case' 0 C--N 1.329 -0.291 0 N-CA-C 111.782 0.29 . . . . 0.0 111.782 178.319 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' D' D ' 63' ' ' ARG . . . . . . . . . . . . . 92.8 mtt-85 -72.97 -21.97 60.77 Favored 'General case' 0 CA--C 1.533 0.324 0 N-CA-C 113.004 0.742 . . . . 0.0 113.004 -176.004 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' D' D ' 64' ' ' THR . . . . . . . . . . . . . 30.8 m -65.2 141.72 58.56 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-O 120.974 0.416 . . . . 0.0 111.085 -174.509 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' D' D ' 65' ' ' LYS . . . . . . . . . . . . . 68.9 mttm -87.7 131.31 34.51 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 115.787 -0.642 . . . . 0.0 109.915 178.17 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' D' D ' 66' ' ' ILE . . . . . . . . . . . . . 60.0 mt -116.27 124.93 73.05 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.272 0 N-CA-C 109.552 -0.536 . . . . 0.0 109.552 179.375 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' D' D ' 67' ' ' THR . . . . . . . . . . . . . 22.7 m -121.28 144.0 48.86 Favored 'General case' 0 C--O 1.233 0.218 0 CA-C-O 121.035 0.445 . . . . 0.0 111.242 -175.307 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' D' D ' 68' ' ' LEU . . . . . . . . . . . . . 14.2 tp -101.91 121.02 41.32 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 115.834 -0.621 . . . . 0.0 110.465 179.486 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' D' D ' 69' ' ' VAL . . . . . . . . . . . . . 44.0 t -103.84 133.39 47.95 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.361 0 CA-C-N 116.137 -0.483 . . . . 0.0 110.001 178.088 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' D' D ' 70' ' ' THR . . . . . . . . . . . . . 18.0 m -138.11 113.95 9.87 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.437 -0.347 . . . . 0.0 110.234 177.757 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' D' D ' 71' ' ' HIS . . . . . . . . . . . . . 41.8 m80 -102.1 152.04 38.16 Favored Pre-proline 0 C--N 1.331 -0.233 0 CA-C-N 116.28 -0.418 . . . . 0.0 110.294 179.612 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' D' D ' 72' ' ' PRO . . . . . . . . . . . . . 96.7 Cg_endo -84.84 -28.44 0.96 Allowed 'Trans proline' 0 N--CA 1.492 1.4 0 C-N-CA 121.552 1.501 . . . . 0.0 112.778 -178.737 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' D' D ' 73' ' ' VAL . . . . . . . . . . . . . 33.5 m -81.16 157.71 4.19 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.341 0 CA-C-O 120.978 0.418 . . . . 0.0 111.003 -178.087 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' D' D ' 74' ' ' ASP . . . . . . . . . . . . . 27.4 t0 -95.56 120.91 36.63 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 115.834 -0.621 . . . . 0.0 109.838 179.872 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' D' D ' 75' ' ' VAL . . . . . . . . . . . . . 42.9 t -112.02 122.76 66.92 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.234 0 CA-C-O 121.245 0.545 . . . . 0.0 110.337 -178.454 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' D' D ' 76' ' ' LEU . . . . . . . . . . . . . 33.7 mt -120.79 142.36 49.66 Favored 'General case' 0 C--N 1.331 -0.225 0 CA-C-N 115.555 -0.748 . . . . 0.0 109.617 177.814 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' D' D ' 77' ' ' GLU . . . . . . . . . . . . . 97.5 mt-10 -135.23 136.98 42.15 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-O 121.091 0.472 . . . . 0.0 111.382 -178.091 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' D' D ' 78' ' ' ALA . . . . . . . . . . . . . . . -124.83 138.37 54.27 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 115.706 -0.679 . . . . 0.0 109.816 176.804 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' D' D ' 79' ' ' LYS . . . . . . . . . . . . . 62.0 mttp -81.54 118.07 22.45 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-O 120.871 0.367 . . . . 0.0 110.666 -178.568 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' D' D ' 80' ' ' ILE . . . . . . . . . . . . . 42.3 mm -139.07 107.27 3.28 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.306 0 N-CA-C 109.264 -0.643 . . . . 0.0 109.264 -178.408 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' D' D ' 81' ' ' LYS . . . . . . . . . . . . . 38.0 ttpt -102.13 128.12 48.76 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-O 120.817 0.341 . . . . 0.0 110.932 -178.054 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' D' D ' 82' ' ' GLY . . . . . . . . . . . . . . . 89.05 42.17 5.69 Favored Glycine 0 CA--C 1.524 0.615 0 C-N-CA 120.725 -0.75 . . . . 0.0 111.444 174.817 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' D' D ' 83' ' ' ILE . . . . . . . . . . . . . 72.4 mt -68.25 134.88 29.5 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.264 0 N-CA-C 109.838 -0.43 . . . . 0.0 109.838 178.319 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' D' D ' 84' ' ' LYS . . . . . . . . . . . . . 30.8 tttp -94.15 -52.71 4.26 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 115.886 -0.597 . . . . 0.0 110.046 -178.22 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' D' D ' 85' ' ' ASP . . . . . . . . . . . . . 6.4 t70 -156.98 154.84 30.28 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 115.767 -0.651 . . . . 0.0 110.167 179.021 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' D' D ' 86' ' ' VAL . . . . . . . . . . . . . 44.5 t -128.72 133.61 66.05 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.219 0 CA-C-O 121.046 0.451 . . . . 0.0 110.791 179.964 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' D' D ' 87' ' ' ILE . . . . . . . . . . . . . 44.2 mm -114.62 122.39 68.64 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.249 0 CA-C-N 115.619 -0.718 . . . . 0.0 109.216 175.304 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' D' D ' 88' ' ' LEU . . . . . . . . . . . . . 34.8 mt -110.92 134.07 52.86 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-O 121.085 0.469 . . . . 0.0 111.34 -176.013 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' D' D ' 89' ' ' ASP . . . . . . . . . . . . . 9.8 t70 -131.92 154.94 48.74 Favored 'General case' 0 C--N 1.331 -0.211 0 CA-C-N 115.793 -0.639 . . . . 0.0 109.508 175.686 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' D' D ' 90' ' ' GLU . . . . . . . . . . . . . 84.7 tt0 -48.33 -38.13 18.31 Favored 'General case' 0 C--N 1.329 -0.284 0 N-CA-C 112.802 0.668 . . . . 0.0 112.802 -171.902 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' D' D ' 91' ' ' ASN . . . . . . . . . . . . . 35.0 m120 -132.0 36.74 3.64 Favored 'General case' 0 N--CA 1.466 0.328 0 N-CA-C 111.782 0.29 . . . . 0.0 111.782 -177.167 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' D' D ' 92' ' ' LEU . . . . . . . . . . . . . 12.9 tp -166.0 145.31 6.11 Favored 'General case' 0 C--N 1.332 -0.195 0 C-N-CA 120.827 -0.349 . . . . 0.0 110.91 -179.393 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' D' D ' 93' ' ' ILE . . . . . . . . . . . . . 68.1 mt -130.26 120.48 49.08 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.189 0 N-CA-C 109.579 -0.526 . . . . 0.0 109.579 -179.684 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' D' D ' 94' ' ' VAL . . . . . . . . . . . . . 46.9 t -121.66 126.13 74.31 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.253 0 N-CA-C 109.723 -0.473 . . . . 0.0 109.723 179.038 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' D' D ' 95' ' ' VAL . . . . . . . . . . . . . 44.1 t -121.16 134.79 63.4 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.236 0 CA-C-N 116.354 -0.385 . . . . 0.0 110.125 -178.902 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' D' D ' 96' ' ' ILE . . . . . . . . . . . . . 63.8 mt -113.68 128.63 70.47 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.316 0 N-CA-C 109.257 -0.646 . . . . 0.0 109.257 178.841 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' D' D ' 97' ' ' THR . . . . . . . . . . . . . 65.8 p -95.35 159.17 15.13 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-O 120.865 0.364 . . . . 0.0 110.443 179.746 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' D' D ' 98' ' ' GLU . . . . . . . . . . . . . 97.4 mt-10 -53.98 -27.5 31.91 Favored 'General case' 0 C--N 1.328 -0.36 0 N-CA-C 112.215 0.45 . . . . 0.0 112.215 -179.372 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' D' D ' 99' ' ' GLU . . . . . . . . . . . . . 45.8 mp0 -76.59 7.92 4.07 Favored 'General case' 0 CA--C 1.536 0.41 0 N-CA-C 113.502 0.927 . . . . 0.0 113.502 -176.733 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' D' D ' 100' ' ' ASN . . . . . . . . . . . . . 4.1 m-20 65.7 35.95 6.62 Favored 'General case' 0 N--CA 1.464 0.238 0 CA-C-N 118.133 0.424 . . . . 0.0 111.335 -178.064 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' D' D ' 101' ' ' GLU . . . . . . . . . . . . . 85.2 tt0 -109.93 142.68 40.94 Favored 'General case' 0 C--N 1.332 -0.179 0 N-CA-C 109.361 -0.607 . . . . 0.0 109.361 172.187 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' D' D ' 102' ' ' VAL . . . . . . . . . . . . . 44.5 t -115.02 126.86 72.72 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.312 0 CA-C-N 116.39 -0.368 . . . . 0.0 110.229 -175.84 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' D' D ' 103' ' ' LEU . . . . . . . . . . . . . 39.3 mt -116.62 129.91 56.43 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 115.678 -0.692 . . . . 0.0 109.897 175.629 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' D' D ' 104' ' ' ILE . . . . . . . . . . . . . 66.6 mt -117.7 124.41 73.02 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.259 0 N-CA-C 110.079 -0.341 . . . . 0.0 110.079 -179.996 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' D' D ' 105' ' ' PHE . . . . . . . . . . . . . 52.9 m-85 -123.72 163.54 20.91 Favored 'General case' 0 C--N 1.333 -0.142 0 O-C-N 123.963 0.79 . . . . 0.0 109.72 -179.376 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' D' D ' 106' ' ' ASN . . . . . . . . . . . . . 45.1 p-10 -97.86 -170.41 1.98 Allowed 'General case' 0 C--N 1.33 -0.281 0 N-CA-C 109.859 -0.422 . . . . 0.0 109.859 175.073 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' D' D ' 107' ' ' GLN . . . . . . . . . . . . . 62.4 tt0 -58.37 -30.04 66.46 Favored 'General case' 0 C--N 1.329 -0.297 0 N-CA-C 111.771 0.286 . . . . 0.0 111.771 179.097 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' D' D ' 108' ' ' ASN . . . . . . . . . . . . . 18.0 t30 -83.8 6.86 19.78 Favored 'General case' 0 CA--C 1.537 0.442 0 N-CA-C 113.389 0.885 . . . . 0.0 113.389 -176.53 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' D' D ' 109' ' ' LEU . . . . . . . . . . . . . 11.0 tp 62.37 37.54 13.68 Favored 'General case' 0 C--O 1.232 0.152 0 CA-C-O 120.957 0.408 . . . . 0.0 111.29 177.972 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' D' D ' 110' ' ' GLU . . . . . . . . . . . . . 95.5 mt-10 -106.44 153.99 21.47 Favored 'General case' 0 C--N 1.331 -0.198 0 CA-C-N 116.518 -0.31 . . . . 0.0 110.198 176.487 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' D' D ' 111' ' ' GLU . . . . . . . . . . . . . 85.0 tt0 -82.31 121.89 27.26 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.366 -0.379 . . . . 0.0 110.761 -177.721 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' D' D ' 112' ' ' LEU . . . . . . . . . . . . . 16.1 mt -110.44 -46.13 3.45 Favored 'General case' 0 C--N 1.331 -0.214 0 CA-C-N 116.198 -0.456 . . . . 0.0 110.723 179.367 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' D' D ' 113' ' ' TYR . . . . . . . . . . . . . 49.2 t80 -136.4 138.25 41.36 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-N 116.361 -0.381 . . . . 0.0 111.106 -179.104 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' D' D ' 114' ' ' ARG . . . . . . . . . . . . . 60.2 ttp180 -137.25 121.72 18.33 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 115.995 -0.548 . . . . 0.0 110.205 176.438 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' D' D ' 115' ' ' GLY . . . . . . . . . . . . . . . -150.05 162.2 29.12 Favored Glycine 0 CA--C 1.523 0.548 0 N-CA-C 110.481 -1.048 . . . . 0.0 110.481 178.903 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' D' D ' 116' ' ' LYS . . . . . . . . . . . . . 54.6 tttm -137.61 133.81 34.81 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.917 0.359 . . . . 0.0 110.219 -179.824 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' D' D ' 117' ' ' PHE . . . . . . . . . . . . . 38.5 m-85 -129.27 115.43 17.6 Favored 'General case' 0 C--N 1.331 -0.2 0 CA-C-O 120.901 0.381 . . . . 0.0 110.393 -175.689 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' D' D ' 118' ' ' GLU . . . . . . . . . . . . . 46.0 tp10 -52.86 -49.86 64.94 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.462 -0.336 . . . . 0.0 111.492 -176.792 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' D' D ' 119' ' ' ASN . . . . . . . . . . . . . 31.3 m120 -94.75 31.07 1.89 Allowed 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.257 -0.429 . . . . 0.0 112.138 -174.099 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' D' D ' 120' ' ' LEU . . . . . . . . . . . . . 17.9 tp -54.87 121.67 9.15 Favored 'General case' 0 C--N 1.332 -0.166 0 CA-C-O 120.698 0.285 . . . . 0.0 110.809 179.078 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' D' D ' 121' ' ' ASN . . . . . . . . . . . . . 15.0 m120 -114.03 -44.07 3.19 Favored 'General case' 0 C--N 1.331 -0.217 0 CA-C-N 116.356 -0.384 . . . . 0.0 110.909 -178.3 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' D' D ' 122' ' ' LYS . . . . . . . . . . . . . 59.9 mtpt -142.91 148.77 37.49 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-O 121.066 0.46 . . . . 0.0 111.74 -176.98 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' D' D ' 123' ' ' VAL . . . . . . . . . . . . . 44.5 t -131.33 128.2 61.11 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.246 0 CA-C-N 115.857 -0.611 . . . . 0.0 109.428 173.765 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' D' D ' 124' ' ' LEU . . . . . . . . . . . . . 60.8 mt -121.52 134.89 55.05 Favored 'General case' 0 C--N 1.331 -0.203 0 CA-C-N 116.357 -0.383 . . . . 0.0 110.558 -178.417 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' D' D ' 125' ' ' VAL . . . . . . . . . . . . . 40.8 t -130.19 131.8 65.54 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.266 0 CA-C-N 116.315 -0.402 . . . . 0.0 110.129 -179.785 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' D' D ' 126' ' ' ARG . . . . . . . . . . . . . 96.2 mtt-85 -140.08 117.69 11.55 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.333 -0.394 . . . . 0.0 110.627 178.487 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' D' D ' 127' ' ' ASN . . . . . . . . . . . . . 82.8 m-20 51.27 -104.96 0.18 Allowed 'General case' 0 CA--C 1.544 0.746 0 CA-C-O 119.032 -0.509 . . . . 0.0 111.408 178.718 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' D' D ' 128' ' ' ASP . . . . . . . . . . . . . 22.8 p-10 -114.03 1.1 14.54 Favored 'General case' 0 N--CA 1.468 0.473 0 CA-C-N 119.518 1.054 . . . . 0.0 113.489 -177.467 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' D' D ' 129' ' ' LEU . . . . . . . . . . . . . 44.7 mt -105.01 141.03 37.32 Favored 'General case' 0 C--O 1.231 0.129 0 CA-C-N 118.105 0.411 . . . . 0.0 110.078 179.245 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' D' D ' 130' ' ' VAL . . . . . . . . . . . . . 44.3 t -126.15 137.63 57.14 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.247 0 CA-C-N 116.388 -0.369 . . . . 0.0 110.153 -178.203 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' D' D ' 131' ' ' VAL . . . . . . . . . . . . . 44.2 t -134.13 134.17 55.48 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.324 0 CA-C-O 121.005 0.431 . . . . 0.0 110.011 177.629 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' D' D ' 132' ' ' ILE . . . . . . . . . . . . . 68.0 mt -117.28 133.61 63.48 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.297 0 CA-C-N 115.919 -0.582 . . . . 0.0 109.49 179.927 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' D' D ' 133' ' ' ILE . . . . . . . . . . . . . 37.1 mm -117.05 120.89 66.43 Favored 'Isoleucine or valine' 0 C--O 1.233 0.206 0 CA-C-O 120.682 0.277 . . . . 0.0 111.093 -175.218 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' D' D ' 134' ' ' ASP . . . . . . . . . . . . . 8.1 p-10 -132.91 147.06 52.29 Favored 'General case' 0 C--N 1.331 -0.234 0 N-CA-C 109.276 -0.638 . . . . 0.0 109.276 174.403 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' D' D ' 135' ' ' GLU . . . . . . . . . . . . . 84.4 tt0 -49.91 -26.42 4.11 Favored 'General case' 0 C--N 1.329 -0.316 0 N-CA-C 112.9 0.704 . . . . 0.0 112.9 -172.222 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' D' D ' 136' ' ' GLN . . . . . . . . . . . . . 31.4 tt0 -83.61 -34.29 25.15 Favored 'General case' 0 C--N 1.331 -0.224 0 N-CA-C 112.399 0.518 . . . . 0.0 112.399 -175.559 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' D' D ' 137' ' ' LYS . . . . . . . . . . . . . 20.5 pttp -168.35 172.37 8.47 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-O 121.544 0.688 . . . . 0.0 112.221 -172.076 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' D' D ' 138' ' ' LEU . . . . . . . . . . . . . 7.7 tt -120.03 131.16 55.03 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 115.093 -0.958 . . . . 0.0 110.258 -178.46 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' D' D ' 139' ' ' THR . . . . . . . . . . . . . 33.8 m -109.04 130.08 55.47 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 116.133 -0.485 . . . . 0.0 110.675 -179.497 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' D' D ' 140' ' ' LEU . . . . . . . . . . . . . 27.1 tp -114.9 121.15 42.32 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 115.765 -0.652 . . . . 0.0 109.315 -179.201 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' D' D ' 141' ' ' ILE . . . . . . . . . . . . . 19.5 mt -119.85 121.96 67.41 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.222 0 N-CA-C 109.858 -0.423 . . . . 0.0 109.858 -175.158 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' D' D ' 142' ' ' ARG . . . . . . . . . . . . . 81.5 mtm180 -116.61 131.59 56.91 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 115.496 -0.775 . . . . 0.0 110.299 -176.823 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' D' D ' 143' ' ' THR . . . . . . . . . . . . . 59.5 p . . . . . 0 C--O 1.221 -0.421 0 CA-C-O 118.044 -0.979 . . . . 0.0 110.62 -179.819 . . . . . . . . 0 0 . 1 . 011 nuclear orig full ' E' E ' -3' ' ' GLU . . . . . . . . . . . . . 95.6 mt-10 . . . . . 0 N--CA 1.489 1.503 0 N-CA-C 109.359 -0.608 . . . . 0.0 109.359 . . . . . . . . . 0 0 . 1 . 011 nuclear orig full ' E' E ' -2' ' ' GLY . . . . . . . . . . . . . . . -71.13 147.31 42.58 Favored Glycine 0 CA--C 1.525 0.688 0 N-CA-C 111.024 -0.83 . . . . 0.0 111.024 -179.733 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' E' E ' -1' ' ' VAL . . . . . . . . . . . . . 44.8 t -96.22 137.63 23.66 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.294 0 N-CA-C 109.918 -0.401 . . . . 0.0 109.918 179.58 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' E' E ' 0' ' ' ILE . . . . . . . . . . . . . 68.3 mt -104.38 133.09 49.42 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.263 0 CA-C-N 116.333 -0.394 . . . . 0.0 110.059 -179.479 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' E' E ' 1' ' ' MET . . . . . . . . . . . . . 25.2 ptp -86.17 150.15 24.6 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-N 116.0 -0.546 . . . . 0.0 110.788 -179.328 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' E' E ' 2' ' ' SER . . . . . . . . . . . . . 2.1 p -123.66 124.53 42.97 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.227 -0.442 . . . . 0.0 109.944 177.872 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' E' E ' 3' ' ' GLU . . . . . . . . . . . . . 80.4 tt0 -143.48 142.3 31.11 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 116.149 -0.478 . . . . 0.0 111.246 -175.384 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' E' E ' 4' ' ' LEU . . . . . . . . . . . . . 16.8 tp -122.26 132.24 54.33 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-N 116.079 -0.509 . . . . 0.0 110.163 176.172 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' E' E ' 5' ' ' LYS . . . . . . . . . . . . . 52.0 mttp -107.25 119.61 39.85 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.469 -0.332 . . . . 0.0 110.51 178.597 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' E' E ' 6' ' ' LEU . . . . . . . . . . . . . 37.6 mt -114.19 147.33 39.09 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 115.354 -0.839 . . . . 0.0 110.669 -178.571 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' E' E ' 7' ' ' LYS . . . . . . . . . . . . . 47.6 tttp -138.47 141.3 30.85 Favored Pre-proline 0 CA--C 1.534 0.343 0 CA-C-O 119.128 -0.463 . . . . 0.0 110.075 174.811 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' E' E ' 8' ' ' PRO . . . . . . . . . . . . . 73.7 Cg_endo -91.51 141.36 2.7 Favored 'Trans proline' 0 N--CA 1.49 1.298 0 C-N-CA 121.664 1.576 . . . . 0.0 111.561 176.047 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' E' E ' 9' ' ' LEU . . . . . . . . . . . . . 67.7 mt -77.2 -47.68 2.59 Favored Pre-proline 0 CA--C 1.533 0.322 0 CA-C-O 118.645 -0.693 . . . . 0.0 112.428 -179.288 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' E' E ' 10' ' ' PRO . . . . . . . . . . . . . 90.6 Cg_endo -79.98 155.36 23.09 Favored 'Trans proline' 0 N--CA 1.496 1.642 0 C-N-CA 121.282 1.321 . . . . 0.0 111.892 176.733 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' E' E ' 11' ' ' LYS . . . . . . . . . . . . . 28.2 ttpt -88.29 92.33 9.12 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-O 120.833 0.349 . . . . 0.0 110.532 178.876 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' E' E ' 12' ' ' VAL . . . . . . . . . . . . . 12.5 p -141.39 143.88 27.02 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.283 0 CA-C-N 116.241 -0.436 . . . . 0.0 110.343 178.68 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' E' E ' 13' ' ' GLU . . . . . . . . . . . . . 15.2 pt-20 -87.13 131.13 34.25 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.362 -0.381 . . . . 0.0 110.704 179.345 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' E' E ' 14' ' ' LEU . . . . . . . . . . . . . 17.5 mt -98.41 155.08 37.25 Favored Pre-proline 0 C--N 1.33 -0.266 0 CA-C-N 116.246 -0.433 . . . . 0.0 110.686 -179.967 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' E' E ' 15' ' ' PRO . . . . . . . . . . . . . 26.5 Cg_exo -61.57 160.07 29.62 Favored 'Trans proline' 0 N--CA 1.496 1.647 0 C-N-CA 121.363 1.375 . . . . 0.0 111.667 176.233 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' E' E ' 16' ' ' PRO . . . . . . . . . . . . . 34.7 Cg_exo -58.87 -40.76 68.97 Favored 'Trans proline' 0 N--CA 1.496 1.667 0 C-N-CA 121.4 1.4 . . . . 0.0 112.963 -177.304 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' E' E ' 17' ' ' ASP . . . . . . . . . . . . . 23.5 p-10 -89.01 11.33 18.58 Favored 'General case' 0 C--N 1.326 -0.417 0 N-CA-C 113.156 0.799 . . . . 0.0 113.156 -177.175 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' E' E ' 18' ' ' PHE . . . . . . . . . . . . . 47.1 t80 -58.04 -43.75 87.0 Favored 'General case' 0 C--N 1.334 -0.1 0 O-C-N 121.944 -0.473 . . . . 0.0 109.972 -179.619 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' E' E ' 19' ' ' VAL . . . . . . . . . . . . . 47.8 t -57.54 -39.3 68.51 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.309 0 CA-C-N 116.028 -0.533 . . . . 0.0 110.406 179.206 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' E' E ' 20' ' ' ASP . . . . . . . . . . . . . 28.3 t0 -58.94 -43.61 91.26 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-O 120.691 0.281 . . . . 0.0 110.579 -178.507 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' E' E ' 21' ' ' VAL . . . . . . . . . . . . . 52.4 t -64.22 -45.14 97.13 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.326 0 C-N-CA 120.689 -0.404 . . . . 0.0 110.354 -178.642 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' E' E ' 22' ' ' ILE . . . . . . . . . . . . . 49.3 mm -58.93 -41.59 83.48 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.327 0 C-N-CA 120.969 -0.292 . . . . 0.0 110.908 -179.929 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' E' E ' 23' ' ' ARG . . . . . . . . . . . . . 42.6 ttp180 -57.07 -47.02 82.01 Favored 'General case' 0 C--N 1.331 -0.209 0 C-N-CA 120.7 -0.4 . . . . 0.0 110.522 178.899 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' E' E ' 24' ' ' ILE . . . . . . . . . . . . . 79.6 mt -61.63 -44.95 99.5 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.302 0 CA-C-N 116.153 -0.476 . . . . 0.0 111.88 -178.559 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' E' E ' 25' ' ' LYS . . . . . . . . . . . . . 13.6 pttp -70.1 -36.21 74.71 Favored 'General case' 0 CA--C 1.533 0.307 0 C-N-CA 120.487 -0.485 . . . . 0.0 111.61 -173.729 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' E' E ' 26' ' ' LEU . . . . . . . . . . . . . 20.7 mt -79.05 -40.52 31.11 Favored 'General case' 0 C--N 1.33 -0.254 0 N-CA-C 112.86 0.689 . . . . 0.0 112.86 -174.482 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' E' E ' 27' ' ' GLN . . . . . . . . . . . . . 8.4 pt20 -47.32 139.47 6.36 Favored 'General case' 0 N--CA 1.467 0.4 0 N-CA-C 112.795 0.665 . . . . 0.0 112.795 -174.644 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' E' E ' 28' ' ' GLY . . . . . . . . . . . . . . . 98.77 -26.63 23.29 Favored Glycine 0 CA--C 1.534 1.239 0 CA-C-N 115.582 -0.736 . . . . 0.0 112.184 -176.021 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' E' E ' 29' ' ' LYS . . . . . . . . . . . . . 98.8 mttt -98.07 155.2 17.24 Favored 'General case' 0 C--O 1.233 0.202 0 CA-C-N 117.116 0.458 . . . . 0.0 111.154 179.21 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' E' E ' 30' ' ' THR . . . . . . . . . . . . . 24.6 m -104.82 137.11 43.1 Favored 'General case' 0 C--N 1.332 -0.186 0 CA-C-N 115.851 -0.613 . . . . 0.0 109.79 174.643 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' E' E ' 31' ' ' VAL . . . . . . . . . . . . . 34.9 m -127.94 159.37 39.01 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.19 0 CA-C-N 116.416 -0.356 . . . . 0.0 110.747 -178.185 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' E' E ' 32' ' ' ARG . . . . . . . . . . . . . 73.9 mtt85 -133.79 149.42 51.42 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-O 121.394 0.616 . . . . 0.0 110.773 179.241 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' E' E ' 33' ' ' THR . . . . . . . . . . . . . 18.4 m -53.54 140.09 29.47 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.143 -0.48 . . . . 0.0 111.18 -179.327 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' E' E ' 34' ' ' GLY . . . . . . . . . . . . . . . 100.69 -17.23 56.82 Favored Glycine 0 CA--C 1.533 1.164 0 CA-C-O 119.622 -0.544 . . . . 0.0 113.151 179.517 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' E' E ' 35' ' ' ASP . . . . . . . . . . . . . 77.1 m-20 -65.78 147.51 53.27 Favored 'General case' 0 C--N 1.333 -0.121 0 CA-C-N 118.058 0.929 . . . . 0.0 111.067 178.764 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' E' E ' 36' ' ' VAL . . . . . . . . . . . . . 45.3 t -125.02 131.71 72.21 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.245 0 CA-C-N 115.843 -0.617 . . . . 0.0 109.874 178.455 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' E' E ' 37' ' ' ILE . . . . . . . . . . . . . 68.1 mt -122.46 139.18 50.17 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.26 0 CA-C-N 116.331 -0.395 . . . . 0.0 109.948 -179.79 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' E' E ' 38' ' ' GLY . . . . . . . . . . . . . . . -111.79 128.63 8.7 Favored Glycine 0 CA--C 1.525 0.714 0 N-CA-C 111.243 -0.743 . . . . 0.0 111.243 179.928 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' E' E ' 39' ' ' ILE . . . . . . . . . . . . . 73.1 mt -127.74 129.94 70.14 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.229 0 N-CA-C 109.984 -0.376 . . . . 0.0 109.984 178.512 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' E' E ' 40' ' ' SER . . . . . . . . . . . . . 43.4 t -92.25 113.91 26.31 Favored 'General case' 0 C--N 1.329 -0.303 0 C-N-CA 120.997 -0.281 . . . . 0.0 110.92 177.501 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' E' E ' 41' ' ' ILE . . . . . . . . . . . . . 45.2 mm -123.06 124.45 70.24 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.207 0 N-CA-C 109.864 -0.421 . . . . 0.0 109.864 179.853 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' E' E ' 42' ' ' LEU . . . . . . . . . . . . . 55.6 mt 57.48 34.47 24.66 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.35 -0.387 . . . . 0.0 111.681 178.755 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' E' E ' 43' ' ' GLY . . . . . . . . . . . . . . . 77.6 -10.1 25.67 Favored Glycine 0 CA--C 1.535 1.314 0 C-N-CA 121.297 -0.478 . . . . 0.0 113.396 177.601 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' E' E ' 44' ' ' LYS . . . . . . . . . . . . . 60.2 tttm -101.65 130.29 47.97 Favored 'General case' 0 C--N 1.332 -0.172 0 CA-C-N 117.976 0.888 . . . . 0.0 109.814 177.396 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' E' E ' 45' ' ' GLU . . . . . . . . . . . . . 39.6 tp10 -83.8 128.72 34.74 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.389 -0.369 . . . . 0.0 110.813 -178.57 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' E' E ' 46' ' ' VAL . . . . . . . . . . . . . 7.3 p -120.64 132.24 70.72 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.277 0 N-CA-C 109.659 -0.497 . . . . 0.0 109.659 177.509 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' E' E ' 47' ' ' LYS . . . . . . . . . . . . . 62.5 mttp -100.72 127.95 46.95 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 115.929 -0.578 . . . . 0.0 111.088 177.245 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' E' E ' 48' ' ' PHE . . . . . . . . . . . . . 92.4 m-85 -109.61 131.73 54.79 Favored 'General case' 0 C--N 1.329 -0.298 0 N-CA-C 109.57 -0.53 . . . . 0.0 109.57 175.304 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' E' E ' 49' ' ' LYS . . . . . . . . . . . . . 47.5 tttp -111.57 139.12 47.28 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.661 -0.245 . . . . 0.0 110.656 -179.953 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' E' E ' 50' ' ' VAL . . . . . . . . . . . . . 45.1 t -83.49 108.42 16.03 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.307 0 N-CA-C 109.34 -0.615 . . . . 0.0 109.34 175.731 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' E' E ' 51' ' ' VAL . . . . . . . . . . . . . 46.7 t -74.2 -50.84 25.83 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.305 0 CA-C-N 116.117 -0.492 . . . . 0.0 109.955 -174.461 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' E' E ' 52' ' ' GLN . . . . . . . . . . . . . 92.2 mt-30 -152.69 152.7 32.03 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-O 121.18 0.514 . . . . 0.0 111.766 -178.54 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' E' E ' 53' ' ' ALA . . . . . . . . . . . . . . . -130.69 131.89 45.08 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 115.213 -0.903 . . . . 0.0 109.762 175.644 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' E' E ' 54' ' ' TYR . . . . . . . . . . . . . 39.5 t80 -129.07 108.96 18.09 Favored Pre-proline 0 CA--C 1.535 0.398 0 CA-C-O 118.306 -0.854 . . . . 0.0 110.277 179.348 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' E' E ' 55' ' ' PRO . . . . . . . . . . . . . 73.7 Cg_endo -77.27 169.28 74.53 Favored 'Cis proline' 0 N--CA 1.499 1.825 0 CA-C-N 121.829 1.689 . . . . 0.0 112.384 -4.473 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' E' E ' 56' ' ' SER . . . . . . . . . . . . . 14.5 m -113.88 122.62 34.44 Favored Pre-proline 0 CA--C 1.539 0.535 0 CA-C-O 118.309 -0.853 . . . . 0.0 109.372 175.275 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' E' E ' 57' ' ' PRO . . . . . . . . . . . . . 42.0 Cg_endo -67.72 167.96 59.48 Favored 'Cis proline' 0 N--CA 1.498 1.787 0 CA-C-N 122.104 1.787 . . . . 0.0 112.076 2.004 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' E' E ' 58' ' ' LEU . . . . . . . . . . . . . 25.6 tp -130.05 137.96 50.5 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-N 115.915 -0.584 . . . . 0.0 110.317 179.875 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' E' E ' 59' ' ' ARG . . . . . . . . . . . . . 66.6 ttt180 -102.36 134.34 45.82 Favored 'General case' 0 C--N 1.329 -0.298 0 N-CA-C 109.671 -0.492 . . . . 0.0 109.671 176.267 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' E' E ' 60' ' ' VAL . . . . . . . . . . . . . 41.1 t -90.34 122.53 41.81 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.192 0 C-N-CA 120.586 -0.446 . . . . 0.0 110.614 -177.851 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' E' E ' 61' ' ' GLU . . . . . . . . . . . . . 77.5 tt0 -131.06 158.14 41.17 Favored 'General case' 0 C--N 1.33 -0.269 0 N-CA-C 109.069 -0.715 . . . . 0.0 109.069 176.696 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' E' E ' 62' ' ' ASP . . . . . . . . . . . . . 64.2 m-20 -52.98 -34.3 55.46 Favored 'General case' 0 C--N 1.328 -0.355 0 N-CA-C 111.686 0.254 . . . . 0.0 111.686 -179.03 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' E' E ' 63' ' ' ARG . . . . . . . . . . . . . 22.6 mmt85 -78.67 -13.02 60.03 Favored 'General case' 0 CA--C 1.535 0.37 0 N-CA-C 113.384 0.883 . . . . 0.0 113.384 -178.549 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' E' E ' 64' ' ' THR . . . . . . . . . . . . . 18.2 m -64.58 146.71 54.23 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-O 120.977 0.417 . . . . 0.0 111.022 -175.654 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' E' E ' 65' ' ' LYS . . . . . . . . . . . . . 22.6 mtpp -86.32 127.2 34.76 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 115.736 -0.665 . . . . 0.0 110.32 -179.883 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' E' E ' 66' ' ' ILE . . . . . . . . . . . . . 60.4 mt -118.2 128.09 75.28 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.307 0 N-CA-C 109.774 -0.454 . . . . 0.0 109.774 178.458 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' E' E ' 67' ' ' THR . . . . . . . . . . . . . 30.7 m -125.88 144.16 50.78 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-O 121.052 0.453 . . . . 0.0 111.168 -176.989 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' E' E ' 68' ' ' LEU . . . . . . . . . . . . . 13.4 tp -104.86 135.66 45.81 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 115.754 -0.657 . . . . 0.0 110.192 179.098 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' E' E ' 69' ' ' VAL . . . . . . . . . . . . . 37.5 t -83.07 146.29 7.22 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.323 0 CA-C-O 121.009 0.433 . . . . 0.0 110.759 -178.607 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' E' E ' 70' ' ' THR . . . . . . . . . . . . . 68.0 p -85.76 174.59 9.24 Favored 'General case' 0 C--N 1.331 -0.2 0 CA-C-N 115.817 -0.629 . . . . 0.0 110.873 -178.978 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' E' E ' 71' ' ' HIS . . . . . . . . . . . . . 73.6 m-70 -67.65 153.4 95.09 Favored Pre-proline 0 CA--C 1.533 0.292 0 CA-C-N 115.955 -0.566 . . . . 0.0 111.207 -177.807 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' E' E ' 72' ' ' PRO . . . . . . . . . . . . . 72.2 Cg_endo -93.25 160.0 2.54 Favored 'Trans proline' 0 N--CA 1.49 1.267 0 C-N-CA 122.045 1.83 . . . . 0.0 112.564 178.189 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' E' E ' 73' ' ' VAL . . . . . . . . . . . . . 35.3 m -70.84 -173.78 0.11 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.228 0 CA-C-N 116.202 -0.454 . . . . 0.0 110.315 176.95 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' E' E ' 74' ' ' ASP . . . . . . . . . . . . . 22.0 t0 -104.04 125.04 50.09 Favored 'General case' 0 C--N 1.332 -0.191 0 C-N-CA 121.02 -0.272 . . . . 0.0 110.27 -178.885 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' E' E ' 75' ' ' VAL . . . . . . . . . . . . . 46.3 t -121.48 124.12 71.09 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.258 0 CA-C-O 121.049 0.452 . . . . 0.0 110.691 -178.86 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' E' E ' 76' ' ' LEU . . . . . . . . . . . . . 6.4 mp -121.39 149.21 43.31 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-N 115.764 -0.653 . . . . 0.0 109.787 176.027 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' E' E ' 77' ' ' GLU . . . . . . . . . . . . . 97.1 mt-10 -138.38 134.45 34.18 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-O 121.028 0.442 . . . . 0.0 111.214 -179.604 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' E' E ' 78' ' ' ALA . . . . . . . . . . . . . . . -121.33 136.18 55.0 Favored 'General case' 0 C--N 1.331 -0.21 0 CA-C-N 115.763 -0.653 . . . . 0.0 109.773 176.709 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' E' E ' 79' ' ' LYS . . . . . . . . . . . . . 40.7 mttm -81.4 117.3 21.74 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-O 120.828 0.347 . . . . 0.0 110.949 -177.478 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' E' E ' 80' ' ' ILE . . . . . . . . . . . . . 38.4 mm -139.28 106.07 2.68 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.27 0 N-CA-C 109.164 -0.68 . . . . 0.0 109.164 -179.475 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' E' E ' 81' ' ' LYS . . . . . . . . . . . . . 42.4 mtmt -99.61 126.74 45.66 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-O 121.041 0.448 . . . . 0.0 111.056 -177.992 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' E' E ' 82' ' ' GLY . . . . . . . . . . . . . . . 89.1 42.23 5.66 Favored Glycine 0 CA--C 1.525 0.695 0 C-N-CA 120.881 -0.676 . . . . 0.0 111.615 176.34 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' E' E ' 83' ' ' ILE . . . . . . . . . . . . . 75.3 mt -68.93 137.09 25.03 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.271 0 N-CA-C 109.734 -0.469 . . . . 0.0 109.734 177.149 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' E' E ' 84' ' ' LYS . . . . . . . . . . . . . 29.8 ttmt -92.49 -51.65 5.03 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-O 121.091 0.472 . . . . 0.0 109.8 -179.958 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' E' E ' 85' ' ' ASP . . . . . . . . . . . . . 5.8 t70 -156.19 152.26 27.63 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 115.492 -0.776 . . . . 0.0 110.234 -179.93 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' E' E ' 86' ' ' VAL . . . . . . . . . . . . . 44.1 t -128.07 130.62 69.75 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.27 0 CA-C-O 120.866 0.365 . . . . 0.0 110.258 179.718 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' E' E ' 87' ' ' ILE . . . . . . . . . . . . . 45.4 mm -117.3 124.19 72.73 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.291 0 CA-C-N 115.907 -0.588 . . . . 0.0 109.5 176.771 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' E' E ' 88' ' ' LEU . . . . . . . . . . . . . 13.4 tp -113.64 131.92 55.96 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-O 121.144 0.497 . . . . 0.0 111.218 -175.75 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' E' E ' 89' ' ' ASP . . . . . . . . . . . . . 9.5 t70 -125.94 153.92 43.58 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 115.63 -0.714 . . . . 0.0 109.312 174.679 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' E' E ' 90' ' ' GLU . . . . . . . . . . . . . 96.2 mt-10 -49.05 -34.55 13.77 Favored 'General case' 0 C--N 1.328 -0.367 0 N-CA-C 112.804 0.668 . . . . 0.0 112.804 -172.402 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' E' E ' 91' ' ' ASN . . . . . . . . . . . . . 85.1 m-20 -132.08 33.03 3.95 Favored 'General case' 0 N--CA 1.465 0.3 0 N-CA-C 112.099 0.407 . . . . 0.0 112.099 -176.285 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' E' E ' 92' ' ' LEU . . . . . . . . . . . . . 14.2 tp -166.05 143.8 5.53 Favored 'General case' 0 C--N 1.331 -0.231 0 C-N-CA 120.994 -0.282 . . . . 0.0 110.819 179.767 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' E' E ' 93' ' ' ILE . . . . . 0.412 HD12 HG23 ' E' ' 93' ' ' ILE . 69.9 mt -124.45 118.6 54.05 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.244 0 N-CA-C 109.577 -0.527 . . . . 0.0 109.577 179.863 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' E' E ' 94' ' ' VAL . . . . . . . . . . . . . 46.4 t -118.75 125.77 74.7 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.213 0 N-CA-C 109.73 -0.47 . . . . 0.0 109.73 179.333 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' E' E ' 95' ' ' VAL . . . . . . . . . . . . . 41.8 t -122.97 133.71 68.25 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.356 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.03 -179.08 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' E' E ' 96' ' ' ILE . . . . . . . . . . . . . 60.9 mt -115.42 127.79 72.87 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.324 0 N-CA-C 109.217 -0.66 . . . . 0.0 109.217 178.658 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' E' E ' 97' ' ' THR . . . . . . . . . . . . . 68.2 p -99.56 155.42 17.59 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-O 120.98 0.419 . . . . 0.0 110.678 -178.876 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' E' E ' 98' ' ' GLU . . . . . . . . . . . . . 45.2 mt-10 -55.64 -23.58 28.72 Favored 'General case' 0 CA--C 1.533 0.325 0 N-CA-C 112.366 0.506 . . . . 0.0 112.366 -179.717 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' E' E ' 99' ' ' GLU . . . . . . . . . . . . . 96.4 mt-10 -76.95 13.06 1.14 Allowed 'General case' 0 CA--C 1.536 0.431 0 N-CA-C 113.192 0.812 . . . . 0.0 113.192 -179.273 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' E' E ' 100' ' ' ASN . . . . . . . . . . . . . 4.0 m-20 63.69 38.07 9.63 Favored 'General case' 0 CA--C 1.529 0.149 0 CA-C-O 121.065 0.459 . . . . 0.0 111.076 178.129 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' E' E ' 101' ' ' GLU . . . . . . . . . . . . . 85.3 tt0 -118.58 144.15 46.3 Favored 'General case' 0 C--N 1.333 -0.134 0 CA-C-N 115.922 -0.581 . . . . 0.0 109.731 176.064 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' E' E ' 102' ' ' VAL . . . . . . . . . . . . . 47.2 t -116.13 127.58 73.69 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.238 0 CA-C-N 116.307 -0.406 . . . . 0.0 110.221 -177.244 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' E' E ' 103' ' ' LEU . . . . . . . . . . . . . 27.9 mt -117.73 132.99 56.39 Favored 'General case' 0 C--N 1.331 -0.213 0 CA-C-N 115.632 -0.713 . . . . 0.0 110.196 176.768 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' E' E ' 104' ' ' ILE . . . . . . . . . . . . . 67.6 mt -120.99 123.35 69.92 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.238 0 N-CA-C 110.198 -0.297 . . . . 0.0 110.198 179.378 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' E' E ' 105' ' ' PHE . . . . . . . . . . . . . 55.8 m-85 -124.91 165.69 17.64 Favored 'General case' 0 C--N 1.332 -0.164 0 O-C-N 123.896 0.748 . . . . 0.0 109.813 179.278 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' E' E ' 106' ' ' ASN . . . . . . . . . . . . . 47.3 p-10 -101.84 -170.96 1.9 Allowed 'General case' 0 C--N 1.331 -0.237 0 N-CA-C 109.966 -0.383 . . . . 0.0 109.966 173.568 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' E' E ' 107' ' ' GLN . . . . . . . . . . . . . 50.3 tt0 -58.57 -30.2 66.98 Favored 'General case' 0 C--N 1.329 -0.299 0 N-CA-C 111.998 0.37 . . . . 0.0 111.998 179.638 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' E' E ' 108' ' ' ASN . . . . . . . . . . . . . 58.1 t30 -83.11 10.79 7.39 Favored 'General case' 0 CA--C 1.537 0.463 0 N-CA-C 112.987 0.736 . . . . 0.0 112.987 -177.422 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' E' E ' 109' ' ' LEU . . . . . . . . . . . . . 8.6 tp 55.09 37.61 29.18 Favored 'General case' 0 C--N 1.332 -0.186 0 CA-C-O 121.039 0.447 . . . . 0.0 111.277 179.006 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' E' E ' 110' ' ' GLU . . . . . . . . . . . . . 70.6 mm-40 -102.9 154.94 18.71 Favored 'General case' 0 C--N 1.331 -0.235 0 N-CA-C 109.771 -0.455 . . . . 0.0 109.771 176.319 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' E' E ' 111' ' ' GLU . . . . . . . . . . . . . 85.0 tt0 -82.84 121.94 27.59 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-O 120.908 0.385 . . . . 0.0 110.598 -177.924 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' E' E ' 112' ' ' LEU . . . . . . . . . . . . . 18.8 mt -108.6 -45.92 3.76 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 115.964 -0.562 . . . . 0.0 110.38 178.34 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' E' E ' 113' ' ' TYR . . . . . . . . . . . . . 64.2 t80 -142.03 139.96 32.48 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.37 -0.377 . . . . 0.0 111.573 -179.9 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' E' E ' 114' ' ' ARG . . . . . . . . . . . . . 59.3 ttp180 -140.71 121.93 14.83 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.031 -0.531 . . . . 0.0 110.104 176.835 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' E' E ' 115' ' ' GLY . . . . . . . . . . . . . . . -150.06 161.35 28.87 Favored Glycine 0 CA--C 1.525 0.698 0 N-CA-C 111.296 -0.721 . . . . 0.0 111.296 178.563 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' E' E ' 116' ' ' LYS . . . . . . . . . . . . . 40.0 ttpt -130.9 140.7 50.23 Favored 'General case' 0 C--N 1.331 -0.215 0 N-CA-C 110.253 -0.277 . . . . 0.0 110.253 179.002 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' E' E ' 117' ' ' PHE . . . . . . . . . . . . . 30.3 m-85 -139.11 114.01 9.33 Favored 'General case' 0 C--N 1.331 -0.214 0 C-N-CA 120.839 -0.344 . . . . 0.0 110.188 -178.517 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' E' E ' 118' ' ' GLU . . . . . . . . . . . . . 95.9 mt-10 -54.83 -41.44 70.7 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 116.47 -0.332 . . . . 0.0 111.216 -176.401 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' E' E ' 119' ' ' ASN . . . . . . . . . . . . . 28.4 m120 -100.36 30.96 3.6 Favored 'General case' 0 C--N 1.33 -0.249 0 N-CA-C 112.176 0.435 . . . . 0.0 112.176 -174.016 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' E' E ' 120' ' ' LEU . . . . . . . . . . . . . 24.8 tp -57.57 119.98 7.51 Favored 'General case' 0 C--N 1.332 -0.155 0 C-N-CA 120.903 -0.319 . . . . 0.0 110.179 177.546 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' E' E ' 121' ' ' ASN . . . . . . . . . . . . . 21.1 m120 -114.19 -44.02 3.17 Favored 'General case' 0 N--CA 1.462 0.149 0 CA-C-N 116.553 -0.294 . . . . 0.0 111.319 -176.708 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' E' E ' 122' ' ' LYS . . . . . . . . . . . . . 35.8 mtmm -140.17 146.29 38.57 Favored 'General case' 0 C--N 1.331 -0.224 0 CA-C-O 121.032 0.444 . . . . 0.0 111.618 -175.825 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' E' E ' 123' ' ' VAL . . . . . . . . . . . . . 44.3 t -128.58 130.81 69.05 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.269 0 CA-C-N 115.998 -0.547 . . . . 0.0 109.796 177.038 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' E' E ' 124' ' ' LEU . . . . . . . . . . . . . 45.9 mt -123.39 129.7 51.66 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-N 116.49 -0.323 . . . . 0.0 110.597 179.645 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' E' E ' 125' ' ' VAL . . . . . . . . . . . . . 42.2 t -132.71 126.72 54.94 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.248 0 CA-C-N 116.231 -0.44 . . . . 0.0 109.982 178.68 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' E' E ' 126' ' ' ARG . . . . . . . . . . . . . 51.8 mmm-85 -140.05 125.14 18.63 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-O 120.918 0.389 . . . . 0.0 110.329 177.996 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' E' E ' 127' ' ' ASN . . . . . . . . . . . . . 67.3 m-80 51.25 -111.61 0.56 Allowed 'General case' 0 CA--C 1.546 0.794 0 CA-C-O 118.598 -0.715 . . . . 0.0 111.172 179.817 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' E' E ' 128' ' ' ASP . . . . . . . . . . . . . 11.6 p-10 -114.14 9.97 17.28 Favored 'General case' 0 CA--C 1.535 0.384 0 CA-C-N 120.089 1.313 . . . . 0.0 113.26 -178.357 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' E' E ' 129' ' ' LEU . . . . . . . . . . . . . 17.2 tp -109.52 138.33 46.05 Favored 'General case' 0 C--O 1.233 0.216 0 O-C-N 121.987 -0.445 . . . . 0.0 110.053 179.199 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' E' E ' 130' ' ' VAL . . . . . . . . . . . . . 41.2 t -125.02 137.19 58.43 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.226 0 CA-C-O 120.958 0.409 . . . . 0.0 110.494 -176.802 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' E' E ' 131' ' ' VAL . . . . . . . . . . . . . 41.8 t -135.82 136.68 49.9 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.259 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.242 177.39 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' E' E ' 132' ' ' ILE . . . . . . . . . . . . . 71.6 mt -118.3 132.98 66.58 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.337 0 CA-C-N 115.886 -0.597 . . . . 0.0 109.446 -179.031 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' E' E ' 133' ' ' ILE . . . . . . . . . . . . . 40.3 mm -117.16 123.77 72.22 Favored 'Isoleucine or valine' 0 C--O 1.233 0.214 0 CA-C-O 121.001 0.429 . . . . 0.0 111.053 -174.914 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' E' E ' 134' ' ' ASP . . . . . . . . . . . . . 6.7 p-10 -131.07 152.75 50.04 Favored 'General case' 0 C--N 1.332 -0.157 0 CA-C-N 116.048 -0.524 . . . . 0.0 109.786 174.723 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' E' E ' 135' ' ' GLU . . . . . . . . . . . . . 46.4 tp10 -49.93 -28.33 6.58 Favored 'General case' 0 C--N 1.328 -0.356 0 N-CA-C 112.91 0.707 . . . . 0.0 112.91 -169.263 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' E' E ' 136' ' ' GLN . . . . . . . . . . . . . 52.7 mt-30 -105.03 -24.96 12.73 Favored 'General case' 0 N--CA 1.464 0.275 0 N-CA-C 112.982 0.734 . . . . 0.0 112.982 -173.767 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' E' E ' 137' ' ' LYS . . . . . . . . . . . . . 59.6 mtpt -143.11 154.14 43.62 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-O 121.229 0.538 . . . . 0.0 111.891 -169.589 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' E' E ' 138' ' ' LEU . . . . . . . . . . . . . 5.7 tt -119.09 124.18 46.27 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 115.546 -0.752 . . . . 0.0 109.378 174.587 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' E' E ' 139' ' ' THR . . . . . . . . . . . . . 30.6 m -110.39 130.54 55.53 Favored 'General case' 0 C--N 1.331 -0.229 0 CA-C-O 120.795 0.331 . . . . 0.0 110.774 -177.173 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' E' E ' 140' ' ' LEU . . . . . . . . . . . . . 12.6 tp -116.52 125.29 51.7 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 115.664 -0.698 . . . . 0.0 109.429 -178.093 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' E' E ' 141' ' ' ILE . . . . . . . . . . . . . 19.3 mt -122.56 117.75 52.99 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.308 0 N-CA-C 109.736 -0.468 . . . . 0.0 109.736 -177.205 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' E' E ' 142' ' ' ARG . . . . . . . . . . . . . 81.2 mtp180 -108.1 128.45 54.69 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 115.39 -0.823 . . . . 0.0 110.398 -176.473 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' E' E ' 143' ' ' THR . . . . . . . . . . . . . 77.8 p . . . . . 0 C--O 1.22 -0.459 0 CA-C-O 118.058 -0.972 . . . . 0.0 110.48 -179.994 . . . . . . . . 0 0 . 1 . 011 nuclear orig full ' F' F ' -3' ' ' GLU . . . . . . . . . . . . . 95.8 mt-10 . . . . . 0 N--CA 1.491 1.602 0 N-CA-C 109.38 -0.6 . . . . 0.0 109.38 . . . . . . . . . 0 0 . 1 . 011 nuclear orig full ' F' F ' -2' ' ' GLY . . . . . . . . . . . . . . . -70.25 130.94 22.06 Favored Glycine 0 CA--C 1.525 0.709 0 N-CA-C 110.679 -0.968 . . . . 0.0 110.679 178.454 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' F' F ' -1' ' ' VAL . . . . . . . . . . . . . 45.1 t -96.03 138.29 21.82 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.343 0 CA-C-O 120.876 0.37 . . . . 0.0 110.168 -179.327 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' F' F ' 0' ' ' ILE . . . . . . . . . . . . . 69.3 mt -105.83 125.04 61.3 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.241 0 N-CA-C 109.718 -0.475 . . . . 0.0 109.718 179.455 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' F' F ' 1' ' ' MET . . . . . . . . . . . . . 27.4 ptm -79.96 138.56 37.11 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.262 -0.426 . . . . 0.0 110.756 -179.598 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' F' F ' 2' ' ' SER . . . . . . . . . . . . . 7.4 p -118.99 133.92 55.52 Favored 'General case' 0 C--N 1.331 -0.21 0 CA-C-O 121.157 0.503 . . . . 0.0 110.356 177.9 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' F' F ' 3' ' ' GLU . . . . . . . . . . . . . 84.7 tt0 -145.19 142.32 29.46 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 115.878 -0.601 . . . . 0.0 110.965 179.951 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' F' F ' 4' ' ' LEU . . . . . . . . . . . . . 17.5 tp -121.34 128.21 52.05 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 115.84 -0.618 . . . . 0.0 109.998 176.597 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' F' F ' 5' ' ' LYS . . . . . . . . . . . . . 62.4 mttp -108.3 121.0 44.0 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.415 -0.357 . . . . 0.0 110.745 179.407 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' F' F ' 6' ' ' LEU . . . . . . . . . . . . . 23.8 mt -114.23 148.47 37.33 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 115.331 -0.85 . . . . 0.0 110.46 -179.461 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' F' F ' 7' ' ' LYS . . . . . . . . . . . . . 77.1 tttt -128.5 138.27 32.7 Favored Pre-proline 0 CA--C 1.533 0.302 0 CA-C-O 118.85 -0.595 . . . . 0.0 109.681 173.518 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' F' F ' 8' ' ' PRO . . . . . . . . . . . . . 95.7 Cg_endo -91.48 135.38 1.72 Allowed 'Trans proline' 0 N--CA 1.49 1.288 0 C-N-CA 121.727 1.618 . . . . 0.0 111.953 178.373 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' F' F ' 9' ' ' LEU . . . . . . . . . . . . . 55.6 mt -75.94 -46.98 3.85 Favored Pre-proline 0 CA--C 1.534 0.338 0 CA-C-O 118.777 -0.63 . . . . 0.0 111.725 179.639 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' F' F ' 10' ' ' PRO . . . . . . . . . . . . . 78.9 Cg_endo -82.86 149.04 13.9 Favored 'Trans proline' 0 N--CA 1.495 1.579 0 C-N-CA 121.246 1.297 . . . . 0.0 111.531 174.098 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' F' F ' 11' ' ' LYS . . . . . . . . . . . . . 53.8 pttt -86.59 112.17 21.32 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-O 121.588 0.709 . . . . 0.0 110.592 178.035 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' F' F ' 12' ' ' VAL . . . . . . . . . . . . . 12.2 p -151.15 149.22 14.32 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.253 0 CA-C-N 115.621 -0.718 . . . . 0.0 110.545 -179.673 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' F' F ' 13' ' ' GLU . . . . . . . . . . . . . 95.7 mt-10 -87.74 125.74 34.59 Favored 'General case' 0 C--N 1.329 -0.283 0 N-CA-C 109.85 -0.426 . . . . 0.0 109.85 176.224 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' F' F ' 14' ' ' LEU . . . . . . . . . . . . . 31.4 mt -97.86 150.71 37.04 Favored Pre-proline 0 C--N 1.33 -0.254 0 CA-C-O 119.407 -0.33 . . . . 0.0 110.679 -178.378 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' F' F ' 15' ' ' PRO . . . . . . . . . . . . . 28.1 Cg_exo -60.69 159.56 27.98 Favored 'Trans proline' 0 N--CA 1.497 1.702 0 C-N-CA 121.297 1.331 . . . . 0.0 112.007 177.826 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' F' F ' 16' ' ' PRO . . . . . . . . . . . . . 31.6 Cg_exo -59.76 -44.27 32.26 Favored 'Trans proline' 0 N--CA 1.497 1.689 0 C-N-CA 121.495 1.463 . . . . 0.0 112.688 -178.594 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' F' F ' 17' ' ' ASP . . . . . . . . . . . . . 9.1 p-10 -83.8 12.55 5.86 Favored 'General case' 0 CA--C 1.534 0.345 0 N-CA-C 113.156 0.799 . . . . 0.0 113.156 -177.709 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' F' F ' 18' ' ' PHE . . . . . . . . . . . . . 52.6 t80 -57.46 -43.77 84.28 Favored 'General case' 0 N--CA 1.458 -0.07 0 O-C-N 121.986 -0.447 . . . . 0.0 110.332 -178.39 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' F' F ' 19' ' ' VAL . . . . . . . . . . . . . 47.7 t -56.48 -44.06 79.5 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.302 0 CA-C-N 116.332 -0.394 . . . . 0.0 110.54 -178.11 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' F' F ' 20' ' ' ASP . . . . . . . . . . . . . 64.0 m-20 -60.01 -42.52 94.48 Favored 'General case' 0 C--N 1.329 -0.288 0 C-N-CA 120.905 -0.318 . . . . 0.0 110.951 -178.115 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' F' F ' 21' ' ' VAL . . . . . . . . . . . . . 50.6 t -64.5 -46.75 91.81 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.246 0 C-N-CA 120.745 -0.382 . . . . 0.0 110.691 -177.556 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' F' F ' 22' ' ' ILE . . . . . . . . . . . . . 51.4 mm -55.49 -46.79 78.95 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.224 0 C-N-CA 120.957 -0.297 . . . . 0.0 110.625 179.623 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' F' F ' 23' ' ' ARG . . . . . . . . . . . . . 55.9 ttp180 -54.8 -50.8 67.63 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-O 120.645 0.26 . . . . 0.0 111.314 -178.707 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' F' F ' 24' ' ' ILE . . . . . . . . . . . . . 75.6 mt -59.48 -41.86 86.0 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.268 0 CA-C-N 116.536 -0.302 . . . . 0.0 111.499 -176.266 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' F' F ' 25' ' ' LYS . . . . . . . . . . . . . 40.5 mmtt -66.41 -43.93 84.41 Favored 'General case' 0 C--N 1.329 -0.291 0 N-CA-C 112.468 0.544 . . . . 0.0 112.468 -178.655 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' F' F ' 26' ' ' LEU . . . . . . . . . . . . . 58.0 mt -78.77 -35.1 45.03 Favored 'General case' 0 C--N 1.33 -0.271 0 N-CA-C 113.77 1.026 . . . . 0.0 113.77 -169.837 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' F' F ' 27' ' ' GLN . . . . . . . . . . . . . 10.3 pt20 -47.39 139.41 6.58 Favored 'General case' 0 N--CA 1.469 0.524 0 N-CA-C 112.758 0.651 . . . . 0.0 112.758 -175.653 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' F' F ' 28' ' ' GLY . . . . . . . . . . . . . . . 101.22 -24.46 31.74 Favored Glycine 0 CA--C 1.534 1.274 0 CA-C-N 115.536 -0.756 . . . . 0.0 112.308 -176.242 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' F' F ' 29' ' ' LYS . . . . . . . . . . . . . 55.2 mttp -97.35 155.1 17.04 Favored 'General case' 0 C--O 1.231 0.129 0 CA-C-N 117.535 0.667 . . . . 0.0 111.253 178.589 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' F' F ' 30' ' ' THR . . . . . . . . . . . . . 41.2 m -106.17 137.49 44.02 Favored 'General case' 0 C--N 1.331 -0.23 0 CA-C-N 116.02 -0.536 . . . . 0.0 109.854 175.828 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' F' F ' 31' ' ' VAL . . . . . . . . . . . . . 34.6 m -130.21 153.08 38.42 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.243 0 CA-C-O 121.055 0.455 . . . . 0.0 111.192 -177.49 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' F' F ' 32' ' ' ARG . . . . . . . . . . . . . 55.5 mtp180 -128.92 152.53 48.46 Favored 'General case' 0 C--N 1.332 -0.187 0 CA-C-N 115.749 -0.66 . . . . 0.0 110.668 177.885 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' F' F ' 33' ' ' THR . . . . . . . . . . . . . 14.0 m -54.09 137.83 39.18 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 115.98 -0.554 . . . . 0.0 111.26 -179.206 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' F' F ' 34' ' ' GLY . . . . . . . . . . . . . . . 101.68 -17.17 55.44 Favored Glycine 0 CA--C 1.533 1.159 0 CA-C-O 119.59 -0.561 . . . . 0.0 113.354 178.804 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' F' F ' 35' ' ' ASP . . . . . . . . . . . . . 75.2 m-20 -65.88 148.03 52.43 Favored 'General case' 0 N--CA 1.461 0.091 0 CA-C-N 118.09 0.945 . . . . 0.0 111.192 179.469 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' F' F ' 36' ' ' VAL . . . . . . . . . . . . . 47.2 t -120.48 129.07 75.98 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.196 0 CA-C-N 115.872 -0.604 . . . . 0.0 109.829 178.789 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' F' F ' 37' ' ' ILE . . . . . . . . . . . . . 63.3 mt -122.29 138.85 51.08 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.226 0 CA-C-N 116.19 -0.459 . . . . 0.0 109.963 -178.958 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' F' F ' 38' ' ' GLY . . . . . . . . . . . . . . . -115.03 128.74 8.25 Favored Glycine 0 CA--C 1.526 0.72 0 N-CA-C 111.143 -0.783 . . . . 0.0 111.143 179.411 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' F' F ' 39' ' ' ILE . . . . . . . . . . . . . 76.6 mt -125.91 138.32 54.91 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.212 0 CA-C-O 120.808 0.337 . . . . 0.0 110.421 179.659 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' F' F ' 40' ' ' SER . . . . . . . . . . . . . 23.0 t -92.71 114.69 27.32 Favored 'General case' 0 C--N 1.332 -0.192 0 CA-C-N 116.335 -0.393 . . . . 0.0 111.059 176.131 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' F' F ' 41' ' ' ILE . . . . . . . . . . . . . 44.6 mm -121.43 122.75 68.05 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.215 0 CA-C-O 120.846 0.355 . . . . 0.0 110.303 179.274 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' F' F ' 42' ' ' LEU . . . . . . . . . . . . . 9.1 tp 52.84 35.38 18.73 Favored 'General case' 0 CA--C 1.532 0.252 0 CA-C-N 116.254 -0.43 . . . . 0.0 111.643 177.128 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' F' F ' 43' ' ' GLY . . . . . . . . . . . . . . . 72.15 30.41 65.26 Favored Glycine 0 CA--C 1.529 0.966 0 C-N-CA 121.058 -0.591 . . . . 0.0 112.165 178.066 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' F' F ' 44' ' ' LYS . . . . . . . . . . . . . 85.9 tttt -139.71 130.66 26.24 Favored 'General case' 0 C--N 1.33 -0.259 0 N-CA-C 109.564 -0.532 . . . . 0.0 109.564 178.886 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' F' F ' 45' ' ' GLU . . . . . . . . . . . . . 85.1 tt0 -82.5 121.66 27.05 Favored 'General case' 0 C--N 1.326 -0.425 0 CA-C-O 120.9 0.381 . . . . 0.0 110.985 -177.496 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' F' F ' 46' ' ' VAL . . . . . . . . . . . . . 9.7 p -118.2 125.74 74.48 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.171 0 N-CA-C 109.385 -0.598 . . . . 0.0 109.385 175.434 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' F' F ' 47' ' ' LYS . . . . . . . . . . . . . 98.8 mttt -98.84 125.56 44.26 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 115.948 -0.569 . . . . 0.0 110.705 179.1 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' F' F ' 48' ' ' PHE . . . . . . . . . . . . . 31.5 m-85 -110.56 131.89 54.66 Favored 'General case' 0 C--N 1.33 -0.267 0 N-CA-C 109.8 -0.444 . . . . 0.0 109.8 178.062 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' F' F ' 49' ' ' LYS . . . . . . . . . . . . . 46.1 tttp -107.05 132.75 52.61 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.26 -0.427 . . . . 0.0 110.081 178.337 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' F' F ' 50' ' ' VAL . . . . . . . . . . . . . 46.5 t -76.47 104.22 4.38 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.295 0 N-CA-C 109.263 -0.644 . . . . 0.0 109.263 177.215 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' F' F ' 51' ' ' VAL . . . . . . . . . . . . . 49.0 t -72.45 -52.41 23.86 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.298 0 N-CA-C 109.538 -0.541 . . . . 0.0 109.538 -175.239 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' F' F ' 52' ' ' GLN . . . . . . . . . . . . . 86.6 mt-30 -151.77 140.73 21.09 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-O 121.245 0.545 . . . . 0.0 111.675 -178.99 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' F' F ' 53' ' ' ALA . . . . . . . . . . . . . . . -116.22 127.58 54.88 Favored 'General case' 0 C--N 1.325 -0.46 0 CA-C-N 114.918 -1.037 . . . . 0.0 109.491 174.712 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' F' F ' 54' ' ' TYR . . . . . . . . . . . . . 27.4 t80 -125.92 109.06 25.02 Favored Pre-proline 0 CA--C 1.534 0.359 0 CA-C-O 118.21 -0.9 . . . . 0.0 110.511 -179.342 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' F' F ' 55' ' ' PRO . . . . . . . . . . . . . 73.3 Cg_endo -77.24 170.09 72.39 Favored 'Cis proline' 0 N--CA 1.501 1.914 0 CA-C-N 121.852 1.697 . . . . 0.0 112.658 -4.617 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' F' F ' 56' ' ' SER . . . . . . . . . . . . . 13.5 m -113.51 126.88 27.49 Favored Pre-proline 0 CA--C 1.54 0.585 0 CA-C-O 118.32 -0.848 . . . . 0.0 109.271 174.511 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' F' F ' 57' ' ' PRO . . . . . . . . . . . . . 57.3 Cg_endo -72.47 150.4 95.01 Favored 'Cis proline' 0 N--CA 1.496 1.66 0 CA-C-N 122.053 1.769 . . . . 0.0 111.692 0.043 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' F' F ' 58' ' ' LEU . . . . . . . . . . . . . 29.6 tp -107.9 137.36 46.03 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.221 -0.445 . . . . 0.0 110.659 -178.143 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' F' F ' 59' ' ' ARG . . . . . . . . . . . . . 73.6 ttt-85 -101.67 123.86 46.36 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 115.845 -0.616 . . . . 0.0 109.498 176.034 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' F' F ' 60' ' ' VAL . . . . . . . . . . . . . 44.6 t -76.51 114.9 17.38 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.239 0 C-N-CA 120.658 -0.417 . . . . 0.0 110.109 -177.426 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' F' F ' 61' ' ' GLU . . . . . . . . . . . . . 84.6 tt0 -131.11 154.21 48.54 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 115.759 -0.655 . . . . 0.0 109.503 179.532 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' F' F ' 62' ' ' ASP . . . . . . . . . . . . . 9.7 t0 -51.54 -32.59 28.6 Favored 'General case' 0 C--N 1.327 -0.376 0 N-CA-C 112.0 0.37 . . . . 0.0 112.0 -177.924 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' F' F ' 63' ' ' ARG . . . . . . . . . . . . . 27.2 mmm180 -72.4 -22.03 61.18 Favored 'General case' 0 N--CA 1.466 0.353 0 N-CA-C 112.934 0.716 . . . . 0.0 112.934 -177.627 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' F' F ' 64' ' ' THR . . . . . . . . . . . . . 21.6 m -67.84 137.87 55.65 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-O 120.825 0.345 . . . . 0.0 110.979 -175.461 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' F' F ' 65' ' ' LYS . . . . . . . . . . . . . 55.9 mtmt -88.95 140.21 29.67 Favored 'General case' 0 C--N 1.331 -0.224 0 CA-C-N 116.224 -0.444 . . . . 0.0 110.573 178.351 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' F' F ' 66' ' ' ILE . . . . . . . . . . . . . 4.3 mp -116.13 127.4 73.74 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.244 0 N-CA-C 109.755 -0.461 . . . . 0.0 109.755 -179.184 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' F' F ' 67' ' ' THR . . . . . . . . . . . . . 21.4 m -124.82 136.95 54.28 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-O 121.002 0.429 . . . . 0.0 110.873 -177.431 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' F' F ' 68' ' ' LEU . . . . . . . . . . . . . 15.9 tp -108.68 133.83 52.23 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.099 -0.501 . . . . 0.0 110.561 178.241 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' F' F ' 69' ' ' VAL . . . . . . . . . . . . . 48.1 t -84.94 135.47 24.77 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.314 0 CA-C-N 116.278 -0.419 . . . . 0.0 109.915 177.814 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' F' F ' 70' ' ' THR . . . . . . . . . . . . . 66.5 p -106.22 174.83 5.71 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.962 -178.308 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' F' F ' 71' ' ' HIS . . . . . . . . . . . . . 80.4 m80 -64.97 156.66 79.56 Favored Pre-proline 0 C--N 1.329 -0.284 0 CA-C-N 116.065 -0.516 . . . . 0.0 110.933 -178.345 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' F' F ' 72' ' ' PRO . . . . . . . . . . . . . 72.1 Cg_endo -80.75 159.99 21.62 Favored 'Trans proline' 0 N--CA 1.493 1.467 0 C-N-CA 121.71 1.607 . . . . 0.0 112.549 -178.512 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' F' F ' 73' ' ' VAL . . . . . . . . . . . . . 31.1 m -107.28 167.29 3.63 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.283 0 CA-C-N 115.989 -0.55 . . . . 0.0 110.165 179.005 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' F' F ' 74' ' ' ASP . . . . . . . . . . . . . 13.5 t70 -95.49 118.72 32.71 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.296 -0.411 . . . . 0.0 110.24 -177.575 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' F' F ' 75' ' ' VAL . . . . . . . . . . . . . 40.3 t -114.82 124.59 71.63 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.241 0 CA-C-O 121.043 0.449 . . . . 0.0 110.297 -178.746 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' F' F ' 76' ' ' LEU . . . . . . . . . . . . . 15.0 mt -128.78 146.15 50.99 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 115.661 -0.7 . . . . 0.0 109.723 178.88 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' F' F ' 77' ' ' GLU . . . . . . . . . . . . . 97.6 mt-10 -135.38 135.94 41.07 Favored 'General case' 0 C--N 1.331 -0.198 0 CA-C-O 121.075 0.464 . . . . 0.0 111.32 -178.502 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' F' F ' 78' ' ' ALA . . . . . . . . . . . . . . . -121.51 140.97 51.51 Favored 'General case' 0 C--N 1.332 -0.184 0 CA-C-N 115.775 -0.648 . . . . 0.0 109.735 176.09 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' F' F ' 79' ' ' LYS . . . . . . . . . . . . . 96.1 mttt -85.26 115.1 22.84 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-O 120.909 0.385 . . . . 0.0 110.865 -178.3 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' F' F ' 80' ' ' ILE . . . . . . . . . . . . . 39.7 mm -139.09 108.39 3.8 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.325 0 N-CA-C 109.239 -0.652 . . . . 0.0 109.239 -178.197 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' F' F ' 81' ' ' LYS . . . . . . . . . . . . . 39.2 ttpt -106.66 134.91 49.07 Favored 'General case' 0 C--N 1.331 -0.226 0 CA-C-O 120.939 0.4 . . . . 0.0 111.178 -177.242 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' F' F ' 82' ' ' GLY . . . . . . . . . . . . . . . 89.09 41.92 5.74 Favored Glycine 0 CA--C 1.523 0.556 0 N-CA-C 111.114 -0.795 . . . . 0.0 111.114 176.404 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' F' F ' 83' ' ' ILE . . . . . . . . . . . . . 68.0 mt -78.13 130.69 35.88 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.363 0 N-CA-C 109.525 -0.546 . . . . 0.0 109.525 178.398 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' F' F ' 84' ' ' LYS . . . . . . . . . . . . . 38.2 ttpt -95.73 -46.35 6.63 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-O 120.863 0.363 . . . . 0.0 110.147 -178.783 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' F' F ' 85' ' ' ASP . . . . . . . . . . . . . 7.2 t70 -152.08 149.15 28.51 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.111 -0.495 . . . . 0.0 110.629 178.581 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' F' F ' 86' ' ' VAL . . . . . . . . . . . . . 42.1 t -126.84 132.7 69.77 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.26 0 CA-C-O 120.859 0.361 . . . . 0.0 110.448 -179.524 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' F' F ' 87' ' ' ILE . . . . . . . . . . . . . 45.5 mm -119.27 124.59 73.33 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.223 0 N-CA-C 109.412 -0.588 . . . . 0.0 109.412 176.439 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' F' F ' 88' ' ' LEU . . . . . . . . . . . . . 16.8 tp -112.36 130.51 55.94 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-O 121.116 0.484 . . . . 0.0 111.19 -176.912 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' F' F ' 89' ' ' ASP . . . . . . . . . . . . . 9.1 t70 -123.64 155.15 38.27 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-N 115.754 -0.657 . . . . 0.0 109.388 175.443 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' F' F ' 90' ' ' GLU . . . . . . . . . . . . . 84.5 tt0 -47.59 -40.55 19.57 Favored 'General case' 0 C--N 1.329 -0.287 0 N-CA-C 112.818 0.673 . . . . 0.0 112.818 -172.07 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' F' F ' 91' ' ' ASN . . . . . . . . . . . . . 33.6 m120 -132.16 38.96 3.45 Favored 'General case' 0 CA--C 1.53 0.187 0 CA-C-O 120.856 0.36 . . . . 0.0 111.496 -178.208 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' F' F ' 92' ' ' LEU . . . . . . . . . . . . . 12.5 tp -166.0 139.63 4.3 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.593 -0.276 . . . . 0.0 110.325 -178.613 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' F' F ' 93' ' ' ILE . . . . . . . . . . . . . 68.2 mt -125.65 122.76 63.08 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.18 0 N-CA-C 109.588 -0.523 . . . . 0.0 109.588 179.851 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' F' F ' 94' ' ' VAL . . . . . . . . . . . . . 45.1 t -122.2 128.41 75.51 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.206 0 CA-C-O 120.977 0.417 . . . . 0.0 109.957 179.703 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' F' F ' 95' ' ' VAL . . . . . . . . . . . . . 41.3 t -119.91 132.93 68.26 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.323 0 CA-C-N 115.899 -0.591 . . . . 0.0 109.744 179.951 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' F' F ' 96' ' ' ILE . . . . . . . . . . . . . 69.5 mt -112.85 124.03 69.1 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 N-CA-C 108.96 -0.756 . . . . 0.0 108.96 177.912 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' F' F ' 97' ' ' THR . . . . . . . . . . . . . 43.6 p -98.51 155.89 17.05 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-O 121.544 0.688 . . . . 0.0 111.545 -175.424 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' F' F ' 98' ' ' GLU . . . . . . . . . . . . . 84.5 tt0 -54.11 -27.38 32.72 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 115.54 -0.755 . . . . 0.0 112.151 -179.864 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' F' F ' 99' ' ' GLU . . . . . . . . . . . . . 95.4 mt-10 -80.32 14.98 1.73 Allowed 'General case' 0 CA--C 1.535 0.381 0 N-CA-C 113.173 0.805 . . . . 0.0 113.173 -176.538 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' F' F ' 100' ' ' ASN . . . . . . . . . . . . . 3.6 m-20 63.0 35.38 13.22 Favored 'General case' 0 C--O 1.233 0.236 0 CA-C-N 118.126 0.421 . . . . 0.0 111.392 179.229 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' F' F ' 101' ' ' GLU . . . . . . . . . . . . . 85.0 tt0 -113.64 145.03 41.92 Favored 'General case' 0 C--N 1.331 -0.238 0 N-CA-C 109.633 -0.506 . . . . 0.0 109.633 174.393 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' F' F ' 102' ' ' VAL . . . . . . . . . . . . . 45.4 t -115.1 125.75 72.49 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.281 0 CA-C-N 116.22 -0.445 . . . . 0.0 109.929 -178.202 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' F' F ' 103' ' ' LEU . . . . . . . . . . . . . 61.2 mt -117.46 129.12 55.63 Favored 'General case' 0 C--N 1.332 -0.191 0 CA-C-N 115.743 -0.662 . . . . 0.0 110.325 177.445 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' F' F ' 104' ' ' ILE . . . . . . . . . . . . . 67.1 mt -119.04 124.49 73.25 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.181 0 N-CA-C 110.11 -0.33 . . . . 0.0 110.11 179.494 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' F' F ' 105' ' ' PHE . . . . . . . . . . . . . 88.9 m-85 -123.41 163.39 20.92 Favored 'General case' 0 C--O 1.232 0.168 0 O-C-N 123.954 0.784 . . . . 0.0 109.937 -179.497 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' F' F ' 106' ' ' ASN . . . . . . . . . . . . . 46.3 p-10 -97.66 -173.09 2.54 Favored 'General case' 0 C--N 1.33 -0.252 0 N-CA-C 109.821 -0.437 . . . . 0.0 109.821 171.821 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' F' F ' 107' ' ' GLN . . . . . . . . . . . . . 55.4 tt0 -60.12 -26.4 66.22 Favored 'General case' 0 C--N 1.328 -0.332 0 N-CA-C 112.19 0.441 . . . . 0.0 112.19 -178.823 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' F' F ' 108' ' ' ASN . . . . . . . . . . . . . 11.9 t-20 -88.68 13.99 11.08 Favored 'General case' 0 CA--C 1.535 0.389 0 N-CA-C 112.865 0.691 . . . . 0.0 112.865 -177.824 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' F' F ' 109' ' ' LEU . . . . . . . . . . . . . 43.2 mt 58.25 34.17 23.84 Favored 'General case' 0 CA--C 1.53 0.202 0 O-C-N 122.138 -0.351 . . . . 0.0 111.84 177.464 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' F' F ' 110' ' ' GLU . . . . . . . . . . . . . 70.5 mm-40 -103.14 142.95 33.27 Favored 'General case' 0 C--N 1.329 -0.31 0 N-CA-C 109.006 -0.738 . . . . 0.0 109.006 173.315 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' F' F ' 111' ' ' GLU . . . . . . . . . . . . . 51.1 tt0 -85.28 121.78 28.51 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-O 121.017 0.437 . . . . 0.0 110.538 -175.41 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' F' F ' 112' ' ' LEU . . . . . . . . . . . . . 44.8 mt -100.95 -42.96 6.21 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 115.708 -0.678 . . . . 0.0 110.68 179.636 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' F' F ' 113' ' ' TYR . . . . . . . . . . . . . 57.5 t80 -133.09 136.54 45.92 Favored 'General case' 0 C--N 1.331 -0.2 0 CA-C-N 116.329 -0.396 . . . . 0.0 111.221 -177.85 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' F' F ' 114' ' ' ARG . . . . . . . . . . . . . 69.8 ttt180 -137.53 118.61 14.41 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 115.716 -0.675 . . . . 0.0 110.142 178.197 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' F' F ' 115' ' ' GLY . . . . . . . . . . . . . . . -149.99 162.3 29.13 Favored Glycine 0 CA--C 1.524 0.605 0 C-N-CA 120.693 -0.765 . . . . 0.0 111.405 179.746 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' F' F ' 116' ' ' LYS . . . . . . . . . . . . . 74.2 tttt -136.97 140.42 42.17 Favored 'General case' 0 C--N 1.328 -0.338 0 N-CA-C 110.085 -0.339 . . . . 0.0 110.085 178.401 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' F' F ' 117' ' ' PHE . . . . . . . . . . . . . 34.8 m-85 -136.6 113.88 10.76 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.309 -0.405 . . . . 0.0 110.214 -177.45 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' F' F ' 118' ' ' GLU . . . . . . . . . . . . . 84.9 tt0 -53.79 -48.93 69.32 Favored 'General case' 0 C--N 1.329 -0.307 0 C-N-CA 121.112 -0.235 . . . . 0.0 111.292 -177.39 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' F' F ' 119' ' ' ASN . . . . . . . . . . . . . 6.0 m120 -92.98 31.12 1.46 Allowed 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 116.273 -0.421 . . . . 0.0 111.999 -175.464 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' F' F ' 120' ' ' LEU . . . . . . . . . . . . . 25.2 tp -55.56 122.77 12.05 Favored 'General case' 0 N--CA 1.462 0.173 0 CA-C-O 120.698 0.285 . . . . 0.0 110.535 178.413 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' F' F ' 121' ' ' ASN . . . . . . . . . . . . . 3.8 m-20 -113.86 -44.03 3.21 Favored 'General case' 0 C--O 1.232 0.146 0 CA-C-N 116.426 -0.352 . . . . 0.0 111.162 -176.189 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' F' F ' 122' ' ' LYS . . . . . . . . . . . . . 39.2 ttpt -146.01 141.6 27.83 Favored 'General case' 0 C--N 1.33 -0.24 0 C-N-CA 120.689 -0.404 . . . . 0.0 111.531 -175.1 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' F' F ' 123' ' ' VAL . . . . . . . . . . . . . 43.9 t -129.28 131.45 67.56 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.267 0 N-CA-C 109.486 -0.561 . . . . 0.0 109.486 174.786 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' F' F ' 124' ' ' LEU . . . . . . . . . . . . . 14.6 tp -127.37 131.85 50.28 Favored 'General case' 0 N--CA 1.464 0.227 0 CA-C-O 120.859 0.362 . . . . 0.0 110.919 -178.718 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' F' F ' 125' ' ' VAL . . . . . . . . . . . . . 45.4 t -126.13 129.43 72.17 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.218 0 CA-C-N 115.992 -0.549 . . . . 0.0 110.059 179.362 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' F' F ' 126' ' ' ARG . . . . . . . . . . . . . 42.0 ttm180 -154.22 131.26 10.99 Favored 'General case' 0 C--N 1.33 -0.27 0 N-CA-C 109.808 -0.441 . . . . 0.0 109.808 177.306 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' F' F ' 127' ' ' ASN . . . . . . . . . . . . . 3.4 t-20 56.67 -155.02 0.32 Allowed 'General case' 0 CA--C 1.538 0.507 0 N-CA-C 109.595 -0.521 . . . . 0.0 109.595 -178.319 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' F' F ' 128' ' ' ASP . . . . . . . . . . . . . 22.1 p-10 -82.5 17.24 1.81 Allowed 'General case' 0 CA--C 1.539 0.52 0 N-CA-C 112.491 0.552 . . . . 0.0 112.491 176.879 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' F' F ' 129' ' ' LEU . . . . . . . . . . . . . 16.5 tp -116.37 137.36 52.22 Favored 'General case' 0 C--O 1.232 0.18 0 N-CA-C 109.934 -0.395 . . . . 0.0 109.934 179.148 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' F' F ' 130' ' ' VAL . . . . . . . . . . . . . 12.6 p -136.9 143.37 35.19 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.25 0 CA-C-O 121.033 0.444 . . . . 0.0 110.663 -179.951 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' F' F ' 131' ' ' VAL . . . . . . . . . . . . . 32.5 m -136.09 146.94 28.42 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.275 0 CA-C-O 121.238 0.542 . . . . 0.0 110.912 178.804 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' F' F ' 132' ' ' ILE . . . . . . . . . . . . . 73.2 mt -122.36 134.01 66.88 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.228 0 CA-C-N 115.505 -0.771 . . . . 0.0 109.581 -179.572 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' F' F ' 133' ' ' ILE . . . . . . . . . . . . . 40.1 mm -115.91 122.79 70.3 Favored 'Isoleucine or valine' 0 C--O 1.234 0.262 0 CA-C-N 116.353 -0.385 . . . . 0.0 110.86 -176.304 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' F' F ' 134' ' ' ASP . . . . . . . . . . . . . 7.3 p-10 -131.88 150.97 52.0 Favored 'General case' 0 C--N 1.331 -0.23 0 CA-C-N 116.128 -0.487 . . . . 0.0 109.744 174.441 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' F' F ' 135' ' ' GLU . . . . . . . . . . . . . 85.6 tt0 -49.92 -25.86 3.62 Favored 'General case' 0 C--N 1.327 -0.378 0 N-CA-C 112.896 0.702 . . . . 0.0 112.896 -170.738 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' F' F ' 136' ' ' GLN . . . . . . . . . . . . . 97.8 mt-30 -105.05 -25.22 12.62 Favored 'General case' 0 N--CA 1.464 0.266 0 N-CA-C 113.015 0.746 . . . . 0.0 113.015 -175.081 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' F' F ' 137' ' ' LYS . . . . . . . . . . . . . 66.2 mttm -140.27 150.21 43.77 Favored 'General case' 0 C--N 1.331 -0.217 0 CA-C-O 121.587 0.708 . . . . 0.0 112.529 -167.529 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' F' F ' 138' ' ' LEU . . . . . . . . . . . . . 13.0 tp -112.99 121.55 44.98 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 114.787 -1.097 . . . . 0.0 109.003 173.103 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' F' F ' 139' ' ' THR . . . . . . . . . . . . . 31.8 m -113.95 126.96 55.73 Favored 'General case' 0 C--N 1.331 -0.215 0 CA-C-O 120.837 0.351 . . . . 0.0 110.862 -178.761 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' F' F ' 140' ' ' LEU . . . . . . . . . . . . . 8.8 tt -116.34 124.13 49.34 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 115.577 -0.738 . . . . 0.0 109.354 179.913 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' F' F ' 141' ' ' ILE . . . . . . . . . . . . . 19.3 mt -121.48 120.88 63.11 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.275 0 CA-C-O 120.923 0.392 . . . . 0.0 109.971 -175.199 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' F' F ' 142' ' ' ARG . . . . . . . . . . . . . 34.7 tpt85 -110.22 127.07 54.77 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-N 115.337 -0.847 . . . . 0.0 109.965 -178.136 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' F' F ' 143' ' ' THR . . . . . . . . . . . . . 34.4 p . . . . . 0 C--O 1.22 -0.458 0 CA-C-O 118.02 -0.991 . . . . 0.0 110.656 -179.748 . . . . . . . . 0 0 . 1 . 012 nuclear orig full ' A' A ' -3' ' ' GLU . . . . . . . . . . . . . 96.0 mt-10 . . . . . 0 N--CA 1.489 1.483 0 N-CA-C 109.469 -0.567 . . . . 0.0 109.469 . . . . . . . . . 0 0 . 1 . 012 nuclear orig full ' A' A ' -2' ' ' GLY . . . . . . . . . . . . . . . -72.93 112.92 4.12 Favored Glycine 0 CA--C 1.526 0.73 0 N-CA-C 111.077 -0.809 . . . . 0.0 111.077 -179.533 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' -1' ' ' VAL . . . . . . . . . . . . . 46.5 t -96.95 135.6 30.54 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.331 0 N-CA-C 110.019 -0.363 . . . . 0.0 110.019 179.006 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 0' ' ' ILE . . . . . . . . . . . . . 44.1 mm -112.47 130.49 66.13 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.215 0 CA-C-N 116.23 -0.441 . . . . 0.0 110.153 179.966 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 27.2 ptm -90.9 138.26 31.73 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.573 179.902 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 1.7 p -113.3 119.48 37.84 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-O 121.377 0.608 . . . . 0.0 110.336 177.931 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 85.1 tt0 -143.05 142.1 31.47 Favored 'General case' 0 C--N 1.327 -0.399 0 CA-C-N 115.451 -0.795 . . . . 0.0 111.114 -178.325 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 4' ' ' LEU . . . . . . . . . . . . . 18.9 tp -123.93 128.18 49.05 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 115.887 -0.597 . . . . 0.0 109.952 176.922 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 5' ' ' LYS . . . . . . . . . . . . . 95.2 mttt -107.24 122.56 46.79 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.572 -0.285 . . . . 0.0 110.71 -179.873 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 58.1 mt -115.54 147.65 40.45 Favored 'General case' 0 C--N 1.331 -0.215 0 CA-C-N 115.577 -0.738 . . . . 0.0 110.244 -179.123 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 26.5 ttpp -125.98 139.7 34.98 Favored Pre-proline 0 CA--C 1.532 0.284 0 CA-C-O 118.983 -0.532 . . . . 0.0 109.725 174.244 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 8' ' ' PRO . . . . . . . . . . . . . 83.7 Cg_endo -91.75 133.61 1.42 Allowed 'Trans proline' 0 N--CA 1.489 1.224 0 C-N-CA 121.786 1.657 . . . . 0.0 111.808 178.275 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 73.2 mt -75.64 -47.01 4.14 Favored Pre-proline 0 CA--C 1.534 0.339 0 CA-C-O 118.527 -0.749 . . . . 0.0 111.948 179.03 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 73.9 Cg_endo -77.88 145.66 22.71 Favored 'Trans proline' 0 N--CA 1.496 1.635 0 CA-C-N 120.427 1.188 . . . . 0.0 111.656 175.154 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 58.1 mttm -84.76 89.53 7.54 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-O 120.815 0.34 . . . . 0.0 110.701 -179.781 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 12.3 p -139.55 146.24 25.72 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.293 0 CA-C-N 116.096 -0.502 . . . . 0.0 110.289 178.989 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 45.4 tp10 -89.47 129.35 35.97 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.342 -0.39 . . . . 0.0 110.254 178.554 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 14' ' ' LEU . . . . . . . . . . . . . 35.2 mt -97.36 144.88 28.69 Favored Pre-proline 0 C--N 1.329 -0.3 0 CA-C-O 119.14 -0.457 . . . . 0.0 110.05 -179.01 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 15' ' ' PRO . . . . . . . . . . . . . 24.8 Cg_exo -61.83 163.03 20.03 Favored 'Trans proline' 0 N--CA 1.498 1.783 0 C-N-CA 121.268 1.312 . . . . 0.0 111.751 178.447 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 16' ' ' PRO . . . . . . . . . . . . . 31.7 Cg_exo -59.52 -36.07 94.1 Favored 'Trans proline' 0 N--CA 1.497 1.698 0 C-N-CA 121.562 1.508 . . . . 0.0 112.971 -177.502 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 17' ' ' ASP . . . . . . . . . . . . . 7.9 p-10 -84.64 0.16 51.24 Favored 'General case' 0 CA--C 1.537 0.459 0 N-CA-C 113.274 0.842 . . . . 0.0 113.274 -177.748 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 18' ' ' PHE . . . . . . . . . . . . . 35.3 t80 -58.64 -43.75 89.85 Favored 'General case' 0 C--N 1.333 -0.128 0 O-C-N 121.95 -0.469 . . . . 0.0 109.963 -177.75 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 19' ' ' VAL . . . . . . . . . . . . . 53.3 t -57.19 -42.51 80.0 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.253 0 CA-C-N 116.155 -0.475 . . . . 0.0 110.383 -179.366 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 19.1 t0 -60.02 -42.89 95.33 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-O 120.775 0.322 . . . . 0.0 111.057 -177.869 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 45.4 t -64.38 -46.49 92.86 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.269 0 C-N-CA 120.784 -0.367 . . . . 0.0 110.361 -177.693 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 22' ' ' ILE . . . . . . . . . . . . . 51.9 mm -56.27 -44.23 78.97 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.223 0 CA-C-O 120.73 0.3 . . . . 0.0 110.54 178.633 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 23' ' ' ARG . . . . . . . . . . . . . 57.3 ttp180 -54.53 -47.82 72.71 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-O 120.774 0.321 . . . . 0.0 111.305 -179.934 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 24' ' ' ILE . . . . . . . . . . . . . 79.9 mt -59.15 -41.41 83.62 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.295 0 CA-C-N 116.438 -0.346 . . . . 0.0 111.022 -178.574 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 58.3 mttm -67.48 -41.0 85.31 Favored 'General case' 0 C--N 1.328 -0.343 0 N-CA-C 112.571 0.582 . . . . 0.0 112.571 -179.006 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 79.5 mt -77.92 -38.67 45.05 Favored 'General case' 0 C--N 1.331 -0.233 0 N-CA-C 113.512 0.93 . . . . 0.0 113.512 -170.227 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 27' ' ' GLN . . . . . . . . . . . . . 9.7 pt20 -46.94 138.62 6.26 Favored 'General case' 0 N--CA 1.468 0.429 0 N-CA-C 112.796 0.665 . . . . 0.0 112.796 -174.722 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 101.13 -25.69 27.36 Favored Glycine 0 CA--C 1.533 1.165 0 CA-C-N 115.609 -0.723 . . . . 0.0 112.341 -177.865 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 69.8 mmtt -98.31 155.18 17.33 Favored 'General case' 0 C--N 1.333 -0.128 0 CA-C-N 117.4 0.6 . . . . 0.0 111.31 178.443 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 30' ' ' THR . . . . . . . . . . . . . 40.2 m -108.88 139.87 43.13 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 115.804 -0.634 . . . . 0.0 109.792 175.244 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 33.6 m -130.69 155.77 42.08 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.222 0 CA-C-O 121.032 0.444 . . . . 0.0 111.144 -177.542 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 32' ' ' ARG . . . . . . . . . . . . . 61.5 mtt85 -129.02 150.58 50.37 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-N 115.862 -0.608 . . . . 0.0 110.733 178.36 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 33' ' ' THR . . . . . . . . . . . . . 23.3 m -53.26 138.91 31.09 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.054 -0.521 . . . . 0.0 111.39 -178.087 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 100.65 -17.2 56.91 Favored Glycine 0 CA--C 1.534 1.266 0 CA-C-O 119.607 -0.552 . . . . 0.0 113.232 178.526 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 79.5 m-20 -66.44 147.31 53.48 Favored 'General case' 0 N--CA 1.461 0.097 0 CA-C-N 118.008 0.904 . . . . 0.0 111.117 178.63 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 42.1 t -121.74 130.35 74.68 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.288 0 CA-C-N 116.083 -0.508 . . . . 0.0 109.865 178.403 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 37' ' ' ILE . . . . . . . . . . . . . 68.4 mt -120.4 138.55 50.56 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.279 0 CA-C-N 116.161 -0.472 . . . . 0.0 109.877 -179.813 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . -117.48 128.72 7.96 Favored Glycine 0 CA--C 1.526 0.735 0 N-CA-C 110.636 -0.986 . . . . 0.0 110.636 178.611 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 39' ' ' ILE . . . . . . . . . . . . . 69.9 mt -123.75 132.46 71.34 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.24 0 CA-C-O 120.735 0.302 . . . . 0.0 110.3 -179.986 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 40' ' ' SER . . . . . . . . . . . . . 30.1 t -92.37 118.35 30.83 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.14 -0.482 . . . . 0.0 110.605 175.698 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 41' ' ' ILE . . . . . . . . . . . . . 69.2 mt -130.71 122.5 52.67 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.234 0 CA-C-O 120.849 0.357 . . . . 0.0 110.499 178.612 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 45.8 mt 55.12 33.91 21.45 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.033 -0.53 . . . . 0.0 111.897 176.666 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . 72.81 28.4 67.09 Favored Glycine 0 CA--C 1.531 1.046 0 C-N-CA 121.016 -0.611 . . . . 0.0 112.375 178.026 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 44' ' ' LYS . . . . . . . . . . . . . 26.4 ttpp -137.24 127.61 26.5 Favored 'General case' 0 C--N 1.331 -0.228 0 N-CA-C 109.54 -0.541 . . . . 0.0 109.54 177.288 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 67.6 tt0 -86.05 126.68 34.35 Favored 'General case' 0 C--N 1.327 -0.392 0 CA-C-N 116.336 -0.393 . . . . 0.0 111.12 -176.851 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 46' ' ' VAL . . . . . . . . . . . . . 10.2 p -119.55 126.81 75.68 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.172 0 N-CA-C 109.909 -0.404 . . . . 0.0 109.909 175.436 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 72.7 mmtt -98.2 125.54 43.29 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 115.927 -0.579 . . . . 0.0 110.752 176.148 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 48' ' ' PHE . . . . . . . . . . . . . 32.8 m-85 -112.16 131.61 55.36 Favored 'General case' 0 C--N 1.329 -0.295 0 N-CA-C 109.185 -0.672 . . . . 0.0 109.185 174.651 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 42.2 tttp -108.4 132.92 53.27 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.484 -0.325 . . . . 0.0 110.208 178.931 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 50' ' ' VAL . . . . . . . . . . . . . 41.3 t -76.23 103.99 4.04 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.332 0 N-CA-C 109.21 -0.663 . . . . 0.0 109.21 177.427 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 51' ' ' VAL . . . . . . . . . . . . . 47.8 t -69.65 -50.19 52.21 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.347 0 CA-C-N 116.086 -0.506 . . . . 0.0 109.801 -174.722 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 52' ' ' GLN . . . . . . . . . . . . . 62.2 tt0 -160.3 140.15 11.25 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 115.875 -0.602 . . . . 0.0 111.724 -177.84 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -112.76 130.67 55.99 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-N 115.735 -0.666 . . . . 0.0 109.709 175.017 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 54' ' ' TYR . . . . . . . . . . . . . 59.5 t80 -129.16 107.94 17.89 Favored Pre-proline 0 CA--C 1.535 0.394 0 CA-C-O 118.324 -0.846 . . . . 0.0 110.457 -179.661 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 55' ' ' PRO . . . . . . . . . . . . . 73.7 Cg_endo -77.1 170.09 72.56 Favored 'Cis proline' 0 N--CA 1.499 1.821 0 CA-C-N 121.829 1.689 . . . . 0.0 112.339 -5.624 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 56' ' ' SER . . . . . . . . . . . . . 20.1 m -114.5 130.71 23.8 Favored Pre-proline 0 CA--C 1.539 0.526 0 CA-C-O 118.412 -0.804 . . . . 0.0 109.506 175.441 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 57' ' ' PRO . . . . . . . . . . . . . 55.2 Cg_endo -71.44 146.99 86.78 Favored 'Cis proline' 0 N--CA 1.496 1.664 0 CA-C-N 121.947 1.731 . . . . 0.0 111.622 -0.914 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 58' ' ' LEU . . . . . . . . . . . . . 22.3 tp -106.53 135.28 48.31 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.28 -0.418 . . . . 0.0 110.22 -179.506 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 59' ' ' ARG . . . . . . . . . . . . . 56.7 ttt85 -105.55 127.12 52.85 Favored 'General case' 0 C--N 1.326 -0.426 0 N-CA-C 109.2 -0.667 . . . . 0.0 109.2 176.639 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 43.4 t -86.03 124.1 40.01 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.234 0 C-N-CA 120.588 -0.445 . . . . 0.0 110.61 -174.528 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 96.0 mt-10 -131.02 172.48 12.04 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 115.774 -0.648 . . . . 0.0 109.877 177.999 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 62' ' ' ASP . . . . . . . . . . . . . 7.5 p-10 -55.56 -32.75 63.25 Favored 'General case' 0 C--N 1.328 -0.339 0 C-N-CA 120.922 -0.311 . . . . 0.0 111.557 179.42 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 63' ' ' ARG . . . . . . . . . . . . . 25.8 ptt180 -86.33 3.74 42.18 Favored 'General case' 0 CA--C 1.537 0.477 0 N-CA-C 113.724 1.009 . . . . 0.0 113.724 -176.94 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 30.7 m -83.51 135.29 34.71 Favored 'General case' 0 C--N 1.333 -0.135 0 CA-C-N 118.04 0.382 . . . . 0.0 110.612 -177.427 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 65' ' ' LYS . . . . . . . . . . . . . 52.1 mtmt -89.72 129.28 36.15 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.064 -0.517 . . . . 0.0 110.503 179.556 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 66' ' ' ILE . . . . . 0.415 HD11 HG23 ' A' ' 66' ' ' ILE . 66.4 mt -114.45 129.08 71.1 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.309 0 N-CA-C 109.41 -0.589 . . . . 0.0 109.41 177.61 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 67' ' ' THR . . . . . . . . . . . . . 22.0 m -125.74 144.64 50.54 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.215 -0.448 . . . . 0.0 111.345 -175.66 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 68' ' ' LEU . . . . . . . . . . . . . 5.6 tt -95.64 126.66 41.07 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 115.805 -0.634 . . . . 0.0 109.43 175.788 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 69' ' ' VAL . . . . . . . . . . . . . 45.6 t -91.12 130.28 40.54 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.326 0 CA-C-O 121.221 0.534 . . . . 0.0 110.959 -175.551 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 70' ' ' THR . . . . . . . . . . . . . 14.4 p -139.0 42.3 2.1 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 115.374 -0.83 . . . . 0.0 109.92 176.422 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 71' ' ' HIS . . . . . . . . . . . . . 22.1 m-70 -95.8 173.3 4.4 Favored Pre-proline 0 CA--C 1.532 0.282 0 CA-C-N 115.932 -0.576 . . . . 0.0 111.245 -174.923 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 72' ' ' PRO . . . . . . . . . . . . . 22.4 Cg_exo -64.95 160.13 42.81 Favored 'Trans proline' 0 N--CA 1.496 1.667 0 C-N-CA 121.617 1.545 . . . . 0.0 111.603 176.395 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 73' ' ' VAL . . . . . . . . . . . . . 34.9 m -69.68 -177.42 0.2 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.275 0 CA-C-N 116.333 -0.394 . . . . 0.0 110.495 -174.364 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 74' ' ' ASP . . . . . . . . . . . . . 25.1 t0 -89.32 120.5 30.72 Favored 'General case' 0 C--N 1.329 -0.292 0 C-N-CA 120.724 -0.39 . . . . 0.0 110.507 -171.208 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 40.0 t -118.67 121.01 65.91 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.212 0 CA-C-O 120.955 0.407 . . . . 0.0 110.52 -178.561 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 76' ' ' LEU . . . . . . . . . . . . . 7.5 mp -117.3 141.31 48.46 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 115.79 -0.641 . . . . 0.0 109.502 175.608 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 77' ' ' GLU . . . . . . . . . . . . . 97.0 mt-10 -132.56 136.13 46.39 Favored 'General case' 0 C--N 1.331 -0.197 0 CA-C-O 121.151 0.5 . . . . 0.0 111.465 -177.724 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 78' ' ' ALA . . . . . . . . . . . . . . . -124.24 131.45 53.53 Favored 'General case' 0 C--N 1.332 -0.185 0 CA-C-N 115.482 -0.781 . . . . 0.0 109.7 176.079 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 79' ' ' LYS . . . . . . . . . . . . . 99.2 mttt -78.31 117.48 19.6 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-O 120.918 0.39 . . . . 0.0 110.714 -177.533 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 80' ' ' ILE . . . . . . . . . . . . . 38.7 mm -139.24 111.47 5.55 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.311 0 N-CA-C 109.241 -0.652 . . . . 0.0 109.241 -177.448 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 81' ' ' LYS . . . . . . . . . . . . . 20.0 pttp -106.31 127.41 53.23 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-O 121.165 0.507 . . . . 0.0 111.608 -176.721 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . 89.01 42.16 5.71 Favored Glycine 0 CA--C 1.525 0.691 0 C-N-CA 120.883 -0.675 . . . . 0.0 111.832 174.267 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 83' ' ' ILE . . . . . . . . . . . . . 71.1 mt -71.49 138.0 22.58 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.231 0 N-CA-C 109.921 -0.4 . . . . 0.0 109.921 178.314 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 84' ' ' LYS . . . . . . . . . . . . . 31.0 ttmt -88.96 -53.09 4.75 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 115.943 -0.572 . . . . 0.0 109.788 -179.605 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 85' ' ' ASP . . . . . . . . . . . . . 7.2 t0 -157.39 151.91 25.19 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 115.51 -0.768 . . . . 0.0 110.136 179.637 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 86' ' ' VAL . . . . . . . . . . . . . 41.9 t -126.59 131.7 70.99 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.187 0 CA-C-O 120.956 0.408 . . . . 0.0 110.375 -179.138 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 87' ' ' ILE . . . . . . . . . . . . . 5.0 mp -117.37 124.75 73.43 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.224 0 N-CA-C 109.351 -0.611 . . . . 0.0 109.351 175.998 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 88' ' ' LEU . . . . . . . . . . . . . 10.6 tp -111.88 129.54 56.13 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-O 120.991 0.424 . . . . 0.0 111.098 -176.15 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 89' ' ' ASP . . . . . . . . . . . . . 13.4 t70 -125.22 150.55 46.9 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-N 115.789 -0.641 . . . . 0.0 109.535 175.428 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 84.4 tt0 -48.67 -34.88 12.68 Favored 'General case' 0 C--N 1.328 -0.351 0 N-CA-C 112.772 0.656 . . . . 0.0 112.772 -172.946 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 91' ' ' ASN . . . . . . . . . . . . . 25.1 m120 -130.48 29.79 4.79 Favored 'General case' 0 N--CA 1.468 0.459 0 N-CA-C 112.184 0.439 . . . . 0.0 112.184 -176.559 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 92' ' ' LEU . . . . . . . . . . . . . 12.4 tp -166.09 141.99 4.9 Favored 'General case' 0 C--N 1.33 -0.275 0 C-N-CA 121.103 -0.239 . . . . 0.0 110.384 179.569 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 93' ' ' ILE . . . . . . . . . . . . . 74.2 mt -124.79 123.49 65.93 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.23 0 N-CA-C 109.609 -0.515 . . . . 0.0 109.609 179.191 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 94' ' ' VAL . . . . . . . . . . . . . 45.5 t -122.56 126.87 74.66 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.241 0 N-CA-C 109.876 -0.416 . . . . 0.0 109.876 179.856 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 95' ' ' VAL . . . . . . . . . . . . . 47.8 t -121.46 132.53 70.47 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.292 0 CA-C-N 116.028 -0.533 . . . . 0.0 109.862 -179.293 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 96' ' ' ILE . . . . . . . . . . . . . 57.3 mt -112.83 126.42 70.22 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.337 0 N-CA-C 109.021 -0.733 . . . . 0.0 109.021 178.62 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 97' ' ' THR . . . . . . . . . . . . . 72.9 p -101.73 154.27 19.05 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-O 121.265 0.555 . . . . 0.0 111.137 -176.426 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 98' ' ' GLU . . . . . . . . . . . . . 48.0 tp10 -54.14 -25.92 24.84 Favored 'General case' 0 CA--C 1.535 0.366 0 CA-C-N 116.111 -0.495 . . . . 0.0 112.107 -179.809 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 99' ' ' GLU . . . . . . . . . . . . . 40.0 tt0 -80.13 18.11 0.91 Allowed 'General case' 0 CA--C 1.539 0.522 0 N-CA-C 112.573 0.582 . . . . 0.0 112.573 -176.688 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 100' ' ' ASN . . . . . . . . . . . . . 2.9 m-20 62.97 37.12 12.09 Favored 'General case' 0 CA--C 1.529 0.163 0 O-C-N 121.738 -0.601 . . . . 0.0 111.141 176.378 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 101' ' ' GLU . . . . . . . . . . . . . 84.5 tt0 -118.71 143.09 47.09 Favored 'General case' 0 C--N 1.332 -0.182 0 CA-C-N 116.072 -0.513 . . . . 0.0 109.925 176.231 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 102' ' ' VAL . . . . . . . . . . . . . 47.0 t -114.97 125.57 72.33 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.278 0 N-CA-C 109.761 -0.459 . . . . 0.0 109.761 179.858 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 103' ' ' LEU . . . . . . . . . . . . . 54.4 mt -116.71 135.12 54.03 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 115.732 -0.667 . . . . 0.0 109.955 178.886 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 104' ' ' ILE . . . . . . . . . . . . . 72.9 mt -122.97 123.09 67.25 Favored 'Isoleucine or valine' 0 C--O 1.234 0.246 0 N-CA-C 110.349 -0.241 . . . . 0.0 110.349 -178.674 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 105' ' ' PHE . . . . . . . . . . . . . 85.5 m-85 -123.82 165.43 17.35 Favored 'General case' 0 C--O 1.232 0.184 0 O-C-N 123.996 0.81 . . . . 0.0 110.071 -178.618 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 106' ' ' ASN . . . . . . . . . . . . . 47.4 p-10 -101.3 -169.96 1.77 Allowed 'General case' 0 C--N 1.329 -0.317 0 N-CA-C 109.577 -0.527 . . . . 0.0 109.577 171.769 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 107' ' ' GLN . . . . . . . . . . . . . 47.7 tt0 -59.01 -29.97 67.65 Favored 'General case' 0 C--N 1.329 -0.312 0 N-CA-C 112.006 0.373 . . . . 0.0 112.006 -178.975 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 108' ' ' ASN . . . . . . . . . . . . . 6.7 t-20 -87.07 12.31 11.73 Favored 'General case' 0 CA--C 1.533 0.321 0 N-CA-C 113.015 0.746 . . . . 0.0 113.015 -176.653 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 109' ' ' LEU . . . . . . . . . . . . . 24.9 mt 58.56 37.03 25.5 Favored 'General case' 0 C--O 1.233 0.191 0 CA-C-O 120.828 0.346 . . . . 0.0 111.497 177.245 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 110' ' ' GLU . . . . . . . . . . . . . 95.4 mt-10 -104.66 146.87 28.32 Favored 'General case' 0 C--N 1.329 -0.293 0 N-CA-C 110.013 -0.365 . . . . 0.0 110.013 176.513 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 111' ' ' GLU . . . . . . . . . . . . . 98.8 mt-10 -76.16 121.94 23.59 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-O 120.989 0.423 . . . . 0.0 111.204 -178.304 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 112' ' ' LEU . . . . . . . . . . . . . 50.3 mt -107.47 -45.81 3.99 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 115.767 -0.651 . . . . 0.0 110.033 175.985 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 113' ' ' TYR . . . . . . . . . . . . . 63.2 t80 -140.64 138.71 34.55 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.012 -0.54 . . . . 0.0 110.859 179.973 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 114' ' ' ARG . . . . . . . . . . . . . 36.5 mtm105 -144.03 124.15 13.67 Favored 'General case' 0 C--N 1.331 -0.221 0 CA-C-N 116.388 -0.369 . . . . 0.0 110.494 176.309 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 115' ' ' GLY . . . . . . . . . . . . . . . -150.15 143.66 10.98 Favored Glycine 0 CA--C 1.524 0.614 0 N-CA-C 110.939 -0.864 . . . . 0.0 110.939 179.345 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 116' ' ' LYS . . . . . . . . . . . . . 35.3 ttmt -114.15 140.43 48.53 Favored 'General case' 0 C--N 1.331 -0.201 0 CA-C-O 120.861 0.362 . . . . 0.0 110.054 177.032 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 117' ' ' PHE . . . . . . . . . . . . . 32.5 m-85 -137.63 115.04 11.09 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.19 -0.459 . . . . 0.0 109.889 -176.487 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 118' ' ' GLU . . . . . . . . . . . . . 96.0 mt-10 -54.64 -44.12 72.91 Favored 'General case' 0 C--N 1.328 -0.335 0 C-N-CA 120.965 -0.294 . . . . 0.0 111.321 -175.698 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 119' ' ' ASN . . . . . . . . . . . . . 25.1 m120 -96.44 30.58 2.5 Favored 'General case' 0 C--N 1.33 -0.248 0 N-CA-C 112.29 0.478 . . . . 0.0 112.29 -174.878 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 120' ' ' LEU . . . . . . . . . . . . . 28.7 tp -60.6 126.74 28.55 Favored 'General case' 0 C--N 1.332 -0.189 0 N-CA-C 109.83 -0.433 . . . . 0.0 109.83 177.287 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 121' ' ' ASN . . . . . . . . . . . . . 55.8 m-80 -110.88 -44.09 3.68 Favored 'General case' 0 C--N 1.331 -0.225 0 CA-C-N 116.361 -0.381 . . . . 0.0 111.128 -176.863 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 122' ' ' LYS . . . . . . . . . . . . . 56.2 pttt -161.44 159.21 27.82 Favored 'General case' 0 C--N 1.332 -0.167 0 C-N-CA 120.428 -0.509 . . . . 0.0 111.84 -179.266 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 123' ' ' VAL . . . . . . . . . . . . . 38.0 t -131.18 135.86 58.89 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.221 0 CA-C-N 116.094 -0.503 . . . . 0.0 110.321 -179.481 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 124' ' ' LEU . . . . . . . . . . . . . 46.0 mt -119.85 130.53 54.92 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.068 -0.514 . . . . 0.0 109.788 177.773 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 125' ' ' VAL . . . . . . . . . . . . . 13.6 p -138.29 137.49 43.91 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.2 0 CA-C-O 121.073 0.464 . . . . 0.0 111.166 -179.026 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 126' ' ' ARG . . . . . . . . . . . . . 14.0 ptm180 -163.28 135.97 5.41 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 115.804 -0.634 . . . . 0.0 109.776 175.673 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 127' ' ' ASN . . . . . . . . . . . . . 78.6 m-20 55.34 -154.55 0.3 Allowed 'General case' 0 CA--C 1.539 0.544 0 N-CA-C 110.074 -0.343 . . . . 0.0 110.074 179.875 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 128' ' ' ASP . . . . . . . . . . . . . 20.0 p-10 -80.15 15.49 1.51 Allowed 'General case' 0 CA--C 1.536 0.411 0 N-CA-C 112.938 0.718 . . . . 0.0 112.938 179.394 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 129' ' ' LEU . . . . . . . . . . . . . 13.9 tp -119.68 132.42 55.67 Favored 'General case' 0 C--O 1.232 0.142 0 CA-C-N 118.154 0.434 . . . . 0.0 110.223 179.575 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 130' ' ' VAL . . . . . . . . . . . . . 14.1 p -138.87 145.36 27.88 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.292 0 CA-C-O 120.979 0.418 . . . . 0.0 110.604 178.912 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 131' ' ' VAL . . . . . . . . . . . . . 43.1 t -135.04 138.68 48.57 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.252 0 CA-C-N 116.18 -0.464 . . . . 0.0 110.223 179.3 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 132' ' ' ILE . . . . . . . . . . . . . 67.6 mt -112.52 131.68 63.36 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.331 0 N-CA-C 109.349 -0.611 . . . . 0.0 109.349 179.849 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 133' ' ' ILE . . . . . . . . . . . . . 43.8 mm -115.02 123.21 70.48 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.254 0 CA-C-O 120.667 0.27 . . . . 0.0 111.083 -174.945 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 134' ' ' ASP . . . . . . . . . . . . . 7.2 p-10 -135.93 147.64 48.2 Favored 'General case' 0 C--N 1.332 -0.186 0 N-CA-C 109.584 -0.524 . . . . 0.0 109.584 172.896 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 135' ' ' GLU . . . . . . . . . . . . . 84.6 tt0 -49.81 -27.65 5.3 Favored 'General case' 0 C--N 1.327 -0.409 0 N-CA-C 112.767 0.654 . . . . 0.0 112.767 -172.749 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 136' ' ' GLN . . . . . . . . . . . . . 48.2 tt0 -83.57 -32.76 25.63 Favored 'General case' 0 C--O 1.235 0.323 0 N-CA-C 112.34 0.496 . . . . 0.0 112.34 -174.967 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 137' ' ' LYS . . . . . . . . . . . . . 52.0 pttt -167.04 169.88 12.49 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-O 121.497 0.665 . . . . 0.0 112.098 -172.365 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 138' ' ' LEU . . . . . . . . . . . . . 8.8 tt -119.87 129.25 54.3 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 115.273 -0.876 . . . . 0.0 110.065 179.439 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 139' ' ' THR . . . . . . . . . . . . . 44.4 m -110.03 127.01 54.57 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.084 -0.507 . . . . 0.0 110.294 179.657 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 140' ' ' LEU . . . . . . . . . . . . . 8.7 tt -110.8 123.33 49.87 Favored 'General case' 0 C--N 1.328 -0.329 0 N-CA-C 109.421 -0.585 . . . . 0.0 109.421 179.782 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 141' ' ' ILE . . . . . . . . . . . . . 18.9 mt -124.64 123.59 66.33 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.259 0 CA-C-O 120.964 0.412 . . . . 0.0 109.933 -175.336 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 142' ' ' ARG . . . . . . . . . . . . . 69.4 ttt180 -111.59 119.73 39.69 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 115.75 -0.659 . . . . 0.0 109.587 178.598 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 143' ' ' THR . . . . . . . . . . . . . 71.0 p . . . . . 0 C--O 1.22 -0.46 0 CA-C-O 117.981 -1.009 . . . . 0.0 110.606 -178.451 . . . . . . . . 0 0 . 1 . 012 nuclear orig full ' B' B ' -3' ' ' GLU . . . . . . . . . . . . . 95.2 mt-10 . . . . . 0 N--CA 1.489 1.525 0 N-CA-C 109.245 -0.65 . . . . 0.0 109.245 . . . . . . . . . 0 0 . 1 . 012 nuclear orig full ' B' B ' -2' ' ' GLY . . . . . . . . . . . . . . . -68.59 150.06 50.31 Favored Glycine 0 CA--C 1.524 0.616 0 N-CA-C 110.904 -0.878 . . . . 0.0 110.904 179.623 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' B' B ' -1' ' ' VAL . . . . . . . . . . . . . 44.0 t -96.14 132.92 39.18 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.282 0 CA-C-O 120.873 0.368 . . . . 0.0 110.032 -179.641 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' B' B ' 0' ' ' ILE . . . . . . . . . . . . . 70.4 mt -116.67 134.04 61.4 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.239 0 CA-C-N 116.202 -0.454 . . . . 0.0 109.95 -179.779 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' B' B ' 1' ' ' MET . . . . . . . . . . . . . 25.6 ptp -81.51 151.34 27.83 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.146 -0.479 . . . . 0.0 110.509 179.395 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' B' B ' 2' ' ' SER . . . . . . . . . . . . . 9.6 p -107.78 135.25 49.52 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.16 -0.473 . . . . 0.0 110.558 179.554 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' B' B ' 3' ' ' GLU . . . . . . . . . . . . . 95.0 mt-10 -139.84 142.39 36.6 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.021 -0.536 . . . . 0.0 110.954 -178.532 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' B' B ' 4' ' ' LEU . . . . . . . . . . . . . 4.3 tt -126.14 124.73 41.19 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 115.829 -0.623 . . . . 0.0 109.559 176.899 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' B' B ' 5' ' ' LYS . . . . . . . . . . . . . 96.1 mttt -108.12 120.87 43.58 Favored 'General case' 0 C--O 1.234 0.265 0 CA-C-O 120.755 0.312 . . . . 0.0 110.913 -178.2 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' B' B ' 6' ' ' LEU . . . . . . . . . . . . . 54.4 mt -114.82 148.96 37.79 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 115.439 -0.8 . . . . 0.0 110.656 -178.992 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' B' B ' 7' ' ' LYS . . . . . . . . . . . . . 26.3 ttpp -136.53 140.78 33.33 Favored Pre-proline 0 CA--C 1.532 0.267 0 CA-C-O 119.166 -0.445 . . . . 0.0 109.991 174.701 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' B' B ' 8' ' ' PRO . . . . . . . . . . . . . 87.9 Cg_endo -91.88 138.98 2.09 Favored 'Trans proline' 0 N--CA 1.49 1.274 0 C-N-CA 121.756 1.638 . . . . 0.0 111.638 177.645 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' B' B ' 9' ' ' LEU . . . . . . . . . . . . . 69.0 mt -73.65 -46.99 7.2 Favored Pre-proline 0 CA--C 1.534 0.357 0 CA-C-O 118.682 -0.675 . . . . 0.0 111.961 -179.991 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' B' B ' 10' ' ' PRO . . . . . . . . . . . . . 83.1 Cg_endo -81.36 150.81 17.43 Favored 'Trans proline' 0 N--CA 1.497 1.7 0 C-N-CA 121.166 1.244 . . . . 0.0 111.824 174.738 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' B' B ' 11' ' ' LYS . . . . . . . . . . . . . 39.4 ttpt -87.6 94.26 9.67 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.442 -0.345 . . . . 0.0 110.325 178.648 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' B' B ' 12' ' ' VAL . . . . . . . . . . . . . 12.0 p -140.07 142.19 32.29 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.297 0 CA-C-N 116.211 -0.449 . . . . 0.0 110.394 179.252 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' B' B ' 13' ' ' GLU . . . . . . . . . . . . . 41.9 mt-10 -75.69 132.24 40.41 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-O 120.802 0.335 . . . . 0.0 110.251 178.623 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' B' B ' 14' ' ' LEU . . . . . . . . . . . . . 30.5 mt -98.32 153.16 38.16 Favored Pre-proline 0 C--N 1.33 -0.253 0 CA-C-N 116.346 -0.388 . . . . 0.0 110.666 -179.224 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' B' B ' 15' ' ' PRO . . . . . . . . . . . . . 27.7 Cg_exo -61.12 154.12 59.66 Favored 'Trans proline' 0 N--CA 1.496 1.667 0 C-N-CA 121.276 1.317 . . . . 0.0 111.599 177.626 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' B' B ' 16' ' ' PRO . . . . . . . . . . . . . 33.9 Cg_exo -57.74 -36.44 98.39 Favored 'Trans proline' 0 N--CA 1.498 1.751 0 C-N-CA 121.389 1.393 . . . . 0.0 112.793 -178.896 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' B' B ' 17' ' ' ASP . . . . . . . . . . . . . 18.0 p-10 -92.43 15.04 14.89 Favored 'General case' 0 C--N 1.327 -0.383 0 N-CA-C 113.02 0.748 . . . . 0.0 113.02 -177.489 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' B' B ' 18' ' ' PHE . . . . . . . . . . . . . 44.4 t80 -58.38 -44.69 89.0 Favored 'General case' 0 C--O 1.228 -0.078 0 O-C-N 122.008 -0.432 . . . . 0.0 110.057 -177.722 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' B' B ' 19' ' ' VAL . . . . . . . . . . . . . 48.4 t -56.91 -42.97 79.59 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.305 0 CA-C-N 116.055 -0.521 . . . . 0.0 110.53 -178.346 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' B' B ' 20' ' ' ASP . . . . . . . . . . . . . 32.9 t0 -59.59 -43.49 93.67 Favored 'General case' 0 C--N 1.329 -0.315 0 C-N-CA 120.887 -0.325 . . . . 0.0 111.026 -177.22 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' B' B ' 21' ' ' VAL . . . . . . . . . . . . . 45.1 t -64.88 -46.52 91.58 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.248 0 C-N-CA 120.716 -0.393 . . . . 0.0 110.43 -178.116 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' B' B ' 22' ' ' ILE . . . . . . . . . . . . . 50.9 mm -57.8 -38.87 67.98 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.324 0 CA-C-O 120.668 0.271 . . . . 0.0 110.407 179.272 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' B' B ' 23' ' ' ARG . . . . . . . . . . . . . 57.1 ttp180 -55.84 -49.87 72.11 Favored 'General case' 0 C--N 1.331 -0.216 0 CA-C-O 120.976 0.417 . . . . 0.0 110.558 177.861 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' B' B ' 24' ' ' ILE . . . . . . . . . . . . . 74.0 mt -60.85 -43.85 96.45 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.334 0 CA-C-N 115.834 -0.621 . . . . 0.0 111.73 -177.398 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' B' B ' 25' ' ' LYS . . . . . . . . . . . . . 14.8 pttp -72.97 -36.62 67.14 Favored 'General case' 0 CA--C 1.533 0.298 0 C-N-CA 120.526 -0.47 . . . . 0.0 111.901 -172.933 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' B' B ' 26' ' ' LEU . . . . . . . . . . . . . 42.0 mt -80.21 -41.78 24.53 Favored 'General case' 0 C--N 1.331 -0.22 0 N-CA-C 113.185 0.809 . . . . 0.0 113.185 -173.796 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' B' B ' 27' ' ' GLN . . . . . . . . . . . . . 10.6 pt20 -47.18 139.28 6.19 Favored 'General case' 0 N--CA 1.469 0.484 0 N-CA-C 112.73 0.641 . . . . 0.0 112.73 -174.539 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' B' B ' 28' ' ' GLY . . . . . . . . . . . . . . . 99.48 -26.0 26.08 Favored Glycine 0 CA--C 1.533 1.179 0 CA-C-N 115.687 -0.688 . . . . 0.0 112.255 -176.877 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' B' B ' 29' ' ' LYS . . . . . . . . . . . . . 56.4 mtmt -98.9 155.16 17.54 Favored 'General case' 0 C--O 1.232 0.164 0 CA-C-N 117.247 0.523 . . . . 0.0 111.103 179.425 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' B' B ' 30' ' ' THR . . . . . . . . . . . . . 31.4 m -105.38 137.73 42.72 Favored 'General case' 0 C--N 1.332 -0.195 0 CA-C-N 116.101 -0.499 . . . . 0.0 110.094 176.949 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' B' B ' 31' ' ' VAL . . . . . . . . . . . . . 34.3 m -130.71 160.41 41.93 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.236 0 CA-C-O 120.911 0.386 . . . . 0.0 110.971 -178.372 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' B' B ' 32' ' ' ARG . . . . . . . . . . . . . 80.3 mtm180 -134.24 149.26 50.95 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 115.907 -0.588 . . . . 0.0 110.477 177.844 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' B' B ' 33' ' ' THR . . . . . . . . . . . . . 24.7 m -53.41 141.63 24.11 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.443 -0.344 . . . . 0.0 111.39 -178.363 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' B' B ' 34' ' ' GLY . . . . . . . . . . . . . . . 99.49 -17.13 58.12 Favored Glycine 0 CA--C 1.533 1.194 0 CA-C-O 119.687 -0.507 . . . . 0.0 113.23 179.762 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' B' B ' 35' ' ' ASP . . . . . . . . . . . . . 76.1 m-20 -65.33 147.99 52.47 Favored 'General case' 0 C--O 1.231 0.123 0 CA-C-N 118.037 0.919 . . . . 0.0 111.041 178.739 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' B' B ' 36' ' ' VAL . . . . . . . . . . . . . 46.7 t -120.58 129.96 75.03 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.204 0 CA-C-N 115.829 -0.623 . . . . 0.0 109.887 179.099 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' B' B ' 37' ' ' ILE . . . . . . . . . . . . . 69.9 mt -120.31 139.18 48.42 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.219 0 N-CA-C 109.841 -0.429 . . . . 0.0 109.841 179.848 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' B' B ' 38' ' ' GLY . . . . . . . . . . . . . . . -114.04 128.74 8.4 Favored Glycine 0 CA--C 1.525 0.691 0 N-CA-C 111.256 -0.738 . . . . 0.0 111.256 -179.683 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' B' B ' 39' ' ' ILE . . . . . . . . . . . . . 69.4 mt -122.9 127.97 75.01 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.218 0 N-CA-C 109.64 -0.504 . . . . 0.0 109.64 177.418 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' B' B ' 40' ' ' SER . . . . . . . . . . . . . 56.3 p -91.95 118.12 30.45 Favored 'General case' 0 C--N 1.33 -0.257 0 C-N-CA 120.908 -0.317 . . . . 0.0 110.75 177.527 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' B' B ' 41' ' ' ILE . . . . . . . . . . . . . 73.8 mt -134.63 128.25 50.68 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.234 0 CA-C-O 120.732 0.301 . . . . 0.0 110.266 178.786 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' B' B ' 42' ' ' LEU . . . . . . . . . . . . . 49.3 mt 57.76 33.08 22.8 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.24 -0.436 . . . . 0.0 111.858 178.543 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' B' B ' 43' ' ' GLY . . . . . . . . . . . . . . . 77.29 -10.05 23.77 Favored Glycine 0 CA--C 1.535 1.334 0 C-N-CA 121.276 -0.487 . . . . 0.0 113.472 178.03 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' B' B ' 44' ' ' LYS . . . . . . . . . . . . . 65.3 tttm -102.22 129.91 48.75 Favored 'General case' 0 C--O 1.233 0.195 0 CA-C-N 117.948 0.874 . . . . 0.0 109.964 177.224 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' B' B ' 45' ' ' GLU . . . . . . . . . . . . . 44.7 tp10 -84.7 125.66 32.71 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.43 -0.35 . . . . 0.0 110.55 178.998 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' B' B ' 46' ' ' VAL . . . . . . . . . . . . . 7.5 p -113.74 128.77 70.48 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.258 0 N-CA-C 109.336 -0.616 . . . . 0.0 109.336 177.108 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' B' B ' 47' ' ' LYS . . . . . . . . . . . . . 93.5 mttt -100.05 126.58 46.27 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 115.849 -0.614 . . . . 0.0 111.12 178.725 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' B' B ' 48' ' ' PHE . . . . . . . . . . . . . 95.3 m-85 -109.48 131.9 54.64 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.079 -0.51 . . . . 0.0 109.679 176.358 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' B' B ' 49' ' ' LYS . . . . . . . . . . . . . 86.4 tttt -107.12 134.73 49.8 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.18 -0.463 . . . . 0.0 110.366 179.25 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' B' B ' 50' ' ' VAL . . . . . . . . . . . . . 46.2 t -79.0 106.42 9.97 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.336 0 N-CA-C 109.167 -0.679 . . . . 0.0 109.167 175.695 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' B' B ' 51' ' ' VAL . . . . . . . . . . . . . 52.5 t -69.9 -52.81 27.73 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.354 0 N-CA-C 109.613 -0.514 . . . . 0.0 109.613 -174.844 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' B' B ' 52' ' ' GLN . . . . . . . . . . . . . 90.7 mt-30 -153.75 151.64 29.82 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-O 121.274 0.559 . . . . 0.0 111.86 -178.114 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' B' B ' 53' ' ' ALA . . . . . . . . . . . . . . . -127.29 132.55 50.29 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 115.065 -0.971 . . . . 0.0 109.323 174.561 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' B' B ' 54' ' ' TYR . . . . . . . . . . . . . 39.7 t80 -129.06 109.78 18.2 Favored Pre-proline 0 CA--C 1.533 0.318 0 CA-C-O 118.183 -0.913 . . . . 0.0 110.381 -179.697 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' B' B ' 55' ' ' PRO . . . . . . . . . . . . . 73.6 Cg_endo -77.1 170.1 72.53 Favored 'Cis proline' 0 N--CA 1.502 2.006 0 CA-C-N 121.907 1.717 . . . . 0.0 112.594 -5.443 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' B' B ' 56' ' ' SER . . . . . . . . . . . . . 15.5 m -116.56 128.05 26.29 Favored Pre-proline 0 CA--C 1.539 0.537 0 CA-C-O 118.409 -0.805 . . . . 0.0 109.37 175.276 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' B' B ' 57' ' ' PRO . . . . . . . . . . . . . 36.6 Cg_endo -66.2 166.04 59.15 Favored 'Cis proline' 0 N--CA 1.499 1.799 0 CA-C-N 121.986 1.745 . . . . 0.0 111.662 -0.113 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' B' B ' 58' ' ' LEU . . . . . . . . . . . . . 29.7 tp -130.21 135.92 48.66 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.318 -0.401 . . . . 0.0 110.734 -179.716 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' B' B ' 59' ' ' ARG . . . . . . . . . . . . . 58.2 ttp180 -101.82 126.75 48.76 Favored 'General case' 0 C--N 1.328 -0.366 0 N-CA-C 109.237 -0.653 . . . . 0.0 109.237 175.815 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' B' B ' 60' ' ' VAL . . . . . . . . . . . . . 46.9 t -78.56 117.98 24.96 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.192 0 C-N-CA 120.546 -0.462 . . . . 0.0 109.915 -177.352 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' B' B ' 61' ' ' GLU . . . . . . . . . . . . . 74.4 tt0 -131.12 159.6 37.16 Favored 'General case' 0 C--N 1.328 -0.337 0 N-CA-C 109.422 -0.584 . . . . 0.0 109.422 -179.504 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' B' B ' 62' ' ' ASP . . . . . . . . . . . . . 52.2 m-20 -51.51 -32.17 26.62 Favored 'General case' 0 C--N 1.328 -0.355 0 N-CA-C 112.074 0.398 . . . . 0.0 112.074 -179.367 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' B' B ' 63' ' ' ARG . . . . . . . . . . . . . 14.5 ptm180 -85.15 5.4 30.06 Favored 'General case' 0 CA--C 1.535 0.403 0 N-CA-C 113.733 1.012 . . . . 0.0 113.733 -175.739 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' B' B ' 64' ' ' THR . . . . . . . . . . . . . 24.4 m -89.72 136.4 33.06 Favored 'General case' 0 C--N 1.332 -0.18 0 CA-C-N 118.151 0.432 . . . . 0.0 110.401 -178.647 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' B' B ' 65' ' ' LYS . . . . . . . . . . . . . 55.1 mtmt -89.1 128.38 35.76 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.299 -0.41 . . . . 0.0 110.31 -179.994 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' B' B ' 66' ' ' ILE . . . . . . . . . . . . . 66.1 mt -113.68 127.18 71.16 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.294 0 N-CA-C 109.638 -0.504 . . . . 0.0 109.638 179.998 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' B' B ' 67' ' ' THR . . . . . . . . . . . . . 23.4 m -126.97 144.09 51.11 Favored 'General case' 0 C--N 1.332 -0.185 0 CA-C-N 116.122 -0.49 . . . . 0.0 111.069 -175.903 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' B' B ' 68' ' ' LEU . . . . . . . . . . . . . 42.8 mt -104.07 135.18 46.05 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 115.942 -0.572 . . . . 0.0 110.61 177.887 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' B' B ' 69' ' ' VAL . . . . . . . . . . . . . 43.1 t -100.42 140.76 18.67 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.339 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.004 178.969 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' B' B ' 70' ' ' THR . . . . . . . . . . . . . 6.7 p -131.13 -45.25 1.02 Allowed 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.088 -0.505 . . . . 0.0 110.531 -178.58 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' B' B ' 71' ' ' HIS . . . . . . . . . . . . . 89.2 m-70 -106.18 154.4 39.68 Favored Pre-proline 0 C--N 1.33 -0.277 0 CA-C-N 116.267 -0.424 . . . . 0.0 110.521 -179.792 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' B' B ' 72' ' ' PRO . . . . . . . . . . . . . 93.9 Cg_endo -83.19 -7.76 10.94 Favored 'Trans proline' 0 N--CA 1.496 1.654 0 C-N-CA 121.532 1.488 . . . . 0.0 113.809 179.401 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' B' B ' 73' ' ' VAL . . . . . . . . . . . . . 33.8 m -125.68 171.13 14.81 Favored 'Isoleucine or valine' 0 C--N 1.334 -0.092 0 CA-C-O 120.66 0.267 . . . . 0.0 110.376 -179.289 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' B' B ' 74' ' ' ASP . . . . . . . . . . . . . 38.8 t0 -95.66 119.28 33.89 Favored 'General case' 0 C--N 1.329 -0.287 0 N-CA-C 110.121 -0.326 . . . . 0.0 110.121 -177.644 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' B' B ' 75' ' ' VAL . . . . . . . . . . . . . 40.6 t -122.52 125.2 72.31 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.295 0 CA-C-O 121.142 0.496 . . . . 0.0 110.818 -177.652 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' B' B ' 76' ' ' LEU . . . . . . . . . . . . . 5.9 mp -121.99 145.29 48.27 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 115.67 -0.695 . . . . 0.0 109.619 175.361 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' B' B ' 77' ' ' GLU . . . . . . . . . . . . . 97.3 mt-10 -134.38 132.06 38.97 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-O 121.061 0.458 . . . . 0.0 111.133 -178.634 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' B' B ' 78' ' ' ALA . . . . . . . . . . . . . . . -120.84 134.28 55.29 Favored 'General case' 0 C--N 1.33 -0.239 0 CA-C-N 115.761 -0.654 . . . . 0.0 109.84 177.028 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' B' B ' 79' ' ' LYS . . . . . . . . . . . . . 94.4 mttt -79.1 120.79 24.14 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-O 120.809 0.337 . . . . 0.0 110.566 -178.575 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' B' B ' 80' ' ' ILE . . . . . . . . . . . . . 26.8 mm -139.09 110.06 4.76 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.28 0 N-CA-C 109.148 -0.686 . . . . 0.0 109.148 -177.465 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' B' B ' 81' ' ' LYS . . . . . . . . . . . . . 49.0 pttt -99.42 123.39 43.66 Favored 'General case' 0 C--N 1.33 -0.283 0 CA-C-O 121.104 0.478 . . . . 0.0 111.419 -176.778 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' B' B ' 82' ' ' GLY . . . . . . . . . . . . . . . 88.85 42.18 5.76 Favored Glycine 0 CA--C 1.524 0.617 0 C-N-CA 120.769 -0.729 . . . . 0.0 111.664 173.404 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' B' B ' 83' ' ' ILE . . . . . . . . . . . . . 76.8 mt -64.38 135.13 28.45 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.285 0 N-CA-C 109.861 -0.422 . . . . 0.0 109.861 178.669 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' B' B ' 84' ' ' LYS . . . . . . . . . . . . . 84.7 tttt -92.63 -53.85 4.02 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 115.903 -0.589 . . . . 0.0 110.348 -177.326 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' B' B ' 85' ' ' ASP . . . . . . . . . . . . . 3.7 t70 -158.29 158.01 33.58 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 115.678 -0.692 . . . . 0.0 110.147 -178.783 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' B' B ' 86' ' ' VAL . . . . . . . . . . . . . 40.3 t -135.56 134.08 51.87 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.248 0 CA-C-O 121.023 0.44 . . . . 0.0 110.746 -177.69 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' B' B ' 87' ' ' ILE . . . . . . . . . . . . . 44.2 mm -117.48 127.68 74.88 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.226 0 CA-C-N 115.751 -0.659 . . . . 0.0 109.389 174.386 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' B' B ' 88' ' ' LEU . . . . . . . . . . . . . 17.3 tp -112.55 133.06 54.81 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-O 121.01 0.434 . . . . 0.0 111.19 -176.673 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' B' B ' 89' ' ' ASP . . . . . . . . . . . . . 9.0 t0 -128.22 150.51 50.0 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 115.743 -0.662 . . . . 0.0 109.43 176.591 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' B' B ' 90' ' ' GLU . . . . . . . . . . . . . 84.3 tt0 -48.03 -37.63 15.32 Favored 'General case' 0 CA--C 1.531 0.25 0 N-CA-C 112.612 0.597 . . . . 0.0 112.612 -173.336 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' B' B ' 91' ' ' ASN . . . . . . . . . . . . . 84.9 m-20 -131.6 35.07 3.85 Favored 'General case' 0 N--CA 1.465 0.285 0 CA-C-O 120.816 0.341 . . . . 0.0 111.639 -177.301 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' B' B ' 92' ' ' LEU . . . . . . . . . . . . . 11.6 tp -166.07 142.41 5.05 Favored 'General case' 0 C--N 1.331 -0.22 0 CA-C-O 120.673 0.273 . . . . 0.0 110.339 179.723 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' B' B ' 93' ' ' ILE . . . . . . . . . . . . . 70.1 mt -125.47 124.36 66.77 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.343 0 N-CA-C 109.622 -0.51 . . . . 0.0 109.622 -179.896 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' B' B ' 94' ' ' VAL . . . . . . . . . . . . . 41.0 t -124.79 127.33 72.58 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.252 0 N-CA-C 110.008 -0.368 . . . . 0.0 110.008 179.39 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' B' B ' 95' ' ' VAL . . . . . . . . . . . . . 40.1 t -123.37 137.67 55.88 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.293 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.036 -179.48 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' B' B ' 96' ' ' ILE . . . . . . . . . . . . . 65.1 mt -116.46 130.43 71.29 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.256 0 N-CA-C 109.158 -0.682 . . . . 0.0 109.158 178.254 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' B' B ' 97' ' ' THR . . . . . . . . . . . . . 65.4 p -103.96 155.78 18.38 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-O 121.029 0.443 . . . . 0.0 111.255 -177.324 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' B' B ' 98' ' ' GLU . . . . . . . . . . . . . 85.1 tt0 -54.04 -24.54 17.49 Favored 'General case' 0 CA--C 1.534 0.332 0 N-CA-C 112.068 0.396 . . . . 0.0 112.068 178.922 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' B' B ' 99' ' ' GLU . . . . . . . . . . . . . 70.9 mm-40 -76.4 13.49 0.94 Allowed 'General case' 0 CA--C 1.535 0.4 0 N-CA-C 113.2 0.815 . . . . 0.0 113.2 -179.333 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' B' B ' 100' ' ' ASN . . . . . . . . . . . . . 2.3 m-20 64.62 38.1 7.37 Favored 'General case' 0 C--O 1.232 0.15 0 CA-C-O 120.988 0.423 . . . . 0.0 110.788 177.813 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' B' B ' 101' ' ' GLU . . . . . . . . . . . . . 46.2 mt-10 -115.84 143.94 44.72 Favored 'General case' 0 C--N 1.332 -0.16 0 CA-C-N 116.074 -0.512 . . . . 0.0 110.399 177.078 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' B' B ' 102' ' ' VAL . . . . . . . . . . . . . 47.2 t -115.11 126.46 72.7 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.357 0 N-CA-C 109.245 -0.65 . . . . 0.0 109.245 176.864 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' B' B ' 103' ' ' LEU . . . . . . . . . . . . . 6.4 mp -121.9 132.88 54.8 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-N 116.008 -0.542 . . . . 0.0 110.386 177.796 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' B' B ' 104' ' ' ILE . . . . . . . . . . . . . 71.6 mt -117.62 124.77 73.5 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.315 0 CA-C-N 115.834 -0.621 . . . . 0.0 109.914 -179.092 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' B' B ' 105' ' ' PHE . . . . . . . . . . . . . 75.9 m-85 -123.46 162.23 23.25 Favored 'General case' 0 C--N 1.331 -0.222 0 O-C-N 123.985 0.803 . . . . 0.0 109.823 179.786 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' B' B ' 106' ' ' ASN . . . . . . . . . . . . . 47.9 p-10 -97.22 -170.41 2.02 Favored 'General case' 0 C--N 1.329 -0.31 0 N-CA-C 109.919 -0.4 . . . . 0.0 109.919 173.939 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' B' B ' 107' ' ' GLN . . . . . . . . . . . . . 47.5 tt0 -59.0 -30.05 67.69 Favored 'General case' 0 C--N 1.329 -0.287 0 N-CA-C 111.888 0.329 . . . . 0.0 111.888 179.607 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' B' B ' 108' ' ' ASN . . . . . . . . . . . . . 56.4 t30 -83.96 7.76 17.32 Favored 'General case' 0 CA--C 1.536 0.412 0 N-CA-C 113.259 0.837 . . . . 0.0 113.259 -177.022 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' B' B ' 109' ' ' LEU . . . . . . . . . . . . . 9.8 tp 60.52 36.35 20.0 Favored 'General case' 0 CA--C 1.529 0.165 0 CA-C-O 120.965 0.412 . . . . 0.0 111.413 178.613 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' B' B ' 110' ' ' GLU . . . . . . . . . . . . . 70.6 mm-40 -101.35 147.5 26.25 Favored 'General case' 0 C--N 1.329 -0.322 0 N-CA-C 109.685 -0.487 . . . . 0.0 109.685 175.837 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' B' B ' 111' ' ' GLU . . . . . . . . . . . . . 85.2 tt0 -79.51 121.95 25.85 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-O 120.94 0.4 . . . . 0.0 110.483 -177.508 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' B' B ' 112' ' ' LEU . . . . . . . . . . . . . 20.5 mt -108.26 -46.04 3.8 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 115.911 -0.586 . . . . 0.0 110.548 179.379 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' B' B ' 113' ' ' TYR . . . . . . . . . . . . . 64.4 t80 -140.27 135.17 32.01 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.145 -0.48 . . . . 0.0 111.364 -178.667 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' B' B ' 114' ' ' ARG . . . . . . . . . . . . . 71.6 ttt180 -142.16 125.16 16.2 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.306 -0.406 . . . . 0.0 110.158 176.141 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' B' B ' 115' ' ' GLY . . . . . . . . . . . . . . . -150.04 149.14 21.0 Favored Glycine 0 CA--C 1.523 0.582 0 N-CA-C 111.175 -0.77 . . . . 0.0 111.175 179.115 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' B' B ' 116' ' ' LYS . . . . . . . . . . . . . 35.3 ttpt -114.22 131.75 56.36 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-O 120.732 0.301 . . . . 0.0 110.422 178.283 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' B' B ' 117' ' ' PHE . . . . . . . . . . . . . 43.1 m-85 -129.46 113.94 15.52 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.279 -0.419 . . . . 0.0 109.938 -179.244 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' B' B ' 118' ' ' GLU . . . . . . . . . . . . . 84.6 tt0 -54.91 -48.5 73.0 Favored 'General case' 0 C--N 1.329 -0.318 0 C-N-CA 120.901 -0.319 . . . . 0.0 111.419 -175.601 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' B' B ' 119' ' ' ASN . . . . . . . . . . . . . 91.0 m-20 -94.44 31.2 1.79 Allowed 'General case' 0 C--N 1.33 -0.279 0 N-CA-C 112.187 0.44 . . . . 0.0 112.187 -174.199 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' B' B ' 120' ' ' LEU . . . . . . . . . . . . . 21.9 tp -53.28 123.67 12.51 Favored 'General case' 0 N--CA 1.464 0.254 0 CA-C-O 120.713 0.292 . . . . 0.0 110.953 178.221 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' B' B ' 121' ' ' ASN . . . . . . . . . . . . . 43.2 m-20 -106.37 -44.16 4.59 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-N 116.337 -0.392 . . . . 0.0 110.909 -177.533 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' B' B ' 122' ' ' LYS . . . . . . . . . . . . . 50.7 pttt -161.14 157.73 26.41 Favored 'General case' 0 C--N 1.331 -0.225 0 C-N-CA 120.454 -0.498 . . . . 0.0 112.204 -179.462 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' B' B ' 123' ' ' VAL . . . . . . . . . . . . . 44.0 t -125.6 131.16 72.4 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.246 0 CA-C-N 115.805 -0.634 . . . . 0.0 109.845 177.522 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' B' B ' 124' ' ' LEU . . . . . . . . . . . . . 76.8 mt -116.73 133.3 56.17 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.301 -0.408 . . . . 0.0 110.392 179.979 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' B' B ' 125' ' ' VAL . . . . . . . . . . . . . 47.3 t -131.74 129.51 61.27 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.215 0 CA-C-N 116.284 -0.417 . . . . 0.0 110.228 -179.057 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' B' B ' 126' ' ' ARG . . . . . . . . . . . . . 77.0 mtt180 -141.3 119.79 12.36 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-O 121.076 0.465 . . . . 0.0 110.458 176.538 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' B' B ' 127' ' ' ASN . . . . . . . . . . . . . 42.4 t-20 50.63 -106.47 0.24 Allowed 'General case' 0 CA--C 1.543 0.711 0 CA-C-O 119.003 -0.523 . . . . 0.0 111.37 -179.106 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' B' B ' 128' ' ' ASP . . . . . . . . . . . . . 11.7 p-10 -114.12 2.51 14.92 Favored 'General case' 0 N--CA 1.467 0.407 0 CA-C-N 119.642 1.11 . . . . 0.0 113.466 -177.334 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' B' B ' 129' ' ' LEU . . . . . . . . . . . . . 11.6 tp -104.96 136.85 43.68 Favored 'General case' 0 C--O 1.232 0.134 0 CA-C-N 118.267 0.485 . . . . 0.0 109.849 -179.916 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' B' B ' 130' ' ' VAL . . . . . . . . . . . . . 43.0 t -125.14 138.08 55.51 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.268 0 CA-C-O 121.061 0.457 . . . . 0.0 110.406 -176.885 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' B' B ' 131' ' ' VAL . . . . . . . . . . . . . 44.2 t -134.52 135.24 54.01 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.34 0 CA-C-N 115.895 -0.593 . . . . 0.0 110.008 177.915 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' B' B ' 132' ' ' ILE . . . . . . . . . . . . . 73.7 mt -115.79 132.28 65.69 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.281 0 N-CA-C 109.501 -0.555 . . . . 0.0 109.501 179.752 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' B' B ' 133' ' ' ILE . . . . . . . . . . . . . 42.7 mm -116.33 125.14 73.24 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.226 0 CA-C-N 116.569 -0.287 . . . . 0.0 111.074 -174.624 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' B' B ' 134' ' ' ASP . . . . . . . . . . . . . 10.1 p-10 -137.45 150.07 47.34 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 116.19 -0.459 . . . . 0.0 109.846 173.378 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' B' B ' 135' ' ' GLU . . . . . . . . . . . . . 40.1 tp10 -49.91 -27.2 4.91 Favored 'General case' 0 C--N 1.327 -0.371 0 N-CA-C 112.791 0.663 . . . . 0.0 112.791 -172.066 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' B' B ' 136' ' ' GLN . . . . . . . . . . . . . 63.2 tt0 -87.14 -33.72 19.32 Favored 'General case' 0 C--N 1.331 -0.221 0 N-CA-C 112.497 0.554 . . . . 0.0 112.497 -174.747 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' B' B ' 137' ' ' LYS . . . . . . . . . . . . . 48.3 pttt -162.1 171.22 17.84 Favored 'General case' 0 C--N 1.332 -0.181 0 CA-C-O 121.537 0.684 . . . . 0.0 112.525 -171.445 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' B' B ' 138' ' ' LEU . . . . . . . . . . . . . 7.2 tt -121.45 128.74 52.45 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 114.918 -1.037 . . . . 0.0 109.896 178.531 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' B' B ' 139' ' ' THR . . . . . . . . . . . . . 39.4 m -108.18 127.13 53.55 Favored 'General case' 0 C--N 1.331 -0.221 0 CA-C-N 116.292 -0.413 . . . . 0.0 110.425 -179.929 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' B' B ' 140' ' ' LEU . . . . . . . . . . . . . 29.6 tp -112.2 120.9 43.35 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 115.788 -0.642 . . . . 0.0 109.531 -179.09 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' B' B ' 141' ' ' ILE . . . . . . . . . . . . . 19.1 mt -121.72 119.63 59.35 Favored 'Isoleucine or valine' 0 C--O 1.233 0.198 0 CA-C-O 121.09 0.471 . . . . 0.0 110.282 -175.249 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' B' B ' 142' ' ' ARG . . . . . . . . . . . . . 83.1 mtp180 -108.03 125.87 52.06 Favored 'General case' 0 C--N 1.331 -0.217 0 CA-C-N 115.206 -0.906 . . . . 0.0 110.091 179.044 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' B' B ' 143' ' ' THR . . . . . . . . . . . . . 15.2 p . . . . . 0 C--O 1.219 -0.501 0 CA-C-O 118.046 -0.978 . . . . 0.0 110.495 179.831 . . . . . . . . 0 0 . 1 . 012 nuclear orig full ' C' C ' -3' ' ' GLU . . . . . . . . . . . . . 96.1 mt-10 . . . . . 0 N--CA 1.489 1.499 0 N-CA-C 109.427 -0.583 . . . . 0.0 109.427 . . . . . . . . . 0 0 . 1 . 012 nuclear orig full ' C' C ' -2' ' ' GLY . . . . . . . . . . . . . . . -67.78 131.45 28.68 Favored Glycine 0 CA--C 1.524 0.641 0 N-CA-C 111.094 -0.802 . . . . 0.0 111.094 -179.348 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' C' C ' -1' ' ' VAL . . . . . . . . . . . . . 45.1 t -96.54 126.39 49.23 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 N-CA-C 109.689 -0.486 . . . . 0.0 109.689 178.98 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' C' C ' 0' ' ' ILE . . . . . . . . . . . . . 71.6 mt -120.31 139.29 48.07 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.222 0 CA-C-N 116.251 -0.431 . . . . 0.0 110.35 -177.599 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' C' C ' 1' ' ' MET . . . . . . . . . . . . . 25.2 ptp -143.51 149.09 36.98 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 115.947 -0.57 . . . . 0.0 110.411 178.253 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' C' C ' 2' ' ' SER . . . . . . . . . . . . . 4.1 p -118.89 132.49 56.1 Favored 'General case' 0 C--N 1.332 -0.184 0 CA-C-O 120.85 0.357 . . . . 0.0 110.826 -179.264 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' C' C ' 3' ' ' GLU . . . . . . . . . . . . . 57.0 mp0 -140.49 140.35 35.3 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.074 -0.512 . . . . 0.0 110.867 179.267 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' C' C ' 4' ' ' LEU . . . . . . . . . . . . . 14.8 tp -125.17 127.94 47.6 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.046 -0.525 . . . . 0.0 110.111 176.46 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' C' C ' 5' ' ' LYS . . . . . . . . . . . . . 87.9 mttt -109.3 122.93 48.41 Favored 'General case' 0 C--O 1.235 0.294 0 CA-C-O 120.66 0.267 . . . . 0.0 110.888 178.929 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' C' C ' 6' ' ' LEU . . . . . . . . . . . . . 67.2 mt -114.72 145.07 42.49 Favored 'General case' 0 N--CA 1.463 0.216 0 CA-C-N 115.676 -0.693 . . . . 0.0 110.362 179.491 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' C' C ' 7' ' ' LYS . . . . . . . . . . . . . 73.6 tttt -125.25 137.02 28.99 Favored Pre-proline 0 CA--C 1.534 0.335 0 CA-C-O 118.866 -0.588 . . . . 0.0 109.703 174.635 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' C' C ' 8' ' ' PRO . . . . . . . . . . . . . 83.5 Cg_endo -92.04 132.68 1.24 Allowed 'Trans proline' 0 N--CA 1.489 1.249 0 C-N-CA 121.663 1.575 . . . . 0.0 111.759 178.528 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' C' C ' 9' ' ' LEU . . . . . . . . . . . . . 55.7 mt -69.63 -46.74 25.76 Favored Pre-proline 0 CA--C 1.532 0.272 0 CA-C-O 118.742 -0.647 . . . . 0.0 112.079 -179.557 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' C' C ' 10' ' ' PRO . . . . . . . . . . . . . 88.4 Cg_endo -80.79 155.65 20.61 Favored 'Trans proline' 0 N--CA 1.495 1.611 0 C-N-CA 121.184 1.256 . . . . 0.0 111.78 174.769 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' C' C ' 11' ' ' LYS . . . . . . . . . . . . . 79.1 mttt -87.7 101.37 13.6 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.415 -0.357 . . . . 0.0 110.503 178.978 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' C' C ' 12' ' ' VAL . . . . . . . . . . . . . 12.2 p -145.33 144.36 21.45 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.299 0 CA-C-N 116.299 -0.41 . . . . 0.0 110.836 -179.251 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' C' C ' 13' ' ' GLU . . . . . . . . . . . . . 43.5 mt-10 -92.36 126.23 37.35 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.252 -0.431 . . . . 0.0 109.879 176.25 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' C' C ' 14' ' ' LEU . . . . . . . . . . . . . 17.3 mt -97.22 152.81 38.49 Favored Pre-proline 0 C--N 1.33 -0.267 0 CA-C-N 116.501 -0.318 . . . . 0.0 110.742 -177.649 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' C' C ' 15' ' ' PRO . . . . . . . . . . . . . 33.6 Cg_exo -59.77 159.23 25.44 Favored 'Trans proline' 0 N--CA 1.496 1.67 0 C-N-CA 121.311 1.341 . . . . 0.0 111.884 178.348 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' C' C ' 16' ' ' PRO . . . . . . . . . . . . . 29.6 Cg_exo -59.9 -34.84 95.15 Favored 'Trans proline' 0 N--CA 1.497 1.725 0 C-N-CA 121.383 1.389 . . . . 0.0 112.811 -177.675 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' C' C ' 17' ' ' ASP . . . . . . . . . . . . . 10.7 p-10 -90.18 8.74 31.46 Favored 'General case' 0 CA--C 1.536 0.423 0 N-CA-C 113.284 0.846 . . . . 0.0 113.284 -176.896 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' C' C ' 18' ' ' PHE . . . . . . . . . . . . . 53.6 t80 -57.8 -45.55 85.91 Favored 'General case' 0 C--N 1.334 -0.101 0 O-C-N 122.057 -0.402 . . . . 0.0 110.33 -178.516 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' C' C ' 19' ' ' VAL . . . . . . . . . . . . . 48.7 t -56.75 -42.11 76.62 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.289 0 CA-C-N 116.523 -0.308 . . . . 0.0 110.414 -178.633 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' C' C ' 20' ' ' ASP . . . . . . . . . . . . . 14.9 t0 -59.7 -44.0 93.87 Favored 'General case' 0 C--N 1.328 -0.352 0 C-N-CA 120.841 -0.343 . . . . 0.0 110.762 -177.939 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' C' C ' 21' ' ' VAL . . . . . . . . . . . . . 45.3 t -64.8 -46.28 92.51 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.279 0 C-N-CA 120.753 -0.379 . . . . 0.0 110.498 -177.636 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' C' C ' 22' ' ' ILE . . . . . . . . . . . . . 50.3 mm -56.9 -39.98 68.76 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.333 0 C-N-CA 120.983 -0.287 . . . . 0.0 110.637 179.957 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' C' C ' 23' ' ' ARG . . . . . . . . . . . . . 45.1 ttp180 -57.26 -50.38 73.09 Favored 'General case' 0 C--N 1.331 -0.21 0 C-N-CA 120.673 -0.411 . . . . 0.0 110.386 177.194 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' C' C ' 24' ' ' ILE . . . . . . . . . . . . . 71.8 mt -60.44 -39.84 82.35 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.335 0 CA-C-N 115.995 -0.548 . . . . 0.0 111.827 -176.824 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' C' C ' 25' ' ' LYS . . . . . . . . . . . . . 14.9 pttp -77.11 -37.28 54.56 Favored 'General case' 0 CA--C 1.534 0.33 0 C-N-CA 120.592 -0.443 . . . . 0.0 111.938 -173.597 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' C' C ' 26' ' ' LEU . . . . . . . . . . . . . 49.0 mt -79.43 -32.42 42.82 Favored 'General case' 0 C--N 1.333 -0.146 0 N-CA-C 113.479 0.918 . . . . 0.0 113.479 -173.083 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' C' C ' 27' ' ' GLN . . . . . . . . . . . . . 11.0 pt20 -46.32 139.54 4.72 Favored 'General case' 0 N--CA 1.47 0.538 0 N-CA-C 112.922 0.712 . . . . 0.0 112.922 -174.839 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' C' C ' 28' ' ' GLY . . . . . . . . . . . . . . . 99.86 -26.66 23.58 Favored Glycine 0 CA--C 1.531 1.084 0 CA-C-N 115.697 -0.683 . . . . 0.0 112.255 -177.528 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' C' C ' 29' ' ' LYS . . . . . . . . . . . . . 94.0 mttt -97.09 155.09 16.96 Favored 'General case' 0 C--N 1.332 -0.193 0 CA-C-N 117.351 0.575 . . . . 0.0 110.854 178.237 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' C' C ' 30' ' ' THR . . . . . . . . . . . . . 28.5 m -107.27 138.13 44.02 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 116.104 -0.498 . . . . 0.0 110.104 177.072 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' C' C ' 31' ' ' VAL . . . . . . . . . . . . . 34.4 m -127.51 151.97 34.99 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.244 0 CA-C-N 116.242 -0.435 . . . . 0.0 110.571 -179.393 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' C' C ' 32' ' ' ARG . . . . . . . . . . . . . 67.0 ttt180 -132.74 149.83 52.23 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-O 121.179 0.514 . . . . 0.0 110.267 179.809 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' C' C ' 33' ' ' THR . . . . . . . . . . . . . 26.1 m -52.82 138.4 29.56 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.368 -0.378 . . . . 0.0 111.499 -177.394 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' C' C ' 34' ' ' GLY . . . . . . . . . . . . . . . 101.42 -17.21 55.81 Favored Glycine 0 CA--C 1.534 1.278 0 CA-C-O 119.651 -0.527 . . . . 0.0 113.17 179.444 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' C' C ' 35' ' ' ASP . . . . . . . . . . . . . 75.2 m-20 -66.56 148.34 52.03 Favored 'General case' 0 N--CA 1.461 0.111 0 CA-C-N 118.072 0.936 . . . . 0.0 111.224 178.869 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' C' C ' 36' ' ' VAL . . . . . . . . . . . . . 42.5 t -121.5 129.0 75.97 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.247 0 CA-C-N 115.88 -0.6 . . . . 0.0 109.809 177.638 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' C' C ' 37' ' ' ILE . . . . . . . . . . . . . 64.5 mt -120.92 138.15 52.32 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.244 0 CA-C-N 116.237 -0.438 . . . . 0.0 109.948 -179.811 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' C' C ' 38' ' ' GLY . . . . . . . . . . . . . . . -116.47 126.93 7.25 Favored Glycine 0 CA--C 1.524 0.645 0 N-CA-C 110.828 -0.909 . . . . 0.0 110.828 178.402 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' C' C ' 39' ' ' ILE . . . . . . . . . . . . . 72.1 mt -123.71 131.18 73.45 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.247 0 N-CA-C 110.136 -0.32 . . . . 0.0 110.136 179.395 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' C' C ' 40' ' ' SER . . . . . . . . . . . . . 54.4 p -91.33 117.51 29.72 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.43 -0.35 . . . . 0.0 110.823 177.615 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' C' C ' 41' ' ' ILE . . . . . . . . . . . . . 72.6 mt -134.4 127.51 50.47 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.197 0 N-CA-C 110.067 -0.346 . . . . 0.0 110.067 177.857 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' C' C ' 42' ' ' LEU . . . . . . . . . . . . . 9.5 tp 57.73 34.72 24.8 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.163 -0.471 . . . . 0.0 111.562 178.258 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' C' C ' 43' ' ' GLY . . . . . . . . . . . . . . . 77.42 -10.08 24.52 Favored Glycine 0 CA--C 1.534 1.261 0 C-N-CA 121.334 -0.46 . . . . 0.0 113.467 177.32 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' C' C ' 44' ' ' LYS . . . . . . . . . . . . . 95.0 mttt -104.65 134.26 48.12 Favored 'General case' 0 C--N 1.333 -0.11 0 CA-C-N 117.993 0.897 . . . . 0.0 110.361 178.357 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' C' C ' 45' ' ' GLU . . . . . . . . . . . . . 84.8 tt0 -85.85 128.68 34.88 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.337 -0.392 . . . . 0.0 110.866 178.275 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' C' C ' 46' ' ' VAL . . . . . . . . . . . . . 9.7 p -115.38 124.57 72.05 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.167 0 N-CA-C 109.417 -0.586 . . . . 0.0 109.417 175.219 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' C' C ' 47' ' ' LYS . . . . . . . . . . . . . 98.5 mttt -98.96 122.91 42.84 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.021 -0.536 . . . . 0.0 110.673 178.562 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' C' C ' 48' ' ' PHE . . . . . . . . . . . . . 40.2 m-85 -109.78 131.86 54.68 Favored 'General case' 0 C--N 1.329 -0.283 0 N-CA-C 109.607 -0.516 . . . . 0.0 109.607 177.5 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' C' C ' 49' ' ' LYS . . . . . . . . . . . . . 48.5 tttp -108.12 133.64 52.11 Favored 'General case' 0 C--N 1.329 -0.285 0 N-CA-C 109.96 -0.385 . . . . 0.0 109.96 178.201 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' C' C ' 50' ' ' VAL . . . . . . . . . . . . . 44.5 t -74.91 107.04 5.1 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.322 0 N-CA-C 109.261 -0.644 . . . . 0.0 109.261 177.854 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' C' C ' 51' ' ' VAL . . . . . . . . . . . . . 46.4 t -71.14 -48.91 52.29 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.252 0 CA-C-N 116.155 -0.475 . . . . 0.0 109.731 -174.735 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' C' C ' 52' ' ' GLN . . . . . . . . . . . . . 50.3 tt0 -163.73 139.49 6.49 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 115.823 -0.626 . . . . 0.0 111.442 -178.859 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' C' C ' 53' ' ' ALA . . . . . . . . . . . . . . . -116.13 132.88 56.53 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-N 115.78 -0.646 . . . . 0.0 109.728 174.863 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' C' C ' 54' ' ' TYR . . . . . . . . . . . . . 46.8 t80 -129.02 111.88 18.48 Favored Pre-proline 0 CA--C 1.535 0.397 0 CA-C-O 118.22 -0.895 . . . . 0.0 110.395 179.455 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' C' C ' 55' ' ' PRO . . . . . . . . . . . . . 73.2 Cg_endo -77.27 169.04 75.18 Favored 'Cis proline' 0 N--CA 1.501 1.912 0 CA-C-N 121.897 1.713 . . . . 0.0 112.22 -6.949 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' C' C ' 56' ' ' SER . . . . . . . . . . . . . 15.4 m -116.84 137.21 23.57 Favored Pre-proline 0 CA--C 1.538 0.495 0 CA-C-O 118.552 -0.737 . . . . 0.0 109.667 175.477 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' C' C ' 57' ' ' PRO . . . . . . . . . . . . . 48.6 Cg_endo -70.38 145.67 81.44 Favored 'Cis proline' 0 N--CA 1.497 1.701 0 CA-C-N 121.683 1.637 . . . . 0.0 111.334 -3.955 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' C' C ' 58' ' ' LEU . . . . . . . . . . . . . 19.3 tp -106.89 135.91 47.64 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.469 -0.332 . . . . 0.0 110.659 -177.402 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' C' C ' 59' ' ' ARG . . . . . . . . . . . . . 28.6 ttm180 -100.97 126.77 47.65 Favored 'General case' 0 C--N 1.327 -0.409 0 N-CA-C 109.51 -0.552 . . . . 0.0 109.51 176.134 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' C' C ' 60' ' ' VAL . . . . . . . . . . . . . 43.3 t -76.01 116.4 18.96 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.249 0 C-N-CA 120.729 -0.388 . . . . 0.0 110.047 -177.202 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' C' C ' 61' ' ' GLU . . . . . . . . . . . . . 95.8 mt-10 -131.02 167.32 19.24 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 115.84 -0.618 . . . . 0.0 110.104 178.994 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' C' C ' 62' ' ' ASP . . . . . . . . . . . . . 12.1 p-10 -55.65 -32.47 63.22 Favored 'General case' 0 C--N 1.328 -0.351 0 N-CA-C 111.837 0.31 . . . . 0.0 111.837 -178.46 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' C' C ' 63' ' ' ARG . . . . . . . . . . . . . 40.4 ptt180 -82.52 0.52 42.17 Favored 'General case' 0 CA--C 1.537 0.463 0 N-CA-C 113.749 1.018 . . . . 0.0 113.749 -175.068 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' C' C ' 64' ' ' THR . . . . . . . . . . . . . 33.2 m -82.55 134.33 35.19 Favored 'General case' 0 C--N 1.333 -0.151 0 CA-C-N 118.159 0.436 . . . . 0.0 110.903 -176.258 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' C' C ' 65' ' ' LYS . . . . . . . . . . . . . 53.6 mtmt -89.26 127.35 35.76 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 115.935 -0.575 . . . . 0.0 109.879 177.017 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' C' C ' 66' ' ' ILE . . . . . . . . . . . . . 64.5 mt -111.82 126.6 69.23 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.314 0 N-CA-C 109.656 -0.498 . . . . 0.0 109.656 -179.115 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' C' C ' 67' ' ' THR . . . . . . . . . . . . . 23.5 m -124.49 144.69 49.96 Favored 'General case' 0 C--N 1.331 -0.229 0 CA-C-O 121.281 0.562 . . . . 0.0 111.227 -175.453 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' C' C ' 68' ' ' LEU . . . . . . . . . . . . . 20.6 tp -100.33 135.72 41.33 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 115.573 -0.74 . . . . 0.0 110.243 177.731 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' C' C ' 69' ' ' VAL . . . . . . . . . . . . . 46.0 t -82.94 134.31 27.19 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 N-CA-C 109.839 -0.43 . . . . 0.0 109.839 178.931 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' C' C ' 70' ' ' THR . . . . . . . . . . . . . 33.6 p -107.25 -175.96 2.94 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 116.11 -0.495 . . . . 0.0 110.964 -177.049 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' C' C ' 71' ' ' HIS . . . . . . . . . . . . . 84.7 m-70 -64.94 158.41 70.69 Favored Pre-proline 0 C--N 1.329 -0.296 0 CA-C-N 115.848 -0.615 . . . . 0.0 110.207 179.895 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' C' C ' 72' ' ' PRO . . . . . . . . . . . . . 32.1 Cg_endo -64.85 -20.14 64.45 Favored 'Trans proline' 0 N--CA 1.498 1.74 0 C-N-CA 121.241 1.294 . . . . 0.0 112.993 -178.622 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' C' C ' 73' ' ' VAL . . . . . . . . . . . . . 31.5 m -127.19 146.56 32.84 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.184 0 CA-C-O 121.077 0.465 . . . . 0.0 110.844 178.456 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' C' C ' 74' ' ' ASP . . . . . . . . . . . . . 26.0 t0 -98.47 122.07 41.2 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-N 115.571 -0.741 . . . . 0.0 109.411 177.19 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' C' C ' 75' ' ' VAL . . . . . . . . . . . . . 44.3 t -114.09 123.78 70.09 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.226 0 CA-C-O 121.095 0.474 . . . . 0.0 110.742 -176.38 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' C' C ' 76' ' ' LEU . . . . . . . . . . . . . 5.9 mp -124.93 144.8 50.16 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 115.669 -0.696 . . . . 0.0 109.696 175.288 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' C' C ' 77' ' ' GLU . . . . . . . . . . . . . 97.3 mt-10 -134.12 134.92 42.78 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-O 120.98 0.419 . . . . 0.0 111.141 -178.219 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' C' C ' 78' ' ' ALA . . . . . . . . . . . . . . . -120.19 135.44 54.98 Favored 'General case' 0 C--N 1.331 -0.219 0 CA-C-N 115.825 -0.625 . . . . 0.0 109.953 177.166 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' C' C ' 79' ' ' LYS . . . . . . . . . . . . . 28.9 mtpp -84.0 117.1 23.17 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-O 120.81 0.338 . . . . 0.0 110.79 -177.91 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' C' C ' 80' ' ' ILE . . . . . . . . . . . . . 41.6 mm -139.15 112.15 6.2 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.28 0 N-CA-C 109.355 -0.609 . . . . 0.0 109.355 -177.877 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' C' C ' 81' ' ' LYS . . . . . . . . . . . . . 49.6 pttt -98.72 125.96 44.19 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-O 120.969 0.414 . . . . 0.0 111.402 -177.922 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' C' C ' 82' ' ' GLY . . . . . . . . . . . . . . . 89.05 42.18 5.69 Favored Glycine 0 CA--C 1.526 0.73 0 C-N-CA 121.003 -0.618 . . . . 0.0 112.013 174.25 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' C' C ' 83' ' ' ILE . . . . . . . . . . . . . 72.7 mt -71.23 135.57 27.71 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.281 0 N-CA-C 109.326 -0.62 . . . . 0.0 109.326 176.038 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' C' C ' 84' ' ' LYS . . . . . . . . . . . . . 28.4 ttpp -102.68 -51.27 3.35 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-O 120.913 0.387 . . . . 0.0 110.597 -177.289 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' C' C ' 85' ' ' ASP . . . . . . . . . . . . . 8.5 t0 -143.69 144.07 31.7 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.008 -0.542 . . . . 0.0 110.545 -178.651 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' C' C ' 86' ' ' VAL . . . . . . . . . . . . . 42.9 t -125.91 131.19 72.1 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 CA-C-O 120.897 0.38 . . . . 0.0 110.24 179.742 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' C' C ' 87' ' ' ILE . . . . . . . . . . . . . 5.1 mp -119.23 125.39 74.41 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.261 0 N-CA-C 109.573 -0.528 . . . . 0.0 109.573 176.808 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' C' C ' 88' ' ' LEU . . . . . . . . . . . . . 11.6 tp -115.91 131.35 56.96 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-O 120.992 0.425 . . . . 0.0 110.992 -177.159 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' C' C ' 89' ' ' ASP . . . . . . . . . . . . . 9.5 t70 -128.19 158.86 36.93 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-N 115.906 -0.588 . . . . 0.0 109.495 176.625 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' C' C ' 90' ' ' GLU . . . . . . . . . . . . . 83.7 tt0 -46.92 -38.81 11.12 Favored 'General case' 0 CA--C 1.531 0.217 0 N-CA-C 113.029 0.752 . . . . 0.0 113.029 -171.905 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' C' C ' 91' ' ' ASN . . . . . . . . . . . . . 30.5 t30 -132.09 26.36 4.56 Favored 'General case' 0 N--CA 1.467 0.416 0 N-CA-C 112.552 0.575 . . . . 0.0 112.552 -177.553 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' C' C ' 92' ' ' LEU . . . . . . . . . . . . . 9.2 mt -149.32 142.38 24.91 Favored 'General case' 0 C--N 1.331 -0.238 0 N-CA-C 109.98 -0.378 . . . . 0.0 109.98 -177.843 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' C' C ' 93' ' ' ILE . . . . . . . . . . . . . 75.3 mt -127.43 117.71 47.66 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.283 0 N-CA-C 109.38 -0.6 . . . . 0.0 109.38 177.256 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' C' C ' 94' ' ' VAL . . . . . . . . . . . . . 44.1 t -122.9 127.55 74.84 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.225 0 CA-C-O 120.959 0.409 . . . . 0.0 110.066 -179.229 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' C' C ' 95' ' ' VAL . . . . . . . . . . . . . 44.8 t -120.34 132.62 69.47 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.355 0 CA-C-N 115.886 -0.597 . . . . 0.0 109.688 -179.982 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' C' C ' 96' ' ' ILE . . . . . . . . . . . . . 66.3 mt -115.58 128.5 72.79 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.243 0 N-CA-C 109.218 -0.66 . . . . 0.0 109.218 178.789 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' C' C ' 97' ' ' THR . . . . . . . . . . . . . 67.6 p -101.53 160.46 14.42 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-O 121.144 0.497 . . . . 0.0 111.131 -176.949 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' C' C ' 98' ' ' GLU . . . . . . . . . . . . . 96.8 mt-10 -54.01 -26.6 27.14 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.117 -0.492 . . . . 0.0 112.284 -179.318 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' C' C ' 99' ' ' GLU . . . . . . . . . . . . . 71.0 mm-40 -79.18 15.65 1.13 Allowed 'General case' 0 CA--C 1.534 0.342 0 N-CA-C 113.183 0.808 . . . . 0.0 113.183 -177.549 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' C' C ' 100' ' ' ASN . . . . . . . . . . . . . 3.2 m-20 61.6 38.08 15.7 Favored 'General case' 0 N--CA 1.463 0.191 0 CA-C-O 121.14 0.495 . . . . 0.0 110.978 178.476 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' C' C ' 101' ' ' GLU . . . . . . . . . . . . . 84.6 tt0 -114.44 141.14 48.05 Favored 'General case' 0 C--N 1.332 -0.169 0 CA-C-N 116.108 -0.496 . . . . 0.0 109.762 176.306 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' C' C ' 102' ' ' VAL . . . . . . . . . . . . . 43.0 t -115.13 125.79 72.52 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.324 0 CA-C-N 116.17 -0.468 . . . . 0.0 109.894 -178.234 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' C' C ' 103' ' ' LEU . . . . . . . . . . . . . 34.9 mt -115.41 129.0 56.44 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 115.732 -0.667 . . . . 0.0 109.9 175.821 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' C' C ' 104' ' ' ILE . . . . . . . . . . . . . 65.1 mt -117.19 120.56 65.37 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.193 0 N-CA-C 110.261 -0.274 . . . . 0.0 110.261 -178.273 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' C' C ' 105' ' ' PHE . . . . . . . . . . . . . 56.9 m-85 -122.12 166.27 14.82 Favored 'General case' 0 C--N 1.333 -0.119 0 O-C-N 124.009 0.818 . . . . 0.0 109.722 178.931 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' C' C ' 106' ' ' ASN . . . . . . . . . . . . . 46.3 p-10 -101.07 -171.15 1.95 Allowed 'General case' 0 C--N 1.331 -0.203 0 N-CA-C 110.062 -0.347 . . . . 0.0 110.062 173.714 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' C' C ' 107' ' ' GLN . . . . . . . . . . . . . 46.2 tt0 -60.34 -26.97 66.98 Favored 'General case' 0 CA--C 1.533 0.31 0 N-CA-C 112.142 0.423 . . . . 0.0 112.142 179.494 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' C' C ' 108' ' ' ASN . . . . . . . . . . . . . 53.3 t30 -84.2 6.96 20.62 Favored 'General case' 0 CA--C 1.537 0.459 0 N-CA-C 113.159 0.8 . . . . 0.0 113.159 -178.343 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' C' C ' 109' ' ' LEU . . . . . . . . . . . . . 11.9 tp 61.64 36.86 16.42 Favored 'General case' 0 C--O 1.232 0.177 0 CA-C-O 120.932 0.396 . . . . 0.0 111.405 179.013 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' C' C ' 110' ' ' GLU . . . . . . . . . . . . . 95.7 mt-10 -108.01 153.46 23.06 Favored 'General case' 0 C--N 1.33 -0.262 0 N-CA-C 109.6 -0.519 . . . . 0.0 109.6 175.059 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' C' C ' 111' ' ' GLU . . . . . . . . . . . . . 55.8 tt0 -90.73 124.14 34.87 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-O 121.017 0.437 . . . . 0.0 111.146 -174.694 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' C' C ' 112' ' ' LEU . . . . . . . . . . . . . 25.6 mt -106.84 -46.07 4.04 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 115.87 -0.604 . . . . 0.0 110.914 179.787 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' C' C ' 113' ' ' TYR . . . . . . . . . . . . . 49.0 t80 -137.63 141.44 41.21 Favored 'General case' 0 C--N 1.331 -0.209 0 CA-C-N 116.319 -0.401 . . . . 0.0 110.802 -177.367 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' C' C ' 114' ' ' ARG . . . . . . . . . . . . . 36.7 ptt-85 -145.39 125.03 13.25 Favored 'General case' 0 C--N 1.331 -0.235 0 C-N-CA 120.94 -0.304 . . . . 0.0 110.825 178.002 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' C' C ' 115' ' ' GLY . . . . . . . . . . . . . . . -150.19 160.78 28.69 Favored Glycine 0 CA--C 1.525 0.666 0 C-N-CA 120.699 -0.762 . . . . 0.0 111.408 179.791 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' C' C ' 116' ' ' LYS . . . . . . . . . . . . . 36.7 ttpt -125.75 130.15 50.91 Favored 'General case' 0 C--N 1.331 -0.219 0 N-CA-C 109.412 -0.588 . . . . 0.0 109.412 174.344 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' C' C ' 117' ' ' PHE . . . . . . . . . . . . . 49.9 m-85 -130.56 114.64 15.72 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-O 120.958 0.409 . . . . 0.0 110.598 -174.215 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' C' C ' 118' ' ' GLU . . . . . . . . . . . . . 46.2 tp10 -52.88 -51.28 61.72 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.301 -0.409 . . . . 0.0 111.622 -176.086 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' C' C ' 119' ' ' ASN . . . . . . . . . . . . . 28.9 m120 -95.41 31.01 2.07 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.259 -0.428 . . . . 0.0 112.075 -174.103 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' C' C ' 120' ' ' LEU . . . . . . . . . . . . . 19.3 tp -54.94 122.54 11.09 Favored 'General case' 0 C--O 1.232 0.157 0 CA-C-O 120.729 0.299 . . . . 0.0 110.813 179.228 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' C' C ' 121' ' ' ASN . . . . . . . . . . . . . 17.3 m120 -103.26 -44.07 5.28 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.399 -0.364 . . . . 0.0 110.681 -177.316 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' C' C ' 122' ' ' LYS . . . . . . . . . . . . . 24.2 pttm -166.96 155.11 9.71 Favored 'General case' 0 C--N 1.331 -0.219 0 C-N-CA 120.572 -0.451 . . . . 0.0 111.843 -179.732 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' C' C ' 123' ' ' VAL . . . . . . . . . . . . . 43.0 t -123.33 135.26 63.82 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.284 0 CA-C-N 116.021 -0.536 . . . . 0.0 109.626 176.82 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' C' C ' 124' ' ' LEU . . . . . . . . . . . . . 31.5 mt -128.19 142.19 51.25 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-O 120.954 0.407 . . . . 0.0 110.977 -177.604 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' C' C ' 125' ' ' VAL . . . . . . . . . . . . . 35.9 m -133.48 141.18 45.07 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.293 0 CA-C-N 115.994 -0.548 . . . . 0.0 110.55 178.16 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' C' C ' 126' ' ' ARG . . . . . . . . . . . . . 19.6 ttm180 -162.86 127.61 3.1 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.122 -0.49 . . . . 0.0 109.72 178.196 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' C' C ' 127' ' ' ASN . . . . . . . . . . . . . 36.0 m120 56.4 -150.78 0.43 Allowed 'General case' 0 CA--C 1.541 0.627 0 N-CA-C 109.519 -0.548 . . . . 0.0 109.519 -176.494 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' C' C ' 128' ' ' ASP . . . . . . . . . . . . . 12.7 p-10 -82.35 16.32 2.1 Favored 'General case' 0 CA--C 1.535 0.393 0 CA-C-N 118.875 0.761 . . . . 0.0 112.762 178.725 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' C' C ' 129' ' ' LEU . . . . . . . . . . . . . 17.9 tp -107.22 133.31 51.98 Favored 'General case' 0 C--O 1.232 0.141 0 CA-C-N 118.084 0.402 . . . . 0.0 110.51 179.845 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' C' C ' 130' ' ' VAL . . . . . . . . . . . . . 45.2 t -121.71 133.25 68.72 Favored 'Isoleucine or valine' 0 C--N 1.333 -0.144 0 N-CA-C 109.374 -0.602 . . . . 0.0 109.374 177.787 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' C' C ' 131' ' ' VAL . . . . . . . . . . . . . 43.9 t -135.28 136.61 51.09 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.208 0 CA-C-O 121.084 0.468 . . . . 0.0 110.919 -177.904 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' C' C ' 132' ' ' ILE . . . . . . . . . . . . . 69.8 mt -116.69 128.91 73.94 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.292 0 CA-C-N 115.658 -0.701 . . . . 0.0 109.231 178.302 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' C' C ' 133' ' ' ILE . . . . . . . . . . . . . 42.1 mm -114.49 123.58 70.3 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.213 0 CA-C-O 120.741 0.305 . . . . 0.0 110.947 -175.239 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' C' C ' 134' ' ' ASP . . . . . . . . . . . . . 8.9 p-10 -135.31 146.65 48.68 Favored 'General case' 0 C--N 1.331 -0.2 0 N-CA-C 109.553 -0.536 . . . . 0.0 109.553 173.396 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' C' C ' 135' ' ' GLU . . . . . . . . . . . . . 85.4 tt0 -50.09 -26.17 4.18 Favored 'General case' 0 C--N 1.327 -0.405 0 N-CA-C 112.878 0.695 . . . . 0.0 112.878 -172.696 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' C' C ' 136' ' ' GLN . . . . . . . . . . . . . 96.1 mt-30 -85.18 -30.63 23.77 Favored 'General case' 0 C--O 1.234 0.278 0 N-CA-C 112.581 0.585 . . . . 0.0 112.581 -175.384 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' C' C ' 137' ' ' LYS . . . . . . . . . . . . . 19.8 pttp -168.19 170.14 10.41 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-O 121.513 0.673 . . . . 0.0 112.242 -173.29 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' C' C ' 138' ' ' LEU . . . . . . . . . . . . . 7.4 tt -118.89 128.16 54.17 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 115.126 -0.943 . . . . 0.0 109.933 -179.9 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' C' C ' 139' ' ' THR . . . . . . . . . . . . . 39.1 m -109.03 126.11 52.78 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-N 116.246 -0.434 . . . . 0.0 110.09 178.63 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' C' C ' 140' ' ' LEU . . . . . . . . . . . . . 9.0 tp -112.77 123.4 50.22 Favored 'General case' 0 C--N 1.329 -0.303 0 N-CA-C 109.292 -0.633 . . . . 0.0 109.292 -178.588 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' C' C ' 141' ' ' ILE . . . . . . . . . . . . . 19.0 mt -121.9 125.53 73.33 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.29 0 CA-C-O 121.085 0.469 . . . . 0.0 110.303 -173.887 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' C' C ' 142' ' ' ARG . . . . . . . . . . . . . 23.2 mmm180 -109.44 129.33 55.55 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 115.459 -0.791 . . . . 0.0 109.93 179.13 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' C' C ' 143' ' ' THR . . . . . . . . . . . . . 26.9 p . . . . . 0 C--O 1.22 -0.493 0 CA-C-O 117.997 -1.002 . . . . 0.0 110.628 -179.465 . . . . . . . . 0 0 . 1 . 012 nuclear orig full ' D' D ' -3' ' ' GLU . . . . . . . . . . . . . 95.7 mt-10 . . . . . 0 N--CA 1.489 1.514 0 N-CA-C 109.362 -0.607 . . . . 0.0 109.362 . . . . . . . . . 0 0 . 1 . 012 nuclear orig full ' D' D ' -2' ' ' GLY . . . . . . . . . . . . . . . -82.71 144.77 23.29 Favored Glycine 0 CA--C 1.525 0.678 0 N-CA-C 111.041 -0.823 . . . . 0.0 111.041 179.872 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' D' D ' -1' ' ' VAL . . . . . . . . . . . . . 47.3 t -142.1 143.61 26.32 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.249 0 N-CA-C 110.039 -0.356 . . . . 0.0 110.039 179.731 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' D' D ' 0' ' ' ILE . . . . . . . . . . . . . 69.6 mt -99.83 130.61 48.67 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.258 0 N-CA-C 109.869 -0.419 . . . . 0.0 109.869 179.569 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' D' D ' 1' ' ' MET . . . . . . . . . . . . . 25.4 ptt? -80.32 136.52 36.43 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.319 -0.401 . . . . 0.0 110.659 -179.197 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' D' D ' 2' ' ' SER . . . . . . . . . . . . . 4.4 p -106.01 128.78 54.06 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-O 121.009 0.433 . . . . 0.0 110.374 178.704 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' D' D ' 3' ' ' GLU . . . . . . . . . . . . . 85.0 tt0 -141.12 139.65 34.0 Favored 'General case' 0 C--N 1.326 -0.424 0 CA-C-N 115.873 -0.603 . . . . 0.0 111.147 -177.957 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' D' D ' 4' ' ' LEU . . . . . . . . . . . . . 18.0 tp -123.68 125.61 45.09 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 115.936 -0.575 . . . . 0.0 110.084 176.956 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' D' D ' 5' ' ' LYS . . . . . . . . . . . . . 67.1 mttm -104.22 119.91 40.0 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.218 -0.446 . . . . 0.0 110.401 178.768 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' D' D ' 6' ' ' LEU . . . . . . . . . . . . . 59.1 mt -116.32 147.31 41.69 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 115.393 -0.821 . . . . 0.0 110.324 -178.241 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' D' D ' 7' ' ' LYS . . . . . . . . . . . . . 83.7 tttt -134.67 136.23 25.03 Favored Pre-proline 0 CA--C 1.535 0.372 0 CA-C-O 118.931 -0.557 . . . . 0.0 109.844 176.254 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' D' D ' 8' ' ' PRO . . . . . . . . . . . . . 90.2 Cg_endo -91.6 140.59 2.52 Favored 'Trans proline' 0 N--CA 1.488 1.195 0 C-N-CA 121.751 1.634 . . . . 0.0 111.506 177.323 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' D' D ' 9' ' ' LEU . . . . . . . . . . . . . 62.3 mt -75.55 -47.9 4.07 Favored Pre-proline 0 CA--C 1.534 0.355 0 CA-C-O 118.586 -0.721 . . . . 0.0 112.336 -178.525 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' D' D ' 10' ' ' PRO . . . . . . . . . . . . . 88.1 Cg_endo -80.01 154.92 22.81 Favored 'Trans proline' 0 N--CA 1.497 1.689 0 C-N-CA 121.224 1.282 . . . . 0.0 112.187 177.166 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' D' D ' 11' ' ' LYS . . . . . . . . . . . . . 55.0 tptt -85.97 100.0 11.83 Favored 'General case' 0 C--N 1.328 -0.329 0 N-CA-C 109.914 -0.402 . . . . 0.0 109.914 176.767 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' D' D ' 12' ' ' VAL . . . . . . . . . . . . . 12.2 p -141.17 146.14 24.04 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.346 0 CA-C-O 120.956 0.408 . . . . 0.0 110.819 -178.386 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' D' D ' 13' ' ' GLU . . . . . . . . . . . . . 95.6 mt-10 -93.57 114.86 27.31 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 115.99 -0.55 . . . . 0.0 109.76 176.324 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' D' D ' 14' ' ' LEU . . . . . . . . . . . . . 38.8 mt -87.75 151.96 50.8 Favored Pre-proline 0 C--N 1.329 -0.304 0 CA-C-N 116.442 -0.344 . . . . 0.0 110.718 -177.164 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' D' D ' 15' ' ' PRO . . . . . . . . . . . . . 33.7 Cg_exo -57.34 158.66 18.07 Favored 'Trans proline' 0 N--CA 1.496 1.62 0 C-N-CA 121.26 1.306 . . . . 0.0 111.809 179.511 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' D' D ' 16' ' ' PRO . . . . . . . . . . . . . 30.7 Cg_exo -59.31 -36.64 94.15 Favored 'Trans proline' 0 N--CA 1.497 1.701 0 C-N-CA 121.432 1.421 . . . . 0.0 112.845 -177.776 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' D' D ' 17' ' ' ASP . . . . . . . . . . . . . 22.0 p-10 -89.96 11.29 20.94 Favored 'General case' 0 CA--C 1.537 0.46 0 N-CA-C 113.139 0.792 . . . . 0.0 113.139 -177.939 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' D' D ' 18' ' ' PHE . . . . . . . . . . . . . 47.7 t80 -58.0 -42.97 86.34 Favored 'General case' 0 N--CA 1.457 -0.108 0 O-C-N 121.983 -0.448 . . . . 0.0 110.16 -178.451 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' D' D ' 19' ' ' VAL . . . . . . . . . . . . . 48.1 t -57.51 -42.48 81.06 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.326 0 CA-C-N 116.244 -0.435 . . . . 0.0 110.376 -179.067 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' D' D ' 20' ' ' ASP . . . . . . . . . . . . . 11.7 t70 -59.62 -42.8 93.48 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-O 120.756 0.313 . . . . 0.0 110.857 -177.802 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' D' D ' 21' ' ' VAL . . . . . . . . . . . . . 46.5 t -64.42 -47.6 88.74 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.303 0 C-N-CA 120.74 -0.384 . . . . 0.0 110.507 -177.999 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' D' D ' 22' ' ' ILE . . . . . . . . . . . . . 49.9 mm -58.53 -38.46 70.72 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.283 0 C-N-CA 120.904 -0.319 . . . . 0.0 110.734 -179.644 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' D' D ' 23' ' ' ARG . . . . . . . . . . . . . 55.1 ttp180 -56.62 -49.23 75.56 Favored 'General case' 0 C--N 1.331 -0.22 0 CA-C-O 120.837 0.351 . . . . 0.0 110.533 178.066 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' D' D ' 24' ' ' ILE . . . . . . . . . . . . . 74.5 mt -61.26 -43.45 96.53 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.272 0 CA-C-N 116.04 -0.527 . . . . 0.0 111.968 -177.883 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' D' D ' 25' ' ' LYS . . . . . . . . . . . . . 15.1 pttp -71.65 -36.59 70.75 Favored 'General case' 0 CA--C 1.533 0.315 0 C-N-CA 120.364 -0.534 . . . . 0.0 111.702 -173.621 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' D' D ' 26' ' ' LEU . . . . . . . . . . . . . 18.9 mt -78.16 -43.38 28.86 Favored 'General case' 0 C--N 1.332 -0.177 0 N-CA-C 112.735 0.643 . . . . 0.0 112.735 -173.558 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' D' D ' 27' ' ' GLN . . . . . . . . . . . . . 11.1 pt20 -47.58 137.86 8.62 Favored 'General case' 0 N--CA 1.468 0.472 0 N-CA-C 112.647 0.61 . . . . 0.0 112.647 -175.946 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' D' D ' 28' ' ' GLY . . . . . . . . . . . . . . . 100.17 -27.38 20.6 Favored Glycine 0 CA--C 1.534 1.231 0 CA-C-N 115.631 -0.713 . . . . 0.0 112.013 -176.35 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' D' D ' 29' ' ' LYS . . . . . . . . . . . . . 56.1 mttm -98.52 155.16 17.41 Favored 'General case' 0 C--O 1.233 0.215 0 CA-C-N 117.144 0.472 . . . . 0.0 110.979 179.267 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' D' D ' 30' ' ' THR . . . . . . . . . . . . . 39.5 m -106.38 139.46 40.83 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 116.13 -0.486 . . . . 0.0 110.03 175.668 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' D' D ' 31' ' ' VAL . . . . . . . . . . . . . 34.5 m -128.66 158.67 40.97 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.289 0 CA-C-N 116.305 -0.407 . . . . 0.0 110.847 -178.304 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' D' D ' 32' ' ' ARG . . . . . . . . . . . . . 59.7 mtm180 -135.5 149.48 49.52 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.048 -0.523 . . . . 0.0 110.587 178.415 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' D' D ' 33' ' ' THR . . . . . . . . . . . . . 25.6 m -53.67 139.88 30.94 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.346 -0.388 . . . . 0.0 111.323 -178.186 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' D' D ' 34' ' ' GLY . . . . . . . . . . . . . . . 100.47 -17.13 57.18 Favored Glycine 0 CA--C 1.533 1.185 0 CA-C-O 119.702 -0.499 . . . . 0.0 113.304 178.672 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' D' D ' 35' ' ' ASP . . . . . . . . . . . . . 79.9 m-20 -66.2 147.88 52.66 Favored 'General case' 0 C--O 1.232 0.143 0 CA-C-N 118.053 0.926 . . . . 0.0 111.14 178.931 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' D' D ' 36' ' ' VAL . . . . . . . . . . . . . 45.1 t -123.42 131.13 73.68 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.224 0 CA-C-N 116.007 -0.542 . . . . 0.0 109.908 178.111 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' D' D ' 37' ' ' ILE . . . . . . . . . . . . . 66.4 mt -122.36 139.69 48.52 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.268 0 CA-C-N 116.28 -0.418 . . . . 0.0 110.042 -178.454 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' D' D ' 38' ' ' GLY . . . . . . . . . . . . . . . -111.81 128.77 8.76 Favored Glycine 0 CA--C 1.526 0.759 0 N-CA-C 111.08 -0.808 . . . . 0.0 111.08 179.472 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' D' D ' 39' ' ' ILE . . . . . . . . . . . . . 71.2 mt -122.54 134.18 66.5 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.187 0 N-CA-C 110.077 -0.342 . . . . 0.0 110.077 179.071 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' D' D ' 40' ' ' SER . . . . . . . . . . . . . 35.0 t -93.58 124.32 37.49 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.412 -0.358 . . . . 0.0 111.009 176.6 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' D' D ' 41' ' ' ILE . . . . . . . . . . . . . 71.3 mt -129.22 118.41 46.13 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.171 0 CA-C-O 120.826 0.346 . . . . 0.0 110.371 177.954 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' D' D ' 42' ' ' LEU . . . . . . . . . . . . . 56.2 mt 51.94 35.96 17.2 Favored 'General case' 0 C--O 1.233 0.201 0 CA-C-N 116.182 -0.463 . . . . 0.0 111.882 176.107 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' D' D ' 43' ' ' GLY . . . . . . . . . . . . . . . 73.98 31.65 59.65 Favored Glycine 0 CA--C 1.53 0.988 0 C-N-CA 121.115 -0.564 . . . . 0.0 112.123 178.162 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' D' D ' 44' ' ' LYS . . . . . . . . . . . . . 53.4 tttm -137.21 128.28 27.66 Favored 'General case' 0 C--N 1.329 -0.316 0 N-CA-C 109.536 -0.542 . . . . 0.0 109.536 177.94 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' D' D ' 45' ' ' GLU . . . . . . . . . . . . . 84.4 tt0 -83.83 123.14 29.6 Favored 'General case' 0 C--N 1.329 -0.318 0 C-N-CA 120.748 -0.381 . . . . 0.0 111.244 -177.766 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' D' D ' 46' ' ' VAL . . . . . . . . . . . . . 7.5 p -121.06 127.2 75.88 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.226 0 N-CA-C 109.342 -0.614 . . . . 0.0 109.342 175.497 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' D' D ' 47' ' ' LYS . . . . . . . . . . . . . 97.9 mttt -100.83 130.28 46.82 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.121 -0.491 . . . . 0.0 111.486 179.702 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' D' D ' 48' ' ' PHE . . . . . . . . . . . . . 93.6 m-85 -114.13 131.84 56.28 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.11 -0.495 . . . . 0.0 109.72 176.1 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' D' D ' 49' ' ' LYS . . . . . . . . . . . . . 71.5 tttt -108.66 138.66 44.62 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.628 -0.26 . . . . 0.0 110.494 179.148 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' D' D ' 50' ' ' VAL . . . . . . . . . . . . . 45.4 t -81.55 109.87 16.27 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.259 0 N-CA-C 109.443 -0.577 . . . . 0.0 109.443 177.047 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' D' D ' 51' ' ' VAL . . . . . . . . . . . . . 47.6 t -73.92 -47.63 42.11 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.304 0 CA-C-N 116.131 -0.486 . . . . 0.0 110.11 -174.322 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' D' D ' 52' ' ' GLN . . . . . . . . . . . . . 49.5 tt0 -162.65 139.09 7.54 Favored 'General case' 0 C--N 1.331 -0.219 0 C-N-CA 120.21 -0.596 . . . . 0.0 111.731 -178.126 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' D' D ' 53' ' ' ALA . . . . . . . . . . . . . . . -110.09 130.77 55.48 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 115.573 -0.739 . . . . 0.0 109.49 173.764 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' D' D ' 54' ' ' TYR . . . . . . . . . . . . . 24.9 t80 -126.76 108.09 22.67 Favored Pre-proline 0 CA--C 1.534 0.353 0 CA-C-O 118.379 -0.819 . . . . 0.0 110.553 -177.669 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' D' D ' 55' ' ' PRO . . . . . . . . . . . . . 73.3 Cg_endo -77.17 170.02 72.66 Favored 'Cis proline' 0 N--CA 1.5 1.896 0 CA-C-N 121.747 1.66 . . . . 0.0 112.139 -6.248 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' D' D ' 56' ' ' SER . . . . . . . . . . . . . 20.3 m -110.56 128.35 25.49 Favored Pre-proline 0 CA--C 1.538 0.511 0 CA-C-O 118.435 -0.793 . . . . 0.0 109.674 176.441 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' D' D ' 57' ' ' PRO . . . . . . . . . . . . . 46.6 Cg_endo -70.21 165.44 77.92 Favored 'Cis proline' 0 N--CA 1.496 1.676 0 CA-C-N 121.932 1.726 . . . . 0.0 111.677 -0.455 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' D' D ' 58' ' ' LEU . . . . . . . . . . . . . 25.0 tp -129.92 135.99 48.97 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.441 -0.345 . . . . 0.0 110.538 -179.234 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' D' D ' 59' ' ' ARG . . . . . . . . . . . . . 76.3 ttt180 -105.31 134.37 48.53 Favored 'General case' 0 C--N 1.327 -0.388 0 N-CA-C 109.419 -0.586 . . . . 0.0 109.419 175.725 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' D' D ' 60' ' ' VAL . . . . . . . . . . . . . 43.9 t -88.58 123.07 40.75 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.275 0 C-N-CA 120.644 -0.423 . . . . 0.0 110.359 -177.062 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' D' D ' 61' ' ' GLU . . . . . . . . . . . . . 94.7 mt-10 -131.09 173.42 11.03 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.077 -0.51 . . . . 0.0 109.962 177.242 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' D' D ' 62' ' ' ASP . . . . . . . . . . . . . 75.9 m-20 -54.39 -32.81 57.95 Favored 'General case' 0 C--N 1.327 -0.376 0 C-N-CA 120.964 -0.294 . . . . 0.0 111.635 179.786 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' D' D ' 63' ' ' ARG . . . . . . . . . . . . . 26.4 ptt180 -87.41 5.25 39.74 Favored 'General case' 0 CA--C 1.537 0.476 0 N-CA-C 113.652 0.982 . . . . 0.0 113.652 -176.32 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' D' D ' 64' ' ' THR . . . . . . . . . . . . . 28.5 m -82.3 133.74 35.25 Favored 'General case' 0 C--N 1.331 -0.211 0 CA-C-N 118.027 0.376 . . . . 0.0 110.602 -178.724 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' D' D ' 65' ' ' LYS . . . . . . . . . . . . . 87.1 mttt -89.71 124.62 34.77 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 116.106 -0.497 . . . . 0.0 110.02 178.75 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' D' D ' 66' ' ' ILE . . . . . . . . . . . . . 58.8 mt -113.6 129.4 69.49 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.305 0 N-CA-C 109.68 -0.489 . . . . 0.0 109.68 179.329 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' D' D ' 67' ' ' THR . . . . . . . . . . . . . 24.4 m -127.82 138.55 52.75 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-O 121.063 0.458 . . . . 0.0 111.124 -177.672 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' D' D ' 68' ' ' LEU . . . . . . . . . . . . . 7.0 mp -100.65 124.15 45.84 Favored 'General case' 0 C--N 1.331 -0.206 0 CA-C-N 115.927 -0.579 . . . . 0.0 109.908 176.217 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' D' D ' 69' ' ' VAL . . . . . . . . . . . . . 41.9 t -102.24 137.0 31.75 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.29 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.495 -176.729 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' D' D ' 70' ' ' THR . . . . . . . . . . . . . 7.3 t -150.0 -40.57 0.14 Allowed 'General case' 0 C--N 1.331 -0.205 0 CA-C-N 116.148 -0.478 . . . . 0.0 110.966 178.847 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' D' D ' 71' ' ' HIS . . . . . . . . . . . . . 58.0 m-70 -148.66 86.44 5.82 Favored Pre-proline 0 CA--C 1.534 0.33 0 CA-C-N 116.478 -0.328 . . . . 0.0 110.605 -178.215 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' D' D ' 72' ' ' PRO . . . . . . . . . . . . . 91.1 Cg_endo -84.55 132.46 4.99 Favored 'Trans proline' 0 N--CA 1.495 1.565 0 C-N-CA 121.537 1.491 . . . . 0.0 113.382 -176.544 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' D' D ' 73' ' ' VAL . . . . . . . . . . . . . 26.9 m -138.99 170.8 15.68 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.265 0 CA-C-N 115.76 -0.655 . . . . 0.0 109.815 174.001 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' D' D ' 74' ' ' ASP . . . . . . . . . . . . . 30.3 t0 -104.21 117.22 33.7 Favored 'General case' 0 C--N 1.33 -0.274 0 N-CA-C 109.884 -0.413 . . . . 0.0 109.884 179.466 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' D' D ' 75' ' ' VAL . . . . . . . . . . . . . 46.7 t -119.63 126.15 75.04 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.281 0 CA-C-O 121.066 0.46 . . . . 0.0 110.817 -176.91 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' D' D ' 76' ' ' LEU . . . . . . . . . . . . . 5.5 mp -125.23 143.97 50.69 Favored 'General case' 0 C--N 1.332 -0.178 0 CA-C-N 115.71 -0.677 . . . . 0.0 109.787 175.388 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' D' D ' 77' ' ' GLU . . . . . . . . . . . . . 97.1 mt-10 -133.63 136.42 44.8 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-O 120.986 0.422 . . . . 0.0 111.074 -178.31 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' D' D ' 78' ' ' ALA . . . . . . . . . . . . . . . -124.31 132.85 53.58 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 115.883 -0.598 . . . . 0.0 109.919 176.953 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' D' D ' 79' ' ' LYS . . . . . . . . . . . . . 59.5 mtpt -79.26 117.09 19.94 Favored 'General case' 0 C--N 1.331 -0.225 0 CA-C-N 116.312 -0.404 . . . . 0.0 110.644 -178.027 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' D' D ' 80' ' ' ILE . . . . . . . . . . . . . 43.3 mm -139.16 112.16 6.2 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.322 0 N-CA-C 109.079 -0.711 . . . . 0.0 109.079 -177.426 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' D' D ' 81' ' ' LYS . . . . . . . . . . . . . 55.4 pttt -104.6 129.44 52.71 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-O 120.995 0.426 . . . . 0.0 111.65 -175.909 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' D' D ' 82' ' ' GLY . . . . . . . . . . . . . . . 89.12 42.11 5.68 Favored Glycine 0 CA--C 1.524 0.653 0 CA-C-N 115.835 -0.621 . . . . 0.0 111.701 174.478 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' D' D ' 83' ' ' ILE . . . . . . . . . . . . . 69.2 mt -73.21 136.87 24.55 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.27 0 N-CA-C 109.526 -0.546 . . . . 0.0 109.526 177.207 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' D' D ' 84' ' ' LYS . . . . . . . . . . . . . 39.7 ttpt -102.25 -48.42 4.2 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-O 120.849 0.357 . . . . 0.0 110.517 -178.348 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' D' D ' 85' ' ' ASP . . . . . . . . . . . . . 12.8 t70 -146.8 145.2 29.83 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.7 -179.33 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' D' D ' 86' ' ' VAL . . . . . . . . . . . . . 43.7 t -126.38 129.56 71.9 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.223 0 CA-C-N 116.325 -0.398 . . . . 0.0 110.204 179.855 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' D' D ' 87' ' ' ILE . . . . . . . . . . . . . 5.0 mp -122.27 128.16 75.4 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.227 0 N-CA-C 109.865 -0.42 . . . . 0.0 109.865 177.689 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' D' D ' 88' ' ' LEU . . . . . . . . . . . . . 68.4 mt -112.01 136.18 51.68 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-O 121.011 0.434 . . . . 0.0 111.211 -178.814 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' D' D ' 89' ' ' ASP . . . . . . . . . . . . . 9.1 t70 -130.12 154.28 47.65 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 115.812 -0.631 . . . . 0.0 109.55 175.334 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' D' D ' 90' ' ' GLU . . . . . . . . . . . . . 96.2 mt-10 -48.92 -37.4 19.76 Favored 'General case' 0 C--N 1.329 -0.325 0 N-CA-C 112.773 0.657 . . . . 0.0 112.773 -172.207 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' D' D ' 91' ' ' ASN . . . . . . . . . . . . . 86.5 m-20 -132.03 33.39 3.92 Favored 'General case' 0 N--CA 1.465 0.297 0 N-CA-C 111.914 0.338 . . . . 0.0 111.914 -176.966 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' D' D ' 92' ' ' LEU . . . . . . . . . . . . . 7.4 tp -166.06 142.37 5.04 Favored 'General case' 0 C--N 1.332 -0.17 0 C-N-CA 120.952 -0.299 . . . . 0.0 110.635 -179.344 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' D' D ' 93' ' ' ILE . . . . . . . . . . . . . 73.8 mt -124.05 124.81 69.72 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.261 0 N-CA-C 109.479 -0.563 . . . . 0.0 109.479 178.605 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' D' D ' 94' ' ' VAL . . . . . . . . . . . . . 43.8 t -123.34 125.89 72.45 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.188 0 CA-C-O 120.972 0.415 . . . . 0.0 109.96 -179.798 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' D' D ' 95' ' ' VAL . . . . . . . . . . . . . 44.6 t -120.78 131.46 72.8 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.261 0 CA-C-N 115.964 -0.562 . . . . 0.0 109.643 179.31 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' D' D ' 96' ' ' ILE . . . . . . . . . . . . . 63.2 mt -115.72 128.04 73.11 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.256 0 N-CA-C 109.446 -0.575 . . . . 0.0 109.446 -179.282 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' D' D ' 97' ' ' THR . . . . . . . . . . . . . 70.7 p -100.9 159.15 15.44 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-O 121.152 0.501 . . . . 0.0 111.111 -177.307 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' D' D ' 98' ' ' GLU . . . . . . . . . . . . . 46.5 tp10 -53.9 -26.53 25.55 Favored 'General case' 0 C--N 1.327 -0.392 0 CA-C-N 116.079 -0.509 . . . . 0.0 112.098 179.751 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' D' D ' 99' ' ' GLU . . . . . . . . . . . . . 19.9 tp10 -79.72 16.76 1.04 Allowed 'General case' 0 CA--C 1.539 0.524 0 N-CA-C 112.777 0.658 . . . . 0.0 112.777 -175.998 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' D' D ' 100' ' ' ASN . . . . . . . . . . . . . 3.7 m-20 60.88 30.87 19.91 Favored 'General case' 0 CA--C 1.532 0.285 0 O-C-N 121.958 -0.464 . . . . 0.0 111.682 178.424 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' D' D ' 101' ' ' GLU . . . . . . . . . . . . . 84.7 tt0 -112.53 144.21 42.39 Favored 'General case' 0 C--N 1.332 -0.157 0 N-CA-C 109.548 -0.538 . . . . 0.0 109.548 175.045 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' D' D ' 102' ' ' VAL . . . . . . . . . . . . . 44.3 t -118.71 130.12 73.99 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.252 0 CA-C-O 120.954 0.407 . . . . 0.0 110.16 -176.587 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' D' D ' 103' ' ' LEU . . . . . . . . . . . . . 21.2 mt -113.01 129.65 56.42 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 115.435 -0.802 . . . . 0.0 109.989 176.359 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' D' D ' 104' ' ' ILE . . . . . . . . . . . . . 66.3 mt -115.46 120.14 63.85 Favored 'Isoleucine or valine' 0 C--O 1.234 0.248 0 N-CA-C 110.169 -0.308 . . . . 0.0 110.169 -179.604 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' D' D ' 105' ' ' PHE . . . . . . . . . . . . . 73.5 m-85 -123.83 167.08 14.55 Favored 'General case' 0 C--N 1.333 -0.117 0 O-C-N 123.876 0.735 . . . . 0.0 109.976 -179.736 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' D' D ' 106' ' ' ASN . . . . . . . . . . . . . 48.8 p-10 -102.97 -170.81 1.85 Allowed 'General case' 0 C--N 1.33 -0.256 0 N-CA-C 109.903 -0.406 . . . . 0.0 109.903 172.762 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' D' D ' 107' ' ' GLN . . . . . . . . . . . . . 42.9 tt0 -61.23 -29.25 69.72 Favored 'General case' 0 N--CA 1.464 0.249 0 N-CA-C 111.902 0.334 . . . . 0.0 111.902 -179.893 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' D' D ' 108' ' ' ASN . . . . . . . . . . . . . 4.2 t-20 -81.9 11.7 4.77 Favored 'General case' 0 CA--C 1.538 0.511 0 N-CA-C 112.771 0.656 . . . . 0.0 112.771 -179.498 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' D' D ' 109' ' ' LEU . . . . . . . . . . . . . 10.9 tp 54.58 36.72 26.56 Favored 'General case' 0 C--O 1.233 0.202 0 CA-C-O 120.982 0.42 . . . . 0.0 111.4 178.554 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' D' D ' 110' ' ' GLU . . . . . . . . . . . . . 95.3 mt-10 -103.02 143.22 32.86 Favored 'General case' 0 C--N 1.328 -0.328 0 N-CA-C 109.369 -0.604 . . . . 0.0 109.369 175.091 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' D' D ' 111' ' ' GLU . . . . . . . . . . . . . 73.7 tt0 -82.67 121.87 27.41 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-O 121.017 0.437 . . . . 0.0 110.296 -176.479 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' D' D ' 112' ' ' LEU . . . . . . . . . . . . . 45.9 mt -107.0 -45.96 4.03 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-N 115.86 -0.609 . . . . 0.0 110.65 -179.137 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' D' D ' 113' ' ' TYR . . . . . . . . . . . . . 55.3 t80 -135.23 138.53 43.65 Favored 'General case' 0 C--N 1.332 -0.188 0 CA-C-O 120.845 0.355 . . . . 0.0 111.278 -178.567 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' D' D ' 114' ' ' ARG . . . . . . . . . . . . . 70.1 ttt180 -136.13 123.81 22.41 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 115.914 -0.584 . . . . 0.0 110.077 177.67 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' D' D ' 115' ' ' GLY . . . . . . . . . . . . . . . -149.96 157.46 27.23 Favored Glycine 0 CA--C 1.523 0.591 0 N-CA-C 111.136 -0.786 . . . . 0.0 111.136 -179.91 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' D' D ' 116' ' ' LYS . . . . . . . . . . . . . 67.3 tttt -131.77 129.79 41.02 Favored 'General case' 0 C--N 1.328 -0.352 0 N-CA-C 109.734 -0.469 . . . . 0.0 109.734 178.846 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' D' D ' 117' ' ' PHE . . . . . . . . . . . . . 49.0 m-85 -125.17 114.23 18.72 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.289 -0.414 . . . . 0.0 110.184 -174.837 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' D' D ' 118' ' ' GLU . . . . . . . . . . . . . 48.7 mp0 -56.9 -46.14 82.12 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.344 -0.389 . . . . 0.0 110.851 -175.297 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' D' D ' 119' ' ' ASN . . . . . . . . . . . . . 23.9 m120 -97.36 31.1 2.6 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.099 -0.5 . . . . 0.0 112.109 -174.678 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' D' D ' 120' ' ' LEU . . . . . . . . . . . . . 7.2 tt -54.91 120.1 6.37 Favored 'General case' 0 N--CA 1.462 0.148 0 CA-C-O 120.817 0.341 . . . . 0.0 110.598 178.337 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' D' D ' 121' ' ' ASN . . . . . . . . . . . . . 43.3 m-20 -105.11 -44.03 4.88 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 116.303 -0.408 . . . . 0.0 110.874 -176.731 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' D' D ' 122' ' ' LYS . . . . . . . . . . . . . 55.8 pttt -162.41 153.89 18.14 Favored 'General case' 0 C--N 1.331 -0.204 0 C-N-CA 120.427 -0.509 . . . . 0.0 112.028 -179.118 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' D' D ' 123' ' ' VAL . . . . . . . . . . . . . 42.0 t -125.81 136.49 60.67 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.248 0 CA-C-N 115.806 -0.633 . . . . 0.0 109.948 179.663 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' D' D ' 124' ' ' LEU . . . . . . . . . . . . . 48.4 mt -125.72 131.13 52.61 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.278 -0.419 . . . . 0.0 110.133 178.782 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' D' D ' 125' ' ' VAL . . . . . . . . . . . . . 13.5 p -134.88 134.06 53.7 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.259 0 CA-C-O 121.113 0.482 . . . . 0.0 110.809 179.616 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' D' D ' 126' ' ' ARG . . . . . . . . . . . . . 79.0 mtp180 -147.6 122.69 10.13 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 115.513 -0.767 . . . . 0.0 109.301 177.969 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' D' D ' 127' ' ' ASN . . . . . . . . . . . . . 1.5 t-20 57.03 -148.65 0.49 Allowed 'General case' 0 CA--C 1.542 0.643 0 N-CA-C 109.579 -0.526 . . . . 0.0 109.579 -178.371 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' D' D ' 128' ' ' ASP . . . . . . . . . . . . . 19.7 p-10 -81.44 12.99 3.23 Favored 'General case' 0 CA--C 1.538 0.488 0 N-CA-C 113.044 0.757 . . . . 0.0 113.044 178.507 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' D' D ' 129' ' ' LEU . . . . . . . . . . . . . 32.9 mt -107.41 133.0 52.57 Favored 'General case' 0 C--O 1.231 0.128 0 N-CA-C 109.542 -0.54 . . . . 0.0 109.542 178.545 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' D' D ' 130' ' ' VAL . . . . . . . . . . . . . 14.7 p -138.32 139.69 41.31 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.204 0 CA-C-O 121.273 0.559 . . . . 0.0 111.314 -179.758 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' D' D ' 131' ' ' VAL . . . . . . . . . . . . . 46.4 t -136.08 140.16 44.43 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.237 0 CA-C-N 115.784 -0.644 . . . . 0.0 110.271 179.446 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' D' D ' 132' ' ' ILE . . . . . . . . . . . . . 72.4 mt -116.78 133.99 61.73 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.263 0 CA-C-N 115.966 -0.561 . . . . 0.0 109.754 -179.717 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' D' D ' 133' ' ' ILE . . . . . . . . . . . . . 42.8 mm -114.25 123.64 70.11 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.222 0 CA-C-N 116.603 -0.271 . . . . 0.0 110.926 -176.434 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' D' D ' 134' ' ' ASP . . . . . . . . . . . . . 7.0 p-10 -135.21 147.95 49.49 Favored 'General case' 0 C--N 1.332 -0.16 0 N-CA-C 109.637 -0.505 . . . . 0.0 109.637 174.459 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' D' D ' 135' ' ' GLU . . . . . . . . . . . . . 84.9 tt0 -50.06 -28.2 6.74 Favored 'General case' 0 C--N 1.328 -0.355 0 N-CA-C 112.923 0.712 . . . . 0.0 112.923 -171.287 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' D' D ' 136' ' ' GLN . . . . . . . . . . . . . 97.2 mt-30 -83.26 -35.11 25.59 Favored 'General case' 0 C--O 1.234 0.253 0 N-CA-C 112.538 0.569 . . . . 0.0 112.538 -175.829 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' D' D ' 137' ' ' LYS . . . . . . . . . . . . . 24.8 pttm -163.36 172.07 15.14 Favored 'General case' 0 C--N 1.331 -0.217 0 CA-C-O 121.525 0.678 . . . . 0.0 112.413 -171.455 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' D' D ' 138' ' ' LEU . . . . . . . . . . . . . 5.9 tt -117.36 127.6 54.21 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 114.938 -1.028 . . . . 0.0 109.748 178.512 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' D' D ' 139' ' ' THR . . . . . . . . . . . . . 36.9 m -107.64 125.76 51.74 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.207 -0.451 . . . . 0.0 110.187 -179.414 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' D' D ' 140' ' ' LEU . . . . . . . . . . . . . 6.1 tt -113.06 119.34 37.52 Favored 'General case' 0 C--N 1.327 -0.392 0 CA-C-N 115.824 -0.626 . . . . 0.0 109.651 -176.951 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' D' D ' 141' ' ' ILE . . . . . . . . . . . . . 22.2 mt -123.05 125.48 72.21 Favored 'Isoleucine or valine' 0 C--O 1.234 0.244 0 CA-C-O 121.033 0.444 . . . . 0.0 110.396 -175.03 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' D' D ' 142' ' ' ARG . . . . . . . . . . . . . 61.4 mmt-85 -121.96 129.33 52.41 Favored 'General case' 0 C--N 1.331 -0.203 0 CA-C-N 115.548 -0.751 . . . . 0.0 110.466 -178.62 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' D' D ' 143' ' ' THR . . . . . . . . . . . . . 41.1 p . . . . . 0 C--O 1.219 -0.55 0 CA-C-O 118.046 -0.978 . . . . 0.0 110.6 -179.874 . . . . . . . . 0 0 . 1 . 012 nuclear orig full ' E' E ' -3' ' ' GLU . . . . . . . . . . . . . 12.8 pt-20 . . . . . 0 N--CA 1.49 1.574 0 N-CA-C 109.947 -0.39 . . . . 0.0 109.947 . . . . . . . . . 0 0 . 1 . 012 nuclear orig full ' E' E ' -2' ' ' GLY . . . . . . . . . . . . . . . -82.59 127.53 8.01 Favored Glycine 0 CA--C 1.523 0.563 0 N-CA-C 110.856 -0.898 . . . . 0.0 110.856 178.787 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' E' E ' -1' ' ' VAL . . . . . . . . . . . . . 43.0 t -96.79 133.41 38.33 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.329 0 CA-C-O 120.818 0.342 . . . . 0.0 110.08 -179.942 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' E' E ' 0' ' ' ILE . . . . . . . . . . . . . 42.9 mm -111.35 132.41 59.97 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.204 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.087 -179.811 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' E' E ' 1' ' ' MET . . . . . . . . . . . . . 25.5 ptp -91.39 155.19 18.66 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.322 -0.399 . . . . 0.0 110.684 -179.637 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' E' E ' 2' ' ' SER . . . . . . . . . . . . . 2.4 p -122.48 128.95 51.49 Favored 'General case' 0 C--N 1.332 -0.178 0 CA-C-N 116.168 -0.469 . . . . 0.0 110.395 178.87 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' E' E ' 3' ' ' GLU . . . . . . . . . . . . . 84.8 tt0 -142.6 142.84 32.2 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.083 -0.508 . . . . 0.0 111.045 179.238 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' E' E ' 4' ' ' LEU . . . . . . . . . . . . . 21.4 tp -122.01 128.19 51.14 Favored 'General case' 0 C--N 1.331 -0.21 0 CA-C-N 115.875 -0.602 . . . . 0.0 110.183 177.918 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' E' E ' 5' ' ' LYS . . . . . . . . . . . . . 89.2 mttt -105.43 121.11 43.24 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.3 -0.409 . . . . 0.0 110.485 178.298 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' E' E ' 6' ' ' LEU . . . . . . . . . . . . . 29.6 mt -116.79 150.29 38.56 Favored 'General case' 0 C--N 1.332 -0.187 0 CA-C-N 115.289 -0.869 . . . . 0.0 110.735 -178.097 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' E' E ' 7' ' ' LYS . . . . . . . . . . . . . 23.7 ttmt -138.35 135.32 18.16 Favored Pre-proline 0 CA--C 1.535 0.392 0 CA-C-O 118.846 -0.597 . . . . 0.0 109.933 174.984 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' E' E ' 8' ' ' PRO . . . . . . . . . . . . . 93.1 Cg_endo -90.72 143.11 3.45 Favored 'Trans proline' 0 N--CA 1.492 1.43 0 C-N-CA 121.602 1.535 . . . . 0.0 111.837 178.394 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' E' E ' 9' ' ' LEU . . . . . . . . . . . . . 35.3 mt -78.14 -47.67 2.09 Favored Pre-proline 0 CA--C 1.533 0.307 0 CA-C-O 118.759 -0.638 . . . . 0.0 112.099 -179.179 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' E' E ' 10' ' ' PRO . . . . . . . . . . . . . 76.8 Cg_endo -82.31 145.38 13.48 Favored 'Trans proline' 0 N--CA 1.495 1.593 0 C-N-CA 121.235 1.29 . . . . 0.0 111.681 175.689 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' E' E ' 11' ' ' LYS . . . . . . . . . . . . . 53.3 pttt -85.27 114.72 22.57 Favored 'General case' 0 C--N 1.331 -0.214 0 CA-C-O 121.453 0.644 . . . . 0.0 110.326 177.426 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' E' E ' 12' ' ' VAL . . . . . . . . . . . . . 12.1 p -151.11 150.93 12.92 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.299 0 CA-C-N 115.732 -0.667 . . . . 0.0 110.83 -177.538 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' E' E ' 13' ' ' GLU . . . . . . . . . . . . . 14.6 mm-40 -86.93 122.38 30.72 Favored 'General case' 0 C--N 1.331 -0.239 0 N-CA-C 110.019 -0.363 . . . . 0.0 110.019 175.901 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' E' E ' 14' ' ' LEU . . . . . . . . . . . . . 46.3 mt -98.7 149.54 35.84 Favored Pre-proline 0 CA--C 1.533 0.308 0 CA-C-O 119.318 -0.372 . . . . 0.0 110.632 -178.533 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' E' E ' 15' ' ' PRO . . . . . . . . . . . . . 24.6 Cg_exo -62.94 161.7 28.46 Favored 'Trans proline' 0 N--CA 1.499 1.818 0 C-N-CA 121.297 1.331 . . . . 0.0 111.876 176.81 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' E' E ' 16' ' ' PRO . . . . . . . . . . . . . 25.8 Cg_exo -61.28 -37.46 73.09 Favored 'Trans proline' 0 N--CA 1.499 1.807 0 C-N-CA 121.546 1.498 . . . . 0.0 112.967 -177.719 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' E' E ' 17' ' ' ASP . . . . . . . . . . . . . 13.0 p-10 -89.34 8.2 31.81 Favored 'General case' 0 CA--C 1.536 0.406 0 N-CA-C 113.351 0.871 . . . . 0.0 113.351 -176.786 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' E' E ' 18' ' ' PHE . . . . . . . . . . . . . 42.7 t80 -58.18 -42.78 86.82 Favored 'General case' 0 C--N 1.334 -0.086 0 O-C-N 121.925 -0.485 . . . . 0.0 110.099 -178.267 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' E' E ' 19' ' ' VAL . . . . . . . . . . . . . 54.9 t -57.12 -43.09 80.8 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.352 0 CA-C-N 116.225 -0.443 . . . . 0.0 110.306 -179.678 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' E' E ' 20' ' ' ASP . . . . . . . . . . . . . 75.2 m-20 -59.83 -41.74 91.99 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-O 120.782 0.325 . . . . 0.0 110.928 -177.846 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' E' E ' 21' ' ' VAL . . . . . . . . . . . . . 44.7 t -63.81 -46.36 94.61 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 C-N-CA 120.79 -0.364 . . . . 0.0 110.328 -177.76 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' E' E ' 22' ' ' ILE . . . . . . . . . . . . . 49.7 mm -55.95 -47.0 80.6 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.275 0 C-N-CA 120.971 -0.292 . . . . 0.0 110.827 178.932 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' E' E ' 23' ' ' ARG . . . . . . . . . . . . . 55.5 ttp180 -54.8 -48.73 72.38 Favored 'General case' 0 C--N 1.33 -0.275 0 C-N-CA 120.982 -0.287 . . . . 0.0 111.461 -178.323 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' E' E ' 24' ' ' ILE . . . . . . . . . . . . . 81.2 mt -59.0 -44.68 91.72 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.332 0 C-N-CA 121.102 -0.239 . . . . 0.0 111.179 -177.035 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' E' E ' 25' ' ' LYS . . . . . . . . . . . . . 57.3 mttm -64.5 -40.07 94.97 Favored 'General case' 0 C--N 1.327 -0.406 0 N-CA-C 112.356 0.502 . . . . 0.0 112.356 -178.48 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' E' E ' 26' ' ' LEU . . . . . . . . . . . . . 47.2 mt -79.27 -40.65 29.98 Favored 'General case' 0 C--N 1.33 -0.271 0 N-CA-C 113.573 0.953 . . . . 0.0 113.573 -171.367 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' E' E ' 27' ' ' GLN . . . . . . . . . . . . . 10.3 pt20 -46.7 137.04 7.33 Favored 'General case' 0 N--CA 1.47 0.544 0 N-CA-C 112.75 0.648 . . . . 0.0 112.75 -174.591 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' E' E ' 28' ' ' GLY . . . . . . . . . . . . . . . 100.52 -25.86 26.73 Favored Glycine 0 CA--C 1.534 1.222 0 CA-C-N 115.531 -0.759 . . . . 0.0 112.252 -176.082 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' E' E ' 29' ' ' LYS . . . . . . . . . . . . . 62.2 mttp -97.94 155.22 17.19 Favored 'General case' 0 C--N 1.332 -0.175 0 CA-C-N 117.265 0.532 . . . . 0.0 111.148 179.073 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' E' E ' 30' ' ' THR . . . . . . . . . . . . . 34.4 m -105.2 140.79 37.82 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 115.78 -0.645 . . . . 0.0 110.075 176.184 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' E' E ' 31' ' ' VAL . . . . . . . . . . . . . 35.0 m -126.44 151.16 32.67 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.234 0 CA-C-O 121.004 0.43 . . . . 0.0 111.229 -177.791 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' E' E ' 32' ' ' ARG . . . . . . . . . . . . . 67.0 mtp85 -128.12 151.04 49.69 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 115.68 -0.691 . . . . 0.0 110.846 177.362 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' E' E ' 33' ' ' THR . . . . . . . . . . . . . 15.2 m -54.29 139.34 36.67 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 115.987 -0.552 . . . . 0.0 111.186 -178.817 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' E' E ' 34' ' ' GLY . . . . . . . . . . . . . . . 98.77 -17.16 58.68 Favored Glycine 0 CA--C 1.533 1.162 0 C-N-CA 121.019 -0.61 . . . . 0.0 113.306 178.27 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' E' E ' 35' ' ' ASP . . . . . . . . . . . . . 73.3 m-20 -63.88 149.86 46.16 Favored 'General case' 0 C--O 1.231 0.09 0 CA-C-N 118.081 0.941 . . . . 0.0 111.016 179.685 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' E' E ' 36' ' ' VAL . . . . . . . . . . . . . 44.6 t -124.08 130.16 73.89 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.217 0 CA-C-N 116.05 -0.523 . . . . 0.0 109.923 178.971 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' E' E ' 37' ' ' ILE . . . . . . . . . . . . . 62.6 mt -122.03 140.41 46.04 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.244 0 CA-C-N 116.378 -0.374 . . . . 0.0 110.069 -179.465 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' E' E ' 38' ' ' GLY . . . . . . . . . . . . . . . -114.06 128.84 8.44 Favored Glycine 0 CA--C 1.524 0.638 0 N-CA-C 111.086 -0.806 . . . . 0.0 111.086 178.766 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' E' E ' 39' ' ' ILE . . . . . . . . . . . . . 71.7 mt -122.59 135.87 61.25 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.217 0 N-CA-C 110.075 -0.343 . . . . 0.0 110.075 178.935 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' E' E ' 40' ' ' SER . . . . . . . . . . . . . 53.0 p -93.4 117.37 29.99 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.519 -0.31 . . . . 0.0 111.202 176.015 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' E' E ' 41' ' ' ILE . . . . . . . . . . . . . 44.4 mm -121.71 121.61 64.83 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.181 0 CA-C-N 116.469 -0.332 . . . . 0.0 110.118 178.176 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' E' E ' 42' ' ' LEU . . . . . . . . . . . . . 83.8 mt 52.53 33.66 13.87 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.43 -0.35 . . . . 0.0 111.853 177.41 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' E' E ' 43' ' ' GLY . . . . . . . . . . . . . . . 73.22 32.09 60.68 Favored Glycine 0 CA--C 1.529 0.915 0 C-N-CA 121.049 -0.596 . . . . 0.0 112.125 178.797 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' E' E ' 44' ' ' LYS . . . . . . . . . . . . . 80.2 tttt -138.72 130.37 27.61 Favored 'General case' 0 C--N 1.33 -0.257 0 N-CA-C 109.482 -0.562 . . . . 0.0 109.482 179.064 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' E' E ' 45' ' ' GLU . . . . . . . . . . . . . 82.0 tt0 -83.1 124.83 30.85 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-O 120.799 0.333 . . . . 0.0 111.248 -176.144 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' E' E ' 46' ' ' VAL . . . . . . . . . . . . . 7.3 p -122.09 128.11 75.48 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.175 0 N-CA-C 109.493 -0.558 . . . . 0.0 109.493 174.909 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' E' E ' 47' ' ' LYS . . . . . . . . . . . . . 94.6 mttt -100.27 129.56 46.29 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.035 -0.53 . . . . 0.0 111.38 179.099 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' E' E ' 48' ' ' PHE . . . . . . . . . . . . . 95.3 m-85 -113.27 132.01 55.7 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.088 -0.505 . . . . 0.0 109.826 175.383 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' E' E ' 49' ' ' LYS . . . . . . . . . . . . . 80.6 tttt -105.51 137.74 42.84 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.41 -0.359 . . . . 0.0 110.21 179.278 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' E' E ' 50' ' ' VAL . . . . . . . . . . . . . 42.1 t -78.06 107.3 9.8 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.332 0 N-CA-C 109.533 -0.543 . . . . 0.0 109.533 177.427 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' E' E ' 51' ' ' VAL . . . . . . . . . . . . . 52.1 t -71.54 -48.76 50.96 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.288 0 CA-C-N 116.082 -0.508 . . . . 0.0 109.882 -174.557 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' E' E ' 52' ' ' GLN . . . . . . . . . . . . . 62.5 tt0 -167.46 138.68 3.05 Favored 'General case' 0 C--N 1.331 -0.211 0 C-N-CA 120.323 -0.551 . . . . 0.0 111.682 -179.271 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' E' E ' 53' ' ' ALA . . . . . . . . . . . . . . . -107.19 130.82 54.67 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 115.669 -0.696 . . . . 0.0 109.642 175.098 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' E' E ' 54' ' ' TYR . . . . . . . . . . . . . 30.1 t80 -127.65 106.9 20.76 Favored Pre-proline 0 CA--C 1.534 0.348 0 CA-C-O 118.39 -0.814 . . . . 0.0 110.598 -177.975 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' E' E ' 55' ' ' PRO . . . . . . . . . . . . . 73.1 Cg_endo -77.19 170.07 72.49 Favored 'Cis proline' 0 N--CA 1.5 1.867 0 CA-C-N 121.725 1.652 . . . . 0.0 112.323 -5.726 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' E' E ' 56' ' ' SER . . . . . . . . . . . . . 16.3 m -111.39 129.99 23.52 Favored Pre-proline 0 CA--C 1.538 0.502 0 CA-C-O 118.414 -0.803 . . . . 0.0 109.48 175.272 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' E' E ' 57' ' ' PRO . . . . . . . . . . . . . 56.9 Cg_endo -72.36 147.7 89.56 Favored 'Cis proline' 0 N--CA 1.497 1.702 0 CA-C-N 121.956 1.734 . . . . 0.0 111.792 -0.918 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' E' E ' 58' ' ' LEU . . . . . . . . . . . . . 18.1 tp -108.08 136.6 47.49 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.32 -0.4 . . . . 0.0 110.534 -179.203 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' E' E ' 59' ' ' ARG . . . . . . . . . . . . . 32.2 ttm180 -106.1 130.02 54.08 Favored 'General case' 0 C--N 1.328 -0.329 0 N-CA-C 109.565 -0.532 . . . . 0.0 109.565 176.35 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' E' E ' 60' ' ' VAL . . . . . . . . . . . . . 40.4 t -86.71 123.0 39.47 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.219 0 C-N-CA 120.544 -0.463 . . . . 0.0 110.487 -176.904 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' E' E ' 61' ' ' GLU . . . . . . . . . . . . . 95.0 mt-10 -131.01 170.79 14.01 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 115.895 -0.593 . . . . 0.0 109.909 177.727 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' E' E ' 62' ' ' ASP . . . . . . . . . . . . . 60.3 m-20 -55.0 -33.63 62.73 Favored 'General case' 0 C--N 1.328 -0.361 0 N-CA-C 111.827 0.306 . . . . 0.0 111.827 -177.627 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' E' E ' 63' ' ' ARG . . . . . . . . . . . . . 40.0 ptt180 -89.55 5.28 46.25 Favored 'General case' 0 CA--C 1.536 0.438 0 N-CA-C 113.818 1.044 . . . . 0.0 113.818 -175.496 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' E' E ' 64' ' ' THR . . . . . . . . . . . . . 31.4 m -76.27 139.85 41.3 Favored 'General case' 0 C--N 1.332 -0.184 0 CA-C-O 120.851 0.358 . . . . 0.0 110.859 -177.874 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' E' E ' 65' ' ' LYS . . . . . . . . . . . . . 99.6 mttt -88.32 129.4 35.4 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.05 -0.523 . . . . 0.0 110.192 178.601 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' E' E ' 66' ' ' ILE . . . . . . . . . . . . . 57.7 mt -114.04 127.34 71.49 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.312 0 N-CA-C 109.728 -0.471 . . . . 0.0 109.728 -179.705 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' E' E ' 67' ' ' THR . . . . . . . . . . . . . 26.9 m -128.26 139.11 52.61 Favored 'General case' 0 C--N 1.331 -0.221 0 CA-C-O 121.063 0.459 . . . . 0.0 111.001 -177.426 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' E' E ' 68' ' ' LEU . . . . . . . . . . . . . 7.7 mp -106.0 136.71 45.18 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 115.922 -0.581 . . . . 0.0 110.28 176.778 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' E' E ' 69' ' ' VAL . . . . . . . . . . . . . 39.2 t -90.41 131.76 36.79 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.371 0 N-CA-C 109.932 -0.396 . . . . 0.0 109.932 178.731 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' E' E ' 70' ' ' THR . . . . . . . . . . . . . 80.4 p -105.98 178.06 4.67 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.163 -0.471 . . . . 0.0 110.532 -179.01 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' E' E ' 71' ' ' HIS . . . . . . . . . . . . . 34.9 t60 -64.99 130.9 95.05 Favored Pre-proline 0 CA--C 1.535 0.396 0 CA-C-O 118.827 -0.606 . . . . 0.0 109.978 -178.53 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' E' E ' 72' ' ' PRO . . . . . . . . . . . . . 96.3 Cg_endo -91.04 159.03 3.91 Favored 'Trans proline' 0 N--CA 1.49 1.284 0 C-N-CA 121.69 1.593 . . . . 0.0 112.26 -179.434 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' E' E ' 73' ' ' VAL . . . . . . . . . . . . . 32.8 m -70.02 168.6 1.58 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.318 0 CA-C-N 116.136 -0.484 . . . . 0.0 110.421 178.862 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' E' E ' 74' ' ' ASP . . . . . . . . . . . . . 46.8 t0 -92.29 118.82 31.28 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.161 -0.472 . . . . 0.0 109.925 -179.615 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' E' E ' 75' ' ' VAL . . . . . . . . . . . . . 38.9 t -119.35 121.22 65.94 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.208 0 CA-C-O 120.988 0.423 . . . . 0.0 110.373 -179.756 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' E' E ' 76' ' ' LEU . . . . . . . . . . . . . 5.1 mp -122.26 146.41 47.31 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 115.851 -0.613 . . . . 0.0 109.752 176.527 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' E' E ' 77' ' ' GLU . . . . . . . . . . . . . 97.9 mt-10 -135.8 133.39 37.83 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-O 121.021 0.439 . . . . 0.0 111.125 -179.208 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' E' E ' 78' ' ' ALA . . . . . . . . . . . . . . . -121.81 133.28 54.9 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 115.729 -0.669 . . . . 0.0 109.727 176.364 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' E' E ' 79' ' ' LYS . . . . . . . . . . . . . 49.1 tptt -80.01 118.04 21.39 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-O 120.899 0.38 . . . . 0.0 110.477 -177.3 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' E' E ' 80' ' ' ILE . . . . . . . . . . . . . 41.2 mm -139.17 109.25 4.18 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.288 0 N-CA-C 109.235 -0.654 . . . . 0.0 109.235 -177.369 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' E' E ' 81' ' ' LYS . . . . . . . . . . . . . 57.5 pttt -102.23 127.31 49.24 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-O 120.938 0.399 . . . . 0.0 111.493 -177.283 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' E' E ' 82' ' ' GLY . . . . . . . . . . . . . . . 89.09 42.09 5.7 Favored Glycine 0 CA--C 1.526 0.735 0 C-N-CA 120.637 -0.792 . . . . 0.0 111.78 173.852 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' E' E ' 83' ' ' ILE . . . . . . . . . . . . . 74.0 mt -68.28 138.61 22.19 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.28 0 N-CA-C 109.932 -0.396 . . . . 0.0 109.932 178.203 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' E' E ' 84' ' ' LYS . . . . . . . . . . . . . 23.5 ttmt -95.92 -53.58 3.63 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.09 -0.505 . . . . 0.0 110.306 -179.721 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' E' E ' 85' ' ' ASP . . . . . . . . . . . . . 12.4 t70 -154.49 157.67 38.73 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 115.724 -0.671 . . . . 0.0 110.33 -178.401 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' E' E ' 86' ' ' VAL . . . . . . . . . . . . . 42.0 t -137.02 136.13 47.63 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.307 0 CA-C-O 120.939 0.4 . . . . 0.0 110.67 -178.172 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' E' E ' 87' ' ' ILE . . . . . . . . . . . . . 5.1 mp -119.78 127.58 75.88 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 CA-C-N 115.774 -0.648 . . . . 0.0 109.42 176.608 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' E' E ' 88' ' ' LEU . . . . . . . . . . . . . 18.8 tp -115.69 136.41 53.09 Favored 'General case' 0 C--N 1.332 -0.192 0 CA-C-O 121.02 0.438 . . . . 0.0 111.406 -177.0 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' E' E ' 89' ' ' ASP . . . . . . . . . . . . . 42.0 t0 -134.87 160.75 37.26 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 115.777 -0.647 . . . . 0.0 109.729 176.532 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' E' E ' 90' ' ' GLU . . . . . . . . . . . . . 96.3 mt-10 -47.65 -37.6 13.15 Favored 'General case' 0 N--CA 1.463 0.179 0 N-CA-C 113.064 0.764 . . . . 0.0 113.064 -171.82 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' E' E ' 91' ' ' ASN . . . . . . . . . . . . . 5.2 p30 -132.06 23.89 4.56 Favored 'General case' 0 N--CA 1.469 0.483 0 N-CA-C 112.79 0.663 . . . . 0.0 112.79 -176.833 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' E' E ' 92' ' ' LEU . . . . . . . . . . . . . 44.5 mt -148.39 141.2 24.66 Favored 'General case' 0 C--N 1.331 -0.225 0 CA-C-O 120.823 0.344 . . . . 0.0 110.589 -178.556 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' E' E ' 93' ' ' ILE . . . . . . . . . . . . . 72.1 mt -123.7 114.27 40.79 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.362 0 N-CA-C 109.098 -0.705 . . . . 0.0 109.098 176.288 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' E' E ' 94' ' ' VAL . . . . . . . . . . . . . 43.7 t -116.55 127.02 74.28 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.236 0 N-CA-C 109.823 -0.436 . . . . 0.0 109.823 -178.741 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' E' E ' 95' ' ' VAL . . . . . . . . . . . . . 43.9 t -123.21 135.02 64.55 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 CA-C-N 116.217 -0.447 . . . . 0.0 109.934 -179.059 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' E' E ' 96' ' ' ILE . . . . . . . . . . . . . 65.2 mt -115.31 127.4 72.9 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.351 0 N-CA-C 109.391 -0.596 . . . . 0.0 109.391 178.506 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' E' E ' 97' ' ' THR . . . . . . . . . . . . . 66.7 p -101.8 157.29 16.95 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-O 121.05 0.452 . . . . 0.0 111.077 -177.852 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' E' E ' 98' ' ' GLU . . . . . . . . . . . . . 12.8 pt-20 -55.63 -21.7 19.1 Favored 'General case' 0 CA--C 1.533 0.314 0 N-CA-C 112.669 0.618 . . . . 0.0 112.669 -179.42 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' E' E ' 99' ' ' GLU . . . . . . . . . . . . . 48.4 mp0 -78.74 14.29 1.38 Allowed 'General case' 0 CA--C 1.537 0.463 0 N-CA-C 113.04 0.755 . . . . 0.0 113.04 -179.68 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' E' E ' 100' ' ' ASN . . . . . . . . . . . . . 3.0 m-20 62.76 37.88 12.2 Favored 'General case' 0 C--O 1.233 0.201 0 CA-C-O 121.068 0.461 . . . . 0.0 110.949 178.24 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' E' E ' 101' ' ' GLU . . . . . . . . . . . . . 84.9 tt0 -118.99 141.69 48.45 Favored 'General case' 0 C--N 1.332 -0.164 0 CA-C-N 116.014 -0.539 . . . . 0.0 109.895 177.223 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' E' E ' 102' ' ' VAL . . . . . . . . . . . . . 46.5 t -114.93 127.47 72.46 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.293 0 CA-C-N 116.324 -0.398 . . . . 0.0 110.041 -178.68 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' E' E ' 103' ' ' LEU . . . . . . . . . . . . . 25.7 mt -117.08 132.54 56.66 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 115.561 -0.745 . . . . 0.0 110.503 177.82 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' E' E ' 104' ' ' ILE . . . . . . . . . . . . . 65.9 mt -119.53 122.16 68.17 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.237 0 N-CA-C 110.22 -0.289 . . . . 0.0 110.22 178.782 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' E' E ' 105' ' ' PHE . . . . . . . . . . . . . 47.2 m-85 -122.26 162.3 21.71 Favored 'General case' 0 C--N 1.333 -0.146 0 O-C-N 124.005 0.815 . . . . 0.0 109.981 177.748 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' E' E ' 106' ' ' ASN . . . . . . . . . . . . . 41.4 p-10 -97.03 -169.93 1.95 Allowed 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.606 -0.27 . . . . 0.0 110.499 175.554 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' E' E ' 107' ' ' GLN . . . . . . . . . . . . . 46.4 tt0 -56.15 -30.2 61.83 Favored 'General case' 0 CA--C 1.531 0.247 0 N-CA-C 112.05 0.389 . . . . 0.0 112.05 -179.516 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' E' E ' 108' ' ' ASN . . . . . . . . . . . . . 30.6 t30 -90.79 12.9 17.82 Favored 'General case' 0 CA--C 1.535 0.373 0 N-CA-C 113.41 0.893 . . . . 0.0 113.41 -175.356 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' E' E ' 109' ' ' LEU . . . . . . . . . . . . . 11.3 tp 58.8 38.92 24.61 Favored 'General case' 0 C--N 1.331 -0.212 0 CA-C-O 121.168 0.508 . . . . 0.0 111.103 178.552 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' E' E ' 110' ' ' GLU . . . . . . . . . . . . . 96.0 mt-10 -102.64 151.93 21.78 Favored 'General case' 0 C--N 1.329 -0.292 0 N-CA-C 109.788 -0.449 . . . . 0.0 109.788 175.419 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' E' E ' 111' ' ' GLU . . . . . . . . . . . . . 85.1 tt0 -81.68 121.98 27.05 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-O 120.922 0.391 . . . . 0.0 110.507 -178.872 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' E' E ' 112' ' ' LEU . . . . . . . . . . . . . 17.5 mt -110.04 -45.98 3.53 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 115.962 -0.563 . . . . 0.0 110.518 179.185 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' E' E ' 113' ' ' TYR . . . . . . . . . . . . . 58.7 t80 -140.72 136.87 33.02 Favored 'General case' 0 C--N 1.331 -0.227 0 C-N-CA 120.771 -0.372 . . . . 0.0 111.398 -179.06 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' E' E ' 114' ' ' ARG . . . . . . . . . . . . . 22.0 ttm180 -135.69 124.77 24.36 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 115.958 -0.564 . . . . 0.0 109.721 174.979 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' E' E ' 115' ' ' GLY . . . . . . . . . . . . . . . -149.38 148.79 20.48 Favored Glycine 0 CA--C 1.525 0.701 0 N-CA-C 111.12 -0.792 . . . . 0.0 111.12 178.758 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' E' E ' 116' ' ' LYS . . . . . . . . . . . . . 40.3 ttpt -119.86 136.85 54.33 Favored 'General case' 0 C--N 1.33 -0.266 0 N-CA-C 110.096 -0.335 . . . . 0.0 110.096 179.172 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' E' E ' 117' ' ' PHE . . . . . . . . . . . . . 46.1 m-85 -134.49 116.11 14.72 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-N 116.302 -0.408 . . . . 0.0 110.229 -177.148 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' E' E ' 118' ' ' GLU . . . . . . . . . . . . . 84.8 tt0 -53.64 -45.07 70.07 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 116.597 -0.274 . . . . 0.0 111.515 -177.252 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' E' E ' 119' ' ' ASN . . . . . . . . . . . . . 4.2 m-80 -99.27 31.12 3.2 Favored 'General case' 0 C--N 1.33 -0.263 0 N-CA-C 112.156 0.428 . . . . 0.0 112.156 -175.225 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' E' E ' 120' ' ' LEU . . . . . . . . . . . . . 15.0 tp -55.22 120.69 7.42 Favored 'General case' 0 C--N 1.333 -0.151 0 O-C-N 122.308 -0.245 . . . . 0.0 110.694 178.465 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' E' E ' 121' ' ' ASN . . . . . . . . . . . . . 72.1 m-20 -108.82 -44.05 4.1 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.478 -0.328 . . . . 0.0 111.084 -176.728 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' E' E ' 122' ' ' LYS . . . . . . . . . . . . . 57.2 pttt -162.4 160.21 26.14 Favored 'General case' 0 CA--C 1.529 0.143 0 C-N-CA 120.43 -0.508 . . . . 0.0 112.064 -178.59 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' E' E ' 123' ' ' VAL . . . . . . . . . . . . . 42.1 t -129.08 137.87 55.99 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.201 0 CA-C-N 115.947 -0.57 . . . . 0.0 109.86 179.011 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' E' E ' 124' ' ' LEU . . . . . . . . . . . . . 80.9 mt -124.94 140.35 53.0 Favored 'General case' 0 C--N 1.332 -0.189 0 CA-C-O 120.87 0.367 . . . . 0.0 110.794 -179.007 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' E' E ' 125' ' ' VAL . . . . . . . . . . . . . 46.5 t -127.55 133.95 66.66 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.234 0 CA-C-N 116.105 -0.498 . . . . 0.0 109.822 178.118 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' E' E ' 126' ' ' ARG . . . . . . . . . . . . . 49.3 ttt85 -138.57 113.76 9.43 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-O 120.884 0.374 . . . . 0.0 110.28 -179.647 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' E' E ' 127' ' ' ASN . . . . . . . . . . . . . 12.1 m120 53.04 -104.82 0.21 Allowed 'General case' 0 CA--C 1.543 0.68 0 CA-C-O 119.2 -0.429 . . . . 0.0 111.196 179.513 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' E' E ' 128' ' ' ASP . . . . . . . . . . . . . 13.5 p-10 -113.57 0.78 14.76 Favored 'General case' 0 N--CA 1.467 0.422 0 CA-C-N 119.447 1.021 . . . . 0.0 113.549 -176.108 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' E' E ' 129' ' ' LEU . . . . . . . . . . . . . 71.4 mt -108.18 147.36 31.43 Favored 'General case' 0 C--N 1.332 -0.174 0 O-C-N 121.952 -0.467 . . . . 0.0 110.061 179.454 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' E' E ' 130' ' ' VAL . . . . . . . . . . . . . 12.4 p -129.42 140.05 50.15 Favored 'Isoleucine or valine' 0 C--O 1.233 0.22 0 CA-C-O 120.981 0.42 . . . . 0.0 110.595 -178.831 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' E' E ' 131' ' ' VAL . . . . . . . . . . . . . 40.7 t -135.94 139.28 46.25 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.25 0 CA-C-N 115.953 -0.567 . . . . 0.0 110.425 -178.506 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' E' E ' 132' ' ' ILE . . . . . . . . . . . . . 73.2 mt -114.09 133.51 59.88 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 N-CA-C 109.406 -0.59 . . . . 0.0 109.406 178.838 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' E' E ' 133' ' ' ILE . . . . . . . . . . . . . 43.3 mm -115.34 123.3 70.75 Favored 'Isoleucine or valine' 0 C--O 1.234 0.251 0 CA-C-O 120.936 0.398 . . . . 0.0 111.113 -174.36 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' E' E ' 134' ' ' ASP . . . . . . . . . . . . . 9.5 p-10 -136.18 147.41 47.66 Favored 'General case' 0 C--N 1.331 -0.224 0 N-CA-C 109.337 -0.616 . . . . 0.0 109.337 173.666 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' E' E ' 135' ' ' GLU . . . . . . . . . . . . . 43.3 tp10 -51.33 -28.06 11.28 Favored 'General case' 0 C--N 1.327 -0.408 0 N-CA-C 112.641 0.608 . . . . 0.0 112.641 -172.893 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' E' E ' 136' ' ' GLN . . . . . . . . . . . . . 97.6 mt-30 -80.48 -31.62 37.28 Favored 'General case' 0 C--N 1.33 -0.239 0 N-CA-C 112.629 0.603 . . . . 0.0 112.629 -176.63 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' E' E ' 137' ' ' LYS . . . . . . . . . . . . . 17.6 ptpt -170.08 175.26 5.1 Favored 'General case' 0 C--N 1.331 -0.227 0 CA-C-O 121.526 0.679 . . . . 0.0 112.374 -171.669 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' E' E ' 138' ' ' LEU . . . . . . . . . . . . . 7.8 tt -123.16 130.16 52.39 Favored 'General case' 0 C--N 1.331 -0.199 0 CA-C-N 115.145 -0.934 . . . . 0.0 110.23 -179.524 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' E' E ' 139' ' ' THR . . . . . . . . . . . . . 35.1 m -107.26 125.88 51.71 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.245 -0.434 . . . . 0.0 110.442 179.518 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' E' E ' 140' ' ' LEU . . . . . . . . . . . . . 19.0 tp -113.84 121.37 43.81 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 115.788 -0.642 . . . . 0.0 109.555 -177.594 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' E' E ' 141' ' ' ILE . . . . . . . . . . . . . 19.3 mt -122.01 119.9 59.89 Favored 'Isoleucine or valine' 0 C--O 1.235 0.296 0 CA-C-O 120.974 0.416 . . . . 0.0 110.081 -177.229 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' E' E ' 142' ' ' ARG . . . . . . . . . . . . . 78.0 mtp180 -103.9 123.85 47.88 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 115.264 -0.88 . . . . 0.0 110.382 179.644 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' E' E ' 143' ' ' THR . . . . . . . . . . . . . 37.3 p . . . . . 0 C--O 1.22 -0.456 0 CA-C-O 118.028 -0.987 . . . . 0.0 110.648 -179.989 . . . . . . . . 0 0 . 1 . 012 nuclear orig full ' F' F ' -3' ' ' GLU . . . . . . . . . . . . . 69.2 mm-40 . . . . . 0 N--CA 1.49 1.566 0 N-CA-C 109.258 -0.645 . . . . 0.0 109.258 . . . . . . . . . 0 0 . 1 . 012 nuclear orig full ' F' F ' -2' ' ' GLY . . . . . . . . . . . . . . . -69.31 143.8 39.79 Favored Glycine 0 CA--C 1.525 0.676 0 N-CA-C 110.959 -0.856 . . . . 0.0 110.959 179.956 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' F' F ' -1' ' ' VAL . . . . . . . . . . . . . 46.9 t -141.38 138.0 32.92 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.258 0 N-CA-C 109.984 -0.376 . . . . 0.0 109.984 179.85 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' F' F ' 0' ' ' ILE . . . . . . . . . . . . . 72.5 mt -111.48 134.03 55.2 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.195 0 CA-C-N 116.206 -0.452 . . . . 0.0 109.959 179.802 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' F' F ' 1' ' ' MET . . . . . . . . . . . . . 25.6 ptp -94.98 163.97 13.09 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.085 -0.507 . . . . 0.0 111.006 -178.966 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' F' F ' 2' ' ' SER . . . . . . . . . . . . . 11.8 p -111.89 135.46 52.48 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.135 -0.484 . . . . 0.0 110.403 178.676 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' F' F ' 3' ' ' GLU . . . . . . . . . . . . . 95.5 mt-10 -140.81 141.87 34.7 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.117 -0.492 . . . . 0.0 110.982 -177.817 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' F' F ' 4' ' ' LEU . . . . . . . . . . . . . 28.6 tp -128.42 128.62 44.8 Favored 'General case' 0 C--N 1.331 -0.22 0 CA-C-N 115.928 -0.578 . . . . 0.0 110.22 176.869 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' F' F ' 5' ' ' LYS . . . . . . . . . . . . . 99.0 mttt -108.16 121.61 45.21 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-O 120.954 0.407 . . . . 0.0 110.538 178.376 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' F' F ' 6' ' ' LEU . . . . . . . . . . . . . 70.3 mt -116.41 148.49 40.63 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 115.364 -0.835 . . . . 0.0 110.483 -179.122 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' F' F ' 7' ' ' LYS . . . . . . . . . . . . . 78.0 tttt -139.57 139.02 21.11 Favored Pre-proline 0 CA--C 1.533 0.305 0 CA-C-O 119.086 -0.483 . . . . 0.0 109.924 175.894 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' F' F ' 8' ' ' PRO . . . . . . . . . . . . . 93.5 Cg_endo -91.41 145.11 3.3 Favored 'Trans proline' 0 N--CA 1.491 1.34 0 C-N-CA 121.724 1.616 . . . . 0.0 111.944 178.414 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' F' F ' 9' ' ' LEU . . . . . . . . . . . . . 64.4 mt -80.89 -47.67 1.15 Allowed Pre-proline 0 CA--C 1.534 0.331 0 CA-C-O 118.671 -0.68 . . . . 0.0 112.078 179.805 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' F' F ' 10' ' ' PRO . . . . . . . . . . . . . 88.5 Cg_endo -80.81 145.24 15.84 Favored 'Trans proline' 0 N--CA 1.497 1.686 0 C-N-CA 121.104 1.203 . . . . 0.0 111.555 175.995 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' F' F ' 11' ' ' LYS . . . . . . . . . . . . . 39.0 pttt -78.56 111.33 14.51 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-O 121.563 0.697 . . . . 0.0 110.382 177.873 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' F' F ' 12' ' ' VAL . . . . . . . . . . . . . 11.7 p -151.02 144.83 16.76 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.351 0 CA-C-N 115.629 -0.714 . . . . 0.0 110.512 -178.292 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' F' F ' 13' ' ' GLU . . . . . . . . . . . . . 40.1 mt-10 -86.25 124.55 32.75 Favored 'General case' 0 C--N 1.33 -0.26 0 N-CA-C 109.965 -0.383 . . . . 0.0 109.965 177.015 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' F' F ' 14' ' ' LEU . . . . . . . . . . . . . 19.3 mt -96.76 148.05 33.85 Favored Pre-proline 0 C--N 1.33 -0.273 0 CA-C-O 119.184 -0.436 . . . . 0.0 110.072 -179.263 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' F' F ' 15' ' ' PRO . . . . . . . . . . . . . 28.3 Cg_exo -60.54 159.13 28.99 Favored 'Trans proline' 0 N--CA 1.497 1.705 0 C-N-CA 121.28 1.32 . . . . 0.0 111.439 177.318 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' F' F ' 16' ' ' PRO . . . . . . . . . . . . . 38.7 Cg_exo -58.49 -35.95 98.04 Favored 'Trans proline' 0 N--CA 1.496 1.668 0 C-N-CA 121.418 1.412 . . . . 0.0 112.639 -178.617 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' F' F ' 17' ' ' ASP . . . . . . . . . . . . . 7.3 p-10 -91.66 11.55 24.06 Favored 'General case' 0 CA--C 1.535 0.396 0 N-CA-C 113.152 0.797 . . . . 0.0 113.152 -177.637 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' F' F ' 18' ' ' PHE . . . . . . . . . . . . . 52.2 t80 -58.29 -45.47 87.89 Favored 'General case' 0 C--N 1.333 -0.112 0 O-C-N 122.02 -0.425 . . . . 0.0 110.075 -177.67 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' F' F ' 19' ' ' VAL . . . . . . . . . . . . . 13.7 p -55.89 -40.99 65.21 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 CA-C-N 116.114 -0.494 . . . . 0.0 110.904 -179.125 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' F' F ' 20' ' ' ASP . . . . . . . . . . . . . 80.7 m-20 -61.22 -42.84 99.29 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-O 120.818 0.342 . . . . 0.0 110.975 -178.558 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' F' F ' 21' ' ' VAL . . . . . . . . . . . . . 48.1 t -63.84 -46.07 95.32 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.291 0 C-N-CA 120.759 -0.376 . . . . 0.0 110.318 -178.03 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' F' F ' 22' ' ' ILE . . . . . . . . . . . . . 49.2 mm -56.58 -46.02 82.47 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.258 0 C-N-CA 120.948 -0.301 . . . . 0.0 110.622 178.917 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' F' F ' 23' ' ' ARG . . . . . . . . . . . . . 25.8 ttp180 -54.33 -49.43 69.75 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-O 120.594 0.235 . . . . 0.0 111.418 -178.843 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' F' F ' 24' ' ' ILE . . . . . . . . . . . . . 77.1 mt -59.71 -44.07 92.87 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.368 0 CA-C-N 116.629 -0.259 . . . . 0.0 111.291 -177.194 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' F' F ' 25' ' ' LYS . . . . . . . . . . . . . 62.8 mttm -66.18 -38.18 87.41 Favored 'General case' 0 C--N 1.327 -0.371 0 N-CA-C 112.28 0.474 . . . . 0.0 112.28 -178.455 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' F' F ' 26' ' ' LEU . . . . . . . . . . . . . 58.2 mt -79.13 -40.52 30.8 Favored 'General case' 0 C--N 1.33 -0.241 0 N-CA-C 113.349 0.87 . . . . 0.0 113.349 -172.446 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' F' F ' 27' ' ' GLN . . . . . . . . . . . . . 11.2 pt20 -47.1 141.49 4.28 Favored 'General case' 0 N--CA 1.47 0.534 0 N-CA-C 112.726 0.639 . . . . 0.0 112.726 -174.359 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' F' F ' 28' ' ' GLY . . . . . . . . . . . . . . . 96.91 -25.76 25.39 Favored Glycine 0 CA--C 1.534 1.227 0 CA-C-N 115.626 -0.715 . . . . 0.0 112.1 -176.638 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' F' F ' 29' ' ' LYS . . . . . . . . . . . . . 59.1 mtpt -98.33 155.1 17.37 Favored 'General case' 0 C--O 1.233 0.217 0 CA-C-N 117.275 0.538 . . . . 0.0 111.002 179.284 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' F' F ' 30' ' ' THR . . . . . . . . . . . . . 31.4 m -111.45 139.27 47.0 Favored 'General case' 0 C--N 1.331 -0.217 0 CA-C-N 116.093 -0.503 . . . . 0.0 110.217 175.743 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' F' F ' 31' ' ' VAL . . . . . . . . . . . . . 35.2 m -134.37 164.43 34.26 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.225 0 CA-C-O 120.796 0.331 . . . . 0.0 110.981 -179.22 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' F' F ' 32' ' ' ARG . . . . . . . . . . . . . 77.9 mtp180 -131.3 153.97 49.01 Favored 'General case' 0 C--N 1.331 -0.223 0 CA-C-O 121.227 0.537 . . . . 0.0 110.735 177.908 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' F' F ' 33' ' ' THR . . . . . . . . . . . . . 32.3 m -53.78 140.94 28.41 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.221 -0.445 . . . . 0.0 111.222 -179.603 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' F' F ' 34' ' ' GLY . . . . . . . . . . . . . . . 99.9 -17.13 57.72 Favored Glycine 0 CA--C 1.531 1.068 0 C-N-CA 121.211 -0.519 . . . . 0.0 113.26 179.371 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' F' F ' 35' ' ' ASP . . . . . . . . . . . . . 65.6 m-20 -65.23 149.34 50.1 Favored 'General case' 0 C--O 1.231 0.121 0 CA-C-N 118.089 0.945 . . . . 0.0 111.188 179.044 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' F' F ' 36' ' ' VAL . . . . . . . . . . . . . 46.4 t -122.71 130.16 74.69 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.256 0 CA-C-N 115.78 -0.645 . . . . 0.0 109.867 178.909 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' F' F ' 37' ' ' ILE . . . . . . . . . . . . . 69.7 mt -122.07 139.47 48.95 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.234 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.044 -179.524 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' F' F ' 38' ' ' GLY . . . . . . . . . . . . . . . -113.86 129.17 8.64 Favored Glycine 0 CA--C 1.525 0.703 0 N-CA-C 111.115 -0.794 . . . . 0.0 111.115 -179.933 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' F' F ' 39' ' ' ILE . . . . . . . . . . . . . 67.7 mt -120.0 133.73 65.79 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.216 0 N-CA-C 110.084 -0.339 . . . . 0.0 110.084 178.964 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' F' F ' 40' ' ' SER . . . . . . . . . . . . . 53.6 p -93.4 120.04 33.21 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.343 -0.389 . . . . 0.0 110.844 175.399 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' F' F ' 41' ' ' ILE . . . . . . . . . . . . . 68.9 mt -129.81 122.55 54.94 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.179 0 CA-C-O 120.787 0.327 . . . . 0.0 110.462 177.903 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' F' F ' 42' ' ' LEU . . . . . . . . . . . . . 8.9 tp 52.23 35.11 16.0 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-N 116.131 -0.486 . . . . 0.0 111.628 177.308 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' F' F ' 43' ' ' GLY . . . . . . . . . . . . . . . 72.07 32.32 63.32 Favored Glycine 0 CA--C 1.529 0.952 0 C-N-CA 121.05 -0.595 . . . . 0.0 111.907 178.253 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' F' F ' 44' ' ' LYS . . . . . . . . . . . . . 54.4 tttp -137.94 128.79 27.02 Favored 'General case' 0 C--N 1.329 -0.296 0 N-CA-C 109.668 -0.493 . . . . 0.0 109.668 179.259 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' F' F ' 45' ' ' GLU . . . . . . . . . . . . . 84.6 tt0 -84.23 124.68 31.46 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-O 120.878 0.37 . . . . 0.0 111.298 -178.215 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' F' F ' 46' ' ' VAL . . . . . . . . . . . . . 7.1 p -121.0 127.74 75.99 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.209 0 N-CA-C 109.299 -0.63 . . . . 0.0 109.299 174.261 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' F' F ' 47' ' ' LYS . . . . . . . . . . . . . 93.1 mttt -99.98 127.24 46.21 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.062 -0.517 . . . . 0.0 111.006 179.583 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' F' F ' 48' ' ' PHE . . . . . . . . . . . . . 94.0 m-85 -111.07 131.96 54.65 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.305 -0.407 . . . . 0.0 109.951 175.961 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' F' F ' 49' ' ' LYS . . . . . . . . . . . . . 84.0 tttt -107.24 135.5 48.65 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.281 -0.418 . . . . 0.0 110.218 179.457 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' F' F ' 50' ' ' VAL . . . . . . . . . . . . . 46.4 t -79.38 108.02 12.47 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.295 0 N-CA-C 109.22 -0.659 . . . . 0.0 109.22 176.541 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' F' F ' 51' ' ' VAL . . . . . . . . . . . . . 47.8 t -70.9 -48.11 58.54 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.267 0 CA-C-N 115.991 -0.549 . . . . 0.0 109.974 -173.768 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' F' F ' 52' ' ' GLN . . . . . . . . . . . . . 63.2 tt0 -163.67 140.08 6.83 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.05 -0.523 . . . . 0.0 111.553 -178.233 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' F' F ' 53' ' ' ALA . . . . . . . . . . . . . . . -111.9 130.49 55.81 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-N 115.565 -0.743 . . . . 0.0 109.54 174.137 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' F' F ' 54' ' ' TYR . . . . . . . . . . . . . 41.8 t80 -129.06 110.16 18.24 Favored Pre-proline 0 C--N 1.327 -0.38 0 CA-C-O 118.358 -0.829 . . . . 0.0 110.484 -179.3 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' F' F ' 55' ' ' PRO . . . . . . . . . . . . . 73.8 Cg_endo -76.99 169.69 73.74 Favored 'Cis proline' 0 N--CA 1.498 1.783 0 CA-C-N 121.906 1.716 . . . . 0.0 112.296 -4.343 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' F' F ' 56' ' ' SER . . . . . . . . . . . . . 13.7 m -113.45 128.03 26.16 Favored Pre-proline 0 CA--C 1.539 0.553 0 CA-C-O 118.448 -0.787 . . . . 0.0 109.383 176.706 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' F' F ' 57' ' ' PRO . . . . . . . . . . . . . 38.5 Cg_endo -66.96 165.35 67.11 Favored 'Cis proline' 0 N--CA 1.497 1.693 0 CA-C-N 121.924 1.723 . . . . 0.0 111.463 0.388 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' F' F ' 58' ' ' LEU . . . . . . . . . . . . . 27.7 tp -129.26 135.76 49.2 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-O 120.934 0.397 . . . . 0.0 110.612 -179.31 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' F' F ' 59' ' ' ARG . . . . . . . . . . . . . 40.6 ttm180 -106.56 137.21 44.98 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-N 115.897 -0.592 . . . . 0.0 109.569 176.309 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' F' F ' 60' ' ' VAL . . . . . . . . . . . . . 44.2 t -91.0 122.7 42.66 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 C-N-CA 120.601 -0.44 . . . . 0.0 110.272 -178.178 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' F' F ' 61' ' ' GLU . . . . . . . . . . . . . 70.6 mm-40 -131.09 167.76 18.57 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 115.938 -0.574 . . . . 0.0 110.006 177.208 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' F' F ' 62' ' ' ASP . . . . . . . . . . . . . 75.1 m-20 -54.68 -32.95 60.16 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-N 116.58 -0.282 . . . . 0.0 111.748 -178.715 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' F' F ' 63' ' ' ARG . . . . . . . . . . . . . 7.0 ptp180 -89.45 8.55 30.36 Favored 'General case' 0 CA--C 1.536 0.413 0 N-CA-C 113.527 0.936 . . . . 0.0 113.527 -175.499 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' F' F ' 64' ' ' THR . . . . . . . . . . . . . 30.3 m -85.2 137.77 32.79 Favored 'General case' 0 C--O 1.232 0.155 0 CA-C-N 118.115 0.416 . . . . 0.0 110.343 -178.644 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' F' F ' 65' ' ' LYS . . . . . . . . . . . . . 97.3 mttt -88.58 125.94 35.03 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-N 116.27 -0.423 . . . . 0.0 110.041 -179.899 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' F' F ' 66' ' ' ILE . . . . . . . . . . . . . 64.9 mt -115.24 128.77 72.3 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.279 0 N-CA-C 109.812 -0.44 . . . . 0.0 109.812 -179.825 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' F' F ' 67' ' ' THR . . . . . . . . . . . . . 18.6 m -124.65 138.7 54.29 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.74 -177.726 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' F' F ' 68' ' ' LEU . . . . . . . . . . . . . 7.1 mp -103.98 128.87 51.54 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 115.895 -0.593 . . . . 0.0 110.226 177.218 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' F' F ' 69' ' ' VAL . . . . . . . . . . . . . 43.9 t -101.29 133.51 44.42 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.303 0 CA-C-N 116.287 -0.415 . . . . 0.0 109.967 179.658 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' F' F ' 70' ' ' THR . . . . . . . . . . . . . 9.5 m -136.99 95.56 3.14 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.344 -0.389 . . . . 0.0 110.806 -179.573 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' F' F ' 71' ' ' HIS . . . . . . . . . . . . . 40.6 t-80 -148.26 64.87 8.36 Favored Pre-proline 0 CA--C 1.536 0.436 0 CA-C-N 116.089 -0.505 . . . . 0.0 110.199 176.015 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' F' F ' 72' ' ' PRO . . . . . . . . . . . . . 68.9 Cg_endo -94.96 37.39 0.16 Allowed 'Trans proline' 0 N--CA 1.488 1.172 0 C-N-CA 121.955 1.77 . . . . 0.0 112.75 -177.827 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' F' F ' 73' ' ' VAL . . . . . . . . . . . . . 27.5 m -104.08 141.11 20.37 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.235 0 CA-C-O 121.248 0.547 . . . . 0.0 111.079 -178.937 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' F' F ' 74' ' ' ASP . . . . . . . . . . . . . 33.5 t0 -96.61 119.83 35.81 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 115.477 -0.783 . . . . 0.0 109.236 176.583 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' F' F ' 75' ' ' VAL . . . . . . . . . . . . . 42.0 t -109.6 123.15 65.25 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.247 0 CA-C-O 121.178 0.514 . . . . 0.0 110.521 -176.73 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' F' F ' 76' ' ' LEU . . . . . . . . . . . . . 23.8 mt -128.9 141.27 51.33 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 115.485 -0.78 . . . . 0.0 109.281 177.508 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' F' F ' 77' ' ' GLU . . . . . . . . . . . . . 45.7 tt0 -136.76 133.07 35.62 Favored 'General case' 0 C--N 1.331 -0.225 0 C-N-CA 120.736 -0.386 . . . . 0.0 110.978 -176.354 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' F' F ' 78' ' ' ALA . . . . . . . . . . . . . . . -120.6 135.55 55.07 Favored 'General case' 0 C--N 1.332 -0.177 0 CA-C-N 116.259 -0.428 . . . . 0.0 110.281 179.796 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' F' F ' 79' ' ' LYS . . . . . . . . . . . . . 87.1 mttt -79.49 120.87 24.48 Favored 'General case' 0 C--N 1.331 -0.209 0 CA-C-O 120.853 0.359 . . . . 0.0 110.787 -179.242 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' F' F ' 80' ' ' ILE . . . . . . . . . . . . . 37.2 mm -139.14 108.16 3.65 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.314 0 N-CA-C 108.869 -0.789 . . . . 0.0 108.869 -177.78 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' F' F ' 81' ' ' LYS . . . . . . . . . . . . . 79.5 tttt -99.96 125.79 46.02 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-O 120.837 0.351 . . . . 0.0 111.43 -174.834 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' F' F ' 82' ' ' GLY . . . . . . . . . . . . . . . 89.05 42.14 5.7 Favored Glycine 0 CA--C 1.525 0.683 0 C-N-CA 120.956 -0.64 . . . . 0.0 111.617 174.417 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' F' F ' 83' ' ' ILE . . . . . . . . . . . . . 68.5 mt -68.83 138.23 22.78 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.29 0 CA-C-O 120.921 0.391 . . . . 0.0 110.019 179.695 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' F' F ' 84' ' ' LYS . . . . . . . . . . . . . 38.2 tttp -99.91 -53.12 3.25 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 115.924 -0.58 . . . . 0.0 110.158 -179.475 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' F' F ' 85' ' ' ASP . . . . . . . . . . . . . 11.1 t0 -151.85 148.31 27.66 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 115.748 -0.66 . . . . 0.0 110.241 179.72 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' F' F ' 86' ' ' VAL . . . . . . . . . . . . . 45.3 t -125.94 130.24 72.33 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.191 0 CA-C-O 120.898 0.38 . . . . 0.0 110.308 -179.309 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' F' F ' 87' ' ' ILE . . . . . . . . . . . . . 46.2 mm -121.75 130.21 74.8 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.246 0 CA-C-N 115.926 -0.579 . . . . 0.0 109.948 177.365 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' F' F ' 88' ' ' LEU . . . . . . . . . . . . . 58.5 mt -108.17 137.25 46.47 Favored 'General case' 0 C--N 1.332 -0.194 0 CA-C-O 121.04 0.448 . . . . 0.0 111.361 -177.966 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' F' F ' 89' ' ' ASP . . . . . . . . . . . . . 13.8 t70 -126.58 153.14 45.67 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 115.653 -0.703 . . . . 0.0 109.489 176.695 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' F' F ' 90' ' ' GLU . . . . . . . . . . . . . 84.8 tt0 -47.54 -36.12 10.0 Favored 'General case' 0 C--N 1.329 -0.288 0 N-CA-C 112.851 0.686 . . . . 0.0 112.851 -172.259 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' F' F ' 91' ' ' ASN . . . . . . . . . . . . . 16.9 t30 -131.96 19.99 4.55 Favored 'General case' 0 N--CA 1.468 0.435 0 N-CA-C 112.995 0.739 . . . . 0.0 112.995 -178.411 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' F' F ' 92' ' ' LEU . . . . . . . . . . . . . 35.7 mt -150.28 152.83 35.12 Favored 'General case' 0 C--N 1.331 -0.209 0 CA-C-O 120.824 0.345 . . . . 0.0 110.513 -177.114 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' F' F ' 93' ' ' ILE . . . . . . . . . . . . . 71.9 mt -126.77 121.27 57.99 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.379 0 N-CA-C 109.319 -0.623 . . . . 0.0 109.319 177.206 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' F' F ' 94' ' ' VAL . . . . . . . . . . . . . 45.4 t -117.47 125.83 74.27 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.268 0 N-CA-C 109.829 -0.434 . . . . 0.0 109.829 -178.907 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' F' F ' 95' ' ' VAL . . . . . . . . . . . . . 46.1 t -122.16 133.03 69.72 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.291 0 CA-C-N 116.071 -0.513 . . . . 0.0 109.919 -179.468 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' F' F ' 96' ' ' ILE . . . . . . . . . . . . . 57.4 mt -114.77 127.77 72.15 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.323 0 N-CA-C 109.141 -0.689 . . . . 0.0 109.141 178.473 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' F' F ' 97' ' ' THR . . . . . . . . . . . . . 74.0 p -99.33 159.34 15.08 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-O 121.139 0.495 . . . . 0.0 111.423 -177.303 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' F' F ' 98' ' ' GLU . . . . . . . . . . . . . 12.6 pt-20 -54.69 -28.02 44.62 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.091 -0.504 . . . . 0.0 112.263 -179.135 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' F' F ' 99' ' ' GLU . . . . . . . . . . . . . 70.9 mm-40 -80.28 14.39 1.97 Allowed 'General case' 0 CA--C 1.535 0.397 0 N-CA-C 113.084 0.772 . . . . 0.0 113.084 -177.684 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' F' F ' 100' ' ' ASN . . . . . . . . . . . . . 5.3 m-20 62.09 35.25 15.91 Favored 'General case' 0 C--N 1.332 -0.164 0 CA-C-O 120.96 0.41 . . . . 0.0 111.354 179.56 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' F' F ' 101' ' ' GLU . . . . . . . . . . . . . 84.5 tt0 -106.61 143.0 35.35 Favored 'General case' 0 C--N 1.333 -0.145 0 N-CA-C 109.513 -0.551 . . . . 0.0 109.513 172.008 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' F' F ' 102' ' ' VAL . . . . . . . . . . . . . 43.2 t -115.02 125.45 72.34 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.311 0 N-CA-C 109.823 -0.436 . . . . 0.0 109.823 -177.867 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' F' F ' 103' ' ' LEU . . . . . . . . . . . . . 42.5 mt -116.81 129.13 55.9 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 115.762 -0.654 . . . . 0.0 110.17 177.508 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' F' F ' 104' ' ' ILE . . . . . . . . . . . . . 70.3 mt -118.36 119.43 61.24 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.261 0 N-CA-C 110.118 -0.327 . . . . 0.0 110.118 179.187 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' F' F ' 105' ' ' PHE . . . . . . . . . . . . . 65.8 m-85 -119.81 166.32 13.42 Favored 'General case' 0 C--N 1.331 -0.202 0 O-C-N 124.169 0.918 . . . . 0.0 109.591 178.858 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' F' F ' 106' ' ' ASN . . . . . . . . . . . . . 43.6 p-10 -99.3 -170.91 1.98 Allowed 'General case' 0 C--N 1.329 -0.284 0 N-CA-C 109.756 -0.461 . . . . 0.0 109.756 171.834 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' F' F ' 107' ' ' GLN . . . . . . . . . . . . . 43.0 tp60 -57.82 -27.91 63.58 Favored 'General case' 0 CA--C 1.533 0.323 0 N-CA-C 112.005 0.372 . . . . 0.0 112.005 -179.815 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' F' F ' 108' ' ' ASN . . . . . . . . . . . . . 23.5 t30 -90.47 13.85 14.6 Favored 'General case' 0 CA--C 1.534 0.336 0 N-CA-C 113.067 0.766 . . . . 0.0 113.067 -175.997 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' F' F ' 109' ' ' LEU . . . . . . . . . . . . . 47.5 mt 57.95 38.0 26.85 Favored 'General case' 0 C--O 1.232 0.144 0 CA-C-O 120.975 0.416 . . . . 0.0 111.468 177.292 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' F' F ' 110' ' ' GLU . . . . . . . . . . . . . 95.7 mt-10 -102.07 155.12 18.39 Favored 'General case' 0 C--N 1.329 -0.319 0 N-CA-C 109.939 -0.393 . . . . 0.0 109.939 176.076 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' F' F ' 111' ' ' GLU . . . . . . . . . . . . . 84.9 tt0 -85.85 121.91 29.17 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-O 120.914 0.388 . . . . 0.0 110.698 -178.067 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' F' F ' 112' ' ' LEU . . . . . . . . . . . . . 32.5 mt -111.8 -45.97 3.29 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.043 -0.526 . . . . 0.0 110.414 178.297 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' F' F ' 113' ' ' TYR . . . . . . . . . . . . . 63.3 t80 -138.79 135.79 35.0 Favored 'General case' 0 C--N 1.331 -0.213 0 CA-C-N 116.43 -0.35 . . . . 0.0 111.117 179.351 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' F' F ' 114' ' ' ARG . . . . . . . . . . . . . 59.6 ttp180 -137.69 122.3 18.55 Favored 'General case' 0 C--N 1.331 -0.227 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.308 177.65 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' F' F ' 115' ' ' GLY . . . . . . . . . . . . . . . -150.08 161.1 28.79 Favored Glycine 0 CA--C 1.525 0.668 0 N-CA-C 111.053 -0.819 . . . . 0.0 111.053 177.943 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' F' F ' 116' ' ' LYS . . . . . . . . . . . . . 83.4 tttt -134.9 128.97 33.59 Favored 'General case' 0 C--N 1.33 -0.274 0 N-CA-C 109.972 -0.381 . . . . 0.0 109.972 177.703 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' F' F ' 117' ' ' PHE . . . . . . . . . . . . . 30.8 m-85 -129.03 118.85 23.23 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 116.402 -0.363 . . . . 0.0 110.047 -174.778 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' F' F ' 118' ' ' GLU . . . . . . . . . . . . . 95.9 mt-10 -55.59 -40.25 71.77 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.469 -0.332 . . . . 0.0 110.987 -177.264 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' F' F ' 119' ' ' ASN . . . . . . . . . . . . . 19.1 m120 -101.28 30.99 3.88 Favored 'General case' 0 C--N 1.33 -0.257 0 N-CA-C 112.047 0.388 . . . . 0.0 112.047 -175.022 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' F' F ' 120' ' ' LEU . . . . . . . . . . . . . 17.5 tp -58.08 124.48 19.5 Favored 'General case' 0 C--N 1.333 -0.15 0 CA-C-O 120.752 0.311 . . . . 0.0 110.221 178.781 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' F' F ' 121' ' ' ASN . . . . . . . . . . . . . 17.6 m120 -109.23 -44.19 3.99 Favored 'General case' 0 C--N 1.331 -0.222 0 CA-C-N 116.328 -0.396 . . . . 0.0 111.116 -176.962 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' F' F ' 122' ' ' LYS . . . . . . . . . . . . . 19.5 ptpt -163.65 163.15 24.42 Favored 'General case' 0 C--N 1.331 -0.199 0 CA-C-O 121.099 0.476 . . . . 0.0 111.726 -179.043 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' F' F ' 123' ' ' VAL . . . . . . . . . . . . . 42.2 t -132.95 137.15 54.38 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.251 0 CA-C-N 116.023 -0.535 . . . . 0.0 110.006 178.613 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' F' F ' 124' ' ' LEU . . . . . . . . . . . . . 80.0 mt -120.77 138.52 53.97 Favored 'General case' 0 C--N 1.331 -0.224 0 CA-C-N 116.293 -0.412 . . . . 0.0 110.535 -179.418 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' F' F ' 125' ' ' VAL . . . . . . . . . . . . . 12.0 p -133.63 130.28 56.25 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.246 0 CA-C-O 120.938 0.399 . . . . 0.0 110.785 179.641 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' F' F ' 126' ' ' ARG . . . . . . . . . . . . . 79.4 mtt85 -151.32 125.12 9.1 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 115.851 -0.613 . . . . 0.0 109.948 175.469 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' F' F ' 127' ' ' ASN . . . . . . . . . . . . . 17.3 m120 55.99 -149.32 0.46 Allowed 'General case' 0 CA--C 1.54 0.579 0 N-CA-C 109.897 -0.408 . . . . 0.0 109.897 178.99 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' F' F ' 128' ' ' ASP . . . . . . . . . . . . . 24.3 p-10 -82.17 13.08 3.67 Favored 'General case' 0 CA--C 1.537 0.446 0 N-CA-C 112.995 0.739 . . . . 0.0 112.995 -179.96 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' F' F ' 129' ' ' LEU . . . . . . . . . . . . . 19.9 tp -112.5 133.45 54.56 Favored 'General case' 0 C--O 1.232 0.182 0 CA-C-N 118.171 0.441 . . . . 0.0 110.104 179.196 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' F' F ' 130' ' ' VAL . . . . . . . . . . . . . 33.7 m -131.55 141.56 45.46 Favored 'Isoleucine or valine' 0 C--O 1.232 0.136 0 CA-C-O 120.782 0.325 . . . . 0.0 110.506 -179.651 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' F' F ' 131' ' ' VAL . . . . . . . . . . . . . 40.0 t -136.09 140.29 44.17 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.305 0 CA-C-O 120.986 0.422 . . . . 0.0 110.525 -179.104 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' F' F ' 132' ' ' ILE . . . . . . . . . . . . . 69.4 mt -115.16 133.8 60.28 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.249 0 N-CA-C 109.255 -0.646 . . . . 0.0 109.255 178.035 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' F' F ' 133' ' ' ILE . . . . . . . . . . . . . 42.7 mm -115.11 124.4 71.7 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.229 0 CA-C-N 116.568 -0.287 . . . . 0.0 110.859 -175.051 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' F' F ' 134' ' ' ASP . . . . . . . . . . . . . 7.2 p-10 -134.6 147.5 50.23 Favored 'General case' 0 C--N 1.332 -0.195 0 N-CA-C 109.605 -0.517 . . . . 0.0 109.605 174.089 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' F' F ' 135' ' ' GLU . . . . . . . . . . . . . 85.2 tt0 -50.7 -27.55 7.3 Favored 'General case' 0 C--N 1.328 -0.335 0 N-CA-C 112.822 0.675 . . . . 0.0 112.822 -173.129 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' F' F ' 136' ' ' GLN . . . . . . . . . . . . . 97.5 mt-30 -81.55 -32.47 32.2 Favored 'General case' 0 C--N 1.331 -0.239 0 N-CA-C 112.663 0.616 . . . . 0.0 112.663 -176.784 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' F' F ' 137' ' ' LYS . . . . . . . . . . . . . 53.3 pttt -169.02 173.54 6.83 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-O 121.562 0.696 . . . . 0.0 112.576 -172.458 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' F' F ' 138' ' ' LEU . . . . . . . . . . . . . 4.6 tt -117.07 129.74 56.19 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 115.113 -0.949 . . . . 0.0 109.923 179.622 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' F' F ' 139' ' ' THR . . . . . . . . . . . . . 33.2 m -112.22 124.68 52.97 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.421 -0.354 . . . . 0.0 110.199 178.917 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' F' F ' 140' ' ' LEU . . . . . . . . . . . . . 7.8 tt -113.86 125.19 53.79 Favored 'General case' 0 C--N 1.33 -0.281 0 N-CA-C 109.326 -0.62 . . . . 0.0 109.326 -178.724 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' F' F ' 141' ' ' ILE . . . . . . . . . . . . . 20.1 mt -121.98 125.32 72.97 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.272 0 CA-C-O 121.03 0.443 . . . . 0.0 110.022 -175.39 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' F' F ' 142' ' ' ARG . . . . . . . . . . . . . 39.1 tpt85 -113.8 128.04 56.25 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 115.132 -0.94 . . . . 0.0 109.944 -177.403 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' F' F ' 143' ' ' THR . . . . . . . . . . . . . 23.5 p . . . . . 0 C--O 1.22 -0.49 0 CA-C-O 117.953 -1.023 . . . . 0.0 110.516 -179.328 . . . . . . . . 0 0 . 1 . 013 nuclear orig full ' A' A ' -3' ' ' GLU . . . . . . . . . . . . . 95.8 mt-10 . . . . . 0 N--CA 1.489 1.52 0 N-CA-C 109.401 -0.592 . . . . 0.0 109.401 . . . . . . . . . 0 0 . 1 . 013 nuclear orig full ' A' A ' -2' ' ' GLY . . . . . . . . . . . . . . . -69.92 137.86 29.0 Favored Glycine 0 CA--C 1.523 0.559 0 N-CA-C 110.786 -0.926 . . . . 0.0 110.786 179.152 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' -1' ' ' VAL . . . . . . . . . . . . . 43.1 t -96.18 134.38 33.97 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.321 0 CA-C-O 120.821 0.343 . . . . 0.0 110.108 -179.875 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 0' ' ' ILE . . . . . . . . . . . . . 70.2 mt -109.78 121.08 62.13 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.272 0 N-CA-C 109.704 -0.48 . . . . 0.0 109.704 179.258 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 25.6 ptp -82.62 142.25 31.88 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.102 -0.499 . . . . 0.0 110.662 -179.219 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 2.6 p -114.34 130.96 56.7 Favored 'General case' 0 C--N 1.331 -0.224 0 CA-C-N 115.977 -0.556 . . . . 0.0 110.711 -178.971 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 82.8 tt0 -145.87 144.03 29.96 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.169 -0.469 . . . . 0.0 111.011 179.58 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 4' ' ' LEU . . . . . . . . . . . . . 14.8 tp -125.9 132.43 52.14 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.069 -0.514 . . . . 0.0 110.109 177.227 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 5' ' ' LYS . . . . . . . . . . . . . 68.3 mttm -109.75 122.74 48.18 Favored 'General case' 0 C--O 1.233 0.195 0 CA-C-N 116.345 -0.389 . . . . 0.0 110.823 179.941 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 31.2 mt -113.84 150.0 34.21 Favored 'General case' 0 C--N 1.331 -0.217 0 CA-C-N 115.349 -0.841 . . . . 0.0 110.196 -179.781 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 81.9 tttt -133.0 138.8 32.65 Favored Pre-proline 0 CA--C 1.534 0.332 0 CA-C-O 118.949 -0.548 . . . . 0.0 109.525 174.077 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 8' ' ' PRO . . . . . . . . . . . . . 88.5 Cg_endo -91.66 141.3 2.61 Favored 'Trans proline' 0 N--CA 1.489 1.253 0 C-N-CA 121.747 1.631 . . . . 0.0 112.16 179.741 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 62.5 mt -77.41 -47.4 2.51 Favored Pre-proline 0 CA--C 1.535 0.393 0 CA-C-O 118.69 -0.672 . . . . 0.0 112.074 178.729 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 97.8 Cg_endo -81.77 152.98 17.26 Favored 'Trans proline' 0 N--CA 1.495 1.604 0 C-N-CA 121.293 1.329 . . . . 0.0 111.995 176.088 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 46.3 tttp -88.68 98.08 11.49 Favored 'General case' 0 C--N 1.331 -0.237 0 C-N-CA 120.89 -0.324 . . . . 0.0 110.189 177.682 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 12.3 p -141.47 147.94 21.6 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.308 0 CA-C-N 116.283 -0.417 . . . . 0.0 110.673 -178.48 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 93.6 mt-10 -88.94 124.35 34.15 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.259 -0.428 . . . . 0.0 109.993 177.904 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 14' ' ' LEU . . . . . . . . . . . . . 26.2 mt -98.15 149.81 36.1 Favored Pre-proline 0 CA--C 1.534 0.335 0 CA-C-O 119.266 -0.397 . . . . 0.0 110.508 -179.25 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 15' ' ' PRO . . . . . . . . . . . . . 26.9 Cg_exo -62.06 158.55 38.52 Favored 'Trans proline' 0 N--CA 1.498 1.744 0 C-N-CA 121.282 1.322 . . . . 0.0 112.015 177.416 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 16' ' ' PRO . . . . . . . . . . . . . 32.9 Cg_exo -59.78 -35.66 93.64 Favored 'Trans proline' 0 N--CA 1.498 1.765 0 C-N-CA 121.384 1.389 . . . . 0.0 112.676 -179.739 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 17' ' ' ASP . . . . . . . . . . . . . 18.7 p-10 -86.91 8.81 21.5 Favored 'General case' 0 C--N 1.327 -0.376 0 N-CA-C 113.276 0.843 . . . . 0.0 113.276 -177.644 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 18' ' ' PHE . . . . . . . . . . . . . 37.9 t80 -58.12 -47.86 81.99 Favored 'General case' 0 N--CA 1.457 -0.081 0 O-C-N 121.963 -0.46 . . . . 0.0 110.194 -177.158 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 19' ' ' VAL . . . . . . . . . . . . . 14.8 p -55.92 -41.3 66.79 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.339 0 CA-C-N 116.359 -0.382 . . . . 0.0 111.141 -177.614 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 49.8 m-20 -60.26 -44.74 95.04 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-O 120.805 0.336 . . . . 0.0 111.045 -177.387 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 47.0 t -64.78 -48.44 84.47 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.283 0 C-N-CA 120.726 -0.39 . . . . 0.0 110.495 -177.648 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 22' ' ' ILE . . . . . . . . . . . . . 44.5 mm -56.92 -43.86 81.3 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.247 0 CA-C-O 120.777 0.322 . . . . 0.0 110.489 179.957 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 23' ' ' ARG . . . . . . . . . . . . . 32.1 ttp180 -54.58 -49.76 69.62 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.65 -0.25 . . . . 0.0 111.283 -178.637 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 24' ' ' ILE . . . . . . . . . . . . . 75.9 mt -59.41 -41.39 84.3 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.238 0 C-N-CA 120.971 -0.291 . . . . 0.0 111.148 -177.622 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 91.9 mttt -64.97 -43.47 92.56 Favored 'General case' 0 C--N 1.329 -0.295 0 N-CA-C 112.439 0.533 . . . . 0.0 112.439 -179.437 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 88.7 mt -79.75 -36.81 36.74 Favored 'General case' 0 C--N 1.331 -0.217 0 N-CA-C 113.589 0.959 . . . . 0.0 113.589 -170.541 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 27' ' ' GLN . . . . . . . . . . . . . 9.1 pt20 -47.13 142.17 3.9 Favored 'General case' 0 N--CA 1.469 0.508 0 N-CA-C 112.699 0.629 . . . . 0.0 112.699 -175.04 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 99.15 -24.99 30.02 Favored Glycine 0 CA--C 1.534 1.237 0 CA-C-N 115.591 -0.732 . . . . 0.0 112.251 -176.155 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 68.3 mttm -97.52 155.15 17.08 Favored 'General case' 0 C--O 1.232 0.177 0 CA-C-N 117.399 0.599 . . . . 0.0 111.028 178.635 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 30' ' ' THR . . . . . . . . . . . . . 30.2 m -103.25 137.68 41.06 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 115.887 -0.597 . . . . 0.0 109.933 176.13 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 35.2 m -126.33 153.52 34.89 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.248 0 CA-C-N 116.404 -0.362 . . . . 0.0 110.468 -179.4 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 32' ' ' ARG . . . . . . . . . . . . . 60.3 ttp180 -131.23 148.58 52.71 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.048 -0.524 . . . . 0.0 110.458 179.293 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 33' ' ' THR . . . . . . . . . . . . . 17.2 m -53.12 138.7 30.61 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.266 -0.425 . . . . 0.0 111.365 -177.936 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 99.91 -17.2 57.62 Favored Glycine 0 CA--C 1.532 1.155 0 CA-C-O 119.718 -0.49 . . . . 0.0 113.228 179.873 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 72.9 m-20 -66.2 151.73 46.35 Favored 'General case' 0 C--N 1.334 -0.107 0 CA-C-N 118.039 0.92 . . . . 0.0 111.288 179.404 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 45.2 t -122.73 130.46 74.47 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.198 0 CA-C-N 115.756 -0.656 . . . . 0.0 109.884 177.784 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 37' ' ' ILE . . . . . . . . . . . . . 65.3 mt -120.66 138.06 52.37 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.231 0 CA-C-N 116.18 -0.464 . . . . 0.0 109.834 -179.921 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . -116.04 128.55 8.05 Favored Glycine 0 CA--C 1.525 0.665 0 N-CA-C 110.991 -0.844 . . . . 0.0 110.991 179.582 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 39' ' ' ILE . . . . . . . . . . . . . 75.1 mt -126.82 134.28 66.59 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.226 0 CA-C-O 120.695 0.283 . . . . 0.0 110.285 179.445 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 40' ' ' SER . . . . . . . . . . . . . 53.2 p -92.39 114.61 27.2 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-N 116.225 -0.443 . . . . 0.0 110.758 175.949 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 41' ' ' ILE . . . . . . . . . . . . . 43.1 mm -120.47 117.42 53.26 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.26 0 CA-C-O 120.937 0.398 . . . . 0.0 110.601 179.545 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 1.3 tt 51.66 45.96 27.29 Favored 'General case' 0 CA--C 1.531 0.248 0 CA-C-O 121.404 0.621 . . . . 0.0 111.004 176.701 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . 70.76 21.68 78.01 Favored Glycine 0 CA--C 1.532 1.138 0 C-N-CA 121.175 -0.536 . . . . 0.0 112.851 175.523 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 44' ' ' LYS . . . . . . . . . . . . . 56.5 mttm -133.14 129.31 37.71 Favored 'General case' 0 C--N 1.332 -0.178 0 CA-C-N 117.55 0.675 . . . . 0.0 110.09 179.195 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 84.5 tt0 -83.95 123.81 30.36 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 116.552 -0.294 . . . . 0.0 111.067 -178.568 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 46' ' ' VAL . . . . . . . . . . . . . 10.4 p -121.21 124.17 71.49 Favored 'Isoleucine or valine' 0 C--O 1.233 0.194 0 N-CA-C 109.687 -0.486 . . . . 0.0 109.687 174.674 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 93.8 mttt -99.6 127.18 45.69 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.095 -0.502 . . . . 0.0 110.783 177.702 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 48' ' ' PHE . . . . . . . . . . . . . 35.8 m-85 -110.81 131.95 54.61 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 115.855 -0.612 . . . . 0.0 109.666 177.593 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 84.2 tttt -106.52 135.78 47.44 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.246 -0.434 . . . . 0.0 110.215 179.058 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 50' ' ' VAL . . . . . . . . . . . . . 45.1 t -79.21 105.33 8.38 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.317 0 N-CA-C 109.549 -0.537 . . . . 0.0 109.549 177.622 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 51' ' ' VAL . . . . . . . . . . . . . 50.5 t -70.14 -54.32 19.33 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.366 0 N-CA-C 109.36 -0.607 . . . . 0.0 109.36 -176.347 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 52' ' ' GLN . . . . . . . . . . . . . 91.7 mt-30 -153.52 154.35 34.16 Favored 'General case' 0 C--N 1.331 -0.22 0 CA-C-N 115.913 -0.585 . . . . 0.0 111.595 -178.864 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -129.35 134.34 47.85 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 115.148 -0.933 . . . . 0.0 109.779 175.984 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 54' ' ' TYR . . . . . . . . . . . . . 57.3 t80 -128.75 107.24 18.54 Favored Pre-proline 0 CA--C 1.534 0.345 0 CA-C-O 118.281 -0.866 . . . . 0.0 110.449 -178.891 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 55' ' ' PRO . . . . . . . . . . . . . 73.5 Cg_endo -77.16 170.07 72.52 Favored 'Cis proline' 0 N--CA 1.5 1.854 0 CA-C-N 121.688 1.639 . . . . 0.0 112.405 -5.77 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 56' ' ' SER . . . . . . . . . . . . . 32.6 m -113.93 126.94 27.38 Favored Pre-proline 0 CA--C 1.54 0.57 0 CA-C-O 118.31 -0.852 . . . . 0.0 109.51 175.486 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 57' ' ' PRO . . . . . . . . . . . . . 52.7 Cg_endo -71.06 167.21 75.33 Favored 'Cis proline' 0 N--CA 1.497 1.677 0 CA-C-N 122.084 1.78 . . . . 0.0 111.89 -0.387 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 58' ' ' LEU . . . . . . . . . . . . . 18.9 tp -130.57 138.27 50.09 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.232 -0.44 . . . . 0.0 110.542 -179.426 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 59' ' ' ARG . . . . . . . . . . . . . 55.2 ttp180 -105.38 128.17 53.36 Favored 'General case' 0 C--N 1.329 -0.317 0 N-CA-C 109.118 -0.697 . . . . 0.0 109.118 175.031 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 40.2 t -82.84 123.12 38.22 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.196 0 C-N-CA 120.581 -0.448 . . . . 0.0 110.638 -173.835 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 95.1 mt-10 -131.07 168.76 16.87 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 115.78 -0.646 . . . . 0.0 109.998 177.958 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 62' ' ' ASP . . . . . . . . . . . . . 51.7 m-20 -54.36 -32.4 56.83 Favored 'General case' 0 C--N 1.329 -0.283 0 N-CA-C 111.747 0.277 . . . . 0.0 111.747 -179.712 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 63' ' ' ARG . . . . . . . . . . . . . 41.0 ptt180 -87.45 5.65 37.87 Favored 'General case' 0 CA--C 1.537 0.473 0 N-CA-C 113.712 1.004 . . . . 0.0 113.712 -174.999 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 28.8 m -87.4 139.14 30.85 Favored 'General case' 0 C--N 1.332 -0.179 0 CA-C-N 117.994 0.361 . . . . 0.0 110.537 -179.867 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 65' ' ' LYS . . . . . . . . . . . . . 61.8 mttm -87.63 130.44 34.77 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.096 -0.502 . . . . 0.0 110.281 179.154 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 66' ' ' ILE . . . . . . . . . . . . . 57.7 mt -115.47 124.93 72.47 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.316 0 N-CA-C 109.436 -0.579 . . . . 0.0 109.436 178.231 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 67' ' ' THR . . . . . . . . . . . . . 24.9 m -129.42 148.3 51.32 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-O 121.189 0.518 . . . . 0.0 111.531 -175.608 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 68' ' ' LEU . . . . . . . . . . . . . 4.0 tt -102.3 129.33 48.7 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 115.764 -0.653 . . . . 0.0 109.589 176.52 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 69' ' ' VAL . . . . . . . . . . . . . 41.7 t -96.34 138.62 21.14 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.241 0 CA-C-O 120.962 0.41 . . . . 0.0 110.826 -175.562 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 70' ' ' THR . . . . . . . . . . . . . 10.2 t -88.35 -175.42 5.0 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-N 115.754 -0.657 . . . . 0.0 110.29 179.393 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 71' ' ' HIS . . . . . . . . . . . . . 82.2 t60 -117.6 81.69 14.88 Favored Pre-proline 0 CA--C 1.533 0.296 0 CA-C-N 116.746 -0.206 . . . . 0.0 111.096 -177.295 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 72' ' ' PRO . . . . . . . . . . . . . 94.4 Cg_endo -93.0 154.46 2.67 Favored 'Trans proline' 0 N--CA 1.489 1.225 0 C-N-CA 122.022 1.814 . . . . 0.0 111.916 176.698 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 73' ' ' VAL . . . . . . . . . . . . . 33.7 m -71.5 151.16 8.82 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.184 0 CA-C-O 121.029 0.442 . . . . 0.0 110.933 179.875 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 74' ' ' ASP . . . . . . . . . . . . . 5.3 t0 -98.87 123.41 43.12 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 115.724 -0.671 . . . . 0.0 109.655 177.628 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 42.4 t -115.09 122.36 69.0 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.178 0 CA-C-O 121.038 0.446 . . . . 0.0 110.572 -177.783 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 76' ' ' LEU . . . . . . . . . . . . . 5.2 mp -121.09 142.87 49.44 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 115.623 -0.717 . . . . 0.0 109.739 176.386 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 77' ' ' GLU . . . . . . . . . . . . . 45.9 mt-10 -134.65 137.54 43.71 Favored 'General case' 0 C--N 1.331 -0.196 0 CA-C-O 120.955 0.407 . . . . 0.0 111.158 -179.355 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 78' ' ' ALA . . . . . . . . . . . . . . . -126.68 144.32 50.96 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 115.934 -0.576 . . . . 0.0 110.299 177.92 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 79' ' ' LYS . . . . . . . . . . . . . 40.8 mmtm -82.99 116.04 22.09 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.392 -0.367 . . . . 0.0 110.688 -179.541 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 80' ' ' ILE . . . . . . . . . . . . . 39.5 mm -139.09 110.69 5.16 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.286 0 N-CA-C 109.42 -0.585 . . . . 0.0 109.42 -179.288 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 81' ' ' LYS . . . . . . . . . . . . . 63.8 tttt -111.26 132.59 54.24 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-O 120.877 0.37 . . . . 0.0 111.064 -178.05 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . 89.04 42.11 5.71 Favored Glycine 0 CA--C 1.524 0.654 0 N-CA-C 111.432 -0.667 . . . . 0.0 111.432 175.46 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 83' ' ' ILE . . . . . . . . . . . . . 72.4 mt -76.54 137.68 22.12 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.326 0 N-CA-C 109.673 -0.491 . . . . 0.0 109.673 178.364 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 84' ' ' LYS . . . . . . . . . . . . . 39.3 ttpt -98.27 -48.14 5.18 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-N 116.241 -0.436 . . . . 0.0 110.036 -179.07 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 85' ' ' ASP . . . . . . . . . . . . . 5.5 t70 -155.12 155.77 34.58 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.089 -0.505 . . . . 0.0 110.814 179.357 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 86' ' ' VAL . . . . . . . . . . . . . 41.6 t -132.24 135.79 57.51 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.222 0 CA-C-O 120.962 0.411 . . . . 0.0 110.803 -178.423 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 87' ' ' ILE . . . . . . . . . . . . . 47.9 mm -119.22 123.59 71.6 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.308 0 CA-C-N 115.883 -0.599 . . . . 0.0 109.632 175.027 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 88' ' ' LEU . . . . . . . . . . . . . 14.2 tp -111.46 130.58 55.67 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-O 120.816 0.341 . . . . 0.0 110.89 -177.798 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 89' ' ' ASP . . . . . . . . . . . . . 6.9 t0 -130.89 156.02 45.76 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.048 -0.523 . . . . 0.0 109.704 178.328 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 79.5 tt0 -47.86 -39.61 19.12 Favored 'General case' 0 C--N 1.33 -0.27 0 N-CA-C 112.845 0.683 . . . . 0.0 112.845 -171.675 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 91' ' ' ASN . . . . . . . . . . . . . 16.4 m120 -123.58 14.98 9.52 Favored 'General case' 0 N--CA 1.467 0.406 0 N-CA-C 113.312 0.856 . . . . 0.0 113.312 -175.884 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 92' ' ' LEU . . . . . . . . . . . . . 33.4 mt -149.82 146.03 26.92 Favored 'General case' 0 C--N 1.331 -0.225 0 CA-C-N 117.93 0.332 . . . . 0.0 110.52 -176.214 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 93' ' ' ILE . . . . . . . . . . . . . 73.6 mt -127.62 116.92 45.12 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.331 0 N-CA-C 109.113 -0.699 . . . . 0.0 109.113 175.913 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 94' ' ' VAL . . . . . . . . . . . . . 45.0 t -116.7 126.87 74.36 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.278 0 N-CA-C 109.889 -0.412 . . . . 0.0 109.889 -177.941 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 95' ' ' VAL . . . . . . . . . . . . . 43.0 t -121.06 133.93 66.11 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.293 0 CA-C-N 116.177 -0.465 . . . . 0.0 109.807 179.465 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 96' ' ' ILE . . . . . . . . . . . . . 66.3 mt -113.52 126.1 70.9 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.365 0 N-CA-C 109.071 -0.714 . . . . 0.0 109.071 178.818 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 97' ' ' THR . . . . . . . . . . . . . 72.5 p -101.75 158.24 16.26 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-O 121.519 0.676 . . . . 0.0 111.593 -175.701 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 98' ' ' GLU . . . . . . . . . . . . . 82.4 tt0 -53.83 -27.3 28.73 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 115.549 -0.75 . . . . 0.0 112.295 179.991 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 99' ' ' GLU . . . . . . . . . . . . . 95.3 mt-10 -78.83 14.42 1.36 Allowed 'General case' 0 CA--C 1.535 0.369 0 N-CA-C 113.282 0.845 . . . . 0.0 113.282 -176.866 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 100' ' ' ASN . . . . . . . . . . . . . 3.2 m-20 61.03 37.5 17.92 Favored 'General case' 0 CA--C 1.53 0.211 0 CA-C-O 121.08 0.467 . . . . 0.0 110.891 -179.782 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 101' ' ' GLU . . . . . . . . . . . . . 84.3 tt0 -115.78 145.78 42.51 Favored 'General case' 0 C--O 1.232 0.16 0 CA-C-N 116.142 -0.481 . . . . 0.0 109.732 176.473 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 102' ' ' VAL . . . . . . . . . . . . . 45.7 t -114.95 125.3 72.24 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.298 0 N-CA-C 109.805 -0.442 . . . . 0.0 109.805 -177.332 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 103' ' ' LEU . . . . . . . . . . . . . 39.0 mt -116.3 126.48 53.6 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 115.634 -0.712 . . . . 0.0 110.185 177.263 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 104' ' ' ILE . . . . . . . . . . . . . 64.3 mt -117.59 120.11 63.75 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.214 0 N-CA-C 110.142 -0.318 . . . . 0.0 110.142 -179.993 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 105' ' ' PHE . . . . . . . . . . . . . 68.6 m-85 -119.95 165.57 14.47 Favored 'General case' 0 C--N 1.332 -0.19 0 O-C-N 123.818 0.698 . . . . 0.0 109.526 178.94 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 106' ' ' ASN . . . . . . . . . . . . . 36.7 p-10 -99.59 -170.33 1.88 Allowed 'General case' 0 C--N 1.331 -0.218 0 N-CA-C 109.952 -0.388 . . . . 0.0 109.952 174.926 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 107' ' ' GLN . . . . . . . . . . . . . 48.6 tp60 -59.47 -30.15 68.32 Favored 'General case' 0 C--N 1.328 -0.328 0 N-CA-C 111.94 0.348 . . . . 0.0 111.94 179.474 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 108' ' ' ASN . . . . . . . . . . . . . 4.7 t-20 -84.35 9.19 13.78 Favored 'General case' 0 CA--C 1.537 0.477 0 N-CA-C 113.204 0.816 . . . . 0.0 113.204 -177.326 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 109' ' ' LEU . . . . . . . . . . . . . 9.8 tp 61.67 35.04 17.23 Favored 'General case' 0 CA--C 1.531 0.222 0 CA-C-O 120.868 0.366 . . . . 0.0 111.545 178.64 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 110' ' ' GLU . . . . . . . . . . . . . 70.6 mm-40 -104.86 142.92 33.89 Favored 'General case' 0 C--N 1.33 -0.276 0 N-CA-C 109.373 -0.603 . . . . 0.0 109.373 174.719 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 111' ' ' GLU . . . . . . . . . . . . . 48.7 tt0 -83.63 121.85 27.81 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-O 120.892 0.377 . . . . 0.0 110.201 -176.725 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 112' ' ' LEU . . . . . . . . . . . . . 52.2 mt -105.1 -42.25 5.35 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 115.86 -0.609 . . . . 0.0 110.619 -179.526 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 113' ' ' TYR . . . . . . . . . . . . . 51.7 t80 -133.05 131.61 40.84 Favored 'General case' 0 C--N 1.331 -0.204 0 CA-C-O 121.01 0.433 . . . . 0.0 111.042 -179.095 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 114' ' ' ARG . . . . . . . . . . . . . 57.1 ttt180 -132.48 119.01 20.02 Favored 'General case' 0 C--N 1.331 -0.226 0 CA-C-N 115.745 -0.661 . . . . 0.0 109.812 177.242 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 115' ' ' GLY . . . . . . . . . . . . . . . -150.14 159.28 28.04 Favored Glycine 0 CA--C 1.522 0.522 0 N-CA-C 110.766 -0.934 . . . . 0.0 110.766 179.136 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 116' ' ' LYS . . . . . . . . . . . . . 34.3 ttmt -130.24 139.61 50.78 Favored 'General case' 0 C--N 1.329 -0.296 0 N-CA-C 110.03 -0.359 . . . . 0.0 110.03 177.646 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 117' ' ' PHE . . . . . . . . . . . . . 49.1 m-85 -134.87 113.96 12.09 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.288 -0.415 . . . . 0.0 110.012 -176.832 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 118' ' ' GLU . . . . . . . . . . . . . 79.6 tt0 -53.72 -43.28 68.91 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.64 -0.254 . . . . 0.0 111.263 -176.47 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 119' ' ' ASN . . . . . . . . . . . . . 32.5 m120 -99.31 30.99 3.26 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.091 -0.504 . . . . 0.0 112.119 -174.781 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 120' ' ' LEU . . . . . . . . . . . . . 15.4 tp -55.24 122.83 11.96 Favored 'General case' 0 N--CA 1.462 0.171 0 CA-C-O 120.751 0.31 . . . . 0.0 110.66 179.22 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 121' ' ' ASN . . . . . . . . . . . . . 64.9 t30 -113.33 -44.15 3.27 Favored 'General case' 0 C--N 1.331 -0.197 0 CA-C-N 116.362 -0.381 . . . . 0.0 111.046 -176.871 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 122' ' ' LYS . . . . . . . . . . . . . 93.4 mttt -144.26 148.1 34.43 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-O 121.057 0.456 . . . . 0.0 112.014 -177.869 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 123' ' ' VAL . . . . . . . . . . . . . 45.6 t -126.66 123.59 63.33 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.288 0 N-CA-C 109.066 -0.716 . . . . 0.0 109.066 172.567 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 124' ' ' LEU . . . . . . . . . . . . . 62.1 mt -125.74 136.93 53.72 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-O 120.855 0.36 . . . . 0.0 111.047 -176.954 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 125' ' ' VAL . . . . . . . . . . . . . 11.4 p -134.75 130.31 52.69 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.308 0 CA-C-N 115.967 -0.56 . . . . 0.0 110.148 178.196 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 126' ' ' ARG . . . . . . . . . . . . . 35.7 mmt180 -140.46 127.2 20.42 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.186 179.14 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 127' ' ' ASN . . . . . . . . . . . . . 12.5 t-20 52.04 -111.58 0.59 Allowed 'General case' 0 CA--C 1.544 0.742 0 CA-C-O 118.696 -0.668 . . . . 0.0 110.933 -179.969 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 128' ' ' ASP . . . . . . . . . . . . . 13.3 p-10 -114.06 8.6 17.09 Favored 'General case' 0 CA--C 1.537 0.45 0 CA-C-N 120.073 1.306 . . . . 0.0 113.23 179.918 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 129' ' ' LEU . . . . . . . . . . . . . 14.3 tp -106.41 135.61 47.61 Favored 'General case' 0 C--O 1.231 0.115 0 CA-C-N 118.037 0.38 . . . . 0.0 110.144 -179.993 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 130' ' ' VAL . . . . . . . . . . . . . 43.1 t -119.82 135.86 58.79 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.202 0 N-CA-C 109.831 -0.433 . . . . 0.0 109.831 -179.475 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 131' ' ' VAL . . . . . . . . . . . . . 21.0 m -136.04 138.8 46.88 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.239 0 CA-C-O 121.314 0.578 . . . . 0.0 110.94 177.928 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 132' ' ' ILE . . . . . . . . . . . . . 72.2 mt -118.86 131.12 72.58 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.319 0 CA-C-N 115.353 -0.84 . . . . 0.0 109.001 178.871 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 133' ' ' ILE . . . . . . . . . . . . . 39.3 mm -115.86 123.96 71.73 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.271 0 CA-C-N 116.596 -0.275 . . . . 0.0 110.747 -174.211 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 134' ' ' ASP . . . . . . . . . . . . . 13.4 p-10 -136.02 154.57 51.02 Favored 'General case' 0 C--N 1.332 -0.181 0 CA-C-N 116.295 -0.412 . . . . 0.0 110.086 176.409 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 135' ' ' GLU . . . . . . . . . . . . . 75.9 tt0 -50.02 -29.27 8.38 Favored 'General case' 0 C--N 1.328 -0.346 0 N-CA-C 113.4 0.889 . . . . 0.0 113.4 -168.815 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 136' ' ' GLN . . . . . . . . . . . . . 14.5 pt20 -99.83 -17.01 17.86 Favored 'General case' 0 C--O 1.235 0.34 0 N-CA-C 113.596 0.962 . . . . 0.0 113.596 -171.233 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 137' ' ' LYS . . . . . . . . . . . . . 19.2 pttp -168.04 172.2 9.01 Favored 'General case' 0 C--O 1.232 0.152 0 CA-C-O 121.692 0.758 . . . . 0.0 112.661 -175.41 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 138' ' ' LEU . . . . . . . . . . . . . 7.0 tt -123.26 129.55 51.52 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 114.71 -1.132 . . . . 0.0 110.01 178.985 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 139' ' ' THR . . . . . . . . . . . . . 30.4 m -108.3 127.99 54.35 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-N 116.247 -0.433 . . . . 0.0 110.579 179.69 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 140' ' ' LEU . . . . . . . . . . . . . 29.1 tp -111.93 123.33 50.02 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 115.61 -0.723 . . . . 0.0 109.159 -179.074 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 141' ' ' ILE . . . . . . . . . . . . . 19.6 mt -122.13 121.57 64.34 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.354 0 CA-C-O 120.911 0.386 . . . . 0.0 110.07 -174.662 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 142' ' ' ARG . . . . . . . . . . . . . 77.6 mtp180 -105.04 118.51 36.71 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 115.588 -0.733 . . . . 0.0 109.836 179.413 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 143' ' ' THR . . . . . . . . . . . . . 73.0 p . . . . . 0 C--O 1.221 -0.428 0 CA-C-O 117.976 -1.011 . . . . 0.0 110.592 -178.69 . . . . . . . . 0 0 . 1 . 013 nuclear orig full ' B' B ' -3' ' ' GLU . . . . . . . . . . . . . 95.5 mt-10 . . . . . 0 N--CA 1.492 1.634 0 N-CA-C 109.299 -0.63 . . . . 0.0 109.299 . . . . . . . . . 0 0 . 1 . 013 nuclear orig full ' B' B ' -2' ' ' GLY . . . . . . . . . . . . . . . -91.98 143.91 16.83 Favored Glycine 0 CA--C 1.525 0.669 0 N-CA-C 111.049 -0.821 . . . . 0.0 111.049 179.645 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' B' B ' -1' ' ' VAL . . . . . . . . . . . . . 44.6 t -96.82 136.94 25.95 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.323 0 CA-C-O 120.821 0.343 . . . . 0.0 110.082 179.855 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' B' B ' 0' ' ' ILE . . . . . . . . . . . . . 71.2 mt -108.17 131.46 58.55 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 N-CA-C 109.537 -0.542 . . . . 0.0 109.537 178.92 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' B' B ' 1' ' ' MET . . . . . . . . . . . . . 22.7 ptt? -78.99 128.04 32.76 Favored 'General case' 0 C--N 1.331 -0.21 0 C-N-CA 120.743 -0.383 . . . . 0.0 110.87 -177.905 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' B' B ' 2' ' ' SER . . . . . . . . . . . . . 3.1 p -123.1 131.02 53.52 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.096 -0.502 . . . . 0.0 110.077 177.445 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' B' B ' 3' ' ' GLU . . . . . . . . . . . . . 78.2 tt0 -140.64 137.57 33.7 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.622 -179.4 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' B' B ' 4' ' ' LEU . . . . . . . . . . . . . 12.6 tp -121.77 127.67 50.89 Favored 'General case' 0 C--N 1.331 -0.2 0 CA-C-N 116.096 -0.502 . . . . 0.0 110.143 177.501 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' B' B ' 5' ' ' LYS . . . . . . . . . . . . . 94.9 mttt -102.44 121.27 42.01 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.34 -0.391 . . . . 0.0 110.422 178.2 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' B' B ' 6' ' ' LEU . . . . . . . . . . . . . 59.5 mt -116.34 148.43 40.6 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-N 115.538 -0.756 . . . . 0.0 110.507 -178.98 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' B' B ' 7' ' ' LYS . . . . . . . . . . . . . 47.8 tttp -137.67 138.3 23.91 Favored Pre-proline 0 CA--C 1.534 0.341 0 CA-C-O 118.935 -0.555 . . . . 0.0 110.14 175.502 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' B' B ' 8' ' ' PRO . . . . . . . . . . . . . 98.9 Cg_endo -91.98 138.31 1.95 Allowed 'Trans proline' 0 N--CA 1.491 1.326 0 C-N-CA 121.803 1.669 . . . . 0.0 111.544 176.51 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' B' B ' 9' ' ' LEU . . . . . . . . . . . . . 65.7 mt -73.27 -47.33 7.77 Favored Pre-proline 0 CA--C 1.533 0.326 0 CA-C-O 118.751 -0.642 . . . . 0.0 112.238 -178.583 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' B' B ' 10' ' ' PRO . . . . . . . . . . . . . 87.8 Cg_endo -81.16 152.58 18.51 Favored 'Trans proline' 0 N--CA 1.496 1.672 0 C-N-CA 121.234 1.29 . . . . 0.0 111.894 175.807 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' B' B ' 11' ' ' LYS . . . . . . . . . . . . . 68.1 mttm -85.54 102.91 13.92 Favored 'General case' 0 C--N 1.33 -0.24 0 N-CA-C 110.106 -0.331 . . . . 0.0 110.106 177.459 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' B' B ' 12' ' ' VAL . . . . . . . . . . . . . 12.2 p -139.79 145.31 26.84 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.281 0 CA-C-N 116.335 -0.393 . . . . 0.0 110.722 -178.242 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' B' B ' 13' ' ' GLU . . . . . . . . . . . . . 95.5 mt-10 -87.83 121.32 30.11 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.094 -0.503 . . . . 0.0 109.887 177.13 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' B' B ' 14' ' ' LEU . . . . . . . . . . . . . 16.3 mt -97.71 153.0 38.43 Favored Pre-proline 0 C--N 1.329 -0.321 0 CA-C-N 116.498 -0.319 . . . . 0.0 110.678 -176.931 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' B' B ' 15' ' ' PRO . . . . . . . . . . . . . 26.0 Cg_exo -62.24 155.67 55.34 Favored 'Trans proline' 0 N--CA 1.497 1.713 0 C-N-CA 121.288 1.325 . . . . 0.0 111.581 176.076 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' B' B ' 16' ' ' PRO . . . . . . . . . . . . . 35.0 Cg_exo -58.0 -35.75 98.54 Favored 'Trans proline' 0 N--CA 1.498 1.742 0 C-N-CA 121.418 1.412 . . . . 0.0 112.704 -179.619 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' B' B ' 17' ' ' ASP . . . . . . . . . . . . . 17.8 p-10 -89.15 11.53 18.36 Favored 'General case' 0 C--N 1.327 -0.39 0 N-CA-C 113.202 0.816 . . . . 0.0 113.202 -177.462 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' B' B ' 18' ' ' PHE . . . . . . . . . . . . . 47.3 t80 -58.1 -42.64 86.13 Favored 'General case' 0 C--N 1.334 -0.088 0 O-C-N 121.905 -0.497 . . . . 0.0 110.023 -178.174 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' B' B ' 19' ' ' VAL . . . . . . . . . . . . . 49.1 t -58.0 -42.89 83.8 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.319 0 CA-C-N 116.438 -0.346 . . . . 0.0 110.283 -178.42 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' B' B ' 20' ' ' ASP . . . . . . . . . . . . . 81.2 m-20 -59.66 -42.16 92.19 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-O 120.796 0.331 . . . . 0.0 110.91 -177.955 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' B' B ' 21' ' ' VAL . . . . . . . . . . . . . 47.0 t -64.35 -49.31 81.53 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.321 0 CA-C-N 116.361 -0.381 . . . . 0.0 110.412 -178.215 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' B' B ' 22' ' ' ILE . . . . . . . . . . . . . 49.5 mm -56.89 -43.29 80.06 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.271 0 C-N-CA 120.993 -0.283 . . . . 0.0 110.542 179.592 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' B' B ' 23' ' ' ARG . . . . . . . . . . . . . 38.3 ttp180 -54.17 -49.63 68.86 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-O 120.732 0.301 . . . . 0.0 111.303 -178.73 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' B' B ' 24' ' ' ILE . . . . . . . . . . . . . 69.6 mt -60.44 -41.92 89.22 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.265 0 CA-C-N 116.416 -0.357 . . . . 0.0 110.899 -178.573 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' B' B ' 25' ' ' LYS . . . . . . . . . . . . . 88.4 mttt -64.91 -40.17 94.66 Favored 'General case' 0 C--N 1.328 -0.344 0 N-CA-C 112.469 0.544 . . . . 0.0 112.469 -179.096 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' B' B ' 26' ' ' LEU . . . . . . . . . . . . . 57.8 mt -77.81 -41.81 35.95 Favored 'General case' 0 C--N 1.33 -0.276 0 N-CA-C 113.141 0.793 . . . . 0.0 113.141 -171.408 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' B' B ' 27' ' ' GLN . . . . . . . . . . . . . 10.3 pt20 -46.86 135.62 9.0 Favored 'General case' 0 N--CA 1.469 0.516 0 N-CA-C 112.717 0.636 . . . . 0.0 112.717 -175.929 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' B' B ' 28' ' ' GLY . . . . . . . . . . . . . . . 101.06 -25.38 28.51 Favored Glycine 0 CA--C 1.533 1.161 0 CA-C-N 115.671 -0.695 . . . . 0.0 112.483 -177.792 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' B' B ' 29' ' ' LYS . . . . . . . . . . . . . 97.5 mttt -98.63 155.09 17.48 Favored 'General case' 0 C--N 1.331 -0.207 0 CA-C-N 117.398 0.599 . . . . 0.0 111.163 178.78 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' B' B ' 30' ' ' THR . . . . . . . . . . . . . 25.7 m -104.65 137.71 42.06 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.076 -0.511 . . . . 0.0 109.921 175.186 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' B' B ' 31' ' ' VAL . . . . . . . . . . . . . 34.5 m -128.26 155.64 40.02 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.254 0 CA-C-O 120.824 0.345 . . . . 0.0 110.894 -178.798 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' B' B ' 32' ' ' ARG . . . . . . . . . . . . . 97.1 mtt180 -133.51 149.93 51.7 Favored 'General case' 0 C--N 1.331 -0.225 0 CA-C-O 121.193 0.521 . . . . 0.0 110.654 177.823 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' B' B ' 33' ' ' THR . . . . . . . . . . . . . 23.6 m -53.21 139.64 28.65 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.237 -0.438 . . . . 0.0 111.419 -178.2 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' B' B ' 34' ' ' GLY . . . . . . . . . . . . . . . 99.4 -17.12 58.22 Favored Glycine 0 CA--C 1.531 1.092 0 C-N-CA 121.18 -0.533 . . . . 0.0 113.28 178.891 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' B' B ' 35' ' ' ASP . . . . . . . . . . . . . 75.6 m-20 -65.79 148.95 50.95 Favored 'General case' 0 C--O 1.232 0.145 0 CA-C-N 118.109 0.954 . . . . 0.0 111.152 179.631 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' B' B ' 36' ' ' VAL . . . . . . . . . . . . . 42.5 t -122.71 130.59 74.39 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.207 0 CA-C-N 115.938 -0.574 . . . . 0.0 109.966 177.7 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' B' B ' 37' ' ' ILE . . . . . . . . . . . . . 66.4 mt -121.63 139.23 49.36 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.305 0 N-CA-C 109.772 -0.455 . . . . 0.0 109.772 -179.721 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' B' B ' 38' ' ' GLY . . . . . . . . . . . . . . . -113.37 128.8 8.53 Favored Glycine 0 CA--C 1.526 0.77 0 N-CA-C 111.384 -0.686 . . . . 0.0 111.384 -178.673 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' B' B ' 39' ' ' ILE . . . . . . . . . . . . . 68.5 mt -123.89 127.91 73.95 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.204 0 N-CA-C 109.771 -0.455 . . . . 0.0 109.771 178.084 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' B' B ' 40' ' ' SER . . . . . . . . . . . . . 30.6 t -93.81 123.15 36.96 Favored 'General case' 0 C--N 1.329 -0.294 0 C-N-CA 120.923 -0.311 . . . . 0.0 111.005 176.589 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' B' B ' 41' ' ' ILE . . . . . . . . . . . . . 70.4 mt -131.73 125.67 56.09 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.233 0 CA-C-O 120.877 0.37 . . . . 0.0 110.588 178.834 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' B' B ' 42' ' ' LEU . . . . . . . . . . . . . 9.9 tp 54.62 35.45 23.69 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.067 -0.515 . . . . 0.0 111.623 176.88 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' B' B ' 43' ' ' GLY . . . . . . . . . . . . . . . 71.96 27.29 70.75 Favored Glycine 0 CA--C 1.531 1.087 0 C-N-CA 121.078 -0.582 . . . . 0.0 112.392 177.34 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' B' B ' 44' ' ' LYS . . . . . . . . . . . . . 91.4 mttt -138.05 126.84 23.82 Favored 'General case' 0 C--N 1.331 -0.211 0 N-CA-C 109.434 -0.58 . . . . 0.0 109.434 178.292 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' B' B ' 45' ' ' GLU . . . . . . . . . . . . . 29.1 tp10 -85.25 129.22 34.85 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-O 120.801 0.334 . . . . 0.0 111.233 -175.887 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' B' B ' 46' ' ' VAL . . . . . . . . . . . . . 7.4 p -122.36 129.48 75.26 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.2 0 N-CA-C 109.435 -0.58 . . . . 0.0 109.435 174.865 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' B' B ' 47' ' ' LYS . . . . . . . . . . . . . 69.0 mmtt -100.42 128.26 46.53 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.023 -0.535 . . . . 0.0 111.336 177.545 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' B' B ' 48' ' ' PHE . . . . . . . . . . . . . 91.7 m-85 -109.93 131.84 54.69 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 115.954 -0.566 . . . . 0.0 109.58 175.096 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' B' B ' 49' ' ' LYS . . . . . . . . . . . . . 41.5 tttp -108.62 137.63 46.25 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.422 -0.353 . . . . 0.0 110.365 179.638 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' B' B ' 50' ' ' VAL . . . . . . . . . . . . . 44.8 t -78.98 107.1 11.05 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.213 0 N-CA-C 109.326 -0.62 . . . . 0.0 109.326 176.352 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' B' B ' 51' ' ' VAL . . . . . . . . . . . . . 46.4 t -69.0 -48.97 67.06 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.329 0 CA-C-N 115.935 -0.575 . . . . 0.0 109.8 -174.097 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' B' B ' 52' ' ' GLN . . . . . . . . . . . . . 60.1 tt0 -170.1 147.93 3.28 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 115.838 -0.619 . . . . 0.0 111.274 -178.863 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' B' B ' 53' ' ' ALA . . . . . . . . . . . . . . . -122.77 136.78 54.98 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.085 -0.507 . . . . 0.0 110.34 178.843 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' B' B ' 54' ' ' TYR . . . . . . . . . . . . . 47.0 t80 -129.16 111.84 18.29 Favored Pre-proline 0 CA--C 1.535 0.387 0 CA-C-O 118.265 -0.874 . . . . 0.0 110.212 177.995 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' B' B ' 55' ' ' PRO . . . . . . . . . . . . . 73.4 Cg_endo -77.17 167.88 78.46 Favored 'Cis proline' 0 N--CA 1.5 1.901 0 CA-C-N 121.932 1.726 . . . . 0.0 112.127 -6.991 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' B' B ' 56' ' ' SER . . . . . . . . . . . . . 24.0 m -117.22 133.12 23.21 Favored Pre-proline 0 CA--C 1.537 0.476 0 CA-C-O 118.492 -0.766 . . . . 0.0 109.576 175.102 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' B' B ' 57' ' ' PRO . . . . . . . . . . . . . 36.4 Cg_endo -66.34 164.0 67.66 Favored 'Cis proline' 0 N--CA 1.499 1.809 0 CA-C-N 121.953 1.733 . . . . 0.0 111.375 -2.504 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' B' B ' 58' ' ' LEU . . . . . . . . . . . . . 23.0 tp -129.27 135.72 49.15 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.328 -0.396 . . . . 0.0 110.513 -179.217 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' B' B ' 59' ' ' ARG . . . . . . . . . . . . . 74.7 ttt180 -102.45 126.86 49.62 Favored 'General case' 0 C--N 1.327 -0.376 0 N-CA-C 109.241 -0.652 . . . . 0.0 109.241 175.362 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' B' B ' 60' ' ' VAL . . . . . . . . . . . . . 40.7 t -81.35 121.81 35.39 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.322 0 C-N-CA 120.634 -0.426 . . . . 0.0 110.402 -175.045 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' B' B ' 61' ' ' GLU . . . . . . . . . . . . . 95.1 mt-10 -131.11 165.38 23.4 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 115.803 -0.635 . . . . 0.0 109.634 176.698 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' B' B ' 62' ' ' ASP . . . . . . . . . . . . . 80.0 m-20 -53.82 -32.62 53.41 Favored 'General case' 0 C--N 1.328 -0.364 0 N-CA-C 111.787 0.291 . . . . 0.0 111.787 -179.852 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' B' B ' 63' ' ' ARG . . . . . . . . . . . . . 24.7 mmm180 -72.82 -18.96 61.41 Favored 'General case' 0 CA--C 1.535 0.379 0 N-CA-C 113.092 0.775 . . . . 0.0 113.092 -177.085 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' B' B ' 64' ' ' THR . . . . . . . . . . . . . 25.8 m -72.44 138.98 47.47 Favored 'General case' 0 C--N 1.331 -0.204 0 CA-C-O 120.962 0.411 . . . . 0.0 111.24 -174.642 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' B' B ' 65' ' ' LYS . . . . . . . . . . . . . 98.4 mttt -90.81 136.45 33.06 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 115.887 -0.597 . . . . 0.0 110.429 178.615 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' B' B ' 66' ' ' ILE . . . . . . . . . . . . . 60.6 mt -117.1 129.33 73.82 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.233 0 N-CA-C 109.662 -0.496 . . . . 0.0 109.662 179.147 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' B' B ' 67' ' ' THR . . . . . . . . . . . . . 28.0 m -125.74 144.85 50.45 Favored 'General case' 0 N--CA 1.463 0.205 0 CA-C-O 121.133 0.492 . . . . 0.0 111.581 -175.581 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' B' B ' 68' ' ' LEU . . . . . . . . . . . . . 4.4 tt -96.45 127.27 42.29 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 115.614 -0.721 . . . . 0.0 109.559 177.026 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' B' B ' 69' ' ' VAL . . . . . . . . . . . . . 40.7 t -83.87 134.43 26.97 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.361 0 CA-C-O 121.155 0.502 . . . . 0.0 111.14 -176.121 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' B' B ' 70' ' ' THR . . . . . . . . . . . . . 15.4 p -134.73 -170.04 2.47 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 115.419 -0.809 . . . . 0.0 109.442 177.227 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' B' B ' 71' ' ' HIS . . . . . . . . . . . . . 50.4 t60 -120.38 59.98 7.22 Favored Pre-proline 0 CA--C 1.54 0.569 0 CA-C-O 120.774 0.321 . . . . 0.0 111.775 179.584 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' B' B ' 72' ' ' PRO . . . . . . . . . . . . . 45.3 Cg_endo -91.34 160.08 3.71 Favored 'Trans proline' 0 N--CA 1.492 1.433 0 C-N-CA 121.965 1.777 . . . . 0.0 112.015 170.784 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' B' B ' 73' ' ' VAL . . . . . . . . . . . . . 33.8 m -69.98 165.62 2.52 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.229 0 N-CA-C 109.616 -0.512 . . . . 0.0 109.616 175.168 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' B' B ' 74' ' ' ASP . . . . . . . . . . . . . 12.6 t70 -96.62 121.2 38.19 Favored 'General case' 0 C--N 1.33 -0.264 0 C-N-CA 120.779 -0.369 . . . . 0.0 110.346 -176.082 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' B' B ' 75' ' ' VAL . . . . . . . . . . . . . 41.3 t -115.87 126.04 73.23 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.184 0 CA-C-O 121.057 0.456 . . . . 0.0 110.66 -178.263 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' B' B ' 76' ' ' LEU . . . . . . . . . . . . . 15.6 mt -127.59 148.16 50.36 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 115.587 -0.733 . . . . 0.0 109.367 176.929 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' B' B ' 77' ' ' GLU . . . . . . . . . . . . . 98.0 mt-10 -136.87 141.44 42.78 Favored 'General case' 0 C--N 1.333 -0.125 0 CA-C-O 121.173 0.511 . . . . 0.0 111.532 -176.423 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' B' B ' 78' ' ' ALA . . . . . . . . . . . . . . . -127.01 133.5 50.52 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 115.529 -0.76 . . . . 0.0 109.794 176.394 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' B' B ' 79' ' ' LYS . . . . . . . . . . . . . 85.8 tttt -78.12 116.68 18.76 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-O 120.891 0.377 . . . . 0.0 110.728 -177.608 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' B' B ' 80' ' ' ILE . . . . . . . . . . . . . 37.9 mm -139.15 108.43 3.77 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.302 0 N-CA-C 109.432 -0.581 . . . . 0.0 109.432 -176.447 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' B' B ' 81' ' ' LYS . . . . . . . . . . . . . 38.6 ttpt -104.36 127.7 52.07 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-O 120.839 0.352 . . . . 0.0 110.939 -177.629 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' B' B ' 82' ' ' GLY . . . . . . . . . . . . . . . 89.05 42.13 5.7 Favored Glycine 0 CA--C 1.525 0.675 0 C-N-CA 120.847 -0.692 . . . . 0.0 111.687 175.522 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' B' B ' 83' ' ' ILE . . . . . 0.417 HD13 HG21 ' B' ' 83' ' ' ILE . 72.2 mt -70.12 136.05 26.9 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.339 0 N-CA-C 109.669 -0.493 . . . . 0.0 109.669 177.515 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' B' B ' 84' ' ' LYS . . . . . . . . . . . . . 81.1 tttt -94.19 -52.12 4.51 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 115.996 -0.547 . . . . 0.0 110.307 -179.025 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' B' B ' 85' ' ' ASP . . . . . . . . . . . . . 9.5 t70 -156.33 155.79 32.85 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 115.838 -0.619 . . . . 0.0 110.439 179.936 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' B' B ' 86' ' ' VAL . . . . . . . . . . . . . 42.5 t -126.35 133.67 68.21 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.18 0 CA-C-O 121.048 0.451 . . . . 0.0 110.67 -178.338 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' B' B ' 87' ' ' ILE . . . . . . . . . . . . . 44.7 mm -118.42 121.15 66.4 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.282 0 CA-C-N 115.644 -0.707 . . . . 0.0 109.245 175.264 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' B' B ' 88' ' ' LEU . . . . . . . . . . . . . 17.7 tp -109.98 132.51 54.09 Favored 'General case' 0 C--N 1.332 -0.194 0 CA-C-O 120.907 0.384 . . . . 0.0 111.428 -175.055 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' B' B ' 89' ' ' ASP . . . . . . . . . . . . . 9.8 t70 -129.49 153.33 48.09 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 115.91 -0.586 . . . . 0.0 109.56 175.869 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' B' B ' 90' ' ' GLU . . . . . . . . . . . . . 83.5 tt0 -48.21 -36.33 13.54 Favored 'General case' 0 C--N 1.329 -0.294 0 N-CA-C 112.738 0.644 . . . . 0.0 112.738 -172.641 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' B' B ' 91' ' ' ASN . . . . . . . . . . . . . 7.1 p30 -132.09 29.37 4.37 Favored 'General case' 0 N--CA 1.466 0.341 0 N-CA-C 112.301 0.482 . . . . 0.0 112.301 -177.378 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' B' B ' 92' ' ' LEU . . . . . . . . . . . . . 5.0 mt -154.78 143.16 20.48 Favored 'General case' 0 C--N 1.331 -0.213 0 N-CA-C 109.809 -0.441 . . . . 0.0 109.809 -178.474 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' B' B ' 93' ' ' ILE . . . . . . . . . . . . . 70.6 mt -123.38 112.26 32.75 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.213 0 N-CA-C 108.926 -0.768 . . . . 0.0 108.926 176.752 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' B' B ' 94' ' ' VAL . . . . . . . . . . . . . 46.3 t -116.05 125.56 73.2 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.258 0 N-CA-C 109.589 -0.523 . . . . 0.0 109.589 -179.599 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' B' B ' 95' ' ' VAL . . . . . . . . . . . . . 43.2 t -122.93 135.81 61.79 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.349 0 CA-C-N 116.127 -0.488 . . . . 0.0 109.976 -178.141 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' B' B ' 96' ' ' ILE . . . . . . . . . . . . . 63.8 mt -111.6 127.58 68.67 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.355 0 N-CA-C 109.075 -0.713 . . . . 0.0 109.075 178.145 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' B' B ' 97' ' ' THR . . . . . . . . . . . . . 78.4 p -101.18 156.79 17.22 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-O 120.967 0.413 . . . . 0.0 111.136 -177.479 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' B' B ' 98' ' ' GLU . . . . . . . . . . . . . 13.5 pt-20 -53.87 -23.62 13.16 Favored 'General case' 0 CA--C 1.533 0.319 0 N-CA-C 112.434 0.531 . . . . 0.0 112.434 -179.97 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' B' B ' 99' ' ' GLU . . . . . . . . . . . . . 95.6 mt-10 -79.24 14.5 1.48 Allowed 'General case' 0 CA--C 1.536 0.433 0 N-CA-C 112.969 0.729 . . . . 0.0 112.969 -178.212 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' B' B ' 100' ' ' ASN . . . . . . . . . . . . . 2.4 m-20 61.71 37.95 15.47 Favored 'General case' 0 CA--C 1.529 0.169 0 CA-C-O 121.081 0.467 . . . . 0.0 110.893 178.9 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' B' B ' 101' ' ' GLU . . . . . . . . . . . . . 83.5 tt0 -116.53 144.74 43.98 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-N 116.039 -0.528 . . . . 0.0 109.728 176.561 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' B' B ' 102' ' ' VAL . . . . . . . . . . . . . 46.1 t -114.94 123.6 70.78 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.314 0 N-CA-C 109.592 -0.521 . . . . 0.0 109.592 -179.942 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' B' B ' 103' ' ' LEU . . . . . . . . . . . . . 70.9 mt -114.34 131.78 56.43 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 115.806 -0.634 . . . . 0.0 110.255 178.411 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' B' B ' 104' ' ' ILE . . . . . . . . . . . . . 66.7 mt -117.9 117.54 55.26 Favored 'Isoleucine or valine' 0 C--O 1.234 0.252 0 CA-C-N 116.441 -0.345 . . . . 0.0 110.247 -178.756 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' B' B ' 105' ' ' PHE . . . . . . . . . . . . . 82.7 m-85 -117.43 163.29 16.6 Favored 'General case' 0 C--N 1.332 -0.157 0 O-C-N 124.241 0.963 . . . . 0.0 109.846 -179.906 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' B' B ' 106' ' ' ASN . . . . . . . . . . . . . 52.9 p-10 -102.41 -172.26 2.1 Favored 'General case' 0 C--N 1.331 -0.211 0 N-CA-C 109.757 -0.46 . . . . 0.0 109.757 171.256 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' B' B ' 107' ' ' GLN . . . . . . . . . . . . . 48.9 tt0 -58.45 -29.73 66.4 Favored 'General case' 0 C--N 1.328 -0.329 0 N-CA-C 112.227 0.454 . . . . 0.0 112.227 -178.066 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' B' B ' 108' ' ' ASN . . . . . . . . . . . . . 11.7 t-20 -88.74 14.16 10.8 Favored 'General case' 0 CA--C 1.535 0.385 0 N-CA-C 112.862 0.69 . . . . 0.0 112.862 -176.22 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' B' B ' 109' ' ' LEU . . . . . . . . . . . . . 71.6 mt 58.61 35.53 24.56 Favored 'General case' 0 C--O 1.234 0.238 0 CA-C-O 120.822 0.344 . . . . 0.0 111.547 178.771 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' B' B ' 110' ' ' GLU . . . . . . . . . . . . . 43.3 mt-10 -105.27 141.32 37.0 Favored 'General case' 0 C--N 1.329 -0.299 0 N-CA-C 109.771 -0.455 . . . . 0.0 109.771 176.35 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' B' B ' 111' ' ' GLU . . . . . . . . . . . . . 97.7 mt-10 -77.29 125.51 29.44 Favored 'General case' 0 C--N 1.327 -0.399 0 CA-C-N 116.331 -0.395 . . . . 0.0 111.257 -176.77 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' B' B ' 112' ' ' LEU . . . . . . . . . . . . . 11.6 mt -106.71 -45.99 4.08 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.041 -0.527 . . . . 0.0 110.176 176.889 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' B' B ' 113' ' ' TYR . . . . . . . . . . . . . 55.9 t80 -140.45 140.69 35.43 Favored 'General case' 0 C--N 1.33 -0.243 0 C-N-CA 120.74 -0.384 . . . . 0.0 110.956 -178.84 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' B' B ' 114' ' ' ARG . . . . . . . . . . . . . 21.0 mtp-105 -139.36 126.22 20.88 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.244 -0.435 . . . . 0.0 110.209 176.04 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' B' B ' 115' ' ' GLY . . . . . . . . . . . . . . . -150.07 142.81 10.03 Favored Glycine 0 CA--C 1.523 0.532 0 N-CA-C 111.229 -0.748 . . . . 0.0 111.229 179.826 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' B' B ' 116' ' ' LYS . . . . . . . . . . . . . 39.1 ttpt -112.02 132.82 54.57 Favored 'General case' 0 C--N 1.33 -0.245 0 N-CA-C 109.774 -0.454 . . . . 0.0 109.774 177.955 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' B' B ' 117' ' ' PHE . . . . . . . . . . . . . 40.9 m-85 -134.27 113.87 12.42 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-O 120.942 0.401 . . . . 0.0 110.198 -176.532 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' B' B ' 118' ' ' GLU . . . . . . . . . . . . . 95.8 mt-10 -56.34 -41.93 76.9 Favored 'General case' 0 C--N 1.326 -0.426 0 CA-C-N 116.13 -0.487 . . . . 0.0 111.196 -174.594 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' B' B ' 119' ' ' ASN . . . . . . . . . . . . . 88.5 m-20 -100.6 31.12 3.61 Favored 'General case' 0 C--N 1.329 -0.295 0 N-CA-C 112.213 0.449 . . . . 0.0 112.213 -173.853 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' B' B ' 120' ' ' LEU . . . . . . . . . . . . . 9.7 tp -55.25 122.03 10.18 Favored 'General case' 0 N--CA 1.462 0.158 0 C-N-CA 121.044 -0.262 . . . . 0.0 110.674 178.062 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' B' B ' 121' ' ' ASN . . . . . . . . . . . . . 3.5 m-20 -114.09 -44.14 3.17 Favored 'General case' 0 C--N 1.332 -0.153 0 CA-C-N 116.63 -0.259 . . . . 0.0 111.18 -176.242 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' B' B ' 122' ' ' LYS . . . . . . . . . . . . . 16.1 ttmm -151.79 142.65 22.97 Favored 'General case' 0 C--N 1.331 -0.206 0 C-N-CA 120.363 -0.535 . . . . 0.0 111.712 -176.828 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' B' B ' 123' ' ' VAL . . . . . . . . . . . . . 46.2 t -120.72 130.79 74.18 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.256 0 CA-C-N 115.825 -0.625 . . . . 0.0 109.628 177.139 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' B' B ' 124' ' ' LEU . . . . . . . . . . . . . 75.4 mt -127.83 138.48 52.72 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-O 120.831 0.348 . . . . 0.0 110.692 -178.424 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' B' B ' 125' ' ' VAL . . . . . . . . . . . . . 35.0 m -130.7 143.15 41.78 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.245 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.909 -179.567 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' B' B ' 126' ' ' ARG . . . . . . . . . . . . . 94.3 mtt-85 -148.34 117.72 6.94 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 115.832 -0.622 . . . . 0.0 109.397 176.205 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' B' B ' 127' ' ' ASN . . . . . . . . . . . . . 79.8 m-20 56.61 -143.35 0.71 Allowed 'General case' 0 CA--C 1.541 0.615 0 CA-C-O 119.138 -0.458 . . . . 0.0 109.773 -179.39 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' B' B ' 128' ' ' ASP . . . . . . . . . . . . . 12.0 p-10 -85.76 10.28 14.06 Favored 'General case' 0 CA--C 1.535 0.396 0 CA-C-N 119.248 0.931 . . . . 0.0 113.229 179.953 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' B' B ' 129' ' ' LEU . . . . . . . . . . . . . 28.2 mt -111.22 145.15 39.22 Favored 'General case' 0 N--CA 1.463 0.189 0 O-C-N 121.841 -0.537 . . . . 0.0 109.762 179.112 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' B' B ' 130' ' ' VAL . . . . . . . . . . . . . 32.6 m -137.13 148.09 26.53 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.262 0 CA-C-O 121.315 0.578 . . . . 0.0 111.923 -175.943 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' B' B ' 131' ' ' VAL . . . . . . . . . . . . . 43.9 t -136.14 137.7 48.14 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.225 0 CA-C-N 115.535 -0.757 . . . . 0.0 110.087 177.504 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' B' B ' 132' ' ' ILE . . . . . . . . . . . . . 75.3 mt -118.77 132.02 69.87 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.287 0 CA-C-N 116.028 -0.533 . . . . 0.0 109.669 -179.757 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' B' B ' 133' ' ' ILE . . . . . . . . . . . . . 41.0 mm -115.62 122.83 70.23 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.251 0 CA-C-N 116.414 -0.357 . . . . 0.0 110.883 -175.339 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' B' B ' 134' ' ' ASP . . . . . . . . . . . . . 9.3 p-10 -136.91 144.24 43.37 Favored 'General case' 0 C--N 1.331 -0.222 0 N-CA-C 109.691 -0.485 . . . . 0.0 109.691 173.282 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' B' B ' 135' ' ' GLU . . . . . . . . . . . . . 33.0 tp10 -49.91 -24.38 2.48 Favored 'General case' 0 C--N 1.326 -0.431 0 N-CA-C 112.806 0.669 . . . . 0.0 112.806 -172.394 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' B' B ' 136' ' ' GLN . . . . . . . . . . . . . 48.1 tt0 -82.51 -38.57 23.65 Favored 'General case' 0 C--N 1.332 -0.168 0 N-CA-C 112.082 0.401 . . . . 0.0 112.082 -176.934 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' B' B ' 137' ' ' LYS . . . . . . . . . . . . . 58.7 pttt -160.01 168.55 25.37 Favored 'General case' 0 C--O 1.234 0.256 0 CA-C-O 121.495 0.664 . . . . 0.0 112.119 -173.1 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' B' B ' 138' ' ' LEU . . . . . . . . . . . . . 5.1 tt -116.39 127.45 54.65 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 115.155 -0.93 . . . . 0.0 109.781 178.38 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' B' B ' 139' ' ' THR . . . . . . . . . . . . . 31.8 m -109.79 124.83 51.96 Favored 'General case' 0 C--N 1.331 -0.217 0 CA-C-O 120.738 0.304 . . . . 0.0 110.381 179.926 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' B' B ' 140' ' ' LEU . . . . . . . . . . . . . 11.2 tp -114.86 117.27 30.23 Favored 'General case' 0 C--N 1.328 -0.367 0 N-CA-C 108.897 -0.779 . . . . 0.0 108.897 -179.183 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' B' B ' 141' ' ' ILE . . . . . . . . . . . . . 18.9 mt -117.22 117.01 53.85 Favored 'Isoleucine or valine' 0 C--O 1.236 0.361 0 CA-C-O 121.129 0.49 . . . . 0.0 110.069 -174.373 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' B' B ' 142' ' ' ARG . . . . . . . . . . . . . 2.0 mtp85 -103.72 135.01 46.09 Favored 'General case' 0 C--N 1.331 -0.201 0 CA-C-N 115.033 -0.985 . . . . 0.0 109.824 -177.353 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' B' B ' 143' ' ' THR . . . . . . . . . . . . . 72.7 p . . . . . 0 C--O 1.22 -0.478 0 CA-C-O 118.241 -0.885 . . . . 0.0 110.763 -179.722 . . . . . . . . 0 0 . 1 . 013 nuclear orig full ' C' C ' -3' ' ' GLU . . . . . . . . . . . . . 84.8 tt0 . . . . . 0 N--CA 1.491 1.609 0 N-CA-C 109.256 -0.646 . . . . 0.0 109.256 . . . . . . . . . 0 0 . 1 . 013 nuclear orig full ' C' C ' -2' ' ' GLY . . . . . . . . . . . . . . . -71.31 145.16 38.72 Favored Glycine 0 CA--C 1.524 0.617 0 N-CA-C 110.686 -0.966 . . . . 0.0 110.686 178.718 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' C' C ' -1' ' ' VAL . . . . . . . . . . . . . 47.4 t -93.88 133.78 33.78 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.275 0 N-CA-C 109.902 -0.407 . . . . 0.0 109.902 179.868 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' C' C ' 0' ' ' ILE . . . . . . . . . . . . . 71.6 mt -110.41 129.94 64.58 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.217 0 CA-C-N 116.127 -0.488 . . . . 0.0 109.875 -179.082 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' C' C ' 1' ' ' MET . . . . . . . . . . . . . 24.9 ptp -80.98 133.3 35.48 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.062 -0.517 . . . . 0.0 110.938 -178.626 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' C' C ' 2' ' ' SER . . . . . . . . . . . . . 2.4 p -127.24 124.95 40.08 Favored 'General case' 0 C--N 1.332 -0.191 0 CA-C-N 116.084 -0.507 . . . . 0.0 110.274 177.919 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' C' C ' 3' ' ' GLU . . . . . . . . . . . . . 84.2 tt0 -139.77 140.1 36.62 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 115.918 -0.583 . . . . 0.0 111.045 -177.244 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' C' C ' 4' ' ' LEU . . . . . . . . . . . . . 18.0 tp -126.7 130.16 49.83 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.028 -0.533 . . . . 0.0 110.203 177.752 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' C' C ' 5' ' ' LYS . . . . . . . . . . . . . 61.4 mttp -109.06 119.8 40.63 Favored 'General case' 0 C--O 1.233 0.22 0 CA-C-O 120.9 0.381 . . . . 0.0 110.693 179.054 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' C' C ' 6' ' ' LEU . . . . . . . . . . . . . 36.6 mt -115.04 148.82 38.38 Favored 'General case' 0 C--N 1.331 -0.211 0 CA-C-N 115.359 -0.837 . . . . 0.0 110.554 179.495 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' C' C ' 7' ' ' LYS . . . . . . . . . . . . . 25.9 ttpp -135.25 135.29 22.36 Favored Pre-proline 0 CA--C 1.535 0.392 0 CA-C-O 118.773 -0.632 . . . . 0.0 109.966 176.418 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' C' C ' 8' ' ' PRO . . . . . . . . . . . . . 89.7 Cg_endo -88.82 136.6 3.12 Favored 'Trans proline' 0 N--CA 1.492 1.383 0 C-N-CA 121.534 1.489 . . . . 0.0 111.515 176.344 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' C' C ' 9' ' ' LEU . . . . . . . . . . . . . 51.1 mt -73.32 -47.62 7.57 Favored Pre-proline 0 CA--C 1.534 0.335 0 CA-C-O 118.616 -0.707 . . . . 0.0 112.17 -178.237 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' C' C ' 10' ' ' PRO . . . . . . . . . . . . . 97.8 Cg_endo -79.8 145.57 18.06 Favored 'Trans proline' 0 N--CA 1.495 1.598 0 C-N-CA 121.104 1.202 . . . . 0.0 111.639 175.381 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' C' C ' 11' ' ' LYS . . . . . . . . . . . . . 52.9 pttt -78.43 111.88 14.9 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-O 121.601 0.715 . . . . 0.0 110.561 179.026 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' C' C ' 12' ' ' VAL . . . . . . . . . . . . . 12.4 p -151.11 148.32 14.99 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.295 0 CA-C-N 115.609 -0.723 . . . . 0.0 110.612 -179.437 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' C' C ' 13' ' ' GLU . . . . . . . . . . . . . 49.1 mp0 -91.65 120.78 32.72 Favored 'General case' 0 C--N 1.331 -0.236 0 N-CA-C 109.752 -0.462 . . . . 0.0 109.752 174.997 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' C' C ' 14' ' ' LEU . . . . . . . . . . . . . 14.7 mt -89.01 152.11 47.88 Favored Pre-proline 0 C--N 1.329 -0.287 0 CA-C-N 116.501 -0.318 . . . . 0.0 110.768 -176.984 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' C' C ' 15' ' ' PRO . . . . . . . . . . . . . 37.0 Cg_exo -59.8 162.33 16.11 Favored 'Trans proline' 0 N--CA 1.498 1.768 0 C-N-CA 121.329 1.353 . . . . 0.0 111.835 176.771 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' C' C ' 16' ' ' PRO . . . . . . . . . . . . . 37.9 Cg_exo -58.46 -44.02 41.13 Favored 'Trans proline' 0 N--CA 1.497 1.731 0 C-N-CA 121.444 1.429 . . . . 0.0 112.861 -177.242 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' C' C ' 17' ' ' ASP . . . . . . . . . . . . . 23.3 p-10 -92.44 17.05 10.53 Favored 'General case' 0 CA--C 1.536 0.433 0 N-CA-C 112.924 0.712 . . . . 0.0 112.924 -176.964 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' C' C ' 18' ' ' PHE . . . . . . . . . . . . . 52.8 t80 -57.24 -41.8 80.25 Favored 'General case' 0 C--N 1.333 -0.128 0 O-C-N 122.106 -0.371 . . . . 0.0 110.227 -179.193 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' C' C ' 19' ' ' VAL . . . . . . . . . . . . . 48.7 t -56.93 -43.41 80.51 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.303 0 CA-C-N 116.434 -0.348 . . . . 0.0 110.317 -179.468 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' C' C ' 20' ' ' ASP . . . . . . . . . . . . . 16.4 m-20 -60.1 -42.57 94.97 Favored 'General case' 0 C--N 1.33 -0.272 0 C-N-CA 120.98 -0.288 . . . . 0.0 111.173 -178.821 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' C' C ' 21' ' ' VAL . . . . . . . . . . . . . 48.3 t -63.96 -46.62 93.52 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.278 0 C-N-CA 120.794 -0.362 . . . . 0.0 110.37 -177.491 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' C' C ' 22' ' ' ILE . . . . . . . . . . . . . 51.4 mm -56.42 -45.82 81.88 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.208 0 CA-C-O 120.747 0.308 . . . . 0.0 110.423 178.221 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' C' C ' 23' ' ' ARG . . . . . . . . . . . . . 50.6 ttp180 -54.6 -47.83 72.9 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.589 -0.278 . . . . 0.0 111.488 -178.501 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' C' C ' 24' ' ' ILE . . . . . . . . . . . . . 76.5 mt -59.85 -44.09 93.38 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.362 0 CA-C-O 120.606 0.241 . . . . 0.0 111.045 -178.376 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' C' C ' 25' ' ' LYS . . . . . . . . . . . . . 54.7 mtmt -64.62 -41.44 96.19 Favored 'General case' 0 C--N 1.327 -0.377 0 N-CA-C 112.367 0.506 . . . . 0.0 112.367 -178.332 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' C' C ' 26' ' ' LEU . . . . . . . . . . . . . 79.6 mt -79.2 -40.35 31.0 Favored 'General case' 0 C--N 1.33 -0.266 0 N-CA-C 113.416 0.895 . . . . 0.0 113.416 -171.397 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' C' C ' 27' ' ' GLN . . . . . . . . . . . . . 9.9 pt20 -46.78 139.5 5.32 Favored 'General case' 0 N--CA 1.47 0.526 0 N-CA-C 112.703 0.631 . . . . 0.0 112.703 -175.041 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' C' C ' 28' ' ' GLY . . . . . . . . . . . . . . . 100.72 -26.19 25.54 Favored Glycine 0 CA--C 1.534 1.271 0 CA-C-N 115.467 -0.788 . . . . 0.0 112.179 -176.586 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' C' C ' 29' ' ' LYS . . . . . . . . . . . . . 99.1 mttt -98.6 155.12 17.46 Favored 'General case' 0 C--N 1.331 -0.198 0 CA-C-N 117.411 0.605 . . . . 0.0 111.365 179.277 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' C' C ' 30' ' ' THR . . . . . . . . . . . . . 38.1 m -103.28 135.91 44.03 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 115.886 -0.597 . . . . 0.0 109.979 175.758 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' C' C ' 31' ' ' VAL . . . . . . . . . . . . . 34.7 m -130.01 152.95 38.17 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.229 0 CA-C-O 120.934 0.397 . . . . 0.0 110.867 -178.597 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' C' C ' 32' ' ' ARG . . . . . . . . . . . . . 34.5 ttp180 -130.59 149.84 52.07 Favored 'General case' 0 C--N 1.331 -0.221 0 CA-C-N 116.027 -0.533 . . . . 0.0 110.452 179.519 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' C' C ' 33' ' ' THR . . . . . . . . . . . . . 19.1 m -52.65 139.17 26.77 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.241 -0.436 . . . . 0.0 111.498 -177.111 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' C' C ' 34' ' ' GLY . . . . . . . . . . . . . . . 100.21 -17.19 57.34 Favored Glycine 0 CA--C 1.533 1.165 0 CA-C-O 119.644 -0.531 . . . . 0.0 113.179 179.321 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' C' C ' 35' ' ' ASP . . . . . . . . . . . . . 70.9 m-20 -65.41 149.24 50.35 Favored 'General case' 0 C--O 1.231 0.083 0 CA-C-N 118.087 0.944 . . . . 0.0 111.276 179.303 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' C' C ' 36' ' ' VAL . . . . . . . . . . . . . 45.2 t -123.3 130.71 74.12 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.215 0 CA-C-N 115.735 -0.666 . . . . 0.0 109.658 178.065 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' C' C ' 37' ' ' ILE . . . . . . . . . . . . . 67.8 mt -121.06 138.57 51.04 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.24 0 CA-C-N 116.306 -0.406 . . . . 0.0 110.05 -179.609 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' C' C ' 38' ' ' GLY . . . . . . . . . . . . . . . -110.47 128.77 8.97 Favored Glycine 0 CA--C 1.525 0.703 0 N-CA-C 110.859 -0.896 . . . . 0.0 110.859 179.263 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' C' C ' 39' ' ' ILE . . . . . . . . . . . . . 73.2 mt -122.68 129.56 75.11 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.226 0 N-CA-C 110.069 -0.345 . . . . 0.0 110.069 179.812 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' C' C ' 40' ' ' SER . . . . . . . . . . . . . 87.3 p -93.15 120.34 33.34 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.425 -0.352 . . . . 0.0 110.991 176.744 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' C' C ' 41' ' ' ILE . . . . . . . . . . . . . 70.2 mt -133.3 127.49 54.17 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.258 0 CA-C-O 120.886 0.374 . . . . 0.0 110.446 177.955 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' C' C ' 42' ' ' LEU . . . . . . . . . . . . . 11.2 tp 53.23 34.53 17.85 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.035 -0.53 . . . . 0.0 111.593 177.1 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' C' C ' 43' ' ' GLY . . . . . . . . . . . . . . . 71.2 31.07 66.62 Favored Glycine 0 CA--C 1.531 1.061 0 C-N-CA 121.094 -0.574 . . . . 0.0 111.941 177.907 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' C' C ' 44' ' ' LYS . . . . . . . . . . . . . 80.5 tttt -138.43 126.83 23.14 Favored 'General case' 0 C--N 1.329 -0.296 0 N-CA-C 109.751 -0.463 . . . . 0.0 109.751 179.834 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' C' C ' 45' ' ' GLU . . . . . . . . . . . . . 81.9 tt0 -84.37 122.83 29.49 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-N 116.45 -0.341 . . . . 0.0 111.003 -178.398 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' C' C ' 46' ' ' VAL . . . . . . . . . . . . . 7.2 p -119.88 130.29 74.38 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.302 0 N-CA-C 109.449 -0.574 . . . . 0.0 109.449 175.877 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' C' C ' 47' ' ' LYS . . . . . . . . . . . . . 64.9 mttp -100.27 127.86 46.47 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 115.979 -0.555 . . . . 0.0 111.356 178.768 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' C' C ' 48' ' ' PHE . . . . . . . . . . . . . 94.6 m-85 -111.33 131.88 54.83 Favored 'General case' 0 C--N 1.33 -0.273 0 N-CA-C 109.674 -0.491 . . . . 0.0 109.674 175.495 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' C' C ' 49' ' ' LYS . . . . . . . . . . . . . 83.3 tttt -108.48 137.06 47.06 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.401 -0.363 . . . . 0.0 110.654 179.869 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' C' C ' 50' ' ' VAL . . . . . . . . . . . . . 41.0 t -83.21 107.57 15.01 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.243 0 N-CA-C 109.421 -0.585 . . . . 0.0 109.421 176.465 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' C' C ' 51' ' ' VAL . . . . . . . . . . . . . 48.9 t -72.46 -53.48 19.23 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.275 0 N-CA-C 109.581 -0.525 . . . . 0.0 109.581 -175.455 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' C' C ' 52' ' ' GLN . . . . . . . . . . . . . 90.9 mt-30 -154.07 151.6 29.5 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.02 -0.536 . . . . 0.0 111.832 -177.647 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' C' C ' 53' ' ' ALA . . . . . . . . . . . . . . . -130.12 133.78 46.88 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 115.318 -0.855 . . . . 0.0 109.827 174.463 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' C' C ' 54' ' ' TYR . . . . . . . . . . . . . 53.7 t80 -129.16 111.27 18.22 Favored Pre-proline 0 CA--C 1.535 0.377 0 CA-C-O 118.267 -0.873 . . . . 0.0 110.395 178.662 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' C' C ' 55' ' ' PRO . . . . . . . . . . . . . 73.3 Cg_endo -77.1 166.33 82.64 Favored 'Cis proline' 0 N--CA 1.499 1.84 0 CA-C-N 121.919 1.721 . . . . 0.0 112.348 -6.855 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' C' C ' 56' ' ' SER . . . . . . . . . . . . . 20.3 m -116.74 135.94 23.09 Favored Pre-proline 0 CA--C 1.538 0.519 0 CA-C-O 118.423 -0.798 . . . . 0.0 109.363 173.775 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' C' C ' 57' ' ' PRO . . . . . . . . . . . . . 49.4 Cg_endo -70.0 146.03 81.58 Favored 'Cis proline' 0 N--CA 1.497 1.733 0 CA-C-N 121.832 1.69 . . . . 0.0 111.473 -1.837 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' C' C ' 58' ' ' LEU . . . . . . . . . . . . . 31.9 tp -108.16 137.65 45.77 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.331 -0.395 . . . . 0.0 110.696 -177.704 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' C' C ' 59' ' ' ARG . . . . . . . . . . . . . 55.6 ttp180 -102.89 125.23 49.56 Favored 'General case' 0 C--N 1.327 -0.377 0 N-CA-C 109.227 -0.657 . . . . 0.0 109.227 174.653 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' C' C ' 60' ' ' VAL . . . . . . . . . . . . . 45.8 t -79.66 120.78 31.66 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.293 0 C-N-CA 120.689 -0.404 . . . . 0.0 110.65 -174.717 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' C' C ' 61' ' ' GLU . . . . . . . . . . . . . 43.3 mt-10 -131.03 163.05 28.44 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 115.747 -0.661 . . . . 0.0 109.675 176.542 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' C' C ' 62' ' ' ASP . . . . . . . . . . . . . 9.3 p-10 -53.36 -32.58 49.93 Favored 'General case' 0 C--N 1.328 -0.342 0 N-CA-C 111.894 0.331 . . . . 0.0 111.894 -178.634 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' C' C ' 63' ' ' ARG . . . . . . . . . . . . . 47.8 mtp180 -73.52 -21.5 60.37 Favored 'General case' 0 CA--C 1.534 0.335 0 N-CA-C 113.033 0.753 . . . . 0.0 113.033 -176.216 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' C' C ' 64' ' ' THR . . . . . . . . . . . . . 30.2 m -61.53 138.53 58.29 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-O 120.973 0.416 . . . . 0.0 111.341 -174.02 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' C' C ' 65' ' ' LYS . . . . . . . . . . . . . 40.5 ttpt -89.34 120.37 30.62 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 115.821 -0.627 . . . . 0.0 109.946 177.631 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' C' C ' 66' ' ' ILE . . . . . . . . . . . . . 64.0 mt -113.19 130.26 67.42 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.201 0 CA-C-O 120.894 0.378 . . . . 0.0 109.989 -178.434 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' C' C ' 67' ' ' THR . . . . . . . . . . . . . 25.5 m -129.41 147.36 51.22 Favored 'General case' 0 C--N 1.332 -0.186 0 CA-C-N 116.106 -0.497 . . . . 0.0 111.173 -177.815 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' C' C ' 68' ' ' LEU . . . . . . . . . . . . . 62.8 mt -100.38 136.67 39.91 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 115.851 -0.613 . . . . 0.0 110.381 177.038 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' C' C ' 69' ' ' VAL . . . . . . . . . . . . . 43.3 t -96.99 135.47 30.99 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.361 0 CA-C-N 116.136 -0.484 . . . . 0.0 109.995 179.266 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' C' C ' 70' ' ' THR . . . . . . . . . . . . . 47.9 p -131.33 174.83 9.67 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 116.209 -0.451 . . . . 0.0 110.886 -178.076 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' C' C ' 71' ' ' HIS . . . . . . . . . . . . . 19.6 m-70 -64.9 159.47 63.28 Favored Pre-proline 0 C--N 1.329 -0.315 0 CA-C-N 115.842 -0.617 . . . . 0.0 110.478 179.832 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' C' C ' 72' ' ' PRO . . . . . . . . . . . . . 30.9 Cg_endo -64.97 -28.4 57.96 Favored 'Trans proline' 0 N--CA 1.497 1.704 0 C-N-CA 121.114 1.209 . . . . 0.0 112.179 177.816 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' C' C ' 73' ' ' VAL . . . . . . . . . . . . . 33.2 m -132.21 151.91 35.73 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.19 0 CA-C-O 120.978 0.418 . . . . 0.0 110.718 177.827 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' C' C ' 74' ' ' ASP . . . . . . . . . . . . . 27.7 t0 -102.16 121.62 42.58 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 115.698 -0.683 . . . . 0.0 109.405 176.745 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' C' C ' 75' ' ' VAL . . . . . . . . . . . . . 43.1 t -110.82 121.32 63.33 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.249 0 CA-C-O 121.056 0.455 . . . . 0.0 110.825 -175.543 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' C' C ' 76' ' ' LEU . . . . . . . . . . . . . 21.9 mt -117.86 141.9 47.91 Favored 'General case' 0 C--N 1.331 -0.206 0 CA-C-N 115.598 -0.728 . . . . 0.0 109.693 176.114 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' C' C ' 77' ' ' GLU . . . . . . . . . . . . . 97.9 mt-10 -136.2 135.53 39.2 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-O 120.98 0.419 . . . . 0.0 111.307 -178.168 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' C' C ' 78' ' ' ALA . . . . . . . . . . . . . . . -124.61 134.56 52.88 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 115.627 -0.715 . . . . 0.0 109.882 176.801 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' C' C ' 79' ' ' LYS . . . . . . . . . . . . . 66.3 mmtt -78.54 121.25 24.36 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-O 120.976 0.417 . . . . 0.0 110.597 179.851 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' C' C ' 80' ' ' ILE . . . . . . . . . . . . . 42.2 mm -139.06 115.06 9.41 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.305 0 N-CA-C 109.291 -0.633 . . . . 0.0 109.291 -178.422 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' C' C ' 81' ' ' LYS . . . . . . . . . . . . . 46.7 pttt -104.11 123.37 47.13 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-O 121.085 0.469 . . . . 0.0 111.096 -178.437 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' C' C ' 82' ' ' GLY . . . . . . . . . . . . . . . 89.07 42.13 5.69 Favored Glycine 0 CA--C 1.525 0.697 0 C-N-CA 120.701 -0.761 . . . . 0.0 111.838 174.358 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' C' C ' 83' ' ' ILE . . . . . . . . . . . . . 70.6 mt -64.22 138.45 23.04 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.272 0 N-CA-C 109.73 -0.471 . . . . 0.0 109.73 177.691 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' C' C ' 84' ' ' LYS . . . . . . . . . . . . . 77.4 tttt -100.14 -51.15 3.75 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 115.995 -0.548 . . . . 0.0 110.465 -177.325 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' C' C ' 85' ' ' ASP . . . . . . . . . . . . . 5.1 t0 -156.51 152.26 27.13 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.014 -0.539 . . . . 0.0 110.319 -179.707 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' C' C ' 86' ' ' VAL . . . . . . . . . . . . . 44.0 t -130.16 132.73 65.04 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.229 0 CA-C-O 121.021 0.438 . . . . 0.0 110.622 -179.461 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' C' C ' 87' ' ' ILE . . . . . . . . . . . . . 43.5 mm -122.04 125.19 72.75 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.29 0 CA-C-N 115.948 -0.569 . . . . 0.0 109.604 176.098 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' C' C ' 88' ' ' LEU . . . . . . . . . . . . . 14.8 tp -111.03 129.27 55.96 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-O 120.84 0.352 . . . . 0.0 111.139 -177.145 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' C' C ' 89' ' ' ASP . . . . . . . . . . . . . 12.6 t70 -121.38 151.25 40.36 Favored 'General case' 0 C--N 1.33 -0.258 0 N-CA-C 109.555 -0.535 . . . . 0.0 109.555 176.67 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' C' C ' 90' ' ' GLU . . . . . . . . . . . . . 83.5 tt0 -48.86 -33.24 10.24 Favored 'General case' 0 C--N 1.328 -0.342 0 N-CA-C 112.64 0.607 . . . . 0.0 112.64 -173.082 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' C' C ' 91' ' ' ASN . . . . . . . . . . . . . 79.2 m-20 -131.99 28.14 4.5 Favored 'General case' 0 N--CA 1.466 0.333 0 N-CA-C 112.411 0.523 . . . . 0.0 112.411 -175.764 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' C' C ' 92' ' ' LEU . . . . . . . . . . . . . 11.7 tp -166.2 150.94 8.05 Favored 'General case' 0 C--N 1.33 -0.245 0 C-N-CA 120.835 -0.346 . . . . 0.0 110.851 -179.281 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' C' C ' 93' ' ' ILE . . . . . . . . . . . . . 69.0 mt -126.87 125.72 67.21 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.173 0 N-CA-C 109.757 -0.46 . . . . 0.0 109.757 179.629 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' C' C ' 94' ' ' VAL . . . . . . . . . . . . . 43.2 t -123.14 128.67 75.1 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.238 0 N-CA-C 110.077 -0.342 . . . . 0.0 110.077 178.957 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' C' C ' 95' ' ' VAL . . . . . . . . . . . . . 40.9 t -124.23 136.86 59.08 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.235 0 CA-C-O 120.933 0.397 . . . . 0.0 110.072 -179.406 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' C' C ' 96' ' ' ILE . . . . . . . . . . . . . 59.7 mt -114.31 130.11 69.16 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.335 0 N-CA-C 109.266 -0.642 . . . . 0.0 109.266 179.035 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' C' C ' 97' ' ' THR . . . . . . . . . . . . . 68.1 p -102.93 154.36 19.29 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-O 121.253 0.549 . . . . 0.0 111.192 -177.704 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' C' C ' 98' ' ' GLU . . . . . . . . . . . . . 84.0 tt0 -53.86 -24.61 16.41 Favored 'General case' 0 CA--C 1.533 0.322 0 N-CA-C 112.299 0.481 . . . . 0.0 112.299 179.625 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' C' C ' 99' ' ' GLU . . . . . . . . . . . . . 13.8 mm-40 -77.67 14.71 0.97 Allowed 'General case' 0 CA--C 1.535 0.391 0 N-CA-C 113.266 0.839 . . . . 0.0 113.266 -177.471 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' C' C ' 100' ' ' ASN . . . . . . . . . . . . . 2.9 m-20 62.89 38.05 11.64 Favored 'General case' 0 N--CA 1.464 0.245 0 CA-C-O 121.116 0.484 . . . . 0.0 110.757 178.686 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' C' C ' 101' ' ' GLU . . . . . . . . . . . . . 83.6 tt0 -122.36 145.97 47.77 Favored 'General case' 0 C--N 1.331 -0.217 0 CA-C-N 116.182 -0.463 . . . . 0.0 109.924 177.773 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' C' C ' 102' ' ' VAL . . . . . . . . . . . . . 44.1 t -114.95 129.26 71.44 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.232 0 CA-C-N 116.302 -0.408 . . . . 0.0 110.047 -177.396 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' C' C ' 103' ' ' LEU . . . . . . . . . . . . . 27.6 mt -119.63 131.55 55.49 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 115.59 -0.732 . . . . 0.0 110.131 177.06 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' C' C ' 104' ' ' ILE . . . . . . . . . . . . . 72.3 mt -117.15 125.07 73.73 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.276 0 N-CA-C 109.816 -0.438 . . . . 0.0 109.816 178.872 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' C' C ' 105' ' ' PHE . . . . . . . . . . . . . 93.8 m-85 -122.49 163.44 19.89 Favored 'General case' 0 C--O 1.232 0.144 0 O-C-N 123.904 0.752 . . . . 0.0 109.945 -177.909 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' C' C ' 106' ' ' ASN . . . . . . . . . . . . . 44.9 p-10 -101.08 -171.25 1.96 Allowed 'General case' 0 C--N 1.332 -0.19 0 CA-C-N 116.549 -0.296 . . . . 0.0 110.249 174.755 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' C' C ' 107' ' ' GLN . . . . . . . . . . . . . 40.4 tt0 -58.32 -29.51 65.97 Favored 'General case' 0 CA--C 1.533 0.297 0 N-CA-C 112.027 0.38 . . . . 0.0 112.027 -179.972 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' C' C ' 108' ' ' ASN . . . . . . . . . . . . . 5.1 t-20 -85.27 7.9 20.51 Favored 'General case' 0 CA--C 1.538 0.506 0 N-CA-C 113.279 0.844 . . . . 0.0 113.279 -176.559 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' C' C ' 109' ' ' LEU . . . . . . . . . . . . . 10.7 tp 60.07 36.97 21.3 Favored 'General case' 0 CA--C 1.531 0.225 0 CA-C-O 120.98 0.419 . . . . 0.0 111.28 179.513 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' C' C ' 110' ' ' GLU . . . . . . . . . . . . . 70.6 mm-40 -108.83 147.96 31.3 Favored 'General case' 0 C--N 1.33 -0.269 0 N-CA-C 109.653 -0.499 . . . . 0.0 109.653 175.199 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' C' C ' 111' ' ' GLU . . . . . . . . . . . . . 55.4 tt0 -82.57 121.92 27.42 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-O 120.958 0.409 . . . . 0.0 111.022 -174.122 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' C' C ' 112' ' ' LEU . . . . . . . . . . . . . 11.8 mt -103.28 -46.2 4.67 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 115.936 -0.574 . . . . 0.0 110.888 179.47 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' C' C ' 113' ' ' TYR . . . . . . . . . . . . . 64.2 t80 -133.34 136.6 45.48 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 116.464 -0.335 . . . . 0.0 111.397 -177.444 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' C' C ' 114' ' ' ARG . . . . . . . . . . . . . 35.8 ttp180 -135.44 121.0 19.36 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 115.918 -0.583 . . . . 0.0 110.316 177.841 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' C' C ' 115' ' ' GLY . . . . . . . . . . . . . . . -150.01 145.44 13.54 Favored Glycine 0 CA--C 1.524 0.638 0 N-CA-C 111.062 -0.815 . . . . 0.0 111.062 178.122 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' C' C ' 116' ' ' LYS . . . . . . . . . . . . . 34.6 ttpt -117.16 138.34 51.73 Favored 'General case' 0 C--N 1.33 -0.249 0 N-CA-C 109.9 -0.407 . . . . 0.0 109.9 177.974 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' C' C ' 117' ' ' PHE . . . . . . . . . . . . . 46.1 m-85 -135.47 113.97 11.66 Favored 'General case' 0 C--N 1.33 -0.264 0 N-CA-C 109.941 -0.392 . . . . 0.0 109.941 -178.573 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' C' C ' 118' ' ' GLU . . . . . . . . . . . . . 45.8 tp10 -55.05 -42.66 72.98 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.391 -0.368 . . . . 0.0 111.211 -176.304 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' C' C ' 119' ' ' ASN . . . . . . . . . . . . . 4.7 m120 -99.81 31.11 3.37 Favored 'General case' 0 C--N 1.33 -0.247 0 N-CA-C 112.255 0.465 . . . . 0.0 112.255 -173.852 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' C' C ' 120' ' ' LEU . . . . . . . . . . . . . 15.9 tp -56.02 119.99 6.75 Favored 'General case' 0 N--CA 1.461 0.118 0 CA-C-O 120.783 0.325 . . . . 0.0 110.377 177.603 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' C' C ' 121' ' ' ASN . . . . . . . . . . . . . 7.8 t-20 -113.84 -44.1 3.21 Favored 'General case' 0 C--N 1.332 -0.157 0 CA-C-N 116.457 -0.338 . . . . 0.0 110.944 -176.208 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' C' C ' 122' ' ' LYS . . . . . . . . . . . . . 61.8 mtpt -140.23 146.17 38.32 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-O 121.079 0.466 . . . . 0.0 111.518 -177.682 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' C' C ' 123' ' ' VAL . . . . . . . . . . . . . 47.7 t -124.16 126.88 72.93 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.319 0 CA-C-N 115.816 -0.629 . . . . 0.0 109.582 175.557 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' C' C ' 124' ' ' LEU . . . . . . . . . . . . . 50.9 mt -114.5 127.75 55.97 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.141 -0.481 . . . . 0.0 110.126 -179.331 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' C' C ' 125' ' ' VAL . . . . . . . . . . . . . 41.4 t -135.6 121.93 32.3 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.33 0 CA-C-O 120.765 0.317 . . . . 0.0 110.259 179.478 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' C' C ' 126' ' ' ARG . . . . . . . . . . . . . 79.0 mtt85 -151.39 136.15 17.19 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 116.094 -0.503 . . . . 0.0 109.696 175.831 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' C' C ' 127' ' ' ASN . . . . . . . . . . . . . 75.6 m-20 56.13 -152.1 0.38 Allowed 'General case' 0 CA--C 1.539 0.532 0 N-CA-C 109.702 -0.481 . . . . 0.0 109.702 -178.202 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' C' C ' 128' ' ' ASP . . . . . . . . . . . . . 20.2 p-10 -88.08 21.54 2.72 Favored 'General case' 0 CA--C 1.534 0.346 0 CA-C-N 118.596 0.635 . . . . 0.0 112.377 176.806 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' C' C ' 129' ' ' LEU . . . . . . . . . . . . . 1.4 tt -115.43 134.67 54.87 Favored 'General case' 0 C--O 1.235 0.312 0 O-C-N 122.039 -0.413 . . . . 0.0 109.963 -179.338 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' C' C ' 130' ' ' VAL . . . . . . . . . . . . . 41.6 t -123.06 139.88 48.45 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.313 0 CA-C-O 121.017 0.437 . . . . 0.0 110.579 -175.788 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' C' C ' 131' ' ' VAL . . . . . . . . . . . . . 41.4 t -135.99 135.8 50.14 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.278 0 CA-C-N 116.097 -0.501 . . . . 0.0 110.266 178.209 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' C' C ' 132' ' ' ILE . . . . . . . . . . . . . 71.8 mt -117.44 131.53 69.88 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.314 0 N-CA-C 109.502 -0.555 . . . . 0.0 109.502 179.297 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' C' C ' 133' ' ' ILE . . . . . . . . . . . . . 35.7 mm -115.6 119.62 62.36 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.25 0 CA-C-O 120.803 0.335 . . . . 0.0 110.86 -176.387 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' C' C ' 134' ' ' ASP . . . . . . . . . . . . . 5.9 p-10 -129.71 148.81 51.63 Favored 'General case' 0 C--N 1.332 -0.193 0 CA-C-N 116.016 -0.538 . . . . 0.0 109.734 176.502 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' C' C ' 135' ' ' GLU . . . . . . . . . . . . . 75.2 tt0 -50.29 -27.55 6.31 Favored 'General case' 0 C--N 1.328 -0.333 0 N-CA-C 113.096 0.776 . . . . 0.0 113.096 -170.884 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' C' C ' 136' ' ' GLN . . . . . . . . . . . . . 13.9 pt20 -101.94 -14.65 17.11 Favored 'General case' 0 CA--C 1.535 0.378 0 N-CA-C 113.514 0.931 . . . . 0.0 113.514 -172.237 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' C' C ' 137' ' ' LYS . . . . . . . . . . . . . 13.3 ptpt -168.52 168.2 11.17 Favored 'General case' 0 N--CA 1.462 0.175 0 CA-C-O 121.622 0.725 . . . . 0.0 112.228 178.743 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' C' C ' 138' ' ' LEU . . . . . . . . . . . . . 5.8 tt -119.39 129.57 54.87 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 114.957 -1.019 . . . . 0.0 109.737 179.395 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' C' C ' 139' ' ' THR . . . . . . . . . . . . . 38.6 m -110.29 130.04 55.62 Favored 'General case' 0 C--N 1.331 -0.214 0 CA-C-N 116.449 -0.341 . . . . 0.0 110.488 -179.218 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' C' C ' 140' ' ' LEU . . . . . . . . . . . . . 15.2 tp -115.71 125.29 52.62 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 115.688 -0.687 . . . . 0.0 109.41 -178.661 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' C' C ' 141' ' ' ILE . . . . . . . . . . . . . 19.2 mt -122.73 117.4 51.77 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.24 0 CA-C-O 120.861 0.362 . . . . 0.0 110.032 -175.33 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' C' C ' 142' ' ' ARG . . . . . . . . . . . . . 81.3 mtm180 -108.26 125.32 51.53 Favored 'General case' 0 C--N 1.331 -0.196 0 CA-C-N 115.499 -0.773 . . . . 0.0 109.939 179.917 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' C' C ' 143' ' ' THR . . . . . . . . . . . . . 43.7 p . . . . . 0 C--O 1.221 -0.417 0 CA-C-O 117.991 -1.004 . . . . 0.0 110.648 -178.532 . . . . . . . . 0 0 . 1 . 013 nuclear orig full ' D' D ' -3' ' ' GLU . . . . . . . . . . . . . 21.3 pt-20 . . . . . 0 N--CA 1.491 1.581 0 N-CA-C 109.443 -0.577 . . . . 0.0 109.443 . . . . . . . . . 0 0 . 1 . 013 nuclear orig full ' D' D ' -2' ' ' GLY . . . . . . . . . . . . . . . -94.85 139.8 14.7 Favored Glycine 0 CA--C 1.525 0.68 0 N-CA-C 111.037 -0.825 . . . . 0.0 111.037 179.993 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' D' D ' -1' ' ' VAL . . . . . . . . . . . . . 44.4 t -96.48 136.6 26.79 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.361 0 N-CA-C 110.008 -0.367 . . . . 0.0 110.008 179.494 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' D' D ' 0' ' ' ILE . . . . . . . . . . . . . 70.9 mt -114.99 137.79 47.35 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.191 0 CA-C-N 116.249 -0.432 . . . . 0.0 110.204 -179.355 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' D' D ' 1' ' ' MET . . . . . . . . . . . . . 25.7 ptm -79.76 140.2 37.0 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 115.999 -0.546 . . . . 0.0 110.728 -179.893 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' D' D ' 2' ' ' SER . . . . . . . . . . . . . 2.5 p -128.0 124.98 38.52 Favored 'General case' 0 C--N 1.331 -0.218 0 CA-C-N 116.254 -0.43 . . . . 0.0 110.36 177.792 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' D' D ' 3' ' ' GLU . . . . . . . . . . . . . 83.7 tt0 -141.54 142.26 33.54 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-N 115.931 -0.577 . . . . 0.0 111.056 -177.123 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' D' D ' 4' ' ' LEU . . . . . . . . . . . . . 21.6 tp -124.81 129.77 51.08 Favored 'General case' 0 C--N 1.331 -0.213 0 CA-C-N 116.109 -0.496 . . . . 0.0 110.192 175.803 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' D' D ' 5' ' ' LYS . . . . . . . . . . . . . 68.7 mttm -104.7 120.08 40.51 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-N 116.25 -0.432 . . . . 0.0 110.542 178.635 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' D' D ' 6' ' ' LEU . . . . . . . . . . . . . 45.5 mt -115.22 146.76 41.12 Favored 'General case' 0 C--N 1.331 -0.223 0 CA-C-N 115.389 -0.823 . . . . 0.0 110.236 -179.872 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' D' D ' 7' ' ' LYS . . . . . . . . . . . . . 85.5 tttt -132.71 131.76 22.26 Favored Pre-proline 0 CA--C 1.537 0.453 0 CA-C-O 118.67 -0.681 . . . . 0.0 110.2 176.465 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' D' D ' 8' ' ' PRO . . . . . . . . . . . . . 95.1 Cg_endo -87.37 140.78 5.55 Favored 'Trans proline' 0 N--CA 1.491 1.362 0 C-N-CA 121.508 1.472 . . . . 0.0 111.632 175.776 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' D' D ' 9' ' ' LEU . . . . . . . . . . . . . 37.2 mt -79.98 -49.21 1.3 Allowed Pre-proline 0 CA--C 1.535 0.376 0 CA-C-O 118.566 -0.731 . . . . 0.0 112.494 -177.927 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' D' D ' 10' ' ' PRO . . . . . . . . . . . . . 85.6 Cg_endo -77.5 154.32 31.29 Favored 'Trans proline' 0 N--CA 1.498 1.752 0 C-N-CA 121.183 1.255 . . . . 0.0 112.27 179.808 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' D' D ' 11' ' ' LYS . . . . . . . . . . . . . 80.8 tttt -88.1 100.18 12.75 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 116.236 -0.438 . . . . 0.0 110.382 178.438 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' D' D ' 12' ' ' VAL . . . . . . . . . . . . . 12.3 p -143.94 147.89 19.31 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.273 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.667 -178.985 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' D' D ' 13' ' ' GLU . . . . . . . . . . . . . 70.7 mm-40 -81.55 123.14 28.4 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.229 -0.441 . . . . 0.0 109.999 177.13 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' D' D ' 14' ' ' LEU . . . . . . . . . . . . . 18.2 mt -98.12 147.02 32.51 Favored Pre-proline 0 CA--C 1.532 0.285 0 CA-C-O 119.158 -0.448 . . . . 0.0 110.444 -179.203 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' D' D ' 15' ' ' PRO . . . . . . . . . . . . . 27.1 Cg_exo -61.8 156.0 51.02 Favored 'Trans proline' 0 N--CA 1.499 1.807 0 C-N-CA 121.316 1.344 . . . . 0.0 112.004 177.489 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' D' D ' 16' ' ' PRO . . . . . . . . . . . . . 32.1 Cg_exo -59.85 -37.2 87.77 Favored 'Trans proline' 0 N--CA 1.497 1.689 0 C-N-CA 121.398 1.399 . . . . 0.0 112.55 178.962 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' D' D ' 17' ' ' ASP . . . . . . . . . . . . . 8.8 p-10 -87.53 15.77 6.29 Favored 'General case' 0 CA--C 1.536 0.419 0 N-CA-C 112.869 0.692 . . . . 0.0 112.869 -177.529 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' D' D ' 18' ' ' PHE . . . . . . . . . . . . . 35.7 t80 -56.38 -47.34 79.13 Favored 'General case' 0 C--N 1.334 -0.089 0 O-C-N 122.031 -0.418 . . . . 0.0 110.536 -178.283 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' D' D ' 19' ' ' VAL . . . . . . . . . . . . . 48.5 t -55.05 -40.89 56.28 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.259 0 C-N-CA 121.139 -0.224 . . . . 0.0 110.915 -177.337 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' D' D ' 20' ' ' ASP . . . . . . . . . . . . . 70.0 m-20 -60.06 -45.01 94.29 Favored 'General case' 0 C--N 1.331 -0.233 0 C-N-CA 120.864 -0.335 . . . . 0.0 110.959 -178.143 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' D' D ' 21' ' ' VAL . . . . . . . . . . . . . 47.5 t -65.52 -46.27 90.26 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.336 0 C-N-CA 120.631 -0.428 . . . . 0.0 110.585 -178.316 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' D' D ' 22' ' ' ILE . . . . . . . . . . . . . 49.4 mm -55.61 -58.67 4.01 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.295 0 C-N-CA 121.074 -0.25 . . . . 0.0 111.038 -178.101 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' D' D ' 23' ' ' ARG . . . . . . . . . . . . . 12.2 ptm180 -55.83 -42.78 76.25 Favored 'General case' 0 C--N 1.332 -0.183 0 C-N-CA 120.71 -0.396 . . . . 0.0 111.747 -174.662 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' D' D ' 24' ' ' ILE . . . . . . . . . . . . . 74.4 mt -59.78 -42.66 89.59 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.321 0 C-N-CA 120.871 -0.331 . . . . 0.0 111.314 -177.502 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' D' D ' 25' ' ' LYS . . . . . . . . . . . . . 97.5 mttt -69.08 -42.02 76.76 Favored 'General case' 0 C--N 1.329 -0.298 0 N-CA-C 112.457 0.54 . . . . 0.0 112.457 -179.808 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' D' D ' 26' ' ' LEU . . . . . . . . . . . . . 86.9 mt -78.87 -30.9 45.32 Favored 'General case' 0 C--N 1.329 -0.3 0 N-CA-C 113.708 1.003 . . . . 0.0 113.708 -169.851 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' D' D ' 27' ' ' GLN . . . . . . . . . . . . . 10.7 pt20 -47.45 141.4 4.98 Favored 'General case' 0 N--CA 1.469 0.497 0 N-CA-C 112.679 0.622 . . . . 0.0 112.679 -175.223 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' D' D ' 28' ' ' GLY . . . . . . . . . . . . . . . 100.07 -22.38 40.43 Favored Glycine 0 CA--C 1.533 1.158 0 CA-C-N 115.709 -0.678 . . . . 0.0 112.495 -177.109 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' D' D ' 29' ' ' LYS . . . . . . . . . . . . . 74.2 mmtt -96.59 155.02 16.95 Favored 'General case' 0 C--O 1.232 0.137 0 CA-C-N 117.588 0.694 . . . . 0.0 110.721 177.901 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' D' D ' 30' ' ' THR . . . . . . . . . . . . . 32.3 m -106.6 136.76 45.83 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.154 -0.475 . . . . 0.0 109.885 176.225 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' D' D ' 31' ' ' VAL . . . . . . . . . . . . . 34.8 m -129.47 156.27 41.8 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.203 0 CA-C-O 120.907 0.384 . . . . 0.0 110.864 -178.289 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' D' D ' 32' ' ' ARG . . . . . . . . . . . . . 54.0 ttp180 -133.99 150.82 51.28 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 115.857 -0.611 . . . . 0.0 110.384 178.652 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' D' D ' 33' ' ' THR . . . . . . . . . . . . . 27.4 m -53.06 139.99 26.66 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.419 -0.355 . . . . 0.0 111.339 -179.37 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' D' D ' 34' ' ' GLY . . . . . . . . . . . . . . . 99.74 -17.18 57.81 Favored Glycine 0 CA--C 1.533 1.181 0 CA-C-O 119.762 -0.466 . . . . 0.0 113.218 179.909 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' D' D ' 35' ' ' ASP . . . . . . . . . . . . . 73.4 m-20 -66.89 149.21 50.92 Favored 'General case' 0 C--O 1.231 0.122 0 CA-C-N 118.019 0.909 . . . . 0.0 111.3 178.609 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' D' D ' 36' ' ' VAL . . . . . . . . . . . . . 45.9 t -122.24 129.46 75.31 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.286 0 CA-C-N 115.815 -0.63 . . . . 0.0 109.692 177.463 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' D' D ' 37' ' ' ILE . . . . . . . . . . . . . 66.6 mt -119.9 138.08 51.65 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.264 0 CA-C-N 116.367 -0.379 . . . . 0.0 110.042 -178.942 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' D' D ' 38' ' ' GLY . . . . . . . . . . . . . . . -112.3 128.79 8.69 Favored Glycine 0 CA--C 1.524 0.653 0 N-CA-C 111.009 -0.836 . . . . 0.0 111.009 179.487 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' D' D ' 39' ' ' ILE . . . . . . . . . . . . . 72.1 mt -122.91 132.58 71.1 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.184 0 N-CA-C 110.039 -0.356 . . . . 0.0 110.039 179.319 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' D' D ' 40' ' ' SER . . . . . . . . . . . . . 13.6 t -92.51 119.41 31.97 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.474 -0.33 . . . . 0.0 110.647 176.153 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' D' D ' 41' ' ' ILE . . . . . . . . . . . . . 73.0 mt -131.1 115.99 31.74 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.208 0 CA-C-O 120.987 0.422 . . . . 0.0 110.691 179.51 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' D' D ' 42' ' ' LEU . . . . . . . . . . . . . 1.4 tt 52.58 48.17 23.12 Favored 'General case' 0 CA--C 1.532 0.288 0 CA-C-N 115.738 -0.665 . . . . 0.0 110.989 175.9 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' D' D ' 43' ' ' GLY . . . . . . . . . . . . . . . 70.19 16.44 73.13 Favored Glycine 0 CA--C 1.534 1.266 0 C-N-CA 121.064 -0.589 . . . . 0.0 113.089 174.75 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' D' D ' 44' ' ' LYS . . . . . . . . . . . . . 53.3 mtmt -128.38 130.01 47.07 Favored 'General case' 0 C--N 1.333 -0.133 0 CA-C-N 117.788 0.794 . . . . 0.0 110.304 179.629 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' D' D ' 45' ' ' GLU . . . . . . . . . . . . . 81.4 tt0 -84.84 124.51 31.67 Favored 'General case' 0 C--N 1.327 -0.406 0 CA-C-N 116.451 -0.341 . . . . 0.0 110.737 -179.858 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' D' D ' 46' ' ' VAL . . . . . . . . . . . . . 7.3 p -122.26 127.06 75.07 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.235 0 N-CA-C 109.651 -0.5 . . . . 0.0 109.651 176.498 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' D' D ' 47' ' ' LYS . . . . . . . . . . . . . 99.3 mttt -101.03 130.66 47.07 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.008 -0.542 . . . . 0.0 111.481 178.171 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' D' D ' 48' ' ' PHE . . . . . . . . . . . . . 92.1 m-85 -113.86 131.95 56.08 Favored 'General case' 0 C--N 1.329 -0.303 0 N-CA-C 109.559 -0.534 . . . . 0.0 109.559 174.592 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' D' D ' 49' ' ' LYS . . . . . . . . . . . . . 80.6 tttt -107.99 137.44 45.98 Favored 'General case' 0 C--N 1.329 -0.309 0 N-CA-C 110.284 -0.265 . . . . 0.0 110.284 178.8 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' D' D ' 50' ' ' VAL . . . . . . . . . . . . . 45.6 t -81.69 109.2 15.61 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.252 0 N-CA-C 109.236 -0.653 . . . . 0.0 109.236 176.889 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' D' D ' 51' ' ' VAL . . . . . . . . . . . . . 48.8 t -74.35 -47.07 41.96 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.278 0 CA-C-N 115.902 -0.59 . . . . 0.0 110.213 -173.809 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' D' D ' 52' ' ' GLN . . . . . . . . . . . . . 31.2 tt0 -163.88 142.49 7.63 Favored 'General case' 0 C--N 1.332 -0.19 0 C-N-CA 120.26 -0.576 . . . . 0.0 111.789 -178.432 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' D' D ' 53' ' ' ALA . . . . . . . . . . . . . . . -118.55 132.33 56.21 Favored 'General case' 0 C--N 1.332 -0.184 0 CA-C-N 115.812 -0.631 . . . . 0.0 110.194 177.207 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' D' D ' 54' ' ' TYR . . . . . . . . . . . . . 55.0 t80 -128.98 107.92 18.14 Favored Pre-proline 0 CA--C 1.534 0.362 0 CA-C-O 118.252 -0.88 . . . . 0.0 110.557 -179.849 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' D' D ' 55' ' ' PRO . . . . . . . . . . . . . 73.8 Cg_endo -77.27 170.08 72.37 Favored 'Cis proline' 0 N--CA 1.501 1.914 0 CA-C-N 121.89 1.711 . . . . 0.0 112.274 -5.67 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' D' D ' 56' ' ' SER . . . . . . . . . . . . . 32.8 m -116.46 133.57 22.97 Favored Pre-proline 0 CA--C 1.539 0.547 0 CA-C-O 118.418 -0.801 . . . . 0.0 109.408 174.447 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' D' D ' 57' ' ' PRO . . . . . . . . . . . . . 41.9 Cg_endo -67.8 166.33 66.7 Favored 'Cis proline' 0 N--CA 1.499 1.8 0 CA-C-N 121.874 1.705 . . . . 0.0 111.524 -1.446 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' D' D ' 58' ' ' LEU . . . . . . . . . . . . . 38.5 tp -129.27 138.03 51.41 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.239 -0.437 . . . . 0.0 110.173 179.657 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' D' D ' 59' ' ' ARG . . . . . . . . . . . . . 72.7 ttt-85 -101.95 129.32 48.19 Favored 'General case' 0 C--N 1.329 -0.306 0 N-CA-C 109.405 -0.591 . . . . 0.0 109.405 178.013 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' D' D ' 60' ' ' VAL . . . . . . . . . . . . . 41.5 t -78.5 113.77 18.23 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.299 0 C-N-CA 120.782 -0.367 . . . . 0.0 110.255 -176.165 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' D' D ' 61' ' ' GLU . . . . . . . . . . . . . 82.8 tt0 -131.24 151.57 51.35 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 115.913 -0.585 . . . . 0.0 109.66 175.998 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' D' D ' 62' ' ' ASP . . . . . . . . . . . . . 50.6 m-20 -49.58 -32.08 11.92 Favored 'General case' 0 C--N 1.327 -0.396 0 N-CA-C 112.129 0.418 . . . . 0.0 112.129 179.394 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' D' D ' 63' ' ' ARG . . . . . . . . . . . . . 35.0 mtp180 -75.0 -21.75 58.95 Favored 'General case' 0 CA--C 1.533 0.32 0 N-CA-C 113.1 0.778 . . . . 0.0 113.1 -174.859 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' D' D ' 64' ' ' THR . . . . . . . . . . . . . 23.1 m -70.23 146.72 50.48 Favored 'General case' 0 C--N 1.331 -0.222 0 CA-C-O 120.726 0.298 . . . . 0.0 110.995 -175.536 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' D' D ' 65' ' ' LYS . . . . . . . . . . . . . 40.2 ttpt -88.28 121.64 30.9 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-O 121.068 0.461 . . . . 0.0 110.306 179.64 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' D' D ' 66' ' ' ILE . . . . . . . . . . . . . 69.1 mt -113.75 125.22 70.99 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.271 0 N-CA-C 109.556 -0.535 . . . . 0.0 109.556 -178.24 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' D' D ' 67' ' ' THR . . . . . . . . . . . . . 10.8 m -123.92 141.73 51.78 Favored 'General case' 0 C--N 1.331 -0.216 0 CA-C-O 121.062 0.458 . . . . 0.0 111.295 -174.57 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' D' D ' 68' ' ' LEU . . . . . . . . . . . . . 5.7 tt -100.21 125.48 46.37 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 115.746 -0.661 . . . . 0.0 109.735 177.132 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' D' D ' 69' ' ' VAL . . . . . . . . . . . . . 45.2 t -99.71 130.59 48.54 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 CA-C-O 121.048 0.452 . . . . 0.0 110.5 -176.697 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' D' D ' 70' ' ' THR . . . . . . . . . . . . . 7.8 t -150.04 24.9 0.83 Allowed 'General case' 0 CA--C 1.535 0.375 0 CA-C-N 115.875 -0.602 . . . . 0.0 112.175 177.645 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' D' D ' 71' ' ' HIS . . . . . . . . . . . . . 10.9 m80 -149.97 86.45 5.28 Favored Pre-proline 0 CA--C 1.534 0.328 0 N-CA-C 110.192 -0.299 . . . . 0.0 110.192 -179.705 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' D' D ' 72' ' ' PRO . . . . . . . . . . . . . 74.5 Cg_endo -80.58 -26.7 3.74 Favored 'Trans proline' 0 N--CA 1.494 1.516 0 C-N-CA 121.473 1.448 . . . . 0.0 113.195 -175.728 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' D' D ' 73' ' ' VAL . . . . . . . . . . . . . 34.5 m -72.91 179.95 0.39 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.299 0 C-N-CA 121.035 -0.266 . . . . 0.0 110.534 -179.218 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' D' D ' 74' ' ' ASP . . . . . . . . . . . . . 15.6 t0 -100.85 116.48 32.82 Favored 'General case' 0 C--N 1.332 -0.162 0 N-CA-C 109.965 -0.383 . . . . 0.0 109.965 -178.795 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' D' D ' 75' ' ' VAL . . . . . . . . . . . . . 45.2 t -113.77 124.08 70.07 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.196 0 CA-C-O 121.057 0.456 . . . . 0.0 110.304 -177.992 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' D' D ' 76' ' ' LEU . . . . . . . . . . . . . 19.2 mt -127.85 145.51 50.91 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 115.726 -0.67 . . . . 0.0 109.872 179.014 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' D' D ' 77' ' ' GLU . . . . . . . . . . . . . 97.0 mt-10 -134.03 138.62 45.48 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-O 121.092 0.472 . . . . 0.0 111.359 -178.526 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' D' D ' 78' ' ' ALA . . . . . . . . . . . . . . . -125.2 138.83 54.13 Favored 'General case' 0 C--N 1.331 -0.226 0 CA-C-N 115.743 -0.662 . . . . 0.0 109.708 176.301 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' D' D ' 79' ' ' LYS . . . . . . . . . . . . . 69.2 mttm -75.12 122.8 24.15 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-O 120.913 0.387 . . . . 0.0 110.797 -177.865 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' D' D ' 80' ' ' ILE . . . . . . . . . . . . . 24.5 mm -139.11 114.42 8.54 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.263 0 N-CA-C 109.29 -0.633 . . . . 0.0 109.29 -177.09 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' D' D ' 81' ' ' LYS . . . . . . . . . . . . . 61.7 mttp -113.42 123.24 49.61 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-O 120.866 0.365 . . . . 0.0 111.493 -175.722 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' D' D ' 82' ' ' GLY . . . . . . . . . . . . . . . 89.04 42.08 5.72 Favored Glycine 0 CA--C 1.525 0.715 0 C-N-CA 121.004 -0.617 . . . . 0.0 112.006 174.201 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' D' D ' 83' ' ' ILE . . . . . . . . . . . . . 68.9 mt -68.74 137.39 24.48 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.269 0 N-CA-C 109.992 -0.373 . . . . 0.0 109.992 178.668 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' D' D ' 84' ' ' LYS . . . . . . . . . . . . . 25.6 ttpt -105.94 -47.27 3.9 Favored 'General case' 0 C--N 1.331 -0.217 0 CA-C-N 116.455 -0.339 . . . . 0.0 110.165 177.91 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' D' D ' 85' ' ' ASP . . . . . . . . . . . . . 12.0 t70 -150.34 151.04 32.27 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.043 -0.526 . . . . 0.0 110.441 -179.272 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' D' D ' 86' ' ' VAL . . . . . . . . . . . . . 40.5 t -138.13 137.01 44.7 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.235 0 CA-C-O 121.029 0.443 . . . . 0.0 110.764 -179.266 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' D' D ' 87' ' ' ILE . . . . . . . . . . . . . 46.2 mm -122.16 130.65 74.38 Favored 'Isoleucine or valine' 0 C--O 1.233 0.192 0 CA-C-N 115.781 -0.645 . . . . 0.0 109.793 177.159 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' D' D ' 88' ' ' LEU . . . . . . . . . . . . . 18.8 tp -116.85 132.16 56.77 Favored 'General case' 0 C--N 1.331 -0.201 0 CA-C-O 121.021 0.439 . . . . 0.0 111.161 -177.623 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' D' D ' 89' ' ' ASP . . . . . . . . . . . . . 5.5 t70 -130.66 156.29 45.15 Favored 'General case' 0 C--N 1.331 -0.204 0 CA-C-N 115.835 -0.621 . . . . 0.0 109.668 175.483 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' D' D ' 90' ' ' GLU . . . . . . . . . . . . . 83.9 tt0 -47.04 -39.49 12.9 Favored 'General case' 0 C--N 1.331 -0.201 0 N-CA-C 112.97 0.73 . . . . 0.0 112.97 -172.359 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' D' D ' 91' ' ' ASN . . . . . . . . . . . . . 21.6 p-10 -131.99 36.03 3.7 Favored 'General case' 0 C--O 1.233 0.22 0 N-CA-C 111.767 0.284 . . . . 0.0 111.767 -176.215 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' D' D ' 92' ' ' LEU . . . . . . . . . . . . . 16.0 tp -165.86 138.73 4.17 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-O 120.754 0.312 . . . . 0.0 110.605 -179.821 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' D' D ' 93' ' ' ILE . . . . . . . . . . . . . 73.2 mt -124.27 123.11 65.74 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.204 0 N-CA-C 109.431 -0.581 . . . . 0.0 109.431 179.55 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' D' D ' 94' ' ' VAL . . . . . . . . . . . . . 46.0 t -124.03 128.2 73.94 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.299 0 N-CA-C 109.897 -0.409 . . . . 0.0 109.897 -178.783 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' D' D ' 95' ' ' VAL . . . . . . . . . . . . . 40.7 t -123.78 135.28 63.99 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.346 0 CA-C-N 116.133 -0.485 . . . . 0.0 109.965 -178.611 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' D' D ' 96' ' ' ILE . . . . . . . . . . . . . 66.2 mt -117.13 128.47 74.49 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.237 0 N-CA-C 109.394 -0.595 . . . . 0.0 109.394 178.661 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' D' D ' 97' ' ' THR . . . . . . . . . . . . . 71.2 p -104.35 157.06 17.41 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-O 121.388 0.613 . . . . 0.0 111.502 -176.56 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' D' D ' 98' ' ' GLU . . . . . . . . . . . . . 12.8 pt-20 -54.85 -24.49 23.33 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 115.73 -0.668 . . . . 0.0 112.492 -179.444 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' D' D ' 99' ' ' GLU . . . . . . . . . . . . . 14.8 mm-40 -80.2 16.8 1.16 Allowed 'General case' 0 CA--C 1.536 0.441 0 N-CA-C 112.959 0.725 . . . . 0.0 112.959 -178.578 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' D' D ' 100' ' ' ASN . . . . . . . . . . . . . 4.2 m-20 62.47 37.84 13.13 Favored 'General case' 0 C--O 1.233 0.198 0 CA-C-O 121.019 0.437 . . . . 0.0 110.976 178.344 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' D' D ' 101' ' ' GLU . . . . . . . . . . . . . 84.4 tt0 -114.99 140.84 48.71 Favored 'General case' 0 C--N 1.331 -0.213 0 CA-C-N 116.127 -0.488 . . . . 0.0 109.912 177.364 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' D' D ' 102' ' ' VAL . . . . . . . . . . . . . 44.7 t -114.83 124.77 71.81 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.287 0 N-CA-C 109.656 -0.498 . . . . 0.0 109.656 179.282 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' D' D ' 103' ' ' LEU . . . . . . . . . . . . . 22.0 mt -116.6 133.6 55.82 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 115.805 -0.634 . . . . 0.0 110.155 179.055 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' D' D ' 104' ' ' ILE . . . . . . . . . . . . . 69.1 mt -121.73 121.92 65.59 Favored 'Isoleucine or valine' 0 C--O 1.234 0.239 0 CA-C-N 116.577 -0.283 . . . . 0.0 110.323 -178.35 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' D' D ' 105' ' ' PHE . . . . . . . . . . . . . 74.1 m-85 -123.81 165.81 16.68 Favored 'General case' 0 C--N 1.333 -0.141 0 O-C-N 123.994 0.808 . . . . 0.0 109.937 179.933 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' D' D ' 106' ' ' ASN . . . . . . . . . . . . . 49.8 p-10 -100.54 -174.03 2.55 Favored 'General case' 0 C--N 1.331 -0.209 0 N-CA-C 109.816 -0.438 . . . . 0.0 109.816 171.422 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' D' D ' 107' ' ' GLN . . . . . . . . . . . . . 34.7 tp60 -59.21 -25.37 63.92 Favored 'General case' 0 CA--C 1.533 0.313 0 N-CA-C 112.331 0.493 . . . . 0.0 112.331 -178.016 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' D' D ' 108' ' ' ASN . . . . . . . . . . . . . 9.7 t30 -91.45 14.17 15.52 Favored 'General case' 0 CA--C 1.534 0.365 0 N-CA-C 112.9 0.704 . . . . 0.0 112.9 -176.553 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' D' D ' 109' ' ' LEU . . . . . . . . . . . . . 76.8 mt 58.77 33.57 23.15 Favored 'General case' 0 CA--C 1.529 0.172 0 CA-C-O 120.789 0.328 . . . . 0.0 111.864 179.162 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' D' D ' 110' ' ' GLU . . . . . . . . . . . . . 70.5 mm-40 -100.21 134.82 42.58 Favored 'General case' 0 C--N 1.329 -0.284 0 N-CA-C 108.932 -0.766 . . . . 0.0 108.932 173.85 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' D' D ' 111' ' ' GLU . . . . . . . . . . . . . 45.2 tt0 -82.18 121.79 27.06 Favored 'General case' 0 C--N 1.328 -0.355 0 C-N-CA 120.643 -0.423 . . . . 0.0 110.519 -174.566 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' D' D ' 112' ' ' LEU . . . . . . . . . . . . . 34.2 mt -97.85 -45.99 6.11 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 115.851 -0.613 . . . . 0.0 110.552 179.282 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' D' D ' 113' ' ' TYR . . . . . . . . . . . . . 58.6 t80 -140.84 144.7 35.49 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.072 -0.513 . . . . 0.0 111.1 -177.854 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' D' D ' 114' ' ' ARG . . . . . . . . . . . . . 33.4 ptt180 -145.89 125.11 12.95 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 115.825 -0.625 . . . . 0.0 110.21 173.617 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' D' D ' 115' ' ' GLY . . . . . . . . . . . . . . . -149.98 143.14 10.38 Favored Glycine 0 CA--C 1.523 0.536 0 N-CA-C 110.82 -0.912 . . . . 0.0 110.82 -179.706 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' D' D ' 116' ' ' LYS . . . . . . . . . . . . . 31.4 ttmt -115.86 132.53 56.62 Favored 'General case' 0 C--N 1.329 -0.318 0 N-CA-C 109.974 -0.38 . . . . 0.0 109.974 179.184 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' D' D ' 117' ' ' PHE . . . . . . . . . . . . . 52.0 m-85 -123.52 116.27 22.91 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.123 -0.49 . . . . 0.0 110.087 -177.085 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' D' D ' 118' ' ' GLU . . . . . . . . . . . . . 84.1 tt0 -53.69 -48.47 69.48 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.576 -0.284 . . . . 0.0 111.355 -176.63 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' D' D ' 119' ' ' ASN . . . . . . . . . . . . . 87.0 m-20 -95.25 31.05 2.02 Favored 'General case' 0 C--N 1.33 -0.27 0 N-CA-C 112.203 0.446 . . . . 0.0 112.203 -174.964 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' D' D ' 120' ' ' LEU . . . . . . . . . . . . . 14.6 tp -55.34 120.32 6.92 Favored 'General case' 0 C--N 1.331 -0.202 0 CA-C-O 120.714 0.292 . . . . 0.0 110.525 178.298 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' D' D ' 121' ' ' ASN . . . . . . . . . . . . . 60.3 m-80 -113.99 -44.1 3.19 Favored 'General case' 0 C--O 1.231 0.109 0 CA-C-N 116.522 -0.308 . . . . 0.0 111.332 -176.795 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' D' D ' 122' ' ' LYS . . . . . . . . . . . . . 53.3 mttm -140.86 145.7 36.54 Favored 'General case' 0 C--N 1.331 -0.219 0 CA-C-O 120.965 0.412 . . . . 0.0 111.665 -177.647 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' D' D ' 123' ' ' VAL . . . . . . . . . . . . . 45.5 t -131.58 127.51 59.48 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.258 0 CA-C-N 116.014 -0.539 . . . . 0.0 109.696 175.319 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' D' D ' 124' ' ' LEU . . . . . . . . . . . . . 14.2 tp -131.29 133.47 45.41 Favored 'General case' 0 C--N 1.33 -0.251 0 N-CA-C 110.108 -0.33 . . . . 0.0 110.108 179.13 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' D' D ' 125' ' ' VAL . . . . . . . . . . . . . 32.8 m -141.24 138.5 33.39 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 CA-C-O 120.883 0.373 . . . . 0.0 111.074 -178.89 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' D' D ' 126' ' ' ARG . . . . . . . . . . . . . 98.5 mtt180 -144.04 131.05 20.5 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 115.933 -0.576 . . . . 0.0 110.249 178.64 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' D' D ' 127' ' ' ASN . . . . . . . . . . . . . 56.5 t30 52.84 -113.46 0.77 Allowed 'General case' 0 CA--C 1.546 0.813 0 CA-C-O 118.626 -0.702 . . . . 0.0 110.849 179.366 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' D' D ' 128' ' ' ASP . . . . . . . . . . . . . 12.9 p-10 -114.03 12.65 18.01 Favored 'General case' 0 CA--C 1.536 0.416 0 CA-C-N 120.126 1.33 . . . . 0.0 113.144 179.929 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' D' D ' 129' ' ' LEU . . . . . . . . . . . . . 15.8 tp -107.0 131.92 53.52 Favored 'General case' 0 C--O 1.232 0.171 0 N-CA-C 110.002 -0.37 . . . . 0.0 110.002 179.095 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' D' D ' 130' ' ' VAL . . . . . . . . . . . . . 46.5 t -122.7 133.76 67.88 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.246 0 CA-C-O 120.773 0.321 . . . . 0.0 110.353 -177.0 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' D' D ' 131' ' ' VAL . . . . . . . . . . . . . 42.8 t -135.52 133.55 52.03 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.191 0 CA-C-O 121.093 0.473 . . . . 0.0 110.204 176.441 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' D' D ' 132' ' ' ILE . . . . . . . . . . . . . 72.5 mt -122.15 134.0 66.73 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.25 0 CA-C-N 115.743 -0.662 . . . . 0.0 109.606 -178.728 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' D' D ' 133' ' ' ILE . . . . . . . . . . . . . 40.3 mm -114.98 124.39 71.6 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.251 0 CA-C-O 120.693 0.282 . . . . 0.0 110.92 -175.298 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' D' D ' 134' ' ' ASP . . . . . . . . . . . . . 9.6 p-10 -134.63 147.83 50.27 Favored 'General case' 0 C--N 1.332 -0.179 0 N-CA-C 109.721 -0.474 . . . . 0.0 109.721 174.804 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' D' D ' 135' ' ' GLU . . . . . . . . . . . . . 43.2 tp10 -50.49 -29.48 10.56 Favored 'General case' 0 C--N 1.329 -0.296 0 N-CA-C 112.845 0.683 . . . . 0.0 112.845 -171.43 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' D' D ' 136' ' ' GLN . . . . . . . . . . . . . 98.7 mt-30 -81.17 -32.71 33.48 Favored 'General case' 0 C--N 1.331 -0.197 0 N-CA-C 112.63 0.604 . . . . 0.0 112.63 -176.016 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' D' D ' 137' ' ' LYS . . . . . . . . . . . . . 37.7 pttt -167.67 172.87 8.93 Favored 'General case' 0 C--N 1.331 -0.223 0 CA-C-O 121.625 0.726 . . . . 0.0 112.261 -172.234 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' D' D ' 138' ' ' LEU . . . . . . . . . . . . . 5.5 tt -115.06 127.64 55.75 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 115.029 -0.987 . . . . 0.0 109.828 179.158 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' D' D ' 139' ' ' THR . . . . . . . . . . . . . 28.1 m -106.2 124.86 50.24 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.143 -0.481 . . . . 0.0 110.145 -179.675 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' D' D ' 140' ' ' LEU . . . . . . . . . . . . . 11.6 tp -115.67 121.65 43.17 Favored 'General case' 0 C--N 1.327 -0.376 0 N-CA-C 109.311 -0.626 . . . . 0.0 109.311 -178.54 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' D' D ' 141' ' ' ILE . . . . . . . . . . . . . 19.5 mt -119.13 116.75 51.95 Favored 'Isoleucine or valine' 0 C--O 1.234 0.274 0 CA-C-O 120.924 0.392 . . . . 0.0 109.966 -174.847 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' D' D ' 142' ' ' ARG . . . . . . . . . . . . . 81.7 mtp180 -106.87 131.23 54.2 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-N 115.27 -0.877 . . . . 0.0 110.626 -177.751 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' D' D ' 143' ' ' THR . . . . . . . . . . . . . 33.6 p . . . . . 0 C--O 1.221 -0.441 0 CA-C-O 117.907 -1.045 . . . . 0.0 110.893 179.624 . . . . . . . . 0 0 . 1 . 013 nuclear orig full ' E' E ' -3' ' ' GLU . . . . . . . . . . . . . 45.5 mp0 . . . . . 0 N--CA 1.489 1.484 0 N-CA-C 109.336 -0.616 . . . . 0.0 109.336 . . . . . . . . . 0 0 . 1 . 013 nuclear orig full ' E' E ' -2' ' ' GLY . . . . . . . . . . . . . . . -61.87 128.84 43.36 Favored Glycine 0 CA--C 1.525 0.68 0 N-CA-C 110.546 -1.021 . . . . 0.0 110.546 178.788 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' E' E ' -1' ' ' VAL . . . . . . . . . . . . . 46.1 t -93.8 138.1 21.22 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.332 0 N-CA-C 110.014 -0.365 . . . . 0.0 110.014 -179.235 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' E' E ' 0' ' ' ILE . . . . . . . . . . . . . 68.6 mt -103.58 142.25 17.71 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.276 0 CA-C-N 116.071 -0.513 . . . . 0.0 110.041 -177.983 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' E' E ' 1' ' ' MET . . . . . . . . . . . . . 25.2 ptm -77.61 132.82 38.44 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.043 -0.526 . . . . 0.0 110.693 -179.077 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' E' E ' 2' ' ' SER . . . . . . . . . . . . . 11.1 p -123.24 138.31 54.67 Favored 'General case' 0 C--N 1.331 -0.217 0 CA-C-N 116.187 -0.46 . . . . 0.0 110.646 179.851 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' E' E ' 3' ' ' GLU . . . . . . . . . . . . . 77.6 tt0 -141.0 140.7 34.37 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.773 179.787 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' E' E ' 4' ' ' LEU . . . . . . . . . . . . . 5.2 tt -125.82 128.28 47.42 Favored 'General case' 0 C--N 1.331 -0.215 0 CA-C-N 116.087 -0.506 . . . . 0.0 110.124 177.79 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' E' E ' 5' ' ' LYS . . . . . . . . . . . . . 68.9 mttm -105.04 122.59 46.19 Favored 'General case' 0 C--O 1.235 0.291 0 CA-C-N 116.428 -0.351 . . . . 0.0 110.868 -179.307 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' E' E ' 6' ' ' LEU . . . . . . . . . . . . . 64.6 mt -114.61 148.99 37.3 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-N 115.633 -0.712 . . . . 0.0 110.899 -179.153 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' E' E ' 7' ' ' LYS . . . . . . . . . . . . . 79.6 tttt -138.61 134.38 17.29 Favored Pre-proline 0 CA--C 1.535 0.387 0 CA-C-O 118.893 -0.575 . . . . 0.0 109.909 174.676 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' E' E ' 8' ' ' PRO . . . . . . . . . . . . . 88.8 Cg_endo -88.63 142.29 4.9 Favored 'Trans proline' 0 N--CA 1.492 1.42 0 C-N-CA 121.536 1.49 . . . . 0.0 111.624 177.497 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' E' E ' 9' ' ' LEU . . . . . . . . . . . . . 73.7 mt -76.03 -47.27 3.71 Favored Pre-proline 0 CA--C 1.534 0.341 0 CA-C-O 118.792 -0.623 . . . . 0.0 112.058 -178.432 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' E' E ' 10' ' ' PRO . . . . . . . . . . . . . 97.7 Cg_endo -82.34 149.1 14.91 Favored 'Trans proline' 0 N--CA 1.495 1.603 0 C-N-CA 121.276 1.318 . . . . 0.0 111.712 174.463 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' E' E ' 11' ' ' LYS . . . . . . . . . . . . . 59.8 mttp -88.47 97.6 11.16 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-O 120.886 0.374 . . . . 0.0 110.558 178.648 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' E' E ' 12' ' ' VAL . . . . . . . . . . . . . 11.9 p -139.54 148.28 23.45 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.274 0 CA-C-N 115.946 -0.57 . . . . 0.0 110.216 179.79 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' E' E ' 13' ' ' GLU . . . . . . . . . . . . . 81.1 tt0 -81.95 121.72 26.86 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.35 -0.386 . . . . 0.0 109.974 179.085 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' E' E ' 14' ' ' LEU . . . . . . . . . . . . . 31.2 mt -95.89 150.48 37.38 Favored Pre-proline 0 CA--C 1.532 0.271 0 CA-C-N 116.355 -0.384 . . . . 0.0 110.466 -178.581 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' E' E ' 15' ' ' PRO . . . . . . . . . . . . . 33.1 Cg_exo -60.09 158.91 27.98 Favored 'Trans proline' 0 N--CA 1.497 1.728 0 C-N-CA 121.182 1.254 . . . . 0.0 112.024 178.9 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' E' E ' 16' ' ' PRO . . . . . . . . . . . . . 26.8 Cg_exo -60.69 -44.05 28.59 Favored 'Trans proline' 0 N--CA 1.497 1.708 0 C-N-CA 121.453 1.435 . . . . 0.0 112.962 -178.106 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' E' E ' 17' ' ' ASP . . . . . . . . . . . . . 14.3 p-10 -82.69 9.83 8.81 Favored 'General case' 0 C--N 1.327 -0.388 0 N-CA-C 113.259 0.837 . . . . 0.0 113.259 -176.772 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' E' E ' 18' ' ' PHE . . . . . . . . . . . . . 48.0 t80 -57.45 -42.95 83.49 Favored 'General case' 0 N--CA 1.457 -0.089 0 O-C-N 121.896 -0.502 . . . . 0.0 110.243 -178.539 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' E' E ' 19' ' ' VAL . . . . . . . . . . . . . 47.7 t -56.88 -44.63 82.56 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.362 0 CA-C-N 116.384 -0.371 . . . . 0.0 110.473 -177.945 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' E' E ' 20' ' ' ASP . . . . . . . . . . . . . 72.3 m-20 -59.61 -41.31 90.07 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-O 120.773 0.32 . . . . 0.0 110.78 -177.824 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' E' E ' 21' ' ' VAL . . . . . . . . . . . . . 46.4 t -64.24 -46.36 93.6 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.323 0 C-N-CA 120.725 -0.39 . . . . 0.0 110.476 -178.239 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' E' E ' 22' ' ' ILE . . . . . . . . . . . . . 48.6 mm -61.6 -35.58 68.03 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.266 0 C-N-CA 121.034 -0.267 . . . . 0.0 111.058 -179.852 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' E' E ' 23' ' ' ARG . . . . . . . . . . . . . 58.1 ttp180 -57.38 -47.79 80.74 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-O 120.965 0.412 . . . . 0.0 110.355 176.971 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' E' E ' 24' ' ' ILE . . . . . . . . . . . . . 76.0 mt -61.83 -46.67 96.0 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.238 0 CA-C-N 115.928 -0.578 . . . . 0.0 112.02 -178.037 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' E' E ' 25' ' ' LYS . . . . . . . . . . . . . 12.6 ptmm? -68.45 -35.17 77.21 Favored 'General case' 0 CA--C 1.532 0.283 0 C-N-CA 120.632 -0.427 . . . . 0.0 111.824 -174.05 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' E' E ' 26' ' ' LEU . . . . . . . . . . . . . 63.3 mt -79.19 -46.45 17.88 Favored 'General case' 0 C--N 1.331 -0.219 0 N-CA-C 112.963 0.727 . . . . 0.0 112.963 -174.918 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' E' E ' 27' ' ' GLN . . . . . . . . . . . . . 11.1 pt20 -46.52 140.84 4.05 Favored 'General case' 0 N--CA 1.468 0.466 0 N-CA-C 112.937 0.717 . . . . 0.0 112.937 -173.786 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' E' E ' 28' ' ' GLY . . . . . . . . . . . . . . . 100.72 -29.93 11.37 Favored Glycine 0 CA--C 1.53 1.01 0 CA-C-N 115.382 -0.827 . . . . 0.0 112.0 -176.776 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' E' E ' 29' ' ' LYS . . . . . . . . . . . . . 98.4 mttt -99.52 155.3 17.64 Favored 'General case' 0 C--O 1.234 0.273 0 CA-C-N 117.137 0.469 . . . . 0.0 111.58 179.435 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' E' E ' 30' ' ' THR . . . . . . . . . . . . . 32.2 m -97.12 140.03 32.23 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 115.93 -0.577 . . . . 0.0 110.266 176.203 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' E' E ' 31' ' ' VAL . . . . . . . . . . . . . 35.1 m -131.13 153.7 39.52 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.238 0 CA-C-N 116.234 -0.439 . . . . 0.0 110.711 -179.616 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' E' E ' 32' ' ' ARG . . . . . . . . . . . . . 75.9 mtt180 -132.7 150.1 52.2 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.04 -0.527 . . . . 0.0 110.489 178.476 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' E' E ' 33' ' ' THR . . . . . . . . . . . . . 26.6 m -53.17 140.56 25.71 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 116.241 -0.436 . . . . 0.0 111.416 -178.016 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' E' E ' 34' ' ' GLY . . . . . . . . . . . . . . . 99.62 -17.22 57.86 Favored Glycine 0 CA--C 1.531 1.082 0 C-N-CA 121.208 -0.52 . . . . 0.0 113.259 179.447 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' E' E ' 35' ' ' ASP . . . . . . . . . . . . . 75.9 m-20 -66.11 148.89 51.14 Favored 'General case' 0 C--N 1.334 -0.098 0 CA-C-N 118.092 0.946 . . . . 0.0 110.908 178.272 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' E' E ' 36' ' ' VAL . . . . . . . . . . . . . 44.1 t -123.76 132.52 71.24 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.214 0 CA-C-N 116.096 -0.502 . . . . 0.0 109.918 178.166 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' E' E ' 37' ' ' ILE . . . . . . . . . . . . . 66.8 mt -118.43 138.79 47.99 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.317 0 CA-C-N 116.12 -0.491 . . . . 0.0 109.766 -179.648 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' E' E ' 38' ' ' GLY . . . . . . . . . . . . . . . -110.87 128.77 8.91 Favored Glycine 0 CA--C 1.526 0.751 0 N-CA-C 111.171 -0.771 . . . . 0.0 111.171 -179.337 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' E' E ' 39' ' ' ILE . . . . . . . . . . . . . 77.0 mt -123.84 136.05 61.5 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.199 0 CA-C-O 120.791 0.329 . . . . 0.0 110.123 179.018 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' E' E ' 40' ' ' SER . . . . . . . . . . . . . 78.0 p -93.64 124.07 37.38 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.705 174.8 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' E' E ' 41' ' ' ILE . . . . . . . . . . . . . 70.7 mt -127.82 118.62 49.4 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.2 0 CA-C-O 120.919 0.39 . . . . 0.0 110.373 177.785 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' E' E ' 42' ' ' LEU . . . . . . . . . . . . . 44.4 mt 51.37 34.32 11.64 Favored 'General case' 0 CA--C 1.531 0.213 0 CA-C-N 116.202 -0.454 . . . . 0.0 111.952 177.621 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' E' E ' 43' ' ' GLY . . . . . . . . . . . . . . . 74.65 32.4 57.41 Favored Glycine 0 CA--C 1.528 0.898 0 C-N-CA 121.138 -0.553 . . . . 0.0 112.095 178.303 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' E' E ' 44' ' ' LYS . . . . . . . . . . . . . 47.8 tptt -137.14 131.32 32.43 Favored 'General case' 0 C--N 1.33 -0.253 0 N-CA-C 109.549 -0.537 . . . . 0.0 109.549 177.776 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' E' E ' 45' ' ' GLU . . . . . . . . . . . . . 69.0 tt0 -85.13 123.3 30.49 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 116.538 -0.301 . . . . 0.0 111.415 -174.666 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' E' E ' 46' ' ' VAL . . . . . . . . . . . . . 7.1 p -124.99 128.7 73.27 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.21 0 CA-C-O 120.904 0.383 . . . . 0.0 110.056 176.412 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' E' E ' 47' ' ' LYS . . . . . . . . . . . . . 34.9 mmtp -101.77 132.81 47.3 Favored 'General case' 0 C--N 1.331 -0.21 0 CA-C-N 115.934 -0.575 . . . . 0.0 111.653 177.604 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' E' E ' 48' ' ' PHE . . . . . . . . . . . . . 89.6 m-85 -114.73 131.9 56.62 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-N 115.922 -0.581 . . . . 0.0 109.734 174.258 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' E' E ' 49' ' ' LYS . . . . . . . . . . . . . 57.6 tttm -106.67 139.8 40.54 Favored 'General case' 0 C--O 1.233 0.23 0 CA-C-N 116.69 -0.232 . . . . 0.0 110.586 179.426 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' E' E ' 50' ' ' VAL . . . . . . . . . . . . . 47.2 t -80.88 108.14 13.92 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.282 0 N-CA-C 109.155 -0.683 . . . . 0.0 109.155 176.026 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' E' E ' 51' ' ' VAL . . . . . . . . . . . . . 47.8 t -71.31 -47.88 57.27 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.309 0 CA-C-N 116.158 -0.474 . . . . 0.0 110.125 -174.266 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' E' E ' 52' ' ' GLN . . . . . . . . . . . . . 48.3 tt0 -164.86 141.58 5.95 Favored 'General case' 0 C--N 1.332 -0.169 0 C-N-CA 120.128 -0.629 . . . . 0.0 111.693 -178.338 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' E' E ' 53' ' ' ALA . . . . . . . . . . . . . . . -115.0 133.11 56.32 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 115.764 -0.653 . . . . 0.0 110.001 176.5 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' E' E ' 54' ' ' TYR . . . . . . . . . . . . . 13.7 t80 -129.19 110.89 18.14 Favored Pre-proline 0 CA--C 1.534 0.364 0 CA-C-O 118.198 -0.906 . . . . 0.0 110.358 178.556 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' E' E ' 55' ' ' PRO . . . . . . . . . . . . . 72.3 Cg_endo -77.28 170.13 72.23 Favored 'Cis proline' 0 N--CA 1.5 1.862 0 CA-C-N 122.062 1.772 . . . . 0.0 112.075 -6.444 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' E' E ' 56' ' ' SER . . . . . . . . . . . . . 48.8 m -123.18 139.09 30.97 Favored Pre-proline 0 CA--C 1.538 0.485 0 CA-C-O 118.501 -0.761 . . . . 0.0 109.505 174.758 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' E' E ' 57' ' ' PRO . . . . . . . . . . . . . 36.7 Cg_endo -67.07 144.29 69.51 Favored 'Cis proline' 0 N--CA 1.499 1.849 0 CA-C-N 121.764 1.666 . . . . 0.0 111.489 -3.54 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' E' E ' 58' ' ' LEU . . . . . . . . . . . . . 19.6 tp -108.37 136.33 48.18 Favored 'General case' 0 C--N 1.331 -0.239 0 CA-C-N 116.313 -0.403 . . . . 0.0 111.024 -176.905 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' E' E ' 59' ' ' ARG . . . . . . . . . . . . . 74.5 ttt180 -103.63 123.78 47.62 Favored 'General case' 0 C--N 1.329 -0.32 0 N-CA-C 108.823 -0.806 . . . . 0.0 108.823 173.04 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' E' E ' 60' ' ' VAL . . . . . . . . . . . . . 43.9 t -81.67 123.02 37.51 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.258 0 C-N-CA 120.475 -0.49 . . . . 0.0 110.58 -173.367 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' E' E ' 61' ' ' GLU . . . . . . . . . . . . . 70.6 mm-40 -131.09 165.06 24.09 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 115.824 -0.625 . . . . 0.0 109.727 176.471 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' E' E ' 62' ' ' ASP . . . . . . . . . . . . . 11.7 t0 -52.62 -30.83 33.49 Favored 'General case' 0 C--N 1.328 -0.338 0 N-CA-C 111.983 0.364 . . . . 0.0 111.983 -179.822 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' E' E ' 63' ' ' ARG . . . . . . . . . . . . . 90.8 mtt-85 -71.78 -22.01 61.64 Favored 'General case' 0 CA--C 1.533 0.302 0 N-CA-C 112.829 0.677 . . . . 0.0 112.829 -176.309 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' E' E ' 64' ' ' THR . . . . . . . . . . . . . 27.3 m -73.03 136.82 45.08 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-O 120.844 0.354 . . . . 0.0 111.203 -174.246 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' E' E ' 65' ' ' LYS . . . . . . . . . . . . . 57.2 mtmt -90.08 132.61 35.32 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 115.956 -0.566 . . . . 0.0 110.454 177.946 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' E' E ' 66' ' ' ILE . . . . . . . . . . . . . 66.4 mt -112.62 128.2 69.43 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.283 0 N-CA-C 109.571 -0.529 . . . . 0.0 109.571 178.837 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' E' E ' 67' ' ' THR . . . . . . . . . . . . . 21.9 m -122.85 144.67 49.05 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-O 121.219 0.533 . . . . 0.0 111.317 -175.425 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' E' E ' 68' ' ' LEU . . . . . . . . . . . . . 6.2 tt -98.6 125.29 43.8 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 115.601 -0.727 . . . . 0.0 109.96 178.698 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' E' E ' 69' ' ' VAL . . . . . . . . . . . . . 43.0 t -87.95 128.55 40.27 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.284 0 CA-C-O 120.964 0.411 . . . . 0.0 110.258 -178.315 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' E' E ' 70' ' ' THR . . . . . . . . . . . . . 81.5 p -105.72 177.19 4.93 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.033 -0.53 . . . . 0.0 110.95 -177.368 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' E' E ' 71' ' ' HIS . . . . . . . . . . . . . 54.1 m-70 -64.91 168.22 7.7 Favored Pre-proline 0 C--N 1.329 -0.3 0 CA-C-N 115.672 -0.694 . . . . 0.0 110.519 -179.345 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' E' E ' 72' ' ' PRO . . . . . . . . . . . . . 18.7 Cg_exo -64.86 -5.55 10.83 Favored 'Trans proline' 0 N--CA 1.498 1.776 0 C-N-CA 121.322 1.348 . . . . 0.0 113.763 -177.82 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' E' E ' 73' ' ' VAL . . . . . . . . . . . . . 27.0 m -124.4 154.61 31.76 Favored 'Isoleucine or valine' 0 N--CA 1.461 0.112 0 CA-C-O 121.078 0.466 . . . . 0.0 110.564 177.632 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' E' E ' 74' ' ' ASP . . . . . . . . . . . . . 19.2 t0 -98.88 117.77 34.14 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 115.729 -0.669 . . . . 0.0 109.514 178.306 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' E' E ' 75' ' ' VAL . . . . . . . . . . . . . 43.3 t -109.0 119.34 58.38 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.251 0 CA-C-O 121.034 0.445 . . . . 0.0 110.279 -178.235 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' E' E ' 76' ' ' LEU . . . . . . . . . . . . . 28.7 mt -119.77 143.24 47.93 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 115.653 -0.703 . . . . 0.0 109.731 178.254 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' E' E ' 77' ' ' GLU . . . . . . . . . . . . . 97.2 mt-10 -134.86 129.38 34.35 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-O 121.071 0.463 . . . . 0.0 111.011 -178.294 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' E' E ' 78' ' ' ALA . . . . . . . . . . . . . . . -115.1 127.11 55.39 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 115.707 -0.679 . . . . 0.0 109.531 177.121 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' E' E ' 79' ' ' LYS . . . . . . . . . . . . . 95.4 mttt -75.18 117.7 17.3 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-O 121.014 0.435 . . . . 0.0 110.747 -177.793 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' E' E ' 80' ' ' ILE . . . . . . . . . . . . . 25.2 mm -139.27 111.23 5.33 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.378 0 N-CA-C 108.918 -0.771 . . . . 0.0 108.918 -178.601 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' E' E ' 81' ' ' LYS . . . . . . . . . . . . . 20.4 pttp -101.55 128.48 47.79 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-O 121.179 0.514 . . . . 0.0 111.402 -176.883 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' E' E ' 82' ' ' GLY . . . . . . . . . . . . . . . 89.19 42.14 5.66 Favored Glycine 0 CA--C 1.527 0.789 0 CA-C-N 115.697 -0.683 . . . . 0.0 111.858 175.6 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' E' E ' 83' ' ' ILE . . . . . . . . . . . . . 68.6 mt -69.37 137.37 24.36 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.337 0 N-CA-C 109.675 -0.491 . . . . 0.0 109.675 176.737 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' E' E ' 84' ' ' LYS . . . . . . . . . . . . . 23.4 ttpp -104.72 -51.73 3.01 Favored 'General case' 0 C--N 1.331 -0.212 0 CA-C-O 120.935 0.398 . . . . 0.0 110.252 179.968 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' E' E ' 85' ' ' ASP . . . . . . . . . . . . . 11.3 t70 -147.88 148.73 31.16 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 115.988 -0.551 . . . . 0.0 110.525 -178.865 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' E' E ' 86' ' ' VAL . . . . . . . . . . . . . 43.3 t -130.37 133.58 63.67 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.212 0 CA-C-O 120.984 0.421 . . . . 0.0 110.621 -179.498 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' E' E ' 87' ' ' ILE . . . . . . . . . . . . . 43.3 mm -119.31 122.87 70.16 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 CA-C-N 115.769 -0.651 . . . . 0.0 109.374 176.532 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' E' E ' 88' ' ' LEU . . . . . . . . . . . . . 60.4 mt -113.4 133.06 55.37 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-O 120.962 0.41 . . . . 0.0 111.312 -176.86 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' E' E ' 89' ' ' ASP . . . . . . . . . . . . . 6.5 t0 -134.2 157.56 45.93 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 115.821 -0.627 . . . . 0.0 109.72 176.627 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' E' E ' 90' ' ' GLU . . . . . . . . . . . . . 82.6 tt0 -46.41 -39.08 9.9 Favored 'General case' 0 C--N 1.329 -0.287 0 N-CA-C 113.295 0.85 . . . . 0.0 113.295 -170.588 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' E' E ' 91' ' ' ASN . . . . . . . . . . . . . 44.2 t30 -124.54 11.64 8.6 Favored 'General case' 0 N--CA 1.469 0.499 0 N-CA-C 113.528 0.936 . . . . 0.0 113.528 -174.231 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' E' E ' 92' ' ' LEU . . . . . . . . . . . . . 18.5 mt -148.22 143.48 27.04 Favored 'General case' 0 C--N 1.333 -0.141 0 CA-C-N 117.941 0.337 . . . . 0.0 110.36 -176.322 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' E' E ' 93' ' ' ILE . . . . . . . . . . . . . 70.1 mt -123.98 117.37 50.73 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.294 0 N-CA-C 109.222 -0.658 . . . . 0.0 109.222 176.724 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' E' E ' 94' ' ' VAL . . . . . . . . . . . . . 44.5 t -116.59 125.99 73.83 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.281 0 N-CA-C 109.791 -0.448 . . . . 0.0 109.791 -179.44 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' E' E ' 95' ' ' VAL . . . . . . . . . . . . . 43.4 t -118.81 133.45 65.61 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.34 0 CA-C-N 115.987 -0.552 . . . . 0.0 109.83 -179.601 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' E' E ' 96' ' ' ILE . . . . . . . . . . . . . 68.7 mt -114.17 127.11 71.74 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.305 0 N-CA-C 109.255 -0.646 . . . . 0.0 109.255 178.085 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' E' E ' 97' ' ' THR . . . . . . . . . . . . . 76.4 p -99.59 158.94 15.4 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-O 121.207 0.527 . . . . 0.0 111.117 -177.242 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' E' E ' 98' ' ' GLU . . . . . . . . . . . . . 96.8 mt-10 -53.82 -25.69 20.65 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.079 -0.509 . . . . 0.0 112.181 179.296 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' E' E ' 99' ' ' GLU . . . . . . . . . . . . . 34.7 tt0 -79.34 15.29 1.27 Allowed 'General case' 0 CA--C 1.539 0.533 0 N-CA-C 112.623 0.601 . . . . 0.0 112.623 -177.277 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' E' E ' 100' ' ' ASN . . . . . . . . . . . . . 2.8 m-20 61.16 37.94 17.21 Favored 'General case' 0 CA--C 1.53 0.186 0 O-C-N 121.815 -0.553 . . . . 0.0 110.936 178.752 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' E' E ' 101' ' ' GLU . . . . . . . . . . . . . 84.0 tt0 -115.27 145.11 42.78 Favored 'General case' 0 C--N 1.332 -0.182 0 CA-C-N 116.023 -0.535 . . . . 0.0 109.8 176.89 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' E' E ' 102' ' ' VAL . . . . . . . . . . . . . 45.5 t -115.02 124.22 71.46 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.331 0 CA-C-N 116.121 -0.491 . . . . 0.0 109.867 -178.251 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' E' E ' 103' ' ' LEU . . . . . . . . . . . . . 22.3 mt -118.48 128.16 54.32 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 115.8 -0.636 . . . . 0.0 110.144 176.667 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' E' E ' 104' ' ' ILE . . . . . . . . . . . . . 71.5 mt -118.42 122.28 69.14 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.257 0 N-CA-C 110.284 -0.265 . . . . 0.0 110.284 -179.652 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' E' E ' 105' ' ' PHE . . . . . . . . . . . . . 71.3 m-85 -120.79 165.84 14.58 Favored 'General case' 0 C--N 1.332 -0.161 0 O-C-N 124.035 0.835 . . . . 0.0 110.265 -179.985 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' E' E ' 106' ' ' ASN . . . . . . . . . . . . . 53.4 p-10 -99.35 -169.98 1.84 Allowed 'General case' 0 C--N 1.331 -0.236 0 N-CA-C 109.826 -0.435 . . . . 0.0 109.826 172.731 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' E' E ' 107' ' ' GLN . . . . . . . . . . . . . 38.7 tp60 -57.45 -27.77 62.75 Favored 'General case' 0 CA--C 1.534 0.334 0 N-CA-C 112.193 0.442 . . . . 0.0 112.193 -177.889 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' E' E ' 108' ' ' ASN . . . . . . . . . . . . . 9.1 t-20 -93.68 14.34 19.38 Favored 'General case' 0 CA--C 1.534 0.351 0 N-CA-C 113.136 0.791 . . . . 0.0 113.136 -175.453 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' E' E ' 109' ' ' LEU . . . . . . . . . . . . . 72.5 mt 58.72 35.81 24.57 Favored 'General case' 0 CA--C 1.53 0.176 0 CA-C-O 120.881 0.372 . . . . 0.0 111.55 179.494 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' E' E ' 110' ' ' GLU . . . . . . . . . . . . . 95.9 mt-10 -99.26 148.19 24.39 Favored 'General case' 0 C--N 1.33 -0.282 0 N-CA-C 109.774 -0.454 . . . . 0.0 109.774 175.894 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' E' E ' 111' ' ' GLU . . . . . . . . . . . . . 57.1 tt0 -79.9 122.86 27.2 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.399 -0.364 . . . . 0.0 111.016 -176.273 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' E' E ' 112' ' ' LEU . . . . . . . . . . . . . 17.0 mt -109.89 -45.98 3.55 Favored 'General case' 0 C--N 1.331 -0.202 0 CA-C-N 116.207 -0.451 . . . . 0.0 110.616 177.584 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' E' E ' 113' ' ' TYR . . . . . . . . . . . . . 53.2 t80 -138.47 135.5 35.23 Favored 'General case' 0 C--N 1.331 -0.238 0 C-N-CA 120.837 -0.345 . . . . 0.0 111.079 -179.318 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' E' E ' 114' ' ' ARG . . . . . . . . . . . . . 61.3 ttp180 -136.19 123.45 21.83 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-N 116.228 -0.442 . . . . 0.0 110.373 178.047 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' E' E ' 115' ' ' GLY . . . . . . . . . . . . . . . -150.14 158.91 27.88 Favored Glycine 0 CA--C 1.526 0.726 0 N-CA-C 111.181 -0.768 . . . . 0.0 111.181 177.956 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' E' E ' 116' ' ' LYS . . . . . . . . . . . . . 39.5 ttpt -127.75 137.46 52.44 Favored 'General case' 0 C--N 1.331 -0.238 0 N-CA-C 109.497 -0.557 . . . . 0.0 109.497 175.105 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' E' E ' 117' ' ' PHE . . . . . . . . . . . . . 37.1 m-85 -139.75 113.89 8.95 Favored 'General case' 0 C--N 1.331 -0.209 0 C-N-CA 120.697 -0.401 . . . . 0.0 110.214 -177.094 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' E' E ' 118' ' ' GLU . . . . . . . . . . . . . 96.1 mt-10 -56.86 -43.92 81.66 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.398 -0.364 . . . . 0.0 110.891 -176.67 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' E' E ' 119' ' ' ASN . . . . . . . . . . . . . 79.0 m-20 -93.87 28.66 2.32 Favored 'General case' 0 C--N 1.329 -0.299 0 N-CA-C 112.312 0.486 . . . . 0.0 112.312 -174.943 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' E' E ' 120' ' ' LEU . . . . . . . . . . . . . 18.6 tp -59.3 123.46 16.79 Favored 'General case' 0 C--N 1.333 -0.122 0 N-CA-C 109.945 -0.391 . . . . 0.0 109.945 177.645 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' E' E ' 121' ' ' ASN . . . . . . . . . . . . . 67.3 m-80 -114.13 -43.92 3.19 Favored 'General case' 0 C--N 1.332 -0.19 0 CA-C-N 116.509 -0.314 . . . . 0.0 110.953 -177.526 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' E' E ' 122' ' ' LYS . . . . . . . . . . . . . 98.6 mttt -144.03 148.05 34.69 Favored 'General case' 0 C--N 1.332 -0.195 0 CA-C-O 121.089 0.471 . . . . 0.0 111.714 -177.109 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' E' E ' 123' ' ' VAL . . . . . . . . . . . . . 45.8 t -127.95 129.97 69.82 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.341 0 N-CA-C 109.183 -0.673 . . . . 0.0 109.183 173.528 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' E' E ' 124' ' ' LEU . . . . . . . . . . . . . 28.2 mt -129.31 137.74 51.19 Favored 'General case' 0 N--CA 1.463 0.206 0 CA-C-O 121.047 0.451 . . . . 0.0 111.036 -176.147 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' E' E ' 125' ' ' VAL . . . . . . . . . . . . . 41.4 t -124.71 129.46 73.63 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.225 0 CA-C-N 115.77 -0.65 . . . . 0.0 109.922 179.725 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' E' E ' 126' ' ' ARG . . . . . . . . . . . . . 43.4 mmm-85 -140.61 115.32 9.56 Favored 'General case' 0 C--N 1.329 -0.298 0 N-CA-C 109.416 -0.587 . . . . 0.0 109.416 177.869 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' E' E ' 127' ' ' ASN . . . . . . . . . . . . . 78.5 m-20 56.02 -149.84 0.45 Allowed 'General case' 0 CA--C 1.541 0.629 0 N-CA-C 109.838 -0.43 . . . . 0.0 109.838 -179.93 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' E' E ' 128' ' ' ASP . . . . . . . . . . . . . 38.4 p30 -80.01 14.19 1.93 Allowed 'General case' 0 CA--C 1.535 0.39 0 N-CA-C 112.932 0.716 . . . . 0.0 112.932 179.136 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' E' E ' 129' ' ' LEU . . . . . . . . . . . . . 14.3 tp -111.93 136.46 51.22 Favored 'General case' 0 C--O 1.232 0.141 0 N-CA-C 109.688 -0.486 . . . . 0.0 109.688 177.289 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' E' E ' 130' ' ' VAL . . . . . . . . . . . . . 11.3 p -129.09 140.75 48.4 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.254 0 CA-C-O 120.934 0.397 . . . . 0.0 110.341 -177.924 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' E' E ' 131' ' ' VAL . . . . . . . . . . . . . 35.1 m -136.05 145.1 31.56 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.252 0 CA-C-O 121.237 0.541 . . . . 0.0 111.292 -179.096 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' E' E ' 132' ' ' ILE . . . . . . . . . . . . . 72.5 mt -118.94 133.69 64.98 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.32 0 CA-C-N 115.269 -0.878 . . . . 0.0 109.243 179.986 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' E' E ' 133' ' ' ILE . . . . . . . . . . . . . 39.5 mm -115.37 119.84 62.96 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.274 0 CA-C-O 120.722 0.296 . . . . 0.0 110.885 -175.399 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' E' E ' 134' ' ' ASP . . . . . . . . . . . . . 9.5 p-10 -131.79 148.26 52.55 Favored 'General case' 0 C--N 1.332 -0.173 0 N-CA-C 109.542 -0.54 . . . . 0.0 109.542 175.221 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' E' E ' 135' ' ' GLU . . . . . . . . . . . . . 84.8 tt0 -49.87 -27.61 5.4 Favored 'General case' 0 C--N 1.326 -0.422 0 N-CA-C 112.796 0.665 . . . . 0.0 112.796 -172.567 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' E' E ' 136' ' ' GLN . . . . . . . . . . . . . 98.4 mt-30 -81.85 -34.45 30.11 Favored 'General case' 0 C--N 1.33 -0.249 0 N-CA-C 112.746 0.647 . . . . 0.0 112.746 -176.192 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' E' E ' 137' ' ' LYS . . . . . . . . . . . . . 54.1 pttt -167.93 171.53 9.71 Favored 'General case' 0 C--N 1.332 -0.196 0 CA-C-O 121.66 0.743 . . . . 0.0 112.573 -171.131 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' E' E ' 138' ' ' LEU . . . . . . . . . . . . . 3.4 tt -114.05 127.91 56.15 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 114.73 -1.123 . . . . 0.0 109.679 -179.958 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' E' E ' 139' ' ' THR . . . . . . . . . . . . . 30.5 m -108.86 128.02 54.55 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-O 120.715 0.293 . . . . 0.0 110.401 179.219 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' E' E ' 140' ' ' LEU . . . . . . . . . . . . . 8.0 tt -117.57 124.34 48.44 Favored 'General case' 0 C--N 1.329 -0.285 0 N-CA-C 109.359 -0.608 . . . . 0.0 109.359 -178.594 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' E' E ' 141' ' ' ILE . . . . . . . . . . . . . 19.5 mt -120.94 121.73 65.87 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.305 0 N-CA-C 109.714 -0.476 . . . . 0.0 109.714 -175.431 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' E' E ' 142' ' ' ARG . . . . . . . . . . . . . 73.7 ttt180 -112.7 130.21 56.13 Favored 'General case' 0 C--N 1.331 -0.208 0 CA-C-N 115.709 -0.678 . . . . 0.0 110.407 -176.89 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' E' E ' 143' ' ' THR . . . . . . . . . . . . . 50.8 p . . . . . 0 C--O 1.22 -0.475 0 CA-C-O 117.997 -1.001 . . . . 0.0 110.603 -179.81 . . . . . . . . 0 0 . 1 . 013 nuclear orig full ' F' F ' -3' ' ' GLU . . . . . . . . . . . . . 95.8 mt-10 . . . . . 0 N--CA 1.491 1.594 0 N-CA-C 109.368 -0.604 . . . . 0.0 109.368 . . . . . . . . . 0 0 . 1 . 013 nuclear orig full ' F' F ' -2' ' ' GLY . . . . . . . . . . . . . . . -60.69 150.0 42.9 Favored Glycine 0 CA--C 1.525 0.662 0 N-CA-C 110.706 -0.958 . . . . 0.0 110.706 178.807 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' F' F ' -1' ' ' VAL . . . . . . . . . . . . . 44.0 t -94.85 127.48 46.79 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.358 0 CA-C-O 120.917 0.389 . . . . 0.0 110.17 -179.096 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' F' F ' 0' ' ' ILE . . . . . . . . . . . . . 71.8 mt -120.88 124.16 71.74 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.269 0 CA-C-N 116.05 -0.523 . . . . 0.0 109.676 178.833 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' F' F ' 1' ' ' MET . . . . . . . . . . . . . 25.6 ptp -84.68 140.82 31.03 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.26 -0.427 . . . . 0.0 110.615 -178.712 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' F' F ' 2' ' ' SER . . . . . . . . . . . . . 3.0 p -110.51 127.54 55.22 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-O 121.134 0.492 . . . . 0.0 110.449 178.916 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' F' F ' 3' ' ' GLU . . . . . . . . . . . . . 84.2 tt0 -140.17 139.14 35.66 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 115.69 -0.687 . . . . 0.0 110.771 -178.827 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' F' F ' 4' ' ' LEU . . . . . . . . . . . . . 19.1 tp -122.13 124.75 44.62 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 115.985 -0.552 . . . . 0.0 110.376 178.497 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' F' F ' 5' ' ' LYS . . . . . . . . . . . . . 97.9 mttt -101.92 118.84 37.75 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.146 -0.479 . . . . 0.0 110.28 177.261 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' F' F ' 6' ' ' LEU . . . . . . . . . . . . . 31.0 mt -114.99 148.28 38.99 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 115.486 -0.779 . . . . 0.0 110.242 -179.07 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' F' F ' 7' ' ' LYS . . . . . . . . . . . . . 52.3 tttp -137.2 140.71 31.84 Favored Pre-proline 0 CA--C 1.534 0.34 0 CA-C-O 119.124 -0.465 . . . . 0.0 110.047 175.433 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' F' F ' 8' ' ' PRO . . . . . . . . . . . . . 89.3 Cg_endo -91.85 139.37 2.17 Favored 'Trans proline' 0 N--CA 1.49 1.293 0 C-N-CA 121.736 1.624 . . . . 0.0 111.745 177.898 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' F' F ' 9' ' ' LEU . . . . . . . . . . . . . 46.1 mt -77.68 -47.66 2.34 Favored Pre-proline 0 CA--C 1.534 0.35 0 CA-C-O 118.682 -0.675 . . . . 0.0 112.237 -179.663 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' F' F ' 10' ' ' PRO . . . . . . . . . . . . . 86.2 Cg_endo -80.6 152.93 20.18 Favored 'Trans proline' 0 N--CA 1.495 1.616 0 C-N-CA 121.185 1.257 . . . . 0.0 111.89 176.064 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' F' F ' 11' ' ' LYS . . . . . . . . . . . . . 60.7 tttm -88.8 93.66 9.66 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-O 120.818 0.342 . . . . 0.0 110.456 179.038 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' F' F ' 12' ' ' VAL . . . . . . . . . . . . . 13.0 p -141.38 143.34 27.86 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.231 0 CA-C-N 116.318 -0.401 . . . . 0.0 110.701 -179.525 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' F' F ' 13' ' ' GLU . . . . . . . . . . . . . 45.9 mp0 -77.67 132.83 38.38 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.29 -0.414 . . . . 0.0 110.255 178.065 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' F' F ' 14' ' ' LEU . . . . . . . . . . . . . 31.0 mt -98.37 147.74 33.55 Favored Pre-proline 0 CA--C 1.533 0.307 0 CA-C-O 119.185 -0.436 . . . . 0.0 110.233 -179.738 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' F' F ' 15' ' ' PRO . . . . . . . . . . . . . 25.8 Cg_exo -62.17 158.95 36.94 Favored 'Trans proline' 0 N--CA 1.498 1.741 0 C-N-CA 121.335 1.356 . . . . 0.0 111.876 176.793 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' F' F ' 16' ' ' PRO . . . . . . . . . . . . . 38.7 Cg_exo -58.56 -41.17 67.31 Favored 'Trans proline' 0 N--CA 1.498 1.785 0 C-N-CA 121.497 1.465 . . . . 0.0 112.808 -177.72 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' F' F ' 17' ' ' ASP . . . . . . . . . . . . . 19.2 p-10 -85.71 9.02 17.55 Favored 'General case' 0 C--N 1.326 -0.414 0 N-CA-C 113.23 0.826 . . . . 0.0 113.23 -177.609 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' F' F ' 18' ' ' PHE . . . . . . . . . . . . . 36.7 t80 -58.34 -45.43 88.14 Favored 'General case' 0 C--N 1.333 -0.114 0 O-C-N 121.998 -0.439 . . . . 0.0 110.152 -177.594 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' F' F ' 19' ' ' VAL . . . . . . . . . . . . . 13.6 p -56.69 -41.51 74.63 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.329 0 CA-C-N 116.25 -0.432 . . . . 0.0 110.954 -178.738 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' F' F ' 20' ' ' ASP . . . . . . . . . . . . . 30.0 m-20 -60.53 -43.5 97.07 Favored 'General case' 0 C--N 1.331 -0.198 0 C-N-CA 120.937 -0.305 . . . . 0.0 111.12 -178.087 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' F' F ' 21' ' ' VAL . . . . . . . . . . . . . 47.0 t -64.58 -46.11 93.52 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.255 0 C-N-CA 120.834 -0.346 . . . . 0.0 110.519 -177.498 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' F' F ' 22' ' ' ILE . . . . . . . . . . . . . 51.5 mm -57.46 -41.05 77.93 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.288 0 C-N-CA 121.089 -0.244 . . . . 0.0 110.628 179.418 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' F' F ' 23' ' ' ARG . . . . . . . . . . . . . 32.0 ttp180 -56.14 -48.29 76.55 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-O 120.945 0.402 . . . . 0.0 110.718 178.04 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' F' F ' 24' ' ' ILE . . . . . . . . . . . . . 73.0 mt -61.66 -42.48 94.38 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.306 0 CA-C-N 116.014 -0.539 . . . . 0.0 111.941 -177.969 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' F' F ' 25' ' ' LYS . . . . . . . . . . . . . 16.4 pttp -73.58 -35.07 65.4 Favored 'General case' 0 CA--C 1.533 0.314 0 C-N-CA 120.537 -0.465 . . . . 0.0 111.801 -173.326 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' F' F ' 26' ' ' LEU . . . . . . . . . . . . . 64.5 mt -79.07 -43.06 24.94 Favored 'General case' 0 C--N 1.33 -0.258 0 N-CA-C 112.971 0.73 . . . . 0.0 112.971 -174.528 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' F' F ' 27' ' ' GLN . . . . . . . . . . . . . 10.6 pt20 -46.73 139.67 5.12 Favored 'General case' 0 N--CA 1.469 0.505 0 N-CA-C 112.884 0.698 . . . . 0.0 112.884 -174.54 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' F' F ' 28' ' ' GLY . . . . . . . . . . . . . . . 100.31 -29.99 11.1 Favored Glycine 0 CA--C 1.529 0.948 0 CA-C-N 115.471 -0.786 . . . . 0.0 111.971 -177.915 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' F' F ' 29' ' ' LYS . . . . . . . . . . . . . 98.1 mttt -98.09 155.2 17.25 Favored 'General case' 0 C--O 1.233 0.19 0 CA-C-O 121.061 0.458 . . . . 0.0 111.035 177.988 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' F' F ' 30' ' ' THR . . . . . . . . . . . . . 23.9 m -103.91 139.43 39.09 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.019 -0.537 . . . . 0.0 109.994 175.816 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' F' F ' 31' ' ' VAL . . . . . . . . . . . . . 34.9 m -127.34 157.61 38.93 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.288 0 CA-C-N 116.254 -0.43 . . . . 0.0 110.514 -179.125 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' F' F ' 32' ' ' ARG . . . . . . . . . . . . . 56.3 ttp180 -133.77 151.92 51.73 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-O 121.178 0.514 . . . . 0.0 110.612 179.569 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' F' F ' 33' ' ' THR . . . . . . . . . . . . . 20.7 m -53.09 138.43 31.06 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 116.221 -0.445 . . . . 0.0 111.406 -178.489 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' F' F ' 34' ' ' GLY . . . . . . . . . . . . . . . 100.84 -17.08 56.9 Favored Glycine 0 CA--C 1.534 1.223 0 CA-C-O 119.584 -0.565 . . . . 0.0 113.262 179.16 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' F' F ' 35' ' ' ASP . . . . . . . . . . . . . 63.2 m-20 -65.13 149.45 49.88 Favored 'General case' 0 N--CA 1.461 0.096 0 CA-C-N 118.006 0.903 . . . . 0.0 111.308 179.602 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' F' F ' 36' ' ' VAL . . . . . . . . . . . . . 45.8 t -125.15 129.63 73.2 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.196 0 CA-C-N 115.686 -0.688 . . . . 0.0 109.71 178.399 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' F' F ' 37' ' ' ILE . . . . . . . . . . . . . 68.4 mt -122.29 138.92 50.85 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.265 0 N-CA-C 109.839 -0.43 . . . . 0.0 109.839 -179.948 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' F' F ' 38' ' ' GLY . . . . . . . . . . . . . . . -111.07 128.87 8.93 Favored Glycine 0 CA--C 1.524 0.654 0 N-CA-C 111.191 -0.764 . . . . 0.0 111.191 -179.372 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' F' F ' 39' ' ' ILE . . . . . . . . . . . . . 72.4 mt -122.57 136.47 59.28 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.215 0 N-CA-C 109.902 -0.407 . . . . 0.0 109.902 179.014 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' F' F ' 40' ' ' SER . . . . . . . . . . . . . 21.8 t -92.74 118.32 30.95 Favored 'General case' 0 C--N 1.33 -0.25 0 C-N-CA 120.956 -0.298 . . . . 0.0 110.802 176.26 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' F' F ' 41' ' ' ILE . . . . . . . . . . . . . 47.8 mm -128.77 115.77 38.38 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.207 0 CA-C-O 120.811 0.339 . . . . 0.0 110.273 178.331 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' F' F ' 42' ' ' LEU . . . . . . . . . . . . . 11.4 tp 57.14 37.16 28.34 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 116.137 -0.483 . . . . 0.0 111.386 178.428 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' F' F ' 43' ' ' GLY . . . . . . . . . . . . . . . 77.67 -10.09 26.21 Favored Glycine 0 CA--C 1.534 1.268 0 C-N-CA 121.316 -0.469 . . . . 0.0 113.5 177.074 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' F' F ' 44' ' ' LYS . . . . . . . . . . . . . 38.7 mmtm -97.52 135.5 39.27 Favored 'General case' 0 C--N 1.332 -0.193 0 CA-C-N 117.966 0.883 . . . . 0.0 110.17 177.277 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' F' F ' 45' ' ' GLU . . . . . . . . . . . . . 82.7 tt0 -84.65 125.99 32.96 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.358 -0.383 . . . . 0.0 110.819 179.873 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' F' F ' 46' ' ' VAL . . . . . . . . . . . . . 7.3 p -119.34 126.44 75.34 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.159 0 N-CA-C 109.437 -0.579 . . . . 0.0 109.437 176.135 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' F' F ' 47' ' ' LYS . . . . . . . . . . . . . 60.4 mttp -100.1 127.46 46.33 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 115.865 -0.607 . . . . 0.0 111.007 178.806 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' F' F ' 48' ' ' PHE . . . . . . . . . . . . . 93.9 m-85 -109.89 131.91 54.64 Favored 'General case' 0 C--N 1.33 -0.262 0 N-CA-C 109.817 -0.438 . . . . 0.0 109.817 175.925 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' F' F ' 49' ' ' LYS . . . . . . . . . . . . . 53.7 tttp -108.44 138.83 44.09 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.406 -0.361 . . . . 0.0 110.349 179.128 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' F' F ' 50' ' ' VAL . . . . . . . . . . . . . 45.2 t -81.77 108.69 15.13 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.257 0 N-CA-C 109.384 -0.598 . . . . 0.0 109.384 176.226 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' F' F ' 51' ' ' VAL . . . . . . . . . . . . . 48.5 t -74.89 -48.06 34.66 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.276 0 CA-C-N 115.988 -0.551 . . . . 0.0 110.068 -174.015 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' F' F ' 52' ' ' GLN . . . . . . . . . . . . . 62.6 tt0 -158.7 133.94 8.52 Favored 'General case' 0 C--N 1.331 -0.23 0 C-N-CA 120.241 -0.584 . . . . 0.0 111.811 -177.518 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' F' F ' 53' ' ' ALA . . . . . . . . . . . . . . . -108.22 127.29 53.71 Favored 'General case' 0 C--N 1.332 -0.185 0 CA-C-N 115.667 -0.697 . . . . 0.0 109.644 174.395 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' F' F ' 54' ' ' TYR . . . . . . . . . . . . . 56.5 t80 -123.38 107.45 32.24 Favored Pre-proline 0 CA--C 1.534 0.346 0 CA-C-O 118.304 -0.855 . . . . 0.0 110.643 -178.606 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' F' F ' 55' ' ' PRO . . . . . . . . . . . . . 74.0 Cg_endo -76.96 169.86 73.28 Favored 'Cis proline' 0 N--CA 1.5 1.887 0 CA-C-N 121.725 1.652 . . . . 0.0 112.434 -5.681 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' F' F ' 56' ' ' SER . . . . . . . . . . . . . 25.1 m -108.52 124.55 34.1 Favored Pre-proline 0 CA--C 1.538 0.51 0 CA-C-O 118.372 -0.823 . . . . 0.0 109.561 175.819 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' F' F ' 57' ' ' PRO . . . . . . . . . . . . . 48.1 Cg_endo -70.19 166.66 74.6 Favored 'Cis proline' 0 N--CA 1.498 1.771 0 CA-C-N 122.106 1.788 . . . . 0.0 111.824 0.391 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' F' F ' 58' ' ' LEU . . . . . . . . . . . . . 24.2 tp -129.09 135.37 48.81 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.137 -0.483 . . . . 0.0 110.296 -179.926 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' F' F ' 59' ' ' ARG . . . . . . . . . . . . . 52.1 ttp180 -104.56 131.87 51.46 Favored 'General case' 0 C--N 1.327 -0.4 0 N-CA-C 109.68 -0.489 . . . . 0.0 109.68 178.749 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' F' F ' 60' ' ' VAL . . . . . . . . . . . . . 45.3 t -86.2 123.22 39.45 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.214 0 C-N-CA 120.671 -0.411 . . . . 0.0 110.404 -175.469 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' F' F ' 61' ' ' GLU . . . . . . . . . . . . . 95.3 mt-10 -131.06 166.26 21.43 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 115.942 -0.572 . . . . 0.0 110.14 177.806 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' F' F ' 62' ' ' ASP . . . . . . . . . . . . . 64.0 m-20 -54.92 -32.75 61.5 Favored 'General case' 0 C--N 1.327 -0.382 0 C-N-CA 121.096 -0.242 . . . . 0.0 111.604 179.536 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' F' F ' 63' ' ' ARG . . . . . . . . . . . . . 10.3 ptm180 -87.78 6.91 32.88 Favored 'General case' 0 CA--C 1.537 0.446 0 N-CA-C 113.59 0.959 . . . . 0.0 113.59 -176.73 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' F' F ' 64' ' ' THR . . . . . . . . . . . . . 11.8 m -82.41 139.98 33.72 Favored 'General case' 0 C--N 1.333 -0.137 0 CA-C-N 118.051 0.387 . . . . 0.0 110.655 -177.967 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' F' F ' 65' ' ' LYS . . . . . . . . . . . . . 97.9 mttt -89.15 125.05 34.89 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.085 179.21 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' F' F ' 66' ' ' ILE . . . . . . . . . . . . . 59.4 mt -116.36 127.93 73.83 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.262 0 N-CA-C 109.679 -0.489 . . . . 0.0 109.679 179.0 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' F' F ' 67' ' ' THR . . . . . . . . . . . . . 25.1 m -129.13 145.63 51.25 Favored 'General case' 0 C--N 1.331 -0.214 0 CA-C-O 121.112 0.482 . . . . 0.0 111.42 -176.658 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' F' F ' 68' ' ' LEU . . . . . . . . . . . . . 15.5 tp -95.09 120.58 35.55 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 115.79 -0.641 . . . . 0.0 109.527 175.899 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' F' F ' 69' ' ' VAL . . . . . . . . . . . . . 40.1 t -103.85 139.68 24.13 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 CA-C-O 121.046 0.451 . . . . 0.0 111.181 -173.847 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' F' F ' 70' ' ' THR . . . . . . . . . . . . . 47.2 m -102.59 134.95 45.11 Favored 'General case' 0 C--N 1.328 -0.341 0 N-CA-C 109.068 -0.715 . . . . 0.0 109.068 172.542 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' F' F ' 71' ' ' HIS . . . . . . . . . . . . . 65.1 m-70 -126.48 165.2 29.54 Favored Pre-proline 0 N--CA 1.464 0.264 0 N-CA-C 111.845 0.313 . . . . 0.0 111.845 -174.499 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' F' F ' 72' ' ' PRO . . . . . . . . . . . . . 8.1 Cg_exo -68.34 160.19 50.09 Favored 'Trans proline' 0 N--CA 1.495 1.607 0 C-N-CA 121.782 1.655 . . . . 0.0 112.07 177.915 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' F' F ' 73' ' ' VAL . . . . . . . . . . . . . 35.8 m -69.9 -174.1 0.11 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.312 0 N-CA-C 109.694 -0.484 . . . . 0.0 109.694 178.928 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' F' F ' 74' ' ' ASP . . . . . . . . . . . . . 7.2 t70 -90.64 115.17 27.54 Favored 'General case' 0 C--N 1.331 -0.226 0 C-N-CA 120.645 -0.422 . . . . 0.0 110.31 -173.593 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' F' F ' 75' ' ' VAL . . . . . . . . . . . . . 44.5 t -114.89 120.45 64.55 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.228 0 CA-C-O 121.038 0.447 . . . . 0.0 110.085 -179.272 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' F' F ' 76' ' ' LEU . . . . . . . . . . . . . 20.6 mt -124.47 144.29 50.17 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 115.662 -0.699 . . . . 0.0 109.717 179.34 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' F' F ' 77' ' ' GLU . . . . . . . . . . . . . 46.6 mt-10 -134.11 135.86 43.48 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-O 121.073 0.463 . . . . 0.0 111.286 -177.761 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' F' F ' 78' ' ' ALA . . . . . . . . . . . . . . . -122.64 127.71 49.7 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 115.483 -0.78 . . . . 0.0 109.457 175.712 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' F' F ' 79' ' ' LYS . . . . . . . . . . . . . 37.7 tttp -79.79 120.29 23.86 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-O 120.993 0.425 . . . . 0.0 110.828 -175.785 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' F' F ' 80' ' ' ILE . . . . . . . . . . . . . 37.5 mm -139.3 108.85 3.84 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.291 0 N-CA-C 108.983 -0.747 . . . . 0.0 108.983 -179.289 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' F' F ' 81' ' ' LYS . . . . . . . . . . . . . 39.7 ttpt -99.26 123.69 43.74 Favored 'General case' 0 C--N 1.329 -0.298 0 C-N-CA 120.862 -0.335 . . . . 0.0 110.97 -176.236 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' F' F ' 82' ' ' GLY . . . . . . . . . . . . . . . 89.21 42.18 5.64 Favored Glycine 0 CA--C 1.525 0.708 0 C-N-CA 120.7 -0.762 . . . . 0.0 111.677 176.368 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' F' F ' 83' ' ' ILE . . . . . . . . . . . . . 75.3 mt -67.2 140.31 19.57 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.338 0 N-CA-C 109.875 -0.417 . . . . 0.0 109.875 177.603 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' F' F ' 84' ' ' LYS . . . . . . . . . . . . . 47.0 tttp -100.82 -53.94 2.94 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.029 -0.532 . . . . 0.0 110.654 -178.644 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' F' F ' 85' ' ' ASP . . . . . . . . . . . . . 13.5 t70 -146.22 149.43 33.9 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 115.916 -0.584 . . . . 0.0 110.705 -178.095 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' F' F ' 86' ' ' VAL . . . . . . . . . . . . . 41.3 t -128.51 127.56 67.09 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.221 0 CA-C-O 120.815 0.341 . . . . 0.0 110.364 -179.782 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' F' F ' 87' ' ' ILE . . . . . . . . . . . . . 44.4 mm -120.84 130.39 74.67 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.223 0 CA-C-N 116.071 -0.513 . . . . 0.0 109.923 178.674 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' F' F ' 88' ' ' LEU . . . . . . . . . . . . . 27.1 mt -115.47 137.4 52.09 Favored 'General case' 0 C--N 1.332 -0.182 0 CA-C-O 120.951 0.405 . . . . 0.0 111.069 -178.946 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' F' F ' 89' ' ' ASP . . . . . . . . . . . . . 7.4 t70 -135.31 162.19 33.28 Favored 'General case' 0 C--N 1.331 -0.239 0 CA-C-N 115.999 -0.546 . . . . 0.0 110.084 177.335 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' F' F ' 90' ' ' GLU . . . . . . . . . . . . . 96.4 mt-10 -45.15 -48.14 12.27 Favored 'General case' 0 N--CA 1.465 0.307 0 N-CA-C 113.149 0.796 . . . . 0.0 113.149 -171.263 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' F' F ' 91' ' ' ASN . . . . . . . . . . . . . 21.0 t-20 -132.04 39.91 3.39 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-O 120.974 0.416 . . . . 0.0 110.861 -177.606 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' F' F ' 92' ' ' LEU . . . . . . . . . . . . . 10.7 tp -163.45 138.01 6.14 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.355 -0.384 . . . . 0.0 110.89 -177.539 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' F' F ' 93' ' ' ILE . . . . . . . . . . . . . 69.0 mt -122.3 124.81 71.79 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.311 0 N-CA-C 109.226 -0.657 . . . . 0.0 109.226 177.29 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' F' F ' 94' ' ' VAL . . . . . . . . . . . . . 45.8 t -123.54 128.62 74.68 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.258 0 CA-C-O 120.983 0.42 . . . . 0.0 110.069 -178.931 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' F' F ' 95' ' ' VAL . . . . . . . . . . . . . 44.4 t -121.58 134.76 63.89 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.314 0 CA-C-N 115.921 -0.581 . . . . 0.0 109.724 178.958 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' F' F ' 96' ' ' ILE . . . . . . . . . . . . . 61.6 mt -114.47 127.71 71.83 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.354 0 N-CA-C 109.146 -0.687 . . . . 0.0 109.146 178.493 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' F' F ' 97' ' ' THR . . . . . . . . . . . . . 58.3 p -98.5 159.5 14.91 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-O 121.102 0.477 . . . . 0.0 111.177 -177.498 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' F' F ' 98' ' ' GLU . . . . . . . . . . . . . 80.4 tt0 -53.88 -28.16 34.55 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.171 -0.468 . . . . 0.0 112.092 -179.622 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' F' F ' 99' ' ' GLU . . . . . . . . . . . . . 95.6 mt-10 -79.96 16.5 1.17 Allowed 'General case' 0 CA--C 1.535 0.392 0 N-CA-C 113.043 0.757 . . . . 0.0 113.043 -177.263 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' F' F ' 100' ' ' ASN . . . . . . . . . . . . . 4.2 m-20 62.48 38.04 12.95 Favored 'General case' 0 CA--C 1.53 0.198 0 CA-C-O 121.009 0.433 . . . . 0.0 111.072 177.757 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' F' F ' 101' ' ' GLU . . . . . . . . . . . . . 83.6 tt0 -111.8 144.05 41.74 Favored 'General case' 0 C--N 1.332 -0.186 0 CA-C-N 116.004 -0.544 . . . . 0.0 109.775 175.891 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' F' F ' 102' ' ' VAL . . . . . . . . . . . . . 42.7 t -115.02 125.09 72.24 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.293 0 N-CA-C 109.798 -0.445 . . . . 0.0 109.798 -178.67 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' F' F ' 103' ' ' LEU . . . . . . . . . . . . . 44.1 mt -118.3 131.63 56.33 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 115.725 -0.67 . . . . 0.0 110.046 178.395 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' F' F ' 104' ' ' ILE . . . . . . . . . . . . . 67.3 mt -121.09 123.09 69.25 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.245 0 CA-C-O 120.66 0.266 . . . . 0.0 110.374 -179.787 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' F' F ' 105' ' ' PHE . . . . . . . . . . . . . 48.7 m-85 -123.95 167.42 14.17 Favored 'General case' 0 C--N 1.333 -0.122 0 CA-C-N 115.358 -0.837 . . . . 0.0 109.885 178.931 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' F' F ' 106' ' ' ASN . . . . . . . . . . . . . 36.8 p-10 -98.74 -169.97 1.86 Allowed 'General case' 0 C--N 1.331 -0.207 0 N-CA-C 109.866 -0.42 . . . . 0.0 109.866 172.919 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' F' F ' 107' ' ' GLN . . . . . . . . . . . . . 49.2 tt0 -58.6 -30.08 66.94 Favored 'General case' 0 C--N 1.329 -0.31 0 N-CA-C 112.048 0.388 . . . . 0.0 112.048 -179.339 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' F' F ' 108' ' ' ASN . . . . . . . . . . . . . 5.7 t30 -91.33 14.01 15.77 Favored 'General case' 0 CA--C 1.535 0.394 0 N-CA-C 113.153 0.797 . . . . 0.0 113.153 -176.631 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' F' F ' 109' ' ' LEU . . . . . . . . . . . . . 30.7 mt 59.25 34.61 23.12 Favored 'General case' 0 C--N 1.332 -0.167 0 N-CA-C 111.992 0.367 . . . . 0.0 111.992 177.019 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' F' F ' 110' ' ' GLU . . . . . . . . . . . . . 95.9 mt-10 -98.64 136.37 38.81 Favored 'General case' 0 C--N 1.328 -0.338 0 N-CA-C 109.049 -0.723 . . . . 0.0 109.049 173.187 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' F' F ' 111' ' ' GLU . . . . . . . . . . . . . 56.1 tt0 -78.64 121.9 25.27 Favored 'General case' 0 C--N 1.327 -0.401 0 CA-C-O 120.898 0.38 . . . . 0.0 110.743 -173.727 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' F' F ' 112' ' ' LEU . . . . . . . . . . . . . 15.3 mt -103.73 -45.97 4.65 Favored 'General case' 0 C--N 1.331 -0.204 0 CA-C-N 115.868 -0.606 . . . . 0.0 110.703 179.574 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' F' F ' 113' ' ' TYR . . . . . . . . . . . . . 44.5 t80 -136.26 141.88 43.93 Favored 'General case' 0 C--N 1.331 -0.239 0 CA-C-N 116.193 -0.458 . . . . 0.0 111.181 -177.174 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' F' F ' 114' ' ' ARG . . . . . . . . . . . . . 32.3 ptt180 -147.06 123.25 10.86 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.107 -0.497 . . . . 0.0 110.826 176.893 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' F' F ' 115' ' ' GLY . . . . . . . . . . . . . . . -150.09 163.02 29.37 Favored Glycine 0 CA--C 1.523 0.554 0 N-CA-C 110.789 -0.924 . . . . 0.0 110.789 179.472 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' F' F ' 116' ' ' LYS . . . . . . . . . . . . . 38.3 ttpt -130.17 135.77 48.54 Favored 'General case' 0 C--N 1.329 -0.295 0 O-C-N 122.627 -0.337 . . . . 0.0 110.123 179.066 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' F' F ' 117' ' ' PHE . . . . . . . . . . . . . 48.6 m-85 -133.58 114.85 14.01 Favored 'General case' 0 C--N 1.331 -0.206 0 CA-C-O 120.967 0.413 . . . . 0.0 110.176 -176.95 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' F' F ' 118' ' ' GLU . . . . . . . . . . . . . 70.6 mm-40 -54.54 -41.1 69.34 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 116.412 -0.358 . . . . 0.0 111.371 -176.319 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' F' F ' 119' ' ' ASN . . . . . . . . . . . . . 85.6 m-20 -100.73 31.04 3.68 Favored 'General case' 0 C--N 1.33 -0.276 0 N-CA-C 112.176 0.435 . . . . 0.0 112.176 -173.919 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' F' F ' 120' ' ' LEU . . . . . . . . . . . . . 15.0 tp -56.59 119.92 6.91 Favored 'General case' 0 C--N 1.332 -0.19 0 CA-C-O 120.707 0.289 . . . . 0.0 110.379 178.254 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' F' F ' 121' ' ' ASN . . . . . . . . . . . . . 72.9 m-20 -114.15 -44.13 3.16 Favored 'General case' 0 C--N 1.333 -0.141 0 CA-C-N 116.368 -0.378 . . . . 0.0 111.282 -177.647 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' F' F ' 122' ' ' LYS . . . . . . . . . . . . . 53.4 mtmt -145.3 151.27 38.08 Favored 'General case' 0 C--N 1.331 -0.239 0 CA-C-O 121.042 0.449 . . . . 0.0 111.749 -176.234 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' F' F ' 123' ' ' VAL . . . . . . . . . . . . . 46.7 t -130.8 127.97 62.3 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.235 0 CA-C-N 116.01 -0.541 . . . . 0.0 109.545 174.697 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' F' F ' 124' ' ' LEU . . . . . . . . . . . . . 41.2 mt -115.99 136.99 52.52 Favored 'General case' 0 C--N 1.331 -0.196 0 CA-C-N 116.307 -0.406 . . . . 0.0 110.709 -178.736 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' F' F ' 125' ' ' VAL . . . . . . . . . . . . . 35.1 m -128.43 138.16 55.4 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.209 0 CA-C-N 116.265 -0.425 . . . . 0.0 110.817 -179.359 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' F' F ' 126' ' ' ARG . . . . . . . . . . . . . 96.3 mtt-85 -143.9 111.44 5.98 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.102 -0.499 . . . . 0.0 110.38 177.155 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' F' F ' 127' ' ' ASN . . . . . . . . . . . . . 79.1 m-20 53.13 -104.95 0.22 Allowed 'General case' 0 CA--C 1.544 0.722 0 CA-C-O 119.122 -0.466 . . . . 0.0 111.057 -179.847 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' F' F ' 128' ' ' ASP . . . . . . . . . . . . . 12.3 p-10 -113.98 0.17 14.28 Favored 'General case' 0 CA--C 1.536 0.434 0 CA-C-N 119.509 1.049 . . . . 0.0 113.386 -177.531 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' F' F ' 129' ' ' LEU . . . . . . . . . . . . . 9.9 mp -105.0 147.84 27.38 Favored 'General case' 0 CA--C 1.523 -0.096 0 N-CA-C 109.669 -0.493 . . . . 0.0 109.669 177.842 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' F' F ' 130' ' ' VAL . . . . . . . . . . . . . 13.1 p -137.37 145.19 29.88 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.245 0 CA-C-O 121.23 0.538 . . . . 0.0 110.87 -176.757 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' F' F ' 131' ' ' VAL . . . . . . . . . . . . . 44.1 t -134.61 136.97 51.97 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.294 0 CA-C-N 115.722 -0.672 . . . . 0.0 109.869 178.079 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' F' F ' 132' ' ' ILE . . . . . . . . . . . . . 71.1 mt -114.18 132.2 63.92 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.335 0 N-CA-C 109.452 -0.573 . . . . 0.0 109.452 -178.825 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' F' F ' 133' ' ' ILE . . . . . . . . . . . . . 43.0 mm -117.77 121.8 68.28 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.27 0 CA-C-O 120.791 0.329 . . . . 0.0 110.621 -176.041 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' F' F ' 134' ' ' ASP . . . . . . . . . . . . . 7.1 p-10 -132.38 148.56 52.42 Favored 'General case' 0 C--N 1.33 -0.249 0 N-CA-C 109.578 -0.527 . . . . 0.0 109.578 174.934 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' F' F ' 135' ' ' GLU . . . . . . . . . . . . . 32.3 tp10 -49.9 -24.4 2.48 Favored 'General case' 0 C--N 1.328 -0.328 0 N-CA-C 112.943 0.72 . . . . 0.0 112.943 -169.775 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' F' F ' 136' ' ' GLN . . . . . . . . . . . . . 60.7 tt0 -105.02 -26.42 12.15 Favored 'General case' 0 N--CA 1.466 0.327 0 N-CA-C 112.748 0.647 . . . . 0.0 112.748 -174.637 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' F' F ' 137' ' ' LYS . . . . . . . . . . . . . 77.3 mttt -141.7 154.0 45.02 Favored 'General case' 0 C--N 1.331 -0.198 0 CA-C-O 121.252 0.549 . . . . 0.0 111.798 -171.731 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' F' F ' 138' ' ' LEU . . . . . . . . . . . . . 6.1 tt -120.29 124.97 46.9 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 115.616 -0.72 . . . . 0.0 109.299 173.765 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' F' F ' 139' ' ' THR . . . . . . . . . . . . . 31.1 m -114.21 129.83 56.63 Favored 'General case' 0 C--N 1.332 -0.191 0 CA-C-N 116.385 -0.37 . . . . 0.0 110.757 -177.362 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' F' F ' 140' ' ' LEU . . . . . . . . . . . . . 7.4 tt -116.87 121.53 41.75 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 115.686 -0.688 . . . . 0.0 109.387 -179.119 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' F' F ' 141' ' ' ILE . . . . . . . . . . . . . 19.0 mt -121.37 118.5 56.2 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.253 0 N-CA-C 109.778 -0.453 . . . . 0.0 109.778 -176.764 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' F' F ' 142' ' ' ARG . . . . . . . . . . . . . 61.7 ttt180 -110.87 127.77 55.55 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 115.5 -0.773 . . . . 0.0 110.403 -176.86 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' F' F ' 143' ' ' THR . . . . . . . . . . . . . 42.3 p . . . . . 0 C--O 1.22 -0.458 0 CA-C-O 117.989 -1.005 . . . . 0.0 110.66 -179.706 . . . . . . . . 0 0 . 1 . 014 nuclear orig full ' A' A ' -3' ' ' GLU . . . . . . . . . . . . . 95.8 mt-10 . . . . . 0 N--CA 1.491 1.606 0 N-CA-C 109.269 -0.641 . . . . 0.0 109.269 . . . . . . . . . 0 0 . 1 . 014 nuclear orig full ' A' A ' -2' ' ' GLY . . . . . . . . . . . . . . . -65.78 141.06 41.39 Favored Glycine 0 CA--C 1.526 0.723 0 N-CA-C 110.777 -0.929 . . . . 0.0 110.777 179.359 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' -1' ' ' VAL . . . . . . . . . . . . . 46.3 t -96.24 137.68 23.55 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.305 0 N-CA-C 109.83 -0.433 . . . . 0.0 109.83 179.742 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 0' ' ' ILE . . . . . . . . . . . . . 70.3 mt -104.17 132.23 51.17 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.288 0 CA-C-N 116.151 -0.477 . . . . 0.0 110.204 -177.649 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 25.8 ptt? -81.7 170.49 15.71 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.003 -0.544 . . . . 0.0 110.526 179.343 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 41.1 p -118.8 148.57 42.7 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-N 116.252 -0.431 . . . . 0.0 110.485 -179.369 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 95.2 mt-10 -140.54 142.71 35.16 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.174 -0.466 . . . . 0.0 111.243 -178.162 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 4' ' ' LEU . . . . . . . . . . . . . 56.0 mt -119.73 130.1 54.83 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 115.819 -0.628 . . . . 0.0 110.317 175.319 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 5' ' ' LYS . . . . . . . . . . . . . 67.1 mttm -107.38 120.57 42.52 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.306 -0.406 . . . . 0.0 110.436 177.242 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 73.9 mt -116.82 150.81 37.74 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 115.532 -0.758 . . . . 0.0 110.378 -179.238 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 74.8 tttt -140.69 139.11 19.33 Favored Pre-proline 0 CA--C 1.534 0.335 0 CA-C-O 119.167 -0.444 . . . . 0.0 110.092 175.594 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 8' ' ' PRO . . . . . . . . . . . . . 86.4 Cg_endo -91.76 140.99 2.52 Favored 'Trans proline' 0 N--CA 1.49 1.267 0 C-N-CA 121.733 1.622 . . . . 0.0 111.672 176.971 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 68.8 mt -74.05 -47.93 6.22 Favored Pre-proline 0 C--N 1.328 -0.348 0 CA-C-O 118.622 -0.704 . . . . 0.0 112.243 -178.473 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 89.0 Cg_endo -80.76 146.36 16.58 Favored 'Trans proline' 0 N--CA 1.495 1.614 0 C-N-CA 121.211 1.274 . . . . 0.0 111.931 176.419 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 63.3 mttm -85.8 95.82 9.55 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-O 120.943 0.401 . . . . 0.0 110.416 178.234 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 11.7 p -139.87 149.23 22.34 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.277 0 CA-C-N 115.894 -0.594 . . . . 0.0 110.348 -179.465 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 45.5 tp10 -87.25 122.21 30.73 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 116.337 -0.392 . . . . 0.0 110.322 178.966 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 14' ' ' LEU . . . . . . . . . . . . . 44.7 mt -97.91 157.65 34.23 Favored Pre-proline 0 C--N 1.329 -0.296 0 CA-C-N 116.163 -0.471 . . . . 0.0 110.861 -179.188 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 15' ' ' PRO . . . . . . . . . . . . . 36.9 Cg_exo -59.56 158.31 28.26 Favored 'Trans proline' 0 N--CA 1.496 1.663 0 C-N-CA 121.413 1.408 . . . . 0.0 111.875 178.719 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 16' ' ' PRO . . . . . . . . . . . . . 33.4 Cg_exo -59.2 -42.65 48.27 Favored 'Trans proline' 0 N--CA 1.496 1.649 0 C-N-CA 121.516 1.478 . . . . 0.0 112.84 -177.606 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 17' ' ' ASP . . . . . . . . . . . . . 7.9 p-10 -87.43 13.42 10.01 Favored 'General case' 0 CA--C 1.536 0.414 0 N-CA-C 113.072 0.767 . . . . 0.0 113.072 -177.06 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 18' ' ' PHE . . . . . . . . . . . . . 42.0 t80 -57.16 -45.45 83.61 Favored 'General case' 0 C--N 1.334 -0.088 0 O-C-N 122.041 -0.412 . . . . 0.0 110.238 -178.994 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 19' ' ' VAL . . . . . . . . . . . . . 47.0 t -57.43 -43.37 82.53 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.262 0 CA-C-N 116.154 -0.475 . . . . 0.0 110.378 -178.451 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 32.0 m-20 -59.1 -41.96 89.37 Favored 'General case' 0 C--N 1.331 -0.224 0 C-N-CA 120.916 -0.314 . . . . 0.0 111.082 -177.634 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 46.9 t -64.55 -44.46 96.83 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.264 0 C-N-CA 120.709 -0.396 . . . . 0.0 110.427 -178.372 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 22' ' ' ILE . . . . . . . . . . . . . 50.9 mm -56.94 -40.14 70.11 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 C-N-CA 120.987 -0.285 . . . . 0.0 110.567 178.709 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 23' ' ' ARG . . . . . . . . . . . . . 53.4 ttp180 -57.13 -48.88 77.58 Favored 'General case' 0 C--N 1.331 -0.214 0 CA-C-O 121.018 0.437 . . . . 0.0 110.468 177.136 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 24' ' ' ILE . . . . . . . . . . . . . 72.7 mt -61.15 -39.5 82.63 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.324 0 CA-C-N 115.839 -0.619 . . . . 0.0 111.944 -177.089 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 16.6 pttp -77.35 -36.07 54.1 Favored 'General case' 0 CA--C 1.535 0.389 0 C-N-CA 120.537 -0.465 . . . . 0.0 111.806 -174.218 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 83.4 mt -77.89 -38.55 45.57 Favored 'General case' 0 C--N 1.33 -0.275 0 N-CA-C 112.979 0.733 . . . . 0.0 112.979 -173.304 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 27' ' ' GLN . . . . . . . . . . . . . 10.1 pt20 -46.92 139.84 5.23 Favored 'General case' 0 N--CA 1.469 0.48 0 N-CA-C 112.867 0.691 . . . . 0.0 112.867 -175.265 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 100.77 -27.76 19.06 Favored Glycine 0 CA--C 1.532 1.122 0 CA-C-N 115.573 -0.739 . . . . 0.0 112.166 -177.544 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 38.0 mmtm -97.84 155.12 17.2 Favored 'General case' 0 C--O 1.232 0.169 0 CA-C-N 117.202 0.501 . . . . 0.0 111.095 178.159 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 30' ' ' THR . . . . . . . . . . . . . 32.3 m -98.92 137.0 38.11 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.107 -0.497 . . . . 0.0 109.884 175.55 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 34.7 m -126.44 151.73 33.27 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.222 0 CA-C-O 120.826 0.346 . . . . 0.0 110.655 -179.296 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 32' ' ' ARG . . . . . . . . . . . . . 76.2 ttt-85 -136.09 149.12 48.58 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.089 -0.505 . . . . 0.0 110.448 178.59 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 33' ' ' THR . . . . . . . . . . . . . 32.1 m -52.92 139.81 26.4 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.386 -0.37 . . . . 0.0 111.301 -178.448 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 100.87 -17.17 56.74 Favored Glycine 0 CA--C 1.533 1.172 0 CA-C-O 119.744 -0.476 . . . . 0.0 113.218 179.644 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 76.7 m-20 -66.69 147.94 52.59 Favored 'General case' 0 N--CA 1.461 0.099 0 CA-C-N 118.028 0.914 . . . . 0.0 111.149 178.728 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 44.6 t -124.25 130.15 73.78 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.197 0 CA-C-N 115.882 -0.599 . . . . 0.0 109.8 178.02 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 37' ' ' ILE . . . . . . . . . . . . . 66.7 mt -122.37 139.65 48.66 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.234 0 CA-C-N 116.266 -0.425 . . . . 0.0 110.126 -179.019 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . -110.18 128.78 9.02 Favored Glycine 0 CA--C 1.526 0.74 0 N-CA-C 111.053 -0.819 . . . . 0.0 111.053 179.586 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 39' ' ' ILE . . . . . . . . . . . . . 73.7 mt -123.87 135.09 64.65 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.171 0 N-CA-C 110.247 -0.279 . . . . 0.0 110.247 179.585 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 40' ' ' SER . . . . . . . . . . . . . 96.6 p -92.97 120.94 33.81 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.398 -0.365 . . . . 0.0 110.984 176.07 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 41' ' ' ILE . . . . . . . . . . . . . 48.1 mm -128.62 115.06 35.92 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.187 0 CA-C-O 120.834 0.35 . . . . 0.0 110.371 177.698 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 1.3 tt 54.52 44.47 28.71 Favored 'General case' 0 CA--C 1.532 0.251 0 CA-C-O 121.392 0.615 . . . . 0.0 110.546 177.636 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . 70.64 16.28 73.96 Favored Glycine 0 CA--C 1.534 1.278 0 C-N-CA 121.093 -0.575 . . . . 0.0 113.12 175.469 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 44' ' ' LYS . . . . . . . . . . . . . 58.5 mtpt -124.05 132.61 53.7 Favored 'General case' 0 C--N 1.332 -0.17 0 CA-C-N 117.765 0.783 . . . . 0.0 109.902 179.413 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 84.8 tt0 -84.46 123.28 30.07 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 116.444 -0.344 . . . . 0.0 111.115 -179.156 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 46' ' ' VAL . . . . . . . . . . . . . 7.3 p -121.64 128.49 75.8 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.244 0 N-CA-C 109.333 -0.617 . . . . 0.0 109.333 175.731 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 66.6 mttm -100.77 128.58 46.76 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.099 -0.5 . . . . 0.0 111.259 178.602 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 48' ' ' PHE . . . . . . . . . . . . . 93.1 m-85 -110.81 131.79 54.75 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-N 116.129 -0.487 . . . . 0.0 109.811 175.603 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 78.5 tttt -108.61 137.41 46.6 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 116.314 -0.403 . . . . 0.0 110.382 179.342 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 50' ' ' VAL . . . . . . . . . . . . . 45.8 t -79.95 109.72 14.79 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.366 0 N-CA-C 109.275 -0.639 . . . . 0.0 109.275 176.326 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 51' ' ' VAL . . . . . . . . . . . . . 55.9 t -71.47 -47.31 59.39 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.324 0 CA-C-N 116.055 -0.521 . . . . 0.0 109.895 -173.795 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 52' ' ' GLN . . . . . . . . . . . . . 61.6 tt0 -171.14 142.14 1.74 Allowed 'General case' 0 C--N 1.33 -0.244 0 C-N-CA 120.145 -0.622 . . . . 0.0 111.557 -178.657 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -114.38 136.08 53.38 Favored 'General case' 0 C--N 1.331 -0.239 0 CA-C-N 115.711 -0.677 . . . . 0.0 109.99 176.135 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 54' ' ' TYR . . . . . . . . . . . . . 30.5 t80 -129.07 108.33 18.04 Favored Pre-proline 0 CA--C 1.536 0.433 0 CA-C-O 118.21 -0.9 . . . . 0.0 110.393 179.616 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 55' ' ' PRO . . . . . . . . . . . . . 73.8 Cg_endo -77.17 169.99 72.71 Favored 'Cis proline' 0 N--CA 1.5 1.873 0 CA-C-N 121.824 1.687 . . . . 0.0 112.318 -5.371 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 56' ' ' SER . . . . . . . . . . . . . 66.6 m -117.45 136.51 23.55 Favored Pre-proline 0 CA--C 1.538 0.514 0 CA-C-O 118.482 -0.771 . . . . 0.0 109.885 175.688 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 57' ' ' PRO . . . . . . . . . . . . . 50.5 Cg_endo -71.24 163.09 86.6 Favored 'Cis proline' 0 N--CA 1.497 1.706 0 CA-C-N 121.791 1.675 . . . . 0.0 111.291 -5.867 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 58' ' ' LEU . . . . . . . . . . . . . 39.4 tp -129.69 138.69 51.3 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-O 121.042 0.449 . . . . 0.0 110.67 -179.205 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 59' ' ' ARG . . . . . . . . . . . . . 41.6 ttm180 -95.58 125.5 40.22 Favored 'General case' 0 C--N 1.326 -0.449 0 CA-C-N 115.717 -0.674 . . . . 0.0 109.219 174.177 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 39.9 t -77.18 116.57 20.73 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.241 0 C-N-CA 120.678 -0.409 . . . . 0.0 110.332 -175.082 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 70.6 mm-40 -131.22 161.77 31.48 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.018 -0.537 . . . . 0.0 109.756 175.977 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 62' ' ' ASP . . . . . . . . . . . . . 81.4 m-20 -52.32 -28.0 17.53 Favored 'General case' 0 C--N 1.328 -0.335 0 N-CA-C 112.034 0.383 . . . . 0.0 112.034 177.816 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 63' ' ' ARG . . . . . . . . . . . . . 77.6 mtp85 -70.77 -22.01 62.44 Favored 'General case' 0 CA--C 1.534 0.331 0 N-CA-C 112.879 0.696 . . . . 0.0 112.879 -176.444 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 29.6 m -80.63 142.05 34.38 Favored 'General case' 0 C--N 1.331 -0.227 0 CA-C-O 121.041 0.448 . . . . 0.0 111.119 -175.239 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 65' ' ' LYS . . . . . . . . . . . . . 96.8 mttt -90.11 138.18 31.73 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 115.902 -0.59 . . . . 0.0 110.066 179.176 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 66' ' ' ILE . . . . . . . . . . . . . 63.9 mt -117.55 129.75 73.52 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.212 0 N-CA-C 110.03 -0.359 . . . . 0.0 110.03 179.329 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 67' ' ' THR . . . . . . . . . . . . . 33.4 m -127.19 142.34 51.51 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-O 121.091 0.472 . . . . 0.0 110.861 -178.855 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 68' ' ' LEU . . . . . . . . . . . . . 15.4 tp -101.76 123.3 45.49 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.081 -0.509 . . . . 0.0 110.187 178.057 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 69' ' ' VAL . . . . . . . . . . . . . 45.8 t -102.7 118.46 49.63 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.275 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.07 -179.631 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 70' ' ' THR . . . . . . . . . . . . . 5.0 t -150.01 -46.01 0.13 Allowed 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.365 177.689 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 71' ' ' HIS . . . . . . . . . . . . . 78.8 m80 -150.03 153.91 36.17 Favored Pre-proline 0 C--N 1.329 -0.32 0 CA-C-N 116.253 -0.431 . . . . 0.0 110.637 179.066 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 72' ' ' PRO . . . . . . . . . . . . . 60.8 Cg_endo -73.92 -19.62 20.5 Favored 'Trans proline' 0 N--CA 1.496 1.649 0 C-N-CA 121.364 1.376 . . . . 0.0 113.158 178.212 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 73' ' ' VAL . . . . . . . . . . . . . 34.8 m -125.66 169.5 16.98 Favored 'Isoleucine or valine' 0 C--O 1.232 0.132 0 CA-C-O 120.772 0.32 . . . . 0.0 110.602 -178.49 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 74' ' ' ASP . . . . . . . . . . . . . 10.5 t0 -91.96 118.29 30.62 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.272 -0.422 . . . . 0.0 109.903 -178.336 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 43.9 t -111.63 120.67 62.62 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.254 0 CA-C-O 121.249 0.547 . . . . 0.0 110.329 -178.635 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 76' ' ' LEU . . . . . . . . . . . . . 18.3 mt -121.38 139.44 53.44 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 115.463 -0.79 . . . . 0.0 109.035 176.787 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 77' ' ' GLU . . . . . . . . . . . . . 26.0 tt0 -135.71 141.62 44.94 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-O 120.986 0.422 . . . . 0.0 111.361 -174.476 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 78' ' ' ALA . . . . . . . . . . . . . . . -132.14 135.26 46.26 Favored 'General case' 0 C--N 1.331 -0.201 0 CA-C-N 115.821 -0.627 . . . . 0.0 110.073 176.572 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 79' ' ' LYS . . . . . . . . . . . . . 62.3 mtpt -77.95 123.28 26.6 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-O 120.868 0.366 . . . . 0.0 110.43 -179.616 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 80' ' ' ILE . . . . . . . . . . . . . 38.1 mm -139.19 108.81 3.92 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.257 0 N-CA-C 109.018 -0.734 . . . . 0.0 109.018 -176.87 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 81' ' ' LYS . . . . . . . . . . . . . 95.0 mttt -102.48 125.63 49.27 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-O 120.897 0.379 . . . . 0.0 111.148 -176.12 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . 89.06 42.05 5.72 Favored Glycine 0 CA--C 1.524 0.618 0 C-N-CA 120.818 -0.706 . . . . 0.0 111.547 174.644 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 83' ' ' ILE . . . . . . . . . . . . . 73.5 mt -68.12 135.7 27.95 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.339 0 N-CA-C 109.674 -0.491 . . . . 0.0 109.674 177.939 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 84' ' ' LYS . . . . . . . . . . . . . 82.9 tttt -96.84 -53.51 3.51 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.025 -0.534 . . . . 0.0 110.18 -179.136 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 85' ' ' ASP . . . . . . . . . . . . . 8.7 t70 -154.52 151.74 29.26 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 115.627 -0.715 . . . . 0.0 110.327 -179.916 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 86' ' ' VAL . . . . . . . . . . . . . 44.1 t -130.15 132.22 65.37 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.298 0 CA-C-O 121.049 0.452 . . . . 0.0 110.383 179.774 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 87' ' ' ILE . . . . . . . . . . . . . 5.1 mp -117.78 124.09 72.59 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.242 0 N-CA-C 108.975 -0.75 . . . . 0.0 108.975 176.255 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 88' ' ' LEU . . . . . . . . . . . . . 14.4 tp -112.39 128.45 56.31 Favored 'General case' 0 C--N 1.331 -0.226 0 CA-C-O 121.073 0.463 . . . . 0.0 111.309 -175.497 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 89' ' ' ASP . . . . . . . . . . . . . 5.9 t70 -120.65 155.47 33.75 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 115.831 -0.622 . . . . 0.0 109.415 175.833 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 44.4 mp0 -51.02 -36.35 39.07 Favored 'General case' 0 C--N 1.328 -0.33 0 N-CA-C 112.464 0.542 . . . . 0.0 112.464 -171.448 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 91' ' ' ASN . . . . . . . . . . . . . 84.8 m-20 -132.05 33.07 3.95 Favored 'General case' 0 N--CA 1.465 0.309 0 N-CA-C 111.963 0.357 . . . . 0.0 111.963 -176.729 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 92' ' ' LEU . . . . . . . . . . . . . 10.4 tp -166.09 146.63 6.48 Favored 'General case' 0 C--N 1.331 -0.217 0 C-N-CA 120.997 -0.281 . . . . 0.0 110.593 179.525 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 93' ' ' ILE . . . . . . . . . . . . . 63.8 mt -127.09 125.81 67.03 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.238 0 N-CA-C 109.724 -0.473 . . . . 0.0 109.724 -179.611 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 94' ' ' VAL . . . . . . . . . . . . . 45.1 t -122.21 126.04 73.76 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.197 0 N-CA-C 109.742 -0.466 . . . . 0.0 109.742 177.874 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 95' ' ' VAL . . . . . . . . . . . . . 43.5 t -122.61 134.95 64.27 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.235 0 N-CA-C 110.055 -0.35 . . . . 0.0 110.055 -179.047 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 96' ' ' ILE . . . . . . . . . . . . . 61.6 mt -114.43 129.86 69.76 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.322 0 N-CA-C 109.341 -0.614 . . . . 0.0 109.341 178.632 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 97' ' ' THR . . . . . . . . . . . . . 63.4 p -100.26 156.74 17.05 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-O 121.01 0.434 . . . . 0.0 110.814 -179.706 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 98' ' ' GLU . . . . . . . . . . . . . 45.6 tp10 -54.01 -28.1 36.02 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.304 -0.407 . . . . 0.0 112.071 -178.233 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 99' ' ' GLU . . . . . . . . . . . . . 96.0 mt-10 -79.78 16.89 1.02 Allowed 'General case' 0 CA--C 1.534 0.363 0 N-CA-C 113.218 0.821 . . . . 0.0 113.218 -175.465 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 100' ' ' ASN . . . . . . . . . . . . . 3.7 m-20 62.93 37.91 11.61 Favored 'General case' 0 N--CA 1.464 0.232 0 CA-C-O 121.159 0.504 . . . . 0.0 111.021 177.973 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 101' ' ' GLU . . . . . . . . . . . . . 84.5 tt0 -116.8 144.03 44.97 Favored 'General case' 0 C--N 1.332 -0.169 0 N-CA-C 109.583 -0.525 . . . . 0.0 109.583 175.262 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 102' ' ' VAL . . . . . . . . . . . . . 41.1 t -116.4 128.55 73.7 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.283 0 CA-C-O 120.923 0.392 . . . . 0.0 110.187 -176.035 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 103' ' ' LEU . . . . . . . . . . . . . 27.0 mt -118.21 130.29 55.99 Favored 'General case' 0 C--N 1.331 -0.239 0 CA-C-N 115.643 -0.708 . . . . 0.0 110.053 176.215 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 104' ' ' ILE . . . . . . . . . . . . . 70.3 mt -117.85 122.67 70.3 Favored 'Isoleucine or valine' 0 C--O 1.234 0.259 0 N-CA-C 110.136 -0.32 . . . . 0.0 110.136 179.822 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 105' ' ' PHE . . . . . . . . . . . . . 80.7 m-85 -122.11 164.19 18.17 Favored 'General case' 0 C--N 1.331 -0.208 0 O-C-N 124.037 0.836 . . . . 0.0 110.143 -178.353 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 106' ' ' ASN . . . . . . . . . . . . . 44.3 p-10 -100.54 -170.05 1.81 Allowed 'General case' 0 C--N 1.331 -0.198 0 N-CA-C 109.884 -0.413 . . . . 0.0 109.884 172.35 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 107' ' ' GLN . . . . . . . . . . . . . 30.2 tt0 -59.16 -29.99 67.84 Favored 'General case' 0 C--N 1.328 -0.329 0 N-CA-C 112.008 0.374 . . . . 0.0 112.008 -179.508 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 108' ' ' ASN . . . . . . . . . . . . . 3.0 t-20 -84.67 8.31 17.38 Favored 'General case' 0 CA--C 1.536 0.413 0 N-CA-C 113.271 0.841 . . . . 0.0 113.271 -176.751 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 109' ' ' LEU . . . . . . . . . . . . . 11.3 tp 61.6 36.51 16.74 Favored 'General case' 0 C--O 1.233 0.185 0 CA-C-O 120.89 0.376 . . . . 0.0 111.309 178.823 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 110' ' ' GLU . . . . . . . . . . . . . 16.1 mm-40 -103.35 155.46 18.46 Favored 'General case' 0 C--N 1.33 -0.282 0 N-CA-C 109.847 -0.427 . . . . 0.0 109.847 176.056 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 111' ' ' GLU . . . . . . . . . . . . . 44.6 tp10 -84.83 121.96 28.47 Favored 'General case' 0 C--N 1.331 -0.231 0 C-N-CA 120.807 -0.357 . . . . 0.0 110.791 -178.092 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 112' ' ' LEU . . . . . . . . . . . . . 49.7 mt -107.0 -46.05 4.01 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.091 -0.504 . . . . 0.0 110.397 177.735 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 113' ' ' TYR . . . . . . . . . . . . . 60.0 t80 -136.35 135.45 38.85 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.22 -0.446 . . . . 0.0 110.863 179.68 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 114' ' ' ARG . . . . . . . . . . . . . 61.5 ttp85 -135.66 119.09 16.84 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 116.086 -0.506 . . . . 0.0 110.028 178.624 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 115' ' ' GLY . . . . . . . . . . . . . . . -150.04 159.56 28.15 Favored Glycine 0 CA--C 1.523 0.586 0 C-N-CA 120.693 -0.765 . . . . 0.0 111.441 179.855 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 116' ' ' LYS . . . . . . . . . . . . . 39.3 ttpt -130.04 138.26 50.67 Favored 'General case' 0 C--N 1.33 -0.282 0 N-CA-C 109.858 -0.423 . . . . 0.0 109.858 176.47 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 117' ' ' PHE . . . . . . . . . . . . . 38.6 m-85 -137.38 114.04 10.38 Favored 'General case' 0 C--N 1.329 -0.319 0 N-CA-C 110.121 -0.325 . . . . 0.0 110.121 -176.453 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 118' ' ' GLU . . . . . . . . . . . . . 21.7 pt-20 -55.54 -39.71 70.92 Favored 'General case' 0 C--N 1.33 -0.276 0 C-N-CA 120.942 -0.303 . . . . 0.0 111.08 -176.615 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 119' ' ' ASN . . . . . . . . . . . . . 92.8 m-20 -100.01 29.98 3.97 Favored 'General case' 0 C--N 1.33 -0.251 0 N-CA-C 112.252 0.464 . . . . 0.0 112.252 -175.182 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 120' ' ' LEU . . . . . . . . . . . . . 13.8 tp -59.72 120.36 9.35 Favored 'General case' 0 C--N 1.331 -0.209 0 N-CA-C 109.775 -0.454 . . . . 0.0 109.775 177.751 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 121' ' ' ASN . . . . . . . . . . . . . 83.3 m-20 -113.31 -43.99 3.29 Favored 'General case' 0 C--N 1.332 -0.188 0 CA-C-N 116.578 -0.283 . . . . 0.0 111.027 -176.819 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 122' ' ' LYS . . . . . . . . . . . . . 93.4 mttt -144.2 146.93 33.01 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-O 121.054 0.454 . . . . 0.0 111.672 -178.354 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 123' ' ' VAL . . . . . . . . . . . . . 44.2 t -123.22 123.45 67.77 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.334 0 N-CA-C 109.375 -0.602 . . . . 0.0 109.375 174.474 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 124' ' ' LEU . . . . . . . . . . . . . 7.3 mp -114.03 127.23 55.85 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.308 -0.405 . . . . 0.0 110.209 -179.064 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 125' ' ' VAL . . . . . . . . . . . . . 11.4 p -135.31 134.08 52.56 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.328 0 CA-C-N 116.504 -0.316 . . . . 0.0 110.326 -179.602 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 126' ' ' ARG . . . . . . . . . . . . . 44.8 ttt180 -146.4 119.67 8.94 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.471 178.903 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 127' ' ' ASN . . . . . . . . . . . . . 19.1 t-20 51.26 -104.88 0.18 Allowed 'General case' 0 CA--C 1.544 0.72 0 CA-C-O 119.121 -0.466 . . . . 0.0 111.42 179.309 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 128' ' ' ASP . . . . . . . . . . . . . 20.1 p-10 -112.12 0.35 15.87 Favored 'General case' 0 N--CA 1.468 0.45 0 CA-C-N 119.448 1.022 . . . . 0.0 113.653 -174.444 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 129' ' ' LEU . . . . . . . . . . . . . 76.3 mt -107.63 138.85 43.1 Favored 'General case' 0 C--O 1.231 0.117 0 CA-C-N 118.33 0.514 . . . . 0.0 110.358 179.676 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 130' ' ' VAL . . . . . . . . . . . . . 44.0 t -127.7 135.63 62.6 Favored 'Isoleucine or valine' 0 N--CA 1.462 0.156 0 CA-C-O 120.925 0.393 . . . . 0.0 110.248 -178.932 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 131' ' ' VAL . . . . . . . . . . . . . 40.9 t -134.01 134.16 55.78 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.283 0 CA-C-N 116.083 -0.508 . . . . 0.0 110.006 178.144 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 132' ' ' ILE . . . . . . . . . . . . . 72.2 mt -111.25 129.78 65.95 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.317 0 N-CA-C 109.363 -0.606 . . . . 0.0 109.363 179.653 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 133' ' ' ILE . . . . . . . . . . . . . 41.9 mm -113.67 118.8 59.26 Favored 'Isoleucine or valine' 0 C--O 1.234 0.265 0 CA-C-O 120.92 0.39 . . . . 0.0 110.865 -175.426 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 134' ' ' ASP . . . . . . . . . . . . . 8.6 p-10 -131.03 147.03 52.58 Favored 'General case' 0 C--N 1.331 -0.218 0 N-CA-C 109.303 -0.629 . . . . 0.0 109.303 174.823 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 135' ' ' GLU . . . . . . . . . . . . . 39.0 tp10 -49.89 -28.15 6.2 Favored 'General case' 0 C--N 1.326 -0.417 0 N-CA-C 112.662 0.616 . . . . 0.0 112.662 -172.564 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 136' ' ' GLN . . . . . . . . . . . . . 97.8 mt-30 -82.59 -33.71 27.92 Favored 'General case' 0 C--N 1.331 -0.226 0 N-CA-C 112.806 0.669 . . . . 0.0 112.806 -176.073 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 137' ' ' LYS . . . . . . . . . . . . . 53.7 pttt -166.33 172.98 10.48 Favored 'General case' 0 C--O 1.232 0.165 0 CA-C-O 121.72 0.772 . . . . 0.0 112.746 -172.458 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 138' ' ' LEU . . . . . . . . . . . . . 4.2 tt -117.83 128.88 55.28 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-N 114.767 -1.106 . . . . 0.0 109.798 179.479 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 139' ' ' THR . . . . . . . . . . . . . 29.2 m -108.9 127.27 53.9 Favored 'General case' 0 C--N 1.331 -0.23 0 CA-C-N 116.422 -0.354 . . . . 0.0 110.241 178.611 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 140' ' ' LEU . . . . . . . . . . . . . 7.4 tt -111.48 121.77 46.08 Favored 'General case' 0 C--N 1.327 -0.382 0 N-CA-C 109.347 -0.612 . . . . 0.0 109.347 -178.594 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 141' ' ' ILE . . . . . . . . . . . . . 19.3 mt -121.08 120.62 62.73 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 CA-C-O 120.955 0.407 . . . . 0.0 110.181 -175.275 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 142' ' ' ARG . . . . . . . . . . . . . 76.4 mtp180 -106.87 122.11 45.75 Favored 'General case' 0 C--N 1.33 -0.239 0 CA-C-N 115.258 -0.883 . . . . 0.0 109.758 179.527 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 143' ' ' THR . . . . . . . . . . . . . 27.6 p . . . . . 0 C--O 1.22 -0.468 0 CA-C-O 117.996 -1.002 . . . . 0.0 110.523 179.907 . . . . . . . . 0 0 . 1 . 014 nuclear orig full ' B' B ' -3' ' ' GLU . . . . . . . . . . . . . 96.1 mt-10 . . . . . 0 N--CA 1.489 1.509 0 N-CA-C 109.473 -0.565 . . . . 0.0 109.473 . . . . . . . . . 0 0 . 1 . 014 nuclear orig full ' B' B ' -2' ' ' GLY . . . . . . . . . . . . . . . -61.47 143.35 48.62 Favored Glycine 0 CA--C 1.524 0.628 0 N-CA-C 110.903 -0.879 . . . . 0.0 110.903 179.938 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' B' B ' -1' ' ' VAL . . . . . . . . . . . . . 44.0 t -96.17 135.89 28.82 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.382 0 N-CA-C 110.066 -0.346 . . . . 0.0 110.066 -179.906 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' B' B ' 0' ' ' ILE . . . . . . . . . . . . . 68.3 mt -107.45 131.14 58.37 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.275 0 CA-C-N 116.391 -0.368 . . . . 0.0 110.011 -179.111 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' B' B ' 1' ' ' MET . . . . . . . . . . . . . 26.1 ptt? -84.31 143.87 29.23 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.516 179.642 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' B' B ' 2' ' ' SER . . . . . . . . . . . . . 2.8 p -106.6 135.59 47.85 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.425 179.511 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' B' B ' 3' ' ' GLU . . . . . . . . . . . . . 84.5 tt0 -139.95 139.1 36.04 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-O 120.996 0.426 . . . . 0.0 111.114 -179.248 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' B' B ' 4' ' ' LEU . . . . . . . . . . . . . 4.7 tt -123.24 125.32 44.86 Favored 'General case' 0 C--N 1.331 -0.22 0 CA-C-N 115.689 -0.687 . . . . 0.0 109.752 177.868 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' B' B ' 5' ' ' LYS . . . . . . . . . . . . . 62.7 mttp -106.07 122.57 46.45 Favored 'General case' 0 C--O 1.234 0.269 0 CA-C-O 120.841 0.353 . . . . 0.0 110.877 -179.551 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' B' B ' 6' ' ' LEU . . . . . . . . . . . . . 79.2 mt -114.08 154.43 27.75 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 115.367 -0.833 . . . . 0.0 110.787 -179.179 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' B' B ' 7' ' ' LYS . . . . . . . . . . . . . 62.9 tttm -143.23 140.54 17.89 Favored Pre-proline 0 CA--C 1.533 0.326 0 CA-C-O 119.152 -0.452 . . . . 0.0 110.057 174.007 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' B' B ' 8' ' ' PRO . . . . . . . . . . . . . 71.8 Cg_endo -90.27 139.56 3.01 Favored 'Trans proline' 0 N--CA 1.49 1.282 0 C-N-CA 121.723 1.615 . . . . 0.0 111.407 176.959 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' B' B ' 9' ' ' LEU . . . . . . . . . . . . . 53.6 mt -77.68 -46.69 2.43 Favored Pre-proline 0 C--N 1.329 -0.308 0 CA-C-O 118.811 -0.614 . . . . 0.0 112.102 -177.486 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' B' B ' 10' ' ' PRO . . . . . . . . . . . . . 76.8 Cg_endo -84.08 157.72 13.3 Favored 'Trans proline' 0 N--CA 1.495 1.609 0 C-N-CA 121.353 1.369 . . . . 0.0 111.686 173.771 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' B' B ' 11' ' ' LYS . . . . . . . . . . . . . 24.5 pttm -86.91 114.64 23.71 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-O 121.527 0.68 . . . . 0.0 110.544 177.417 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' B' B ' 12' ' ' VAL . . . . . . . . . . . . . 12.4 p -151.01 148.67 14.79 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.289 0 CA-C-N 115.659 -0.7 . . . . 0.0 110.447 -179.886 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' B' B ' 13' ' ' GLU . . . . . . . . . . . . . 84.5 tt0 -89.06 119.58 29.7 Favored 'General case' 0 C--N 1.329 -0.326 0 N-CA-C 109.877 -0.416 . . . . 0.0 109.877 176.494 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' B' B ' 14' ' ' LEU . . . . . . . . . . . . . 21.4 mt -93.92 147.54 33.68 Favored Pre-proline 0 C--N 1.329 -0.317 0 CA-C-O 119.102 -0.475 . . . . 0.0 110.479 -176.91 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' B' B ' 15' ' ' PRO . . . . . . . . . . . . . 25.3 Cg_exo -62.65 160.41 32.58 Favored 'Trans proline' 0 N--CA 1.497 1.733 0 C-N-CA 121.284 1.322 . . . . 0.0 112.001 177.714 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' B' B ' 16' ' ' PRO . . . . . . . . . . . . . 39.0 Cg_exo -58.88 -44.13 38.07 Favored 'Trans proline' 0 N--CA 1.498 1.781 0 C-N-CA 121.365 1.377 . . . . 0.0 112.892 -178.716 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' B' B ' 17' ' ' ASP . . . . . . . . . . . . . 11.1 p-10 -83.77 10.33 9.74 Favored 'General case' 0 C--N 1.327 -0.404 0 N-CA-C 113.169 0.803 . . . . 0.0 113.169 -177.03 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' B' B ' 18' ' ' PHE . . . . . . . . . . . . . 36.1 t80 -57.91 -43.03 85.91 Favored 'General case' 0 C--N 1.334 -0.084 0 O-C-N 121.975 -0.453 . . . . 0.0 110.088 -178.746 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' B' B ' 19' ' ' VAL . . . . . . . . . . . . . 48.3 t -57.4 -43.39 82.47 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.352 0 CA-C-N 116.247 -0.433 . . . . 0.0 110.403 -179.514 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' B' B ' 20' ' ' ASP . . . . . . . . . . . . . 53.6 m-20 -59.97 -42.57 94.44 Favored 'General case' 0 C--N 1.331 -0.204 0 C-N-CA 120.979 -0.288 . . . . 0.0 110.996 -177.299 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' B' B ' 21' ' ' VAL . . . . . . . . . . . . . 48.3 t -64.53 -45.53 95.34 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.319 0 C-N-CA 120.728 -0.389 . . . . 0.0 110.433 -178.089 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' B' B ' 22' ' ' ILE . . . . . . . . . . . . . 50.0 mm -58.73 -40.63 80.14 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.318 0 C-N-CA 121.081 -0.247 . . . . 0.0 110.681 179.227 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' B' B ' 23' ' ' ARG . . . . . . . . . . . . . 46.2 ttp180 -56.15 -48.29 76.56 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-O 120.984 0.421 . . . . 0.0 110.585 178.503 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' B' B ' 24' ' ' ILE . . . . . . . . . . . . . 72.5 mt -61.5 -45.19 99.15 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.274 0 CA-C-N 115.94 -0.573 . . . . 0.0 111.769 -177.966 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' B' B ' 25' ' ' LYS . . . . . . . . . . . . . 15.6 pttp -71.22 -37.35 72.05 Favored 'General case' 0 CA--C 1.534 0.36 0 C-N-CA 120.615 -0.434 . . . . 0.0 111.838 -172.545 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' B' B ' 26' ' ' LEU . . . . . . . . . . . . . 23.7 mt -80.5 -42.23 22.86 Favored 'General case' 0 C--N 1.33 -0.245 0 N-CA-C 113.096 0.776 . . . . 0.0 113.096 -174.674 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' B' B ' 27' ' ' GLN . . . . . . . . . . . . . 10.5 pt20 -47.0 139.98 5.21 Favored 'General case' 0 N--CA 1.469 0.487 0 N-CA-C 112.751 0.649 . . . . 0.0 112.751 -174.875 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' B' B ' 28' ' ' GLY . . . . . . . . . . . . . . . 99.92 -24.51 31.85 Favored Glycine 0 CA--C 1.533 1.187 0 CA-C-N 115.525 -0.762 . . . . 0.0 112.274 -175.539 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' B' B ' 29' ' ' LYS . . . . . . . . . . . . . 65.2 mttm -98.79 155.09 17.53 Favored 'General case' 0 C--O 1.233 0.187 0 CA-C-N 117.288 0.544 . . . . 0.0 111.009 179.525 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' B' B ' 30' ' ' THR . . . . . . . . . . . . . 31.8 m -100.21 135.26 41.92 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.196 -0.457 . . . . 0.0 109.885 175.436 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' B' B ' 31' ' ' VAL . . . . . . . . . . . . . 35.0 m -127.84 154.46 38.4 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.245 0 CA-C-O 120.897 0.379 . . . . 0.0 110.967 -178.379 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' B' B ' 32' ' ' ARG . . . . . . . . . . . . . 85.6 mtm180 -133.32 151.03 51.85 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 115.823 -0.626 . . . . 0.0 110.396 178.259 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' B' B ' 33' ' ' THR . . . . . . . . . . . . . 23.7 m -53.29 138.51 32.23 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.338 -0.392 . . . . 0.0 111.362 -178.336 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' B' B ' 34' ' ' GLY . . . . . . . . . . . . . . . 101.11 -17.05 56.62 Favored Glycine 0 CA--C 1.531 1.084 0 CA-C-O 119.658 -0.523 . . . . 0.0 113.269 178.978 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' B' B ' 35' ' ' ASP . . . . . . . . . . . . . 69.2 m-20 -64.55 148.93 49.75 Favored 'General case' 0 N--CA 1.461 0.107 0 CA-C-N 118.123 0.962 . . . . 0.0 111.018 179.098 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' B' B ' 36' ' ' VAL . . . . . . . . . . . . . 45.3 t -125.47 132.02 71.49 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.217 0 CA-C-N 115.825 -0.625 . . . . 0.0 109.869 179.157 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' B' B ' 37' ' ' ILE . . . . . . . . . . . . . 68.5 mt -120.22 138.07 51.97 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.234 0 CA-C-N 116.141 -0.482 . . . . 0.0 109.853 179.624 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' B' B ' 38' ' ' GLY . . . . . . . . . . . . . . . -108.05 128.74 9.27 Favored Glycine 0 CA--C 1.524 0.61 0 N-CA-C 110.872 -0.891 . . . . 0.0 110.872 179.848 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' B' B ' 39' ' ' ILE . . . . . . . . . . . . . 75.5 mt -125.63 137.12 58.69 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.259 0 N-CA-C 110.186 -0.302 . . . . 0.0 110.186 179.994 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' B' B ' 40' ' ' SER . . . . . . . . . . . . . 42.2 p -92.8 119.17 31.88 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.378 -0.374 . . . . 0.0 110.924 176.227 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' B' B ' 41' ' ' ILE . . . . . . . . . . . . . 47.6 mm -129.59 117.91 43.66 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.189 0 CA-C-O 120.716 0.293 . . . . 0.0 110.325 178.69 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' B' B ' 42' ' ' LEU . . . . . . . . . . . . . 51.0 mt 57.88 34.32 24.21 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.317 -0.401 . . . . 0.0 111.819 177.7 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' B' B ' 43' ' ' GLY . . . . . . . . . . . . . . . 78.74 -10.1 33.45 Favored Glycine 0 CA--C 1.534 1.236 0 C-N-CA 121.215 -0.517 . . . . 0.0 113.438 177.539 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' B' B ' 44' ' ' LYS . . . . . . . . . . . . . 72.9 mmtt -97.82 138.63 34.88 Favored 'General case' 0 C--N 1.333 -0.132 0 CA-C-N 117.854 0.827 . . . . 0.0 109.946 176.912 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' B' B ' 45' ' ' GLU . . . . . . . . . . . . . 84.8 tt0 -84.07 125.16 31.85 Favored 'General case' 0 C--N 1.328 -0.35 0 C-N-CA 120.874 -0.33 . . . . 0.0 110.76 179.447 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' B' B ' 46' ' ' VAL . . . . . . . . . . . . . 7.4 p -121.77 127.8 75.57 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.182 0 N-CA-C 109.627 -0.509 . . . . 0.0 109.627 177.603 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' B' B ' 47' ' ' LYS . . . . . . . . . . . . . 64.0 mttp -100.45 130.43 46.53 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 115.91 -0.586 . . . . 0.0 111.16 178.911 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' B' B ' 48' ' ' PHE . . . . . . . . . . . . . 93.6 m-85 -112.73 131.84 55.49 Favored 'General case' 0 C--N 1.33 -0.258 0 N-CA-C 109.889 -0.411 . . . . 0.0 109.889 175.748 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' B' B ' 49' ' ' LYS . . . . . . . . . . . . . 85.6 tttt -108.82 139.73 43.24 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.279 -0.418 . . . . 0.0 110.846 -178.499 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' B' B ' 50' ' ' VAL . . . . . . . . . . . . . 46.2 t -83.13 108.0 15.39 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.346 0 N-CA-C 109.301 -0.629 . . . . 0.0 109.301 174.852 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' B' B ' 51' ' ' VAL . . . . . . . . . . . . . 47.7 t -72.7 -48.11 47.43 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.306 0 CA-C-N 116.118 -0.492 . . . . 0.0 110.001 -173.06 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' B' B ' 52' ' ' GLN . . . . . . . . . . . . . 60.4 tt0 -165.25 146.97 7.63 Favored 'General case' 0 C--N 1.33 -0.246 0 C-N-CA 120.266 -0.574 . . . . 0.0 111.863 -177.972 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' B' B ' 53' ' ' ALA . . . . . . . . . . . . . . . -123.23 134.54 54.11 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 115.677 -0.692 . . . . 0.0 109.929 176.48 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' B' B ' 54' ' ' TYR . . . . . . . . . . . . . 33.4 t80 -129.14 112.16 18.35 Favored Pre-proline 0 CA--C 1.535 0.403 0 CA-C-O 118.184 -0.912 . . . . 0.0 110.289 178.726 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' B' B ' 55' ' ' PRO . . . . . . . . . . . . . 73.5 Cg_endo -77.11 169.22 74.86 Favored 'Cis proline' 0 N--CA 1.5 1.904 0 CA-C-N 121.99 1.747 . . . . 0.0 112.212 -6.698 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' B' B ' 56' ' ' SER . . . . . . . . . . . . . 13.8 m -117.25 137.19 23.76 Favored Pre-proline 0 CA--C 1.537 0.467 0 CA-C-O 118.537 -0.744 . . . . 0.0 109.802 175.296 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' B' B ' 57' ' ' PRO . . . . . . . . . . . . . 32.4 Cg_endo -65.71 162.94 67.82 Favored 'Cis proline' 0 N--CA 1.498 1.757 0 CA-C-N 121.761 1.665 . . . . 0.0 111.309 -4.724 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' B' B ' 58' ' ' LEU . . . . . . . . . . . . . 31.7 tp -129.18 137.52 51.2 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-O 120.945 0.402 . . . . 0.0 110.511 -178.651 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' B' B ' 59' ' ' ARG . . . . . . . . . . . . . 27.0 ttm180 -101.49 127.43 48.18 Favored 'General case' 0 C--N 1.327 -0.392 0 N-CA-C 109.301 -0.629 . . . . 0.0 109.301 176.151 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' B' B ' 60' ' ' VAL . . . . . . . . . . . . . 46.9 t -79.57 117.73 25.82 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.33 0 C-N-CA 120.677 -0.409 . . . . 0.0 110.095 -175.967 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' B' B ' 61' ' ' GLU . . . . . . . . . . . . . 70.8 mm-40 -131.06 161.83 31.17 Favored 'General case' 0 C--N 1.331 -0.208 0 CA-C-N 116.047 -0.524 . . . . 0.0 110.284 178.846 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' B' B ' 62' ' ' ASP . . . . . . . . . . . . . 67.4 m-20 -54.53 -32.45 58.22 Favored 'General case' 0 C--N 1.327 -0.396 0 CA-C-N 116.463 -0.335 . . . . 0.0 111.748 -179.901 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' B' B ' 63' ' ' ARG . . . . . . . . . . . . . 13.8 ptp180 -84.24 10.09 11.29 Favored 'General case' 0 CA--C 1.535 0.398 0 N-CA-C 113.471 0.915 . . . . 0.0 113.471 -175.854 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' B' B ' 64' ' ' THR . . . . . . . . . . . . . 32.3 m -94.92 143.0 26.82 Favored 'General case' 0 C--O 1.231 0.128 0 CA-C-N 118.02 0.373 . . . . 0.0 110.632 -179.73 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' B' B ' 65' ' ' LYS . . . . . . . . . . . . . 92.3 mttt -88.52 129.0 35.56 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.155 -0.475 . . . . 0.0 110.267 179.633 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' B' B ' 66' ' ' ILE . . . . . . . . . . . . . 59.5 mt -115.08 130.21 69.99 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.196 0 N-CA-C 109.707 -0.479 . . . . 0.0 109.707 179.479 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' B' B ' 67' ' ' THR . . . . . . . . . . . . . 28.0 m -132.49 144.68 50.61 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-O 121.111 0.482 . . . . 0.0 111.3 -177.923 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' B' B ' 68' ' ' LEU . . . . . . . . . . . . . 7.3 mp -100.61 132.49 45.98 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 115.96 -0.564 . . . . 0.0 109.94 174.79 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' B' B ' 69' ' ' VAL . . . . . . . . . . . . . 42.6 t -94.25 105.97 17.53 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.268 0 CA-C-N 116.392 -0.367 . . . . 0.0 110.281 -178.9 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' B' B ' 70' ' ' THR . . . . . . . . . . . . . 7.6 t -150.01 32.62 0.68 Allowed 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 116.219 -0.446 . . . . 0.0 111.511 178.877 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' B' B ' 71' ' ' HIS . . . . . . . . . . . . . 18.9 t-80 -133.42 75.87 68.9 Favored Pre-proline 0 CA--C 1.534 0.36 0 N-CA-C 110.403 -0.221 . . . . 0.0 110.403 -179.824 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' B' B ' 72' ' ' PRO . . . . . . . . . . . . . 89.5 Cg_endo -83.59 -18.29 5.79 Favored 'Trans proline' 0 N--CA 1.494 1.538 0 C-N-CA 121.639 1.559 . . . . 0.0 113.471 -179.14 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' B' B ' 73' ' ' VAL . . . . . . . . . . . . . 34.6 m -125.96 165.92 22.97 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.162 0 CA-C-O 120.793 0.33 . . . . 0.0 110.603 -178.198 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' B' B ' 74' ' ' ASP . . . . . . . . . . . . . 36.1 t0 -94.66 117.57 30.34 Favored 'General case' 0 C--N 1.329 -0.309 0 N-CA-C 109.669 -0.493 . . . . 0.0 109.669 -179.443 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' B' B ' 75' ' ' VAL . . . . . . . . . . . . . 44.0 t -117.9 124.66 73.4 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.287 0 CA-C-O 121.123 0.487 . . . . 0.0 110.771 -176.382 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' B' B ' 76' ' ' LEU . . . . . . . . . . . . . 5.3 mp -122.55 148.45 45.18 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 115.539 -0.755 . . . . 0.0 109.47 174.964 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' B' B ' 77' ' ' GLU . . . . . . . . . . . . . 45.8 mt-10 -135.05 139.52 44.85 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-O 120.999 0.428 . . . . 0.0 111.471 -177.645 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' B' B ' 78' ' ' ALA . . . . . . . . . . . . . . . -128.39 132.29 48.52 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 115.701 -0.681 . . . . 0.0 109.642 175.585 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' B' B ' 79' ' ' LYS . . . . . . . . . . . . . 84.5 mttt -76.72 121.45 23.31 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-O 121.077 0.465 . . . . 0.0 110.851 -178.072 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' B' B ' 80' ' ' ILE . . . . . . . . . . . . . 43.5 mm -139.19 109.36 4.23 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.27 0 N-CA-C 108.963 -0.754 . . . . 0.0 108.963 -177.854 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' B' B ' 81' ' ' LYS . . . . . . . . . . . . . 93.5 mttt -101.98 124.38 47.5 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-O 120.916 0.388 . . . . 0.0 111.346 -176.244 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' B' B ' 82' ' ' GLY . . . . . . . . . . . . . . . 89.07 42.16 5.69 Favored Glycine 0 CA--C 1.526 0.72 0 C-N-CA 120.956 -0.64 . . . . 0.0 111.841 174.666 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' B' B ' 83' ' ' ILE . . . . . . . . . . . . . 69.0 mt -67.39 136.86 25.85 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.28 0 N-CA-C 109.632 -0.507 . . . . 0.0 109.632 177.116 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' B' B ' 84' ' ' LYS . . . . . . . . . . . . . 38.6 ttpt -101.56 -52.4 3.23 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-O 121.022 0.439 . . . . 0.0 110.422 -178.673 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' B' B ' 85' ' ' ASP . . . . . . . . . . . . . 10.7 t70 -145.46 147.77 32.55 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 115.943 -0.571 . . . . 0.0 110.458 -178.644 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' B' B ' 86' ' ' VAL . . . . . . . . . . . . . 42.2 t -129.68 130.85 67.0 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.26 0 CA-C-O 120.905 0.383 . . . . 0.0 110.373 -179.617 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' B' B ' 87' ' ' ILE . . . . . . . . . . . . . 5.0 mp -119.74 123.74 71.54 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.214 0 N-CA-C 109.313 -0.625 . . . . 0.0 109.313 176.105 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' B' B ' 88' ' ' LEU . . . . . . . . . . . . . 17.9 tp -111.01 127.77 55.64 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-O 121.038 0.447 . . . . 0.0 110.972 -177.774 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' B' B ' 89' ' ' ASP . . . . . . . . . . . . . 8.2 t70 -121.61 152.12 39.64 Favored 'General case' 0 C--N 1.331 -0.201 0 CA-C-N 115.797 -0.638 . . . . 0.0 109.6 177.005 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' B' B ' 90' ' ' GLU . . . . . . . . . . . . . 96.4 mt-10 -48.84 -36.24 16.43 Favored 'General case' 0 C--N 1.328 -0.337 0 N-CA-C 112.642 0.608 . . . . 0.0 112.642 -173.04 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' B' B ' 91' ' ' ASN . . . . . . . . . . . . . 30.5 m120 -132.21 32.87 3.93 Favored 'General case' 0 N--CA 1.466 0.336 0 N-CA-C 111.909 0.337 . . . . 0.0 111.909 -177.001 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' B' B ' 92' ' ' LEU . . . . . . . . . . . . . 15.5 tp -166.13 144.42 5.66 Favored 'General case' 0 C--N 1.331 -0.206 0 C-N-CA 121.028 -0.269 . . . . 0.0 110.574 179.722 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' B' B ' 93' ' ' ILE . . . . . . . . . . . . . 70.1 mt -123.36 122.38 65.09 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.279 0 N-CA-C 109.594 -0.521 . . . . 0.0 109.594 178.741 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' B' B ' 94' ' ' VAL . . . . . . . . . . . . . 47.3 t -120.65 125.03 73.63 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 N-CA-C 109.776 -0.453 . . . . 0.0 109.776 179.281 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' B' B ' 95' ' ' VAL . . . . . . . . . . . . . 43.5 t -124.04 134.6 66.11 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.325 0 CA-C-N 116.286 -0.415 . . . . 0.0 109.976 -178.726 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' B' B ' 96' ' ' ILE . . . . . . . . . . . . . 58.3 mt -117.6 126.96 75.04 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.255 0 N-CA-C 109.367 -0.605 . . . . 0.0 109.367 179.343 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' B' B ' 97' ' ' THR . . . . . . . . . . . . . 77.1 p -98.32 157.72 16.01 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-O 121.188 0.518 . . . . 0.0 111.137 -178.086 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' B' B ' 98' ' ' GLU . . . . . . . . . . . . . 80.2 tt0 -53.92 -29.23 41.26 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 116.1 -0.5 . . . . 0.0 112.059 -178.675 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' B' B ' 99' ' ' GLU . . . . . . . . . . . . . 39.3 tt0 -80.01 15.89 1.35 Allowed 'General case' 0 CA--C 1.541 0.61 0 N-CA-C 112.599 0.592 . . . . 0.0 112.599 -176.074 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' B' B ' 100' ' ' ASN . . . . . . . . . . . . . 4.8 m-20 63.8 33.18 12.98 Favored 'General case' 0 CA--C 1.532 0.271 0 O-C-N 121.873 -0.517 . . . . 0.0 111.703 177.859 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' B' B ' 101' ' ' GLU . . . . . . . . . . . . . 84.7 tt0 -106.47 141.94 36.95 Favored 'General case' 0 C--N 1.331 -0.215 0 N-CA-C 109.506 -0.553 . . . . 0.0 109.506 172.179 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' B' B ' 102' ' ' VAL . . . . . . . . . . . . . 45.2 t -116.89 128.18 74.35 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.299 0 N-CA-C 109.805 -0.443 . . . . 0.0 109.805 -177.813 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' B' B ' 103' ' ' LEU . . . . . . . . . . . . . 26.8 mt -118.8 131.2 56.09 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 115.839 -0.619 . . . . 0.0 110.611 178.185 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' B' B ' 104' ' ' ILE . . . . . . . . . . . . . 69.7 mt -116.17 120.12 63.93 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.245 0 N-CA-C 109.72 -0.474 . . . . 0.0 109.72 178.076 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' B' B ' 105' ' ' PHE . . . . . . . . . . . . . 70.7 m-85 -123.13 163.87 19.74 Favored 'General case' 0 C--N 1.331 -0.207 0 O-C-N 123.81 0.694 . . . . 0.0 109.722 179.867 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' B' B ' 106' ' ' ASN . . . . . . . . . . . . . 48.1 p-10 -98.87 -170.75 1.98 Allowed 'General case' 0 C--N 1.329 -0.298 0 N-CA-C 109.754 -0.461 . . . . 0.0 109.754 172.742 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' B' B ' 107' ' ' GLN . . . . . . . . . . . . . 44.7 tt0 -61.04 -30.05 70.08 Favored 'General case' 0 C--N 1.328 -0.369 0 N-CA-C 111.851 0.315 . . . . 0.0 111.851 -179.159 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' B' B ' 108' ' ' ASN . . . . . . . . . . . . . 13.7 t-20 -82.77 6.4 18.27 Favored 'General case' 0 CA--C 1.537 0.469 0 N-CA-C 113.215 0.821 . . . . 0.0 113.215 -178.421 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' B' B ' 109' ' ' LEU . . . . . . . . . . . . . 10.7 tp 61.95 39.34 13.59 Favored 'General case' 0 C--O 1.233 0.209 0 CA-C-O 121.246 0.546 . . . . 0.0 111.197 178.267 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' B' B ' 110' ' ' GLU . . . . . . . . . . . . . 70.8 mm-40 -105.77 157.83 17.17 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.105 176.419 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' B' B ' 111' ' ' GLU . . . . . . . . . . . . . 84.6 tt0 -83.17 121.99 27.8 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-O 120.901 0.381 . . . . 0.0 111.064 -176.613 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' B' B ' 112' ' ' LEU . . . . . . . . . . . . . 34.0 mt -108.29 -46.09 3.79 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-N 115.959 -0.564 . . . . 0.0 110.133 176.462 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' B' B ' 113' ' ' TYR . . . . . . . . . . . . . 63.0 t80 -143.39 135.94 27.32 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.091 -0.504 . . . . 0.0 111.182 179.141 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' B' B ' 114' ' ' ARG . . . . . . . . . . . . . 26.3 ttm180 -133.16 122.7 24.41 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.235 -0.439 . . . . 0.0 109.88 175.669 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' B' B ' 115' ' ' GLY . . . . . . . . . . . . . . . -150.08 152.34 24.27 Favored Glycine 0 CA--C 1.523 0.556 0 N-CA-C 110.69 -0.964 . . . . 0.0 110.69 179.293 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' B' B ' 116' ' ' LYS . . . . . . . . . . . . . 60.8 tttm -129.2 127.46 41.36 Favored 'General case' 0 C--N 1.328 -0.343 0 N-CA-C 109.697 -0.482 . . . . 0.0 109.697 178.351 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' B' B ' 117' ' ' PHE . . . . . . . . . . . . . 49.8 m-85 -123.27 114.06 19.72 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.258 -0.428 . . . . 0.0 110.257 -174.917 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' B' B ' 118' ' ' GLU . . . . . . . . . . . . . 84.7 tt0 -53.99 -43.29 69.86 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 116.363 -0.381 . . . . 0.0 111.357 -176.716 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' B' B ' 119' ' ' ASN . . . . . . . . . . . . . 17.7 m-80 -99.26 31.01 3.23 Favored 'General case' 0 C--N 1.33 -0.257 0 N-CA-C 112.275 0.472 . . . . 0.0 112.275 -174.203 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' B' B ' 120' ' ' LEU . . . . . . . . . . . . . 21.3 tp -56.4 120.26 7.37 Favored 'General case' 0 C--O 1.232 0.148 0 C-N-CA 121.014 -0.274 . . . . 0.0 110.445 177.877 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' B' B ' 121' ' ' ASN . . . . . . . . . . . . . 72.2 m-20 -114.16 -43.99 3.17 Favored 'General case' 0 C--O 1.232 0.181 0 CA-C-N 116.574 -0.284 . . . . 0.0 111.162 -177.283 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' B' B ' 122' ' ' LYS . . . . . . . . . . . . . 95.1 mttt -145.55 150.43 36.4 Favored 'General case' 0 C--N 1.329 -0.283 0 C-N-CA 120.69 -0.404 . . . . 0.0 111.489 -177.17 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' B' B ' 123' ' ' VAL . . . . . . . . . . . . . 43.8 t -132.77 133.26 59.36 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.235 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.107 177.896 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' B' B ' 124' ' ' LEU . . . . . . . . . . . . . 77.8 mt -120.76 130.53 54.07 Favored 'General case' 0 C--O 1.233 0.202 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.596 178.745 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' B' B ' 125' ' ' VAL . . . . . . . . . . . . . 44.8 t -128.21 128.04 68.16 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.281 0 N-CA-C 109.861 -0.422 . . . . 0.0 109.861 179.054 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' B' B ' 126' ' ' ARG . . . . . . . . . . . . . 73.3 mtp85 -140.4 115.06 9.49 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-O 120.812 0.339 . . . . 0.0 110.792 179.468 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' B' B ' 127' ' ' ASN . . . . . . . . . . . . . 21.0 t-20 51.39 -104.91 0.18 Allowed 'General case' 0 CA--C 1.544 0.718 0 CA-C-O 119.131 -0.461 . . . . 0.0 111.382 178.367 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' B' B ' 128' ' ' ASP . . . . . . . . . . . . . 18.3 p-10 -114.0 2.51 15.01 Favored 'General case' 0 N--CA 1.468 0.436 0 CA-C-N 119.562 1.074 . . . . 0.0 113.432 -177.14 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' B' B ' 129' ' ' LEU . . . . . . . . . . . . . 13.3 tp -106.45 136.89 45.41 Favored 'General case' 0 C--N 1.331 -0.218 0 CA-C-N 118.146 0.43 . . . . 0.0 109.909 178.835 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' B' B ' 130' ' ' VAL . . . . . . . . . . . . . 42.5 t -124.7 136.18 61.52 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.242 0 CA-C-O 120.881 0.372 . . . . 0.0 110.314 -177.358 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' B' B ' 131' ' ' VAL . . . . . . . . . . . . . 46.4 t -134.81 133.83 53.94 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.214 0 CA-C-N 116.264 -0.425 . . . . 0.0 110.187 177.984 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' B' B ' 132' ' ' ILE . . . . . . . . . . . . . 75.7 mt -117.59 133.73 63.43 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.343 0 N-CA-C 109.64 -0.504 . . . . 0.0 109.64 -179.688 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' B' B ' 133' ' ' ILE . . . . . . . . . . . . . 35.6 mm -115.76 123.25 70.93 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.242 0 CA-C-O 120.748 0.309 . . . . 0.0 111.064 -175.448 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' B' B ' 134' ' ' ASP . . . . . . . . . . . . . 9.8 p-10 -134.09 149.77 51.13 Favored 'General case' 0 C--N 1.331 -0.22 0 N-CA-C 109.621 -0.511 . . . . 0.0 109.621 174.755 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' B' B ' 135' ' ' GLU . . . . . . . . . . . . . 40.8 tp10 -50.05 -30.05 10.04 Favored 'General case' 0 C--N 1.328 -0.338 0 N-CA-C 112.651 0.612 . . . . 0.0 112.651 -170.896 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' B' B ' 136' ' ' GLN . . . . . . . . . . . . . 98.2 mt-30 -81.41 -36.4 29.54 Favored 'General case' 0 C--N 1.329 -0.3 0 N-CA-C 112.687 0.625 . . . . 0.0 112.687 -175.981 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' B' B ' 137' ' ' LYS . . . . . . . . . . . . . 20.4 pttm -163.07 172.52 14.82 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-O 121.626 0.727 . . . . 0.0 112.391 -169.706 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' B' B ' 138' ' ' LEU . . . . . . . . . . . . . 6.7 tt -118.53 129.16 55.19 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 114.94 -1.027 . . . . 0.0 109.842 178.27 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' B' B ' 139' ' ' THR . . . . . . . . . . . . . 31.5 m -108.23 128.16 54.47 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.207 -0.452 . . . . 0.0 110.328 -179.857 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' B' B ' 140' ' ' LEU . . . . . . . . . . . . . 9.4 tp -114.02 122.56 47.28 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 115.763 -0.653 . . . . 0.0 109.567 -178.058 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' B' B ' 141' ' ' ILE . . . . . . . . . . . . . 19.6 mt -121.37 119.71 59.85 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.34 0 N-CA-C 109.949 -0.389 . . . . 0.0 109.949 -175.322 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' B' B ' 142' ' ' ARG . . . . . . . . . . . . . 45.2 ttp180 -114.05 127.9 56.15 Favored 'General case' 0 C--N 1.331 -0.229 0 CA-C-N 115.517 -0.765 . . . . 0.0 110.314 -177.216 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' B' B ' 143' ' ' THR . . . . . . . . . . . . . 20.3 p . . . . . 0 C--O 1.22 -0.489 0 CA-C-O 118.09 -0.957 . . . . 0.0 110.625 -179.661 . . . . . . . . 0 0 . 1 . 014 nuclear orig full ' C' C ' -3' ' ' GLU . . . . . . . . . . . . . 95.6 mt-10 . . . . . 0 N--CA 1.49 1.562 0 N-CA-C 109.284 -0.636 . . . . 0.0 109.284 . . . . . . . . . 0 0 . 1 . 014 nuclear orig full ' C' C ' -2' ' ' GLY . . . . . . . . . . . . . . . -76.91 142.24 27.33 Favored Glycine 0 CA--C 1.525 0.678 0 N-CA-C 111.009 -0.836 . . . . 0.0 111.009 179.998 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' C' C ' -1' ' ' VAL . . . . . . . . . . . . . 42.0 t -96.8 136.51 27.36 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.378 0 N-CA-C 110.026 -0.361 . . . . 0.0 110.026 179.788 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' C' C ' 0' ' ' ILE . . . . . . . . . . . . . 72.5 mt -104.21 127.09 58.75 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.264 0 N-CA-C 109.84 -0.429 . . . . 0.0 109.84 178.844 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' C' C ' 1' ' ' MET . . . . . . . . . . . . . 24.2 ptm -144.84 144.87 31.35 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.849 -178.341 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' C' C ' 2' ' ' SER . . . . . . . . . . . . . 5.5 p -130.95 130.5 43.51 Favored 'General case' 0 C--N 1.331 -0.202 0 CA-C-O 121.119 0.485 . . . . 0.0 110.954 179.129 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' C' C ' 3' ' ' GLU . . . . . . . . . . . . . 45.9 mp0 -139.45 142.19 37.41 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 115.785 -0.643 . . . . 0.0 110.707 179.232 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' C' C ' 4' ' ' LEU . . . . . . . . . . . . . 14.3 tp -124.52 127.42 47.4 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 116.085 -0.507 . . . . 0.0 110.214 176.593 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' C' C ' 5' ' ' LYS . . . . . . . . . . . . . 60.7 mttp -104.41 121.1 42.71 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.404 -0.362 . . . . 0.0 110.538 177.926 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' C' C ' 6' ' ' LEU . . . . . . . . . . . . . 54.8 mt -116.8 149.94 39.14 Favored 'General case' 0 C--N 1.331 -0.225 0 CA-C-N 115.603 -0.726 . . . . 0.0 110.927 -178.155 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' C' C ' 7' ' ' LYS . . . . . . . . . . . . . 59.7 tttm -138.07 142.91 37.39 Favored Pre-proline 0 CA--C 1.534 0.341 0 CA-C-N 116.28 -0.418 . . . . 0.0 109.958 175.448 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' C' C ' 8' ' ' PRO . . . . . . . . . . . . . 96.7 Cg_endo -91.46 143.39 3.02 Favored 'Trans proline' 0 N--CA 1.49 1.317 0 C-N-CA 121.763 1.642 . . . . 0.0 112.01 179.04 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' C' C ' 9' ' ' LEU . . . . . . . . . . . . . 50.5 mt -85.57 -48.19 0.58 Allowed Pre-proline 0 CA--C 1.534 0.363 0 CA-C-O 118.661 -0.685 . . . . 0.0 112.393 -179.544 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' C' C ' 10' ' ' PRO . . . . . . . . . . . . . 90.8 Cg_endo -79.97 157.97 23.93 Favored 'Trans proline' 0 N--CA 1.497 1.677 0 C-N-CA 121.17 1.247 . . . . 0.0 111.99 176.976 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' C' C ' 11' ' ' LYS . . . . . . . . . . . . . 1.9 ttmp? -88.35 95.35 10.16 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 116.333 -0.394 . . . . 0.0 110.548 179.358 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' C' C ' 12' ' ' VAL . . . . . . . . . . . . . 12.7 p -144.78 147.34 19.18 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.284 0 CA-C-N 116.296 -0.411 . . . . 0.0 110.669 -179.596 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' C' C ' 13' ' ' GLU . . . . . . . . . . . . . 84.7 tt0 -94.09 129.54 40.59 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.348 -0.387 . . . . 0.0 110.145 177.685 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' C' C ' 14' ' ' LEU . . . . . . . . . . . . . 18.3 mt -97.47 153.05 38.5 Favored Pre-proline 0 C--N 1.329 -0.304 0 CA-C-N 116.458 -0.337 . . . . 0.0 110.9 -176.575 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' C' C ' 15' ' ' PRO . . . . . . . . . . . . . 25.6 Cg_exo -62.48 162.19 25.08 Favored 'Trans proline' 0 N--CA 1.498 1.753 0 C-N-CA 121.242 1.295 . . . . 0.0 111.939 176.905 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' C' C ' 16' ' ' PRO . . . . . . . . . . . . . 25.6 Cg_exo -61.32 -36.58 78.32 Favored 'Trans proline' 0 N--CA 1.499 1.811 0 C-N-CA 121.423 1.415 . . . . 0.0 112.611 -178.488 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' C' C ' 17' ' ' ASP . . . . . . . . . . . . . 19.4 p-10 -89.5 9.72 25.51 Favored 'General case' 0 CA--C 1.535 0.4 0 N-CA-C 113.35 0.87 . . . . 0.0 113.35 -176.882 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' C' C ' 18' ' ' PHE . . . . . . . . . . . . . 47.3 t80 -58.07 -43.24 86.86 Favored 'General case' 0 C--O 1.227 -0.101 0 O-C-N 122.051 -0.406 . . . . 0.0 110.078 -178.281 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' C' C ' 19' ' ' VAL . . . . . . . . . . . . . 54.6 t -57.04 -42.17 78.85 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.321 0 CA-C-N 116.415 -0.357 . . . . 0.0 110.458 -178.751 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' C' C ' 20' ' ' ASP . . . . . . . . . . . . . 38.7 t0 -59.59 -43.52 93.66 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-O 120.874 0.369 . . . . 0.0 110.814 -178.153 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' C' C ' 21' ' ' VAL . . . . . . . . . . . . . 48.2 t -64.81 -46.01 93.3 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.326 0 CA-C-N 116.34 -0.391 . . . . 0.0 110.511 -178.23 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' C' C ' 22' ' ' ILE . . . . . . . . . . . . . 50.5 mm -59.77 -37.84 73.21 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.311 0 C-N-CA 120.946 -0.302 . . . . 0.0 110.779 -179.353 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' C' C ' 23' ' ' ARG . . . . . . . . . . . . . 36.7 ttp180 -57.75 -49.15 77.53 Favored 'General case' 0 C--N 1.33 -0.263 0 C-N-CA 120.689 -0.404 . . . . 0.0 110.457 178.187 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' C' C ' 24' ' ' ILE . . . . . . . . . . . . . 74.1 mt -61.45 -44.55 98.74 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.295 0 CA-C-N 116.1 -0.5 . . . . 0.0 111.952 -177.225 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' C' C ' 25' ' ' LYS . . . . . . . . . . . . . 0.7 OUTLIER -70.06 -34.52 73.31 Favored 'General case' 0 CA--C 1.534 0.361 0 C-N-CA 120.834 -0.346 . . . . 0.0 111.815 -174.676 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' C' C ' 26' ' ' LEU . . . . . . . . . . . . . 89.4 mt -78.78 -45.03 21.89 Favored 'General case' 0 C--N 1.331 -0.22 0 N-CA-C 113.085 0.772 . . . . 0.0 113.085 -174.18 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' C' C ' 27' ' ' GLN . . . . . . . . . . . . . 11.3 pt20 -47.29 139.78 6.03 Favored 'General case' 0 N--CA 1.469 0.517 0 N-CA-C 112.674 0.62 . . . . 0.0 112.674 -174.542 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' C' C ' 28' ' ' GLY . . . . . . . . . . . . . . . 99.75 -25.42 28.33 Favored Glycine 0 CA--C 1.535 1.286 0 CA-C-N 115.497 -0.774 . . . . 0.0 112.235 -176.535 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' C' C ' 29' ' ' LYS . . . . . . . . . . . . . 90.2 mttt -97.95 155.17 17.21 Favored 'General case' 0 C--O 1.232 0.169 0 CA-C-N 117.285 0.543 . . . . 0.0 110.963 178.755 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' C' C ' 30' ' ' THR . . . . . . . . . . . . . 24.8 m -106.65 136.63 46.13 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.034 -0.53 . . . . 0.0 109.977 175.515 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' C' C ' 31' ' ' VAL . . . . . . . . . . . . . 34.8 m -132.11 158.05 43.22 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.219 0 CA-C-O 120.889 0.375 . . . . 0.0 111.211 -177.378 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' C' C ' 32' ' ' ARG . . . . . . . . . . . . . 75.2 mtp180 -134.24 153.22 51.98 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-O 121.299 0.571 . . . . 0.0 110.809 178.656 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' C' C ' 33' ' ' THR . . . . . . . . . . . . . 28.0 m -53.52 139.74 30.39 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 116.066 -0.515 . . . . 0.0 111.317 -179.047 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' C' C ' 34' ' ' GLY . . . . . . . . . . . . . . . 99.78 -17.23 57.69 Favored Glycine 0 CA--C 1.533 1.173 0 CA-C-O 119.67 -0.517 . . . . 0.0 113.289 178.21 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' C' C ' 35' ' ' ASP . . . . . . . . . . . . . 79.2 m-20 -66.6 147.9 52.64 Favored 'General case' 0 C--O 1.232 0.172 0 CA-C-N 118.072 0.936 . . . . 0.0 111.166 178.901 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' C' C ' 36' ' ' VAL . . . . . . . . . . . . . 43.1 t -121.79 129.8 75.15 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.239 0 CA-C-N 116.039 -0.528 . . . . 0.0 109.696 177.282 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' C' C ' 37' ' ' ILE . . . . . . . . . . . . . 68.0 mt -120.84 139.57 47.69 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.322 0 CA-C-N 116.343 -0.39 . . . . 0.0 110.052 -178.726 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' C' C ' 38' ' ' GLY . . . . . . . . . . . . . . . -110.62 128.76 8.94 Favored Glycine 0 CA--C 1.526 0.728 0 N-CA-C 111.208 -0.757 . . . . 0.0 111.208 -179.953 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' C' C ' 39' ' ' ILE . . . . . . . . . . . . . 72.8 mt -123.52 137.94 55.04 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.255 0 N-CA-C 109.965 -0.383 . . . . 0.0 109.965 178.999 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' C' C ' 40' ' ' SER . . . . . . . . . . . . . 46.7 t -92.2 113.93 26.33 Favored 'General case' 0 C--N 1.329 -0.296 0 C-N-CA 120.896 -0.321 . . . . 0.0 110.742 176.479 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' C' C ' 41' ' ' ILE . . . . . . . . . . . . . 45.2 mm -122.54 114.91 44.33 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.214 0 N-CA-C 110.026 -0.361 . . . . 0.0 110.026 179.093 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' C' C ' 42' ' ' LEU . . . . . . . . . . . . . 79.5 mt 57.33 35.11 25.66 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.456 -0.338 . . . . 0.0 111.686 178.806 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' C' C ' 43' ' ' GLY . . . . . . . . . . . . . . . 77.98 -10.14 28.05 Favored Glycine 0 CA--C 1.534 1.249 0 C-N-CA 121.311 -0.471 . . . . 0.0 113.575 177.903 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' C' C ' 44' ' ' LYS . . . . . . . . . . . . . 61.9 tttm -96.1 134.2 39.44 Favored 'General case' 0 C--N 1.333 -0.111 0 CA-C-N 117.742 0.771 . . . . 0.0 109.762 176.445 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' C' C ' 45' ' ' GLU . . . . . . . . . . . . . 84.5 tt0 -83.04 123.63 29.66 Favored 'General case' 0 C--N 1.328 -0.335 0 C-N-CA 120.789 -0.365 . . . . 0.0 110.629 -179.73 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' C' C ' 46' ' ' VAL . . . . . . . . . . . . . 7.3 p -117.71 127.26 75.08 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.257 0 N-CA-C 109.448 -0.575 . . . . 0.0 109.448 177.235 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' C' C ' 47' ' ' LYS . . . . . . . . . . . . . 54.8 mtpt -99.51 127.99 45.6 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 115.848 -0.614 . . . . 0.0 110.89 178.858 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' C' C ' 48' ' ' PHE . . . . . . . . . . . . . 92.2 m-85 -110.98 131.97 54.6 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.272 -0.422 . . . . 0.0 110.017 176.153 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' C' C ' 49' ' ' LYS . . . . . . . . . . . . . 78.7 tttt -107.64 135.66 48.7 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.409 -0.36 . . . . 0.0 110.207 179.479 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' C' C ' 50' ' ' VAL . . . . . . . . . . . . . 43.9 t -81.16 109.57 15.64 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.272 0 N-CA-C 109.408 -0.59 . . . . 0.0 109.408 176.833 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' C' C ' 51' ' ' VAL . . . . . . . . . . . . . 48.8 t -70.12 -47.91 65.1 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.292 0 N-CA-C 109.785 -0.45 . . . . 0.0 109.785 -174.923 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' C' C ' 52' ' ' GLN . . . . . . . . . . . . . 46.1 tt0 -168.11 139.95 2.92 Favored 'General case' 0 C--N 1.33 -0.267 0 C-N-CA 120.278 -0.569 . . . . 0.0 111.638 -179.217 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' C' C ' 53' ' ' ALA . . . . . . . . . . . . . . . -110.59 133.45 53.3 Favored 'General case' 0 C--N 1.33 -0.239 0 CA-C-N 115.673 -0.694 . . . . 0.0 109.904 176.059 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' C' C ' 54' ' ' TYR . . . . . . . . . . . . . 30.3 t80 -129.08 112.12 18.42 Favored Pre-proline 0 CA--C 1.536 0.44 0 CA-C-O 118.247 -0.882 . . . . 0.0 110.551 179.396 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' C' C ' 55' ' ' PRO . . . . . . . . . . . . . 72.6 Cg_endo -77.07 165.79 84.0 Favored 'Cis proline' 0 N--CA 1.499 1.826 0 CA-C-N 121.953 1.733 . . . . 0.0 112.205 -7.299 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' C' C ' 56' ' ' SER . . . . . . . . . . . . . 41.8 m -113.82 130.8 23.49 Favored Pre-proline 0 CA--C 1.538 0.492 0 CA-C-O 118.529 -0.748 . . . . 0.0 109.337 175.072 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' C' C ' 57' ' ' PRO . . . . . . . . . . . . . 50.0 Cg_endo -69.55 145.47 79.04 Favored 'Cis proline' 0 N--CA 1.498 1.738 0 CA-C-N 121.885 1.709 . . . . 0.0 111.626 0.711 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' C' C ' 58' ' ' LEU . . . . . . . . . . . . . 21.8 tp -108.16 134.53 50.89 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.291 -0.413 . . . . 0.0 110.761 -178.784 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' C' C ' 59' ' ' ARG . . . . . . . . . . . . . 31.5 ttm180 -100.78 128.55 46.78 Favored 'General case' 0 C--N 1.328 -0.361 0 N-CA-C 109.325 -0.62 . . . . 0.0 109.325 175.227 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' C' C ' 60' ' ' VAL . . . . . . . . . . . . . 44.2 t -84.35 116.94 28.93 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.266 0 C-N-CA 120.613 -0.435 . . . . 0.0 110.411 -177.522 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' C' C ' 61' ' ' GLU . . . . . . . . . . . . . 65.2 mm-40 -126.14 163.68 22.59 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-N 115.744 -0.662 . . . . 0.0 109.774 176.862 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' C' C ' 62' ' ' ASP . . . . . . . . . . . . . 62.7 m-20 -52.72 -32.38 42.62 Favored 'General case' 0 C--N 1.329 -0.32 0 N-CA-C 111.794 0.294 . . . . 0.0 111.794 178.921 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' C' C ' 63' ' ' ARG . . . . . . . . . . . . . 92.6 mtt-85 -73.69 -22.08 60.04 Favored 'General case' 0 CA--C 1.533 0.312 0 N-CA-C 112.922 0.712 . . . . 0.0 112.922 -177.163 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' C' C ' 64' ' ' THR . . . . . . . . . . . . . 35.7 m -67.82 136.83 54.74 Favored 'General case' 0 C--N 1.332 -0.187 0 CA-C-O 120.982 0.42 . . . . 0.0 110.999 -173.631 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' C' C ' 65' ' ' LYS . . . . . . . . . . . . . 55.2 mtmt -90.56 132.11 35.9 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 115.807 -0.633 . . . . 0.0 110.578 178.484 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' C' C ' 66' ' ' ILE . . . . . . . . . . . . . 64.8 mt -113.65 128.55 70.48 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.258 0 N-CA-C 109.645 -0.502 . . . . 0.0 109.645 178.909 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' C' C ' 67' ' ' THR . . . . . . . . . . . . . 18.0 m -127.27 142.67 51.41 Favored 'General case' 0 C--O 1.233 0.218 0 CA-C-O 121.047 0.451 . . . . 0.0 111.11 -177.147 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' C' C ' 68' ' ' LEU . . . . . . . . . . . . . 13.7 tp -100.43 133.81 44.31 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 115.912 -0.586 . . . . 0.0 109.832 176.975 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' C' C ' 69' ' ' VAL . . . . . . . . . . . . . 42.9 t -82.88 117.58 29.06 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.305 0 C-N-CA 120.745 -0.382 . . . . 0.0 110.274 -178.408 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' C' C ' 70' ' ' THR . . . . . . . . . . . . . 69.7 p -145.48 172.92 12.51 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.016 -0.538 . . . . 0.0 110.675 -179.817 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' C' C ' 71' ' ' HIS . . . . . . . . . . . . . 5.6 t60 -127.04 89.6 51.56 Favored Pre-proline 0 CA--C 1.534 0.335 0 CA-C-N 116.286 -0.415 . . . . 0.0 110.794 -178.76 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' C' C ' 72' ' ' PRO . . . . . . . . . . . . . 73.7 Cg_endo -78.72 158.83 28.2 Favored 'Trans proline' 0 N--CA 1.495 1.591 0 C-N-CA 121.512 1.475 . . . . 0.0 112.886 -178.907 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' C' C ' 73' ' ' VAL . . . . . . . . . . . . . 35.9 m -127.0 174.38 10.89 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.157 0 CA-C-N 115.952 -0.567 . . . . 0.0 110.043 177.46 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' C' C ' 74' ' ' ASP . . . . . . . . . . . . . 21.4 t0 -99.06 122.9 42.9 Favored 'General case' 0 C--N 1.329 -0.291 0 C-N-CA 120.896 -0.322 . . . . 0.0 110.24 -177.552 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' C' C ' 75' ' ' VAL . . . . . . . . . . . . . 41.5 t -119.96 123.33 70.6 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.2 0 CA-C-O 121.044 0.449 . . . . 0.0 110.527 -179.225 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' C' C ' 76' ' ' LEU . . . . . . . . . . . . . 5.3 mp -119.49 147.63 44.2 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 115.671 -0.695 . . . . 0.0 109.788 176.285 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' C' C ' 77' ' ' GLU . . . . . . . . . . . . . 97.8 mt-10 -136.06 134.37 38.36 Favored 'General case' 0 C--N 1.331 -0.211 0 CA-C-O 121.074 0.464 . . . . 0.0 111.327 -179.303 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' C' C ' 78' ' ' ALA . . . . . . . . . . . . . . . -124.22 133.45 53.52 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 115.696 -0.684 . . . . 0.0 109.603 176.083 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' C' C ' 79' ' ' LYS . . . . . . . . . . . . . 50.0 mtpt -81.52 119.07 23.29 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-O 120.975 0.417 . . . . 0.0 110.697 -178.273 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' C' C ' 80' ' ' ILE . . . . . . . . . . . . . 44.1 mm -139.18 103.09 1.83 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.338 0 N-CA-C 109.009 -0.737 . . . . 0.0 109.009 -177.1 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' C' C ' 81' ' ' LYS . . . . . . . . . . . . . 73.2 mttt -92.2 127.9 37.85 Favored 'General case' 0 C--N 1.328 -0.359 0 C-N-CA 120.644 -0.422 . . . . 0.0 111.037 -176.776 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' C' C ' 82' ' ' GLY . . . . . . . . . . . . . . . 88.98 42.18 5.71 Favored Glycine 0 CA--C 1.523 0.591 0 C-N-CA 120.889 -0.672 . . . . 0.0 112.204 173.978 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' C' C ' 83' ' ' ILE . . . . . . . . . . . . . 67.9 mt -71.26 131.89 33.96 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.217 0 N-CA-C 109.306 -0.627 . . . . 0.0 109.306 176.206 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' C' C ' 84' ' ' LYS . . . . . . . . . . . . . 28.0 ttpp -101.47 -45.73 5.21 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-O 120.724 0.297 . . . . 0.0 110.741 -176.375 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' C' C ' 85' ' ' ASP . . . . . . . . . . . . . 9.1 t70 -148.25 147.08 28.97 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.324 -0.398 . . . . 0.0 110.674 179.897 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' C' C ' 86' ' ' VAL . . . . . . . . . . . . . 44.2 t -131.74 132.41 61.96 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.229 0 CA-C-O 120.967 0.413 . . . . 0.0 110.683 -178.827 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' C' C ' 87' ' ' ILE . . . . . . . . . . . . . 5.1 mp -122.9 130.42 74.48 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.256 0 CA-C-N 115.79 -0.641 . . . . 0.0 109.439 175.814 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' C' C ' 88' ' ' LEU . . . . . . . . . . . . . 23.9 tp -115.49 132.53 56.59 Favored 'General case' 0 N--CA 1.463 0.22 0 CA-C-O 120.991 0.424 . . . . 0.0 111.484 -177.086 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' C' C ' 89' ' ' ASP . . . . . . . . . . . . . 13.8 t70 -120.63 156.62 31.29 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 115.709 -0.678 . . . . 0.0 109.477 175.747 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' C' C ' 90' ' ' GLU . . . . . . . . . . . . . 70.9 mm-40 -48.05 -42.32 28.17 Favored 'General case' 0 N--CA 1.465 0.29 0 N-CA-C 112.723 0.638 . . . . 0.0 112.723 -171.629 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' C' C ' 91' ' ' ASN . . . . . . . . . . . . . 6.3 p30 -132.07 38.49 3.5 Favored 'General case' 0 C--O 1.233 0.223 0 CA-C-O 120.692 0.282 . . . . 0.0 111.488 -178.316 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' C' C ' 92' ' ' LEU . . . . . . . . . . . . . 9.9 tp -165.7 145.19 6.4 Favored 'General case' 0 C--N 1.332 -0.191 0 C-N-CA 120.754 -0.378 . . . . 0.0 110.6 -178.966 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' C' C ' 93' ' ' ILE . . . . . . . . . . . . . 55.9 mt -123.53 125.76 71.99 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.226 0 N-CA-C 109.814 -0.439 . . . . 0.0 109.814 -177.715 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' C' C ' 94' ' ' VAL . . . . . . . . . . . . . 45.8 t -124.01 126.41 72.4 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.221 0 N-CA-C 109.872 -0.418 . . . . 0.0 109.872 178.781 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' C' C ' 95' ' ' VAL . . . . . . . . . . . . . 42.4 t -126.63 137.76 56.82 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.229 0 CA-C-N 116.285 -0.416 . . . . 0.0 110.374 -178.203 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' C' C ' 96' ' ' ILE . . . . . . . . . . . . . 54.8 mt -116.65 129.44 73.14 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.28 0 N-CA-C 109.276 -0.638 . . . . 0.0 109.276 178.505 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' C' C ' 97' ' ' THR . . . . . . . . . . . . . 64.6 p -106.08 157.73 17.33 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-O 121.334 0.588 . . . . 0.0 111.628 -175.955 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' C' C ' 98' ' ' GLU . . . . . . . . . . . . . 12.8 pt-20 -53.87 -23.7 13.46 Favored 'General case' 0 CA--C 1.535 0.375 0 CA-C-N 115.818 -0.628 . . . . 0.0 112.491 179.013 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' C' C ' 99' ' ' GLU . . . . . . . . . . . . . 96.5 mt-10 -77.76 13.31 1.37 Allowed 'General case' 0 CA--C 1.536 0.433 0 N-CA-C 113.074 0.768 . . . . 0.0 113.074 -178.321 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' C' C ' 100' ' ' ASN . . . . . . . . . . . . . 1.9 m-20 61.78 37.53 15.54 Favored 'General case' 0 N--CA 1.463 0.18 0 CA-C-O 120.995 0.426 . . . . 0.0 110.759 179.599 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' C' C ' 101' ' ' GLU . . . . . . . . . . . . . 84.4 tt0 -118.92 145.21 45.94 Favored 'General case' 0 C--O 1.232 0.184 0 CA-C-N 116.058 -0.519 . . . . 0.0 109.919 179.221 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' C' C ' 102' ' ' VAL . . . . . . . . . . . . . 46.8 t -114.98 125.32 72.27 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 N-CA-C 109.646 -0.501 . . . . 0.0 109.646 -179.096 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' C' C ' 103' ' ' LEU . . . . . . . . . . . . . 37.5 mt -116.14 131.77 56.85 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-N 115.707 -0.678 . . . . 0.0 110.423 178.567 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' C' C ' 104' ' ' ILE . . . . . . . . . . . . . 66.3 mt -118.46 121.34 66.83 Favored 'Isoleucine or valine' 0 C--O 1.234 0.277 0 CA-C-N 116.332 -0.395 . . . . 0.0 110.003 177.892 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' C' C ' 105' ' ' PHE . . . . . . . . . . . . . 80.0 m-85 -120.65 162.76 19.13 Favored 'General case' 0 C--N 1.331 -0.219 0 O-C-N 123.994 0.809 . . . . 0.0 109.905 -179.749 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' C' C ' 106' ' ' ASN . . . . . . . . . . . . . 46.4 p-10 -101.09 -170.59 1.86 Allowed 'General case' 0 C--N 1.329 -0.296 0 N-CA-C 110.013 -0.366 . . . . 0.0 110.013 173.76 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' C' C ' 107' ' ' GLN . . . . . . . . . . . . . 46.2 tt0 -58.67 -29.87 66.92 Favored 'General case' 0 C--N 1.329 -0.293 0 N-CA-C 111.942 0.349 . . . . 0.0 111.942 -179.999 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' C' C ' 108' ' ' ASN . . . . . . . . . . . . . 9.7 t30 -85.12 9.98 13.39 Favored 'General case' 0 CA--C 1.535 0.381 0 N-CA-C 113.137 0.791 . . . . 0.0 113.137 -177.177 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' C' C ' 109' ' ' LEU . . . . . . . . . . . . . 8.7 tp 59.18 36.25 23.83 Favored 'General case' 0 C--O 1.232 0.159 0 O-C-N 122.159 -0.338 . . . . 0.0 111.406 178.441 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' C' C ' 110' ' ' GLU . . . . . . . . . . . . . 95.6 mt-10 -105.17 159.81 15.57 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-O 120.758 0.313 . . . . 0.0 110.35 177.766 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' C' C ' 111' ' ' GLU . . . . . . . . . . . . . 84.6 tt0 -84.67 121.98 28.42 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.309 -0.405 . . . . 0.0 110.851 -178.402 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' C' C ' 112' ' ' LEU . . . . . . . . . . . . . 14.7 mt -109.93 -46.07 3.53 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-N 116.081 -0.509 . . . . 0.0 110.158 177.211 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' C' C ' 113' ' ' TYR . . . . . . . . . . . . . 53.2 t80 -139.33 136.94 35.34 Favored 'General case' 0 C--N 1.331 -0.224 0 CA-C-N 116.254 -0.43 . . . . 0.0 111.082 179.854 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' C' C ' 114' ' ' ARG . . . . . . . . . . . . . 71.3 ttp85 -139.09 121.11 15.63 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.054 -0.521 . . . . 0.0 110.18 177.785 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' C' C ' 115' ' ' GLY . . . . . . . . . . . . . . . -150.06 159.85 28.28 Favored Glycine 0 CA--C 1.524 0.634 0 N-CA-C 110.908 -0.877 . . . . 0.0 110.908 178.316 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' C' C ' 116' ' ' LYS . . . . . . . . . . . . . 1.4 ttmp? -131.73 142.64 49.85 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-O 120.822 0.344 . . . . 0.0 110.288 178.491 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' C' C ' 117' ' ' PHE . . . . . . . . . . . . . 31.0 m-85 -138.92 115.46 10.56 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.182 -0.463 . . . . 0.0 109.948 -177.183 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' C' C ' 118' ' ' GLU . . . . . . . . . . . . . 82.9 tt0 -52.9 -48.81 66.93 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.528 -0.305 . . . . 0.0 111.662 -176.005 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' C' C ' 119' ' ' ASN . . . . . . . . . . . . . 4.0 p30 -97.25 31.13 2.55 Favored 'General case' 0 C--N 1.33 -0.259 0 N-CA-C 112.101 0.408 . . . . 0.0 112.101 -175.349 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' C' C ' 120' ' ' LEU . . . . . . . . . . . . . 15.1 tp -52.96 126.55 20.82 Favored 'General case' 0 N--CA 1.463 0.212 0 CA-C-O 120.45 0.167 . . . . 0.0 110.862 177.813 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' C' C ' 121' ' ' ASN . . . . . . . . . . . . . 51.3 t30 -113.76 -44.2 3.21 Favored 'General case' 0 C--N 1.33 -0.258 0 C-N-CA 121.165 -0.214 . . . . 0.0 111.258 -176.133 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' C' C ' 122' ' ' LYS . . . . . . . . . . . . . 88.2 mttt -148.08 151.91 36.46 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-O 121.016 0.436 . . . . 0.0 111.81 -177.267 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' C' C ' 123' ' ' VAL . . . . . . . . . . . . . 42.9 t -131.12 128.92 62.67 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 CA-C-N 115.949 -0.569 . . . . 0.0 109.503 173.865 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' C' C ' 124' ' ' LEU . . . . . . . . . . . . . 62.0 mt -122.35 136.79 54.96 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.43 -0.35 . . . . 0.0 110.308 -178.814 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' C' C ' 125' ' ' VAL . . . . . . . . . . . . . 12.9 p -133.16 134.59 57.52 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.219 0 CA-C-O 120.997 0.427 . . . . 0.0 110.768 -179.463 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' C' C ' 126' ' ' ARG . . . . . . . . . . . . . 88.8 mtt180 -151.67 135.24 16.2 Favored 'General case' 0 C--N 1.327 -0.37 0 N-CA-C 109.094 -0.706 . . . . 0.0 109.094 176.123 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' C' C ' 127' ' ' ASN . . . . . . . . . . . . . 9.7 p30 48.88 -150.37 0.17 Allowed 'General case' 0 CA--C 1.541 0.62 0 CA-C-O 119.431 -0.318 . . . . 0.0 110.932 179.078 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' C' C ' 128' ' ' ASP . . . . . . . . . . . . . 10.2 p-10 -81.83 18.05 1.38 Allowed 'General case' 0 CA--C 1.535 0.4 0 N-CA-C 112.723 0.638 . . . . 0.0 112.723 179.393 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' C' C ' 129' ' ' LEU . . . . . . . . . . . . . 73.0 mt -117.6 137.66 52.46 Favored 'General case' 0 C--O 1.233 0.184 0 O-C-N 122.083 -0.386 . . . . 0.0 110.416 179.477 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' C' C ' 130' ' ' VAL . . . . . . . . . . . . . 43.8 t -128.72 140.45 49.21 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.212 0 CA-C-N 116.254 -0.43 . . . . 0.0 110.091 -179.151 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' C' C ' 131' ' ' VAL . . . . . . . . . . . . . 41.4 t -135.46 135.27 51.83 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.226 0 CA-C-O 121.033 0.445 . . . . 0.0 110.273 178.504 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' C' C ' 132' ' ' ILE . . . . . . . . . . . . . 70.6 mt -114.51 133.31 61.0 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.352 0 CA-C-N 115.741 -0.663 . . . . 0.0 109.399 179.263 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' C' C ' 133' ' ' ILE . . . . . . . . . . . . . 39.5 mm -114.8 122.77 69.59 Favored 'Isoleucine or valine' 0 C--O 1.234 0.237 0 CA-C-O 120.714 0.292 . . . . 0.0 110.817 -175.389 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' C' C ' 134' ' ' ASP . . . . . . . . . . . . . 8.2 p-10 -131.92 150.61 52.1 Favored 'General case' 0 C--N 1.331 -0.2 0 N-CA-C 109.855 -0.424 . . . . 0.0 109.855 176.091 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' C' C ' 135' ' ' GLU . . . . . . . . . . . . . 84.7 tt0 -49.89 -26.97 4.58 Favored 'General case' 0 C--N 1.327 -0.39 0 N-CA-C 112.902 0.704 . . . . 0.0 112.902 -172.117 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' C' C ' 136' ' ' GLN . . . . . . . . . . . . . 94.0 mt-30 -93.35 -24.71 18.01 Favored 'General case' 0 C--N 1.33 -0.281 0 N-CA-C 113.088 0.774 . . . . 0.0 113.088 -172.626 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' C' C ' 137' ' ' LYS . . . . . . . . . . . . . 55.6 pttt -170.0 173.72 5.87 Favored 'General case' 0 C--O 1.232 0.163 0 CA-C-O 121.583 0.706 . . . . 0.0 112.553 -173.432 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' C' C ' 138' ' ' LEU . . . . . . . . . . . . . 4.4 tt -118.51 129.75 55.54 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 114.967 -1.015 . . . . 0.0 109.937 179.592 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' C' C ' 139' ' ' THR . . . . . . . . . . . . . 25.9 m -109.83 124.75 51.87 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.406 -0.361 . . . . 0.0 110.319 178.834 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' C' C ' 140' ' ' LEU . . . . . . . . . . . . . 7.9 tt -111.52 125.18 53.63 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 115.705 -0.679 . . . . 0.0 109.381 -178.665 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' C' C ' 141' ' ' ILE . . . . . . . . . . . . . 19.3 mt -125.08 120.16 57.66 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.251 0 CA-C-O 120.993 0.425 . . . . 0.0 110.058 -176.011 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' C' C ' 142' ' ' ARG . . . . . . . . . . . . . 59.3 ttp180 -110.8 126.96 55.17 Favored 'General case' 0 C--N 1.331 -0.21 0 CA-C-N 115.574 -0.739 . . . . 0.0 110.19 179.352 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' C' C ' 143' ' ' THR . . . . . . . . . . . . . 24.3 p . . . . . 0 C--O 1.22 -0.464 0 CA-C-O 118.078 -0.963 . . . . 0.0 110.524 179.58 . . . . . . . . 0 0 . 1 . 014 nuclear orig full ' D' D ' -3' ' ' GLU . . . . . . . . . . . . . 12.1 pt-20 . . . . . 0 N--CA 1.49 1.544 0 N-CA-C 109.483 -0.562 . . . . 0.0 109.483 . . . . . . . . . 0 0 . 1 . 014 nuclear orig full ' D' D ' -2' ' ' GLY . . . . . . . . . . . . . . . -79.04 149.94 33.32 Favored Glycine 0 CA--C 1.525 0.67 0 N-CA-C 110.999 -0.84 . . . . 0.0 110.999 -179.95 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' D' D ' -1' ' ' VAL . . . . . . . . . . . . . 45.1 t -96.25 134.15 34.9 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.32 0 CA-C-O 120.85 0.357 . . . . 0.0 110.083 179.688 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' D' D ' 0' ' ' ILE . . . . . . . . . . . . . 73.4 mt -116.55 131.4 69.25 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.196 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.115 -178.98 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' D' D ' 1' ' ' MET . . . . . . . . . . . . . 25.3 ptp -144.21 179.02 7.49 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.789 179.618 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' D' D ' 2' ' ' SER . . . . . . . . . . . . . 2.8 p -108.06 132.87 53.11 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.202 -0.454 . . . . 0.0 110.521 179.541 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' D' D ' 3' ' ' GLU . . . . . . . . . . . . . 95.8 mt-10 -141.3 140.51 33.85 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.168 -0.469 . . . . 0.0 111.166 -179.217 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' D' D ' 4' ' ' LEU . . . . . . . . . . . . . 17.8 tp -125.34 131.57 52.98 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 115.928 -0.578 . . . . 0.0 110.062 176.139 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' D' D ' 5' ' ' LYS . . . . . . . . . . . . . 95.2 mttt -109.8 119.93 40.88 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.424 -0.353 . . . . 0.0 110.577 179.514 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' D' D ' 6' ' ' LEU . . . . . . . . . . . . . 51.5 mt -115.07 145.77 41.98 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 115.365 -0.834 . . . . 0.0 110.555 -177.821 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' D' D ' 7' ' ' LYS . . . . . . . . . . . . . 61.8 tttp -132.65 134.36 24.6 Favored Pre-proline 0 CA--C 1.537 0.458 0 CA-C-O 118.7 -0.667 . . . . 0.0 109.966 177.153 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' D' D ' 8' ' ' PRO . . . . . . . . . . . . . 90.5 Cg_endo -89.54 139.39 3.39 Favored 'Trans proline' 0 N--CA 1.491 1.336 0 C-N-CA 121.437 1.425 . . . . 0.0 111.634 176.531 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' D' D ' 9' ' ' LEU . . . . . . . . . . . . . 55.0 mt -78.02 -47.8 2.15 Favored Pre-proline 0 CA--C 1.533 0.301 0 CA-C-O 118.65 -0.69 . . . . 0.0 112.417 -178.356 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' D' D ' 10' ' ' PRO . . . . . . . . . . . . . 84.2 Cg_endo -80.33 152.53 20.79 Favored 'Trans proline' 0 N--CA 1.497 1.711 0 C-N-CA 121.232 1.288 . . . . 0.0 111.83 176.725 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' D' D ' 11' ' ' LYS . . . . . . . . . . . . . 53.5 tttp -87.97 98.37 11.47 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-O 120.924 0.392 . . . . 0.0 110.373 178.767 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' D' D ' 12' ' ' VAL . . . . . . . . . . . . . 11.9 p -141.12 147.07 22.83 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.262 0 CA-C-N 116.037 -0.529 . . . . 0.0 110.432 -179.538 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' D' D ' 13' ' ' GLU . . . . . . . . . . . . . 96.1 mt-10 -84.87 124.01 31.13 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.347 -0.388 . . . . 0.0 110.371 179.06 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' D' D ' 14' ' ' LEU . . . . . . . . . . . . . 39.8 mt -98.88 144.82 28.87 Favored Pre-proline 0 CA--C 1.534 0.356 0 CA-C-O 119.005 -0.522 . . . . 0.0 110.186 -179.511 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' D' D ' 15' ' ' PRO . . . . . . . . . . . . . 25.2 Cg_exo -62.38 159.32 36.26 Favored 'Trans proline' 0 N--CA 1.497 1.728 0 C-N-CA 121.247 1.298 . . . . 0.0 111.964 177.091 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' D' D ' 16' ' ' PRO . . . . . . . . . . . . . 38.2 Cg_exo -58.32 -41.25 68.13 Favored 'Trans proline' 0 N--CA 1.498 1.758 0 C-N-CA 121.463 1.442 . . . . 0.0 112.948 -178.467 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' D' D ' 17' ' ' ASP . . . . . . . . . . . . . 14.5 p-10 -81.9 5.99 17.22 Favored 'General case' 0 C--N 1.326 -0.432 0 N-CA-C 113.208 0.818 . . . . 0.0 113.208 -177.599 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' D' D ' 18' ' ' PHE . . . . . . . . . . . . . 55.1 t80 -57.59 -42.33 82.97 Favored 'General case' 0 N--CA 1.457 -0.075 0 O-C-N 121.937 -0.477 . . . . 0.0 110.228 -179.514 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' D' D ' 19' ' ' VAL . . . . . . . . . . . . . 47.7 t -56.63 -43.26 78.45 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.263 0 CA-C-N 116.301 -0.409 . . . . 0.0 110.371 -179.358 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' D' D ' 20' ' ' ASP . . . . . . . . . . . . . 81.4 m-20 -60.48 -41.95 95.26 Favored 'General case' 0 C--N 1.33 -0.26 0 C-N-CA 120.981 -0.288 . . . . 0.0 110.895 -178.085 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' D' D ' 21' ' ' VAL . . . . . . . . . . . . . 47.2 t -64.18 -47.93 87.87 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.27 0 C-N-CA 120.742 -0.383 . . . . 0.0 110.35 -177.821 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' D' D ' 22' ' ' ILE . . . . . . . . . . . . . 50.7 mm -56.11 -46.36 80.96 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.25 0 CA-C-O 120.762 0.315 . . . . 0.0 110.604 179.205 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' D' D ' 23' ' ' ARG . . . . . . . . . . . . . 52.8 ttp180 -54.9 -50.53 68.53 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 116.535 -0.302 . . . . 0.0 111.518 -178.064 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' D' D ' 24' ' ' ILE . . . . . . . . . . . . . 74.9 mt -60.16 -42.17 89.23 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 C-N-CA 121.056 -0.258 . . . . 0.0 111.351 -176.397 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' D' D ' 25' ' ' LYS . . . . . . . . . . . . . 43.6 mtmt -66.85 -39.81 87.7 Favored 'General case' 0 C--N 1.329 -0.316 0 N-CA-C 112.386 0.513 . . . . 0.0 112.386 -178.72 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' D' D ' 26' ' ' LEU . . . . . . . . . . . . . 92.2 mt -78.48 -40.92 34.04 Favored 'General case' 0 C--N 1.331 -0.23 0 N-CA-C 112.881 0.697 . . . . 0.0 112.881 -173.096 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' D' D ' 27' ' ' GLN . . . . . . . . . . . . . 9.1 pt20 -46.61 140.39 4.46 Favored 'General case' 0 N--CA 1.469 0.496 0 N-CA-C 112.691 0.626 . . . . 0.0 112.691 -176.082 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' D' D ' 28' ' ' GLY . . . . . . . . . . . . . . . 99.51 -26.51 24.08 Favored Glycine 0 CA--C 1.532 1.126 0 CA-C-N 115.511 -0.768 . . . . 0.0 112.144 -176.394 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' D' D ' 29' ' ' LYS . . . . . . . . . . . . . 98.7 mttt -97.86 155.2 17.17 Favored 'General case' 0 C--O 1.234 0.269 0 CA-C-N 117.267 0.534 . . . . 0.0 111.134 178.59 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' D' D ' 30' ' ' THR . . . . . . . . . . . . . 18.5 m -105.8 135.58 46.96 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.002 -0.544 . . . . 0.0 109.695 174.922 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' D' D ' 31' ' ' VAL . . . . . . . . . . . . . 35.1 m -128.35 159.68 39.43 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.245 0 CA-C-N 116.382 -0.372 . . . . 0.0 110.681 -177.916 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' D' D ' 32' ' ' ARG . . . . . . . . . . . . . 57.8 ttp180 -132.75 149.8 52.24 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-O 121.22 0.533 . . . . 0.0 110.507 179.561 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' D' D ' 33' ' ' THR . . . . . . . . . . . . . 22.4 m -53.1 139.58 28.07 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 116.333 -0.394 . . . . 0.0 111.326 -178.412 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' D' D ' 34' ' ' GLY . . . . . . . . . . . . . . . 101.26 -17.05 56.36 Favored Glycine 0 CA--C 1.532 1.155 0 CA-C-O 119.645 -0.53 . . . . 0.0 113.251 179.703 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' D' D ' 35' ' ' ASP . . . . . . . . . . . . . 62.8 m-20 -64.09 148.59 49.49 Favored 'General case' 0 C--O 1.231 0.1 0 CA-C-N 118.037 0.918 . . . . 0.0 111.222 179.102 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' D' D ' 36' ' ' VAL . . . . . . . . . . . . . 45.7 t -124.71 128.82 73.62 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.234 0 CA-C-N 115.577 -0.738 . . . . 0.0 109.541 178.185 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' D' D ' 37' ' ' ILE . . . . . . . . . . . . . 66.0 mt -121.21 138.32 52.0 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.256 0 CA-C-N 116.273 -0.421 . . . . 0.0 110.02 -179.293 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' D' D ' 38' ' ' GLY . . . . . . . . . . . . . . . -108.38 128.53 9.14 Favored Glycine 0 CA--C 1.524 0.646 0 N-CA-C 110.754 -0.938 . . . . 0.0 110.754 178.408 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' D' D ' 39' ' ' ILE . . . . . . . . . . . . . 71.9 mt -123.23 138.16 54.13 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.265 0 N-CA-C 109.934 -0.395 . . . . 0.0 109.934 179.803 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' D' D ' 40' ' ' SER . . . . . . . . . . . . . 79.2 p -90.32 118.47 29.84 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.316 -0.402 . . . . 0.0 110.55 176.654 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' D' D ' 41' ' ' ILE . . . . . . . . . . . . . 48.5 mm -129.5 116.11 37.6 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.266 0 CA-C-N 116.453 -0.339 . . . . 0.0 110.177 179.269 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' D' D ' 42' ' ' LEU . . . . . . . . . . . . . 78.1 mt 57.46 35.77 26.27 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.217 -0.447 . . . . 0.0 111.568 177.991 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' D' D ' 43' ' ' GLY . . . . . . . . . . . . . . . 77.79 -10.1 26.99 Favored Glycine 0 CA--C 1.534 1.237 0 C-N-CA 121.303 -0.475 . . . . 0.0 113.537 177.141 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' D' D ' 44' ' ' LYS . . . . . . . . . . . . . 48.5 tttp -101.52 139.8 36.68 Favored 'General case' 0 C--N 1.333 -0.128 0 CA-C-N 117.838 0.819 . . . . 0.0 109.831 177.123 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' D' D ' 45' ' ' GLU . . . . . . . . . . . . . 84.5 tt0 -83.54 127.81 34.02 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-O 120.957 0.408 . . . . 0.0 110.931 -179.201 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' D' D ' 46' ' ' VAL . . . . . . . . . . . . . 7.4 p -121.15 126.9 75.66 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.169 0 N-CA-C 109.339 -0.615 . . . . 0.0 109.339 176.294 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' D' D ' 47' ' ' LYS . . . . . . . . . . . . . 66.3 mttm -100.31 130.12 46.38 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.166 -0.47 . . . . 0.0 111.415 179.063 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' D' D ' 48' ' ' PHE . . . . . . . . . . . . . 95.4 m-85 -112.96 131.99 55.53 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 115.97 -0.559 . . . . 0.0 109.769 176.192 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' D' D ' 49' ' ' LYS . . . . . . . . . . . . . 81.6 tttt -108.31 137.81 45.65 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.297 -0.41 . . . . 0.0 110.497 179.644 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' D' D ' 50' ' ' VAL . . . . . . . . . . . . . 46.2 t -82.41 107.05 13.94 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.287 0 N-CA-C 109.169 -0.678 . . . . 0.0 109.169 175.785 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' D' D ' 51' ' ' VAL . . . . . . . . . . . . . 46.2 t -72.15 -52.38 24.85 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.318 0 CA-C-N 116.041 -0.527 . . . . 0.0 109.683 -174.442 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' D' D ' 52' ' ' GLN . . . . . . . . . . . . . 91.6 mt-30 -152.43 151.57 30.94 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-O 121.291 0.567 . . . . 0.0 111.595 -178.011 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' D' D ' 53' ' ' ALA . . . . . . . . . . . . . . . -127.01 130.66 50.45 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 115.012 -0.995 . . . . 0.0 109.871 176.658 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' D' D ' 54' ' ' TYR . . . . . . . . . . . . . 68.2 t80 -128.66 106.78 18.74 Favored Pre-proline 0 C--N 1.327 -0.384 0 CA-C-O 118.355 -0.831 . . . . 0.0 110.248 -179.776 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' D' D ' 55' ' ' PRO . . . . . . . . . . . . . 73.3 Cg_endo -77.13 170.07 72.56 Favored 'Cis proline' 0 N--CA 1.501 1.919 0 CA-C-N 121.786 1.674 . . . . 0.0 112.631 -3.156 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' D' D ' 56' ' ' SER . . . . . . . . . . . . . 13.6 m -112.15 121.35 39.55 Favored Pre-proline 0 CA--C 1.539 0.522 0 CA-C-O 118.258 -0.877 . . . . 0.0 109.447 175.584 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' D' D ' 57' ' ' PRO . . . . . . . . . . . . . 54.3 Cg_endo -70.6 170.99 59.53 Favored 'Cis proline' 0 N--CA 1.497 1.704 0 CA-C-N 122.11 1.789 . . . . 0.0 112.109 1.35 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' D' D ' 58' ' ' LEU . . . . . . . . . . . . . 19.3 tp -130.15 137.6 50.21 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 115.885 -0.598 . . . . 0.0 110.246 -179.285 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' D' D ' 59' ' ' ARG . . . . . . . . . . . . . 32.6 ttp180 -106.77 126.74 52.69 Favored 'General case' 0 C--N 1.328 -0.338 0 N-CA-C 109.367 -0.605 . . . . 0.0 109.367 176.169 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' D' D ' 60' ' ' VAL . . . . . . . . . . . . . 47.8 t -83.35 122.4 37.51 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.239 0 C-N-CA 120.667 -0.413 . . . . 0.0 110.384 -174.544 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' D' D ' 61' ' ' GLU . . . . . . . . . . . . . 93.8 mt-10 -131.09 166.94 19.97 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-N 115.794 -0.639 . . . . 0.0 110.081 179.656 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' D' D ' 62' ' ' ASP . . . . . . . . . . . . . 81.9 m-20 -55.41 -32.91 63.05 Favored 'General case' 0 C--N 1.328 -0.363 0 C-N-CA 120.951 -0.3 . . . . 0.0 111.49 179.085 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' D' D ' 63' ' ' ARG . . . . . . . . . . . . . 7.4 ptp180 -89.49 10.13 23.92 Favored 'General case' 0 CA--C 1.535 0.389 0 N-CA-C 113.408 0.892 . . . . 0.0 113.408 -176.225 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' D' D ' 64' ' ' THR . . . . . . . . . . . . . 28.6 m -90.91 137.36 32.42 Favored 'General case' 0 C--O 1.232 0.147 0 CA-C-N 118.126 0.421 . . . . 0.0 110.24 -179.732 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' D' D ' 65' ' ' LYS . . . . . . . . . . . . . 2.2 mptp? -88.52 129.25 35.51 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 116.228 -0.442 . . . . 0.0 110.303 -178.317 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' D' D ' 66' ' ' ILE . . . . . . . . . . . . . 63.6 mt -114.68 129.93 69.95 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.298 0 N-CA-C 109.713 -0.477 . . . . 0.0 109.713 178.594 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' D' D ' 67' ' ' THR . . . . . . . . . . . . . 26.7 m -121.73 136.68 54.94 Favored 'General case' 0 C--N 1.33 -0.239 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.536 -179.22 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' D' D ' 68' ' ' LEU . . . . . . . . . . . . . 19.1 tp -105.2 124.75 50.06 Favored 'General case' 0 C--N 1.33 -0.283 0 CA-C-N 115.936 -0.574 . . . . 0.0 110.218 178.819 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' D' D ' 69' ' ' VAL . . . . . . . . . . . . . 46.8 t -100.88 112.18 32.91 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.323 0 N-CA-C 109.757 -0.46 . . . . 0.0 109.757 179.44 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' D' D ' 70' ' ' THR . . . . . . . . . . . . . 7.1 m -150.16 -35.91 0.16 Allowed 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.067 -0.515 . . . . 0.0 111.369 -179.236 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' D' D ' 71' ' ' HIS . . . . . . . . . . . . . 50.6 t-80 -110.12 89.79 8.77 Favored Pre-proline 0 C--N 1.331 -0.203 0 CA-C-N 116.689 -0.232 . . . . 0.0 111.333 -175.593 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' D' D ' 72' ' ' PRO . . . . . . . . . . . . . 71.8 Cg_endo -80.66 -30.19 1.96 Allowed 'Trans proline' 0 N--CA 1.495 1.596 0 C-N-CA 121.364 1.376 . . . . 0.0 111.997 172.555 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' D' D ' 73' ' ' VAL . . . . . . . . . . . . . 30.2 m -145.45 171.41 5.27 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.308 0 N-CA-C 109.566 -0.531 . . . . 0.0 109.566 175.787 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' D' D ' 74' ' ' ASP . . . . . . . . . . . . . 33.2 t0 -96.06 115.04 26.83 Favored 'General case' 0 C--N 1.329 -0.314 0 N-CA-C 109.82 -0.437 . . . . 0.0 109.82 179.384 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' D' D ' 75' ' ' VAL . . . . . . . . . . . . . 40.0 t -113.42 123.76 69.39 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.206 0 CA-C-O 121.069 0.461 . . . . 0.0 110.24 -178.721 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' D' D ' 76' ' ' LEU . . . . . . . . . . . . . 22.0 mt -126.26 140.42 52.54 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 115.706 -0.679 . . . . 0.0 109.782 179.05 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' D' D ' 77' ' ' GLU . . . . . . . . . . . . . 97.2 mt-10 -133.21 134.39 44.0 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-O 121.018 0.437 . . . . 0.0 111.242 -178.635 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' D' D ' 78' ' ' ALA . . . . . . . . . . . . . . . -124.63 132.82 53.4 Favored 'General case' 0 C--N 1.331 -0.202 0 CA-C-N 115.766 -0.652 . . . . 0.0 109.936 177.026 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' D' D ' 79' ' ' LYS . . . . . . . . . . . . . 98.3 mttt -77.85 119.01 20.73 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-O 120.948 0.404 . . . . 0.0 110.924 -177.673 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' D' D ' 80' ' ' ILE . . . . . . . . . . . . . 41.3 mm -139.17 110.56 4.99 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.271 0 N-CA-C 109.034 -0.728 . . . . 0.0 109.034 -177.839 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' D' D ' 81' ' ' LYS . . . . . . . . . . . . . 84.3 mttt -104.16 127.0 51.73 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-O 120.765 0.316 . . . . 0.0 111.213 -177.023 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' D' D ' 82' ' ' GLY . . . . . . . . . . . . . . . 88.21 42.2 5.98 Favored Glycine 0 CA--C 1.525 0.667 0 C-N-CA 120.621 -0.8 . . . . 0.0 111.857 173.807 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' D' D ' 83' ' ' ILE . . . . . . . . . . . . . 73.1 mt -71.01 134.27 30.31 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.323 0 N-CA-C 109.858 -0.423 . . . . 0.0 109.858 178.093 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' D' D ' 84' ' ' LYS . . . . . . . . . . . . . 53.3 tttp -89.18 -53.43 4.57 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.09 -0.505 . . . . 0.0 110.063 -179.504 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' D' D ' 85' ' ' ASP . . . . . . . . . . . . . 13.2 t70 -151.52 149.52 29.31 Favored 'General case' 0 C--N 1.327 -0.396 0 CA-C-N 115.671 -0.695 . . . . 0.0 110.529 -179.033 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' D' D ' 86' ' ' VAL . . . . . . . . . . . . . 41.0 t -127.48 128.32 69.72 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.242 0 CA-C-O 120.848 0.356 . . . . 0.0 110.069 178.971 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' D' D ' 87' ' ' ILE . . . . . . . . . . . . . 44.5 mm -116.73 126.38 74.15 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.253 0 N-CA-C 109.582 -0.525 . . . . 0.0 109.582 177.452 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' D' D ' 88' ' ' LEU . . . . . . . . . . . . . 13.0 tp -111.89 133.27 54.19 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-O 121.099 0.476 . . . . 0.0 111.108 -176.864 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' D' D ' 89' ' ' ASP . . . . . . . . . . . . . 12.3 t70 -127.34 158.15 38.03 Favored 'General case' 0 C--N 1.331 -0.23 0 CA-C-N 115.705 -0.679 . . . . 0.0 109.424 176.021 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' D' D ' 90' ' ' GLU . . . . . . . . . . . . . 96.4 mt-10 -46.94 -39.46 12.38 Favored 'General case' 0 C--N 1.33 -0.261 0 N-CA-C 113.066 0.765 . . . . 0.0 113.066 -171.342 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' D' D ' 91' ' ' ASN . . . . . . . . . . . . . 87.1 m-20 -132.04 26.05 4.58 Favored 'General case' 0 N--CA 1.467 0.424 0 N-CA-C 112.631 0.604 . . . . 0.0 112.631 -177.742 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' D' D ' 92' ' ' LEU . . . . . . . . . . . . . 10.2 mt -151.37 144.26 24.49 Favored 'General case' 0 C--N 1.329 -0.285 0 N-CA-C 109.962 -0.384 . . . . 0.0 109.962 -177.706 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' D' D ' 93' ' ' ILE . . . . . . . . . . . . . 70.9 mt -126.92 117.72 48.53 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 N-CA-C 109.241 -0.652 . . . . 0.0 109.241 178.133 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' D' D ' 94' ' ' VAL . . . . . . . . . . . . . 44.3 t -118.99 125.71 74.73 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.271 0 N-CA-C 109.77 -0.455 . . . . 0.0 109.77 -178.832 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' D' D ' 95' ' ' VAL . . . . . . . . . . . . . 45.3 t -121.04 132.8 69.59 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.294 0 CA-C-N 115.949 -0.568 . . . . 0.0 109.79 -179.411 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' D' D ' 96' ' ' ILE . . . . . . . . . . . . . 63.2 mt -113.35 125.12 70.57 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.325 0 N-CA-C 109.114 -0.698 . . . . 0.0 109.114 178.72 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' D' D ' 97' ' ' THR . . . . . . . . . . . . . 69.2 p -99.49 157.34 16.5 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-O 121.315 0.579 . . . . 0.0 111.312 -176.471 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' D' D ' 98' ' ' GLU . . . . . . . . . . . . . 78.2 tt0 -53.89 -24.37 15.82 Favored 'General case' 0 CA--C 1.534 0.364 0 CA-C-N 115.953 -0.567 . . . . 0.0 112.245 178.846 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' D' D ' 99' ' ' GLU . . . . . . . . . . . . . 36.1 tt0 -78.4 13.7 1.47 Allowed 'General case' 0 CA--C 1.54 0.586 0 N-CA-C 112.684 0.624 . . . . 0.0 112.684 -177.438 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' D' D ' 100' ' ' ASN . . . . . . . . . . . . . 3.2 m-20 61.32 38.02 16.65 Favored 'General case' 0 CA--C 1.53 0.175 0 O-C-N 121.871 -0.518 . . . . 0.0 110.974 179.651 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' D' D ' 101' ' ' GLU . . . . . . . . . . . . . 84.4 tt0 -118.79 143.94 46.61 Favored 'General case' 0 C--N 1.331 -0.2 0 CA-C-N 115.947 -0.57 . . . . 0.0 109.72 176.932 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' D' D ' 102' ' ' VAL . . . . . . . . . . . . . 47.4 t -115.0 124.65 71.87 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.323 0 CA-C-N 116.251 -0.432 . . . . 0.0 109.863 -178.537 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' D' D ' 103' ' ' LEU . . . . . . . . . . . . . 69.5 mt -114.13 129.89 56.61 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 115.842 -0.617 . . . . 0.0 109.971 176.823 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' D' D ' 104' ' ' ILE . . . . . . . . . . . . . 66.7 mt -120.0 119.47 60.25 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.225 0 N-CA-C 110.087 -0.338 . . . . 0.0 110.087 -178.028 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' D' D ' 105' ' ' PHE . . . . . . . . . . . . . 54.2 m-85 -121.42 162.77 19.85 Favored 'General case' 0 C--N 1.331 -0.219 0 O-C-N 123.998 0.811 . . . . 0.0 109.661 179.959 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' D' D ' 106' ' ' ASN . . . . . . . . . . . . . 41.1 p-10 -95.52 -169.99 2.07 Favored 'General case' 0 C--N 1.33 -0.272 0 N-CA-C 109.782 -0.451 . . . . 0.0 109.782 173.2 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' D' D ' 107' ' ' GLN . . . . . . . . . . . . . 45.1 tt0 -58.64 -30.04 66.99 Favored 'General case' 0 C--N 1.329 -0.313 0 N-CA-C 111.847 0.314 . . . . 0.0 111.847 178.951 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' D' D ' 108' ' ' ASN . . . . . . . . . . . . . 21.1 t-20 -84.17 6.61 21.85 Favored 'General case' 0 CA--C 1.536 0.425 0 N-CA-C 113.339 0.866 . . . . 0.0 113.339 -176.68 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' D' D ' 109' ' ' LEU . . . . . . . . . . . . . 11.6 tp 62.23 37.71 13.98 Favored 'General case' 0 CA--C 1.531 0.219 0 CA-C-O 121.013 0.435 . . . . 0.0 111.196 178.456 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' D' D ' 110' ' ' GLU . . . . . . . . . . . . . 42.9 mt-10 -107.26 151.49 25.39 Favored 'General case' 0 C--N 1.33 -0.273 0 N-CA-C 109.859 -0.423 . . . . 0.0 109.859 176.016 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' D' D ' 111' ' ' GLU . . . . . . . . . . . . . 97.7 mt-10 -79.02 121.94 25.56 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-O 121.008 0.432 . . . . 0.0 111.136 -178.575 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' D' D ' 112' ' ' LEU . . . . . . . . . . . . . 29.9 mt -106.92 -45.9 4.06 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 115.888 -0.596 . . . . 0.0 109.811 175.468 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' D' D ' 113' ' ' TYR . . . . . . . . . . . . . 53.4 t80 -141.23 142.92 33.92 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 115.858 -0.61 . . . . 0.0 110.381 179.485 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' D' D ' 114' ' ' ARG . . . . . . . . . . . . . 35.6 ptt-85 -150.58 124.06 9.01 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-O 121.128 0.49 . . . . 0.0 110.841 177.316 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' D' D ' 115' ' ' GLY . . . . . . . . . . . . . . . -150.19 163.0 29.39 Favored Glycine 0 CA--C 1.525 0.673 0 N-CA-C 111.076 -0.81 . . . . 0.0 111.076 -179.417 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' D' D ' 116' ' ' LYS . . . . . . . . . . . . . 34.0 ttpt -131.03 134.55 46.78 Favored 'General case' 0 C--N 1.33 -0.265 0 N-CA-C 109.846 -0.428 . . . . 0.0 109.846 177.717 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' D' D ' 117' ' ' PHE . . . . . . . . . . . . . 26.3 m-85 -133.07 120.44 21.31 Favored 'General case' 0 C--N 1.331 -0.218 0 CA-C-O 120.894 0.378 . . . . 0.0 110.232 -174.915 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' D' D ' 118' ' ' GLU . . . . . . . . . . . . . 46.4 tp10 -51.52 -52.08 49.84 Favored 'General case' 0 C--N 1.328 -0.351 0 N-CA-C 112.01 0.374 . . . . 0.0 112.01 -174.757 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' D' D ' 119' ' ' ASN . . . . . . . . . . . . . 3.3 p30 -100.06 31.28 3.38 Favored 'General case' 0 C--N 1.33 -0.265 0 N-CA-C 112.173 0.434 . . . . 0.0 112.173 -173.735 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' D' D ' 120' ' ' LEU . . . . . . . . . . . . . 14.1 tp -52.92 125.95 18.76 Favored 'General case' 0 N--CA 1.464 0.229 0 O-C-N 122.343 -0.223 . . . . 0.0 110.985 178.263 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' D' D ' 121' ' ' ASN . . . . . . . . . . . . . 4.3 t-20 -113.96 -44.15 3.19 Favored 'General case' 0 C--N 1.331 -0.229 0 C-N-CA 121.129 -0.229 . . . . 0.0 111.218 -176.839 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' D' D ' 122' ' ' LYS . . . . . . . . . . . . . 49.3 mttm -141.98 146.91 36.14 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-O 120.983 0.42 . . . . 0.0 111.908 -177.309 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' D' D ' 123' ' ' VAL . . . . . . . . . . . . . 43.7 t -130.44 123.28 55.01 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.261 0 N-CA-C 109.22 -0.659 . . . . 0.0 109.22 173.106 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' D' D ' 124' ' ' LEU . . . . . . . . . . . . . 6.2 mp -122.97 139.31 54.21 Favored 'General case' 0 C--N 1.332 -0.173 0 CA-C-O 120.93 0.395 . . . . 0.0 111.222 -175.763 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' D' D ' 125' ' ' VAL . . . . . . . . . . . . . 11.0 p -133.15 131.99 58.52 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.194 0 CA-C-N 115.921 -0.581 . . . . 0.0 110.239 178.182 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' D' D ' 126' ' ' ARG . . . . . . . . . . . . . 55.9 mtp180 -144.49 120.91 10.98 Favored 'General case' 0 C--N 1.331 -0.23 0 CA-C-N 116.482 -0.326 . . . . 0.0 110.947 179.012 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' D' D ' 127' ' ' ASN . . . . . . . . . . . . . 30.8 m120 49.96 -105.97 0.2 Allowed 'General case' 0 CA--C 1.543 0.696 0 CA-C-O 119.043 -0.503 . . . . 0.0 111.546 178.537 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' D' D ' 128' ' ' ASP . . . . . . . . . . . . . 12.0 p-10 -114.06 4.76 15.79 Favored 'General case' 0 N--CA 1.468 0.456 0 CA-C-N 119.684 1.129 . . . . 0.0 113.372 -178.455 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' D' D ' 129' ' ' LEU . . . . . . . . . . . . . 11.4 tp -106.01 131.27 53.5 Favored 'General case' 0 C--N 1.332 -0.19 0 N-CA-C 109.867 -0.42 . . . . 0.0 109.867 178.845 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' D' D ' 130' ' ' VAL . . . . . . . . . . . . . 44.1 t -119.23 134.06 64.06 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.283 0 N-CA-C 109.603 -0.517 . . . . 0.0 109.603 178.77 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' D' D ' 131' ' ' VAL . . . . . . . . . . . . . 40.4 t -136.06 135.22 50.38 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.246 0 CA-C-O 121.054 0.454 . . . . 0.0 110.504 -178.948 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' D' D ' 132' ' ' ILE . . . . . . . . . . . . . 68.4 mt -115.69 133.39 62.22 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.271 0 CA-C-N 115.75 -0.659 . . . . 0.0 109.24 177.317 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' D' D ' 133' ' ' ILE . . . . . . . . . . . . . 36.9 mm -116.67 120.69 65.76 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.308 0 CA-C-N 116.356 -0.384 . . . . 0.0 110.743 -174.093 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' D' D ' 134' ' ' ASP . . . . . . . . . . . . . 18.9 p-10 -138.93 150.87 46.4 Favored 'General case' 0 C--N 1.331 -0.202 0 N-CA-C 109.821 -0.437 . . . . 0.0 109.821 173.682 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' D' D ' 135' ' ' GLU . . . . . . . . . . . . . 39.8 tp10 -50.07 -25.92 3.91 Favored 'General case' 0 C--N 1.328 -0.356 0 N-CA-C 113.389 0.885 . . . . 0.0 113.389 -168.375 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' D' D ' 136' ' ' GLN . . . . . . . . . . . . . 20.5 pt20 -99.02 -18.15 17.91 Favored 'General case' 0 N--CA 1.464 0.262 0 N-CA-C 113.566 0.95 . . . . 0.0 113.566 -172.356 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' D' D ' 137' ' ' LYS . . . . . . . . . . . . . 54.6 pttt -161.61 166.73 26.44 Favored 'General case' 0 C--O 1.233 0.193 0 CA-C-O 121.999 0.904 . . . . 0.0 113.344 -175.146 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' D' D ' 138' ' ' LEU . . . . . . . . . . . . . 12.2 tp -117.1 125.73 51.73 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 114.143 -1.389 . . . . 0.0 109.345 176.043 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' D' D ' 139' ' ' THR . . . . . . . . . . . . . 19.4 m -108.41 123.19 48.47 Favored 'General case' 0 C--N 1.331 -0.209 0 CA-C-O 120.705 0.288 . . . . 0.0 110.485 179.289 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' D' D ' 140' ' ' LEU . . . . . . . . . . . . . 7.6 tt -112.81 120.74 42.51 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 115.568 -0.742 . . . . 0.0 109.136 -179.09 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' D' D ' 141' ' ' ILE . . . . . . . . . . . . . 19.3 mt -120.91 120.24 61.76 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.367 0 CA-C-O 121.007 0.432 . . . . 0.0 109.953 -176.152 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' D' D ' 142' ' ' ARG . . . . . . . . . . . . . 71.5 ttt180 -106.89 120.28 41.61 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 115.332 -0.849 . . . . 0.0 110.188 -179.778 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' D' D ' 143' ' ' THR . . . . . . . . . . . . . 73.2 p . . . . . 0 C--O 1.22 -0.469 0 CA-C-O 118.011 -0.995 . . . . 0.0 110.63 -179.295 . . . . . . . . 0 0 . 1 . 014 nuclear orig full ' E' E ' -3' ' ' GLU . . . . . . . . . . . . . 45.8 tp10 . . . . . 0 N--CA 1.491 1.593 0 N-CA-C 109.361 -0.607 . . . . 0.0 109.361 . . . . . . . . . 0 0 . 1 . 014 nuclear orig full ' E' E ' -2' ' ' GLY . . . . . . . . . . . . . . . -64.38 148.39 51.08 Favored Glycine 0 CA--C 1.525 0.692 0 N-CA-C 110.803 -0.919 . . . . 0.0 110.803 179.94 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' E' E ' -1' ' ' VAL . . . . . . . . . . . . . 43.2 t -96.38 138.24 22.18 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.309 0 N-CA-C 110.158 -0.312 . . . . 0.0 110.158 -179.197 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' E' E ' 0' ' ' ILE . . . . . . . . . . . . . 70.1 mt -106.16 125.56 61.78 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 N-CA-C 109.664 -0.495 . . . . 0.0 109.664 178.605 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' E' E ' 1' ' ' MET . . . . . . . . . . . . . 24.4 ptp -91.68 131.09 37.32 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.064 -0.516 . . . . 0.0 110.557 -179.491 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' E' E ' 2' ' ' SER . . . . . . . . . . . . . 6.4 p -122.9 136.65 54.94 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-O 121.038 0.447 . . . . 0.0 110.961 -178.378 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' E' E ' 3' ' ' GLU . . . . . . . . . . . . . 83.5 tt0 -141.27 142.18 33.91 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 115.804 -0.634 . . . . 0.0 110.893 179.946 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' E' E ' 4' ' ' LEU . . . . . . . . . . . . . 3.6 tt -123.44 123.32 40.4 Favored 'General case' 0 C--N 1.33 -0.251 0 N-CA-C 109.702 -0.481 . . . . 0.0 109.702 177.978 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' E' E ' 5' ' ' LYS . . . . . . . . . . . . . 49.1 mtmt -103.31 119.62 39.21 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.205 -0.452 . . . . 0.0 111.035 -179.263 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' E' E ' 6' ' ' LEU . . . . . . . . . . . . . 15.1 mt -116.01 153.36 31.8 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 115.731 -0.668 . . . . 0.0 110.585 178.768 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' E' E ' 7' ' ' LYS . . . . . . . . . . . . . 59.5 tttp -135.02 136.89 25.86 Favored Pre-proline 0 CA--C 1.534 0.35 0 CA-C-O 119.047 -0.502 . . . . 0.0 109.987 174.609 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' E' E ' 8' ' ' PRO . . . . . . . . . . . . . 88.5 Cg_endo -91.4 137.58 2.07 Favored 'Trans proline' 0 N--CA 1.49 1.287 0 C-N-CA 121.76 1.64 . . . . 0.0 111.366 178.119 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' E' E ' 9' ' ' LEU . . . . . . . . . . . . . 27.0 mt -83.03 -47.66 0.81 Allowed Pre-proline 0 CA--C 1.533 0.309 0 CA-C-O 118.743 -0.646 . . . . 0.0 112.429 -177.133 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' E' E ' 10' ' ' PRO . . . . . . . . . . . . . 62.8 Cg_endo -83.75 156.22 13.73 Favored 'Trans proline' 0 N--CA 1.495 1.609 0 C-N-CA 121.39 1.393 . . . . 0.0 112.151 177.115 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' E' E ' 11' ' ' LYS . . . . . . . . . . . . . 20.2 pttp -78.93 116.59 19.34 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-O 121.286 0.565 . . . . 0.0 110.286 175.523 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' E' E ' 12' ' ' VAL . . . . . . . . . . . . . 12.6 p -150.65 151.99 11.95 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.28 0 CA-C-N 115.779 -0.646 . . . . 0.0 110.756 -177.192 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' E' E ' 13' ' ' GLU . . . . . . . . . . . . . 13.0 pt-20 -91.88 130.95 37.54 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.555 178.394 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' E' E ' 14' ' ' LEU . . . . . . . . . . . . . 31.4 mt -99.87 130.69 25.89 Favored Pre-proline 0 CA--C 1.536 0.437 0 CA-C-O 118.715 -0.66 . . . . 0.0 110.621 -178.341 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' E' E ' 15' ' ' PRO . . . . . . . . . . . . . 23.0 Cg_exo -65.1 161.16 38.35 Favored 'Trans proline' 0 N--CA 1.499 1.842 0 C-N-CA 121.301 1.334 . . . . 0.0 111.893 175.826 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' E' E ' 16' ' ' PRO . . . . . . . . . . . . . 30.4 Cg_exo -59.96 -32.94 95.79 Favored 'Trans proline' 0 N--CA 1.496 1.627 0 C-N-CA 121.442 1.428 . . . . 0.0 112.635 -179.096 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' E' E ' 17' ' ' ASP . . . . . . . . . . . . . 11.3 p-10 -91.13 14.44 14.16 Favored 'General case' 0 CA--C 1.535 0.38 0 N-CA-C 112.989 0.737 . . . . 0.0 112.989 -178.412 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' E' E ' 18' ' ' PHE . . . . . . . . . . . . . 47.8 t80 -55.82 -49.13 74.11 Favored 'General case' 0 C--N 1.334 -0.076 0 O-C-N 121.977 -0.452 . . . . 0.0 110.7 -177.839 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' E' E ' 19' ' ' VAL . . . . . . . . . . . . . 47.5 t -55.77 -42.33 69.6 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.304 0 CA-C-N 116.578 -0.283 . . . . 0.0 110.723 -176.703 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' E' E ' 20' ' ' ASP . . . . . . . . . . . . . 60.5 m-20 -60.12 -43.03 95.95 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-O 120.849 0.357 . . . . 0.0 110.922 -177.85 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' E' E ' 21' ' ' VAL . . . . . . . . . . . . . 44.9 t -64.98 -47.54 87.69 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.306 0 C-N-CA 120.718 -0.393 . . . . 0.0 110.415 -178.036 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' E' E ' 22' ' ' ILE . . . . . . . . . . . . . 50.2 mm -55.71 -58.72 3.92 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.263 0 C-N-CA 120.92 -0.312 . . . . 0.0 111.108 -178.3 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' E' E ' 23' ' ' ARG . . . . . . . . . . . . . 7.5 ptm180 -56.48 -43.44 79.63 Favored 'General case' 0 C--N 1.332 -0.177 0 C-N-CA 120.618 -0.433 . . . . 0.0 111.859 -173.783 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' E' E ' 24' ' ' ILE . . . . . . . . . . . . . 78.0 mt -60.79 -43.68 95.88 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.293 0 C-N-CA 120.996 -0.281 . . . . 0.0 111.588 -176.682 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' E' E ' 25' ' ' LYS . . . . . . . . . . . . . 98.3 mttt -71.07 -40.73 71.42 Favored 'General case' 0 C--N 1.329 -0.299 0 N-CA-C 112.421 0.526 . . . . 0.0 112.421 -178.365 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' E' E ' 26' ' ' LEU . . . . . . . . . . . . . 77.1 mt -80.31 -32.59 37.98 Favored 'General case' 0 C--N 1.329 -0.289 0 N-CA-C 113.708 1.003 . . . . 0.0 113.708 -170.859 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' E' E ' 27' ' ' GLN . . . . . . . . . . . . . 9.8 pt20 -47.41 142.13 4.38 Favored 'General case' 0 N--CA 1.469 0.516 0 N-CA-C 112.602 0.593 . . . . 0.0 112.602 -175.61 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' E' E ' 28' ' ' GLY . . . . . . . . . . . . . . . 99.02 -22.17 42.27 Favored Glycine 0 CA--C 1.532 1.149 0 CA-C-N 115.63 -0.714 . . . . 0.0 112.561 -177.494 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' E' E ' 29' ' ' LYS . . . . . . . . . . . . . 28.5 mmtp -96.5 154.97 16.97 Favored 'General case' 0 C--O 1.231 0.122 0 CA-C-N 117.734 0.767 . . . . 0.0 110.846 178.424 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' E' E ' 30' ' ' THR . . . . . . . . . . . . . 41.2 m -110.13 138.64 46.22 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-N 115.803 -0.635 . . . . 0.0 110.307 178.446 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' E' E ' 31' ' ' VAL . . . . . . . . . . . . . 34.7 m -133.4 159.33 42.9 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.247 0 CA-C-N 116.233 -0.44 . . . . 0.0 111.026 -179.159 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' E' E ' 32' ' ' ARG . . . . . . . . . . . . . 77.8 mtp180 -131.98 153.34 50.43 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 115.874 -0.603 . . . . 0.0 110.424 176.408 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' E' E ' 33' ' ' THR . . . . . . . . . . . . . 30.6 m -53.1 139.68 27.8 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.37 -0.377 . . . . 0.0 111.395 -177.915 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' E' E ' 34' ' ' GLY . . . . . . . . . . . . . . . 99.39 -17.14 58.2 Favored Glycine 0 CA--C 1.532 1.153 0 CA-C-O 119.601 -0.555 . . . . 0.0 113.274 178.157 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' E' E ' 35' ' ' ASP . . . . . . . . . . . . . 74.2 m-20 -65.37 148.08 52.33 Favored 'General case' 0 N--CA 1.461 0.112 0 CA-C-N 118.043 0.921 . . . . 0.0 111.211 179.318 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' E' E ' 36' ' ' VAL . . . . . . . . . . . . . 44.4 t -119.61 129.59 75.15 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 CA-C-N 115.649 -0.705 . . . . 0.0 109.705 178.875 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' E' E ' 37' ' ' ILE . . . . . . . . . . . . . 68.9 mt -121.17 139.03 49.62 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.29 0 CA-C-N 116.272 -0.422 . . . . 0.0 109.971 -179.374 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' E' E ' 38' ' ' GLY . . . . . . . . . . . . . . . -112.19 128.7 8.67 Favored Glycine 0 CA--C 1.525 0.701 0 N-CA-C 110.502 -1.039 . . . . 0.0 110.502 177.698 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' E' E ' 39' ' ' ILE . . . . . . . . . . . . . 72.1 mt -123.1 133.42 69.14 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.279 0 N-CA-C 109.944 -0.391 . . . . 0.0 109.944 -179.522 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' E' E ' 40' ' ' SER . . . . . . . . . . . . . 43.2 t -93.44 120.62 33.93 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.444 -0.344 . . . . 0.0 110.949 176.281 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' E' E ' 41' ' ' ILE . . . . . . . . . . . . . 73.6 mt -122.47 114.79 43.89 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.195 0 CA-C-O 120.955 0.407 . . . . 0.0 110.104 177.856 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' E' E ' 42' ' ' LEU . . . . . . . . . . . . . 1.3 tt 51.01 44.18 28.68 Favored 'General case' 0 CA--C 1.532 0.274 0 CA-C-O 121.479 0.656 . . . . 0.0 110.829 177.866 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' E' E ' 43' ' ' GLY . . . . . . . . . . . . . . . 71.26 27.8 71.07 Favored Glycine 0 CA--C 1.531 1.084 0 C-N-CA 121.113 -0.565 . . . . 0.0 112.392 176.095 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' E' E ' 44' ' ' LYS . . . . . . . . . . . . . 61.2 tttm -133.9 129.88 36.99 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-N 117.188 0.494 . . . . 0.0 109.952 178.8 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' E' E ' 45' ' ' GLU . . . . . . . . . . . . . 82.6 tt0 -83.35 122.92 29.11 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-O 120.873 0.368 . . . . 0.0 111.274 -177.008 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' E' E ' 46' ' ' VAL . . . . . . . . . . . . . 7.4 p -122.53 128.41 75.36 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.228 0 N-CA-C 109.441 -0.577 . . . . 0.0 109.441 175.213 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' E' E ' 47' ' ' LYS . . . . . . . . . . . . . 62.5 mtpt -100.56 133.14 45.43 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 115.992 -0.549 . . . . 0.0 111.262 179.943 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' E' E ' 48' ' ' PHE . . . . . . . . . . . . . 96.0 m-85 -120.47 132.06 55.04 Favored 'General case' 0 C--N 1.331 -0.219 0 CA-C-N 116.102 -0.499 . . . . 0.0 110.075 176.897 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' E' E ' 49' ' ' LYS . . . . . . . . . . . . . 60.6 tttm -106.32 137.73 43.76 Favored 'General case' 0 C--O 1.233 0.202 0 CA-C-N 116.504 -0.316 . . . . 0.0 110.418 178.076 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' E' E ' 50' ' ' VAL . . . . . . . . . . . . . 44.0 t -80.45 105.22 9.9 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.279 0 N-CA-C 109.133 -0.692 . . . . 0.0 109.133 175.101 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' E' E ' 51' ' ' VAL . . . . . . . . . . . . . 48.0 t -70.18 -49.32 55.87 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.35 0 CA-C-N 115.956 -0.566 . . . . 0.0 109.968 -174.057 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' E' E ' 52' ' ' GLN . . . . . . . . . . . . . 60.0 tt0 -163.31 140.09 7.25 Favored 'General case' 0 C--N 1.332 -0.183 0 C-N-CA 120.179 -0.608 . . . . 0.0 111.681 -179.185 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' E' E ' 53' ' ' ALA . . . . . . . . . . . . . . . -113.64 130.96 56.31 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 115.821 -0.627 . . . . 0.0 109.907 176.238 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' E' E ' 54' ' ' TYR . . . . . . . . . . . . . 65.1 t80 -129.08 109.98 18.19 Favored Pre-proline 0 CA--C 1.535 0.385 0 CA-C-O 118.274 -0.869 . . . . 0.0 110.207 179.588 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' E' E ' 55' ' ' PRO . . . . . . . . . . . . . 73.4 Cg_endo -77.18 170.1 72.43 Favored 'Cis proline' 0 N--CA 1.499 1.838 0 CA-C-N 121.948 1.731 . . . . 0.0 112.541 -3.918 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' E' E ' 56' ' ' SER . . . . . . . . . . . . . 13.4 m -115.12 128.97 25.46 Favored Pre-proline 0 CA--C 1.539 0.546 0 CA-C-O 118.356 -0.83 . . . . 0.0 109.315 175.412 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' E' E ' 57' ' ' PRO . . . . . . . . . . . . . 44.3 Cg_endo -68.27 166.56 68.16 Favored 'Cis proline' 0 N--CA 1.497 1.722 0 CA-C-N 122.037 1.763 . . . . 0.0 111.576 0.407 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' E' E ' 58' ' ' LEU . . . . . . . . . . . . . 23.3 tp -129.84 138.57 51.06 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-O 121.022 0.439 . . . . 0.0 110.417 -179.148 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' E' E ' 59' ' ' ARG . . . . . . . . . . . . . 55.3 ttp180 -107.1 130.16 54.72 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 115.632 -0.713 . . . . 0.0 109.51 176.969 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' E' E ' 60' ' ' VAL . . . . . . . . . . . . . 43.7 t -77.74 119.9 27.35 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.252 0 C-N-CA 120.74 -0.384 . . . . 0.0 110.266 -177.079 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' E' E ' 61' ' ' GLU . . . . . . . . . . . . . 43.0 mt-10 -130.95 155.06 47.43 Favored 'General case' 0 C--N 1.331 -0.213 0 CA-C-N 115.944 -0.571 . . . . 0.0 110.528 179.148 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' E' E ' 62' ' ' ASP . . . . . . . . . . . . . 28.6 m-20 -54.61 -32.99 59.73 Favored 'General case' 0 C--N 1.326 -0.429 0 CA-C-N 116.491 -0.322 . . . . 0.0 111.777 179.683 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' E' E ' 63' ' ' ARG . . . . . . . . . . . . . 9.3 ptm180 -88.96 7.66 33.5 Favored 'General case' 0 CA--C 1.536 0.441 0 N-CA-C 113.652 0.982 . . . . 0.0 113.652 -175.082 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' E' E ' 64' ' ' THR . . . . . . . . . . . . . 23.3 m -89.51 146.15 24.81 Favored 'General case' 0 C--N 1.331 -0.196 0 CA-C-N 118.066 0.394 . . . . 0.0 110.319 179.648 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' E' E ' 65' ' ' LYS . . . . . . . . . . . . . 94.7 mttt -84.74 121.82 28.22 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-O 120.841 0.353 . . . . 0.0 110.211 179.914 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' E' E ' 66' ' ' ILE . . . . . . . . . . . . . 58.1 mt -112.52 122.53 66.91 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.263 0 N-CA-C 109.237 -0.653 . . . . 0.0 109.237 179.648 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' E' E ' 67' ' ' THR . . . . . . . . . . . . . 9.6 m -129.95 143.41 50.78 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-O 121.127 0.489 . . . . 0.0 111.679 -172.911 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' E' E ' 68' ' ' LEU . . . . . . . . . . . . . 7.9 mp -94.57 133.18 38.48 Favored 'General case' 0 C--N 1.331 -0.239 0 CA-C-N 115.799 -0.637 . . . . 0.0 109.631 173.859 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' E' E ' 69' ' ' VAL . . . . . . . . . . . . . 41.8 t -90.59 119.18 37.28 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.342 0 CA-C-O 121.034 0.445 . . . . 0.0 110.764 -176.864 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' E' E ' 70' ' ' THR . . . . . . . . . . . . . 28.5 m -150.04 111.36 4.43 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 115.782 -0.645 . . . . 0.0 109.931 175.793 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' E' E ' 71' ' ' HIS . . . . . . . . . . . . . 97.5 m-70 -150.03 160.48 33.45 Favored Pre-proline 0 C--N 1.33 -0.264 0 C-N-CA 120.758 -0.377 . . . . 0.0 111.187 -177.844 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' E' E ' 72' ' ' PRO . . . . . . . . . . . . . 76.1 Cg_endo -87.37 158.19 8.12 Favored 'Trans proline' 0 N--CA 1.491 1.354 0 C-N-CA 121.747 1.631 . . . . 0.0 112.183 178.312 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' E' E ' 73' ' ' VAL . . . . . . . . . . . . . 32.9 m -70.14 156.28 7.22 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.336 0 CA-C-N 116.253 -0.43 . . . . 0.0 111.226 -179.371 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' E' E ' 74' ' ' ASP . . . . . . . . . . . . . 10.6 t0 -101.07 124.11 46.28 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 115.777 -0.647 . . . . 0.0 109.882 178.366 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' E' E ' 75' ' ' VAL . . . . . . . . . . . . . 41.7 t -111.53 125.02 68.82 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.224 0 CA-C-O 121.133 0.492 . . . . 0.0 110.622 -178.111 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' E' E ' 76' ' ' LEU . . . . . . . . . . . . . 42.5 mt -121.28 143.45 49.16 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 115.593 -0.731 . . . . 0.0 109.6 177.22 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' E' E ' 77' ' ' GLU . . . . . . . . . . . . . 97.9 mt-10 -136.47 134.66 37.88 Favored 'General case' 0 C--N 1.331 -0.201 0 CA-C-O 120.996 0.427 . . . . 0.0 111.462 -178.662 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' E' E ' 78' ' ' ALA . . . . . . . . . . . . . . . -121.86 137.11 54.91 Favored 'General case' 0 C--N 1.331 -0.206 0 CA-C-N 115.728 -0.669 . . . . 0.0 109.751 175.738 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' E' E ' 79' ' ' LYS . . . . . . . . . . . . . 61.5 mtpt -84.49 120.73 26.66 Favored 'General case' 0 C--N 1.331 -0.219 0 CA-C-O 120.884 0.373 . . . . 0.0 110.831 -178.166 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' E' E ' 80' ' ' ILE . . . . . . . . . . . . . 22.6 mm -139.16 124.84 22.38 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.231 0 CA-C-N 115.937 -0.574 . . . . 0.0 109.688 -177.235 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' E' E ' 81' ' ' LYS . . . . . . . . . . . . . 64.8 mmtt -110.22 123.85 50.54 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-O 120.837 0.351 . . . . 0.0 111.419 -179.169 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' E' E ' 82' ' ' GLY . . . . . . . . . . . . . . . 89.06 42.15 5.69 Favored Glycine 0 CA--C 1.524 0.638 0 C-N-CA 120.698 -0.763 . . . . 0.0 112.044 171.664 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' E' E ' 83' ' ' ILE . . . . . . . . . . . . . 71.9 mt -61.66 135.92 25.73 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.335 0 CA-C-O 120.958 0.408 . . . . 0.0 109.957 178.691 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' E' E ' 84' ' ' LYS . . . . . . . . . . . . . 72.7 tttt -96.54 -50.8 4.58 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 115.739 -0.664 . . . . 0.0 110.021 -179.001 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' E' E ' 85' ' ' ASP . . . . . . . . . . . . . 6.1 t0 -156.12 150.11 25.25 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 115.54 -0.755 . . . . 0.0 110.075 179.261 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' E' E ' 86' ' ' VAL . . . . . . . . . . . . . 45.7 t -129.1 129.29 67.77 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.268 0 CA-C-O 120.92 0.391 . . . . 0.0 110.315 -179.26 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' E' E ' 87' ' ' ILE . . . . . . . . . . . . . 43.1 mm -118.39 125.18 74.13 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.285 0 CA-C-N 115.99 -0.55 . . . . 0.0 109.767 176.489 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' E' E ' 88' ' ' LEU . . . . . . . . . . . . . 52.1 mt -111.04 136.03 50.67 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-O 121.078 0.466 . . . . 0.0 111.437 -178.14 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' E' E ' 89' ' ' ASP . . . . . . . . . . . . . 13.8 t70 -131.42 153.56 49.58 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 115.537 -0.756 . . . . 0.0 109.319 175.384 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' E' E ' 90' ' ' GLU . . . . . . . . . . . . . 46.2 tp10 -47.28 -39.2 14.03 Favored 'General case' 0 N--CA 1.464 0.264 0 N-CA-C 112.817 0.673 . . . . 0.0 112.817 -172.872 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' E' E ' 91' ' ' ASN . . . . . . . . . . . . . 30.2 m120 -132.11 35.51 3.71 Favored 'General case' 0 N--CA 1.464 0.258 0 C-N-CA 120.974 -0.29 . . . . 0.0 111.743 -177.336 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' E' E ' 92' ' ' LEU . . . . . . . . . . . . . 11.3 tp -166.1 145.82 6.19 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-O 120.781 0.324 . . . . 0.0 110.775 -179.835 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' E' E ' 93' ' ' ILE . . . . . . . . . . . . . 72.1 mt -130.63 125.64 59.16 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.24 0 N-CA-C 109.716 -0.475 . . . . 0.0 109.716 -179.736 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' E' E ' 94' ' ' VAL . . . . . . . . . . . . . 44.3 t -122.89 126.39 73.73 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.292 0 N-CA-C 109.722 -0.473 . . . . 0.0 109.722 178.986 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' E' E ' 95' ' ' VAL . . . . . . . . . . . . . 45.5 t -123.71 132.73 70.89 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.207 0 N-CA-C 109.915 -0.402 . . . . 0.0 109.915 -178.863 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' E' E ' 96' ' ' ILE . . . . . . . . . . . . . 56.0 mt -118.1 134.64 61.08 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.308 0 N-CA-C 109.125 -0.694 . . . . 0.0 109.125 179.51 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' E' E ' 97' ' ' THR . . . . . . . . . . . . . 58.0 p -109.86 157.29 19.36 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-O 121.357 0.599 . . . . 0.0 111.452 -177.174 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' E' E ' 98' ' ' GLU . . . . . . . . . . . . . 96.4 mt-10 -55.13 -22.1 15.56 Favored 'General case' 0 C--N 1.329 -0.306 0 N-CA-C 112.531 0.567 . . . . 0.0 112.531 179.204 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' E' E ' 99' ' ' GLU . . . . . . . . . . . . . 38.4 tt0 -78.75 14.93 1.16 Allowed 'General case' 0 CA--C 1.54 0.57 0 N-CA-C 112.52 0.563 . . . . 0.0 112.52 -178.614 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' E' E ' 100' ' ' ASN . . . . . . . . . . . . . 2.8 m-20 61.96 37.88 14.7 Favored 'General case' 0 CA--C 1.529 0.167 0 O-C-N 121.763 -0.585 . . . . 0.0 110.857 178.537 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' E' E ' 101' ' ' GLU . . . . . . . . . . . . . 84.5 tt0 -120.57 143.57 48.55 Favored 'General case' 0 C--N 1.333 -0.134 0 CA-C-N 116.051 -0.522 . . . . 0.0 109.73 177.821 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' E' E ' 102' ' ' VAL . . . . . . . . . . . . . 41.1 t -120.94 130.85 74.22 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.267 0 CA-C-N 116.313 -0.403 . . . . 0.0 110.049 -178.247 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' E' E ' 103' ' ' LEU . . . . . . . . . . . . . 5.2 mp -121.33 136.8 54.92 Favored 'General case' 0 C--N 1.331 -0.203 0 CA-C-N 115.938 -0.574 . . . . 0.0 110.486 176.456 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' E' E ' 104' ' ' ILE . . . . . . . . . . . . . 68.2 mt -117.56 122.46 69.89 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.297 0 CA-C-N 115.639 -0.71 . . . . 0.0 109.688 -179.551 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' E' E ' 105' ' ' PHE . . . . . . . . . . . . . 55.5 m-85 -123.26 165.76 16.4 Favored 'General case' 0 C--N 1.331 -0.207 0 O-C-N 123.961 0.788 . . . . 0.0 109.455 179.421 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' E' E ' 106' ' ' ASN . . . . . . . . . . . . . 44.0 p-10 -101.65 -171.84 2.05 Favored 'General case' 0 C--N 1.331 -0.225 0 N-CA-C 109.891 -0.411 . . . . 0.0 109.891 173.746 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' E' E ' 107' ' ' GLN . . . . . . . . . . . . . 43.2 tt0 -60.27 -29.88 69.09 Favored 'General case' 0 C--N 1.328 -0.347 0 N-CA-C 111.912 0.338 . . . . 0.0 111.912 179.886 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' E' E ' 108' ' ' ASN . . . . . . . . . . . . . 60.5 t30 -81.9 6.51 15.61 Favored 'General case' 0 CA--C 1.536 0.405 0 N-CA-C 113.278 0.844 . . . . 0.0 113.278 -177.944 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' E' E ' 109' ' ' LEU . . . . . . . . . . . . . 8.8 tp 62.1 36.45 15.23 Favored 'General case' 0 C--O 1.232 0.163 0 CA-C-O 120.966 0.412 . . . . 0.0 111.533 177.905 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' E' E ' 110' ' ' GLU . . . . . . . . . . . . . 70.9 mm-40 -104.26 148.63 26.12 Favored 'General case' 0 C--N 1.329 -0.315 0 N-CA-C 109.807 -0.442 . . . . 0.0 109.807 175.796 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' E' E ' 111' ' ' GLU . . . . . . . . . . . . . 77.3 tt0 -80.22 122.03 26.35 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.429 -0.351 . . . . 0.0 110.971 -176.528 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' E' E ' 112' ' ' LEU . . . . . . . . . . . . . 26.7 mt -105.02 -46.18 4.34 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 116.29 -0.414 . . . . 0.0 110.725 178.596 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' E' E ' 113' ' ' TYR . . . . . . . . . . . . . 64.5 t80 -143.75 139.8 29.61 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.353 -0.385 . . . . 0.0 111.376 -178.875 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' E' E ' 114' ' ' ARG . . . . . . . . . . . . . 60.8 ttp180 -141.07 120.89 13.49 Favored 'General case' 0 C--N 1.33 -0.239 0 CA-C-N 116.274 -0.421 . . . . 0.0 110.165 176.008 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' E' E ' 115' ' ' GLY . . . . . . . . . . . . . . . -150.01 161.7 28.96 Favored Glycine 0 CA--C 1.524 0.652 0 N-CA-C 110.898 -0.881 . . . . 0.0 110.898 178.557 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' E' E ' 116' ' ' LYS . . . . . . . . . . . . . 32.8 ttmt -128.72 139.56 52.16 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-O 120.777 0.322 . . . . 0.0 110.411 179.462 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' E' E ' 117' ' ' PHE . . . . . . . . . . . . . 43.5 m-85 -131.6 115.48 16.14 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.233 -0.44 . . . . 0.0 110.187 -176.949 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' E' E ' 118' ' ' GLU . . . . . . . . . . . . . 96.3 mt-10 -54.64 -46.5 73.95 Favored 'General case' 0 C--N 1.329 -0.299 0 C-N-CA 121.003 -0.279 . . . . 0.0 111.408 -176.004 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' E' E ' 119' ' ' ASN . . . . . . . . . . . . . 28.6 m120 -97.4 31.04 2.63 Favored 'General case' 0 C--N 1.33 -0.269 0 N-CA-C 112.318 0.488 . . . . 0.0 112.318 -174.22 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' E' E ' 120' ' ' LEU . . . . . . . . . . . . . 19.0 tp -55.43 120.82 7.73 Favored 'General case' 0 C--O 1.232 0.175 0 C-N-CA 121.197 -0.201 . . . . 0.0 110.688 178.125 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' E' E ' 121' ' ' ASN . . . . . . . . . . . . . 31.4 m120 -114.04 -44.15 3.18 Favored 'General case' 0 C--N 1.332 -0.195 0 CA-C-N 116.689 -0.232 . . . . 0.0 111.361 -177.321 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' E' E ' 122' ' ' LYS . . . . . . . . . . . . . 93.5 mttt -146.95 154.09 40.85 Favored 'General case' 0 C--N 1.331 -0.222 0 CA-C-O 121.064 0.459 . . . . 0.0 111.895 -176.313 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' E' E ' 123' ' ' VAL . . . . . . . . . . . . . 43.3 t -132.69 133.8 59.07 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.27 0 CA-C-N 115.971 -0.559 . . . . 0.0 110.089 177.142 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' E' E ' 124' ' ' LEU . . . . . . . . . . . . . 54.4 mt -124.17 134.97 53.18 Favored 'General case' 0 C--N 1.33 -0.239 0 CA-C-N 116.591 -0.277 . . . . 0.0 110.545 179.846 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' E' E ' 125' ' ' VAL . . . . . . . . . . . . . 35.4 m -134.75 135.67 53.07 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.255 0 CA-C-N 116.454 -0.339 . . . . 0.0 110.836 -179.685 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' E' E ' 126' ' ' ARG . . . . . . . . . . . . . 29.9 mtp180 -148.87 124.79 10.61 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-O 121.01 0.433 . . . . 0.0 110.974 175.925 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' E' E ' 127' ' ' ASN . . . . . . . . . . . . . 23.0 t-20 49.92 -106.52 0.22 Allowed 'General case' 0 CA--C 1.543 0.708 0 CA-C-N 116.094 -0.503 . . . . 0.0 111.544 179.066 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' E' E ' 128' ' ' ASP . . . . . . . . . . . . . 23.7 p-10 -114.01 3.26 15.26 Favored 'General case' 0 N--CA 1.467 0.413 0 CA-C-N 119.63 1.105 . . . . 0.0 113.469 -177.014 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' E' E ' 129' ' ' LEU . . . . . . . . . . . . . 15.1 tp -105.23 134.94 47.51 Favored 'General case' 0 C--N 1.334 -0.106 0 N-CA-C 109.876 -0.416 . . . . 0.0 109.876 179.182 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' E' E ' 130' ' ' VAL . . . . . . . . . . . . . 44.6 t -124.29 135.58 63.26 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.246 0 N-CA-C 109.925 -0.398 . . . . 0.0 109.925 -179.532 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' E' E ' 131' ' ' VAL . . . . . . . . . . . . . 43.4 t -134.01 133.94 55.88 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.262 0 CA-C-O 121.037 0.446 . . . . 0.0 110.094 179.004 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' E' E ' 132' ' ' ILE . . . . . . . . . . . . . 71.0 mt -114.71 132.36 64.12 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.322 0 CA-C-N 115.808 -0.633 . . . . 0.0 109.306 179.36 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' E' E ' 133' ' ' ILE . . . . . . . . . . . . . 39.3 mm -114.93 120.0 63.32 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.231 0 CA-C-O 120.892 0.377 . . . . 0.0 110.954 -174.909 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' E' E ' 134' ' ' ASP . . . . . . . . . . . . . 9.2 p-10 -132.91 145.3 50.8 Favored 'General case' 0 C--N 1.33 -0.25 0 N-CA-C 109.35 -0.611 . . . . 0.0 109.35 174.516 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' E' E ' 135' ' ' GLU . . . . . . . . . . . . . 76.9 tt0 -49.92 -25.72 3.5 Favored 'General case' 0 C--N 1.327 -0.397 0 N-CA-C 112.859 0.688 . . . . 0.0 112.859 -171.304 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' E' E ' 136' ' ' GLN . . . . . . . . . . . . . 44.2 tt0 -82.69 -38.1 23.86 Favored 'General case' 0 C--O 1.233 0.226 0 N-CA-C 112.136 0.421 . . . . 0.0 112.136 -176.172 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' E' E ' 137' ' ' LYS . . . . . . . . . . . . . 18.2 pttp -160.74 169.25 23.14 Favored 'General case' 0 C--O 1.233 0.207 0 CA-C-O 121.451 0.643 . . . . 0.0 112.126 -173.351 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' E' E ' 138' ' ' LEU . . . . . . . . . . . . . 5.9 tt -114.6 127.4 55.76 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 115.221 -0.899 . . . . 0.0 109.63 177.446 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' E' E ' 139' ' ' THR . . . . . . . . . . . . . 23.4 m -105.21 124.03 48.84 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.275 -179.37 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' E' E ' 140' ' ' LEU . . . . . . . . . . . . . 35.4 tp -110.79 119.94 40.76 Favored 'General case' 0 C--N 1.327 -0.384 0 N-CA-C 109.287 -0.635 . . . . 0.0 109.287 -179.153 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' E' E ' 141' ' ' ILE . . . . . . . . . . . . . 19.3 mt -121.26 117.11 51.73 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.353 0 CA-C-O 121.002 0.43 . . . . 0.0 109.863 -176.211 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' E' E ' 142' ' ' ARG . . . . . . . . . . . . . 73.9 mtp180 -103.76 129.08 51.11 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 115.433 -0.803 . . . . 0.0 110.417 179.653 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' E' E ' 143' ' ' THR . . . . . . . . . . . . . 11.9 p . . . . . 0 C--O 1.219 -0.506 0 CA-C-O 117.997 -1.001 . . . . 0.0 110.531 179.999 . . . . . . . . 0 0 . 1 . 014 nuclear orig full ' F' F ' -3' ' ' GLU . . . . . . . . . . . . . 84.2 tt0 . . . . . 0 N--CA 1.49 1.557 0 N-CA-C 109.243 -0.651 . . . . 0.0 109.243 . . . . . . . . . 0 0 . 1 . 014 nuclear orig full ' F' F ' -2' ' ' GLY . . . . . . . . . . . . . . . -95.05 149.96 19.53 Favored Glycine 0 CA--C 1.526 0.732 0 N-CA-C 111.488 -0.645 . . . . 0.0 111.488 -177.476 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' F' F ' -1' ' ' VAL . . . . . . . . . . . . . 45.0 t -141.65 139.31 31.76 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.274 0 N-CA-C 109.736 -0.468 . . . . 0.0 109.736 178.684 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' F' F ' 0' ' ' ILE . . . . . . . . . . . . . 71.0 mt -104.4 120.88 55.42 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.253 0 CA-C-O 120.877 0.37 . . . . 0.0 110.048 -179.446 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' F' F ' 1' ' ' MET . . . . . . . . . . . . . 22.4 ptm -145.07 142.39 29.67 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.099 -0.5 . . . . 0.0 110.81 -179.486 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' F' F ' 2' ' ' SER . . . . . . . . . . . . . 3.5 p -121.95 129.07 52.2 Favored 'General case' 0 C--N 1.331 -0.217 0 CA-C-O 120.904 0.383 . . . . 0.0 110.624 178.75 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' F' F ' 3' ' ' GLU . . . . . . . . . . . . . 95.0 mt-10 -140.16 141.43 36.03 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.025 -0.534 . . . . 0.0 111.141 -177.573 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' F' F ' 4' ' ' LEU . . . . . . . . . . . . . 15.5 tp -125.49 126.99 45.76 Favored 'General case' 0 C--N 1.331 -0.225 0 CA-C-N 115.832 -0.622 . . . . 0.0 110.198 176.828 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' F' F ' 5' ' ' LYS . . . . . . . . . . . . . 95.4 mttt -105.35 120.97 42.92 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.412 -0.358 . . . . 0.0 110.812 178.886 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' F' F ' 6' ' ' LEU . . . . . . . . . . . . . 77.6 mt -116.09 150.27 37.61 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-N 115.495 -0.775 . . . . 0.0 110.371 -179.885 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' F' F ' 7' ' ' LYS . . . . . . . . . . . . . 58.3 tttp -140.96 137.87 17.47 Favored Pre-proline 0 CA--C 1.535 0.369 0 CA-C-O 119.025 -0.512 . . . . 0.0 110.26 176.52 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' F' F ' 8' ' ' PRO . . . . . . . . . . . . . 80.9 Cg_endo -91.73 143.76 2.93 Favored 'Trans proline' 0 N--CA 1.491 1.333 0 C-N-CA 121.69 1.593 . . . . 0.0 111.65 177.065 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' F' F ' 9' ' ' LEU . . . . . . . . . . . . . 64.7 mt -76.69 -48.67 2.86 Favored Pre-proline 0 CA--C 1.534 0.33 0 CA-C-O 118.606 -0.712 . . . . 0.0 112.529 -177.796 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' F' F ' 10' ' ' PRO . . . . . . . . . . . . . 83.7 Cg_endo -79.62 147.71 19.92 Favored 'Trans proline' 0 N--CA 1.497 1.729 0 C-N-CA 121.166 1.244 . . . . 0.0 111.627 178.033 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' F' F ' 11' ' ' LYS . . . . . . . . . . . . . 53.5 pttt -79.36 108.85 13.19 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-O 121.778 0.799 . . . . 0.0 110.315 177.563 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' F' F ' 12' ' ' VAL . . . . . . . . . . . . . 11.7 p -148.37 145.25 18.53 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.291 0 CA-C-N 115.425 -0.807 . . . . 0.0 110.12 -179.134 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' F' F ' 13' ' ' GLU . . . . . . . . . . . . . 41.0 tp10 -87.78 123.18 32.31 Favored 'General case' 0 C--N 1.329 -0.312 0 N-CA-C 109.884 -0.413 . . . . 0.0 109.884 179.165 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' F' F ' 14' ' ' LEU . . . . . . . . . . . . . 33.5 mt -98.09 149.08 35.36 Favored Pre-proline 0 CA--C 1.532 0.288 0 CA-C-N 116.404 -0.362 . . . . 0.0 110.644 -177.258 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' F' F ' 15' ' ' PRO . . . . . . . . . . . . . 25.4 Cg_exo -62.62 159.54 36.36 Favored 'Trans proline' 0 N--CA 1.498 1.791 0 C-N-CA 121.25 1.3 . . . . 0.0 111.978 176.86 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' F' F ' 16' ' ' PRO . . . . . . . . . . . . . 27.9 Cg_exo -60.47 -34.83 92.51 Favored 'Trans proline' 0 N--CA 1.496 1.639 0 C-N-CA 121.414 1.409 . . . . 0.0 112.494 -179.659 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' F' F ' 17' ' ' ASP . . . . . . . . . . . . . 22.2 p-10 -88.04 10.79 17.89 Favored 'General case' 0 CA--C 1.535 0.393 0 N-CA-C 113.024 0.75 . . . . 0.0 113.024 -178.431 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' F' F ' 18' ' ' PHE . . . . . . . . . . . . . 30.1 t80 -58.01 -42.01 84.32 Favored 'General case' 0 N--CA 1.457 -0.115 0 O-C-N 121.932 -0.48 . . . . 0.0 110.158 -178.507 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' F' F ' 19' ' ' VAL . . . . . . . . . . . . . 49.1 t -56.35 -42.86 75.61 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.282 0 CA-C-N 116.469 -0.332 . . . . 0.0 110.41 -179.676 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' F' F ' 20' ' ' ASP . . . . . . . . . . . . . 81.7 m-20 -60.15 -43.0 96.08 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.428 -0.351 . . . . 0.0 110.884 -178.049 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' F' F ' 21' ' ' VAL . . . . . . . . . . . . . 48.7 t -64.18 -48.11 87.08 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.309 0 C-N-CA 120.832 -0.347 . . . . 0.0 110.548 -177.39 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' F' F ' 22' ' ' ILE . . . . . . . . . . . . . 50.1 mm -55.9 -47.44 79.83 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.312 0 C-N-CA 121.036 -0.266 . . . . 0.0 110.74 -179.978 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' F' F ' 23' ' ' ARG . . . . . . . . . . . . . 54.6 ttp180 -55.38 -48.8 73.76 Favored 'General case' 0 C--N 1.33 -0.276 0 C-N-CA 121.038 -0.265 . . . . 0.0 111.337 -178.291 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' F' F ' 24' ' ' ILE . . . . . . . . . . . . . 73.9 mt -58.48 -41.98 83.18 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.281 0 CA-C-O 120.706 0.288 . . . . 0.0 110.799 -177.378 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' F' F ' 25' ' ' LYS . . . . . . . . . . . . . 51.7 mtpt -65.55 -43.66 89.21 Favored 'General case' 0 C--N 1.327 -0.382 0 N-CA-C 112.319 0.489 . . . . 0.0 112.319 -178.697 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' F' F ' 26' ' ' LEU . . . . . . . . . . . . . 79.5 mt -79.74 -33.2 40.97 Favored 'General case' 0 C--N 1.331 -0.201 0 N-CA-C 113.874 1.064 . . . . 0.0 113.874 -169.549 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' F' F ' 27' ' ' GLN . . . . . . . . . . . . . 10.8 pt20 -46.76 139.42 5.35 Favored 'General case' 0 N--CA 1.469 0.507 0 N-CA-C 113.027 0.751 . . . . 0.0 113.027 -173.497 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' F' F ' 28' ' ' GLY . . . . . . . . . . . . . . . 99.35 -23.61 35.58 Favored Glycine 0 CA--C 1.535 1.292 0 CA-C-N 115.442 -0.799 . . . . 0.0 112.451 -178.962 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' F' F ' 29' ' ' LYS . . . . . . . . . . . . . 61.1 mttp -97.89 155.15 17.2 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 117.527 0.664 . . . . 0.0 111.136 179.682 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' F' F ' 30' ' ' THR . . . . . . . . . . . . . 36.3 m -104.61 137.01 43.09 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 115.931 -0.577 . . . . 0.0 109.852 175.586 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' F' F ' 31' ' ' VAL . . . . . . . . . . . . . 34.9 m -129.64 153.54 38.94 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.21 0 CA-C-O 121.003 0.43 . . . . 0.0 110.953 -178.379 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' F' F ' 32' ' ' ARG . . . . . . . . . . . . . 38.9 ttm180 -133.66 149.41 51.55 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 115.991 -0.549 . . . . 0.0 110.454 -179.991 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' F' F ' 33' ' ' THR . . . . . . . . . . . . . 21.4 m -52.17 138.7 25.27 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.307 -0.406 . . . . 0.0 111.563 -176.17 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' F' F ' 34' ' ' GLY . . . . . . . . . . . . . . . 100.48 -17.1 57.21 Favored Glycine 0 CA--C 1.533 1.209 0 CA-C-O 119.64 -0.533 . . . . 0.0 113.326 178.536 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' F' F ' 35' ' ' ASP . . . . . . . . . . . . . 80.2 m-20 -66.2 147.37 53.42 Favored 'General case' 0 C--N 1.332 -0.155 0 CA-C-N 118.014 0.907 . . . . 0.0 110.953 178.856 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' F' F ' 36' ' ' VAL . . . . . . . . . . . . . 46.3 t -122.32 129.99 74.88 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.197 0 CA-C-N 115.965 -0.561 . . . . 0.0 109.849 178.225 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' F' F ' 37' ' ' ILE . . . . . . . . . . . . . 69.3 mt -121.83 139.93 47.38 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.247 0 CA-C-N 116.194 -0.457 . . . . 0.0 109.955 -179.138 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' F' F ' 38' ' ' GLY . . . . . . . . . . . . . . . -113.64 128.74 8.46 Favored Glycine 0 CA--C 1.526 0.743 0 N-CA-C 111.282 -0.727 . . . . 0.0 111.282 -179.928 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' F' F ' 39' ' ' ILE . . . . . . . . . . . . . 70.0 mt -121.03 134.94 62.8 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.171 0 N-CA-C 109.959 -0.386 . . . . 0.0 109.959 178.269 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' F' F ' 40' ' ' SER . . . . . . . . . . . . . 87.4 p -92.16 120.68 32.97 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 116.422 -0.353 . . . . 0.0 110.62 175.537 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' F' F ' 41' ' ' ILE . . . . . . . . . . . . . 72.2 mt -132.36 117.56 32.45 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.207 0 CA-C-O 120.757 0.313 . . . . 0.0 110.157 178.554 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' F' F ' 42' ' ' LEU . . . . . . . . . . . . . 8.4 tp 57.95 35.85 25.67 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.176 -0.466 . . . . 0.0 111.363 178.515 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' F' F ' 43' ' ' GLY . . . . . . . . . . . . . . . 77.41 -10.08 24.43 Favored Glycine 0 CA--C 1.535 1.326 0 C-N-CA 121.26 -0.495 . . . . 0.0 113.381 177.431 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' F' F ' 44' ' ' LYS . . . . . . . . . . . . . 59.2 tttm -98.28 134.29 41.51 Favored 'General case' 0 C--N 1.333 -0.126 0 CA-C-N 117.996 0.898 . . . . 0.0 109.897 177.905 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' F' F ' 45' ' ' GLU . . . . . . . . . . . . . 82.3 tt0 -84.53 128.14 34.43 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.325 -0.398 . . . . 0.0 110.903 -179.423 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' F' F ' 46' ' ' VAL . . . . . . . . . . . . . 7.3 p -121.87 126.84 75.1 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.211 0 N-CA-C 109.632 -0.507 . . . . 0.0 109.632 175.936 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' F' F ' 47' ' ' LYS . . . . . . . . . . . . . 59.5 mtpt -100.58 128.85 46.5 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 115.895 -0.593 . . . . 0.0 111.24 179.573 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' F' F ' 48' ' ' PHE . . . . . . . . . . . . . 95.8 m-85 -113.28 131.88 55.76 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.279 -0.419 . . . . 0.0 110.064 176.361 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' F' F ' 49' ' ' LYS . . . . . . . . . . . . . 57.0 tttm -108.66 139.69 43.09 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.47 -0.332 . . . . 0.0 110.471 178.326 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' F' F ' 50' ' ' VAL . . . . . . . . . . . . . 45.2 t -82.22 109.18 15.96 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.308 0 N-CA-C 109.137 -0.69 . . . . 0.0 109.137 175.66 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' F' F ' 51' ' ' VAL . . . . . . . . . . . . . 47.0 t -73.5 -48.4 41.48 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.294 0 CA-C-N 116.015 -0.539 . . . . 0.0 110.032 -173.81 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' F' F ' 52' ' ' GLN . . . . . . . . . . . . . 61.4 tt0 -163.82 139.48 6.38 Favored 'General case' 0 C--N 1.33 -0.239 0 C-N-CA 120.264 -0.574 . . . . 0.0 111.817 -177.604 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' F' F ' 53' ' ' ALA . . . . . . . . . . . . . . . -116.63 131.45 56.95 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 115.832 -0.622 . . . . 0.0 110.108 175.839 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' F' F ' 54' ' ' TYR . . . . . . . . . . . . . 69.0 t80 -129.12 110.63 18.22 Favored Pre-proline 0 CA--C 1.534 0.352 0 CA-C-O 118.343 -0.837 . . . . 0.0 110.393 178.959 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' F' F ' 55' ' ' PRO . . . . . . . . . . . . . 73.9 Cg_endo -77.1 170.1 72.53 Favored 'Cis proline' 0 N--CA 1.499 1.831 0 CA-C-N 121.977 1.742 . . . . 0.0 112.292 -5.93 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' F' F ' 56' ' ' SER . . . . . . . . . . . . . 14.3 m -116.16 135.55 22.83 Favored Pre-proline 0 CA--C 1.54 0.571 0 CA-C-O 118.425 -0.798 . . . . 0.0 109.678 176.155 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' F' F ' 57' ' ' PRO . . . . . . . . . . . . . 56.8 Cg_endo -72.47 148.94 92.67 Favored 'Cis proline' 0 N--CA 1.496 1.651 0 CA-C-N 121.694 1.641 . . . . 0.0 111.339 -3.024 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' F' F ' 58' ' ' LEU . . . . . . . . . . . . . 37.7 tp -107.43 137.78 44.85 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-O 120.929 0.395 . . . . 0.0 110.688 -177.096 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' F' F ' 59' ' ' ARG . . . . . . . . . . . . . 61.0 ttt180 -98.92 125.81 44.44 Favored 'General case' 0 C--N 1.325 -0.457 0 CA-C-N 115.783 -0.644 . . . . 0.0 109.292 176.527 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' F' F ' 60' ' ' VAL . . . . . . . . . . . . . 42.0 t -84.34 114.87 25.45 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.246 0 C-N-CA 120.642 -0.423 . . . . 0.0 110.352 -174.975 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' F' F ' 61' ' ' GLU . . . . . . . . . . . . . 41.0 mt-10 -131.16 160.94 33.29 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 115.931 -0.577 . . . . 0.0 109.827 177.329 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' F' F ' 62' ' ' ASP . . . . . . . . . . . . . 74.4 m-20 -53.24 -32.49 48.58 Favored 'General case' 0 C--N 1.329 -0.283 0 N-CA-C 111.858 0.318 . . . . 0.0 111.858 -179.789 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' F' F ' 63' ' ' ARG . . . . . . . . . . . . . 83.1 mtp180 -72.87 -22.03 60.84 Favored 'General case' 0 CA--C 1.533 0.306 0 N-CA-C 112.913 0.708 . . . . 0.0 112.913 -177.048 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' F' F ' 64' ' ' THR . . . . . . . . . . . . . 32.5 m -69.55 142.67 53.57 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-O 120.82 0.343 . . . . 0.0 110.815 -175.455 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' F' F ' 65' ' ' LYS . . . . . . . . . . . . . 97.7 mttt -88.73 123.22 32.95 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.066 -0.515 . . . . 0.0 110.065 179.698 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' F' F ' 66' ' ' ILE . . . . . . . . . . . . . 63.0 mt -113.58 129.35 69.54 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.295 0 N-CA-C 109.702 -0.481 . . . . 0.0 109.702 -179.916 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' F' F ' 67' ' ' THR . . . . . . . . . . . . . 28.1 m -128.26 142.65 51.09 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.144 -0.48 . . . . 0.0 111.082 -177.473 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' F' F ' 68' ' ' LEU . . . . . . . . . . . . . 4.8 tt -103.48 127.16 50.92 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 115.876 -0.602 . . . . 0.0 109.484 177.135 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' F' F ' 69' ' ' VAL . . . . . . . . . . . . . 42.8 t -84.09 129.39 37.68 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.343 0 CA-C-O 121.047 0.451 . . . . 0.0 110.915 -175.225 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' F' F ' 70' ' ' THR . . . . . . . . . . . . . 74.9 p -145.78 -178.29 6.03 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 115.794 -0.639 . . . . 0.0 110.405 178.438 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' F' F ' 71' ' ' HIS . . . . . . . . . . . . . 73.9 m80 -64.92 162.32 38.92 Favored Pre-proline 0 C--N 1.33 -0.279 0 CA-C-N 116.405 -0.361 . . . . 0.0 110.177 178.626 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' F' F ' 72' ' ' PRO . . . . . . . . . . . . . 11.1 Cg_endo -81.07 -30.16 1.76 Allowed 'Trans proline' 0 N--CA 1.491 1.341 0 C-N-CA 121.501 1.467 . . . . 0.0 112.81 -175.051 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' F' F ' 73' ' ' VAL . . . . . . . . . . . . . 29.6 m -150.14 154.26 9.27 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.225 0 CA-C-O 121.203 0.525 . . . . 0.0 111.471 178.618 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' F' F ' 74' ' ' ASP . . . . . . . . . . . . . 10.0 t70 -102.96 119.32 38.64 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 115.441 -0.8 . . . . 0.0 109.503 175.898 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' F' F ' 75' ' ' VAL . . . . . . . . . . . . . 44.9 t -111.13 123.89 67.43 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.217 0 CA-C-O 121.15 0.5 . . . . 0.0 110.556 -177.347 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' F' F ' 76' ' ' LEU . . . . . . . . . . . . . 25.9 mt -125.93 147.37 49.51 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 115.561 -0.745 . . . . 0.0 109.615 178.546 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' F' F ' 77' ' ' GLU . . . . . . . . . . . . . 98.4 mt-10 -136.24 135.6 39.18 Favored 'General case' 0 C--N 1.331 -0.204 0 CA-C-O 121.134 0.493 . . . . 0.0 111.457 -177.318 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' F' F ' 78' ' ' ALA . . . . . . . . . . . . . . . -123.34 129.2 50.98 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 115.493 -0.776 . . . . 0.0 109.699 176.14 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' F' F ' 79' ' ' LYS . . . . . . . . . . . . . 96.8 mttt -76.88 119.23 20.36 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-O 120.915 0.388 . . . . 0.0 110.836 -178.585 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' F' F ' 80' ' ' ILE . . . . . . . . . . . . . 42.6 mm -139.09 116.68 11.64 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.326 0 N-CA-C 108.781 -0.822 . . . . 0.0 108.781 -178.186 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' F' F ' 81' ' ' LYS . . . . . . . . . . . . . 17.6 ptpt -105.96 127.72 53.34 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-O 121.303 0.573 . . . . 0.0 111.323 -175.696 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' F' F ' 82' ' ' GLY . . . . . . . . . . . . . . . 88.75 42.17 5.8 Favored Glycine 0 CA--C 1.525 0.684 0 CA-C-N 115.725 -0.67 . . . . 0.0 111.838 173.795 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' F' F ' 83' ' ' ILE . . . . . . . . . . . . . 74.6 mt -69.88 140.91 17.86 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.292 0 CA-C-O 121.043 0.449 . . . . 0.0 110.053 179.021 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' F' F ' 84' ' ' LYS . . . . . . . . . . . . . 67.5 tttt -99.75 -53.98 3.04 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 115.868 -0.605 . . . . 0.0 110.204 -178.869 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' F' F ' 85' ' ' ASP . . . . . . . . . . . . . 5.6 t70 -155.38 155.78 34.23 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 115.817 -0.629 . . . . 0.0 110.134 -179.021 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' F' F ' 86' ' ' VAL . . . . . . . . . . . . . 44.3 t -135.6 135.66 51.18 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.238 0 CA-C-O 121.038 0.447 . . . . 0.0 110.806 -178.135 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' F' F ' 87' ' ' ILE . . . . . . . . . . . . . 44.2 mm -119.38 128.5 75.85 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.199 0 CA-C-N 115.708 -0.678 . . . . 0.0 109.466 176.139 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' F' F ' 88' ' ' LEU . . . . . . . . . . . . . 24.0 tp -111.98 131.51 55.35 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-O 120.89 0.376 . . . . 0.0 110.996 -177.803 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' F' F ' 89' ' ' ASP . . . . . . . . . . . . . 10.0 t70 -126.09 154.05 43.63 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 116.036 -0.529 . . . . 0.0 109.597 176.39 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' F' F ' 90' ' ' GLU . . . . . . . . . . . . . 46.5 tp10 -47.29 -38.36 12.43 Favored 'General case' 0 C--N 1.33 -0.253 0 N-CA-C 112.794 0.665 . . . . 0.0 112.794 -172.394 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' F' F ' 91' ' ' ASN . . . . . . . . . . . . . 15.0 t-20 -132.06 33.34 3.92 Favored 'General case' 0 N--CA 1.466 0.353 0 C-N-CA 120.883 -0.327 . . . . 0.0 111.855 -175.889 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' F' F ' 92' ' ' LEU . . . . . . . . . . . . . 10.1 tp -166.12 148.31 7.01 Favored 'General case' 0 C--N 1.332 -0.169 0 C-N-CA 120.705 -0.398 . . . . 0.0 111.043 179.205 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' F' F ' 93' ' ' ILE . . . . . . . . . . . . . 67.4 mt -125.55 124.49 66.9 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.211 0 N-CA-C 109.588 -0.523 . . . . 0.0 109.588 -179.883 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' F' F ' 94' ' ' VAL . . . . . . . . . . . . . 43.7 t -122.27 126.57 74.45 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.186 0 N-CA-C 109.91 -0.404 . . . . 0.0 109.91 179.466 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' F' F ' 95' ' ' VAL . . . . . . . . . . . . . 46.3 t -123.59 135.0 64.81 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.175 0 CA-C-N 116.338 -0.392 . . . . 0.0 110.103 -179.175 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' F' F ' 96' ' ' ILE . . . . . . . . . . . . . 65.1 mt -116.48 130.64 70.95 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.265 0 N-CA-C 109.38 -0.6 . . . . 0.0 109.38 178.606 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' F' F ' 97' ' ' THR . . . . . . . . . . . . . 81.5 p -101.3 159.86 14.9 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-O 121.039 0.447 . . . . 0.0 111.19 -179.154 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' F' F ' 98' ' ' GLU . . . . . . . . . . . . . 45.1 mt-10 -54.35 -26.32 29.31 Favored 'General case' 0 C--N 1.328 -0.359 0 N-CA-C 112.257 0.465 . . . . 0.0 112.257 -179.497 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' F' F ' 99' ' ' GLU . . . . . . . . . . . . . 14.3 mm-40 -78.53 14.86 1.14 Allowed 'General case' 0 CA--C 1.535 0.366 0 N-CA-C 113.183 0.808 . . . . 0.0 113.183 -178.012 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' F' F ' 100' ' ' ASN . . . . . . . . . . . . . 7.6 m-20 60.13 37.46 20.85 Favored 'General case' 0 CA--C 1.529 0.138 0 CA-C-O 121.019 0.437 . . . . 0.0 111.091 -179.845 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' F' F ' 101' ' ' GLU . . . . . . . . . . . . . 84.7 tt0 -112.04 141.03 46.22 Favored 'General case' 0 C--N 1.331 -0.223 0 CA-C-N 116.023 -0.535 . . . . 0.0 109.659 174.09 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' F' F ' 102' ' ' VAL . . . . . . . . . . . . . 42.8 t -114.98 127.8 72.39 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.293 0 N-CA-C 109.9 -0.408 . . . . 0.0 109.9 -178.848 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' F' F ' 103' ' ' LEU . . . . . . . . . . . . . 6.4 mp -117.6 134.48 54.83 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 115.668 -0.696 . . . . 0.0 110.164 176.739 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' F' F ' 104' ' ' ILE . . . . . . . . . . . . . 66.2 mt -117.37 123.87 72.32 Favored 'Isoleucine or valine' 0 C--O 1.233 0.211 0 CA-C-N 116.267 -0.424 . . . . 0.0 109.957 -179.601 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' F' F ' 105' ' ' PHE . . . . . . . . . . . . . 92.3 m-85 -123.25 161.36 24.72 Favored 'General case' 0 C--N 1.332 -0.184 0 O-C-N 123.992 0.808 . . . . 0.0 109.97 -179.548 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' F' F ' 106' ' ' ASN . . . . . . . . . . . . . 44.3 p-10 -99.42 -171.74 2.13 Favored 'General case' 0 C--N 1.33 -0.277 0 N-CA-C 110.209 -0.293 . . . . 0.0 110.209 175.266 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' F' F ' 107' ' ' GLN . . . . . . . . . . . . . 50.7 tt0 -58.87 -28.21 65.92 Favored 'General case' 0 C--N 1.329 -0.316 0 N-CA-C 112.176 0.436 . . . . 0.0 112.176 179.7 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' F' F ' 108' ' ' ASN . . . . . . . . . . . . . 2.7 t-20 -85.63 7.75 22.11 Favored 'General case' 0 CA--C 1.538 0.486 0 N-CA-C 113.252 0.834 . . . . 0.0 113.252 -176.857 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' F' F ' 109' ' ' LEU . . . . . . . . . . . . . 11.7 tp 59.94 38.13 21.15 Favored 'General case' 0 CA--C 1.53 0.181 0 CA-C-O 121.086 0.47 . . . . 0.0 111.166 178.984 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' F' F ' 110' ' ' GLU . . . . . . . . . . . . . 95.7 mt-10 -108.22 148.76 29.5 Favored 'General case' 0 C--N 1.33 -0.267 0 N-CA-C 109.73 -0.47 . . . . 0.0 109.73 175.274 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' F' F ' 111' ' ' GLU . . . . . . . . . . . . . 60.0 tt0 -83.51 121.88 27.8 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-O 120.774 0.321 . . . . 0.0 110.725 -175.763 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' F' F ' 112' ' ' LEU . . . . . . . . . . . . . 27.7 mt -106.92 -46.05 4.03 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.1 -0.5 . . . . 0.0 110.814 179.673 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' F' F ' 113' ' ' TYR . . . . . . . . . . . . . 60.1 t80 -134.86 141.88 46.47 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 116.437 -0.347 . . . . 0.0 111.229 -178.227 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' F' F ' 114' ' ' ARG . . . . . . . . . . . . . 36.9 ptt180 -146.61 121.05 9.66 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.738 178.12 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' F' F ' 115' ' ' GLY . . . . . . . . . . . . . . . -150.12 149.75 21.69 Favored Glycine 0 CA--C 1.526 0.744 0 N-CA-C 111.203 -0.759 . . . . 0.0 111.203 178.332 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' F' F ' 116' ' ' LYS . . . . . . . . . . . . . 35.1 ttmt -115.35 136.77 52.75 Favored 'General case' 0 C--N 1.331 -0.233 0 N-CA-C 110.133 -0.321 . . . . 0.0 110.133 176.678 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' F' F ' 117' ' ' PHE . . . . . . . . . . . . . 44.1 m-85 -132.35 114.52 14.48 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-O 120.974 0.416 . . . . 0.0 110.137 -177.344 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' F' F ' 118' ' ' GLU . . . . . . . . . . . . . 96.2 mt-10 -53.97 -46.94 71.8 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.336 -0.393 . . . . 0.0 111.427 -175.775 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' F' F ' 119' ' ' ASN . . . . . . . . . . . . . 28.6 m120 -94.43 31.06 1.81 Allowed 'General case' 0 C--N 1.328 -0.342 0 N-CA-C 112.165 0.432 . . . . 0.0 112.165 -174.334 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' F' F ' 120' ' ' LEU . . . . . . . . . . . . . 16.0 tp -57.35 119.98 7.39 Favored 'General case' 0 C--N 1.332 -0.169 0 N-CA-C 110.175 -0.305 . . . . 0.0 110.175 177.657 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' F' F ' 121' ' ' ASN . . . . . . . . . . . . . 81.2 m-20 -114.1 -44.08 3.17 Favored 'General case' 0 C--O 1.233 0.223 0 CA-C-N 116.365 -0.379 . . . . 0.0 111.026 -178.419 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' F' F ' 122' ' ' LYS . . . . . . . . . . . . . 98.4 mttt -145.77 149.55 34.57 Favored 'General case' 0 C--N 1.333 -0.128 0 CA-C-O 121.092 0.472 . . . . 0.0 111.856 -178.319 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' F' F ' 123' ' ' VAL . . . . . . . . . . . . . 46.8 t -124.92 126.66 71.64 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.211 0 CA-C-N 115.694 -0.684 . . . . 0.0 109.497 175.043 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' F' F ' 124' ' ' LEU . . . . . . . . . . . . . 6.2 mp -117.88 133.94 55.43 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.473 -0.331 . . . . 0.0 110.434 -179.314 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' F' F ' 125' ' ' VAL . . . . . . . . . . . . . 12.0 p -133.77 135.91 54.74 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.285 0 CA-C-N 116.233 -0.44 . . . . 0.0 110.522 -179.875 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' F' F ' 126' ' ' ARG . . . . . . . . . . . . . 95.9 mtt-85 -143.31 116.88 9.17 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.115 -0.493 . . . . 0.0 110.267 177.716 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' F' F ' 127' ' ' ASN . . . . . . . . . . . . . 64.3 t30 52.56 -104.98 0.21 Allowed 'General case' 0 CA--C 1.544 0.744 0 CA-C-O 118.986 -0.53 . . . . 0.0 111.357 179.74 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' F' F ' 128' ' ' ASP . . . . . . . . . . . . . 8.6 p-10 -114.08 4.43 15.64 Favored 'General case' 0 CA--C 1.537 0.463 0 CA-C-N 119.526 1.057 . . . . 0.0 113.547 -176.623 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' F' F ' 129' ' ' LEU . . . . . . . . . . . . . 14.6 tp -107.37 139.0 42.53 Favored 'General case' 0 C--N 1.332 -0.173 0 CA-C-N 118.207 0.458 . . . . 0.0 110.292 179.693 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' F' F ' 130' ' ' VAL . . . . . . . . . . . . . 41.3 t -126.71 137.14 58.73 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.233 0 CA-C-O 120.942 0.401 . . . . 0.0 110.424 -178.339 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' F' F ' 131' ' ' VAL . . . . . . . . . . . . . 43.0 t -136.02 136.46 49.63 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.271 0 CA-C-N 116.239 -0.437 . . . . 0.0 110.198 176.916 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' F' F ' 132' ' ' ILE . . . . . . . . . . . . . 77.5 mt -116.57 133.16 64.07 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.257 0 CA-C-N 115.908 -0.587 . . . . 0.0 109.605 -179.071 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' F' F ' 133' ' ' ILE . . . . . . . . . . . . . 41.2 mm -116.53 125.26 73.44 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.249 0 CA-C-N 116.377 -0.374 . . . . 0.0 111.112 -174.66 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' F' F ' 134' ' ' ASP . . . . . . . . . . . . . 11.7 p-10 -139.02 151.6 46.94 Favored 'General case' 0 C--N 1.333 -0.135 0 CA-C-N 116.198 -0.455 . . . . 0.0 109.912 174.037 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' F' F ' 135' ' ' GLU . . . . . . . . . . . . . 84.8 tt0 -50.82 -27.94 8.39 Favored 'General case' 0 C--N 1.33 -0.267 0 N-CA-C 112.862 0.69 . . . . 0.0 112.862 -172.513 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' F' F ' 136' ' ' GLN . . . . . . . . . . . . . 96.9 mt-30 -84.9 -30.02 24.73 Favored 'General case' 0 C--N 1.329 -0.291 0 N-CA-C 112.63 0.604 . . . . 0.0 112.63 -174.663 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' F' F ' 137' ' ' LYS . . . . . . . . . . . . . 56.7 pttt -169.08 173.16 7.01 Favored 'General case' 0 C--O 1.233 0.212 0 CA-C-O 121.683 0.754 . . . . 0.0 112.672 -170.267 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' F' F ' 138' ' ' LEU . . . . . . . . . . . . . 4.7 tt -121.73 128.9 52.29 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 114.77 -1.105 . . . . 0.0 109.673 178.862 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' F' F ' 139' ' ' THR . . . . . . . . . . . . . 42.1 m -111.71 126.09 54.67 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.443 -0.344 . . . . 0.0 110.146 179.402 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' F' F ' 140' ' ' LEU . . . . . . . . . . . . . 6.3 tt -113.0 124.14 51.94 Favored 'General case' 0 C--N 1.329 -0.291 0 N-CA-C 109.579 -0.526 . . . . 0.0 109.579 -178.625 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' F' F ' 141' ' ' ILE . . . . . . . . . . . . . 19.4 mt -122.55 120.42 60.91 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.309 0 CA-C-O 121.014 0.435 . . . . 0.0 110.049 -175.128 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' F' F ' 142' ' ' ARG . . . . . . . . . . . . . 67.7 ttt180 -111.4 126.97 55.5 Favored 'General case' 0 C--N 1.332 -0.17 0 CA-C-N 115.376 -0.829 . . . . 0.0 110.492 -177.114 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' F' F ' 143' ' ' THR . . . . . . . . . . . . . 56.0 p . . . . . 0 C--O 1.219 -0.52 0 CA-C-O 118.12 -0.943 . . . . 0.0 110.623 179.921 . . . . . . . . 0 0 . 1 . 015 nuclear orig full ' A' A ' -3' ' ' GLU . . . . . . . . . . . . . 96.2 mt-10 . . . . . 0 N--CA 1.489 1.519 0 N-CA-C 109.52 -0.548 . . . . 0.0 109.52 . . . . . . . . . 0 0 . 1 . 015 nuclear orig full ' A' A ' -2' ' ' GLY . . . . . . . . . . . . . . . -71.97 150.03 45.37 Favored Glycine 0 CA--C 1.524 0.614 0 N-CA-C 110.733 -0.947 . . . . 0.0 110.733 178.581 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' -1' ' ' VAL . . . . . . . . . . . . . 44.3 t -89.86 129.19 41.17 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.318 0 CA-C-O 120.921 0.391 . . . . 0.0 110.036 -179.085 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 0' ' ' ILE . . . . . . . . . . . . . 74.2 mt -119.5 131.3 72.49 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.25 0 CA-C-N 116.023 -0.535 . . . . 0.0 109.804 179.79 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 25.5 ptp -83.01 140.87 32.47 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.319 -0.4 . . . . 0.0 110.661 -179.704 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 40.9 p -115.56 141.17 48.42 Favored 'General case' 0 C--N 1.331 -0.218 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.384 179.466 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 95.2 mt-10 -141.32 140.56 33.83 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.194 -0.457 . . . . 0.0 111.355 -177.861 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 4' ' ' LEU . . . . . . . . . . . . . 75.9 mt -121.82 128.38 51.6 Favored 'General case' 0 C--O 1.233 0.226 0 CA-C-N 115.951 -0.568 . . . . 0.0 110.17 174.884 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 5' ' ' LYS . . . . . . . . . . . . . 68.5 mttm -107.55 122.15 46.09 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.451 -0.341 . . . . 0.0 110.259 177.769 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 70.5 mt -118.14 144.29 45.8 Favored 'General case' 0 C--N 1.331 -0.224 0 CA-C-N 115.769 -0.65 . . . . 0.0 110.287 -179.105 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 59.3 tttm -121.64 135.13 24.89 Favored Pre-proline 0 CA--C 1.534 0.363 0 CA-C-O 118.675 -0.679 . . . . 0.0 109.603 175.475 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 8' ' ' PRO . . . . . . . . . . . . . 84.9 Cg_endo -90.04 131.79 1.86 Allowed 'Trans proline' 0 N--CA 1.488 1.176 0 C-N-CA 121.605 1.537 . . . . 0.0 111.735 178.054 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 28.2 mt -73.65 -47.4 7.06 Favored Pre-proline 0 CA--C 1.535 0.384 0 CA-C-O 118.604 -0.712 . . . . 0.0 111.972 -179.072 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 95.5 Cg_endo -79.76 151.04 21.66 Favored 'Trans proline' 0 N--CA 1.497 1.697 0 C-N-CA 121.056 1.171 . . . . 0.0 111.873 176.049 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 19.2 ttpp -85.65 107.06 17.37 Favored 'General case' 0 C--N 1.33 -0.27 0 C-N-CA 120.885 -0.326 . . . . 0.0 110.31 178.895 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 12.0 p -149.22 147.68 16.34 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.323 0 CA-C-N 116.352 -0.385 . . . . 0.0 110.805 -179.153 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 94.7 mt-10 -95.75 110.05 22.26 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.087 -0.506 . . . . 0.0 109.668 175.843 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 14' ' ' LEU . . . . . . . . . . . . . 51.2 mt -86.54 148.78 47.39 Favored Pre-proline 0 CA--C 1.533 0.307 0 CA-C-O 119.303 -0.379 . . . . 0.0 110.481 -176.793 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 15' ' ' PRO . . . . . . . . . . . . . 28.6 Cg_exo -61.03 159.57 29.28 Favored 'Trans proline' 0 N--CA 1.497 1.685 0 C-N-CA 121.269 1.313 . . . . 0.0 111.738 177.263 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 16' ' ' PRO . . . . . . . . . . . . . 32.7 Cg_exo -59.75 -35.89 93.14 Favored 'Trans proline' 0 N--CA 1.498 1.74 0 C-N-CA 121.374 1.383 . . . . 0.0 112.692 -178.736 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 17' ' ' ASP . . . . . . . . . . . . . 8.5 p-10 -84.03 4.85 28.14 Favored 'General case' 0 CA--C 1.536 0.423 0 N-CA-C 113.26 0.837 . . . . 0.0 113.26 -177.959 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 18' ' ' PHE . . . . . . . . . . . . . 40.2 t80 -58.47 -46.03 87.43 Favored 'General case' 0 N--CA 1.456 -0.145 0 O-C-N 121.912 -0.493 . . . . 0.0 109.978 -178.699 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 19' ' ' VAL . . . . . . . . . . . . . 47.9 t -57.12 -41.22 77.3 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.368 0 CA-C-N 116.236 -0.438 . . . . 0.0 110.479 -177.743 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 74.9 m-20 -60.34 -45.16 94.43 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-O 120.756 0.313 . . . . 0.0 111.043 -177.356 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 46.5 t -64.98 -46.46 91.52 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.276 0 C-N-CA 120.692 -0.403 . . . . 0.0 110.436 -177.761 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 22' ' ' ILE . . . . . . . . . . . . . 51.6 mm -57.32 -42.36 80.16 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.218 0 CA-C-O 120.899 0.38 . . . . 0.0 110.362 178.389 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 23' ' ' ARG . . . . . . . . . . . . . 59.7 ttp180 -53.71 -49.17 68.67 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-O 120.794 0.33 . . . . 0.0 111.278 -179.223 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 24' ' ' ILE . . . . . . . . . . . . . 70.2 mt -60.67 -41.48 88.33 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.255 0 CA-C-N 116.497 -0.32 . . . . 0.0 110.935 -179.488 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 52.9 mmtt -63.15 -37.4 87.07 Favored 'General case' 0 C--N 1.329 -0.314 0 N-CA-C 112.073 0.397 . . . . 0.0 112.073 179.239 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 58.9 mt -79.06 -42.4 26.51 Favored 'General case' 0 C--N 1.329 -0.297 0 N-CA-C 113.347 0.869 . . . . 0.0 113.347 -172.125 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 27' ' ' GLN . . . . . . . . . . . . . 10.3 pt20 -47.37 140.68 5.42 Favored 'General case' 0 N--CA 1.47 0.545 0 N-CA-C 112.716 0.636 . . . . 0.0 112.716 -174.735 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 98.09 -25.21 28.55 Favored Glycine 0 CA--C 1.532 1.147 0 CA-C-N 115.541 -0.754 . . . . 0.0 112.398 -178.627 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 69.1 mttm -97.73 155.11 17.17 Favored 'General case' 0 C--N 1.332 -0.181 0 CA-C-N 117.397 0.598 . . . . 0.0 110.81 179.375 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 30' ' ' THR . . . . . . . . . . . . . 33.1 m -102.96 137.53 41.03 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.242 -0.435 . . . . 0.0 110.076 177.297 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 35.0 m -126.67 151.4 33.28 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.251 0 CA-C-N 116.325 -0.398 . . . . 0.0 110.97 -178.998 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 32' ' ' ARG . . . . . . . . . . . . . 62.0 mtt85 -133.26 148.71 51.97 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 115.665 -0.698 . . . . 0.0 110.202 176.645 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 33' ' ' THR . . . . . . . . . . . . . 21.5 m -53.4 138.24 33.59 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-O 120.86 0.362 . . . . 0.0 111.372 -177.644 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 101.0 -17.05 56.79 Favored Glycine 0 CA--C 1.533 1.165 0 CA-C-O 119.656 -0.525 . . . . 0.0 113.359 178.587 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 80.3 m-20 -66.5 150.03 49.57 Favored 'General case' 0 N--CA 1.463 0.202 0 CA-C-N 118.043 0.922 . . . . 0.0 111.359 179.592 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 46.2 t -122.58 129.59 75.11 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.236 0 CA-C-N 116.029 -0.532 . . . . 0.0 109.852 177.524 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 37' ' ' ILE . . . . . . . . . . . . . 62.1 mt -122.08 139.83 47.87 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.235 0 CA-C-N 116.228 -0.442 . . . . 0.0 109.962 -178.495 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . -117.01 128.3 7.82 Favored Glycine 0 CA--C 1.524 0.605 0 N-CA-C 110.89 -0.884 . . . . 0.0 110.89 178.284 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 39' ' ' ILE . . . . . . . . . . . . . 75.6 mt -127.25 132.46 69.58 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.29 0 CA-C-O 120.765 0.317 . . . . 0.0 110.199 179.754 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 40' ' ' SER . . . . . . . . . . . . . 13.0 t -93.04 122.18 35.14 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.304 -0.407 . . . . 0.0 110.923 176.419 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 41' ' ' ILE . . . . . . . . . . . . . 5.1 mp -128.72 120.83 53.37 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.232 0 N-CA-C 109.902 -0.407 . . . . 0.0 109.902 176.728 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 6.8 mp 56.62 35.42 26.07 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-O 121.088 0.47 . . . . 0.0 111.203 -179.704 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . 80.14 -10.14 43.27 Favored Glycine 0 CA--C 1.533 1.198 0 C-N-CA 121.255 -0.498 . . . . 0.0 113.538 176.169 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 44' ' ' LYS . . . . . . . . . . . . . 61.7 mttp -99.68 131.25 45.79 Favored 'General case' 0 C--O 1.23 0.049 0 CA-C-N 117.891 0.846 . . . . 0.0 110.207 178.419 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 83.0 tt0 -85.57 131.06 34.43 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.371 -0.377 . . . . 0.0 111.301 -178.989 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 46' ' ' VAL . . . . . . . . . . . . . 10.0 p -123.09 125.06 71.51 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.167 0 N-CA-C 109.565 -0.531 . . . . 0.0 109.565 173.786 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 66.6 mttm -99.28 127.07 45.23 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.133 -0.485 . . . . 0.0 111.042 177.856 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 48' ' ' PHE . . . . . . . . . . . . . 39.4 m-85 -112.68 131.81 55.47 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 115.918 -0.583 . . . . 0.0 110.004 178.656 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 77.8 tttt -106.4 132.36 52.52 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.471 -0.331 . . . . 0.0 110.231 178.204 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 50' ' ' VAL . . . . . . . . . . . . . 45.3 t -75.63 105.16 4.34 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.244 0 N-CA-C 109.401 -0.592 . . . . 0.0 109.401 178.002 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 51' ' ' VAL . . . . . . . . . . . . . 48.5 t -69.73 -49.64 56.29 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 N-CA-C 109.751 -0.463 . . . . 0.0 109.751 -175.035 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 52' ' ' GLN . . . . . . . . . . . . . 62.7 tt0 -167.01 147.42 5.61 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 115.971 -0.559 . . . . 0.0 111.498 -178.718 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -123.11 134.99 54.19 Favored 'General case' 0 C--N 1.332 -0.19 0 CA-C-N 116.035 -0.53 . . . . 0.0 109.972 176.884 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 54' ' ' TYR . . . . . . . . . . . . . 64.0 t80 -129.11 113.88 18.58 Favored Pre-proline 0 CA--C 1.535 0.375 0 CA-C-O 118.103 -0.951 . . . . 0.0 110.246 178.443 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 55' ' ' PRO . . . . . . . . . . . . . 72.8 Cg_endo -77.16 170.15 72.31 Favored 'Cis proline' 0 N--CA 1.501 1.956 0 CA-C-N 122.154 1.805 . . . . 0.0 111.842 -8.476 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 56' ' ' SER . . . . . . . . . . . . . 14.7 m -123.67 141.91 37.8 Favored Pre-proline 0 CA--C 1.538 0.51 0 CA-C-O 118.755 -0.641 . . . . 0.0 109.81 175.483 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 57' ' ' PRO . . . . . . . . . . . . . 37.1 Cg_endo -67.27 158.39 82.78 Favored 'Cis proline' 0 N--CA 1.5 1.892 0 CA-C-N 121.466 1.559 . . . . 0.0 111.179 -5.023 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 58' ' ' LEU . . . . . . . . . . . . . 27.9 tp -128.44 137.19 51.71 Favored 'General case' 0 C--N 1.331 -0.223 0 CA-C-O 120.833 0.349 . . . . 0.0 110.808 -178.201 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 59' ' ' ARG . . . . . . . . . . . . . 57.2 ttp180 -100.34 122.92 43.88 Favored 'General case' 0 C--N 1.328 -0.357 0 N-CA-C 108.919 -0.771 . . . . 0.0 108.919 173.613 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 40.1 t -70.25 124.62 26.74 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.327 0 C-N-CA 120.718 -0.393 . . . . 0.0 110.396 -174.21 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 42.9 mt-10 -131.04 160.69 33.88 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 115.851 -0.613 . . . . 0.0 109.907 176.798 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 62' ' ' ASP . . . . . . . . . . . . . 70.6 m-20 -52.36 -31.72 35.0 Favored 'General case' 0 CA--C 1.533 0.314 0 N-CA-C 111.957 0.355 . . . . 0.0 111.957 179.137 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 63' ' ' ARG . . . . . . . . . . . . . 79.3 mtp180 -71.41 -21.74 61.95 Favored 'General case' 0 CA--C 1.532 0.281 0 N-CA-C 113.026 0.75 . . . . 0.0 113.026 -175.5 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 19.4 m -70.81 140.56 51.25 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-O 120.948 0.404 . . . . 0.0 111.288 -173.786 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 65' ' ' LYS . . . . . . . . . . . . . 97.8 mttt -89.24 136.7 32.88 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-N 115.936 -0.575 . . . . 0.0 109.972 177.407 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 66' ' ' ILE . . . . . . . . . . . . . 65.4 mt -123.02 128.8 75.27 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.264 0 N-CA-C 110.009 -0.367 . . . . 0.0 110.009 -178.575 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 67' ' ' THR . . . . . . . . . . . . . 9.3 m -124.04 144.24 49.96 Favored 'General case' 0 N--CA 1.463 0.213 0 CA-C-O 120.951 0.405 . . . . 0.0 111.421 -176.224 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 68' ' ' LEU . . . . . . . . . . . . . 5.9 tt -104.56 123.95 48.44 Favored 'General case' 0 C--N 1.332 -0.158 0 CA-C-N 116.041 -0.527 . . . . 0.0 110.283 178.83 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 69' ' ' VAL . . . . . . . . . . . . . 41.9 t -104.47 142.23 18.33 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.277 0 CA-C-O 121.021 0.439 . . . . 0.0 111.163 -177.549 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 70' ' ' THR . . . . . . . . . . . . . 7.4 p -130.1 173.6 10.59 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-N 115.814 -0.63 . . . . 0.0 109.505 174.926 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 71' ' ' HIS . . . . . . . . . . . . . 7.4 t60 -120.17 61.06 7.6 Favored Pre-proline 0 CA--C 1.538 0.483 0 N-CA-C 112.247 0.462 . . . . 0.0 112.247 -176.608 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 72' ' ' PRO . . . . . . . . . . . . . 62.0 Cg_endo -91.9 156.89 3.37 Favored 'Trans proline' 0 N--CA 1.491 1.381 0 C-N-CA 121.762 1.641 . . . . 0.0 111.102 168.137 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 73' ' ' VAL . . . . . . . . . . . . . 35.4 m -71.88 141.91 16.03 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.175 0 C-N-CA 120.562 -0.455 . . . . 0.0 110.332 177.946 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 74' ' ' ASP . . . . . . . . . . . . . 17.9 t0 -97.68 124.89 42.17 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 115.867 -0.606 . . . . 0.0 109.744 179.712 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 40.6 t -115.75 124.48 72.21 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.311 0 CA-C-O 121.061 0.458 . . . . 0.0 110.682 -176.163 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 76' ' ' LEU . . . . . . . . . . . . . 6.4 mp -122.43 142.72 50.25 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-N 115.848 -0.615 . . . . 0.0 110.007 176.358 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 77' ' ' GLU . . . . . . . . . . . . . 96.8 mt-10 -134.38 143.12 47.44 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-O 121.097 0.475 . . . . 0.0 111.242 179.739 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 78' ' ' ALA . . . . . . . . . . . . . . . -129.83 145.17 51.59 Favored 'General case' 0 C--N 1.332 -0.185 0 CA-C-N 115.712 -0.676 . . . . 0.0 109.997 176.492 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 79' ' ' LYS . . . . . . . . . . . . . 33.8 mmtm -77.39 116.7 18.2 Favored 'General case' 0 C--N 1.331 -0.219 0 CA-C-N 116.374 -0.375 . . . . 0.0 110.405 179.538 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 80' ' ' ILE . . . . . . . . . . . . . 35.3 mm -139.11 106.78 3.04 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.251 0 N-CA-C 109.26 -0.644 . . . . 0.0 109.26 -178.243 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 81' ' ' LYS . . . . . . . . . . . . . 38.7 tttp -109.77 130.93 55.47 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-O 120.971 0.415 . . . . 0.0 111.104 -177.135 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . 88.99 42.07 5.73 Favored Glycine 0 CA--C 1.525 0.689 0 C-N-CA 121.03 -0.605 . . . . 0.0 111.66 175.336 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 83' ' ' ILE . . . . . . . . . . . . . 67.9 mt -74.02 137.1 23.9 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.265 0 N-CA-C 110.007 -0.368 . . . . 0.0 110.007 179.307 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 84' ' ' LYS . . . . . . . . . . . . . 58.0 tttp -96.26 -52.88 3.82 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-N 116.007 -0.542 . . . . 0.0 109.875 179.035 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 85' ' ' ASP . . . . . . . . . . . . . 4.0 t70 -155.67 157.26 36.37 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 115.871 -0.604 . . . . 0.0 110.593 -179.101 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 86' ' ' VAL . . . . . . . . . . . . . 45.2 t -132.37 135.89 57.16 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.204 0 CA-C-O 120.994 0.426 . . . . 0.0 110.408 179.856 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 87' ' ' ILE . . . . . . . . . . . . . 42.3 mm -116.16 123.14 71.03 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.356 0 N-CA-C 109.161 -0.681 . . . . 0.0 109.161 176.968 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 88' ' ' LEU . . . . . . . . . . . . . 14.0 tp -109.61 130.47 55.51 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-O 121.075 0.464 . . . . 0.0 110.956 -176.597 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 89' ' ' ASP . . . . . . . . . . . . . 10.9 t70 -128.95 154.86 46.16 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-N 115.87 -0.604 . . . . 0.0 109.489 177.162 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 76.2 tt0 -48.22 -35.58 12.17 Favored 'General case' 0 C--N 1.329 -0.307 0 N-CA-C 112.808 0.669 . . . . 0.0 112.808 -172.444 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 91' ' ' ASN . . . . . . . . . . . . . 94.5 m-20 -128.43 18.3 6.4 Favored 'General case' 0 N--CA 1.469 0.487 0 N-CA-C 113.127 0.788 . . . . 0.0 113.127 -176.519 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 92' ' ' LEU . . . . . . . . . . . . . 28.5 mt -149.66 147.48 28.15 Favored 'General case' 0 C--N 1.331 -0.226 0 CA-C-O 121.0 0.429 . . . . 0.0 110.752 -177.637 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 93' ' ' ILE . . . . . . . . . . . . . 65.7 mt -127.0 113.48 32.86 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.315 0 N-CA-C 108.892 -0.781 . . . . 0.0 108.892 177.284 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 94' ' ' VAL . . . . . . . . . . . . . 45.4 t -116.08 129.42 72.5 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.241 0 N-CA-C 110.044 -0.354 . . . . 0.0 110.044 -177.93 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 95' ' ' VAL . . . . . . . . . . . . . 41.4 t -122.74 135.17 63.69 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.388 0 CA-C-N 116.111 -0.495 . . . . 0.0 110.078 -178.338 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 96' ' ' ILE . . . . . . . . . . . . . 66.0 mt -115.62 128.61 72.8 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.271 0 N-CA-C 109.364 -0.606 . . . . 0.0 109.364 178.278 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 97' ' ' THR . . . . . . . . . . . . . 79.0 p -102.43 159.51 15.36 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-O 121.132 0.492 . . . . 0.0 111.386 -177.675 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 98' ' ' GLU . . . . . . . . . . . . . 45.6 mt-10 -54.06 -25.88 23.86 Favored 'General case' 0 CA--C 1.532 0.264 0 N-CA-C 112.335 0.494 . . . . 0.0 112.335 179.736 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 99' ' ' GLU . . . . . . . . . . . . . 95.8 mt-10 -77.84 13.48 1.35 Allowed 'General case' 0 CA--C 1.535 0.37 0 N-CA-C 113.167 0.803 . . . . 0.0 113.167 -178.048 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 100' ' ' ASN . . . . . . . . . . . . . 3.3 m-20 60.87 36.59 18.93 Favored 'General case' 0 CA--C 1.529 0.173 0 CA-C-O 120.956 0.408 . . . . 0.0 110.998 -179.833 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 101' ' ' GLU . . . . . . . . . . . . . 82.9 tt0 -113.59 143.22 44.92 Favored 'General case' 0 C--N 1.332 -0.178 0 N-CA-C 109.381 -0.6 . . . . 0.0 109.381 176.348 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 102' ' ' VAL . . . . . . . . . . . . . 43.1 t -115.29 125.74 72.64 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.356 0 CA-C-O 120.909 0.385 . . . . 0.0 109.996 -177.625 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 103' ' ' LEU . . . . . . . . . . . . . 23.4 mt -114.15 130.92 56.59 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 115.518 -0.764 . . . . 0.0 109.966 176.667 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 104' ' ' ILE . . . . . . . . . . . . . 67.8 mt -119.37 118.84 58.77 Favored 'Isoleucine or valine' 0 C--O 1.234 0.27 0 N-CA-C 110.118 -0.327 . . . . 0.0 110.118 -179.846 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 105' ' ' PHE . . . . . . . . . . . . . 79.7 m-85 -117.98 164.07 15.64 Favored 'General case' 0 C--N 1.332 -0.182 0 O-C-N 123.979 0.799 . . . . 0.0 109.604 178.04 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 106' ' ' ASN . . . . . . . . . . . . . 44.2 p-10 -101.11 -170.49 1.85 Allowed 'General case' 0 C--N 1.331 -0.22 0 N-CA-C 109.992 -0.373 . . . . 0.0 109.992 173.652 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 107' ' ' GLN . . . . . . . . . . . . . 57.9 tt0 -57.43 -29.99 64.61 Favored 'General case' 0 CA--C 1.534 0.36 0 N-CA-C 111.839 0.311 . . . . 0.0 111.839 178.673 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 108' ' ' ASN . . . . . . . . . . . . . 60.3 t30 -83.94 7.42 18.37 Favored 'General case' 0 CA--C 1.536 0.434 0 N-CA-C 113.373 0.879 . . . . 0.0 113.373 -176.515 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 109' ' ' LEU . . . . . . . . . . . . . 11.2 tp 60.32 37.38 20.3 Favored 'General case' 0 CA--C 1.53 0.194 0 CA-C-O 120.955 0.407 . . . . 0.0 111.208 179.434 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 110' ' ' GLU . . . . . . . . . . . . . 70.8 mm-40 -106.88 160.95 15.13 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 116.466 -0.334 . . . . 0.0 110.169 177.85 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 111' ' ' GLU . . . . . . . . . . . . . 83.0 tt0 -85.31 122.75 29.92 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.312 -0.404 . . . . 0.0 110.801 -178.15 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 112' ' ' LEU . . . . . . . . . . . . . 17.0 mt -111.19 -46.11 3.35 Favored 'General case' 0 C--N 1.332 -0.189 0 CA-C-N 116.223 -0.444 . . . . 0.0 110.566 177.176 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 113' ' ' TYR . . . . . . . . . . . . . 46.8 t80 -141.67 139.71 33.05 Favored 'General case' 0 C--N 1.332 -0.195 0 CA-C-N 116.371 -0.377 . . . . 0.0 110.97 179.895 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 114' ' ' ARG . . . . . . . . . . . . . 58.7 ttp180 -143.09 116.02 8.81 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.068 -0.515 . . . . 0.0 110.125 178.921 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 115' ' ' GLY . . . . . . . . . . . . . . . -150.26 163.05 29.43 Favored Glycine 0 CA--C 1.525 0.678 0 N-CA-C 111.0 -0.84 . . . . 0.0 111.0 -179.506 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 116' ' ' LYS . . . . . . . . . . . . . 34.5 ttmt -128.38 137.54 51.94 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-O 120.723 0.297 . . . . 0.0 110.27 177.229 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 117' ' ' PHE . . . . . . . . . . . . . 54.4 m-85 -131.47 114.95 15.54 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.324 -0.398 . . . . 0.0 110.286 -177.007 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 118' ' ' GLU . . . . . . . . . . . . . 46.4 tp10 -53.76 -47.81 70.35 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.554 -0.294 . . . . 0.0 111.491 -176.067 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 119' ' ' ASN . . . . . . . . . . . . . 6.4 m120 -97.14 31.02 2.55 Favored 'General case' 0 C--N 1.329 -0.302 0 N-CA-C 112.088 0.403 . . . . 0.0 112.088 -174.126 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 120' ' ' LEU . . . . . . . . . . . . . 12.3 tp -56.63 122.22 11.55 Favored 'General case' 0 C--N 1.331 -0.224 0 C-N-CA 121.026 -0.27 . . . . 0.0 110.496 179.08 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 121' ' ' ASN . . . . . . . . . . . . . 29.2 m120 -112.78 -44.01 3.37 Favored 'General case' 0 C--O 1.232 0.157 0 CA-C-N 116.564 -0.289 . . . . 0.0 111.115 -177.299 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 122' ' ' LYS . . . . . . . . . . . . . 96.1 mttt -146.42 149.17 33.2 Favored 'General case' 0 C--N 1.331 -0.218 0 CA-C-O 120.996 0.427 . . . . 0.0 111.725 -179.544 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 123' ' ' VAL . . . . . . . . . . . . . 44.5 t -126.87 123.48 62.77 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.327 0 N-CA-C 108.971 -0.752 . . . . 0.0 108.971 171.628 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 124' ' ' LEU . . . . . . . . . . . . . 13.6 tp -120.54 137.31 54.45 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.395 -0.366 . . . . 0.0 110.537 -175.703 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 125' ' ' VAL . . . . . . . . . . . . . 43.9 t -125.36 132.76 70.67 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.243 0 CA-C-N 116.101 -0.499 . . . . 0.0 110.27 -179.412 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 126' ' ' ARG . . . . . . . . . . . . . 40.3 mmt180 -131.77 108.06 9.19 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 115.96 -0.563 . . . . 0.0 109.933 176.686 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 127' ' ' ASN . . . . . . . . . . . . . 7.8 m120 54.12 -104.83 0.23 Allowed 'General case' 0 CA--C 1.543 0.688 0 CA-C-O 119.037 -0.506 . . . . 0.0 110.935 179.85 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 128' ' ' ASP . . . . . . . . . . . . . 7.5 p-10 -113.31 4.17 16.28 Favored 'General case' 0 N--CA 1.468 0.458 0 CA-C-N 119.575 1.08 . . . . 0.0 113.387 -176.886 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 129' ' ' LEU . . . . . . . . . . . . . 76.3 mt -104.97 139.51 39.57 Favored 'General case' 0 C--N 1.332 -0.162 0 CA-C-N 118.17 0.441 . . . . 0.0 110.051 177.412 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 130' ' ' VAL . . . . . . . . . . . . . 44.8 t -120.5 135.45 60.68 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.223 0 CA-C-N 116.271 -0.422 . . . . 0.0 110.004 -177.485 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 131' ' ' VAL . . . . . . . . . . . . . 42.7 t -132.6 132.53 59.94 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.29 0 CA-C-O 120.985 0.421 . . . . 0.0 109.993 177.562 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 132' ' ' ILE . . . . . . . . . . . . . 70.8 mt -115.3 130.76 69.31 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 N-CA-C 109.251 -0.648 . . . . 0.0 109.251 178.903 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 133' ' ' ILE . . . . . . . . . . . . . 43.1 mm -115.97 121.11 66.72 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.287 0 CA-C-N 116.305 -0.407 . . . . 0.0 110.531 -175.651 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 134' ' ' ASP . . . . . . . . . . . . . 7.1 p-10 -133.0 149.98 52.19 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.045 -0.525 . . . . 0.0 109.626 175.8 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 135' ' ' GLU . . . . . . . . . . . . . 78.7 tt0 -49.79 -25.99 3.54 Favored 'General case' 0 C--N 1.327 -0.391 0 N-CA-C 113.005 0.743 . . . . 0.0 113.005 -169.244 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 136' ' ' GLN . . . . . . . . . . . . . 87.7 mt-30 -103.95 -27.43 12.17 Favored 'General case' 0 N--CA 1.465 0.32 0 N-CA-C 112.955 0.724 . . . . 0.0 112.955 -174.745 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 137' ' ' LYS . . . . . . . . . . . . . 60.5 mtpt -140.48 152.54 45.7 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-O 121.333 0.587 . . . . 0.0 111.775 -170.227 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 138' ' ' LEU . . . . . . . . . . . . . 5.1 tt -117.7 121.69 41.53 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 115.504 -0.771 . . . . 0.0 109.145 172.684 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 139' ' ' THR . . . . . . . . . . . . . 26.5 m -108.5 126.63 53.13 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.425 -0.352 . . . . 0.0 110.604 -177.242 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 140' ' ' LEU . . . . . . . . . . . . . 12.9 tp -113.63 119.07 36.19 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 115.651 -0.704 . . . . 0.0 109.156 -179.73 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 141' ' ' ILE . . . . . . . . . . . . . 19.4 mt -119.02 120.73 64.88 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.328 0 N-CA-C 109.851 -0.426 . . . . 0.0 109.851 -174.734 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 142' ' ' ARG . . . . . . . . . . . . . 81.1 mtm180 -110.7 125.46 53.5 Favored 'General case' 0 C--N 1.331 -0.218 0 CA-C-N 115.677 -0.692 . . . . 0.0 110.203 -178.493 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 143' ' ' THR . . . . . . . . . . . . . 82.3 p . . . . . 0 C--O 1.22 -0.483 0 CA-C-O 118.04 -0.981 . . . . 0.0 110.589 -179.199 . . . . . . . . 0 0 . 1 . 015 nuclear orig full ' B' B ' -3' ' ' GLU . . . . . . . . . . . . . 73.7 tt0 . . . . . 0 N--CA 1.49 1.543 0 N-CA-C 109.112 -0.699 . . . . 0.0 109.112 . . . . . . . . . 0 0 . 1 . 015 nuclear orig full ' B' B ' -2' ' ' GLY . . . . . . . . . . . . . . . -82.95 149.75 27.01 Favored Glycine 0 CA--C 1.524 0.617 0 N-CA-C 110.721 -0.951 . . . . 0.0 110.721 178.58 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' B' B ' -1' ' ' VAL . . . . . . . . . . . . . 46.0 t -86.95 133.06 30.88 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.295 0 N-CA-C 109.793 -0.447 . . . . 0.0 109.793 179.826 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' B' B ' 0' ' ' ILE . . . . . . . . . . . . . 43.7 mm -96.2 126.9 48.71 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.346 0 CA-C-N 116.248 -0.433 . . . . 0.0 110.011 -178.699 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' B' B ' 1' ' ' MET . . . . . . . . . . . . . 23.5 ptm -81.21 133.72 35.5 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.191 -0.458 . . . . 0.0 111.005 -177.715 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' B' B ' 2' ' ' SER . . . . . . . . . . . . . 7.0 p -124.47 134.91 52.9 Favored 'General case' 0 C--N 1.331 -0.199 0 CA-C-N 116.124 -0.489 . . . . 0.0 110.59 179.831 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' B' B ' 3' ' ' GLU . . . . . . . . . . . . . 92.4 mt-10 -141.74 142.02 33.26 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 115.977 -0.556 . . . . 0.0 110.821 -179.299 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' B' B ' 4' ' ' LEU . . . . . . . . . . . . . 18.6 tp -127.41 130.95 50.26 Favored 'General case' 0 C--N 1.331 -0.23 0 CA-C-N 116.37 -0.377 . . . . 0.0 110.219 176.179 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' B' B ' 5' ' ' LYS . . . . . . . . . . . . . 68.5 mttm -110.64 120.46 42.49 Favored 'General case' 0 C--N 1.331 -0.215 0 CA-C-N 116.347 -0.388 . . . . 0.0 110.581 179.393 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' B' B ' 6' ' ' LEU . . . . . . . . . . . . . 65.5 mt -114.82 147.94 39.15 Favored 'General case' 0 C--N 1.331 -0.225 0 CA-C-N 115.303 -0.862 . . . . 0.0 110.687 -178.492 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' B' B ' 7' ' ' LYS . . . . . . . . . . . . . 74.7 tttt -133.55 135.06 24.42 Favored Pre-proline 0 CA--C 1.535 0.366 0 CA-C-O 118.848 -0.596 . . . . 0.0 109.933 176.174 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' B' B ' 8' ' ' PRO . . . . . . . . . . . . . 93.9 Cg_endo -90.79 142.26 3.25 Favored 'Trans proline' 0 N--CA 1.489 1.263 0 C-N-CA 121.666 1.577 . . . . 0.0 111.721 177.579 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' B' B ' 9' ' ' LEU . . . . . . . . . . . . . 47.0 mt -81.13 -47.22 1.13 Allowed Pre-proline 0 CA--C 1.533 0.323 0 CA-C-O 118.714 -0.66 . . . . 0.0 112.258 -178.544 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' B' B ' 10' ' ' PRO . . . . . . . . . . . . . 86.5 Cg_endo -80.69 150.46 18.85 Favored 'Trans proline' 0 N--CA 1.497 1.722 0 C-N-CA 121.179 1.253 . . . . 0.0 111.879 175.17 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' B' B ' 11' ' ' LYS . . . . . . . . . . . . . 33.9 ttmt -85.65 100.04 11.7 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-O 120.879 0.371 . . . . 0.0 110.57 178.463 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' B' B ' 12' ' ' VAL . . . . . . . . . . . . . 12.1 p -143.66 138.82 25.7 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.273 0 CA-C-N 116.125 -0.489 . . . . 0.0 110.493 179.22 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' B' B ' 13' ' ' GLU . . . . . . . . . . . . . 15.0 mm-40 -74.93 129.49 37.74 Favored 'General case' 0 C--N 1.329 -0.316 0 N-CA-C 109.955 -0.387 . . . . 0.0 109.955 177.098 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' B' B ' 14' ' ' LEU . . . . . . . . . . . . . 33.2 mt -97.86 146.32 31.26 Favored Pre-proline 0 CA--C 1.533 0.304 0 CA-C-O 119.142 -0.456 . . . . 0.0 110.265 -179.379 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' B' B ' 15' ' ' PRO . . . . . . . . . . . . . 26.2 Cg_exo -61.96 160.04 31.36 Favored 'Trans proline' 0 N--CA 1.498 1.768 0 C-N-CA 121.251 1.3 . . . . 0.0 112.001 177.818 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' B' B ' 16' ' ' PRO . . . . . . . . . . . . . 27.5 Cg_exo -60.37 -35.04 92.69 Favored 'Trans proline' 0 N--CA 1.496 1.634 0 C-N-CA 121.452 1.435 . . . . 0.0 112.659 -179.446 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' B' B ' 17' ' ' ASP . . . . . . . . . . . . . 10.3 p-10 -87.61 9.49 21.07 Favored 'General case' 0 CA--C 1.535 0.399 0 N-CA-C 113.168 0.803 . . . . 0.0 113.168 -178.073 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' B' B ' 18' ' ' PHE . . . . . . . . . . . . . 28.8 t80 -57.25 -41.38 79.51 Favored 'General case' 0 CA--C 1.527 0.073 0 O-C-N 121.939 -0.476 . . . . 0.0 110.296 -178.971 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' B' B ' 19' ' ' VAL . . . . . . . . . . . . . 50.0 t -56.94 -42.73 79.28 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 CA-C-N 116.399 -0.364 . . . . 0.0 110.396 -179.983 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' B' B ' 20' ' ' ASP . . . . . . . . . . . . . 4.9 t70 -60.28 -39.68 87.76 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-O 120.849 0.357 . . . . 0.0 110.747 -178.603 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' B' B ' 21' ' ' VAL . . . . . . . . . . . . . 46.2 t -64.28 -47.99 87.37 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.314 0 C-N-CA 120.755 -0.378 . . . . 0.0 110.24 -179.316 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' B' B ' 22' ' ' ILE . . . . . . . . . . . . . 51.7 mm -55.59 -58.04 5.93 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.237 0 C-N-CA 120.954 -0.298 . . . . 0.0 111.171 -178.38 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' B' B ' 23' ' ' ARG . . . . . . . . . . . . . 12.0 ptm180 -55.85 -42.97 76.59 Favored 'General case' 0 CA--C 1.531 0.223 0 C-N-CA 120.527 -0.469 . . . . 0.0 111.792 -173.797 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' B' B ' 24' ' ' ILE . . . . . . . . . . . . . 75.5 mt -60.81 -44.17 96.98 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.264 0 C-N-CA 120.815 -0.354 . . . . 0.0 111.421 -177.958 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' B' B ' 25' ' ' LYS . . . . . . . . . . . . . 68.6 mttm -67.71 -42.66 81.64 Favored 'General case' 0 C--N 1.329 -0.311 0 N-CA-C 112.558 0.577 . . . . 0.0 112.558 -178.306 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' B' B ' 26' ' ' LEU . . . . . . . . . . . . . 29.3 mt -79.45 -35.83 39.77 Favored 'General case' 0 C--N 1.33 -0.265 0 N-CA-C 113.522 0.934 . . . . 0.0 113.522 -170.782 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' B' B ' 27' ' ' GLN . . . . . . . . . . . . . 9.4 pt20 -47.13 138.62 6.69 Favored 'General case' 0 N--CA 1.47 0.556 0 N-CA-C 112.742 0.645 . . . . 0.0 112.742 -175.502 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' B' B ' 28' ' ' GLY . . . . . . . . . . . . . . . 98.4 -23.19 37.24 Favored Glycine 0 CA--C 1.534 1.279 0 CA-C-N 115.636 -0.711 . . . . 0.0 112.386 -177.298 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' B' B ' 29' ' ' LYS . . . . . . . . . . . . . 64.6 mttp -97.64 155.1 17.14 Favored 'General case' 0 C--O 1.233 0.229 0 CA-C-N 117.382 0.591 . . . . 0.0 111.084 179.297 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' B' B ' 30' ' ' THR . . . . . . . . . . . . . 27.4 m -102.95 135.87 43.82 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.119 -0.491 . . . . 0.0 109.87 175.565 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' B' B ' 31' ' ' VAL . . . . . . . . . . . . . 34.9 m -128.48 153.85 38.51 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.212 0 CA-C-O 120.928 0.394 . . . . 0.0 110.706 -178.161 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' B' B ' 32' ' ' ARG . . . . . . . . . . . . . 91.8 mtm-85 -132.68 147.71 52.33 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-O 121.283 0.563 . . . . 0.0 110.883 179.868 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' B' B ' 33' ' ' THR . . . . . . . . . . . . . 26.4 m -53.23 140.18 27.19 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.127 -0.488 . . . . 0.0 111.344 -177.971 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' B' B ' 34' ' ' GLY . . . . . . . . . . . . . . . 100.15 -17.09 57.55 Favored Glycine 0 CA--C 1.533 1.166 0 CA-C-O 119.608 -0.551 . . . . 0.0 113.22 179.574 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' B' B ' 35' ' ' ASP . . . . . . . . . . . . . 76.9 m-20 -65.19 148.92 50.82 Favored 'General case' 0 C--N 1.333 -0.109 0 CA-C-N 118.037 0.918 . . . . 0.0 111.08 178.924 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' B' B ' 36' ' ' VAL . . . . . . . . . . . . . 46.8 t -120.53 129.95 75.02 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.275 0 CA-C-N 115.83 -0.623 . . . . 0.0 109.625 177.337 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' B' B ' 37' ' ' ILE . . . . . . . . . . . . . 70.0 mt -118.8 138.93 47.91 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.274 0 CA-C-N 116.137 -0.483 . . . . 0.0 109.867 -178.242 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' B' B ' 38' ' ' GLY . . . . . . . . . . . . . . . -115.36 128.88 8.28 Favored Glycine 0 CA--C 1.525 0.707 0 N-CA-C 110.915 -0.874 . . . . 0.0 110.915 179.596 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' B' B ' 39' ' ' ILE . . . . . . . . . . . . . 76.2 mt -125.09 137.0 59.07 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.28 0 N-CA-C 110.195 -0.298 . . . . 0.0 110.195 -179.839 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' B' B ' 40' ' ' SER . . . . . . . . . . . . . 32.0 t -93.12 122.94 36.02 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.346 -0.388 . . . . 0.0 110.726 175.181 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' B' B ' 41' ' ' ILE . . . . . . . . . . . . . 71.4 mt -129.19 118.33 45.98 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.226 0 CA-C-O 120.929 0.395 . . . . 0.0 110.344 178.367 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' B' B ' 42' ' ' LEU . . . . . . . . . . . . . 1.3 tt 50.68 45.27 27.16 Favored 'General case' 0 N--CA 1.465 0.288 0 CA-C-O 121.421 0.629 . . . . 0.0 111.047 176.621 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' B' B ' 43' ' ' GLY . . . . . . . . . . . . . . . 70.43 24.7 76.56 Favored Glycine 0 CA--C 1.531 1.064 0 C-N-CA 121.093 -0.575 . . . . 0.0 112.585 175.433 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' B' B ' 44' ' ' LYS . . . . . . . . . . . . . 35.5 ttpt -136.57 133.43 36.38 Favored 'General case' 0 C--N 1.333 -0.145 0 CA-C-N 117.438 0.619 . . . . 0.0 110.213 179.672 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' B' B ' 45' ' ' GLU . . . . . . . . . . . . . 68.0 tt0 -84.08 127.8 34.14 Favored 'General case' 0 C--N 1.326 -0.419 0 CA-C-N 116.437 -0.347 . . . . 0.0 111.203 -177.096 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' B' B ' 46' ' ' VAL . . . . . . . . . . . . . 7.5 p -125.51 128.38 72.42 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.2 0 CA-C-O 121.138 0.494 . . . . 0.0 109.837 175.88 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' B' B ' 47' ' ' LYS . . . . . . . . . . . . . 34.0 mmtp -100.29 131.78 46.03 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 115.789 -0.641 . . . . 0.0 111.457 178.417 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' B' B ' 48' ' ' PHE . . . . . . . . . . . . . 96.3 m-85 -118.04 131.98 56.41 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 115.976 -0.556 . . . . 0.0 109.812 175.313 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' B' B ' 49' ' ' LYS . . . . . . . . . . . . . 83.4 tttt -106.95 138.68 42.66 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.757 -0.202 . . . . 0.0 110.468 178.984 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' B' B ' 50' ' ' VAL . . . . . . . . . . . . . 43.4 t -84.14 108.57 16.57 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.298 0 N-CA-C 109.423 -0.584 . . . . 0.0 109.423 176.768 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' B' B ' 51' ' ' VAL . . . . . . . . . . . . . 47.1 t -73.51 -51.79 23.9 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.277 0 CA-C-N 116.022 -0.536 . . . . 0.0 109.842 -174.603 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' B' B ' 52' ' ' GLN . . . . . . . . . . . . . 88.0 mt-30 -153.89 151.45 29.48 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-N 116.06 -0.518 . . . . 0.0 111.769 -177.912 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' B' B ' 53' ' ' ALA . . . . . . . . . . . . . . . -130.85 134.61 46.96 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 115.371 -0.832 . . . . 0.0 109.651 174.468 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' B' B ' 54' ' ' TYR . . . . . . . . . . . . . 35.8 t80 -129.09 114.2 18.65 Favored Pre-proline 0 CA--C 1.535 0.366 0 CA-C-O 118.062 -0.97 . . . . 0.0 110.407 178.669 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' B' B ' 55' ' ' PRO . . . . . . . . . . . . . 74.1 Cg_endo -77.2 166.19 82.81 Favored 'Cis proline' 0 N--CA 1.5 1.875 0 CA-C-N 122.181 1.815 . . . . 0.0 112.081 -7.468 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' B' B ' 56' ' ' SER . . . . . . . . . . . . . 13.7 m -115.79 127.38 26.83 Favored Pre-proline 0 CA--C 1.538 0.502 0 CA-C-O 118.436 -0.793 . . . . 0.0 109.048 175.297 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' B' B ' 57' ' ' PRO . . . . . . . . . . . . . 44.3 Cg_endo -68.09 146.95 79.3 Favored 'Cis proline' 0 N--CA 1.498 1.75 0 CA-C-N 121.981 1.743 . . . . 0.0 111.855 2.007 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' B' B ' 58' ' ' LEU . . . . . . . . . . . . . 22.7 tp -108.31 137.1 46.85 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.158 -0.473 . . . . 0.0 110.556 -179.381 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' B' B ' 59' ' ' ARG . . . . . . . . . . . . . 23.6 ttm180 -100.91 124.85 47.22 Favored 'General case' 0 C--N 1.326 -0.434 0 N-CA-C 109.341 -0.614 . . . . 0.0 109.341 176.281 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' B' B ' 60' ' ' VAL . . . . . . . . . . . . . 40.9 t -82.68 120.16 33.56 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.281 0 C-N-CA 120.739 -0.385 . . . . 0.0 110.684 -174.374 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' B' B ' 61' ' ' GLU . . . . . . . . . . . . . 71.0 mm-40 -131.17 155.98 46.1 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 115.926 -0.579 . . . . 0.0 109.845 175.138 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' B' B ' 62' ' ' ASP . . . . . . . . . . . . . 21.6 m-20 -52.25 -33.86 43.45 Favored 'General case' 0 C--N 1.328 -0.33 0 N-CA-C 111.842 0.312 . . . . 0.0 111.842 -179.998 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' B' B ' 63' ' ' ARG . . . . . . . . . . . . . 94.6 mtt180 -73.17 -21.89 60.6 Favored 'General case' 0 CA--C 1.532 0.273 0 N-CA-C 113.05 0.759 . . . . 0.0 113.05 -176.559 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' B' B ' 64' ' ' THR . . . . . . . . . . . . . 27.1 m -62.61 143.42 57.31 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-O 120.731 0.3 . . . . 0.0 110.514 -176.983 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' B' B ' 65' ' ' LYS . . . . . . . . . . . . . 54.6 mttm -85.18 124.17 31.53 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.283 -0.417 . . . . 0.0 110.097 179.38 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' B' B ' 66' ' ' ILE . . . . . . . . . . . . . 58.2 mt -115.22 124.06 71.44 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.307 0 N-CA-C 109.646 -0.502 . . . . 0.0 109.646 -179.42 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' B' B ' 67' ' ' THR . . . . . . . . . . . . . 14.4 m -127.64 144.58 51.06 Favored 'General case' 0 C--N 1.333 -0.151 0 CA-C-O 121.01 0.433 . . . . 0.0 111.118 -176.617 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' B' B ' 68' ' ' LEU . . . . . . . . . . . . . 6.5 mp -107.06 140.63 39.57 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.132 -0.485 . . . . 0.0 110.901 178.538 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' B' B ' 69' ' ' VAL . . . . . . . . . . . . . 42.7 t -95.27 147.46 5.83 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 CA-C-N 115.883 -0.598 . . . . 0.0 110.23 179.728 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' B' B ' 70' ' ' THR . . . . . . . . . . . . . 69.5 p -84.69 166.08 17.35 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-O 120.973 0.416 . . . . 0.0 110.957 -178.32 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' B' B ' 71' ' ' HIS . . . . . . . . . . . . . 65.8 m80 -75.01 161.95 75.39 Favored Pre-proline 0 CA--C 1.532 0.277 0 CA-C-N 115.999 -0.546 . . . . 0.0 111.221 -177.784 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' B' B ' 72' ' ' PRO . . . . . . . . . . . . . 72.6 Cg_endo -87.93 159.98 7.41 Favored 'Trans proline' 0 N--CA 1.489 1.263 0 C-N-CA 121.878 1.718 . . . . 0.0 112.773 -179.232 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' B' B ' 73' ' ' VAL . . . . . . . . . . . . . 34.7 m -70.04 179.58 0.35 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.295 0 CA-C-N 116.094 -0.503 . . . . 0.0 110.83 -179.956 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' B' B ' 74' ' ' ASP . . . . . . . . . . . . . 19.3 t0 -104.62 123.61 47.87 Favored 'General case' 0 C--N 1.331 -0.225 0 CA-C-N 116.389 -0.368 . . . . 0.0 110.087 -179.699 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' B' B ' 75' ' ' VAL . . . . . . . . . . . . . 42.6 t -117.44 121.72 68.24 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.221 0 CA-C-O 120.993 0.425 . . . . 0.0 110.538 -178.381 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' B' B ' 76' ' ' LEU . . . . . . . . . . . . . 5.7 mp -120.99 142.09 50.11 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 115.846 -0.615 . . . . 0.0 109.904 176.012 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' B' B ' 77' ' ' GLU . . . . . . . . . . . . . 97.5 mt-10 -133.59 134.89 43.85 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-O 121.01 0.433 . . . . 0.0 110.962 -178.991 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' B' B ' 78' ' ' ALA . . . . . . . . . . . . . . . -122.82 140.88 52.45 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 115.896 -0.593 . . . . 0.0 109.977 177.26 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' B' B ' 79' ' ' LYS . . . . . . . . . . . . . 70.4 mmtt -75.0 115.86 15.09 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-O 120.972 0.415 . . . . 0.0 110.442 179.905 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' B' B ' 80' ' ' ILE . . . . . . . . . . . . . 35.2 mm -139.04 105.87 2.74 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.328 0 N-CA-C 109.022 -0.733 . . . . 0.0 109.022 -178.302 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' B' B ' 81' ' ' LYS . . . . . . . . . . . . . 54.6 pttt -115.44 132.29 56.67 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-O 121.1 0.476 . . . . 0.0 111.195 -177.313 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' B' B ' 82' ' ' GLY . . . . . . . . . . . . . . . 89.07 42.09 5.71 Favored Glycine 0 CA--C 1.526 0.731 0 N-CA-C 111.135 -0.786 . . . . 0.0 111.135 179.239 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' B' B ' 83' ' ' ILE . . . . . . . . . . . . . 72.6 mt -71.55 139.27 20.1 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.293 0 CA-C-O 120.827 0.346 . . . . 0.0 110.162 -179.813 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' B' B ' 84' ' ' LYS . . . . . . . . . . . . . 15.2 ttmm -96.55 -54.07 3.37 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-O 121.179 0.514 . . . . 0.0 109.939 178.2 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' B' B ' 85' ' ' ASP . . . . . . . . . . . . . 8.9 t70 -155.44 146.41 22.45 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 115.508 -0.769 . . . . 0.0 110.125 -179.425 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' B' B ' 86' ' ' VAL . . . . . . . . . . . . . 43.6 t -124.2 129.2 74.16 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.256 0 CA-C-O 120.93 0.395 . . . . 0.0 110.249 179.888 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' B' B ' 87' ' ' ILE . . . . . . . . . . . . . 44.2 mm -118.34 124.76 73.61 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.262 0 CA-C-N 115.887 -0.597 . . . . 0.0 109.496 177.297 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' B' B ' 88' ' ' LEU . . . . . . . . . . . . . 15.3 tp -114.26 124.36 51.84 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-O 121.088 0.471 . . . . 0.0 111.238 -176.898 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' B' B ' 89' ' ' ASP . . . . . . . . . . . . . 5.7 t70 -112.44 159.61 18.58 Favored 'General case' 0 C--N 1.33 -0.24 0 N-CA-C 108.99 -0.744 . . . . 0.0 108.99 175.419 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' B' B ' 90' ' ' GLU . . . . . . . . . . . . . 94.5 mt-10 -48.28 -42.61 31.3 Favored 'General case' 0 N--CA 1.465 0.291 0 N-CA-C 112.689 0.626 . . . . 0.0 112.689 -171.479 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' B' B ' 91' ' ' ASN . . . . . . . . . . . . . 33.8 p-10 -132.2 37.06 3.58 Favored 'General case' 0 N--CA 1.464 0.251 0 N-CA-C 111.753 0.279 . . . . 0.0 111.753 -178.691 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' B' B ' 92' ' ' LEU . . . . . . . . . . . . . 15.9 tp -160.6 140.1 10.82 Favored 'General case' 0 C--N 1.331 -0.237 0 C-N-CA 120.826 -0.35 . . . . 0.0 110.667 -177.877 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' B' B ' 93' ' ' ILE . . . . . 0.401 HD12 HG21 ' B' ' 93' ' ' ILE . 68.2 mt -122.7 123.12 67.61 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.198 0 N-CA-C 109.679 -0.489 . . . . 0.0 109.679 -178.663 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' B' B ' 94' ' ' VAL . . . . . . . . . . . . . 46.8 t -124.46 125.77 70.8 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.243 0 N-CA-C 109.718 -0.475 . . . . 0.0 109.718 177.629 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' B' B ' 95' ' ' VAL . . . . . . . . . . . . . 44.4 t -122.3 133.44 68.56 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.341 0 CA-C-N 116.022 -0.536 . . . . 0.0 109.789 -179.178 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' B' B ' 96' ' ' ILE . . . . . . . . . . . . . 51.7 mt -114.07 127.33 71.53 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.329 0 N-CA-C 108.782 -0.822 . . . . 0.0 108.782 178.301 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' B' B ' 97' ' ' THR . . . . . . . . . . . . . 82.7 p -99.0 153.76 18.61 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-O 121.292 0.568 . . . . 0.0 111.279 -176.85 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' B' B ' 98' ' ' GLU . . . . . . . . . . . . . 73.0 tt0 -53.97 -24.02 15.21 Favored 'General case' 0 C--N 1.325 -0.471 0 CA-C-N 115.811 -0.631 . . . . 0.0 112.166 179.322 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' B' B ' 99' ' ' GLU . . . . . . . . . . . . . 91.1 mt-10 -82.07 16.09 2.07 Favored 'General case' 0 CA--C 1.535 0.389 0 N-CA-C 113.082 0.771 . . . . 0.0 113.082 -176.981 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' B' B ' 100' ' ' ASN . . . . . . . . . . . . . 2.7 m-20 64.78 36.97 7.66 Favored 'General case' 0 CA--C 1.53 0.201 0 CA-C-O 121.001 0.429 . . . . 0.0 111.343 177.218 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' B' B ' 101' ' ' GLU . . . . . . . . . . . . . 82.7 tt0 -118.1 145.05 45.15 Favored 'General case' 0 C--N 1.331 -0.199 0 CA-C-N 116.147 -0.479 . . . . 0.0 110.031 175.294 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' B' B ' 102' ' ' VAL . . . . . . . . . . . . . 44.4 t -118.13 128.5 75.18 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.295 0 N-CA-C 110.137 -0.32 . . . . 0.0 110.137 -179.286 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' B' B ' 103' ' ' LEU . . . . . . . . . . . . . 6.1 mp -120.95 135.37 55.22 Favored 'General case' 0 C--N 1.331 -0.224 0 CA-C-N 115.94 -0.573 . . . . 0.0 110.489 177.642 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' B' B ' 104' ' ' ILE . . . . . . . . . . . . . 70.0 mt -121.82 124.74 72.11 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.276 0 CA-C-N 116.509 -0.314 . . . . 0.0 110.454 -179.848 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' B' B ' 105' ' ' PHE . . . . . . . . . . . . . 62.8 m-85 -123.23 166.0 15.98 Favored 'General case' 0 C--O 1.232 0.134 0 O-C-N 124.033 0.833 . . . . 0.0 109.873 -179.534 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' B' B ' 106' ' ' ASN . . . . . . . . . . . . . 43.7 p-10 -102.52 -170.66 1.84 Allowed 'General case' 0 CA--C 1.53 0.197 0 N-CA-C 110.164 -0.309 . . . . 0.0 110.164 173.894 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' B' B ' 107' ' ' GLN . . . . . . . . . . . . . 40.4 tt0 -59.05 -30.09 67.79 Favored 'General case' 0 C--N 1.33 -0.267 0 N-CA-C 112.085 0.402 . . . . 0.0 112.085 -179.265 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' B' B ' 108' ' ' ASN . . . . . . . . . . . . . 5.3 t30 -85.53 11.03 11.42 Favored 'General case' 0 CA--C 1.536 0.412 0 N-CA-C 113.052 0.76 . . . . 0.0 113.052 -176.915 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' B' B ' 109' ' ' LEU . . . . . . . . . . . . . 9.0 tp 60.59 34.81 20.15 Favored 'General case' 0 C--N 1.331 -0.215 0 CA-C-O 120.758 0.313 . . . . 0.0 111.558 178.905 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' B' B ' 110' ' ' GLU . . . . . . . . . . . . . 95.7 mt-10 -103.01 147.02 27.47 Favored 'General case' 0 C--N 1.33 -0.258 0 N-CA-C 109.68 -0.489 . . . . 0.0 109.68 176.205 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' B' B ' 111' ' ' GLU . . . . . . . . . . . . . 55.5 tt0 -85.49 121.88 28.83 Favored 'General case' 0 C--N 1.328 -0.362 0 C-N-CA 120.831 -0.348 . . . . 0.0 110.68 -177.273 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' B' B ' 112' ' ' LEU . . . . . . . . . . . . . 37.3 mt -104.39 -46.03 4.5 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.122 -0.49 . . . . 0.0 110.88 179.151 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' B' B ' 113' ' ' TYR . . . . . . . . . . . . . 66.3 t80 -136.5 144.9 44.55 Favored 'General case' 0 N--CA 1.464 0.23 0 CA-C-O 120.969 0.414 . . . . 0.0 111.132 -179.053 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' B' B ' 114' ' ' ARG . . . . . . . . . . . . . 14.3 ptt180 -146.55 124.39 11.94 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 115.621 -0.718 . . . . 0.0 110.365 178.765 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' B' B ' 115' ' ' GLY . . . . . . . . . . . . . . . -150.16 155.26 26.14 Favored Glycine 0 CA--C 1.523 0.539 0 N-CA-C 110.908 -0.877 . . . . 0.0 110.908 -179.948 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' B' B ' 116' ' ' LYS . . . . . . . . . . . . . 19.8 ttmt -126.66 140.46 52.4 Favored 'General case' 0 C--N 1.331 -0.228 0 N-CA-C 109.638 -0.504 . . . . 0.0 109.638 178.667 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' B' B ' 117' ' ' PHE . . . . . . . . . . . . . 32.2 m-85 -138.51 114.02 9.68 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-O 120.935 0.398 . . . . 0.0 110.258 -176.35 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' B' B ' 118' ' ' GLU . . . . . . . . . . . . . 75.1 tt0 -53.42 -49.73 66.7 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 116.528 -0.306 . . . . 0.0 111.432 -176.638 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' B' B ' 119' ' ' ASN . . . . . . . . . . . . . 33.7 m120 -91.45 30.47 1.3 Allowed 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.081 -0.508 . . . . 0.0 112.213 -174.324 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' B' B ' 120' ' ' LEU . . . . . . . . . . . . . 14.2 tp -56.73 122.14 11.42 Favored 'General case' 0 C--N 1.332 -0.154 0 CA-C-O 120.666 0.27 . . . . 0.0 110.459 178.579 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' B' B ' 121' ' ' ASN . . . . . . . . . . . . . 44.8 m-20 -114.01 -44.08 3.19 Favored 'General case' 0 C--N 1.332 -0.174 0 CA-C-N 116.485 -0.325 . . . . 0.0 110.956 -176.844 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' B' B ' 122' ' ' LYS . . . . . . . . . . . . . 99.1 mttt -143.76 148.64 35.91 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-O 121.027 0.441 . . . . 0.0 111.448 -177.765 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' B' B ' 123' ' ' VAL . . . . . . . . . . . . . 45.2 t -125.0 125.85 70.21 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.292 0 CA-C-N 115.885 -0.598 . . . . 0.0 109.572 175.605 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' B' B ' 124' ' ' LEU . . . . . . . . . . . . . 28.2 mt -112.08 125.44 54.1 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 116.239 -0.437 . . . . 0.0 110.333 -179.448 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' B' B ' 125' ' ' VAL . . . . . . . . . . . . . 44.2 t -133.54 126.4 51.71 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.276 0 CA-C-N 116.495 -0.32 . . . . 0.0 110.365 -179.124 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' B' B ' 126' ' ' ARG . . . . . . . . . . . . . 69.2 ttt-85 -162.61 141.67 9.0 Favored 'General case' 0 C--N 1.329 -0.32 0 N-CA-C 109.611 -0.515 . . . . 0.0 109.611 175.094 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' B' B ' 127' ' ' ASN . . . . . . . . . . . . . 10.1 p30 48.88 -151.99 0.13 Allowed 'General case' 0 CA--C 1.54 0.563 0 CA-C-O 119.373 -0.346 . . . . 0.0 111.001 178.988 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' B' B ' 128' ' ' ASP . . . . . . . . . . . . . 13.7 p-10 -83.55 21.54 1.19 Allowed 'General case' 0 CA--C 1.533 0.307 0 CA-C-N 118.512 0.596 . . . . 0.0 112.517 179.271 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' B' B ' 129' ' ' LEU . . . . . . . . . . . . . 17.1 tp -119.66 135.23 54.9 Favored 'General case' 0 C--O 1.233 0.235 0 CA-C-O 120.969 0.414 . . . . 0.0 110.327 179.541 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' B' B ' 130' ' ' VAL . . . . . . . . . . . . . 44.6 t -128.58 135.65 61.88 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.233 0 CA-C-N 115.961 -0.563 . . . . 0.0 109.802 179.322 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' B' B ' 131' ' ' VAL . . . . . . . . . . . . . 43.1 t -133.82 135.59 55.05 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.285 0 CA-C-O 120.924 0.392 . . . . 0.0 110.16 179.705 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' B' B ' 132' ' ' ILE . . . . . . . . . . . . . 72.8 mt -116.22 129.76 72.1 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.327 0 N-CA-C 109.341 -0.614 . . . . 0.0 109.341 -179.958 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' B' B ' 133' ' ' ILE . . . . . . . . . . . . . 41.9 mm -116.72 120.51 65.22 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.21 0 CA-C-O 120.807 0.337 . . . . 0.0 110.859 -175.779 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' B' B ' 134' ' ' ASP . . . . . . . . . . . . . 7.7 p-10 -134.22 145.59 49.31 Favored 'General case' 0 C--N 1.33 -0.265 0 N-CA-C 109.601 -0.518 . . . . 0.0 109.601 175.11 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' B' B ' 135' ' ' GLU . . . . . . . . . . . . . 73.9 tt0 -49.96 -25.45 3.3 Favored 'General case' 0 C--N 1.329 -0.309 0 N-CA-C 112.975 0.731 . . . . 0.0 112.975 -170.578 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' B' B ' 136' ' ' GLN . . . . . . . . . . . . . 97.1 mt-30 -96.81 -31.83 12.42 Favored 'General case' 0 C--O 1.234 0.276 0 N-CA-C 112.256 0.465 . . . . 0.0 112.256 -176.291 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' B' B ' 137' ' ' LYS . . . . . . . . . . . . . 92.5 mttt -139.53 152.87 47.27 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-O 121.172 0.511 . . . . 0.0 111.48 -170.408 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' B' B ' 138' ' ' LEU . . . . . . . . . . . . . 6.2 tt -119.34 119.55 34.33 Favored 'General case' 0 C--N 1.327 -0.4 0 N-CA-C 108.977 -0.749 . . . . 0.0 108.977 172.682 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' B' B ' 139' ' ' THR . . . . . . . . . . . . . 28.3 m -111.16 130.32 55.67 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-O 120.655 0.264 . . . . 0.0 110.803 -175.899 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' B' B ' 140' ' ' LEU . . . . . . . . . . . . . 10.6 tp -115.28 120.62 40.28 Favored 'General case' 0 C--N 1.328 -0.353 0 N-CA-C 109.299 -0.63 . . . . 0.0 109.299 -179.526 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' B' B ' 141' ' ' ILE . . . . . . . . . . . . . 19.5 mt -119.88 124.92 73.69 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.242 0 CA-C-O 121.077 0.465 . . . . 0.0 110.158 -175.044 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' B' B ' 142' ' ' ARG . . . . . . . . . . . . . 82.1 mtp180 -108.35 121.66 45.38 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 115.404 -0.816 . . . . 0.0 110.004 179.472 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' B' B ' 143' ' ' THR . . . . . . . . . . . . . 81.2 p . . . . . 0 C--O 1.219 -0.516 0 CA-C-O 117.932 -1.032 . . . . 0.0 110.747 -178.885 . . . . . . . . 0 0 . 1 . 015 nuclear orig full ' C' C ' -3' ' ' GLU . . . . . . . . . . . . . 21.9 pt-20 . . . . . 0 N--CA 1.491 1.62 0 N-CA-C 110.215 -0.291 . . . . 0.0 110.215 . . . . . . . . . 0 0 . 1 . 015 nuclear orig full ' C' C ' -2' ' ' GLY . . . . . . . . . . . . . . . -100.09 132.94 11.11 Favored Glycine 0 CA--C 1.524 0.609 0 N-CA-C 111.066 -0.814 . . . . 0.0 111.066 -179.945 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' C' C ' -1' ' ' VAL . . . . . . . . . . . . . 45.1 t -140.59 138.33 35.78 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.255 0 N-CA-C 109.829 -0.434 . . . . 0.0 109.829 179.0 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' C' C ' 0' ' ' ILE . . . . . . . . . . . . . 69.3 mt -106.08 129.78 58.74 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.34 0 CA-C-N 116.243 -0.435 . . . . 0.0 109.83 -179.48 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' C' C ' 1' ' ' MET . . . . . . . . . . . . . 25.3 ptt? -77.89 137.52 38.41 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.363 -0.38 . . . . 0.0 110.393 179.696 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' C' C ' 2' ' ' SER . . . . . . . . . . . . . 8.0 p -124.61 149.47 47.03 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-O 121.094 0.473 . . . . 0.0 111.146 -178.184 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' C' C ' 3' ' ' GLU . . . . . . . . . . . . . 47.7 mp0 -137.72 140.44 40.71 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 115.81 -0.632 . . . . 0.0 110.578 179.789 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' C' C ' 4' ' ' LEU . . . . . . . . . . . . . 13.4 tp -123.19 128.66 50.34 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 115.813 -0.63 . . . . 0.0 109.923 178.259 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' C' C ' 5' ' ' LYS . . . . . . . . . . . . . 61.3 mttp -108.89 119.61 40.07 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.538 -0.301 . . . . 0.0 110.922 -179.801 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' C' C ' 6' ' ' LEU . . . . . . . . . . . . . 38.8 mt -114.04 147.68 38.28 Favored 'General case' 0 C--N 1.331 -0.227 0 CA-C-N 115.279 -0.873 . . . . 0.0 110.232 179.286 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' C' C ' 7' ' ' LYS . . . . . . . . . . . . . 75.1 tttt -136.87 137.15 22.48 Favored Pre-proline 0 CA--C 1.534 0.33 0 CA-C-O 118.999 -0.524 . . . . 0.0 110.113 176.763 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' C' C ' 8' ' ' PRO . . . . . . . . . . . . . 98.5 Cg_endo -90.86 139.67 2.7 Favored 'Trans proline' 0 N--CA 1.491 1.328 0 C-N-CA 121.646 1.564 . . . . 0.0 111.813 177.839 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' C' C ' 9' ' ' LEU . . . . . . . . . . . . . 37.9 mt -76.3 -48.09 3.31 Favored Pre-proline 0 CA--C 1.533 0.307 0 CA-C-O 118.649 -0.691 . . . . 0.0 112.288 -179.242 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' C' C ' 10' ' ' PRO . . . . . . . . . . . . . 81.4 Cg_endo -78.26 147.36 23.11 Favored 'Trans proline' 0 N--CA 1.496 1.666 0 C-N-CA 121.003 1.135 . . . . 0.0 111.648 176.714 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' C' C ' 11' ' ' LYS . . . . . . . . . . . . . 7.3 ttpm? -86.56 87.69 7.5 Favored 'General case' 0 C--N 1.33 -0.273 0 C-N-CA 120.846 -0.342 . . . . 0.0 110.428 -179.652 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' C' C ' 12' ' ' VAL . . . . . . . . . . . . . 11.6 p -136.32 143.45 35.68 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.271 0 CA-C-N 116.03 -0.532 . . . . 0.0 110.324 179.776 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' C' C ' 13' ' ' GLU . . . . . . . . . . . . . 94.8 mt-10 -79.03 131.03 36.14 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.349 -0.387 . . . . 0.0 110.581 -179.664 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' C' C ' 14' ' ' LEU . . . . . . . . . . . . . 21.2 mt -99.42 152.52 37.83 Favored Pre-proline 0 CA--C 1.532 0.276 0 CA-C-N 116.275 -0.421 . . . . 0.0 110.787 179.236 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' C' C ' 15' ' ' PRO . . . . . . . . . . . . . 26.6 Cg_exo -61.91 157.28 44.26 Favored 'Trans proline' 0 N--CA 1.498 1.738 0 C-N-CA 121.312 1.341 . . . . 0.0 111.793 175.961 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' C' C ' 16' ' ' PRO . . . . . . . . . . . . . 33.1 Cg_exo -57.47 -41.62 70.01 Favored 'Trans proline' 0 N--CA 1.497 1.694 0 C-N-CA 121.418 1.412 . . . . 0.0 112.901 -178.478 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' C' C ' 17' ' ' ASP . . . . . . . . . . . . . 19.8 p-10 -86.35 11.93 11.21 Favored 'General case' 0 CA--C 1.536 0.433 0 N-CA-C 113.105 0.78 . . . . 0.0 113.105 -177.64 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' C' C ' 18' ' ' PHE . . . . . . . . . . . . . 51.7 t80 -57.59 -43.33 84.53 Favored 'General case' 0 C--N 1.334 -0.08 0 O-C-N 121.986 -0.446 . . . . 0.0 110.171 -178.431 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' C' C ' 19' ' ' VAL . . . . . . . . . . . . . 14.9 p -56.59 -41.94 74.89 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.243 0 CA-C-N 116.29 -0.414 . . . . 0.0 110.919 -178.732 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' C' C ' 20' ' ' ASP . . . . . . . . . . . . . 34.7 m-20 -60.44 -41.59 94.36 Favored 'General case' 0 C--N 1.331 -0.222 0 CA-C-O 120.831 0.348 . . . . 0.0 110.9 -178.758 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' C' C ' 21' ' ' VAL . . . . . . . . . . . . . 48.6 t -63.69 -46.96 93.23 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.287 0 CA-C-N 116.343 -0.389 . . . . 0.0 110.261 -178.828 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' C' C ' 22' ' ' ILE . . . . . . . . . . . . . 50.3 mm -56.68 -45.31 82.64 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.243 0 CA-C-O 120.822 0.344 . . . . 0.0 110.577 178.851 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' C' C ' 23' ' ' ARG . . . . . . . . . . . . . 49.1 ttp180 -54.22 -49.0 70.45 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.649 -0.25 . . . . 0.0 111.374 -178.018 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' C' C ' 24' ' ' ILE . . . . . . . . . . . . . 73.2 mt -59.49 -43.8 91.48 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.321 0 CA-C-O 120.864 0.364 . . . . 0.0 110.842 -178.751 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' C' C ' 25' ' ' LYS . . . . . . . . . . . . . 60.6 mtpt -62.61 -40.52 97.19 Favored 'General case' 0 C--N 1.327 -0.409 0 N-CA-C 112.113 0.412 . . . . 0.0 112.113 -178.298 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' C' C ' 26' ' ' LEU . . . . . . . . . . . . . 89.8 mt -79.86 -43.43 22.32 Favored 'General case' 0 C--N 1.33 -0.246 0 N-CA-C 113.352 0.871 . . . . 0.0 113.352 -171.759 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' C' C ' 27' ' ' GLN . . . . . . . . . . . . . 10.3 pt20 -46.78 138.62 6.05 Favored 'General case' 0 N--CA 1.468 0.468 0 N-CA-C 112.822 0.675 . . . . 0.0 112.822 -173.813 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' C' C ' 28' ' ' GLY . . . . . . . . . . . . . . . 100.22 -25.87 26.66 Favored Glycine 0 CA--C 1.533 1.174 0 CA-C-N 115.402 -0.817 . . . . 0.0 112.359 -177.338 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' C' C ' 29' ' ' LYS . . . . . . . . . . . . . 63.0 mttp -98.71 155.09 17.51 Favored 'General case' 0 C--N 1.332 -0.194 0 CA-C-N 117.396 0.598 . . . . 0.0 111.367 179.779 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' C' C ' 30' ' ' THR . . . . . . . . . . . . . 28.6 m -96.87 136.4 37.48 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 115.985 -0.552 . . . . 0.0 110.012 175.445 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' C' C ' 31' ' ' VAL . . . . . . . . . . . . . 34.9 m -128.94 148.76 33.26 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.316 0 CA-C-N 116.282 -0.417 . . . . 0.0 110.654 -179.368 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' C' C ' 32' ' ' ARG . . . . . . . . . . . . . 53.9 ttp180 -131.34 147.78 52.61 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-O 121.191 0.52 . . . . 0.0 110.332 178.661 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' C' C ' 33' ' ' THR . . . . . . . . . . . . . 17.5 m -52.99 138.82 29.47 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.383 -0.371 . . . . 0.0 111.46 -177.4 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' C' C ' 34' ' ' GLY . . . . . . . . . . . . . . . 101.51 -17.2 55.68 Favored Glycine 0 CA--C 1.533 1.214 0 CA-C-O 119.66 -0.522 . . . . 0.0 113.135 -179.782 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' C' C ' 35' ' ' ASP . . . . . . . . . . . . . 67.2 m-20 -65.14 149.84 49.2 Favored 'General case' 0 C--O 1.231 0.127 0 CA-C-N 118.046 0.923 . . . . 0.0 111.249 179.127 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' C' C ' 36' ' ' VAL . . . . . . . . . . . . . 46.0 t -123.3 131.46 73.13 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.239 0 CA-C-N 115.788 -0.642 . . . . 0.0 109.835 177.784 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' C' C ' 37' ' ' ILE . . . . . . . . . . . . . 69.7 mt -120.57 139.36 48.08 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.234 0 CA-C-N 116.254 -0.43 . . . . 0.0 109.984 -179.115 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' C' C ' 38' ' ' GLY . . . . . . . . . . . . . . . -113.83 128.84 8.48 Favored Glycine 0 CA--C 1.526 0.721 0 N-CA-C 111.095 -0.802 . . . . 0.0 111.095 -179.972 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' C' C ' 39' ' ' ILE . . . . . . . . . . . . . 72.8 mt -123.18 133.44 69.09 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.265 0 N-CA-C 110.026 -0.361 . . . . 0.0 110.026 179.116 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' C' C ' 40' ' ' SER . . . . . . . . . . . . . 85.8 p -92.11 122.64 34.8 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.454 -0.339 . . . . 0.0 110.684 176.222 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' C' C ' 41' ' ' ILE . . . . . . . . . . . . . 73.3 mt -135.39 118.13 22.65 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.176 0 CA-C-O 120.95 0.405 . . . . 0.0 110.467 178.738 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' C' C ' 42' ' ' LEU . . . . . . . . . . . . . 1.4 tt 55.17 45.48 25.87 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-O 121.496 0.665 . . . . 0.0 110.424 177.79 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' C' C ' 43' ' ' GLY . . . . . . . . . . . . . . . 74.99 -10.01 10.4 Favored Glycine 0 CA--C 1.535 1.31 0 C-N-CA 121.239 -0.505 . . . . 0.0 113.761 174.679 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' C' C ' 44' ' ' LYS . . . . . . . . . . . . . 93.1 mttt -104.79 137.61 42.32 Favored 'General case' 0 C--N 1.334 -0.103 0 CA-C-N 118.116 0.958 . . . . 0.0 110.6 -179.464 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' C' C ' 45' ' ' GLU . . . . . . . . . . . . . 79.5 tt0 -85.58 130.0 34.68 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.247 -0.433 . . . . 0.0 111.002 179.453 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' C' C ' 46' ' ' VAL . . . . . . . . . . . . . 7.4 p -123.24 127.96 74.69 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.247 0 N-CA-C 109.587 -0.523 . . . . 0.0 109.587 175.369 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' C' C ' 47' ' ' LYS . . . . . . . . . . . . . 57.3 mtmt -101.47 129.71 47.58 Favored 'General case' 0 C--N 1.331 -0.201 0 CA-C-N 115.888 -0.596 . . . . 0.0 111.626 179.824 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' C' C ' 48' ' ' PHE . . . . . . . . . . . . . 93.1 m-85 -113.85 132.07 56.03 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.079 -0.509 . . . . 0.0 110.154 176.861 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' C' C ' 49' ' ' LYS . . . . . . . . . . . . . 77.8 tttt -106.18 139.56 40.5 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.558 -0.292 . . . . 0.0 110.635 178.978 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' C' C ' 50' ' ' VAL . . . . . . . . . . . . . 44.9 t -83.64 105.61 13.38 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.252 0 N-CA-C 109.194 -0.669 . . . . 0.0 109.194 174.64 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' C' C ' 51' ' ' VAL . . . . . . . . . . . . . 48.7 t -69.65 -54.89 17.13 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.39 0 CA-C-N 115.791 -0.64 . . . . 0.0 109.513 -175.041 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' C' C ' 52' ' ' GLN . . . . . . . . . . . . . 88.5 mt-30 -155.26 154.36 32.04 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 115.882 -0.599 . . . . 0.0 111.906 -177.561 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' C' C ' 53' ' ' ALA . . . . . . . . . . . . . . . -131.6 132.49 44.11 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 115.334 -0.848 . . . . 0.0 109.782 174.1 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' C' C ' 54' ' ' TYR . . . . . . . . . . . . . 19.8 t80 -129.11 110.45 18.21 Favored Pre-proline 0 CA--C 1.533 0.32 0 CA-C-O 118.142 -0.932 . . . . 0.0 110.092 177.224 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' C' C ' 55' ' ' PRO . . . . . . . . . . . . . 72.7 Cg_endo -77.1 170.1 72.51 Favored 'Cis proline' 0 N--CA 1.5 1.869 0 CA-C-N 121.983 1.744 . . . . 0.0 112.326 -4.973 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' C' C ' 56' ' ' SER . . . . . . . . . . . . . 67.2 m -128.19 138.9 33.98 Favored Pre-proline 0 CA--C 1.536 0.429 0 CA-C-O 118.585 -0.721 . . . . 0.0 109.32 174.039 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' C' C ' 57' ' ' PRO . . . . . . . . . . . . . 40.4 Cg_endo -68.53 143.12 70.03 Favored 'Cis proline' 0 N--CA 1.498 1.789 0 CA-C-N 121.662 1.629 . . . . 0.0 111.678 -1.093 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' C' C ' 58' ' ' LEU . . . . . . . . . . . . . 27.8 tp -107.58 138.03 44.54 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.055 -0.52 . . . . 0.0 110.764 -176.085 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' C' C ' 59' ' ' ARG . . . . . . . . . . . . . 43.1 ttp180 -101.44 119.31 38.57 Favored 'General case' 0 C--N 1.328 -0.354 0 N-CA-C 108.894 -0.78 . . . . 0.0 108.894 173.698 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' C' C ' 60' ' ' VAL . . . . . . . . . . . . . 45.0 t -72.25 120.04 19.97 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.258 0 C-N-CA 120.644 -0.423 . . . . 0.0 110.3 -173.677 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' C' C ' 61' ' ' GLU . . . . . . . . . . . . . 42.8 mt-10 -131.04 162.61 29.42 Favored 'General case' 0 C--N 1.331 -0.23 0 CA-C-N 116.03 -0.532 . . . . 0.0 110.284 178.411 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' C' C ' 62' ' ' ASP . . . . . . . . . . . . . 7.7 p-10 -56.19 -32.54 64.46 Favored 'General case' 0 C--N 1.329 -0.304 0 N-CA-C 111.922 0.342 . . . . 0.0 111.922 -178.412 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' C' C ' 63' ' ' ARG . . . . . . . . . . . . . 40.4 ptt180 -81.4 3.83 23.05 Favored 'General case' 0 CA--C 1.537 0.452 0 N-CA-C 113.746 1.017 . . . . 0.0 113.746 -175.582 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' C' C ' 64' ' ' THR . . . . . . . . . . . . . 26.4 m -87.99 138.75 31.17 Favored 'General case' 0 C--N 1.332 -0.166 0 CA-C-N 118.103 0.41 . . . . 0.0 110.48 -179.061 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' C' C ' 65' ' ' LYS . . . . . . . . . . . . . 95.4 mttt -87.93 128.31 35.37 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.373 -0.376 . . . . 0.0 110.127 -179.755 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' C' C ' 66' ' ' ILE . . . . . . . . . . . . . 59.1 mt -115.64 131.62 67.48 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.215 0 N-CA-C 109.936 -0.394 . . . . 0.0 109.936 -179.329 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' C' C ' 67' ' ' THR . . . . . . . . . . . . . 26.3 m -124.69 138.21 54.31 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-N 116.151 -0.477 . . . . 0.0 110.723 -179.689 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' C' C ' 68' ' ' LEU . . . . . . . . . . . . . 48.2 mt -103.06 122.82 45.44 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 115.902 -0.59 . . . . 0.0 110.297 177.367 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' C' C ' 69' ' ' VAL . . . . . . . . . . . . . 43.3 t -102.44 144.89 12.87 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.351 0 CA-C-N 115.926 -0.579 . . . . 0.0 110.042 -179.809 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' C' C ' 70' ' ' THR . . . . . . . . . . . . . 8.5 m -128.43 -41.86 1.52 Allowed 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.097 -0.501 . . . . 0.0 110.011 178.809 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' C' C ' 71' ' ' HIS . . . . . . . . . . . . . 24.0 m-70 -105.54 152.69 40.06 Favored Pre-proline 0 C--N 1.331 -0.229 0 N-CA-C 109.812 -0.44 . . . . 0.0 109.812 175.647 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' C' C ' 72' ' ' PRO . . . . . . . . . . . . . 33.3 Cg_endo -65.01 -22.71 62.13 Favored 'Trans proline' 0 N--CA 1.496 1.667 0 C-N-CA 121.219 1.279 . . . . 0.0 112.867 179.159 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' C' C ' 73' ' ' VAL . . . . . . . . . . . . . 30.4 m -105.44 164.3 4.15 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.211 0 N-CA-C 110.138 -0.319 . . . . 0.0 110.138 179.289 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' C' C ' 74' ' ' ASP . . . . . . . . . . . . . 13.6 t0 -96.38 119.04 34.15 Favored 'General case' 0 C--N 1.33 -0.253 0 N-CA-C 109.919 -0.401 . . . . 0.0 109.919 -177.498 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' C' C ' 75' ' ' VAL . . . . . . . . . . . . . 43.2 t -119.44 122.95 70.25 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.208 0 CA-C-O 121.125 0.488 . . . . 0.0 110.811 -176.954 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' C' C ' 76' ' ' LEU . . . . . . . . . . . . . 5.8 mp -121.05 141.48 50.72 Favored 'General case' 0 C--N 1.331 -0.205 0 CA-C-N 115.647 -0.706 . . . . 0.0 109.12 174.112 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' C' C ' 77' ' ' GLU . . . . . . . . . . . . . 31.3 tt0 -132.08 132.13 43.02 Favored 'General case' 0 C--N 1.331 -0.209 0 CA-C-O 120.841 0.353 . . . . 0.0 110.902 -176.161 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' C' C ' 78' ' ' ALA . . . . . . . . . . . . . . . -119.1 142.44 47.9 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 116.002 -0.545 . . . . 0.0 109.869 177.454 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' C' C ' 79' ' ' LYS . . . . . . . . . . . . . 81.3 tttt -84.45 119.73 25.47 Favored 'General case' 0 C--N 1.328 -0.332 0 C-N-CA 120.934 -0.307 . . . . 0.0 110.58 -178.69 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' C' C ' 80' ' ' ILE . . . . . . . . . . . . . 44.8 mm -138.26 117.94 14.96 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.27 0 N-CA-C 109.533 -0.543 . . . . 0.0 109.533 -177.486 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' C' C ' 81' ' ' LYS . . . . . . . . . . . . . 59.4 mtmt -112.83 125.69 54.62 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.407 -0.361 . . . . 0.0 111.37 -176.298 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' C' C ' 82' ' ' GLY . . . . . . . . . . . . . . . 89.13 42.11 5.68 Favored Glycine 0 CA--C 1.524 0.595 0 C-N-CA 120.865 -0.683 . . . . 0.0 111.458 175.485 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' C' C ' 83' ' ' ILE . . . . . . . . . . . . . 70.1 mt -67.59 132.77 32.34 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.291 0 N-CA-C 109.835 -0.431 . . . . 0.0 109.835 178.909 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' C' C ' 84' ' ' LYS . . . . . . . . . . . . . 59.4 tttp -93.5 -49.25 6.0 Favored 'General case' 0 C--N 1.327 -0.407 0 CA-C-N 116.011 -0.54 . . . . 0.0 109.837 179.967 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' C' C ' 85' ' ' ASP . . . . . . . . . . . . . 5.1 t0 -159.84 153.14 22.15 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 115.71 -0.677 . . . . 0.0 110.28 179.031 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' C' C ' 86' ' ' VAL . . . . . . . . . . . . . 42.6 t -125.92 131.75 71.46 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.274 0 CA-C-O 120.868 0.366 . . . . 0.0 110.199 -179.939 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' C' C ' 87' ' ' ILE . . . . . . . . . . . . . 44.2 mm -120.13 129.27 75.68 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.264 0 CA-C-N 116.027 -0.533 . . . . 0.0 109.632 178.981 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' C' C ' 88' ' ' LEU . . . . . . . . . . . . . 12.4 tp -112.31 130.77 55.84 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-O 120.985 0.421 . . . . 0.0 111.296 -175.857 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' C' C ' 89' ' ' ASP . . . . . . . . . . . . . 13.1 t70 -125.27 152.01 45.2 Favored 'General case' 0 C--N 1.33 -0.249 0 N-CA-C 109.272 -0.64 . . . . 0.0 109.272 175.016 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' C' C ' 90' ' ' GLU . . . . . . . . . . . . . 95.4 mt-10 -48.92 -37.8 20.93 Favored 'General case' 0 C--N 1.329 -0.324 0 N-CA-C 112.754 0.649 . . . . 0.0 112.754 -171.804 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' C' C ' 91' ' ' ASN . . . . . . . . . . . . . 14.7 m-80 -125.49 16.7 8.23 Favored 'General case' 0 N--CA 1.468 0.474 0 N-CA-C 113.21 0.819 . . . . 0.0 113.21 -177.352 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' C' C ' 92' ' ' LEU . . . . . . . . . . . . . 12.5 mt -148.86 143.26 26.15 Favored 'General case' 0 C--N 1.333 -0.114 0 N-CA-C 110.112 -0.329 . . . . 0.0 110.112 -176.605 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' C' C ' 93' ' ' ILE . . . . . . . . . . . . . 73.7 mt -121.23 119.27 58.7 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.353 0 N-CA-C 109.157 -0.683 . . . . 0.0 109.157 177.55 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' C' C ' 94' ' ' VAL . . . . . . . . . . . . . 45.3 t -118.73 127.16 75.68 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.201 0 CA-C-O 121.023 0.439 . . . . 0.0 110.061 -178.314 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' C' C ' 95' ' ' VAL . . . . . . . . . . . . . 44.9 t -118.97 132.91 67.5 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.357 0 CA-C-N 115.784 -0.644 . . . . 0.0 109.519 178.681 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' C' C ' 96' ' ' ILE . . . . . . . . . . . . . 68.3 mt -112.67 126.06 70.01 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.346 0 N-CA-C 109.214 -0.662 . . . . 0.0 109.214 178.775 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' C' C ' 97' ' ' THR . . . . . . . . . . . . . 60.6 p -99.76 158.27 15.91 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-O 121.313 0.578 . . . . 0.0 111.386 -176.904 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' C' C ' 98' ' ' GLU . . . . . . . . . . . . . 83.8 tt0 -53.88 -26.71 26.17 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.049 -0.523 . . . . 0.0 112.23 179.73 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' C' C ' 99' ' ' GLU . . . . . . . . . . . . . 71.0 mm-40 -78.87 15.35 1.1 Allowed 'General case' 0 CA--C 1.534 0.353 0 N-CA-C 113.185 0.809 . . . . 0.0 113.185 -177.691 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' C' C ' 100' ' ' ASN . . . . . . . . . . . . . 4.1 m-20 60.88 38.16 17.97 Favored 'General case' 0 C--O 1.232 0.146 0 CA-C-O 121.101 0.477 . . . . 0.0 110.823 179.833 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' C' C ' 101' ' ' GLU . . . . . . . . . . . . . 83.7 tt0 -114.83 144.36 43.65 Favored 'General case' 0 C--N 1.332 -0.16 0 CA-C-N 116.001 -0.545 . . . . 0.0 109.64 177.016 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' C' C ' 102' ' ' VAL . . . . . . . . . . . . . 44.4 t -114.93 124.84 71.98 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.306 0 N-CA-C 109.919 -0.401 . . . . 0.0 109.919 -178.156 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' C' C ' 103' ' ' LEU . . . . . . . . . . . . . 28.7 mt -113.64 131.28 56.2 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 115.717 -0.674 . . . . 0.0 110.198 176.6 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' C' C ' 104' ' ' ILE . . . . . . . . . . . . . 73.5 mt -120.36 119.06 58.76 Favored 'Isoleucine or valine' 0 C--O 1.235 0.325 0 N-CA-C 110.295 -0.261 . . . . 0.0 110.295 -179.79 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' C' C ' 105' ' ' PHE . . . . . . . . . . . . . 79.7 m-85 -120.19 167.37 12.32 Favored 'General case' 0 C--N 1.331 -0.217 0 O-C-N 124.205 0.941 . . . . 0.0 109.766 178.956 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' C' C ' 106' ' ' ASN . . . . . . . . . . . . . 39.7 p-10 -103.77 -169.91 1.7 Allowed 'General case' 0 CA--C 1.53 0.181 0 N-CA-C 109.703 -0.48 . . . . 0.0 109.703 171.394 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' C' C ' 107' ' ' GLN . . . . . . . . . . . . . 50.0 tt0 -58.69 -30.12 67.15 Favored 'General case' 0 C--N 1.329 -0.302 0 N-CA-C 111.862 0.319 . . . . 0.0 111.862 179.361 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' C' C ' 108' ' ' ASN . . . . . . . . . . . . . 45.7 t30 -89.21 12.88 14.66 Favored 'General case' 0 CA--C 1.535 0.393 0 N-CA-C 113.048 0.759 . . . . 0.0 113.048 -176.855 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' C' C ' 109' ' ' LEU . . . . . . . . . . . . . 63.3 mt 58.28 35.72 25.12 Favored 'General case' 0 C--N 1.332 -0.182 0 CA-C-O 120.755 0.312 . . . . 0.0 111.767 175.934 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' C' C ' 110' ' ' GLU . . . . . . . . . . . . . 70.3 mm-40 -103.91 135.28 45.74 Favored 'General case' 0 C--N 1.33 -0.264 0 N-CA-C 110.014 -0.365 . . . . 0.0 110.014 175.238 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' C' C ' 111' ' ' GLU . . . . . . . . . . . . . 98.1 mt-10 -67.14 123.62 20.78 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-O 121.044 0.45 . . . . 0.0 111.071 -178.39 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' C' C ' 112' ' ' LEU . . . . . . . . . . . . . 13.9 mt -105.99 -43.88 4.74 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-N 115.793 -0.64 . . . . 0.0 109.946 175.78 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' C' C ' 113' ' ' TYR . . . . . . . . . . . . . 65.0 t80 -143.86 140.76 29.96 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.236 -0.438 . . . . 0.0 111.637 -179.315 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' C' C ' 114' ' ' ARG . . . . . . . . . . . . . 37.2 ttm180 -136.31 128.1 29.16 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 115.797 -0.638 . . . . 0.0 109.96 174.026 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' C' C ' 115' ' ' GLY . . . . . . . . . . . . . . . -150.04 159.41 28.09 Favored Glycine 0 CA--C 1.526 0.774 0 N-CA-C 111.169 -0.772 . . . . 0.0 111.169 177.441 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' C' C ' 116' ' ' LYS . . . . . . . . . . . . . 33.7 ttpt -130.81 136.6 48.85 Favored 'General case' 0 C--N 1.33 -0.244 0 N-CA-C 109.974 -0.38 . . . . 0.0 109.974 177.555 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' C' C ' 117' ' ' PHE . . . . . . . . . . . . . 40.8 m-85 -135.14 117.14 15.3 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-O 120.703 0.287 . . . . 0.0 110.39 -176.672 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' C' C ' 118' ' ' GLU . . . . . . . . . . . . . 70.6 mm-40 -54.65 -46.32 73.96 Favored 'General case' 0 C--N 1.329 -0.29 0 C-N-CA 120.996 -0.282 . . . . 0.0 111.38 -177.014 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' C' C ' 119' ' ' ASN . . . . . . . . . . . . . 6.0 m120 -95.99 30.99 2.24 Favored 'General case' 0 C--N 1.329 -0.322 0 N-CA-C 112.046 0.387 . . . . 0.0 112.046 -175.457 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' C' C ' 120' ' ' LEU . . . . . . . . . . . . . 14.0 tp -57.82 120.93 9.3 Favored 'General case' 0 C--O 1.232 0.154 0 CA-C-O 120.679 0.276 . . . . 0.0 110.39 179.008 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' C' C ' 121' ' ' ASN . . . . . . . . . . . . . 93.9 m-20 -114.16 -43.96 3.18 Favored 'General case' 0 C--N 1.331 -0.217 0 CA-C-N 116.38 -0.373 . . . . 0.0 111.311 -178.304 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' C' C ' 122' ' ' LYS . . . . . . . . . . . . . 97.2 mttt -144.28 151.11 38.93 Favored 'General case' 0 C--N 1.331 -0.215 0 C-N-CA 120.647 -0.421 . . . . 0.0 111.848 -175.993 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' C' C ' 123' ' ' VAL . . . . . . . . . . . . . 46.1 t -132.08 128.59 59.4 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.311 0 N-CA-C 109.259 -0.645 . . . . 0.0 109.259 172.159 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' C' C ' 124' ' ' LEU . . . . . . . . . . . . . 8.7 tp -128.31 143.27 51.0 Favored 'General case' 0 N--CA 1.464 0.245 0 CA-C-O 120.726 0.298 . . . . 0.0 110.91 -175.845 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' C' C ' 125' ' ' VAL . . . . . . . . . . . . . 35.0 m -130.19 143.84 39.78 Favored 'Isoleucine or valine' 0 C--O 1.232 0.177 0 CA-C-N 116.35 -0.386 . . . . 0.0 111.254 -178.637 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' C' C ' 126' ' ' ARG . . . . . . . . . . . . . 96.0 mtt-85 -149.73 124.9 10.08 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 116.246 -0.434 . . . . 0.0 110.781 175.634 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' C' C ' 127' ' ' ASN . . . . . . . . . . . . . 24.8 m120 49.63 -109.18 0.35 Allowed 'General case' 0 CA--C 1.545 0.764 0 CA-C-O 118.828 -0.606 . . . . 0.0 111.649 178.938 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' C' C ' 128' ' ' ASP . . . . . . . . . . . . . 19.5 p-10 -114.09 7.3 16.68 Favored 'General case' 0 N--CA 1.469 0.482 0 CA-C-N 119.891 1.223 . . . . 0.0 113.371 -177.442 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' C' C ' 129' ' ' LEU . . . . . . . . . . . . . 42.1 mt -113.7 147.88 37.4 Favored 'General case' 0 C--O 1.232 0.14 0 N-CA-C 109.795 -0.446 . . . . 0.0 109.795 178.723 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' C' C ' 130' ' ' VAL . . . . . . . . . . . . . 12.9 p -133.62 143.18 39.55 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.222 0 CA-C-O 121.166 0.508 . . . . 0.0 110.511 -179.758 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' C' C ' 131' ' ' VAL . . . . . . . . . . . . . 41.1 t -132.92 138.4 51.82 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.248 0 CA-C-N 115.848 -0.614 . . . . 0.0 110.234 -178.068 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' C' C ' 132' ' ' ILE . . . . . . . . . . . . . 72.2 mt -116.8 133.86 62.15 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.331 0 N-CA-C 109.308 -0.627 . . . . 0.0 109.308 179.471 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' C' C ' 133' ' ' ILE . . . . . . . . . . . . . 40.1 mm -117.02 122.89 71.08 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.245 0 CA-C-N 116.673 -0.239 . . . . 0.0 110.81 -174.756 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' C' C ' 134' ' ' ASP . . . . . . . . . . . . . 7.2 p-10 -135.59 150.28 49.63 Favored 'General case' 0 C--N 1.331 -0.225 0 N-CA-C 110.003 -0.369 . . . . 0.0 110.003 175.55 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' C' C ' 135' ' ' GLU . . . . . . . . . . . . . 44.8 tp10 -50.67 -28.08 8.26 Favored 'General case' 0 C--N 1.328 -0.361 0 N-CA-C 112.756 0.65 . . . . 0.0 112.756 -173.218 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' C' C ' 136' ' ' GLN . . . . . . . . . . . . . 96.9 mt-30 -86.17 -29.22 23.41 Favored 'General case' 0 C--N 1.33 -0.253 0 N-CA-C 112.805 0.669 . . . . 0.0 112.805 -174.98 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' C' C ' 137' ' ' LYS . . . . . . . . . . . . . 43.1 pttt -170.14 173.67 5.77 Favored 'General case' 0 C--N 1.332 -0.189 0 CA-C-O 121.53 0.681 . . . . 0.0 112.503 -172.544 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' C' C ' 138' ' ' LEU . . . . . . . . . . . . . 5.5 tt -118.55 128.62 54.74 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 114.967 -1.015 . . . . 0.0 109.766 179.168 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' C' C ' 139' ' ' THR . . . . . . . . . . . . . 31.9 m -107.09 128.16 54.13 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.43 -0.35 . . . . 0.0 110.281 179.798 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' C' C ' 140' ' ' LEU . . . . . . . . . . . . . 11.0 tp -114.6 121.42 43.38 Favored 'General case' 0 C--N 1.328 -0.339 0 N-CA-C 109.23 -0.655 . . . . 0.0 109.23 -178.718 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' C' C ' 141' ' ' ILE . . . . . . . . . . . . . 20.1 mt -119.28 121.6 66.97 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 CA-C-O 121.032 0.444 . . . . 0.0 110.04 -175.803 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' C' C ' 142' ' ' ARG . . . . . . . . . . . . . 69.5 mtt180 -109.35 128.83 55.41 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 114.989 -1.005 . . . . 0.0 109.849 -175.263 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' C' C ' 143' ' ' THR . . . . . . . . . . . . . 36.3 p . . . . . 0 C--O 1.219 -0.513 0 CA-C-O 118.098 -0.954 . . . . 0.0 110.608 -179.3 . . . . . . . . 0 0 . 1 . 015 nuclear orig full ' D' D ' -3' ' ' GLU . . . . . . . . . . . . . 96.0 mt-10 . . . . . 0 N--CA 1.49 1.537 0 N-CA-C 109.504 -0.554 . . . . 0.0 109.504 . . . . . . . . . 0 0 . 1 . 015 nuclear orig full ' D' D ' -2' ' ' GLY . . . . . . . . . . . . . . . -77.71 150.04 35.71 Favored Glycine 0 CA--C 1.524 0.653 0 N-CA-C 111.043 -0.823 . . . . 0.0 111.043 179.947 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' D' D ' -1' ' ' VAL . . . . . . . . . . . . . 44.7 t -94.28 130.48 43.11 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.302 0 CA-C-O 120.89 0.376 . . . . 0.0 110.0 179.932 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' D' D ' 0' ' ' ILE . . . . . . . . . . . . . 72.9 mt -120.68 134.58 63.66 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.192 0 CA-C-N 116.131 -0.486 . . . . 0.0 109.874 -179.513 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' D' D ' 1' ' ' MET . . . . . . . . . . . . . 25.6 ptp -83.3 136.39 34.39 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.316 -0.402 . . . . 0.0 110.728 -179.905 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' D' D ' 2' ' ' SER . . . . . . . . . . . . . 25.2 p -122.56 138.96 54.41 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.211 -0.45 . . . . 0.0 110.574 179.517 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' D' D ' 3' ' ' GLU . . . . . . . . . . . . . 95.3 mt-10 -141.13 138.78 33.72 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.1 -0.5 . . . . 0.0 111.489 -177.498 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' D' D ' 4' ' ' LEU . . . . . . . . . . . . . 70.1 mt -118.96 127.74 53.75 Favored 'General case' 0 C--N 1.331 -0.214 0 CA-C-N 115.953 -0.567 . . . . 0.0 110.079 174.392 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' D' D ' 5' ' ' LYS . . . . . . . . . . . . . 98.7 mttt -109.67 122.4 47.38 Favored 'General case' 0 C--O 1.235 0.311 0 CA-C-O 120.673 0.273 . . . . 0.0 110.659 177.225 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' D' D ' 6' ' ' LEU . . . . . . . . . . . . . 46.8 mt -113.94 146.55 39.93 Favored 'General case' 0 C--N 1.331 -0.219 0 CA-C-N 115.435 -0.802 . . . . 0.0 109.919 179.786 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' D' D ' 7' ' ' LYS . . . . . . . . . . . . . 76.4 tttt -131.28 137.63 31.01 Favored Pre-proline 0 CA--C 1.533 0.318 0 CA-C-O 118.935 -0.555 . . . . 0.0 109.732 175.74 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' D' D ' 8' ' ' PRO . . . . . . . . . . . . . 85.9 Cg_endo -90.96 135.18 1.86 Allowed 'Trans proline' 0 N--CA 1.489 1.225 0 C-N-CA 121.705 1.603 . . . . 0.0 111.825 179.316 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' D' D ' 9' ' ' LEU . . . . . . . . . . . . . 38.0 mt -73.3 -45.13 7.86 Favored Pre-proline 0 CA--C 1.533 0.311 0 CA-C-O 119.019 -0.515 . . . . 0.0 111.036 179.79 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' D' D ' 10' ' ' PRO . . . . . . . . . . . . . 64.5 Cg_endo -86.11 152.82 9.6 Favored 'Trans proline' 0 N--CA 1.492 1.425 0 C-N-CA 121.241 1.294 . . . . 0.0 111.066 169.041 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' D' D ' 11' ' ' LYS . . . . . . . . . . . . . 25.5 pttm -86.1 119.86 26.86 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-O 121.291 0.567 . . . . 0.0 110.461 177.084 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' D' D ' 12' ' ' VAL . . . . . . . . . . . . . 13.1 p -150.47 143.29 17.22 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.327 0 CA-C-N 115.928 -0.578 . . . . 0.0 110.523 -179.966 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' D' D ' 13' ' ' GLU . . . . . . . . . . . . . 43.3 mt-10 -90.36 110.47 21.55 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.296 -0.411 . . . . 0.0 110.04 177.808 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' D' D ' 14' ' ' LEU . . . . . . . . . . . . . 15.8 mt -88.08 153.05 51.47 Favored Pre-proline 0 C--N 1.33 -0.281 0 CA-C-N 116.345 -0.389 . . . . 0.0 110.646 -178.154 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' D' D ' 15' ' ' PRO . . . . . . . . . . . . . 25.4 Cg_exo -62.58 155.16 60.19 Favored 'Trans proline' 0 N--CA 1.497 1.679 0 C-N-CA 121.267 1.311 . . . . 0.0 111.35 175.17 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' D' D ' 16' ' ' PRO . . . . . . . . . . . . . 36.5 Cg_exo -58.02 -35.64 98.61 Favored 'Trans proline' 0 N--CA 1.497 1.723 0 C-N-CA 121.318 1.345 . . . . 0.0 112.923 -178.68 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' D' D ' 17' ' ' ASP . . . . . . . . . . . . . 10.8 p-10 -85.48 5.96 28.99 Favored 'General case' 0 CA--C 1.536 0.411 0 N-CA-C 113.336 0.865 . . . . 0.0 113.336 -176.508 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' D' D ' 18' ' ' PHE . . . . . . . . . . . . . 42.3 t80 -58.37 -44.49 88.9 Favored 'General case' 0 C--N 1.334 -0.101 0 O-C-N 121.939 -0.475 . . . . 0.0 109.892 -179.251 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' D' D ' 19' ' ' VAL . . . . . . . . . . . . . 47.6 t -56.76 -42.6 77.79 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.284 0 CA-C-N 116.243 -0.435 . . . . 0.0 110.316 -179.423 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' D' D ' 20' ' ' ASP . . . . . . . . . . . . . 9.6 t70 -59.47 -42.59 92.39 Favored 'General case' 0 C--N 1.33 -0.278 0 C-N-CA 120.853 -0.339 . . . . 0.0 110.72 -177.522 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' D' D ' 21' ' ' VAL . . . . . . . . . . . . . 47.3 t -64.42 -46.37 93.12 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 C-N-CA 120.754 -0.378 . . . . 0.0 110.646 -177.611 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' D' D ' 22' ' ' ILE . . . . . . . . . . . . . 45.4 mm -58.57 -40.27 78.38 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.267 0 C-N-CA 121.05 -0.26 . . . . 0.0 110.758 -179.449 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' D' D ' 23' ' ' ARG . . . . . . . . . . . . . 35.4 ttp180 -57.73 -49.64 75.88 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-O 121.148 0.499 . . . . 0.0 110.32 177.285 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' D' D ' 24' ' ' ILE . . . . . . . . . . . . . 66.0 mt -60.96 -38.41 79.32 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.304 0 CA-C-N 115.737 -0.665 . . . . 0.0 111.841 -176.781 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' D' D ' 25' ' ' LYS . . . . . . . . . . . . . 35.5 pttt -77.21 -37.57 53.14 Favored 'General case' 0 CA--C 1.534 0.341 0 C-N-CA 120.396 -0.521 . . . . 0.0 111.864 -174.952 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' D' D ' 26' ' ' LEU . . . . . . . . . . . . . 72.0 mt -77.7 -32.42 52.99 Favored 'General case' 0 C--N 1.331 -0.238 0 N-CA-C 113.237 0.828 . . . . 0.0 113.237 -172.354 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' D' D ' 27' ' ' GLN . . . . . . . . . . . . . 5.8 pt20 -45.71 135.71 6.58 Favored 'General case' 0 N--CA 1.469 0.517 0 N-CA-C 112.951 0.723 . . . . 0.0 112.951 -175.49 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' D' D ' 28' ' ' GLY . . . . . . . . . . . . . . . 99.37 -24.76 30.93 Favored Glycine 0 CA--C 1.534 1.223 0 CA-C-N 115.62 -0.718 . . . . 0.0 112.441 -177.713 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' D' D ' 29' ' ' LYS . . . . . . . . . . . . . 69.0 mttm -98.05 155.17 17.25 Favored 'General case' 0 C--N 1.333 -0.12 0 CA-C-N 117.29 0.545 . . . . 0.0 111.002 179.599 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' D' D ' 30' ' ' THR . . . . . . . . . . . . . 21.6 m -101.1 140.19 35.74 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.36 -0.382 . . . . 0.0 110.465 178.206 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' D' D ' 31' ' ' VAL . . . . . . . . . . . . . 34.9 m -130.14 150.4 34.58 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.232 0 CA-C-N 116.232 -0.44 . . . . 0.0 110.992 -179.418 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' D' D ' 32' ' ' ARG . . . . . . . . . . . . . 82.0 mtm180 -135.42 151.09 50.1 Favored 'General case' 0 C--N 1.331 -0.23 0 CA-C-O 121.258 0.551 . . . . 0.0 110.672 178.275 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' D' D ' 33' ' ' THR . . . . . . . . . . . . . 29.3 m -53.65 139.93 30.6 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.273 -0.421 . . . . 0.0 111.193 -179.49 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' D' D ' 34' ' ' GLY . . . . . . . . . . . . . . . 101.01 -17.02 56.82 Favored Glycine 0 CA--C 1.532 1.131 0 CA-C-O 119.703 -0.498 . . . . 0.0 113.244 179.609 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' D' D ' 35' ' ' ASP . . . . . . . . . . . . . 67.5 m-20 -65.15 148.63 51.33 Favored 'General case' 0 C--O 1.232 0.133 0 CA-C-N 118.103 0.951 . . . . 0.0 110.999 178.739 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' D' D ' 36' ' ' VAL . . . . . . . . . . . . . 45.4 t -126.75 131.76 70.79 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.232 0 CA-C-N 116.044 -0.525 . . . . 0.0 109.935 179.444 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' D' D ' 37' ' ' ILE . . . . . . . . . . . . . 63.0 mt -124.89 139.78 50.01 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.215 0 CA-C-N 116.226 -0.443 . . . . 0.0 110.173 -179.09 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' D' D ' 38' ' ' GLY . . . . . . . . . . . . . . . -113.83 128.41 8.28 Favored Glycine 0 CA--C 1.526 0.724 0 N-CA-C 110.741 -0.944 . . . . 0.0 110.741 177.73 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' D' D ' 39' ' ' ILE . . . . . . . . . . . . . 70.6 mt -126.92 137.72 57.0 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.282 0 CA-C-O 120.654 0.264 . . . . 0.0 110.297 -179.758 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' D' D ' 40' ' ' SER . . . . . . . . . . . . . 42.9 t -92.11 120.8 33.06 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.307 -0.406 . . . . 0.0 110.755 176.058 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' D' D ' 41' ' ' ILE . . . . . . . . . . . . . 67.7 mt -126.57 117.51 48.4 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.193 0 CA-C-O 120.707 0.289 . . . . 0.0 110.268 178.672 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' D' D ' 42' ' ' LEU . . . . . . . . . . . . . 8.2 mp 50.94 39.13 22.05 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-O 121.094 0.474 . . . . 0.0 111.729 177.262 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' D' D ' 43' ' ' GLY . . . . . . . . . . . . . . . 75.36 26.57 65.55 Favored Glycine 0 CA--C 1.531 1.077 0 C-N-CA 121.218 -0.515 . . . . 0.0 112.669 175.742 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' D' D ' 44' ' ' LYS . . . . . . . . . . . . . 98.8 mttt -136.56 129.35 30.76 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 117.142 0.471 . . . . 0.0 109.798 176.606 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' D' D ' 45' ' ' GLU . . . . . . . . . . . . . 73.0 tt0 -84.16 123.38 30.02 Favored 'General case' 0 C--N 1.329 -0.314 0 C-N-CA 120.788 -0.365 . . . . 0.0 110.8 -178.102 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' D' D ' 46' ' ' VAL . . . . . . . . . . . . . 11.3 p -117.22 127.29 74.79 Favored 'Isoleucine or valine' 0 C--O 1.233 0.196 0 N-CA-C 109.832 -0.433 . . . . 0.0 109.832 176.368 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' D' D ' 47' ' ' LYS . . . . . . . . . . . . . 34.3 mmtp -98.23 122.91 41.96 Favored 'General case' 0 C--N 1.327 -0.404 0 CA-C-N 115.927 -0.578 . . . . 0.0 110.659 177.165 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' D' D ' 48' ' ' PHE . . . . . . . . . . . . . 30.6 m-85 -108.32 131.79 54.37 Favored 'General case' 0 C--N 1.33 -0.276 0 N-CA-C 109.668 -0.493 . . . . 0.0 109.668 175.693 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' D' D ' 49' ' ' LYS . . . . . . . . . . . . . 60.1 tttm -108.82 136.12 48.9 Favored 'General case' 0 C--N 1.329 -0.316 0 N-CA-C 110.04 -0.355 . . . . 0.0 110.04 175.858 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' D' D ' 50' ' ' VAL . . . . . . . . . . . . . 45.3 t -77.63 107.05 8.71 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.343 0 N-CA-C 109.176 -0.675 . . . . 0.0 109.176 176.487 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' D' D ' 51' ' ' VAL . . . . . . . . . . . . . 45.0 t -70.96 -48.75 54.27 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.315 0 CA-C-N 116.132 -0.486 . . . . 0.0 109.781 -174.221 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' D' D ' 52' ' ' GLN . . . . . . . . . . . . . 62.2 tt0 -164.66 139.8 5.55 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 115.983 -0.553 . . . . 0.0 111.187 -176.614 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' D' D ' 53' ' ' ALA . . . . . . . . . . . . . . . -120.37 135.87 54.89 Favored 'General case' 0 C--N 1.332 -0.191 0 CA-C-N 116.009 -0.541 . . . . 0.0 109.868 174.342 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' D' D ' 54' ' ' TYR . . . . . . . . . . . . . 43.7 t80 -129.11 116.58 18.9 Favored Pre-proline 0 CA--C 1.536 0.413 0 CA-C-O 118.091 -0.957 . . . . 0.0 110.338 178.226 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' D' D ' 55' ' ' PRO . . . . . . . . . . . . . 73.8 Cg_endo -77.13 170.07 72.57 Favored 'Cis proline' 0 N--CA 1.501 1.94 0 CA-C-N 122.015 1.756 . . . . 0.0 111.56 -9.836 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' D' D ' 56' ' ' SER . . . . . . . . . . . . . 13.7 m -128.03 141.72 42.15 Favored Pre-proline 0 CA--C 1.536 0.41 0 CA-C-O 118.625 -0.702 . . . . 0.0 109.575 174.777 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' D' D ' 57' ' ' PRO . . . . . . . . . . . . . 49.8 Cg_endo -69.94 141.71 67.49 Favored 'Cis proline' 0 N--CA 1.5 1.859 0 CA-C-N 121.489 1.567 . . . . 0.0 111.689 -1.082 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' D' D ' 58' ' ' LEU . . . . . . . . . . . . . 28.1 tp -108.53 138.74 44.34 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-N 116.381 -0.372 . . . . 0.0 110.881 -177.989 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' D' D ' 59' ' ' ARG . . . . . . . . . . . . . 66.9 ttp85 -99.67 124.14 44.61 Favored 'General case' 0 C--N 1.328 -0.332 0 N-CA-C 109.099 -0.704 . . . . 0.0 109.099 173.323 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' D' D ' 60' ' ' VAL . . . . . . . . . . . . . 41.1 t -72.78 120.28 21.12 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.254 0 CA-C-O 120.964 0.411 . . . . 0.0 110.51 -175.066 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' D' D ' 61' ' ' GLU . . . . . . . . . . . . . 74.7 tt0 -131.09 156.79 44.62 Favored 'General case' 0 C--N 1.328 -0.331 0 N-CA-C 108.874 -0.787 . . . . 0.0 108.874 175.991 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' D' D ' 62' ' ' ASP . . . . . . . . . . . . . 53.1 m-20 -49.6 -30.37 8.67 Favored 'General case' 0 CA--C 1.534 0.336 0 N-CA-C 112.378 0.51 . . . . 0.0 112.378 -179.169 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' D' D ' 63' ' ' ARG . . . . . . . . . . . . . 94.2 mtt180 -72.5 -21.96 61.12 Favored 'General case' 0 CA--C 1.533 0.3 0 N-CA-C 113.118 0.784 . . . . 0.0 113.118 -175.217 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' D' D ' 64' ' ' THR . . . . . . . . . . . . . 34.2 m -66.57 139.78 57.93 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-O 120.871 0.367 . . . . 0.0 110.913 -176.257 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' D' D ' 65' ' ' LYS . . . . . . . . . . . . . 99.4 mttt -89.09 130.69 35.49 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.093 -0.503 . . . . 0.0 109.906 176.971 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' D' D ' 66' ' ' ILE . . . . . . . . . . . . . 4.0 mp -112.39 124.14 68.79 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.229 0 N-CA-C 109.518 -0.549 . . . . 0.0 109.518 178.517 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' D' D ' 67' ' ' THR . . . . . . . . . . . . . 24.4 m -119.94 137.34 54.11 Favored 'General case' 0 C--N 1.331 -0.208 0 CA-C-O 121.102 0.477 . . . . 0.0 110.877 -176.985 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' D' D ' 68' ' ' LEU . . . . . . . . . . . . . 17.3 tp -103.16 122.17 44.16 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 115.831 -0.622 . . . . 0.0 109.99 178.084 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' D' D ' 69' ' ' VAL . . . . . . . . . . . . . 44.7 t -102.17 127.24 55.91 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.366 0 CA-C-N 116.285 -0.416 . . . . 0.0 110.061 -179.47 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' D' D ' 70' ' ' THR . . . . . . . . . . . . . 18.1 m -85.29 -52.89 5.58 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.227 -0.442 . . . . 0.0 110.475 179.891 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' D' D ' 71' ' ' HIS . . . . . . . . . . . . . 53.5 m-70 -149.87 152.95 35.37 Favored Pre-proline 0 CA--C 1.531 0.244 0 CA-C-N 116.251 -0.431 . . . . 0.0 110.654 179.551 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' D' D ' 72' ' ' PRO . . . . . . . . . . . . . 90.7 Cg_endo -88.98 -24.17 0.79 Allowed 'Trans proline' 0 N--CA 1.491 1.331 0 C-N-CA 121.729 1.619 . . . . 0.0 112.94 176.492 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' D' D ' 73' ' ' VAL . . . . . . . . . . . . . 35.2 m -125.52 175.82 7.19 Favored 'Isoleucine or valine' 0 C--N 1.333 -0.152 0 CA-C-O 120.684 0.278 . . . . 0.0 110.254 -178.931 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' D' D ' 74' ' ' ASP . . . . . . . . . . . . . 17.9 t0 -99.85 123.73 44.4 Favored 'General case' 0 C--N 1.331 -0.233 0 N-CA-C 110.04 -0.356 . . . . 0.0 110.04 -178.242 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' D' D ' 75' ' ' VAL . . . . . . . . . . . . . 43.3 t -117.96 122.82 70.62 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.197 0 CA-C-O 120.922 0.391 . . . . 0.0 110.494 -177.862 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' D' D ' 76' ' ' LEU . . . . . . . . . . . . . 8.0 mp -124.42 149.33 46.87 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 115.848 -0.615 . . . . 0.0 109.737 176.25 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' D' D ' 77' ' ' GLU . . . . . . . . . . . . . 97.2 mt-10 -136.3 136.6 39.9 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-O 121.049 0.452 . . . . 0.0 111.138 -178.476 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' D' D ' 78' ' ' ALA . . . . . . . . . . . . . . . -119.23 128.75 54.49 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 115.707 -0.679 . . . . 0.0 109.803 176.511 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' D' D ' 79' ' ' LYS . . . . . . . . . . . . . 32.9 ttmt -79.46 118.05 20.98 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-O 120.963 0.411 . . . . 0.0 110.986 -176.348 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' D' D ' 80' ' ' ILE . . . . . . . . . . . . . 37.1 mm -139.2 104.37 2.16 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.272 0 N-CA-C 109.067 -0.716 . . . . 0.0 109.067 -178.848 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' D' D ' 81' ' ' LYS . . . . . . . . . . . . . 84.5 tttt -95.0 125.56 39.75 Favored 'General case' 0 C--N 1.329 -0.287 0 C-N-CA 120.758 -0.377 . . . . 0.0 110.944 -177.277 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' D' D ' 82' ' ' GLY . . . . . . . . . . . . . . . 89.03 42.2 5.69 Favored Glycine 0 CA--C 1.524 0.594 0 N-CA-C 111.237 -0.745 . . . . 0.0 111.237 176.401 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' D' D ' 83' ' ' ILE . . . . . . . . . . . . . 71.1 mt -65.4 131.51 31.18 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.273 0 N-CA-C 109.68 -0.489 . . . . 0.0 109.68 177.521 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' D' D ' 84' ' ' LYS . . . . . . . . . . . . . 48.6 tttp -89.97 -50.54 5.96 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.025 -0.534 . . . . 0.0 109.947 -179.117 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' D' D ' 85' ' ' ASP . . . . . . . . . . . . . 10.0 t70 -159.85 153.12 22.1 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 115.653 -0.703 . . . . 0.0 110.173 178.366 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' D' D ' 86' ' ' VAL . . . . . . . . . . . . . 41.3 t -127.4 132.63 69.23 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.244 0 CA-C-O 120.965 0.412 . . . . 0.0 110.48 -179.328 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' D' D ' 87' ' ' ILE . . . . . . . . . . . . . 5.0 mp -119.95 122.83 69.55 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.238 0 N-CA-C 109.329 -0.619 . . . . 0.0 109.329 176.471 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' D' D ' 88' ' ' LEU . . . . . . . . . . . . . 86.1 mt -109.49 137.18 47.72 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-O 121.157 0.503 . . . . 0.0 111.307 -177.73 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' D' D ' 89' ' ' ASP . . . . . . . . . . . . . 8.6 t70 -131.48 156.47 45.6 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 115.598 -0.728 . . . . 0.0 109.29 176.499 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' D' D ' 90' ' ' GLU . . . . . . . . . . . . . 48.1 mp0 -50.85 -29.07 10.85 Favored 'General case' 0 C--N 1.327 -0.387 0 N-CA-C 112.544 0.572 . . . . 0.0 112.544 -171.177 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' D' D ' 91' ' ' ASN . . . . . . . . . . . . . 54.0 t30 -131.61 13.74 4.94 Favored 'General case' 0 N--CA 1.468 0.464 0 N-CA-C 113.307 0.854 . . . . 0.0 113.307 -176.228 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' D' D ' 92' ' ' LEU . . . . . . . . . . . . . 41.8 mt -147.82 148.72 31.2 Favored 'General case' 0 C--N 1.331 -0.204 0 CA-C-N 118.04 0.382 . . . . 0.0 110.55 -176.85 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' D' D ' 93' ' ' ILE . . . . . . . . . . . . . 72.3 mt -126.09 114.08 37.03 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.357 0 N-CA-C 109.063 -0.717 . . . . 0.0 109.063 175.845 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' D' D ' 94' ' ' VAL . . . . . . . . . . . . . 42.3 t -115.29 125.49 72.56 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.24 0 N-CA-C 109.816 -0.438 . . . . 0.0 109.816 -178.945 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' D' D ' 95' ' ' VAL . . . . . . . . . . . . . 44.6 t -119.29 133.24 66.77 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.283 0 CA-C-N 116.056 -0.52 . . . . 0.0 109.813 -179.83 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' D' D ' 96' ' ' ILE . . . . . . . . . . . . . 64.2 mt -111.7 126.0 69.05 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.358 0 N-CA-C 108.804 -0.813 . . . . 0.0 108.804 177.239 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' D' D ' 97' ' ' THR . . . . . . . . . . . . . 60.3 p -99.82 159.89 14.72 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-O 121.215 0.531 . . . . 0.0 111.388 -176.315 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' D' D ' 98' ' ' GLU . . . . . . . . . . . . . 81.0 tt0 -53.89 -26.28 24.23 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.043 -0.526 . . . . 0.0 112.12 179.254 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' D' D ' 99' ' ' GLU . . . . . . . . . . . . . 95.6 mt-10 -78.01 13.07 1.53 Allowed 'General case' 0 CA--C 1.536 0.432 0 N-CA-C 113.146 0.795 . . . . 0.0 113.146 -177.794 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' D' D ' 100' ' ' ASN . . . . . . . . . . . . . 3.0 m-20 60.47 37.74 19.61 Favored 'General case' 0 CA--C 1.529 0.167 0 CA-C-O 121.126 0.489 . . . . 0.0 110.961 -179.443 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' D' D ' 101' ' ' GLU . . . . . . . . . . . . . 83.4 tt0 -113.74 145.5 41.28 Favored 'General case' 0 C--N 1.332 -0.169 0 N-CA-C 109.45 -0.574 . . . . 0.0 109.45 176.097 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' D' D ' 102' ' ' VAL . . . . . . . . . . . . . 46.3 t -114.82 121.44 66.91 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.319 0 N-CA-C 109.615 -0.513 . . . . 0.0 109.615 -178.817 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' D' D ' 103' ' ' LEU . . . . . . . . . . . . . 39.0 mt -115.31 127.59 55.54 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 115.705 -0.68 . . . . 0.0 109.925 177.593 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' D' D ' 104' ' ' ILE . . . . . . . . . . . . . 68.4 mt -118.87 120.5 64.24 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.271 0 N-CA-C 110.164 -0.31 . . . . 0.0 110.164 -178.627 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' D' D ' 105' ' ' PHE . . . . . . . . . . . . . 54.8 m-85 -119.72 165.91 13.9 Favored 'General case' 0 C--N 1.331 -0.202 0 O-C-N 123.978 0.798 . . . . 0.0 109.542 179.268 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' D' D ' 106' ' ' ASN . . . . . . . . . . . . . 39.2 p-10 -97.32 -173.0 2.54 Favored 'General case' 0 C--N 1.329 -0.294 0 N-CA-C 109.683 -0.488 . . . . 0.0 109.683 172.597 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' D' D ' 107' ' ' GLN . . . . . . . . . . . . . 43.3 tp60 -58.77 -27.68 65.2 Favored 'General case' 0 CA--C 1.534 0.355 0 N-CA-C 111.78 0.289 . . . . 0.0 111.78 178.382 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' D' D ' 108' ' ' ASN . . . . . . . . . . . . . 9.2 t30 -84.54 9.6 13.15 Favored 'General case' 0 CA--C 1.536 0.415 0 N-CA-C 113.147 0.795 . . . . 0.0 113.147 -177.17 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' D' D ' 109' ' ' LEU . . . . . . . . . . . . . 18.8 mt 58.89 34.34 23.6 Favored 'General case' 0 CA--C 1.53 0.21 0 CA-C-O 120.942 0.401 . . . . 0.0 111.804 178.777 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' D' D ' 110' ' ' GLU . . . . . . . . . . . . . 70.7 mm-40 -107.25 141.52 38.44 Favored 'General case' 0 C--N 1.33 -0.275 0 N-CA-C 108.998 -0.742 . . . . 0.0 108.998 173.14 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' D' D ' 111' ' ' GLU . . . . . . . . . . . . . 52.1 tt0 -85.04 123.38 30.51 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-O 121.186 0.517 . . . . 0.0 111.07 -173.369 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' D' D ' 112' ' ' LEU . . . . . . . . . . . . . 30.4 mt -101.35 -43.23 6.02 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 115.625 -0.716 . . . . 0.0 110.89 178.852 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' D' D ' 113' ' ' TYR . . . . . . . . . . . . . 43.9 t80 -133.01 135.98 45.76 Favored 'General case' 0 C--N 1.332 -0.164 0 CA-C-O 120.784 0.326 . . . . 0.0 111.548 -176.367 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' D' D ' 114' ' ' ARG . . . . . . . . . . . . . 32.3 ttm180 -134.19 120.26 19.84 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-N 115.892 -0.594 . . . . 0.0 110.067 176.664 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' D' D ' 115' ' ' GLY . . . . . . . . . . . . . . . -150.01 159.73 28.22 Favored Glycine 0 CA--C 1.523 0.555 0 N-CA-C 110.825 -0.91 . . . . 0.0 110.825 178.659 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' D' D ' 116' ' ' LYS . . . . . . . . . . . . . 32.9 ttmt -136.05 139.7 43.27 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-O 120.817 0.341 . . . . 0.0 110.288 178.067 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' D' D ' 117' ' ' PHE . . . . . . . . . . . . . 20.4 m-85 -138.19 119.97 15.25 Favored 'General case' 0 C--N 1.331 -0.236 0 N-CA-C 109.911 -0.404 . . . . 0.0 109.911 -177.427 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' D' D ' 118' ' ' GLU . . . . . . . . . . . . . 96.1 mt-10 -55.51 -40.17 71.42 Favored 'General case' 0 C--N 1.329 -0.326 0 C-N-CA 120.916 -0.313 . . . . 0.0 110.915 -178.224 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' D' D ' 119' ' ' ASN . . . . . . . . . . . . . 78.3 m-20 -97.23 28.94 3.38 Favored 'General case' 0 C--N 1.331 -0.218 0 N-CA-C 112.35 0.5 . . . . 0.0 112.35 -174.795 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' D' D ' 120' ' ' LEU . . . . . . . . . . . . . 16.7 tp -58.18 119.97 7.81 Favored 'General case' 0 C--N 1.333 -0.131 0 N-CA-C 110.125 -0.324 . . . . 0.0 110.125 178.237 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' D' D ' 121' ' ' ASN . . . . . . . . . . . . . 66.2 t30 -114.01 -44.22 3.17 Favored 'General case' 0 C--N 1.331 -0.227 0 CA-C-N 116.511 -0.313 . . . . 0.0 111.273 -177.053 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' D' D ' 122' ' ' LYS . . . . . . . . . . . . . 59.8 mttm -146.7 154.5 41.5 Favored 'General case' 0 C--N 1.33 -0.241 0 C-N-CA 120.653 -0.419 . . . . 0.0 111.739 -176.434 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' D' D ' 123' ' ' VAL . . . . . . . . . . . . . 43.8 t -131.71 129.95 61.66 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.243 0 CA-C-N 115.971 -0.559 . . . . 0.0 109.731 175.221 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' D' D ' 124' ' ' LEU . . . . . . . . . . . . . 30.3 mt -118.92 133.7 55.66 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-N 116.31 -0.405 . . . . 0.0 110.623 -179.164 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' D' D ' 125' ' ' VAL . . . . . . . . . . . . . 45.3 t -129.01 124.41 60.81 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 N-CA-C 109.895 -0.409 . . . . 0.0 109.895 178.153 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' D' D ' 126' ' ' ARG . . . . . . . . . . . . . 44.1 mtp180 -148.87 130.92 15.33 Favored 'General case' 0 C--N 1.329 -0.296 0 N-CA-C 109.69 -0.485 . . . . 0.0 109.69 179.189 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' D' D ' 127' ' ' ASN . . . . . . . . . . . . . 37.2 t30 56.32 -152.54 0.38 Allowed 'General case' 0 CA--C 1.539 0.527 0 N-CA-C 109.742 -0.466 . . . . 0.0 109.742 -179.943 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' D' D ' 128' ' ' ASP . . . . . . . . . . . . . 12.3 p-10 -84.05 18.67 2.01 Favored 'General case' 0 CA--C 1.536 0.428 0 CA-C-N 118.506 0.594 . . . . 0.0 112.602 177.936 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' D' D ' 129' ' ' LEU . . . . . . . . . . . . . 15.3 tp -117.82 138.83 51.82 Favored 'General case' 0 C--O 1.232 0.181 0 O-C-N 122.172 -0.33 . . . . 0.0 110.164 179.632 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' D' D ' 130' ' ' VAL . . . . . . . . . . . . . 12.5 p -129.11 141.18 47.27 Favored 'Isoleucine or valine' 0 N--CA 1.462 0.171 0 CA-C-O 121.133 0.492 . . . . 0.0 110.248 179.891 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' D' D ' 131' ' ' VAL . . . . . . . . . . . . . 58.8 t -136.06 137.56 48.47 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.276 0 CA-C-N 115.85 -0.614 . . . . 0.0 110.555 -177.197 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' D' D ' 132' ' ' ILE . . . . . . . . . . . . . 74.4 mt -114.14 133.94 58.59 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.243 0 CA-C-N 115.881 -0.599 . . . . 0.0 109.441 179.296 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' D' D ' 133' ' ' ILE . . . . . . . . . . . . . 42.9 mm -116.29 122.23 69.27 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.243 0 CA-C-O 120.822 0.344 . . . . 0.0 110.8 -175.323 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' D' D ' 134' ' ' ASP . . . . . . . . . . . . . 7.2 p-10 -136.03 146.04 46.69 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.148 -0.478 . . . . 0.0 109.838 175.248 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' D' D ' 135' ' ' GLU . . . . . . . . . . . . . 80.6 tt0 -49.85 -22.97 1.65 Allowed 'General case' 0 C--N 1.328 -0.344 0 N-CA-C 113.076 0.769 . . . . 0.0 113.076 -171.464 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' D' D ' 136' ' ' GLN . . . . . . . . . . . . . 13.3 pt20 -100.9 -30.44 11.66 Favored 'General case' 0 N--CA 1.464 0.249 0 N-CA-C 112.674 0.62 . . . . 0.0 112.674 -175.587 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' D' D ' 137' ' ' LYS . . . . . . . . . . . . . 87.3 mttt -142.6 158.05 44.07 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-O 121.407 0.622 . . . . 0.0 112.129 -173.019 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' D' D ' 138' ' ' LEU . . . . . . . . . . . . . 4.6 tt -118.48 122.13 41.96 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-N 115.174 -0.921 . . . . 0.0 108.883 171.459 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' D' D ' 139' ' ' THR . . . . . . . . . . . . . 28.0 m -111.16 125.06 53.39 Favored 'General case' 0 C--N 1.332 -0.162 0 CA-C-O 120.644 0.259 . . . . 0.0 110.899 -176.71 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' D' D ' 140' ' ' LEU . . . . . . . . . . . . . 7.7 tt -114.03 125.68 54.27 Favored 'General case' 0 C--N 1.327 -0.388 0 N-CA-C 109.294 -0.632 . . . . 0.0 109.294 -179.265 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' D' D ' 141' ' ' ILE . . . . . . . . . . . . . 19.7 mt -123.28 120.37 60.08 Favored 'Isoleucine or valine' 0 C--O 1.235 0.311 0 N-CA-C 109.715 -0.476 . . . . 0.0 109.715 -176.146 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' D' D ' 142' ' ' ARG . . . . . . . . . . . . . 61.2 ttt180 -114.51 127.24 55.7 Favored 'General case' 0 C--N 1.332 -0.177 0 CA-C-N 115.448 -0.796 . . . . 0.0 110.327 -176.347 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' D' D ' 143' ' ' THR . . . . . . . . . . . . . 28.7 p . . . . . 0 C--O 1.219 -0.516 0 CA-C-O 118.018 -0.992 . . . . 0.0 110.597 -179.68 . . . . . . . . 0 0 . 1 . 015 nuclear orig full ' E' E ' -3' ' ' GLU . . . . . . . . . . . . . 96.0 mt-10 . . . . . 0 N--CA 1.49 1.554 0 N-CA-C 109.382 -0.599 . . . . 0.0 109.382 . . . . . . . . . 0 0 . 1 . 015 nuclear orig full ' E' E ' -2' ' ' GLY . . . . . . . . . . . . . . . -73.08 143.57 33.45 Favored Glycine 0 CA--C 1.523 0.592 0 N-CA-C 110.706 -0.958 . . . . 0.0 110.706 178.918 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' E' E ' -1' ' ' VAL . . . . . . . . . . . . . 45.6 t -95.85 123.14 47.93 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.297 0 N-CA-C 109.851 -0.426 . . . . 0.0 109.851 179.934 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' E' E ' 0' ' ' ILE . . . . . . . . . . . . . 71.7 mt -127.36 140.07 50.14 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.242 0 CA-C-N 116.144 -0.48 . . . . 0.0 109.992 -178.343 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' E' E ' 1' ' ' MET . . . . . . . . . . . . . 25.8 ptm -93.54 134.48 35.77 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.063 -0.517 . . . . 0.0 110.629 179.437 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' E' E ' 2' ' ' SER . . . . . . . . . . . . . 4.9 p -126.67 130.28 50.11 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-O 121.103 0.478 . . . . 0.0 110.67 179.226 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' E' E ' 3' ' ' GLU . . . . . . . . . . . . . 79.8 tt0 -145.83 143.06 29.4 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 115.884 -0.598 . . . . 0.0 111.021 -178.003 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' E' E ' 4' ' ' LEU . . . . . . . . . . . . . 15.1 tp -123.59 135.37 53.93 Favored 'General case' 0 C--N 1.331 -0.217 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.281 177.359 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' E' E ' 5' ' ' LYS . . . . . . . . . . . . . 90.3 mttt -109.09 120.04 41.34 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.23 -0.441 . . . . 0.0 110.38 178.87 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' E' E ' 6' ' ' LEU . . . . . . . . . . . . . 59.4 mt -116.58 142.89 46.3 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 115.63 -0.713 . . . . 0.0 111.096 -177.815 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' E' E ' 7' ' ' LYS . . . . . . . . . . . . . 60.3 tttm -133.89 140.6 36.92 Favored Pre-proline 0 CA--C 1.534 0.338 0 CA-C-O 119.015 -0.517 . . . . 0.0 110.033 176.522 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' E' E ' 8' ' ' PRO . . . . . . . . . . . . . 98.1 Cg_endo -90.78 143.73 3.5 Favored 'Trans proline' 0 N--CA 1.49 1.314 0 C-N-CA 121.804 1.669 . . . . 0.0 111.866 178.247 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' E' E ' 9' ' ' LEU . . . . . . . . . . . . . 43.6 mt -84.08 -48.26 0.7 Allowed Pre-proline 0 CA--C 1.534 0.342 0 CA-C-O 118.683 -0.675 . . . . 0.0 112.389 -179.205 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' E' E ' 10' ' ' PRO . . . . . . . . . . . . . 88.1 Cg_endo -79.91 158.02 24.13 Favored 'Trans proline' 0 N--CA 1.496 1.642 0 C-N-CA 121.258 1.305 . . . . 0.0 111.845 177.408 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' E' E ' 11' ' ' LYS . . . . . . . . . . . . . 39.3 ttpt -88.0 94.84 9.91 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-O 120.863 0.363 . . . . 0.0 110.422 179.47 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' E' E ' 12' ' ' VAL . . . . . . . . . . . . . 12.4 p -143.15 143.47 24.86 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.286 0 CA-C-N 116.23 -0.441 . . . . 0.0 110.583 179.099 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' E' E ' 13' ' ' GLU . . . . . . . . . . . . . 70.6 mm-40 -84.4 132.62 34.56 Favored 'General case' 0 C--N 1.33 -0.254 0 N-CA-C 109.951 -0.388 . . . . 0.0 109.951 177.263 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' E' E ' 14' ' ' LEU . . . . . . . . . . . . . 48.8 mt -97.97 147.7 33.43 Favored Pre-proline 0 CA--C 1.532 0.278 0 CA-C-O 119.309 -0.376 . . . . 0.0 110.381 -178.151 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' E' E ' 15' ' ' PRO . . . . . . . . . . . . . 24.9 Cg_exo -62.69 161.72 27.49 Favored 'Trans proline' 0 N--CA 1.498 1.749 0 C-N-CA 121.25 1.3 . . . . 0.0 111.825 175.98 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' E' E ' 16' ' ' PRO . . . . . . . . . . . . . 31.2 Cg_exo -59.38 -39.51 76.21 Favored 'Trans proline' 0 N--CA 1.497 1.691 0 C-N-CA 121.422 1.414 . . . . 0.0 112.661 -178.219 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' E' E ' 17' ' ' ASP . . . . . . . . . . . . . 22.8 p-10 -88.71 11.28 18.03 Favored 'General case' 0 CA--C 1.535 0.387 0 N-CA-C 113.172 0.805 . . . . 0.0 113.172 -177.646 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' E' E ' 18' ' ' PHE . . . . . . . . . . . . . 43.5 t80 -57.82 -44.53 86.46 Favored 'General case' 0 C--N 1.335 -0.056 0 O-C-N 122.014 -0.429 . . . . 0.0 110.121 -178.059 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' E' E ' 19' ' ' VAL . . . . . . . . . . . . . 47.6 t -58.16 -41.52 80.99 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.336 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.309 -179.069 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' E' E ' 20' ' ' ASP . . . . . . . . . . . . . 76.2 m-20 -59.72 -42.35 92.89 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-O 120.851 0.358 . . . . 0.0 110.805 -177.655 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' E' E ' 21' ' ' VAL . . . . . . . . . . . . . 47.0 t -64.6 -47.87 87.2 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.294 0 CA-C-N 116.36 -0.382 . . . . 0.0 110.42 -178.194 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' E' E ' 22' ' ' ILE . . . . . . . . . . . . . 49.6 mm -56.05 -45.03 80.32 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.256 0 CA-C-O 120.727 0.299 . . . . 0.0 110.662 179.102 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' E' E ' 23' ' ' ARG . . . . . . . . . . . . . 59.4 ttp180 -54.09 -49.94 67.94 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-O 120.694 0.283 . . . . 0.0 111.388 -178.313 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' E' E ' 24' ' ' ILE . . . . . . . . . . . . . 71.2 mt -60.06 -44.59 95.25 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.271 0 CA-C-N 116.626 -0.261 . . . . 0.0 111.105 -178.044 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' E' E ' 25' ' ' LYS . . . . . . . . . . . . . 83.4 mttt -64.84 -37.91 89.21 Favored 'General case' 0 C--N 1.329 -0.308 0 N-CA-C 112.394 0.516 . . . . 0.0 112.394 -177.694 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' E' E ' 26' ' ' LEU . . . . . . . . . . . . . 50.0 mt -79.27 -42.19 26.42 Favored 'General case' 0 C--N 1.331 -0.221 0 N-CA-C 113.53 0.937 . . . . 0.0 113.53 -172.046 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' E' E ' 27' ' ' GLN . . . . . . . . . . . . . 11.1 pt20 -46.83 141.88 3.71 Favored 'General case' 0 N--CA 1.469 0.491 0 N-CA-C 112.905 0.705 . . . . 0.0 112.905 -173.772 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' E' E ' 28' ' ' GLY . . . . . . . . . . . . . . . 97.75 -26.26 23.96 Favored Glycine 0 CA--C 1.531 1.086 0 CA-C-N 115.418 -0.81 . . . . 0.0 112.184 -177.818 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' E' E ' 29' ' ' LYS . . . . . . . . . . . . . 69.5 mttm -97.77 155.12 17.18 Favored 'General case' 0 C--N 1.331 -0.222 0 CA-C-N 117.365 0.583 . . . . 0.0 110.976 178.249 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' E' E ' 30' ' ' THR . . . . . . . . . . . . . 19.2 m -106.79 137.12 45.42 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 115.931 -0.577 . . . . 0.0 109.727 175.149 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' E' E ' 31' ' ' VAL . . . . . . . . . . . . . 35.0 m -128.17 154.97 39.5 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.253 0 CA-C-O 120.973 0.416 . . . . 0.0 110.862 -177.691 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' E' E ' 32' ' ' ARG . . . . . . . . . . . . . 59.1 ttm-85 -127.24 146.1 50.54 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.04 -0.527 . . . . 0.0 110.327 -179.972 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' E' E ' 33' ' ' THR . . . . . . . . . . . . . 18.6 m -53.08 139.26 28.91 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.469 -0.332 . . . . 0.0 111.355 -177.861 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' E' E ' 34' ' ' GLY . . . . . . . . . . . . . . . 101.13 -17.13 56.44 Favored Glycine 0 CA--C 1.532 1.156 0 CA-C-O 119.674 -0.514 . . . . 0.0 113.243 -179.826 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' E' E ' 35' ' ' ASP . . . . . . . . . . . . . 78.8 m-20 -66.51 149.03 51.05 Favored 'General case' 0 C--O 1.23 0.071 0 CA-C-N 118.018 0.909 . . . . 0.0 111.198 178.542 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' E' E ' 36' ' ' VAL . . . . . . . . . . . . . 44.0 t -123.38 131.95 72.25 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.18 0 CA-C-N 115.865 -0.607 . . . . 0.0 109.786 177.985 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' E' E ' 37' ' ' ILE . . . . . . . . . . . . . 67.8 mt -121.91 140.65 45.21 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.21 0 CA-C-N 116.256 -0.429 . . . . 0.0 109.952 -178.936 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' E' E ' 38' ' ' GLY . . . . . . . . . . . . . . . -110.71 128.81 8.95 Favored Glycine 0 CA--C 1.527 0.802 0 N-CA-C 111.348 -0.701 . . . . 0.0 111.348 -179.528 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' E' E ' 39' ' ' ILE . . . . . . . . . . . . . 72.8 mt -123.83 134.25 67.0 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.207 0 N-CA-C 110.135 -0.32 . . . . 0.0 110.135 179.134 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' E' E ' 40' ' ' SER . . . . . . . . . . . . . 19.5 p -93.57 114.19 26.47 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.508 -0.314 . . . . 0.0 110.993 176.214 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' E' E ' 41' ' ' ILE . . . . . . . . . . . . . 44.7 mm -121.58 124.46 71.75 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.269 0 CA-C-O 120.789 0.328 . . . . 0.0 110.334 179.074 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' E' E ' 42' ' ' LEU . . . . . . . . . . . . . 57.7 mt 52.0 33.06 11.11 Favored 'General case' 0 C--N 1.331 -0.23 0 CA-C-N 116.254 -0.43 . . . . 0.0 111.933 177.359 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' E' E ' 43' ' ' GLY . . . . . . . . . . . . . . . 72.4 33.65 61.22 Favored Glycine 0 CA--C 1.529 0.932 0 C-N-CA 121.091 -0.576 . . . . 0.0 111.749 178.747 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' E' E ' 44' ' ' LYS . . . . . . . . . . . . . 21.1 tptm -138.86 131.23 28.54 Favored 'General case' 0 C--N 1.329 -0.3 0 N-CA-C 109.463 -0.569 . . . . 0.0 109.463 179.539 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' E' E ' 45' ' ' GLU . . . . . . . . . . . . . 80.9 tt0 -82.52 119.25 23.99 Favored 'General case' 0 C--N 1.328 -0.359 0 C-N-CA 120.795 -0.362 . . . . 0.0 110.941 -177.267 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' E' E ' 46' ' ' VAL . . . . . . . . . . . . . 7.4 p -119.97 126.44 75.29 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.18 0 N-CA-C 109.451 -0.574 . . . . 0.0 109.451 176.26 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' E' E ' 47' ' ' LYS . . . . . . . . . . . . . 63.2 mttp -99.97 129.53 46.05 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 115.898 -0.592 . . . . 0.0 111.206 178.916 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' E' E ' 48' ' ' PHE . . . . . . . . . . . . . 87.4 m-85 -112.01 131.8 55.18 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.062 -0.517 . . . . 0.0 110.191 177.162 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' E' E ' 49' ' ' LYS . . . . . . . . . . . . . 79.0 tttt -107.71 135.71 48.68 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.343 -0.39 . . . . 0.0 110.63 -179.666 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' E' E ' 50' ' ' VAL . . . . . . . . . . . . . 45.9 t -81.41 107.55 13.72 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.242 0 N-CA-C 109.123 -0.695 . . . . 0.0 109.123 175.406 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' E' E ' 51' ' ' VAL . . . . . . . . . . . . . 42.9 t -73.14 -50.85 29.01 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.346 0 CA-C-N 115.994 -0.548 . . . . 0.0 109.791 -174.399 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' E' E ' 52' ' ' GLN . . . . . . . . . . . . . 70.2 mt-30 -154.92 155.1 33.69 Favored 'General case' 0 C--N 1.331 -0.218 0 CA-C-O 121.135 0.493 . . . . 0.0 111.699 -179.332 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' E' E ' 53' ' ' ALA . . . . . . . . . . . . . . . -131.68 133.78 45.24 Favored 'General case' 0 C--N 1.33 -0.283 0 CA-C-N 115.364 -0.835 . . . . 0.0 109.886 175.629 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' E' E ' 54' ' ' TYR . . . . . . . . . . . . . 57.7 t80 -129.13 109.08 18.03 Favored Pre-proline 0 CA--C 1.534 0.344 0 CA-C-O 118.284 -0.865 . . . . 0.0 110.439 179.399 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' E' E ' 55' ' ' PRO . . . . . . . . . . . . . 72.8 Cg_endo -77.1 169.8 73.32 Favored 'Cis proline' 0 N--CA 1.498 1.746 0 CA-C-N 121.911 1.718 . . . . 0.0 112.356 -5.457 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' E' E ' 56' ' ' SER . . . . . . . . . . . . . 30.7 m -116.6 129.03 25.57 Favored Pre-proline 0 CA--C 1.538 0.516 0 CA-C-O 118.368 -0.825 . . . . 0.0 109.404 175.244 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' E' E ' 57' ' ' PRO . . . . . . . . . . . . . 42.6 Cg_endo -68.97 148.93 85.87 Favored 'Cis proline' 0 N--CA 1.498 1.771 0 CA-C-N 122.052 1.768 . . . . 0.0 111.815 -0.586 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' E' E ' 58' ' ' LEU . . . . . . . . . . . . . 23.5 tp -108.2 138.53 44.32 Favored 'General case' 0 C--N 1.331 -0.222 0 CA-C-N 116.101 -0.499 . . . . 0.0 110.667 -178.304 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' E' E ' 59' ' ' ARG . . . . . . . . . . . . . 60.6 ttt180 -103.44 131.33 50.63 Favored 'General case' 0 C--N 1.328 -0.346 0 N-CA-C 109.404 -0.591 . . . . 0.0 109.404 175.872 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' E' E ' 60' ' ' VAL . . . . . . . . . . . . . 42.1 t -89.71 119.0 36.1 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.287 0 C-N-CA 120.669 -0.412 . . . . 0.0 110.516 -176.483 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' E' E ' 61' ' ' GLU . . . . . . . . . . . . . 95.1 mt-10 -131.18 167.46 19.12 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.104 -0.498 . . . . 0.0 110.002 176.525 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' E' E ' 62' ' ' ASP . . . . . . . . . . . . . 80.5 m-20 -54.4 -32.71 57.77 Favored 'General case' 0 C--N 1.328 -0.365 0 N-CA-C 111.678 0.251 . . . . 0.0 111.678 -179.712 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' E' E ' 63' ' ' ARG . . . . . . . . . . . . . 11.1 ptm180 -85.7 6.41 27.81 Favored 'General case' 0 CA--C 1.536 0.423 0 N-CA-C 113.551 0.945 . . . . 0.0 113.551 -175.505 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' E' E ' 64' ' ' THR . . . . . . . . . . . . . 23.8 m -85.66 138.68 31.98 Favored 'General case' 0 C--N 1.332 -0.155 0 CA-C-N 118.237 0.472 . . . . 0.0 110.591 -179.09 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' E' E ' 65' ' ' LYS . . . . . . . . . . . . . 48.7 mtmt -87.68 129.78 35.02 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-O 120.949 0.404 . . . . 0.0 110.322 178.565 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' E' E ' 66' ' ' ILE . . . . . . . . . . . . . 58.8 mt -113.11 124.87 70.18 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.316 0 N-CA-C 109.504 -0.554 . . . . 0.0 109.504 179.73 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' E' E ' 67' ' ' THR . . . . . . . . . . . . . 17.8 m -115.48 137.78 51.7 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-O 121.077 0.465 . . . . 0.0 110.663 -177.582 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' E' E ' 68' ' ' LEU . . . . . . . . . . . . . 15.8 tp -104.34 136.13 44.5 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 115.817 -0.628 . . . . 0.0 110.772 -178.333 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' E' E ' 69' ' ' VAL . . . . . . . . . . . . . 46.7 t -82.81 155.14 3.87 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 N-CA-C 109.48 -0.563 . . . . 0.0 109.48 175.923 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' E' E ' 70' ' ' THR . . . . . . . . . . . . . 60.9 p -78.36 161.96 26.8 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-O 121.198 0.523 . . . . 0.0 111.139 -172.514 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' E' E ' 71' ' ' HIS . . . . . . . . . . . . . 23.6 m80 -108.55 170.91 4.97 Favored Pre-proline 0 CA--C 1.532 0.266 0 CA-C-N 115.357 -0.838 . . . . 0.0 110.324 -174.703 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' E' E ' 72' ' ' PRO . . . . . . . . . . . . . 23.9 Cg_exo -64.87 160.1 42.66 Favored 'Trans proline' 0 N--CA 1.495 1.58 0 C-N-CA 121.514 1.476 . . . . 0.0 111.507 175.883 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' E' E ' 73' ' ' VAL . . . . . . . . . . . . . 30.1 m -69.69 166.8 2.03 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.279 0 CA-C-O 120.905 0.383 . . . . 0.0 111.143 -172.999 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' E' E ' 74' ' ' ASP . . . . . . . . . . . . . 12.3 t70 -91.28 122.78 34.19 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 115.882 -0.599 . . . . 0.0 110.48 -174.048 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' E' E ' 75' ' ' VAL . . . . . . . . . . . . . 44.3 t -116.99 120.71 65.92 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.248 0 CA-C-O 121.14 0.495 . . . . 0.0 110.134 178.98 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' E' E ' 76' ' ' LEU . . . . . . . . . . . . . 16.5 mt -122.31 143.23 49.75 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 115.603 -0.726 . . . . 0.0 109.75 178.098 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' E' E ' 77' ' ' GLU . . . . . . . . . . . . . 96.0 mt-10 -136.89 135.51 37.88 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-O 121.048 0.451 . . . . 0.0 111.112 -177.804 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' E' E ' 78' ' ' ALA . . . . . . . . . . . . . . . -119.93 139.69 52.05 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 115.643 -0.708 . . . . 0.0 109.795 176.678 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' E' E ' 79' ' ' LYS . . . . . . . . . . . . . 54.7 mttp -87.94 114.5 24.62 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.412 -0.358 . . . . 0.0 110.774 -177.058 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' E' E ' 80' ' ' ILE . . . . . . . . . . . . . 33.4 mm -139.05 103.7 2.04 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.325 0 N-CA-C 109.252 -0.647 . . . . 0.0 109.252 -178.703 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' E' E ' 81' ' ' LYS . . . . . . . . . . . . . 37.9 ttpt -98.12 130.51 44.89 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-O 120.93 0.395 . . . . 0.0 110.547 -178.5 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' E' E ' 82' ' ' GLY . . . . . . . . . . . . . . . 89.15 42.13 5.67 Favored Glycine 0 CA--C 1.523 0.563 0 N-CA-C 111.142 -0.783 . . . . 0.0 111.142 178.053 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' E' E ' 83' ' ' ILE . . . . . . . . . . . . . 71.8 mt -72.43 135.38 27.91 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.291 0 N-CA-C 109.323 -0.621 . . . . 0.0 109.323 176.459 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' E' E ' 84' ' ' LYS . . . . . . . . . . . . . 31.4 ttpt -100.0 -50.67 3.92 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-O 120.888 0.375 . . . . 0.0 110.528 -177.062 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' E' E ' 85' ' ' ASP . . . . . . . . . . . . . 8.1 t70 -147.24 150.17 34.32 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.109 -0.496 . . . . 0.0 110.655 -178.783 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' E' E ' 86' ' ' VAL . . . . . . . . . . . . . 42.5 t -131.28 130.71 63.33 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.202 0 CA-C-O 120.993 0.425 . . . . 0.0 110.527 -179.333 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' E' E ' 87' ' ' ILE . . . . . . . . . . . . . 43.6 mm -118.59 125.59 74.5 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.189 0 N-CA-C 109.444 -0.576 . . . . 0.0 109.444 175.843 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' E' E ' 88' ' ' LEU . . . . . . . . . . . . . 17.2 tp -112.98 128.83 56.6 Favored 'General case' 0 C--N 1.331 -0.201 0 CA-C-O 120.924 0.392 . . . . 0.0 111.135 -176.949 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' E' E ' 89' ' ' ASP . . . . . . . . . . . . . 6.7 t70 -125.95 156.28 40.03 Favored 'General case' 0 C--N 1.331 -0.22 0 CA-C-N 115.988 -0.551 . . . . 0.0 109.927 177.172 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' E' E ' 90' ' ' GLU . . . . . . . . . . . . . 64.0 tt0 -45.73 -46.19 14.88 Favored 'General case' 0 N--CA 1.464 0.238 0 N-CA-C 112.988 0.736 . . . . 0.0 112.988 -172.166 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' E' E ' 91' ' ' ASN . . . . . . . . . . . . . 41.0 t30 -132.17 39.98 3.37 Favored 'General case' 0 C--N 1.332 -0.173 0 CA-C-O 121.124 0.488 . . . . 0.0 110.882 -177.647 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' E' E ' 92' ' ' LEU . . . . . . . . . . . . . 11.9 tp -165.39 138.14 4.36 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.243 -0.435 . . . . 0.0 110.168 -178.453 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' E' E ' 93' ' ' ILE . . . . . . . . . . . . . 70.8 mt -126.08 125.17 67.47 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.29 0 N-CA-C 109.905 -0.406 . . . . 0.0 109.905 -178.531 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' E' E ' 94' ' ' VAL . . . . . . . . . . . . . 43.7 t -122.87 126.61 74.06 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.187 0 N-CA-C 109.938 -0.393 . . . . 0.0 109.938 179.369 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' E' E ' 95' ' ' VAL . . . . . . . . . . . . . 43.7 t -121.43 133.79 66.83 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.317 0 CA-C-N 116.1 -0.5 . . . . 0.0 109.699 179.555 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' E' E ' 96' ' ' ILE . . . . . . . . . . . . . 68.4 mt -117.36 129.63 73.54 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.283 0 N-CA-C 109.348 -0.612 . . . . 0.0 109.348 -179.778 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' E' E ' 97' ' ' THR . . . . . . . . . . . . . 61.6 p -105.31 162.42 13.44 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-O 121.549 0.69 . . . . 0.0 111.896 -174.53 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' E' E ' 98' ' ' GLU . . . . . . . . . . . . . 13.1 mm-40 -53.8 -28.91 38.0 Favored 'General case' 0 CA--C 1.531 0.241 0 CA-C-N 115.727 -0.669 . . . . 0.0 112.121 179.254 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' E' E ' 99' ' ' GLU . . . . . . . . . . . . . 95.2 mt-10 -79.53 16.92 0.95 Allowed 'General case' 0 CA--C 1.535 0.402 0 N-CA-C 113.164 0.801 . . . . 0.0 113.164 -175.032 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' E' E ' 100' ' ' ASN . . . . . . . . . . . . . 4.0 m-20 62.11 38.12 14.07 Favored 'General case' 0 N--CA 1.463 0.208 0 CA-C-O 121.094 0.473 . . . . 0.0 110.84 177.935 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' E' E ' 101' ' ' GLU . . . . . . . . . . . . . 83.3 tt0 -120.41 143.04 48.67 Favored 'General case' 0 C--N 1.331 -0.203 0 CA-C-N 116.184 -0.462 . . . . 0.0 109.979 178.242 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' E' E ' 102' ' ' VAL . . . . . . . . . . . . . 43.1 t -115.03 127.71 72.48 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.282 0 CA-C-N 116.262 -0.426 . . . . 0.0 109.938 179.135 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' E' E ' 103' ' ' LEU . . . . . . . . . . . . . 6.3 mp -116.34 131.53 56.92 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-N 115.676 -0.693 . . . . 0.0 109.786 175.954 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' E' E ' 104' ' ' ILE . . . . . . . . . . . . . 69.7 mt -118.74 123.69 71.94 Favored 'Isoleucine or valine' 0 C--O 1.234 0.269 0 N-CA-C 110.118 -0.327 . . . . 0.0 110.118 -179.004 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' E' E ' 105' ' ' PHE . . . . . . . . . . . . . 57.5 m-85 -124.6 164.28 20.17 Favored 'General case' 0 C--N 1.332 -0.191 0 O-C-N 124.07 0.856 . . . . 0.0 109.774 -179.725 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' E' E ' 106' ' ' ASN . . . . . . . . . . . . . 44.1 p-10 -96.71 -169.87 1.96 Allowed 'General case' 0 C--N 1.331 -0.199 0 N-CA-C 110.114 -0.328 . . . . 0.0 110.114 173.749 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' E' E ' 107' ' ' GLN . . . . . . . . . . . . . 46.5 tt0 -58.2 -30.04 66.15 Favored 'General case' 0 C--N 1.33 -0.279 0 N-CA-C 111.927 0.344 . . . . 0.0 111.927 -179.897 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' E' E ' 108' ' ' ASN . . . . . . . . . . . . . 11.9 t-20 -88.58 13.29 12.43 Favored 'General case' 0 CA--C 1.535 0.389 0 N-CA-C 113.037 0.754 . . . . 0.0 113.037 -176.578 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' E' E ' 109' ' ' LEU . . . . . . . . . . . . . 21.2 mt 57.06 33.81 23.92 Favored 'General case' 0 CA--C 1.53 0.196 0 N-CA-C 111.812 0.301 . . . . 0.0 111.812 179.01 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' E' E ' 110' ' ' GLU . . . . . . . . . . . . . 96.0 mt-10 -100.19 132.7 45.41 Favored 'General case' 0 C--N 1.329 -0.311 0 N-CA-C 109.171 -0.677 . . . . 0.0 109.171 174.688 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' E' E ' 111' ' ' GLU . . . . . . . . . . . . . 52.6 tt0 -74.79 121.84 22.39 Favored 'General case' 0 C--N 1.327 -0.385 0 CA-C-O 121.017 0.437 . . . . 0.0 110.875 -173.606 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' E' E ' 112' ' ' LEU . . . . . . . . . . . . . 73.4 mt -100.64 -46.12 5.28 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 115.872 -0.603 . . . . 0.0 110.61 179.519 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' E' E ' 113' ' ' TYR . . . . . . . . . . . . . 64.2 t80 -140.89 143.66 34.8 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.121 -0.491 . . . . 0.0 111.277 -177.237 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' E' E ' 114' ' ' ARG . . . . . . . . . . . . . 47.0 ptt85 -144.25 126.14 15.32 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.09 -0.504 . . . . 0.0 110.603 176.417 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' E' E ' 115' ' ' GLY . . . . . . . . . . . . . . . -150.03 147.52 17.83 Favored Glycine 0 CA--C 1.524 0.646 0 N-CA-C 111.11 -0.796 . . . . 0.0 111.11 179.203 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' E' E ' 116' ' ' LYS . . . . . . . . . . . . . 37.1 ttpt -118.72 135.53 54.44 Favored 'General case' 0 C--N 1.33 -0.264 0 N-CA-C 109.92 -0.4 . . . . 0.0 109.92 177.64 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' E' E ' 117' ' ' PHE . . . . . . . . . . . . . 43.0 m-85 -127.25 115.42 19.03 Favored 'General case' 0 C--N 1.331 -0.211 0 CA-C-N 116.215 -0.448 . . . . 0.0 109.914 -177.2 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' E' E ' 118' ' ' GLU . . . . . . . . . . . . . 96.1 mt-10 -53.99 -48.26 70.58 Favored 'General case' 0 C--N 1.33 -0.282 0 C-N-CA 121.005 -0.278 . . . . 0.0 111.344 -176.364 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' E' E ' 119' ' ' ASN . . . . . . . . . . . . . 65.7 m-80 -95.69 31.13 2.12 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 115.964 -0.562 . . . . 0.0 112.074 -174.828 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' E' E ' 120' ' ' LEU . . . . . . . . . . . . . 17.5 tp -53.23 119.92 5.34 Favored 'General case' 0 N--CA 1.463 0.215 0 CA-C-O 120.795 0.331 . . . . 0.0 110.909 179.421 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' E' E ' 121' ' ' ASN . . . . . . . . . . . . . 43.2 m-80 -114.13 -44.13 3.17 Favored 'General case' 0 C--N 1.333 -0.15 0 CA-C-N 116.273 -0.421 . . . . 0.0 111.102 -177.581 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' E' E ' 122' ' ' LYS . . . . . . . . . . . . . 18.7 mtpp -139.79 142.5 36.7 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.33 -0.395 . . . . 0.0 111.706 -174.876 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' E' E ' 123' ' ' VAL . . . . . . . . . . . . . 46.4 t -132.81 126.16 53.7 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.377 0 N-CA-C 109.339 -0.615 . . . . 0.0 109.339 172.953 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' E' E ' 124' ' ' LEU . . . . . . . . . . . . . 7.4 tp -129.09 130.94 47.13 Favored 'General case' 0 C--O 1.232 0.179 0 CA-C-O 120.939 0.4 . . . . 0.0 110.538 -178.114 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' E' E ' 125' ' ' VAL . . . . . . . . . . . . . 41.5 t -124.75 133.17 70.12 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.218 0 CA-C-N 116.014 -0.539 . . . . 0.0 109.884 179.345 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' E' E ' 126' ' ' ARG . . . . . . . . . . . . . 34.7 ttm180 -155.68 124.04 5.88 Favored 'General case' 0 C--N 1.328 -0.327 0 N-CA-C 109.619 -0.512 . . . . 0.0 109.619 179.06 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' E' E ' 127' ' ' ASN . . . . . . . . . . . . . 32.1 t30 57.97 -154.44 0.36 Allowed 'General case' 0 CA--C 1.538 0.487 0 N-CA-C 109.296 -0.631 . . . . 0.0 109.296 -175.936 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' E' E ' 128' ' ' ASP . . . . . . . . . . . . . 9.0 p-10 -80.94 16.5 1.45 Allowed 'General case' 0 CA--C 1.536 0.424 0 N-CA-C 112.51 0.559 . . . . 0.0 112.51 176.635 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' E' E ' 129' ' ' LEU . . . . . . . . . . . . . 26.3 tp -107.7 131.28 54.59 Favored 'General case' 0 C--O 1.232 0.155 0 O-C-N 122.019 -0.426 . . . . 0.0 110.014 177.865 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' E' E ' 130' ' ' VAL . . . . . . . . . . . . . 44.6 t -125.3 134.93 65.58 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.27 0 N-CA-C 109.843 -0.428 . . . . 0.0 109.843 -179.352 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' E' E ' 131' ' ' VAL . . . . . . . . . . . . . 43.4 t -134.05 133.42 56.01 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.252 0 CA-C-O 121.137 0.494 . . . . 0.0 110.252 178.388 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' E' E ' 132' ' ' ILE . . . . . . . . . . . . . 73.1 mt -119.63 132.96 67.95 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.252 0 CA-C-N 115.601 -0.727 . . . . 0.0 109.411 179.648 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' E' E ' 133' ' ' ILE . . . . . . . . . . . . . 42.8 mm -118.03 123.27 71.41 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.277 0 CA-C-O 120.886 0.374 . . . . 0.0 111.2 -174.029 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' E' E ' 134' ' ' ASP . . . . . . . . . . . . . 5.3 p-10 -127.38 151.6 48.58 Favored 'General case' 0 C--N 1.331 -0.227 0 CA-C-N 115.843 -0.617 . . . . 0.0 109.6 173.397 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' E' E ' 135' ' ' GLU . . . . . . . . . . . . . 43.2 tp10 -49.73 -26.38 3.76 Favored 'General case' 0 C--N 1.329 -0.314 0 N-CA-C 112.86 0.689 . . . . 0.0 112.86 -169.859 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' E' E ' 136' ' ' GLN . . . . . . . . . . . . . 97.3 mt-30 -102.9 -31.12 10.41 Favored 'General case' 0 N--CA 1.464 0.228 0 N-CA-C 112.851 0.686 . . . . 0.0 112.851 -174.345 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' E' E ' 137' ' ' LYS . . . . . . . . . . . . . 27.7 ttpp -144.17 153.91 42.59 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-O 121.223 0.535 . . . . 0.0 111.673 -166.689 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' E' E ' 138' ' ' LEU . . . . . . . . . . . . . 6.8 tt -118.73 126.31 51.61 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 115.616 -0.72 . . . . 0.0 110.056 178.388 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' E' E ' 139' ' ' THR . . . . . . . . . . . . . 33.4 m -107.45 125.44 51.25 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.095 -179.901 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' E' E ' 140' ' ' LEU . . . . . . . . . . . . . 7.5 tp -113.91 120.25 40.06 Favored 'General case' 0 C--N 1.329 -0.299 0 N-CA-C 109.065 -0.717 . . . . 0.0 109.065 -179.948 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' E' E ' 141' ' ' ILE . . . . . . . . . . . . . 18.3 mt -120.99 126.09 74.8 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.268 0 CA-C-O 120.894 0.378 . . . . 0.0 110.459 -172.779 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' E' E ' 142' ' ' ARG . . . . . . . . . . . . . 77.9 mtp180 -109.12 130.65 55.48 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 115.651 -0.704 . . . . 0.0 109.977 176.571 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' E' E ' 143' ' ' THR . . . . . . . . . . . . . 58.9 p . . . . . 0 C--O 1.22 -0.453 0 CA-C-O 118.025 -0.988 . . . . 0.0 110.452 -179.937 . . . . . . . . 0 0 . 1 . 015 nuclear orig full ' F' F ' -3' ' ' GLU . . . . . . . . . . . . . 46.2 mp0 . . . . . 0 N--CA 1.491 1.617 0 N-CA-C 109.323 -0.621 . . . . 0.0 109.323 . . . . . . . . . 0 0 . 1 . 015 nuclear orig full ' F' F ' -2' ' ' GLY . . . . . . . . . . . . . . . -92.7 110.93 3.99 Favored Glycine 0 CA--C 1.524 0.622 0 N-CA-C 110.661 -0.976 . . . . 0.0 110.661 178.728 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' F' F ' -1' ' ' VAL . . . . . . . . . . . . . 45.9 t -88.01 138.77 18.49 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.341 0 N-CA-C 109.863 -0.421 . . . . 0.0 109.863 -179.668 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' F' F ' 0' ' ' ILE . . . . . . . . . . . . . 41.2 mm -94.18 124.98 46.86 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.328 0 CA-C-N 116.227 -0.442 . . . . 0.0 109.926 179.944 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' F' F ' 1' ' ' MET . . . . . . . . . . . . . 26.1 ptt? -81.57 128.45 33.93 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.126 -0.488 . . . . 0.0 111.126 -177.701 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' F' F ' 2' ' ' SER . . . . . . . . . . . . . 7.6 p -111.57 139.94 46.6 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.028 -0.533 . . . . 0.0 110.31 178.26 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' F' F ' 3' ' ' GLU . . . . . . . . . . . . . 81.1 tt0 -143.79 143.89 31.55 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.333 -0.394 . . . . 0.0 111.356 -176.836 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' F' F ' 4' ' ' LEU . . . . . . . . . . . . . 24.1 tp -124.52 129.87 51.42 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 115.872 -0.604 . . . . 0.0 109.87 175.305 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' F' F ' 5' ' ' LYS . . . . . . . . . . . . . 99.3 mttt -110.58 122.08 46.88 Favored 'General case' 0 C--O 1.234 0.26 0 CA-C-N 116.395 -0.366 . . . . 0.0 110.901 -179.513 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' F' F ' 6' ' ' LEU . . . . . . . . . . . . . 32.8 mt -114.52 146.69 40.42 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 115.342 -0.845 . . . . 0.0 110.263 -179.264 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' F' F ' 7' ' ' LYS . . . . . . . . . . . . . 36.7 ttmt -132.92 137.76 30.35 Favored Pre-proline 0 CA--C 1.534 0.338 0 CA-C-O 118.974 -0.536 . . . . 0.0 109.805 174.758 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' F' F ' 8' ' ' PRO . . . . . . . . . . . . . 83.6 Cg_endo -91.52 141.65 2.74 Favored 'Trans proline' 0 N--CA 1.49 1.305 0 C-N-CA 121.773 1.649 . . . . 0.0 112.014 179.359 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' F' F ' 9' ' ' LEU . . . . . . . . . . . . . 37.6 mt -78.44 -46.59 2.01 Favored Pre-proline 0 CA--C 1.534 0.328 0 CA-C-O 118.765 -0.636 . . . . 0.0 111.735 179.056 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' F' F ' 10' ' ' PRO . . . . . . . . . . . . . 91.1 Cg_endo -83.08 145.96 12.54 Favored 'Trans proline' 0 N--CA 1.494 1.54 0 C-N-CA 121.218 1.279 . . . . 0.0 111.52 173.452 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' F' F ' 11' ' ' LYS . . . . . . . . . . . . . 19.8 pttp -84.01 116.78 23.0 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-O 121.324 0.583 . . . . 0.0 110.545 177.988 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' F' F ' 12' ' ' VAL . . . . . . . . . . . . . 11.9 p -151.06 143.88 16.71 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.306 0 CA-C-N 115.662 -0.699 . . . . 0.0 110.274 -179.662 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' F' F ' 13' ' ' GLU . . . . . . . . . . . . . 43.3 mt-10 -83.13 117.16 22.69 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.517 -0.311 . . . . 0.0 110.26 178.53 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' F' F ' 14' ' ' LEU . . . . . . . . . . . . . 34.7 mt -98.41 142.31 24.38 Favored Pre-proline 0 CA--C 1.534 0.358 0 CA-C-O 118.997 -0.525 . . . . 0.0 109.853 -179.695 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' F' F ' 15' ' ' PRO . . . . . . . . . . . . . 26.4 Cg_exo -61.22 160.93 24.79 Favored 'Trans proline' 0 N--CA 1.497 1.724 0 C-N-CA 121.202 1.268 . . . . 0.0 111.828 178.282 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' F' F ' 16' ' ' PRO . . . . . . . . . . . . . 32.7 Cg_exo -59.55 -37.52 88.23 Favored 'Trans proline' 0 N--CA 1.497 1.684 0 C-N-CA 121.508 1.472 . . . . 0.0 112.633 -178.303 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' F' F ' 17' ' ' ASP . . . . . . . . . . . . . 13.6 p-10 -86.44 7.94 23.83 Favored 'General case' 0 CA--C 1.536 0.423 0 N-CA-C 113.132 0.79 . . . . 0.0 113.132 -177.989 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' F' F ' 18' ' ' PHE . . . . . . . . . . . . . 52.0 t80 -58.26 -43.8 88.05 Favored 'General case' 0 N--CA 1.457 -0.102 0 O-C-N 121.985 -0.447 . . . . 0.0 109.991 -179.55 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' F' F ' 19' ' ' VAL . . . . . . . . . . . . . 47.1 t -57.33 -40.86 76.65 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.324 0 CA-C-N 116.112 -0.494 . . . . 0.0 110.322 -179.626 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' F' F ' 20' ' ' ASP . . . . . . . . . . . . . 36.6 t0 -60.37 -43.56 96.46 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-O 120.769 0.319 . . . . 0.0 110.974 -178.258 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' F' F ' 21' ' ' VAL . . . . . . . . . . . . . 47.3 t -64.35 -45.94 94.53 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.279 0 C-N-CA 120.821 -0.352 . . . . 0.0 110.361 -178.382 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' F' F ' 22' ' ' ILE . . . . . . . . . . . . . 50.9 mm -56.21 -43.36 76.15 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.271 0 CA-C-O 120.768 0.318 . . . . 0.0 110.49 177.957 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' F' F ' 23' ' ' ARG . . . . . . . . . . . . . 58.8 ttp180 -55.26 -49.09 72.94 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-O 120.723 0.296 . . . . 0.0 111.182 179.693 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' F' F ' 24' ' ' ILE . . . . . . . . . . . . . 73.7 mt -59.32 -41.34 83.88 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.293 0 CA-C-N 116.447 -0.342 . . . . 0.0 111.042 -177.608 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' F' F ' 25' ' ' LYS . . . . . . . . . . . . . 48.0 mttm -69.04 -42.53 76.2 Favored 'General case' 0 C--N 1.328 -0.344 0 N-CA-C 112.696 0.628 . . . . 0.0 112.696 -178.056 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' F' F ' 26' ' ' LEU . . . . . . . . . . . . . 53.6 mt -79.47 -34.58 41.34 Favored 'General case' 0 C--N 1.331 -0.225 0 N-CA-C 113.72 1.007 . . . . 0.0 113.72 -170.451 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' F' F ' 27' ' ' GLN . . . . . . . . . . . . . 8.3 pt20 -46.67 138.37 6.1 Favored 'General case' 0 N--CA 1.469 0.486 0 N-CA-C 112.998 0.74 . . . . 0.0 112.998 -174.18 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' F' F ' 28' ' ' GLY . . . . . . . . . . . . . . . 100.23 -24.58 31.55 Favored Glycine 0 CA--C 1.533 1.163 0 CA-C-N 115.528 -0.76 . . . . 0.0 112.525 -177.963 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' F' F ' 29' ' ' LYS . . . . . . . . . . . . . 68.7 mttm -98.04 155.08 17.28 Favored 'General case' 0 C--O 1.232 0.177 0 CA-C-N 117.387 0.594 . . . . 0.0 111.337 179.637 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' F' F ' 30' ' ' THR . . . . . . . . . . . . . 29.5 m -105.92 139.43 40.49 Favored 'General case' 0 C--N 1.331 -0.218 0 CA-C-N 115.928 -0.578 . . . . 0.0 110.345 177.989 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' F' F ' 31' ' ' VAL . . . . . . . . . . . . . 34.4 m -129.9 156.71 42.33 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.271 0 CA-C-N 116.357 -0.383 . . . . 0.0 110.616 179.918 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' F' F ' 32' ' ' ARG . . . . . . . . . . . . . 68.1 mtm180 -131.68 152.41 50.89 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-O 121.099 0.476 . . . . 0.0 110.853 177.55 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' F' F ' 33' ' ' THR . . . . . . . . . . . . . 19.8 m -53.39 138.69 32.46 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.304 -0.407 . . . . 0.0 111.175 -179.534 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' F' F ' 34' ' ' GLY . . . . . . . . . . . . . . . 99.59 -17.21 57.91 Favored Glycine 0 CA--C 1.532 1.151 0 C-N-CA 121.211 -0.519 . . . . 0.0 113.268 178.869 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' F' F ' 35' ' ' ASP . . . . . . . . . . . . . 74.3 m-20 -66.83 149.87 49.95 Favored 'General case' 0 N--CA 1.462 0.145 0 CA-C-N 118.076 0.938 . . . . 0.0 111.191 178.98 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' F' F ' 36' ' ' VAL . . . . . . . . . . . . . 43.9 t -121.83 130.0 74.97 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.209 0 N-CA-C 109.607 -0.516 . . . . 0.0 109.607 177.018 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' F' F ' 37' ' ' ILE . . . . . . . . . . . . . 66.2 mt -121.29 138.48 51.52 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.245 0 CA-C-N 116.186 -0.461 . . . . 0.0 109.978 -178.627 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' F' F ' 38' ' ' GLY . . . . . . . . . . . . . . . -113.61 128.02 8.12 Favored Glycine 0 CA--C 1.524 0.652 0 N-CA-C 110.936 -0.866 . . . . 0.0 110.936 179.219 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' F' F ' 39' ' ' ILE . . . . . . . . . . . . . 78.4 mt -127.9 140.49 49.02 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.186 0 CA-C-O 120.789 0.328 . . . . 0.0 110.265 179.2 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' F' F ' 40' ' ' SER . . . . . . . . . . . . . 42.7 t -91.26 115.5 28.07 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.226 -0.443 . . . . 0.0 110.649 176.392 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' F' F ' 41' ' ' ILE . . . . . . . . . . . . . 44.8 mm -119.62 113.22 40.24 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.231 0 N-CA-C 109.961 -0.385 . . . . 0.0 109.961 178.439 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' F' F ' 42' ' ' LEU . . . . . . . . . . . . . 69.1 mt 57.62 36.1 26.39 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.415 -0.357 . . . . 0.0 111.498 179.5 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' F' F ' 43' ' ' GLY . . . . . . . . . . . . . . . 80.34 -10.2 44.35 Favored Glycine 0 CA--C 1.533 1.197 0 C-N-CA 121.289 -0.482 . . . . 0.0 113.517 177.306 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' F' F ' 44' ' ' LYS . . . . . . . . . . . . . 42.8 tttp -99.6 134.68 42.14 Favored 'General case' 0 C--N 1.333 -0.132 0 CA-C-N 117.831 0.816 . . . . 0.0 110.007 177.339 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' F' F ' 45' ' ' GLU . . . . . . . . . . . . . 83.8 tt0 -82.61 127.99 33.89 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-O 120.797 0.332 . . . . 0.0 110.838 -179.014 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' F' F ' 46' ' ' VAL . . . . . . . . . . . . . 10.7 p -121.63 126.11 74.32 Favored 'Isoleucine or valine' 0 C--N 1.333 -0.15 0 N-CA-C 109.639 -0.504 . . . . 0.0 109.639 175.759 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' F' F ' 47' ' ' LYS . . . . . . . . . . . . . 97.7 mttt -99.23 124.82 44.6 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.044 -0.525 . . . . 0.0 110.807 178.235 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' F' F ' 48' ' ' PHE . . . . . . . . . . . . . 32.6 m-85 -108.84 131.89 54.54 Favored 'General case' 0 C--N 1.33 -0.277 0 N-CA-C 109.798 -0.445 . . . . 0.0 109.798 176.548 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' F' F ' 49' ' ' LYS . . . . . . . . . . . . . 34.6 tttp -106.86 135.51 48.29 Favored 'General case' 0 C--N 1.328 -0.355 0 N-CA-C 109.849 -0.426 . . . . 0.0 109.849 177.518 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' F' F ' 50' ' ' VAL . . . . . . . . . . . . . 45.2 t -76.99 106.82 7.37 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.308 0 N-CA-C 109.438 -0.579 . . . . 0.0 109.438 178.027 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' F' F ' 51' ' ' VAL . . . . . . . . . . . . . 47.0 t -73.91 -47.87 41.19 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.324 0 CA-C-N 116.22 -0.446 . . . . 0.0 109.982 -175.009 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' F' F ' 52' ' ' GLN . . . . . . . . . . . . . 63.0 tt0 -159.75 143.85 14.7 Favored 'General case' 0 C--N 1.33 -0.275 0 C-N-CA 120.422 -0.511 . . . . 0.0 111.447 -177.874 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' F' F ' 53' ' ' ALA . . . . . . . . . . . . . . . -123.64 132.9 53.97 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 115.747 -0.66 . . . . 0.0 109.778 175.004 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' F' F ' 54' ' ' TYR . . . . . . . . . . . . . 25.9 t80 -129.2 111.59 18.21 Favored Pre-proline 0 CA--C 1.536 0.416 0 CA-C-O 118.13 -0.938 . . . . 0.0 110.386 178.931 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' F' F ' 55' ' ' PRO . . . . . . . . . . . . . 73.6 Cg_endo -77.26 161.25 93.12 Favored 'Cis proline' 0 N--CA 1.499 1.821 0 CA-C-N 121.943 1.729 . . . . 0.0 112.407 -6.835 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' F' F ' 56' ' ' SER . . . . . . . . . . . . . 60.8 m -108.76 130.78 22.32 Favored Pre-proline 0 CA--C 1.539 0.557 0 CA-C-O 118.434 -0.793 . . . . 0.0 109.487 175.304 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' F' F ' 57' ' ' PRO . . . . . . . . . . . . . 36.5 Cg_endo -66.31 163.13 70.1 Favored 'Cis proline' 0 N--CA 1.498 1.78 0 CA-C-N 121.972 1.74 . . . . 0.0 111.601 -1.3 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' F' F ' 58' ' ' LEU . . . . . . . . . . . . . 15.7 tp -129.37 138.98 51.84 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-O 121.026 0.441 . . . . 0.0 110.405 -178.131 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' F' F ' 59' ' ' ARG . . . . . . . . . . . . . 74.2 ttt180 -104.68 136.31 44.44 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 115.836 -0.62 . . . . 0.0 109.683 176.244 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' F' F ' 60' ' ' VAL . . . . . . . . . . . . . 43.3 t -85.35 116.72 29.14 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.262 0 C-N-CA 120.662 -0.415 . . . . 0.0 110.234 -178.345 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' F' F ' 61' ' ' GLU . . . . . . . . . . . . . 39.1 tp10 -131.06 155.54 46.72 Favored 'General case' 0 C--N 1.328 -0.362 0 N-CA-C 109.005 -0.739 . . . . 0.0 109.005 176.856 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' F' F ' 62' ' ' ASP . . . . . . . . . . . . . 13.9 t70 -51.04 -32.37 21.55 Favored 'General case' 0 C--N 1.327 -0.391 0 N-CA-C 112.011 0.374 . . . . 0.0 112.011 -178.868 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' F' F ' 63' ' ' ARG . . . . . . . . . . . . . 87.6 mtt180 -73.21 -22.06 60.52 Favored 'General case' 0 CA--C 1.534 0.335 0 N-CA-C 112.908 0.707 . . . . 0.0 112.908 -176.801 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' F' F ' 64' ' ' THR . . . . . . . . . . . . . 18.9 m -71.8 143.02 49.65 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-O 120.929 0.395 . . . . 0.0 110.88 -175.3 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' F' F ' 65' ' ' LYS . . . . . . . . . . . . . 91.4 mttt -87.71 129.91 34.99 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 115.973 -0.558 . . . . 0.0 110.049 178.809 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' F' F ' 66' ' ' ILE . . . . . . . . . . . . . 58.2 mt -115.9 125.57 73.08 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.226 0 N-CA-C 109.579 -0.526 . . . . 0.0 109.579 178.32 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' F' F ' 67' ' ' THR . . . . . . . . . . . . . 24.6 m -121.79 142.3 50.35 Favored 'General case' 0 C--N 1.331 -0.227 0 CA-C-O 121.008 0.432 . . . . 0.0 111.215 -176.246 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' F' F ' 68' ' ' LEU . . . . . . . . . . . . . 4.9 tt -106.59 125.06 50.52 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 115.743 -0.662 . . . . 0.0 109.85 178.173 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' F' F ' 69' ' ' VAL . . . . . . . . . . . . . 42.6 t -90.37 130.83 38.97 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.316 0 CA-C-O 120.837 0.351 . . . . 0.0 110.296 -178.675 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' F' F ' 70' ' ' THR . . . . . . . . . . . . . 68.2 p -85.55 -29.65 24.01 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.091 -0.504 . . . . 0.0 111.957 -179.235 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' F' F ' 71' ' ' HIS . . . . . . . . . . . . . 70.9 m-70 -65.04 151.66 93.03 Favored Pre-proline 0 C--O 1.234 0.244 0 C-N-CA 121.045 -0.262 . . . . 0.0 110.582 -178.411 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' F' F ' 72' ' ' PRO . . . . . . . . . . . . . 73.5 Cg_endo -83.74 -28.6 1.27 Allowed 'Trans proline' 0 N--CA 1.491 1.325 0 C-N-CA 121.627 1.551 . . . . 0.0 112.77 -179.598 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' F' F ' 73' ' ' VAL . . . . . . . . . . . . . 35.6 m -128.83 163.48 33.54 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.199 0 CA-C-O 120.902 0.382 . . . . 0.0 110.702 -179.372 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' F' F ' 74' ' ' ASP . . . . . . . . . . . . . 14.4 t0 -104.47 118.42 36.57 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.017 -0.538 . . . . 0.0 109.784 179.341 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' F' F ' 75' ' ' VAL . . . . . . . . . . . . . 42.9 t -115.55 124.17 71.76 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.301 0 CA-C-O 120.965 0.412 . . . . 0.0 110.658 -177.466 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' F' F ' 76' ' ' LEU . . . . . . . . . . . . . 8.7 mp -122.61 150.73 42.25 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-N 115.74 -0.664 . . . . 0.0 109.687 175.945 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' F' F ' 77' ' ' GLU . . . . . . . . . . . . . 98.9 mt-10 -135.59 141.47 45.14 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-O 121.183 0.516 . . . . 0.0 111.816 -175.984 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' F' F ' 78' ' ' ALA . . . . . . . . . . . . . . . -127.81 143.83 51.11 Favored 'General case' 0 C--N 1.331 -0.204 0 CA-C-N 115.518 -0.764 . . . . 0.0 109.82 175.868 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' F' F ' 79' ' ' LYS . . . . . . . . . . . . . 37.8 mtmt -95.26 112.33 24.05 Favored 'General case' 0 C--N 1.33 -0.239 0 CA-C-O 120.738 0.304 . . . . 0.0 111.074 -176.89 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' F' F ' 80' ' ' ILE . . . . . . . . . . . . . 39.3 mm -139.23 112.67 6.5 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.238 0 N-CA-C 109.404 -0.591 . . . . 0.0 109.404 -179.265 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' F' F ' 81' ' ' LYS . . . . . . . . . . . . . 56.3 pttt -106.67 131.48 53.76 Favored 'General case' 0 N--CA 1.464 0.242 0 CA-C-O 120.961 0.41 . . . . 0.0 111.389 -178.223 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' F' F ' 82' ' ' GLY . . . . . . . . . . . . . . . 89.13 41.95 5.72 Favored Glycine 0 CA--C 1.527 0.804 0 C-N-CA 121.018 -0.61 . . . . 0.0 111.813 176.154 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' F' F ' 83' ' ' ILE . . . . . . . . . . . . . 74.5 mt -77.13 137.9 21.55 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 N-CA-C 109.351 -0.611 . . . . 0.0 109.351 176.329 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' F' F ' 84' ' ' LYS . . . . . . . . . . . . . 19.3 ttpt -101.47 -46.85 4.86 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.431 -0.35 . . . . 0.0 110.527 -176.897 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' F' F ' 85' ' ' ASP . . . . . . . . . . . . . 13.7 t70 -143.72 146.6 33.29 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.448 -0.342 . . . . 0.0 110.479 -179.176 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' F' F ' 86' ' ' VAL . . . . . . . . . . . . . 44.7 t -128.96 128.86 67.81 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.215 0 CA-C-O 120.91 0.386 . . . . 0.0 110.405 -178.847 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' F' F ' 87' ' ' ILE . . . . . . . . . . . . . 44.7 mm -121.35 128.36 75.91 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.235 0 N-CA-C 109.359 -0.608 . . . . 0.0 109.359 177.903 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' F' F ' 88' ' ' LEU . . . . . . . . . . . . . 62.1 mt -120.21 139.26 52.92 Favored 'General case' 0 C--N 1.332 -0.194 0 CA-C-O 121.207 0.527 . . . . 0.0 111.882 -175.277 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' F' F ' 89' ' ' ASP . . . . . . . . . . . . . 13.4 t70 -133.61 154.92 50.52 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 115.423 -0.808 . . . . 0.0 109.436 175.394 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' F' F ' 90' ' ' GLU . . . . . . . . . . . . . 44.2 mt-10 -49.46 -36.78 23.7 Favored 'General case' 0 C--N 1.329 -0.294 0 N-CA-C 112.832 0.678 . . . . 0.0 112.832 -171.805 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' F' F ' 91' ' ' ASN . . . . . . . . . . . . . 9.1 m120 -127.1 22.11 6.69 Favored 'General case' 0 N--CA 1.468 0.449 0 N-CA-C 112.869 0.692 . . . . 0.0 112.869 -176.651 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' F' F ' 92' ' ' LEU . . . . . . . . . . . . . 5.8 mt -153.49 144.4 22.79 Favored 'General case' 0 C--N 1.331 -0.199 0 N-CA-C 109.573 -0.528 . . . . 0.0 109.573 -177.894 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' F' F ' 93' ' ' ILE . . . . . . . . . . . . . 71.2 mt -127.28 122.25 59.34 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.288 0 N-CA-C 109.407 -0.59 . . . . 0.0 109.407 178.41 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' F' F ' 94' ' ' VAL . . . . . . . . . . . . . 43.5 t -121.95 126.97 75.22 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.242 0 CA-C-O 120.911 0.386 . . . . 0.0 110.014 -179.821 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' F' F ' 95' ' ' VAL . . . . . . . . . . . . . 44.0 t -120.47 133.25 67.78 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.384 0 CA-C-N 115.963 -0.562 . . . . 0.0 109.662 179.671 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' F' F ' 96' ' ' ILE . . . . . . . . . . . . . 66.9 mt -114.99 124.54 71.75 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.231 0 N-CA-C 109.121 -0.696 . . . . 0.0 109.121 178.726 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' F' F ' 97' ' ' THR . . . . . . . . . . . . . 45.3 p -98.28 156.75 16.56 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-O 121.114 0.483 . . . . 0.0 111.474 -176.139 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' F' F ' 98' ' ' GLU . . . . . . . . . . . . . 96.7 mt-10 -54.09 -26.35 26.68 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 116.037 -0.529 . . . . 0.0 112.027 178.307 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' F' F ' 99' ' ' GLU . . . . . . . . . . . . . 34.6 tt0 -79.33 17.03 0.88 Allowed 'General case' 0 CA--C 1.538 0.51 0 N-CA-C 112.582 0.586 . . . . 0.0 112.582 -176.83 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' F' F ' 100' ' ' ASN . . . . . . . . . . . . . 2.0 m120 64.18 36.2 9.68 Favored 'General case' 0 CA--C 1.531 0.224 0 O-C-N 121.84 -0.538 . . . . 0.0 110.984 176.002 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' F' F ' 101' ' ' GLU . . . . . . . . . . . . . 79.1 tt0 -117.15 142.88 46.46 Favored 'General case' 0 C--O 1.231 0.099 0 N-CA-C 109.917 -0.401 . . . . 0.0 109.917 178.248 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' F' F ' 102' ' ' VAL . . . . . . . . . . . . . 43.4 t -115.56 125.16 72.66 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.312 0 N-CA-C 109.728 -0.471 . . . . 0.0 109.728 -179.848 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' F' F ' 103' ' ' LEU . . . . . . . . . . . . . 40.0 mt -117.08 131.06 57.01 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 115.972 -0.558 . . . . 0.0 110.606 178.256 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' F' F ' 104' ' ' ILE . . . . . . . . . . . . . 67.0 mt -117.19 120.08 63.87 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.221 0 CA-C-N 116.405 -0.361 . . . . 0.0 110.314 -179.477 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' F' F ' 105' ' ' PHE . . . . . . . . . . . . . 76.1 m-85 -121.58 167.4 12.93 Favored 'General case' 0 C--O 1.231 0.128 0 O-C-N 124.092 0.87 . . . . 0.0 109.688 178.238 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' F' F ' 106' ' ' ASN . . . . . . . . . . . . . 43.0 p-10 -104.09 -170.99 1.85 Allowed 'General case' 0 C--N 1.332 -0.172 0 N-CA-C 109.657 -0.497 . . . . 0.0 109.657 170.653 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' F' F ' 107' ' ' GLN . . . . . . . . . . . . . 50.3 tt0 -58.41 -29.98 66.51 Favored 'General case' 0 C--N 1.328 -0.338 0 N-CA-C 111.925 0.343 . . . . 0.0 111.925 179.735 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' F' F ' 108' ' ' ASN . . . . . . . . . . . . . 47.1 t30 -88.22 13.7 10.89 Favored 'General case' 0 CA--C 1.534 0.359 0 N-CA-C 112.91 0.707 . . . . 0.0 112.91 -176.484 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' F' F ' 109' ' ' LEU . . . . . . . . . . . . . 82.1 mt 57.2 33.6 23.55 Favored 'General case' 0 CA--C 1.529 0.173 0 N-CA-C 111.823 0.305 . . . . 0.0 111.823 176.875 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' F' F ' 110' ' ' GLU . . . . . . . . . . . . . 95.8 mt-10 -100.0 138.61 36.84 Favored 'General case' 0 C--N 1.331 -0.239 0 N-CA-C 109.339 -0.615 . . . . 0.0 109.339 175.616 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' F' F ' 111' ' ' GLU . . . . . . . . . . . . . 56.7 tt0 -75.49 121.9 23.05 Favored 'General case' 0 C--N 1.328 -0.338 0 C-N-CA 120.64 -0.424 . . . . 0.0 110.532 -175.727 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' F' F ' 112' ' ' LEU . . . . . . . . . . . . . 32.4 mt -104.36 -46.02 4.51 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.065 -0.516 . . . . 0.0 110.657 179.715 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' F' F ' 113' ' ' TYR . . . . . . . . . . . . . 58.8 t80 -143.16 141.06 31.06 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 116.247 -0.433 . . . . 0.0 111.295 -179.35 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' F' F ' 114' ' ' ARG . . . . . . . . . . . . . 39.0 ptt180 -137.81 123.76 20.16 Favored 'General case' 0 C--N 1.331 -0.203 0 CA-C-N 115.837 -0.619 . . . . 0.0 110.252 178.124 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' F' F ' 115' ' ' GLY . . . . . . . . . . . . . . . -150.08 160.94 28.74 Favored Glycine 0 CA--C 1.523 0.582 0 C-N-CA 120.565 -0.826 . . . . 0.0 111.472 -179.289 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' F' F ' 116' ' ' LYS . . . . . . . . . . . . . 32.5 ttpt -127.18 141.4 51.75 Favored 'General case' 0 C--N 1.33 -0.249 0 N-CA-C 109.838 -0.431 . . . . 0.0 109.838 176.487 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' F' F ' 117' ' ' PHE . . . . . . . . . . . . . 43.0 m-85 -141.17 113.82 8.28 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.408 -0.36 . . . . 0.0 110.061 -179.545 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' F' F ' 118' ' ' GLU . . . . . . . . . . . . . 95.9 mt-10 -55.6 -44.13 76.7 Favored 'General case' 0 C--N 1.329 -0.321 0 C-N-CA 120.867 -0.333 . . . . 0.0 111.093 -176.252 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' F' F ' 119' ' ' ASN . . . . . . . . . . . . . 3.5 m120 -98.72 31.11 3.03 Favored 'General case' 0 C--N 1.33 -0.246 0 N-CA-C 112.216 0.45 . . . . 0.0 112.216 -174.387 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' F' F ' 120' ' ' LEU . . . . . . . . . . . . . 17.5 tp -57.04 121.03 9.04 Favored 'General case' 0 N--CA 1.463 0.206 0 N-CA-C 110.092 -0.336 . . . . 0.0 110.092 177.475 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' F' F ' 121' ' ' ASN . . . . . . . . . . . . . 5.3 t30 -114.08 -44.11 3.18 Favored 'General case' 0 C--N 1.332 -0.182 0 C-N-CA 121.208 -0.197 . . . . 0.0 111.25 -176.75 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' F' F ' 122' ' ' LYS . . . . . . . . . . . . . 86.3 mttt -142.97 147.87 35.9 Favored 'General case' 0 C--N 1.332 -0.19 0 CA-C-O 121.164 0.507 . . . . 0.0 111.788 -178.986 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' F' F ' 123' ' ' VAL . . . . . . . . . . . . . 42.9 t -128.74 129.56 68.49 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.186 0 CA-C-N 115.729 -0.668 . . . . 0.0 109.553 174.823 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' F' F ' 124' ' ' LEU . . . . . . . . . . . . . 21.7 mt -123.81 135.32 53.71 Favored 'General case' 0 C--N 1.331 -0.212 0 CA-C-O 120.81 0.338 . . . . 0.0 110.679 -178.841 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' F' F ' 125' ' ' VAL . . . . . . . . . . . . . 11.7 p -136.86 123.95 30.91 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.273 0 CA-C-N 116.233 -0.44 . . . . 0.0 110.214 178.0 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' F' F ' 126' ' ' ARG . . . . . . . . . . . . . 89.6 mtt180 -152.94 132.92 13.33 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.053 -0.521 . . . . 0.0 109.873 178.938 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' F' F ' 127' ' ' ASN . . . . . . . . . . . . . 3.9 m120 55.58 -151.76 0.38 Allowed 'General case' 0 CA--C 1.541 0.602 0 N-CA-C 109.898 -0.408 . . . . 0.0 109.898 179.38 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' F' F ' 128' ' ' ASP . . . . . . . . . . . . . 19.7 p-10 -81.35 15.3 2.05 Favored 'General case' 0 CA--C 1.536 0.417 0 CA-C-N 118.643 0.656 . . . . 0.0 112.764 178.675 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' F' F ' 129' ' ' LEU . . . . . . . . . . . . . 31.7 mt -111.05 131.14 55.31 Favored 'General case' 0 C--O 1.233 0.213 0 O-C-N 121.936 -0.477 . . . . 0.0 110.651 179.588 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' F' F ' 130' ' ' VAL . . . . . . . . . . . . . 41.2 t -122.15 133.64 67.85 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.223 0 N-CA-C 109.115 -0.698 . . . . 0.0 109.115 176.839 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' F' F ' 131' ' ' VAL . . . . . . . . . . . . . 42.6 t -135.73 137.4 49.3 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.213 0 CA-C-O 121.049 0.452 . . . . 0.0 110.694 -176.852 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' F' F ' 132' ' ' ILE . . . . . . . . . . . . . 67.7 mt -120.55 133.42 67.29 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.242 0 CA-C-N 115.748 -0.66 . . . . 0.0 109.604 179.732 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' F' F ' 133' ' ' ILE . . . . . . . . . . . . . 40.5 mm -119.8 120.6 63.79 Favored 'Isoleucine or valine' 0 C--O 1.234 0.269 0 CA-C-O 120.876 0.37 . . . . 0.0 110.949 -177.294 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' F' F ' 134' ' ' ASP . . . . . . . . . . . . . 7.2 p-10 -134.16 146.9 50.62 Favored 'General case' 0 C--N 1.329 -0.285 0 N-CA-C 109.497 -0.556 . . . . 0.0 109.497 174.562 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' F' F ' 135' ' ' GLU . . . . . . . . . . . . . 52.6 tt0 -49.86 -25.96 3.62 Favored 'General case' 0 C--N 1.328 -0.358 0 N-CA-C 112.948 0.722 . . . . 0.0 112.948 -170.145 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' F' F ' 136' ' ' GLN . . . . . . . . . . . . . 60.8 tp60 -99.2 -31.2 11.85 Favored 'General case' 0 C--N 1.332 -0.183 0 N-CA-C 112.384 0.512 . . . . 0.0 112.384 -174.767 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' F' F ' 137' ' ' LYS . . . . . . . . . . . . . 89.4 mttt -139.85 153.9 47.16 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-O 121.214 0.53 . . . . 0.0 111.532 -170.515 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' F' F ' 138' ' ' LEU . . . . . . . . . . . . . 4.3 tt -121.37 126.85 50.43 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 115.625 -0.716 . . . . 0.0 109.32 174.171 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' F' F ' 139' ' ' THR . . . . . . . . . . . . . 31.8 m -116.67 134.21 55.09 Favored 'General case' 0 N--CA 1.462 0.144 0 CA-C-O 120.891 0.377 . . . . 0.0 111.385 -176.338 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' F' F ' 140' ' ' LEU . . . . . . . . . . . . . 24.0 tp -120.99 122.65 40.6 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 115.387 -0.824 . . . . 0.0 109.167 179.721 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' F' F ' 141' ' ' ILE . . . . . . . . . . . . . 19.2 mt -119.87 125.24 74.09 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.323 0 CA-C-O 120.974 0.416 . . . . 0.0 110.278 -175.638 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' F' F ' 142' ' ' ARG . . . . . . . . . . . . . 43.1 mtm180 -107.59 124.67 50.29 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 115.205 -0.907 . . . . 0.0 110.134 178.948 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' F' F ' 143' ' ' THR . . . . . . . . . . . . . 21.5 p . . . . . 0 C--O 1.221 -0.443 0 CA-C-O 117.991 -1.004 . . . . 0.0 110.584 179.852 . . . . . . . . 0 0 . 1 . 016 nuclear orig full ' A' A ' -3' ' ' GLU . . . . . . . . . . . . . 44.6 tp10 . . . . . 0 N--CA 1.491 1.597 0 N-CA-C 109.307 -0.627 . . . . 0.0 109.307 . . . . . . . . . 0 0 . 1 . 016 nuclear orig full ' A' A ' -2' ' ' GLY . . . . . . . . . . . . . . . -82.98 149.96 27.19 Favored Glycine 0 CA--C 1.525 0.687 0 N-CA-C 111.043 -0.823 . . . . 0.0 111.043 179.678 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' -1' ' ' VAL . . . . . . . . . . . . . 45.0 t -92.81 133.3 34.52 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.288 0 N-CA-C 109.932 -0.395 . . . . 0.0 109.932 179.531 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 0' ' ' ILE . . . . . 0.402 HD12 HG23 ' A' ' 0' ' ' ILE . 67.1 mt -115.4 135.27 55.95 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.261 0 CA-C-N 116.298 -0.41 . . . . 0.0 110.124 -178.57 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 25.9 ptt? -82.2 146.72 29.37 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.085 -0.507 . . . . 0.0 110.606 179.18 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 5.0 p -107.82 131.01 54.93 Favored 'General case' 0 C--N 1.331 -0.226 0 CA-C-O 120.932 0.396 . . . . 0.0 110.362 178.455 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 95.5 mt-10 -141.85 142.42 33.12 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.115 -0.493 . . . . 0.0 111.242 -178.061 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 4' ' ' LEU . . . . . . . . . . . . . 18.1 tp -124.32 124.45 42.41 Favored 'General case' 0 C--N 1.331 -0.218 0 CA-C-N 115.757 -0.656 . . . . 0.0 109.848 175.718 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 5' ' ' LYS . . . . . . . . . . . . . 98.0 mttt -105.09 120.55 41.79 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.65 -179.7 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 37.8 mt -115.37 148.81 38.86 Favored 'General case' 0 C--N 1.332 -0.183 0 CA-C-N 115.624 -0.716 . . . . 0.0 110.237 -178.414 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 21.3 ttpt -129.83 135.53 27.64 Favored Pre-proline 0 CA--C 1.534 0.339 0 CA-C-O 118.851 -0.595 . . . . 0.0 109.443 174.276 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 8' ' ' PRO . . . . . . . . . . . . . 76.8 Cg_endo -91.54 135.54 1.72 Allowed 'Trans proline' 0 N--CA 1.489 1.239 0 C-N-CA 121.694 1.596 . . . . 0.0 111.683 177.52 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 48.6 mt -72.15 -47.24 10.99 Favored Pre-proline 0 CA--C 1.533 0.309 0 CA-C-O 118.594 -0.717 . . . . 0.0 112.171 -178.988 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 83.4 Cg_endo -80.8 148.65 17.75 Favored 'Trans proline' 0 N--CA 1.496 1.666 0 C-N-CA 121.217 1.278 . . . . 0.0 111.753 175.905 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 51.2 tptt -85.2 96.05 9.36 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.466 -0.334 . . . . 0.0 110.275 179.234 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 12.5 p -142.52 149.65 18.98 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.243 0 CA-C-N 116.25 -0.432 . . . . 0.0 110.692 -178.326 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 83.1 tt0 -89.92 129.48 36.27 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-N 116.163 -0.471 . . . . 0.0 110.551 179.378 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 14' ' ' LEU . . . . . . . . . . . . . 48.3 mt -98.44 153.06 38.16 Favored Pre-proline 0 CA--C 1.532 0.282 0 CA-C-N 116.425 -0.352 . . . . 0.0 110.888 -178.872 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 15' ' ' PRO . . . . . . . . . . . . . 30.1 Cg_exo -61.19 159.88 28.78 Favored 'Trans proline' 0 N--CA 1.497 1.705 0 C-N-CA 121.356 1.371 . . . . 0.0 111.963 176.627 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 16' ' ' PRO . . . . . . . . . . . . . 31.6 Cg_exo -59.72 -42.17 48.8 Favored 'Trans proline' 0 N--CA 1.495 1.613 0 C-N-CA 121.475 1.45 . . . . 0.0 112.648 -179.068 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 17' ' ' ASP . . . . . . . . . . . . . 13.1 p-10 -84.13 11.65 7.72 Favored 'General case' 0 CA--C 1.535 0.383 0 N-CA-C 113.129 0.789 . . . . 0.0 113.129 -177.676 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 18' ' ' PHE . . . . . . . . . . . . . 31.2 t80 -57.12 -45.04 83.81 Favored 'General case' 0 N--CA 1.458 -0.074 0 O-C-N 121.917 -0.489 . . . . 0.0 110.433 -178.408 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 19' ' ' VAL . . . . . . . . . . . . . 48.0 t -57.06 -41.06 76.85 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.245 0 CA-C-N 116.371 -0.377 . . . . 0.0 110.534 -178.711 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 68.8 m-20 -59.79 -43.38 94.43 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-O 120.899 0.381 . . . . 0.0 110.703 -178.342 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 45.4 t -64.34 -46.56 92.77 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.321 0 CA-C-N 116.281 -0.418 . . . . 0.0 110.56 -178.231 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 22' ' ' ILE . . . . . . . . . . . . . 50.6 mm -55.11 -47.07 77.63 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.222 0 C-N-CA 120.99 -0.284 . . . . 0.0 110.828 179.272 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 23' ' ' ARG . . . . . . . . . . . . . 56.5 ttp180 -54.12 -50.03 67.82 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-O 120.697 0.284 . . . . 0.0 111.329 -179.021 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 24' ' ' ILE . . . . . . . . . . . . . 74.0 mt -58.91 -42.31 85.52 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.239 0 CA-C-N 116.432 -0.349 . . . . 0.0 111.25 -178.157 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 61.9 mtpt -67.76 -41.77 82.8 Favored 'General case' 0 C--N 1.328 -0.354 0 N-CA-C 112.404 0.52 . . . . 0.0 112.404 -177.405 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 49.2 mt -79.43 -37.38 37.21 Favored 'General case' 0 C--N 1.33 -0.28 0 N-CA-C 113.368 0.877 . . . . 0.0 113.368 -169.495 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 27' ' ' GLN . . . . . . . . . . . . . 9.9 pt20 -46.84 136.19 8.39 Favored 'General case' 0 N--CA 1.47 0.553 0 N-CA-C 112.728 0.64 . . . . 0.0 112.728 -176.09 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 99.72 -23.99 33.94 Favored Glycine 0 CA--C 1.534 1.252 0 CA-C-N 115.624 -0.716 . . . . 0.0 112.448 -176.633 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 28.8 mtpp -97.91 155.17 17.2 Favored 'General case' 0 C--O 1.233 0.209 0 CA-C-N 117.344 0.572 . . . . 0.0 111.005 179.983 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 30' ' ' THR . . . . . . . . . . . . . 33.8 m -105.53 138.03 42.39 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.143 -0.481 . . . . 0.0 110.118 176.848 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 35.2 m -129.95 149.48 33.65 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.271 0 CA-C-O 121.018 0.437 . . . . 0.0 110.933 -179.27 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 32' ' ' ARG . . . . . . . . . . . . . 29.5 ttm105 -130.05 148.01 51.86 Favored 'General case' 0 C--N 1.331 -0.239 0 CA-C-N 115.905 -0.589 . . . . 0.0 110.233 178.9 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 33' ' ' THR . . . . . . . . . . . . . 25.4 m -52.24 138.07 27.08 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.397 -0.365 . . . . 0.0 111.496 -177.58 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 100.28 -17.1 57.41 Favored Glycine 0 CA--C 1.533 1.161 0 CA-C-O 119.649 -0.528 . . . . 0.0 113.288 178.862 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 72.6 m-20 -65.85 149.85 49.52 Favored 'General case' 0 C--O 1.231 0.128 0 CA-C-N 118.053 0.927 . . . . 0.0 111.199 -179.965 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 45.6 t -119.8 129.3 75.57 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.275 0 CA-C-N 115.904 -0.589 . . . . 0.0 109.701 177.548 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 37' ' ' ILE . . . . . . . . . . . . . 63.8 mt -120.0 137.24 54.49 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.266 0 CA-C-N 116.162 -0.472 . . . . 0.0 109.797 -179.647 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . -116.45 128.86 8.14 Favored Glycine 0 CA--C 1.525 0.672 0 N-CA-C 110.848 -0.901 . . . . 0.0 110.848 179.948 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 39' ' ' ILE . . . . . . . . . . . . . 68.3 mt -126.66 129.94 71.62 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.169 0 N-CA-C 110.056 -0.349 . . . . 0.0 110.056 179.238 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 40' ' ' SER . . . . . . . . . . . . . 16.8 p -91.31 119.0 30.98 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.1 -0.5 . . . . 0.0 110.4 175.49 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 41' ' ' ILE . . . . . . . . . . . . . 70.2 mt -127.26 113.74 33.5 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.197 0 N-CA-C 110.113 -0.329 . . . . 0.0 110.113 -179.546 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 7.8 mp 56.62 39.25 29.89 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-O 121.247 0.546 . . . . 0.0 110.913 179.184 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . 79.38 -10.23 37.33 Favored Glycine 0 CA--C 1.533 1.172 0 C-N-CA 121.252 -0.499 . . . . 0.0 113.653 175.952 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 44' ' ' LYS . . . . . . . . . . . . . 78.7 tttt -98.27 126.49 43.78 Favored 'General case' 0 C--N 1.333 -0.11 0 CA-C-N 117.913 0.856 . . . . 0.0 110.094 177.882 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 77.3 tt0 -84.9 127.45 34.16 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.372 -0.376 . . . . 0.0 111.081 -179.427 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 46' ' ' VAL . . . . . . . . . . . . . 10.9 p -123.07 125.18 71.73 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.187 0 N-CA-C 110.085 -0.339 . . . . 0.0 110.085 175.874 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 99.1 mttt -99.34 127.88 45.41 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.057 -0.52 . . . . 0.0 111.024 177.248 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 48' ' ' PHE . . . . . . . . . . . . . 34.2 m-85 -112.49 131.91 55.34 Favored 'General case' 0 C--N 1.33 -0.279 0 N-CA-C 109.605 -0.517 . . . . 0.0 109.605 176.913 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 85.9 tttt -105.07 134.36 48.29 Favored 'General case' 0 C--N 1.328 -0.363 0 N-CA-C 110.084 -0.339 . . . . 0.0 110.084 177.562 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 50' ' ' VAL . . . . . . . . . . . . . 43.2 t -77.84 105.09 6.41 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.371 0 N-CA-C 109.491 -0.559 . . . . 0.0 109.491 177.908 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 51' ' ' VAL . . . . . . . . . . . . . 46.9 t -72.88 -47.99 46.81 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.335 0 CA-C-N 116.018 -0.537 . . . . 0.0 110.075 -174.145 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 52' ' ' GLN . . . . . . . . . . . . . 44.4 tt0 -158.44 135.53 9.91 Favored 'General case' 0 C--N 1.33 -0.27 0 C-N-CA 120.274 -0.571 . . . . 0.0 111.796 -177.954 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -110.23 129.44 55.72 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 115.839 -0.619 . . . . 0.0 109.649 175.032 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 54' ' ' TYR . . . . . . . . . . . . . 60.2 t80 -129.03 106.64 18.02 Favored Pre-proline 0 CA--C 1.535 0.378 0 CA-C-O 118.373 -0.823 . . . . 0.0 110.546 -178.437 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 55' ' ' PRO . . . . . . . . . . . . . 73.0 Cg_endo -77.13 168.94 75.59 Favored 'Cis proline' 0 N--CA 1.499 1.81 0 CA-C-N 121.67 1.632 . . . . 0.0 112.458 -5.766 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 56' ' ' SER . . . . . . . . . . . . . 74.3 m -118.01 134.42 23.31 Favored Pre-proline 0 CA--C 1.539 0.556 0 CA-C-O 118.486 -0.769 . . . . 0.0 109.473 174.494 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 57' ' ' PRO . . . . . . . . . . . . . 51.7 Cg_endo -70.78 146.98 85.78 Favored 'Cis proline' 0 N--CA 1.497 1.699 0 CA-C-N 121.88 1.707 . . . . 0.0 111.347 -1.911 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 58' ' ' LEU . . . . . . . . . . . . . 20.6 tp -108.0 136.3 47.93 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 116.39 -0.368 . . . . 0.0 110.86 -177.944 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 59' ' ' ARG . . . . . . . . . . . . . 55.8 ttp180 -104.31 117.94 35.42 Favored 'General case' 0 C--N 1.327 -0.389 0 N-CA-C 109.052 -0.721 . . . . 0.0 109.052 174.018 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 42.4 t -71.55 122.13 23.08 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.353 0 CA-C-N 116.353 -0.385 . . . . 0.0 110.698 -173.114 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 95.4 mt-10 -131.07 165.32 23.51 Favored 'General case' 0 C--N 1.331 -0.225 0 CA-C-N 115.795 -0.639 . . . . 0.0 110.033 177.28 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 62' ' ' ASP . . . . . . . . . . . . . 14.9 m-20 -55.19 -32.68 62.39 Favored 'General case' 0 C--N 1.329 -0.315 0 N-CA-C 111.758 0.281 . . . . 0.0 111.758 -179.252 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 63' ' ' ARG . . . . . . . . . . . . . 17.6 ptm180 -81.35 6.56 13.99 Favored 'General case' 0 CA--C 1.535 0.399 0 N-CA-C 113.524 0.935 . . . . 0.0 113.524 -176.512 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 34.4 m -91.41 136.16 33.31 Favored 'General case' 0 C--O 1.232 0.147 0 CA-C-N 118.26 0.482 . . . . 0.0 110.751 -179.754 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 65' ' ' LYS . . . . . . . . . . . . . 68.7 mttm -89.51 135.42 33.61 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.005 -0.543 . . . . 0.0 110.319 179.473 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 66' ' ' ILE . . . . . . . . . . . . . 4.3 mp -116.45 127.42 74.06 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.282 0 N-CA-C 109.552 -0.536 . . . . 0.0 109.552 178.76 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 67' ' ' THR . . . . . . . . . . . . . 25.0 m -131.38 148.66 52.68 Favored 'General case' 0 N--CA 1.464 0.237 0 CA-C-O 121.137 0.494 . . . . 0.0 111.944 -175.376 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 68' ' ' LEU . . . . . . . . . . . . . 8.5 mp -95.19 129.28 42.36 Favored 'General case' 0 C--N 1.331 -0.219 0 CA-C-N 115.629 -0.714 . . . . 0.0 109.909 175.356 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 69' ' ' VAL . . . . . . . . . . . . . 43.1 t -103.18 143.38 15.42 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.272 0 CA-C-O 120.873 0.368 . . . . 0.0 110.957 -176.935 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 70' ' ' THR . . . . . . . . . . . . . 12.0 m -84.85 130.94 34.58 Favored 'General case' 0 C--N 1.33 -0.27 0 N-CA-C 108.9 -0.778 . . . . 0.0 108.9 172.645 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 71' ' ' HIS . . . . . . . . . . . . . 1.8 m80 -135.44 174.94 4.0 Favored Pre-proline 0 CA--C 1.537 0.457 0 C-N-CA 121.049 -0.261 . . . . 0.0 111.367 -171.515 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 72' ' ' PRO . . . . . . . . . . . . . 22.5 Cg_exo -64.84 160.24 41.87 Favored 'Trans proline' 0 N--CA 1.496 1.632 0 C-N-CA 121.974 1.783 . . . . 0.0 112.671 -179.667 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 73' ' ' VAL . . . . . . . . . . . . . 33.0 m -69.72 -170.61 0.07 OUTLIER 'Isoleucine or valine' 0 C--N 1.33 -0.272 0 CA-C-N 115.767 -0.651 . . . . 0.0 110.481 -174.93 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 74' ' ' ASP . . . . . . . . . . . . . 13.3 t70 -77.17 118.77 20.02 Favored 'General case' 0 C--N 1.329 -0.316 0 C-N-CA 121.01 -0.276 . . . . 0.0 110.432 -170.146 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 41.4 t -124.91 124.11 67.08 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.206 0 CA-C-O 121.141 0.496 . . . . 0.0 110.691 -176.481 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 76' ' ' LEU . . . . . . . . . . . . . 6.4 mp -122.1 150.14 42.58 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 115.586 -0.734 . . . . 0.0 109.22 173.841 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 77' ' ' GLU . . . . . . . . . . . . . 97.0 mt-10 -137.86 137.07 37.74 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-O 121.126 0.489 . . . . 0.0 111.237 -178.073 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 78' ' ' ALA . . . . . . . . . . . . . . . -125.06 129.61 50.6 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 115.708 -0.678 . . . . 0.0 109.532 175.803 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 79' ' ' LYS . . . . . . . . . . . . . 39.2 ttpt -73.69 120.15 18.89 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-O 120.795 0.331 . . . . 0.0 110.575 -177.848 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 80' ' ' ILE . . . . . . . . . . . . . 25.9 mm -139.34 98.48 1.15 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.326 0 N-CA-C 109.268 -0.642 . . . . 0.0 109.268 -178.238 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 81' ' ' LYS . . . . . . . . . . . . . 56.2 mtmt -95.75 127.22 41.59 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-O 120.982 0.42 . . . . 0.0 110.97 -177.896 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . 89.18 42.08 5.67 Favored Glycine 0 CA--C 1.525 0.675 0 N-CA-C 111.566 -0.614 . . . . 0.0 111.566 176.43 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 83' ' ' ILE . . . . . . . . . . . . . 69.0 mt -67.26 137.86 23.94 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.289 0 N-CA-C 109.657 -0.497 . . . . 0.0 109.657 176.871 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 84' ' ' LYS . . . . . . . . . . . . . 54.5 tttp -95.46 -49.91 5.22 Favored 'General case' 0 C--N 1.327 -0.395 0 CA-C-N 116.15 -0.477 . . . . 0.0 109.868 -179.031 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 85' ' ' ASP . . . . . . . . . . . . . 10.4 t70 -159.16 149.95 19.77 Favored 'General case' 0 C--N 1.327 -0.401 0 CA-C-N 115.589 -0.732 . . . . 0.0 110.239 178.605 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 86' ' ' VAL . . . . . . . . . . . . . 42.1 t -130.12 131.32 65.94 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.275 0 CA-C-O 120.898 0.38 . . . . 0.0 110.237 179.241 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 87' ' ' ILE . . . . . . . . . . . . . 5.1 mp -119.07 129.01 75.77 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.281 0 CA-C-N 115.89 -0.596 . . . . 0.0 109.395 178.383 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 88' ' ' LEU . . . . . . . . . . . . . 13.3 tp -118.58 133.24 56.01 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-O 121.069 0.461 . . . . 0.0 111.302 -176.078 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 89' ' ' ASP . . . . . . . . . . . . . 12.8 t70 -130.92 159.03 38.63 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 115.637 -0.71 . . . . 0.0 109.38 175.109 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 95.8 mt-10 -47.41 -37.69 11.92 Favored 'General case' 0 C--N 1.33 -0.241 0 N-CA-C 113.029 0.751 . . . . 0.0 113.029 -172.362 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 91' ' ' ASN . . . . . . . . . . . . . 69.7 m-80 -132.11 36.38 3.65 Favored 'General case' 0 N--CA 1.464 0.235 0 N-CA-C 111.877 0.325 . . . . 0.0 111.877 -175.443 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 92' ' ' LEU . . . . . . . . . . . . . 19.3 tp -166.07 139.68 4.26 Favored 'General case' 0 C--N 1.332 -0.181 0 C-N-CA 120.836 -0.346 . . . . 0.0 110.99 -179.288 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 93' ' ' ILE . . . . . . . . . . . . . 68.9 mt -126.27 118.03 50.22 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.164 0 N-CA-C 109.089 -0.708 . . . . 0.0 109.089 177.625 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 94' ' ' VAL . . . . . . . . . . . . . 42.9 t -120.25 127.0 75.87 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.289 0 N-CA-C 109.903 -0.406 . . . . 0.0 109.903 -179.004 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 95' ' ' VAL . . . . . . . . . . . . . 42.7 t -120.89 134.04 65.6 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.311 0 CA-C-N 116.131 -0.486 . . . . 0.0 109.983 -179.435 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 96' ' ' ILE . . . . . . . . . . . . . 57.5 mt -115.42 127.62 72.92 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.324 0 N-CA-C 109.155 -0.683 . . . . 0.0 109.155 178.105 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 97' ' ' THR . . . . . . . . . . . . . 59.4 p -101.95 153.31 19.98 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-O 121.015 0.436 . . . . 0.0 110.955 -177.752 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 98' ' ' GLU . . . . . . . . . . . . . 96.4 mt-10 -53.9 -23.4 12.62 Favored 'General case' 0 CA--C 1.534 0.36 0 N-CA-C 112.297 0.481 . . . . 0.0 112.297 179.426 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 99' ' ' GLU . . . . . . . . . . . . . 95.0 mt-10 -78.79 15.27 1.1 Allowed 'General case' 0 CA--C 1.536 0.419 0 N-CA-C 113.121 0.785 . . . . 0.0 113.121 -177.536 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 100' ' ' ASN . . . . . . . . . . . . . 3.6 m-20 64.01 38.07 8.86 Favored 'General case' 0 N--CA 1.463 0.188 0 CA-C-O 120.972 0.415 . . . . 0.0 110.965 177.435 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 101' ' ' GLU . . . . . . . . . . . . . 83.4 tt0 -119.22 142.82 47.68 Favored 'General case' 0 C--N 1.332 -0.165 0 CA-C-N 116.177 -0.465 . . . . 0.0 109.876 176.551 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 102' ' ' VAL . . . . . . . . . . . . . 45.5 t -115.77 126.46 73.31 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.283 0 CA-C-N 116.117 -0.492 . . . . 0.0 109.759 -178.845 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 103' ' ' LEU . . . . . . . . . . . . . 46.6 mt -120.48 132.41 55.19 Favored 'General case' 0 C--N 1.331 -0.202 0 CA-C-N 115.992 -0.549 . . . . 0.0 110.517 178.313 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 104' ' ' ILE . . . . . . . . . . . . . 67.7 mt -118.95 122.43 69.33 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.256 0 CA-C-N 116.332 -0.395 . . . . 0.0 110.324 -178.48 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 105' ' ' PHE . . . . . . . . . . . . . 85.8 m-85 -123.99 165.06 18.1 Favored 'General case' 0 C--O 1.232 0.17 0 O-C-N 123.895 0.747 . . . . 0.0 109.892 -179.527 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 106' ' ' ASN . . . . . . . . . . . . . 46.8 p-10 -100.63 -171.36 2.0 Favored 'General case' 0 C--N 1.331 -0.21 0 N-CA-C 109.742 -0.466 . . . . 0.0 109.742 172.665 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 107' ' ' GLN . . . . . . . . . . . . . 29.4 tt0 -61.09 -29.85 70.0 Favored 'General case' 0 C--N 1.329 -0.285 0 N-CA-C 111.974 0.361 . . . . 0.0 111.974 -178.642 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 108' ' ' ASN . . . . . . . . . . . . . 3.8 t-20 -83.54 10.69 8.44 Favored 'General case' 0 CA--C 1.537 0.457 0 N-CA-C 113.014 0.746 . . . . 0.0 113.014 -178.303 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 109' ' ' LEU . . . . . . . . . . . . . 7.6 tp 57.72 37.72 27.32 Favored 'General case' 0 CA--C 1.529 0.172 0 CA-C-O 121.206 0.527 . . . . 0.0 111.341 179.277 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 110' ' ' GLU . . . . . . . . . . . . . 70.8 mm-40 -103.93 142.7 33.97 Favored 'General case' 0 C--N 1.33 -0.266 0 N-CA-C 109.33 -0.619 . . . . 0.0 109.33 174.071 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 111' ' ' GLU . . . . . . . . . . . . . 48.6 tt0 -79.14 121.94 25.63 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-N 116.454 -0.339 . . . . 0.0 110.893 -176.062 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 112' ' ' LEU . . . . . . . . . . . . . 44.1 mt -102.93 -46.12 4.76 Favored 'General case' 0 C--N 1.33 -0.239 0 CA-C-N 116.128 -0.487 . . . . 0.0 110.515 179.589 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 113' ' ' TYR . . . . . . . . . . . . . 63.9 t80 -140.59 145.02 36.17 Favored 'General case' 0 C--N 1.332 -0.182 0 CA-C-N 116.397 -0.365 . . . . 0.0 111.061 -179.682 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 114' ' ' ARG . . . . . . . . . . . . . 39.0 ptt180 -144.59 126.7 15.58 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.085 -0.507 . . . . 0.0 110.462 178.807 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 115' ' ' GLY . . . . . . . . . . . . . . . -150.05 150.75 22.85 Favored Glycine 0 CA--C 1.524 0.602 0 C-N-CA 120.682 -0.77 . . . . 0.0 111.192 179.654 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 116' ' ' LYS . . . . . . . . . . . . . 27.5 ttpp -123.45 135.77 54.26 Favored 'General case' 0 C--N 1.33 -0.274 0 N-CA-C 109.687 -0.486 . . . . 0.0 109.687 177.27 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 117' ' ' PHE . . . . . . . . . . . . . 36.2 m-85 -134.07 113.92 12.62 Favored 'General case' 0 C--N 1.33 -0.262 0 N-CA-C 110.037 -0.357 . . . . 0.0 110.037 -177.291 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 118' ' ' GLU . . . . . . . . . . . . . 83.5 tt0 -55.09 -44.72 75.16 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.383 -0.371 . . . . 0.0 111.185 -177.123 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 119' ' ' ASN . . . . . . . . . . . . . 85.2 m-20 -95.48 30.99 2.1 Favored 'General case' 0 C--N 1.33 -0.264 0 N-CA-C 112.214 0.45 . . . . 0.0 112.214 -175.649 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 120' ' ' LEU . . . . . . . . . . . . . 24.8 tp -57.63 122.16 12.08 Favored 'General case' 0 C--N 1.333 -0.132 0 N-CA-C 110.141 -0.318 . . . . 0.0 110.141 176.656 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 121' ' ' ASN . . . . . . . . . . . . . 61.5 m-20 -114.05 -43.99 3.19 Favored 'General case' 0 C--N 1.332 -0.187 0 CA-C-N 116.647 -0.251 . . . . 0.0 110.998 -176.773 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 122' ' ' LYS . . . . . . . . . . . . . 98.1 mttt -145.91 150.87 36.91 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-O 121.061 0.457 . . . . 0.0 111.505 -177.596 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 123' ' ' VAL . . . . . . . . . . . . . 43.5 t -128.75 131.16 68.72 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.253 0 CA-C-N 115.955 -0.566 . . . . 0.0 109.695 176.516 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 124' ' ' LEU . . . . . . . . . . . . . 34.0 mt -121.76 128.75 52.1 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.277 -0.419 . . . . 0.0 110.16 -179.547 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 125' ' ' VAL . . . . . . . . . . . . . 35.6 m -140.07 141.45 33.71 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 CA-C-O 120.862 0.363 . . . . 0.0 110.81 179.688 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 126' ' ' ARG . . . . . . . . . . . . . 51.0 ttp180 -161.29 129.66 4.4 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.07 -0.514 . . . . 0.0 110.622 177.502 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 127' ' ' ASN . . . . . . . . . . . . . 6.1 m120 52.77 -111.24 0.58 Allowed 'General case' 0 CA--C 1.544 0.741 0 CA-C-O 118.871 -0.585 . . . . 0.0 111.024 179.347 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 128' ' ' ASP . . . . . . . . . . . . . 11.9 p-10 -114.04 12.21 17.89 Favored 'General case' 0 N--CA 1.466 0.337 0 CA-C-N 119.892 1.224 . . . . 0.0 113.244 -177.747 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 129' ' ' LEU . . . . . . . . . . . . . 30.5 mt -107.7 134.11 51.15 Favored 'General case' 0 C--N 1.333 -0.147 0 O-C-N 121.968 -0.457 . . . . 0.0 110.136 178.013 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 130' ' ' VAL . . . . . . . . . . . . . 45.5 t -125.08 131.02 73.03 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.229 0 N-CA-C 109.58 -0.526 . . . . 0.0 109.58 178.759 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 131' ' ' VAL . . . . . . . . . . . . . 42.2 t -135.61 133.81 51.75 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.307 0 CA-C-O 120.999 0.428 . . . . 0.0 110.192 178.514 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 132' ' ' ILE . . . . . . . . . . . . . 74.6 mt -114.48 130.63 68.47 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.378 0 CA-C-N 115.81 -0.632 . . . . 0.0 109.308 179.44 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 133' ' ' ILE . . . . . . . . . . . . . 42.9 mm -114.56 119.24 60.96 Favored 'Isoleucine or valine' 0 C--O 1.234 0.263 0 CA-C-O 120.874 0.368 . . . . 0.0 110.748 -175.353 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 134' ' ' ASP . . . . . . . . . . . . . 9.6 p-10 -133.94 147.95 51.12 Favored 'General case' 0 C--N 1.331 -0.225 0 N-CA-C 109.678 -0.489 . . . . 0.0 109.678 176.282 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 135' ' ' GLU . . . . . . . . . . . . . 78.8 tt0 -49.9 -27.84 5.81 Favored 'General case' 0 C--N 1.328 -0.368 0 N-CA-C 112.833 0.679 . . . . 0.0 112.833 -173.698 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 136' ' ' GLN . . . . . . . . . . . . . 48.2 tt0 -79.05 -37.39 39.11 Favored 'General case' 0 C--O 1.233 0.229 0 N-CA-C 111.973 0.361 . . . . 0.0 111.973 -176.064 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 137' ' ' LYS . . . . . . . . . . . . . 51.8 pttt -166.32 175.46 8.22 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-O 121.689 0.756 . . . . 0.0 112.197 -171.129 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 138' ' ' LEU . . . . . . . . . . . . . 4.8 tt -119.46 128.45 54.02 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 114.877 -1.056 . . . . 0.0 109.757 178.7 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 139' ' ' THR . . . . . . . . . . . . . 19.5 m -109.12 124.08 50.23 Favored 'General case' 0 C--N 1.331 -0.205 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.598 -179.496 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 140' ' ' LEU . . . . . . . . . . . . . 48.0 tp -112.09 120.43 41.82 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 115.982 -0.554 . . . . 0.0 109.574 -179.166 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 141' ' ' ILE . . . . . . . . . . . . . 19.1 mt -122.95 120.65 61.18 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.278 0 CA-C-O 120.993 0.425 . . . . 0.0 110.088 -176.198 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 142' ' ' ARG . . . . . . . . . . . . . 22.3 mtp-105 -97.59 121.23 39.25 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 115.463 -0.79 . . . . 0.0 109.976 176.49 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 143' ' ' THR . . . . . . . . . . . . . 48.2 p . . . . . 0 C--O 1.22 -0.459 0 CA-C-O 118.051 -0.976 . . . . 0.0 110.423 179.339 . . . . . . . . 0 0 . 1 . 016 nuclear orig full ' B' B ' -3' ' ' GLU . . . . . . . . . . . . . 96.0 mt-10 . . . . . 0 N--CA 1.49 1.542 0 N-CA-C 109.416 -0.587 . . . . 0.0 109.416 . . . . . . . . . 0 0 . 1 . 016 nuclear orig full ' B' B ' -2' ' ' GLY . . . . . . . . . . . . . . . -77.77 149.97 35.52 Favored Glycine 0 CA--C 1.525 0.701 0 N-CA-C 110.895 -0.882 . . . . 0.0 110.895 179.411 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' B' B ' -1' ' ' VAL . . . . . . . . . . . . . 44.9 t -88.08 131.05 36.66 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.277 0 CA-C-O 120.887 0.375 . . . . 0.0 110.252 -179.695 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' B' B ' 0' ' ' ILE . . . . . . . . . . . . . 72.6 mt -119.78 136.67 56.15 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.252 0 CA-C-N 116.003 -0.544 . . . . 0.0 109.79 179.532 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' B' B ' 1' ' ' MET . . . . . . . . . . . . . 25.4 ptp -78.13 134.65 37.65 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-O 121.012 0.434 . . . . 0.0 111.236 -177.614 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' B' B ' 2' ' ' SER . . . . . . . . . . . . . 2.3 p -131.02 125.18 32.61 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-N 115.918 -0.583 . . . . 0.0 110.017 177.271 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' B' B ' 3' ' ' GLU . . . . . . . . . . . . . 81.3 tt0 -140.94 142.46 34.36 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-N 116.172 -0.467 . . . . 0.0 111.158 -176.266 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' B' B ' 4' ' ' LEU . . . . . . . . . . . . . 11.4 tp -123.6 130.95 53.43 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 115.946 -0.57 . . . . 0.0 109.744 176.298 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' B' B ' 5' ' ' LYS . . . . . . . . . . . . . 91.5 mttt -110.87 121.43 45.33 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 116.31 -0.405 . . . . 0.0 110.729 -178.307 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' B' B ' 6' ' ' LEU . . . . . . . . . . . . . 55.9 mt -116.54 151.27 36.51 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 115.569 -0.741 . . . . 0.0 110.653 -178.856 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' B' B ' 7' ' ' LYS . . . . . . . . . . . . . 59.1 tttt -139.04 135.42 17.46 Favored Pre-proline 0 CA--C 1.535 0.396 0 CA-C-O 118.966 -0.54 . . . . 0.0 110.152 175.936 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' B' B ' 8' ' ' PRO . . . . . . . . . . . . . 94.7 Cg_endo -92.04 144.79 2.89 Favored 'Trans proline' 0 N--CA 1.49 1.274 0 C-N-CA 121.814 1.676 . . . . 0.0 111.632 177.359 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' B' B ' 9' ' ' LEU . . . . . . . . . . . . . 47.3 mt -86.54 -47.91 0.52 Allowed Pre-proline 0 CA--C 1.534 0.345 0 CA-C-O 118.701 -0.666 . . . . 0.0 112.646 -177.981 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' B' B ' 10' ' ' PRO . . . . . . . . . . . . . 97.3 Cg_endo -81.91 160.77 18.54 Favored 'Trans proline' 0 N--CA 1.495 1.616 0 C-N-CA 121.421 1.414 . . . . 0.0 112.063 177.802 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' B' B ' 11' ' ' LYS . . . . . . . . . . . . . 52.5 pttt -85.67 121.67 28.67 Favored 'General case' 0 C--N 1.331 -0.196 0 CA-C-O 120.953 0.406 . . . . 0.0 110.377 178.145 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' B' B ' 12' ' ' VAL . . . . . . . . . . . . . 12.5 p -151.09 144.81 16.7 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.251 0 CA-C-N 116.226 -0.443 . . . . 0.0 110.705 -179.971 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' B' B ' 13' ' ' GLU . . . . . . . . . . . . . 81.4 tt0 -91.88 108.98 20.32 Favored 'General case' 0 C--N 1.329 -0.325 0 N-CA-C 109.718 -0.475 . . . . 0.0 109.718 176.263 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' B' B ' 14' ' ' LEU . . . . . . . . . . . . . 81.2 mt -84.44 143.41 41.56 Favored Pre-proline 0 CA--C 1.534 0.343 0 CA-C-O 119.168 -0.444 . . . . 0.0 110.666 -175.923 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' B' B ' 15' ' ' PRO . . . . . . . . . . . . . 24.8 Cg_exo -63.06 163.33 22.97 Favored 'Trans proline' 0 N--CA 1.497 1.703 0 C-N-CA 121.301 1.334 . . . . 0.0 111.879 175.608 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' B' B ' 16' ' ' PRO . . . . . . . . . . . . . 29.6 Cg_exo -60.17 -39.17 71.28 Favored 'Trans proline' 0 N--CA 1.496 1.671 0 C-N-CA 121.478 1.452 . . . . 0.0 112.846 -178.105 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' B' B ' 17' ' ' ASP . . . . . . . . . . . . . 20.1 p-10 -90.74 12.5 18.96 Favored 'General case' 0 CA--C 1.536 0.423 0 N-CA-C 113.161 0.8 . . . . 0.0 113.161 -176.814 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' B' B ' 18' ' ' PHE . . . . . . . . . . . . . 33.9 t80 -56.21 -46.0 79.66 Favored 'General case' 0 C--N 1.334 -0.104 0 O-C-N 121.937 -0.477 . . . . 0.0 110.671 -178.364 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' B' B ' 19' ' ' VAL . . . . . . . . . . . . . 46.6 t -55.48 -43.54 72.64 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.277 0 CA-C-N 116.61 -0.268 . . . . 0.0 110.858 -177.931 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' B' B ' 20' ' ' ASP . . . . . . . . . . . . . 50.7 m-20 -60.01 -43.79 94.99 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-O 120.988 0.423 . . . . 0.0 111.017 -177.682 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' B' B ' 21' ' ' VAL . . . . . . . . . . . . . 45.1 t -64.38 -46.6 92.54 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.259 0 CA-C-N 116.401 -0.363 . . . . 0.0 110.573 -177.554 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' B' B ' 22' ' ' ILE . . . . . . . . . . . . . 50.7 mm -56.27 -44.5 79.7 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.206 0 C-N-CA 120.926 -0.31 . . . . 0.0 110.564 178.678 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' B' B ' 23' ' ' ARG . . . . . . . . . . . . . 55.7 ttp180 -53.36 -48.08 68.85 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-O 120.722 0.296 . . . . 0.0 111.396 -179.76 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' B' B ' 24' ' ' ILE . . . . . . . . . . . . . 71.4 mt -58.97 -44.53 91.27 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.251 0 CA-C-N 116.496 -0.32 . . . . 0.0 110.938 -179.228 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' B' B ' 25' ' ' LYS . . . . . . . . . . . . . 53.0 mttm -65.59 -35.27 80.33 Favored 'General case' 0 C--N 1.327 -0.404 0 N-CA-C 112.3 0.482 . . . . 0.0 112.3 -178.051 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' B' B ' 26' ' ' LEU . . . . . . . . . . . . . 56.1 mt -80.01 -46.02 17.36 Favored 'General case' 0 C--N 1.329 -0.31 0 N-CA-C 112.943 0.72 . . . . 0.0 112.943 -172.896 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' B' B ' 27' ' ' GLN . . . . . . . . . . . . . 11.2 pt20 -46.56 138.74 5.63 Favored 'General case' 0 N--CA 1.468 0.464 0 N-CA-C 112.677 0.621 . . . . 0.0 112.677 -174.909 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' B' B ' 28' ' ' GLY . . . . . . . . . . . . . . . 100.09 -24.92 30.24 Favored Glycine 0 CA--C 1.533 1.195 0 CA-C-N 115.599 -0.728 . . . . 0.0 112.412 -177.869 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' B' B ' 29' ' ' LYS . . . . . . . . . . . . . 67.9 mttm -97.72 155.08 17.18 Favored 'General case' 0 C--N 1.331 -0.198 0 CA-C-N 117.402 0.601 . . . . 0.0 111.145 179.656 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' B' B ' 30' ' ' THR . . . . . . . . . . . . . 28.9 m -106.04 133.34 50.9 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 115.861 -0.609 . . . . 0.0 109.778 175.008 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' B' B ' 31' ' ' VAL . . . . . . . . . . . . . 35.2 m -128.63 156.1 40.86 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.214 0 CA-C-N 116.437 -0.347 . . . . 0.0 110.693 -178.619 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' B' B ' 32' ' ' ARG . . . . . . . . . . . . . 72.2 ttt180 -132.73 148.03 52.33 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.036 -0.529 . . . . 0.0 110.351 178.929 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' B' B ' 33' ' ' THR . . . . . . . . . . . . . 19.6 m -52.64 138.09 29.27 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-O 120.858 0.361 . . . . 0.0 111.396 -178.25 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' B' B ' 34' ' ' GLY . . . . . . . . . . . . . . . 102.13 -17.24 54.51 Favored Glycine 0 CA--C 1.534 1.23 0 CA-C-N 116.074 -0.512 . . . . 0.0 113.235 179.286 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' B' B ' 35' ' ' ASP . . . . . . . . . . . . . 78.6 m-20 -66.91 151.17 48.09 Favored 'General case' 0 N--CA 1.462 0.158 0 CA-C-N 117.972 0.886 . . . . 0.0 111.052 178.715 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' B' B ' 36' ' ' VAL . . . . . . . . . . . . . 44.4 t -124.25 132.73 70.91 Favored 'Isoleucine or valine' 0 C--N 1.333 -0.145 0 CA-C-N 115.959 -0.564 . . . . 0.0 109.902 178.234 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' B' B ' 37' ' ' ILE . . . . . . . . . . . . . 68.5 mt -119.66 140.16 44.58 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.189 0 CA-C-N 116.063 -0.517 . . . . 0.0 109.96 -179.258 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' B' B ' 38' ' ' GLY . . . . . . . . . . . . . . . -116.95 128.84 8.07 Favored Glycine 0 CA--C 1.525 0.714 0 N-CA-C 111.043 -0.823 . . . . 0.0 111.043 179.598 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' B' B ' 39' ' ' ILE . . . . . . . . . . . . . 76.9 mt -128.89 139.68 51.26 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.248 0 N-CA-C 110.147 -0.316 . . . . 0.0 110.147 179.245 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' B' B ' 40' ' ' SER . . . . . . . . . . . . . 53.7 p -93.22 126.01 38.12 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.263 -0.426 . . . . 0.0 110.863 175.26 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' B' B ' 41' ' ' ILE . . . . . . . . . . . . . 68.6 mt -134.99 113.94 16.62 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.247 0 CA-C-O 120.826 0.346 . . . . 0.0 110.534 177.702 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' B' B ' 42' ' ' LEU . . . . . . . . . . . . . 1.5 tt 56.33 47.84 18.3 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-O 121.52 0.676 . . . . 0.0 110.358 177.604 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' B' B ' 43' ' ' GLY . . . . . . . . . . . . . . . 72.2 -5.49 14.05 Favored Glycine 0 CA--C 1.536 1.351 0 C-N-CA 121.162 -0.542 . . . . 0.0 113.724 175.118 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' B' B ' 44' ' ' LYS . . . . . . . . . . . . . 80.6 tttt -108.85 135.04 50.71 Favored 'General case' 0 C--N 1.332 -0.181 0 CA-C-N 118.049 0.924 . . . . 0.0 110.19 -179.212 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' B' B ' 45' ' ' GLU . . . . . . . . . . . . . 84.1 tt0 -83.73 130.65 34.95 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-N 116.458 -0.337 . . . . 0.0 111.079 -179.075 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' B' B ' 46' ' ' VAL . . . . . . . . . . . . . 7.3 p -124.04 125.06 70.25 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.189 0 CA-C-O 121.002 0.43 . . . . 0.0 109.875 175.616 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' B' B ' 47' ' ' LYS . . . . . . . . . . . . . 91.9 mttt -100.08 131.46 46.02 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 115.951 -0.568 . . . . 0.0 111.031 176.529 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' B' B ' 48' ' ' PHE . . . . . . . . . . . . . 94.6 m-85 -113.08 131.88 55.64 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.057 -0.52 . . . . 0.0 109.644 175.341 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' B' B ' 49' ' ' LYS . . . . . . . . . . . . . 76.1 tttt -107.22 135.46 48.71 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.605 -0.27 . . . . 0.0 110.302 178.094 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' B' B ' 50' ' ' VAL . . . . . . . . . . . . . 43.9 t -81.16 107.48 13.48 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.315 0 N-CA-C 109.219 -0.66 . . . . 0.0 109.219 176.268 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' B' B ' 51' ' ' VAL . . . . . . . . . . . . . 40.4 t -74.88 -49.65 28.29 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.337 0 CA-C-N 115.982 -0.554 . . . . 0.0 110.14 -172.716 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' B' B ' 52' ' ' GLN . . . . . . . . . . . . . 85.8 mt-30 -154.34 152.98 30.87 Favored 'General case' 0 C--N 1.331 -0.199 0 C-N-CA 120.449 -0.5 . . . . 0.0 111.797 -177.304 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' B' B ' 53' ' ' ALA . . . . . . . . . . . . . . . -130.35 130.5 44.51 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 115.339 -0.846 . . . . 0.0 109.643 175.016 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' B' B ' 54' ' ' TYR . . . . . . . . . . . . . 19.1 t80 -129.13 105.91 17.95 Favored Pre-proline 0 CA--C 1.534 0.357 0 CA-C-O 118.357 -0.83 . . . . 0.0 110.464 -179.572 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' B' B ' 55' ' ' PRO . . . . . . . . . . . . . 73.8 Cg_endo -77.2 170.06 72.49 Favored 'Cis proline' 0 N--CA 1.5 1.912 0 CA-C-N 121.673 1.633 . . . . 0.0 112.474 -5.98 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' B' B ' 56' ' ' SER . . . . . . . . . . . . . 36.0 m -116.42 134.16 22.89 Favored Pre-proline 0 CA--C 1.539 0.524 0 CA-C-O 118.461 -0.781 . . . . 0.0 109.606 175.17 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' B' B ' 57' ' ' PRO . . . . . . . . . . . . . 36.2 Cg_endo -67.07 166.53 62.35 Favored 'Cis proline' 0 N--CA 1.497 1.732 0 CA-C-N 121.856 1.698 . . . . 0.0 111.349 -3.727 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' B' B ' 58' ' ' LEU . . . . . . . . . . . . . 31.4 tp -130.77 138.04 49.75 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.239 -0.437 . . . . 0.0 110.512 -179.324 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' B' B ' 59' ' ' ARG . . . . . . . . . . . . . 59.8 ttm-85 -105.47 127.34 52.95 Favored 'General case' 0 C--N 1.327 -0.37 0 N-CA-C 109.148 -0.686 . . . . 0.0 109.148 175.0 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' B' B ' 60' ' ' VAL . . . . . . . . . . . . . 40.1 t -81.2 123.99 38.33 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.338 0 C-N-CA 120.651 -0.42 . . . . 0.0 110.872 -173.788 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' B' B ' 61' ' ' GLU . . . . . . . . . . . . . 95.7 mt-10 -131.0 162.55 29.52 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 115.691 -0.686 . . . . 0.0 109.666 176.251 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' B' B ' 62' ' ' ASP . . . . . . . . . . . . . 78.7 m-20 -54.85 -33.96 62.35 Favored 'General case' 0 C--N 1.328 -0.329 0 C-N-CA 121.015 -0.274 . . . . 0.0 111.646 -178.86 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' B' B ' 63' ' ' ARG . . . . . . . . . . . . . 7.3 mmm180 -76.18 -10.3 59.3 Favored 'General case' 0 CA--C 1.537 0.446 0 N-CA-C 113.186 0.81 . . . . 0.0 113.186 -176.74 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' B' B ' 64' ' ' THR . . . . . . . . . . . . . 30.0 m -72.27 145.32 47.98 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-O 121.004 0.43 . . . . 0.0 111.246 -175.915 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' B' B ' 65' ' ' LYS . . . . . . . . . . . . . 23.9 mtpp -89.58 127.52 35.9 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 115.878 -0.601 . . . . 0.0 110.265 178.491 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' B' B ' 66' ' ' ILE . . . . . 0.4 HD12 HG21 ' B' ' 66' ' ' ILE . 55.7 mt -114.77 129.93 70.07 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.245 0 N-CA-C 109.779 -0.452 . . . . 0.0 109.779 179.59 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' B' B ' 67' ' ' THR . . . . . . . . . . . . . 25.9 m -127.76 143.63 51.12 Favored 'General case' 0 C--N 1.332 -0.176 0 CA-C-O 121.171 0.51 . . . . 0.0 111.586 -176.842 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' B' B ' 68' ' ' LEU . . . . . . . . . . . . . 16.0 tp -100.95 125.47 47.53 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 115.59 -0.732 . . . . 0.0 109.622 175.666 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' B' B ' 69' ' ' VAL . . . . . . . . . . . . . 40.2 t -95.47 138.32 21.43 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.309 0 CA-C-O 120.895 0.379 . . . . 0.0 110.64 -176.264 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' B' B ' 70' ' ' THR . . . . . . . . . . . . . 25.7 m -108.09 150.46 27.15 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-N 115.881 -0.6 . . . . 0.0 110.794 -179.327 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' B' B ' 71' ' ' HIS . . . . . . . . . . . . . 47.8 m-70 -137.4 156.71 74.96 Favored Pre-proline 0 CA--C 1.532 0.269 0 CA-C-N 116.249 -0.432 . . . . 0.0 110.393 179.203 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' B' B ' 72' ' ' PRO . . . . . . . . . . . . . 57.9 Cg_endo -73.69 -30.0 10.06 Favored 'Trans proline' 0 N--CA 1.495 1.56 0 C-N-CA 121.274 1.316 . . . . 0.0 112.775 -176.424 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' B' B ' 73' ' ' VAL . . . . . . . . . . . . . 35.4 m -135.46 159.66 40.3 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.22 0 CA-C-O 120.854 0.359 . . . . 0.0 110.697 179.806 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' B' B ' 74' ' ' ASP . . . . . . . . . . . . . 18.6 t0 -104.09 115.43 30.42 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.001 -0.545 . . . . 0.0 109.893 179.245 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' B' B ' 75' ' ' VAL . . . . . . . . . . . . . 40.8 t -116.69 123.58 71.82 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.291 0 CA-C-O 121.086 0.47 . . . . 0.0 110.738 -176.271 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' B' B ' 76' ' ' LEU . . . . . . . . . . . . . 4.9 mp -125.19 146.63 49.42 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 115.635 -0.712 . . . . 0.0 109.516 176.273 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' B' B ' 77' ' ' GLU . . . . . . . . . . . . . 46.4 mt-10 -134.22 141.11 46.91 Favored 'General case' 0 C--N 1.331 -0.227 0 CA-C-O 120.944 0.402 . . . . 0.0 111.119 -178.513 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' B' B ' 78' ' ' ALA . . . . . . . . . . . . . . . -129.81 135.34 48.3 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 115.879 -0.601 . . . . 0.0 109.925 176.289 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' B' B ' 79' ' ' LYS . . . . . . . . . . . . . 43.3 pttt -80.36 121.59 25.88 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-O 121.123 0.487 . . . . 0.0 111.18 -176.951 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' B' B ' 80' ' ' ILE . . . . . . . . . . . . . 23.7 mm -139.45 112.26 5.87 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.327 0 N-CA-C 109.119 -0.697 . . . . 0.0 109.119 -179.018 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' B' B ' 81' ' ' LYS . . . . . . . . . . . . . 36.2 ttpt -100.45 123.08 44.2 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-O 120.911 0.386 . . . . 0.0 111.148 -178.363 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' B' B ' 82' ' ' GLY . . . . . . . . . . . . . . . 89.17 42.07 5.68 Favored Glycine 0 CA--C 1.527 0.792 0 C-N-CA 120.859 -0.686 . . . . 0.0 112.225 173.732 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' B' B ' 83' ' ' ILE . . . . . . . . . . . . . 69.2 mt -67.46 136.1 27.26 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.321 0 N-CA-C 109.689 -0.486 . . . . 0.0 109.689 175.993 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' B' B ' 84' ' ' LYS . . . . . . . . . . . . . 38.6 ttpt -104.48 -48.21 3.88 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-O 120.873 0.368 . . . . 0.0 110.584 -178.266 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' B' B ' 85' ' ' ASP . . . . . . . . . . . . . 13.8 t70 -143.37 146.64 33.68 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.06 -0.518 . . . . 0.0 110.631 -178.594 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' B' B ' 86' ' ' VAL . . . . . . . . . . . . . 44.7 t -131.08 132.69 63.42 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.268 0 CA-C-O 120.863 0.363 . . . . 0.0 110.389 -179.285 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' B' B ' 87' ' ' ILE . . . . . . . . . . . . . 5.2 mp -123.97 128.09 73.95 Favored 'Isoleucine or valine' 0 C--O 1.233 0.187 0 CA-C-N 115.945 -0.571 . . . . 0.0 109.762 177.527 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' B' B ' 88' ' ' LEU . . . . . . . . . . . . . 18.8 tp -113.62 133.14 55.46 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.284 -0.416 . . . . 0.0 110.953 -177.901 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' B' B ' 89' ' ' ASP . . . . . . . . . . . . . 6.4 t0 -132.33 160.5 36.1 Favored 'General case' 0 C--N 1.331 -0.199 0 CA-C-N 116.171 -0.468 . . . . 0.0 109.848 177.955 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' B' B ' 90' ' ' GLU . . . . . . . . . . . . . 95.7 mt-10 -44.95 -47.29 11.38 Favored 'General case' 0 N--CA 1.465 0.28 0 N-CA-C 113.328 0.862 . . . . 0.0 113.328 -171.785 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' B' B ' 91' ' ' ASN . . . . . . . . . . . . . 77.7 m-20 -124.26 21.48 8.76 Favored 'General case' 0 N--CA 1.468 0.428 0 N-CA-C 112.809 0.67 . . . . 0.0 112.809 -176.237 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' B' B ' 92' ' ' LEU . . . . . . . . . . . . . 26.6 mt -148.23 145.96 28.46 Favored 'General case' 0 C--N 1.331 -0.208 0 CA-C-O 120.757 0.313 . . . . 0.0 110.872 -174.861 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' B' B ' 93' ' ' ILE . . . . . . . . . . . . . 71.7 mt -125.58 115.93 44.86 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.319 0 N-CA-C 108.898 -0.779 . . . . 0.0 108.898 176.683 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' B' B ' 94' ' ' VAL . . . . . . . . . . . . . 43.6 t -116.45 127.06 74.16 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.322 0 N-CA-C 109.95 -0.389 . . . . 0.0 109.95 -177.283 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' B' B ' 95' ' ' VAL . . . . . . . . . . . . . 43.7 t -122.56 134.4 65.86 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.265 0 CA-C-N 116.099 -0.5 . . . . 0.0 109.91 -179.318 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' B' B ' 96' ' ' ILE . . . . . . . . . . . . . 68.8 mt -118.07 126.75 75.15 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.287 0 N-CA-C 109.349 -0.611 . . . . 0.0 109.349 178.981 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' B' B ' 97' ' ' THR . . . . . . . . . . . . . 69.6 p -99.39 157.08 16.66 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-O 121.274 0.559 . . . . 0.0 111.495 -176.029 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' B' B ' 98' ' ' GLU . . . . . . . . . . . . . 12.1 pt-20 -53.82 -25.23 18.45 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 115.966 -0.561 . . . . 0.0 112.489 -179.275 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' B' B ' 99' ' ' GLU . . . . . . . . . . . . . 95.6 mt-10 -81.97 17.85 1.47 Allowed 'General case' 0 CA--C 1.535 0.366 0 N-CA-C 113.021 0.748 . . . . 0.0 113.021 -177.529 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' B' B ' 100' ' ' ASN . . . . . . . . . . . . . 3.2 m-20 61.75 37.96 15.34 Favored 'General case' 0 C--O 1.232 0.175 0 CA-C-O 120.955 0.407 . . . . 0.0 110.98 177.86 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' B' B ' 101' ' ' GLU . . . . . . . . . . . . . 83.9 tt0 -115.2 142.97 45.94 Favored 'General case' 0 C--N 1.331 -0.208 0 N-CA-C 109.709 -0.478 . . . . 0.0 109.709 176.35 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' B' B ' 102' ' ' VAL . . . . . . . . . . . . . 44.4 t -116.04 127.06 73.75 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.34 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.037 -177.247 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' B' B ' 103' ' ' LEU . . . . . . . . . . . . . 45.3 mt -120.44 131.12 54.63 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 115.828 -0.624 . . . . 0.0 110.243 177.081 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' B' B ' 104' ' ' ILE . . . . . . . . . . . . . 67.5 mt -119.68 121.47 66.3 Favored 'Isoleucine or valine' 0 C--O 1.234 0.285 0 CA-C-N 116.471 -0.331 . . . . 0.0 110.182 -178.791 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' B' B ' 105' ' ' PHE . . . . . . . . . . . . . 51.2 m-85 -123.38 163.95 19.81 Favored 'General case' 0 C--N 1.334 -0.089 0 O-C-N 123.838 0.711 . . . . 0.0 109.769 178.7 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' B' B ' 106' ' ' ASN . . . . . . . . . . . . . 43.3 p-10 -97.06 -169.95 1.95 Allowed 'General case' 0 C--N 1.331 -0.221 0 N-CA-C 110.096 -0.335 . . . . 0.0 110.096 174.845 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' B' B ' 107' ' ' GLN . . . . . . . . . . . . . 50.7 tt0 -59.55 -30.0 68.31 Favored 'General case' 0 C--N 1.328 -0.327 0 N-CA-C 111.886 0.328 . . . . 0.0 111.886 179.029 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' B' B ' 108' ' ' ASN . . . . . . . . . . . . . 65.9 t30 -82.56 7.09 15.52 Favored 'General case' 0 CA--C 1.536 0.421 0 N-CA-C 113.283 0.846 . . . . 0.0 113.283 -177.864 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' B' B ' 109' ' ' LEU . . . . . . . . . . . . . 11.9 tp 60.21 37.49 20.57 Favored 'General case' 0 C--N 1.331 -0.2 0 CA-C-O 121.112 0.482 . . . . 0.0 111.218 179.464 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' B' B ' 110' ' ' GLU . . . . . . . . . . . . . 70.9 mm-40 -103.61 148.43 26.01 Favored 'General case' 0 C--N 1.33 -0.264 0 N-CA-C 109.639 -0.504 . . . . 0.0 109.639 175.199 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' B' B ' 111' ' ' GLU . . . . . . . . . . . . . 62.6 tt0 -84.97 122.04 28.64 Favored 'General case' 0 C--N 1.327 -0.396 0 CA-C-O 120.893 0.377 . . . . 0.0 110.586 -176.75 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' B' B ' 112' ' ' LEU . . . . . . . . . . . . . 45.5 mt -109.57 -45.99 3.6 Favored 'General case' 0 C--N 1.332 -0.171 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.722 179.963 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' B' B ' 113' ' ' TYR . . . . . . . . . . . . . 55.5 t80 -133.33 139.12 46.68 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.328 -0.396 . . . . 0.0 110.872 -178.861 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' B' B ' 114' ' ' ARG . . . . . . . . . . . . . 34.7 ptt-85 -145.12 121.01 10.63 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.235 -0.438 . . . . 0.0 110.726 179.624 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' B' B ' 115' ' ' GLY . . . . . . . . . . . . . . . -150.24 159.2 28.01 Favored Glycine 0 CA--C 1.524 0.646 0 C-N-CA 120.871 -0.681 . . . . 0.0 111.439 178.88 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' B' B ' 116' ' ' LYS . . . . . . . . . . . . . 38.6 ttpt -125.59 130.71 52.2 Favored 'General case' 0 C--N 1.33 -0.251 0 N-CA-C 109.525 -0.546 . . . . 0.0 109.525 175.524 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' B' B ' 117' ' ' PHE . . . . . . . . . . . . . 44.5 m-85 -132.43 116.31 16.64 Favored 'General case' 0 C--N 1.331 -0.224 0 CA-C-O 120.934 0.397 . . . . 0.0 110.481 -174.535 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' B' B ' 118' ' ' GLU . . . . . . . . . . . . . 95.8 mt-10 -53.46 -45.03 69.37 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.374 -0.376 . . . . 0.0 111.503 -177.228 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' B' B ' 119' ' ' ASN . . . . . . . . . . . . . 4.6 m120 -97.12 29.72 3.03 Favored 'General case' 0 C--N 1.33 -0.249 0 N-CA-C 112.403 0.52 . . . . 0.0 112.403 -173.958 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' B' B ' 120' ' ' LEU . . . . . . . . . . . . . 17.8 tp -59.07 119.89 8.13 Favored 'General case' 0 C--N 1.331 -0.205 0 N-CA-C 110.067 -0.346 . . . . 0.0 110.067 177.647 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' B' B ' 121' ' ' ASN . . . . . . . . . . . . . 72.8 m-20 -114.07 -44.03 3.18 Favored 'General case' 0 C--N 1.332 -0.167 0 CA-C-N 116.493 -0.321 . . . . 0.0 111.162 -177.521 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' B' B ' 122' ' ' LYS . . . . . . . . . . . . . 97.8 mttt -143.77 151.37 39.9 Favored 'General case' 0 C--N 1.332 -0.162 0 CA-C-O 121.184 0.516 . . . . 0.0 111.748 -176.353 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' B' B ' 123' ' ' VAL . . . . . . . . . . . . . 45.1 t -128.38 126.71 66.19 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.22 0 CA-C-N 115.83 -0.623 . . . . 0.0 109.515 175.225 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' B' B ' 124' ' ' LEU . . . . . . . . . . . . . 7.0 mp -114.36 131.61 56.49 Favored 'General case' 0 C--N 1.332 -0.186 0 CA-C-N 116.373 -0.376 . . . . 0.0 110.772 -178.179 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' B' B ' 125' ' ' VAL . . . . . . . . . . . . . 9.2 p -131.94 131.33 61.68 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.215 0 CA-C-N 116.151 -0.477 . . . . 0.0 109.855 178.024 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' B' B ' 126' ' ' ARG . . . . . . . . . . . . . 48.2 ttt180 -151.44 128.77 11.28 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-O 120.951 0.405 . . . . 0.0 110.772 178.74 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' B' B ' 127' ' ' ASN . . . . . . . . . . . . . 6.9 m120 52.1 -112.73 0.69 Allowed 'General case' 0 CA--C 1.545 0.756 0 CA-C-O 118.837 -0.601 . . . . 0.0 111.029 179.242 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' B' B ' 128' ' ' ASP . . . . . . . . . . . . . 10.9 p-10 -114.17 10.16 17.27 Favored 'General case' 0 N--CA 1.468 0.447 0 CA-C-N 119.934 1.243 . . . . 0.0 113.216 -177.288 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' B' B ' 129' ' ' LEU . . . . . . . . . . . . . 77.9 mt -118.43 149.81 40.62 Favored 'General case' 0 C--O 1.233 0.235 0 CA-C-N 118.212 0.46 . . . . 0.0 110.445 -178.605 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' B' B ' 130' ' ' VAL . . . . . . . . . . . . . 32.9 m -135.43 144.6 33.57 Favored 'Isoleucine or valine' 0 C--O 1.232 0.182 0 CA-C-O 121.326 0.584 . . . . 0.0 111.042 -179.876 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' B' B ' 131' ' ' VAL . . . . . . . . . . . . . 45.7 t -136.03 137.88 48.11 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.324 0 CA-C-N 115.595 -0.73 . . . . 0.0 109.901 179.013 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' B' B ' 132' ' ' ILE . . . . . . . . . . . . . 71.6 mt -112.32 130.35 66.19 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.337 0 N-CA-C 109.317 -0.623 . . . . 0.0 109.317 179.452 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' B' B ' 133' ' ' ILE . . . . . . . . . . . . . 38.9 mm -114.48 120.09 63.22 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.255 0 CA-C-O 120.752 0.31 . . . . 0.0 111.007 -174.513 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' B' B ' 134' ' ' ASP . . . . . . . . . . . . . 6.9 p-10 -130.93 146.3 52.3 Favored 'General case' 0 C--N 1.332 -0.194 0 N-CA-C 109.465 -0.568 . . . . 0.0 109.465 175.048 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' B' B ' 135' ' ' GLU . . . . . . . . . . . . . 33.6 tt0 -49.95 -27.49 5.41 Favored 'General case' 0 C--N 1.329 -0.323 0 N-CA-C 112.731 0.641 . . . . 0.0 112.731 -173.262 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' B' B ' 136' ' ' GLN . . . . . . . . . . . . . 98.7 mt-30 -79.4 -36.2 39.51 Favored 'General case' 0 C--N 1.331 -0.202 0 N-CA-C 112.175 0.435 . . . . 0.0 112.175 -176.86 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' B' B ' 137' ' ' LYS . . . . . . . . . . . . . 45.6 pttt -169.45 175.39 5.51 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-O 121.448 0.642 . . . . 0.0 112.148 -172.137 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' B' B ' 138' ' ' LEU . . . . . . . . . . . . . 7.7 tt -118.18 129.5 55.55 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 115.266 -0.879 . . . . 0.0 110.355 -179.459 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' B' B ' 139' ' ' THR . . . . . . . . . . . . . 32.7 m -107.35 126.45 52.48 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 115.923 -0.58 . . . . 0.0 110.238 178.191 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' B' B ' 140' ' ' LEU . . . . . . . . . . . . . 12.3 tp -111.63 119.11 37.59 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 115.904 -0.589 . . . . 0.0 109.652 -176.602 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' B' B ' 141' ' ' ILE . . . . . . . . . . . . . 27.2 mt -121.71 121.47 64.47 Favored 'Isoleucine or valine' 0 C--O 1.234 0.245 0 CA-C-O 121.351 0.596 . . . . 0.0 110.525 -173.969 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' B' B ' 142' ' ' ARG . . . . . . . . . . . . . 0.5 OUTLIER -108.25 123.99 49.62 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 114.903 -1.044 . . . . 0.0 110.068 -179.794 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' B' B ' 143' ' ' THR . . . . . . . . . . . . . 40.3 p . . . . . 0 C--O 1.219 -0.516 0 CA-C-O 118.002 -0.999 . . . . 0.0 110.574 179.443 . . . . . . . . 0 0 . 1 . 016 nuclear orig full ' C' C ' -3' ' ' GLU . . . . . . . . . . . . . 96.0 mt-10 . . . . . 0 N--CA 1.489 1.524 0 N-CA-C 109.387 -0.598 . . . . 0.0 109.387 . . . . . . . . . 0 0 . 1 . 016 nuclear orig full ' C' C ' -2' ' ' GLY . . . . . . . . . . . . . . . -65.36 148.62 51.4 Favored Glycine 0 CA--C 1.524 0.602 0 N-CA-C 111.114 -0.795 . . . . 0.0 111.114 -179.435 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' C' C ' -1' ' ' VAL . . . . . . . . . . . . . 45.3 t -141.62 128.56 20.41 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.304 0 N-CA-C 109.934 -0.395 . . . . 0.0 109.934 179.452 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' C' C ' 0' ' ' ILE . . . . . . . . . . . . . 71.4 mt -120.43 128.96 76.05 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.27 0 CA-C-N 116.051 -0.522 . . . . 0.0 109.686 179.485 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' C' C ' 1' ' ' MET . . . . . . . . . . . . . 24.6 ptt? -82.56 127.43 33.33 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-O 120.919 0.39 . . . . 0.0 110.715 -179.14 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' C' C ' 2' ' ' SER . . . . . . . . . . . . . 2.9 p -107.97 144.91 34.6 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 116.035 -0.529 . . . . 0.0 110.691 -179.952 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' C' C ' 3' ' ' GLU . . . . . . . . . . . . . 45.0 mt-10 -140.12 143.1 36.05 Favored 'General case' 0 C--N 1.331 -0.227 0 CA-C-N 116.027 -0.533 . . . . 0.0 110.981 -179.656 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' C' C ' 4' ' ' LEU . . . . . . . . . . . . . 2.4 tt -124.57 124.35 42.05 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 115.65 -0.705 . . . . 0.0 109.535 177.075 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' C' C ' 5' ' ' LYS . . . . . . . . . . . . . 78.6 mttt -103.87 118.77 37.48 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.721 -178.564 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' C' C ' 6' ' ' LEU . . . . . . . . . . . . . 27.3 mt -116.79 147.96 41.61 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 115.566 -0.743 . . . . 0.0 110.317 -179.172 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' C' C ' 7' ' ' LYS . . . . . . . . . . . . . 81.2 tttt -134.87 139.87 33.49 Favored Pre-proline 0 CA--C 1.533 0.308 0 CA-C-O 119.124 -0.465 . . . . 0.0 109.957 175.643 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' C' C ' 8' ' ' PRO . . . . . . . . . . . . . 88.4 Cg_endo -91.34 137.74 2.12 Favored 'Trans proline' 0 N--CA 1.489 1.236 0 C-N-CA 121.722 1.615 . . . . 0.0 111.555 177.813 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' C' C ' 9' ' ' LEU . . . . . . . . . . . . . 68.0 mt -77.73 -47.79 2.3 Favored Pre-proline 0 CA--C 1.535 0.396 0 CA-C-O 118.634 -0.698 . . . . 0.0 112.444 -178.25 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' C' C ' 10' ' ' PRO . . . . . . . . . . . . . 88.9 Cg_endo -80.28 152.84 21.08 Favored 'Trans proline' 0 N--CA 1.497 1.678 0 C-N-CA 121.135 1.223 . . . . 0.0 112.03 177.006 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' C' C ' 11' ' ' LYS . . . . . . . . . . . . . 33.9 mmtp -85.65 97.57 10.19 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.354 -0.384 . . . . 0.0 110.396 177.851 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' C' C ' 12' ' ' VAL . . . . . . . . . . . . . 11.8 p -140.03 145.17 26.76 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.288 0 CA-C-N 116.107 -0.497 . . . . 0.0 110.308 179.778 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' C' C ' 13' ' ' GLU . . . . . . . . . . . . . 70.5 tt0 -84.27 116.16 22.83 Favored 'General case' 0 C--N 1.328 -0.333 0 N-CA-C 109.756 -0.461 . . . . 0.0 109.756 178.179 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' C' C ' 14' ' ' LEU . . . . . . . . . . . . . 19.0 mt -87.21 152.24 52.55 Favored Pre-proline 0 C--N 1.328 -0.33 0 CA-C-N 116.421 -0.354 . . . . 0.0 111.079 -175.131 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' C' C ' 15' ' ' PRO . . . . . . . . . . . . . 26.8 Cg_exo -61.95 161.61 25.2 Favored 'Trans proline' 0 N--CA 1.496 1.65 0 C-N-CA 121.443 1.428 . . . . 0.0 111.698 176.451 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' C' C ' 16' ' ' PRO . . . . . . . . . . . . . 24.0 Cg_exo -62.81 -38.14 50.74 Favored 'Trans proline' 0 N--CA 1.497 1.729 0 C-N-CA 121.485 1.457 . . . . 0.0 112.75 -179.248 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' C' C ' 17' ' ' ASP . . . . . . . . . . . . . 9.4 p-10 -93.88 15.84 15.7 Favored 'General case' 0 C--N 1.327 -0.388 0 N-CA-C 113.154 0.798 . . . . 0.0 113.154 -175.688 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' C' C ' 18' ' ' PHE . . . . . . . . . . . . . 38.2 t80 -57.06 -47.03 81.97 Favored 'General case' 0 C--N 1.334 -0.076 0 O-C-N 122.06 -0.4 . . . . 0.0 110.595 -176.998 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' C' C ' 19' ' ' VAL . . . . . . . . . . . . . 46.3 t -56.33 -46.28 81.69 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.323 0 CA-C-N 116.464 -0.335 . . . . 0.0 110.852 -176.261 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' C' C ' 20' ' ' ASP . . . . . . . . . . . . . 77.2 m-20 -60.08 -41.55 92.7 Favored 'General case' 0 C--N 1.329 -0.298 0 C-N-CA 120.939 -0.304 . . . . 0.0 111.159 -177.066 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' C' C ' 21' ' ' VAL . . . . . . . . . . . . . 44.5 t -64.04 -46.75 92.95 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.29 0 C-N-CA 120.759 -0.376 . . . . 0.0 110.383 -177.968 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' C' C ' 22' ' ' ILE . . . . . . . . . . . . . 51.5 mm -56.36 -46.32 81.8 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.218 0 C-N-CA 120.951 -0.3 . . . . 0.0 110.567 178.352 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' C' C ' 23' ' ' ARG . . . . . . . . . . . . . 56.4 ttp180 -52.88 -49.05 66.64 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-O 120.652 0.263 . . . . 0.0 111.558 -178.798 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' C' C ' 24' ' ' ILE . . . . . . . . . . . . . 71.3 mt -58.32 -47.75 86.84 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.341 0 CA-C-N 116.661 -0.245 . . . . 0.0 110.802 -178.187 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' C' C ' 25' ' ' LYS . . . . . . . . . . . . . 40.4 mmtt -60.76 -43.96 97.34 Favored 'General case' 0 C--N 1.329 -0.315 0 N-CA-C 112.129 0.418 . . . . 0.0 112.129 -177.959 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' C' C ' 26' ' ' LEU . . . . . . . . . . . . . 81.8 mt -80.88 -29.21 35.75 Favored 'General case' 0 C--N 1.33 -0.273 0 N-CA-C 113.392 0.886 . . . . 0.0 113.392 -170.721 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' C' C ' 27' ' ' GLN . . . . . . . . . . . . . 4.4 pt20 -45.87 134.53 7.78 Favored 'General case' 0 N--CA 1.467 0.423 0 N-CA-C 112.856 0.687 . . . . 0.0 112.856 -174.931 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' C' C ' 28' ' ' GLY . . . . . . . . . . . . . . . 101.11 -20.21 48.45 Favored Glycine 0 CA--C 1.533 1.191 0 CA-C-N 115.948 -0.569 . . . . 0.0 112.863 -179.038 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' C' C ' 29' ' ' LYS . . . . . . . . . . . . . 59.9 mtpt -97.53 155.08 17.11 Favored 'General case' 0 C--N 1.332 -0.17 0 CA-C-N 117.78 0.79 . . . . 0.0 111.153 179.84 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' C' C ' 30' ' ' THR . . . . . . . . . . . . . 42.6 m -107.38 138.41 43.63 Favored 'General case' 0 C--N 1.332 -0.164 0 CA-C-N 116.157 -0.474 . . . . 0.0 110.038 176.262 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' C' C ' 31' ' ' VAL . . . . . . . . . . . . . 35.0 m -131.33 160.61 42.19 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.252 0 CA-C-N 116.38 -0.373 . . . . 0.0 110.771 -178.928 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' C' C ' 32' ' ' ARG . . . . . . . . . . . . . 21.1 mtp-105 -132.99 153.3 51.6 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-O 121.37 0.605 . . . . 0.0 110.552 178.236 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' C' C ' 33' ' ' THR . . . . . . . . . . . . . 17.9 m -52.98 139.72 26.97 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.022 -0.536 . . . . 0.0 111.457 -177.817 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' C' C ' 34' ' ' GLY . . . . . . . . . . . . . . . 99.85 -17.06 57.87 Favored Glycine 0 CA--C 1.532 1.108 0 CA-C-O 119.623 -0.543 . . . . 0.0 113.447 177.678 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' C' C ' 35' ' ' ASP . . . . . . . . . . . . . 70.9 m-20 -64.23 148.85 49.19 Favored 'General case' 0 C--O 1.232 0.167 0 CA-C-N 118.004 0.902 . . . . 0.0 111.17 -179.833 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' C' C ' 36' ' ' VAL . . . . . . . . . . . . . 45.9 t -122.63 129.69 75.03 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.241 0 CA-C-N 115.794 -0.639 . . . . 0.0 109.629 178.117 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' C' C ' 37' ' ' ILE . . . . . 0.4 HG23 HD12 ' C' ' 37' ' ' ILE . 67.7 mt -121.82 140.23 46.44 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.278 0 CA-C-N 116.396 -0.365 . . . . 0.0 110.129 -178.146 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' C' C ' 38' ' ' GLY . . . . . . . . . . . . . . . -113.2 128.96 8.62 Favored Glycine 0 CA--C 1.526 0.745 0 N-CA-C 111.082 -0.807 . . . . 0.0 111.082 -179.845 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' C' C ' 39' ' ' ILE . . . . . . . . . . . . . 76.2 mt -124.24 142.64 40.35 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.205 0 N-CA-C 110.025 -0.361 . . . . 0.0 110.025 179.564 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' C' C ' 40' ' ' SER . . . . . . . . . . . . . 89.7 p -91.3 120.47 32.22 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.361 -0.381 . . . . 0.0 111.067 177.888 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' C' C ' 41' ' ' ILE . . . . . . . . . . . . . 46.3 mm -130.16 114.96 30.9 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.242 0 CA-C-N 116.435 -0.348 . . . . 0.0 110.098 177.904 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' C' C ' 42' ' ' LEU . . . . . . . . . . . . . 49.0 mt 58.03 35.16 24.97 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.391 -0.368 . . . . 0.0 111.566 178.248 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' C' C ' 43' ' ' GLY . . . . . . . . . . . . . . . 77.89 -10.08 27.74 Favored Glycine 0 CA--C 1.533 1.203 0 C-N-CA 121.316 -0.469 . . . . 0.0 113.499 177.81 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' C' C ' 44' ' ' LYS . . . . . . . . . . . . . 68.4 mmtt -98.04 139.47 33.81 Favored 'General case' 0 C--N 1.333 -0.11 0 CA-C-N 117.96 0.88 . . . . 0.0 109.869 176.057 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' C' C ' 45' ' ' GLU . . . . . . . . . . . . . 82.2 tt0 -83.3 123.81 29.99 Favored 'General case' 0 C--N 1.329 -0.315 0 C-N-CA 120.936 -0.306 . . . . 0.0 110.713 179.536 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' C' C ' 46' ' ' VAL . . . . . . . . . . . . . 7.7 p -115.5 128.37 72.74 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.167 0 N-CA-C 109.511 -0.552 . . . . 0.0 109.511 177.441 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' C' C ' 47' ' ' LYS . . . . . . . . . . . . . 67.4 mttm -100.24 130.74 46.4 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 115.97 -0.559 . . . . 0.0 111.56 -179.927 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' C' C ' 48' ' ' PHE . . . . . . . . . . . . . 91.1 m-85 -115.31 131.91 56.78 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.079 -0.509 . . . . 0.0 109.714 175.813 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' C' C ' 49' ' ' LYS . . . . . . . . . . . . . 82.8 tttt -107.92 137.18 46.37 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.498 -0.319 . . . . 0.0 110.716 -179.478 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' C' C ' 50' ' ' VAL . . . . . . . . . . . . . 44.3 t -82.29 105.64 12.36 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.262 0 N-CA-C 109.543 -0.54 . . . . 0.0 109.543 176.288 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' C' C ' 51' ' ' VAL . . . . . . . . . . . . . 46.4 t -71.0 -52.89 24.08 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.333 0 CA-C-N 115.926 -0.579 . . . . 0.0 109.75 -174.914 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' C' C ' 52' ' ' GLN . . . . . . . . . . . . . 81.9 mt-30 -154.57 149.92 27.19 Favored 'General case' 0 C--N 1.331 -0.198 0 C-N-CA 120.41 -0.516 . . . . 0.0 111.58 -177.418 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' C' C ' 53' ' ' ALA . . . . . . . . . . . . . . . -122.89 130.69 53.17 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 115.41 -0.813 . . . . 0.0 109.43 174.833 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' C' C ' 54' ' ' TYR . . . . . . . . . . . . . 67.9 t80 -129.0 107.41 18.08 Favored Pre-proline 0 CA--C 1.533 0.318 0 CA-C-O 118.215 -0.898 . . . . 0.0 110.493 -179.416 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' C' C ' 55' ' ' PRO . . . . . . . . . . . . . 73.1 Cg_endo -77.09 170.05 72.67 Favored 'Cis proline' 0 N--CA 1.5 1.907 0 CA-C-N 121.726 1.652 . . . . 0.0 112.583 -5.07 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' C' C ' 56' ' ' SER . . . . . . . . . . . . . 32.5 m -115.71 132.12 23.33 Favored Pre-proline 0 CA--C 1.538 0.516 0 CA-C-O 118.429 -0.796 . . . . 0.0 109.515 175.428 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' C' C ' 57' ' ' PRO . . . . . . . . . . . . . 33.5 Cg_endo -65.76 166.26 55.41 Favored 'Cis proline' 0 N--CA 1.498 1.785 0 CA-C-N 121.971 1.74 . . . . 0.0 111.378 -2.583 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' C' C ' 58' ' ' LEU . . . . . . . . . . . . . 19.4 tp -130.5 138.58 50.31 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-O 121.018 0.437 . . . . 0.0 110.662 -179.919 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' C' C ' 59' ' ' ARG . . . . . . . . . . . . . 78.6 ttt-85 -103.61 128.4 50.9 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 115.579 -0.737 . . . . 0.0 109.47 175.767 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' C' C ' 60' ' ' VAL . . . . . . . . . . . . . 43.2 t -78.86 112.93 17.48 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.344 0 CA-C-O 120.817 0.342 . . . . 0.0 110.378 -177.114 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' C' C ' 61' ' ' GLU . . . . . . . . . . . . . 72.9 tt0 -130.95 157.01 44.11 Favored 'General case' 0 C--N 1.329 -0.314 0 N-CA-C 109.359 -0.608 . . . . 0.0 109.359 177.936 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' C' C ' 62' ' ' ASP . . . . . . . . . . . . . 9.5 t0 -51.7 -30.79 23.51 Favored 'General case' 0 C--N 1.326 -0.414 0 N-CA-C 112.213 0.449 . . . . 0.0 112.213 -177.479 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' C' C ' 63' ' ' ARG . . . . . . . . . . . . . 73.8 mtp180 -72.66 -22.06 60.99 Favored 'General case' 0 CA--C 1.532 0.288 0 N-CA-C 112.966 0.728 . . . . 0.0 112.966 -175.38 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' C' C ' 64' ' ' THR . . . . . . . . . . . . . 32.3 m -73.69 140.58 46.14 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-O 120.895 0.379 . . . . 0.0 110.829 -176.226 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' C' C ' 65' ' ' LYS . . . . . . . . . . . . . 42.1 mtmt -89.22 127.79 35.78 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.099 -0.501 . . . . 0.0 110.12 177.868 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' C' C ' 66' ' ' ILE . . . . . . . . . . . . . 64.8 mt -109.48 125.73 66.62 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.32 0 N-CA-C 109.427 -0.583 . . . . 0.0 109.427 179.152 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' C' C ' 67' ' ' THR . . . . . . . . . . . . . 23.1 m -124.81 142.29 51.53 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-O 121.277 0.56 . . . . 0.0 111.358 -174.9 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' C' C ' 68' ' ' LEU . . . . . . . . . . . . . 43.8 mt -95.25 127.73 41.54 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 115.59 -0.732 . . . . 0.0 109.894 176.123 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' C' C ' 69' ' ' VAL . . . . . . . . . . . . . 43.1 t -97.73 135.86 30.68 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.412 0 CA-C-N 116.233 -0.44 . . . . 0.0 110.157 -178.973 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' C' C ' 70' ' ' THR . . . . . . . . . . . . . 41.4 p -131.09 30.05 4.6 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.263 -0.426 . . . . 0.0 111.752 -179.579 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' C' C ' 71' ' ' HIS . . . . . . . . . . . . . 59.7 m80 -116.42 147.87 40.54 Favored Pre-proline 0 CA--C 1.531 0.225 0 N-CA-C 109.595 -0.52 . . . . 0.0 109.595 176.574 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' C' C ' 72' ' ' PRO . . . . . . . . . . . . . 98.3 Cg_endo -86.32 -28.85 0.58 Allowed 'Trans proline' 0 N--CA 1.491 1.361 0 C-N-CA 121.589 1.526 . . . . 0.0 112.793 -177.164 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' C' C ' 73' ' ' VAL . . . . . . . . . . . . . 34.8 m -130.92 155.57 42.04 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.272 0 CA-C-O 120.717 0.294 . . . . 0.0 110.799 -178.341 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' C' C ' 74' ' ' ASP . . . . . . . . . . . . . 35.6 t0 -102.83 118.06 36.0 Favored 'General case' 0 C--N 1.331 -0.199 0 N-CA-C 109.455 -0.572 . . . . 0.0 109.455 177.835 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' C' C ' 75' ' ' VAL . . . . . . . . . . . . . 39.9 t -118.63 123.88 72.25 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.245 0 CA-C-O 121.141 0.496 . . . . 0.0 110.795 -176.634 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' C' C ' 76' ' ' LEU . . . . . . . . . . . . . 6.7 mp -117.62 150.39 39.11 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 115.503 -0.771 . . . . 0.0 109.613 176.184 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' C' C ' 77' ' ' GLU . . . . . . . . . . . . . 47.2 mt-10 -134.62 132.32 38.85 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-O 120.963 0.411 . . . . 0.0 111.019 179.916 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' C' C ' 78' ' ' ALA . . . . . . . . . . . . . . . -124.66 127.76 47.8 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 115.838 -0.619 . . . . 0.0 109.919 177.05 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' C' C ' 79' ' ' LYS . . . . . . . . . . . . . 14.4 ptpt -72.81 119.29 16.85 Favored 'General case' 0 C--N 1.331 -0.239 0 CA-C-O 121.239 0.543 . . . . 0.0 110.589 -178.772 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' C' C ' 80' ' ' ILE . . . . . . . . . . . . . 24.1 mm -139.44 105.59 2.43 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.285 0 N-CA-C 109.213 -0.662 . . . . 0.0 109.213 -177.781 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' C' C ' 81' ' ' LYS . . . . . . . . . . . . . 55.9 pttt -98.91 126.83 44.68 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-O 121.032 0.444 . . . . 0.0 111.26 -177.205 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' C' C ' 82' ' ' GLY . . . . . . . . . . . . . . . 89.16 42.03 5.69 Favored Glycine 0 CA--C 1.526 0.754 0 CA-C-N 115.838 -0.619 . . . . 0.0 111.834 175.05 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' C' C ' 83' ' ' ILE . . . . . . . . . . . . . 67.3 mt -71.99 139.35 19.88 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.391 0 N-CA-C 109.551 -0.537 . . . . 0.0 109.551 176.57 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' C' C ' 84' ' ' LYS . . . . . . . . . . . . . 20.2 ttpp -102.28 -50.21 3.68 Favored 'General case' 0 C--N 1.331 -0.215 0 CA-C-O 120.895 0.378 . . . . 0.0 110.317 -178.857 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' C' C ' 85' ' ' ASP . . . . . . . . . . . . . 11.1 t70 -150.95 150.0 30.29 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.034 -0.53 . . . . 0.0 110.641 -179.184 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' C' C ' 86' ' ' VAL . . . . . . . . . . . . . 44.7 t -132.93 131.12 59.06 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.275 0 CA-C-O 120.89 0.376 . . . . 0.0 110.3 179.779 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' C' C ' 87' ' ' ILE . . . . . . . . . . . . . 40.3 mm -119.5 127.08 75.86 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.233 0 N-CA-C 109.359 -0.608 . . . . 0.0 109.359 177.457 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' C' C ' 88' ' ' LEU . . . . . . . . . . . . . 20.4 tp -113.03 132.15 55.5 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-O 120.973 0.416 . . . . 0.0 111.119 -177.209 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' C' C ' 89' ' ' ASP . . . . . . . . . . . . . 8.6 t70 -125.1 156.5 38.19 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 115.77 -0.65 . . . . 0.0 109.587 176.272 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' C' C ' 90' ' ' GLU . . . . . . . . . . . . . 95.4 mt-10 -47.02 -39.28 12.34 Favored 'General case' 0 C--N 1.329 -0.301 0 N-CA-C 113.007 0.743 . . . . 0.0 113.007 -172.167 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' C' C ' 91' ' ' ASN . . . . . . . . . . . . . 3.7 t-20 -132.09 34.8 3.77 Favored 'General case' 0 N--CA 1.464 0.251 0 N-CA-C 111.832 0.308 . . . . 0.0 111.832 -175.862 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' C' C ' 92' ' ' LEU . . . . . . . . . . . . . 11.4 tp -166.09 146.03 6.27 Favored 'General case' 0 C--N 1.332 -0.187 0 C-N-CA 120.755 -0.378 . . . . 0.0 111.058 -179.335 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' C' C ' 93' ' ' ILE . . . . . . . . . . . . . 64.4 mt -125.3 123.42 65.05 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.18 0 N-CA-C 109.575 -0.528 . . . . 0.0 109.575 178.622 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' C' C ' 94' ' ' VAL . . . . . . . . . . . . . 47.0 t -122.64 125.02 71.92 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.218 0 N-CA-C 109.887 -0.412 . . . . 0.0 109.887 178.806 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' C' C ' 95' ' ' VAL . . . . . . . . . . . . . 44.3 t -121.61 135.8 60.6 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.273 0 CA-C-N 116.068 -0.515 . . . . 0.0 110.049 -178.38 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' C' C ' 96' ' ' ILE . . . . . . . . . . . . . 64.9 mt -117.87 127.31 75.17 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.307 0 N-CA-C 109.647 -0.501 . . . . 0.0 109.647 -179.949 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' C' C ' 97' ' ' THR . . . . . . . . . . . . . 81.2 p -98.94 156.41 16.91 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-O 121.021 0.439 . . . . 0.0 110.984 -178.965 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' C' C ' 98' ' ' GLU . . . . . . . . . . . . . 14.2 pt-20 -55.58 -22.18 20.83 Favored 'General case' 0 CA--C 1.534 0.343 0 N-CA-C 112.603 0.594 . . . . 0.0 112.603 -178.736 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' C' C ' 99' ' ' GLU . . . . . . . . . . . . . 51.0 mp0 -81.22 15.49 1.92 Allowed 'General case' 0 CA--C 1.535 0.399 0 N-CA-C 112.95 0.722 . . . . 0.0 112.95 -178.881 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' C' C ' 100' ' ' ASN . . . . . . . . . . . . . 22.3 m-20 59.66 37.37 22.42 Favored 'General case' 0 C--N 1.332 -0.153 0 CA-C-O 121.026 0.441 . . . . 0.0 111.159 -179.428 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' C' C ' 101' ' ' GLU . . . . . . . . . . . . . 84.4 tt0 -111.91 142.35 44.41 Favored 'General case' 0 C--N 1.333 -0.132 0 N-CA-C 109.575 -0.528 . . . . 0.0 109.575 173.198 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' C' C ' 102' ' ' VAL . . . . . . . . . . . . . 44.3 t -114.95 127.93 72.31 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.249 0 CA-C-N 116.27 -0.423 . . . . 0.0 109.998 -177.025 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' C' C ' 103' ' ' LEU . . . . . . . . . . . . . 39.8 mt -117.01 131.56 56.92 Favored 'General case' 0 C--N 1.331 -0.216 0 CA-C-N 115.604 -0.726 . . . . 0.0 110.224 177.087 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' C' C ' 104' ' ' ILE . . . . . . . . . . . . . 66.8 mt -118.44 122.9 70.66 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.255 0 CA-C-N 116.491 -0.322 . . . . 0.0 110.155 -179.865 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' C' C ' 105' ' ' PHE . . . . . . . . . . . . . 89.7 m-85 -124.85 162.66 23.88 Favored 'General case' 0 N--CA 1.462 0.135 0 O-C-N 123.983 0.802 . . . . 0.0 110.3 -178.3 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' C' C ' 106' ' ' ASN . . . . . . . . . . . . . 41.3 p-10 -100.27 -169.95 1.8 Allowed 'General case' 0 C--N 1.331 -0.21 0 CA-C-N 116.309 -0.405 . . . . 0.0 109.934 174.018 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' C' C ' 107' ' ' GLN . . . . . . . . . . . . . 32.3 tt0 -58.49 -30.01 66.68 Favored 'General case' 0 CA--C 1.532 0.252 0 N-CA-C 111.998 0.37 . . . . 0.0 111.998 179.553 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' C' C ' 108' ' ' ASN . . . . . . . . . . . . . 10.7 t-20 -84.24 9.62 12.46 Favored 'General case' 0 CA--C 1.536 0.407 0 N-CA-C 113.114 0.783 . . . . 0.0 113.114 -176.787 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' C' C ' 109' ' ' LEU . . . . . . . . . . . . . 11.1 tp 56.13 35.85 26.39 Favored 'General case' 0 CA--C 1.531 0.225 0 CA-C-O 120.898 0.38 . . . . 0.0 111.266 -179.97 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' C' C ' 110' ' ' GLU . . . . . . . . . . . . . 42.8 mt-10 -103.17 147.62 26.79 Favored 'General case' 0 C--N 1.331 -0.22 0 N-CA-C 109.522 -0.547 . . . . 0.0 109.522 175.613 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' C' C ' 111' ' ' GLU . . . . . . . . . . . . . 50.9 tt0 -79.68 121.9 25.88 Favored 'General case' 0 C--N 1.327 -0.396 0 CA-C-O 120.822 0.344 . . . . 0.0 110.877 -175.838 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' C' C ' 112' ' ' LEU . . . . . . . . . . . . . 22.9 mt -106.03 -45.89 4.23 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-N 116.029 -0.532 . . . . 0.0 110.42 178.805 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' C' C ' 113' ' ' TYR . . . . . . . . . . . . . 53.4 t80 -136.26 138.79 42.17 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-O 120.905 0.383 . . . . 0.0 111.294 -178.849 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' C' C ' 114' ' ' ARG . . . . . . . . . . . . . 58.8 ttp180 -137.08 121.62 18.37 Favored 'General case' 0 C--N 1.331 -0.197 0 CA-C-N 115.775 -0.648 . . . . 0.0 110.221 178.164 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' C' C ' 115' ' ' GLY . . . . . . . . . . . . . . . -150.0 151.13 23.25 Favored Glycine 0 CA--C 1.523 0.584 0 N-CA-C 111.094 -0.802 . . . . 0.0 111.094 178.033 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' C' C ' 116' ' ' LYS . . . . . . . . . . . . . 72.6 tttt -130.01 133.19 46.6 Favored 'General case' 0 C--N 1.33 -0.261 0 N-CA-C 109.793 -0.447 . . . . 0.0 109.793 178.013 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' C' C ' 117' ' ' PHE . . . . . . . . . . . . . 23.1 m-85 -133.5 113.94 13.04 Favored 'General case' 0 C--N 1.331 -0.226 0 CA-C-O 120.884 0.373 . . . . 0.0 110.339 -174.136 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' C' C ' 118' ' ' GLU . . . . . . . . . . . . . 95.7 mt-10 -54.15 -50.43 66.98 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.396 -0.365 . . . . 0.0 111.179 -177.736 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' C' C ' 119' ' ' ASN . . . . . . . . . . . . . 35.6 m120 -89.67 29.64 1.13 Allowed 'General case' 0 C--N 1.33 -0.278 0 N-CA-C 112.261 0.467 . . . . 0.0 112.261 -174.922 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' C' C ' 120' ' ' LEU . . . . . . . . . . . . . 30.6 tp -57.95 121.22 10.05 Favored 'General case' 0 C--N 1.332 -0.162 0 N-CA-C 110.161 -0.311 . . . . 0.0 110.161 177.313 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' C' C ' 121' ' ' ASN . . . . . . . . . . . . . 32.1 m120 -114.11 -43.41 3.24 Favored 'General case' 0 C--N 1.331 -0.209 0 CA-C-N 116.326 -0.397 . . . . 0.0 111.017 -177.155 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' C' C ' 122' ' ' LYS . . . . . . . . . . . . . 67.9 mttm -138.68 144.34 39.57 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-O 121.152 0.501 . . . . 0.0 111.614 -175.909 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' C' C ' 123' ' ' VAL . . . . . . . . . . . . . 45.7 t -124.55 126.23 71.41 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.21 0 CA-C-N 115.715 -0.675 . . . . 0.0 109.448 176.146 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' C' C ' 124' ' ' LEU . . . . . . . . . . . . . 27.3 mt -123.18 131.0 53.52 Favored 'General case' 0 C--N 1.332 -0.166 0 CA-C-O 120.642 0.258 . . . . 0.0 110.683 -178.212 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' C' C ' 125' ' ' VAL . . . . . . . . . . . . . 35.1 m -136.31 134.41 49.84 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.288 0 CA-C-N 116.321 -0.4 . . . . 0.0 110.752 179.896 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' C' C ' 126' ' ' ARG . . . . . . . . . . . . . 95.7 mtt-85 -146.28 118.17 8.19 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.325 -0.398 . . . . 0.0 110.671 178.053 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' C' C ' 127' ' ' ASN . . . . . . . . . . . . . 34.8 m120 49.84 -104.97 0.16 Allowed 'General case' 0 CA--C 1.544 0.718 0 CA-C-O 119.202 -0.428 . . . . 0.0 111.78 177.599 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' C' C ' 128' ' ' ASP . . . . . . . . . . . . . 13.0 p-10 -114.23 13.5 17.94 Favored 'General case' 0 N--CA 1.467 0.408 0 CA-C-N 119.406 1.003 . . . . 0.0 113.263 -175.112 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' C' C ' 129' ' ' LEU . . . . . . . . . . . . . 24.4 tp -118.32 136.83 53.48 Favored 'General case' 0 C--N 1.332 -0.161 0 O-C-N 122.029 -0.42 . . . . 0.0 110.046 177.592 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' C' C ' 130' ' ' VAL . . . . . . . . . . . . . 42.4 t -125.09 136.56 60.47 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.196 0 CA-C-O 120.926 0.393 . . . . 0.0 110.025 -179.347 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' C' C ' 131' ' ' VAL . . . . . . . . . . . . . 41.8 t -136.02 135.26 50.46 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.291 0 CA-C-O 121.131 0.491 . . . . 0.0 110.167 178.022 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' C' C ' 132' ' ' ILE . . . . . . . . . . . . . 73.1 mt -117.08 129.85 72.95 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.323 0 CA-C-N 115.717 -0.674 . . . . 0.0 109.388 -179.295 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' C' C ' 133' ' ' ILE . . . . . . . . . . . . . 37.6 mm -115.46 120.3 64.31 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.301 0 CA-C-O 120.608 0.242 . . . . 0.0 111.047 -174.494 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' C' C ' 134' ' ' ASP . . . . . . . . . . . . . 7.5 p-10 -130.42 149.87 51.9 Favored 'General case' 0 C--N 1.333 -0.138 0 N-CA-C 109.944 -0.391 . . . . 0.0 109.944 174.655 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' C' C ' 135' ' ' GLU . . . . . . . . . . . . . 58.0 tt0 -49.92 -25.93 3.69 Favored 'General case' 0 C--N 1.327 -0.375 0 N-CA-C 113.088 0.773 . . . . 0.0 113.088 -170.889 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' C' C ' 136' ' ' GLN . . . . . . . . . . . . . 30.1 tt0 -95.38 -26.87 15.71 Favored 'General case' 0 CA--C 1.531 0.221 0 N-CA-C 112.765 0.654 . . . . 0.0 112.765 -172.472 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' C' C ' 137' ' ' LYS . . . . . . . . . . . . . 58.3 pttt -163.86 167.46 20.72 Favored 'General case' 0 C--O 1.233 0.193 0 CA-C-O 121.576 0.703 . . . . 0.0 112.162 -175.114 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' C' C ' 138' ' ' LEU . . . . . . . . . . . . . 6.3 tt -117.12 128.43 55.12 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 115.029 -0.987 . . . . 0.0 109.928 179.712 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' C' C ' 139' ' ' THR . . . . . . . . . . . . . 27.7 m -108.24 124.83 50.9 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.156 -0.474 . . . . 0.0 110.402 179.236 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' C' C ' 140' ' ' LEU . . . . . . . . . . . . . 10.5 tp -111.21 120.47 42.38 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 115.853 -0.612 . . . . 0.0 109.355 -178.977 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' C' C ' 141' ' ' ILE . . . . . . . . . . . . . 18.9 mt -123.21 118.28 54.18 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.269 0 CA-C-O 121.118 0.485 . . . . 0.0 110.081 -174.862 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' C' C ' 142' ' ' ARG . . . . . . . . . . . . . 72.1 mtp180 -94.55 107.74 19.71 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 115.435 -0.802 . . . . 0.0 110.176 176.736 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' C' C ' 143' ' ' THR . . . . . . . . . . . . . 13.6 p . . . . . 0 C--O 1.22 -0.457 0 CA-C-O 117.967 -1.016 . . . . 0.0 110.507 -179.866 . . . . . . . . 0 0 . 1 . 016 nuclear orig full ' D' D ' -3' ' ' GLU . . . . . . . . . . . . . 95.8 mt-10 . . . . . 0 N--CA 1.488 1.473 0 N-CA-C 109.489 -0.56 . . . . 0.0 109.489 . . . . . . . . . 0 0 . 1 . 016 nuclear orig full ' D' D ' -2' ' ' GLY . . . . . . . . . . . . . . . -68.93 146.17 44.42 Favored Glycine 0 CA--C 1.526 0.722 0 N-CA-C 111.111 -0.796 . . . . 0.0 111.111 -179.558 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' D' D ' -1' ' ' VAL . . . . . . . . . . . . . 42.8 t -96.62 137.76 23.59 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.33 0 CA-C-O 120.8 0.333 . . . . 0.0 110.288 -179.937 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' D' D ' 0' ' ' ILE . . . . . . . . . . . . . 69.0 mt -113.01 132.63 61.28 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.24 0 CA-C-N 116.185 -0.461 . . . . 0.0 109.863 178.617 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' D' D ' 1' ' ' MET . . . . . . . . . . . . . 25.1 ptp -94.65 146.71 23.95 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.269 -0.423 . . . . 0.0 110.692 -179.546 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' D' D ' 2' ' ' SER . . . . . . . . . . . . . 3.9 p -118.16 129.96 55.83 Favored 'General case' 0 C--N 1.331 -0.216 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.613 179.076 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' D' D ' 3' ' ' GLU . . . . . . . . . . . . . 80.7 tt0 -146.6 142.93 28.45 Favored 'General case' 0 C--N 1.327 -0.396 0 CA-C-N 115.987 -0.551 . . . . 0.0 111.019 -178.658 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' D' D ' 4' ' ' LEU . . . . . . . . . . . . . 17.2 tp -124.3 132.27 53.56 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.01 -0.541 . . . . 0.0 110.056 177.171 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' D' D ' 5' ' ' LYS . . . . . . . . . . . . . 66.4 mttm -111.13 121.76 46.14 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 116.331 -0.395 . . . . 0.0 110.513 -179.176 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' D' D ' 6' ' ' LEU . . . . . . . . . . . . . 71.1 mt -117.2 151.43 36.9 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 115.668 -0.696 . . . . 0.0 110.94 -177.384 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' D' D ' 7' ' ' LYS . . . . . . . . . . . . . 74.9 tttt -142.5 141.72 21.47 Favored Pre-proline 0 CA--C 1.532 0.278 0 CA-C-N 116.18 -0.464 . . . . 0.0 109.952 174.005 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' D' D ' 8' ' ' PRO . . . . . . . . . . . . . 84.1 Cg_endo -90.76 144.8 3.7 Favored 'Trans proline' 0 N--CA 1.491 1.325 0 C-N-CA 121.74 1.627 . . . . 0.0 112.081 179.039 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' D' D ' 9' ' ' LEU . . . . . . . . . . . . . 40.9 mt -81.07 -47.18 1.14 Allowed Pre-proline 0 CA--C 1.533 0.292 0 CA-C-O 118.71 -0.662 . . . . 0.0 112.048 179.784 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' D' D ' 10' ' ' PRO . . . . . . . . . . . . . 88.1 Cg_endo -81.34 154.3 18.68 Favored 'Trans proline' 0 N--CA 1.497 1.711 0 C-N-CA 121.149 1.233 . . . . 0.0 111.643 175.223 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' D' D ' 11' ' ' LYS . . . . . . . . . . . . . 61.6 tttm -88.71 100.41 13.1 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.473 -0.331 . . . . 0.0 110.513 179.392 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' D' D ' 12' ' ' VAL . . . . . . . . . . . . . 12.3 p -144.92 146.44 19.98 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.233 0 CA-C-N 116.22 -0.446 . . . . 0.0 110.679 -179.516 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' D' D ' 13' ' ' GLU . . . . . . . . . . . . . 95.1 mt-10 -82.57 130.56 35.14 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 116.28 -0.418 . . . . 0.0 109.97 176.782 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' D' D ' 14' ' ' LEU . . . . . . . . . . . . . 16.8 mt -97.52 146.93 32.25 Favored Pre-proline 0 CA--C 1.533 0.303 0 CA-C-O 119.223 -0.418 . . . . 0.0 110.238 -178.476 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' D' D ' 15' ' ' PRO . . . . . . . . . . . . . 30.5 Cg_exo -60.43 159.36 27.68 Favored 'Trans proline' 0 N--CA 1.497 1.721 0 C-N-CA 121.328 1.352 . . . . 0.0 111.783 177.176 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' D' D ' 16' ' ' PRO . . . . . . . . . . . . . 39.4 Cg_exo -58.4 -41.04 69.67 Favored 'Trans proline' 0 N--CA 1.497 1.683 0 C-N-CA 121.472 1.448 . . . . 0.0 112.676 -178.261 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' D' D ' 17' ' ' ASP . . . . . . . . . . . . . 12.6 p-10 -87.82 13.01 11.55 Favored 'General case' 0 CA--C 1.535 0.404 0 N-CA-C 113.086 0.772 . . . . 0.0 113.086 -178.084 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' D' D ' 18' ' ' PHE . . . . . . . . . . . . . 46.6 t80 -58.26 -45.01 88.61 Favored 'General case' 0 C--N 1.334 -0.079 0 CA-C-O 120.935 0.398 . . . . 0.0 110.078 -178.542 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' D' D ' 19' ' ' VAL . . . . . . . . . . . . . 47.7 t -56.87 -41.2 75.64 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.249 0 CA-C-N 116.142 -0.481 . . . . 0.0 110.438 -178.805 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' D' D ' 20' ' ' ASP . . . . . . . . . . . . . 71.1 m-20 -60.39 -44.0 96.1 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-O 120.811 0.339 . . . . 0.0 111.071 -178.074 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' D' D ' 21' ' ' VAL . . . . . . . . . . . . . 46.1 t -64.22 -48.6 84.89 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 CA-C-N 116.353 -0.385 . . . . 0.0 110.484 -177.844 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' D' D ' 22' ' ' ILE . . . . . . . . . . . . . 50.6 mm -55.09 -47.92 76.62 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.241 0 CA-C-O 120.687 0.279 . . . . 0.0 110.829 179.356 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' D' D ' 23' ' ' ARG . . . . . . . . . . . . . 3.7 tmm_? -53.5 -53.38 52.33 Favored 'General case' 0 C--N 1.329 -0.313 0 N-CA-C 111.605 0.224 . . . . 0.0 111.605 -177.719 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' D' D ' 24' ' ' ILE . . . . . . . . . . . . . 72.2 mt -60.31 -41.86 88.64 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.28 0 N-CA-C 111.659 0.244 . . . . 0.0 111.659 -175.711 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' D' D ' 25' ' ' LYS . . . . . . . . . . . . . 53.0 mttm -67.79 -36.95 81.37 Favored 'General case' 0 C--N 1.328 -0.334 0 N-CA-C 112.147 0.425 . . . . 0.0 112.147 -177.707 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' D' D ' 26' ' ' LEU . . . . . . . . . . . . . 26.5 mt -79.46 -41.94 26.41 Favored 'General case' 0 C--N 1.33 -0.275 0 N-CA-C 112.798 0.666 . . . . 0.0 112.798 -173.617 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' D' D ' 27' ' ' GLN . . . . . . . . . . . . . 8.9 pt20 -46.0 138.57 4.99 Favored 'General case' 0 N--CA 1.47 0.554 0 N-CA-C 112.686 0.625 . . . . 0.0 112.686 -175.669 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' D' D ' 28' ' ' GLY . . . . . . . . . . . . . . . 100.79 -27.86 18.59 Favored Glycine 0 CA--C 1.53 1.02 0 CA-C-N 115.334 -0.848 . . . . 0.0 112.073 -176.086 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' D' D ' 29' ' ' LYS . . . . . . . . . . . . . 94.4 mttt -97.91 155.14 17.22 Favored 'General case' 0 C--O 1.232 0.164 0 CA-C-N 117.186 0.493 . . . . 0.0 111.01 178.796 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' D' D ' 30' ' ' THR . . . . . . . . . . . . . 25.2 m -103.96 139.39 39.18 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.167 -0.47 . . . . 0.0 110.33 176.935 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' D' D ' 31' ' ' VAL . . . . . . . . . . . . . 35.1 m -128.76 151.05 35.0 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.278 0 CA-C-O 121.047 0.451 . . . . 0.0 110.91 -178.922 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' D' D ' 32' ' ' ARG . . . . . . . . . . . . . 26.3 ttm180 -129.05 146.25 51.06 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 115.971 -0.559 . . . . 0.0 110.212 178.895 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' D' D ' 33' ' ' THR . . . . . . . . . . . . . 16.9 m -52.5 139.07 26.2 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.455 -0.339 . . . . 0.0 111.488 -177.301 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' D' D ' 34' ' ' GLY . . . . . . . . . . . . . . . 101.1 -17.21 56.38 Favored Glycine 0 CA--C 1.532 1.151 0 CA-C-O 119.702 -0.499 . . . . 0.0 113.242 179.962 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' D' D ' 35' ' ' ASP . . . . . . . . . . . . . 74.3 m-20 -66.08 149.65 49.94 Favored 'General case' 0 N--CA 1.461 0.095 0 CA-C-N 118.033 0.916 . . . . 0.0 111.15 179.176 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' D' D ' 36' ' ' VAL . . . . . . . . . . . . . 45.9 t -122.12 130.74 74.31 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.193 0 CA-C-N 115.838 -0.619 . . . . 0.0 109.776 177.947 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' D' D ' 37' ' ' ILE . . . . . . . . . . . . . 71.9 mt -121.13 140.13 46.2 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.218 0 CA-C-N 116.299 -0.409 . . . . 0.0 109.994 -179.149 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' D' D ' 38' ' ' GLY . . . . . . . . . . . . . . . -114.26 128.91 8.44 Favored Glycine 0 CA--C 1.526 0.767 0 N-CA-C 111.297 -0.721 . . . . 0.0 111.297 -178.685 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' D' D ' 39' ' ' ILE . . . . . . . . . . . . . 72.2 mt -123.51 135.63 62.69 Favored 'Isoleucine or valine' 0 C--N 1.333 -0.135 0 N-CA-C 109.963 -0.384 . . . . 0.0 109.963 178.268 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' D' D ' 40' ' ' SER . . . . . . . . . . . . . 23.1 t -92.71 123.12 35.76 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-N 116.521 -0.309 . . . . 0.0 111.018 176.786 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' D' D ' 41' ' ' ILE . . . . . . . . . . . . . 73.2 mt -132.21 112.9 20.49 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.167 0 CA-C-O 120.844 0.355 . . . . 0.0 110.315 177.511 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' D' D ' 42' ' ' LEU . . . . . . . . . . . . . 1.4 tt 54.5 47.35 22.97 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-O 121.53 0.681 . . . . 0.0 110.647 178.237 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' D' D ' 43' ' ' GLY . . . . . . . . . . . . . . . 75.23 -10.1 11.51 Favored Glycine 0 CA--C 1.535 1.289 0 CA-C-O 119.692 -0.504 . . . . 0.0 113.796 175.274 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' D' D ' 44' ' ' LYS . . . . . . . . . . . . . 35.8 mmtm -99.79 132.65 45.01 Favored 'General case' 0 C--N 1.332 -0.165 0 CA-C-N 118.066 0.933 . . . . 0.0 110.378 -179.981 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' D' D ' 45' ' ' GLU . . . . . . . . . . . . . 80.3 tt0 -84.45 122.83 29.52 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.22 -0.446 . . . . 0.0 110.806 178.635 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' D' D ' 46' ' ' VAL . . . . . . . . . . . . . 7.7 p -117.19 124.27 72.81 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.199 0 N-CA-C 109.542 -0.54 . . . . 0.0 109.542 176.09 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' D' D ' 47' ' ' LYS . . . . . . . . . . . . . 57.7 mtmt -99.94 129.58 46.03 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 115.812 -0.631 . . . . 0.0 111.18 179.515 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' D' D ' 48' ' ' PHE . . . . . . . . . . . . . 91.3 m-85 -112.34 132.36 55.03 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-N 116.166 -0.47 . . . . 0.0 109.982 177.277 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' D' D ' 49' ' ' LYS . . . . . . . . . . . . . 76.1 tttt -105.84 135.54 47.09 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.348 -0.387 . . . . 0.0 110.41 179.581 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' D' D ' 50' ' ' VAL . . . . . . . . . . . . . 44.1 t -79.47 107.2 11.64 Favored 'Isoleucine or valine' 0 C--O 1.232 0.177 0 N-CA-C 109.324 -0.621 . . . . 0.0 109.324 175.717 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' D' D ' 51' ' ' VAL . . . . . . . . . . . . . 48.2 t -71.21 -51.69 32.54 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.344 0 CA-C-N 115.998 -0.547 . . . . 0.0 109.787 -174.376 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' D' D ' 52' ' ' GLN . . . . . . . . . . . . . 45.1 mt-30 -155.53 150.73 26.83 Favored 'General case' 0 C--N 1.331 -0.221 0 CA-C-O 121.18 0.514 . . . . 0.0 111.74 -177.467 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' D' D ' 53' ' ' ALA . . . . . . . . . . . . . . . -125.19 127.27 46.53 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 115.216 -0.902 . . . . 0.0 109.604 175.907 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' D' D ' 54' ' ' TYR . . . . . . . . . . . . . 62.6 t80 -126.37 107.32 24.02 Favored Pre-proline 0 CA--C 1.535 0.392 0 CA-C-O 118.321 -0.847 . . . . 0.0 110.689 -178.242 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' D' D ' 55' ' ' PRO . . . . . . . . . . . . . 74.1 Cg_endo -77.12 170.02 72.71 Favored 'Cis proline' 0 N--CA 1.499 1.836 0 CA-C-N 121.697 1.642 . . . . 0.0 112.355 -6.022 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' D' D ' 56' ' ' SER . . . . . . . . . . . . . 14.5 m -110.59 128.69 24.93 Favored Pre-proline 0 CA--C 1.539 0.526 0 CA-C-O 118.407 -0.806 . . . . 0.0 109.384 175.739 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' D' D ' 57' ' ' PRO . . . . . . . . . . . . . 61.2 Cg_endo -74.84 149.09 93.3 Favored 'Cis proline' 0 N--CA 1.496 1.639 0 CA-C-N 121.96 1.736 . . . . 0.0 111.716 -0.714 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' D' D ' 58' ' ' LEU . . . . . . . . . . . . . 27.9 tp -108.19 137.52 46.02 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.227 -0.442 . . . . 0.0 110.454 -179.04 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' D' D ' 59' ' ' ARG . . . . . . . . . . . . . 25.5 ttm180 -103.82 126.59 51.06 Favored 'General case' 0 C--N 1.327 -0.383 0 N-CA-C 109.394 -0.595 . . . . 0.0 109.394 176.029 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' D' D ' 60' ' ' VAL . . . . . . . . . . . . . 45.6 t -78.8 116.63 22.96 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.231 0 C-N-CA 120.684 -0.407 . . . . 0.0 110.409 -174.833 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' D' D ' 61' ' ' GLU . . . . . . . . . . . . . 94.7 mt-10 -131.06 163.1 28.36 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 116.0 -0.545 . . . . 0.0 109.849 177.795 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' D' D ' 62' ' ' ASP . . . . . . . . . . . . . 14.2 t0 -52.81 -32.99 47.06 Favored 'General case' 0 C--N 1.329 -0.296 0 N-CA-C 111.864 0.32 . . . . 0.0 111.864 -178.67 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' D' D ' 63' ' ' ARG . . . . . . . . . . . . . 77.2 mtt85 -73.64 -21.97 60.13 Favored 'General case' 0 C--N 1.33 -0.258 0 N-CA-C 113.076 0.769 . . . . 0.0 113.076 -176.061 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' D' D ' 64' ' ' THR . . . . . . . . . . . . . 31.4 m -66.14 138.39 57.69 Favored 'General case' 0 C--N 1.331 -0.211 0 CA-C-O 120.955 0.407 . . . . 0.0 111.14 -175.14 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' D' D ' 65' ' ' LYS . . . . . . . . . . . . . 93.2 mttt -89.01 136.62 32.92 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 115.763 -0.653 . . . . 0.0 109.827 176.969 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' D' D ' 66' ' ' ILE . . . . . . . . . . . . . 58.1 mt -115.8 127.21 73.46 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.294 0 N-CA-C 109.852 -0.425 . . . . 0.0 109.852 -179.181 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' D' D ' 67' ' ' THR . . . . . . . . . . . . . 26.5 m -126.45 147.57 49.78 Favored 'General case' 0 N--CA 1.463 0.215 0 CA-C-O 121.148 0.499 . . . . 0.0 111.362 -175.928 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' D' D ' 68' ' ' LEU . . . . . . . . . . . . . 8.9 mp -102.43 137.83 40.15 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 115.869 -0.605 . . . . 0.0 110.454 177.389 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' D' D ' 69' ' ' VAL . . . . . . . . . . . . . 44.5 t -83.08 136.0 23.69 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 CA-C-N 116.409 -0.359 . . . . 0.0 110.364 179.414 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' D' D ' 70' ' ' THR . . . . . . . . . . . . . 10.4 t -107.69 -170.36 1.68 Allowed 'General case' 0 C--N 1.331 -0.233 0 CA-C-N 116.051 -0.522 . . . . 0.0 110.686 -178.444 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' D' D ' 71' ' ' HIS . . . . . . . . . . . . . 22.1 m-70 -64.96 168.34 7.51 Favored Pre-proline 0 CA--C 1.53 0.209 0 CA-C-N 116.364 -0.38 . . . . 0.0 110.333 179.396 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' D' D ' 72' ' ' PRO . . . . . . . . . . . . . 18.6 Cg_exo -64.75 -30.18 59.34 Favored 'Trans proline' 0 N--CA 1.496 1.676 0 C-N-CA 121.23 1.287 . . . . 0.0 112.201 -179.152 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' D' D ' 73' ' ' VAL . . . . . . . . . . . . . 3.5 m -153.77 100.7 0.15 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 CA-C-O 121.138 0.494 . . . . 0.0 110.992 175.1 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' D' D ' 74' ' ' ASP . . . . . . . . . . . . . 6.0 t70 -93.1 118.77 31.59 Favored 'General case' 0 C--N 1.327 -0.409 0 N-CA-C 108.691 -0.855 . . . . 0.0 108.691 173.136 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' D' D ' 75' ' ' VAL . . . . . . . . . . . . . 36.6 t -111.44 126.8 68.86 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.313 0 CA-C-O 121.241 0.543 . . . . 0.0 111.312 -171.754 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' D' D ' 76' ' ' LEU . . . . . . . . . . . . . 5.9 mp -125.97 145.53 50.25 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 115.363 -0.835 . . . . 0.0 109.531 174.672 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' D' D ' 77' ' ' GLU . . . . . . . . . . . . . 97.7 mt-10 -135.26 137.81 42.91 Favored 'General case' 0 N--CA 1.463 0.202 0 CA-C-O 120.982 0.42 . . . . 0.0 111.183 -179.468 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' D' D ' 78' ' ' ALA . . . . . . . . . . . . . . . -131.41 142.12 49.97 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 115.885 -0.598 . . . . 0.0 110.199 177.492 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' D' D ' 79' ' ' LYS . . . . . . . . . . . . . 71.2 mmtt -82.05 122.2 27.52 Favored 'General case' 0 C--N 1.331 -0.239 0 CA-C-O 121.058 0.456 . . . . 0.0 111.276 -178.031 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' D' D ' 80' ' ' ILE . . . . . . . . . . . . . 41.6 mm -139.17 118.94 13.97 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.304 0 N-CA-C 108.926 -0.768 . . . . 0.0 108.926 179.889 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' D' D ' 81' ' ' LYS . . . . . . . . . . . . . 47.5 pttt -112.28 125.56 54.29 Favored 'General case' 0 N--CA 1.464 0.269 0 CA-C-O 121.051 0.453 . . . . 0.0 111.381 -177.051 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' D' D ' 82' ' ' GLY . . . . . . . . . . . . . . . 88.52 42.22 5.86 Favored Glycine 0 CA--C 1.525 0.677 0 C-N-CA 120.825 -0.702 . . . . 0.0 111.689 173.659 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' D' D ' 83' ' ' ILE . . . . . . . . . . . . . 70.1 mt -63.55 138.64 22.63 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.33 0 CA-C-O 121.017 0.437 . . . . 0.0 110.206 179.343 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' D' D ' 84' ' ' LYS . . . . . . . . . . . . . 83.7 tttt -96.96 -50.3 4.68 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 115.792 -0.64 . . . . 0.0 109.718 179.306 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' D' D ' 85' ' ' ASP . . . . . . . . . . . . . 9.8 t70 -158.63 152.52 23.57 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 115.636 -0.711 . . . . 0.0 110.182 179.214 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' D' D ' 86' ' ' VAL . . . . . . . . . . . . . 43.4 t -130.48 130.13 64.93 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.297 0 CA-C-O 120.863 0.364 . . . . 0.0 110.429 -178.991 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' D' D ' 87' ' ' ILE . . . . . . . . . . . . . 5.0 mp -119.6 126.13 75.02 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.261 0 N-CA-C 109.43 -0.582 . . . . 0.0 109.43 176.696 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' D' D ' 88' ' ' LEU . . . . . . . . . . . . . 12.9 tp -113.45 126.19 55.06 Favored 'General case' 0 C--N 1.331 -0.23 0 CA-C-O 120.987 0.422 . . . . 0.0 111.29 -176.636 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' D' D ' 89' ' ' ASP . . . . . . . . . . . . . 9.3 t0 -118.52 151.42 37.88 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 115.871 -0.604 . . . . 0.0 109.524 175.77 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' D' D ' 90' ' ' GLU . . . . . . . . . . . . . 95.4 mt-10 -48.63 -36.85 16.72 Favored 'General case' 0 C--N 1.33 -0.263 0 N-CA-C 112.782 0.66 . . . . 0.0 112.782 -173.054 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' D' D ' 91' ' ' ASN . . . . . . . . . . . . . 36.2 m120 -130.95 31.58 4.45 Favored 'General case' 0 N--CA 1.465 0.307 0 N-CA-C 112.022 0.378 . . . . 0.0 112.022 -176.711 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' D' D ' 92' ' ' LEU . . . . . . . . . . . . . 13.1 tp -166.14 139.38 4.12 Favored 'General case' 0 C--N 1.33 -0.274 0 N-CA-C 110.06 -0.348 . . . . 0.0 110.06 -179.818 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' D' D ' 93' ' ' ILE . . . . . . . . . . . . . 66.2 mt -125.01 124.15 67.02 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.255 0 N-CA-C 109.698 -0.482 . . . . 0.0 109.698 -178.435 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' D' D ' 94' ' ' VAL . . . . . . . . . . . . . 43.0 t -125.72 127.15 71.2 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.256 0 CA-C-O 121.023 0.44 . . . . 0.0 110.169 -179.367 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' D' D ' 95' ' ' VAL . . . . . . . . . . . . . 43.7 t -122.17 135.4 62.39 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.262 0 CA-C-N 115.893 -0.594 . . . . 0.0 109.856 179.845 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' D' D ' 96' ' ' ILE . . . . . . . . . . . . . 58.5 mt -115.43 129.29 71.95 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.323 0 N-CA-C 109.24 -0.652 . . . . 0.0 109.24 179.631 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' D' D ' 97' ' ' THR . . . . . . . . . . . . . 69.7 p -103.92 157.71 16.91 Favored 'General case' 0 C--N 1.331 -0.211 0 CA-C-O 121.381 0.61 . . . . 0.0 111.631 -176.522 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' D' D ' 98' ' ' GLU . . . . . . . . . . . . . 44.6 tp10 -53.77 -29.05 38.31 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 115.832 -0.622 . . . . 0.0 112.16 -178.871 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' D' D ' 99' ' ' GLU . . . . . . . . . . . . . 12.9 pt-20 -80.1 18.07 0.91 Allowed 'General case' 0 CA--C 1.534 0.359 0 N-CA-C 113.12 0.785 . . . . 0.0 113.12 -176.419 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' D' D ' 100' ' ' ASN . . . . . . . . . . . . . 4.6 m-20 62.91 38.13 11.53 Favored 'General case' 0 CA--C 1.529 0.151 0 CA-C-O 121.039 0.447 . . . . 0.0 110.897 177.773 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' D' D ' 101' ' ' GLU . . . . . . . . . . . . . 82.8 tt0 -114.71 142.07 46.99 Favored 'General case' 0 C--N 1.332 -0.173 0 CA-C-N 116.111 -0.495 . . . . 0.0 109.743 176.707 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' D' D ' 102' ' ' VAL . . . . . . . . . . . . . 44.8 t -115.84 125.97 73.18 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.312 0 N-CA-C 109.754 -0.462 . . . . 0.0 109.754 -179.49 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' D' D ' 103' ' ' LEU . . . . . . . . . . . . . 47.7 mt -117.15 130.31 56.53 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 115.746 -0.661 . . . . 0.0 110.295 177.777 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' D' D ' 104' ' ' ILE . . . . . . . . . . . . . 68.9 mt -120.06 121.35 65.64 Favored 'Isoleucine or valine' 0 C--O 1.235 0.316 0 N-CA-C 110.095 -0.335 . . . . 0.0 110.095 -179.139 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' D' D ' 105' ' ' PHE . . . . . . . . . . . . . 62.5 m-85 -122.69 162.65 21.57 Favored 'General case' 0 C--N 1.332 -0.159 0 O-C-N 123.924 0.765 . . . . 0.0 110.099 -178.902 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' D' D ' 106' ' ' ASN . . . . . . . . . . . . . 43.5 p30 -96.03 -171.63 2.37 Favored 'General case' 0 C--N 1.328 -0.348 0 N-CA-C 109.368 -0.604 . . . . 0.0 109.368 172.174 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' D' D ' 107' ' ' GLN . . . . . . . . . . . . . 45.8 tt0 -60.97 -29.9 69.94 Favored 'General case' 0 C--N 1.329 -0.325 0 N-CA-C 112.027 0.38 . . . . 0.0 112.027 -178.634 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' D' D ' 108' ' ' ASN . . . . . . . . . . . . . 6.7 t-20 -82.58 8.59 11.42 Favored 'General case' 0 CA--C 1.537 0.463 0 N-CA-C 113.15 0.796 . . . . 0.0 113.15 -178.069 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' D' D ' 109' ' ' LEU . . . . . . . . . . . . . 11.7 tp 61.67 37.92 15.61 Favored 'General case' 0 CA--C 1.53 0.182 0 CA-C-O 121.089 0.471 . . . . 0.0 111.324 178.122 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' D' D ' 110' ' ' GLU . . . . . . . . . . . . . 70.7 mm-40 -105.72 154.5 20.38 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.272 -0.422 . . . . 0.0 110.058 175.98 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' D' D ' 111' ' ' GLU . . . . . . . . . . . . . 44.4 mt-10 -83.61 122.19 28.25 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-O 120.852 0.358 . . . . 0.0 111.336 -177.88 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' D' D ' 112' ' ' LEU . . . . . . . . . . . . . 95.0 mt -106.25 -45.92 4.18 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.054 -0.521 . . . . 0.0 109.903 175.516 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' D' D ' 113' ' ' TYR . . . . . . . . . . . . . 59.9 t80 -140.0 139.95 36.14 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-N 116.26 -0.427 . . . . 0.0 110.808 179.602 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' D' D ' 114' ' ' ARG . . . . . . . . . . . . . 34.2 ptt180 -145.31 123.01 11.84 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.222 -0.445 . . . . 0.0 110.536 178.579 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' D' D ' 115' ' ' GLY . . . . . . . . . . . . . . . -150.12 156.91 26.97 Favored Glycine 0 CA--C 1.525 0.717 0 C-N-CA 120.694 -0.765 . . . . 0.0 111.641 179.516 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' D' D ' 116' ' ' LYS . . . . . . . . . . . . . 27.1 ttpp -128.44 133.13 48.48 Favored 'General case' 0 C--N 1.33 -0.259 0 N-CA-C 109.826 -0.435 . . . . 0.0 109.826 176.849 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' D' D ' 117' ' ' PHE . . . . . . . . . . . . . 31.4 m-85 -130.41 113.94 14.95 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-O 120.85 0.357 . . . . 0.0 110.237 -175.896 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' D' D ' 118' ' ' GLU . . . . . . . . . . . . . 95.9 mt-10 -52.97 -47.88 67.84 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.477 -0.328 . . . . 0.0 111.491 -176.981 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' D' D ' 119' ' ' ASN . . . . . . . . . . . . . 3.6 m-20 -94.96 31.01 1.95 Allowed 'General case' 0 C--N 1.329 -0.326 0 N-CA-C 112.338 0.496 . . . . 0.0 112.338 -174.131 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' D' D ' 120' ' ' LEU . . . . . . . . . . . . . 18.6 tp -55.96 124.5 17.91 Favored 'General case' 0 C--N 1.333 -0.146 0 CA-C-O 120.565 0.222 . . . . 0.0 110.507 176.86 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' D' D ' 121' ' ' ASN . . . . . . . . . . . . . 35.1 m120 -111.94 -44.0 3.51 Favored 'General case' 0 C--N 1.331 -0.222 0 CA-C-N 116.596 -0.275 . . . . 0.0 110.959 -177.605 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' D' D ' 122' ' ' LYS . . . . . . . . . . . . . 97.9 mttt -144.73 146.1 32.02 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-O 121.001 0.429 . . . . 0.0 111.621 -178.112 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' D' D ' 123' ' ' VAL . . . . . . . . . . . . . 45.6 t -125.69 125.28 68.25 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.26 0 N-CA-C 109.446 -0.575 . . . . 0.0 109.446 175.162 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' D' D ' 124' ' ' LEU . . . . . . . . . . . . . 49.3 mt -124.07 131.05 53.51 Favored 'General case' 0 C--N 1.331 -0.227 0 CA-C-O 120.676 0.274 . . . . 0.0 110.737 -178.169 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' D' D ' 125' ' ' VAL . . . . . . . . . . . . . 34.8 m -132.09 131.48 61.26 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.294 0 CA-C-N 116.274 -0.421 . . . . 0.0 110.389 179.285 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' D' D ' 126' ' ' ARG . . . . . . . . . . . . . 94.3 mtt180 -144.13 125.44 14.71 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-O 121.068 0.461 . . . . 0.0 111.12 -179.555 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' D' D ' 127' ' ' ASN . . . . . . . . . . . . . 6.7 m120 49.98 -109.53 0.38 Allowed 'General case' 0 CA--C 1.545 0.772 0 CA-C-O 118.972 -0.537 . . . . 0.0 111.685 177.334 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' D' D ' 128' ' ' ASP . . . . . . . . . . . . . 11.3 p-10 -114.15 8.72 17.01 Favored 'General case' 0 N--CA 1.469 0.479 0 CA-C-N 119.71 1.141 . . . . 0.0 113.224 -176.194 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' D' D ' 129' ' ' LEU . . . . . . . . . . . . . 58.4 mt -121.98 143.63 49.36 Favored 'General case' 0 C--N 1.333 -0.145 0 N-CA-C 109.483 -0.562 . . . . 0.0 109.483 177.357 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' D' D ' 130' ' ' VAL . . . . . . . . . . . . . 34.9 m -134.8 146.04 31.38 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.288 0 CA-C-O 121.229 0.537 . . . . 0.0 110.644 179.848 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' D' D ' 131' ' ' VAL . . . . . . . . . . . . . 43.1 t -136.03 139.84 45.09 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.396 0 CA-C-N 115.758 -0.655 . . . . 0.0 110.112 -179.789 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' D' D ' 132' ' ' ILE . . . . . . . . . . . . . 71.6 mt -114.59 130.95 68.08 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.322 0 N-CA-C 109.209 -0.663 . . . . 0.0 109.209 178.89 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' D' D ' 133' ' ' ILE . . . . . . . . . . . . . 40.3 mm -112.45 118.94 59.09 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.263 0 CA-C-N 116.438 -0.346 . . . . 0.0 110.763 -174.767 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' D' D ' 134' ' ' ASP . . . . . . . . . . . . . 6.6 p-10 -129.0 145.27 51.29 Favored 'General case' 0 C--N 1.331 -0.214 0 N-CA-C 109.396 -0.594 . . . . 0.0 109.396 175.984 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' D' D ' 135' ' ' GLU . . . . . . . . . . . . . 39.7 tp10 -49.95 -27.32 5.19 Favored 'General case' 0 C--O 1.235 0.315 0 N-CA-C 112.63 0.604 . . . . 0.0 112.63 -174.155 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' D' D ' 136' ' ' GLN . . . . . . . . . . . . . 95.4 mt-30 -76.88 -39.5 50.81 Favored 'General case' 0 C--O 1.235 0.319 0 CA-C-O 120.814 0.34 . . . . 0.0 111.893 -177.884 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' D' D ' 137' ' ' LYS . . . . . . . . . . . . . 55.0 pttt -170.01 176.91 4.51 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-O 121.475 0.655 . . . . 0.0 112.328 -171.825 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' D' D ' 138' ' ' LEU . . . . . . . . . . . . . 6.8 tt -117.23 129.3 55.84 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 115.065 -0.97 . . . . 0.0 110.317 -178.515 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' D' D ' 139' ' ' THR . . . . . . . . . . . . . 35.6 m -109.08 124.88 51.47 Favored 'General case' 0 C--N 1.331 -0.219 0 CA-C-N 116.024 -0.535 . . . . 0.0 110.179 178.577 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' D' D ' 140' ' ' LEU . . . . . . . . . . . . . 5.8 tt -111.29 122.14 47.08 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 115.781 -0.645 . . . . 0.0 109.308 -178.145 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' D' D ' 141' ' ' ILE . . . . . . . . . . . . . 19.6 mt -122.79 118.55 55.37 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.221 0 CA-C-O 121.177 0.513 . . . . 0.0 110.201 -175.993 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' D' D ' 142' ' ' ARG . . . . . . . . . . . . . 92.6 mtt180 -92.77 120.45 33.16 Favored 'General case' 0 C--O 1.234 0.24 0 CA-C-N 115.223 -0.899 . . . . 0.0 109.823 176.865 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' D' D ' 143' ' ' THR . . . . . . . . . . . . . 67.1 p . . . . . 0 C--O 1.221 -0.428 0 CA-C-O 118.006 -0.997 . . . . 0.0 110.464 179.724 . . . . . . . . 0 0 . 1 . 016 nuclear orig full ' E' E ' -3' ' ' GLU . . . . . . . . . . . . . 43.1 mp0 . . . . . 0 N--CA 1.49 1.543 0 N-CA-C 109.243 -0.651 . . . . 0.0 109.243 . . . . . . . . . 0 0 . 1 . 016 nuclear orig full ' E' E ' -2' ' ' GLY . . . . . . . . . . . . . . . -89.41 126.86 8.43 Favored Glycine 0 CA--C 1.525 0.702 0 N-CA-C 110.895 -0.882 . . . . 0.0 110.895 179.304 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' E' E ' -1' ' ' VAL . . . . . . . . . . . . . 42.9 t -142.31 144.45 24.92 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.357 0 CA-C-O 120.885 0.374 . . . . 0.0 110.125 -179.414 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' E' E ' 0' ' ' ILE . . . . . . . . . . . . . 43.4 mm -113.39 145.02 19.84 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.226 0 CA-C-N 116.116 -0.493 . . . . 0.0 110.109 -179.985 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' E' E ' 1' ' ' MET . . . . . . . . . . . . . 25.2 ptp -143.05 163.61 32.35 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 116.312 -0.404 . . . . 0.0 110.754 -179.859 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' E' E ' 2' ' ' SER . . . . . . . . . . . . . 13.1 p -114.1 137.27 51.96 Favored 'General case' 0 C--N 1.331 -0.202 0 CA-C-O 121.087 0.47 . . . . 0.0 110.809 -177.98 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' E' E ' 3' ' ' GLU . . . . . . . . . . . . . 46.8 tt0 -152.46 145.63 24.65 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 116.059 -0.519 . . . . 0.0 111.152 -177.227 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' E' E ' 4' ' ' LEU . . . . . . . . . . . . . 18.4 tp -124.04 129.4 50.84 Favored 'General case' 0 C--N 1.331 -0.198 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.281 177.397 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' E' E ' 5' ' ' LYS . . . . . . . . . . . . . 67.6 mttm -108.24 123.1 48.26 Favored 'General case' 0 C--N 1.331 -0.215 0 CA-C-N 116.339 -0.391 . . . . 0.0 110.888 179.047 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' E' E ' 6' ' ' LEU . . . . . . . . . . . . . 33.7 mt -115.83 146.3 42.1 Favored 'General case' 0 N--CA 1.464 0.227 0 CA-C-N 115.641 -0.709 . . . . 0.0 110.155 179.132 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' E' E ' 7' ' ' LYS . . . . . . . . . . . . . 31.2 ttmt -128.32 136.76 29.57 Favored Pre-proline 0 CA--C 1.534 0.329 0 CA-C-O 118.88 -0.581 . . . . 0.0 109.585 174.912 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' E' E ' 8' ' ' PRO . . . . . . . . . . . . . 83.1 Cg_endo -92.0 141.51 2.47 Favored 'Trans proline' 0 N--CA 1.49 1.271 0 C-N-CA 121.719 1.613 . . . . 0.0 112.126 178.53 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' E' E ' 9' ' ' LEU . . . . . . . . . . . . . 20.3 mt -78.95 -46.91 1.72 Allowed Pre-proline 0 CA--C 1.534 0.359 0 CA-C-O 118.628 -0.701 . . . . 0.0 111.712 178.419 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' E' E ' 10' ' ' PRO . . . . . . . . . . . . . 91.5 Cg_endo -81.79 150.79 16.54 Favored 'Trans proline' 0 N--CA 1.495 1.615 0 C-N-CA 121.156 1.237 . . . . 0.0 111.539 174.645 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' E' E ' 11' ' ' LYS . . . . . . . . . . . . . 25.1 pttm -86.91 115.84 24.58 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-O 121.389 0.614 . . . . 0.0 110.742 179.423 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' E' E ' 12' ' ' VAL . . . . . . . . . . . . . 12.4 p -151.16 144.77 16.64 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.295 0 CA-C-N 115.822 -0.627 . . . . 0.0 110.341 177.496 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' E' E ' 13' ' ' GLU . . . . . . . . . . . . . 81.5 tt0 -92.83 114.18 26.67 Favored 'General case' 0 C--N 1.329 -0.32 0 N-CA-C 109.749 -0.463 . . . . 0.0 109.749 176.13 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' E' E ' 14' ' ' LEU . . . . . . . . . . . . . 27.9 mt -86.29 144.22 37.96 Favored Pre-proline 0 CA--C 1.533 0.301 0 CA-C-O 119.075 -0.488 . . . . 0.0 110.238 -176.508 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' E' E ' 15' ' ' PRO . . . . . . . . . . . . . 29.4 Cg_exo -60.34 162.62 16.83 Favored 'Trans proline' 0 N--CA 1.498 1.758 0 C-N-CA 121.271 1.314 . . . . 0.0 111.667 178.221 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' E' E ' 16' ' ' PRO . . . . . . . . . . . . . 33.0 Cg_exo -59.09 -38.86 84.7 Favored 'Trans proline' 0 N--CA 1.497 1.711 0 C-N-CA 121.511 1.474 . . . . 0.0 112.904 -176.892 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' E' E ' 17' ' ' ASP . . . . . . . . . . . . . 14.8 p-10 -83.94 1.67 42.41 Favored 'General case' 0 C--N 1.327 -0.383 0 N-CA-C 113.326 0.861 . . . . 0.0 113.326 -177.376 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' E' E ' 18' ' ' PHE . . . . . . . . . . . . . 61.5 t80 -58.15 -46.4 85.73 Favored 'General case' 0 N--CA 1.457 -0.088 0 O-C-N 121.899 -0.5 . . . . 0.0 110.255 -178.048 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' E' E ' 19' ' ' VAL . . . . . . . . . . . . . 46.6 t -55.45 -43.02 70.39 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.264 0 CA-C-N 116.269 -0.423 . . . . 0.0 110.639 -178.082 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' E' E ' 20' ' ' ASP . . . . . . . . . . . . . 9.5 t0 -60.31 -43.15 96.61 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-O 120.803 0.335 . . . . 0.0 110.844 -178.588 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' E' E ' 21' ' ' VAL . . . . . . . . . . . . . 47.5 t -64.19 -45.88 95.06 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.299 0 C-N-CA 120.882 -0.327 . . . . 0.0 110.603 -177.851 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' E' E ' 22' ' ' ILE . . . . . . . . . . . . . 51.5 mm -55.53 -46.27 78.89 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.251 0 CA-C-O 120.822 0.344 . . . . 0.0 110.521 178.372 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' E' E ' 23' ' ' ARG . . . . . . . . . . . . . 60.0 ttp180 -53.31 -50.88 64.01 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.65 -0.25 . . . . 0.0 111.509 179.744 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' E' E ' 24' ' ' ILE . . . . . . . . . . . . . 73.7 mt -58.81 -42.9 86.87 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.27 0 CA-C-N 116.546 -0.297 . . . . 0.0 111.332 -176.737 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' E' E ' 25' ' ' LYS . . . . . . . . . . . . . 93.1 mttt -68.88 -38.59 79.79 Favored 'General case' 0 C--N 1.328 -0.332 0 N-CA-C 112.379 0.511 . . . . 0.0 112.379 -177.639 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' E' E ' 26' ' ' LEU . . . . . . . . . . . . . 78.3 mt -79.85 -38.81 31.96 Favored 'General case' 0 C--N 1.331 -0.236 0 N-CA-C 113.311 0.856 . . . . 0.0 113.311 -170.947 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' E' E ' 27' ' ' GLN . . . . . . . . . . . . . 10.3 pt20 -46.79 140.03 4.93 Favored 'General case' 0 N--CA 1.47 0.559 0 N-CA-C 112.643 0.609 . . . . 0.0 112.643 -175.376 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' E' E ' 28' ' ' GLY . . . . . . . . . . . . . . . 101.4 -26.02 26.06 Favored Glycine 0 CA--C 1.533 1.201 0 CA-C-N 115.57 -0.741 . . . . 0.0 112.174 -175.811 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' E' E ' 29' ' ' LYS . . . . . . . . . . . . . 88.0 mttt -97.51 155.06 17.11 Favored 'General case' 0 C--O 1.232 0.178 0 CA-C-N 117.374 0.587 . . . . 0.0 111.147 178.713 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' E' E ' 30' ' ' THR . . . . . . . . . . . . . 20.8 m -102.57 140.72 36.48 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 115.947 -0.57 . . . . 0.0 110.28 176.735 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' E' E ' 31' ' ' VAL . . . . . . . . . . . . . 34.9 m -128.4 147.48 32.94 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.25 0 CA-C-O 120.901 0.381 . . . . 0.0 110.64 -179.566 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' E' E ' 32' ' ' ARG . . . . . . . . . . . . . 68.8 ttt-85 -130.12 147.16 51.82 Favored 'General case' 0 C--N 1.331 -0.21 0 CA-C-N 116.07 -0.514 . . . . 0.0 110.415 179.541 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' E' E ' 33' ' ' THR . . . . . . . . . . . . . 22.9 m -52.46 139.36 25.28 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 116.458 -0.337 . . . . 0.0 111.594 -177.958 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' E' E ' 34' ' ' GLY . . . . . . . . . . . . . . . 97.48 -17.13 59.52 Favored Glycine 0 CA--C 1.533 1.179 0 C-N-CA 121.176 -0.535 . . . . 0.0 113.322 178.837 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' E' E ' 35' ' ' ASP . . . . . . . . . . . . . 77.1 m-20 -66.16 151.17 47.53 Favored 'General case' 0 C--O 1.231 0.087 0 CA-C-N 118.032 0.916 . . . . 0.0 111.057 179.838 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' E' E ' 36' ' ' VAL . . . . . . . . . . . . . 44.1 t -123.95 128.05 73.95 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.236 0 N-CA-C 109.678 -0.49 . . . . 0.0 109.678 177.038 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' E' E ' 37' ' ' ILE . . . . . . . . . . . . . 60.7 mt -120.78 137.5 54.31 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.26 0 CA-C-N 116.023 -0.535 . . . . 0.0 109.87 -179.473 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' E' E ' 38' ' ' GLY . . . . . . . . . . . . . . . -113.91 127.35 7.77 Favored Glycine 0 CA--C 1.526 0.748 0 N-CA-C 110.854 -0.898 . . . . 0.0 110.854 178.867 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' E' E ' 39' ' ' ILE . . . . . . . . . . . . . 72.7 mt -126.23 126.53 69.57 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.237 0 N-CA-C 110.005 -0.368 . . . . 0.0 110.005 179.451 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' E' E ' 40' ' ' SER . . . . . . . . . . . . . 80.2 p -93.33 123.1 36.38 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.398 -0.364 . . . . 0.0 111.052 176.423 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' E' E ' 41' ' ' ILE . . . . . . . . . . . . . 71.4 mt -137.3 127.97 39.38 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.215 0 CA-C-O 120.943 0.401 . . . . 0.0 110.21 177.11 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' E' E ' 42' ' ' LEU . . . . . . . . . . . . . 8.7 tp 58.47 35.15 24.5 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.045 -0.525 . . . . 0.0 111.522 179.257 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' E' E ' 43' ' ' GLY . . . . . . . . . . . . . . . 72.48 14.61 77.37 Favored Glycine 0 CA--C 1.535 1.285 0 C-N-CA 121.246 -0.502 . . . . 0.0 113.222 176.933 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' E' E ' 44' ' ' LYS . . . . . . . . . . . . . 72.0 mmtt -124.45 130.28 52.18 Favored 'General case' 0 N--CA 1.462 0.172 0 CA-C-N 117.89 0.845 . . . . 0.0 110.203 178.129 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' E' E ' 45' ' ' GLU . . . . . . . . . . . . . 79.1 tt0 -85.34 122.78 30.0 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 115.954 -0.567 . . . . 0.0 111.11 -179.812 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' E' E ' 46' ' ' VAL . . . . . . . . . . . . . 10.9 p -118.82 123.0 70.79 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.197 0 N-CA-C 109.555 -0.535 . . . . 0.0 109.555 174.376 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' E' E ' 47' ' ' LYS . . . . . . . . . . . . . 68.1 mttm -99.33 126.93 45.28 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 115.984 -0.553 . . . . 0.0 111.014 179.114 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' E' E ' 48' ' ' PHE . . . . . . . . . . . . . 29.1 m-85 -111.09 131.82 54.77 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.116 -0.493 . . . . 0.0 109.944 177.446 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' E' E ' 49' ' ' LYS . . . . . . . . . . . . . 80.9 tttt -107.11 137.19 45.64 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.374 -0.376 . . . . 0.0 110.284 177.557 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' E' E ' 50' ' ' VAL . . . . . . . . . . . . . 42.9 t -74.15 106.72 4.19 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.345 0 N-CA-C 109.812 -0.44 . . . . 0.0 109.812 178.682 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' E' E ' 51' ' ' VAL . . . . . . . . . . . . . 46.1 t -70.75 -50.34 44.73 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.277 0 O-C-N 123.65 0.594 . . . . 0.0 109.704 -176.104 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' E' E ' 52' ' ' GLN . . . . . . . . . . . . . 56.3 tt0 -168.02 138.19 2.66 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 115.908 -0.587 . . . . 0.0 111.145 -179.19 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' E' E ' 53' ' ' ALA . . . . . . . . . . . . . . . -112.15 132.4 54.9 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 115.873 -0.603 . . . . 0.0 110.135 177.04 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' E' E ' 54' ' ' TYR . . . . . . . . . . . . . 22.9 t80 -127.97 107.22 20.1 Favored Pre-proline 0 CA--C 1.534 0.345 0 CA-C-O 118.285 -0.864 . . . . 0.0 110.364 179.778 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' E' E ' 55' ' ' PRO . . . . . . . . . . . . . 73.3 Cg_endo -77.06 170.05 72.7 Favored 'Cis proline' 0 N--CA 1.5 1.888 0 CA-C-N 121.682 1.637 . . . . 0.0 112.488 -5.286 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' E' E ' 56' ' ' SER . . . . . . . . . . . . . 70.5 m -115.54 129.93 24.73 Favored Pre-proline 0 CA--C 1.539 0.538 0 CA-C-O 118.427 -0.796 . . . . 0.0 109.35 175.391 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' E' E ' 57' ' ' PRO . . . . . . . . . . . . . 60.8 Cg_endo -74.34 150.61 95.81 Favored 'Cis proline' 0 N--CA 1.497 1.684 0 CA-C-N 121.952 1.733 . . . . 0.0 111.722 -0.31 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' E' E ' 58' ' ' LEU . . . . . . . . . . . . . 21.4 tp -109.02 138.11 45.88 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 116.299 -0.409 . . . . 0.0 110.85 -177.84 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' E' E ' 59' ' ' ARG . . . . . . . . . . . . . 78.0 ttt180 -101.75 125.88 48.5 Favored 'General case' 0 C--N 1.328 -0.339 0 N-CA-C 109.244 -0.65 . . . . 0.0 109.244 173.537 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' E' E ' 60' ' ' VAL . . . . . . . . . . . . . 46.8 t -77.81 114.64 18.6 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.308 0 C-N-CA 120.72 -0.392 . . . . 0.0 110.378 -176.88 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' E' E ' 61' ' ' GLU . . . . . . . . . . . . . 44.2 mt-10 -131.01 161.19 32.51 Favored 'General case' 0 C--N 1.332 -0.167 0 CA-C-N 115.933 -0.576 . . . . 0.0 110.012 177.663 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' E' E ' 62' ' ' ASP . . . . . . . . . . . . . 77.9 m-20 -54.4 -33.71 59.86 Favored 'General case' 0 C--N 1.328 -0.352 0 N-CA-C 112.088 0.403 . . . . 0.0 112.088 -175.798 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' E' E ' 63' ' ' ARG . . . . . . . . . . . . . 25.0 mmm180 -74.87 -17.21 60.62 Favored 'General case' 0 CA--C 1.535 0.391 0 N-CA-C 113.125 0.787 . . . . 0.0 113.125 -175.427 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' E' E ' 64' ' ' THR . . . . . . . . . . . . . 11.4 m -75.77 142.93 42.24 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-O 120.852 0.358 . . . . 0.0 110.865 -176.131 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' E' E ' 65' ' ' LYS . . . . . . . . . . . . . 95.6 mttt -89.63 139.76 30.23 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.111 -0.495 . . . . 0.0 110.531 179.938 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' E' E ' 66' ' ' ILE . . . . . 0.415 HD13 HG23 ' E' ' 66' ' ' ILE . 55.3 mt -113.81 133.37 59.99 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.287 0 N-CA-C 109.837 -0.431 . . . . 0.0 109.837 178.256 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' E' E ' 67' ' ' THR . . . . . . . . . . . . . 25.3 m -128.34 139.14 52.56 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-O 121.056 0.455 . . . . 0.0 111.166 -178.191 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' E' E ' 68' ' ' LEU . . . . . . . . . . . . . 7.2 mp -100.31 124.46 45.8 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 115.826 -0.625 . . . . 0.0 109.853 176.411 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' E' E ' 69' ' ' VAL . . . . . . . . . . . . . 43.8 t -100.7 139.52 21.85 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.372 0 CA-C-N 116.118 -0.492 . . . . 0.0 110.409 -176.685 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' E' E ' 70' ' ' THR . . . . . . . . . . . . . 3.3 m -131.64 117.87 19.27 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.02 -0.536 . . . . 0.0 110.099 178.087 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' E' E ' 71' ' ' HIS . . . . . . . . . . . . . 2.1 m80 -96.5 160.01 30.54 Favored Pre-proline 0 C--N 1.327 -0.372 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.264 -179.21 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' E' E ' 72' ' ' PRO . . . . . . . . . . . . . 51.5 Cg_endo -69.73 -23.54 30.84 Favored 'Trans proline' 0 N--CA 1.497 1.691 0 C-N-CA 121.313 1.342 . . . . 0.0 112.822 -179.93 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' E' E ' 73' ' ' VAL . . . . . . . . . . . . . 34.7 m -118.28 147.44 21.75 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.172 0 CA-C-O 120.98 0.419 . . . . 0.0 110.616 -179.853 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' E' E ' 74' ' ' ASP . . . . . . . . . . . . . 9.7 t0 -104.33 120.39 41.09 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.025 -0.534 . . . . 0.0 109.822 179.104 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' E' E ' 75' ' ' VAL . . . . . . . . . . . . . 40.5 t -114.39 123.05 69.68 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.18 0 CA-C-O 121.055 0.455 . . . . 0.0 110.955 -175.4 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' E' E ' 76' ' ' LEU . . . . . . . . . . . . . 6.0 mp -123.34 146.71 47.72 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 115.657 -0.701 . . . . 0.0 109.591 175.632 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' E' E ' 77' ' ' GLU . . . . . . . . . . . . . 97.1 mt-10 -134.03 140.84 46.95 Favored 'General case' 0 N--CA 1.463 0.207 0 CA-C-O 121.167 0.508 . . . . 0.0 111.383 -178.418 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' E' E ' 78' ' ' ALA . . . . . . . . . . . . . . . -130.51 129.51 42.98 Favored 'General case' 0 C--N 1.332 -0.193 0 CA-C-N 115.684 -0.689 . . . . 0.0 109.751 175.849 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' E' E ' 79' ' ' LYS . . . . . . . . . . . . . 37.3 mmtm -71.74 119.54 16.04 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-O 120.886 0.374 . . . . 0.0 110.981 -178.234 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' E' E ' 80' ' ' ILE . . . . . . . . . . . . . 32.1 mm -139.31 99.91 1.32 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.259 0 N-CA-C 109.089 -0.708 . . . . 0.0 109.089 -178.213 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' E' E ' 81' ' ' LYS . . . . . . . . . . . . . 53.0 pttt -101.51 128.13 47.89 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-O 121.103 0.478 . . . . 0.0 111.31 -176.639 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' E' E ' 82' ' ' GLY . . . . . . . . . . . . . . . 89.21 41.95 5.7 Favored Glycine 0 CA--C 1.526 0.777 0 CA-C-N 115.799 -0.637 . . . . 0.0 111.66 177.2 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' E' E ' 83' ' ' ILE . . . . . . . . . . . . . 73.7 mt -68.94 144.66 13.95 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 CA-C-O 121.034 0.445 . . . . 0.0 110.234 179.078 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' E' E ' 84' ' ' LYS . . . . . . . . . . . . . 87.6 tttt -100.99 -51.77 3.46 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 115.792 -0.64 . . . . 0.0 109.993 -179.905 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' E' E ' 85' ' ' ASP . . . . . . . . . . . . . 7.9 t70 -160.44 154.69 23.33 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 115.597 -0.729 . . . . 0.0 110.057 179.459 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' E' E ' 86' ' ' VAL . . . . . . . . . . . . . 40.6 t -132.95 131.61 59.04 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.212 0 CA-C-O 121.06 0.457 . . . . 0.0 110.576 -178.588 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' E' E ' 87' ' ' ILE . . . . . . . . . . . . . 44.9 mm -119.45 128.23 75.86 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.208 0 CA-C-N 115.804 -0.634 . . . . 0.0 109.556 176.515 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' E' E ' 88' ' ' LEU . . . . . . . . . . . . . 84.2 mt -110.29 137.82 47.5 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-O 121.111 0.481 . . . . 0.0 111.499 -177.363 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' E' E ' 89' ' ' ASP . . . . . . . . . . . . . 10.9 t70 -127.07 153.23 46.24 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 115.502 -0.772 . . . . 0.0 109.074 174.436 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' E' E ' 90' ' ' GLU . . . . . . . . . . . . . 95.8 mt-10 -48.06 -36.91 13.9 Favored 'General case' 0 C--N 1.33 -0.244 0 N-CA-C 112.903 0.705 . . . . 0.0 112.903 -172.605 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' E' E ' 91' ' ' ASN . . . . . . . . . . . . . 27.6 m120 -132.06 32.03 4.08 Favored 'General case' 0 N--CA 1.465 0.277 0 N-CA-C 112.102 0.408 . . . . 0.0 112.102 -176.848 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' E' E ' 92' ' ' LEU . . . . . . . . . . . . . 8.1 tp -166.09 152.94 9.59 Favored 'General case' 0 C--N 1.33 -0.247 0 C-N-CA 120.897 -0.321 . . . . 0.0 110.81 -179.44 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' E' E ' 93' ' ' ILE . . . . . . . . . . . . . 73.0 mt -130.37 129.91 65.08 Favored 'Isoleucine or valine' 0 N--CA 1.462 0.166 0 N-CA-C 109.971 -0.381 . . . . 0.0 109.971 179.171 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' E' E ' 94' ' ' VAL . . . . . . . . . . . . . 44.7 t -122.56 125.0 71.97 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.246 0 N-CA-C 109.597 -0.52 . . . . 0.0 109.597 176.942 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' E' E ' 95' ' ' VAL . . . . . . . . . . . . . 43.5 t -120.66 134.52 63.82 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.295 0 CA-C-N 116.285 -0.416 . . . . 0.0 110.145 -177.929 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' E' E ' 96' ' ' ILE . . . . . . . . . . . . . 66.9 mt -115.83 129.4 72.25 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 N-CA-C 109.361 -0.607 . . . . 0.0 109.361 178.985 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' E' E ' 97' ' ' THR . . . . . . . . . . . . . 77.8 p -101.28 155.89 17.76 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-O 121.033 0.444 . . . . 0.0 111.111 -178.028 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' E' E ' 98' ' ' GLU . . . . . . . . . . . . . 12.8 pt-20 -54.05 -22.14 10.07 Favored 'General case' 0 CA--C 1.535 0.393 0 N-CA-C 112.613 0.598 . . . . 0.0 112.613 -179.256 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' E' E ' 99' ' ' GLU . . . . . . . . . . . . . 31.2 tt0 -83.38 18.15 1.9 Allowed 'General case' 0 CA--C 1.536 0.417 0 N-CA-C 112.79 0.663 . . . . 0.0 112.79 -177.333 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' E' E ' 100' ' ' ASN . . . . . . . . . . . . . 2.6 m-20 62.16 37.98 14.03 Favored 'General case' 0 CA--C 1.53 0.198 0 CA-C-O 121.011 0.434 . . . . 0.0 110.828 177.961 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' E' E ' 101' ' ' GLU . . . . . . . . . . . . . 81.4 tt0 -119.75 141.55 49.35 Favored 'General case' 0 C--N 1.332 -0.195 0 N-CA-C 109.765 -0.457 . . . . 0.0 109.765 177.684 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' E' E ' 102' ' ' VAL . . . . . . . . . . . . . 41.0 t -115.12 128.69 72.2 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.271 0 N-CA-C 110.216 -0.29 . . . . 0.0 110.216 -178.238 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' E' E ' 103' ' ' LEU . . . . . . . . . . . . . 7.0 mp -116.5 136.69 52.77 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 115.559 -0.746 . . . . 0.0 109.93 176.864 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' E' E ' 104' ' ' ILE . . . . . . . . . . . . . 68.2 mt -116.02 121.82 68.26 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.259 0 N-CA-C 109.766 -0.457 . . . . 0.0 109.766 179.742 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' E' E ' 105' ' ' PHE . . . . . . . . . . . . . 93.0 m-85 -123.33 165.76 16.44 Favored 'General case' 0 C--N 1.332 -0.163 0 O-C-N 124.281 0.988 . . . . 0.0 109.997 -177.713 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' E' E ' 106' ' ' ASN . . . . . . . . . . . . . 46.0 p-10 -104.0 -171.61 1.96 Allowed 'General case' 0 C--N 1.331 -0.197 0 N-CA-C 109.61 -0.515 . . . . 0.0 109.61 171.205 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' E' E ' 107' ' ' GLN . . . . . . . . . . . . . 20.7 tt0 -60.55 -24.37 65.35 Favored 'General case' 0 CA--C 1.534 0.35 0 N-CA-C 112.221 0.452 . . . . 0.0 112.221 179.831 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' E' E ' 108' ' ' ASN . . . . . . . . . . . . . 26.1 t30 -90.19 13.66 14.57 Favored 'General case' 0 CA--C 1.534 0.356 0 N-CA-C 112.978 0.733 . . . . 0.0 112.978 -178.609 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' E' E ' 109' ' ' LEU . . . . . . . . . . . . . 46.0 mt 56.73 35.24 25.91 Favored 'General case' 0 CA--C 1.53 0.206 0 CA-C-N 117.866 0.303 . . . . 0.0 111.557 177.511 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' E' E ' 110' ' ' GLU . . . . . . . . . . . . . 71.0 mm-40 -102.38 146.8 27.53 Favored 'General case' 0 C--N 1.33 -0.269 0 N-CA-C 109.906 -0.405 . . . . 0.0 109.906 176.926 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' E' E ' 111' ' ' GLU . . . . . . . . . . . . . 79.6 tt0 -82.29 124.73 30.23 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-O 120.953 0.406 . . . . 0.0 111.254 -175.993 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' E' E ' 112' ' ' LEU . . . . . . . . . . . . . 15.4 mt -108.38 -46.05 3.78 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 115.915 -0.584 . . . . 0.0 110.061 176.569 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' E' E ' 113' ' ' TYR . . . . . . . . . . . . . 48.3 t80 -142.55 145.06 33.22 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.169 -0.469 . . . . 0.0 111.317 -178.915 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' E' E ' 114' ' ' ARG . . . . . . . . . . . . . 55.1 ttp180 -151.02 125.26 9.38 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-O 121.065 0.459 . . . . 0.0 110.448 174.798 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' E' E ' 115' ' ' GLY . . . . . . . . . . . . . . . -150.13 155.65 26.34 Favored Glycine 0 CA--C 1.524 0.64 0 N-CA-C 110.67 -0.972 . . . . 0.0 110.67 178.374 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' E' E ' 116' ' ' LYS . . . . . . . . . . . . . 38.8 ttpt -114.9 140.29 49.1 Favored 'General case' 0 C--N 1.331 -0.197 0 O-C-N 122.593 -0.357 . . . . 0.0 110.338 179.14 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' E' E ' 117' ' ' PHE . . . . . . . . . . . . . 41.4 m-85 -133.95 114.59 13.43 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.2 -0.455 . . . . 0.0 110.17 -177.778 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' E' E ' 118' ' ' GLU . . . . . . . . . . . . . 70.8 mm-40 -51.28 -53.16 38.34 Favored 'General case' 0 C--N 1.33 -0.27 0 N-CA-C 111.837 0.31 . . . . 0.0 111.837 -175.925 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' E' E ' 119' ' ' ASN . . . . . . . . . . . . . 25.2 m120 -94.22 31.07 1.76 Allowed 'General case' 0 C--N 1.328 -0.334 0 N-CA-C 112.176 0.436 . . . . 0.0 112.176 -174.128 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' E' E ' 120' ' ' LEU . . . . . . . . . . . . . 12.9 tp -54.33 119.82 5.7 Favored 'General case' 0 N--CA 1.464 0.257 0 CA-C-O 120.749 0.309 . . . . 0.0 110.854 179.156 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' E' E ' 121' ' ' ASN . . . . . . . . . . . . . 88.8 m-20 -114.1 -44.03 3.18 Favored 'General case' 0 C--N 1.332 -0.176 0 CA-C-N 116.356 -0.384 . . . . 0.0 111.141 -178.036 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' E' E ' 122' ' ' LYS . . . . . . . . . . . . . 63.2 mtpt -140.63 148.61 41.14 Favored 'General case' 0 C--N 1.331 -0.211 0 CA-C-O 121.137 0.494 . . . . 0.0 111.682 -175.754 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' E' E ' 123' ' ' VAL . . . . . . . . . . . . . 43.5 t -131.27 126.45 58.81 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.261 0 CA-C-N 115.79 -0.641 . . . . 0.0 109.359 174.052 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' E' E ' 124' ' ' LEU . . . . . . . . . . . . . 41.1 mt -121.61 135.61 54.98 Favored 'General case' 0 C--N 1.331 -0.22 0 CA-C-N 116.496 -0.32 . . . . 0.0 110.565 -177.898 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' E' E ' 125' ' ' VAL . . . . . . . . . . . . . 11.6 p -134.0 129.26 54.11 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.277 0 CA-C-N 116.257 -0.429 . . . . 0.0 110.249 179.151 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' E' E ' 126' ' ' ARG . . . . . . . . . . . . . 52.1 mmm-85 -137.33 116.16 12.27 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.348 179.32 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' E' E ' 127' ' ' ASN . . . . . . . . . . . . . 7.1 m-80 52.65 -104.85 0.21 Allowed 'General case' 0 CA--C 1.543 0.689 0 CA-C-O 119.205 -0.426 . . . . 0.0 111.273 178.956 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' E' E ' 128' ' ' ASP . . . . . . . . . . . . . 10.9 p-10 -114.1 2.25 14.86 Favored 'General case' 0 N--CA 1.468 0.468 0 CA-C-N 119.48 1.036 . . . . 0.0 113.464 -176.458 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' E' E ' 129' ' ' LEU . . . . . . . . . . . . . 14.5 tp -105.36 135.1 47.36 Favored 'General case' 0 C--N 1.333 -0.146 0 CA-C-N 118.233 0.469 . . . . 0.0 110.012 179.018 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' E' E ' 130' ' ' VAL . . . . . . . . . . . . . 43.1 t -121.32 135.58 61.03 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.192 0 CA-C-O 120.897 0.379 . . . . 0.0 110.003 -178.288 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' E' E ' 131' ' ' VAL . . . . . . . . . . . . . 43.5 t -135.64 134.14 51.65 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.202 0 CA-C-O 120.991 0.424 . . . . 0.0 110.176 178.541 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' E' E ' 132' ' ' ILE . . . . . 0.404 HD12 HG21 ' E' ' 132' ' ' ILE . 71.5 mt -116.86 132.32 66.94 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.352 0 CA-C-N 115.713 -0.676 . . . . 0.0 109.357 179.748 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' E' E ' 133' ' ' ILE . . . . . . . . . . . . . 39.9 mm -116.0 119.26 61.37 Favored 'Isoleucine or valine' 0 C--O 1.234 0.25 0 CA-C-O 120.79 0.329 . . . . 0.0 111.029 -173.862 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' E' E ' 134' ' ' ASP . . . . . . . . . . . . . 10.4 p-10 -131.11 144.98 51.81 Favored 'General case' 0 C--N 1.332 -0.18 0 N-CA-C 109.454 -0.573 . . . . 0.0 109.454 174.584 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' E' E ' 135' ' ' GLU . . . . . . . . . . . . . 80.0 tt0 -49.8 -26.07 3.62 Favored 'General case' 0 C--N 1.328 -0.334 0 N-CA-C 112.95 0.722 . . . . 0.0 112.95 -171.656 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' E' E ' 136' ' ' GLN . . . . . . . . . . . . . 35.0 tt0 -80.9 -38.33 28.15 Favored 'General case' 0 C--O 1.234 0.256 0 N-CA-C 111.887 0.328 . . . . 0.0 111.887 -176.417 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' E' E ' 137' ' ' LYS . . . . . . . . . . . . . 15.3 pttp -162.02 171.56 17.37 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-O 121.602 0.715 . . . . 0.0 112.119 -172.423 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' E' E ' 138' ' ' LEU . . . . . . . . . . . . . 3.6 tt -114.07 126.51 55.19 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 114.864 -1.062 . . . . 0.0 109.744 179.171 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' E' E ' 139' ' ' THR . . . . . . . . . . . . . 26.2 m -105.32 123.39 47.78 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.338 -0.392 . . . . 0.0 110.529 -179.858 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' E' E ' 140' ' ' LEU . . . . . . . . . . . . . 7.6 tt -110.67 122.28 47.41 Favored 'General case' 0 C--N 1.327 -0.401 0 N-CA-C 109.251 -0.648 . . . . 0.0 109.251 -179.35 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' E' E ' 141' ' ' ILE . . . . . . . . . . . . . 19.7 mt -122.46 113.89 40.28 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.264 0 N-CA-C 109.786 -0.45 . . . . 0.0 109.786 -176.45 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' E' E ' 142' ' ' ARG . . . . . . . . . . . . . 67.8 ttp85 -103.05 129.7 49.94 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 115.416 -0.811 . . . . 0.0 110.831 -177.934 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' E' E ' 143' ' ' THR . . . . . . . . . . . . . 81.3 p . . . . . 0 C--O 1.22 -0.47 0 CA-C-O 117.873 -1.06 . . . . 0.0 110.834 179.463 . . . . . . . . 0 0 . 1 . 016 nuclear orig full ' F' F ' -3' ' ' GLU . . . . . . . . . . . . . 95.6 mt-10 . . . . . 0 N--CA 1.491 1.587 0 N-CA-C 109.307 -0.627 . . . . 0.0 109.307 . . . . . . . . . 0 0 . 1 . 016 nuclear orig full ' F' F ' -2' ' ' GLY . . . . . . . . . . . . . . . -62.71 131.29 43.52 Favored Glycine 0 CA--C 1.525 0.669 0 N-CA-C 111.222 -0.751 . . . . 0.0 111.222 -178.994 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' F' F ' -1' ' ' VAL . . . . . . . . . . . . . 44.7 t -96.54 140.75 16.7 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.27 0 N-CA-C 110.068 -0.345 . . . . 0.0 110.068 179.11 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' F' F ' 0' ' ' ILE . . . . . . . . . . . . . 67.3 mt -104.18 132.05 51.6 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.307 0 CA-C-N 116.261 -0.427 . . . . 0.0 109.982 -179.802 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' F' F ' 1' ' ' MET . . . . . . . . . . . . . 23.5 ptp -85.48 143.6 28.45 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.14 -0.482 . . . . 0.0 110.685 179.763 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' F' F ' 2' ' ' SER . . . . . . . . . . . . . 6.8 p -114.45 132.55 56.22 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.252 -0.431 . . . . 0.0 110.723 -179.566 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' F' F ' 3' ' ' GLU . . . . . . . . . . . . . 81.8 tt0 -141.35 141.06 33.87 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 115.963 -0.562 . . . . 0.0 111.032 -179.07 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' F' F ' 4' ' ' LEU . . . . . . . . . . . . . 15.2 tp -125.58 132.02 52.61 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.049 -0.523 . . . . 0.0 110.01 176.618 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' F' F ' 5' ' ' LYS . . . . . . . . . . . . . 65.1 mttm -111.61 120.18 41.21 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.249 -0.432 . . . . 0.0 110.606 -179.673 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' F' F ' 6' ' ' LEU . . . . . . . . . . . . . 67.1 mt -114.35 150.34 34.72 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 115.477 -0.783 . . . . 0.0 110.279 -178.609 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' F' F ' 7' ' ' LYS . . . . . . . . . . . . . 40.9 tttp -137.65 139.72 27.8 Favored Pre-proline 0 CA--C 1.534 0.353 0 CA-C-O 119.048 -0.501 . . . . 0.0 110.145 176.758 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' F' F ' 8' ' ' PRO . . . . . . . . . . . . . 94.0 Cg_endo -90.21 139.92 3.13 Favored 'Trans proline' 0 N--CA 1.489 1.263 0 C-N-CA 121.746 1.63 . . . . 0.0 111.662 177.575 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' F' F ' 9' ' ' LEU . . . . . . . . . . . . . 46.8 mt -78.7 -47.64 1.81 Allowed Pre-proline 0 CA--C 1.533 0.3 0 CA-C-O 118.652 -0.689 . . . . 0.0 112.181 -178.963 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' F' F ' 10' ' ' PRO . . . . . . . . . . . . . 92.1 Cg_endo -79.47 150.18 21.9 Favored 'Trans proline' 0 N--CA 1.496 1.647 0 C-N-CA 121.139 1.226 . . . . 0.0 111.766 175.95 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' F' F ' 11' ' ' LYS . . . . . . . . . . . . . 82.9 tttt -86.31 101.43 13.07 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.295 -0.411 . . . . 0.0 110.371 179.256 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' F' F ' 12' ' ' VAL . . . . . . . . . . . . . 12.5 p -146.64 149.84 15.55 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.255 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.76 -178.526 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' F' F ' 13' ' ' GLU . . . . . . . . . . . . . 70.7 mm-40 -79.87 126.64 31.25 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.152 -0.477 . . . . 0.0 110.098 177.112 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' F' F ' 14' ' ' LEU . . . . . . . . . . . . . 37.8 mt -97.53 144.48 28.03 Favored Pre-proline 0 CA--C 1.533 0.291 0 CA-C-O 119.012 -0.518 . . . . 0.0 110.038 179.464 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' F' F ' 15' ' ' PRO . . . . . . . . . . . . . 25.7 Cg_exo -62.01 153.97 65.23 Favored 'Trans proline' 0 N--CA 1.497 1.72 0 C-N-CA 121.204 1.27 . . . . 0.0 111.442 177.133 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' F' F ' 16' ' ' PRO . . . . . . . . . . . . . 31.2 Cg_exo -57.2 -38.84 94.14 Favored 'Trans proline' 0 N--CA 1.497 1.715 0 C-N-CA 121.412 1.408 . . . . 0.0 112.856 -179.244 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' F' F ' 17' ' ' ASP . . . . . . . . . . . . . 21.7 p-10 -85.98 9.63 16.45 Favored 'General case' 0 CA--C 1.537 0.444 0 N-CA-C 113.319 0.859 . . . . 0.0 113.319 -177.138 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' F' F ' 18' ' ' PHE . . . . . . . . . . . . . 43.3 t80 -58.47 -48.51 80.51 Favored 'General case' 0 N--CA 1.457 -0.109 0 O-C-N 121.971 -0.455 . . . . 0.0 110.153 -177.239 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' F' F ' 19' ' ' VAL . . . . . . . . . . . . . 14.0 p -54.46 -41.36 53.58 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.256 0 CA-C-N 116.378 -0.374 . . . . 0.0 111.284 -177.611 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' F' F ' 20' ' ' ASP . . . . . . . . . . . . . 73.3 m-20 -60.87 -45.95 92.52 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-O 120.823 0.344 . . . . 0.0 111.039 -177.806 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' F' F ' 21' ' ' VAL . . . . . . . . . . . . . 46.4 t -64.34 -46.92 91.71 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 C-N-CA 120.76 -0.376 . . . . 0.0 110.573 -177.103 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' F' F ' 22' ' ' ILE . . . . . . . . . . . . . 49.1 mm -56.21 -46.72 81.39 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.221 0 C-N-CA 120.917 -0.313 . . . . 0.0 110.647 179.347 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' F' F ' 23' ' ' ARG . . . . . . . . . . . . . 50.9 ttp180 -53.51 -48.42 69.02 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-O 120.639 0.257 . . . . 0.0 111.468 -178.477 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' F' F ' 24' ' ' ILE . . . . . . . . . . . . . 73.1 mt -59.58 -43.38 90.84 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.337 0 C-N-CA 121.072 -0.251 . . . . 0.0 111.05 -178.984 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' F' F ' 25' ' ' LYS . . . . . . . . . . . . . 53.5 mtmt -64.61 -39.1 93.11 Favored 'General case' 0 C--N 1.329 -0.307 0 N-CA-C 112.255 0.465 . . . . 0.0 112.255 -178.409 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' F' F ' 26' ' ' LEU . . . . . . . . . . . . . 63.3 mt -79.8 -40.59 28.27 Favored 'General case' 0 C--N 1.329 -0.298 0 N-CA-C 113.501 0.926 . . . . 0.0 113.501 -170.591 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' F' F ' 27' ' ' GLN . . . . . . . . . . . . . 10.6 pt20 -46.38 138.4 5.66 Favored 'General case' 0 N--CA 1.469 0.506 0 N-CA-C 112.995 0.739 . . . . 0.0 112.995 -173.821 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' F' F ' 28' ' ' GLY . . . . . . . . . . . . . . . 100.92 -26.88 23.05 Favored Glycine 0 CA--C 1.533 1.201 0 CA-C-N 115.611 -0.722 . . . . 0.0 112.185 -177.379 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' F' F ' 29' ' ' LYS . . . . . . . . . . . . . 83.1 mttt -97.98 155.12 17.25 Favored 'General case' 0 C--O 1.233 0.187 0 CA-C-N 117.329 0.564 . . . . 0.0 111.227 179.6 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' F' F ' 30' ' ' THR . . . . . . . . . . . . . 40.9 m -101.19 140.54 35.34 Favored 'General case' 0 C--N 1.33 -0.239 0 CA-C-N 116.01 -0.541 . . . . 0.0 110.375 177.755 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' F' F ' 31' ' ' VAL . . . . . . . . . . . . . 35.4 m -129.79 152.97 38.14 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.164 0 CA-C-N 116.313 -0.403 . . . . 0.0 110.327 178.673 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' F' F ' 32' ' ' ARG . . . . . . . . . . . . . 50.1 ttt180 -132.04 149.08 52.51 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-O 121.185 0.517 . . . . 0.0 110.277 178.529 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' F' F ' 33' ' ' THR . . . . . . . . . . . . . 19.5 m -52.46 137.63 29.34 Favored 'General case' 0 C--N 1.331 -0.212 0 CA-C-N 116.369 -0.378 . . . . 0.0 111.44 -178.218 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' F' F ' 34' ' ' GLY . . . . . . . . . . . . . . . 100.51 -17.15 57.11 Favored Glycine 0 CA--C 1.534 1.238 0 C-N-CA 121.172 -0.537 . . . . 0.0 113.188 179.532 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' F' F ' 35' ' ' ASP . . . . . . . . . . . . . 52.2 m-20 -64.54 151.04 45.59 Favored 'General case' 0 C--N 1.333 -0.115 0 CA-C-N 118.034 0.917 . . . . 0.0 111.19 -179.817 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' F' F ' 36' ' ' VAL . . . . . . . . . . . . . 44.7 t -127.85 130.92 70.12 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.199 0 CA-C-N 115.815 -0.629 . . . . 0.0 109.858 178.685 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' F' F ' 37' ' ' ILE . . . . . . . . . . . . . 66.0 mt -124.37 142.76 40.1 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.231 0 CA-C-N 116.282 -0.417 . . . . 0.0 110.033 -178.73 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' F' F ' 38' ' ' GLY . . . . . . . . . . . . . . . -111.98 128.84 8.77 Favored Glycine 0 CA--C 1.526 0.75 0 N-CA-C 111.036 -0.826 . . . . 0.0 111.036 179.133 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' F' F ' 39' ' ' ILE . . . . . . . . . . . . . 76.2 mt -125.14 135.68 63.26 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.224 0 N-CA-C 110.107 -0.331 . . . . 0.0 110.107 179.469 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' F' F ' 40' ' ' SER . . . . . . . . . . . . . 60.0 p -92.86 116.41 29.01 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.307 -0.406 . . . . 0.0 111.046 176.431 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' F' F ' 41' ' ' ILE . . . . . . . . . . . . . 44.5 mm -121.54 121.52 64.76 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.205 0 CA-C-O 120.86 0.362 . . . . 0.0 110.235 178.865 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' F' F ' 42' ' ' LEU . . . . . . . . . . . . . 60.3 mt 52.28 34.69 15.24 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.166 -0.47 . . . . 0.0 111.819 176.961 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' F' F ' 43' ' ' GLY . . . . . . . . . . . . . . . 72.98 32.56 60.61 Favored Glycine 0 CA--C 1.529 0.939 0 C-N-CA 121.047 -0.597 . . . . 0.0 112.064 177.869 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' F' F ' 44' ' ' LYS . . . . . . . . . . . . . 28.0 ttpp -139.92 132.96 29.51 Favored 'General case' 0 C--N 1.329 -0.322 0 N-CA-C 109.635 -0.506 . . . . 0.0 109.635 177.657 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' F' F ' 45' ' ' GLU . . . . . . . . . . . . . 79.5 tt0 -82.25 121.11 26.23 Favored 'General case' 0 C--N 1.328 -0.326 0 C-N-CA 120.928 -0.309 . . . . 0.0 111.134 -177.025 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' F' F ' 46' ' ' VAL . . . . . . . . . . . . . 7.5 p -120.88 127.03 75.89 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.254 0 N-CA-C 109.454 -0.572 . . . . 0.0 109.454 175.384 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' F' F ' 47' ' ' LYS . . . . . . . . . . . . . 69.0 mttm -100.02 129.93 46.13 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 115.96 -0.564 . . . . 0.0 111.159 179.338 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' F' F ' 48' ' ' PHE . . . . . . . . . . . . . 92.0 m-85 -113.18 131.81 55.73 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.233 -0.439 . . . . 0.0 110.002 177.489 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' F' F ' 49' ' ' LYS . . . . . . . . . . . . . 76.5 tttt -109.52 139.33 44.64 Favored 'General case' 0 C--N 1.331 -0.205 0 CA-C-N 116.409 -0.359 . . . . 0.0 110.581 178.839 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' F' F ' 50' ' ' VAL . . . . . . . . . . . . . 43.6 t -82.59 108.85 15.87 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.212 0 N-CA-C 109.528 -0.545 . . . . 0.0 109.528 176.251 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' F' F ' 51' ' ' VAL . . . . . . . . . . . . . 46.9 t -71.64 -53.68 19.74 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.338 0 CA-C-N 115.91 -0.586 . . . . 0.0 109.536 -175.316 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' F' F ' 52' ' ' GLN . . . . . . . . . . . . . 85.2 mt-30 -154.63 152.55 30.12 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-O 121.114 0.483 . . . . 0.0 111.481 -177.31 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' F' F ' 53' ' ' ALA . . . . . . . . . . . . . . . -129.79 133.3 46.89 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 115.496 -0.774 . . . . 0.0 109.858 175.156 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' F' F ' 54' ' ' TYR . . . . . . . . . . . . . 29.7 t80 -129.08 107.91 18.0 Favored Pre-proline 0 C--N 1.328 -0.331 0 CA-C-O 118.27 -0.871 . . . . 0.0 110.211 179.218 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' F' F ' 55' ' ' PRO . . . . . . . . . . . . . 73.9 Cg_endo -77.2 170.07 72.48 Favored 'Cis proline' 0 N--CA 1.501 1.916 0 CA-C-N 121.881 1.707 . . . . 0.0 112.549 -4.245 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' F' F ' 56' ' ' SER . . . . . . . . . . . . . 60.6 m -117.2 130.74 24.42 Favored Pre-proline 0 CA--C 1.538 0.495 0 CA-C-O 118.413 -0.803 . . . . 0.0 109.602 175.494 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' F' F ' 57' ' ' PRO . . . . . . . . . . . . . 31.3 Cg_endo -65.06 167.32 46.71 Favored 'Cis proline' 0 N--CA 1.498 1.749 0 CA-C-N 121.953 1.733 . . . . 0.0 111.542 -2.848 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' F' F ' 58' ' ' LEU . . . . . . . . . . . . . 18.2 tp -130.77 139.06 50.21 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.081 -0.509 . . . . 0.0 110.203 -179.81 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' F' F ' 59' ' ' ARG . . . . . . . . . . . . . 41.4 ttm180 -101.77 134.35 45.08 Favored 'General case' 0 C--N 1.326 -0.445 0 N-CA-C 109.276 -0.638 . . . . 0.0 109.276 174.523 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' F' F ' 60' ' ' VAL . . . . . . . . . . . . . 42.2 t -84.53 119.29 33.21 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.299 0 C-N-CA 120.569 -0.452 . . . . 0.0 110.161 -178.631 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' F' F ' 61' ' ' GLU . . . . . . . . . . . . . 70.5 tt0 -131.14 155.57 46.77 Favored 'General case' 0 C--N 1.327 -0.373 0 N-CA-C 109.094 -0.706 . . . . 0.0 109.094 176.276 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' F' F ' 62' ' ' ASP . . . . . . . . . . . . . 10.4 p-10 -52.49 -29.78 26.68 Favored 'General case' 0 C--N 1.326 -0.438 0 N-CA-C 112.064 0.394 . . . . 0.0 112.064 -177.72 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' F' F ' 63' ' ' ARG . . . . . . . . . . . . . 84.5 mtt-85 -75.5 -21.97 57.57 Favored 'General case' 0 CA--C 1.532 0.26 0 N-CA-C 113.092 0.775 . . . . 0.0 113.092 -175.902 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' F' F ' 64' ' ' THR . . . . . . . . . . . . . 31.5 m -67.07 146.47 54.28 Favored 'General case' 0 C--N 1.331 -0.227 0 CA-C-O 120.903 0.382 . . . . 0.0 111.195 -174.148 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' F' F ' 65' ' ' LYS . . . . . . . . . . . . . 68.3 mttm -88.63 127.65 35.57 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 115.954 -0.566 . . . . 0.0 110.036 177.691 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' F' F ' 66' ' ' ILE . . . . . . . . . . . . . 60.6 mt -115.02 127.43 72.58 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.322 0 N-CA-C 109.637 -0.505 . . . . 0.0 109.637 179.343 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' F' F ' 67' ' ' THR . . . . . . . . . . . . . 26.0 m -124.73 143.54 50.71 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-O 121.166 0.508 . . . . 0.0 111.357 -176.435 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' F' F ' 68' ' ' LEU . . . . . . . . . . . . . 6.3 tt -96.45 121.72 38.57 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 115.557 -0.747 . . . . 0.0 109.525 175.473 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' F' F ' 69' ' ' VAL . . . . . . . . . . . . . 42.2 t -99.14 133.96 39.92 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.291 0 CA-C-O 120.89 0.376 . . . . 0.0 110.177 -177.668 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' F' F ' 70' ' ' THR . . . . . . . . . . . . . 24.2 m -131.52 134.4 46.08 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.01 -0.541 . . . . 0.0 110.474 -179.618 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' F' F ' 71' ' ' HIS . . . . . . . . . . . . . 10.5 m80 -131.31 164.12 44.62 Favored Pre-proline 0 C--N 1.33 -0.259 0 CA-C-N 116.006 -0.543 . . . . 0.0 109.864 179.794 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' F' F ' 72' ' ' PRO . . . . . . . . . . . . . 29.9 Cg_endo -65.05 -28.46 57.28 Favored 'Trans proline' 0 N--CA 1.495 1.582 0 C-N-CA 121.177 1.251 . . . . 0.0 112.257 179.212 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' F' F ' 73' ' ' VAL . . . . . . . . . . . . . 33.5 m -135.51 158.3 40.01 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.234 0 CA-C-O 121.044 0.449 . . . . 0.0 110.929 178.624 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' F' F ' 74' ' ' ASP . . . . . . . . . . . . . 12.9 t70 -98.75 118.35 35.29 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 115.697 -0.683 . . . . 0.0 109.463 176.505 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' F' F ' 75' ' ' VAL . . . . . . . . . . . . . 38.5 t -111.5 125.44 68.81 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.298 0 CA-C-O 121.083 0.468 . . . . 0.0 110.619 -176.351 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' F' F ' 76' ' ' LEU . . . . . . . . . . . . . 21.1 mt -129.5 147.98 51.36 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 115.575 -0.739 . . . . 0.0 109.765 178.793 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' F' F ' 77' ' ' GLU . . . . . . . . . . . . . 43.9 mp0 -135.57 136.49 41.16 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-O 120.981 0.419 . . . . 0.0 111.01 -179.301 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' F' F ' 78' ' ' ALA . . . . . . . . . . . . . . . -123.12 135.25 54.28 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 115.701 -0.681 . . . . 0.0 109.935 176.903 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' F' F ' 79' ' ' LYS . . . . . . . . . . . . . 99.0 mttt -74.93 120.25 20.22 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-O 120.85 0.357 . . . . 0.0 110.801 -177.565 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' F' F ' 80' ' ' ILE . . . . . . . . . . . . . 31.6 mm -139.19 104.6 2.23 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.241 0 N-CA-C 108.956 -0.757 . . . . 0.0 108.956 -178.635 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' F' F ' 81' ' ' LYS . . . . . . . . . . . . . 60.4 tttm -99.11 121.55 41.15 Favored 'General case' 0 C--N 1.327 -0.403 0 CA-C-O 120.881 0.372 . . . . 0.0 111.318 -175.47 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' F' F ' 82' ' ' GLY . . . . . . . . . . . . . . . 89.17 42.17 5.65 Favored Glycine 0 CA--C 1.525 0.681 0 C-N-CA 121.026 -0.607 . . . . 0.0 111.99 174.705 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' F' F ' 83' ' ' ILE . . . . . . . . . . . . . 71.7 mt -66.3 137.38 24.99 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.314 0 N-CA-C 109.65 -0.5 . . . . 0.0 109.65 175.909 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' F' F ' 84' ' ' LYS . . . . . . . . . . . . . 24.1 ttpp -102.38 -50.6 3.56 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-O 120.863 0.363 . . . . 0.0 110.464 -179.758 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' F' F ' 85' ' ' ASP . . . . . . . . . . . . . 8.6 t70 -149.41 151.33 33.86 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 115.976 -0.556 . . . . 0.0 110.648 -179.59 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' F' F ' 86' ' ' VAL . . . . . . . . . . . . . 44.0 t -131.34 132.84 62.76 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.248 0 CA-C-O 120.895 0.379 . . . . 0.0 110.547 -178.645 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' F' F ' 87' ' ' ILE . . . . . . . . . . . . . 5.1 mp -121.94 129.93 75.01 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.289 0 N-CA-C 109.364 -0.606 . . . . 0.0 109.364 176.315 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' F' F ' 88' ' ' LEU . . . . . . . . . . . . . 13.9 tp -115.29 134.58 55.0 Favored 'General case' 0 C--N 1.332 -0.182 0 CA-C-O 121.182 0.515 . . . . 0.0 111.693 -175.366 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' F' F ' 89' ' ' ASP . . . . . . . . . . . . . 7.4 t0 -126.53 148.9 49.66 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 115.465 -0.788 . . . . 0.0 109.0 174.067 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' F' F ' 90' ' ' GLU . . . . . . . . . . . . . 93.5 mt-10 -49.38 -34.08 15.28 Favored 'General case' 0 C--N 1.329 -0.286 0 N-CA-C 112.625 0.602 . . . . 0.0 112.625 -173.769 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' F' F ' 91' ' ' ASN . . . . . . . . . . . . . 21.9 m120 -128.05 30.32 5.26 Favored 'General case' 0 N--CA 1.465 0.323 0 N-CA-C 112.187 0.44 . . . . 0.0 112.187 -176.974 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' F' F ' 92' ' ' LEU . . . . . . . . . . . . . 13.4 tp -166.19 147.57 6.68 Favored 'General case' 0 C--N 1.332 -0.179 0 CA-C-O 120.609 0.242 . . . . 0.0 110.52 -179.993 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' F' F ' 93' ' ' ILE . . . . . . . . . . . . . 70.4 mt -128.83 123.39 59.02 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.254 0 N-CA-C 109.541 -0.54 . . . . 0.0 109.541 179.416 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' F' F ' 94' ' ' VAL . . . . . . . . . . . . . 44.0 t -122.05 129.21 75.57 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.253 0 CA-C-O 120.884 0.373 . . . . 0.0 110.137 -179.424 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' F' F ' 95' ' ' VAL . . . . . . . . . . . . . 43.9 t -124.63 136.1 61.76 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.275 0 CA-C-N 116.04 -0.527 . . . . 0.0 110.054 -179.452 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' F' F ' 96' ' ' ILE . . . . . . . . . . . . . 59.6 mt -116.05 128.48 73.33 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.274 0 N-CA-C 109.255 -0.646 . . . . 0.0 109.255 178.783 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' F' F ' 97' ' ' THR . . . . . . . . . . . . . 82.6 p -102.89 156.63 17.53 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-O 121.156 0.503 . . . . 0.0 111.559 -175.845 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' F' F ' 98' ' ' GLU . . . . . . . . . . . . . 45.0 mt-10 -53.93 -26.04 23.39 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 116.099 -0.5 . . . . 0.0 112.179 179.395 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' F' F ' 99' ' ' GLU . . . . . . . . . . . . . 71.2 mm-40 -79.36 16.32 1.04 Allowed 'General case' 0 CA--C 1.535 0.377 0 N-CA-C 113.158 0.799 . . . . 0.0 113.158 -176.973 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' F' F ' 100' ' ' ASN . . . . . . . . . . . . . 2.1 m-20 62.11 32.78 17.35 Favored 'General case' 0 CA--C 1.531 0.232 0 CA-C-N 117.996 0.362 . . . . 0.0 111.555 178.412 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' F' F ' 101' ' ' GLU . . . . . . . . . . . . . 84.1 tt0 -112.56 144.71 41.59 Favored 'General case' 0 C--O 1.232 0.164 0 N-CA-C 109.735 -0.469 . . . . 0.0 109.735 175.412 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' F' F ' 102' ' ' VAL . . . . . . . . . . . . . 46.5 t -117.21 127.19 74.8 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.367 0 N-CA-C 109.67 -0.493 . . . . 0.0 109.67 -179.087 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' F' F ' 103' ' ' LEU . . . . . . . . . . . . . 27.9 mt -118.99 133.69 55.66 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 115.919 -0.582 . . . . 0.0 110.275 179.561 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' F' F ' 104' ' ' ILE . . . . . . . . . . . . . 70.5 mt -120.2 121.94 67.04 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.205 0 CA-C-N 116.469 -0.332 . . . . 0.0 110.295 -179.791 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' F' F ' 105' ' ' PHE . . . . . . . . . . . . . 81.4 m-85 -120.17 164.03 16.84 Favored 'General case' 0 C--N 1.332 -0.194 0 O-C-N 124.043 0.84 . . . . 0.0 109.681 179.504 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' F' F ' 106' ' ' ASN . . . . . . . . . . . . . 38.8 p-10 -97.41 -171.75 2.27 Favored 'General case' 0 C--N 1.331 -0.216 0 N-CA-C 109.957 -0.386 . . . . 0.0 109.957 174.091 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' F' F ' 107' ' ' GLN . . . . . . . . . . . . . 29.5 tt0 -60.01 -30.07 68.9 Favored 'General case' 0 C--N 1.33 -0.263 0 N-CA-C 111.986 0.365 . . . . 0.0 111.986 179.73 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' F' F ' 108' ' ' ASN . . . . . . . . . . . . . 44.6 t30 -82.71 6.04 19.3 Favored 'General case' 0 CA--C 1.536 0.433 0 N-CA-C 113.246 0.832 . . . . 0.0 113.246 -177.354 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' F' F ' 109' ' ' LEU . . . . . . . . . . . . . 12.6 tp 63.13 40.84 8.61 Favored 'General case' 0 C--O 1.233 0.189 0 CA-C-O 121.229 0.537 . . . . 0.0 111.091 178.107 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' F' F ' 110' ' ' GLU . . . . . . . . . . . . . 43.8 mt-10 -111.67 150.68 29.82 Favored 'General case' 0 C--N 1.33 -0.271 0 N-CA-C 109.814 -0.439 . . . . 0.0 109.814 174.639 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' F' F ' 111' ' ' GLU . . . . . . . . . . . . . 62.8 tt0 -84.75 121.98 28.46 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.389 -0.369 . . . . 0.0 110.956 -176.292 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' F' F ' 112' ' ' LEU . . . . . . . . . . . . . 57.7 mt -109.83 -46.02 3.55 Favored 'General case' 0 C--N 1.333 -0.144 0 CA-C-N 116.277 -0.419 . . . . 0.0 110.796 179.771 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' F' F ' 113' ' ' TYR . . . . . . . . . . . . . 61.0 t80 -132.99 140.56 47.83 Favored 'General case' 0 N--CA 1.464 0.271 0 CA-C-O 120.852 0.358 . . . . 0.0 110.745 -179.551 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' F' F ' 114' ' ' ARG . . . . . . . . . . . . . 36.0 ptt180 -143.99 123.46 13.17 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 115.848 -0.615 . . . . 0.0 110.347 178.384 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' F' F ' 115' ' ' GLY . . . . . . . . . . . . . . . -150.13 160.82 28.69 Favored Glycine 0 CA--C 1.525 0.661 0 N-CA-C 111.196 -0.762 . . . . 0.0 111.196 179.58 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' F' F ' 116' ' ' LYS . . . . . . . . . . . . . 76.8 tttt -130.5 140.6 50.51 Favored 'General case' 0 C--N 1.329 -0.287 0 N-CA-C 109.846 -0.428 . . . . 0.0 109.846 177.597 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' F' F ' 117' ' ' PHE . . . . . . . . . . . . . 30.8 m-85 -139.28 114.02 9.26 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.11 -0.495 . . . . 0.0 109.975 -177.222 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' F' F ' 118' ' ' GLU . . . . . . . . . . . . . 44.9 tp10 -52.05 -45.81 64.86 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.534 -0.303 . . . . 0.0 111.565 -176.927 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' F' F ' 119' ' ' ASN . . . . . . . . . . . . . 86.4 m-20 -98.52 31.14 2.96 Favored 'General case' 0 C--N 1.329 -0.299 0 N-CA-C 112.185 0.439 . . . . 0.0 112.185 -174.608 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' F' F ' 120' ' ' LEU . . . . . . . . . . . . . 17.5 tp -55.33 120.12 6.61 Favored 'General case' 0 N--CA 1.462 0.146 0 O-C-N 122.266 -0.271 . . . . 0.0 110.608 178.067 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' F' F ' 121' ' ' ASN . . . . . . . . . . . . . 89.1 m-20 -112.49 -44.09 3.41 Favored 'General case' 0 C--O 1.232 0.167 0 CA-C-N 116.579 -0.282 . . . . 0.0 111.219 -176.491 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' F' F ' 122' ' ' LYS . . . . . . . . . . . . . 92.4 mttt -146.68 150.24 35.02 Favored 'General case' 0 C--N 1.333 -0.138 0 C-N-CA 120.389 -0.524 . . . . 0.0 111.978 -177.862 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' F' F ' 123' ' ' VAL . . . . . . . . . . . . . 46.1 t -125.62 126.05 69.63 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.224 0 CA-C-N 115.726 -0.67 . . . . 0.0 109.53 175.471 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' F' F ' 124' ' ' LEU . . . . . . . . . . . . . 48.3 mt -115.97 132.99 56.49 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.399 -0.364 . . . . 0.0 110.363 -178.685 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' F' F ' 125' ' ' VAL . . . . . . . . . . . . . 34.9 m -131.73 137.1 55.83 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.211 0 CA-C-O 120.868 0.366 . . . . 0.0 111.074 -177.902 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' F' F ' 126' ' ' ARG . . . . . . . . . . . . . 96.7 mtt-85 -145.43 111.37 5.55 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.151 -0.477 . . . . 0.0 110.575 176.179 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' F' F ' 127' ' ' ASN . . . . . . . . . . . . . 6.2 m120 53.29 -104.91 0.22 Allowed 'General case' 0 CA--C 1.542 0.651 0 CA-C-O 119.07 -0.49 . . . . 0.0 111.193 178.869 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' F' F ' 128' ' ' ASP . . . . . . . . . . . . . 13.3 p-10 -113.66 3.22 15.53 Favored 'General case' 0 N--CA 1.469 0.495 0 CA-C-N 119.454 1.025 . . . . 0.0 113.378 -176.239 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' F' F ' 129' ' ' LEU . . . . . . . . . . . . . 17.2 tp -106.82 139.66 40.89 Favored 'General case' 0 C--N 1.334 -0.104 0 N-CA-C 109.787 -0.449 . . . . 0.0 109.787 177.853 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' F' F ' 130' ' ' VAL . . . . . . . . . . . . . 41.8 t -129.36 139.79 50.85 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.231 0 CA-C-O 121.064 0.459 . . . . 0.0 110.339 -177.565 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' F' F ' 131' ' ' VAL . . . . . . . . . . . . . 44.6 t -136.1 135.61 50.01 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.319 0 CA-C-N 116.015 -0.539 . . . . 0.0 109.838 176.915 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' F' F ' 132' ' ' ILE . . . . . . . . . . . . . 71.3 mt -117.57 134.05 62.4 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.292 0 CA-C-N 116.141 -0.481 . . . . 0.0 109.709 -178.681 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' F' F ' 133' ' ' ILE . . . . . . . . . . . . . 43.0 mm -115.3 123.24 70.67 Favored 'Isoleucine or valine' 0 C--O 1.233 0.217 0 CA-C-N 116.277 -0.42 . . . . 0.0 111.003 -175.054 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' F' F ' 134' ' ' ASP . . . . . . . . . . . . . 8.1 p-10 -134.87 145.48 48.32 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 115.892 -0.595 . . . . 0.0 109.505 173.952 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' F' F ' 135' ' ' GLU . . . . . . . . . . . . . 40.1 tp10 -49.9 -24.83 2.72 Favored 'General case' 0 CA--C 1.534 0.346 0 N-CA-C 112.737 0.643 . . . . 0.0 112.737 -173.901 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' F' F ' 136' ' ' GLN . . . . . . . . . . . . . 60.1 tt0 -81.91 -36.76 27.74 Favored 'General case' 0 C--O 1.234 0.243 0 N-CA-C 111.859 0.318 . . . . 0.0 111.859 -176.533 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' F' F ' 137' ' ' LYS . . . . . . . . . . . . . 20.0 pttp -168.18 175.36 6.59 Favored 'General case' 0 C--N 1.331 -0.201 0 CA-C-O 121.503 0.668 . . . . 0.0 111.984 -173.0 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' F' F ' 138' ' ' LEU . . . . . . . . . . . . . 7.3 tt -118.94 129.79 55.36 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 115.107 -0.951 . . . . 0.0 110.15 179.563 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' F' F ' 139' ' ' THR . . . . . . . . . . . . . 37.7 m -110.39 130.02 55.64 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.104 -0.498 . . . . 0.0 110.508 -179.984 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' F' F ' 140' ' ' LEU . . . . . . . . . . . . . 5.2 tt -115.38 123.98 50.04 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 115.855 -0.611 . . . . 0.0 109.755 -178.091 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' F' F ' 141' ' ' ILE . . . . . . . . . . . . . 18.8 mt -123.4 124.69 70.32 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.184 0 N-CA-C 110.015 -0.365 . . . . 0.0 110.015 -174.379 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' F' F ' 142' ' ' ARG . . . . . . . . . . . . . 77.1 ttt180 -120.91 134.57 55.3 Favored 'General case' 0 C--O 1.234 0.259 0 CA-C-N 116.106 -0.497 . . . . 0.0 110.297 -178.823 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' F' F ' 143' ' ' THR . . . . . . . . . . . . . 21.5 p . . . . . 0 C--O 1.219 -0.533 0 CA-C-O 117.99 -1.005 . . . . 0.0 110.567 -179.607 . . . . . . . . 0 0 . 1 . 017 nuclear orig full ' A' A ' -3' ' ' GLU . . . . . . . . . . . . . 78.6 tt0 . . . . . 0 N--CA 1.489 1.491 0 N-CA-C 109.232 -0.655 . . . . 0.0 109.232 . . . . . . . . . 0 0 . 1 . 017 nuclear orig full ' A' A ' -2' ' ' GLY . . . . . . . . . . . . . . . -74.55 150.04 41.08 Favored Glycine 0 CA--C 1.525 0.691 0 N-CA-C 110.899 -0.88 . . . . 0.0 110.899 179.775 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' -1' ' ' VAL . . . . . . . . . . . . . 42.3 t -94.33 130.89 42.58 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.243 0 CA-C-O 120.906 0.384 . . . . 0.0 110.061 -179.536 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 0' ' ' ILE . . . . . . . . . . . . . 68.7 mt -119.35 131.91 70.67 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.214 0 CA-C-N 116.12 -0.491 . . . . 0.0 110.007 -179.709 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 26.5 ptm -94.34 134.04 37.26 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.238 -0.437 . . . . 0.0 110.344 178.179 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 7.1 p -117.95 131.61 56.49 Favored 'General case' 0 C--N 1.332 -0.172 0 CA-C-O 121.084 0.469 . . . . 0.0 110.598 179.307 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 95.6 mt-10 -141.23 141.41 34.03 Favored 'General case' 0 C--N 1.327 -0.406 0 CA-C-N 115.861 -0.609 . . . . 0.0 110.876 -179.096 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 4' ' ' LEU . . . . . . . . . . . . . 3.7 tt -128.19 124.95 38.04 Favored 'General case' 0 C--N 1.33 -0.268 0 N-CA-C 109.679 -0.489 . . . . 0.0 109.679 176.887 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 5' ' ' LYS . . . . . . . . . . . . . 63.0 mttp -107.7 122.61 47.08 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-O 120.625 0.25 . . . . 0.0 111.087 -179.189 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 25.2 mt -114.0 144.51 42.97 Favored 'General case' 0 C--O 1.232 0.145 0 CA-C-N 115.542 -0.754 . . . . 0.0 110.525 179.419 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 24.8 ttmt -126.52 139.38 34.56 Favored Pre-proline 0 CA--C 1.531 0.247 0 N-CA-C 109.537 -0.542 . . . . 0.0 109.537 173.224 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 8' ' ' PRO . . . . . . . . . . . . . 98.3 Cg_endo -91.5 141.76 2.76 Favored 'Trans proline' 0 N--CA 1.491 1.335 0 C-N-CA 121.715 1.61 . . . . 0.0 112.156 -179.674 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 56.3 mt -80.07 -47.22 1.39 Allowed Pre-proline 0 CA--C 1.534 0.364 0 CA-C-O 118.64 -0.695 . . . . 0.0 112.222 178.799 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 89.8 Cg_endo -80.98 153.79 19.36 Favored 'Trans proline' 0 N--CA 1.496 1.644 0 C-N-CA 121.168 1.245 . . . . 0.0 111.749 176.142 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 19.4 tptp -88.23 99.09 11.95 Favored 'General case' 0 C--N 1.33 -0.274 0 N-CA-C 110.005 -0.369 . . . . 0.0 110.005 179.303 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 12.7 p -142.34 148.54 20.09 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.258 0 CA-C-N 116.326 -0.397 . . . . 0.0 110.928 -177.766 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 84.2 tt0 -93.69 121.1 34.78 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.05 -0.523 . . . . 0.0 110.04 176.628 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 14' ' ' LEU . . . . . . . . . . . . . 46.6 mt -98.58 152.3 37.84 Favored Pre-proline 0 CA--C 1.533 0.29 0 CA-C-N 116.468 -0.333 . . . . 0.0 110.843 -178.309 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 15' ' ' PRO . . . . . . . . . . . . . 28.6 Cg_exo -61.03 158.65 33.24 Favored 'Trans proline' 0 N--CA 1.498 1.74 0 C-N-CA 121.3 1.333 . . . . 0.0 112.013 177.706 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 16' ' ' PRO . . . . . . . . . . . . . 29.5 Cg_exo -59.99 -36.08 91.04 Favored 'Trans proline' 0 N--CA 1.497 1.677 0 C-N-CA 121.443 1.429 . . . . 0.0 112.689 -179.919 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 17' ' ' ASP . . . . . . . . . . . . . 21.7 p-10 -85.84 8.72 19.02 Favored 'General case' 0 CA--C 1.536 0.406 0 N-CA-C 113.295 0.85 . . . . 0.0 113.295 -177.172 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 18' ' ' PHE . . . . . . . . . . . . . 41.9 t80 -58.09 -44.01 87.36 Favored 'General case' 0 N--CA 1.457 -0.087 0 O-C-N 122.03 -0.419 . . . . 0.0 110.102 -178.713 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 19' ' ' VAL . . . . . . . . . . . . . 48.5 t -56.15 -42.66 73.64 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.291 0 CA-C-N 116.275 -0.42 . . . . 0.0 110.457 -178.81 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 73.0 m-20 -59.89 -43.68 94.67 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-O 120.791 0.329 . . . . 0.0 110.885 -177.907 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 45.8 t -64.35 -45.57 95.61 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.292 0 C-N-CA 120.715 -0.394 . . . . 0.0 110.574 -177.466 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 22' ' ' ILE . . . . . . . . . . . . . 51.1 mm -55.36 -47.61 77.83 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.254 0 C-N-CA 120.921 -0.312 . . . . 0.0 110.73 179.26 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 23' ' ' ARG . . . . . . . . . . . . . 55.6 ttp180 -55.44 -49.1 73.34 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-O 120.704 0.288 . . . . 0.0 111.207 -178.48 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 24' ' ' ILE . . . . . . . . . . . . . 71.6 mt -58.99 -41.72 84.06 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.258 0 CA-C-N 116.529 -0.305 . . . . 0.0 111.351 -176.419 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 83.6 mttt -71.75 -41.1 68.86 Favored 'General case' 0 C--N 1.328 -0.346 0 N-CA-C 112.714 0.635 . . . . 0.0 112.714 -178.02 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 34.2 mt -78.53 -32.58 48.03 Favored 'General case' 0 C--N 1.328 -0.343 0 N-CA-C 113.697 0.999 . . . . 0.0 113.697 -170.332 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 27' ' ' GLN . . . . . . . . . . . . . 10.2 pt20 -47.11 140.76 4.81 Favored 'General case' 0 N--CA 1.468 0.463 0 N-CA-C 112.771 0.656 . . . . 0.0 112.771 -175.873 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 99.62 -24.11 33.49 Favored Glycine 0 CA--C 1.534 1.222 0 CA-C-N 115.696 -0.684 . . . . 0.0 112.399 -178.047 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 57.2 mtpt -97.62 155.06 17.15 Favored 'General case' 0 C--N 1.333 -0.13 0 CA-C-N 117.531 0.666 . . . . 0.0 111.125 179.312 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 30' ' ' THR . . . . . . . . . . . . . 41.0 m -105.18 137.32 43.14 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 115.89 -0.595 . . . . 0.0 110.036 176.273 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 34.7 m -129.08 152.27 36.96 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.213 0 CA-C-O 120.932 0.396 . . . . 0.0 110.932 -178.402 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 32' ' ' ARG . . . . . . . . . . . . . 68.3 ttp85 -130.28 148.51 52.12 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 115.94 -0.573 . . . . 0.0 110.477 179.924 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 33' ' ' THR . . . . . . . . . . . . . 25.0 m -52.99 139.3 28.17 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.308 -0.405 . . . . 0.0 111.435 -178.024 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 100.16 -17.12 57.49 Favored Glycine 0 CA--C 1.532 1.137 0 CA-C-O 119.698 -0.501 . . . . 0.0 113.342 179.437 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 77.8 m-20 -66.43 149.58 50.2 Favored 'General case' 0 C--N 1.334 -0.102 0 CA-C-N 118.055 0.927 . . . . 0.0 111.228 179.122 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 47.4 t -122.35 130.55 74.44 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.199 0 CA-C-N 115.881 -0.6 . . . . 0.0 109.729 177.922 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 37' ' ' ILE . . . . . . . . . . . . . 65.4 mt -122.56 140.24 46.98 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.282 0 CA-C-N 116.063 -0.517 . . . . 0.0 109.998 -178.196 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . -113.89 128.45 8.28 Favored Glycine 0 CA--C 1.525 0.71 0 N-CA-C 110.983 -0.847 . . . . 0.0 110.983 178.343 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 39' ' ' ILE . . . . . . . . . . . . . 73.9 mt -127.95 136.63 59.77 Favored 'Isoleucine or valine' 0 N--CA 1.462 0.175 0 N-CA-C 110.069 -0.345 . . . . 0.0 110.069 178.928 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 40' ' ' SER . . . . . . . . . . . . . 88.3 p -92.69 118.99 31.64 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.481 -0.327 . . . . 0.0 111.15 177.014 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 41' ' ' ILE . . . . . . . . . . . . . 45.2 mm -121.66 121.99 65.84 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.214 0 CA-C-N 116.438 -0.346 . . . . 0.0 110.232 178.327 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 38.1 mt 53.25 34.25 17.27 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.265 -0.425 . . . . 0.0 111.918 176.602 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . 75.72 27.51 62.81 Favored Glycine 0 CA--C 1.53 1.016 0 C-N-CA 121.077 -0.583 . . . . 0.0 112.594 176.646 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 44' ' ' LYS . . . . . . . . . . . . . 24.7 ttpp -140.33 133.44 29.51 Favored 'General case' 0 C--N 1.33 -0.25 0 N-CA-C 109.427 -0.583 . . . . 0.0 109.427 176.582 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 84.3 tt0 -82.85 126.12 32.09 Favored 'General case' 0 C--N 1.329 -0.318 0 C-N-CA 120.796 -0.361 . . . . 0.0 111.327 -176.325 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 46' ' ' VAL . . . . . . . . . . . . . 9.2 p -120.29 125.67 74.44 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.199 0 N-CA-C 109.166 -0.679 . . . . 0.0 109.166 173.975 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 95.5 mttt -99.2 127.67 45.21 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.085 -0.507 . . . . 0.0 110.807 179.076 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 48' ' ' PHE . . . . . . . . . . . . . 37.7 m-85 -111.39 131.89 54.85 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.075 -0.511 . . . . 0.0 109.998 178.486 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 80.4 tttt -106.61 134.86 49.09 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.45 -0.341 . . . . 0.0 110.164 177.469 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 50' ' ' VAL . . . . . . . . . . . . . 44.4 t -78.16 106.14 8.29 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.285 0 N-CA-C 109.559 -0.534 . . . . 0.0 109.559 177.949 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 51' ' ' VAL . . . . . . . . . . . . . 48.7 t -71.25 -49.96 44.61 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.303 0 CA-C-N 115.946 -0.57 . . . . 0.0 109.83 -175.457 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 52' ' ' GLN . . . . . . . . . . . . . 62.0 tt0 -158.55 139.63 13.09 Favored 'General case' 0 C--N 1.33 -0.28 0 C-N-CA 120.278 -0.569 . . . . 0.0 111.764 -177.82 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -115.5 131.52 56.91 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 115.569 -0.741 . . . . 0.0 109.739 174.976 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 54' ' ' TYR . . . . . . . . . . . . . 43.6 t80 -129.03 110.21 18.29 Favored Pre-proline 0 CA--C 1.535 0.397 0 CA-C-O 118.208 -0.901 . . . . 0.0 110.52 -179.334 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 55' ' ' PRO . . . . . . . . . . . . . 72.9 Cg_endo -77.1 169.95 72.9 Favored 'Cis proline' 0 N--CA 1.498 1.781 0 CA-C-N 121.913 1.719 . . . . 0.0 112.228 -5.067 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 56' ' ' SER . . . . . . . . . . . . . 15.0 m -113.64 127.88 26.34 Favored Pre-proline 0 CA--C 1.539 0.529 0 CA-C-O 118.446 -0.788 . . . . 0.0 109.633 176.616 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 57' ' ' PRO . . . . . . . . . . . . . 60.4 Cg_endo -74.11 149.55 94.17 Favored 'Cis proline' 0 N--CA 1.498 1.739 0 CA-C-N 122.002 1.751 . . . . 0.0 111.685 0.063 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 58' ' ' LEU . . . . . . . . . . . . . 32.0 tp -108.16 137.09 46.74 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.229 -0.441 . . . . 0.0 110.606 -178.253 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 59' ' ' ARG . . . . . . . . . . . . . 52.8 ttp180 -104.4 127.94 52.17 Favored 'General case' 0 C--N 1.328 -0.338 0 N-CA-C 109.24 -0.652 . . . . 0.0 109.24 175.345 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 42.2 t -83.5 121.26 36.01 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.259 0 C-N-CA 120.731 -0.388 . . . . 0.0 110.771 -173.758 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 95.8 mt-10 -131.12 165.02 24.18 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 115.667 -0.697 . . . . 0.0 109.627 175.749 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 62' ' ' ASP . . . . . . . . . . . . . 19.0 p-10 -53.78 -32.49 52.69 Favored 'General case' 0 C--N 1.329 -0.322 0 C-N-CA 121.035 -0.266 . . . . 0.0 111.663 179.428 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 63' ' ' ARG . . . . . . . . . . . . . 67.7 mtp180 -72.52 -22.08 61.09 Favored 'General case' 0 CA--C 1.532 0.282 0 N-CA-C 112.963 0.727 . . . . 0.0 112.963 -176.814 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 25.8 m -69.18 138.97 54.54 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-O 120.981 0.42 . . . . 0.0 110.876 -174.982 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 65' ' ' LYS . . . . . . . . . . . . . 90.8 mttt -88.56 127.78 35.55 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 115.964 -0.562 . . . . 0.0 109.854 178.673 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 66' ' ' ILE . . . . . . . . . . . . . 63.4 mt -112.47 129.01 68.79 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.189 0 N-CA-C 109.62 -0.511 . . . . 0.0 109.62 178.718 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 67' ' ' THR . . . . . . . . . . . . . 19.4 m -121.03 136.29 55.02 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.09 -0.504 . . . . 0.0 110.689 -177.311 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 68' ' ' LEU . . . . . . . . . . . . . 17.7 tp -106.06 124.94 50.38 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 115.938 -0.574 . . . . 0.0 110.342 178.753 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 69' ' ' VAL . . . . . . . . . . . . . 45.7 t -98.22 130.07 47.55 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.361 0 N-CA-C 109.639 -0.504 . . . . 0.0 109.639 177.621 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 70' ' ' THR . . . . . . . . . . . . . 4.7 m -107.16 109.26 21.05 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.308 -0.405 . . . . 0.0 110.809 -177.759 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 71' ' ' HIS . . . . . . . . . . . . . 30.4 m80 -149.93 158.39 37.06 Favored Pre-proline 0 C--N 1.33 -0.281 0 CA-C-N 116.048 -0.524 . . . . 0.0 110.439 177.096 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 72' ' ' PRO . . . . . . . . . . . . . 52.1 Cg_endo -84.11 -23.77 2.88 Favored 'Trans proline' 0 N--CA 1.49 1.315 0 C-N-CA 121.558 1.505 . . . . 0.0 113.044 179.269 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 73' ' ' VAL . . . . . . . . . . . . . 35.3 m -132.44 167.38 26.65 Favored 'Isoleucine or valine' 0 C--O 1.232 0.145 0 CA-C-O 121.006 0.431 . . . . 0.0 110.955 -179.028 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 74' ' ' ASP . . . . . . . . . . . . . 7.2 t70 -101.2 122.62 43.96 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 115.777 -0.647 . . . . 0.0 109.71 179.333 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 42.7 t -119.19 128.84 75.81 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.322 0 CA-C-O 121.188 0.518 . . . . 0.0 110.899 -176.342 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 76' ' ' LEU . . . . . . . . . . . . . 5.0 mp -124.56 145.63 49.48 Favored 'General case' 0 C--N 1.332 -0.161 0 CA-C-N 115.643 -0.708 . . . . 0.0 109.818 174.679 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 77' ' ' GLU . . . . . . . . . . . . . 97.5 mt-10 -136.15 133.04 36.78 Favored 'General case' 0 C--N 1.331 -0.226 0 CA-C-O 120.927 0.394 . . . . 0.0 111.3 -179.935 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 78' ' ' ALA . . . . . . . . . . . . . . . -121.53 139.62 53.26 Favored 'General case' 0 C--N 1.331 -0.197 0 CA-C-N 115.82 -0.627 . . . . 0.0 109.698 176.105 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 79' ' ' LYS . . . . . . . . . . . . . 32.8 ttpt -76.96 119.85 21.27 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-O 120.889 0.376 . . . . 0.0 110.247 -179.919 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 80' ' ' ILE . . . . . . . . . . . . . 22.9 mm -139.24 111.86 5.86 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.327 0 N-CA-C 109.007 -0.738 . . . . 0.0 109.007 -178.544 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 81' ' ' LYS . . . . . . . . . . . . . 79.0 tttt -115.77 129.09 56.31 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-O 120.902 0.382 . . . . 0.0 110.657 -177.138 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . 89.11 41.98 5.72 Favored Glycine 0 CA--C 1.525 0.704 0 N-CA-C 111.342 -0.703 . . . . 0.0 111.342 178.085 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 83' ' ' ILE . . . . . . . . . . . . . 75.9 mt -67.33 140.21 19.7 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.309 0 CA-C-O 120.902 0.382 . . . . 0.0 109.993 178.593 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 84' ' ' LYS . . . . . . . . . . . . . 71.6 tttt -99.71 -52.03 3.57 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.043 -0.526 . . . . 0.0 110.074 -179.901 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 85' ' ' ASP . . . . . . . . . . . . . 5.0 t70 -159.86 156.73 27.86 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 115.758 -0.656 . . . . 0.0 110.365 179.809 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 86' ' ' VAL . . . . . . . . . . . . . 40.7 t -131.13 132.87 63.22 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.228 0 CA-C-O 120.983 0.42 . . . . 0.0 110.744 -178.94 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 87' ' ' ILE . . . . . . . . . . . . . 43.9 mm -120.07 126.82 75.68 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.268 0 CA-C-N 115.771 -0.649 . . . . 0.0 109.361 177.08 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 88' ' ' LEU . . . . . . . . . . . . . 19.1 tp -114.84 134.33 55.22 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-O 120.944 0.402 . . . . 0.0 111.423 -176.8 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 89' ' ' ASP . . . . . . . . . . . . . 13.5 t70 -129.38 157.17 42.67 Favored 'General case' 0 C--N 1.331 -0.226 0 CA-C-N 115.787 -0.642 . . . . 0.0 109.606 176.719 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 60.2 mp0 -48.51 -35.96 14.24 Favored 'General case' 0 C--N 1.332 -0.192 0 N-CA-C 113.06 0.763 . . . . 0.0 113.06 -171.154 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 91' ' ' ASN . . . . . . . . . . . . . 27.6 t30 -130.65 18.35 5.21 Favored 'General case' 0 N--CA 1.47 0.534 0 N-CA-C 113.15 0.796 . . . . 0.0 113.15 -177.238 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 92' ' ' LEU . . . . . . . . . . . . . 22.6 mt -146.99 142.52 27.59 Favored 'General case' 0 C--N 1.331 -0.216 0 N-CA-C 110.221 -0.288 . . . . 0.0 110.221 -177.595 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 93' ' ' ILE . . . . . . . . . . . . . 71.9 mt -123.21 117.86 52.89 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.354 0 N-CA-C 109.312 -0.625 . . . . 0.0 109.312 177.695 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 94' ' ' VAL . . . . . . . . . . . . . 41.9 t -120.24 128.75 76.0 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.25 0 CA-C-O 120.959 0.409 . . . . 0.0 110.102 -178.987 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 95' ' ' VAL . . . . . . . . . . . . . 42.5 t -123.24 135.56 62.79 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.367 0 CA-C-N 115.933 -0.576 . . . . 0.0 109.77 179.616 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 96' ' ' ILE . . . . . . . . . . . . . 66.9 mt -114.17 130.94 67.53 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.36 0 N-CA-C 109.425 -0.583 . . . . 0.0 109.425 179.259 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 97' ' ' THR . . . . . . . . . . . . . 60.4 p -104.65 158.09 16.73 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-O 121.04 0.447 . . . . 0.0 111.267 -177.825 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 98' ' ' GLU . . . . . . . . . . . . . 97.3 mt-10 -53.98 -26.03 23.89 Favored 'General case' 0 C--N 1.328 -0.355 0 N-CA-C 112.371 0.508 . . . . 0.0 112.371 -179.763 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 99' ' ' GLU . . . . . . . . . . . . . 95.6 mt-10 -78.56 14.62 1.22 Allowed 'General case' 0 CA--C 1.536 0.417 0 N-CA-C 113.171 0.804 . . . . 0.0 113.171 -177.343 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 100' ' ' ASN . . . . . . . . . . . . . 3.6 m-20 62.17 37.94 14.02 Favored 'General case' 0 N--CA 1.462 0.172 0 CA-C-O 121.125 0.488 . . . . 0.0 110.894 178.818 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 101' ' ' GLU . . . . . . . . . . . . . 84.6 tt0 -115.36 144.24 44.07 Favored 'General case' 0 C--O 1.233 0.2 0 CA-C-N 116.047 -0.524 . . . . 0.0 109.807 176.584 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 102' ' ' VAL . . . . . . . . . . . . . 45.1 t -115.03 124.69 71.93 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.338 0 CA-C-N 116.067 -0.515 . . . . 0.0 109.94 -178.339 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 103' ' ' LEU . . . . . . . . . . . . . 23.2 mt -115.13 126.82 55.09 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 115.753 -0.658 . . . . 0.0 110.168 176.449 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 104' ' ' ILE . . . . . . . . . . . . . 72.6 mt -118.21 120.42 64.37 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.232 0 N-CA-C 109.983 -0.377 . . . . 0.0 109.983 179.438 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 105' ' ' PHE . . . . . . . . . . . . . 53.5 m-85 -120.32 162.33 19.63 Favored 'General case' 0 C--N 1.332 -0.178 0 CA-C-N 115.5 -0.773 . . . . 0.0 110.052 179.955 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 106' ' ' ASN . . . . . . . . . . . . . 43.1 p-10 -93.8 -169.83 2.19 Favored 'General case' 0 C--N 1.329 -0.311 0 N-CA-C 109.785 -0.45 . . . . 0.0 109.785 173.375 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 107' ' ' GLN . . . . . . . . . . . . . 48.6 tt0 -57.64 -30.03 65.06 Favored 'General case' 0 CA--C 1.532 0.268 0 N-CA-C 112.061 0.393 . . . . 0.0 112.061 179.37 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 108' ' ' ASN . . . . . . . . . . . . . 49.4 t30 -84.72 9.48 13.87 Favored 'General case' 0 CA--C 1.536 0.412 0 N-CA-C 113.251 0.834 . . . . 0.0 113.251 -177.131 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 109' ' ' LEU . . . . . . . . . . . . . 10.9 tp 58.28 37.03 26.03 Favored 'General case' 0 C--N 1.331 -0.23 0 CA-C-O 120.983 0.421 . . . . 0.0 111.28 179.167 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 110' ' ' GLU . . . . . . . . . . . . . 95.7 mt-10 -106.64 159.48 16.16 Favored 'General case' 0 C--N 1.332 -0.174 0 CA-C-O 120.811 0.338 . . . . 0.0 110.166 176.846 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 111' ' ' GLU . . . . . . . . . . . . . 80.4 tt0 -81.58 121.92 26.93 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.282 -0.417 . . . . 0.0 111.213 -175.646 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 112' ' ' LEU . . . . . . . . . . . . . 15.3 mt -110.29 -46.08 3.48 Favored 'General case' 0 C--N 1.331 -0.227 0 CA-C-N 116.064 -0.516 . . . . 0.0 109.829 175.238 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 113' ' ' TYR . . . . . . . . . . . . . 58.7 t80 -139.24 136.6 35.13 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.145 -0.48 . . . . 0.0 110.931 178.849 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 114' ' ' ARG . . . . . . . . . . . . . 63.3 ttt180 -140.3 122.06 15.4 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 116.095 -0.502 . . . . 0.0 110.187 178.117 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 115' ' ' GLY . . . . . . . . . . . . . . . -150.08 161.66 28.96 Favored Glycine 0 CA--C 1.525 0.703 0 C-N-CA 120.732 -0.747 . . . . 0.0 111.391 179.676 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 116' ' ' LYS . . . . . . . . . . . . . 39.8 ttpt -128.88 136.17 50.07 Favored 'General case' 0 C--N 1.33 -0.27 0 N-CA-C 109.869 -0.419 . . . . 0.0 109.869 177.179 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 117' ' ' PHE . . . . . . . . . . . . . 39.3 m-85 -134.55 113.88 12.23 Favored 'General case' 0 C--N 1.329 -0.285 0 N-CA-C 109.878 -0.416 . . . . 0.0 109.878 -178.012 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 118' ' ' GLU . . . . . . . . . . . . . 12.9 pt-20 -57.06 -39.29 74.64 Favored 'General case' 0 C--N 1.329 -0.313 0 C-N-CA 120.726 -0.39 . . . . 0.0 111.084 -176.415 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 119' ' ' ASN . . . . . . . . . . . . . 32.7 m120 -94.81 26.0 3.79 Favored 'General case' 0 C--N 1.331 -0.207 0 N-CA-C 112.644 0.609 . . . . 0.0 112.644 -174.558 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 120' ' ' LEU . . . . . . . . . . . . . 17.5 tp -58.55 125.01 21.58 Favored 'General case' 0 C--N 1.333 -0.139 0 CA-C-O 120.816 0.341 . . . . 0.0 110.227 178.973 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 121' ' ' ASN . . . . . . . . . . . . . 4.2 m120 -113.96 -44.16 3.19 Favored 'General case' 0 C--N 1.332 -0.186 0 CA-C-N 116.262 -0.426 . . . . 0.0 110.581 -179.141 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 122' ' ' LYS . . . . . . . . . . . . . 56.6 pttt -159.71 157.93 30.41 Favored 'General case' 0 C--N 1.332 -0.186 0 C-N-CA 120.525 -0.47 . . . . 0.0 111.671 -179.624 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 123' ' ' VAL . . . . . . . . . . . . . 43.7 t -129.99 136.78 58.11 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.229 0 CA-C-N 116.022 -0.535 . . . . 0.0 110.09 179.956 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 124' ' ' LEU . . . . . . . . . . . . . 78.4 mt -119.82 133.96 55.41 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.152 -0.476 . . . . 0.0 110.81 -178.93 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 125' ' ' VAL . . . . . . . . . . . . . 48.3 t -126.91 127.25 69.67 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.218 0 N-CA-C 109.482 -0.562 . . . . 0.0 109.482 176.671 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 126' ' ' ARG . . . . . . . . . . . . . 41.7 ttt180 -144.01 124.4 13.89 Favored 'General case' 0 C--N 1.33 -0.242 0 C-N-CA 120.763 -0.375 . . . . 0.0 110.834 -179.192 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 127' ' ' ASN . . . . . . . . . . . . . 3.5 m120 51.2 -106.63 0.26 Allowed 'General case' 0 CA--C 1.544 0.726 0 CA-C-O 118.934 -0.555 . . . . 0.0 111.311 179.916 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 128' ' ' ASP . . . . . . . . . . . . . 10.9 p-10 -114.09 0.4 14.28 Favored 'General case' 0 N--CA 1.467 0.407 0 CA-C-N 119.754 1.161 . . . . 0.0 113.463 -177.883 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 129' ' ' LEU . . . . . . . . . . . . . 30.6 mt -104.91 141.73 36.02 Favored 'General case' 0 C--O 1.232 0.161 0 CA-C-N 118.249 0.477 . . . . 0.0 110.668 -178.429 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 130' ' ' VAL . . . . . . . . . . . . . 46.2 t -123.42 133.59 68.73 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.274 0 CA-C-N 115.973 -0.558 . . . . 0.0 109.574 178.422 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 131' ' ' VAL . . . . . . . . . . . . . 44.4 t -133.86 135.8 54.69 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.27 0 CA-C-O 121.119 0.485 . . . . 0.0 110.162 179.451 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 132' ' ' ILE . . . . . . . . . . . . . 73.8 mt -113.41 130.94 66.5 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.289 0 CA-C-N 115.668 -0.696 . . . . 0.0 109.249 179.423 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 133' ' ' ILE . . . . . . . . . . . . . 42.1 mm -114.2 120.33 63.66 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.277 0 CA-C-O 120.888 0.375 . . . . 0.0 110.727 -176.356 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 134' ' ' ASP . . . . . . . . . . . . . 7.1 p-10 -132.36 145.96 51.62 Favored 'General case' 0 C--N 1.33 -0.255 0 N-CA-C 109.104 -0.702 . . . . 0.0 109.104 174.003 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 135' ' ' GLU . . . . . . . . . . . . . 41.8 tp10 -49.69 -24.66 2.39 Favored 'General case' 0 C--N 1.328 -0.34 0 N-CA-C 112.881 0.697 . . . . 0.0 112.881 -170.961 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 136' ' ' GLN . . . . . . . . . . . . . 54.1 tp60 -96.53 -34.08 11.59 Favored 'General case' 0 CA--C 1.53 0.18 0 N-CA-C 112.223 0.453 . . . . 0.0 112.223 -175.871 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 137' ' ' LYS . . . . . . . . . . . . . 65.3 mttt -141.22 156.57 45.89 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-O 121.31 0.576 . . . . 0.0 111.905 -169.551 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 138' ' ' LEU . . . . . . . . . . . . . 5.1 tt -119.41 122.9 42.81 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 115.392 -0.822 . . . . 0.0 109.042 172.028 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 139' ' ' THR . . . . . . . . . . . . . 24.8 m -107.06 128.11 54.08 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.552 -0.295 . . . . 0.0 110.548 -178.107 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 140' ' ' LEU . . . . . . . . . . . . . 44.4 tp -113.32 119.73 38.69 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 115.74 -0.664 . . . . 0.0 109.417 -179.08 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 141' ' ' ILE . . . . . . . . . . . . . 19.3 mt -119.89 118.11 55.96 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.264 0 CA-C-O 121.006 0.431 . . . . 0.0 109.88 -176.713 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 142' ' ' ARG . . . . . . . . . . . . . 78.1 mtm180 -104.47 129.7 52.45 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 115.285 -0.871 . . . . 0.0 110.549 -178.693 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 143' ' ' THR . . . . . . . . . . . . . 77.1 p . . . . . 0 C--O 1.22 -0.466 0 CA-C-O 117.944 -1.027 . . . . 0.0 110.482 179.501 . . . . . . . . 0 0 . 1 . 017 nuclear orig full ' B' B ' -3' ' ' GLU . . . . . . . . . . . . . 95.6 mt-10 . . . . . 0 N--CA 1.49 1.543 0 N-CA-C 109.308 -0.627 . . . . 0.0 109.308 . . . . . . . . . 0 0 . 1 . 017 nuclear orig full ' B' B ' -2' ' ' GLY . . . . . . . . . . . . . . . -76.86 139.05 23.04 Favored Glycine 0 CA--C 1.524 0.595 0 N-CA-C 110.92 -0.872 . . . . 0.0 110.92 179.273 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' B' B ' -1' ' ' VAL . . . . . . . . . . . . . 45.3 t -141.42 132.03 26.41 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.258 0 N-CA-C 110.04 -0.356 . . . . 0.0 110.04 -179.899 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' B' B ' 0' ' ' ILE . . . . . . . . . . . . . 72.0 mt -119.77 128.09 75.9 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.2 0 CA-C-N 116.198 -0.455 . . . . 0.0 109.818 178.403 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' B' B ' 1' ' ' MET . . . . . . . . . . . . . 24.8 ptt? -81.79 124.59 29.79 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 116.256 -0.429 . . . . 0.0 110.539 179.625 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' B' B ' 2' ' ' SER . . . . . . . . . . . . . 12.5 p -123.97 132.64 53.74 Favored 'General case' 0 C--N 1.331 -0.207 0 CA-C-N 116.235 -0.439 . . . . 0.0 110.37 179.216 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' B' B ' 3' ' ' GLU . . . . . . . . . . . . . 43.6 mt-10 -140.52 145.02 36.28 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-N 115.751 -0.658 . . . . 0.0 110.999 -176.989 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' B' B ' 4' ' ' LEU . . . . . . . . . . . . . 23.1 tp -124.28 128.25 48.87 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.063 -0.517 . . . . 0.0 110.131 174.747 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' B' B ' 5' ' ' LYS . . . . . . . . . . . . . 63.8 mmtt -105.45 113.8 27.58 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 115.988 -0.551 . . . . 0.0 111.121 -179.202 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' B' B ' 6' ' ' LEU . . . . . . . . . . . . . 28.7 mt -113.71 137.48 51.55 Favored 'General case' 0 C--N 1.333 -0.147 0 O-C-N 124.034 0.834 . . . . 0.0 109.659 178.214 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' B' B ' 7' ' ' LYS . . . . . . . . . . . . . 57.7 tttp -123.2 137.95 29.14 Favored Pre-proline 0 CA--C 1.533 0.32 0 CA-C-O 118.853 -0.594 . . . . 0.0 109.862 177.333 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' B' B ' 8' ' ' PRO . . . . . . . . . . . . . 85.0 Cg_endo -90.41 137.2 2.44 Favored 'Trans proline' 0 N--CA 1.491 1.377 0 C-N-CA 121.625 1.55 . . . . 0.0 111.872 179.062 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' B' B ' 9' ' ' LEU . . . . . . . . . . . . . 39.5 mt -80.43 -48.57 1.23 Allowed Pre-proline 0 CA--C 1.535 0.374 0 CA-C-O 118.555 -0.736 . . . . 0.0 112.441 -179.69 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' B' B ' 10' ' ' PRO . . . . . . . . . . . . . 90.0 Cg_endo -78.88 156.21 27.0 Favored 'Trans proline' 0 N--CA 1.497 1.694 0 C-N-CA 121.183 1.256 . . . . 0.0 112.051 178.727 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' B' B ' 11' ' ' LYS . . . . . . . . . . . . . 60.6 mttp -82.71 93.13 7.32 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.353 -0.385 . . . . 0.0 110.333 178.476 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' B' B ' 12' ' ' VAL . . . . . . . . . . . . . 12.7 p -140.16 146.91 24.05 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.303 0 CA-C-N 116.296 -0.411 . . . . 0.0 110.718 -179.262 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' B' B ' 13' ' ' GLU . . . . . . . . . . . . . 84.7 tt0 -97.66 129.04 44.77 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.345 -0.389 . . . . 0.0 110.057 177.823 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' B' B ' 14' ' ' LEU . . . . . . . . . . . . . 27.3 mt -98.37 149.91 36.2 Favored Pre-proline 0 CA--C 1.532 0.282 0 CA-C-O 119.298 -0.382 . . . . 0.0 110.65 -177.12 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' B' B ' 15' ' ' PRO . . . . . . . . . . . . . 24.2 Cg_exo -63.68 160.57 35.87 Favored 'Trans proline' 0 N--CA 1.498 1.737 0 C-N-CA 121.366 1.377 . . . . 0.0 111.733 175.36 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' B' B ' 16' ' ' PRO . . . . . . . . . . . . . 30.4 Cg_exo -59.84 -35.81 92.86 Favored 'Trans proline' 0 N--CA 1.498 1.737 0 C-N-CA 121.47 1.447 . . . . 0.0 112.688 -178.589 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' B' B ' 17' ' ' ASP . . . . . . . . . . . . . 38.1 p30 -90.2 9.6 27.87 Favored 'General case' 0 CA--C 1.535 0.391 0 N-CA-C 113.367 0.877 . . . . 0.0 113.367 -177.553 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' B' B ' 18' ' ' PHE . . . . . . . . . . . . . 37.4 t80 -58.43 -46.38 86.61 Favored 'General case' 0 N--CA 1.458 -0.059 0 O-C-N 121.965 -0.459 . . . . 0.0 110.017 -177.598 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' B' B ' 19' ' ' VAL . . . . . . . . . . . . . 48.5 t -56.86 -41.72 76.63 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.399 0 CA-C-N 116.228 -0.442 . . . . 0.0 110.392 -178.176 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' B' B ' 20' ' ' ASP . . . . . . . . . . . . . 78.3 m-20 -60.14 -44.0 95.29 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-O 120.784 0.326 . . . . 0.0 111.0 -177.399 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' B' B ' 21' ' ' VAL . . . . . . . . . . . . . 48.0 t -64.5 -46.13 93.65 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.294 0 C-N-CA 120.765 -0.374 . . . . 0.0 110.468 -177.648 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' B' B ' 22' ' ' ILE . . . . . . . . . . . . . 50.1 mm -56.31 -44.73 80.48 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.25 0 C-N-CA 120.857 -0.337 . . . . 0.0 110.582 179.083 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' B' B ' 23' ' ' ARG . . . . . . . . . . . . . 59.6 ttp180 -54.49 -48.81 71.4 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-O 120.763 0.316 . . . . 0.0 111.17 -179.549 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' B' B ' 24' ' ' ILE . . . . . . . . . . . . . 74.2 mt -59.52 -41.1 83.69 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.247 0 CA-C-N 116.336 -0.393 . . . . 0.0 111.424 -176.66 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' B' B ' 25' ' ' LYS . . . . . . . . . . . . . 97.7 mttt -70.07 -43.33 71.38 Favored 'General case' 0 C--N 1.33 -0.273 0 N-CA-C 112.719 0.637 . . . . 0.0 112.719 -178.625 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' B' B ' 26' ' ' LEU . . . . . . . . . . . . . 92.2 mt -78.11 -34.23 50.12 Favored 'General case' 0 C--N 1.33 -0.26 0 N-CA-C 113.444 0.905 . . . . 0.0 113.444 -170.336 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' B' B ' 27' ' ' GLN . . . . . . . . . . . . . 6.6 pt20 -46.98 139.38 5.66 Favored 'General case' 0 N--CA 1.468 0.47 0 N-CA-C 112.755 0.65 . . . . 0.0 112.755 -175.95 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' B' B ' 28' ' ' GLY . . . . . . . . . . . . . . . 100.8 -23.95 33.79 Favored Glycine 0 CA--C 1.535 1.283 0 CA-C-N 115.671 -0.695 . . . . 0.0 112.384 -176.232 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' B' B ' 29' ' ' LYS . . . . . . . . . . . . . 45.4 mtmt -97.99 155.16 17.23 Favored 'General case' 0 C--O 1.231 0.1 0 CA-C-N 117.396 0.598 . . . . 0.0 111.037 178.804 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' B' B ' 30' ' ' THR . . . . . . . . . . . . . 32.0 m -105.05 137.7 42.39 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 116.043 -0.526 . . . . 0.0 110.236 177.978 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' B' B ' 31' ' ' VAL . . . . . . . . . . . . . 35.2 m -131.35 158.26 43.29 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.22 0 CA-C-O 120.865 0.364 . . . . 0.0 110.898 -179.153 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' B' B ' 32' ' ' ARG . . . . . . . . . . . . . 98.1 mtt180 -135.63 153.15 51.74 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-O 121.284 0.564 . . . . 0.0 110.77 178.245 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' B' B ' 33' ' ' THR . . . . . . . . . . . . . 19.8 m -53.6 140.67 28.05 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.153 -0.476 . . . . 0.0 111.441 -178.478 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' B' B ' 34' ' ' GLY . . . . . . . . . . . . . . . 99.29 -17.11 58.34 Favored Glycine 0 CA--C 1.532 1.109 0 CA-C-N 116.09 -0.505 . . . . 0.0 113.309 178.996 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' B' B ' 35' ' ' ASP . . . . . . . . . . . . . 78.2 m-20 -67.02 149.14 51.03 Favored 'General case' 0 N--CA 1.462 0.13 0 CA-C-N 118.036 0.918 . . . . 0.0 111.194 178.946 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' B' B ' 36' ' ' VAL . . . . . . . . . . . . . 45.7 t -119.48 129.84 74.8 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.197 0 CA-C-N 115.895 -0.593 . . . . 0.0 109.668 176.768 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' B' B ' 37' ' ' ILE . . . . . . . . . . . . . 65.1 mt -119.08 137.71 52.17 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.275 0 CA-C-N 116.125 -0.489 . . . . 0.0 109.968 -178.93 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' B' B ' 38' ' ' GLY . . . . . . . . . . . . . . . -113.34 127.77 8.04 Favored Glycine 0 CA--C 1.526 0.725 0 N-CA-C 110.873 -0.891 . . . . 0.0 110.873 179.43 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' B' B ' 39' ' ' ILE . . . . . . . . . . . . . 72.2 mt -125.6 131.55 71.94 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.27 0 N-CA-C 110.127 -0.323 . . . . 0.0 110.127 179.254 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' B' B ' 40' ' ' SER . . . . . . . . . . . . . 26.7 p -92.15 114.68 27.28 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.418 -0.356 . . . . 0.0 110.997 176.875 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' B' B ' 41' ' ' ILE . . . . . . . . . . . . . 44.1 mm -121.44 123.43 69.62 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.236 0 CA-C-N 116.483 -0.326 . . . . 0.0 110.33 179.714 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' B' B ' 42' ' ' LEU . . . . . . . . . . . . . 6.7 mp 52.94 34.53 17.02 Favored 'General case' 0 CA--C 1.533 0.29 0 CA-C-N 116.292 -0.413 . . . . 0.0 111.505 177.92 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' B' B ' 43' ' ' GLY . . . . . . . . . . . . . . . 72.67 30.48 63.96 Favored Glycine 0 CA--C 1.53 0.999 0 C-N-CA 121.199 -0.524 . . . . 0.0 112.211 177.888 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' B' B ' 44' ' ' LYS . . . . . . . . . . . . . 61.5 tttm -138.21 128.94 26.69 Favored 'General case' 0 C--N 1.329 -0.288 0 N-CA-C 109.585 -0.524 . . . . 0.0 109.585 178.132 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' B' B ' 45' ' ' GLU . . . . . . . . . . . . . 84.7 tt0 -83.28 122.0 27.85 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-O 120.817 0.342 . . . . 0.0 111.019 -177.153 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' B' B ' 46' ' ' VAL . . . . . . . . . . . . . 10.6 p -119.98 125.03 73.85 Favored 'Isoleucine or valine' 0 C--O 1.232 0.147 0 N-CA-C 109.444 -0.576 . . . . 0.0 109.444 174.651 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' B' B ' 47' ' ' LYS . . . . . . . . . . . . . 99.3 mttt -99.91 128.31 46.01 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.145 -0.479 . . . . 0.0 111.025 179.094 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' B' B ' 48' ' ' PHE . . . . . . . . . . . . . 26.7 m-85 -110.74 131.84 54.7 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 115.946 -0.57 . . . . 0.0 109.588 175.489 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' B' B ' 49' ' ' LYS . . . . . . . . . . . . . 60.8 tttm -105.62 135.42 47.05 Favored 'General case' 0 C--N 1.327 -0.37 0 N-CA-C 109.867 -0.42 . . . . 0.0 109.867 177.047 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' B' B ' 50' ' ' VAL . . . . . . . . . . . . . 47.3 t -79.99 104.99 8.93 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.326 0 N-CA-C 109.563 -0.532 . . . . 0.0 109.563 178.509 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' B' B ' 51' ' ' VAL . . . . . . . . . . . . . 46.4 t -69.88 -51.86 36.49 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.335 0 CA-C-N 115.945 -0.57 . . . . 0.0 109.8 -176.721 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' B' B ' 52' ' ' GLN . . . . . . . . . . . . . 92.4 mt-30 -151.88 151.36 31.18 Favored 'General case' 0 C--N 1.334 -0.105 0 C-N-CA 120.244 -0.582 . . . . 0.0 111.957 -179.456 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' B' B ' 53' ' ' ALA . . . . . . . . . . . . . . . -126.8 131.11 51.34 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 115.092 -0.958 . . . . 0.0 109.555 174.402 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' B' B ' 54' ' ' TYR . . . . . . . . . . . . . 30.2 t80 -129.12 109.67 18.1 Favored Pre-proline 0 C--N 1.328 -0.351 0 CA-C-O 118.201 -0.904 . . . . 0.0 110.31 178.902 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' B' B ' 55' ' ' PRO . . . . . . . . . . . . . 73.7 Cg_endo -77.28 168.3 77.18 Favored 'Cis proline' 0 N--CA 1.5 1.911 0 CA-C-N 121.985 1.745 . . . . 0.0 112.634 -3.558 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' B' B ' 56' ' ' SER . . . . . . . . . . . . . 13.5 m -114.63 125.84 28.64 Favored Pre-proline 0 CA--C 1.538 0.516 0 CA-C-O 118.368 -0.825 . . . . 0.0 109.241 174.907 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' B' B ' 57' ' ' PRO . . . . . . . . . . . . . 44.8 Cg_endo -68.67 168.38 63.03 Favored 'Cis proline' 0 N--CA 1.496 1.66 0 CA-C-N 122.041 1.764 . . . . 0.0 111.573 1.325 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' B' B ' 58' ' ' LEU . . . . . . . . . . . . . 26.9 tp -129.23 135.64 49.07 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.137 179.28 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' B' B ' 59' ' ' ARG . . . . . . . . . . . . . 69.8 ttt180 -104.16 124.27 48.8 Favored 'General case' 0 C--N 1.327 -0.388 0 N-CA-C 109.277 -0.638 . . . . 0.0 109.277 177.413 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' B' B ' 60' ' ' VAL . . . . . . . . . . . . . 46.5 t -73.2 115.45 14.1 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.234 0 C-N-CA 120.61 -0.436 . . . . 0.0 110.078 -175.488 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' B' B ' 61' ' ' GLU . . . . . . . . . . . . . 75.0 tt0 -131.02 155.08 47.46 Favored 'General case' 0 C--N 1.329 -0.314 0 N-CA-C 109.152 -0.685 . . . . 0.0 109.152 177.897 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' B' B ' 62' ' ' ASP . . . . . . . . . . . . . 13.6 t70 -52.0 -32.79 35.37 Favored 'General case' 0 C--N 1.327 -0.405 0 N-CA-C 111.946 0.351 . . . . 0.0 111.946 -177.732 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' B' B ' 63' ' ' ARG . . . . . . . . . . . . . 98.6 mtt180 -74.16 -22.14 59.56 Favored 'General case' 0 C--N 1.33 -0.272 0 N-CA-C 113.04 0.756 . . . . 0.0 113.04 -177.185 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' B' B ' 64' ' ' THR . . . . . . . . . . . . . 31.0 m -64.84 136.85 57.34 Favored 'General case' 0 C--N 1.331 -0.226 0 CA-C-O 120.725 0.298 . . . . 0.0 110.57 -176.843 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' B' B ' 65' ' ' LYS . . . . . . . . . . . . . 40.3 ttpt -88.66 124.6 34.24 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-O 121.079 0.466 . . . . 0.0 110.176 -179.976 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' B' B ' 66' ' ' ILE . . . . . . . . . . . . . 69.9 mt -108.09 126.59 64.66 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.298 0 N-CA-C 109.815 -0.439 . . . . 0.0 109.815 -177.906 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' B' B ' 67' ' ' THR . . . . . . . . . . . . . 42.1 m -120.69 139.93 52.34 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.039 -0.528 . . . . 0.0 110.769 -176.422 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' B' B ' 68' ' ' LEU . . . . . . . . . . . . . 19.8 tp -105.0 131.94 51.88 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 115.796 -0.638 . . . . 0.0 110.463 179.749 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' B' B ' 69' ' ' VAL . . . . . . . . . . . . . 43.1 t -92.81 129.89 42.7 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.315 0 CA-C-N 116.146 -0.479 . . . . 0.0 109.76 178.69 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' B' B ' 70' ' ' THR . . . . . . . . . . . . . 2.3 m -107.96 166.71 10.51 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.835 -177.843 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' B' B ' 71' ' ' HIS . . . . . . . . . . . . . 17.2 m-70 -65.01 167.3 9.89 Favored Pre-proline 0 C--N 1.329 -0.295 0 CA-C-N 115.998 -0.546 . . . . 0.0 109.967 178.521 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' B' B ' 72' ' ' PRO . . . . . . . . . . . . . 18.5 Cg_exo -64.82 -30.09 58.63 Favored 'Trans proline' 0 N--CA 1.497 1.72 0 C-N-CA 121.167 1.244 . . . . 0.0 111.99 179.238 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' B' B ' 73' ' ' VAL . . . . . . . . . . . . . 17.2 m -149.51 138.39 15.16 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.263 0 CA-C-O 121.171 0.51 . . . . 0.0 110.78 174.747 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' B' B ' 74' ' ' ASP . . . . . . . . . . . . . 18.1 t0 -103.43 121.42 42.76 Favored 'General case' 0 C--N 1.328 -0.36 0 N-CA-C 108.955 -0.757 . . . . 0.0 108.955 175.441 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' B' B ' 75' ' ' VAL . . . . . . . . . . . . . 41.8 t -114.86 124.99 72.05 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.225 0 CA-C-O 121.135 0.493 . . . . 0.0 110.954 -175.017 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' B' B ' 76' ' ' LEU . . . . . . . . . . . . . 5.6 mp -125.13 147.37 49.05 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 115.394 -0.821 . . . . 0.0 109.492 175.069 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' B' B ' 77' ' ' GLU . . . . . . . . . . . . . 97.6 mt-10 -133.35 131.23 39.85 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-O 121.053 0.454 . . . . 0.0 111.165 -178.444 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' B' B ' 78' ' ' ALA . . . . . . . . . . . . . . . -117.67 139.08 51.5 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 115.67 -0.696 . . . . 0.0 109.662 176.822 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' B' B ' 79' ' ' LYS . . . . . . . . . . . . . 9.4 mtpm? -87.34 117.88 26.41 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-O 120.948 0.404 . . . . 0.0 110.707 -178.501 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' B' B ' 80' ' ' ILE . . . . . . . . . . . . . 25.2 mm -139.08 114.29 8.45 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.268 0 N-CA-C 108.979 -0.749 . . . . 0.0 108.979 -177.958 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' B' B ' 81' ' ' LYS . . . . . . . . . . . . . 53.8 tttp -103.92 127.3 51.45 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-O 120.812 0.339 . . . . 0.0 111.402 -175.718 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' B' B ' 82' ' ' GLY . . . . . . . . . . . . . . . 89.19 41.98 5.7 Favored Glycine 0 CA--C 1.527 0.843 0 C-N-CA 120.839 -0.696 . . . . 0.0 112.258 173.271 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' B' B ' 83' ' ' ILE . . . . . . . . . . . . . 69.7 mt -73.57 138.91 20.31 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.347 0 N-CA-C 109.571 -0.529 . . . . 0.0 109.571 176.961 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' B' B ' 84' ' ' LYS . . . . . . . . . . . . . 38.5 ttpt -103.52 -49.08 3.78 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-N 116.294 -0.412 . . . . 0.0 110.606 -177.828 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' B' B ' 85' ' ' ASP . . . . . . . . . . . . . 12.2 t70 -144.49 148.51 34.62 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.091 -0.504 . . . . 0.0 110.603 -178.532 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' B' B ' 86' ' ' VAL . . . . . . . . . . . . . 46.4 t -130.38 133.12 64.33 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.247 0 CA-C-O 120.87 0.367 . . . . 0.0 110.428 -179.189 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' B' B ' 87' ' ' ILE . . . . . . . . . . . . . 5.0 mp -122.64 124.38 70.52 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.195 0 CA-C-N 115.935 -0.575 . . . . 0.0 109.522 176.617 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' B' B ' 88' ' ' LEU . . . . . . . . . . . . . 16.0 tp -109.74 129.61 55.6 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-O 120.866 0.365 . . . . 0.0 110.709 -178.629 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' B' B ' 89' ' ' ASP . . . . . . . . . . . . . 13.4 t70 -128.23 155.68 44.16 Favored 'General case' 0 C--N 1.331 -0.215 0 CA-C-N 116.12 -0.491 . . . . 0.0 110.031 178.122 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' B' B ' 90' ' ' GLU . . . . . . . . . . . . . 96.2 mt-10 -47.5 -36.84 10.84 Favored 'General case' 0 C--N 1.328 -0.357 0 N-CA-C 113.055 0.761 . . . . 0.0 113.055 -171.457 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' B' B ' 91' ' ' ASN . . . . . . . . . . . . . 66.0 m-80 -129.01 16.54 6.22 Favored 'General case' 0 N--CA 1.469 0.502 0 N-CA-C 113.285 0.846 . . . . 0.0 113.285 -176.435 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' B' B ' 92' ' ' LEU . . . . . . . . . . . . . 11.4 mt -148.73 144.89 27.37 Favored 'General case' 0 C--N 1.331 -0.198 0 CA-C-O 120.818 0.342 . . . . 0.0 110.248 -176.265 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' B' B ' 93' ' ' ILE . . . . . . . . . . . . . 72.3 mt -121.59 116.43 49.48 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.224 0 N-CA-C 108.838 -0.801 . . . . 0.0 108.838 174.946 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' B' B ' 94' ' ' VAL . . . . . . . . . . . . . 43.9 t -115.7 125.8 73.0 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.294 0 N-CA-C 109.68 -0.489 . . . . 0.0 109.68 -178.084 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' B' B ' 95' ' ' VAL . . . . . . . . . . . . . 41.9 t -120.8 132.74 69.55 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.315 0 CA-C-N 116.065 -0.516 . . . . 0.0 109.681 -179.636 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' B' B ' 96' ' ' ILE . . . . . . . . . . . . . 70.7 mt -114.31 125.27 71.57 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.353 0 N-CA-C 109.228 -0.656 . . . . 0.0 109.228 178.577 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' B' B ' 97' ' ' THR . . . . . . . . . . . . . 54.6 p -96.2 155.29 16.82 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-O 121.164 0.506 . . . . 0.0 111.115 -177.583 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' B' B ' 98' ' ' GLU . . . . . . . . . . . . . 12.6 pt-20 -55.4 -20.67 12.82 Favored 'General case' 0 C--N 1.328 -0.338 0 N-CA-C 112.707 0.632 . . . . 0.0 112.707 -179.396 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' B' B ' 99' ' ' GLU . . . . . . . . . . . . . 12.8 pt-20 -84.56 17.61 2.62 Favored 'General case' 0 CA--C 1.535 0.377 0 N-CA-C 113.117 0.784 . . . . 0.0 113.117 -178.7 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' B' B ' 100' ' ' ASN . . . . . . . . . . . . . 3.1 m-20 62.86 37.95 11.8 Favored 'General case' 0 N--CA 1.462 0.171 0 CA-C-O 121.084 0.468 . . . . 0.0 111.129 177.29 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' B' B ' 101' ' ' GLU . . . . . . . . . . . . . 84.6 tt0 -117.72 141.01 48.88 Favored 'General case' 0 C--N 1.332 -0.158 0 N-CA-C 109.77 -0.456 . . . . 0.0 109.77 175.358 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' B' B ' 102' ' ' VAL . . . . . . . . . . . . . 45.2 t -114.96 127.67 72.42 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.329 0 N-CA-C 109.991 -0.374 . . . . 0.0 109.991 -178.134 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' B' B ' 103' ' ' LEU . . . . . . . . . . . . . 29.4 mt -119.27 133.99 55.45 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 115.762 -0.653 . . . . 0.0 110.19 177.599 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' B' B ' 104' ' ' ILE . . . . . . . . . . . . . 69.8 mt -118.73 121.48 67.05 Favored 'Isoleucine or valine' 0 C--O 1.233 0.215 0 CA-C-N 116.52 -0.309 . . . . 0.0 110.272 -179.449 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' B' B ' 105' ' ' PHE . . . . . . . . . . . . . 90.1 m-85 -118.57 163.31 16.98 Favored 'General case' 0 C--O 1.232 0.143 0 O-C-N 124.116 0.885 . . . . 0.0 109.692 178.442 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' B' B ' 106' ' ' ASN . . . . . . . . . . . . . 44.6 p-10 -101.21 -170.64 1.87 Allowed 'General case' 0 C--N 1.33 -0.276 0 N-CA-C 110.185 -0.302 . . . . 0.0 110.185 174.1 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' B' B ' 107' ' ' GLN . . . . . . . . . . . . . 42.4 tt0 -57.49 -26.89 61.98 Favored 'General case' 0 C--N 1.328 -0.331 0 N-CA-C 112.325 0.491 . . . . 0.0 112.325 179.526 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' B' B ' 108' ' ' ASN . . . . . . . . . . . . . 21.4 t-20 -92.41 13.53 19.26 Favored 'General case' 0 CA--C 1.535 0.396 0 N-CA-C 113.144 0.794 . . . . 0.0 113.144 -176.43 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' B' B ' 109' ' ' LEU . . . . . . . . . . . . . 38.9 mt 57.26 32.92 22.54 Favored 'General case' 0 C--O 1.233 0.22 0 N-CA-C 112.013 0.375 . . . . 0.0 112.013 178.332 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' B' B ' 110' ' ' GLU . . . . . . . . . . . . . 70.7 mm-40 -103.21 140.19 37.69 Favored 'General case' 0 C--N 1.329 -0.303 0 N-CA-C 109.497 -0.557 . . . . 0.0 109.497 175.203 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' B' B ' 111' ' ' GLU . . . . . . . . . . . . . 52.7 tt0 -76.95 121.72 23.87 Favored 'General case' 0 C--N 1.326 -0.418 0 CA-C-N 116.426 -0.352 . . . . 0.0 110.512 -175.698 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' B' B ' 112' ' ' LEU . . . . . . . . . . . . . 85.6 mt -103.09 -45.77 4.83 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.13 -0.487 . . . . 0.0 110.522 178.841 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' B' B ' 113' ' ' TYR . . . . . . . . . . . . . 65.0 t80 -137.87 144.06 41.21 Favored 'General case' 0 C--N 1.331 -0.2 0 CA-C-N 116.188 -0.46 . . . . 0.0 111.29 -178.105 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' B' B ' 114' ' ' ARG . . . . . . . . . . . . . 37.3 ptt180 -145.59 125.47 13.52 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 115.994 -0.548 . . . . 0.0 110.513 177.429 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' B' B ' 115' ' ' GLY . . . . . . . . . . . . . . . -150.22 149.22 21.07 Favored Glycine 0 CA--C 1.525 0.668 0 N-CA-C 111.12 -0.792 . . . . 0.0 111.12 179.467 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' B' B ' 116' ' ' LYS . . . . . . . . . . . . . 7.4 ttpm? -114.49 137.6 51.65 Favored 'General case' 0 C--N 1.33 -0.265 0 N-CA-C 109.661 -0.496 . . . . 0.0 109.661 176.288 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' B' B ' 117' ' ' PHE . . . . . . . . . . . . . 39.0 m-85 -137.02 113.79 10.37 Favored 'General case' 0 C--N 1.329 -0.305 0 N-CA-C 109.962 -0.384 . . . . 0.0 109.962 -179.036 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' B' B ' 118' ' ' GLU . . . . . . . . . . . . . 96.3 mt-10 -57.91 -42.42 84.69 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.332 -0.395 . . . . 0.0 110.742 -176.371 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' B' B ' 119' ' ' ASN . . . . . . . . . . . . . 69.1 m-80 -97.22 31.1 2.55 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.207 -0.451 . . . . 0.0 112.094 -174.707 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' B' B ' 120' ' ' LEU . . . . . . . . . . . . . 24.2 tp -57.1 121.23 9.54 Favored 'General case' 0 C--N 1.333 -0.136 0 C-N-CA 120.944 -0.302 . . . . 0.0 110.429 177.969 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' B' B ' 121' ' ' ASN . . . . . . . . . . . . . 27.2 m-80 -103.43 -43.56 5.38 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.356 -0.384 . . . . 0.0 110.287 -179.556 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' B' B ' 122' ' ' LYS . . . . . . . . . . . . . 53.6 pttt -165.95 152.98 9.87 Favored 'General case' 0 C--N 1.331 -0.222 0 CA-C-O 121.186 0.517 . . . . 0.0 111.892 179.047 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' B' B ' 123' ' ' VAL . . . . . . . . . . . . . 45.1 t -119.71 132.46 69.39 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.261 0 CA-C-N 115.852 -0.613 . . . . 0.0 109.538 177.911 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' B' B ' 124' ' ' LEU . . . . . . . . . . . . . 6.5 mp -119.36 136.42 54.28 Favored 'General case' 0 C--N 1.332 -0.193 0 CA-C-N 116.156 -0.474 . . . . 0.0 110.673 -177.757 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' B' B ' 125' ' ' VAL . . . . . . . . . . . . . 46.0 t -119.2 131.89 70.62 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.273 0 CA-C-N 116.002 -0.545 . . . . 0.0 109.833 178.36 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' B' B ' 126' ' ' ARG . . . . . . . . . . . . . 40.7 mmt180 -133.27 99.14 4.44 Favored 'General case' 0 C--N 1.331 -0.21 0 CA-C-N 116.25 -0.432 . . . . 0.0 110.278 179.12 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' B' B ' 127' ' ' ASN . . . . . . . . . . . . . 34.3 t-20 53.42 -104.89 0.22 Allowed 'General case' 0 CA--C 1.542 0.65 0 CA-C-O 119.02 -0.514 . . . . 0.0 111.157 178.793 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' B' B ' 128' ' ' ASP . . . . . . . . . . . . . 19.5 p-10 -105.86 -3.09 22.3 Favored 'General case' 0 CA--C 1.537 0.468 0 CA-C-N 119.562 1.074 . . . . 0.0 113.684 -175.971 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' B' B ' 129' ' ' LEU . . . . . . . . . . . . . 60.2 mt -105.09 142.84 34.16 Favored 'General case' 0 C--N 1.332 -0.157 0 O-C-N 122.102 -0.374 . . . . 0.0 110.116 178.571 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' B' B ' 130' ' ' VAL . . . . . . . . . . . . . 42.9 t -121.27 135.88 60.02 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.213 0 N-CA-C 110.016 -0.365 . . . . 0.0 110.016 -178.582 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' B' B ' 131' ' ' VAL . . . . . . . . . . . . . 39.6 t -133.13 133.34 58.47 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.278 0 CA-C-O 120.932 0.396 . . . . 0.0 110.275 179.479 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' B' B ' 132' ' ' ILE . . . . . . . . . . . . . 73.1 mt -114.06 130.17 68.73 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.363 0 N-CA-C 109.263 -0.643 . . . . 0.0 109.263 178.604 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' B' B ' 133' ' ' ILE . . . . . . . . . . . . . 42.3 mm -111.98 119.61 60.46 Favored 'Isoleucine or valine' 0 C--O 1.234 0.247 0 CA-C-O 120.877 0.37 . . . . 0.0 110.878 -176.095 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' B' B ' 134' ' ' ASP . . . . . . . . . . . . . 7.4 p-10 -132.88 143.56 49.59 Favored 'General case' 0 C--N 1.33 -0.246 0 N-CA-C 109.312 -0.625 . . . . 0.0 109.312 175.449 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' B' B ' 135' ' ' GLU . . . . . . . . . . . . . 77.7 tt0 -49.99 -25.77 3.64 Favored 'General case' 0 C--N 1.327 -0.389 0 N-CA-C 112.697 0.629 . . . . 0.0 112.697 -174.599 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' B' B ' 136' ' ' GLN . . . . . . . . . . . . . 47.7 tt0 -85.54 -31.42 22.71 Favored 'General case' 0 C--O 1.233 0.192 0 N-CA-C 112.386 0.513 . . . . 0.0 112.386 -175.388 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' B' B ' 137' ' ' LYS . . . . . . . . . . . . . 18.2 ptpt -164.7 174.06 11.17 Favored 'General case' 0 C--O 1.233 0.205 0 CA-C-O 121.64 0.733 . . . . 0.0 112.193 -175.359 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' B' B ' 138' ' ' LEU . . . . . . . . . . . . . 6.5 tt -119.5 128.87 54.37 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 114.938 -1.028 . . . . 0.0 109.504 176.418 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' B' B ' 139' ' ' THR . . . . . . . . . . . . . 25.4 m -108.1 126.0 52.24 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.315 -0.402 . . . . 0.0 110.467 -179.933 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' B' B ' 140' ' ' LEU . . . . . . . . . . . . . 17.2 tp -112.95 119.9 39.55 Favored 'General case' 0 C--N 1.331 -0.209 0 CA-C-N 115.791 -0.64 . . . . 0.0 109.304 -178.926 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' B' B ' 141' ' ' ILE . . . . . . . . . . . . . 19.2 mt -119.16 123.19 70.93 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.289 0 CA-C-O 120.884 0.373 . . . . 0.0 110.118 -173.845 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' B' B ' 142' ' ' ARG . . . . . . . . . . . . . 72.7 mtt180 -108.79 127.58 54.14 Favored 'General case' 0 C--N 1.331 -0.239 0 CA-C-N 115.439 -0.801 . . . . 0.0 110.027 -176.301 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' B' B ' 143' ' ' THR . . . . . . . . . . . . . 52.9 p . . . . . 0 C--O 1.221 -0.442 0 CA-C-O 117.992 -1.004 . . . . 0.0 110.576 179.804 . . . . . . . . 0 0 . 1 . 017 nuclear orig full ' C' C ' -3' ' ' GLU . . . . . . . . . . . . . 95.6 mt-10 . . . . . 0 N--CA 1.49 1.537 0 N-CA-C 109.344 -0.613 . . . . 0.0 109.344 . . . . . . . . . 0 0 . 1 . 017 nuclear orig full ' C' C ' -2' ' ' GLY . . . . . . . . . . . . . . . -67.29 105.67 1.43 Allowed Glycine 0 CA--C 1.524 0.647 0 N-CA-C 111.067 -0.813 . . . . 0.0 111.067 -179.559 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' C' C ' -1' ' ' VAL . . . . . . . . . . . . . 43.5 t -140.95 138.81 34.39 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.336 0 N-CA-C 109.991 -0.374 . . . . 0.0 109.991 179.093 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' C' C ' 0' ' ' ILE . . . . . . . . . . . . . 72.6 mt -107.26 130.24 59.73 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.289 0 CA-C-N 116.283 -0.417 . . . . 0.0 109.943 -179.505 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' C' C ' 1' ' ' MET . . . . . . . . . . . . . 25.8 ptm -84.04 131.49 34.81 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.106 -0.497 . . . . 0.0 110.468 178.937 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' C' C ' 2' ' ' SER . . . . . . . . . . . . . 55.2 p -117.04 146.0 43.36 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-N 116.291 -0.413 . . . . 0.0 110.554 -179.95 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' C' C ' 3' ' ' GLU . . . . . . . . . . . . . 42.7 mt-10 -140.37 141.07 35.64 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.039 -0.528 . . . . 0.0 111.013 -178.458 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' C' C ' 4' ' ' LEU . . . . . . . . . . . . . 19.0 tp -124.27 128.28 48.92 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 115.808 -0.633 . . . . 0.0 109.976 176.19 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' C' C ' 5' ' ' LYS . . . . . . . . . . . . . 99.1 mttt -110.36 123.43 49.83 Favored 'General case' 0 C--O 1.234 0.254 0 CA-C-O 120.672 0.272 . . . . 0.0 110.929 179.877 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' C' C ' 6' ' ' LEU . . . . . . . . . . . . . 52.4 mt -114.61 145.62 41.77 Favored 'General case' 0 C--N 1.332 -0.185 0 CA-C-N 115.559 -0.746 . . . . 0.0 110.146 178.586 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' C' C ' 7' ' ' LYS . . . . . . . . . . . . . 35.7 ttpt -127.36 141.41 40.78 Favored Pre-proline 0 CA--C 1.533 0.319 0 CA-C-O 119.071 -0.49 . . . . 0.0 109.711 175.286 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' C' C ' 8' ' ' PRO . . . . . . . . . . . . . 91.7 Cg_endo -91.69 138.56 2.1 Favored 'Trans proline' 0 N--CA 1.489 1.211 0 C-N-CA 121.718 1.612 . . . . 0.0 112.129 179.255 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' C' C ' 9' ' ' LEU . . . . . . . . . . . . . 67.8 mt -78.19 -47.16 2.12 Favored Pre-proline 0 C--N 1.329 -0.312 0 CA-C-O 118.714 -0.66 . . . . 0.0 111.826 178.189 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' C' C ' 10' ' ' PRO . . . . . . . . . . . . . 85.5 Cg_endo -81.14 151.61 18.19 Favored 'Trans proline' 0 N--CA 1.495 1.613 0 C-N-CA 121.14 1.226 . . . . 0.0 111.536 174.58 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' C' C ' 11' ' ' LYS . . . . . . . . . . . . . 66.7 tttt -88.33 98.85 11.82 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-O 120.836 0.351 . . . . 0.0 110.194 178.712 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' C' C ' 12' ' ' VAL . . . . . . . . . . . . . 13.2 p -140.03 147.14 23.93 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.285 0 CA-C-N 116.29 -0.414 . . . . 0.0 110.727 -178.463 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' C' C ' 13' ' ' GLU . . . . . . . . . . . . . 84.1 tt0 -88.96 123.82 33.66 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.21 -0.45 . . . . 0.0 109.908 176.978 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' C' C ' 14' ' ' LEU . . . . . . . . . . . . . 22.2 mt -98.14 152.29 37.94 Favored Pre-proline 0 C--N 1.329 -0.299 0 CA-C-N 116.402 -0.363 . . . . 0.0 110.84 -177.189 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' C' C ' 15' ' ' PRO . . . . . . . . . . . . . 25.6 Cg_exo -62.31 157.02 47.6 Favored 'Trans proline' 0 N--CA 1.498 1.761 0 C-N-CA 121.261 1.308 . . . . 0.0 111.713 176.116 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' C' C ' 16' ' ' PRO . . . . . . . . . . . . . 39.5 Cg_exo -58.72 -36.47 97.08 Favored 'Trans proline' 0 N--CA 1.498 1.776 0 C-N-CA 121.389 1.393 . . . . 0.0 112.65 -179.533 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' C' C ' 17' ' ' ASP . . . . . . . . . . . . . 16.6 p-10 -85.66 7.94 21.46 Favored 'General case' 0 CA--C 1.535 0.393 0 N-CA-C 113.23 0.826 . . . . 0.0 113.23 -177.641 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' C' C ' 18' ' ' PHE . . . . . . . . . . . . . 43.9 t80 -58.09 -46.8 84.89 Favored 'General case' 0 N--CA 1.456 -0.126 0 O-C-N 121.983 -0.448 . . . . 0.0 110.285 -176.876 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' C' C ' 19' ' ' VAL . . . . . . . . . . . . . 14.7 p -55.48 -41.76 64.72 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.288 0 CA-C-N 116.523 -0.308 . . . . 0.0 111.029 -178.019 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' C' C ' 20' ' ' ASP . . . . . . . . . . . . . 78.3 m-20 -61.4 -44.44 97.14 Favored 'General case' 0 C--N 1.329 -0.286 0 C-N-CA 120.935 -0.306 . . . . 0.0 111.231 -178.198 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' C' C ' 21' ' ' VAL . . . . . . . . . . . . . 47.6 t -64.11 -45.22 97.12 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.287 0 C-N-CA 120.715 -0.394 . . . . 0.0 110.447 -176.953 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' C' C ' 22' ' ' ILE . . . . . . . . . . . . . 51.0 mm -56.5 -46.25 82.27 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.227 0 C-N-CA 120.872 -0.331 . . . . 0.0 110.55 178.614 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' C' C ' 23' ' ' ARG . . . . . . . . . . . . . 56.1 ttp180 -54.89 -46.75 74.84 Favored 'General case' 0 C--N 1.329 -0.302 0 C-N-CA 121.057 -0.257 . . . . 0.0 111.384 -179.269 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' C' C ' 24' ' ' ILE . . . . . . . . . . . . . 79.7 mt -59.58 -43.87 91.97 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.303 0 C-N-CA 121.075 -0.25 . . . . 0.0 111.246 -177.987 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' C' C ' 25' ' ' LYS . . . . . . . . . . . . . 97.4 mttt -66.01 -42.1 90.12 Favored 'General case' 0 C--N 1.328 -0.361 0 N-CA-C 112.504 0.557 . . . . 0.0 112.504 -178.878 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' C' C ' 26' ' ' LEU . . . . . . . . . . . . . 93.0 mt -77.91 -38.79 44.88 Favored 'General case' 0 C--N 1.33 -0.254 0 N-CA-C 113.216 0.821 . . . . 0.0 113.216 -170.833 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' C' C ' 27' ' ' GLN . . . . . . . . . . . . . 9.9 pt20 -47.19 139.94 5.66 Favored 'General case' 0 N--CA 1.469 0.521 0 N-CA-C 112.709 0.633 . . . . 0.0 112.709 -176.137 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' C' C ' 28' ' ' GLY . . . . . . . . . . . . . . . 100.61 -26.15 25.69 Favored Glycine 0 CA--C 1.534 1.269 0 CA-C-N 115.598 -0.728 . . . . 0.0 112.14 -176.3 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' C' C ' 29' ' ' LYS . . . . . . . . . . . . . 37.9 mtmm -98.79 155.02 17.57 Favored 'General case' 0 C--N 1.332 -0.181 0 CA-C-N 117.295 0.547 . . . . 0.0 111.292 179.115 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' C' C ' 30' ' ' THR . . . . . . . . . . . . . 50.1 m -107.84 136.45 47.55 Favored 'General case' 0 C--N 1.332 -0.19 0 CA-C-N 116.147 -0.479 . . . . 0.0 109.991 176.349 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' C' C ' 31' ' ' VAL . . . . . . . . . . . . . 34.9 m -132.2 162.16 40.16 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.247 0 CA-C-N 116.302 -0.408 . . . . 0.0 111.036 -178.347 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' C' C ' 32' ' ' ARG . . . . . . . . . . . . . 81.6 mtt180 -132.29 152.43 51.38 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 115.989 -0.551 . . . . 0.0 110.591 178.654 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' C' C ' 33' ' ' THR . . . . . . . . . . . . . 28.8 m -53.61 140.18 29.63 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.299 -0.41 . . . . 0.0 111.237 -179.313 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' C' C ' 34' ' ' GLY . . . . . . . . . . . . . . . 100.49 -17.16 57.12 Favored Glycine 0 CA--C 1.532 1.139 0 CA-C-O 119.589 -0.562 . . . . 0.0 113.17 179.755 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' C' C ' 35' ' ' ASP . . . . . . . . . . . . . 72.1 m-20 -65.98 149.69 49.83 Favored 'General case' 0 N--CA 1.461 0.123 0 CA-C-N 118.127 0.963 . . . . 0.0 111.151 178.79 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' C' C ' 36' ' ' VAL . . . . . . . . . . . . . 43.5 t -122.6 130.82 74.23 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.213 0 CA-C-N 115.968 -0.56 . . . . 0.0 109.934 178.9 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' C' C ' 37' ' ' ILE . . . . . . . . . . . . . 69.3 mt -122.53 140.55 45.99 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.205 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.093 -178.928 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' C' C ' 38' ' ' GLY . . . . . . . . . . . . . . . -115.7 128.73 8.17 Favored Glycine 0 CA--C 1.525 0.708 0 N-CA-C 111.177 -0.769 . . . . 0.0 111.177 179.42 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' C' C ' 39' ' ' ILE . . . . . . . . . . . . . 72.9 mt -125.9 135.69 63.12 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.306 0 N-CA-C 110.136 -0.32 . . . . 0.0 110.136 179.245 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' C' C ' 40' ' ' SER . . . . . . . . . . . . . 9.7 t -93.32 114.08 26.43 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.343 -0.389 . . . . 0.0 111.132 177.268 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' C' C ' 41' ' ' ILE . . . . . . . . . . . . . 45.8 mm -122.58 119.55 58.46 Favored 'Isoleucine or valine' 0 CA--C 1.529 0.153 0 N-CA-C 110.07 -0.344 . . . . 0.0 110.07 178.758 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' C' C ' 42' ' ' LEU . . . . . . . . . . . . . 41.3 mt 57.39 34.06 24.15 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.394 -0.366 . . . . 0.0 111.916 177.479 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' C' C ' 43' ' ' GLY . . . . . . . . . . . . . . . 79.32 -10.13 37.37 Favored Glycine 0 CA--C 1.535 1.325 0 C-N-CA 121.271 -0.49 . . . . 0.0 113.485 177.312 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' C' C ' 44' ' ' LYS . . . . . . . . . . . . . 64.0 mmtt -100.46 134.72 42.99 Favored 'General case' 0 C--N 1.332 -0.156 0 CA-C-N 117.887 0.844 . . . . 0.0 110.079 175.878 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' C' C ' 45' ' ' GLU . . . . . . . . . . . . . 84.0 tt0 -85.18 131.57 34.41 Favored 'General case' 0 C--N 1.326 -0.425 0 CA-C-N 116.455 -0.339 . . . . 0.0 111.159 -179.279 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' C' C ' 46' ' ' VAL . . . . . . . . . . . . . 9.5 p -120.97 125.77 74.41 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.189 0 N-CA-C 109.585 -0.524 . . . . 0.0 109.585 174.428 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' C' C ' 47' ' ' LYS . . . . . . . . . . . . . 82.8 mttt -98.8 125.96 44.31 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 115.993 -0.549 . . . . 0.0 110.524 177.83 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' C' C ' 48' ' ' PHE . . . . . . . . . . . . . 31.0 m-85 -110.53 131.91 54.64 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.359 -0.382 . . . . 0.0 110.175 178.293 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' C' C ' 49' ' ' LYS . . . . . . . . . . . . . 58.5 tttt -105.92 132.42 52.05 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.251 -0.431 . . . . 0.0 109.97 177.677 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' C' C ' 50' ' ' VAL . . . . . . . . . . . . . 46.0 t -75.74 104.98 4.29 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.247 0 N-CA-C 109.14 -0.689 . . . . 0.0 109.14 176.552 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' C' C ' 51' ' ' VAL . . . . . . . . . . . . . 47.3 t -69.17 -48.51 68.43 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.324 0 CA-C-N 116.085 -0.507 . . . . 0.0 109.925 -173.418 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' C' C ' 52' ' ' GLN . . . . . . . . . . . . . 46.9 tt0 -168.33 146.83 4.34 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 115.95 -0.568 . . . . 0.0 111.381 -178.706 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' C' C ' 53' ' ' ALA . . . . . . . . . . . . . . . -122.61 136.54 54.91 Favored 'General case' 0 C--N 1.331 -0.209 0 CA-C-N 115.842 -0.617 . . . . 0.0 110.109 177.032 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' C' C ' 54' ' ' TYR . . . . . . . . . . . . . 58.3 t80 -129.12 112.11 18.37 Favored Pre-proline 0 CA--C 1.534 0.329 0 CA-C-O 118.081 -0.961 . . . . 0.0 110.202 177.55 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' C' C ' 55' ' ' PRO . . . . . . . . . . . . . 72.8 Cg_endo -77.31 170.14 72.16 Favored 'Cis proline' 0 N--CA 1.499 1.829 0 CA-C-N 122.015 1.755 . . . . 0.0 112.337 -6.283 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' C' C ' 56' ' ' SER . . . . . . . . . . . . . 25.5 m -122.25 135.65 25.67 Favored Pre-proline 0 CA--C 1.538 0.491 0 CA-C-O 118.513 -0.756 . . . . 0.0 109.537 175.049 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' C' C ' 57' ' ' PRO . . . . . . . . . . . . . 34.9 Cg_endo -66.29 160.85 75.13 Favored 'Cis proline' 0 N--CA 1.499 1.799 0 CA-C-N 121.864 1.701 . . . . 0.0 111.525 -2.839 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' C' C ' 58' ' ' LEU . . . . . . . . . . . . . 30.3 tp -127.57 136.4 51.64 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-O 121.118 0.485 . . . . 0.0 110.713 -178.101 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' C' C ' 59' ' ' ARG . . . . . . . . . . . . . 20.7 ttm180 -103.01 122.52 44.78 Favored 'General case' 0 C--N 1.327 -0.411 0 N-CA-C 108.919 -0.771 . . . . 0.0 108.919 173.936 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' C' C ' 60' ' ' VAL . . . . . . . . . . . . . 39.9 t -77.72 120.81 29.09 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.323 0 C-N-CA 120.561 -0.456 . . . . 0.0 110.349 -173.647 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' C' C ' 61' ' ' GLU . . . . . . . . . . . . . 96.3 mt-10 -131.13 165.5 23.15 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 115.679 -0.691 . . . . 0.0 109.567 176.807 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' C' C ' 62' ' ' ASP . . . . . . . . . . . . . 7.8 p-10 -53.09 -31.25 40.9 Favored 'General case' 0 C--N 1.329 -0.325 0 N-CA-C 111.912 0.338 . . . . 0.0 111.912 179.816 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' C' C ' 63' ' ' ARG . . . . . . . . . . . . . 87.6 mtt180 -71.77 -22.1 61.64 Favored 'General case' 0 CA--C 1.533 0.293 0 N-CA-C 112.962 0.727 . . . . 0.0 112.962 -176.307 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' C' C ' 64' ' ' THR . . . . . . . . . . . . . 32.9 m -74.48 136.6 42.26 Favored 'General case' 0 C--N 1.332 -0.192 0 CA-C-O 120.918 0.389 . . . . 0.0 110.832 -175.956 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' C' C ' 65' ' ' LYS . . . . . . . . . . . . . 96.0 mttt -89.36 133.88 34.31 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.023 -0.535 . . . . 0.0 109.977 179.013 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' C' C ' 66' ' ' ILE . . . . . . . . . . . . . 65.3 mt -115.48 130.56 69.87 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.266 0 N-CA-C 109.976 -0.379 . . . . 0.0 109.976 179.739 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' C' C ' 67' ' ' THR . . . . . . . . . . . . . 23.8 m -122.54 138.42 54.58 Favored 'General case' 0 C--N 1.331 -0.214 0 CA-C-N 115.929 -0.578 . . . . 0.0 110.516 -179.071 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' C' C ' 68' ' ' LEU . . . . . . . . . . . . . 5.8 tt -106.24 124.34 49.44 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 115.959 -0.564 . . . . 0.0 110.173 178.795 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' C' C ' 69' ' ' VAL . . . . . . . . . . . . . 46.6 t -98.1 128.82 49.14 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.283 0 N-CA-C 109.598 -0.519 . . . . 0.0 109.598 179.016 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' C' C ' 70' ' ' THR . . . . . . . . . . . . . 24.0 m -107.35 92.47 4.09 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.209 -0.45 . . . . 0.0 110.735 -177.976 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' C' C ' 71' ' ' HIS . . . . . . . . . . . . . 51.4 m80 -150.05 146.92 20.98 Favored Pre-proline 0 C--N 1.329 -0.319 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.195 177.377 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' C' C ' 72' ' ' PRO . . . . . . . . . . . . . 86.8 Cg_endo -91.1 -7.27 3.72 Favored 'Trans proline' 0 N--CA 1.492 1.44 0 C-N-CA 121.786 1.657 . . . . 0.0 113.831 178.215 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' C' C ' 73' ' ' VAL . . . . . . . . . . . . . 34.0 m -130.59 170.91 18.57 Favored 'Isoleucine or valine' 0 C--O 1.231 0.094 0 CA-C-O 120.894 0.378 . . . . 0.0 110.871 -176.762 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' C' C ' 74' ' ' ASP . . . . . . . . . . . . . 8.0 t70 -103.84 126.03 50.68 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.105 -0.498 . . . . 0.0 109.737 179.993 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' C' C ' 75' ' ' VAL . . . . . . . . . . . . . 40.5 t -121.13 127.95 75.95 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.345 0 CA-C-O 121.169 0.509 . . . . 0.0 110.957 -176.633 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' C' C ' 76' ' ' LEU . . . . . . . . . . . . . 5.2 mp -121.47 144.67 48.56 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 115.488 -0.778 . . . . 0.0 109.523 174.244 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' C' C ' 77' ' ' GLU . . . . . . . . . . . . . 47.1 mt-10 -133.92 137.84 45.15 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-O 121.033 0.444 . . . . 0.0 111.127 -177.629 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' C' C ' 78' ' ' ALA . . . . . . . . . . . . . . . -125.79 128.61 47.96 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 115.78 -0.646 . . . . 0.0 109.707 176.477 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' C' C ' 79' ' ' LYS . . . . . . . . . . . . . 54.1 mtmt -77.45 122.72 25.59 Favored 'General case' 0 C--N 1.331 -0.214 0 CA-C-O 121.044 0.449 . . . . 0.0 110.667 -178.327 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' C' C ' 80' ' ' ILE . . . . . . . . . . . . . 39.4 mm -139.05 114.16 8.36 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.356 0 N-CA-C 109.178 -0.675 . . . . 0.0 109.178 -177.779 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' C' C ' 81' ' ' LYS . . . . . . . . . . . . . 31.8 ttpt -101.4 121.99 42.92 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-O 120.821 0.343 . . . . 0.0 111.002 -177.461 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' C' C ' 82' ' ' GLY . . . . . . . . . . . . . . . 89.12 42.23 5.65 Favored Glycine 0 CA--C 1.527 0.786 0 C-N-CA 120.683 -0.77 . . . . 0.0 111.91 174.246 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' C' C ' 83' ' ' ILE . . . . . . . . . . . . . 73.4 mt -67.74 131.91 32.87 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.341 0 N-CA-C 109.468 -0.567 . . . . 0.0 109.468 175.944 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' C' C ' 84' ' ' LYS . . . . . . . . . . . . . 72.8 tttt -88.84 -53.26 4.69 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-O 121.046 0.451 . . . . 0.0 110.181 -178.22 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' C' C ' 85' ' ' ASP . . . . . . . . . . . . . 11.5 t70 -155.85 152.96 29.0 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 115.626 -0.715 . . . . 0.0 110.146 179.201 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' C' C ' 86' ' ' VAL . . . . . . . . . . . . . 46.6 t -128.65 130.59 68.9 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.252 0 CA-C-O 120.961 0.41 . . . . 0.0 110.564 -178.475 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' C' C ' 87' ' ' ILE . . . . . . . . . . . . . 45.0 mm -119.58 126.54 75.42 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.303 0 CA-C-N 115.781 -0.645 . . . . 0.0 109.612 177.453 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' C' C ' 88' ' ' LEU . . . . . . . . . . . . . 86.5 mt -111.15 139.34 46.61 Favored 'General case' 0 C--N 1.331 -0.214 0 CA-C-O 121.152 0.501 . . . . 0.0 111.286 -178.151 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' C' C ' 89' ' ' ASP . . . . . . . . . . . . . 46.8 t0 -130.57 162.94 28.18 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 115.462 -0.79 . . . . 0.0 109.457 176.864 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' C' C ' 90' ' ' GLU . . . . . . . . . . . . . 45.5 tp10 -44.99 -44.51 9.96 Favored 'General case' 0 N--CA 1.465 0.293 0 N-CA-C 113.222 0.823 . . . . 0.0 113.222 -170.874 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' C' C ' 91' ' ' ASN . . . . . . . . . . . . . 31.0 m120 -132.12 26.41 4.55 Favored 'General case' 0 N--CA 1.467 0.381 0 N-CA-C 112.473 0.546 . . . . 0.0 112.473 -178.478 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' C' C ' 92' ' ' LEU . . . . . . . . . . . . . 36.5 mt -146.58 144.87 29.86 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-O 120.736 0.303 . . . . 0.0 110.51 -176.931 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' C' C ' 93' ' ' ILE . . . . . . . . . . . . . 65.3 mt -124.18 115.07 43.75 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.311 0 N-CA-C 109.104 -0.702 . . . . 0.0 109.104 177.505 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' C' C ' 94' ' ' VAL . . . . . . . . . . . . . 46.6 t -115.89 126.4 73.39 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.218 0 N-CA-C 109.763 -0.458 . . . . 0.0 109.763 -179.382 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' C' C ' 95' ' ' VAL . . . . . . . . . . . . . 43.2 t -121.18 133.72 66.86 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.372 0 CA-C-N 116.047 -0.524 . . . . 0.0 109.935 -178.893 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' C' C ' 96' ' ' ILE . . . . . . . . . . . . . 67.8 mt -110.14 124.52 66.95 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.317 0 N-CA-C 108.939 -0.763 . . . . 0.0 108.939 177.637 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' C' C ' 97' ' ' THR . . . . . . . . . . . . . 82.7 p -97.8 155.01 17.23 Favored 'General case' 0 C--N 1.327 -0.395 0 CA-C-O 121.059 0.457 . . . . 0.0 111.025 -177.176 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' C' C ' 98' ' ' GLU . . . . . . . . . . . . . 84.2 tt0 -53.79 -23.22 11.36 Favored 'General case' 0 C--N 1.327 -0.399 0 N-CA-C 112.379 0.511 . . . . 0.0 112.379 -179.835 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' C' C ' 99' ' ' GLU . . . . . . . . . . . . . 68.9 mm-40 -82.26 15.05 2.58 Favored 'General case' 0 CA--C 1.536 0.412 0 N-CA-C 113.2 0.815 . . . . 0.0 113.2 -176.569 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' C' C ' 100' ' ' ASN . . . . . . . . . . . . . 3.0 m-20 62.83 33.5 15.18 Favored 'General case' 0 N--CA 1.465 0.276 0 CA-C-O 120.914 0.387 . . . . 0.0 111.535 179.336 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' C' C ' 101' ' ' GLU . . . . . . . . . . . . . 84.9 tt0 -113.12 145.88 40.17 Favored 'General case' 0 C--N 1.331 -0.225 0 N-CA-C 109.639 -0.504 . . . . 0.0 109.639 174.144 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' C' C ' 102' ' ' VAL . . . . . . . . . . . . . 44.9 t -114.87 123.56 70.68 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.316 0 N-CA-C 109.717 -0.475 . . . . 0.0 109.717 -178.484 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' C' C ' 103' ' ' LEU . . . . . . . . . . . . . 35.5 mt -115.29 132.74 56.52 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 115.804 -0.634 . . . . 0.0 109.82 178.888 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' C' C ' 104' ' ' ILE . . . . . . . . . . . . . 64.6 mt -123.86 121.56 62.54 Favored 'Isoleucine or valine' 0 C--O 1.234 0.248 0 N-CA-C 110.432 -0.21 . . . . 0.0 110.432 -179.241 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' C' C ' 105' ' ' PHE . . . . . . . . . . . . . 61.8 m-85 -118.91 165.29 14.25 Favored 'General case' 0 C--N 1.33 -0.254 0 O-C-N 124.104 0.878 . . . . 0.0 109.617 178.561 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' C' C ' 106' ' ' ASN . . . . . . . . . . . . . 40.9 p-10 -101.21 -169.9 1.76 Allowed 'General case' 0 C--N 1.33 -0.25 0 N-CA-C 109.857 -0.423 . . . . 0.0 109.857 173.627 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' C' C ' 107' ' ' GLN . . . . . . . . . . . . . 49.2 tt0 -56.42 -29.69 61.89 Favored 'General case' 0 CA--C 1.534 0.332 0 N-CA-C 111.823 0.305 . . . . 0.0 111.823 176.744 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' C' C ' 108' ' ' ASN . . . . . . . . . . . . . 8.0 t-20 -84.35 9.57 12.81 Favored 'General case' 0 CA--C 1.536 0.43 0 N-CA-C 113.205 0.816 . . . . 0.0 113.205 -176.684 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' C' C ' 109' ' ' LEU . . . . . . . . . . . . . 8.0 tp 56.05 36.55 27.59 Favored 'General case' 0 C--N 1.332 -0.167 0 CA-C-O 120.923 0.392 . . . . 0.0 111.339 179.442 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' C' C ' 110' ' ' GLU . . . . . . . . . . . . . 70.5 mm-40 -107.79 150.29 27.17 Favored 'General case' 0 C--N 1.333 -0.141 0 N-CA-C 110.07 -0.344 . . . . 0.0 110.07 176.876 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' C' C ' 111' ' ' GLU . . . . . . . . . . . . . 98.0 mt-10 -77.16 122.29 24.8 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-O 120.876 0.37 . . . . 0.0 111.051 -178.296 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' C' C ' 112' ' ' LEU . . . . . . . . . . . . . 17.9 mt -108.62 -46.0 3.75 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 115.988 -0.551 . . . . 0.0 110.388 177.08 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' C' C ' 113' ' ' TYR . . . . . . . . . . . . . 59.6 t80 -136.75 137.68 40.13 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.359 -0.382 . . . . 0.0 111.048 179.943 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' C' C ' 114' ' ' ARG . . . . . . . . . . . . . 72.4 mtm180 -141.44 122.08 14.25 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 115.998 -0.546 . . . . 0.0 110.482 178.111 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' C' C ' 115' ' ' GLY . . . . . . . . . . . . . . . -150.11 160.91 28.73 Favored Glycine 0 CA--C 1.525 0.708 0 N-CA-C 111.03 -0.828 . . . . 0.0 111.03 178.572 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' C' C ' 116' ' ' LYS . . . . . . . . . . . . . 72.5 tttt -134.27 133.43 40.79 Favored 'General case' 0 C--N 1.33 -0.266 0 N-CA-C 110.021 -0.363 . . . . 0.0 110.021 179.27 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' C' C ' 117' ' ' PHE . . . . . . . . . . . . . 31.2 m-85 -133.06 123.15 25.25 Favored 'General case' 0 C--N 1.331 -0.202 0 CA-C-O 120.932 0.396 . . . . 0.0 110.363 -174.457 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' C' C ' 118' ' ' GLU . . . . . . . . . . . . . 43.4 mt-10 -53.77 -48.54 69.65 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.459 -0.337 . . . . 0.0 111.4 -176.49 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' C' C ' 119' ' ' ASN . . . . . . . . . . . . . 67.5 m-80 -98.57 31.03 3.01 Favored 'General case' 0 C--N 1.329 -0.321 0 N-CA-C 112.255 0.465 . . . . 0.0 112.255 -174.098 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' C' C ' 120' ' ' LEU . . . . . . . . . . . . . 18.4 tp -56.6 120.27 7.49 Favored 'General case' 0 N--CA 1.462 0.15 0 C-N-CA 121.04 -0.264 . . . . 0.0 110.325 177.888 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' C' C ' 121' ' ' ASN . . . . . . . . . . . . . 9.8 t-20 -109.42 -44.03 3.98 Favored 'General case' 0 C--N 1.331 -0.219 0 CA-C-N 116.58 -0.282 . . . . 0.0 111.192 -175.646 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' C' C ' 122' ' ' LYS . . . . . . . . . . . . . 15.9 ptpt -154.77 153.54 31.39 Favored 'General case' 0 C--N 1.332 -0.187 0 CA-C-O 121.286 0.565 . . . . 0.0 112.019 -178.291 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' C' C ' 123' ' ' VAL . . . . . . . . . . . . . 45.6 t -121.68 130.89 74.2 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.224 0 CA-C-N 115.698 -0.683 . . . . 0.0 109.474 176.223 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' C' C ' 124' ' ' LEU . . . . . . . . . . . . . 6.2 mp -121.4 140.02 52.69 Favored 'General case' 0 C--N 1.331 -0.215 0 CA-C-N 116.319 -0.401 . . . . 0.0 110.635 -178.05 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' C' C ' 125' ' ' VAL . . . . . . . . . . . . . 35.2 m -134.78 140.12 46.16 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.258 0 CA-C-N 116.334 -0.394 . . . . 0.0 110.453 178.237 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' C' C ' 126' ' ' ARG . . . . . . . . . . . . . 52.5 ttt85 -149.13 118.69 6.95 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-O 120.907 0.384 . . . . 0.0 110.615 178.322 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' C' C ' 127' ' ' ASN . . . . . . . . . . . . . 35.7 t30 50.83 -104.95 0.18 Allowed 'General case' 0 CA--C 1.542 0.668 0 CA-C-N 116.144 -0.48 . . . . 0.0 111.572 179.862 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' C' C ' 128' ' ' ASP . . . . . . . . . . . . . 11.8 p-10 -110.61 -0.17 17.34 Favored 'General case' 0 CA--C 1.536 0.413 0 CA-C-N 119.501 1.046 . . . . 0.0 113.658 -175.043 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' C' C ' 129' ' ' LEU . . . . . . . . . . . . . 88.0 mt -106.35 142.73 35.54 Favored 'General case' 0 C--O 1.232 0.138 0 CA-C-N 118.186 0.448 . . . . 0.0 110.838 -179.451 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' C' C ' 130' ' ' VAL . . . . . . . . . . . . . 47.0 t -122.04 135.91 60.63 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.302 0 N-CA-C 109.619 -0.511 . . . . 0.0 109.619 178.625 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' C' C ' 131' ' ' VAL . . . . . . . . . . . . . 42.9 t -133.48 137.1 53.64 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.269 0 CA-C-O 121.018 0.437 . . . . 0.0 110.624 -178.726 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' C' C ' 132' ' ' ILE . . . . . . . . . . . . . 74.3 mt -115.61 130.46 70.21 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.304 0 CA-C-N 115.642 -0.708 . . . . 0.0 109.262 178.762 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' C' C ' 133' ' ' ILE . . . . . . . . . . . . . 43.7 mm -116.62 121.32 67.4 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.215 0 CA-C-O 120.774 0.321 . . . . 0.0 111.04 -175.447 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' C' C ' 134' ' ' ASP . . . . . . . . . . . . . 8.2 p-10 -136.11 144.3 45.03 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 115.878 -0.601 . . . . 0.0 109.443 173.756 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' C' C ' 135' ' ' GLU . . . . . . . . . . . . . 42.2 tp10 -49.81 -23.85 2.08 Favored 'General case' 0 C--N 1.327 -0.395 0 N-CA-C 112.724 0.639 . . . . 0.0 112.724 -172.226 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' C' C ' 136' ' ' GLN . . . . . . . . . . . . . 50.5 tt0 -93.13 -36.77 12.48 Favored 'General case' 0 C--O 1.233 0.2 0 N-CA-C 112.082 0.401 . . . . 0.0 112.082 -176.468 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' C' C ' 137' ' ' LYS . . . . . . . . . . . . . 89.9 mttt -140.12 155.06 47.15 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-O 121.251 0.548 . . . . 0.0 111.648 -171.185 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' C' C ' 138' ' ' LEU . . . . . . . . . . . . . 5.2 tt -117.8 123.54 46.22 Favored 'General case' 0 C--N 1.329 -0.321 0 N-CA-C 108.881 -0.785 . . . . 0.0 108.881 171.544 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' C' C ' 139' ' ' THR . . . . . . . . . . . . . 31.2 m -113.35 131.11 56.09 Favored 'General case' 0 C--N 1.331 -0.215 0 CA-C-O 120.875 0.369 . . . . 0.0 111.05 -176.353 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' C' C ' 140' ' ' LEU . . . . . . . . . . . . . 6.8 tt -116.61 122.67 45.3 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 115.333 -0.849 . . . . 0.0 108.914 -179.407 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' C' C ' 141' ' ' ILE . . . . . . . . . . . . . 19.5 mt -119.81 120.41 63.21 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.276 0 CA-C-O 120.929 0.395 . . . . 0.0 110.02 -176.239 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' C' C ' 142' ' ' ARG . . . . . . . . . . . . . 57.6 mtp180 -105.05 124.38 49.43 Favored 'General case' 0 C--N 1.331 -0.212 0 CA-C-N 115.431 -0.804 . . . . 0.0 110.014 179.319 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' C' C ' 143' ' ' THR . . . . . . . . . . . . . 21.3 p . . . . . 0 C--O 1.221 -0.44 0 CA-C-O 117.98 -1.009 . . . . 0.0 110.572 -179.248 . . . . . . . . 0 0 . 1 . 017 nuclear orig full ' D' D ' -3' ' ' GLU . . . . . . . . . . . . . 84.6 tt0 . . . . . 0 N--CA 1.489 1.504 0 N-CA-C 109.356 -0.609 . . . . 0.0 109.356 . . . . . . . . . 0 0 . 1 . 017 nuclear orig full ' D' D ' -2' ' ' GLY . . . . . . . . . . . . . . . -59.87 148.42 42.49 Favored Glycine 0 CA--C 1.524 0.601 0 N-CA-C 111.006 -0.838 . . . . 0.0 111.006 -179.31 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' D' D ' -1' ' ' VAL . . . . . . . . . . . . . 40.7 t -95.77 136.15 27.64 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.284 0 N-CA-C 109.897 -0.409 . . . . 0.0 109.897 179.851 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' D' D ' 0' ' ' ILE . . . . . . . . . . . . . 71.5 mt -111.22 140.22 31.53 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.241 0 CA-C-N 116.097 -0.501 . . . . 0.0 109.941 -179.085 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' D' D ' 1' ' ' MET . . . . . . . . . . . . . 25.1 ptp -141.82 145.59 34.89 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.109 -0.496 . . . . 0.0 110.495 -179.407 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' D' D ' 2' ' ' SER . . . . . . . . . . . . . 2.9 p -114.94 141.55 47.81 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.616 -179.437 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' D' D ' 3' ' ' GLU . . . . . . . . . . . . . 94.3 mt-10 -141.19 139.82 33.91 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.12 -0.491 . . . . 0.0 111.158 -178.798 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' D' D ' 4' ' ' LEU . . . . . . . . . . . . . 21.7 tp -123.27 128.96 50.69 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 115.869 -0.605 . . . . 0.0 109.763 174.799 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' D' D ' 5' ' ' LYS . . . . . . . . . . . . . 94.8 mttt -112.75 121.6 45.2 Favored 'General case' 0 C--O 1.235 0.302 0 CA-C-O 120.897 0.38 . . . . 0.0 111.014 -177.95 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' D' D ' 6' ' ' LEU . . . . . . . . . . . . . 61.9 mt -114.94 142.17 46.97 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-N 115.225 -0.898 . . . . 0.0 110.274 -179.185 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' D' D ' 7' ' ' LYS . . . . . . . . . . . . . 44.7 tttm -122.35 140.48 32.72 Favored Pre-proline 0 CA--C 1.533 0.291 0 CA-C-O 119.017 -0.516 . . . . 0.0 109.993 176.056 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' D' D ' 8' ' ' PRO . . . . . . . . . . . . . 96.9 Cg_endo -91.72 137.76 1.97 Allowed 'Trans proline' 0 N--CA 1.49 1.316 0 C-N-CA 121.83 1.687 . . . . 0.0 111.964 179.45 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' D' D ' 9' ' ' LEU . . . . . . . . . . . . . 26.3 mt -77.54 -48.28 2.34 Favored Pre-proline 0 CA--C 1.535 0.371 0 CA-C-O 118.675 -0.678 . . . . 0.0 112.341 -179.991 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' D' D ' 10' ' ' PRO . . . . . . . . . . . . . 87.0 Cg_endo -80.23 159.35 23.29 Favored 'Trans proline' 0 N--CA 1.497 1.685 0 C-N-CA 121.308 1.339 . . . . 0.0 112.219 177.961 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' D' D ' 11' ' ' LYS . . . . . . . . . . . . . 82.5 mttt -86.54 95.69 9.82 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.51 -0.314 . . . . 0.0 110.318 177.543 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' D' D ' 12' ' ' VAL . . . . . . . . . . . . . 12.4 p -142.2 147.55 21.26 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.324 0 CA-C-N 116.238 -0.437 . . . . 0.0 110.443 179.928 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' D' D ' 13' ' ' GLU . . . . . . . . . . . . . 45.5 tp10 -92.09 121.83 34.01 Favored 'General case' 0 C--N 1.328 -0.336 0 N-CA-C 109.985 -0.376 . . . . 0.0 109.985 177.797 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' D' D ' 14' ' ' LEU . . . . . . . . . . . . . 41.0 mt -93.02 138.15 23.41 Favored Pre-proline 0 C--N 1.329 -0.305 0 CA-C-O 118.88 -0.581 . . . . 0.0 110.073 -178.666 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' D' D ' 15' ' ' PRO . . . . . . . . . . . . . 28.7 Cg_exo -60.47 158.55 31.25 Favored 'Trans proline' 0 N--CA 1.498 1.782 0 C-N-CA 121.268 1.312 . . . . 0.0 111.953 178.995 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' D' D ' 16' ' ' PRO . . . . . . . . . . . . . 39.3 Cg_exo -58.91 -35.52 98.47 Favored 'Trans proline' 0 N--CA 1.498 1.766 0 C-N-CA 121.527 1.485 . . . . 0.0 112.894 -179.469 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' D' D ' 17' ' ' ASP . . . . . . . . . . . . . 15.8 p-10 -82.18 2.65 30.62 Favored 'General case' 0 CA--C 1.537 0.454 0 N-CA-C 113.296 0.85 . . . . 0.0 113.296 -177.682 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' D' D ' 18' ' ' PHE . . . . . . . . . . . . . 36.7 t80 -58.15 -47.08 84.45 Favored 'General case' 0 C--N 1.333 -0.115 0 O-C-N 121.933 -0.48 . . . . 0.0 110.019 -178.242 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' D' D ' 19' ' ' VAL . . . . . . . . . . . . . 12.7 p -55.19 -41.73 62.03 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 CA-C-N 116.353 -0.385 . . . . 0.0 111.197 -178.094 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' D' D ' 20' ' ' ASP . . . . . . . . . . . . . 7.7 t0 -60.91 -44.31 97.36 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-O 120.9 0.381 . . . . 0.0 110.827 -177.811 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' D' D ' 21' ' ' VAL . . . . . . . . . . . . . 45.5 t -64.62 -45.71 94.61 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.324 0 CA-C-N 116.326 -0.397 . . . . 0.0 110.41 -177.486 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' D' D ' 22' ' ' ILE . . . . . . . . . . . . . 49.5 mm -55.55 -47.73 78.31 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.264 0 C-N-CA 121.096 -0.242 . . . . 0.0 110.672 179.533 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' D' D ' 23' ' ' ARG . . . . . . . . . . . . . 47.0 ttp180 -55.15 -49.05 72.8 Favored 'General case' 0 C--N 1.331 -0.219 0 C-N-CA 121.042 -0.263 . . . . 0.0 111.155 -178.33 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' D' D ' 24' ' ' ILE . . . . . 0.426 HG22 HD11 ' D' ' 24' ' ' ILE . 71.4 mt -58.93 -43.97 89.85 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.281 0 C-N-CA 121.05 -0.26 . . . . 0.0 111.251 -176.308 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' D' D ' 25' ' ' LYS . . . . . . . . . . . . . 49.2 mttm -68.18 -41.05 82.05 Favored 'General case' 0 C--N 1.328 -0.332 0 N-CA-C 112.582 0.586 . . . . 0.0 112.582 -177.86 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' D' D ' 26' ' ' LEU . . . . . . . . . . . . . 36.1 mt -79.46 -33.49 42.32 Favored 'General case' 0 C--N 1.329 -0.311 0 N-CA-C 113.837 1.051 . . . . 0.0 113.837 -170.421 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' D' D ' 27' ' ' GLN . . . . . . . . . . . . . 10.6 pt20 -46.84 140.76 4.43 Favored 'General case' 0 N--CA 1.469 0.514 0 N-CA-C 112.956 0.725 . . . . 0.0 112.956 -174.247 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' D' D ' 28' ' ' GLY . . . . . . . . . . . . . . . 98.14 -24.15 33.05 Favored Glycine 0 CA--C 1.532 1.141 0 CA-C-N 115.571 -0.74 . . . . 0.0 112.427 -178.355 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' D' D ' 29' ' ' LYS . . . . . . . . . . . . . 48.9 mtpt -97.45 155.11 17.07 Favored 'General case' 0 C--N 1.333 -0.126 0 CA-C-N 117.425 0.612 . . . . 0.0 110.783 179.101 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' D' D ' 30' ' ' THR . . . . . . . . . . . . . 23.5 m -104.51 139.84 38.83 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.196 -0.456 . . . . 0.0 110.338 178.876 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' D' D ' 31' ' ' VAL . . . . . . . . . . . . . 34.4 m -130.98 150.28 34.44 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.303 0 CA-C-N 116.101 -0.5 . . . . 0.0 110.783 -179.176 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' D' D ' 32' ' ' ARG . . . . . . . . . . . . . 83.0 mtm180 -128.67 150.34 50.29 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 115.913 -0.585 . . . . 0.0 110.475 178.324 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' D' D ' 33' ' ' THR . . . . . . . . . . . . . 15.0 m -53.64 138.53 34.51 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.305 -0.407 . . . . 0.0 111.385 -178.036 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' D' D ' 34' ' ' GLY . . . . . . . . . . . . . . . 100.43 -17.23 57.07 Favored Glycine 0 CA--C 1.532 1.145 0 CA-C-O 119.67 -0.517 . . . . 0.0 113.192 179.589 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' D' D ' 35' ' ' ASP . . . . . . . . . . . . . 75.1 m-20 -66.35 149.8 49.84 Favored 'General case' 0 N--CA 1.461 0.085 0 CA-C-N 118.015 0.907 . . . . 0.0 111.087 178.838 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' D' D ' 36' ' ' VAL . . . . . . . . . . . . . 44.2 t -118.77 130.75 73.17 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.244 0 CA-C-N 115.908 -0.587 . . . . 0.0 109.839 178.08 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' D' D ' 37' ' ' ILE . . . . . . . . . . . . . 64.7 mt -119.72 138.12 51.38 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.233 0 N-CA-C 109.854 -0.425 . . . . 0.0 109.854 -179.723 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' D' D ' 38' ' ' GLY . . . . . . . . . . . . . . . -113.54 127.89 8.07 Favored Glycine 0 CA--C 1.525 0.661 0 N-CA-C 110.782 -0.927 . . . . 0.0 110.782 179.064 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' D' D ' 39' ' ' ILE . . . . . . . . . . . . . 78.0 mt -128.25 137.46 57.39 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.237 0 CA-C-O 120.814 0.34 . . . . 0.0 110.313 179.626 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' D' D ' 40' ' ' SER . . . . . . . . . . . . . 32.4 t -91.54 116.53 28.94 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.248 -0.433 . . . . 0.0 110.598 175.285 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' D' D ' 41' ' ' ILE . . . . . . . . . . . . . 44.0 mm -119.83 114.34 43.86 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.216 0 CA-C-O 120.886 0.374 . . . . 0.0 110.177 178.823 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' D' D ' 42' ' ' LEU . . . . . . . . . . . . . 1.3 tt 52.27 46.23 27.02 Favored 'General case' 0 CA--C 1.532 0.262 0 CA-C-O 121.399 0.618 . . . . 0.0 111.036 177.527 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' D' D ' 43' ' ' GLY . . . . . . . . . . . . . . . 70.9 25.79 75.14 Favored Glycine 0 CA--C 1.532 1.109 0 C-N-CA 121.1 -0.571 . . . . 0.0 112.532 175.398 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' D' D ' 44' ' ' LYS . . . . . . . . . . . . . 85.9 tttt -136.01 129.65 32.35 Favored 'General case' 0 C--N 1.331 -0.221 0 CA-C-N 117.274 0.537 . . . . 0.0 109.975 179.323 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' D' D ' 45' ' ' GLU . . . . . . . . . . . . . 84.7 tt0 -82.47 119.33 24.07 Favored 'General case' 0 C--N 1.328 -0.355 0 C-N-CA 120.816 -0.354 . . . . 0.0 110.842 -179.275 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' D' D ' 46' ' ' VAL . . . . . . . . . . . . . 10.0 p -118.57 125.17 74.16 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.179 0 N-CA-C 109.425 -0.583 . . . . 0.0 109.425 175.391 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' D' D ' 47' ' ' LYS . . . . . . . . . . . . . 39.6 mtmt -98.73 126.77 44.45 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 115.953 -0.567 . . . . 0.0 110.729 177.809 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' D' D ' 48' ' ' PHE . . . . . . . . . . . . . 45.9 m-85 -111.2 131.95 54.71 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 115.747 -0.66 . . . . 0.0 109.928 178.532 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' D' D ' 49' ' ' LYS . . . . . . . . . . . . . 38.2 tttp -104.48 131.78 51.46 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.334 -0.394 . . . . 0.0 110.09 178.531 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' D' D ' 50' ' ' VAL . . . . . . . . . . . . . 45.7 t -77.04 105.33 5.79 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.33 0 N-CA-C 109.204 -0.665 . . . . 0.0 109.204 177.623 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' D' D ' 51' ' ' VAL . . . . . . . . . . . . . 48.8 t -71.27 -52.5 26.37 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.317 0 CA-C-N 116.064 -0.516 . . . . 0.0 109.683 -174.93 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' D' D ' 52' ' ' GLN . . . . . . . . . . . . . 89.4 mt-30 -153.7 151.17 29.33 Favored 'General case' 0 C--N 1.331 -0.239 0 CA-C-N 115.995 -0.548 . . . . 0.0 111.845 -178.308 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' D' D ' 53' ' ' ALA . . . . . . . . . . . . . . . -129.74 133.24 46.91 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 115.145 -0.934 . . . . 0.0 109.561 174.057 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' D' D ' 54' ' ' TYR . . . . . . . . . . . . . 44.0 t80 -129.08 112.04 18.42 Favored Pre-proline 0 CA--C 1.536 0.419 0 CA-C-O 118.107 -0.949 . . . . 0.0 110.124 178.122 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' D' D ' 55' ' ' PRO . . . . . . . . . . . . . 73.3 Cg_endo -77.19 167.56 79.31 Favored 'Cis proline' 0 N--CA 1.5 1.857 0 CA-C-N 121.907 1.717 . . . . 0.0 112.585 -5.875 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' D' D ' 56' ' ' SER . . . . . . . . . . . . . 13.6 m -117.34 134.09 23.14 Favored Pre-proline 0 CA--C 1.539 0.549 0 CA-C-O 118.483 -0.77 . . . . 0.0 109.292 174.204 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' D' D ' 57' ' ' PRO . . . . . . . . . . . . . 56.0 Cg_endo -70.68 147.7 87.16 Favored 'Cis proline' 0 N--CA 1.498 1.785 0 CA-C-N 121.844 1.694 . . . . 0.0 111.415 -1.608 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' D' D ' 58' ' ' LEU . . . . . . . . . . . . . 24.2 tp -107.84 138.14 44.62 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-O 120.896 0.379 . . . . 0.0 110.495 -179.139 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' D' D ' 59' ' ' ARG . . . . . . . . . . . . . 61.2 ttt180 -103.04 120.25 40.32 Favored 'General case' 0 C--N 1.327 -0.397 0 N-CA-C 108.981 -0.748 . . . . 0.0 108.981 174.812 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' D' D ' 60' ' ' VAL . . . . . . . . . . . . . 42.4 t -71.93 119.7 18.93 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.277 0 C-N-CA 120.615 -0.434 . . . . 0.0 110.198 -174.276 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' D' D ' 61' ' ' GLU . . . . . . . . . . . . . 81.3 tt0 -131.14 152.15 50.72 Favored 'General case' 0 C--N 1.328 -0.33 0 N-CA-C 109.268 -0.641 . . . . 0.0 109.268 178.166 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' D' D ' 62' ' ' ASP . . . . . . . . . . . . . 19.3 p-10 -54.48 -31.97 56.89 Favored 'General case' 0 N--CA 1.465 0.301 0 C-N-CA 120.751 -0.38 . . . . 0.0 111.835 -176.405 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' D' D ' 63' ' ' ARG . . . . . . . . . . . . . 77.6 mtp180 -72.32 -21.24 61.36 Favored 'General case' 0 CA--C 1.535 0.38 0 N-CA-C 112.816 0.673 . . . . 0.0 112.816 -177.514 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' D' D ' 64' ' ' THR . . . . . . . . . . . . . 33.1 m -72.26 146.91 46.92 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-O 120.926 0.393 . . . . 0.0 110.905 -176.238 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' D' D ' 65' ' ' LYS . . . . . . . . . . . . . 68.8 mttm -90.14 131.67 35.86 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.018 -0.537 . . . . 0.0 110.819 -179.229 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' D' D ' 66' ' ' ILE . . . . . . . . . . . . . 68.3 mt -118.2 130.52 72.94 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.24 0 N-CA-C 109.655 -0.498 . . . . 0.0 109.655 178.391 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' D' D ' 67' ' ' THR . . . . . . . . . . . . . 29.5 m -126.48 139.65 53.07 Favored 'General case' 0 C--N 1.332 -0.194 0 CA-C-O 121.169 0.509 . . . . 0.0 111.253 -177.537 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' D' D ' 68' ' ' LEU . . . . . . . . . . . . . 51.0 mt -103.83 132.77 49.77 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 115.733 -0.667 . . . . 0.0 110.121 176.62 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' D' D ' 69' ' ' VAL . . . . . . . . . . . . . 41.8 t -102.06 141.25 18.66 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.239 0 CA-C-N 116.358 -0.383 . . . . 0.0 110.562 -178.314 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' D' D ' 70' ' ' THR . . . . . . . . . . . . . 9.5 t -88.76 -179.81 6.07 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 115.959 -0.564 . . . . 0.0 110.628 179.989 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' D' D ' 71' ' ' HIS . . . . . . . . . . . . . 37.7 t-80 -103.08 103.51 34.69 Favored Pre-proline 0 CA--C 1.534 0.343 0 CA-C-O 119.049 -0.501 . . . . 0.0 110.926 -177.757 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' D' D ' 72' ' ' PRO . . . . . . . . . . . . . 74.3 Cg_endo -85.96 156.47 10.02 Favored 'Trans proline' 0 N--CA 1.492 1.39 0 C-N-CA 121.588 1.525 . . . . 0.0 112.436 178.483 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' D' D ' 73' ' ' VAL . . . . . . . . . . . . . 34.8 m -70.9 166.65 2.28 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.241 0 CA-C-N 116.295 -0.411 . . . . 0.0 110.716 179.985 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' D' D ' 74' ' ' ASP . . . . . . . . . . . . . 39.7 t0 -101.77 119.03 38.14 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.309 -0.405 . . . . 0.0 110.126 -179.836 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' D' D ' 75' ' ' VAL . . . . . . . . . . . . . 44.3 t -114.0 123.04 69.27 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.25 0 CA-C-O 121.131 0.491 . . . . 0.0 110.268 -179.451 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' D' D ' 76' ' ' LEU . . . . . . . . . . . . . 33.9 mt -123.4 141.58 51.85 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 115.616 -0.72 . . . . 0.0 109.511 178.535 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' D' D ' 77' ' ' GLU . . . . . . . . . . . . . 96.7 mt-10 -134.75 138.6 44.47 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-O 121.211 0.529 . . . . 0.0 111.375 -177.849 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' D' D ' 78' ' ' ALA . . . . . . . . . . . . . . . -125.11 137.31 54.18 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 115.556 -0.747 . . . . 0.0 109.581 175.809 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' D' D ' 79' ' ' LYS . . . . . . . . . . . . . 65.0 mttp -80.17 117.91 21.39 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-O 120.864 0.364 . . . . 0.0 110.65 -179.017 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' D' D ' 80' ' ' ILE . . . . . . . . . . . . . 40.7 mm -138.96 102.82 1.84 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.32 0 N-CA-C 109.135 -0.691 . . . . 0.0 109.135 -178.052 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' D' D ' 81' ' ' LYS . . . . . . . . . . . . . 78.1 tttt -99.49 128.37 45.6 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-O 120.889 0.376 . . . . 0.0 110.92 -176.195 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' D' D ' 82' ' ' GLY . . . . . . . . . . . . . . . 89.07 42.21 5.67 Favored Glycine 0 CA--C 1.526 0.743 0 C-N-CA 120.987 -0.625 . . . . 0.0 111.862 175.791 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' D' D ' 83' ' ' ILE . . . . . . . . . . . . . 70.1 mt -70.17 137.77 23.36 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.311 0 N-CA-C 109.358 -0.608 . . . . 0.0 109.358 175.874 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' D' D ' 84' ' ' LYS . . . . . . . . . . . . . 38.5 ttpt -99.57 -46.59 5.4 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.343 -0.39 . . . . 0.0 110.243 -178.541 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' D' D ' 85' ' ' ASP . . . . . . . . . . . . . 8.0 t70 -155.11 152.66 29.76 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.072 -0.513 . . . . 0.0 110.663 179.21 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' D' D ' 86' ' ' VAL . . . . . . . . . . . . . 44.0 t -128.57 134.82 63.87 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.19 0 CA-C-O 120.91 0.386 . . . . 0.0 110.347 179.843 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' D' D ' 87' ' ' ILE . . . . . . . . . . . . . 43.7 mm -119.73 125.34 74.23 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.228 0 CA-C-N 115.909 -0.587 . . . . 0.0 109.719 178.152 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' D' D ' 88' ' ' LEU . . . . . . . . . . . . . 14.7 tp -111.05 131.46 55.04 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-O 120.835 0.35 . . . . 0.0 110.96 -177.622 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' D' D ' 89' ' ' ASP . . . . . . . . . . . . . 13.6 t70 -133.1 157.44 45.28 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 116.151 -0.477 . . . . 0.0 110.039 177.737 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' D' D ' 90' ' ' GLU . . . . . . . . . . . . . 82.6 tt0 -46.18 -39.11 9.19 Favored 'General case' 0 C--N 1.331 -0.23 0 N-CA-C 113.127 0.788 . . . . 0.0 113.127 -172.146 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' D' D ' 91' ' ' ASN . . . . . . . . . . . . . 82.8 m-20 -130.75 22.76 5.01 Favored 'General case' 0 N--CA 1.469 0.488 0 N-CA-C 112.762 0.653 . . . . 0.0 112.762 -176.785 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' D' D ' 92' ' ' LEU . . . . . . . . . . . . . 37.6 mt -149.05 141.22 23.97 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-O 120.826 0.346 . . . . 0.0 110.581 -176.931 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' D' D ' 93' ' ' ILE . . . . . . . . . . . . . 69.5 mt -122.08 113.11 37.52 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.255 0 N-CA-C 108.638 -0.875 . . . . 0.0 108.638 174.895 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' D' D ' 94' ' ' VAL . . . . . . . . . . . . . 41.4 t -116.57 128.93 73.79 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.291 0 CA-C-O 120.949 0.404 . . . . 0.0 110.013 -176.955 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' D' D ' 95' ' ' VAL . . . . . . . . . . . . . 46.1 t -121.65 132.58 70.46 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.282 0 CA-C-N 116.021 -0.536 . . . . 0.0 109.808 -179.826 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' D' D ' 96' ' ' ILE . . . . . . . . . . . . . 62.8 mt -113.29 126.41 70.71 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.322 0 N-CA-C 109.074 -0.713 . . . . 0.0 109.074 178.482 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' D' D ' 97' ' ' THR . . . . . . . . . . . . . 81.0 p -101.79 156.91 17.22 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-O 121.085 0.469 . . . . 0.0 111.44 -175.262 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' D' D ' 98' ' ' GLU . . . . . . . . . . . . . 46.1 mt-10 -55.62 -25.35 38.29 Favored 'General case' 0 CA--C 1.533 0.298 0 N-CA-C 112.324 0.49 . . . . 0.0 112.324 178.783 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' D' D ' 99' ' ' GLU . . . . . . . . . . . . . 14.1 mm-40 -76.12 11.92 1.33 Allowed 'General case' 0 CA--C 1.537 0.467 0 N-CA-C 113.161 0.8 . . . . 0.0 113.161 -179.708 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' D' D ' 100' ' ' ASN . . . . . . . . . . . . . 3.2 m-20 62.72 38.0 12.22 Favored 'General case' 0 CA--C 1.529 0.147 0 CA-C-O 121.039 0.447 . . . . 0.0 110.949 179.113 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' D' D ' 101' ' ' GLU . . . . . . . . . . . . . 84.8 tt0 -117.69 145.29 44.51 Favored 'General case' 0 C--N 1.332 -0.155 0 N-CA-C 109.505 -0.554 . . . . 0.0 109.505 176.658 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' D' D ' 102' ' ' VAL . . . . . . . . . . . . . 42.2 t -115.8 124.45 72.22 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.337 0 CA-C-N 116.272 -0.422 . . . . 0.0 109.98 -178.406 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' D' D ' 103' ' ' LEU . . . . . . . . . . . . . 19.3 mt -115.17 127.85 55.8 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 115.69 -0.686 . . . . 0.0 110.129 176.87 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' D' D ' 104' ' ' ILE . . . . . . . . . . . . . 65.6 mt -119.95 120.32 62.83 Favored 'Isoleucine or valine' 0 C--O 1.233 0.223 0 N-CA-C 110.136 -0.32 . . . . 0.0 110.136 -179.496 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' D' D ' 105' ' ' PHE . . . . . . . . . . . . . 46.3 m-85 -120.44 164.2 16.75 Favored 'General case' 0 C--N 1.334 -0.109 0 O-C-N 123.885 0.741 . . . . 0.0 109.977 179.61 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' D' D ' 106' ' ' ASN . . . . . . . . . . . . . 43.4 p-10 -99.24 -169.79 1.81 Allowed 'General case' 0 C--N 1.332 -0.192 0 N-CA-C 110.1 -0.333 . . . . 0.0 110.1 174.883 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' D' D ' 107' ' ' GLN . . . . . . . . . . . . . 62.3 tt0 -57.37 -30.16 64.64 Favored 'General case' 0 C--N 1.33 -0.243 0 N-CA-C 112.121 0.415 . . . . 0.0 112.121 -179.581 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' D' D ' 108' ' ' ASN . . . . . . . . . . . . . 5.4 t30 -88.43 11.24 17.48 Favored 'General case' 0 CA--C 1.536 0.424 0 N-CA-C 113.304 0.853 . . . . 0.0 113.304 -176.405 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' D' D ' 109' ' ' LEU . . . . . . . . . . . . . 9.5 tp 60.63 36.07 19.76 Favored 'General case' 0 CA--C 1.531 0.213 0 O-C-N 122.141 -0.349 . . . . 0.0 111.446 178.452 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' D' D ' 110' ' ' GLU . . . . . . . . . . . . . 95.5 mt-10 -107.84 152.22 24.69 Favored 'General case' 0 C--N 1.331 -0.237 0 N-CA-C 109.836 -0.431 . . . . 0.0 109.836 176.495 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' D' D ' 111' ' ' GLU . . . . . . . . . . . . . 97.3 mt-10 -78.48 126.87 31.36 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-O 121.102 0.477 . . . . 0.0 111.661 -176.359 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' D' D ' 112' ' ' LEU . . . . . . . . . . . . . 30.9 mt -108.93 -46.03 3.69 Favored 'General case' 0 C--N 1.332 -0.181 0 CA-C-N 115.573 -0.74 . . . . 0.0 109.952 174.736 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' D' D ' 113' ' ' TYR . . . . . . . . . . . . . 50.8 t80 -140.45 137.45 33.92 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.095 -0.502 . . . . 0.0 110.91 -179.813 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' D' D ' 114' ' ' ARG . . . . . . . . . . . . . 60.2 ttp180 -142.15 119.09 11.24 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.262 -0.426 . . . . 0.0 110.416 178.701 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' D' D ' 115' ' ' GLY . . . . . . . . . . . . . . . -150.19 162.59 29.27 Favored Glycine 0 CA--C 1.525 0.687 0 N-CA-C 111.021 -0.832 . . . . 0.0 111.021 179.3 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' D' D ' 116' ' ' LYS . . . . . . . . . . . . . 35.0 ttmt -131.66 135.44 46.9 Favored 'General case' 0 C--N 1.33 -0.251 0 N-CA-C 110.024 -0.362 . . . . 0.0 110.024 177.221 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' D' D ' 117' ' ' PHE . . . . . . . . . . . . . 39.8 m-85 -132.2 120.78 22.69 Favored 'General case' 0 C--N 1.331 -0.211 0 CA-C-O 120.86 0.362 . . . . 0.0 110.46 -174.532 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' D' D ' 118' ' ' GLU . . . . . . . . . . . . . 95.9 mt-10 -53.97 -48.53 70.25 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.413 -0.358 . . . . 0.0 111.571 -175.438 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' D' D ' 119' ' ' ASN . . . . . . . . . . . . . 9.4 m120 -99.28 31.11 3.2 Favored 'General case' 0 C--N 1.329 -0.288 0 N-CA-C 112.201 0.445 . . . . 0.0 112.201 -173.771 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' D' D ' 120' ' ' LEU . . . . . . . . . . . . . 23.7 tp -54.88 127.7 29.83 Favored 'General case' 0 C--N 1.332 -0.169 0 CA-C-O 120.805 0.336 . . . . 0.0 110.8 179.544 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' D' D ' 121' ' ' ASN . . . . . . . . . . . . . 95.1 m-20 -111.11 -44.05 3.65 Favored 'General case' 0 C--O 1.233 0.211 0 CA-C-N 116.287 -0.415 . . . . 0.0 111.109 -177.496 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' D' D ' 122' ' ' LYS . . . . . . . . . . . . . 19.0 ptpt -164.34 166.99 20.28 Favored 'General case' 0 N--CA 1.463 0.176 0 CA-C-O 121.277 0.56 . . . . 0.0 112.149 -178.285 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' D' D ' 123' ' ' VAL . . . . . . . . . . . . . 45.5 t -131.49 139.36 50.89 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.207 0 CA-C-N 115.584 -0.735 . . . . 0.0 110.121 179.749 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' D' D ' 124' ' ' LEU . . . . . . . . . . . . . 37.2 mt -121.55 138.9 54.11 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-N 116.313 -0.403 . . . . 0.0 110.737 -179.151 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' D' D ' 125' ' ' VAL . . . . . . . . . . . . . 35.6 m -135.06 134.12 53.23 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.211 0 CA-C-N 116.585 -0.28 . . . . 0.0 110.939 178.922 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' D' D ' 126' ' ' ARG . . . . . . . . . . . . . 22.3 mtp-105 -148.87 118.31 6.92 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 116.523 -0.308 . . . . 0.0 111.048 177.0 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' D' D ' 127' ' ' ASN . . . . . . . . . . . . . 34.6 m120 48.97 -104.89 0.14 Allowed 'General case' 0 CA--C 1.545 0.76 0 CA-C-O 119.193 -0.432 . . . . 0.0 111.976 175.604 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' D' D ' 128' ' ' ASP . . . . . . . . . . . . . 19.2 p-10 -114.05 14.61 18.38 Favored 'General case' 0 N--CA 1.468 0.463 0 CA-C-N 119.407 1.003 . . . . 0.0 113.28 -174.968 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' D' D ' 129' ' ' LEU . . . . . . . . . . . . . 19.1 tp -123.62 139.22 54.22 Favored 'General case' 0 C--N 1.331 -0.233 0 N-CA-C 109.736 -0.468 . . . . 0.0 109.736 177.458 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' D' D ' 130' ' ' VAL . . . . . . . . . . . . . 13.4 p -131.91 140.54 47.78 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.202 0 CA-C-O 121.173 0.511 . . . . 0.0 110.317 179.523 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' D' D ' 131' ' ' VAL . . . . . . . . . . . . . 40.7 t -135.99 140.46 43.98 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.241 0 CA-C-N 115.864 -0.607 . . . . 0.0 110.493 -177.013 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' D' D ' 132' ' ' ILE . . . . . . . . . . . . . 73.4 mt -115.8 131.33 68.52 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.283 0 N-CA-C 109.188 -0.671 . . . . 0.0 109.188 177.501 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' D' D ' 133' ' ' ILE . . . . . . . . . . . . . 43.6 mm -115.12 119.63 62.32 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.191 0 CA-C-O 120.716 0.293 . . . . 0.0 110.752 -175.904 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' D' D ' 134' ' ' ASP . . . . . . . . . . . . . 8.0 p-10 -133.01 144.25 49.96 Favored 'General case' 0 C--N 1.331 -0.233 0 N-CA-C 109.425 -0.583 . . . . 0.0 109.425 175.896 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' D' D ' 135' ' ' GLU . . . . . . . . . . . . . 83.4 tt0 -49.93 -26.86 4.55 Favored 'General case' 0 C--N 1.327 -0.391 0 N-CA-C 112.779 0.659 . . . . 0.0 112.779 -173.63 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' D' D ' 136' ' ' GLN . . . . . . . . . . . . . 97.3 mt-30 -79.01 -36.89 40.44 Favored 'General case' 0 C--O 1.233 0.225 0 N-CA-C 112.448 0.536 . . . . 0.0 112.448 -178.122 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' D' D ' 137' ' ' LYS . . . . . . . . . . . . . 1.2 ptpm? -164.39 174.11 11.41 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-O 121.671 0.748 . . . . 0.0 112.223 -173.206 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' D' D ' 138' ' ' LEU . . . . . . . . . . . . . 5.7 tt -117.89 127.3 53.72 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 114.905 -1.043 . . . . 0.0 109.553 177.637 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' D' D ' 139' ' ' THR . . . . . . . . . . . . . 42.4 m -106.42 123.61 48.34 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.354 -0.385 . . . . 0.0 110.152 179.301 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' D' D ' 140' ' ' LEU . . . . . . . . . . . . . 14.1 tp -110.61 118.41 36.13 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-N 115.723 -0.672 . . . . 0.0 109.33 -177.901 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' D' D ' 141' ' ' ILE . . . . . . . . . . . . . 19.4 mt -120.11 118.25 56.27 Favored 'Isoleucine or valine' 0 C--O 1.234 0.279 0 CA-C-O 121.045 0.45 . . . . 0.0 110.042 -176.632 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' D' D ' 142' ' ' ARG . . . . . . . . . . . . . 81.3 mtp180 -92.03 128.98 38.08 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 115.433 -0.803 . . . . 0.0 110.009 177.459 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' D' D ' 143' ' ' THR . . . . . . . . . . . . . 63.6 p . . . . . 0 C--O 1.221 -0.431 0 CA-C-O 117.965 -1.017 . . . . 0.0 110.424 -179.701 . . . . . . . . 0 0 . 1 . 017 nuclear orig full ' E' E ' -3' ' ' GLU . . . . . . . . . . . . . 95.9 mt-10 . . . . . 0 N--CA 1.491 1.606 0 N-CA-C 109.344 -0.613 . . . . 0.0 109.344 . . . . . . . . . 0 0 . 1 . 017 nuclear orig full ' E' E ' -2' ' ' GLY . . . . . . . . . . . . . . . -80.19 145.63 27.05 Favored Glycine 0 CA--C 1.525 0.666 0 N-CA-C 111.142 -0.783 . . . . 0.0 111.142 -179.799 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' E' E ' -1' ' ' VAL . . . . . . . . . . . . . 45.1 t -96.42 137.37 24.48 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.303 0 N-CA-C 109.872 -0.418 . . . . 0.0 109.872 179.144 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' E' E ' 0' ' ' ILE . . . . . . . . . . . . . 43.0 mm -108.47 134.36 50.61 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.265 0 CA-C-N 116.357 -0.383 . . . . 0.0 110.419 -178.698 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' E' E ' 1' ' ' MET . . . . . . . . . . . . . 25.2 ptp -87.2 142.43 27.91 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.079 -0.509 . . . . 0.0 110.318 178.816 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' E' E ' 2' ' ' SER . . . . . . . . . . . . . 2.7 p -123.53 126.45 46.72 Favored 'General case' 0 C--N 1.331 -0.215 0 CA-C-O 121.138 0.494 . . . . 0.0 110.856 -179.995 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' E' E ' 3' ' ' GLU . . . . . . . . . . . . . 84.2 tt0 -141.53 138.23 32.58 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 115.699 -0.682 . . . . 0.0 110.882 -179.911 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' E' E ' 4' ' ' LEU . . . . . . . . . . . . . 13.6 tp -123.47 127.13 47.95 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.113 -0.494 . . . . 0.0 109.983 176.78 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' E' E ' 5' ' ' LYS . . . . . . . . . . . . . 91.5 mttt -107.2 121.24 44.14 Favored 'General case' 0 C--N 1.331 -0.23 0 CA-C-N 116.442 -0.345 . . . . 0.0 110.627 178.844 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' E' E ' 6' ' ' LEU . . . . . . . . . . . . . 30.6 mt -115.97 147.05 41.59 Favored 'General case' 0 C--N 1.331 -0.222 0 CA-C-N 115.529 -0.76 . . . . 0.0 110.385 -179.147 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' E' E ' 7' ' ' LYS . . . . . . . . . . . . . 36.9 ttmt -133.18 137.93 30.48 Favored Pre-proline 0 CA--C 1.535 0.384 0 CA-C-O 119.028 -0.51 . . . . 0.0 109.928 176.246 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' E' E ' 8' ' ' PRO . . . . . . . . . . . . . 85.9 Cg_endo -90.63 143.97 3.67 Favored 'Trans proline' 0 N--CA 1.49 1.314 0 C-N-CA 121.798 1.665 . . . . 0.0 111.84 178.805 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' E' E ' 9' ' ' LEU . . . . . . . . . . . . . 57.8 mt -81.15 -48.47 1.07 Allowed Pre-proline 0 CA--C 1.534 0.335 0 CA-C-O 118.669 -0.682 . . . . 0.0 112.385 -178.915 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' E' E ' 10' ' ' PRO . . . . . . . . . . . . . 86.0 Cg_endo -80.41 154.24 21.27 Favored 'Trans proline' 0 N--CA 1.496 1.637 0 C-N-CA 121.281 1.321 . . . . 0.0 111.934 177.169 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' E' E ' 11' ' ' LYS . . . . . . . . . . . . . 46.8 pttt -85.06 111.01 19.35 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-O 121.543 0.687 . . . . 0.0 110.426 177.415 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' E' E ' 12' ' ' VAL . . . . . . . . . . . . . 12.7 p -151.09 151.0 12.86 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.276 0 CA-C-N 115.769 -0.65 . . . . 0.0 110.858 -179.196 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' E' E ' 13' ' ' GLU . . . . . . . . . . . . . 95.2 mt-10 -94.26 120.93 35.22 Favored 'General case' 0 C--N 1.329 -0.32 0 N-CA-C 109.827 -0.434 . . . . 0.0 109.827 175.842 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' E' E ' 14' ' ' LEU . . . . . . . . . . . . . 27.4 mt -97.35 150.96 37.37 Favored Pre-proline 0 CA--C 1.532 0.265 0 CA-C-O 119.333 -0.365 . . . . 0.0 110.735 -177.916 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' E' E ' 15' ' ' PRO . . . . . . . . . . . . . 28.0 Cg_exo -60.86 159.5 28.9 Favored 'Trans proline' 0 N--CA 1.497 1.735 0 C-N-CA 121.339 1.359 . . . . 0.0 111.977 178.055 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' E' E ' 16' ' ' PRO . . . . . . . . . . . . . 27.5 Cg_exo -60.14 -37.22 85.2 Favored 'Trans proline' 0 N--CA 1.496 1.661 0 C-N-CA 121.464 1.443 . . . . 0.0 112.497 -179.006 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' E' E ' 17' ' ' ASP . . . . . . . . . . . . . 19.6 p-10 -86.84 10.26 16.61 Favored 'General case' 0 CA--C 1.537 0.455 0 N-CA-C 113.144 0.794 . . . . 0.0 113.144 -177.89 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' E' E ' 18' ' ' PHE . . . . . . . . . . . . . 59.7 t80 -57.56 -45.66 84.89 Favored 'General case' 0 N--CA 1.458 -0.059 0 O-C-N 122.059 -0.401 . . . . 0.0 110.275 -178.075 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' E' E ' 19' ' ' VAL . . . . . . . . . . . . . 14.4 p -56.35 -41.46 71.4 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.307 0 CA-C-N 116.499 -0.318 . . . . 0.0 110.858 -178.832 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' E' E ' 20' ' ' ASP . . . . . . . . . . . . . 67.0 m-20 -60.78 -41.17 94.99 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-O 120.762 0.315 . . . . 0.0 110.7 -179.54 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' E' E ' 21' ' ' VAL . . . . . . . . . . . . . 50.0 t -64.02 -43.91 97.69 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.323 0 CA-C-N 116.346 -0.388 . . . . 0.0 110.148 -178.359 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' E' E ' 22' ' ' ILE . . . . . . . . . . . . . 46.2 mm -55.8 -49.15 76.45 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.227 0 C-N-CA 120.889 -0.324 . . . . 0.0 110.705 178.373 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' E' E ' 23' ' ' ARG . . . . . . . . . . . . . 30.7 ttp180 -54.86 -50.28 69.04 Favored 'General case' 0 C--N 1.33 -0.261 0 C-N-CA 121.013 -0.275 . . . . 0.0 111.466 -178.452 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' E' E ' 24' ' ' ILE . . . . . . . . . . . . . 75.0 mt -58.77 -46.43 90.79 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.293 0 C-N-CA 120.988 -0.285 . . . . 0.0 111.132 -176.308 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' E' E ' 25' ' ' LYS . . . . . . . . . . . . . 8.5 mtpm? -67.17 -42.31 84.5 Favored 'General case' 0 C--N 1.328 -0.366 0 N-CA-C 112.283 0.475 . . . . 0.0 112.283 -176.607 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' E' E ' 26' ' ' LEU . . . . . . . . . . . . . 42.3 mt -80.11 -29.72 39.0 Favored 'General case' 0 C--N 1.33 -0.252 0 N-CA-C 113.326 0.861 . . . . 0.0 113.326 -171.957 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' E' E ' 27' ' ' GLN . . . . . . . . . . . . . 6.0 pt20 -45.99 134.49 8.06 Favored 'General case' 0 N--CA 1.467 0.406 0 N-CA-C 112.78 0.659 . . . . 0.0 112.78 -174.38 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' E' E ' 28' ' ' GLY . . . . . . . . . . . . . . . 99.78 -21.94 42.67 Favored Glycine 0 CA--C 1.535 1.325 0 CA-C-N 115.815 -0.629 . . . . 0.0 112.477 -177.428 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' E' E ' 29' ' ' LYS . . . . . . . . . . . . . 9.1 mtpm? -97.39 155.16 17.03 Favored 'General case' 0 C--N 1.331 -0.2 0 CA-C-N 117.542 0.671 . . . . 0.0 110.875 179.63 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' E' E ' 30' ' ' THR . . . . . . . . . . . . . 37.8 m -102.42 139.03 38.57 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 115.929 -0.578 . . . . 0.0 110.424 177.997 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' E' E ' 31' ' ' VAL . . . . . . . . . . . . . 35.4 m -126.26 150.3 31.76 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.266 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.127 179.028 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' E' E ' 32' ' ' ARG . . . . . . . . . . . . . 66.9 ttt-85 -136.04 148.4 48.34 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-O 121.06 0.457 . . . . 0.0 110.332 179.377 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' E' E ' 33' ' ' THR . . . . . . . . . . . . . 28.0 m -52.84 138.27 29.95 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.35 -0.386 . . . . 0.0 111.515 -177.195 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' E' E ' 34' ' ' GLY . . . . . . . . . . . . . . . 98.44 -17.04 59.06 Favored Glycine 0 CA--C 1.533 1.189 0 CA-C-N 116.141 -0.482 . . . . 0.0 113.316 178.536 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' E' E ' 35' ' ' ASP . . . . . . . . . . . . . 81.2 m-20 -66.66 149.31 50.7 Favored 'General case' 0 C--O 1.231 0.131 0 CA-C-N 117.976 0.888 . . . . 0.0 111.312 179.85 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' E' E ' 36' ' ' VAL . . . . . . . . . . . . . 47.0 t -118.79 129.41 75.04 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.233 0 CA-C-N 115.745 -0.661 . . . . 0.0 109.674 176.679 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' E' E ' 37' ' ' ILE . . . . . . . . . . . . . 70.3 mt -120.17 138.46 50.64 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.26 0 N-CA-C 109.82 -0.437 . . . . 0.0 109.82 179.909 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' E' E ' 38' ' ' GLY . . . . . . . . . . . . . . . -111.9 128.57 8.65 Favored Glycine 0 CA--C 1.525 0.689 0 N-CA-C 111.055 -0.818 . . . . 0.0 111.055 179.384 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' E' E ' 39' ' ' ILE . . . . . . . . . . . . . 73.8 mt -127.59 135.98 61.72 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.189 0 CA-C-O 120.731 0.3 . . . . 0.0 110.267 179.186 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' E' E ' 40' ' ' SER . . . . . . . . . . . . . 91.0 p -92.99 116.24 28.87 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.278 -0.419 . . . . 0.0 110.733 174.429 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' E' E ' 41' ' ' ILE . . . . . . . . . . . . . 44.0 mm -121.1 123.17 69.43 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.216 0 CA-C-N 116.552 -0.294 . . . . 0.0 110.431 179.588 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' E' E ' 42' ' ' LEU . . . . . . . . . . . . . 47.0 mt 52.27 33.27 12.29 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.303 -0.408 . . . . 0.0 111.951 176.919 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' E' E ' 43' ' ' GLY . . . . . . . . . . . . . . . 74.15 31.69 59.27 Favored Glycine 0 CA--C 1.528 0.88 0 C-N-CA 121.135 -0.555 . . . . 0.0 112.159 177.711 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' E' E ' 44' ' ' LYS . . . . . . . . . . . . . 67.6 tttt -139.58 135.54 33.48 Favored 'General case' 0 C--N 1.329 -0.308 0 N-CA-C 109.674 -0.491 . . . . 0.0 109.674 177.747 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' E' E ' 45' ' ' GLU . . . . . . . . . . . . . 83.6 tt0 -82.16 120.92 25.95 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-O 120.861 0.362 . . . . 0.0 110.971 -177.098 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' E' E ' 46' ' ' VAL . . . . . . . . . . . . . 7.6 p -124.58 125.04 69.46 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.179 0 N-CA-C 109.41 -0.589 . . . . 0.0 109.41 176.277 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' E' E ' 47' ' ' LYS . . . . . . . . . . . . . 96.1 mttt -101.08 134.5 43.99 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.019 -0.537 . . . . 0.0 111.31 177.768 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' E' E ' 48' ' ' PHE . . . . . . . . . . . . . 88.5 m-85 -115.19 132.89 56.46 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 115.88 -0.6 . . . . 0.0 109.965 176.553 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' E' E ' 49' ' ' LYS . . . . . . . . . . . . . 83.3 tttt -105.33 136.91 43.99 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 116.347 -0.388 . . . . 0.0 109.987 177.303 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' E' E ' 50' ' ' VAL . . . . . . . . . . . . . 43.1 t -80.42 109.92 15.42 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.277 0 N-CA-C 109.353 -0.61 . . . . 0.0 109.353 176.821 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' E' E ' 51' ' ' VAL . . . . . . . . . . . . . 53.4 t -68.91 -47.33 76.46 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.24 0 CA-C-N 115.898 -0.592 . . . . 0.0 109.889 -174.777 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' E' E ' 52' ' ' GLN . . . . . . . . . . . . . 48.7 tt0 -167.85 141.77 3.46 Favored 'General case' 0 C--N 1.331 -0.219 0 C-N-CA 120.342 -0.543 . . . . 0.0 111.672 -179.688 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' E' E ' 53' ' ' ALA . . . . . . . . . . . . . . . -111.58 131.49 55.22 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 115.55 -0.75 . . . . 0.0 109.675 175.742 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' E' E ' 54' ' ' TYR . . . . . . . . . . . . . 50.6 t80 -127.67 106.48 20.8 Favored Pre-proline 0 CA--C 1.536 0.418 0 CA-C-O 118.319 -0.848 . . . . 0.0 110.438 -179.61 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' E' E ' 55' ' ' PRO . . . . . . . . . . . . . 73.4 Cg_endo -77.02 170.02 72.83 Favored 'Cis proline' 0 N--CA 1.499 1.836 0 CA-C-N 121.696 1.641 . . . . 0.0 112.607 -2.91 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' E' E ' 56' ' ' SER . . . . . . . . . . . . . 13.6 m -109.49 121.19 43.1 Favored Pre-proline 0 CA--C 1.539 0.537 0 CA-C-O 118.381 -0.819 . . . . 0.0 109.563 177.22 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' E' E ' 57' ' ' PRO . . . . . . . . . . . . . 61.1 Cg_endo -74.36 169.3 74.38 Favored 'Cis proline' 0 N--CA 1.497 1.686 0 CA-C-N 122.049 1.767 . . . . 0.0 112.073 0.97 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' E' E ' 58' ' ' LEU . . . . . . . . . . . . . 26.3 tp -128.13 136.16 50.78 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 115.999 -0.546 . . . . 0.0 110.014 179.755 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' E' E ' 59' ' ' ARG . . . . . . . . . . . . . 39.4 ttm180 -101.2 124.99 47.77 Favored 'General case' 0 C--N 1.326 -0.425 0 CA-C-N 115.89 -0.595 . . . . 0.0 109.467 178.512 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' E' E ' 60' ' ' VAL . . . . . . . . . . . . . 42.9 t -80.04 116.56 24.36 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.207 0 C-N-CA 120.57 -0.452 . . . . 0.0 110.353 -175.691 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' E' E ' 61' ' ' GLU . . . . . . . . . . . . . 95.6 mt-10 -131.04 166.07 21.85 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 115.792 -0.64 . . . . 0.0 110.045 178.765 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' E' E ' 62' ' ' ASP . . . . . . . . . . . . . 81.1 m-20 -54.94 -32.6 61.46 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.505 -0.316 . . . . 0.0 111.763 -179.991 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' E' E ' 63' ' ' ARG . . . . . . . . . . . . . 16.8 ptp180 -85.5 7.71 21.88 Favored 'General case' 0 CA--C 1.535 0.402 0 N-CA-C 113.536 0.939 . . . . 0.0 113.536 -175.751 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' E' E ' 64' ' ' THR . . . . . . . . . . . . . 34.0 m -94.35 141.79 28.16 Favored 'General case' 0 C--N 1.332 -0.166 0 CA-C-N 118.156 0.435 . . . . 0.0 110.587 -177.969 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' E' E ' 65' ' ' LYS . . . . . . . . . . . . . 98.3 mttt -88.87 126.8 35.54 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.09 -0.504 . . . . 0.0 110.195 179.234 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' E' E ' 66' ' ' ILE . . . . . . . . . . . . . 59.4 mt -114.23 126.45 71.75 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.292 0 N-CA-C 109.542 -0.54 . . . . 0.0 109.542 178.23 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' E' E ' 67' ' ' THR . . . . . . . . . . . . . 20.6 m -119.46 134.83 55.03 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-O 120.944 0.402 . . . . 0.0 110.481 -178.497 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' E' E ' 68' ' ' LEU . . . . . . . . . . . . . 6.4 tt -103.95 119.01 38.03 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 115.886 -0.597 . . . . 0.0 110.113 179.247 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' E' E ' 69' ' ' VAL . . . . . . . . . . . . . 47.2 t -102.32 141.53 18.3 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.371 0 CA-C-N 115.988 -0.551 . . . . 0.0 109.711 179.248 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' E' E ' 70' ' ' THR . . . . . . . . . . . . . 7.8 t -130.25 129.8 43.77 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-O 121.025 0.441 . . . . 0.0 110.437 -179.872 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' E' E ' 71' ' ' HIS . . . . . . . . . . . . . 33.3 m80 -132.25 154.87 81.77 Favored Pre-proline 0 C--N 1.33 -0.272 0 CA-C-N 115.822 -0.626 . . . . 0.0 110.011 179.205 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' E' E ' 72' ' ' PRO . . . . . . . . . . . . . 86.6 Cg_endo -87.13 21.37 1.07 Allowed 'Trans proline' 0 N--CA 1.492 1.39 0 C-N-CA 121.534 1.489 . . . . 0.0 113.075 179.369 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' E' E ' 73' ' ' VAL . . . . . . . . . . . . . 26.7 m -130.5 149.28 33.4 Favored 'Isoleucine or valine' 0 C--O 1.232 0.136 0 CA-C-O 121.06 0.457 . . . . 0.0 110.968 -179.985 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' E' E ' 74' ' ' ASP . . . . . . . . . . . . . 19.6 t0 -112.33 119.13 37.23 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 115.738 -0.665 . . . . 0.0 109.521 177.646 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' E' E ' 75' ' ' VAL . . . . . . . . . . . . . 43.8 t -110.63 126.53 67.96 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.258 0 CA-C-O 121.141 0.496 . . . . 0.0 111.0 -174.983 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' E' E ' 76' ' ' LEU . . . . . . . . . . . . . 23.0 mt -128.76 144.52 51.19 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 115.456 -0.793 . . . . 0.0 109.475 176.379 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' E' E ' 77' ' ' GLU . . . . . . . . . . . . . 98.0 mt-10 -131.72 139.33 48.97 Favored 'General case' 0 C--N 1.332 -0.163 0 CA-C-O 121.117 0.484 . . . . 0.0 111.622 -177.07 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' E' E ' 78' ' ' ALA . . . . . . . . . . . . . . . -126.68 129.41 48.39 Favored 'General case' 0 C--N 1.331 -0.196 0 CA-C-N 115.573 -0.74 . . . . 0.0 109.685 175.693 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' E' E ' 79' ' ' LYS . . . . . . . . . . . . . 51.8 pttt -75.85 121.09 22.11 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-O 121.471 0.653 . . . . 0.0 110.997 -177.996 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' E' E ' 80' ' ' ILE . . . . . . . . . . . . . 41.2 mm -139.28 107.52 3.26 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.224 0 CA-C-N 115.531 -0.759 . . . . 0.0 109.111 -177.131 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' E' E ' 81' ' ' LYS . . . . . . . . . . . . . 31.7 ttpt -103.61 126.94 51.06 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-O 120.838 0.351 . . . . 0.0 111.111 -177.199 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' E' E ' 82' ' ' GLY . . . . . . . . . . . . . . . 89.03 42.01 5.74 Favored Glycine 0 CA--C 1.526 0.722 0 C-N-CA 120.8 -0.714 . . . . 0.0 111.716 174.977 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' E' E ' 83' ' ' ILE . . . . . . . . . . . . . 70.8 mt -65.48 138.97 22.11 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.356 0 CA-C-O 120.931 0.396 . . . . 0.0 110.033 179.194 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' E' E ' 84' ' ' LYS . . . . . . . . . . . . . 57.0 tttp -98.72 -50.27 4.3 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 115.964 -0.562 . . . . 0.0 109.893 179.043 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' E' E ' 85' ' ' ASP . . . . . . . . . . . . . 5.3 t70 -157.92 153.4 26.16 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 115.647 -0.706 . . . . 0.0 110.228 178.696 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' E' E ' 86' ' ' VAL . . . . . . . . . . . . . 44.6 t -128.39 131.77 68.7 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.208 0 CA-C-O 121.014 0.435 . . . . 0.0 110.559 -178.838 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' E' E ' 87' ' ' ILE . . . . . . . . . . . . . 4.9 mp -117.99 123.3 71.46 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.253 0 CA-C-N 115.743 -0.662 . . . . 0.0 109.245 175.149 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' E' E ' 88' ' ' LEU . . . . . . . . . . . . . 13.0 tp -111.08 130.98 55.44 Favored 'General case' 0 C--N 1.331 -0.198 0 CA-C-O 120.99 0.424 . . . . 0.0 111.032 -177.328 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' E' E ' 89' ' ' ASP . . . . . . . . . . . . . 13.2 t70 -126.65 153.12 45.81 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 115.867 -0.606 . . . . 0.0 109.451 176.51 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' E' E ' 90' ' ' GLU . . . . . . . . . . . . . 80.4 tt0 -47.81 -33.42 7.25 Favored 'General case' 0 C--N 1.331 -0.23 0 N-CA-C 112.866 0.691 . . . . 0.0 112.866 -172.271 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' E' E ' 91' ' ' ASN . . . . . . . . . . . . . 3.8 p30 -129.14 14.55 6.22 Favored 'General case' 0 N--CA 1.469 0.509 0 N-CA-C 113.349 0.87 . . . . 0.0 113.349 -175.905 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' E' E ' 92' ' ' LEU . . . . . . . . . . . . . 34.9 mt -149.42 147.17 27.95 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-O 120.796 0.331 . . . . 0.0 110.508 -176.355 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' E' E ' 93' ' ' ILE . . . . . . . . . . . . . 71.7 mt -125.07 117.17 49.25 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.274 0 N-CA-C 109.319 -0.623 . . . . 0.0 109.319 177.696 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' E' E ' 94' ' ' VAL . . . . . . . . . . . . . 46.6 t -116.39 125.85 73.6 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.273 0 N-CA-C 109.753 -0.462 . . . . 0.0 109.753 -179.897 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' E' E ' 95' ' ' VAL . . . . . . . . . . . . . 38.7 t -122.74 132.93 70.32 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.293 0 CA-C-N 116.113 -0.494 . . . . 0.0 109.838 -179.097 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' E' E ' 96' ' ' ILE . . . . . . . . . . . . . 59.4 mt -114.53 129.57 70.37 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.327 0 N-CA-C 109.224 -0.658 . . . . 0.0 109.224 178.451 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' E' E ' 97' ' ' THR . . . . . . . . . . . . . 68.1 p -101.51 157.79 16.56 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-O 121.001 0.429 . . . . 0.0 110.968 -177.762 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' E' E ' 98' ' ' GLU . . . . . . . . . . . . . 44.6 mt-10 -53.81 -25.01 17.34 Favored 'General case' 0 C--N 1.329 -0.298 0 N-CA-C 112.489 0.551 . . . . 0.0 112.489 179.982 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' E' E ' 99' ' ' GLU . . . . . . . . . . . . . 96.4 mt-10 -78.1 14.69 1.08 Allowed 'General case' 0 CA--C 1.536 0.42 0 N-CA-C 113.331 0.863 . . . . 0.0 113.331 -177.052 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' E' E ' 100' ' ' ASN . . . . . . . . . . . . . 2.2 m-20 63.06 34.43 13.82 Favored 'General case' 0 N--CA 1.464 0.264 0 CA-C-N 117.909 0.322 . . . . 0.0 111.352 178.032 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' E' E ' 101' ' ' GLU . . . . . . . . . . . . . 81.4 tt0 -116.49 144.23 44.59 Favored 'General case' 0 C--N 1.332 -0.189 0 N-CA-C 109.582 -0.525 . . . . 0.0 109.582 175.195 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' E' E ' 102' ' ' VAL . . . . . . . . . . . . . 46.2 t -118.94 127.47 75.79 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.257 0 N-CA-C 109.864 -0.421 . . . . 0.0 109.864 -178.269 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' E' E ' 103' ' ' LEU . . . . . . . . . . . . . 6.1 mp -118.39 135.8 54.12 Favored 'General case' 0 C--N 1.332 -0.188 0 CA-C-N 115.829 -0.623 . . . . 0.0 110.112 177.26 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' E' E ' 104' ' ' ILE . . . . . . . . . . . . . 66.2 mt -119.46 122.0 67.84 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.265 0 N-CA-C 110.147 -0.316 . . . . 0.0 110.147 -179.723 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' E' E ' 105' ' ' PHE . . . . . . . . . . . . . 73.7 m-85 -118.84 163.67 16.55 Favored 'General case' 0 C--N 1.33 -0.245 0 O-C-N 123.991 0.807 . . . . 0.0 109.405 179.353 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' E' E ' 106' ' ' ASN . . . . . . . . . . . . . 47.6 p-10 -96.64 -170.93 2.15 Favored 'General case' 0 C--N 1.331 -0.201 0 N-CA-C 109.803 -0.443 . . . . 0.0 109.803 172.714 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' E' E ' 107' ' ' GLN . . . . . . . . . . . . . 42.1 tt0 -59.73 -27.62 66.64 Favored 'General case' 0 C--N 1.327 -0.373 0 N-CA-C 112.104 0.409 . . . . 0.0 112.104 -179.963 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' E' E ' 108' ' ' ASN . . . . . . . . . . . . . 6.9 t-20 -88.14 13.9 10.33 Favored 'General case' 0 CA--C 1.536 0.418 0 N-CA-C 112.874 0.694 . . . . 0.0 112.874 -178.161 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' E' E ' 109' ' ' LEU . . . . . . . . . . . . . 42.0 mt 57.25 32.3 21.51 Favored 'General case' 0 CA--C 1.529 0.172 0 N-CA-C 112.013 0.375 . . . . 0.0 112.013 178.697 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' E' E ' 110' ' ' GLU . . . . . . . . . . . . . 95.1 mt-10 -101.18 140.02 36.05 Favored 'General case' 0 C--N 1.33 -0.261 0 N-CA-C 109.125 -0.694 . . . . 0.0 109.125 174.269 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' E' E ' 111' ' ' GLU . . . . . . . . . . . . . 44.7 tt0 -82.43 121.91 27.34 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-O 120.948 0.404 . . . . 0.0 110.69 -174.605 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' E' E ' 112' ' ' LEU . . . . . . . . . . . . . 14.0 mt -102.12 -45.18 5.23 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 115.909 -0.587 . . . . 0.0 110.547 179.338 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' E' E ' 113' ' ' TYR . . . . . . . . . . . . . 57.4 t80 -134.8 143.51 47.12 Favored 'General case' 0 C--N 1.331 -0.218 0 CA-C-N 116.387 -0.37 . . . . 0.0 111.078 -177.536 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' E' E ' 114' ' ' ARG . . . . . . . . . . . . . 35.1 ptt180 -147.06 125.49 12.36 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.18 -0.463 . . . . 0.0 110.727 177.863 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' E' E ' 115' ' ' GLY . . . . . . . . . . . . . . . -150.15 162.97 29.38 Favored Glycine 0 CA--C 1.523 0.572 0 N-CA-C 110.834 -0.907 . . . . 0.0 110.834 -179.927 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' E' E ' 116' ' ' LYS . . . . . . . . . . . . . 30.7 ttmt -132.06 138.97 48.37 Favored 'General case' 0 C--N 1.329 -0.305 0 O-C-N 122.59 -0.359 . . . . 0.0 110.051 177.922 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' E' E ' 117' ' ' PHE . . . . . . . . . . . . . 28.0 m-85 -137.09 114.78 11.22 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-O 120.875 0.369 . . . . 0.0 110.038 -175.938 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' E' E ' 118' ' ' GLU . . . . . . . . . . . . . 96.8 mt-10 -54.27 -43.03 70.64 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.458 -0.337 . . . . 0.0 111.333 -176.679 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' E' E ' 119' ' ' ASN . . . . . . . . . . . . . 59.2 m-80 -98.9 31.06 3.1 Favored 'General case' 0 C--N 1.331 -0.215 0 CA-C-N 116.222 -0.444 . . . . 0.0 112.159 -174.257 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' E' E ' 120' ' ' LEU . . . . . . . . . . . . . 25.1 tp -57.03 119.82 6.96 Favored 'General case' 0 C--N 1.333 -0.127 0 C-N-CA 121.028 -0.269 . . . . 0.0 110.322 177.937 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' E' E ' 121' ' ' ASN . . . . . . . . . . . . . 9.9 t-20 -114.14 -44.14 3.16 Favored 'General case' 0 C--N 1.332 -0.182 0 CA-C-N 116.545 -0.298 . . . . 0.0 111.192 -177.28 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' E' E ' 122' ' ' LYS . . . . . . . . . . . . . 61.8 mtpt -144.29 152.59 41.0 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-O 121.048 0.451 . . . . 0.0 111.561 -176.814 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' E' E ' 123' ' ' VAL . . . . . . . . . . . . . 43.5 t -132.32 131.89 60.64 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.238 0 CA-C-N 116.01 -0.541 . . . . 0.0 109.808 175.983 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' E' E ' 124' ' ' LEU . . . . . . . . . . . . . 52.6 mt -120.15 133.12 55.58 Favored 'General case' 0 C--N 1.331 -0.213 0 CA-C-N 116.275 -0.421 . . . . 0.0 110.624 -179.339 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' E' E ' 125' ' ' VAL . . . . . . . . . . . . . 43.3 t -127.83 120.34 53.8 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.188 0 N-CA-C 109.788 -0.449 . . . . 0.0 109.788 177.818 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' E' E ' 126' ' ' ARG . . . . . . . . . . . . . 51.2 mtp180 -148.87 138.86 22.16 Favored 'General case' 0 C--N 1.329 -0.323 0 N-CA-C 109.661 -0.496 . . . . 0.0 109.661 179.615 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' E' E ' 127' ' ' ASN . . . . . . . . . . . . . 4.9 p-10 48.67 -151.13 0.14 Allowed 'General case' 0 CA--C 1.54 0.585 0 CA-C-O 119.434 -0.317 . . . . 0.0 111.024 177.353 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' E' E ' 128' ' ' ASP . . . . . . . . . . . . . 13.3 p-10 -84.14 22.84 1.14 Allowed 'General case' 0 CA--C 1.534 0.332 0 CA-C-N 118.541 0.61 . . . . 0.0 112.416 178.653 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' E' E ' 129' ' ' LEU . . . . . . . . . . . . . 15.0 tp -127.08 140.4 52.31 Favored 'General case' 0 C--O 1.233 0.2 0 O-C-N 122.072 -0.393 . . . . 0.0 110.354 -179.398 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' E' E ' 130' ' ' VAL . . . . . . . . . . . . . 30.9 m -129.5 142.81 42.98 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.218 0 CA-C-O 121.001 0.429 . . . . 0.0 110.468 179.297 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' E' E ' 131' ' ' VAL . . . . . . . . . . . . . 39.8 t -136.1 138.92 46.65 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.234 0 CA-C-N 116.118 -0.492 . . . . 0.0 110.545 -177.77 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' E' E ' 132' ' ' ILE . . . . . . . . . . . . . 73.8 mt -117.18 132.22 67.61 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.289 0 N-CA-C 109.347 -0.612 . . . . 0.0 109.347 177.761 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' E' E ' 133' ' ' ILE . . . . . . . . . . . . . 35.2 mm -115.65 122.39 69.32 Favored 'Isoleucine or valine' 0 C--O 1.234 0.278 0 CA-C-O 120.656 0.265 . . . . 0.0 111.06 -174.766 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' E' E ' 134' ' ' ASP . . . . . . . . . . . . . 7.5 p-10 -135.15 146.44 48.78 Favored 'General case' 0 C--N 1.329 -0.31 0 N-CA-C 109.374 -0.602 . . . . 0.0 109.374 174.812 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' E' E ' 135' ' ' GLU . . . . . . . . . . . . . 84.4 tt0 -49.91 -26.37 4.06 Favored 'General case' 0 CA--C 1.532 0.285 0 N-CA-C 112.721 0.637 . . . . 0.0 112.721 -174.242 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' E' E ' 136' ' ' GLN . . . . . . . . . . . . . 24.9 tt0 -77.64 -38.56 47.63 Favored 'General case' 0 C--O 1.234 0.28 0 CA-C-O 120.896 0.379 . . . . 0.0 111.933 -177.01 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' E' E ' 137' ' ' LYS . . . . . . . . . . . . . 17.4 ptpt -166.83 176.47 7.05 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-O 121.496 0.665 . . . . 0.0 111.621 -173.364 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' E' E ' 138' ' ' LEU . . . . . . . . . . . . . 7.4 tt -119.62 128.07 53.53 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 115.243 -0.89 . . . . 0.0 109.954 177.83 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' E' E ' 139' ' ' THR . . . . . . . . . . . . . 36.9 m -105.94 125.85 51.49 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.245 -0.434 . . . . 0.0 110.372 179.869 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' E' E ' 140' ' ' LEU . . . . . . . . . . . . . 21.3 tp -113.08 119.52 38.12 Favored 'General case' 0 C--N 1.329 -0.306 0 N-CA-C 109.018 -0.734 . . . . 0.0 109.018 -179.137 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' E' E ' 141' ' ' ILE . . . . . . . . . . . . . 19.5 mt -119.17 121.64 67.18 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.309 0 CA-C-O 121.042 0.449 . . . . 0.0 110.012 -175.944 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' E' E ' 142' ' ' ARG . . . . . . . . . . . . . 78.9 mtp180 -109.97 115.76 30.38 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 115.126 -0.943 . . . . 0.0 109.901 -177.748 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' E' E ' 143' ' ' THR . . . . . . . . . . . . . 34.9 p . . . . . 0 C--O 1.219 -0.51 0 CA-C-O 118.037 -0.983 . . . . 0.0 110.649 -178.24 . . . . . . . . 0 0 . 1 . 017 nuclear orig full ' F' F ' -3' ' ' GLU . . . . . . . . . . . . . 70.4 mm-40 . . . . . 0 N--CA 1.49 1.573 0 N-CA-C 109.484 -0.562 . . . . 0.0 109.484 . . . . . . . . . 0 0 . 1 . 017 nuclear orig full ' F' F ' -2' ' ' GLY . . . . . . . . . . . . . . . -70.32 150.01 47.95 Favored Glycine 0 CA--C 1.525 0.67 0 N-CA-C 110.91 -0.876 . . . . 0.0 110.91 179.111 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' F' F ' -1' ' ' VAL . . . . . . . . . . . . . 45.8 t -94.03 129.89 43.72 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.328 0 N-CA-C 109.851 -0.426 . . . . 0.0 109.851 179.878 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' F' F ' 0' ' ' ILE . . . . . . . . . . . . . 43.6 mm -116.91 133.88 62.21 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.259 0 CA-C-N 116.249 -0.432 . . . . 0.0 110.283 -178.986 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' F' F ' 1' ' ' MET . . . . . . . . . . . . . 24.6 ptp -80.85 138.27 36.19 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.018 -0.537 . . . . 0.0 110.683 -179.947 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' F' F ' 2' ' ' SER . . . . . . . . . . . . . 50.6 p -123.7 141.06 52.37 Favored 'General case' 0 C--N 1.332 -0.184 0 CA-C-O 120.986 0.422 . . . . 0.0 110.534 178.968 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' F' F ' 3' ' ' GLU . . . . . . . . . . . . . 84.7 tt0 -142.01 140.45 32.67 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.041 -0.527 . . . . 0.0 111.376 -178.777 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' F' F ' 4' ' ' LEU . . . . . . . . . . . . . 67.9 mt -120.16 134.0 55.36 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.042 -0.526 . . . . 0.0 110.2 176.253 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' F' F ' 5' ' ' LYS . . . . . . . . . . . . . 68.1 mttm -109.97 119.85 40.6 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.303 -0.408 . . . . 0.0 110.275 178.194 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' F' F ' 6' ' ' LEU . . . . . . . . . . . . . 57.1 mt -114.51 147.51 39.28 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 115.382 -0.826 . . . . 0.0 110.472 -178.109 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' F' F ' 7' ' ' LYS . . . . . . . . . . . . . 56.4 tttm -136.84 137.14 22.52 Favored Pre-proline 0 CA--C 1.534 0.34 0 CA-C-O 118.901 -0.571 . . . . 0.0 109.962 176.78 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' F' F ' 8' ' ' PRO . . . . . . . . . . . . . 97.3 Cg_endo -91.97 141.98 2.55 Favored 'Trans proline' 0 N--CA 1.488 1.2 0 C-N-CA 121.688 1.592 . . . . 0.0 111.776 177.397 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' F' F ' 9' ' ' LEU . . . . . . . . . . . . . 21.9 mt -79.79 -47.3 1.46 Allowed Pre-proline 0 CA--C 1.532 0.274 0 CA-C-O 118.697 -0.668 . . . . 0.0 111.92 -178.94 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' F' F ' 10' ' ' PRO . . . . . . . . . . . . . 96.0 Cg_endo -81.66 140.61 11.83 Favored 'Trans proline' 0 N--CA 1.494 1.55 0 C-N-CA 121.188 1.258 . . . . 0.0 111.509 175.254 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' F' F ' 11' ' ' LYS . . . . . . . . . . . . . 46.3 tptt -79.94 98.09 7.01 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-O 120.863 0.363 . . . . 0.0 110.184 179.726 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' F' F ' 12' ' ' VAL . . . . . . . . . . . . . 12.7 p -138.16 145.81 27.98 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.245 0 CA-C-N 116.132 -0.485 . . . . 0.0 110.542 -179.357 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' F' F ' 13' ' ' GLU . . . . . . . . . . . . . 84.6 tt0 -83.56 126.13 32.49 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.353 -0.385 . . . . 0.0 110.403 179.515 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' F' F ' 14' ' ' LEU . . . . . . . . . . . . . 15.5 mt -98.13 149.86 36.15 Favored Pre-proline 0 CA--C 1.532 0.284 0 CA-C-N 116.338 -0.392 . . . . 0.0 110.352 -178.593 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' F' F ' 15' ' ' PRO . . . . . . . . . . . . . 25.8 Cg_exo -62.51 164.11 19.03 Favored 'Trans proline' 0 N--CA 1.496 1.628 0 C-N-CA 121.277 1.318 . . . . 0.0 111.916 176.001 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' F' F ' 16' ' ' PRO . . . . . . . . . . . . . 27.6 Cg_exo -60.32 -41.84 46.86 Favored 'Trans proline' 0 N--CA 1.498 1.748 0 C-N-CA 121.439 1.426 . . . . 0.0 112.842 -177.974 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' F' F ' 17' ' ' ASP . . . . . . . . . . . . . 7.9 p-10 -88.67 11.09 18.45 Favored 'General case' 0 C--N 1.327 -0.376 0 N-CA-C 113.249 0.833 . . . . 0.0 113.249 -176.679 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' F' F ' 18' ' ' PHE . . . . . . . . . . . . . 49.2 t80 -57.18 -42.72 81.69 Favored 'General case' 0 C--N 1.334 -0.07 0 O-C-N 121.922 -0.486 . . . . 0.0 110.25 -178.816 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' F' F ' 19' ' ' VAL . . . . . . . . . . . . . 47.7 t -57.52 -43.05 82.3 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.321 0 CA-C-N 116.144 -0.48 . . . . 0.0 110.36 -179.092 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' F' F ' 20' ' ' ASP . . . . . . . . . . . . . 8.6 t70 -59.85 -41.13 90.74 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-O 120.873 0.368 . . . . 0.0 110.726 -178.217 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' F' F ' 21' ' ' VAL . . . . . . . . . . . . . 51.1 t -64.36 -47.2 90.58 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.332 0 CA-C-N 116.323 -0.398 . . . . 0.0 110.392 -178.2 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' F' F ' 22' ' ' ILE . . . . . . . . . . . . . 50.5 mm -55.93 -45.37 80.0 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.202 0 C-N-CA 120.928 -0.309 . . . . 0.0 110.662 179.201 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' F' F ' 23' ' ' ARG . . . . . . . . . . . . . 36.1 ttp180 -53.83 -50.7 65.62 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-O 120.675 0.274 . . . . 0.0 111.428 -178.999 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' F' F ' 24' ' ' ILE . . . . . . . . . . . . . 71.5 mt -60.31 -41.36 86.83 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.264 0 CA-C-N 116.514 -0.312 . . . . 0.0 111.314 -177.18 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' F' F ' 25' ' ' LYS . . . . . . . . . . . . . 82.3 mttt -66.39 -39.02 88.81 Favored 'General case' 0 C--N 1.33 -0.265 0 N-CA-C 112.354 0.502 . . . . 0.0 112.354 -178.674 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' F' F ' 26' ' ' LEU . . . . . . . . . . . . . 75.7 mt -78.42 -41.9 31.64 Favored 'General case' 0 C--N 1.33 -0.278 0 N-CA-C 113.005 0.742 . . . . 0.0 113.005 -173.39 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' F' F ' 27' ' ' GLN . . . . . . . . . . . . . 9.1 pt20 -46.91 142.1 3.66 Favored 'General case' 0 N--CA 1.47 0.538 0 N-CA-C 112.694 0.627 . . . . 0.0 112.694 -175.377 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' F' F ' 28' ' ' GLY . . . . . . . . . . . . . . . 98.94 -29.77 11.09 Favored Glycine 0 CA--C 1.531 1.087 0 CA-C-N 115.514 -0.766 . . . . 0.0 111.96 -177.477 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' F' F ' 29' ' ' LYS . . . . . . . . . . . . . 8.7 mtpm? -98.66 155.14 17.47 Favored 'General case' 0 C--O 1.232 0.167 0 CA-C-O 121.013 0.435 . . . . 0.0 110.955 179.264 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' F' F ' 30' ' ' THR . . . . . . . . . . . . . 29.7 m -97.28 138.4 34.82 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.151 -0.477 . . . . 0.0 109.947 175.682 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' F' F ' 31' ' ' VAL . . . . . . . . . . . . . 35.3 m -124.94 151.45 30.56 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.257 0 CA-C-N 116.289 -0.414 . . . . 0.0 110.82 -178.47 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' F' F ' 32' ' ' ARG . . . . . . . . . . . . . 61.5 mtp180 -135.3 152.19 51.26 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-O 121.398 0.618 . . . . 0.0 110.717 176.82 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' F' F ' 33' ' ' THR . . . . . . . . . . . . . 8.4 m -54.0 138.3 37.48 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 115.973 -0.558 . . . . 0.0 111.18 -179.085 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' F' F ' 34' ' ' GLY . . . . . . . . . . . . . . . 101.57 -17.08 55.79 Favored Glycine 0 CA--C 1.532 1.139 0 CA-C-O 119.539 -0.59 . . . . 0.0 113.293 178.768 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' F' F ' 35' ' ' ASP . . . . . . . . . . . . . 74.2 m-20 -65.27 148.81 51.04 Favored 'General case' 0 N--CA 1.461 0.113 0 CA-C-N 118.134 0.967 . . . . 0.0 111.25 179.869 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' F' F ' 36' ' ' VAL . . . . . . . . . . . . . 44.8 t -122.48 129.84 74.96 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.16 0 CA-C-N 115.741 -0.663 . . . . 0.0 109.793 178.308 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' F' F ' 37' ' ' ILE . . . . . . . . . . . . . 70.4 mt -122.71 140.18 47.28 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.185 0 CA-C-N 116.233 -0.439 . . . . 0.0 109.96 -179.813 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' F' F ' 38' ' ' GLY . . . . . . . . . . . . . . . -114.0 128.78 8.42 Favored Glycine 0 CA--C 1.525 0.679 0 N-CA-C 111.211 -0.756 . . . . 0.0 111.211 -179.973 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' F' F ' 39' ' ' ILE . . . . . . . . . . . . . 72.4 mt -126.25 130.27 72.03 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.214 0 N-CA-C 109.746 -0.465 . . . . 0.0 109.746 178.539 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' F' F ' 40' ' ' SER . . . . . . . . . . . . . 83.7 p -93.45 121.62 35.04 Favored 'General case' 0 C--N 1.331 -0.227 0 C-N-CA 120.945 -0.302 . . . . 0.0 111.456 178.826 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' F' F ' 41' ' ' ILE . . . . . . . . . . . . . 44.5 mm -133.4 129.13 55.99 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.181 0 CA-C-N 116.427 -0.351 . . . . 0.0 110.163 177.813 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' F' F ' 42' ' ' LEU . . . . . . . . . . . . . 70.3 mt 57.6 32.99 22.67 Favored 'General case' 0 C--N 1.33 -0.249 0 N-CA-C 112.023 0.379 . . . . 0.0 112.023 176.93 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' F' F ' 43' ' ' GLY . . . . . . . . . . . . . . . 77.46 -10.12 24.6 Favored Glycine 0 CA--C 1.533 1.205 0 C-N-CA 121.108 -0.568 . . . . 0.0 113.553 177.502 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' F' F ' 44' ' ' LYS . . . . . . . . . . . . . 37.6 mmtm -103.25 136.31 43.26 Favored 'General case' 0 C--O 1.232 0.173 0 CA-C-N 117.988 0.894 . . . . 0.0 110.051 176.638 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' F' F ' 45' ' ' GLU . . . . . . . . . . . . . 35.1 tp10 -84.58 127.56 34.13 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.344 -0.389 . . . . 0.0 110.628 -179.805 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' F' F ' 46' ' ' VAL . . . . . . . . . . . . . 5.8 p -115.22 126.67 72.85 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.223 0 N-CA-C 109.212 -0.662 . . . . 0.0 109.212 176.23 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' F' F ' 47' ' ' LYS . . . . . . . . . . . . . 63.4 mttm -100.14 128.99 46.12 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 115.791 -0.641 . . . . 0.0 110.924 -179.482 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' F' F ' 48' ' ' PHE . . . . . . . . . . . . . 95.6 m-85 -113.73 131.83 56.04 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.358 -0.383 . . . . 0.0 110.324 177.884 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' F' F ' 49' ' ' LYS . . . . . . . . . . . . . 80.0 tttt -108.06 139.01 43.34 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.357 -0.383 . . . . 0.0 110.633 178.214 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' F' F ' 50' ' ' VAL . . . . . . . . . . . . . 45.0 t -82.11 107.33 14.0 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.343 0 N-CA-C 109.224 -0.658 . . . . 0.0 109.224 175.011 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' F' F ' 51' ' ' VAL . . . . . . . . . . . . . 50.3 t -72.25 -51.87 27.42 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.258 0 CA-C-N 116.103 -0.499 . . . . 0.0 109.757 -174.753 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' F' F ' 52' ' ' GLN . . . . . . . . . . . . . 90.7 mt-30 -153.84 153.23 31.73 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-O 121.296 0.57 . . . . 0.0 111.722 -178.564 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' F' F ' 53' ' ' ALA . . . . . . . . . . . . . . . -129.98 132.64 46.37 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 115.252 -0.885 . . . . 0.0 109.635 173.825 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' F' F ' 54' ' ' TYR . . . . . . . . . . . . . 41.1 t80 -129.09 110.58 18.24 Favored Pre-proline 0 CA--C 1.536 0.406 0 CA-C-O 118.231 -0.89 . . . . 0.0 110.555 179.974 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' F' F ' 55' ' ' PRO . . . . . . . . . . . . . 74.4 Cg_endo -77.21 169.37 74.35 Favored 'Cis proline' 0 N--CA 1.5 1.869 0 CA-C-N 121.823 1.687 . . . . 0.0 112.165 -7.971 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' F' F ' 56' ' ' SER . . . . . . . . . . . . . 13.6 m -117.84 135.03 23.22 Favored Pre-proline 0 CA--C 1.538 0.487 0 CA-C-O 118.515 -0.755 . . . . 0.0 109.599 174.809 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' F' F ' 57' ' ' PRO . . . . . . . . . . . . . 58.8 Cg_endo -73.18 162.01 92.69 Favored 'Cis proline' 0 N--CA 1.498 1.736 0 CA-C-N 121.898 1.714 . . . . 0.0 111.412 -2.656 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' F' F ' 58' ' ' LEU . . . . . . . . . . . . . 23.9 tp -130.88 139.64 50.13 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-O 121.003 0.43 . . . . 0.0 110.936 -179.673 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' F' F ' 59' ' ' ARG . . . . . . . . . . . . . 35.7 ttm180 -97.84 125.22 42.59 Favored 'General case' 0 C--N 1.327 -0.399 0 N-CA-C 109.087 -0.708 . . . . 0.0 109.087 173.052 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' F' F ' 60' ' ' VAL . . . . . . . . . . . . . 43.4 t -79.44 119.86 29.59 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.262 0 C-N-CA 120.599 -0.44 . . . . 0.0 110.426 -175.144 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' F' F ' 61' ' ' GLU . . . . . . . . . . . . . 95.2 mt-10 -131.08 169.93 15.21 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 115.792 -0.64 . . . . 0.0 109.742 176.592 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' F' F ' 62' ' ' ASP . . . . . . . . . . . . . 80.1 m-20 -52.8 -32.37 43.66 Favored 'General case' 0 C--N 1.329 -0.305 0 N-CA-C 111.948 0.351 . . . . 0.0 111.948 -178.417 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' F' F ' 63' ' ' ARG . . . . . . . . . . . . . 85.4 mtt180 -72.29 -22.06 61.26 Favored 'General case' 0 CA--C 1.533 0.308 0 N-CA-C 113.019 0.748 . . . . 0.0 113.019 -175.661 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' F' F ' 64' ' ' THR . . . . . . . . . . . . . 33.1 m -68.72 135.43 51.29 Favored 'General case' 0 C--N 1.331 -0.229 0 CA-C-O 120.995 0.426 . . . . 0.0 111.049 -175.099 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' F' F ' 65' ' ' LYS . . . . . . . . . . . . . 63.3 mttm -89.95 136.47 33.02 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 115.912 -0.585 . . . . 0.0 110.064 177.922 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' F' F ' 66' ' ' ILE . . . . . . . . . . . . . 60.1 mt -118.29 129.95 73.86 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.185 0 N-CA-C 109.851 -0.426 . . . . 0.0 109.851 179.06 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' F' F ' 67' ' ' THR . . . . . . . . . . . . . 24.2 m -124.88 142.26 51.57 Favored 'General case' 0 C--N 1.332 -0.186 0 CA-C-O 121.103 0.477 . . . . 0.0 110.9 -178.878 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' F' F ' 68' ' ' LEU . . . . . . . . . . . . . 7.1 tt -98.78 123.0 42.73 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 115.944 -0.571 . . . . 0.0 109.822 177.396 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' F' F ' 69' ' ' VAL . . . . . . . . . . . . . 41.3 t -103.18 123.44 56.64 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.304 0 CA-C-N 116.354 -0.385 . . . . 0.0 110.817 -176.774 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' F' F ' 70' ' ' THR . . . . . . . . . . . . . 18.2 m -109.46 109.64 20.53 Favored 'General case' 0 C--N 1.33 -0.247 0 N-CA-C 109.298 -0.63 . . . . 0.0 109.298 172.979 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' F' F ' 71' ' ' HIS . . . . . . . . . . . . . 2.0 m-70 -146.15 174.47 3.4 Favored Pre-proline 0 CA--C 1.536 0.409 0 C-N-CA 120.807 -0.357 . . . . 0.0 110.775 -175.617 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' F' F ' 72' ' ' PRO . . . . . . . . . . . . . 18.9 Cg_exo -64.87 160.09 42.73 Favored 'Trans proline' 0 N--CA 1.494 1.516 0 C-N-CA 121.594 1.529 . . . . 0.0 111.745 177.712 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' F' F ' 73' ' ' VAL . . . . . . . . . . . . . 33.1 m -69.78 175.6 0.58 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.284 0 CA-C-N 116.291 -0.413 . . . . 0.0 110.112 -178.061 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' F' F ' 74' ' ' ASP . . . . . . . . . . . . . 14.4 t0 -92.85 117.49 30.08 Favored 'General case' 0 C--N 1.331 -0.227 0 C-N-CA 120.735 -0.386 . . . . 0.0 110.3 -173.729 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' F' F ' 75' ' ' VAL . . . . . . . . . . . . . 41.8 t -113.72 120.43 63.56 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.287 0 CA-C-O 121.101 0.477 . . . . 0.0 110.075 -179.785 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' F' F ' 76' ' ' LEU . . . . . . . . . . . . . 15.4 mt -125.17 144.17 50.58 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 115.728 -0.669 . . . . 0.0 109.686 178.129 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' F' F ' 77' ' ' GLU . . . . . . . . . . . . . 97.4 mt-10 -134.6 132.69 39.35 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-O 121.151 0.501 . . . . 0.0 110.981 -176.855 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' F' F ' 78' ' ' ALA . . . . . . . . . . . . . . . -116.33 127.29 54.56 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 115.658 -0.701 . . . . 0.0 109.719 177.309 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' F' F ' 79' ' ' LYS . . . . . . . . . . . . . 52.5 mtmt -78.39 116.31 18.71 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-O 120.85 0.357 . . . . 0.0 110.691 -177.586 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' F' F ' 80' ' ' ILE . . . . . . . . . . . . . 40.1 mm -139.14 106.25 2.83 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.295 0 N-CA-C 109.003 -0.74 . . . . 0.0 109.003 -177.313 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' F' F ' 81' ' ' LYS . . . . . . . . . . . . . 44.3 tptt -98.05 124.17 42.42 Favored 'General case' 0 C--N 1.328 -0.355 0 C-N-CA 120.788 -0.365 . . . . 0.0 110.806 -175.95 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' F' F ' 82' ' ' GLY . . . . . . . . . . . . . . . 89.09 42.24 5.66 Favored Glycine 0 CA--C 1.524 0.648 0 C-N-CA 120.756 -0.735 . . . . 0.0 111.798 175.423 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' F' F ' 83' ' ' ILE . . . . . . . . . . . . . 75.7 mt -66.45 141.09 18.45 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.286 0 N-CA-C 109.815 -0.439 . . . . 0.0 109.815 177.122 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' F' F ' 84' ' ' LYS . . . . . . . . . . . . . 41.6 tttp -95.4 -53.42 3.77 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 115.93 -0.577 . . . . 0.0 110.361 -178.775 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' F' F ' 85' ' ' ASP . . . . . . . . . . . . . 12.9 t70 -153.21 151.98 30.69 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 115.714 -0.675 . . . . 0.0 110.419 -179.711 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' F' F ' 86' ' ' VAL . . . . . . . . . . . . . 44.6 t -127.22 130.68 71.01 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.266 0 CA-C-O 120.951 0.405 . . . . 0.0 110.406 -179.113 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' F' F ' 87' ' ' ILE . . . . . . . . . . . . . 5.0 mp -122.03 129.02 75.74 Favored 'Isoleucine or valine' 0 C--O 1.233 0.206 0 CA-C-N 115.932 -0.576 . . . . 0.0 109.604 176.954 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' F' F ' 88' ' ' LEU . . . . . . . . . . . . . 18.5 tp -112.32 128.36 56.26 Favored 'General case' 0 C--N 1.332 -0.183 0 CA-C-O 121.03 0.443 . . . . 0.0 110.983 -179.0 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' F' F ' 89' ' ' ASP . . . . . . . . . . . . . 6.5 t0 -117.28 152.1 35.56 Favored 'General case' 0 C--N 1.329 -0.3 0 N-CA-C 109.093 -0.706 . . . . 0.0 109.093 175.63 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' F' F ' 90' ' ' GLU . . . . . . . . . . . . . 84.3 tt0 -48.86 -30.57 5.96 Favored 'General case' 0 C--N 1.329 -0.299 0 N-CA-C 112.83 0.678 . . . . 0.0 112.83 -172.534 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' F' F ' 91' ' ' ASN . . . . . . . . . . . . . 7.3 m120 -130.55 15.78 5.43 Favored 'General case' 0 N--CA 1.468 0.468 0 N-CA-C 113.308 0.855 . . . . 0.0 113.308 -177.051 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' F' F ' 92' ' ' LEU . . . . . . . . . . . . . 55.7 mt -149.96 149.59 30.62 Favored 'General case' 0 C--N 1.332 -0.195 0 CA-C-N 117.964 0.347 . . . . 0.0 110.764 -176.396 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' F' F ' 93' ' ' ILE . . . . . . . . . . . . . 68.2 mt -122.16 119.63 59.01 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.244 0 N-CA-C 108.985 -0.746 . . . . 0.0 108.985 176.631 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' F' F ' 94' ' ' VAL . . . . . . . . . . . . . 47.6 t -120.67 127.31 75.91 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.254 0 CA-C-O 121.008 0.432 . . . . 0.0 110.016 -178.785 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' F' F ' 95' ' ' VAL . . . . . . . . . . . . . 40.4 t -122.87 134.84 64.84 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.342 0 CA-C-N 115.809 -0.632 . . . . 0.0 109.876 -179.754 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' F' F ' 96' ' ' ILE . . . . . . . . . . . . . 59.1 mt -114.48 125.65 71.83 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.379 0 N-CA-C 108.947 -0.76 . . . . 0.0 108.947 178.266 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' F' F ' 97' ' ' THR . . . . . . . . . . . . . 73.9 p -98.91 155.23 17.51 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-O 121.221 0.534 . . . . 0.0 111.438 -175.585 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' F' F ' 98' ' ' GLU . . . . . . . . . . . . . 22.1 pt-20 -54.26 -21.76 10.01 Favored 'General case' 0 CA--C 1.534 0.353 0 N-CA-C 112.568 0.581 . . . . 0.0 112.568 179.339 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' F' F ' 99' ' ' GLU . . . . . . . . . . . . . 34.7 tt0 -83.74 18.11 2.07 Favored 'General case' 0 CA--C 1.539 0.542 0 N-CA-C 112.394 0.516 . . . . 0.0 112.394 -177.548 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' F' F ' 100' ' ' ASN . . . . . . . . . . . . . 3.6 m-20 62.04 37.98 14.37 Favored 'General case' 0 C--O 1.232 0.183 0 CA-C-O 121.161 0.505 . . . . 0.0 111.029 177.247 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' F' F ' 101' ' ' GLU . . . . . . . . . . . . . 84.2 tt0 -118.13 143.36 46.55 Favored 'General case' 0 C--N 1.331 -0.219 0 CA-C-N 116.147 -0.479 . . . . 0.0 109.998 176.836 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' F' F ' 102' ' ' VAL . . . . . . . . . . . . . 44.8 t -114.9 125.54 72.25 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.345 0 N-CA-C 109.822 -0.436 . . . . 0.0 109.822 -179.268 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' F' F ' 103' ' ' LEU . . . . . . . . . . . . . 21.2 mt -118.79 129.45 55.25 Favored 'General case' 0 C--N 1.331 -0.223 0 CA-C-N 115.791 -0.64 . . . . 0.0 110.28 178.116 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' F' F ' 104' ' ' ILE . . . . . . . . . . . . . 67.4 mt -118.63 121.56 67.3 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.251 0 N-CA-C 109.974 -0.38 . . . . 0.0 109.974 178.575 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' F' F ' 105' ' ' PHE . . . . . . . . . . . . . 52.7 m-85 -120.74 163.59 17.88 Favored 'General case' 0 C--N 1.332 -0.176 0 O-C-N 123.978 0.799 . . . . 0.0 109.623 179.647 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' F' F ' 106' ' ' ASN . . . . . . . . . . . . . 48.7 p-10 -97.67 -173.45 2.63 Favored 'General case' 0 C--N 1.328 -0.34 0 N-CA-C 109.618 -0.512 . . . . 0.0 109.618 171.887 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' F' F ' 107' ' ' GLN . . . . . . . . . . . . . 47.2 tt0 -58.57 -26.56 63.72 Favored 'General case' 0 C--N 1.329 -0.317 0 N-CA-C 112.349 0.5 . . . . 0.0 112.349 -178.543 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' F' F ' 108' ' ' ASN . . . . . . . . . . . . . 8.3 t-20 -89.63 14.07 12.55 Favored 'General case' 0 CA--C 1.535 0.379 0 N-CA-C 112.96 0.726 . . . . 0.0 112.96 -176.725 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' F' F ' 109' ' ' LEU . . . . . . . . . . . . . 48.9 mt 57.56 38.98 28.08 Favored 'General case' 0 C--N 1.332 -0.154 0 CA-C-O 121.163 0.506 . . . . 0.0 111.504 178.01 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' F' F ' 110' ' ' GLU . . . . . . . . . . . . . 95.9 mt-10 -104.05 161.03 14.34 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.076 -0.511 . . . . 0.0 109.958 176.466 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' F' F ' 111' ' ' GLU . . . . . . . . . . . . . 84.6 tt0 -89.64 122.33 32.67 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-O 120.905 0.383 . . . . 0.0 110.922 -177.869 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' F' F ' 112' ' ' LEU . . . . . . . . . . . . . 14.0 mt -112.1 -46.04 3.24 Favored 'General case' 0 C--N 1.332 -0.195 0 CA-C-N 116.071 -0.513 . . . . 0.0 110.419 178.029 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' F' F ' 113' ' ' TYR . . . . . . . . . . . . . 54.3 t80 -140.84 134.61 30.37 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.286 -0.416 . . . . 0.0 110.921 179.85 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' F' F ' 114' ' ' ARG . . . . . . . . . . . . . 43.4 ttp180 -141.71 122.49 14.37 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.489 -0.323 . . . . 0.0 110.479 177.782 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' F' F ' 115' ' ' GLY . . . . . . . . . . . . . . . -150.16 146.94 16.6 Favored Glycine 0 CA--C 1.526 0.72 0 N-CA-C 111.193 -0.763 . . . . 0.0 111.193 178.998 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' F' F ' 116' ' ' LYS . . . . . . . . . . . . . 33.2 ttpt -115.2 133.76 55.75 Favored 'General case' 0 C--N 1.33 -0.24 0 N-CA-C 109.776 -0.453 . . . . 0.0 109.776 176.228 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' F' F ' 117' ' ' PHE . . . . . . . . . . . . . 52.3 m-85 -131.77 114.59 14.92 Favored 'General case' 0 C--N 1.332 -0.184 0 CA-C-O 120.924 0.392 . . . . 0.0 110.279 -176.298 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' F' F ' 118' ' ' GLU . . . . . . . . . . . . . 84.4 tt0 -54.26 -45.39 72.4 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.443 -0.344 . . . . 0.0 111.539 -176.015 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' F' F ' 119' ' ' ASN . . . . . . . . . . . . . 9.2 m120 -97.54 30.94 2.7 Favored 'General case' 0 C--N 1.33 -0.281 0 N-CA-C 112.178 0.436 . . . . 0.0 112.178 -174.934 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' F' F ' 120' ' ' LEU . . . . . . . . . . . . . 23.9 tp -58.01 126.95 29.68 Favored 'General case' 0 C--N 1.333 -0.148 0 CA-C-O 120.76 0.314 . . . . 0.0 110.304 178.411 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' F' F ' 121' ' ' ASN . . . . . . . . . . . . . 20.8 t-20 -109.77 -44.0 3.92 Favored 'General case' 0 C--N 1.332 -0.181 0 CA-C-N 116.376 -0.374 . . . . 0.0 110.946 -177.987 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' F' F ' 122' ' ' LYS . . . . . . . . . . . . . 18.8 ptpt -161.29 159.72 28.91 Favored 'General case' 0 C--N 1.333 -0.136 0 CA-C-O 121.141 0.496 . . . . 0.0 111.82 -179.33 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' F' F ' 123' ' ' VAL . . . . . . . . . . . . . 45.8 t -127.27 135.59 63.02 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.199 0 CA-C-N 115.867 -0.606 . . . . 0.0 109.749 177.15 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' F' F ' 124' ' ' LEU . . . . . . . . . . . . . 6.5 mp -118.53 130.41 55.9 Favored 'General case' 0 C--N 1.331 -0.22 0 CA-C-N 116.37 -0.377 . . . . 0.0 110.636 -179.22 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' F' F ' 125' ' ' VAL . . . . . . . . . . . . . 44.6 t -131.69 127.71 59.4 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.236 0 CA-C-N 116.331 -0.395 . . . . 0.0 110.17 179.371 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' F' F ' 126' ' ' ARG . . . . . . . . . . . . . 78.7 mtt180 -149.98 133.63 16.72 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-O 120.95 0.405 . . . . 0.0 110.889 177.154 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' F' F ' 127' ' ' ASN . . . . . . . . . . . . . 9.4 m120 52.48 -118.28 1.29 Allowed 'General case' 0 CA--C 1.545 0.77 0 CA-C-O 118.657 -0.687 . . . . 0.0 110.798 178.826 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' F' F ' 128' ' ' ASP . . . . . . . . . . . . . 8.2 p-10 -113.26 13.55 19.17 Favored 'General case' 0 N--CA 1.469 0.477 0 CA-C-N 120.107 1.321 . . . . 0.0 112.838 -179.624 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' F' F ' 129' ' ' LEU . . . . . . . . . . . . . 13.5 tp -116.26 139.2 50.62 Favored 'General case' 0 C--O 1.233 0.187 0 N-CA-C 109.832 -0.433 . . . . 0.0 109.832 179.121 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' F' F ' 130' ' ' VAL . . . . . . . . . . . . . 13.0 p -134.06 141.22 44.44 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.196 0 CA-C-O 121.1 0.476 . . . . 0.0 110.554 -179.326 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' F' F ' 131' ' ' VAL . . . . . . . . . . . . . 35.3 m -136.06 147.45 28.16 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.362 0 CA-C-N 115.963 -0.562 . . . . 0.0 110.801 179.212 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' F' F ' 132' ' ' ILE . . . . . . . . . . . . . 71.0 mt -118.43 131.05 72.33 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.373 0 CA-C-N 115.736 -0.665 . . . . 0.0 109.285 -179.873 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' F' F ' 133' ' ' ILE . . . . . . . . . . . . . 43.4 mm -115.6 121.81 68.08 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.241 0 CA-C-O 120.753 0.311 . . . . 0.0 110.708 -175.979 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' F' F ' 134' ' ' ASP . . . . . . . . . . . . . 7.6 p-10 -133.88 149.15 51.32 Favored 'General case' 0 C--N 1.331 -0.212 0 N-CA-C 109.586 -0.524 . . . . 0.0 109.586 174.562 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' F' F ' 135' ' ' GLU . . . . . . . . . . . . . 84.9 tt0 -49.84 -24.33 2.38 Favored 'General case' 0 C--N 1.326 -0.423 0 N-CA-C 112.949 0.722 . . . . 0.0 112.949 -170.869 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' F' F ' 136' ' ' GLN . . . . . . . . . . . . . 48.5 tt0 -104.68 -25.57 12.65 Favored 'General case' 0 N--CA 1.465 0.297 0 N-CA-C 112.846 0.684 . . . . 0.0 112.846 -174.484 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' F' F ' 137' ' ' LYS . . . . . . . . . . . . . 88.5 mttt -141.62 151.72 43.36 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-O 121.169 0.509 . . . . 0.0 111.777 -171.23 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' F' F ' 138' ' ' LEU . . . . . . . . . . . . . 5.0 tt -120.04 120.27 35.81 Favored 'General case' 0 C--N 1.329 -0.29 0 N-CA-C 109.151 -0.685 . . . . 0.0 109.151 172.502 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' F' F ' 139' ' ' THR . . . . . . . . . . . . . 40.6 m -110.92 131.15 55.29 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.416 -0.356 . . . . 0.0 110.792 -176.956 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' F' F ' 140' ' ' LEU . . . . . . . . . . . . . 8.0 tt -116.26 123.77 48.53 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 115.769 -0.651 . . . . 0.0 109.309 -179.671 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' F' F ' 141' ' ' ILE . . . . . . . . . . . . . 19.2 mt -122.54 121.1 62.77 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.295 0 CA-C-O 121.08 0.467 . . . . 0.0 110.072 -175.811 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' F' F ' 142' ' ' ARG . . . . . . . . . . . . . 65.8 ttt180 -109.98 129.23 55.7 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 115.318 -0.855 . . . . 0.0 110.364 -178.992 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' F' F ' 143' ' ' THR . . . . . . . . . . . . . 81.3 p . . . . . 0 C--O 1.219 -0.505 0 CA-C-O 117.915 -1.04 . . . . 0.0 110.484 178.927 . . . . . . . . 0 0 . 1 . 018 nuclear orig full ' A' A ' -3' ' ' GLU . . . . . . . . . . . . . 83.7 tt0 . . . . . 0 N--CA 1.489 1.508 0 N-CA-C 109.367 -0.605 . . . . 0.0 109.367 . . . . . . . . . 0 0 . 1 . 018 nuclear orig full ' A' A ' -2' ' ' GLY . . . . . . . . . . . . . . . -67.64 150.05 51.13 Favored Glycine 0 CA--C 1.526 0.759 0 N-CA-C 110.956 -0.858 . . . . 0.0 110.956 179.358 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' -1' ' ' VAL . . . . . . . . . . . . . 46.9 t -95.55 131.43 42.36 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.292 0 CA-C-O 120.891 0.377 . . . . 0.0 109.997 179.864 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 0' ' ' ILE . . . . . . . . . . . . . 70.0 mt -119.01 138.1 50.83 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.208 0 CA-C-N 116.156 -0.474 . . . . 0.0 110.184 -179.397 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 25.1 ptt? -143.48 145.37 32.53 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.02 -0.536 . . . . 0.0 110.443 178.867 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 79.0 p -123.8 150.6 44.28 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 116.265 -0.425 . . . . 0.0 110.625 -179.102 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 44.5 mp0 -138.2 141.26 40.01 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.098 -0.501 . . . . 0.0 110.882 -178.523 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 4' ' ' LEU . . . . . . . . . . . . . 15.1 tp -126.77 131.05 51.38 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 115.939 -0.573 . . . . 0.0 110.077 177.274 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 5' ' ' LYS . . . . . . . . . . . . . 68.9 mttm -114.04 121.52 44.12 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-O 120.901 0.381 . . . . 0.0 110.923 -179.164 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 63.7 mt -115.45 141.05 48.57 Favored 'General case' 0 C--N 1.331 -0.227 0 CA-C-N 115.237 -0.892 . . . . 0.0 110.046 179.686 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 86.3 tttt -121.0 136.87 25.95 Favored Pre-proline 0 CA--C 1.533 0.308 0 CA-C-O 118.867 -0.587 . . . . 0.0 109.751 177.032 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 8' ' ' PRO . . . . . . . . . . . . . 93.0 Cg_endo -89.03 131.91 2.25 Favored 'Trans proline' 0 N--CA 1.491 1.327 0 C-N-CA 121.699 1.599 . . . . 0.0 111.921 179.088 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 57.1 mt -70.95 -47.91 14.57 Favored Pre-proline 0 CA--C 1.533 0.321 0 CA-C-O 118.575 -0.726 . . . . 0.0 112.211 -179.985 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 71.5 Cg_endo -77.77 153.13 29.5 Favored 'Trans proline' 0 N--CA 1.496 1.626 0 C-N-CA 121.14 1.227 . . . . 0.0 111.913 176.528 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 58.7 tttm -87.18 89.71 8.09 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-O 120.842 0.353 . . . . 0.0 110.266 179.634 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 12.1 p -139.34 148.01 23.93 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.245 0 CA-C-N 116.231 -0.441 . . . . 0.0 110.707 -178.072 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 95.6 mt-10 -90.89 128.53 36.79 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.141 -0.481 . . . . 0.0 110.026 177.248 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 14' ' ' LEU . . . . . . . . . . . . . 24.0 mt -98.0 152.55 38.11 Favored Pre-proline 0 CA--C 1.532 0.267 0 CA-C-O 119.512 -0.28 . . . . 0.0 110.801 -178.586 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 15' ' ' PRO . . . . . . . . . . . . . 25.5 Cg_exo -62.09 159.06 36.07 Favored 'Trans proline' 0 N--CA 1.497 1.727 0 C-N-CA 121.281 1.321 . . . . 0.0 112.165 177.513 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 16' ' ' PRO . . . . . . . . . . . . . 37.5 Cg_exo -58.35 -45.02 33.37 Favored 'Trans proline' 0 N--CA 1.498 1.792 0 C-N-CA 121.437 1.425 . . . . 0.0 112.866 -178.863 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 17' ' ' ASP . . . . . . . . . . . . . 19.8 p-10 -85.32 12.9 7.28 Favored 'General case' 0 C--N 1.326 -0.435 0 N-CA-C 113.14 0.793 . . . . 0.0 113.14 -177.016 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 18' ' ' PHE . . . . . . . . . . . . . 42.6 t80 -58.36 -46.79 85.61 Favored 'General case' 0 CA--C 1.523 -0.078 0 O-C-N 122.096 -0.378 . . . . 0.0 110.162 -177.963 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 19' ' ' VAL . . . . . . . . . . . . . 14.0 p -55.92 -40.23 61.43 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.347 0 CA-C-N 116.227 -0.442 . . . . 0.0 111.104 -178.345 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 78.3 m-20 -61.15 -45.18 95.69 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-O 120.783 0.325 . . . . 0.0 111.093 -177.977 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 60.7 t -64.66 -47.02 90.6 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 C-N-CA 120.781 -0.368 . . . . 0.0 110.591 -177.919 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 22' ' ' ILE . . . . . . . . . . . . . 50.5 mm -56.89 -43.35 80.18 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.189 0 C-N-CA 120.829 -0.348 . . . . 0.0 110.483 179.142 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 23' ' ' ARG . . . . . . . . . . . . . 43.2 ttp180 -54.71 -49.38 70.86 Favored 'General case' 0 C--N 1.33 -0.257 0 C-N-CA 121.143 -0.223 . . . . 0.0 111.309 -178.727 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 24' ' ' ILE . . . . . . . . . . . . . 73.2 mt -59.25 -39.84 79.78 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.244 0 C-N-CA 120.869 -0.332 . . . . 0.0 110.751 -178.699 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 8.3 mtpm? -66.05 -41.82 90.33 Favored 'General case' 0 C--N 1.327 -0.385 0 N-CA-C 112.276 0.473 . . . . 0.0 112.276 -179.253 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 67.0 mt -80.75 -36.07 32.46 Favored 'General case' 0 C--N 1.331 -0.228 0 N-CA-C 113.881 1.067 . . . . 0.0 113.881 -171.134 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 27' ' ' GLN . . . . . . . . . . . . . 8.9 pt20 -46.85 141.49 3.97 Favored 'General case' 0 N--CA 1.47 0.527 0 N-CA-C 112.81 0.67 . . . . 0.0 112.81 -175.17 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 98.64 -24.21 33.07 Favored Glycine 0 CA--C 1.533 1.201 0 CA-C-N 115.673 -0.694 . . . . 0.0 112.354 -176.886 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 60.5 mttp -98.07 155.22 17.23 Favored 'General case' 0 C--O 1.232 0.16 0 CA-C-N 117.45 0.625 . . . . 0.0 110.901 179.167 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 30' ' ' THR . . . . . . . . . . . . . 30.9 m -104.51 136.71 43.56 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.161 -0.472 . . . . 0.0 109.88 176.25 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 33.9 m -129.27 152.51 37.35 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.194 0 CA-C-O 120.987 0.423 . . . . 0.0 110.975 -178.683 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 32' ' ' ARG . . . . . . . . . . . . . 94.2 mtt180 -129.34 152.3 49.05 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-O 121.32 0.581 . . . . 0.0 110.614 179.943 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 33' ' ' THR . . . . . . . . . . . . . 21.4 m -53.63 139.75 31.01 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-N 116.162 -0.472 . . . . 0.0 111.202 -179.297 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 98.62 -17.09 58.88 Favored Glycine 0 CA--C 1.534 1.263 0 C-N-CA 121.106 -0.569 . . . . 0.0 113.269 178.844 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 58.7 m-20 -64.14 149.7 47.18 Favored 'General case' 0 C--O 1.231 0.11 0 CA-C-N 117.997 0.898 . . . . 0.0 111.369 -179.609 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 45.6 t -119.46 126.55 75.44 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.288 0 CA-C-N 115.458 -0.792 . . . . 0.0 109.538 177.896 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 37' ' ' ILE . . . . . . . . . . . . . 69.4 mt -120.71 138.34 51.52 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.226 0 CA-C-N 116.397 -0.365 . . . . 0.0 110.05 -179.072 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . -118.67 128.77 7.84 Favored Glycine 0 CA--C 1.525 0.66 0 N-CA-C 110.98 -0.848 . . . . 0.0 110.98 179.467 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 39' ' ' ILE . . . . . . . . . . . . . 70.8 mt -123.21 134.58 65.8 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.184 0 N-CA-C 109.938 -0.393 . . . . 0.0 109.938 178.228 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 40' ' ' SER . . . . . . . . . . . . . 23.2 t -91.49 120.54 32.4 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 116.272 -0.422 . . . . 0.0 111.04 178.72 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 41' ' ' ILE . . . . . . . . . . . . . 71.4 mt -127.5 116.38 43.39 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.234 0 CA-C-N 116.41 -0.359 . . . . 0.0 110.16 177.392 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 1.3 tt 49.58 47.65 22.41 Favored 'General case' 0 CA--C 1.533 0.311 0 CA-C-O 121.468 0.652 . . . . 0.0 111.43 177.166 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . 71.24 21.73 78.51 Favored Glycine 0 CA--C 1.532 1.094 0 C-N-CA 121.102 -0.571 . . . . 0.0 112.862 174.632 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 44' ' ' LYS . . . . . . . . . . . . . 85.3 tttt -135.14 126.43 28.3 Favored 'General case' 0 C--N 1.331 -0.222 0 CA-C-N 117.636 0.718 . . . . 0.0 109.881 178.959 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 84.9 tt0 -84.72 125.82 32.86 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.485 -0.325 . . . . 0.0 111.176 -178.682 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 46' ' ' VAL . . . . . . . . . . . . . 10.3 p -113.34 123.25 68.8 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.252 0 N-CA-C 109.144 -0.687 . . . . 0.0 109.144 174.072 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 88.6 mttt -98.98 122.94 42.9 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 115.92 -0.582 . . . . 0.0 110.857 179.726 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 48' ' ' PHE . . . . . . . . . . . . . 31.0 m-85 -108.76 131.87 54.53 Favored 'General case' 0 C--N 1.329 -0.3 0 N-CA-C 109.71 -0.478 . . . . 0.0 109.71 176.924 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 76.6 tttt -106.57 130.62 54.3 Favored 'General case' 0 C--N 1.328 -0.33 0 N-CA-C 109.964 -0.384 . . . . 0.0 109.964 178.239 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 50' ' ' VAL . . . . . . . . . . . . . 45.5 t -74.82 105.29 3.75 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.305 0 N-CA-C 109.366 -0.605 . . . . 0.0 109.366 178.433 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 51' ' ' VAL . . . . . . . . . . . . . 48.2 t -70.35 -54.01 20.42 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.303 0 N-CA-C 109.475 -0.565 . . . . 0.0 109.475 -175.916 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 52' ' ' GLN . . . . . . . . . . . . . 89.9 mt-30 -153.73 150.15 28.23 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 115.856 -0.611 . . . . 0.0 111.79 -178.129 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -127.21 131.57 50.61 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 115.041 -0.981 . . . . 0.0 109.524 173.5 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 54' ' ' TYR . . . . . . . . . . . . . 14.5 t80 -129.06 110.24 18.25 Favored Pre-proline 0 C--N 1.329 -0.304 0 CA-C-O 118.198 -0.906 . . . . 0.0 110.234 177.453 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 55' ' ' PRO . . . . . . . . . . . . . 75.4 Cg_endo -77.31 170.22 71.94 Favored 'Cis proline' 0 N--CA 1.5 1.861 0 CA-C-N 121.958 1.735 . . . . 0.0 112.492 -5.927 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 56' ' ' SER . . . . . . . . . . . . . 14.1 m -123.91 138.9 31.34 Favored Pre-proline 0 CA--C 1.537 0.462 0 CA-C-O 118.499 -0.762 . . . . 0.0 109.401 173.532 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 57' ' ' PRO . . . . . . . . . . . . . 39.3 Cg_endo -67.67 144.28 71.07 Favored 'Cis proline' 0 N--CA 1.499 1.797 0 CA-C-N 121.695 1.641 . . . . 0.0 111.61 -2.627 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 58' ' ' LEU . . . . . . . . . . . . . 15.7 tp -107.16 136.92 46.17 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-O 120.934 0.397 . . . . 0.0 110.629 -176.841 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 59' ' ' ARG . . . . . . . . . . . . . 56.5 ttp180 -103.73 124.9 49.73 Favored 'General case' 0 C--N 1.327 -0.378 0 N-CA-C 109.272 -0.64 . . . . 0.0 109.272 176.229 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 43.9 t -77.87 116.42 21.39 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 C-N-CA 120.73 -0.388 . . . . 0.0 110.745 -173.306 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 95.2 mt-10 -131.02 161.1 32.72 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 115.699 -0.682 . . . . 0.0 109.531 175.028 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 62' ' ' ASP . . . . . . . . . . . . . 70.0 m-20 -52.36 -31.67 34.77 Favored 'General case' 0 C--N 1.328 -0.349 0 N-CA-C 112.179 0.437 . . . . 0.0 112.179 -178.001 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 63' ' ' ARG . . . . . . . . . . . . . 87.5 mtt180 -70.92 -22.07 62.29 Favored 'General case' 0 CA--C 1.533 0.301 0 N-CA-C 113.038 0.755 . . . . 0.0 113.038 -174.942 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 27.8 m -68.43 137.16 54.28 Favored 'General case' 0 C--N 1.332 -0.188 0 CA-C-O 120.925 0.393 . . . . 0.0 111.061 -175.482 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 65' ' ' LYS . . . . . . . . . . . . . 90.5 mttt -88.92 127.62 35.66 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 115.984 -0.553 . . . . 0.0 109.772 177.832 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 66' ' ' ILE . . . . . . . . . . . . . 65.4 mt -118.06 130.24 73.22 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.278 0 CA-C-O 120.773 0.32 . . . . 0.0 110.236 -177.502 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 67' ' ' THR . . . . . . . . . . . . . 31.4 m -125.55 139.82 53.27 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-O 121.064 0.459 . . . . 0.0 110.967 -178.844 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 68' ' ' LEU . . . . . . . . . . . . . 7.1 mp -105.82 133.57 50.35 Favored 'General case' 0 C--N 1.331 -0.211 0 CA-C-N 115.941 -0.572 . . . . 0.0 110.442 177.264 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 69' ' ' VAL . . . . . . . . . . . . . 43.1 t -97.81 140.22 18.38 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.37 0 CA-C-N 115.947 -0.57 . . . . 0.0 110.318 -179.29 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 70' ' ' THR . . . . . . . . . . . . . 18.1 p -130.51 -51.19 1.08 Allowed 'General case' 0 C--N 1.331 -0.228 0 CA-C-N 116.269 -0.423 . . . . 0.0 110.597 -179.256 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 71' ' ' HIS . . . . . . . . . . . . . 75.3 m80 -77.76 139.31 62.31 Favored Pre-proline 0 CA--C 1.533 0.323 0 CA-C-O 118.667 -0.683 . . . . 0.0 109.964 179.912 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 72' ' ' PRO . . . . . . . . . . . . . 11.4 Cg_exo -65.85 -30.11 49.55 Favored 'Trans proline' 0 N--CA 1.498 1.762 0 C-N-CA 120.998 1.132 . . . . 0.0 112.313 177.841 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 73' ' ' VAL . . . . . . . . . . . . . 35.4 m -147.93 169.91 3.45 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.243 0 CA-C-N 116.511 -0.313 . . . . 0.0 110.659 -179.292 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 74' ' ' ASP . . . . . . . . . . . . . 31.6 t0 -100.2 118.87 37.41 Favored 'General case' 0 C--N 1.33 -0.264 0 N-CA-C 109.717 -0.475 . . . . 0.0 109.717 177.908 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 40.9 t -114.74 123.87 70.84 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.249 0 CA-C-O 121.083 0.468 . . . . 0.0 110.776 -177.253 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 76' ' ' LEU . . . . . . . . . . . . . 5.5 mp -120.96 144.35 48.53 Favored 'General case' 0 C--N 1.331 -0.226 0 CA-C-N 115.667 -0.697 . . . . 0.0 109.59 175.185 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 77' ' ' GLU . . . . . . . . . . . . . 97.8 mt-10 -133.96 138.01 45.19 Favored 'General case' 0 C--N 1.331 -0.213 0 CA-C-O 121.112 0.482 . . . . 0.0 111.445 -178.95 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 78' ' ' ALA . . . . . . . . . . . . . . . -127.12 142.05 51.61 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 115.579 -0.737 . . . . 0.0 109.745 177.314 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 79' ' ' LYS . . . . . . . . . . . . . 47.3 pttt -85.79 120.78 27.58 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-O 121.23 0.538 . . . . 0.0 110.967 -178.218 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 80' ' ' ILE . . . . . . . . . . . . . 37.0 mm -139.2 114.9 8.9 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.312 0 CA-C-N 115.768 -0.651 . . . . 0.0 109.411 -179.159 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 81' ' ' LYS . . . . . . . . . . . . . 97.7 mttt -107.4 126.96 53.14 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-O 120.804 0.335 . . . . 0.0 111.011 -179.178 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . 89.05 42.17 5.69 Favored Glycine 0 CA--C 1.525 0.683 0 C-N-CA 120.845 -0.693 . . . . 0.0 111.65 175.526 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 83' ' ' ILE . . . . . . . . . . . . . 69.7 mt -69.91 138.2 22.56 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.309 0 CA-C-O 120.901 0.381 . . . . 0.0 110.042 178.514 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 84' ' ' LYS . . . . . . . . . . . . . 63.4 tttm -94.5 -54.05 3.67 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-N 115.945 -0.57 . . . . 0.0 110.07 -179.104 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 85' ' ' ASP . . . . . . . . . . . . . 7.2 t70 -158.01 154.95 28.52 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 115.652 -0.704 . . . . 0.0 110.412 -179.969 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 86' ' ' VAL . . . . . . . . . . . . . 40.0 t -131.94 132.32 61.5 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.259 0 CA-C-O 120.914 0.388 . . . . 0.0 110.576 179.473 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 87' ' ' ILE . . . . . . . . . . . . . 5.1 mp -118.9 128.37 75.73 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.281 0 CA-C-N 115.816 -0.629 . . . . 0.0 109.414 176.044 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 88' ' ' LEU . . . . . . . . . . . . . 16.9 tp -110.95 134.6 52.45 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-O 121.138 0.494 . . . . 0.0 111.414 -176.234 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 89' ' ' ASP . . . . . . . . . . . . . 12.9 t70 -127.14 149.75 49.81 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 115.602 -0.727 . . . . 0.0 109.36 175.129 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 83.6 tt0 -48.89 -32.57 9.15 Favored 'General case' 0 C--N 1.33 -0.264 0 N-CA-C 112.606 0.595 . . . . 0.0 112.606 -173.357 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 91' ' ' ASN . . . . . . . . . . . . . 79.2 m-20 -131.18 29.67 4.62 Favored 'General case' 0 N--CA 1.465 0.316 0 N-CA-C 112.216 0.45 . . . . 0.0 112.216 -176.368 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 92' ' ' LEU . . . . . . . . . . . . . 8.1 tp -166.21 148.83 7.07 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-O 120.784 0.326 . . . . 0.0 110.602 179.299 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 93' ' ' ILE . . . . . . . . . . . . . 69.9 mt -126.74 122.99 61.92 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.277 0 N-CA-C 109.487 -0.56 . . . . 0.0 109.487 178.931 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 94' ' ' VAL . . . . . . . . . . . . . 42.8 t -121.27 127.6 75.81 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.265 0 N-CA-C 110.084 -0.339 . . . . 0.0 110.084 -179.442 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 95' ' ' VAL . . . . . . . . . . . . . 43.4 t -125.66 136.0 62.19 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.239 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.228 -179.294 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 96' ' ' ILE . . . . . . . . . . . . . 51.6 mt -115.86 129.42 72.25 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 N-CA-C 109.112 -0.699 . . . . 0.0 109.112 178.495 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 97' ' ' THR . . . . . . . . . . . . . 81.7 p -101.21 159.06 15.57 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-O 121.105 0.479 . . . . 0.0 111.16 -178.024 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 98' ' ' GLU . . . . . . . . . . . . . 84.8 tt0 -53.85 -28.37 35.47 Favored 'General case' 0 CA--C 1.533 0.312 0 CA-C-N 116.208 -0.451 . . . . 0.0 112.152 -178.797 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 99' ' ' GLU . . . . . . . . . . . . . 96.0 mt-10 -79.04 14.61 1.35 Allowed 'General case' 0 CA--C 1.535 0.375 0 N-CA-C 113.22 0.822 . . . . 0.0 113.22 -176.316 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 100' ' ' ASN . . . . . . . . . . . . . 3.3 m-20 61.54 33.23 18.51 Favored 'General case' 0 N--CA 1.464 0.24 0 CA-C-N 118.067 0.394 . . . . 0.0 111.639 -179.833 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 101' ' ' GLU . . . . . . . . . . . . . 84.9 tt0 -107.61 144.2 34.99 Favored 'General case' 0 C--O 1.232 0.143 0 N-CA-C 109.607 -0.516 . . . . 0.0 109.607 173.08 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 102' ' ' VAL . . . . . . . . . . . . . 42.7 t -114.93 126.07 72.41 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.304 0 CA-C-N 116.294 -0.412 . . . . 0.0 110.009 -177.627 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 103' ' ' LEU . . . . . . . . . . . . . 21.2 mt -115.72 129.7 56.57 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 115.79 -0.641 . . . . 0.0 109.889 177.324 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 104' ' ' ILE . . . . . . . . . . . . . 68.3 mt -118.49 121.51 67.24 Favored 'Isoleucine or valine' 0 C--O 1.235 0.297 0 N-CA-C 110.13 -0.322 . . . . 0.0 110.13 179.274 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 105' ' ' PHE . . . . . . . . . . . . . 78.3 m-85 -118.92 164.47 15.4 Favored 'General case' 0 C--N 1.333 -0.126 0 O-C-N 124.129 0.893 . . . . 0.0 109.757 -179.499 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 106' ' ' ASN . . . . . . . . . . . . . 42.3 p-10 -101.66 -170.83 1.88 Allowed 'General case' 0 C--N 1.331 -0.221 0 N-CA-C 110.039 -0.356 . . . . 0.0 110.039 173.54 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 107' ' ' GLN . . . . . . . . . . . . . 59.4 tt0 -57.67 -28.69 64.0 Favored 'General case' 0 CA--C 1.534 0.341 0 N-CA-C 111.894 0.331 . . . . 0.0 111.894 177.243 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 108' ' ' ASN . . . . . . . . . . . . . 50.1 t30 -82.94 3.28 30.61 Favored 'General case' 0 CA--C 1.536 0.415 0 N-CA-C 113.353 0.872 . . . . 0.0 113.353 -176.447 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 109' ' ' LEU . . . . . . . . . . . . . 11.5 tp 62.66 39.6 11.09 Favored 'General case' 0 CA--C 1.529 0.172 0 CA-C-O 121.115 0.483 . . . . 0.0 111.051 178.378 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 110' ' ' GLU . . . . . . . . . . . . . 95.5 mt-10 -114.28 150.32 34.61 Favored 'General case' 0 C--N 1.331 -0.198 0 CA-C-N 116.366 -0.379 . . . . 0.0 110.278 176.31 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 111' ' ' GLU . . . . . . . . . . . . . 45.6 mt-10 -76.07 123.62 26.08 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 116.359 -0.382 . . . . 0.0 110.894 -179.739 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 112' ' ' LEU . . . . . . . . . . . . . 16.3 mt -110.04 -46.05 3.52 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.142 -0.481 . . . . 0.0 110.178 176.665 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 113' ' ' TYR . . . . . . . . . . . . . 41.0 t80 -134.79 136.73 42.77 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.235 -0.439 . . . . 0.0 110.659 -179.682 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 114' ' ' ARG . . . . . . . . . . . . . 65.8 ttp85 -141.37 123.25 15.36 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.406 -0.361 . . . . 0.0 110.569 178.014 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 115' ' ' GLY . . . . . . . . . . . . . . . -150.14 163.04 29.39 Favored Glycine 0 CA--C 1.523 0.556 0 N-CA-C 111.054 -0.819 . . . . 0.0 111.054 -179.192 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 116' ' ' LYS . . . . . . . . . . . . . 57.1 tttm -131.56 136.63 47.98 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-O 120.781 0.324 . . . . 0.0 110.188 178.656 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 117' ' ' PHE . . . . . . . . . . . . . 36.2 m-85 -136.34 115.58 12.55 Favored 'General case' 0 C--N 1.331 -0.209 0 CA-C-N 116.245 -0.434 . . . . 0.0 110.283 -176.062 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 118' ' ' GLU . . . . . . . . . . . . . 45.4 mp0 -56.48 -44.46 80.64 Favored 'General case' 0 C--N 1.327 -0.381 0 C-N-CA 120.781 -0.368 . . . . 0.0 111.098 -175.194 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 119' ' ' ASN . . . . . . . . . . . . . 11.4 m120 -98.01 30.97 2.85 Favored 'General case' 0 C--N 1.33 -0.259 0 N-CA-C 112.194 0.442 . . . . 0.0 112.194 -174.011 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 120' ' ' LEU . . . . . . . . . . . . . 21.9 tp -57.64 123.29 15.11 Favored 'General case' 0 C--N 1.332 -0.163 0 C-N-CA 120.854 -0.338 . . . . 0.0 110.379 177.941 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 121' ' ' ASN . . . . . . . . . . . . . 34.6 m120 -114.09 -44.08 3.18 Favored 'General case' 0 C--O 1.233 0.191 0 CA-C-N 116.548 -0.296 . . . . 0.0 111.002 -177.561 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 122' ' ' LYS . . . . . . . . . . . . . 98.3 mttt -144.49 149.16 35.49 Favored 'General case' 0 C--N 1.331 -0.198 0 CA-C-O 121.152 0.501 . . . . 0.0 111.621 -176.365 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 123' ' ' VAL . . . . . . . . . . . . . 47.3 t -129.67 128.55 65.77 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.276 0 CA-C-N 115.733 -0.667 . . . . 0.0 109.538 175.952 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 124' ' ' LEU . . . . . . . . . . . . . 75.0 mt -119.72 134.83 55.08 Favored 'General case' 0 C--N 1.331 -0.219 0 CA-C-N 116.48 -0.327 . . . . 0.0 110.443 -178.213 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 125' ' ' VAL . . . . . . . . . . . . . 12.4 p -140.13 130.93 30.6 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.223 0 CA-C-O 120.878 0.37 . . . . 0.0 110.97 -179.76 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 126' ' ' ARG . . . . . . . . . . . . . 72.8 mtt180 -152.55 134.1 14.53 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 115.822 -0.626 . . . . 0.0 109.674 175.848 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 127' ' ' ASN . . . . . . . . . . . . . 31.5 m120 55.74 -147.77 0.51 Allowed 'General case' 0 CA--C 1.542 0.647 0 N-CA-C 109.729 -0.471 . . . . 0.0 109.729 -178.855 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 128' ' ' ASP . . . . . . . . . . . . . 9.3 p-10 -87.23 14.62 7.45 Favored 'General case' 0 CA--C 1.536 0.409 0 CA-C-N 118.809 0.732 . . . . 0.0 112.934 178.641 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 129' ' ' LEU . . . . . . . . . . . . . 80.5 mt -110.89 138.21 47.57 Favored 'General case' 0 C--O 1.233 0.216 0 O-C-N 121.974 -0.454 . . . . 0.0 110.273 179.575 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 130' ' ' VAL . . . . . . . . . . . . . 14.4 p -134.03 142.14 41.97 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.176 0 CA-C-O 121.177 0.513 . . . . 0.0 110.847 -178.937 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 131' ' ' VAL . . . . . . . . . . . . . 44.5 t -135.76 138.51 47.7 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.228 0 CA-C-N 115.876 -0.602 . . . . 0.0 110.243 -178.923 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 132' ' ' ILE . . . . . . . . . . . . . 72.6 mt -115.87 132.39 65.48 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.298 0 CA-C-N 115.948 -0.569 . . . . 0.0 109.488 -179.856 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 133' ' ' ILE . . . . . . . . . . . . . 39.0 mm -116.9 117.37 55.18 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.21 0 CA-C-N 116.5 -0.318 . . . . 0.0 110.624 -176.333 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 134' ' ' ASP . . . . . . . . . . . . . 7.2 p-10 -128.63 151.43 49.5 Favored 'General case' 0 C--N 1.331 -0.204 0 N-CA-C 109.629 -0.508 . . . . 0.0 109.629 175.252 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 135' ' ' GLU . . . . . . . . . . . . . 45.8 tp10 -49.92 -28.16 6.31 Favored 'General case' 0 C--N 1.327 -0.398 0 N-CA-C 112.748 0.647 . . . . 0.0 112.748 -171.056 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 136' ' ' GLN . . . . . . . . . . . . . 76.9 mt-30 -103.45 -22.95 13.58 Favored 'General case' 0 N--CA 1.464 0.254 0 N-CA-C 113.144 0.794 . . . . 0.0 113.144 -173.874 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 137' ' ' LYS . . . . . . . . . . . . . 94.9 mttt -141.93 147.19 36.65 Favored 'General case' 0 C--N 1.331 -0.224 0 CA-C-O 121.376 0.608 . . . . 0.0 112.007 -168.695 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 138' ' ' LEU . . . . . . . . . . . . . 10.5 tp -111.66 118.3 35.29 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 115.193 -0.912 . . . . 0.0 108.863 172.326 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 139' ' ' THR . . . . . . . . . . . . . 24.9 m -111.98 125.61 54.25 Favored 'General case' 0 N--CA 1.463 0.21 0 CA-C-O 120.695 0.283 . . . . 0.0 110.882 -176.819 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 140' ' ' LEU . . . . . . . . . . . . . 11.6 tp -114.03 122.96 48.51 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 115.664 -0.698 . . . . 0.0 109.23 179.534 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 141' ' ' ILE . . . . . . . . . . . . . 20.3 mt -123.15 122.66 66.01 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.243 0 CA-C-O 120.997 0.427 . . . . 0.0 110.3 -175.778 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 142' ' ' ARG . . . . . . . . . . . . . 84.2 mtp180 -106.91 123.22 47.86 Favored 'General case' 0 C--N 1.331 -0.22 0 CA-C-N 115.264 -0.88 . . . . 0.0 110.068 179.252 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 143' ' ' THR . . . . . . . . . . . . . 26.6 p . . . . . 0 C--O 1.221 -0.428 0 CA-C-O 117.939 -1.029 . . . . 0.0 110.58 179.742 . . . . . . . . 0 0 . 1 . 018 nuclear orig full ' B' B ' -3' ' ' GLU . . . . . . . . . . . . . 95.6 mt-10 . . . . . 0 N--CA 1.49 1.543 0 N-CA-C 109.423 -0.584 . . . . 0.0 109.423 . . . . . . . . . 0 0 . 1 . 018 nuclear orig full ' B' B ' -2' ' ' GLY . . . . . . . . . . . . . . . -73.27 140.25 28.14 Favored Glycine 0 CA--C 1.526 0.768 0 N-CA-C 111.095 -0.802 . . . . 0.0 111.095 -179.778 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' B' B ' -1' ' ' VAL . . . . . . . . . . . . . 43.2 t -141.83 137.34 31.16 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.349 0 N-CA-C 109.998 -0.371 . . . . 0.0 109.998 179.36 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' B' B ' 0' ' ' ILE . . . . . . . . . . . . . 70.8 mt -114.04 133.83 58.83 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.246 0 CA-C-O 120.896 0.379 . . . . 0.0 110.069 -179.557 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' B' B ' 1' ' ' MET . . . . . . . . . . . . . 25.8 ptt? -143.76 177.95 8.16 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.002 -0.545 . . . . 0.0 110.557 -179.322 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' B' B ' 2' ' ' SER . . . . . . . . . . . . . 2.8 p -124.88 127.59 47.36 Favored 'General case' 0 C--N 1.332 -0.178 0 CA-C-O 120.901 0.382 . . . . 0.0 110.606 -179.042 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' B' B ' 3' ' ' GLU . . . . . . . . . . . . . 84.6 tt0 -142.64 142.55 32.1 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 115.981 -0.554 . . . . 0.0 111.193 -178.297 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' B' B ' 4' ' ' LEU . . . . . . . . . . . . . 13.4 tp -123.05 131.01 53.52 Favored 'General case' 0 C--N 1.331 -0.209 0 CA-C-N 115.757 -0.656 . . . . 0.0 110.143 177.109 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' B' B ' 5' ' ' LYS . . . . . . . . . . . . . 94.6 mttt -107.72 121.8 45.44 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.232 -0.44 . . . . 0.0 110.433 178.727 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' B' B ' 6' ' ' LEU . . . . . . . . . . . . . 44.4 mt -115.88 148.18 40.25 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 115.554 -0.748 . . . . 0.0 110.195 -179.283 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' B' B ' 7' ' ' LYS . . . . . . . . . . . . . 83.4 tttt -135.35 140.31 34.02 Favored Pre-proline 0 CA--C 1.535 0.388 0 CA-C-O 119.092 -0.48 . . . . 0.0 110.118 176.335 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' B' B ' 8' ' ' PRO . . . . . . . . . . . . . 88.8 Cg_endo -92.04 143.71 2.74 Favored 'Trans proline' 0 N--CA 1.491 1.345 0 C-N-CA 121.718 1.612 . . . . 0.0 111.653 177.689 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' B' B ' 9' ' ' LEU . . . . . . . . . . . . . 75.3 mt -81.8 -47.67 1.0 Allowed Pre-proline 0 CA--C 1.535 0.384 0 CA-C-O 118.611 -0.709 . . . . 0.0 112.303 -179.321 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' B' B ' 10' ' ' PRO . . . . . . . . . . . . . 95.1 Cg_endo -79.61 154.48 23.84 Favored 'Trans proline' 0 N--CA 1.496 1.662 0 C-N-CA 121.125 1.217 . . . . 0.0 111.869 176.412 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' B' B ' 11' ' ' LYS . . . . . . . . . . . . . 62.2 tttm -88.46 102.79 15.25 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-N 116.378 -0.374 . . . . 0.0 110.439 179.058 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' B' B ' 12' ' ' VAL . . . . . . . . . . . . . 12.8 p -149.67 144.29 17.82 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.319 0 CA-C-N 116.294 -0.412 . . . . 0.0 110.875 179.945 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' B' B ' 13' ' ' GLU . . . . . . . . . . . . . 95.8 mt-10 -79.62 131.99 36.14 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.14 -0.482 . . . . 0.0 110.062 177.468 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' B' B ' 14' ' ' LEU . . . . . . . . . . . . . 26.6 mt -98.67 147.97 33.91 Favored Pre-proline 0 CA--C 1.534 0.337 0 CA-C-O 119.252 -0.404 . . . . 0.0 110.623 -177.955 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' B' B ' 15' ' ' PRO . . . . . . . . . . . . . 24.7 Cg_exo -62.88 158.26 43.88 Favored 'Trans proline' 0 N--CA 1.498 1.772 0 C-N-CA 121.328 1.352 . . . . 0.0 111.779 176.828 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' B' B ' 16' ' ' PRO . . . . . . . . . . . . . 33.6 Cg_exo -59.2 -39.31 79.87 Favored 'Trans proline' 0 N--CA 1.498 1.748 0 C-N-CA 121.508 1.472 . . . . 0.0 112.714 -177.581 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' B' B ' 17' ' ' ASP . . . . . . . . . . . . . 24.1 p-10 -89.12 11.9 17.25 Favored 'General case' 0 C--N 1.328 -0.358 0 N-CA-C 113.154 0.798 . . . . 0.0 113.154 -177.411 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' B' B ' 18' ' ' PHE . . . . . . . . . . . . . 44.2 t80 -58.09 -45.82 86.53 Favored 'General case' 0 C--N 1.335 -0.056 0 O-C-N 121.993 -0.442 . . . . 0.0 110.081 -178.458 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' B' B ' 19' ' ' VAL . . . . . . . . . . . . . 13.7 p -56.57 -40.52 69.23 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.297 0 CA-C-N 116.15 -0.477 . . . . 0.0 110.878 -179.219 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' B' B ' 20' ' ' ASP . . . . . . . . . . . . . 9.8 t70 -60.53 -44.78 95.71 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-O 120.768 0.318 . . . . 0.0 111.032 -177.766 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' B' B ' 21' ' ' VAL . . . . . . . . . . . . . 46.9 t -64.3 -47.83 88.04 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.282 0 C-N-CA 120.676 -0.41 . . . . 0.0 110.377 -177.891 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' B' B ' 22' ' ' ILE . . . . . . . . . . . . . 51.1 mm -55.92 -46.16 80.23 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.261 0 CA-C-O 120.672 0.273 . . . . 0.0 110.589 179.813 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' B' B ' 23' ' ' ARG . . . . . . . . . . . . . 60.4 ttp180 -54.38 -50.88 66.48 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.779 -0.191 . . . . 0.0 111.39 -178.281 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' B' B ' 24' ' ' ILE . . . . . . . . . . . . . 75.6 mt -59.8 -42.47 89.05 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.298 0 C-N-CA 121.036 -0.266 . . . . 0.0 110.939 -177.686 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' B' B ' 25' ' ' LYS . . . . . . . . . . . . . 60.3 mtpt -64.6 -39.38 93.62 Favored 'General case' 0 C--N 1.328 -0.333 0 N-CA-C 112.232 0.456 . . . . 0.0 112.232 -177.898 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' B' B ' 26' ' ' LEU . . . . . . . . . . . . . 55.7 mt -79.0 -43.5 24.23 Favored 'General case' 0 C--N 1.33 -0.268 0 N-CA-C 113.089 0.774 . . . . 0.0 113.089 -172.454 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' B' B ' 27' ' ' GLN . . . . . . . . . . . . . 10.3 pt20 -46.55 139.31 5.17 Favored 'General case' 0 N--CA 1.469 0.475 0 N-CA-C 112.841 0.682 . . . . 0.0 112.841 -174.084 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' B' B ' 28' ' ' GLY . . . . . . . . . . . . . . . 100.23 -28.06 17.47 Favored Glycine 0 CA--C 1.533 1.192 0 CA-C-N 115.43 -0.805 . . . . 0.0 112.083 -176.215 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' B' B ' 29' ' ' LYS . . . . . . . . . . . . . 55.5 mtmt -98.88 155.16 17.53 Favored 'General case' 0 C--O 1.233 0.226 0 CA-C-N 117.085 0.442 . . . . 0.0 111.248 178.494 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' B' B ' 30' ' ' THR . . . . . . . . . . . . . 35.2 m -104.35 140.39 37.96 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.13 -0.486 . . . . 0.0 110.115 176.305 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' B' B ' 31' ' ' VAL . . . . . . . . . . . . . 35.2 m -129.08 156.61 41.78 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.274 0 CA-C-N 116.321 -0.399 . . . . 0.0 110.627 -179.575 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' B' B ' 32' ' ' ARG . . . . . . . . . . . . . 62.7 ttt180 -133.37 148.64 51.85 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.066 -0.516 . . . . 0.0 110.143 179.076 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' B' B ' 33' ' ' THR . . . . . . . . . . . . . 18.0 m -53.05 139.11 29.14 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.43 -0.35 . . . . 0.0 111.414 -177.248 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' B' B ' 34' ' ' GLY . . . . . . . . . . . . . . . 100.94 -17.19 56.64 Favored Glycine 0 CA--C 1.532 1.142 0 CA-C-O 119.571 -0.572 . . . . 0.0 113.281 179.085 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' B' B ' 35' ' ' ASP . . . . . . . . . . . . . 79.4 m-20 -66.28 149.3 50.56 Favored 'General case' 0 C--N 1.334 -0.09 0 CA-C-N 118.119 0.959 . . . . 0.0 111.077 179.04 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' B' B ' 36' ' ' VAL . . . . . . . . . . . . . 44.3 t -121.71 129.88 75.1 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.204 0 CA-C-N 115.92 -0.582 . . . . 0.0 109.826 178.523 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' B' B ' 37' ' ' ILE . . . . . . . . . . . . . 65.8 mt -120.8 138.69 50.43 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.254 0 N-CA-C 109.982 -0.377 . . . . 0.0 109.982 -179.534 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' B' B ' 38' ' ' GLY . . . . . . . . . . . . . . . -111.61 128.87 8.84 Favored Glycine 0 CA--C 1.526 0.723 0 N-CA-C 111.07 -0.812 . . . . 0.0 111.07 -179.94 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' B' B ' 39' ' ' ILE . . . . . . . . . . . . . 72.3 mt -123.11 138.52 52.82 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.188 0 N-CA-C 110.165 -0.309 . . . . 0.0 110.165 179.161 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' B' B ' 40' ' ' SER . . . . . . . . . . . . . 32.9 t -93.22 117.13 29.71 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.481 -0.327 . . . . 0.0 110.981 175.636 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' B' B ' 41' ' ' ILE . . . . . . . . . . . . . 47.7 mm -125.68 122.96 63.49 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.262 0 CA-C-O 120.844 0.354 . . . . 0.0 110.586 178.694 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' B' B ' 42' ' ' LEU . . . . . . . . . . . . . 65.3 mt 52.61 33.63 14.06 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.185 -0.462 . . . . 0.0 111.881 177.368 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' B' B ' 43' ' ' GLY . . . . . . . . . . . . . . . 73.19 31.19 61.79 Favored Glycine 0 CA--C 1.529 0.963 0 C-N-CA 121.09 -0.576 . . . . 0.0 112.194 177.951 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' B' B ' 44' ' ' LYS . . . . . . . . . . . . . 40.3 ttpt -138.57 133.72 32.91 Favored 'General case' 0 C--N 1.329 -0.303 0 N-CA-C 109.663 -0.495 . . . . 0.0 109.663 178.098 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' B' B ' 45' ' ' GLU . . . . . . . . . . . . . 78.0 tt0 -83.2 118.55 23.68 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-O 120.918 0.39 . . . . 0.0 110.814 -177.598 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' B' B ' 46' ' ' VAL . . . . . . . . . . . . . 7.4 p -117.18 128.08 74.6 Favored 'Isoleucine or valine' 0 N--CA 1.462 0.159 0 N-CA-C 109.611 -0.514 . . . . 0.0 109.611 177.917 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' B' B ' 47' ' ' LYS . . . . . . . . . . . . . 32.3 mmtp -98.93 129.5 45.26 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 115.96 -0.564 . . . . 0.0 111.357 178.721 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' B' B ' 48' ' ' PHE . . . . . . . . . . . . . 90.5 m-85 -114.08 131.83 56.25 Favored 'General case' 0 C--N 1.329 -0.296 0 N-CA-C 109.378 -0.601 . . . . 0.0 109.378 173.966 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' B' B ' 49' ' ' LYS . . . . . . . . . . . . . 59.5 tttm -108.28 138.54 44.39 Favored 'General case' 0 C--N 1.329 -0.308 0 N-CA-C 110.315 -0.254 . . . . 0.0 110.315 179.359 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' B' B ' 50' ' ' VAL . . . . . . . . . . . . . 44.8 t -78.99 107.88 11.96 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.299 0 N-CA-C 109.226 -0.657 . . . . 0.0 109.226 176.529 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' B' B ' 51' ' ' VAL . . . . . . . . . . . . . 52.9 t -73.04 -48.17 45.14 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.271 0 CA-C-N 115.938 -0.574 . . . . 0.0 110.225 -173.573 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' B' B ' 52' ' ' GLN . . . . . . . . . . . . . 45.3 tt0 -162.62 145.17 10.87 Favored 'General case' 0 C--N 1.332 -0.192 0 C-N-CA 120.303 -0.559 . . . . 0.0 111.554 -177.711 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' B' B ' 53' ' ' ALA . . . . . . . . . . . . . . . -121.1 133.89 55.23 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 115.821 -0.627 . . . . 0.0 110.044 176.76 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' B' B ' 54' ' ' TYR . . . . . . . . . . . . . 33.9 t80 -129.01 106.97 18.02 Favored Pre-proline 0 CA--C 1.534 0.342 0 CA-C-O 118.303 -0.856 . . . . 0.0 110.355 179.435 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' B' B ' 55' ' ' PRO . . . . . . . . . . . . . 73.8 Cg_endo -77.13 169.27 74.69 Favored 'Cis proline' 0 N--CA 1.5 1.858 0 CA-C-N 121.812 1.683 . . . . 0.0 112.503 -4.478 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' B' B ' 56' ' ' SER . . . . . . . . . . . . . 67.4 m -115.3 128.07 26.26 Favored Pre-proline 0 CA--C 1.539 0.543 0 CA-C-O 118.454 -0.784 . . . . 0.0 109.466 175.891 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' B' B ' 57' ' ' PRO . . . . . . . . . . . . . 40.0 Cg_endo -67.84 167.38 62.69 Favored 'Cis proline' 0 N--CA 1.496 1.666 0 CA-C-N 121.984 1.744 . . . . 0.0 111.648 -0.845 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' B' B ' 58' ' ' LEU . . . . . . . . . . . . . 31.4 tp -129.85 136.71 49.87 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.187 -0.46 . . . . 0.0 110.334 179.674 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' B' B ' 59' ' ' ARG . . . . . . . . . . . . . 53.6 ttp180 -103.06 128.3 49.98 Favored 'General case' 0 C--N 1.326 -0.417 0 N-CA-C 109.16 -0.682 . . . . 0.0 109.16 176.898 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' B' B ' 60' ' ' VAL . . . . . . . . . . . . . 42.1 t -84.05 127.64 39.6 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.185 0 C-N-CA 120.533 -0.467 . . . . 0.0 110.622 -174.139 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' B' B ' 61' ' ' GLU . . . . . . . . . . . . . 96.0 mt-10 -129.9 159.13 37.55 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 115.558 -0.747 . . . . 0.0 109.611 176.969 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' B' B ' 62' ' ' ASP . . . . . . . . . . . . . 6.8 t0 -53.5 -32.47 50.49 Favored 'General case' 0 C--N 1.328 -0.363 0 N-CA-C 111.88 0.326 . . . . 0.0 111.88 -178.58 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' B' B ' 63' ' ' ARG . . . . . . . . . . . . . 28.7 ptt180 -90.04 6.23 43.24 Favored 'General case' 0 CA--C 1.537 0.476 0 N-CA-C 113.878 1.066 . . . . 0.0 113.878 -175.633 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' B' B ' 64' ' ' THR . . . . . . . . . . . . . 25.7 m -75.11 147.23 40.74 Favored 'General case' 0 C--N 1.331 -0.206 0 CA-C-O 121.006 0.432 . . . . 0.0 111.069 -177.854 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' B' B ' 65' ' ' LYS . . . . . . . . . . . . . 25.2 mtpp -84.94 126.71 33.74 Favored 'General case' 0 C--N 1.331 -0.227 0 CA-C-N 115.893 -0.594 . . . . 0.0 110.208 179.453 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' B' B ' 66' ' ' ILE . . . . . . . . . . . . . 60.4 mt -121.94 132.17 71.51 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.235 0 N-CA-C 110.151 -0.314 . . . . 0.0 110.151 -179.426 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' B' B ' 67' ' ' THR . . . . . . . . . . . . . 29.6 m -130.11 141.55 50.68 Favored 'General case' 0 C--N 1.332 -0.154 0 CA-C-O 121.02 0.438 . . . . 0.0 111.184 -179.458 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' B' B ' 68' ' ' LEU . . . . . . . . . . . . . 7.0 mp -103.02 124.26 48.19 Favored 'General case' 0 C--N 1.332 -0.195 0 CA-C-N 115.942 -0.572 . . . . 0.0 110.427 177.013 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' B' B ' 69' ' ' VAL . . . . . . . . . . . . . 46.2 t -103.08 128.45 56.02 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.284 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.169 179.606 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' B' B ' 70' ' ' THR . . . . . . . . . . . . . 30.9 p -138.43 153.83 48.86 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.389 -0.369 . . . . 0.0 110.813 178.188 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' B' B ' 71' ' ' HIS . . . . . . . . . . . . . 77.0 m-70 -149.98 82.06 6.68 Favored Pre-proline 0 C--N 1.328 -0.327 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.349 177.992 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' B' B ' 72' ' ' PRO . . . . . . . . . . . . . 92.2 Cg_endo -86.98 160.05 8.76 Favored 'Trans proline' 0 N--CA 1.49 1.32 0 C-N-CA 121.676 1.584 . . . . 0.0 112.599 -178.225 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' B' B ' 73' ' ' VAL . . . . . . . . . . . . . 27.1 m -99.84 159.32 3.65 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.251 0 CA-C-N 116.096 -0.502 . . . . 0.0 110.365 178.764 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' B' B ' 74' ' ' ASP . . . . . . . . . . . . . 36.3 t0 -97.78 116.26 29.65 Favored 'General case' 0 C--N 1.329 -0.289 0 N-CA-C 109.732 -0.47 . . . . 0.0 109.732 -179.28 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' B' B ' 75' ' ' VAL . . . . . . . . . . . . . 42.0 t -112.38 122.15 66.07 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.171 0 CA-C-O 121.112 0.482 . . . . 0.0 110.388 -177.97 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' B' B ' 76' ' ' LEU . . . . . . . . . . . . . 14.7 mt -124.82 133.7 53.02 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 115.537 -0.756 . . . . 0.0 109.2 177.422 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' B' B ' 77' ' ' GLU . . . . . . . . . . . . . 35.9 tt0 -131.91 136.89 47.73 Favored 'General case' 0 C--N 1.331 -0.222 0 CA-C-O 121.013 0.435 . . . . 0.0 110.98 -176.25 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' B' B ' 78' ' ' ALA . . . . . . . . . . . . . . . -123.87 139.81 53.6 Favored 'General case' 0 C--N 1.331 -0.219 0 CA-C-N 115.947 -0.57 . . . . 0.0 110.214 178.08 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' B' B ' 79' ' ' LYS . . . . . . . . . . . . . 50.0 pttt -73.37 118.15 15.98 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-O 121.292 0.567 . . . . 0.0 110.453 179.402 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' B' B ' 80' ' ' ILE . . . . . . . . . . . . . 38.0 mm -139.22 109.68 4.4 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.346 0 CA-C-N 115.906 -0.588 . . . . 0.0 109.718 -177.734 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' B' B ' 81' ' ' LYS . . . . . . . . . . . . . 67.6 mttm -110.76 130.6 55.53 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-O 120.948 0.404 . . . . 0.0 110.927 -179.67 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' B' B ' 82' ' ' GLY . . . . . . . . . . . . . . . 89.05 42.22 5.68 Favored Glycine 0 CA--C 1.525 0.698 0 C-N-CA 120.971 -0.633 . . . . 0.0 111.655 175.527 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' B' B ' 83' ' ' ILE . . . . . . . . . . . . . 71.9 mt -66.91 132.35 32.27 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.317 0 N-CA-C 109.672 -0.492 . . . . 0.0 109.672 177.688 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' B' B ' 84' ' ' LYS . . . . . . . . . . . . . 44.9 tttp -96.37 -52.72 3.87 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-O 121.091 0.472 . . . . 0.0 110.227 -178.742 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' B' B ' 85' ' ' ASP . . . . . . . . . . . . . 7.3 t70 -150.98 149.41 29.56 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 115.647 -0.706 . . . . 0.0 110.118 179.422 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' B' B ' 86' ' ' VAL . . . . . . . . . . . . . 43.2 t -128.6 128.77 68.31 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.292 0 CA-C-O 120.887 0.375 . . . . 0.0 110.529 -178.307 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' B' B ' 87' ' ' ILE . . . . . . . . . . . . . 43.7 mm -120.3 125.2 73.93 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.224 0 CA-C-N 116.002 -0.545 . . . . 0.0 109.968 176.251 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' B' B ' 88' ' ' LEU . . . . . . . . . . . . . 19.2 tp -109.64 130.04 55.54 Favored 'General case' 0 C--N 1.331 -0.225 0 CA-C-O 120.967 0.413 . . . . 0.0 111.141 -178.086 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' B' B ' 89' ' ' ASP . . . . . . . . . . . . . 12.7 t70 -123.12 151.6 41.91 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 115.827 -0.624 . . . . 0.0 109.583 176.0 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' B' B ' 90' ' ' GLU . . . . . . . . . . . . . 96.8 mt-10 -47.08 -36.56 8.32 Favored 'General case' 0 C--N 1.33 -0.253 0 N-CA-C 112.993 0.738 . . . . 0.0 112.993 -173.061 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' B' B ' 91' ' ' ASN . . . . . . . . . . . . . 3.4 p-10 -130.47 19.69 5.23 Favored 'General case' 0 N--CA 1.467 0.421 0 N-CA-C 113.051 0.76 . . . . 0.0 113.051 -177.668 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' B' B ' 92' ' ' LEU . . . . . . . . . . . . . 16.5 mt -148.89 143.16 26.05 Favored 'General case' 0 C--N 1.332 -0.169 0 N-CA-C 109.982 -0.377 . . . . 0.0 109.982 -177.336 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' B' B ' 93' ' ' ILE . . . . . . . . . . . . . 70.7 mt -120.09 118.03 55.55 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.328 0 N-CA-C 109.314 -0.624 . . . . 0.0 109.314 178.003 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' B' B ' 94' ' ' VAL . . . . . . . . . . . . . 48.4 t -119.22 123.5 71.44 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.207 0 N-CA-C 109.901 -0.407 . . . . 0.0 109.901 -179.304 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' B' B ' 95' ' ' VAL . . . . . . . . . . . . . 44.3 t -122.4 132.83 70.32 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.397 0 CA-C-N 115.916 -0.584 . . . . 0.0 109.876 -179.439 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' B' B ' 96' ' ' ILE . . . . . . . . . . . . . 67.0 mt -112.78 126.77 70.22 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.287 0 N-CA-C 109.12 -0.696 . . . . 0.0 109.12 178.265 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' B' B ' 97' ' ' THR . . . . . . . . . . . . . 68.2 p -99.6 152.72 19.72 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-O 120.877 0.37 . . . . 0.0 110.929 -178.543 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' B' B ' 98' ' ' GLU . . . . . . . . . . . . . 45.0 mt-10 -53.87 -24.23 15.19 Favored 'General case' 0 CA--C 1.533 0.324 0 N-CA-C 112.346 0.498 . . . . 0.0 112.346 179.927 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' B' B ' 99' ' ' GLU . . . . . . . . . . . . . 31.1 tt0 -79.27 15.54 1.19 Allowed 'General case' 0 CA--C 1.539 0.549 0 N-CA-C 112.697 0.629 . . . . 0.0 112.697 -177.306 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' B' B ' 100' ' ' ASN . . . . . . . . . . . . . 3.8 m-20 63.56 38.0 9.99 Favored 'General case' 0 CA--C 1.531 0.213 0 CA-C-O 121.006 0.432 . . . . 0.0 111.107 177.366 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' B' B ' 101' ' ' GLU . . . . . . . . . . . . . 85.0 tt0 -118.95 143.26 47.13 Favored 'General case' 0 C--N 1.331 -0.202 0 CA-C-N 116.042 -0.526 . . . . 0.0 109.909 176.014 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' B' B ' 102' ' ' VAL . . . . . . . . . . . . . 45.0 t -114.99 126.29 72.53 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.273 0 CA-C-N 116.262 -0.427 . . . . 0.0 109.946 -177.534 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' B' B ' 103' ' ' LEU . . . . . . . . . . . . . 21.2 mt -116.0 129.38 56.35 Favored 'General case' 0 C--N 1.331 -0.201 0 CA-C-N 115.848 -0.614 . . . . 0.0 110.555 178.263 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' B' B ' 104' ' ' ILE . . . . . . . . . . . . . 66.9 mt -118.82 119.55 61.37 Favored 'Isoleucine or valine' 0 C--O 1.233 0.215 0 CA-C-N 116.443 -0.344 . . . . 0.0 110.109 179.216 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' B' B ' 105' ' ' PHE . . . . . . . . . . . . . 66.8 m-85 -120.72 164.69 16.17 Favored 'General case' 0 C--N 1.331 -0.212 0 O-C-N 123.972 0.795 . . . . 0.0 109.878 178.741 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' B' B ' 106' ' ' ASN . . . . . . . . . . . . . 46.0 p-10 -101.08 -171.49 2.01 Favored 'General case' 0 N--CA 1.463 0.215 0 N-CA-C 110.267 -0.272 . . . . 0.0 110.267 174.605 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' B' B ' 107' ' ' GLN . . . . . . . . . . . . . 60.3 tt0 -59.47 -29.37 67.77 Favored 'General case' 0 CA--C 1.531 0.225 0 N-CA-C 112.021 0.378 . . . . 0.0 112.021 -179.347 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' B' B ' 108' ' ' ASN . . . . . . . . . . . . . 17.9 t30 -86.59 10.01 16.78 Favored 'General case' 0 CA--C 1.536 0.426 0 N-CA-C 113.189 0.811 . . . . 0.0 113.189 -177.115 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' B' B ' 109' ' ' LEU . . . . . . . . . . . . . 12.9 tp 59.68 41.65 18.24 Favored 'General case' 0 C--N 1.331 -0.198 0 CA-C-O 121.25 0.548 . . . . 0.0 110.897 178.318 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' B' B ' 110' ' ' GLU . . . . . . . . . . . . . 70.9 mm-40 -108.07 156.79 18.88 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.138 -0.483 . . . . 0.0 109.866 176.133 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' B' B ' 111' ' ' GLU . . . . . . . . . . . . . 84.9 tt0 -84.39 121.96 28.28 Favored 'General case' 0 C--N 1.329 -0.298 0 C-N-CA 120.845 -0.342 . . . . 0.0 110.79 -178.566 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' B' B ' 112' ' ' LEU . . . . . . . . . . . . . 28.4 mt -110.58 -46.18 3.42 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 116.16 -0.473 . . . . 0.0 110.547 178.169 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' B' B ' 113' ' ' TYR . . . . . . . . . . . . . 54.0 t80 -142.17 134.24 27.44 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.357 -0.383 . . . . 0.0 111.249 -179.941 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' B' B ' 114' ' ' ARG . . . . . . . . . . . . . 29.9 ttm180 -135.28 124.27 24.21 Favored 'General case' 0 C--N 1.329 -0.292 0 N-CA-C 109.839 -0.43 . . . . 0.0 109.839 175.44 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' B' B ' 115' ' ' GLY . . . . . . . . . . . . . . . -150.03 151.64 23.67 Favored Glycine 0 CA--C 1.523 0.569 0 C-N-CA 120.754 -0.736 . . . . 0.0 111.325 179.213 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' B' B ' 116' ' ' LYS . . . . . . . . . . . . . 39.1 ttpt -121.94 136.43 54.92 Favored 'General case' 0 C--N 1.328 -0.333 0 N-CA-C 109.662 -0.495 . . . . 0.0 109.662 177.744 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' B' B ' 117' ' ' PHE . . . . . . . . . . . . . 40.6 m-85 -135.2 113.76 11.66 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-O 121.082 0.468 . . . . 0.0 110.074 -176.861 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' B' B ' 118' ' ' GLU . . . . . . . . . . . . . 97.0 mt-10 -53.86 -43.78 69.82 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.073 -0.512 . . . . 0.0 111.662 -174.256 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' B' B ' 119' ' ' ASN . . . . . . . . . . . . . 5.6 p30 -104.63 31.13 4.91 Favored 'General case' 0 C--N 1.33 -0.257 0 N-CA-C 112.244 0.461 . . . . 0.0 112.244 -173.942 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' B' B ' 120' ' ' LEU . . . . . . . . . . . . . 13.7 tp -53.48 126.05 20.14 Favored 'General case' 0 N--CA 1.464 0.238 0 CA-C-O 120.469 0.176 . . . . 0.0 110.8 177.72 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' B' B ' 121' ' ' ASN . . . . . . . . . . . . . 77.3 m-20 -114.1 -44.12 3.17 Favored 'General case' 0 N--CA 1.462 0.173 0 C-N-CA 121.195 -0.202 . . . . 0.0 111.283 -176.843 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' B' B ' 122' ' ' LYS . . . . . . . . . . . . . 62.2 mtpt -142.1 145.69 34.57 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-O 121.121 0.486 . . . . 0.0 111.727 -176.775 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' B' B ' 123' ' ' VAL . . . . . . . . . . . . . 44.0 t -127.24 127.52 69.35 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.264 0 N-CA-C 109.21 -0.663 . . . . 0.0 109.21 174.909 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' B' B ' 124' ' ' LEU . . . . . . . . . . . . . 51.1 mt -128.03 136.38 51.18 Favored 'General case' 0 C--N 1.331 -0.196 0 CA-C-O 120.853 0.358 . . . . 0.0 111.097 -177.216 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' B' B ' 125' ' ' VAL . . . . . . . . . . . . . 11.1 p -133.97 133.65 56.11 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.249 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.027 177.304 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' B' B ' 126' ' ' ARG . . . . . . . . . . . . . 77.0 mtp85 -146.64 126.47 13.52 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-O 120.86 0.362 . . . . 0.0 111.073 -179.275 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' B' B ' 127' ' ' ASN . . . . . . . . . . . . . 7.6 m-80 49.23 -105.21 0.15 Allowed 'General case' 0 CA--C 1.545 0.76 0 CA-C-O 119.036 -0.507 . . . . 0.0 111.784 178.162 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' B' B ' 128' ' ' ASP . . . . . . . . . . . . . 15.9 p-10 -114.09 3.02 15.11 Favored 'General case' 0 CA--C 1.535 0.396 0 CA-C-N 119.552 1.069 . . . . 0.0 113.546 -176.36 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' B' B ' 129' ' ' LEU . . . . . . . . . . . . . 52.8 mt -111.48 140.85 45.73 Favored 'General case' 0 C--N 1.333 -0.114 0 O-C-N 121.972 -0.455 . . . . 0.0 110.522 -179.078 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' B' B ' 130' ' ' VAL . . . . . . . . . . . . . 46.5 t -122.98 134.85 64.9 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.326 0 N-CA-C 109.401 -0.592 . . . . 0.0 109.401 177.839 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' B' B ' 131' ' ' VAL . . . . . . . . . . . . . 39.3 t -134.36 138.06 50.53 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.223 0 CA-C-O 121.187 0.518 . . . . 0.0 110.45 -179.002 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' B' B ' 132' ' ' ILE . . . . . . . . . . . . . 70.7 mt -116.76 130.19 72.04 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.339 0 CA-C-N 115.556 -0.747 . . . . 0.0 109.388 179.508 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' B' B ' 133' ' ' ILE . . . . . . . . . . . . . 40.4 mm -112.2 119.25 59.72 Favored 'Isoleucine or valine' 0 C--O 1.233 0.221 0 CA-C-O 120.855 0.36 . . . . 0.0 110.67 -177.241 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' B' B ' 134' ' ' ASP . . . . . . . . . . . . . 7.2 p-10 -134.13 148.78 51.01 Favored 'General case' 0 C--N 1.331 -0.206 0 CA-C-N 116.103 -0.499 . . . . 0.0 109.76 177.156 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' B' B ' 135' ' ' GLU . . . . . . . . . . . . . 42.8 tp10 -49.9 -30.0 9.33 Favored 'General case' 0 C--N 1.328 -0.36 0 N-CA-C 112.576 0.584 . . . . 0.0 112.576 -173.523 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' B' B ' 136' ' ' GLN . . . . . . . . . . . . . 43.2 tp60 -80.18 -34.91 37.13 Favored 'General case' 0 C--N 1.33 -0.251 0 N-CA-C 112.282 0.475 . . . . 0.0 112.282 -175.046 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' B' B ' 137' ' ' LYS . . . . . . . . . . . . . 40.0 pttt -170.0 174.2 5.64 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-O 121.452 0.644 . . . . 0.0 112.179 -170.512 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' B' B ' 138' ' ' LEU . . . . . . . . . . . . . 6.1 tt -118.0 128.21 54.56 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 115.186 -0.915 . . . . 0.0 109.9 178.969 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' B' B ' 139' ' ' THR . . . . . . . . . . . . . 34.0 m -106.27 127.76 53.48 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.261 -0.427 . . . . 0.0 110.396 -179.87 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' B' B ' 140' ' ' LEU . . . . . . . . . . . . . 5.5 tt -113.88 121.02 42.71 Favored 'General case' 0 C--N 1.328 -0.351 0 N-CA-C 109.149 -0.686 . . . . 0.0 109.149 -178.922 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' B' B ' 141' ' ' ILE . . . . . . . . . . . . . 19.1 mt -119.88 116.81 51.65 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.303 0 N-CA-C 109.814 -0.439 . . . . 0.0 109.814 -176.604 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' B' B ' 142' ' ' ARG . . . . . . . . . . . . . 68.5 ttt180 -108.18 131.97 54.11 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 115.417 -0.81 . . . . 0.0 110.463 -177.092 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' B' B ' 143' ' ' THR . . . . . . . . . . . . . 35.2 p . . . . . 0 C--O 1.22 -0.45 0 CA-C-O 117.936 -1.03 . . . . 0.0 110.522 179.092 . . . . . . . . 0 0 . 1 . 018 nuclear orig full ' C' C ' -3' ' ' GLU . . . . . . . . . . . . . 85.4 tt0 . . . . . 0 N--CA 1.49 1.564 0 N-CA-C 109.393 -0.595 . . . . 0.0 109.393 . . . . . . . . . 0 0 . 1 . 018 nuclear orig full ' C' C ' -2' ' ' GLY . . . . . . . . . . . . . . . -79.46 135.98 16.38 Favored Glycine 0 CA--C 1.526 0.726 0 N-CA-C 111.035 -0.826 . . . . 0.0 111.035 179.411 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' C' C ' -1' ' ' VAL . . . . . . . . . . . . . 42.9 t -141.48 143.08 28.07 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.237 0 N-CA-C 110.067 -0.346 . . . . 0.0 110.067 179.559 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' C' C ' 0' ' ' ILE . . . . . . . . . . . . . 44.8 mm -106.88 138.19 33.92 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.194 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.422 -179.165 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' C' C ' 1' ' ' MET . . . . . . . . . . . . . 25.2 ptp -88.58 162.81 16.16 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 116.049 -0.523 . . . . 0.0 110.635 179.927 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' C' C ' 2' ' ' SER . . . . . . . . . . . . . 12.6 p -119.87 143.2 48.05 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-O 121.024 0.44 . . . . 0.0 110.906 -179.646 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' C' C ' 3' ' ' GLU . . . . . . . . . . . . . 95.8 mt-10 -141.0 142.44 34.26 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 115.863 -0.608 . . . . 0.0 110.961 -178.356 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' C' C ' 4' ' ' LEU . . . . . . . . . . . . . 16.2 tp -122.73 127.05 48.7 Favored 'General case' 0 C--N 1.331 -0.207 0 CA-C-N 116.103 -0.499 . . . . 0.0 109.719 175.402 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' C' C ' 5' ' ' LYS . . . . . . . . . . . . . 52.5 mttp -108.07 122.12 46.23 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-O 120.763 0.315 . . . . 0.0 110.995 -179.109 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' C' C ' 6' ' ' LEU . . . . . . . . . . . . . 27.6 mt -116.21 151.81 34.98 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 115.543 -0.753 . . . . 0.0 110.522 179.863 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' C' C ' 7' ' ' LYS . . . . . . . . . . . . . 74.2 tttt -144.02 139.56 16.11 Favored Pre-proline 0 CA--C 1.534 0.331 0 CA-C-O 119.124 -0.465 . . . . 0.0 109.949 173.569 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' C' C ' 8' ' ' PRO . . . . . . . . . . . . . 80.3 Cg_endo -90.65 141.54 3.23 Favored 'Trans proline' 0 N--CA 1.491 1.364 0 C-N-CA 121.66 1.573 . . . . 0.0 111.72 176.764 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' C' C ' 9' ' ' LEU . . . . . . . . . . . . . 54.6 mt -73.78 -47.97 6.66 Favored Pre-proline 0 CA--C 1.535 0.392 0 CA-C-O 118.665 -0.683 . . . . 0.0 112.472 -178.519 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' C' C ' 10' ' ' PRO . . . . . . . . . . . . . 88.1 Cg_endo -80.66 152.3 19.73 Favored 'Trans proline' 0 N--CA 1.497 1.677 0 C-N-CA 121.313 1.342 . . . . 0.0 111.99 177.422 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' C' C ' 11' ' ' LYS . . . . . . . . . . . . . 73.8 mmtt -82.49 102.0 11.06 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-O 120.929 0.395 . . . . 0.0 110.222 177.524 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' C' C ' 12' ' ' VAL . . . . . . . . . . . . . 12.9 p -141.31 146.4 23.53 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 CA-C-N 116.136 -0.483 . . . . 0.0 110.466 -179.225 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' C' C ' 13' ' ' GLU . . . . . . . . . . . . . 85.0 tt0 -85.19 124.44 31.84 Favored 'General case' 0 C--N 1.329 -0.306 0 N-CA-C 109.93 -0.396 . . . . 0.0 109.93 177.429 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' C' C ' 14' ' ' LEU . . . . . . . . . . . . . 48.8 mt -93.12 142.8 25.81 Favored Pre-proline 0 CA--C 1.533 0.314 0 CA-C-O 119.072 -0.49 . . . . 0.0 110.379 -177.453 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' C' C ' 15' ' ' PRO . . . . . . . . . . . . . 35.6 Cg_exo -60.22 162.1 17.94 Favored 'Trans proline' 0 N--CA 1.496 1.665 0 C-N-CA 121.353 1.369 . . . . 0.0 112.034 176.887 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' C' C ' 16' ' ' PRO . . . . . . . . . . . . . 38.3 Cg_exo -58.2 -42.33 57.87 Favored 'Trans proline' 0 N--CA 1.496 1.632 0 C-N-CA 121.507 1.472 . . . . 0.0 112.897 -176.399 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' C' C ' 17' ' ' ASP . . . . . . . . . . . . . 15.2 p-10 -92.87 13.03 21.68 Favored 'General case' 0 C--N 1.327 -0.383 0 N-CA-C 113.239 0.829 . . . . 0.0 113.239 -175.966 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' C' C ' 18' ' ' PHE . . . . . . . . . . . . . 41.8 t80 -57.71 -43.98 85.59 Favored 'General case' 0 C--O 1.231 0.1 0 CA-C-O 121.073 0.463 . . . . 0.0 110.08 -178.188 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' C' C ' 19' ' ' VAL . . . . . . . . . . . . . 44.9 t -59.47 -42.39 87.66 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.346 0 CA-C-N 116.122 -0.49 . . . . 0.0 110.21 -179.259 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' C' C ' 20' ' ' ASP . . . . . . . . . . . . . 78.5 m-20 -59.69 -42.66 93.46 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-O 120.732 0.301 . . . . 0.0 110.951 -177.361 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' C' C ' 21' ' ' VAL . . . . . . . . . . . . . 43.7 t -64.58 -46.8 91.46 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.318 0 C-N-CA 120.79 -0.364 . . . . 0.0 110.315 -177.755 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' C' C ' 22' ' ' ILE . . . . . . . . . . . . . 24.5 mm -59.32 -40.1 80.58 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.276 0 C-N-CA 120.869 -0.332 . . . . 0.0 110.362 -179.017 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' C' C ' 23' ' ' ARG . . . . . . . . . . . . . 55.8 ttp180 -55.36 -50.04 70.72 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-O 121.038 0.447 . . . . 0.0 110.736 178.335 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' C' C ' 24' ' ' ILE . . . . . . . . . . . . . 78.0 mt -60.21 -46.06 95.2 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.327 0 CA-C-N 116.005 -0.543 . . . . 0.0 111.595 -177.379 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' C' C ' 25' ' ' LYS . . . . . . . . . . . . . 17.7 ptpt -67.47 -39.15 85.28 Favored 'General case' 0 CA--C 1.534 0.358 0 C-N-CA 120.584 -0.446 . . . . 0.0 111.94 -173.71 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' C' C ' 26' ' ' LEU . . . . . . . . . . . . . 21.8 mt -79.49 -31.66 42.33 Favored 'General case' 0 C--N 1.33 -0.255 0 N-CA-C 113.045 0.757 . . . . 0.0 113.045 -174.765 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' C' C ' 27' ' ' GLN . . . . . . . . . . . . . 4.5 pt20 -45.9 135.48 7.14 Favored 'General case' 0 CA--C 1.536 0.436 0 N-CA-C 112.78 0.659 . . . . 0.0 112.78 -175.083 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' C' C ' 28' ' ' GLY . . . . . . . . . . . . . . . 97.06 -21.14 47.83 Favored Glycine 0 CA--C 1.534 1.264 0 CA-C-N 115.985 -0.552 . . . . 0.0 112.683 -177.822 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' C' C ' 29' ' ' LYS . . . . . . . . . . . . . 61.7 mttp -97.53 155.14 17.08 Favored 'General case' 0 C--N 1.331 -0.213 0 CA-C-N 117.522 0.661 . . . . 0.0 110.963 -178.984 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' C' C ' 30' ' ' THR . . . . . . . . . . . . . 13.9 m -104.02 139.72 38.74 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.337 177.989 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' C' C ' 31' ' ' VAL . . . . . . . . . . . . . 34.0 m -131.61 157.35 43.15 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.206 0 CA-C-N 116.234 -0.439 . . . . 0.0 110.856 -179.151 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' C' C ' 32' ' ' ARG . . . . . . . . . . . . . 81.7 mtt85 -133.65 150.7 51.57 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-N 115.957 -0.565 . . . . 0.0 110.744 176.828 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' C' C ' 33' ' ' THR . . . . . . . . . . . . . 33.5 m -53.41 139.98 28.95 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.206 -0.452 . . . . 0.0 111.282 -178.944 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' C' C ' 34' ' ' GLY . . . . . . . . . . . . . . . 98.65 -16.98 59.02 Favored Glycine 0 CA--C 1.532 1.125 0 CA-C-O 119.638 -0.535 . . . . 0.0 113.329 178.332 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' C' C ' 35' ' ' ASP . . . . . . . . . . . . . 76.9 m-20 -64.3 149.08 48.86 Favored 'General case' 0 C--O 1.231 0.125 0 CA-C-N 118.054 0.927 . . . . 0.0 111.225 -179.865 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' C' C ' 36' ' ' VAL . . . . . . . . . . . . . 46.2 t -121.07 129.66 75.46 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.211 0 CA-C-N 115.777 -0.647 . . . . 0.0 109.816 178.644 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' C' C ' 37' ' ' ILE . . . . . . . . . . . . . 72.1 mt -123.23 139.98 48.27 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.276 0 CA-C-N 116.182 -0.463 . . . . 0.0 109.994 -179.77 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' C' C ' 38' ' ' GLY . . . . . . . . . . . . . . . -108.91 128.67 9.15 Favored Glycine 0 CA--C 1.526 0.736 0 N-CA-C 111.317 -0.713 . . . . 0.0 111.317 -179.302 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' C' C ' 39' ' ' ILE . . . . . . . . . . . . . 77.7 mt -128.34 135.36 62.82 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.187 0 CA-C-O 120.757 0.313 . . . . 0.0 110.185 178.535 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' C' C ' 40' ' ' SER . . . . . . . . . . . . . 32.6 p -92.78 117.03 29.57 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.324 -0.398 . . . . 0.0 110.822 175.377 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' C' C ' 41' ' ' ILE . . . . . . . . . . . . . 45.7 mm -121.12 112.91 37.66 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.21 0 CA-C-O 120.794 0.331 . . . . 0.0 110.186 178.686 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' C' C ' 42' ' ' LEU . . . . . . . . . . . . . 2.0 tt 55.58 48.56 18.4 Favored 'General case' 0 CA--C 1.533 0.307 0 CA-C-O 121.538 0.685 . . . . 0.0 110.098 178.643 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' C' C ' 43' ' ' GLY . . . . . . . . . . . . . . . 71.77 -5.48 11.92 Favored Glycine 0 CA--C 1.536 1.359 0 C-N-CA 121.125 -0.559 . . . . 0.0 113.766 175.642 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' C' C ' 44' ' ' LYS . . . . . . . . . . . . . 25.6 tptp -103.34 132.97 49.17 Favored 'General case' 0 C--O 1.231 0.126 0 CA-C-N 117.975 0.888 . . . . 0.0 110.031 -178.716 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' C' C ' 45' ' ' GLU . . . . . . . . . . . . . 82.5 tt0 -82.34 119.7 24.48 Favored 'General case' 0 C--N 1.329 -0.32 0 C-N-CA 120.808 -0.357 . . . . 0.0 110.78 -178.476 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' C' C ' 46' ' ' VAL . . . . . . . . . . . . . 7.2 p -122.8 124.52 70.65 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.21 0 N-CA-C 109.42 -0.585 . . . . 0.0 109.42 177.283 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' C' C ' 47' ' ' LYS . . . . . . . . . . . . . 53.7 mtmt -100.88 132.0 46.49 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.073 -0.512 . . . . 0.0 111.124 177.201 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' C' C ' 48' ' ' PHE . . . . . . . . . . . . . 84.3 m-85 -109.42 134.17 52.17 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 115.87 -0.605 . . . . 0.0 110.417 179.741 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' C' C ' 49' ' ' LYS . . . . . . . . . . . . . 87.5 tttt -105.3 134.36 48.54 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 115.844 -0.616 . . . . 0.0 110.05 178.589 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' C' C ' 50' ' ' VAL . . . . . . . . . . . . . 44.6 t -77.87 106.69 8.62 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.243 0 N-CA-C 109.147 -0.686 . . . . 0.0 109.147 174.873 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' C' C ' 51' ' ' VAL . . . . . . . . . . . . . 45.8 t -68.71 -46.63 79.37 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.308 0 CA-C-N 116.107 -0.497 . . . . 0.0 110.018 -172.59 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' C' C ' 52' ' ' GLN . . . . . . . . . . . . . 45.0 tt0 -171.39 145.25 2.09 Favored 'General case' 0 C--N 1.331 -0.207 0 C-N-CA 120.229 -0.588 . . . . 0.0 111.662 -179.361 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' C' C ' 53' ' ' ALA . . . . . . . . . . . . . . . -116.63 132.1 56.77 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 115.766 -0.652 . . . . 0.0 110.013 176.459 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' C' C ' 54' ' ' TYR . . . . . . . . . . . . . 48.2 t80 -129.11 108.87 18.03 Favored Pre-proline 0 CA--C 1.535 0.39 0 CA-C-O 118.264 -0.874 . . . . 0.0 110.242 177.983 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' C' C ' 55' ' ' PRO . . . . . . . . . . . . . 72.4 Cg_endo -77.11 168.5 76.83 Favored 'Cis proline' 0 N--CA 1.498 1.774 0 CA-C-N 121.865 1.702 . . . . 0.0 112.504 -3.823 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' C' C ' 56' ' ' SER . . . . . . . . . . . . . 50.2 m -115.71 130.49 24.31 Favored Pre-proline 0 CA--C 1.538 0.501 0 CA-C-O 118.456 -0.783 . . . . 0.0 109.373 174.446 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' C' C ' 57' ' ' PRO . . . . . . . . . . . . . 54.8 Cg_endo -70.0 165.3 77.7 Favored 'Cis proline' 0 N--CA 1.497 1.732 0 CA-C-N 121.918 1.721 . . . . 0.0 111.432 0.606 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' C' C ' 58' ' ' LEU . . . . . . . . . . . . . 29.3 tp -129.73 137.51 50.61 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-O 120.908 0.385 . . . . 0.0 110.419 -179.957 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' C' C ' 59' ' ' ARG . . . . . . . . . . . . . 64.7 ttp85 -106.98 125.72 51.38 Favored 'General case' 0 C--N 1.328 -0.332 0 N-CA-C 109.328 -0.619 . . . . 0.0 109.328 176.917 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' C' C ' 60' ' ' VAL . . . . . . . . . . . . . 45.0 t -75.48 115.97 17.66 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.288 0 CA-C-O 120.878 0.37 . . . . 0.0 110.656 -173.884 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' C' C ' 61' ' ' GLU . . . . . . . . . . . . . 39.1 tp10 -131.05 154.76 47.89 Favored 'General case' 0 C--N 1.33 -0.263 0 N-CA-C 109.062 -0.718 . . . . 0.0 109.062 176.77 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' C' C ' 62' ' ' ASP . . . . . . . . . . . . . 83.4 m-20 -50.86 -32.33 20.01 Favored 'General case' 0 C--N 1.326 -0.444 0 N-CA-C 112.162 0.43 . . . . 0.0 112.162 -176.612 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' C' C ' 63' ' ' ARG . . . . . . . . . . . . . 75.4 mtt85 -72.37 -22.19 61.18 Favored 'General case' 0 C--N 1.33 -0.261 0 N-CA-C 113.154 0.798 . . . . 0.0 113.154 -175.627 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' C' C ' 64' ' ' THR . . . . . . . . . . . . . 33.3 m -68.81 140.36 55.26 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-O 120.86 0.362 . . . . 0.0 110.697 -176.778 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' C' C ' 65' ' ' LYS . . . . . . . . . . . . . 97.2 mttt -88.08 134.64 33.71 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.045 -0.525 . . . . 0.0 109.989 179.159 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' C' C ' 66' ' ' ILE . . . . . . . . . . . . . 53.7 mt -111.09 129.84 65.64 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.238 0 N-CA-C 109.607 -0.516 . . . . 0.0 109.607 -178.248 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' C' C ' 67' ' ' THR . . . . . . . . . . . . . 34.6 m -123.69 140.24 53.19 Favored 'General case' 0 C--N 1.331 -0.223 0 CA-C-O 121.079 0.466 . . . . 0.0 111.295 -175.724 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' C' C ' 68' ' ' LEU . . . . . . . . . . . . . 8.2 mp -101.4 122.88 44.55 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 115.667 -0.697 . . . . 0.0 110.1 176.077 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' C' C ' 69' ' ' VAL . . . . . . . . . . . . . 46.2 t -101.67 134.4 42.19 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.325 0 N-CA-C 109.878 -0.416 . . . . 0.0 109.878 179.592 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' C' C ' 70' ' ' THR . . . . . . . . . . . . . 15.9 p -132.79 120.41 21.57 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 116.243 -0.435 . . . . 0.0 110.646 179.433 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' C' C ' 71' ' ' HIS . . . . . . . . . . . . . 40.7 m80 -121.3 154.68 59.02 Favored Pre-proline 0 C--N 1.33 -0.282 0 CA-C-N 116.005 -0.543 . . . . 0.0 109.656 177.49 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' C' C ' 72' ' ' PRO . . . . . . . . . . . . . 58.3 Cg_endo -72.74 -30.14 11.96 Favored 'Trans proline' 0 N--CA 1.495 1.579 0 C-N-CA 121.152 1.234 . . . . 0.0 112.538 -177.002 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' C' C ' 73' ' ' VAL . . . . . . . . . . . . . 21.1 m -153.61 160.3 2.94 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.27 0 CA-C-O 121.137 0.494 . . . . 0.0 111.038 179.198 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' C' C ' 74' ' ' ASP . . . . . . . . . . . . . 7.0 t0 -107.95 122.92 47.81 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 115.572 -0.74 . . . . 0.0 109.371 175.251 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' C' C ' 75' ' ' VAL . . . . . . . . . . . . . 40.1 t -112.52 121.32 64.63 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.231 0 CA-C-O 121.128 0.49 . . . . 0.0 110.676 -177.69 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' C' C ' 76' ' ' LEU . . . . . . . . . . . . . 6.4 mp -119.57 148.48 43.26 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 115.573 -0.74 . . . . 0.0 109.621 176.309 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' C' C ' 77' ' ' GLU . . . . . . . . . . . . . 98.0 mt-10 -137.84 133.58 34.1 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-O 121.108 0.48 . . . . 0.0 111.129 -177.988 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' C' C ' 78' ' ' ALA . . . . . . . . . . . . . . . -118.74 128.0 54.08 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 115.674 -0.693 . . . . 0.0 109.672 176.724 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' C' C ' 79' ' ' LYS . . . . . . . . . . . . . 61.7 mttp -83.87 114.94 22.01 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-O 121.05 0.452 . . . . 0.0 110.897 -176.072 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' C' C ' 80' ' ' ILE . . . . . . . . . . . . . 43.7 mm -139.26 107.33 3.19 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.28 0 N-CA-C 109.025 -0.731 . . . . 0.0 109.025 -178.023 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' C' C ' 81' ' ' LYS . . . . . . . . . . . . . 77.4 tttt -95.34 127.41 41.37 Favored 'General case' 0 C--N 1.328 -0.369 0 C-N-CA 120.676 -0.409 . . . . 0.0 110.687 -177.837 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' C' C ' 82' ' ' GLY . . . . . . . . . . . . . . . 89.29 42.03 5.65 Favored Glycine 0 CA--C 1.524 0.645 0 C-N-CA 120.749 -0.738 . . . . 0.0 111.744 176.426 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' C' C ' 83' ' ' ILE . . . . . . . . . . . . . 67.9 mt -68.39 139.28 20.92 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.324 0 N-CA-C 109.47 -0.567 . . . . 0.0 109.47 176.586 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' C' C ' 84' ' ' LYS . . . . . . . . . . . . . 68.5 tttt -98.42 -54.14 3.13 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.112 -0.495 . . . . 0.0 110.704 -176.009 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' C' C ' 85' ' ' ASP . . . . . . . . . . . . . 6.9 t70 -152.14 155.31 37.6 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 115.885 -0.598 . . . . 0.0 110.353 -177.883 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' C' C ' 86' ' ' VAL . . . . . . . . . . . . . 40.3 t -133.17 132.23 58.48 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.254 0 CA-C-O 121.017 0.437 . . . . 0.0 110.729 -178.485 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' C' C ' 87' ' ' ILE . . . . . . . . . . . . . 45.1 mm -117.63 122.28 69.47 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.276 0 CA-C-N 115.776 -0.647 . . . . 0.0 109.325 174.431 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' C' C ' 88' ' ' LEU . . . . . . . . . . . . . 13.4 tp -113.04 130.75 56.04 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-O 120.992 0.425 . . . . 0.0 110.998 -176.219 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' C' C ' 89' ' ' ASP . . . . . . . . . . . . . 11.7 t70 -128.65 160.24 33.06 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 115.888 -0.597 . . . . 0.0 109.863 178.38 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' C' C ' 90' ' ' GLU . . . . . . . . . . . . . 83.3 tt0 -46.23 -41.13 12.45 Favored 'General case' 0 CA--C 1.532 0.282 0 N-CA-C 113.073 0.768 . . . . 0.0 113.073 -172.041 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' C' C ' 91' ' ' ASN . . . . . . . . . . . . . 25.6 m120 -132.05 27.55 4.53 Favored 'General case' 0 N--CA 1.467 0.409 0 N-CA-C 112.44 0.533 . . . . 0.0 112.44 -177.451 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' C' C ' 92' ' ' LEU . . . . . . . . . . . . . 12.2 mt -149.98 141.17 23.11 Favored 'General case' 0 C--N 1.33 -0.265 0 N-CA-C 110.221 -0.288 . . . . 0.0 110.221 -177.43 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' C' C ' 93' ' ' ILE . . . . . 0.411 HD12 HG23 ' C' ' 93' ' ' ILE . 73.0 mt -124.5 113.63 37.22 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.284 0 N-CA-C 109.075 -0.713 . . . . 0.0 109.075 176.887 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' C' C ' 94' ' ' VAL . . . . . . . . . . . . . 45.0 t -116.6 126.49 74.08 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.247 0 N-CA-C 109.806 -0.442 . . . . 0.0 109.806 -179.388 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' C' C ' 95' ' ' VAL . . . . . . . . . . . . . 40.2 t -124.38 136.63 59.89 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.325 0 CA-C-N 116.28 -0.418 . . . . 0.0 110.056 -178.687 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' C' C ' 96' ' ' ILE . . . . . . . . . . . . . 61.4 mt -116.55 130.55 71.19 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.361 0 N-CA-C 109.221 -0.659 . . . . 0.0 109.221 179.112 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' C' C ' 97' ' ' THR . . . . . . . . . . . . . 71.4 p -98.37 159.99 14.58 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-O 120.908 0.385 . . . . 0.0 110.619 -178.346 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' C' C ' 98' ' ' GLU . . . . . . . . . . . . . 12.8 pt-20 -53.99 -19.27 4.45 Favored 'General case' 0 CA--C 1.535 0.367 0 N-CA-C 112.801 0.667 . . . . 0.0 112.801 -179.266 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' C' C ' 99' ' ' GLU . . . . . . . . . . . . . 37.1 tt0 -85.67 16.34 4.02 Favored 'General case' 0 CA--C 1.539 0.545 0 N-CA-C 112.567 0.58 . . . . 0.0 112.567 -177.259 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' C' C ' 100' ' ' ASN . . . . . . . . . . . . . 3.4 m-20 61.14 38.06 17.18 Favored 'General case' 0 CA--C 1.529 0.17 0 O-C-N 121.818 -0.551 . . . . 0.0 110.971 178.564 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' C' C ' 101' ' ' GLU . . . . . . . . . . . . . 82.0 tt0 -116.12 143.24 45.74 Favored 'General case' 0 C--N 1.331 -0.207 0 N-CA-C 109.444 -0.576 . . . . 0.0 109.444 175.831 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' C' C ' 102' ' ' VAL . . . . . . . . . . . . . 44.4 t -117.66 128.41 74.87 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.263 0 CA-C-O 120.972 0.415 . . . . 0.0 110.098 -177.609 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' C' C ' 103' ' ' LEU . . . . . . . . . . . . . 25.0 mt -118.38 136.35 53.8 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 115.564 -0.743 . . . . 0.0 109.752 176.164 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' C' C ' 104' ' ' ILE . . . . . . . . . . . . . 69.2 mt -118.19 121.34 66.99 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.244 0 N-CA-C 109.844 -0.428 . . . . 0.0 109.844 179.725 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' C' C ' 105' ' ' PHE . . . . . . . . . . . . . 53.9 m-85 -118.11 161.31 20.06 Favored 'General case' 0 C--N 1.333 -0.139 0 O-C-N 124.183 0.927 . . . . 0.0 109.836 -179.328 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' C' C ' 106' ' ' ASN . . . . . . . . . . . . . 44.7 p-10 -98.82 -171.04 2.03 Favored 'General case' 0 C--N 1.33 -0.246 0 N-CA-C 110.049 -0.352 . . . . 0.0 110.049 175.427 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' C' C ' 107' ' ' GLN . . . . . . . . . . . . . 41.0 tt0 -58.29 -30.13 66.39 Favored 'General case' 0 C--N 1.329 -0.284 0 N-CA-C 111.968 0.358 . . . . 0.0 111.968 -179.459 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' C' C ' 108' ' ' ASN . . . . . . . . . . . . . 12.9 t30 -86.17 8.78 19.68 Favored 'General case' 0 CA--C 1.535 0.398 0 N-CA-C 113.475 0.917 . . . . 0.0 113.475 -175.954 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' C' C ' 109' ' ' LEU . . . . . . . . . . . . . 11.9 tp 62.96 38.55 11.06 Favored 'General case' 0 CA--C 1.53 0.185 0 CA-C-O 121.073 0.464 . . . . 0.0 111.301 177.752 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' C' C ' 110' ' ' GLU . . . . . . . . . . . . . 70.7 mm-40 -109.16 157.43 18.78 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 116.37 -0.377 . . . . 0.0 110.114 176.211 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' C' C ' 111' ' ' GLU . . . . . . . . . . . . . 98.5 mt-10 -86.35 124.24 32.48 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-O 120.806 0.336 . . . . 0.0 111.263 -178.401 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' C' C ' 112' ' ' LEU . . . . . . . . . . . . . 13.5 mt -111.14 -45.99 3.37 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 115.982 -0.554 . . . . 0.0 110.711 178.479 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' C' C ' 113' ' ' TYR . . . . . . . . . . . . . 61.6 t80 -135.85 142.45 44.79 Favored 'General case' 0 N--CA 1.464 0.256 0 C-N-CA 120.749 -0.381 . . . . 0.0 111.532 -178.224 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' C' C ' 114' ' ' ARG . . . . . . . . . . . . . 51.3 mtt85 -135.75 125.88 26.2 Favored 'General case' 0 C--N 1.331 -0.21 0 CA-C-N 115.996 -0.547 . . . . 0.0 109.937 179.684 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' C' C ' 115' ' ' GLY . . . . . . . . . . . . . . . -150.13 155.06 26.04 Favored Glycine 0 CA--C 1.524 0.65 0 C-N-CA 120.643 -0.789 . . . . 0.0 111.296 177.886 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' C' C ' 116' ' ' LYS . . . . . . . . . . . . . 36.1 ttpt -129.98 136.07 49.02 Favored 'General case' 0 C--N 1.331 -0.224 0 N-CA-C 109.64 -0.504 . . . . 0.0 109.64 175.875 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' C' C ' 117' ' ' PHE . . . . . . . . . . . . . 40.0 m-85 -137.7 113.92 10.08 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-O 120.927 0.394 . . . . 0.0 110.313 -176.033 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' C' C ' 118' ' ' GLU . . . . . . . . . . . . . 95.7 mt-10 -56.0 -46.4 78.74 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.388 -0.369 . . . . 0.0 110.976 -176.321 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' C' C ' 119' ' ' ASN . . . . . . . . . . . . . 71.0 m-80 -95.86 31.03 2.19 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.102 -0.499 . . . . 0.0 112.002 -174.99 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' C' C ' 120' ' ' LEU . . . . . . . . . . . . . 12.2 tp -56.7 119.96 7.02 Favored 'General case' 0 C--N 1.333 -0.144 0 C-N-CA 120.993 -0.283 . . . . 0.0 110.278 178.284 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' C' C ' 121' ' ' ASN . . . . . . . . . . . . . 56.3 m-20 -114.08 -44.2 3.17 Favored 'General case' 0 C--N 1.331 -0.226 0 CA-C-N 116.491 -0.322 . . . . 0.0 110.983 -176.883 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' C' C ' 122' ' ' LYS . . . . . . . . . . . . . 92.5 mttt -143.26 145.21 32.54 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-O 121.126 0.489 . . . . 0.0 111.688 -178.133 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' C' C ' 123' ' ' VAL . . . . . . . . . . . . . 43.8 t -124.75 126.2 71.11 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.262 0 CA-C-N 115.735 -0.666 . . . . 0.0 109.325 174.997 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' C' C ' 124' ' ' LEU . . . . . . . . . . . . . 74.4 mt -115.13 129.45 56.67 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.507 -0.315 . . . . 0.0 110.379 -177.122 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' C' C ' 125' ' ' VAL . . . . . . . . . . . . . 43.6 t -127.9 122.6 58.99 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.225 0 CA-C-N 116.282 -0.417 . . . . 0.0 109.898 178.851 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' C' C ' 126' ' ' ARG . . . . . . . . . . . . . 80.9 mtt85 -151.99 135.6 16.18 Favored 'General case' 0 C--N 1.33 -0.255 0 N-CA-C 109.748 -0.464 . . . . 0.0 109.748 178.267 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' C' C ' 127' ' ' ASN . . . . . . . . . . . . . 3.1 m120 55.99 -154.99 0.3 Allowed 'General case' 0 CA--C 1.539 0.549 0 N-CA-C 109.644 -0.502 . . . . 0.0 109.644 -179.282 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' C' C ' 128' ' ' ASP . . . . . . . . . . . . . 9.3 p-10 -84.88 21.47 1.58 Allowed 'General case' 0 CA--C 1.535 0.384 0 CA-C-N 118.432 0.56 . . . . 0.0 112.199 175.831 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' C' C ' 129' ' ' LEU . . . . . . . . . . . . . 12.8 tp -116.42 137.76 51.9 Favored 'General case' 0 C--O 1.234 0.254 0 CA-C-O 120.91 0.386 . . . . 0.0 110.381 -179.676 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' C' C ' 130' ' ' VAL . . . . . . . . . . . . . 42.8 t -124.33 136.8 59.32 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.204 0 CA-C-N 116.079 -0.509 . . . . 0.0 110.049 -178.864 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' C' C ' 131' ' ' VAL . . . . . . . . . . . . . 44.6 t -136.02 137.79 48.24 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.292 0 CA-C-O 120.946 0.403 . . . . 0.0 110.329 179.181 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' C' C ' 132' ' ' ILE . . . . . . . . . . . . . 72.4 mt -121.26 134.09 65.74 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.247 0 CA-C-N 116.064 -0.516 . . . . 0.0 109.795 -179.027 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' C' C ' 133' ' ' ILE . . . . . . . . . . . . . 42.9 mm -117.2 121.56 67.97 Favored 'Isoleucine or valine' 0 C--O 1.233 0.228 0 CA-C-O 120.834 0.349 . . . . 0.0 111.156 -176.275 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' C' C ' 134' ' ' ASP . . . . . . . . . . . . . 6.9 p-10 -133.47 147.12 51.65 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 115.78 -0.645 . . . . 0.0 109.52 174.003 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' C' C ' 135' ' ' GLU . . . . . . . . . . . . . 83.3 tt0 -50.05 -25.05 3.05 Favored 'General case' 0 C--N 1.327 -0.373 0 N-CA-C 112.96 0.726 . . . . 0.0 112.96 -171.247 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' C' C ' 136' ' ' GLN . . . . . . . . . . . . . 95.6 mm-40 -93.46 -35.03 13.17 Favored 'General case' 0 C--N 1.33 -0.267 0 N-CA-C 112.633 0.605 . . . . 0.0 112.633 -176.379 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' C' C ' 137' ' ' LYS . . . . . . . . . . . . . 50.0 mtmt -146.2 154.74 42.1 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-O 121.303 0.573 . . . . 0.0 112.056 -169.13 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' C' C ' 138' ' ' LEU . . . . . . . . . . . . . 5.5 tt -116.81 123.45 47.15 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 115.349 -0.841 . . . . 0.0 109.16 175.151 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' C' C ' 139' ' ' THR . . . . . . . . . . . . . 30.7 m -111.57 129.71 55.98 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 116.483 -0.326 . . . . 0.0 110.97 -175.939 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' C' C ' 140' ' ' LEU . . . . . . . . . . . . . 7.4 tt -117.77 124.36 48.24 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 115.747 -0.66 . . . . 0.0 109.449 -179.624 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' C' C ' 141' ' ' ILE . . . . . . . . . . . . . 19.0 mt -122.43 120.54 61.35 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.277 0 N-CA-C 109.909 -0.404 . . . . 0.0 109.909 -175.972 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' C' C ' 142' ' ' ARG . . . . . . . . . . . . . 78.3 ttt-85 -111.24 131.2 55.32 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 115.84 -0.618 . . . . 0.0 110.099 -178.086 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' C' C ' 143' ' ' THR . . . . . . . . . . . . . 41.4 p . . . . . 0 C--O 1.219 -0.518 0 CA-C-O 117.96 -1.019 . . . . 0.0 110.618 -179.365 . . . . . . . . 0 0 . 1 . 018 nuclear orig full ' D' D ' -3' ' ' GLU . . . . . . . . . . . . . 22.2 pt-20 . . . . . 0 N--CA 1.493 1.679 0 N-CA-C 110.155 -0.313 . . . . 0.0 110.155 . . . . . . . . . 0 0 . 1 . 018 nuclear orig full ' D' D ' -2' ' ' GLY . . . . . . . . . . . . . . . -66.39 140.41 39.15 Favored Glycine 0 CA--C 1.526 0.744 0 N-CA-C 110.887 -0.885 . . . . 0.0 110.887 179.896 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' D' D ' -1' ' ' VAL . . . . . . . . . . . . . 43.7 t -141.32 133.91 29.67 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.305 0 N-CA-C 110.023 -0.362 . . . . 0.0 110.023 -179.853 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' D' D ' 0' ' ' ILE . . . . . . . . . . . . . 44.3 mm -117.41 133.35 64.44 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.238 0 CA-C-N 116.326 -0.397 . . . . 0.0 110.33 179.791 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' D' D ' 1' ' ' MET . . . . . . . . . . . . . 26.0 ptt? -84.23 133.64 34.57 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.135 -0.484 . . . . 0.0 110.635 -179.782 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' D' D ' 2' ' ' SER . . . . . . . . . . . . . 79.5 p -124.57 145.2 49.73 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.312 -0.404 . . . . 0.0 110.522 179.571 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' D' D ' 3' ' ' GLU . . . . . . . . . . . . . 84.9 tt0 -140.22 138.4 35.06 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.063 -0.517 . . . . 0.0 110.987 -178.647 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' D' D ' 4' ' ' LEU . . . . . . . . . . . . . 4.9 tt -124.25 130.23 52.15 Favored 'General case' 0 C--N 1.332 -0.187 0 CA-C-N 115.96 -0.564 . . . . 0.0 110.137 178.309 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' D' D ' 5' ' ' LYS . . . . . . . . . . . . . 67.6 mttm -109.65 122.58 47.78 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.455 -0.339 . . . . 0.0 111.017 -178.739 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' D' D ' 6' ' ' LEU . . . . . . . . . . . . . 79.6 mt -115.38 149.78 37.41 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 115.369 -0.832 . . . . 0.0 110.331 179.793 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' D' D ' 7' ' ' LYS . . . . . . . . . . . . . 64.1 tttm -137.45 137.07 21.29 Favored Pre-proline 0 CA--C 1.534 0.338 0 CA-C-O 119.014 -0.517 . . . . 0.0 110.087 176.587 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' D' D ' 8' ' ' PRO . . . . . . . . . . . . . 93.1 Cg_endo -92.01 141.73 2.49 Favored 'Trans proline' 0 N--CA 1.49 1.3 0 C-N-CA 121.823 1.682 . . . . 0.0 111.491 176.701 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' D' D ' 9' ' ' LEU . . . . . . . . . . . . . 66.7 mt -75.86 -47.48 3.84 Favored Pre-proline 0 CA--C 1.533 0.292 0 CA-C-O 118.74 -0.648 . . . . 0.0 112.219 -178.439 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' D' D ' 10' ' ' PRO . . . . . . . . . . . . . 98.6 Cg_endo -81.74 149.04 16.04 Favored 'Trans proline' 0 N--CA 1.495 1.612 0 C-N-CA 121.184 1.256 . . . . 0.0 111.852 175.542 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' D' D ' 11' ' ' LYS . . . . . . . . . . . . . 24.3 tptp -88.86 100.53 13.24 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-O 120.764 0.316 . . . . 0.0 110.399 179.539 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' D' D ' 12' ' ' VAL . . . . . . . . . . . . . 11.4 p -139.62 142.23 33.19 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.233 0 CA-C-N 116.358 -0.383 . . . . 0.0 110.548 -179.206 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' D' D ' 13' ' ' GLU . . . . . . . . . . . . . 43.1 mp0 -78.17 122.44 25.65 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 116.3 -0.409 . . . . 0.0 110.165 178.041 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' D' D ' 14' ' ' LEU . . . . . . . . . . . . . 35.8 mt -98.4 153.44 38.02 Favored Pre-proline 0 CA--C 1.532 0.285 0 CA-C-N 116.462 -0.336 . . . . 0.0 110.51 -179.283 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' D' D ' 15' ' ' PRO . . . . . . . . . . . . . 33.5 Cg_exo -60.56 157.41 36.92 Favored 'Trans proline' 0 N--CA 1.496 1.653 0 C-N-CA 121.256 1.304 . . . . 0.0 111.792 176.801 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' D' D ' 16' ' ' PRO . . . . . . . . . . . . . 36.2 Cg_exo -58.83 -37.39 94.05 Favored 'Trans proline' 0 N--CA 1.498 1.737 0 C-N-CA 121.376 1.384 . . . . 0.0 112.654 -178.177 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' D' D ' 17' ' ' ASP . . . . . . . . . . . . . 7.1 p-10 -88.46 9.94 21.9 Favored 'General case' 0 CA--C 1.534 0.355 0 N-CA-C 113.284 0.846 . . . . 0.0 113.284 -176.832 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' D' D ' 18' ' ' PHE . . . . . . . . . . . . . 19.8 t80 -57.72 -45.06 86.25 Favored 'General case' 0 C--N 1.334 -0.091 0 O-C-N 121.916 -0.49 . . . . 0.0 110.041 -177.653 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' D' D ' 19' ' ' VAL . . . . . . . . . . . . . 48.0 t -57.61 -43.15 82.82 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.286 0 CA-C-N 116.273 -0.421 . . . . 0.0 110.548 -178.521 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' D' D ' 20' ' ' ASP . . . . . . . . . . . . . 82.5 m-20 -60.15 -42.56 95.15 Favored 'General case' 0 C--N 1.33 -0.258 0 C-N-CA 120.837 -0.345 . . . . 0.0 111.112 -176.789 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' D' D ' 21' ' ' VAL . . . . . . . . . . . . . 45.6 t -64.73 -46.28 92.67 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.33 0 C-N-CA 120.807 -0.357 . . . . 0.0 110.347 -177.863 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' D' D ' 22' ' ' ILE . . . . . . . . . . . . . 50.5 mm -56.91 -42.98 79.61 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.229 0 C-N-CA 120.815 -0.354 . . . . 0.0 110.441 178.379 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' D' D ' 23' ' ' ARG . . . . . . . . . . . . . 54.7 ttp180 -53.5 -47.39 69.9 Favored 'General case' 0 C--N 1.33 -0.266 0 O-C-N 122.32 -0.237 . . . . 0.0 111.339 -179.208 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' D' D ' 24' ' ' ILE . . . . . . . . . . . . . 71.7 mt -60.02 -43.41 92.52 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.342 0 C-N-CA 120.933 -0.307 . . . . 0.0 110.698 179.541 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' D' D ' 25' ' ' LYS . . . . . . . . . . . . . 89.0 mttt -61.73 -38.09 86.62 Favored 'General case' 0 C--N 1.328 -0.343 0 N-CA-C 112.379 0.511 . . . . 0.0 112.379 -179.564 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' D' D ' 26' ' ' LEU . . . . . . . . . . . . . 86.3 mt -77.99 -46.63 20.52 Favored 'General case' 0 C--N 1.329 -0.32 0 N-CA-C 112.702 0.63 . . . . 0.0 112.702 -171.719 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' D' D ' 27' ' ' GLN . . . . . . . . . . . . . 11.2 pt20 -47.03 137.76 7.25 Favored 'General case' 0 N--CA 1.47 0.556 0 N-CA-C 112.75 0.648 . . . . 0.0 112.75 -175.839 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' D' D ' 28' ' ' GLY . . . . . . . . . . . . . . . 101.14 -26.86 23.1 Favored Glycine 0 CA--C 1.531 1.092 0 CA-C-N 115.591 -0.731 . . . . 0.0 112.312 -178.454 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' D' D ' 29' ' ' LYS . . . . . . . . . . . . . 87.4 mttt -99.67 155.14 17.77 Favored 'General case' 0 C--N 1.332 -0.182 0 CA-C-N 117.398 0.599 . . . . 0.0 111.385 179.707 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' D' D ' 30' ' ' THR . . . . . . . . . . . . . 22.2 m -101.07 135.38 42.63 Favored 'General case' 0 C--N 1.33 -0.239 0 CA-C-N 116.099 -0.501 . . . . 0.0 109.662 174.119 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' D' D ' 31' ' ' VAL . . . . . . . . . . . . . 34.3 m -127.48 156.33 39.12 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.226 0 CA-C-O 120.866 0.365 . . . . 0.0 111.14 -177.644 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' D' D ' 32' ' ' ARG . . . . . . . . . . . . . 72.8 mtt85 -132.93 149.35 52.25 Favored 'General case' 0 C--O 1.233 0.186 0 CA-C-N 115.724 -0.671 . . . . 0.0 110.838 178.864 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' D' D ' 33' ' ' THR . . . . . . . . . . . . . 23.7 m -53.8 140.46 29.97 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.07 -0.514 . . . . 0.0 111.146 -179.784 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' D' D ' 34' ' ' GLY . . . . . . . . . . . . . . . 99.7 -17.08 57.99 Favored Glycine 0 CA--C 1.531 1.047 0 C-N-CA 121.105 -0.569 . . . . 0.0 113.31 178.753 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' D' D ' 35' ' ' ASP . . . . . . . . . . . . . 75.8 m-20 -62.15 147.63 47.03 Favored 'General case' 0 N--CA 1.461 0.125 0 CA-C-N 118.054 0.927 . . . . 0.0 111.156 179.683 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' D' D ' 36' ' ' VAL . . . . . . . . . . . . . 46.5 t -124.63 129.12 73.79 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.234 0 CA-C-N 115.659 -0.7 . . . . 0.0 109.721 178.883 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' D' D ' 37' ' ' ILE . . . . . . . . . . . . . 68.0 mt -120.74 137.6 53.95 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.229 0 N-CA-C 109.857 -0.423 . . . . 0.0 109.857 -179.706 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' D' D ' 38' ' ' GLY . . . . . . . . . . . . . . . -111.5 128.74 8.8 Favored Glycine 0 CA--C 1.525 0.666 0 N-CA-C 111.018 -0.833 . . . . 0.0 111.018 179.606 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' D' D ' 39' ' ' ILE . . . . . . . . . . . . . 69.6 mt -125.44 126.64 70.89 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.228 0 N-CA-C 109.849 -0.426 . . . . 0.0 109.849 178.782 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' D' D ' 40' ' ' SER . . . . . . . . . . . . . 46.6 t -93.4 120.45 33.69 Favored 'General case' 0 C--N 1.33 -0.262 0 C-N-CA 120.825 -0.35 . . . . 0.0 110.88 176.158 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' D' D ' 41' ' ' ILE . . . . . . . . . . . . . 71.1 mt -132.88 125.47 52.32 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.186 0 CA-C-O 120.749 0.309 . . . . 0.0 110.316 178.589 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' D' D ' 42' ' ' LEU . . . . . . . . . . . . . 61.4 mt 57.5 34.39 24.54 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.098 -0.501 . . . . 0.0 111.891 177.296 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' D' D ' 43' ' ' GLY . . . . . . . . . . . . . . . 78.52 -10.11 31.88 Favored Glycine 0 CA--C 1.535 1.295 0 C-N-CA 121.192 -0.528 . . . . 0.0 113.463 176.975 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' D' D ' 44' ' ' LYS . . . . . . . . . . . . . 52.7 mtmt -101.76 130.25 48.13 Favored 'General case' 0 C--N 1.333 -0.14 0 CA-C-N 117.884 0.842 . . . . 0.0 110.066 176.65 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' D' D ' 45' ' ' GLU . . . . . . . . . . . . . 38.9 tp10 -85.53 130.33 34.6 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.4 -0.364 . . . . 0.0 110.777 -179.924 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' D' D ' 46' ' ' VAL . . . . . . . . . . . . . 7.2 p -121.61 129.46 75.5 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.235 0 N-CA-C 109.631 -0.507 . . . . 0.0 109.631 176.298 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' D' D ' 47' ' ' LYS . . . . . . . . . . . . . 98.5 mttt -101.03 130.44 47.03 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 115.892 -0.595 . . . . 0.0 111.119 178.387 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' D' D ' 48' ' ' PHE . . . . . . . . . . . . . 95.3 m-85 -113.41 131.83 55.85 Favored 'General case' 0 C--N 1.33 -0.244 0 N-CA-C 109.831 -0.433 . . . . 0.0 109.831 176.211 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' D' D ' 49' ' ' LYS . . . . . . . . . . . . . 81.8 tttt -110.5 139.11 46.05 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.402 -0.363 . . . . 0.0 110.63 179.454 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' D' D ' 50' ' ' VAL . . . . . . . . . . . . . 42.5 t -83.53 108.13 15.76 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.276 0 N-CA-C 109.4 -0.593 . . . . 0.0 109.4 175.59 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' D' D ' 51' ' ' VAL . . . . . . . . . . . . . 48.8 t -70.37 -48.26 61.36 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.314 0 CA-C-N 116.039 -0.528 . . . . 0.0 109.851 -173.816 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' D' D ' 52' ' ' GLN . . . . . . . . . . . . . 14.0 pt20 -167.79 157.6 10.24 Favored 'General case' 0 C--N 1.331 -0.201 0 C-N-CA 120.115 -0.634 . . . . 0.0 112.017 -179.864 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' D' D ' 53' ' ' ALA . . . . . . . . . . . . . . . -133.85 135.28 43.62 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 115.314 -0.857 . . . . 0.0 109.97 177.317 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' D' D ' 54' ' ' TYR . . . . . . . . . . . . . 13.8 t80 -129.01 111.69 18.47 Favored Pre-proline 0 CA--C 1.535 0.39 0 CA-C-O 118.24 -0.886 . . . . 0.0 110.133 179.163 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' D' D ' 55' ' ' PRO . . . . . . . . . . . . . 73.4 Cg_endo -77.12 170.21 72.21 Favored 'Cis proline' 0 N--CA 1.501 1.93 0 CA-C-N 121.899 1.714 . . . . 0.0 112.127 -7.587 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' D' D ' 56' ' ' SER . . . . . . . . . . . . . 66.0 m -129.71 140.64 39.23 Favored Pre-proline 0 CA--C 1.538 0.499 0 CA-C-O 118.71 -0.662 . . . . 0.0 109.489 174.52 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' D' D ' 57' ' ' PRO . . . . . . . . . . . . . 38.3 Cg_endo -68.05 156.31 87.46 Favored 'Cis proline' 0 N--CA 1.499 1.836 0 CA-C-N 121.559 1.592 . . . . 0.0 111.723 -2.018 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' D' D ' 58' ' ' LEU . . . . . . . . . . . . . 32.4 tp -128.75 138.86 52.34 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.252 -0.431 . . . . 0.0 110.778 -176.664 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' D' D ' 59' ' ' ARG . . . . . . . . . . . . . 60.1 ttt180 -100.48 120.36 39.88 Favored 'General case' 0 C--N 1.327 -0.4 0 N-CA-C 108.904 -0.776 . . . . 0.0 108.904 173.413 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' D' D ' 60' ' ' VAL . . . . . . . . . . . . . 43.3 t -72.63 126.38 33.12 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.252 0 C-N-CA 120.67 -0.412 . . . . 0.0 110.279 -174.084 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' D' D ' 61' ' ' GLU . . . . . . . . . . . . . 95.5 mt-10 -130.39 162.88 28.12 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 115.85 -0.613 . . . . 0.0 109.687 178.567 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' D' D ' 62' ' ' ASP . . . . . . . . . . . . . 5.2 t70 -53.34 -32.08 47.44 Favored 'General case' 0 C--N 1.328 -0.353 0 N-CA-C 111.782 0.29 . . . . 0.0 111.782 -179.638 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' D' D ' 63' ' ' ARG . . . . . . . . . . . . . 34.4 ptt180 -84.07 4.26 30.98 Favored 'General case' 0 CA--C 1.537 0.456 0 N-CA-C 113.779 1.029 . . . . 0.0 113.779 -174.926 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' D' D ' 64' ' ' THR . . . . . . . . . . . . . 35.4 m -86.93 139.61 30.45 Favored 'General case' 0 C--N 1.332 -0.186 0 CA-C-N 118.211 0.46 . . . . 0.0 110.713 -178.659 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' D' D ' 65' ' ' LYS . . . . . . . . . . . . . 67.5 mttm -90.14 134.05 34.51 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.252 -0.431 . . . . 0.0 110.581 -179.443 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' D' D ' 66' ' ' ILE . . . . . . . . . . . . . 58.8 mt -116.35 134.32 60.15 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.201 0 CA-C-O 120.897 0.379 . . . . 0.0 110.002 -179.719 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' D' D ' 67' ' ' THR . . . . . . . . . . . . . 34.6 m -125.31 141.46 52.07 Favored 'General case' 0 C--N 1.332 -0.17 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.92 -178.344 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' D' D ' 68' ' ' LEU . . . . . . . . . . . . . 5.3 tt -105.93 124.03 48.92 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.002 -0.544 . . . . 0.0 110.128 178.468 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' D' D ' 69' ' ' VAL . . . . . . . . . . . . . 44.4 t -102.82 140.3 21.49 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.24 0 CA-C-N 116.352 -0.385 . . . . 0.0 110.578 -177.237 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' D' D ' 70' ' ' THR . . . . . . . . . . . . . 11.2 p -140.83 -45.24 0.39 Allowed 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 116.265 -0.425 . . . . 0.0 110.964 178.846 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' D' D ' 71' ' ' HIS . . . . . . . . . . . . . 62.7 m80 -99.5 101.21 12.53 Favored Pre-proline 0 CA--C 1.534 0.348 0 CA-C-O 118.955 -0.545 . . . . 0.0 110.415 -177.977 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' D' D ' 72' ' ' PRO . . . . . . . . . . . . . 33.1 Cg_endo -64.82 -29.91 58.68 Favored 'Trans proline' 0 N--CA 1.5 1.87 0 C-N-CA 121.275 1.317 . . . . 0.0 112.407 -178.423 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' D' D ' 73' ' ' VAL . . . . . . . . . . . . . 27.7 m -75.21 -177.63 0.3 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.316 0 C-N-CA 120.948 -0.301 . . . . 0.0 110.468 178.651 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' D' D ' 74' ' ' ASP . . . . . . . . . . . . . 10.3 t0 -103.68 117.98 35.66 Favored 'General case' 0 C--N 1.33 -0.242 0 N-CA-C 109.796 -0.446 . . . . 0.0 109.796 179.821 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' D' D ' 75' ' ' VAL . . . . . . . . . . . . . 45.4 t -113.52 122.86 68.46 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.227 0 CA-C-O 121.173 0.511 . . . . 0.0 110.474 -178.756 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' D' D ' 76' ' ' LEU . . . . . . . . . . . . . 24.5 mt -122.71 138.04 54.73 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 115.398 -0.819 . . . . 0.0 109.035 176.451 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' D' D ' 77' ' ' GLU . . . . . . . . . . . . . 58.6 tt0 -136.84 135.34 37.83 Favored 'General case' 0 C--N 1.331 -0.197 0 CA-C-O 121.027 0.441 . . . . 0.0 110.995 -177.133 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' D' D ' 78' ' ' ALA . . . . . . . . . . . . . . . -122.47 137.67 54.8 Favored 'General case' 0 C--N 1.331 -0.203 0 CA-C-N 115.862 -0.608 . . . . 0.0 109.926 178.517 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' D' D ' 79' ' ' LYS . . . . . . . . . . . . . 54.2 mtmt -81.97 120.41 25.21 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-O 120.884 0.374 . . . . 0.0 110.483 179.831 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' D' D ' 80' ' ' ILE . . . . . . . . . . . . . 42.6 mm -138.99 112.55 6.76 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.344 0 N-CA-C 109.254 -0.647 . . . . 0.0 109.254 -177.423 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' D' D ' 81' ' ' LYS . . . . . . . . . . . . . 9.3 mtmp? -103.33 126.88 50.72 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-O 120.91 0.386 . . . . 0.0 111.259 -177.158 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' D' D ' 82' ' ' GLY . . . . . . . . . . . . . . . 89.18 42.06 5.68 Favored Glycine 0 CA--C 1.525 0.712 0 C-N-CA 120.989 -0.624 . . . . 0.0 111.645 174.795 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' D' D ' 83' ' ' ILE . . . . . . . . . . . . . 72.5 mt -69.92 134.71 29.65 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.331 0 N-CA-C 109.501 -0.555 . . . . 0.0 109.501 176.347 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' D' D ' 84' ' ' LYS . . . . . . . . . . . . . 35.7 ttpt -98.65 -54.11 3.12 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-O 121.057 0.456 . . . . 0.0 110.423 -178.811 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' D' D ' 85' ' ' ASP . . . . . . . . . . . . . 10.6 t70 -148.53 149.94 32.5 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 115.758 -0.656 . . . . 0.0 110.387 -178.168 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' D' D ' 86' ' ' VAL . . . . . . . . . . . . . 40.7 t -127.41 129.51 70.58 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.252 0 CA-C-O 120.813 0.339 . . . . 0.0 110.474 -178.906 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' D' D ' 87' ' ' ILE . . . . . . . . . . . . . 43.7 mm -119.49 130.87 73.48 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.255 0 CA-C-N 115.98 -0.554 . . . . 0.0 109.61 177.305 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' D' D ' 88' ' ' LEU . . . . . . . . . . . . . 19.3 tp -115.42 135.79 53.75 Favored 'General case' 0 C--N 1.331 -0.205 0 CA-C-O 120.952 0.406 . . . . 0.0 111.544 -175.797 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' D' D ' 89' ' ' ASP . . . . . . . . . . . . . 13.3 t70 -128.67 156.97 42.6 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-N 115.755 -0.657 . . . . 0.0 109.537 176.091 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' D' D ' 90' ' ' GLU . . . . . . . . . . . . . 70.8 mm-40 -46.96 -38.53 10.79 Favored 'General case' 0 N--CA 1.465 0.305 0 N-CA-C 113.035 0.754 . . . . 0.0 113.035 -171.102 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' D' D ' 91' ' ' ASN . . . . . . . . . . . . . 59.7 m-80 -131.97 20.0 4.54 Favored 'General case' 0 N--CA 1.467 0.413 0 N-CA-C 112.968 0.729 . . . . 0.0 112.968 -177.421 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' D' D ' 92' ' ' LEU . . . . . . . . . . . . . 15.8 mt -147.04 143.93 28.73 Favored 'General case' 0 C--N 1.331 -0.213 0 N-CA-C 110.141 -0.318 . . . . 0.0 110.141 -176.654 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' D' D ' 93' ' ' ILE . . . . . . . . . . . . . 75.2 mt -123.55 119.5 57.44 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.285 0 N-CA-C 109.294 -0.632 . . . . 0.0 109.294 179.035 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' D' D ' 94' ' ' VAL . . . . . . . . . . . . . 46.5 t -118.35 125.09 74.04 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.208 0 CA-C-O 120.988 0.423 . . . . 0.0 109.912 -178.57 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' D' D ' 95' ' ' VAL . . . . . . . . . . . . . 47.0 t -118.72 131.98 69.91 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.344 0 CA-C-N 115.862 -0.608 . . . . 0.0 109.643 -179.564 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' D' D ' 96' ' ' ILE . . . . . . . . . . . . . 68.7 mt -112.61 126.79 70.04 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.328 0 N-CA-C 109.184 -0.672 . . . . 0.0 109.184 178.354 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' D' D ' 97' ' ' THR . . . . . . . . . . . . . 78.4 p -97.63 159.64 14.8 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-O 121.28 0.562 . . . . 0.0 111.214 -176.678 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' D' D ' 98' ' ' GLU . . . . . . . . . . . . . 85.4 tt0 -53.96 -27.48 31.5 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 115.906 -0.588 . . . . 0.0 112.202 -179.061 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' D' D ' 99' ' ' GLU . . . . . . . . . . . . . 95.2 mt-10 -82.32 15.4 2.47 Favored 'General case' 0 CA--C 1.535 0.403 0 N-CA-C 113.14 0.793 . . . . 0.0 113.14 -176.581 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' D' D ' 100' ' ' ASN . . . . . . . . . . . . . 4.1 m-20 62.2 35.63 15.41 Favored 'General case' 0 C--N 1.331 -0.212 0 CA-C-O 120.949 0.404 . . . . 0.0 111.441 179.675 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' D' D ' 101' ' ' GLU . . . . . . . . . . . . . 84.2 tt0 -109.04 143.83 37.84 Favored 'General case' 0 C--N 1.331 -0.203 0 N-CA-C 109.595 -0.521 . . . . 0.0 109.595 173.227 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' D' D ' 102' ' ' VAL . . . . . . . . . . . . . 43.0 t -114.94 125.24 72.21 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.292 0 CA-C-N 116.206 -0.452 . . . . 0.0 109.944 -177.399 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' D' D ' 103' ' ' LEU . . . . . . . . . . . . . 16.8 mt -116.13 130.18 56.68 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 115.877 -0.601 . . . . 0.0 110.256 177.532 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' D' D ' 104' ' ' ILE . . . . . . . . . . . . . 70.9 mt -116.98 121.94 68.92 Favored 'Isoleucine or valine' 0 C--O 1.235 0.299 0 N-CA-C 110.286 -0.265 . . . . 0.0 110.286 179.83 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' D' D ' 105' ' ' PHE . . . . . . . . . . . . . 86.7 m-85 -121.67 163.47 18.95 Favored 'General case' 0 CA--C 1.528 0.134 0 O-C-N 124.052 0.845 . . . . 0.0 109.885 179.0 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' D' D ' 106' ' ' ASN . . . . . . . . . . . . . 40.6 p-10 -96.72 -169.94 1.97 Allowed 'General case' 0 C--N 1.33 -0.274 0 N-CA-C 109.913 -0.403 . . . . 0.0 109.913 173.075 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' D' D ' 107' ' ' GLN . . . . . . . . . . . . . 34.3 tt0 -60.59 -30.09 69.6 Favored 'General case' 0 CA--C 1.532 0.269 0 C-N-CA 121.014 -0.275 . . . . 0.0 111.628 179.565 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' D' D ' 108' ' ' ASN . . . . . . . . . . . . . 4.0 t-20 -82.67 4.79 23.5 Favored 'General case' 0 CA--C 1.536 0.421 0 N-CA-C 113.355 0.872 . . . . 0.0 113.355 -178.454 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' D' D ' 109' ' ' LEU . . . . . . . . . . . . . 7.4 tp 63.87 36.69 10.13 Favored 'General case' 0 CA--C 1.53 0.185 0 O-C-N 122.13 -0.356 . . . . 0.0 111.467 177.492 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' D' D ' 110' ' ' GLU . . . . . . . . . . . . . 95.5 mt-10 -105.13 154.49 20.11 Favored 'General case' 0 C--N 1.331 -0.222 0 N-CA-C 109.887 -0.412 . . . . 0.0 109.887 176.401 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' D' D ' 111' ' ' GLU . . . . . . . . . . . . . 83.6 tt0 -80.46 124.87 29.29 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-O 120.952 0.406 . . . . 0.0 110.928 -176.506 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' D' D ' 112' ' ' LEU . . . . . . . . . . . . . 31.8 mt -111.89 -46.08 3.27 Favored 'General case' 0 C--N 1.331 -0.216 0 CA-C-N 115.995 -0.548 . . . . 0.0 110.511 178.355 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' D' D ' 113' ' ' TYR . . . . . . . . . . . . . 58.1 t80 -142.21 140.35 32.3 Favored 'General case' 0 C--N 1.328 -0.331 0 C-N-CA 120.792 -0.363 . . . . 0.0 111.242 -179.644 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' D' D ' 114' ' ' ARG . . . . . . . . . . . . . 33.6 ttp180 -136.82 126.48 25.4 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.202 -0.454 . . . . 0.0 110.419 176.975 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' D' D ' 115' ' ' GLY . . . . . . . . . . . . . . . -150.05 158.93 27.89 Favored Glycine 0 CA--C 1.524 0.636 0 N-CA-C 110.78 -0.928 . . . . 0.0 110.78 178.164 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' D' D ' 116' ' ' LYS . . . . . . . . . . . . . 79.3 tttt -136.02 131.75 35.38 Favored 'General case' 0 C--N 1.328 -0.331 0 N-CA-C 109.925 -0.398 . . . . 0.0 109.925 178.879 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' D' D ' 117' ' ' PHE . . . . . . . . . . . . . 32.4 m-85 -132.72 117.56 18.0 Favored 'General case' 0 N--CA 1.463 0.214 0 CA-C-O 120.929 0.395 . . . . 0.0 110.599 -173.72 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' D' D ' 118' ' ' GLU . . . . . . . . . . . . . 46.5 tp10 -52.88 -50.96 62.79 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.296 -0.411 . . . . 0.0 111.393 -177.577 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' D' D ' 119' ' ' ASN . . . . . . . . . . . . . 79.4 m-20 -93.61 31.07 1.62 Allowed 'General case' 0 C--N 1.33 -0.27 0 N-CA-C 112.202 0.445 . . . . 0.0 112.202 -173.783 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' D' D ' 120' ' ' LEU . . . . . . . . . . . . . 20.2 tp -58.36 124.58 20.01 Favored 'General case' 0 C--N 1.332 -0.195 0 N-CA-C 110.075 -0.343 . . . . 0.0 110.075 177.474 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' D' D ' 121' ' ' ASN . . . . . . . . . . . . . 4.4 m-20 -114.03 -44.09 3.18 Favored 'General case' 0 C--N 1.331 -0.213 0 CA-C-N 116.56 -0.291 . . . . 0.0 110.963 -178.143 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' D' D ' 122' ' ' LYS . . . . . . . . . . . . . 85.1 mttt -146.45 149.98 34.74 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-O 121.156 0.503 . . . . 0.0 111.902 -176.414 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' D' D ' 123' ' ' VAL . . . . . . . . . . . . . 44.1 t -124.91 128.88 73.47 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.299 0 N-CA-C 109.211 -0.663 . . . . 0.0 109.211 172.873 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' D' D ' 124' ' ' LEU . . . . . . . . . . . . . 6.6 mp -121.89 135.96 54.91 Favored 'General case' 0 C--N 1.332 -0.176 0 CA-C-N 116.609 -0.269 . . . . 0.0 110.732 -176.273 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' D' D ' 125' ' ' VAL . . . . . . . . . . . . . 35.5 m -136.72 130.21 45.96 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.193 0 CA-C-O 120.955 0.407 . . . . 0.0 110.983 178.734 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' D' D ' 126' ' ' ARG . . . . . . . . . . . . . 95.2 mtt180 -151.69 130.19 12.19 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 115.911 -0.586 . . . . 0.0 109.802 176.901 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' D' D ' 127' ' ' ASN . . . . . . . . . . . . . 4.1 m120 56.6 -152.38 0.39 Allowed 'General case' 0 CA--C 1.539 0.536 0 N-CA-C 109.764 -0.458 . . . . 0.0 109.764 179.68 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' D' D ' 128' ' ' ASP . . . . . . . . . . . . . 15.4 p-10 -80.47 14.59 1.96 Allowed 'General case' 0 CA--C 1.536 0.423 0 N-CA-C 112.876 0.695 . . . . 0.0 112.876 178.662 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' D' D ' 129' ' ' LEU . . . . . . . . . . . . . 11.6 tp -114.17 132.63 56.02 Favored 'General case' 0 N--CA 1.46 0.045 0 CA-C-N 118.09 0.404 . . . . 0.0 109.911 179.049 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' D' D ' 130' ' ' VAL . . . . . . . . . . . . . 34.5 m -132.07 142.39 42.97 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.193 0 CA-C-O 121.086 0.469 . . . . 0.0 110.157 176.763 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' D' D ' 131' ' ' VAL . . . . . . . . . . . . . 34.4 m -136.14 148.79 27.41 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 CA-C-O 121.191 0.519 . . . . 0.0 111.21 -179.255 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' D' D ' 132' ' ' ILE . . . . . . . . . . . . . 75.2 mt -115.44 130.66 69.65 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.383 0 CA-C-N 115.4 -0.818 . . . . 0.0 109.024 178.307 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' D' D ' 133' ' ' ILE . . . . . . . . . . . . . 42.3 mm -115.27 115.2 48.66 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.197 0 CA-C-O 120.884 0.373 . . . . 0.0 110.753 -175.993 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' D' D ' 134' ' ' ASP . . . . . . . . . . . . . 6.1 p-10 -125.88 145.51 50.22 Favored 'General case' 0 C--N 1.333 -0.12 0 N-CA-C 109.371 -0.603 . . . . 0.0 109.371 174.95 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' D' D ' 135' ' ' GLU . . . . . . . . . . . . . 46.2 tp10 -49.75 -26.58 3.98 Favored 'General case' 0 C--N 1.327 -0.388 0 N-CA-C 112.761 0.652 . . . . 0.0 112.761 -169.318 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' D' D ' 136' ' ' GLN . . . . . . . . . . . . . 99.1 mm-40 -92.95 -39.74 10.97 Favored 'General case' 0 C--N 1.332 -0.179 0 N-CA-C 112.293 0.479 . . . . 0.0 112.293 -177.126 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' D' D ' 137' ' ' LYS . . . . . . . . . . . . . 28.0 mtpp -137.99 155.02 49.28 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-O 121.277 0.56 . . . . 0.0 111.698 -170.015 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' D' D ' 138' ' ' LEU . . . . . . . . . . . . . 5.3 tt -116.06 125.34 52.29 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 115.547 -0.752 . . . . 0.0 109.286 174.407 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' D' D ' 139' ' ' THR . . . . . . . . . . . . . 39.9 m -110.67 129.65 55.77 Favored 'General case' 0 C--N 1.332 -0.183 0 CA-C-N 116.406 -0.361 . . . . 0.0 110.993 -177.6 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' D' D ' 140' ' ' LEU . . . . . . . . . . . . . 6.5 tt -111.17 123.59 50.5 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 115.499 -0.773 . . . . 0.0 109.322 -179.502 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' D' D ' 141' ' ' ILE . . . . . . . . . . . . . 18.8 mt -125.36 118.38 52.4 Favored 'Isoleucine or valine' 0 C--O 1.234 0.255 0 CA-C-O 120.964 0.411 . . . . 0.0 110.404 -177.199 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' D' D ' 142' ' ' ARG . . . . . . . . . . . . . 15.9 mmt180 -102.91 122.75 45.19 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 115.425 -0.807 . . . . 0.0 109.777 175.079 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' D' D ' 143' ' ' THR . . . . . . . . . . . . . 2.5 p . . . . . 0 C--O 1.22 -0.487 0 CA-C-O 117.983 -1.008 . . . . 0.0 110.568 179.898 . . . . . . . . 0 0 . 1 . 018 nuclear orig full ' E' E ' -3' ' ' GLU . . . . . . . . . . . . . 95.8 mt-10 . . . . . 0 N--CA 1.489 1.52 0 N-CA-C 109.366 -0.605 . . . . 0.0 109.366 . . . . . . . . . 0 0 . 1 . 018 nuclear orig full ' E' E ' -2' ' ' GLY . . . . . . . . . . . . . . . -70.42 150.03 47.83 Favored Glycine 0 CA--C 1.526 0.719 0 N-CA-C 111.001 -0.84 . . . . 0.0 111.001 179.524 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' E' E ' -1' ' ' VAL . . . . . . . . . . . . . 48.1 t -94.91 138.91 19.7 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.29 0 N-CA-C 110.008 -0.367 . . . . 0.0 110.008 -179.897 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' E' E ' 0' ' ' ILE . . . . . . . . . . . . . 69.7 mt -106.33 140.78 23.34 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.23 0 CA-C-O 121.048 0.451 . . . . 0.0 110.276 -178.465 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' E' E ' 1' ' ' MET . . . . . . . . . . . . . 25.9 ptt? -78.34 135.35 37.46 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 115.804 -0.634 . . . . 0.0 111.083 -178.844 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' E' E ' 2' ' ' SER . . . . . . . . . . . . . 3.9 p -127.32 136.38 51.85 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.141 -0.481 . . . . 0.0 110.287 178.305 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' E' E ' 3' ' ' GLU . . . . . . . . . . . . . 30.4 tp10 -139.14 139.75 37.71 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.244 -0.435 . . . . 0.0 110.79 -176.215 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' E' E ' 4' ' ' LEU . . . . . . . . . . . . . 18.1 tp -126.01 130.79 51.88 Favored 'General case' 0 C--N 1.332 -0.184 0 N-CA-C 109.881 -0.415 . . . . 0.0 109.881 174.809 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' E' E ' 5' ' ' LYS . . . . . . . . . . . . . 99.3 mttt -116.33 123.98 48.99 Favored 'General case' 0 C--O 1.235 0.297 0 CA-C-O 120.734 0.302 . . . . 0.0 111.192 -178.236 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' E' E ' 6' ' ' LEU . . . . . . . . . . . . . 50.8 mt -113.98 147.11 39.14 Favored 'General case' 0 N--CA 1.461 0.117 0 CA-C-N 115.437 -0.801 . . . . 0.0 110.272 178.837 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' E' E ' 7' ' ' LYS . . . . . . . . . . . . . 82.2 tttt -129.37 141.02 40.36 Favored Pre-proline 0 CA--C 1.533 0.302 0 CA-C-O 119.137 -0.459 . . . . 0.0 109.883 175.031 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' E' E ' 8' ' ' PRO . . . . . . . . . . . . . 90.0 Cg_endo -91.84 146.17 3.13 Favored 'Trans proline' 0 N--CA 1.49 1.272 0 C-N-CA 121.916 1.744 . . . . 0.0 112.163 179.392 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' E' E ' 9' ' ' LEU . . . . . . . . . . . . . 37.1 mt -86.79 -49.23 0.48 Allowed Pre-proline 0 CA--C 1.535 0.376 0 CA-C-O 118.682 -0.675 . . . . 0.0 112.562 178.818 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' E' E ' 10' ' ' PRO . . . . . . . . . . . . . 97.2 Cg_endo -77.93 161.65 29.87 Favored 'Trans proline' 0 N--CA 1.497 1.725 0 C-N-CA 121.256 1.304 . . . . 0.0 112.444 -179.665 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' E' E ' 11' ' ' LYS . . . . . . . . . . . . . 25.1 tptp -86.93 95.44 9.9 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-N 116.231 -0.441 . . . . 0.0 110.085 177.536 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' E' E ' 12' ' ' VAL . . . . . . . . . . . . . 12.5 p -142.18 147.63 21.2 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 CA-C-N 116.313 -0.403 . . . . 0.0 110.838 -179.008 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' E' E ' 13' ' ' GLU . . . . . . . . . . . . . 95.9 mt-10 -93.81 122.6 36.45 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.029 -0.532 . . . . 0.0 110.128 177.507 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' E' E ' 14' ' ' LEU . . . . . . . . . . . . . 22.3 mt -97.65 151.26 37.51 Favored Pre-proline 0 CA--C 1.533 0.301 0 CA-C-O 119.329 -0.367 . . . . 0.0 110.464 -178.714 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' E' E ' 15' ' ' PRO . . . . . . . . . . . . . 37.8 Cg_exo -59.46 156.06 38.25 Favored 'Trans proline' 0 N--CA 1.498 1.775 0 C-N-CA 121.241 1.294 . . . . 0.0 111.835 178.391 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' E' E ' 16' ' ' PRO . . . . . . . . . . . . . 31.4 Cg_exo -56.83 -38.99 94.57 Favored 'Trans proline' 0 N--CA 1.497 1.711 0 C-N-CA 121.333 1.355 . . . . 0.0 112.475 -179.856 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' E' E ' 17' ' ' ASP . . . . . . . . . . . . . 23.1 p-10 -93.48 20.18 7.56 Favored 'General case' 0 C--N 1.329 -0.324 0 N-CA-C 112.665 0.617 . . . . 0.0 112.665 -178.242 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' E' E ' 18' ' ' PHE . . . . . . . . . . . . . 62.5 t80 -57.11 -41.6 79.28 Favored 'General case' 0 C--O 1.227 -0.101 0 O-C-N 122.051 -0.405 . . . . 0.0 110.308 -178.329 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' E' E ' 19' ' ' VAL . . . . . . . . . . . . . 52.2 t -54.91 -45.82 75.84 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.289 0 CA-C-N 116.396 -0.365 . . . . 0.0 110.815 -178.912 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' E' E ' 20' ' ' ASP . . . . . . . . . . . . . 80.8 m-20 -60.28 -41.4 93.25 Favored 'General case' 0 C--N 1.331 -0.222 0 C-N-CA 120.905 -0.318 . . . . 0.0 110.886 -178.165 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' E' E ' 21' ' ' VAL . . . . . . . . . . . . . 47.9 t -63.92 -47.15 91.89 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.306 0 C-N-CA 120.736 -0.386 . . . . 0.0 110.398 -177.931 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' E' E ' 22' ' ' ILE . . . . . . . . . . . . . 51.3 mm -57.18 -43.83 82.4 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.197 0 C-N-CA 120.856 -0.338 . . . . 0.0 110.529 179.158 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' E' E ' 23' ' ' ARG . . . . . . . . . . . . . 28.7 ttp180 -54.56 -48.24 72.3 Favored 'General case' 0 C--N 1.331 -0.201 0 C-N-CA 121.082 -0.247 . . . . 0.0 111.286 -179.472 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' E' E ' 24' ' ' ILE . . . . . . . . . . . . . 72.9 mt -58.52 -44.44 89.18 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.377 0 C-N-CA 120.959 -0.297 . . . . 0.0 110.708 -177.92 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' E' E ' 25' ' ' LYS . . . . . . . . . . . . . 24.5 mtpp -64.68 -44.01 91.71 Favored 'General case' 0 C--N 1.329 -0.291 0 N-CA-C 112.456 0.539 . . . . 0.0 112.456 -178.046 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' E' E ' 26' ' ' LEU . . . . . . . . . . . . . 79.1 mt -84.03 -25.29 30.02 Favored 'General case' 0 C--N 1.329 -0.289 0 N-CA-C 113.388 0.884 . . . . 0.0 113.388 -171.667 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' E' E ' 27' ' ' GLN . . . . . . . . . . . . . 6.1 pt20 -46.13 135.84 7.32 Favored 'General case' 0 N--CA 1.467 0.416 0 N-CA-C 112.757 0.651 . . . . 0.0 112.757 -174.41 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' E' E ' 28' ' ' GLY . . . . . . . . . . . . . . . 98.86 -22.3 41.67 Favored Glycine 0 CA--C 1.535 1.291 0 CA-C-N 115.792 -0.64 . . . . 0.0 112.516 -177.474 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' E' E ' 29' ' ' LYS . . . . . . . . . . . . . 8.2 mtpm? -97.53 155.08 17.11 Favored 'General case' 0 C--N 1.331 -0.2 0 CA-C-N 117.474 0.637 . . . . 0.0 110.925 179.523 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' E' E ' 30' ' ' THR . . . . . . . . . . . . . 22.3 m -109.77 139.27 45.02 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.337 177.115 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' E' E ' 31' ' ' VAL . . . . . . . . . . . . . 35.1 m -128.35 157.7 40.67 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.266 0 CA-C-N 116.254 -0.43 . . . . 0.0 110.505 -179.528 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' E' E ' 32' ' ' ARG . . . . . . . . . . . . . 53.0 ttp180 -132.21 150.92 52.04 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-O 121.198 0.523 . . . . 0.0 110.579 179.139 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' E' E ' 33' ' ' THR . . . . . . . . . . . . . 27.6 m -52.81 138.88 28.37 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.264 -0.425 . . . . 0.0 111.471 -177.812 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' E' E ' 34' ' ' GLY . . . . . . . . . . . . . . . 99.36 -17.23 58.1 Favored Glycine 0 CA--C 1.532 1.142 0 CA-C-N 116.151 -0.477 . . . . 0.0 113.2 179.087 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' E' E ' 35' ' ' ASP . . . . . . . . . . . . . 78.7 m-20 -67.46 149.39 50.27 Favored 'General case' 0 C--N 1.334 -0.085 0 CA-C-N 118.059 0.929 . . . . 0.0 111.204 178.539 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' E' E ' 36' ' ' VAL . . . . . . . . . . . . . 43.4 t -119.27 129.1 75.69 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.216 0 CA-C-N 115.945 -0.57 . . . . 0.0 109.582 176.785 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' E' E ' 37' ' ' ILE . . . . . . . . . . . . . 64.3 mt -118.19 138.35 49.19 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 CA-C-N 116.178 -0.464 . . . . 0.0 109.76 -178.967 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' E' E ' 38' ' ' GLY . . . . . . . . . . . . . . . -116.51 127.64 7.57 Favored Glycine 0 CA--C 1.523 0.567 0 N-CA-C 110.88 -0.888 . . . . 0.0 110.88 179.097 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' E' E ' 39' ' ' ILE . . . . . . . . . . . . . 72.0 mt -127.22 126.78 68.49 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.214 0 N-CA-C 110.136 -0.32 . . . . 0.0 110.136 179.135 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' E' E ' 40' ' ' SER . . . . . . . . . . . . . 53.8 p -92.52 122.41 34.93 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.374 -0.375 . . . . 0.0 110.826 176.632 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' E' E ' 41' ' ' ILE . . . . . . . . . . . . . 70.6 mt -132.22 130.55 60.64 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.228 0 CA-C-O 120.808 0.337 . . . . 0.0 110.22 177.502 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' E' E ' 42' ' ' LEU . . . . . . . . . . . . . 64.7 mt 56.87 32.94 22.32 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 116.144 -0.48 . . . . 0.0 111.959 178.176 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' E' E ' 43' ' ' GLY . . . . . . . . . . . . . . . 72.95 23.69 77.39 Favored Glycine 0 CA--C 1.531 1.039 0 C-N-CA 121.067 -0.587 . . . . 0.0 112.71 177.717 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' E' E ' 44' ' ' LYS . . . . . . . . . . . . . 99.4 mttt -138.66 128.65 25.34 Favored 'General case' 0 C--N 1.331 -0.206 0 CA-C-N 117.404 0.602 . . . . 0.0 109.861 178.051 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' E' E ' 45' ' ' GLU . . . . . . . . . . . . . 44.0 tp10 -85.55 132.36 34.2 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.42 -0.354 . . . . 0.0 111.539 -176.835 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' E' E ' 46' ' ' VAL . . . . . . . . . . . . . 8.8 p -121.92 127.93 75.52 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.186 0 N-CA-C 109.343 -0.614 . . . . 0.0 109.343 172.81 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' E' E ' 47' ' ' LYS . . . . . . . . . . . . . 55.4 mtmt -98.42 127.21 44.25 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.142 -0.481 . . . . 0.0 110.833 177.781 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' E' E ' 48' ' ' PHE . . . . . . . . . . . . . 43.0 m-85 -114.21 131.9 56.3 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 115.925 -0.58 . . . . 0.0 109.683 177.333 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' E' E ' 49' ' ' LYS . . . . . . . . . . . . . 75.8 tttt -105.81 134.81 48.33 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 116.417 -0.356 . . . . 0.0 110.102 178.483 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' E' E ' 50' ' ' VAL . . . . . . . . . . . . . 45.8 t -78.7 107.15 10.64 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.339 0 N-CA-C 109.245 -0.65 . . . . 0.0 109.245 177.752 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' E' E ' 51' ' ' VAL . . . . . . . . . . . . . 48.4 t -73.56 -51.11 26.43 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.316 0 CA-C-N 116.152 -0.476 . . . . 0.0 109.769 -174.567 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' E' E ' 52' ' ' GLN . . . . . . . . . . . . . 90.4 mt-30 -152.77 149.61 28.53 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-O 121.249 0.547 . . . . 0.0 111.963 -177.803 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' E' E ' 53' ' ' ALA . . . . . . . . . . . . . . . -130.46 130.63 44.48 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 114.978 -1.01 . . . . 0.0 109.243 173.143 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' E' E ' 54' ' ' TYR . . . . . . . . . . . . . 6.9 t80 -129.14 109.33 18.03 Favored Pre-proline 0 CA--C 1.534 0.361 0 CA-C-O 118.203 -0.903 . . . . 0.0 110.138 179.011 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' E' E ' 55' ' ' PRO . . . . . . . . . . . . . 74.1 Cg_endo -77.07 170.08 72.61 Favored 'Cis proline' 0 N--CA 1.5 1.895 0 CA-C-N 122.012 1.754 . . . . 0.0 112.593 -4.795 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' E' E ' 56' ' ' SER . . . . . . . . . . . . . 13.6 m -116.39 132.67 23.2 Favored Pre-proline 0 CA--C 1.539 0.546 0 CA-C-O 118.359 -0.829 . . . . 0.0 109.579 176.058 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' E' E ' 57' ' ' PRO . . . . . . . . . . . . . 48.3 Cg_endo -70.57 165.34 79.21 Favored 'Cis proline' 0 N--CA 1.496 1.663 0 CA-C-N 121.975 1.741 . . . . 0.0 111.536 -2.572 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' E' E ' 58' ' ' LEU . . . . . . . . . . . . . 22.5 tp -129.9 138.19 50.79 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.2 -0.455 . . . . 0.0 110.273 -179.563 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' E' E ' 59' ' ' ARG . . . . . . . . . . . . . 53.9 ttp180 -105.83 136.24 45.83 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-N 115.924 -0.58 . . . . 0.0 109.463 176.684 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' E' E ' 60' ' ' VAL . . . . . . . . . . . . . 39.9 t -89.62 116.34 30.88 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.264 0 CA-C-O 121.04 0.448 . . . . 0.0 110.638 -175.172 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' E' E ' 61' ' ' GLU . . . . . . . . . . . . . 95.6 mt-10 -131.05 173.28 11.16 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 115.552 -0.749 . . . . 0.0 109.455 175.501 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' E' E ' 62' ' ' ASP . . . . . . . . . . . . . 58.8 m-20 -53.72 -33.96 57.33 Favored 'General case' 0 C--N 1.328 -0.347 0 N-CA-C 111.778 0.288 . . . . 0.0 111.778 -178.821 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' E' E ' 63' ' ' ARG . . . . . . . . . . . . . 26.2 mmm180 -76.57 -17.81 59.01 Favored 'General case' 0 CA--C 1.533 0.317 0 N-CA-C 113.224 0.824 . . . . 0.0 113.224 -176.28 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' E' E ' 64' ' ' THR . . . . . . . . . . . . . 19.0 m -68.95 136.16 52.11 Favored 'General case' 0 C--N 1.331 -0.208 0 CA-C-O 120.896 0.379 . . . . 0.0 110.707 -174.919 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' E' E ' 65' ' ' LYS . . . . . . . . . . . . . 43.4 mtpt -90.06 122.33 32.95 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.098 -0.501 . . . . 0.0 109.9 179.946 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' E' E ' 66' ' ' ILE . . . . . . . . . . . . . 62.3 mt -113.83 131.95 64.23 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.234 0 CA-C-O 120.896 0.379 . . . . 0.0 110.35 -176.975 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' E' E ' 67' ' ' THR . . . . . . . . . . . . . 41.4 m -126.84 139.42 53.1 Favored 'General case' 0 C--O 1.234 0.24 0 CA-C-N 115.923 -0.58 . . . . 0.0 110.59 179.137 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' E' E ' 68' ' ' LEU . . . . . . . . . . . . . 5.4 tt -107.05 124.25 49.38 Favored 'General case' 0 C--N 1.327 -0.397 0 CA-C-N 115.787 -0.642 . . . . 0.0 109.894 177.461 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' E' E ' 69' ' ' VAL . . . . . . . . . . . . . 44.2 t -99.95 129.46 50.57 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.379 0 N-CA-C 109.644 -0.502 . . . . 0.0 109.644 -179.251 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' E' E ' 70' ' ' THR . . . . . . . . . . . . . 7.5 t -145.71 115.92 7.47 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-O 121.191 0.519 . . . . 0.0 111.167 -178.76 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' E' E ' 71' ' ' HIS . . . . . . . . . . . . . 17.4 t-80 -144.8 66.27 13.04 Favored Pre-proline 0 CA--C 1.534 0.363 0 CA-C-N 115.886 -0.597 . . . . 0.0 110.205 176.063 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' E' E ' 72' ' ' PRO . . . . . . . . . . . . . 73.5 Cg_endo -94.6 158.06 1.93 Allowed 'Trans proline' 0 N--CA 1.487 1.131 0 C-N-CA 122.154 1.902 . . . . 0.0 112.516 -178.724 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' E' E ' 73' ' ' VAL . . . . . . . . . . . . . 35.1 m -70.04 156.54 7.09 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.302 0 CA-C-N 116.1 -0.5 . . . . 0.0 109.882 176.487 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' E' E ' 74' ' ' ASP . . . . . . . . . . . . . 19.5 t0 -95.41 115.05 26.89 Favored 'General case' 0 C--N 1.332 -0.191 0 N-CA-C 109.764 -0.458 . . . . 0.0 109.764 -178.493 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' E' E ' 75' ' ' VAL . . . . . . . . . . . . . 38.4 t -118.6 126.39 75.14 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.218 0 CA-C-O 121.0 0.428 . . . . 0.0 110.655 -176.547 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' E' E ' 76' ' ' LEU . . . . . . . . . . . . . 5.8 mp -127.32 147.48 50.25 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 115.646 -0.707 . . . . 0.0 109.863 177.125 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' E' E ' 77' ' ' GLU . . . . . . . . . . . . . 96.3 mt-10 -134.21 133.33 40.77 Favored 'General case' 0 C--N 1.332 -0.19 0 CA-C-O 121.078 0.466 . . . . 0.0 111.27 -178.748 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' E' E ' 78' ' ' ALA . . . . . . . . . . . . . . . -122.3 141.29 51.68 Favored 'General case' 0 C--N 1.331 -0.221 0 CA-C-N 115.7 -0.682 . . . . 0.0 109.739 176.347 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' E' E ' 79' ' ' LYS . . . . . . . . . . . . . 82.3 tttt -84.5 117.51 23.73 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-O 120.889 0.376 . . . . 0.0 110.641 -178.262 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' E' E ' 80' ' ' ILE . . . . . . . . . . . . . 42.9 mm -137.95 110.74 7.15 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.381 0 N-CA-C 108.953 -0.758 . . . . 0.0 108.953 -178.858 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' E' E ' 81' ' ' LYS . . . . . . . . . . . . . 55.3 pttt -100.18 125.91 46.38 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-O 120.895 0.378 . . . . 0.0 111.336 -176.589 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' E' E ' 82' ' ' GLY . . . . . . . . . . . . . . . 87.85 42.17 6.11 Favored Glycine 0 CA--C 1.525 0.683 0 C-N-CA 120.825 -0.702 . . . . 0.0 111.714 175.072 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' E' E ' 83' ' ' ILE . . . . . . . . . . . . . 73.4 mt -66.77 127.35 28.07 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.271 0 N-CA-C 109.508 -0.552 . . . . 0.0 109.508 177.548 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' E' E ' 84' ' ' LYS . . . . . . . . . . . . . 59.8 tttt -82.58 -48.44 10.97 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 115.928 -0.578 . . . . 0.0 110.145 -178.25 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' E' E ' 85' ' ' ASP . . . . . . . . . . . . . 33.2 t0 -163.94 159.03 20.4 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 115.851 -0.613 . . . . 0.0 110.653 179.022 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' E' E ' 86' ' ' VAL . . . . . . . . . . . . . 43.2 t -129.33 136.25 59.86 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.27 0 CA-C-O 121.031 0.443 . . . . 0.0 110.55 -179.606 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' E' E ' 87' ' ' ILE . . . . . . . . . . . . . 44.0 mm -123.18 128.55 75.01 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.227 0 CA-C-N 115.821 -0.627 . . . . 0.0 109.685 176.605 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' E' E ' 88' ' ' LEU . . . . . . . . . . . . . 17.4 tp -111.89 133.84 53.83 Favored 'General case' 0 N--CA 1.464 0.227 0 CA-C-O 121.052 0.453 . . . . 0.0 111.43 -175.539 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' E' E ' 89' ' ' ASP . . . . . . . . . . . . . 13.8 t70 -125.66 157.49 37.13 Favored 'General case' 0 C--N 1.331 -0.222 0 CA-C-N 115.688 -0.687 . . . . 0.0 109.679 176.252 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' E' E ' 90' ' ' GLU . . . . . . . . . . . . . 84.1 tt0 -45.56 -42.71 11.31 Favored 'General case' 0 N--CA 1.465 0.314 0 N-CA-C 113.087 0.773 . . . . 0.0 113.087 -171.632 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' E' E ' 91' ' ' ASN . . . . . . . . . . . . . 3.3 t-20 -132.16 25.78 4.55 Favored 'General case' 0 N--CA 1.468 0.446 0 N-CA-C 112.464 0.542 . . . . 0.0 112.464 -178.703 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' E' E ' 92' ' ' LEU . . . . . . . . . . . . . 28.5 mt -149.34 145.22 26.9 Favored 'General case' 0 C--N 1.331 -0.213 0 CA-C-O 120.721 0.296 . . . . 0.0 110.202 -177.376 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' E' E ' 93' ' ' ILE . . . . . . . . . . . . . 66.0 mt -123.71 121.12 61.64 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.292 0 N-CA-C 109.327 -0.62 . . . . 0.0 109.327 178.798 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' E' E ' 94' ' ' VAL . . . . . . . . . . . . . 46.8 t -117.52 126.67 74.82 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.282 0 N-CA-C 109.655 -0.498 . . . . 0.0 109.655 179.956 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' E' E ' 95' ' ' VAL . . . . . . . . . . . . . 38.8 t -121.47 134.15 65.73 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.331 0 CA-C-N 116.102 -0.499 . . . . 0.0 109.731 -178.872 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' E' E ' 96' ' ' ILE . . . . . . . . . . . . . 65.3 mt -113.81 127.07 71.36 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.33 0 N-CA-C 109.267 -0.642 . . . . 0.0 109.267 178.674 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' E' E ' 97' ' ' THR . . . . . . . . . . . . . 68.5 p -98.09 152.38 19.38 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-O 121.108 0.48 . . . . 0.0 111.102 -178.311 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' E' E ' 98' ' ' GLU . . . . . . . . . . . . . 85.0 tt0 -53.95 -23.44 13.08 Favored 'General case' 0 CA--C 1.535 0.377 0 N-CA-C 112.313 0.486 . . . . 0.0 112.313 179.738 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' E' E ' 99' ' ' GLU . . . . . . . . . . . . . 36.6 tt0 -80.94 18.08 1.08 Allowed 'General case' 0 CA--C 1.54 0.571 0 N-CA-C 112.5 0.556 . . . . 0.0 112.5 -177.012 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' E' E ' 100' ' ' ASN . . . . . . . . . . . . . 2.5 m-20 61.54 37.92 16.02 Favored 'General case' 0 CA--C 1.53 0.206 0 O-C-N 121.869 -0.519 . . . . 0.0 110.997 178.365 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' E' E ' 101' ' ' GLU . . . . . . . . . . . . . 85.1 tt0 -119.71 140.71 50.25 Favored 'General case' 0 C--N 1.332 -0.19 0 CA-C-N 116.099 -0.5 . . . . 0.0 109.66 176.703 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' E' E ' 102' ' ' VAL . . . . . . . . . . . . . 41.7 t -115.58 127.86 73.01 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.257 0 N-CA-C 109.732 -0.47 . . . . 0.0 109.732 -177.581 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' E' E ' 103' ' ' LEU . . . . . . . . . . . . . 5.0 mp -124.1 137.94 54.5 Favored 'General case' 0 C--N 1.331 -0.216 0 CA-C-N 116.33 -0.396 . . . . 0.0 110.607 177.506 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' E' E ' 104' ' ' ILE . . . . . . . . . . . . . 64.3 mt -117.63 126.3 74.63 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.274 0 CA-C-N 115.892 -0.594 . . . . 0.0 109.927 -178.893 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' E' E ' 105' ' ' PHE . . . . . . . . . . . . . 98.9 m-85 -120.86 161.35 21.69 Favored 'General case' 0 C--N 1.332 -0.18 0 O-C-N 124.046 0.841 . . . . 0.0 110.275 -179.008 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' E' E ' 106' ' ' ASN . . . . . . . . . . . . . 43.6 p-10 -99.0 -169.8 1.83 Allowed 'General case' 0 CA--C 1.532 0.284 0 CA-C-N 116.351 -0.386 . . . . 0.0 110.123 175.128 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' E' E ' 107' ' ' GLN . . . . . . . . . . . . . 20.4 tt0 -56.33 -30.05 62.1 Favored 'General case' 0 C--N 1.329 -0.303 0 N-CA-C 111.811 0.3 . . . . 0.0 111.811 179.732 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' E' E ' 108' ' ' ASN . . . . . . . . . . . . . 13.1 t30 -90.72 14.1 14.36 Favored 'General case' 0 CA--C 1.535 0.396 0 N-CA-C 113.197 0.814 . . . . 0.0 113.197 -175.889 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' E' E ' 109' ' ' LEU . . . . . . . . . . . . . 11.0 tp 54.88 36.0 25.64 Favored 'General case' 0 C--N 1.332 -0.191 0 CA-C-O 120.829 0.347 . . . . 0.0 111.506 178.501 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' E' E ' 110' ' ' GLU . . . . . . . . . . . . . 70.6 mm-40 -101.29 151.33 22.02 Favored 'General case' 0 C--N 1.33 -0.271 0 N-CA-C 109.808 -0.442 . . . . 0.0 109.808 176.514 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' E' E ' 111' ' ' GLU . . . . . . . . . . . . . 44.0 tp10 -78.52 122.03 25.35 Favored 'General case' 0 C--N 1.329 -0.296 0 C-N-CA 120.698 -0.401 . . . . 0.0 110.825 -176.901 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' E' E ' 112' ' ' LEU . . . . . . . . . . . . . 15.3 mt -110.58 -45.97 3.45 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.115 -0.493 . . . . 0.0 110.428 177.837 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' E' E ' 113' ' ' TYR . . . . . . . . . . . . . 55.7 t80 -137.27 137.22 38.8 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 116.402 -0.363 . . . . 0.0 110.862 -179.585 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' E' E ' 114' ' ' ARG . . . . . . . . . . . . . 56.0 ttp180 -143.45 119.71 10.85 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.422 -0.354 . . . . 0.0 110.413 179.03 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' E' E ' 115' ' ' GLY . . . . . . . . . . . . . . . -150.16 153.75 25.26 Favored Glycine 0 CA--C 1.525 0.704 0 N-CA-C 111.075 -0.81 . . . . 0.0 111.075 178.376 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' E' E ' 116' ' ' LYS . . . . . . . . . . . . . 27.5 ttpp -116.97 143.7 45.42 Favored 'General case' 0 C--N 1.33 -0.262 0 N-CA-C 109.955 -0.387 . . . . 0.0 109.955 177.662 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' E' E ' 117' ' ' PHE . . . . . . . . . . . . . 51.2 m-85 -139.19 114.63 9.78 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-O 120.935 0.397 . . . . 0.0 110.204 -178.24 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' E' E ' 118' ' ' GLU . . . . . . . . . . . . . 95.6 mt-10 -53.61 -50.15 66.28 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.472 -0.331 . . . . 0.0 111.411 -175.558 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' E' E ' 119' ' ' ASN . . . . . . . . . . . . . 2.6 m120 -93.63 31.02 1.63 Allowed 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.192 -0.458 . . . . 0.0 112.158 -175.222 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' E' E ' 120' ' ' LEU . . . . . . . . . . . . . 16.2 tp -57.11 122.89 13.46 Favored 'General case' 0 C--N 1.333 -0.14 0 CA-C-O 120.721 0.296 . . . . 0.0 110.277 178.563 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' E' E ' 121' ' ' ASN . . . . . . . . . . . . . 13.7 m120 -112.13 -44.17 3.45 Favored 'General case' 0 C--N 1.332 -0.185 0 CA-C-N 116.395 -0.366 . . . . 0.0 110.991 -177.183 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' E' E ' 122' ' ' LYS . . . . . . . . . . . . . 80.2 mttt -146.2 145.7 30.53 Favored 'General case' 0 C--N 1.332 -0.194 0 C-N-CA 120.575 -0.45 . . . . 0.0 111.832 -177.282 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' E' E ' 123' ' ' VAL . . . . . . . . . . . . . 46.9 t -127.89 123.83 61.66 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.291 0 N-CA-C 108.883 -0.784 . . . . 0.0 108.883 171.96 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' E' E ' 124' ' ' LEU . . . . . . . . . . . . . 69.0 mt -132.66 145.9 51.44 Favored 'General case' 0 C--N 1.331 -0.2 0 CA-C-O 121.048 0.451 . . . . 0.0 111.492 -175.036 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' E' E ' 125' ' ' VAL . . . . . . . . . . . . . 11.9 p -135.17 137.41 50.33 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.238 0 CA-C-N 115.834 -0.621 . . . . 0.0 110.395 178.915 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' E' E ' 126' ' ' ARG . . . . . . . . . . . . . 25.3 mmt180 -140.35 124.64 17.73 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 115.976 -0.556 . . . . 0.0 110.206 178.605 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' E' E ' 127' ' ' ASN . . . . . . . . . . . . . 14.9 m-80 51.4 -106.67 0.27 Allowed 'General case' 0 CA--C 1.543 0.695 0 CA-C-O 118.976 -0.535 . . . . 0.0 111.36 179.739 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' E' E ' 128' ' ' ASP . . . . . . . . . . . . . 14.8 p-10 -114.07 5.93 16.21 Favored 'General case' 0 N--CA 1.468 0.43 0 CA-C-N 119.723 1.147 . . . . 0.0 113.468 -176.948 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' E' E ' 129' ' ' LEU . . . . . . . . . . . . . 15.8 tp -111.56 134.5 53.09 Favored 'General case' 0 C--N 1.333 -0.138 0 CA-C-N 118.261 0.482 . . . . 0.0 110.472 -179.492 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' E' E ' 130' ' ' VAL . . . . . . . . . . . . . 45.0 t -118.66 134.84 60.99 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.183 0 N-CA-C 109.523 -0.547 . . . . 0.0 109.523 178.657 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' E' E ' 131' ' ' VAL . . . . . . . . . . . . . 39.4 t -136.05 141.01 42.87 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.258 0 CA-C-O 121.119 0.485 . . . . 0.0 110.704 -178.525 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' E' E ' 132' ' ' ILE . . . . . . . . . . . . . 71.5 mt -117.96 132.54 67.5 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.279 0 CA-C-N 115.457 -0.792 . . . . 0.0 109.413 178.669 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' E' E ' 133' ' ' ILE . . . . . . . . . . . . . 44.0 mm -115.8 121.97 68.5 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.246 0 CA-C-O 120.747 0.308 . . . . 0.0 110.675 -176.769 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' E' E ' 134' ' ' ASP . . . . . . . . . . . . . 7.3 p-10 -134.37 149.68 50.84 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.02 -0.536 . . . . 0.0 109.795 175.47 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' E' E ' 135' ' ' GLU . . . . . . . . . . . . . 42.9 tp10 -49.78 -26.71 4.13 Favored 'General case' 0 C--N 1.327 -0.383 0 N-CA-C 112.85 0.685 . . . . 0.0 112.85 -170.442 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' E' E ' 136' ' ' GLN . . . . . . . . . . . . . 55.3 mt-30 -102.78 -25.67 13.43 Favored 'General case' 0 N--CA 1.466 0.367 0 N-CA-C 112.888 0.699 . . . . 0.0 112.888 -174.532 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' E' E ' 137' ' ' LYS . . . . . . . . . . . . . 82.7 mttt -143.21 153.31 42.7 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-O 121.23 0.538 . . . . 0.0 111.714 -170.239 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' E' E ' 138' ' ' LEU . . . . . . . . . . . . . 5.8 tt -118.29 121.15 39.7 Favored 'General case' 0 C--N 1.328 -0.352 0 N-CA-C 108.744 -0.836 . . . . 0.0 108.744 171.667 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' E' E ' 139' ' ' THR . . . . . . . . . . . . . 23.8 m -109.27 128.19 54.88 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.452 -0.34 . . . . 0.0 110.54 -176.344 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' E' E ' 140' ' ' LEU . . . . . . . . . . . . . 7.1 tt -114.37 122.12 45.69 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 115.724 -0.671 . . . . 0.0 109.494 -178.835 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' E' E ' 141' ' ' ILE . . . . . . . . . . . . . 19.1 mt -122.84 116.81 49.9 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.288 0 N-CA-C 109.601 -0.518 . . . . 0.0 109.601 -176.897 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' E' E ' 142' ' ' ARG . . . . . . . . . . . . . 71.5 ttt180 -101.52 120.67 40.67 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 115.671 -0.695 . . . . 0.0 110.458 -179.107 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' E' E ' 143' ' ' THR . . . . . . . . . . . . . 16.4 p . . . . . 0 C--O 1.22 -0.472 0 CA-C-O 118.009 -0.996 . . . . 0.0 110.469 179.678 . . . . . . . . 0 0 . 1 . 018 nuclear orig full ' F' F ' -3' ' ' GLU . . . . . . . . . . . . . 70.5 mm-40 . . . . . 0 N--CA 1.49 1.574 0 N-CA-C 109.467 -0.568 . . . . 0.0 109.467 . . . . . . . . . 0 0 . 1 . 018 nuclear orig full ' F' F ' -2' ' ' GLY . . . . . . . . . . . . . . . -75.39 149.95 39.55 Favored Glycine 0 CA--C 1.527 0.806 0 N-CA-C 111.04 -0.824 . . . . 0.0 111.04 179.953 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' F' F ' -1' ' ' VAL . . . . . . . . . . . . . 43.9 t -88.41 126.26 41.69 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.292 0 N-CA-C 109.871 -0.418 . . . . 0.0 109.871 179.742 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' F' F ' 0' ' ' ILE . . . . . . . . . . . . . 70.8 mt -122.65 130.62 74.37 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.229 0 CA-C-N 116.264 -0.426 . . . . 0.0 110.268 -177.971 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' F' F ' 1' ' ' MET . . . . . . . . . . . . . 25.5 ptp -95.77 149.42 21.52 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.054 -0.521 . . . . 0.0 110.371 177.642 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' F' F ' 2' ' ' SER . . . . . . . . . . . . . 4.9 p -124.28 132.8 53.59 Favored 'General case' 0 C--N 1.332 -0.188 0 CA-C-O 120.908 0.385 . . . . 0.0 110.803 179.754 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' F' F ' 3' ' ' GLU . . . . . . . . . . . . . 85.2 tt0 -142.61 140.38 31.64 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.155 -0.475 . . . . 0.0 111.225 -179.119 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' F' F ' 4' ' ' LEU . . . . . . . . . . . . . 14.9 tp -125.55 135.09 51.88 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.03 -0.532 . . . . 0.0 110.049 177.163 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' F' F ' 5' ' ' LYS . . . . . . . . . . . . . 69.0 mttm -112.43 120.73 42.65 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.237 -0.438 . . . . 0.0 110.58 178.764 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' F' F ' 6' ' ' LEU . . . . . . . . . . . . . 73.4 mt -114.93 146.06 41.56 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 115.294 -0.866 . . . . 0.0 110.043 -179.968 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' F' F ' 7' ' ' LYS . . . . . . . . . . . . . 53.4 tttm -133.88 140.2 35.71 Favored Pre-proline 0 CA--C 1.534 0.334 0 CA-C-O 119.115 -0.469 . . . . 0.0 110.245 177.576 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' F' F ' 8' ' ' PRO . . . . . . . . . . . . . 94.4 Cg_endo -91.95 139.07 2.07 Favored 'Trans proline' 0 N--CA 1.489 1.22 0 C-N-CA 121.668 1.578 . . . . 0.0 111.537 176.798 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' F' F ' 9' ' ' LEU . . . . . . . . . . . . . 56.5 mt -71.57 -47.9 12.46 Favored Pre-proline 0 C--N 1.329 -0.315 0 CA-C-O 118.613 -0.708 . . . . 0.0 112.176 -178.889 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' F' F ' 10' ' ' PRO . . . . . . . . . . . . . 97.4 Cg_endo -79.46 157.9 25.55 Favored 'Trans proline' 0 N--CA 1.495 1.616 0 C-N-CA 121.197 1.264 . . . . 0.0 112.291 177.061 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' F' F ' 11' ' ' LYS . . . . . . . . . . . . . 6.6 tmtm? -87.21 97.28 10.68 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.256 178.756 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' F' F ' 12' ' ' VAL . . . . . . . . . . . . . 13.0 p -143.63 146.62 20.93 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.23 0 CA-C-N 116.301 -0.408 . . . . 0.0 110.778 179.607 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' F' F ' 13' ' ' GLU . . . . . . . . . . . . . 94.5 mt-10 -82.71 135.12 35.1 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.079 -0.509 . . . . 0.0 110.256 178.23 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' F' F ' 14' ' ' LEU . . . . . . . . . . . . . 15.2 mt -98.18 141.59 23.21 Favored Pre-proline 0 CA--C 1.534 0.328 0 CA-C-O 118.887 -0.578 . . . . 0.0 110.099 179.536 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' F' F ' 15' ' ' PRO . . . . . . . . . . . . . 26.0 Cg_exo -62.24 159.92 33.09 Favored 'Trans proline' 0 N--CA 1.496 1.658 0 C-N-CA 121.297 1.331 . . . . 0.0 111.711 176.113 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' F' F ' 16' ' ' PRO . . . . . . . . . . . . . 39.6 Cg_exo -58.42 -41.23 67.64 Favored 'Trans proline' 0 N--CA 1.496 1.657 0 C-N-CA 121.499 1.466 . . . . 0.0 112.907 -177.313 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' F' F ' 17' ' ' ASP . . . . . . . . . . . . . 24.2 p-10 -84.71 6.99 22.06 Favored 'General case' 0 CA--C 1.538 0.498 0 N-CA-C 113.261 0.837 . . . . 0.0 113.261 -177.38 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' F' F ' 18' ' ' PHE . . . . . . . . . . . . . 41.2 t80 -57.83 -45.72 85.78 Favored 'General case' 0 C--N 1.334 -0.099 0 O-C-N 122.012 -0.43 . . . . 0.0 110.161 -177.798 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' F' F ' 19' ' ' VAL . . . . . . . . . . . . . 48.7 t -56.71 -44.37 81.28 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.304 0 CA-C-N 116.298 -0.41 . . . . 0.0 110.559 -178.101 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' F' F ' 20' ' ' ASP . . . . . . . . . . . . . 29.2 m-20 -59.67 -42.06 92.01 Favored 'General case' 0 C--N 1.329 -0.296 0 C-N-CA 120.896 -0.322 . . . . 0.0 111.089 -177.711 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' F' F ' 21' ' ' VAL . . . . . . . . . . . . . 46.9 t -63.48 -45.63 97.34 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.285 0 C-N-CA 120.824 -0.35 . . . . 0.0 110.17 -177.738 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' F' F ' 22' ' ' ILE . . . . . . . . . . . . . 51.7 mm -55.56 -48.2 77.73 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 C-N-CA 121.085 -0.246 . . . . 0.0 110.679 178.568 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' F' F ' 23' ' ' ARG . . . . . . . . . . . . . 41.5 ttp180 -54.97 -47.46 74.53 Favored 'General case' 0 C--N 1.328 -0.339 0 C-N-CA 121.074 -0.25 . . . . 0.0 111.395 -177.937 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' F' F ' 24' ' ' ILE . . . . . . . . . . . . . 82.5 mt -58.8 -45.72 91.25 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.29 0 C-N-CA 121.144 -0.222 . . . . 0.0 111.341 -177.442 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' F' F ' 25' ' ' LYS . . . . . . . . . . . . . 93.0 mttt -67.78 -42.68 81.3 Favored 'General case' 0 C--N 1.328 -0.333 0 N-CA-C 112.538 0.57 . . . . 0.0 112.538 -177.56 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' F' F ' 26' ' ' LEU . . . . . . . . . . . . . 94.6 mt -77.68 -37.76 49.0 Favored 'General case' 0 C--N 1.329 -0.287 0 N-CA-C 113.288 0.848 . . . . 0.0 113.288 -170.128 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' F' F ' 27' ' ' GLN . . . . . . . . . . . . . 10.3 pt20 -47.19 137.95 7.49 Favored 'General case' 0 N--CA 1.468 0.451 0 N-CA-C 112.698 0.629 . . . . 0.0 112.698 -174.917 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' F' F ' 28' ' ' GLY . . . . . . . . . . . . . . . 100.77 -26.21 25.47 Favored Glycine 0 CA--C 1.533 1.184 0 CA-C-N 115.533 -0.758 . . . . 0.0 112.26 -177.435 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' F' F ' 29' ' ' LYS . . . . . . . . . . . . . 91.4 mttt -97.79 155.06 17.21 Favored 'General case' 0 C--N 1.332 -0.167 0 CA-C-N 117.375 0.588 . . . . 0.0 110.946 178.101 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' F' F ' 30' ' ' THR . . . . . . . . . . . . . 26.2 m -106.06 138.44 42.25 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.006 -0.543 . . . . 0.0 110.152 177.244 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' F' F ' 31' ' ' VAL . . . . . . . . . . . . . 34.1 m -128.64 157.1 41.34 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.267 0 CA-C-N 116.343 -0.39 . . . . 0.0 110.722 -178.792 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' F' F ' 32' ' ' ARG . . . . . . . . . . . . . 98.6 mtt180 -130.15 150.28 51.48 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-O 121.243 0.544 . . . . 0.0 110.654 177.824 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' F' F ' 33' ' ' THR . . . . . . . . . . . . . 15.2 m -53.66 138.34 35.09 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.217 -0.447 . . . . 0.0 111.187 -178.787 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' F' F ' 34' ' ' GLY . . . . . . . . . . . . . . . 100.88 -17.05 56.91 Favored Glycine 0 CA--C 1.532 1.15 0 CA-C-O 119.614 -0.548 . . . . 0.0 113.287 179.381 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' F' F ' 35' ' ' ASP . . . . . . . . . . . . . 73.5 m-20 -65.25 149.43 49.95 Favored 'General case' 0 C--O 1.231 0.13 0 CA-C-N 118.049 0.924 . . . . 0.0 111.264 179.49 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' F' F ' 36' ' ' VAL . . . . . . . . . . . . . 46.6 t -123.13 131.91 72.36 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.171 0 CA-C-N 115.88 -0.6 . . . . 0.0 110.038 178.884 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' F' F ' 37' ' ' ILE . . . . . . . . . . . . . 67.5 mt -123.67 142.66 39.58 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.28 0 CA-C-N 116.156 -0.475 . . . . 0.0 109.811 -179.959 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' F' F ' 38' ' ' GLY . . . . . . . . . . . . . . . -113.09 128.78 8.56 Favored Glycine 0 CA--C 1.527 0.791 0 N-CA-C 111.335 -0.706 . . . . 0.0 111.335 -179.574 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' F' F ' 39' ' ' ILE . . . . . . . . . . . . . 72.0 mt -126.61 127.3 70.1 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.18 0 N-CA-C 109.829 -0.434 . . . . 0.0 109.829 177.862 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' F' F ' 40' ' ' SER . . . . . . . . . . . . . 42.3 t -93.42 116.43 28.97 Favored 'General case' 0 C--N 1.329 -0.29 0 C-N-CA 120.918 -0.313 . . . . 0.0 110.836 175.815 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' F' F ' 41' ' ' ILE . . . . . . . . . . . . . 44.2 mm -122.78 121.91 64.55 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.188 0 CA-C-O 120.934 0.397 . . . . 0.0 110.362 179.853 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' F' F ' 42' ' ' LEU . . . . . . . . . . . . . 1.3 tt 54.94 46.44 24.37 Favored 'General case' 0 C--N 1.331 -0.211 0 CA-C-O 121.366 0.603 . . . . 0.0 110.686 177.118 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' F' F ' 43' ' ' GLY . . . . . . . . . . . . . . . 70.5 10.05 65.99 Favored Glycine 0 CA--C 1.534 1.259 0 C-N-CA 121.232 -0.509 . . . . 0.0 113.32 174.522 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' F' F ' 44' ' ' LYS . . . . . . . . . . . . . 43.1 tptt -124.83 127.18 46.76 Favored 'General case' 0 C--N 1.333 -0.146 0 CA-C-N 117.986 0.893 . . . . 0.0 109.767 -178.715 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' F' F ' 45' ' ' GLU . . . . . . . . . . . . . 36.9 tp10 -83.43 127.43 33.68 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-O 120.875 0.369 . . . . 0.0 110.943 -177.148 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' F' F ' 46' ' ' VAL . . . . . . . . . . . . . 7.5 p -124.32 130.59 73.59 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.194 0 N-CA-C 109.491 -0.559 . . . . 0.0 109.491 176.191 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' F' F ' 47' ' ' LYS . . . . . . . . . . . . . 30.0 mtpp -100.7 131.21 46.71 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.054 -0.521 . . . . 0.0 111.221 178.292 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' F' F ' 48' ' ' PHE . . . . . . . . . . . . . 89.1 m-85 -113.26 131.91 55.73 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.242 -0.435 . . . . 0.0 110.367 178.118 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' F' F ' 49' ' ' LYS . . . . . . . . . . . . . 82.1 tttt -107.31 137.21 45.78 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.169 -0.469 . . . . 0.0 110.412 178.492 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' F' F ' 50' ' ' VAL . . . . . . . . . . . . . 47.6 t -80.32 106.89 12.08 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.316 0 N-CA-C 109.138 -0.689 . . . . 0.0 109.138 175.061 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' F' F ' 51' ' ' VAL . . . . . . . . . . . . . 55.2 t -70.51 -48.22 60.58 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.286 0 CA-C-N 116.114 -0.494 . . . . 0.0 109.932 -173.373 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' F' F ' 52' ' ' GLN . . . . . . . . . . . . . 21.4 pt20 -164.64 158.92 18.42 Favored 'General case' 0 C--N 1.331 -0.229 0 C-N-CA 120.156 -0.618 . . . . 0.0 111.859 -179.505 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' F' F ' 53' ' ' ALA . . . . . . . . . . . . . . . -135.46 135.86 40.85 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 115.361 -0.836 . . . . 0.0 110.495 179.347 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' F' F ' 54' ' ' TYR . . . . . . . . . . . . . 59.6 t80 -128.98 110.52 18.4 Favored Pre-proline 0 CA--C 1.534 0.345 0 CA-C-O 118.225 -0.893 . . . . 0.0 110.211 177.232 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' F' F ' 55' ' ' PRO . . . . . . . . . . . . . 72.6 Cg_endo -77.15 166.27 82.72 Favored 'Cis proline' 0 N--CA 1.5 1.859 0 CA-C-N 121.988 1.746 . . . . 0.0 112.322 -6.0 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' F' F ' 56' ' ' SER . . . . . . . . . . . . . 43.5 m -116.03 130.09 24.69 Favored Pre-proline 0 CA--C 1.538 0.488 0 CA-C-O 118.387 -0.816 . . . . 0.0 109.293 174.059 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' F' F ' 57' ' ' PRO . . . . . . . . . . . . . 37.6 Cg_endo -66.72 163.64 70.72 Favored 'Cis proline' 0 N--CA 1.498 1.788 0 CA-C-N 122.054 1.769 . . . . 0.0 111.701 -0.172 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' F' F ' 58' ' ' LEU . . . . . . . . . . . . . 24.7 tp -129.37 137.38 50.92 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.349 -179.025 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' F' F ' 59' ' ' ARG . . . . . . . . . . . . . 74.8 ttt180 -105.18 128.59 53.47 Favored 'General case' 0 C--N 1.327 -0.391 0 N-CA-C 109.272 -0.64 . . . . 0.0 109.272 175.657 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' F' F ' 60' ' ' VAL . . . . . . . . . . . . . 45.5 t -79.01 123.09 35.52 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.306 0 C-N-CA 120.686 -0.405 . . . . 0.0 110.347 -175.432 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' F' F ' 61' ' ' GLU . . . . . . . . . . . . . 95.4 mt-10 -131.09 162.75 29.17 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 115.732 -0.667 . . . . 0.0 109.949 177.894 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' F' F ' 62' ' ' ASP . . . . . . . . . . . . . 16.7 p-10 -56.8 -32.84 66.08 Favored 'General case' 0 C--N 1.328 -0.342 0 C-N-CA 120.941 -0.304 . . . . 0.0 111.522 179.329 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' F' F ' 63' ' ' ARG . . . . . . . . . . . . . 17.0 ptm180 -82.9 5.4 21.98 Favored 'General case' 0 CA--C 1.537 0.462 0 N-CA-C 113.558 0.947 . . . . 0.0 113.558 -176.602 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' F' F ' 64' ' ' THR . . . . . . . . . . . . . 19.4 m -88.53 141.97 28.09 Favored 'General case' 0 C--O 1.231 0.126 0 CA-C-N 118.235 0.471 . . . . 0.0 110.753 -177.66 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' F' F ' 65' ' ' LYS . . . . . . . . . . . . . 97.7 mttt -87.4 125.64 34.39 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.264 -0.425 . . . . 0.0 109.918 178.514 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' F' F ' 66' ' ' ILE . . . . . . . . . . . . . 59.0 mt -116.36 124.92 73.11 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.336 0 N-CA-C 109.712 -0.477 . . . . 0.0 109.712 179.708 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' F' F ' 67' ' ' THR . . . . . . . . . . . . . 19.6 m -123.8 146.03 48.64 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-O 121.043 0.449 . . . . 0.0 111.247 -176.231 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' F' F ' 68' ' ' LEU . . . . . . . . . . . . . 49.8 mt -99.05 134.34 42.03 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 115.77 -0.65 . . . . 0.0 110.486 177.637 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' F' F ' 69' ' ' VAL . . . . . . . . . . . . . 46.6 t -101.86 135.11 40.18 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.328 0 CA-C-N 115.878 -0.601 . . . . 0.0 109.913 179.039 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' F' F ' 70' ' ' THR . . . . . . . . . . . . . 7.7 t -132.01 177.27 7.68 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.073 -0.512 . . . . 0.0 110.3 -179.294 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' F' F ' 71' ' ' HIS . . . . . . . . . . . . . 93.9 m-70 -64.96 150.06 95.72 Favored Pre-proline 0 C--N 1.331 -0.219 0 CA-C-N 116.414 -0.357 . . . . 0.0 110.212 -179.124 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' F' F ' 72' ' ' PRO . . . . . . . . . . . . . 66.8 Cg_endo -74.97 -30.13 7.54 Favored 'Trans proline' 0 N--CA 1.495 1.574 0 C-N-CA 121.321 1.347 . . . . 0.0 112.542 -176.821 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' F' F ' 73' ' ' VAL . . . . . . . . . . . . . 31.0 m -140.09 146.03 25.42 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.226 0 CA-C-O 121.096 0.474 . . . . 0.0 111.213 179.234 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' F' F ' 74' ' ' ASP . . . . . . . . . . . . . 9.6 t0 -101.9 120.86 41.07 Favored 'General case' 0 C--N 1.327 -0.383 0 N-CA-C 109.042 -0.725 . . . . 0.0 109.042 174.724 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' F' F ' 75' ' ' VAL . . . . . . . . . . . . . 40.5 t -109.39 123.16 65.06 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.288 0 CA-C-O 121.207 0.527 . . . . 0.0 110.779 -175.939 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' F' F ' 76' ' ' LEU . . . . . . . . . . . . . 15.4 mt -129.55 144.25 51.19 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 115.477 -0.783 . . . . 0.0 109.127 177.101 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' F' F ' 77' ' ' GLU . . . . . . . . . . . . . 56.2 tt0 -138.86 139.99 38.31 Favored 'General case' 0 C--N 1.332 -0.184 0 C-N-CA 120.671 -0.411 . . . . 0.0 111.269 -175.148 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' F' F ' 78' ' ' ALA . . . . . . . . . . . . . . . -124.4 140.02 53.35 Favored 'General case' 0 C--N 1.331 -0.229 0 CA-C-N 115.947 -0.57 . . . . 0.0 110.308 178.217 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' F' F ' 79' ' ' LYS . . . . . . . . . . . . . 3.9 mptp? -82.75 116.36 22.07 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-N 116.427 -0.351 . . . . 0.0 110.685 -178.529 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' F' F ' 80' ' ' ILE . . . . . . . . . . . . . 40.0 mm -139.2 107.04 3.08 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.279 0 N-CA-C 109.391 -0.596 . . . . 0.0 109.391 -178.855 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' F' F ' 81' ' ' LYS . . . . . . . . . . . . . 99.3 mttt -105.19 133.61 49.68 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-O 120.902 0.382 . . . . 0.0 110.975 -179.037 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' F' F ' 82' ' ' GLY . . . . . . . . . . . . . . . 88.9 42.23 5.73 Favored Glycine 0 CA--C 1.524 0.63 0 N-CA-C 111.228 -0.749 . . . . 0.0 111.228 176.549 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' F' F ' 83' ' ' ILE . . . . . . . . . . . . . 72.8 mt -72.56 135.91 26.74 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.336 0 N-CA-C 109.964 -0.384 . . . . 0.0 109.964 179.382 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' F' F ' 84' ' ' LYS . . . . . . . . . . . . . 54.7 tttp -98.4 -53.96 3.19 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 115.971 -0.559 . . . . 0.0 110.329 -178.535 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' F' F ' 85' ' ' ASP . . . . . . . . . . . . . 7.4 t0 -149.6 148.31 29.18 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 115.85 -0.613 . . . . 0.0 110.327 -178.808 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' F' F ' 86' ' ' VAL . . . . . . . . . . . . . 42.3 t -129.79 129.39 66.18 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.274 0 CA-C-O 120.906 0.384 . . . . 0.0 110.456 -179.527 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' F' F ' 87' ' ' ILE . . . . . . . . . . . . . 45.6 mm -118.66 125.96 74.82 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.268 0 CA-C-N 116.006 -0.543 . . . . 0.0 109.734 175.809 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' F' F ' 88' ' ' LEU . . . . . . . . . . . . . 38.5 mt -113.02 136.82 52.27 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-O 121.12 0.486 . . . . 0.0 111.303 -177.973 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' F' F ' 89' ' ' ASP . . . . . . . . . . . . . 7.6 t70 -134.85 155.29 50.92 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 115.687 -0.688 . . . . 0.0 109.618 175.538 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' F' F ' 90' ' ' GLU . . . . . . . . . . . . . 95.7 mt-10 -48.78 -33.15 9.82 Favored 'General case' 0 C--N 1.329 -0.324 0 N-CA-C 112.927 0.714 . . . . 0.0 112.927 -172.542 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' F' F ' 91' ' ' ASN . . . . . . . . . . . . . 27.9 t30 -130.44 18.86 5.29 Favored 'General case' 0 N--CA 1.469 0.493 0 N-CA-C 113.063 0.764 . . . . 0.0 113.063 -176.056 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' F' F ' 92' ' ' LEU . . . . . . . . . . . . . 12.0 mt -151.66 143.63 23.83 Favored 'General case' 0 C--N 1.333 -0.151 0 N-CA-C 109.976 -0.379 . . . . 0.0 109.976 -177.225 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' F' F ' 93' ' ' ILE . . . . . . . . . . . . . 71.9 mt -128.82 118.11 46.24 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 N-CA-C 109.278 -0.638 . . . . 0.0 109.278 176.086 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' F' F ' 94' ' ' VAL . . . . . . . . . . . . . 44.5 t -120.84 127.02 75.89 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.344 0 N-CA-C 109.998 -0.371 . . . . 0.0 109.998 -178.538 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' F' F ' 95' ' ' VAL . . . . . . . . . . . . . 44.0 t -123.14 134.11 67.16 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.33 0 CA-C-N 116.064 -0.516 . . . . 0.0 109.95 -179.593 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' F' F ' 96' ' ' ILE . . . . . . . . . . . . . 52.8 mt -113.61 127.54 70.9 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.345 0 N-CA-C 109.006 -0.738 . . . . 0.0 109.006 178.391 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' F' F ' 97' ' ' THR . . . . . . . . . . . . . 66.1 p -99.42 157.15 16.62 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-O 121.204 0.526 . . . . 0.0 111.069 -177.142 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' F' F ' 98' ' ' GLU . . . . . . . . . . . . . 81.9 tt0 -53.98 -27.87 34.22 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 116.127 -0.488 . . . . 0.0 112.056 179.909 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' F' F ' 99' ' ' GLU . . . . . . . . . . . . . 95.9 mt-10 -76.92 12.54 1.32 Allowed 'General case' 0 CA--C 1.536 0.404 0 N-CA-C 113.329 0.863 . . . . 0.0 113.329 -176.737 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' F' F ' 100' ' ' ASN . . . . . . . . . . . . . 3.9 m-20 63.57 34.61 12.37 Favored 'General case' 0 CA--C 1.531 0.248 0 CA-C-O 120.964 0.412 . . . . 0.0 111.369 179.328 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' F' F ' 101' ' ' GLU . . . . . . . . . . . . . 84.0 tt0 -113.96 145.6 41.29 Favored 'General case' 0 C--N 1.333 -0.133 0 N-CA-C 109.52 -0.548 . . . . 0.0 109.52 173.607 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' F' F ' 102' ' ' VAL . . . . . . . . . . . . . 43.9 t -118.12 128.93 75.13 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.253 0 CA-C-O 120.849 0.356 . . . . 0.0 110.096 -177.802 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' F' F ' 103' ' ' LEU . . . . . . . . . . . . . 48.4 mt -115.84 130.43 56.83 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 115.479 -0.782 . . . . 0.0 109.823 178.372 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' F' F ' 104' ' ' ILE . . . . . . . . . . . . . 62.5 mt -119.87 121.59 66.43 Favored 'Isoleucine or valine' 0 C--O 1.233 0.23 0 N-CA-C 110.152 -0.314 . . . . 0.0 110.152 179.597 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' F' F ' 105' ' ' PHE . . . . . . . . . . . . . 30.8 m-85 -124.25 165.78 17.03 Favored 'General case' 0 C--N 1.333 -0.149 0 O-C-N 123.936 0.773 . . . . 0.0 109.521 178.152 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' F' F ' 106' ' ' ASN . . . . . . . . . . . . . 44.1 p-10 -96.99 -170.0 1.96 Allowed 'General case' 0 C--N 1.329 -0.29 0 N-CA-C 109.861 -0.422 . . . . 0.0 109.861 172.858 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' F' F ' 107' ' ' GLN . . . . . . . . . . . . . 47.8 tt0 -60.1 -30.14 69.05 Favored 'General case' 0 CA--C 1.532 0.286 0 N-CA-C 111.873 0.323 . . . . 0.0 111.873 179.532 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' F' F ' 108' ' ' ASN . . . . . . . . . . . . . 7.1 t-20 -82.5 8.19 12.34 Favored 'General case' 0 CA--C 1.537 0.457 0 N-CA-C 113.219 0.822 . . . . 0.0 113.219 -178.31 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' F' F ' 109' ' ' LEU . . . . . . . . . . . . . 11.0 tp 59.76 37.45 22.07 Favored 'General case' 0 CA--C 1.529 0.17 0 CA-C-O 120.977 0.418 . . . . 0.0 111.294 178.255 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' F' F ' 110' ' ' GLU . . . . . . . . . . . . . 70.7 mm-40 -104.04 163.68 12.22 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.416 -0.356 . . . . 0.0 110.109 177.228 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' F' F ' 111' ' ' GLU . . . . . . . . . . . . . 83.6 tt0 -84.86 124.18 31.31 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-N 116.328 -0.397 . . . . 0.0 111.053 -177.215 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' F' F ' 112' ' ' LEU . . . . . . . . . . . . . 15.3 mt -112.64 -46.06 3.18 Favored 'General case' 0 C--N 1.331 -0.197 0 CA-C-N 116.051 -0.522 . . . . 0.0 110.014 175.163 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' F' F ' 113' ' ' TYR . . . . . . . . . . . . . 57.7 t80 -148.25 137.91 22.28 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.228 -0.442 . . . . 0.0 111.036 179.775 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' F' F ' 114' ' ' ARG . . . . . . . . . . . . . 31.1 mtp180 -137.13 123.77 21.05 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.346 -0.388 . . . . 0.0 109.995 174.713 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' F' F ' 115' ' ' GLY . . . . . . . . . . . . . . . -149.46 160.15 28.34 Favored Glycine 0 CA--C 1.523 0.544 0 N-CA-C 110.832 -0.907 . . . . 0.0 110.832 -179.658 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' F' F ' 116' ' ' LYS . . . . . . . . . . . . . 72.5 tttt -133.32 133.64 42.79 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-O 120.844 0.354 . . . . 0.0 110.184 179.622 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' F' F ' 117' ' ' PHE . . . . . . . . . . . . . 23.6 m-85 -132.1 115.64 16.01 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.192 -0.458 . . . . 0.0 109.843 -175.459 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' F' F ' 118' ' ' GLU . . . . . . . . . . . . . 85.2 tt0 -55.4 -40.09 70.99 Favored 'General case' 0 C--N 1.329 -0.324 0 C-N-CA 120.902 -0.319 . . . . 0.0 111.213 -177.152 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' F' F ' 119' ' ' ASN . . . . . . . . . . . . . 4.5 m-80 -97.8 30.99 2.77 Favored 'General case' 0 C--N 1.33 -0.282 0 N-CA-C 112.173 0.434 . . . . 0.0 112.173 -176.084 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' F' F ' 120' ' ' LEU . . . . . . . . . . . . . 11.7 tp -56.54 122.31 11.7 Favored 'General case' 0 C--N 1.333 -0.146 0 C-N-CA 121.065 -0.254 . . . . 0.0 110.641 178.991 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' F' F ' 121' ' ' ASN . . . . . . . . . . . . . 10.5 t-20 -108.16 -44.14 4.22 Favored 'General case' 0 C--O 1.233 0.192 0 CA-C-N 116.578 -0.283 . . . . 0.0 111.05 -177.859 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' F' F ' 122' ' ' LYS . . . . . . . . . . . . . 55.7 pttt -165.94 161.73 17.73 Favored 'General case' 0 C--N 1.332 -0.17 0 C-N-CA 120.398 -0.521 . . . . 0.0 112.218 -179.223 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' F' F ' 123' ' ' VAL . . . . . . . . . . . . . 44.1 t -131.36 137.38 55.61 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.202 0 CA-C-N 115.809 -0.632 . . . . 0.0 109.956 178.959 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' F' F ' 124' ' ' LEU . . . . . . . . . . . . . 88.4 mt -122.38 136.8 54.97 Favored 'General case' 0 C--N 1.331 -0.223 0 CA-C-N 116.498 -0.319 . . . . 0.0 110.944 -179.47 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' F' F ' 125' ' ' VAL . . . . . . . . . . . . . 44.3 t -126.12 129.27 72.19 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.217 0 CA-C-N 116.096 -0.502 . . . . 0.0 109.849 178.576 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' F' F ' 126' ' ' ARG . . . . . . . . . . . . . 27.3 mmt85 -139.85 118.12 12.03 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.408 -0.36 . . . . 0.0 110.701 179.122 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' F' F ' 127' ' ' ASN . . . . . . . . . . . . . 4.9 m-20 49.66 -105.0 0.16 Allowed 'General case' 0 CA--C 1.545 0.759 0 CA-C-O 119.052 -0.499 . . . . 0.0 111.678 178.438 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' F' F ' 128' ' ' ASP . . . . . . . . . . . . . 17.5 p-10 -114.0 1.21 14.6 Favored 'General case' 0 N--CA 1.468 0.429 0 CA-C-N 119.571 1.078 . . . . 0.0 113.401 -178.046 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' F' F ' 129' ' ' LEU . . . . . . . . . . . . . 62.1 mt -107.32 142.86 36.44 Favored 'General case' 0 C--N 1.333 -0.131 0 N-CA-C 109.782 -0.451 . . . . 0.0 109.782 179.508 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' F' F ' 130' ' ' VAL . . . . . . . . . . . . . 41.9 t -129.5 140.31 49.43 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.287 0 CA-C-O 120.911 0.386 . . . . 0.0 110.066 -179.12 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' F' F ' 131' ' ' VAL . . . . . . . . . . . . . 34.8 m -135.93 142.0 40.23 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.267 0 CA-C-O 121.151 0.5 . . . . 0.0 110.838 178.882 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' F' F ' 132' ' ' ILE . . . . . . . . . . . . . 73.7 mt -118.61 134.0 63.64 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.259 0 CA-C-N 115.649 -0.705 . . . . 0.0 109.37 -179.78 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' F' F ' 133' ' ' ILE . . . . . . . . . . . . . 38.7 mm -116.79 122.51 70.11 Favored 'Isoleucine or valine' 0 C--O 1.234 0.278 0 CA-C-O 120.828 0.347 . . . . 0.0 111.077 -175.161 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' F' F ' 134' ' ' ASP . . . . . . . . . . . . . 6.1 p-10 -134.2 147.24 50.7 Favored 'General case' 0 C--N 1.332 -0.183 0 CA-C-N 115.87 -0.605 . . . . 0.0 109.577 172.693 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' F' F ' 135' ' ' GLU . . . . . . . . . . . . . 81.9 tt0 -49.94 -23.91 2.25 Favored 'General case' 0 C--N 1.328 -0.369 0 N-CA-C 113.088 0.773 . . . . 0.0 113.088 -170.147 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' F' F ' 136' ' ' GLN . . . . . . . . . . . . . 47.6 tt0 -104.69 -26.27 12.37 Favored 'General case' 0 CA--C 1.531 0.238 0 N-CA-C 112.748 0.648 . . . . 0.0 112.748 -174.625 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' F' F ' 137' ' ' LYS . . . . . . . . . . . . . 7.2 ttpm? -143.87 150.14 37.99 Favored 'General case' 0 C--N 1.332 -0.167 0 CA-C-O 121.36 0.6 . . . . 0.0 111.781 -170.5 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' F' F ' 138' ' ' LEU . . . . . . . . . . . . . 5.7 tt -116.87 126.62 53.29 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 115.466 -0.788 . . . . 0.0 109.241 175.183 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' F' F ' 139' ' ' THR . . . . . . . . . . . . . 26.4 m -112.44 128.27 56.27 Favored 'General case' 0 C--N 1.331 -0.208 0 CA-C-N 116.592 -0.276 . . . . 0.0 110.82 -178.106 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' F' F ' 140' ' ' LEU . . . . . . . . . . . . . 36.5 tp -112.71 120.24 40.85 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 115.573 -0.739 . . . . 0.0 109.263 179.783 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' F' F ' 141' ' ' ILE . . . . . . . . . . . . . 19.3 mt -119.83 119.73 61.17 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.28 0 N-CA-C 109.863 -0.421 . . . . 0.0 109.863 -175.009 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' F' F ' 142' ' ' ARG . . . . . . . . . . . . . 78.9 mtp180 -108.9 130.11 55.43 Favored 'General case' 0 C--N 1.331 -0.23 0 CA-C-N 115.556 -0.747 . . . . 0.0 110.624 -177.948 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' F' F ' 143' ' ' THR . . . . . . . . . . . . . 26.5 p . . . . . 0 C--O 1.22 -0.485 0 CA-C-O 118.106 -0.95 . . . . 0.0 110.532 -179.238 . . . . . . . . 0 0 . 1 . 019 nuclear orig full ' A' A ' -3' ' ' GLU . . . . . . . . . . . . . 84.5 tt0 . . . . . 0 N--CA 1.491 1.577 0 N-CA-C 109.463 -0.569 . . . . 0.0 109.463 . . . . . . . . . 0 0 . 1 . 019 nuclear orig full ' A' A ' -2' ' ' GLY . . . . . . . . . . . . . . . -64.75 145.38 49.38 Favored Glycine 0 CA--C 1.524 0.62 0 N-CA-C 111.0 -0.84 . . . . 0.0 111.0 -179.969 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' -1' ' ' VAL . . . . . . . . . . . . . 43.4 t -96.09 132.65 39.79 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.34 0 N-CA-C 110.125 -0.324 . . . . 0.0 110.125 -179.618 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 0' ' ' ILE . . . . . . . . . . . . . 46.8 mm -119.01 137.88 51.54 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.207 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.306 179.701 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 14.9 ptm -77.82 129.11 35.03 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 115.932 -0.576 . . . . 0.0 110.49 -179.982 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 3.9 p -129.17 127.35 41.17 Favored 'General case' 0 C--N 1.332 -0.176 0 CA-C-O 121.149 0.5 . . . . 0.0 110.692 -178.597 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 95.7 mt-10 -141.26 144.36 34.63 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 115.593 -0.731 . . . . 0.0 110.996 -176.55 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 4' ' ' LEU . . . . . . . . . . . . . 21.8 tp -122.46 125.6 46.15 Favored 'General case' 0 C--N 1.331 -0.206 0 CA-C-N 115.919 -0.582 . . . . 0.0 109.758 174.431 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 5' ' ' LYS . . . . . . . . . . . . . 90.5 mttt -104.64 120.95 42.52 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.341 -0.391 . . . . 0.0 110.685 -179.51 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 65.9 mt -117.82 147.27 43.19 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 115.575 -0.739 . . . . 0.0 110.7 -178.08 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 56.6 tttt -140.31 139.37 20.66 Favored Pre-proline 0 CA--C 1.533 0.314 0 CA-C-O 119.066 -0.492 . . . . 0.0 109.953 175.103 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 8' ' ' PRO . . . . . . . . . . . . . 94.1 Cg_endo -91.81 146.63 3.18 Favored 'Trans proline' 0 N--CA 1.49 1.319 0 C-N-CA 121.623 1.549 . . . . 0.0 111.834 178.119 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 59.1 mt -78.64 -47.18 1.87 Allowed Pre-proline 0 CA--C 1.534 0.359 0 CA-C-O 118.724 -0.655 . . . . 0.0 112.029 179.96 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 87.8 Cg_endo -81.34 151.37 17.68 Favored 'Trans proline' 0 N--CA 1.495 1.609 0 C-N-CA 121.195 1.264 . . . . 0.0 111.939 175.774 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 34.4 mmtp -84.26 100.43 11.21 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.445 -0.343 . . . . 0.0 110.347 177.703 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 12.5 p -140.28 143.73 29.02 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.275 0 CA-C-N 116.233 -0.439 . . . . 0.0 110.545 -179.794 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 15.0 pt-20 -89.62 130.84 35.86 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.198 -0.455 . . . . 0.0 110.224 177.72 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 14' ' ' LEU . . . . . . . . . . . . . 35.0 mt -98.24 153.72 37.95 Favored Pre-proline 0 C--O 1.234 0.241 0 CA-C-N 116.377 -0.374 . . . . 0.0 111.16 -176.5 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 15' ' ' PRO . . . . . . . . . . . . . 24.8 Cg_exo -63.0 165.44 16.59 Favored 'Trans proline' 0 N--CA 1.496 1.667 0 C-N-CA 121.37 1.38 . . . . 0.0 111.806 174.657 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 16' ' ' PRO . . . . . . . . . . . . . 26.5 Cg_exo -60.71 -46.32 17.36 Favored 'Trans proline' 0 N--CA 1.498 1.763 0 C-N-CA 121.48 1.454 . . . . 0.0 112.912 -177.649 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 17' ' ' ASP . . . . . . . . . . . . . 22.4 p-10 -86.06 11.31 11.96 Favored 'General case' 0 C--N 1.327 -0.412 0 N-CA-C 113.207 0.817 . . . . 0.0 113.207 -176.508 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 18' ' ' PHE . . . . . . . . . . . . . 37.5 t80 -57.03 -40.5 76.86 Favored 'General case' 0 C--N 1.334 -0.091 0 O-C-N 121.877 -0.514 . . . . 0.0 110.461 -179.215 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 19' ' ' VAL . . . . . . . . . . . . . 47.7 t -56.91 -44.06 81.63 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.285 0 CA-C-N 116.344 -0.389 . . . . 0.0 110.412 -179.683 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 18.1 t70 -59.79 -41.55 91.42 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-O 120.892 0.377 . . . . 0.0 110.702 -178.031 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 47.5 t -63.76 -47.74 89.63 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.308 0 CA-C-N 116.422 -0.353 . . . . 0.0 110.487 -178.021 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 22' ' ' ILE . . . . . . . . . . . . . 50.6 mm -56.16 -44.61 79.58 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.201 0 C-N-CA 120.863 -0.335 . . . . 0.0 110.656 179.07 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 23' ' ' ARG . . . . . . . . . . . . . 51.2 ttp180 -53.62 -49.1 68.59 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-O 120.715 0.293 . . . . 0.0 111.462 -179.393 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 24' ' ' ILE . . . . . . . . . . . . . 71.8 mt -59.24 -44.63 92.45 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.268 0 CA-C-N 116.441 -0.345 . . . . 0.0 111.157 -178.329 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 79.3 mttt -64.06 -41.38 97.37 Favored 'General case' 0 C--N 1.329 -0.318 0 N-CA-C 112.377 0.51 . . . . 0.0 112.377 -177.554 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 65.2 mt -79.48 -42.34 25.51 Favored 'General case' 0 C--N 1.329 -0.307 0 N-CA-C 113.147 0.795 . . . . 0.0 113.147 -171.108 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 27' ' ' GLN . . . . . . . . . . . . . 10.2 pt20 -46.58 138.43 5.91 Favored 'General case' 0 N--CA 1.469 0.491 0 N-CA-C 112.816 0.673 . . . . 0.0 112.816 -175.533 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 100.77 -25.65 27.56 Favored Glycine 0 CA--C 1.531 1.086 0 CA-C-N 115.498 -0.774 . . . . 0.0 112.387 -178.515 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 85.6 mttt -98.68 155.22 17.43 Favored 'General case' 0 C--O 1.233 0.197 0 CA-C-N 117.428 0.614 . . . . 0.0 111.467 179.47 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 30' ' ' THR . . . . . . . . . . . . . 29.9 m -100.79 137.14 39.57 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 115.836 -0.62 . . . . 0.0 109.748 175.125 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 34.0 m -128.81 151.77 36.04 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.24 0 CA-C-O 120.829 0.347 . . . . 0.0 111.076 -177.602 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 32' ' ' ARG . . . . . . . . . . . . . 75.5 mtp180 -131.08 150.23 52.24 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-O 121.294 0.569 . . . . 0.0 110.541 177.241 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 33' ' ' THR . . . . . . . . . . . . . 17.6 m -53.17 138.2 32.2 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.163 -0.471 . . . . 0.0 111.471 -178.611 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 102.07 -17.23 54.63 Favored Glycine 0 CA--C 1.531 1.06 0 CA-C-O 119.67 -0.517 . . . . 0.0 113.333 178.06 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 79.7 m-20 -65.82 146.07 55.2 Favored 'General case' 0 C--O 1.231 0.107 0 CA-C-N 118.075 0.938 . . . . 0.0 110.98 179.268 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 46.9 t -121.19 129.19 75.9 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.197 0 CA-C-N 115.943 -0.571 . . . . 0.0 109.806 178.603 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 37' ' ' ILE . . . . . . . . . . . . . 67.7 mt -119.62 138.23 50.92 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.228 0 CA-C-N 116.211 -0.45 . . . . 0.0 109.835 -179.522 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . -112.15 128.68 8.66 Favored Glycine 0 CA--C 1.525 0.682 0 N-CA-C 111.034 -0.826 . . . . 0.0 111.034 179.963 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 39' ' ' ILE . . . . . . . . . . . . . 72.3 mt -127.41 127.18 68.72 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.206 0 N-CA-C 109.848 -0.427 . . . . 0.0 109.848 178.453 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 40' ' ' SER . . . . . . . . . . . . . 45.7 t -92.72 124.88 37.05 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.476 -0.329 . . . . 0.0 110.79 177.0 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 41' ' ' ILE . . . . . . . . . . . . . 73.9 mt -128.67 116.41 41.22 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.158 0 CA-C-O 120.92 0.391 . . . . 0.0 110.186 178.261 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 1.3 tt 54.91 46.71 23.83 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-O 121.441 0.639 . . . . 0.0 110.616 177.835 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . 75.97 -10.05 15.87 Favored Glycine 0 CA--C 1.533 1.194 0 CA-C-N 116.042 -0.526 . . . . 0.0 113.667 174.35 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 44' ' ' LYS . . . . . . . . . . . . . 46.6 mtmt -104.41 126.92 51.94 Favored 'General case' 0 C--N 1.332 -0.175 0 CA-C-N 118.178 0.989 . . . . 0.0 110.328 179.224 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 39.5 tp10 -84.83 134.25 34.3 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-O 120.96 0.409 . . . . 0.0 111.34 -177.699 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 46' ' ' VAL . . . . . . . . . . . . . 7.4 p -127.81 130.65 70.14 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.175 0 CA-C-N 116.085 -0.507 . . . . 0.0 109.851 176.075 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 97.7 mttt -100.89 131.54 46.72 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.146 -0.479 . . . . 0.0 111.452 177.59 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 48' ' ' PHE . . . . . . . . . . . . . 90.4 m-85 -113.9 131.77 56.17 Favored 'General case' 0 C--N 1.33 -0.278 0 N-CA-C 109.535 -0.542 . . . . 0.0 109.535 175.246 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 45.3 tttp -108.07 137.23 46.41 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-O 120.715 0.293 . . . . 0.0 110.736 179.405 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 50' ' ' VAL . . . . . . . . . . . . . 45.0 t -78.91 107.04 10.87 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.236 0 N-CA-C 109.157 -0.683 . . . . 0.0 109.157 175.163 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 51' ' ' VAL . . . . . . . . . . . . . 47.5 t -73.23 -47.68 45.94 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.356 0 CA-C-N 116.263 -0.426 . . . . 0.0 110.053 -173.555 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 52' ' ' GLN . . . . . . . . . . . . . 62.0 tt0 -162.69 141.96 9.04 Favored 'General case' 0 C--N 1.331 -0.201 0 C-N-CA 120.158 -0.617 . . . . 0.0 111.838 -178.129 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -114.92 130.7 56.96 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 115.65 -0.705 . . . . 0.0 109.9 176.057 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 54' ' ' TYR . . . . . . . . . . . . . 37.9 t80 -129.15 107.44 17.85 Favored Pre-proline 0 CA--C 1.534 0.338 0 CA-C-O 118.292 -0.861 . . . . 0.0 110.52 -179.726 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 55' ' ' PRO . . . . . . . . . . . . . 72.4 Cg_endo -77.2 169.98 72.71 Favored 'Cis proline' 0 N--CA 1.499 1.85 0 CA-C-N 121.778 1.671 . . . . 0.0 112.562 -5.145 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 56' ' ' SER . . . . . . . . . . . . . 16.1 m -115.34 133.21 22.76 Favored Pre-proline 0 CA--C 1.538 0.506 0 CA-C-O 118.457 -0.782 . . . . 0.0 109.494 174.764 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 57' ' ' PRO . . . . . . . . . . . . . 56.0 Cg_endo -71.62 147.98 89.3 Favored 'Cis proline' 0 N--CA 1.497 1.71 0 CA-C-N 121.851 1.697 . . . . 0.0 111.502 -2.171 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 58' ' ' LEU . . . . . . . . . . . . . 22.2 tp -108.05 137.11 46.61 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-O 120.926 0.393 . . . . 0.0 110.74 -177.952 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 59' ' ' ARG . . . . . . . . . . . . . 77.2 ttt180 -102.89 122.05 43.76 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-N 115.882 -0.599 . . . . 0.0 109.401 175.714 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 43.3 t -79.31 119.81 29.33 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.254 0 C-N-CA 120.633 -0.427 . . . . 0.0 110.331 -176.3 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 75.3 tt0 -130.88 158.72 39.45 Favored 'General case' 0 C--N 1.328 -0.33 0 N-CA-C 109.059 -0.719 . . . . 0.0 109.059 177.435 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 62' ' ' ASP . . . . . . . . . . . . . 68.4 m-20 -50.98 -31.11 16.93 Favored 'General case' 0 C--N 1.327 -0.381 0 N-CA-C 112.211 0.448 . . . . 0.0 112.211 -178.65 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 63' ' ' ARG . . . . . . . . . . . . . 7.1 ptp180 -86.25 4.63 38.01 Favored 'General case' 0 CA--C 1.535 0.383 0 N-CA-C 113.728 1.01 . . . . 0.0 113.728 -175.579 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 17.9 m -86.65 141.85 28.65 Favored 'General case' 0 C--N 1.332 -0.162 0 CA-C-N 118.188 0.449 . . . . 0.0 110.371 -178.667 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 65' ' ' LYS . . . . . . . . . . . . . 37.3 ttpt -89.08 130.74 35.48 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-O 121.0 0.428 . . . . 0.0 110.607 -177.94 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 66' ' ' ILE . . . . . . . . . . . . . 64.7 mt -111.78 131.52 62.93 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.288 0 N-CA-C 109.857 -0.423 . . . . 0.0 109.857 -179.104 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 67' ' ' THR . . . . . . . . . . . . . 28.5 m -125.7 138.25 53.87 Favored 'General case' 0 C--N 1.332 -0.166 0 CA-C-O 121.059 0.457 . . . . 0.0 110.865 -177.928 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 68' ' ' LEU . . . . . . . . . . . . . 6.8 mp -102.19 133.13 47.55 Favored 'General case' 0 C--N 1.33 -0.239 0 CA-C-N 115.889 -0.596 . . . . 0.0 110.332 178.132 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 69' ' ' VAL . . . . . . . . . . . . . 45.3 t -98.51 141.57 16.1 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.331 0 CA-C-N 116.065 -0.516 . . . . 0.0 110.097 179.27 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 70' ' ' THR . . . . . . . . . . . . . 76.6 p -129.97 158.21 40.2 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.283 -179.501 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 71' ' ' HIS . . . . . . . . . . . . . 20.8 m-70 -71.41 152.64 94.07 Favored Pre-proline 0 C--N 1.329 -0.314 0 CA-C-N 116.049 -0.523 . . . . 0.0 110.738 -178.782 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 72' ' ' PRO . . . . . . . . . . . . . 91.7 Cg_endo -83.36 -21.04 4.62 Favored 'Trans proline' 0 N--CA 1.494 1.521 0 C-N-CA 121.502 1.468 . . . . 0.0 113.195 -179.94 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 73' ' ' VAL . . . . . . . . . . . . . 35.2 m -88.98 161.38 2.7 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.278 0 CA-C-O 120.81 0.338 . . . . 0.0 110.705 -178.679 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 74' ' ' ASP . . . . . . . . . . . . . 23.9 t0 -101.78 115.92 31.59 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.181 -0.463 . . . . 0.0 109.839 -179.677 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 42.3 t -115.78 124.54 72.29 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.204 0 CA-C-O 121.073 0.463 . . . . 0.0 110.906 -175.712 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 76' ' ' LEU . . . . . . . . . . . . . 5.0 mp -121.08 137.17 54.78 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 115.625 -0.716 . . . . 0.0 109.336 174.162 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 77' ' ' GLU . . . . . . . . . . . . . 96.9 mt-10 -131.75 133.11 44.42 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-O 120.967 0.413 . . . . 0.0 111.141 -178.568 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 78' ' ' ALA . . . . . . . . . . . . . . . -122.39 137.74 54.76 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 115.813 -0.631 . . . . 0.0 109.923 176.971 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 79' ' ' LYS . . . . . . . . . . . . . 99.2 mttt -75.92 117.25 17.45 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-O 120.983 0.421 . . . . 0.0 110.285 179.541 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 80' ' ' ILE . . . . . . . . . . . . . 42.8 mm -139.1 102.6 1.76 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.394 0 N-CA-C 109.382 -0.599 . . . . 0.0 109.382 -176.888 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 81' ' ' LYS . . . . . . . . . . . . . 97.1 mttt -99.7 131.35 45.74 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-O 120.981 0.42 . . . . 0.0 111.198 -177.704 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . 89.02 42.1 5.72 Favored Glycine 0 CA--C 1.526 0.742 0 CA-C-N 115.893 -0.594 . . . . 0.0 111.779 174.866 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 83' ' ' ILE . . . . . . . . . . . . . 70.5 mt -69.3 136.62 25.89 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.354 0 N-CA-C 109.833 -0.432 . . . . 0.0 109.833 178.068 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 84' ' ' LYS . . . . . . . . . . . . . 59.5 tttt -99.11 -53.7 3.18 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.115 -0.493 . . . . 0.0 110.285 -178.395 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 85' ' ' ASP . . . . . . . . . . . . . 8.6 t70 -155.12 154.65 32.69 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 115.857 -0.611 . . . . 0.0 110.4 179.841 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 86' ' ' VAL . . . . . . . . . . . . . 42.2 t -129.41 132.0 66.9 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.225 0 CA-C-O 120.942 0.401 . . . . 0.0 110.642 -178.756 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 87' ' ' ILE . . . . . . . . . . . . . 5.0 mp -119.62 126.81 75.68 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.219 0 CA-C-N 115.975 -0.557 . . . . 0.0 109.566 176.81 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 88' ' ' LEU . . . . . . . . . . . . . 66.8 mt -107.02 135.29 48.83 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-O 121.075 0.464 . . . . 0.0 111.322 -177.949 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 89' ' ' ASP . . . . . . . . . . . . . 13.1 t70 -127.89 152.15 48.2 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 115.758 -0.655 . . . . 0.0 109.536 175.532 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 83.3 tt0 -47.28 -39.68 15.06 Favored 'General case' 0 C--N 1.33 -0.266 0 N-CA-C 112.792 0.664 . . . . 0.0 112.792 -172.978 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 91' ' ' ASN . . . . . . . . . . . . . 29.0 p30 -132.03 34.95 3.77 Favored 'General case' 0 N--CA 1.464 0.245 0 N-CA-C 111.695 0.257 . . . . 0.0 111.695 -177.673 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 92' ' ' LEU . . . . . . . . . . . . . 8.0 tp -166.11 147.0 6.59 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-O 120.73 0.3 . . . . 0.0 110.533 -178.718 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 93' ' ' ILE . . . . . . . . . . . . . 74.6 mt -129.72 122.92 55.99 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.267 0 N-CA-C 109.545 -0.539 . . . . 0.0 109.545 179.881 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 94' ' ' VAL . . . . . . . . . . . . . 40.3 t -121.06 128.06 76.0 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.271 0 CA-C-O 120.854 0.359 . . . . 0.0 110.051 -179.519 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 95' ' ' VAL . . . . . . . . . . . . . 42.0 t -120.12 134.29 64.12 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.314 0 CA-C-N 116.031 -0.531 . . . . 0.0 109.804 179.695 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 96' ' ' ILE . . . . . . . . . . . . . 63.3 mt -111.18 128.77 67.42 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.409 0 N-CA-C 109.166 -0.679 . . . . 0.0 109.166 178.856 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 97' ' ' THR . . . . . . . . . . . . . 75.8 p -100.82 157.63 16.57 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-O 121.343 0.592 . . . . 0.0 111.283 -177.412 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 98' ' ' GLU . . . . . . . . . . . . . 84.7 tt0 -53.92 -28.16 35.12 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.001 -0.545 . . . . 0.0 112.066 -179.478 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 99' ' ' GLU . . . . . . . . . . . . . 44.9 mp0 -80.58 17.73 1.07 Allowed 'General case' 0 CA--C 1.534 0.34 0 N-CA-C 112.984 0.735 . . . . 0.0 112.984 -176.339 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 100' ' ' ASN . . . . . . . . . . . . . 4.1 m-20 61.51 37.97 16.08 Favored 'General case' 0 CA--C 1.529 0.157 0 CA-C-O 121.063 0.459 . . . . 0.0 110.938 178.459 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 101' ' ' GLU . . . . . . . . . . . . . 84.9 tt0 -117.83 144.72 45.13 Favored 'General case' 0 C--N 1.331 -0.232 0 N-CA-C 109.671 -0.492 . . . . 0.0 109.671 176.307 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 102' ' ' VAL . . . . . . . . . . . . . 45.6 t -114.98 126.2 72.51 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.257 0 CA-C-O 120.887 0.375 . . . . 0.0 110.152 -177.483 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 103' ' ' LEU . . . . . . . . . . . . . 42.5 mt -114.3 130.98 56.67 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-N 115.592 -0.731 . . . . 0.0 109.822 176.614 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 104' ' ' ILE . . . . . . . . . . . . . 67.7 mt -122.37 120.96 62.55 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.236 0 N-CA-C 110.436 -0.209 . . . . 0.0 110.436 -177.312 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 105' ' ' PHE . . . . . . . . . . . . . 43.8 m-85 -123.83 166.63 15.28 Favored 'General case' 0 C--N 1.332 -0.193 0 O-C-N 124.041 0.838 . . . . 0.0 109.798 179.64 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 106' ' ' ASN . . . . . . . . . . . . . 41.2 p-10 -96.21 -169.91 2.0 Favored 'General case' 0 C--N 1.329 -0.302 0 N-CA-C 109.377 -0.601 . . . . 0.0 109.377 171.545 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 107' ' ' GLN . . . . . . . . . . . . . 48.0 tt0 -59.61 -30.04 68.42 Favored 'General case' 0 CA--C 1.532 0.256 0 C-N-CA 120.74 -0.384 . . . . 0.0 111.644 177.688 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 108' ' ' ASN . . . . . . . . . . . . . 13.9 t30 -81.89 6.32 16.18 Favored 'General case' 0 CA--C 1.537 0.476 0 N-CA-C 113.178 0.807 . . . . 0.0 113.178 -178.145 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 109' ' ' LEU . . . . . . . . . . . . . 8.9 tp 61.88 36.94 15.65 Favored 'General case' 0 C--O 1.232 0.155 0 O-C-N 122.123 -0.36 . . . . 0.0 111.526 176.567 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 110' ' ' GLU . . . . . . . . . . . . . 96.0 mt-10 -104.99 149.61 25.62 Favored 'General case' 0 C--N 1.33 -0.267 0 N-CA-C 110.032 -0.358 . . . . 0.0 110.032 176.018 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 111' ' ' GLU . . . . . . . . . . . . . 98.8 mt-10 -76.61 122.62 24.9 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-O 120.99 0.424 . . . . 0.0 111.222 -178.101 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 112' ' ' LEU . . . . . . . . . . . . . 16.1 mt -110.78 -45.94 3.42 Favored 'General case' 0 C--N 1.332 -0.177 0 CA-C-N 115.953 -0.567 . . . . 0.0 110.188 176.986 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 113' ' ' TYR . . . . . . . . . . . . . 34.5 t80 -138.65 140.69 38.96 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.859 179.381 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 114' ' ' ARG . . . . . . . . . . . . . 78.3 mtp180 -143.05 122.4 13.07 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.078 -0.51 . . . . 0.0 110.355 179.074 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 115' ' ' GLY . . . . . . . . . . . . . . . -150.12 153.79 25.29 Favored Glycine 0 CA--C 1.525 0.67 0 N-CA-C 111.22 -0.752 . . . . 0.0 111.22 179.73 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 116' ' ' LYS . . . . . . . . . . . . . 40.3 ttpt -126.47 129.46 48.73 Favored 'General case' 0 C--N 1.331 -0.226 0 N-CA-C 109.72 -0.474 . . . . 0.0 109.72 178.778 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 117' ' ' PHE . . . . . . . . . . . . . 41.6 m-85 -130.56 114.96 16.11 Favored 'General case' 0 C--N 1.333 -0.15 0 CA-C-O 120.851 0.358 . . . . 0.0 110.631 -174.155 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 118' ' ' GLU . . . . . . . . . . . . . 84.7 tt0 -53.93 -46.69 71.6 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.418 -0.355 . . . . 0.0 111.379 -177.875 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 119' ' ' ASN . . . . . . . . . . . . . 33.0 m120 -94.77 30.44 2.06 Favored 'General case' 0 C--N 1.329 -0.299 0 N-CA-C 112.241 0.46 . . . . 0.0 112.241 -175.197 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 120' ' ' LEU . . . . . . . . . . . . . 17.1 tp -58.47 123.4 16.06 Favored 'General case' 0 C--N 1.332 -0.153 0 N-CA-C 110.204 -0.295 . . . . 0.0 110.204 177.575 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 121' ' ' ASN . . . . . . . . . . . . . 14.7 m120 -113.77 -44.19 3.21 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-N 116.678 -0.237 . . . . 0.0 110.989 -178.399 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 122' ' ' LYS . . . . . . . . . . . . . 97.3 mttt -148.28 150.31 33.42 Favored 'General case' 0 C--N 1.331 -0.236 0 C-N-CA 120.549 -0.46 . . . . 0.0 111.523 -178.04 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 123' ' ' VAL . . . . . . . . . . . . . 43.9 t -130.13 132.23 65.4 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.185 0 CA-C-N 115.967 -0.561 . . . . 0.0 109.55 175.825 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 124' ' ' LEU . . . . . . . . . . . . . 17.6 tp -127.62 136.9 52.27 Favored 'General case' 0 C--N 1.332 -0.162 0 CA-C-O 120.808 0.337 . . . . 0.0 110.621 -178.188 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 125' ' ' VAL . . . . . . . . . . . . . 11.4 p -125.59 128.05 72.07 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.22 0 CA-C-N 116.112 -0.495 . . . . 0.0 110.252 178.978 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 126' ' ' ARG . . . . . . . . . . . . . 51.8 mmm-85 -140.84 123.9 16.46 Favored 'General case' 0 C--N 1.33 -0.269 0 N-CA-C 109.19 -0.67 . . . . 0.0 109.19 178.909 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 127' ' ' ASN . . . . . . . . . . . . . 37.1 t30 57.25 -150.99 0.43 Allowed 'General case' 0 CA--C 1.539 0.546 0 N-CA-C 109.56 -0.533 . . . . 0.0 109.56 -179.074 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 128' ' ' ASP . . . . . . . . . . . . . 19.5 p-10 -83.57 14.75 3.54 Favored 'General case' 0 CA--C 1.537 0.46 0 CA-C-N 118.637 0.653 . . . . 0.0 112.694 177.024 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 129' ' ' LEU . . . . . . . . . . . . . 40.2 mt -114.1 145.09 42.1 Favored 'General case' 0 C--O 1.231 0.119 0 O-C-N 121.975 -0.453 . . . . 0.0 109.83 179.06 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 130' ' ' VAL . . . . . . . . . . . . . 12.3 p -133.73 144.98 34.24 Favored 'Isoleucine or valine' 0 C--O 1.233 0.206 0 CA-C-O 121.248 0.547 . . . . 0.0 110.756 -176.914 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 131' ' ' VAL . . . . . . . . . . . . . 45.3 t -134.36 137.35 51.74 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.303 0 CA-C-N 115.707 -0.679 . . . . 0.0 110.063 179.695 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 132' ' ' ILE . . . . . . . . . . . . . 72.1 mt -116.53 132.82 65.05 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.367 0 CA-C-N 115.757 -0.656 . . . . 0.0 109.336 179.47 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 133' ' ' ILE . . . . . . . . . . . . . 42.6 mm -114.55 120.18 63.52 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.259 0 CA-C-O 120.693 0.282 . . . . 0.0 110.879 -175.356 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 134' ' ' ASP . . . . . . . . . . . . . 8.4 p-10 -130.62 143.25 50.62 Favored 'General case' 0 C--N 1.33 -0.244 0 N-CA-C 109.351 -0.611 . . . . 0.0 109.351 174.732 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 135' ' ' GLU . . . . . . . . . . . . . 39.6 tp10 -50.0 -26.32 4.18 Favored 'General case' 0 C--N 1.328 -0.328 0 N-CA-C 112.89 0.7 . . . . 0.0 112.89 -171.939 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 136' ' ' GLN . . . . . . . . . . . . . 97.0 mt-30 -80.43 -35.1 35.52 Favored 'General case' 0 C--N 1.331 -0.218 0 N-CA-C 112.022 0.378 . . . . 0.0 112.022 -176.962 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 137' ' ' LYS . . . . . . . . . . . . . 49.7 pttt -167.64 172.61 9.19 Favored 'General case' 0 C--N 1.331 -0.219 0 CA-C-O 121.478 0.656 . . . . 0.0 112.052 -173.828 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 138' ' ' LEU . . . . . . . . . . . . . 6.1 tt -113.99 129.81 56.58 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 115.164 -0.925 . . . . 0.0 110.114 -179.48 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 139' ' ' THR . . . . . . . . . . . . . 24.8 m -108.63 126.41 52.93 Favored 'General case' 0 C--N 1.332 -0.179 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.568 179.964 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 140' ' ' LEU . . . . . . . . . . . . . 11.1 tp -114.26 122.89 48.14 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-N 115.753 -0.658 . . . . 0.0 109.404 -178.846 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 141' ' ' ILE . . . . . . . . . . . . . 19.9 mt -121.48 120.38 61.69 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.273 0 CA-C-O 120.954 0.407 . . . . 0.0 109.94 -176.41 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 142' ' ' ARG . . . . . . . . . . . . . 72.0 mtp180 -110.61 118.03 35.12 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 115.327 -0.851 . . . . 0.0 110.64 -177.405 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 143' ' ' THR . . . . . . . . . . . . . 33.7 p . . . . . 0 C--O 1.219 -0.502 0 CA-C-O 117.891 -1.052 . . . . 0.0 110.533 179.929 . . . . . . . . 0 0 . 1 . 019 nuclear orig full ' B' B ' -3' ' ' GLU . . . . . . . . . . . . . 45.3 mp0 . . . . . 0 N--CA 1.489 1.511 0 N-CA-C 109.28 -0.637 . . . . 0.0 109.28 . . . . . . . . . 0 0 . 1 . 019 nuclear orig full ' B' B ' -2' ' ' GLY . . . . . . . . . . . . . . . -69.55 138.5 30.45 Favored Glycine 0 CA--C 1.524 0.643 0 N-CA-C 111.082 -0.807 . . . . 0.0 111.082 -179.69 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' B' B ' -1' ' ' VAL . . . . . . . . . . . . . 44.7 t -142.16 143.92 25.81 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.351 0 CA-C-O 120.871 0.367 . . . . 0.0 110.064 179.899 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' B' B ' 0' ' ' ILE . . . . . 0.413 HD11 HG21 ' B' ' 0' ' ' ILE . 69.4 mt -91.52 133.15 34.01 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.281 0 CA-C-N 116.246 -0.434 . . . . 0.0 109.85 179.371 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' B' B ' 1' ' ' MET . . . . . . . . . . . . . 25.2 ptp -78.74 138.13 38.09 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.199 -0.455 . . . . 0.0 111.146 -177.57 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' B' B ' 2' ' ' SER . . . . . . . . . . . . . 7.3 p -122.99 134.4 54.33 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 116.017 -0.538 . . . . 0.0 110.358 178.091 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' B' B ' 3' ' ' GLU . . . . . . . . . . . . . 94.5 mt-10 -140.71 142.96 34.79 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.112 -0.495 . . . . 0.0 111.022 -177.943 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' B' B ' 4' ' ' LEU . . . . . . . . . . . . . 17.7 tp -127.85 127.86 44.2 Favored 'General case' 0 C--N 1.331 -0.205 0 CA-C-N 116.087 -0.506 . . . . 0.0 109.865 175.538 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' B' B ' 5' ' ' LYS . . . . . . . . . . . . . 98.6 mttt -109.02 122.74 47.89 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-O 120.487 0.184 . . . . 0.0 110.87 -179.673 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' B' B ' 6' ' ' LEU . . . . . . . . . . . . . 53.6 mt -114.94 143.89 44.44 Favored 'General case' 0 N--CA 1.463 0.215 0 O-C-N 123.8 0.688 . . . . 0.0 110.946 179.679 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' B' B ' 7' ' ' LYS . . . . . . . . . . . . . 84.3 tttt -129.88 135.47 27.55 Favored Pre-proline 0 CA--C 1.535 0.366 0 CA-C-O 118.811 -0.614 . . . . 0.0 109.643 175.226 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' B' B ' 8' ' ' PRO . . . . . . . . . . . . . 71.8 Cg_endo -90.48 142.85 3.59 Favored 'Trans proline' 0 N--CA 1.492 1.396 0 C-N-CA 121.578 1.519 . . . . 0.0 112.421 179.726 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' B' B ' 9' ' ' LEU . . . . . . . . . . . . . 19.5 mt -87.08 -49.64 0.46 Allowed Pre-proline 0 CA--C 1.535 0.386 0 CA-C-O 118.669 -0.682 . . . . 0.0 112.477 -179.399 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' B' B ' 10' ' ' PRO . . . . . . . . . . . . . 95.7 Cg_endo -79.12 163.03 25.64 Favored 'Trans proline' 0 N--CA 1.496 1.657 0 C-N-CA 121.317 1.344 . . . . 0.0 112.315 -178.995 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' B' B ' 11' ' ' LYS . . . . . . . . . . . . . 26.5 tptp -87.09 104.06 15.98 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.404 178.604 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' B' B ' 12' ' ' VAL . . . . . . . . . . . . . 12.5 p -147.83 147.09 17.57 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.231 0 CA-C-N 116.31 -0.404 . . . . 0.0 110.684 -179.661 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' B' B ' 13' ' ' GLU . . . . . . . . . . . . . 84.7 tt0 -100.34 124.57 45.99 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.158 -0.474 . . . . 0.0 110.079 177.447 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' B' B ' 14' ' ' LEU . . . . . . . . . . . . . 30.3 mt -98.93 151.46 37.4 Favored Pre-proline 0 CA--C 1.533 0.291 0 CA-C-O 119.311 -0.376 . . . . 0.0 111.228 -176.329 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' B' B ' 15' ' ' PRO . . . . . . . . . . . . . 24.2 Cg_exo -63.84 162.25 29.46 Favored 'Trans proline' 0 N--CA 1.498 1.792 0 C-N-CA 121.372 1.382 . . . . 0.0 111.97 175.625 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' B' B ' 16' ' ' PRO . . . . . . . . . . . . . 24.7 Cg_exo -62.41 -37.91 56.82 Favored 'Trans proline' 0 N--CA 1.497 1.694 0 C-N-CA 121.409 1.406 . . . . 0.0 112.469 179.235 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' B' B ' 17' ' ' ASP . . . . . . . . . . . . . 10.0 p-10 -85.25 12.33 8.28 Favored 'General case' 0 CA--C 1.536 0.423 0 N-CA-C 113.012 0.745 . . . . 0.0 113.012 -178.303 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' B' B ' 18' ' ' PHE . . . . . . . . . . . . . 18.7 t80 -56.8 -41.55 77.94 Favored 'General case' 0 C--N 1.334 -0.095 0 O-C-N 121.899 -0.5 . . . . 0.0 110.358 -179.183 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' B' B ' 19' ' ' VAL . . . . . . . . . . . . . 46.8 t -55.63 -41.08 62.99 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.205 0 CA-C-N 116.5 -0.318 . . . . 0.0 110.577 -179.45 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' B' B ' 20' ' ' ASP . . . . . . . . . . . . . 74.6 m-20 -59.33 -41.49 89.26 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-O 121.015 0.436 . . . . 0.0 110.427 179.942 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' B' B ' 21' ' ' VAL . . . . . . . . . . . . . 47.9 t -64.11 -46.0 94.92 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.306 0 CA-C-N 116.136 -0.484 . . . . 0.0 110.386 179.936 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' B' B ' 22' ' ' ILE . . . . . . . . . . . . . 51.2 mm -53.98 -60.02 1.66 Allowed 'Isoleucine or valine' 0 CA--C 1.53 0.191 0 C-N-CA 120.959 -0.296 . . . . 0.0 111.42 -178.324 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' B' B ' 23' ' ' ARG . . . . . . . . . . . . . 6.0 ptm180 -54.84 -44.75 74.2 Favored 'General case' 0 CA--C 1.53 0.184 0 C-N-CA 120.513 -0.475 . . . . 0.0 111.853 -174.244 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' B' B ' 24' ' ' ILE . . . . . . . . . . . . . 81.0 mt -61.03 -45.12 99.18 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.268 0 C-N-CA 120.836 -0.346 . . . . 0.0 111.663 -176.67 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' B' B ' 25' ' ' LYS . . . . . . . . . . . . . 72.1 mmtt -68.78 -42.56 77.22 Favored 'General case' 0 C--N 1.33 -0.267 0 N-CA-C 112.355 0.502 . . . . 0.0 112.355 -177.186 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' B' B ' 26' ' ' LEU . . . . . . . . . . . . . 83.0 mt -79.4 -33.97 42.26 Favored 'General case' 0 C--N 1.33 -0.275 0 N-CA-C 113.679 0.992 . . . . 0.0 113.679 -168.571 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' B' B ' 27' ' ' GLN . . . . . . . . . . . . . 10.6 pt20 -46.7 141.27 3.95 Favored 'General case' 0 N--CA 1.469 0.504 0 N-CA-C 112.785 0.661 . . . . 0.0 112.785 -175.577 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' B' B ' 28' ' ' GLY . . . . . . . . . . . . . . . 101.59 -27.16 21.73 Favored Glycine 0 CA--C 1.531 1.077 0 CA-C-N 115.612 -0.722 . . . . 0.0 112.205 -177.389 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' B' B ' 29' ' ' LYS . . . . . . . . . . . . . 68.0 mttm -97.48 155.09 17.09 Favored 'General case' 0 C--O 1.232 0.155 0 CA-C-N 117.451 0.625 . . . . 0.0 111.07 178.051 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' B' B ' 30' ' ' THR . . . . . . . . . . . . . 29.8 m -107.38 139.63 41.57 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.032 -0.531 . . . . 0.0 110.294 177.719 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' B' B ' 31' ' ' VAL . . . . . . . . . . . . . 34.5 m -129.25 152.97 38.0 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.212 0 CA-C-N 116.211 -0.45 . . . . 0.0 110.658 -179.256 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' B' B ' 32' ' ' ARG . . . . . . . . . . . . . 57.8 ttt180 -130.78 151.11 51.58 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-O 121.119 0.485 . . . . 0.0 110.243 178.798 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' B' B ' 33' ' ' THR . . . . . . . . . . . . . 21.6 m -52.12 137.16 28.39 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.366 -0.379 . . . . 0.0 111.676 -176.705 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' B' B ' 34' ' ' GLY . . . . . . . . . . . . . . . 100.61 -17.21 56.92 Favored Glycine 0 CA--C 1.532 1.154 0 CA-C-N 116.042 -0.526 . . . . 0.0 113.39 178.283 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' B' B ' 35' ' ' ASP . . . . . . . . . . . . . 78.3 m-20 -67.4 151.22 47.8 Favored 'General case' 0 C--O 1.231 0.129 0 CA-C-N 118.002 0.901 . . . . 0.0 111.244 179.141 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' B' B ' 36' ' ' VAL . . . . . . . . . . . . . 45.8 t -120.66 130.12 74.88 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.252 0 CA-C-N 115.996 -0.547 . . . . 0.0 109.806 177.429 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' B' B ' 37' ' ' ILE . . . . . . . . . . . . . 63.0 mt -119.53 138.24 50.81 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.256 0 CA-C-N 116.16 -0.473 . . . . 0.0 109.743 -179.132 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' B' B ' 38' ' ' GLY . . . . . . . . . . . . . . . -116.02 128.72 8.13 Favored Glycine 0 CA--C 1.526 0.724 0 N-CA-C 111.096 -0.802 . . . . 0.0 111.096 -179.765 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' B' B ' 39' ' ' ILE . . . . . . . . . . . . . 74.8 mt -130.58 131.0 65.16 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.237 0 N-CA-C 110.134 -0.321 . . . . 0.0 110.134 178.878 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' B' B ' 40' ' ' SER . . . . . . . . . . . . . 68.2 p -92.79 115.22 27.91 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 116.418 -0.355 . . . . 0.0 110.911 176.47 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' B' B ' 41' ' ' ILE . . . . . . . . . . . . . 44.0 mm -122.07 128.86 75.7 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.232 0 CA-C-N 116.476 -0.329 . . . . 0.0 110.276 -179.934 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' B' B ' 42' ' ' LEU . . . . . . . . . . . . . 49.9 mt 55.32 33.52 20.91 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.24 -0.436 . . . . 0.0 111.825 177.263 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' B' B ' 43' ' ' GLY . . . . . . . . . . . . . . . 72.56 27.62 69.09 Favored Glycine 0 CA--C 1.531 1.052 0 C-N-CA 121.203 -0.522 . . . . 0.0 112.393 177.646 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' B' B ' 44' ' ' LYS . . . . . . . . . . . . . 49.4 tptt -141.9 128.32 20.05 Favored 'General case' 0 C--N 1.331 -0.227 0 N-CA-C 109.65 -0.5 . . . . 0.0 109.65 177.832 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' B' B ' 45' ' ' GLU . . . . . . . . . . . . . 44.1 tp10 -82.93 128.06 34.1 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-O 120.891 0.377 . . . . 0.0 111.323 -176.147 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' B' B ' 46' ' ' VAL . . . . . . . . . . . . . 8.5 p -121.86 128.08 75.59 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.255 0 N-CA-C 109.5 -0.556 . . . . 0.0 109.5 174.765 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' B' B ' 47' ' ' LYS . . . . . . . . . . . . . 52.0 mtpt -98.86 127.26 44.74 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.011 -0.54 . . . . 0.0 110.616 177.41 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' B' B ' 48' ' ' PHE . . . . . . . . . . . . . 46.1 m-85 -111.05 131.84 54.74 Favored 'General case' 0 C--N 1.329 -0.309 0 N-CA-C 109.667 -0.494 . . . . 0.0 109.667 177.082 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' B' B ' 49' ' ' LYS . . . . . . . . . . . . . 77.5 tttt -104.71 133.32 49.75 Favored 'General case' 0 C--N 1.328 -0.327 0 N-CA-C 109.926 -0.398 . . . . 0.0 109.926 178.225 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' B' B ' 50' ' ' VAL . . . . . . . . . . . . . 42.3 t -77.76 105.45 6.8 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.28 0 N-CA-C 109.38 -0.6 . . . . 0.0 109.38 178.169 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' B' B ' 51' ' ' VAL . . . . . . . . . . . . . 49.8 t -73.02 -47.28 48.7 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.372 0 CA-C-N 116.061 -0.518 . . . . 0.0 109.879 -174.693 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' B' B ' 52' ' ' GLN . . . . . . . . . . . . . 62.1 tt0 -158.97 138.43 11.59 Favored 'General case' 0 C--N 1.33 -0.274 0 C-N-CA 120.417 -0.513 . . . . 0.0 111.486 -178.241 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' B' B ' 53' ' ' ALA . . . . . . . . . . . . . . . -117.13 130.7 56.8 Favored 'General case' 0 C--N 1.332 -0.193 0 CA-C-N 115.687 -0.688 . . . . 0.0 109.632 172.058 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' B' B ' 54' ' ' TYR . . . . . . . . . . . . . 57.9 t80 -129.18 112.17 18.29 Favored Pre-proline 0 CA--C 1.536 0.432 0 CA-C-O 118.189 -0.91 . . . . 0.0 110.359 178.933 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' B' B ' 55' ' ' PRO . . . . . . . . . . . . . 74.3 Cg_endo -77.11 168.89 75.76 Favored 'Cis proline' 0 N--CA 1.5 1.9 0 CA-C-N 121.973 1.74 . . . . 0.0 112.156 -6.002 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' B' B ' 56' ' ' SER . . . . . . . . . . . . . 13.5 m -116.6 134.88 22.84 Favored Pre-proline 0 CA--C 1.538 0.492 0 CA-C-O 118.478 -0.772 . . . . 0.0 109.456 175.881 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' B' B ' 57' ' ' PRO . . . . . . . . . . . . . 56.0 Cg_endo -72.11 146.73 86.87 Favored 'Cis proline' 0 N--CA 1.497 1.728 0 CA-C-N 121.842 1.694 . . . . 0.0 111.496 -2.229 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' B' B ' 58' ' ' LEU . . . . . . . . . . . . . 25.0 tp -108.35 136.81 47.36 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.378 -0.374 . . . . 0.0 110.832 -177.667 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' B' B ' 59' ' ' ARG . . . . . . . . . . . . . 29.0 ttm180 -100.51 125.9 46.89 Favored 'General case' 0 C--N 1.328 -0.34 0 N-CA-C 109.371 -0.603 . . . . 0.0 109.371 175.521 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' B' B ' 60' ' ' VAL . . . . . . . . . . . . . 40.8 t -78.04 121.73 31.44 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.247 0 C-N-CA 120.828 -0.349 . . . . 0.0 110.848 -174.798 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' B' B ' 61' ' ' GLU . . . . . . . . . . . . . 42.9 mt-10 -130.96 154.05 48.55 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 115.744 -0.662 . . . . 0.0 109.822 175.308 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' B' B ' 62' ' ' ASP . . . . . . . . . . . . . 19.8 p-10 -53.72 -33.64 56.26 Favored 'General case' 0 C--N 1.327 -0.397 0 N-CA-C 111.843 0.312 . . . . 0.0 111.843 -177.792 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' B' B ' 63' ' ' ARG . . . . . . . . . . . . . 36.5 mmt180 -75.66 -18.61 59.59 Favored 'General case' 0 CA--C 1.535 0.371 0 N-CA-C 113.099 0.778 . . . . 0.0 113.099 -175.969 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' B' B ' 64' ' ' THR . . . . . . . . . . . . . 24.0 m -67.2 147.91 52.46 Favored 'General case' 0 C--N 1.332 -0.172 0 CA-C-N 117.724 0.238 . . . . 0.0 110.48 -177.06 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' B' B ' 65' ' ' LYS . . . . . . . . . . . . . 98.4 mttt -87.61 122.95 31.95 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-O 120.937 0.398 . . . . 0.0 110.116 -179.648 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' B' B ' 66' ' ' ILE . . . . . . . . . . . . . 63.4 mt -108.57 120.27 59.64 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.26 0 N-CA-C 109.581 -0.526 . . . . 0.0 109.581 179.183 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' B' B ' 67' ' ' THR . . . . . . . . . . . . . 4.6 m -109.36 140.69 42.73 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-O 121.338 0.59 . . . . 0.0 111.132 -173.511 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' B' B ' 68' ' ' LEU . . . . . . . . . . . . . 7.0 tt -104.38 126.07 51.16 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 115.202 -0.908 . . . . 0.0 110.121 -178.926 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' B' B ' 69' ' ' VAL . . . . . . . . . . . . . 45.1 t -82.91 155.18 3.85 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.19 0 CA-C-N 115.931 -0.577 . . . . 0.0 109.966 178.887 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' B' B ' 70' ' ' THR . . . . . . . . . . . . . 74.4 p -74.66 161.66 29.47 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-O 121.097 0.475 . . . . 0.0 110.274 -172.835 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' B' B ' 71' ' ' HIS . . . . . . . . . . . . . 25.3 m-70 -124.92 174.04 4.23 Favored Pre-proline 0 C--N 1.33 -0.263 0 CA-C-N 115.656 -0.702 . . . . 0.0 110.28 -169.776 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' B' B ' 72' ' ' PRO . . . . . . . . . . . . . 26.3 Cg_exo -64.79 160.38 40.99 Favored 'Trans proline' 0 N--CA 1.494 1.548 0 C-N-CA 121.522 1.481 . . . . 0.0 110.632 171.339 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' B' B ' 73' ' ' VAL . . . . . . . . . . . . . 34.2 m -69.51 167.65 1.76 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.368 0 C-N-CA 120.762 -0.375 . . . . 0.0 110.377 -168.316 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' B' B ' 74' ' ' ASP . . . . . . . . . . . . . 26.4 t0 -78.85 123.89 27.68 Favored 'General case' 0 C--N 1.331 -0.205 0 CA-C-N 116.259 -0.428 . . . . 0.0 111.156 -165.058 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' B' B ' 75' ' ' VAL . . . . . . . . . . . . . 47.0 t -119.7 118.83 58.5 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.218 0 CA-C-N 116.138 -0.483 . . . . 0.0 110.098 -179.571 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' B' B ' 76' ' ' LEU . . . . . . . . . . . . . 23.8 mt -124.33 145.37 49.46 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 115.63 -0.714 . . . . 0.0 109.688 -179.966 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' B' B ' 77' ' ' GLU . . . . . . . . . . . . . 96.0 mt-10 -136.42 134.94 38.28 Favored 'General case' 0 C--N 1.331 -0.227 0 CA-C-O 121.056 0.455 . . . . 0.0 111.184 -178.606 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' B' B ' 78' ' ' ALA . . . . . . . . . . . . . . . -123.57 131.23 53.57 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 115.611 -0.722 . . . . 0.0 109.701 176.462 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' B' B ' 79' ' ' LYS . . . . . . . . . . . . . 97.3 mttt -77.32 120.33 22.19 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-O 121.043 0.449 . . . . 0.0 111.266 -175.389 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' B' B ' 80' ' ' ILE . . . . . . . . . . . . . 25.9 mm -139.27 101.14 1.49 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.256 0 N-CA-C 109.015 -0.735 . . . . 0.0 109.015 179.11 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' B' B ' 81' ' ' LYS . . . . . . . . . . . . . 68.6 tttt -93.06 124.6 37.15 Favored 'General case' 0 C--N 1.328 -0.332 0 C-N-CA 120.776 -0.37 . . . . 0.0 110.993 -177.01 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' B' B ' 82' ' ' GLY . . . . . . . . . . . . . . . 89.2 42.14 5.65 Favored Glycine 0 CA--C 1.524 0.641 0 C-N-CA 120.738 -0.744 . . . . 0.0 111.416 176.288 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' B' B ' 83' ' ' ILE . . . . . . . . . . . . . 72.1 mt -64.45 137.76 24.31 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.352 0 N-CA-C 109.91 -0.404 . . . . 0.0 109.91 177.884 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' B' B ' 84' ' ' LYS . . . . . . . . . . . . . 80.2 tttt -93.51 -51.38 4.98 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 115.932 -0.576 . . . . 0.0 110.001 -179.426 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' B' B ' 85' ' ' ASP . . . . . . . . . . . . . 9.9 t70 -159.87 153.59 22.78 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 115.514 -0.766 . . . . 0.0 110.062 179.558 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' B' B ' 86' ' ' VAL . . . . . . . . . . . . . 43.9 t -129.94 132.15 65.8 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.212 0 CA-C-O 121.021 0.438 . . . . 0.0 110.479 -179.166 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' B' B ' 87' ' ' ILE . . . . . . . . . . . . . 43.5 mm -120.12 125.38 74.17 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.265 0 CA-C-N 115.665 -0.698 . . . . 0.0 109.221 177.132 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' B' B ' 88' ' ' LEU . . . . . . . . . . . . . 12.0 tp -114.51 127.92 56.06 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-O 121.021 0.439 . . . . 0.0 111.254 -176.788 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' B' B ' 89' ' ' ASP . . . . . . . . . . . . . 11.2 t70 -117.81 153.66 33.1 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 115.702 -0.681 . . . . 0.0 109.407 175.931 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' B' B ' 90' ' ' GLU . . . . . . . . . . . . . 84.6 tt0 -47.78 -35.5 10.12 Favored 'General case' 0 C--N 1.33 -0.282 0 N-CA-C 112.869 0.692 . . . . 0.0 112.869 -172.836 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' B' B ' 91' ' ' ASN . . . . . . . . . . . . . 18.3 p-10 -132.06 31.36 4.16 Favored 'General case' 0 N--CA 1.466 0.326 0 N-CA-C 112.256 0.465 . . . . 0.0 112.256 -175.808 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' B' B ' 92' ' ' LEU . . . . . . . . . . . . . 6.7 tp -166.13 145.1 5.9 Favored 'General case' 0 C--N 1.331 -0.213 0 C-N-CA 120.934 -0.307 . . . . 0.0 110.54 -179.619 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' B' B ' 93' ' ' ILE . . . . . . . . . . . . . 68.8 mt -123.14 123.36 67.67 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.264 0 N-CA-C 109.704 -0.48 . . . . 0.0 109.704 -179.413 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' B' B ' 94' ' ' VAL . . . . . . . . . . . . . 43.5 t -121.38 124.96 73.04 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.239 0 CA-C-O 120.967 0.413 . . . . 0.0 110.024 179.689 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' B' B ' 95' ' ' VAL . . . . . . . . . . . . . 45.9 t -119.68 133.4 66.58 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.283 0 CA-C-N 115.917 -0.583 . . . . 0.0 109.928 -179.071 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' B' B ' 96' ' ' ILE . . . . . . . . . . . . . 61.8 mt -114.59 126.38 72.12 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.366 0 N-CA-C 109.467 -0.568 . . . . 0.0 109.467 178.988 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' B' B ' 97' ' ' THR . . . . . . . . . . . . . 67.4 p -95.94 156.21 16.43 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-O 120.99 0.424 . . . . 0.0 110.812 -179.267 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' B' B ' 98' ' ' GLU . . . . . . . . . . . . . 40.1 tp10 -53.92 -28.66 38.19 Favored 'General case' 0 C--N 1.329 -0.287 0 N-CA-C 112.144 0.424 . . . . 0.0 112.144 -178.401 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' B' B ' 99' ' ' GLU . . . . . . . . . . . . . 14.7 pt-20 -81.54 17.25 1.45 Allowed 'General case' 0 CA--C 1.535 0.373 0 N-CA-C 113.326 0.862 . . . . 0.0 113.326 -176.19 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' B' B ' 100' ' ' ASN . . . . . . . . . . . . . 4.9 m-20 64.89 34.65 9.0 Favored 'General case' 0 N--CA 1.463 0.216 0 CA-C-O 120.793 0.33 . . . . 0.0 111.678 176.959 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' B' B ' 101' ' ' GLU . . . . . . . . . . . . . 84.5 tt0 -108.84 141.78 40.38 Favored 'General case' 0 C--N 1.331 -0.2 0 N-CA-C 109.642 -0.503 . . . . 0.0 109.642 172.226 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' B' B ' 102' ' ' VAL . . . . . . . . . . . . . 46.3 t -114.96 125.9 72.41 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.308 0 N-CA-C 109.967 -0.382 . . . . 0.0 109.967 -177.846 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' B' B ' 103' ' ' LEU . . . . . . . . . . . . . 57.4 mt -117.26 129.79 56.14 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 115.845 -0.616 . . . . 0.0 110.13 177.944 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' B' B ' 104' ' ' ILE . . . . . . . . . . . . . 67.8 mt -118.31 120.84 65.6 Favored 'Isoleucine or valine' 0 C--O 1.234 0.289 0 N-CA-C 110.161 -0.311 . . . . 0.0 110.161 -178.976 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' B' B ' 105' ' ' PHE . . . . . . . . . . . . . 74.6 m-85 -123.53 165.16 17.6 Favored 'General case' 0 C--N 1.333 -0.15 0 O-C-N 123.92 0.763 . . . . 0.0 109.836 -179.252 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' B' B ' 106' ' ' ASN . . . . . . . . . . . . . 46.7 p-10 -99.51 -170.77 1.95 Allowed 'General case' 0 C--N 1.33 -0.274 0 N-CA-C 109.788 -0.449 . . . . 0.0 109.788 171.832 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' B' B ' 107' ' ' GLN . . . . . . . . . . . . . 51.0 tt0 -57.58 -27.64 62.87 Favored 'General case' 0 C--N 1.327 -0.373 0 N-CA-C 112.305 0.483 . . . . 0.0 112.305 -178.944 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' B' B ' 108' ' ' ASN . . . . . . . . . . . . . 14.4 t30 -93.5 14.31 19.11 Favored 'General case' 0 CA--C 1.535 0.379 0 N-CA-C 113.0 0.741 . . . . 0.0 113.0 -175.43 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' B' B ' 109' ' ' LEU . . . . . . . . . . . . . 71.1 mt 59.12 37.7 24.04 Favored 'General case' 0 C--N 1.332 -0.189 0 CA-C-O 121.067 0.461 . . . . 0.0 111.377 177.596 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' B' B ' 110' ' ' GLU . . . . . . . . . . . . . 43.4 mt-10 -103.46 163.43 12.29 Favored 'General case' 0 C--N 1.331 -0.225 0 CA-C-N 116.388 -0.369 . . . . 0.0 110.223 177.331 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' B' B ' 111' ' ' GLU . . . . . . . . . . . . . 82.6 tt0 -84.58 124.9 31.94 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-O 120.94 0.4 . . . . 0.0 111.243 -177.22 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' B' B ' 112' ' ' LEU . . . . . . . . . . . . . 20.0 mt -113.02 -45.99 3.14 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 115.905 -0.589 . . . . 0.0 109.6 172.84 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' B' B ' 113' ' ' TYR . . . . . . . . . . . . . 34.9 t80 -150.64 137.04 18.72 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.02 -0.536 . . . . 0.0 110.821 179.097 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' B' B ' 114' ' ' ARG . . . . . . . . . . . . . 57.0 mtm180 -140.39 124.4 17.46 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-O 120.733 0.302 . . . . 0.0 110.306 175.242 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' B' B ' 115' ' ' GLY . . . . . . . . . . . . . . . -150.15 162.9 29.36 Favored Glycine 0 CA--C 1.523 0.566 0 N-CA-C 110.632 -0.987 . . . . 0.0 110.632 -179.555 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' B' B ' 116' ' ' LYS . . . . . . . . . . . . . 82.7 tttt -133.37 130.83 39.32 Favored 'General case' 0 C--N 1.33 -0.278 0 N-CA-C 109.918 -0.401 . . . . 0.0 109.918 178.553 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' B' B ' 117' ' ' PHE . . . . . . . . . . . . . 46.5 m-85 -125.79 118.43 25.51 Favored 'General case' 0 C--N 1.331 -0.227 0 CA-C-O 121.015 0.436 . . . . 0.0 110.49 -174.862 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' B' B ' 118' ' ' GLU . . . . . . . . . . . . . 44.5 tp10 -52.83 -49.38 65.82 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.397 -0.365 . . . . 0.0 111.572 -176.979 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' B' B ' 119' ' ' ASN . . . . . . . . . . . . . 20.4 m120 -95.76 31.21 2.12 Favored 'General case' 0 C--N 1.33 -0.253 0 N-CA-C 112.11 0.411 . . . . 0.0 112.11 -174.803 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' B' B ' 120' ' ' LEU . . . . . . . . . . . . . 13.7 tp -55.04 123.38 13.4 Favored 'General case' 0 N--CA 1.462 0.134 0 CA-C-O 120.711 0.291 . . . . 0.0 110.769 178.282 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' B' B ' 121' ' ' ASN . . . . . . . . . . . . . 60.5 t30 -113.58 -44.01 3.25 Favored 'General case' 0 C--N 1.332 -0.184 0 CA-C-N 116.337 -0.392 . . . . 0.0 110.822 -177.742 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' B' B ' 122' ' ' LYS . . . . . . . . . . . . . 97.8 mttt -148.53 150.72 33.87 Favored 'General case' 0 C--N 1.331 -0.229 0 CA-C-O 121.119 0.485 . . . . 0.0 111.562 -178.434 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' B' B ' 123' ' ' VAL . . . . . . . . . . . . . 47.4 t -131.74 129.35 61.19 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.224 0 N-CA-C 109.325 -0.62 . . . . 0.0 109.325 174.812 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' B' B ' 124' ' ' LEU . . . . . . . . . . . . . 67.3 mt -130.87 142.65 50.39 Favored 'General case' 0 C--N 1.331 -0.203 0 CA-C-O 120.959 0.409 . . . . 0.0 110.769 -177.438 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' B' B ' 125' ' ' VAL . . . . . . . . . . . . . 12.1 p -135.7 138.32 48.07 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.255 0 CA-C-N 116.005 -0.543 . . . . 0.0 110.555 179.946 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' B' B ' 126' ' ' ARG . . . . . . . . . . . . . 75.3 mtt180 -148.08 121.95 9.35 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 115.838 -0.619 . . . . 0.0 109.393 178.04 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' B' B ' 127' ' ' ASN . . . . . . . . . . . . . 71.6 m-80 57.04 -147.44 0.52 Allowed 'General case' 0 CA--C 1.541 0.614 0 N-CA-C 109.602 -0.518 . . . . 0.0 109.602 -178.278 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' B' B ' 128' ' ' ASP . . . . . . . . . . . . . 23.1 p-10 -83.44 12.62 5.3 Favored 'General case' 0 CA--C 1.537 0.464 0 CA-C-N 118.845 0.748 . . . . 0.0 112.989 179.199 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' B' B ' 129' ' ' LEU . . . . . . . . . . . . . 19.6 tp -109.03 136.45 48.53 Favored 'General case' 0 C--O 1.231 0.084 0 N-CA-C 109.747 -0.464 . . . . 0.0 109.747 178.32 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' B' B ' 130' ' ' VAL . . . . . . . . . . . . . 12.3 p -131.3 141.76 45.12 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.213 0 CA-C-O 120.982 0.42 . . . . 0.0 110.637 -178.806 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' B' B ' 131' ' ' VAL . . . . . . . . . . . . . 41.5 t -136.14 138.37 47.3 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 CA-C-N 116.021 -0.536 . . . . 0.0 110.495 -178.741 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' B' B ' 132' ' ' ILE . . . . . . . . . . . . . 73.1 mt -116.79 133.64 62.82 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.323 0 CA-C-N 115.591 -0.731 . . . . 0.0 109.244 178.448 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' B' B ' 133' ' ' ILE . . . . . . . . . . . . . 41.1 mm -115.94 120.81 65.9 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.268 0 CA-C-O 120.714 0.293 . . . . 0.0 111.018 -175.521 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' B' B ' 134' ' ' ASP . . . . . . . . . . . . . 7.5 p-10 -131.98 144.98 51.19 Favored 'General case' 0 C--N 1.33 -0.262 0 N-CA-C 109.433 -0.58 . . . . 0.0 109.433 175.124 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' B' B ' 135' ' ' GLU . . . . . . . . . . . . . 83.7 tt0 -50.06 -26.23 4.2 Favored 'General case' 0 C--N 1.328 -0.348 0 N-CA-C 112.861 0.689 . . . . 0.0 112.861 -173.682 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' B' B ' 136' ' ' GLN . . . . . . . . . . . . . 97.1 mt-30 -78.51 -35.8 45.81 Favored 'General case' 0 C--O 1.234 0.245 0 N-CA-C 112.058 0.392 . . . . 0.0 112.058 -177.465 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' B' B ' 137' ' ' LYS . . . . . . . . . . . . . 56.2 pttt -170.0 173.66 5.89 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-O 121.426 0.631 . . . . 0.0 111.907 -172.613 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' B' B ' 138' ' ' LEU . . . . . . . . . . . . . 8.2 tt -116.31 130.14 56.63 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 115.415 -0.811 . . . . 0.0 110.136 179.557 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' B' B ' 139' ' ' THR . . . . . . . . . . . . . 25.8 m -108.07 124.35 50.07 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.069 -0.514 . . . . 0.0 110.501 179.995 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' B' B ' 140' ' ' LEU . . . . . . . . . . . . . 49.7 tp -113.08 121.07 43.48 Favored 'General case' 0 C--N 1.328 -0.351 0 N-CA-C 109.094 -0.706 . . . . 0.0 109.094 -179.241 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' B' B ' 141' ' ' ILE . . . . . . . . . . . . . 19.0 mt -121.23 121.1 63.95 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.309 0 CA-C-O 120.985 0.422 . . . . 0.0 110.189 -175.261 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' B' B ' 142' ' ' ARG . . . . . . . . . . . . . 61.4 mtp180 -105.21 120.81 42.45 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 115.15 -0.932 . . . . 0.0 109.985 179.363 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' B' B ' 143' ' ' THR . . . . . . . . . . . . . 35.9 p . . . . . 0 C--O 1.22 -0.486 0 CA-C-O 118.065 -0.969 . . . . 0.0 110.604 -179.697 . . . . . . . . 0 0 . 1 . 019 nuclear orig full ' C' C ' -3' ' ' GLU . . . . . . . . . . . . . 84.8 tt0 . . . . . 0 N--CA 1.49 1.541 0 N-CA-C 109.278 -0.638 . . . . 0.0 109.278 . . . . . . . . . 0 0 . 1 . 019 nuclear orig full ' C' C ' -2' ' ' GLY . . . . . . . . . . . . . . . -78.59 149.98 34.13 Favored Glycine 0 CA--C 1.526 0.742 0 N-CA-C 111.007 -0.837 . . . . 0.0 111.007 179.391 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' C' C ' -1' ' ' VAL . . . . . . . . . . . . . 43.1 t -94.92 137.46 23.22 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.303 0 N-CA-C 109.998 -0.371 . . . . 0.0 109.998 179.591 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' C' C ' 0' ' ' ILE . . . . . . . . . . . . . 43.8 mm -104.55 131.92 52.4 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.282 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.201 -179.348 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' C' C ' 1' ' ' MET . . . . . . . . . . . . . 26.4 ptm -78.43 139.13 38.75 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.022 -0.535 . . . . 0.0 110.948 -179.286 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' C' C ' 2' ' ' SER . . . . . . . . . . . . . 3.1 p -117.91 127.96 54.36 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.351 177.474 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' C' C ' 3' ' ' GLU . . . . . . . . . . . . . 84.8 tt0 -141.24 141.61 33.99 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 115.89 -0.595 . . . . 0.0 110.954 -178.891 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' C' C ' 4' ' ' LEU . . . . . . . . . . . . . 19.2 tp -126.14 129.08 48.35 Favored 'General case' 0 C--N 1.331 -0.216 0 CA-C-N 115.866 -0.606 . . . . 0.0 110.257 177.73 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' C' C ' 5' ' ' LYS . . . . . . . . . . . . . 66.9 mttm -105.35 120.96 42.88 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.255 -0.429 . . . . 0.0 110.543 178.728 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' C' C ' 6' ' ' LEU . . . . . . . . . . . . . 55.1 mt -116.56 146.53 42.57 Favored 'General case' 0 C--N 1.331 -0.23 0 O-C-N 123.831 0.707 . . . . 0.0 110.109 -179.703 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' C' C ' 7' ' ' LYS . . . . . . . . . . . . . 49.8 tttp -126.83 137.67 30.99 Favored Pre-proline 0 CA--C 1.534 0.329 0 CA-C-O 118.901 -0.571 . . . . 0.0 109.912 175.664 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' C' C ' 8' ' ' PRO . . . . . . . . . . . . . 89.8 Cg_endo -92.1 131.72 1.17 Allowed 'Trans proline' 0 N--CA 1.489 1.257 0 C-N-CA 121.661 1.574 . . . . 0.0 111.673 178.016 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' C' C ' 9' ' ' LEU . . . . . . . . . . . . . 64.8 mt -70.98 -46.59 15.0 Favored Pre-proline 0 CA--C 1.533 0.303 0 CA-C-O 118.808 -0.615 . . . . 0.0 112.191 -179.053 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' C' C ' 10' ' ' PRO . . . . . . . . . . . . . 85.8 Cg_endo -81.79 147.89 15.47 Favored 'Trans proline' 0 N--CA 1.495 1.617 0 C-N-CA 121.237 1.291 . . . . 0.0 111.574 174.26 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' C' C ' 11' ' ' LYS . . . . . . . . . . . . . 60.7 tttm -88.14 96.54 10.57 Favored 'General case' 0 C--N 1.33 -0.254 0 C-N-CA 120.862 -0.335 . . . . 0.0 110.455 179.145 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' C' C ' 12' ' ' VAL . . . . . . . . . . . . . 12.5 p -140.06 146.78 24.35 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.321 0 CA-C-N 116.241 -0.436 . . . . 0.0 110.512 -179.79 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' C' C ' 13' ' ' GLU . . . . . . . . . . . . . 81.4 tt0 -85.86 125.8 33.57 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.243 -0.435 . . . . 0.0 110.008 177.949 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' C' C ' 14' ' ' LEU . . . . . . . . . . . . . 17.6 mt -96.94 149.63 35.94 Favored Pre-proline 0 CA--C 1.532 0.263 0 CA-C-O 119.262 -0.399 . . . . 0.0 110.366 -178.708 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' C' C ' 15' ' ' PRO . . . . . . . . . . . . . 26.1 Cg_exo -61.76 160.65 28.01 Favored 'Trans proline' 0 N--CA 1.497 1.732 0 C-N-CA 121.23 1.287 . . . . 0.0 111.852 177.496 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' C' C ' 16' ' ' PRO . . . . . . . . . . . . . 34.0 Cg_exo -59.5 -34.01 97.07 Favored 'Trans proline' 0 N--CA 1.498 1.754 0 C-N-CA 121.437 1.425 . . . . 0.0 112.714 -178.127 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' C' C ' 17' ' ' ASP . . . . . . . . . . . . . 18.5 p-10 -87.88 3.58 47.91 Favored 'General case' 0 CA--C 1.536 0.435 0 N-CA-C 113.409 0.892 . . . . 0.0 113.409 -177.042 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' C' C ' 18' ' ' PHE . . . . . . . . . . . . . 43.3 t80 -58.18 -46.5 85.64 Favored 'General case' 0 C--N 1.334 -0.091 0 O-C-N 122.046 -0.409 . . . . 0.0 110.098 -177.689 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' C' C ' 19' ' ' VAL . . . . . . . . . . . . . 47.8 t -56.75 -43.0 78.59 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.372 0 CA-C-N 116.27 -0.423 . . . . 0.0 110.608 -177.895 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' C' C ' 20' ' ' ASP . . . . . . . . . . . . . 67.7 m-20 -59.66 -43.0 94.11 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-O 120.786 0.327 . . . . 0.0 110.813 -177.549 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' C' C ' 21' ' ' VAL . . . . . . . . . . . . . 46.2 t -64.01 -45.41 96.78 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.32 0 C-N-CA 120.818 -0.353 . . . . 0.0 110.425 -177.848 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' C' C ' 22' ' ' ILE . . . . . . . . . . . . . 51.8 mm -54.96 -48.44 75.26 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.276 0 C-N-CA 120.993 -0.283 . . . . 0.0 110.743 179.032 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' C' C ' 23' ' ' ARG . . . . . . . . . . . . . 54.3 ttp180 -54.65 -47.93 72.93 Favored 'General case' 0 C--N 1.33 -0.258 0 C-N-CA 121.022 -0.271 . . . . 0.0 111.355 -178.328 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' C' C ' 24' ' ' ILE . . . . . . . . . . . . . 74.2 mt -59.11 -42.89 87.98 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.34 0 C-N-CA 121.184 -0.206 . . . . 0.0 111.208 -177.901 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' C' C ' 25' ' ' LYS . . . . . . . . . . . . . 73.9 mmtt -66.68 -41.37 88.21 Favored 'General case' 0 C--N 1.328 -0.335 0 N-CA-C 112.253 0.464 . . . . 0.0 112.253 -178.428 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' C' C ' 26' ' ' LEU . . . . . . . . . . . . . 83.1 mt -79.22 -38.76 34.9 Favored 'General case' 0 C--N 1.328 -0.332 0 N-CA-C 113.283 0.845 . . . . 0.0 113.283 -169.872 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' C' C ' 27' ' ' GLN . . . . . . . . . . . . . 10.4 pt20 -47.06 140.05 5.28 Favored 'General case' 0 N--CA 1.468 0.444 0 N-CA-C 112.78 0.659 . . . . 0.0 112.78 -175.831 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' C' C ' 28' ' ' GLY . . . . . . . . . . . . . . . 99.15 -25.7 27.21 Favored Glycine 0 CA--C 1.533 1.159 0 CA-C-N 115.687 -0.688 . . . . 0.0 112.297 -177.013 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' C' C ' 29' ' ' LYS . . . . . . . . . . . . . 87.5 mttt -97.89 155.11 17.22 Favored 'General case' 0 C--N 1.331 -0.199 0 CA-C-N 117.357 0.579 . . . . 0.0 111.053 179.362 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' C' C ' 30' ' ' THR . . . . . . . . . . . . . 26.2 m -103.79 138.3 40.59 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.133 -0.485 . . . . 0.0 110.1 176.696 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' C' C ' 31' ' ' VAL . . . . . . . . . . . . . 34.4 m -129.85 151.14 35.39 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.201 0 CA-C-O 120.868 0.366 . . . . 0.0 110.986 -178.429 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' C' C ' 32' ' ' ARG . . . . . . . . . . . . . 71.3 mtt85 -127.91 149.19 50.42 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 115.971 -0.558 . . . . 0.0 110.489 178.743 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' C' C ' 33' ' ' THR . . . . . . . . . . . . . 30.3 m -53.18 138.76 30.85 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.43 -0.35 . . . . 0.0 111.375 -179.175 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' C' C ' 34' ' ' GLY . . . . . . . . . . . . . . . 100.23 -17.2 57.32 Favored Glycine 0 CA--C 1.533 1.159 0 C-N-CA 121.307 -0.473 . . . . 0.0 113.223 179.266 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' C' C ' 35' ' ' ASP . . . . . . . . . . . . . 76.2 m-20 -66.63 149.3 50.69 Favored 'General case' 0 N--CA 1.462 0.151 0 CA-C-N 117.967 0.883 . . . . 0.0 111.155 179.361 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' C' C ' 36' ' ' VAL . . . . . . . . . . . . . 44.6 t -119.3 128.99 75.83 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.26 0 CA-C-N 115.845 -0.616 . . . . 0.0 109.674 177.929 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' C' C ' 37' ' ' ILE . . . . . . . . . . . . . 65.6 mt -119.83 138.28 50.95 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.271 0 CA-C-N 116.151 -0.477 . . . . 0.0 109.804 -179.466 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' C' C ' 38' ' ' GLY . . . . . . . . . . . . . . . -116.9 128.71 8.02 Favored Glycine 0 CA--C 1.525 0.667 0 N-CA-C 111.121 -0.792 . . . . 0.0 111.121 -179.653 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' C' C ' 39' ' ' ILE . . . . . . . . . . . . . 70.7 mt -127.0 127.05 69.35 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.256 0 N-CA-C 109.961 -0.385 . . . . 0.0 109.961 178.268 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' C' C ' 40' ' ' SER . . . . . . . . . . . . . 59.6 p -91.41 113.94 26.34 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.561 -0.29 . . . . 0.0 110.988 177.773 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' C' C ' 41' ' ' ILE . . . . . . . . . . . . . 45.5 mm -123.3 128.14 74.69 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.248 0 CA-C-N 116.408 -0.36 . . . . 0.0 110.063 179.694 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' C' C ' 42' ' ' LEU . . . . . . . . . . . . . 69.8 mt 58.02 33.86 23.63 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 116.194 -0.457 . . . . 0.0 111.779 176.934 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' C' C ' 43' ' ' GLY . . . . . . . . . . . . . . . 73.11 21.81 79.5 Favored Glycine 0 CA--C 1.533 1.195 0 C-N-CA 121.227 -0.511 . . . . 0.0 112.89 177.623 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' C' C ' 44' ' ' LYS . . . . . . . . . . . . . 67.6 mttm -138.25 130.54 28.88 Favored 'General case' 0 C--N 1.332 -0.16 0 CA-C-N 117.41 0.605 . . . . 0.0 109.919 177.548 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' C' C ' 45' ' ' GLU . . . . . . . . . . . . . 43.5 tp10 -84.06 127.26 33.78 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.367 -0.379 . . . . 0.0 111.413 -177.545 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' C' C ' 46' ' ' VAL . . . . . . . . . . . . . 8.9 p -116.06 127.3 73.7 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.282 0 N-CA-C 109.249 -0.648 . . . . 0.0 109.249 173.312 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' C' C ' 47' ' ' LYS . . . . . . . . . . . . . 64.8 mttp -98.07 126.16 43.38 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 116.104 -0.498 . . . . 0.0 110.787 178.715 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' C' C ' 48' ' ' PHE . . . . . . . . . . . . . 34.2 m-85 -110.82 131.88 54.67 Favored 'General case' 0 C--N 1.328 -0.345 0 N-CA-C 109.453 -0.573 . . . . 0.0 109.453 177.159 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' C' C ' 49' ' ' LYS . . . . . . . . . . . . . 45.2 tttp -105.65 133.27 50.67 Favored 'General case' 0 C--N 1.328 -0.354 0 N-CA-C 110.085 -0.339 . . . . 0.0 110.085 178.831 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' C' C ' 50' ' ' VAL . . . . . . . . . . . . . 46.2 t -75.79 102.4 2.83 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.324 0 N-CA-C 109.189 -0.671 . . . . 0.0 109.189 176.669 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' C' C ' 51' ' ' VAL . . . . . . . . . . . . . 47.0 t -70.03 -48.18 64.22 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.279 0 CA-C-N 116.005 -0.543 . . . . 0.0 109.895 -174.293 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' C' C ' 52' ' ' GLN . . . . . . . . . . . . . 62.0 tt0 -160.14 138.92 10.54 Favored 'General case' 0 C--N 1.33 -0.252 0 C-N-CA 120.382 -0.527 . . . . 0.0 111.631 -178.8 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' C' C ' 53' ' ' ALA . . . . . . . . . . . . . . . -111.55 130.97 55.57 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 115.665 -0.698 . . . . 0.0 109.806 176.012 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' C' C ' 54' ' ' TYR . . . . . . . . . . . . . 45.7 t80 -128.93 107.32 18.19 Favored Pre-proline 0 CA--C 1.535 0.395 0 CA-C-O 118.335 -0.841 . . . . 0.0 110.54 -179.04 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' C' C ' 55' ' ' PRO . . . . . . . . . . . . . 73.7 Cg_endo -77.12 170.04 72.65 Favored 'Cis proline' 0 N--CA 1.499 1.81 0 CA-C-N 121.784 1.673 . . . . 0.0 112.355 -6.158 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' C' C ' 56' ' ' SER . . . . . . . . . . . . . 69.8 m -117.06 132.33 23.52 Favored Pre-proline 0 CA--C 1.539 0.544 0 CA-C-O 118.492 -0.766 . . . . 0.0 109.476 175.371 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' C' C ' 57' ' ' PRO . . . . . . . . . . . . . 44.2 Cg_endo -69.35 147.4 83.72 Favored 'Cis proline' 0 N--CA 1.498 1.767 0 CA-C-N 121.909 1.718 . . . . 0.0 111.335 -1.46 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' C' C ' 58' ' ' LEU . . . . . . . . . . . . . 27.0 tp -107.06 136.63 46.59 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.372 -0.377 . . . . 0.0 110.68 -178.017 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' C' C ' 59' ' ' ARG . . . . . . . . . . . . . 75.4 ttt180 -102.12 120.79 41.02 Favored 'General case' 0 C--N 1.325 -0.482 0 N-CA-C 109.364 -0.606 . . . . 0.0 109.364 176.27 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' C' C ' 60' ' ' VAL . . . . . . . . . . . . . 40.8 t -74.31 122.09 26.9 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.268 0 C-N-CA 120.633 -0.427 . . . . 0.0 110.09 -176.021 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' C' C ' 61' ' ' GLU . . . . . . . . . . . . . 32.4 tp10 -130.72 157.78 41.87 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 115.994 -0.548 . . . . 0.0 109.759 -178.409 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' C' C ' 62' ' ' ASP . . . . . . . . . . . . . 35.7 m-20 -53.22 -32.5 48.51 Favored 'General case' 0 C--N 1.326 -0.417 0 N-CA-C 111.762 0.282 . . . . 0.0 111.762 179.947 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' C' C ' 63' ' ' ARG . . . . . . . . . . . . . 9.5 ptm180 -86.25 6.56 29.07 Favored 'General case' 0 CA--C 1.535 0.397 0 N-CA-C 113.551 0.945 . . . . 0.0 113.551 -177.522 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' C' C ' 64' ' ' THR . . . . . . . . . . . . . 37.6 m -83.58 137.87 33.64 Favored 'General case' 0 C--N 1.332 -0.166 0 CA-C-N 118.095 0.407 . . . . 0.0 110.569 -178.144 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' C' C ' 65' ' ' LYS . . . . . . . . . . . . . 53.4 mtmt -89.67 127.27 35.9 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 116.016 -0.538 . . . . 0.0 110.279 178.232 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' C' C ' 66' ' ' ILE . . . . . . . . . . . . . 64.1 mt -113.52 125.72 70.84 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.288 0 N-CA-C 109.413 -0.588 . . . . 0.0 109.413 178.957 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' C' C ' 67' ' ' THR . . . . . . . . . . . . . 20.9 m -125.21 143.67 50.83 Favored 'General case' 0 C--N 1.331 -0.208 0 CA-C-O 121.139 0.495 . . . . 0.0 111.221 -175.858 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' C' C ' 68' ' ' LEU . . . . . . . . . . . . . 7.8 mp -97.34 132.81 42.71 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 115.738 -0.665 . . . . 0.0 110.129 176.471 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' C' C ' 69' ' ' VAL . . . . . . . . . . . . . 43.1 t -89.94 120.56 38.94 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.38 0 CA-C-N 116.242 -0.435 . . . . 0.0 110.073 179.303 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' C' C ' 70' ' ' THR . . . . . . . . . . . . . 20.5 m -135.12 146.76 49.13 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.059 -0.519 . . . . 0.0 110.496 -178.922 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' C' C ' 71' ' ' HIS . . . . . . . . . . . . . 34.7 t60 -125.23 73.34 66.69 Favored Pre-proline 0 CA--C 1.535 0.367 0 CA-C-N 116.246 -0.434 . . . . 0.0 110.285 179.104 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' C' C ' 72' ' ' PRO . . . . . . . . . . . . . 90.4 Cg_endo -90.2 154.17 4.67 Favored 'Trans proline' 0 N--CA 1.489 1.232 0 C-N-CA 121.946 1.764 . . . . 0.0 112.256 179.788 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' C' C ' 73' ' ' VAL . . . . . . . . . . . . . 35.8 m -76.39 168.55 1.98 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.306 0 CA-C-N 116.151 -0.477 . . . . 0.0 110.354 178.955 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' C' C ' 74' ' ' ASP . . . . . . . . . . . . . 29.4 t0 -101.06 117.53 35.2 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.253 -0.43 . . . . 0.0 110.071 -178.802 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' C' C ' 75' ' ' VAL . . . . . . . . . . . . . 43.5 t -111.48 120.95 63.13 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.241 0 CA-C-O 120.992 0.425 . . . . 0.0 110.315 -179.266 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' C' C ' 76' ' ' LEU . . . . . . . . . . . . . 29.5 mt -123.42 145.41 48.81 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 115.869 -0.605 . . . . 0.0 109.604 179.212 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' C' C ' 77' ' ' GLU . . . . . . . . . . . . . 45.4 mt-10 -136.83 135.47 37.96 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-O 121.035 0.445 . . . . 0.0 111.149 -177.25 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' C' C ' 78' ' ' ALA . . . . . . . . . . . . . . . -122.17 125.84 47.0 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 115.615 -0.721 . . . . 0.0 109.465 176.862 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' C' C ' 79' ' ' LYS . . . . . . . . . . . . . 47.4 pttt -78.63 119.86 22.49 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-O 121.437 0.637 . . . . 0.0 111.208 -175.781 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' C' C ' 80' ' ' ILE . . . . . . . . . . . . . 38.8 mm -139.39 110.25 4.57 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.246 0 CA-C-N 115.478 -0.783 . . . . 0.0 108.993 -179.832 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' C' C ' 81' ' ' LYS . . . . . . . . . . . . . 25.1 mtpp -97.77 123.99 41.94 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-O 120.894 0.378 . . . . 0.0 111.097 -177.977 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' C' C ' 82' ' ' GLY . . . . . . . . . . . . . . . 89.19 42.22 5.63 Favored Glycine 0 CA--C 1.527 0.839 0 C-N-CA 120.85 -0.691 . . . . 0.0 111.604 175.8 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' C' C ' 83' ' ' ILE . . . . . . . . . . . . . 69.2 mt -65.24 136.58 26.45 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.35 0 N-CA-C 109.732 -0.469 . . . . 0.0 109.732 177.477 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' C' C ' 84' ' ' LYS . . . . . . . . . . . . . 26.9 ttmt -88.64 -48.74 7.33 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.136 -0.484 . . . . 0.0 110.114 -179.508 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' C' C ' 85' ' ' ASP . . . . . . . . . . . . . 4.6 t70 -162.97 157.69 21.34 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 115.799 -0.637 . . . . 0.0 110.537 179.311 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' C' C ' 86' ' ' VAL . . . . . . . . . . . . . 41.1 t -130.22 133.81 63.56 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.277 0 CA-C-O 120.984 0.421 . . . . 0.0 110.469 -178.535 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' C' C ' 87' ' ' ILE . . . . . . . . . . . . . 5.0 mp -119.36 125.97 74.91 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.257 0 CA-C-N 115.848 -0.615 . . . . 0.0 109.474 176.993 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' C' C ' 88' ' ' LEU . . . . . . . . . . . . . 54.5 mt -110.52 135.6 50.94 Favored 'General case' 0 C--N 1.332 -0.187 0 CA-C-O 120.998 0.427 . . . . 0.0 111.495 -176.776 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' C' C ' 89' ' ' ASP . . . . . . . . . . . . . 9.0 t70 -131.46 153.16 50.04 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 115.777 -0.647 . . . . 0.0 109.554 174.802 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' C' C ' 90' ' ' GLU . . . . . . . . . . . . . 95.4 mt-10 -48.33 -38.58 19.46 Favored 'General case' 0 C--N 1.33 -0.274 0 N-CA-C 112.666 0.617 . . . . 0.0 112.666 -172.858 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' C' C ' 91' ' ' ASN . . . . . . . . . . . . . 19.0 p30 -132.02 36.82 3.64 Favored 'General case' 0 N--CA 1.463 0.221 0 CA-C-O 120.807 0.336 . . . . 0.0 111.404 -177.294 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' C' C ' 92' ' ' LEU . . . . . . . . . . . . . 13.1 tp -166.07 142.85 5.18 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.578 -0.283 . . . . 0.0 110.626 -179.155 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' C' C ' 93' ' ' ILE . . . . . . . . . . . . . 67.0 mt -127.47 122.16 58.79 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.262 0 N-CA-C 109.461 -0.57 . . . . 0.0 109.461 178.741 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' C' C ' 94' ' ' VAL . . . . . . . . . . . . . 44.9 t -120.8 125.47 74.1 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.228 0 N-CA-C 109.757 -0.46 . . . . 0.0 109.757 179.252 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' C' C ' 95' ' ' VAL . . . . . . . . . . . . . 45.1 t -119.87 132.61 69.13 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.264 0 CA-C-N 116.015 -0.538 . . . . 0.0 109.77 -179.642 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' C' C ' 96' ' ' ILE . . . . . . . . . . . . . 65.9 mt -113.48 125.19 70.71 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.34 0 N-CA-C 109.106 -0.702 . . . . 0.0 109.106 179.025 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' C' C ' 97' ' ' THR . . . . . . . . . . . . . 73.0 p -99.74 151.43 21.24 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-O 121.118 0.485 . . . . 0.0 111.183 -177.185 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' C' C ' 98' ' ' GLU . . . . . . . . . . . . . 85.6 tt0 -53.87 -24.98 17.69 Favored 'General case' 0 C--N 1.33 -0.265 0 N-CA-C 112.343 0.497 . . . . 0.0 112.343 -179.603 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' C' C ' 99' ' ' GLU . . . . . . . . . . . . . 71.1 mm-40 -79.31 16.35 1.02 Allowed 'General case' 0 CA--C 1.534 0.356 0 N-CA-C 113.033 0.753 . . . . 0.0 113.033 -178.102 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' C' C ' 100' ' ' ASN . . . . . . . . . . . . . 4.5 m-20 64.19 37.95 8.49 Favored 'General case' 0 C--O 1.233 0.222 0 CA-C-O 121.0 0.428 . . . . 0.0 111.076 177.326 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' C' C ' 101' ' ' GLU . . . . . . . . . . . . . 84.2 tt0 -118.29 143.65 46.43 Favored 'General case' 0 C--N 1.333 -0.145 0 CA-C-N 116.1 -0.5 . . . . 0.0 109.795 176.711 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' C' C ' 102' ' ' VAL . . . . . . . . . . . . . 42.8 t -115.04 126.11 72.54 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.335 0 CA-C-N 116.434 -0.348 . . . . 0.0 110.063 -178.689 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' C' C ' 103' ' ' LEU . . . . . . . . . . . . . 15.1 mt -115.57 126.87 54.76 Favored 'General case' 0 C--N 1.331 -0.205 0 CA-C-N 115.484 -0.78 . . . . 0.0 110.028 176.873 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' C' C ' 104' ' ' ILE . . . . . . . . . . . . . 68.4 mt -119.22 121.11 65.8 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.275 0 N-CA-C 110.293 -0.262 . . . . 0.0 110.293 -179.973 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' C' C ' 105' ' ' PHE . . . . . . . . . . . . . 35.7 m-85 -125.35 167.05 15.47 Favored 'General case' 0 C--N 1.334 -0.105 0 O-C-N 123.838 0.711 . . . . 0.0 110.166 179.788 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' C' C ' 106' ' ' ASN . . . . . . . . . . . . . 41.3 p-10 -99.95 -169.79 1.79 Allowed 'General case' 0 C--N 1.33 -0.254 0 N-CA-C 110.01 -0.367 . . . . 0.0 110.01 174.399 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' C' C ' 107' ' ' GLN . . . . . . . . . . . . . 46.5 tt0 -58.36 -29.46 66.01 Favored 'General case' 0 C--N 1.329 -0.318 0 N-CA-C 112.006 0.373 . . . . 0.0 112.006 179.421 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' C' C ' 108' ' ' ASN . . . . . . . . . . . . . 10.3 t30 -86.75 13.01 9.51 Favored 'General case' 0 CA--C 1.536 0.435 0 N-CA-C 113.051 0.76 . . . . 0.0 113.051 -177.977 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' C' C ' 109' ' ' LEU . . . . . . . . . . . . . 7.9 tp 55.67 37.83 29.37 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-O 120.947 0.403 . . . . 0.0 111.36 178.277 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' C' C ' 110' ' ' GLU . . . . . . . . . . . . . 96.0 mt-10 -103.04 156.85 17.39 Favored 'General case' 0 C--N 1.33 -0.255 0 N-CA-C 109.832 -0.433 . . . . 0.0 109.832 175.947 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' C' C ' 111' ' ' GLU . . . . . . . . . . . . . 84.6 tt0 -84.31 121.99 28.29 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-O 120.952 0.406 . . . . 0.0 111.127 -176.852 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' C' C ' 112' ' ' LEU . . . . . . . . . . . . . 27.2 mt -105.72 -46.11 4.23 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-N 115.979 -0.555 . . . . 0.0 110.057 176.586 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' C' C ' 113' ' ' TYR . . . . . . . . . . . . . 59.6 t80 -145.49 138.88 26.42 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.048 -0.523 . . . . 0.0 110.856 -179.689 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' C' C ' 114' ' ' ARG . . . . . . . . . . . . . 27.1 ttm180 -141.88 126.29 17.7 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.32 -0.4 . . . . 0.0 110.266 176.965 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' C' C ' 115' ' ' GLY . . . . . . . . . . . . . . . -150.21 160.82 28.7 Favored Glycine 0 CA--C 1.524 0.597 0 N-CA-C 111.101 -0.799 . . . . 0.0 111.101 179.333 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' C' C ' 116' ' ' LYS . . . . . . . . . . . . . 38.9 ttpt -130.39 134.18 46.95 Favored 'General case' 0 C--N 1.33 -0.253 0 N-CA-C 110.035 -0.357 . . . . 0.0 110.035 177.24 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' C' C ' 117' ' ' PHE . . . . . . . . . . . . . 47.5 m-85 -126.99 118.64 24.9 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.333 -0.394 . . . . 0.0 110.464 -176.337 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' C' C ' 118' ' ' GLU . . . . . . . . . . . . . 95.9 mt-10 -51.86 -51.61 55.48 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.39 -0.368 . . . . 0.0 111.697 -175.629 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' C' C ' 119' ' ' ASN . . . . . . . . . . . . . 70.5 m-80 -98.03 31.01 2.84 Favored 'General case' 0 C--N 1.329 -0.294 0 N-CA-C 112.19 0.441 . . . . 0.0 112.19 -173.485 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' C' C ' 120' ' ' LEU . . . . . . . . . . . . . 6.5 tt -56.27 121.3 9.2 Favored 'General case' 0 C--N 1.333 -0.129 0 CA-C-O 120.727 0.299 . . . . 0.0 110.562 178.751 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' C' C ' 121' ' ' ASN . . . . . . . . . . . . . 74.5 m-20 -114.03 -44.12 3.18 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 116.364 -0.38 . . . . 0.0 111.159 -176.44 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' C' C ' 122' ' ' LYS . . . . . . . . . . . . . 55.2 mtmt -142.87 150.73 40.24 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-O 121.149 0.499 . . . . 0.0 111.513 -176.379 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' C' C ' 123' ' ' VAL . . . . . . . . . . . . . 45.8 t -130.38 133.46 63.84 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.228 0 CA-C-N 115.863 -0.608 . . . . 0.0 109.653 177.812 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' C' C ' 124' ' ' LEU . . . . . . . . . . . . . 30.1 mt -125.14 127.78 47.38 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.468 -0.333 . . . . 0.0 110.416 -179.852 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' C' C ' 125' ' ' VAL . . . . . . . . . . . . . 43.0 t -132.57 131.09 60.04 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.262 0 CA-C-N 116.183 -0.462 . . . . 0.0 109.97 -179.829 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' C' C ' 126' ' ' ARG . . . . . . . . . . . . . 78.1 mtt180 -145.95 119.77 9.28 Favored 'General case' 0 C--N 1.331 -0.22 0 CA-C-N 116.348 -0.387 . . . . 0.0 110.79 178.88 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' C' C ' 127' ' ' ASN . . . . . . . . . . . . . 64.1 t30 51.12 -105.75 0.22 Allowed 'General case' 0 CA--C 1.543 0.696 0 CA-C-O 119.023 -0.513 . . . . 0.0 111.476 179.188 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' C' C ' 128' ' ' ASP . . . . . . . . . . . . . 16.1 p-10 -114.08 5.27 15.96 Favored 'General case' 0 N--CA 1.469 0.483 0 CA-C-N 119.602 1.092 . . . . 0.0 113.442 -177.084 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' C' C ' 129' ' ' LEU . . . . . . . . . . . . . 26.1 mt -105.01 133.22 50.17 Favored 'General case' 0 C--N 1.332 -0.184 0 N-CA-C 109.555 -0.535 . . . . 0.0 109.555 177.703 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' C' C ' 130' ' ' VAL . . . . . . . . . . . . . 46.3 t -128.11 132.02 68.85 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.287 0 CA-C-O 120.881 0.372 . . . . 0.0 110.218 -178.508 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' C' C ' 131' ' ' VAL . . . . . . . . . . . . . 35.2 m -136.15 138.69 46.86 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.228 0 CA-C-O 121.15 0.5 . . . . 0.0 111.059 177.246 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' C' C ' 132' ' ' ILE . . . . . . . . . . . . . 71.4 mt -116.4 131.55 68.62 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.303 0 CA-C-N 115.67 -0.695 . . . . 0.0 109.26 179.189 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' C' C ' 133' ' ' ILE . . . . . . . . . . . . . 33.3 mm -115.09 120.66 65.24 Favored 'Isoleucine or valine' 0 C--O 1.234 0.255 0 CA-C-O 120.762 0.315 . . . . 0.0 111.316 -173.958 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' C' C ' 134' ' ' ASP . . . . . . . . . . . . . 10.0 p-10 -132.94 148.43 52.28 Favored 'General case' 0 C--N 1.33 -0.255 0 N-CA-C 109.538 -0.542 . . . . 0.0 109.538 175.066 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' C' C ' 135' ' ' GLU . . . . . . . . . . . . . 85.3 tt0 -49.94 -25.37 3.21 Favored 'General case' 0 C--N 1.328 -0.355 0 N-CA-C 112.864 0.691 . . . . 0.0 112.864 -172.281 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' C' C ' 136' ' ' GLN . . . . . . . . . . . . . 97.5 mt-30 -84.16 -37.83 21.43 Favored 'General case' 0 C--O 1.234 0.245 0 N-CA-C 112.305 0.483 . . . . 0.0 112.305 -176.588 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' C' C ' 137' ' ' LYS . . . . . . . . . . . . . 22.7 pttm -162.16 174.71 12.55 Favored 'General case' 0 C--N 1.331 -0.224 0 CA-C-O 121.507 0.67 . . . . 0.0 112.402 -170.634 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' C' C ' 138' ' ' LEU . . . . . . . . . . . . . 7.0 tt -122.6 128.1 50.25 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 114.903 -1.044 . . . . 0.0 109.918 178.558 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' C' C ' 139' ' ' THR . . . . . . . . . . . . . 30.1 m -104.15 124.05 48.39 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.121 -0.491 . . . . 0.0 110.236 179.012 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' C' C ' 140' ' ' LEU . . . . . . . . . . . . . 19.4 tp -109.25 119.56 39.87 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 115.719 -0.673 . . . . 0.0 109.674 -177.808 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' C' C ' 141' ' ' ILE . . . . . . . . . . . . . 19.0 mt -121.15 120.93 63.55 Favored 'Isoleucine or valine' 0 C--O 1.235 0.297 0 CA-C-O 120.986 0.422 . . . . 0.0 110.235 -175.093 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' C' C ' 142' ' ' ARG . . . . . . . . . . . . . 1.1 mpt_? -109.94 127.03 54.51 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 115.312 -0.858 . . . . 0.0 110.08 -179.296 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' C' C ' 143' ' ' THR . . . . . . . . . . . . . 40.7 p . . . . . 0 C--O 1.22 -0.464 0 CA-C-O 118.013 -0.994 . . . . 0.0 110.621 179.145 . . . . . . . . 0 0 . 1 . 019 nuclear orig full ' D' D ' -3' ' ' GLU . . . . . . . . . . . . . 85.0 tt0 . . . . . 0 N--CA 1.489 1.51 0 N-CA-C 109.335 -0.617 . . . . 0.0 109.335 . . . . . . . . . 0 0 . 1 . 019 nuclear orig full ' D' D ' -2' ' ' GLY . . . . . . . . . . . . . . . -87.58 138.91 15.58 Favored Glycine 0 CA--C 1.525 0.664 0 N-CA-C 111.34 -0.704 . . . . 0.0 111.34 -178.3 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' D' D ' -1' ' ' VAL . . . . . . . . . . . . . 44.8 t -96.82 138.33 22.17 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 N-CA-C 110.075 -0.342 . . . . 0.0 110.075 178.812 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' D' D ' 0' ' ' ILE . . . . . . . . . . . . . 46.2 mm -109.33 132.82 56.42 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.276 0 CA-C-N 116.296 -0.411 . . . . 0.0 110.06 179.193 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' D' D ' 1' ' ' MET . . . . . . . . . . . . . 24.6 ptp -143.81 145.76 32.59 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.185 -0.461 . . . . 0.0 110.478 -179.91 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' D' D ' 2' ' ' SER . . . . . . . . . . . . . 7.6 p -131.03 130.11 42.88 Favored 'General case' 0 C--O 1.232 0.16 0 CA-C-O 121.124 0.488 . . . . 0.0 110.917 -178.63 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' D' D ' 3' ' ' GLU . . . . . . . . . . . . . 43.6 mp0 -137.85 142.19 40.75 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 115.619 -0.719 . . . . 0.0 110.571 -178.991 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' D' D ' 4' ' ' LEU . . . . . . . . . . . . . 4.2 tt -123.9 123.13 39.74 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 115.753 -0.658 . . . . 0.0 109.78 177.24 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' D' D ' 5' ' ' LYS . . . . . . . . . . . . . 63.6 mttp -102.63 121.51 42.54 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-O 120.77 0.319 . . . . 0.0 110.825 -179.984 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' D' D ' 6' ' ' LEU . . . . . . . . . . . . . 64.7 mt -114.37 148.3 37.84 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 115.553 -0.748 . . . . 0.0 110.614 179.836 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' D' D ' 7' ' ' LYS . . . . . . . . . . . . . 22.7 ttmm -139.82 141.32 27.17 Favored Pre-proline 0 CA--C 1.534 0.339 0 N-CA-C 109.811 -0.44 . . . . 0.0 109.811 174.826 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' D' D ' 8' ' ' PRO . . . . . . . . . . . . . 96.4 Cg_endo -91.22 139.16 2.41 Favored 'Trans proline' 0 N--CA 1.49 1.316 0 C-N-CA 121.694 1.596 . . . . 0.0 111.663 177.988 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' D' D ' 9' ' ' LEU . . . . . . . . . . . . . 49.2 mt -78.28 -45.84 2.13 Favored Pre-proline 0 CA--C 1.533 0.313 0 CA-C-O 118.838 -0.601 . . . . 0.0 111.788 -179.655 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' D' D ' 10' ' ' PRO . . . . . . . . . . . . . 74.7 Cg_endo -84.63 150.75 11.51 Favored 'Trans proline' 0 N--CA 1.495 1.604 0 C-N-CA 121.224 1.283 . . . . 0.0 111.364 171.804 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' D' D ' 11' ' ' LYS . . . . . . . . . . . . . 19.8 pttp -83.47 117.28 22.98 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-O 121.385 0.612 . . . . 0.0 110.423 178.4 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' D' D ' 12' ' ' VAL . . . . . . . . . . . . . 12.3 p -151.05 148.58 14.84 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.271 0 CA-C-N 115.837 -0.62 . . . . 0.0 110.625 -179.965 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' D' D ' 13' ' ' GLU . . . . . . . . . . . . . 44.7 mp0 -91.07 121.59 33.0 Favored 'General case' 0 C--N 1.328 -0.346 0 N-CA-C 109.866 -0.42 . . . . 0.0 109.866 176.663 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' D' D ' 14' ' ' LEU . . . . . . . . . . . . . 15.7 mt -98.09 147.8 33.6 Favored Pre-proline 0 CA--C 1.533 0.3 0 CA-C-O 119.23 -0.414 . . . . 0.0 110.627 -177.801 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' D' D ' 15' ' ' PRO . . . . . . . . . . . . . 24.4 Cg_exo -63.33 162.41 27.11 Favored 'Trans proline' 0 N--CA 1.497 1.685 0 C-N-CA 121.39 1.393 . . . . 0.0 111.813 175.877 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' D' D ' 16' ' ' PRO . . . . . . . . . . . . . 27.8 Cg_exo -60.27 -33.94 94.21 Favored 'Trans proline' 0 N--CA 1.497 1.723 0 C-N-CA 121.495 1.463 . . . . 0.0 112.687 -178.724 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' D' D ' 17' ' ' ASP . . . . . . . . . . . . . 23.1 p-10 -90.07 6.73 41.11 Favored 'General case' 0 CA--C 1.536 0.421 0 N-CA-C 113.447 0.906 . . . . 0.0 113.447 -176.936 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' D' D ' 18' ' ' PHE . . . . . . . . . . . . . 53.4 t80 -58.04 -42.87 86.31 Favored 'General case' 0 C--N 1.335 -0.036 0 O-C-N 122.045 -0.409 . . . . 0.0 110.171 -178.777 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' D' D ' 19' ' ' VAL . . . . . . . . . . . . . 47.3 t -56.6 -43.46 78.74 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 CA-C-N 116.236 -0.438 . . . . 0.0 110.514 -179.27 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' D' D ' 20' ' ' ASP . . . . . . . . . . . . . 79.3 m-20 -60.26 -42.02 94.48 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-O 120.696 0.284 . . . . 0.0 110.923 -178.276 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' D' D ' 21' ' ' VAL . . . . . . . . . . . . . 46.3 t -64.12 -48.38 86.04 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.294 0 C-N-CA 120.854 -0.339 . . . . 0.0 110.517 -177.871 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' D' D ' 22' ' ' ILE . . . . . . . . . . . . . 50.3 mm -55.97 -45.45 80.15 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.218 0 CA-C-O 120.867 0.365 . . . . 0.0 110.577 179.087 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' D' D ' 23' ' ' ARG . . . . . . . . . . . . . 53.7 ttp180 -54.13 -49.93 68.07 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.602 -0.272 . . . . 0.0 111.427 -178.86 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' D' D ' 24' ' ' ILE . . . . . . . . . . . . . 77.5 mt -59.78 -41.5 85.73 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.267 0 C-N-CA 121.172 -0.211 . . . . 0.0 111.253 -178.065 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' D' D ' 25' ' ' LYS . . . . . . . . . . . . . 73.2 mmtt -63.51 -42.56 98.48 Favored 'General case' 0 C--N 1.328 -0.346 0 N-CA-C 112.015 0.376 . . . . 0.0 112.015 -179.695 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' D' D ' 26' ' ' LEU . . . . . . . . . . . . . 74.5 mt -79.87 -40.19 28.88 Favored 'General case' 0 C--N 1.329 -0.311 0 N-CA-C 113.344 0.868 . . . . 0.0 113.344 -170.856 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' D' D ' 27' ' ' GLN . . . . . . . . . . . . . 8.6 pt20 -46.67 140.94 4.12 Favored 'General case' 0 N--CA 1.47 0.526 0 N-CA-C 112.785 0.661 . . . . 0.0 112.785 -174.923 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' D' D ' 28' ' ' GLY . . . . . . . . . . . . . . . 98.57 -27.6 18.84 Favored Glycine 0 CA--C 1.533 1.186 0 CA-C-N 115.527 -0.761 . . . . 0.0 112.123 -177.87 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' D' D ' 29' ' ' LYS . . . . . . . . . . . . . 67.3 mttm -98.39 155.14 17.38 Favored 'General case' 0 C--O 1.232 0.181 0 CA-C-N 117.229 0.515 . . . . 0.0 111.044 179.636 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' D' D ' 30' ' ' THR . . . . . . . . . . . . . 37.9 m -100.7 137.65 38.81 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.075 -0.511 . . . . 0.0 110.062 176.095 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' D' D ' 31' ' ' VAL . . . . . . . . . . . . . 34.6 m -128.4 157.31 40.88 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.282 0 CA-C-O 120.992 0.425 . . . . 0.0 110.716 -178.953 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' D' D ' 32' ' ' ARG . . . . . . . . . . . . . 94.2 mtt180 -133.72 151.26 51.57 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 115.74 -0.664 . . . . 0.0 110.446 177.832 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' D' D ' 33' ' ' THR . . . . . . . . . . . . . 30.0 m -53.12 138.52 31.03 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.496 -0.32 . . . . 0.0 111.317 -179.339 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' D' D ' 34' ' ' GLY . . . . . . . . . . . . . . . 101.28 -17.13 56.19 Favored Glycine 0 CA--C 1.533 1.17 0 CA-C-O 119.593 -0.559 . . . . 0.0 113.305 179.124 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' D' D ' 35' ' ' ASP . . . . . . . . . . . . . 67.9 m-20 -65.26 148.95 50.79 Favored 'General case' 0 N--CA 1.461 0.122 0 CA-C-N 118.039 0.92 . . . . 0.0 110.987 179.332 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' D' D ' 36' ' ' VAL . . . . . . . . . . . . . 44.7 t -124.23 130.86 73.54 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.25 0 CA-C-N 115.858 -0.61 . . . . 0.0 109.916 179.49 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' D' D ' 37' ' ' ILE . . . . . . . . . . . . . 65.4 mt -119.7 138.19 51.12 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.267 0 CA-C-N 116.195 -0.457 . . . . 0.0 109.787 179.396 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' D' D ' 38' ' ' GLY . . . . . . . . . . . . . . . -114.33 128.72 8.34 Favored Glycine 0 CA--C 1.524 0.637 0 N-CA-C 111.096 -0.801 . . . . 0.0 111.096 -179.699 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' D' D ' 39' ' ' ILE . . . . . . . . . . . . . 72.7 mt -127.34 131.03 70.84 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.282 0 N-CA-C 109.863 -0.421 . . . . 0.0 109.863 178.373 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' D' D ' 40' ' ' SER . . . . . . . . . . . . . 51.8 p -91.92 121.1 33.2 Favored 'General case' 0 C--N 1.329 -0.292 0 C-N-CA 120.894 -0.322 . . . . 0.0 110.81 176.348 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' D' D ' 41' ' ' ILE . . . . . . . . . . . . . 71.9 mt -130.02 119.29 46.68 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.201 0 CA-C-O 120.833 0.349 . . . . 0.0 110.295 179.918 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' D' D ' 42' ' ' LEU . . . . . . . . . . . . . 83.5 mt 58.15 33.41 23.14 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.073 -0.512 . . . . 0.0 111.874 177.551 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' D' D ' 43' ' ' GLY . . . . . . . . . . . . . . . 82.57 -10.1 56.8 Favored Glycine 0 CA--C 1.533 1.216 0 C-N-CA 121.22 -0.514 . . . . 0.0 113.468 176.746 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' D' D ' 44' ' ' LYS . . . . . . . . . . . . . 68.2 tttt -103.34 129.51 50.39 Favored 'General case' 0 C--N 1.332 -0.167 0 CA-C-N 117.948 0.874 . . . . 0.0 109.851 176.885 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' D' D ' 45' ' ' GLU . . . . . . . . . . . . . 39.9 tp10 -84.22 131.14 34.78 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-O 120.816 0.341 . . . . 0.0 110.99 -179.47 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' D' D ' 46' ' ' VAL . . . . . . . . . . . . . 7.3 p -120.99 129.03 76.13 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.191 0 N-CA-C 109.69 -0.485 . . . . 0.0 109.69 176.793 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' D' D ' 47' ' ' LYS . . . . . . . . . . . . . 65.2 mmtt -99.59 126.6 45.61 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 115.87 -0.605 . . . . 0.0 110.931 177.075 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' D' D ' 48' ' ' PHE . . . . . . . . . . . . . 95.8 m-85 -108.78 131.74 54.66 Favored 'General case' 0 C--N 1.328 -0.328 0 N-CA-C 109.399 -0.593 . . . . 0.0 109.399 175.193 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' D' D ' 49' ' ' LYS . . . . . . . . . . . . . 74.3 tttt -109.01 135.48 50.11 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.467 -0.333 . . . . 0.0 110.501 179.934 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' D' D ' 50' ' ' VAL . . . . . . . . . . . . . 43.7 t -78.72 106.05 8.95 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.293 0 N-CA-C 109.187 -0.671 . . . . 0.0 109.187 175.73 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' D' D ' 51' ' ' VAL . . . . . . . . . . . . . 52.9 t -68.8 -47.63 75.23 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.315 0 CA-C-N 116.077 -0.511 . . . . 0.0 109.992 -173.251 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' D' D ' 52' ' ' GLN . . . . . . . . . . . . . 62.8 tt0 -170.18 144.2 2.57 Favored 'General case' 0 C--N 1.33 -0.271 0 C-N-CA 120.262 -0.575 . . . . 0.0 111.839 -178.996 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' D' D ' 53' ' ' ALA . . . . . . . . . . . . . . . -116.46 134.32 55.0 Favored 'General case' 0 C--N 1.331 -0.213 0 CA-C-N 115.641 -0.709 . . . . 0.0 109.831 175.948 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' D' D ' 54' ' ' TYR . . . . . . . . . . . . . 48.7 t80 -129.06 112.82 18.52 Favored Pre-proline 0 CA--C 1.534 0.343 0 CA-C-O 118.194 -0.908 . . . . 0.0 110.442 178.578 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' D' D ' 55' ' ' PRO . . . . . . . . . . . . . 74.0 Cg_endo -77.18 167.86 78.5 Favored 'Cis proline' 0 N--CA 1.499 1.84 0 CA-C-N 122.002 1.751 . . . . 0.0 112.14 -7.727 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' D' D ' 56' ' ' SER . . . . . . . . . . . . . 13.6 m -117.11 140.64 27.34 Favored Pre-proline 0 CA--C 1.537 0.454 0 CA-C-O 118.674 -0.679 . . . . 0.0 109.741 174.802 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' D' D ' 57' ' ' PRO . . . . . . . . . . . . . 38.2 Cg_endo -68.0 159.95 82.92 Favored 'Cis proline' 0 N--CA 1.498 1.786 0 CA-C-N 121.596 1.606 . . . . 0.0 111.139 -3.544 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' D' D ' 58' ' ' LEU . . . . . . . . . . . . . 20.7 tp -129.6 137.16 50.55 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-O 120.995 0.426 . . . . 0.0 110.473 -178.136 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' D' D ' 59' ' ' ARG . . . . . . . . . . . . . 41.7 ttp180 -104.57 126.6 51.81 Favored 'General case' 0 C--N 1.327 -0.379 0 N-CA-C 109.24 -0.652 . . . . 0.0 109.24 175.342 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' D' D ' 60' ' ' VAL . . . . . . . . . . . . . 41.4 t -80.06 123.45 36.87 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.291 0 C-N-CA 120.676 -0.409 . . . . 0.0 110.649 -173.411 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' D' D ' 61' ' ' GLU . . . . . . . . . . . . . 95.9 mt-10 -131.05 164.19 25.97 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 115.782 -0.645 . . . . 0.0 109.78 177.34 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' D' D ' 62' ' ' ASP . . . . . . . . . . . . . 76.4 m-20 -53.19 -32.5 48.29 Favored 'General case' 0 C--N 1.328 -0.345 0 N-CA-C 111.81 0.3 . . . . 0.0 111.81 -179.981 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' D' D ' 63' ' ' ARG . . . . . . . . . . . . . 95.7 mtt180 -74.48 -21.99 59.3 Favored 'General case' 0 CA--C 1.533 0.294 0 N-CA-C 112.945 0.72 . . . . 0.0 112.945 -176.986 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' D' D ' 64' ' ' THR . . . . . . . . . . . . . 26.8 m -64.84 137.17 57.61 Favored 'General case' 0 C--N 1.331 -0.223 0 CA-C-O 120.965 0.412 . . . . 0.0 110.572 -175.599 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' D' D ' 65' ' ' LYS . . . . . . . . . . . . . 39.8 ttpt -89.14 123.78 33.72 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 115.903 -0.589 . . . . 0.0 110.317 -179.721 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' D' D ' 66' ' ' ILE . . . . . . . . . . . . . 62.7 mt -111.48 130.2 65.46 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.261 0 N-CA-C 109.94 -0.393 . . . . 0.0 109.94 -178.564 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' D' D ' 67' ' ' THR . . . . . . . . . . . . . 8.1 m -130.1 146.97 51.79 Favored 'General case' 0 C--N 1.332 -0.192 0 CA-C-O 121.068 0.461 . . . . 0.0 111.231 -176.663 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' D' D ' 68' ' ' LEU . . . . . . . . . . . . . 54.0 mt -99.35 135.36 40.88 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 115.836 -0.62 . . . . 0.0 110.266 177.47 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' D' D ' 69' ' ' VAL . . . . . . . . . . . . . 42.0 t -96.04 140.14 17.75 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.299 0 CA-C-N 116.408 -0.36 . . . . 0.0 110.351 179.839 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' D' D ' 70' ' ' THR . . . . . . . . . . . . . 7.0 t -98.45 163.47 12.67 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.226 -0.443 . . . . 0.0 110.719 -179.586 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' D' D ' 71' ' ' HIS . . . . . . . . . . . . . 30.4 m80 -86.98 158.21 53.36 Favored Pre-proline 0 C--N 1.33 -0.253 0 CA-C-N 116.16 -0.473 . . . . 0.0 110.878 -178.718 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' D' D ' 72' ' ' PRO . . . . . . . . . . . . . 46.3 Cg_endo -69.8 158.97 55.1 Favored 'Trans proline' 0 N--CA 1.495 1.581 0 C-N-CA 121.404 1.402 . . . . 0.0 112.184 179.271 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' D' D ' 73' ' ' VAL . . . . . . . . . . . . . 34.6 m -72.92 149.66 8.43 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.278 0 CA-C-N 116.095 -0.502 . . . . 0.0 110.874 -179.522 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' D' D ' 74' ' ' ASP . . . . . . . . . . . . . 23.6 t0 -96.84 124.66 40.88 Favored 'General case' 0 C--N 1.33 -0.264 0 N-CA-C 109.548 -0.538 . . . . 0.0 109.548 178.516 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' D' D ' 75' ' ' VAL . . . . . . . . . . . . . 40.6 t -114.31 122.88 69.31 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.258 0 CA-C-O 121.064 0.459 . . . . 0.0 110.7 -177.524 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' D' D ' 76' ' ' LEU . . . . . . . . . . . . . 5.5 mp -124.76 152.41 43.86 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 115.653 -0.703 . . . . 0.0 109.608 175.951 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' D' D ' 77' ' ' GLU . . . . . . . . . . . . . 98.4 mt-10 -137.35 139.66 40.95 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-O 121.068 0.461 . . . . 0.0 111.34 -177.669 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' D' D ' 78' ' ' ALA . . . . . . . . . . . . . . . -125.58 137.99 53.92 Favored 'General case' 0 C--N 1.331 -0.217 0 CA-C-N 115.711 -0.677 . . . . 0.0 109.841 176.778 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' D' D ' 79' ' ' LYS . . . . . . . . . . . . . 68.8 mttm -88.94 115.82 26.77 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.39 -0.368 . . . . 0.0 110.848 -177.747 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' D' D ' 80' ' ' ILE . . . . . . . . . . . . . 36.2 mm -139.18 111.7 5.8 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.267 0 N-CA-C 109.153 -0.684 . . . . 0.0 109.153 -177.863 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' D' D ' 81' ' ' LYS . . . . . . . . . . . . . 39.7 ttpt -100.7 126.85 47.27 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-O 120.928 0.394 . . . . 0.0 111.279 -176.558 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' D' D ' 82' ' ' GLY . . . . . . . . . . . . . . . 89.18 42.15 5.65 Favored Glycine 0 CA--C 1.526 0.746 0 N-CA-C 111.534 -0.626 . . . . 0.0 111.534 175.548 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' D' D ' 83' ' ' ILE . . . . . . . . . . . . . 67.8 mt -68.26 139.4 20.77 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.348 0 CA-C-O 120.849 0.357 . . . . 0.0 110.111 179.008 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' D' D ' 84' ' ' LYS . . . . . . . . . . . . . 30.3 ttmt -96.66 -53.64 3.49 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.041 -0.527 . . . . 0.0 109.949 179.467 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' D' D ' 85' ' ' ASP . . . . . . . . . . . . . 7.1 t70 -155.41 152.63 29.27 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 115.507 -0.77 . . . . 0.0 110.117 -179.53 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' D' D ' 86' ' ' VAL . . . . . . . . . . . . . 41.6 t -130.13 132.52 65.22 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.215 0 CA-C-O 120.879 0.371 . . . . 0.0 110.533 -179.476 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' D' D ' 87' ' ' ILE . . . . . . . . . . . . . 45.0 mm -119.37 127.61 75.85 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.263 0 CA-C-N 115.902 -0.59 . . . . 0.0 109.643 177.271 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' D' D ' 88' ' ' LEU . . . . . . . . . . . . . 14.7 tp -110.45 131.3 55.17 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.377 -0.374 . . . . 0.0 110.967 -178.16 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' D' D ' 89' ' ' ASP . . . . . . . . . . . . . 13.3 t70 -124.82 152.2 44.22 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.033 -0.531 . . . . 0.0 109.821 177.611 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' D' D ' 90' ' ' GLU . . . . . . . . . . . . . 96.2 mt-10 -48.56 -34.65 11.82 Favored 'General case' 0 C--N 1.328 -0.368 0 N-CA-C 112.605 0.595 . . . . 0.0 112.605 -173.878 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' D' D ' 91' ' ' ASN . . . . . . . . . . . . . 33.6 m120 -132.05 30.99 4.21 Favored 'General case' 0 CA--C 1.531 0.219 0 N-CA-C 112.167 0.432 . . . . 0.0 112.167 -176.179 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' D' D ' 92' ' ' LEU . . . . . . . . . . . . . 10.8 tp -166.06 149.35 7.49 Favored 'General case' 0 C--N 1.331 -0.215 0 CA-C-O 120.795 0.331 . . . . 0.0 111.089 -179.749 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' D' D ' 93' ' ' ILE . . . . . . . . . . . . . 72.6 mt -126.25 120.23 56.13 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.22 0 N-CA-C 109.298 -0.63 . . . . 0.0 109.298 177.426 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' D' D ' 94' ' ' VAL . . . . . . . . . . . . . 45.1 t -120.39 127.19 75.89 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.233 0 CA-C-O 120.818 0.342 . . . . 0.0 110.092 -178.637 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' D' D ' 95' ' ' VAL . . . . . . . . . . . . . 43.9 t -122.91 134.22 66.7 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.341 0 CA-C-N 116.123 -0.489 . . . . 0.0 109.98 -179.062 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' D' D ' 96' ' ' ILE . . . . . . . . . . . . . 60.9 mt -115.97 128.15 73.34 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.317 0 N-CA-C 109.478 -0.564 . . . . 0.0 109.478 179.143 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' D' D ' 97' ' ' THR . . . . . . . . . . . . . 66.9 p -100.98 154.01 19.05 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-O 121.138 0.494 . . . . 0.0 111.011 -178.171 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' D' D ' 98' ' ' GLU . . . . . . . . . . . . . 96.4 mt-10 -56.94 -23.86 48.5 Favored 'General case' 0 CA--C 1.533 0.325 0 N-CA-C 112.469 0.544 . . . . 0.0 112.469 -178.736 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' D' D ' 99' ' ' GLU . . . . . . . . . . . . . 71.1 mm-40 -80.5 18.08 0.99 Allowed 'General case' 0 CA--C 1.533 0.324 0 N-CA-C 112.961 0.726 . . . . 0.0 112.961 -178.699 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' D' D ' 100' ' ' ASN . . . . . . . . . . . . . 3.8 m-20 64.09 38.12 8.62 Favored 'General case' 0 N--CA 1.463 0.191 0 CA-C-O 121.063 0.459 . . . . 0.0 111.049 176.899 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' D' D ' 101' ' ' GLU . . . . . . . . . . . . . 84.5 tt0 -116.68 143.07 46.08 Favored 'General case' 0 C--N 1.332 -0.162 0 CA-C-N 116.068 -0.515 . . . . 0.0 109.884 177.125 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' D' D ' 102' ' ' VAL . . . . . . . . . . . . . 43.5 t -114.99 126.93 72.71 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.287 0 CA-C-N 116.275 -0.42 . . . . 0.0 109.891 -178.801 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' D' D ' 103' ' ' LEU . . . . . . . . . . . . . 44.9 mt -118.16 134.28 55.14 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 115.668 -0.696 . . . . 0.0 109.632 179.532 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' D' D ' 104' ' ' ILE . . . . . . . . . . . . . 73.2 mt -126.11 122.81 62.48 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.266 0 C-N-CA 121.213 -0.195 . . . . 0.0 110.562 -176.819 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' D' D ' 105' ' ' PHE . . . . . . . . . . . . . 49.7 m-85 -127.36 165.94 18.79 Favored 'General case' 0 C--N 1.333 -0.112 0 O-C-N 123.993 0.808 . . . . 0.0 110.075 -179.781 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' D' D ' 106' ' ' ASN . . . . . . . . . . . . . 45.7 p-10 -101.85 -170.01 1.76 Allowed 'General case' 0 C--N 1.331 -0.227 0 N-CA-C 109.94 -0.392 . . . . 0.0 109.94 174.379 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' D' D ' 107' ' ' GLN . . . . . . . . . . . . . 39.0 tt0 -58.72 -30.1 67.19 Favored 'General case' 0 C--N 1.33 -0.269 0 N-CA-C 111.996 0.369 . . . . 0.0 111.996 179.73 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' D' D ' 108' ' ' ASN . . . . . . . . . . . . . 11.3 t-20 -83.55 7.99 15.5 Favored 'General case' 0 CA--C 1.534 0.357 0 N-CA-C 113.238 0.829 . . . . 0.0 113.238 -176.836 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' D' D ' 109' ' ' LEU . . . . . . . . . . . . . 12.8 tp 61.29 38.55 16.35 Favored 'General case' 0 CA--C 1.529 0.154 0 CA-C-O 120.999 0.428 . . . . 0.0 111.028 178.388 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' D' D ' 110' ' ' GLU . . . . . . . . . . . . . 95.5 mt-10 -108.21 152.81 24.09 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 116.396 -0.365 . . . . 0.0 110.373 177.937 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' D' D ' 111' ' ' GLU . . . . . . . . . . . . . 94.9 mt-10 -77.69 125.31 29.14 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-O 120.913 0.387 . . . . 0.0 111.123 -179.543 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' D' D ' 112' ' ' LEU . . . . . . . . . . . . . 83.4 mt -107.99 -45.36 3.99 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 115.975 -0.557 . . . . 0.0 109.664 173.297 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' D' D ' 113' ' ' TYR . . . . . . . . . . . . . 64.6 t80 -147.31 141.55 26.21 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.133 -0.485 . . . . 0.0 111.555 -179.252 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' D' D ' 114' ' ' ARG . . . . . . . . . . . . . 65.3 mtt180 -139.36 124.65 19.07 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 115.874 -0.603 . . . . 0.0 110.3 173.69 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' D' D ' 115' ' ' GLY . . . . . . . . . . . . . . . -150.06 157.43 27.21 Favored Glycine 0 CA--C 1.525 0.683 0 N-CA-C 110.862 -0.895 . . . . 0.0 110.862 178.69 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' D' D ' 116' ' ' LYS . . . . . . . . . . . . . 39.7 ttpt -129.12 139.04 52.12 Favored 'General case' 0 C--N 1.329 -0.322 0 N-CA-C 110.103 -0.332 . . . . 0.0 110.103 178.195 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' D' D ' 117' ' ' PHE . . . . . . . . . . . . . 47.9 m-85 -132.15 116.01 16.46 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.283 -0.417 . . . . 0.0 110.489 -176.196 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' D' D ' 118' ' ' GLU . . . . . . . . . . . . . 84.7 tt0 -51.95 -52.93 46.88 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.407 -0.36 . . . . 0.0 111.659 -176.853 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' D' D ' 119' ' ' ASN . . . . . . . . . . . . . 96.3 m-20 -93.65 31.14 1.62 Allowed 'General case' 0 C--N 1.329 -0.29 0 N-CA-C 112.227 0.454 . . . . 0.0 112.227 -174.525 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' D' D ' 120' ' ' LEU . . . . . . . . . . . . . 15.8 tp -54.08 122.1 9.48 Favored 'General case' 0 N--CA 1.464 0.231 0 O-C-N 122.289 -0.257 . . . . 0.0 110.671 177.562 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' D' D ' 121' ' ' ASN . . . . . . . . . . . . . 26.7 m120 -114.09 -44.02 3.18 Favored 'General case' 0 C--O 1.232 0.166 0 CA-C-N 116.595 -0.275 . . . . 0.0 111.188 -175.977 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' D' D ' 122' ' ' LYS . . . . . . . . . . . . . 44.4 mtmt -145.68 146.52 31.32 Favored 'General case' 0 C--N 1.331 -0.215 0 C-N-CA 120.538 -0.465 . . . . 0.0 111.665 -176.471 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' D' D ' 123' ' ' VAL . . . . . . . . . . . . . 44.0 t -129.02 130.5 68.31 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.275 0 CA-C-N 115.849 -0.614 . . . . 0.0 109.53 176.096 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' D' D ' 124' ' ' LEU . . . . . . . . . . . . . 14.9 tp -128.34 135.34 49.45 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-O 120.78 0.324 . . . . 0.0 110.612 -178.555 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' D' D ' 125' ' ' VAL . . . . . . . . . . . . . 34.9 m -133.61 141.0 45.44 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.195 0 CA-C-N 116.328 -0.396 . . . . 0.0 111.031 -178.719 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' D' D ' 126' ' ' ARG . . . . . . . . . . . . . 78.2 mtt180 -149.41 125.19 10.49 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.554 176.267 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' D' D ' 127' ' ' ASN . . . . . . . . . . . . . 18.8 t-20 52.51 -111.37 0.58 Allowed 'General case' 0 CA--C 1.545 0.755 0 CA-C-O 118.734 -0.65 . . . . 0.0 111.046 178.849 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' D' D ' 128' ' ' ASP . . . . . . . . . . . . . 21.5 p-10 -114.15 10.7 17.4 Favored 'General case' 0 N--CA 1.468 0.454 0 CA-C-N 120.044 1.293 . . . . 0.0 113.081 -179.747 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' D' D ' 129' ' ' LEU . . . . . . . . . . . . . 13.1 tp -107.29 135.77 48.25 Favored 'General case' 0 C--N 1.332 -0.165 0 N-CA-C 109.877 -0.416 . . . . 0.0 109.877 178.914 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' D' D ' 130' ' ' VAL . . . . . . . . . . . . . 44.3 t -123.79 136.16 61.12 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.239 0 CA-C-O 120.869 0.366 . . . . 0.0 110.023 -178.127 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' D' D ' 131' ' ' VAL . . . . . . . . . . . . . 43.4 t -133.87 133.71 56.35 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.258 0 CA-C-O 121.027 0.441 . . . . 0.0 110.059 177.561 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' D' D ' 132' ' ' ILE . . . . . . . . . . . . . 71.6 mt -118.01 131.51 70.55 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.335 0 CA-C-N 115.724 -0.671 . . . . 0.0 109.604 -179.273 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' D' D ' 133' ' ' ILE . . . . . . . . . . . . . 36.8 mm -116.19 124.33 72.35 Favored 'Isoleucine or valine' 0 C--O 1.233 0.197 0 CA-C-O 120.804 0.335 . . . . 0.0 111.106 -175.062 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' D' D ' 134' ' ' ASP . . . . . . . . . . . . . 11.6 p-10 -135.22 151.33 50.52 Favored 'General case' 0 C--N 1.332 -0.18 0 CA-C-N 116.104 -0.498 . . . . 0.0 109.916 174.603 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' D' D ' 135' ' ' GLU . . . . . . . . . . . . . 84.6 tt0 -49.95 -26.24 4.01 Favored 'General case' 0 C--O 1.236 0.354 0 N-CA-C 113.571 0.952 . . . . 0.0 113.571 -168.493 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' D' D ' 136' ' ' GLN . . . . . . . . . . . . . 14.3 pt20 -100.15 -19.55 16.39 Favored 'General case' 0 N--CA 1.466 0.352 0 N-CA-C 113.314 0.857 . . . . 0.0 113.314 -172.491 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' D' D ' 137' ' ' LYS . . . . . . . . . . . . . 56.8 pttt -165.88 170.54 13.69 Favored 'General case' 0 C--O 1.232 0.139 0 CA-C-O 121.645 0.736 . . . . 0.0 112.344 -176.693 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' D' D ' 138' ' ' LEU . . . . . . . . . . . . . 7.2 tt -121.23 127.67 51.67 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 114.919 -1.037 . . . . 0.0 109.827 178.938 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' D' D ' 139' ' ' THR . . . . . . . . . . . . . 42.1 m -106.18 126.71 52.55 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.089 -0.505 . . . . 0.0 110.331 179.895 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' D' D ' 140' ' ' LEU . . . . . . . . . . . . . 5.7 tt -110.74 122.49 47.94 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 115.748 -0.66 . . . . 0.0 109.27 -179.203 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' D' D ' 141' ' ' ILE . . . . . . . . . . . . . 19.1 mt -122.21 116.16 48.32 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.294 0 N-CA-C 109.867 -0.42 . . . . 0.0 109.867 -175.176 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' D' D ' 142' ' ' ARG . . . . . . . . . . . . . 58.9 ttp180 -108.75 129.29 55.37 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 115.64 -0.709 . . . . 0.0 110.507 -178.784 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' D' D ' 143' ' ' THR . . . . . . . . . . . . . 70.2 p . . . . . 0 C--O 1.22 -0.475 0 CA-C-O 118.223 -0.894 . . . . 0.0 110.894 179.695 . . . . . . . . 0 0 . 1 . 019 nuclear orig full ' E' E ' -3' ' ' GLU . . . . . . . . . . . . . 70.4 mm-40 . . . . . 0 N--CA 1.489 1.518 0 N-CA-C 109.317 -0.623 . . . . 0.0 109.317 . . . . . . . . . 0 0 . 1 . 019 nuclear orig full ' E' E ' -2' ' ' GLY . . . . . . . . . . . . . . . -85.78 124.82 7.02 Favored Glycine 0 CA--C 1.524 0.63 0 N-CA-C 111.013 -0.835 . . . . 0.0 111.013 179.999 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' E' E ' -1' ' ' VAL . . . . . . . . . . . . . 43.3 t -141.81 135.92 30.17 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.337 0 N-CA-C 110.074 -0.343 . . . . 0.0 110.074 179.673 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' E' E ' 0' ' ' ILE . . . . . . . . . . . . . 67.3 mt -116.33 143.32 26.7 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.195 0 CA-C-N 116.245 -0.434 . . . . 0.0 109.933 179.996 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' E' E ' 1' ' ' MET . . . . . . . . . . . . . 26.0 ptm -87.2 142.32 27.99 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.083 -0.508 . . . . 0.0 110.583 179.845 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' E' E ' 2' ' ' SER . . . . . . . . . . . . . 2.1 p -130.29 123.51 30.21 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.026 178.504 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' E' E ' 3' ' ' GLU . . . . . . . . . . . . . 89.2 mt-10 -139.29 140.75 37.71 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.016 -0.538 . . . . 0.0 111.103 -175.374 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' E' E ' 4' ' ' LEU . . . . . . . . . . . . . 16.0 tp -122.89 124.93 44.35 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 115.785 -0.643 . . . . 0.0 109.506 173.979 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' E' E ' 5' ' ' LYS . . . . . . . . . . . . . 60.7 mttp -108.83 120.26 41.98 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 116.397 -0.365 . . . . 0.0 110.573 -179.265 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' E' E ' 6' ' ' LEU . . . . . . . . . . . . . 54.1 mt -113.91 143.43 44.71 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 115.402 -0.817 . . . . 0.0 110.041 -178.796 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' E' E ' 7' ' ' LYS . . . . . . . . . . . . . 78.4 tttt -122.71 135.77 26.04 Favored Pre-proline 0 CA--C 1.535 0.388 0 CA-C-O 118.84 -0.6 . . . . 0.0 109.542 176.087 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' E' E ' 8' ' ' PRO . . . . . . . . . . . . . 72.4 Cg_endo -88.9 131.54 2.27 Favored 'Trans proline' 0 N--CA 1.49 1.309 0 C-N-CA 121.566 1.511 . . . . 0.0 111.814 178.938 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' E' E ' 9' ' ' LEU . . . . . . . . . . . . . 73.9 mt -70.36 -51.22 13.55 Favored Pre-proline 0 C--N 1.329 -0.313 0 CA-C-O 118.694 -0.67 . . . . 0.0 111.817 -178.703 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' E' E ' 10' ' ' PRO . . . . . . . . . . . . . 70.3 Cg_endo -74.66 151.24 41.08 Favored 'Trans proline' 0 N--CA 1.497 1.713 0 C-N-CA 121.076 1.184 . . . . 0.0 111.891 175.226 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' E' E ' 11' ' ' LYS . . . . . . . . . . . . . 70.6 mmtt -83.92 89.11 7.16 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-O 120.879 0.371 . . . . 0.0 110.42 178.511 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' E' E ' 12' ' ' VAL . . . . . . . . . . . . . 12.2 p -140.06 144.81 27.32 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.276 0 CA-C-N 116.024 -0.535 . . . . 0.0 110.359 179.877 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' E' E ' 13' ' ' GLU . . . . . . . . . . . . . 84.9 tt0 -91.79 130.62 37.53 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.275 -0.42 . . . . 0.0 110.241 178.626 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' E' E ' 14' ' ' LEU . . . . . . . . . . . . . 19.9 mt -97.65 152.98 38.45 Favored Pre-proline 0 C--N 1.33 -0.251 0 CA-C-N 116.258 -0.428 . . . . 0.0 110.796 -177.509 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' E' E ' 15' ' ' PRO . . . . . . . . . . . . . 27.9 Cg_exo -60.81 159.28 29.51 Favored 'Trans proline' 0 N--CA 1.497 1.692 0 C-N-CA 121.334 1.356 . . . . 0.0 111.795 176.833 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' E' E ' 16' ' ' PRO . . . . . . . . . . . . . 38.6 Cg_exo -58.48 -37.04 96.58 Favored 'Trans proline' 0 N--CA 1.497 1.727 0 C-N-CA 121.362 1.374 . . . . 0.0 112.704 -178.211 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' E' E ' 17' ' ' ASP . . . . . . . . . . . . . 10.5 p-10 -94.47 15.43 17.83 Favored 'General case' 0 C--N 1.328 -0.345 0 N-CA-C 113.063 0.764 . . . . 0.0 113.063 -177.088 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' E' E ' 18' ' ' PHE . . . . . . . . . . . . . 51.9 t80 -58.03 -44.34 87.28 Favored 'General case' 0 N--CA 1.46 0.06 0 O-C-N 122.0 -0.437 . . . . 0.0 110.085 -178.788 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' E' E ' 19' ' ' VAL . . . . . . . . . . . . . 47.4 t -56.61 -40.83 71.52 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.344 0 CA-C-N 116.255 -0.43 . . . . 0.0 110.35 -179.764 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' E' E ' 20' ' ' ASP . . . . . . . . . . . . . 70.1 m-20 -60.07 -42.69 95.09 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-O 120.801 0.334 . . . . 0.0 110.85 -178.274 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' E' E ' 21' ' ' VAL . . . . . . . . . . . . . 47.5 t -65.38 -52.02 57.0 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.278 0 C-N-CA 120.828 -0.349 . . . . 0.0 110.613 -178.334 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' E' E ' 22' ' ' ILE . . . . . . . . . . . . . 48.7 mm -54.32 -54.57 20.49 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.231 0 CA-C-O 120.743 0.306 . . . . 0.0 111.24 -177.493 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' E' E ' 23' ' ' ARG . . . . . . . . . . . . . 14.4 ptm180 -61.34 -45.29 95.04 Favored 'General case' 0 CA--C 1.532 0.275 0 N-CA-C 112.166 0.432 . . . . 0.0 112.166 -173.656 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' E' E ' 24' ' ' ILE . . . . . . . . . . . . . 73.0 mt -61.85 -38.53 80.78 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.209 0 O-C-N 122.138 -0.352 . . . . 0.0 111.224 -175.474 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' E' E ' 25' ' ' LYS . . . . . . . . . . . . . 66.6 mttm -72.33 -43.81 63.56 Favored 'General case' 0 C--N 1.331 -0.237 0 N-CA-C 112.077 0.399 . . . . 0.0 112.077 -178.971 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' E' E ' 26' ' ' LEU . . . . . . . . . . . . . 56.4 mt -87.03 -8.19 57.38 Favored 'General case' 0 CA--C 1.533 0.303 0 N-CA-C 113.835 1.05 . . . . 0.0 113.835 -173.627 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' E' E ' 27' ' ' GLN . . . . . . . . . . . . . 3.4 pt20 -46.59 143.13 2.82 Favored 'General case' 0 N--CA 1.467 0.412 0 O-C-N 121.592 -0.692 . . . . 0.0 112.451 -179.706 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' E' E ' 28' ' ' GLY . . . . . . . . . . . . . . . 100.07 -22.49 39.92 Favored Glycine 0 CA--C 1.533 1.212 0 CA-C-N 115.885 -0.598 . . . . 0.0 112.467 -177.953 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' E' E ' 29' ' ' LYS . . . . . . . . . . . . . 34.8 mmtp -89.6 154.98 19.55 Favored 'General case' 0 C--O 1.233 0.186 0 CA-C-N 117.599 0.699 . . . . 0.0 110.632 177.994 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' E' E ' 30' ' ' THR . . . . . . . . . . . . . 9.1 m -107.95 139.77 42.07 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.093 -0.503 . . . . 0.0 110.17 178.269 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' E' E ' 31' ' ' VAL . . . . . . . . . . . . . 35.0 m -127.91 152.87 36.55 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.263 0 CA-C-O 120.929 0.395 . . . . 0.0 110.755 -178.963 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' E' E ' 32' ' ' ARG . . . . . . . . . . . . . 83.5 mtt180 -131.68 150.31 52.19 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.025 -0.534 . . . . 0.0 110.366 177.565 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' E' E ' 33' ' ' THR . . . . . . . . . . . . . 22.0 m -52.8 138.64 28.88 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.366 -0.379 . . . . 0.0 111.457 -178.383 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' E' E ' 34' ' ' GLY . . . . . . . . . . . . . . . 100.16 -17.13 57.47 Favored Glycine 0 CA--C 1.532 1.101 0 CA-C-N 116.18 -0.464 . . . . 0.0 113.28 179.485 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' E' E ' 35' ' ' ASP . . . . . . . . . . . . . 77.0 m-20 -67.97 149.51 49.65 Favored 'General case' 0 N--CA 1.462 0.125 0 CA-C-N 117.989 0.894 . . . . 0.0 111.183 178.683 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' E' E ' 36' ' ' VAL . . . . . . . . . . . . . 44.6 t -120.95 128.81 76.13 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.219 0 CA-C-N 116.063 -0.517 . . . . 0.0 109.688 176.775 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' E' E ' 37' ' ' ILE . . . . . . . . . . . . . 62.9 mt -119.08 138.4 49.93 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 CA-C-N 116.089 -0.505 . . . . 0.0 109.923 -178.539 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' E' E ' 38' ' ' GLY . . . . . . . . . . . . . . . -116.42 128.14 7.81 Favored Glycine 0 CA--C 1.526 0.757 0 N-CA-C 110.937 -0.865 . . . . 0.0 110.937 179.285 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' E' E ' 39' ' ' ILE . . . . . . . . . . . . . 73.5 mt -128.82 131.07 68.7 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.216 0 N-CA-C 110.066 -0.346 . . . . 0.0 110.066 178.893 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' E' E ' 40' ' ' SER . . . . . . . . . . . . . 46.8 t -91.79 113.94 26.34 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.392 -0.367 . . . . 0.0 110.965 177.908 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' E' E ' 41' ' ' ILE . . . . . . . . . . . . . 45.9 mm -123.24 123.45 67.76 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.22 0 N-CA-C 109.835 -0.431 . . . . 0.0 109.835 179.467 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' E' E ' 42' ' ' LEU . . . . . . . . . . . . . 68.7 mt 57.85 34.85 24.84 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.307 -0.406 . . . . 0.0 111.683 177.94 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' E' E ' 43' ' ' GLY . . . . . . . . . . . . . . . 78.94 -10.22 34.22 Favored Glycine 0 CA--C 1.534 1.219 0 C-N-CA 121.248 -0.501 . . . . 0.0 113.43 177.094 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' E' E ' 44' ' ' LYS . . . . . . . . . . . . . 30.4 ttmt -102.83 129.36 49.48 Favored 'General case' 0 N--CA 1.461 0.078 0 CA-C-N 117.982 0.891 . . . . 0.0 110.157 177.103 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' E' E ' 45' ' ' GLU . . . . . . . . . . . . . 39.9 tp10 -84.18 127.54 34.0 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 116.283 -0.417 . . . . 0.0 110.93 -179.662 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' E' E ' 46' ' ' VAL . . . . . . . . . . . . . 9.2 p -119.27 125.9 74.86 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.22 0 N-CA-C 109.675 -0.491 . . . . 0.0 109.675 176.468 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' E' E ' 47' ' ' LYS . . . . . . . . . . . . . 62.8 mttp -99.23 126.81 45.12 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.023 -0.535 . . . . 0.0 110.889 177.266 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' E' E ' 48' ' ' PHE . . . . . . . . . . . . . 41.1 m-85 -110.55 131.87 54.68 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.035 -0.529 . . . . 0.0 109.805 177.138 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' E' E ' 49' ' ' LYS . . . . . . . . . . . . . 78.9 tttt -105.95 132.24 52.29 Favored 'General case' 0 C--N 1.328 -0.351 0 N-CA-C 110.074 -0.343 . . . . 0.0 110.074 177.887 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' E' E ' 50' ' ' VAL . . . . . . . . . . . . . 46.6 t -77.1 107.55 8.68 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.331 0 N-CA-C 109.449 -0.574 . . . . 0.0 109.449 178.023 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' E' E ' 51' ' ' VAL . . . . . . . . . . . . . 46.6 t -71.55 -52.71 24.22 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.339 0 N-CA-C 109.545 -0.539 . . . . 0.0 109.545 -175.943 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' E' E ' 52' ' ' GLN . . . . . . . . . . . . . 83.3 mt-30 -154.74 152.5 29.96 Favored 'General case' 0 C--N 1.331 -0.207 0 CA-C-O 121.252 0.549 . . . . 0.0 111.66 -178.105 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' E' E ' 53' ' ' ALA . . . . . . . . . . . . . . . -130.2 131.96 45.8 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 115.313 -0.858 . . . . 0.0 109.545 174.141 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' E' E ' 54' ' ' TYR . . . . . . . . . . . . . 59.8 t80 -129.04 110.29 18.28 Favored Pre-proline 0 CA--C 1.535 0.374 0 CA-C-O 118.205 -0.902 . . . . 0.0 110.32 179.457 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' E' E ' 55' ' ' PRO . . . . . . . . . . . . . 73.9 Cg_endo -77.16 169.82 73.18 Favored 'Cis proline' 0 N--CA 1.5 1.865 0 CA-C-N 121.987 1.745 . . . . 0.0 112.153 -5.638 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' E' E ' 56' ' ' SER . . . . . . . . . . . . . 13.7 m -115.89 132.44 23.2 Favored Pre-proline 0 CA--C 1.538 0.488 0 CA-C-O 118.458 -0.782 . . . . 0.0 109.155 175.416 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' E' E ' 57' ' ' PRO . . . . . . . . . . . . . 50.9 Cg_endo -69.75 164.12 80.01 Favored 'Cis proline' 0 N--CA 1.498 1.753 0 CA-C-N 121.928 1.724 . . . . 0.0 111.684 0.166 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' E' E ' 58' ' ' LEU . . . . . . . . . . . . . 36.8 tp -129.82 139.4 51.24 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.079 179.821 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' E' E ' 59' ' ' ARG . . . . . . . . . . . . . 26.6 ttm180 -103.83 139.11 39.47 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.246 -0.434 . . . . 0.0 110.05 178.983 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' E' E ' 60' ' ' VAL . . . . . . . . . . . . . 42.9 t -86.64 111.22 21.18 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.196 0 CA-C-O 120.84 0.352 . . . . 0.0 110.34 -177.991 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' E' E ' 61' ' ' GLU . . . . . . . . . . . . . 81.3 tt0 -131.17 154.44 48.37 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 115.845 -0.616 . . . . 0.0 109.58 177.407 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' E' E ' 62' ' ' ASP . . . . . . . . . . . . . 9.4 p-10 -52.82 -23.74 7.55 Favored 'General case' 0 C--N 1.326 -0.433 0 N-CA-C 112.467 0.543 . . . . 0.0 112.467 -179.579 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' E' E ' 63' ' ' ARG . . . . . . . . . . . . . 23.8 mmm180 -84.72 -14.22 49.03 Favored 'General case' 0 CA--C 1.534 0.349 0 N-CA-C 113.443 0.905 . . . . 0.0 113.443 -177.066 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' E' E ' 64' ' ' THR . . . . . . . . . . . . . 14.0 m -76.58 151.84 36.15 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-O 120.937 0.399 . . . . 0.0 111.05 -176.066 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' E' E ' 65' ' ' LYS . . . . . . . . . . . . . 45.7 mtpt -90.49 118.7 30.16 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.134 179.063 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' E' E ' 66' ' ' ILE . . . . . 0.416 HG21 HD13 ' E' ' 66' ' ' ILE . 72.0 mt -117.62 124.67 73.37 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.219 0 N-CA-C 109.741 -0.466 . . . . 0.0 109.741 -178.344 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' E' E ' 67' ' ' THR . . . . . . . . . . . . . 27.4 m -132.1 151.06 51.98 Favored 'General case' 0 C--N 1.332 -0.182 0 CA-C-O 121.269 0.557 . . . . 0.0 111.876 -173.437 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' E' E ' 68' ' ' LEU . . . . . . . . . . . . . 78.9 mt -98.66 127.99 44.79 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-N 115.548 -0.751 . . . . 0.0 110.126 175.474 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' E' E ' 69' ' ' VAL . . . . . . . . . . . . . 44.3 t -102.57 144.93 12.87 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.268 0 CA-C-N 116.05 -0.523 . . . . 0.0 110.193 -178.729 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' E' E ' 70' ' ' THR . . . . . . . . . . . . . 8.0 t -131.79 122.62 26.1 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-O 120.924 0.392 . . . . 0.0 110.675 178.645 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' E' E ' 71' ' ' HIS . . . . . . . . . . . . . 32.0 m80 -139.73 160.78 59.72 Favored Pre-proline 0 C--N 1.33 -0.274 0 CA-C-N 116.055 -0.521 . . . . 0.0 109.867 177.796 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' E' E ' 72' ' ' PRO . . . . . . . . . . . . . 4.2 Cg_exo -71.82 -30.11 14.62 Favored 'Trans proline' 0 N--CA 1.495 1.577 0 C-N-CA 121.255 1.303 . . . . 0.0 112.286 -176.765 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' E' E ' 73' ' ' VAL . . . . . . . . . . . . . 31.5 m -155.17 162.25 1.87 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.217 0 CA-C-O 121.174 0.511 . . . . 0.0 111.097 -178.641 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' E' E ' 74' ' ' ASP . . . . . . . . . . . . . 16.6 t0 -106.94 122.55 46.64 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 115.496 -0.775 . . . . 0.0 109.232 174.273 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' E' E ' 75' ' ' VAL . . . . . . . . . . . . . 41.2 t -117.83 125.68 74.31 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.294 0 CA-C-O 121.112 0.482 . . . . 0.0 110.809 -176.916 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' E' E ' 76' ' ' LEU . . . . . . . . . . . . . 6.1 mp -127.37 151.11 49.21 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-N 115.566 -0.743 . . . . 0.0 109.62 176.437 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' E' E ' 77' ' ' GLU . . . . . . . . . . . . . 97.0 mt-10 -136.48 136.03 39.1 Favored 'General case' 0 C--N 1.332 -0.171 0 CA-C-O 121.068 0.461 . . . . 0.0 111.26 -177.4 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' E' E ' 78' ' ' ALA . . . . . . . . . . . . . . . -121.05 138.85 53.98 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-N 115.737 -0.665 . . . . 0.0 109.819 176.838 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' E' E ' 79' ' ' LYS . . . . . . . . . . . . . 99.7 mttt -83.59 118.85 24.09 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-O 120.951 0.405 . . . . 0.0 111.0 -176.982 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' E' E ' 80' ' ' ILE . . . . . . . . . . . . . 42.0 mm -139.25 115.43 9.5 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.2 0 N-CA-C 109.346 -0.613 . . . . 0.0 109.346 -178.229 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' E' E ' 81' ' ' LYS . . . . . . . . . . . . . 64.7 mttm -109.44 125.51 52.51 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-O 120.854 0.359 . . . . 0.0 111.09 -177.705 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' E' E ' 82' ' ' GLY . . . . . . . . . . . . . . . 89.09 42.12 5.69 Favored Glycine 0 CA--C 1.523 0.582 0 C-N-CA 120.774 -0.727 . . . . 0.0 111.419 175.994 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' E' E ' 83' ' ' ILE . . . . . . . . . . . . . 72.9 mt -66.06 133.31 31.14 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.297 0 CA-C-O 120.942 0.401 . . . . 0.0 110.01 178.181 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' E' E ' 84' ' ' LYS . . . . . . . . . . . . . 85.9 tttt -91.67 -53.14 4.42 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-N 115.936 -0.574 . . . . 0.0 109.97 -179.633 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' E' E ' 85' ' ' ASP . . . . . . . . . . . . . 13.3 t70 -156.24 151.02 26.03 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 115.553 -0.749 . . . . 0.0 110.059 179.402 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' E' E ' 86' ' ' VAL . . . . . . . . . . . . . 43.3 t -125.87 129.63 72.44 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.287 0 CA-C-O 120.937 0.399 . . . . 0.0 110.439 -178.986 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' E' E ' 87' ' ' ILE . . . . . . . . . . . . . 44.5 mm -118.28 126.15 74.82 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.208 0 CA-C-N 115.979 -0.555 . . . . 0.0 109.714 177.008 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' E' E ' 88' ' ' LEU . . . . . . . . . . . . . 14.2 tp -108.8 131.08 55.32 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-O 120.972 0.415 . . . . 0.0 111.004 -177.591 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' E' E ' 89' ' ' ASP . . . . . . . . . . . . . 7.7 t70 -119.61 154.07 34.52 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 115.787 -0.642 . . . . 0.0 109.5 176.781 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' E' E ' 90' ' ' GLU . . . . . . . . . . . . . 82.4 tt0 -46.28 -43.57 15.8 Favored 'General case' 0 N--CA 1.464 0.263 0 N-CA-C 112.871 0.693 . . . . 0.0 112.871 -173.106 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' E' E ' 91' ' ' ASN . . . . . . . . . . . . . 16.0 t-20 -132.15 39.11 3.44 Favored 'General case' 0 C--N 1.331 -0.217 0 CA-C-O 120.907 0.384 . . . . 0.0 111.195 -178.815 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' E' E ' 92' ' ' LEU . . . . . . . . . . . . . 10.5 tp -166.08 147.26 6.72 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 116.526 -0.307 . . . . 0.0 110.386 -178.708 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' E' E ' 93' ' ' ILE . . . . . . . . . . . . . 65.8 mt -128.78 123.49 59.31 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.214 0 N-CA-C 109.483 -0.562 . . . . 0.0 109.483 -178.972 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' E' E ' 94' ' ' VAL . . . . . . . . . . . . . 44.1 t -124.24 129.36 74.07 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.216 0 CA-C-O 121.021 0.438 . . . . 0.0 110.035 -179.841 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' E' E ' 95' ' ' VAL . . . . . . . . . . . . . 42.5 t -122.04 135.83 60.89 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.328 0 CA-C-N 115.881 -0.599 . . . . 0.0 109.926 -178.906 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' E' E ' 96' ' ' ILE . . . . . . . . . . . . . 62.0 mt -111.92 126.7 69.33 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.355 0 N-CA-C 109.215 -0.661 . . . . 0.0 109.215 178.068 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' E' E ' 97' ' ' THR . . . . . . . . . . . . . 68.3 p -97.16 155.91 16.63 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-O 121.168 0.509 . . . . 0.0 111.134 -178.176 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' E' E ' 98' ' ' GLU . . . . . . . . . . . . . 82.6 tt0 -53.86 -25.88 21.89 Favored 'General case' 0 C--N 1.327 -0.372 0 N-CA-C 112.304 0.483 . . . . 0.0 112.304 -178.941 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' E' E ' 99' ' ' GLU . . . . . . . . . . . . . 71.2 mm-40 -81.56 16.16 1.83 Allowed 'General case' 0 CA--C 1.536 0.413 0 N-CA-C 113.137 0.791 . . . . 0.0 113.137 -176.74 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' E' E ' 100' ' ' ASN . . . . . . . . . . . . . 3.5 m-20 62.89 34.33 14.37 Favored 'General case' 0 CA--C 1.531 0.227 0 CA-C-O 120.909 0.385 . . . . 0.0 111.519 178.644 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' E' E ' 101' ' ' GLU . . . . . . . . . . . . . 84.6 tt0 -112.65 143.63 43.52 Favored 'General case' 0 C--N 1.334 -0.093 0 N-CA-C 109.69 -0.485 . . . . 0.0 109.69 173.422 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' E' E ' 102' ' ' VAL . . . . . . . . . . . . . 45.6 t -115.21 129.43 71.47 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.322 0 CA-C-N 116.49 -0.323 . . . . 0.0 110.297 -177.414 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' E' E ' 103' ' ' LEU . . . . . . . . . . . . . 51.1 mt -117.85 130.75 56.45 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-N 115.7 -0.682 . . . . 0.0 110.415 177.31 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' E' E ' 104' ' ' ILE . . . . . . . . . . . . . 70.7 mt -117.45 122.86 70.88 Favored 'Isoleucine or valine' 0 C--O 1.233 0.226 0 N-CA-C 110.154 -0.313 . . . . 0.0 110.154 178.373 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' E' E ' 105' ' ' PHE . . . . . . . . . . . . . 74.3 m-85 -123.6 164.36 19.19 Favored 'General case' 0 C--O 1.232 0.132 0 O-C-N 123.905 0.753 . . . . 0.0 109.876 -179.781 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' E' E ' 106' ' ' ASN . . . . . . . . . . . . . 43.5 p-10 -99.07 -170.02 1.86 Allowed 'General case' 0 C--N 1.33 -0.254 0 N-CA-C 109.738 -0.467 . . . . 0.0 109.738 172.381 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' E' E ' 107' ' ' GLN . . . . . . . . . . . . . 48.8 tt0 -57.91 -29.8 65.4 Favored 'General case' 0 C--N 1.329 -0.298 0 N-CA-C 112.025 0.38 . . . . 0.0 112.025 179.982 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' E' E ' 108' ' ' ASN . . . . . . . . . . . . . 22.5 t30 -88.69 13.14 12.99 Favored 'General case' 0 CA--C 1.535 0.388 0 N-CA-C 113.094 0.776 . . . . 0.0 113.094 -176.024 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' E' E ' 109' ' ' LEU . . . . . . . . . . . . . 38.4 mt 57.43 36.18 26.77 Favored 'General case' 0 C--N 1.333 -0.149 0 CA-C-O 120.941 0.4 . . . . 0.0 111.566 177.811 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' E' E ' 110' ' ' GLU . . . . . . . . . . . . . 95.6 mt-10 -100.56 155.26 17.95 Favored 'General case' 0 C--N 1.33 -0.258 0 N-CA-C 109.72 -0.474 . . . . 0.0 109.72 176.191 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' E' E ' 111' ' ' GLU . . . . . . . . . . . . . 84.4 tt0 -82.26 121.91 27.25 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-O 120.883 0.373 . . . . 0.0 110.92 -177.707 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' E' E ' 112' ' ' LEU . . . . . . . . . . . . . 75.2 mt -107.9 -45.99 3.87 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.017 -0.538 . . . . 0.0 110.047 176.416 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' E' E ' 113' ' ' TYR . . . . . . . . . . . . . 63.3 t80 -143.28 135.76 27.32 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.153 -0.476 . . . . 0.0 111.52 -179.395 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' E' E ' 114' ' ' ARG . . . . . . . . . . . . . 21.4 ttm180 -131.13 123.88 29.52 Favored 'General case' 0 C--N 1.331 -0.201 0 CA-C-N 115.775 -0.648 . . . . 0.0 109.623 173.529 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' E' E ' 115' ' ' GLY . . . . . . . . . . . . . . . -150.0 156.41 26.73 Favored Glycine 0 CA--C 1.523 0.539 0 N-CA-C 110.85 -0.9 . . . . 0.0 110.85 178.531 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' E' E ' 116' ' ' LYS . . . . . . . . . . . . . 55.6 tttt -132.68 140.31 48.08 Favored 'General case' 0 C--N 1.329 -0.309 0 O-C-N 122.646 -0.326 . . . . 0.0 110.16 179.245 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' E' E ' 117' ' ' PHE . . . . . . . . . . . . . 18.2 m-85 -139.63 113.82 8.95 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-O 120.887 0.375 . . . . 0.0 110.091 -176.194 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' E' E ' 118' ' ' GLU . . . . . . . . . . . . . 83.2 tt0 -53.3 -47.43 69.22 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.453 -0.339 . . . . 0.0 111.573 -175.84 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' E' E ' 119' ' ' ASN . . . . . . . . . . . . . 74.4 m-20 -95.15 31.12 1.98 Allowed 'General case' 0 C--N 1.332 -0.196 0 N-CA-C 112.265 0.468 . . . . 0.0 112.265 -174.45 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' E' E ' 120' ' ' LEU . . . . . . . . . . . . . 22.1 tp -55.85 122.95 12.66 Favored 'General case' 0 C--N 1.333 -0.136 0 CA-C-O 120.724 0.297 . . . . 0.0 110.52 177.146 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' E' E ' 121' ' ' ASN . . . . . . . . . . . . . 62.7 t30 -112.2 -44.08 3.46 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-N 116.362 -0.381 . . . . 0.0 110.718 -177.977 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' E' E ' 122' ' ' LYS . . . . . . . . . . . . . 98.0 mttt -143.45 144.76 32.15 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-O 120.96 0.409 . . . . 0.0 111.661 -177.476 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' E' E ' 123' ' ' VAL . . . . . . . . . . . . . 46.7 t -123.61 122.37 64.77 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.284 0 N-CA-C 109.136 -0.69 . . . . 0.0 109.136 173.826 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' E' E ' 124' ' ' LEU . . . . . . . . . . . . . 5.6 mp -120.59 132.3 55.08 Favored 'General case' 0 C--N 1.331 -0.203 0 CA-C-N 116.483 -0.326 . . . . 0.0 110.389 -177.155 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' E' E ' 125' ' ' VAL . . . . . . . . . . . . . 35.1 m -135.56 138.74 47.7 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.314 0 CA-C-N 116.379 -0.373 . . . . 0.0 110.736 179.279 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' E' E ' 126' ' ' ARG . . . . . . . . . . . . . 32.8 ptt-85 -150.19 125.23 9.95 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 116.088 -0.506 . . . . 0.0 110.178 177.926 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' E' E ' 127' ' ' ASN . . . . . . . . . . . . . 85.5 m-20 55.07 -123.38 2.03 Favored 'General case' 0 CA--C 1.546 0.804 0 CA-C-O 118.529 -0.748 . . . . 0.0 110.209 -178.191 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' E' E ' 128' ' ' ASP . . . . . . . . . . . . . 23.3 p-10 -106.07 12.29 30.51 Favored 'General case' 0 CA--C 1.536 0.431 0 CA-C-N 120.235 1.379 . . . . 0.0 113.088 179.349 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' E' E ' 129' ' ' LEU . . . . . . . . . . . . . 5.0 tt -106.14 132.63 51.98 Favored 'General case' 0 C--O 1.231 0.121 0 N-CA-C 109.653 -0.499 . . . . 0.0 109.653 179.079 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' E' E ' 130' ' ' VAL . . . . . . . . . . . . . 46.4 t -122.05 136.32 59.3 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.248 0 CA-C-O 120.894 0.378 . . . . 0.0 110.185 -177.926 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' E' E ' 131' ' ' VAL . . . . . . . . . . . . . 42.1 t -135.11 135.5 52.46 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.19 0 CA-C-O 121.128 0.49 . . . . 0.0 110.076 177.668 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' E' E ' 132' ' ' ILE . . . . . . . . . . . . . 74.7 mt -118.1 132.34 68.21 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.338 0 CA-C-N 115.746 -0.661 . . . . 0.0 109.532 -178.86 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' E' E ' 133' ' ' ILE . . . . . . . . . . . . . 37.5 mm -116.88 121.9 68.78 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.205 0 CA-C-O 120.78 0.324 . . . . 0.0 111.075 -174.694 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' E' E ' 134' ' ' ASP . . . . . . . . . . . . . 10.2 p-10 -135.23 149.84 49.96 Favored 'General case' 0 C--N 1.331 -0.221 0 CA-C-N 116.03 -0.532 . . . . 0.0 109.767 175.225 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' E' E ' 135' ' ' GLU . . . . . . . . . . . . . 85.1 tt0 -49.92 -26.67 4.36 Favored 'General case' 0 C--N 1.329 -0.318 0 N-CA-C 113.019 0.748 . . . . 0.0 113.019 -172.159 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' E' E ' 136' ' ' GLN . . . . . . . . . . . . . 99.7 mm-40 -85.55 -32.11 22.33 Favored 'General case' 0 C--O 1.235 0.299 0 N-CA-C 112.401 0.519 . . . . 0.0 112.401 -174.935 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' E' E ' 137' ' ' LYS . . . . . . . . . . . . . 55.7 pttt -168.54 174.07 7.04 Favored 'General case' 0 C--N 1.332 -0.186 0 CA-C-O 121.5 0.667 . . . . 0.0 112.257 -171.008 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' E' E ' 138' ' ' LEU . . . . . . . . . . . . . 8.7 tt -121.88 130.1 53.09 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 115.032 -0.985 . . . . 0.0 110.264 179.8 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' E' E ' 139' ' ' THR . . . . . . . . . . . . . 38.0 m -108.3 130.27 55.19 Favored 'General case' 0 C--N 1.331 -0.23 0 CA-C-N 116.163 -0.471 . . . . 0.0 110.653 -179.546 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' E' E ' 140' ' ' LEU . . . . . . . . . . . . . 12.3 tp -116.34 121.8 43.02 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 115.724 -0.671 . . . . 0.0 109.332 -179.271 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' E' E ' 141' ' ' ILE . . . . . . . . . . . . . 18.9 mt -120.57 121.65 65.98 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.288 0 CA-C-O 120.976 0.417 . . . . 0.0 110.296 -175.152 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' E' E ' 142' ' ' ARG . . . . . . . . . . . . . 66.4 mtp180 -108.93 130.86 55.46 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 115.264 -0.88 . . . . 0.0 110.438 179.906 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' E' E ' 143' ' ' THR . . . . . . . . . . . . . 19.1 p . . . . . 0 C--O 1.221 -0.417 0 CA-C-O 117.988 -1.006 . . . . 0.0 110.492 178.782 . . . . . . . . 0 0 . 1 . 019 nuclear orig full ' F' F ' -3' ' ' GLU . . . . . . . . . . . . . 84.6 tt0 . . . . . 0 N--CA 1.49 1.56 0 N-CA-C 109.473 -0.566 . . . . 0.0 109.473 . . . . . . . . . 0 0 . 1 . 019 nuclear orig full ' F' F ' -2' ' ' GLY . . . . . . . . . . . . . . . -68.54 136.97 30.2 Favored Glycine 0 CA--C 1.524 0.627 0 N-CA-C 110.658 -0.977 . . . . 0.0 110.658 178.539 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' F' F ' -1' ' ' VAL . . . . . . . . . . . . . 43.3 t -95.65 133.83 35.3 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.297 0 N-CA-C 110.003 -0.369 . . . . 0.0 110.003 -179.58 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' F' F ' 0' ' ' ILE . . . . . . . . . . . . . 71.5 mt -109.84 123.57 65.84 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.266 0 CA-C-N 116.169 -0.469 . . . . 0.0 110.037 -179.093 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' F' F ' 1' ' ' MET . . . . . . . . . . . . . 16.0 ptm -89.34 132.78 34.78 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.098 -0.501 . . . . 0.0 110.594 -179.987 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' F' F ' 2' ' ' SER . . . . . . . . . . . . . 11.7 p -118.77 132.77 56.15 Favored 'General case' 0 C--N 1.332 -0.182 0 CA-C-O 121.006 0.431 . . . . 0.0 110.824 -179.335 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' F' F ' 3' ' ' GLU . . . . . . . . . . . . . 95.6 mt-10 -141.3 141.08 33.94 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 115.779 -0.646 . . . . 0.0 110.823 -179.284 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' F' F ' 4' ' ' LEU . . . . . . . . . . . . . 12.5 tp -129.38 131.05 46.74 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.235 -0.439 . . . . 0.0 110.267 177.115 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' F' F ' 5' ' ' LYS . . . . . . . . . . . . . 98.7 mttt -113.77 121.62 44.62 Favored 'General case' 0 C--O 1.234 0.247 0 CA-C-N 116.505 -0.316 . . . . 0.0 110.825 -179.708 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' F' F ' 6' ' ' LEU . . . . . . . . . . . . . 66.7 mt -114.05 145.08 42.08 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-N 115.478 -0.783 . . . . 0.0 110.007 179.372 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' F' F ' 7' ' ' LYS . . . . . . . . . . . . . 27.2 ttpp -126.72 141.22 39.7 Favored Pre-proline 0 CA--C 1.534 0.329 0 CA-C-O 119.059 -0.496 . . . . 0.0 109.804 176.134 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' F' F ' 8' ' ' PRO . . . . . . . . . . . . . 97.8 Cg_endo -92.07 137.2 1.76 Allowed 'Trans proline' 0 N--CA 1.49 1.295 0 C-N-CA 121.799 1.666 . . . . 0.0 111.897 178.801 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' F' F ' 9' ' ' LEU . . . . . . . . . . . . . 63.0 mt -75.64 -46.93 4.15 Favored Pre-proline 0 CA--C 1.535 0.384 0 CA-C-O 118.764 -0.636 . . . . 0.0 112.076 179.255 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' F' F ' 10' ' ' PRO . . . . . . . . . . . . . 71.1 Cg_endo -83.44 158.29 14.64 Favored 'Trans proline' 0 N--CA 1.497 1.691 0 C-N-CA 121.294 1.329 . . . . 0.0 112.179 175.583 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' F' F ' 11' ' ' LYS . . . . . . . . . . . . . 37.0 mmtm -79.19 105.33 10.44 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.396 -0.365 . . . . 0.0 110.167 176.044 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' F' F ' 12' ' ' VAL . . . . . . . . . . . . . 12.7 p -145.58 141.18 22.22 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.312 0 CA-C-O 120.833 0.349 . . . . 0.0 110.863 -179.602 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' F' F ' 13' ' ' GLU . . . . . . . . . . . . . 15.2 mm-40 -95.45 124.82 39.67 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.202 -0.454 . . . . 0.0 109.874 175.378 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' F' F ' 14' ' ' LEU . . . . . . . . . . . . . 44.6 mt -96.79 151.49 37.88 Favored Pre-proline 0 C--N 1.328 -0.332 0 CA-C-N 116.411 -0.359 . . . . 0.0 110.497 -177.131 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' F' F ' 15' ' ' PRO . . . . . . . . . . . . . 35.4 Cg_exo -59.3 158.49 26.37 Favored 'Trans proline' 0 N--CA 1.497 1.716 0 C-N-CA 121.27 1.313 . . . . 0.0 111.795 178.715 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' F' F ' 16' ' ' PRO . . . . . . . . . . . . . 37.1 Cg_exo -59.03 -37.75 91.42 Favored 'Trans proline' 0 N--CA 1.497 1.677 0 C-N-CA 121.472 1.448 . . . . 0.0 112.516 -179.485 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' F' F ' 17' ' ' ASP . . . . . . . . . . . . . 18.2 p-10 -89.04 14.02 11.63 Favored 'General case' 0 CA--C 1.536 0.406 0 N-CA-C 112.984 0.735 . . . . 0.0 112.984 -178.77 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' F' F ' 18' ' ' PHE . . . . . . . . . . . . . 53.0 t80 -58.4 -45.25 88.74 Favored 'General case' 0 N--CA 1.457 -0.082 0 O-C-N 121.975 -0.453 . . . . 0.0 110.122 -177.487 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' F' F ' 19' ' ' VAL . . . . . . . . . . . . . 14.6 p -55.15 -41.39 59.89 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.243 0 CA-C-N 116.512 -0.313 . . . . 0.0 111.066 -177.96 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' F' F ' 20' ' ' ASP . . . . . . . . . . . . . 68.5 m-20 -60.5 -44.47 95.95 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-O 120.83 0.348 . . . . 0.0 110.852 -179.19 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' F' F ' 21' ' ' VAL . . . . . . . . . . . . . 50.4 t -64.07 -48.37 86.2 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.308 0 CA-C-N 116.43 -0.35 . . . . 0.0 110.568 -177.478 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' F' F ' 22' ' ' ILE . . . . . . . . . . . . . 49.0 mm -58.01 -43.55 85.21 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.288 0 C-N-CA 120.926 -0.309 . . . . 0.0 110.754 -178.885 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' F' F ' 23' ' ' ARG . . . . . . . . . . . . . 55.7 ttp180 -55.92 -47.56 77.29 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-O 120.654 0.264 . . . . 0.0 110.832 -179.98 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' F' F ' 24' ' ' ILE . . . . . . . . . . . . . 69.0 mt -60.49 -41.03 86.17 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.29 0 CA-C-N 116.578 -0.283 . . . . 0.0 111.643 -178.473 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' F' F ' 25' ' ' LYS . . . . . . . . . . . . . 14.9 ptpt -74.13 -35.14 64.08 Favored 'General case' 0 CA--C 1.534 0.327 0 N-CA-C 112.317 0.488 . . . . 0.0 112.317 -175.063 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' F' F ' 26' ' ' LEU . . . . . . . . . . . . . 22.7 mt -80.66 -38.89 28.27 Favored 'General case' 0 C--N 1.327 -0.378 0 N-CA-C 113.31 0.855 . . . . 0.0 113.31 -173.662 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' F' F ' 27' ' ' GLN . . . . . . . . . . . . . 10.0 pt20 -46.47 141.23 3.74 Favored 'General case' 0 N--CA 1.47 0.528 0 N-CA-C 112.784 0.661 . . . . 0.0 112.784 -174.411 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' F' F ' 28' ' ' GLY . . . . . . . . . . . . . . . 101.14 -25.92 26.52 Favored Glycine 0 CA--C 1.532 1.122 0 CA-C-N 115.464 -0.789 . . . . 0.0 112.262 -176.477 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' F' F ' 29' ' ' LYS . . . . . . . . . . . . . 55.5 mtpt -98.04 155.04 17.31 Favored 'General case' 0 C--N 1.332 -0.161 0 CA-C-N 117.483 0.642 . . . . 0.0 111.183 178.827 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' F' F ' 30' ' ' THR . . . . . . . . . . . . . 29.9 m -103.63 138.97 39.56 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 115.988 -0.551 . . . . 0.0 109.964 176.127 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' F' F ' 31' ' ' VAL . . . . . . . . . . . . . 35.0 m -129.46 156.25 41.78 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.235 0 CA-C-N 116.382 -0.372 . . . . 0.0 110.972 -178.26 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' F' F ' 32' ' ' ARG . . . . . . . . . . . . . 93.6 mtm-85 -133.31 148.41 51.9 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 115.731 -0.668 . . . . 0.0 110.248 177.439 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' F' F ' 33' ' ' THR . . . . . . . . . . . . . 19.0 m -53.03 140.03 26.35 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.411 -0.359 . . . . 0.0 111.372 -178.442 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' F' F ' 34' ' ' GLY . . . . . . . . . . . . . . . 100.33 -17.14 57.3 Favored Glycine 0 CA--C 1.532 1.144 0 CA-C-O 119.609 -0.55 . . . . 0.0 113.251 179.765 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' F' F ' 35' ' ' ASP . . . . . . . . . . . . . 73.3 m-20 -65.66 149.28 50.36 Favored 'General case' 0 N--CA 1.462 0.151 0 CA-C-N 118.04 0.92 . . . . 0.0 111.094 179.435 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' F' F ' 36' ' ' VAL . . . . . . . . . . . . . 45.6 t -124.83 131.31 72.8 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.174 0 CA-C-N 115.963 -0.562 . . . . 0.0 109.801 178.335 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' F' F ' 37' ' ' ILE . . . . . . . . . . . . . 65.1 mt -122.09 140.0 47.35 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.224 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.027 -178.678 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' F' F ' 38' ' ' GLY . . . . . . . . . . . . . . . -113.76 128.63 8.39 Favored Glycine 0 CA--C 1.524 0.639 0 N-CA-C 110.888 -0.885 . . . . 0.0 110.888 178.329 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' F' F ' 39' ' ' ILE . . . . . . . . . . . . . 71.8 mt -127.52 133.97 66.64 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.197 0 N-CA-C 110.093 -0.336 . . . . 0.0 110.093 179.439 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' F' F ' 40' ' ' SER . . . . . . . . . . . . . 20.4 t -92.35 124.26 36.28 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.376 -0.375 . . . . 0.0 111.298 178.381 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' F' F ' 41' ' ' ILE . . . . . . . . . . . . . 68.9 mt -134.35 121.9 38.46 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.236 0 N-CA-C 110.058 -0.349 . . . . 0.0 110.058 176.436 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' F' F ' 42' ' ' LEU . . . . . . . . . . . . . 45.0 mt 58.84 35.13 24.11 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.087 -0.506 . . . . 0.0 111.694 177.942 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' F' F ' 43' ' ' GLY . . . . . . . . . . . . . . . 74.35 13.13 81.78 Favored Glycine 0 CA--C 1.534 1.231 0 C-N-CA 121.135 -0.555 . . . . 0.0 113.371 176.964 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' F' F ' 44' ' ' LYS . . . . . . . . . . . . . 94.9 mttt -126.21 130.98 52.03 Favored 'General case' 0 C--N 1.332 -0.155 0 CA-C-N 117.847 0.824 . . . . 0.0 109.785 177.191 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' F' F ' 45' ' ' GLU . . . . . . . . . . . . . 83.9 tt0 -84.81 130.5 34.66 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-O 120.887 0.375 . . . . 0.0 111.39 -178.391 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' F' F ' 46' ' ' VAL . . . . . . . . . . . . . 9.8 p -117.96 128.26 75.09 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.236 0 N-CA-C 109.566 -0.531 . . . . 0.0 109.566 174.508 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' F' F ' 47' ' ' LYS . . . . . . . . . . . . . 92.3 mttt -98.13 124.29 42.61 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.157 -0.474 . . . . 0.0 110.693 177.846 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' F' F ' 48' ' ' PHE . . . . . . . . . . . . . 33.5 m-85 -108.43 131.79 54.43 Favored 'General case' 0 C--N 1.329 -0.32 0 N-CA-C 109.571 -0.529 . . . . 0.0 109.571 175.866 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' F' F ' 49' ' ' LYS . . . . . . . . . . . . . 46.6 tttm -108.58 134.2 51.67 Favored 'General case' 0 C--N 1.331 -0.227 0 CA-C-N 116.342 -0.39 . . . . 0.0 110.202 177.678 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' F' F ' 50' ' ' VAL . . . . . . . . . . . . . 45.0 t -78.74 105.68 8.38 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.342 0 N-CA-C 109.368 -0.604 . . . . 0.0 109.368 177.227 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' F' F ' 51' ' ' VAL . . . . . . . . . . . . . 47.8 t -69.68 -52.78 28.65 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.276 0 N-CA-C 109.534 -0.543 . . . . 0.0 109.534 -175.903 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' F' F ' 52' ' ' GLN . . . . . . . . . . . . . 87.8 mt-30 -153.54 151.12 29.42 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 115.889 -0.596 . . . . 0.0 111.544 -178.634 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' F' F ' 53' ' ' ALA . . . . . . . . . . . . . . . -128.82 134.17 48.25 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 115.021 -0.99 . . . . 0.0 109.493 175.089 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' F' F ' 54' ' ' TYR . . . . . . . . . . . . . 84.3 t80 -129.12 111.47 18.31 Favored Pre-proline 0 CA--C 1.535 0.401 0 CA-C-O 118.15 -0.929 . . . . 0.0 110.387 -179.862 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' F' F ' 55' ' ' PRO . . . . . . . . . . . . . 73.4 Cg_endo -77.07 169.18 75.01 Favored 'Cis proline' 0 N--CA 1.5 1.879 0 CA-C-N 121.94 1.729 . . . . 0.0 112.303 -5.952 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' F' F ' 56' ' ' SER . . . . . . . . . . . . . 13.7 m -116.76 128.16 26.21 Favored Pre-proline 0 CA--C 1.538 0.509 0 CA-C-O 118.366 -0.826 . . . . 0.0 109.274 174.686 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' F' F ' 57' ' ' PRO . . . . . . . . . . . . . 37.2 Cg_endo -66.68 165.44 64.93 Favored 'Cis proline' 0 N--CA 1.496 1.647 0 CA-C-N 122.023 1.758 . . . . 0.0 111.78 0.259 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' F' F ' 58' ' ' LEU . . . . . . . . . . . . . 26.6 tp -130.08 135.85 48.69 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.155 -0.475 . . . . 0.0 110.276 179.296 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' F' F ' 59' ' ' ARG . . . . . . . . . . . . . 58.2 ttt-85 -103.82 125.02 49.97 Favored 'General case' 0 C--N 1.327 -0.406 0 N-CA-C 109.278 -0.638 . . . . 0.0 109.278 175.39 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' F' F ' 60' ' ' VAL . . . . . . . . . . . . . 47.6 t -76.86 117.81 22.36 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.318 0 C-N-CA 120.756 -0.378 . . . . 0.0 110.362 -175.127 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' F' F ' 61' ' ' GLU . . . . . . . . . . . . . 95.6 mt-10 -130.95 166.44 20.95 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 115.728 -0.669 . . . . 0.0 109.661 177.917 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' F' F ' 62' ' ' ASP . . . . . . . . . . . . . 82.0 m-20 -53.97 -32.58 54.41 Favored 'General case' 0 C--N 1.329 -0.312 0 C-N-CA 121.012 -0.275 . . . . 0.0 111.688 179.651 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' F' F ' 63' ' ' ARG . . . . . . . . . . . . . 49.8 ptt85 -78.41 -1.0 31.38 Favored 'General case' 0 CA--C 1.537 0.46 0 N-CA-C 113.781 1.03 . . . . 0.0 113.781 -175.838 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' F' F ' 64' ' ' THR . . . . . . . . . . . . . 34.3 m -86.6 134.75 33.61 Favored 'General case' 0 C--O 1.232 0.161 0 CA-C-N 118.164 0.438 . . . . 0.0 110.808 -177.158 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' F' F ' 65' ' ' LYS . . . . . . . . . . . . . 90.9 mttt -90.01 128.11 36.2 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.01 -0.541 . . . . 0.0 110.211 178.208 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' F' F ' 66' ' ' ILE . . . . . . . . . . . . . 63.3 mt -114.04 130.93 67.38 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.252 0 N-CA-C 109.886 -0.412 . . . . 0.0 109.886 -179.682 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' F' F ' 67' ' ' THR . . . . . . . . . . . . . 30.5 m -125.5 143.57 50.94 Favored 'General case' 0 C--N 1.331 -0.227 0 CA-C-N 116.013 -0.54 . . . . 0.0 111.113 -177.977 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' F' F ' 68' ' ' LEU . . . . . . . . . . . . . 20.6 tp -101.48 123.87 46.22 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 115.687 -0.688 . . . . 0.0 110.118 177.431 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' F' F ' 69' ' ' VAL . . . . . . . . . . . . . 44.4 t -101.37 126.74 55.15 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.309 0 CA-C-N 116.281 -0.418 . . . . 0.0 110.034 -179.25 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' F' F ' 70' ' ' THR . . . . . . . . . . . . . 9.0 m -87.93 -39.1 15.03 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.132 -0.485 . . . . 0.0 111.035 -178.871 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' F' F ' 71' ' ' HIS . . . . . . . . . . . . . 98.3 m-70 -74.84 151.17 86.56 Favored Pre-proline 0 C--N 1.33 -0.257 0 CA-C-N 116.481 -0.327 . . . . 0.0 111.099 -176.503 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' F' F ' 72' ' ' PRO . . . . . . . . . . . . . 85.7 Cg_endo -91.81 -4.89 3.88 Favored 'Trans proline' 0 N--CA 1.493 1.462 0 C-N-CA 121.859 1.706 . . . . 0.0 113.866 178.394 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' F' F ' 73' ' ' VAL . . . . . . . . . . . . . 34.3 m -120.26 161.87 19.39 Favored 'Isoleucine or valine' 0 N--CA 1.462 0.164 0 CA-C-O 120.893 0.378 . . . . 0.0 111.002 -177.573 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' F' F ' 74' ' ' ASP . . . . . . . . . . . . . 33.0 t0 -100.79 124.08 45.92 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 115.842 -0.617 . . . . 0.0 110.233 -178.923 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' F' F ' 75' ' ' VAL . . . . . . . . . . . . . 42.5 t -118.1 123.17 71.25 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.24 0 CA-C-O 121.027 0.441 . . . . 0.0 110.594 -178.294 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' F' F ' 76' ' ' LEU . . . . . . . . . . . . . 5.5 mp -121.94 147.89 45.47 Favored 'General case' 0 C--N 1.331 -0.217 0 CA-C-N 115.744 -0.662 . . . . 0.0 109.686 175.661 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' F' F ' 77' ' ' GLU . . . . . . . . . . . . . 96.4 mt-10 -137.63 132.17 32.61 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-O 121.005 0.431 . . . . 0.0 111.165 -178.712 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' F' F ' 78' ' ' ALA . . . . . . . . . . . . . . . -115.33 131.01 57.07 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 115.744 -0.662 . . . . 0.0 109.859 177.17 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' F' F ' 79' ' ' LYS . . . . . . . . . . . . . 34.3 tptt -85.75 117.42 24.62 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-O 120.798 0.332 . . . . 0.0 110.955 -176.71 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' F' F ' 80' ' ' ILE . . . . . . . . . . . . . 39.1 mm -139.23 107.46 3.26 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.272 0 N-CA-C 109.227 -0.657 . . . . 0.0 109.227 -179.314 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' F' F ' 81' ' ' LYS . . . . . . . . . . . . . 38.8 ttpt -89.08 121.47 31.45 Favored 'General case' 0 C--N 1.328 -0.334 0 C-N-CA 120.865 -0.334 . . . . 0.0 111.084 -177.207 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' F' F ' 82' ' ' GLY . . . . . . . . . . . . . . . 89.21 42.19 5.64 Favored Glycine 0 CA--C 1.525 0.698 0 C-N-CA 120.561 -0.828 . . . . 0.0 111.651 174.239 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' F' F ' 83' ' ' ILE . . . . . . . . . . . . . 73.9 mt -65.45 139.79 20.75 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.306 0 N-CA-C 109.623 -0.51 . . . . 0.0 109.623 176.997 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' F' F ' 84' ' ' LYS . . . . . . . . . . . . . 84.3 tttt -94.72 -53.27 3.93 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.028 -0.533 . . . . 0.0 110.49 -176.773 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' F' F ' 85' ' ' ASP . . . . . . . . . . . . . 9.3 t70 -154.12 153.1 31.25 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 115.787 -0.642 . . . . 0.0 110.313 -179.39 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' F' F ' 86' ' ' VAL . . . . . . . . . . . . . 44.4 t -130.79 131.12 64.66 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.247 0 CA-C-O 120.846 0.355 . . . . 0.0 110.616 -179.009 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' F' F ' 87' ' ' ILE . . . . . . . . . . . . . 5.1 mp -123.13 126.57 73.76 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.249 0 CA-C-N 115.992 -0.549 . . . . 0.0 109.566 176.892 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' F' F ' 88' ' ' LEU . . . . . . . . . . . . . 53.7 mt -113.18 137.76 50.98 Favored 'General case' 0 C--N 1.331 -0.224 0 CA-C-O 121.12 0.486 . . . . 0.0 111.649 -175.963 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' F' F ' 89' ' ' ASP . . . . . . . . . . . . . 12.3 t0 -133.23 150.76 51.93 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 115.592 -0.731 . . . . 0.0 109.279 174.973 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' F' F ' 90' ' ' GLU . . . . . . . . . . . . . 82.9 tt0 -48.18 -38.01 17.15 Favored 'General case' 0 C--N 1.33 -0.258 0 N-CA-C 112.827 0.677 . . . . 0.0 112.827 -173.385 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' F' F ' 91' ' ' ASN . . . . . . . . . . . . . 26.5 m120 -128.44 32.93 4.77 Favored 'General case' 0 N--CA 1.466 0.361 0 N-CA-C 111.794 0.294 . . . . 0.0 111.794 -177.077 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' F' F ' 92' ' ' LEU . . . . . . . . . . . . . 19.3 tp -166.13 138.9 4.01 Favored 'General case' 0 C--N 1.33 -0.259 0 N-CA-C 110.2 -0.296 . . . . 0.0 110.2 -179.438 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' F' F ' 93' ' ' ILE . . . . . . . . . . . . . 71.0 mt -126.36 122.46 61.3 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.279 0 N-CA-C 109.666 -0.494 . . . . 0.0 109.666 178.368 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' F' F ' 94' ' ' VAL . . . . . . . . . . . . . 43.8 t -120.78 126.25 75.01 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.265 0 N-CA-C 109.887 -0.412 . . . . 0.0 109.887 179.995 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' F' F ' 95' ' ' VAL . . . . . . . . . . . . . 42.7 t -121.45 133.77 66.92 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.282 0 CA-C-N 115.939 -0.573 . . . . 0.0 109.665 179.849 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' F' F ' 96' ' ' ILE . . . . . . . . . . . . . 60.9 mt -115.5 126.66 73.12 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.323 0 N-CA-C 109.363 -0.606 . . . . 0.0 109.363 179.039 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' F' F ' 97' ' ' THR . . . . . . . . . . . . . 80.8 p -96.5 156.52 16.31 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-O 120.863 0.363 . . . . 0.0 110.765 -179.191 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' F' F ' 98' ' ' GLU . . . . . . . . . . . . . 40.8 tp10 -53.82 -25.54 19.97 Favored 'General case' 0 CA--C 1.533 0.317 0 N-CA-C 112.111 0.411 . . . . 0.0 112.111 -179.461 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' F' F ' 99' ' ' GLU . . . . . . . . . . . . . 18.1 tp10 -80.05 17.42 1.0 Allowed 'General case' 0 CA--C 1.538 0.503 0 N-CA-C 112.858 0.688 . . . . 0.0 112.858 -177.732 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' F' F ' 100' ' ' ASN . . . . . . . . . . . . . 3.6 m-20 63.1 35.59 12.83 Favored 'General case' 0 CA--C 1.531 0.233 0 CA-C-O 120.882 0.372 . . . . 0.0 111.435 176.39 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' F' F ' 101' ' ' GLU . . . . . . . . . . . . . 83.9 tt0 -113.19 142.06 46.23 Favored 'General case' 0 C--N 1.332 -0.173 0 N-CA-C 109.866 -0.42 . . . . 0.0 109.866 175.355 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' F' F ' 102' ' ' VAL . . . . . . . . . . . . . 45.8 t -115.01 126.17 72.53 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.266 0 N-CA-C 109.896 -0.409 . . . . 0.0 109.896 -178.537 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' F' F ' 103' ' ' LEU . . . . . . . . . . . . . 58.2 mt -116.1 133.85 55.57 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 115.685 -0.689 . . . . 0.0 109.796 177.798 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' F' F ' 104' ' ' ILE . . . . . . . . . . . . . 73.8 mt -121.53 119.41 58.87 Favored 'Isoleucine or valine' 0 C--O 1.233 0.23 0 N-CA-C 110.211 -0.292 . . . . 0.0 110.211 -178.939 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' F' F ' 105' ' ' PHE . . . . . . . . . . . . . 35.5 m-85 -121.79 168.2 12.11 Favored 'General case' 0 C--N 1.332 -0.153 0 O-C-N 124.222 0.951 . . . . 0.0 109.907 -179.968 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' F' F ' 106' ' ' ASN . . . . . . . . . . . . . 45.5 p-10 -102.56 -170.03 1.75 Allowed 'General case' 0 C--N 1.33 -0.273 0 N-CA-C 109.509 -0.552 . . . . 0.0 109.509 171.917 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' F' F ' 107' ' ' GLN . . . . . . . . . . . . . 57.1 tt0 -58.21 -26.1 62.4 Favored 'General case' 0 CA--C 1.534 0.337 0 N-CA-C 112.162 0.43 . . . . 0.0 112.162 179.024 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' F' F ' 108' ' ' ASN . . . . . . . . . . . . . 5.6 t-20 -91.16 13.29 17.43 Favored 'General case' 0 CA--C 1.536 0.426 0 N-CA-C 112.974 0.731 . . . . 0.0 112.974 -176.729 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' F' F ' 109' ' ' LEU . . . . . . . . . . . . . 67.7 mt 57.17 35.44 26.24 Favored 'General case' 0 CA--C 1.53 0.178 0 CA-C-O 120.714 0.292 . . . . 0.0 111.543 177.795 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' F' F ' 110' ' ' GLU . . . . . . . . . . . . . 70.8 mm-40 -102.75 149.27 24.63 Favored 'General case' 0 C--N 1.33 -0.282 0 N-CA-C 109.897 -0.409 . . . . 0.0 109.897 176.249 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' F' F ' 111' ' ' GLU . . . . . . . . . . . . . 98.6 mt-10 -81.47 121.97 26.94 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-O 120.997 0.427 . . . . 0.0 111.38 -176.644 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' F' F ' 112' ' ' LEU . . . . . . . . . . . . . 44.7 mt -105.52 -45.69 4.38 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 115.852 -0.613 . . . . 0.0 109.905 175.94 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' F' F ' 113' ' ' TYR . . . . . . . . . . . . . 61.5 t80 -141.92 140.86 32.91 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 115.976 -0.556 . . . . 0.0 110.761 179.928 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' F' F ' 114' ' ' ARG . . . . . . . . . . . . . 71.7 mtm180 -145.17 121.0 10.59 Favored 'General case' 0 C--N 1.331 -0.226 0 CA-C-N 116.358 -0.383 . . . . 0.0 110.557 177.65 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' F' F ' 115' ' ' GLY . . . . . . . . . . . . . . . -150.13 162.67 29.28 Favored Glycine 0 CA--C 1.525 0.677 0 N-CA-C 110.908 -0.877 . . . . 0.0 110.908 -179.603 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' F' F ' 116' ' ' LYS . . . . . . . . . . . . . 1.9 ttmp? -126.43 136.0 52.1 Favored 'General case' 0 C--N 1.33 -0.267 0 N-CA-C 109.933 -0.395 . . . . 0.0 109.933 176.47 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' F' F ' 117' ' ' PHE . . . . . . . . . . . . . 60.6 m-85 -128.91 115.13 17.38 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.237 -0.438 . . . . 0.0 110.264 -176.519 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' F' F ' 118' ' ' GLU . . . . . . . . . . . . . 84.5 tt0 -51.83 -49.16 63.38 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 116.431 -0.349 . . . . 0.0 111.742 -175.718 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' F' F ' 119' ' ' ASN . . . . . . . . . . . . . 5.2 m120 -98.8 31.08 3.06 Favored 'General case' 0 C--N 1.33 -0.249 0 N-CA-C 112.126 0.417 . . . . 0.0 112.126 -174.053 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' F' F ' 120' ' ' LEU . . . . . . . . . . . . . 19.1 tp -54.5 121.29 8.07 Favored 'General case' 0 N--CA 1.462 0.157 0 CA-C-O 120.671 0.272 . . . . 0.0 110.959 179.056 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' F' F ' 121' ' ' ASN . . . . . . . . . . . . . 6.6 t-20 -113.97 -44.08 3.19 Favored 'General case' 0 C--N 1.333 -0.113 0 CA-C-N 116.536 -0.302 . . . . 0.0 111.008 -177.352 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' F' F ' 122' ' ' LYS . . . . . . . . . . . . . 95.8 mttt -146.9 151.36 36.93 Favored 'General case' 0 C--N 1.331 -0.209 0 CA-C-O 121.064 0.459 . . . . 0.0 111.734 -178.416 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' F' F ' 123' ' ' VAL . . . . . . . . . . . . . 46.1 t -129.52 124.41 59.54 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.325 0 N-CA-C 109.181 -0.674 . . . . 0.0 109.181 173.058 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' F' F ' 124' ' ' LEU . . . . . . . . . . . . . 6.1 mp -117.1 138.79 51.4 Favored 'General case' 0 C--N 1.331 -0.215 0 CA-C-O 120.818 0.342 . . . . 0.0 110.492 -176.699 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' F' F ' 125' ' ' VAL . . . . . . . . . . . . . 35.2 m -135.16 140.06 45.84 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.238 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.996 -179.514 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' F' F ' 126' ' ' ARG . . . . . . . . . . . . . 6.7 ptm85 -139.86 118.98 12.69 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 115.938 -0.574 . . . . 0.0 109.966 176.052 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' F' F ' 127' ' ' ASN . . . . . . . . . . . . . 29.9 m120 52.55 -107.65 0.35 Allowed 'General case' 0 CA--C 1.544 0.747 0 CA-C-O 118.968 -0.539 . . . . 0.0 111.053 -178.221 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' F' F ' 128' ' ' ASP . . . . . . . . . . . . . 9.5 p-10 -114.17 3.9 15.36 Favored 'General case' 0 N--CA 1.467 0.4 0 CA-C-N 119.746 1.157 . . . . 0.0 113.476 -178.378 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' F' F ' 129' ' ' LEU . . . . . . . . . . . . . 10.4 tp -105.04 141.81 35.94 Favored 'General case' 0 C--O 1.232 0.142 0 N-CA-C 109.619 -0.512 . . . . 0.0 109.619 179.413 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' F' F ' 130' ' ' VAL . . . . . . . . . . . . . 14.5 p -133.12 143.4 39.44 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.249 0 CA-C-O 121.312 0.577 . . . . 0.0 111.5 -175.538 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' F' F ' 131' ' ' VAL . . . . . . . . . . . . . 43.8 t -136.06 137.58 48.45 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.232 0 CA-C-N 115.591 -0.732 . . . . 0.0 109.949 177.882 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' F' F ' 132' ' ' ILE . . . . . . . . . . . . . 69.6 mt -114.21 134.08 58.23 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.257 0 CA-C-N 116.075 -0.511 . . . . 0.0 109.628 -179.215 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' F' F ' 133' ' ' ILE . . . . . . . . . . . . . 43.2 mm -117.92 119.53 61.79 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.238 0 CA-C-O 121.007 0.432 . . . . 0.0 110.819 -176.549 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' F' F ' 134' ' ' ASP . . . . . . . . . . . . . 7.3 p-10 -132.84 144.68 50.37 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 115.77 -0.65 . . . . 0.0 109.329 174.834 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' F' F ' 135' ' ' GLU . . . . . . . . . . . . . 85.5 tt0 -49.86 -25.04 2.8 Favored 'General case' 0 C--N 1.328 -0.332 0 N-CA-C 112.942 0.719 . . . . 0.0 112.942 -170.745 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' F' F ' 136' ' ' GLN . . . . . . . . . . . . . 97.4 mt-30 -94.09 -34.47 12.97 Favored 'General case' 0 C--N 1.331 -0.221 0 N-CA-C 112.112 0.412 . . . . 0.0 112.112 -176.953 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' F' F ' 137' ' ' LYS . . . . . . . . . . . . . 78.6 mttt -139.91 153.21 46.91 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-O 121.247 0.546 . . . . 0.0 111.702 -170.149 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' F' F ' 138' ' ' LEU . . . . . . . . . . . . . 6.6 tt -117.56 123.07 45.35 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 115.53 -0.759 . . . . 0.0 108.973 170.94 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' F' F ' 139' ' ' THR . . . . . . . . . . . . . 31.3 m -114.55 128.58 56.4 Favored 'General case' 0 C--N 1.331 -0.218 0 CA-C-N 116.327 -0.397 . . . . 0.0 111.053 -175.537 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' F' F ' 140' ' ' LEU . . . . . . . . . . . . . 7.3 tt -114.18 125.08 53.53 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 115.619 -0.719 . . . . 0.0 109.308 179.634 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' F' F ' 141' ' ' ILE . . . . . . . . . . . . . 19.0 mt -124.72 119.78 57.07 Favored 'Isoleucine or valine' 0 C--O 1.235 0.31 0 CA-C-O 121.005 0.431 . . . . 0.0 110.52 -175.301 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' F' F ' 142' ' ' ARG . . . . . . . . . . . . . 94.1 mtt180 -94.69 125.25 39.22 Favored 'General case' 0 C--N 1.332 -0.182 0 CA-C-N 115.249 -0.887 . . . . 0.0 109.387 174.527 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' F' F ' 143' ' ' THR . . . . . . . . . . . . . 45.1 p . . . . . 0 C--O 1.221 -0.437 0 CA-C-O 117.982 -1.009 . . . . 0.0 110.61 179.58 . . . . . . . . 0 0 . 1 . 020 nuclear orig full ' A' A ' -3' ' ' GLU . . . . . . . . . . . . . 46.3 tp10 . . . . . 0 N--CA 1.49 1.571 0 N-CA-C 109.356 -0.609 . . . . 0.0 109.356 . . . . . . . . . 0 0 . 1 . 020 nuclear orig full ' A' A ' -2' ' ' GLY . . . . . . . . . . . . . . . -64.82 149.95 51.49 Favored Glycine 0 CA--C 1.523 0.564 0 N-CA-C 110.83 -0.908 . . . . 0.0 110.83 179.7 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' -1' ' ' VAL . . . . . . . . . . . . . 43.9 t -95.78 133.98 34.92 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.298 0 N-CA-C 109.974 -0.38 . . . . 0.0 109.974 -179.605 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 0' ' ' ILE . . . . . . . . . . . . . 42.9 mm -108.17 128.27 63.75 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.325 0 CA-C-N 116.211 -0.449 . . . . 0.0 109.893 179.856 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 24.0 ptm -86.57 125.23 33.65 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-O 121.053 0.454 . . . . 0.0 110.722 -178.531 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 59.9 p -117.14 145.99 43.46 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 115.93 -0.577 . . . . 0.0 110.063 178.511 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 95.6 mt-10 -139.95 142.75 36.36 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-O 121.08 0.467 . . . . 0.0 111.385 -177.423 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 4' ' ' LEU . . . . . . . . . . . . . 39.0 mt -120.86 127.52 51.96 Favored 'General case' 0 C--N 1.331 -0.215 0 CA-C-N 115.603 -0.726 . . . . 0.0 110.043 174.978 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 5' ' ' LYS . . . . . . . . . . . . . 88.8 mttt -108.9 119.43 39.54 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-O 120.862 0.363 . . . . 0.0 110.498 176.364 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 45.6 mt -115.55 146.73 41.47 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 115.297 -0.865 . . . . 0.0 110.234 -179.199 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 75.4 tttt -135.91 136.25 22.93 Favored Pre-proline 0 CA--C 1.534 0.328 0 CA-C-O 118.981 -0.533 . . . . 0.0 110.247 176.125 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 8' ' ' PRO . . . . . . . . . . . . . 89.1 Cg_endo -90.81 141.86 3.17 Favored 'Trans proline' 0 N--CA 1.491 1.361 0 C-N-CA 121.553 1.502 . . . . 0.0 111.526 176.281 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 65.1 mt -73.4 -47.42 7.5 Favored Pre-proline 0 CA--C 1.533 0.313 0 CA-C-O 118.711 -0.661 . . . . 0.0 112.235 -178.266 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 83.2 Cg_endo -80.95 153.11 19.21 Favored 'Trans proline' 0 N--CA 1.495 1.608 0 C-N-CA 121.268 1.312 . . . . 0.0 111.767 175.558 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 24.7 ttpp -86.99 102.57 14.52 Favored 'General case' 0 C--N 1.329 -0.295 0 C-N-CA 120.772 -0.371 . . . . 0.0 110.174 178.588 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 11.8 p -141.33 144.05 26.86 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.291 0 CA-C-N 116.275 -0.42 . . . . 0.0 110.368 -179.412 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 95.3 mt-10 -84.5 129.84 34.81 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.062 178.635 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 14' ' ' LEU . . . . . . . . . . . . . 34.7 mt -98.66 148.54 34.69 Favored Pre-proline 0 CA--C 1.533 0.327 0 CA-C-O 119.229 -0.415 . . . . 0.0 110.629 -177.938 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 15' ' ' PRO . . . . . . . . . . . . . 24.5 Cg_exo -63.51 163.64 23.34 Favored 'Trans proline' 0 N--CA 1.498 1.758 0 C-N-CA 121.382 1.388 . . . . 0.0 111.978 175.992 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 16' ' ' PRO . . . . . . . . . . . . . 25.6 Cg_exo -61.29 -39.91 53.79 Favored 'Trans proline' 0 N--CA 1.496 1.651 0 C-N-CA 121.544 1.496 . . . . 0.0 112.836 -178.511 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 17' ' ' ASP . . . . . . . . . . . . . 7.9 p-10 -83.64 4.57 27.88 Favored 'General case' 0 CA--C 1.535 0.394 0 N-CA-C 113.344 0.868 . . . . 0.0 113.344 -176.973 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 18' ' ' PHE . . . . . . . . . . . . . 39.7 t80 -57.28 -46.66 82.89 Favored 'General case' 0 N--CA 1.457 -0.098 0 O-C-N 121.943 -0.473 . . . . 0.0 110.471 -176.494 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 19' ' ' VAL . . . . . . . . . . . . . 45.9 t -56.05 -47.15 80.71 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.362 0 CA-C-N 116.477 -0.328 . . . . 0.0 110.831 -176.527 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 49.3 m-20 -60.13 -41.09 91.95 Favored 'General case' 0 C--N 1.329 -0.302 0 C-N-CA 120.921 -0.312 . . . . 0.0 111.158 -176.954 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 56.1 t -64.74 -45.3 95.56 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.255 0 C-N-CA 120.746 -0.382 . . . . 0.0 110.504 -177.78 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 22' ' ' ILE . . . . . . . . . . . . . 51.2 mm -56.49 -45.05 81.89 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.235 0 C-N-CA 121.031 -0.268 . . . . 0.0 110.385 178.027 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 23' ' ' ARG . . . . . . . . . . . . . 45.3 ttp180 -53.99 -48.8 70.02 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-O 120.611 0.243 . . . . 0.0 111.375 -179.629 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 24' ' ' ILE . . . . . . . . . . . . . 70.7 mt -60.55 -43.26 94.09 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.349 0 CA-C-O 120.634 0.254 . . . . 0.0 111.025 -178.217 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 74.5 mttt -64.97 -36.48 84.52 Favored 'General case' 0 C--N 1.328 -0.367 0 N-CA-C 112.069 0.396 . . . . 0.0 112.069 -178.804 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 42.6 mt -79.72 -44.19 21.23 Favored 'General case' 0 C--N 1.33 -0.269 0 N-CA-C 113.413 0.894 . . . . 0.0 113.413 -173.396 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 27' ' ' GLN . . . . . . . . . . . . . 11.3 pt20 -46.95 140.08 5.08 Favored 'General case' 0 N--CA 1.469 0.48 0 N-CA-C 112.833 0.679 . . . . 0.0 112.833 -173.619 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 97.55 -26.65 22.18 Favored Glycine 0 CA--C 1.534 1.24 0 CA-C-N 115.525 -0.761 . . . . 0.0 112.169 -176.062 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 65.5 mttm -97.58 155.17 17.09 Favored 'General case' 0 C--O 1.233 0.214 0 CA-C-N 117.108 0.454 . . . . 0.0 110.939 179.009 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 30' ' ' THR . . . . . . . . . . . . . 29.0 m -95.58 136.3 36.15 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.06 -0.518 . . . . 0.0 110.293 176.669 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 35.5 m -121.24 138.87 50.21 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.239 0 CA-C-N 116.352 -0.386 . . . . 0.0 110.612 -179.79 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 32' ' ' ARG . . . . . . . . . . . . . 48.0 tpt85 -134.08 139.11 45.75 Favored 'General case' 0 C--N 1.326 -0.428 0 CA-C-N 115.878 -0.601 . . . . 0.0 110.086 -178.822 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 33' ' ' THR . . . . . . . . . . . . . 19.7 m -51.67 140.58 18.42 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-O 120.922 0.391 . . . . 0.0 111.642 -175.475 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 99.13 -17.34 58.17 Favored Glycine 0 CA--C 1.533 1.181 0 CA-C-N 116.006 -0.543 . . . . 0.0 113.024 -179.372 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 82.0 m-20 -64.95 147.97 52.41 Favored 'General case' 0 C--O 1.231 0.096 0 CA-C-N 118.02 0.91 . . . . 0.0 111.088 179.079 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 46.0 t -120.39 128.18 75.97 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.166 0 CA-C-N 115.712 -0.676 . . . . 0.0 109.66 177.835 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 37' ' ' ILE . . . . . . . . . . . . . 66.9 mt -120.74 138.47 51.09 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.273 0 N-CA-C 109.782 -0.451 . . . . 0.0 109.782 -179.572 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . -114.29 128.68 8.33 Favored Glycine 0 CA--C 1.526 0.762 0 N-CA-C 110.935 -0.866 . . . . 0.0 110.935 179.53 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 39' ' ' ILE . . . . . . . . . . . . . 73.3 mt -126.62 127.01 69.83 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.246 0 N-CA-C 109.936 -0.394 . . . . 0.0 109.936 179.05 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 40' ' ' SER . . . . . . . . . . . . . 45.8 t -93.12 123.24 36.25 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.558 -0.292 . . . . 0.0 110.996 177.31 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 41' ' ' ILE . . . . . . . . . . . . . 73.0 mt -131.16 123.01 52.67 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.21 0 CA-C-O 120.92 0.391 . . . . 0.0 110.059 177.715 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 10.9 tp 56.35 36.8 28.1 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.072 -0.513 . . . . 0.0 111.339 178.847 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . 79.01 -10.08 35.39 Favored Glycine 0 CA--C 1.534 1.227 0 C-N-CA 121.21 -0.519 . . . . 0.0 113.641 175.963 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 44' ' ' LYS . . . . . . . . . . . . . 83.4 tttt -101.15 128.3 47.3 Favored 'General case' 0 C--N 1.334 -0.091 0 CA-C-N 117.968 0.884 . . . . 0.0 109.975 177.699 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 41.2 tp10 -84.94 130.63 34.61 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.373 -0.376 . . . . 0.0 110.921 -178.995 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 46' ' ' VAL . . . . . . . . . . . . . 7.4 p -121.82 132.07 71.69 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.199 0 N-CA-C 109.651 -0.5 . . . . 0.0 109.651 176.419 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 94.1 mttt -100.88 131.1 46.92 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.083 -0.508 . . . . 0.0 111.281 178.982 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 48' ' ' PHE . . . . . . . . . . . . . 92.1 m-85 -115.5 131.88 56.8 Favored 'General case' 0 C--N 1.33 -0.244 0 N-CA-C 109.759 -0.46 . . . . 0.0 109.759 175.598 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 54.4 tttm -108.32 139.32 43.19 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.693 -0.23 . . . . 0.0 110.425 178.022 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 50' ' ' VAL . . . . . . . . . . . . . 44.9 t -79.04 107.84 11.96 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.355 0 N-CA-C 109.262 -0.644 . . . . 0.0 109.262 175.909 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 51' ' ' VAL . . . . . . . . . . . . . 49.2 t -72.06 -48.62 48.82 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.324 0 CA-C-N 116.023 -0.535 . . . . 0.0 109.909 -174.324 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 52' ' ' GLN . . . . . . . . . . . . . 61.8 tt0 -162.95 144.45 9.95 Favored 'General case' 0 C--N 1.331 -0.238 0 C-N-CA 120.345 -0.542 . . . . 0.0 111.917 -178.52 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -121.66 132.61 54.75 Favored 'General case' 0 C--N 1.331 -0.196 0 CA-C-N 115.717 -0.674 . . . . 0.0 109.827 175.913 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 54' ' ' TYR . . . . . . . . . . . . . 22.5 t80 -129.16 110.94 18.2 Favored Pre-proline 0 CA--C 1.535 0.396 0 CA-C-O 118.101 -0.952 . . . . 0.0 110.656 177.787 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 55' ' ' PRO . . . . . . . . . . . . . 71.1 Cg_endo -75.94 170.04 72.86 Favored 'Cis proline' 0 N--CA 1.501 1.929 0 CA-C-N 121.898 1.714 . . . . 0.0 112.578 -7.908 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 56' ' ' SER . . . . . . . . . . . . . 66.3 m -118.36 132.53 23.75 Favored Pre-proline 0 CA--C 1.54 0.58 0 CA-C-O 118.439 -0.791 . . . . 0.0 110.079 178.257 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 57' ' ' PRO . . . . . . . . . . . . . 75.9 Cg_endo -79.22 149.73 84.03 Favored 'Cis proline' 0 N--CA 1.495 1.601 0 CA-C-N 121.932 1.726 . . . . 0.0 111.535 -4.922 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 58' ' ' LEU . . . . . . . . . . . . . 30.6 tp -108.84 140.89 41.66 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.303 -0.408 . . . . 0.0 110.929 -177.817 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 59' ' ' ARG . . . . . . . . . . . . . 78.2 ttt180 -94.06 119.02 32.34 Favored 'General case' 0 C--N 1.328 -0.331 0 N-CA-C 108.809 -0.812 . . . . 0.0 108.809 170.862 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 45.8 t -72.87 120.3 21.28 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.322 0 C-N-CA 120.55 -0.46 . . . . 0.0 110.667 -173.462 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 95.3 mt-10 -131.14 162.68 29.36 Favored 'General case' 0 C--N 1.331 -0.239 0 CA-C-N 115.63 -0.714 . . . . 0.0 109.78 176.945 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 62' ' ' ASP . . . . . . . . . . . . . 12.6 p-10 -54.28 -31.4 53.69 Favored 'General case' 0 C--N 1.329 -0.315 0 N-CA-C 112.185 0.439 . . . . 0.0 112.185 -177.693 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 63' ' ' ARG . . . . . . . . . . . . . 15.2 mmm180 -71.01 -21.81 62.24 Favored 'General case' 0 C--N 1.329 -0.285 0 N-CA-C 113.02 0.748 . . . . 0.0 113.02 -175.787 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 30.3 m -69.76 140.36 53.41 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-O 120.788 0.327 . . . . 0.0 110.997 -175.679 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 65' ' ' LYS . . . . . . . . . . . . . 12.1 mptt -88.91 134.7 33.87 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.154 -0.475 . . . . 0.0 109.836 179.731 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 66' ' ' ILE . . . . . . . . . . . . . 61.1 mt -117.91 131.81 69.57 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.302 0 CA-C-O 120.844 0.354 . . . . 0.0 110.321 -179.067 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 67' ' ' THR . . . . . . . . . . . . . 19.1 m -128.01 135.5 49.98 Favored 'General case' 0 C--N 1.331 -0.23 0 CA-C-N 116.112 -0.495 . . . . 0.0 110.507 178.517 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 68' ' ' LEU . . . . . . . . . . . . . 8.5 mp -107.01 131.39 54.12 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 115.939 -0.573 . . . . 0.0 110.296 177.731 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 69' ' ' VAL . . . . . . . . . . . . . 44.7 t -97.82 116.54 40.66 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.32 0 CA-C-O 121.025 0.44 . . . . 0.0 109.91 178.591 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 70' ' ' THR . . . . . . . . . . . . . 2.8 m -145.06 -43.88 0.23 Allowed 'General case' 0 C--N 1.327 -0.389 0 CA-C-N 115.737 -0.665 . . . . 0.0 110.0 179.437 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 71' ' ' HIS . . . . . . . . . . . . . 96.1 m-70 -134.01 151.7 77.17 Favored Pre-proline 0 C--N 1.33 -0.274 0 CA-C-N 115.864 -0.607 . . . . 0.0 109.928 176.819 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 72' ' ' PRO . . . . . . . . . . . . . 61.0 Cg_endo -73.7 -12.19 24.31 Favored 'Trans proline' 0 N--CA 1.498 1.739 0 C-N-CA 121.346 1.364 . . . . 0.0 113.505 -179.583 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 73' ' ' VAL . . . . . . . . . . . . . 35.2 m -123.88 169.18 15.55 Favored 'Isoleucine or valine' 0 N--CA 1.461 0.108 0 CA-C-O 120.77 0.319 . . . . 0.0 110.395 -178.595 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 74' ' ' ASP . . . . . . . . . . . . . 36.1 t0 -92.86 121.43 34.22 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.228 -0.442 . . . . 0.0 109.998 -177.988 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 40.2 t -118.26 122.64 70.08 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.262 0 CA-C-O 120.922 0.392 . . . . 0.0 110.791 -176.745 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 76' ' ' LEU . . . . . . . . . . . . . 5.6 mp -122.54 146.43 47.42 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 115.869 -0.605 . . . . 0.0 109.832 175.572 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 77' ' ' GLU . . . . . . . . . . . . . 97.9 mt-10 -134.94 141.59 46.31 Favored 'General case' 0 C--N 1.331 -0.218 0 CA-C-O 121.04 0.448 . . . . 0.0 111.419 -179.241 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 78' ' ' ALA . . . . . . . . . . . . . . . -130.62 140.27 50.41 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-N 115.682 -0.69 . . . . 0.0 109.858 175.581 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 79' ' ' LYS . . . . . . . . . . . . . 53.0 mttm -87.49 122.77 31.64 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-O 120.994 0.426 . . . . 0.0 111.239 -177.606 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 80' ' ' ILE . . . . . . . . . . . . . 39.8 mm -139.2 109.26 4.16 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.298 0 N-CA-C 108.994 -0.743 . . . . 0.0 108.994 179.37 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 81' ' ' LYS . . . . . . . . . . . . . 78.2 tttt -97.8 123.37 41.73 Favored 'General case' 0 C--N 1.329 -0.3 0 C-N-CA 120.788 -0.365 . . . . 0.0 110.935 -176.949 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . 89.17 42.21 5.64 Favored Glycine 0 CA--C 1.526 0.741 0 C-N-CA 120.759 -0.734 . . . . 0.0 111.705 175.292 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 83' ' ' ILE . . . . . . . . . . . . . 71.1 mt -66.12 138.52 22.86 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.218 0 N-CA-C 109.736 -0.468 . . . . 0.0 109.736 177.178 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 84' ' ' LYS . . . . . . . . . . . . . 78.5 tttt -96.17 -52.9 3.83 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.031 -0.531 . . . . 0.0 110.405 -179.192 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 85' ' ' ASP . . . . . . . . . . . . . 7.1 t70 -154.19 153.7 32.23 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 115.906 -0.588 . . . . 0.0 110.567 -178.977 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 86' ' ' VAL . . . . . . . . . . . . . 42.6 t -131.77 131.32 62.13 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.242 0 CA-C-O 120.984 0.421 . . . . 0.0 110.468 -179.821 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 87' ' ' ILE . . . . . . . . . . . . . 5.0 mp -119.06 127.91 75.82 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.224 0 N-CA-C 109.301 -0.629 . . . . 0.0 109.301 176.25 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 88' ' ' LEU . . . . . . . . . . . . . 84.8 mt -117.32 138.82 51.52 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-O 121.149 0.499 . . . . 0.0 111.857 -177.071 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 89' ' ' ASP . . . . . . . . . . . . . 13.7 t70 -134.13 157.75 45.4 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-N 115.375 -0.829 . . . . 0.0 109.19 175.014 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 74.0 tt0 -47.5 -38.13 13.28 Favored 'General case' 0 C--N 1.33 -0.244 0 N-CA-C 112.772 0.656 . . . . 0.0 112.772 -172.785 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 91' ' ' ASN . . . . . . . . . . . . . 13.5 p-10 -132.09 35.97 3.68 Favored 'General case' 0 C--N 1.331 -0.207 0 N-CA-C 111.866 0.321 . . . . 0.0 111.866 -176.604 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 92' ' ' LEU . . . . . . . . . . . . . 13.1 tp -163.73 141.72 7.49 Favored 'General case' 0 C--N 1.332 -0.168 0 C-N-CA 120.85 -0.34 . . . . 0.0 110.934 -179.051 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 93' ' ' ILE . . . . . . . . . . . . . 74.8 mt -126.59 120.83 57.19 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.245 0 N-CA-C 109.461 -0.57 . . . . 0.0 109.461 178.268 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 94' ' ' VAL . . . . . . . . . . . . . 43.7 t -120.96 127.17 75.91 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.271 0 N-CA-C 109.873 -0.418 . . . . 0.0 109.873 179.306 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 95' ' ' VAL . . . . . . . . . . . . . 44.4 t -123.42 134.79 65.29 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.283 0 CA-C-N 116.137 -0.483 . . . . 0.0 109.92 -178.908 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 96' ' ' ILE . . . . . . . . . . . . . 65.3 mt -116.51 128.69 73.79 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.294 0 N-CA-C 109.286 -0.635 . . . . 0.0 109.286 179.157 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 97' ' ' THR . . . . . . . . . . . . . 74.1 p -100.7 156.07 17.54 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-O 121.206 0.527 . . . . 0.0 111.177 -177.606 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 98' ' ' GLU . . . . . . . . . . . . . 79.8 tt0 -54.02 -26.26 25.47 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.166 -0.47 . . . . 0.0 112.129 -178.808 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 99' ' ' GLU . . . . . . . . . . . . . 95.4 mt-10 -81.83 16.62 1.76 Allowed 'General case' 0 CA--C 1.535 0.374 0 N-CA-C 113.232 0.826 . . . . 0.0 113.232 -175.814 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 100' ' ' ASN . . . . . . . . . . . . . 3.7 m-20 62.97 36.03 12.87 Favored 'General case' 0 N--CA 1.464 0.243 0 CA-C-O 120.906 0.384 . . . . 0.0 111.345 178.548 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 101' ' ' GLU . . . . . . . . . . . . . 84.2 tt0 -112.33 144.4 41.82 Favored 'General case' 0 C--N 1.332 -0.188 0 CA-C-N 116.126 -0.488 . . . . 0.0 109.858 173.549 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 102' ' ' VAL . . . . . . . . . . . . . 48.1 t -116.19 128.05 73.61 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.283 0 CA-C-N 116.325 -0.398 . . . . 0.0 110.128 -178.324 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 103' ' ' LEU . . . . . . . . . . . . . 21.3 mt -118.97 131.86 56.04 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 115.693 -0.685 . . . . 0.0 110.094 177.475 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 104' ' ' ILE . . . . . . . . . . . . . 70.1 mt -120.76 123.39 70.17 Favored 'Isoleucine or valine' 0 C--O 1.234 0.248 0 N-CA-C 110.398 -0.223 . . . . 0.0 110.398 -179.735 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 105' ' ' PHE . . . . . . . . . . . . . 66.5 m-85 -122.92 166.15 15.52 Favored 'General case' 0 C--O 1.232 0.162 0 O-C-N 123.915 0.759 . . . . 0.0 109.942 -179.486 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 106' ' ' ASN . . . . . . . . . . . . . 38.0 p-10 -103.71 -171.08 1.88 Allowed 'General case' 0 C--N 1.331 -0.235 0 N-CA-C 109.951 -0.389 . . . . 0.0 109.951 172.662 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 107' ' ' GLN . . . . . . . . . . . . . 62.0 tt0 -59.85 -24.83 64.54 Favored 'General case' 0 CA--C 1.533 0.324 0 N-CA-C 112.156 0.428 . . . . 0.0 112.156 177.199 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 108' ' ' ASN . . . . . . . . . . . . . 28.5 t30 -84.51 4.16 33.18 Favored 'General case' 0 CA--C 1.538 0.498 0 N-CA-C 113.16 0.8 . . . . 0.0 113.16 -178.022 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 109' ' ' LEU . . . . . . . . . . . . . 12.0 tp 60.88 37.68 18.28 Favored 'General case' 0 CA--C 1.531 0.232 0 CA-C-O 120.943 0.401 . . . . 0.0 111.209 179.669 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 110' ' ' GLU . . . . . . . . . . . . . 15.1 mm-40 -106.55 150.14 26.44 Favored 'General case' 0 C--N 1.329 -0.294 0 N-CA-C 109.958 -0.386 . . . . 0.0 109.958 176.598 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 111' ' ' GLU . . . . . . . . . . . . . 43.3 tp10 -80.16 121.91 26.16 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-O 120.889 0.376 . . . . 0.0 110.043 179.776 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 112' ' ' LEU . . . . . . . . . . . . . 14.8 mt -108.34 -45.62 3.87 Favored 'General case' 0 C--N 1.331 -0.201 0 CA-C-N 116.07 -0.514 . . . . 0.0 110.142 178.511 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 113' ' ' TYR . . . . . . . . . . . . . 64.0 t80 -137.29 139.36 40.87 Favored 'General case' 0 C--N 1.331 -0.211 0 CA-C-N 116.248 -0.433 . . . . 0.0 111.221 -179.805 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 114' ' ' ARG . . . . . . . . . . . . . 32.4 ttm180 -140.95 124.26 16.61 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 115.888 -0.596 . . . . 0.0 110.275 177.509 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 115' ' ' GLY . . . . . . . . . . . . . . . -149.98 158.39 27.64 Favored Glycine 0 CA--C 1.524 0.61 0 N-CA-C 110.938 -0.865 . . . . 0.0 110.938 178.967 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 116' ' ' LYS . . . . . . . . . . . . . 77.5 tttt -136.65 133.61 36.42 Favored 'General case' 0 C--N 1.329 -0.311 0 N-CA-C 110.097 -0.335 . . . . 0.0 110.097 178.636 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 117' ' ' PHE . . . . . . . . . . . . . 9.7 m-85 -138.08 118.98 14.23 Favored 'General case' 0 C--N 1.33 -0.25 0 C-N-CA 120.754 -0.379 . . . . 0.0 110.103 -174.208 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 118' ' ' GLU . . . . . . . . . . . . . 70.6 mm-40 -55.18 -43.65 74.53 Favored 'General case' 0 C--N 1.33 -0.279 0 C-N-CA 120.847 -0.341 . . . . 0.0 111.027 -177.935 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 119' ' ' ASN . . . . . . . . . . . . . 65.7 m-80 -93.71 28.41 2.36 Favored 'General case' 0 C--N 1.329 -0.288 0 N-CA-C 112.414 0.524 . . . . 0.0 112.414 -174.248 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 120' ' ' LEU . . . . . . . . . . . . . 19.2 tp -58.65 120.25 8.57 Favored 'General case' 0 C--N 1.333 -0.128 0 N-CA-C 110.028 -0.36 . . . . 0.0 110.028 177.263 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 121' ' ' ASN . . . . . . . . . . . . . 10.4 t-20 -112.46 -44.13 3.41 Favored 'General case' 0 C--O 1.232 0.148 0 CA-C-N 116.655 -0.248 . . . . 0.0 111.058 -176.274 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 122' ' ' LYS . . . . . . . . . . . . . 82.8 mttt -144.52 147.46 33.26 Favored 'General case' 0 C--N 1.332 -0.162 0 CA-C-O 121.177 0.513 . . . . 0.0 111.793 -177.928 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 123' ' ' VAL . . . . . . . . . . . . . 45.8 t -123.24 128.64 74.98 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.193 0 CA-C-N 115.759 -0.655 . . . . 0.0 109.459 175.139 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 124' ' ' LEU . . . . . . . . . . . . . 52.5 mt -123.6 141.09 52.35 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-O 120.798 0.332 . . . . 0.0 110.854 -177.063 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 125' ' ' VAL . . . . . . . . . . . . . 34.8 m -135.11 140.93 44.2 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.259 0 CA-C-N 116.287 -0.415 . . . . 0.0 110.992 179.446 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 126' ' ' ARG . . . . . . . . . . . . . 77.6 mtp85 -144.91 111.01 5.5 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 115.975 -0.557 . . . . 0.0 110.396 176.47 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 127' ' ' ASN . . . . . . . . . . . . . 55.8 t30 52.3 -108.54 0.4 Allowed 'General case' 0 CA--C 1.545 0.765 0 CA-C-O 118.83 -0.605 . . . . 0.0 111.344 179.691 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 128' ' ' ASP . . . . . . . . . . . . . 22.9 p-10 -108.09 5.8 26.34 Favored 'General case' 0 N--CA 1.468 0.464 0 CA-C-N 119.876 1.216 . . . . 0.0 113.485 -177.79 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 129' ' ' LEU . . . . . . . . . . . . . 12.1 tp -104.99 138.33 41.37 Favored 'General case' 0 C--N 1.332 -0.175 0 N-CA-C 109.883 -0.414 . . . . 0.0 109.883 178.692 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 130' ' ' VAL . . . . . . . . . . . . . 41.5 t -121.76 137.99 53.53 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.23 0 N-CA-C 110.081 -0.34 . . . . 0.0 110.081 -178.584 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 131' ' ' VAL . . . . . . . . . . . . . 40.0 t -134.71 136.23 52.58 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.248 0 CA-C-O 121.036 0.446 . . . . 0.0 110.45 -179.476 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 132' ' ' ILE . . . . . . . . . . . . . 75.0 mt -118.21 130.69 72.69 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.273 0 CA-C-N 115.738 -0.665 . . . . 0.0 109.49 179.436 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 133' ' ' ILE . . . . . . . . . . . . . 43.0 mm -117.75 123.33 71.55 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.261 0 CA-C-O 120.985 0.422 . . . . 0.0 111.063 -175.907 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 134' ' ' ASP . . . . . . . . . . . . . 7.7 p-10 -135.01 148.18 49.88 Favored 'General case' 0 C--N 1.331 -0.223 0 CA-C-N 115.849 -0.614 . . . . 0.0 109.517 173.92 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 135' ' ' GLU . . . . . . . . . . . . . 43.6 tp10 -49.89 -24.71 2.64 Favored 'General case' 0 C--N 1.326 -0.416 0 N-CA-C 112.797 0.665 . . . . 0.0 112.797 -172.01 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 136' ' ' GLN . . . . . . . . . . . . . 59.7 tp60 -101.11 -27.49 13.22 Favored 'General case' 0 CA--C 1.53 0.211 0 N-CA-C 112.668 0.618 . . . . 0.0 112.668 -174.863 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 137' ' ' LYS . . . . . . . . . . . . . 81.5 mttt -142.36 152.99 43.43 Favored 'General case' 0 C--N 1.332 -0.188 0 CA-C-O 121.17 0.51 . . . . 0.0 111.685 -171.661 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 138' ' ' LEU . . . . . . . . . . . . . 4.7 tt -120.22 122.27 40.56 Favored 'General case' 0 C--N 1.328 -0.346 0 N-CA-C 109.011 -0.737 . . . . 0.0 109.011 171.675 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 139' ' ' THR . . . . . . . . . . . . . 32.8 m -112.62 128.6 56.42 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 116.376 -0.374 . . . . 0.0 110.787 -176.835 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 140' ' ' LEU . . . . . . . . . . . . . 15.0 tp -115.85 121.63 42.96 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 115.522 -0.763 . . . . 0.0 109.264 -179.292 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 141' ' ' ILE . . . . . . . . . . . . . 19.3 mt -119.29 120.15 62.87 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.266 0 CA-C-O 120.888 0.375 . . . . 0.0 110.354 -174.613 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 142' ' ' ARG . . . . . . . . . . . . . 73.1 mtm180 -106.48 127.51 53.36 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-N 115.498 -0.774 . . . . 0.0 110.166 179.629 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 143' ' ' THR . . . . . . . . . . . . . 77.3 p . . . . . 0 C--O 1.221 -0.398 0 CA-C-O 117.922 -1.037 . . . . 0.0 110.577 -179.419 . . . . . . . . 0 0 . 1 . 020 nuclear orig full ' B' B ' -3' ' ' GLU . . . . . . . . . . . . . 70.5 mm-40 . . . . . 0 N--CA 1.49 1.541 0 N-CA-C 109.432 -0.581 . . . . 0.0 109.432 . . . . . . . . . 0 0 . 1 . 020 nuclear orig full ' B' B ' -2' ' ' GLY . . . . . . . . . . . . . . . -69.99 119.54 8.95 Favored Glycine 0 CA--C 1.524 0.656 0 N-CA-C 111.035 -0.826 . . . . 0.0 111.035 -179.67 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' B' B ' -1' ' ' VAL . . . . . . . . . . . . . 45.4 t -96.91 142.62 13.76 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.306 0 CA-C-O 120.87 0.367 . . . . 0.0 110.052 179.904 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' B' B ' 0' ' ' ILE . . . . . . . . . . . . . 70.9 mt -97.67 134.61 35.14 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.283 0 CA-C-N 116.084 -0.507 . . . . 0.0 109.929 -179.733 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' B' B ' 1' ' ' MET . . . . . . . . . . . . . 25.2 ptp -86.7 141.26 29.04 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.114 -0.494 . . . . 0.0 110.574 -179.928 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' B' B ' 2' ' ' SER . . . . . . . . . . . . . 36.4 p -107.88 157.74 17.93 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.687 -179.003 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' B' B ' 3' ' ' GLU . . . . . . . . . . . . . 95.2 mt-10 -140.52 145.96 37.52 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-O 121.026 0.441 . . . . 0.0 111.484 -177.106 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' B' B ' 4' ' ' LEU . . . . . . . . . . . . . 17.2 tp -125.47 131.03 52.93 Favored 'General case' 0 C--N 1.332 -0.191 0 CA-C-N 115.82 -0.627 . . . . 0.0 109.859 175.264 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' B' B ' 5' ' ' LYS . . . . . . . . . . . . . 98.6 mttt -108.55 120.86 43.67 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.42 -0.354 . . . . 0.0 110.837 -179.256 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' B' B ' 6' ' ' LEU . . . . . . . . . . . . . 55.2 mt -114.64 148.71 37.76 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 115.35 -0.841 . . . . 0.0 110.225 -179.728 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' B' B ' 7' ' ' LYS . . . . . . . . . . . . . 58.9 tttp -138.47 140.86 29.38 Favored Pre-proline 0 CA--C 1.535 0.379 0 CA-C-O 119.132 -0.461 . . . . 0.0 110.015 175.139 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' B' B ' 8' ' ' PRO . . . . . . . . . . . . . 90.1 Cg_endo -91.98 142.27 2.58 Favored 'Trans proline' 0 N--CA 1.489 1.247 0 C-N-CA 121.76 1.64 . . . . 0.0 111.922 178.229 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' B' B ' 9' ' ' LEU . . . . . . . . . . . . . 68.8 mt -74.22 -47.35 6.09 Favored Pre-proline 0 CA--C 1.533 0.316 0 CA-C-O 118.64 -0.695 . . . . 0.0 112.105 179.244 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' B' B ' 10' ' ' PRO . . . . . . . . . . . . . 84.0 Cg_endo -80.77 150.39 18.61 Favored 'Trans proline' 0 N--CA 1.495 1.6 0 C-N-CA 121.242 1.295 . . . . 0.0 111.816 175.49 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' B' B ' 11' ' ' LYS . . . . . . . . . . . . . 62.3 mtpt -86.67 97.46 10.58 Favored 'General case' 0 C--N 1.331 -0.229 0 CA-C-O 120.82 0.343 . . . . 0.0 110.362 178.74 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' B' B ' 12' ' ' VAL . . . . . . . . . . . . . 12.6 p -142.67 148.91 19.36 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.259 0 CA-C-N 116.102 -0.499 . . . . 0.0 110.568 -179.186 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' B' B ' 13' ' ' GLU . . . . . . . . . . . . . 82.3 tt0 -87.29 131.5 34.22 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 116.307 -0.406 . . . . 0.0 110.09 178.144 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' B' B ' 14' ' ' LEU . . . . . . . . . . . . . 28.0 mt -96.23 150.9 37.76 Favored Pre-proline 0 CA--C 1.532 0.263 0 CA-C-O 119.376 -0.345 . . . . 0.0 110.62 -178.225 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' B' B ' 15' ' ' PRO . . . . . . . . . . . . . 28.4 Cg_exo -60.75 159.43 28.71 Favored 'Trans proline' 0 N--CA 1.497 1.702 0 C-N-CA 121.307 1.338 . . . . 0.0 111.832 177.228 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' B' B ' 16' ' ' PRO . . . . . . . . . . . . . 38.5 Cg_exo -57.94 -45.0 35.2 Favored 'Trans proline' 0 N--CA 1.498 1.776 0 C-N-CA 121.452 1.435 . . . . 0.0 113.061 -176.73 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' B' B ' 17' ' ' ASP . . . . . . . . . . . . . 22.7 p-10 -87.64 12.47 12.54 Favored 'General case' 0 CA--C 1.536 0.413 0 N-CA-C 113.138 0.792 . . . . 0.0 113.138 -177.303 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' B' B ' 18' ' ' PHE . . . . . . . . . . . . . 48.2 t80 -58.26 -42.69 86.99 Favored 'General case' 0 N--CA 1.457 -0.092 0 O-C-N 122.054 -0.404 . . . . 0.0 110.178 -178.297 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' B' B ' 19' ' ' VAL . . . . . . . . . . . . . 46.3 t -56.94 -43.83 81.33 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 CA-C-N 116.308 -0.405 . . . . 0.0 110.533 -178.384 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' B' B ' 20' ' ' ASP . . . . . . . . . . . . . 36.8 m-20 -59.94 -41.95 92.94 Favored 'General case' 0 C--N 1.33 -0.276 0 C-N-CA 120.924 -0.31 . . . . 0.0 110.908 -177.964 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' B' B ' 21' ' ' VAL . . . . . . . . . . . . . 48.9 t -64.29 -46.65 92.63 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.27 0 C-N-CA 120.661 -0.416 . . . . 0.0 110.376 -177.78 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' B' B ' 22' ' ' ILE . . . . . . . . . . . . . 51.3 mm -56.32 -45.28 81.37 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.275 0 C-N-CA 120.955 -0.298 . . . . 0.0 110.577 179.036 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' B' B ' 23' ' ' ARG . . . . . . . . . . . . . 51.7 ttp180 -54.65 -48.58 72.14 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-O 120.584 0.23 . . . . 0.0 111.224 -178.472 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' B' B ' 24' ' ' ILE . . . . . . . . . . . . . 72.0 mt -59.96 -44.38 94.43 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.268 0 CA-C-N 116.599 -0.273 . . . . 0.0 111.293 -177.675 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' B' B ' 25' ' ' LYS . . . . . . . . . . . . . 35.9 mttm -63.99 -42.16 97.27 Favored 'General case' 0 C--N 1.33 -0.277 0 N-CA-C 112.341 0.496 . . . . 0.0 112.341 -178.82 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' B' B ' 26' ' ' LEU . . . . . . . . . . . . . 92.0 mt -78.42 -42.2 30.82 Favored 'General case' 0 C--N 1.328 -0.35 0 N-CA-C 113.162 0.801 . . . . 0.0 113.162 -170.911 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' B' B ' 27' ' ' GLN . . . . . . . . . . . . . 4.1 pt20 -47.51 140.93 5.45 Favored 'General case' 0 N--CA 1.468 0.459 0 N-CA-C 112.708 0.633 . . . . 0.0 112.708 -174.726 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' B' B ' 28' ' ' GLY . . . . . . . . . . . . . . . 100.7 -26.93 22.8 Favored Glycine 0 CA--C 1.533 1.168 0 CA-C-N 115.564 -0.744 . . . . 0.0 112.205 -177.521 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' B' B ' 29' ' ' LYS . . . . . . . . . . . . . 99.5 mttt -98.71 155.08 17.51 Favored 'General case' 0 C--N 1.332 -0.168 0 CA-C-N 117.379 0.59 . . . . 0.0 111.269 179.32 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' B' B ' 30' ' ' THR . . . . . . . . . . . . . 34.6 m -103.57 135.65 44.77 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 115.75 -0.659 . . . . 0.0 109.763 174.925 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' B' B ' 31' ' ' VAL . . . . . . . . . . . . . 35.4 m -130.86 161.21 41.25 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.245 0 CA-C-N 116.379 -0.373 . . . . 0.0 110.775 -178.805 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' B' B ' 32' ' ' ARG . . . . . . . . . . . . . 70.5 mtm180 -133.75 151.98 51.75 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 115.848 -0.615 . . . . 0.0 110.981 179.748 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' B' B ' 33' ' ' THR . . . . . . . . . . . . . 20.7 m -53.5 139.53 30.87 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.199 -0.455 . . . . 0.0 111.29 -178.758 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' B' B ' 34' ' ' GLY . . . . . . . . . . . . . . . 100.5 -17.01 57.34 Favored Glycine 0 CA--C 1.531 1.086 0 CA-C-O 119.584 -0.565 . . . . 0.0 113.224 178.9 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' B' B ' 35' ' ' ASP . . . . . . . . . . . . . 71.9 m-20 -64.78 148.29 51.5 Favored 'General case' 0 C--O 1.232 0.147 0 CA-C-N 118.183 0.992 . . . . 0.0 111.251 179.639 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' B' B ' 36' ' ' VAL . . . . . . . . . . . . . 46.3 t -117.92 128.41 75.05 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.22 0 CA-C-N 115.527 -0.76 . . . . 0.0 109.739 178.52 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' B' B ' 37' ' ' ILE . . . . . . . . . . . . . 69.8 mt -121.91 138.99 50.32 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.26 0 CA-C-N 116.259 -0.428 . . . . 0.0 109.977 -179.306 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' B' B ' 38' ' ' GLY . . . . . . . . . . . . . . . -114.22 128.97 8.48 Favored Glycine 0 CA--C 1.526 0.742 0 N-CA-C 111.176 -0.769 . . . . 0.0 111.176 -179.203 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' B' B ' 39' ' ' ILE . . . . . . . . . . . . . 75.6 mt -124.06 134.54 66.29 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.253 0 CA-C-O 120.765 0.317 . . . . 0.0 110.164 179.077 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' B' B ' 40' ' ' SER . . . . . . . . . . . . . 53.3 p -92.88 115.95 28.59 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 116.39 -0.368 . . . . 0.0 111.052 176.345 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' B' B ' 41' ' ' ILE . . . . . . . . . . . . . 44.7 mm -121.42 120.78 62.91 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.257 0 CA-C-O 120.775 0.321 . . . . 0.0 110.305 178.461 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' B' B ' 42' ' ' LEU . . . . . . . . . . . . . 62.6 mt 51.75 35.39 15.13 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-N 116.252 -0.431 . . . . 0.0 111.799 176.688 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' B' B ' 43' ' ' GLY . . . . . . . . . . . . . . . 73.88 31.79 59.7 Favored Glycine 0 CA--C 1.528 0.872 0 C-N-CA 121.073 -0.584 . . . . 0.0 112.141 177.706 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' B' B ' 44' ' ' LYS . . . . . . . . . . . . . 23.6 tptm -136.85 128.0 27.9 Favored 'General case' 0 C--N 1.329 -0.293 0 N-CA-C 109.397 -0.594 . . . . 0.0 109.397 177.736 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' B' B ' 45' ' ' GLU . . . . . . . . . . . . . 81.8 tt0 -82.73 117.42 22.64 Favored 'General case' 0 C--N 1.327 -0.373 0 C-N-CA 120.917 -0.313 . . . . 0.0 110.702 -178.356 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' B' B ' 46' ' ' VAL . . . . . . . . . . . . . 7.3 p -115.84 128.58 73.06 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.192 0 N-CA-C 109.412 -0.588 . . . . 0.0 109.412 176.284 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' B' B ' 47' ' ' LYS . . . . . . . . . . . . . 68.6 mttm -99.55 126.93 45.6 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 115.788 -0.642 . . . . 0.0 110.991 179.451 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' B' B ' 48' ' ' PHE . . . . . . . . . . . . . 91.1 m-85 -111.3 131.93 54.77 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-N 116.078 -0.51 . . . . 0.0 109.816 176.996 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' B' B ' 49' ' ' LYS . . . . . . . . . . . . . 83.5 tttt -106.56 134.97 48.88 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-N 116.365 -0.379 . . . . 0.0 110.269 178.6 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' B' B ' 50' ' ' VAL . . . . . . . . . . . . . 45.3 t -78.92 105.59 8.45 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.329 0 N-CA-C 108.993 -0.743 . . . . 0.0 108.993 175.328 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' B' B ' 51' ' ' VAL . . . . . . . . . . . . . 49.0 t -70.1 -53.42 23.58 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.387 0 N-CA-C 109.479 -0.563 . . . . 0.0 109.479 -174.208 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' B' B ' 52' ' ' GLN . . . . . . . . . . . . . 91.7 mt-30 -153.88 152.51 30.72 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 115.947 -0.57 . . . . 0.0 111.695 -177.617 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' B' B ' 53' ' ' ALA . . . . . . . . . . . . . . . -128.2 132.93 48.81 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 115.313 -0.858 . . . . 0.0 109.62 174.87 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' B' B ' 54' ' ' TYR . . . . . . . . . . . . . 58.2 t80 -129.05 107.61 18.01 Favored Pre-proline 0 CA--C 1.534 0.33 0 CA-C-O 118.219 -0.896 . . . . 0.0 110.354 179.767 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' B' B ' 55' ' ' PRO . . . . . . . . . . . . . 73.8 Cg_endo -77.22 169.75 73.32 Favored 'Cis proline' 0 N--CA 1.501 1.926 0 CA-C-N 121.839 1.692 . . . . 0.0 112.863 -4.419 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' B' B ' 56' ' ' SER . . . . . . . . . . . . . 50.6 m -117.59 132.0 23.81 Favored Pre-proline 0 CA--C 1.539 0.537 0 CA-C-O 118.352 -0.832 . . . . 0.0 109.548 174.361 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' B' B ' 57' ' ' PRO . . . . . . . . . . . . . 32.4 Cg_endo -65.21 164.99 57.4 Favored 'Cis proline' 0 N--CA 1.498 1.769 0 CA-C-N 122.027 1.76 . . . . 0.0 111.554 -2.615 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' B' B ' 58' ' ' LEU . . . . . . . . . . . . . 25.0 tp -129.4 137.51 50.96 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-O 120.997 0.427 . . . . 0.0 110.518 -178.284 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' B' B ' 59' ' ' ARG . . . . . . . . . . . . . 75.0 ttt180 -103.4 127.71 50.7 Favored 'General case' 0 C--N 1.326 -0.443 0 CA-C-N 115.731 -0.668 . . . . 0.0 109.225 175.169 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' B' B ' 60' ' ' VAL . . . . . . . . . . . . . 45.6 t -82.07 116.77 26.9 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.232 0 C-N-CA 120.553 -0.459 . . . . 0.0 110.39 -175.928 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' B' B ' 61' ' ' GLU . . . . . . . . . . . . . 70.6 mm-40 -131.14 162.14 30.57 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 115.905 -0.589 . . . . 0.0 109.877 176.618 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' B' B ' 62' ' ' ASP . . . . . . . . . . . . . 43.7 m-20 -53.15 -32.36 47.22 Favored 'General case' 0 C--N 1.328 -0.331 0 N-CA-C 111.807 0.299 . . . . 0.0 111.807 -179.694 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' B' B ' 63' ' ' ARG . . . . . . . . . . . . . 23.7 mmt180 -71.14 -21.94 62.13 Favored 'General case' 0 CA--C 1.532 0.282 0 N-CA-C 112.858 0.688 . . . . 0.0 112.858 -175.99 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' B' B ' 64' ' ' THR . . . . . . . . . . . . . 26.1 m -77.4 140.95 40.01 Favored 'General case' 0 C--N 1.331 -0.226 0 CA-C-O 121.0 0.429 . . . . 0.0 110.877 -175.315 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' B' B ' 65' ' ' LYS . . . . . . . . . . . . . 3.0 mptp? -89.75 134.67 34.05 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 115.976 -0.556 . . . . 0.0 110.233 179.753 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' B' B ' 66' ' ' ILE . . . . . . . . . . . . . 58.9 mt -114.28 129.0 71.04 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.229 0 N-CA-C 109.649 -0.5 . . . . 0.0 109.649 178.083 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' B' B ' 67' ' ' THR . . . . . . . . . . . . . 32.6 m -124.79 139.65 53.65 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-O 121.001 0.429 . . . . 0.0 111.014 -177.128 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' B' B ' 68' ' ' LEU . . . . . . . . . . . . . 6.8 mp -102.76 124.0 47.48 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 115.886 -0.597 . . . . 0.0 110.171 176.196 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' B' B ' 69' ' ' VAL . . . . . . . . . . . . . 44.3 t -101.54 112.54 34.92 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.284 0 CA-C-N 116.345 -0.389 . . . . 0.0 110.021 -179.855 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' B' B ' 70' ' ' THR . . . . . . . . . . . . . 41.3 p -150.02 165.05 33.89 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.142 -0.481 . . . . 0.0 110.678 179.696 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' B' B ' 71' ' ' HIS . . . . . . . . . . . . . 1.5 t60 -140.4 68.09 31.98 Favored Pre-proline 0 CA--C 1.536 0.417 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.326 178.653 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' B' B ' 72' ' ' PRO . . . . . . . . . . . . . 58.6 Cg_endo -90.67 160.08 4.25 Favored 'Trans proline' 0 N--CA 1.489 1.249 0 C-N-CA 121.959 1.772 . . . . 0.0 112.603 -178.467 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' B' B ' 73' ' ' VAL . . . . . . . . . . . . . 30.4 m -105.12 167.0 3.07 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.269 0 CA-C-N 116.016 -0.538 . . . . 0.0 110.06 178.023 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' B' B ' 74' ' ' ASP . . . . . . . . . . . . . 25.2 t0 -103.44 116.42 32.36 Favored 'General case' 0 C--N 1.33 -0.273 0 N-CA-C 109.819 -0.438 . . . . 0.0 109.819 -178.691 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' B' B ' 75' ' ' VAL . . . . . . . . . . . . . 41.7 t -111.34 122.23 65.39 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.243 0 CA-C-O 121.042 0.448 . . . . 0.0 110.355 -178.354 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' B' B ' 76' ' ' LEU . . . . . . . . . . . . . 35.8 mt -119.09 138.69 52.7 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 115.665 -0.698 . . . . 0.0 109.39 177.341 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' B' B ' 77' ' ' GLU . . . . . . . . . . . . . 46.3 mt-10 -134.32 136.37 43.43 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-O 121.14 0.495 . . . . 0.0 111.265 -176.914 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' B' B ' 78' ' ' ALA . . . . . . . . . . . . . . . -125.87 137.55 53.75 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 115.602 -0.726 . . . . 0.0 109.768 176.258 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' B' B ' 79' ' ' LYS . . . . . . . . . . . . . 93.5 mttt -81.73 119.1 23.43 Favored 'General case' 0 C--N 1.329 -0.311 0 C-N-CA 120.811 -0.356 . . . . 0.0 110.438 -179.16 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' B' B ' 80' ' ' ILE . . . . . . . . . . . . . 29.5 mm -134.65 118.46 26.04 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.292 0 CA-C-N 115.721 -0.672 . . . . 0.0 109.234 -176.652 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' B' B ' 81' ' ' LYS . . . . . . . . . . . . . 17.8 ttpt -108.67 123.92 49.73 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-O 120.818 0.342 . . . . 0.0 111.13 -177.073 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' B' B ' 82' ' ' GLY . . . . . . . . . . . . . . . 89.08 42.19 5.68 Favored Glycine 0 CA--C 1.526 0.779 0 C-N-CA 120.838 -0.696 . . . . 0.0 111.816 173.88 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' B' B ' 83' ' ' ILE . . . . . . . . . . . . . 69.9 mt -67.55 138.41 22.78 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.369 0 N-CA-C 109.883 -0.414 . . . . 0.0 109.883 177.969 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' B' B ' 84' ' ' LYS . . . . . . . . . . . . . 39.8 ttpt -100.39 -52.09 3.46 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-O 121.103 0.477 . . . . 0.0 110.046 179.643 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' B' B ' 85' ' ' ASP . . . . . . . . . . . . . 6.5 t70 -153.04 152.35 31.26 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 115.69 -0.687 . . . . 0.0 110.393 -179.955 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' B' B ' 86' ' ' VAL . . . . . . . . . . . . . 41.2 t -129.07 131.73 67.75 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.207 0 CA-C-O 120.871 0.367 . . . . 0.0 110.426 -179.61 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' B' B ' 87' ' ' ILE . . . . . . . . . . . . . 44.3 mm -119.28 126.37 75.28 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.238 0 N-CA-C 109.301 -0.629 . . . . 0.0 109.301 176.251 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' B' B ' 88' ' ' LEU . . . . . . . . . . . . . 81.3 mt -120.95 137.22 54.72 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-O 121.236 0.541 . . . . 0.0 111.706 -176.23 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' B' B ' 89' ' ' ASP . . . . . . . . . . . . . 5.2 t0 -133.09 154.83 50.2 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 115.452 -0.795 . . . . 0.0 109.054 174.823 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' B' B ' 90' ' ' GLU . . . . . . . . . . . . . 84.2 tt0 -48.84 -30.92 6.33 Favored 'General case' 0 C--N 1.33 -0.273 0 N-CA-C 112.804 0.668 . . . . 0.0 112.804 -172.891 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' B' B ' 91' ' ' ASN . . . . . . . . . . . . . 78.2 m-20 -131.54 28.78 4.6 Favored 'General case' 0 N--CA 1.466 0.343 0 N-CA-C 112.521 0.563 . . . . 0.0 112.521 -174.46 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' B' B ' 92' ' ' LEU . . . . . . . . . . . . . 16.9 tp -166.11 143.07 5.22 Favored 'General case' 0 C--N 1.331 -0.217 0 C-N-CA 120.765 -0.374 . . . . 0.0 110.923 179.794 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' B' B ' 93' ' ' ILE . . . . . . . . . . . . . 72.3 mt -125.13 123.83 66.17 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.242 0 N-CA-C 109.633 -0.506 . . . . 0.0 109.633 178.548 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' B' B ' 94' ' ' VAL . . . . . . . . . . . . . 44.1 t -125.41 127.54 71.92 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.238 0 CA-C-O 121.016 0.436 . . . . 0.0 109.996 178.126 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' B' B ' 95' ' ' VAL . . . . . . . . . . . . . 46.1 t -120.7 134.87 62.76 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.312 0 CA-C-N 115.944 -0.571 . . . . 0.0 109.765 179.872 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' B' B ' 96' ' ' ILE . . . . . . . . . . . . . 67.9 mt -115.46 128.46 72.67 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.273 0 N-CA-C 109.416 -0.587 . . . . 0.0 109.416 178.898 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' B' B ' 97' ' ' THR . . . . . . . . . . . . . 74.5 p -102.7 159.11 15.75 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-O 121.283 0.563 . . . . 0.0 111.308 -177.103 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' B' B ' 98' ' ' GLU . . . . . . . . . . . . . 45.0 mt-10 -53.95 -25.01 18.53 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.049 -0.523 . . . . 0.0 112.276 179.736 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' B' B ' 99' ' ' GLU . . . . . . . . . . . . . 33.7 tt0 -80.69 17.37 1.15 Allowed 'General case' 0 CA--C 1.538 0.494 0 N-CA-C 112.519 0.563 . . . . 0.0 112.519 -176.485 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' B' B ' 100' ' ' ASN . . . . . . . . . . . . . 2.4 m-20 60.72 37.97 18.61 Favored 'General case' 0 N--CA 1.463 0.181 0 O-C-N 121.801 -0.562 . . . . 0.0 110.883 179.392 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' B' B ' 101' ' ' GLU . . . . . . . . . . . . . 84.7 tt0 -116.19 144.13 44.59 Favored 'General case' 0 C--N 1.332 -0.169 0 CA-C-N 116.215 -0.448 . . . . 0.0 109.895 178.133 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' B' B ' 102' ' ' VAL . . . . . . . . . . . . . 44.8 t -116.51 127.07 74.22 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.234 0 CA-C-O 120.963 0.411 . . . . 0.0 109.907 -178.724 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' B' B ' 103' ' ' LEU . . . . . . . . . . . . . 51.1 mt -113.33 129.95 56.4 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 115.431 -0.804 . . . . 0.0 110.063 178.2 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' B' B ' 104' ' ' ILE . . . . . . . . . . . . . 67.7 mt -118.82 120.08 62.99 Favored 'Isoleucine or valine' 0 C--O 1.234 0.249 0 N-CA-C 110.213 -0.291 . . . . 0.0 110.213 -179.418 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' B' B ' 105' ' ' PHE . . . . . . . . . . . . . 38.6 m-85 -124.04 163.69 20.91 Favored 'General case' 0 C--N 1.332 -0.168 0 CA-C-N 115.537 -0.756 . . . . 0.0 109.55 178.404 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' B' B ' 106' ' ' ASN . . . . . . . . . . . . . 41.5 p-10 -95.92 -171.68 2.4 Favored 'General case' 0 C--N 1.33 -0.262 0 N-CA-C 109.955 -0.387 . . . . 0.0 109.955 173.949 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' B' B ' 107' ' ' GLN . . . . . . . . . . . . . 39.3 tt0 -59.86 -30.05 68.71 Favored 'General case' 0 C--N 1.328 -0.341 0 N-CA-C 111.806 0.299 . . . . 0.0 111.806 179.782 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' B' B ' 108' ' ' ASN . . . . . . . . . . . . . 3.7 t-20 -83.66 7.54 17.15 Favored 'General case' 0 CA--C 1.535 0.398 0 N-CA-C 113.275 0.843 . . . . 0.0 113.275 -177.366 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' B' B ' 109' ' ' LEU . . . . . . . . . . . . . 12.2 tp 63.01 39.88 9.75 Favored 'General case' 0 C--O 1.232 0.179 0 CA-C-O 121.116 0.484 . . . . 0.0 111.371 176.971 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' B' B ' 110' ' ' GLU . . . . . . . . . . . . . 95.9 mt-10 -108.88 163.44 13.28 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.28 -0.418 . . . . 0.0 110.381 177.064 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' B' B ' 111' ' ' GLU . . . . . . . . . . . . . 82.6 tt0 -84.65 123.63 30.57 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.193 -0.458 . . . . 0.0 111.037 -178.552 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' B' B ' 112' ' ' LEU . . . . . . . . . . . . . 22.7 mt -113.08 -46.02 3.13 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.094 -0.503 . . . . 0.0 110.257 174.374 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' B' B ' 113' ' ' TYR . . . . . . . . . . . . . 53.7 t80 -146.72 140.22 25.74 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.333 -0.394 . . . . 0.0 111.199 -179.998 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' B' B ' 114' ' ' ARG . . . . . . . . . . . . . 33.6 mtp180 -141.7 123.25 15.03 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.381 -0.372 . . . . 0.0 110.276 175.483 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' B' B ' 115' ' ' GLY . . . . . . . . . . . . . . . -150.08 161.08 28.79 Favored Glycine 0 CA--C 1.523 0.576 0 C-N-CA 120.7 -0.762 . . . . 0.0 111.364 179.922 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' B' B ' 116' ' ' LYS . . . . . . . . . . . . . 38.6 ttpt -126.9 138.08 53.25 Favored 'General case' 0 C--N 1.33 -0.25 0 N-CA-C 109.929 -0.397 . . . . 0.0 109.929 177.661 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' B' B ' 117' ' ' PHE . . . . . . . . . . . . . 35.7 m-85 -136.35 113.81 10.86 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-O 120.752 0.311 . . . . 0.0 110.347 -176.556 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' B' B ' 118' ' ' GLU . . . . . . . . . . . . . 44.2 mt-10 -54.83 -45.63 74.49 Favored 'General case' 0 C--N 1.329 -0.29 0 C-N-CA 120.942 -0.303 . . . . 0.0 111.27 -176.986 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' B' B ' 119' ' ' ASN . . . . . . . . . . . . . 34.7 m120 -93.78 28.78 2.25 Favored 'General case' 0 C--N 1.329 -0.287 0 O-C-N 123.554 0.534 . . . . 0.0 112.381 -173.688 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' B' B ' 120' ' ' LEU . . . . . . . . . . . . . 17.9 tp -57.37 119.9 7.26 Favored 'General case' 0 C--N 1.333 -0.141 0 C-N-CA 120.957 -0.297 . . . . 0.0 110.317 177.82 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' B' B ' 121' ' ' ASN . . . . . . . . . . . . . 45.8 t-20 -113.32 -44.06 3.28 Favored 'General case' 0 C--N 1.332 -0.19 0 CA-C-N 116.651 -0.25 . . . . 0.0 111.191 -177.164 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' B' B ' 122' ' ' LYS . . . . . . . . . . . . . 98.7 mttt -143.89 146.37 32.95 Favored 'General case' 0 C--N 1.332 -0.182 0 CA-C-O 121.087 0.47 . . . . 0.0 111.698 -178.351 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' B' B ' 123' ' ' VAL . . . . . . . . . . . . . 47.4 t -127.85 126.08 66.1 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.234 0 CA-C-N 115.756 -0.657 . . . . 0.0 109.375 175.075 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' B' B ' 124' ' ' LEU . . . . . . . . . . . . . 31.2 mt -125.6 134.7 51.83 Favored 'General case' 0 C--N 1.331 -0.212 0 CA-C-O 120.799 0.333 . . . . 0.0 110.675 -178.604 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' B' B ' 125' ' ' VAL . . . . . . . . . . . . . 35.1 m -132.15 144.22 37.74 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.244 0 CA-C-N 116.075 -0.511 . . . . 0.0 110.801 -179.213 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' B' B ' 126' ' ' ARG . . . . . . . . . . . . . 34.3 ptt-85 -152.51 120.49 6.18 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-O 121.328 0.585 . . . . 0.0 111.147 176.0 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' B' B ' 127' ' ' ASN . . . . . . . . . . . . . 82.3 m-20 52.82 -106.24 0.28 Allowed 'General case' 0 CA--C 1.542 0.637 0 CA-C-N 115.457 -0.792 . . . . 0.0 111.284 -179.439 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' B' B ' 128' ' ' ASP . . . . . . . . . . . . . 16.3 p-10 -114.1 0.87 14.42 Favored 'General case' 0 N--CA 1.468 0.445 0 CA-C-N 119.585 1.084 . . . . 0.0 113.372 -176.239 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' B' B ' 129' ' ' LEU . . . . . . . . . . . . . 18.0 tp -109.71 139.8 44.32 Favored 'General case' 0 C--N 1.332 -0.159 0 N-CA-C 109.699 -0.482 . . . . 0.0 109.699 -179.513 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' B' B ' 130' ' ' VAL . . . . . . . . . . . . . 13.2 p -134.39 143.1 38.94 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.2 0 CA-C-O 121.229 0.537 . . . . 0.0 110.9 -177.958 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' B' B ' 131' ' ' VAL . . . . . . . . . . . . . 42.9 t -135.97 139.79 45.27 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.246 0 CA-C-N 115.753 -0.658 . . . . 0.0 110.319 179.024 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' B' B ' 132' ' ' ILE . . . . . . . . . . . . . 72.9 mt -117.29 133.85 62.74 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.264 0 CA-C-N 115.599 -0.728 . . . . 0.0 109.481 179.7 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' B' B ' 133' ' ' ILE . . . . . . . . . . . . . 37.3 mm -115.47 124.21 71.74 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.224 0 CA-C-O 120.681 0.277 . . . . 0.0 110.965 -175.877 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' B' B ' 134' ' ' ASP . . . . . . . . . . . . . 9.6 p-10 -136.13 150.68 49.18 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-N 115.996 -0.547 . . . . 0.0 109.837 174.975 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' B' B ' 135' ' ' GLU . . . . . . . . . . . . . 46.7 tp10 -49.88 -28.95 7.26 Favored 'General case' 0 C--N 1.327 -0.393 0 N-CA-C 112.675 0.62 . . . . 0.0 112.675 -172.111 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' B' B ' 136' ' ' GLN . . . . . . . . . . . . . 58.7 tt0 -86.74 -31.55 20.89 Favored 'General case' 0 C--N 1.331 -0.233 0 N-CA-C 112.562 0.579 . . . . 0.0 112.562 -173.394 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' B' B ' 137' ' ' LYS . . . . . . . . . . . . . 56.9 pttt -166.09 174.66 9.12 Favored 'General case' 0 C--O 1.232 0.143 0 CA-C-O 121.545 0.688 . . . . 0.0 112.498 -172.649 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' B' B ' 138' ' ' LEU . . . . . . . . . . . . . 5.9 tt -120.54 129.84 53.98 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 114.932 -1.031 . . . . 0.0 109.811 179.048 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' B' B ' 139' ' ' THR . . . . . . . . . . . . . 28.2 m -108.51 125.85 52.27 Favored 'General case' 0 C--N 1.331 -0.22 0 CA-C-N 116.272 -0.422 . . . . 0.0 110.357 179.446 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' B' B ' 140' ' ' LEU . . . . . . . . . . . . . 8.0 tt -113.94 121.7 44.72 Favored 'General case' 0 C--N 1.329 -0.315 0 N-CA-C 109.156 -0.683 . . . . 0.0 109.156 -179.171 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' B' B ' 141' ' ' ILE . . . . . . . . . . . . . 19.0 mt -121.64 119.66 59.5 Favored 'Isoleucine or valine' 0 C--O 1.234 0.26 0 CA-C-O 120.949 0.404 . . . . 0.0 110.074 -176.193 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' B' B ' 142' ' ' ARG . . . . . . . . . . . . . 46.2 ttp180 -107.48 129.79 54.91 Favored 'General case' 0 C--N 1.332 -0.163 0 CA-C-N 115.198 -0.91 . . . . 0.0 110.772 -178.779 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' B' B ' 143' ' ' THR . . . . . . . . . . . . . 38.1 p . . . . . 0 C--O 1.22 -0.468 0 CA-C-O 118.044 -0.979 . . . . 0.0 110.516 178.969 . . . . . . . . 0 0 . 1 . 020 nuclear orig full ' C' C ' -3' ' ' GLU . . . . . . . . . . . . . 95.8 mt-10 . . . . . 0 N--CA 1.491 1.619 0 N-CA-C 109.292 -0.633 . . . . 0.0 109.292 . . . . . . . . . 0 0 . 1 . 020 nuclear orig full ' C' C ' -2' ' ' GLY . . . . . . . . . . . . . . . -74.2 144.6 33.54 Favored Glycine 0 CA--C 1.526 0.731 0 N-CA-C 111.005 -0.838 . . . . 0.0 111.005 -179.667 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' C' C ' -1' ' ' VAL . . . . . . . . . . . . . 45.4 t -96.2 131.28 43.38 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.282 0 N-CA-C 109.726 -0.472 . . . . 0.0 109.726 178.857 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' C' C ' 0' ' ' ILE . . . . . . . . . . . . . 44.0 mm -115.08 136.97 50.07 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.239 0 CA-C-N 116.323 -0.399 . . . . 0.0 110.365 -178.466 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' C' C ' 1' ' ' MET . . . . . . . . . . . . . 23.7 ptp -143.96 149.11 36.28 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 115.964 -0.562 . . . . 0.0 110.648 179.853 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' C' C ' 2' ' ' SER . . . . . . . . . . . . . 16.6 p -111.04 135.95 50.78 Favored 'General case' 0 C--N 1.332 -0.164 0 CA-C-O 121.014 0.435 . . . . 0.0 110.52 179.696 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' C' C ' 3' ' ' GLU . . . . . . . . . . . . . 95.5 mt-10 -141.48 141.29 33.65 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 115.978 -0.555 . . . . 0.0 111.089 -179.078 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' C' C ' 4' ' ' LEU . . . . . . . . . . . . . 15.3 tp -126.0 127.53 46.04 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 115.931 -0.577 . . . . 0.0 110.032 176.892 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' C' C ' 5' ' ' LYS . . . . . . . . . . . . . 86.8 mttt -106.5 120.57 42.26 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 116.438 -0.347 . . . . 0.0 110.776 178.162 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' C' C ' 6' ' ' LEU . . . . . . . . . . . . . 27.9 mt -115.05 148.82 38.4 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-N 115.295 -0.866 . . . . 0.0 110.381 179.772 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' C' C ' 7' ' ' LYS . . . . . . . . . . . . . 25.7 ttpp -134.62 133.18 21.13 Favored Pre-proline 0 CA--C 1.534 0.331 0 CA-C-O 118.791 -0.623 . . . . 0.0 110.04 176.875 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' C' C ' 8' ' ' PRO . . . . . . . . . . . . . 59.1 Cg_endo -89.7 135.81 2.53 Favored 'Trans proline' 0 N--CA 1.489 1.229 0 C-N-CA 121.69 1.593 . . . . 0.0 111.586 176.656 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' C' C ' 9' ' ' LEU . . . . . . . . . . . . . 34.2 mt -75.36 -47.47 4.33 Favored Pre-proline 0 CA--C 1.534 0.345 0 CA-C-O 118.581 -0.724 . . . . 0.0 112.085 -177.234 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' C' C ' 10' ' ' PRO . . . . . . . . . . . . . 71.8 Cg_endo -78.65 146.82 21.58 Favored 'Trans proline' 0 N--CA 1.495 1.609 0 C-N-CA 121.052 1.168 . . . . 0.0 111.684 175.143 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' C' C ' 11' ' ' LYS . . . . . . . . . . . . . 21.3 tptm -85.92 99.62 11.54 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-O 120.84 0.352 . . . . 0.0 110.349 -178.625 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' C' C ' 12' ' ' VAL . . . . . . . . . . . . . 12.6 p -143.65 150.12 17.5 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.264 0 CA-C-N 116.207 -0.451 . . . . 0.0 110.665 -179.172 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' C' C ' 13' ' ' GLU . . . . . . . . . . . . . 81.2 tt0 -84.55 127.67 34.18 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.281 -0.418 . . . . 0.0 110.13 178.582 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' C' C ' 14' ' ' LEU . . . . . . . . . . . . . 43.7 mt -96.63 150.03 36.51 Favored Pre-proline 0 CA--C 1.532 0.284 0 CA-C-O 119.368 -0.349 . . . . 0.0 110.627 -178.136 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' C' C ' 15' ' ' PRO . . . . . . . . . . . . . 28.0 Cg_exo -61.23 158.95 32.7 Favored 'Trans proline' 0 N--CA 1.497 1.701 0 C-N-CA 121.26 1.307 . . . . 0.0 111.97 177.754 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' C' C ' 16' ' ' PRO . . . . . . . . . . . . . 26.4 Cg_exo -60.79 -39.34 63.47 Favored 'Trans proline' 0 N--CA 1.496 1.671 0 C-N-CA 121.433 1.422 . . . . 0.0 112.732 -179.128 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' C' C ' 17' ' ' ASP . . . . . . . . . . . . . 19.3 p-10 -87.84 12.76 12.22 Favored 'General case' 0 CA--C 1.535 0.385 0 N-CA-C 113.171 0.804 . . . . 0.0 113.171 -177.006 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' C' C ' 18' ' ' PHE . . . . . . . . . . . . . 42.7 t80 -58.29 -45.39 88.05 Favored 'General case' 0 C--N 1.333 -0.117 0 O-C-N 122.135 -0.353 . . . . 0.0 110.089 -177.754 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' C' C ' 19' ' ' VAL . . . . . . . . . . . . . 47.8 t -55.87 -43.25 73.84 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.355 0 CA-C-N 116.523 -0.308 . . . . 0.0 110.779 -177.356 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' C' C ' 20' ' ' ASP . . . . . . . . . . . . . 7.5 t70 -60.09 -47.29 86.5 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-O 120.799 0.333 . . . . 0.0 111.009 -176.676 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' C' C ' 21' ' ' VAL . . . . . . . . . . . . . 46.4 t -64.4 -43.06 96.99 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.259 0 C-N-CA 120.663 -0.415 . . . . 0.0 110.408 -177.1 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' C' C ' 22' ' ' ILE . . . . . . . . . . . . . 43.9 mm -55.76 -48.31 78.2 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.346 0 N-CA-C 110.438 -0.208 . . . . 0.0 110.438 178.488 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' C' C ' 23' ' ' ARG . . . . . . . . . . . . . 53.8 ttp180 -54.97 -44.48 74.43 Favored 'General case' 0 C--N 1.332 -0.175 0 C-N-CA 120.911 -0.316 . . . . 0.0 111.221 -177.988 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' C' C ' 24' ' ' ILE . . . . . . . . . . . . . 75.0 mt -59.23 -46.9 91.89 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.253 0 CA-C-O 120.721 0.296 . . . . 0.0 110.938 -179.658 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' C' C ' 25' ' ' LYS . . . . . . . . . . . . . 44.2 mtmt -64.63 -38.62 91.63 Favored 'General case' 0 C--N 1.328 -0.331 0 N-CA-C 112.483 0.549 . . . . 0.0 112.483 -177.61 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' C' C ' 26' ' ' LEU . . . . . . . . . . . . . 81.1 mt -79.02 -44.74 21.62 Favored 'General case' 0 C--N 1.33 -0.259 0 N-CA-C 113.268 0.84 . . . . 0.0 113.268 -172.282 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' C' C ' 27' ' ' GLN . . . . . . . . . . . . . 11.6 pt20 -47.01 140.39 4.92 Favored 'General case' 0 N--CA 1.467 0.423 0 N-CA-C 112.812 0.671 . . . . 0.0 112.812 -173.548 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' C' C ' 28' ' ' GLY . . . . . . . . . . . . . . . 98.21 -27.09 20.91 Favored Glycine 0 CA--C 1.533 1.199 0 CA-C-N 115.513 -0.767 . . . . 0.0 112.103 -176.774 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' C' C ' 29' ' ' LYS . . . . . . . . . . . . . 29.2 mtpp -98.0 155.18 17.22 Favored 'General case' 0 C--O 1.232 0.154 0 CA-C-N 117.149 0.474 . . . . 0.0 111.072 179.246 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' C' C ' 30' ' ' THR . . . . . . . . . . . . . 28.7 m -100.37 139.59 35.82 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 115.991 -0.55 . . . . 0.0 110.361 177.307 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' C' C ' 31' ' ' VAL . . . . . . . . . . . . . 35.0 m -130.41 149.84 33.99 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.285 0 CA-C-N 116.319 -0.401 . . . . 0.0 110.759 -179.619 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' C' C ' 32' ' ' ARG . . . . . . . . . . . . . 72.2 mtp180 -132.68 154.09 50.48 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-O 121.198 0.523 . . . . 0.0 110.821 177.07 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' C' C ' 33' ' ' THR . . . . . . . . . . . . . 15.3 m -53.5 136.96 37.32 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-N 116.022 -0.536 . . . . 0.0 111.239 -179.026 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' C' C ' 34' ' ' GLY . . . . . . . . . . . . . . . 101.15 -16.99 56.63 Favored Glycine 0 CA--C 1.532 1.142 0 CA-C-O 119.641 -0.533 . . . . 0.0 113.346 178.24 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' C' C ' 35' ' ' ASP . . . . . . . . . . . . . 61.5 m-20 -64.53 149.61 48.35 Favored 'General case' 0 N--CA 1.461 0.116 0 CA-C-N 118.081 0.941 . . . . 0.0 111.1 179.599 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' C' C ' 36' ' ' VAL . . . . . . . . . . . . . 46.0 t -126.34 130.69 71.93 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.277 0 CA-C-N 115.82 -0.627 . . . . 0.0 109.812 178.682 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' C' C ' 37' ' ' ILE . . . . . . . . . . . . . 68.3 mt -122.2 139.39 49.3 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.259 0 CA-C-N 116.137 -0.483 . . . . 0.0 109.952 -179.458 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' C' C ' 38' ' ' GLY . . . . . . . . . . . . . . . -113.34 128.84 8.55 Favored Glycine 0 CA--C 1.527 0.782 0 N-CA-C 110.908 -0.877 . . . . 0.0 110.908 179.294 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' C' C ' 39' ' ' ILE . . . . . . . . . . . . . 72.7 mt -125.07 129.56 73.3 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.212 0 N-CA-C 109.828 -0.434 . . . . 0.0 109.828 179.091 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' C' C ' 40' ' ' SER . . . . . . . . . . . . . 85.7 p -92.97 121.13 33.99 Favored 'General case' 0 C--N 1.329 -0.294 0 C-N-CA 120.915 -0.314 . . . . 0.0 110.946 176.803 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' C' C ' 41' ' ' ILE . . . . . . . . . . . . . 74.5 mt -131.78 122.47 49.73 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.19 0 CA-C-O 120.756 0.312 . . . . 0.0 110.179 178.363 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' C' C ' 42' ' ' LEU . . . . . . . . . . . . . 82.2 mt 57.5 34.18 24.25 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.146 -0.479 . . . . 0.0 111.756 178.59 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' C' C ' 43' ' ' GLY . . . . . . . . . . . . . . . 80.39 -10.14 45.11 Favored Glycine 0 CA--C 1.534 1.264 0 C-N-CA 121.262 -0.494 . . . . 0.0 113.447 176.879 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' C' C ' 44' ' ' LYS . . . . . . . . . . . . . 96.6 mttt -99.19 129.16 45.41 Favored 'General case' 0 C--N 1.333 -0.127 0 CA-C-N 117.917 0.858 . . . . 0.0 110.052 177.327 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' C' C ' 45' ' ' GLU . . . . . . . . . . . . . 37.7 tp10 -85.18 126.92 34.04 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.414 -0.357 . . . . 0.0 110.481 179.321 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' C' C ' 46' ' ' VAL . . . . . . . . . . . . . 7.4 p -119.23 130.69 73.59 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.227 0 CA-C-O 121.203 0.525 . . . . 0.0 109.824 177.484 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' C' C ' 47' ' ' LYS . . . . . . . . . . . . . 44.6 mmtm -99.09 128.4 45.22 Favored 'General case' 0 C--N 1.331 -0.23 0 CA-C-N 115.719 -0.673 . . . . 0.0 111.281 177.746 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' C' C ' 48' ' ' PHE . . . . . . . . . . . . . 95.5 m-85 -112.3 131.8 55.31 Favored 'General case' 0 C--N 1.33 -0.251 0 N-CA-C 109.634 -0.506 . . . . 0.0 109.634 174.676 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' C' C ' 49' ' ' LYS . . . . . . . . . . . . . 79.7 tttt -107.94 137.53 45.77 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.417 -0.356 . . . . 0.0 110.222 179.103 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' C' C ' 50' ' ' VAL . . . . . . . . . . . . . 44.8 t -82.04 107.72 14.35 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.289 0 N-CA-C 109.389 -0.597 . . . . 0.0 109.389 177.065 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' C' C ' 51' ' ' VAL . . . . . . . . . . . . . 51.8 t -69.58 -47.45 71.51 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.335 0 CA-C-N 116.029 -0.532 . . . . 0.0 109.893 -174.335 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' C' C ' 52' ' ' GLN . . . . . . . . . . . . . 61.3 tt0 -169.74 144.43 2.86 Favored 'General case' 0 C--N 1.331 -0.217 0 C-N-CA 120.288 -0.565 . . . . 0.0 111.648 -179.978 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' C' C ' 53' ' ' ALA . . . . . . . . . . . . . . . -114.51 134.85 54.71 Favored 'General case' 0 C--N 1.331 -0.227 0 CA-C-N 115.627 -0.715 . . . . 0.0 110.117 176.429 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' C' C ' 54' ' ' TYR . . . . . . . . . . . . . 51.0 t80 -128.99 112.08 18.55 Favored Pre-proline 0 CA--C 1.536 0.408 0 CA-C-O 118.189 -0.91 . . . . 0.0 110.453 178.809 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' C' C ' 55' ' ' PRO . . . . . . . . . . . . . 72.7 Cg_endo -77.15 169.36 74.43 Favored 'Cis proline' 0 N--CA 1.5 1.9 0 CA-C-N 122.053 1.769 . . . . 0.0 112.2 -6.336 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' C' C ' 56' ' ' SER . . . . . . . . . . . . . 14.7 m -117.23 135.87 23.25 Favored Pre-proline 0 CA--C 1.538 0.509 0 CA-C-O 118.591 -0.718 . . . . 0.0 109.605 175.272 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' C' C ' 57' ' ' PRO . . . . . . . . . . . . . 49.1 Cg_endo -70.17 146.76 83.92 Favored 'Cis proline' 0 N--CA 1.496 1.653 0 CA-C-N 121.724 1.651 . . . . 0.0 111.355 -3.484 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' C' C ' 58' ' ' LEU . . . . . . . . . . . . . 17.2 tp -107.81 135.87 48.49 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-O 120.847 0.356 . . . . 0.0 110.798 -177.329 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' C' C ' 59' ' ' ARG . . . . . . . . . . . . . 42.4 ttp180 -102.44 119.85 39.51 Favored 'General case' 0 C--N 1.328 -0.349 0 N-CA-C 108.971 -0.752 . . . . 0.0 108.971 174.418 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' C' C ' 60' ' ' VAL . . . . . . . . . . . . . 41.2 t -76.2 122.73 30.97 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.238 0 C-N-CA 120.661 -0.415 . . . . 0.0 110.674 -173.289 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' C' C ' 61' ' ' GLU . . . . . . . . . . . . . 88.3 mt-10 -131.09 163.13 28.32 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 115.938 -0.573 . . . . 0.0 109.749 175.962 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' C' C ' 62' ' ' ASP . . . . . . . . . . . . . 11.4 p-10 -53.87 -30.4 45.59 Favored 'General case' 0 C--N 1.328 -0.339 0 N-CA-C 111.85 0.315 . . . . 0.0 111.85 178.751 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' C' C ' 63' ' ' ARG . . . . . . . . . . . . . 77.8 mtp180 -71.58 -22.08 61.78 Favored 'General case' 0 CA--C 1.533 0.308 0 N-CA-C 112.952 0.723 . . . . 0.0 112.952 -175.958 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' C' C ' 64' ' ' THR . . . . . . . . . . . . . 31.0 m -71.46 141.79 50.22 Favored 'General case' 0 C--N 1.331 -0.213 0 CA-C-O 120.859 0.362 . . . . 0.0 111.381 -174.173 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' C' C ' 65' ' ' LYS . . . . . . . . . . . . . 2.4 mptp? -88.96 129.66 35.59 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 115.925 -0.579 . . . . 0.0 109.849 177.416 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' C' C ' 66' ' ' ILE . . . . . . . . . . . . . 66.8 mt -116.68 127.84 74.2 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.268 0 N-CA-C 109.913 -0.402 . . . . 0.0 109.913 179.615 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' C' C ' 67' ' ' THR . . . . . . . . . . . . . 32.2 m -127.89 143.69 51.1 Favored 'General case' 0 C--N 1.332 -0.164 0 CA-C-N 116.16 -0.473 . . . . 0.0 111.0 -177.25 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' C' C ' 68' ' ' LEU . . . . . . . . . . . . . 28.2 mt -104.44 134.52 47.5 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 115.877 -0.602 . . . . 0.0 110.404 177.435 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' C' C ' 69' ' ' VAL . . . . . . . . . . . . . 44.1 t -100.31 104.62 16.41 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 CA-C-N 116.275 -0.421 . . . . 0.0 110.075 179.432 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' C' C ' 70' ' ' THR . . . . . . . . . . . . . 8.9 t -149.99 159.0 44.73 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 115.985 -0.552 . . . . 0.0 110.235 178.495 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' C' C ' 71' ' ' HIS . . . . . . . . . . . . . 10.8 t60 -128.49 79.43 74.22 Favored Pre-proline 0 CA--C 1.534 0.365 0 CA-C-N 116.73 -0.214 . . . . 0.0 111.151 -177.713 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' C' C ' 72' ' ' PRO . . . . . . . . . . . . . 66.7 Cg_endo -93.91 159.2 2.24 Favored 'Trans proline' 0 C--N 1.314 -1.241 0 C-N-CA 122.09 1.86 . . . . 0.0 111.537 175.114 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' C' C ' 73' ' ' VAL . . . . . . . . . . . . . 31.5 m -104.76 148.17 9.7 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.231 0 CA-C-O 121.069 0.462 . . . . 0.0 110.741 178.671 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' C' C ' 74' ' ' ASP . . . . . . . . . . . . . 13.7 t0 -97.46 119.64 36.37 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 115.58 -0.736 . . . . 0.0 109.437 178.436 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' C' C ' 75' ' ' VAL . . . . . . . . . . . . . 43.0 t -109.75 122.52 64.49 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.221 0 CA-C-O 121.036 0.446 . . . . 0.0 110.402 -177.906 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' C' C ' 76' ' ' LEU . . . . . . . . . . . . . 28.7 mt -123.1 140.53 52.93 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 115.612 -0.722 . . . . 0.0 109.678 178.568 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' C' C ' 77' ' ' GLU . . . . . . . . . . . . . 97.2 mt-10 -132.83 135.67 45.78 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-O 121.082 0.468 . . . . 0.0 111.12 -179.267 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' C' C ' 78' ' ' ALA . . . . . . . . . . . . . . . -124.55 133.92 53.15 Favored 'General case' 0 C--O 1.233 0.221 0 CA-C-N 115.807 -0.633 . . . . 0.0 109.903 177.013 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' C' C ' 79' ' ' LYS . . . . . . . . . . . . . 61.3 mtpt -79.15 118.31 20.98 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-O 120.874 0.369 . . . . 0.0 110.747 -178.068 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' C' C ' 80' ' ' ILE . . . . . . . . . . . . . 34.7 mm -139.18 105.98 2.7 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.285 0 N-CA-C 108.886 -0.783 . . . . 0.0 108.886 -178.462 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' C' C ' 81' ' ' LYS . . . . . . . . . . . . . 23.2 tptm -98.99 126.52 44.71 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-O 120.849 0.357 . . . . 0.0 111.137 -175.715 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' C' C ' 82' ' ' GLY . . . . . . . . . . . . . . . 89.17 42.07 5.68 Favored Glycine 0 CA--C 1.526 0.758 0 C-N-CA 120.755 -0.736 . . . . 0.0 111.798 174.816 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' C' C ' 83' ' ' ILE . . . . . . . . . . . . . 72.5 mt -69.73 136.22 26.62 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.338 0 N-CA-C 109.648 -0.501 . . . . 0.0 109.648 177.182 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' C' C ' 84' ' ' LYS . . . . . . . . . . . . . 22.9 ttmt -94.7 -54.1 3.62 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-O 121.123 0.487 . . . . 0.0 110.121 -179.759 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' C' C ' 85' ' ' ASP . . . . . . . . . . . . . 7.6 t70 -152.31 148.09 27.11 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 115.604 -0.725 . . . . 0.0 110.352 -179.005 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' C' C ' 86' ' ' VAL . . . . . . . . . . . . . 45.3 t -126.9 129.32 71.34 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.275 0 CA-C-O 120.976 0.417 . . . . 0.0 110.225 179.999 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' C' C ' 87' ' ' ILE . . . . . . . . . . . . . 5.1 mp -118.32 129.41 74.67 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.239 0 CA-C-N 115.898 -0.592 . . . . 0.0 109.524 177.403 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' C' C ' 88' ' ' LEU . . . . . . . . . . . . . 26.9 mt -111.14 140.15 45.92 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-O 120.96 0.409 . . . . 0.0 111.312 -177.277 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' C' C ' 89' ' ' ASP . . . . . . . . . . . . . 36.0 t0 -132.16 157.39 44.4 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 115.811 -0.631 . . . . 0.0 109.542 177.314 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' C' C ' 90' ' ' GLU . . . . . . . . . . . . . 40.5 mp0 -49.66 -34.09 17.45 Favored 'General case' 0 C--N 1.331 -0.222 0 N-CA-C 112.914 0.709 . . . . 0.0 112.914 -171.448 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' C' C ' 91' ' ' ASN . . . . . . . . . . . . . 26.2 m120 -130.23 16.22 5.58 Favored 'General case' 0 N--CA 1.469 0.492 0 N-CA-C 113.256 0.836 . . . . 0.0 113.256 -177.225 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' C' C ' 92' ' ' LEU . . . . . . . . . . . . . 28.9 mt -148.12 149.76 32.61 Favored 'General case' 0 C--N 1.332 -0.188 0 CA-C-O 120.798 0.332 . . . . 0.0 110.763 -175.568 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' C' C ' 93' ' ' ILE . . . . . . . . . . . . . 68.1 mt -126.01 118.25 51.18 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.292 0 N-CA-C 109.041 -0.725 . . . . 0.0 109.041 175.648 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' C' C ' 94' ' ' VAL . . . . . . . . . . . . . 44.5 t -117.61 125.54 74.15 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.255 0 CA-C-O 121.034 0.445 . . . . 0.0 109.956 -178.727 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' C' C ' 95' ' ' VAL . . . . . . . . . . . . . 42.3 t -120.1 134.64 62.93 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.307 0 CA-C-N 115.859 -0.61 . . . . 0.0 109.852 -178.94 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' C' C ' 96' ' ' ILE . . . . . . . . . . . . . 64.9 mt -114.17 126.03 71.59 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.279 0 N-CA-C 109.016 -0.735 . . . . 0.0 109.016 177.432 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' C' C ' 97' ' ' THR . . . . . . . . . . . . . 76.2 p -100.87 157.49 16.68 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-O 120.908 0.385 . . . . 0.0 111.093 -176.317 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' C' C ' 98' ' ' GLU . . . . . . . . . . . . . 13.0 pt-20 -53.96 -22.57 10.61 Favored 'General case' 0 CA--C 1.535 0.366 0 N-CA-C 112.279 0.474 . . . . 0.0 112.279 178.019 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' C' C ' 99' ' ' GLU . . . . . . . . . . . . . 95.3 mt-10 -78.18 12.51 1.83 Allowed 'General case' 0 CA--C 1.536 0.434 0 N-CA-C 113.022 0.749 . . . . 0.0 113.022 179.605 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' C' C ' 100' ' ' ASN . . . . . . . . . . . . . 2.1 m-20 61.87 38.07 14.86 Favored 'General case' 0 CA--C 1.53 0.207 0 CA-C-O 121.028 0.442 . . . . 0.0 110.923 179.48 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' C' C ' 101' ' ' GLU . . . . . . . . . . . . . 42.0 mt-10 -111.17 148.71 32.17 Favored 'General case' 0 CA--C 1.521 -0.17 0 CA-C-N 115.988 -0.551 . . . . 0.0 110.494 176.019 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' C' C ' 102' ' ' VAL . . . . . . . . . . . . . 46.6 t -114.85 120.9 65.76 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.293 0 CA-C-N 115.487 -0.779 . . . . 0.0 109.126 177.114 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' C' C ' 103' ' ' LEU . . . . . . . . . . . . . 22.1 mt -111.56 126.12 54.65 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 115.68 -0.691 . . . . 0.0 109.994 177.851 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' C' C ' 104' ' ' ILE . . . . . . . . . . . . . 68.4 mt -111.94 114.21 46.39 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.325 0 N-CA-C 109.58 -0.526 . . . . 0.0 109.58 179.318 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' C' C ' 105' ' ' PHE . . . . . . . . . . . . . 95.6 m-85 -117.23 163.12 16.78 Favored 'General case' 0 C--N 1.332 -0.169 0 O-C-N 124.056 0.847 . . . . 0.0 109.956 -179.796 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' C' C ' 106' ' ' ASN . . . . . . . . . . . . . 51.1 p-10 -104.05 -170.73 1.82 Allowed 'General case' 0 C--N 1.328 -0.362 0 N-CA-C 109.661 -0.496 . . . . 0.0 109.661 171.805 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' C' C ' 107' ' ' GLN . . . . . . . . . . . . . 45.4 tt0 -58.39 -28.9 65.6 Favored 'General case' 0 C--N 1.328 -0.35 0 N-CA-C 112.071 0.397 . . . . 0.0 112.071 178.513 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' C' C ' 108' ' ' ASN . . . . . . . . . . . . . 48.6 t30 -89.49 6.86 39.01 Favored 'General case' 0 CA--C 1.536 0.427 0 N-CA-C 113.202 0.815 . . . . 0.0 113.202 -175.857 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' C' C ' 109' ' ' LEU . . . . . . . . . . . . . 89.0 mt 59.09 31.94 21.74 Favored 'General case' 0 C--N 1.332 -0.157 0 N-CA-C 112.034 0.383 . . . . 0.0 112.034 175.968 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' C' C ' 110' ' ' GLU . . . . . . . . . . . . . 14.0 pt-20 -106.09 144.22 33.11 Favored 'General case' 0 C--N 1.332 -0.165 0 N-CA-C 109.616 -0.513 . . . . 0.0 109.616 173.867 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' C' C ' 111' ' ' GLU . . . . . . . . . . . . . 54.5 tt0 -66.79 121.95 16.59 Favored 'General case' 0 C--N 1.327 -0.412 0 CA-C-N 116.12 -0.491 . . . . 0.0 111.528 -172.281 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' C' C ' 112' ' ' LEU . . . . . . . . . . . . . 10.7 mt -101.41 -46.16 5.09 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.039 -0.528 . . . . 0.0 109.653 174.009 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' C' C ' 113' ' ' TYR . . . . . . . . . . . . . 64.0 t80 -148.48 140.55 23.98 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.059 -0.519 . . . . 0.0 111.133 178.023 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' C' C ' 114' ' ' ARG . . . . . . . . . . . . . 29.6 ttm180 -137.61 126.12 23.54 Favored 'General case' 0 C--N 1.329 -0.289 0 N-CA-C 109.819 -0.438 . . . . 0.0 109.819 175.803 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' C' C ' 115' ' ' GLY . . . . . . . . . . . . . . . -150.12 161.56 28.94 Favored Glycine 0 CA--C 1.522 0.505 0 N-CA-C 110.753 -0.939 . . . . 0.0 110.753 -179.089 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' C' C ' 116' ' ' LYS . . . . . . . . . . . . . 26.4 ttpp -127.84 134.35 49.42 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-O 120.755 0.312 . . . . 0.0 110.363 -179.614 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' C' C ' 117' ' ' PHE . . . . . . . . . . . . . 59.2 m-85 -134.37 113.91 12.39 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.249 -0.432 . . . . 0.0 109.982 -178.932 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' C' C ' 118' ' ' GLU . . . . . . . . . . . . . 44.4 mp0 -58.06 -39.47 78.56 Favored 'General case' 0 C--N 1.328 -0.332 0 C-N-CA 120.629 -0.429 . . . . 0.0 110.745 -175.649 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' C' C ' 119' ' ' ASN . . . . . . . . . . . . . 3.5 m120 -100.06 30.73 3.62 Favored 'General case' 0 C--N 1.329 -0.286 0 N-CA-C 112.169 0.433 . . . . 0.0 112.169 -175.341 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' C' C ' 120' ' ' LEU . . . . . . . . . . . . . 18.5 tp -58.85 119.85 7.94 Favored 'General case' 0 C--N 1.332 -0.157 0 N-CA-C 110.029 -0.36 . . . . 0.0 110.029 178.279 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' C' C ' 121' ' ' ASN . . . . . . . . . . . . . 87.0 m-20 -114.16 -44.16 3.16 Favored 'General case' 0 C--N 1.333 -0.137 0 CA-C-N 116.493 -0.322 . . . . 0.0 111.302 -178.272 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' C' C ' 122' ' ' LYS . . . . . . . . . . . . . 62.1 mtpt -143.51 151.27 40.07 Favored 'General case' 0 C--N 1.33 -0.239 0 CA-C-O 120.973 0.416 . . . . 0.0 111.532 -175.258 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' C' C ' 123' ' ' VAL . . . . . . . . . . . . . 43.6 t -135.2 135.16 52.55 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.245 0 CA-C-N 116.143 -0.48 . . . . 0.0 109.866 176.059 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' C' C ' 124' ' ' LEU . . . . . . . . . . . . . 55.8 mt -126.0 141.88 51.77 Favored 'General case' 0 C--N 1.331 -0.221 0 CA-C-O 120.897 0.38 . . . . 0.0 110.839 -177.962 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' C' C ' 125' ' ' VAL . . . . . . . . . . . . . 34.9 m -135.93 138.72 47.17 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.201 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.74 179.039 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' C' C ' 126' ' ' ARG . . . . . . . . . . . . . 46.6 ptt85 -152.53 131.08 12.23 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-O 120.849 0.357 . . . . 0.0 110.774 175.873 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' C' C ' 127' ' ' ASN . . . . . . . . . . . . . 89.7 m-20 50.71 -115.43 0.86 Allowed 'General case' 0 CA--C 1.546 0.797 0 CA-C-O 118.67 -0.681 . . . . 0.0 111.177 -179.77 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' C' C ' 128' ' ' ASP . . . . . . . . . . . . . 8.7 p-10 -114.11 16.06 18.19 Favored 'General case' 0 CA--C 1.536 0.433 0 CA-C-N 120.17 1.35 . . . . 0.0 112.848 -179.884 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' C' C ' 129' ' ' LEU . . . . . . . . . . . . . 5.7 tt -111.96 136.75 50.89 Favored 'General case' 0 C--O 1.234 0.252 0 N-CA-C 110.024 -0.361 . . . . 0.0 110.024 -179.617 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' C' C ' 130' ' ' VAL . . . . . . . . . . . . . 43.2 t -117.99 135.88 56.97 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.185 0 CA-C-N 116.39 -0.368 . . . . 0.0 110.109 -177.442 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' C' C ' 131' ' ' VAL . . . . . . . . . . . . . 43.4 t -133.79 133.78 56.51 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.214 0 CA-C-O 120.938 0.399 . . . . 0.0 110.289 178.513 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' C' C ' 132' ' ' ILE . . . . . . . . . . . . . 70.6 mt -119.82 133.31 66.99 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.233 0 N-CA-C 109.513 -0.551 . . . . 0.0 109.513 -179.567 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' C' C ' 133' ' ' ILE . . . . . . . . . . . . . 40.9 mm -117.77 120.78 65.7 Favored 'Isoleucine or valine' 0 C--O 1.234 0.266 0 CA-C-O 120.801 0.334 . . . . 0.0 111.102 -175.301 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' C' C ' 134' ' ' ASP . . . . . . . . . . . . . 6.9 p-10 -132.43 148.0 52.39 Favored 'General case' 0 C--N 1.33 -0.251 0 N-CA-C 109.708 -0.478 . . . . 0.0 109.708 176.322 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' C' C ' 135' ' ' GLU . . . . . . . . . . . . . 41.6 tp10 -49.98 -29.42 8.5 Favored 'General case' 0 C--N 1.327 -0.387 0 N-CA-C 112.648 0.61 . . . . 0.0 112.648 -173.667 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' C' C ' 136' ' ' GLN . . . . . . . . . . . . . 93.9 mt-30 -79.96 -33.32 39.63 Favored 'General case' 0 C--O 1.234 0.268 0 N-CA-C 112.321 0.489 . . . . 0.0 112.321 -175.302 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' C' C ' 137' ' ' LYS . . . . . . . . . . . . . 46.8 pttt -169.93 174.65 5.49 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-O 121.403 0.621 . . . . 0.0 112.31 -172.451 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' C' C ' 138' ' ' LEU . . . . . . . . . . . . . 5.2 tt -116.12 129.88 56.54 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 115.116 -0.947 . . . . 0.0 109.951 179.499 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' C' C ' 139' ' ' THR . . . . . . . . . . . . . 27.0 m -108.39 126.61 53.07 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-N 116.318 -0.401 . . . . 0.0 110.366 179.855 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' C' C ' 140' ' ' LEU . . . . . . . . . . . . . 14.3 tp -114.44 121.37 43.33 Favored 'General case' 0 C--N 1.33 -0.273 0 N-CA-C 109.048 -0.723 . . . . 0.0 109.048 -179.463 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' C' C ' 141' ' ' ILE . . . . . . . . . . . . . 19.5 mt -119.91 115.6 47.91 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.279 0 CA-C-O 120.978 0.418 . . . . 0.0 109.906 -175.888 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' C' C ' 142' ' ' ARG . . . . . . . . . . . . . 84.2 mtm180 -105.29 132.04 51.99 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 115.243 -0.889 . . . . 0.0 110.841 -175.933 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' C' C ' 143' ' ' THR . . . . . . . . . . . . . 29.8 p . . . . . 0 C--O 1.221 -0.411 0 CA-C-O 118.188 -0.911 . . . . 0.0 110.844 179.495 . . . . . . . . 0 0 . 1 . 020 nuclear orig full ' D' D ' -3' ' ' GLU . . . . . . . . . . . . . 95.8 mt-10 . . . . . 0 N--CA 1.49 1.528 0 N-CA-C 109.369 -0.604 . . . . 0.0 109.369 . . . . . . . . . 0 0 . 1 . 020 nuclear orig full ' D' D ' -2' ' ' GLY . . . . . . . . . . . . . . . -77.63 115.81 4.35 Favored Glycine 0 CA--C 1.525 0.69 0 N-CA-C 111.161 -0.776 . . . . 0.0 111.161 -179.286 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' D' D ' -1' ' ' VAL . . . . . . . . . . . . . 43.2 t -141.57 138.22 32.22 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.328 0 N-CA-C 109.961 -0.385 . . . . 0.0 109.961 178.846 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' D' D ' 0' ' ' ILE . . . . . . . . . . . . . 73.5 mt -106.63 117.5 52.54 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.258 0 N-CA-C 109.761 -0.459 . . . . 0.0 109.761 179.192 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' D' D ' 1' ' ' MET . . . . . . . . . . . . . 25.6 ptm -85.17 144.68 28.03 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.583 -179.466 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' D' D ' 2' ' ' SER . . . . . . . . . . . . . 6.8 p -127.5 134.68 49.78 Favored 'General case' 0 C--N 1.333 -0.151 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.718 -179.248 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' D' D ' 3' ' ' GLU . . . . . . . . . . . . . 95.6 mt-10 -140.22 138.23 34.92 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.03 -0.532 . . . . 0.0 110.897 179.236 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' D' D ' 4' ' ' LEU . . . . . . . . . . . . . 17.2 tp -122.86 128.33 50.21 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 115.911 -0.586 . . . . 0.0 110.249 178.095 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' D' D ' 5' ' ' LYS . . . . . . . . . . . . . 67.6 mttm -105.54 121.4 43.88 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.382 -0.372 . . . . 0.0 110.468 178.219 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' D' D ' 6' ' ' LEU . . . . . . . . . . . . . 73.8 mt -117.65 149.46 40.68 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 115.622 -0.717 . . . . 0.0 110.778 -178.78 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' D' D ' 7' ' ' LYS . . . . . . . . . . . . . 35.5 ttpt -139.55 139.41 22.29 Favored Pre-proline 0 CA--C 1.535 0.376 0 CA-C-O 119.136 -0.459 . . . . 0.0 110.135 175.704 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' D' D ' 8' ' ' PRO . . . . . . . . . . . . . 94.0 Cg_endo -92.09 144.06 2.76 Favored 'Trans proline' 0 N--CA 1.49 1.267 0 C-N-CA 121.778 1.652 . . . . 0.0 111.659 177.053 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' D' D ' 9' ' ' LEU . . . . . . . . . . . . . 45.1 mt -80.25 -48.23 1.29 Allowed Pre-proline 0 CA--C 1.534 0.349 0 CA-C-O 118.665 -0.683 . . . . 0.0 112.445 -178.602 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' D' D ' 10' ' ' PRO . . . . . . . . . . . . . 86.1 Cg_endo -79.75 152.61 22.52 Favored 'Trans proline' 0 N--CA 1.496 1.632 0 C-N-CA 121.213 1.276 . . . . 0.0 112.055 177.318 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' D' D ' 11' ' ' LYS . . . . . . . . . . . . . 90.2 mttt -85.38 97.85 10.22 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.483 -0.326 . . . . 0.0 110.534 178.374 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' D' D ' 12' ' ' VAL . . . . . . . . . . . . . 12.1 p -144.32 143.12 23.57 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.288 0 CA-C-N 116.222 -0.445 . . . . 0.0 110.524 179.743 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' D' D ' 13' ' ' GLU . . . . . . . . . . . . . 45.8 mp0 -81.89 127.01 32.57 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.342 -0.39 . . . . 0.0 110.037 176.956 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' D' D ' 14' ' ' LEU . . . . . . . . . . . . . 22.5 mt -97.28 144.79 28.53 Favored Pre-proline 0 CA--C 1.533 0.311 0 CA-C-O 119.019 -0.515 . . . . 0.0 110.11 -179.688 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' D' D ' 15' ' ' PRO . . . . . . . . . . . . . 29.8 Cg_exo -59.95 160.32 22.38 Favored 'Trans proline' 0 N--CA 1.497 1.709 0 C-N-CA 121.241 1.294 . . . . 0.0 112.085 179.079 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' D' D ' 16' ' ' PRO . . . . . . . . . . . . . 31.6 Cg_exo -59.3 -37.83 88.56 Favored 'Trans proline' 0 N--CA 1.497 1.691 0 C-N-CA 121.452 1.434 . . . . 0.0 112.905 -177.424 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' D' D ' 17' ' ' ASP . . . . . . . . . . . . . 13.7 p-10 -85.33 4.17 36.34 Favored 'General case' 0 CA--C 1.537 0.46 0 N-CA-C 113.301 0.852 . . . . 0.0 113.301 -177.204 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' D' D ' 18' ' ' PHE . . . . . . . . . . . . . 48.2 t80 -58.29 -47.17 84.52 Favored 'General case' 0 C--N 1.334 -0.102 0 O-C-N 122.03 -0.419 . . . . 0.0 110.151 -177.275 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' D' D ' 19' ' ' VAL . . . . . . . . . . . . . 47.5 t -56.72 -42.94 78.26 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.356 0 CA-C-N 116.335 -0.393 . . . . 0.0 110.504 -177.789 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' D' D ' 20' ' ' ASP . . . . . . . . . . . . . 53.4 m-20 -59.82 -41.79 92.07 Favored 'General case' 0 C--N 1.328 -0.333 0 C-N-CA 120.913 -0.315 . . . . 0.0 110.896 -177.851 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' D' D ' 21' ' ' VAL . . . . . . . . . . . . . 47.7 t -64.63 -46.26 92.97 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.275 0 C-N-CA 120.811 -0.356 . . . . 0.0 110.491 -178.06 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' D' D ' 22' ' ' ILE . . . . . . . . . . . . . 46.8 mm -57.75 -40.44 75.69 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.317 0 C-N-CA 120.745 -0.382 . . . . 0.0 110.615 179.726 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' D' D ' 23' ' ' ARG . . . . . . . . . . . . . 59.1 ttp180 -55.69 -49.97 71.55 Favored 'General case' 0 C--N 1.331 -0.219 0 CA-C-O 120.969 0.414 . . . . 0.0 110.843 178.11 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' D' D ' 24' ' ' ILE . . . . . . . . . . . . . 74.1 mt -61.36 -40.26 85.57 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.324 0 CA-C-N 115.918 -0.583 . . . . 0.0 111.925 -176.666 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' D' D ' 25' ' ' LYS . . . . . . . . . . . . . 7.7 ptmm? -72.19 -36.46 69.23 Favored 'General case' 0 CA--C 1.531 0.239 0 C-N-CA 120.534 -0.466 . . . . 0.0 111.882 -176.145 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' D' D ' 26' ' ' LEU . . . . . . . . . . . . . 77.0 mt -77.7 -40.25 41.96 Favored 'General case' 0 C--N 1.33 -0.243 0 N-CA-C 113.194 0.813 . . . . 0.0 113.194 -173.23 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' D' D ' 27' ' ' GLN . . . . . . . . . . . . . 10.5 pt20 -47.53 137.12 9.26 Favored 'General case' 0 N--CA 1.471 0.58 0 N-CA-C 112.661 0.615 . . . . 0.0 112.661 -175.901 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' D' D ' 28' ' ' GLY . . . . . . . . . . . . . . . 99.63 -24.84 30.58 Favored Glycine 0 CA--C 1.533 1.21 0 CA-C-N 115.545 -0.752 . . . . 0.0 112.304 -176.345 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' D' D ' 29' ' ' LYS . . . . . . . . . . . . . 72.9 mmtt -98.11 155.18 17.26 Favored 'General case' 0 C--N 1.331 -0.218 0 CA-C-N 117.318 0.559 . . . . 0.0 111.232 179.352 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' D' D ' 30' ' ' THR . . . . . . . . . . . . . 24.4 m -105.79 135.85 46.47 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 115.784 -0.643 . . . . 0.0 109.859 175.342 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' D' D ' 31' ' ' VAL . . . . . . . . . . . . . 34.8 m -130.83 155.52 41.96 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.276 0 CA-C-O 120.994 0.426 . . . . 0.0 110.926 -178.225 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' D' D ' 32' ' ' ARG . . . . . . . . . . . . . 84.8 mtm180 -131.65 150.78 52.03 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.012 -0.54 . . . . 0.0 110.863 179.143 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' D' D ' 33' ' ' THR . . . . . . . . . . . . . 20.8 m -53.5 140.37 28.36 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.111 -0.495 . . . . 0.0 111.293 -179.09 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' D' D ' 34' ' ' GLY . . . . . . . . . . . . . . . 98.99 -17.17 58.55 Favored Glycine 0 CA--C 1.533 1.189 0 C-N-CA 121.103 -0.57 . . . . 0.0 113.207 179.699 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' D' D ' 35' ' ' ASP . . . . . . . . . . . . . 69.1 m-20 -65.47 148.87 50.99 Favored 'General case' 0 C--O 1.232 0.138 0 CA-C-N 118.013 0.907 . . . . 0.0 111.122 178.99 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' D' D ' 36' ' ' VAL . . . . . . . . . . . . . 45.7 t -122.97 130.03 74.72 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.251 0 CA-C-N 115.774 -0.648 . . . . 0.0 109.704 178.594 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' D' D ' 37' ' ' ILE . . . . . . . . . . . . . 69.7 mt -120.12 137.93 52.33 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.276 0 N-CA-C 109.767 -0.457 . . . . 0.0 109.767 179.442 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' D' D ' 38' ' ' GLY . . . . . . . . . . . . . . . -112.52 128.79 8.65 Favored Glycine 0 CA--C 1.526 0.724 0 N-CA-C 111.11 -0.796 . . . . 0.0 111.11 -179.078 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' D' D ' 39' ' ' ILE . . . . . . . . . . . . . 75.8 mt -124.23 135.55 63.33 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.261 0 CA-C-O 120.795 0.331 . . . . 0.0 110.164 178.999 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' D' D ' 40' ' ' SER . . . . . . . . . . . . . 23.0 t -92.71 120.74 33.41 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.321 -0.399 . . . . 0.0 110.723 176.142 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' D' D ' 41' ' ' ILE . . . . . . . . . . . . . 70.3 mt -132.09 118.16 35.89 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.23 0 N-CA-C 110.107 -0.331 . . . . 0.0 110.107 178.272 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' D' D ' 42' ' ' LEU . . . . . . . . . . . . . 5.4 mp 56.11 36.96 28.32 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.179 -0.464 . . . . 0.0 111.326 179.315 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' D' D ' 43' ' ' GLY . . . . . . . . . . . . . . . 77.48 -10.07 24.99 Favored Glycine 0 CA--C 1.533 1.209 0 C-N-CA 121.279 -0.486 . . . . 0.0 113.531 176.54 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' D' D ' 44' ' ' LYS . . . . . . . . . . . . . 61.9 mttp -97.19 135.96 38.39 Favored 'General case' 0 C--N 1.333 -0.123 0 CA-C-N 117.993 0.897 . . . . 0.0 110.151 177.398 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' D' D ' 45' ' ' GLU . . . . . . . . . . . . . 80.8 tt0 -85.2 126.9 34.03 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.282 -0.417 . . . . 0.0 110.758 179.817 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' D' D ' 46' ' ' VAL . . . . . . . . . . . . . 7.1 p -121.15 127.13 75.81 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.224 0 N-CA-C 109.597 -0.52 . . . . 0.0 109.597 175.895 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' D' D ' 47' ' ' LYS . . . . . . . . . . . . . 58.4 mttm -100.63 129.48 46.56 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 115.862 -0.608 . . . . 0.0 111.139 178.051 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' D' D ' 48' ' ' PHE . . . . . . . . . . . . . 92.5 m-85 -111.12 131.75 54.84 Favored 'General case' 0 C--N 1.329 -0.319 0 N-CA-C 109.61 -0.515 . . . . 0.0 109.61 174.807 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' D' D ' 49' ' ' LYS . . . . . . . . . . . . . 83.3 tttt -108.82 138.15 45.62 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.414 -0.357 . . . . 0.0 110.486 179.76 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' D' D ' 50' ' ' VAL . . . . . . . . . . . . . 44.9 t -80.3 109.56 14.93 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.285 0 N-CA-C 109.292 -0.632 . . . . 0.0 109.292 176.141 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' D' D ' 51' ' ' VAL . . . . . . . . . . . . . 51.2 t -71.81 -47.14 57.94 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.273 0 CA-C-N 115.988 -0.551 . . . . 0.0 109.97 -174.084 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' D' D ' 52' ' ' GLN . . . . . . . . . . . . . 47.6 tt0 -170.93 145.09 2.29 Favored 'General case' 0 C--N 1.33 -0.28 0 C-N-CA 120.433 -0.507 . . . . 0.0 111.439 -179.8 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' D' D ' 53' ' ' ALA . . . . . . . . . . . . . . . -121.14 136.18 55.02 Favored 'General case' 0 C--N 1.331 -0.227 0 CA-C-N 115.903 -0.589 . . . . 0.0 110.474 178.499 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' D' D ' 54' ' ' TYR . . . . . . . . . . . . . 35.6 t80 -129.16 113.59 18.49 Favored Pre-proline 0 CA--C 1.536 0.406 0 CA-C-O 118.24 -0.886 . . . . 0.0 110.117 176.142 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' D' D ' 55' ' ' PRO . . . . . . . . . . . . . 72.8 Cg_endo -77.29 170.08 72.35 Favored 'Cis proline' 0 N--CA 1.499 1.825 0 CA-C-N 122.037 1.763 . . . . 0.0 112.057 -6.089 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' D' D ' 56' ' ' SER . . . . . . . . . . . . . 17.5 m -122.51 134.1 24.74 Favored Pre-proline 0 CA--C 1.538 0.508 0 CA-C-O 118.519 -0.753 . . . . 0.0 109.496 175.204 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' D' D ' 57' ' ' PRO . . . . . . . . . . . . . 38.4 Cg_endo -67.2 145.54 73.63 Favored 'Cis proline' 0 N--CA 1.498 1.777 0 CA-C-N 121.834 1.691 . . . . 0.0 111.562 -1.67 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' D' D ' 58' ' ' LEU . . . . . . . . . . . . . 23.7 tp -106.25 136.05 46.65 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.263 -0.426 . . . . 0.0 110.736 -177.626 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' D' D ' 59' ' ' ARG . . . . . . . . . . . . . 42.1 ttm180 -103.28 127.83 50.5 Favored 'General case' 0 C--N 1.328 -0.367 0 N-CA-C 109.247 -0.649 . . . . 0.0 109.247 174.945 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' D' D ' 60' ' ' VAL . . . . . . . . . . . . . 45.5 t -84.18 120.28 34.73 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.242 0 C-N-CA 120.689 -0.404 . . . . 0.0 110.37 -175.916 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' D' D ' 61' ' ' GLU . . . . . . . . . . . . . 43.9 mt-10 -131.11 167.19 19.53 Favored 'General case' 0 C--N 1.331 -0.214 0 CA-C-N 115.735 -0.666 . . . . 0.0 109.858 177.391 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' D' D ' 62' ' ' ASP . . . . . . . . . . . . . 13.3 t70 -53.81 -32.57 53.19 Favored 'General case' 0 C--N 1.327 -0.377 0 N-CA-C 111.776 0.287 . . . . 0.0 111.776 -179.879 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' D' D ' 63' ' ' ARG . . . . . . . . . . . . . 26.5 ptt180 -82.99 3.79 28.65 Favored 'General case' 0 CA--C 1.536 0.434 0 N-CA-C 113.793 1.034 . . . . 0.0 113.793 -175.629 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' D' D ' 64' ' ' THR . . . . . . . . . . . . . 38.0 m -86.98 135.12 33.4 Favored 'General case' 0 C--N 1.333 -0.148 0 CA-C-N 118.117 0.417 . . . . 0.0 110.584 -178.343 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' D' D ' 65' ' ' LYS . . . . . . . . . . . . . 93.4 mttt -90.24 129.54 36.48 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.066 -0.515 . . . . 0.0 110.237 178.917 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' D' D ' 66' ' ' ILE . . . . . . . . . . . . . 63.4 mt -112.67 129.52 68.12 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.314 0 N-CA-C 109.725 -0.472 . . . . 0.0 109.725 179.641 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' D' D ' 67' ' ' THR . . . . . . . . . . . . . 29.3 m -124.02 138.11 54.5 Favored 'General case' 0 C--N 1.331 -0.204 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.807 -178.267 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' D' D ' 68' ' ' LEU . . . . . . . . . . . . . 7.8 mp -102.49 129.73 49.1 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-N 115.845 -0.616 . . . . 0.0 110.219 178.2 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' D' D ' 69' ' ' VAL . . . . . . . . . . . . . 45.4 t -98.46 126.36 51.58 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 N-CA-C 109.86 -0.422 . . . . 0.0 109.86 179.476 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' D' D ' 70' ' ' THR . . . . . . . . . . . . . 6.9 t -149.96 -39.83 0.14 Allowed 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 116.277 -0.419 . . . . 0.0 111.035 -178.74 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' D' D ' 71' ' ' HIS . . . . . . . . . . . . . 46.7 m-70 -125.77 86.48 57.47 Favored Pre-proline 0 CA--C 1.533 0.298 0 CA-C-N 116.389 -0.369 . . . . 0.0 110.576 -178.382 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' D' D ' 72' ' ' PRO . . . . . . . . . . . . . 14.2 Cg_exo -64.99 -30.0 57.06 Favored 'Trans proline' 0 N--CA 1.496 1.669 0 C-N-CA 121.517 1.478 . . . . 0.0 112.585 -177.276 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' D' D ' 73' ' ' VAL . . . . . . . . . . . . . 30.7 m -76.0 160.15 5.1 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.325 0 CA-C-O 121.067 0.46 . . . . 0.0 111.253 -177.038 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' D' D ' 74' ' ' ASP . . . . . . . . . . . . . 8.3 t0 -101.54 118.42 36.91 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 115.696 -0.684 . . . . 0.0 109.598 178.539 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' D' D ' 75' ' ' VAL . . . . . . . . . . . . . 40.8 t -110.2 123.71 66.33 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.244 0 CA-C-O 120.99 0.424 . . . . 0.0 110.481 -177.179 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' D' D ' 76' ' ' LEU . . . . . . . . . . . . . 30.0 mt -128.49 147.41 50.68 Favored 'General case' 0 C--N 1.331 -0.22 0 CA-C-N 115.794 -0.639 . . . . 0.0 110.066 178.854 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' D' D ' 77' ' ' GLU . . . . . . . . . . . . . 97.1 mt-10 -136.75 140.65 42.73 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-O 120.98 0.419 . . . . 0.0 110.99 -177.95 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' D' D ' 78' ' ' ALA . . . . . . . . . . . . . . . -125.67 127.39 46.19 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 115.799 -0.637 . . . . 0.0 109.748 176.878 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' D' D ' 79' ' ' LYS . . . . . . . . . . . . . 48.8 mmtm -71.59 119.37 15.66 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-O 120.849 0.357 . . . . 0.0 110.848 -178.096 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' D' D ' 80' ' ' ILE . . . . . . . . . . . . . 41.3 mm -139.09 112.73 6.75 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.289 0 N-CA-C 108.885 -0.783 . . . . 0.0 108.885 -179.298 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' D' D ' 81' ' ' LYS . . . . . . . . . . . . . 83.2 tttt -102.65 123.67 46.79 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-O 120.833 0.349 . . . . 0.0 111.205 -174.534 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' D' D ' 82' ' ' GLY . . . . . . . . . . . . . . . 89.22 41.99 5.68 Favored Glycine 0 CA--C 1.526 0.747 0 C-N-CA 120.824 -0.703 . . . . 0.0 112.064 173.702 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' D' D ' 83' ' ' ILE . . . . . . . . . . . . . 67.6 mt -68.25 139.63 20.39 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.311 0 N-CA-C 109.802 -0.444 . . . . 0.0 109.802 177.249 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' D' D ' 84' ' ' LYS . . . . . . . . . . . . . 39.7 ttpt -102.62 -47.9 4.29 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.165 -0.47 . . . . 0.0 110.295 -179.081 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' D' D ' 85' ' ' ASP . . . . . . . . . . . . . 7.5 t70 -152.31 151.04 30.4 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.068 -0.515 . . . . 0.0 110.552 179.903 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' D' D ' 86' ' ' VAL . . . . . . . . . . . . . 42.0 t -129.04 131.5 68.02 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.241 0 CA-C-O 120.917 0.389 . . . . 0.0 110.394 179.513 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' D' D ' 87' ' ' ILE . . . . . . . . . . . . . 5.1 mp -118.64 127.35 75.62 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.245 0 N-CA-C 109.472 -0.566 . . . . 0.0 109.472 177.506 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' D' D ' 88' ' ' LEU . . . . . . . . . . . . . 20.6 tp -111.66 123.45 50.26 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.382 -0.372 . . . . 0.0 110.691 -176.963 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' D' D ' 89' ' ' ASP . . . . . . . . . . . . . 12.8 t70 -121.23 156.14 33.1 Favored 'General case' 0 C--N 1.332 -0.184 0 CA-C-N 116.419 -0.355 . . . . 0.0 110.235 -179.983 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' D' D ' 90' ' ' GLU . . . . . . . . . . . . . 68.1 tt0 -46.04 -45.7 16.22 Favored 'General case' 0 N--CA 1.465 0.291 0 N-CA-C 112.972 0.73 . . . . 0.0 112.972 -171.832 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' D' D ' 91' ' ' ASN . . . . . . . . . . . . . 8.4 t-20 -129.59 34.76 4.29 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-O 120.709 0.29 . . . . 0.0 111.665 -176.039 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' D' D ' 92' ' ' LEU . . . . . . . . . . . . . 7.0 tp -166.14 146.38 6.33 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-O 120.944 0.402 . . . . 0.0 110.554 179.68 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' D' D ' 93' ' ' ILE . . . . . . . . . . . . . 66.7 mt -122.26 123.0 67.8 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.366 0 N-CA-C 109.13 -0.693 . . . . 0.0 109.13 179.146 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' D' D ' 94' ' ' VAL . . . . . . . . . . . . . 43.1 t -119.33 128.19 75.84 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.246 0 CA-C-O 120.839 0.352 . . . . 0.0 110.053 -178.122 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' D' D ' 95' ' ' VAL . . . . . . . . . . . . . 42.4 t -123.12 132.59 71.11 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.302 0 CA-C-N 116.043 -0.526 . . . . 0.0 109.882 179.474 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' D' D ' 96' ' ' ILE . . . . . . . . . . . . . 67.5 mt -116.2 127.87 73.67 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.312 0 N-CA-C 109.268 -0.642 . . . . 0.0 109.268 179.077 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' D' D ' 97' ' ' THR . . . . . . . . . . . . . 70.0 p -99.76 158.27 15.91 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-O 121.029 0.442 . . . . 0.0 111.026 -177.664 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' D' D ' 98' ' ' GLU . . . . . . . . . . . . . 44.8 tp10 -54.03 -26.13 24.89 Favored 'General case' 0 CA--C 1.534 0.34 0 CA-C-N 116.224 -0.444 . . . . 0.0 111.916 179.058 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' D' D ' 99' ' ' GLU . . . . . . . . . . . . . 34.5 tt0 -76.3 11.47 1.54 Allowed 'General case' 0 CA--C 1.539 0.533 0 N-CA-C 112.765 0.654 . . . . 0.0 112.765 -177.512 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' D' D ' 100' ' ' ASN . . . . . . . . . . . . . 2.1 m-20 62.81 32.15 16.07 Favored 'General case' 0 CA--C 1.532 0.277 0 O-C-N 121.705 -0.622 . . . . 0.0 111.555 178.983 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' D' D ' 101' ' ' GLU . . . . . . . . . . . . . 78.5 tt0 -109.75 144.66 37.85 Favored 'General case' 0 C--O 1.234 0.241 0 N-CA-C 109.631 -0.507 . . . . 0.0 109.631 172.887 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' D' D ' 102' ' ' VAL . . . . . . . . . . . . . 44.6 t -116.13 128.2 73.5 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.248 0 CA-C-N 116.432 -0.349 . . . . 0.0 110.134 -178.592 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' D' D ' 103' ' ' LEU . . . . . . . . . . . . . 21.1 mt -116.2 130.52 56.83 Favored 'General case' 0 C--N 1.331 -0.208 0 CA-C-N 115.717 -0.674 . . . . 0.0 110.163 176.973 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' D' D ' 104' ' ' ILE . . . . . . . . . . . . . 66.9 mt -116.82 120.5 65.22 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.299 0 N-CA-C 110.018 -0.364 . . . . 0.0 110.018 179.621 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' D' D ' 105' ' ' PHE . . . . . . . . . . . . . 62.8 m-85 -120.8 165.12 15.59 Favored 'General case' 0 C--N 1.333 -0.123 0 O-C-N 123.893 0.746 . . . . 0.0 109.807 178.777 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' D' D ' 106' ' ' ASN . . . . . . . . . . . . . 42.9 p-10 -98.94 -170.05 1.87 Allowed 'General case' 0 C--N 1.331 -0.229 0 N-CA-C 109.936 -0.394 . . . . 0.0 109.936 173.549 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' D' D ' 107' ' ' GLN . . . . . . . . . . . . . 48.7 tt0 -60.5 -30.03 69.46 Favored 'General case' 0 C--N 1.329 -0.289 0 N-CA-C 111.955 0.354 . . . . 0.0 111.955 179.946 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' D' D ' 108' ' ' ASN . . . . . . . . . . . . . 6.6 t-20 -83.27 6.78 18.46 Favored 'General case' 0 CA--C 1.536 0.425 0 N-CA-C 113.223 0.824 . . . . 0.0 113.223 -178.371 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' D' D ' 109' ' ' LEU . . . . . . . . . . . . . 10.2 tp 62.41 37.69 13.41 Favored 'General case' 0 CA--C 1.529 0.167 0 O-C-N 122.087 -0.383 . . . . 0.0 111.377 178.244 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' D' D ' 110' ' ' GLU . . . . . . . . . . . . . 70.7 mm-40 -105.89 162.24 13.75 Favored 'General case' 0 C--N 1.33 -0.255 0 N-CA-C 109.765 -0.457 . . . . 0.0 109.765 176.014 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' D' D ' 111' ' ' GLU . . . . . . . . . . . . . 83.9 tt0 -86.67 127.45 34.95 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-O 120.938 0.399 . . . . 0.0 111.208 -176.357 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' D' D ' 112' ' ' LEU . . . . . . . . . . . . . 15.6 mt -113.03 -46.09 3.13 Favored 'General case' 0 C--N 1.331 -0.197 0 CA-C-N 115.953 -0.567 . . . . 0.0 110.418 176.579 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' D' D ' 113' ' ' TYR . . . . . . . . . . . . . 38.2 t80 -143.06 138.73 30.13 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.269 -0.423 . . . . 0.0 111.26 -179.295 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' D' D ' 114' ' ' ARG . . . . . . . . . . . . . 27.4 ttm180 -137.42 122.61 19.24 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.338 -0.392 . . . . 0.0 109.968 174.908 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' D' D ' 115' ' ' GLY . . . . . . . . . . . . . . . -150.07 163.1 29.38 Favored Glycine 0 CA--C 1.526 0.775 0 N-CA-C 111.115 -0.794 . . . . 0.0 111.115 179.031 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' D' D ' 116' ' ' LYS . . . . . . . . . . . . . 88.2 tttt -131.69 138.19 48.59 Favored 'General case' 0 C--N 1.33 -0.241 0 N-CA-C 110.046 -0.353 . . . . 0.0 110.046 178.628 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' D' D ' 117' ' ' PHE . . . . . . . . . . . . . 27.6 m-85 -139.05 113.96 9.32 Favored 'General case' 0 C--N 1.331 -0.205 0 CA-C-N 116.26 -0.427 . . . . 0.0 109.963 -176.657 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' D' D ' 118' ' ' GLU . . . . . . . . . . . . . 70.7 mm-40 -54.5 -47.78 72.65 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.564 -0.289 . . . . 0.0 111.542 -174.982 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' D' D ' 119' ' ' ASN . . . . . . . . . . . . . 29.5 m120 -93.59 31.06 1.61 Allowed 'General case' 0 C--N 1.329 -0.315 0 N-CA-C 112.15 0.426 . . . . 0.0 112.15 -174.319 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' D' D ' 120' ' ' LEU . . . . . . . . . . . . . 10.3 tp -56.06 120.69 7.89 Favored 'General case' 0 C--N 1.333 -0.139 0 C-N-CA 121.078 -0.249 . . . . 0.0 110.584 177.864 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' D' D ' 121' ' ' ASN . . . . . . . . . . . . . 36.2 m120 -113.78 -44.05 3.22 Favored 'General case' 0 C--O 1.233 0.204 0 CA-C-N 116.575 -0.284 . . . . 0.0 111.178 -177.582 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' D' D ' 122' ' ' LYS . . . . . . . . . . . . . 98.3 mttt -145.72 150.11 35.65 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-O 121.081 0.467 . . . . 0.0 111.945 -177.978 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' D' D ' 123' ' ' VAL . . . . . . . . . . . . . 44.0 t -127.67 127.56 68.6 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.166 0 CA-C-N 115.811 -0.631 . . . . 0.0 109.485 175.292 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' D' D ' 124' ' ' LEU . . . . . . . . . . . . . 35.6 mt -118.02 136.59 53.44 Favored 'General case' 0 C--N 1.332 -0.161 0 CA-C-N 116.426 -0.352 . . . . 0.0 110.606 -179.231 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' D' D ' 125' ' ' VAL . . . . . . . . . . . . . 34.9 m -121.82 141.95 40.16 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.223 0 CA-C-N 116.128 -0.487 . . . . 0.0 110.608 -179.293 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' D' D ' 126' ' ' ARG . . . . . . . . . . . . . 36.5 ptt180 -148.05 114.78 6.04 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-O 121.292 0.567 . . . . 0.0 110.462 177.725 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' D' D ' 127' ' ' ASN . . . . . . . . . . . . . 60.6 t30 49.48 -107.74 0.26 Allowed 'General case' 0 CA--C 1.546 0.823 0 CA-C-O 118.967 -0.539 . . . . 0.0 111.432 -178.516 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' D' D ' 128' ' ' ASP . . . . . . . . . . . . . 20.4 p-10 -114.08 4.98 15.85 Favored 'General case' 0 N--CA 1.469 0.482 0 CA-C-N 119.813 1.188 . . . . 0.0 113.264 179.726 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' D' D ' 129' ' ' LEU . . . . . . . . . . . . . 25.1 mt -108.82 152.75 24.46 Favored 'General case' 0 C--O 1.233 0.222 0 N-CA-C 109.349 -0.612 . . . . 0.0 109.349 178.332 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' D' D ' 130' ' ' VAL . . . . . . . . . . . . . 33.3 m -139.34 150.17 22.84 Favored 'Isoleucine or valine' 0 N--CA 1.462 0.153 0 CA-C-O 121.462 0.649 . . . . 0.0 111.804 -177.756 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' D' D ' 131' ' ' VAL . . . . . . . . . . . . . 43.4 t -136.09 138.49 47.21 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.267 0 CA-C-N 115.321 -0.854 . . . . 0.0 109.891 177.277 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' D' D ' 132' ' ' ILE . . . . . . . . . . . . . 70.6 mt -118.03 133.97 63.14 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.305 0 CA-C-N 116.086 -0.506 . . . . 0.0 109.702 -178.538 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' D' D ' 133' ' ' ILE . . . . . . . . . . . . . 42.9 mm -115.07 124.06 71.34 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.287 0 CA-C-N 116.399 -0.364 . . . . 0.0 110.846 -175.643 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' D' D ' 134' ' ' ASP . . . . . . . . . . . . . 8.9 p-10 -136.6 146.58 46.23 Favored 'General case' 0 C--N 1.332 -0.166 0 N-CA-C 109.651 -0.5 . . . . 0.0 109.651 174.227 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' D' D ' 135' ' ' GLU . . . . . . . . . . . . . 45.7 tp10 -49.9 -28.4 6.58 Favored 'General case' 0 C--N 1.328 -0.346 0 N-CA-C 112.874 0.694 . . . . 0.0 112.874 -172.05 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' D' D ' 136' ' ' GLN . . . . . . . . . . . . . 36.5 tt0 -80.48 -35.6 34.56 Favored 'General case' 0 C--N 1.331 -0.21 0 N-CA-C 112.236 0.458 . . . . 0.0 112.236 -176.048 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' D' D ' 137' ' ' LYS . . . . . . . . . . . . . 58.5 pttt -167.05 172.59 9.98 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-O 121.61 0.719 . . . . 0.0 112.193 -171.994 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' D' D ' 138' ' ' LEU . . . . . . . . . . . . . 5.0 tt -115.8 128.39 55.8 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 115.046 -0.979 . . . . 0.0 109.847 179.749 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' D' D ' 139' ' ' THR . . . . . . . . . . . . . 38.5 m -109.62 130.25 55.53 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.303 -0.408 . . . . 0.0 110.377 -179.459 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' D' D ' 140' ' ' LEU . . . . . . . . . . . . . 10.0 tp -118.46 127.54 53.75 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.025 -0.534 . . . . 0.0 109.914 -178.26 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' D' D ' 141' ' ' ILE . . . . . . . . . . . . . 19.0 mt -125.71 121.64 60.41 Favored 'Isoleucine or valine' 0 C--O 1.234 0.28 0 N-CA-C 109.898 -0.408 . . . . 0.0 109.898 -176.043 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' D' D ' 142' ' ' ARG . . . . . . . . . . . . . 73.9 mtm180 -115.42 123.48 48.73 Favored 'General case' 0 N--CA 1.463 0.179 0 CA-C-N 116.132 -0.485 . . . . 0.0 109.872 -179.463 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' D' D ' 143' ' ' THR . . . . . . . . . . . . . 25.2 p . . . . . 0 C--O 1.219 -0.526 0 CA-C-O 118.047 -0.977 . . . . 0.0 110.57 -179.263 . . . . . . . . 0 0 . 1 . 020 nuclear orig full ' E' E ' -3' ' ' GLU . . . . . . . . . . . . . 95.8 mt-10 . . . . . 0 N--CA 1.49 1.553 0 N-CA-C 109.427 -0.583 . . . . 0.0 109.427 . . . . . . . . . 0 0 . 1 . 020 nuclear orig full ' E' E ' -2' ' ' GLY . . . . . . . . . . . . . . . -62.05 127.36 40.44 Favored Glycine 0 CA--C 1.524 0.602 0 N-CA-C 111.166 -0.774 . . . . 0.0 111.166 -178.657 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' E' E ' -1' ' ' VAL . . . . . . . . . . . . . 44.1 t -96.58 140.92 16.38 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 N-CA-C 109.772 -0.455 . . . . 0.0 109.772 178.568 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' E' E ' 0' ' ' ILE . . . . . . . . . . . . . 43.7 mm -88.34 144.42 9.2 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.272 0 CA-C-N 116.266 -0.425 . . . . 0.0 110.508 -177.804 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' E' E ' 1' ' ' MET . . . . . . . . . . . . . 24.5 ptp -76.94 170.31 16.73 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.081 -0.509 . . . . 0.0 110.407 179.311 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' E' E ' 2' ' ' SER . . . . . . . . . . . . . 87.3 p -131.08 158.5 40.22 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-O 121.042 0.449 . . . . 0.0 111.173 -177.367 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' E' E ' 3' ' ' GLU . . . . . . . . . . . . . 47.6 mp0 -138.74 144.7 39.6 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 115.855 -0.611 . . . . 0.0 110.986 -178.468 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' E' E ' 4' ' ' LEU . . . . . . . . . . . . . 16.8 tp -125.02 125.13 43.38 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 115.809 -0.632 . . . . 0.0 109.931 176.298 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' E' E ' 5' ' ' LYS . . . . . . . . . . . . . 69.2 mttm -106.39 121.71 44.79 Favored 'General case' 0 C--N 1.331 -0.224 0 CA-C-N 116.362 -0.381 . . . . 0.0 110.634 179.078 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' E' E ' 6' ' ' LEU . . . . . . . . . . . . . 77.1 mt -118.65 147.87 43.32 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 115.492 -0.776 . . . . 0.0 110.522 179.768 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' E' E ' 7' ' ' LYS . . . . . . . . . . . . . 84.9 tttt -140.25 142.46 29.93 Favored Pre-proline 0 C--N 1.329 -0.316 0 N-CA-C 109.666 -0.494 . . . . 0.0 109.666 175.687 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' E' E ' 8' ' ' PRO . . . . . . . . . . . . . 85.1 Cg_endo -90.86 147.45 3.87 Favored 'Trans proline' 0 N--CA 1.492 1.391 0 C-N-CA 121.779 1.653 . . . . 0.0 112.081 179.584 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' E' E ' 9' ' ' LEU . . . . . . . . . . . . . 37.4 mt -84.03 -47.69 0.72 Allowed Pre-proline 0 C--N 1.329 -0.301 0 CA-C-O 118.598 -0.715 . . . . 0.0 112.012 178.929 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' E' E ' 10' ' ' PRO . . . . . . . . . . . . . 97.3 Cg_endo -80.76 154.42 20.27 Favored 'Trans proline' 0 N--CA 1.495 1.602 0 C-N-CA 121.124 1.216 . . . . 0.0 111.667 176.052 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' E' E ' 11' ' ' LYS . . . . . . . . . . . . . 58.2 mtpt -88.71 100.99 13.56 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-O 120.804 0.335 . . . . 0.0 110.471 -179.969 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' E' E ' 12' ' ' VAL . . . . . . . . . . . . . 12.3 p -139.6 143.94 29.67 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.224 0 CA-C-N 116.18 -0.464 . . . . 0.0 110.62 -179.225 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' E' E ' 13' ' ' GLU . . . . . . . . . . . . . 45.5 mp0 -90.98 117.41 29.55 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.31 -0.405 . . . . 0.0 110.018 177.254 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' E' E ' 14' ' ' LEU . . . . . . . . . . . . . 25.3 mt -97.93 155.3 37.23 Favored Pre-proline 0 C--N 1.329 -0.283 0 CA-C-N 116.334 -0.394 . . . . 0.0 111.03 -176.832 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' E' E ' 15' ' ' PRO . . . . . . . . . . . . . 32.9 Cg_exo -60.46 161.27 21.0 Favored 'Trans proline' 0 N--CA 1.496 1.676 0 C-N-CA 121.316 1.344 . . . . 0.0 112.048 177.067 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' E' E ' 16' ' ' PRO . . . . . . . . . . . . . 24.6 Cg_exo -61.82 -34.88 81.45 Favored 'Trans proline' 0 N--CA 1.497 1.725 0 C-N-CA 121.472 1.448 . . . . 0.0 112.753 -178.954 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' E' E ' 17' ' ' ASP . . . . . . . . . . . . . 15.7 p-10 -88.38 11.65 16.27 Favored 'General case' 0 CA--C 1.534 0.336 0 N-CA-C 113.24 0.829 . . . . 0.0 113.24 -176.408 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' E' E ' 18' ' ' PHE . . . . . . . . . . . . . 37.3 t80 -56.91 -45.53 82.57 Favored 'General case' 0 C--O 1.231 0.118 0 O-C-N 122.024 -0.423 . . . . 0.0 110.334 -178.377 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' E' E ' 19' ' ' VAL . . . . . . . . . . . . . 13.2 p -56.55 -41.57 73.58 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.317 0 CA-C-N 116.544 -0.298 . . . . 0.0 110.898 -179.013 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' E' E ' 20' ' ' ASP . . . . . . . . . . . . . 78.1 m-20 -61.05 -43.12 99.37 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-O 120.837 0.351 . . . . 0.0 110.889 -178.545 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' E' E ' 21' ' ' VAL . . . . . . . . . . . . . 48.8 t -64.3 -44.86 97.34 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.319 0 C-N-CA 120.797 -0.361 . . . . 0.0 110.448 -176.952 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' E' E ' 22' ' ' ILE . . . . . . . . . . . . . 49.8 mm -55.2 -50.62 62.74 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.247 0 C-N-CA 121.151 -0.22 . . . . 0.0 110.716 178.72 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' E' E ' 23' ' ' ARG . . . . . . . . . . . . . 37.8 ttp180 -55.21 -48.65 73.57 Favored 'General case' 0 C--N 1.329 -0.311 0 C-N-CA 120.949 -0.3 . . . . 0.0 111.567 -177.778 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' E' E ' 24' ' ' ILE . . . . . . . . . . . . . 75.4 mt -58.91 -43.72 89.21 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 C-N-CA 121.054 -0.258 . . . . 0.0 111.368 -176.126 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' E' E ' 25' ' ' LYS . . . . . . . . . . . . . 93.1 mttt -69.34 -39.62 78.04 Favored 'General case' 0 C--N 1.33 -0.268 0 N-CA-C 112.556 0.576 . . . . 0.0 112.556 -178.302 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' E' E ' 26' ' ' LEU . . . . . . . . . . . . . 79.2 mt -78.98 -33.49 45.07 Favored 'General case' 0 C--N 1.331 -0.219 0 N-CA-C 113.673 0.99 . . . . 0.0 113.673 -170.745 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' E' E ' 27' ' ' GLN . . . . . . . . . . . . . 6.3 pt20 -46.4 137.42 6.5 Favored 'General case' 0 N--CA 1.469 0.5 0 N-CA-C 112.861 0.689 . . . . 0.0 112.861 -174.406 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' E' E ' 28' ' ' GLY . . . . . . . . . . . . . . . 99.99 -23.73 34.89 Favored Glycine 0 CA--C 1.533 1.198 0 CA-C-N 115.68 -0.691 . . . . 0.0 112.53 -177.448 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' E' E ' 29' ' ' LYS . . . . . . . . . . . . . 97.7 mttt -97.59 155.13 17.11 Favored 'General case' 0 C--O 1.233 0.235 0 CA-C-N 117.459 0.63 . . . . 0.0 111.132 179.512 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' E' E ' 30' ' ' THR . . . . . . . . . . . . . 27.0 m -103.28 138.52 39.95 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.085 -0.507 . . . . 0.0 110.272 177.545 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' E' E ' 31' ' ' VAL . . . . . . . . . . . . . 34.9 m -130.23 156.73 42.54 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.239 0 CA-C-N 116.385 -0.371 . . . . 0.0 110.879 -178.923 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' E' E ' 32' ' ' ARG . . . . . . . . . . . . . 79.0 mtm180 -136.1 150.4 49.1 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-O 121.32 0.581 . . . . 0.0 110.819 178.112 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' E' E ' 33' ' ' THR . . . . . . . . . . . . . 17.6 m -53.55 141.43 25.54 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.128 -0.487 . . . . 0.0 111.27 -178.625 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' E' E ' 34' ' ' GLY . . . . . . . . . . . . . . . 99.64 -17.08 58.06 Favored Glycine 0 CA--C 1.532 1.149 0 CA-C-O 119.699 -0.501 . . . . 0.0 113.275 179.609 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' E' E ' 35' ' ' ASP . . . . . . . . . . . . . 76.6 m-20 -66.03 147.69 52.95 Favored 'General case' 0 C--O 1.23 0.071 0 CA-C-N 118.054 0.927 . . . . 0.0 111.152 179.054 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' E' E ' 36' ' ' VAL . . . . . . . . . . . . . 46.4 t -122.54 127.97 75.2 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.204 0 CA-C-N 115.83 -0.623 . . . . 0.0 109.649 177.803 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' E' E ' 37' ' ' ILE . . . . . . . . . . . . . 68.2 mt -119.31 138.66 49.28 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.239 0 CA-C-N 116.247 -0.433 . . . . 0.0 109.928 -179.499 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' E' E ' 38' ' ' GLY . . . . . . . . . . . . . . . -110.34 128.58 8.9 Favored Glycine 0 CA--C 1.525 0.7 0 N-CA-C 111.025 -0.83 . . . . 0.0 111.025 179.891 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' E' E ' 39' ' ' ILE . . . . . . . . . . . . . 75.4 mt -126.13 139.34 51.83 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.2 0 N-CA-C 110.027 -0.36 . . . . 0.0 110.027 178.835 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' E' E ' 40' ' ' SER . . . . . . . . . . . . . 31.0 t -92.28 116.66 29.16 Favored 'General case' 0 C--N 1.329 -0.297 0 C-N-CA 120.935 -0.306 . . . . 0.0 110.936 176.107 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' E' E ' 41' ' ' ILE . . . . . . . . . . . . . 46.0 mm -124.59 115.96 46.06 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.157 0 N-CA-C 110.112 -0.329 . . . . 0.0 110.112 178.584 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' E' E ' 42' ' ' LEU . . . . . . . . . . . . . 70.4 mt 57.58 33.43 23.24 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-N 116.196 -0.457 . . . . 0.0 111.793 179.437 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' E' E ' 43' ' ' GLY . . . . . . . . . . . . . . . 81.78 -10.05 53.44 Favored Glycine 0 CA--C 1.534 1.261 0 C-N-CA 121.26 -0.495 . . . . 0.0 113.435 177.043 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' E' E ' 44' ' ' LYS . . . . . . . . . . . . . 53.1 mtpt -100.45 140.45 34.68 Favored 'General case' 0 C--N 1.333 -0.134 0 CA-C-N 117.892 0.846 . . . . 0.0 110.198 178.321 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' E' E ' 45' ' ' GLU . . . . . . . . . . . . . 80.7 tt0 -83.98 126.05 32.65 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.464 -0.334 . . . . 0.0 110.985 -178.752 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' E' E ' 46' ' ' VAL . . . . . . . . . . . . . 7.6 p -120.68 124.37 72.27 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.224 0 N-CA-C 109.409 -0.589 . . . . 0.0 109.409 175.836 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' E' E ' 47' ' ' LYS . . . . . . . . . . . . . 93.1 mttt -100.51 128.5 46.55 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.011 -0.54 . . . . 0.0 111.132 178.027 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' E' E ' 48' ' ' PHE . . . . . . . . . . . . . 93.5 m-85 -109.56 131.96 54.58 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.249 -0.432 . . . . 0.0 110.015 176.499 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' E' E ' 49' ' ' LYS . . . . . . . . . . . . . 80.0 tttt -107.49 134.59 50.3 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.312 -0.403 . . . . 0.0 110.293 179.53 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' E' E ' 50' ' ' VAL . . . . . . . . . . . . . 46.2 t -77.13 110.01 12.31 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.304 0 N-CA-C 109.287 -0.635 . . . . 0.0 109.287 176.393 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' E' E ' 51' ' ' VAL . . . . . . . . . . . . . 48.4 t -74.28 -47.08 42.29 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.278 0 CA-C-N 116.073 -0.512 . . . . 0.0 110.233 -173.852 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' E' E ' 52' ' ' GLN . . . . . . . . . . . . . 61.9 tt0 -168.01 140.08 3.0 Favored 'General case' 0 C--N 1.331 -0.228 0 C-N-CA 120.409 -0.516 . . . . 0.0 111.351 -177.942 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' E' E ' 53' ' ' ALA . . . . . . . . . . . . . . . -117.18 134.46 54.75 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 115.798 -0.637 . . . . 0.0 110.179 175.62 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' E' E ' 54' ' ' TYR . . . . . . . . . . . . . 55.5 t80 -129.05 112.69 18.53 Favored Pre-proline 0 CA--C 1.535 0.375 0 CA-C-O 118.146 -0.93 . . . . 0.0 110.378 177.877 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' E' E ' 55' ' ' PRO . . . . . . . . . . . . . 74.0 Cg_endo -77.09 168.13 77.89 Favored 'Cis proline' 0 N--CA 1.5 1.902 0 CA-C-N 122.14 1.8 . . . . 0.0 112.273 -6.925 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' E' E ' 56' ' ' SER . . . . . . . . . . . . . 15.5 m -116.89 133.79 23.04 Favored Pre-proline 0 CA--C 1.538 0.506 0 CA-C-O 118.414 -0.803 . . . . 0.0 109.572 175.198 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' E' E ' 57' ' ' PRO . . . . . . . . . . . . . 39.4 Cg_endo -67.54 161.11 79.13 Favored 'Cis proline' 0 N--CA 1.497 1.716 0 CA-C-N 121.864 1.701 . . . . 0.0 111.29 -1.695 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' E' E ' 58' ' ' LEU . . . . . . . . . . . . . 21.3 tp -125.99 138.39 53.74 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-O 120.969 0.414 . . . . 0.0 110.46 -178.967 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' E' E ' 59' ' ' ARG . . . . . . . . . . . . . 74.6 ttt180 -103.25 127.0 50.7 Favored 'General case' 0 C--N 1.327 -0.4 0 CA-C-N 115.737 -0.665 . . . . 0.0 109.355 176.249 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' E' E ' 60' ' ' VAL . . . . . . . . . . . . . 41.8 t -77.35 116.74 21.21 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.26 0 C-N-CA 120.672 -0.411 . . . . 0.0 110.156 -176.441 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' E' E ' 61' ' ' GLU . . . . . . . . . . . . . 95.7 mt-10 -131.15 162.17 30.5 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 115.907 -0.588 . . . . 0.0 110.145 178.423 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' E' E ' 62' ' ' ASP . . . . . . . . . . . . . 79.3 m-20 -54.79 -32.67 60.5 Favored 'General case' 0 C--N 1.328 -0.346 0 C-N-CA 121.065 -0.254 . . . . 0.0 111.667 -179.851 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' E' E ' 63' ' ' ARG . . . . . . . . . . . . . 10.8 ptm180 -82.6 6.82 16.47 Favored 'General case' 0 CA--C 1.534 0.354 0 N-CA-C 113.744 1.016 . . . . 0.0 113.744 -175.887 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' E' E ' 64' ' ' THR . . . . . . . . . . . . . 27.6 m -93.43 140.14 29.91 Favored 'General case' 0 C--O 1.232 0.133 0 CA-C-N 118.16 0.436 . . . . 0.0 110.486 -179.62 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' E' E ' 65' ' ' LYS . . . . . . . . . . . . . 68.3 mttm -88.62 124.2 33.83 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.277 -0.42 . . . . 0.0 110.008 179.558 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' E' E ' 66' ' ' ILE . . . . . . . . . . . . . 56.5 mt -113.58 129.8 68.74 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.253 0 N-CA-C 109.815 -0.439 . . . . 0.0 109.815 -179.814 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' E' E ' 67' ' ' THR . . . . . . . . . . . . . 19.0 m -127.21 133.97 50.18 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-O 121.245 0.545 . . . . 0.0 110.767 179.949 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' E' E ' 68' ' ' LEU . . . . . . . . . . . . . 21.7 tp -108.27 122.85 47.8 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 115.737 -0.665 . . . . 0.0 109.72 176.55 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' E' E ' 69' ' ' VAL . . . . . . . . . . . . . 44.6 t -100.89 102.52 13.57 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.209 0 N-CA-C 109.723 -0.473 . . . . 0.0 109.723 179.236 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' E' E ' 70' ' ' THR . . . . . . . . . . . . . 14.5 m -150.23 -44.32 0.13 Allowed 'General case' 0 C--N 1.33 -0.265 0 CA-C-O 121.093 0.473 . . . . 0.0 111.333 178.889 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' E' E ' 71' ' ' HIS . . . . . . . . . . . . . 26.3 m80 -106.52 170.29 5.91 Favored Pre-proline 0 CA--C 1.535 0.369 0 CA-C-N 115.598 -0.728 . . . . 0.0 112.462 -168.031 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' E' E ' 72' ' ' PRO . . . . . . . . . . . . . 23.1 Cg_exo -64.93 160.33 41.78 Favored 'Trans proline' 0 N--CA 1.497 1.72 0 C-N-CA 122.096 1.864 . . . . 0.0 111.943 174.44 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' E' E ' 73' ' ' VAL . . . . . . . . . . . . . 34.3 m -69.49 -173.51 0.1 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.277 0 CA-C-N 116.133 -0.485 . . . . 0.0 110.293 -173.804 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' E' E ' 74' ' ' ASP . . . . . . . . . . . . . 13.9 t70 -77.35 114.98 16.73 Favored 'General case' 0 C--N 1.328 -0.338 0 C-N-CA 120.362 -0.535 . . . . 0.0 110.274 -168.414 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' E' E ' 75' ' ' VAL . . . . . . . . . . . . . 46.8 t -119.38 117.91 55.63 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.273 0 CA-C-O 121.16 0.505 . . . . 0.0 109.733 -179.654 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' E' E ' 76' ' ' LEU . . . . . . . . . . . . . 15.2 mt -124.59 148.57 47.78 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 115.459 -0.791 . . . . 0.0 109.613 -178.329 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' E' E ' 77' ' ' GLU . . . . . . . . . . . . . 45.3 mt-10 -138.77 135.46 34.7 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-O 121.15 0.5 . . . . 0.0 111.266 -177.604 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' E' E ' 78' ' ' ALA . . . . . . . . . . . . . . . -121.78 129.24 52.52 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 115.562 -0.745 . . . . 0.0 109.622 175.708 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' E' E ' 79' ' ' LYS . . . . . . . . . . . . . 48.7 mttm -75.83 117.84 18.0 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-O 121.008 0.433 . . . . 0.0 110.875 -178.55 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' E' E ' 80' ' ' ILE . . . . . . . . . . . . . 38.4 mm -139.14 102.5 1.73 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.261 0 N-CA-C 108.908 -0.775 . . . . 0.0 108.908 -177.95 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' E' E ' 81' ' ' LYS . . . . . . . . . . . . . 53.5 mttp -96.31 127.82 42.66 Favored 'General case' 0 C--N 1.327 -0.397 0 C-N-CA 120.783 -0.367 . . . . 0.0 111.305 -176.489 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' E' E ' 82' ' ' GLY . . . . . . . . . . . . . . . 89.14 42.18 5.66 Favored Glycine 0 CA--C 1.525 0.703 0 C-N-CA 120.714 -0.755 . . . . 0.0 111.867 173.588 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' E' E ' 83' ' ' ILE . . . . . . . . . . . . . 70.7 mt -70.95 135.0 28.98 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.358 0 N-CA-C 109.477 -0.564 . . . . 0.0 109.477 177.186 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' E' E ' 84' ' ' LYS . . . . . . . . . . . . . 31.1 ttpt -94.34 -51.64 4.7 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-O 121.023 0.44 . . . . 0.0 110.212 -177.521 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' E' E ' 85' ' ' ASP . . . . . . . . . . . . . 8.9 t70 -149.49 149.31 30.57 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 115.696 -0.684 . . . . 0.0 110.068 -179.383 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' E' E ' 86' ' ' VAL . . . . . . . . . . . . . 39.6 t -132.3 133.65 59.99 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.244 0 CA-C-O 120.959 0.409 . . . . 0.0 110.502 -179.671 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' E' E ' 87' ' ' ILE . . . . . . . . . . . . . 5.0 mp -118.94 123.48 71.56 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 N-CA-C 109.206 -0.665 . . . . 0.0 109.206 176.717 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' E' E ' 88' ' ' LEU . . . . . . . . . . . . . 14.0 tp -109.43 119.52 39.72 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.401 -0.363 . . . . 0.0 110.475 -179.068 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' E' E ' 89' ' ' ASP . . . . . . . . . . . . . 6.6 t70 -112.28 153.92 26.43 Favored 'General case' 0 C--N 1.33 -0.28 0 N-CA-C 109.628 -0.508 . . . . 0.0 109.628 178.249 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' E' E ' 90' ' ' GLU . . . . . . . . . . . . . 82.0 tt0 -47.76 -36.86 12.22 Favored 'General case' 0 C--N 1.329 -0.296 0 N-CA-C 112.685 0.624 . . . . 0.0 112.685 -173.364 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' E' E ' 91' ' ' ASN . . . . . . . . . . . . . 13.2 p30 -131.97 32.19 4.08 Favored 'General case' 0 N--CA 1.465 0.285 0 N-CA-C 112.29 0.478 . . . . 0.0 112.29 -175.79 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' E' E ' 92' ' ' LEU . . . . . . . . . . . . . 6.4 tp -166.02 144.68 5.87 Favored 'General case' 0 C--N 1.332 -0.183 0 C-N-CA 120.686 -0.406 . . . . 0.0 111.016 -179.656 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' E' E ' 93' ' ' ILE . . . . . . . . . . . . . 62.3 mt -119.82 119.87 61.59 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.24 0 N-CA-C 109.346 -0.613 . . . . 0.0 109.346 -179.787 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' E' E ' 94' ' ' VAL . . . . . . . . . . . . . 45.5 t -122.22 126.44 74.3 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.293 0 CA-C-O 120.849 0.357 . . . . 0.0 110.212 -178.984 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' E' E ' 95' ' ' VAL . . . . . . . . . . . . . 42.9 t -123.65 134.23 66.99 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.209 0 CA-C-N 116.109 -0.496 . . . . 0.0 110.093 -179.356 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' E' E ' 96' ' ' ILE . . . . . . . . . . . . . 66.6 mt -117.13 127.54 74.69 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.257 0 N-CA-C 109.509 -0.552 . . . . 0.0 109.509 178.634 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' E' E ' 97' ' ' THR . . . . . . . . . . . . . 82.0 p -99.28 157.33 16.46 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-O 121.13 0.491 . . . . 0.0 111.282 -177.433 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' E' E ' 98' ' ' GLU . . . . . . . . . . . . . 96.7 mt-10 -54.62 -26.45 32.89 Favored 'General case' 0 C--N 1.328 -0.328 0 N-CA-C 112.236 0.458 . . . . 0.0 112.236 -179.829 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' E' E ' 99' ' ' GLU . . . . . . . . . . . . . 95.7 mt-10 -78.22 14.7 1.11 Allowed 'General case' 0 CA--C 1.536 0.43 0 N-CA-C 113.1 0.778 . . . . 0.0 113.1 -177.425 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' E' E ' 100' ' ' ASN . . . . . . . . . . . . . 4.5 m-20 63.47 38.03 10.19 Favored 'General case' 0 C--O 1.232 0.149 0 CA-C-O 121.055 0.455 . . . . 0.0 110.951 178.11 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' E' E ' 101' ' ' GLU . . . . . . . . . . . . . 83.3 tt0 -119.24 141.31 49.03 Favored 'General case' 0 C--N 1.332 -0.192 0 N-CA-C 109.601 -0.518 . . . . 0.0 109.601 176.178 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' E' E ' 102' ' ' VAL . . . . . . . . . . . . . 41.8 t -115.03 130.9 68.76 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.271 0 CA-C-O 120.812 0.339 . . . . 0.0 110.407 -177.527 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' E' E ' 103' ' ' LEU . . . . . . . . . . . . . 27.1 mt -119.29 130.89 55.64 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 115.454 -0.794 . . . . 0.0 109.992 176.725 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' E' E ' 104' ' ' ILE . . . . . . . . . . . . . 72.4 mt -119.65 123.56 71.26 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.252 0 N-CA-C 110.096 -0.335 . . . . 0.0 110.096 179.506 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' E' E ' 105' ' ' PHE . . . . . . . . . . . . . 66.9 m-85 -124.86 162.99 23.16 Favored 'General case' 0 C--N 1.332 -0.159 0 O-C-N 123.735 0.647 . . . . 0.0 110.482 -177.792 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' E' E ' 106' ' ' ASN . . . . . . . . . . . . . 40.6 p-10 -100.7 -169.98 1.79 Allowed 'General case' 0 CA--C 1.531 0.218 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.263 175.592 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' E' E ' 107' ' ' GLN . . . . . . . . . . . . . 47.2 tt0 -59.09 -29.97 67.74 Favored 'General case' 0 CA--C 1.531 0.232 0 N-CA-C 112.017 0.377 . . . . 0.0 112.017 179.917 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' E' E ' 108' ' ' ASN . . . . . . . . . . . . . 12.2 t-20 -86.01 9.62 16.57 Favored 'General case' 0 CA--C 1.534 0.348 0 N-CA-C 113.275 0.842 . . . . 0.0 113.275 -177.087 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' E' E ' 109' ' ' LEU . . . . . . . . . . . . . 12.1 tp 57.76 40.11 26.55 Favored 'General case' 0 CA--C 1.529 0.169 0 CA-C-O 121.206 0.527 . . . . 0.0 111.012 178.33 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' E' E ' 110' ' ' GLU . . . . . . . . . . . . . 95.5 mt-10 -108.32 156.93 18.83 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.202 -0.454 . . . . 0.0 109.99 175.953 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' E' E ' 111' ' ' GLU . . . . . . . . . . . . . 35.5 tt0 -81.61 122.08 27.15 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-O 120.892 0.377 . . . . 0.0 110.744 -177.304 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' E' E ' 112' ' ' LEU . . . . . . . . . . . . . 16.8 mt -107.74 -45.94 3.91 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 115.991 -0.549 . . . . 0.0 110.219 175.996 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' E' E ' 113' ' ' TYR . . . . . . . . . . . . . 63.2 t80 -139.5 135.08 33.13 Favored 'General case' 0 C--N 1.332 -0.19 0 C-N-CA 120.814 -0.355 . . . . 0.0 111.456 179.624 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' E' E ' 114' ' ' ARG . . . . . . . . . . . . . 19.4 ttm180 -133.76 123.85 25.61 Favored 'General case' 0 C--N 1.331 -0.224 0 CA-C-N 115.811 -0.631 . . . . 0.0 109.72 175.58 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' E' E ' 115' ' ' GLY . . . . . . . . . . . . . . . -150.11 141.36 8.72 Favored Glycine 0 CA--C 1.524 0.655 0 N-CA-C 111.272 -0.731 . . . . 0.0 111.272 178.906 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' E' E ' 116' ' ' LYS . . . . . . . . . . . . . 17.1 ttpp -116.57 130.72 56.9 Favored 'General case' 0 C--N 1.332 -0.194 0 N-CA-C 109.748 -0.464 . . . . 0.0 109.748 177.443 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' E' E ' 117' ' ' PHE . . . . . . . . . . . . . 38.6 m-85 -130.58 114.04 14.96 Favored 'General case' 0 C--N 1.331 -0.213 0 CA-C-O 120.782 0.325 . . . . 0.0 110.211 -175.696 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' E' E ' 118' ' ' GLU . . . . . . . . . . . . . 96.0 mt-10 -55.54 -41.49 73.29 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.406 -0.361 . . . . 0.0 111.102 -176.695 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' E' E ' 119' ' ' ASN . . . . . . . . . . . . . 34.7 m-80 -99.57 30.96 3.36 Favored 'General case' 0 C--N 1.33 -0.268 0 N-CA-C 112.121 0.415 . . . . 0.0 112.121 -174.123 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' E' E ' 120' ' ' LEU . . . . . . . . . . . . . 13.7 tp -55.33 121.3 8.61 Favored 'General case' 0 C--N 1.333 -0.115 0 CA-C-O 120.747 0.308 . . . . 0.0 110.736 178.382 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' E' E ' 121' ' ' ASN . . . . . . . . . . . . . 72.0 m-80 -112.51 -44.13 3.4 Favored 'General case' 0 C--N 1.332 -0.175 0 CA-C-N 116.316 -0.402 . . . . 0.0 110.841 -178.145 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' E' E ' 122' ' ' LYS . . . . . . . . . . . . . 35.4 mtmm -147.47 147.05 29.78 Favored 'General case' 0 C--N 1.331 -0.231 0 C-N-CA 120.6 -0.44 . . . . 0.0 111.783 -177.985 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' E' E ' 123' ' ' VAL . . . . . . . . . . . . . 45.5 t -123.94 127.27 73.54 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.233 0 CA-C-N 115.88 -0.6 . . . . 0.0 109.562 176.133 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' E' E ' 124' ' ' LEU . . . . . . . . . . . . . 51.5 mt -119.73 136.36 54.46 Favored 'General case' 0 C--N 1.331 -0.23 0 CA-C-N 116.355 -0.384 . . . . 0.0 110.673 -177.743 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' E' E ' 125' ' ' VAL . . . . . . . . . . . . . 12.1 p -133.31 135.25 56.58 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.265 0 CA-C-O 120.749 0.309 . . . . 0.0 110.392 178.505 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' E' E ' 126' ' ' ARG . . . . . . . . . . . . . 95.8 mtt-85 -144.5 120.9 10.97 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-N 116.093 -0.503 . . . . 0.0 110.566 179.139 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' E' E ' 127' ' ' ASN . . . . . . . . . . . . . 94.9 m-20 50.4 -108.02 0.31 Allowed 'General case' 0 CA--C 1.544 0.721 0 CA-C-O 118.854 -0.593 . . . . 0.0 111.428 179.662 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' E' E ' 128' ' ' ASP . . . . . . . . . . . . . 11.0 p-10 -114.08 6.85 16.54 Favored 'General case' 0 CA--C 1.536 0.436 0 CA-C-N 119.796 1.18 . . . . 0.0 113.417 -177.776 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' E' E ' 129' ' ' LEU . . . . . . . . . . . . . 6.1 mp -110.75 150.04 29.66 Favored 'General case' 0 C--O 1.233 0.189 0 CA-C-N 118.206 0.457 . . . . 0.0 110.435 178.666 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' E' E ' 130' ' ' VAL . . . . . . . . . . . . . 40.6 t -130.86 140.98 47.35 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.237 0 CA-C-N 116.271 -0.422 . . . . 0.0 110.406 -178.213 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' E' E ' 131' ' ' VAL . . . . . . . . . . . . . 41.3 t -134.92 135.88 52.51 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 CA-C-N 116.096 -0.502 . . . . 0.0 109.806 177.835 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' E' E ' 132' ' ' ILE . . . . . . . . . . . . . 71.3 mt -119.29 133.68 65.32 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.25 0 N-CA-C 109.737 -0.468 . . . . 0.0 109.737 -179.842 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' E' E ' 133' ' ' ILE . . . . . . . . . . . . . 41.8 mm -115.9 123.58 71.35 Favored 'Isoleucine or valine' 0 C--O 1.233 0.223 0 CA-C-N 116.39 -0.368 . . . . 0.0 110.663 -176.867 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' E' E ' 134' ' ' ASP . . . . . . . . . . . . . 10.1 p-10 -134.88 150.14 50.4 Favored 'General case' 0 C--N 1.331 -0.237 0 N-CA-C 109.75 -0.463 . . . . 0.0 109.75 175.332 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' E' E ' 135' ' ' GLU . . . . . . . . . . . . . 40.6 tp10 -49.95 -27.29 5.14 Favored 'General case' 0 C--N 1.328 -0.347 0 N-CA-C 112.809 0.67 . . . . 0.0 112.809 -171.581 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' E' E ' 136' ' ' GLN . . . . . . . . . . . . . 43.4 tt0 -89.99 -29.97 18.09 Favored 'General case' 0 C--O 1.234 0.266 0 N-CA-C 112.619 0.6 . . . . 0.0 112.619 -173.388 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' E' E ' 137' ' ' LYS . . . . . . . . . . . . . 52.2 pttt -163.86 173.02 13.23 Favored 'General case' 0 C--N 1.332 -0.179 0 CA-C-O 121.528 0.68 . . . . 0.0 112.448 -173.238 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' E' E ' 138' ' ' LEU . . . . . . . . . . . . . 6.4 tt -121.15 129.94 53.49 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 115.03 -0.986 . . . . 0.0 109.928 178.579 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' E' E ' 139' ' ' THR . . . . . . . . . . . . . 27.9 m -111.78 129.49 56.11 Favored 'General case' 0 C--N 1.331 -0.211 0 CA-C-N 116.315 -0.402 . . . . 0.0 110.676 -178.856 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' E' E ' 140' ' ' LEU . . . . . . . . . . . . . 8.7 tp -117.14 120.7 39.1 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 115.748 -0.66 . . . . 0.0 109.363 -177.989 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' E' E ' 141' ' ' ILE . . . . . . . . . . . . . 19.4 mt -119.49 121.42 66.33 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.239 0 CA-C-O 120.818 0.342 . . . . 0.0 110.219 -175.701 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' E' E ' 142' ' ' ARG . . . . . . . . . . . . . 75.1 mtp180 -111.85 130.4 55.83 Favored 'General case' 0 C--N 1.331 -0.222 0 CA-C-N 115.556 -0.747 . . . . 0.0 110.185 -178.666 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' E' E ' 143' ' ' THR . . . . . . . . . . . . . 39.9 p . . . . . 0 C--O 1.219 -0.506 0 CA-C-O 118.011 -0.995 . . . . 0.0 110.598 179.953 . . . . . . . . 0 0 . 1 . 020 nuclear orig full ' F' F ' -3' ' ' GLU . . . . . . . . . . . . . 80.1 tt0 . . . . . 0 N--CA 1.49 1.563 0 N-CA-C 109.239 -0.652 . . . . 0.0 109.239 . . . . . . . . . 0 0 . 1 . 020 nuclear orig full ' F' F ' -2' ' ' GLY . . . . . . . . . . . . . . . -102.66 138.93 14.2 Favored Glycine 0 CA--C 1.524 0.639 0 N-CA-C 111.025 -0.83 . . . . 0.0 111.025 -179.947 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' F' F ' -1' ' ' VAL . . . . . . . . . . . . . 46.7 t -96.39 138.16 22.37 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.284 0 N-CA-C 109.776 -0.453 . . . . 0.0 109.776 178.702 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' F' F ' 0' ' ' ILE . . . . . . . . . . . . . 70.5 mt -96.2 139.71 18.67 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.269 0 CA-C-N 116.319 -0.401 . . . . 0.0 110.101 -178.24 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' F' F ' 1' ' ' MET . . . . . . . . . . . . . 26.1 ptt? -77.05 130.35 37.3 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.04 -0.527 . . . . 0.0 110.441 -179.557 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' F' F ' 2' ' ' SER . . . . . . . . . . . . . 6.2 p -108.34 139.38 43.13 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-N 116.1 -0.5 . . . . 0.0 110.805 -178.536 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' F' F ' 3' ' ' GLU . . . . . . . . . . . . . 33.1 tp10 -139.18 133.58 31.6 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 115.723 -0.671 . . . . 0.0 110.194 -178.102 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' F' F ' 4' ' ' LEU . . . . . . . . . . . . . 19.7 tp -125.15 127.59 47.08 Favored 'General case' 0 C--N 1.331 -0.196 0 N-CA-C 110.071 -0.344 . . . . 0.0 110.071 175.23 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' F' F ' 5' ' ' LYS . . . . . . . . . . . . . 98.7 mttt -111.14 121.39 45.18 Favored 'General case' 0 C--O 1.235 0.302 0 CA-C-O 120.831 0.348 . . . . 0.0 110.827 179.378 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' F' F ' 6' ' ' LEU . . . . . . . . . . . . . 60.4 mt -114.46 143.31 45.15 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 115.369 -0.832 . . . . 0.0 109.898 179.549 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' F' F ' 7' ' ' LYS . . . . . . . . . . . . . 80.6 tttt -123.43 134.23 25.08 Favored Pre-proline 0 CA--C 1.534 0.339 0 CA-C-O 118.893 -0.575 . . . . 0.0 109.812 175.96 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' F' F ' 8' ' ' PRO . . . . . . . . . . . . . 94.4 Cg_endo -92.03 136.57 1.69 Allowed 'Trans proline' 0 N--CA 1.489 1.261 0 C-N-CA 121.607 1.538 . . . . 0.0 111.703 177.722 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' F' F ' 9' ' ' LEU . . . . . . . . . . . . . 63.0 mt -79.32 -47.53 1.57 Allowed Pre-proline 0 CA--C 1.533 0.301 0 CA-C-O 118.61 -0.71 . . . . 0.0 112.1 -179.486 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' F' F ' 10' ' ' PRO . . . . . . . . . . . . . 90.1 Cg_endo -80.9 149.82 18.04 Favored 'Trans proline' 0 N--CA 1.496 1.63 0 C-N-CA 121.207 1.271 . . . . 0.0 111.87 176.502 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' F' F ' 11' ' ' LYS . . . . . . . . . . . . . 45.3 tttp -88.25 111.2 21.39 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-O 120.753 0.311 . . . . 0.0 110.371 178.99 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' F' F ' 12' ' ' VAL . . . . . . . . . . . . . 12.4 p -145.52 146.78 19.24 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.299 0 CA-C-O 120.898 0.38 . . . . 0.0 110.801 -178.645 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' F' F ' 13' ' ' GLU . . . . . . . . . . . . . 70.3 mm-40 -88.22 108.95 19.55 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.084 -0.507 . . . . 0.0 110.382 175.384 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' F' F ' 14' ' ' LEU . . . . . . . . . . . . . 38.9 mt -91.75 147.04 34.23 Favored Pre-proline 0 C--N 1.328 -0.361 0 CA-C-N 116.125 -0.489 . . . . 0.0 110.012 -179.439 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' F' F ' 15' ' ' PRO . . . . . . . . . . . . . 36.3 Cg_exo -58.37 157.42 26.51 Favored 'Trans proline' 0 N--CA 1.497 1.705 0 C-N-CA 121.237 1.291 . . . . 0.0 111.823 179.024 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' F' F ' 16' ' ' PRO . . . . . . . . . . . . . 36.9 Cg_exo -58.22 -36.79 97.45 Favored 'Trans proline' 0 N--CA 1.497 1.73 0 C-N-CA 121.384 1.389 . . . . 0.0 112.876 -178.505 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' F' F ' 17' ' ' ASP . . . . . . . . . . . . . 8.7 p-10 -83.51 12.19 5.98 Favored 'General case' 0 CA--C 1.536 0.412 0 N-CA-C 113.146 0.795 . . . . 0.0 113.146 -177.803 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' F' F ' 18' ' ' PHE . . . . . . . . . . . . . 45.6 t80 -56.78 -45.86 81.88 Favored 'General case' 0 N--CA 1.457 -0.096 0 O-C-N 122.007 -0.433 . . . . 0.0 110.424 -178.566 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' F' F ' 19' ' ' VAL . . . . . . . . . . . . . 15.0 p -54.85 -41.04 55.24 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.273 0 CA-C-N 116.549 -0.296 . . . . 0.0 111.175 -178.176 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' F' F ' 20' ' ' ASP . . . . . . . . . . . . . 73.7 m-20 -60.72 -45.25 94.99 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-O 120.814 0.34 . . . . 0.0 111.075 -178.429 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' F' F ' 21' ' ' VAL . . . . . . . . . . . . . 47.6 t -64.64 -46.97 90.83 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.328 0 C-N-CA 120.65 -0.42 . . . . 0.0 110.574 -177.273 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' F' F ' 22' ' ' ILE . . . . . . . . . . . . . 50.8 mm -56.46 -45.73 81.97 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.271 0 CA-C-O 120.875 0.369 . . . . 0.0 110.462 179.443 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' F' F ' 23' ' ' ARG . . . . . . . . . . . . . 32.3 ttp180 -53.64 -49.03 68.78 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.655 -0.248 . . . . 0.0 111.369 -179.076 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' F' F ' 24' ' ' ILE . . . . . . . . . . . . . 67.8 mt -59.27 -48.27 87.55 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.336 0 C-N-CA 121.039 -0.265 . . . . 0.0 111.193 -177.361 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' F' F ' 25' ' ' LYS . . . . . . . . . . . . . 98.8 mttt -64.35 -36.23 83.45 Favored 'General case' 0 C--N 1.329 -0.286 0 N-CA-C 112.538 0.57 . . . . 0.0 112.538 -177.029 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' F' F ' 26' ' ' LEU . . . . . . . . . . . . . 53.4 mt -77.47 -43.77 31.19 Favored 'General case' 0 C--N 1.33 -0.259 0 N-CA-C 112.869 0.692 . . . . 0.0 112.869 -173.169 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' F' F ' 27' ' ' GLN . . . . . . . . . . . . . 10.9 pt20 -47.4 137.91 8.1 Favored 'General case' 0 N--CA 1.468 0.439 0 N-CA-C 112.714 0.635 . . . . 0.0 112.714 -175.424 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' F' F ' 28' ' ' GLY . . . . . . . . . . . . . . . 101.02 -26.45 24.63 Favored Glycine 0 CA--C 1.533 1.165 0 CA-C-N 115.587 -0.733 . . . . 0.0 112.235 -176.998 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' F' F ' 29' ' ' LYS . . . . . . . . . . . . . 66.7 mmtt -98.14 155.1 17.31 Favored 'General case' 0 C--O 1.233 0.217 0 CA-C-N 117.311 0.556 . . . . 0.0 111.26 178.792 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' F' F ' 30' ' ' THR . . . . . . . . . . . . . 26.9 m -107.95 139.8 42.04 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 115.882 -0.599 . . . . 0.0 110.152 176.741 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' F' F ' 31' ' ' VAL . . . . . . . . . . . . . 34.7 m -129.5 157.67 42.19 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.267 0 CA-C-N 116.373 -0.376 . . . . 0.0 111.08 -178.121 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' F' F ' 32' ' ' ARG . . . . . . . . . . . . . 88.7 mtt180 -131.03 149.02 52.8 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 115.7 -0.682 . . . . 0.0 110.34 177.01 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' F' F ' 33' ' ' THR . . . . . . . . . . . . . 14.1 m -53.5 138.47 33.72 Favored 'General case' 0 C--N 1.332 -0.189 0 CA-C-N 116.489 -0.323 . . . . 0.0 111.271 -177.949 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' F' F ' 34' ' ' GLY . . . . . . . . . . . . . . . 100.72 -17.04 57.06 Favored Glycine 0 CA--C 1.532 1.139 0 CA-C-O 119.632 -0.538 . . . . 0.0 113.298 179.326 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' F' F ' 35' ' ' ASP . . . . . . . . . . . . . 54.1 m-20 -63.0 150.63 41.93 Favored 'General case' 0 C--O 1.233 0.206 0 CA-C-N 118.121 0.961 . . . . 0.0 111.316 -179.926 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' F' F ' 36' ' ' VAL . . . . . . . . . . . . . 45.3 t -123.33 129.48 74.79 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.232 0 CA-C-N 115.76 -0.655 . . . . 0.0 109.822 178.582 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' F' F ' 37' ' ' ILE . . . . . . . . . . . . . 67.5 mt -124.84 140.41 48.08 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.257 0 CA-C-N 116.304 -0.407 . . . . 0.0 110.183 -179.096 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' F' F ' 38' ' ' GLY . . . . . . . . . . . . . . . -118.65 128.71 7.81 Favored Glycine 0 CA--C 1.525 0.689 0 N-CA-C 111.181 -0.768 . . . . 0.0 111.181 179.322 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' F' F ' 39' ' ' ILE . . . . . . . . . . . . . 77.4 mt -127.36 141.25 46.83 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.276 0 N-CA-C 110.234 -0.284 . . . . 0.0 110.234 179.218 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' F' F ' 40' ' ' SER . . . . . . . . . . . . . 76.8 p -92.48 119.11 31.66 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.445 -0.343 . . . . 0.0 110.995 176.068 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' F' F ' 41' ' ' ILE . . . . . . . . . . . . . 43.8 mm -121.05 118.74 57.22 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.195 0 CA-C-N 116.463 -0.335 . . . . 0.0 110.141 178.125 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' F' F ' 42' ' ' LEU . . . . . . . . . . . . . 64.5 mt 52.05 34.42 13.97 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.308 -0.405 . . . . 0.0 111.907 177.194 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' F' F ' 43' ' ' GLY . . . . . . . . . . . . . . . 76.74 28.8 58.52 Favored Glycine 0 CA--C 1.53 1.028 0 C-N-CA 121.185 -0.531 . . . . 0.0 112.523 176.693 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' F' F ' 44' ' ' LYS . . . . . . . . . . . . . 7.8 ttpm? -140.52 131.28 25.79 Favored 'General case' 0 C--N 1.33 -0.242 0 N-CA-C 109.289 -0.634 . . . . 0.0 109.289 176.316 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' F' F ' 45' ' ' GLU . . . . . . . . . . . . . 81.3 tt0 -82.4 126.71 32.5 Favored 'General case' 0 C--N 1.328 -0.332 0 C-N-CA 120.865 -0.334 . . . . 0.0 111.263 -175.806 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' F' F ' 46' ' ' VAL . . . . . . . . . . . . . 10.4 p -118.2 124.96 73.88 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.2 0 N-CA-C 109.532 -0.544 . . . . 0.0 109.532 175.091 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' F' F ' 47' ' ' LYS . . . . . . . . . . . . . 62.0 mttp -99.14 125.53 44.71 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 115.866 -0.606 . . . . 0.0 110.942 178.105 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' F' F ' 48' ' ' PHE . . . . . . . . . . . . . 33.7 m-85 -110.26 131.91 54.64 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.037 -0.529 . . . . 0.0 109.921 177.384 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' F' F ' 49' ' ' LYS . . . . . . . . . . . . . 43.0 tttp -107.67 132.99 52.74 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 116.31 -0.404 . . . . 0.0 109.975 176.402 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' F' F ' 50' ' ' VAL . . . . . . . . . . . . . 44.0 t -76.81 107.82 8.71 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.312 0 N-CA-C 109.483 -0.562 . . . . 0.0 109.483 178.701 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' F' F ' 51' ' ' VAL . . . . . . . . . . . . . 44.7 t -72.43 -50.42 35.31 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.289 0 CA-C-N 116.022 -0.535 . . . . 0.0 109.825 -174.747 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' F' F ' 52' ' ' GLN . . . . . . . . . . . . . 62.8 tt0 -159.06 144.61 16.25 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 115.836 -0.62 . . . . 0.0 111.501 -176.908 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' F' F ' 53' ' ' ALA . . . . . . . . . . . . . . . -123.25 132.43 54.02 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 115.524 -0.762 . . . . 0.0 109.931 175.971 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' F' F ' 54' ' ' TYR . . . . . . . . . . . . . 67.7 t80 -129.13 112.81 18.43 Favored Pre-proline 0 CA--C 1.536 0.407 0 CA-C-O 118.154 -0.927 . . . . 0.0 110.261 177.351 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' F' F ' 55' ' ' PRO . . . . . . . . . . . . . 74.4 Cg_endo -77.05 166.97 81.17 Favored 'Cis proline' 0 N--CA 1.501 1.919 0 CA-C-N 122.09 1.782 . . . . 0.0 112.467 -5.4 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' F' F ' 56' ' ' SER . . . . . . . . . . . . . 13.7 m -114.05 124.99 29.96 Favored Pre-proline 0 CA--C 1.539 0.535 0 CA-C-O 118.369 -0.824 . . . . 0.0 109.381 176.506 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' F' F ' 57' ' ' PRO . . . . . . . . . . . . . 39.5 Cg_endo -67.16 166.24 64.07 Favored 'Cis proline' 0 N--CA 1.498 1.751 0 CA-C-N 122.065 1.773 . . . . 0.0 111.556 0.939 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' F' F ' 58' ' ' LEU . . . . . . . . . . . . . 24.0 tp -127.46 135.0 49.81 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.227 -0.442 . . . . 0.0 110.365 179.958 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' F' F ' 59' ' ' ARG . . . . . . . . . . . . . 57.4 ttp180 -106.63 123.1 47.61 Favored 'General case' 0 C--N 1.328 -0.358 0 N-CA-C 109.244 -0.65 . . . . 0.0 109.244 177.129 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' F' F ' 60' ' ' VAL . . . . . . . . . . . . . 44.5 t -78.12 122.22 32.57 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.347 0 C-N-CA 120.753 -0.379 . . . . 0.0 110.546 -174.049 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' F' F ' 61' ' ' GLU . . . . . . . . . . . . . 95.5 mt-10 -131.06 164.92 24.36 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-N 115.804 -0.635 . . . . 0.0 109.784 176.293 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' F' F ' 62' ' ' ASP . . . . . . . . . . . . . 80.5 m-20 -53.94 -32.66 54.4 Favored 'General case' 0 C--N 1.328 -0.342 0 C-N-CA 121.027 -0.269 . . . . 0.0 111.646 -179.663 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' F' F ' 63' ' ' ARG . . . . . . . . . . . . . 24.4 mmt180 -73.07 -21.39 60.79 Favored 'General case' 0 CA--C 1.533 0.32 0 N-CA-C 113.034 0.753 . . . . 0.0 113.034 -177.519 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' F' F ' 64' ' ' THR . . . . . . . . . . . . . 30.9 m -68.08 137.35 54.91 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-O 120.882 0.373 . . . . 0.0 111.009 -174.201 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' F' F ' 65' ' ' LYS . . . . . . . . . . . . . 97.9 mttt -90.36 132.17 35.73 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.038 -0.528 . . . . 0.0 109.992 178.525 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' F' F ' 66' ' ' ILE . . . . . . . . . . . . . 64.2 mt -119.51 131.39 72.25 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.264 0 CA-C-O 120.934 0.397 . . . . 0.0 110.071 -179.822 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' F' F ' 67' ' ' THR . . . . . . . . . . . . . 22.9 m -123.39 139.03 54.45 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 115.96 -0.563 . . . . 0.0 110.651 -179.412 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' F' F ' 68' ' ' LEU . . . . . . . . . . . . . 6.3 tt -107.68 121.13 44.08 Favored 'General case' 0 C--N 1.331 -0.225 0 CA-C-N 116.108 -0.496 . . . . 0.0 110.506 179.673 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' F' F ' 69' ' ' VAL . . . . . . . . . . . . . 46.8 t -102.77 116.99 47.47 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.345 0 N-CA-C 109.594 -0.521 . . . . 0.0 109.594 177.808 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' F' F ' 70' ' ' THR . . . . . . . . . . . . . 7.3 t -150.08 -33.86 0.18 Allowed 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.392 -0.367 . . . . 0.0 111.785 -178.831 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' F' F ' 71' ' ' HIS . . . . . . . . . . . . . 64.5 m-70 -111.69 91.44 14.76 Favored Pre-proline 0 CA--C 1.533 0.3 0 CA-C-O 119.462 -0.304 . . . . 0.0 111.152 -176.361 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' F' F ' 72' ' ' PRO . . . . . . . . . . . . . 30.5 Cg_endo -78.26 -23.04 9.21 Favored 'Trans proline' 0 N--CA 1.494 1.508 0 C-N-CA 121.24 1.293 . . . . 0.0 112.743 175.832 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' F' F ' 73' ' ' VAL . . . . . . . . . . . . . 35.6 m -122.83 178.24 3.32 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.219 0 N-CA-C 109.747 -0.464 . . . . 0.0 109.747 177.314 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' F' F ' 74' ' ' ASP . . . . . . . . . . . . . 12.0 t0 -96.43 117.19 30.37 Favored 'General case' 0 C--N 1.332 -0.192 0 C-N-CA 120.743 -0.383 . . . . 0.0 110.065 -176.284 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' F' F ' 75' ' ' VAL . . . . . . . . . . . . . 41.9 t -116.99 122.21 69.54 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.253 0 CA-C-O 120.985 0.421 . . . . 0.0 110.522 -178.043 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' F' F ' 76' ' ' LEU . . . . . . . . . . . . . 6.2 mp -119.85 144.96 47.08 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 115.675 -0.693 . . . . 0.0 109.782 176.51 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' F' F ' 77' ' ' GLU . . . . . . . . . . . . . 46.3 mt-10 -136.11 136.75 40.38 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-O 121.082 0.468 . . . . 0.0 111.351 -179.278 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' F' F ' 78' ' ' ALA . . . . . . . . . . . . . . . -123.97 132.27 53.68 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-N 115.68 -0.691 . . . . 0.0 109.7 175.873 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' F' F ' 79' ' ' LYS . . . . . . . . . . . . . 62.1 mttp -81.17 117.37 21.66 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-O 120.925 0.393 . . . . 0.0 110.669 -178.814 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' F' F ' 80' ' ' ILE . . . . . . . . . . . . . 40.3 mm -139.04 112.25 6.44 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.37 0 N-CA-C 109.13 -0.693 . . . . 0.0 109.13 -177.002 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' F' F ' 81' ' ' LYS . . . . . . . . . . . . . 79.0 tttt -102.08 127.49 48.96 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-O 120.852 0.358 . . . . 0.0 111.071 -177.668 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' F' F ' 82' ' ' GLY . . . . . . . . . . . . . . . 89.07 42.15 5.69 Favored Glycine 0 CA--C 1.525 0.691 0 C-N-CA 120.872 -0.68 . . . . 0.0 112.037 174.481 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' F' F ' 83' ' ' ILE . . . . . . . . . . . . . 68.7 mt -71.6 136.93 24.73 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.351 0 N-CA-C 109.281 -0.637 . . . . 0.0 109.281 175.684 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' F' F ' 84' ' ' LYS . . . . . . . . . . . . . 27.7 ttpp -94.94 -48.92 5.79 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-O 121.03 0.443 . . . . 0.0 110.047 -178.717 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' F' F ' 85' ' ' ASP . . . . . . . . . . . . . 10.0 t70 -154.57 153.38 31.32 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 115.756 -0.656 . . . . 0.0 110.562 -179.682 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' F' F ' 86' ' ' VAL . . . . . . . . . . . . . 41.9 t -128.98 133.47 66.01 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.202 0 CA-C-O 121.043 0.449 . . . . 0.0 110.243 179.201 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' F' F ' 87' ' ' ILE . . . . . . . . . . . . . 43.9 mm -117.77 123.69 72.04 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.263 0 CA-C-N 115.777 -0.647 . . . . 0.0 109.277 177.21 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' F' F ' 88' ' ' LEU . . . . . . . . . . . . . 14.7 tp -115.02 125.28 53.4 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-O 121.147 0.498 . . . . 0.0 111.44 -175.701 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' F' F ' 89' ' ' ASP . . . . . . . . . . . . . 13.2 t70 -118.4 154.78 31.86 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 115.525 -0.761 . . . . 0.0 109.147 174.185 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' F' F ' 90' ' ' GLU . . . . . . . . . . . . . 96.0 mt-10 -48.7 -39.92 26.35 Favored 'General case' 0 C--N 1.329 -0.302 0 N-CA-C 112.717 0.636 . . . . 0.0 112.717 -172.187 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' F' F ' 91' ' ' ASN . . . . . . . . . . . . . 21.8 p30 -132.15 38.09 3.52 Favored 'General case' 0 N--CA 1.464 0.259 0 CA-C-O 120.815 0.341 . . . . 0.0 111.477 -178.291 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' F' F ' 92' ' ' LEU . . . . . . . . . . . . . 18.4 tp -165.64 137.99 4.15 Favored 'General case' 0 C--N 1.329 -0.298 0 N-CA-C 110.25 -0.278 . . . . 0.0 110.25 -179.996 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' F' F ' 93' ' ' ILE . . . . . . . . . . . . . 71.5 mt -125.02 126.49 71.24 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.23 0 N-CA-C 109.91 -0.404 . . . . 0.0 109.91 -176.956 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' F' F ' 94' ' ' VAL . . . . . . . . . . . . . 44.0 t -125.05 128.47 73.04 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.207 0 N-CA-C 109.915 -0.402 . . . . 0.0 109.915 178.212 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' F' F ' 95' ' ' VAL . . . . . . . . . . . . . 44.0 t -120.14 133.4 67.0 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.302 0 CA-C-N 116.096 -0.502 . . . . 0.0 109.749 179.001 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' F' F ' 96' ' ' ILE . . . . . . . . . . . . . 64.3 mt -115.66 128.11 73.02 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.293 0 N-CA-C 109.462 -0.57 . . . . 0.0 109.462 179.545 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' F' F ' 97' ' ' THR . . . . . . . . . . . . . 72.7 p -103.74 157.76 16.85 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-O 121.331 0.586 . . . . 0.0 111.516 -176.392 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' F' F ' 98' ' ' GLU . . . . . . . . . . . . . 70.8 mm-40 -53.9 -26.02 23.04 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 115.994 -0.548 . . . . 0.0 112.397 179.709 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' F' F ' 99' ' ' GLU . . . . . . . . . . . . . 36.1 tt0 -79.99 16.99 1.05 Allowed 'General case' 0 CA--C 1.538 0.51 0 N-CA-C 112.588 0.588 . . . . 0.0 112.588 -176.441 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' F' F ' 100' ' ' ASN . . . . . . . . . . . . . 2.6 m-20 60.85 37.76 18.34 Favored 'General case' 0 C--O 1.232 0.165 0 O-C-N 121.761 -0.587 . . . . 0.0 110.95 178.454 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' F' F ' 101' ' ' GLU . . . . . . . . . . . . . 84.2 tt0 -116.37 144.38 44.34 Favored 'General case' 0 C--N 1.331 -0.225 0 CA-C-N 115.99 -0.55 . . . . 0.0 109.679 176.852 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' F' F ' 102' ' ' VAL . . . . . . . . . . . . . 44.6 t -117.63 126.37 74.68 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.357 0 CA-C-N 116.24 -0.436 . . . . 0.0 109.839 -178.257 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' F' F ' 103' ' ' LEU . . . . . . . . . . . . . 40.7 mt -116.39 129.22 56.13 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 115.717 -0.674 . . . . 0.0 110.121 176.692 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' F' F ' 104' ' ' ILE . . . . . . . . . . . . . 72.2 mt -116.62 122.08 69.09 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.257 0 N-CA-C 110.136 -0.32 . . . . 0.0 110.136 -179.596 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' F' F ' 105' ' ' PHE . . . . . . . . . . . . . 58.6 m-85 -121.21 166.38 14.07 Favored 'General case' 0 C--N 1.332 -0.162 0 O-C-N 124.087 0.867 . . . . 0.0 109.837 -178.968 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' F' F ' 106' ' ' ASN . . . . . . . . . . . . . 42.1 p-10 -102.79 -170.83 1.85 Allowed 'General case' 0 C--N 1.331 -0.231 0 N-CA-C 110.011 -0.366 . . . . 0.0 110.011 172.501 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' F' F ' 107' ' ' GLN . . . . . . . . . . . . . 45.4 tt0 -59.58 -30.16 68.46 Favored 'General case' 0 C--N 1.328 -0.358 0 N-CA-C 111.903 0.335 . . . . 0.0 111.903 179.106 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' F' F ' 108' ' ' ASN . . . . . . . . . . . . . 12.3 t-20 -81.84 6.19 16.45 Favored 'General case' 0 CA--C 1.537 0.467 0 N-CA-C 113.221 0.822 . . . . 0.0 113.221 -177.768 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' F' F ' 109' ' ' LEU . . . . . . . . . . . . . 9.7 tp 61.6 36.82 16.59 Favored 'General case' 0 CA--C 1.53 0.178 0 CA-C-O 120.905 0.383 . . . . 0.0 111.369 178.816 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' F' F ' 110' ' ' GLU . . . . . . . . . . . . . 43.0 mt-10 -106.36 158.44 16.88 Favored 'General case' 0 C--N 1.33 -0.264 0 N-CA-C 109.623 -0.51 . . . . 0.0 109.623 175.805 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' F' F ' 111' ' ' GLU . . . . . . . . . . . . . 44.1 mp0 -87.07 121.97 30.26 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-O 121.106 0.479 . . . . 0.0 111.212 -177.985 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' F' F ' 112' ' ' LEU . . . . . . . . . . . . . 42.9 mt -101.19 -45.95 5.2 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 115.611 -0.722 . . . . 0.0 110.095 175.768 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' F' F ' 113' ' ' TYR . . . . . . . . . . . . . 64.3 t80 -141.79 137.28 31.44 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.049 -0.523 . . . . 0.0 111.613 -178.054 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' F' F ' 114' ' ' ARG . . . . . . . . . . . . . 92.3 mtt180 -129.06 123.65 32.84 Favored 'General case' 0 C--N 1.331 -0.23 0 N-CA-C 109.3 -0.63 . . . . 0.0 109.3 175.245 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' F' F ' 115' ' ' GLY . . . . . . . . . . . . . . . -150.06 157.68 27.33 Favored Glycine 0 CA--C 1.525 0.661 0 C-N-CA 120.447 -0.882 . . . . 0.0 111.807 -179.835 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' F' F ' 116' ' ' LYS . . . . . . . . . . . . . 39.7 ttpt -128.72 140.7 51.61 Favored 'General case' 0 C--N 1.33 -0.263 0 N-CA-C 109.848 -0.427 . . . . 0.0 109.848 176.695 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' F' F ' 117' ' ' PHE . . . . . . . . . . . . . 47.2 m-85 -139.56 114.28 9.33 Favored 'General case' 0 C--N 1.329 -0.283 0 C-N-CA 120.836 -0.346 . . . . 0.0 110.334 -178.257 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' F' F ' 118' ' ' GLU . . . . . . . . . . . . . 84.4 tt0 -53.58 -45.87 70.13 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.523 -0.308 . . . . 0.0 111.405 -176.489 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' F' F ' 119' ' ' ASN . . . . . . . . . . . . . 85.4 m-20 -97.51 31.03 2.66 Favored 'General case' 0 C--N 1.331 -0.22 0 N-CA-C 112.182 0.438 . . . . 0.0 112.182 -174.86 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' F' F ' 120' ' ' LEU . . . . . . . . . . . . . 22.8 tp -57.51 120.44 8.28 Favored 'General case' 0 C--N 1.332 -0.174 0 CA-C-O 120.638 0.256 . . . . 0.0 110.326 178.146 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' F' F ' 121' ' ' ASN . . . . . . . . . . . . . 35.1 m120 -114.13 -44.13 3.17 Favored 'General case' 0 C--N 1.332 -0.188 0 CA-C-N 116.62 -0.263 . . . . 0.0 111.159 -177.521 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' F' F ' 122' ' ' LYS . . . . . . . . . . . . . 92.8 mttt -144.43 150.16 37.23 Favored 'General case' 0 C--N 1.332 -0.189 0 C-N-CA 120.598 -0.441 . . . . 0.0 111.646 -177.448 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' F' F ' 123' ' ' VAL . . . . . . . . . . . . . 42.5 t -132.91 129.32 57.76 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.267 0 N-CA-C 109.526 -0.546 . . . . 0.0 109.526 174.044 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' F' F ' 124' ' ' LEU . . . . . . . . . . . . . 80.4 mt -127.92 144.28 51.1 Favored 'General case' 0 C--N 1.331 -0.209 0 CA-C-O 120.754 0.311 . . . . 0.0 111.23 -176.87 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' F' F ' 125' ' ' VAL . . . . . . . . . . . . . 34.6 m -132.49 143.95 38.3 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.182 0 CA-C-N 116.173 -0.467 . . . . 0.0 111.18 -179.584 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' F' F ' 126' ' ' ARG . . . . . . . . . . . . . 76.7 mtp85 -145.58 116.49 7.78 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 116.006 -0.543 . . . . 0.0 110.408 176.406 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' F' F ' 127' ' ' ASN . . . . . . . . . . . . . 88.2 m-20 51.52 -104.84 0.19 Allowed 'General case' 0 CA--C 1.544 0.729 0 CA-C-O 119.087 -0.483 . . . . 0.0 111.283 179.824 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' F' F ' 128' ' ' ASP . . . . . . . . . . . . . 11.7 p-10 -114.03 0.19 14.25 Favored 'General case' 0 N--CA 1.468 0.463 0 CA-C-N 119.619 1.1 . . . . 0.0 113.318 -178.079 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' F' F ' 129' ' ' LEU . . . . . . . . . . . . . 17.2 tp -104.93 140.32 38.34 Favored 'General case' 0 C--N 1.332 -0.187 0 N-CA-C 109.565 -0.531 . . . . 0.0 109.565 178.463 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' F' F ' 130' ' ' VAL . . . . . . . . . . . . . 13.1 p -133.71 143.37 38.91 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.236 0 CA-C-O 121.257 0.551 . . . . 0.0 110.663 -179.357 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' F' F ' 131' ' ' VAL . . . . . . . . . . . . . 43.4 t -134.67 138.86 48.76 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.259 0 CA-C-N 115.766 -0.652 . . . . 0.0 110.162 -179.372 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' F' F ' 132' ' ' ILE . . . . . . . . . . . . . 69.5 mt -115.26 133.02 62.83 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.345 0 CA-C-N 115.625 -0.716 . . . . 0.0 109.078 179.003 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' F' F ' 133' ' ' ILE . . . . . . . . . . . . . 41.5 mm -117.13 123.55 71.95 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.211 0 CA-C-O 120.727 0.299 . . . . 0.0 110.949 -174.664 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' F' F ' 134' ' ' ASP . . . . . . . . . . . . . 8.1 p-10 -136.68 147.24 46.71 Favored 'General case' 0 C--N 1.331 -0.202 0 N-CA-C 109.654 -0.498 . . . . 0.0 109.654 174.13 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' F' F ' 135' ' ' GLU . . . . . . . . . . . . . 38.6 tp10 -49.89 -26.42 4.08 Favored 'General case' 0 C--N 1.328 -0.334 0 N-CA-C 112.709 0.633 . . . . 0.0 112.709 -172.348 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' F' F ' 136' ' ' GLN . . . . . . . . . . . . . 65.5 tp60 -81.9 -39.07 24.36 Favored 'General case' 0 C--O 1.233 0.21 0 N-CA-C 112.077 0.399 . . . . 0.0 112.077 -176.764 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' F' F ' 137' ' ' LYS . . . . . . . . . . . . . 50.4 pttt -161.48 172.24 16.78 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-O 121.484 0.659 . . . . 0.0 112.2 -171.303 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' F' F ' 138' ' ' LEU . . . . . . . . . . . . . 7.2 tt -119.58 129.82 54.83 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 115.111 -0.949 . . . . 0.0 109.664 178.584 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' F' F ' 139' ' ' THR . . . . . . . . . . . . . 21.6 m -109.34 126.64 53.6 Favored 'General case' 0 C--N 1.331 -0.21 0 CA-C-N 116.24 -0.436 . . . . 0.0 110.4 -179.677 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' F' F ' 140' ' ' LEU . . . . . . . . . . . . . 25.6 tp -112.09 120.06 40.56 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 115.73 -0.668 . . . . 0.0 109.417 -178.665 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' F' F ' 141' ' ' ILE . . . . . . . . . . . . . 19.5 mt -120.91 122.95 69.11 Favored 'Isoleucine or valine' 0 C--O 1.235 0.307 0 CA-C-O 121.022 0.439 . . . . 0.0 110.108 -175.591 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' F' F ' 142' ' ' ARG . . . . . . . . . . . . . 76.9 mtt180 -113.24 131.96 55.7 Favored 'General case' 0 C--O 1.233 0.206 0 CA-C-N 115.302 -0.863 . . . . 0.0 109.961 -175.969 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' F' F ' 143' ' ' THR . . . . . . . . . . . . . 52.0 p . . . . . 0 C--O 1.221 -0.418 0 CA-C-O 118.024 -0.989 . . . . 0.0 110.408 178.275 . . . . . . . . 0 0 . 1 . 001 nuclear build core ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 1.9 p . . . . . 0 C--O 1.231 0.125 0 CA-C-O 120.942 0.401 . . . . 18.2 110.564 . . . . . . . . . 0 0 . 1 . 001 nuclear build core ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 84.7 tt0 -143.85 141.64 30.43 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 116.023 -0.535 . . . . 15.68 111.114 -179.308 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 4' ' ' LEU . . . . . . . . . . . . . 19.0 tp -122.62 127.84 49.89 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-N 116.019 -0.537 . . . . 13.41 110.087 177.485 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 5' ' ' LYS . . . . . . . . . . . . . 72.6 mttt -109.81 121.44 45.23 Favored 'General case' 0 C--O 1.234 0.246 0 CA-C-O 120.916 0.389 . . . . 11.98 110.709 178.94 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 31.1 mt -114.33 149.18 36.41 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 115.205 -0.907 . . . . 10.99 110.371 -178.719 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 19.5 ttmm -133.85 139.41 33.35 Favored Pre-proline 0 CA--C 1.536 0.418 0 CA-C-O 119.095 -0.479 . . . . 9.31 109.799 175.17 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 8' ' ' PRO . . . . . . . . . . . . . 90.3 Cg_endo -91.82 134.47 1.49 Allowed 'Trans proline' 0 N--CA 1.49 1.293 0 C-N-CA 121.718 1.612 . . . . 9.35 111.649 177.427 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 59.0 mt -71.78 -46.54 12.3 Favored Pre-proline 0 C--N 1.329 -0.295 0 CA-C-O 118.723 -0.656 . . . . 13.42 111.838 -179.703 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 92.4 Cg_endo -80.47 146.85 17.5 Favored 'Trans proline' 0 N--CA 1.494 1.556 0 C-N-CA 121.077 1.185 . . . . 13.21 111.582 173.071 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 93.4 mttt -87.09 92.21 8.97 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-O 120.872 0.367 . . . . 12.71 110.561 -179.942 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 12.4 p -138.63 143.74 31.6 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.292 0 CA-C-N 116.111 -0.495 . . . . 13.83 110.414 179.672 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 94.8 mt-10 -82.24 131.35 35.23 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.298 -0.41 . . . . 13.84 110.126 178.055 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 14' ' ' LEU . . . . . . . . . . . . . 30.8 mt -93.92 150.32 38.38 Favored Pre-proline 0 C--N 1.328 -0.328 0 CA-C-N 116.358 -0.383 . . . . 13.0 110.164 -179.483 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 15' ' ' PRO . . . . . . . . . . . . . 39.2 Cg_exo -57.9 159.92 16.59 Favored 'Trans proline' 0 N--CA 1.497 1.684 0 C-N-CA 121.213 1.275 . . . . 15.42 111.624 179.515 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 16' ' ' PRO . . . . . . . . . . . . . 39.7 Cg_exo -58.54 -39.78 80.12 Favored 'Trans proline' 0 N--CA 1.497 1.698 0 C-N-CA 121.479 1.453 . . . . 16.07 112.866 -177.39 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 17' ' ' ASP . . . . . . . . . . . . . 19.5 p-10 -88.4 9.11 24.61 Favored 'General case' 0 C--N 1.326 -0.415 0 N-CA-C 113.22 0.822 . . . . 16.69 113.22 -178.168 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 18' ' ' PHE . . . . . . . . . . . . . 50.3 t80 -58.27 -48.05 81.68 Favored 'General case' 0 N--CA 1.457 -0.103 0 O-C-N 121.91 -0.494 . . . . 13.52 110.19 -176.316 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 19' ' ' VAL . . . . . . . . . . . . . 46.4 t -54.8 -47.95 73.93 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.345 0 CA-C-N 116.446 -0.343 . . . . 12.65 111.167 -175.077 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 2.6 p30 -62.71 -38.24 89.65 Favored 'General case' 0 C--N 1.332 -0.175 0 C-N-CA 120.572 -0.451 . . . . 15.76 111.336 -176.245 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 54.7 t -64.34 -46.79 92.09 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.181 0 C-N-CA 120.582 -0.447 . . . . 15.45 110.213 -179.775 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 22' ' ' ILE . . . . . 0.615 HG22 HD12 ' A' ' 26' ' ' LEU . 51.6 mm -56.71 -45.26 82.72 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.248 0 C-N-CA 121.036 -0.266 . . . . 13.87 110.454 178.96 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 23' ' ' ARG . . . . . . . . . . . . . 59.5 ttp180 -53.98 -48.43 70.36 Favored 'General case' 0 C--N 1.329 -0.295 0 C-N-CA 121.179 -0.208 . . . . 16.33 111.32 -179.273 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 24' ' ' ILE . . . . . . . . . . . . . 76.1 mt -58.97 -46.58 91.47 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.339 0 C-N-CA 120.877 -0.329 . . . . 17.1 110.86 -177.965 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 99.6 mttt -64.25 -38.08 89.77 Favored 'General case' 0 C--N 1.329 -0.324 0 N-CA-C 112.546 0.572 . . . . 16.69 112.546 -177.948 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 26' ' ' LEU . . . . . 0.615 HD12 HG22 ' A' ' 22' ' ' ILE . 49.7 mt -77.89 -41.6 36.09 Favored 'General case' 0 C--N 1.33 -0.247 0 N-CA-C 113.093 0.775 . . . . 16.62 113.093 -172.015 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 27' ' ' GLN . . . . . . . . . . . . . 14.3 pt20 -47.69 139.35 7.33 Favored 'General case' 0 N--CA 1.468 0.462 0 N-CA-C 112.77 0.656 . . . . 18.08 112.77 -174.426 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 100.29 -24.11 33.35 Favored Glycine 0 CA--C 1.535 1.287 0 CA-C-N 115.532 -0.758 . . . . 19.92 112.259 -175.698 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 98.0 mttt -97.78 155.19 17.14 Favored 'General case' 0 C--O 1.233 0.228 0 CA-C-N 117.369 0.585 . . . . 19.41 110.993 178.568 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 30' ' ' THR . . . . . . . . . . . . . 29.5 m -104.01 139.2 39.46 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 115.907 -0.588 . . . . 20.61 110.034 176.141 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 34.8 m -126.34 150.58 32.06 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.221 0 CA-C-N 116.408 -0.36 . . . . 17.93 110.719 -178.997 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 32' ' ' ARG . . . . . . . . . . . . . 32.4 ttm105 -134.94 147.33 49.75 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-O 121.16 0.505 . . . . 23.02 110.31 177.519 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 33' ' ' THR . . . . . . . . . . . . . 15.9 m -52.18 137.93 27.07 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.214 -0.448 . . . . 17.9 111.534 -177.355 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 100.71 -17.0 57.13 Favored Glycine 0 CA--C 1.532 1.147 0 CA-C-O 119.663 -0.52 . . . . 17.01 113.301 178.819 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 78.6 m-20 -65.8 147.8 52.8 Favored 'General case' 0 N--CA 1.462 0.146 0 CA-C-N 118.022 0.911 . . . . 18.86 111.125 179.135 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 44.8 t -123.25 129.76 74.7 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.173 0 CA-C-N 115.927 -0.579 . . . . 17.24 109.852 177.888 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 37' ' ' ILE . . . . . . . . . . . . . 65.0 mt -122.57 139.02 50.74 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.279 0 CA-C-N 116.345 -0.389 . . . . 15.76 109.961 -179.749 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . -112.9 128.79 8.59 Favored Glycine 0 CA--C 1.527 0.787 0 N-CA-C 111.013 -0.835 . . . . 17.43 111.013 179.281 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 39' ' ' ILE . . . . . . . . . . . . . 76.7 mt -123.9 136.25 60.89 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.22 0 N-CA-C 109.994 -0.373 . . . . 17.07 109.994 179.046 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 40' ' ' SER . . . . . . . . . . . . . 34.5 t -91.91 118.16 30.48 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-O 120.696 0.284 . . . . 20.45 111.09 178.181 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 41' ' ' ILE . . . . . . . . . . . . . 45.2 mm -120.93 116.71 50.67 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.237 0 CA-C-N 116.283 -0.417 . . . . 18.94 110.23 178.881 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 7.5 mp 50.92 35.62 12.95 Favored 'General case' 0 N--CA 1.464 0.228 0 CA-C-N 116.345 -0.389 . . . . 21.68 111.751 177.708 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . 76.05 31.13 56.2 Favored Glycine 0 CA--C 1.529 0.946 0 C-N-CA 121.082 -0.58 . . . . 22.22 112.274 177.57 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 44' ' ' LYS . . . . . . . . . . . . . 59.6 tttp -136.64 129.11 30.22 Favored 'General case' 0 C--N 1.33 -0.262 0 N-CA-C 109.484 -0.561 . . . . 20.38 109.484 176.862 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 82.1 tt0 -81.73 115.08 20.8 Favored 'General case' 0 C--N 1.329 -0.324 0 C-N-CA 120.75 -0.38 . . . . 20.21 110.663 -178.22 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 46' ' ' VAL . . . . . . . . . . . . . 6.8 p -110.86 125.17 68.16 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.24 0 N-CA-C 109.061 -0.718 . . . . 16.13 109.061 175.967 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 9.5 mtmp? -99.9 125.61 45.91 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 115.702 -0.681 . . . . 18.68 111.282 -178.568 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 48' ' ' PHE . . . . . . . . . . . . . 96.0 m-85 -111.26 131.9 54.78 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-N 116.188 -0.46 . . . . 13.1 109.899 177.268 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 49.1 tttm -108.31 139.07 43.55 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.357 -0.383 . . . . 14.45 110.513 178.941 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 50' ' ' VAL . . . . . . . . . . . . . 44.2 t -82.46 111.47 18.9 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.298 0 N-CA-C 109.505 -0.554 . . . . 13.58 109.505 176.683 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 51' ' ' VAL . . . . . . . . . . . . . 45.9 t -77.74 -46.54 26.98 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.321 0 CA-C-N 116.129 -0.487 . . . . 13.24 110.27 -174.014 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 52' ' ' GLN . . . . . . . . . . . . . 59.9 tt0 -157.82 135.35 10.43 Favored 'General case' 0 C--N 1.33 -0.276 0 C-N-CA 120.413 -0.515 . . . . 15.29 111.526 -177.0 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -113.2 118.78 35.63 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 115.401 -0.818 . . . . 16.95 109.596 173.497 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 54' ' ' TYR . . . . . . . . . . . . . 16.9 t80 -116.91 107.14 46.53 Favored Pre-proline 0 CA--C 1.534 0.351 0 CA-C-O 118.246 -0.883 . . . . 21.06 110.613 -177.757 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 55' ' ' PRO . . . . . . . . . . . . . 73.0 Cg_endo -76.98 169.98 72.96 Favored 'Cis proline' 0 N--CA 1.499 1.828 0 CA-C-N 121.758 1.664 . . . . 20.7 112.605 -3.775 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 56' ' ' SER . . . . . . . . . . . . . 13.6 m -105.2 117.73 57.7 Favored Pre-proline 0 CA--C 1.538 0.513 0 CA-C-O 118.41 -0.805 . . . . 21.83 109.546 176.92 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 57' ' ' PRO . . . . . . . . . . . . . 72.1 Cg_endo -77.84 171.05 68.85 Favored 'Cis proline' 0 N--CA 1.495 1.604 0 CA-C-N 121.968 1.738 . . . . 22.39 112.422 2.164 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 58' ' ' LEU . . . . . . . . . . . . . 25.6 tp -128.18 138.14 52.35 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 115.789 -0.641 . . . . 18.81 110.348 -178.735 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 59' ' ' ARG . . . . . . . . . . . . . 59.9 ttt85 -101.12 129.74 47.06 Favored 'General case' 0 C--N 1.326 -0.419 0 CA-C-N 115.949 -0.569 . . . . 22.37 109.549 176.441 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 42.1 t -88.79 116.7 30.86 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.229 0 C-N-CA 120.572 -0.451 . . . . 17.4 110.496 -176.631 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 94.8 mt-10 -131.14 168.76 16.9 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 115.967 -0.56 . . . . 20.44 109.581 174.953 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 62' ' ' ASP . . . . . . . . . . . . . 2.1 m-20 -53.91 -34.34 59.25 Favored 'General case' 0 C--N 1.329 -0.312 0 C-N-CA 121.046 -0.262 . . . . 18.68 111.693 -177.783 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 63' ' ' ARG . . . . . . . . . . . . . 28.2 mmm180 -73.87 -17.65 61.02 Favored 'General case' 0 CA--C 1.533 0.313 0 N-CA-C 113.234 0.827 . . . . 22.37 113.234 -176.169 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 18.0 m -69.94 141.72 53.02 Favored 'General case' 0 C--N 1.332 -0.191 0 CA-C-O 120.838 0.351 . . . . 16.58 111.014 -174.887 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 65' ' ' LYS . . . . . . . . . . . . . 93.8 mttt -88.5 132.66 34.41 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.098 -0.501 . . . . 17.07 109.988 178.732 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 66' ' ' ILE . . . . . . . . . . . . . 53.7 mt -117.56 131.91 68.9 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.233 0 N-CA-C 110.012 -0.366 . . . . 12.48 110.012 179.921 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 67' ' ' THR . . . . . . . . . . . . . 18.8 m -130.96 135.86 48.03 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-O 121.011 0.434 . . . . 10.9 110.788 178.796 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 68' ' ' LEU . . . . . 0.497 ' N ' HD12 ' A' ' 68' ' ' LEU . 6.7 mp . . . . . 0 C--N 1.329 -0.314 0 CA-C-N 116.124 -0.489 . . . . 8.22 110.43 176.685 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 74' ' ' ASP . . . . . . . . . . . . . 29.6 t70 . . . . . 0 C--O 1.231 0.115 0 N-CA-C 110.217 -0.29 . . . . 0.96 110.217 . . . . . . . . . 0 0 . 1 . 001 nuclear build core ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 44.7 t -112.72 122.7 67.39 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.228 0 CA-C-O 121.148 0.499 . . . . 0.71 110.243 -179.551 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 76' ' ' LEU . . . . . . . . . . . . . 36.0 mt -124.12 139.24 54.13 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 115.56 -0.745 . . . . 1.13 109.403 177.802 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 77' ' ' GLU . . . . . . . . . . . . . 96.8 mt-10 -129.99 142.24 50.66 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-O 121.136 0.493 . . . . 1.42 111.142 -177.224 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 78' ' ' ALA . . . . . . . . . . . . . . . -131.64 136.56 47.83 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 115.479 -0.782 . . . . 0.57 109.937 177.334 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 79' ' ' LYS . . . . . 0.58 ' O ' HD13 ' A' ' 80' ' ' ILE . 38.0 tttp -81.23 119.57 23.79 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-O 120.91 0.386 . . . . 2.96 110.939 -176.537 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 80' ' ' ILE . . . . . 0.58 HD13 ' O ' ' A' ' 79' ' ' LYS . 42.0 mm -139.13 108.45 3.8 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.324 0 N-CA-C 109.089 -0.708 . . . . 0.56 109.089 -178.347 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 81' ' ' LYS . . . . . . . . . . . . . 37.9 tttp -102.78 125.44 49.52 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-O 120.95 0.405 . . . . 2.85 111.114 -176.818 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . 89.01 42.13 5.71 Favored Glycine 0 CA--C 1.526 0.757 0 C-N-CA 121.057 -0.592 . . . . 0.57 111.93 174.993 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 83' ' ' ILE . . . . . . . . . . . . . 72.2 mt -68.14 136.35 26.68 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 N-CA-C 109.641 -0.503 . . . . 0.55 109.641 177.01 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 84' ' ' LYS . . . . . . . . . . . . . 40.2 ttpt -104.93 -46.94 4.15 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.35 -0.387 . . . . 1.44 110.306 -178.432 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 85' ' ' ASP . . . . . . . . . . . . . 20.7 t70 -149.49 148.48 29.46 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.068 -0.514 . . . . 0.79 110.455 179.319 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 86' ' ' VAL . . . . . . . . . . . . . 43.2 t -130.89 133.31 63.24 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.227 0 CA-C-O 120.955 0.407 . . . . 0.54 110.375 -179.887 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 87' ' ' ILE . . . . . . . . . . . . . 45.1 mm -120.55 127.74 75.95 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.231 0 CA-C-N 115.821 -0.627 . . . . 1.41 109.781 178.537 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 88' ' ' LEU . . . . . . . . . . . . . 54.5 mt -107.82 135.49 49.14 Favored 'General case' 0 C--N 1.331 -0.221 0 CA-C-N 116.276 -0.42 . . . . 1.56 110.974 -179.659 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 89' ' ' ASP . . . . . . . . . . . . . 12.2 t70 -130.78 155.48 46.6 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.005 -0.543 . . . . 0.97 109.655 176.988 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 96.8 mt-10 -48.69 -36.35 15.95 Favored 'General case' 0 C--N 1.329 -0.3 0 N-CA-C 112.818 0.673 . . . . 2.49 112.818 -171.478 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 91' ' ' ASN . . . . . . . . . . . . . 12.6 t-20 -131.99 22.2 4.54 Favored 'General case' 0 N--CA 1.468 0.452 0 N-CA-C 112.781 0.659 . . . . 2.35 112.781 -177.572 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 92' ' ' LEU . . . . . . . . . . . . . 23.1 mt -150.06 147.1 27.4 Favored 'General case' 0 C--N 1.332 -0.153 0 CA-C-O 120.799 0.333 . . . . 1.35 110.395 -177.348 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 93' ' ' ILE . . . . . . . . . . . . . 70.6 mt -124.24 117.94 52.24 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.272 0 N-CA-C 109.104 -0.702 . . . . 0.52 109.104 175.964 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 94' ' ' VAL . . . . . . . . . . . . . 46.4 t -118.96 127.08 75.82 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.268 0 CA-C-O 120.91 0.386 . . . . 0.46 110.028 -178.427 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 95' ' ' VAL . . . . . . . . . . . . . 43.7 t -120.88 132.7 69.72 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.308 0 CA-C-N 115.945 -0.571 . . . . 0.42 109.733 179.912 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 96' ' ' ILE . . . . . . . . . . . . . 67.5 mt -114.21 126.94 71.83 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.24 0 N-CA-C 109.215 -0.661 . . . . 0.51 109.215 178.859 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 97' ' ' THR . . . . . . . . . . . . . 69.6 p -102.6 155.64 18.15 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-O 121.241 0.543 . . . . 0.53 111.228 -176.41 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 98' ' ' GLU . . . . . . . . . . . . . 48.6 mt-10 -54.27 -23.54 15.32 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.017 -0.538 . . . . 2.42 112.275 178.279 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 99' ' ' GLU . . . . . . . . . . . . . 95.0 mt-10 -76.82 13.28 1.07 Allowed 'General case' 0 CA--C 1.536 0.406 0 N-CA-C 113.24 0.829 . . . . 2.34 113.24 -178.278 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 100' ' ' ASN . . . . . . . . . . . . . 1.7 m120 64.35 36.28 9.2 Favored 'General case' 0 CA--C 1.53 0.19 0 CA-C-O 120.944 0.402 . . . . 0.6 110.922 177.545 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 101' ' ' GLU . . . . . . . . . . . . . 84.3 tt0 -122.43 143.93 49.37 Favored 'General case' 0 C--N 1.333 -0.139 0 CA-C-N 116.239 -0.437 . . . . 0.54 109.916 178.586 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 102' ' ' VAL . . . . . . . . . . . . . 45.4 t -115.09 126.79 72.77 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.231 0 N-CA-C 109.811 -0.441 . . . . 0.41 109.811 -179.713 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 103' ' ' LEU . . . . . . . . . . . . . 27.6 mt -114.69 130.11 56.77 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 115.723 -0.671 . . . . 0.77 110.051 177.308 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 104' ' ' ILE . . . . . . . . . . . . . 72.4 mt -116.63 121.44 67.67 Favored 'Isoleucine or valine' 0 C--O 1.234 0.279 0 CA-C-N 116.552 -0.295 . . . . 0.43 110.321 -179.193 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 105' ' ' PHE . . . . . . . . . . . . . 88.3 m-85 -120.9 161.26 21.86 Favored 'General case' 0 C--N 1.333 -0.134 0 O-C-N 123.953 0.783 . . . . 0.48 109.884 -179.856 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 106' ' ' ASN . . . . . . . . . . . . . 39.0 p30 -95.87 -173.19 2.77 Favored 'General case' 0 C--N 1.33 -0.276 0 N-CA-C 110.065 -0.346 . . . . 0.63 110.065 175.314 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 107' ' ' GLN . . . . . . . . . . . . . 61.1 tt0 -60.17 -30.06 69.09 Favored 'General case' 0 C--N 1.329 -0.29 0 N-CA-C 111.936 0.347 . . . . 1.47 111.936 -179.98 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 108' ' ' ASN . . . . . . . . . . . . . 50.7 t30 -82.33 8.66 10.71 Favored 'General case' 0 CA--C 1.537 0.446 0 N-CA-C 113.043 0.757 . . . . 1.35 113.043 -177.831 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 109' ' ' LEU . . . . . . . . . . . . . 13.0 tp 61.47 39.83 14.53 Favored 'General case' 0 C--O 1.233 0.193 0 CA-C-O 121.324 0.583 . . . . 1.14 110.975 179.229 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 110' ' ' GLU . . . . . . . . . . . . . 95.2 mt-10 -109.97 152.2 26.17 Favored 'General case' 0 C--N 1.33 -0.244 0 N-CA-C 109.532 -0.544 . . . . 1.92 109.532 175.535 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 111' ' ' GLU . . . . . . . . . . . . . 81.2 tt0 -88.02 122.3 31.45 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-O 120.828 0.347 . . . . 1.78 110.941 -175.555 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 112' ' ' LEU . . . . . . . . . . . . . 51.8 mt -106.09 -46.1 4.17 Favored 'General case' 0 C--N 1.332 -0.186 0 CA-C-N 116.14 -0.482 . . . . 0.56 111.139 179.539 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 113' ' ' TYR . . . . . . . . . . . . . 61.4 t80 -136.76 138.23 40.71 Favored 'General case' 0 C--N 1.331 -0.213 0 CA-C-O 120.912 0.386 . . . . 0.5 111.545 -176.148 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 114' ' ' ARG . . . . . . . . . . . . . 38.9 ttm180 -132.54 122.89 25.52 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 115.878 -0.601 . . . . 2.76 109.773 175.612 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 115' ' ' GLY . . . . . . . . . . . . . . . -150.1 138.62 6.84 Favored Glycine 0 CA--C 1.523 0.543 0 N-CA-C 111.07 -0.812 . . . . 0.43 111.07 178.779 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 116' ' ' LYS . . . . . . . . . . . . . 34.0 ttmt -114.95 140.22 49.19 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-O 120.818 0.342 . . . . 1.57 110.079 177.256 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 117' ' ' PHE . . . . . . . . . . . . . 32.4 m-85 -136.89 114.93 11.49 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.147 -0.479 . . . . 0.49 109.892 -176.724 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 118' ' ' GLU . . . . . . . . . . . . . 84.2 tt0 -51.39 -49.4 61.61 Favored 'General case' 0 C--N 1.328 -0.358 0 N-CA-C 111.869 0.322 . . . . 2.77 111.869 -176.221 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 119' ' ' ASN . . . . . . . . . . . . . 97.7 m-20 -98.07 31.29 2.77 Favored 'General case' 0 C--N 1.328 -0.335 0 N-CA-C 112.221 0.452 . . . . 1.35 112.221 -174.321 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 120' ' ' LEU . . . . . . . . . . . . . 21.8 tp -54.57 120.74 7.12 Favored 'General case' 0 N--CA 1.463 0.19 0 O-C-N 122.243 -0.286 . . . . 0.56 110.71 178.727 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 121' ' ' ASN . . . . . . . . . . . . . 85.9 m-20 -113.81 -44.0 3.22 Favored 'General case' 0 C--N 1.332 -0.181 0 CA-C-N 116.459 -0.337 . . . . 1.74 111.07 -176.465 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 122' ' ' LYS . . . . . . . . . . . . . 84.9 mttt -142.93 145.3 32.9 Favored 'General case' 0 C--N 1.331 -0.227 0 CA-C-O 121.148 0.499 . . . . 1.94 111.705 -178.129 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 123' ' ' VAL . . . . . . . . . . . . . 46.4 t -121.8 122.57 67.21 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.249 0 N-CA-C 108.978 -0.749 . . . . 0.55 108.978 173.363 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 124' ' ' LEU . . . . . 0.511 HD12 ' N ' ' A' ' 124' ' ' LEU . 6.8 mp -108.9 122.97 48.32 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 116.272 -0.422 . . . . 1.63 110.349 -177.301 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 125' ' ' VAL . . . . . . . . . . . . . 44.2 t -126.16 125.37 67.69 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.307 0 N-CA-C 109.608 -0.516 . . . . 1.58 109.608 178.825 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 126' ' ' ARG . . . . . . . . . . . . . 81.2 mtt-85 -143.94 123.84 13.5 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-O 121.045 0.45 . . . . 3.09 110.774 -179.535 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 127' ' ' ASN . . . . . . . . . . . . . 18.9 t-20 50.91 -105.23 0.19 Allowed 'General case' 0 CA--C 1.543 0.709 0 CA-C-O 118.965 -0.54 . . . . 2.33 111.398 179.764 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 128' ' ' ASP . . . . . . . . . . . . . 9.1 p-10 -114.16 -1.51 13.65 Favored 'General case' 0 CA--C 1.537 0.452 0 CA-C-N 119.697 1.135 . . . . 1.17 113.522 -177.425 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 129' ' ' LEU . . . . . . . . . . . . . 79.3 mt -105.58 144.24 32.62 Favored 'General case' 0 C--O 1.232 0.162 0 CA-C-N 118.207 0.458 . . . . 1.96 110.876 -177.398 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 130' ' ' VAL . . . . . . . . . . . . . 45.1 t -127.35 134.99 64.6 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.169 0 CA-C-O 121.075 0.464 . . . . 1.37 110.251 -179.354 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 131' ' ' VAL . . . . . 0.455 HG22 HD12 ' A' ' 140' ' ' LEU . 45.5 t -133.02 135.35 57.04 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.287 0 CA-C-N 116.088 -0.505 . . . . 1.07 109.906 177.517 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 132' ' ' ILE . . . . . . . . . . . . . 68.5 mt -113.46 131.17 65.97 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.304 0 N-CA-C 109.381 -0.6 . . . . 0.42 109.381 -179.976 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 133' ' ' ILE . . . . . . . . . . . . . 41.9 mm -118.55 120.77 65.26 Favored 'Isoleucine or valine' 0 C--O 1.233 0.22 0 CA-C-O 120.954 0.407 . . . . 0.5 111.111 -175.384 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 134' ' ' ASP . . . . . . . . . . . . . 3.6 p30 -135.59 146.73 48.26 Favored 'General case' 0 C--N 1.332 -0.196 0 N-CA-C 109.362 -0.607 . . . . 0.55 109.362 173.19 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 135' ' ' GLU . . . . . . . . . . . . . 85.9 tt0 -49.88 -23.76 2.1 Favored 'General case' 0 C--N 1.326 -0.454 0 N-CA-C 112.85 0.685 . . . . 2.04 112.85 -172.658 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 136' ' ' GLN . . . . . . . . . . . . . 52.0 mt-30 -87.57 -36.27 17.65 Favored 'General case' 0 C--O 1.234 0.251 0 N-CA-C 112.586 0.587 . . . . 2.11 112.586 -176.203 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 137' ' ' LYS . . . . . . . . . . . . . 40.7 pttt -157.44 167.45 30.18 Favored 'General case' 0 C--N 1.331 -0.197 0 CA-C-O 121.514 0.673 . . . . 1.56 112.277 -172.87 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 138' ' ' LEU . . . . . 0.415 HD23 ' N ' ' A' ' 139' ' ' THR . 6.1 tt -121.31 128.74 52.62 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 115.084 -0.962 . . . . 0.97 109.701 178.006 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 139' ' ' THR . . . . . 0.415 ' N ' HD23 ' A' ' 138' ' ' LEU . 28.6 m -111.78 129.9 55.98 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.41 -0.359 . . . . 0.44 110.46 -179.411 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 140' ' ' LEU . . . . . 0.455 HD12 HG22 ' A' ' 131' ' ' VAL . 21.6 tp -111.75 118.82 36.64 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 115.679 -0.691 . . . . 1.03 109.165 179.734 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 141' ' ' ILE . . . . . . . . . . . . . 19.5 mt -119.09 118.02 56.22 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.314 0 N-CA-C 109.569 -0.53 . . . . 0.5 109.569 -176.794 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 142' ' ' ARG . . . . . . . . . . . . . 49.5 ttp180 -110.84 124.81 52.78 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 115.354 -0.839 . . . . 2.87 110.174 -176.6 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 143' ' ' THR . . . . . . . . . . . . . 27.6 p . . . . . 0 C--O 1.219 -0.525 0 CA-C-O 117.977 -1.011 . . . . 1.48 110.6 -179.242 . . . . . . . . 0 0 . 1 . 001 nuclear build core ' B' B ' 2' ' ' SER . . . . . . . . . . . . . 2.0 p . . . . . 0 C--O 1.232 0.183 0 CA-C-O 121.125 0.488 . . . . 19.08 110.598 . . . . . . . . . 0 0 . 1 . 001 nuclear build core ' B' B ' 3' ' ' GLU . . . . . . . . . . . . . 93.2 mt-10 -140.71 141.86 34.9 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-N 115.781 -0.645 . . . . 16.48 110.956 -178.157 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 4' ' ' LEU . . . . . 0.503 HD21 HD21 ' B' ' 6' ' ' LEU . 12.7 tp -125.6 130.05 50.87 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 115.986 -0.552 . . . . 14.28 109.874 176.336 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' B' B ' 5' ' ' LYS . . . . . . . . . . . . . 94.8 mttt -106.73 119.77 40.22 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.37 -0.377 . . . . 12.15 110.285 179.839 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 6' ' ' LEU . . . . . 0.503 HD21 HD21 ' B' ' 4' ' ' LEU . 75.7 mt -117.13 148.68 41.34 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 115.477 -0.783 . . . . 11.97 110.257 -176.982 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' B' B ' 7' ' ' LYS . . . . . . . . . . . . . 34.1 ttmt -132.76 134.83 25.08 Favored Pre-proline 0 CA--C 1.535 0.385 0 CA-C-O 118.853 -0.594 . . . . 9.81 110.118 177.578 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 8' ' ' PRO . . . . . . . . . . . . . 74.3 Cg_endo -91.61 131.87 1.33 Allowed 'Trans proline' 0 N--CA 1.491 1.329 0 C-N-CA 121.668 1.578 . . . . 9.83 111.606 176.537 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 9' ' ' LEU . . . . . . . . . . . . . 72.8 mt -70.95 -52.12 10.1 Favored Pre-proline 0 CA--C 1.533 0.295 0 CA-C-O 118.591 -0.718 . . . . 13.18 112.106 -177.526 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 10' ' ' PRO . . . . . . . . . . . . . 38.4 Cg_endo -68.59 141.8 51.45 Favored 'Trans proline' 0 N--CA 1.498 1.78 0 CA-C-N 120.287 1.138 . . . . 13.3 111.613 175.072 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 11' ' ' LYS . . . . . . . . . . . . . 69.1 mttm -87.04 97.38 10.69 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.408 -0.36 . . . . 12.9 110.645 -179.921 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 12' ' ' VAL . . . . . . . . . . . . . 11.8 p -139.38 142.08 34.05 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.325 0 CA-C-N 116.021 -0.536 . . . . 14.63 110.385 -179.902 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 13' ' ' GLU . . . . . . . . . . . . . 47.7 mt-10 -73.48 120.44 19.08 Favored 'General case' 0 C--N 1.329 -0.317 0 N-CA-C 110.007 -0.368 . . . . 14.92 110.007 177.64 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 14' ' ' LEU . . . . . . . . . . . . . 26.3 mt -95.84 143.16 25.65 Favored Pre-proline 0 CA--C 1.533 0.303 0 CA-C-O 118.928 -0.558 . . . . 14.87 109.752 179.953 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 15' ' ' PRO . . . . . . . . . . . . . 29.6 Cg_exo -59.82 159.82 23.63 Favored 'Trans proline' 0 N--CA 1.497 1.682 0 C-N-CA 121.253 1.302 . . . . 17.71 111.545 178.764 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 16' ' ' PRO . . . . . . . . . . . . . 37.4 Cg_exo -58.88 -40.11 75.04 Favored 'Trans proline' 0 N--CA 1.498 1.791 0 C-N-CA 121.429 1.419 . . . . 18.26 112.799 -177.813 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 17' ' ' ASP . . . . . . . . . . . . . 3.1 p30 -87.5 10.88 16.26 Favored 'General case' 0 CA--C 1.536 0.409 0 N-CA-C 113.05 0.759 . . . . 19.81 113.05 -178.61 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 18' ' ' PHE . . . . . . . . . . . . . 50.2 t80 -58.62 -44.97 90.13 Favored 'General case' 0 CA--C 1.523 -0.095 0 O-C-N 121.902 -0.499 . . . . 16.3 109.883 -178.348 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 19' ' ' VAL . . . . . . . . . . . . . 13.7 p -56.0 -39.04 55.58 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.283 0 CA-C-N 116.121 -0.491 . . . . 15.53 110.827 179.838 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 20' ' ' ASP . . . . . . . . . . . . . 31.0 t0 -60.11 -44.91 94.51 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-O 120.767 0.318 . . . . 19.22 110.717 -179.032 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 21' ' ' VAL . . . . . . . . . . . . . 47.7 t -64.24 -45.82 95.14 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.293 0 C-N-CA 120.757 -0.377 . . . . 18.61 110.43 -177.813 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 22' ' ' ILE . . . . . 0.659 HG22 HD12 ' B' ' 26' ' ' LEU . 51.0 mm -55.82 -47.3 79.75 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.224 0 C-N-CA 121.002 -0.279 . . . . 16.42 110.651 179.525 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' B' B ' 23' ' ' ARG . . . . . . . . . . . . . 43.7 ttp180 -55.25 -48.11 74.46 Favored 'General case' 0 C--N 1.329 -0.291 0 C-N-CA 121.064 -0.254 . . . . 19.83 111.346 -178.354 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 24' ' ' ILE . . . . . . . . . . . . . 72.9 mt -59.26 -41.28 83.52 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.297 0 C-N-CA 121.076 -0.25 . . . . 20.56 110.96 -177.964 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 25' ' ' LYS . . . . . . . . . . . . . 8.3 mtpm? -69.45 -38.91 78.01 Favored 'General case' 0 C--N 1.328 -0.356 0 N-CA-C 112.274 0.472 . . . . 19.42 112.274 -178.122 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 26' ' ' LEU . . . . . 0.659 HD12 HG22 ' B' ' 22' ' ' ILE . 37.9 mt -79.35 -38.08 35.94 Favored 'General case' 0 C--N 1.329 -0.291 0 N-CA-C 113.587 0.958 . . . . 18.5 113.587 -171.457 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' B' B ' 27' ' ' GLN . . . . . . . . . . . . . 14.9 pt20 -46.77 141.08 4.13 Favored 'General case' 0 N--CA 1.47 0.554 0 N-CA-C 112.747 0.647 . . . . 21.33 112.747 -175.189 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 28' ' ' GLY . . . . . . . . . . . . . . . 100.26 -23.68 34.97 Favored Glycine 0 CA--C 1.533 1.17 0 CA-C-N 115.481 -0.781 . . . . 21.4 112.289 -176.152 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 29' ' ' LYS . . . . . . . . . . . . . 68.5 mttm -98.06 155.11 17.27 Favored 'General case' 0 C--O 1.233 0.194 0 CA-C-N 117.559 0.679 . . . . 20.58 111.212 178.986 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 30' ' ' THR . . . . . . . . . . . . . 30.7 m -104.93 139.46 39.62 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 115.953 -0.567 . . . . 21.06 109.936 176.303 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 31' ' ' VAL . . . . . . . . . . . . . 34.8 m -129.78 149.09 33.28 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.252 0 CA-C-O 120.954 0.407 . . . . 18.25 111.167 -177.957 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 32' ' ' ARG . . . . . . . . . . . . . 75.2 mtt85 -124.69 149.15 47.52 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 115.823 -0.626 . . . . 22.16 110.166 177.427 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 33' ' ' THR . . . . . . . . . . . . . 23.6 m -53.83 136.7 39.94 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.369 -0.378 . . . . 17.28 111.356 -179.053 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 34' ' ' GLY . . . . . . . . . . . . . . . 100.0 -17.11 57.65 Favored Glycine 0 CA--C 1.531 1.053 0 CA-C-O 119.585 -0.564 . . . . 16.47 113.386 177.457 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 35' ' ' ASP . . . . . . . . . . . . . 81.8 m-20 -66.0 146.93 54.11 Favored 'General case' 0 C--O 1.231 0.117 0 CA-C-N 118.111 0.956 . . . . 18.38 111.17 -179.366 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 36' ' ' VAL . . . . . . . . . . . . . 44.5 t -121.17 128.83 76.07 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.235 0 CA-C-N 115.999 -0.546 . . . . 17.19 109.698 176.982 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 37' ' ' ILE . . . . . . . . . . . . . 64.6 mt -120.57 138.81 49.84 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.305 0 CA-C-N 116.238 -0.437 . . . . 16.42 110.019 -178.138 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 38' ' ' GLY . . . . . . . . . . . . . . . -106.63 127.24 8.79 Favored Glycine 0 CA--C 1.524 0.615 0 N-CA-C 110.927 -0.869 . . . . 18.22 110.927 178.424 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 39' ' ' ILE . . . . . . . . . . . . . 76.8 mt -127.72 141.48 46.29 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.264 0 N-CA-C 110.048 -0.353 . . . . 18.12 110.048 179.583 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 40' ' ' SER . . . . . 0.427 ' O ' HD13 ' B' ' 41' ' ' ILE . 40.6 t -91.8 118.83 31.06 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-O 120.813 0.34 . . . . 21.59 110.96 177.189 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' B' B ' 41' ' ' ILE . . . . . 0.438 HG22 HD13 ' B' ' 42' ' ' LEU . 47.3 mm -124.7 120.0 57.65 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.213 0 CA-C-N 116.149 -0.478 . . . . 20.26 110.487 178.989 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' B' B ' 42' ' ' LEU . . . . . 0.438 HD13 HG22 ' B' ' 41' ' ' ILE . 7.8 mp 52.06 35.87 17.37 Favored 'General case' 0 C--N 1.331 -0.2 0 CA-C-N 116.301 -0.409 . . . . 22.74 111.638 177.848 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' B' B ' 43' ' ' GLY . . . . . . . . . . . . . . . 72.8 31.5 62.31 Favored Glycine 0 CA--C 1.529 0.956 0 C-N-CA 121.131 -0.557 . . . . 23.04 112.101 178.375 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 44' ' ' LYS . . . . . . . . . . . . . 85.1 tttt -137.71 131.46 31.39 Favored 'General case' 0 C--N 1.329 -0.311 0 N-CA-C 109.57 -0.53 . . . . 21.05 109.57 178.416 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 45' ' ' GLU . . . . . . . . . . . . . 81.7 tt0 -80.17 111.0 16.12 Favored 'General case' 0 C--N 1.328 -0.337 0 C-N-CA 120.657 -0.417 . . . . 20.06 110.238 -179.222 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 46' ' ' VAL . . . . . . . . . . . . . 7.0 p -109.86 128.2 66.16 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.188 0 N-CA-C 109.332 -0.618 . . . . 16.65 109.332 178.954 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 47' ' ' LYS . . . . . . . . . . . . . 44.0 mttm -98.54 124.28 43.2 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 115.781 -0.645 . . . . 18.21 110.666 178.409 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 48' ' ' PHE . . . . . . . . . . . . . 96.4 m-85 -108.99 131.79 54.73 Favored 'General case' 0 C--N 1.328 -0.351 0 N-CA-C 109.679 -0.489 . . . . 13.38 109.679 176.013 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 49' ' ' LYS . . . . . . . . . . . . . 42.6 tttp -109.18 137.97 46.26 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.484 -0.326 . . . . 14.08 110.593 178.246 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 50' ' ' VAL . . . . . 0.433 ' HA ' HD23 ' B' ' 6' ' ' LEU . 48.1 t -82.41 106.85 13.73 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.369 0 N-CA-C 109.156 -0.683 . . . . 13.85 109.156 175.527 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' B' B ' 51' ' ' VAL . . . . . . . . . . . . . 48.2 t -69.92 -52.35 31.85 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.354 0 N-CA-C 109.476 -0.564 . . . . 12.96 109.476 -176.113 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 52' ' ' GLN . . . . . . . . . . . . . 46.6 mt-30 -155.14 152.72 29.8 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 115.914 -0.584 . . . . 14.9 111.61 -179.401 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 53' ' ' ALA . . . . . . . . . . . . . . . -127.27 131.31 50.56 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 115.327 -0.851 . . . . 16.72 109.847 176.473 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 54' ' ' TYR . . . . . . . . . . . . . 9.8 t80 -129.1 107.5 17.93 Favored Pre-proline 0 CA--C 1.535 0.367 0 CA-C-O 118.337 -0.839 . . . . 20.83 110.496 -179.829 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 55' ' ' PRO . . . . . . . . . . . . . 73.2 Cg_endo -77.11 170.0 72.77 Favored 'Cis proline' 0 N--CA 1.5 1.882 0 CA-C-N 121.781 1.672 . . . . 20.51 112.397 -5.952 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 56' ' ' SER . . . . . . . . . . . . . 18.7 m -116.54 133.21 23.03 Favored Pre-proline 0 CA--C 1.538 0.494 0 CA-C-O 118.445 -0.788 . . . . 21.17 109.433 174.37 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 57' ' ' PRO . . . . . . . . . . . . . 55.4 Cg_endo -71.72 149.04 91.86 Favored 'Cis proline' 0 N--CA 1.497 1.728 0 CA-C-N 121.967 1.738 . . . . 21.75 111.566 -1.057 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 58' ' ' LEU . . . . . . . . . . . . . 26.7 tp -107.63 136.24 47.73 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.438 -0.347 . . . . 18.89 110.467 -178.873 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 59' ' ' ARG . . . . . . . . . . . . . 71.3 ttt-85 -106.64 119.23 38.74 Favored 'General case' 0 C--N 1.327 -0.371 0 N-CA-C 109.131 -0.692 . . . . 23.48 109.131 177.239 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 60' ' ' VAL . . . . . . . . . . . . . 44.7 t -78.05 122.27 32.6 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.286 0 C-N-CA 120.753 -0.379 . . . . 19.33 110.428 -173.96 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 61' ' ' GLU . . . . . . . . . . . . . 46.9 mt-10 -131.0 174.31 10.13 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.065 -0.516 . . . . 21.74 109.882 176.923 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 62' ' ' ASP . . . . . . . . . . . . . 10.9 t70 -54.29 -32.71 57.06 Favored 'General case' 0 C--N 1.327 -0.381 0 C-N-CA 121.037 -0.265 . . . . 21.65 111.668 -178.812 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 63' ' ' ARG . . . . . . . . . . . . . 39.9 ptt180 -89.49 5.14 46.75 Favored 'General case' 0 CA--C 1.537 0.452 0 N-CA-C 113.715 1.006 . . . . 24.12 113.715 -176.152 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 64' ' ' THR . . . . . . . . . . . . . 38.7 m -81.1 130.7 35.14 Favored 'General case' 0 C--N 1.331 -0.2 0 CA-C-N 118.134 0.425 . . . . 18.66 110.386 -179.717 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 65' ' ' LYS . . . . . . . . . . . . . 91.0 mttt -90.47 130.37 36.54 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.353 -0.385 . . . . 18.71 110.469 -179.715 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 66' ' ' ILE . . . . . . . . . . . . . 65.1 mt -116.48 132.35 66.37 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.232 0 CA-C-O 120.923 0.392 . . . . 14.83 110.006 179.456 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 67' ' ' THR . . . . . . . . . . . . . 30.4 m -120.4 139.37 52.91 Favored 'General case' 0 C--N 1.331 -0.22 0 CA-C-N 116.04 -0.527 . . . . 12.49 110.637 -178.938 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 68' ' ' LEU . . . . . . . . . . . . . 6.8 mp . . . . . 0 C--N 1.332 -0.193 0 CA-C-N 116.209 -0.45 . . . . 10.14 110.781 179.692 . . . . . . . . 0 0 . 1 . 001 nuclear build core ' B' B ' 73' ' ' VAL . . . . . . . . . . . . . 34.5 m . . . . . 0 C--O 1.231 0.08 0 CA-C-O 120.675 0.274 . . . . 1.07 110.53 . . . . . . . . . 0 0 . 1 . 001 nuclear build core ' B' B ' 74' ' ' ASP . . . . . . . . . . . . . 29.8 t0 -94.01 120.23 33.98 Favored 'General case' 0 C--N 1.331 -0.229 0 CA-C-N 116.446 -0.343 . . . . 0.93 110.159 -179.631 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 75' ' ' VAL . . . . . . . . . . . . . 43.4 t -118.76 121.77 67.75 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.212 0 CA-C-O 121.046 0.45 . . . . 0.66 110.688 -177.86 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 76' ' ' LEU . . . . . . . . . . . . . 6.0 mp -123.66 146.49 48.18 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-N 115.82 -0.627 . . . . 1.16 109.672 175.284 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 77' ' ' GLU . . . . . . . . . . . . . 98.1 mt-10 -135.54 139.74 44.18 Favored 'General case' 0 N--CA 1.462 0.161 0 CA-C-O 121.015 0.436 . . . . 1.33 111.582 -177.642 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 78' ' ' ALA . . . . . . . . . . . . . . . -127.73 137.79 52.56 Favored 'General case' 0 C--N 1.331 -0.223 0 CA-C-N 115.639 -0.71 . . . . 0.63 109.69 175.474 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 79' ' ' LYS . . . . . 0.605 ' O ' HD13 ' B' ' 80' ' ' ILE . 49.8 pttt -84.64 123.15 30.03 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-O 121.073 0.464 . . . . 3.1 110.937 -179.019 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' B' B ' 80' ' ' ILE . . . . . 0.605 HD13 ' O ' ' B' ' 79' ' ' LYS . 40.0 mm -139.16 117.54 12.51 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.28 0 N-CA-C 109.421 -0.585 . . . . 0.65 109.421 -177.659 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' B' B ' 81' ' ' LYS . . . . . . . . . . . . . 85.4 tttt -104.14 121.79 43.97 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-O 120.795 0.331 . . . . 2.96 111.122 -177.292 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 82' ' ' GLY . . . . . . . . . . . . . . . 89.11 42.2 5.67 Favored Glycine 0 CA--C 1.526 0.733 0 C-N-CA 120.648 -0.786 . . . . 0.68 112.069 173.618 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 83' ' ' ILE . . . . . . . . . . . . . 69.3 mt -67.43 137.92 23.78 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.282 0 N-CA-C 109.669 -0.493 . . . . 0.62 109.669 176.625 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 84' ' ' LYS . . . . . . . . . . . . . 80.5 tttt -93.46 -54.07 3.82 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.078 -0.51 . . . . 1.62 110.379 -178.388 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 85' ' ' ASP . . . . . . . . . . . . . 19.5 t70 -156.43 152.92 28.07 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 115.63 -0.714 . . . . 0.7 110.138 -179.085 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 86' ' ' VAL . . . . . . . . . . . . . 45.1 t -127.5 131.07 70.57 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.25 0 CA-C-O 121.096 0.474 . . . . 0.48 110.543 -179.092 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 87' ' ' ILE . . . . . 0.491 ' N ' HD12 ' B' ' 87' ' ' ILE . 5.1 mp -118.94 125.13 74.23 Favored 'Isoleucine or valine' 0 C--O 1.233 0.23 0 CA-C-N 115.668 -0.696 . . . . 1.38 109.276 176.64 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' B' B ' 88' ' ' LEU . . . . . . . . . . . . . 16.6 tp -110.05 127.28 54.75 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-O 120.926 0.393 . . . . 1.67 110.958 -177.415 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 89' ' ' ASP . . . . . . . . . . . . . 14.6 t70 -118.89 158.17 26.21 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 115.813 -0.631 . . . . 0.85 109.408 177.09 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 90' ' ' GLU . . . . . . . . . . . . . 95.1 mt-10 -47.31 -40.35 16.83 Favored 'General case' 0 C--N 1.33 -0.265 0 N-CA-C 113.0 0.741 . . . . 2.51 113.0 -171.33 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 91' ' ' ASN . . . . . . . . . . . . . 69.9 m-80 -132.09 26.51 4.56 Favored 'General case' 0 N--CA 1.466 0.373 0 N-CA-C 112.469 0.544 . . . . 2.35 112.469 -178.023 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 92' ' ' LEU . . . . . . . . . . . . . 84.9 mt -150.51 143.22 24.57 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-O 120.748 0.308 . . . . 1.45 110.448 -178.731 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 93' ' ' ILE . . . . . . . . . . . . . 74.5 mt -118.53 113.37 41.63 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.346 0 N-CA-C 109.257 -0.646 . . . . 0.54 109.257 178.181 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 94' ' ' VAL . . . . . . . . . . . . . 46.1 t -115.35 124.95 72.41 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.201 0 CA-C-O 120.939 0.4 . . . . 0.45 109.99 -178.43 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 95' ' ' VAL . . . . . . . . . . . . . 42.7 t -121.91 134.34 65.49 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.285 0 CA-C-N 116.07 -0.514 . . . . 0.43 109.881 -179.122 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 96' ' ' ILE . . . . . . . . . . . . . 64.6 mt -112.89 128.71 69.48 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.365 0 N-CA-C 109.075 -0.713 . . . . 0.5 109.075 177.831 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 97' ' ' THR . . . . . . . . . . . . . 69.6 p -98.37 158.72 15.4 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-O 121.153 0.501 . . . . 0.56 111.082 -178.043 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 98' ' ' GLU . . . . . . . . . . . . . 83.6 tt0 -53.93 -27.66 32.18 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.148 -0.478 . . . . 3.05 112.081 -179.819 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 99' ' ' GLU . . . . . . . . . . . . . 95.5 mt-10 -81.31 16.78 1.49 Allowed 'General case' 0 CA--C 1.534 0.363 0 N-CA-C 113.152 0.797 . . . . 2.29 113.152 -176.588 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 100' ' ' ASN . . . . . . . . . . . . . 4.3 m-20 62.89 38.05 11.65 Favored 'General case' 0 N--CA 1.462 0.158 0 CA-C-O 121.073 0.464 . . . . 0.66 111.158 177.265 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 101' ' ' GLU . . . . . . . . . . . . . 84.6 tt0 -115.18 144.46 43.65 Favored 'General case' 0 C--N 1.333 -0.132 0 CA-C-N 116.1 -0.5 . . . . 0.69 109.738 174.937 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 102' ' ' VAL . . . . . . . . . . . . . 45.0 t -115.5 126.23 72.98 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 CA-C-N 116.257 -0.429 . . . . 0.48 110.083 -177.812 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 103' ' ' LEU . . . . . . . . . . . . . 55.6 mt -119.23 132.48 55.93 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 115.789 -0.641 . . . . 1.28 110.014 177.15 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 104' ' ' ILE . . . . . . . . . . . . . 66.7 mt -121.34 121.61 65.18 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.236 0 N-CA-C 110.369 -0.234 . . . . 0.51 110.369 179.047 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 105' ' ' PHE . . . . . . . . . . . . . 76.0 m-85 -115.81 166.32 12.09 Favored 'General case' 0 C--N 1.332 -0.175 0 O-C-N 124.205 0.941 . . . . 0.55 109.643 177.911 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 106' ' ' ASN . . . . . . . . . . . . . 52.0 p-10 -100.08 -171.57 2.07 Favored 'General case' 0 C--N 1.331 -0.213 0 N-CA-C 110.086 -0.338 . . . . 0.71 110.086 173.546 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 107' ' ' GLN . . . . . . . . . . . . . 50.2 tt0 -58.37 -30.15 66.56 Favored 'General case' 0 CA--C 1.532 0.286 0 N-CA-C 111.901 0.334 . . . . 1.83 111.901 178.574 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 108' ' ' ASN . . . . . . . . . . . . . 63.6 t30 -83.03 8.16 13.63 Favored 'General case' 0 CA--C 1.535 0.388 0 N-CA-C 113.212 0.819 . . . . 1.5 113.212 -177.147 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 109' ' ' LEU . . . . . . . . . . . . . 11.9 tp 60.92 37.43 18.33 Favored 'General case' 0 CA--C 1.53 0.186 0 CA-C-O 120.99 0.424 . . . . 1.18 111.197 179.028 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 110' ' ' GLU . . . . . . . . . . . . . 47.6 mt-10 -110.09 153.09 25.16 Favored 'General case' 0 C--N 1.33 -0.24 0 N-CA-C 109.751 -0.463 . . . . 1.97 109.751 176.436 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 111' ' ' GLU . . . . . . . . . . . . . 73.7 tt0 -86.76 123.17 31.61 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-O 120.855 0.359 . . . . 1.84 110.926 -174.931 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 112' ' ' LEU . . . . . . . . . . . . . 32.9 mt -108.9 -46.06 3.69 Favored 'General case' 0 C--N 1.332 -0.186 0 CA-C-N 116.198 -0.455 . . . . 0.75 111.27 -179.55 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 113' ' ' TYR . . . . . . . . . . . . . 71.6 t80 -136.83 142.3 42.87 Favored 'General case' 0 N--CA 1.464 0.244 0 CA-C-O 120.778 0.323 . . . . 0.68 111.064 -178.202 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 114' ' ' ARG . . . . . . . . . . . . . 25.0 ptt180 -144.52 127.25 16.21 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.05 -0.523 . . . . 3.02 110.927 -179.989 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 115' ' ' GLY . . . . . . . . . . . . . . . -150.19 160.46 28.55 Favored Glycine 0 CA--C 1.525 0.659 0 N-CA-C 111.242 -0.743 . . . . 0.53 111.242 178.614 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 116' ' ' LYS . . . . . . . . . . . . . 7.9 ttpm? -129.65 134.45 47.69 Favored 'General case' 0 C--N 1.33 -0.267 0 N-CA-C 109.782 -0.451 . . . . 1.72 109.782 175.911 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 117' ' ' PHE . . . . . . . . . . . . . 38.3 m-85 -134.46 113.97 12.39 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-O 120.815 0.34 . . . . 0.56 110.258 -176.939 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 118' ' ' GLU . . . . . . . . . . . . . 95.9 mt-10 -55.29 -40.94 71.66 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.424 -0.353 . . . . 2.56 111.129 -176.371 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 119' ' ' ASN . . . . . . . . . . . . . 7.2 m120 -102.84 31.12 4.33 Favored 'General case' 0 C--N 1.331 -0.227 0 CA-C-N 116.272 -0.422 . . . . 1.35 112.136 -174.431 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 120' ' ' LEU . . . . . . . . . . . . . 18.8 tp -56.23 120.46 7.6 Favored 'General case' 0 N--CA 1.462 0.156 0 C-N-CA 120.971 -0.292 . . . . 0.57 110.403 178.418 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 121' ' ' ASN . . . . . . . . . . . . . 64.2 t30 -114.08 -44.1 3.18 Favored 'General case' 0 C--O 1.233 0.186 0 CA-C-N 116.504 -0.316 . . . . 1.95 111.239 -175.891 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 122' ' ' LYS . . . . . . . . . . . . . 91.0 mttt -146.22 150.32 35.61 Favored 'General case' 0 C--N 1.331 -0.197 0 CA-C-O 121.192 0.52 . . . . 1.8 111.981 -176.339 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 123' ' ' VAL . . . . . . . . . . . . . 45.4 t -124.73 128.86 73.64 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.245 0 CA-C-N 115.651 -0.704 . . . . 0.57 109.391 174.723 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 124' ' ' LEU . . . . . . . . . . . . . 72.5 mt -120.8 132.43 55.02 Favored 'General case' 0 C--N 1.33 -0.273 0 N-CA-C 110.181 -0.303 . . . . 1.68 110.181 -178.194 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 125' ' ' VAL . . . . . . . . . . . . . 35.1 m -138.43 132.44 41.61 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.25 0 CA-C-O 120.971 0.415 . . . . 1.73 111.085 -179.754 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 126' ' ' ARG . . . . . . . . . . . . . 89.3 mtt-85 -151.58 132.92 14.57 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 115.777 -0.647 . . . . 2.53 109.714 176.605 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 127' ' ' ASN . . . . . . . . . . . . . 32.0 t30 56.67 -147.82 0.51 Allowed 'General case' 0 CA--C 1.541 0.623 0 N-CA-C 109.686 -0.487 . . . . 2.3 109.686 -179.415 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 128' ' ' ASP . . . . . . . . . . . . . 4.5 p30 -88.04 16.89 5.46 Favored 'General case' 0 CA--C 1.536 0.433 0 CA-C-N 118.75 0.705 . . . . 1.02 112.725 178.446 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 129' ' ' LEU . . . . . . . . . . . . . 15.0 tp -115.37 136.08 53.46 Favored 'General case' 0 C--O 1.232 0.167 0 O-C-N 122.118 -0.364 . . . . 1.86 110.073 179.389 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 130' ' ' VAL . . . . . 0.496 HG23 ' HB ' ' B' ' 141' ' ' ILE . 32.6 m -131.53 144.0 38.81 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.27 0 CA-C-O 120.995 0.426 . . . . 1.48 111.0 -178.546 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' B' B ' 131' ' ' VAL . . . . . 0.43 HG13 ' O ' ' B' ' 139' ' ' THR . 42.8 t -136.04 140.07 44.65 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 CA-C-N 116.022 -0.536 . . . . 0.7 110.34 179.796 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' B' B ' 132' ' ' ILE . . . . . . . . . . . . . 72.4 mt -112.95 133.88 57.37 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.323 0 N-CA-C 109.422 -0.584 . . . . 0.45 109.422 178.256 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 133' ' ' ILE . . . . . . . . . . . . . 38.5 mm -114.68 116.97 54.18 Favored 'Isoleucine or valine' 0 C--O 1.233 0.232 0 CA-C-N 116.534 -0.303 . . . . 0.54 110.767 -176.118 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 134' ' ' ASP . . . . . . . . . . . . . 7.6 p-10 -129.61 149.79 51.22 Favored 'General case' 0 C--N 1.331 -0.215 0 N-CA-C 109.594 -0.521 . . . . 0.56 109.594 174.963 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 135' ' ' GLU . . . . . . . . . . . . . 85.0 tt0 -49.9 -25.94 3.65 Favored 'General case' 0 C--N 1.327 -0.372 0 N-CA-C 112.719 0.637 . . . . 1.64 112.719 -172.113 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 136' ' ' GLN . . . . . . . . . . . . . 53.0 mt-30 -101.82 -25.68 13.73 Favored 'General case' 0 C--O 1.233 0.218 0 N-CA-C 112.892 0.701 . . . . 2.0 112.892 -173.939 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 137' ' ' LYS . . . . . . . . . . . . . 86.5 mttt -144.84 150.67 37.52 Favored 'General case' 0 C--N 1.331 -0.227 0 CA-C-O 121.482 0.658 . . . . 1.9 112.559 -168.503 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 138' ' ' LEU . . . . . . . . . . . . . 12.5 tp -112.65 117.6 32.71 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 114.888 -1.051 . . . . 0.74 108.78 172.64 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 139' ' ' THR . . . . . 0.43 ' O ' HG13 ' B' ' 131' ' ' VAL . 22.1 m -110.54 124.97 52.83 Favored 'General case' 0 C--N 1.332 -0.182 0 CA-C-O 120.596 0.236 . . . . 0.47 110.753 -177.266 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' B' B ' 140' ' ' LEU . . . . . 0.464 ' C ' HD23 ' B' ' 140' ' ' LEU . 6.5 tt -116.1 122.73 45.99 Favored 'General case' 0 C--N 1.33 -0.249 0 N-CA-C 109.484 -0.561 . . . . 0.86 109.484 -178.261 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' B' B ' 141' ' ' ILE . . . . . 0.496 ' HB ' HG23 ' B' ' 130' ' ' VAL . 19.8 mt -120.71 122.95 69.26 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.298 0 CA-C-O 120.949 0.404 . . . . 0.56 110.015 -175.397 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' B' B ' 142' ' ' ARG . . . . . . . . . . . . . 67.5 mtm180 -104.4 126.38 51.45 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 115.281 -0.872 . . . . 3.56 109.938 179.78 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 143' ' ' THR . . . . . . . . . . . . . 23.0 p . . . . . 0 C--O 1.22 -0.497 0 CA-C-O 117.963 -1.018 . . . . 1.46 110.645 -179.576 . . . . . . . . 0 0 . 1 . 001 nuclear build core ' C' C ' 2' ' ' SER . . . . . . . . . . . . . 51.0 p . . . . . 0 C--O 1.231 0.099 0 CA-C-O 120.996 0.427 . . . . 21.19 110.875 . . . . . . . . . 0 0 . 1 . 001 nuclear build core ' C' C ' 3' ' ' GLU . . . . . . . . . . . . . 95.2 mt-10 -140.02 142.57 36.22 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 115.832 -0.622 . . . . 18.63 110.711 -179.463 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' C' C ' 4' ' ' LEU . . . . . 0.409 HD12 HD23 ' C' ' 58' ' ' LEU . 4.0 tt -123.78 124.02 41.78 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.083 -0.508 . . . . 16.59 109.788 176.63 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' C' C ' 5' ' ' LYS . . . . . . . . . . . . . 57.3 mttm -100.12 121.7 41.81 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.298 -0.41 . . . . 14.18 110.866 -179.314 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' C' C ' 6' ' ' LEU . . . . . . . . . . . . . 60.6 mt -117.59 146.3 43.72 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 115.557 -0.747 . . . . 13.76 110.67 -179.437 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' C' C ' 7' ' ' LYS . . . . . . . . . . . . . 38.5 ttmt -138.89 139.14 22.8 Favored Pre-proline 0 CA--C 1.533 0.318 0 CA-C-O 119.115 -0.469 . . . . 11.14 109.998 174.779 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' C' C ' 8' ' ' PRO . . . . . . . . . . . . . 94.1 Cg_endo -91.95 146.12 3.05 Favored 'Trans proline' 0 N--CA 1.489 1.258 0 C-N-CA 121.82 1.68 . . . . 10.45 112.098 178.817 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' C' C ' 9' ' ' LEU . . . . . . . . . . . . . 70.2 mt -75.89 -46.34 3.93 Favored Pre-proline 0 CA--C 1.533 0.31 0 CA-C-O 118.742 -0.647 . . . . 14.46 111.596 178.035 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' C' C ' 10' ' ' PRO . . . . . . . . . . . . . 84.6 Cg_endo -81.76 142.68 12.85 Favored 'Trans proline' 0 N--CA 1.495 1.574 0 C-N-CA 121.024 1.15 . . . . 13.28 111.227 172.308 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' C' C ' 11' ' ' LYS . . . . . . . . . . . . . 53.7 tttm -86.33 109.94 19.33 Favored 'General case' 0 C--N 1.331 -0.223 0 C-N-CA 120.68 -0.408 . . . . 12.2 110.524 -179.254 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' C' C ' 12' ' ' VAL . . . . . . . . . . . . . 11.6 p -147.38 145.62 18.95 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.299 0 CA-C-N 116.003 -0.544 . . . . 13.43 110.402 -179.294 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' C' C ' 13' ' ' GLU . . . . . . . . . . . . . 46.1 mt-10 -81.15 130.28 34.95 Favored 'General case' 0 C--N 1.329 -0.286 0 N-CA-C 110.096 -0.335 . . . . 13.26 110.096 177.91 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' C' C ' 14' ' ' LEU . . . . . . . . . . . . . 17.3 mt -98.78 143.94 27.27 Favored Pre-proline 0 CA--C 1.533 0.326 0 CA-C-O 118.987 -0.53 . . . . 13.07 110.336 -178.215 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' C' C ' 15' ' ' PRO . . . . . . . . . . . . . 23.2 Cg_exo -64.49 161.09 36.49 Favored 'Trans proline' 0 N--CA 1.498 1.754 0 C-N-CA 121.36 1.373 . . . . 15.43 111.733 176.333 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' C' C ' 16' ' ' PRO . . . . . . . . . . . . . 35.7 Cg_exo -59.12 -35.32 98.18 Favored 'Trans proline' 0 N--CA 1.498 1.748 0 C-N-CA 121.508 1.472 . . . . 15.95 112.979 -178.545 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' C' C ' 17' ' ' ASP . . . . . . . . . . . . . 11.6 p-10 -83.3 -0.71 50.9 Favored 'General case' 0 CA--C 1.537 0.452 0 N-CA-C 113.35 0.87 . . . . 17.37 113.35 -177.397 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' C' C ' 18' ' ' PHE . . . . . . . . . . . . . 29.2 t80 -58.34 -44.26 88.65 Favored 'General case' 0 C--N 1.334 -0.107 0 O-C-N 121.972 -0.455 . . . . 14.54 110.082 -177.343 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' C' C ' 19' ' ' VAL . . . . . . . . . . . . . 49.7 t -57.14 -43.96 82.47 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.288 0 CA-C-N 116.132 -0.485 . . . . 15.03 110.423 -177.737 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' C' C ' 20' ' ' ASP . . . . . . . . . . . . . 2.0 m-20 -60.07 -43.31 95.54 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.551 -0.295 . . . . 17.45 111.029 -177.653 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' C' C ' 21' ' ' VAL . . . . . . . . . . . . . 46.4 t -63.84 -45.49 96.94 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.289 0 C-N-CA 120.707 -0.397 . . . . 17.27 110.545 -176.94 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' C' C ' 22' ' ' ILE . . . . . 0.599 HG22 HD12 ' C' ' 26' ' ' LEU . 50.6 mm -55.9 -48.58 78.25 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.226 0 C-N-CA 121.038 -0.265 . . . . 16.84 110.71 179.014 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' C' C ' 23' ' ' ARG . . . . . . . . . . . . . 49.3 ttp180 -54.84 -45.76 74.55 Favored 'General case' 0 C--N 1.331 -0.234 0 C-N-CA 120.92 -0.312 . . . . 19.12 111.347 -178.245 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' C' C ' 24' ' ' ILE . . . . . . . . . . . . . 75.5 mt -58.94 -45.33 92.03 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.253 0 C-N-CA 121.013 -0.275 . . . . 20.12 111.073 -178.696 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' C' C ' 25' ' ' LYS . . . . . . . . . . . . . 53.6 mttm -65.81 -38.1 88.04 Favored 'General case' 0 C--N 1.328 -0.349 0 N-CA-C 112.418 0.525 . . . . 20.06 112.418 -178.325 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' C' C ' 26' ' ' LEU . . . . . 0.599 HD12 HG22 ' C' ' 22' ' ' ILE . 62.8 mt -78.51 -39.82 36.99 Favored 'General case' 0 C--N 1.33 -0.25 0 N-CA-C 113.697 0.999 . . . . 20.37 113.697 -170.443 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' C' C ' 27' ' ' GLN . . . . . . . . . . . . . 18.5 pt20 -47.39 138.66 7.29 Favored 'General case' 0 N--CA 1.469 0.478 0 N-CA-C 112.827 0.677 . . . . 21.9 112.827 -174.772 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' C' C ' 28' ' ' GLY . . . . . . . . . . . . . . . 98.62 -22.05 42.86 Favored Glycine 0 CA--C 1.534 1.234 0 CA-C-N 115.772 -0.649 . . . . 24.11 112.683 -177.737 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' C' C ' 29' ' ' LYS . . . . . . . . . . . . . 63.3 mttp -98.26 155.07 17.37 Favored 'General case' 0 C--N 1.333 -0.129 0 CA-C-N 117.521 0.661 . . . . 22.95 111.02 -179.964 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' C' C ' 30' ' ' THR . . . . . . . . . . . . . 41.7 m -105.73 135.25 47.49 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.165 -0.47 . . . . 24.58 109.826 175.33 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' C' C ' 31' ' ' VAL . . . . . . . . . . . . . 34.9 m -130.56 150.5 34.68 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.289 0 CA-C-O 120.979 0.419 . . . . 21.44 111.171 -177.815 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' C' C ' 32' ' ' ARG . . . . . . . . . . . . . 56.0 ttp180 -131.71 151.0 51.97 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 115.772 -0.649 . . . . 25.8 110.182 177.674 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' C' C ' 33' ' ' THR . . . . . . . . . . . . . 23.5 m -52.92 138.82 29.09 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.423 -0.353 . . . . 20.32 111.436 -177.761 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' C' C ' 34' ' ' GLY . . . . . . . . . . . . . . . 101.25 -17.23 56.08 Favored Glycine 0 CA--C 1.533 1.177 0 CA-C-O 119.695 -0.503 . . . . 19.11 113.276 179.24 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' C' C ' 35' ' ' ASP . . . . . . . . . . . . . 75.1 m-20 -67.0 152.48 45.7 Favored 'General case' 0 N--CA 1.461 0.103 0 CA-C-N 118.046 0.923 . . . . 21.47 111.417 178.984 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' C' C ' 36' ' ' VAL . . . . . . . . . . . . . 44.9 t -121.03 130.98 74.12 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.227 0 CA-C-N 115.969 -0.56 . . . . 19.32 109.99 178.423 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' C' C ' 37' ' ' ILE . . . . . . . . . . . . . 71.9 mt -123.61 140.87 45.83 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.23 0 CA-C-N 116.158 -0.474 . . . . 17.81 109.858 179.972 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' C' C ' 38' ' ' GLY . . . . . . . . . . . . . . . -113.42 128.93 8.58 Favored Glycine 0 CA--C 1.528 0.851 0 N-CA-C 111.272 -0.731 . . . . 18.91 111.272 -179.548 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' C' C ' 39' ' ' ILE . . . . . . . . . . . . . 68.7 mt -124.83 132.37 71.41 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.199 0 N-CA-C 109.911 -0.403 . . . . 17.92 109.911 178.395 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' C' C ' 40' ' ' SER . . . . . 0.52 ' O ' HD13 ' C' ' 41' ' ' ILE . 15.7 t -92.78 117.92 30.53 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-N 116.546 -0.297 . . . . 20.9 111.009 177.093 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' C' C ' 41' ' ' ILE . . . . . 0.52 HD13 ' O ' ' C' ' 40' ' ' SER . 47.4 mm -130.89 128.2 62.36 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.217 0 CA-C-O 120.711 0.291 . . . . 18.73 110.223 178.847 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' C' C ' 42' ' ' LEU . . . . . . . . . . . . . 23.1 mt 57.33 33.53 23.42 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.196 -0.456 . . . . 20.86 111.873 177.985 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' C' C ' 43' ' ' GLY . . . . . . . . . . . . . . . 77.64 -10.1 25.89 Favored Glycine 0 CA--C 1.535 1.311 0 C-N-CA 121.188 -0.529 . . . . 21.69 113.421 177.341 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' C' C ' 44' ' ' LYS . . . . . . . . . . . . . 65.6 tttt -104.87 135.46 46.19 Favored 'General case' 0 C--N 1.332 -0.162 0 CA-C-N 117.938 0.869 . . . . 19.99 110.105 177.58 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' C' C ' 45' ' ' GLU . . . . . . . . . . . . . 84.6 tt0 -83.72 131.14 34.95 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.36 -0.382 . . . . 20.5 110.91 -179.734 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' C' C ' 46' ' ' VAL . . . . . . . . . . . . . 7.3 p -120.76 130.64 74.36 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.229 0 N-CA-C 109.369 -0.604 . . . . 16.54 109.369 175.99 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' C' C ' 47' ' ' LYS . . . . . . . . . . . . . 66.8 mttm -99.26 126.89 45.17 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 115.877 -0.601 . . . . 19.31 110.709 178.949 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' C' C ' 48' ' ' PHE . . . . . . . . . . . . . 85.2 m-85 -111.27 131.96 54.74 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.366 -0.379 . . . . 15.05 110.085 177.921 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' C' C ' 49' ' ' LYS . . . . . . . . . . . . . 78.9 tttt -105.16 136.09 45.3 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.228 -0.442 . . . . 16.18 109.913 178.156 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' C' C ' 50' ' ' VAL . . . . . . . . . . . . . 46.6 t -78.22 107.85 10.81 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.312 0 N-CA-C 109.161 -0.681 . . . . 16.26 109.161 177.174 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' C' C ' 51' ' ' VAL . . . . . . . . . . . . . 48.9 t -70.22 -47.87 64.71 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.304 0 CA-C-N 115.964 -0.562 . . . . 15.45 109.956 -174.298 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' C' C ' 52' ' ' GLN . . . . . . . . . . . . . 48.4 tt0 -168.99 140.1 2.43 Favored 'General case' 0 C--N 1.33 -0.255 0 C-N-CA 120.389 -0.524 . . . . 17.03 111.581 -179.004 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' C' C ' 53' ' ' ALA . . . . . . . . . . . . . . . -109.65 133.3 53.28 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 115.85 -0.614 . . . . 19.6 109.799 174.922 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' C' C ' 54' ' ' TYR . . . . . . . . . . . . . 10.0 t80 -129.03 107.39 18.03 Favored Pre-proline 0 CA--C 1.534 0.35 0 CA-C-O 118.27 -0.871 . . . . 23.17 110.389 -179.942 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' C' C ' 55' ' ' PRO . . . . . . . . . . . . . 72.7 Cg_endo -77.21 170.03 72.59 Favored 'Cis proline' 0 N--CA 1.501 1.932 0 CA-C-N 121.798 1.678 . . . . 23.64 112.558 -6.009 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' C' C ' 56' ' ' SER . . . . . . . . . . . . . 20.0 m -116.59 140.21 26.44 Favored Pre-proline 0 CA--C 1.539 0.524 0 CA-C-O 118.616 -0.707 . . . . 24.73 109.737 174.763 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' C' C ' 57' ' ' PRO . . . . . . . . . . . . . 57.0 Cg_endo -73.36 148.01 91.04 Favored 'Cis proline' 0 N--CA 1.499 1.809 0 CA-C-N 121.621 1.615 . . . . 25.61 111.161 -6.123 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' C' C ' 58' ' ' LEU . . . . . 0.409 HD23 HD12 ' C' ' 4' ' ' LEU . 25.1 tp -107.47 139.3 42.18 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-O 120.986 0.422 . . . . 22.18 110.759 -177.487 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' C' C ' 59' ' ' ARG . . . . . . . . . . . . . 54.3 ttp180 -103.91 119.42 38.89 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 115.543 -0.753 . . . . 26.61 109.016 174.598 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' C' C ' 60' ' ' VAL . . . . . . . . . . . . . 40.9 t -72.58 120.18 20.67 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.286 0 C-N-CA 120.872 -0.331 . . . . 21.45 110.726 -173.092 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' C' C ' 61' ' ' GLU . . . . . . . . . . . . . 94.8 mt-10 -131.03 164.9 24.39 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 115.774 -0.648 . . . . 24.7 109.764 175.979 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' C' C ' 62' ' ' ASP . . . . . . . . . . . . . 39.4 m-20 -53.87 -32.49 53.32 Favored 'General case' 0 C--N 1.328 -0.349 0 C-N-CA 120.982 -0.287 . . . . 22.78 111.763 -179.865 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' C' C ' 63' ' ' ARG . . . . . . . . . . . . . 28.5 ptt180 -78.77 0.23 27.73 Favored 'General case' 0 CA--C 1.537 0.468 0 N-CA-C 113.799 1.037 . . . . 25.71 113.799 -175.445 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' C' C ' 64' ' ' THR . . . . . . . . . . . . . 32.5 m -86.28 136.4 33.17 Favored 'General case' 0 C--N 1.333 -0.148 0 CA-C-N 118.146 0.43 . . . . 20.03 110.797 -177.926 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' C' C ' 65' ' ' LYS . . . . . . . . . . . . . 62.8 mttm -89.67 131.08 35.83 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.166 -0.47 . . . . 19.19 110.192 178.924 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' C' C ' 66' ' ' ILE . . . . . . . . . . . . . 58.2 mt -112.2 130.18 66.35 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.254 0 N-CA-C 109.631 -0.507 . . . . 15.6 109.631 -179.808 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' C' C ' 67' ' ' THR . . . . . . . . . . . . . 26.5 m -124.78 137.34 54.33 Favored 'General case' 0 C--N 1.332 -0.167 0 CA-C-O 121.01 0.433 . . . . 13.36 111.022 -177.307 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' C' C ' 68' ' ' LEU . . . . . . . . . . . . . 53.9 mt . . . . . 0 C--N 1.329 -0.305 0 CA-C-N 115.859 -0.61 . . . . 10.54 110.209 177.806 . . . . . . . . 0 0 . 1 . 001 nuclear build core ' C' C ' 73' ' ' VAL . . . . . . . . . . . . . 33.8 m . . . . . 0 N--CA 1.462 0.152 0 CA-C-O 120.87 0.367 . . . . 1.13 110.48 . . . . . . . . . 0 0 . 1 . 001 nuclear build core ' C' C ' 74' ' ' ASP . . . . . 0.408 ' OD2' HD11 ' C' ' 76' ' ' LEU . 6.7 t70 -103.36 128.33 50.48 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 115.978 -0.555 . . . . 0.81 109.778 -179.514 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' C' C ' 75' ' ' VAL . . . . . 0.422 ' C ' HD12 ' C' ' 76' ' ' LEU . 41.0 t -114.63 122.9 69.67 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.209 0 CA-C-O 121.063 0.458 . . . . 0.61 110.745 -176.878 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' C' C ' 76' ' ' LEU . . . . . 0.433 ' N ' HD12 ' C' ' 76' ' ' LEU . 6.8 mp -119.88 139.56 52.2 Favored 'General case' 0 C--N 1.33 -0.277 0 N-CA-C 108.875 -0.787 . . . . 1.07 108.875 173.831 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' C' C ' 77' ' ' GLU . . . . . . . . . . . . . 59.6 tt0 -137.29 136.25 37.86 Favored 'General case' 0 C--N 1.333 -0.14 0 C-N-CA 120.496 -0.482 . . . . 1.18 111.416 -174.237 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' C' C ' 78' ' ' ALA . . . . . 0.516 ' HB2' HD21 ' C' ' 109' ' ' LEU . . . -124.07 137.43 54.57 Favored 'General case' 0 C--N 1.331 -0.199 0 CA-C-N 115.771 -0.65 . . . . 0.56 109.835 177.45 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' C' C ' 79' ' ' LYS . . . . . 0.58 ' O ' HD13 ' C' ' 80' ' ' ILE . 68.1 mttm -79.84 120.27 23.85 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-O 120.976 0.417 . . . . 3.18 110.621 -179.542 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' C' C ' 80' ' ' ILE . . . . . 0.58 HD13 ' O ' ' C' ' 79' ' ' LYS . 43.4 mm -139.11 114.05 8.13 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.311 0 N-CA-C 109.13 -0.693 . . . . 0.53 109.13 -176.95 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' C' C ' 81' ' ' LYS . . . . . . . . . . . . . 41.6 tttp -110.22 130.42 55.55 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-O 120.974 0.416 . . . . 2.98 111.247 -176.362 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' C' C ' 82' ' ' GLY . . . . . . . . . . . . . . . 89.13 42.08 5.69 Favored Glycine 0 CA--C 1.526 0.722 0 CA-C-N 115.857 -0.61 . . . . 0.52 111.692 175.694 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' C' C ' 83' ' ' ILE . . . . . . . . . . . . . 67.7 mt -69.95 138.34 22.26 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.279 0 N-CA-C 109.833 -0.432 . . . . 0.54 109.833 178.54 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' C' C ' 84' ' ' LYS . . . . . . . . . . . . . 35.3 tttp -101.01 -54.03 2.9 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.068 -0.515 . . . . 1.68 110.366 -178.658 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' C' C ' 85' ' ' ASP . . . . . . . . . . . . . 13.3 t70 -151.97 151.33 31.06 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 115.862 -0.608 . . . . 0.76 110.353 -179.7 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' C' C ' 86' ' ' VAL . . . . . . . . . . . . . 44.6 t -131.06 130.43 63.77 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.235 0 CA-C-O 120.93 0.395 . . . . 0.54 110.596 -178.657 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' C' C ' 87' ' ' ILE . . . . . . . . . . . . . 46.1 mm -119.88 127.29 75.88 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.221 0 CA-C-N 115.883 -0.599 . . . . 1.38 109.71 176.297 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' C' C ' 88' ' ' LEU . . . . . . . . . . . . . 14.1 tp -110.02 131.5 55.0 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-O 120.869 0.366 . . . . 1.66 110.969 -178.228 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' C' C ' 89' ' ' ASP . . . . . . . . . . . . . 21.8 t70 -123.42 156.68 35.01 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-N 116.087 -0.506 . . . . 0.95 109.939 178.389 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' C' C ' 90' ' ' GLU . . . . . . . . . . . . . 81.2 tt0 -46.33 -40.17 11.38 Favored 'General case' 0 C--N 1.33 -0.255 0 N-CA-C 113.048 0.758 . . . . 2.43 113.048 -171.738 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' C' C ' 91' ' ' ASN . . . . . . . . . . . . . 6.3 p-10 -132.1 23.03 4.51 Favored 'General case' 0 N--CA 1.468 0.434 0 N-CA-C 112.779 0.659 . . . . 2.22 112.779 -178.546 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' C' C ' 92' ' ' LEU . . . . . . . . . . . . . 15.1 mt -149.26 148.79 29.98 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-O 120.734 0.302 . . . . 1.45 110.262 -176.504 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' C' C ' 93' ' ' ILE . . . . . . . . . . . . . 75.7 mt -125.84 120.23 56.75 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.262 0 N-CA-C 109.41 -0.589 . . . . 0.48 109.41 177.005 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' C' C ' 94' ' ' VAL . . . . . 0.679 HG21 HG21 ' C' ' 125' ' ' VAL . 46.4 t -118.65 124.97 74.01 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.244 0 N-CA-C 109.765 -0.457 . . . . 0.47 109.765 -179.603 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' C' C ' 95' ' ' VAL . . . . . . . . . . . . . 41.6 t -122.02 134.49 65.13 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.328 0 CA-C-N 116.038 -0.528 . . . . 0.41 109.946 -178.226 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' C' C ' 96' ' ' ILE . . . . . . . . . . . . . 62.6 mt -115.85 127.73 73.35 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.341 0 N-CA-C 109.004 -0.739 . . . . 0.46 109.004 178.039 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' C' C ' 97' ' ' THR . . . . . . . . . . . . . 81.4 p -99.56 157.45 16.44 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-O 121.199 0.523 . . . . 0.43 111.1 -178.262 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' C' C ' 98' ' ' GLU . . . . . . . . . . . . . 85.0 tt0 -54.01 -27.82 34.23 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.065 -0.516 . . . . 2.33 112.043 179.771 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' C' C ' 99' ' ' GLU . . . . . . . . . . . . . 94.6 mt-10 -77.49 12.14 1.71 Allowed 'General case' 0 CA--C 1.537 0.458 0 N-CA-C 113.162 0.801 . . . . 2.1 113.162 -177.676 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' C' C ' 100' ' ' ASN . . . . . . . . . . . . . 3.4 m-20 63.57 33.59 13.22 Favored 'General case' 0 CA--C 1.532 0.262 0 CA-C-O 120.904 0.383 . . . . 0.51 111.565 179.174 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' C' C ' 101' ' ' GLU . . . . . . . . . . . . . 85.1 tt0 -107.71 144.74 34.4 Favored 'General case' 0 C--N 1.333 -0.15 0 N-CA-C 109.715 -0.476 . . . . 0.45 109.715 172.833 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' C' C ' 102' ' ' VAL . . . . . . . . . . . . . 45.7 t -115.35 127.08 73.05 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.317 0 CA-C-N 116.255 -0.429 . . . . 0.41 109.851 -177.876 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' C' C ' 103' ' ' LEU . . . . . . . . . . . . . 27.0 mt -117.78 131.41 56.59 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-N 115.883 -0.599 . . . . 0.59 110.407 178.526 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' C' C ' 104' ' ' ILE . . . . . . . . . . . . . 68.9 mt -117.34 119.79 62.92 Favored 'Isoleucine or valine' 0 C--O 1.233 0.219 0 N-CA-C 110.132 -0.321 . . . . 0.45 110.132 178.308 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' C' C ' 105' ' ' PHE . . . . . . . . . . . . . 95.8 m-85 -120.65 166.9 13.04 Favored 'General case' 0 C--N 1.332 -0.158 0 O-C-N 124.136 0.897 . . . . 0.46 110.038 179.676 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' C' C ' 106' ' ' ASN . . . . . . . . . . . . . 35.5 p30 -101.11 -171.94 2.08 Favored 'General case' 0 C--N 1.33 -0.265 0 N-CA-C 110.17 -0.307 . . . . 0.56 110.17 173.073 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' C' C ' 107' ' ' GLN . . . . . . . . . . . . . 63.0 tt0 -60.56 -30.29 69.7 Favored 'General case' 0 CA--C 1.531 0.236 0 N-CA-C 111.803 0.298 . . . . 1.49 111.803 179.633 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' C' C ' 108' ' ' ASN . . . . . . . . . . . . . 3.6 t-20 -82.94 9.28 10.39 Favored 'General case' 0 CA--C 1.536 0.426 0 N-CA-C 112.976 0.732 . . . . 1.39 112.976 -178.375 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' C' C ' 109' ' ' LEU . . . . . 0.516 HD21 ' HB2' ' C' ' 78' ' ' ALA . 7.6 tp 61.24 32.99 19.33 Favored 'General case' 0 CA--C 1.53 0.193 0 O-C-N 122.228 -0.295 . . . . 0.96 111.741 179.14 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' C' C ' 110' ' ' GLU . . . . . . . . . . . . . 94.9 mt-10 -100.89 142.3 32.55 Favored 'General case' 0 C--N 1.33 -0.265 0 N-CA-C 109.319 -0.623 . . . . 1.9 109.319 174.724 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' C' C ' 111' ' ' GLU . . . . . . . . . . . . . 60.6 tt0 -85.05 121.99 28.61 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-O 120.893 0.378 . . . . 1.86 110.807 -175.14 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' C' C ' 112' ' ' LEU . . . . . . . . . . . . . 60.3 mt -99.71 -46.13 5.52 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 115.94 -0.573 . . . . 0.63 110.877 179.256 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' C' C ' 113' ' ' TYR . . . . . . . . . . . . . 85.5 t80 -137.15 140.0 41.55 Favored 'General case' 0 N--CA 1.464 0.242 0 CA-C-O 121.078 0.466 . . . . 0.53 111.59 -178.1 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' C' C ' 114' ' ' ARG . . . . . . . . . . . . . 41.1 ttm180 -130.5 124.57 32.24 Favored 'General case' 0 C--N 1.331 -0.23 0 CA-C-N 115.361 -0.836 . . . . 2.7 109.862 175.993 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' C' C ' 115' ' ' GLY . . . . . . . . . . . . . . . -147.18 159.02 27.91 Favored Glycine 0 CA--C 1.523 0.572 0 N-CA-C 110.56 -1.016 . . . . 0.45 110.56 178.474 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' C' C ' 116' ' ' LYS . . . . . . . . . . . . . 77.3 tttt -137.49 133.12 34.25 Favored 'General case' 0 C--N 1.329 -0.305 0 N-CA-C 109.996 -0.372 . . . . 1.58 109.996 179.385 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' C' C ' 117' ' ' PHE . . . . . . . . . . . . . 35.6 m-85 -134.18 115.75 14.56 Favored 'General case' 0 C--N 1.331 -0.223 0 CA-C-N 116.386 -0.37 . . . . 0.56 110.226 -174.82 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' C' C ' 118' ' ' GLU . . . . . . . . . . . . . 95.2 mt-10 -54.64 -40.88 69.43 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.472 -0.331 . . . . 2.11 111.498 -175.623 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' C' C ' 119' ' ' ASN . . . . . . . . . . . . . 30.6 m120 -100.53 31.16 3.58 Favored 'General case' 0 C--N 1.33 -0.244 0 N-CA-C 112.266 0.469 . . . . 1.52 112.266 -173.187 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' C' C ' 120' ' ' LEU . . . . . . . . . . . . . 14.2 tp -53.79 120.03 5.73 Favored 'General case' 0 N--CA 1.464 0.267 0 CA-C-O 120.676 0.274 . . . . 0.49 110.907 178.048 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' C' C ' 121' ' ' ASN . . . . . . . . . . . . . 19.9 m120 -113.92 -44.15 3.19 Favored 'General case' 0 C--N 1.331 -0.2 0 CA-C-N 116.441 -0.345 . . . . 1.98 110.992 -177.699 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' C' C ' 122' ' ' LYS . . . . . . . . . . . . . 97.9 mttt -146.44 150.31 35.38 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-O 121.059 0.457 . . . . 1.85 111.644 -178.022 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' C' C ' 123' ' ' VAL . . . . . . . . . . . . . 44.7 t -129.78 127.58 64.31 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.303 0 N-CA-C 109.383 -0.599 . . . . 0.62 109.383 174.536 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' C' C ' 124' ' ' LEU . . . . . . . . . . . . . 71.0 mt -117.18 132.34 56.67 Favored 'General case' 0 N--CA 1.463 0.223 0 CA-C-N 116.547 -0.297 . . . . 1.7 110.663 -178.066 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' C' C ' 125' ' ' VAL . . . . . 0.679 HG21 HG21 ' C' ' 94' ' ' VAL . 43.7 t -132.63 121.8 45.81 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.206 0 CA-C-N 116.234 -0.439 . . . . 1.65 110.283 -179.411 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' C' C ' 126' ' ' ARG . . . . . . . . . . . . . 80.5 mtt85 -152.69 137.31 16.89 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.287 -0.415 . . . . 3.27 110.152 176.647 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' C' C ' 127' ' ' ASN . . . . . . . . . . . . . 20.1 m120 54.82 -154.44 0.28 Allowed 'General case' 0 CA--C 1.539 0.53 0 N-CA-C 110.102 -0.332 . . . . 2.28 110.102 178.562 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' C' C ' 128' ' ' ASP . . . . . . . . . . . . . 4.2 p30 -82.9 19.71 1.32 Allowed 'General case' 0 CA--C 1.534 0.332 0 N-CA-C 112.483 0.549 . . . . 1.11 112.483 178.543 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' C' C ' 129' ' ' LEU . . . . . . . . . . . . . 15.5 tp -122.75 137.09 55.02 Favored 'General case' 0 C--O 1.233 0.193 0 O-C-N 122.019 -0.426 . . . . 2.08 110.381 179.935 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' C' C ' 130' ' ' VAL . . . . . 0.553 HG23 ' HB ' ' C' ' 141' ' ' ILE . 32.1 m -132.8 143.68 38.89 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.215 0 CA-C-O 120.957 0.408 . . . . 1.44 110.379 178.527 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' C' C ' 131' ' ' VAL . . . . . 0.503 HG12 HD22 ' D' ' 88' ' ' LEU . 14.1 p -136.05 141.15 42.48 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.283 0 CA-C-N 116.349 -0.387 . . . . 0.91 110.683 179.9 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' C' C ' 132' ' ' ILE . . . . . . . . . . . . . 74.1 mt -114.64 131.84 65.57 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.354 0 N-CA-C 109.196 -0.668 . . . . 0.49 109.196 178.751 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' C' C ' 133' ' ' ILE . . . . . . . . . . . . . 42.7 mm -117.37 120.14 63.98 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.232 0 CA-C-O 120.946 0.403 . . . . 0.47 110.901 -175.659 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' C' C ' 134' ' ' ASP . . . . . . . . . . . . . 7.2 p-10 -130.79 144.29 51.34 Favored 'General case' 0 C--N 1.33 -0.257 0 N-CA-C 109.072 -0.714 . . . . 0.53 109.072 173.689 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' C' C ' 135' ' ' GLU . . . . . . . . . . . . . 84.4 tt0 -49.78 -25.35 2.97 Favored 'General case' 0 C--N 1.327 -0.379 0 N-CA-C 112.852 0.686 . . . . 2.0 112.852 -170.559 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' C' C ' 136' ' ' GLN . . . . . . . . . . . . . 94.7 mt-30 -92.78 -36.97 12.59 Favored 'General case' 0 C--N 1.332 -0.183 0 N-CA-C 112.105 0.409 . . . . 2.24 112.105 -177.499 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' C' C ' 137' ' ' LYS . . . . . . . . . . . . . 41.6 mttp -136.83 151.53 49.24 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-O 121.03 0.443 . . . . 1.48 111.1 -168.453 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' C' C ' 138' ' ' LEU . . . . . . . . . . . . . 5.2 tt -118.91 121.47 40.05 Favored 'General case' 0 C--N 1.332 -0.19 0 N-CA-C 109.047 -0.723 . . . . 0.81 109.047 173.133 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' C' C ' 139' ' ' THR . . . . . 0.454 ' O ' HG23 ' C' ' 131' ' ' VAL . 33.1 m -114.19 127.38 55.87 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-O 120.711 0.291 . . . . 0.54 111.066 -176.565 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' C' C ' 140' ' ' LEU . . . . . . . . . . . . . 21.6 tp -111.03 123.84 50.98 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 115.599 -0.728 . . . . 1.11 109.158 179.922 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' C' C ' 141' ' ' ILE . . . . . 0.553 ' HB ' HG23 ' C' ' 130' ' ' VAL . 19.5 mt -122.19 121.61 64.38 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.298 0 CA-C-O 120.981 0.419 . . . . 0.65 110.073 -173.906 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' C' C ' 142' ' ' ARG . . . . . . . . . . . . . 59.3 mtp180 . . . . . 0 C--N 1.329 -0.299 0 CA-C-N 115.419 -0.809 . . . . 4.0 110.001 178.762 . . . . . . . . 0 0 . 1 . 001 nuclear build core ' D' D ' 2' ' ' SER . . . . . . . . . . . . . 3.6 p . . . . . 0 C--O 1.232 0.143 0 CA-C-O 120.844 0.354 . . . . 19.86 110.477 . . . . . . . . . 0 0 . 1 . 001 nuclear build core ' D' D ' 3' ' ' GLU . . . . . . . . . . . . . 84.7 tt0 -139.71 139.57 36.6 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.137 -0.483 . . . . 17.06 110.807 -179.434 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' D' D ' 4' ' ' LEU . . . . . 0.426 HD21 HD21 ' D' ' 6' ' ' LEU . 15.3 tp -124.42 126.09 45.36 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 115.912 -0.585 . . . . 14.92 110.117 177.695 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' D' D ' 5' ' ' LYS . . . . . . . . . . . . . 46.5 mttm -102.49 120.48 40.59 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.328 -0.396 . . . . 12.31 110.389 177.795 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' D' D ' 6' ' ' LEU . . . . . 0.426 HD21 HD21 ' D' ' 4' ' ' LEU . 78.4 mt -117.63 149.25 41.01 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 115.564 -0.744 . . . . 12.66 110.663 -179.145 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' D' D ' 7' ' ' LYS . . . . . . . . . . . . . 77.5 tttt -136.77 135.68 20.54 Favored Pre-proline 0 CA--C 1.534 0.359 0 CA-C-O 118.764 -0.636 . . . . 10.07 109.792 176.266 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' D' D ' 8' ' ' PRO . . . . . . . . . . . . . 86.9 Cg_endo -87.83 143.91 6.17 Favored 'Trans proline' 0 N--CA 1.492 1.395 0 C-N-CA 121.546 1.497 . . . . 10.15 111.635 178.43 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' D' D ' 9' ' ' LEU . . . . . . . . . . . . . 21.7 mt -79.86 -46.99 1.46 Allowed Pre-proline 0 CA--C 1.533 0.305 0 CA-C-O 118.746 -0.645 . . . . 13.43 111.91 -178.884 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' D' D ' 10' ' ' PRO . . . . . . . . . . . . . 92.3 Cg_endo -80.69 148.9 18.14 Favored 'Trans proline' 0 N--CA 1.495 1.603 0 C-N-CA 121.194 1.263 . . . . 13.55 111.646 174.127 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' D' D ' 11' ' ' LYS . . . . . . . . . . . . . 96.0 mttt -88.71 102.1 14.65 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-O 120.886 0.374 . . . . 13.05 110.767 179.961 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' D' D ' 12' ' ' VAL . . . . . . . . . . . . . 12.2 p -141.03 143.85 27.61 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 CA-C-N 116.108 -0.496 . . . . 14.73 110.391 179.145 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' D' D ' 13' ' ' GLU . . . . . . . . . . . . . 45.9 mt-10 -79.72 124.65 28.78 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.408 -0.36 . . . . 15.06 110.38 179.245 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' D' D ' 14' ' ' LEU . . . . . . . . . . . . . 22.7 mt -99.52 147.78 33.81 Favored Pre-proline 0 CA--C 1.534 0.332 0 CA-C-O 119.185 -0.436 . . . . 15.04 110.534 -178.139 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' D' D ' 15' ' ' PRO . . . . . . . . . . . . . 23.8 Cg_exo -64.1 160.82 36.28 Favored 'Trans proline' 0 N--CA 1.499 1.821 0 C-N-CA 121.298 1.332 . . . . 17.83 111.816 175.018 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' D' D ' 16' ' ' PRO . . . . . . . . . . . . . 28.1 Cg_exo -60.02 -36.76 88.53 Favored 'Trans proline' 0 N--CA 1.496 1.64 0 C-N-CA 121.486 1.457 . . . . 18.35 112.795 -178.408 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' D' D ' 17' ' ' ASP . . . . . . . . . . . . . 2.9 p30 -88.27 9.22 23.85 Favored 'General case' 0 CA--C 1.535 0.402 0 N-CA-C 113.189 0.811 . . . . 20.13 113.189 -177.775 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' D' D ' 18' ' ' PHE . . . . . . . . . . . . . 61.8 t80 -57.53 -42.44 82.87 Favored 'General case' 0 N--CA 1.46 0.042 0 O-C-N 121.983 -0.448 . . . . 16.67 110.172 -179.443 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' D' D ' 19' ' ' VAL . . . . . . . . . . . . . 48.0 t -56.91 -42.53 78.67 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.321 0 CA-C-N 116.264 -0.426 . . . . 16.27 110.428 -179.353 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' D' D ' 20' ' ' ASP . . . . . . . . . . . . . 18.4 t70 -59.98 -42.16 93.57 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-O 120.8 0.333 . . . . 19.6 110.89 -178.12 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' D' D ' 21' ' ' VAL . . . . . . . . . . . . . 46.2 t -64.26 -46.61 92.82 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.269 0 C-N-CA 120.793 -0.363 . . . . 19.26 110.452 -177.938 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' D' D ' 22' ' ' ILE . . . . . 0.503 HG22 HD12 ' D' ' 26' ' ' LEU . 49.0 mm -56.23 -44.41 79.25 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.211 0 C-N-CA 120.962 -0.295 . . . . 17.48 110.565 178.651 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' D' D ' 23' ' ' ARG . . . . . . . . . . . . . 55.9 ttp180 -54.15 -49.38 69.39 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-O 120.673 0.273 . . . . 20.79 111.444 -179.689 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' D' D ' 24' ' ' ILE . . . . . . . . . . . . . 76.9 mt -58.88 -43.01 87.45 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.308 0 CA-C-N 116.48 -0.327 . . . . 21.9 111.135 -177.474 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' D' D ' 25' ' ' LYS . . . . . . . . . . . . . 63.4 mttm -66.39 -43.25 86.36 Favored 'General case' 0 C--N 1.328 -0.355 0 N-CA-C 112.619 0.6 . . . . 20.64 112.619 -178.438 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' D' D ' 26' ' ' LEU . . . . . 0.503 HD12 HG22 ' D' ' 22' ' ' ILE . 92.8 mt -78.71 -37.54 41.29 Favored 'General case' 0 C--N 1.331 -0.228 0 N-CA-C 113.55 0.944 . . . . 19.88 113.55 -170.385 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' D' D ' 27' ' ' GLN . . . . . . . . . . . . . 15.1 pt20 -46.75 138.99 5.67 Favored 'General case' 0 N--CA 1.469 0.488 0 N-CA-C 112.765 0.654 . . . . 22.91 112.765 -175.305 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' D' D ' 28' ' ' GLY . . . . . . . . . . . . . . . 100.3 -23.42 35.94 Favored Glycine 0 CA--C 1.534 1.263 0 CA-C-N 115.606 -0.725 . . . . 23.12 112.393 -176.572 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' D' D ' 29' ' ' LYS . . . . . . . . . . . . . 68.8 mttm -98.44 155.11 17.41 Favored 'General case' 0 C--O 1.233 0.2 0 CA-C-N 117.441 0.621 . . . . 21.77 111.253 179.436 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' D' D ' 30' ' ' THR . . . . . . . . . . . . . 40.8 m -102.98 137.88 40.58 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.034 -0.53 . . . . 22.51 109.938 175.362 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' D' D ' 31' ' ' VAL . . . . . . . . . . . . . 34.8 m -128.19 154.38 38.79 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.249 0 CA-C-O 120.911 0.386 . . . . 19.36 110.854 -178.708 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' D' D ' 32' ' ' ARG . . . . . . . . . . . . . 43.6 mtm180 -133.46 151.53 51.8 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 115.742 -0.663 . . . . 23.0 110.307 177.908 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' D' D ' 33' ' ' THR . . . . . . . . . . . . . 31.9 m -53.2 137.77 33.47 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.498 -0.319 . . . . 17.54 111.458 -178.155 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' D' D ' 34' ' ' GLY . . . . . . . . . . . . . . . 98.91 -17.02 58.8 Favored Glycine 0 CA--C 1.532 1.147 0 CA-C-O 119.65 -0.528 . . . . 16.71 113.365 177.927 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' D' D ' 35' ' ' ASP . . . . . . . . . . . . . 75.2 m-20 -65.72 149.69 49.72 Favored 'General case' 0 C--O 1.231 0.108 0 CA-C-N 118.012 0.906 . . . . 19.02 111.198 179.96 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' D' D ' 36' ' ' VAL . . . . . . . . . . . . . 46.3 t -118.66 130.11 73.96 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.251 0 CA-C-N 115.847 -0.615 . . . . 17.79 109.682 177.304 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' D' D ' 37' ' ' ILE . . . . . . . . . . . . . 64.1 mt -115.55 136.98 50.62 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.298 0 CA-C-N 116.11 -0.496 . . . . 17.21 109.764 179.912 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' D' D ' 38' ' ' GLY . . . . . . . . . . . . . . . -109.53 127.61 8.55 Favored Glycine 0 CA--C 1.524 0.635 0 N-CA-C 110.73 -0.948 . . . . 18.84 110.73 178.945 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' D' D ' 39' ' ' ILE . . . . . . . . . . . . . 72.2 mt -121.19 130.73 74.37 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.206 0 N-CA-C 109.911 -0.403 . . . . 18.53 109.911 179.222 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' D' D ' 40' ' ' SER . . . . . . . . . . . . . 78.0 p -92.24 119.18 31.6 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.233 -0.44 . . . . 21.82 110.74 176.506 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' D' D ' 41' ' ' ILE . . . . . . . . . . . . . 72.6 mt -129.59 116.91 40.53 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.244 0 N-CA-C 109.954 -0.387 . . . . 20.47 109.954 177.938 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' D' D ' 42' ' ' LEU . . . . . . . . . . . . . 69.8 mt 58.08 33.23 22.96 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.269 -0.423 . . . . 22.9 111.698 179.173 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' D' D ' 43' ' ' GLY . . . . . . . . . . . . . . . 80.9 -10.13 48.82 Favored Glycine 0 CA--C 1.535 1.293 0 C-N-CA 121.188 -0.53 . . . . 23.16 113.433 177.303 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' D' D ' 44' ' ' LYS . . . . . . . . . . . . . 94.6 mttt -99.05 137.33 37.73 Favored 'General case' 0 C--N 1.332 -0.173 0 CA-C-N 117.966 0.883 . . . . 21.23 110.285 178.622 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' D' D ' 45' ' ' GLU . . . . . . . . . . . . . 84.7 tt0 -85.21 130.61 34.57 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.257 -0.429 . . . . 20.64 111.474 -178.686 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' D' D ' 46' ' ' VAL . . . . . . . . . . . . . 7.4 p -125.37 126.2 70.26 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.22 0 N-CA-C 109.275 -0.639 . . . . 16.96 109.275 173.333 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' D' D ' 47' ' ' LYS . . . . . . . . . . . . . 9.7 mtmp? -101.46 131.27 47.67 Favored 'General case' 0 C--N 1.331 -0.23 0 CA-C-N 116.165 -0.47 . . . . 18.29 111.688 179.204 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' D' D ' 48' ' ' PHE . . . . . . . . . . . . . 92.2 m-85 -114.58 133.63 55.67 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 115.893 -0.594 . . . . 13.84 109.985 176.32 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' D' D ' 49' ' ' LYS . . . . . . . . . . . . . 60.7 tttm -105.33 137.61 42.86 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.743 -0.208 . . . . 13.73 110.559 179.065 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' D' D ' 50' ' ' VAL . . . . . . . . . . . . . 44.2 t -81.04 108.35 14.28 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.268 0 N-CA-C 109.275 -0.639 . . . . 14.42 109.275 175.862 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' D' D ' 51' ' ' VAL . . . . . . . . . . . . . 48.4 t -73.23 -47.35 47.23 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.351 0 CA-C-N 116.224 -0.443 . . . . 12.84 110.107 -173.821 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' D' D ' 52' ' ' GLN . . . . . . . . . . . . . 48.4 tt0 -162.54 136.82 6.5 Favored 'General case' 0 C--N 1.331 -0.234 0 C-N-CA 120.354 -0.538 . . . . 14.45 111.648 -178.378 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' D' D ' 53' ' ' ALA . . . . . . . . . . . . . . . -110.06 131.3 55.18 Favored 'General case' 0 C--N 1.332 -0.19 0 CA-C-N 115.852 -0.613 . . . . 16.93 109.891 175.482 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' D' D ' 54' ' ' TYR . . . . . . . . . . . . . 8.9 t80 -129.02 108.34 18.12 Favored Pre-proline 0 CA--C 1.534 0.361 0 CA-C-O 118.333 -0.842 . . . . 20.68 110.47 179.8 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' D' D ' 55' ' ' PRO . . . . . . . . . . . . . 74.2 Cg_endo -77.14 170.05 72.6 Favored 'Cis proline' 0 N--CA 1.5 1.858 0 CA-C-N 121.831 1.689 . . . . 21.15 112.481 -5.288 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' D' D ' 56' ' ' SER . . . . . . . . . . . . . 50.1 m -117.29 133.62 23.17 Favored Pre-proline 0 CA--C 1.538 0.515 0 CA-C-O 118.511 -0.757 . . . . 21.68 109.714 175.307 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' D' D ' 57' ' ' PRO . . . . . . . . . . . . . 38.0 Cg_endo -68.09 165.15 72.06 Favored 'Cis proline' 0 N--CA 1.496 1.666 0 CA-C-N 121.828 1.689 . . . . 22.71 111.217 -3.535 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' D' D ' 58' ' ' LEU . . . . . . . . . . . . . 25.0 tp -130.2 136.29 49.08 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-O 120.937 0.399 . . . . 19.85 110.891 -179.001 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' D' D ' 59' ' ' ARG . . . . . . . . . . . . . 55.8 ttp180 -101.73 124.39 47.3 Favored 'General case' 0 C--N 1.327 -0.377 0 N-CA-C 109.08 -0.711 . . . . 25.3 109.08 174.383 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' D' D ' 60' ' ' VAL . . . . . . . . . . . . . 41.3 t -82.12 122.49 36.96 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.304 0 C-N-CA 120.677 -0.409 . . . . 20.84 110.491 -174.538 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' D' D ' 61' ' ' GLU . . . . . . . . . . . . . 45.2 mt-10 -131.13 169.72 15.51 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 115.972 -0.558 . . . . 23.88 109.74 177.415 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' D' D ' 62' ' ' ASP . . . . . . . . . . . . . 6.9 p-10 -55.3 -32.32 62.34 Favored 'General case' 0 C--N 1.328 -0.366 0 N-CA-C 111.743 0.275 . . . . 23.34 111.743 -179.123 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' D' D ' 63' ' ' ARG . . . . . . . . . . . . . 40.2 ptt180 -77.63 -8.44 57.88 Favored 'General case' 0 CA--C 1.537 0.451 0 N-CA-C 113.669 0.988 . . . . 25.78 113.669 -176.415 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' D' D ' 64' ' ' THR . . . . . . . . . . . . . 36.9 m -77.29 136.68 38.51 Favored 'General case' 0 C--N 1.333 -0.116 0 CA-C-O 120.902 0.382 . . . . 19.75 110.73 -176.149 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' D' D ' 65' ' ' LYS . . . . . . . . . . . . . 61.2 mttm -89.51 127.6 35.88 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.026 -0.534 . . . . 18.76 110.031 178.043 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' D' D ' 66' ' ' ILE . . . . . . . . . . . . . 62.5 mt -113.31 127.78 70.44 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.284 0 N-CA-C 109.66 -0.496 . . . . 15.71 109.66 179.376 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' D' D ' 67' ' ' THR . . . . . . . . . . . . . 18.3 m -124.37 141.74 51.83 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.226 -0.443 . . . . 12.72 110.825 -176.925 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' D' D ' 68' ' ' LEU . . . . . . . . . . . . . 16.6 tp . . . . . 0 C--N 1.329 -0.313 0 CA-C-N 115.938 -0.574 . . . . 10.78 110.038 178.545 . . . . . . . . 0 0 . 1 . 001 nuclear build core ' D' D ' 73' ' ' VAL . . . . . . . . . . . . . 34.9 m . . . . . 0 N--CA 1.461 0.122 0 CA-C-O 120.841 0.353 . . . . 1.1 110.578 . . . . . . . . . 0 0 . 1 . 001 nuclear build core ' D' D ' 74' ' ' ASP . . . . . . . . . . . . . 21.5 t70 -100.57 118.49 36.85 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.088 -0.506 . . . . 0.93 109.947 179.648 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' D' D ' 75' ' ' VAL . . . . . . . . . . . . . 43.9 t -113.97 122.38 67.97 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.213 0 CA-C-O 121.118 0.485 . . . . 0.71 110.555 -177.654 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' D' D ' 76' ' ' LEU . . . . . . . . . . . . . 14.1 mt -125.92 138.26 53.76 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 115.52 -0.764 . . . . 1.2 109.059 175.77 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' D' D ' 77' ' ' GLU . . . . . . . . . . . . . 73.3 tt0 -136.43 141.93 43.62 Favored 'General case' 0 C--N 1.332 -0.17 0 CA-C-O 121.118 0.485 . . . . 1.29 111.591 -173.762 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' D' D ' 78' ' ' ALA . . . . . . . . . . . . . . . -127.88 145.12 51.05 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 115.52 -0.764 . . . . 0.68 109.94 177.476 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' D' D ' 79' ' ' LYS . . . . . 0.563 ' O ' HD13 ' D' ' 80' ' ' ILE . 45.8 mttm -81.48 123.86 28.97 Favored 'General case' 0 C--N 1.331 -0.234 0 C-N-CA 120.753 -0.379 . . . . 3.12 110.688 178.913 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' D' D ' 80' ' ' ILE . . . . . 0.563 HD13 ' O ' ' D' ' 79' ' ' LYS . 42.8 mm -138.46 113.7 9.23 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.343 0 N-CA-C 109.212 -0.662 . . . . 0.59 109.212 -179.15 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' D' D ' 81' ' ' LYS . . . . . . . . . . . . . 58.6 mttp -102.04 121.94 43.14 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-O 120.784 0.326 . . . . 3.19 111.243 -176.536 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' D' D ' 82' ' ' GLY . . . . . . . . . . . . . . . 89.07 42.14 5.69 Favored Glycine 0 CA--C 1.525 0.702 0 C-N-CA 120.935 -0.65 . . . . 0.48 112.006 173.702 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' D' D ' 83' ' ' ILE . . . . . . . . . . . . . 76.3 mt -65.69 136.93 25.88 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.257 0 N-CA-C 109.765 -0.457 . . . . 0.52 109.765 177.113 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' D' D ' 84' ' ' LYS . . . . . . . . . . . . . 55.2 tttp -98.66 -53.63 3.25 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.21 -0.45 . . . . 1.6 110.275 -178.757 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' D' D ' 85' ' ' ASP . . . . . . . . . . . . . 20.9 t0 -152.86 149.72 28.57 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 115.755 -0.657 . . . . 0.83 110.28 -179.756 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' D' D ' 86' ' ' VAL . . . . . . . . . . . . . 40.5 t -133.79 131.16 56.42 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.286 0 CA-C-O 120.973 0.416 . . . . 0.47 110.56 -179.702 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' D' D ' 87' ' ' ILE . . . . . . . . . . . . . 45.3 mm -119.85 129.54 75.27 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.243 0 CA-C-N 115.795 -0.639 . . . . 1.31 109.695 176.857 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' D' D ' 88' ' ' LEU . . . . . 0.503 HD22 HG12 ' C' ' 131' ' ' VAL . 17.0 tp -112.6 135.75 52.96 Favored 'General case' 0 C--N 1.331 -0.203 0 CA-C-O 121.083 0.468 . . . . 1.72 111.289 -177.354 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' D' D ' 89' ' ' ASP . . . . . . . . . . . . . 20.6 t70 -128.62 155.11 45.48 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 115.545 -0.752 . . . . 0.88 109.253 174.587 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' D' D ' 90' ' ' GLU . . . . . . . . . . . . . 82.6 tt0 -46.97 -39.95 13.43 Favored 'General case' 0 C--N 1.33 -0.243 0 N-CA-C 112.964 0.727 . . . . 2.54 112.964 -171.887 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' D' D ' 91' ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER -132.07 37.85 3.55 Favored 'General case' 0 N--CA 1.463 0.189 0 CA-C-O 120.836 0.351 . . . . 2.21 111.437 -177.223 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' D' D ' 92' ' ' LEU . . . . . . . . . . . . . 11.7 tp -166.09 140.37 4.43 Favored 'General case' 0 C--N 1.33 -0.246 0 C-N-CA 121.01 -0.276 . . . . 1.41 110.602 -179.038 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' D' D ' 93' ' ' ILE . . . . . . . . . . . . . 71.3 mt -124.14 122.62 64.75 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.188 0 N-CA-C 109.653 -0.499 . . . . 0.47 109.653 178.679 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' D' D ' 94' ' ' VAL . . . . . 0.706 HG21 HG11 ' D' ' 125' ' ' VAL . 42.9 t -120.77 125.07 73.64 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.214 0 N-CA-C 109.901 -0.407 . . . . 0.44 109.901 179.52 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' D' D ' 95' ' ' VAL . . . . . . . . . . . . . 42.9 t -123.88 135.16 64.42 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.25 0 CA-C-N 116.097 -0.502 . . . . 0.38 110.109 -178.448 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' D' D ' 96' ' ' ILE . . . . . . . . . . . . . 58.3 mt -116.59 128.49 73.94 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.28 0 N-CA-C 109.256 -0.646 . . . . 0.51 109.256 178.37 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' D' D ' 97' ' ' THR . . . . . . . . . . . . . 81.2 p -103.7 155.79 18.3 Favored 'General case' 0 C--N 1.331 -0.222 0 CA-C-O 121.356 0.598 . . . . 0.48 111.561 -176.74 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' D' D ' 98' ' ' GLU . . . . . . . . . . . . . 84.8 tt0 -54.0 -27.26 30.6 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 115.836 -0.62 . . . . 2.67 112.191 179.504 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' D' D ' 99' ' ' GLU . . . . . . . . . . . . . 46.0 mp0 -78.93 16.2 0.94 Allowed 'General case' 0 CA--C 1.536 0.406 0 N-CA-C 113.123 0.786 . . . . 2.3 113.123 -177.474 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' D' D ' 100' ' ' ASN . . . . . . . . . . . . . 1.8 m-20 63.59 37.34 10.37 Favored 'General case' 0 CA--C 1.529 0.147 0 CA-C-O 121.007 0.432 . . . . 0.62 110.945 176.757 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' D' D ' 101' ' ' GLU . . . . . . . . . . . . . 84.9 tt0 -116.52 144.69 44.03 Favored 'General case' 0 C--N 1.332 -0.157 0 CA-C-N 116.187 -0.461 . . . . 1.1 109.892 176.88 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' D' D ' 102' ' ' VAL . . . . . . . . . . . . . 46.7 t -114.98 125.36 72.28 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.32 0 CA-C-N 116.116 -0.493 . . . . 0.43 109.815 -179.206 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' D' D ' 103' ' ' LEU . . . . . 0.408 HD23 ' HG3' ' D' ' 114' ' ' ARG . 19.2 mt -117.36 128.93 55.52 Favored 'General case' 0 C--N 1.331 -0.219 0 CA-C-N 115.789 -0.642 . . . . 0.97 110.19 178.08 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' D' D ' 104' ' ' ILE . . . . . . . . . . . . . 71.9 mt -119.09 120.69 64.68 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.278 0 N-CA-C 110.042 -0.355 . . . . 0.39 110.042 177.807 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' D' D ' 105' ' ' PHE . . . . . . . . . . . . . 97.4 m-85 -118.47 161.23 20.34 Favored 'General case' 0 C--N 1.332 -0.187 0 O-C-N 124.084 0.865 . . . . 0.42 110.129 -178.627 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' D' D ' 106' ' ' ASN . . . . . . . . . . . . . 18.4 p-10 -93.26 -170.63 2.44 Favored 'General case' 0 C--N 1.329 -0.315 0 N-CA-C 109.805 -0.443 . . . . 0.53 109.805 172.278 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' D' D ' 107' ' ' GLN . . . . . . . . . . . . . 48.8 tt0 -59.63 -30.2 68.54 Favored 'General case' 0 C--N 1.328 -0.336 0 N-CA-C 112.0 0.37 . . . . 1.77 112.0 -179.849 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' D' D ' 108' ' ' ASN . . . . . . . . . . . . . 5.5 t-20 -85.55 8.29 19.86 Favored 'General case' 0 CA--C 1.536 0.428 0 N-CA-C 113.293 0.849 . . . . 1.37 113.293 -177.292 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' D' D ' 109' ' ' LEU . . . . . . . . . . . . . 13.6 tp 61.97 43.76 8.84 Favored 'General case' 0 C--N 1.332 -0.18 0 CA-C-O 121.377 0.608 . . . . 1.37 110.854 178.797 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' D' D ' 110' ' ' GLU . . . . . . . . . . . . . 77.7 mm-40 -114.23 143.66 44.48 Favored 'General case' 0 C--N 1.331 -0.224 0 CA-C-N 116.035 -0.53 . . . . 2.08 109.998 176.557 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' D' D ' 111' ' ' GLU . . . . . . . . . . . . . 96.3 mt-10 -72.03 123.02 21.9 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-O 120.908 0.385 . . . . 1.92 111.197 -177.392 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' D' D ' 112' ' ' LEU . . . . . . . . . . . . . 12.3 mt -108.09 -44.89 4.06 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 115.932 -0.576 . . . . 0.62 109.795 175.0 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' D' D ' 113' ' ' TYR . . . . . . . . . . . . . 71.9 t80 -136.62 132.32 34.9 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 115.969 -0.56 . . . . 0.58 110.549 178.785 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' D' D ' 114' ' ' ARG . . . . . 0.408 ' HG3' HD23 ' D' ' 103' ' ' LEU . 56.3 ttp180 -139.74 121.75 15.66 Favored 'General case' 0 C--N 1.331 -0.225 0 CA-C-O 120.823 0.344 . . . . 3.47 110.498 178.662 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' D' D ' 115' ' ' GLY . . . . . . . . . . . . . . . -150.12 163.07 29.39 Favored Glycine 0 CA--C 1.524 0.604 0 N-CA-C 110.949 -0.86 . . . . 0.52 110.949 179.779 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' D' D ' 116' ' ' LYS . . . . . . . . . . . . . 40.2 ttpt -128.84 138.1 51.86 Favored 'General case' 0 C--N 1.331 -0.237 0 N-CA-C 110.098 -0.334 . . . . 1.54 110.098 177.84 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' D' D ' 117' ' ' PHE . . . . . . . . . . . . . 42.6 m-85 -135.81 113.89 11.34 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-N 116.334 -0.394 . . . . 0.55 110.148 -177.757 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' D' D ' 118' ' ' GLU . . . . . . . . . . . . . 96.9 mt-10 -56.97 -43.74 81.93 Favored 'General case' 0 C--N 1.328 -0.338 0 C-N-CA 120.883 -0.327 . . . . 2.59 110.832 -177.0 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' D' D ' 119' ' ' ASN . . . . . . . . . . . . . 10.1 m120 -96.44 30.98 2.36 Favored 'General case' 0 C--N 1.328 -0.349 0 N-CA-C 112.116 0.413 . . . . 1.6 112.116 -174.765 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' D' D ' 120' ' ' LEU . . . . . . . . . . . . . 20.2 tp -57.7 120.0 7.61 Favored 'General case' 0 N--CA 1.461 0.104 0 N-CA-C 110.009 -0.367 . . . . 0.63 110.009 176.854 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' D' D ' 121' ' ' ASN . . . . . . . . . . . . . 8.4 t-20 -111.95 -44.1 3.5 Favored 'General case' 0 C--N 1.332 -0.156 0 CA-C-N 116.597 -0.274 . . . . 2.02 111.132 -175.423 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' D' D ' 122' ' ' LYS . . . . . . . . . . . . . 98.4 mttt -143.82 145.17 32.15 Favored 'General case' 0 C--N 1.33 -0.274 0 C-N-CA 120.691 -0.404 . . . . 1.81 111.728 -177.316 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' D' D ' 123' ' ' VAL . . . . . . . . . . . . . 45.0 t -127.92 128.73 69.41 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.295 0 N-CA-C 109.383 -0.599 . . . . 0.62 109.383 175.318 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' D' D ' 124' ' ' LEU . . . . . . . . . . . . . 8.2 tp -130.81 134.73 47.09 Favored 'General case' 0 C--N 1.332 -0.179 0 CA-C-O 120.932 0.396 . . . . 1.62 110.367 -178.292 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' D' D ' 125' ' ' VAL . . . . . 0.706 HG11 HG21 ' D' ' 94' ' ' VAL . 35.1 m -130.66 137.53 55.87 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.208 0 CA-C-N 116.251 -0.431 . . . . 1.73 110.991 -178.551 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' D' D ' 126' ' ' ARG . . . . . . . . . . . . . 96.7 mtt-85 -148.71 119.21 7.4 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 115.947 -0.57 . . . . 3.32 109.934 176.097 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' D' D ' 127' ' ' ASN . . . . . . . . . . . . . 2.0 t30 56.29 -149.06 0.47 Allowed 'General case' 0 CA--C 1.541 0.632 0 N-CA-C 109.723 -0.473 . . . . 2.38 109.723 179.669 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' D' D ' 128' ' ' ASP . . . . . . . . . . . . . 11.8 p-10 -80.43 13.06 2.61 Favored 'General case' 0 CA--C 1.537 0.444 0 CA-C-N 118.78 0.718 . . . . 1.18 112.93 -179.993 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' D' D ' 129' ' ' LEU . . . . . . . . . . . . . 15.7 tp -110.02 133.15 53.5 Favored 'General case' 0 C--O 1.232 0.175 0 CA-C-N 118.217 0.462 . . . . 1.83 110.085 178.423 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' D' D ' 130' ' ' VAL . . . . . . . . . . . . . 41.4 t -122.65 139.81 48.37 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.308 0 CA-C-N 116.578 -0.283 . . . . 1.36 110.498 -176.987 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' D' D ' 131' ' ' VAL . . . . . 0.413 HG22 HD12 ' D' ' 140' ' ' LEU . 40.7 t -133.93 134.86 55.62 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.192 0 CA-C-O 121.087 0.47 . . . . 0.64 110.484 177.536 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' D' D ' 132' ' ' ILE . . . . . . . . . . . . . 72.3 mt -117.95 134.07 62.74 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.269 0 CA-C-N 115.61 -0.723 . . . . 0.49 109.424 179.294 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' D' D ' 133' ' ' ILE . . . . . . . . . . . . . 29.7 mm -115.35 120.57 65.06 Favored 'Isoleucine or valine' 0 C--O 1.234 0.262 0 CA-C-N 116.5 -0.318 . . . . 0.52 110.763 -175.254 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' D' D ' 134' ' ' ASP . . . . . . . . . . . . . 5.6 p-10 -136.41 148.14 47.63 Favored 'General case' 0 C--N 1.331 -0.203 0 CA-C-N 116.327 -0.397 . . . . 0.59 109.946 176.331 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' D' D ' 135' ' ' GLU . . . . . . . . . . . . . 84.6 tt0 -49.85 -28.46 6.51 Favored 'General case' 0 C--O 1.236 0.352 0 N-CA-C 112.582 0.586 . . . . 1.68 112.582 -175.277 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' D' D ' 136' ' ' GLN . . . . . . . . . . . . . 94.8 mt-30 -78.26 -36.12 47.29 Favored 'General case' 0 C--N 1.331 -0.223 0 N-CA-C 112.414 0.524 . . . . 2.43 112.414 -176.458 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' D' D ' 137' ' ' LYS . . . . . . . . . . . . . 35.3 pttt -170.06 177.0 4.44 Favored 'General case' 0 C--O 1.233 0.217 0 CA-C-O 121.827 0.822 . . . . 1.39 113.117 -170.821 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' D' D ' 138' ' ' LEU . . . . . . . . . . . . . 9.5 tp -113.18 129.2 56.59 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 114.233 -1.348 . . . . 0.76 109.797 178.311 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' D' D ' 139' ' ' THR . . . . . . . . . . . . . 36.9 m -112.09 126.02 54.73 Favored 'General case' 0 C--N 1.331 -0.22 0 CA-C-O 120.673 0.273 . . . . 0.47 110.616 179.197 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' D' D ' 140' ' ' LEU . . . . . 0.413 HD12 HG22 ' D' ' 131' ' ' VAL . 17.1 tp -115.01 124.28 51.23 Favored 'General case' 0 C--N 1.329 -0.299 0 N-CA-C 108.905 -0.776 . . . . 1.08 108.905 179.261 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' D' D ' 141' ' ' ILE . . . . . . . . . . . . . 20.0 mt -119.91 118.54 57.37 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.375 0 N-CA-C 109.808 -0.441 . . . . 0.53 109.808 -175.796 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' D' D ' 142' ' ' ARG . . . . . . . . . . . . . 74.3 ttt180 -109.75 124.02 50.53 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-N 115.141 -0.936 . . . . 2.96 110.453 -175.472 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' D' D ' 143' ' ' THR . . . . . . . . . . . . . 22.6 p . . . . . 0 C--O 1.22 -0.485 0 CA-C-O 118.015 -0.993 . . . . 1.86 110.601 -179.75 . . . . . . . . 0 0 . 1 . 001 nuclear build core ' E' E ' 2' ' ' SER . . . . . . . . . . . . . 2.0 p . . . . . 0 N--CA 1.461 0.12 0 CA-C-O 121.075 0.464 . . . . 17.92 110.299 . . . . . . . . . 0 0 . 1 . 001 nuclear build core ' E' E ' 3' ' ' GLU . . . . . . . . . . . . . 85.0 tt0 -140.33 139.14 35.37 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-N 115.711 -0.677 . . . . 15.6 110.869 -178.485 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' E' E ' 4' ' ' LEU . . . . . 0.428 HD21 HD21 ' E' ' 6' ' ' LEU . 18.8 tp -122.56 126.34 47.55 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 115.987 -0.551 . . . . 14.43 110.154 177.248 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' E' E ' 5' ' ' LYS . . . . . . . . . . . . . 91.4 mttt -103.43 120.31 40.58 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.238 -0.437 . . . . 11.5 110.319 178.028 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' E' E ' 6' ' ' LEU . . . . . 0.43 HD23 ' HA ' ' E' ' 50' ' ' VAL . 69.6 mt -118.32 149.9 40.4 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 115.565 -0.743 . . . . 12.06 110.437 -178.68 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' E' E ' 7' ' ' LYS . . . . . . . . . . . . . 59.8 tttm -135.67 141.69 38.06 Favored Pre-proline 0 CA--C 1.534 0.351 0 CA-C-O 119.192 -0.432 . . . . 10.04 110.039 176.976 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' E' E ' 8' ' ' PRO . . . . . . . . . . . . . 75.1 Cg_endo -88.52 136.97 3.39 Favored 'Trans proline' 0 N--CA 1.49 1.295 0 C-N-CA 121.643 1.562 . . . . 9.88 111.568 178.924 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' E' E ' 9' ' ' LEU . . . . . . . . . . . . . 81.8 mt -77.72 -52.17 1.7 Allowed Pre-proline 0 C--N 1.33 -0.258 0 CA-C-O 119.057 -0.497 . . . . 13.89 111.587 -177.95 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' E' E ' 10' ' ' PRO . . . . . . . . . . . . . 57.2 Cg_endo -73.19 148.3 43.9 Favored 'Trans proline' 0 N--CA 1.496 1.67 0 C-N-CA 121.049 1.166 . . . . 13.57 111.439 172.399 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' E' E ' 11' ' ' LYS . . . . . . . . . . . . . 63.9 mttp -82.91 97.34 8.63 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-O 120.84 0.352 . . . . 12.82 110.853 -179.124 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' E' E ' 12' ' ' VAL . . . . . . . . . . . . . 12.3 p -142.72 144.25 24.6 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.334 0 CA-C-N 116.09 -0.505 . . . . 14.34 110.422 178.802 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' E' E ' 13' ' ' GLU . . . . . . . . . . . . . 85.0 tt0 -87.0 129.39 34.9 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.312 -0.403 . . . . 14.37 109.947 177.539 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' E' E ' 14' ' ' LEU . . . . . . . . . . . . . 21.3 mt -91.36 148.19 37.07 Favored Pre-proline 0 CA--C 1.533 0.309 0 C-N-CA 120.804 -0.358 . . . . 13.43 110.51 -176.701 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' E' E ' 15' ' ' PRO . . . . . . . . . . . . . 26.5 Cg_exo -62.22 161.2 27.62 Favored 'Trans proline' 0 N--CA 1.496 1.632 0 C-N-CA 121.321 1.348 . . . . 15.98 111.84 175.497 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' E' E ' 16' ' ' PRO . . . . . . . . . . . . . 35.7 Cg_exo -59.08 -31.88 96.38 Favored 'Trans proline' 0 N--CA 1.496 1.673 0 C-N-CA 121.45 1.433 . . . . 15.78 112.704 -178.779 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' E' E ' 17' ' ' ASP . . . . . . . . . . . . . 3.0 p30 -93.58 8.5 40.54 Favored 'General case' 0 CA--C 1.535 0.403 0 N-CA-C 113.302 0.853 . . . . 17.13 113.302 -176.847 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' E' E ' 18' ' ' PHE . . . . . . . . . . . . . 47.4 t80 -57.93 -44.47 86.93 Favored 'General case' 0 C--N 1.334 -0.105 0 CA-C-N 118.098 0.408 . . . . 14.38 110.184 -178.074 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' E' E ' 19' ' ' VAL . . . . . . . . . . . . . 47.8 t -57.35 -42.95 81.44 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 CA-C-N 116.311 -0.404 . . . . 13.57 110.345 -178.624 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' E' E ' 20' ' ' ASP . . . . . . . . . . . . . 8.5 m-20 -59.2 -41.98 89.86 Favored 'General case' 0 C--N 1.329 -0.32 0 C-N-CA 120.85 -0.34 . . . . 15.68 110.554 -178.268 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' E' E ' 21' ' ' VAL . . . . . . . . . . . . . 47.1 t -64.78 -46.78 91.03 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.347 0 C-N-CA 120.829 -0.348 . . . . 17.06 110.612 -178.079 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' E' E ' 22' ' ' ILE . . . . . 0.655 HG22 HD12 ' E' ' 26' ' ' LEU . 48.3 mm -61.22 -34.65 61.48 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 C-N-CA 120.981 -0.287 . . . . 15.74 111.253 -178.303 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' E' E ' 23' ' ' ARG . . . . . . . . . . . . . 58.3 ttp180 -60.52 -51.58 68.82 Favored 'General case' 0 C--N 1.331 -0.235 0 C-N-CA 120.537 -0.465 . . . . 16.75 110.164 176.135 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' E' E ' 24' ' ' ILE . . . . . . . . . . . . . 78.5 mt -60.76 -39.3 81.3 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.323 0 CA-C-N 115.968 -0.56 . . . . 18.88 111.985 -176.467 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' E' E ' 25' ' ' LYS . . . . . . . . . . . . . 11.7 ptmm? -76.67 -39.39 52.28 Favored 'General case' 0 CA--C 1.535 0.37 0 N-CA-C 112.003 0.371 . . . . 19.21 112.003 -174.615 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' E' E ' 26' ' ' LEU . . . . . 0.655 HD12 HG22 ' E' ' 22' ' ' ILE . 30.6 mt -78.82 -32.34 46.19 Favored 'General case' 0 C--N 1.332 -0.183 0 N-CA-C 113.51 0.93 . . . . 18.9 113.51 -172.267 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' E' E ' 27' ' ' GLN . . . . . . . . . . . . . 17.3 pt20 -46.69 139.02 5.57 Favored 'General case' 0 N--CA 1.471 0.593 0 N-CA-C 112.862 0.689 . . . . 20.23 112.862 -175.481 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' E' E ' 28' ' ' GLY . . . . . . . . . . . . . . . 97.17 -22.17 42.2 Favored Glycine 0 CA--C 1.534 1.245 0 CA-C-N 115.554 -0.748 . . . . 22.39 112.554 -177.284 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' E' E ' 29' ' ' LYS . . . . . . . . . . . . . 93.1 mttt -98.29 155.14 17.34 Favored 'General case' 0 C--O 1.232 0.176 0 CA-C-N 117.419 0.609 . . . . 22.36 111.136 -179.469 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' E' E ' 30' ' ' THR . . . . . . . . . . . . . 30.5 m -105.68 139.33 40.44 Favored 'General case' 0 C--N 1.332 -0.191 0 CA-C-N 116.029 -0.532 . . . . 22.55 110.341 177.659 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' E' E ' 31' ' ' VAL . . . . . . . . . . . . . 34.8 m -131.15 154.11 40.15 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.21 0 CA-C-N 116.33 -0.395 . . . . 19.56 110.821 -179.766 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' E' E ' 32' ' ' ARG . . . . . . . . . . . . . 22.2 ttp180 -136.15 151.32 49.63 Favored 'General case' 0 C--N 1.331 -0.219 0 CA-C-O 121.225 0.535 . . . . 24.48 110.439 177.004 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' E' E ' 33' ' ' THR . . . . . . . . . . . . . 41.9 m -52.78 138.64 28.75 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 116.258 -0.428 . . . . 18.58 111.417 -179.228 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' E' E ' 34' ' ' GLY . . . . . . . . . . . . . . . 98.68 -17.1 58.84 Favored Glycine 0 CA--C 1.531 1.092 0 CA-C-N 116.048 -0.524 . . . . 17.78 113.369 177.312 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' E' E ' 35' ' ' ASP . . . . . . . . . . . . . 80.9 m-20 -66.6 147.39 53.34 Favored 'General case' 0 C--O 1.231 0.129 0 CA-C-N 118.015 0.907 . . . . 20.26 111.232 179.488 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' E' E ' 36' ' ' VAL . . . . . . . . . . . . . 44.1 t -121.13 128.2 75.99 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.264 0 N-CA-C 109.443 -0.577 . . . . 18.85 109.443 175.96 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' E' E ' 37' ' ' ILE . . . . . . . . . . . . . 66.4 mt -120.32 139.72 46.71 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.271 0 CA-C-N 116.328 -0.396 . . . . 17.65 110.156 -177.96 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' E' E ' 38' ' ' GLY . . . . . . . . . . . . . . . -108.22 128.57 9.18 Favored Glycine 0 CA--C 1.524 0.653 0 N-CA-C 110.884 -0.887 . . . . 19.38 110.884 177.739 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' E' E ' 39' ' ' ILE . . . . . . . . . . . . . 74.4 mt -124.48 135.31 64.22 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.193 0 N-CA-C 110.085 -0.339 . . . . 18.73 110.085 179.479 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' E' E ' 40' ' ' SER . . . . . 0.51 ' O ' HD13 ' E' ' 41' ' ' ILE . 34.6 t -92.56 116.96 29.46 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.433 -0.349 . . . . 22.11 110.86 176.241 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' E' E ' 41' ' ' ILE . . . . . 0.51 HD13 ' O ' ' E' ' 40' ' ' SER . 48.5 mm -128.94 128.16 67.03 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.19 0 CA-C-O 120.778 0.323 . . . . 20.19 110.407 179.37 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' E' E ' 42' ' ' LEU . . . . . . . . . . . . . 56.7 mt 54.59 33.03 18.24 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.194 -0.457 . . . . 22.67 111.856 177.824 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' E' E ' 43' ' ' GLY . . . . . . . . . . . . . . . 71.16 28.74 69.68 Favored Glycine 0 CA--C 1.532 1.106 0 C-N-CA 121.109 -0.567 . . . . 23.39 112.176 177.872 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' E' E ' 44' ' ' LYS . . . . . . . . . . . . . 45.9 tttp -141.75 137.7 31.81 Favored 'General case' 0 C--N 1.33 -0.263 0 N-CA-C 109.773 -0.454 . . . . 21.45 109.773 179.464 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' E' E ' 45' ' ' GLU . . . . . . . . . . . . . 83.7 tt0 -82.36 126.64 32.4 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-O 120.934 0.397 . . . . 21.32 111.18 -176.993 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' E' E ' 46' ' ' VAL . . . . . . . . . . . . . 7.6 p -124.32 129.83 73.84 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.222 0 N-CA-C 109.367 -0.605 . . . . 17.3 109.367 175.822 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' E' E ' 47' ' ' LYS . . . . . . . . . . . . . 98.7 mttt -101.07 132.61 46.43 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.087 -0.506 . . . . 19.29 111.364 179.799 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' E' E ' 48' ' ' PHE . . . . . . . . . . . . . 92.3 m-85 -117.01 132.02 56.8 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.267 -0.424 . . . . 14.33 110.364 176.952 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' E' E ' 49' ' ' LYS . . . . . . . . . . . . . 84.6 tttt -106.78 137.28 45.11 Favored 'General case' 0 C--N 1.331 -0.23 0 CA-C-N 116.503 -0.317 . . . . 14.41 110.45 178.045 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' E' E ' 50' ' ' VAL . . . . . 0.43 ' HA ' HD23 ' E' ' 6' ' ' LEU . 44.7 t -84.29 111.13 19.68 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.258 0 N-CA-C 109.245 -0.65 . . . . 14.75 109.245 175.701 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' E' E ' 51' ' ' VAL . . . . . . . . . . . . . 46.8 t -72.66 -46.72 53.37 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.317 0 CA-C-N 116.265 -0.425 . . . . 13.28 110.053 -174.269 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' E' E ' 52' ' ' GLN . . . . . . . . . . . . . 46.9 tt0 -169.04 142.6 2.87 Favored 'General case' 0 C--N 1.331 -0.205 0 C-N-CA 120.295 -0.562 . . . . 14.71 111.776 -178.922 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' E' E ' 53' ' ' ALA . . . . . . . . . . . . . . . -116.13 135.41 53.95 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-N 115.714 -0.675 . . . . 17.09 110.106 176.589 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' E' E ' 54' ' ' TYR . . . . . . . . . . . . . 62.5 t80 -128.94 109.23 18.34 Favored Pre-proline 0 CA--C 1.536 0.427 0 CA-C-O 118.26 -0.876 . . . . 20.27 110.181 178.688 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' E' E ' 55' ' ' PRO . . . . . . . . . . . . . 74.0 Cg_endo -77.09 170.06 72.65 Favored 'Cis proline' 0 N--CA 1.499 1.826 0 CA-C-N 121.81 1.682 . . . . 20.84 112.445 -4.544 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' E' E ' 56' ' ' SER . . . . . . . . . . . . . 13.6 m -113.99 126.96 27.34 Favored Pre-proline 0 CA--C 1.538 0.498 0 CA-C-O 118.405 -0.807 . . . . 22.33 109.476 176.28 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' E' E ' 57' ' ' PRO . . . . . . . . . . . . . 56.9 Cg_endo -72.64 169.04 73.39 Favored 'Cis proline' 0 N--CA 1.497 1.704 0 CA-C-N 122.083 1.78 . . . . 23.32 111.848 -0.096 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' E' E ' 58' ' ' LEU . . . . . . . . . . . . . 28.9 tp -130.0 137.7 50.42 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.139 -0.482 . . . . 19.78 110.294 179.95 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' E' E ' 59' ' ' ARG . . . . . . . . . . . . . 52.2 ttp180 -105.19 128.75 53.55 Favored 'General case' 0 C--N 1.328 -0.35 0 N-CA-C 109.239 -0.652 . . . . 24.23 109.239 176.106 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' E' E ' 60' ' ' VAL . . . . . . . . . . . . . 41.9 t -85.39 119.08 33.38 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.272 0 C-N-CA 120.607 -0.437 . . . . 18.94 110.919 -173.992 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' E' E ' 61' ' ' GLU . . . . . . . . . . . . . 47.2 mt-10 -131.03 170.11 14.94 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 115.703 -0.68 . . . . 21.28 109.492 174.29 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' E' E ' 62' ' ' ASP . . . . . . . . . . . . . 4.5 m-20 -53.23 -32.67 49.46 Favored 'General case' 0 C--N 1.329 -0.308 0 N-CA-C 111.925 0.343 . . . . 19.55 111.925 -177.609 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' E' E ' 63' ' ' ARG . . . . . . . . . . . . . 98.2 mtt180 -73.13 -22.0 60.62 Favored 'General case' 0 CA--C 1.533 0.289 0 N-CA-C 113.038 0.755 . . . . 21.98 113.038 -176.188 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' E' E ' 64' ' ' THR . . . . . . . . . . . . . 26.7 m -66.42 137.24 56.71 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-O 120.983 0.42 . . . . 17.14 111.061 -174.692 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' E' E ' 65' ' ' LYS . . . . . . . . . . . . . 67.5 mttm -89.71 129.79 36.08 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 115.927 -0.579 . . . . 16.15 109.967 177.207 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' E' E ' 66' ' ' ILE . . . . . . . . . . . . . 63.2 mt -118.83 129.57 74.86 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.287 0 N-CA-C 109.849 -0.426 . . . . 13.46 109.849 -179.775 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' E' E ' 67' ' ' THR . . . . . . . . . . . . . 25.9 m -127.38 139.82 52.59 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-O 120.95 0.405 . . . . 10.58 110.994 -178.165 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' E' E ' 68' ' ' LEU . . . . . . . . . . . . . 65.4 mt . . . . . 0 C--N 1.331 -0.226 0 CA-C-N 116.056 -0.52 . . . . 8.76 110.528 177.912 . . . . . . . . 0 0 . 1 . 001 nuclear build core ' E' E ' 73' ' ' VAL . . . . . . . . . . . . . 26.9 m . . . . . 0 C--O 1.232 0.138 0 CA-C-O 120.972 0.415 . . . . 1.03 110.452 . . . . . . . . . 0 0 . 1 . 001 nuclear build core ' E' E ' 74' ' ' ASP . . . . . . . . . . . . . 21.6 t0 -96.08 119.91 35.42 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 115.907 -0.588 . . . . 0.96 109.544 179.853 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' E' E ' 75' ' ' VAL . . . . . . . . . . . . . 41.8 t -107.54 119.32 56.93 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.268 0 CA-C-O 121.071 0.462 . . . . 0.72 110.233 -178.973 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' E' E ' 76' ' ' LEU . . . . . . . . . . . . . 34.8 mt -115.11 137.86 51.54 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 115.592 -0.731 . . . . 1.25 109.435 177.232 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' E' E ' 77' ' ' GLU . . . . . . . . . . . . . 98.0 mt-10 -134.06 131.45 38.84 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-O 121.064 0.459 . . . . 1.17 111.061 -177.769 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' E' E ' 78' ' ' ALA . . . . . . . . . . . . . . . -119.1 124.07 45.99 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 115.654 -0.703 . . . . 0.61 109.625 176.419 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' E' E ' 79' ' ' LYS . . . . . 0.606 ' O ' HD13 ' E' ' 80' ' ' ILE . 7.8 ttpm? -74.58 122.82 23.73 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-O 120.876 0.369 . . . . 2.97 110.615 -177.162 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' E' E ' 80' ' ' ILE . . . . . 0.606 HD13 ' O ' ' E' ' 79' ' ' LYS . 39.6 mm -139.06 113.72 7.84 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.298 0 N-CA-C 109.009 -0.737 . . . . 0.63 109.009 -178.443 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' E' E ' 81' ' ' LYS . . . . . . . . . . . . . 29.2 tttp -98.94 118.12 35.0 Favored 'General case' 0 C--N 1.327 -0.397 0 CA-C-N 116.524 -0.307 . . . . 2.98 110.646 -175.381 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' E' E ' 82' ' ' GLY . . . . . . . . . . . . . . . 89.16 42.32 5.62 Favored Glycine 0 CA--C 1.527 0.818 0 C-N-CA 120.421 -0.895 . . . . 0.62 112.058 175.282 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' E' E ' 83' ' ' ILE . . . . . . . . . . . . . 77.1 mt -61.67 142.37 16.37 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.293 0 N-CA-C 109.704 -0.48 . . . . 0.62 109.704 175.994 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' E' E ' 84' ' ' LYS . . . . . . . . . . . . . 84.9 tttt -98.68 -54.02 3.14 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.11 -0.495 . . . . 1.64 110.536 -178.293 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' E' E ' 85' ' ' ASP . . . . . . . . . . . . . 11.6 t70 -156.37 155.67 32.58 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 115.769 -0.651 . . . . 0.83 110.254 -178.912 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' E' E ' 86' ' ' VAL . . . . . . . . . . . . . 43.5 t -129.28 130.86 67.86 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.268 0 CA-C-O 121.048 0.451 . . . . 0.58 110.622 -178.308 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' E' E ' 87' ' ' ILE . . . . . . . . . . . . . 44.1 mm -118.74 122.81 70.34 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.281 0 CA-C-N 115.651 -0.704 . . . . 1.46 109.249 175.653 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' E' E ' 88' ' ' LEU . . . . . . . . . . . . . 14.4 tp -115.03 131.7 56.84 Favored 'General case' 0 C--N 1.331 -0.217 0 CA-C-O 121.014 0.435 . . . . 1.69 111.256 -176.072 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' E' E ' 89' ' ' ASP . . . . . . . . . . . . . 21.3 t70 -125.5 154.41 42.12 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 115.788 -0.642 . . . . 0.91 109.472 175.427 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' E' E ' 90' ' ' GLU . . . . . . . . . . . . . 48.1 mt-10 -49.46 -34.43 16.79 Favored 'General case' 0 C--N 1.328 -0.336 0 N-CA-C 112.845 0.683 . . . . 2.25 112.845 -171.653 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' E' E ' 91' ' ' ASN . . . . . . . . . . . . . 37.6 p-10 -132.0 32.2 4.07 Favored 'General case' 0 N--CA 1.466 0.33 0 N-CA-C 112.17 0.433 . . . . 2.37 112.17 -176.096 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' E' E ' 92' ' ' LEU . . . . . . . . . . . . . 16.0 tp -166.04 141.75 4.87 Favored 'General case' 0 C--N 1.329 -0.292 0 C-N-CA 120.886 -0.326 . . . . 1.45 110.668 179.56 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' E' E ' 93' ' ' ILE . . . . . . . . . . . . . 69.1 mt -121.45 121.75 65.43 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.217 0 N-CA-C 109.722 -0.473 . . . . 0.57 109.722 -179.583 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' E' E ' 94' ' ' VAL . . . . . . . . . . . . . 45.1 t -122.74 126.64 74.21 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.202 0 N-CA-C 109.969 -0.382 . . . . 0.53 109.969 179.212 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' E' E ' 95' ' ' VAL . . . . . . . . . . . . . 42.2 t -124.0 135.88 62.15 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.307 0 CA-C-N 116.276 -0.42 . . . . 0.75 110.01 -179.377 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' E' E ' 96' ' ' ILE . . . . . . . . . . . . . 59.2 mt -115.38 132.46 64.66 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.248 0 N-CA-C 109.429 -0.582 . . . . 0.54 109.429 179.408 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' E' E ' 97' ' ' THR . . . . . . . . . . . . . 68.9 p -103.56 158.92 16.03 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-O 120.906 0.384 . . . . 0.59 110.782 -179.579 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' E' E ' 98' ' ' GLU . . . . . . . . . . . . . 96.9 mt-10 -53.85 -24.21 15.04 Favored 'General case' 0 CA--C 1.533 0.327 0 N-CA-C 112.413 0.523 . . . . 2.63 112.413 -179.983 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' E' E ' 99' ' ' GLU . . . . . . . . . . . . . 95.3 mt-10 -78.43 14.36 1.27 Allowed 'General case' 0 CA--C 1.535 0.385 0 N-CA-C 113.218 0.821 . . . . 2.62 113.218 -176.7 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' E' E ' 100' ' ' ASN . . . . . . . . . . . . . 2.7 m-20 61.8 38.03 15.11 Favored 'General case' 0 N--CA 1.463 0.193 0 CA-C-O 121.148 0.499 . . . . 0.76 110.922 179.221 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' E' E ' 101' ' ' GLU . . . . . . . . . . . . . 61.2 tt0 -119.98 142.35 48.86 Favored 'General case' 0 C--N 1.331 -0.217 0 CA-C-N 116.093 -0.503 . . . . 0.85 109.673 176.404 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' E' E ' 102' ' ' VAL . . . . . . . . . . . . . 46.3 t -115.25 130.19 70.22 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.291 0 CA-C-N 116.227 -0.442 . . . . 0.49 110.162 -178.521 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' E' E ' 103' ' ' LEU . . . . . . . . . . . . . 20.0 mt -117.35 133.93 55.41 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 115.502 -0.772 . . . . 1.1 110.066 176.221 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' E' E ' 104' ' ' ILE . . . . . 0.604 HD13 HG11 ' E' ' 130' ' ' VAL . 67.0 mt -119.48 124.91 73.81 Favored 'Isoleucine or valine' 0 C--O 1.234 0.284 0 N-CA-C 110.192 -0.299 . . . . 0.49 110.192 179.912 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' E' E ' 105' ' ' PHE . . . . . . . . . . . . . 67.4 m-85 -123.92 163.4 21.39 Favored 'General case' 0 C--O 1.232 0.151 0 O-C-N 124.013 0.821 . . . . 0.56 110.182 -179.444 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' E' E ' 106' ' ' ASN . . . . . . . . . . . . . 40.1 p30 -98.39 -171.94 2.23 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.421 -0.354 . . . . 0.71 110.327 175.651 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' E' E ' 107' ' ' GLN . . . . . . . . . . . . . 59.5 tt0 -58.37 -29.53 66.08 Favored 'General case' 0 CA--C 1.534 0.329 0 N-CA-C 111.858 0.318 . . . . 1.69 111.858 178.774 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' E' E ' 108' ' ' ASN . . . . . . . . . . . . . 7.5 t-20 -83.24 10.95 7.29 Favored 'General case' 0 CA--C 1.536 0.422 0 N-CA-C 112.933 0.716 . . . . 1.39 112.933 -177.729 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' E' E ' 109' ' ' LEU . . . . . . . . . . . . . 12.5 tp 54.82 37.66 28.91 Favored 'General case' 0 C--N 1.332 -0.169 0 CA-C-O 121.023 0.44 . . . . 1.41 111.08 -179.509 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' E' E ' 110' ' ' GLU . . . . . . . . . . . . . 95.4 mt-10 -104.78 145.91 29.7 Favored 'General case' 0 C--N 1.331 -0.224 0 N-CA-C 109.704 -0.48 . . . . 1.89 109.704 175.275 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' E' E ' 111' ' ' GLU . . . . . . . . . . . . . 80.2 tt0 -83.69 122.15 28.24 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.401 -0.363 . . . . 1.32 110.747 -175.783 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' E' E ' 112' ' ' LEU . . . . . . . . . . . . . 49.4 mt -109.14 -45.26 3.79 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-N 116.095 -0.502 . . . . 0.64 111.128 -179.275 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' E' E ' 113' ' ' TYR . . . . . . . . . . . . . 58.0 t80 -132.96 137.58 46.62 Favored 'General case' 0 N--CA 1.464 0.238 0 CA-C-O 120.839 0.352 . . . . 0.47 111.36 -176.828 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' E' E ' 114' ' ' ARG . . . . . . . . . . . . . 47.5 ttp180 -138.73 123.66 18.88 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 115.831 -0.622 . . . . 2.83 110.123 177.361 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' E' E ' 115' ' ' GLY . . . . . . . . . . . . . . . -150.14 140.09 7.78 Favored Glycine 0 CA--C 1.526 0.719 0 C-N-CA 120.737 -0.744 . . . . 0.48 111.356 178.732 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' E' E ' 116' ' ' LYS . . . . . . . . . . . . . 27.5 ttpp -110.37 134.59 52.15 Favored 'General case' 0 C--N 1.33 -0.24 0 N-CA-C 109.748 -0.464 . . . . 1.84 109.748 176.618 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' E' E ' 117' ' ' PHE . . . . . . . . . . . . . 31.7 m-85 -135.57 113.9 11.52 Favored 'General case' 0 C--N 1.332 -0.191 0 C-N-CA 120.871 -0.331 . . . . 0.59 110.158 -176.817 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' E' E ' 118' ' ' GLU . . . . . . . . . . . . . 96.3 mt-10 -55.59 -45.71 77.36 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.519 -0.31 . . . . 2.45 111.176 -176.191 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' E' E ' 119' ' ' ASN . . . . . . . . . . . . . 68.3 m-80 -95.99 30.0 2.56 Favored 'General case' 0 C--N 1.329 -0.287 0 N-CA-C 112.22 0.452 . . . . 1.54 112.22 -174.172 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' E' E ' 120' ' ' LEU . . . . . . . . . . . . . 22.0 tp -58.39 122.13 12.54 Favored 'General case' 0 C--N 1.333 -0.149 0 N-CA-C 110.027 -0.36 . . . . 0.64 110.027 177.509 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' E' E ' 121' ' ' ASN . . . . . . . . . . . . . 68.2 m-20 -113.99 -44.07 3.19 Favored 'General case' 0 C--O 1.232 0.147 0 CA-C-N 116.534 -0.303 . . . . 1.89 111.094 -178.081 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' E' E ' 122' ' ' LYS . . . . . . . . . . . . . 60.7 mttm -145.1 149.51 35.16 Favored 'General case' 0 C--N 1.332 -0.18 0 CA-C-O 121.28 0.562 . . . . 1.81 112.064 -177.028 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' E' E ' 123' ' ' VAL . . . . . . . . . . . . . 47.3 t -126.68 129.66 71.59 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.239 0 CA-C-N 115.627 -0.715 . . . . 0.54 109.461 175.536 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' E' E ' 124' ' ' LEU . . . . . . . . . . . . . 57.6 mt -121.98 139.56 53.53 Favored 'General case' 0 N--CA 1.463 0.212 0 CA-C-N 116.551 -0.295 . . . . 1.39 110.792 -178.114 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' E' E ' 125' ' ' VAL . . . . . 0.585 HG12 HG23 ' E' ' 130' ' ' VAL . 34.3 m -137.23 139.87 43.25 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.239 0 CA-C-O 121.042 0.448 . . . . 1.56 111.603 -178.723 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' E' E ' 126' ' ' ARG . . . . . . . . . . . . . 93.4 mtt-85 -147.77 115.57 6.41 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 115.687 -0.688 . . . . 3.5 110.19 174.207 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' E' E ' 127' ' ' ASN . . . . . . . . . . . . . 93.4 m-20 53.79 -129.92 2.21 Favored 'General case' 0 CA--C 1.545 0.786 0 CA-C-O 118.557 -0.735 . . . . 2.24 110.552 179.578 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' E' E ' 128' ' ' ASP . . . . . . . . . . . . . 5.1 p30 -91.82 5.78 48.6 Favored 'General case' 0 CA--C 1.536 0.42 0 CA-C-N 120.078 1.308 . . . . 1.0 113.457 -178.216 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' E' E ' 129' ' ' LEU . . . . . . . . . . . . . 15.3 tp -105.41 134.51 48.41 Favored 'General case' 0 C--N 1.333 -0.115 0 CA-C-N 118.17 0.441 . . . . 1.81 109.834 178.555 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' E' E ' 130' ' ' VAL . . . . . 0.604 HG11 HD13 ' E' ' 104' ' ' ILE . 12.4 p -132.17 143.32 40.37 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.165 0 CA-C-O 121.019 0.438 . . . . 1.29 110.705 -177.943 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' E' E ' 131' ' ' VAL . . . . . 0.581 HG22 HD12 ' E' ' 140' ' ' LEU . 38.9 t -136.0 140.09 44.66 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.278 0 CA-C-N 116.034 -0.53 . . . . 0.91 110.437 -179.086 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' E' E ' 132' ' ' ILE . . . . . . . . . . . . . 76.3 mt -114.98 133.88 59.78 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.288 0 CA-C-N 115.67 -0.695 . . . . 0.53 109.472 179.515 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' E' E ' 133' ' ' ILE . . . . . . . . . . . . . 38.0 mm -116.57 119.16 61.14 Favored 'Isoleucine or valine' 0 C--O 1.236 0.345 0 CA-C-N 116.537 -0.301 . . . . 0.46 110.989 -175.58 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' E' E ' 134' ' ' ASP . . . . . . . . . . . . . 5.8 p-10 -135.21 148.5 49.65 Favored 'General case' 0 C--N 1.332 -0.167 0 N-CA-C 109.809 -0.441 . . . . 0.56 109.809 174.753 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' E' E ' 135' ' ' GLU . . . . . . . . . . . . . 44.6 tp10 -50.01 -28.06 6.41 Favored 'General case' 0 C--N 1.329 -0.323 0 N-CA-C 112.702 0.63 . . . . 2.01 112.702 -172.222 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' E' E ' 136' ' ' GLN . . . . . . . . . . . . . 95.9 mt-30 -81.98 -37.63 26.33 Favored 'General case' 0 C--O 1.234 0.272 0 N-CA-C 112.683 0.623 . . . . 2.44 112.683 -175.694 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' E' E ' 137' ' ' LYS . . . . . . . . . . . . . 20.3 pttp -160.47 169.52 22.85 Favored 'General case' 0 C--O 1.234 0.251 0 CA-C-O 121.825 0.821 . . . . 1.77 113.192 -169.801 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' E' E ' 138' ' ' LEU . . . . . . . . . . . . . 7.7 tp -111.96 127.83 55.98 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 114.085 -1.416 . . . . 0.51 109.459 177.859 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' E' E ' 139' ' ' THR . . . . . . . . . . . . . 27.3 m -113.59 123.59 50.33 Favored 'General case' 0 C--N 1.331 -0.221 0 CA-C-O 120.614 0.245 . . . . 0.42 110.39 178.699 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' E' E ' 140' ' ' LEU . . . . . 0.581 HD12 HG22 ' E' ' 131' ' ' VAL . 8.1 tp -113.36 121.39 44.21 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 115.884 -0.598 . . . . 1.01 109.44 -179.439 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' E' E ' 141' ' ' ILE . . . . . 0.514 ' HB ' HG13 ' E' ' 130' ' ' VAL . 19.4 mt -121.14 122.79 68.46 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.307 0 CA-C-O 121.053 0.454 . . . . 0.49 109.791 -176.218 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' E' E ' 142' ' ' ARG . . . . . . . . . . . . . 50.6 ttp180 -117.35 129.46 55.89 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 115.382 -0.826 . . . . 3.09 110.587 -175.51 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' E' E ' 143' ' ' THR . . . . . . . . . . . . . 11.6 p . . . . . 0 C--O 1.22 -0.458 0 CA-C-O 117.938 -1.03 . . . . 1.57 110.603 179.642 . . . . . . . . 0 0 . 1 . 001 nuclear build core ' F' F ' 1' ' ' MET . . . . . . . . . . . . . 26.2 ptt? . . . . . 0 C--O 1.231 0.102 0 CA-C-O 120.945 0.402 . . . . 22.8 111.283 . . . . . . . . . 0 0 . 1 . 001 nuclear build core ' F' F ' 2' ' ' SER . . . . . . . . . . . . . 4.4 p -121.85 135.71 54.91 Favored 'General case' 0 C--N 1.332 -0.187 0 CA-C-N 116.001 -0.545 . . . . 20.13 110.4 177.243 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' F' F ' 3' ' ' GLU . . . . . . . . . . . . . 46.0 mt-10 -141.25 142.74 33.9 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.218 -0.446 . . . . 17.46 111.133 -178.055 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' F' F ' 4' ' ' LEU . . . . . . . . . . . . . 13.5 tp -127.24 133.25 50.24 Favored 'General case' 0 C--N 1.331 -0.202 0 CA-C-N 115.886 -0.597 . . . . 15.24 109.989 176.813 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' F' F ' 5' ' ' LYS . . . . . . . . . . . . . 92.6 mttt -112.99 120.68 42.22 Favored 'General case' 0 C--O 1.234 0.273 0 CA-C-N 116.409 -0.359 . . . . 13.01 110.952 -179.573 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' F' F ' 6' ' ' LEU . . . . . . . . . . . . . 35.6 mt -113.91 149.06 35.73 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 115.289 -0.869 . . . . 12.6 110.23 179.713 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' F' F ' 7' ' ' LYS . . . . . . . . . . . . . 42.6 tttt -139.71 142.01 29.9 Favored Pre-proline 0 CA--C 1.533 0.307 0 CA-C-O 119.176 -0.44 . . . . 10.04 110.248 174.553 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' F' F ' 8' ' ' PRO . . . . . . . . . . . . . 85.5 Cg_endo -91.62 139.58 2.32 Favored 'Trans proline' 0 N--CA 1.489 1.241 0 C-N-CA 121.838 1.692 . . . . 9.67 111.782 177.997 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' F' F ' 9' ' ' LEU . . . . . . . . . . . . . 83.6 mt -70.1 -47.57 21.38 Favored Pre-proline 0 CA--C 1.533 0.293 0 CA-C-O 118.656 -0.688 . . . . 13.6 111.975 179.612 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' F' F ' 10' ' ' PRO . . . . . . . . . . . . . 84.4 Cg_endo -80.52 151.52 19.79 Favored 'Trans proline' 0 N--CA 1.495 1.586 0 C-N-CA 121.172 1.248 . . . . 13.17 111.859 175.615 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' F' F ' 11' ' ' LYS . . . . . . . . . . . . . 28.0 ttpt -83.69 103.75 13.25 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-O 120.81 0.338 . . . . 12.33 110.183 178.286 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' F' F ' 12' ' ' VAL . . . . . . . . . . . . . 12.7 p -141.02 147.41 22.59 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.258 0 CA-C-N 116.164 -0.471 . . . . 14.09 110.574 -178.589 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' F' F ' 13' ' ' GLU . . . . . . . . . . . . . 95.2 mt-10 -85.92 124.89 32.89 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 116.349 -0.387 . . . . 14.23 110.376 179.152 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' F' F ' 14' ' ' LEU . . . . . . . . . . . . . 30.9 mt -99.48 147.37 33.25 Favored Pre-proline 0 CA--C 1.532 0.284 0 CA-C-O 119.163 -0.446 . . . . 14.0 110.471 -179.186 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' F' F ' 15' ' ' PRO . . . . . . . . . . . . . 24.0 Cg_exo -63.85 154.65 68.55 Favored 'Trans proline' 0 N--CA 1.499 1.836 0 C-N-CA 121.354 1.369 . . . . 16.72 112.07 176.964 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' F' F ' 16' ' ' PRO . . . . . . . . . . . . . 39.8 Cg_exo -59.45 -35.58 95.78 Favored 'Trans proline' 0 N--CA 1.498 1.738 0 C-N-CA 121.368 1.379 . . . . 17.12 112.381 177.836 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' F' F ' 17' ' ' ASP . . . . . . . . . . . . . 6.1 p-10 -82.92 11.87 5.59 Favored 'General case' 0 C--N 1.327 -0.398 0 N-CA-C 112.95 0.722 . . . . 18.76 112.95 -179.341 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' F' F ' 18' ' ' PHE . . . . . . . . . . . . . 36.7 t80 -57.34 -44.17 84.05 Favored 'General case' 0 C--O 1.227 -0.11 0 O-C-N 121.914 -0.491 . . . . 15.4 110.196 -178.523 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' F' F ' 19' ' ' VAL . . . . . . . . . . . . . 47.4 t -55.55 -42.1 66.84 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.29 0 CA-C-N 116.417 -0.356 . . . . 15.15 110.786 -177.825 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' F' F ' 20' ' ' ASP . . . . . . . . . . . . . 5.2 t70 -60.14 -44.1 95.2 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-O 120.9 0.381 . . . . 18.08 110.969 -177.498 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' F' F ' 21' ' ' VAL . . . . . . . . . . . . . 47.5 t -65.6 -47.91 84.58 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.307 0 C-N-CA 120.576 -0.449 . . . . 18.15 110.593 -178.625 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' F' F ' 22' ' ' ILE . . . . . 0.456 ' CG2' HD12 ' F' ' 26' ' ' LEU . 49.1 mm -55.45 -58.46 4.53 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.315 0 C-N-CA 121.119 -0.232 . . . . 16.72 111.151 -177.976 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' F' F ' 23' ' ' ARG . . . . . . . . . . . . . 6.1 ptm180 -54.99 -44.0 74.06 Favored 'General case' 0 CA--C 1.53 0.189 0 C-N-CA 120.54 -0.464 . . . . 19.2 111.632 -173.696 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' F' F ' 24' ' ' ILE . . . . . . . . . . . . . 85.0 mt -60.06 -43.46 92.76 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.223 0 C-N-CA 120.796 -0.361 . . . . 20.65 111.404 -177.362 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' F' F ' 25' ' ' LYS . . . . . . . . . . . . . 93.3 mttt -71.55 -43.85 65.63 Favored 'General case' 0 C--N 1.33 -0.281 0 N-CA-C 112.823 0.675 . . . . 19.9 112.823 -177.933 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' F' F ' 26' ' ' LEU . . . . . 0.456 HD12 ' CG2' ' F' ' 22' ' ' ILE . 79.0 mt -79.04 -27.36 43.16 Favored 'General case' 0 C--N 1.329 -0.289 0 N-CA-C 113.777 1.029 . . . . 19.69 113.777 -169.301 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' F' F ' 27' ' ' GLN . . . . . . . . . . . . . 18.0 pt20 -46.78 139.83 5.07 Favored 'General case' 0 N--CA 1.469 0.523 0 N-CA-C 112.894 0.702 . . . . 21.81 112.894 -175.741 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' F' F ' 28' ' ' GLY . . . . . . . . . . . . . . . 100.66 -20.41 48.28 Favored Glycine 0 CA--C 1.534 1.221 0 CA-C-N 115.501 -0.772 . . . . 23.21 112.744 -179.0 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' F' F ' 29' ' ' LYS . . . . . . . . . . . . . 62.0 mttp -96.34 155.08 16.91 Favored 'General case' 0 C--O 1.231 0.101 0 CA-C-N 117.843 0.821 . . . . 22.44 110.99 177.726 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' F' F ' 30' ' ' THR . . . . . . . . . . . . . 30.1 m -107.02 138.97 42.17 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 115.96 -0.564 . . . . 23.24 109.948 177.584 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' F' F ' 31' ' ' VAL . . . . . . . . . . . . . 35.1 m -128.33 152.61 36.68 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.172 0 CA-C-N 116.352 -0.386 . . . . 20.1 110.779 -179.045 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' F' F ' 32' ' ' ARG . . . . . . . . . . . . . 2.8 mpt_? -131.37 150.72 52.04 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.009 -0.541 . . . . 24.75 109.976 177.195 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' F' F ' 33' ' ' THR . . . . . . . . . . . . . 14.6 m -53.68 137.39 37.53 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.426 -0.352 . . . . 18.77 111.394 -177.953 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' F' F ' 34' ' ' GLY . . . . . . . . . . . . . . . 99.88 -17.08 57.81 Favored Glycine 0 CA--C 1.533 1.198 0 C-N-CA 121.186 -0.531 . . . . 17.72 113.348 178.869 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' F' F ' 35' ' ' ASP . . . . . . . . . . . . . 60.1 m-20 -64.92 150.71 47.37 Favored 'General case' 0 C--O 1.231 0.091 0 CA-C-N 117.977 0.888 . . . . 20.13 111.487 -179.253 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' F' F ' 36' ' ' VAL . . . . . . . . . . . . . 47.7 t -121.91 129.14 75.68 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.205 0 CA-C-N 115.641 -0.709 . . . . 18.53 109.844 178.037 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' F' F ' 37' ' ' ILE . . . . . . . . . . . . . 73.9 mt -122.09 140.48 45.89 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.245 0 CA-C-N 116.299 -0.41 . . . . 17.49 110.068 -179.731 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' F' F ' 38' ' ' GLY . . . . . . . . . . . . . . . -110.52 128.68 8.92 Favored Glycine 0 CA--C 1.526 0.761 0 N-CA-C 111.092 -0.803 . . . . 19.07 111.092 179.476 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' F' F ' 39' ' ' ILE . . . . . . . . . . . . . 74.7 mt -123.47 133.35 69.43 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.262 0 N-CA-C 110.087 -0.338 . . . . 18.48 110.087 178.845 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' F' F ' 40' ' ' SER . . . . . . . . . . . . . 25.0 t -93.46 123.03 36.49 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.509 -0.314 . . . . 21.9 111.352 177.584 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' F' F ' 41' ' ' ILE . . . . . . . . . . . . . 73.2 mt -123.79 116.41 48.03 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.214 0 CA-C-N 116.348 -0.387 . . . . 20.06 110.136 176.667 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' F' F ' 42' ' ' LEU . . . . . . . . . . . . . 8.7 mp 51.06 37.08 16.98 Favored 'General case' 0 N--CA 1.465 0.313 0 CA-C-O 121.174 0.511 . . . . 22.47 111.507 178.694 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' F' F ' 43' ' ' GLY . . . . . . . . . . . . . . . 74.06 32.21 58.82 Favored Glycine 0 CA--C 1.529 0.948 0 C-N-CA 121.163 -0.541 . . . . 23.1 112.016 178.95 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' F' F ' 44' ' ' LYS . . . . . . . . . . . . . 87.6 tttt -130.62 125.9 35.27 Favored 'General case' 0 C--N 1.331 -0.232 0 N-CA-C 109.535 -0.543 . . . . 21.12 109.535 177.227 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' F' F ' 45' ' ' GLU . . . . . . . . . . . . . 82.1 tt0 -84.39 115.6 22.61 Favored 'General case' 0 C--N 1.328 -0.369 0 C-N-CA 120.811 -0.356 . . . . 20.71 110.966 -178.891 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' F' F ' 46' ' ' VAL . . . . . . . . . . . . . 7.3 p -115.25 130.36 69.93 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.243 0 N-CA-C 109.191 -0.67 . . . . 16.87 109.191 175.38 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' F' F ' 47' ' ' LYS . . . . . . . . . . . . . 63.5 mttp -99.48 125.81 45.3 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 115.97 -0.559 . . . . 18.86 111.119 179.089 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' F' F ' 48' ' ' PHE . . . . . . . . . . . . . 87.6 m-85 -108.9 131.95 54.53 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.078 -0.51 . . . . 14.18 109.899 176.735 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' F' F ' 49' ' ' LYS . . . . . . . . . . . . . 46.8 tttm -106.31 137.34 44.44 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.222 -0.445 . . . . 14.73 110.326 179.483 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' F' F ' 50' ' ' VAL . . . . . . . . . . . . . 47.6 t -81.04 107.09 13.0 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.333 0 N-CA-C 109.324 -0.621 . . . . 14.98 109.324 175.769 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' F' F ' 51' ' ' VAL . . . . . . . . . . . . . 56.6 t -70.57 -53.49 22.22 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.312 0 CA-C-N 115.864 -0.607 . . . . 13.92 109.452 -175.282 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' F' F ' 52' ' ' GLN . . . . . . . . . . . . . 88.1 mt-30 -154.34 151.96 29.68 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 115.99 -0.55 . . . . 15.71 111.822 -178.31 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' F' F ' 53' ' ' ALA . . . . . . . . . . . . . . . -129.68 130.79 45.98 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 115.21 -0.905 . . . . 18.15 109.552 174.06 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' F' F ' 54' ' ' TYR . . . . . . . . . . . . . 8.3 t80 -129.18 110.55 18.12 Favored Pre-proline 0 CA--C 1.535 0.383 0 CA-C-O 118.214 -0.898 . . . . 22.12 110.038 177.652 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' F' F ' 55' ' ' PRO . . . . . . . . . . . . . 74.0 Cg_endo -77.16 169.75 73.37 Favored 'Cis proline' 0 N--CA 1.5 1.857 0 CA-C-N 121.999 1.75 . . . . 22.21 112.666 -2.796 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' F' F ' 56' ' ' SER . . . . . . . . . . . . . 13.6 m -116.82 127.95 26.37 Favored Pre-proline 0 CA--C 1.539 0.554 0 CA-C-O 118.383 -0.818 . . . . 23.18 109.474 176.643 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' F' F ' 57' ' ' PRO . . . . . . . . . . . . . 37.6 Cg_endo -66.95 167.94 55.24 Favored 'Cis proline' 0 N--CA 1.497 1.726 0 CA-C-N 121.994 1.748 . . . . 24.03 111.466 -1.103 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' F' F ' 58' ' ' LEU . . . . . . . . . . . . . 33.5 tp -129.43 135.82 49.15 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-O 120.935 0.398 . . . . 20.69 110.507 -179.834 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' F' F ' 59' ' ' ARG . . . . . . . . . . . . . 52.5 ttt85 -97.56 127.23 43.35 Favored 'General case' 0 C--N 1.326 -0.417 0 N-CA-C 109.259 -0.645 . . . . 25.29 109.259 177.237 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' F' F ' 60' ' ' VAL . . . . . . . . . . . . . 42.6 t -82.52 114.68 23.77 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.208 0 C-N-CA 120.564 -0.454 . . . . 20.51 110.2 -176.169 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' F' F ' 61' ' ' GLU . . . . . . . . . . . . . 95.7 mt-10 -131.14 158.15 41.24 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 115.806 -0.634 . . . . 23.66 110.117 177.844 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' F' F ' 62' ' ' ASP . . . . . . . . . . . . . 4.6 p-10 -55.51 -32.46 62.91 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-N 116.511 -0.313 . . . . 21.75 111.513 177.951 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' F' F ' 63' ' ' ARG . . . . . . . . . . . . . 14.4 ptp180 -75.59 -4.94 42.84 Favored 'General case' 0 CA--C 1.535 0.389 0 N-CA-C 113.578 0.955 . . . . 25.02 113.578 -177.177 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' F' F ' 64' ' ' THR . . . . . . . . . . . . . 30.5 m -91.76 145.97 24.14 Favored 'General case' 0 C--N 1.332 -0.156 0 CA-C-N 118.271 0.487 . . . . 19.14 110.376 -178.036 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' F' F ' 65' ' ' LYS . . . . . . . . . . . . . 51.9 mtmt -87.55 124.9 33.97 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-O 121.109 0.481 . . . . 19.04 110.328 179.998 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' F' F ' 66' ' ' ILE . . . . . . . . . . . . . 71.5 mt -116.29 124.38 72.46 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.289 0 N-CA-C 109.704 -0.48 . . . . 15.12 109.704 -179.555 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' F' F ' 67' ' ' THR . . . . . . . . . . . . . 25.3 m -123.59 146.27 48.28 Favored 'General case' 0 C--N 1.331 -0.223 0 CA-C-O 121.054 0.455 . . . . 12.47 111.201 -175.776 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' F' F ' 68' ' ' LEU . . . . . 0.49 HD12 ' N ' ' F' ' 68' ' ' LEU . 8.2 mp . . . . . 0 C--N 1.329 -0.291 0 CA-C-N 115.902 -0.59 . . . . 9.77 110.664 178.796 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' F' F ' 73' ' ' VAL . . . . . . . . . . . . . 33.4 m . . . . . 0 C--O 1.231 0.093 0 CA-C-O 120.88 0.371 . . . . 1.16 110.737 . . . . . . . . . 0 0 . 1 . 001 nuclear build core ' F' F ' 74' ' ' ASP . . . . . 0.431 ' OD1' HD11 ' F' ' 76' ' ' LEU . 2.5 t70 -101.35 127.96 47.74 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 115.954 -0.567 . . . . 1.06 109.947 179.825 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' F' F ' 75' ' ' VAL . . . . . . . . . . . . . 42.2 t -119.59 124.31 72.68 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.277 0 CA-C-O 120.935 0.398 . . . . 0.62 110.607 -178.273 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' F' F ' 76' ' ' LEU . . . . . 0.431 HD11 ' OD1' ' F' ' 74' ' ' ASP . 5.8 mp -122.48 140.72 52.42 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 115.825 -0.625 . . . . 1.06 109.79 175.689 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' F' F ' 77' ' ' GLU . . . . . . . . . . . . . 98.2 mt-10 -133.69 140.75 47.23 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-O 121.075 0.464 . . . . 1.24 111.324 -178.442 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' F' F ' 78' ' ' ALA . . . . . . . . . . . . . . . -130.9 130.2 43.21 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 115.8 -0.636 . . . . 0.61 109.971 176.326 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' F' F ' 79' ' ' LYS . . . . . 0.584 ' O ' HD13 ' F' ' 80' ' ' ILE . 35.5 mmtt -76.55 119.43 20.37 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-O 121.05 0.452 . . . . 2.99 110.847 179.334 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' F' F ' 80' ' ' ILE . . . . . 0.584 HD13 ' O ' ' F' ' 79' ' ' LYS . 41.1 mm -139.26 100.86 1.45 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.285 0 N-CA-C 108.814 -0.81 . . . . 0.65 108.814 -179.093 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' F' F ' 81' ' ' LYS . . . . . . . . . . . . . 81.3 tttt -91.41 127.5 36.88 Favored 'General case' 0 C--N 1.327 -0.388 0 C-N-CA 120.804 -0.358 . . . . 3.19 111.085 -174.967 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' F' F ' 82' ' ' GLY . . . . . . . . . . . . . . . 89.16 42.16 5.66 Favored Glycine 0 CA--C 1.525 0.715 0 C-N-CA 120.772 -0.728 . . . . 0.65 111.974 174.961 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' F' F ' 83' ' ' ILE . . . . . . . . . . . . . 70.4 mt -72.78 138.02 22.28 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.241 0 N-CA-C 109.611 -0.514 . . . . 0.6 109.611 175.802 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' F' F ' 84' ' ' LYS . . . . . . . . . . . . . 55.7 tttp -97.89 -53.99 3.23 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.13 -0.486 . . . . 1.54 110.377 -178.325 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' F' F ' 85' ' ' ASP . . . . . . . . . . . . . 22.5 t70 -148.88 148.5 29.93 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 115.92 -0.582 . . . . 0.75 110.54 -177.381 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' F' F ' 86' ' ' VAL . . . . . . . . . . . . . 43.8 t -129.77 130.25 66.58 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.259 0 CA-C-O 120.924 0.393 . . . . 0.48 110.49 -179.518 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' F' F ' 87' ' ' ILE . . . . . 0.496 HD12 ' N ' ' F' ' 87' ' ' ILE . 5.1 mp -115.59 125.66 72.86 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.283 0 CA-C-N 115.8 -0.636 . . . . 1.33 109.352 176.51 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' F' F ' 88' ' ' LEU . . . . . . . . . . . . . 18.1 tp -111.49 131.2 55.39 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-O 121.056 0.455 . . . . 1.67 111.297 -176.465 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' F' F ' 89' ' ' ASP . . . . . . . . . . . . . 31.4 t0 -130.99 153.97 48.66 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 115.718 -0.674 . . . . 0.83 109.546 176.225 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' F' F ' 90' ' ' GLU . . . . . . . . . . . . . 95.9 mt-10 -49.34 -37.98 26.49 Favored 'General case' 0 C--N 1.328 -0.331 0 N-CA-C 112.749 0.648 . . . . 2.21 112.749 -171.959 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' F' F ' 91' ' ' ASN . . . . . . . . . . . . . 25.6 m120 -122.57 14.54 10.23 Favored 'General case' 0 N--CA 1.469 0.5 0 N-CA-C 113.193 0.812 . . . . 2.27 113.193 -176.84 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' F' F ' 92' ' ' LEU . . . . . . . . . . . . . 49.0 mt -148.74 141.52 24.6 Favored 'General case' 0 C--N 1.332 -0.195 0 CA-C-O 120.838 0.351 . . . . 1.42 110.516 -175.919 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' F' F ' 93' ' ' ILE . . . . . . . . . . . . . 73.2 mt -124.65 116.17 46.63 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.37 0 N-CA-C 109.063 -0.717 . . . . 0.46 109.063 176.256 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' F' F ' 94' ' ' VAL . . . . . 0.558 HG11 HG11 ' F' ' 123' ' ' VAL . 45.0 t -117.36 125.16 73.84 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.249 0 N-CA-C 109.907 -0.405 . . . . 0.46 109.907 -178.439 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' F' F ' 95' ' ' VAL . . . . . . . . . . . . . 42.2 t -120.84 133.41 67.6 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.344 0 CA-C-N 116.055 -0.52 . . . . 0.42 109.766 -179.739 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' F' F ' 96' ' ' ILE . . . . . . . . . . . . . 59.1 mt -114.01 128.11 71.12 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.297 0 N-CA-C 109.124 -0.695 . . . . 0.46 109.124 178.353 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' F' F ' 97' ' ' THR . . . . . . . . . . . . . 62.7 p -101.1 161.37 13.65 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-O 121.034 0.445 . . . . 0.5 110.999 -177.65 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' F' F ' 98' ' ' GLU . . . . . . . . . . . . . 97.3 mt-10 -54.03 -26.09 24.71 Favored 'General case' 0 CA--C 1.532 0.284 0 N-CA-C 112.345 0.498 . . . . 2.47 112.345 179.958 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' F' F ' 99' ' ' GLU . . . . . . . . . . . . . 95.1 mt-10 -77.69 13.08 1.4 Allowed 'General case' 0 CA--C 1.535 0.384 0 N-CA-C 113.24 0.829 . . . . 2.06 113.24 -177.748 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' F' F ' 100' ' ' ASN . . . . . . . . . . . . . 2.9 m-20 61.23 37.61 17.22 Favored 'General case' 0 CA--C 1.529 0.169 0 CA-C-O 121.106 0.479 . . . . 0.74 110.955 179.442 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' F' F ' 101' ' ' GLU . . . . . . . . . . . . . 84.0 tt0 -115.93 144.72 43.67 Favored 'General case' 0 C--N 1.334 -0.108 0 CA-C-N 116.062 -0.517 . . . . 0.54 109.606 176.182 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' F' F ' 102' ' ' VAL . . . . . . . . . . . . . 45.5 t -114.97 125.35 72.27 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.261 0 CA-C-N 116.291 -0.413 . . . . 0.44 109.963 -178.092 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' F' F ' 103' ' ' LEU . . . . . . . . . . . . . 26.4 mt -113.44 128.84 56.59 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 115.621 -0.718 . . . . 0.86 109.909 175.883 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' F' F ' 104' ' ' ILE . . . . . . . . . . . . . 65.3 mt -118.42 119.16 60.37 Favored 'Isoleucine or valine' 0 C--O 1.233 0.229 0 N-CA-C 110.308 -0.256 . . . . 0.45 110.308 -179.25 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' F' F ' 105' ' ' PHE . . . . . . . . . . . . . 49.0 m-85 -118.99 169.45 9.89 Favored 'General case' 0 C--N 1.332 -0.157 0 CA-C-N 115.423 -0.808 . . . . 0.49 109.71 177.152 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' F' F ' 106' ' ' ASN . . . . . . . . . . . . . 51.2 p-10 -102.03 -170.15 1.78 Allowed 'General case' 0 C--N 1.33 -0.277 0 N-CA-C 109.886 -0.413 . . . . 0.62 109.886 172.987 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' F' F ' 107' ' ' GLN . . . . . 0.423 ' O ' HD21 ' E' ' 140' ' ' LEU . 48.5 tt0 -59.79 -29.96 68.58 Favored 'General case' 0 C--N 1.33 -0.264 0 N-CA-C 111.766 0.284 . . . . 1.17 111.766 178.535 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' F' F ' 108' ' ' ASN . . . . . . . . . . . . . 3.6 t-20 -81.9 9.88 7.39 Favored 'General case' 0 CA--C 1.537 0.459 0 N-CA-C 112.976 0.732 . . . . 1.23 112.976 -178.496 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' F' F ' 109' ' ' LEU . . . . . . . . . . . . . 8.1 tp 58.12 36.38 25.85 Favored 'General case' 0 CA--C 1.529 0.164 0 CA-C-O 120.874 0.369 . . . . 1.33 111.461 177.9 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' F' F ' 110' ' ' GLU . . . . . . . . . . . . . 47.2 mt-10 -105.1 151.22 24.28 Favored 'General case' 0 C--N 1.33 -0.241 0 N-CA-C 109.781 -0.451 . . . . 1.71 109.781 176.67 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' F' F ' 111' ' ' GLU . . . . . . . . . . . . . 83.1 tt0 -83.92 121.92 28.03 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-O 120.858 0.361 . . . . 1.71 110.73 -176.634 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' F' F ' 112' ' ' LEU . . . . . . . . . . . . . 37.4 mt -107.77 -46.2 3.85 Favored 'General case' 0 C--N 1.332 -0.181 0 CA-C-N 116.112 -0.494 . . . . 0.69 110.809 179.241 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' F' F ' 113' ' ' TYR . . . . . . . . . . . . . 42.9 t80 -138.82 139.66 38.27 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-N 116.385 -0.37 . . . . 0.57 111.377 -178.249 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' F' F ' 114' ' ' ARG . . . . . . . . . . . . . 23.7 ttp-105 -136.15 123.75 22.29 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 115.913 -0.585 . . . . 2.6 110.167 176.234 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' F' F ' 115' ' ' GLY . . . . . . . . . . . . . . . -150.06 155.4 26.22 Favored Glycine 0 CA--C 1.521 0.446 0 N-CA-C 110.855 -0.898 . . . . 0.53 110.855 178.677 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' F' F ' 116' ' ' LYS . . . . . . . . . . . . . 33.9 ttmt -127.44 137.78 52.8 Favored 'General case' 0 C--N 1.329 -0.284 0 N-CA-C 109.925 -0.398 . . . . 1.66 109.925 177.009 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' F' F ' 117' ' ' PHE . . . . . . . . . . . . . 31.9 m-85 -137.42 114.51 10.77 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.254 -0.43 . . . . 0.53 109.932 -176.002 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' F' F ' 118' ' ' GLU . . . . . . . . . . . . . 84.4 tt0 -53.77 -42.36 68.16 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.557 -0.292 . . . . 2.71 111.349 -177.134 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' F' F ' 119' ' ' ASN . . . . . . . . . . . . . 30.8 m-80 -99.51 31.14 3.26 Favored 'General case' 0 C--N 1.33 -0.272 0 N-CA-C 112.075 0.398 . . . . 1.32 112.075 -175.062 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' F' F ' 120' ' ' LEU . . . . . . . . . . . . . 25.8 tp -58.53 119.94 7.94 Favored 'General case' 0 C--N 1.332 -0.171 0 N-CA-C 110.033 -0.358 . . . . 0.48 110.033 178.34 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' F' F ' 121' ' ' ASN . . . . . . . . . . . . . 48.3 t30 -114.16 -43.98 3.18 Favored 'General case' 0 C--N 1.332 -0.173 0 CA-C-N 116.372 -0.376 . . . . 1.85 110.909 -178.146 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' F' F ' 122' ' ' LYS . . . . . . . . . . . . . 57.1 mttm -141.62 146.81 36.66 Favored 'General case' 0 C--N 1.331 -0.227 0 CA-C-O 121.111 0.481 . . . . 1.96 111.577 -176.011 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' F' F ' 123' ' ' VAL . . . . . 0.558 HG11 HG11 ' F' ' 94' ' ' VAL . 46.7 t -130.12 129.53 65.47 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.307 0 N-CA-C 109.177 -0.675 . . . . 0.49 109.177 173.82 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' F' F ' 124' ' ' LEU . . . . . . . . . . . . . 81.8 mt -130.95 139.81 50.09 Favored 'General case' 0 C--N 1.332 -0.192 0 CA-C-O 121.086 0.469 . . . . 1.57 111.322 -175.613 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' F' F ' 125' ' ' VAL . . . . . 0.619 HG12 HG23 ' F' ' 130' ' ' VAL . 35.8 m -128.0 131.54 69.43 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.216 0 CA-C-N 115.696 -0.683 . . . . 1.64 110.213 177.689 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' F' F ' 126' ' ' ARG . . . . . . . . . . . . . 77.6 mtt180 -147.39 124.29 11.3 Favored 'General case' 0 C--N 1.327 -0.372 0 N-CA-C 109.656 -0.498 . . . . 3.24 109.656 178.639 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' F' F ' 127' ' ' ASN . . . . . . . . . . . . . 18.4 t30 56.85 -152.3 0.39 Allowed 'General case' 0 CA--C 1.54 0.565 0 N-CA-C 109.57 -0.53 . . . . 2.21 109.57 -178.828 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' F' F ' 128' ' ' ASP . . . . . . . . . . . . . 20.7 p-10 -81.13 14.65 2.22 Favored 'General case' 0 CA--C 1.537 0.46 0 N-CA-C 112.772 0.656 . . . . 1.07 112.772 178.235 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' F' F ' 129' ' ' LEU . . . . . . . . . . . . . 16.5 tp -114.33 137.24 52.06 Favored 'General case' 0 C--O 1.232 0.166 0 O-C-N 122.027 -0.42 . . . . 1.85 109.953 179.315 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' F' F ' 130' ' ' VAL . . . . . 0.619 HG23 HG12 ' F' ' 125' ' ' VAL . 12.3 p -130.22 141.81 45.39 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.268 0 CA-C-O 120.842 0.353 . . . . 1.29 110.528 -178.18 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' F' F ' 131' ' ' VAL . . . . . 0.401 ' CG2' HD21 ' F' ' 138' ' ' LEU . 14.7 p -136.17 143.01 37.1 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.207 0 CA-C-O 121.063 0.458 . . . . 0.89 111.386 -179.584 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' F' F ' 132' ' ' ILE . . . . . . . . . . . . . 70.2 mt -116.15 132.68 64.97 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.32 0 CA-C-N 115.577 -0.738 . . . . 0.41 109.044 176.188 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' F' F ' 133' ' ' ILE . . . . . . . . . . . . . 37.3 mm -116.05 121.75 68.12 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.296 0 CA-C-O 120.785 0.326 . . . . 0.39 111.386 -173.601 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' F' F ' 134' ' ' ASP . . . . . . . . . . . . . 2.8 p30 -130.68 148.64 52.49 Favored 'General case' 0 C--N 1.331 -0.219 0 N-CA-C 109.534 -0.543 . . . . 0.51 109.534 174.294 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' F' F ' 135' ' ' GLU . . . . . . . . . . . . . 84.4 tt0 -50.96 -27.53 7.86 Favored 'General case' 0 C--N 1.326 -0.424 0 N-CA-C 112.955 0.724 . . . . 1.83 112.955 -171.939 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' F' F ' 136' ' ' GLN . . . . . . . . . . . . . 98.1 mt-30 -86.18 -27.82 24.31 Favored 'General case' 0 C--O 1.234 0.24 0 N-CA-C 112.845 0.683 . . . . 1.86 112.845 -175.251 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' F' F ' 137' ' ' LYS . . . . . . . . . . . . . 33.2 pttt -170.01 172.72 6.35 Favored 'General case' 0 C--N 1.331 -0.208 0 CA-C-O 121.588 0.708 . . . . 1.76 112.378 -173.178 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' F' F ' 138' ' ' LEU . . . . . 0.401 HD21 ' CG2' ' F' ' 131' ' ' VAL . 7.1 tt -120.06 130.17 54.56 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 114.998 -1.001 . . . . 0.78 110.048 -179.428 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' F' F ' 139' ' ' THR . . . . . . . . . . . . . 46.5 m -108.51 120.59 42.88 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 116.207 -0.451 . . . . 0.45 109.92 177.786 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' F' F ' 140' ' ' LEU . . . . . . . . . . . . . 17.6 tp -109.71 125.85 53.08 Favored 'General case' 0 C--N 1.329 -0.291 0 N-CA-C 109.31 -0.626 . . . . 1.13 109.31 -178.015 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' F' F ' 141' ' ' ILE . . . . . 0.538 ' HB ' HG13 ' F' ' 130' ' ' VAL . 19.4 mt -123.46 122.76 65.89 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.275 0 CA-C-O 120.843 0.354 . . . . 0.53 110.19 -172.918 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' F' F ' 142' ' ' ARG . . . . . . . . . . . . . 80.6 mtp180 -108.04 126.64 52.97 Favored 'General case' 0 C--N 1.331 -0.219 0 CA-C-N 115.491 -0.777 . . . . 3.85 110.269 -179.466 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' F' F ' 143' ' ' THR . . . . . . . . . . . . . 66.5 p . . . . . 0 C--O 1.22 -0.472 0 CA-C-O 118.09 -0.957 . . . . 1.61 110.493 179.749 . . . . . . . . 0 0 . 1 . 002 nuclear build core ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 2.8 p . . . . . 0 N--CA 1.461 0.119 0 CA-C-O 120.896 0.379 . . . . 0.0 110.479 . . . . . . . . . 0 0 . 1 . 002 nuclear build core ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 84.4 tt0 -140.17 143.36 36.08 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.187 -0.46 . . . . 0.0 110.988 -178.721 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 4' ' ' LEU . . . . . 0.437 HD12 HD23 ' A' ' 58' ' ' LEU . 4.9 tt -127.88 127.24 43.06 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 115.864 -0.607 . . . . 0.0 109.997 177.964 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 5' ' ' LYS . . . . . 0.418 ' N ' HD23 ' A' ' 4' ' ' LEU . 98.0 mttt -108.7 122.8 47.87 Favored 'General case' 0 C--O 1.234 0.249 0 CA-C-O 120.771 0.32 . . . . 0.0 110.909 -179.586 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 22.4 mt -113.99 150.06 34.4 Favored 'General case' 0 C--N 1.332 -0.177 0 CA-C-N 115.393 -0.821 . . . . 0.0 110.065 179.552 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 61.0 tttt -137.95 137.2 20.8 Favored Pre-proline 0 CA--C 1.535 0.377 0 CA-C-O 118.942 -0.552 . . . . 0.0 110.007 175.852 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 8' ' ' PRO . . . . . . . . . . . . . 85.9 Cg_endo -87.61 141.7 5.66 Favored 'Trans proline' 0 N--CA 1.492 1.386 0 C-N-CA 121.541 1.494 . . . . 0.0 111.792 177.575 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 46.7 mt -78.23 -47.07 2.11 Favored Pre-proline 0 CA--C 1.533 0.305 0 CA-C-O 118.745 -0.645 . . . . 0.0 112.275 -179.118 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 92.4 Cg_endo -81.98 153.9 17.05 Favored 'Trans proline' 0 N--CA 1.496 1.655 0 C-N-CA 121.269 1.313 . . . . 0.0 111.901 175.353 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 59.8 mttp -89.38 99.93 12.83 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.458 -0.337 . . . . 0.0 110.82 179.513 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 12.0 p -145.76 143.08 21.78 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.268 0 CA-C-N 116.236 -0.438 . . . . 0.0 110.493 179.198 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 43.9 mp0 -79.88 125.87 30.27 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.379 -0.373 . . . . 0.0 110.148 177.687 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 14' ' ' LEU . . . . . . . . . . . . . 29.5 mt -97.89 154.59 37.75 Favored Pre-proline 0 C--N 1.329 -0.284 0 CA-C-N 116.487 -0.324 . . . . 0.0 111.02 -177.651 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 15' ' ' PRO . . . . . . . . . . . . . 35.4 Cg_exo -59.88 160.6 21.17 Favored 'Trans proline' 0 N--CA 1.497 1.686 0 C-N-CA 121.364 1.376 . . . . 0.0 111.872 177.957 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 16' ' ' PRO . . . . . . . . . . . . . 25.7 Cg_exo -61.33 -43.19 29.74 Favored 'Trans proline' 0 N--CA 1.497 1.686 0 C-N-CA 121.571 1.514 . . . . 0.0 112.571 -179.031 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 17' ' ' ASP . . . . . . . . . . . . . 17.9 p-10 -88.34 17.0 5.57 Favored 'General case' 0 CA--C 1.535 0.371 0 N-CA-C 112.953 0.723 . . . . 0.0 112.953 -177.219 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 18' ' ' PHE . . . . . . . . . . . . . 42.7 t80 -58.27 -45.87 87.07 Favored 'General case' 0 C--N 1.334 -0.087 0 O-C-N 122.142 -0.349 . . . . 0.0 110.081 -178.489 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 19' ' ' VAL . . . . . . . . . . . . . 13.3 p -55.59 -39.69 55.72 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 CA-C-N 116.423 -0.353 . . . . 0.0 110.937 -179.532 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 77.5 m-20 -60.42 -46.65 89.27 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-O 120.926 0.393 . . . . 0.0 110.876 -178.378 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 46.4 t -64.27 -47.25 90.59 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.347 0 CA-C-N 116.365 -0.38 . . . . 0.0 110.561 -177.229 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 22' ' ' ILE . . . . . 0.506 HG22 HD12 ' A' ' 26' ' ' LEU . 50.9 mm -56.36 -45.33 81.5 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.218 0 C-N-CA 120.947 -0.301 . . . . 0.0 110.58 179.335 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 23' ' ' ARG . . . . . . . . . . . . . 59.2 ttp180 -54.24 -46.5 72.57 Favored 'General case' 0 C--N 1.33 -0.27 0 C-N-CA 121.164 -0.215 . . . . 0.0 111.366 -179.062 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 24' ' ' ILE . . . . . . . . . . . . . 74.7 mt -58.91 -45.09 92.03 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 C-N-CA 121.137 -0.225 . . . . 0.0 111.057 -179.467 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 93.8 mttt -65.22 -40.66 94.39 Favored 'General case' 0 C--N 1.329 -0.302 0 N-CA-C 112.352 0.501 . . . . 0.0 112.352 -177.89 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 26' ' ' LEU . . . . . 0.506 HD12 HG22 ' A' ' 22' ' ' ILE . 80.1 mt -79.64 -42.19 25.37 Favored 'General case' 0 C--N 1.33 -0.274 0 N-CA-C 112.898 0.703 . . . . 0.0 112.898 -171.575 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 27' ' ' GLN . . . . . . . . . . . . . 14.2 pt20 -46.05 139.51 4.41 Favored 'General case' 0 N--CA 1.469 0.49 0 N-CA-C 112.79 0.663 . . . . 0.0 112.79 -175.292 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 101.33 -28.61 15.21 Favored Glycine 0 CA--C 1.531 1.058 0 CA-C-N 115.483 -0.781 . . . . 0.0 111.973 -176.779 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 90.4 mttt -98.16 155.23 17.26 Favored 'General case' 0 C--O 1.233 0.203 0 CA-C-N 117.267 0.533 . . . . 0.0 111.055 178.452 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 30' ' ' THR . . . . . . . . . . . . . 38.0 m -101.6 138.36 38.69 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.235 -0.438 . . . . 0.0 109.831 175.026 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 34.5 m -126.31 156.45 36.8 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.191 0 CA-C-N 116.45 -0.341 . . . . 0.0 110.675 -178.822 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 32' ' ' ARG . . . . . . . . . . . . . 90.4 mtt180 -132.93 150.39 52.16 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.0 -0.545 . . . . 0.0 110.683 178.858 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 33' ' ' THR . . . . . . . . . . . . . 24.5 m -52.5 139.07 26.24 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.177 -0.465 . . . . 0.0 111.453 -178.643 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 99.47 -17.14 58.13 Favored Glycine 0 CA--C 1.533 1.175 0 CA-C-O 119.631 -0.538 . . . . 0.0 113.29 178.598 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 74.7 m-20 -65.6 148.72 51.27 Favored 'General case' 0 C--N 1.334 -0.073 0 CA-C-N 118.081 0.941 . . . . 0.0 110.954 179.463 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 46.9 t -123.13 130.1 74.58 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.249 0 CA-C-N 115.87 -0.605 . . . . 0.0 109.797 178.241 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 37' ' ' ILE . . . . . . . . . . . . . 63.3 mt -117.57 137.97 49.76 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.275 0 N-CA-C 109.844 -0.428 . . . . 0.0 109.844 -179.742 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . -108.3 128.75 9.25 Favored Glycine 0 CA--C 1.525 0.701 0 N-CA-C 110.957 -0.857 . . . . 0.0 110.957 179.885 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 39' ' ' ILE . . . . . . . . . . . . . 75.8 mt -127.02 135.51 63.41 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.244 0 N-CA-C 110.12 -0.326 . . . . 0.0 110.12 179.4 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 40' ' ' SER . . . . . . . . . . . . . 11.1 p -92.04 115.15 27.82 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.218 -0.447 . . . . 0.0 110.751 176.085 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 41' ' ' ILE . . . . . . . . . . . . . 43.7 mm -120.82 116.78 50.98 Favored 'Isoleucine or valine' 0 N--CA 1.462 0.171 0 CA-C-O 120.772 0.32 . . . . 0.0 110.498 -179.81 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 6.8 mp 50.9 37.12 16.51 Favored 'General case' 0 C--N 1.331 -0.219 0 CA-C-O 121.081 0.467 . . . . 0.0 111.656 177.301 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . 75.16 30.71 58.52 Favored Glycine 0 CA--C 1.528 0.886 0 C-N-CA 121.072 -0.585 . . . . 0.0 112.345 176.67 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 44' ' ' LYS . . . . . . . . . . . . . 16.5 ttmm -136.04 132.69 36.56 Favored 'General case' 0 C--N 1.33 -0.274 0 N-CA-C 109.861 -0.422 . . . . 0.0 109.861 176.652 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 79.0 tt0 -81.79 113.34 19.68 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.408 -0.36 . . . . 0.0 110.747 -178.844 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 46' ' ' VAL . . . . . . . . . . . . . 7.3 p -116.01 125.92 73.31 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.195 0 N-CA-C 109.628 -0.508 . . . . 0.0 109.628 177.936 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 97.1 mttt -100.48 130.0 46.5 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 115.965 -0.561 . . . . 0.0 111.287 178.445 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 48' ' ' PHE . . . . . . . . . . . . . 80.7 m-85 -111.2 131.95 54.71 Favored 'General case' 0 C--N 1.329 -0.296 0 N-CA-C 109.749 -0.463 . . . . 0.0 109.749 175.902 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 85.5 tttt -107.04 137.01 45.92 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.288 -0.415 . . . . 0.0 110.674 -179.172 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 50' ' ' VAL . . . . . . . . . . . . . 42.9 t -81.26 108.78 14.86 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.262 0 N-CA-C 109.462 -0.57 . . . . 0.0 109.462 176.094 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 51' ' ' VAL . . . . . . . . . . . . . 45.2 t -70.2 -49.29 55.97 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.288 0 CA-C-N 115.971 -0.559 . . . . 0.0 109.924 -174.116 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 52' ' ' GLN . . . . . . . . . . . . . 46.6 tt0 -168.13 142.5 3.45 Favored 'General case' 0 C--N 1.33 -0.273 0 C-N-CA 120.082 -0.647 . . . . 0.0 112.009 -177.378 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 53' ' ' ALA . . . . . 0.453 ' HB3' ' OG ' ' A' ' 56' ' ' SER . . . -113.08 133.39 55.02 Favored 'General case' 0 C--N 1.331 -0.215 0 CA-C-N 115.395 -0.82 . . . . 0.0 109.81 175.496 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 54' ' ' TYR . . . . . . . . . . . . . 50.5 t80 -129.03 107.29 18.02 Favored Pre-proline 0 CA--C 1.534 0.351 0 CA-C-O 118.314 -0.85 . . . . 0.0 110.41 179.709 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 55' ' ' PRO . . . . . . . . . . . . . 72.6 Cg_endo -77.14 169.19 74.92 Favored 'Cis proline' 0 N--CA 1.5 1.884 0 CA-C-N 121.764 1.666 . . . . 0.0 112.291 -4.827 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 56' ' ' SER . . . . . 0.453 ' OG ' ' HB3' ' A' ' 53' ' ' ALA . 74.7 m -117.3 137.31 23.9 Favored Pre-proline 0 CA--C 1.538 0.49 0 CA-C-O 118.494 -0.765 . . . . 0.0 109.691 175.114 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 57' ' ' PRO . . . . . . . . . . . . . 36.5 Cg_endo -66.72 161.66 75.03 Favored 'Cis proline' 0 N--CA 1.499 1.797 0 CA-C-N 121.746 1.659 . . . . 0.0 111.388 -3.385 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 58' ' ' LEU . . . . . 0.437 HD23 HD12 ' A' ' 4' ' ' LEU . 28.8 tp -130.03 137.29 50.18 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-O 120.945 0.403 . . . . 0.0 110.676 -178.785 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 59' ' ' ARG . . . . . . . . . . . . . 73.8 ttt180 -99.11 135.4 40.56 Favored 'General case' 0 C--N 1.327 -0.394 0 N-CA-C 109.513 -0.551 . . . . 0.0 109.513 175.395 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 40.3 t -84.93 116.33 28.28 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.287 0 C-N-CA 120.652 -0.419 . . . . 0.0 110.453 -177.398 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 34.6 tp10 -131.03 155.49 46.78 Favored 'General case' 0 C--N 1.329 -0.288 0 N-CA-C 109.088 -0.708 . . . . 0.0 109.088 177.138 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 62' ' ' ASP . . . . . . . . . . . . . 77.4 m-20 -51.68 -32.26 29.15 Favored 'General case' 0 C--N 1.326 -0.438 0 N-CA-C 112.134 0.42 . . . . 0.0 112.134 -175.787 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 63' ' ' ARG . . . . . . . . . . . . . 34.5 mmt180 -74.48 -21.61 59.49 Favored 'General case' 0 C--N 1.33 -0.281 0 N-CA-C 113.022 0.749 . . . . 0.0 113.022 -175.447 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 20.8 m -63.29 141.44 58.76 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-O 120.849 0.357 . . . . 0.0 110.824 -176.148 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 65' ' ' LYS . . . . . . . . . . . . . 94.4 mttt -84.06 123.96 30.59 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.191 -0.459 . . . . 0.0 109.796 178.013 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 66' ' ' ILE . . . . . . . . . . . . . 54.9 mt -113.83 129.7 69.25 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.247 0 N-CA-C 109.994 -0.373 . . . . 0.0 109.994 -178.803 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 67' ' ' THR . . . . . . . . . . . . . 12.0 m -125.16 136.63 53.78 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-N 116.234 -0.439 . . . . 0.0 110.736 -179.058 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 68' ' ' LEU . . . . . 0.433 ' N ' HD12 ' A' ' 68' ' ' LEU . 7.4 mp . . . . . 0 C--N 1.331 -0.231 0 CA-C-N 116.04 -0.527 . . . . 0.0 110.906 179.397 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 74' ' ' ASP . . . . . . . . . . . . . 15.9 t0 . . . . . 0 CA--C 1.523 -0.064 0 N-CA-C 109.93 -0.396 . . . . 0.0 109.93 . . . . . . . . . 0 0 . 1 . 002 nuclear build core ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 40.9 t -112.98 122.52 67.28 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.271 0 CA-C-O 121.164 0.507 . . . . 0.0 110.432 -178.877 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 76' ' ' LEU . . . . . . . . . . . . . 23.4 mt -119.77 140.52 50.61 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 115.507 -0.77 . . . . 0.0 109.242 178.44 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 77' ' ' GLU . . . . . . . . . . . . . 98.4 mt-10 -136.18 136.96 40.42 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-O 121.102 0.477 . . . . 0.0 111.492 -177.204 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 78' ' ' ALA . . . . . 0.571 ' HB2' HD21 ' A' ' 109' ' ' LEU . . . -125.76 136.15 52.84 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 115.554 -0.748 . . . . 0.0 109.947 176.842 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 79' ' ' LYS . . . . . 0.601 ' O ' HD13 ' A' ' 80' ' ' ILE . 43.3 mmtm -81.52 113.62 19.69 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.405 -0.361 . . . . 0.0 110.562 -179.48 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 80' ' ' ILE . . . . . 0.601 HD13 ' O ' ' A' ' 79' ' ' LYS . 28.5 mm -139.22 104.12 2.09 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.355 0 N-CA-C 109.26 -0.644 . . . . 0.0 109.26 -179.633 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 81' ' ' LYS . . . . . . . . . . . . . 60.4 mtpt -99.71 131.42 45.71 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-O 120.851 0.357 . . . . 0.0 110.81 -177.307 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . 89.2 42.07 5.67 Favored Glycine 0 CA--C 1.525 0.707 0 N-CA-C 111.194 -0.762 . . . . 0.0 111.194 178.34 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 83' ' ' ILE . . . . . . . . . . . . . 70.1 mt -71.08 137.54 23.59 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.308 0 N-CA-C 109.486 -0.561 . . . . 0.0 109.486 176.801 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 84' ' ' LYS . . . . . . . . . . . . . 38.1 ttpt -98.91 -52.62 3.51 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-O 120.843 0.354 . . . . 0.0 110.379 -178.687 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 85' ' ' ASP . . . . . . . . . . . . . 12.6 t70 -151.76 153.16 33.77 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.039 -0.528 . . . . 0.0 110.692 -179.167 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 86' ' ' VAL . . . . . . . . . . . . . 41.9 t -131.4 132.97 62.59 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.248 0 CA-C-O 120.964 0.412 . . . . 0.0 110.421 -178.763 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 87' ' ' ILE . . . . . 0.494 HD12 ' N ' ' A' ' 87' ' ' ILE . 5.1 mp -122.31 129.66 75.13 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.225 0 CA-C-N 115.819 -0.628 . . . . 0.0 109.358 177.351 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 88' ' ' LEU . . . . . . . . . . . . . 25.5 tp -116.28 132.52 56.64 Favored 'General case' 0 C--N 1.331 -0.219 0 CA-C-O 120.995 0.426 . . . . 0.0 111.433 -176.4 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 89' ' ' ASP . . . . . . . . . . . . . 13.4 t70 -127.04 154.84 44.14 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 115.764 -0.653 . . . . 0.0 109.511 175.668 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 96.1 mt-10 -46.72 -39.36 11.42 Favored 'General case' 0 C--N 1.329 -0.288 0 N-CA-C 113.222 0.823 . . . . 0.0 113.222 -171.735 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 91' ' ' ASN . . . . . . . . . . . . . 12.8 m120 -129.56 22.25 5.52 Favored 'General case' 0 N--CA 1.469 0.496 0 N-CA-C 112.802 0.667 . . . . 0.0 112.802 -177.409 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 92' ' ' LEU . . . . . . . . . . . . . 10.1 mt -150.09 141.91 23.74 Favored 'General case' 0 C--N 1.331 -0.209 0 N-CA-C 109.564 -0.532 . . . . 0.0 109.564 -178.094 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 93' ' ' ILE . . . . . . . . . . . . . 72.2 mt -123.99 121.28 61.73 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 N-CA-C 109.412 -0.588 . . . . 0.0 109.412 178.382 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 94' ' ' VAL . . . . . . . . . . . . . 46.3 t -120.3 126.86 75.72 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.264 0 CA-C-O 120.853 0.359 . . . . 0.0 110.145 -178.215 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 95' ' ' VAL . . . . . . . . . . . . . 41.5 t -122.48 134.3 66.1 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.316 0 CA-C-N 116.001 -0.545 . . . . 0.0 109.801 -179.731 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 96' ' ' ILE . . . . . . . . . . . . . 64.4 mt -115.9 126.73 73.53 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.255 0 N-CA-C 109.405 -0.591 . . . . 0.0 109.405 179.221 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 97' ' ' THR . . . . . . . . . . . . . 70.9 p -103.26 157.34 17.08 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-O 121.356 0.598 . . . . 0.0 111.639 -175.505 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 98' ' ' GLU . . . . . . . . . . . . . 81.5 tt0 -53.96 -26.83 27.63 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 115.893 -0.594 . . . . 0.0 112.303 -178.832 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 99' ' ' GLU . . . . . . . . . . . . . 43.2 mt-10 -80.33 17.62 1.03 Allowed 'General case' 0 CA--C 1.533 0.317 0 N-CA-C 113.069 0.766 . . . . 0.0 113.069 -177.096 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 100' ' ' ASN . . . . . . . . . . . . . 3.2 m-20 61.65 37.37 16.08 Favored 'General case' 0 CA--C 1.53 0.174 0 CA-C-O 121.09 0.472 . . . . 0.0 111.014 178.292 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 101' ' ' GLU . . . . . . . . . . . . . 84.2 tt0 -113.12 143.5 44.25 Favored 'General case' 0 C--O 1.232 0.139 0 CA-C-N 116.083 -0.508 . . . . 0.0 109.966 176.52 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 102' ' ' VAL . . . . . . . . . . . . . 46.2 t -114.98 123.8 71.03 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.27 0 N-CA-C 109.658 -0.497 . . . . 0.0 109.658 -179.653 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 103' ' ' LEU . . . . . . . . . . . . . 22.4 mt -115.98 129.51 56.41 Favored 'General case' 0 C--N 1.331 -0.199 0 CA-C-N 115.696 -0.684 . . . . 0.0 110.355 178.36 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 104' ' ' ILE . . . . . 0.519 HD13 HG21 ' A' ' 130' ' ' VAL . 70.5 mt -118.29 120.27 63.87 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.246 0 CA-C-N 116.446 -0.343 . . . . 0.0 110.189 179.081 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 105' ' ' PHE . . . . . . . . . . . . . 57.9 m-85 -121.3 165.4 15.55 Favored 'General case' 0 C--N 1.332 -0.168 0 O-C-N 123.932 0.77 . . . . 0.0 110.155 179.478 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 106' ' ' ASN . . . . . . . . . . . . . 40.9 p-10 -96.88 -169.93 1.96 Allowed 'General case' 0 C--N 1.331 -0.205 0 N-CA-C 109.913 -0.403 . . . . 0.0 109.913 173.636 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 107' ' ' GLN . . . . . . . . . . . . . 63.3 tt0 -58.96 -30.1 67.66 Favored 'General case' 0 C--N 1.329 -0.306 0 N-CA-C 111.781 0.289 . . . . 0.0 111.781 178.38 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 108' ' ' ASN . . . . . . . . . . . . . 52.2 t30 -83.47 7.22 17.59 Favored 'General case' 0 CA--C 1.536 0.437 0 N-CA-C 113.304 0.853 . . . . 0.0 113.304 -177.698 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 109' ' ' LEU . . . . . 0.571 HD21 ' HB2' ' A' ' 78' ' ' ALA . 11.4 tp 59.6 37.24 22.65 Favored 'General case' 0 C--N 1.332 -0.165 0 CA-C-O 121.017 0.437 . . . . 0.0 111.349 178.409 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 110' ' ' GLU . . . . . . . . . . . . . 70.7 mm-40 -103.55 152.12 22.09 Favored 'General case' 0 C--N 1.331 -0.216 0 N-CA-C 109.886 -0.413 . . . . 0.0 109.886 176.019 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 111' ' ' GLU . . . . . . . . . . . . . 83.4 tt0 -79.35 121.98 25.8 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-O 120.944 0.402 . . . . 0.0 110.73 -177.598 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 112' ' ' LEU . . . . . . . . . . . . . 28.8 mt -111.32 -46.04 3.34 Favored 'General case' 0 C--N 1.331 -0.229 0 CA-C-N 116.063 -0.517 . . . . 0.0 110.145 178.1 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 113' ' ' TYR . . . . . . . . . . . . . 59.8 t80 -138.99 133.43 31.73 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-N 116.115 -0.493 . . . . 0.0 111.009 179.59 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 114' ' ' ARG . . . . . . . . . . . . . 60.1 ttp180 -137.19 122.91 19.9 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.167 -0.469 . . . . 0.0 110.179 176.692 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 115' ' ' GLY . . . . . . . . . . . . . . . -150.07 146.66 16.06 Favored Glycine 0 CA--C 1.524 0.618 0 N-CA-C 110.91 -0.876 . . . . 0.0 110.91 178.974 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 116' ' ' LYS . . . . . . . . . . . . . 14.1 ttmm -116.42 134.93 54.3 Favored 'General case' 0 C--N 1.33 -0.271 0 N-CA-C 109.932 -0.396 . . . . 0.0 109.932 178.663 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 117' ' ' PHE . . . . . . . . . . . . . 48.8 m-85 -132.55 116.92 17.32 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-O 121.01 0.433 . . . . 0.0 110.331 -176.123 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 118' ' ' GLU . . . . . . . . . . . . . 43.8 mp0 -55.22 -45.06 75.96 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 116.246 -0.434 . . . . 0.0 111.133 -175.529 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 119' ' ' ASN . . . . . . . . . . . . . 35.1 m120 -98.71 31.0 3.06 Favored 'General case' 0 C--N 1.33 -0.24 0 N-CA-C 112.208 0.447 . . . . 0.0 112.208 -174.331 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 120' ' ' LEU . . . . . . . . . . . . . 31.5 tp -56.79 121.4 9.76 Favored 'General case' 0 C--N 1.333 -0.14 0 CA-C-O 120.752 0.31 . . . . 0.0 110.471 178.028 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 121' ' ' ASN . . . . . . . . . . . . . 20.3 m120 -114.05 -44.12 3.18 Favored 'General case' 0 C--N 1.333 -0.146 0 CA-C-N 116.414 -0.357 . . . . 0.0 111.204 -177.328 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 122' ' ' LYS . . . . . . . . . . . . . 96.1 mttt -144.1 149.85 37.2 Favored 'General case' 0 C--N 1.331 -0.205 0 CA-C-O 121.01 0.433 . . . . 0.0 111.72 -175.609 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 123' ' ' VAL . . . . . . . . . . . . . 47.1 t -129.69 130.4 66.81 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.27 0 N-CA-C 109.399 -0.593 . . . . 0.0 109.399 174.658 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 124' ' ' LEU . . . . . . . . . . . . . 69.9 mt -125.07 140.04 53.25 Favored 'General case' 0 N--CA 1.464 0.267 0 CA-C-O 120.782 0.325 . . . . 0.0 111.094 -177.237 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 125' ' ' VAL . . . . . . . . . . . . . 10.4 p -132.22 131.21 60.97 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.19 0 CA-C-N 116.009 -0.541 . . . . 0.0 110.332 -179.928 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 126' ' ' ARG . . . . . . . . . . . . . 35.3 mmt180 -142.3 118.03 10.45 Favored 'General case' 0 C--N 1.332 -0.192 0 CA-C-O 120.841 0.353 . . . . 0.0 110.733 178.44 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 127' ' ' ASN . . . . . . . . . . . . . 18.3 t-20 50.07 -104.89 0.16 Allowed 'General case' 0 CA--C 1.543 0.702 0 CA-C-O 119.098 -0.477 . . . . 0.0 111.664 178.017 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 128' ' ' ASP . . . . . . . . . . . . . 22.6 p-10 -114.08 3.8 15.41 Favored 'General case' 0 CA--C 1.537 0.478 0 CA-C-N 119.562 1.074 . . . . 0.0 113.451 -176.689 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 129' ' ' LEU . . . . . . . . . . . . . 14.4 tp -110.91 139.76 45.96 Favored 'General case' 0 C--N 1.332 -0.191 0 N-CA-C 109.673 -0.491 . . . . 0.0 109.673 178.374 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 130' ' ' VAL . . . . . 0.519 HG21 HD13 ' A' ' 104' ' ' ILE . 30.1 m -128.64 140.75 48.4 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.226 0 CA-C-O 120.892 0.377 . . . . 0.0 110.176 178.792 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 131' ' ' VAL . . . . . . . . . . . . . 43.8 t -136.06 140.52 43.78 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 CA-C-O 121.257 0.551 . . . . 0.0 110.458 -178.754 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 132' ' ' ILE . . . . . . . . . . . . . 71.8 mt -114.87 132.17 64.88 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.336 0 CA-C-N 115.415 -0.811 . . . . 0.0 109.302 179.28 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 133' ' ' ILE . . . . . . . . . . . . . 39.0 mm -114.25 118.76 59.44 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.236 0 CA-C-N 116.53 -0.304 . . . . 0.0 110.74 -175.604 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 134' ' ' ASP . . . . . . . . . . . . . 8.1 p-10 -133.63 146.31 50.79 Favored 'General case' 0 C--N 1.33 -0.254 0 N-CA-C 109.587 -0.523 . . . . 0.0 109.587 174.95 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 135' ' ' GLU . . . . . . . . . . . . . 80.1 tt0 -49.85 -24.21 2.32 Favored 'General case' 0 C--N 1.328 -0.359 0 N-CA-C 112.782 0.66 . . . . 0.0 112.782 -172.644 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 136' ' ' GLN . . . . . . . . . . . . . 98.7 mt-30 -93.73 -35.35 12.83 Favored 'General case' 0 C--N 1.333 -0.126 0 N-CA-C 112.294 0.479 . . . . 0.0 112.294 -176.243 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 137' ' ' LYS . . . . . . . . . . . . . 88.6 mttt -142.32 153.62 44.02 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-O 121.59 0.709 . . . . 0.0 112.622 -167.788 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 138' ' ' LEU . . . . . . . . . . . . . 14.3 tp -110.7 116.87 32.06 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 114.725 -1.125 . . . . 0.0 108.76 170.725 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 139' ' ' THR . . . . . . . . . . . . . 31.7 m -107.68 121.14 44.09 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-O 120.558 0.218 . . . . 0.0 110.775 -178.165 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 140' ' ' LEU . . . . . 0.475 HD23 ' C ' ' A' ' 140' ' ' LEU . 7.4 tt -112.85 122.83 48.82 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 115.885 -0.598 . . . . 0.0 109.426 -179.372 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 141' ' ' ILE . . . . . 0.514 ' HB ' HG23 ' A' ' 130' ' ' VAL . 18.9 mt -124.09 122.57 64.7 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.254 0 CA-C-O 121.007 0.432 . . . . 0.0 109.891 -175.863 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 142' ' ' ARG . . . . . . . . . . . . . 71.4 ttt180 -108.86 125.24 51.78 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 115.443 -0.799 . . . . 0.0 110.468 -179.196 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 143' ' ' THR . . . . . . . . . . . . . 5.6 p . . . . . 0 C--O 1.219 -0.536 0 CA-C-O 118.028 -0.986 . . . . 0.0 110.457 179.799 . . . . . . . . 0 0 . 1 . 002 nuclear build core ' B' B ' 2' ' ' SER . . . . . . . . . . . . . 90.2 p . . . . . 0 C--O 1.231 0.13 0 CA-C-O 120.795 0.331 . . . . 0.0 110.269 . . . . . . . . . 0 0 . 1 . 002 nuclear build core ' B' B ' 3' ' ' GLU . . . . . . . . . . . . . 95.2 mt-10 -140.41 143.74 35.8 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.274 -0.421 . . . . 0.0 111.147 -177.712 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 4' ' ' LEU . . . . . . . . . . . . . 38.9 mt -121.32 127.01 50.88 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 115.811 -0.631 . . . . 0.0 110.037 175.939 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 5' ' ' LYS . . . . . . . . . . . . . 91.8 mttt -104.64 120.46 41.37 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.29 -0.414 . . . . 0.0 110.468 178.843 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 6' ' ' LEU . . . . . . . . . . . . . 57.8 mt -115.46 148.03 39.91 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 115.564 -0.744 . . . . 0.0 110.406 -179.171 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 7' ' ' LYS . . . . . . . . . . . . . 82.2 tttt -139.95 137.85 18.84 Favored Pre-proline 0 CA--C 1.534 0.357 0 CA-C-O 119.046 -0.502 . . . . 0.0 109.976 176.86 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 8' ' ' PRO . . . . . . . . . . . . . 98.0 Cg_endo -91.44 142.48 2.9 Favored 'Trans proline' 0 N--CA 1.49 1.295 0 C-N-CA 121.734 1.623 . . . . 0.0 111.718 177.719 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 9' ' ' LEU . . . . . . . . . . . . . 52.8 mt -79.23 -46.71 1.64 Allowed Pre-proline 0 CA--C 1.532 0.278 0 CA-C-O 118.847 -0.597 . . . . 0.0 112.105 -179.055 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 10' ' ' PRO . . . . . 0.443 ' HG2' HG23 ' B' ' 46' ' ' VAL . 65.7 Cg_endo -84.36 156.57 12.63 Favored 'Trans proline' 0 N--CA 1.496 1.663 0 C-N-CA 121.309 1.339 . . . . 0.0 111.631 174.488 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' B' B ' 11' ' ' LYS . . . . . . . . . . . . . 20.0 pttm -86.16 120.85 27.97 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-O 120.998 0.428 . . . . 0.0 110.045 176.494 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 12' ' ' VAL . . . . . . . . . . . . . 12.0 p -151.02 148.79 14.7 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.327 0 CA-C-N 116.081 -0.509 . . . . 0.0 110.637 -178.26 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 13' ' ' GLU . . . . . . . . . . . . . 84.7 tt0 -91.62 116.58 28.99 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.279 -0.419 . . . . 0.0 110.132 177.464 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 14' ' ' LEU . . . . . . . . . . . . . 29.5 mt -98.15 146.52 31.66 Favored Pre-proline 0 CA--C 1.532 0.287 0 CA-C-O 119.171 -0.442 . . . . 0.0 110.425 -177.491 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 15' ' ' PRO . . . . . . . . . . . . . 24.0 Cg_exo -64.01 162.18 30.3 Favored 'Trans proline' 0 N--CA 1.498 1.769 0 C-N-CA 121.335 1.357 . . . . 0.0 111.86 176.409 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 16' ' ' PRO . . . . . . . . . . . . . 27.0 Cg_exo -61.14 -35.34 86.64 Favored 'Trans proline' 0 N--CA 1.497 1.699 0 C-N-CA 121.484 1.456 . . . . 0.0 112.511 -179.585 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 17' ' ' ASP . . . . . . . . . . . . . 7.1 p-10 -85.86 6.27 28.98 Favored 'General case' 0 CA--C 1.535 0.388 0 N-CA-C 113.302 0.852 . . . . 0.0 113.302 -177.226 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 18' ' ' PHE . . . . . . . . . . . . . 51.5 t80 -57.48 -43.41 84.07 Favored 'General case' 0 C--N 1.334 -0.105 0 O-C-N 121.891 -0.506 . . . . 0.0 110.152 -179.038 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 19' ' ' VAL . . . . . 0.412 HG13 ' N ' ' B' ' 20' ' ' ASP . 12.3 p -56.85 -41.76 76.62 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.345 0 CA-C-N 116.304 -0.407 . . . . 0.0 110.763 -179.509 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' B' B ' 20' ' ' ASP . . . . . 0.412 ' N ' HG13 ' B' ' 19' ' ' VAL . 71.5 m-20 -60.68 -42.04 96.32 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-O 120.893 0.378 . . . . 0.0 110.881 -178.203 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' B' B ' 21' ' ' VAL . . . . . . . . . . . . . 50.6 t -64.42 -47.17 90.56 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.332 0 CA-C-N 116.314 -0.403 . . . . 0.0 110.512 -178.488 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 22' ' ' ILE . . . . . 0.586 HG22 HD12 ' B' ' 26' ' ' LEU . 50.5 mm -57.5 -40.21 73.43 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.281 0 C-N-CA 120.916 -0.313 . . . . 0.0 110.675 179.95 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' B' B ' 23' ' ' ARG . . . . . . . . . . . . . 46.4 ttp180 -55.95 -50.75 69.92 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-O 120.927 0.394 . . . . 0.0 110.774 177.571 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 24' ' ' ILE . . . . . . . . . . . . . 67.7 mt -62.17 -41.23 90.52 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.278 0 CA-C-N 116.047 -0.524 . . . . 0.0 112.078 -176.667 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 25' ' ' LYS . . . . . 0.469 ' HE2' HD11 ' B' ' 39' ' ' ILE . 14.9 pttp -73.32 -34.88 65.93 Favored 'General case' 0 CA--C 1.533 0.324 0 C-N-CA 120.687 -0.405 . . . . 0.0 111.79 -174.125 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' B' B ' 26' ' ' LEU . . . . . 0.586 HD12 HG22 ' B' ' 22' ' ' ILE . 75.6 mt -79.86 -43.09 22.94 Favored 'General case' 0 C--N 1.33 -0.255 0 N-CA-C 112.426 0.528 . . . . 0.0 112.426 -174.912 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' B' B ' 27' ' ' GLN . . . . . . . . . . . . . 14.2 pt20 -46.36 139.21 5.0 Favored 'General case' 0 N--CA 1.469 0.478 0 N-CA-C 112.838 0.681 . . . . 0.0 112.838 -175.554 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 28' ' ' GLY . . . . . . . . . . . . . . . 101.35 -29.53 12.32 Favored Glycine 0 CA--C 1.531 1.078 0 CA-C-N 115.355 -0.838 . . . . 0.0 112.031 -177.289 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 29' ' ' LYS . . . . . . . . . . . . . 73.7 mmtt -98.16 155.17 17.29 Favored 'General case' 0 C--N 1.332 -0.196 0 CA-C-N 117.194 0.497 . . . . 0.0 110.964 178.466 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 30' ' ' THR . . . . . . . . . . . . . 27.9 m -92.2 135.43 34.01 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.081 -0.509 . . . . 0.0 109.906 175.107 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 31' ' ' VAL . . . . . . . . . . . . . 34.9 m -122.51 145.09 29.84 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.227 0 CA-C-O 120.896 0.379 . . . . 0.0 110.57 -179.152 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 32' ' ' ARG . . . . . . . . . . . . . 73.1 ttt-85 -136.0 148.86 48.61 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 115.863 -0.608 . . . . 0.0 110.383 178.436 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 33' ' ' THR . . . . . . . . . . . . . 26.8 m -52.62 140.7 22.5 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.357 -0.383 . . . . 0.0 111.493 -178.543 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 34' ' ' GLY . . . . . . . . . . . . . . . 100.17 -17.3 57.23 Favored Glycine 0 CA--C 1.533 1.187 0 CA-C-O 119.675 -0.514 . . . . 0.0 113.159 179.678 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 35' ' ' ASP . . . . . . . . . . . . . 75.5 m-20 -65.96 148.87 51.12 Favored 'General case' 0 C--O 1.231 0.092 0 CA-C-N 118.091 0.946 . . . . 0.0 111.054 178.648 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 36' ' ' VAL . . . . . . . . . . . . . 43.4 t -126.44 130.92 71.85 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.2 0 CA-C-N 116.199 -0.455 . . . . 0.0 109.91 178.414 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 37' ' ' ILE . . . . . . . . . . . . . 65.5 mt -122.73 139.69 48.79 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.237 0 CA-C-N 116.174 -0.466 . . . . 0.0 109.984 -179.758 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 38' ' ' GLY . . . . . . . . . . . . . . . -109.31 128.76 9.13 Favored Glycine 0 CA--C 1.526 0.738 0 N-CA-C 111.086 -0.805 . . . . 0.0 111.086 179.518 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 39' ' ' ILE . . . . . 0.469 HD11 ' HE2' ' B' ' 25' ' ' LYS . 65.5 mt -125.69 126.82 70.82 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.249 0 N-CA-C 109.802 -0.444 . . . . 0.0 109.802 178.621 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' B' B ' 40' ' ' SER . . . . . 0.55 ' O ' HD13 ' B' ' 41' ' ' ILE . 41.2 t -92.44 117.32 29.81 Favored 'General case' 0 C--N 1.329 -0.307 0 C-N-CA 120.961 -0.296 . . . . 0.0 110.914 177.075 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' B' B ' 41' ' ' ILE . . . . . 0.55 HD13 ' O ' ' B' ' 40' ' ' SER . 45.3 mm -130.32 124.64 58.08 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.227 0 CA-C-O 120.722 0.296 . . . . 0.0 110.288 179.45 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' B' B ' 42' ' ' LEU . . . . . . . . . . . . . 77.9 mt 58.54 35.1 24.4 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.19 -0.459 . . . . 0.0 111.678 177.307 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 43' ' ' GLY . . . . . . . . . . . . . . . 77.54 -10.12 25.09 Favored Glycine 0 CA--C 1.534 1.261 0 C-N-CA 121.212 -0.518 . . . . 0.0 113.479 177.586 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 44' ' ' LYS . . . . . . . . . . . . . 60.3 mttp -102.49 130.13 49.21 Favored 'General case' 0 C--O 1.232 0.154 0 CA-C-N 117.977 0.888 . . . . 0.0 110.175 177.505 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 45' ' ' GLU . . . . . . . . . . . . . 38.1 tp10 -84.48 128.14 34.42 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-O 120.797 0.332 . . . . 0.0 110.887 179.552 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 46' ' ' VAL . . . . . 0.443 HG23 ' HG2' ' B' ' 10' ' ' PRO . 7.3 p -119.56 129.44 75.32 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.235 0 N-CA-C 109.617 -0.512 . . . . 0.0 109.617 176.741 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' B' B ' 47' ' ' LYS . . . . . . . . . . . . . 35.0 mmtp -99.78 126.91 45.93 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.074 -0.512 . . . . 0.0 110.885 177.833 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 48' ' ' PHE . . . . . . . . . . . . . 91.2 m-85 -108.68 131.81 54.54 Favored 'General case' 0 C--N 1.33 -0.247 0 N-CA-C 109.824 -0.435 . . . . 0.0 109.824 176.461 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 49' ' ' LYS . . . . . . . . . . . . . 85.0 tttt -108.29 136.83 47.29 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.274 -0.421 . . . . 0.0 110.276 178.698 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 50' ' ' VAL . . . . . . . . . . . . . 44.2 t -78.37 108.47 11.83 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.368 0 N-CA-C 109.318 -0.623 . . . . 0.0 109.318 176.304 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 51' ' ' VAL . . . . . . . . . . . . . 48.0 t -69.68 -48.32 65.9 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.298 0 CA-C-N 116.044 -0.525 . . . . 0.0 109.898 -174.27 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 52' ' ' GLN . . . . . . . . . . . . . 47.5 tt0 -169.2 142.56 2.78 Favored 'General case' 0 C--N 1.33 -0.266 0 C-N-CA 120.256 -0.578 . . . . 0.0 111.774 -178.551 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 53' ' ' ALA . . . . . . . . . . . . . . . -111.83 134.17 53.57 Favored 'General case' 0 C--N 1.332 -0.191 0 CA-C-N 115.594 -0.73 . . . . 0.0 109.867 175.572 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 54' ' ' TYR . . . . . . . . . . . . . 41.8 t80 -129.04 108.01 18.07 Favored Pre-proline 0 CA--C 1.534 0.36 0 CA-C-O 118.279 -0.867 . . . . 0.0 110.387 179.823 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 55' ' ' PRO . . . . . . . . . . . . . 73.7 Cg_endo -77.16 170.11 72.4 Favored 'Cis proline' 0 N--CA 1.5 1.863 0 CA-C-N 121.826 1.688 . . . . 0.0 112.396 -6.059 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 56' ' ' SER . . . . . . . . . . . . . 20.9 m -116.1 135.19 22.74 Favored Pre-proline 0 CA--C 1.539 0.544 0 CA-C-O 118.489 -0.767 . . . . 0.0 109.709 175.874 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 57' ' ' PRO . . . . . . . . . . . . . 60.8 Cg_endo -75.15 161.62 94.38 Favored 'Cis proline' 0 N--CA 1.497 1.714 0 CA-C-N 121.792 1.676 . . . . 0.0 111.346 -4.982 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 58' ' ' LEU . . . . . . . . . . . . . 40.4 tp -129.98 138.54 50.88 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-O 120.922 0.392 . . . . 0.0 110.335 -179.791 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 59' ' ' ARG . . . . . . . . . . . . . 74.3 ttt180 -95.52 125.99 40.5 Favored 'General case' 0 C--N 1.326 -0.456 0 N-CA-C 109.229 -0.656 . . . . 0.0 109.229 175.235 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 60' ' ' VAL . . . . . . . . . . . . . 49.9 t -74.76 114.49 14.76 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.331 0 C-N-CA 120.709 -0.396 . . . . 0.0 110.392 -174.587 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 61' ' ' GLU . . . . . . . . . . . . . 70.9 mm-40 -131.1 164.53 25.26 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 115.901 -0.59 . . . . 0.0 110.021 176.542 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 62' ' ' ASP . . . . . . . . . . . . . 13.4 t70 -52.34 -30.32 27.97 Favored 'General case' 0 C--N 1.328 -0.345 0 N-CA-C 112.149 0.426 . . . . 0.0 112.149 -179.408 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 63' ' ' ARG . . . . . . . . . . . . . 39.9 mmt180 -72.05 -20.8 61.62 Favored 'General case' 0 CA--C 1.533 0.301 0 N-CA-C 112.968 0.729 . . . . 0.0 112.968 -174.837 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 64' ' ' THR . . . . . . . . . . . . . 32.9 m -75.66 139.44 41.98 Favored 'General case' 0 C--N 1.331 -0.207 0 CA-C-O 120.947 0.403 . . . . 0.0 111.0 -175.896 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 65' ' ' LYS . . . . . . . . . . . . . 2.3 mptm? -89.4 137.56 32.22 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 115.882 -0.599 . . . . 0.0 109.994 177.457 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 66' ' ' ILE . . . . . . . . . . . . . 60.3 mt -116.51 130.88 70.59 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.29 0 N-CA-C 110.047 -0.353 . . . . 0.0 110.047 179.602 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 67' ' ' THR . . . . . . . . . . . . . 25.5 m -125.06 137.76 54.2 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 116.241 -0.436 . . . . 0.0 110.932 -178.631 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 68' ' ' LEU . . . . . 0.417 HD12 ' N ' ' B' ' 68' ' ' LEU . 8.4 mp . . . . . 0 C--N 1.33 -0.275 0 CA-C-N 115.99 -0.55 . . . . 0.0 110.588 178.835 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 73' ' ' VAL . . . . . . . . . . . . . 28.9 m . . . . . 0 C--O 1.232 0.142 0 N-CA-C 109.909 -0.404 . . . . 0.0 109.909 . . . . . . . . . 0 0 . 1 . 002 nuclear build core ' B' B ' 74' ' ' ASP . . . . . . . . . . . . . 8.8 t70 -97.28 115.01 26.86 Favored 'General case' 0 C--N 1.329 -0.292 0 N-CA-C 109.803 -0.443 . . . . 0.0 109.803 -178.924 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 75' ' ' VAL . . . . . . . . . . . . . 46.3 t -113.08 120.29 62.71 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.242 0 CA-C-O 121.059 0.457 . . . . 0.0 110.223 -178.164 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 76' ' ' LEU . . . . . . . . . . . . . 26.9 mt -123.45 139.74 53.72 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 115.586 -0.734 . . . . 0.0 109.588 178.739 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 77' ' ' GLU . . . . . . . . . . . . . 97.5 mt-10 -134.61 130.97 37.25 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-O 121.101 0.477 . . . . 0.0 111.18 -178.134 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 78' ' ' ALA . . . . . 0.588 ' HB2' HD21 ' B' ' 109' ' ' LEU . . . -120.97 130.46 53.83 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 115.582 -0.736 . . . . 0.0 109.702 177.005 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' B' B ' 79' ' ' LYS . . . . . 0.646 ' O ' HD13 ' B' ' 80' ' ' ILE . 9.1 ptpp? -73.7 120.97 20.04 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-O 121.201 0.524 . . . . 0.0 110.381 -179.306 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' B' B ' 80' ' ' ILE . . . . . 0.646 HD13 ' O ' ' B' ' 79' ' ' LYS . 36.8 mm -139.12 108.66 3.9 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.288 0 N-CA-C 109.133 -0.691 . . . . 0.0 109.133 -177.648 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' B' B ' 81' ' ' LYS . . . . . . . . . . . . . 45.6 tttm -107.52 125.93 51.89 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-O 120.877 0.37 . . . . 0.0 111.205 -175.827 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 82' ' ' GLY . . . . . . . . . . . . . . . 89.18 42.0 5.69 Favored Glycine 0 CA--C 1.525 0.665 0 C-N-CA 120.773 -0.727 . . . . 0.0 111.811 175.005 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 83' ' ' ILE . . . . . . . . . . . . . 69.7 mt -69.15 139.94 19.64 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.315 0 N-CA-C 109.936 -0.394 . . . . 0.0 109.936 178.206 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 84' ' ' LYS . . . . . . . . . . . . . 53.1 tttp -96.74 -51.98 4.09 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.158 -0.474 . . . . 0.0 110.221 -179.199 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 85' ' ' ASP . . . . . . . . . . . . . 3.8 t70 -155.62 155.13 32.73 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 115.784 -0.644 . . . . 0.0 110.386 -179.902 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 86' ' ' VAL . . . . . . . . . . . . . 44.2 t -133.51 132.33 57.53 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.198 0 CA-C-O 121.05 0.452 . . . . 0.0 110.715 -177.957 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 87' ' ' ILE . . . . . . . . . . . . . 46.5 mm -121.26 128.12 75.91 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.194 0 CA-C-N 115.693 -0.685 . . . . 0.0 109.439 175.361 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 88' ' ' LEU . . . . . . . . . . . . . 12.8 tp -113.84 133.17 55.58 Favored 'General case' 0 C--N 1.331 -0.212 0 CA-C-O 120.997 0.427 . . . . 0.0 111.298 -176.793 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 89' ' ' ASP . . . . . . . . . . . . . 6.8 t70 -124.96 157.88 34.99 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-N 115.863 -0.608 . . . . 0.0 109.684 176.375 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 90' ' ' GLU . . . . . . . . . . . . . 44.3 mt-10 -44.99 -45.87 10.83 Favored 'General case' 0 N--CA 1.465 0.285 0 N-CA-C 113.272 0.841 . . . . 0.0 113.272 -172.025 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 91' ' ' ASN . . . . . . . . . . . . . 7.7 p-10 -131.97 37.7 3.58 Favored 'General case' 0 N--CA 1.463 0.22 0 CA-C-O 120.801 0.334 . . . . 0.0 111.373 -176.836 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 92' ' ' LEU . . . . . . . . . . . . . 4.3 tp -166.0 144.09 5.68 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-O 120.812 0.339 . . . . 0.0 110.33 179.916 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 93' ' ' ILE . . . . . . . . . . . . . 62.9 mt -125.42 124.74 67.65 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.279 0 N-CA-C 109.709 -0.478 . . . . 0.0 109.709 -177.658 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 94' ' ' VAL . . . . . . . . . . . . . 46.5 t -122.4 125.92 73.43 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.242 0 N-CA-C 109.917 -0.401 . . . . 0.0 109.917 179.527 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 95' ' ' VAL . . . . . . . . . . . . . 45.4 t -124.01 138.09 54.84 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.32 0 CA-C-N 116.131 -0.486 . . . . 0.0 110.113 -178.749 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 96' ' ' ILE . . . . . . . . . . . . . 61.8 mt -116.44 128.51 73.76 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.315 0 N-CA-C 109.255 -0.646 . . . . 0.0 109.255 178.556 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 97' ' ' THR . . . . . . . . . . . . . 71.8 p -102.9 159.61 15.34 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-O 121.265 0.555 . . . . 0.0 111.436 -175.888 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 98' ' ' GLU . . . . . . . . . . . . . 84.9 tt0 -53.91 -25.73 21.64 Favored 'General case' 0 CA--C 1.532 0.272 0 CA-C-N 116.083 -0.508 . . . . 0.0 112.161 179.327 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 99' ' ' GLU . . . . . . . . . . . . . 41.2 mt-10 -78.66 14.93 1.14 Allowed 'General case' 0 CA--C 1.535 0.39 0 N-CA-C 113.097 0.777 . . . . 0.0 113.097 -177.773 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 100' ' ' ASN . . . . . . . . . . . . . 2.4 m-20 60.63 38.01 18.89 Favored 'General case' 0 CA--C 1.529 0.167 0 CA-C-O 121.018 0.437 . . . . 0.0 110.713 179.481 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 101' ' ' GLU . . . . . . . . . . . . . 84.9 tt0 -117.29 146.31 43.41 Favored 'General case' 0 C--N 1.332 -0.173 0 CA-C-N 116.078 -0.51 . . . . 0.0 109.795 178.189 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 102' ' ' VAL . . . . . . . . . . . . . 44.9 t -114.95 124.74 71.91 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.275 0 CA-C-N 116.258 -0.428 . . . . 0.0 109.85 -178.158 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 103' ' ' LEU . . . . . . . . . . . . . 50.9 mt -115.15 132.69 56.52 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 115.715 -0.675 . . . . 0.0 109.996 178.594 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 104' ' ' ILE . . . . . 0.449 HD12 ' HB3' ' B' ' 113' ' ' TYR . 66.6 mt -123.22 119.59 58.02 Favored 'Isoleucine or valine' 0 C--O 1.233 0.2 0 N-CA-C 110.375 -0.231 . . . . 0.0 110.375 -178.334 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' B' B ' 105' ' ' PHE . . . . . . . . . . . . . 47.1 m-85 -121.17 164.61 16.62 Favored 'General case' 0 C--N 1.331 -0.211 0 CA-C-N 115.471 -0.786 . . . . 0.0 109.809 178.841 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 106' ' ' ASN . . . . . . . . . . . . . 47.4 p-10 -97.67 -169.98 1.92 Allowed 'General case' 0 C--N 1.33 -0.282 0 N-CA-C 109.652 -0.499 . . . . 0.0 109.652 172.851 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 107' ' ' GLN . . . . . . . . . . . . . 62.6 tt0 -59.67 -30.07 68.5 Favored 'General case' 0 C--N 1.33 -0.27 0 N-CA-C 111.879 0.325 . . . . 0.0 111.879 179.81 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 108' ' ' ASN . . . . . . . . . . . . . 3.1 t-20 -83.24 8.76 12.39 Favored 'General case' 0 CA--C 1.536 0.432 0 N-CA-C 113.148 0.796 . . . . 0.0 113.148 -177.535 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 109' ' ' LEU . . . . . 0.588 HD21 ' HB2' ' B' ' 78' ' ' ALA . 11.1 tp 60.99 36.21 18.71 Favored 'General case' 0 CA--C 1.53 0.198 0 CA-C-O 120.838 0.351 . . . . 0.0 111.434 178.845 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' B' B ' 110' ' ' GLU . . . . . . . . . . . . . 95.3 mt-10 -105.9 151.2 24.86 Favored 'General case' 0 C--N 1.33 -0.264 0 N-CA-C 109.898 -0.408 . . . . 0.0 109.898 176.884 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 111' ' ' GLU . . . . . . . . . . . . . 99.4 mt-10 -79.77 121.97 26.03 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-O 120.961 0.41 . . . . 0.0 111.34 -177.107 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 112' ' ' LEU . . . . . . . . . . . . . 16.3 mt -106.6 -45.74 4.16 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 115.894 -0.593 . . . . 0.0 110.086 176.418 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 113' ' ' TYR . . . . . 0.449 ' HB3' HD12 ' B' ' 104' ' ' ILE . 61.1 t80 -141.16 142.92 34.0 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 116.104 -0.498 . . . . 0.0 111.006 -179.488 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' B' B ' 114' ' ' ARG . . . . . . . . . . . . . 83.7 mtp180 -144.86 122.12 11.55 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.097 -0.502 . . . . 0.0 110.285 177.388 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 115' ' ' GLY . . . . . . . . . . . . . . . -150.05 162.59 29.23 Favored Glycine 0 CA--C 1.524 0.646 0 N-CA-C 111.006 -0.837 . . . . 0.0 111.006 179.881 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 116' ' ' LYS . . . . . . . . . . . . . 21.6 ttpt -129.1 140.8 51.42 Favored 'General case' 0 C--N 1.33 -0.267 0 N-CA-C 110.204 -0.295 . . . . 0.0 110.204 179.376 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 117' ' ' PHE . . . . . . . . . . . . . 29.1 m-85 -140.8 113.91 8.48 Favored 'General case' 0 C--N 1.331 -0.215 0 N-CA-C 109.927 -0.397 . . . . 0.0 109.927 -178.919 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 118' ' ' GLU . . . . . . . . . . . . . 70.8 mm-40 -56.19 -40.1 73.44 Favored 'General case' 0 C--N 1.329 -0.304 0 C-N-CA 120.912 -0.315 . . . . 0.0 110.944 -177.164 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 119' ' ' ASN . . . . . . . . . . . . . 80.7 m-20 -98.02 30.73 2.95 Favored 'General case' 0 C--N 1.33 -0.261 0 N-CA-C 112.168 0.432 . . . . 0.0 112.168 -175.502 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 120' ' ' LEU . . . . . . . . . . . . . 15.3 tp -58.29 123.69 16.92 Favored 'General case' 0 C--N 1.332 -0.184 0 N-CA-C 110.177 -0.305 . . . . 0.0 110.177 177.051 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 121' ' ' ASN . . . . . . . . . . . . . 77.7 m-20 -114.09 -44.08 3.18 Favored 'General case' 0 C--N 1.332 -0.195 0 CA-C-N 116.545 -0.298 . . . . 0.0 110.866 -178.475 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 122' ' ' LYS . . . . . . . . . . . . . 97.2 mttt -148.58 153.69 38.71 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-O 121.052 0.453 . . . . 0.0 111.569 -178.288 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 123' ' ' VAL . . . . . . . . . . . . . 46.1 t -133.91 130.87 55.9 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.228 0 CA-C-N 115.95 -0.568 . . . . 0.0 109.658 175.13 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 124' ' ' LEU . . . . . . . . . . . . . 64.5 mt -120.56 138.67 53.74 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.176 -0.465 . . . . 0.0 110.476 -178.206 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 125' ' ' VAL . . . . . . . . . . . . . 11.9 p -133.19 127.35 54.36 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.254 0 CA-C-N 116.463 -0.335 . . . . 0.0 110.266 178.413 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 126' ' ' ARG . . . . . . . . . . . . . 40.8 mmt180 -136.84 116.11 12.61 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.3 -0.409 . . . . 0.0 110.339 -179.707 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 127' ' ' ASN . . . . . . . . . . . . . 47.8 t30 52.67 -106.27 0.28 Allowed 'General case' 0 CA--C 1.543 0.71 0 CA-C-O 119.039 -0.505 . . . . 0.0 111.058 -179.986 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 128' ' ' ASP . . . . . . . . . . . . . 19.0 p-10 -114.09 2.92 15.07 Favored 'General case' 0 CA--C 1.536 0.426 0 CA-C-N 119.665 1.12 . . . . 0.0 113.422 -178.449 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 129' ' ' LEU . . . . . 0.547 HD23 ' N ' ' B' ' 130' ' ' VAL . 2.5 tt -104.86 135.72 45.7 Favored 'General case' 0 C--N 1.332 -0.17 0 N-CA-C 109.583 -0.525 . . . . 0.0 109.583 179.324 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' B' B ' 130' ' ' VAL . . . . . 0.547 ' N ' HD23 ' B' ' 129' ' ' LEU . 42.0 t -123.13 139.64 49.25 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.298 0 CA-C-O 120.799 0.333 . . . . 0.0 110.176 -177.678 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' B' B ' 131' ' ' VAL . . . . . . . . . . . . . 39.9 t -135.8 135.17 51.07 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.284 0 CA-C-N 116.235 -0.438 . . . . 0.0 110.162 179.561 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 132' ' ' ILE . . . . . . . . . . . . . 71.1 mt -117.52 132.45 67.3 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 N-CA-C 109.37 -0.604 . . . . 0.0 109.37 178.493 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 133' ' ' ILE . . . . . . . . . . . . . 37.7 mm -117.79 122.31 69.46 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.268 0 CA-C-O 120.617 0.246 . . . . 0.0 111.09 -174.272 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 134' ' ' ASP . . . . . . . . . . . . . 9.1 p-10 -137.38 147.82 45.76 Favored 'General case' 0 C--N 1.331 -0.207 0 CA-C-N 116.179 -0.464 . . . . 0.0 109.794 174.862 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 135' ' ' GLU . . . . . . . . . . . . . 85.5 tt0 -49.78 -24.67 2.5 Favored 'General case' 0 C--N 1.328 -0.333 0 N-CA-C 112.875 0.695 . . . . 0.0 112.875 -173.239 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 136' ' ' GLN . . . . . . . . . . . . . 56.1 tp60 -83.91 -37.64 22.11 Favored 'General case' 0 C--O 1.235 0.316 0 N-CA-C 111.959 0.355 . . . . 0.0 111.959 -175.762 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 137' ' ' LYS . . . . . . . . . . . . . 54.0 pttt -161.28 171.92 17.53 Favored 'General case' 0 C--N 1.331 -0.239 0 CA-C-O 121.558 0.694 . . . . 0.0 112.072 -172.394 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 138' ' ' LEU . . . . . . . . . . . . . 4.7 tt -118.36 126.21 51.62 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 114.962 -1.017 . . . . 0.0 109.649 177.425 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 139' ' ' THR . . . . . . . . . . . . . 16.9 m -106.88 126.19 51.99 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-N 116.24 -0.436 . . . . 0.0 110.616 -178.735 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 140' ' ' LEU . . . . . . . . . . . . . 30.8 tp -114.98 122.51 46.46 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 115.655 -0.702 . . . . 0.0 109.456 -178.405 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 141' ' ' ILE . . . . . . . . . . . . . 19.3 mt -121.86 119.79 59.71 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.282 0 N-CA-C 110.142 -0.318 . . . . 0.0 110.142 -175.039 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 142' ' ' ARG . . . . . . . . . . . . . 82.0 mtm180 -110.18 127.45 54.94 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 115.661 -0.699 . . . . 0.0 110.286 -179.585 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 143' ' ' THR . . . . . . . . . . . . . 41.6 p . . . . . 0 C--O 1.22 -0.467 0 CA-C-O 118.037 -0.982 . . . . 0.0 110.68 -179.436 . . . . . . . . 0 0 . 1 . 002 nuclear build core ' C' C ' 2' ' ' SER . . . . . . . . . . . . . 2.6 p . . . . . 0 N--CA 1.461 0.113 0 CA-C-O 120.902 0.382 . . . . 0.0 110.336 . . . . . . . . . 0 0 . 1 . 002 nuclear build core ' C' C ' 3' ' ' GLU . . . . . . . . . . . . . 95.5 mt-10 -140.99 140.34 34.33 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 116.049 -0.523 . . . . 0.0 111.063 -177.9 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' C' C ' 4' ' ' LEU . . . . . . . . . . . . . 16.1 tp -126.62 128.52 46.91 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 115.996 -0.547 . . . . 0.0 110.098 176.508 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' C' C ' 5' ' ' LYS . . . . . . . . . . . . . 97.4 mttt -109.27 121.5 45.31 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.4 -0.363 . . . . 0.0 110.478 179.531 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' C' C ' 6' ' ' LEU . . . . . . . . . . . . . 62.1 mt -116.21 148.8 40.05 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 115.616 -0.72 . . . . 0.0 110.293 -178.398 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' C' C ' 7' ' ' LYS . . . . . . . . . . . . . 75.6 tttt -136.4 138.54 27.16 Favored Pre-proline 0 CA--C 1.535 0.374 0 CA-C-O 118.996 -0.526 . . . . 0.0 110.2 176.774 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' C' C ' 8' ' ' PRO . . . . . . . . . . . . . 94.2 Cg_endo -91.81 142.76 2.74 Favored 'Trans proline' 0 N--CA 1.489 1.263 0 C-N-CA 121.725 1.617 . . . . 0.0 111.664 176.959 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' C' C ' 9' ' ' LEU . . . . . . . . . . . . . 36.9 mt -82.52 -47.83 0.88 Allowed Pre-proline 0 CA--C 1.534 0.343 0 CA-C-O 118.74 -0.647 . . . . 0.0 112.495 -177.681 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' C' C ' 10' ' ' PRO . . . . . . . . . . . . . 94.5 Cg_endo -81.65 161.13 19.2 Favored 'Trans proline' 0 N--CA 1.497 1.694 0 C-N-CA 121.24 1.293 . . . . 0.0 111.969 177.101 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' C' C ' 11' ' ' LYS . . . . . . . . . . . . . 91.0 mttt -86.52 103.11 14.73 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.389 -0.368 . . . . 0.0 110.38 177.825 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' C' C ' 12' ' ' VAL . . . . . . . . . . . . . 11.9 p -141.71 143.61 26.93 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.276 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.371 179.847 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' C' C ' 13' ' ' GLU . . . . . . . . . . . . . 82.5 tt0 -90.82 122.81 33.86 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 116.323 -0.399 . . . . 0.0 109.987 177.967 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' C' C ' 14' ' ' LEU . . . . . . . . . . . . . 25.3 mt -96.9 152.38 38.36 Favored Pre-proline 0 C--N 1.329 -0.311 0 CA-C-N 116.458 -0.337 . . . . 0.0 111.03 -175.973 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' C' C ' 15' ' ' PRO . . . . . . . . . . . . . 26.6 Cg_exo -61.72 163.11 19.48 Favored 'Trans proline' 0 N--CA 1.497 1.711 0 C-N-CA 121.255 1.303 . . . . 0.0 111.892 176.634 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' C' C ' 16' ' ' PRO . . . . . . . . . . . . . 25.2 Cg_exo -61.64 -44.44 21.77 Favored 'Trans proline' 0 N--CA 1.497 1.713 0 C-N-CA 121.516 1.478 . . . . 0.0 112.668 -178.472 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' C' C ' 17' ' ' ASP . . . . . . . . . . . . . 22.3 p-10 -88.72 16.23 7.07 Favored 'General case' 0 C--N 1.327 -0.385 0 N-CA-C 112.994 0.738 . . . . 0.0 112.994 -177.13 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' C' C ' 18' ' ' PHE . . . . . 0.522 ' CZ ' HD11 ' C' ' 22' ' ' ILE . 63.4 t80 -57.6 -41.53 81.43 Favored 'General case' 0 C--N 1.335 -0.064 0 O-C-N 122.053 -0.404 . . . . 0.0 110.315 -178.59 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' C' C ' 19' ' ' VAL . . . . . . . . . . . . . 44.3 t -56.26 -45.56 81.22 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.338 0 CA-C-N 116.47 -0.332 . . . . 0.0 110.624 -178.173 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' C' C ' 20' ' ' ASP . . . . . . . . . . . . . 51.4 m-20 -60.6 -40.43 91.77 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-O 120.763 0.316 . . . . 0.0 111.021 -178.295 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' C' C ' 21' ' ' VAL . . . . . . . . . . . . . 48.2 t -64.0 -48.46 85.91 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.328 0 C-N-CA 120.769 -0.373 . . . . 0.0 110.421 -178.373 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' C' C ' 22' ' ' ILE . . . . . 0.542 HG22 HD12 ' C' ' 26' ' ' LEU . 51.5 mm -55.61 -44.37 76.41 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.299 0 CA-C-O 120.895 0.379 . . . . 0.0 110.461 178.29 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' C' C ' 23' ' ' ARG . . . . . . . . . . . . . 56.6 ttp180 -52.51 -52.26 55.44 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-O 120.717 0.294 . . . . 0.0 111.609 -179.955 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' C' C ' 24' ' ' ILE . . . . . . . . . . . . . 71.1 mt -59.4 -40.63 82.12 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.294 0 CA-C-N 116.407 -0.361 . . . . 0.0 111.389 -176.338 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' C' C ' 25' ' ' LYS . . . . . . . . . . . . . 91.3 mttt -67.2 -37.83 84.31 Favored 'General case' 0 C--N 1.329 -0.288 0 N-CA-C 112.179 0.437 . . . . 0.0 112.179 -179.53 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' C' C ' 26' ' ' LEU . . . . . 0.542 HD12 HG22 ' C' ' 22' ' ' ILE . 68.2 mt -79.13 -41.18 29.15 Favored 'General case' 0 C--N 1.329 -0.295 0 N-CA-C 113.125 0.787 . . . . 0.0 113.125 -171.297 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' C' C ' 27' ' ' GLN . . . . . . . . . . . . . 13.8 pt20 -46.68 139.0 5.57 Favored 'General case' 0 N--CA 1.47 0.558 0 N-CA-C 112.659 0.614 . . . . 0.0 112.659 -176.151 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' C' C ' 28' ' ' GLY . . . . . . . . . . . . . . . 101.13 -26.87 23.07 Favored Glycine 0 CA--C 1.532 1.114 0 CA-C-N 115.536 -0.756 . . . . 0.0 112.213 -177.441 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' C' C ' 29' ' ' LYS . . . . . . . . . . . . . 61.7 mtpt -98.22 155.2 17.29 Favored 'General case' 0 C--N 1.333 -0.138 0 CA-C-N 117.32 0.56 . . . . 0.0 111.2 179.595 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' C' C ' 30' ' ' THR . . . . . . . . . . . . . 36.0 m -105.91 135.63 47.0 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 115.962 -0.563 . . . . 0.0 109.939 175.705 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' C' C ' 31' ' ' VAL . . . . . . . . . . . . . 34.5 m -132.87 158.32 43.24 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.271 0 CA-C-O 120.947 0.403 . . . . 0.0 111.019 -177.587 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' C' C ' 32' ' ' ARG . . . . . . . . . . . . . 50.7 mtp180 -134.89 152.71 51.97 Favored 'General case' 0 C--N 1.331 -0.219 0 CA-C-O 121.353 0.597 . . . . 0.0 110.706 178.736 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' C' C ' 33' ' ' THR . . . . . . . . . . . . . 22.1 m -52.57 140.17 23.68 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 115.997 -0.547 . . . . 0.0 111.509 -178.347 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' C' C ' 34' ' ' GLY . . . . . . . . . . . . . . . 100.0 -17.22 57.51 Favored Glycine 0 CA--C 1.532 1.117 0 CA-C-O 119.553 -0.582 . . . . 0.0 113.258 178.092 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' C' C ' 35' ' ' ASP . . . . . . . . . . . . . 77.5 m-20 -66.06 148.08 52.36 Favored 'General case' 0 N--CA 1.461 0.109 0 CA-C-N 118.148 0.974 . . . . 0.0 110.897 178.836 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' C' C ' 36' ' ' VAL . . . . . . . . . . . . . 44.2 t -124.92 132.8 70.85 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.238 0 CA-C-N 116.169 -0.468 . . . . 0.0 109.955 178.648 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' C' C ' 37' ' ' ILE . . . . . . . . . . . . . 67.8 mt -123.43 141.64 42.97 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.286 0 CA-C-N 116.072 -0.513 . . . . 0.0 110.04 -178.714 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' C' C ' 38' ' ' GLY . . . . . . . . . . . . . . . -111.56 129.0 8.91 Favored Glycine 0 CA--C 1.525 0.673 0 N-CA-C 111.021 -0.832 . . . . 0.0 111.021 179.667 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' C' C ' 39' ' ' ILE . . . . . . . . . . . . . 76.3 mt -125.39 137.34 57.96 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.193 0 CA-C-O 120.731 0.3 . . . . 0.0 110.205 179.805 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' C' C ' 40' ' ' SER . . . . . . . . . . . . . 35.8 t -93.4 124.6 37.5 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.273 -0.421 . . . . 0.0 110.903 175.643 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' C' C ' 41' ' ' ILE . . . . . 0.432 HD12 HG11 ' C' ' 46' ' ' VAL . 73.1 mt -130.56 119.59 46.21 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.181 0 CA-C-O 120.845 0.355 . . . . 0.0 110.336 177.757 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' C' C ' 42' ' ' LEU . . . . . . . . . . . . . 7.3 mp 51.71 37.24 19.66 Favored 'General case' 0 C--N 1.331 -0.221 0 CA-C-N 116.06 -0.518 . . . . 0.0 111.489 177.306 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' C' C ' 43' ' ' GLY . . . . . . . . . . . . . . . 72.58 30.88 63.58 Favored Glycine 0 CA--C 1.528 0.892 0 C-N-CA 121.07 -0.586 . . . . 0.0 112.309 176.837 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' C' C ' 44' ' ' LYS . . . . . . . . . . . . . 82.4 tttt -137.75 131.62 31.56 Favored 'General case' 0 C--N 1.33 -0.265 0 N-CA-C 109.692 -0.484 . . . . 0.0 109.692 177.085 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' C' C ' 45' ' ' GLU . . . . . . . . . . . . . 81.2 tt0 -82.91 123.08 29.07 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-O 120.725 0.298 . . . . 0.0 111.179 -177.345 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' C' C ' 46' ' ' VAL . . . . . 0.432 HG11 HD12 ' C' ' 41' ' ' ILE . 7.3 p -121.58 128.24 75.77 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.223 0 N-CA-C 109.624 -0.51 . . . . 0.0 109.624 176.212 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' C' C ' 47' ' ' LYS . . . . . . . . . . . . . 66.8 mttm -99.45 129.99 45.68 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.008 -0.542 . . . . 0.0 111.138 178.668 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' C' C ' 48' ' ' PHE . . . . . . . . . . . . . 91.6 m-85 -113.82 131.86 56.09 Favored 'General case' 0 C--N 1.33 -0.269 0 N-CA-C 109.873 -0.418 . . . . 0.0 109.873 176.255 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' C' C ' 49' ' ' LYS . . . . . . . . . . . . . 63.6 tttm -109.28 139.23 44.48 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.528 -0.305 . . . . 0.0 110.7 178.323 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' C' C ' 50' ' ' VAL . . . . . . . . . . . . . 45.7 t -81.17 108.54 14.56 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.352 0 N-CA-C 109.327 -0.62 . . . . 0.0 109.327 175.614 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' C' C ' 51' ' ' VAL . . . . . . . . . . . . . 46.7 t -70.04 -48.66 61.37 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.316 0 CA-C-N 116.131 -0.486 . . . . 0.0 109.8 -174.494 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' C' C ' 52' ' ' GLN . . . . . . . . . . . . . 61.6 tt0 -165.72 148.21 7.51 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.063 -0.517 . . . . 0.0 111.691 -178.964 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' C' C ' 53' ' ' ALA . . . . . . . . . . . . . . . -123.35 133.55 54.11 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 115.655 -0.702 . . . . 0.0 110.01 177.928 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' C' C ' 54' ' ' TYR . . . . . . . . . . . . . 10.3 t80 -129.02 111.98 18.5 Favored Pre-proline 0 CA--C 1.536 0.409 0 CA-C-O 118.179 -0.915 . . . . 0.0 110.483 178.977 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' C' C ' 55' ' ' PRO . . . . . . . . . . . . . 73.2 Cg_endo -77.23 168.27 77.32 Favored 'Cis proline' 0 N--CA 1.501 1.918 0 CA-C-N 122.028 1.76 . . . . 0.0 112.278 -6.782 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' C' C ' 56' ' ' SER . . . . . . . . . . . . . 13.5 m -117.35 132.33 23.59 Favored Pre-proline 0 CA--C 1.539 0.533 0 CA-C-O 118.453 -0.784 . . . . 0.0 109.292 174.21 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' C' C ' 57' ' ' PRO . . . . . . . . . . . . . 54.2 Cg_endo -70.08 147.15 84.72 Favored 'Cis proline' 0 N--CA 1.497 1.735 0 CA-C-N 121.834 1.691 . . . . 0.0 111.573 -0.109 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' C' C ' 58' ' ' LEU . . . . . . . . . . . . . 24.6 tp -108.51 136.51 48.0 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.409 -0.359 . . . . 0.0 110.843 -178.427 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' C' C ' 59' ' ' ARG . . . . . . . . . . . . . 59.2 ttt85 -102.95 121.11 41.86 Favored 'General case' 0 C--N 1.326 -0.421 0 N-CA-C 109.288 -0.634 . . . . 0.0 109.288 175.15 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' C' C ' 60' ' ' VAL . . . . . . . . . . . . . 42.5 t -76.42 118.42 22.78 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.28 0 C-N-CA 120.728 -0.389 . . . . 0.0 110.559 -174.881 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' C' C ' 61' ' ' GLU . . . . . . . . . . . . . 71.0 mm-40 -130.99 162.7 29.18 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 115.984 -0.553 . . . . 0.0 109.779 176.377 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' C' C ' 62' ' ' ASP . . . . . . . . . . . . . 80.3 m-20 -52.41 -30.5 29.66 Favored 'General case' 0 C--N 1.329 -0.302 0 N-CA-C 112.05 0.389 . . . . 0.0 112.05 179.758 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' C' C ' 63' ' ' ARG . . . . . . . . . . . . . 77.1 mtp85 -72.61 -21.85 61.05 Favored 'General case' 0 CA--C 1.533 0.294 0 N-CA-C 112.894 0.702 . . . . 0.0 112.894 -175.956 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' C' C ' 64' ' ' THR . . . . . . . . . . . . . 26.4 m -69.52 137.7 52.72 Favored 'General case' 0 C--N 1.331 -0.215 0 CA-C-O 120.993 0.425 . . . . 0.0 111.292 -174.683 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' C' C ' 65' ' ' LYS . . . . . . . . . . . . . 98.7 mttt -90.08 135.61 33.55 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 115.832 -0.622 . . . . 0.0 110.111 177.561 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' C' C ' 66' ' ' ILE . . . . . . . . . . . . . 64.4 mt -117.66 132.89 66.14 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.224 0 CA-C-O 120.868 0.366 . . . . 0.0 110.166 -179.787 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' C' C ' 67' ' ' THR . . . . . . . . . . . . . 30.1 m -122.39 139.61 53.64 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 115.988 -0.551 . . . . 0.0 110.813 -179.188 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' C' C ' 68' ' ' LEU . . . . . . . . . . . . . 4.1 tt . . . . . 0 C--N 1.329 -0.299 0 CA-C-N 115.982 -0.554 . . . . 0.0 110.29 178.971 . . . . . . . . 0 0 . 1 . 002 nuclear build core ' C' C ' 73' ' ' VAL . . . . . . . . . . . . . 30.2 m . . . . . 0 N--CA 1.461 0.088 0 CA-C-O 120.658 0.265 . . . . 0.0 110.382 . . . . . . . . . 0 0 . 1 . 002 nuclear build core ' C' C ' 74' ' ' ASP . . . . . . . . . . . . . 25.8 t0 -98.59 119.91 38.13 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.463 -0.335 . . . . 0.0 110.243 -177.552 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' C' C ' 75' ' ' VAL . . . . . . . . . . . . . 44.2 t -114.84 121.79 67.64 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.222 0 CA-C-O 121.176 0.513 . . . . 0.0 110.379 -179.277 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' C' C ' 76' ' ' LEU . . . . . . . . . . . . . 24.3 mt -118.92 146.58 44.83 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 115.553 -0.749 . . . . 0.0 109.628 178.119 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' C' C ' 77' ' ' GLU . . . . . . . . . . . . . 97.6 mt-10 -138.62 129.35 26.39 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-O 121.051 0.453 . . . . 0.0 111.204 -179.214 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' C' C ' 78' ' ' ALA . . . . . 0.746 ' HB2' HD21 ' C' ' 109' ' ' LEU . . . -116.94 136.5 52.9 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 115.797 -0.638 . . . . 0.0 109.787 177.345 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' C' C ' 79' ' ' LYS . . . . . 0.627 ' O ' HD13 ' C' ' 80' ' ' ILE . 52.2 pttt -84.79 119.4 25.26 Favored 'General case' 0 C--N 1.331 -0.218 0 CA-C-O 121.237 0.541 . . . . 0.0 111.006 -177.247 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' C' C ' 80' ' ' ILE . . . . . 0.627 HD13 ' O ' ' C' ' 79' ' ' LYS . 36.0 mm -139.43 117.98 12.26 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.212 0 N-CA-C 109.277 -0.638 . . . . 0.0 109.277 179.946 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' C' C ' 81' ' ' LYS . . . . . . . . . . . . . 57.2 tttm -103.36 122.54 45.05 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-O 120.777 0.322 . . . . 0.0 111.031 -178.037 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' C' C ' 82' ' ' GLY . . . . . . . . . . . . . . . 89.24 42.13 5.64 Favored Glycine 0 CA--C 1.526 0.719 0 C-N-CA 120.819 -0.705 . . . . 0.0 111.831 175.044 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' C' C ' 83' ' ' ILE . . . . . . . . . . . . . 75.3 mt -66.97 137.42 24.87 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.312 0 N-CA-C 109.858 -0.423 . . . . 0.0 109.858 177.318 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' C' C ' 84' ' ' LYS . . . . . . . . . . . . . 80.0 tttt -96.74 -54.02 3.36 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 115.971 -0.558 . . . . 0.0 110.326 -177.727 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' C' C ' 85' ' ' ASP . . . . . . . . . . . . . 8.1 t70 -151.14 150.01 30.15 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 115.748 -0.66 . . . . 0.0 110.407 -177.648 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' C' C ' 86' ' ' VAL . . . . . . . . . . . . . 44.6 t -129.04 129.18 67.87 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.266 0 CA-C-O 120.896 0.379 . . . . 0.0 110.435 -179.483 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' C' C ' 87' ' ' ILE . . . . . 0.497 ' N ' HD12 ' C' ' 87' ' ' ILE . 5.0 mp -117.45 125.56 74.11 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.288 0 CA-C-N 115.909 -0.587 . . . . 0.0 109.481 176.872 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' C' C ' 88' ' ' LEU . . . . . . . . . . . . . 16.7 tp -110.5 129.68 55.73 Favored 'General case' 0 C--N 1.331 -0.221 0 CA-C-N 116.373 -0.376 . . . . 0.0 110.719 -179.025 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' C' C ' 89' ' ' ASP . . . . . . . . . . . . . 11.9 t70 -126.63 154.75 43.58 Favored 'General case' 0 C--N 1.331 -0.222 0 CA-C-N 116.119 -0.491 . . . . 0.0 109.945 178.0 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' C' C ' 90' ' ' GLU . . . . . . . . . . . . . 77.8 tt0 -45.73 -35.14 4.04 Favored 'General case' 0 C--N 1.329 -0.299 0 N-CA-C 113.332 0.864 . . . . 0.0 113.332 -172.218 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' C' C ' 91' ' ' ASN . . . . . . . . . . . . . 56.7 m-80 -130.87 15.27 5.28 Favored 'General case' 0 N--CA 1.469 0.488 0 N-CA-C 113.309 0.855 . . . . 0.0 113.309 -175.587 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' C' C ' 92' ' ' LEU . . . . . . . . . . . . . 8.5 mt -150.34 151.97 33.71 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 118.131 0.423 . . . . 0.0 110.33 -176.414 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' C' C ' 93' ' ' ILE . . . . . . . . . . . . . 70.1 mt -129.15 119.29 48.63 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.316 0 N-CA-C 109.172 -0.677 . . . . 0.0 109.172 177.342 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' C' C ' 94' ' ' VAL . . . . . 0.56 HG21 HG11 ' C' ' 125' ' ' VAL . 45.7 t -119.91 127.98 75.91 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.252 0 CA-C-O 120.875 0.369 . . . . 0.0 110.08 -178.364 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' C' C ' 95' ' ' VAL . . . . . . . . . . . . . 42.5 t -122.46 134.02 66.93 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.25 0 CA-C-N 116.045 -0.525 . . . . 0.0 109.899 -179.984 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' C' C ' 96' ' ' ILE . . . . . . . . . . . . . 64.9 mt -114.54 127.65 71.93 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.386 0 N-CA-C 109.384 -0.599 . . . . 0.0 109.384 179.435 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' C' C ' 97' ' ' THR . . . . . . . . . . . . . 68.1 p -97.8 156.46 16.57 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-O 120.92 0.391 . . . . 0.0 110.732 -179.495 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' C' C ' 98' ' ' GLU . . . . . . . . . . . . . 45.6 tp10 -53.82 -26.5 24.44 Favored 'General case' 0 CA--C 1.534 0.336 0 N-CA-C 112.1 0.407 . . . . 0.0 112.1 -179.531 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' C' C ' 99' ' ' GLU . . . . . . . . . . . . . 28.3 tt0 -79.74 17.26 0.95 Allowed 'General case' 0 CA--C 1.536 0.417 0 N-CA-C 113.004 0.742 . . . . 0.0 113.004 -176.467 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' C' C ' 100' ' ' ASN . . . . . . . . . . . . . 3.0 m-20 62.74 31.39 16.6 Favored 'General case' 0 CA--C 1.532 0.272 0 O-C-N 122.11 -0.369 . . . . 0.0 111.908 176.765 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' C' C ' 101' ' ' GLU . . . . . . . . . . . . . 84.8 tt0 -111.92 142.55 44.18 Favored 'General case' 0 C--N 1.332 -0.165 0 N-CA-C 109.594 -0.521 . . . . 0.0 109.594 173.762 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' C' C ' 102' ' ' VAL . . . . . . . . . . . . . 43.3 t -115.42 129.33 71.87 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.306 0 CA-C-N 116.368 -0.378 . . . . 0.0 110.213 -177.449 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' C' C ' 103' ' ' LEU . . . . . . . . . . . . . 39.9 mt -115.96 129.7 56.5 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 115.601 -0.727 . . . . 0.0 109.822 176.9 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' C' C ' 104' ' ' ILE . . . . . . . . . . . . . 67.4 mt -117.97 121.19 66.73 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.228 0 N-CA-C 110.343 -0.243 . . . . 0.0 110.343 -178.784 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' C' C ' 105' ' ' PHE . . . . . . . . . . . . . 52.7 m-85 -122.66 166.95 14.06 Favored 'General case' 0 C--N 1.333 -0.139 0 O-C-N 123.872 0.732 . . . . 0.0 109.948 179.625 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' C' C ' 106' ' ' ASN . . . . . . . . . . . . . 43.9 p-10 -102.23 -169.97 1.75 Allowed 'General case' 0 C--N 1.33 -0.245 0 N-CA-C 109.972 -0.381 . . . . 0.0 109.972 174.883 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' C' C ' 107' ' ' GLN . . . . . . . . . . . . . 43.2 tt0 -57.19 -29.52 63.75 Favored 'General case' 0 C--N 1.33 -0.274 0 N-CA-C 111.915 0.339 . . . . 0.0 111.915 178.19 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' C' C ' 108' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER -84.67 11.5 8.85 Favored 'General case' 0 CA--C 1.535 0.384 0 N-CA-C 113.009 0.744 . . . . 0.0 113.009 -176.96 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' C' C ' 109' ' ' LEU . . . . . 0.746 HD21 ' HB2' ' C' ' 78' ' ' ALA . 9.7 tp 53.65 37.23 25.56 Favored 'General case' 0 C--O 1.233 0.19 0 CA-C-O 121.064 0.459 . . . . 0.0 111.254 -179.809 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' C' C ' 110' ' ' GLU . . . . . . . . . . . . . 95.8 mt-10 -104.8 145.36 30.48 Favored 'General case' 0 C--N 1.33 -0.25 0 N-CA-C 109.566 -0.531 . . . . 0.0 109.566 175.499 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' C' C ' 111' ' ' GLU . . . . . . . . . . . . . 71.0 tt0 -80.01 121.93 26.1 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-O 120.893 0.377 . . . . 0.0 110.576 -176.738 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' C' C ' 112' ' ' LEU . . . . . . . . . . . . . 10.8 mt -107.66 -46.05 3.9 Favored 'General case' 0 C--N 1.331 -0.218 0 CA-C-N 116.066 -0.515 . . . . 0.0 110.386 -179.54 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' C' C ' 113' ' ' TYR . . . . . . . . . . . . . 55.6 t80 -136.79 142.2 42.94 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-N 116.336 -0.393 . . . . 0.0 111.085 -178.784 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' C' C ' 114' ' ' ARG . . . . . . . . . . . . . 35.9 ptt-85 -142.52 124.59 15.34 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.063 -0.517 . . . . 0.0 110.363 177.507 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' C' C ' 115' ' ' GLY . . . . . . . . . . . . . . . -150.11 162.6 29.25 Favored Glycine 0 CA--C 1.524 0.629 0 N-CA-C 111.123 -0.791 . . . . 0.0 111.123 -179.765 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' C' C ' 116' ' ' LYS . . . . . . . . . . . . . 69.2 tttt -132.09 136.73 47.38 Favored 'General case' 0 C--N 1.329 -0.319 0 N-CA-C 109.797 -0.445 . . . . 0.0 109.797 177.266 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' C' C ' 117' ' ' PHE . . . . . . . . . . . . . 38.2 m-85 -133.67 114.8 13.88 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-O 120.905 0.383 . . . . 0.0 110.179 -175.595 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' C' C ' 118' ' ' GLU . . . . . . . . . . . . . 71.0 mm-40 -51.07 -52.42 43.59 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.454 -0.339 . . . . 0.0 111.792 -176.042 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' C' C ' 119' ' ' ASN . . . . . . . . . . . . . 3.2 m120 -95.63 31.18 2.09 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.274 -0.421 . . . . 0.0 112.024 -174.193 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' C' C ' 120' ' ' LEU . . . . . . . . . . . . . 18.3 tp -53.57 121.24 7.36 Favored 'General case' 0 N--CA 1.463 0.22 0 O-C-N 122.234 -0.291 . . . . 0.0 110.929 178.704 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' C' C ' 121' ' ' ASN . . . . . . . . . . . . . 69.2 m-20 -113.75 -43.85 3.25 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.341 -0.391 . . . . 0.0 110.929 -177.096 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' C' C ' 122' ' ' LYS . . . . . . . . . . . . . 97.1 mttt -144.69 147.47 33.05 Favored 'General case' 0 C--N 1.332 -0.177 0 CA-C-O 121.154 0.502 . . . . 0.0 111.946 -176.993 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' C' C ' 123' ' ' VAL . . . . . . . . . . . . . 45.6 t -125.82 125.43 68.31 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.259 0 N-CA-C 109.079 -0.711 . . . . 0.0 109.079 173.351 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' C' C ' 124' ' ' LEU . . . . . . . . . . . . . 59.9 mt -123.9 138.76 54.43 Favored 'General case' 0 C--N 1.331 -0.216 0 CA-C-O 120.877 0.37 . . . . 0.0 110.99 -176.232 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' C' C ' 125' ' ' VAL . . . . . 0.56 HG11 HG21 ' C' ' 94' ' ' VAL . 35.7 m -133.97 140.51 46.16 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.28 0 CA-C-N 116.018 -0.537 . . . . 0.0 110.365 178.399 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' C' C ' 126' ' ' ARG . . . . . . . . . . . . . 38.9 ttt180 -151.09 122.66 7.95 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-O 120.98 0.419 . . . . 0.0 110.67 177.634 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' C' C ' 127' ' ' ASN . . . . . . . . . . . . . 20.3 t-20 52.08 -107.29 0.32 Allowed 'General case' 0 CA--C 1.543 0.687 0 CA-C-O 118.968 -0.539 . . . . 0.0 111.177 -179.048 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' C' C ' 128' ' ' ASP . . . . . . . . . . . . . 17.7 p-10 -114.17 5.07 15.78 Favored 'General case' 0 N--CA 1.467 0.413 0 CA-C-N 119.654 1.116 . . . . 0.0 113.468 -177.223 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' C' C ' 129' ' ' LEU . . . . . . . . . . . . . 18.3 tp -106.66 138.62 42.49 Favored 'General case' 0 C--O 1.232 0.147 0 O-C-N 122.008 -0.432 . . . . 0.0 110.362 -179.419 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' C' C ' 130' ' ' VAL . . . . . . . . . . . . . 40.4 t -121.33 135.36 61.75 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.227 0 N-CA-C 109.724 -0.472 . . . . 0.0 109.724 179.938 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' C' C ' 131' ' ' VAL . . . . . 0.436 HG22 HD12 ' C' ' 140' ' ' LEU . 43.0 t -136.01 136.82 49.42 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.24 0 CA-C-O 120.997 0.427 . . . . 0.0 110.419 179.985 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' C' C ' 132' ' ' ILE . . . . . . . . . . . . . 68.5 mt -118.42 133.87 63.86 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.314 0 CA-C-N 115.853 -0.612 . . . . 0.0 109.491 179.058 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' C' C ' 133' ' ' ILE . . . . . . . . . . . . . 37.6 mm -116.78 119.31 61.62 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.231 0 CA-C-N 116.52 -0.309 . . . . 0.0 110.941 -175.361 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' C' C ' 134' ' ' ASP . . . . . . . . . . . . . 7.4 p-10 -130.13 148.95 52.03 Favored 'General case' 0 C--N 1.332 -0.182 0 N-CA-C 109.727 -0.471 . . . . 0.0 109.727 174.258 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' C' C ' 135' ' ' GLU . . . . . . . . . . . . . 39.2 tp10 -49.95 -24.57 2.63 Favored 'General case' 0 C--N 1.329 -0.302 0 N-CA-C 112.996 0.739 . . . . 0.0 112.996 -170.471 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' C' C ' 136' ' ' GLN . . . . . . . . . . . . . 52.8 mt-30 -104.76 -26.63 12.19 Favored 'General case' 0 N--CA 1.464 0.248 0 N-CA-C 112.773 0.657 . . . . 0.0 112.773 -174.113 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' C' C ' 137' ' ' LYS . . . . . . . . . . . . . 56.6 mtpt -141.15 150.0 42.23 Favored 'General case' 0 C--N 1.332 -0.194 0 CA-C-O 121.404 0.621 . . . . 0.0 112.099 -169.038 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' C' C ' 138' ' ' LEU . . . . . . . . . . . . . 18.1 tp -111.12 120.6 42.86 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 115.054 -0.975 . . . . 0.0 109.045 173.259 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' C' C ' 139' ' ' THR . . . . . . . . . . . . . 27.0 m -109.82 126.02 53.36 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-O 120.82 0.343 . . . . 0.0 110.973 -178.23 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' C' C ' 140' ' ' LEU . . . . . 0.436 HD12 HG22 ' C' ' 131' ' ' VAL . 17.7 tp -115.61 122.71 46.42 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 115.471 -0.786 . . . . 0.0 109.309 -179.361 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' C' C ' 141' ' ' ILE . . . . . . . . . . . . . 19.5 mt -121.76 119.42 58.74 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 N-CA-C 109.763 -0.458 . . . . 0.0 109.763 -176.37 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' C' C ' 142' ' ' ARG . . . . . . . . . . . . . 82.6 mtm180 . . . . . 0 C--N 1.33 -0.271 0 CA-C-N 115.691 -0.686 . . . . 0.0 110.721 -177.769 . . . . . . . . 0 0 . 1 . 002 nuclear build core ' D' D ' 2' ' ' SER . . . . . . . . . . . . . 92.7 p . . . . . 0 C--O 1.231 0.085 0 CA-C-O 121.01 0.433 . . . . 0.0 110.742 . . . . . . . . . 0 0 . 1 . 002 nuclear build core ' D' D ' 3' ' ' GLU . . . . . . . . . . . . . 47.1 mp0 -139.41 144.58 38.17 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 115.933 -0.576 . . . . 0.0 111.227 -176.669 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' D' D ' 4' ' ' LEU . . . . . . . . . . . . . 16.4 tp -123.32 126.8 47.54 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 115.777 -0.647 . . . . 0.0 109.685 175.187 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' D' D ' 5' ' ' LYS . . . . . . . . . . . . . 88.3 mttt -109.02 121.0 44.21 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.384 -0.371 . . . . 0.0 110.642 -178.542 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' D' D ' 6' ' ' LEU . . . . . . . . . . . . . 47.8 mt -115.48 144.5 43.75 Favored 'General case' 0 C--N 1.331 -0.21 0 CA-C-N 115.87 -0.605 . . . . 0.0 110.256 -179.844 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' D' D ' 7' ' ' LYS . . . . . . . . . . . . . 45.4 tttp -127.37 136.89 29.59 Favored Pre-proline 0 CA--C 1.532 0.278 0 CA-C-O 118.886 -0.578 . . . . 0.0 109.465 175.17 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' D' D ' 8' ' ' PRO . . . . . . . . . . . . . 71.9 Cg_endo -90.41 132.99 1.82 Allowed 'Trans proline' 0 N--CA 1.49 1.319 0 C-N-CA 121.619 1.546 . . . . 0.0 111.858 178.548 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' D' D ' 9' ' ' LEU . . . . . . . . . . . . . 43.0 mt -72.26 -46.99 10.77 Favored Pre-proline 0 C--N 1.329 -0.313 0 CA-C-O 118.69 -0.671 . . . . 0.0 111.963 -179.956 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' D' D ' 10' ' ' PRO . . . . . . . . . . . . . 93.2 Cg_endo -82.37 146.63 13.94 Favored 'Trans proline' 0 N--CA 1.496 1.62 0 C-N-CA 121.178 1.252 . . . . 0.0 111.635 174.978 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' D' D ' 11' ' ' LYS . . . . . . . . . . . . . 25.1 pttm -71.67 119.2 15.49 Favored 'General case' 0 C--N 1.331 -0.203 0 N-CA-C 109.692 -0.484 . . . . 0.0 109.692 177.19 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' D' D ' 12' ' ' VAL . . . . . . . . . . . . . 12.2 p -151.17 149.51 14.07 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.288 0 CA-C-N 116.094 -0.503 . . . . 0.0 111.127 -176.414 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' D' D ' 13' ' ' GLU . . . . . . . . . . . . . 42.5 mt-10 -108.46 109.98 21.38 Favored 'General case' 0 C--N 1.331 -0.227 0 CA-C-N 115.985 -0.552 . . . . 0.0 109.81 175.466 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' D' D ' 14' ' ' LEU . . . . . . . . . . . . . 16.1 mt -97.6 152.1 37.98 Favored Pre-proline 0 CA--C 1.532 0.282 0 CA-C-O 119.398 -0.334 . . . . 0.0 110.915 -176.724 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' D' D ' 15' ' ' PRO . . . . . . . . . . . . . 25.5 Cg_exo -62.36 160.41 31.39 Favored 'Trans proline' 0 N--CA 1.498 1.769 0 C-N-CA 121.337 1.358 . . . . 0.0 111.894 176.999 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' D' D ' 16' ' ' PRO . . . . . . . . . . . . . 27.2 Cg_exo -60.98 -37.79 73.91 Favored 'Trans proline' 0 N--CA 1.498 1.758 0 C-N-CA 121.479 1.453 . . . . 0.0 112.643 -179.7 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' D' D ' 17' ' ' ASP . . . . . . . . . . . . . 11.1 p-10 -81.63 4.9 19.93 Favored 'General case' 0 CA--C 1.536 0.429 0 N-CA-C 113.303 0.853 . . . . 0.0 113.303 -177.501 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' D' D ' 18' ' ' PHE . . . . . . . . . . . . . 52.4 t80 -57.5 -44.26 84.85 Favored 'General case' 0 C--N 1.335 -0.059 0 O-C-N 121.929 -0.482 . . . . 0.0 110.272 -178.286 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' D' D ' 19' ' ' VAL . . . . . . . . . . . . . 44.0 t -55.52 -44.16 75.17 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.289 0 CA-C-N 116.396 -0.365 . . . . 0.0 110.804 -178.144 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' D' D ' 20' ' ' ASP . . . . . . . . . . . . . 13.4 t70 -59.8 -42.2 92.93 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-O 120.888 0.375 . . . . 0.0 110.809 -177.761 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' D' D ' 21' ' ' VAL . . . . . . . . . . . . . 45.2 t -64.31 -46.48 93.08 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.28 0 C-N-CA 120.742 -0.383 . . . . 0.0 110.534 -178.3 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' D' D ' 22' ' ' ILE . . . . . 0.604 HG22 HD12 ' D' ' 26' ' ' LEU . 51.4 mm -55.12 -47.38 77.32 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.232 0 C-N-CA 121.087 -0.245 . . . . 0.0 110.662 178.931 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' D' D ' 23' ' ' ARG . . . . . . . . . . . . . 52.6 ttp180 -53.74 -51.92 61.81 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-O 120.659 0.266 . . . . 0.0 111.418 -178.792 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' D' D ' 24' ' ' ILE . . . . . . . . . . . . . 71.2 mt -58.54 -43.15 86.45 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.344 0 C-N-CA 121.034 -0.266 . . . . 0.0 111.451 -175.705 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' D' D ' 25' ' ' LYS . . . . . . . . . . . . . 60.1 mttm -66.67 -43.68 83.82 Favored 'General case' 0 C--N 1.33 -0.269 0 N-CA-C 112.183 0.438 . . . . 0.0 112.183 -177.768 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' D' D ' 26' ' ' LEU . . . . . 0.604 HD12 HG22 ' D' ' 22' ' ' ILE . 27.1 mt -81.73 -25.95 34.98 Favored 'General case' 0 C--N 1.329 -0.298 0 N-CA-C 113.1 0.778 . . . . 0.0 113.1 -172.825 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' D' D ' 27' ' ' GLN . . . . . . . . . . . . . 5.8 pt20 -45.76 139.28 4.19 Favored 'General case' 0 N--CA 1.467 0.412 0 N-CA-C 112.819 0.674 . . . . 0.0 112.819 -174.666 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' D' D ' 28' ' ' GLY . . . . . . . . . . . . . . . 100.43 -26.95 22.63 Favored Glycine 0 CA--C 1.532 1.14 0 CA-C-N 115.755 -0.657 . . . . 0.0 112.116 -177.671 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' D' D ' 29' ' ' LYS . . . . . . . . . . . . . 64.0 mttp -96.72 155.09 16.92 Favored 'General case' 0 C--N 1.332 -0.175 0 CA-C-N 117.376 0.588 . . . . 0.0 110.788 178.525 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' D' D ' 30' ' ' THR . . . . . . . . . . . . . 35.3 m -108.11 141.24 40.11 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.196 -0.456 . . . . 0.0 110.489 178.993 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' D' D ' 31' ' ' VAL . . . . . . . . . . . . . 35.4 m -127.96 156.5 39.99 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.234 0 CA-C-N 116.097 -0.501 . . . . 0.0 110.32 179.147 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' D' D ' 32' ' ' ARG . . . . . . . . . . . . . 72.9 ttt-85 -130.17 150.28 51.49 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-O 121.116 0.484 . . . . 0.0 110.456 179.703 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' D' D ' 33' ' ' THR . . . . . . . . . . . . . 14.9 m -52.39 137.15 30.03 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.376 -0.375 . . . . 0.0 111.478 -178.148 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' D' D ' 34' ' ' GLY . . . . . . . . . . . . . . . 100.84 -17.17 56.77 Favored Glycine 0 CA--C 1.533 1.175 0 CA-C-O 119.691 -0.505 . . . . 0.0 113.241 179.021 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' D' D ' 35' ' ' ASP . . . . . . . . . . . . . 73.4 m-20 -66.58 150.96 48.24 Favored 'General case' 0 C--O 1.231 0.124 0 CA-C-N 118.083 0.941 . . . . 0.0 111.364 179.992 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' D' D ' 36' ' ' VAL . . . . . . . . . . . . . 41.9 t -122.01 127.81 75.44 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.228 0 CA-C-N 115.934 -0.575 . . . . 0.0 109.684 177.652 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' D' D ' 37' ' ' ILE . . . . . . . . . . . . . 61.8 mt -121.33 138.53 51.39 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.256 0 N-CA-C 109.882 -0.414 . . . . 0.0 109.882 -179.253 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' D' D ' 38' ' ' GLY . . . . . . . . . . . . . . . -117.52 128.85 8.01 Favored Glycine 0 CA--C 1.526 0.764 0 N-CA-C 111.123 -0.791 . . . . 0.0 111.123 -179.892 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' D' D ' 39' ' ' ILE . . . . . . . . . . . . . 74.5 mt -126.21 136.62 60.29 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.176 0 CA-C-O 120.785 0.326 . . . . 0.0 110.179 178.903 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' D' D ' 40' ' ' SER . . . . . . . . . . . . . 63.7 p -91.59 122.44 34.16 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.219 -0.446 . . . . 0.0 110.816 176.216 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' D' D ' 41' ' ' ILE . . . . . . . . . . . . . 68.3 mt -130.46 117.55 39.78 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.231 0 CA-C-O 120.89 0.376 . . . . 0.0 110.244 178.262 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' D' D ' 42' ' ' LEU . . . . . 0.555 HD23 ' O ' ' D' ' 42' ' ' LEU . 1.3 tt 54.62 43.73 29.75 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-O 121.419 0.628 . . . . 0.0 110.401 177.603 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' D' D ' 43' ' ' GLY . . . . . . . . . . . . . . . 71.12 19.0 76.96 Favored Glycine 0 CA--C 1.533 1.157 0 C-N-CA 121.211 -0.519 . . . . 0.0 113.089 175.411 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' D' D ' 44' ' ' LYS . . . . . . . . . . . . . 53.1 mttm -131.05 130.5 43.33 Favored 'General case' 0 C--N 1.333 -0.137 0 CA-C-N 117.774 0.787 . . . . 0.0 110.342 178.836 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' D' D ' 45' ' ' GLU . . . . . . . . . . . . . 84.8 tt0 -84.1 124.93 31.63 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 116.499 -0.319 . . . . 0.0 111.258 -178.917 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' D' D ' 46' ' ' VAL . . . . . 0.412 HG13 ' O ' ' D' ' 46' ' ' VAL . 10.1 p -117.84 124.71 73.46 Favored 'Isoleucine or valine' 0 N--CA 1.462 0.172 0 N-CA-C 109.577 -0.527 . . . . 0.0 109.577 174.549 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' D' D ' 47' ' ' LYS . . . . . . . . . . . . . 64.7 mttp -98.52 124.11 43.07 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.076 -0.511 . . . . 0.0 110.859 178.529 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' D' D ' 48' ' ' PHE . . . . . . . . . . . . . 34.3 m-85 -108.49 131.87 54.39 Favored 'General case' 0 C--N 1.329 -0.324 0 N-CA-C 109.563 -0.532 . . . . 0.0 109.563 176.545 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' D' D ' 49' ' ' LYS . . . . . . . . . . . . . 46.6 tttp -107.48 133.65 51.66 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.367 -0.379 . . . . 0.0 110.137 178.202 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' D' D ' 50' ' ' VAL . . . . . . . . . . . . . 44.1 t -76.63 104.4 4.64 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.325 0 N-CA-C 109.414 -0.587 . . . . 0.0 109.414 177.802 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' D' D ' 51' ' ' VAL . . . . . . . . . . . . . 52.5 t -69.83 -53.38 24.38 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.324 0 CA-C-N 115.985 -0.552 . . . . 0.0 109.646 -175.732 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' D' D ' 52' ' ' GLN . . . . . . . . . . . . . 87.9 mt-30 -153.73 152.2 30.49 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 115.949 -0.569 . . . . 0.0 111.377 -177.752 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' D' D ' 53' ' ' ALA . . . . . . . . . . . . . . . -131.04 129.9 42.58 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 115.231 -0.895 . . . . 0.0 109.55 175.198 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' D' D ' 54' ' ' TYR . . . . . . . . . . . . . 54.3 t80 -128.35 108.01 19.36 Favored Pre-proline 0 CA--C 1.534 0.339 0 CA-C-O 118.179 -0.915 . . . . 0.0 110.276 -179.536 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' D' D ' 55' ' ' PRO . . . . . . . . . . . . . 74.0 Cg_endo -77.09 170.08 72.59 Favored 'Cis proline' 0 N--CA 1.5 1.859 0 CA-C-N 121.754 1.662 . . . . 0.0 112.608 -3.981 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' D' D ' 56' ' ' SER . . . . . . . . . . . . . 13.6 m -112.88 131.72 22.64 Favored Pre-proline 0 CA--C 1.539 0.53 0 CA-C-O 118.438 -0.791 . . . . 0.0 109.666 176.17 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' D' D ' 57' ' ' PRO . . . . . . . . . . . . . 42.2 Cg_endo -69.42 168.17 67.25 Favored 'Cis proline' 0 N--CA 1.496 1.66 0 CA-C-N 121.929 1.725 . . . . 0.0 111.374 -3.732 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' D' D ' 58' ' ' LEU . . . . . . . . . . . . . 44.9 tp -130.24 137.67 50.15 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-O 120.955 0.407 . . . . 0.0 110.256 -179.804 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' D' D ' 59' ' ' ARG . . . . . . . . . . . . . 74.0 ttt180 -104.2 134.47 47.38 Favored 'General case' 0 C--N 1.327 -0.396 0 CA-C-N 115.918 -0.583 . . . . 0.0 109.767 178.033 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' D' D ' 60' ' ' VAL . . . . . . . . . . . . . 42.6 t -76.98 112.91 15.43 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.316 0 C-N-CA 120.821 -0.351 . . . . 0.0 110.183 -177.545 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' D' D ' 61' ' ' GLU . . . . . . . . . . . . . 96.0 mt-10 -131.08 162.05 30.69 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.001 -0.545 . . . . 0.0 110.077 178.944 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' D' D ' 62' ' ' ASP . . . . . . . . . . . . . 6.4 t70 -53.63 -31.86 48.98 Favored 'General case' 0 C--N 1.327 -0.375 0 N-CA-C 111.862 0.319 . . . . 0.0 111.862 -179.092 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' D' D ' 63' ' ' ARG . . . . . . . . . . . . . 39.4 ptt180 -84.66 3.91 34.9 Favored 'General case' 0 CA--C 1.537 0.449 0 N-CA-C 113.774 1.027 . . . . 0.0 113.774 -174.555 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' D' D ' 64' ' ' THR . . . . . . . . . . . . . 25.7 m -92.02 138.84 31.21 Favored 'General case' 0 C--N 1.333 -0.152 0 CA-C-N 118.155 0.434 . . . . 0.0 110.854 -177.805 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' D' D ' 65' ' ' LYS . . . . . . . . . . . . . 68.0 mttm -88.62 127.84 35.57 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.069 -0.514 . . . . 0.0 109.894 177.834 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' D' D ' 66' ' ' ILE . . . . . . . . . . . . . 59.8 mt -115.65 126.43 73.18 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.228 0 N-CA-C 109.684 -0.487 . . . . 0.0 109.684 179.314 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' D' D ' 67' ' ' THR . . . . . . . . . . . . . 28.4 m -126.8 145.04 50.78 Favored 'General case' 0 C--O 1.233 0.216 0 CA-C-O 121.271 0.558 . . . . 0.0 111.637 -175.448 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' D' D ' 68' ' ' LEU . . . . . 0.464 ' C ' HD23 ' D' ' 68' ' ' LEU . 6.1 tt . . . . . 0 C--N 1.33 -0.281 0 CA-C-N 115.435 -0.802 . . . . 0.0 109.528 175.366 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' D' D ' 73' ' ' VAL . . . . . . . . . . . . . 35.1 m . . . . . 0 C--O 1.231 0.101 0 CA-C-O 120.966 0.413 . . . . 0.0 111.18 . . . . . . . . . 0 0 . 1 . 002 nuclear build core ' D' D ' 74' ' ' ASP . . . . . . . . . . . . . 12.5 t0 -94.89 123.24 38.24 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 115.893 -0.594 . . . . 0.0 110.294 -176.873 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' D' D ' 75' ' ' VAL . . . . . . . . . . . . . 47.1 t -116.33 121.9 68.57 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.209 0 CA-C-O 121.143 0.496 . . . . 0.0 110.204 -179.323 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' D' D ' 76' ' ' LEU . . . . . . . . . . . . . 36.8 mt -123.67 144.6 49.54 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 115.547 -0.751 . . . . 0.0 109.68 -179.54 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' D' D ' 77' ' ' GLU . . . . . . . . . . . . . 97.2 mt-10 -137.74 131.29 31.09 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-O 121.096 0.474 . . . . 0.0 111.274 -178.946 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' D' D ' 78' ' ' ALA . . . . . . . . . . . . . . . -118.94 139.82 51.02 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 115.693 -0.685 . . . . 0.0 109.974 177.183 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' D' D ' 79' ' ' LYS . . . . . 0.603 ' O ' HD13 ' D' ' 80' ' ' ILE . 35.2 tptt -80.47 116.43 20.51 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.513 -0.312 . . . . 0.0 110.818 -177.586 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' D' D ' 80' ' ' ILE . . . . . 0.603 HD13 ' O ' ' D' ' 79' ' ' LYS . 40.7 mm -139.11 108.18 3.69 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.237 0 CA-C-N 116.325 -0.398 . . . . 0.0 109.971 -176.542 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' D' D ' 81' ' ' LYS . . . . . . . . . . . . . 51.1 mttm -103.56 129.09 50.71 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-O 120.761 0.315 . . . . 0.0 111.18 -179.088 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' D' D ' 82' ' ' GLY . . . . . . . . . . . . . . . 89.05 42.16 5.69 Favored Glycine 0 CA--C 1.524 0.656 0 C-N-CA 120.828 -0.701 . . . . 0.0 111.545 173.64 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' D' D ' 83' ' ' ILE . . . . . . . . . . . . . 72.7 mt -67.15 131.1 32.93 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.365 0 N-CA-C 109.915 -0.402 . . . . 0.0 109.915 178.646 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' D' D ' 84' ' ' LYS . . . . . . . . . . . . . 76.3 tttt -91.15 -50.45 5.83 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-O 121.198 0.523 . . . . 0.0 109.665 179.619 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' D' D ' 85' ' ' ASP . . . . . . . . . . . . . 5.1 t70 -160.43 155.3 24.25 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 115.448 -0.796 . . . . 0.0 110.193 178.939 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' D' D ' 86' ' ' VAL . . . . . . . . . . . . . 40.1 t -131.54 133.31 61.91 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.285 0 CA-C-O 121.039 0.447 . . . . 0.0 110.175 179.699 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' D' D ' 87' ' ' ILE . . . . . . . . . . . . . 44.7 mm -119.05 128.46 75.8 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.294 0 CA-C-N 115.79 -0.641 . . . . 0.0 109.584 178.659 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' D' D ' 88' ' ' LEU . . . . . . . . . . . . . 21.8 tp -108.53 130.14 55.29 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-N 116.282 -0.417 . . . . 0.0 111.117 -177.638 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' D' D ' 89' ' ' ASP . . . . . . . . . . . . . 13.6 t70 -121.68 150.89 41.1 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 115.846 -0.616 . . . . 0.0 109.352 175.691 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' D' D ' 90' ' ' GLU . . . . . . . . . . . . . 43.8 tp10 -47.29 -36.34 9.07 Favored 'General case' 0 C--N 1.331 -0.206 0 N-CA-C 112.868 0.692 . . . . 0.0 112.868 -173.327 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' D' D ' 91' ' ' ASN . . . . . . . . . . . . . 86.9 m-20 -132.14 32.4 4.01 Favored 'General case' 0 N--CA 1.463 0.209 0 N-CA-C 112.097 0.406 . . . . 0.0 112.097 -176.332 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' D' D ' 92' ' ' LEU . . . . . . . . . . . . . 9.0 tp -166.15 151.23 8.32 Favored 'General case' 0 C--N 1.331 -0.223 0 C-N-CA 120.871 -0.332 . . . . 0.0 111.016 179.929 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' D' D ' 93' ' ' ILE . . . . . . . . . . . . . 71.2 mt -125.84 122.7 62.64 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.234 0 N-CA-C 109.429 -0.582 . . . . 0.0 109.429 179.707 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' D' D ' 94' ' ' VAL . . . . . . . . . . . . . 41.9 t -120.1 127.59 75.9 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.186 0 N-CA-C 110.09 -0.337 . . . . 0.0 110.09 -179.201 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' D' D ' 95' ' ' VAL . . . . . . . . . . . . . 44.4 t -123.27 133.47 69.02 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.275 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.042 -179.797 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' D' D ' 96' ' ' ILE . . . . . . . . . . . . . 65.5 mt -115.61 127.52 73.16 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.225 0 N-CA-C 109.559 -0.534 . . . . 0.0 109.559 179.231 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' D' D ' 97' ' ' THR . . . . . . . . . . . . . 66.4 p -100.47 153.58 19.24 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-O 121.081 0.467 . . . . 0.0 110.882 -178.656 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' D' D ' 98' ' ' GLU . . . . . . . . . . . . . 12.7 pt-20 -53.96 -21.71 8.65 Favored 'General case' 0 CA--C 1.534 0.362 0 N-CA-C 112.532 0.567 . . . . 0.0 112.532 -179.409 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' D' D ' 99' ' ' GLU . . . . . . . . . . . . . 96.2 mt-10 -81.34 14.99 2.16 Favored 'General case' 0 CA--C 1.534 0.364 0 N-CA-C 113.077 0.769 . . . . 0.0 113.077 -177.071 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' D' D ' 100' ' ' ASN . . . . . . . . . . . . . 4.7 m-20 62.18 34.86 15.91 Favored 'General case' 0 CA--C 1.53 0.203 0 CA-C-N 118.085 0.402 . . . . 0.0 111.182 -179.904 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' D' D ' 101' ' ' GLU . . . . . . . . . . . . . 83.5 tt0 -112.37 142.04 45.38 Favored 'General case' 0 C--N 1.333 -0.148 0 N-CA-C 109.534 -0.543 . . . . 0.0 109.534 174.552 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' D' D ' 102' ' ' VAL . . . . . . . . . . . . . 46.7 t -115.0 126.57 72.62 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.277 0 N-CA-C 109.847 -0.427 . . . . 0.0 109.847 -178.239 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' D' D ' 103' ' ' LEU . . . . . . . . . . . . . 26.0 mt -116.64 127.87 54.84 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 115.658 -0.701 . . . . 0.0 110.022 177.703 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' D' D ' 104' ' ' ILE . . . . . . . . . . . . . 67.9 mt -117.61 122.68 70.39 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.262 0 CA-C-N 116.408 -0.36 . . . . 0.0 110.219 -179.336 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' D' D ' 105' ' ' PHE . . . . . . . . . . . . . 66.2 m-85 -124.5 163.16 22.45 Favored 'General case' 0 C--N 1.331 -0.202 0 O-C-N 123.804 0.69 . . . . 0.0 109.757 179.521 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' D' D ' 106' ' ' ASN . . . . . . . . . . . . . 45.8 p-10 -96.83 -173.11 2.62 Favored 'General case' 0 C--N 1.329 -0.308 0 N-CA-C 109.59 -0.522 . . . . 0.0 109.59 173.889 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' D' D ' 107' ' ' GLN . . . . . . . . . . . . . 28.6 tt0 -60.85 -23.99 65.55 Favored 'General case' 0 CA--C 1.534 0.337 0 N-CA-C 112.312 0.486 . . . . 0.0 112.312 179.862 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' D' D ' 108' ' ' ASN . . . . . . . . . . . . . 60.6 t30 -86.53 10.22 16.0 Favored 'General case' 0 CA--C 1.536 0.43 0 N-CA-C 113.037 0.754 . . . . 0.0 113.037 -178.737 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' D' D ' 109' ' ' LEU . . . . . . . . . . . . . 12.3 tp 57.04 38.94 29.54 Favored 'General case' 0 C--N 1.332 -0.194 0 CA-C-O 121.152 0.501 . . . . 0.0 111.206 178.885 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' D' D ' 110' ' ' GLU . . . . . . . . . . . . . 70.9 mm-40 -107.1 148.82 28.32 Favored 'General case' 0 C--N 1.33 -0.265 0 N-CA-C 109.832 -0.432 . . . . 0.0 109.832 175.566 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' D' D ' 111' ' ' GLU . . . . . . . . . . . . . 83.1 tt0 -78.16 121.89 24.92 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.27 -0.423 . . . . 0.0 110.821 -177.683 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' D' D ' 112' ' ' LEU . . . . . . . . . . . . . 31.4 mt -109.6 -46.05 3.58 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-N 116.256 -0.429 . . . . 0.0 110.686 179.564 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' D' D ' 113' ' ' TYR . . . . . . . . . . . . . 58.0 t80 -140.71 135.31 31.45 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 116.264 -0.425 . . . . 0.0 110.927 -179.2 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' D' D ' 114' ' ' ARG . . . . . . . . . . . . . 69.6 ttp85 -136.42 122.03 19.65 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.138 -0.483 . . . . 0.0 110.117 178.035 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' D' D ' 115' ' ' GLY . . . . . . . . . . . . . . . -150.03 153.14 24.91 Favored Glycine 0 CA--C 1.524 0.652 0 N-CA-C 110.996 -0.842 . . . . 0.0 110.996 179.015 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' D' D ' 116' ' ' LYS . . . . . . . . . . . . . 63.4 tttt -129.5 132.13 46.82 Favored 'General case' 0 C--N 1.329 -0.321 0 N-CA-C 109.825 -0.435 . . . . 0.0 109.825 177.941 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' D' D ' 117' ' ' PHE . . . . . . . . . . . . . 37.3 m-85 -128.13 117.25 21.27 Favored 'General case' 0 C--N 1.332 -0.187 0 CA-C-O 120.963 0.411 . . . . 0.0 110.232 -175.11 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' D' D ' 118' ' ' GLU . . . . . . . . . . . . . 44.9 tp10 -51.67 -51.21 57.68 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.403 -0.362 . . . . 0.0 111.61 -177.078 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' D' D ' 119' ' ' ASN . . . . . . . . . . . . . 3.6 m120 -94.48 30.95 1.85 Allowed 'General case' 0 C--N 1.329 -0.287 0 N-CA-C 112.249 0.463 . . . . 0.0 112.249 -174.927 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' D' D ' 120' ' ' LEU . . . . . . . . . . . . . 15.6 tp -56.7 121.09 8.97 Favored 'General case' 0 C--N 1.332 -0.167 0 CA-C-O 120.597 0.237 . . . . 0.0 110.41 178.032 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' D' D ' 121' ' ' ASN . . . . . . . . . . . . . 33.1 m120 -114.08 -44.0 3.19 Favored 'General case' 0 C--O 1.232 0.171 0 CA-C-N 116.723 -0.217 . . . . 0.0 111.147 -176.649 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' D' D ' 122' ' ' LYS . . . . . . . . . . . . . 61.4 mtpt -139.13 138.58 37.13 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-O 120.92 0.391 . . . . 0.0 111.314 -176.674 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' D' D ' 123' ' ' VAL . . . . . . . . . . . . . 45.1 t -126.93 126.2 67.98 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.326 0 N-CA-C 109.375 -0.602 . . . . 0.0 109.375 175.26 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' D' D ' 124' ' ' LEU . . . . . . . . . . . . . 59.5 mt -131.21 136.43 48.24 Favored 'General case' 0 C--N 1.332 -0.194 0 CA-C-O 120.95 0.405 . . . . 0.0 110.781 -177.444 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' D' D ' 125' ' ' VAL . . . . . 0.413 HG23 HG22 ' D' ' 130' ' ' VAL . 11.6 p -133.95 138.57 50.17 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.284 0 CA-C-N 116.113 -0.494 . . . . 0.0 110.355 178.863 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' D' D ' 126' ' ' ARG . . . . . . . . . . . . . 96.7 mtt180 -149.1 126.82 11.74 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 115.769 -0.65 . . . . 0.0 109.425 177.778 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' D' D ' 127' ' ' ASN . . . . . . . . . . . . . 1.8 t-20 57.63 -147.47 0.51 Allowed 'General case' 0 CA--C 1.541 0.62 0 N-CA-C 109.418 -0.586 . . . . 0.0 109.418 -178.352 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' D' D ' 128' ' ' ASP . . . . . . . . . . . . . 8.7 p-10 -87.32 17.38 4.44 Favored 'General case' 0 CA--C 1.534 0.36 0 CA-C-N 118.892 0.769 . . . . 0.0 112.657 178.03 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' D' D ' 129' ' ' LEU . . . . . . . . . . . . . 13.3 tp -112.5 136.16 52.35 Favored 'General case' 0 C--O 1.231 0.098 0 O-C-N 122.003 -0.435 . . . . 0.0 109.988 179.001 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' D' D ' 130' ' ' VAL . . . . . 0.413 HG22 HG23 ' D' ' 125' ' ' VAL . 39.0 t -124.89 140.05 49.19 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.338 0 CA-C-O 120.768 0.318 . . . . 0.0 110.354 -176.646 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' D' D ' 131' ' ' VAL . . . . . . . . . . . . . 44.2 t -136.07 136.48 49.52 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.206 0 CA-C-O 121.144 0.497 . . . . 0.0 110.309 177.459 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' D' D ' 132' ' ' ILE . . . . . . . . . . . . . 71.3 mt -120.41 134.16 64.78 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.229 0 CA-C-N 115.69 -0.686 . . . . 0.0 109.645 -179.105 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' D' D ' 133' ' ' ILE . . . . . . . . . . . . . 43.5 mm -117.44 120.96 66.44 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.215 0 CA-C-O 121.142 0.496 . . . . 0.0 111.045 -175.915 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' D' D ' 134' ' ' ASP . . . . . . . . . . . . . 6.7 p-10 -131.71 145.82 51.84 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 115.671 -0.695 . . . . 0.0 109.449 174.216 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' D' D ' 135' ' ' GLU . . . . . . . . . . . . . 41.2 tp10 -49.74 -24.63 2.43 Favored 'General case' 0 C--N 1.328 -0.361 0 N-CA-C 112.872 0.693 . . . . 0.0 112.872 -171.584 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' D' D ' 136' ' ' GLN . . . . . . . . . . . . . 96.9 mt-30 -94.25 -33.23 13.33 Favored 'General case' 0 C--O 1.232 0.166 0 N-CA-C 112.356 0.502 . . . . 0.0 112.356 -175.932 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' D' D ' 137' ' ' LYS . . . . . . . . . . . . . 54.4 mtmt -148.17 158.11 43.89 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-O 121.388 0.613 . . . . 0.0 112.114 -170.445 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' D' D ' 138' ' ' LEU . . . . . 0.412 ' C ' HD23 ' D' ' 138' ' ' LEU . 5.6 tt -116.6 124.77 50.62 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 115.219 -0.9 . . . . 0.0 109.323 174.783 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' D' D ' 139' ' ' THR . . . . . . . . . . . . . 34.5 m -110.12 131.1 55.36 Favored 'General case' 0 C--N 1.331 -0.208 0 CA-C-N 116.366 -0.379 . . . . 0.0 110.863 -176.735 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' D' D ' 140' ' ' LEU . . . . . 0.472 ' C ' HD23 ' D' ' 140' ' ' LEU . 6.1 tt -119.79 124.02 45.12 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 115.543 -0.753 . . . . 0.0 109.303 -178.735 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' D' D ' 141' ' ' ILE . . . . . 0.437 ' N ' HD23 ' D' ' 140' ' ' LEU . 19.1 mt -121.28 120.25 61.49 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.314 0 CA-C-O 120.779 0.323 . . . . 0.0 110.131 -174.723 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' D' D ' 142' ' ' ARG . . . . . . . . . . . . . 82.8 mtp180 -110.32 127.66 55.15 Favored 'General case' 0 C--N 1.331 -0.226 0 CA-C-N 115.613 -0.722 . . . . 0.0 110.426 -179.039 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' D' D ' 143' ' ' THR . . . . . . . . . . . . . 59.8 p . . . . . 0 C--O 1.22 -0.463 0 CA-C-O 117.942 -1.028 . . . . 0.0 110.575 179.73 . . . . . . . . 0 0 . 1 . 002 nuclear build core ' E' E ' 2' ' ' SER . . . . . . . . . . . . . 3.6 p . . . . . 0 C--O 1.231 0.084 0 CA-C-O 120.955 0.407 . . . . 0.0 110.46 . . . . . . . . . 0 0 . 1 . 002 nuclear build core ' E' E ' 3' ' ' GLU . . . . . . . . . . . . . 28.6 tp10 -139.44 137.55 35.71 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 115.745 -0.661 . . . . 0.0 110.503 -176.511 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' E' E ' 4' ' ' LEU . . . . . . . . . . . . . 17.8 tp -124.12 126.15 45.71 Favored 'General case' 0 C--N 1.33 -0.244 0 N-CA-C 109.564 -0.532 . . . . 0.0 109.564 174.525 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' E' E ' 5' ' ' LYS . . . . . . . . . . . . . 66.4 mttm -112.85 122.13 46.75 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-O 120.948 0.404 . . . . 0.0 110.87 -177.668 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' E' E ' 6' ' ' LEU . . . . . 0.461 HD23 ' HA ' ' E' ' 50' ' ' VAL . 59.2 mt -113.89 143.87 43.97 Favored 'General case' 0 C--N 1.331 -0.23 0 CA-C-N 115.199 -0.909 . . . . 0.0 110.161 -179.421 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' E' E ' 7' ' ' LYS . . . . . . . . . . . . . 84.8 tttt -121.05 135.22 24.68 Favored Pre-proline 0 CA--C 1.535 0.398 0 CA-C-O 118.858 -0.591 . . . . 0.0 109.529 176.167 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' E' E ' 8' ' ' PRO . . . . . . . . . . . . . 97.6 Cg_endo -91.19 132.65 1.5 Allowed 'Trans proline' 0 N--CA 1.49 1.275 0 C-N-CA 121.683 1.589 . . . . 0.0 111.765 178.484 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' E' E ' 9' ' ' LEU . . . . . . . . . . . . . 46.9 mt -74.31 -47.02 6.02 Favored Pre-proline 0 CA--C 1.533 0.32 0 CA-C-O 118.709 -0.662 . . . . 0.0 112.176 -177.55 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' E' E ' 10' ' ' PRO . . . . . . . . . . . . . 84.4 Cg_endo -81.41 153.37 18.2 Favored 'Trans proline' 0 N--CA 1.496 1.671 0 C-N-CA 121.158 1.239 . . . . 0.0 111.726 174.95 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' E' E ' 11' ' ' LYS . . . . . . . . . . . . . 57.1 tttm -86.77 99.44 11.8 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.418 -0.356 . . . . 0.0 110.3 178.747 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' E' E ' 12' ' ' VAL . . . . . . . . . . . . . 12.0 p -141.5 147.54 21.98 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.254 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.571 -178.59 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' E' E ' 13' ' ' GLU . . . . . . . . . . . . . 43.1 tp10 -93.76 122.36 36.15 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.059 -0.519 . . . . 0.0 110.045 177.61 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' E' E ' 14' ' ' LEU . . . . . . . . . . . . . 20.7 mt -95.94 148.94 35.33 Favored Pre-proline 0 C--N 1.329 -0.292 0 CA-C-O 119.328 -0.368 . . . . 0.0 110.465 -178.161 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' E' E ' 15' ' ' PRO . . . . . . . . . . . . . 24.8 Cg_exo -62.46 160.25 32.54 Favored 'Trans proline' 0 N--CA 1.497 1.731 0 C-N-CA 121.214 1.276 . . . . 0.0 111.722 177.404 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' E' E ' 16' ' ' PRO . . . . . . . . . . . . . 29.9 Cg_exo -60.06 -32.37 94.7 Favored 'Trans proline' 0 N--CA 1.497 1.685 0 C-N-CA 121.385 1.39 . . . . 0.0 112.718 -178.659 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' E' E ' 17' ' ' ASP . . . . . . . . . . . . . 18.1 p-10 -88.39 4.73 45.25 Favored 'General case' 0 CA--C 1.536 0.422 0 N-CA-C 113.326 0.861 . . . . 0.0 113.326 -177.414 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' E' E ' 18' ' ' PHE . . . . . . . . . . . . . 52.4 t80 -58.23 -43.2 87.64 Favored 'General case' 0 C--N 1.334 -0.077 0 O-C-N 121.998 -0.439 . . . . 0.0 110.042 -178.606 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' E' E ' 19' ' ' VAL . . . . . . . . . . . . . 47.2 t -55.54 -42.81 69.99 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.28 0 CA-C-N 116.33 -0.395 . . . . 0.0 110.585 -179.425 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' E' E ' 20' ' ' ASP . . . . . . . . . . . . . 76.7 m-20 -60.57 -42.99 97.76 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-O 120.801 0.334 . . . . 0.0 110.926 -178.485 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' E' E ' 21' ' ' VAL . . . . . . . . . . . . . 45.7 t -64.01 -46.32 94.24 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.265 0 C-N-CA 120.792 -0.363 . . . . 0.0 110.463 -177.757 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' E' E ' 22' ' ' ILE . . . . . 0.68 HG22 HD12 ' E' ' 26' ' ' LEU . 51.5 mm -55.67 -46.29 79.4 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.234 0 CA-C-O 120.788 0.328 . . . . 0.0 110.548 178.45 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' E' E ' 23' ' ' ARG . . . . . . . . . . . . . 54.6 ttp180 -53.1 -50.97 63.35 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-O 120.669 0.271 . . . . 0.0 111.569 -179.887 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' E' E ' 24' ' ' ILE . . . . . . . . . . . . . 74.6 mt -58.35 -47.28 88.22 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.312 0 CA-C-N 116.505 -0.316 . . . . 0.0 111.452 -176.3 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' E' E ' 25' ' ' LYS . . . . . . . . . . . . . 76.0 mttt -65.49 -40.59 93.26 Favored 'General case' 0 C--N 1.329 -0.298 0 N-CA-C 112.428 0.529 . . . . 0.0 112.428 -176.613 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' E' E ' 26' ' ' LEU . . . . . 0.68 HD12 HG22 ' E' ' 22' ' ' ILE . 40.6 mt -79.65 -38.6 33.35 Favored 'General case' 0 C--N 1.33 -0.245 0 N-CA-C 113.19 0.811 . . . . 0.0 113.19 -171.143 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' E' E ' 27' ' ' GLN . . . . . . . . . . . . . 13.1 pt20 -46.88 139.46 5.47 Favored 'General case' 0 N--CA 1.468 0.443 0 N-CA-C 112.785 0.661 . . . . 0.0 112.785 -174.976 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' E' E ' 28' ' ' GLY . . . . . . . . . . . . . . . 99.61 -25.54 27.86 Favored Glycine 0 CA--C 1.534 1.229 0 CA-C-N 115.559 -0.746 . . . . 0.0 112.178 -176.209 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' E' E ' 29' ' ' LYS . . . . . . . . . . . . . 95.6 mttt -97.21 155.19 16.95 Favored 'General case' 0 C--O 1.233 0.186 0 CA-C-N 117.324 0.562 . . . . 0.0 110.918 178.935 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' E' E ' 30' ' ' THR . . . . . . . . . . . . . 23.6 m -104.68 137.66 42.16 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 115.922 -0.581 . . . . 0.0 110.035 175.83 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' E' E ' 31' ' ' VAL . . . . . . . . . . . . . 35.2 m -127.82 155.69 39.36 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.235 0 CA-C-N 116.381 -0.372 . . . . 0.0 110.685 -179.235 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' E' E ' 32' ' ' ARG . . . . . . . . . . . . . 78.2 mtt85 -132.6 150.49 52.15 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.079 -0.51 . . . . 0.0 110.402 177.821 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' E' E ' 33' ' ' THR . . . . . . . . . . . . . 22.3 m -52.8 139.1 27.71 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.302 -0.408 . . . . 0.0 111.419 -179.194 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' E' E ' 34' ' ' GLY . . . . . . . . . . . . . . . 101.03 -17.21 56.49 Favored Glycine 0 CA--C 1.532 1.141 0 CA-C-O 119.69 -0.505 . . . . 0.0 113.165 179.751 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' E' E ' 35' ' ' ASP . . . . . . . . . . . . . 73.5 m-20 -66.95 149.64 50.33 Favored 'General case' 0 C--O 1.231 0.104 0 CA-C-N 118.08 0.94 . . . . 0.0 111.147 178.859 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' E' E ' 36' ' ' VAL . . . . . . . . . . . . . 43.1 t -121.83 130.89 74.19 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.24 0 CA-C-N 116.107 -0.497 . . . . 0.0 109.843 178.188 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' E' E ' 37' ' ' ILE . . . . . . . . . . . . . 65.1 mt -121.32 139.18 49.28 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.194 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.0 -178.971 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' E' E ' 38' ' ' GLY . . . . . . . . . . . . . . . -116.66 129.0 8.18 Favored Glycine 0 CA--C 1.525 0.676 0 N-CA-C 111.137 -0.785 . . . . 0.0 111.137 -179.873 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' E' E ' 39' ' ' ILE . . . . . . . . . . . . . 76.5 mt -127.26 139.96 50.44 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.224 0 CA-C-O 120.755 0.312 . . . . 0.0 110.243 179.351 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' E' E ' 40' ' ' SER . . . . . . . . . . . . . 13.3 t -92.6 126.02 37.5 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.288 -0.414 . . . . 0.0 111.059 177.0 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' E' E ' 41' ' ' ILE . . . . . . . . . . . . . 65.5 mt -129.53 117.0 41.12 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.193 0 CA-C-O 120.863 0.363 . . . . 0.0 110.126 177.088 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' E' E ' 42' ' ' LEU . . . . . . . . . . . . . 7.2 mp 51.78 38.18 22.44 Favored 'General case' 0 CA--C 1.53 0.195 0 CA-C-N 116.101 -0.499 . . . . 0.0 111.598 176.747 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' E' E ' 43' ' ' GLY . . . . . . . . . . . . . . . 74.17 29.1 62.96 Favored Glycine 0 CA--C 1.529 0.969 0 C-N-CA 121.156 -0.545 . . . . 0.0 112.51 176.663 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' E' E ' 44' ' ' LYS . . . . . . . . . . . . . 30.0 ttpt -139.13 128.39 24.07 Favored 'General case' 0 C--N 1.33 -0.281 0 N-CA-C 109.523 -0.547 . . . . 0.0 109.523 176.578 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' E' E ' 45' ' ' GLU . . . . . . . . . . . . . 84.3 tt0 -83.1 125.66 31.73 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-O 120.799 0.333 . . . . 0.0 111.305 -177.111 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' E' E ' 46' ' ' VAL . . . . . 0.402 HG13 ' O ' ' E' ' 46' ' ' VAL . 9.2 p -117.38 124.96 73.7 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.183 0 N-CA-C 109.558 -0.534 . . . . 0.0 109.558 174.852 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' E' E ' 47' ' ' LYS . . . . . . . . . . . . . 62.5 mttp -98.16 126.46 43.64 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.06 -0.518 . . . . 0.0 110.904 177.973 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' E' E ' 48' ' ' PHE . . . . . . . . . . . . . 33.0 m-85 -110.13 131.86 54.68 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.025 -0.534 . . . . 0.0 109.679 176.568 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' E' E ' 49' ' ' LYS . . . . . . . . . . . . . 70.2 tttt -106.53 130.55 54.29 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.378 -0.373 . . . . 0.0 110.159 178.581 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' E' E ' 50' ' ' VAL . . . . . 0.461 ' HA ' HD23 ' E' ' 6' ' ' LEU . 46.4 t -74.73 103.16 2.52 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.258 0 N-CA-C 109.151 -0.685 . . . . 0.0 109.151 176.821 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' E' E ' 51' ' ' VAL . . . . . . . . . . . . . 47.3 t -69.58 -52.97 27.12 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.289 0 N-CA-C 109.478 -0.564 . . . . 0.0 109.478 -174.687 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' E' E ' 52' ' ' GLN . . . . . . . . . . . . . 81.3 mt-30 -154.49 149.93 27.27 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 115.986 -0.552 . . . . 0.0 111.624 -178.101 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' E' E ' 53' ' ' ALA . . . . . . . . . . . . . . . -128.26 133.21 48.75 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 115.305 -0.861 . . . . 0.0 109.542 175.046 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' E' E ' 54' ' ' TYR . . . . . . . . . . . . . 58.8 t80 -129.03 110.44 18.32 Favored Pre-proline 0 C--N 1.327 -0.372 0 CA-C-O 118.202 -0.904 . . . . 0.0 110.191 179.123 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' E' E ' 55' ' ' PRO . . . . . . . . . . . . . 73.7 Cg_endo -77.21 168.36 77.08 Favored 'Cis proline' 0 N--CA 1.5 1.865 0 CA-C-N 121.828 1.689 . . . . 0.0 112.511 -5.453 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' E' E ' 56' ' ' SER . . . . . . . . . . . . . 17.7 m -116.76 131.36 23.96 Favored Pre-proline 0 CA--C 1.537 0.479 0 CA-C-O 118.392 -0.813 . . . . 0.0 109.361 174.104 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' E' E ' 57' ' ' PRO . . . . . . . . . . . . . 38.6 Cg_endo -67.13 164.98 69.45 Favored 'Cis proline' 0 N--CA 1.497 1.72 0 CA-C-N 121.96 1.736 . . . . 0.0 111.522 -0.919 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' E' E ' 58' ' ' LEU . . . . . . . . . . . . . 27.0 tp -130.44 137.0 49.59 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.218 -0.447 . . . . 0.0 110.316 -179.535 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' E' E ' 59' ' ' ARG . . . . . . . . . . . . . 41.1 ttm180 -103.05 132.67 49.14 Favored 'General case' 0 C--N 1.327 -0.373 0 N-CA-C 109.525 -0.546 . . . . 0.0 109.525 176.65 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' E' E ' 60' ' ' VAL . . . . . . . . . . . . . 45.8 t -83.24 115.44 25.65 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.284 0 C-N-CA 120.751 -0.379 . . . . 0.0 110.532 -176.9 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' E' E ' 61' ' ' GLU . . . . . . . . . . . . . 15.6 mm-40 -131.06 163.54 27.41 Favored 'General case' 0 C--N 1.331 -0.23 0 CA-C-N 115.75 -0.659 . . . . 0.0 109.714 175.165 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' E' E ' 62' ' ' ASP . . . . . . . . . . . . . 78.4 m-20 -53.13 -32.35 47.1 Favored 'General case' 0 C--N 1.328 -0.35 0 N-CA-C 111.917 0.34 . . . . 0.0 111.917 -178.95 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' E' E ' 63' ' ' ARG . . . . . . . . . . . . . 84.0 mtt180 -74.03 -22.02 59.72 Favored 'General case' 0 C--N 1.33 -0.26 0 N-CA-C 112.992 0.738 . . . . 0.0 112.992 -176.619 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' E' E ' 64' ' ' THR . . . . . . . . . . . . . 37.8 m -64.78 140.07 58.83 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-O 120.913 0.387 . . . . 0.0 110.835 -175.947 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' E' E ' 65' ' ' LYS . . . . . . . . . . . . . 25.0 mtpp -90.05 123.17 33.7 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.061 -0.518 . . . . 0.0 109.995 179.567 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' E' E ' 66' ' ' ILE . . . . . . . . . . . . . 57.3 mt -113.79 131.13 66.53 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.241 0 CA-C-O 120.85 0.357 . . . . 0.0 110.351 -177.623 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' E' E ' 67' ' ' THR . . . . . . . . . . . . . 30.9 m -132.49 139.84 48.12 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.127 -0.488 . . . . 0.0 111.012 -179.122 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' E' E ' 68' ' ' LEU . . . . . 0.446 HD12 ' N ' ' E' ' 68' ' ' LEU . 8.1 mp . . . . . 0 C--N 1.329 -0.295 0 CA-C-N 116.039 -0.528 . . . . 0.0 110.203 176.836 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' E' E ' 73' ' ' VAL . . . . . . . . . . . . . 34.6 m . . . . . 0 C--O 1.232 0.155 0 CA-C-O 120.804 0.335 . . . . 0.0 110.663 . . . . . . . . . 0 0 . 1 . 002 nuclear build core ' E' E ' 74' ' ' ASP . . . . . . . . . . . . . 26.4 t0 -99.33 120.57 39.78 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.222 -0.445 . . . . 0.0 109.998 -178.901 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' E' E ' 75' ' ' VAL . . . . . . . . . . . . . 46.8 t -112.61 121.3 64.66 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.19 0 CA-C-O 121.031 0.443 . . . . 0.0 110.358 -178.477 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' E' E ' 76' ' ' LEU . . . . . . . . . . . . . 41.2 mt -118.42 144.75 45.72 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 115.626 -0.716 . . . . 0.0 109.737 178.713 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' E' E ' 77' ' ' GLU . . . . . . . . . . . . . 97.3 mt-10 -139.43 130.2 26.07 Favored 'General case' 0 C--N 1.331 -0.205 0 CA-C-O 120.999 0.428 . . . . 0.0 111.327 -179.416 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' E' E ' 78' ' ' ALA . . . . . 0.557 ' HB2' HD21 ' E' ' 109' ' ' LEU . . . -119.16 135.28 54.74 Favored 'General case' 0 C--N 1.331 -0.212 0 CA-C-N 115.797 -0.638 . . . . 0.0 109.775 176.689 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' E' E ' 79' ' ' LYS . . . . . 0.591 ' O ' HD13 ' E' ' 80' ' ' ILE . 91.0 mttt -77.13 118.62 19.85 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-O 120.882 0.373 . . . . 0.0 110.711 -179.452 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' E' E ' 80' ' ' ILE . . . . . 0.591 HD13 ' O ' ' E' ' 79' ' ' LYS . 41.1 mm -139.13 106.04 2.75 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.39 0 N-CA-C 109.138 -0.69 . . . . 0.0 109.138 -178.077 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' E' E ' 81' ' ' LYS . . . . . . . . . . . . . 76.0 tttt -105.24 127.34 52.88 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-O 120.895 0.379 . . . . 0.0 111.164 -176.0 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' E' E ' 82' ' ' GLY . . . . . . . . . . . . . . . 89.13 42.09 5.69 Favored Glycine 0 CA--C 1.524 0.638 0 N-CA-C 111.615 -0.594 . . . . 0.0 111.615 176.346 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' E' E ' 83' ' ' ILE . . . . . . . . . . . . . 72.4 mt -69.64 140.18 19.1 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.294 0 N-CA-C 109.836 -0.431 . . . . 0.0 109.836 177.446 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' E' E ' 84' ' ' LYS . . . . . . . . . . . . . 49.4 tttp -98.17 -51.06 4.14 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 115.9 -0.591 . . . . 0.0 110.263 -178.733 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' E' E ' 85' ' ' ASP . . . . . . . . . . . . . 6.5 t70 -155.27 151.72 28.39 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 115.764 -0.653 . . . . 0.0 110.316 179.67 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' E' E ' 86' ' ' VAL . . . . . . . . . . . . . 44.2 t -130.44 131.41 65.24 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.221 0 CA-C-O 120.931 0.395 . . . . 0.0 110.553 -178.719 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' E' E ' 87' ' ' ILE . . . . . 0.49 ' N ' HD12 ' E' ' 87' ' ' ILE . 5.0 mp -120.6 126.65 75.49 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.22 0 CA-C-N 115.889 -0.596 . . . . 0.0 109.494 176.382 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' E' E ' 88' ' ' LEU . . . . . . . . . . . . . 47.2 mt -116.0 137.76 51.82 Favored 'General case' 0 N--CA 1.462 0.167 0 CA-C-O 121.045 0.45 . . . . 0.0 111.468 -176.88 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' E' E ' 89' ' ' ASP . . . . . . . . . . . . . 8.7 t70 -136.14 156.73 48.27 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 115.655 -0.702 . . . . 0.0 109.584 175.202 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' E' E ' 90' ' ' GLU . . . . . . . . . . . . . 40.8 mp0 -51.23 -34.01 30.45 Favored 'General case' 0 C--N 1.328 -0.326 0 N-CA-C 112.507 0.558 . . . . 0.0 112.507 -171.919 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' E' E ' 91' ' ' ASN . . . . . . . . . . . . . 7.8 m120 -130.28 32.01 4.54 Favored 'General case' 0 N--CA 1.465 0.313 0 N-CA-C 112.062 0.393 . . . . 0.0 112.062 -175.897 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' E' E ' 92' ' ' LEU . . . . . . . . . . . . . 13.8 tp -166.11 141.77 4.82 Favored 'General case' 0 C--N 1.331 -0.239 0 C-N-CA 120.945 -0.302 . . . . 0.0 110.526 179.242 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' E' E ' 93' ' ' ILE . . . . . . . . . . . . . 71.9 mt -128.73 119.48 49.94 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.207 0 N-CA-C 109.121 -0.696 . . . . 0.0 109.121 176.686 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' E' E ' 94' ' ' VAL . . . . . . . . . . . . . 47.6 t -123.53 128.27 74.52 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.286 0 CA-C-O 121.037 0.446 . . . . 0.0 110.019 -178.898 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' E' E ' 95' ' ' VAL . . . . . . . . . . . . . 41.6 t -121.04 135.5 61.02 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.347 0 CA-C-N 115.807 -0.633 . . . . 0.0 109.821 -179.831 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' E' E ' 96' ' ' ILE . . . . . . . . . . . . . 49.9 mt -111.18 126.31 68.56 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.36 0 N-CA-C 108.959 -0.756 . . . . 0.0 108.959 178.041 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' E' E ' 97' ' ' THR . . . . . . . . . . . . . 74.7 p -96.27 155.73 16.64 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-O 121.114 0.483 . . . . 0.0 111.005 -177.747 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' E' E ' 98' ' ' GLU . . . . . . . . . . . . . 79.2 tt0 -53.84 -27.37 29.29 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.153 -0.476 . . . . 0.0 112.1 -179.143 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' E' E ' 99' ' ' GLU . . . . . . . . . . . . . 12.7 pt-20 -81.08 18.01 1.14 Allowed 'General case' 0 CA--C 1.535 0.374 0 N-CA-C 113.181 0.808 . . . . 0.0 113.181 -176.946 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' E' E ' 100' ' ' ASN . . . . . . . . . . . . . 3.4 m-20 63.52 37.43 10.49 Favored 'General case' 0 N--CA 1.463 0.179 0 CA-C-O 121.063 0.459 . . . . 0.0 111.204 176.831 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' E' E ' 101' ' ' GLU . . . . . . . . . . . . . 84.6 tt0 -116.22 146.02 42.67 Favored 'General case' 0 C--N 1.333 -0.131 0 CA-C-N 116.202 -0.454 . . . . 0.0 109.982 175.981 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' E' E ' 102' ' ' VAL . . . . . . . . . . . . . 46.8 t -115.08 126.1 72.57 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.346 0 CA-C-N 116.34 -0.391 . . . . 0.0 110.144 -177.668 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' E' E ' 103' ' ' LEU . . . . . . . . . . . . . 35.1 mt -117.82 128.54 54.95 Favored 'General case' 0 C--N 1.332 -0.169 0 CA-C-N 115.777 -0.647 . . . . 0.0 110.083 176.832 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' E' E ' 104' ' ' ILE . . . . . 0.599 HD13 HG11 ' E' ' 130' ' ' VAL . 68.9 mt -119.13 122.71 69.9 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.225 0 CA-C-N 116.722 -0.217 . . . . 0.0 110.422 -179.072 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' E' E ' 105' ' ' PHE . . . . . . . . . . . . . 55.5 m-85 -122.8 166.8 14.39 Favored 'General case' 0 C--O 1.232 0.137 0 O-C-N 123.917 0.76 . . . . 0.0 109.753 179.494 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' E' E ' 106' ' ' ASN . . . . . . . . . . . . . 45.9 p-10 -99.11 -170.04 1.86 Allowed 'General case' 0 C--N 1.33 -0.276 0 N-CA-C 109.758 -0.46 . . . . 0.0 109.758 173.079 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' E' E ' 107' ' ' GLN . . . . . . . . . . . . . 46.9 tt0 -60.61 -30.0 69.57 Favored 'General case' 0 C--N 1.329 -0.289 0 N-CA-C 111.932 0.345 . . . . 0.0 111.932 -179.675 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' E' E ' 108' ' ' ASN . . . . . . . . . . . . . 3.2 t-20 -81.96 7.84 12.05 Favored 'General case' 0 CA--C 1.536 0.416 0 N-CA-C 113.108 0.781 . . . . 0.0 113.108 -177.891 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' E' E ' 109' ' ' LEU . . . . . 0.557 HD21 ' HB2' ' E' ' 78' ' ' ALA . 11.4 tp 61.42 35.97 17.53 Favored 'General case' 0 CA--C 1.53 0.19 0 O-C-N 122.106 -0.371 . . . . 0.0 111.442 178.724 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' E' E ' 110' ' ' GLU . . . . . . . . . . . . . 42.8 mt-10 -104.9 143.15 33.55 Favored 'General case' 0 C--N 1.33 -0.256 0 N-CA-C 109.586 -0.524 . . . . 0.0 109.586 175.288 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' E' E ' 111' ' ' GLU . . . . . . . . . . . . . 61.0 tt0 -79.72 121.98 26.01 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-O 120.877 0.37 . . . . 0.0 110.727 -176.661 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' E' E ' 112' ' ' LEU . . . . . . . . . . . . . 20.3 mt -105.98 -46.13 4.18 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 116.123 -0.489 . . . . 0.0 110.665 179.864 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' E' E ' 113' ' ' TYR . . . . . . . . . . . . . 57.1 t80 -134.31 138.26 44.83 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-O 120.901 0.382 . . . . 0.0 111.26 -178.077 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' E' E ' 114' ' ' ARG . . . . . . . . . . . . . 52.7 ttp180 -136.09 123.49 22.0 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 115.842 -0.617 . . . . 0.0 110.325 177.494 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' E' E ' 115' ' ' GLY . . . . . . . . . . . . . . . -150.0 157.98 27.46 Favored Glycine 0 CA--C 1.524 0.601 0 N-CA-C 110.915 -0.874 . . . . 0.0 110.915 179.0 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' E' E ' 116' ' ' LYS . . . . . . . . . . . . . 31.9 ttmt -131.83 138.95 48.7 Favored 'General case' 0 C--N 1.329 -0.303 0 N-CA-C 109.886 -0.413 . . . . 0.0 109.886 177.317 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' E' E ' 117' ' ' PHE . . . . . . . . . . . . . 39.1 m-85 -137.74 114.61 10.65 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-O 120.867 0.365 . . . . 0.0 110.208 -175.769 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' E' E ' 118' ' ' GLU . . . . . . . . . . . . . 81.2 tt0 -52.81 -44.51 66.7 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.493 -0.321 . . . . 0.0 111.503 -177.078 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' E' E ' 119' ' ' ASN . . . . . . . . . . . . . 36.5 m120 -95.77 30.69 2.27 Favored 'General case' 0 C--N 1.33 -0.248 0 N-CA-C 112.262 0.467 . . . . 0.0 112.262 -174.938 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' E' E ' 120' ' ' LEU . . . . . . . . . . . . . 13.9 tp -57.35 121.02 9.19 Favored 'General case' 0 C--N 1.332 -0.169 0 CA-C-O 120.631 0.253 . . . . 0.0 110.385 178.068 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' E' E ' 121' ' ' ASN . . . . . . . . . . . . . 66.7 m-20 -114.09 -44.12 3.17 Favored 'General case' 0 C--N 1.332 -0.188 0 CA-C-N 116.471 -0.331 . . . . 0.0 111.101 -178.794 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' E' E ' 122' ' ' LYS . . . . . . . . . . . . . 63.2 mtpt -145.5 152.12 39.27 Favored 'General case' 0 C--N 1.332 -0.171 0 CA-C-O 121.041 0.448 . . . . 0.0 111.714 -176.447 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' E' E ' 123' ' ' VAL . . . . . . . . . . . . . 47.2 t -130.85 131.95 64.19 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.252 0 CA-C-N 115.943 -0.571 . . . . 0.0 109.482 174.461 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' E' E ' 124' ' ' LEU . . . . . . . . . . . . . 83.0 mt -125.72 140.48 52.66 Favored 'General case' 0 C--N 1.332 -0.181 0 CA-C-O 120.827 0.346 . . . . 0.0 110.911 -177.549 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' E' E ' 125' ' ' VAL . . . . . . . . . . . . . 34.5 m -132.89 142.79 41.37 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.182 0 CA-C-N 116.127 -0.488 . . . . 0.0 110.764 179.878 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' E' E ' 126' ' ' ARG . . . . . . . . . . . . . 96.2 mtt-85 -148.05 112.15 5.18 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.443 177.105 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' E' E ' 127' ' ' ASN . . . . . . . . . . . . . 17.1 m120 53.85 -104.93 0.23 Allowed 'General case' 0 CA--C 1.543 0.699 0 CA-C-O 119.078 -0.487 . . . . 0.0 111.017 179.542 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' E' E ' 128' ' ' ASP . . . . . . . . . . . . . 18.7 p-10 -113.98 3.5 15.38 Favored 'General case' 0 N--CA 1.468 0.453 0 CA-C-N 119.508 1.049 . . . . 0.0 113.473 -177.487 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' E' E ' 129' ' ' LEU . . . . . . . . . . . . . 12.4 tp -104.92 140.47 38.1 Favored 'General case' 0 C--N 1.331 -0.215 0 N-CA-C 109.609 -0.515 . . . . 0.0 109.609 178.034 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' E' E ' 130' ' ' VAL . . . . . 0.599 HG11 HD13 ' E' ' 104' ' ' ILE . 13.4 p -132.92 139.2 50.14 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.184 0 CA-C-O 121.132 0.491 . . . . 0.0 110.742 -178.28 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' E' E ' 131' ' ' VAL . . . . . 0.589 HG22 HD12 ' E' ' 140' ' ' LEU . 38.4 t -136.11 140.85 43.11 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.267 0 CA-C-N 115.96 -0.564 . . . . 0.0 110.565 -179.792 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' E' E ' 132' ' ' ILE . . . . . . . . . . . . . 70.0 mt -116.17 133.08 63.8 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.27 0 CA-C-N 115.747 -0.66 . . . . 0.0 109.433 178.957 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' E' E ' 133' ' ' ILE . . . . . . . . . . . . . 39.0 mm -116.1 123.26 71.13 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.228 0 CA-C-O 120.678 0.275 . . . . 0.0 111.1 -174.898 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' E' E ' 134' ' ' ASP . . . . . . . . . . . . . 9.3 p-10 -136.18 149.73 48.72 Favored 'General case' 0 C--N 1.331 -0.226 0 CA-C-N 116.253 -0.431 . . . . 0.0 110.101 175.428 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' E' E ' 135' ' ' GLU . . . . . . . . . . . . . 81.5 tt0 -49.96 -27.33 5.22 Favored 'General case' 0 C--N 1.329 -0.299 0 N-CA-C 112.878 0.696 . . . . 0.0 112.878 -173.753 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' E' E ' 136' ' ' GLN . . . . . . . . . . . . . 94.8 mt-30 -83.24 -34.48 25.83 Favored 'General case' 0 C--O 1.233 0.232 0 N-CA-C 112.304 0.483 . . . . 0.0 112.304 -175.621 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' E' E ' 137' ' ' LYS . . . . . . . . . . . . . 15.2 pttp -167.51 174.23 8.04 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-O 121.597 0.713 . . . . 0.0 112.194 -170.941 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' E' E ' 138' ' ' LEU . . . . . 0.427 ' C ' HD23 ' E' ' 138' ' ' LEU . 6.3 tt -119.42 126.65 51.86 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 114.951 -1.022 . . . . 0.0 109.923 178.652 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' E' E ' 139' ' ' THR . . . . . . . . . . . . . 25.9 m -105.82 122.91 47.06 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.139 -0.482 . . . . 0.0 110.217 179.367 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' E' E ' 140' ' ' LEU . . . . . 0.589 HD12 HG22 ' E' ' 131' ' ' VAL . 10.6 tp -111.91 121.48 45.14 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 115.94 -0.573 . . . . 0.0 109.619 -177.428 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' E' E ' 141' ' ' ILE . . . . . 0.522 ' HB ' HG13 ' E' ' 130' ' ' VAL . 19.4 mt -122.0 118.68 56.31 Favored 'Isoleucine or valine' 0 C--O 1.234 0.265 0 CA-C-O 121.168 0.509 . . . . 0.0 110.121 -176.799 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' E' E ' 142' ' ' ARG . . . . . . . . . . . . . 78.6 mtp180 -102.75 110.13 21.96 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 115.058 -0.973 . . . . 0.0 110.114 178.985 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' E' E ' 143' ' ' THR . . . . . . . . . . . . . 69.6 p . . . . . 0 C--O 1.219 -0.538 0 CA-C-O 118.041 -0.98 . . . . 0.0 110.558 -178.561 . . . . . . . . 0 0 . 1 . 002 nuclear build core ' F' F ' 1' ' ' MET . . . . . . . . . . . . . 25.3 ptp . . . . . 0 C--O 1.232 0.156 0 CA-C-O 120.806 0.336 . . . . 0.0 110.778 . . . . . . . . . 0 0 . 1 . 002 nuclear build core ' F' F ' 2' ' ' SER . . . . . . . . . . . . . 10.1 p -112.22 134.47 53.75 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.562 179.319 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' F' F ' 3' ' ' GLU . . . . . . . . . . . . . 40.6 mt-10 -139.61 141.6 37.11 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 115.991 -0.55 . . . . 0.0 110.653 -179.544 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' F' F ' 4' ' ' LEU . . . . . 0.427 HD12 HD23 ' F' ' 58' ' ' LEU . 3.1 tt -128.01 125.63 39.77 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-N 115.896 -0.593 . . . . 0.0 109.945 179.11 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' F' F ' 5' ' ' LYS . . . . . . . . . . . . . 97.9 mttt -106.28 120.05 40.84 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.297 -0.411 . . . . 0.0 110.655 -179.811 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' F' F ' 6' ' ' LEU . . . . . . . . . . . . . 64.1 mt -114.01 150.06 34.46 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 115.538 -0.756 . . . . 0.0 110.485 -178.88 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' F' F ' 7' ' ' LYS . . . . . . . . . . . . . 82.3 tttt -137.15 134.74 19.03 Favored Pre-proline 0 CA--C 1.534 0.365 0 CA-C-O 118.806 -0.616 . . . . 0.0 109.676 175.021 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' F' F ' 8' ' ' PRO . . . . . . . . . . . . . 71.8 Cg_endo -89.6 135.97 2.61 Favored 'Trans proline' 0 N--CA 1.49 1.319 0 C-N-CA 121.615 1.544 . . . . 0.0 111.483 177.838 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' F' F ' 9' ' ' LEU . . . . . . . . . . . . . 37.9 mt -72.93 -47.1 8.54 Favored Pre-proline 0 CA--C 1.533 0.325 0 CA-C-O 118.689 -0.672 . . . . 0.0 112.318 -177.538 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' F' F ' 10' ' ' PRO . . . . . . . . . . . . . 92.5 Cg_endo -80.68 149.87 18.61 Favored 'Trans proline' 0 N--CA 1.495 1.576 0 C-N-CA 121.104 1.203 . . . . 0.0 111.757 175.586 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' F' F ' 11' ' ' LYS . . . . . . . . . . . . . 83.6 tttt -84.1 96.9 9.06 Favored 'General case' 0 C--N 1.33 -0.275 0 C-N-CA 120.836 -0.346 . . . . 0.0 110.49 179.358 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' F' F ' 12' ' ' VAL . . . . . . . . . . . . . 12.1 p -142.77 144.39 24.36 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.364 0 CA-C-N 116.123 -0.49 . . . . 0.0 110.434 179.678 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' F' F ' 13' ' ' GLU . . . . . . . . . . . . . 43.7 mp0 -85.67 125.37 33.12 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.224 -0.444 . . . . 0.0 110.045 177.666 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' F' F ' 14' ' ' LEU . . . . . . . . . . . . . 45.7 mt -95.15 153.52 39.73 Favored Pre-proline 0 C--N 1.329 -0.303 0 CA-C-N 116.444 -0.344 . . . . 0.0 110.81 -177.8 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' F' F ' 15' ' ' PRO . . . . . . . . . . . . . 36.8 Cg_exo -59.33 160.14 20.67 Favored 'Trans proline' 0 N--CA 1.497 1.7 0 C-N-CA 121.296 1.331 . . . . 0.0 111.704 177.743 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' F' F ' 16' ' ' PRO . . . . . . . . . . . . . 27.5 Cg_exo -60.25 -43.13 36.98 Favored 'Trans proline' 0 N--CA 1.498 1.737 0 C-N-CA 121.381 1.388 . . . . 0.0 112.802 -177.628 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' F' F ' 17' ' ' ASP . . . . . . . . . . . . . 16.3 p-10 -87.72 12.5 12.65 Favored 'General case' 0 C--N 1.326 -0.422 0 N-CA-C 113.182 0.808 . . . . 0.0 113.182 -176.377 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' F' F ' 18' ' ' PHE . . . . . . . . . . . . . 48.1 t80 -58.0 -44.64 87.33 Favored 'General case' 0 C--N 1.334 -0.074 0 O-C-N 122.04 -0.413 . . . . 0.0 110.151 -178.241 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' F' F ' 19' ' ' VAL . . . . . 0.41 HG13 ' N ' ' F' ' 20' ' ' ASP . 14.6 p -56.46 -42.08 74.18 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.333 0 CA-C-N 116.36 -0.382 . . . . 0.0 110.941 -178.474 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' F' F ' 20' ' ' ASP . . . . . 0.41 ' N ' HG13 ' F' ' 19' ' ' VAL . 79.9 m-20 -60.98 -42.12 97.77 Favored 'General case' 0 C--O 1.233 0.234 0 CA-C-O 120.884 0.373 . . . . 0.0 110.957 -178.051 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' F' F ' 21' ' ' VAL . . . . . . . . . . . . . 46.9 t -64.0 -47.37 90.74 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 CA-C-N 116.343 -0.39 . . . . 0.0 110.406 -178.395 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' F' F ' 22' ' ' ILE . . . . . 0.51 HG22 HD12 ' F' ' 26' ' ' LEU . 50.1 mm -55.96 -43.96 76.67 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.182 0 CA-C-O 120.774 0.321 . . . . 0.0 110.66 178.769 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' F' F ' 23' ' ' ARG . . . . . . . . . . . . . 56.0 ttp180 -52.86 -52.36 57.57 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-O 120.709 0.29 . . . . 0.0 111.519 179.986 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' F' F ' 24' ' ' ILE . . . . . . . . . . . . . 69.3 mt -59.63 -40.62 82.68 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.268 0 CA-C-N 116.414 -0.357 . . . . 0.0 111.273 -177.051 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' F' F ' 25' ' ' LYS . . . . . . . . . . . . . 46.4 mttm -65.46 -42.06 92.7 Favored 'General case' 0 C--N 1.327 -0.377 0 N-CA-C 112.192 0.442 . . . . 0.0 112.192 -178.626 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' F' F ' 26' ' ' LEU . . . . . 0.51 HD12 HG22 ' F' ' 22' ' ' ILE . 74.4 mt -80.58 -38.03 30.21 Favored 'General case' 0 C--N 1.33 -0.261 0 N-CA-C 113.39 0.885 . . . . 0.0 113.39 -170.841 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' F' F ' 27' ' ' GLN . . . . . . . . . . . . . 12.4 pt20 -46.48 139.78 4.74 Favored 'General case' 0 N--CA 1.469 0.479 0 N-CA-C 112.871 0.693 . . . . 0.0 112.871 -174.946 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' F' F ' 28' ' ' GLY . . . . . . . . . . . . . . . 99.29 -25.4 28.37 Favored Glycine 0 CA--C 1.533 1.193 0 CA-C-N 115.507 -0.77 . . . . 0.0 112.264 -177.035 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' F' F ' 29' ' ' LYS . . . . . . . . . . . . . 33.5 mmtp -97.61 155.15 17.1 Favored 'General case' 0 C--O 1.233 0.198 0 CA-C-N 117.335 0.568 . . . . 0.0 110.771 178.982 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' F' F ' 30' ' ' THR . . . . . . . . . . . . . 25.2 m -107.21 136.65 46.68 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 115.928 -0.578 . . . . 0.0 109.827 175.428 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' F' F ' 31' ' ' VAL . . . . . . . . . . . . . 35.0 m -129.78 161.15 39.94 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.267 0 CA-C-N 116.473 -0.33 . . . . 0.0 110.814 -177.959 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' F' F ' 32' ' ' ARG . . . . . . . . . . . . . 92.7 mtt180 -132.56 151.22 52.0 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-O 121.307 0.575 . . . . 0.0 110.595 178.88 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' F' F ' 33' ' ' THR . . . . . . . . . . . . . 24.1 m -52.45 140.54 22.18 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.112 -0.494 . . . . 0.0 111.396 -178.467 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' F' F ' 34' ' ' GLY . . . . . . . . . . . . . . . 99.28 -17.09 58.39 Favored Glycine 0 CA--C 1.532 1.135 0 CA-C-O 119.596 -0.558 . . . . 0.0 113.218 178.977 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' F' F ' 35' ' ' ASP . . . . . . . . . . . . . 54.3 m-20 -63.3 150.48 43.18 Favored 'General case' 0 C--O 1.232 0.142 0 CA-C-N 118.09 0.945 . . . . 0.0 111.0 179.365 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' F' F ' 36' ' ' VAL . . . . . . . . . . . . . 42.4 t -125.72 130.44 72.53 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.293 0 CA-C-N 115.801 -0.636 . . . . 0.0 109.706 178.763 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' F' F ' 37' ' ' ILE . . . . . . . . . . . . . 65.2 mt -120.66 138.92 49.57 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.294 0 CA-C-N 116.336 -0.393 . . . . 0.0 110.098 -178.921 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' F' F ' 38' ' ' GLY . . . . . . . . . . . . . . . -109.13 128.86 9.21 Favored Glycine 0 CA--C 1.525 0.689 0 N-CA-C 110.872 -0.891 . . . . 0.0 110.872 179.02 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' F' F ' 39' ' ' ILE . . . . . . . . . . . . . 74.4 mt -123.57 134.91 65.03 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.256 0 N-CA-C 110.176 -0.305 . . . . 0.0 110.176 179.828 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' F' F ' 40' ' ' SER . . . . . . . . . . . . . 88.0 p -92.65 118.63 31.24 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.895 176.383 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' F' F ' 41' ' ' ILE . . . . . . . . . . . . . 44.5 mm -120.48 113.01 38.68 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.263 0 CA-C-O 120.751 0.31 . . . . 0.0 110.247 178.799 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' F' F ' 42' ' ' LEU . . . . . 0.409 HD12 ' N ' ' F' ' 42' ' ' LEU . 7.9 mp 51.21 37.4 18.37 Favored 'General case' 0 C--N 1.331 -0.223 0 CA-C-N 116.151 -0.477 . . . . 0.0 111.748 177.006 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' F' F ' 43' ' ' GLY . . . . . . . . . . . . . . . 75.95 29.84 58.4 Favored Glycine 0 CA--C 1.53 1.03 0 C-N-CA 121.151 -0.547 . . . . 0.0 112.33 177.606 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' F' F ' 44' ' ' LYS . . . . . . . . . . . . . 60.0 mtpt -135.29 127.88 30.76 Favored 'General case' 0 C--N 1.329 -0.295 0 N-CA-C 109.65 -0.5 . . . . 0.0 109.65 177.062 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' F' F ' 45' ' ' GLU . . . . . . . . . . . . . 84.2 tt0 -82.73 123.42 29.29 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-O 120.822 0.344 . . . . 0.0 111.322 -176.738 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' F' F ' 46' ' ' VAL . . . . . . . . . . . . . 7.1 p -123.23 128.4 74.89 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.202 0 N-CA-C 109.592 -0.521 . . . . 0.0 109.592 175.386 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' F' F ' 47' ' ' LYS . . . . . . . . . . . . . 63.6 mttp -99.53 128.79 45.65 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.125 -0.489 . . . . 0.0 111.229 178.099 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' F' F ' 48' ' ' PHE . . . . . . . . . . . . . 91.5 m-85 -111.64 131.9 54.96 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.023 -0.535 . . . . 0.0 109.746 176.196 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' F' F ' 49' ' ' LYS . . . . . . . . . . . . . 71.9 tttt -106.6 136.18 46.83 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.4 -0.364 . . . . 0.0 110.455 -179.654 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' F' F ' 50' ' ' VAL . . . . . . . . . . . . . 45.4 t -81.11 105.62 11.25 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.292 0 N-CA-C 109.53 -0.544 . . . . 0.0 109.53 176.691 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' F' F ' 51' ' ' VAL . . . . . . . . . . . . . 47.6 t -70.21 -51.96 34.34 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.33 0 CA-C-N 115.879 -0.6 . . . . 0.0 109.73 -174.387 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' F' F ' 52' ' ' GLN . . . . . . . . . . . . . 77.8 mt-30 -154.62 147.67 24.68 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-O 121.175 0.512 . . . . 0.0 111.756 -177.261 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' F' F ' 53' ' ' ALA . . . . . 0.456 ' HB1' ' HB2' ' F' ' 58' ' ' LEU . . . -122.39 128.84 51.46 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 115.19 -0.914 . . . . 0.0 109.317 175.282 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' F' F ' 54' ' ' TYR . . . . . . . . . . . . . 45.7 t80 -126.77 109.53 22.51 Favored Pre-proline 0 CA--C 1.534 0.335 0 CA-C-O 118.383 -0.817 . . . . 0.0 110.443 -178.479 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' F' F ' 55' ' ' PRO . . . . . . . . . . . . . 74.4 Cg_endo -77.09 170.04 72.69 Favored 'Cis proline' 0 N--CA 1.5 1.902 0 CA-C-N 121.768 1.667 . . . . 0.0 112.536 -5.091 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' F' F ' 56' ' ' SER . . . . . . . . . . . . . 13.7 m -112.27 126.91 27.6 Favored Pre-proline 0 CA--C 1.539 0.542 0 CA-C-O 118.409 -0.805 . . . . 0.0 109.642 176.52 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' F' F ' 57' ' ' PRO . . . . . . . . . . . . . 33.7 Cg_endo -65.27 169.15 41.16 Favored 'Cis proline' 0 N--CA 1.498 1.791 0 CA-C-N 122.083 1.78 . . . . 0.0 111.475 -1.543 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' F' F ' 58' ' ' LEU . . . . . 0.456 ' HB2' ' HB1' ' F' ' 53' ' ' ALA . 34.0 tp -130.61 137.05 49.45 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-O 120.971 0.415 . . . . 0.0 110.574 -179.313 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' F' F ' 59' ' ' ARG . . . . . . . . . . . . . 71.1 ttt180 -104.68 129.24 52.88 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 115.773 -0.648 . . . . 0.0 109.575 177.695 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' F' F ' 60' ' ' VAL . . . . . . . . . . . . . 42.3 t -86.74 119.17 34.23 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.272 0 C-N-CA 120.744 -0.382 . . . . 0.0 110.353 -176.131 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' F' F ' 61' ' ' GLU . . . . . . . . . . . . . 95.3 mt-10 -131.08 168.04 18.07 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.329 178.28 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' F' F ' 62' ' ' ASP . . . . . . . . . . . . . 55.8 m-20 -54.01 -32.51 54.43 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.641 -0.254 . . . . 0.0 111.641 179.259 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' F' F ' 63' ' ' ARG . . . . . . . . . . . . . 6.8 ptp180 -85.5 9.08 16.85 Favored 'General case' 0 CA--C 1.537 0.447 0 N-CA-C 113.508 0.929 . . . . 0.0 113.508 -175.892 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' F' F ' 64' ' ' THR . . . . . . . . . . . . . 30.1 m -85.43 134.81 34.05 Favored 'General case' 0 C--N 1.333 -0.124 0 CA-C-N 118.085 0.402 . . . . 0.0 110.813 -178.749 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' F' F ' 65' ' ' LYS . . . . . . . . . . . . . 52.4 mtmt -88.74 124.6 34.28 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.234 -0.439 . . . . 0.0 109.932 177.426 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' F' F ' 66' ' ' ILE . . . . . . . . . . . . . 62.3 mt -112.51 128.54 69.12 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.325 0 N-CA-C 109.835 -0.431 . . . . 0.0 109.835 -178.572 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' F' F ' 67' ' ' THR . . . . . . . . . . . . . 28.5 m -126.15 141.82 51.78 Favored 'General case' 0 C--N 1.331 -0.222 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.972 -177.05 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' F' F ' 68' ' ' LEU . . . . . 0.476 HD12 ' N ' ' F' ' 68' ' ' LEU . 8.5 mp . . . . . 0 C--N 1.329 -0.312 0 CA-C-N 115.966 -0.561 . . . . 0.0 110.104 178.061 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' F' F ' 73' ' ' VAL . . . . . . . . . . . . . 35.6 m . . . . . 0 C--O 1.232 0.156 0 N-CA-C 109.681 -0.489 . . . . 0.0 109.681 . . . . . . . . . 0 0 . 1 . 002 nuclear build core ' F' F ' 74' ' ' ASP . . . . . . . . . . . . . 39.7 t0 -88.85 114.91 25.98 Favored 'General case' 0 C--N 1.328 -0.343 0 N-CA-C 109.982 -0.377 . . . . 0.0 109.982 -177.596 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' F' F ' 75' ' ' VAL . . . . . . . . . . . . . 41.4 t -111.05 120.79 62.47 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.287 0 CA-C-O 121.07 0.462 . . . . 0.0 110.242 -178.784 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' F' F ' 76' ' ' LEU . . . . . . . . . . . . . 15.3 mt -128.55 143.81 51.03 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 115.732 -0.667 . . . . 0.0 109.692 179.097 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' F' F ' 77' ' ' GLU . . . . . . . . . . . . . 97.3 mt-10 -131.94 131.26 42.5 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-O 120.989 0.424 . . . . 0.0 111.093 -177.153 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' F' F ' 78' ' ' ALA . . . . . . . . . . . . . . . -117.94 128.38 54.75 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 115.747 -0.661 . . . . 0.0 109.621 177.148 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' F' F ' 79' ' ' LYS . . . . . 0.595 ' O ' HD13 ' F' ' 80' ' ' ILE . 95.2 mttt -79.93 120.63 24.41 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-O 120.904 0.383 . . . . 0.0 110.857 -177.085 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' F' F ' 80' ' ' ILE . . . . . 0.595 HD13 ' O ' ' F' ' 79' ' ' LYS . 41.4 mm -139.1 108.68 3.93 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.309 0 N-CA-C 109.072 -0.714 . . . . 0.0 109.072 -177.322 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' F' F ' 81' ' ' LYS . . . . . . . . . . . . . 82.7 tttt -97.53 123.79 41.54 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-O 120.868 0.366 . . . . 0.0 111.239 -175.913 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' F' F ' 82' ' ' GLY . . . . . . . . . . . . . . . 89.22 42.02 5.68 Favored Glycine 0 CA--C 1.526 0.724 0 C-N-CA 120.884 -0.674 . . . . 0.0 111.907 174.647 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' F' F ' 83' ' ' ILE . . . . . . . . . . . . . 71.4 mt -68.7 136.71 25.85 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.304 0 N-CA-C 109.661 -0.496 . . . . 0.0 109.661 176.571 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' F' F ' 84' ' ' LYS . . . . . . . . . . . . . 36.7 ttpt -101.36 -51.31 3.52 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-O 120.868 0.366 . . . . 0.0 110.262 -178.908 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' F' F ' 85' ' ' ASP . . . . . . . . . . . . . 11.9 t70 -148.22 148.65 30.74 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 115.874 -0.603 . . . . 0.0 110.385 -179.752 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' F' F ' 86' ' ' VAL . . . . . . . . . . . . . 46.3 t -133.56 132.95 57.52 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.269 0 CA-C-O 121.0 0.429 . . . . 0.0 110.494 -178.98 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' F' F ' 87' ' ' ILE . . . . . 0.498 HD12 ' N ' ' F' ' 87' ' ' ILE . 5.0 mp -119.82 127.25 75.87 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.202 0 CA-C-N 115.859 -0.61 . . . . 0.0 109.474 175.901 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' F' F ' 88' ' ' LEU . . . . . . . . . . . . . 12.8 tp -112.6 129.94 56.2 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.3 -0.409 . . . . 0.0 111.022 -177.453 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' F' F ' 89' ' ' ASP . . . . . . . . . . . . . 6.2 t70 -123.94 156.36 36.49 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 115.868 -0.606 . . . . 0.0 109.747 176.794 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' F' F ' 90' ' ' GLU . . . . . . . . . . . . . 96.3 mt-10 -46.15 -41.93 13.21 Favored 'General case' 0 C--N 1.332 -0.192 0 N-CA-C 113.15 0.796 . . . . 0.0 113.15 -172.58 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' F' F ' 91' ' ' ASN . . . . . . . . . . . . . 54.0 m-80 -132.09 36.6 3.64 Favored 'General case' 0 N--CA 1.464 0.259 0 CA-C-O 120.732 0.301 . . . . 0.0 111.569 -176.575 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' F' F ' 92' ' ' LEU . . . . . . . . . . . . . 12.6 tp -166.07 144.98 5.91 Favored 'General case' 0 C--N 1.331 -0.232 0 C-N-CA 120.927 -0.309 . . . . 0.0 110.746 -179.752 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' F' F ' 93' ' ' ILE . . . . . . . . . . . . . 68.7 mt -127.3 123.63 62.31 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.253 0 N-CA-C 109.584 -0.524 . . . . 0.0 109.584 179.795 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' F' F ' 94' ' ' VAL . . . . . 0.446 HG21 HG11 ' F' ' 125' ' ' VAL . 47.2 t -123.09 125.4 72.02 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.27 0 N-CA-C 109.907 -0.405 . . . . 0.0 109.907 -179.92 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' F' F ' 95' ' ' VAL . . . . . . . . . . . . . 43.4 t -121.16 135.81 60.13 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.325 0 CA-C-N 115.902 -0.59 . . . . 0.0 109.97 -177.877 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' F' F ' 96' ' ' ILE . . . . . . . . . . . . . 60.3 mt -117.62 126.51 74.76 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.286 0 N-CA-C 109.258 -0.645 . . . . 0.0 109.258 178.58 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' F' F ' 97' ' ' THR . . . . . . . . . . . . . 64.0 p -102.6 157.61 16.81 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-O 121.081 0.467 . . . . 0.0 111.36 -176.432 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' F' F ' 98' ' ' GLU . . . . . . . . . . . . . 12.5 pt-20 -53.88 -22.17 9.33 Favored 'General case' 0 CA--C 1.534 0.345 0 N-CA-C 112.51 0.559 . . . . 0.0 112.51 -179.936 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' F' F ' 99' ' ' GLU . . . . . . . . . . . . . 16.9 tt0 -78.94 14.56 1.34 Allowed 'General case' 0 CA--C 1.537 0.444 0 N-CA-C 112.855 0.687 . . . . 0.0 112.855 -178.061 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' F' F ' 100' ' ' ASN . . . . . . . . . . . . . 3.6 m-20 59.92 38.09 21.23 Favored 'General case' 0 CA--C 1.531 0.214 0 CA-C-O 121.027 0.441 . . . . 0.0 110.599 -179.536 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' F' F ' 101' ' ' GLU . . . . . . . . . . . . . 84.7 tt0 -118.24 143.49 46.51 Favored 'General case' 0 C--N 1.332 -0.163 0 CA-C-N 116.014 -0.539 . . . . 0.0 109.776 178.429 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' F' F ' 102' ' ' VAL . . . . . . . . . . . . . 43.6 t -114.95 126.75 72.61 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.269 0 CA-C-N 116.182 -0.463 . . . . 0.0 109.946 -177.862 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' F' F ' 103' ' ' LEU . . . . . . . . . . . . . 27.0 mt -116.53 130.78 56.94 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 115.665 -0.698 . . . . 0.0 110.267 177.704 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' F' F ' 104' ' ' ILE . . . . . . . . . . . . . 66.5 mt -118.38 120.75 65.28 Favored 'Isoleucine or valine' 0 C--O 1.234 0.25 0 N-CA-C 110.053 -0.351 . . . . 0.0 110.053 179.669 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' F' F ' 105' ' ' PHE . . . . . . . . . . . . . 84.3 m-85 -123.47 164.87 18.08 Favored 'General case' 0 C--N 1.333 -0.15 0 O-C-N 123.928 0.768 . . . . 0.0 109.91 179.742 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' F' F ' 106' ' ' ASN . . . . . . . . . . . . . 45.4 p-10 -100.07 -171.31 2.02 Favored 'General case' 0 C--N 1.331 -0.229 0 N-CA-C 109.88 -0.415 . . . . 0.0 109.88 172.934 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' F' F ' 107' ' ' GLN . . . . . . . . . . . . . 48.7 tt0 -58.67 -28.23 65.54 Favored 'General case' 0 C--N 1.328 -0.365 0 N-CA-C 112.278 0.473 . . . . 0.0 112.278 -178.693 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' F' F ' 108' ' ' ASN . . . . . . . . . . . . . 14.0 t30 -91.4 14.11 15.59 Favored 'General case' 0 CA--C 1.534 0.359 0 N-CA-C 113.177 0.806 . . . . 0.0 113.177 -176.336 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' F' F ' 109' ' ' LEU . . . . . . . . . . . . . 28.2 mt 59.15 37.2 24.09 Favored 'General case' 0 CA--C 1.529 0.144 0 CA-C-O 121.03 0.443 . . . . 0.0 111.551 177.122 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' F' F ' 110' ' ' GLU . . . . . . . . . . . . . 95.7 mt-10 -100.6 150.15 23.01 Favored 'General case' 0 C--N 1.329 -0.285 0 N-CA-C 109.818 -0.438 . . . . 0.0 109.818 176.058 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' F' F ' 111' ' ' GLU . . . . . . . . . . . . . 84.9 tt0 -82.38 122.01 27.45 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-O 120.918 0.389 . . . . 0.0 110.713 -178.255 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' F' F ' 112' ' ' LEU . . . . . . . . . . . . . 60.6 mt -110.91 -46.02 3.39 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.029 -0.532 . . . . 0.0 110.334 178.872 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' F' F ' 113' ' ' TYR . . . . . . . . . . . . . 52.6 t80 -140.96 138.58 33.87 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-O 120.874 0.368 . . . . 0.0 111.393 -179.791 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' F' F ' 114' ' ' ARG . . . . . . . . . . . . . 31.4 ttp180 -138.61 123.02 18.34 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 115.863 -0.608 . . . . 0.0 109.955 176.29 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' F' F ' 115' ' ' GLY . . . . . . . . . . . . . . . -150.08 157.78 27.37 Favored Glycine 0 CA--C 1.523 0.581 0 C-N-CA 120.794 -0.717 . . . . 0.0 111.35 179.002 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' F' F ' 116' ' ' LYS . . . . . . . . . . . . . 39.8 ttpt -127.7 140.74 51.88 Favored 'General case' 0 C--N 1.331 -0.228 0 N-CA-C 110.139 -0.319 . . . . 0.0 110.139 178.446 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' F' F ' 117' ' ' PHE . . . . . 0.472 ' HE2' HD13 ' F' ' 132' ' ' ILE . 44.2 m-85 -136.16 115.01 12.13 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-O 120.865 0.364 . . . . 0.0 110.292 -178.331 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' F' F ' 118' ' ' GLU . . . . . . . . . . . . . 84.9 tt0 -52.23 -46.9 65.89 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.43 -0.35 . . . . 0.0 111.561 -177.515 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' F' F ' 119' ' ' ASN . . . . . . . . . . . . . 18.0 m120 -97.01 31.02 2.51 Favored 'General case' 0 C--N 1.329 -0.285 0 N-CA-C 112.105 0.409 . . . . 0.0 112.105 -175.213 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' F' F ' 120' ' ' LEU . . . . . . . . . . . . . 15.5 tp -56.29 120.11 7.07 Favored 'General case' 0 C--N 1.331 -0.202 0 CA-C-O 120.694 0.283 . . . . 0.0 110.543 178.392 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' F' F ' 121' ' ' ASN . . . . . . . . . . . . . 12.5 m120 -114.06 -44.02 3.19 Favored 'General case' 0 C--N 1.332 -0.181 0 CA-C-N 116.499 -0.319 . . . . 0.0 111.225 -177.53 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' F' F ' 122' ' ' LYS . . . . . . . . . . . . . 88.4 mttt -144.7 153.84 42.14 Favored 'General case' 0 C--N 1.332 -0.195 0 CA-C-O 121.096 0.474 . . . . 0.0 111.912 -176.104 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' F' F ' 123' ' ' VAL . . . . . . . . . . . . . 44.3 t -129.29 129.04 67.23 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.261 0 CA-C-N 115.735 -0.666 . . . . 0.0 109.621 175.428 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' F' F ' 124' ' ' LEU . . . . . . . . . . . . . 34.0 mt -116.69 133.25 56.24 Favored 'General case' 0 C--N 1.331 -0.208 0 CA-C-N 116.305 -0.407 . . . . 0.0 110.275 -179.251 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' F' F ' 125' ' ' VAL . . . . . 0.446 HG11 HG21 ' F' ' 94' ' ' VAL . 34.3 m -136.21 139.03 46.33 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.298 0 CA-C-N 116.506 -0.315 . . . . 0.0 110.831 -179.032 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' F' F ' 126' ' ' ARG . . . . . . . . . . . . . 19.2 ttm180 -157.63 127.46 6.11 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-O 120.974 0.416 . . . . 0.0 110.88 175.913 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' F' F ' 127' ' ' ASN . . . . . . . . . . . . . 78.8 m-20 52.9 -113.09 0.74 Allowed 'General case' 0 CA--C 1.544 0.73 0 CA-C-O 118.748 -0.644 . . . . 0.0 110.858 -179.77 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' F' F ' 128' ' ' ASP . . . . . . . . . . . . . 18.9 p-10 -114.17 9.84 17.21 Favored 'General case' 0 CA--C 1.536 0.42 0 CA-C-N 119.978 1.263 . . . . 0.0 113.074 -178.233 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' F' F ' 129' ' ' LEU . . . . . . . . . . . . . 15.1 tp -109.02 138.69 44.97 Favored 'General case' 0 C--O 1.233 0.211 0 O-C-N 122.056 -0.403 . . . . 0.0 109.93 179.123 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' F' F ' 130' ' ' VAL . . . . . . . . . . . . . 43.0 t -125.36 139.49 51.1 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.24 0 CA-C-N 116.311 -0.404 . . . . 0.0 110.002 -178.968 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' F' F ' 131' ' ' VAL . . . . . . . . . . . . . 43.6 t -135.62 135.62 51.14 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.338 0 CA-C-N 116.239 -0.437 . . . . 0.0 109.959 178.287 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' F' F ' 132' ' ' ILE . . . . . 0.472 HD13 ' HE2' ' F' ' 117' ' ' PHE . 69.3 mt -114.41 134.13 58.31 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.323 0 N-CA-C 109.41 -0.589 . . . . 0.0 109.41 -179.926 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' F' F ' 133' ' ' ILE . . . . . . . . . . . . . 39.2 mm -116.22 117.88 56.97 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.211 0 CA-C-N 116.295 -0.411 . . . . 0.0 111.006 -174.594 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' F' F ' 134' ' ' ASP . . . . . . . . . . . . . 7.0 p-10 -129.81 149.64 51.47 Favored 'General case' 0 C--N 1.332 -0.177 0 N-CA-C 109.582 -0.525 . . . . 0.0 109.582 174.085 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' F' F ' 135' ' ' GLU . . . . . . . . . . . . . 39.7 tp10 -49.87 -26.17 3.83 Favored 'General case' 0 C--N 1.327 -0.39 0 N-CA-C 112.988 0.736 . . . . 0.0 112.988 -169.676 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' F' F ' 136' ' ' GLN . . . . . . . . . . . . . 96.9 mt-30 -105.09 -24.27 12.8 Favored 'General case' 0 N--CA 1.466 0.353 0 N-CA-C 113.178 0.807 . . . . 0.0 113.178 -174.654 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' F' F ' 137' ' ' LYS . . . . . . . . . . . . . 38.6 ttpt -140.86 147.75 39.44 Favored 'General case' 0 C--N 1.331 -0.21 0 CA-C-O 121.515 0.674 . . . . 0.0 112.35 -168.32 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' F' F ' 138' ' ' LEU . . . . . . . . . . . . . 16.3 tp -111.67 121.19 44.46 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 114.863 -1.062 . . . . 0.0 109.069 173.567 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' F' F ' 139' ' ' THR . . . . . . . . . . . . . 21.7 m -110.88 126.39 54.64 Favored 'General case' 0 C--N 1.332 -0.179 0 CA-C-O 120.689 0.28 . . . . 0.0 110.963 -178.328 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' F' F ' 140' ' ' LEU . . . . . 0.479 HD23 ' C ' ' F' ' 140' ' ' LEU . 7.8 tt -114.56 123.45 49.38 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 115.592 -0.731 . . . . 0.0 109.247 179.701 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' F' F ' 141' ' ' ILE . . . . . . . . . . . . . 19.5 mt -122.09 121.42 63.99 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.326 0 CA-C-O 120.988 0.423 . . . . 0.0 109.929 -175.545 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' F' F ' 142' ' ' ARG . . . . . . . . . . . . . 72.3 ttt-85 -113.91 131.43 56.3 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 115.268 -0.878 . . . . 0.0 110.452 -176.917 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' F' F ' 143' ' ' THR . . . . . . . . . . . . . 20.1 p . . . . . 0 C--O 1.221 -0.422 0 CA-C-O 117.991 -1.005 . . . . 0.0 110.522 179.458 . . . . . . . . 0 0 . 1 . 003 nuclear build core ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 6.7 p . . . . . 0 C--O 1.232 0.169 0 CA-C-O 120.901 0.381 . . . . 0.0 110.96 . . . . . . . . . 0 0 . 1 . 003 nuclear build core ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 53.7 mp0 -140.96 141.48 34.45 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.065 -0.516 . . . . 0.0 111.005 179.04 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 4' ' ' LEU . . . . . . . . . . . . . 15.8 tp -128.22 130.44 47.97 Favored 'General case' 0 C--N 1.331 -0.206 0 CA-C-N 116.067 -0.515 . . . . 0.0 110.106 175.833 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 5' ' ' LYS . . . . . . . . . . . . . 66.8 mttm -113.71 121.58 44.54 Favored 'General case' 0 C--O 1.235 0.308 0 CA-C-N 116.356 -0.384 . . . . 0.0 110.845 -179.765 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 45.1 mt -114.17 145.46 41.64 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 115.413 -0.812 . . . . 0.0 110.3 -179.271 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 78.6 tttt -131.75 136.96 29.27 Favored Pre-proline 0 CA--C 1.535 0.374 0 CA-C-O 119.011 -0.519 . . . . 0.0 109.934 176.573 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 8' ' ' PRO . . . . . . . . . . . . . 85.5 Cg_endo -91.9 143.32 2.77 Favored 'Trans proline' 0 N--CA 1.491 1.358 0 C-N-CA 121.786 1.657 . . . . 0.0 111.864 178.623 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 43.4 mt -77.94 -47.79 2.19 Favored Pre-proline 0 CA--C 1.534 0.349 0 CA-C-O 118.657 -0.687 . . . . 0.0 112.22 179.787 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 95.0 Cg_endo -81.19 156.21 19.66 Favored 'Trans proline' 0 N--CA 1.496 1.649 0 C-N-CA 121.253 1.302 . . . . 0.0 112.128 177.075 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 62.9 tttm -88.96 107.33 18.96 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.358 -0.383 . . . . 0.0 110.435 177.908 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 12.7 p -147.83 146.29 18.16 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.336 0 CA-C-O 120.814 0.34 . . . . 0.0 110.763 -179.855 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 70.7 mm-40 -84.47 130.28 34.78 Favored 'General case' 0 C--N 1.33 -0.275 0 N-CA-C 109.874 -0.417 . . . . 0.0 109.874 177.033 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 14' ' ' LEU . . . . . . . . . . . . . 32.9 mt -98.56 145.04 29.21 Favored Pre-proline 0 CA--C 1.534 0.357 0 CA-C-O 119.042 -0.504 . . . . 0.0 110.472 -178.653 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 15' ' ' PRO . . . . . . . . . . . . . 24.7 Cg_exo -62.85 160.37 33.61 Favored 'Trans proline' 0 N--CA 1.497 1.722 0 C-N-CA 121.359 1.373 . . . . 0.0 112.053 176.749 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 16' ' ' PRO . . . . . . . . . . . . . 27.8 Cg_exo -60.4 -33.04 94.58 Favored 'Trans proline' 0 N--CA 1.497 1.7 0 C-N-CA 121.556 1.504 . . . . 0.0 112.693 -179.637 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 17' ' ' ASP . . . . . . . . . . . . . 11.0 p-10 -86.16 4.42 38.54 Favored 'General case' 0 CA--C 1.536 0.42 0 N-CA-C 113.264 0.839 . . . . 0.0 113.264 -177.583 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 18' ' ' PHE . . . . . . . . . . . . . 23.0 t80 -57.45 -44.79 85.05 Favored 'General case' 0 N--CA 1.457 -0.093 0 O-C-N 121.878 -0.514 . . . . 0.0 110.252 -177.374 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 19' ' ' VAL . . . . . . . . . . . . . 48.4 t -55.9 -46.07 80.12 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.36 0 CA-C-N 116.449 -0.342 . . . . 0.0 110.823 -177.532 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 79.8 m-20 -59.59 -42.01 91.57 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-O 120.771 0.319 . . . . 0.0 110.951 -176.855 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 48.0 t -64.13 -47.48 89.93 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.25 0 C-N-CA 120.645 -0.422 . . . . 0.0 110.495 -177.701 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 22' ' ' ILE . . . . . 0.528 HG22 HD12 ' A' ' 26' ' ' LEU . 51.6 mm -55.82 -47.05 80.1 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.237 0 C-N-CA 120.978 -0.289 . . . . 0.0 110.684 179.631 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 23' ' ' ARG . . . . . . . . . . . . . 50.9 ttp180 -54.35 -49.39 69.89 Favored 'General case' 0 C--N 1.329 -0.286 0 C-N-CA 121.005 -0.278 . . . . 0.0 111.419 -177.626 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 24' ' ' ILE . . . . . . . . . . . . . 74.0 mt -60.32 -45.12 96.87 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.235 0 C-N-CA 121.117 -0.233 . . . . 0.0 111.26 -177.197 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 56.2 mmtt -64.67 -38.7 91.91 Favored 'General case' 0 C--N 1.328 -0.334 0 N-CA-C 112.259 0.466 . . . . 0.0 112.259 -177.571 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 26' ' ' LEU . . . . . 0.528 HD12 HG22 ' A' ' 22' ' ' ILE . 91.2 mt -78.33 -44.8 24.25 Favored 'General case' 0 C--N 1.33 -0.273 0 N-CA-C 112.983 0.734 . . . . 0.0 112.983 -172.27 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 27' ' ' GLN . . . . . . . . . . . . . 15.4 pt20 -47.23 139.41 6.2 Favored 'General case' 0 N--CA 1.469 0.492 0 N-CA-C 112.714 0.635 . . . . 0.0 112.714 -175.495 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 99.37 -26.34 24.74 Favored Glycine 0 CA--C 1.533 1.17 0 CA-C-N 115.613 -0.721 . . . . 0.0 112.245 -177.744 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 89.9 mttt -98.5 155.1 17.43 Favored 'General case' 0 C--O 1.233 0.191 0 CA-C-N 117.248 0.524 . . . . 0.0 111.439 179.756 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 30' ' ' THR . . . . . . . . . . . . . 24.2 m -105.78 135.17 47.68 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 115.717 -0.674 . . . . 0.0 109.774 174.906 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 34.8 m -131.73 157.13 43.1 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.276 0 CA-C-N 116.353 -0.385 . . . . 0.0 111.006 -177.739 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 32' ' ' ARG . . . . . . . . . . . . . 91.6 mtm-85 -130.61 150.42 51.82 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-O 121.289 0.566 . . . . 0.0 110.902 179.43 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 33' ' ' THR . . . . . . . . . . . . . 20.3 m -53.47 140.63 27.43 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.076 -0.511 . . . . 0.0 111.299 -178.634 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 99.63 -17.08 58.06 Favored Glycine 0 CA--C 1.534 1.278 0 C-N-CA 121.116 -0.564 . . . . 0.0 113.155 179.252 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 73.0 m-20 -64.68 148.46 50.96 Favored 'General case' 0 C--O 1.232 0.136 0 CA-C-N 118.081 0.941 . . . . 0.0 111.127 179.278 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 46.5 t -118.94 129.43 75.14 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.208 0 CA-C-N 115.721 -0.672 . . . . 0.0 109.686 178.529 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 37' ' ' ILE . . . . . . . . . . . . . 69.0 mt -121.22 138.73 50.63 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.265 0 CA-C-N 116.14 -0.482 . . . . 0.0 109.907 -179.158 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . -113.53 128.94 8.57 Favored Glycine 0 CA--C 1.526 0.758 0 N-CA-C 110.989 -0.844 . . . . 0.0 110.989 -179.976 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 39' ' ' ILE . . . . . . . . . . . . . 70.7 mt -123.43 136.99 58.22 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.218 0 N-CA-C 110.041 -0.355 . . . . 0.0 110.041 179.478 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 40' ' ' SER . . . . . . . . . . . . . 13.4 p -92.83 121.68 34.45 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.344 -0.389 . . . . 0.0 110.961 176.406 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 41' ' ' ILE . . . . . 0.413 HG22 HD13 ' A' ' 42' ' ' LEU . 70.6 mt -129.42 114.1 30.19 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.218 0 N-CA-C 109.756 -0.461 . . . . 0.0 109.756 177.136 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 42' ' ' LEU . . . . . 0.413 HD13 HG22 ' A' ' 41' ' ' ILE . 8.6 mp 57.22 35.29 25.98 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-O 120.954 0.407 . . . . 0.0 111.337 -178.973 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . 77.79 -10.13 26.77 Favored Glycine 0 CA--C 1.536 1.359 0 C-N-CA 121.275 -0.488 . . . . 0.0 113.414 178.218 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 44' ' ' LYS . . . . . . . . . . . . . 25.5 ttpt -91.77 129.97 37.64 Favored 'General case' 0 C--N 1.331 -0.226 0 CA-C-N 117.915 0.858 . . . . 0.0 109.811 176.693 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 84.4 tt0 -84.05 125.97 32.61 Favored 'General case' 0 C--N 1.327 -0.392 0 C-N-CA 120.874 -0.33 . . . . 0.0 110.805 -179.731 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 46' ' ' VAL . . . . . . . . . . . . . 7.5 p -119.4 129.25 75.52 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.187 0 N-CA-C 109.553 -0.536 . . . . 0.0 109.553 176.147 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 59.0 mtpt -100.34 126.39 46.68 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 115.704 -0.68 . . . . 0.0 111.059 179.238 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 48' ' ' PHE . . . . . . . . . . . . . 94.0 m-85 -111.33 131.9 54.81 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.198 -0.456 . . . . 0.0 109.918 176.361 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 78.4 tttt -107.28 135.61 48.5 Favored 'General case' 0 C--N 1.329 -0.322 0 N-CA-C 110.155 -0.313 . . . . 0.0 110.155 178.265 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 50' ' ' VAL . . . . . . . . . . . . . 45.0 t -79.7 109.56 14.41 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.285 0 N-CA-C 109.333 -0.617 . . . . 0.0 109.333 177.047 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 51' ' ' VAL . . . . . . . . . . . . . 49.1 t -72.4 -52.37 24.18 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.321 0 CA-C-N 115.993 -0.548 . . . . 0.0 109.626 -174.885 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 52' ' ' GLN . . . . . . . . . . . . . 90.8 mt-30 -153.42 150.27 28.64 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.061 -0.518 . . . . 0.0 111.769 -177.821 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -130.16 132.81 46.22 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 115.208 -0.905 . . . . 0.0 109.611 174.725 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 54' ' ' TYR . . . . . . . . . . . . . 37.4 t80 -129.07 113.02 18.53 Favored Pre-proline 0 CA--C 1.535 0.392 0 CA-C-O 118.144 -0.931 . . . . 0.0 110.496 179.092 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 55' ' ' PRO . . . . . . . . . . . . . 74.4 Cg_endo -77.11 167.37 79.96 Favored 'Cis proline' 0 N--CA 1.5 1.854 0 CA-C-N 121.97 1.739 . . . . 0.0 112.475 -6.872 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 56' ' ' SER . . . . . . . . . . . . . 13.6 m -116.09 127.02 27.09 Favored Pre-proline 0 CA--C 1.538 0.502 0 CA-C-O 118.427 -0.797 . . . . 0.0 109.239 175.859 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 57' ' ' PRO . . . . . . . . . . . . . 46.7 Cg_endo -69.7 148.65 87.03 Favored 'Cis proline' 0 N--CA 1.498 1.741 0 CA-C-N 122.067 1.774 . . . . 0.0 111.862 0.497 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 58' ' ' LEU . . . . . . . . . . . . . 23.2 tp -107.52 137.18 46.02 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.014 -0.539 . . . . 0.0 110.742 -178.898 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 59' ' ' ARG . . . . . . . . . . . . . 56.9 ttp180 -104.04 120.12 40.39 Favored 'General case' 0 C--N 1.327 -0.383 0 N-CA-C 109.205 -0.665 . . . . 0.0 109.205 174.513 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 40.3 t -81.37 122.35 36.28 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.232 0 C-N-CA 120.626 -0.429 . . . . 0.0 110.74 -173.453 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 91.1 mt-10 -131.07 164.15 26.06 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 115.96 -0.564 . . . . 0.0 109.675 176.567 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 62' ' ' ASP . . . . . . . . . . . . . 44.5 m-20 -53.04 -32.8 48.79 Favored 'General case' 0 C--N 1.328 -0.347 0 N-CA-C 111.852 0.316 . . . . 0.0 111.852 -179.739 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 63' ' ' ARG . . . . . . . . . . . . . 68.4 mtp180 -72.47 -21.79 61.16 Favored 'General case' 0 CA--C 1.534 0.335 0 N-CA-C 112.907 0.706 . . . . 0.0 112.907 -176.354 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 31.1 m -68.77 140.14 55.32 Favored 'General case' 0 C--N 1.331 -0.2 0 CA-C-O 120.86 0.362 . . . . 0.0 111.057 -175.675 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 65' ' ' LYS . . . . . . . . . . . . . 50.3 mtmt -89.5 134.24 34.2 Favored 'General case' 0 C--N 1.331 -0.23 0 CA-C-N 116.11 -0.496 . . . . 0.0 110.444 178.316 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 66' ' ' ILE . . . . . . . . . . . . . 61.0 mt -118.27 132.59 67.67 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.254 0 N-CA-C 109.98 -0.378 . . . . 0.0 109.98 179.917 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 67' ' ' THR . . . . . . . . . . . . . 20.5 m -124.18 136.81 54.46 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-O 121.028 0.442 . . . . 0.0 110.918 -179.362 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 68' ' ' LEU . . . . . . . . . . . . . 30.6 mt . . . . . 0 C--N 1.329 -0.294 0 CA-C-N 115.881 -0.599 . . . . 0.0 110.431 177.498 . . . . . . . . 0 0 . 1 . 003 nuclear build core ' A' A ' 74' ' ' ASP . . . . . 0.509 ' OD1' HD11 ' A' ' 76' ' ' LEU . 4.9 t70 . . . . . 0 C--O 1.231 0.099 0 N-CA-C 110.275 -0.269 . . . . 0.0 110.275 . . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 42.8 t -117.8 123.65 71.98 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.26 0 CA-C-O 120.931 0.396 . . . . 0.0 110.646 -177.937 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 76' ' ' LEU . . . . . 0.509 HD11 ' OD1' ' A' ' 74' ' ' ASP . 5.8 mp -121.81 148.48 44.63 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 115.848 -0.615 . . . . 0.0 109.679 175.537 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 77' ' ' GLU . . . . . . . . . . . . . 96.6 mt-10 -137.68 134.93 35.99 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-O 120.991 0.424 . . . . 0.0 111.354 -178.308 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 78' ' ' ALA . . . . . . . . . . . . . . . -119.95 135.44 54.9 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 115.718 -0.674 . . . . 0.0 109.679 176.266 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 79' ' ' LYS . . . . . 0.612 ' O ' HD13 ' A' ' 80' ' ' ILE . 62.0 mttp -84.78 115.56 22.79 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-O 120.816 0.341 . . . . 0.0 111.078 -176.578 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 80' ' ' ILE . . . . . 0.612 HD13 ' O ' ' A' ' 79' ' ' LYS . 39.6 mm -139.3 108.56 3.71 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.27 0 N-CA-C 109.301 -0.629 . . . . 0.0 109.301 -178.082 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 81' ' ' LYS . . . . . . . . . . . . . 63.6 mttp -94.53 126.25 39.69 Favored 'General case' 0 C--N 1.33 -0.249 0 C-N-CA 120.629 -0.428 . . . . 0.0 111.175 -179.734 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . 89.08 42.1 5.7 Favored Glycine 0 CA--C 1.527 0.821 0 C-N-CA 120.679 -0.772 . . . . 0.0 112.119 173.798 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 83' ' ' ILE . . . . . . . . . . . . . 72.9 mt -68.84 137.91 23.42 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.291 0 N-CA-C 109.597 -0.52 . . . . 0.0 109.597 176.19 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 84' ' ' LYS . . . . . . . . . . . . . 14.2 ttmm -93.08 -54.05 3.88 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-O 121.104 0.478 . . . . 0.0 110.216 -178.029 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 85' ' ' ASP . . . . . . . . . . . . . 13.1 t70 -151.22 151.41 31.83 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 115.611 -0.722 . . . . 0.0 110.55 -178.725 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 86' ' ' VAL . . . . . . . . . . . . . 44.1 t -128.58 129.43 68.72 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.255 0 CA-C-O 121.016 0.436 . . . . 0.0 110.083 178.914 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 87' ' ' ILE . . . . . 0.493 HD12 ' N ' ' A' ' 87' ' ' ILE . 5.1 mp -119.33 124.04 72.31 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.207 0 N-CA-C 109.229 -0.656 . . . . 0.0 109.229 178.22 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 88' ' ' LEU . . . . . . . . . . . . . 15.9 tp -113.79 126.74 55.54 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-O 121.077 0.465 . . . . 0.0 111.259 -175.758 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 89' ' ' ASP . . . . . . . . . . . . . 13.0 t70 -121.87 152.45 39.57 Favored 'General case' 0 C--N 1.331 -0.223 0 N-CA-C 109.232 -0.655 . . . . 0.0 109.232 174.994 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 44.4 mt-10 -49.83 -35.18 22.08 Favored 'General case' 0 C--N 1.328 -0.348 0 N-CA-C 112.812 0.671 . . . . 0.0 112.812 -172.179 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 91' ' ' ASN . . . . . . . . . . . . . 87.9 m-20 -126.87 26.77 6.11 Favored 'General case' 0 N--CA 1.467 0.391 0 N-CA-C 112.596 0.591 . . . . 0.0 112.596 -175.272 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 92' ' ' LEU . . . . . . . . . . . . . 7.2 tp -166.2 141.39 4.61 Favored 'General case' 0 C--N 1.33 -0.239 0 CA-C-O 120.728 0.299 . . . . 0.0 110.387 178.233 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 93' ' ' ILE . . . . . . . . . . . . . 68.1 mt -120.61 122.4 67.9 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.267 0 N-CA-C 109.407 -0.59 . . . . 0.0 109.407 179.327 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 94' ' ' VAL . . . . . . . . . . . . . 48.0 t -120.92 125.81 74.47 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.267 0 CA-C-O 120.981 0.419 . . . . 0.0 109.993 -179.864 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 95' ' ' VAL . . . . . . . . . . . . . 44.9 t -119.81 132.25 70.04 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.249 0 CA-C-N 115.867 -0.606 . . . . 0.0 109.543 178.872 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 96' ' ' ILE . . . . . . . . . . . . . 63.3 mt -114.0 125.56 71.31 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.293 0 N-CA-C 109.077 -0.712 . . . . 0.0 109.077 179.069 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 97' ' ' THR . . . . . . . . . . . . . 80.3 p -97.66 156.46 16.53 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-O 121.011 0.434 . . . . 0.0 110.864 -177.78 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 98' ' ' GLU . . . . . . . . . . . . . 84.4 tt0 -53.88 -24.32 15.61 Favored 'General case' 0 CA--C 1.534 0.343 0 N-CA-C 112.163 0.431 . . . . 0.0 112.163 179.348 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 99' ' ' GLU . . . . . . . . . . . . . 96.0 mt-10 -76.4 11.69 1.49 Allowed 'General case' 0 CA--C 1.537 0.451 0 N-CA-C 113.227 0.825 . . . . 0.0 113.227 -178.597 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 100' ' ' ASN . . . . . . . . . . . . . 2.1 m-20 63.2 37.16 11.45 Favored 'General case' 0 CA--C 1.53 0.203 0 CA-C-O 121.005 0.431 . . . . 0.0 111.093 178.601 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 101' ' ' GLU . . . . . . . . . . . . . 68.5 tt0 -117.08 145.41 43.76 Favored 'General case' 0 C--N 1.332 -0.173 0 N-CA-C 109.386 -0.598 . . . . 0.0 109.386 175.654 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 102' ' ' VAL . . . . . . . . . . . . . 43.6 t -117.19 126.2 74.38 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.249 0 N-CA-C 109.869 -0.419 . . . . 0.0 109.869 -178.308 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 103' ' ' LEU . . . . . . . . . . . . . 28.7 mt -115.68 130.53 56.89 Favored 'General case' 0 C--N 1.331 -0.225 0 CA-C-N 115.552 -0.749 . . . . 0.0 110.157 176.409 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 104' ' ' ILE . . . . . 0.418 HD13 HG11 ' A' ' 130' ' ' VAL . 67.2 mt -116.78 120.45 65.08 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.294 0 N-CA-C 109.972 -0.381 . . . . 0.0 109.972 179.606 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 105' ' ' PHE . . . . . . . . . . . . . 66.3 m-85 -120.03 166.34 13.51 Favored 'General case' 0 C--N 1.333 -0.143 0 CA-C-N 115.323 -0.853 . . . . 0.0 109.622 179.754 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 106' ' ' ASN . . . . . . . . . . . . . 51.9 p-10 -101.49 -170.96 1.9 Allowed 'General case' 0 C--N 1.33 -0.257 0 N-CA-C 109.976 -0.379 . . . . 0.0 109.976 174.159 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 107' ' ' GLN . . . . . . . . . . . . . 13.8 tt0 -59.6 -28.02 66.81 Favored 'General case' 0 CA--C 1.533 0.301 0 N-CA-C 112.131 0.419 . . . . 0.0 112.131 179.997 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 108' ' ' ASN . . . . . . . . . . . . . 6.0 t-20 -85.22 13.37 6.46 Favored 'General case' 0 CA--C 1.536 0.418 0 N-CA-C 112.81 0.671 . . . . 0.0 112.81 -178.891 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 109' ' ' LEU . . . . . . . . . . . . . 7.1 tp 54.64 37.03 27.42 Favored 'General case' 0 CA--C 1.529 0.161 0 CA-C-O 120.935 0.398 . . . . 0.0 111.385 179.212 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 110' ' ' GLU . . . . . . . . . . . . . 95.6 mt-10 -104.33 148.6 26.2 Favored 'General case' 0 C--N 1.331 -0.216 0 N-CA-C 109.742 -0.466 . . . . 0.0 109.742 175.717 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 111' ' ' GLU . . . . . . . . . . . . . 61.3 tt0 -85.06 121.86 28.45 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-O 120.798 0.332 . . . . 0.0 110.611 -176.434 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 112' ' ' LEU . . . . . . . . . . . . . 15.0 mt -107.48 -46.13 3.91 Favored 'General case' 0 C--N 1.331 -0.225 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.699 179.886 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 113' ' ' TYR . . . . . . . . . . . . . 57.5 t80 -133.05 139.28 47.1 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.399 -0.364 . . . . 0.0 110.802 -178.101 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 114' ' ' ARG . . . . . . . . . . . . . 26.4 ptt180 -141.36 123.07 15.21 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.769 -179.923 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 115' ' ' GLY . . . . . . . . . . . . . . . -150.13 158.81 27.84 Favored Glycine 0 CA--C 1.522 0.471 0 N-CA-C 110.931 -0.868 . . . . 0.0 110.931 179.892 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 116' ' ' LYS . . . . . . . . . . . . . 33.0 ttmt -131.44 135.85 47.48 Favored 'General case' 0 C--N 1.327 -0.379 0 N-CA-C 109.868 -0.419 . . . . 0.0 109.868 177.464 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 117' ' ' PHE . . . . . . . . . . . . . 25.2 m-85 -137.91 113.86 9.9 Favored 'General case' 0 C--N 1.329 -0.319 0 N-CA-C 109.8 -0.444 . . . . 0.0 109.8 -175.805 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 118' ' ' GLU . . . . . . . . . . . . . 84.7 tt0 -56.31 -40.5 74.47 Favored 'General case' 0 C--N 1.33 -0.272 0 C-N-CA 120.787 -0.365 . . . . 0.0 110.959 -177.362 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 119' ' ' ASN . . . . . . . . . . . . . 5.4 m120 -97.5 30.62 2.82 Favored 'General case' 0 C--N 1.33 -0.263 0 N-CA-C 112.251 0.463 . . . . 0.0 112.251 -175.034 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 120' ' ' LEU . . . . . . . . . . . . . 23.9 tp -59.21 120.26 8.89 Favored 'General case' 0 C--N 1.332 -0.167 0 N-CA-C 109.859 -0.422 . . . . 0.0 109.859 176.545 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 121' ' ' ASN . . . . . . . . . . . . . 31.8 m120 -113.49 -44.18 3.24 Favored 'General case' 0 C--N 1.331 -0.223 0 CA-C-N 116.609 -0.268 . . . . 0.0 111.032 -177.162 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 122' ' ' LYS . . . . . . . . . . . . . 60.6 mtpt -143.52 144.42 31.96 Favored 'General case' 0 C--N 1.331 -0.22 0 CA-C-O 121.015 0.435 . . . . 0.0 111.383 -178.46 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 123' ' ' VAL . . . . . . . . . . . . . 47.7 t -128.9 127.53 66.35 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.297 0 N-CA-C 109.298 -0.63 . . . . 0.0 109.298 174.897 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 124' ' ' LEU . . . . . . . . . . . . . 51.8 mt -126.23 132.58 51.71 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-O 120.791 0.329 . . . . 0.0 110.654 -178.636 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 125' ' ' VAL . . . . . . . . . . . . . 11.6 p -134.45 136.0 53.3 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.34 0 CA-C-N 116.111 -0.495 . . . . 0.0 110.375 179.32 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 126' ' ' ARG . . . . . . . . . . . . . 76.2 mtt180 -143.91 127.79 17.35 Favored 'General case' 0 C--N 1.327 -0.395 0 CA-C-N 115.846 -0.615 . . . . 0.0 109.365 178.158 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 127' ' ' ASN . . . . . . . . . . . . . 79.9 m-20 56.83 -134.72 1.24 Allowed 'General case' 0 CA--C 1.544 0.743 0 CA-C-O 118.679 -0.677 . . . . 0.0 109.65 -178.285 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 128' ' ' ASP . . . . . . . . . . . . . 8.4 p-10 -99.06 15.81 24.64 Favored 'General case' 0 CA--C 1.535 0.389 0 CA-C-N 119.923 1.238 . . . . 0.0 113.057 178.641 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 129' ' ' LEU . . . . . 0.512 HD12 ' N ' ' A' ' 129' ' ' LEU . 7.0 mp -114.27 141.23 47.84 Favored 'General case' 0 N--CA 1.463 0.224 0 N-CA-C 109.874 -0.417 . . . . 0.0 109.874 178.346 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 130' ' ' VAL . . . . . 0.479 HG13 ' HB ' ' A' ' 141' ' ' ILE . 14.6 p -140.06 146.47 24.81 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.234 0 CA-C-O 121.312 0.577 . . . . 0.0 111.682 -176.432 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 131' ' ' VAL . . . . . 0.463 HG22 HD12 ' A' ' 140' ' ' LEU . 44.2 t -136.02 139.52 45.7 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.264 0 CA-C-N 115.712 -0.677 . . . . 0.0 110.196 177.105 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 132' ' ' ILE . . . . . . . . . . . . . 70.9 mt -115.58 132.68 64.25 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.335 0 CA-C-N 115.998 -0.547 . . . . 0.0 109.673 -179.82 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 133' ' ' ILE . . . . . . . . . . . . . 41.1 mm -116.94 123.43 71.79 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.241 0 CA-C-O 120.781 0.324 . . . . 0.0 111.078 -175.127 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 134' ' ' ASP . . . . . . . . . . . . . 10.3 p-10 -136.61 149.4 48.0 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-N 116.227 -0.442 . . . . 0.0 109.981 175.255 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 135' ' ' GLU . . . . . . . . . . . . . 41.8 tp10 -49.95 -28.36 6.66 Favored 'General case' 0 C--N 1.327 -0.385 0 N-CA-C 112.673 0.62 . . . . 0.0 112.673 -171.986 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 136' ' ' GLN . . . . . . . . . . . . . 97.6 mt-30 -83.47 -34.96 25.27 Favored 'General case' 0 C--O 1.234 0.242 0 N-CA-C 112.707 0.632 . . . . 0.0 112.707 -175.96 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 137' ' ' LYS . . . . . . . . . . . . . 56.3 pttt -164.08 174.51 11.24 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-O 121.6 0.714 . . . . 0.0 112.529 -171.055 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 138' ' ' LEU . . . . . 0.409 ' C ' HD23 ' A' ' 138' ' ' LEU . 6.9 tt -121.33 128.43 52.28 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 114.889 -1.05 . . . . 0.0 109.881 177.716 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 139' ' ' THR . . . . . . . . . . . . . 47.0 m -109.26 127.98 54.7 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-N 116.117 -0.492 . . . . 0.0 109.882 178.282 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 140' ' ' LEU . . . . . 0.463 HD12 HG22 ' A' ' 131' ' ' VAL . 6.9 tp -114.56 121.36 43.24 Favored 'General case' 0 C--N 1.327 -0.395 0 CA-C-N 115.983 -0.553 . . . . 0.0 109.608 -176.574 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 141' ' ' ILE . . . . . 0.479 ' HB ' HG13 ' A' ' 130' ' ' VAL . 18.9 mt -121.75 118.49 55.91 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.245 0 N-CA-C 109.885 -0.413 . . . . 0.0 109.885 -175.817 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 142' ' ' ARG . . . . . . . . . . . . . 34.4 mmt180 -116.21 134.81 54.51 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 115.557 -0.747 . . . . 0.0 110.054 -178.248 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 143' ' ' THR . . . . . . . . . . . . . 48.8 p . . . . . 0 C--O 1.221 -0.444 0 CA-C-O 118.041 -0.98 . . . . 0.0 110.775 179.363 . . . . . . . . 0 0 . 1 . 003 nuclear build core ' B' B ' 2' ' ' SER . . . . . . . . . . . . . 96.8 p . . . . . 0 C--O 1.231 0.119 0 CA-C-O 121.003 0.43 . . . . 0.0 110.627 . . . . . . . . . 0 0 . 1 . 003 nuclear build core ' B' B ' 3' ' ' GLU . . . . . . . . . . . . . 95.3 mt-10 -139.4 141.27 37.54 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 115.879 -0.6 . . . . 0.0 110.804 -179.223 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 4' ' ' LEU . . . . . . . . . . . . . 5.2 tt -126.14 128.01 46.64 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.131 -0.486 . . . . 0.0 109.803 177.342 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 5' ' ' LYS . . . . . . . . . . . . . 92.5 mttt -110.19 122.28 47.27 Favored 'General case' 0 C--O 1.235 0.315 0 CA-C-O 120.873 0.368 . . . . 0.0 111.034 -178.313 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 6' ' ' LEU . . . . . . . . . . . . . 48.9 mt -114.02 148.42 37.02 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 115.296 -0.866 . . . . 0.0 110.536 -179.5 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 7' ' ' LYS . . . . . . . . . . . . . 35.8 ttpt -134.63 139.5 32.7 Favored Pre-proline 0 CA--C 1.534 0.356 0 CA-C-O 119.023 -0.513 . . . . 0.0 110.022 175.683 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 8' ' ' PRO . . . . . . . . . . . . . 84.9 Cg_endo -91.76 141.72 2.62 Favored 'Trans proline' 0 N--CA 1.489 1.257 0 C-N-CA 121.754 1.636 . . . . 0.0 111.61 177.731 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 9' ' ' LEU . . . . . . . . . . . . . 24.1 mt -79.35 -47.62 1.56 Allowed Pre-proline 0 CA--C 1.534 0.343 0 CA-C-O 118.696 -0.669 . . . . 0.0 112.203 -178.397 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 10' ' ' PRO . . . . . . . . . . . . . 89.6 Cg_endo -81.22 155.53 19.37 Favored 'Trans proline' 0 N--CA 1.495 1.581 0 C-N-CA 121.213 1.275 . . . . 0.0 111.95 176.059 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 11' ' ' LYS . . . . . . . . . . . . . 85.5 tttt -83.71 96.02 8.58 Favored 'General case' 0 C--N 1.33 -0.282 0 C-N-CA 120.832 -0.347 . . . . 0.0 110.099 177.465 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 12' ' ' VAL . . . . . . . . . . . . . 12.1 p -136.28 145.64 30.39 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.276 0 CA-C-N 116.1 -0.5 . . . . 0.0 110.411 -178.64 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 13' ' ' GLU . . . . . . . . . . . . . 81.9 tt0 -91.72 126.32 36.76 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.152 -0.476 . . . . 0.0 110.109 178.562 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 14' ' ' LEU . . . . . . . . . . . . . 27.5 mt -98.1 145.25 29.47 Favored Pre-proline 0 CA--C 1.532 0.281 0 CA-C-O 119.167 -0.444 . . . . 0.0 110.365 -177.932 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 15' ' ' PRO . . . . . . . . . . . . . 24.0 Cg_exo -63.71 160.0 38.68 Favored 'Trans proline' 0 N--CA 1.497 1.695 0 C-N-CA 121.331 1.354 . . . . 0.0 111.694 176.144 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 16' ' ' PRO . . . . . . . . . . . . . 37.5 Cg_exo -59.22 -31.6 95.53 Favored 'Trans proline' 0 N--CA 1.495 1.613 0 C-N-CA 121.474 1.45 . . . . 0.0 112.737 -179.747 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 17' ' ' ASP . . . . . . . . . . . . . 10.0 p-10 -88.1 3.97 47.11 Favored 'General case' 0 CA--C 1.536 0.404 0 N-CA-C 113.319 0.859 . . . . 0.0 113.319 -177.323 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 18' ' ' PHE . . . . . . . . . . . . . 39.2 t80 -58.26 -47.03 84.86 Favored 'General case' 0 C--N 1.334 -0.107 0 O-C-N 121.931 -0.481 . . . . 0.0 110.121 -177.64 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 19' ' ' VAL . . . . . . . . . . . . . 47.3 t -56.6 -40.83 71.5 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 CA-C-N 116.249 -0.432 . . . . 0.0 110.54 -178.236 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 20' ' ' ASP . . . . . . . . . . . . . 74.3 m-20 -59.63 -44.79 93.35 Favored 'General case' 0 C--N 1.33 -0.269 0 C-N-CA 120.919 -0.312 . . . . 0.0 110.797 -177.398 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 21' ' ' VAL . . . . . . . . . . . . . 46.9 t -64.69 -45.48 95.14 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.255 0 C-N-CA 120.702 -0.399 . . . . 0.0 110.522 -177.61 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 22' ' ' ILE . . . . . 0.588 HG22 HD12 ' B' ' 26' ' ' LEU . 50.7 mm -58.71 -40.59 79.96 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.299 0 C-N-CA 120.98 -0.288 . . . . 0.0 110.826 -179.803 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' B' B ' 23' ' ' ARG . . . . . . . . . . . . . 52.2 ttp180 -56.73 -47.07 80.82 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-O 120.891 0.377 . . . . 0.0 110.515 178.713 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 24' ' ' ILE . . . . . . . . . . . . . 77.3 mt -60.87 -44.8 98.51 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.261 0 CA-C-N 115.979 -0.555 . . . . 0.0 111.822 -178.852 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 25' ' ' LYS . . . . . . . . . . . . . 12.5 pttp -71.69 -36.56 70.63 Favored 'General case' 0 CA--C 1.533 0.309 0 C-N-CA 120.372 -0.531 . . . . 0.0 111.851 -173.042 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 26' ' ' LEU . . . . . 0.588 HD12 HG22 ' B' ' 22' ' ' ILE . 24.8 mt -78.94 -42.68 26.33 Favored 'General case' 0 C--N 1.331 -0.228 0 N-CA-C 113.186 0.81 . . . . 0.0 113.186 -173.435 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' B' B ' 27' ' ' GLN . . . . . . . . . . . . . 16.7 pt20 -47.17 138.24 7.16 Favored 'General case' 0 N--CA 1.47 0.553 0 N-CA-C 112.696 0.628 . . . . 0.0 112.696 -175.356 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 28' ' ' GLY . . . . . . . . . . . . . . . 101.5 -25.95 26.26 Favored Glycine 0 CA--C 1.532 1.122 0 CA-C-N 115.669 -0.696 . . . . 0.0 112.295 -176.391 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 29' ' ' LYS . . . . . . . . . . . . . 63.8 mttp -98.14 155.15 17.28 Favored 'General case' 0 C--O 1.232 0.175 0 CA-C-N 117.5 0.65 . . . . 0.0 111.256 178.219 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 30' ' ' THR . . . . . . . . . . . . . 41.3 m -100.49 136.23 40.68 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.015 -0.539 . . . . 0.0 109.83 175.157 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 31' ' ' VAL . . . . . . . . . . . . . 35.2 m -125.78 153.72 33.98 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.314 0 CA-C-O 120.902 0.382 . . . . 0.0 110.622 -178.738 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 32' ' ' ARG . . . . . . . . . . . . . 34.2 ttp180 -132.39 147.55 52.39 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 115.897 -0.592 . . . . 0.0 110.242 178.118 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 33' ' ' THR . . . . . . . . . . . . . 17.0 m -53.42 139.37 30.8 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.394 -0.366 . . . . 0.0 111.355 -178.342 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 34' ' ' GLY . . . . . . . . . . . . . . . 101.1 -17.18 56.42 Favored Glycine 0 CA--C 1.534 1.219 0 CA-C-O 119.69 -0.505 . . . . 0.0 113.274 179.842 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 35' ' ' ASP . . . . . . . . . . . . . 70.5 m-20 -64.46 149.34 48.71 Favored 'General case' 0 C--O 1.232 0.148 0 CA-C-N 118.017 0.908 . . . . 0.0 111.478 179.506 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 36' ' ' VAL . . . . . . . . . . . . . 44.9 t -121.4 130.25 74.82 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.216 0 CA-C-N 115.752 -0.658 . . . . 0.0 109.791 178.148 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 37' ' ' ILE . . . . . . . . . . . . . 69.7 mt -121.7 139.59 48.3 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.267 0 CA-C-N 116.294 -0.412 . . . . 0.0 110.095 -179.548 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 38' ' ' GLY . . . . . . . . . . . . . . . -111.52 128.85 8.85 Favored Glycine 0 CA--C 1.525 0.712 0 N-CA-C 111.017 -0.833 . . . . 0.0 111.017 179.634 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 39' ' ' ILE . . . . . . . . . . . . . 73.9 mt -123.3 137.12 57.71 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.201 0 N-CA-C 110.072 -0.344 . . . . 0.0 110.072 179.521 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 40' ' ' SER . . . . . . . . . . . . . 59.6 p -91.78 115.91 28.45 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.559 -0.291 . . . . 0.0 111.117 177.612 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 41' ' ' ILE . . . . . . . . . . . . . 44.7 mm -121.39 114.2 42.27 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.231 0 N-CA-C 109.772 -0.455 . . . . 0.0 109.772 178.159 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 42' ' ' LEU . . . . . . . . . . . . . 6.4 mp 56.9 35.5 26.44 Favored 'General case' 0 CA--C 1.532 0.26 0 CA-C-O 120.973 0.416 . . . . 0.0 111.342 -179.378 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 43' ' ' GLY . . . . . . . . . . . . . . . 77.91 -10.06 27.93 Favored Glycine 0 CA--C 1.534 1.276 0 C-N-CA 121.249 -0.5 . . . . 0.0 113.472 177.725 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 44' ' ' LYS . . . . . . . . . . . . . 61.1 tttm -96.32 134.33 39.6 Favored 'General case' 0 C--N 1.331 -0.197 0 CA-C-N 117.901 0.851 . . . . 0.0 109.819 176.651 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 45' ' ' GLU . . . . . . . . . . . . . 82.9 tt0 -83.5 127.94 34.11 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-O 120.867 0.365 . . . . 0.0 111.084 -177.863 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 46' ' ' VAL . . . . . . . . . . . . . 7.3 p -120.53 130.07 74.89 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.265 0 N-CA-C 109.315 -0.624 . . . . 0.0 109.315 175.541 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 47' ' ' LYS . . . . . . . . . . . . . 79.8 mttt -100.4 128.64 46.41 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.076 -0.511 . . . . 0.0 111.366 179.317 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 48' ' ' PHE . . . . . . . . . . . . . 92.1 m-85 -112.89 131.91 55.53 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 115.88 -0.6 . . . . 0.0 109.78 176.705 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 49' ' ' LYS . . . . . . . . . . . . . 66.8 tttt -107.19 137.45 45.22 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.48 -0.327 . . . . 0.0 110.64 179.68 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 50' ' ' VAL . . . . . . . . . . . . . 45.0 t -80.71 107.22 12.82 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.241 0 N-CA-C 109.17 -0.678 . . . . 0.0 109.17 175.613 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 51' ' ' VAL . . . . . . . . . . . . . 49.4 t -71.47 -54.14 18.29 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.292 0 N-CA-C 109.493 -0.558 . . . . 0.0 109.493 -174.516 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 52' ' ' GLN . . . . . . . . . . . . . 90.8 mt-30 -154.7 154.07 32.31 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 115.93 -0.577 . . . . 0.0 112.097 -176.74 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 53' ' ' ALA . . . . . 0.518 ' HB3' ' OG ' ' B' ' 56' ' ' SER . . . -132.6 134.37 44.83 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 115.191 -0.913 . . . . 0.0 109.784 174.421 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' B' B ' 54' ' ' TYR . . . . . . . . . . . . . 58.6 t80 -129.21 111.31 18.16 Favored Pre-proline 0 CA--C 1.533 0.309 0 CA-C-O 118.147 -0.93 . . . . 0.0 110.344 178.007 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 55' ' ' PRO . . . . . . . . . . . . . 74.4 Cg_endo -77.14 170.15 72.34 Favored 'Cis proline' 0 N--CA 1.5 1.907 0 CA-C-N 121.996 1.749 . . . . 0.0 111.957 -6.859 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 56' ' ' SER . . . . . 0.518 ' OG ' ' HB3' ' B' ' 53' ' ' ALA . 68.8 m -125.02 136.24 27.85 Favored Pre-proline 0 CA--C 1.538 0.491 0 CA-C-O 118.556 -0.735 . . . . 0.0 109.457 175.969 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' B' B ' 57' ' ' PRO . . . . . . . . . . . . . 37.2 Cg_endo -67.32 160.67 79.1 Favored 'Cis proline' 0 N--CA 1.499 1.852 0 CA-C-N 121.771 1.668 . . . . 0.0 111.689 -2.129 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 58' ' ' LEU . . . . . . . . . . . . . 29.4 tp -129.27 138.07 51.42 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-O 120.993 0.425 . . . . 0.0 110.593 -178.558 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 59' ' ' ARG . . . . . . . . . . . . . 57.2 ttp180 -101.02 121.22 41.39 Favored 'General case' 0 C--N 1.327 -0.38 0 N-CA-C 109.12 -0.696 . . . . 0.0 109.12 174.325 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 60' ' ' VAL . . . . . . . . . . . . . 47.4 t -72.14 122.07 23.77 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.361 0 C-N-CA 120.848 -0.341 . . . . 0.0 110.365 -173.969 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 61' ' ' GLU . . . . . . . . . . . . . 95.4 mt-10 -131.04 165.73 22.57 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.0 -0.546 . . . . 0.0 110.206 179.213 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 62' ' ' ASP . . . . . . . . . . . . . 48.2 m-20 -55.01 -32.61 61.94 Favored 'General case' 0 C--N 1.329 -0.324 0 N-CA-C 111.766 0.284 . . . . 0.0 111.766 -179.25 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 63' ' ' ARG . . . . . . . . . . . . . 32.5 ptt180 -83.35 3.36 31.95 Favored 'General case' 0 CA--C 1.538 0.487 0 N-CA-C 113.583 0.957 . . . . 0.0 113.583 -175.36 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 64' ' ' THR . . . . . . . . . . . . . 40.1 m -85.01 135.29 34.08 Favored 'General case' 0 C--N 1.331 -0.217 0 CA-C-N 118.137 0.426 . . . . 0.0 110.258 -178.997 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 65' ' ' LYS . . . . . . . . . . . . . 99.1 mttt -88.97 127.36 35.66 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.012 179.245 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 66' ' ' ILE . . . . . . . . . . . . . 58.4 mt -112.74 129.48 68.27 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.328 0 N-CA-C 109.859 -0.422 . . . . 0.0 109.859 -178.531 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 67' ' ' THR . . . . . . . . . . . . . 23.9 m -124.46 138.7 54.33 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-O 121.045 0.45 . . . . 0.0 110.801 -177.527 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 68' ' ' LEU . . . . . 0.415 HD12 ' N ' ' B' ' 68' ' ' LEU . 7.6 mp . . . . . 0 C--N 1.33 -0.281 0 CA-C-N 115.972 -0.558 . . . . 0.0 110.242 177.025 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 73' ' ' VAL . . . . . . . . . . . . . 33.1 m . . . . . 0 N--CA 1.461 0.097 0 CA-C-O 121.018 0.437 . . . . 0.0 110.983 . . . . . . . . . 0 0 . 1 . 003 nuclear build core ' B' B ' 74' ' ' ASP . . . . . . . . . . . . . 4.8 t0 -98.93 125.59 44.39 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 115.828 -0.623 . . . . 0.0 110.101 -179.601 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 75' ' ' VAL . . . . . . . . . . . . . 42.9 t -119.14 123.35 71.23 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.286 0 CA-C-O 121.084 0.468 . . . . 0.0 110.509 -179.402 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 76' ' ' LEU . . . . . . . . . . . . . 6.6 mp -120.39 148.38 43.84 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-N 115.691 -0.686 . . . . 0.0 109.741 176.043 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 77' ' ' GLU . . . . . . . . . . . . . 98.5 mt-10 -137.86 138.3 38.97 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-O 121.015 0.436 . . . . 0.0 111.577 -179.024 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 78' ' ' ALA . . . . . 0.613 ' HB2' HD21 ' B' ' 109' ' ' LEU . . . -130.47 134.29 46.97 Favored 'General case' 0 C--N 1.331 -0.227 0 CA-C-N 115.755 -0.657 . . . . 0.0 109.728 175.541 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' B' B ' 79' ' ' LYS . . . . . 0.603 ' O ' HD13 ' B' ' 80' ' ' ILE . 30.0 ttmt -81.2 119.53 23.72 Favored 'General case' 0 C--N 1.331 -0.204 0 CA-C-O 120.925 0.393 . . . . 0.0 110.603 -179.38 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' B' B ' 80' ' ' ILE . . . . . 0.603 HD13 ' O ' ' B' ' 79' ' ' LYS . 41.7 mm -139.15 108.43 3.77 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.367 0 N-CA-C 109.201 -0.666 . . . . 0.0 109.201 -177.439 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' B' B ' 81' ' ' LYS . . . . . . . . . . . . . 55.6 mtpt -100.49 129.16 46.4 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-O 120.941 0.4 . . . . 0.0 111.257 -176.642 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 82' ' ' GLY . . . . . . . . . . . . . . . 89.16 42.11 5.67 Favored Glycine 0 CA--C 1.526 0.725 0 C-N-CA 120.956 -0.64 . . . . 0.0 111.726 174.344 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 83' ' ' ILE . . . . . . . . . . . . . 68.2 mt -69.13 136.02 27.16 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.407 0 N-CA-C 109.563 -0.532 . . . . 0.0 109.563 177.625 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 84' ' ' LYS . . . . . . . . . . . . . 25.2 ttpp -100.5 -51.66 3.56 Favored 'General case' 0 C--N 1.332 -0.195 0 CA-C-O 121.002 0.429 . . . . 0.0 110.082 179.938 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 85' ' ' ASP . . . . . . . . . . . . . 13.4 t70 -149.16 147.16 28.11 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 115.812 -0.631 . . . . 0.0 110.358 179.754 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 86' ' ' VAL . . . . . . . . . . . . . 42.7 t -129.34 130.29 67.53 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.24 0 CA-C-O 120.969 0.414 . . . . 0.0 110.251 179.427 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 87' ' ' ILE . . . . . . . . . . . . . 44.6 mm -118.25 125.04 73.99 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.28 0 CA-C-N 115.847 -0.615 . . . . 0.0 109.555 177.347 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 88' ' ' LEU . . . . . . . . . . . . . 44.5 mt -116.84 135.56 53.64 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-O 121.292 0.568 . . . . 0.0 111.688 -177.025 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 89' ' ' ASP . . . . . . . . . . . . . 7.3 t0 -128.58 155.96 44.1 Favored 'General case' 0 C--N 1.327 -0.403 0 CA-C-N 115.156 -0.929 . . . . 0.0 108.642 174.78 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 90' ' ' GLU . . . . . . . . . . . . . 76.9 tt0 -48.67 -36.09 15.27 Favored 'General case' 0 C--N 1.329 -0.285 0 N-CA-C 112.562 0.578 . . . . 0.0 112.562 -172.749 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 91' ' ' ASN . . . . . . . . . . . . . 26.3 m120 -132.07 37.23 3.6 Favored 'General case' 0 CA--C 1.531 0.248 0 N-CA-C 111.757 0.281 . . . . 0.0 111.757 -176.953 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 92' ' ' LEU . . . . . 0.41 HD21 ' CG2' ' B' ' 130' ' ' VAL . 26.3 tp -166.06 139.72 4.28 Favored 'General case' 0 C--N 1.33 -0.265 0 C-N-CA 121.005 -0.278 . . . . 0.0 110.801 -179.377 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' B' B ' 93' ' ' ILE . . . . . . . . . . . . . 72.3 mt -126.39 122.48 61.31 Favored 'Isoleucine or valine' 0 N--CA 1.462 0.157 0 N-CA-C 109.648 -0.501 . . . . 0.0 109.648 178.605 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 94' ' ' VAL . . . . . 0.428 HG21 HG11 ' B' ' 125' ' ' VAL . 43.8 t -124.61 126.19 71.28 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.239 0 N-CA-C 109.774 -0.454 . . . . 0.0 109.774 177.994 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' B' B ' 95' ' ' VAL . . . . . . . . . . . . . 44.6 t -120.73 133.59 66.9 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.336 0 CA-C-N 116.009 -0.541 . . . . 0.0 109.806 -179.165 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 96' ' ' ILE . . . . . . . . . . . . . 61.1 mt -115.4 128.29 72.66 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.25 0 N-CA-C 109.257 -0.646 . . . . 0.0 109.257 178.788 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 97' ' ' THR . . . . . . . . . . . . . 82.1 p -102.96 155.62 18.23 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-O 121.279 0.561 . . . . 0.0 111.343 -176.368 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 98' ' ' GLU . . . . . . . . . . . . . 13.2 pt-20 -55.08 -17.02 3.43 Favored 'General case' 0 CA--C 1.535 0.382 0 N-CA-C 112.814 0.672 . . . . 0.0 112.814 179.277 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 99' ' ' GLU . . . . . . . . . . . . . 41.7 mt-10 -85.36 16.29 3.81 Favored 'General case' 0 CA--C 1.535 0.402 0 N-CA-C 112.952 0.723 . . . . 0.0 112.952 -178.674 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 100' ' ' ASN . . . . . . . . . . . . . 3.6 m-20 62.36 38.02 13.34 Favored 'General case' 0 CA--C 1.529 0.166 0 CA-C-O 121.046 0.451 . . . . 0.0 110.869 178.505 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 101' ' ' GLU . . . . . . . . . . . . . 84.3 tt0 -121.26 143.63 49.05 Favored 'General case' 0 C--N 1.332 -0.187 0 CA-C-N 116.2 -0.455 . . . . 0.0 110.045 177.955 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 102' ' ' VAL . . . . . . . . . . . . . 43.9 t -116.73 127.59 74.31 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.28 0 CA-C-N 116.341 -0.39 . . . . 0.0 110.102 -178.671 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 103' ' ' LEU . . . . . 0.511 ' N ' HD12 ' B' ' 103' ' ' LEU . 6.2 mp -116.86 134.31 54.93 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 115.747 -0.66 . . . . 0.0 110.285 176.745 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' B' B ' 104' ' ' ILE . . . . . . . . . . . . . 71.3 mt -120.87 123.24 69.78 Favored 'Isoleucine or valine' 0 C--O 1.234 0.285 0 CA-C-N 116.612 -0.267 . . . . 0.0 110.56 -178.885 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 105' ' ' PHE . . . . . . . . . . . . . 60.0 m-85 -124.98 167.24 14.99 Favored 'General case' 0 C--O 1.232 0.178 0 O-C-N 124.07 0.856 . . . . 0.0 109.736 -179.665 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 106' ' ' ASN . . . . . . . . . . . . . 44.8 p-10 -104.11 -170.23 1.74 Allowed 'General case' 0 C--N 1.331 -0.237 0 N-CA-C 110.15 -0.315 . . . . 0.0 110.15 174.218 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 107' ' ' GLN . . . . . . . . . . . . . 37.9 tt0 -58.64 -30.11 67.04 Favored 'General case' 0 C--N 1.33 -0.278 0 N-CA-C 112.047 0.388 . . . . 0.0 112.047 -179.603 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 108' ' ' ASN . . . . . . . . . . . . . 5.4 t30 -86.02 10.6 13.74 Favored 'General case' 0 CA--C 1.536 0.43 0 N-CA-C 113.116 0.784 . . . . 0.0 113.116 -176.699 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 109' ' ' LEU . . . . . 0.613 HD21 ' HB2' ' B' ' 78' ' ' ALA . 8.5 tp 59.38 37.63 23.21 Favored 'General case' 0 C--N 1.332 -0.173 0 CA-C-O 121.034 0.445 . . . . 0.0 111.315 178.69 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' B' B ' 110' ' ' GLU . . . . . . . . . . . . . 94.9 mt-10 -105.18 138.5 41.28 Favored 'General case' 0 C--N 1.329 -0.3 0 N-CA-C 109.222 -0.659 . . . . 0.0 109.222 173.718 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 111' ' ' GLU . . . . . . . . . . . . . 47.8 tt0 -85.54 121.77 28.7 Favored 'General case' 0 C--N 1.329 -0.308 0 C-N-CA 120.708 -0.397 . . . . 0.0 110.249 -176.492 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 112' ' ' LEU . . . . . . . . . . . . . 58.2 mt -103.06 -42.89 5.65 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.074 -0.512 . . . . 0.0 110.527 179.687 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 113' ' ' TYR . . . . . . . . . . . . . 64.3 t80 -133.02 141.23 48.16 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.297 -0.411 . . . . 0.0 111.254 -177.1 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 114' ' ' ARG . . . . . . . . . . . . . 36.5 ptt180 -149.27 124.09 9.91 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.092 -0.504 . . . . 0.0 110.541 177.407 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 115' ' ' GLY . . . . . . . . . . . . . . . -150.02 158.9 27.87 Favored Glycine 0 CA--C 1.524 0.601 0 N-CA-C 111.254 -0.739 . . . . 0.0 111.254 179.933 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 116' ' ' LYS . . . . . . . . . . . . . 34.4 ttpt -125.07 134.92 52.32 Favored 'General case' 0 C--N 1.33 -0.257 0 N-CA-C 110.02 -0.363 . . . . 0.0 110.02 178.491 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 117' ' ' PHE . . . . . . . . . . . . . 51.5 m-85 -129.08 115.21 17.38 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-O 120.97 0.414 . . . . 0.0 110.155 -177.064 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 118' ' ' GLU . . . . . . . . . . . . . 95.8 mt-10 -53.6 -49.79 67.03 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.387 -0.37 . . . . 0.0 111.526 -175.633 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 119' ' ' ASN . . . . . . . . . . . . . 87.2 m-20 -96.7 31.13 2.4 Favored 'General case' 0 C--N 1.328 -0.342 0 N-CA-C 112.207 0.447 . . . . 0.0 112.207 -174.169 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 120' ' ' LEU . . . . . . . . . . . . . 17.1 tp -53.44 121.84 8.48 Favored 'General case' 0 N--CA 1.464 0.271 0 CA-C-O 120.599 0.238 . . . . 0.0 110.88 178.062 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 121' ' ' ASN . . . . . . . . . . . . . 34.4 m120 -114.07 -44.17 3.17 Favored 'General case' 0 N--CA 1.463 0.203 0 CA-C-N 116.547 -0.297 . . . . 0.0 111.213 -176.289 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 122' ' ' LYS . . . . . . . . . . . . . 97.2 mttt -144.61 150.7 37.88 Favored 'General case' 0 C--N 1.331 -0.206 0 CA-C-O 120.982 0.42 . . . . 0.0 111.591 -177.386 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 123' ' ' VAL . . . . . . . . . . . . . 45.9 t -130.44 127.94 63.13 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.298 0 N-CA-C 109.437 -0.579 . . . . 0.0 109.437 174.929 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 124' ' ' LEU . . . . . . . . . . . . . 52.7 mt -127.35 138.09 52.94 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-O 120.871 0.367 . . . . 0.0 110.633 -178.067 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 125' ' ' VAL . . . . . 0.428 HG11 HG21 ' B' ' 94' ' ' VAL . 34.7 m -135.73 140.09 45.01 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.24 0 CA-C-N 116.221 -0.445 . . . . 0.0 110.885 -179.53 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' B' B ' 126' ' ' ARG . . . . . . . . . . . . . 90.5 mtt-85 -140.69 112.12 7.36 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 115.889 -0.596 . . . . 0.0 110.199 177.117 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 127' ' ' ASN . . . . . . . . . . . . . 26.2 m-20 48.96 -105.01 0.14 Allowed 'General case' 0 CA--C 1.541 0.618 0 CA-C-O 119.299 -0.381 . . . . 0.0 111.79 -179.964 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 128' ' ' ASP . . . . . . . . . . . . . 13.0 p-10 -106.08 1.02 26.01 Favored 'General case' 0 CA--C 1.536 0.414 0 N-CA-C 113.692 0.997 . . . . 0.0 113.692 -174.957 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 129' ' ' LEU . . . . . . . . . . . . . 14.5 tp -104.94 131.82 51.96 Favored 'General case' 0 C--N 1.332 -0.188 0 CA-C-N 118.125 0.421 . . . . 0.0 109.996 178.479 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 130' ' ' VAL . . . . . 0.41 ' CG2' HD21 ' B' ' 92' ' ' LEU . 46.8 t -118.95 132.97 67.3 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.252 0 N-CA-C 109.828 -0.434 . . . . 0.0 109.828 -179.618 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' B' B ' 131' ' ' VAL . . . . . . . . . . . . . 42.1 t -134.96 134.37 53.44 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.196 0 CA-C-O 121.042 0.449 . . . . 0.0 110.416 179.396 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 132' ' ' ILE . . . . . . . . . . . . . 74.0 mt -117.25 133.78 62.91 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 CA-C-N 115.773 -0.649 . . . . 0.0 109.294 -179.799 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 133' ' ' ILE . . . . . . . . . . . . . 43.0 mm -117.62 123.86 72.29 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.224 0 CA-C-O 121.031 0.443 . . . . 0.0 111.086 -173.931 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 134' ' ' ASP . . . . . . . . . . . . . 9.1 p-10 -135.03 144.67 47.43 Favored 'General case' 0 C--N 1.33 -0.242 0 N-CA-C 109.228 -0.656 . . . . 0.0 109.228 173.777 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 135' ' ' GLU . . . . . . . . . . . . . 38.0 tp10 -49.93 -25.56 3.36 Favored 'General case' 0 C--N 1.326 -0.439 0 N-CA-C 112.719 0.637 . . . . 0.0 112.719 -174.553 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 136' ' ' GLN . . . . . . . . . . . . . 47.6 tt0 -80.43 -33.77 36.62 Favored 'General case' 0 C--O 1.233 0.212 0 N-CA-C 112.364 0.505 . . . . 0.0 112.364 -176.705 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 137' ' ' LYS . . . . . . . . . . . . . 57.7 pttt -169.98 175.3 5.16 Favored 'General case' 0 C--N 1.332 -0.182 0 CA-C-O 121.461 0.648 . . . . 0.0 112.182 -174.901 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 138' ' ' LEU . . . . . . . . . . . . . 6.1 tt -120.28 129.47 54.04 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-N 115.221 -0.9 . . . . 0.0 110.188 -179.96 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 139' ' ' THR . . . . . . . . . . . . . 36.2 m -110.19 128.21 55.36 Favored 'General case' 0 C--N 1.332 -0.181 0 CA-C-N 116.341 -0.391 . . . . 0.0 110.656 179.995 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 140' ' ' LEU . . . . . 0.477 ' C ' HD23 ' B' ' 140' ' ' LEU . 7.4 tt -112.27 124.36 52.29 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 115.656 -0.702 . . . . 0.0 109.2 -179.428 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' B' B ' 141' ' ' ILE . . . . . . . . . . . . . 19.5 mt -124.08 117.46 50.92 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.36 0 CA-C-O 121.053 0.454 . . . . 0.0 109.959 -176.439 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 142' ' ' ARG . . . . . . . . . . . . . 60.0 ttt-85 -107.54 126.51 52.62 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 115.594 -0.73 . . . . 0.0 110.698 -179.195 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 143' ' ' THR . . . . . . . . . . . . . 25.3 p . . . . . 0 C--O 1.221 -0.409 0 CA-C-O 118.248 -0.882 . . . . 0.0 110.938 179.138 . . . . . . . . 0 0 . 1 . 003 nuclear build core ' C' C ' 2' ' ' SER . . . . . . . . . . . . . 6.9 p . . . . . 0 N--CA 1.461 0.087 0 CA-C-O 120.843 0.354 . . . . 0.0 110.054 . . . . . . . . . 0 0 . 1 . 003 nuclear build core ' C' C ' 3' ' ' GLU . . . . . . . . . . . . . 95.6 mt-10 -140.77 141.14 34.85 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.107 -0.497 . . . . 0.0 111.134 -177.388 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' C' C ' 4' ' ' LEU . . . . . . . . . . . . . 19.7 tp -125.38 130.38 51.8 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 115.713 -0.676 . . . . 0.0 110.122 176.799 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' C' C ' 5' ' ' LYS . . . . . . . . . . . . . 61.4 mttp -108.4 120.16 41.6 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.483 -0.326 . . . . 0.0 110.66 179.534 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' C' C ' 6' ' ' LEU . . . . . . . . . . . . . 46.6 mt -114.36 147.17 39.57 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 115.499 -0.773 . . . . 0.0 110.459 -178.642 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' C' C ' 7' ' ' LYS . . . . . . . . . . . . . 83.2 tttt -135.15 135.97 23.82 Favored Pre-proline 0 CA--C 1.535 0.402 0 CA-C-O 118.87 -0.586 . . . . 0.0 109.88 175.901 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' C' C ' 8' ' ' PRO . . . . . . . . . . . . . 79.1 Cg_endo -90.5 143.25 3.65 Favored 'Trans proline' 0 N--CA 1.49 1.313 0 C-N-CA 121.745 1.63 . . . . 0.0 111.794 178.255 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' C' C ' 9' ' ' LEU . . . . . . . . . . . . . 41.2 mt -81.59 -48.75 0.99 Allowed Pre-proline 0 CA--C 1.534 0.359 0 CA-C-O 118.706 -0.664 . . . . 0.0 112.527 -178.601 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' C' C ' 10' ' ' PRO . . . . . . . . . . . . . 91.5 Cg_endo -78.97 154.68 25.96 Favored 'Trans proline' 0 N--CA 1.498 1.755 0 C-N-CA 121.113 1.209 . . . . 0.0 111.983 178.161 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' C' C ' 11' ' ' LYS . . . . . . . . . . . . . 72.4 tttt -88.46 94.26 9.81 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-N 116.345 -0.389 . . . . 0.0 110.499 179.47 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' C' C ' 12' ' ' VAL . . . . . . . . . . . . . 13.0 p -141.96 147.99 21.05 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.282 0 CA-C-N 116.236 -0.438 . . . . 0.0 110.533 -179.989 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' C' C ' 13' ' ' GLU . . . . . . . . . . . . . 84.3 tt0 -87.98 128.76 35.39 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.246 -0.434 . . . . 0.0 110.403 179.151 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' C' C ' 14' ' ' LEU . . . . . . . . . . . . . 19.2 mt -98.5 151.39 37.45 Favored Pre-proline 0 CA--C 1.533 0.296 0 CA-C-N 116.467 -0.333 . . . . 0.0 110.677 -178.438 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' C' C ' 15' ' ' PRO . . . . . . . . . . . . . 27.4 Cg_exo -61.84 161.25 26.02 Favored 'Trans proline' 0 N--CA 1.497 1.714 0 C-N-CA 121.395 1.397 . . . . 0.0 112.042 177.298 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' C' C ' 16' ' ' PRO . . . . . . . . . . . . . 26.0 Cg_exo -61.51 -38.55 62.13 Favored 'Trans proline' 0 N--CA 1.497 1.705 0 C-N-CA 121.412 1.408 . . . . 0.0 112.699 179.97 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' C' C ' 17' ' ' ASP . . . . . . . . . . . . . 21.3 p-10 -84.84 9.26 14.71 Favored 'General case' 0 CA--C 1.535 0.403 0 N-CA-C 113.232 0.827 . . . . 0.0 113.232 -176.951 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' C' C ' 18' ' ' PHE . . . . . . . . . . . . . 45.1 t80 -56.83 -48.06 78.89 Favored 'General case' 0 N--CA 1.456 -0.14 0 O-C-N 121.978 -0.451 . . . . 0.0 110.662 -177.287 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' C' C ' 19' ' ' VAL . . . . . 0.416 HG13 ' N ' ' C' ' 20' ' ' ASP . 14.9 p -54.82 -43.15 66.19 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.259 0 C-N-CA 121.007 -0.277 . . . . 0.0 111.441 -176.404 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' C' C ' 20' ' ' ASP . . . . . 0.416 ' N ' HG13 ' C' ' 19' ' ' VAL . 42.1 m-20 -62.37 -43.28 99.19 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-O 120.759 0.314 . . . . 0.0 111.217 -177.637 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' C' C ' 21' ' ' VAL . . . . . . . . . . . . . 47.9 t -64.63 -44.38 96.7 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.288 0 C-N-CA 120.637 -0.425 . . . . 0.0 110.534 -177.199 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' C' C ' 22' ' ' ILE . . . . . 0.684 HG22 HD12 ' C' ' 26' ' ' LEU . 50.8 mm -56.16 -46.7 81.23 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.21 0 C-N-CA 121.029 -0.268 . . . . 0.0 110.477 178.313 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' C' C ' 23' ' ' ARG . . . . . . . . . . . . . 55.3 ttp180 -54.21 -48.45 71.02 Favored 'General case' 0 C--N 1.33 -0.28 0 C-N-CA 121.06 -0.256 . . . . 0.0 111.336 -178.754 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' C' C ' 24' ' ' ILE . . . . . . . . . . . . . 73.8 mt -59.89 -43.93 93.21 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.331 0 CA-C-N 116.685 -0.234 . . . . 0.0 111.249 -177.815 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' C' C ' 25' ' ' LYS . . . . . . . . . . . . . 80.6 mttt -67.66 -40.43 84.49 Favored 'General case' 0 C--N 1.328 -0.352 0 N-CA-C 112.666 0.617 . . . . 0.0 112.666 -177.164 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' C' C ' 26' ' ' LEU . . . . . 0.684 HD12 HG22 ' C' ' 22' ' ' ILE . 36.8 mt -79.19 -39.43 33.38 Favored 'General case' 0 C--N 1.33 -0.274 0 N-CA-C 113.303 0.853 . . . . 0.0 113.303 -171.849 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' C' C ' 27' ' ' GLN . . . . . . . . . . . . . 14.1 pt20 -46.62 140.76 4.2 Favored 'General case' 0 N--CA 1.47 0.533 0 N-CA-C 112.732 0.641 . . . . 0.0 112.732 -175.088 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' C' C ' 28' ' ' GLY . . . . . . . . . . . . . . . 100.97 -24.82 30.61 Favored Glycine 0 CA--C 1.532 1.136 0 CA-C-N 115.388 -0.824 . . . . 0.0 112.31 -177.2 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' C' C ' 29' ' ' LYS . . . . . . . . . . . . . 69.0 mttm -97.42 155.07 17.08 Favored 'General case' 0 C--N 1.331 -0.202 0 CA-C-N 117.609 0.705 . . . . 0.0 110.904 177.317 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' C' C ' 30' ' ' THR . . . . . . . . . . . . . 13.8 m -106.6 133.69 50.9 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.07 -0.514 . . . . 0.0 109.624 175.257 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' C' C ' 31' ' ' VAL . . . . . . . . . . . . . 34.4 m -130.2 156.63 42.45 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.278 0 CA-C-O 120.982 0.42 . . . . 0.0 110.94 -176.823 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' C' C ' 32' ' ' ARG . . . . . . . . . . . . . 36.0 mtp180 -129.77 153.59 48.07 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-O 121.433 0.635 . . . . 0.0 110.84 179.476 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' C' C ' 33' ' ' THR . . . . . . . . . . . . . 24.5 m -53.84 138.85 35.09 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-N 115.907 -0.588 . . . . 0.0 111.231 -179.664 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' C' C ' 34' ' ' GLY . . . . . . . . . . . . . . . 100.95 -17.04 56.85 Favored Glycine 0 CA--C 1.532 1.136 0 CA-C-O 119.678 -0.512 . . . . 0.0 113.307 179.411 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' C' C ' 35' ' ' ASP . . . . . . . . . . . . . 62.7 m-20 -65.58 149.9 49.32 Favored 'General case' 0 C--O 1.232 0.155 0 CA-C-N 118.036 0.918 . . . . 0.0 111.315 179.496 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' C' C ' 36' ' ' VAL . . . . . . . . . . . . . 46.3 t -119.01 128.97 75.78 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.232 0 CA-C-N 115.779 -0.646 . . . . 0.0 109.686 177.836 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' C' C ' 37' ' ' ILE . . . . . . . . . . . . . 70.1 mt -120.35 139.42 47.7 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.255 0 CA-C-N 116.274 -0.421 . . . . 0.0 109.939 -178.568 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' C' C ' 38' ' ' GLY . . . . . . . . . . . . . . . -113.03 128.88 8.61 Favored Glycine 0 CA--C 1.526 0.763 0 N-CA-C 110.977 -0.849 . . . . 0.0 110.977 -179.924 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' C' C ' 39' ' ' ILE . . . . . . . . . . . . . 75.1 mt -123.24 136.97 58.18 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.243 0 N-CA-C 110.085 -0.339 . . . . 0.0 110.085 179.16 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' C' C ' 40' ' ' SER . . . . . . . . . . . . . 84.0 p -93.13 124.24 36.97 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.359 -0.382 . . . . 0.0 110.95 175.883 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' C' C ' 41' ' ' ILE . . . . . . . . . . . . . 72.7 mt -127.5 113.1 30.25 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.225 0 CA-C-O 120.925 0.393 . . . . 0.0 110.213 177.262 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' C' C ' 42' ' ' LEU . . . . . 0.535 ' O ' HD23 ' C' ' 42' ' ' LEU . 1.3 tt 49.4 47.46 22.38 Favored 'General case' 0 CA--C 1.533 0.318 0 CA-C-O 121.529 0.68 . . . . 0.0 111.357 177.73 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' C' C ' 43' ' ' GLY . . . . . . . . . . . . . . . 70.68 24.16 77.16 Favored Glycine 0 CA--C 1.53 1.01 0 C-N-CA 121.116 -0.564 . . . . 0.0 112.563 175.946 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' C' C ' 44' ' ' LYS . . . . . . . . . . . . . 17.0 ttmm -132.14 129.5 39.93 Favored 'General case' 0 C--N 1.331 -0.215 0 CA-C-N 117.515 0.658 . . . . 0.0 109.956 179.049 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' C' C ' 45' ' ' GLU . . . . . . . . . . . . . 81.6 tt0 -84.07 125.79 32.45 Favored 'General case' 0 C--N 1.327 -0.381 0 C-N-CA 120.856 -0.338 . . . . 0.0 111.148 -177.787 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' C' C ' 46' ' ' VAL . . . . . . . . . . . . . 7.4 p -123.22 129.68 74.76 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.19 0 N-CA-C 109.614 -0.513 . . . . 0.0 109.614 174.773 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' C' C ' 47' ' ' LYS . . . . . . . . . . . . . 64.1 mttp -99.67 129.98 45.85 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.117 -0.492 . . . . 0.0 111.157 177.757 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' C' C ' 48' ' ' PHE . . . . . . . . . . . . . 92.8 m-85 -113.04 132.05 55.55 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 115.792 -0.64 . . . . 0.0 109.769 175.276 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' C' C ' 49' ' ' LYS . . . . . . . . . . . . . 84.1 tttt -106.13 135.43 47.61 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.412 -0.358 . . . . 0.0 110.142 179.359 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' C' C ' 50' ' ' VAL . . . . . . . . . . . . . 44.9 t -81.41 108.13 14.31 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.321 0 N-CA-C 109.304 -0.628 . . . . 0.0 109.304 176.749 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' C' C ' 51' ' ' VAL . . . . . . . . . . . . . 44.0 t -73.31 -51.23 26.6 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.333 0 CA-C-N 116.079 -0.51 . . . . 0.0 109.843 -174.302 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' C' C ' 52' ' ' GLN . . . . . . . . . . . . . 91.3 mt-30 -152.9 151.84 30.83 Favored 'General case' 0 C--N 1.333 -0.148 0 CA-C-O 121.095 0.474 . . . . 0.0 111.743 -178.104 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' C' C ' 53' ' ' ALA . . . . . . . . . . . . . . . -130.05 131.95 46.0 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 115.374 -0.83 . . . . 0.0 109.841 174.525 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' C' C ' 54' ' ' TYR . . . . . . . . . . . . . 15.5 t80 -129.16 111.34 18.24 Favored Pre-proline 0 CA--C 1.536 0.41 0 CA-C-O 118.159 -0.924 . . . . 0.0 110.33 177.423 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' C' C ' 55' ' ' PRO . . . . . . . . . . . . . 73.4 Cg_endo -77.26 167.0 80.73 Favored 'Cis proline' 0 N--CA 1.501 1.92 0 CA-C-N 122.03 1.761 . . . . 0.0 112.356 -6.056 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' C' C ' 56' ' ' SER . . . . . . . . . . . . . 13.6 m -116.89 130.73 24.37 Favored Pre-proline 0 CA--C 1.538 0.503 0 CA-C-O 118.384 -0.817 . . . . 0.0 109.158 174.086 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' C' C ' 57' ' ' PRO . . . . . . . . . . . . . 42.7 Cg_endo -68.42 146.99 80.38 Favored 'Cis proline' 0 N--CA 1.497 1.706 0 CA-C-N 122.011 1.754 . . . . 0.0 111.527 -0.353 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' C' C ' 58' ' ' LEU . . . . . . . . . . . . . 22.7 tp -107.36 135.44 48.84 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.145 -0.479 . . . . 0.0 110.403 -178.876 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' C' C ' 59' ' ' ARG . . . . . . . . . . . . . 48.6 ttt180 -102.08 122.92 45.05 Favored 'General case' 0 C--N 1.326 -0.433 0 N-CA-C 109.134 -0.691 . . . . 0.0 109.134 176.707 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' C' C ' 60' ' ' VAL . . . . . . . . . . . . . 43.8 t -78.26 117.53 23.77 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.207 0 C-N-CA 120.633 -0.427 . . . . 0.0 110.084 -175.565 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' C' C ' 61' ' ' GLU . . . . . . . . . . . . . 95.8 mt-10 -131.06 162.92 28.77 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.025 -0.534 . . . . 0.0 109.992 178.355 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' C' C ' 62' ' ' ASP . . . . . . . . . . . . . 10.0 t0 -53.55 -32.16 49.58 Favored 'General case' 0 C--N 1.327 -0.402 0 N-CA-C 111.834 0.309 . . . . 0.0 111.834 -179.117 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' C' C ' 63' ' ' ARG . . . . . . . . . . . . . 33.6 ptt180 -84.11 3.43 34.81 Favored 'General case' 0 CA--C 1.536 0.424 0 N-CA-C 113.762 1.023 . . . . 0.0 113.762 -174.972 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' C' C ' 64' ' ' THR . . . . . . . . . . . . . 34.8 m -86.53 139.26 31.03 Favored 'General case' 0 C--O 1.232 0.144 0 CA-C-N 118.171 0.442 . . . . 0.0 110.742 -178.003 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' C' C ' 65' ' ' LYS . . . . . . . . . . . . . 98.7 mttt -89.35 127.67 35.83 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.157 -0.474 . . . . 0.0 110.205 178.918 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' C' C ' 66' ' ' ILE . . . . . . . . . . . . . 63.8 mt -114.06 127.46 71.46 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.269 0 N-CA-C 109.638 -0.505 . . . . 0.0 109.638 179.995 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' C' C ' 67' ' ' THR . . . . . . . . . . . . . 22.6 m -123.5 139.24 54.22 Favored 'General case' 0 C--N 1.331 -0.216 0 CA-C-N 116.223 -0.444 . . . . 0.0 110.818 -177.459 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' C' C ' 68' ' ' LEU . . . . . . . . . . . . . 30.4 mt . . . . . 0 C--N 1.329 -0.299 0 CA-C-N 115.881 -0.6 . . . . 0.0 110.124 178.126 . . . . . . . . 0 0 . 1 . 003 nuclear build core ' C' C ' 73' ' ' VAL . . . . . . . . . . . . . 27.6 m . . . . . 0 C--O 1.23 0.064 0 CA-C-O 121.118 0.485 . . . . 0.0 110.348 . . . . . . . . . 0 0 . 1 . 003 nuclear build core ' C' C ' 74' ' ' ASP . . . . . . . . . . . . . 13.6 t70 -89.76 119.85 30.51 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 115.743 -0.662 . . . . 0.0 109.717 179.854 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' C' C ' 75' ' ' VAL . . . . . . . . . . . . . 45.1 t -110.43 121.15 62.72 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.203 0 CA-C-O 121.204 0.526 . . . . 0.0 110.327 -178.56 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' C' C ' 76' ' ' LEU . . . . . . . . . . . . . 18.6 mt -121.08 141.69 50.54 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 115.377 -0.829 . . . . 0.0 109.192 177.468 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' C' C ' 77' ' ' GLU . . . . . . . . . . . . . 97.9 mt-10 -134.14 134.02 41.71 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-O 121.204 0.526 . . . . 0.0 111.338 -177.425 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' C' C ' 78' ' ' ALA . . . . . 0.517 ' HB2' HD21 ' C' ' 109' ' ' LEU . . . -122.9 129.51 51.7 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 115.455 -0.793 . . . . 0.0 109.654 176.593 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' C' C ' 79' ' ' LYS . . . . . 0.676 ' O ' HD13 ' C' ' 80' ' ' ILE . 80.6 tttt -73.98 119.7 18.55 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.477 -0.328 . . . . 0.0 110.241 -179.013 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' C' C ' 80' ' ' ILE . . . . . 0.676 HD13 ' O ' ' C' ' 79' ' ' LYS . 35.7 mm -139.13 116.21 10.86 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.304 0 N-CA-C 109.403 -0.591 . . . . 0.0 109.403 -176.279 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' C' C ' 81' ' ' LYS . . . . . . . . . . . . . 21.1 pttp -110.73 124.18 51.47 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-O 121.246 0.546 . . . . 0.0 111.284 -177.033 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' C' C ' 82' ' ' GLY . . . . . . . . . . . . . . . 89.2 42.09 5.67 Favored Glycine 0 CA--C 1.528 0.854 0 CA-C-N 115.675 -0.693 . . . . 0.0 112.053 175.677 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' C' C ' 83' ' ' ILE . . . . . . . . . . . . . 68.2 mt -69.56 137.09 24.87 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.248 0 N-CA-C 109.487 -0.56 . . . . 0.0 109.487 176.498 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' C' C ' 84' ' ' LYS . . . . . . . . . . . . . 28.1 ttpp -103.68 -52.13 3.04 Favored 'General case' 0 C--N 1.331 -0.201 0 CA-C-O 120.852 0.358 . . . . 0.0 110.524 -179.104 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' C' C ' 85' ' ' ASP . . . . . . . . . . . . . 13.3 t70 -143.54 145.31 32.44 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.077 -0.511 . . . . 0.0 110.653 -178.597 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' C' C ' 86' ' ' VAL . . . . . . . . . . . . . 44.4 t -127.66 129.2 70.15 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.234 0 CA-C-O 120.871 0.367 . . . . 0.0 110.382 179.89 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' C' C ' 87' ' ' ILE . . . . . . . . . . . . . 43.9 mm -118.5 123.98 72.41 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.26 0 CA-C-N 116.041 -0.527 . . . . 0.0 109.604 176.598 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' C' C ' 88' ' ' LEU . . . . . . . . . . . . . 68.2 mt -113.66 137.22 51.91 Favored 'General case' 0 C--N 1.331 -0.201 0 CA-C-O 121.081 0.467 . . . . 0.0 111.687 -176.347 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' C' C ' 89' ' ' ASP . . . . . . . . . . . . . 10.2 t70 -132.62 156.35 47.08 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 115.631 -0.713 . . . . 0.0 109.204 174.352 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' C' C ' 90' ' ' GLU . . . . . . . . . . . . . 82.0 tt0 -47.4 -41.62 20.35 Favored 'General case' 0 N--CA 1.464 0.228 0 N-CA-C 112.95 0.722 . . . . 0.0 112.95 -171.633 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' C' C ' 91' ' ' ASN . . . . . . . . . . . . . 15.7 p-10 -132.14 38.49 3.49 Favored 'General case' 0 N--CA 1.465 0.298 0 CA-C-O 120.821 0.343 . . . . 0.0 111.345 -177.934 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' C' C ' 92' ' ' LEU . . . . . . . . . . . . . 20.7 tp -164.74 139.88 5.5 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.59 -0.277 . . . . 0.0 110.258 -178.872 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' C' C ' 93' ' ' ILE . . . . . . . . . . . . . 66.3 mt -130.18 124.2 57.53 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.221 0 N-CA-C 109.576 -0.527 . . . . 0.0 109.576 -177.886 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' C' C ' 94' ' ' VAL . . . . . 0.579 HG21 HG11 ' C' ' 125' ' ' VAL . 46.7 t -125.81 127.91 71.69 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.265 0 N-CA-C 109.848 -0.427 . . . . 0.0 109.848 178.551 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' C' C ' 95' ' ' VAL . . . . . . . . . . . . . 42.4 t -122.08 136.09 60.06 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.283 0 CA-C-N 115.979 -0.555 . . . . 0.0 109.852 -179.089 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' C' C ' 96' ' ' ILE . . . . . . . . . . . . . 60.4 mt -116.12 127.61 73.66 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.328 0 N-CA-C 109.348 -0.612 . . . . 0.0 109.348 179.51 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' C' C ' 97' ' ' THR . . . . . . . . . . . . . 80.6 p -99.3 157.7 16.22 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-O 120.983 0.42 . . . . 0.0 110.952 -177.81 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' C' C ' 98' ' ' GLU . . . . . . . . . . . . . 96.2 mt-10 -53.98 -25.54 21.41 Favored 'General case' 0 CA--C 1.534 0.336 0 N-CA-C 112.306 0.484 . . . . 0.0 112.306 -179.03 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' C' C ' 99' ' ' GLU . . . . . . . . . . . . . 95.7 mt-10 -79.39 15.79 1.17 Allowed 'General case' 0 CA--C 1.535 0.379 0 N-CA-C 113.197 0.814 . . . . 0.0 113.197 -177.541 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' C' C ' 100' ' ' ASN . . . . . . . . . . . . . 2.6 m-20 62.05 37.27 14.87 Favored 'General case' 0 C--O 1.233 0.216 0 CA-C-O 121.076 0.465 . . . . 0.0 111.064 178.948 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' C' C ' 101' ' ' GLU . . . . . . . . . . . . . 83.6 tt0 -111.96 143.04 43.6 Favored 'General case' 0 C--N 1.333 -0.147 0 N-CA-C 109.611 -0.514 . . . . 0.0 109.611 176.436 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' C' C ' 102' ' ' VAL . . . . . . . . . . . . . 43.7 t -114.97 123.76 70.97 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.275 0 CA-C-N 116.123 -0.489 . . . . 0.0 109.833 -178.753 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' C' C ' 103' ' ' LEU . . . . . . . . . . . . . 69.1 mt -116.58 127.53 54.58 Favored 'General case' 0 C--N 1.331 -0.207 0 CA-C-N 115.76 -0.654 . . . . 0.0 109.902 176.086 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' C' C ' 104' ' ' ILE . . . . . . . . . . . . . 65.2 mt -114.84 123.41 70.49 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.289 0 N-CA-C 109.855 -0.424 . . . . 0.0 109.855 -179.665 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' C' C ' 105' ' ' PHE . . . . . . . . . . . . . 81.9 m-85 -123.53 162.1 23.58 Favored 'General case' 0 C--N 1.331 -0.226 0 O-C-N 123.864 0.728 . . . . 0.0 109.788 -178.333 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' C' C ' 106' ' ' ASN . . . . . . . . . . . . . 38.9 p30 -98.03 -173.98 2.74 Favored 'General case' 0 C--N 1.328 -0.334 0 N-CA-C 109.553 -0.536 . . . . 0.0 109.553 173.942 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' C' C ' 107' ' ' GLN . . . . . . . . . . . . . 45.7 tt0 -59.37 -29.06 67.42 Favored 'General case' 0 CA--C 1.532 0.264 0 N-CA-C 112.004 0.372 . . . . 0.0 112.004 -179.836 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' C' C ' 108' ' ' ASN . . . . . . . . . . . . . 52.9 t30 -81.94 8.59 10.07 Favored 'General case' 0 CA--C 1.537 0.472 0 N-CA-C 113.14 0.792 . . . . 0.0 113.14 -177.485 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' C' C ' 109' ' ' LEU . . . . . 0.517 HD21 ' HB2' ' C' ' 78' ' ' ALA . 13.2 tp 58.9 40.45 22.63 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-O 121.293 0.568 . . . . 0.0 110.981 178.425 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' C' C ' 110' ' ' GLU . . . . . . . . . . . . . 95.9 mt-10 -110.26 147.39 33.92 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.05 -0.523 . . . . 0.0 109.711 174.089 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' C' C ' 111' ' ' GLU . . . . . . . . . . . . . 55.5 tt0 -82.58 121.96 27.48 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.402 -0.363 . . . . 0.0 110.497 -176.043 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' C' C ' 112' ' ' LEU . . . . . . . . . . . . . 24.3 mt -105.37 -46.09 4.3 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.079 -0.51 . . . . 0.0 110.892 -179.549 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' C' C ' 113' ' ' TYR . . . . . . . . . . . . . 55.3 t80 -135.54 140.45 44.73 Favored 'General case' 0 C--N 1.331 -0.239 0 CA-C-N 116.221 -0.445 . . . . 0.0 110.805 -178.881 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' C' C ' 114' ' ' ARG . . . . . . . . . . . . . 36.1 ptt180 -143.61 120.88 11.56 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-O 121.183 0.516 . . . . 0.0 110.902 178.327 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' C' C ' 115' ' ' GLY . . . . . . . . . . . . . . . -150.19 163.04 29.4 Favored Glycine 0 CA--C 1.524 0.631 0 N-CA-C 110.866 -0.894 . . . . 0.0 110.866 -179.328 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' C' C ' 116' ' ' LYS . . . . . . . . . . . . . 40.0 ttpt -128.75 136.13 50.15 Favored 'General case' 0 C--N 1.33 -0.266 0 O-C-N 122.616 -0.343 . . . . 0.0 110.082 177.439 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' C' C ' 117' ' ' PHE . . . . . . . . . . . . . 61.9 m-85 -132.2 114.24 14.24 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-O 120.902 0.382 . . . . 0.0 110.448 -176.263 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' C' C ' 118' ' ' GLU . . . . . . . . . . . . . 70.8 mm-40 -53.47 -50.88 64.38 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.447 -0.342 . . . . 0.0 111.499 -176.205 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' C' C ' 119' ' ' ASN . . . . . . . . . . . . . 83.1 m-20 -94.73 31.06 1.88 Allowed 'General case' 0 C--N 1.329 -0.31 0 N-CA-C 112.187 0.44 . . . . 0.0 112.187 -174.083 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' C' C ' 120' ' ' LEU . . . . . . . . . . . . . 16.7 tp -56.46 124.71 19.1 Favored 'General case' 0 C--O 1.232 0.161 0 CA-C-O 120.659 0.266 . . . . 0.0 110.556 178.484 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' C' C ' 121' ' ' ASN . . . . . . . . . . . . . 35.5 m120 -114.03 -43.97 3.2 Favored 'General case' 0 C--N 1.332 -0.167 0 CA-C-N 116.483 -0.326 . . . . 0.0 111.044 -177.871 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' C' C ' 122' ' ' LYS . . . . . . . . . . . . . 55.5 mttm -145.3 148.09 33.06 Favored 'General case' 0 C--N 1.33 -0.239 0 CA-C-O 121.071 0.463 . . . . 0.0 111.815 -176.937 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' C' C ' 123' ' ' VAL . . . . . . . . . . . . . 45.4 t -128.0 124.23 62.29 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 N-CA-C 108.909 -0.774 . . . . 0.0 108.909 171.965 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' C' C ' 124' ' ' LEU . . . . . . . . . . . . . 11.3 tp -123.29 135.66 54.33 Favored 'General case' 0 C--N 1.332 -0.185 0 CA-C-O 120.765 0.317 . . . . 0.0 110.914 -174.941 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' C' C ' 125' ' ' VAL . . . . . 0.773 HG12 HG23 ' C' ' 130' ' ' VAL . 35.7 m -131.34 139.18 51.46 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.229 0 CA-C-N 116.225 -0.443 . . . . 0.0 110.886 -179.507 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' C' C ' 126' ' ' ARG . . . . . . . . . . . . . 89.0 mtt180 -146.6 125.07 12.37 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.167 -0.469 . . . . 0.0 110.51 175.83 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' C' C ' 127' ' ' ASN . . . . . . . . . . . . . 29.2 t30 51.62 -109.31 0.43 Allowed 'General case' 0 CA--C 1.545 0.753 0 CA-C-O 118.824 -0.608 . . . . 0.0 111.199 -179.989 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' C' C ' 128' ' ' ASP . . . . . . . . . . . . . 14.3 p-10 -114.01 5.76 16.22 Favored 'General case' 0 N--CA 1.468 0.438 0 CA-C-N 119.818 1.19 . . . . 0.0 113.413 -177.918 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' C' C ' 129' ' ' LEU . . . . . . . . . . . . . 13.2 tp -109.89 136.6 48.93 Favored 'General case' 0 C--N 1.334 -0.108 0 N-CA-C 109.718 -0.475 . . . . 0.0 109.718 179.445 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' C' C ' 130' ' ' VAL . . . . . 0.773 HG23 HG12 ' C' ' 125' ' ' VAL . 12.9 p -129.54 140.7 48.42 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.205 0 CA-C-O 121.047 0.451 . . . . 0.0 110.46 -179.521 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' C' C ' 131' ' ' VAL . . . . . . . . . . . . . 43.0 t -135.72 138.29 48.07 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.314 0 CA-C-O 121.125 0.488 . . . . 0.0 110.18 179.689 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' C' C ' 132' ' ' ILE . . . . . . . . . . . . . 69.2 mt -110.64 131.23 62.34 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.328 0 CA-C-N 115.527 -0.76 . . . . 0.0 109.11 179.335 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' C' C ' 133' ' ' ILE . . . . . . . . . . . . . 42.4 mm -115.22 119.75 62.69 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.222 0 CA-C-O 120.859 0.361 . . . . 0.0 110.893 -174.716 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' C' C ' 134' ' ' ASP . . . . . . . . . . . . . 8.0 p-10 -132.17 144.24 50.53 Favored 'General case' 0 C--N 1.33 -0.253 0 N-CA-C 109.271 -0.64 . . . . 0.0 109.271 174.7 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' C' C ' 135' ' ' GLU . . . . . . . . . . . . . 84.2 tt0 -49.97 -26.41 4.2 Favored 'General case' 0 C--N 1.327 -0.395 0 N-CA-C 112.774 0.657 . . . . 0.0 112.774 -173.643 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' C' C ' 136' ' ' GLN . . . . . . . . . . . . . 62.8 tt0 -78.95 -36.59 41.39 Favored 'General case' 0 CA--C 1.531 0.217 0 N-CA-C 112.196 0.443 . . . . 0.0 112.196 -177.237 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' C' C ' 137' ' ' LYS . . . . . . . . . . . . . 34.5 pttt -167.27 172.29 9.96 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-O 121.482 0.658 . . . . 0.0 112.025 -173.258 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' C' C ' 138' ' ' LEU . . . . . 0.433 HD23 ' C ' ' C' ' 138' ' ' LEU . 7.1 tt -117.01 128.78 55.52 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 115.223 -0.899 . . . . 0.0 109.953 179.213 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' C' C ' 139' ' ' THR . . . . . . . . . . . . . 32.7 m -110.46 123.47 49.97 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.164 178.885 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' C' C ' 140' ' ' LEU . . . . . 0.479 ' C ' HD23 ' C' ' 140' ' ' LEU . 7.0 tt -107.95 123.11 48.13 Favored 'General case' 0 C--N 1.327 -0.408 0 N-CA-C 108.947 -0.76 . . . . 0.0 108.947 -179.49 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' C' C ' 141' ' ' ILE . . . . . 0.456 ' HB ' HG13 ' C' ' 130' ' ' VAL . 20.0 mt -124.96 118.64 53.71 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.248 0 CA-C-O 121.205 0.526 . . . . 0.0 109.944 -176.448 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' C' C ' 142' ' ' ARG . . . . . . . . . . . . . 67.1 ttt-85 . . . . . 0 C--N 1.328 -0.344 0 CA-C-N 115.221 -0.9 . . . . 0.0 109.929 178.919 . . . . . . . . 0 0 . 1 . 003 nuclear build core ' D' D ' 2' ' ' SER . . . . . . . . . . . . . 2.3 p . . . . . 0 C--O 1.233 0.187 0 CA-C-O 121.002 0.43 . . . . 0.0 110.271 . . . . . . . . . 0 0 . 1 . 003 nuclear build core ' D' D ' 3' ' ' GLU . . . . . . . . . . . . . 84.3 tt0 -140.03 141.24 36.3 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 115.778 -0.646 . . . . 0.0 110.983 -176.666 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' D' D ' 4' ' ' LEU . . . . . . . . . . . . . 12.6 tp -125.38 127.64 46.9 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-N 115.927 -0.579 . . . . 0.0 110.18 176.568 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' D' D ' 5' ' ' LYS . . . . . . . . . . . . . 98.8 mttt -108.8 121.58 45.38 Favored 'General case' 0 C--O 1.235 0.322 0 CA-C-N 116.532 -0.304 . . . . 0.0 110.905 179.931 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' D' D ' 6' ' ' LEU . . . . . . . . . . . . . 40.5 mt -114.02 148.32 37.19 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-N 115.352 -0.84 . . . . 0.0 110.289 179.989 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' D' D ' 7' ' ' LYS . . . . . . . . . . . . . 57.8 tttm -128.72 137.04 30.1 Favored Pre-proline 0 CA--C 1.535 0.383 0 CA-C-O 118.831 -0.604 . . . . 0.0 109.703 173.62 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' D' D ' 8' ' ' PRO . . . . . . . . . . . . . 90.8 Cg_endo -90.84 134.05 1.77 Allowed 'Trans proline' 0 N--CA 1.491 1.344 0 C-N-CA 121.7 1.6 . . . . 0.0 111.694 178.081 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' D' D ' 9' ' ' LEU . . . . . . . . . . . . . 35.5 mt -73.38 -46.98 7.69 Favored Pre-proline 0 CA--C 1.532 0.277 0 CA-C-O 118.701 -0.666 . . . . 0.0 112.056 -178.845 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' D' D ' 10' ' ' PRO . . . . . . . . . . . . . 91.7 Cg_endo -81.78 150.38 16.42 Favored 'Trans proline' 0 N--CA 1.495 1.614 0 C-N-CA 121.267 1.311 . . . . 0.0 111.64 174.61 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' D' D ' 11' ' ' LYS . . . . . . . . . . . . . 49.9 pttt -85.38 111.29 19.79 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-O 121.626 0.727 . . . . 0.0 110.606 178.367 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' D' D ' 12' ' ' VAL . . . . . . . . . . . . . 12.3 p -151.12 148.28 15.01 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.309 0 CA-C-N 115.57 -0.741 . . . . 0.0 110.348 179.339 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' D' D ' 13' ' ' GLU . . . . . . . . . . . . . 45.5 tp10 -94.0 122.16 36.23 Favored 'General case' 0 C--N 1.33 -0.282 0 N-CA-C 110.002 -0.37 . . . . 0.0 110.002 177.584 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' D' D ' 14' ' ' LEU . . . . . . . . . . . . . 46.4 mt -98.02 152.44 38.05 Favored Pre-proline 0 CA--C 1.532 0.272 0 CA-C-O 119.439 -0.315 . . . . 0.0 110.758 -177.558 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' D' D ' 15' ' ' PRO . . . . . . . . . . . . . 27.8 Cg_exo -61.13 159.84 28.69 Favored 'Trans proline' 0 N--CA 1.497 1.684 0 C-N-CA 121.315 1.343 . . . . 0.0 111.977 177.499 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' D' D ' 16' ' ' PRO . . . . . . . . . . . . . 29.8 Cg_exo -59.96 -36.36 90.31 Favored 'Trans proline' 0 N--CA 1.497 1.692 0 C-N-CA 121.434 1.423 . . . . 0.0 112.742 -178.536 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' D' D ' 17' ' ' ASP . . . . . . . . . . . . . 8.2 p-10 -88.18 8.88 24.95 Favored 'General case' 0 CA--C 1.536 0.404 0 N-CA-C 113.24 0.829 . . . . 0.0 113.24 -177.388 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' D' D ' 18' ' ' PHE . . . . . . . . . . . . . 43.6 t80 -58.16 -46.13 86.22 Favored 'General case' 0 CA--C 1.524 -0.031 0 O-C-N 121.887 -0.508 . . . . 0.0 109.973 -178.391 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' D' D ' 19' ' ' VAL . . . . . . . . . . . . . 13.8 p -57.47 -40.6 75.58 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.34 0 CA-C-N 116.121 -0.49 . . . . 0.0 110.723 -179.519 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' D' D ' 20' ' ' ASP . . . . . . . . . . . . . 22.2 m-20 -59.49 -43.14 93.39 Favored 'General case' 0 C--N 1.331 -0.228 0 C-N-CA 120.88 -0.328 . . . . 0.0 110.846 -178.143 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' D' D ' 21' ' ' VAL . . . . . . . . . . . . . 47.7 t -64.92 -46.3 92.14 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.246 0 C-N-CA 120.717 -0.393 . . . . 0.0 110.472 -178.192 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' D' D ' 22' ' ' ILE . . . . . 0.51 HG22 HD12 ' D' ' 26' ' ' LEU . 45.2 mm -59.33 -35.82 60.4 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.256 0 C-N-CA 120.843 -0.343 . . . . 0.0 110.98 -179.872 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' D' D ' 23' ' ' ARG . . . . . . . . . . . . . 33.1 ttp180 -59.45 -49.74 76.63 Favored 'General case' 0 C--N 1.33 -0.242 0 C-N-CA 120.621 -0.432 . . . . 0.0 110.19 176.789 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' D' D ' 24' ' ' ILE . . . . . . . . . . . . . 75.6 mt -61.34 -39.8 83.94 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.322 0 CA-C-N 116.155 -0.475 . . . . 0.0 112.085 -177.034 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' D' D ' 25' ' ' LYS . . . . . . . . . . . . . 10.2 ptmt -75.06 -40.43 60.29 Favored 'General case' 0 CA--C 1.535 0.38 0 C-N-CA 120.537 -0.465 . . . . 0.0 111.98 -175.144 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' D' D ' 26' ' ' LEU . . . . . 0.51 HD12 HG22 ' D' ' 22' ' ' ILE . 24.2 mt -79.04 -33.92 44.32 Favored 'General case' 0 C--N 1.331 -0.225 0 N-CA-C 113.337 0.866 . . . . 0.0 113.337 -172.978 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' D' D ' 27' ' ' GLN . . . . . . . . . . . . . 12.9 pt20 -46.55 139.66 4.91 Favored 'General case' 0 N--CA 1.47 0.527 0 N-CA-C 112.726 0.639 . . . . 0.0 112.726 -176.3 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' D' D ' 28' ' ' GLY . . . . . . . . . . . . . . . 100.24 -24.59 31.53 Favored Glycine 0 CA--C 1.534 1.231 0 CA-C-N 115.688 -0.687 . . . . 0.0 112.134 -174.287 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' D' D ' 29' ' ' LYS . . . . . . . . . . . . . 99.4 mttt -97.83 155.22 17.15 Favored 'General case' 0 C--N 1.333 -0.113 0 CA-C-N 117.334 0.567 . . . . 0.0 110.985 178.791 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' D' D ' 30' ' ' THR . . . . . . . . . . . . . 17.8 m -105.56 140.52 38.52 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 115.949 -0.569 . . . . 0.0 110.179 176.447 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' D' D ' 31' ' ' VAL . . . . . . . . . . . . . 35.1 m -126.66 149.51 31.73 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.224 0 CA-C-N 116.398 -0.365 . . . . 0.0 110.793 -179.393 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' D' D ' 32' ' ' ARG . . . . . . . . . . . . . 93.1 mtt180 -129.91 149.18 51.75 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-O 121.29 0.567 . . . . 0.0 110.431 179.348 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' D' D ' 33' ' ' THR . . . . . . . . . . . . . 21.2 m -53.24 137.49 34.37 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.169 -0.468 . . . . 0.0 111.546 -176.671 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' D' D ' 34' ' ' GLY . . . . . . . . . . . . . . . 99.31 -16.98 58.5 Favored Glycine 0 CA--C 1.531 1.067 0 C-N-CA 121.243 -0.503 . . . . 0.0 113.358 177.278 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' D' D ' 35' ' ' ASP . . . . . . . . . . . . . 81.3 m-20 -65.89 147.98 52.51 Favored 'General case' 0 C--O 1.231 0.117 0 CA-C-N 118.045 0.923 . . . . 0.0 111.127 -179.879 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' D' D ' 36' ' ' VAL . . . . . . . . . . . . . 46.4 t -119.95 129.5 75.36 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.266 0 CA-C-N 115.971 -0.559 . . . . 0.0 109.646 176.891 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' D' D ' 37' ' ' ILE . . . . . . . . . . . . . 63.0 mt -119.33 138.02 51.38 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.267 0 N-CA-C 109.864 -0.421 . . . . 0.0 109.864 -178.306 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' D' D ' 38' ' ' GLY . . . . . . . . . . . . . . . -115.77 128.2 7.92 Favored Glycine 0 CA--C 1.526 0.763 0 N-CA-C 110.881 -0.888 . . . . 0.0 110.881 179.04 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' D' D ' 39' ' ' ILE . . . . . . . . . . . . . 68.7 mt -126.15 127.42 70.85 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.223 0 N-CA-C 110.011 -0.366 . . . . 0.0 110.011 179.036 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' D' D ' 40' ' ' SER . . . . . . . . . . . . . 42.5 t -93.12 119.92 32.85 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.509 -0.314 . . . . 0.0 111.03 176.935 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' D' D ' 41' ' ' ILE . . . . . . . . . . . . . 71.6 mt -132.93 129.96 58.21 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.206 0 CA-C-O 120.795 0.331 . . . . 0.0 110.441 178.144 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' D' D ' 42' ' ' LEU . . . . . . . . . . . . . 74.0 mt 56.74 33.01 22.24 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.204 -0.453 . . . . 0.0 111.853 177.401 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' D' D ' 43' ' ' GLY . . . . . . . . . . . . . . . 72.85 24.81 75.34 Favored Glycine 0 CA--C 1.532 1.129 0 C-N-CA 121.149 -0.548 . . . . 0.0 112.55 177.712 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' D' D ' 44' ' ' LYS . . . . . . . . . . . . . 67.3 mttm -136.85 127.01 26.2 Favored 'General case' 0 C--N 1.331 -0.214 0 CA-C-N 117.162 0.481 . . . . 0.0 109.899 178.001 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' D' D ' 45' ' ' GLU . . . . . . . . . . . . . 39.2 tp10 -85.53 126.29 33.74 Favored 'General case' 0 C--N 1.328 -0.349 0 C-N-CA 120.776 -0.369 . . . . 0.0 110.968 -178.979 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' D' D ' 46' ' ' VAL . . . . . . . . . . . . . 9.0 p -118.14 126.43 74.96 Favored 'Isoleucine or valine' 0 C--O 1.233 0.224 0 N-CA-C 109.417 -0.586 . . . . 0.0 109.417 174.778 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' D' D ' 47' ' ' LYS . . . . . . . . . . . . . 62.0 mttp -98.89 125.62 44.35 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 116.111 -0.495 . . . . 0.0 110.886 177.762 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' D' D ' 48' ' ' PHE . . . . . . . . . . . . . 38.4 m-85 -111.22 131.86 54.79 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 115.79 -0.641 . . . . 0.0 109.458 177.166 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' D' D ' 49' ' ' LYS . . . . . . . . . . . . . 46.0 tttp -105.44 133.33 50.37 Favored 'General case' 0 C--N 1.328 -0.355 0 N-CA-C 110.174 -0.306 . . . . 0.0 110.174 178.823 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' D' D ' 50' ' ' VAL . . . . . . . . . . . . . 44.0 t -77.94 103.44 5.01 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.299 0 N-CA-C 109.243 -0.651 . . . . 0.0 109.243 177.894 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' D' D ' 51' ' ' VAL . . . . . . . . . . . . . 48.1 t -72.21 -48.36 49.19 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.324 0 CA-C-N 116.105 -0.498 . . . . 0.0 110.068 -173.664 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' D' D ' 52' ' ' GLN . . . . . . . . . . . . . 62.6 tt0 -159.13 141.44 13.86 Favored 'General case' 0 C--N 1.33 -0.27 0 C-N-CA 120.298 -0.561 . . . . 0.0 111.749 -178.542 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' D' D ' 53' ' ' ALA . . . . . . . . . . . . . . . -120.66 132.41 55.09 Favored 'General case' 0 C--N 1.331 -0.2 0 CA-C-N 115.96 -0.564 . . . . 0.0 109.889 175.172 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' D' D ' 54' ' ' TYR . . . . . . . . . . . . . 71.5 t80 -129.05 111.17 18.37 Favored Pre-proline 0 CA--C 1.534 0.355 0 CA-C-O 118.231 -0.89 . . . . 0.0 110.522 179.522 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' D' D ' 55' ' ' PRO . . . . . . . . . . . . . 72.7 Cg_endo -77.24 169.9 72.89 Favored 'Cis proline' 0 N--CA 1.5 1.872 0 CA-C-N 121.945 1.73 . . . . 0.0 112.086 -7.417 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' D' D ' 56' ' ' SER . . . . . . . . . . . . . 13.7 m -119.27 134.32 23.73 Favored Pre-proline 0 CA--C 1.538 0.507 0 CA-C-O 118.51 -0.757 . . . . 0.0 109.403 174.219 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' D' D ' 57' ' ' PRO . . . . . . . . . . . . . 48.7 Cg_endo -69.85 144.7 77.56 Favored 'Cis proline' 0 N--CA 1.498 1.745 0 CA-C-N 121.857 1.699 . . . . 0.0 111.496 -0.695 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' D' D ' 58' ' ' LEU . . . . . . . . . . . . . 19.6 tp -106.75 134.55 49.72 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.369 -0.378 . . . . 0.0 110.57 -178.756 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' D' D ' 59' ' ' ARG . . . . . . . . . . . . . 19.9 ttm180 -103.59 125.52 50.17 Favored 'General case' 0 C--N 1.327 -0.395 0 N-CA-C 109.158 -0.682 . . . . 0.0 109.158 175.823 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' D' D ' 60' ' ' VAL . . . . . . . . . . . . . 43.1 t -82.23 123.51 38.29 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.25 0 C-N-CA 120.557 -0.457 . . . . 0.0 110.491 -175.659 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' D' D ' 61' ' ' GLU . . . . . . . . . . . . . 95.3 mt-10 -129.71 172.3 11.77 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 115.721 -0.672 . . . . 0.0 109.36 176.689 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' D' D ' 62' ' ' ASP . . . . . . . . . . . . . 69.2 m-20 -53.89 -32.37 53.11 Favored 'General case' 0 C--N 1.328 -0.332 0 C-N-CA 121.068 -0.253 . . . . 0.0 111.636 178.595 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' D' D ' 63' ' ' ARG . . . . . . . . . . . . . 40.7 ptt180 -83.86 -0.38 50.97 Favored 'General case' 0 CA--C 1.537 0.475 0 N-CA-C 113.754 1.02 . . . . 0.0 113.754 -176.037 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' D' D ' 64' ' ' THR . . . . . . . . . . . . . 25.3 m -76.31 132.11 39.61 Favored 'General case' 0 C--N 1.333 -0.127 0 CA-C-N 118.158 0.435 . . . . 0.0 110.733 -176.234 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' D' D ' 65' ' ' LYS . . . . . . . . . . . . . 36.5 ttpt -89.78 122.62 33.03 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.191 -0.459 . . . . 0.0 110.136 179.249 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' D' D ' 66' ' ' ILE . . . . . . . . . . . . . 61.9 mt -112.8 131.98 62.85 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.268 0 N-CA-C 109.918 -0.401 . . . . 0.0 109.918 -178.229 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' D' D ' 67' ' ' THR . . . . . . . . . . . . . 24.4 m -130.05 143.82 51.0 Favored 'General case' 0 C--O 1.234 0.268 0 CA-C-O 121.172 0.51 . . . . 0.0 111.496 -177.835 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' D' D ' 68' ' ' LEU . . . . . 0.475 ' C ' HD23 ' D' ' 68' ' ' LEU . 8.2 tt . . . . . 0 C--N 1.328 -0.347 0 CA-C-N 115.656 -0.702 . . . . 0.0 109.553 175.908 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' D' D ' 73' ' ' VAL . . . . . . . . . . . . . 27.4 m . . . . . 0 C--O 1.232 0.132 0 CA-C-O 120.85 0.357 . . . . 0.0 110.41 . . . . . . . . . 0 0 . 1 . 003 nuclear build core ' D' D ' 74' ' ' ASP . . . . . . . . . . . . . 42.6 t0 -90.87 115.08 27.64 Favored 'General case' 0 C--N 1.326 -0.44 0 CA-C-N 115.981 -0.554 . . . . 0.0 109.719 179.471 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' D' D ' 75' ' ' VAL . . . . . . . . . . . . . 46.0 t -112.27 120.11 61.77 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.264 0 CA-C-O 121.238 0.542 . . . . 0.0 110.279 -178.943 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' D' D ' 76' ' ' LEU . . . . . . . . . . . . . 23.4 mt -122.67 144.33 49.21 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 115.408 -0.815 . . . . 0.0 109.446 179.53 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' D' D ' 77' ' ' GLU . . . . . . . . . . . . . 45.9 mt-10 -135.64 137.31 41.74 Favored 'General case' 0 N--CA 1.463 0.212 0 CA-C-O 121.219 0.533 . . . . 0.0 111.688 -176.914 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' D' D ' 78' ' ' ALA . . . . . 0.606 ' HB2' HD21 ' D' ' 109' ' ' LEU . . . -126.52 131.6 51.56 Favored 'General case' 0 C--N 1.332 -0.184 0 CA-C-N 115.507 -0.77 . . . . 0.0 109.725 175.558 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' D' D ' 79' ' ' LYS . . . . . 0.522 ' O ' HD13 ' D' ' 80' ' ' ILE . 64.7 mttp -81.32 118.46 22.66 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-O 120.832 0.349 . . . . 0.0 110.718 -177.913 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' D' D ' 80' ' ' ILE . . . . . 0.522 HD13 ' O ' ' D' ' 79' ' ' LYS . 24.8 mm -139.26 114.71 8.57 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.306 0 N-CA-C 109.57 -0.53 . . . . 0.0 109.57 -177.91 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' D' D ' 81' ' ' LYS . . . . . . . . . . . . . 97.9 mttt -98.64 123.71 43.0 Favored 'General case' 0 C--N 1.33 -0.28 0 C-N-CA 120.907 -0.317 . . . . 0.0 110.993 -179.938 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' D' D ' 82' ' ' GLY . . . . . . . . . . . . . . . 89.21 42.18 5.64 Favored Glycine 0 CA--C 1.524 0.654 0 C-N-CA 120.676 -0.773 . . . . 0.0 112.168 173.057 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' D' D ' 83' ' ' ILE . . . . . . . . . . . . . 73.5 mt -65.4 133.23 30.85 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.279 0 N-CA-C 109.314 -0.625 . . . . 0.0 109.314 175.194 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' D' D ' 84' ' ' LYS . . . . . . . . . . . . . 28.2 ttpp -97.71 -53.14 3.51 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-O 120.981 0.42 . . . . 0.0 110.51 -176.734 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' D' D ' 85' ' ' ASP . . . . . . . . . . . . . 13.9 t70 -147.54 146.67 29.53 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 115.868 -0.606 . . . . 0.0 110.396 -179.475 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' D' D ' 86' ' ' VAL . . . . . . . . . . . . . 45.0 t -128.91 129.39 68.17 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.299 0 CA-C-O 121.01 0.433 . . . . 0.0 110.545 -179.53 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' D' D ' 87' ' ' ILE . . . . . . . . . . . . . 43.6 mm -116.46 121.87 68.55 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.274 0 N-CA-C 109.087 -0.709 . . . . 0.0 109.087 175.451 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' D' D ' 88' ' ' LEU . . . . . . . . . . . . . 10.0 tp -114.93 131.58 56.84 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-O 121.047 0.451 . . . . 0.0 111.327 -174.907 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' D' D ' 89' ' ' ASP . . . . . . . . . . . . . 12.8 t70 -129.62 152.28 49.3 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 115.697 -0.683 . . . . 0.0 109.358 175.359 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' D' D ' 90' ' ' GLU . . . . . . . . . . . . . 95.9 mt-10 -50.65 -31.61 16.72 Favored 'General case' 0 C--N 1.328 -0.366 0 N-CA-C 112.477 0.547 . . . . 0.0 112.477 -173.115 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' D' D ' 91' ' ' ASN . . . . . . . . . . . . . 23.6 p30 -128.54 27.69 5.51 Favored 'General case' 0 N--CA 1.465 0.32 0 N-CA-C 112.607 0.595 . . . . 0.0 112.607 -175.779 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' D' D ' 92' ' ' LEU . . . . . . . . . . . . . 15.1 tp -166.11 143.11 5.24 Favored 'General case' 0 C--N 1.331 -0.196 0 C-N-CA 121.074 -0.25 . . . . 0.0 110.662 179.445 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' D' D ' 93' ' ' ILE . . . . . . . . . . . . . 75.6 mt -126.17 119.66 54.78 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.263 0 N-CA-C 109.552 -0.536 . . . . 0.0 109.552 178.082 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' D' D ' 94' ' ' VAL . . . . . . . . . . . . . 43.8 t -118.3 124.16 72.69 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.255 0 N-CA-C 109.627 -0.509 . . . . 0.0 109.627 178.954 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' D' D ' 95' ' ' VAL . . . . . . . . . . . . . 44.7 t -121.38 132.65 70.15 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.275 0 CA-C-N 116.233 -0.44 . . . . 0.0 109.934 -178.586 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' D' D ' 96' ' ' ILE . . . . . . . . . . . . . 67.7 mt -115.58 127.36 73.18 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 N-CA-C 109.244 -0.65 . . . . 0.0 109.244 179.128 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' D' D ' 97' ' ' THR . . . . . . . . . . . . . 80.5 p -101.47 159.68 15.08 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-O 121.364 0.602 . . . . 0.0 111.48 -176.18 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' D' D ' 98' ' ' GLU . . . . . . . . . . . . . 84.4 tt0 -53.95 -26.46 25.75 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 115.836 -0.62 . . . . 0.0 112.264 179.965 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' D' D ' 99' ' ' GLU . . . . . . . . . . . . . 43.3 mt-10 -79.49 15.64 1.24 Allowed 'General case' 0 CA--C 1.534 0.35 0 N-CA-C 113.115 0.783 . . . . 0.0 113.115 -177.169 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' D' D ' 100' ' ' ASN . . . . . . . . . . . . . 3.2 m-20 61.3 38.02 16.7 Favored 'General case' 0 N--CA 1.463 0.183 0 CA-C-O 121.16 0.505 . . . . 0.0 110.962 178.948 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' D' D ' 101' ' ' GLU . . . . . . . . . . . . . 84.1 tt0 -117.47 142.1 47.55 Favored 'General case' 0 C--N 1.333 -0.14 0 N-CA-C 109.636 -0.505 . . . . 0.0 109.636 176.308 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' D' D ' 102' ' ' VAL . . . . . . . . . . . . . 43.0 t -114.94 126.15 72.44 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.351 0 N-CA-C 109.947 -0.39 . . . . 0.0 109.947 -179.149 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' D' D ' 103' ' ' LEU . . . . . . . . . . . . . 45.7 mt -115.95 133.34 56.13 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 115.728 -0.669 . . . . 0.0 109.948 177.179 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' D' D ' 104' ' ' ILE . . . . . 0.641 HD13 HG11 ' D' ' 130' ' ' VAL . 68.2 mt -118.35 120.71 65.18 Favored 'Isoleucine or valine' 0 C--O 1.233 0.221 0 N-CA-C 110.112 -0.329 . . . . 0.0 110.112 -179.475 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' D' D ' 105' ' ' PHE . . . . . . . . . . . . . 55.8 m-85 -122.8 167.35 13.62 Favored 'General case' 0 C--N 1.332 -0.158 0 O-C-N 124.011 0.82 . . . . 0.0 109.933 -179.694 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' D' D ' 106' ' ' ASN . . . . . . . . . . . . . 41.2 p-10 -101.48 -170.84 1.89 Allowed 'General case' 0 C--N 1.331 -0.205 0 N-CA-C 109.95 -0.389 . . . . 0.0 109.95 172.922 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' D' D ' 107' ' ' GLN . . . . . . . . . . . . . 47.4 tt0 -60.57 -29.99 69.51 Favored 'General case' 0 C--N 1.33 -0.273 0 N-CA-C 111.904 0.335 . . . . 0.0 111.904 179.754 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' D' D ' 108' ' ' ASN . . . . . . . . . . . . . 4.0 t-20 -82.18 7.41 13.7 Favored 'General case' 0 CA--C 1.537 0.443 0 N-CA-C 113.143 0.794 . . . . 0.0 113.143 -178.026 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' D' D ' 109' ' ' LEU . . . . . 0.606 HD21 ' HB2' ' D' ' 78' ' ' ALA . 10.0 tp 62.31 36.67 14.45 Favored 'General case' 0 CA--C 1.53 0.204 0 CA-C-O 120.881 0.372 . . . . 0.0 111.393 178.082 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' D' D ' 110' ' ' GLU . . . . . . . . . . . . . 70.7 mm-40 -104.57 155.55 18.73 Favored 'General case' 0 C--N 1.33 -0.243 0 N-CA-C 109.503 -0.554 . . . . 0.0 109.503 175.348 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' D' D ' 111' ' ' GLU . . . . . . . . . . . . . 66.2 tt0 -91.07 124.68 35.48 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-O 120.982 0.42 . . . . 0.0 111.0 -176.003 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' D' D ' 112' ' ' LEU . . . . . . . . . . . . . 23.8 mt -108.77 -45.93 3.73 Favored 'General case' 0 C--N 1.331 -0.204 0 CA-C-N 116.097 -0.501 . . . . 0.0 110.861 179.264 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' D' D ' 113' ' ' TYR . . . . . 0.463 ' HB3' HD12 ' D' ' 104' ' ' ILE . 51.1 t80 -138.32 143.18 39.83 Favored 'General case' 0 N--CA 1.462 0.174 0 C-N-CA 120.835 -0.346 . . . . 0.0 111.074 -178.027 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' D' D ' 114' ' ' ARG . . . . . . . . . . . . . 36.2 ptt-85 -142.57 127.8 18.7 Favored 'General case' 0 C--N 1.331 -0.217 0 CA-C-N 116.274 -0.421 . . . . 0.0 110.85 177.094 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' D' D ' 115' ' ' GLY . . . . . . . . . . . . . . . -150.15 141.72 9.04 Favored Glycine 0 CA--C 1.524 0.621 0 N-CA-C 111.439 -0.665 . . . . 0.0 111.439 178.559 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' D' D ' 116' ' ' LYS . . . . . . . . . . . . . 39.5 ttpt -111.74 134.38 53.34 Favored 'General case' 0 C--N 1.331 -0.198 0 N-CA-C 109.485 -0.561 . . . . 0.0 109.485 175.101 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' D' D ' 117' ' ' PHE . . . . . . . . . . . . . 42.1 m-85 -135.79 113.95 11.4 Favored 'General case' 0 C--N 1.331 -0.225 0 CA-C-O 120.967 0.413 . . . . 0.0 110.394 -175.912 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' D' D ' 118' ' ' GLU . . . . . . . . . . . . . 70.7 mm-40 -55.13 -48.76 73.2 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.313 -0.403 . . . . 0.0 111.257 -175.811 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' D' D ' 119' ' ' ASN . . . . . . . . . . . . . 11.7 m-80 -96.01 31.05 2.23 Favored 'General case' 0 C--N 1.328 -0.344 0 N-CA-C 112.149 0.426 . . . . 0.0 112.149 -174.04 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' D' D ' 120' ' ' LEU . . . . . . . . . . . . . 15.7 tp -56.48 122.23 11.48 Favored 'General case' 0 C--N 1.332 -0.175 0 CA-C-O 120.686 0.279 . . . . 0.0 110.391 177.538 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' D' D ' 121' ' ' ASN . . . . . . . . . . . . . 12.5 t-20 -112.17 -44.12 3.46 Favored 'General case' 0 C--N 1.332 -0.18 0 CA-C-N 116.488 -0.323 . . . . 0.0 110.846 -176.027 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' D' D ' 122' ' ' LYS . . . . . . . . . . . . . 98.3 mttt -146.37 149.61 34.1 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-O 121.112 0.482 . . . . 0.0 111.51 -178.489 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' D' D ' 123' ' ' VAL . . . . . . . . . . . . . 46.4 t -130.31 126.33 61.14 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.289 0 N-CA-C 109.25 -0.648 . . . . 0.0 109.25 172.928 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' D' D ' 124' ' ' LEU . . . . . 0.453 HD22 HD12 ' E' ' 88' ' ' LEU . 6.2 mp -114.71 137.09 52.34 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-O 120.824 0.345 . . . . 0.0 111.0 -176.52 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' D' D ' 125' ' ' VAL . . . . . . . . . . . . . 44.3 t -122.83 132.15 71.88 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.179 0 CA-C-N 115.911 -0.586 . . . . 0.0 109.939 179.861 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' D' D ' 126' ' ' ARG . . . . . . . . . . . . . 25.7 mmt180 -134.86 104.66 6.08 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 116.124 -0.489 . . . . 0.0 110.215 178.021 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' D' D ' 127' ' ' ASN . . . . . . . . . . . . . 35.0 m120 53.98 -104.98 0.23 Allowed 'General case' 0 CA--C 1.544 0.733 0 CA-C-O 119.053 -0.499 . . . . 0.0 110.922 179.75 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' D' D ' 128' ' ' ASP . . . . . . . . . . . . . 13.8 p-10 -112.33 2.65 16.6 Favored 'General case' 0 CA--C 1.536 0.431 0 CA-C-N 119.579 1.081 . . . . 0.0 113.498 -177.574 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' D' D ' 129' ' ' LEU . . . . . . . . . . . . . 26.1 mt -105.01 148.66 26.51 Favored 'General case' 0 C--O 1.231 0.124 0 N-CA-C 109.726 -0.472 . . . . 0.0 109.726 177.263 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' D' D ' 130' ' ' VAL . . . . . 0.641 HG11 HD13 ' D' ' 104' ' ' ILE . 12.7 p -133.04 141.03 45.87 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.233 0 CA-C-O 121.301 0.572 . . . . 0.0 110.784 -177.682 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' D' D ' 131' ' ' VAL . . . . . 0.571 HG22 HD12 ' D' ' 140' ' ' LEU . 38.9 t -134.43 135.96 53.4 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 CA-C-N 115.716 -0.675 . . . . 0.0 109.924 178.909 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' D' D ' 132' ' ' ILE . . . . . . . . . . . . . 70.6 mt -113.87 132.21 63.53 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.366 0 N-CA-C 109.394 -0.595 . . . . 0.0 109.394 -178.717 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' D' D ' 133' ' ' ILE . . . . . . . . . . . . . 35.4 mm -117.31 120.39 64.78 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.261 0 CA-C-O 120.837 0.351 . . . . 0.0 110.78 -176.06 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' D' D ' 134' ' ' ASP . . . . . . . . . . . . . 9.3 p-10 -129.89 148.95 51.81 Favored 'General case' 0 C--N 1.329 -0.284 0 N-CA-C 109.419 -0.586 . . . . 0.0 109.419 175.179 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' D' D ' 135' ' ' GLU . . . . . . . . . . . . . 54.6 tt0 -50.03 -25.43 3.38 Favored 'General case' 0 C--N 1.327 -0.39 0 N-CA-C 112.746 0.647 . . . . 0.0 112.746 -172.414 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' D' D ' 136' ' ' GLN . . . . . . . . . . . . . 43.0 tt0 -89.86 -31.1 17.49 Favored 'General case' 0 C--O 1.233 0.208 0 N-CA-C 112.542 0.571 . . . . 0.0 112.542 -174.058 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' D' D ' 137' ' ' LYS . . . . . . . . . . . . . 25.1 pttm -164.07 174.09 11.74 Favored 'General case' 0 C--O 1.232 0.176 0 CA-C-O 121.434 0.635 . . . . 0.0 112.57 -174.373 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' D' D ' 138' ' ' LEU . . . . . 0.401 ' C ' HD23 ' D' ' 138' ' ' LEU . 7.4 tt -122.44 130.33 52.98 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 115.197 -0.91 . . . . 0.0 110.109 179.564 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' D' D ' 139' ' ' THR . . . . . 0.407 HG23 ' HG2' ' E' ' 77' ' ' GLU . 34.9 m -112.68 129.77 56.28 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-N 116.341 -0.39 . . . . 0.0 110.677 179.914 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' D' D ' 140' ' ' LEU . . . . . 0.571 HD12 HG22 ' D' ' 131' ' ' VAL . 19.5 tp -113.98 120.41 40.55 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 115.567 -0.742 . . . . 0.0 109.462 -178.241 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' D' D ' 141' ' ' ILE . . . . . 0.482 ' HB ' HG13 ' D' ' 130' ' ' VAL . 20.1 mt -120.3 119.49 60.07 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.281 0 CA-C-O 121.193 0.52 . . . . 0.0 109.93 -177.589 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' D' D ' 142' ' ' ARG . . . . . . . . . . . . . 84.6 mtm180 -111.17 133.29 53.64 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 114.941 -1.027 . . . . 0.0 110.689 -174.699 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' D' D ' 143' ' ' THR . . . . . . . . . . . . . 48.7 p . . . . . 0 C--O 1.22 -0.465 0 CA-C-O 118.03 -0.986 . . . . 0.0 110.371 179.588 . . . . . . . . 0 0 . 1 . 003 nuclear build core ' E' E ' 2' ' ' SER . . . . . . . . . . . . . 15.9 p . . . . . 0 N--CA 1.461 0.084 0 CA-C-O 120.92 0.391 . . . . 0.0 110.949 . . . . . . . . . 0 0 . 1 . 003 nuclear build core ' E' E ' 3' ' ' GLU . . . . . . . . . . . . . 95.7 mt-10 -140.61 139.33 34.88 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 115.992 -0.549 . . . . 0.0 110.927 -179.864 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' E' E ' 4' ' ' LEU . . . . . . . . . . . . . 17.4 tp -122.94 126.76 47.84 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-N 116.071 -0.513 . . . . 0.0 110.155 176.533 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' E' E ' 5' ' ' LYS . . . . . . . . . . . . . 86.4 mttt -106.96 121.6 44.76 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.3 -0.409 . . . . 0.0 110.711 179.024 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' E' E ' 6' ' ' LEU . . . . . . . . . . . . . 75.9 mt -116.78 151.3 36.74 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 115.46 -0.791 . . . . 0.0 110.58 -179.394 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' E' E ' 7' ' ' LYS . . . . . . . . . . . . . 33.9 ttpt -140.32 142.14 28.58 Favored Pre-proline 0 CA--C 1.534 0.338 0 N-CA-C 109.764 -0.458 . . . . 0.0 109.764 175.088 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' E' E ' 8' ' ' PRO . . . . . . . . . . . . . 92.2 Cg_endo -89.03 147.91 5.6 Favored 'Trans proline' 0 N--CA 1.491 1.372 0 C-N-CA 121.654 1.569 . . . . 0.0 112.024 -179.896 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' E' E ' 9' ' ' LEU . . . . . . . . . . . . . 84.3 mt -84.23 -52.07 0.56 Allowed Pre-proline 0 C--N 1.329 -0.284 0 CA-C-O 118.855 -0.593 . . . . 0.0 111.551 -179.94 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' E' E ' 10' ' ' PRO . . . . . . . . . . . . . 61.6 Cg_endo -73.43 155.66 50.56 Favored 'Trans proline' 0 N--CA 1.498 1.762 0 C-N-CA 121.093 1.196 . . . . 0.0 111.898 173.469 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' E' E ' 11' ' ' LYS . . . . . . . . . . . . . 62.1 mtpt -89.07 98.93 12.04 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.433 -0.349 . . . . 0.0 110.749 179.207 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' E' E ' 12' ' ' VAL . . . . . . . . . . . . . 12.6 p -142.68 142.58 26.5 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.288 0 CA-C-N 116.335 -0.393 . . . . 0.0 110.667 179.809 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' E' E ' 13' ' ' GLU . . . . . . . . . . . . . 45.1 mp0 -84.74 128.28 34.53 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 116.267 -0.424 . . . . 0.0 109.86 176.754 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' E' E ' 14' ' ' LEU . . . . . . . . . . . . . 32.3 mt -98.5 148.99 35.29 Favored Pre-proline 0 CA--C 1.533 0.293 0 CA-C-O 119.197 -0.43 . . . . 0.0 110.499 -177.585 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' E' E ' 15' ' ' PRO . . . . . . . . . . . . . 26.3 Cg_exo -62.37 159.96 33.44 Favored 'Trans proline' 0 N--CA 1.497 1.71 0 C-N-CA 121.245 1.296 . . . . 0.0 111.478 174.869 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' E' E ' 16' ' ' PRO . . . . . . . . . . . . . 38.6 Cg_exo -58.68 -34.34 98.86 Favored 'Trans proline' 0 N--CA 1.496 1.666 0 C-N-CA 121.413 1.409 . . . . 0.0 112.899 -178.32 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' E' E ' 17' ' ' ASP . . . . . . . . . . . . . 22.9 p-10 -91.4 8.43 36.3 Favored 'General case' 0 CA--C 1.534 0.362 0 N-CA-C 113.341 0.867 . . . . 0.0 113.341 -177.193 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' E' E ' 18' ' ' PHE . . . . . . . . . . . . . 52.3 t80 -58.19 -43.85 87.77 Favored 'General case' 0 N--CA 1.457 -0.093 0 O-C-N 121.944 -0.472 . . . . 0.0 110.058 -178.162 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' E' E ' 19' ' ' VAL . . . . . . . . . . . . . 48.7 t -58.17 -42.52 83.51 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.304 0 CA-C-N 116.207 -0.452 . . . . 0.0 110.234 -178.909 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' E' E ' 20' ' ' ASP . . . . . . . . . . . . . 7.5 t70 -59.92 -42.09 93.15 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-O 120.833 0.349 . . . . 0.0 110.83 -177.92 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' E' E ' 21' ' ' VAL . . . . . . . . . . . . . 48.3 t -64.73 -46.18 92.94 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.332 0 CA-C-N 116.405 -0.361 . . . . 0.0 110.483 -177.723 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' E' E ' 22' ' ' ILE . . . . . 0.627 HG22 HD12 ' E' ' 26' ' ' LEU . 29.3 mm -57.0 -45.13 83.74 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.257 0 N-CA-C 110.172 -0.307 . . . . 0.0 110.172 179.266 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' E' E ' 23' ' ' ARG . . . . . . . . . . . . . 2.3 tmm_? -54.39 -48.77 71.18 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-O 120.573 0.225 . . . . 0.0 111.246 -178.935 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' E' E ' 24' ' ' ILE . . . . . . . . . . . . . 72.8 mt -59.02 -42.98 87.91 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.316 0 C-N-CA 120.943 -0.303 . . . . 0.0 110.963 -177.828 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' E' E ' 25' ' ' LYS . . . . . . . . . . . . . 96.2 mttt -66.34 -41.7 89.21 Favored 'General case' 0 C--N 1.329 -0.293 0 N-CA-C 112.759 0.652 . . . . 0.0 112.759 -178.874 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' E' E ' 26' ' ' LEU . . . . . 0.627 HD12 HG22 ' E' ' 22' ' ' ILE . 48.6 mt -78.48 -37.31 43.65 Favored 'General case' 0 C--N 1.327 -0.372 0 N-CA-C 113.689 0.996 . . . . 0.0 113.689 -169.812 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' E' E ' 27' ' ' GLN . . . . . . . . . . . . . 16.1 pt20 -47.23 138.85 6.7 Favored 'General case' 0 N--CA 1.467 0.422 0 N-CA-C 112.765 0.654 . . . . 0.0 112.765 -175.261 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' E' E ' 28' ' ' GLY . . . . . . . . . . . . . . . 101.17 -24.53 31.52 Favored Glycine 0 CA--C 1.532 1.139 0 CA-C-N 115.552 -0.749 . . . . 0.0 112.405 -177.182 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' E' E ' 29' ' ' LYS . . . . . . . . . . . . . 86.5 mttt -98.4 155.06 17.42 Favored 'General case' 0 C--O 1.233 0.198 0 CA-C-N 117.594 0.697 . . . . 0.0 111.381 179.376 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' E' E ' 30' ' ' THR . . . . . . . . . . . . . 30.5 m -104.39 136.7 43.49 Favored 'General case' 0 C--N 1.331 -0.226 0 CA-C-N 116.011 -0.54 . . . . 0.0 110.268 177.42 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' E' E ' 31' ' ' VAL . . . . . . . . . . . . . 35.0 m -132.29 157.06 43.0 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.329 0 CA-C-N 116.327 -0.397 . . . . 0.0 110.831 -179.123 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' E' E ' 32' ' ' ARG . . . . . . . . . . . . . 96.9 mtt180 -132.12 154.84 49.08 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 115.954 -0.566 . . . . 0.0 110.44 176.673 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' E' E ' 33' ' ' THR . . . . . . . . . . . . . 29.1 m -53.53 138.13 34.71 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.307 -0.406 . . . . 0.0 111.279 -178.978 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' E' E ' 34' ' ' GLY . . . . . . . . . . . . . . . 100.16 -17.11 57.51 Favored Glycine 0 CA--C 1.532 1.107 0 CA-C-O 119.616 -0.547 . . . . 0.0 113.295 178.744 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' E' E ' 35' ' ' ASP . . . . . . . . . . . . . 54.1 m-20 -65.37 150.18 48.73 Favored 'General case' 0 C--N 1.334 -0.077 0 CA-C-N 118.019 0.909 . . . . 0.0 111.137 179.818 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' E' E ' 36' ' ' VAL . . . . . . . . . . . . . 44.6 t -121.56 130.0 75.02 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.233 0 CA-C-N 115.67 -0.696 . . . . 0.0 109.76 178.536 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' E' E ' 37' ' ' ILE . . . . . . . . . . . . . 69.7 mt -119.31 138.66 49.27 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.29 0 CA-C-N 116.275 -0.421 . . . . 0.0 109.923 -179.636 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' E' E ' 38' ' ' GLY . . . . . . . . . . . . . . . -112.27 128.95 8.77 Favored Glycine 0 CA--C 1.526 0.77 0 N-CA-C 111.086 -0.806 . . . . 0.0 111.086 -179.505 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' E' E ' 39' ' ' ILE . . . . . . . . . . . . . 71.1 mt -122.03 134.14 66.21 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.275 0 N-CA-C 109.899 -0.408 . . . . 0.0 109.899 178.895 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' E' E ' 40' ' ' SER . . . . . . . . . . . . . 53.8 p -93.39 122.71 36.08 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.323 -0.398 . . . . 0.0 110.857 175.509 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' E' E ' 41' ' ' ILE . . . . . . . . . . . . . 71.4 mt -131.85 114.37 24.57 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.225 0 N-CA-C 110.021 -0.363 . . . . 0.0 110.021 177.678 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' E' E ' 42' ' ' LEU . . . . . . . . . . . . . 7.9 mp 56.6 37.57 28.92 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-O 121.086 0.47 . . . . 0.0 111.074 -179.707 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' E' E ' 43' ' ' GLY . . . . . . . . . . . . . . . 77.42 -10.08 24.53 Favored Glycine 0 CA--C 1.534 1.219 0 C-N-CA 121.296 -0.478 . . . . 0.0 113.473 177.043 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' E' E ' 44' ' ' LYS . . . . . . . . . . . . . 68.7 mttm -93.99 132.97 37.93 Favored 'General case' 0 C--N 1.333 -0.121 0 CA-C-N 118.005 0.903 . . . . 0.0 110.069 178.093 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' E' E ' 45' ' ' GLU . . . . . . . . . . . . . 69.3 tt0 -86.46 127.28 34.83 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.172 -0.467 . . . . 0.0 111.04 -177.816 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' E' E ' 46' ' ' VAL . . . . . . . . . . . . . 7.2 p -124.84 128.13 73.04 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.198 0 CA-C-O 120.943 0.401 . . . . 0.0 109.98 176.627 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' E' E ' 47' ' ' LYS . . . . . . . . . . . . . 72.6 mmtt -100.08 133.91 43.78 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-N 115.972 -0.558 . . . . 0.0 111.525 177.631 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' E' E ' 48' ' ' PHE . . . . . . . . . . . . . 91.1 m-85 -116.34 131.98 56.79 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 115.907 -0.588 . . . . 0.0 109.782 174.046 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' E' E ' 49' ' ' LYS . . . . . . . . . . . . . 82.4 tttt -105.73 136.34 45.53 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.488 -0.324 . . . . 0.0 110.527 -179.927 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' E' E ' 50' ' ' VAL . . . . . . . . . . . . . 45.0 t -80.53 108.67 14.16 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.331 0 N-CA-C 109.196 -0.668 . . . . 0.0 109.196 176.089 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' E' E ' 51' ' ' VAL . . . . . . . . . . . . . 47.5 t -74.63 -47.21 39.75 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.289 0 CA-C-N 116.139 -0.482 . . . . 0.0 110.174 -172.968 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' E' E ' 52' ' ' GLN . . . . . . . . . . . . . 48.2 tt0 -164.85 138.49 4.9 Favored 'General case' 0 C--N 1.331 -0.236 0 C-N-CA 120.155 -0.618 . . . . 0.0 111.749 -177.954 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' E' E ' 53' ' ' ALA . . . . . . . . . . . . . . . -116.46 133.6 55.82 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 115.9 -0.591 . . . . 0.0 110.169 176.835 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' E' E ' 54' ' ' TYR . . . . . . . . . . . . . 38.5 t80 -129.13 112.47 18.4 Favored Pre-proline 0 CA--C 1.535 0.398 0 CA-C-O 118.154 -0.927 . . . . 0.0 110.171 177.607 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' E' E ' 55' ' ' PRO . . . . . . . . . . . . . 72.2 Cg_endo -77.09 168.72 76.23 Favored 'Cis proline' 0 N--CA 1.5 1.904 0 CA-C-N 122.082 1.779 . . . . 0.0 112.426 -5.346 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' E' E ' 56' ' ' SER . . . . . . . . . . . . . 13.6 m -117.57 134.08 23.21 Favored Pre-proline 0 CA--C 1.54 0.562 0 CA-C-O 118.455 -0.783 . . . . 0.0 109.595 174.764 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' E' E ' 57' ' ' PRO . . . . . . . . . . . . . 36.0 Cg_endo -66.36 164.7 65.68 Favored 'Cis proline' 0 N--CA 1.498 1.751 0 CA-C-N 121.862 1.701 . . . . 0.0 111.299 -3.177 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' E' E ' 58' ' ' LEU . . . . . . . . . . . . . 23.4 tp -129.96 138.82 51.06 Favored 'General case' 0 C--N 1.331 -0.222 0 CA-C-O 121.081 0.467 . . . . 0.0 110.584 179.61 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' E' E ' 59' ' ' ARG . . . . . . . . . . . . . 75.1 ttt180 -106.06 123.31 47.8 Favored 'General case' 0 C--N 1.329 -0.295 0 N-CA-C 109.084 -0.71 . . . . 0.0 109.084 174.115 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' E' E ' 60' ' ' VAL . . . . . . . . . . . . . 44.3 t -73.52 118.95 19.69 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.351 0 C-N-CA 120.735 -0.386 . . . . 0.0 110.166 -175.198 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' E' E ' 61' ' ' GLU . . . . . . . . . . . . . 95.0 mt-10 -131.05 162.43 29.84 Favored 'General case' 0 C--N 1.331 -0.222 0 CA-C-N 116.107 -0.497 . . . . 0.0 110.109 178.455 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' E' E ' 62' ' ' ASP . . . . . . . . . . . . . 65.2 m-20 -53.57 -32.84 52.58 Favored 'General case' 0 C--N 1.326 -0.427 0 N-CA-C 111.751 0.278 . . . . 0.0 111.751 -178.898 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' E' E ' 63' ' ' ARG . . . . . . . . . . . . . 27.6 mmm180 -72.69 -21.35 61.07 Favored 'General case' 0 C--N 1.33 -0.267 0 N-CA-C 113.054 0.761 . . . . 0.0 113.054 -176.159 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' E' E ' 64' ' ' THR . . . . . . . . . . . . . 29.6 m -72.56 139.37 47.47 Favored 'General case' 0 C--N 1.331 -0.21 0 CA-C-O 120.869 0.366 . . . . 0.0 111.183 -174.409 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' E' E ' 65' ' ' LYS . . . . . . . . . . . . . 13.1 mptt -89.04 134.34 34.03 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.009 -0.541 . . . . 0.0 109.982 178.68 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' E' E ' 66' ' ' ILE . . . . . . . . . . . . . 64.4 mt -116.96 131.75 68.72 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.326 0 CA-C-O 120.885 0.374 . . . . 0.0 110.076 -179.772 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' E' E ' 67' ' ' THR . . . . . . . . . . . . . 32.5 m -127.6 140.44 52.1 Favored 'General case' 0 C--N 1.332 -0.19 0 CA-C-N 116.047 -0.524 . . . . 0.0 110.821 -178.559 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' E' E ' 68' ' ' LEU . . . . . 0.428 ' C ' HD23 ' E' ' 68' ' ' LEU . 5.0 tt . . . . . 0 C--N 1.33 -0.243 0 CA-C-N 115.994 -0.548 . . . . 0.0 109.649 177.044 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' E' E ' 73' ' ' VAL . . . . . . . . . . . . . 33.9 m . . . . . 0 C--O 1.232 0.149 0 CA-C-O 120.866 0.365 . . . . 0.0 110.41 . . . . . . . . . 0 0 . 1 . 003 nuclear build core ' E' E ' 74' ' ' ASP . . . . . . . . . . . . . 7.3 t0 -95.34 126.44 40.65 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.009 -0.542 . . . . 0.0 110.228 -176.924 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' E' E ' 75' ' ' VAL . . . . . 0.444 ' C ' HD12 ' E' ' 76' ' ' LEU . 40.4 t -119.17 123.79 71.96 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.205 0 CA-C-O 121.025 0.44 . . . . 0.0 110.583 -178.514 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' E' E ' 76' ' ' LEU . . . . . 0.444 HD12 ' C ' ' E' ' 75' ' ' VAL . 6.3 mp -123.94 146.24 48.6 Favored 'General case' 0 C--N 1.331 -0.224 0 CA-C-N 115.828 -0.624 . . . . 0.0 109.908 176.195 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' E' E ' 77' ' ' GLU . . . . . 0.407 ' HG2' HG23 ' D' ' 139' ' ' THR . 45.9 mt-10 -135.69 136.86 41.22 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-O 121.011 0.434 . . . . 0.0 111.22 -178.883 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' E' E ' 78' ' ' ALA . . . . . 0.424 ' HB2' HD21 ' E' ' 109' ' ' LEU . . . -125.95 133.44 51.83 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 115.816 -0.629 . . . . 0.0 109.674 176.145 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' E' E ' 79' ' ' LYS . . . . . 0.565 ' O ' HD13 ' E' ' 80' ' ' ILE . 84.0 mttt -80.51 120.3 24.31 Favored 'General case' 0 C--N 1.331 -0.215 0 CA-C-O 121.091 0.472 . . . . 0.0 110.754 -178.199 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' E' E ' 80' ' ' ILE . . . . . 0.565 HD13 ' O ' ' E' ' 79' ' ' LYS . 43.1 mm -139.18 108.68 3.86 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.335 0 N-CA-C 108.961 -0.755 . . . . 0.0 108.961 -176.991 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' E' E ' 81' ' ' LYS . . . . . . . . . . . . . 68.8 mttm -97.84 126.73 43.36 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-O 120.877 0.37 . . . . 0.0 111.199 -176.265 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' E' E ' 82' ' ' GLY . . . . . . . . . . . . . . . 89.08 42.14 5.69 Favored Glycine 0 CA--C 1.527 0.791 0 C-N-CA 120.911 -0.662 . . . . 0.0 111.725 174.992 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' E' E ' 83' ' ' ILE . . . . . . . . . . . . . 75.5 mt -66.83 138.52 22.75 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.314 0 CA-C-O 120.945 0.402 . . . . 0.0 109.94 178.34 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' E' E ' 84' ' ' LYS . . . . . . . . . . . . . 83.8 tttt -99.22 -53.97 3.09 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 115.989 -0.55 . . . . 0.0 110.34 -178.815 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' E' E ' 85' ' ' ASP . . . . . . . . . . . . . 5.9 t0 -154.69 151.4 28.71 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-N 115.746 -0.661 . . . . 0.0 110.044 -178.943 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' E' E ' 86' ' ' VAL . . . . . . . . . . . . . 42.8 t -131.9 130.77 61.7 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.233 0 CA-C-O 120.961 0.41 . . . . 0.0 110.537 -179.181 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' E' E ' 87' ' ' ILE . . . . . . . . . . . . . 44.5 mm -119.04 128.89 75.78 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.221 0 CA-C-N 115.863 -0.608 . . . . 0.0 109.705 177.011 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' E' E ' 88' ' ' LEU . . . . . 0.453 HD12 HD22 ' D' ' 124' ' ' LEU . 27.5 mt -114.54 139.33 49.67 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-O 121.151 0.501 . . . . 0.0 111.463 -177.635 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' E' E ' 89' ' ' ASP . . . . . . . . . . . . . 11.6 t70 -132.96 156.83 46.56 Favored 'General case' 0 C--N 1.331 -0.23 0 CA-C-N 115.517 -0.765 . . . . 0.0 109.388 175.39 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' E' E ' 90' ' ' GLU . . . . . . . . . . . . . 96.0 mt-10 -48.44 -38.52 20.0 Favored 'General case' 0 C--N 1.327 -0.371 0 N-CA-C 112.796 0.665 . . . . 0.0 112.796 -171.507 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' E' E ' 91' ' ' ASN . . . . . . . . . . . . . 33.5 m120 -132.11 34.73 3.77 Favored 'General case' 0 N--CA 1.465 0.278 0 C-N-CA 120.961 -0.296 . . . . 0.0 111.703 -176.494 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' E' E ' 92' ' ' LEU . . . . . . . . . . . . . 9.7 tp -166.16 145.55 6.02 Favored 'General case' 0 C--N 1.33 -0.258 0 C-N-CA 120.885 -0.326 . . . . 0.0 110.717 -179.66 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' E' E ' 93' ' ' ILE . . . . . . . . . . . . . 67.7 mt -127.79 125.96 65.98 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.222 0 N-CA-C 109.711 -0.477 . . . . 0.0 109.711 178.989 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' E' E ' 94' ' ' VAL . . . . . . . . . . . . . 47.1 t -122.99 127.14 74.62 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.267 0 N-CA-C 109.797 -0.446 . . . . 0.0 109.797 178.868 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' E' E ' 95' ' ' VAL . . . . . . . . . . . . . 44.2 t -122.93 135.38 63.18 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.294 0 CA-C-N 116.328 -0.396 . . . . 0.0 110.061 -179.252 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' E' E ' 96' ' ' ILE . . . . . . . . . . . . . 61.9 mt -116.31 128.75 73.54 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.326 0 N-CA-C 109.304 -0.628 . . . . 0.0 109.304 179.341 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' E' E ' 97' ' ' THR . . . . . . . . . . . . . 75.7 p -101.67 157.09 17.08 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-O 121.191 0.52 . . . . 0.0 111.371 -177.353 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' E' E ' 98' ' ' GLU . . . . . . . . . . . . . 84.6 tt0 -53.99 -26.66 27.14 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-N 116.008 -0.542 . . . . 0.0 112.133 -179.793 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' E' E ' 99' ' ' GLU . . . . . . . . . . . . . 45.7 mp0 -79.14 16.25 0.99 Allowed 'General case' 0 CA--C 1.536 0.426 0 N-CA-C 113.013 0.746 . . . . 0.0 113.013 -177.931 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' E' E ' 100' ' ' ASN . . . . . . . . . . . . . 3.8 m-20 62.95 38.08 11.44 Favored 'General case' 0 C--O 1.233 0.186 0 CA-C-O 120.952 0.406 . . . . 0.0 110.939 177.397 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' E' E ' 101' ' ' GLU . . . . . . . . . . . . . 84.5 tt0 -116.49 142.5 46.78 Favored 'General case' 0 C--N 1.331 -0.221 0 CA-C-N 116.078 -0.51 . . . . 0.0 109.801 177.124 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' E' E ' 102' ' ' VAL . . . . . . . . . . . . . 46.4 t -115.12 126.46 72.71 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.22 0 N-CA-C 109.87 -0.419 . . . . 0.0 109.87 -178.615 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' E' E ' 103' ' ' LEU . . . . . . . . . . . . . 42.5 mt -118.29 133.43 55.9 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-N 115.692 -0.685 . . . . 0.0 110.249 177.098 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' E' E ' 104' ' ' ILE . . . . . . . . . . . . . 68.5 mt -118.1 123.36 71.53 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.316 0 N-CA-C 109.986 -0.375 . . . . 0.0 109.986 179.632 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' E' E ' 105' ' ' PHE . . . . . . . . . . . . . 75.4 m-85 -122.43 165.69 15.94 Favored 'General case' 0 C--N 1.332 -0.157 0 O-C-N 124.047 0.842 . . . . 0.0 109.607 -179.964 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' E' E ' 106' ' ' ASN . . . . . . . . . . . . . 50.5 p-10 -101.54 -171.23 1.95 Allowed 'General case' 0 C--N 1.331 -0.204 0 N-CA-C 110.002 -0.37 . . . . 0.0 110.002 174.996 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' E' E ' 107' ' ' GLN . . . . . . . . . . . . . 45.8 tt0 -59.13 -29.3 67.29 Favored 'General case' 0 C--N 1.329 -0.3 0 N-CA-C 112.003 0.372 . . . . 0.0 112.003 -179.733 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' E' E ' 108' ' ' ASN . . . . . . . . . . . . . 14.4 t-20 -84.55 10.48 10.89 Favored 'General case' 0 CA--C 1.536 0.42 0 N-CA-C 113.035 0.754 . . . . 0.0 113.035 -177.508 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' E' E ' 109' ' ' LEU . . . . . 0.424 HD21 ' HB2' ' E' ' 78' ' ' ALA . 8.7 tp 58.33 36.77 25.79 Favored 'General case' 0 CA--C 1.531 0.226 0 CA-C-O 121.046 0.45 . . . . 0.0 111.373 179.711 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' E' E ' 110' ' ' GLU . . . . . . . . . . . . . 43.4 mt-10 -103.65 152.84 21.31 Favored 'General case' 0 C--N 1.33 -0.244 0 N-CA-C 109.662 -0.496 . . . . 0.0 109.662 175.676 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' E' E ' 111' ' ' GLU . . . . . . . . . . . . . 58.9 tt0 -87.29 121.91 30.36 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-O 120.914 0.387 . . . . 0.0 110.763 -176.315 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' E' E ' 112' ' ' LEU . . . . . . . . . . . . . 13.8 mt -105.18 -46.06 4.34 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 115.978 -0.556 . . . . 0.0 110.834 -179.895 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' E' E ' 113' ' ' TYR . . . . . 0.413 ' CE1' HG21 ' F' ' 75' ' ' VAL . 65.3 t80 -139.91 143.75 36.79 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.299 -0.41 . . . . 0.0 111.221 -178.431 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' E' E ' 114' ' ' ARG . . . . . . . . . . . . . 38.8 ptt180 -144.55 123.28 12.59 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.096 -0.502 . . . . 0.0 110.796 178.128 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' E' E ' 115' ' ' GLY . . . . . . . . . . . . . . . -150.13 158.81 27.84 Favored Glycine 0 CA--C 1.525 0.703 0 N-CA-C 110.934 -0.866 . . . . 0.0 110.934 178.205 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' E' E ' 116' ' ' LYS . . . . . . . . . . . . . 37.4 ttpt -127.87 139.01 52.88 Favored 'General case' 0 C--N 1.331 -0.224 0 O-C-N 122.634 -0.333 . . . . 0.0 110.29 178.118 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' E' E ' 117' ' ' PHE . . . . . . . . . . . . . 39.8 m-85 -133.75 114.96 13.99 Favored 'General case' 0 C--N 1.329 -0.296 0 N-CA-C 110.0 -0.37 . . . . 0.0 110.0 -178.153 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' E' E ' 118' ' ' GLU . . . . . . . . . . . . . 84.3 tt0 -53.57 -43.2 68.33 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.64 -0.255 . . . . 0.0 111.542 -175.97 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' E' E ' 119' ' ' ASN . . . . . . . . . . . . . 82.3 m-20 -100.17 31.0 3.53 Favored 'General case' 0 C--N 1.33 -0.24 0 N-CA-C 112.154 0.428 . . . . 0.0 112.154 -174.185 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' E' E ' 120' ' ' LEU . . . . . 0.421 HD11 HG23 ' E' ' 132' ' ' ILE . 13.9 tp -54.97 121.04 7.82 Favored 'General case' 0 C--N 1.331 -0.207 0 CA-C-O 120.663 0.268 . . . . 0.0 110.745 178.716 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' E' E ' 121' ' ' ASN . . . . . . . . . . . . . 46.1 t30 -114.03 -43.93 3.2 Favored 'General case' 0 C--O 1.232 0.167 0 CA-C-N 116.598 -0.273 . . . . 0.0 111.516 -176.184 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' E' E ' 122' ' ' LYS . . . . . . . . . . . . . 57.9 mtpt -140.08 144.55 36.88 Favored 'General case' 0 C--N 1.332 -0.159 0 CA-C-O 120.938 0.399 . . . . 0.0 111.741 -176.084 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' E' E ' 123' ' ' VAL . . . . . . . . . . . . . 46.7 t -127.1 124.9 65.34 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 N-CA-C 109.381 -0.6 . . . . 0.0 109.381 174.078 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' E' E ' 124' ' ' LEU . . . . . . . . . . . . . 51.6 mt -126.73 139.32 53.23 Favored 'General case' 0 C--N 1.331 -0.201 0 CA-C-O 120.95 0.405 . . . . 0.0 110.967 -177.186 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' E' E ' 125' ' ' VAL . . . . . . . . . . . . . 34.9 m -132.01 139.03 51.28 Favored 'Isoleucine or valine' 0 C--N 1.333 -0.145 0 CA-C-N 116.017 -0.538 . . . . 0.0 110.911 -179.871 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' E' E ' 126' ' ' ARG . . . . . . . . . . . . . 77.1 mtp85 -140.52 109.41 6.04 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 115.958 -0.565 . . . . 0.0 110.29 175.422 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' E' E ' 127' ' ' ASN . . . . . . . . . . . . . 94.5 m-20 53.32 -104.9 0.22 Allowed 'General case' 0 CA--C 1.542 0.663 0 CA-C-O 119.067 -0.492 . . . . 0.0 111.136 -179.897 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' E' E ' 128' ' ' ASP . . . . . . . . . . . . . 14.6 p-10 -113.69 5.41 16.44 Favored 'General case' 0 CA--C 1.537 0.447 0 CA-C-N 119.496 1.044 . . . . 0.0 113.393 -177.334 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' E' E ' 129' ' ' LEU . . . . . . . . . . . . . 3.9 tt -105.11 131.51 52.51 Favored 'General case' 0 C--N 1.332 -0.154 0 N-CA-C 109.367 -0.605 . . . . 0.0 109.367 177.809 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' E' E ' 130' ' ' VAL . . . . . . . . . . . . . 44.2 t -120.6 137.05 55.64 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.218 0 CA-C-O 120.765 0.317 . . . . 0.0 110.165 -177.236 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' E' E ' 131' ' ' VAL . . . . . . . . . . . . . 41.8 t -135.95 138.07 48.0 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.249 0 CA-C-O 121.203 0.525 . . . . 0.0 110.459 178.926 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' E' E ' 132' ' ' ILE . . . . . 0.421 HG23 HD11 ' E' ' 120' ' ' LEU . 76.4 mt -119.93 134.0 64.87 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.324 0 CA-C-N 115.513 -0.767 . . . . 0.0 109.51 -179.739 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' E' E ' 133' ' ' ILE . . . . . . . . . . . . . 42.8 mm -117.21 125.32 73.89 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.23 0 CA-C-O 120.798 0.332 . . . . 0.0 110.865 -176.142 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' E' E ' 134' ' ' ASP . . . . . . . . . . . . . 7.7 p-10 -137.03 148.72 47.0 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.0 -0.545 . . . . 0.0 109.568 174.187 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' E' E ' 135' ' ' GLU . . . . . . . . . . . . . 43.5 tp10 -49.81 -25.88 3.48 Favored 'General case' 0 C--N 1.327 -0.377 0 N-CA-C 112.792 0.664 . . . . 0.0 112.792 -171.585 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' E' E ' 136' ' ' GLN . . . . . . . . . . . . . 97.3 mt-30 -96.5 -33.06 11.98 Favored 'General case' 0 CA--C 1.53 0.178 0 N-CA-C 112.476 0.547 . . . . 0.0 112.476 -175.995 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' E' E ' 137' ' ' LYS . . . . . . . . . . . . . 84.5 mttt -141.37 154.56 45.72 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-O 121.233 0.54 . . . . 0.0 111.697 -168.427 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' E' E ' 138' ' ' LEU . . . . . 0.407 ' C ' HD23 ' E' ' 138' ' ' LEU . 4.5 tt -117.56 119.68 35.74 Favored 'General case' 0 C--N 1.33 -0.246 0 N-CA-C 108.965 -0.754 . . . . 0.0 108.965 171.071 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' E' E ' 139' ' ' THR . . . . . . . . . . . . . 25.3 m -106.05 128.8 54.1 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.454 -0.339 . . . . 0.0 110.712 -176.53 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' E' E ' 140' ' ' LEU . . . . . 0.468 HD23 ' N ' ' E' ' 141' ' ' ILE . 5.4 tt -116.56 122.85 45.88 Favored 'General case' 0 C--N 1.329 -0.322 0 N-CA-C 109.068 -0.716 . . . . 0.0 109.068 -179.221 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' E' E ' 141' ' ' ILE . . . . . 0.468 ' N ' HD23 ' E' ' 140' ' ' LEU . 18.9 mt -121.99 118.79 56.69 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.288 0 CA-C-O 121.025 0.44 . . . . 0.0 109.981 -176.757 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' E' E ' 142' ' ' ARG . . . . . . . . . . . . . 84.4 mtp180 -103.7 125.27 50.08 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 115.285 -0.871 . . . . 0.0 110.341 -179.576 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' E' E ' 143' ' ' THR . . . . . . . . . . . . . 43.2 p . . . . . 0 C--O 1.22 -0.472 0 CA-C-O 118.015 -0.993 . . . . 0.0 110.527 -179.781 . . . . . . . . 0 0 . 1 . 003 nuclear build core ' F' F ' 1' ' ' MET . . . . . . . . . . . . . 27.3 ptm . . . . . 0 C--O 1.232 0.15 0 CA-C-O 120.903 0.383 . . . . 0.0 110.564 . . . . . . . . . 0 0 . 1 . 003 nuclear build core ' F' F ' 2' ' ' SER . . . . . . . . . . . . . 4.5 p -117.78 130.1 56.09 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.135 177.686 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' F' F ' 3' ' ' GLU . . . . . . . . . . . . . 83.3 tt0 -142.08 137.74 31.23 Favored 'General case' 0 C--N 1.327 -0.4 0 CA-C-N 115.988 -0.551 . . . . 0.0 111.062 -177.928 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' F' F ' 4' ' ' LEU . . . . . . . . . . . . . 17.1 tp -124.54 131.1 53.49 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.059 176.816 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' F' F ' 5' ' ' LYS . . . . . . . . . . . . . 69.0 mttm -110.28 122.29 47.3 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.305 -0.407 . . . . 0.0 110.602 179.962 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' F' F ' 6' ' ' LEU . . . . . . . . . . . . . 30.3 mt -113.88 149.44 35.12 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 115.234 -0.893 . . . . 0.0 109.954 -178.895 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' F' F ' 7' ' ' LYS . . . . . . . . . . . . . 52.4 tttp -137.11 137.15 22.03 Favored Pre-proline 0 CA--C 1.534 0.34 0 CA-C-O 118.857 -0.592 . . . . 0.0 109.994 175.569 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' F' F ' 8' ' ' PRO . . . . . . . . . . . . . 74.3 Cg_endo -91.45 138.41 2.18 Favored 'Trans proline' 0 N--CA 1.49 1.276 0 C-N-CA 121.675 1.583 . . . . 0.0 111.708 177.259 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' F' F ' 9' ' ' LEU . . . . . . . . . . . . . 58.1 mt -74.78 -48.18 4.92 Favored Pre-proline 0 CA--C 1.534 0.336 0 CA-C-O 118.629 -0.7 . . . . 0.0 112.277 -178.881 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' F' F ' 10' ' ' PRO . . . . . . . . . . . . . 95.3 Cg_endo -78.79 156.8 27.6 Favored 'Trans proline' 0 N--CA 1.496 1.653 0 C-N-CA 121.081 1.187 . . . . 0.0 112.008 177.381 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' F' F ' 11' ' ' LYS . . . . . . . . . . . . . 81.8 tttt -87.92 101.76 14.06 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.396 -0.365 . . . . 0.0 110.266 179.32 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' F' F ' 12' ' ' VAL . . . . . . . . . . . . . 12.3 p -143.57 149.3 18.2 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.295 0 CA-C-N 116.2 -0.454 . . . . 0.0 110.744 -178.313 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' F' F ' 13' ' ' GLU . . . . . . . . . . . . . 84.0 tt0 -91.43 127.6 36.94 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.302 -0.408 . . . . 0.0 109.989 177.598 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' F' F ' 14' ' ' LEU . . . . . . . . . . . . . 29.9 mt -98.83 146.04 30.97 Favored Pre-proline 0 CA--C 1.534 0.333 0 CA-C-O 119.183 -0.437 . . . . 0.0 110.632 -177.711 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' F' F ' 15' ' ' PRO . . . . . . . . . . . . . 23.8 Cg_exo -64.44 158.61 48.44 Favored 'Trans proline' 0 N--CA 1.497 1.707 0 C-N-CA 121.401 1.4 . . . . 0.0 111.777 174.309 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' F' F ' 16' ' ' PRO . . . . . . . . . . . . . 37.8 Cg_exo -57.98 -43.51 47.93 Favored 'Trans proline' 0 N--CA 1.496 1.648 0 C-N-CA 121.477 1.451 . . . . 0.0 112.97 -177.834 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' F' F ' 17' ' ' ASP . . . . . . . . . . . . . 23.2 p-10 -82.42 7.73 13.41 Favored 'General case' 0 CA--C 1.536 0.429 0 N-CA-C 113.252 0.834 . . . . 0.0 113.252 -177.615 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' F' F ' 18' ' ' PHE . . . . . . . . . . . . . 45.7 t80 -58.05 -45.11 87.57 Favored 'General case' 0 N--CA 1.458 -0.069 0 O-C-N 121.996 -0.44 . . . . 0.0 110.183 -178.179 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' F' F ' 19' ' ' VAL . . . . . 0.407 HG13 ' N ' ' F' ' 20' ' ' ASP . 14.4 p -56.98 -41.96 78.12 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.35 0 CA-C-N 116.34 -0.391 . . . . 0.0 110.935 -178.585 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' F' F ' 20' ' ' ASP . . . . . 0.407 ' N ' HG13 ' F' ' 19' ' ' VAL . 67.6 m-20 -60.85 -42.13 97.23 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-O 120.884 0.373 . . . . 0.0 110.9 -178.125 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' F' F ' 21' ' ' VAL . . . . . . . . . . . . . 52.9 t -64.36 -47.37 89.84 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.32 0 CA-C-N 116.374 -0.376 . . . . 0.0 110.353 -178.107 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' F' F ' 22' ' ' ILE . . . . . . . . . . . . . 51.0 mm -56.72 -43.49 79.47 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.283 0 CA-C-O 120.773 0.32 . . . . 0.0 110.479 178.764 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' F' F ' 23' ' ' ARG . . . . . . . . . . . . . 42.2 ttp180 -54.4 -49.12 70.66 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.632 -0.258 . . . . 0.0 111.432 -179.003 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' F' F ' 24' ' ' ILE . . . . . . . . . . . . . 73.4 mt -59.37 -43.72 90.88 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.284 0 C-N-CA 121.072 -0.251 . . . . 0.0 111.019 -178.071 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' F' F ' 25' ' ' LYS . . . . . . . . . . . . . 99.0 mttt -63.79 -41.8 97.87 Favored 'General case' 0 C--N 1.327 -0.382 0 N-CA-C 112.526 0.565 . . . . 0.0 112.526 -178.255 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' F' F ' 26' ' ' LEU . . . . . . . . . . . . . 93.3 mt -79.49 -41.64 26.98 Favored 'General case' 0 C--N 1.329 -0.318 0 N-CA-C 113.14 0.793 . . . . 0.0 113.14 -172.511 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' F' F ' 27' ' ' GLN . . . . . . . . . . . . . 14.1 pt20 -46.41 142.16 3.19 Favored 'General case' 0 N--CA 1.469 0.482 0 N-CA-C 112.9 0.704 . . . . 0.0 112.9 -173.581 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' F' F ' 28' ' ' GLY . . . . . . . . . . . . . . . 101.26 -29.85 11.64 Favored Glycine 0 CA--C 1.529 0.953 0 CA-C-N 115.15 -0.932 . . . . 0.0 111.941 -177.182 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' F' F ' 29' ' ' LYS . . . . . . . . . . . . . 93.3 mttt -98.62 155.18 17.43 Favored 'General case' 0 C--N 1.332 -0.173 0 CA-C-N 117.329 0.564 . . . . 0.0 111.129 177.981 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' F' F ' 30' ' ' THR . . . . . . . . . . . . . 34.8 m -102.58 138.91 38.86 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.163 -0.471 . . . . 0.0 110.063 176.657 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' F' F ' 31' ' ' VAL . . . . . . . . . . . . . 34.9 m -128.91 158.6 41.47 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.186 0 CA-C-N 116.413 -0.358 . . . . 0.0 110.808 -178.8 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' F' F ' 32' ' ' ARG . . . . . . . . . . . . . 96.9 mtt180 -130.79 151.74 50.89 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 115.922 -0.581 . . . . 0.0 110.5 178.735 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' F' F ' 33' ' ' THR . . . . . . . . . . . . . 18.4 m -53.97 138.78 36.13 Favored 'General case' 0 C--N 1.331 -0.239 0 CA-C-N 116.19 -0.459 . . . . 0.0 111.153 -179.519 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' F' F ' 34' ' ' GLY . . . . . . . . . . . . . . . 101.82 -17.12 55.29 Favored Glycine 0 CA--C 1.534 1.225 0 CA-C-O 119.618 -0.546 . . . . 0.0 113.191 -179.915 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' F' F ' 35' ' ' ASP . . . . . . . . . . . . . 56.7 m-20 -64.71 149.57 48.89 Favored 'General case' 0 C--O 1.232 0.14 0 CA-C-N 118.146 0.973 . . . . 0.0 111.29 179.434 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' F' F ' 36' ' ' VAL . . . . . . . . . . . . . 46.3 t -124.32 130.07 73.76 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.303 0 CA-C-N 115.698 -0.683 . . . . 0.0 109.845 179.565 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' F' F ' 37' ' ' ILE . . . . . . . . . . . . . 69.1 mt -121.97 139.42 49.05 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.219 0 CA-C-N 116.216 -0.447 . . . . 0.0 109.835 179.95 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' F' F ' 38' ' ' GLY . . . . . . . . . . . . . . . -114.41 128.88 8.41 Favored Glycine 0 CA--C 1.526 0.75 0 N-CA-C 110.943 -0.863 . . . . 0.0 110.943 -179.974 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' F' F ' 39' ' ' ILE . . . . . . . . . . . . . 70.8 mt -119.37 129.89 74.69 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.245 0 N-CA-C 109.929 -0.397 . . . . 0.0 109.929 179.059 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' F' F ' 40' ' ' SER . . . . . . . . . . . . . 22.8 t -93.74 118.9 32.03 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.437 -0.347 . . . . 0.0 110.788 175.732 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' F' F ' 41' ' ' ILE . . . . . . . . . . . . . 71.4 mt -124.76 117.06 49.2 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.269 0 CA-C-O 120.787 0.327 . . . . 0.0 110.315 178.808 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' F' F ' 42' ' ' LEU . . . . . . . . . . . . . 6.9 mp 51.04 36.93 16.52 Favored 'General case' 0 N--CA 1.463 0.21 0 CA-C-O 121.143 0.497 . . . . 0.0 111.548 178.17 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' F' F ' 43' ' ' GLY . . . . . . . . . . . . . . . 73.88 30.79 60.95 Favored Glycine 0 CA--C 1.529 0.941 0 C-N-CA 121.184 -0.531 . . . . 0.0 112.324 177.636 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' F' F ' 44' ' ' LYS . . . . . . . . . . . . . 64.1 mttp -132.5 127.21 34.71 Favored 'General case' 0 C--N 1.331 -0.233 0 N-CA-C 109.679 -0.489 . . . . 0.0 109.679 177.231 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' F' F ' 45' ' ' GLU . . . . . . . . . . . . . 80.2 tt0 -84.79 122.77 29.61 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-O 120.843 0.354 . . . . 0.0 111.215 -177.535 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' F' F ' 46' ' ' VAL . . . . . . . . . . . . . 7.6 p -122.2 126.45 74.34 Favored 'Isoleucine or valine' 0 C--O 1.233 0.186 0 N-CA-C 109.329 -0.619 . . . . 0.0 109.329 174.625 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' F' F ' 47' ' ' LYS . . . . . . . . . . . . . 93.7 mttt -100.33 130.48 46.44 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.123 -0.49 . . . . 0.0 111.342 179.871 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' F' F ' 48' ' ' PHE . . . . . . . . . . . . . 91.7 m-85 -114.21 131.79 56.34 Favored 'General case' 0 C--N 1.33 -0.267 0 N-CA-C 109.637 -0.505 . . . . 0.0 109.637 175.095 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' F' F ' 49' ' ' LYS . . . . . . . . . . . . . 37.2 tttp -109.38 139.9 43.76 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.452 -0.34 . . . . 0.0 110.542 179.846 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' F' F ' 50' ' ' VAL . . . . . . . . . . . . . 43.4 t -82.96 108.22 15.5 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.225 0 N-CA-C 109.267 -0.642 . . . . 0.0 109.267 175.513 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' F' F ' 51' ' ' VAL . . . . . . . . . . . . . 48.0 t -73.08 -53.08 19.48 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.32 0 CA-C-N 115.926 -0.579 . . . . 0.0 109.615 -174.404 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' F' F ' 52' ' ' GLN . . . . . . . . . . . . . 88.7 mt-30 -154.09 151.44 29.29 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.022 -0.535 . . . . 0.0 111.972 -177.493 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' F' F ' 53' ' ' ALA . . . . . . . . . . . . . . . -128.18 132.96 48.84 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 115.214 -0.903 . . . . 0.0 109.683 174.975 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' F' F ' 54' ' ' TYR . . . . . . . . . . . . . 25.7 t80 -129.07 108.41 18.06 Favored Pre-proline 0 CA--C 1.535 0.4 0 CA-C-O 118.327 -0.844 . . . . 0.0 110.256 179.07 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' F' F ' 55' ' ' PRO . . . . . . . . . . . . . 73.2 Cg_endo -77.16 169.0 75.4 Favored 'Cis proline' 0 N--CA 1.501 1.919 0 CA-C-N 121.853 1.698 . . . . 0.0 112.453 -5.205 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' F' F ' 56' ' ' SER . . . . . . . . . . . . . 54.3 m -116.72 130.42 24.56 Favored Pre-proline 0 CA--C 1.539 0.536 0 CA-C-O 118.413 -0.803 . . . . 0.0 109.229 174.819 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' F' F ' 57' ' ' PRO . . . . . . . . . . . . . 38.1 Cg_endo -67.15 164.65 70.31 Favored 'Cis proline' 0 N--CA 1.498 1.741 0 CA-C-N 121.991 1.747 . . . . 0.0 111.584 -0.282 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' F' F ' 58' ' ' LEU . . . . . . . . . . . . . 29.7 tp -129.75 136.2 49.35 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-N 116.26 -0.427 . . . . 0.0 110.297 179.702 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' F' F ' 59' ' ' ARG . . . . . . . . . . . . . 70.5 ttt180 -100.42 128.57 46.44 Favored 'General case' 0 C--N 1.326 -0.423 0 N-CA-C 109.188 -0.671 . . . . 0.0 109.188 176.244 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' F' F ' 60' ' ' VAL . . . . . . . . . . . . . 46.9 t -80.65 115.01 22.45 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.254 0 C-N-CA 120.588 -0.445 . . . . 0.0 110.096 -175.075 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' F' F ' 61' ' ' GLU . . . . . . . . . . . . . 95.3 mt-10 -130.99 160.53 34.29 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 115.841 -0.618 . . . . 0.0 109.758 178.221 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' F' F ' 62' ' ' ASP . . . . . . . . . . . . . 15.0 p-10 -53.25 -31.45 43.56 Favored 'General case' 0 C--N 1.327 -0.387 0 N-CA-C 111.925 0.343 . . . . 0.0 111.925 179.944 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' F' F ' 63' ' ' ARG . . . . . . . . . . . . . 39.7 mtp180 -71.86 -22.11 61.57 Favored 'General case' 0 CA--C 1.532 0.27 0 N-CA-C 112.894 0.701 . . . . 0.0 112.894 -176.095 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' F' F ' 64' ' ' THR . . . . . . . . . . . . . 34.2 m -72.73 141.13 48.16 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-O 121.013 0.435 . . . . 0.0 111.013 -175.612 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' F' F ' 65' ' ' LYS . . . . . . . . . . . . . 97.5 mttt -89.18 131.2 35.42 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 115.851 -0.613 . . . . 0.0 109.84 177.635 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' F' F ' 66' ' ' ILE . . . . . . . . . . . . . 59.9 mt -116.01 129.03 73.06 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.228 0 N-CA-C 109.798 -0.445 . . . . 0.0 109.798 179.37 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' F' F ' 67' ' ' THR . . . . . . . . . . . . . 23.8 m -127.05 142.63 51.49 Favored 'General case' 0 C--N 1.331 -0.227 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.892 -178.148 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' F' F ' 68' ' ' LEU . . . . . . . . . . . . . 6.7 mp . . . . . 0 C--N 1.329 -0.314 0 CA-C-N 116.023 -0.535 . . . . 0.0 110.321 176.948 . . . . . . . . 0 0 . 1 . 003 nuclear build core ' F' F ' 73' ' ' VAL . . . . . . . . . . . . . 24.5 m . . . . . 0 C--O 1.231 0.117 0 CA-C-O 121.356 0.598 . . . . 0.0 110.933 . . . . . . . . . 0 0 . 1 . 003 nuclear build core ' F' F ' 74' ' ' ASP . . . . . . . . . . . . . 12.3 t0 -99.41 124.1 44.25 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 115.404 -0.816 . . . . 0.0 108.981 176.053 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' F' F ' 75' ' ' VAL . . . . . 0.413 HG21 ' CE1' ' E' ' 113' ' ' TYR . 41.8 t -112.83 124.08 69.13 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.245 0 CA-C-O 121.072 0.463 . . . . 0.0 110.839 -174.35 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' F' F ' 76' ' ' LEU . . . . . . . . . . . . . 5.8 mp -125.76 146.87 49.59 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 115.549 -0.75 . . . . 0.0 109.638 175.394 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' F' F ' 77' ' ' GLU . . . . . . . . . . . . . 97.7 mt-10 -134.22 130.88 37.84 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-O 120.977 0.418 . . . . 0.0 110.889 -178.075 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' F' F ' 78' ' ' ALA . . . . . . . . . . . . . . . -114.47 134.21 55.18 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 115.709 -0.678 . . . . 0.0 109.502 176.806 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' F' F ' 79' ' ' LYS . . . . . 0.648 ' O ' HD13 ' F' ' 80' ' ' ILE . 25.7 pttm -77.55 119.31 20.95 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-O 121.472 0.653 . . . . 0.0 110.792 -178.644 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' F' F ' 80' ' ' ILE . . . . . 0.648 HD13 ' O ' ' F' ' 79' ' ' LYS . 36.6 mm -139.26 113.87 7.66 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.282 0 CA-C-N 115.546 -0.752 . . . . 0.0 109.103 -178.795 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' F' F ' 81' ' ' LYS . . . . . . . . . . . . . 24.5 pttm -114.32 128.01 56.14 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-O 120.991 0.424 . . . . 0.0 111.269 -177.252 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' F' F ' 82' ' ' GLY . . . . . . . . . . . . . . . 88.89 42.21 5.73 Favored Glycine 0 CA--C 1.527 0.794 0 N-CA-C 111.483 -0.647 . . . . 0.0 111.483 177.078 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' F' F ' 83' ' ' ILE . . . . . . . . . . . . . 72.9 mt -69.88 140.95 17.79 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 CA-C-O 120.871 0.367 . . . . 0.0 110.197 179.633 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' F' F ' 84' ' ' LYS . . . . . . . . . . . . . 54.7 tttp -101.6 -50.88 3.59 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-N 115.951 -0.568 . . . . 0.0 109.984 178.746 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' F' F ' 85' ' ' ASP . . . . . . . . . . . . . 6.5 t0 -153.71 149.26 27.31 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 115.792 -0.64 . . . . 0.0 110.402 -179.543 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' F' F ' 86' ' ' VAL . . . . . . . . . . . . . 42.1 t -132.2 129.73 60.13 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.185 0 CA-C-O 120.882 0.372 . . . . 0.0 110.319 -179.852 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' F' F ' 87' ' ' ILE . . . . . 0.494 HD12 ' N ' ' F' ' 87' ' ' ILE . 4.9 mp -120.1 126.65 75.5 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.245 0 N-CA-C 109.548 -0.538 . . . . 0.0 109.548 176.321 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' F' F ' 88' ' ' LEU . . . . . . . . . . . . . 59.0 mt -111.59 136.9 50.17 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-O 121.103 0.478 . . . . 0.0 111.263 -177.798 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' F' F ' 89' ' ' ASP . . . . . . . . . . . . . 12.6 t70 -129.49 153.66 47.77 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 115.646 -0.706 . . . . 0.0 109.285 175.742 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' F' F ' 90' ' ' GLU . . . . . . . . . . . . . 43.6 tp10 -48.47 -33.99 10.33 Favored 'General case' 0 C--N 1.329 -0.326 0 N-CA-C 112.918 0.71 . . . . 0.0 112.918 -172.011 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' F' F ' 91' ' ' ASN . . . . . . . . . . . . . 83.3 m-20 -131.25 27.54 4.79 Favored 'General case' 0 N--CA 1.466 0.343 0 N-CA-C 112.514 0.561 . . . . 0.0 112.514 -175.381 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' F' F ' 92' ' ' LEU . . . . . . . . . . . . . 6.6 tp -166.13 150.46 7.94 Favored 'General case' 0 C--N 1.331 -0.199 0 C-N-CA 120.83 -0.348 . . . . 0.0 110.752 -179.981 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' F' F ' 93' ' ' ILE . . . . . . . . . . . . . 71.8 mt -129.03 126.14 63.95 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.216 0 N-CA-C 109.693 -0.484 . . . . 0.0 109.693 178.927 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' F' F ' 94' ' ' VAL . . . . . . . . . . . . . 44.8 t -121.8 127.16 75.39 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.258 0 N-CA-C 109.735 -0.468 . . . . 0.0 109.735 178.8 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' F' F ' 95' ' ' VAL . . . . . . . . . . . . . 42.4 t -124.16 136.3 60.86 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.25 0 CA-C-N 116.091 -0.504 . . . . 0.0 110.054 -178.361 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' F' F ' 96' ' ' ILE . . . . . 0.559 HD11 ' HB ' ' F' ' 123' ' ' VAL . 47.3 mt -118.27 130.93 72.41 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.235 0 N-CA-C 109.37 -0.604 . . . . 0.0 109.37 179.306 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' F' F ' 97' ' ' THR . . . . . . . . . . . . . 67.3 p -103.16 157.21 17.16 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-O 121.1 0.476 . . . . 0.0 111.101 -178.586 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' F' F ' 98' ' ' GLU . . . . . . . . . . . . . 96.5 mt-10 -53.84 -26.01 22.35 Favored 'General case' 0 C--N 1.328 -0.354 0 N-CA-C 112.424 0.527 . . . . 0.0 112.424 -178.79 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' F' F ' 99' ' ' GLU . . . . . . . . . . . . . 95.7 mt-10 -79.62 16.8 1.0 Allowed 'General case' 0 CA--C 1.534 0.352 0 N-CA-C 113.213 0.82 . . . . 0.0 113.213 -176.126 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' F' F ' 100' ' ' ASN . . . . . . . . . . . . . 3.6 m-20 62.72 37.4 12.68 Favored 'General case' 0 C--O 1.234 0.24 0 CA-C-O 121.212 0.53 . . . . 0.0 111.038 178.136 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' F' F ' 101' ' ' GLU . . . . . . . . . . . . . 84.5 tt0 -117.65 139.85 50.44 Favored 'General case' 0 C--N 1.333 -0.142 0 N-CA-C 109.378 -0.601 . . . . 0.0 109.378 176.217 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' F' F ' 102' ' ' VAL . . . . . . . . . . . . . 45.0 t -117.57 129.89 73.32 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 N-CA-C 109.847 -0.427 . . . . 0.0 109.847 -177.377 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' F' F ' 103' ' ' LEU . . . . . . . . . . . . . 4.7 mp -123.09 137.99 54.78 Favored 'General case' 0 C--N 1.331 -0.219 0 CA-C-N 116.144 -0.48 . . . . 0.0 110.715 178.288 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' F' F ' 104' ' ' ILE . . . . . . . . . . . . . 65.5 mt -117.8 124.7 73.44 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.255 0 CA-C-N 115.802 -0.635 . . . . 0.0 109.882 179.989 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' F' F ' 105' ' ' PHE . . . . . . . . . . . . . 89.9 m-85 -122.43 161.47 23.45 Favored 'General case' 0 C--N 1.332 -0.187 0 O-C-N 123.969 0.793 . . . . 0.0 109.817 179.458 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' F' F ' 106' ' ' ASN . . . . . . . . . . . . . 47.2 p-10 -97.5 -171.35 2.17 Favored 'General case' 0 C--N 1.331 -0.209 0 N-CA-C 109.932 -0.396 . . . . 0.0 109.932 173.132 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' F' F ' 107' ' ' GLN . . . . . . . . . . . . . 48.4 tt0 -57.3 -30.12 64.47 Favored 'General case' 0 C--N 1.328 -0.348 0 N-CA-C 112.043 0.386 . . . . 0.0 112.043 -179.188 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' F' F ' 108' ' ' ASN . . . . . . . . . . . . . 13.0 t-20 -88.73 14.02 11.09 Favored 'General case' 0 CA--C 1.534 0.349 0 N-CA-C 112.973 0.731 . . . . 0.0 112.973 -175.612 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' F' F ' 109' ' ' LEU . . . . . . . . . . . . . 33.5 mt 57.97 33.4 23.15 Favored 'General case' 0 C--O 1.233 0.19 0 N-CA-C 111.756 0.28 . . . . 0.0 111.756 179.247 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' F' F ' 110' ' ' GLU . . . . . . . . . . . . . 43.3 mt-10 -98.05 145.24 26.73 Favored 'General case' 0 C--N 1.33 -0.277 0 N-CA-C 109.594 -0.521 . . . . 0.0 109.594 175.924 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' F' F ' 111' ' ' GLU . . . . . . . . . . . . . 53.7 tt0 -81.24 122.02 26.89 Favored 'General case' 0 C--N 1.328 -0.351 0 C-N-CA 120.725 -0.39 . . . . 0.0 110.487 -176.992 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' F' F ' 112' ' ' LEU . . . . . . . . . . . . . 58.2 mt -106.53 -46.09 4.09 Favored 'General case' 0 C--N 1.331 -0.226 0 CA-C-N 116.135 -0.484 . . . . 0.0 110.42 178.178 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' F' F ' 113' ' ' TYR . . . . . . . . . . . . . 64.6 t80 -138.36 137.08 36.98 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.134 -0.485 . . . . 0.0 111.169 -179.017 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' F' F ' 114' ' ' ARG . . . . . . . . . . . . . 56.1 ttp180 -141.45 121.29 13.55 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.277 -0.419 . . . . 0.0 109.949 174.848 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' F' F ' 115' ' ' GLY . . . . . . . . . . . . . . . -148.52 160.96 28.54 Favored Glycine 0 CA--C 1.524 0.595 0 N-CA-C 111.069 -0.812 . . . . 0.0 111.069 179.826 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' F' F ' 116' ' ' LYS . . . . . . . . . . . . . 40.2 ttpt -124.36 141.93 51.69 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-O 120.64 0.257 . . . . 0.0 110.385 -179.901 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' F' F ' 117' ' ' PHE . . . . . . . . . . . . . 47.4 m-85 -135.24 113.9 11.76 Favored 'General case' 0 C--N 1.332 -0.184 0 CA-C-O 120.907 0.384 . . . . 0.0 110.019 179.459 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' F' F ' 118' ' ' GLU . . . . . . . . . . . . . 82.1 tt0 -53.95 -51.69 63.03 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.457 -0.338 . . . . 0.0 111.376 -176.348 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' F' F ' 119' ' ' ASN . . . . . . . . . . . . . 87.6 m-20 -93.84 31.19 1.65 Allowed 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.052 -0.522 . . . . 0.0 112.19 -174.712 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' F' F ' 120' ' ' LEU . . . . . . . . . . . . . 12.9 tp -54.2 124.08 14.69 Favored 'General case' 0 N--CA 1.462 0.153 0 CA-C-O 120.624 0.249 . . . . 0.0 110.738 178.348 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' F' F ' 121' ' ' ASN . . . . . . . . . . . . . 12.4 m120 -112.15 -44.06 3.47 Favored 'General case' 0 C--O 1.232 0.137 0 CA-C-N 116.62 -0.264 . . . . 0.0 110.944 -176.679 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' F' F ' 122' ' ' LYS . . . . . . . . . . . . . 98.2 mttt -146.66 143.16 28.57 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-O 120.917 0.389 . . . . 0.0 111.387 -178.875 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' F' F ' 123' ' ' VAL . . . . . 0.559 ' HB ' HD11 ' F' ' 96' ' ' ILE . 46.5 t -126.77 127.43 70.01 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.314 0 N-CA-C 109.19 -0.67 . . . . 0.0 109.19 175.049 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' F' F ' 124' ' ' LEU . . . . . . . . . . . . . 13.9 tp -134.05 140.05 46.41 Favored 'General case' 0 C--N 1.331 -0.227 0 CA-C-O 120.947 0.403 . . . . 0.0 110.805 -176.797 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' F' F ' 125' ' ' VAL . . . . . . . . . . . . . 12.2 p -131.51 140.03 49.26 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.215 0 CA-C-N 116.239 -0.437 . . . . 0.0 110.335 178.492 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' F' F ' 126' ' ' ARG . . . . . . . . . . . . . 96.6 mtt-85 -136.97 124.24 21.85 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.064 -0.516 . . . . 0.0 110.402 179.297 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' F' F ' 127' ' ' ASN . . . . . . . . . . . . . 67.7 m-80 52.02 -106.46 0.27 Allowed 'General case' 0 CA--C 1.544 0.73 0 CA-C-O 119.044 -0.503 . . . . 0.0 111.104 179.997 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' F' F ' 128' ' ' ASP . . . . . . . . . . . . . 8.1 p-10 -114.09 1.67 14.68 Favored 'General case' 0 CA--C 1.536 0.414 0 CA-C-N 119.629 1.104 . . . . 0.0 113.459 -177.86 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' F' F ' 129' ' ' LEU . . . . . . . . . . . . . 29.3 mt -107.35 145.12 33.26 Favored 'General case' 0 C--N 1.333 -0.11 0 O-C-N 121.962 -0.461 . . . . 0.0 110.383 -178.571 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' F' F ' 130' ' ' VAL . . . . . . . . . . . . . 43.3 t -122.18 136.31 59.44 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.231 0 CA-C-O 120.909 0.385 . . . . 0.0 110.072 -178.109 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' F' F ' 131' ' ' VAL . . . . . . . . . . . . . 42.4 t -131.69 133.61 61.27 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.247 0 CA-C-N 116.209 -0.451 . . . . 0.0 109.812 177.651 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' F' F ' 132' ' ' ILE . . . . . . . . . . . . . 71.0 mt -119.68 132.14 70.25 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.317 0 CA-C-N 115.966 -0.561 . . . . 0.0 109.536 -179.143 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' F' F ' 133' ' ' ILE . . . . . . . . . . . . . 37.4 mm -116.84 123.39 71.69 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.331 0 CA-C-O 120.916 0.388 . . . . 0.0 110.855 -175.274 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' F' F ' 134' ' ' ASP . . . . . . . . . . . . . 9.3 p-10 -134.07 149.12 51.12 Favored 'General case' 0 C--N 1.329 -0.298 0 N-CA-C 109.606 -0.516 . . . . 0.0 109.606 174.661 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' F' F ' 135' ' ' GLU . . . . . . . . . . . . . 84.3 tt0 -49.87 -26.58 4.19 Favored 'General case' 0 C--N 1.327 -0.386 0 N-CA-C 112.71 0.633 . . . . 0.0 112.71 -173.283 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' F' F ' 136' ' ' GLN . . . . . . . . . . . . . 36.3 tt0 -84.72 -36.47 21.8 Favored 'General case' 0 C--O 1.234 0.289 0 N-CA-C 112.19 0.441 . . . . 0.0 112.19 -174.729 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' F' F ' 137' ' ' LYS . . . . . . . . . . . . . 20.4 pttp -163.08 171.7 16.02 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-O 121.539 0.685 . . . . 0.0 112.375 -171.32 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' F' F ' 138' ' ' LEU . . . . . 0.513 HD23 ' N ' ' F' ' 139' ' ' THR . 3.9 tt -116.33 127.64 54.86 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 114.995 -1.002 . . . . 0.0 109.661 178.808 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' F' F ' 139' ' ' THR . . . . . 0.513 ' N ' HD23 ' F' ' 138' ' ' LEU . 28.4 m -108.46 127.82 54.25 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-O 120.772 0.32 . . . . 0.0 110.676 -179.88 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' F' F ' 140' ' ' LEU . . . . . . . . . . . . . 10.0 tp -113.57 120.48 41.11 Favored 'General case' 0 C--N 1.328 -0.339 0 N-CA-C 109.175 -0.676 . . . . 0.0 109.175 -179.367 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' F' F ' 141' ' ' ILE . . . . . . . . . . . . . 18.9 mt -120.56 118.36 56.29 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.299 0 CA-C-O 120.986 0.422 . . . . 0.0 109.966 -174.76 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' F' F ' 142' ' ' ARG . . . . . . . . . . . . . 83.9 mtm180 -108.86 128.18 54.69 Favored 'General case' 0 C--N 1.332 -0.19 0 CA-C-N 115.543 -0.753 . . . . 0.0 110.318 -179.255 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' F' F ' 143' ' ' THR . . . . . . . . . . . . . 22.6 p . . . . . 0 C--O 1.22 -0.462 0 CA-C-O 117.94 -1.028 . . . . 0.0 110.669 -179.42 . . . . . . . . 0 0 . 1 . 004 nuclear build core ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 3.8 p . . . . . 0 N--CA 1.463 0.206 0 CA-C-O 121.065 0.459 . . . . 0.0 110.875 . . . . . . . . . 0 0 . 1 . 004 nuclear build core ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 95.6 mt-10 -140.32 139.57 35.46 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 115.737 -0.665 . . . . 0.0 110.904 -179.974 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 4' ' ' LEU . . . . . . . . . . . . . 18.6 tp -125.91 129.54 49.52 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 115.922 -0.581 . . . . 0.0 110.19 177.641 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 5' ' ' LYS . . . . . . . . . . . . . 64.0 mttp -111.65 121.12 44.29 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.393 -0.367 . . . . 0.0 110.784 179.892 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 18.8 mt -114.09 148.17 37.55 Favored 'General case' 0 C--N 1.332 -0.193 0 CA-C-N 115.52 -0.764 . . . . 0.0 109.771 179.449 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 48.4 tttp -126.09 137.88 31.06 Favored Pre-proline 0 CA--C 1.533 0.3 0 CA-C-O 118.863 -0.589 . . . . 0.0 109.842 174.954 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 8' ' ' PRO . . . . . . . . . . . . . 91.6 Cg_endo -90.51 134.93 2.02 Favored 'Trans proline' 0 N--CA 1.489 1.219 0 C-N-CA 121.729 1.619 . . . . 0.0 111.791 179.182 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 22.1 mt -80.16 -47.92 1.33 Allowed Pre-proline 0 CA--C 1.533 0.307 0 CA-C-O 118.654 -0.688 . . . . 0.0 112.238 -178.844 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 90.8 Cg_endo -79.53 152.26 22.98 Favored 'Trans proline' 0 N--CA 1.497 1.677 0 C-N-CA 121.065 1.176 . . . . 0.0 111.914 176.977 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 22.9 tptm -84.35 92.38 8.01 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.39 -0.368 . . . . 0.0 110.312 178.841 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 12.0 p -139.97 144.11 28.77 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.339 0 CA-C-N 116.151 -0.477 . . . . 0.0 110.441 179.957 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 95.5 mt-10 -89.18 122.23 32.26 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.339 -0.391 . . . . 0.0 110.194 178.063 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 14' ' ' LEU . . . . . . . . . . . . . 28.5 mt -93.91 144.77 28.67 Favored Pre-proline 0 C--N 1.329 -0.29 0 CA-C-O 118.971 -0.538 . . . . 0.0 109.99 -179.354 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 15' ' ' PRO . . . . . . . . . . . . . 31.0 Cg_exo -59.53 159.92 22.19 Favored 'Trans proline' 0 N--CA 1.498 1.757 0 C-N-CA 121.256 1.304 . . . . 0.0 111.713 179.095 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 16' ' ' PRO . . . . . . . . . . . . . 37.0 Cg_exo -58.59 -41.21 66.64 Favored 'Trans proline' 0 N--CA 1.496 1.648 0 C-N-CA 121.477 1.451 . . . . 0.0 112.757 -178.226 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 17' ' ' ASP . . . . . . . . . . . . . 19.1 p-10 -82.34 6.14 18.0 Favored 'General case' 0 CA--C 1.536 0.434 0 N-CA-C 113.274 0.842 . . . . 0.0 113.274 -178.008 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 18' ' ' PHE . . . . . . . . . . . . . 58.1 t80 -57.99 -45.18 87.22 Favored 'General case' 0 C--N 1.334 -0.084 0 O-C-N 121.938 -0.476 . . . . 0.0 110.119 -178.389 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 19' ' ' VAL . . . . . . . . . . . . . 48.3 t -56.33 -43.77 77.98 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.297 0 CA-C-N 116.291 -0.413 . . . . 0.0 110.628 -177.959 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 80.6 m-20 -60.31 -42.61 95.93 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.497 -0.32 . . . . 0.0 110.964 -178.068 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 45.6 t -64.01 -46.48 93.79 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.282 0 C-N-CA 120.846 -0.342 . . . . 0.0 110.56 -177.711 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 22' ' ' ILE . . . . . 0.517 HG22 HD12 ' A' ' 26' ' ' LEU . 50.8 mm -55.54 -46.02 78.85 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.241 0 CA-C-O 120.727 0.299 . . . . 0.0 110.549 178.649 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 23' ' ' ARG . . . . . . . . . . . . . 53.7 ttp180 -53.36 -49.15 67.74 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-O 120.711 0.291 . . . . 0.0 111.412 179.959 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 24' ' ' ILE . . . . . . . . . . . . . 73.9 mt -58.81 -40.54 80.18 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.306 0 CA-C-N 116.483 -0.326 . . . . 0.0 111.133 -178.345 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 51.4 mttm -70.91 -37.54 72.94 Favored 'General case' 0 C--N 1.329 -0.308 0 N-CA-C 112.511 0.56 . . . . 0.0 112.511 -178.272 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 26' ' ' LEU . . . . . 0.517 HD12 HG22 ' A' ' 22' ' ' ILE . 67.6 mt -78.73 -35.85 44.14 Favored 'General case' 0 C--N 1.33 -0.265 0 N-CA-C 113.199 0.814 . . . . 0.0 113.199 -170.062 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 27' ' ' GLN . . . . . . . . . . . . . 21.2 pt20 -46.57 135.98 8.07 Favored 'General case' 0 N--CA 1.468 0.426 0 N-CA-C 112.822 0.675 . . . . 0.0 112.822 -176.319 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 101.15 -20.69 46.35 Favored Glycine 0 CA--C 1.535 1.294 0 CA-C-N 115.759 -0.655 . . . . 0.0 112.644 -177.84 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 56.5 mtpt -97.12 155.11 16.96 Favored 'General case' 0 C--O 1.233 0.196 0 CA-C-N 117.695 0.747 . . . . 0.0 111.061 178.84 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 30' ' ' THR . . . . . . . . . . . . . 44.5 m -106.96 133.76 51.13 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 115.95 -0.568 . . . . 0.0 109.613 174.356 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 34.7 m -128.81 153.19 38.02 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.241 0 CA-C-O 121.017 0.437 . . . . 0.0 110.961 -177.43 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 32' ' ' ARG . . . . . . . . . . . . . 96.9 mtt180 -132.81 150.92 52.11 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 115.897 -0.592 . . . . 0.0 110.623 179.365 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 33' ' ' THR . . . . . . . . . . . . . 12.5 m -53.03 139.01 29.23 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.232 -0.44 . . . . 0.0 111.295 -178.638 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 100.65 -17.14 56.99 Favored Glycine 0 CA--C 1.532 1.109 0 C-N-CA 121.205 -0.521 . . . . 0.0 113.232 179.275 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 54.4 m-20 -64.48 151.07 45.3 Favored 'General case' 0 C--O 1.232 0.136 0 CA-C-N 118.099 0.949 . . . . 0.0 111.308 -179.621 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 47.5 t -125.04 128.33 72.96 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.258 0 CA-C-N 115.767 -0.651 . . . . 0.0 109.621 178.223 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 37' ' ' ILE . . . . . . . . . . . . . 64.1 mt -123.41 140.43 47.03 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.173 0 CA-C-N 116.29 -0.414 . . . . 0.0 110.039 -178.656 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . -115.07 128.77 8.26 Favored Glycine 0 CA--C 1.526 0.752 0 N-CA-C 110.815 -0.914 . . . . 0.0 110.815 178.179 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 39' ' ' ILE . . . . . . . . . . . . . 74.5 mt -126.42 138.08 55.79 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.221 0 CA-C-O 120.75 0.31 . . . . 0.0 110.205 -179.907 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 40' ' ' SER . . . . . . . . . . . . . 35.1 t -91.51 113.94 26.34 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.616 175.491 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 41' ' ' ILE . . . . . . . . . . . . . 45.3 mm -119.66 119.99 62.08 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.214 0 CA-C-O 120.76 0.314 . . . . 0.0 110.415 -179.852 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 37.3 mt 52.74 35.08 17.62 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.192 -0.458 . . . . 0.0 111.744 177.007 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . 73.25 31.0 61.91 Favored Glycine 0 CA--C 1.529 0.947 0 C-N-CA 121.106 -0.569 . . . . 0.0 112.264 177.976 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 44' ' ' LYS . . . . . . . . . . . . . 21.0 tptp -141.36 130.8 23.79 Favored 'General case' 0 C--N 1.329 -0.315 0 N-CA-C 109.548 -0.538 . . . . 0.0 109.548 178.142 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 82.7 tt0 -81.53 121.62 26.53 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-O 120.883 0.373 . . . . 0.0 111.277 -176.397 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 46' ' ' VAL . . . . . . . . . . . . . 9.0 p -119.61 124.5 73.02 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.175 0 N-CA-C 109.564 -0.532 . . . . 0.0 109.564 175.754 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 97.7 mttt -98.83 128.71 45.11 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 116.09 -0.505 . . . . 0.0 110.843 178.326 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 48' ' ' PHE . . . . . . . . . . . . . 30.1 m-85 -113.63 131.81 55.99 Favored 'General case' 0 C--N 1.33 -0.267 0 N-CA-C 109.86 -0.422 . . . . 0.0 109.86 177.862 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 83.1 tttt -107.24 135.79 48.16 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 116.39 -0.368 . . . . 0.0 110.193 177.629 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 50' ' ' VAL . . . . . . . . . . . . . 43.9 t -79.52 107.64 12.17 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.33 0 N-CA-C 109.682 -0.488 . . . . 0.0 109.682 178.228 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 51' ' ' VAL . . . . . . . . . . . . . 47.5 t -72.51 -51.95 26.07 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.354 0 CA-C-N 115.872 -0.604 . . . . 0.0 109.619 -176.046 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 52' ' ' GLN . . . . . . . . . . . . . 63.0 mt-30 -155.59 147.62 23.44 Favored 'General case' 0 C--N 1.331 -0.225 0 C-N-CA 120.346 -0.541 . . . . 0.0 111.698 -177.672 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -124.38 132.08 53.52 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 115.231 -0.895 . . . . 0.0 109.419 174.512 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 54' ' ' TYR . . . . . . . . . . . . . 38.3 t80 -129.03 110.69 18.34 Favored Pre-proline 0 CA--C 1.535 0.368 0 CA-C-O 118.181 -0.914 . . . . 0.0 110.353 179.836 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 55' ' ' PRO . . . . . . . . . . . . . 73.8 Cg_endo -77.15 170.01 72.71 Favored 'Cis proline' 0 N--CA 1.501 1.914 0 CA-C-N 121.947 1.731 . . . . 0.0 112.335 -6.405 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 56' ' ' SER . . . . . . . . . . . . . 13.6 m -117.48 132.73 23.43 Favored Pre-proline 0 CA--C 1.539 0.555 0 CA-C-O 118.476 -0.773 . . . . 0.0 109.487 175.185 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 57' ' ' PRO . . . . . . . . . . . . . 43.5 Cg_endo -69.53 148.59 86.52 Favored 'Cis proline' 0 N--CA 1.498 1.785 0 CA-C-N 121.823 1.687 . . . . 0.0 111.348 -2.082 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 58' ' ' LEU . . . . . . . . . . . . . 19.0 tp -107.65 135.83 48.44 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.327 -0.397 . . . . 0.0 110.591 -178.168 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 59' ' ' ARG . . . . . . . . . . . . . 23.0 ttm180 -102.83 123.54 46.68 Favored 'General case' 0 C--N 1.327 -0.4 0 N-CA-C 109.293 -0.632 . . . . 0.0 109.293 175.751 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 40.5 t -82.14 119.8 32.38 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.359 0 CA-C-O 120.933 0.396 . . . . 0.0 110.807 -174.067 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 95.6 mt-10 -130.98 165.33 23.41 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 115.817 -0.629 . . . . 0.0 109.417 175.12 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 62' ' ' ASP . . . . . . . . . . . . . 64.1 m-20 -52.37 -32.01 36.44 Favored 'General case' 0 C--N 1.328 -0.332 0 N-CA-C 111.948 0.351 . . . . 0.0 111.948 -178.548 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 63' ' ' ARG . . . . . . . . . . . . . 74.4 mtt180 -73.41 -21.96 60.35 Favored 'General case' 0 CA--C 1.533 0.291 0 N-CA-C 112.84 0.682 . . . . 0.0 112.84 -175.719 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 30.6 m -69.52 134.58 49.04 Favored 'General case' 0 C--N 1.331 -0.208 0 CA-C-O 120.787 0.327 . . . . 0.0 110.952 -175.823 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 65' ' ' LYS . . . . . . . . . . . . . 57.6 mtmt -90.55 133.77 34.85 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.52 179.206 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 66' ' ' ILE . . . . . . . . . . . . . 65.4 mt -117.12 131.14 70.7 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.234 0 N-CA-C 109.995 -0.372 . . . . 0.0 109.995 -179.84 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 67' ' ' THR . . . . . . . . . . . . . 31.6 m -127.19 143.55 51.23 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.876 -178.645 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 68' ' ' LEU . . . . . . . . . . . . . 15.4 tp . . . . . 0 C--N 1.33 -0.243 0 CA-C-N 116.119 -0.491 . . . . 0.0 110.127 177.596 . . . . . . . . 0 0 . 1 . 004 nuclear build core ' A' A ' 74' ' ' ASP . . . . . . . . . . . . . 7.1 t70 . . . . . 0 N--CA 1.457 -0.109 0 N-CA-C 109.806 -0.442 . . . . 0.0 109.806 . . . . . . . . . 0 0 . 1 . 004 nuclear build core ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 42.7 t -113.94 125.04 71.15 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.268 0 CA-C-O 121.154 0.502 . . . . 0.0 110.508 -177.424 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 76' ' ' LEU . . . . . . . . . . . . . 37.7 mt -125.77 140.08 52.98 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 115.578 -0.737 . . . . 0.0 109.73 177.787 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 77' ' ' GLU . . . . . . . . . . . . . 45.9 mt-10 -132.75 136.41 46.34 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-O 120.983 0.42 . . . . 0.0 111.193 -178.751 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 78' ' ' ALA . . . . . . . . . . . . . . . -124.92 136.96 54.25 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-N 115.76 -0.654 . . . . 0.0 110.01 177.128 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 79' ' ' LYS . . . . . 0.511 ' O ' HD13 ' A' ' 80' ' ' ILE . 74.6 mmtt -78.86 119.55 22.22 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-O 120.808 0.337 . . . . 0.0 110.516 -178.54 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 80' ' ' ILE . . . . . 0.511 HD13 ' O ' ' A' ' 79' ' ' LYS . 24.2 mm -139.27 113.33 7.05 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.267 0 N-CA-C 109.303 -0.629 . . . . 0.0 109.303 -177.237 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 81' ' ' LYS . . . . . . . . . . . . . 38.5 ttpt -105.86 124.24 49.26 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-O 120.855 0.36 . . . . 0.0 111.226 -177.809 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . 89.12 42.16 5.67 Favored Glycine 0 CA--C 1.525 0.663 0 C-N-CA 120.758 -0.734 . . . . 0.0 111.886 173.655 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 83' ' ' ILE . . . . . . . . . . . . . 72.1 mt -65.64 132.79 31.26 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 CA-C-O 120.973 0.416 . . . . 0.0 110.019 178.185 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 84' ' ' LYS . . . . . . . . . . . . . 30.3 ttmt -91.87 -50.67 5.6 Favored 'General case' 0 C--N 1.331 -0.204 0 CA-C-N 116.067 -0.515 . . . . 0.0 109.883 179.493 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 85' ' ' ASP . . . . . . . . . . . . . 5.7 t70 -159.75 157.0 28.6 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 115.715 -0.675 . . . . 0.0 110.474 179.73 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 86' ' ' VAL . . . . . . . . . . . . . 42.1 t -127.86 132.46 68.78 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.221 0 CA-C-O 121.049 0.452 . . . . 0.0 110.457 -179.038 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 87' ' ' ILE . . . . . . . . . . . . . 43.2 mm -119.64 124.4 72.82 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.216 0 CA-C-N 115.863 -0.608 . . . . 0.0 109.731 177.463 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 88' ' ' LEU . . . . . . . . . . . . . 50.5 mt -108.42 136.68 47.64 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-O 120.986 0.422 . . . . 0.0 111.286 -178.521 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 89' ' ' ASP . . . . . . . . . . . . . 6.5 t70 -130.41 155.36 46.53 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 115.72 -0.673 . . . . 0.0 109.546 176.177 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 96.2 mt-10 -47.29 -36.66 9.51 Favored 'General case' 0 C--N 1.33 -0.253 0 N-CA-C 113.099 0.777 . . . . 0.0 113.099 -172.148 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 91' ' ' ASN . . . . . . . . . . . . . 35.9 t30 -132.1 21.24 4.48 Favored 'General case' 0 N--CA 1.467 0.417 0 N-CA-C 112.95 0.722 . . . . 0.0 112.95 -177.429 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 92' ' ' LEU . . . . . . . . . . . . . 20.2 mt -151.25 150.43 30.56 Favored 'General case' 0 C--N 1.333 -0.152 0 N-CA-C 110.138 -0.319 . . . . 0.0 110.138 -176.597 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 93' ' ' ILE . . . . . . . . . . . . . 76.2 mt -129.09 120.41 51.57 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.186 0 N-CA-C 109.325 -0.62 . . . . 0.0 109.325 176.159 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 94' ' ' VAL . . . . . . . . . . . . . 43.2 t -118.02 127.01 75.3 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.282 0 N-CA-C 109.68 -0.489 . . . . 0.0 109.68 -179.863 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 95' ' ' VAL . . . . . . . . . . . . . 42.8 t -120.78 135.08 62.11 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.36 0 CA-C-N 116.171 -0.468 . . . . 0.0 109.819 -179.258 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 96' ' ' ILE . . . . . . . . . . . . . 58.6 mt -113.99 128.23 71.03 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.338 0 N-CA-C 109.258 -0.645 . . . . 0.0 109.258 179.594 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 97' ' ' THR . . . . . . . . . . . . . 70.6 p -99.67 154.12 18.54 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-O 120.856 0.36 . . . . 0.0 110.686 -179.09 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 98' ' ' GLU . . . . . . . . . . . . . 96.0 mt-10 -54.76 -23.21 16.86 Favored 'General case' 0 CA--C 1.533 0.319 0 N-CA-C 112.451 0.537 . . . . 0.0 112.451 -179.701 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 99' ' ' GLU . . . . . . . . . . . . . 43.0 mt-10 -79.6 16.14 1.16 Allowed 'General case' 0 CA--C 1.535 0.379 0 N-CA-C 113.05 0.759 . . . . 0.0 113.05 -179.458 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 100' ' ' ASN . . . . . . . . . . . . . 3.6 m-20 63.57 37.97 9.97 Favored 'General case' 0 CA--C 1.529 0.144 0 CA-C-O 121.05 0.452 . . . . 0.0 110.967 177.694 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 101' ' ' GLU . . . . . . . . . . . . . 83.0 tt0 -114.38 142.36 46.45 Favored 'General case' 0 C--N 1.332 -0.162 0 CA-C-N 116.118 -0.492 . . . . 0.0 109.731 176.618 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 102' ' ' VAL . . . . . . . . . . . . . 43.6 t -115.14 123.72 71.04 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 N-CA-C 109.693 -0.484 . . . . 0.0 109.693 -179.731 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 103' ' ' LEU . . . . . . . . . . . . . 36.4 mt -116.57 130.6 56.84 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 115.877 -0.601 . . . . 0.0 110.05 178.294 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 104' ' ' ILE . . . . . 0.595 HD13 HG11 ' A' ' 130' ' ' VAL . 65.5 mt -115.35 118.95 60.41 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.324 0 N-CA-C 109.934 -0.395 . . . . 0.0 109.934 -179.591 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 105' ' ' PHE . . . . . . . . . . . . . 96.9 m-85 -118.29 162.86 17.57 Favored 'General case' 0 C--O 1.233 0.192 0 O-C-N 124.061 0.851 . . . . 0.0 110.079 -178.643 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 106' ' ' ASN . . . . . . . . . . . . . 53.2 p-10 -96.36 -169.95 2.0 Favored 'General case' 0 C--N 1.329 -0.285 0 N-CA-C 109.297 -0.631 . . . . 0.0 109.297 170.664 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 107' ' ' GLN . . . . . . . . . . . . . 44.1 tt0 -57.82 -27.53 63.25 Favored 'General case' 0 C--N 1.328 -0.335 0 N-CA-C 112.405 0.52 . . . . 0.0 112.405 -178.067 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 108' ' ' ASN . . . . . . . . . . . . . 19.6 t30 -94.63 14.25 21.65 Favored 'General case' 0 CA--C 1.534 0.333 0 N-CA-C 113.033 0.753 . . . . 0.0 113.033 -175.149 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 109' ' ' LEU . . . . . . . . . . . . . 91.4 mt 60.4 34.65 20.6 Favored 'General case' 0 CA--C 1.529 0.162 0 CA-C-O 120.756 0.312 . . . . 0.0 111.679 178.169 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 110' ' ' GLU . . . . . . . . . . . . . 96.2 mt-10 -101.47 141.16 34.75 Favored 'General case' 0 C--N 1.33 -0.265 0 N-CA-C 109.717 -0.475 . . . . 0.0 109.717 175.973 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 111' ' ' GLU . . . . . . . . . . . . . 96.4 mt-10 -73.13 121.86 20.91 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-O 120.945 0.402 . . . . 0.0 111.242 -176.719 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 112' ' ' LEU . . . . . . . . . . . . . 17.3 mt -103.43 -45.04 4.98 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 115.861 -0.608 . . . . 0.0 109.737 173.718 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 113' ' ' TYR . . . . . 0.432 ' HB3' HD12 ' A' ' 104' ' ' ILE . 61.8 t80 -142.03 142.48 32.89 Favored 'General case' 0 C--N 1.331 -0.224 0 CA-C-N 115.8 -0.636 . . . . 0.0 110.158 178.251 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 114' ' ' ARG . . . . . . . . . . . . . 33.6 ptt180 -150.65 123.59 8.71 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-O 120.957 0.408 . . . . 0.0 110.966 178.699 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 115' ' ' GLY . . . . . . . . . . . . . . . -150.2 163.03 29.4 Favored Glycine 0 CA--C 1.524 0.624 0 N-CA-C 110.664 -0.974 . . . . 0.0 110.664 -179.385 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 116' ' ' LYS . . . . . . . . . . . . . 29.8 ttmt -127.51 136.23 51.46 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-O 120.883 0.373 . . . . 0.0 110.185 178.604 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 117' ' ' PHE . . . . . . . . . . . . . 43.0 m-85 -131.44 115.15 15.81 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.12 -0.491 . . . . 0.0 110.161 -177.051 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 118' ' ' GLU . . . . . . . . . . . . . 96.2 mt-10 -54.0 -42.08 68.65 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.564 -0.289 . . . . 0.0 111.356 -176.895 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 119' ' ' ASN . . . . . . . . . . . . . 33.6 m120 -99.75 31.02 3.38 Favored 'General case' 0 CA--C 1.531 0.215 0 N-CA-C 112.132 0.419 . . . . 0.0 112.132 -174.809 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 120' ' ' LEU . . . . . . . . . . . . . 13.4 tp -56.83 121.19 9.28 Favored 'General case' 0 C--N 1.332 -0.177 0 CA-C-O 120.756 0.312 . . . . 0.0 110.562 178.41 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 121' ' ' ASN . . . . . . . . . . . . . 6.2 m120 -113.97 -44.01 3.2 Favored 'General case' 0 C--N 1.331 -0.204 0 CA-C-N 116.324 -0.398 . . . . 0.0 110.876 -178.981 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 122' ' ' LYS . . . . . . . . . . . . . 63.9 mtpt -139.68 144.54 37.64 Favored 'General case' 0 C--N 1.331 -0.211 0 CA-C-O 120.972 0.415 . . . . 0.0 111.631 -175.989 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 123' ' ' VAL . . . . . . . . . . . . . 45.2 t -131.36 122.52 51.02 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.305 0 N-CA-C 109.126 -0.694 . . . . 0.0 109.126 172.788 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 124' ' ' LEU . . . . . . . . . . . . . 14.3 tp -127.87 136.04 50.85 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-O 120.82 0.343 . . . . 0.0 110.813 -176.057 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 125' ' ' VAL . . . . . . . . . . . . . 12.6 p -134.03 137.01 52.88 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.205 0 CA-C-N 116.288 -0.414 . . . . 0.0 110.412 178.938 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 126' ' ' ARG . . . . . . . . . . . . . 26.3 mmt180 -141.77 124.99 16.39 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.118 -0.492 . . . . 0.0 110.368 179.43 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 127' ' ' ASN . . . . . . . . . . . . . 81.8 m-20 51.87 -105.02 0.2 Allowed 'General case' 0 CA--C 1.543 0.691 0 CA-C-N 115.982 -0.554 . . . . 0.0 111.356 178.949 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 128' ' ' ASP . . . . . . . . . . . . . 10.3 p-10 -114.21 0.45 14.22 Favored 'General case' 0 N--CA 1.466 0.368 0 CA-C-N 119.506 1.048 . . . . 0.0 113.656 -175.77 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 129' ' ' LEU . . . . . . . . . . . . . 47.4 mt -111.85 145.71 38.99 Favored 'General case' 0 C--O 1.231 0.117 0 CA-C-N 118.166 0.439 . . . . 0.0 110.344 -179.417 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 130' ' ' VAL . . . . . 0.595 HG11 HD13 ' A' ' 104' ' ' ILE . 12.5 p -134.16 141.21 44.38 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.217 0 CA-C-O 121.15 0.5 . . . . 0.0 110.559 -179.843 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 131' ' ' VAL . . . . . . . . . . . . . 44.3 t -135.84 139.6 45.78 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.271 0 CA-C-N 115.985 -0.552 . . . . 0.0 110.109 -179.784 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 132' ' ' ILE . . . . . . . . . . . . . 74.4 mt -118.65 133.42 65.54 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.268 0 CA-C-N 115.708 -0.678 . . . . 0.0 109.49 179.883 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 133' ' ' ILE . . . . . . . . . . . . . 38.1 mm -116.2 121.37 67.35 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.256 0 CA-C-N 116.39 -0.368 . . . . 0.0 110.78 -175.156 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 134' ' ' ASP . . . . . . . . . . . . . 8.4 p-10 -131.94 147.93 52.49 Favored 'General case' 0 C--N 1.332 -0.183 0 N-CA-C 109.871 -0.418 . . . . 0.0 109.871 175.33 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 135' ' ' GLU . . . . . . . . . . . . . 78.8 tt0 -49.86 -26.64 4.22 Favored 'General case' 0 C--N 1.328 -0.336 0 N-CA-C 113.02 0.748 . . . . 0.0 113.02 -172.742 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 136' ' ' GLN . . . . . . . . . . . . . 98.5 mt-30 -85.43 -32.04 22.54 Favored 'General case' 0 C--O 1.234 0.243 0 N-CA-C 112.425 0.528 . . . . 0.0 112.425 -175.428 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 137' ' ' LYS . . . . . . . . . . . . . 48.3 pttt -168.31 173.24 7.86 Favored 'General case' 0 C--N 1.332 -0.161 0 CA-C-O 121.646 0.736 . . . . 0.0 112.417 -173.226 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 138' ' ' LEU . . . . . 0.459 HD23 ' N ' ' A' ' 139' ' ' THR . 3.6 tt -115.7 129.11 56.35 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 114.831 -1.077 . . . . 0.0 109.996 -179.572 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 139' ' ' THR . . . . . 0.459 ' N ' HD23 ' A' ' 138' ' ' LEU . 39.0 m -110.67 123.51 50.16 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 116.221 -0.445 . . . . 0.0 110.223 179.358 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 140' ' ' LEU . . . . . 0.477 HD23 ' C ' ' A' ' 140' ' ' LEU . 6.1 tt -113.28 122.33 47.09 Favored 'General case' 0 C--N 1.328 -0.351 0 N-CA-C 109.567 -0.531 . . . . 0.0 109.567 -178.961 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 141' ' ' ILE . . . . . 0.542 ' HB ' HG13 ' A' ' 130' ' ' VAL . 19.6 mt -121.67 118.5 55.98 Favored 'Isoleucine or valine' 0 C--O 1.235 0.303 0 CA-C-O 121.104 0.478 . . . . 0.0 109.899 -175.938 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 142' ' ' ARG . . . . . . . . . . . . . 58.9 ttt180 -108.31 132.28 53.87 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 115.298 -0.864 . . . . 0.0 110.734 -177.198 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 143' ' ' THR . . . . . . . . . . . . . 56.0 p . . . . . 0 C--O 1.22 -0.483 0 CA-C-O 118.026 -0.988 . . . . 0.0 110.601 178.934 . . . . . . . . 0 0 . 1 . 004 nuclear build core ' B' B ' 2' ' ' SER . . . . . . . . . . . . . 6.7 p . . . . . 0 N--CA 1.462 0.171 0 CA-C-O 121.072 0.463 . . . . 0.0 110.88 . . . . . . . . . 0 0 . 1 . 004 nuclear build core ' B' B ' 3' ' ' GLU . . . . . . . . . . . . . 95.5 mt-10 -141.15 141.56 34.14 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 115.79 -0.641 . . . . 0.0 110.897 -179.226 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B ' 4' ' ' LEU . . . . . . . . . . . . . 18.8 tp -127.15 128.33 45.99 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 115.955 -0.566 . . . . 0.0 110.12 177.056 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B ' 5' ' ' LYS . . . . . . . . . . . . . 83.1 mttt -104.93 119.62 39.45 Favored 'General case' 0 C--O 1.234 0.267 0 CA-C-N 116.084 -0.507 . . . . 0.0 110.462 178.828 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B ' 6' ' ' LEU . . . . . . . . . . . . . 45.1 mt -116.57 144.38 44.44 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 115.458 -0.792 . . . . 0.0 110.313 -178.967 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B ' 7' ' ' LYS . . . . . . . . . . . . . 82.9 tttt -133.05 138.36 31.59 Favored Pre-proline 0 CA--C 1.534 0.328 0 CA-C-O 119.007 -0.521 . . . . 0.0 109.988 177.247 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B ' 8' ' ' PRO . . . . . . . . . . . . . 89.7 Cg_endo -92.09 144.19 2.78 Favored 'Trans proline' 0 N--CA 1.489 1.223 0 C-N-CA 121.717 1.611 . . . . 0.0 111.97 178.155 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B ' 9' ' ' LEU . . . . . . . . . . . . . 62.4 mt -81.09 -47.65 1.11 Allowed Pre-proline 0 CA--C 1.534 0.36 0 CA-C-O 118.637 -0.697 . . . . 0.0 112.319 -179.946 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B ' 10' ' ' PRO . . . . . . . . . . . . . 86.8 Cg_endo -80.3 151.43 20.36 Favored 'Trans proline' 0 N--CA 1.496 1.656 0 C-N-CA 121.125 1.217 . . . . 0.0 111.888 176.999 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B ' 11' ' ' LYS . . . . . . . . . . . . . 96.5 mttt -87.47 96.98 10.58 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.432 -0.349 . . . . 0.0 110.492 178.79 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B ' 12' ' ' VAL . . . . . . . . . . . . . 12.6 p -142.06 147.07 21.9 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.328 0 CA-C-N 116.237 -0.438 . . . . 0.0 110.5 -179.932 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B ' 13' ' ' GLU . . . . . . . . . . . . . 84.4 tt0 -84.92 127.9 34.37 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.253 -0.43 . . . . 0.0 110.055 178.069 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B ' 14' ' ' LEU . . . . . . . . . . . . . 36.5 mt -96.41 149.96 36.51 Favored Pre-proline 0 CA--C 1.533 0.309 0 CA-C-O 119.311 -0.376 . . . . 0.0 110.713 -177.154 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B ' 15' ' ' PRO . . . . . . . . . . . . . 27.8 Cg_exo -60.99 158.39 34.27 Favored 'Trans proline' 0 N--CA 1.499 1.797 0 C-N-CA 121.269 1.313 . . . . 0.0 111.964 178.272 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B ' 16' ' ' PRO . . . . . . . . . . . . . 35.7 Cg_exo -59.09 -41.02 64.85 Favored 'Trans proline' 0 N--CA 1.497 1.692 0 C-N-CA 121.439 1.426 . . . . 0.0 112.714 -179.218 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B ' 17' ' ' ASP . . . . . . . . . . . . . 15.8 p-10 -84.73 11.59 8.79 Favored 'General case' 0 CA--C 1.535 0.388 0 N-CA-C 113.155 0.798 . . . . 0.0 113.155 -178.183 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B ' 18' ' ' PHE . . . . . . . . . . . . . 44.9 t80 -57.6 -45.73 84.94 Favored 'General case' 0 C--N 1.335 -0.064 0 O-C-N 121.949 -0.47 . . . . 0.0 110.305 -177.833 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B ' 19' ' ' VAL . . . . . 0.413 HG13 ' N ' ' B' ' 20' ' ' ASP . 15.0 p -55.88 -42.21 69.98 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.326 0 CA-C-N 116.475 -0.329 . . . . 0.0 111.075 -177.599 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' B' B ' 20' ' ' ASP . . . . . 0.413 ' N ' HG13 ' B' ' 19' ' ' VAL . 32.8 m-20 -60.76 -42.85 98.27 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-O 120.9 0.381 . . . . 0.0 110.923 -178.397 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' B' B ' 21' ' ' VAL . . . . . . . . . . . . . 46.9 t -63.8 -45.41 97.25 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.264 0 C-N-CA 120.735 -0.386 . . . . 0.0 110.4 -178.52 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B ' 22' ' ' ILE . . . . . 0.566 HG22 HD12 ' B' ' 26' ' ' LEU . 50.7 mm -55.7 -47.13 79.57 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.262 0 C-N-CA 121.001 -0.28 . . . . 0.0 110.592 178.366 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' B' B ' 23' ' ' ARG . . . . . . . . . . . . . 47.0 ttp180 -53.41 -51.66 61.87 Favored 'General case' 0 C--N 1.329 -0.292 0 C-N-CA 121.13 -0.228 . . . . 0.0 111.534 -178.615 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B ' 24' ' ' ILE . . . . . . . . . . . . . 71.9 mt -59.52 -44.24 92.56 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.319 0 C-N-CA 121.112 -0.235 . . . . 0.0 111.163 -177.293 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B ' 25' ' ' LYS . . . . . . . . . . . . . 8.7 mtpm? -64.94 -40.1 94.51 Favored 'General case' 0 C--N 1.328 -0.357 0 N-CA-C 112.178 0.436 . . . . 0.0 112.178 -176.946 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B ' 26' ' ' LEU . . . . . 0.566 HD12 HG22 ' B' ' 22' ' ' ILE . 74.6 mt -80.09 -43.41 21.8 Favored 'General case' 0 C--N 1.33 -0.276 0 N-CA-C 112.945 0.72 . . . . 0.0 112.945 -172.106 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' B' B ' 27' ' ' GLN . . . . . . . . . . . . . 15.4 pt20 -46.39 137.67 6.27 Favored 'General case' 0 N--CA 1.469 0.487 0 N-CA-C 112.81 0.67 . . . . 0.0 112.81 -174.996 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B ' 28' ' ' GLY . . . . . . . . . . . . . . . 100.85 -26.31 25.11 Favored Glycine 0 CA--C 1.533 1.196 0 CA-C-N 115.518 -0.765 . . . . 0.0 112.216 -176.575 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B ' 29' ' ' LYS . . . . . . . . . . . . . 35.2 mmtp -97.79 155.08 17.2 Favored 'General case' 0 C--N 1.332 -0.159 0 CA-C-N 117.251 0.526 . . . . 0.0 111.012 179.28 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B ' 30' ' ' THR . . . . . . . . . . . . . 43.5 m -108.01 134.4 50.97 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 115.934 -0.576 . . . . 0.0 109.869 175.202 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B ' 31' ' ' VAL . . . . . . . . . . . . . 34.5 m -129.39 155.56 41.31 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.251 0 CA-C-O 120.9 0.381 . . . . 0.0 111.049 -177.363 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B ' 32' ' ' ARG . . . . . . . . . . . . . 92.5 mtt180 -129.9 152.9 48.87 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-O 121.291 0.567 . . . . 0.0 110.604 179.16 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B ' 33' ' ' THR . . . . . . . . . . . . . 18.2 m -52.82 139.02 28.03 Favored 'General case' 0 C--N 1.331 -0.225 0 CA-C-N 116.228 -0.442 . . . . 0.0 111.39 -179.001 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B ' 34' ' ' GLY . . . . . . . . . . . . . . . 100.31 -17.12 57.34 Favored Glycine 0 CA--C 1.533 1.172 0 C-N-CA 121.219 -0.515 . . . . 0.0 113.224 179.346 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B ' 35' ' ' ASP . . . . . . . . . . . . . 56.1 m-20 -66.04 150.5 48.59 Favored 'General case' 0 C--O 1.23 0.041 0 CA-C-N 118.043 0.922 . . . . 0.0 111.055 179.443 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B ' 36' ' ' VAL . . . . . . . . . . . . . 46.5 t -123.06 129.72 74.86 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.207 0 CA-C-N 115.748 -0.66 . . . . 0.0 109.677 178.39 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B ' 37' ' ' ILE . . . . . . . . . . . . . 64.8 mt -120.1 138.34 50.98 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.297 0 N-CA-C 109.755 -0.461 . . . . 0.0 109.755 179.816 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B ' 38' ' ' GLY . . . . . . . . . . . . . . . -112.36 128.86 8.71 Favored Glycine 0 CA--C 1.525 0.716 0 N-CA-C 110.731 -0.948 . . . . 0.0 110.731 179.552 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B ' 39' ' ' ILE . . . . . . . . . . . . . 73.4 mt -121.12 136.18 58.91 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.277 0 N-CA-C 110.043 -0.354 . . . . 0.0 110.043 179.831 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B ' 40' ' ' SER . . . . . 0.527 ' O ' HD13 ' B' ' 41' ' ' ILE . 74.6 p -91.65 116.16 28.64 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.246 -0.434 . . . . 0.0 110.78 176.185 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' B' B ' 41' ' ' ILE . . . . . 0.527 HD13 ' O ' ' B' ' 40' ' ' SER . 48.1 mm -128.74 118.13 46.42 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.165 0 N-CA-C 110.063 -0.347 . . . . 0.0 110.063 178.711 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' B' B ' 42' ' ' LEU . . . . . . . . . . . . . 38.7 mt 58.1 34.53 24.29 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.212 -0.449 . . . . 0.0 111.52 179.325 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B ' 43' ' ' GLY . . . . . . . . . . . . . . . 77.47 -10.14 24.54 Favored Glycine 0 CA--C 1.535 1.286 0 C-N-CA 121.315 -0.469 . . . . 0.0 113.424 178.047 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B ' 44' ' ' LYS . . . . . . . . . . . . . 47.7 mtmt -98.85 137.47 37.38 Favored 'General case' 0 C--N 1.333 -0.144 0 CA-C-N 117.897 0.848 . . . . 0.0 110.198 177.965 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B ' 45' ' ' GLU . . . . . . . . . . . . . 83.8 tt0 -84.46 128.18 34.44 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.293 -0.412 . . . . 0.0 111.287 -179.409 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B ' 46' ' ' VAL . . . . . . . . . . . . . 7.2 p -120.61 129.14 75.93 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.197 0 N-CA-C 109.508 -0.553 . . . . 0.0 109.508 175.465 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B ' 47' ' ' LYS . . . . . . . . . . . . . 98.8 mttt -99.4 128.32 45.51 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.009 -0.541 . . . . 0.0 111.007 179.001 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B ' 48' ' ' PHE . . . . . . . . . . . . . 93.2 m-85 -113.08 131.85 55.65 Favored 'General case' 0 C--N 1.331 -0.232 0 N-CA-C 109.67 -0.493 . . . . 0.0 109.67 175.041 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B ' 49' ' ' LYS . . . . . . . . . . . . . 79.2 tttt -106.98 136.14 47.35 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.304 -0.407 . . . . 0.0 110.426 -179.777 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B ' 50' ' ' VAL . . . . . . . . . . . . . 42.2 t -80.08 106.99 11.99 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 N-CA-C 109.433 -0.58 . . . . 0.0 109.433 176.799 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B ' 51' ' ' VAL . . . . . . . . . . . . . 46.7 t -75.15 -48.21 32.83 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.286 0 CA-C-N 116.064 -0.516 . . . . 0.0 110.077 -174.044 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B ' 52' ' ' GLN . . . . . . . . . . . . . 62.6 tt0 -159.46 137.05 9.96 Favored 'General case' 0 C--N 1.33 -0.251 0 C-N-CA 120.475 -0.49 . . . . 0.0 111.397 -177.692 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B ' 53' ' ' ALA . . . . . 0.484 ' HB1' ' HB2' ' B' ' 58' ' ' LEU . . . -114.23 130.76 56.63 Favored 'General case' 0 C--N 1.331 -0.23 0 CA-C-N 115.783 -0.644 . . . . 0.0 109.755 174.561 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' B' B ' 54' ' ' TYR . . . . . . . . . . . . . 30.2 t80 -129.08 110.76 18.29 Favored Pre-proline 0 CA--C 1.535 0.399 0 CA-C-O 118.334 -0.841 . . . . 0.0 110.329 179.495 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B ' 55' ' ' PRO . . . . . . . . . . . . . 73.9 Cg_endo -77.11 170.08 72.56 Favored 'Cis proline' 0 N--CA 1.499 1.823 0 CA-C-N 121.918 1.721 . . . . 0.0 112.44 -4.554 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B ' 56' ' ' SER . . . . . . . . . . . . . 13.7 m -116.18 129.46 25.2 Favored Pre-proline 0 CA--C 1.539 0.548 0 CA-C-O 118.347 -0.835 . . . . 0.0 109.37 175.96 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B ' 57' ' ' PRO . . . . . . . . . . . . . 50.8 Cg_endo -69.99 148.18 86.7 Favored 'Cis proline' 0 N--CA 1.497 1.735 0 CA-C-N 122.053 1.769 . . . . 0.0 111.561 -0.771 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B ' 58' ' ' LEU . . . . . 0.484 ' HB2' ' HB1' ' B' ' 53' ' ' ALA . 22.4 tp -106.48 135.44 47.97 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-O 120.851 0.357 . . . . 0.0 110.454 -178.994 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' B' B ' 59' ' ' ARG . . . . . . . . . . . . . 52.9 ttp180 -105.82 121.85 44.9 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-N 115.873 -0.603 . . . . 0.0 109.377 177.307 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B ' 60' ' ' VAL . . . . . . . . . . . . . 42.6 t -79.09 122.92 35.31 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.287 0 C-N-CA 120.807 -0.357 . . . . 0.0 110.591 -173.848 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B ' 61' ' ' GLU . . . . . . . . . . . . . 95.5 mt-10 -131.03 165.62 22.8 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.021 -0.536 . . . . 0.0 110.149 178.195 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B ' 62' ' ' ASP . . . . . . . . . . . . . 14.9 p-10 -55.87 -32.59 63.8 Favored 'General case' 0 C--N 1.329 -0.324 0 N-CA-C 111.781 0.289 . . . . 0.0 111.781 -179.147 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B ' 63' ' ' ARG . . . . . . . . . . . . . 11.0 ptm180 -86.41 4.58 38.87 Favored 'General case' 0 CA--C 1.537 0.47 0 N-CA-C 113.527 0.936 . . . . 0.0 113.527 -176.15 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B ' 64' ' ' THR . . . . . . . . . . . . . 31.5 m -83.54 137.86 33.66 Favored 'General case' 0 C--N 1.332 -0.166 0 CA-C-N 118.231 0.469 . . . . 0.0 110.443 -178.22 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B ' 65' ' ' LYS . . . . . . . . . . . . . 67.7 mttm -88.24 123.72 33.15 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.219 -179.911 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B ' 66' ' ' ILE . . . . . . . . . . . . . 62.6 mt -111.94 126.59 69.35 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.283 0 N-CA-C 109.574 -0.528 . . . . 0.0 109.574 179.63 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B ' 67' ' ' THR . . . . . . . . . . . . . 18.4 m -122.08 139.32 53.86 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 116.176 -0.465 . . . . 0.0 110.908 -177.119 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B ' 68' ' ' LEU . . . . . . . . . . . . . 15.7 tp . . . . . 0 C--N 1.329 -0.304 0 CA-C-N 115.841 -0.618 . . . . 0.0 110.236 178.624 . . . . . . . . 0 0 . 1 . 004 nuclear build core ' B' B ' 73' ' ' VAL . . . . . . . . . . . . . 34.2 m . . . . . 0 C--O 1.232 0.162 0 CA-C-O 120.836 0.35 . . . . 0.0 110.703 . . . . . . . . . 0 0 . 1 . 004 nuclear build core ' B' B ' 74' ' ' ASP . . . . . . . . . . . . . 13.8 t0 -99.53 123.52 43.87 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.152 -0.476 . . . . 0.0 110.051 -179.444 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B ' 75' ' ' VAL . . . . . . . . . . . . . 41.5 t -115.24 123.89 71.28 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.261 0 CA-C-O 120.905 0.383 . . . . 0.0 110.617 -177.788 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B ' 76' ' ' LEU . . . . . . . . . . . . . 4.4 mp -124.84 144.99 50.01 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 115.934 -0.576 . . . . 0.0 109.697 176.261 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B ' 77' ' ' GLU . . . . . . . . . . . . . 97.4 mt-10 -134.96 138.53 44.13 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-O 121.0 0.429 . . . . 0.0 111.243 -178.068 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B ' 78' ' ' ALA . . . . . . . . . . . . . . . -125.76 130.5 51.61 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 115.697 -0.683 . . . . 0.0 109.674 176.229 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B ' 79' ' ' LYS . . . . . 0.597 ' O ' HD13 ' B' ' 80' ' ' ILE . 62.1 mtpt -79.02 119.44 22.17 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-O 120.865 0.364 . . . . 0.0 110.898 -177.481 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' B' B ' 80' ' ' ILE . . . . . 0.597 HD13 ' O ' ' B' ' 79' ' ' LYS . 41.6 mm -139.19 109.31 4.2 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.311 0 N-CA-C 109.138 -0.69 . . . . 0.0 109.138 -177.721 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' B' B ' 81' ' ' LYS . . . . . . . . . . . . . 60.6 tttm -101.81 126.55 48.71 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-O 120.842 0.353 . . . . 0.0 111.223 -176.642 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B ' 82' ' ' GLY . . . . . . . . . . . . . . . 89.2 42.11 5.66 Favored Glycine 0 CA--C 1.527 0.784 0 C-N-CA 120.885 -0.674 . . . . 0.0 112.017 174.193 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B ' 83' ' ' ILE . . . . . . . . . . . . . 72.5 mt -70.13 136.34 26.29 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.269 0 N-CA-C 109.676 -0.49 . . . . 0.0 109.676 176.407 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B ' 84' ' ' LYS . . . . . . . . . . . . . 19.7 ttpp -101.0 -50.14 3.9 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-O 120.9 0.381 . . . . 0.0 110.461 -178.176 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B ' 85' ' ' ASP . . . . . . . . . . . . . 10.8 t70 -147.1 148.13 31.29 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 115.987 -0.551 . . . . 0.0 110.348 -179.729 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B ' 86' ' ' VAL . . . . . . . . . . . . . 42.2 t -130.71 132.62 64.12 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.232 0 CA-C-O 121.05 0.452 . . . . 0.0 110.578 -178.365 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B ' 87' ' ' ILE . . . . . 0.5 ' N ' HD12 ' B' ' 87' ' ' ILE . 5.1 mp -122.62 123.02 67.47 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.217 0 N-CA-C 109.208 -0.664 . . . . 0.0 109.208 176.102 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' B' B ' 88' ' ' LEU . . . . . . . . . . . . . 33.8 mt -111.66 136.29 51.08 Favored 'General case' 0 C--N 1.332 -0.182 0 CA-C-O 121.223 0.535 . . . . 0.0 111.352 -176.129 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B ' 89' ' ' ASP . . . . . . . . . . . . . 11.3 t70 -129.19 146.25 51.15 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 115.511 -0.768 . . . . 0.0 109.296 175.333 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B ' 90' ' ' GLU . . . . . . . . . . . . . 12.8 pt-20 -51.09 -28.8 11.42 Favored 'General case' 0 C--N 1.328 -0.347 0 N-CA-C 112.522 0.564 . . . . 0.0 112.522 -174.017 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B ' 91' ' ' ASN . . . . . . . . . . . . . 92.1 m-20 -127.26 22.67 6.54 Favored 'General case' 0 N--CA 1.469 0.486 0 N-CA-C 112.8 0.667 . . . . 0.0 112.8 -176.558 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B ' 92' ' ' LEU . . . . . . . . . . . . . 7.4 tp -166.24 148.54 6.94 Favored 'General case' 0 C--N 1.331 -0.237 0 N-CA-C 110.302 -0.258 . . . . 0.0 110.302 179.471 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B ' 93' ' ' ILE . . . . . . . . . . . . . 71.0 mt -128.18 123.97 61.42 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.285 0 N-CA-C 109.848 -0.427 . . . . 0.0 109.848 179.145 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B ' 94' ' ' VAL . . . . . . . . . . . . . 40.8 t -122.13 125.88 73.61 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.182 0 N-CA-C 109.98 -0.378 . . . . 0.0 109.98 179.038 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B ' 95' ' ' VAL . . . . . . . . . . . . . 41.8 t -120.82 134.66 63.54 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.329 0 CA-C-N 116.026 -0.533 . . . . 0.0 109.815 -179.959 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B ' 96' ' ' ILE . . . . . 0.418 HD11 ' HB ' ' B' ' 123' ' ' VAL . 67.4 mt -115.76 126.15 73.18 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.209 0 N-CA-C 109.381 -0.6 . . . . 0.0 109.381 179.071 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' B' B ' 97' ' ' THR . . . . . . . . . . . . . 73.5 p -99.89 158.36 15.86 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-O 121.307 0.575 . . . . 0.0 111.326 -176.404 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B ' 98' ' ' GLU . . . . . . . . . . . . . 43.7 tp10 -53.83 -26.62 25.21 Favored 'General case' 0 CA--C 1.533 0.311 0 CA-C-N 116.052 -0.522 . . . . 0.0 112.267 -179.174 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B ' 99' ' ' GLU . . . . . . . . . . . . . 95.7 mt-10 -79.91 17.6 0.94 Allowed 'General case' 0 CA--C 1.535 0.377 0 N-CA-C 113.151 0.797 . . . . 0.0 113.151 -176.212 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B ' 100' ' ' ASN . . . . . . . . . . . . . 4.2 m-20 62.42 38.1 13.1 Favored 'General case' 0 N--CA 1.463 0.175 0 CA-C-O 121.115 0.484 . . . . 0.0 110.894 177.954 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B ' 101' ' ' GLU . . . . . . . . . . . . . 84.4 tt0 -119.04 141.86 48.34 Favored 'General case' 0 C--N 1.332 -0.184 0 CA-C-N 116.208 -0.451 . . . . 0.0 109.869 177.562 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B ' 102' ' ' VAL . . . . . . . . . . . . . 46.2 t -115.08 127.54 72.6 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.264 0 N-CA-C 109.895 -0.409 . . . . 0.0 109.895 -178.915 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B ' 103' ' ' LEU . . . . . . . . . . . . . 28.8 mt -118.58 131.9 56.2 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-N 115.78 -0.646 . . . . 0.0 110.306 177.845 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B ' 104' ' ' ILE . . . . . . . . . . . . . 71.4 mt -119.52 121.85 67.39 Favored 'Isoleucine or valine' 0 C--O 1.234 0.283 0 CA-C-N 116.606 -0.27 . . . . 0.0 110.426 -179.106 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B ' 105' ' ' PHE . . . . . . . . . . . . . 53.2 m-85 -123.18 168.44 12.42 Favored 'General case' 0 C--N 1.333 -0.122 0 O-C-N 124.115 0.885 . . . . 0.0 109.901 179.499 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B ' 106' ' ' ASN . . . . . . . . . . . . . 44.0 p-10 -100.38 -170.61 1.89 Allowed 'General case' 0 CA--C 1.531 0.217 0 N-CA-C 109.789 -0.448 . . . . 0.0 109.789 171.754 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B ' 107' ' ' GLN . . . . . . . . . . . . . 63.3 tt0 -58.55 -30.06 66.83 Favored 'General case' 0 C--N 1.328 -0.339 0 N-CA-C 111.858 0.318 . . . . 0.0 111.858 179.567 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B ' 108' ' ' ASN . . . . . . . . . . . . . 59.8 t30 -86.85 14.06 7.88 Favored 'General case' 0 CA--C 1.534 0.343 0 N-CA-C 112.923 0.712 . . . . 0.0 112.923 -176.757 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B ' 109' ' ' LEU . . . . . . . . . . . . . 34.5 mt 58.35 33.19 22.91 Favored 'General case' 0 C--N 1.332 -0.188 0 N-CA-C 111.877 0.325 . . . . 0.0 111.877 177.262 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B ' 110' ' ' GLU . . . . . . . . . . . . . 70.5 mm-40 -98.97 138.82 35.52 Favored 'General case' 0 C--N 1.331 -0.226 0 N-CA-C 109.21 -0.663 . . . . 0.0 109.21 174.426 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B ' 111' ' ' GLU . . . . . . . . . . . . . 42.2 tt0 -85.72 121.81 28.91 Favored 'General case' 0 C--N 1.327 -0.408 0 CA-C-O 120.942 0.401 . . . . 0.0 110.574 -176.243 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B ' 112' ' ' LEU . . . . . . . . . . . . . 38.6 mt -105.73 -42.4 5.18 Favored 'General case' 0 C--N 1.331 -0.227 0 CA-C-N 116.007 -0.542 . . . . 0.0 110.466 179.745 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B ' 113' ' ' TYR . . . . . . . . . . . . . 63.9 t80 -132.89 138.7 47.07 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-N 116.274 -0.421 . . . . 0.0 110.883 -178.452 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B ' 114' ' ' ARG . . . . . . . . . . . . . 24.6 ptt180 -147.89 122.22 9.65 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.3 -0.409 . . . . 0.0 110.619 179.126 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B ' 115' ' ' GLY . . . . . . . . . . . . . . . -150.13 148.15 19.1 Favored Glycine 0 CA--C 1.525 0.701 0 C-N-CA 120.682 -0.77 . . . . 0.0 111.451 179.761 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B ' 116' ' ' LYS . . . . . . . . . . . . . 21.3 ttpp -116.44 131.93 56.81 Favored 'General case' 0 C--N 1.33 -0.26 0 N-CA-C 109.717 -0.475 . . . . 0.0 109.717 176.517 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B ' 117' ' ' PHE . . . . . 0.477 ' HE2' HD13 ' B' ' 132' ' ' ILE . 47.5 m-85 -127.12 116.85 21.29 Favored 'General case' 0 C--N 1.331 -0.216 0 CA-C-O 120.945 0.403 . . . . 0.0 110.243 -176.47 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' B' B ' 118' ' ' GLU . . . . . . . . . . . . . 95.8 mt-10 -52.97 -47.03 68.47 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.309 -0.405 . . . . 0.0 111.476 -176.293 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B ' 119' ' ' ASN . . . . . . . . . . . . . 82.6 m-20 -98.16 31.02 2.88 Favored 'General case' 0 C--N 1.33 -0.256 0 N-CA-C 112.173 0.435 . . . . 0.0 112.173 -173.805 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B ' 120' ' ' LEU . . . . . . . . . . . . . 21.4 tp -56.72 121.82 10.69 Favored 'General case' 0 C--N 1.332 -0.184 0 CA-C-O 120.677 0.275 . . . . 0.0 110.466 177.778 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B ' 121' ' ' ASN . . . . . . . . . . . . . 31.4 m120 -113.98 -44.14 3.19 Favored 'General case' 0 N--CA 1.462 0.155 0 CA-C-N 116.554 -0.294 . . . . 0.0 111.323 -176.684 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B ' 122' ' ' LYS . . . . . . . . . . . . . 55.4 mtmt -147.67 152.7 38.28 Favored 'General case' 0 C--N 1.332 -0.172 0 C-N-CA 120.651 -0.42 . . . . 0.0 111.62 -177.701 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B ' 123' ' ' VAL . . . . . 0.418 ' HB ' HD11 ' B' ' 96' ' ' ILE . 46.2 t -132.77 132.18 59.52 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.243 0 CA-C-N 115.919 -0.582 . . . . 0.0 109.862 177.715 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' B' B ' 124' ' ' LEU . . . . . . . . . . . . . 23.9 mt -121.15 136.13 55.03 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.231 -0.44 . . . . 0.0 110.548 -179.059 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B ' 125' ' ' VAL . . . . . . . . . . . . . 43.5 t -130.46 130.73 65.28 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.262 0 CA-C-N 116.335 -0.393 . . . . 0.0 110.019 179.078 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B ' 126' ' ' ARG . . . . . . . . . . . . . 89.8 mtt-85 -142.05 121.14 12.93 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-O 120.935 0.398 . . . . 0.0 110.642 178.578 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B ' 127' ' ' ASN . . . . . . . . . . . . . 58.4 m-80 51.46 -107.75 0.33 Allowed 'General case' 0 CA--C 1.545 0.761 0 CA-C-O 118.881 -0.581 . . . . 0.0 111.146 179.404 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B ' 128' ' ' ASP . . . . . . . . . . . . . 14.7 p-10 -114.19 4.26 15.47 Favored 'General case' 0 CA--C 1.537 0.445 0 CA-C-N 119.802 1.183 . . . . 0.0 113.257 -178.111 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B ' 129' ' ' LEU . . . . . . . . . . . . . 72.6 mt -107.75 144.93 34.21 Favored 'General case' 0 C--O 1.231 0.109 0 CA-C-N 118.142 0.428 . . . . 0.0 110.09 -179.916 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B ' 130' ' ' VAL . . . . . . . . . . . . . 41.4 t -127.67 140.22 49.73 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.185 0 CA-C-O 120.98 0.419 . . . . 0.0 110.156 -177.739 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B ' 131' ' ' VAL . . . . . 0.505 HG22 HD12 ' B' ' 140' ' ' LEU . 41.0 t -135.01 134.84 53.23 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.277 0 CA-C-N 116.15 -0.477 . . . . 0.0 110.025 178.317 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' B' B ' 132' ' ' ILE . . . . . 0.477 HD13 ' HE2' ' B' ' 117' ' ' PHE . 69.9 mt -118.07 132.84 66.72 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.274 0 CA-C-N 115.984 -0.553 . . . . 0.0 109.606 -179.468 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' B' B ' 133' ' ' ILE . . . . . . . . . . . . . 34.0 mm -116.0 123.49 71.32 Favored 'Isoleucine or valine' 0 C--O 1.234 0.262 0 CA-C-N 116.511 -0.313 . . . . 0.0 110.894 -175.598 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B ' 134' ' ' ASP . . . . . . . . . . . . . 7.9 p-10 -132.61 155.11 49.31 Favored 'General case' 0 C--N 1.332 -0.196 0 CA-C-N 116.434 -0.348 . . . . 0.0 110.089 174.371 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B ' 135' ' ' GLU . . . . . . . . . . . . . 80.7 tt0 -49.83 -28.66 6.71 Favored 'General case' 0 C--N 1.328 -0.364 0 N-CA-C 113.17 0.804 . . . . 0.0 113.17 -169.951 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B ' 136' ' ' GLN . . . . . . . . . . . . . 97.5 mt-30 -99.22 -24.78 14.73 Favored 'General case' 0 C--O 1.233 0.227 0 N-CA-C 113.096 0.776 . . . . 0.0 113.096 -171.761 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B ' 137' ' ' LYS . . . . . . . . . . . . . 57.0 pttt -161.01 168.25 24.89 Favored 'General case' 0 C--O 1.232 0.163 0 CA-C-O 121.619 0.723 . . . . 0.0 112.56 -173.23 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B ' 138' ' ' LEU . . . . . 0.413 ' C ' HD23 ' B' ' 138' ' ' LEU . 6.9 tt -120.07 128.36 53.41 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 114.848 -1.069 . . . . 0.0 110.009 178.219 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' B' B ' 139' ' ' THR . . . . . . . . . . . . . 43.1 m -106.49 127.82 53.6 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.068 -0.515 . . . . 0.0 110.28 179.562 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B ' 140' ' ' LEU . . . . . 0.505 HD12 HG22 ' B' ' 131' ' ' VAL . 19.3 tp -114.92 119.26 35.95 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 115.795 -0.639 . . . . 0.0 109.674 -177.969 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' B' B ' 141' ' ' ILE . . . . . . . . . . . . . 19.3 mt -119.35 119.91 62.07 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.221 0 CA-C-O 120.95 0.405 . . . . 0.0 110.015 -174.516 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B ' 142' ' ' ARG . . . . . . . . . . . . . 76.2 mtm180 -113.77 126.21 54.96 Favored 'General case' 0 C--N 1.332 -0.166 0 CA-C-N 115.44 -0.8 . . . . 0.0 110.369 -177.97 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B ' 143' ' ' THR . . . . . . . . . . . . . 52.0 p . . . . . 0 C--O 1.22 -0.493 0 CA-C-O 118.123 -0.942 . . . . 0.0 110.527 -179.564 . . . . . . . . 0 0 . 1 . 004 nuclear build core ' C' C ' 2' ' ' SER . . . . . 0.435 ' HB2' HD11 ' C' ' 58' ' ' LEU . 3.9 p . . . . . 0 N--CA 1.462 0.151 0 CA-C-O 120.861 0.362 . . . . 0.0 110.597 . . . . . . . . . 1 1 . 1 . 004 nuclear build core ' C' C ' 3' ' ' GLU . . . . . . . . . . . . . 93.6 mt-10 -141.04 140.9 34.33 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 115.974 -0.557 . . . . 0.0 110.879 -179.292 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' C' C ' 4' ' ' LEU . . . . . . . . . . . . . 15.5 tp -125.21 130.29 51.8 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 116.151 -0.477 . . . . 0.0 110.01 175.629 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' C' C ' 5' ' ' LYS . . . . . . . . . . . . . 96.5 mttt -111.77 121.85 46.21 Favored 'General case' 0 C--N 1.332 -0.192 0 CA-C-N 116.686 -0.234 . . . . 0.0 110.939 -178.512 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' C' C ' 6' ' ' LEU . . . . . . . . . . . . . 27.7 mt -114.3 140.91 48.23 Favored 'General case' 0 C--O 1.234 0.27 0 CA-C-N 115.504 -0.771 . . . . 0.0 110.591 -179.506 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' C' C ' 7' ' ' LYS . . . . . . . . . . . . . 41.1 tttp -121.54 137.88 27.6 Favored Pre-proline 0 CA--C 1.534 0.351 0 CA-C-O 118.935 -0.555 . . . . 0.0 109.592 174.934 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' C' C ' 8' ' ' PRO . . . . . . . . . . . . . 86.9 Cg_endo -91.93 134.68 1.49 Allowed 'Trans proline' 0 N--CA 1.488 1.193 0 C-N-CA 121.682 1.588 . . . . 0.0 111.831 178.858 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' C' C ' 9' ' ' LEU . . . . . . . . . . . . . 49.0 mt -76.66 -46.26 3.15 Favored Pre-proline 0 CA--C 1.533 0.319 0 CA-C-O 118.791 -0.623 . . . . 0.0 111.764 -179.908 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' C' C ' 10' ' ' PRO . . . . . . . . . . . . . 79.2 Cg_endo -83.78 140.46 9.19 Favored 'Trans proline' 0 N--CA 1.495 1.575 0 C-N-CA 121.288 1.325 . . . . 0.0 111.408 173.259 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' C' C ' 11' ' ' LYS . . . . . . . . . . . . . 48.8 pttt -78.96 111.34 15.05 Favored 'General case' 0 C--N 1.331 -0.214 0 CA-C-O 121.449 0.642 . . . . 0.0 110.174 178.414 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' C' C ' 12' ' ' VAL . . . . . . . . . . . . . 11.6 p -151.1 151.99 11.79 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.373 0 CA-C-N 115.711 -0.677 . . . . 0.0 110.589 -178.553 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' C' C ' 13' ' ' GLU . . . . . . . . . . . . . 80.6 tt0 -91.04 124.51 35.33 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.303 -0.408 . . . . 0.0 110.082 177.241 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' C' C ' 14' ' ' LEU . . . . . . . . . . . . . 23.8 mt -95.16 150.87 38.29 Favored Pre-proline 0 C--N 1.329 -0.284 0 CA-C-O 119.332 -0.366 . . . . 0.0 110.511 -179.141 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' C' C ' 15' ' ' PRO . . . . . . . . . . . . . 28.2 Cg_exo -60.51 157.86 34.56 Favored 'Trans proline' 0 N--CA 1.496 1.673 0 C-N-CA 121.257 1.305 . . . . 0.0 111.65 177.623 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' C' C ' 16' ' ' PRO . . . . . . . . . . . . . 38.4 Cg_exo -58.27 -39.79 81.52 Favored 'Trans proline' 0 N--CA 1.497 1.722 0 C-N-CA 121.428 1.419 . . . . 0.0 112.634 -178.718 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' C' C ' 17' ' ' ASP . . . . . . . . . . . . . 19.5 p-10 -87.79 12.76 12.13 Favored 'General case' 0 CA--C 1.536 0.421 0 N-CA-C 113.027 0.751 . . . . 0.0 113.027 -177.896 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' C' C ' 18' ' ' PHE . . . . . . . . . . . . . 45.9 t80 -57.85 -41.29 82.05 Favored 'General case' 0 C--O 1.228 -0.046 0 O-C-N 122.008 -0.432 . . . . 0.0 110.271 -178.664 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' C' C ' 19' ' ' VAL . . . . . . . . . . . . . 48.5 t -56.49 -43.83 79.0 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.271 0 CA-C-N 116.529 -0.305 . . . . 0.0 110.429 -179.484 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' C' C ' 20' ' ' ASP . . . . . . . . . . . . . 35.3 m-20 -60.31 -41.18 92.95 Favored 'General case' 0 C--N 1.33 -0.282 0 C-N-CA 120.872 -0.331 . . . . 0.0 110.719 -178.935 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' C' C ' 21' ' ' VAL . . . . . . . . . . . . . 47.9 t -63.33 -49.23 83.77 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 C-N-CA 120.836 -0.346 . . . . 0.0 110.344 -178.232 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' C' C ' 22' ' ' ILE . . . . . 0.478 HG22 HD12 ' C' ' 26' ' ' LEU . 50.6 mm -55.63 -47.57 78.79 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.268 0 CA-C-O 120.696 0.284 . . . . 0.0 110.828 179.482 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' C' C ' 23' ' ' ARG . . . . . . . . . . . . . 50.8 ttp180 -53.97 -50.65 66.06 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-O 120.619 0.247 . . . . 0.0 111.444 -177.832 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' C' C ' 24' ' ' ILE . . . . . . . . . . . . . 75.5 mt -58.66 -43.0 86.58 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.286 0 CA-C-N 116.688 -0.233 . . . . 0.0 111.139 -177.454 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' C' C ' 25' ' ' LYS . . . . . . . . . . . . . 42.8 mttm -65.37 -40.88 94.08 Favored 'General case' 0 C--N 1.328 -0.348 0 N-CA-C 112.223 0.453 . . . . 0.0 112.223 -178.264 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' C' C ' 26' ' ' LEU . . . . . 0.478 HD12 HG22 ' C' ' 22' ' ' ILE . 91.9 mt -79.98 -39.4 30.16 Favored 'General case' 0 C--N 1.33 -0.253 0 N-CA-C 113.546 0.943 . . . . 0.0 113.546 -170.061 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' C' C ' 27' ' ' GLN . . . . . . . . . . . . . 17.3 pt20 -46.35 138.71 5.36 Favored 'General case' 0 N--CA 1.47 0.527 0 N-CA-C 112.922 0.712 . . . . 0.0 112.922 -174.162 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' C' C ' 28' ' ' GLY . . . . . . . . . . . . . . . 99.95 -27.27 21.06 Favored Glycine 0 CA--C 1.534 1.263 0 CA-C-N 115.47 -0.786 . . . . 0.0 112.175 -177.074 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' C' C ' 29' ' ' LYS . . . . . . . . . . . . . 99.0 mttt -97.83 155.15 17.18 Favored 'General case' 0 C--O 1.234 0.272 0 CA-C-O 121.107 0.48 . . . . 0.0 111.26 179.457 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' C' C ' 30' ' ' THR . . . . . . . . . . . . . 36.2 m -104.82 138.93 40.33 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 115.903 -0.59 . . . . 0.0 110.057 176.14 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' C' C ' 31' ' ' VAL . . . . . . . . . . . . . 35.3 m -126.76 149.94 32.2 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.197 0 CA-C-O 120.878 0.37 . . . . 0.0 110.814 -178.702 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' C' C ' 32' ' ' ARG . . . . . . . . . . . . . 73.8 mtt85 -128.28 148.1 50.63 Favored 'General case' 0 C--N 1.331 -0.239 0 CA-C-N 116.041 -0.527 . . . . 0.0 110.481 178.788 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' C' C ' 33' ' ' THR . . . . . . . . . . . . . 11.2 m -52.68 137.89 29.96 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.292 -0.413 . . . . 0.0 111.497 -177.763 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' C' C ' 34' ' ' GLY . . . . . . . . . . . . . . . 101.31 -17.16 56.09 Favored Glycine 0 CA--C 1.532 1.134 0 CA-C-O 119.643 -0.532 . . . . 0.0 113.241 179.221 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' C' C ' 35' ' ' ASP . . . . . . . . . . . . . 77.9 m-20 -66.47 150.49 48.87 Favored 'General case' 0 N--CA 1.462 0.168 0 CA-C-N 118.062 0.931 . . . . 0.0 110.912 178.917 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' C' C ' 36' ' ' VAL . . . . . . . . . . . . . 43.9 t -124.49 132.57 71.15 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.264 0 CA-C-N 116.107 -0.497 . . . . 0.0 109.908 178.503 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' C' C ' 37' ' ' ILE . . . . . . . . . . . . . 64.3 mt -120.82 139.21 48.79 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.187 0 CA-C-N 116.065 -0.516 . . . . 0.0 109.863 -179.53 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' C' C ' 38' ' ' GLY . . . . . . . . . . . . . . . -116.16 128.7 8.1 Favored Glycine 0 CA--C 1.526 0.752 0 N-CA-C 110.922 -0.871 . . . . 0.0 110.922 178.826 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' C' C ' 39' ' ' ILE . . . . . . . . . . . . . 71.2 mt -124.53 135.27 64.4 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.215 0 CA-C-O 120.733 0.302 . . . . 0.0 110.209 179.806 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' C' C ' 40' ' ' SER . . . . . . . . . . . . . 78.9 p -92.05 121.99 34.12 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.2 -0.455 . . . . 0.0 110.885 176.942 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' C' C ' 41' ' ' ILE . . . . . . . . . . . . . 71.0 mt -130.68 120.69 48.62 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.166 0 CA-C-O 120.772 0.32 . . . . 0.0 110.461 178.07 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' C' C ' 42' ' ' LEU . . . . . . . . . . . . . 76.4 mt 53.21 35.32 19.66 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.141 -0.481 . . . . 0.0 111.703 177.349 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' C' C ' 43' ' ' GLY . . . . . . . . . . . . . . . 72.47 30.44 64.49 Favored Glycine 0 CA--C 1.53 0.994 0 C-N-CA 121.051 -0.595 . . . . 0.0 112.173 178.015 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' C' C ' 44' ' ' LYS . . . . . . . . . . . . . 29.5 ttmt -138.78 128.7 25.16 Favored 'General case' 0 C--N 1.33 -0.258 0 N-CA-C 109.616 -0.513 . . . . 0.0 109.616 178.195 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' C' C ' 45' ' ' GLU . . . . . . . . . . . . . 83.1 tt0 -83.8 124.25 30.73 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-O 120.705 0.288 . . . . 0.0 111.41 -177.566 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' C' C ' 46' ' ' VAL . . . . . 0.417 ' O ' HG13 ' C' ' 46' ' ' VAL . 10.2 p -115.89 123.1 70.84 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.245 0 N-CA-C 109.485 -0.561 . . . . 0.0 109.485 173.618 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' C' C ' 47' ' ' LYS . . . . . . . . . . . . . 61.9 mtpt -98.3 124.35 42.88 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.03 -0.532 . . . . 0.0 110.76 179.016 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' C' C ' 48' ' ' PHE . . . . . . . . . . . . . 32.7 m-85 -110.78 131.84 54.71 Favored 'General case' 0 C--N 1.33 -0.247 0 N-CA-C 109.659 -0.497 . . . . 0.0 109.659 177.178 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' C' C ' 49' ' ' LYS . . . . . . . . . . . . . 82.8 tttt -106.51 132.36 52.61 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.224 179.068 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' C' C ' 50' ' ' VAL . . . . . . . . . . . . . 42.7 t -75.92 103.54 3.52 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.335 0 N-CA-C 109.432 -0.581 . . . . 0.0 109.432 178.021 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' C' C ' 51' ' ' VAL . . . . . . . . . . . . . 44.9 t -69.47 -54.07 21.56 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 CA-C-N 115.898 -0.592 . . . . 0.0 109.449 -175.437 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' C' C ' 52' ' ' GLN . . . . . . . . . . . . . 89.1 mt-30 -153.27 150.73 29.26 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.007 -0.542 . . . . 0.0 111.531 -177.961 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' C' C ' 53' ' ' ALA . . . . . . . . . . . . . . . -126.92 131.65 51.06 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 115.157 -0.929 . . . . 0.0 109.478 174.637 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' C' C ' 54' ' ' TYR . . . . . . . . . . . . . 78.0 t80 -129.1 109.62 18.13 Favored Pre-proline 0 CA--C 1.534 0.359 0 CA-C-O 118.281 -0.866 . . . . 0.0 110.464 -179.17 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' C' C ' 55' ' ' PRO . . . . . . . . . . . . . 73.6 Cg_endo -77.15 170.02 72.68 Favored 'Cis proline' 0 N--CA 1.501 1.936 0 CA-C-N 121.895 1.713 . . . . 0.0 112.269 -6.057 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' C' C ' 56' ' ' SER . . . . . . . . . . . . . 13.6 m -116.28 131.15 23.96 Favored Pre-proline 0 CA--C 1.538 0.487 0 CA-C-O 118.46 -0.781 . . . . 0.0 109.36 174.972 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' C' C ' 57' ' ' PRO . . . . . . . . . . . . . 55.3 Cg_endo -71.38 146.83 86.3 Favored 'Cis proline' 0 N--CA 1.497 1.73 0 CA-C-N 121.996 1.749 . . . . 0.0 111.531 -1.055 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' C' C ' 58' ' ' LEU . . . . . 0.435 HD11 ' HB2' ' C' ' 2' ' ' SER . 14.4 tp -105.97 136.59 45.36 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.286 -0.416 . . . . 0.0 110.651 -178.422 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' C' C ' 59' ' ' ARG . . . . . . . . . . . . . 78.6 ttt180 -103.58 122.46 45.02 Favored 'General case' 0 C--N 1.327 -0.394 0 N-CA-C 109.308 -0.627 . . . . 0.0 109.308 175.788 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' C' C ' 60' ' ' VAL . . . . . . . . . . . . . 42.2 t -80.09 123.71 37.21 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.315 0 C-N-CA 120.704 -0.398 . . . . 0.0 110.48 -175.346 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' C' C ' 61' ' ' GLU . . . . . . . . . . . . . 95.6 mt-10 -130.84 164.25 25.62 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 115.705 -0.679 . . . . 0.0 109.745 177.645 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' C' C ' 62' ' ' ASP . . . . . . . . . . . . . 48.1 m-20 -53.37 -32.1 47.76 Favored 'General case' 0 C--N 1.327 -0.371 0 N-CA-C 111.895 0.331 . . . . 0.0 111.895 -179.178 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' C' C ' 63' ' ' ARG . . . . . . . . . . . . . 35.9 ptt180 -88.5 5.17 43.86 Favored 'General case' 0 CA--C 1.537 0.46 0 N-CA-C 113.676 0.991 . . . . 0.0 113.676 -174.929 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' C' C ' 64' ' ' THR . . . . . . . . . . . . . 26.0 m -84.59 141.66 30.52 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-N 118.19 0.45 . . . . 0.0 110.653 -178.7 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' C' C ' 65' ' ' LYS . . . . . . . . . . . . . 98.8 mttt -89.52 133.53 34.54 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-O 121.092 0.473 . . . . 0.0 110.646 -179.195 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' C' C ' 66' ' ' ILE . . . . . . . . . . . . . 60.4 mt -114.15 127.26 71.66 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.237 0 N-CA-C 109.579 -0.526 . . . . 0.0 109.579 179.482 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' C' C ' 67' ' ' THR . . . . . . . . . . . . . 15.1 m -120.5 142.66 49.1 Favored 'General case' 0 C--N 1.331 -0.214 0 CA-C-O 121.176 0.512 . . . . 0.0 111.149 -175.597 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' C' C ' 68' ' ' LEU . . . . . . . . . . . . . 34.2 mt . . . . . 0 C--N 1.329 -0.301 0 CA-C-N 115.761 -0.654 . . . . 0.0 110.534 179.605 . . . . . . . . 0 0 . 1 . 004 nuclear build core ' C' C ' 73' ' ' VAL . . . . . . . . . . . . . 34.6 m . . . . . 0 CA--C 1.528 0.129 0 CA-C-O 120.469 0.176 . . . . 0.0 110.618 . . . . . . . . . 0 0 . 1 . 004 nuclear build core ' C' C ' 74' ' ' ASP . . . . . . . . . . . . . 15.7 t0 -96.06 122.75 39.22 Favored 'General case' 0 C--N 1.333 -0.147 0 C-N-CA 120.753 -0.379 . . . . 0.0 110.489 -174.094 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' C' C ' 75' ' ' VAL . . . . . . . . . . . . . 41.2 t -121.07 121.17 64.28 Favored 'Isoleucine or valine' 0 N--CA 1.462 0.166 0 CA-C-O 121.119 0.485 . . . . 0.0 110.498 -179.364 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' C' C ' 76' ' ' LEU . . . . . . . . . . . . . 5.4 mp -118.01 150.78 38.71 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 115.651 -0.704 . . . . 0.0 109.501 175.833 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' C' C ' 77' ' ' GLU . . . . . . . . . . . . . 97.7 mt-10 -136.87 136.59 38.84 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-O 121.042 0.449 . . . . 0.0 111.214 -177.769 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' C' C ' 78' ' ' ALA . . . . . 0.618 ' HB2' HD21 ' C' ' 109' ' ' LEU . . . -124.77 135.91 53.39 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 115.669 -0.696 . . . . 0.0 109.712 176.353 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' C' C ' 79' ' ' LYS . . . . . 0.664 ' O ' HD13 ' C' ' 80' ' ' ILE . 99.0 mttt -81.73 119.04 23.35 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-O 120.913 0.387 . . . . 0.0 110.757 -178.498 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' C' C ' 80' ' ' ILE . . . . . 0.664 HD13 ' O ' ' C' ' 79' ' ' LYS . 35.5 mm -139.1 105.6 2.61 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.334 0 N-CA-C 109.22 -0.659 . . . . 0.0 109.22 -178.013 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' C' C ' 81' ' ' LYS . . . . . . . . . . . . . 53.4 mtmt -98.12 125.24 43.04 Favored 'General case' 0 C--N 1.329 -0.314 0 C-N-CA 120.95 -0.3 . . . . 0.0 111.167 -176.934 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' C' C ' 82' ' ' GLY . . . . . . . . . . . . . . . 89.17 42.04 5.69 Favored Glycine 0 CA--C 1.526 0.728 0 C-N-CA 120.786 -0.721 . . . . 0.0 112.048 174.816 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' C' C ' 83' ' ' ILE . . . . . . . . . . . . . 76.5 mt -69.8 138.3 22.38 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.336 0 N-CA-C 109.676 -0.491 . . . . 0.0 109.676 176.749 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' C' C ' 84' ' ' LYS . . . . . . . . . . . . . 38.0 ttpt -101.58 -50.56 3.69 Favored 'General case' 0 C--N 1.331 -0.23 0 CA-C-O 120.942 0.401 . . . . 0.0 110.381 -178.77 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' C' C ' 85' ' ' ASP . . . . . . . . . . . . . 6.6 t0 -149.65 147.51 28.19 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 115.938 -0.574 . . . . 0.0 110.509 -178.572 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' C' C ' 86' ' ' VAL . . . . . . . . . . . . . 43.7 t -129.35 133.64 65.12 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.215 0 CA-C-O 120.925 0.393 . . . . 0.0 110.414 -179.043 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' C' C ' 87' ' ' ILE . . . . . 0.502 ' N ' HD12 ' C' ' 87' ' ' ILE . 4.9 mp -121.94 127.6 75.42 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.215 0 CA-C-N 115.854 -0.612 . . . . 0.0 109.449 176.62 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' C' C ' 88' ' ' LEU . . . . . . . . . . . . . 22.3 tp -118.07 131.52 56.44 Favored 'General case' 0 C--N 1.331 -0.221 0 CA-C-O 121.078 0.466 . . . . 0.0 111.339 -177.279 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' C' C ' 89' ' ' ASP . . . . . . . . . . . . . 14.0 t70 -130.84 152.02 50.63 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 115.616 -0.72 . . . . 0.0 109.293 174.987 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' C' C ' 90' ' ' GLU . . . . . . . . . . . . . 84.9 tt0 -47.81 -35.73 10.62 Favored 'General case' 0 C--N 1.329 -0.286 0 N-CA-C 113.079 0.77 . . . . 0.0 113.079 -172.299 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' C' C ' 91' ' ' ASN . . . . . . . . . . . . . 35.9 m120 -115.4 2.88 14.03 Favored 'General case' 0 N--CA 1.468 0.462 0 N-CA-C 113.734 1.012 . . . . 0.0 113.734 -174.664 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' C' C ' 92' ' ' LEU . . . . . . . . . . . . . 40.7 mt -148.77 147.31 28.66 Favored 'General case' 0 C--N 1.332 -0.196 0 CA-C-N 118.305 0.502 . . . . 0.0 110.972 -175.228 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' C' C ' 93' ' ' ILE . . . . . . . . . . . . . 69.4 mt -125.18 122.05 62.16 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.278 0 N-CA-C 109.383 -0.599 . . . . 0.0 109.383 176.998 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' C' C ' 94' ' ' VAL . . . . . 0.433 HG21 HG21 ' C' ' 125' ' ' VAL . 42.9 t -121.87 127.12 75.34 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.267 0 CA-C-O 120.802 0.334 . . . . 0.0 110.155 -179.448 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' C' C ' 95' ' ' VAL . . . . . . . . . . . . . 45.8 t -122.7 132.64 70.86 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.249 0 CA-C-N 116.094 -0.503 . . . . 0.0 109.786 179.151 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' C' C ' 96' ' ' ILE . . . . . . . . . . . . . 62.7 mt -115.77 128.37 73.05 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.247 0 N-CA-C 109.433 -0.581 . . . . 0.0 109.433 179.75 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' C' C ' 97' ' ' THR . . . . . . . . . . . . . 64.9 p -105.3 163.16 12.82 Favored 'General case' 0 N--CA 1.464 0.233 0 CA-C-O 121.244 0.545 . . . . 0.0 111.68 -174.636 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' C' C ' 98' ' ' GLU . . . . . . . . . . . . . 14.9 mm-40 -53.78 -27.29 28.11 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 115.933 -0.576 . . . . 0.0 112.203 177.676 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' C' C ' 99' ' ' GLU . . . . . . . . . . . . . 71.1 mm-40 -75.26 9.74 1.93 Allowed 'General case' 0 CA--C 1.535 0.395 0 N-CA-C 113.284 0.846 . . . . 0.0 113.284 -177.681 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' C' C ' 100' ' ' ASN . . . . . . . . . . . . . 3.1 m-20 61.03 31.63 19.86 Favored 'General case' 0 CA--C 1.534 0.342 0 CA-C-N 118.268 0.485 . . . . 0.0 111.302 -178.611 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' C' C ' 101' ' ' GLU . . . . . . . . . . . . . 84.5 tt0 -109.63 145.14 36.95 Favored 'General case' 0 C--O 1.233 0.199 0 N-CA-C 109.729 -0.471 . . . . 0.0 109.729 174.569 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' C' C ' 102' ' ' VAL . . . . . . . . . . . . . 45.2 t -114.99 124.12 71.34 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.302 0 CA-C-N 116.137 -0.483 . . . . 0.0 109.783 -179.834 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' C' C ' 103' ' ' LEU . . . . . . . . . . . . . 21.5 mt -112.26 127.69 56.05 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 115.845 -0.616 . . . . 0.0 109.982 176.902 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' C' C ' 104' ' ' ILE . . . . . . . . . . . . . 66.3 mt -116.88 119.74 62.92 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.261 0 N-CA-C 110.268 -0.271 . . . . 0.0 110.268 -179.728 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' C' C ' 105' ' ' PHE . . . . . . . . . . . . . 44.7 m-85 -119.83 168.87 10.66 Favored 'General case' 0 C--N 1.332 -0.158 0 CA-C-N 115.421 -0.809 . . . . 0.0 110.078 179.183 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' C' C ' 106' ' ' ASN . . . . . . . . . . . . . 46.9 p-10 -103.02 -170.48 1.8 Allowed 'General case' 0 CA--C 1.53 0.187 0 N-CA-C 110.018 -0.364 . . . . 0.0 110.018 174.46 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' C' C ' 107' ' ' GLN . . . . . . . . . . . . . 57.0 tt0 -60.94 -23.2 65.12 Favored 'General case' 0 CA--C 1.532 0.272 0 N-CA-C 112.52 0.563 . . . . 0.0 112.52 -179.803 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' C' C ' 108' ' ' ASN . . . . . . . . . . . . . 37.5 t30 -89.88 14.02 13.12 Favored 'General case' 0 CA--C 1.536 0.406 0 N-CA-C 112.89 0.7 . . . . 0.0 112.89 -179.413 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' C' C ' 109' ' ' LEU . . . . . 0.618 HD21 ' HB2' ' C' ' 78' ' ' ALA . 10.4 tp 54.96 37.95 29.68 Favored 'General case' 0 C--O 1.232 0.144 0 CA-C-O 121.036 0.446 . . . . 0.0 111.225 178.732 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' C' C ' 110' ' ' GLU . . . . . . . . . . . . . 70.7 mm-40 -107.98 155.93 19.79 Favored 'General case' 0 C--N 1.331 -0.237 0 N-CA-C 109.921 -0.4 . . . . 0.0 109.921 175.423 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' C' C ' 111' ' ' GLU . . . . . . . . . . . . . 65.8 tt0 -84.56 122.02 28.43 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-N 116.278 -0.419 . . . . 0.0 111.053 -176.245 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' C' C ' 112' ' ' LEU . . . . . . . . . . . . . 36.2 mt -105.44 -46.04 4.3 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.343 -0.39 . . . . 0.0 110.376 177.58 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' C' C ' 113' ' ' TYR . . . . . . . . . . . . . 56.8 t80 -143.68 141.35 30.5 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.301 -0.409 . . . . 0.0 110.966 -179.487 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' C' C ' 114' ' ' ARG . . . . . . . . . . . . . 58.2 ttp180 -139.45 125.27 19.6 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.248 -0.433 . . . . 0.0 110.332 177.642 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' C' C ' 115' ' ' GLY . . . . . . . . . . . . . . . -149.97 151.11 23.23 Favored Glycine 0 CA--C 1.524 0.624 0 N-CA-C 110.905 -0.878 . . . . 0.0 110.905 -179.963 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' C' C ' 116' ' ' LYS . . . . . . . . . . . . . 53.3 tttt -122.09 134.85 54.76 Favored 'General case' 0 C--N 1.328 -0.355 0 N-CA-C 110.021 -0.363 . . . . 0.0 110.021 179.03 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' C' C ' 117' ' ' PHE . . . . . . . . . . . . . 40.9 m-85 -132.31 114.95 15.01 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-N 116.256 -0.429 . . . . 0.0 110.2 -175.921 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' C' C ' 118' ' ' GLU . . . . . . . . . . . . . 43.2 mt-10 -53.32 -44.95 68.8 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.478 -0.328 . . . . 0.0 111.599 -176.625 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' C' C ' 119' ' ' ASN . . . . . . . . . . . . . 30.4 m120 -100.06 31.07 3.46 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.238 -0.437 . . . . 0.0 112.098 -174.271 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' C' C ' 120' ' ' LEU . . . . . . . . . . . . . 13.2 tp -55.39 119.83 6.19 Favored 'General case' 0 N--CA 1.462 0.174 0 C-N-CA 120.984 -0.286 . . . . 0.0 110.696 178.456 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' C' C ' 121' ' ' ASN . . . . . . . . . . . . . 8.2 t-20 -113.98 -44.07 3.19 Favored 'General case' 0 C--N 1.331 -0.209 0 CA-C-N 116.477 -0.329 . . . . 0.0 111.257 -175.884 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' C' C ' 122' ' ' LYS . . . . . . . . . . . . . 95.1 mttt -142.13 148.74 38.8 Favored 'General case' 0 C--N 1.331 -0.216 0 CA-C-O 121.055 0.455 . . . . 0.0 111.602 -176.255 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' C' C ' 123' ' ' VAL . . . . . . . . . . . . . 47.1 t -132.04 124.58 53.21 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.267 0 CA-C-N 115.846 -0.616 . . . . 0.0 109.418 174.222 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' C' C ' 124' ' ' LEU . . . . . . . . . . . . . 6.3 mp -119.71 134.72 55.12 Favored 'General case' 0 N--CA 1.463 0.191 0 CA-C-N 116.453 -0.34 . . . . 0.0 110.711 -178.118 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' C' C ' 125' ' ' VAL . . . . . 0.519 HG22 HG23 ' C' ' 130' ' ' VAL . 43.5 t -132.58 124.23 50.95 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.254 0 CA-C-N 116.144 -0.48 . . . . 0.0 110.183 -179.82 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' C' C ' 126' ' ' ARG . . . . . . . . . . . . . 59.9 mtm180 -151.86 135.74 16.42 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.32 -0.4 . . . . 0.0 109.95 176.7 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' C' C ' 127' ' ' ASN . . . . . . . . . . . . . 5.5 m120 55.0 -154.22 0.3 Allowed 'General case' 0 CA--C 1.54 0.559 0 N-CA-C 110.073 -0.343 . . . . 0.0 110.073 177.852 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' C' C ' 128' ' ' ASP . . . . . . . . . . . . . 15.1 p-10 -83.05 20.74 1.16 Allowed 'General case' 0 CA--C 1.533 0.309 0 N-CA-C 112.509 0.559 . . . . 0.0 112.509 178.13 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' C' C ' 129' ' ' LEU . . . . . . . . . . . . . 14.5 tp -123.15 137.1 54.99 Favored 'General case' 0 C--O 1.234 0.269 0 O-C-N 122.052 -0.405 . . . . 0.0 110.311 179.091 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' C' C ' 130' ' ' VAL . . . . . 0.519 HG23 HG22 ' C' ' 125' ' ' VAL . 12.3 p -132.74 143.29 40.07 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.255 0 CA-C-O 120.999 0.428 . . . . 0.0 110.2 179.412 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' C' C ' 131' ' ' VAL . . . . . . . . . . . . . 41.5 t -136.04 138.93 46.72 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.37 0 CA-C-N 116.032 -0.531 . . . . 0.0 110.339 -178.436 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' C' C ' 132' ' ' ILE . . . . . . . . . . . . . 71.3 mt -116.09 132.45 65.59 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.323 0 CA-C-N 115.614 -0.721 . . . . 0.0 109.141 177.683 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' C' C ' 133' ' ' ILE . . . . . . . . . . . . . 41.4 mm -116.8 121.61 68.12 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.237 0 CA-C-O 120.753 0.311 . . . . 0.0 110.927 -174.464 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' C' C ' 134' ' ' ASP . . . . . . . . . . . . . 8.1 p-10 -135.42 146.48 48.31 Favored 'General case' 0 C--N 1.332 -0.18 0 CA-C-N 116.006 -0.543 . . . . 0.0 109.589 175.316 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' C' C ' 135' ' ' GLU . . . . . . . . . . . . . 83.2 tt0 -50.53 -27.67 7.09 Favored 'General case' 0 C--N 1.329 -0.321 0 N-CA-C 112.827 0.677 . . . . 0.0 112.827 -172.967 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' C' C ' 136' ' ' GLN . . . . . . . . . . . . . 98.4 mt-30 -79.7 -33.24 41.19 Favored 'General case' 0 C--N 1.331 -0.203 0 N-CA-C 112.263 0.468 . . . . 0.0 112.263 -176.226 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' C' C ' 137' ' ' LYS . . . . . . . . . . . . . 56.1 pttt -169.74 174.7 5.61 Favored 'General case' 0 C--N 1.331 -0.21 0 CA-C-O 121.524 0.678 . . . . 0.0 112.257 -172.894 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' C' C ' 138' ' ' LEU . . . . . 0.41 HD23 ' N ' ' C' ' 139' ' ' THR . 6.0 tt -119.14 130.38 55.51 Favored 'General case' 0 C--N 1.331 -0.226 0 CA-C-N 114.973 -1.012 . . . . 0.0 110.236 -179.109 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' C' C ' 139' ' ' THR . . . . . 0.41 ' N ' HD23 ' C' ' 138' ' ' LEU . 21.7 m -108.52 121.76 45.65 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.141 -0.482 . . . . 0.0 110.755 179.551 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' C' C ' 140' ' ' LEU . . . . . . . . . . . . . 33.3 tp -109.59 118.9 37.8 Favored 'General case' 0 C--N 1.329 -0.283 0 N-CA-C 109.058 -0.719 . . . . 0.0 109.058 -179.975 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' C' C ' 141' ' ' ILE . . . . . 0.516 ' HB ' HG13 ' C' ' 130' ' ' VAL . 22.1 mt -121.82 121.61 64.72 Favored 'Isoleucine or valine' 0 C--O 1.234 0.259 0 CA-C-O 121.089 0.471 . . . . 0.0 110.225 -175.627 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' C' C ' 142' ' ' ARG . . . . . . . . . . . . . 80.6 mtp180 . . . . . 0 C--N 1.33 -0.25 0 CA-C-N 115.273 -0.876 . . . . 0.0 110.111 178.265 . . . . . . . . 0 0 . 1 . 004 nuclear build core ' D' D ' 2' ' ' SER . . . . . . . . . . . . . 18.2 p . . . . . 0 C--O 1.231 0.131 0 CA-C-O 120.88 0.371 . . . . 0.0 110.274 . . . . . . . . . 0 0 . 1 . 004 nuclear build core ' D' D ' 3' ' ' GLU . . . . . . . . . . . . . 75.4 tt0 -148.0 139.23 23.46 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.235 -0.439 . . . . 0.0 111.305 -176.816 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' D' D ' 4' ' ' LEU . . . . . . . . . . . . . 16.1 tp -124.01 130.2 52.18 Favored 'General case' 0 C--N 1.331 -0.214 0 CA-C-N 116.051 -0.522 . . . . 0.0 110.031 176.477 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' D' D ' 5' ' ' LYS . . . . . . . . . . . . . 65.3 mttm -112.66 123.22 49.81 Favored 'General case' 0 C--O 1.233 0.215 0 CA-C-N 116.516 -0.311 . . . . 0.0 110.944 -179.734 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' D' D ' 6' ' ' LEU . . . . . . . . . . . . . 55.0 mt -115.72 143.19 45.72 Favored 'General case' 0 N--CA 1.463 0.206 0 CA-C-N 115.609 -0.723 . . . . 0.0 110.63 -179.299 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' D' D ' 7' ' ' LYS . . . . . . . . . . . . . 52.1 tttm -124.36 139.37 32.77 Favored Pre-proline 0 CA--C 1.536 0.409 0 CA-C-O 118.88 -0.581 . . . . 0.0 109.434 175.474 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' D' D ' 8' ' ' PRO . . . . . . . . . . . . . 86.4 Cg_endo -91.72 143.07 2.84 Favored 'Trans proline' 0 N--CA 1.491 1.363 0 C-N-CA 121.707 1.605 . . . . 0.0 112.026 179.647 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' D' D ' 9' ' ' LEU . . . . . . . . . . . . . 48.9 mt -81.98 -46.59 1.01 Allowed Pre-proline 0 CA--C 1.533 0.302 0 CA-C-O 118.757 -0.64 . . . . 0.0 112.113 178.595 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' D' D ' 10' ' ' PRO . . . . . . . . . . . . . 83.6 Cg_endo -83.46 151.5 13.43 Favored 'Trans proline' 0 N--CA 1.495 1.57 0 C-N-CA 121.316 1.344 . . . . 0.0 111.693 174.928 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' D' D ' 11' ' ' LYS . . . . . . . . . . . . . 53.4 pttt -84.98 116.68 23.51 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-O 121.234 0.54 . . . . 0.0 110.144 177.41 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' D' D ' 12' ' ' VAL . . . . . . . . . . . . . 12.1 p -151.06 149.63 14.01 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.223 0 CA-C-N 116.023 -0.535 . . . . 0.0 110.777 -178.457 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' D' D ' 13' ' ' GLU . . . . . . . . . . . . . 84.7 tt0 -99.16 111.69 24.02 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.262 -0.426 . . . . 0.0 110.225 177.164 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' D' D ' 14' ' ' LEU . . . . . . . . . . . . . 20.0 mt -98.37 158.05 33.32 Favored Pre-proline 0 C--N 1.33 -0.274 0 CA-C-N 116.513 -0.312 . . . . 0.0 111.27 -177.469 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' D' D ' 15' ' ' PRO . . . . . . . . . . . . . 23.1 Cg_exo -64.72 161.53 35.48 Favored 'Trans proline' 0 N--CA 1.496 1.671 0 C-N-CA 121.424 1.416 . . . . 0.0 111.876 176.973 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' D' D ' 16' ' ' PRO . . . . . . . . . . . . . 24.6 Cg_exo -62.2 -39.8 45.81 Favored 'Trans proline' 0 N--CA 1.496 1.667 0 C-N-CA 121.53 1.487 . . . . 0.0 112.622 -179.182 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' D' D ' 17' ' ' ASP . . . . . . . . . . . . . 16.2 p-10 -84.66 9.58 13.46 Favored 'General case' 0 CA--C 1.537 0.446 0 N-CA-C 113.175 0.805 . . . . 0.0 113.175 -177.109 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' D' D ' 18' ' ' PHE . . . . . 0.434 ' HE1' HD13 ' D' ' 41' ' ' ILE . 48.0 t80 -56.64 -46.47 81.0 Favored 'General case' 0 C--N 1.334 -0.097 0 O-C-N 121.983 -0.448 . . . . 0.0 110.465 -178.397 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' D' D ' 19' ' ' VAL . . . . . . . . . . . . . 48.0 t -56.65 -42.7 77.22 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.338 0 CA-C-N 116.354 -0.385 . . . . 0.0 110.595 -178.006 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' D' D ' 20' ' ' ASP . . . . . . . . . . . . . 9.9 t0 -59.63 -42.46 92.76 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-O 120.79 0.329 . . . . 0.0 110.839 -177.82 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' D' D ' 21' ' ' VAL . . . . . . . . . . . . . 46.5 t -64.02 -45.96 95.21 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.257 0 C-N-CA 120.806 -0.358 . . . . 0.0 110.479 -178.524 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' D' D ' 22' ' ' ILE . . . . . 0.446 HG22 HD12 ' D' ' 26' ' ' LEU . 51.4 mm -54.33 -48.49 67.86 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.258 0 O-C-N 122.289 -0.257 . . . . 0.0 110.812 178.812 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' D' D ' 23' ' ' ARG . . . . . . . . . . . . . 54.1 ttp180 -54.24 -52.12 62.35 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-O 120.793 0.33 . . . . 0.0 111.43 -178.905 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' D' D ' 24' ' ' ILE . . . . . . . . . . . . . 71.4 mt -56.85 -44.2 81.58 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.315 0 CA-C-N 116.541 -0.299 . . . . 0.0 111.271 -174.703 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' D' D ' 25' ' ' LYS . . . . . . . . . . . . . 80.9 mttt -69.34 -43.95 72.64 Favored 'General case' 0 C--N 1.329 -0.311 0 N-CA-C 112.428 0.529 . . . . 0.0 112.428 -177.466 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' D' D ' 26' ' ' LEU . . . . . 0.446 HD12 HG22 ' D' ' 22' ' ' ILE . 59.3 mt -83.35 -16.15 47.17 Favored 'General case' 0 C--N 1.329 -0.307 0 N-CA-C 113.786 1.032 . . . . 0.0 113.786 -170.12 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' D' D ' 27' ' ' GLN . . . . . . . . . . . . . 20.5 pt20 -46.65 151.44 0.58 Allowed 'General case' 0 N--CA 1.468 0.439 0 N-CA-C 112.837 0.68 . . . . 0.0 112.837 -177.013 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' D' D ' 28' ' ' GLY . . . . . . . . . . . . . . . 84.74 -18.18 27.07 Favored Glycine 0 CA--C 1.537 1.438 0 CA-C-N 114.937 -1.029 . . . . 0.0 113.055 -173.636 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' D' D ' 29' ' ' LYS . . . . . . . . . . . . . 51.7 mttm -86.5 134.81 33.64 Favored 'General case' 0 CA--C 1.535 0.371 0 CA-C-N 118.273 1.037 . . . . 0.0 112.596 179.343 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' D' D ' 30' ' ' THR . . . . . . . . . . . . . 26.7 m -88.73 132.77 34.46 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 115.531 -0.759 . . . . 0.0 109.593 175.791 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' D' D ' 31' ' ' VAL . . . . . . . . . . . . . 35.0 m -126.46 148.8 31.14 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.29 0 CA-C-O 120.767 0.318 . . . . 0.0 111.066 -177.532 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' D' D ' 32' ' ' ARG . . . . . . . . . . . . . 75.6 mtt180 -131.29 151.07 51.85 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 116.056 -0.52 . . . . 0.0 110.381 177.764 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' D' D ' 33' ' ' THR . . . . . . . . . . . . . 12.6 m -52.93 137.63 32.02 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.243 -0.435 . . . . 0.0 111.43 -178.49 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' D' D ' 34' ' ' GLY . . . . . . . . . . . . . . . 100.74 -17.1 56.97 Favored Glycine 0 CA--C 1.533 1.177 0 CA-C-O 119.642 -0.532 . . . . 0.0 113.228 178.779 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' D' D ' 35' ' ' ASP . . . . . . . . . . . . . 62.1 m-20 -65.34 150.32 48.48 Favored 'General case' 0 C--O 1.232 0.156 0 CA-C-N 118.038 0.919 . . . . 0.0 111.224 -179.733 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' D' D ' 36' ' ' VAL . . . . . . . . . . . . . 46.8 t -121.22 128.27 75.95 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.272 0 CA-C-N 115.776 -0.647 . . . . 0.0 109.682 178.031 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' D' D ' 37' ' ' ILE . . . . . . . . . . . . . 65.2 mt -122.25 139.24 49.8 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.243 0 CA-C-N 116.159 -0.473 . . . . 0.0 109.807 -179.29 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' D' D ' 38' ' ' GLY . . . . . . . . . . . . . . . -118.47 128.9 7.92 Favored Glycine 0 CA--C 1.526 0.721 0 N-CA-C 111.2 -0.76 . . . . 0.0 111.2 -179.613 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' D' D ' 39' ' ' ILE . . . . . . . . . . . . . 70.3 mt -124.7 130.51 73.39 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.179 0 N-CA-C 109.881 -0.414 . . . . 0.0 109.881 178.196 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' D' D ' 40' ' ' SER . . . . . . . . . . . . . 18.4 m -92.47 124.83 36.8 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.301 -0.409 . . . . 0.0 111.116 177.634 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' D' D ' 41' ' ' ILE . . . . . 0.434 HD13 ' HE1' ' D' ' 18' ' ' PHE . 66.8 mt -135.65 122.84 34.97 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.204 0 N-CA-C 110.02 -0.363 . . . . 0.0 110.02 177.749 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' D' D ' 42' ' ' LEU . . . . . . . . . . . . . 68.2 mt 58.2 35.2 24.83 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.176 -0.465 . . . . 0.0 111.522 178.124 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' D' D ' 43' ' ' GLY . . . . . . . . . . . . . . . 77.88 -10.19 27.05 Favored Glycine 0 CA--C 1.534 1.261 0 C-N-CA 121.235 -0.507 . . . . 0.0 113.418 177.278 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' D' D ' 44' ' ' LYS . . . . . . . . . . . . . 57.7 tttm -102.91 131.52 49.78 Favored 'General case' 0 C--N 1.334 -0.071 0 CA-C-N 118.007 0.903 . . . . 0.0 110.144 177.857 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' D' D ' 45' ' ' GLU . . . . . . . . . . . . . 83.6 tt0 -85.77 133.23 34.01 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.328 -0.396 . . . . 0.0 111.539 -179.318 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' D' D ' 46' ' ' VAL . . . . . . . . . . . . . 9.6 p -120.24 123.96 71.67 Favored 'Isoleucine or valine' 0 C--O 1.233 0.208 0 N-CA-C 109.42 -0.585 . . . . 0.0 109.42 173.206 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' D' D ' 47' ' ' LYS . . . . . . . . . . . . . 98.2 mttt -98.72 127.73 44.74 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.092 -0.504 . . . . 0.0 110.79 178.594 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' D' D ' 48' ' ' PHE . . . . . . . . . . . . . 35.9 m-85 -112.17 131.92 55.19 Favored 'General case' 0 C--N 1.33 -0.263 0 N-CA-C 109.714 -0.476 . . . . 0.0 109.714 177.362 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' D' D ' 49' ' ' LYS . . . . . . . . . . . . . 79.5 tttt -107.07 133.04 52.29 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.325 -0.398 . . . . 0.0 109.967 177.531 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' D' D ' 50' ' ' VAL . . . . . . . . . . . . . 43.2 t -76.71 109.83 11.49 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.339 0 N-CA-C 109.631 -0.507 . . . . 0.0 109.631 179.001 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' D' D ' 51' ' ' VAL . . . . . . . . . . . . . 47.3 t -74.17 -48.37 37.65 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.35 0 CA-C-N 116.057 -0.52 . . . . 0.0 109.918 -175.179 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' D' D ' 52' ' ' GLN . . . . . . . . . . . . . 48.4 tt0 -160.72 137.75 9.03 Favored 'General case' 0 C--N 1.33 -0.266 0 C-N-CA 120.299 -0.56 . . . . 0.0 111.595 -178.121 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' D' D ' 53' ' ' ALA . . . . . . . . . . . . . . . -116.64 132.12 56.77 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 115.975 -0.557 . . . . 0.0 109.744 174.619 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' D' D ' 54' ' ' TYR . . . . . . . . . . . . . 50.7 t80 -129.01 112.02 18.51 Favored Pre-proline 0 CA--C 1.535 0.385 0 CA-C-O 118.166 -0.921 . . . . 0.0 110.346 179.12 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' D' D ' 55' ' ' PRO . . . . . . . . . . . . . 73.8 Cg_endo -77.18 168.73 76.1 Favored 'Cis proline' 0 N--CA 1.499 1.822 0 CA-C-N 122.061 1.772 . . . . 0.0 112.368 -6.223 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' D' D ' 56' ' ' SER . . . . . . . . . . . . . 13.5 m -117.11 126.57 27.34 Favored Pre-proline 0 CA--C 1.538 0.505 0 CA-C-O 118.347 -0.835 . . . . 0.0 109.108 174.732 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' D' D ' 57' ' ' PRO . . . . . . . . . . . . . 49.6 Cg_endo -69.55 146.66 82.37 Favored 'Cis proline' 0 N--CA 1.497 1.683 0 CA-C-N 122.063 1.772 . . . . 0.0 112.044 1.934 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' D' D ' 58' ' ' LEU . . . . . . . . . . . . . 17.5 tp -106.28 135.09 48.38 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 115.99 -0.55 . . . . 0.0 110.641 179.745 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' D' D ' 59' ' ' ARG . . . . . . . . . . . . . 1.5 tpm_? -104.58 107.59 18.6 Favored 'General case' 0 C--N 1.327 -0.401 0 N-CA-C 109.01 -0.737 . . . . 0.0 109.01 178.473 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' D' D ' 60' ' ' VAL . . . . . . . . . . . . . 43.1 t -72.69 108.72 4.25 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.378 0 CA-C-O 121.449 0.642 . . . . 0.0 112.005 -174.643 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' D' D ' 61' ' ' GLU . . . . . . . . . . . . . 95.7 mt-10 -125.16 167.21 15.13 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.269 -0.423 . . . . 0.0 109.892 175.624 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' D' D ' 62' ' ' ASP . . . . . . . . . . . . . 7.6 t0 -52.85 -32.36 44.12 Favored 'General case' 0 C--N 1.328 -0.36 0 N-CA-C 112.066 0.395 . . . . 0.0 112.066 -177.035 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' D' D ' 63' ' ' ARG . . . . . . . . . . . . . 34.5 ptt180 -73.66 -17.32 61.16 Favored 'General case' 0 CA--C 1.535 0.38 0 N-CA-C 113.282 0.845 . . . . 0.0 113.282 -175.743 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' D' D ' 64' ' ' THR . . . . . . . . . . . . . 32.6 m -77.54 143.75 38.16 Favored 'General case' 0 C--N 1.331 -0.229 0 CA-C-O 120.872 0.368 . . . . 0.0 111.048 -175.511 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' D' D ' 65' ' ' LYS . . . . . . . . . . . . . 99.1 mttt -89.17 134.62 33.95 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 115.977 -0.556 . . . . 0.0 110.313 178.591 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' D' D ' 66' ' ' ILE . . . . . . . . . . . . . 69.2 mt -118.7 127.66 75.64 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.228 0 N-CA-C 109.733 -0.469 . . . . 0.0 109.733 178.625 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' D' D ' 67' ' ' THR . . . . . . . . . . . . . 20.2 m -116.02 135.87 53.56 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.113 -0.494 . . . . 0.0 110.948 -176.72 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' D' D ' 68' ' ' LEU . . . . . . . . . . . . . 16.7 tp . . . . . 0 C--N 1.33 -0.249 0 CA-C-N 115.726 -0.67 . . . . 0.0 110.319 178.553 . . . . . . . . 0 0 . 1 . 004 nuclear build core ' D' D ' 73' ' ' VAL . . . . . . . . . . . . . 36.0 m . . . . . 0 C--O 1.231 0.13 0 CA-C-O 120.743 0.306 . . . . 0.0 110.182 . . . . . . . . . 0 0 . 1 . 004 nuclear build core ' D' D ' 74' ' ' ASP . . . . . . . . . . . . . 18.5 t0 -95.21 116.66 29.04 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.152 -0.477 . . . . 0.0 109.831 -178.45 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' D' D ' 75' ' ' VAL . . . . . . . . . . . . . 44.6 t -111.68 121.95 65.15 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.227 0 CA-C-O 121.164 0.507 . . . . 0.0 110.547 -177.02 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' D' D ' 76' ' ' LEU . . . . . . . . . . . . . 21.7 mt -122.13 140.47 52.5 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 115.563 -0.744 . . . . 0.0 109.514 177.543 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' D' D ' 77' ' ' GLU . . . . . . . . . . . . . 46.7 mt-10 -133.77 135.88 44.19 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-O 120.92 0.39 . . . . 0.0 111.126 -178.136 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' D' D ' 78' ' ' ALA . . . . . 0.403 ' HB2' HD21 ' D' ' 109' ' ' LEU . . . -124.59 127.18 46.98 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 115.729 -0.669 . . . . 0.0 109.998 177.771 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' D' D ' 79' ' ' LYS . . . . . 0.619 ' O ' HD13 ' D' ' 80' ' ' ILE . 37.0 tptt -75.9 115.72 15.88 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-O 120.864 0.364 . . . . 0.0 110.535 -177.89 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' D' D ' 80' ' ' ILE . . . . . 0.619 HD13 ' O ' ' D' ' 79' ' ' LYS . 40.4 mm -139.26 111.59 5.62 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.287 0 N-CA-C 109.493 -0.558 . . . . 0.0 109.493 -176.355 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' D' D ' 81' ' ' LYS . . . . . . . . . . . . . 99.1 mttt -101.14 123.82 45.89 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-O 120.855 0.36 . . . . 0.0 110.96 -178.091 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' D' D ' 82' ' ' GLY . . . . . . . . . . . . . . . 89.0 42.35 5.66 Favored Glycine 0 CA--C 1.524 0.647 0 C-N-CA 120.791 -0.718 . . . . 0.0 111.826 175.05 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' D' D ' 83' ' ' ILE . . . . . . . . . . . . . 71.8 mt -63.77 136.73 25.89 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.33 0 N-CA-C 109.607 -0.516 . . . . 0.0 109.607 176.338 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' D' D ' 84' ' ' LYS . . . . . . . . . . . . . 76.7 tttt -95.78 -53.95 3.52 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.107 -0.497 . . . . 0.0 110.412 -177.567 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' D' D ' 85' ' ' ASP . . . . . . . . . . . . . 12.9 t70 -151.43 148.87 28.62 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 115.878 -0.601 . . . . 0.0 110.379 -179.21 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' D' D ' 86' ' ' VAL . . . . . . . . . . . . . 42.2 t -127.84 128.17 68.96 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.28 0 CA-C-O 120.886 0.374 . . . . 0.0 110.379 -179.078 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' D' D ' 87' ' ' ILE . . . . . 0.493 HD12 ' N ' ' D' ' 87' ' ' ILE . 4.9 mp -122.36 127.39 75.11 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.153 0 CA-C-N 115.994 -0.548 . . . . 0.0 109.634 176.993 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' D' D ' 88' ' ' LEU . . . . . . . . . . . . . 58.5 mt -110.22 134.96 51.7 Favored 'General case' 0 C--N 1.331 -0.204 0 CA-C-O 121.025 0.441 . . . . 0.0 110.802 -179.784 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' D' D ' 89' ' ' ASP . . . . . . . . . . . . . 4.4 t70 -123.82 163.12 21.85 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 115.775 -0.648 . . . . 0.0 109.526 178.265 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' D' D ' 90' ' ' GLU . . . . . . . . . . . . . 43.6 tp10 -44.92 -46.02 10.72 Favored 'General case' 0 N--CA 1.464 0.255 0 N-CA-C 113.158 0.799 . . . . 0.0 113.158 -171.495 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' D' D ' 91' ' ' ASN . . . . . . . . . . . . . 25.5 p30 -132.1 26.93 4.55 Favored 'General case' 0 N--CA 1.465 0.276 0 N-CA-C 112.408 0.521 . . . . 0.0 112.408 -178.837 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' D' D ' 92' ' ' LEU . . . . . . . . . . . . . 15.3 mt -147.72 150.44 34.32 Favored 'General case' 0 C--N 1.332 -0.164 0 CA-C-O 120.738 0.304 . . . . 0.0 110.493 -176.352 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' D' D ' 93' ' ' ILE . . . . . . . . . . . . . 69.0 mt -126.38 119.55 54.2 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.272 0 N-CA-C 109.363 -0.606 . . . . 0.0 109.363 177.785 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' D' D ' 94' ' ' VAL . . . . . 0.468 HG21 HG11 ' D' ' 125' ' ' VAL . 45.2 t -119.69 126.28 75.16 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.282 0 CA-C-O 120.99 0.424 . . . . 0.0 109.892 -179.743 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' D' D ' 95' ' ' VAL . . . . . . . . . . . . . 45.6 t -124.15 136.22 61.1 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.265 0 CA-C-N 116.003 -0.544 . . . . 0.0 110.046 -179.392 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' D' D ' 96' ' ' ILE . . . . . . . . . . . . . 54.4 mt -114.75 128.52 71.82 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.343 0 N-CA-C 108.979 -0.749 . . . . 0.0 108.979 178.539 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' D' D ' 97' ' ' THR . . . . . . . . . . . . . 55.1 p -101.11 160.53 14.31 Favored 'General case' 0 C--N 1.331 -0.216 0 CA-C-O 121.115 0.484 . . . . 0.0 111.416 -175.824 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' D' D ' 98' ' ' GLU . . . . . . . . . . . . . 84.2 tt0 -53.86 -26.97 27.12 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.192 -0.458 . . . . 0.0 112.094 178.399 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' D' D ' 99' ' ' GLU . . . . . . . . . . . . . 43.6 mt-10 -77.83 14.34 1.11 Allowed 'General case' 0 CA--C 1.536 0.409 0 N-CA-C 113.01 0.744 . . . . 0.0 113.01 -178.921 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' D' D ' 100' ' ' ASN . . . . . . . . . . . . . 1.9 m120 63.58 37.87 10.03 Favored 'General case' 0 CA--C 1.529 0.155 0 CA-C-N 118.103 0.411 . . . . 0.0 110.731 177.288 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' D' D ' 101' ' ' GLU . . . . . . . . . . . . . 96.7 mt-10 -113.12 148.21 35.76 Favored 'General case' 0 C--O 1.232 0.152 0 CA-C-N 116.268 -0.424 . . . . 0.0 110.377 177.356 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' D' D ' 102' ' ' VAL . . . . . . . . . . . . . 45.5 t -114.88 121.73 67.55 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.367 0 CA-C-N 115.662 -0.699 . . . . 0.0 109.412 177.811 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' D' D ' 103' ' ' LEU . . . . . . . . . . . . . 21.1 mt -115.0 125.66 53.85 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 115.811 -0.631 . . . . 0.0 109.889 177.531 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' D' D ' 104' ' ' ILE . . . . . 0.401 HD12 ' HB3' ' D' ' 113' ' ' TYR . 69.5 mt -114.77 118.77 59.7 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 N-CA-C 110.038 -0.356 . . . . 0.0 110.038 -179.648 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' D' D ' 105' ' ' PHE . . . . . . . . . . . . . 27.9 m-85 -119.88 166.1 13.74 Favored 'General case' 0 C--N 1.331 -0.216 0 O-C-N 123.972 0.795 . . . . 0.0 109.929 178.513 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' D' D ' 106' ' ' ASN . . . . . . . . . . . . . 41.3 p-10 -98.27 -170.33 1.95 Allowed 'General case' 0 C--N 1.329 -0.313 0 N-CA-C 109.791 -0.448 . . . . 0.0 109.791 174.614 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' D' D ' 107' ' ' GLN . . . . . . . . . . . . . 58.1 tt0 -59.77 -29.79 68.42 Favored 'General case' 0 CA--C 1.532 0.285 0 N-CA-C 111.827 0.306 . . . . 0.0 111.827 178.675 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' D' D ' 108' ' ' ASN . . . . . . . . . . . . . 5.1 t-20 -81.99 3.19 27.49 Favored 'General case' 0 CA--C 1.536 0.442 0 N-CA-C 113.283 0.846 . . . . 0.0 113.283 -177.443 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' D' D ' 109' ' ' LEU . . . . . 0.403 HD21 ' HB2' ' D' ' 78' ' ' ALA . 9.5 tp 64.48 40.94 5.91 Favored 'General case' 0 CA--C 1.53 0.182 0 CA-C-O 121.13 0.491 . . . . 0.0 111.364 177.543 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' D' D ' 110' ' ' GLU . . . . . . . . . . . . . 70.7 mm-40 -111.11 160.97 16.4 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-N 116.226 -0.443 . . . . 0.0 109.954 175.243 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' D' D ' 111' ' ' GLU . . . . . . . . . . . . . 45.1 tp10 -84.55 127.14 33.89 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-O 120.881 0.372 . . . . 0.0 111.065 -177.113 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' D' D ' 112' ' ' LEU . . . . . . . . . . . . . 18.9 mt -113.05 -46.11 3.12 Favored 'General case' 0 C--O 1.233 0.213 0 CA-C-N 116.017 -0.538 . . . . 0.0 110.388 176.825 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' D' D ' 113' ' ' TYR . . . . . 0.401 ' HB3' HD12 ' D' ' 104' ' ' ILE . 59.3 t80 -141.13 140.32 34.1 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.303 -0.408 . . . . 0.0 111.003 -179.939 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' D' D ' 114' ' ' ARG . . . . . . . . . . . . . 36.5 ttp180 -141.83 125.1 16.46 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 116.443 -0.344 . . . . 0.0 110.543 177.95 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' D' D ' 115' ' ' GLY . . . . . . . . . . . . . . . -150.1 160.95 28.75 Favored Glycine 0 CA--C 1.523 0.56 0 N-CA-C 111.124 -0.79 . . . . 0.0 111.124 178.867 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' D' D ' 116' ' ' LYS . . . . . . . . . . . . . 39.4 ttpt -127.25 134.34 50.09 Favored 'General case' 0 C--N 1.33 -0.281 0 N-CA-C 110.119 -0.326 . . . . 0.0 110.119 177.287 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' D' D ' 117' ' ' PHE . . . . . . . . . . . . . 31.5 m-85 -138.32 113.89 9.69 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.241 -0.436 . . . . 0.0 110.059 -176.739 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' D' D ' 118' ' ' GLU . . . . . . . . . . . . . 41.6 mp0 -55.18 -49.22 72.43 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-N 116.45 -0.341 . . . . 0.0 111.436 -174.504 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' D' D ' 119' ' ' ASN . . . . . . . . . . . . . 2.7 p30 -94.5 31.16 1.81 Allowed 'General case' 0 C--N 1.331 -0.216 0 N-CA-C 112.168 0.433 . . . . 0.0 112.168 -175.337 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' D' D ' 120' ' ' LEU . . . . . . . . . . . . . 26.8 tp -55.7 119.91 6.46 Favored 'General case' 0 C--N 1.332 -0.175 0 N-CA-C 110.344 -0.243 . . . . 0.0 110.344 175.831 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' D' D ' 121' ' ' ASN . . . . . . . . . . . . . 86.6 m-20 -114.19 -44.0 3.17 Favored 'General case' 0 N--CA 1.463 0.202 0 N-CA-C 111.569 0.211 . . . . 0.0 111.569 -175.37 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' D' D ' 122' ' ' LYS . . . . . . . . . . . . . 53.4 mtpt -138.59 149.02 44.83 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-O 121.11 0.481 . . . . 0.0 111.534 -175.419 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' D' D ' 123' ' ' VAL . . . . . 0.431 ' C ' HD12 ' D' ' 124' ' ' LEU . 46.4 t -133.92 126.49 50.55 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.268 0 CA-C-N 116.0 -0.545 . . . . 0.0 109.588 174.108 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' D' D ' 124' ' ' LEU . . . . . 0.431 HD12 ' C ' ' D' ' 123' ' ' VAL . 7.2 mp -116.99 134.44 54.73 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.311 -0.404 . . . . 0.0 110.571 -177.48 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' D' D ' 125' ' ' VAL . . . . . 0.468 HG11 HG21 ' D' ' 94' ' ' VAL . 34.8 m -131.32 125.85 57.65 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.283 0 CA-C-N 116.389 -0.368 . . . . 0.0 110.36 178.492 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' D' D ' 126' ' ' ARG . . . . . . . . . . . . . 91.2 mtt-85 -150.42 126.44 10.51 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.258 -0.428 . . . . 0.0 110.003 179.468 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' D' D ' 127' ' ' ASN . . . . . . . . . . . . . 10.9 t30 55.57 -148.94 0.47 Allowed 'General case' 0 CA--C 1.54 0.575 0 N-CA-C 110.001 -0.37 . . . . 0.0 110.001 179.502 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' D' D ' 128' ' ' ASP . . . . . . . . . . . . . 17.3 p-10 -82.84 15.35 2.73 Favored 'General case' 0 CA--C 1.535 0.388 0 CA-C-N 118.782 0.719 . . . . 0.0 112.931 179.459 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' D' D ' 129' ' ' LEU . . . . . . . . . . . . . 58.6 mt -112.49 138.2 49.59 Favored 'General case' 0 C--O 1.233 0.216 0 CA-C-N 118.171 0.441 . . . . 0.0 110.7 -179.991 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' D' D ' 130' ' ' VAL . . . . . . . . . . . . . 44.7 t -124.16 136.18 61.25 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.217 0 CA-C-N 115.924 -0.58 . . . . 0.0 109.744 179.638 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' D' D ' 131' ' ' VAL . . . . . 0.43 HG22 HD12 ' D' ' 140' ' ' LEU . 42.6 t -134.71 134.21 54.09 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.215 0 CA-C-O 120.964 0.411 . . . . 0.0 110.339 179.645 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' D' D ' 132' ' ' ILE . . . . . . . . . . . . . 73.6 mt -115.86 132.83 64.15 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.321 0 CA-C-N 115.963 -0.562 . . . . 0.0 109.509 -179.805 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' D' D ' 133' ' ' ILE . . . . . . . . . . . . . 35.7 mm -118.46 120.04 63.05 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.247 0 CA-C-O 120.847 0.356 . . . . 0.0 110.943 -174.043 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' D' D ' 134' ' ' ASP . . . . . . . . . . . . . 8.1 p-10 -133.11 147.95 52.14 Favored 'General case' 0 C--N 1.332 -0.185 0 N-CA-C 109.801 -0.444 . . . . 0.0 109.801 174.789 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' D' D ' 135' ' ' GLU . . . . . . . . . . . . . 84.1 tt0 -49.76 -23.86 2.04 Favored 'General case' 0 C--N 1.329 -0.32 0 N-CA-C 113.049 0.759 . . . . 0.0 113.049 -170.962 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' D' D ' 136' ' ' GLN . . . . . . . . . . . . . 39.3 tp60 -89.4 -37.68 14.66 Favored 'General case' 0 C--N 1.33 -0.241 0 N-CA-C 112.146 0.425 . . . . 0.0 112.146 -175.366 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' D' D ' 137' ' ' LYS . . . . . . . . . . . . . 57.0 pttt -156.41 166.0 34.69 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-O 121.525 0.679 . . . . 0.0 112.077 -171.185 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' D' D ' 138' ' ' LEU . . . . . 0.455 HD23 ' N ' ' D' ' 139' ' ' THR . 4.8 tt -117.7 128.4 54.86 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 115.065 -0.97 . . . . 0.0 109.793 178.115 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' D' D ' 139' ' ' THR . . . . . 0.455 ' N ' HD23 ' D' ' 138' ' ' LEU . 29.8 m -110.43 127.4 55.1 Favored 'General case' 0 C--N 1.331 -0.224 0 CA-C-N 116.421 -0.354 . . . . 0.0 110.809 -179.59 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' D' D ' 140' ' ' LEU . . . . . 0.43 HD12 HG22 ' D' ' 131' ' ' VAL . 9.9 tp -112.61 120.12 40.47 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 115.567 -0.742 . . . . 0.0 109.056 -179.912 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' D' D ' 141' ' ' ILE . . . . . . . . . . . . . 19.6 mt -119.66 117.12 52.77 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.283 0 CA-C-O 121.077 0.465 . . . . 0.0 109.933 -175.823 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' D' D ' 142' ' ' ARG . . . . . . . . . . . . . 58.8 ttp180 -108.85 119.1 38.55 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 115.28 -0.873 . . . . 0.0 110.13 -178.344 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' D' D ' 143' ' ' THR . . . . . . . . . . . . . 54.6 p . . . . . 0 C--O 1.22 -0.465 0 CA-C-O 117.983 -1.008 . . . . 0.0 110.749 -178.596 . . . . . . . . 0 0 . 1 . 004 nuclear build core ' E' E ' 2' ' ' SER . . . . . . . . . . . . . 3.0 p . . . . . 0 C--O 1.233 0.197 0 CA-C-O 120.944 0.402 . . . . 0.0 110.629 . . . . . . . . . 0 0 . 1 . 004 nuclear build core ' E' E ' 3' ' ' GLU . . . . . . . . . . . . . 83.4 tt0 -142.27 142.35 32.57 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.034 -0.53 . . . . 0.0 111.203 -178.579 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' E' E ' 4' ' ' LEU . . . . . . . . . . . . . 14.4 tp -123.24 128.58 50.19 Favored 'General case' 0 C--N 1.332 -0.187 0 CA-C-N 115.958 -0.565 . . . . 0.0 110.281 176.85 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' E' E ' 5' ' ' LYS . . . . . . . . . . . . . 75.1 mttt -105.86 121.4 44.0 Favored 'General case' 0 C--O 1.235 0.293 0 CA-C-N 116.306 -0.406 . . . . 0.0 110.57 178.065 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' E' E ' 6' ' ' LEU . . . . . . . . . . . . . 29.3 mt -115.3 149.82 37.22 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 115.531 -0.759 . . . . 0.0 110.251 -179.735 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' E' E ' 7' ' ' LYS . . . . . . . . . . . . . 58.4 tttm -139.6 138.08 19.66 Favored Pre-proline 0 CA--C 1.533 0.305 0 CA-C-O 119.031 -0.509 . . . . 0.0 110.086 175.088 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' E' E ' 8' ' ' PRO . . . . . . . . . . . . . 98.7 Cg_endo -91.44 139.28 2.34 Favored 'Trans proline' 0 N--CA 1.489 1.258 0 C-N-CA 121.716 1.611 . . . . 0.0 111.728 177.396 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' E' E ' 9' ' ' LEU . . . . . . . . . . . . . 57.5 mt -71.46 -46.65 13.36 Favored Pre-proline 0 CA--C 1.533 0.312 0 CA-C-O 118.644 -0.693 . . . . 0.0 112.033 -179.026 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' E' E ' 10' ' ' PRO . . . . . . . . . . . . . 89.9 Cg_endo -82.31 147.36 14.35 Favored 'Trans proline' 0 N--CA 1.495 1.596 0 C-N-CA 121.147 1.231 . . . . 0.0 111.509 174.419 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' E' E ' 11' ' ' LYS . . . . . . . . . . . . . 50.3 pttt -86.51 115.06 23.76 Favored 'General case' 0 C--N 1.331 -0.222 0 CA-C-O 121.383 0.611 . . . . 0.0 110.217 178.122 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' E' E ' 12' ' ' VAL . . . . . . . . . . . . . 11.6 p -151.11 146.59 16.06 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 CA-C-N 115.879 -0.6 . . . . 0.0 110.544 -178.89 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' E' E ' 13' ' ' GLU . . . . . . . . . . . . . 95.8 mt-10 -83.23 118.03 23.35 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.347 -0.388 . . . . 0.0 110.042 177.126 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' E' E ' 14' ' ' LEU . . . . . . . . . . . . . 48.6 mt -96.53 148.8 35.01 Favored Pre-proline 0 C--N 1.33 -0.265 0 CA-C-O 119.282 -0.39 . . . . 0.0 110.665 -177.881 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' E' E ' 15' ' ' PRO . . . . . . . . . . . . . 27.9 Cg_exo -61.31 163.61 16.98 Favored 'Trans proline' 0 N--CA 1.497 1.704 0 C-N-CA 121.339 1.36 . . . . 0.0 112.093 177.015 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' E' E ' 16' ' ' PRO . . . . . . . . . . . . . 24.4 Cg_exo -62.25 -39.58 46.82 Favored 'Trans proline' 0 N--CA 1.497 1.69 0 C-N-CA 121.561 1.508 . . . . 0.0 112.987 -178.296 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' E' E ' 17' ' ' ASP . . . . . . . . . . . . . 22.1 p-10 -85.39 8.42 18.94 Favored 'General case' 0 CA--C 1.535 0.396 0 N-CA-C 113.302 0.853 . . . . 0.0 113.302 -176.304 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' E' E ' 18' ' ' PHE . . . . . . . . . . . . . 32.4 t80 -55.97 -47.87 76.86 Favored 'General case' 0 C--N 1.334 -0.107 0 O-C-N 121.904 -0.498 . . . . 0.0 110.506 -179.359 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' E' E ' 19' ' ' VAL . . . . . . . . . . . . . 14.0 p -56.3 -40.77 68.13 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.272 0 CA-C-N 116.227 -0.442 . . . . 0.0 111.037 -178.985 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' E' E ' 20' ' ' ASP . . . . . . . . . . . . . 20.2 t0 -60.54 -43.78 96.81 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-O 120.793 0.33 . . . . 0.0 111.15 -177.312 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' E' E ' 21' ' ' VAL . . . . . . . . . . . . . 49.1 t -63.67 -46.33 95.0 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.332 0 C-N-CA 120.834 -0.346 . . . . 0.0 110.296 -178.488 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' E' E ' 22' ' ' ILE . . . . . 0.677 HG22 HD12 ' E' ' 26' ' ' LEU . 49.3 mm -55.54 -45.79 78.77 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.227 0 C-N-CA 120.956 -0.298 . . . . 0.0 110.707 178.377 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' E' E ' 23' ' ' ARG . . . . . . . . . . . . . 54.7 ttp180 -53.33 -51.0 63.79 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-O 120.584 0.23 . . . . 0.0 111.538 -178.544 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' E' E ' 24' ' ' ILE . . . . . . . . . . . . . 68.5 mt -59.64 -43.71 91.82 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.287 0 C-N-CA 121.138 -0.225 . . . . 0.0 111.349 -177.221 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' E' E ' 25' ' ' LYS . . . . . . . . . . . . . 97.9 mttt -64.85 -38.45 91.02 Favored 'General case' 0 C--N 1.329 -0.314 0 N-CA-C 112.208 0.447 . . . . 0.0 112.208 -178.247 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' E' E ' 26' ' ' LEU . . . . . 0.677 HD12 HG22 ' E' ' 22' ' ' ILE . 37.5 mt -80.47 -41.77 23.79 Favored 'General case' 0 C--N 1.329 -0.302 0 N-CA-C 113.258 0.836 . . . . 0.0 113.258 -171.675 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' E' E ' 27' ' ' GLN . . . . . . . . . . . . . 12.1 pt20 -46.42 142.68 2.91 Favored 'General case' 0 N--CA 1.469 0.486 0 N-CA-C 112.869 0.692 . . . . 0.0 112.869 -174.325 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' E' E ' 28' ' ' GLY . . . . . . . . . . . . . . . 98.75 -28.68 13.98 Favored Glycine 0 CA--C 1.531 1.066 0 CA-C-N 115.479 -0.782 . . . . 0.0 112.02 -177.467 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' E' E ' 29' ' ' LYS . . . . . . . . . . . . . 87.7 mttt -98.07 155.08 17.29 Favored 'General case' 0 C--N 1.331 -0.224 0 CA-C-N 117.235 0.517 . . . . 0.0 111.08 178.808 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' E' E ' 30' ' ' THR . . . . . . . . . . . . . 40.1 m -102.4 137.39 40.71 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.002 -0.544 . . . . 0.0 109.949 175.679 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' E' E ' 31' ' ' VAL . . . . . . . . . . . . . 34.6 m -127.92 152.81 36.48 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.256 0 CA-C-O 120.939 0.4 . . . . 0.0 110.729 -178.23 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' E' E ' 32' ' ' ARG . . . . . . . . . . . . . 61.1 ttt180 -131.09 147.82 52.66 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-O 121.215 0.531 . . . . 0.0 110.628 -179.527 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' E' E ' 33' ' ' THR . . . . . . . . . . . . . 31.4 m -52.56 140.7 22.25 Favored 'General case' 0 C--N 1.331 -0.23 0 CA-C-N 116.293 -0.412 . . . . 0.0 111.453 -178.552 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' E' E ' 34' ' ' GLY . . . . . . . . . . . . . . . 99.51 -17.2 58.01 Favored Glycine 0 CA--C 1.531 1.087 0 CA-C-O 119.681 -0.511 . . . . 0.0 113.247 179.502 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' E' E ' 35' ' ' ASP . . . . . . . . . . . . . 80.0 m-20 -66.88 147.52 53.13 Favored 'General case' 0 C--O 1.232 0.138 0 CA-C-N 118.013 0.906 . . . . 0.0 111.028 178.531 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' E' E ' 36' ' ' VAL . . . . . . . . . . . . . 44.2 t -120.9 129.31 75.81 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.208 0 CA-C-N 116.082 -0.508 . . . . 0.0 109.713 177.527 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' E' E ' 37' ' ' ILE . . . . . . . . . . . . . 67.2 mt -121.01 138.83 50.16 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.289 0 CA-C-N 116.246 -0.434 . . . . 0.0 109.937 -178.951 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' E' E ' 38' ' ' GLY . . . . . . . . . . . . . . . -109.78 128.86 9.11 Favored Glycine 0 CA--C 1.524 0.656 0 N-CA-C 111.159 -0.776 . . . . 0.0 111.159 -179.64 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' E' E ' 39' ' ' ILE . . . . . . . . . . . . . 74.4 mt -123.61 133.73 68.38 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.203 0 N-CA-C 109.976 -0.379 . . . . 0.0 109.976 179.017 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' E' E ' 40' ' ' SER . . . . . . . . . . . . . 59.7 p -92.87 117.4 30.0 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.284 -0.417 . . . . 0.0 110.797 175.465 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' E' E ' 41' ' ' ILE . . . . . . . . . . . . . 43.8 mm -121.05 118.0 54.76 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.224 0 CA-C-O 120.802 0.334 . . . . 0.0 110.379 -179.864 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' E' E ' 42' ' ' LEU . . . . . . . . . . . . . 61.1 mt 52.65 36.3 20.51 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 116.194 -0.457 . . . . 0.0 111.604 176.646 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' E' E ' 43' ' ' GLY . . . . . . . . . . . . . . . 73.04 30.51 63.08 Favored Glycine 0 CA--C 1.529 0.911 0 C-N-CA 121.135 -0.555 . . . . 0.0 112.275 177.816 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' E' E ' 44' ' ' LYS . . . . . . . . . . . . . 68.7 mttm -138.31 134.27 34.08 Favored 'General case' 0 C--N 1.331 -0.234 0 N-CA-C 109.759 -0.46 . . . . 0.0 109.759 177.757 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' E' E ' 45' ' ' GLU . . . . . . . . . . . . . 80.6 tt0 -83.02 124.46 30.44 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-O 120.839 0.352 . . . . 0.0 111.6 -176.192 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' E' E ' 46' ' ' VAL . . . . . . . . . . . . . 7.2 p -124.61 126.44 71.68 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.19 0 N-CA-C 109.478 -0.564 . . . . 0.0 109.478 173.863 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' E' E ' 47' ' ' LYS . . . . . . . . . . . . . 98.9 mttt -99.91 129.66 46.01 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.064 -0.516 . . . . 0.0 111.081 178.994 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' E' E ' 48' ' ' PHE . . . . . . . . . . . . . 91.1 m-85 -112.69 131.9 55.44 Favored 'General case' 0 C--N 1.33 -0.271 0 N-CA-C 109.872 -0.418 . . . . 0.0 109.872 177.035 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' E' E ' 49' ' ' LYS . . . . . . . . . . . . . 80.0 tttt -106.96 135.99 47.57 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.294 -0.412 . . . . 0.0 110.279 179.067 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' E' E ' 50' ' ' VAL . . . . . . . . . . . . . 46.0 t -77.14 105.02 5.56 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.218 0 N-CA-C 109.192 -0.67 . . . . 0.0 109.192 175.585 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' E' E ' 51' ' ' VAL . . . . . . . . . . . . . 48.6 t -68.71 -47.97 73.75 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.362 0 O-C-N 123.563 0.539 . . . . 0.0 109.744 -173.179 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' E' E ' 52' ' ' GLN . . . . . . . . . . . . . 43.2 tt0 -171.03 142.12 1.78 Allowed 'General case' 0 C--N 1.329 -0.318 0 C-N-CA 120.313 -0.555 . . . . 0.0 111.423 -179.709 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' E' E ' 53' ' ' ALA . . . . . . . . . . . . . . . -114.41 136.03 53.45 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 115.697 -0.683 . . . . 0.0 110.14 177.517 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' E' E ' 54' ' ' TYR . . . . . . . . . . . . . 37.0 t80 -128.99 108.6 18.18 Favored Pre-proline 0 CA--C 1.535 0.374 0 CA-C-O 118.245 -0.883 . . . . 0.0 110.206 178.558 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' E' E ' 55' ' ' PRO . . . . . . . . . . . . . 73.4 Cg_endo -77.15 170.01 72.71 Favored 'Cis proline' 0 N--CA 1.499 1.841 0 CA-C-N 121.769 1.667 . . . . 0.0 112.486 -5.025 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' E' E ' 56' ' ' SER . . . . . . . . . . . . . 41.2 m -117.21 131.39 24.03 Favored Pre-proline 0 CA--C 1.539 0.524 0 CA-C-O 118.399 -0.81 . . . . 0.0 109.509 174.768 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' E' E ' 57' ' ' PRO . . . . . . . . . . . . . 57.0 Cg_endo -72.36 148.26 90.9 Favored 'Cis proline' 0 N--CA 1.497 1.719 0 CA-C-N 121.917 1.72 . . . . 0.0 111.54 -1.173 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' E' E ' 58' ' ' LEU . . . . . . . . . . . . . 23.8 tp -108.26 137.11 46.79 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.561 -178.622 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' E' E ' 59' ' ' ARG . . . . . . . . . . . . . 54.0 ttp180 -99.92 126.06 46.01 Favored 'General case' 0 C--N 1.328 -0.341 0 N-CA-C 109.334 -0.617 . . . . 0.0 109.334 174.92 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' E' E ' 60' ' ' VAL . . . . . . . . . . . . . 40.5 t -83.03 120.43 34.36 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.269 0 C-N-CA 120.599 -0.44 . . . . 0.0 110.578 -174.955 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' E' E ' 61' ' ' GLU . . . . . . . . . . . . . 74.7 tt0 -130.8 156.01 45.72 Favored 'General case' 0 C--N 1.329 -0.326 0 N-CA-C 108.989 -0.745 . . . . 0.0 108.989 176.252 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' E' E ' 62' ' ' ASP . . . . . . . . . . . . . 9.8 p-10 -51.01 -30.62 15.78 Favored 'General case' 0 C--N 1.327 -0.385 0 N-CA-C 112.369 0.507 . . . . 0.0 112.369 -175.312 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' E' E ' 63' ' ' ARG . . . . . . . . . . . . . 76.0 mtt180 -77.89 -22.07 50.3 Favored 'General case' 0 CA--C 1.533 0.322 0 N-CA-C 113.149 0.796 . . . . 0.0 113.149 -174.987 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' E' E ' 64' ' ' THR . . . . . . . . . . . . . 28.3 m -63.37 146.16 54.1 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-O 120.872 0.367 . . . . 0.0 110.964 -175.841 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' E' E ' 65' ' ' LYS . . . . . . . . . . . . . 67.5 mttm -89.2 134.37 34.06 Favored 'General case' 0 C--N 1.331 -0.212 0 CA-C-N 116.121 -0.49 . . . . 0.0 110.662 -179.733 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' E' E ' 66' ' ' ILE . . . . . . . . . . . . . 62.4 mt -120.9 130.97 74.08 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.238 0 N-CA-C 109.993 -0.373 . . . . 0.0 109.993 179.224 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' E' E ' 67' ' ' THR . . . . . . . . . . . . . 19.1 m -129.72 142.82 50.64 Favored 'General case' 0 C--N 1.332 -0.175 0 CA-C-O 120.979 0.418 . . . . 0.0 111.042 -178.403 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' E' E ' 68' ' ' LEU . . . . . 0.506 HD12 ' N ' ' E' ' 68' ' ' LEU . 6.7 mp . . . . . 0 C--N 1.33 -0.24 0 CA-C-N 116.106 -0.497 . . . . 0.0 110.601 177.702 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' E' E ' 73' ' ' VAL . . . . . . . . . . . . . 36.0 m . . . . . 0 C--O 1.231 0.091 0 N-CA-C 110.008 -0.367 . . . . 0.0 110.008 . . . . . . . . . 0 0 . 1 . 004 nuclear build core ' E' E ' 74' ' ' ASP . . . . . . . . . . . . . 18.9 t0 -93.85 118.78 31.91 Favored 'General case' 0 C--N 1.328 -0.331 0 N-CA-C 109.978 -0.378 . . . . 0.0 109.978 -177.84 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' E' E ' 75' ' ' VAL . . . . . 0.419 ' C ' HD12 ' E' ' 76' ' ' LEU . 42.2 t -116.57 121.0 66.66 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.224 0 CA-C-O 121.055 0.455 . . . . 0.0 110.468 -178.445 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' E' E ' 76' ' ' LEU . . . . . 0.419 HD12 ' C ' ' E' ' 75' ' ' VAL . 7.0 mp -119.01 149.06 42.28 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 115.778 -0.646 . . . . 0.0 109.788 176.961 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' E' E ' 77' ' ' GLU . . . . . . . . . . . . . 96.3 mt-10 -136.97 134.63 36.89 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-O 121.006 0.432 . . . . 0.0 111.333 -178.975 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' E' E ' 78' ' ' ALA . . . . . . . . . . . . . . . -121.28 136.63 54.94 Favored 'General case' 0 C--N 1.331 -0.225 0 CA-C-N 115.671 -0.695 . . . . 0.0 109.85 176.959 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' E' E ' 79' ' ' LYS . . . . . 0.452 ' O ' HD13 ' E' ' 80' ' ' ILE . 46.3 mmtm -78.48 119.25 21.51 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-O 120.798 0.332 . . . . 0.0 110.611 179.859 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' E' E ' 80' ' ' ILE . . . . . 0.452 HD13 ' O ' ' E' ' 79' ' ' LYS . 26.4 mm -139.25 110.45 4.85 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.28 0 N-CA-C 108.967 -0.753 . . . . 0.0 108.967 -179.351 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' E' E ' 81' ' ' LYS . . . . . . . . . . . . . 54.8 pttt -103.24 124.56 48.85 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-O 120.948 0.404 . . . . 0.0 111.194 -176.753 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' E' E ' 82' ' ' GLY . . . . . . . . . . . . . . . 88.94 42.2 5.72 Favored Glycine 0 CA--C 1.525 0.695 0 C-N-CA 120.713 -0.756 . . . . 0.0 111.616 174.622 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' E' E ' 83' ' ' ILE . . . . . . . . . . . . . 68.2 mt -66.35 139.7 20.74 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.362 0 N-CA-C 109.779 -0.452 . . . . 0.0 109.779 178.247 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' E' E ' 84' ' ' LYS . . . . . . . . . . . . . 87.6 tttt -101.05 -53.96 2.91 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-N 116.011 -0.54 . . . . 0.0 110.311 -178.217 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' E' E ' 85' ' ' ASP . . . . . . . . . . . . . 9.6 t70 -149.97 146.98 27.33 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 115.754 -0.657 . . . . 0.0 110.187 -178.373 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' E' E ' 86' ' ' VAL . . . . . . . . . . . . . 43.0 t -131.69 129.78 61.61 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.228 0 CA-C-O 121.006 0.431 . . . . 0.0 110.476 -178.495 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' E' E ' 87' ' ' ILE . . . . . 0.495 ' N ' HD12 ' E' ' 87' ' ' ILE . 4.9 mp -119.94 125.05 73.88 Favored 'Isoleucine or valine' 0 C--O 1.233 0.198 0 CA-C-N 115.943 -0.571 . . . . 0.0 109.481 176.2 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' E' E ' 88' ' ' LEU . . . . . . . . . . . . . 16.8 tp -110.54 129.19 55.85 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-O 120.911 0.386 . . . . 0.0 110.737 -179.185 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' E' E ' 89' ' ' ASP . . . . . . . . . . . . . 9.5 t70 -123.79 154.18 39.92 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-N 116.01 -0.541 . . . . 0.0 109.815 178.709 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' E' E ' 90' ' ' GLU . . . . . . . . . . . . . 43.1 mt-10 -47.82 -38.43 15.89 Favored 'General case' 0 C--N 1.33 -0.241 0 N-CA-C 112.71 0.633 . . . . 0.0 112.71 -172.643 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' E' E ' 91' ' ' ASN . . . . . . . . . . . . . 6.6 t-20 -132.1 34.58 3.79 Favored 'General case' 0 N--CA 1.463 0.217 0 N-CA-C 111.738 0.273 . . . . 0.0 111.738 -176.455 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' E' E ' 92' ' ' LEU . . . . . . . . . . . . . 12.5 tp -166.16 148.76 7.11 Favored 'General case' 0 C--N 1.329 -0.286 0 C-N-CA 120.937 -0.305 . . . . 0.0 110.906 -178.991 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' E' E ' 93' ' ' ILE . . . . . . . . . . . . . 72.9 mt -128.18 123.28 59.98 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.178 0 N-CA-C 109.491 -0.559 . . . . 0.0 109.491 178.222 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' E' E ' 94' ' ' VAL . . . . . . . . . . . . . 44.8 t -123.96 126.12 72.0 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.277 0 CA-C-O 120.875 0.369 . . . . 0.0 110.035 -179.66 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' E' E ' 95' ' ' VAL . . . . . . . . . . . . . 41.8 t -123.77 134.73 65.64 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.252 0 CA-C-N 116.104 -0.498 . . . . 0.0 110.21 -178.419 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' E' E ' 96' ' ' ILE . . . . . . . . . . . . . 58.1 mt -115.51 130.06 70.75 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 N-CA-C 109.287 -0.634 . . . . 0.0 109.287 178.359 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' E' E ' 97' ' ' THR . . . . . . . . . . . . . 80.3 p -102.09 158.44 16.16 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-O 121.257 0.551 . . . . 0.0 111.324 -177.034 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' E' E ' 98' ' ' GLU . . . . . . . . . . . . . 83.5 tt0 -53.86 -27.05 27.61 Favored 'General case' 0 CA--C 1.533 0.313 0 N-CA-C 112.3 0.481 . . . . 0.0 112.3 -179.529 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' E' E ' 99' ' ' GLU . . . . . . . . . . . . . 34.7 tt0 -80.77 18.06 1.05 Allowed 'General case' 0 CA--C 1.536 0.418 0 N-CA-C 112.728 0.64 . . . . 0.0 112.728 -176.619 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' E' E ' 100' ' ' ASN . . . . . . . . . . . . . 3.2 m-20 61.06 37.96 17.52 Favored 'General case' 0 N--CA 1.463 0.176 0 O-C-N 121.955 -0.466 . . . . 0.0 110.819 178.366 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' E' E ' 101' ' ' GLU . . . . . . . . . . . . . 84.2 tt0 -116.74 143.11 46.05 Favored 'General case' 0 C--N 1.331 -0.203 0 CA-C-N 116.159 -0.473 . . . . 0.0 109.75 177.379 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' E' E ' 102' ' ' VAL . . . . . . . . . . . . . 44.0 t -115.52 127.55 73.05 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.367 0 CA-C-N 116.419 -0.355 . . . . 0.0 110.132 -177.804 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' E' E ' 103' ' ' LEU . . . . . . . . . . . . . 28.9 mt -117.96 131.14 56.53 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-N 115.677 -0.692 . . . . 0.0 109.889 177.123 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' E' E ' 104' ' ' ILE . . . . . . . . . . . . . 67.4 mt -117.66 122.17 69.19 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.26 0 N-CA-C 110.107 -0.331 . . . . 0.0 110.107 -178.336 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' E' E ' 105' ' ' PHE . . . . . . . . . . . . . 91.5 m-85 -124.11 166.4 15.86 Favored 'General case' 0 C--O 1.232 0.151 0 O-C-N 123.985 0.803 . . . . 0.0 110.131 -178.52 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' E' E ' 106' ' ' ASN . . . . . . . . . . . . . 45.6 p-10 -104.04 -172.51 2.12 Favored 'General case' 0 C--N 1.332 -0.172 0 N-CA-C 109.755 -0.461 . . . . 0.0 109.755 171.131 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' E' E ' 107' ' ' GLN . . . . . . . . . . . . . 14.9 tt0 -58.76 -29.99 67.18 Favored 'General case' 0 CA--C 1.532 0.255 0 N-CA-C 112.065 0.394 . . . . 0.0 112.065 -179.72 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' E' E ' 108' ' ' ASN . . . . . . . . . . . . . 48.4 t30 -86.72 12.7 10.15 Favored 'General case' 0 CA--C 1.534 0.34 0 N-CA-C 113.001 0.741 . . . . 0.0 113.001 -176.384 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' E' E ' 109' ' ' LEU . . . . . . . . . . . . . 34.4 mt 58.2 33.34 23.06 Favored 'General case' 0 C--O 1.232 0.168 0 N-CA-C 111.998 0.37 . . . . 0.0 111.998 176.912 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' E' E ' 110' ' ' GLU . . . . . . . . . . . . . 95.5 mt-10 -101.86 129.94 48.21 Favored 'General case' 0 C--N 1.33 -0.25 0 N-CA-C 109.182 -0.673 . . . . 0.0 109.182 174.582 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' E' E ' 111' ' ' GLU . . . . . . . . . . . . . 45.5 tt0 -74.11 121.99 22.02 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-O 121.073 0.463 . . . . 0.0 110.352 -176.108 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' E' E ' 112' ' ' LEU . . . . . . . . . . . . . 35.4 mt -99.62 -46.07 5.57 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 115.795 -0.639 . . . . 0.0 110.461 -179.612 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' E' E ' 113' ' ' TYR . . . . . . . . . . . . . 57.8 t80 -139.22 145.66 39.53 Favored 'General case' 0 C--N 1.331 -0.208 0 CA-C-N 116.317 -0.402 . . . . 0.0 111.197 -178.166 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' E' E ' 114' ' ' ARG . . . . . . . . . . . . . 45.3 ptt85 -147.35 125.27 11.98 Favored 'General case' 0 C--N 1.33 -0.239 0 CA-C-N 116.07 -0.514 . . . . 0.0 110.663 179.062 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' E' E ' 115' ' ' GLY . . . . . . . . . . . . . . . -150.07 159.11 27.96 Favored Glycine 0 CA--C 1.523 0.538 0 N-CA-C 111.105 -0.798 . . . . 0.0 111.105 178.96 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' E' E ' 116' ' ' LYS . . . . . . . . . . . . . 38.4 ttpt -127.07 132.46 50.66 Favored 'General case' 0 C--N 1.33 -0.268 0 N-CA-C 109.809 -0.441 . . . . 0.0 109.809 178.077 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' E' E ' 117' ' ' PHE . . . . . . . . . . . . . 36.6 m-85 -132.14 113.82 13.77 Favored 'General case' 0 C--N 1.331 -0.213 0 CA-C-O 121.014 0.435 . . . . 0.0 110.376 -175.582 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' E' E ' 118' ' ' GLU . . . . . . . . . . . . . 96.3 mt-10 -54.77 -46.93 74.45 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 116.268 -0.424 . . . . 0.0 111.254 -176.728 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' E' E ' 119' ' ' ASN . . . . . . . . . . . . . 24.4 m120 -95.62 31.01 2.13 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.165 -0.471 . . . . 0.0 112.139 -173.523 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' E' E ' 120' ' ' LEU . . . . . . . . . . . . . 14.7 tp -54.92 119.94 6.14 Favored 'General case' 0 N--CA 1.463 0.191 0 C-N-CA 121.019 -0.272 . . . . 0.0 110.752 177.449 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' E' E ' 121' ' ' ASN . . . . . . . . . . . . . 33.3 t-20 -114.09 -43.97 3.19 Favored 'General case' 0 C--N 1.331 -0.22 0 CA-C-N 116.599 -0.273 . . . . 0.0 111.359 -175.181 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' E' E ' 122' ' ' LYS . . . . . . . . . . . . . 36.5 mtmm -143.3 145.22 32.53 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-O 121.121 0.486 . . . . 0.0 111.63 -176.628 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' E' E ' 123' ' ' VAL . . . . . . . . . . . . . 46.8 t -126.67 127.54 70.25 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.22 0 CA-C-N 115.873 -0.603 . . . . 0.0 109.63 176.525 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' E' E ' 124' ' ' LEU . . . . . . . . . . . . . 50.2 mt -130.33 123.56 30.27 Favored 'General case' 0 C--N 1.331 -0.222 0 CA-C-N 116.441 -0.345 . . . . 0.0 110.186 179.751 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' E' E ' 125' ' ' VAL . . . . . 0.486 HG12 HG13 ' E' ' 130' ' ' VAL . 33.0 m -143.14 136.43 25.58 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.305 0 CA-C-O 120.816 0.341 . . . . 0.0 111.125 -178.937 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' E' E ' 126' ' ' ARG . . . . . . . . . . . . . 63.3 mtm180 -151.02 131.15 13.49 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-O 121.152 0.501 . . . . 0.0 110.876 177.82 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' E' E ' 127' ' ' ASN . . . . . . . . . . . . . 3.7 m120 52.01 -105.05 0.2 Allowed 'General case' 0 CA--C 1.543 0.677 0 CA-C-N 115.827 -0.624 . . . . 0.0 111.489 178.629 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' E' E ' 128' ' ' ASP . . . . . . . . . . . . . 22.8 p-10 -114.13 1.45 14.59 Favored 'General case' 0 N--CA 1.467 0.409 0 CA-C-N 119.345 0.975 . . . . 0.0 113.461 -174.895 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' E' E ' 129' ' ' LEU . . . . . . . . . . . . . 68.7 mt -105.55 128.91 53.86 Favored 'General case' 0 C--N 1.333 -0.126 0 CA-C-N 118.28 0.491 . . . . 0.0 110.301 179.215 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' E' E ' 130' ' ' VAL . . . . . 0.486 HG13 HG12 ' E' ' 125' ' ' VAL . 60.3 t -122.06 128.75 75.67 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.273 0 CA-C-N 115.95 -0.568 . . . . 0.0 109.544 -179.571 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' E' E ' 131' ' ' VAL . . . . . . . . . . . . . 41.8 t -136.03 132.38 50.13 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.227 0 CA-C-O 121.186 0.517 . . . . 0.0 110.288 177.493 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' E' E ' 132' ' ' ILE . . . . . . . . . . . . . 73.5 mt -117.25 131.78 68.96 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.316 0 CA-C-N 115.625 -0.716 . . . . 0.0 109.393 179.784 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' E' E ' 133' ' ' ILE . . . . . . . . . . . . . 36.9 mm -113.04 121.07 64.56 Favored 'Isoleucine or valine' 0 C--O 1.233 0.206 0 CA-C-O 120.741 0.305 . . . . 0.0 111.009 -174.935 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' E' E ' 134' ' ' ASP . . . . . . . . . . . . . 9.7 p-10 -131.73 148.23 52.56 Favored 'General case' 0 C--N 1.332 -0.18 0 N-CA-C 109.727 -0.472 . . . . 0.0 109.727 175.2 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' E' E ' 135' ' ' GLU . . . . . . . . . . . . . 78.2 tt0 -49.9 -26.61 4.27 Favored 'General case' 0 C--N 1.328 -0.331 0 N-CA-C 113.019 0.748 . . . . 0.0 113.019 -171.515 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' E' E ' 136' ' ' GLN . . . . . . . . . . . . . 99.4 mm-40 -86.26 -32.07 21.32 Favored 'General case' 0 C--N 1.331 -0.234 0 N-CA-C 112.411 0.522 . . . . 0.0 112.411 -174.932 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' E' E ' 137' ' ' LYS . . . . . . . . . . . . . 23.8 pttm -167.21 174.04 8.51 Favored 'General case' 0 C--O 1.233 0.191 0 CA-C-O 121.472 0.653 . . . . 0.0 112.429 -172.488 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' E' E ' 138' ' ' LEU . . . . . 0.401 ' C ' HD23 ' E' ' 138' ' ' LEU . 5.6 tt -118.52 127.32 53.51 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 114.925 -1.034 . . . . 0.0 110.033 179.867 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' E' E ' 139' ' ' THR . . . . . . . . . . . . . 28.4 m -104.51 120.39 41.15 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.042 -0.526 . . . . 0.0 110.257 179.439 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' E' E ' 140' ' ' LEU . . . . . 0.473 ' C ' HD23 ' E' ' 140' ' ' LEU . 7.7 tt -108.65 120.65 43.08 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 115.824 -0.626 . . . . 0.0 109.427 -179.974 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' E' E ' 141' ' ' ILE . . . . . . . . . . . . . 18.4 mt -123.84 121.2 61.69 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.265 0 CA-C-O 121.012 0.434 . . . . 0.0 109.833 -175.041 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' E' E ' 142' ' ' ARG . . . . . . . . . . . . . 64.5 ttt180 -109.11 124.12 50.29 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 115.689 -0.687 . . . . 0.0 110.22 179.218 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' E' E ' 143' ' ' THR . . . . . . . . . . . . . 55.9 p . . . . . 0 C--O 1.22 -0.467 0 CA-C-O 118.19 -0.909 . . . . 0.0 110.822 -179.542 . . . . . . . . 0 0 . 1 . 004 nuclear build core ' F' F ' 1' ' ' MET . . . . . . . . . . . . . 27.6 ptm . . . . . 0 C--O 1.23 0.065 0 CA-C-O 120.848 0.356 . . . . 0.0 110.638 . . . . . . . . . 0 0 . 1 . 004 nuclear build core ' F' F ' 2' ' ' SER . . . . . . . . . . . . . 2.5 p -129.32 128.1 42.45 Favored 'General case' 0 C--N 1.331 -0.198 0 CA-C-N 116.113 -0.494 . . . . 0.0 110.596 179.59 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' F' F ' 3' ' ' GLU . . . . . . . . . . . . . 83.8 tt0 -142.29 141.24 32.41 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.151 -0.477 . . . . 0.0 111.293 -179.984 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' F' F ' 4' ' ' LEU . . . . . . . . . . . . . 17.5 tp -127.31 133.23 50.14 Favored 'General case' 0 C--N 1.331 -0.201 0 CA-C-N 116.04 -0.527 . . . . 0.0 110.272 177.782 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' F' F ' 5' ' ' LYS . . . . . . . . . . . . . 98.5 mttt -112.06 121.32 44.66 Favored 'General case' 0 C--N 1.331 -0.212 0 CA-C-N 116.241 -0.436 . . . . 0.0 110.638 179.829 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' F' F ' 6' ' ' LEU . . . . . . . . . . . . . 69.8 mt -115.02 145.86 41.85 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 115.446 -0.797 . . . . 0.0 110.058 179.948 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' F' F ' 7' ' ' LYS . . . . . . . . . . . . . 40.2 ttmt -128.45 138.58 33.36 Favored Pre-proline 0 CA--C 1.533 0.295 0 CA-C-O 119.052 -0.499 . . . . 0.0 109.879 176.166 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' F' F ' 8' ' ' PRO . . . . . . . . . . . . . 94.4 Cg_endo -92.03 139.38 2.09 Favored 'Trans proline' 0 N--CA 1.488 1.197 0 C-N-CA 121.786 1.658 . . . . 0.0 111.963 178.694 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' F' F ' 9' ' ' LEU . . . . . . . . . . . . . 66.3 mt -74.46 -46.6 5.77 Favored Pre-proline 0 CA--C 1.533 0.314 0 CA-C-O 118.691 -0.671 . . . . 0.0 111.967 178.942 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' F' F ' 10' ' ' PRO . . . . . . . . . . . . . 90.0 Cg_endo -81.04 142.29 13.6 Favored 'Trans proline' 0 N--CA 1.496 1.635 0 C-N-CA 121.076 1.184 . . . . 0.0 111.561 174.035 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' F' F ' 11' ' ' LYS . . . . . . . . . . . . . 80.6 tttt -80.98 101.95 9.84 Favored 'General case' 0 C--N 1.329 -0.295 0 C-N-CA 120.802 -0.359 . . . . 0.0 110.441 179.317 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' F' F ' 12' ' ' VAL . . . . . . . . . . . . . 11.9 p -145.35 147.57 18.55 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.291 0 CA-C-N 116.233 -0.439 . . . . 0.0 110.715 -178.592 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' F' F ' 13' ' ' GLU . . . . . . . . . . . . . 70.7 mm-40 -92.9 123.74 36.38 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.033 176.687 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' F' F ' 14' ' ' LEU . . . . . . . . . . . . . 26.1 mt -96.81 154.48 38.32 Favored Pre-proline 0 C--N 1.329 -0.322 0 CA-C-N 116.426 -0.352 . . . . 0.0 110.69 -178.689 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' F' F ' 15' ' ' PRO . . . . . . . . . . . . . 31.3 Cg_exo -57.04 156.2 25.33 Favored 'Trans proline' 0 N--CA 1.496 1.659 0 C-N-CA 121.335 1.356 . . . . 0.0 111.777 179.636 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' F' F ' 16' ' ' PRO . . . . . . . . . . . . . 35.0 Cg_exo -57.81 -37.76 95.24 Favored 'Trans proline' 0 N--CA 1.497 1.677 0 C-N-CA 121.46 1.44 . . . . 0.0 112.802 -178.627 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' F' F ' 17' ' ' ASP . . . . . . . . . . . . . 19.1 p-10 -90.29 13.36 15.54 Favored 'General case' 0 CA--C 1.537 0.445 0 N-CA-C 113.116 0.784 . . . . 0.0 113.116 -177.38 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' F' F ' 18' ' ' PHE . . . . . . . . . . . . . 46.1 t80 -58.11 -45.32 87.46 Favored 'General case' 0 C--N 1.333 -0.126 0 CA-C-O 120.876 0.37 . . . . 0.0 110.089 -178.512 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' F' F ' 19' ' ' VAL . . . . . . . . . . . . . 48.4 t -57.18 -39.67 68.54 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.322 0 CA-C-N 116.25 -0.432 . . . . 0.0 110.505 -178.131 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' F' F ' 20' ' ' ASP . . . . . . . . . . . . . 10.2 t70 -59.85 -46.46 89.2 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-O 121.095 0.474 . . . . 0.0 110.875 -178.315 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' F' F ' 21' ' ' VAL . . . . . . . . . . . . . 49.5 t -64.19 -48.74 84.34 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.305 0 CA-C-N 116.207 -0.451 . . . . 0.0 110.624 -177.925 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' F' F ' 22' ' ' ILE . . . . . 0.565 HG22 HD12 ' F' ' 26' ' ' LEU . 51.0 mm -56.36 -43.45 77.35 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.297 0 CA-C-O 120.888 0.375 . . . . 0.0 110.51 179.135 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' F' F ' 23' ' ' ARG . . . . . . . . . . . . . 41.0 ttp180 -54.2 -47.52 72.0 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.545 -0.298 . . . . 0.0 111.337 -178.535 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' F' F ' 24' ' ' ILE . . . . . . . . . . . . . 73.8 mt -58.68 -44.17 89.26 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.307 0 CA-C-N 116.578 -0.283 . . . . 0.0 111.082 -179.068 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' F' F ' 25' ' ' LYS . . . . . . . . . . . . . 55.8 mttp -64.81 -39.33 93.41 Favored 'General case' 0 N--CA 1.464 0.24 0 N-CA-C 112.461 0.541 . . . . 0.0 112.461 -179.632 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' F' F ' 26' ' ' LEU . . . . . 0.565 HD12 HG22 ' F' ' 22' ' ' ILE . 49.7 mt -78.9 -41.72 29.0 Favored 'General case' 0 C--N 1.33 -0.28 0 N-CA-C 113.299 0.851 . . . . 0.0 113.299 -170.114 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' F' F ' 27' ' ' GLN . . . . . . . . . . . . . 17.9 pt20 -46.66 139.65 5.05 Favored 'General case' 0 N--CA 1.469 0.508 0 N-CA-C 112.817 0.673 . . . . 0.0 112.817 -175.11 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' F' F ' 28' ' ' GLY . . . . . . . . . . . . . . . 100.63 -27.97 18.04 Favored Glycine 0 CA--C 1.53 0.995 0 CA-C-N 115.494 -0.775 . . . . 0.0 112.218 -177.382 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' F' F ' 29' ' ' LYS . . . . . . . . . . . . . 98.2 mttt -97.9 155.07 17.24 Favored 'General case' 0 C--O 1.232 0.18 0 CA-C-N 117.33 0.565 . . . . 0.0 111.247 179.056 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' F' F ' 30' ' ' THR . . . . . . . . . . . . . 42.0 m -103.67 140.28 37.8 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 115.892 -0.594 . . . . 0.0 110.162 176.839 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' F' F ' 31' ' ' VAL . . . . . . . . . . . . . 35.5 m -127.48 155.06 38.53 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.303 0 CA-C-N 116.272 -0.422 . . . . 0.0 110.374 179.429 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' F' F ' 32' ' ' ARG . . . . . . . . . . . . . 35.9 ttp180 -134.03 149.31 51.17 Favored 'General case' 0 C--N 1.331 -0.207 0 CA-C-O 121.305 0.574 . . . . 0.0 110.603 178.678 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' F' F ' 33' ' ' THR . . . . . 0.417 HG23 ' HA ' ' F' ' 52' ' ' GLN . 16.3 m -52.51 139.61 24.85 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-N 116.073 -0.512 . . . . 0.0 111.544 -177.939 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' F' F ' 34' ' ' GLY . . . . . . . . . . . . . . . 98.75 -17.23 58.61 Favored Glycine 0 CA--C 1.533 1.175 0 C-N-CA 121.236 -0.507 . . . . 0.0 113.366 178.947 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' F' F ' 35' ' ' ASP . . . . . . . . . . . . . 76.3 m-20 -65.79 150.17 48.97 Favored 'General case' 0 N--CA 1.462 0.161 0 CA-C-N 117.942 0.871 . . . . 0.0 111.291 -179.891 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' F' F ' 36' ' ' VAL . . . . . . . . . . . . . 44.3 t -119.73 128.93 75.91 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.222 0 CA-C-N 115.798 -0.637 . . . . 0.0 109.725 177.882 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' F' F ' 37' ' ' ILE . . . . . . . . . . . . . 68.8 mt -122.22 139.19 49.94 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.248 0 CA-C-N 116.261 -0.427 . . . . 0.0 109.928 -179.275 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' F' F ' 38' ' ' GLY . . . . . . . . . . . . . . . -115.3 128.35 8.04 Favored Glycine 0 CA--C 1.525 0.693 0 N-CA-C 110.859 -0.896 . . . . 0.0 110.859 178.853 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' F' F ' 39' ' ' ILE . . . . . . . . . . . . . 76.3 mt -127.44 138.6 54.29 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.217 0 CA-C-O 120.74 0.305 . . . . 0.0 110.197 179.921 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' F' F ' 40' ' ' SER . . . . . . . . . . . . . 42.6 t -91.96 114.05 26.48 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.274 -0.421 . . . . 0.0 110.981 176.849 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' F' F ' 41' ' ' ILE . . . . . . . . . . . . . 44.3 mm -122.94 121.06 62.3 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.234 0 N-CA-C 109.665 -0.494 . . . . 0.0 109.665 178.645 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' F' F ' 42' ' ' LEU . . . . . . . . . . . . . 84.2 mt 57.71 33.67 23.51 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 116.454 -0.339 . . . . 0.0 111.662 179.606 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' F' F ' 43' ' ' GLY . . . . . . . . . . . . . . . 77.64 -10.2 25.37 Favored Glycine 0 CA--C 1.535 1.288 0 C-N-CA 121.311 -0.471 . . . . 0.0 113.47 178.114 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' F' F ' 44' ' ' LYS . . . . . . . . . . . . . 98.3 mttt -101.05 138.76 37.66 Favored 'General case' 0 C--N 1.334 -0.108 0 CA-C-N 117.898 0.849 . . . . 0.0 110.05 177.436 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' F' F ' 45' ' ' GLU . . . . . . . . . . . . . 80.9 tt0 -83.75 130.08 34.95 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.431 -0.35 . . . . 0.0 111.263 -178.945 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' F' F ' 46' ' ' VAL . . . . . . . . . . . . . 10.4 p -120.55 125.87 74.61 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.209 0 N-CA-C 109.653 -0.499 . . . . 0.0 109.653 174.512 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' F' F ' 47' ' ' LYS . . . . . . . . . . . . . 29.2 mtpp -98.0 124.98 42.74 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 115.984 -0.553 . . . . 0.0 110.622 177.979 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' F' F ' 48' ' ' PHE . . . . . . . . . . . . . 40.8 m-85 -110.15 131.89 54.65 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.251 -0.431 . . . . 0.0 109.893 177.534 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' F' F ' 49' ' ' LYS . . . . . . . . . . . . . 85.6 tttt -106.34 131.39 53.61 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.209 -0.451 . . . . 0.0 109.811 177.158 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' F' F ' 50' ' ' VAL . . . . . . . . . . . . . 43.8 t -75.59 105.92 4.95 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.335 0 N-CA-C 109.384 -0.598 . . . . 0.0 109.384 177.911 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' F' F ' 51' ' ' VAL . . . . . . . . . . . . . 48.1 t -69.17 -48.01 71.23 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.27 0 CA-C-N 116.062 -0.517 . . . . 0.0 109.761 -174.354 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' F' F ' 52' ' ' GLN . . . . . 0.417 ' HA ' HG23 ' F' ' 33' ' ' THR . 21.4 pt20 -167.01 158.56 12.47 Favored 'General case' 0 C--N 1.331 -0.199 0 C-N-CA 120.249 -0.58 . . . . 0.0 111.79 179.167 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' F' F ' 53' ' ' ALA . . . . . . . . . . . . . . . -133.5 137.04 45.44 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 115.485 -0.779 . . . . 0.0 110.243 179.07 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' F' F ' 54' ' ' TYR . . . . . . . . . . . . . 38.4 t80 -128.98 109.43 18.29 Favored Pre-proline 0 CA--C 1.535 0.372 0 CA-C-O 118.274 -0.87 . . . . 0.0 110.359 -179.425 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' F' F ' 55' ' ' PRO . . . . . . . . . . . . . 74.0 Cg_endo -77.17 169.97 72.77 Favored 'Cis proline' 0 N--CA 1.502 2.002 0 CA-C-N 121.855 1.698 . . . . 0.0 112.145 -7.375 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' F' F ' 56' ' ' SER . . . . . . . . . . . . . 49.0 m -117.82 132.8 23.48 Favored Pre-proline 0 CA--C 1.538 0.483 0 CA-C-O 118.492 -0.766 . . . . 0.0 109.616 175.057 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' F' F ' 57' ' ' PRO . . . . . . . . . . . . . 40.4 Cg_endo -68.56 165.45 72.8 Favored 'Cis proline' 0 N--CA 1.497 1.731 0 CA-C-N 121.88 1.707 . . . . 0.0 111.328 -1.657 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' F' F ' 58' ' ' LEU . . . . . . . . . . . . . 23.4 tp -130.62 137.45 49.63 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-O 120.871 0.367 . . . . 0.0 110.691 -178.049 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' F' F ' 59' ' ' ARG . . . . . . . . . . . . . 57.6 ttt85 -104.05 128.4 51.65 Favored 'General case' 0 C--N 1.328 -0.35 0 N-CA-C 109.464 -0.569 . . . . 0.0 109.464 176.35 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' F' F ' 60' ' ' VAL . . . . . . . . . . . . . 41.1 t -81.48 122.61 36.77 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.267 0 C-N-CA 120.769 -0.372 . . . . 0.0 110.69 -175.159 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' F' F ' 61' ' ' GLU . . . . . . . . . . . . . 44.3 mt-10 -131.12 168.0 18.18 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 115.842 -0.617 . . . . 0.0 109.77 176.892 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' F' F ' 62' ' ' ASP . . . . . . . . . . . . . 10.0 p-10 -55.91 -32.67 63.97 Favored 'General case' 0 C--N 1.329 -0.316 0 N-CA-C 111.803 0.297 . . . . 0.0 111.803 -178.484 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' F' F ' 63' ' ' ARG . . . . . . . . . . . . . 24.5 mmt180 -78.77 -9.33 59.4 Favored 'General case' 0 N--CA 1.467 0.383 0 N-CA-C 113.347 0.869 . . . . 0.0 113.347 -176.772 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' F' F ' 64' ' ' THR . . . . . . . . . . . . . 31.4 m -70.85 138.93 50.67 Favored 'General case' 0 C--N 1.332 -0.165 0 CA-C-O 121.007 0.432 . . . . 0.0 111.148 -175.356 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' F' F ' 65' ' ' LYS . . . . . . . . . . . . . 62.2 mttm -88.95 123.12 32.99 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 115.862 -0.608 . . . . 0.0 109.881 176.425 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' F' F ' 66' ' ' ILE . . . . . . . . . . . . . 61.7 mt -115.2 126.61 72.82 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 N-CA-C 109.779 -0.452 . . . . 0.0 109.779 179.758 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' F' F ' 67' ' ' THR . . . . . . . . . . . . . 28.4 m -125.38 138.76 54.04 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-O 121.126 0.488 . . . . 0.0 111.175 -177.351 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' F' F ' 68' ' ' LEU . . . . . . . . . . . . . 46.3 mt . . . . . 0 C--N 1.329 -0.306 0 CA-C-N 115.753 -0.658 . . . . 0.0 109.959 176.161 . . . . . . . . 0 0 . 1 . 004 nuclear build core ' F' F ' 73' ' ' VAL . . . . . . . . . . . . . 35.9 m . . . . . 0 C--O 1.231 0.08 0 CA-C-O 121.027 0.441 . . . . 0.0 110.814 . . . . . . . . . 0 0 . 1 . 004 nuclear build core ' F' F ' 74' ' ' ASP . . . . . . . . . . . . . 13.5 t0 -105.11 117.9 35.18 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 115.849 -0.614 . . . . 0.0 109.741 177.748 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' F' F ' 75' ' ' VAL . . . . . 0.429 ' C ' HD12 ' F' ' 76' ' ' LEU . 40.1 t -118.06 125.61 74.34 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.267 0 CA-C-O 121.048 0.451 . . . . 0.0 110.61 -178.08 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' F' F ' 76' ' ' LEU . . . . . 0.429 HD12 ' C ' ' F' ' 75' ' ' VAL . 5.7 mp -126.3 145.42 50.43 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 115.672 -0.695 . . . . 0.0 109.559 176.206 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' F' F ' 77' ' ' GLU . . . . . . . . . . . . . 96.7 mt-10 -132.04 129.11 39.62 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-O 121.02 0.438 . . . . 0.0 110.715 -178.064 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' F' F ' 78' ' ' ALA . . . . . . . . . . . . . . . -115.4 132.62 56.56 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 115.75 -0.659 . . . . 0.0 109.999 178.869 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' F' F ' 79' ' ' LYS . . . . . 0.584 ' O ' HD13 ' F' ' 80' ' ' ILE . 20.2 tptm -76.91 116.38 17.52 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-O 120.916 0.389 . . . . 0.0 110.791 -177.424 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' F' F ' 80' ' ' ILE . . . . . 0.584 HD13 ' O ' ' F' ' 79' ' ' LYS . 42.3 mm -139.28 98.45 1.16 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.282 0 N-CA-C 109.152 -0.684 . . . . 0.0 109.152 -176.938 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' F' F ' 81' ' ' LYS . . . . . . . . . . . . . 17.8 pttp -98.4 131.26 44.82 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-O 120.956 0.408 . . . . 0.0 111.454 -175.72 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' F' F ' 82' ' ' GLY . . . . . . . . . . . . . . . 89.12 41.98 5.72 Favored Glycine 0 CA--C 1.524 0.643 0 CA-C-N 115.82 -0.627 . . . . 0.0 111.57 176.076 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' F' F ' 83' ' ' ILE . . . . . . . . . . . . . 65.8 mt -74.59 135.5 27.24 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 N-CA-C 109.453 -0.573 . . . . 0.0 109.453 176.719 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' F' F ' 84' ' ' LYS . . . . . . . . . . . . . 38.0 ttpt -106.94 -42.48 4.91 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-O 120.782 0.325 . . . . 0.0 110.634 -177.805 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' F' F ' 85' ' ' ASP . . . . . . . . . . . . . 9.2 t70 -149.23 149.83 31.6 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.311 -0.404 . . . . 0.0 110.433 179.336 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' F' F ' 86' ' ' VAL . . . . . . . . . . . . . 41.9 t -137.64 136.76 45.9 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.231 0 CA-C-O 120.936 0.398 . . . . 0.0 110.74 -178.915 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' F' F ' 87' ' ' ILE . . . . . . . . . . . . . 4.9 mp -123.83 126.86 73.32 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.251 0 CA-C-N 115.828 -0.624 . . . . 0.0 109.522 176.171 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' F' F ' 88' ' ' LEU . . . . . . . . . . . . . 19.2 tp -114.89 130.26 56.86 Favored 'General case' 0 N--CA 1.463 0.184 0 CA-C-O 121.088 0.47 . . . . 0.0 111.187 -177.525 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' F' F ' 89' ' ' ASP . . . . . . . . . . . . . 4.2 t0 -125.42 156.58 38.6 Favored 'General case' 0 C--N 1.331 -0.207 0 CA-C-N 115.638 -0.71 . . . . 0.0 109.388 175.399 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' F' F ' 90' ' ' GLU . . . . . . . . . . . . . 81.9 tt0 -46.53 -40.89 13.39 Favored 'General case' 0 N--CA 1.463 0.211 0 N-CA-C 113.11 0.781 . . . . 0.0 113.11 -172.445 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' F' F ' 91' ' ' ASN . . . . . . . . . . . . . 71.1 m-80 -132.14 37.75 3.55 Favored 'General case' 0 N--CA 1.465 0.28 0 CA-C-O 120.785 0.326 . . . . 0.0 111.554 -176.479 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' F' F ' 92' ' ' LEU . . . . . . . . . . . . . 17.3 tp -166.08 138.85 4.04 Favored 'General case' 0 C--N 1.33 -0.281 0 C-N-CA 120.931 -0.308 . . . . 0.0 110.589 -179.563 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' F' F ' 93' ' ' ILE . . . . . . . . . . . . . 67.0 mt -124.02 122.42 64.42 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.187 0 N-CA-C 109.769 -0.456 . . . . 0.0 109.769 179.724 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' F' F ' 94' ' ' VAL . . . . . . . . . . . . . 44.8 t -120.92 125.18 73.73 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.222 0 N-CA-C 109.789 -0.448 . . . . 0.0 109.789 178.59 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' F' F ' 95' ' ' VAL . . . . . . . . . . . . . 43.1 t -120.11 134.04 64.88 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.379 0 CA-C-N 116.071 -0.513 . . . . 0.0 109.746 -179.422 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' F' F ' 96' ' ' ILE . . . . . 0.432 HD11 HG21 ' F' ' 123' ' ' VAL . 68.4 mt -116.6 127.88 74.1 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.232 0 N-CA-C 109.458 -0.571 . . . . 0.0 109.458 179.31 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' F' F ' 97' ' ' THR . . . . . . . . . . . . . 77.8 p -101.92 162.23 13.06 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-O 121.5 0.667 . . . . 0.0 111.704 -175.362 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' F' F ' 98' ' ' GLU . . . . . . . . . . . . . 82.1 tt0 -53.82 -28.51 35.92 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 115.442 -0.799 . . . . 0.0 112.361 -178.947 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' F' F ' 99' ' ' GLU . . . . . . . . . . . . . 96.0 mt-10 -81.97 18.04 1.42 Allowed 'General case' 0 CA--C 1.534 0.354 0 N-CA-C 113.116 0.784 . . . . 0.0 113.116 -176.356 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' F' F ' 100' ' ' ASN . . . . . . . . . . . . . 2.7 m-20 62.22 37.65 14.07 Favored 'General case' 0 CA--C 1.53 0.185 0 CA-C-O 121.036 0.446 . . . . 0.0 111.047 177.591 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' F' F ' 101' ' ' GLU . . . . . . . . . . . . . 84.7 tt0 -117.1 144.61 44.48 Favored 'General case' 0 C--N 1.332 -0.193 0 N-CA-C 109.719 -0.475 . . . . 0.0 109.719 177.342 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' F' F ' 102' ' ' VAL . . . . . . . . . . . . . 42.4 t -117.47 127.29 74.94 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.23 0 N-CA-C 109.962 -0.385 . . . . 0.0 109.962 -178.446 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' F' F ' 103' ' ' LEU . . . . . . . . . . . . . 31.5 mt -116.33 132.07 56.77 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 115.572 -0.74 . . . . 0.0 110.036 176.699 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' F' F ' 104' ' ' ILE . . . . . 0.528 HD13 HG11 ' F' ' 130' ' ' VAL . 66.4 mt -117.73 122.21 69.26 Favored 'Isoleucine or valine' 0 C--O 1.234 0.265 0 N-CA-C 110.238 -0.282 . . . . 0.0 110.238 -178.939 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' F' F ' 105' ' ' PHE . . . . . . . . . . . . . 86.5 m-85 -123.48 164.27 19.27 Favored 'General case' 0 C--N 1.332 -0.165 0 O-C-N 123.936 0.773 . . . . 0.0 110.3 -178.857 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' F' F ' 106' ' ' ASN . . . . . . . . . . . . . 46.0 p-10 -99.73 -169.92 1.82 Allowed 'General case' 0 CA--C 1.53 0.2 0 N-CA-C 109.655 -0.498 . . . . 0.0 109.655 171.849 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' F' F ' 107' ' ' GLN . . . . . . . . . . . . . 41.4 tt0 -57.86 -30.06 65.49 Favored 'General case' 0 C--N 1.327 -0.379 0 N-CA-C 112.117 0.414 . . . . 0.0 112.117 -178.767 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' F' F ' 108' ' ' ASN . . . . . . . . . . . . . 4.0 t-20 -91.24 14.11 15.29 Favored 'General case' 0 CA--C 1.535 0.398 0 N-CA-C 113.106 0.78 . . . . 0.0 113.106 -175.558 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' F' F ' 109' ' ' LEU . . . . . . . . . . . . . 40.8 mt 58.12 34.01 23.75 Favored 'General case' 0 CA--C 1.53 0.204 0 CA-C-O 120.718 0.294 . . . . 0.0 111.723 177.914 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' F' F ' 110' ' ' GLU . . . . . . . . . . . . . 96.0 mt-10 -98.92 134.75 41.33 Favored 'General case' 0 C--N 1.329 -0.288 0 N-CA-C 109.408 -0.59 . . . . 0.0 109.408 175.434 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' F' F ' 111' ' ' GLU . . . . . . . . . . . . . 48.4 tt0 -71.7 121.97 19.8 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-O 121.009 0.433 . . . . 0.0 110.729 -175.751 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' F' F ' 112' ' ' LEU . . . . . . . . . . . . . 25.6 mt -105.87 -46.04 4.22 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-N 115.898 -0.592 . . . . 0.0 110.327 178.994 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' F' F ' 113' ' ' TYR . . . . . 0.405 ' HB3' HD12 ' F' ' 104' ' ' ILE . 31.2 t80 -137.95 141.54 40.53 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.11 -0.495 . . . . 0.0 111.05 -179.036 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' F' F ' 114' ' ' ARG . . . . . . . . . . . . . 32.7 ptt180 -141.69 123.58 15.31 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.247 -0.433 . . . . 0.0 110.392 177.206 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' F' F ' 115' ' ' GLY . . . . . . . . . . . . . . . -150.14 160.08 28.38 Favored Glycine 0 CA--C 1.524 0.601 0 N-CA-C 111.16 -0.776 . . . . 0.0 111.16 179.821 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' F' F ' 116' ' ' LYS . . . . . . . . . . . . . 33.4 ttpt -128.96 136.91 50.99 Favored 'General case' 0 C--N 1.33 -0.276 0 N-CA-C 109.908 -0.405 . . . . 0.0 109.908 177.333 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' F' F ' 117' ' ' PHE . . . . . . . . . . . . . 43.4 m-85 -134.1 113.79 12.45 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-O 120.971 0.415 . . . . 0.0 110.238 -177.124 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' F' F ' 118' ' ' GLU . . . . . . . . . . . . . 45.7 tp10 -54.69 -48.88 71.89 Favored 'General case' 0 C--N 1.326 -0.449 0 CA-C-N 116.289 -0.414 . . . . 0.0 111.277 -176.188 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' F' F ' 119' ' ' ASN . . . . . . . . . . . . . 73.3 m-20 -95.17 31.1 1.99 Allowed 'General case' 0 C--N 1.33 -0.275 0 N-CA-C 112.155 0.428 . . . . 0.0 112.155 -173.836 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' F' F ' 120' ' ' LEU . . . . . . . . . . . . . 20.0 tp -54.18 119.91 5.76 Favored 'General case' 0 N--CA 1.464 0.233 0 O-C-N 122.207 -0.308 . . . . 0.0 110.738 177.29 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' F' F ' 121' ' ' ASN . . . . . . . . . . . . . 13.6 t-20 -114.11 -44.03 3.18 Favored 'General case' 0 C--N 1.331 -0.214 0 CA-C-N 116.455 -0.339 . . . . 0.0 110.962 -177.009 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' F' F ' 122' ' ' LYS . . . . . . . . . . . . . 61.9 mtpt -142.0 147.29 36.67 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-O 121.168 0.509 . . . . 0.0 111.233 -177.059 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' F' F ' 123' ' ' VAL . . . . . 0.432 HG21 HD11 ' F' ' 96' ' ' ILE . 44.2 t -128.66 125.98 64.39 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.191 0 N-CA-C 109.312 -0.625 . . . . 0.0 109.312 174.679 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' F' F ' 124' ' ' LEU . . . . . 0.517 HD12 ' N ' ' F' ' 124' ' ' LEU . 6.0 mp -118.17 132.82 56.3 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-O 120.766 0.317 . . . . 0.0 110.696 -177.019 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' F' F ' 125' ' ' VAL . . . . . . . . . . . . . 43.9 t -125.57 127.51 71.69 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.241 0 CA-C-N 116.051 -0.522 . . . . 0.0 110.178 179.918 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' F' F ' 126' ' ' ARG . . . . . . . . . . . . . 40.8 mmt180 -145.22 119.88 9.8 Favored 'General case' 0 C--N 1.328 -0.336 0 N-CA-C 109.478 -0.564 . . . . 0.0 109.478 177.193 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' F' F ' 127' ' ' ASN . . . . . . . . . . . . . 13.8 m120 56.38 -152.73 0.37 Allowed 'General case' 0 CA--C 1.54 0.564 0 N-CA-C 109.737 -0.468 . . . . 0.0 109.737 -179.164 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' F' F ' 128' ' ' ASP . . . . . . . . . . . . . 23.3 p-10 -79.95 14.29 1.87 Allowed 'General case' 0 CA--C 1.537 0.448 0 N-CA-C 112.759 0.652 . . . . 0.0 112.759 177.799 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' F' F ' 129' ' ' LEU . . . . . . . . . . . . . 60.9 mt -109.37 139.75 43.93 Favored 'General case' 0 C--O 1.232 0.181 0 O-C-N 121.955 -0.465 . . . . 0.0 109.747 178.254 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' F' F ' 130' ' ' VAL . . . . . 0.528 HG11 HD13 ' F' ' 104' ' ' ILE . 12.1 p -132.34 141.75 44.45 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.235 0 CA-C-O 121.202 0.525 . . . . 0.0 110.562 -177.746 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' F' F ' 131' ' ' VAL . . . . . . . . . . . . . 42.8 t -135.99 135.2 50.58 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.299 0 CA-C-N 115.794 -0.639 . . . . 0.0 110.035 178.63 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' F' F ' 132' ' ' ILE . . . . . . . . . . . . . 69.0 mt -113.52 130.76 66.98 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.332 0 CA-C-N 115.815 -0.629 . . . . 0.0 109.348 -179.784 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' F' F ' 133' ' ' ILE . . . . . . . . . . . . . 36.8 mm -114.59 120.41 64.19 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.216 0 CA-C-O 120.989 0.423 . . . . 0.0 110.914 -175.044 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' F' F ' 134' ' ' ASP . . . . . . . . . . . . . 6.9 p-10 -132.56 147.45 52.35 Favored 'General case' 0 C--N 1.332 -0.181 0 N-CA-C 109.519 -0.549 . . . . 0.0 109.519 176.007 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' F' F ' 135' ' ' GLU . . . . . . . . . . . . . 84.5 tt0 -49.94 -27.57 5.51 Favored 'General case' 0 C--N 1.329 -0.298 0 N-CA-C 112.703 0.631 . . . . 0.0 112.703 -173.008 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' F' F ' 136' ' ' GLN . . . . . . . . . . . . . 98.5 mt-30 -81.36 -34.48 31.71 Favored 'General case' 0 C--O 1.232 0.183 0 N-CA-C 112.181 0.438 . . . . 0.0 112.181 -176.158 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' F' F ' 137' ' ' LYS . . . . . . . . . . . . . 56.3 pttt -168.01 175.04 6.92 Favored 'General case' 0 C--N 1.332 -0.188 0 CA-C-O 121.506 0.669 . . . . 0.0 112.14 -172.482 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' F' F ' 138' ' ' LEU . . . . . 0.462 HD23 ' C ' ' F' ' 138' ' ' LEU . 8.5 tt -120.13 128.59 53.58 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 115.174 -0.921 . . . . 0.0 110.135 179.205 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' F' F ' 139' ' ' THR . . . . . . . . . . . . . 33.2 m -107.64 122.41 46.65 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-N 116.116 -0.493 . . . . 0.0 110.239 178.906 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' F' F ' 140' ' ' LEU . . . . . 0.463 HD23 ' C ' ' F' ' 140' ' ' LEU . 6.2 tt -111.03 122.27 47.47 Favored 'General case' 0 C--N 1.329 -0.326 0 N-CA-C 109.189 -0.671 . . . . 0.0 109.189 -179.432 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' F' F ' 141' ' ' ILE . . . . . 0.456 ' HB ' HG13 ' F' ' 130' ' ' VAL . 19.8 mt -121.63 116.36 49.25 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.275 0 CA-C-O 121.086 0.47 . . . . 0.0 109.927 -176.113 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' F' F ' 142' ' ' ARG . . . . . . . . . . . . . 61.6 ttt180 -106.07 127.46 53.2 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 114.921 -1.036 . . . . 0.0 110.619 -176.259 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' F' F ' 143' ' ' THR . . . . . . . . . . . . . 75.8 p . . . . . 0 C--O 1.22 -0.46 0 CA-C-O 118.001 -1.0 . . . . 0.0 110.589 179.192 . . . . . . . . 0 0 . 1 . 005 nuclear build core ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 13.7 p . . . . . 0 C--O 1.231 0.108 0 CA-C-O 121.11 0.481 . . . . 0.0 110.618 . . . . . . . . . 0 0 . 1 . 005 nuclear build core ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 84.9 tt0 -140.02 138.94 35.84 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-N 115.724 -0.671 . . . . 0.0 110.676 179.64 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 4' ' ' LEU . . . . . 0.49 HD23 ' N ' ' A' ' 5' ' ' LYS . 3.0 tt -125.7 126.51 44.76 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 115.734 -0.666 . . . . 0.0 109.698 178.579 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 5' ' ' LYS . . . . . 0.49 ' N ' HD23 ' A' ' 4' ' ' LEU . 87.8 mttt -108.99 124.34 50.56 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-O 120.655 0.265 . . . . 0.0 110.864 -179.119 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 6' ' ' LEU . . . . . 0.475 HD23 ' HA ' ' A' ' 50' ' ' VAL . 18.3 mt -122.01 150.29 42.28 Favored 'General case' 0 C--O 1.232 0.163 0 CA-C-N 115.811 -0.631 . . . . 0.0 111.254 -178.879 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 49.3 tttm -138.27 143.47 39.1 Favored Pre-proline 0 C--N 1.329 -0.304 0 CA-C-N 115.757 -0.656 . . . . 0.0 109.792 175.199 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 8' ' ' PRO . . . . . . . . . . . . . 97.5 Cg_endo -89.8 136.72 2.65 Favored 'Trans proline' 0 N--CA 1.489 1.234 0 C-N-CA 121.741 1.628 . . . . 0.0 111.766 178.537 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 40.9 mt -75.9 -45.68 3.93 Favored Pre-proline 0 CA--C 1.532 0.285 0 CA-C-O 119.064 -0.493 . . . . 0.0 111.524 -179.253 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 71.1 Cg_endo -85.1 152.12 10.93 Favored 'Trans proline' 0 N--CA 1.494 1.519 0 C-N-CA 121.234 1.289 . . . . 0.0 111.31 170.534 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 27.5 ttpp -86.23 109.78 19.16 Favored 'General case' 0 C--N 1.33 -0.271 0 C-N-CA 120.702 -0.399 . . . . 0.0 110.235 178.692 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 11.8 p -142.77 145.09 23.55 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.291 0 CA-C-N 116.092 -0.504 . . . . 0.0 110.62 -178.576 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 84.8 tt0 -88.47 121.32 30.72 Favored 'General case' 0 C--N 1.328 -0.344 0 N-CA-C 109.913 -0.403 . . . . 0.0 109.913 176.886 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 14' ' ' LEU . . . . . . . . . . . . . 29.6 mt -98.01 151.56 37.61 Favored Pre-proline 0 C--N 1.33 -0.268 0 CA-C-N 116.354 -0.384 . . . . 0.0 110.976 -176.277 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 15' ' ' PRO . . . . . . . . . . . . . 24.5 Cg_exo -63.31 161.13 31.95 Favored 'Trans proline' 0 N--CA 1.497 1.723 0 C-N-CA 121.322 1.348 . . . . 0.0 111.666 175.436 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 16' ' ' PRO . . . . . . . . . . . . . 26.6 Cg_exo -60.73 -34.0 92.39 Favored 'Trans proline' 0 N--CA 1.496 1.646 0 C-N-CA 121.478 1.452 . . . . 0.0 112.966 -177.722 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 17' ' ' ASP . . . . . . . . . . . . . 18.8 p-10 -90.62 6.6 43.17 Favored 'General case' 0 CA--C 1.537 0.465 0 N-CA-C 113.402 0.89 . . . . 0.0 113.402 -176.833 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 18' ' ' PHE . . . . . . . . . . . . . 49.6 t80 -57.59 -42.93 84.18 Favored 'General case' 0 C--N 1.334 -0.105 0 CA-C-O 120.952 0.406 . . . . 0.0 110.291 -178.021 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 19' ' ' VAL . . . . . . . . . . . . . 47.8 t -57.16 -43.57 81.84 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.346 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.358 -178.827 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 4.2 m-20 -60.15 -41.33 92.54 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.525 -0.307 . . . . 0.0 110.882 -178.381 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 47.0 t -63.58 -46.17 95.66 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 C-N-CA 120.85 -0.34 . . . . 0.0 110.296 -177.385 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 22' ' ' ILE . . . . . 0.564 HG22 HD12 ' A' ' 26' ' ' LEU . 51.0 mm -55.54 -48.63 77.13 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.237 0 CA-C-O 120.81 0.338 . . . . 0.0 110.714 178.778 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 23' ' ' ARG . . . . . . . . . . . . . 55.9 ttp180 -54.31 -48.77 70.93 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.629 -0.26 . . . . 0.0 111.568 -178.057 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 24' ' ' ILE . . . . . . . . . . . . . 78.5 mt -60.11 -42.7 90.92 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.269 0 C-N-CA 121.052 -0.259 . . . . 0.0 111.54 -176.791 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 51.1 mttm -65.13 -40.49 94.52 Favored 'General case' 0 C--N 1.328 -0.327 0 N-CA-C 112.21 0.448 . . . . 0.0 112.21 -179.12 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 26' ' ' LEU . . . . . 0.564 HD12 HG22 ' A' ' 22' ' ' ILE . 37.6 mt -78.96 -40.06 32.83 Favored 'General case' 0 C--N 1.33 -0.271 0 N-CA-C 113.526 0.935 . . . . 0.0 113.526 -171.366 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 27' ' ' GLN . . . . . . . . . . . . . 12.9 pt20 -46.88 141.91 3.75 Favored 'General case' 0 N--CA 1.47 0.545 0 N-CA-C 112.82 0.674 . . . . 0.0 112.82 -175.207 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 97.72 -30.0 10.06 Favored Glycine 0 CA--C 1.531 1.044 0 CA-C-N 115.652 -0.703 . . . . 0.0 111.984 -177.529 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 48.8 mtmt -99.3 155.3 17.58 Favored 'General case' 0 C--O 1.233 0.227 0 CA-C-O 120.993 0.425 . . . . 0.0 111.324 179.304 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 30' ' ' THR . . . . . . . . . . . . . 20.8 m -105.57 140.55 38.49 Favored 'General case' 0 C--N 1.331 -0.212 0 CA-C-N 115.91 -0.586 . . . . 0.0 110.166 176.657 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 35.5 m -129.54 161.43 39.08 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.187 0 CA-C-N 116.41 -0.359 . . . . 0.0 110.848 -179.138 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 32' ' ' ARG . . . . . . . . . . . . . 79.7 mtt85 -127.28 147.37 50.23 Favored 'General case' 0 C--N 1.331 -0.212 0 CA-C-O 121.291 0.567 . . . . 0.0 110.776 179.093 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 33' ' ' THR . . . . . . . . . . . . . 29.2 m -53.91 140.69 29.98 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.248 -0.433 . . . . 0.0 111.146 -179.879 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 98.83 -17.13 58.69 Favored Glycine 0 CA--C 1.532 1.144 0 C-N-CA 121.131 -0.557 . . . . 0.0 113.232 179.33 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 76.1 m-20 -64.63 150.26 47.37 Favored 'General case' 0 C--O 1.232 0.147 0 CA-C-N 118.096 0.948 . . . . 0.0 111.241 179.813 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 45.0 t -119.07 129.65 74.91 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.247 0 CA-C-N 115.713 -0.676 . . . . 0.0 109.81 178.85 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 37' ' ' ILE . . . . . . . . . . . . . 69.2 mt -119.94 138.28 51.03 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.273 0 CA-C-N 116.171 -0.468 . . . . 0.0 109.759 179.414 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . -113.74 128.98 8.56 Favored Glycine 0 CA--C 1.525 0.707 0 N-CA-C 111.029 -0.828 . . . . 0.0 111.029 -179.255 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 39' ' ' ILE . . . . . . . . . . . . . 72.4 mt -123.55 133.97 67.69 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.231 0 N-CA-C 110.188 -0.301 . . . . 0.0 110.188 179.079 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 40' ' ' SER . . . . . . . . . . . . . 45.2 t -93.0 113.93 26.34 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.455 -0.338 . . . . 0.0 110.776 175.597 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 41' ' ' ILE . . . . . . . . . . . . . 44.9 mm -121.51 123.44 69.59 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.265 0 CA-C-O 120.778 0.323 . . . . 0.0 110.45 179.997 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 34.5 mt 52.57 34.09 14.91 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.235 -0.438 . . . . 0.0 111.791 177.292 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . 72.52 32.16 62.28 Favored Glycine 0 CA--C 1.53 0.988 0 C-N-CA 121.113 -0.565 . . . . 0.0 111.889 178.747 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 44' ' ' LYS . . . . . . . . . . . . . 33.7 ttmt -139.21 130.48 26.82 Favored 'General case' 0 C--N 1.329 -0.314 0 N-CA-C 109.767 -0.457 . . . . 0.0 109.767 179.188 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 84.0 tt0 -82.62 122.38 28.03 Favored 'General case' 0 C--N 1.329 -0.29 0 C-N-CA 120.755 -0.378 . . . . 0.0 111.003 -177.848 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 46' ' ' VAL . . . . . . . . . . . . . 7.1 p -120.64 129.1 75.98 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.227 0 N-CA-C 109.338 -0.616 . . . . 0.0 109.338 174.682 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 59.7 mtpt -100.32 127.05 46.71 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 115.748 -0.66 . . . . 0.0 110.858 179.624 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 48' ' ' PHE . . . . . . . . . . . . . 89.5 m-85 -110.44 131.87 54.68 Favored 'General case' 0 C--N 1.33 -0.275 0 N-CA-C 110.017 -0.364 . . . . 0.0 110.017 176.919 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 86.2 tttt -106.33 133.94 50.24 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.258 -0.428 . . . . 0.0 110.415 179.892 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 50' ' ' VAL . . . . . 0.475 ' HA ' HD23 ' A' ' 6' ' ' LEU . 42.1 t -77.76 105.38 6.7 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.236 0 N-CA-C 109.165 -0.68 . . . . 0.0 109.165 176.177 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 51' ' ' VAL . . . . . . . . . . . . . 48.9 t -69.79 -48.52 63.97 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.295 0 CA-C-N 116.022 -0.535 . . . . 0.0 110.146 -173.16 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 52' ' ' GLN . . . . . . . . . . . . . 61.8 tt0 -163.96 144.62 8.51 Favored 'General case' 0 C--N 1.329 -0.296 0 C-N-CA 120.288 -0.565 . . . . 0.0 111.811 -177.911 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 53' ' ' ALA . . . . . 0.442 ' HB1' ' HB2' ' A' ' 58' ' ' LEU . . . -115.18 133.04 56.39 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 115.559 -0.746 . . . . 0.0 109.79 176.016 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 54' ' ' TYR . . . . . . . . . . . . . 9.5 t80 -129.04 108.41 18.09 Favored Pre-proline 0 CA--C 1.535 0.379 0 CA-C-O 118.182 -0.914 . . . . 0.0 110.464 178.499 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 55' ' ' PRO . . . . . . . . . . . . . 72.0 Cg_endo -76.96 168.89 75.87 Favored 'Cis proline' 0 N--CA 1.501 1.952 0 CA-C-N 121.941 1.729 . . . . 0.0 112.408 -4.945 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 56' ' ' SER . . . . . . . . . . . . . 14.4 m -112.33 128.0 26.1 Favored Pre-proline 0 CA--C 1.539 0.535 0 CA-C-O 118.366 -0.826 . . . . 0.0 109.673 176.961 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 57' ' ' PRO . . . . . . . . . . . . . 35.2 Cg_endo -65.72 168.86 44.6 Favored 'Cis proline' 0 N--CA 1.497 1.715 0 CA-C-N 122.029 1.76 . . . . 0.0 111.45 -2.862 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 58' ' ' LEU . . . . . 0.442 ' HB2' ' HB1' ' A' ' 53' ' ' ALA . 30.0 tp -129.95 135.71 48.63 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-O 120.887 0.375 . . . . 0.0 110.707 -179.41 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 59' ' ' ARG . . . . . . . . . . . . . 52.9 ttt180 -106.99 129.12 54.83 Favored 'General case' 0 C--N 1.328 -0.335 0 N-CA-C 108.688 -0.856 . . . . 0.0 108.688 176.521 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 40.6 t -89.85 126.23 42.75 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.183 0 C-N-CA 120.385 -0.526 . . . . 0.0 111.36 -172.607 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 49.8 mp0 -131.07 168.55 17.21 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 115.58 -0.737 . . . . 0.0 109.077 171.917 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 62' ' ' ASP . . . . . . . . . . . . . 18.2 p-10 -53.87 -32.6 53.72 Favored 'General case' 0 C--N 1.329 -0.323 0 C-N-CA 120.931 -0.308 . . . . 0.0 111.815 -178.449 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 63' ' ' ARG . . . . . . . . . . . . . 98.4 mtt180 -71.97 -22.14 61.49 Favored 'General case' 0 CA--C 1.532 0.273 0 N-CA-C 112.896 0.702 . . . . 0.0 112.896 -177.299 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 50.9 m -67.37 130.24 42.43 Favored 'General case' 0 C--N 1.332 -0.193 0 N-CA-C 110.125 -0.324 . . . . 0.0 110.125 -178.275 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 65' ' ' LYS . . . . . . . . . . . . . 50.3 mtmt -89.23 135.79 33.38 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.222 -0.445 . . . . 0.0 110.538 179.825 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 66' ' ' ILE . . . . . . . . . . . . . 65.1 mt -114.8 130.95 68.36 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.229 0 N-CA-C 109.736 -0.468 . . . . 0.0 109.736 -178.408 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 67' ' ' THR . . . . . . . . . . . . . 23.4 m -117.63 134.73 54.57 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.123 -0.49 . . . . 0.0 110.608 -178.524 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 68' ' ' LEU . . . . . . . . . . . . . 15.4 tp . . . . . 0 C--N 1.329 -0.309 0 CA-C-N 115.891 -0.595 . . . . 0.0 110.472 179.585 . . . . . . . . 0 0 . 1 . 005 nuclear build core ' A' A ' 74' ' ' ASP . . . . . . . . . . . . . 13.6 t70 . . . . . 0 N--CA 1.459 0.023 0 N-CA-C 109.557 -0.535 . . . . 0.0 109.557 . . . . . . . . . 0 0 . 1 . 005 nuclear build core ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 41.4 t -122.59 124.26 70.28 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.203 0 CA-C-O 121.077 0.465 . . . . 0.0 110.909 -175.203 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 76' ' ' LEU . . . . . . . . . . . . . 5.1 mp -126.38 147.05 49.83 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 115.664 -0.698 . . . . 0.0 109.603 174.852 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 77' ' ' GLU . . . . . . . . . . . . . 45.9 mt-10 -135.1 140.52 45.55 Favored 'General case' 0 C--N 1.331 -0.207 0 CA-C-O 121.015 0.436 . . . . 0.0 111.425 -178.443 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 78' ' ' ALA . . . . . 0.42 ' HB2' HD21 ' A' ' 109' ' ' LEU . . . -129.92 131.33 45.96 Favored 'General case' 0 C--N 1.331 -0.22 0 CA-C-N 115.774 -0.648 . . . . 0.0 109.842 176.513 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 79' ' ' LYS . . . . . 0.583 ' O ' HD13 ' A' ' 80' ' ' ILE . 16.3 ptpt -74.94 122.57 23.65 Favored 'General case' 0 C--N 1.331 -0.222 0 CA-C-O 121.281 0.562 . . . . 0.0 111.087 -176.801 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 80' ' ' ILE . . . . . 0.583 HD13 ' O ' ' A' ' 79' ' ' LYS . 41.2 mm -139.22 110.57 4.95 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.318 0 CA-C-N 115.779 -0.646 . . . . 0.0 109.289 -177.875 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 81' ' ' LYS . . . . . . . . . . . . . 60.6 mttp -101.37 125.56 48.03 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-O 120.914 0.388 . . . . 0.0 111.293 -178.234 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . 89.15 42.07 5.69 Favored Glycine 0 CA--C 1.525 0.702 0 C-N-CA 121.105 -0.569 . . . . 0.0 111.894 174.254 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 83' ' ' ILE . . . . . . . . . . . . . 71.4 mt -69.55 133.3 32.09 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.33 0 N-CA-C 109.489 -0.56 . . . . 0.0 109.489 175.999 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 84' ' ' LYS . . . . . . . . . . . . . 35.7 ttpt -101.58 -49.58 3.97 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-O 120.742 0.306 . . . . 0.0 110.398 -177.881 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 85' ' ' ASP . . . . . . . . . . . . . 5.6 t70 -150.87 151.26 31.97 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.242 -0.435 . . . . 0.0 110.483 -179.972 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 86' ' ' VAL . . . . . . . . . . . . . 41.0 t -133.89 137.62 52.0 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.261 0 CA-C-O 121.014 0.435 . . . . 0.0 110.537 -179.061 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 87' ' ' ILE . . . . . 0.497 HD12 ' N ' ' A' ' 87' ' ' ILE . 5.0 mp -121.0 130.69 74.42 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.21 0 CA-C-N 115.701 -0.681 . . . . 0.0 109.699 178.134 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 88' ' ' LEU . . . . . . . . . . . . . 15.9 tp -111.79 132.83 54.4 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-O 120.858 0.361 . . . . 0.0 110.743 -178.893 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 89' ' ' ASP . . . . . . . . . . . . . 46.4 t0 -130.6 160.31 34.58 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.161 178.584 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 84.6 tt0 -45.77 -43.1 12.83 Favored 'General case' 0 CA--C 1.532 0.257 0 N-CA-C 113.06 0.763 . . . . 0.0 113.06 -171.392 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 91' ' ' ASN . . . . . . . . . . . . . 3.0 m120 -131.96 26.49 4.6 Favored 'General case' 0 N--CA 1.467 0.394 0 N-CA-C 112.471 0.545 . . . . 0.0 112.471 -178.286 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 92' ' ' LEU . . . . . . . . . . . . . 18.6 mt -148.58 144.47 27.28 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-O 120.759 0.314 . . . . 0.0 110.508 -176.693 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 93' ' ' ILE . . . . . . . . . . . . . 69.3 mt -125.23 116.69 47.65 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.306 0 N-CA-C 108.822 -0.807 . . . . 0.0 108.822 175.694 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 94' ' ' VAL . . . . . . . . . . . . . 44.3 t -117.62 127.85 74.93 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.286 0 N-CA-C 109.904 -0.406 . . . . 0.0 109.904 -177.807 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 95' ' ' VAL . . . . . . . . . . . . . 43.1 t -121.38 133.94 66.31 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.339 0 CA-C-N 116.027 -0.533 . . . . 0.0 109.813 -179.822 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 96' ' ' ILE . . . . . 0.52 HD11 ' HB ' ' A' ' 123' ' ' VAL . 66.8 mt -114.57 125.17 71.82 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.355 0 N-CA-C 109.254 -0.647 . . . . 0.0 109.254 178.63 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 97' ' ' THR . . . . . . . . . . . . . 74.7 p -97.37 156.29 16.52 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-O 121.401 0.62 . . . . 0.0 111.091 -177.388 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 98' ' ' GLU . . . . . . . . . . . . . 84.9 tt0 -53.86 -27.25 28.84 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 115.831 -0.622 . . . . 0.0 112.242 -179.163 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 99' ' ' GLU . . . . . . . . . . . . . 18.8 tp10 -80.8 16.71 1.34 Allowed 'General case' 0 CA--C 1.538 0.491 0 N-CA-C 112.741 0.645 . . . . 0.0 112.741 -176.538 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 100' ' ' ASN . . . . . . . . . . . . . 4.5 m-20 63.43 33.33 13.79 Favored 'General case' 0 C--O 1.233 0.233 0 O-C-N 122.013 -0.43 . . . . 0.0 111.694 177.478 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 101' ' ' GLU . . . . . . . . . . . . . 84.6 tt0 -111.3 142.72 43.16 Favored 'General case' 0 C--N 1.333 -0.147 0 N-CA-C 109.654 -0.498 . . . . 0.0 109.654 173.754 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 102' ' ' VAL . . . . . . . . . . . . . 46.7 t -115.06 127.3 72.67 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.294 0 CA-C-N 116.167 -0.47 . . . . 0.0 109.942 -177.711 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 103' ' ' LEU . . . . . . . . . . . . . 30.5 mt -117.8 129.55 55.74 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 115.809 -0.632 . . . . 0.0 110.279 177.267 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 104' ' ' ILE . . . . . . . . . . . . . 70.9 mt -118.35 120.86 65.65 Favored 'Isoleucine or valine' 0 C--O 1.234 0.244 0 N-CA-C 110.198 -0.297 . . . . 0.0 110.198 179.927 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 105' ' ' PHE . . . . . . . . . . . . . 54.3 m-85 -121.99 164.8 17.03 Favored 'General case' 0 C--N 1.333 -0.15 0 O-C-N 123.87 0.731 . . . . 0.0 109.781 179.377 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 106' ' ' ASN . . . . . 0.414 ' HB3' HD11 ' A' ' 112' ' ' LEU . 45.9 p-10 -99.04 -169.95 1.85 Allowed 'General case' 0 C--N 1.331 -0.219 0 N-CA-C 110.021 -0.363 . . . . 0.0 110.021 174.563 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 107' ' ' GLN . . . . . . . . . . . . . 17.0 tt0 -59.73 -30.1 68.59 Favored 'General case' 0 C--N 1.33 -0.268 0 N-CA-C 111.988 0.366 . . . . 0.0 111.988 -179.744 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 108' ' ' ASN . . . . . . . . . . . . . 7.4 t-20 -82.85 8.83 11.29 Favored 'General case' 0 CA--C 1.536 0.425 0 N-CA-C 113.19 0.811 . . . . 0.0 113.19 -178.0 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 109' ' ' LEU . . . . . 0.42 HD21 ' HB2' ' A' ' 78' ' ' ALA . 12.2 tp 58.98 39.02 24.06 Favored 'General case' 0 C--N 1.332 -0.184 0 CA-C-O 121.162 0.506 . . . . 0.0 111.009 178.966 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 110' ' ' GLU . . . . . . . . . . . . . 70.7 mm-40 -106.91 155.41 19.79 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 116.299 -0.41 . . . . 0.0 109.998 176.595 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 111' ' ' GLU . . . . . . . . . . . . . 84.4 tt0 -83.54 121.92 27.87 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-O 120.835 0.35 . . . . 0.0 110.787 -177.364 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 112' ' ' LEU . . . . . 0.414 HD11 ' HB3' ' A' ' 106' ' ' ASN . 38.5 mt -109.02 -46.0 3.68 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 116.178 -0.465 . . . . 0.0 110.495 177.949 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 113' ' ' TYR . . . . . . . . . . . . . 63.0 t80 -140.29 138.01 34.63 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-O 120.804 0.335 . . . . 0.0 111.388 -179.383 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 114' ' ' ARG . . . . . . . . . . . . . 68.9 ttp85 -136.37 124.82 23.46 Favored 'General case' 0 C--N 1.331 -0.239 0 CA-C-N 115.946 -0.57 . . . . 0.0 110.274 177.535 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 115' ' ' GLY . . . . . . . . . . . . . . . -150.03 157.12 27.08 Favored Glycine 0 CA--C 1.522 0.524 0 N-CA-C 110.784 -0.926 . . . . 0.0 110.784 179.099 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 116' ' ' LYS . . . . . . . . . . . . . 69.8 tttt -134.68 132.23 38.65 Favored 'General case' 0 C--N 1.329 -0.305 0 N-CA-C 109.958 -0.386 . . . . 0.0 109.958 177.641 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 117' ' ' PHE . . . . . . . . . . . . . 39.9 m-85 -127.41 120.6 28.8 Favored 'General case' 0 N--CA 1.463 0.2 0 CA-C-N 116.308 -0.406 . . . . 0.0 110.073 -174.761 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 118' ' ' GLU . . . . . . . . . . . . . 95.6 mt-10 -54.35 -45.89 72.82 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 116.421 -0.354 . . . . 0.0 111.314 -175.851 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 119' ' ' ASN . . . . . . . . . . . . . 88.3 m-20 -101.31 31.11 3.84 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.137 -0.483 . . . . 0.0 112.076 -174.285 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 120' ' ' LEU . . . . . . . . . . . . . 15.0 tp -54.98 119.97 6.21 Favored 'General case' 0 N--CA 1.463 0.214 0 O-C-N 122.264 -0.272 . . . . 0.0 110.615 179.724 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 121' ' ' ASN . . . . . . . . . . . . . 23.9 t-20 -114.18 -44.07 3.17 Favored 'General case' 0 C--O 1.232 0.143 0 CA-C-N 116.487 -0.324 . . . . 0.0 111.151 -177.072 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 122' ' ' LYS . . . . . . . . . . . . . 63.6 mtpt -139.26 142.16 37.78 Favored 'General case' 0 C--N 1.331 -0.225 0 CA-C-O 120.99 0.424 . . . . 0.0 111.594 -175.59 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 123' ' ' VAL . . . . . 0.52 ' HB ' HD11 ' A' ' 96' ' ' ILE . 48.0 t -126.17 125.75 68.32 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 N-CA-C 109.01 -0.737 . . . . 0.0 109.01 173.001 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 124' ' ' LEU . . . . . . . . . . . . . 78.5 mt -121.42 131.13 53.99 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-O 120.843 0.354 . . . . 0.0 110.77 -175.853 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 125' ' ' VAL . . . . . . . . . . . . . 44.5 t -126.15 126.29 69.27 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.239 0 CA-C-N 115.98 -0.555 . . . . 0.0 109.742 178.52 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 126' ' ' ARG . . . . . 0.494 HH11 HD23 ' B' ' 88' ' ' LEU . 82.4 mtt85 -150.9 129.24 12.03 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.299 -0.41 . . . . 0.0 110.045 177.729 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 127' ' ' ASN . . . . . . . . . . . . . 8.8 t-20 56.21 -152.42 0.38 Allowed 'General case' 0 CA--C 1.54 0.581 0 N-CA-C 109.736 -0.468 . . . . 0.0 109.736 179.755 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 128' ' ' ASP . . . . . . . . . . . . . 23.4 p-10 -83.06 18.13 1.76 Allowed 'General case' 0 CA--C 1.536 0.414 0 N-CA-C 112.628 0.603 . . . . 0.0 112.628 178.303 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 129' ' ' LEU . . . . . . . . . . . . . 11.7 tp -117.35 137.2 52.61 Favored 'General case' 0 C--O 1.234 0.241 0 O-C-N 122.079 -0.388 . . . . 0.0 110.472 179.765 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 130' ' ' VAL . . . . . . . . . . . . . 42.0 t -125.84 138.73 53.59 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.188 0 CA-C-N 116.276 -0.42 . . . . 0.0 109.963 -179.424 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 131' ' ' VAL . . . . . . . . . . . . . 35.1 m -136.1 143.98 34.49 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.282 0 CA-C-O 121.152 0.501 . . . . 0.0 111.163 178.143 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 132' ' ' ILE . . . . . . . . . . . . . 69.9 mt -120.9 134.03 65.63 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 CA-C-N 115.657 -0.702 . . . . 0.0 109.606 179.966 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 133' ' ' ILE . . . . . . . . . . . . . 40.8 mm -116.68 117.83 56.75 Favored 'Isoleucine or valine' 0 C--O 1.233 0.224 0 CA-C-O 120.965 0.412 . . . . 0.0 110.711 -176.684 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 134' ' ' ASP . . . . . . . . . . . . . 8.0 p-10 -131.49 148.47 52.64 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 115.844 -0.616 . . . . 0.0 109.408 174.717 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 135' ' ' GLU . . . . . . . . . . . . . 84.8 tt0 -49.76 -24.44 2.35 Favored 'General case' 0 C--N 1.327 -0.399 0 N-CA-C 112.835 0.68 . . . . 0.0 112.835 -171.947 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 136' ' ' GLN . . . . . . . . . . . . . 51.2 tt0 -101.67 -27.72 12.9 Favored 'General case' 0 C--O 1.233 0.212 0 N-CA-C 112.58 0.585 . . . . 0.0 112.58 -173.789 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 137' ' ' LYS . . . . . . . . . . . . . 49.6 mttm -142.13 149.23 39.53 Favored 'General case' 0 C--N 1.332 -0.17 0 N-CA-C 112.766 0.654 . . . . 0.0 112.766 -170.51 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 138' ' ' LEU . . . . . . . . . . . . . 9.9 tp -110.4 118.66 36.87 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 114.891 -1.049 . . . . 0.0 108.732 170.973 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 139' ' ' THR . . . . . . . . . . . . . 31.5 m -111.05 127.47 55.55 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-O 120.67 0.271 . . . . 0.0 110.86 -177.283 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 140' ' ' LEU . . . . . 0.48 HD23 ' C ' ' A' ' 140' ' ' LEU . 7.3 tt -116.05 122.66 45.84 Favored 'General case' 0 C--N 1.329 -0.292 0 N-CA-C 109.251 -0.648 . . . . 0.0 109.251 179.913 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 141' ' ' ILE . . . . . . . . . . . . . 19.0 mt -120.6 123.45 70.41 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.273 0 CA-C-O 120.87 0.367 . . . . 0.0 110.112 -174.378 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 142' ' ' ARG . . . . . . . . . . . . . 76.4 mtp180 -110.94 127.61 55.54 Favored 'General case' 0 C--N 1.331 -0.229 0 CA-C-N 115.521 -0.763 . . . . 0.0 110.164 -178.507 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 143' ' ' THR . . . . . . . . . . . . . 42.0 p . . . . . 0 C--O 1.219 -0.505 0 CA-C-O 118.024 -0.988 . . . . 0.0 110.593 -179.524 . . . . . . . . 0 0 . 1 . 005 nuclear build core ' B' B ' 2' ' ' SER . . . . . . . . . . . . . 5.2 p . . . . . 0 C--O 1.233 0.191 0 CA-C-O 121.034 0.445 . . . . 0.0 111.03 . . . . . . . . . 0 0 . 1 . 005 nuclear build core ' B' B ' 3' ' ' GLU . . . . . . . . . . . . . 33.8 tp10 -139.55 136.4 34.43 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 115.786 -0.643 . . . . 0.0 110.402 -178.52 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B ' 4' ' ' LEU . . . . . . . . . . . . . 21.3 tp -124.49 128.77 49.48 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-O 120.714 0.292 . . . . 0.0 110.355 176.028 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B ' 5' ' ' LYS . . . . . . . . . . . . . 98.3 mttt -105.5 120.94 42.89 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.344 -0.389 . . . . 0.0 110.539 179.074 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B ' 6' ' ' LEU . . . . . . . . . . . . . 79.8 mt -118.21 147.62 43.2 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 115.587 -0.733 . . . . 0.0 110.549 -179.474 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B ' 7' ' ' LYS . . . . . . . . . . . . . 73.5 tttt -134.79 140.11 34.3 Favored Pre-proline 0 CA--C 1.534 0.332 0 CA-C-O 118.985 -0.531 . . . . 0.0 110.038 176.193 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B ' 8' ' ' PRO . . . . . . . . . . . . . 88.1 Cg_endo -91.79 137.17 1.86 Allowed 'Trans proline' 0 N--CA 1.489 1.25 0 C-N-CA 121.649 1.566 . . . . 0.0 111.559 177.804 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B ' 9' ' ' LEU . . . . . . . . . . . . . 68.3 mt -72.32 -46.21 10.55 Favored Pre-proline 0 CA--C 1.533 0.32 0 CA-C-O 118.937 -0.554 . . . . 0.0 111.905 -178.682 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B ' 10' ' ' PRO . . . . . . . . . . . . . 78.1 Cg_endo -84.37 152.09 12.08 Favored 'Trans proline' 0 N--CA 1.495 1.575 0 C-N-CA 121.318 1.345 . . . . 0.0 111.734 172.597 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B ' 11' ' ' LYS . . . . . . . . . . . . . 67.5 mttm -88.91 99.9 12.76 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-O 120.81 0.338 . . . . 0.0 110.614 178.104 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B ' 12' ' ' VAL . . . . . . . . . . . . . 12.6 p -140.91 142.42 30.09 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.28 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.362 179.239 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B ' 13' ' ' GLU . . . . . . . . . . . . . 96.1 mt-10 -78.62 129.26 34.56 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.365 -0.379 . . . . 0.0 110.168 178.166 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B ' 14' ' ' LEU . . . . . . . . . . . . . 29.9 mt -98.03 148.66 34.8 Favored Pre-proline 0 C--N 1.329 -0.301 0 CA-C-O 119.223 -0.417 . . . . 0.0 110.282 -179.016 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B ' 15' ' ' PRO . . . . . . . . . . . . . 30.0 Cg_exo -60.67 160.46 24.55 Favored 'Trans proline' 0 N--CA 1.497 1.681 0 C-N-CA 121.322 1.348 . . . . 0.0 111.492 176.117 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B ' 16' ' ' PRO . . . . . . . . . . . . . 38.8 Cg_exo -58.72 -33.81 98.57 Favored 'Trans proline' 0 N--CA 1.497 1.704 0 C-N-CA 121.375 1.384 . . . . 0.0 112.795 -177.993 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B ' 17' ' ' ASP . . . . . . . . . . . . . 11.6 p-10 -93.76 9.83 35.5 Favored 'General case' 0 CA--C 1.535 0.381 0 N-CA-C 113.287 0.847 . . . . 0.0 113.287 -177.147 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B ' 18' ' ' PHE . . . . . . . . . . . . . 44.4 t80 -58.49 -47.21 84.82 Favored 'General case' 0 C--N 1.334 -0.082 0 CA-C-O 120.963 0.411 . . . . 0.0 110.084 -177.961 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B ' 19' ' ' VAL . . . . . . . . . . . . . 49.0 t -57.41 -40.65 75.66 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.339 0 CA-C-N 116.277 -0.42 . . . . 0.0 110.361 -178.737 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B ' 20' ' ' ASP . . . . . . . . . . . . . 79.8 m-20 -60.4 -43.73 96.38 Favored 'General case' 0 C--N 1.331 -0.205 0 C-N-CA 120.936 -0.306 . . . . 0.0 110.968 -178.272 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B ' 21' ' ' VAL . . . . . . . . . . . . . 49.1 t -64.4 -47.35 89.88 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.262 0 C-N-CA 120.753 -0.379 . . . . 0.0 110.359 -177.448 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B ' 22' ' ' ILE . . . . . . . . . . . . . 48.9 mm -56.29 -46.53 81.61 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.258 0 CA-C-O 120.813 0.34 . . . . 0.0 110.598 179.501 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B ' 23' ' ' ARG . . . . . . . . . . . . . 47.9 ttp180 -54.64 -50.61 67.74 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.532 -0.304 . . . . 0.0 111.391 -178.6 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B ' 24' ' ' ILE . . . . . . . . . . . . . 76.1 mt -60.06 -40.5 83.43 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.268 0 C-N-CA 121.073 -0.251 . . . . 0.0 111.432 -176.78 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B ' 25' ' ' LYS . . . . . . . . . . . . . 52.2 mtmt -66.9 -38.93 87.17 Favored 'General case' 0 C--N 1.328 -0.329 0 N-CA-C 112.114 0.413 . . . . 0.0 112.114 -179.833 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B ' 26' ' ' LEU . . . . . . . . . . . . . 93.3 mt -78.49 -40.49 35.22 Favored 'General case' 0 C--N 1.331 -0.21 0 N-CA-C 113.175 0.806 . . . . 0.0 113.175 -172.441 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B ' 27' ' ' GLN . . . . . . . . . . . . . 13.9 pt20 -46.83 139.06 5.71 Favored 'General case' 0 N--CA 1.471 0.591 0 N-CA-C 112.635 0.605 . . . . 0.0 112.635 -175.467 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B ' 28' ' ' GLY . . . . . . . . . . . . . . . 97.68 -23.08 37.48 Favored Glycine 0 CA--C 1.535 1.283 0 CA-C-N 115.573 -0.74 . . . . 0.0 112.319 -175.931 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B ' 29' ' ' LYS . . . . . . . . . . . . . 96.3 mttt -98.41 155.08 17.41 Favored 'General case' 0 C--O 1.233 0.234 0 CA-C-N 117.486 0.643 . . . . 0.0 111.143 179.135 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B ' 30' ' ' THR . . . . . . . . . . . . . 38.6 m -98.38 137.88 36.44 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-N 116.073 -0.512 . . . . 0.0 110.07 176.091 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B ' 31' ' ' VAL . . . . . . . . . . . . . 34.7 m -128.04 148.48 32.6 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.267 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.902 -178.349 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B ' 32' ' ' ARG . . . . . . . . . . . . . 80.3 mtt180 -133.4 150.72 51.79 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-O 121.326 0.584 . . . . 0.0 110.627 177.83 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B ' 33' ' ' THR . . . . . . . . . . . . . 23.1 m -53.39 138.57 32.77 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.034 -0.53 . . . . 0.0 111.279 -178.369 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B ' 34' ' ' GLY . . . . . . . . . . . . . . . 100.35 -17.22 57.17 Favored Glycine 0 CA--C 1.533 1.178 0 CA-C-O 119.537 -0.591 . . . . 0.0 113.243 178.252 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B ' 35' ' ' ASP . . . . . . . . . . . . . 77.7 m-20 -65.33 148.26 52.0 Favored 'General case' 0 C--N 1.333 -0.132 0 CA-C-N 118.131 0.965 . . . . 0.0 111.043 179.808 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B ' 36' ' ' VAL . . . . . . . . . . . . . 44.5 t -121.06 129.72 75.41 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.228 0 CA-C-N 115.852 -0.613 . . . . 0.0 109.842 178.387 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B ' 37' ' ' ILE . . . . . . . . . . . . . 65.3 mt -117.82 137.84 50.44 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.261 0 CA-C-N 116.19 -0.459 . . . . 0.0 109.843 -179.83 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B ' 38' ' ' GLY . . . . . . . . . . . . . . . -110.6 128.58 8.86 Favored Glycine 0 CA--C 1.526 0.764 0 N-CA-C 110.986 -0.845 . . . . 0.0 110.986 179.561 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B ' 39' ' ' ILE . . . . . . . . . . . . . 73.6 mt -124.34 134.66 66.06 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.178 0 N-CA-C 110.015 -0.365 . . . . 0.0 110.015 179.039 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B ' 40' ' ' SER . . . . . . . . . . . . . 43.0 t -92.62 117.56 30.1 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.535 -0.302 . . . . 0.0 110.873 176.201 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B ' 41' ' ' ILE . . . . . . . . . . . . . 45.3 mm -122.75 114.38 42.06 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.159 0 CA-C-O 120.897 0.38 . . . . 0.0 110.546 179.261 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B ' 42' ' ' LEU . . . . . . . . . . . . . 9.2 tp 53.58 37.84 26.82 Favored 'General case' 0 C--N 1.331 -0.216 0 CA-C-N 116.094 -0.503 . . . . 0.0 111.399 176.862 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B ' 43' ' ' GLY . . . . . . . . . . . . . . . 74.62 25.28 70.38 Favored Glycine 0 CA--C 1.531 1.075 0 C-N-CA 121.126 -0.559 . . . . 0.0 112.725 177.563 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B ' 44' ' ' LYS . . . . . . . . . . . . . 34.6 mmtp -130.18 129.31 43.28 Favored 'General case' 0 C--N 1.331 -0.207 0 N-CA-C 109.546 -0.538 . . . . 0.0 109.546 177.682 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B ' 45' ' ' GLU . . . . . . . . . . . . . 81.1 tt0 -83.1 118.98 23.93 Favored 'General case' 0 C--N 1.329 -0.295 0 C-N-CA 120.762 -0.375 . . . . 0.0 110.762 -179.173 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B ' 46' ' ' VAL . . . . . . . . . . . . . 7.4 p -118.6 126.75 75.42 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.216 0 N-CA-C 109.288 -0.634 . . . . 0.0 109.288 176.489 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B ' 47' ' ' LYS . . . . . . . . . . . . . 56.3 mtmt -100.67 128.73 46.61 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 115.84 -0.618 . . . . 0.0 111.304 178.85 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B ' 48' ' ' PHE . . . . . . . . . . . . . 94.3 m-85 -110.73 131.87 54.68 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 115.999 -0.546 . . . . 0.0 109.774 176.089 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B ' 49' ' ' LYS . . . . . . . . . . . . . 36.1 tttp -106.58 135.64 47.75 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.407 -0.36 . . . . 0.0 110.407 -179.498 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B ' 50' ' ' VAL . . . . . . . . . . . . . 43.7 t -80.18 108.76 13.96 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.207 0 N-CA-C 109.257 -0.646 . . . . 0.0 109.257 176.488 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B ' 51' ' ' VAL . . . . . . . . . . . . . 46.0 t -73.39 -47.94 43.93 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.273 0 CA-C-N 116.141 -0.481 . . . . 0.0 110.11 -174.125 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B ' 52' ' ' GLN . . . . . . . . . . . . . 59.8 tt0 -162.6 140.84 8.57 Favored 'General case' 0 C--N 1.33 -0.262 0 C-N-CA 120.401 -0.52 . . . . 0.0 111.343 -177.37 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B ' 53' ' ' ALA . . . . . . . . . . . . . . . -114.82 131.67 56.74 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 115.45 -0.795 . . . . 0.0 109.971 175.56 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B ' 54' ' ' TYR . . . . . . . . . . . . . 30.9 t80 -129.12 111.54 18.31 Favored Pre-proline 0 CA--C 1.535 0.386 0 CA-C-O 118.302 -0.856 . . . . 0.0 110.232 177.598 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B ' 55' ' ' PRO . . . . . . . . . . . . . 73.5 Cg_endo -77.18 167.94 78.3 Favored 'Cis proline' 0 N--CA 1.499 1.835 0 CA-C-N 121.985 1.745 . . . . 0.0 112.373 -5.955 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B ' 56' ' ' SER . . . . . . . . . . . . . 13.6 m -117.34 134.87 23.06 Favored Pre-proline 0 CA--C 1.538 0.51 0 CA-C-O 118.574 -0.727 . . . . 0.0 109.493 174.049 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B ' 57' ' ' PRO . . . . . . . . . . . . . 39.8 Cg_endo -68.11 146.66 78.64 Favored 'Cis proline' 0 N--CA 1.498 1.744 0 CA-C-N 121.87 1.704 . . . . 0.0 111.329 -3.06 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B ' 58' ' ' LEU . . . . . . . . . . . . . 16.3 tp -107.2 136.8 46.41 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.282 -0.417 . . . . 0.0 110.584 -177.599 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B ' 59' ' ' ARG . . . . . . . . . . . . . 51.2 ttp180 -104.64 119.9 40.07 Favored 'General case' 0 C--N 1.328 -0.342 0 N-CA-C 109.315 -0.624 . . . . 0.0 109.315 175.975 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B ' 60' ' ' VAL . . . . . . . . . . . . . 48.7 t -73.37 122.53 26.47 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.252 0 C-N-CA 120.662 -0.415 . . . . 0.0 110.154 -175.214 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B ' 61' ' ' GLU . . . . . . . . . . . . . 95.8 mt-10 -131.05 163.39 27.71 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 115.934 -0.575 . . . . 0.0 110.422 -179.21 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B ' 62' ' ' ASP . . . . . . . . . . . . . 12.5 t70 -55.15 -32.73 62.34 Favored 'General case' 0 C--N 1.327 -0.401 0 CA-C-N 116.426 -0.352 . . . . 0.0 111.523 178.59 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B ' 63' ' ' ARG . . . . . . . . . . . . . 13.1 ptp180 -89.84 9.6 26.86 Favored 'General case' 0 CA--C 1.534 0.337 0 N-CA-C 113.522 0.934 . . . . 0.0 113.522 -176.016 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B ' 64' ' ' THR . . . . . . . . . . . . . 39.4 m -91.41 133.41 35.49 Favored 'General case' 0 C--N 1.332 -0.16 0 CA-C-N 118.198 0.454 . . . . 0.0 110.087 179.667 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B ' 65' ' ' LYS . . . . . . . . . . . . . 57.6 mtmt -90.0 132.55 35.3 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-O 120.987 0.422 . . . . 0.0 110.648 -177.664 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B ' 66' ' ' ILE . . . . . . . . . . . . . 60.7 mt -114.84 127.84 72.21 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.358 0 N-CA-C 109.755 -0.461 . . . . 0.0 109.755 -179.269 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B ' 67' ' ' THR . . . . . . . . . . . . . 30.6 m -119.12 138.84 52.63 Favored 'General case' 0 C--N 1.332 -0.186 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.941 -176.91 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B ' 68' ' ' LEU . . . . . . . . . . . . . 14.8 tp . . . . . 0 C--N 1.329 -0.324 0 CA-C-N 115.913 -0.585 . . . . 0.0 110.065 178.223 . . . . . . . . 0 0 . 1 . 005 nuclear build core ' B' B ' 73' ' ' VAL . . . . . . . . . . . . . 35.1 m . . . . . 0 N--CA 1.463 0.214 0 CA-C-O 120.859 0.361 . . . . 0.0 111.091 . . . . . . . . . 0 0 . 1 . 005 nuclear build core ' B' B ' 74' ' ' ASP . . . . . . . . . . . . . 38.7 t0 -99.11 122.95 43.02 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 115.963 -0.562 . . . . 0.0 109.94 -178.975 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B ' 75' ' ' VAL . . . . . . . . . . . . . 40.0 t -119.9 124.13 72.18 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.264 0 CA-C-O 121.063 0.459 . . . . 0.0 110.802 -177.609 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B ' 76' ' ' LEU . . . . . . . . . . . . . 5.7 mp -119.65 142.12 48.74 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 115.687 -0.688 . . . . 0.0 109.426 174.696 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B ' 77' ' ' GLU . . . . . . . . . . . . . 97.4 mt-10 -135.6 130.75 34.93 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-O 121.117 0.484 . . . . 0.0 111.011 -177.789 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B ' 78' ' ' ALA . . . . . . . . . . . . . . . -117.46 134.93 54.29 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 115.619 -0.718 . . . . 0.0 109.725 177.007 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B ' 79' ' ' LYS . . . . . 0.568 ' O ' HD13 ' B' ' 80' ' ' ILE . 90.0 mttt -75.49 115.87 15.61 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-O 120.903 0.382 . . . . 0.0 110.236 -179.041 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' B' B ' 80' ' ' ILE . . . . . 0.568 HD13 ' O ' ' B' ' 79' ' ' LYS . 44.0 mm -139.09 119.35 14.69 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.328 0 N-CA-C 109.346 -0.613 . . . . 0.0 109.346 -176.836 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' B' B ' 81' ' ' LYS . . . . . . . . . . . . . 60.0 tttm -117.92 129.67 55.76 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-O 120.924 0.392 . . . . 0.0 111.088 -176.964 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B ' 82' ' ' GLY . . . . . . . . . . . . . . . 88.96 42.13 5.73 Favored Glycine 0 CA--C 1.524 0.651 0 CA-C-N 115.883 -0.599 . . . . 0.0 112.089 175.687 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B ' 83' ' ' ILE . . . . . . . . . . . . . 73.9 mt -73.72 133.01 32.52 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.249 0 N-CA-C 109.229 -0.656 . . . . 0.0 109.229 175.398 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B ' 84' ' ' LYS . . . . . . . . . . . . . 38.4 ttpt -102.47 -45.1 5.17 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.567 -0.288 . . . . 0.0 110.567 -176.94 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B ' 85' ' ' ASP . . . . . . . . . . . . . 9.1 t70 -147.68 149.44 32.46 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.293 -0.412 . . . . 0.0 110.518 -179.914 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B ' 86' ' ' VAL . . . . . . . . . . . . . 40.3 t -130.79 134.55 61.71 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.251 0 CA-C-O 121.002 0.429 . . . . 0.0 110.485 -179.208 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B ' 87' ' ' ILE . . . . . 0.494 ' N ' HD12 ' B' ' 87' ' ' ILE . 5.0 mp -121.8 125.89 73.89 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.214 0 CA-C-N 115.841 -0.618 . . . . 0.0 109.385 176.51 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' B' B ' 88' ' ' LEU . . . . . 0.494 HD23 HH11 ' A' ' 126' ' ' ARG . 8.3 tp -117.91 134.19 55.18 Favored 'General case' 0 C--N 1.331 -0.224 0 CA-C-O 120.9 0.381 . . . . 0.0 111.088 -176.058 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' B' B ' 89' ' ' ASP . . . . . . . . . . . . . 12.4 t70 -134.84 160.12 39.24 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 115.948 -0.569 . . . . 0.0 109.859 177.943 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B ' 90' ' ' GLU . . . . . . . . . . . . . 95.6 mt-10 -48.14 -37.75 16.25 Favored 'General case' 0 C--N 1.331 -0.226 0 N-CA-C 112.991 0.737 . . . . 0.0 112.991 -171.637 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B ' 91' ' ' ASN . . . . . . . . . . . . . 12.2 m120 -130.01 22.35 5.33 Favored 'General case' 0 N--CA 1.468 0.468 0 N-CA-C 112.813 0.672 . . . . 0.0 112.813 -176.621 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B ' 92' ' ' LEU . . . . . . . . . . . . . 51.0 mt -148.45 141.23 24.63 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-O 120.773 0.32 . . . . 0.0 110.599 -178.237 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B ' 93' ' ' ILE . . . . . . . . . . . . . 73.2 mt -124.42 112.78 33.65 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.322 0 N-CA-C 108.858 -0.793 . . . . 0.0 108.858 176.195 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B ' 94' ' ' VAL . . . . . 0.432 HG21 HG21 ' B' ' 125' ' ' VAL . 46.1 t -116.58 127.85 74.09 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.284 0 CA-C-O 120.923 0.392 . . . . 0.0 110.038 -177.681 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' B' B ' 95' ' ' VAL . . . . . . . . . . . . . 42.3 t -121.08 132.7 69.86 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.388 0 CA-C-N 115.885 -0.598 . . . . 0.0 109.595 -179.556 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B ' 96' ' ' ILE . . . . . . . . . . . . . 72.4 mt -115.11 125.16 72.33 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.251 0 N-CA-C 109.192 -0.67 . . . . 0.0 109.192 178.259 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B ' 97' ' ' THR . . . . . . . . . . . . . 80.7 p -98.67 160.42 14.29 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-O 121.33 0.586 . . . . 0.0 111.302 -175.868 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B ' 98' ' ' GLU . . . . . . . . . . . . . 84.3 tt0 -53.84 -26.72 25.77 Favored 'General case' 0 C--N 1.327 -0.385 0 CA-C-N 115.683 -0.69 . . . . 0.0 112.249 179.843 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B ' 99' ' ' GLU . . . . . . . . . . . . . 69.4 mm-40 -79.04 11.59 2.67 Favored 'General case' 0 CA--C 1.536 0.432 0 N-CA-C 113.227 0.825 . . . . 0.0 113.227 -177.36 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B ' 100' ' ' ASN . . . . . . . . . . . . . 3.3 m-20 62.71 32.31 16.2 Favored 'General case' 0 CA--C 1.533 0.29 0 CA-C-N 118.233 0.469 . . . . 0.0 111.756 -179.796 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B ' 101' ' ' GLU . . . . . . . . . . . . . 84.2 tt0 -107.79 144.18 35.31 Favored 'General case' 0 C--N 1.332 -0.187 0 N-CA-C 109.714 -0.476 . . . . 0.0 109.714 171.559 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B ' 102' ' ' VAL . . . . . . . . . . . . . 44.5 t -116.28 126.49 73.78 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.246 0 N-CA-C 110.055 -0.35 . . . . 0.0 110.055 -178.957 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B ' 103' ' ' LEU . . . . . . . . . . . . . 63.7 mt -114.48 131.77 56.51 Favored 'General case' 0 C--N 1.331 -0.23 0 CA-C-N 115.641 -0.709 . . . . 0.0 109.58 178.112 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B ' 104' ' ' ILE . . . . . 0.476 HD12 ' HB3' ' B' ' 113' ' ' TYR . 62.3 mt -122.17 118.64 56.07 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.242 0 N-CA-C 110.293 -0.262 . . . . 0.0 110.293 -178.857 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' B' B ' 105' ' ' PHE . . . . . . . . . . . . . 41.3 m-85 -119.84 165.31 14.76 Favored 'General case' 0 C--N 1.331 -0.196 0 O-C-N 123.986 0.804 . . . . 0.0 109.717 178.032 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B ' 106' ' ' ASN . . . . . . . . . . . . . 46.8 p-10 -98.07 -169.89 1.89 Allowed 'General case' 0 C--N 1.329 -0.313 0 N-CA-C 109.664 -0.495 . . . . 0.0 109.664 172.591 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B ' 107' ' ' GLN . . . . . . . . . . . . . 28.6 tt0 -59.83 -30.21 68.78 Favored 'General case' 0 C--N 1.329 -0.29 0 N-CA-C 111.938 0.347 . . . . 0.0 111.938 -179.905 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B ' 108' ' ' ASN . . . . . . . . . . . . . 14.8 t-20 -83.59 9.32 11.74 Favored 'General case' 0 CA--C 1.538 0.515 0 N-CA-C 113.09 0.774 . . . . 0.0 113.09 -178.354 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B ' 109' ' ' LEU . . . . . . . . . . . . . 9.2 tp 60.38 36.32 20.41 Favored 'General case' 0 C--N 1.332 -0.179 0 CA-C-O 120.918 0.39 . . . . 0.0 111.495 178.921 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B ' 110' ' ' GLU . . . . . . . . . . . . . 70.7 mm-40 -105.65 149.82 26.0 Favored 'General case' 0 C--N 1.33 -0.24 0 N-CA-C 109.978 -0.378 . . . . 0.0 109.978 177.094 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B ' 111' ' ' GLU . . . . . . . . . . . . . 47.2 mp0 -76.86 126.41 30.93 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-O 121.035 0.445 . . . . 0.0 111.357 -177.249 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B ' 112' ' ' LEU . . . . . . . . . . . . . 39.5 mt -110.07 -46.05 3.51 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 115.821 -0.627 . . . . 0.0 109.967 174.974 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B ' 113' ' ' TYR . . . . . 0.476 ' HB3' HD12 ' B' ' 104' ' ' ILE . 65.5 t80 -143.62 140.52 30.17 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 115.975 -0.557 . . . . 0.0 111.134 179.752 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' B' B ' 114' ' ' ARG . . . . . . . . . . . . . 93.2 mtt180 -139.51 125.66 19.98 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.54 173.665 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B ' 115' ' ' GLY . . . . . . . . . . . . . . . -150.16 162.92 29.36 Favored Glycine 0 CA--C 1.524 0.623 0 N-CA-C 111.083 -0.807 . . . . 0.0 111.083 179.491 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B ' 116' ' ' LYS . . . . . . . . . . . . . 87.6 tttt -131.22 135.14 47.12 Favored 'General case' 0 C--N 1.33 -0.277 0 N-CA-C 109.832 -0.432 . . . . 0.0 109.832 177.412 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B ' 117' ' ' PHE . . . . . . . . . . . . . 33.4 m-85 -136.46 114.16 11.12 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.327 -0.397 . . . . 0.0 110.393 -174.789 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B ' 118' ' ' GLU . . . . . . . . . . . . . 83.4 tt0 -52.3 -47.68 65.8 Favored 'General case' 0 C--N 1.327 -0.408 0 CA-C-N 116.475 -0.33 . . . . 0.0 111.618 -176.999 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B ' 119' ' ' ASN . . . . . . . . . . . . . 50.3 m-80 -97.4 30.94 2.66 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.192 -0.458 . . . . 0.0 112.175 -173.826 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B ' 120' ' ' LEU . . . . . . . . . . . . . 12.8 tp -57.15 122.31 12.11 Favored 'General case' 0 C--N 1.332 -0.19 0 C-N-CA 120.987 -0.285 . . . . 0.0 110.318 177.98 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B ' 121' ' ' ASN . . . . . . . . . . . . . 26.3 m120 -113.29 -44.2 3.27 Favored 'General case' 0 C--O 1.232 0.162 0 CA-C-N 116.652 -0.249 . . . . 0.0 111.101 -176.965 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B ' 122' ' ' LYS . . . . . . . . . . . . . 97.1 mttt -148.22 150.65 34.11 Favored 'General case' 0 C--N 1.331 -0.208 0 CA-C-O 121.061 0.458 . . . . 0.0 111.701 -178.684 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B ' 123' ' ' VAL . . . . . . . . . . . . . 43.9 t -127.38 129.09 70.58 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.233 0 N-CA-C 109.447 -0.575 . . . . 0.0 109.447 174.716 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B ' 124' ' ' LEU . . . . . 0.403 ' N ' HD12 ' B' ' 124' ' ' LEU . 6.1 mp -122.06 134.57 54.78 Favored 'General case' 0 C--N 1.332 -0.184 0 CA-C-O 120.863 0.363 . . . . 0.0 110.757 -178.538 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' B' B ' 125' ' ' VAL . . . . . 0.432 HG21 HG21 ' B' ' 94' ' ' VAL . 43.2 t -125.28 128.23 72.59 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.283 0 CA-C-N 115.933 -0.576 . . . . 0.0 109.765 178.21 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' B' B ' 126' ' ' ARG . . . . . . . . . . . . . 30.5 ttm180 -149.15 122.01 8.74 Favored 'General case' 0 C--N 1.33 -0.276 0 N-CA-C 109.809 -0.441 . . . . 0.0 109.809 178.368 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B ' 127' ' ' ASN . . . . . . . . . . . . . 76.9 m-20 56.37 -151.55 0.4 Allowed 'General case' 0 CA--C 1.541 0.609 0 N-CA-C 109.771 -0.455 . . . . 0.0 109.771 179.742 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B ' 128' ' ' ASP . . . . . . . . . . . . . 19.7 p-10 -80.18 15.43 1.54 Allowed 'General case' 0 CA--C 1.535 0.383 0 N-CA-C 112.861 0.689 . . . . 0.0 112.861 178.797 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B ' 129' ' ' LEU . . . . . . . . . . . . . 15.6 tp -111.84 133.66 53.9 Favored 'General case' 0 C--O 1.232 0.133 0 O-C-N 122.0 -0.438 . . . . 0.0 110.287 179.158 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B ' 130' ' ' VAL . . . . . . . . . . . . . 47.7 t -121.91 135.3 62.47 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.222 0 N-CA-C 109.759 -0.46 . . . . 0.0 109.759 -179.953 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B ' 131' ' ' VAL . . . . . . . . . . . . . 42.8 t -134.83 135.62 52.95 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.253 0 CA-C-O 121.029 0.442 . . . . 0.0 110.594 -179.533 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B ' 132' ' ' ILE . . . . . . . . . . . . . 73.1 mt -117.51 132.69 66.57 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.26 0 CA-C-N 115.676 -0.693 . . . . 0.0 109.392 178.84 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B ' 133' ' ' ILE . . . . . . . . . . . . . 44.6 mm -116.34 122.32 69.49 Favored 'Isoleucine or valine' 0 C--O 1.234 0.251 0 CA-C-N 116.55 -0.296 . . . . 0.0 110.931 -176.014 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B ' 134' ' ' ASP . . . . . . . . . . . . . 7.2 p-10 -133.0 146.7 52.01 Favored 'General case' 0 C--N 1.33 -0.258 0 N-CA-C 109.714 -0.476 . . . . 0.0 109.714 174.628 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B ' 135' ' ' GLU . . . . . . . . . . . . . 84.7 tt0 -49.87 -26.27 3.91 Favored 'General case' 0 C--N 1.326 -0.445 0 N-CA-C 112.916 0.71 . . . . 0.0 112.916 -173.321 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B ' 136' ' ' GLN . . . . . . . . . . . . . 61.4 tt0 -84.55 -32.4 23.86 Favored 'General case' 0 C--N 1.331 -0.231 0 N-CA-C 112.42 0.526 . . . . 0.0 112.42 -175.488 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B ' 137' ' ' LYS . . . . . . . . . . . . . 18.1 pttp -168.64 172.74 7.81 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-O 121.436 0.636 . . . . 0.0 112.245 -172.536 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B ' 138' ' ' LEU . . . . . 0.426 HD23 ' N ' ' B' ' 139' ' ' THR . 5.3 tt -117.72 130.1 56.11 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 115.113 -0.948 . . . . 0.0 110.025 -179.217 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' B' B ' 139' ' ' THR . . . . . 0.426 ' N ' HD23 ' B' ' 138' ' ' LEU . 42.2 m -111.53 126.74 55.3 Favored 'General case' 0 C--N 1.331 -0.223 0 CA-C-N 116.147 -0.479 . . . . 0.0 110.384 179.833 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' B' B ' 140' ' ' LEU . . . . . 0.473 HD23 ' N ' ' B' ' 141' ' ' ILE . 5.6 tt -114.18 124.02 51.03 Favored 'General case' 0 C--N 1.329 -0.322 0 N-CA-C 109.261 -0.644 . . . . 0.0 109.261 -179.65 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' B' B ' 141' ' ' ILE . . . . . 0.473 ' N ' HD23 ' B' ' 140' ' ' LEU . 19.1 mt -121.94 125.71 73.53 Favored 'Isoleucine or valine' 0 C--O 1.234 0.266 0 CA-C-O 120.818 0.342 . . . . 0.0 110.15 -173.783 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' B' B ' 142' ' ' ARG . . . . . . . . . . . . . 72.0 mtm180 -114.23 133.94 55.27 Favored 'General case' 0 C--O 1.233 0.233 0 CA-C-N 115.66 -0.7 . . . . 0.0 109.82 -179.267 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B ' 143' ' ' THR . . . . . . . . . . . . . 60.6 p . . . . . 0 C--O 1.219 -0.514 0 CA-C-O 117.957 -1.02 . . . . 0.0 110.449 179.207 . . . . . . . . 0 0 . 1 . 005 nuclear build core ' C' C ' 2' ' ' SER . . . . . . . . . . . . . 2.9 p . . . . . 0 C--O 1.232 0.173 0 CA-C-O 120.862 0.363 . . . . 0.0 110.329 . . . . . . . . . 0 0 . 1 . 005 nuclear build core ' C' C ' 3' ' ' GLU . . . . . . . . . . . . . 94.2 mt-10 -138.51 141.54 39.36 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 115.902 -0.59 . . . . 0.0 110.721 -176.769 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' C' C ' 4' ' ' LEU . . . . . . . . . . . . . 25.2 tp -126.37 126.73 44.36 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.054 -0.521 . . . . 0.0 110.039 176.198 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' C' C ' 5' ' ' LYS . . . . . . . . . . . . . 62.7 mttp -103.83 120.96 42.07 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.508 -0.315 . . . . 0.0 110.647 179.354 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' C' C ' 6' ' ' LEU . . . . . . . . . . . . . 43.1 mt -116.79 143.03 46.16 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 115.536 -0.756 . . . . 0.0 110.556 -178.598 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' C' C ' 7' ' ' LYS . . . . . . . . . . . . . 54.8 tttm -134.3 139.58 33.31 Favored Pre-proline 0 CA--C 1.534 0.349 0 CA-C-O 119.117 -0.468 . . . . 0.0 109.997 176.164 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' C' C ' 8' ' ' PRO . . . . . . . . . . . . . 88.7 Cg_endo -91.94 143.79 2.81 Favored 'Trans proline' 0 N--CA 1.491 1.35 0 C-N-CA 121.721 1.614 . . . . 0.0 111.888 177.812 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' C' C ' 9' ' ' LEU . . . . . . . . . . . . . 63.9 mt -79.2 -48.28 1.55 Allowed Pre-proline 0 CA--C 1.535 0.385 0 CA-C-O 118.638 -0.696 . . . . 0.0 112.242 -179.93 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' C' C ' 10' ' ' PRO . . . . . . . . . . . . . 94.0 Cg_endo -79.51 153.78 23.82 Favored 'Trans proline' 0 N--CA 1.497 1.697 0 C-N-CA 121.149 1.232 . . . . 0.0 111.819 176.949 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' C' C ' 11' ' ' LYS . . . . . . . . . . . . . 51.6 tptt -87.19 96.64 10.39 Favored 'General case' 0 C--N 1.331 -0.226 0 CA-C-N 116.373 -0.376 . . . . 0.0 110.315 178.861 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' C' C ' 12' ' ' VAL . . . . . . . . . . . . . 12.0 p -143.86 143.44 23.93 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.284 0 CA-C-N 116.219 -0.446 . . . . 0.0 110.462 179.019 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' C' C ' 13' ' ' GLU . . . . . . . . . . . . . 12.8 pt-20 -88.09 128.15 35.42 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.351 -0.386 . . . . 0.0 110.296 177.751 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' C' C ' 14' ' ' LEU . . . . . . . . . . . . . 24.4 mt -98.22 153.01 38.26 Favored Pre-proline 0 C--N 1.329 -0.291 0 CA-C-N 116.232 -0.44 . . . . 0.0 110.369 -178.473 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' C' C ' 15' ' ' PRO . . . . . . . . . . . . . 33.6 Cg_exo -59.66 159.97 22.52 Favored 'Trans proline' 0 N--CA 1.495 1.616 0 C-N-CA 121.31 1.34 . . . . 0.0 111.621 178.082 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' C' C ' 16' ' ' PRO . . . . . . . . . . . . . 32.2 Cg_exo -59.42 -32.56 96.68 Favored 'Trans proline' 0 N--CA 1.498 1.743 0 C-N-CA 121.435 1.423 . . . . 0.0 112.714 -177.855 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' C' C ' 17' ' ' ASP . . . . . . . . . . . . . 9.5 p-10 -94.13 9.96 35.7 Favored 'General case' 0 CA--C 1.535 0.388 0 N-CA-C 113.211 0.819 . . . . 0.0 113.211 -177.301 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' C' C ' 18' ' ' PHE . . . . . . . . . . . . . 48.9 t80 -58.13 -42.67 86.33 Favored 'General case' 0 C--O 1.231 0.091 0 O-C-N 121.987 -0.446 . . . . 0.0 110.111 -178.511 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' C' C ' 19' ' ' VAL . . . . . . . . . . . . . 48.7 t -57.7 -42.13 80.96 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.352 0 CA-C-N 116.332 -0.395 . . . . 0.0 110.311 -179.311 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' C' C ' 20' ' ' ASP . . . . . . . . . . . . . 13.6 t70 -60.64 -42.09 96.22 Favored 'General case' 0 C--N 1.329 -0.304 0 C-N-CA 120.988 -0.285 . . . . 0.0 110.99 -178.642 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' C' C ' 21' ' ' VAL . . . . . . . . . . . . . 47.5 t -64.04 -47.56 89.8 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.284 0 C-N-CA 120.713 -0.395 . . . . 0.0 110.38 -177.973 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' C' C ' 22' ' ' ILE . . . . . 0.507 HG22 HD12 ' C' ' 26' ' ' LEU . 51.0 mm -56.67 -43.99 80.28 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.279 0 CA-C-O 120.668 0.27 . . . . 0.0 110.456 178.689 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' C' C ' 23' ' ' ARG . . . . . . . . . . . . . 60.3 ttp180 -54.11 -49.03 70.08 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-O 120.627 0.251 . . . . 0.0 111.419 -179.373 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' C' C ' 24' ' ' ILE . . . . . . . . . . . . . 75.7 mt -59.96 -42.35 89.2 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.295 0 CA-C-N 116.592 -0.276 . . . . 0.0 111.003 -178.348 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' C' C ' 25' ' ' LYS . . . . . . . . . . . . . 54.9 mtmt -67.2 -36.49 81.85 Favored 'General case' 0 C--N 1.328 -0.355 0 N-CA-C 112.299 0.481 . . . . 0.0 112.299 -179.088 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' C' C ' 26' ' ' LEU . . . . . 0.507 HD12 HG22 ' C' ' 22' ' ' ILE . 46.9 mt -77.74 -43.62 30.33 Favored 'General case' 0 C--N 1.33 -0.26 0 N-CA-C 112.899 0.703 . . . . 0.0 112.899 -172.373 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' C' C ' 27' ' ' GLN . . . . . . . . . . . . . 15.0 pt20 -46.91 138.13 6.68 Favored 'General case' 0 N--CA 1.47 0.539 0 N-CA-C 112.564 0.579 . . . . 0.0 112.564 -175.673 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' C' C ' 28' ' ' GLY . . . . . . . . . . . . . . . 100.6 -26.12 25.79 Favored Glycine 0 CA--C 1.533 1.172 0 CA-C-N 115.645 -0.707 . . . . 0.0 112.174 -176.652 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' C' C ' 29' ' ' LYS . . . . . . . . . . . . . 60.3 mmtt -98.06 155.17 17.25 Favored 'General case' 0 C--O 1.232 0.145 0 CA-C-N 117.257 0.529 . . . . 0.0 111.174 178.327 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' C' C ' 30' ' ' THR . . . . . . . . . . . . . 37.7 m -105.94 136.4 45.66 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 115.807 -0.633 . . . . 0.0 109.561 174.26 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' C' C ' 31' ' ' VAL . . . . . . . . . . . . . 34.9 m -127.4 153.75 36.97 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.234 0 CA-C-O 121.172 0.51 . . . . 0.0 111.169 -176.442 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' C' C ' 32' ' ' ARG . . . . . . . . . . . . . 78.2 mtm180 -130.53 150.07 51.91 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 115.537 -0.756 . . . . 0.0 110.26 178.663 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' C' C ' 33' ' ' THR . . . . . . . . . . . . . 24.3 m -53.68 138.95 33.74 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-N 116.453 -0.34 . . . . 0.0 111.285 -178.863 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' C' C ' 34' ' ' GLY . . . . . . . . . . . . . . . 101.0 -17.14 56.66 Favored Glycine 0 CA--C 1.532 1.154 0 CA-C-O 119.621 -0.544 . . . . 0.0 113.306 179.209 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' C' C ' 35' ' ' ASP . . . . . . . . . . . . . 72.5 m-20 -65.25 148.41 51.73 Favored 'General case' 0 C--O 1.232 0.166 0 CA-C-N 118.054 0.927 . . . . 0.0 111.069 179.421 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' C' C ' 36' ' ' VAL . . . . . . . . . . . . . 43.8 t -122.42 131.68 72.69 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.237 0 CA-C-N 115.933 -0.576 . . . . 0.0 109.871 179.111 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' C' C ' 37' ' ' ILE . . . . . . . . . . . . . 67.1 mt -121.06 138.16 52.4 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 CA-C-N 116.114 -0.494 . . . . 0.0 109.902 179.794 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' C' C ' 38' ' ' GLY . . . . . . . . . . . . . . . -112.42 128.63 8.59 Favored Glycine 0 CA--C 1.525 0.692 0 N-CA-C 111.071 -0.812 . . . . 0.0 111.071 179.562 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' C' C ' 39' ' ' ILE . . . . . . . . . . . . . 74.7 mt -124.85 137.13 58.53 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.184 0 N-CA-C 110.128 -0.323 . . . . 0.0 110.128 179.449 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' C' C ' 40' ' ' SER . . . . . . . . . . . . . 41.4 t -92.44 114.06 26.51 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 116.445 -0.343 . . . . 0.0 110.755 176.213 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' C' C ' 41' ' ' ILE . . . . . . . . . . . . . 42.7 mm -119.99 120.67 63.84 Favored 'Isoleucine or valine' 0 N--CA 1.462 0.167 0 CA-C-O 120.737 0.304 . . . . 0.0 110.59 179.879 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' C' C ' 42' ' ' LEU . . . . . . . . . . . . . 47.3 mt 51.85 34.84 14.17 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-N 116.308 -0.405 . . . . 0.0 111.856 176.435 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' C' C ' 43' ' ' GLY . . . . . . . . . . . . . . . 72.88 33.24 60.17 Favored Glycine 0 CA--C 1.529 0.907 0 C-N-CA 121.017 -0.611 . . . . 0.0 111.961 178.665 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' C' C ' 44' ' ' LYS . . . . . . . . . . . . . 55.6 tptt -140.7 129.61 23.2 Favored 'General case' 0 C--N 1.33 -0.268 0 N-CA-C 109.4 -0.593 . . . . 0.0 109.4 178.622 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' C' C ' 45' ' ' GLU . . . . . . . . . . . . . 83.6 tt0 -81.71 119.39 23.78 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-O 120.928 0.394 . . . . 0.0 110.658 -177.782 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' C' C ' 46' ' ' VAL . . . . . . . . . . . . . 7.4 p -117.56 127.06 75.03 Favored 'Isoleucine or valine' 0 C--N 1.333 -0.12 0 N-CA-C 109.303 -0.629 . . . . 0.0 109.303 176.765 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' C' C ' 47' ' ' LYS . . . . . . . . . . . . . 68.0 mttm -100.37 127.36 46.7 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 115.827 -0.624 . . . . 0.0 111.001 179.312 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' C' C ' 48' ' ' PHE . . . . . . . . . . . . . 93.8 m-85 -109.94 131.92 54.62 Favored 'General case' 0 C--N 1.328 -0.347 0 N-CA-C 109.81 -0.441 . . . . 0.0 109.81 175.632 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' C' C ' 49' ' ' LYS . . . . . . . . . . . . . 85.6 tttt -107.75 135.63 48.84 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.437 -0.347 . . . . 0.0 110.385 178.857 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' C' C ' 50' ' ' VAL . . . . . . . . . . . . . 44.6 t -79.76 107.25 11.97 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 N-CA-C 109.198 -0.668 . . . . 0.0 109.198 176.261 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' C' C ' 51' ' ' VAL . . . . . . . . . . . . . 48.4 t -70.36 -46.96 68.97 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.316 0 N-CA-C 109.856 -0.424 . . . . 0.0 109.856 -174.339 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' C' C ' 52' ' ' GLN . . . . . . . . . . . . . 37.4 tt0 -167.14 142.44 4.09 Favored 'General case' 0 C--N 1.33 -0.241 0 C-N-CA 120.314 -0.554 . . . . 0.0 111.711 -179.887 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' C' C ' 53' ' ' ALA . . . . . . . . . . . . . . . -114.69 133.79 55.6 Favored 'General case' 0 C--N 1.331 -0.227 0 CA-C-N 115.761 -0.654 . . . . 0.0 109.745 175.113 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' C' C ' 54' ' ' TYR . . . . . . . . . . . . . 64.2 t80 -129.08 112.81 18.5 Favored Pre-proline 0 CA--C 1.534 0.348 0 CA-C-O 118.259 -0.877 . . . . 0.0 110.52 -179.963 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' C' C ' 55' ' ' PRO . . . . . . . . . . . . . 73.4 Cg_endo -77.18 168.19 77.58 Favored 'Cis proline' 0 N--CA 1.501 1.964 0 CA-C-N 122.05 1.768 . . . . 0.0 112.083 -7.607 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' C' C ' 56' ' ' SER . . . . . . . . . . . . . 14.0 m -117.22 140.42 27.16 Favored Pre-proline 0 CA--C 1.539 0.52 0 CA-C-O 118.599 -0.715 . . . . 0.0 109.828 174.518 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' C' C ' 57' ' ' PRO . . . . . . . . . . . . . 51.5 Cg_endo -70.82 144.2 78.18 Favored 'Cis proline' 0 N--CA 1.498 1.742 0 CA-C-N 121.575 1.598 . . . . 0.0 111.2 -3.742 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' C' C ' 58' ' ' LEU . . . . . . . . . . . . . 16.9 tp -107.49 135.88 48.22 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-O 120.796 0.331 . . . . 0.0 110.981 -176.199 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' C' C ' 59' ' ' ARG . . . . . . . . . . . . . 55.7 ttt180 -101.68 126.06 48.45 Favored 'General case' 0 C--N 1.327 -0.405 0 N-CA-C 109.15 -0.685 . . . . 0.0 109.15 174.254 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' C' C ' 60' ' ' VAL . . . . . . . . . . . . . 42.5 t -83.65 124.48 39.69 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.264 0 C-N-CA 120.64 -0.424 . . . . 0.0 110.549 -175.426 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' C' C ' 61' ' ' GLU . . . . . . . . . . . . . 95.6 mt-10 -129.02 170.74 13.1 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 115.68 -0.691 . . . . 0.0 109.881 177.238 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' C' C ' 62' ' ' ASP . . . . . . . . . . . . . 81.6 m-20 -54.81 -32.51 60.45 Favored 'General case' 0 C--N 1.327 -0.372 0 C-N-CA 121.048 -0.261 . . . . 0.0 111.695 -178.877 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' C' C ' 63' ' ' ARG . . . . . . . . . . . . . 9.2 ptm180 -86.73 6.21 32.47 Favored 'General case' 0 CA--C 1.536 0.415 0 N-CA-C 113.623 0.972 . . . . 0.0 113.623 -175.474 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' C' C ' 64' ' ' THR . . . . . . . . . . . . . 19.8 m -73.36 135.91 44.34 Favored 'General case' 0 C--N 1.332 -0.186 0 CA-C-N 118.138 0.427 . . . . 0.0 110.799 -177.814 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' C' C ' 65' ' ' LYS . . . . . . . . . . . . . 25.3 mtpp -89.94 119.21 30.11 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.098 -0.501 . . . . 0.0 110.001 178.062 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' C' C ' 66' ' ' ILE . . . . . . . . . . . . . 65.6 mt -114.56 131.18 67.41 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.277 0 CA-C-O 120.83 0.348 . . . . 0.0 110.07 -178.681 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' C' C ' 67' ' ' THR . . . . . . . . . . . . . 21.3 m -123.01 134.65 54.3 Favored 'General case' 0 C--N 1.331 -0.224 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.478 -179.253 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' C' C ' 68' ' ' LEU . . . . . . . . . . . . . 21.5 tp . . . . . 0 C--N 1.33 -0.275 0 CA-C-N 115.876 -0.602 . . . . 0.0 110.802 -179.809 . . . . . . . . 0 0 . 1 . 005 nuclear build core ' C' C ' 73' ' ' VAL . . . . . . . . . . . . . 33.0 m . . . . . 0 C--O 1.233 0.236 0 N-CA-C 109.243 -0.651 . . . . 0.0 109.243 . . . . . . . . . 0 0 . 1 . 005 nuclear build core ' C' C ' 74' ' ' ASP . . . . . . . . . . . . . 7.4 t0 -89.13 114.88 26.2 Favored 'General case' 0 C--N 1.331 -0.211 0 N-CA-C 109.09 -0.707 . . . . 0.0 109.09 -178.753 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' C' C ' 75' ' ' VAL . . . . . . . . . . . . . 42.3 t -124.52 122.0 62.85 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.266 0 CA-C-O 121.054 0.454 . . . . 0.0 110.652 -175.109 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' C' C ' 76' ' ' LEU . . . . . 0.455 ' N ' HD12 ' C' ' 76' ' ' LEU . 6.4 mp -118.92 144.54 46.37 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 115.584 -0.735 . . . . 0.0 109.378 175.332 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' C' C ' 77' ' ' GLU . . . . . . . . . . . . . 96.3 mt-10 -134.07 137.49 44.68 Favored 'General case' 0 C--N 1.331 -0.219 0 CA-C-O 120.998 0.428 . . . . 0.0 111.081 -177.653 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' C' C ' 78' ' ' ALA . . . . . 0.579 ' HB2' HD21 ' C' ' 109' ' ' LEU . . . -125.1 135.69 52.93 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 115.738 -0.665 . . . . 0.0 109.79 176.568 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' C' C ' 79' ' ' LYS . . . . . 0.598 ' O ' HD13 ' C' ' 80' ' ' ILE . 61.6 mmtt -78.0 118.5 20.35 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-O 121.002 0.43 . . . . 0.0 110.949 -177.815 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' C' C ' 80' ' ' ILE . . . . . 0.598 HD13 ' O ' ' C' ' 79' ' ' LYS . 41.5 mm -139.1 106.55 2.96 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.327 0 N-CA-C 109.107 -0.701 . . . . 0.0 109.107 -178.951 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' C' C ' 81' ' ' LYS . . . . . . . . . . . . . 99.4 mttt -100.2 127.34 46.48 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-O 120.928 0.394 . . . . 0.0 110.949 -178.145 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' C' C ' 82' ' ' GLY . . . . . . . . . . . . . . . 89.04 42.1 5.71 Favored Glycine 0 CA--C 1.524 0.634 0 C-N-CA 120.968 -0.634 . . . . 0.0 111.722 176.057 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' C' C ' 83' ' ' ILE . . . . . . . . . . . . . 72.5 mt -66.47 137.26 25.21 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.321 0 N-CA-C 109.634 -0.506 . . . . 0.0 109.634 176.339 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' C' C ' 84' ' ' LYS . . . . . . . . . . . . . 39.6 ttpt -101.02 -50.66 3.74 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-O 120.894 0.378 . . . . 0.0 110.389 -179.066 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' C' C ' 85' ' ' ASP . . . . . . . . . . . . . 12.7 t70 -152.44 151.1 30.37 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.078 -0.51 . . . . 0.0 110.783 -179.894 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' C' C ' 86' ' ' VAL . . . . . . . . . . . . . 42.4 t -128.15 131.19 69.54 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.222 0 CA-C-O 120.895 0.379 . . . . 0.0 110.261 179.362 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' C' C ' 87' ' ' ILE . . . . . 0.5 ' N ' HD12 ' C' ' 87' ' ' ILE . 5.0 mp -122.98 131.58 73.01 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.251 0 CA-C-N 116.178 -0.464 . . . . 0.0 109.781 178.884 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' C' C ' 88' ' ' LEU . . . . . . . . . . . . . 80.8 mt -109.31 139.61 44.04 Favored 'General case' 0 C--N 1.331 -0.212 0 CA-C-O 121.03 0.443 . . . . 0.0 111.181 -179.354 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' C' C ' 89' ' ' ASP . . . . . . . . . . . . . 13.6 t70 -129.23 156.25 44.26 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 115.667 -0.697 . . . . 0.0 109.624 177.562 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' C' C ' 90' ' ' GLU . . . . . . . . . . . . . 85.3 tt0 -45.93 -38.77 7.93 Favored 'General case' 0 CA--C 1.532 0.265 0 N-CA-C 113.101 0.778 . . . . 0.0 113.101 -172.151 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' C' C ' 91' ' ' ASN . . . . . . . . . . . . . 78.9 m-20 -132.07 21.48 4.49 Favored 'General case' 0 N--CA 1.469 0.485 0 N-CA-C 112.799 0.666 . . . . 0.0 112.799 -178.035 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' C' C ' 92' ' ' LEU . . . . . . . . . . . . . 40.4 mt -150.59 152.26 33.81 Favored 'General case' 0 C--N 1.331 -0.217 0 CA-C-O 120.997 0.427 . . . . 0.0 110.678 -176.423 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' C' C ' 93' ' ' ILE . . . . . . . . . . . . . 69.8 mt -125.35 123.33 64.79 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.335 0 N-CA-C 109.141 -0.689 . . . . 0.0 109.141 175.727 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' C' C ' 94' ' ' VAL . . . . . . . . . . . . . 42.3 t -119.74 128.78 75.91 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.284 0 CA-C-O 120.964 0.411 . . . . 0.0 110.079 -179.192 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' C' C ' 95' ' ' VAL . . . . . . . . . . . . . 45.5 t -120.48 134.18 64.78 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.322 0 CA-C-N 115.94 -0.573 . . . . 0.0 109.655 179.89 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' C' C ' 96' ' ' ILE . . . . . . . . . . . . . 66.9 mt -115.59 127.05 73.3 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.309 0 N-CA-C 109.283 -0.636 . . . . 0.0 109.283 178.845 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' C' C ' 97' ' ' THR . . . . . . . . . . . . . 68.6 p -100.87 158.22 16.14 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-O 121.139 0.495 . . . . 0.0 111.115 -176.819 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' C' C ' 98' ' ' GLU . . . . . . . . . . . . . 84.6 tt0 -53.85 -26.31 23.87 Favored 'General case' 0 CA--C 1.534 0.335 0 CA-C-N 116.22 -0.445 . . . . 0.0 112.172 179.861 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' C' C ' 99' ' ' GLU . . . . . . . . . . . . . 18.2 tp10 -76.8 9.97 2.52 Favored 'General case' 0 CA--C 1.538 0.517 0 N-CA-C 113.007 0.743 . . . . 0.0 113.007 -177.929 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' C' C ' 100' ' ' ASN . . . . . . . . . . . . . 3.6 m-20 63.32 33.48 13.96 Favored 'General case' 0 N--CA 1.464 0.258 0 O-C-N 121.984 -0.447 . . . . 0.0 111.57 -179.812 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' C' C ' 101' ' ' GLU . . . . . . . . . . . . . 84.7 tt0 -108.64 143.99 36.97 Favored 'General case' 0 C--N 1.332 -0.167 0 N-CA-C 109.666 -0.494 . . . . 0.0 109.666 172.038 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' C' C ' 102' ' ' VAL . . . . . . . . . . . . . 46.9 t -115.61 126.1 73.03 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.27 0 N-CA-C 109.72 -0.474 . . . . 0.0 109.72 -177.958 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' C' C ' 103' ' ' LEU . . . . . . . . . . . . . 30.9 mt -117.3 130.77 56.76 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-N 115.856 -0.611 . . . . 0.0 110.334 177.845 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' C' C ' 104' ' ' ILE . . . . . 0.449 HD13 HG21 ' C' ' 130' ' ' VAL . 64.0 mt -118.28 121.29 66.82 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.207 0 N-CA-C 110.07 -0.345 . . . . 0.0 110.07 179.383 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' C' C ' 105' ' ' PHE . . . . . . . . . . . . . 45.4 m-85 -121.63 167.55 12.78 Favored 'General case' 0 C--N 1.332 -0.182 0 O-C-N 123.851 0.719 . . . . 0.0 109.883 177.993 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' C' C ' 106' ' ' ASN . . . . . . . . . . . . . 45.2 p-10 -97.29 -169.93 1.93 Allowed 'General case' 0 C--N 1.331 -0.209 0 N-CA-C 109.879 -0.415 . . . . 0.0 109.879 173.677 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' C' C ' 107' ' ' GLN . . . . . . . . . . . . . 48.9 tt0 -59.57 -30.13 68.43 Favored 'General case' 0 CA--C 1.532 0.251 0 N-CA-C 111.9 0.333 . . . . 0.0 111.9 179.84 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' C' C ' 108' ' ' ASN . . . . . . . . . . . . . 51.6 t30 -83.78 9.85 10.91 Favored 'General case' 0 CA--C 1.536 0.424 0 N-CA-C 113.062 0.764 . . . . 0.0 113.062 -178.195 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' C' C ' 109' ' ' LEU . . . . . 0.579 HD21 ' HB2' ' C' ' 78' ' ' ALA . 8.0 tp 59.85 36.29 21.93 Favored 'General case' 0 C--N 1.331 -0.223 0 CA-C-O 120.853 0.359 . . . . 0.0 111.366 179.085 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' C' C ' 110' ' ' GLU . . . . . . . . . . . . . 96.0 mt-10 -103.38 150.1 24.13 Favored 'General case' 0 C--N 1.33 -0.26 0 N-CA-C 109.957 -0.386 . . . . 0.0 109.957 176.06 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' C' C ' 111' ' ' GLU . . . . . . . . . . . . . 71.6 tt0 -81.98 121.99 27.21 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-O 120.886 0.374 . . . . 0.0 111.111 -174.713 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' C' C ' 112' ' ' LEU . . . . . . . . . . . . . 34.1 mt -107.08 -46.09 3.99 Favored 'General case' 0 C--N 1.331 -0.21 0 CA-C-N 116.16 -0.473 . . . . 0.0 110.76 178.049 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' C' C ' 113' ' ' TYR . . . . . . . . . . . . . 60.7 t80 -139.34 139.72 37.33 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.201 -0.454 . . . . 0.0 111.14 -178.047 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' C' C ' 114' ' ' ARG . . . . . . . . . . . . . 59.1 ttp180 -137.6 125.53 22.69 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 115.956 -0.565 . . . . 0.0 110.224 177.321 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' C' C ' 115' ' ' GLY . . . . . . . . . . . . . . . -149.98 153.25 24.98 Favored Glycine 0 CA--C 1.523 0.573 0 N-CA-C 110.262 -1.135 . . . . 0.0 110.262 178.505 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' C' C ' 116' ' ' LYS . . . . . . . . . . . . . 59.0 tttm -131.5 128.98 40.48 Favored 'General case' 0 C--N 1.329 -0.325 0 N-CA-C 109.65 -0.5 . . . . 0.0 109.65 179.388 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' C' C ' 117' ' ' PHE . . . . . . . . . . . . . 26.1 m-85 -132.91 117.64 17.94 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.329 -0.396 . . . . 0.0 110.029 -173.153 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' C' C ' 118' ' ' GLU . . . . . . . . . . . . . 95.8 mt-10 -55.18 -39.46 69.58 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.521 -0.308 . . . . 0.0 111.043 -177.774 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' C' C ' 119' ' ' ASN . . . . . . . . . . . . . 29.5 m120 -100.7 30.98 3.7 Favored 'General case' 0 C--N 1.33 -0.271 0 N-CA-C 112.229 0.455 . . . . 0.0 112.229 -173.896 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' C' C ' 120' ' ' LEU . . . . . . . . . . . . . 17.1 tp -57.76 122.56 13.14 Favored 'General case' 0 N--CA 1.462 0.16 0 C-N-CA 120.845 -0.342 . . . . 0.0 110.121 177.462 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' C' C ' 121' ' ' ASN . . . . . . . . . . . . . 21.9 t-20 -112.79 -44.03 3.36 Favored 'General case' 0 C--N 1.332 -0.183 0 CA-C-N 116.554 -0.294 . . . . 0.0 111.41 -175.968 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' C' C ' 122' ' ' LYS . . . . . . . . . . . . . 31.4 ttmt -158.57 151.04 21.84 Favored 'General case' 0 C--N 1.332 -0.188 0 C-N-CA 120.546 -0.462 . . . . 0.0 111.156 -176.721 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' C' C ' 123' ' ' VAL . . . . . 0.439 ' C ' HD12 ' C' ' 124' ' ' LEU . 41.9 t -122.42 131.91 72.22 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.218 0 CA-C-N 116.19 -0.459 . . . . 0.0 109.957 177.687 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' C' C ' 124' ' ' LEU . . . . . 0.463 HD12 ' N ' ' C' ' 124' ' ' LEU . 7.2 mp -116.76 133.67 55.74 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-N 116.147 -0.479 . . . . 0.0 109.999 179.28 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' C' C ' 125' ' ' VAL . . . . . . . . . . . . . 35.2 m -135.25 139.68 46.46 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.289 0 CA-C-O 120.843 0.354 . . . . 0.0 110.922 -179.479 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' C' C ' 126' ' ' ARG . . . . . . . . . . . . . 38.8 ttt180 -163.32 133.63 4.44 Favored 'General case' 0 C--N 1.329 -0.298 0 N-CA-C 109.525 -0.546 . . . . 0.0 109.525 177.015 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' C' C ' 127' ' ' ASN . . . . . . . . . . . . . 33.4 m120 56.85 -155.13 0.32 Allowed 'General case' 0 CA--C 1.538 0.503 0 N-CA-C 109.627 -0.508 . . . . 0.0 109.627 -177.843 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' C' C ' 128' ' ' ASP . . . . . . . . . . . . . 11.6 p-10 -82.31 16.92 1.84 Allowed 'General case' 0 CA--C 1.536 0.421 0 N-CA-C 112.642 0.608 . . . . 0.0 112.642 177.705 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' C' C ' 129' ' ' LEU . . . . . . . . . . . . . 49.3 mt -115.74 142.45 46.73 Favored 'General case' 0 C--O 1.231 0.116 0 O-C-N 122.077 -0.39 . . . . 0.0 110.279 179.723 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' C' C ' 130' ' ' VAL . . . . . 0.498 HG23 ' HB ' ' C' ' 141' ' ' ILE . 32.5 m -134.77 146.8 30.12 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.249 0 CA-C-O 120.986 0.422 . . . . 0.0 110.947 -179.333 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' C' C ' 131' ' ' VAL . . . . . 0.401 ' CG1' HD21 ' C' ' 138' ' ' LEU . 39.1 t -135.99 137.86 48.2 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.299 0 CA-C-N 116.087 -0.506 . . . . 0.0 110.157 178.43 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' C' C ' 132' ' ' ILE . . . . . . . . . . . . . 70.2 mt -112.96 131.75 63.68 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.357 0 N-CA-C 109.341 -0.614 . . . . 0.0 109.341 179.933 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' C' C ' 133' ' ' ILE . . . . . . . . . . . . . 36.6 mm -113.64 122.33 67.57 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.256 0 CA-C-O 120.837 0.351 . . . . 0.0 110.79 -176.15 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' C' C ' 134' ' ' ASP . . . . . . . . . . . . . 9.4 p-10 -132.97 150.06 52.19 Favored 'General case' 0 C--N 1.331 -0.222 0 CA-C-N 116.107 -0.497 . . . . 0.0 109.66 174.741 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' C' C ' 135' ' ' GLU . . . . . . . . . . . . . 40.3 tp10 -50.0 -29.02 7.79 Favored 'General case' 0 C--N 1.327 -0.398 0 N-CA-C 112.715 0.635 . . . . 0.0 112.715 -171.873 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' C' C ' 136' ' ' GLN . . . . . . . . . . . . . 99.6 mm-40 -85.87 -29.52 23.62 Favored 'General case' 0 C--N 1.33 -0.247 0 N-CA-C 112.896 0.702 . . . . 0.0 112.896 -174.086 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' C' C ' 137' ' ' LYS . . . . . . . . . . . . . 21.0 pttm -168.97 173.16 7.12 Favored 'General case' 0 C--O 1.234 0.242 0 CA-C-O 121.496 0.665 . . . . 0.0 112.477 -171.975 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' C' C ' 138' ' ' LEU . . . . . 0.431 HD23 ' C ' ' C' ' 138' ' ' LEU . 7.3 tt -120.71 129.38 53.63 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 115.088 -0.96 . . . . 0.0 109.869 179.594 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' C' C ' 139' ' ' THR . . . . . . . . . . . . . 38.0 m -109.76 128.5 55.33 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 116.112 -0.495 . . . . 0.0 110.444 179.703 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' C' C ' 140' ' ' LEU . . . . . 0.464 ' C ' HD23 ' C' ' 140' ' ' LEU . 5.9 tt -112.01 122.64 48.33 Favored 'General case' 0 C--N 1.329 -0.305 0 N-CA-C 109.039 -0.726 . . . . 0.0 109.039 -179.39 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' C' C ' 141' ' ' ILE . . . . . 0.498 ' HB ' HG23 ' C' ' 130' ' ' VAL . 19.5 mt -121.86 121.39 64.13 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.333 0 CA-C-O 120.98 0.419 . . . . 0.0 109.93 -176.298 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' C' C ' 142' ' ' ARG . . . . . . . . . . . . . 78.9 mtm180 . . . . . 0 C--N 1.329 -0.295 0 CA-C-N 115.463 -0.79 . . . . 0.0 110.169 -178.379 . . . . . . . . 0 0 . 1 . 005 nuclear build core ' D' D ' 2' ' ' SER . . . . . . . . . . . . . 6.5 p . . . . . 0 N--CA 1.462 0.156 0 CA-C-O 120.774 0.321 . . . . 0.0 110.752 . . . . . . . . . 0 0 . 1 . 005 nuclear build core ' D' D ' 3' ' ' GLU . . . . . . . . . . . . . 94.9 mt-10 -140.54 140.14 35.15 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.14 -0.482 . . . . 0.0 110.986 -179.044 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' D' D ' 4' ' ' LEU . . . . . . . . . . . . . 21.0 tp -126.31 128.01 46.46 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 116.129 -0.487 . . . . 0.0 110.223 176.912 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' D' D ' 5' ' ' LYS . . . . . . . . . . . . . 64.1 mttp -107.39 122.19 46.11 Favored 'General case' 0 C--O 1.234 0.274 0 CA-C-N 116.456 -0.338 . . . . 0.0 110.696 178.726 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' D' D ' 6' ' ' LEU . . . . . . . . . . . . . 73.3 mt -118.32 144.12 46.1 Favored 'General case' 0 C--N 1.331 -0.223 0 CA-C-N 115.683 -0.69 . . . . 0.0 110.778 -178.947 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' D' D ' 7' ' ' LYS . . . . . . . . . . . . . 59.3 tttm -133.95 141.76 40.91 Favored Pre-proline 0 CA--C 1.535 0.382 0 CA-C-O 119.12 -0.466 . . . . 0.0 110.158 176.727 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' D' D ' 8' ' ' PRO . . . . . . . . . . . . . 87.5 Cg_endo -91.52 140.64 2.57 Favored 'Trans proline' 0 N--CA 1.49 1.273 0 C-N-CA 121.748 1.632 . . . . 0.0 111.711 177.759 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' D' D ' 9' ' ' LEU . . . . . . . . . . . . . 53.5 mt -77.08 -48.06 2.6 Favored Pre-proline 0 CA--C 1.533 0.301 0 CA-C-O 118.799 -0.619 . . . . 0.0 112.464 -178.707 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' D' D ' 10' ' ' PRO . . . . . 0.42 ' CG ' HG23 ' D' ' 46' ' ' VAL . 85.2 Cg_endo -80.3 160.54 23.03 Favored 'Trans proline' 0 N--CA 1.495 1.605 0 C-N-CA 121.187 1.258 . . . . 0.0 112.071 176.92 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' D' D ' 11' ' ' LYS . . . . . . . . . . . . . 52.6 mttm -88.69 100.62 13.26 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.317 -0.402 . . . . 0.0 110.151 178.241 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' D' D ' 12' ' ' VAL . . . . . . . . . . . . . 12.9 p -145.77 147.34 18.53 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.263 0 CA-C-N 116.363 -0.38 . . . . 0.0 110.882 -178.888 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' D' D ' 13' ' ' GLU . . . . . . . . . . . . . 70.7 mm-40 -92.12 124.0 35.88 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.069 177.526 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' D' D ' 14' ' ' LEU . . . . . . . . . . . . . 36.4 mt -98.02 154.73 37.63 Favored Pre-proline 0 C--N 1.33 -0.258 0 CA-C-N 116.426 -0.352 . . . . 0.0 110.958 -177.88 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' D' D ' 15' ' ' PRO . . . . . . . . . . . . . 28.7 Cg_exo -60.6 154.82 51.74 Favored 'Trans proline' 0 N--CA 1.496 1.661 0 C-N-CA 121.405 1.403 . . . . 0.0 111.857 177.941 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' D' D ' 16' ' ' PRO . . . . . . . . . . . . . 36.4 Cg_exo -58.21 -37.13 96.72 Favored 'Trans proline' 0 N--CA 1.496 1.65 0 C-N-CA 121.4 1.4 . . . . 0.0 112.703 179.749 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' D' D ' 17' ' ' ASP . . . . . . . . . . . . . 15.0 p-10 -87.38 13.46 9.84 Favored 'General case' 0 CA--C 1.536 0.414 0 N-CA-C 112.981 0.734 . . . . 0.0 112.981 -178.384 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' D' D ' 18' ' ' PHE . . . . . . . . . . . . . 48.3 t80 -58.24 -45.09 88.39 Favored 'General case' 0 C--N 1.334 -0.104 0 O-C-N 122.145 -0.347 . . . . 0.0 110.14 -177.997 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' D' D ' 19' ' ' VAL . . . . . 0.402 HG13 ' N ' ' D' ' 20' ' ' ASP . 14.6 p -55.7 -41.38 64.99 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.305 0 CA-C-N 116.478 -0.328 . . . . 0.0 111.073 -178.364 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' D' D ' 20' ' ' ASP . . . . . 0.402 ' N ' HG13 ' D' ' 19' ' ' VAL . 71.5 m-20 -61.09 -43.76 98.4 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-O 120.818 0.342 . . . . 0.0 111.06 -178.329 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' D' D ' 21' ' ' VAL . . . . . . . . . . . . . 46.8 t -65.04 -46.78 90.36 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.318 0 C-N-CA 120.71 -0.396 . . . . 0.0 110.565 -177.285 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' D' D ' 22' ' ' ILE . . . . . 0.686 HG22 HD12 ' D' ' 26' ' ' LEU . 50.1 mm -56.7 -43.69 79.77 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.207 0 C-N-CA 120.959 -0.297 . . . . 0.0 110.493 179.378 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' D' D ' 23' ' ' ARG . . . . . . . . . . . . . 26.8 ttm-85 -52.93 -53.96 41.84 Favored 'General case' 0 C--N 1.331 -0.213 0 CA-C-O 121.413 0.625 . . . . 0.0 111.393 179.293 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' D' D ' 24' ' ' ILE . . . . . . . . . . . . . 78.8 mt -59.34 -41.06 83.06 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.356 0 CA-C-N 115.282 -0.872 . . . . 0.0 111.368 -173.524 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' D' D ' 25' ' ' LYS . . . . . . . . . . . . . 68.0 mttm -69.55 -41.63 75.66 Favored 'General case' 0 C--N 1.33 -0.278 0 N-CA-C 112.651 0.611 . . . . 0.0 112.651 -179.434 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' D' D ' 26' ' ' LEU . . . . . 0.686 HD12 HG22 ' D' ' 22' ' ' ILE . 60.4 mt -78.62 -33.86 47.05 Favored 'General case' 0 C--N 1.33 -0.262 0 N-CA-C 113.674 0.99 . . . . 0.0 113.674 -170.323 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' D' D ' 27' ' ' GLN . . . . . . . . . . . . . 17.5 pt20 -46.74 139.95 4.93 Favored 'General case' 0 N--CA 1.469 0.505 0 N-CA-C 112.863 0.69 . . . . 0.0 112.863 -174.884 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' D' D ' 28' ' ' GLY . . . . . . . . . . . . . . . 96.82 -21.39 46.27 Favored Glycine 0 CA--C 1.534 1.239 0 CA-C-N 115.728 -0.669 . . . . 0.0 112.531 -177.458 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' D' D ' 29' ' ' LYS . . . . . . . . . . . . . 35.1 mmtp -97.34 155.07 17.05 Favored 'General case' 0 C--O 1.232 0.16 0 CA-C-N 117.605 0.703 . . . . 0.0 110.783 179.407 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' D' D ' 30' ' ' THR . . . . . . . . . . . . . 32.0 m -106.0 137.1 44.49 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.043 -0.526 . . . . 0.0 109.868 176.165 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' D' D ' 31' ' ' VAL . . . . . . . . . . . . . 35.1 m -128.5 152.78 37.11 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.243 0 CA-C-O 121.026 0.441 . . . . 0.0 111.057 -178.088 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' D' D ' 32' ' ' ARG . . . . . . . . . . . . . 76.5 mtm180 -130.6 149.37 52.29 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 115.767 -0.652 . . . . 0.0 110.44 178.084 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' D' D ' 33' ' ' THR . . . . . . . . . . . . . 19.4 m -53.44 139.16 31.53 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.449 -0.342 . . . . 0.0 111.392 -178.238 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' D' D ' 34' ' ' GLY . . . . . . . . . . . . . . . 99.58 -17.02 58.2 Favored Glycine 0 CA--C 1.531 1.084 0 CA-C-O 119.684 -0.509 . . . . 0.0 113.296 179.378 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' D' D ' 35' ' ' ASP . . . . . . . . . . . . . 76.7 m-20 -66.17 148.74 51.38 Favored 'General case' 0 N--CA 1.461 0.107 0 CA-C-N 118.056 0.928 . . . . 0.0 111.074 179.145 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' D' D ' 36' ' ' VAL . . . . . . . . . . . . . 44.4 t -120.19 130.56 74.19 Favored 'Isoleucine or valine' 0 C--N 1.333 -0.133 0 CA-C-N 115.811 -0.631 . . . . 0.0 109.981 179.042 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' D' D ' 37' ' ' ILE . . . . . . . . . . . . . 68.3 mt -119.75 137.76 52.56 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.262 0 N-CA-C 109.721 -0.474 . . . . 0.0 109.721 179.103 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' D' D ' 38' ' ' GLY . . . . . . . . . . . . . . . -111.05 128.57 8.79 Favored Glycine 0 CA--C 1.524 0.633 0 N-CA-C 111.394 -0.682 . . . . 0.0 111.394 -178.955 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' D' D ' 39' ' ' ILE . . . . . . . . . . . . . 73.9 mt -129.99 130.47 66.18 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.217 0 N-CA-C 109.817 -0.438 . . . . 0.0 109.817 177.838 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' D' D ' 40' ' ' SER . . . . . . . . . . . . . 59.6 p -92.28 115.19 27.86 Favored 'General case' 0 C--N 1.33 -0.281 0 C-N-CA 120.912 -0.315 . . . . 0.0 110.875 176.968 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' D' D ' 41' ' ' ILE . . . . . . . . . . . . . 44.1 mm -123.39 124.48 69.85 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.223 0 N-CA-C 109.996 -0.372 . . . . 0.0 109.996 -179.754 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' D' D ' 42' ' ' LEU . . . . . . . . . . . . . 56.1 mt 57.67 34.16 24.14 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.362 -0.381 . . . . 0.0 111.729 178.274 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' D' D ' 43' ' ' GLY . . . . . . . . . . . . . . . 77.94 -10.05 28.25 Favored Glycine 0 CA--C 1.535 1.308 0 C-N-CA 121.28 -0.486 . . . . 0.0 113.407 177.713 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' D' D ' 44' ' ' LYS . . . . . . . . . . . . . 61.0 tttm -101.31 130.99 47.57 Favored 'General case' 0 C--N 1.331 -0.211 0 CA-C-N 117.914 0.857 . . . . 0.0 109.846 176.869 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' D' D ' 45' ' ' GLU . . . . . . . . . . . . . 43.3 tp10 -83.23 128.17 34.26 Favored 'General case' 0 C--N 1.329 -0.293 0 C-N-CA 120.817 -0.353 . . . . 0.0 110.727 -179.113 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' D' D ' 46' ' ' VAL . . . . . 0.42 HG23 ' CG ' ' D' ' 10' ' ' PRO . 7.3 p -121.67 131.2 73.63 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.227 0 CA-C-O 121.11 0.481 . . . . 0.0 109.704 177.363 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' D' D ' 47' ' ' LYS . . . . . . . . . . . . . 37.1 mtmm -100.47 128.06 46.64 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 115.879 -0.601 . . . . 0.0 111.069 176.349 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' D' D ' 48' ' ' PHE . . . . . . . . . . . . . 89.9 m-85 -107.97 131.96 54.0 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.077 -0.51 . . . . 0.0 109.75 176.125 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' D' D ' 49' ' ' LYS . . . . . . . . . . . . . 82.8 tttt -107.17 134.57 50.09 Favored 'General case' 0 C--N 1.327 -0.385 0 CA-C-N 116.289 -0.414 . . . . 0.0 110.379 179.856 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' D' D ' 50' ' ' VAL . . . . . . . . . . . . . 46.8 t -76.95 108.68 10.39 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.297 0 N-CA-C 109.037 -0.727 . . . . 0.0 109.037 175.709 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' D' D ' 51' ' ' VAL . . . . . . . . . . . . . 51.0 t -70.67 -47.16 65.82 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.329 0 CA-C-N 116.131 -0.486 . . . . 0.0 109.868 -174.338 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' D' D ' 52' ' ' GLN . . . . . . . . . . . . . 49.6 tt0 -167.94 142.08 3.47 Favored 'General case' 0 C--N 1.33 -0.275 0 C-N-CA 120.308 -0.557 . . . . 0.0 111.567 -179.907 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' D' D ' 53' ' ' ALA . . . . . 0.478 ' HB1' ' HB2' ' D' ' 58' ' ' LEU . . . -115.76 132.87 56.51 Favored 'General case' 0 C--N 1.331 -0.196 0 CA-C-N 115.745 -0.661 . . . . 0.0 110.024 176.255 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' D' D ' 54' ' ' TYR . . . . . . . . . . . . . 75.4 t80 -129.14 112.19 18.35 Favored Pre-proline 0 CA--C 1.536 0.413 0 CA-C-O 118.291 -0.861 . . . . 0.0 110.319 178.503 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' D' D ' 55' ' ' PRO . . . . . . . . . . . . . 73.0 Cg_endo -77.21 170.01 72.62 Favored 'Cis proline' 0 N--CA 1.499 1.836 0 CA-C-N 121.995 1.748 . . . . 0.0 112.119 -5.61 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' D' D ' 56' ' ' SER . . . . . . . . . . . . . 13.5 m -117.2 132.05 23.7 Favored Pre-proline 0 CA--C 1.538 0.502 0 CA-C-O 118.464 -0.779 . . . . 0.0 109.454 175.666 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' D' D ' 57' ' ' PRO . . . . . . . . . . . . . 45.3 Cg_endo -69.37 146.86 82.54 Favored 'Cis proline' 0 N--CA 1.496 1.667 0 CA-C-N 121.902 1.715 . . . . 0.0 111.532 -0.835 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' D' D ' 58' ' ' LEU . . . . . 0.478 ' HB2' ' HB1' ' D' ' 53' ' ' ALA . 27.2 tp -107.61 135.23 49.4 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.275 -0.421 . . . . 0.0 110.527 -179.035 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' D' D ' 59' ' ' ARG . . . . . . . . . . . . . 52.7 ttp180 -102.43 125.28 49.09 Favored 'General case' 0 C--N 1.328 -0.356 0 N-CA-C 109.482 -0.562 . . . . 0.0 109.482 177.101 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' D' D ' 60' ' ' VAL . . . . . . . . . . . . . 41.2 t -81.44 121.37 34.74 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.2 0 C-N-CA 120.745 -0.382 . . . . 0.0 110.505 -174.917 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' D' D ' 61' ' ' GLU . . . . . . . . . . . . . 96.1 mt-10 -131.13 159.92 36.25 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 115.73 -0.668 . . . . 0.0 109.929 177.213 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' D' D ' 62' ' ' ASP . . . . . . . . . . . . . 10.8 t70 -53.66 -32.3 51.02 Favored 'General case' 0 C--N 1.327 -0.376 0 N-CA-C 111.722 0.268 . . . . 0.0 111.722 179.648 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' D' D ' 63' ' ' ARG . . . . . . . . . . . . . 27.8 ptt180 -85.78 5.05 34.19 Favored 'General case' 0 CA--C 1.537 0.459 0 N-CA-C 113.771 1.026 . . . . 0.0 113.771 -175.634 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' D' D ' 64' ' ' THR . . . . . . . . . . . . . 39.9 m -86.19 143.67 27.86 Favored 'General case' 0 C--N 1.332 -0.184 0 CA-C-N 118.002 0.365 . . . . 0.0 110.411 -179.728 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' D' D ' 65' ' ' LYS . . . . . . . . . . . . . 98.7 mttt -87.21 126.08 34.58 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.438 -0.346 . . . . 0.0 110.104 179.968 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' D' D ' 66' ' ' ILE . . . . . . . . . . . . . 65.5 mt -117.71 128.33 74.91 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.295 0 N-CA-C 109.862 -0.422 . . . . 0.0 109.862 -178.969 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' D' D ' 67' ' ' THR . . . . . . . . . . . . . 25.4 m -121.86 136.8 54.94 Favored 'General case' 0 C--N 1.331 -0.202 0 CA-C-O 121.05 0.452 . . . . 0.0 110.981 -177.65 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' D' D ' 68' ' ' LEU . . . . . . . . . . . . . 19.0 tp . . . . . 0 C--N 1.331 -0.231 0 CA-C-N 115.914 -0.585 . . . . 0.0 110.635 179.593 . . . . . . . . 0 0 . 1 . 005 nuclear build core ' D' D ' 73' ' ' VAL . . . . . . . . . . . . . 35.4 m . . . . . 0 C--O 1.231 0.098 0 N-CA-C 109.984 -0.376 . . . . 0.0 109.984 . . . . . . . . . 0 0 . 1 . 005 nuclear build core ' D' D ' 74' ' ' ASP . . . . . . . . . . . . . 12.8 t70 -91.47 118.56 30.67 Favored 'General case' 0 C--N 1.331 -0.217 0 N-CA-C 109.953 -0.388 . . . . 0.0 109.953 -178.832 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' D' D ' 75' ' ' VAL . . . . . . . . . . . . . 45.8 t -117.36 123.67 72.06 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.239 0 CA-C-O 121.184 0.516 . . . . 0.0 110.507 -177.328 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' D' D ' 76' ' ' LEU . . . . . . . . . . . . . 14.6 mt -125.85 144.61 50.59 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-N 115.463 -0.79 . . . . 0.0 109.347 177.726 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' D' D ' 77' ' ' GLU . . . . . . . . . . . . . 97.0 mt-10 -135.67 138.33 42.7 Favored 'General case' 0 C--N 1.332 -0.183 0 CA-C-O 121.029 0.443 . . . . 0.0 111.583 -176.739 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' D' D ' 78' ' ' ALA . . . . . 0.559 ' HB2' HD21 ' D' ' 109' ' ' LEU . . . -127.14 135.28 50.49 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 115.627 -0.715 . . . . 0.0 109.675 175.772 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' D' D ' 79' ' ' LYS . . . . . 0.568 ' O ' HD13 ' D' ' 80' ' ' ILE . 22.7 tptm -78.08 121.83 24.8 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-O 120.914 0.388 . . . . 0.0 110.647 -177.604 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' D' D ' 80' ' ' ILE . . . . . 0.568 HD13 ' O ' ' D' ' 79' ' ' LYS . 43.2 mm -139.22 113.21 7.0 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.325 0 N-CA-C 108.995 -0.743 . . . . 0.0 108.995 -178.358 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' D' D ' 81' ' ' LYS . . . . . . . . . . . . . 76.2 tttt -103.09 123.24 46.27 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-O 120.749 0.309 . . . . 0.0 111.134 -175.809 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' D' D ' 82' ' ' GLY . . . . . . . . . . . . . . . 89.15 42.19 5.65 Favored Glycine 0 CA--C 1.528 0.871 0 C-N-CA 120.925 -0.655 . . . . 0.0 112.356 173.422 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' D' D ' 83' ' ' ILE . . . . . . . . . . . . . 71.4 mt -70.84 139.43 19.99 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.245 0 N-CA-C 109.706 -0.479 . . . . 0.0 109.706 176.359 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' D' D ' 84' ' ' LYS . . . . . . . . . . . . . 38.9 ttpt -107.16 -47.28 3.71 Favored 'General case' 0 C--N 1.331 -0.197 0 CA-C-N 116.451 -0.34 . . . . 0.0 110.631 -178.316 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' D' D ' 85' ' ' ASP . . . . . . . . . . . . . 9.9 t70 -148.35 148.13 30.02 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.253 -0.43 . . . . 0.0 110.489 -179.439 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' D' D ' 86' ' ' VAL . . . . . . . . . . . . . 42.4 t -133.25 134.48 57.39 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.252 0 CA-C-O 121.032 0.444 . . . . 0.0 110.425 179.442 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' D' D ' 87' ' ' ILE . . . . . . . . . . . . . 46.0 mm -120.09 127.52 75.9 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.29 0 CA-C-N 115.799 -0.637 . . . . 0.0 109.658 178.403 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' D' D ' 88' ' ' LEU . . . . . . . . . . . . . 18.2 tp -109.66 127.06 54.3 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-O 120.937 0.398 . . . . 0.0 110.898 -178.612 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' D' D ' 89' ' ' ASP . . . . . . . . . . . . . 13.7 t70 -117.96 154.68 31.54 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 115.926 -0.579 . . . . 0.0 109.559 177.124 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' D' D ' 90' ' ' GLU . . . . . . . . . . . . . 96.3 mt-10 -49.0 -38.63 23.95 Favored 'General case' 0 C--N 1.329 -0.311 0 N-CA-C 112.748 0.648 . . . . 0.0 112.748 -172.195 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' D' D ' 91' ' ' ASN . . . . . . . . . . . . . 37.5 t30 -132.06 35.64 3.71 Favored 'General case' 0 N--CA 1.464 0.258 0 C-N-CA 120.91 -0.316 . . . . 0.0 111.654 -177.797 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' D' D ' 92' ' ' LEU . . . . . . . . . . . . . 9.2 tp -166.06 146.66 6.53 Favored 'General case' 0 C--N 1.33 -0.244 0 C-N-CA 120.8 -0.36 . . . . 0.0 110.815 -179.304 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' D' D ' 93' ' ' ILE . . . . . . . . . . . . . 71.2 mt -125.71 123.66 64.93 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.262 0 N-CA-C 109.501 -0.555 . . . . 0.0 109.501 179.975 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' D' D ' 94' ' ' VAL . . . . . 0.516 HG21 HG11 ' D' ' 125' ' ' VAL . 46.4 t -124.41 129.69 73.82 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.24 0 CA-C-O 121.011 0.434 . . . . 0.0 110.236 179.893 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' D' D ' 95' ' ' VAL . . . . . . . . . . . . . 42.8 t -121.8 135.68 61.14 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.294 0 CA-C-N 115.86 -0.609 . . . . 0.0 109.821 -179.255 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' D' D ' 96' ' ' ILE . . . . . . . . . . . . . 67.8 mt -117.93 128.03 75.11 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.239 0 N-CA-C 109.561 -0.533 . . . . 0.0 109.561 179.043 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' D' D ' 97' ' ' THR . . . . . . . . . . . . . 65.8 p -100.12 159.53 15.03 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-O 121.102 0.477 . . . . 0.0 111.067 -178.16 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' D' D ' 98' ' ' GLU . . . . . . . . . . . . . 44.4 mt-10 -54.49 -26.32 30.71 Favored 'General case' 0 C--N 1.329 -0.319 0 N-CA-C 112.296 0.48 . . . . 0.0 112.296 -179.89 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' D' D ' 99' ' ' GLU . . . . . . . . . . . . . 95.4 mt-10 -76.08 10.77 1.74 Allowed 'General case' 0 CA--C 1.536 0.427 0 N-CA-C 113.326 0.862 . . . . 0.0 113.326 -177.557 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' D' D ' 100' ' ' ASN . . . . . . . . . . . . . 4.4 m-20 64.16 34.64 10.86 Favored 'General case' 0 N--CA 1.463 0.22 0 CA-C-O 120.971 0.415 . . . . 0.0 111.418 179.836 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' D' D ' 101' ' ' GLU . . . . . . . . . . . . . 84.7 tt0 -112.38 141.8 45.67 Favored 'General case' 0 C--N 1.334 -0.102 0 N-CA-C 109.778 -0.453 . . . . 0.0 109.778 173.72 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' D' D ' 102' ' ' VAL . . . . . . . . . . . . . 44.1 t -116.62 128.95 73.85 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.336 0 N-CA-C 109.988 -0.375 . . . . 0.0 109.988 -178.643 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' D' D ' 103' ' ' LEU . . . . . . . . . . . . . 52.9 mt -117.7 134.43 54.91 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 115.747 -0.661 . . . . 0.0 110.202 177.509 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' D' D ' 104' ' ' ILE . . . . . 0.5 HD13 HG21 ' D' ' 130' ' ' VAL . 67.9 mt -119.67 123.41 70.96 Favored 'Isoleucine or valine' 0 C--O 1.234 0.288 0 N-CA-C 110.35 -0.241 . . . . 0.0 110.35 -179.39 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' D' D ' 105' ' ' PHE . . . . . . . . . . . . . 63.9 m-85 -123.69 166.56 15.32 Favored 'General case' 0 C--N 1.333 -0.133 0 O-C-N 123.913 0.758 . . . . 0.0 109.666 179.577 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' D' D ' 106' ' ' ASN . . . . . . . . . . . . . 44.7 p-10 -101.45 -169.97 1.77 Allowed 'General case' 0 C--N 1.331 -0.235 0 N-CA-C 109.82 -0.437 . . . . 0.0 109.82 174.474 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' D' D ' 107' ' ' GLN . . . . . . . . . . . . . 62.2 tt0 -59.73 -30.14 68.63 Favored 'General case' 0 C--N 1.33 -0.273 0 N-CA-C 111.887 0.329 . . . . 0.0 111.887 179.82 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' D' D ' 108' ' ' ASN . . . . . . . . . . . . . 13.1 t-20 -82.05 7.02 14.41 Favored 'General case' 0 CA--C 1.537 0.46 0 N-CA-C 113.067 0.766 . . . . 0.0 113.067 -177.723 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' D' D ' 109' ' ' LEU . . . . . 0.559 HD21 ' HB2' ' D' ' 78' ' ' ALA . 8.0 tp 60.29 36.28 20.67 Favored 'General case' 0 C--N 1.332 -0.163 0 CA-C-O 120.878 0.371 . . . . 0.0 111.488 179.246 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' D' D ' 110' ' ' GLU . . . . . . . . . . . . . 43.1 mt-10 -104.83 150.77 24.54 Favored 'General case' 0 C--N 1.332 -0.176 0 N-CA-C 109.603 -0.517 . . . . 0.0 109.603 175.424 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' D' D ' 111' ' ' GLU . . . . . . . . . . . . . 67.8 tt0 -84.68 121.87 28.28 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-O 120.907 0.384 . . . . 0.0 110.722 -175.774 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' D' D ' 112' ' ' LEU . . . . . . . . . . . . . 11.4 mt -104.29 -46.07 4.51 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.016 -0.538 . . . . 0.0 110.489 179.36 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' D' D ' 113' ' ' TYR . . . . . . . . . . . . . 64.9 t80 -140.95 145.01 35.47 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.189 -0.46 . . . . 0.0 111.319 -178.236 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' D' D ' 114' ' ' ARG . . . . . . . . . . . . . 39.0 ptt85 -142.5 127.75 18.71 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 115.994 -0.548 . . . . 0.0 110.615 177.134 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' D' D ' 115' ' ' GLY . . . . . . . . . . . . . . . -150.06 151.79 23.8 Favored Glycine 0 CA--C 1.522 0.48 0 N-CA-C 110.724 -0.95 . . . . 0.0 110.724 178.788 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' D' D ' 116' ' ' LYS . . . . . . . . . . . . . 79.1 tttt -128.37 128.82 45.24 Favored 'General case' 0 C--N 1.328 -0.335 0 N-CA-C 109.842 -0.429 . . . . 0.0 109.842 178.531 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' D' D ' 117' ' ' PHE . . . . . . . . . . . . . 33.3 m-85 -125.86 117.97 24.48 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.283 -0.417 . . . . 0.0 110.154 -174.302 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' D' D ' 118' ' ' GLU . . . . . . . . . . . . . 96.0 mt-10 -55.02 -43.01 73.3 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.558 -0.292 . . . . 0.0 111.144 -176.615 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' D' D ' 119' ' ' ASN . . . . . . . . . . . . . 66.3 m-80 -99.93 30.98 3.46 Favored 'General case' 0 C--N 1.331 -0.235 0 N-CA-C 112.176 0.435 . . . . 0.0 112.176 -174.273 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' D' D ' 120' ' ' LEU . . . . . . . . . . . . . 17.3 tp -56.11 119.87 6.6 Favored 'General case' 0 C--O 1.232 0.136 0 C-N-CA 120.925 -0.31 . . . . 0.0 110.613 178.539 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' D' D ' 121' ' ' ASN . . . . . . . . . . . . . 15.8 t-20 -114.16 -44.09 3.17 Favored 'General case' 0 C--N 1.332 -0.183 0 CA-C-N 116.592 -0.276 . . . . 0.0 111.416 -177.648 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' D' D ' 122' ' ' LYS . . . . . . . . . . . . . 96.5 mttt -145.23 150.38 36.59 Favored 'General case' 0 C--N 1.332 -0.153 0 C-N-CA 120.54 -0.464 . . . . 0.0 111.828 -176.671 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' D' D ' 123' ' ' VAL . . . . . . . . . . . . . 43.8 t -130.59 130.46 64.86 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.275 0 CA-C-N 115.951 -0.568 . . . . 0.0 109.753 176.318 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' D' D ' 124' ' ' LEU . . . . . . . . . . . . . 75.5 mt -131.1 135.61 47.65 Favored 'General case' 0 C--N 1.331 -0.208 0 CA-C-N 116.628 -0.26 . . . . 0.0 110.536 -179.643 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' D' D ' 125' ' ' VAL . . . . . 0.516 HG11 HG21 ' D' ' 94' ' ' VAL . 34.2 m -141.66 151.32 19.18 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.306 0 CA-C-O 121.007 0.432 . . . . 0.0 111.337 -179.09 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' D' D ' 126' ' ' ARG . . . . . 0.499 ' NH1' HD21 ' E' ' 88' ' ' LEU . 35.8 ptt-85 -154.15 129.75 9.97 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 115.873 -0.603 . . . . 0.0 110.549 175.965 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' D' D ' 127' ' ' ASN . . . . . . . . . . . . . 6.8 m120 51.91 -109.39 0.44 Allowed 'General case' 0 CA--C 1.546 0.809 0 CA-C-O 118.925 -0.559 . . . . 0.0 111.154 -179.927 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' D' D ' 128' ' ' ASP . . . . . . . . . . . . . 18.5 p-10 -114.13 2.92 15.04 Favored 'General case' 0 N--CA 1.468 0.438 0 CA-C-N 119.755 1.161 . . . . 0.0 113.443 -177.998 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' D' D ' 129' ' ' LEU . . . . . . . . . . . . . 48.7 mt -106.82 139.26 41.52 Favored 'General case' 0 C--N 1.333 -0.115 0 N-CA-C 109.558 -0.534 . . . . 0.0 109.558 179.12 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' D' D ' 130' ' ' VAL . . . . . 0.5 HG21 HD13 ' D' ' 104' ' ' ILE . 32.7 m -137.25 144.26 32.29 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.246 0 CA-C-O 121.167 0.508 . . . . 0.0 111.263 -178.322 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' D' D ' 131' ' ' VAL . . . . . . . . . . . . . 41.7 t -136.04 139.69 45.34 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.286 0 CA-C-N 115.878 -0.601 . . . . 0.0 110.243 178.199 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' D' D ' 132' ' ' ILE . . . . . . . . . . . . . 73.7 mt -117.14 133.31 64.28 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 CA-C-N 115.496 -0.774 . . . . 0.0 109.28 179.997 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' D' D ' 133' ' ' ILE . . . . . . . . . . . . . 40.8 mm -115.73 124.27 71.98 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.236 0 CA-C-O 120.72 0.295 . . . . 0.0 110.966 -175.034 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' D' D ' 134' ' ' ASP . . . . . . . . . . . . . 9.5 p-10 -136.46 146.4 46.29 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 115.972 -0.558 . . . . 0.0 109.719 175.548 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' D' D ' 135' ' ' GLU . . . . . . . . . . . . . 86.2 tt0 -50.27 -24.63 3.03 Favored 'General case' 0 C--N 1.327 -0.379 0 N-CA-C 112.85 0.685 . . . . 0.0 112.85 -175.014 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' D' D ' 136' ' ' GLN . . . . . . . . . . . . . 41.6 mt-30 -82.89 -32.48 27.32 Favored 'General case' 0 C--O 1.234 0.241 0 N-CA-C 112.384 0.512 . . . . 0.0 112.384 -177.15 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' D' D ' 137' ' ' LYS . . . . . . . . . . . . . 52.5 pttt -170.09 175.63 4.95 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-O 121.474 0.654 . . . . 0.0 112.295 -173.567 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' D' D ' 138' ' ' LEU . . . . . 0.45 ' C ' HD23 ' D' ' 138' ' ' LEU . 7.5 tt -119.68 127.5 52.95 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 115.184 -0.916 . . . . 0.0 109.944 177.65 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' D' D ' 139' ' ' THR . . . . . . . . . . . . . 44.6 m -110.16 127.3 54.84 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 116.243 -0.435 . . . . 0.0 110.129 -179.896 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' D' D ' 140' ' ' LEU . . . . . 0.469 ' C ' HD23 ' D' ' 140' ' ' LEU . 8.1 tt -117.07 126.23 52.53 Favored 'General case' 0 C--N 1.329 -0.311 0 N-CA-C 109.498 -0.556 . . . . 0.0 109.498 -178.708 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' D' D ' 141' ' ' ILE . . . . . 0.494 ' HB ' HG23 ' D' ' 130' ' ' VAL . 19.1 mt -123.37 121.4 62.67 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.281 0 N-CA-C 109.733 -0.469 . . . . 0.0 109.733 -175.627 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' D' D ' 142' ' ' ARG . . . . . . . . . . . . . 29.5 ttp180 -115.66 128.07 55.64 Favored 'General case' 0 C--N 1.331 -0.212 0 CA-C-N 115.696 -0.683 . . . . 0.0 110.331 -177.205 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' D' D ' 143' ' ' THR . . . . . . . . . . . . . 35.4 p . . . . . 0 C--O 1.22 -0.487 0 CA-C-O 117.976 -1.011 . . . . 0.0 110.53 -179.7 . . . . . . . . 0 0 . 1 . 005 nuclear build core ' E' E ' 2' ' ' SER . . . . . . . . . . . . . 5.3 p . . . . . 0 C--O 1.231 0.094 0 CA-C-O 120.818 0.342 . . . . 0.0 110.129 . . . . . . . . . 0 0 . 1 . 005 nuclear build core ' E' E ' 3' ' ' GLU . . . . . . . . . . . . . 84.9 tt0 -144.41 141.35 29.58 Favored 'General case' 0 C--N 1.327 -0.409 0 CA-C-N 116.198 -0.456 . . . . 0.0 111.182 -178.63 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' E' E ' 4' ' ' LEU . . . . . . . . . . . . . 20.1 tp -122.73 132.07 54.07 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-N 116.04 -0.527 . . . . 0.0 110.102 176.235 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' E' E ' 5' ' ' LYS . . . . . . . . . . . . . 50.2 mtmt -108.27 119.02 38.28 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 116.353 -0.385 . . . . 0.0 110.69 -179.604 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' E' E ' 6' ' ' LEU . . . . . . . . . . . . . 54.8 mt -114.15 142.19 46.55 Favored 'General case' 0 C--N 1.331 -0.229 0 O-C-N 123.86 0.725 . . . . 0.0 111.169 -178.165 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' E' E ' 7' ' ' LYS . . . . . . . . . . . . . 65.5 tttt -132.97 138.48 31.94 Favored Pre-proline 0 CA--C 1.534 0.356 0 CA-C-O 118.922 -0.561 . . . . 0.0 109.672 176.152 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' E' E ' 8' ' ' PRO . . . . . . . . . . . . . 78.1 Cg_endo -90.99 146.55 3.68 Favored 'Trans proline' 0 N--CA 1.49 1.317 0 C-N-CA 121.691 1.594 . . . . 0.0 112.083 178.671 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' E' E ' 9' ' ' LEU . . . . . . . . . . . . . 54.8 mt -86.0 -48.55 0.55 Allowed Pre-proline 0 CA--C 1.535 0.392 0 CA-C-O 118.518 -0.753 . . . . 0.0 112.499 -179.845 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' E' E ' 10' ' ' PRO . . . . . . . . . . . . . 95.6 Cg_endo -78.41 157.13 29.14 Favored 'Trans proline' 0 N--CA 1.496 1.645 0 C-N-CA 121.22 1.28 . . . . 0.0 112.002 178.651 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' E' E ' 11' ' ' LYS . . . . . . . . . . . . . 92.5 mttt -85.18 92.2 8.34 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.311 -0.404 . . . . 0.0 110.539 179.383 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' E' E ' 12' ' ' VAL . . . . . . . . . . . . . 12.6 p -142.5 143.42 25.93 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.281 0 CA-C-N 116.372 -0.376 . . . . 0.0 110.61 179.819 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' E' E ' 13' ' ' GLU . . . . . . . . . . . . . 41.7 mt-10 -93.28 132.49 37.42 Favored 'General case' 0 C--N 1.329 -0.307 0 N-CA-C 109.926 -0.398 . . . . 0.0 109.926 177.349 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' E' E ' 14' ' ' LEU . . . . . . . . . . . . . 21.2 mt -98.5 149.76 36.05 Favored Pre-proline 0 CA--C 1.534 0.342 0 CA-C-O 119.318 -0.373 . . . . 0.0 110.737 -176.351 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' E' E ' 15' ' ' PRO . . . . . . . . . . . . . 23.5 Cg_exo -64.26 161.21 35.16 Favored 'Trans proline' 0 N--CA 1.498 1.791 0 C-N-CA 121.291 1.328 . . . . 0.0 111.971 175.841 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' E' E ' 16' ' ' PRO . . . . . . . . . . . . . 29.7 Cg_exo -59.9 -34.81 95.16 Favored 'Trans proline' 0 N--CA 1.498 1.774 0 C-N-CA 121.451 1.434 . . . . 0.0 112.938 -178.536 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' E' E ' 17' ' ' ASP . . . . . . . . . . . . . 16.5 p-10 -83.91 0.99 45.53 Favored 'General case' 0 CA--C 1.538 0.488 0 N-CA-C 113.375 0.88 . . . . 0.0 113.375 -177.738 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' E' E ' 18' ' ' PHE . . . . . . . . . . . . . 45.9 t80 -57.92 -42.27 84.46 Favored 'General case' 0 C--N 1.333 -0.124 0 O-C-N 121.938 -0.476 . . . . 0.0 110.228 -177.426 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' E' E ' 19' ' ' VAL . . . . . . . . . . . . . 46.7 t -56.19 -45.74 81.05 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.244 0 CA-C-N 116.44 -0.346 . . . . 0.0 110.62 -178.003 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' E' E ' 20' ' ' ASP . . . . . . . . . . . . . 81.3 m-20 -60.14 -40.18 88.92 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-O 120.833 0.349 . . . . 0.0 110.936 -178.217 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' E' E ' 21' ' ' VAL . . . . . . . . . . . . . 46.2 t -63.78 -47.02 92.8 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.265 0 C-N-CA 120.675 -0.41 . . . . 0.0 110.381 -178.262 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' E' E ' 22' ' ' ILE . . . . . 0.642 HG22 HD12 ' E' ' 26' ' ' LEU . 51.7 mm -55.28 -46.74 78.22 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.274 0 C-N-CA 121.131 -0.228 . . . . 0.0 110.771 179.304 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' E' E ' 23' ' ' ARG . . . . . . . . . . . . . 34.6 ttp180 -54.42 -49.36 70.14 Favored 'General case' 0 C--N 1.33 -0.267 0 C-N-CA 121.023 -0.271 . . . . 0.0 111.454 -178.841 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' E' E ' 24' ' ' ILE . . . . . . . . . . . . . 70.3 mt -59.88 -44.13 93.6 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.257 0 CA-C-N 116.549 -0.296 . . . . 0.0 111.223 -177.172 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' E' E ' 25' ' ' LYS . . . . . . . . . . . . . 50.9 mmtt -64.46 -41.85 96.28 Favored 'General case' 0 C--N 1.328 -0.336 0 N-CA-C 112.406 0.521 . . . . 0.0 112.406 -178.027 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' E' E ' 26' ' ' LEU . . . . . 0.642 HD12 HG22 ' E' ' 22' ' ' ILE . 28.8 mt -78.54 -41.59 31.76 Favored 'General case' 0 C--N 1.33 -0.269 0 N-CA-C 113.252 0.834 . . . . 0.0 113.252 -171.181 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' E' E ' 27' ' ' GLN . . . . . . . . . . . . . 14.7 pt20 -46.58 139.03 5.4 Favored 'General case' 0 N--CA 1.469 0.502 0 N-CA-C 112.787 0.662 . . . . 0.0 112.787 -175.056 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' E' E ' 28' ' ' GLY . . . . . . . . . . . . . . . 98.77 -27.04 21.61 Favored Glycine 0 CA--C 1.533 1.174 0 CA-C-N 115.528 -0.76 . . . . 0.0 112.226 -177.247 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' E' E ' 29' ' ' LYS . . . . . . . . . . . . . 46.0 mtmt -98.12 155.16 17.28 Favored 'General case' 0 C--N 1.331 -0.203 0 CA-C-N 117.168 0.484 . . . . 0.0 111.182 179.35 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' E' E ' 30' ' ' THR . . . . . . . . . . . . . 28.8 m -104.15 137.71 41.7 Favored 'General case' 0 C--N 1.331 -0.222 0 CA-C-N 115.908 -0.587 . . . . 0.0 110.149 175.957 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' E' E ' 31' ' ' VAL . . . . . . . . . . . . . 35.2 m -130.6 153.51 39.18 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 CA-C-N 116.361 -0.381 . . . . 0.0 110.94 -178.709 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' E' E ' 32' ' ' ARG . . . . . . . . . . . . . 87.8 mtm-85 -128.1 149.21 50.51 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.138 -0.483 . . . . 0.0 110.653 179.432 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' E' E ' 33' ' ' THR . . . . . . . . . . . . . 29.9 m -53.46 139.22 31.51 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.372 -0.376 . . . . 0.0 111.376 -178.524 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' E' E ' 34' ' ' GLY . . . . . . . . . . . . . . . 99.35 -17.14 58.24 Favored Glycine 0 CA--C 1.532 1.111 0 CA-C-O 119.707 -0.496 . . . . 0.0 113.312 179.217 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' E' E ' 35' ' ' ASP . . . . . . . . . . . . . 77.8 m-20 -66.3 148.62 51.58 Favored 'General case' 0 C--O 1.231 0.129 0 CA-C-N 118.02 0.91 . . . . 0.0 111.078 179.189 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' E' E ' 36' ' ' VAL . . . . . . . . . . . . . 43.9 t -119.91 129.68 75.13 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.2 0 CA-C-N 115.78 -0.645 . . . . 0.0 109.822 178.267 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' E' E ' 37' ' ' ILE . . . . . . . . . . . . . 67.5 mt -116.88 137.51 50.53 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.272 0 N-CA-C 109.739 -0.467 . . . . 0.0 109.739 179.437 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' E' E ' 38' ' ' GLY . . . . . . . . . . . . . . . -114.72 128.67 8.26 Favored Glycine 0 CA--C 1.525 0.672 0 N-CA-C 111.143 -0.783 . . . . 0.0 111.143 -179.164 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' E' E ' 39' ' ' ILE . . . . . . . . . . . . . 77.2 mt -122.41 134.4 65.73 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.249 0 N-CA-C 109.974 -0.38 . . . . 0.0 109.974 178.787 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' E' E ' 40' ' ' SER . . . . . . . . . . . . . 59.8 p -92.74 119.04 31.72 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.441 -0.345 . . . . 0.0 110.829 175.7 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' E' E ' 41' ' ' ILE . . . . . . . . . . . . . 72.3 mt -126.37 122.23 60.76 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.215 0 CA-C-N 116.553 -0.294 . . . . 0.0 110.32 178.652 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' E' E ' 42' ' ' LEU . . . . . . . . . . . . . 44.4 mt 52.11 34.25 13.8 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.251 -0.431 . . . . 0.0 111.853 177.675 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' E' E ' 43' ' ' GLY . . . . . . . . . . . . . . . 72.23 33.2 62.05 Favored Glycine 0 CA--C 1.529 0.935 0 C-N-CA 121.053 -0.594 . . . . 0.0 111.796 179.002 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' E' E ' 44' ' ' LYS . . . . . . . . . . . . . 44.2 tttp -138.35 128.76 26.13 Favored 'General case' 0 C--N 1.328 -0.33 0 N-CA-C 109.696 -0.483 . . . . 0.0 109.696 179.711 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' E' E ' 45' ' ' GLU . . . . . . . . . . . . . 83.7 tt0 -83.03 121.78 27.46 Favored 'General case' 0 C--N 1.328 -0.347 0 C-N-CA 120.786 -0.366 . . . . 0.0 111.127 -177.639 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' E' E ' 46' ' ' VAL . . . . . . . . . . . . . 7.5 p -119.94 125.88 74.73 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.194 0 N-CA-C 109.298 -0.63 . . . . 0.0 109.298 175.087 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' E' E ' 47' ' ' LYS . . . . . . . . . . . . . 96.5 mttt -100.87 129.78 46.78 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 115.964 -0.562 . . . . 0.0 111.437 179.442 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' E' E ' 48' ' ' PHE . . . . . . . . . . . . . 91.7 m-85 -112.73 131.81 55.5 Favored 'General case' 0 C--N 1.33 -0.253 0 N-CA-C 109.612 -0.514 . . . . 0.0 109.612 174.507 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' E' E ' 49' ' ' LYS . . . . . . . . . . . . . 68.5 tttt -107.87 137.42 45.91 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.643 -0.253 . . . . 0.0 110.715 179.817 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' E' E ' 50' ' ' VAL . . . . . . . . . . . . . 46.7 t -81.04 106.57 12.37 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.281 0 N-CA-C 109.175 -0.676 . . . . 0.0 109.175 175.148 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' E' E ' 51' ' ' VAL . . . . . . . . . . . . . 48.0 t -69.68 -53.99 21.64 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.324 0 N-CA-C 109.479 -0.563 . . . . 0.0 109.479 -176.302 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' E' E ' 52' ' ' GLN . . . . . . . . . . . . . 93.7 mt-30 -152.53 154.55 35.67 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.097 -0.501 . . . . 0.0 111.714 -179.226 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' E' E ' 53' ' ' ALA . . . . . 0.41 ' HB1' ' HB2' ' E' ' 58' ' ' LEU . . . -130.49 132.33 45.59 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 115.168 -0.924 . . . . 0.0 109.764 176.056 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' E' E ' 54' ' ' TYR . . . . . . . . . . . . . 57.9 t80 -129.1 108.82 18.04 Favored Pre-proline 0 CA--C 1.534 0.351 0 CA-C-O 118.312 -0.851 . . . . 0.0 110.368 -179.767 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' E' E ' 55' ' ' PRO . . . . . . . . . . . . . 73.8 Cg_endo -77.21 170.03 72.57 Favored 'Cis proline' 0 N--CA 1.499 1.813 0 CA-C-N 121.808 1.682 . . . . 0.0 112.583 -5.154 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' E' E ' 56' ' ' SER . . . . . . . . . . . . . 13.8 m -116.12 128.97 25.57 Favored Pre-proline 0 CA--C 1.539 0.53 0 CA-C-O 118.356 -0.83 . . . . 0.0 109.139 174.425 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' E' E ' 57' ' ' PRO . . . . . . . . . . . . . 54.3 Cg_endo -70.7 149.63 91.18 Favored 'Cis proline' 0 N--CA 1.497 1.684 0 CA-C-N 121.993 1.747 . . . . 0.0 111.733 0.454 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' E' E ' 58' ' ' LEU . . . . . 0.41 ' HB2' ' HB1' ' E' ' 53' ' ' ALA . 25.3 tp -108.39 136.53 47.86 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.572 -179.426 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' E' E ' 59' ' ' ARG . . . . . . . . . . . . . 72.8 ttt180 -104.55 125.96 51.19 Favored 'General case' 0 C--N 1.326 -0.438 0 N-CA-C 109.14 -0.689 . . . . 0.0 109.14 176.0 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' E' E ' 60' ' ' VAL . . . . . . . . . . . . . 45.8 t -80.44 118.07 27.48 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.213 0 C-N-CA 120.521 -0.471 . . . . 0.0 110.48 -174.765 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' E' E ' 61' ' ' GLU . . . . . . . . . . . . . 95.0 mt-10 -131.02 162.81 28.97 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 115.786 -0.643 . . . . 0.0 109.563 176.326 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' E' E ' 62' ' ' ASP . . . . . . . . . . . . . 21.1 p-10 -56.27 -33.12 65.17 Favored 'General case' 0 C--N 1.328 -0.328 0 N-CA-C 111.854 0.316 . . . . 0.0 111.854 -177.15 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' E' E ' 63' ' ' ARG . . . . . . . . . . . . . 27.1 mmm180 -73.31 -17.36 61.32 Favored 'General case' 0 CA--C 1.533 0.317 0 N-CA-C 113.178 0.807 . . . . 0.0 113.178 -177.08 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' E' E ' 64' ' ' THR . . . . . . . . . . . . . 25.7 m -70.07 139.25 52.56 Favored 'General case' 0 C--N 1.332 -0.156 0 CA-C-O 120.865 0.364 . . . . 0.0 110.987 -175.235 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' E' E ' 65' ' ' LYS . . . . . . . . . . . . . 64.4 mttm -86.06 133.94 33.86 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.041 -0.527 . . . . 0.0 109.922 178.167 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' E' E ' 66' ' ' ILE . . . . . . . . . . . . . 64.3 mt -114.31 125.59 71.65 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.29 0 N-CA-C 109.57 -0.53 . . . . 0.0 109.57 178.839 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' E' E ' 67' ' ' THR . . . . . . . . . . . . . 29.5 m -118.12 137.53 52.89 Favored 'General case' 0 C--N 1.331 -0.213 0 CA-C-N 116.06 -0.518 . . . . 0.0 110.555 -178.013 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' E' E ' 68' ' ' LEU . . . . . . . . . . . . . 19.6 tp . . . . . 0 C--N 1.327 -0.37 0 CA-C-N 115.79 -0.641 . . . . 0.0 110.466 -179.222 . . . . . . . . 0 0 . 1 . 005 nuclear build core ' E' E ' 73' ' ' VAL . . . . . . . . . . . . . 34.2 m . . . . . 0 C--O 1.232 0.134 0 CA-C-O 120.621 0.248 . . . . 0.0 110.597 . . . . . . . . . 0 0 . 1 . 005 nuclear build core ' E' E ' 74' ' ' ASP . . . . . . . . . . . . . 33.7 t0 -86.46 117.59 25.35 Favored 'General case' 0 C--N 1.33 -0.259 0 C-N-CA 120.933 -0.307 . . . . 0.0 110.187 -173.862 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' E' E ' 75' ' ' VAL . . . . . . . . . . . . . 46.4 t -117.28 120.78 65.99 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.235 0 CA-C-O 121.126 0.489 . . . . 0.0 110.191 -178.439 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' E' E ' 76' ' ' LEU . . . . . . . . . . . . . 15.7 mt -123.32 142.22 51.17 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 115.559 -0.746 . . . . 0.0 109.502 178.688 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' E' E ' 77' ' ' GLU . . . . . . . . . . . . . 97.1 mt-10 -135.4 129.58 33.53 Favored 'General case' 0 C--N 1.331 -0.227 0 CA-C-O 121.064 0.459 . . . . 0.0 111.058 -177.221 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' E' E ' 78' ' ' ALA . . . . . 0.606 ' HB2' HD21 ' E' ' 109' ' ' LEU . . . -116.25 126.54 53.73 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 115.649 -0.705 . . . . 0.0 109.586 177.24 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' E' E ' 79' ' ' LYS . . . . . 0.436 ' O ' HD13 ' E' ' 80' ' ' ILE . 48.0 pttt -76.72 119.18 20.16 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-O 121.284 0.564 . . . . 0.0 110.962 -177.386 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' E' E ' 80' ' ' ILE . . . . . 0.436 HD13 ' O ' ' E' ' 79' ' ' LYS . 26.8 mm -139.25 106.11 2.71 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.244 0 CA-C-N 115.563 -0.744 . . . . 0.0 109.09 -178.932 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' E' E ' 81' ' ' LYS . . . . . . . . . . . . . 53.1 mtmt -99.5 129.19 45.65 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-O 120.925 0.393 . . . . 0.0 110.865 -178.678 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' E' E ' 82' ' ' GLY . . . . . . . . . . . . . . . 89.16 42.18 5.65 Favored Glycine 0 CA--C 1.525 0.666 0 C-N-CA 120.915 -0.66 . . . . 0.0 111.701 175.423 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' E' E ' 83' ' ' ILE . . . . . . . . . . . . . 75.2 mt -67.95 138.16 23.16 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.302 0 N-CA-C 109.771 -0.455 . . . . 0.0 109.771 176.48 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' E' E ' 84' ' ' LYS . . . . . . . . . . . . . 58.6 tttp -95.06 -52.76 4.08 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.122 -0.49 . . . . 0.0 109.956 -179.702 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' E' E ' 85' ' ' ASP . . . . . . . . . . . . . 6.5 t70 -155.72 153.58 30.15 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 115.792 -0.64 . . . . 0.0 110.371 -179.458 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' E' E ' 86' ' ' VAL . . . . . . . . . . . . . 43.0 t -130.29 132.67 64.86 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.258 0 CA-C-O 120.991 0.424 . . . . 0.0 110.498 -179.628 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' E' E ' 87' ' ' ILE . . . . . . . . . . . . . 45.2 mm -116.95 125.72 74.0 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.252 0 CA-C-N 115.722 -0.672 . . . . 0.0 109.55 176.745 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' E' E ' 88' ' ' LEU . . . . . 0.499 HD21 ' NH1' ' D' ' 126' ' ' ARG . 16.8 tp -110.11 129.87 55.63 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-O 120.852 0.358 . . . . 0.0 110.946 -177.436 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' E' E ' 89' ' ' ASP . . . . . . . . . . . . . 13.9 t70 -125.47 155.7 40.08 Favored 'General case' 0 C--N 1.331 -0.221 0 CA-C-N 116.085 -0.507 . . . . 0.0 109.936 177.637 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' E' E ' 90' ' ' GLU . . . . . . . . . . . . . 45.3 tp10 -45.84 -38.84 7.75 Favored 'General case' 0 C--N 1.33 -0.282 0 N-CA-C 113.132 0.79 . . . . 0.0 113.132 -172.167 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' E' E ' 91' ' ' ASN . . . . . . . . . . . . . 20.9 t30 -132.04 22.37 4.52 Favored 'General case' 0 N--CA 1.468 0.462 0 N-CA-C 112.87 0.692 . . . . 0.0 112.87 -177.147 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' E' E ' 92' ' ' LEU . . . . . 0.413 HD12 ' O ' ' E' ' 127' ' ' ASN . 10.2 mt -149.48 147.14 27.87 Favored 'General case' 0 C--N 1.332 -0.167 0 N-CA-C 110.191 -0.3 . . . . 0.0 110.191 -177.025 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' E' E ' 93' ' ' ILE . . . . . . . . . . . . . 67.6 mt -124.34 119.57 56.88 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.203 0 N-CA-C 109.199 -0.667 . . . . 0.0 109.199 176.213 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' E' E ' 94' ' ' VAL . . . . . . . . . . . . . 45.7 t -118.84 127.44 75.74 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.252 0 N-CA-C 109.849 -0.426 . . . . 0.0 109.849 -179.482 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' E' E ' 95' ' ' VAL . . . . . . . . . . . . . 44.0 t -123.99 135.8 62.38 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.324 0 CA-C-N 116.135 -0.484 . . . . 0.0 110.177 -178.404 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' E' E ' 96' ' ' ILE . . . . . . . . . . . . . 57.7 mt -117.19 129.19 74.12 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.287 0 N-CA-C 109.269 -0.641 . . . . 0.0 109.269 178.117 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' E' E ' 97' ' ' THR . . . . . . . . . . . . . 78.5 p -103.63 158.16 16.56 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-O 121.185 0.517 . . . . 0.0 111.282 -177.431 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' E' E ' 98' ' ' GLU . . . . . . . . . . . . . 70.6 mm-40 -54.23 -25.62 24.12 Favored 'General case' 0 C--N 1.33 -0.247 0 N-CA-C 112.408 0.521 . . . . 0.0 112.408 -179.754 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' E' E ' 99' ' ' GLU . . . . . . . . . . . . . 47.2 mp0 -78.19 14.33 1.21 Allowed 'General case' 0 CA--C 1.535 0.402 0 N-CA-C 113.136 0.791 . . . . 0.0 113.136 -178.032 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' E' E ' 100' ' ' ASN . . . . . . . . . . . . . 3.6 m-20 62.21 37.33 14.32 Favored 'General case' 0 CA--C 1.53 0.201 0 CA-C-O 120.994 0.426 . . . . 0.0 110.997 178.741 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' E' E ' 101' ' ' GLU . . . . . . . . . . . . . 84.7 tt0 -113.99 144.14 43.58 Favored 'General case' 0 C--N 1.331 -0.198 0 CA-C-N 116.02 -0.536 . . . . 0.0 109.735 176.244 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' E' E ' 102' ' ' VAL . . . . . . . . . . . . . 44.3 t -114.98 126.0 72.45 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.299 0 CA-C-N 116.225 -0.443 . . . . 0.0 109.914 -178.803 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' E' E ' 103' ' ' LEU . . . . . . . . . . . . . 21.5 mt -118.29 132.08 56.31 Favored 'General case' 0 C--N 1.331 -0.217 0 CA-C-N 115.662 -0.699 . . . . 0.0 110.31 178.778 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' E' E ' 104' ' ' ILE . . . . . . . . . . . . . 69.7 mt -120.14 123.57 70.96 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.266 0 N-CA-C 110.063 -0.347 . . . . 0.0 110.063 178.601 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' E' E ' 105' ' ' PHE . . . . . . . . . . . . . 70.8 m-85 -124.88 162.43 24.41 Favored 'General case' 0 C--N 1.333 -0.15 0 O-C-N 123.848 0.718 . . . . 0.0 109.89 179.336 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' E' E ' 106' ' ' ASN . . . . . . . . . . . . . 46.0 p-10 -97.22 -170.46 2.03 Favored 'General case' 0 C--N 1.33 -0.266 0 N-CA-C 109.981 -0.377 . . . . 0.0 109.981 174.143 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' E' E ' 107' ' ' GLN . . . . . . . . . . . . . 55.6 tp60 -59.71 -30.07 68.55 Favored 'General case' 0 CA--C 1.531 0.214 0 N-CA-C 111.911 0.337 . . . . 0.0 111.911 179.911 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' E' E ' 108' ' ' ASN . . . . . . . . . . . . . 52.0 t30 -81.92 8.21 11.01 Favored 'General case' 0 CA--C 1.535 0.384 0 N-CA-C 113.109 0.781 . . . . 0.0 113.109 -177.601 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' E' E ' 109' ' ' LEU . . . . . 0.606 HD21 ' HB2' ' E' ' 78' ' ' ALA . 12.7 tp 58.39 38.79 25.75 Favored 'General case' 0 C--N 1.332 -0.183 0 CA-C-O 121.105 0.479 . . . . 0.0 110.901 179.339 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' E' E ' 110' ' ' GLU . . . . . . . . . . . . . 70.8 mm-40 -105.23 149.14 26.22 Favored 'General case' 0 C--N 1.332 -0.192 0 N-CA-C 109.925 -0.398 . . . . 0.0 109.925 176.798 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' E' E ' 111' ' ' GLU . . . . . . . . . . . . . 84.5 tt0 -78.39 121.83 25.01 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 116.419 -0.355 . . . . 0.0 110.616 -177.402 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' E' E ' 112' ' ' LEU . . . . . . . . . . . . . 18.4 mt -110.17 -46.11 3.49 Favored 'General case' 0 C--N 1.331 -0.21 0 CA-C-N 116.283 -0.417 . . . . 0.0 110.697 179.174 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' E' E ' 113' ' ' TYR . . . . . . . . . . . . . 64.3 t80 -138.89 136.27 35.35 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.262 -0.426 . . . . 0.0 111.045 -179.147 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' E' E ' 114' ' ' ARG . . . . . . . . . . . . . 70.1 ttp85 -138.53 120.37 15.37 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-N 116.025 -0.534 . . . . 0.0 110.277 176.695 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' E' E ' 115' ' ' GLY . . . . . . . . . . . . . . . -150.14 145.65 13.95 Favored Glycine 0 CA--C 1.524 0.641 0 N-CA-C 110.842 -0.903 . . . . 0.0 110.842 178.118 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' E' E ' 116' ' ' LYS . . . . . . . . . . . . . 28.4 ttmt -115.26 136.59 52.95 Favored 'General case' 0 C--N 1.331 -0.23 0 O-C-N 122.565 -0.374 . . . . 0.0 110.171 177.94 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' E' E ' 117' ' ' PHE . . . . . . . . . . . . . 58.5 m-85 -131.46 117.37 18.74 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 116.15 -0.477 . . . . 0.0 110.129 -177.018 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' E' E ' 118' ' ' GLU . . . . . . . . . . . . . 96.2 mt-10 -54.43 -41.64 69.6 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.507 -0.315 . . . . 0.0 111.486 -175.31 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' E' E ' 119' ' ' ASN . . . . . . . . . . . . . 19.0 m120 -104.05 31.1 4.73 Favored 'General case' 0 C--N 1.33 -0.249 0 N-CA-C 112.129 0.418 . . . . 0.0 112.129 -173.885 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' E' E ' 120' ' ' LEU . . . . . . . . . . . . . 21.3 tp -56.65 123.29 14.36 Favored 'General case' 0 C--N 1.332 -0.16 0 C-N-CA 121.118 -0.233 . . . . 0.0 110.412 178.555 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' E' E ' 121' ' ' ASN . . . . . . . . . . . . . 27.2 m120 -114.13 -44.28 3.15 Favored 'General case' 0 N--CA 1.462 0.165 0 CA-C-N 116.759 -0.201 . . . . 0.0 111.353 -176.829 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' E' E ' 122' ' ' LYS . . . . . . . . . . . . . 94.4 mttt -147.73 151.52 36.23 Favored 'General case' 0 C--N 1.332 -0.191 0 CA-C-O 121.03 0.443 . . . . 0.0 111.715 -176.963 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' E' E ' 123' ' ' VAL . . . . . . . . . . . . . 42.7 t -132.91 133.13 59.14 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.181 0 N-CA-C 109.633 -0.506 . . . . 0.0 109.633 175.249 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' E' E ' 124' ' ' LEU . . . . . . . . . . . . . 69.9 mt -130.09 137.72 50.33 Favored 'General case' 0 C--N 1.331 -0.197 0 CA-C-N 116.452 -0.34 . . . . 0.0 110.842 -178.772 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' E' E ' 125' ' ' VAL . . . . . . . . . . . . . 11.8 p -136.95 137.17 47.24 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.262 0 CA-C-N 116.385 -0.37 . . . . 0.0 110.651 179.669 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' E' E ' 126' ' ' ARG . . . . . . . . . . . . . 83.3 mtt180 -146.06 130.28 17.54 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.679 177.226 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' E' E ' 127' ' ' ASN . . . . . 0.413 ' O ' HD12 ' E' ' 92' ' ' LEU . 36.3 t30 50.64 -112.22 0.59 Allowed 'General case' 0 CA--C 1.545 0.761 0 CA-C-O 118.64 -0.695 . . . . 0.0 111.46 178.751 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' E' E ' 128' ' ' ASP . . . . . . . . . . . . . 17.3 p-10 -112.59 8.16 19.07 Favored 'General case' 0 N--CA 1.468 0.435 0 CA-C-N 120.157 1.344 . . . . 0.0 113.317 -177.317 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' E' E ' 129' ' ' LEU . . . . . . . . . . . . . 15.5 tp -116.38 137.49 52.11 Favored 'General case' 0 C--N 1.333 -0.139 0 N-CA-C 109.745 -0.465 . . . . 0.0 109.745 178.89 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' E' E ' 130' ' ' VAL . . . . . 0.532 HG13 ' HB ' ' E' ' 141' ' ' ILE . 12.7 p -132.62 143.39 39.86 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.198 0 CA-C-O 121.143 0.497 . . . . 0.0 110.563 -179.556 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' E' E ' 131' ' ' VAL . . . . . . . . . . . . . 39.3 t -135.53 140.72 44.08 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.246 0 CA-C-N 115.969 -0.559 . . . . 0.0 110.383 -178.941 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' E' E ' 132' ' ' ILE . . . . . . . . . . . . . 70.3 mt -115.93 132.86 64.17 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.316 0 CA-C-N 115.752 -0.658 . . . . 0.0 109.355 179.292 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' E' E ' 133' ' ' ILE . . . . . . . . . . . . . 41.9 mm -116.24 124.15 72.18 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.238 0 CA-C-O 120.896 0.379 . . . . 0.0 111.064 -175.061 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' E' E ' 134' ' ' ASP . . . . . . . . . . . . . 7.8 p-10 -135.35 149.76 49.79 Favored 'General case' 0 C--N 1.331 -0.205 0 CA-C-N 116.075 -0.511 . . . . 0.0 109.677 174.574 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' E' E ' 135' ' ' GLU . . . . . . . . . . . . . 40.2 tp10 -50.76 -28.38 9.09 Favored 'General case' 0 C--N 1.327 -0.377 0 N-CA-C 112.709 0.633 . . . . 0.0 112.709 -173.088 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' E' E ' 136' ' ' GLN . . . . . . . . . . . . . 98.3 mt-30 -84.55 -29.82 25.58 Favored 'General case' 0 C--O 1.233 0.229 0 N-CA-C 112.882 0.697 . . . . 0.0 112.882 -175.432 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' E' E ' 137' ' ' LYS . . . . . . . . . . . . . 58.9 pttt -168.86 175.35 5.98 Favored 'General case' 0 C--N 1.332 -0.171 0 CA-C-O 121.609 0.719 . . . . 0.0 112.449 -172.879 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' E' E ' 138' ' ' LEU . . . . . 0.457 ' C ' HD23 ' E' ' 138' ' ' LEU . 8.6 tt -121.62 129.42 52.81 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 114.997 -1.001 . . . . 0.0 109.958 178.475 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' E' E ' 139' ' ' THR . . . . . . . . . . . . . 43.7 m -109.1 128.22 54.82 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.188 179.316 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' E' E ' 140' ' ' LEU . . . . . 0.48 ' C ' HD23 ' E' ' 140' ' ' LEU . 7.2 tt -112.81 125.25 54.14 Favored 'General case' 0 C--N 1.328 -0.35 0 N-CA-C 109.174 -0.676 . . . . 0.0 109.174 -178.828 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' E' E ' 141' ' ' ILE . . . . . 0.532 ' HB ' HG13 ' E' ' 130' ' ' VAL . 19.4 mt -123.57 119.29 56.86 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.277 0 CA-C-O 121.132 0.492 . . . . 0.0 110.09 -176.469 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' E' E ' 142' ' ' ARG . . . . . . . . . . . . . 77.6 ttt-85 -106.39 130.0 54.28 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 115.001 -1.0 . . . . 0.0 110.226 -179.882 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' E' E ' 143' ' ' THR . . . . . . . . . . . . . 44.6 p . . . . . 0 C--O 1.219 -0.514 0 CA-C-O 117.959 -1.02 . . . . 0.0 110.547 179.112 . . . . . . . . 0 0 . 1 . 005 nuclear build core ' F' F ' 1' ' ' MET . . . . . . . . . . . . . 26.2 ptt? . . . . . 0 C--O 1.232 0.154 0 CA-C-O 120.841 0.353 . . . . 0.0 110.957 . . . . . . . . . 0 0 . 1 . 005 nuclear build core ' F' F ' 2' ' ' SER . . . . . . . . . . . . . 14.3 p -130.8 135.33 47.65 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.083 -0.508 . . . . 0.0 110.082 178.419 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' F' F ' 3' ' ' GLU . . . . . . . . . . . . . 46.8 mp0 -139.45 141.15 37.45 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.146 -0.479 . . . . 0.0 111.321 -176.615 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' F' F ' 4' ' ' LEU . . . . . . . . . . . . . 57.6 mt -118.94 124.97 48.35 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 115.606 -0.725 . . . . 0.0 109.85 173.96 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' F' F ' 5' ' ' LYS . . . . . . . . . . . . . 98.3 mttt -102.36 119.81 39.44 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.459 -0.337 . . . . 0.0 110.144 177.646 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' F' F ' 6' ' ' LEU . . . . . . . . . . . . . 70.5 mt -119.45 144.32 47.03 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 115.416 -0.811 . . . . 0.0 110.421 -177.9 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' F' F ' 7' ' ' LYS . . . . . . . . . . . . . 47.4 tttm -134.64 142.78 43.86 Favored Pre-proline 0 CA--C 1.534 0.354 0 CA-C-O 119.2 -0.428 . . . . 0.0 110.142 177.331 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' F' F ' 8' ' ' PRO . . . . . . . . . . . . . 85.0 Cg_endo -92.16 143.35 2.63 Favored 'Trans proline' 0 N--CA 1.49 1.319 0 C-N-CA 121.749 1.633 . . . . 0.0 111.714 176.997 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' F' F ' 9' ' ' LEU . . . . . . . . . . . . . 62.0 mt -76.74 -47.02 3.04 Favored Pre-proline 0 CA--C 1.535 0.367 0 CA-C-O 118.691 -0.671 . . . . 0.0 112.041 179.735 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' F' F ' 10' ' ' PRO . . . . . . . . . . . . . 85.4 Cg_endo -81.71 150.2 16.5 Favored 'Trans proline' 0 N--CA 1.495 1.59 0 C-N-CA 121.185 1.257 . . . . 0.0 111.54 174.604 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' F' F ' 11' ' ' LYS . . . . . . . . . . . . . 54.0 pttt -86.95 113.12 22.45 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-O 121.552 0.692 . . . . 0.0 110.949 179.981 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' F' F ' 12' ' ' VAL . . . . . . . . . . . . . 13.3 p -151.09 148.34 14.99 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.194 0 CA-C-N 115.736 -0.666 . . . . 0.0 110.458 178.901 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' F' F ' 13' ' ' GLU . . . . . . . . . . . . . 45.3 mt-10 -88.0 124.19 33.48 Favored 'General case' 0 C--N 1.331 -0.224 0 CA-C-O 120.759 0.314 . . . . 0.0 110.595 177.836 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' F' F ' 14' ' ' LEU . . . . . . . . . . . . . 22.8 mt -99.77 154.61 37.16 Favored Pre-proline 0 CA--C 1.532 0.285 0 CA-C-N 116.276 -0.42 . . . . 0.0 111.012 -178.282 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' F' F ' 15' ' ' PRO . . . . . . . . . . . . . 27.7 Cg_exo -62.05 162.99 20.83 Favored 'Trans proline' 0 N--CA 1.498 1.736 0 C-N-CA 121.423 1.415 . . . . 0.0 111.963 176.07 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' F' F ' 16' ' ' PRO . . . . . . . . . . . . . 21.5 Cg_exo -64.61 -37.07 39.07 Favored 'Trans proline' 0 N--CA 1.497 1.705 0 C-N-CA 121.592 1.528 . . . . 0.0 112.724 -179.512 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' F' F ' 17' ' ' ASP . . . . . . . . . . . . . 12.7 p-10 -87.09 12.11 12.25 Favored 'General case' 0 CA--C 1.535 0.391 0 N-CA-C 113.142 0.793 . . . . 0.0 113.142 -177.149 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' F' F ' 18' ' ' PHE . . . . . . . . . . . . . 41.1 t80 -56.44 -41.85 77.15 Favored 'General case' 0 CA--C 1.526 0.047 0 O-C-N 121.939 -0.476 . . . . 0.0 110.375 -179.56 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' F' F ' 19' ' ' VAL . . . . . . . . . . . . . 44.3 t -55.98 -43.51 75.28 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.285 0 CA-C-N 116.399 -0.364 . . . . 0.0 110.579 -178.627 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' F' F ' 20' ' ' ASP . . . . . . . . . . . . . 29.8 t0 -59.88 -43.09 94.95 Favored 'General case' 0 C--N 1.33 -0.274 0 C-N-CA 120.915 -0.314 . . . . 0.0 110.784 -177.811 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' F' F ' 21' ' ' VAL . . . . . . . . . . . . . 45.4 t -63.33 -46.44 95.51 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.277 0 C-N-CA 120.63 -0.428 . . . . 0.0 110.437 -177.748 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' F' F ' 22' ' ' ILE . . . . . 0.437 HG22 ' CD1' ' F' ' 26' ' ' LEU . 51.4 mm -55.98 -47.11 80.54 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.275 0 C-N-CA 120.905 -0.318 . . . . 0.0 110.808 179.793 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' F' F ' 23' ' ' ARG . . . . . . . . . . . . . 55.4 ttp180 -55.02 -47.19 75.03 Favored 'General case' 0 C--N 1.331 -0.239 0 C-N-CA 120.932 -0.307 . . . . 0.0 111.303 -178.194 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' F' F ' 24' ' ' ILE . . . . . . . . . . . . . 75.5 mt -59.17 -42.58 87.23 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.268 0 C-N-CA 120.939 -0.304 . . . . 0.0 111.212 -177.672 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' F' F ' 25' ' ' LYS . . . . . . . . . . . . . 50.3 mttm -67.74 -39.57 84.23 Favored 'General case' 0 C--N 1.33 -0.266 0 N-CA-C 112.67 0.619 . . . . 0.0 112.67 -179.51 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' F' F ' 26' ' ' LEU . . . . . 0.437 ' CD1' HG22 ' F' ' 22' ' ' ILE . 95.8 mt -77.37 -39.85 45.96 Favored 'General case' 0 C--N 1.329 -0.307 0 N-CA-C 113.17 0.804 . . . . 0.0 113.17 -170.486 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' F' F ' 27' ' ' GLN . . . . . . . . . . . . . 15.5 pt20 -46.7 139.99 4.86 Favored 'General case' 0 N--CA 1.469 0.476 0 N-CA-C 112.785 0.661 . . . . 0.0 112.785 -174.501 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' F' F ' 28' ' ' GLY . . . . . . . . . . . . . . . 100.56 -29.29 12.67 Favored Glycine 0 CA--C 1.531 1.045 0 CA-C-N 115.592 -0.731 . . . . 0.0 112.016 -177.642 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' F' F ' 29' ' ' LYS . . . . . . . . . . . . . 72.8 mttt -97.92 155.08 17.25 Favored 'General case' 0 C--O 1.233 0.199 0 CA-C-N 117.203 0.501 . . . . 0.0 111.163 178.236 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' F' F ' 30' ' ' THR . . . . . . . . . . . . . 29.6 m -100.67 139.16 36.74 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 115.899 -0.591 . . . . 0.0 109.822 175.272 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' F' F ' 31' ' ' VAL . . . . . . . . . . . . . 35.0 m -122.08 149.55 25.45 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.259 0 CA-C-O 120.926 0.393 . . . . 0.0 110.823 -178.105 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' F' F ' 32' ' ' ARG . . . . . . . . . . . . . 39.1 ttp180 -132.95 147.86 52.28 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-N 115.669 -0.696 . . . . 0.0 110.314 177.582 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' F' F ' 33' ' ' THR . . . . . . . . . . . . . 27.4 m -53.61 137.34 37.16 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.418 -0.355 . . . . 0.0 111.281 -179.348 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' F' F ' 34' ' ' GLY . . . . . . . . . . . . . . . 101.76 -17.22 55.2 Favored Glycine 0 CA--C 1.532 1.108 0 CA-C-O 119.7 -0.5 . . . . 0.0 113.348 178.813 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' F' F ' 35' ' ' ASP . . . . . . . . . . . . . 78.8 m-20 -65.79 147.73 52.91 Favored 'General case' 0 N--CA 1.462 0.147 0 CA-C-N 118.015 0.907 . . . . 0.0 111.058 179.472 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' F' F ' 36' ' ' VAL . . . . . . . . . . . . . 44.3 t -122.97 129.62 74.99 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.267 0 CA-C-N 116.115 -0.493 . . . . 0.0 109.815 178.431 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' F' F ' 37' ' ' ILE . . . . . . . . . . . . . 68.0 mt -119.62 138.64 49.58 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.184 0 CA-C-N 116.123 -0.489 . . . . 0.0 109.846 -179.972 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' F' F ' 38' ' ' GLY . . . . . . . . . . . . . . . -110.58 128.65 8.9 Favored Glycine 0 CA--C 1.525 0.683 0 N-CA-C 111.19 -0.764 . . . . 0.0 111.19 -179.653 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' F' F ' 39' ' ' ILE . . . . . . . . . . . . . 72.5 mt -127.13 128.07 70.09 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.233 0 N-CA-C 109.922 -0.399 . . . . 0.0 109.922 178.537 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' F' F ' 40' ' ' SER . . . . . . . . . . . . . 30.8 t -92.42 121.19 33.65 Favored 'General case' 0 C--N 1.329 -0.305 0 C-N-CA 120.823 -0.351 . . . . 0.0 110.677 175.967 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' F' F ' 41' ' ' ILE . . . . . . . . . . . . . 71.1 mt -127.45 123.99 62.81 Favored 'Isoleucine or valine' 0 N--CA 1.462 0.159 0 CA-C-O 120.935 0.398 . . . . 0.0 110.582 -179.226 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' F' F ' 42' ' ' LEU . . . . . . . . . . . . . 7.0 tp 52.58 37.65 23.78 Favored 'General case' 0 C--N 1.331 -0.219 0 CA-C-N 116.062 -0.517 . . . . 0.0 111.671 175.661 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' F' F ' 43' ' ' GLY . . . . . . . . . . . . . . . 73.18 28.16 66.84 Favored Glycine 0 CA--C 1.53 1.025 0 C-N-CA 121.073 -0.584 . . . . 0.0 112.567 176.569 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' F' F ' 44' ' ' LYS . . . . . . . . . . . . . 62.8 tttm -140.59 126.38 19.28 Favored 'General case' 0 C--N 1.33 -0.272 0 N-CA-C 109.474 -0.565 . . . . 0.0 109.474 177.234 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' F' F ' 45' ' ' GLU . . . . . . . . . . . . . 34.7 tp10 -82.82 124.31 30.18 Favored 'General case' 0 C--N 1.328 -0.331 0 C-N-CA 120.718 -0.393 . . . . 0.0 110.836 -176.876 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' F' F ' 46' ' ' VAL . . . . . . . . . . . . . 7.6 p -120.8 129.45 75.64 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.204 0 N-CA-C 109.561 -0.533 . . . . 0.0 109.561 177.285 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' F' F ' 47' ' ' LYS . . . . . . . . . . . . . 61.3 mmtt -100.23 130.09 46.32 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 115.935 -0.575 . . . . 0.0 111.104 178.572 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' F' F ' 48' ' ' PHE . . . . . . . . . . . . . 94.2 m-85 -112.61 131.86 55.42 Favored 'General case' 0 C--N 1.331 -0.233 0 N-CA-C 109.638 -0.504 . . . . 0.0 109.638 175.795 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' F' F ' 49' ' ' LYS . . . . . . . . . . . . . 48.9 tttp -108.7 136.71 47.83 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.314 -0.403 . . . . 0.0 110.612 179.936 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' F' F ' 50' ' ' VAL . . . . . . . . . . . . . 46.8 t -78.92 106.46 9.92 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.333 0 N-CA-C 108.91 -0.774 . . . . 0.0 108.91 175.155 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' F' F ' 51' ' ' VAL . . . . . . . . . . . . . 47.3 t -74.81 -47.43 37.8 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.327 0 CA-C-N 116.075 -0.511 . . . . 0.0 110.139 -172.957 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' F' F ' 52' ' ' GLN . . . . . . . . . . . . . 57.5 tt0 -160.72 137.84 9.1 Favored 'General case' 0 C--N 1.33 -0.281 0 C-N-CA 120.465 -0.494 . . . . 0.0 111.351 -177.466 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' F' F ' 53' ' ' ALA . . . . . . . . . . . . . . . -114.75 131.79 56.66 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 115.964 -0.562 . . . . 0.0 109.983 174.494 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' F' F ' 54' ' ' TYR . . . . . . . . . . . . . 33.7 t80 -129.01 109.16 18.2 Favored Pre-proline 0 C--N 1.328 -0.334 0 CA-C-O 118.302 -0.856 . . . . 0.0 110.492 179.271 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' F' F ' 55' ' ' PRO . . . . . . . . . . . . . 74.0 Cg_endo -77.14 168.51 76.76 Favored 'Cis proline' 0 N--CA 1.499 1.841 0 CA-C-N 121.951 1.733 . . . . 0.0 112.292 -5.819 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' F' F ' 56' ' ' SER . . . . . . . . . . . . . 69.2 m -117.5 134.78 23.12 Favored Pre-proline 0 CA--C 1.539 0.524 0 CA-C-O 118.466 -0.778 . . . . 0.0 109.704 175.126 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' F' F ' 57' ' ' PRO . . . . . . . . . . . . . 57.6 Cg_endo -73.14 162.82 90.92 Favored 'Cis proline' 0 N--CA 1.496 1.619 0 CA-C-N 121.806 1.681 . . . . 0.0 111.375 -3.501 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' F' F ' 58' ' ' LEU . . . . . . . . . . . . . 33.6 tp -130.0 137.84 50.5 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-O 120.851 0.357 . . . . 0.0 110.793 -178.658 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' F' F ' 59' ' ' ARG . . . . . . . . . . . . . 32.2 ttp180 -99.65 127.52 45.76 Favored 'General case' 0 C--N 1.327 -0.374 0 N-CA-C 109.335 -0.617 . . . . 0.0 109.335 175.459 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' F' F ' 60' ' ' VAL . . . . . . . . . . . . . 41.2 t -80.96 123.15 37.27 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.266 0 C-N-CA 120.598 -0.441 . . . . 0.0 110.506 -175.073 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' F' F ' 61' ' ' GLU . . . . . . . . . . . . . 42.9 mt-10 -131.13 171.38 13.34 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 115.608 -0.724 . . . . 0.0 109.674 176.483 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' F' F ' 62' ' ' ASP . . . . . . . . . . . . . 83.8 m-20 -54.27 -32.59 56.58 Favored 'General case' 0 C--N 1.329 -0.308 0 C-N-CA 120.968 -0.293 . . . . 0.0 111.752 -179.279 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' F' F ' 63' ' ' ARG . . . . . . . . . . . . . 25.0 ptt180 -83.9 2.25 39.46 Favored 'General case' 0 CA--C 1.537 0.455 0 N-CA-C 113.727 1.01 . . . . 0.0 113.727 -175.263 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' F' F ' 64' ' ' THR . . . . . . . . . . . . . 28.4 m -78.44 136.8 37.71 Favored 'General case' 0 C--N 1.333 -0.133 0 CA-C-N 118.119 0.418 . . . . 0.0 110.705 -177.621 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' F' F ' 65' ' ' LYS . . . . . . . . . . . . . 24.6 mtpp -90.35 127.04 36.07 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.037 -0.529 . . . . 0.0 110.218 179.275 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' F' F ' 66' ' ' ILE . . . . . . . . . . . . . 4.3 mp -113.87 131.47 65.65 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.262 0 N-CA-C 110.012 -0.366 . . . . 0.0 110.012 179.628 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' F' F ' 67' ' ' THR . . . . . . . . . . . . . 20.9 m -122.19 132.62 54.54 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-O 121.069 0.462 . . . . 0.0 110.331 178.525 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' F' F ' 68' ' ' LEU . . . . . 0.435 HD23 ' C ' ' F' ' 68' ' ' LEU . 6.2 tt . . . . . 0 C--N 1.328 -0.337 0 CA-C-N 115.825 -0.625 . . . . 0.0 110.002 -179.982 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' F' F ' 73' ' ' VAL . . . . . . . . . . . . . 34.8 m . . . . . 0 N--CA 1.46 0.045 0 CA-C-O 121.109 0.481 . . . . 0.0 111.154 . . . . . . . . . 0 0 . 1 . 005 nuclear build core ' F' F ' 74' ' ' ASP . . . . . . . . . . . . . 12.8 t70 -101.82 123.72 46.24 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 115.542 -0.754 . . . . 0.0 109.594 177.464 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' F' F ' 75' ' ' VAL . . . . . . . . . . . . . 45.1 t -111.86 123.92 68.1 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.253 0 CA-C-O 121.145 0.498 . . . . 0.0 110.527 -178.105 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' F' F ' 76' ' ' LEU . . . . . . . . . . . . . 29.1 mt -123.86 142.23 51.31 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 115.533 -0.758 . . . . 0.0 109.418 177.661 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' F' F ' 77' ' ' GLU . . . . . . . . . . . . . 97.8 mt-10 -133.92 137.98 45.24 Favored 'General case' 0 C--N 1.331 -0.227 0 CA-C-O 121.018 0.437 . . . . 0.0 111.312 -178.145 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' F' F ' 78' ' ' ALA . . . . . 0.688 ' HB2' HD21 ' F' ' 109' ' ' LEU . . . -128.11 136.36 51.06 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 115.718 -0.673 . . . . 0.0 109.722 176.35 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' F' F ' 79' ' ' LYS . . . . . 0.593 ' O ' HD13 ' F' ' 80' ' ' ILE . 19.8 pttp -79.46 123.76 27.83 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-O 121.187 0.518 . . . . 0.0 111.142 -177.893 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' F' F ' 80' ' ' ILE . . . . . 0.593 HD13 ' O ' ' F' ' 79' ' ' LYS . 40.6 mm -139.21 112.73 6.57 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.279 0 CA-C-N 115.725 -0.671 . . . . 0.0 109.278 -178.199 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' F' F ' 81' ' ' LYS . . . . . . . . . . . . . 47.0 tptt -102.1 123.43 45.96 Favored 'General case' 0 C--N 1.329 -0.287 0 C-N-CA 120.921 -0.312 . . . . 0.0 111.072 -177.474 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' F' F ' 82' ' ' GLY . . . . . . . . . . . . . . . 89.07 42.15 5.69 Favored Glycine 0 CA--C 1.525 0.657 0 C-N-CA 120.722 -0.752 . . . . 0.0 111.954 173.551 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' F' F ' 83' ' ' ILE . . . . . . . . . . . . . 72.4 mt -64.04 137.47 24.75 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.29 0 N-CA-C 109.915 -0.402 . . . . 0.0 109.915 178.139 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' F' F ' 84' ' ' LYS . . . . . . . . . . . . . 82.2 tttt -99.43 -53.8 3.12 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 115.999 -0.546 . . . . 0.0 110.42 -178.975 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' F' F ' 85' ' ' ASP . . . . . . . . . . . . . 8.6 t0 -154.96 153.01 30.39 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 115.748 -0.66 . . . . 0.0 109.972 -179.706 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' F' F ' 86' ' ' VAL . . . . . . . . . . . . . 43.2 t -128.85 131.59 68.22 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.24 0 CA-C-O 120.9 0.381 . . . . 0.0 110.767 -178.016 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' F' F ' 87' ' ' ILE . . . . . . . . . . . . . 42.4 mm -118.22 124.26 72.84 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.245 0 CA-C-N 115.782 -0.644 . . . . 0.0 109.503 175.164 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' F' F ' 88' ' ' LEU . . . . . . . . . . . . . 14.8 tp -112.96 131.9 55.56 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-O 120.938 0.399 . . . . 0.0 111.36 -176.185 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' F' F ' 89' ' ' ASP . . . . . . . . . . . . . 13.5 t70 -131.08 151.52 51.35 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 115.861 -0.609 . . . . 0.0 109.442 175.932 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' F' F ' 90' ' ' GLU . . . . . . . . . . . . . 46.6 tp10 -48.96 -35.05 14.19 Favored 'General case' 0 C--N 1.329 -0.32 0 N-CA-C 112.712 0.634 . . . . 0.0 112.712 -172.49 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' F' F ' 91' ' ' ASN . . . . . . . . . . . . . 12.7 p30 -123.36 14.58 9.64 Favored 'General case' 0 N--CA 1.47 0.534 0 N-CA-C 113.452 0.908 . . . . 0.0 113.452 -175.883 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' F' F ' 92' ' ' LEU . . . . . . . . . . . . . 8.1 mt -151.66 143.17 23.53 Favored 'General case' 0 C--N 1.332 -0.171 0 N-CA-C 109.797 -0.446 . . . . 0.0 109.797 -177.101 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' F' F ' 93' ' ' ILE . . . . . . . . . . . . . 71.0 mt -127.26 117.13 46.39 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.346 0 N-CA-C 108.892 -0.781 . . . . 0.0 108.892 176.186 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' F' F ' 94' ' ' VAL . . . . . 0.468 HG21 HG21 ' F' ' 125' ' ' VAL . 48.4 t -121.71 128.11 75.67 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.257 0 CA-C-O 121.147 0.498 . . . . 0.0 110.189 -178.174 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' F' F ' 95' ' ' VAL . . . . . . . . . . . . . 45.2 t -120.78 135.08 62.12 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.358 0 CA-C-N 115.524 -0.762 . . . . 0.0 109.644 -179.168 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' F' F ' 96' ' ' ILE . . . . . . . . . . . . . 62.0 mt -111.66 129.03 67.8 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.358 0 N-CA-C 108.789 -0.819 . . . . 0.0 108.789 178.137 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' F' F ' 97' ' ' THR . . . . . . . . . . . . . 58.1 p -103.93 157.08 17.34 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-O 121.335 0.588 . . . . 0.0 111.235 -176.77 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' F' F ' 98' ' ' GLU . . . . . . . . . . . . . 85.4 tt0 -53.93 -24.03 14.97 Favored 'General case' 0 CA--C 1.534 0.36 0 CA-C-N 115.866 -0.606 . . . . 0.0 112.314 179.581 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' F' F ' 99' ' ' GLU . . . . . . . . . . . . . 41.3 tt0 -79.74 16.69 1.06 Allowed 'General case' 0 CA--C 1.54 0.561 0 N-CA-C 112.401 0.519 . . . . 0.0 112.401 -178.354 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' F' F ' 100' ' ' ASN . . . . . . . . . . . . . 2.2 m-20 60.05 37.39 21.14 Favored 'General case' 0 CA--C 1.53 0.209 0 O-C-N 121.675 -0.64 . . . . 0.0 110.818 178.367 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' F' F ' 101' ' ' GLU . . . . . . . . . . . . . 85.1 tt0 -117.1 145.38 43.81 Favored 'General case' 0 C--N 1.332 -0.186 0 CA-C-N 116.018 -0.537 . . . . 0.0 109.876 178.075 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' F' F ' 102' ' ' VAL . . . . . . . . . . . . . 46.2 t -115.51 124.79 72.36 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.372 0 N-CA-C 109.776 -0.453 . . . . 0.0 109.776 -178.83 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' F' F ' 103' ' ' LEU . . . . . . . . . . . . . 56.3 mt -114.47 129.92 56.69 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 115.83 -0.623 . . . . 0.0 110.016 176.961 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' F' F ' 104' ' ' ILE . . . . . . . . . . . . . 68.9 mt -117.93 118.43 58.25 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.27 0 N-CA-C 109.909 -0.404 . . . . 0.0 109.909 -179.811 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' F' F ' 105' ' ' PHE . . . . . . . . . . . . . 36.0 m-85 -119.36 164.18 16.08 Favored 'General case' 0 C--N 1.332 -0.163 0 O-C-N 123.898 0.749 . . . . 0.0 109.647 179.715 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' F' F ' 106' ' ' ASN . . . . . 0.446 ' HB3' HD11 ' F' ' 112' ' ' LEU . 44.3 p-10 -100.03 -170.65 1.91 Allowed 'General case' 0 C--N 1.33 -0.259 0 N-CA-C 109.808 -0.441 . . . . 0.0 109.808 173.575 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' F' F ' 107' ' ' GLN . . . . . . . . . . . . . 27.9 tt0 -59.75 -29.88 68.47 Favored 'General case' 0 C--N 1.329 -0.29 0 N-CA-C 111.944 0.35 . . . . 0.0 111.944 179.201 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' F' F ' 108' ' ' ASN . . . . . . . . . . . . . 16.6 t-20 -81.88 6.92 14.28 Favored 'General case' 0 CA--C 1.537 0.445 0 N-CA-C 113.232 0.827 . . . . 0.0 113.232 -177.948 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' F' F ' 109' ' ' LEU . . . . . 0.688 HD21 ' HB2' ' F' ' 78' ' ' ALA . 11.1 tp 62.4 36.68 14.18 Favored 'General case' 0 C--O 1.233 0.186 0 O-C-N 122.054 -0.404 . . . . 0.0 111.436 177.248 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' F' F ' 110' ' ' GLU . . . . . . . . . . . . . 70.9 mm-40 -109.58 156.96 19.53 Favored 'General case' 0 C--N 1.331 -0.237 0 N-CA-C 110.107 -0.331 . . . . 0.0 110.107 177.127 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' F' F ' 111' ' ' GLU . . . . . . . . . . . . . 46.4 mp0 -83.69 122.03 28.07 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-O 120.941 0.401 . . . . 0.0 111.053 -178.501 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' F' F ' 112' ' ' LEU . . . . . 0.446 HD11 ' HB3' ' F' ' 106' ' ' ASN . 29.5 mt -104.87 -45.97 4.42 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 115.987 -0.552 . . . . 0.0 109.941 175.117 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' F' F ' 113' ' ' TYR . . . . . . . . . . . . . 64.5 t80 -138.6 137.42 36.93 Favored 'General case' 0 C--N 1.33 -0.239 0 CA-C-N 115.988 -0.551 . . . . 0.0 110.842 -179.7 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' F' F ' 114' ' ' ARG . . . . . . . . . . . . . 83.4 mtm180 -139.61 122.66 16.77 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.448 -0.342 . . . . 0.0 110.315 176.254 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' F' F ' 115' ' ' GLY . . . . . . . . . . . . . . . -150.05 163.0 29.36 Favored Glycine 0 CA--C 1.526 0.722 0 N-CA-C 111.211 -0.756 . . . . 0.0 111.211 -179.937 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' F' F ' 116' ' ' LYS . . . . . . . . . . . . . 8.0 ttpm? -127.47 139.76 52.6 Favored 'General case' 0 C--N 1.33 -0.248 0 N-CA-C 110.074 -0.343 . . . . 0.0 110.074 178.368 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' F' F ' 117' ' ' PHE . . . . . . . . . . . . . 51.8 m-85 -136.44 113.96 10.95 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 116.397 -0.365 . . . . 0.0 110.054 -178.679 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' F' F ' 118' ' ' GLU . . . . . . . . . . . . . 96.1 mt-10 -55.1 -42.9 73.5 Favored 'General case' 0 C--N 1.33 -0.268 0 C-N-CA 121.0 -0.28 . . . . 0.0 111.13 -176.35 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' F' F ' 119' ' ' ASN . . . . . . . . . . . . . 2.4 m120 -97.97 31.0 2.83 Favored 'General case' 0 C--N 1.33 -0.258 0 N-CA-C 112.096 0.406 . . . . 0.0 112.096 -175.107 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' F' F ' 120' ' ' LEU . . . . . . . . . . . . . 14.8 tp -57.6 119.99 7.54 Favored 'General case' 0 C--N 1.333 -0.139 0 N-CA-C 110.264 -0.273 . . . . 0.0 110.264 178.166 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' F' F ' 121' ' ' ASN . . . . . . . . . . . . . 26.5 m120 -114.0 -43.95 3.2 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-N 116.487 -0.324 . . . . 0.0 110.832 -178.376 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' F' F ' 122' ' ' LYS . . . . . . . . . . . . . 38.3 ttpt -144.76 141.5 29.27 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-O 120.87 0.367 . . . . 0.0 111.28 -176.773 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' F' F ' 123' ' ' VAL . . . . . . . . . . . . . 46.1 t -126.69 127.19 69.9 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.315 0 N-CA-C 109.21 -0.663 . . . . 0.0 109.21 173.255 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' F' F ' 124' ' ' LEU . . . . . . . . . . . . . 16.2 tp -129.08 137.67 51.4 Favored 'General case' 0 C--N 1.331 -0.225 0 CA-C-O 121.034 0.445 . . . . 0.0 111.013 -176.344 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' F' F ' 125' ' ' VAL . . . . . 0.468 HG21 HG21 ' F' ' 94' ' ' VAL . 42.3 t -125.14 131.26 72.67 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.259 0 CA-C-N 115.844 -0.616 . . . . 0.0 109.624 177.864 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' F' F ' 126' ' ' ARG . . . . . . . . . . . . . 57.9 ttt180 -147.45 126.79 13.08 Favored 'General case' 0 C--N 1.329 -0.284 0 N-CA-C 109.46 -0.571 . . . . 0.0 109.46 178.858 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' F' F ' 127' ' ' ASN . . . . . . . . . . . . . 79.7 m-20 56.49 -147.13 0.53 Allowed 'General case' 0 CA--C 1.541 0.61 0 N-CA-C 109.682 -0.488 . . . . 0.0 109.682 -178.033 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' F' F ' 128' ' ' ASP . . . . . . . . . . . . . 24.1 p-10 -87.91 18.15 4.38 Favored 'General case' 0 CA--C 1.537 0.46 0 CA-C-N 118.901 0.773 . . . . 0.0 112.605 178.639 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' F' F ' 129' ' ' LEU . . . . . . . . . . . . . 15.6 tp -113.63 137.35 51.71 Favored 'General case' 0 N--CA 1.461 0.116 0 CA-C-N 117.99 0.359 . . . . 0.0 110.315 178.65 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' F' F ' 130' ' ' VAL . . . . . . . . . . . . . 46.1 t -121.89 135.9 60.53 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.215 0 CA-C-N 116.086 -0.506 . . . . 0.0 109.732 -179.963 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' F' F ' 131' ' ' VAL . . . . . . . . . . . . . 41.4 t -134.8 136.35 52.28 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.264 0 CA-C-O 121.104 0.478 . . . . 0.0 110.697 -179.454 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' F' F ' 132' ' ' ILE . . . . . . . . . . . . . 72.2 mt -116.62 132.93 64.84 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.234 0 CA-C-N 115.667 -0.697 . . . . 0.0 109.49 178.598 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' F' F ' 133' ' ' ILE . . . . . . . . . . . . . 42.7 mm -116.83 122.01 69.02 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.242 0 CA-C-O 120.764 0.316 . . . . 0.0 110.802 -176.629 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' F' F ' 134' ' ' ASP . . . . . . . . . . . . . 7.8 p-10 -133.42 146.23 51.0 Favored 'General case' 0 C--N 1.329 -0.29 0 N-CA-C 109.297 -0.631 . . . . 0.0 109.297 174.338 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' F' F ' 135' ' ' GLU . . . . . . . . . . . . . 84.6 tt0 -50.07 -27.79 6.15 Favored 'General case' 0 C--N 1.328 -0.333 0 N-CA-C 112.645 0.609 . . . . 0.0 112.645 -174.212 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' F' F ' 136' ' ' GLN . . . . . . . . . . . . . 95.7 mt-30 -79.09 -34.65 43.39 Favored 'General case' 0 C--O 1.232 0.174 0 N-CA-C 112.35 0.5 . . . . 0.0 112.35 -176.847 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' F' F ' 137' ' ' LYS . . . . . . . . . . . . . 49.8 pttt -170.06 176.2 4.75 Favored 'General case' 0 C--N 1.331 -0.227 0 CA-C-O 121.489 0.661 . . . . 0.0 112.577 -173.143 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' F' F ' 138' ' ' LEU . . . . . . . . . . . . . 6.7 tt -119.36 130.99 55.63 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 115.107 -0.951 . . . . 0.0 110.111 179.875 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' F' F ' 139' ' ' THR . . . . . . . . . . . . . 39.7 m -111.42 129.67 55.95 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.198 -0.455 . . . . 0.0 110.359 179.412 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' F' F ' 140' ' ' LEU . . . . . 0.468 HD23 ' C ' ' F' ' 140' ' ' LEU . 8.5 tt -113.73 125.42 54.1 Favored 'General case' 0 C--N 1.328 -0.365 0 N-CA-C 109.515 -0.55 . . . . 0.0 109.515 -178.867 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' F' F ' 141' ' ' ILE . . . . . . . . . . . . . 19.0 mt -124.55 125.91 70.91 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.371 0 N-CA-C 109.873 -0.417 . . . . 0.0 109.873 -175.64 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' F' F ' 142' ' ' ARG . . . . . . . . . . . . . 23.4 tpt180 -120.37 135.42 55.03 Favored 'General case' 0 C--N 1.332 -0.193 0 CA-C-N 115.973 -0.558 . . . . 0.0 109.936 -178.458 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' F' F ' 143' ' ' THR . . . . . . . . . . . . . 23.9 p . . . . . 0 C--O 1.22 -0.49 0 CA-C-O 118.025 -0.988 . . . . 0.0 110.485 179.776 . . . . . . . . 0 0 . 1 . 006 nuclear build core ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 2.9 p . . . . . 0 C--O 1.232 0.148 0 CA-C-O 120.941 0.401 . . . . 0.0 110.677 . . . . . . . . . 0 0 . 1 . 006 nuclear build core ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 85.4 tt0 -139.71 139.97 36.7 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.092 -0.503 . . . . 0.0 110.909 -179.333 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 4' ' ' LEU . . . . . . . . . . . . . 22.1 tp -121.74 125.7 47.18 Favored 'General case' 0 C--N 1.332 -0.185 0 CA-C-N 115.781 -0.645 . . . . 0.0 110.065 178.256 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 5' ' ' LYS . . . . . . . . . . . . . 64.7 mttp -101.73 121.24 41.7 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.437 -0.347 . . . . 0.0 110.656 178.923 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 85.8 mt -116.34 145.96 42.8 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 115.622 -0.717 . . . . 0.0 110.574 -179.76 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 82.6 tttt -139.34 135.31 17.05 Favored Pre-proline 0 CA--C 1.533 0.326 0 CA-C-O 118.905 -0.569 . . . . 0.0 109.723 177.01 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 8' ' ' PRO . . . . . . . . . . . . . 96.1 Cg_endo -89.49 142.87 4.35 Favored 'Trans proline' 0 N--CA 1.491 1.333 0 C-N-CA 121.621 1.547 . . . . 0.0 111.728 177.954 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 46.3 mt -77.07 -46.44 2.77 Favored Pre-proline 0 C--N 1.329 -0.317 0 CA-C-O 118.889 -0.577 . . . . 0.0 111.644 -179.374 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 94.8 Cg_endo -82.67 144.87 12.71 Favored 'Trans proline' 0 N--CA 1.493 1.497 0 C-N-CA 121.174 1.249 . . . . 0.0 111.361 172.159 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 64.4 mttp -86.58 100.63 12.55 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-O 121.037 0.446 . . . . 0.0 110.596 178.967 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 11.6 p -137.52 145.36 29.42 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.26 0 CA-C-N 115.762 -0.654 . . . . 0.0 110.022 179.765 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 84.1 tt0 -82.13 116.42 21.69 Favored 'General case' 0 C--N 1.329 -0.299 0 N-CA-C 109.973 -0.38 . . . . 0.0 109.973 178.938 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 14' ' ' LEU . . . . . . . . . . . . . 17.9 mt -92.82 153.18 42.12 Favored Pre-proline 0 C--N 1.33 -0.25 0 CA-C-N 116.224 -0.443 . . . . 0.0 110.864 -176.387 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 15' ' ' PRO . . . . . . . . . . . . . 31.1 Cg_exo -60.22 156.58 39.46 Favored 'Trans proline' 0 N--CA 1.495 1.578 0 C-N-CA 121.314 1.343 . . . . 0.0 111.876 177.744 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 16' ' ' PRO . . . . . . . . . . . . . 38.0 Cg_exo -58.02 -38.07 93.38 Favored 'Trans proline' 0 N--CA 1.497 1.714 0 C-N-CA 121.441 1.427 . . . . 0.0 112.777 -177.681 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 17' ' ' ASP . . . . . . . . . . . . . 18.7 p-10 -89.72 10.51 23.08 Favored 'General case' 0 CA--C 1.535 0.393 0 N-CA-C 113.313 0.857 . . . . 0.0 113.313 -176.482 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 18' ' ' PHE . . . . . . . . . . . . . 44.1 t80 -58.09 -44.58 87.68 Favored 'General case' 0 C--N 1.334 -0.068 0 O-C-N 122.047 -0.408 . . . . 0.0 110.121 -177.624 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 19' ' ' VAL . . . . . . . . . . . . . 47.2 t -57.96 -44.6 87.13 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.318 0 CA-C-N 116.251 -0.431 . . . . 0.0 110.4 -178.647 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 14.7 t70 -59.52 -40.23 86.46 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-O 120.829 0.347 . . . . 0.0 110.75 -177.462 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 47.2 t -64.53 -48.61 84.27 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.304 0 CA-C-N 116.382 -0.372 . . . . 0.0 110.251 -178.514 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 22' ' ' ILE . . . . . 0.541 HG22 HD12 ' A' ' 26' ' ' LEU . 51.5 mm -55.18 -42.26 64.69 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.242 0 CA-C-O 120.833 0.349 . . . . 0.0 110.605 179.441 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 23' ' ' ARG . . . . . . . . . . . . . 54.5 ttp180 -53.89 -53.58 50.6 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.464 -0.335 . . . . 0.0 111.49 179.577 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 24' ' ' ILE . . . . . . . . . . . . . 71.9 mt -61.24 -38.76 80.52 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.335 0 CA-C-N 116.56 -0.291 . . . . 0.0 111.508 -177.18 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 59.9 mmtt -65.88 -40.94 92.07 Favored 'General case' 0 C--N 1.329 -0.311 0 N-CA-C 112.104 0.409 . . . . 0.0 112.104 179.884 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 26' ' ' LEU . . . . . 0.541 HD12 HG22 ' A' ' 22' ' ' ILE . 75.7 mt -78.41 -38.18 42.15 Favored 'General case' 0 C--N 1.33 -0.266 0 N-CA-C 113.312 0.856 . . . . 0.0 113.312 -171.205 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 27' ' ' GLN . . . . . . . . . . . . . 10.0 pt20 -46.99 140.22 5.01 Favored 'General case' 0 N--CA 1.47 0.552 0 N-CA-C 112.732 0.641 . . . . 0.0 112.732 -175.541 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 98.22 -26.08 25.09 Favored Glycine 0 CA--C 1.533 1.18 0 CA-C-N 115.58 -0.737 . . . . 0.0 112.242 -176.194 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 58.6 mtpt -98.07 155.12 17.28 Favored 'General case' 0 C--O 1.232 0.177 0 CA-C-N 117.117 0.458 . . . . 0.0 110.764 179.358 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 30' ' ' THR . . . . . . . . . . . . . 25.9 m -103.3 138.35 40.2 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.293 -0.412 . . . . 0.0 110.021 176.63 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 34.3 m -129.19 150.9 35.06 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.215 0 CA-C-O 121.066 0.46 . . . . 0.0 111.145 -178.179 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 32' ' ' ARG . . . . . . . . . . . . . 83.7 mtt180 -132.64 152.85 51.55 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 115.589 -0.732 . . . . 0.0 110.168 177.492 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 33' ' ' THR . . . . . . . . . . . . . 20.9 m -53.35 137.23 35.73 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.3 -0.409 . . . . 0.0 111.359 -177.685 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 102.06 -16.94 55.21 Favored Glycine 0 CA--C 1.532 1.122 0 CA-C-O 119.655 -0.525 . . . . 0.0 113.386 177.619 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 72.3 m-20 -64.26 148.31 50.48 Favored 'General case' 0 N--CA 1.461 0.112 0 CA-C-N 118.125 0.963 . . . . 0.0 110.987 179.494 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 44.7 t -125.83 133.23 69.54 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.19 0 CA-C-N 116.017 -0.538 . . . . 0.0 110.001 179.52 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 37' ' ' ILE . . . . . . . . . . . . . 68.6 mt -122.43 140.18 47.07 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.255 0 CA-C-N 116.081 -0.509 . . . . 0.0 109.981 179.849 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . -113.17 128.91 8.61 Favored Glycine 0 CA--C 1.527 0.815 0 N-CA-C 110.978 -0.849 . . . . 0.0 110.978 179.485 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 39' ' ' ILE . . . . . . . . . . . . . 71.9 mt -122.97 130.14 74.65 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.2 0 N-CA-C 110.091 -0.337 . . . . 0.0 110.091 179.793 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 40' ' ' SER . . . . . . . . . . . . . 35.8 t -94.58 124.79 38.82 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.483 -0.326 . . . . 0.0 111.007 175.377 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 41' ' ' ILE . . . . . . . . . . . . . 71.9 mt -133.42 123.79 47.34 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.247 0 CA-C-O 120.907 0.384 . . . . 0.0 110.567 177.183 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 10.9 tp 52.51 35.93 19.06 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 115.994 -0.548 . . . . 0.0 111.695 177.319 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . 73.23 28.38 66.31 Favored Glycine 0 CA--C 1.53 1.007 0 C-N-CA 121.169 -0.539 . . . . 0.0 112.46 176.6 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 44' ' ' LYS . . . . . . . . . . . . . 94.5 mttt -134.9 129.98 35.19 Favored 'General case' 0 C--N 1.332 -0.189 0 CA-C-N 117.044 0.422 . . . . 0.0 110.01 177.268 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 68.0 tt0 -86.96 125.78 34.29 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 116.067 -0.515 . . . . 0.0 111.371 -175.8 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 46' ' ' VAL . . . . . . . . . . . . . 7.1 p -125.17 129.77 73.16 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.19 0 CA-C-O 120.926 0.393 . . . . 0.0 110.02 175.744 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 56.5 mmtt -100.53 130.91 46.66 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 115.865 -0.607 . . . . 0.0 111.768 177.896 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 48' ' ' PHE . . . . . . . . . . . . . 93.8 m-85 -113.86 131.89 56.1 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.071 -0.513 . . . . 0.0 109.929 175.022 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 83.1 tttt -106.62 137.76 44.03 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.382 -0.372 . . . . 0.0 110.492 179.357 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 50' ' ' VAL . . . . . . . . . . . . . 44.5 t -81.3 105.98 11.86 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.297 0 N-CA-C 108.991 -0.744 . . . . 0.0 108.991 174.735 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 51' ' ' VAL . . . . . . . . . . . . . 45.6 t -69.54 -48.13 67.95 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.349 0 CA-C-N 116.05 -0.523 . . . . 0.0 110.016 -173.075 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 52' ' ' GLN . . . . . . . . . . . . . 48.0 tt0 -167.89 139.9 3.04 Favored 'General case' 0 C--N 1.328 -0.348 0 C-N-CA 120.362 -0.535 . . . . 0.0 111.651 -177.816 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 53' ' ' ALA . . . . . 0.484 ' HB3' ' OG ' ' A' ' 56' ' ' SER . . . -110.47 131.93 54.62 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 115.839 -0.619 . . . . 0.0 109.882 174.776 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 54' ' ' TYR . . . . . . . . . . . . . 40.7 t80 -129.07 110.66 18.28 Favored Pre-proline 0 CA--C 1.535 0.381 0 CA-C-O 118.292 -0.861 . . . . 0.0 110.546 179.769 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 55' ' ' PRO . . . . . . . . . . . . . 71.7 Cg_endo -77.22 166.96 80.91 Favored 'Cis proline' 0 N--CA 1.5 1.866 0 CA-C-N 121.874 1.705 . . . . 0.0 111.978 -7.102 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 56' ' ' SER . . . . . 0.484 ' OG ' ' HB3' ' A' ' 53' ' ' ALA . 51.3 m -118.02 141.97 30.18 Favored Pre-proline 0 CA--C 1.538 0.519 0 CA-C-O 118.699 -0.667 . . . . 0.0 109.596 174.132 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 57' ' ' PRO . . . . . . . . . . . . . 43.9 Cg_endo -68.96 142.87 70.55 Favored 'Cis proline' 0 N--CA 1.499 1.807 0 CA-C-N 121.484 1.566 . . . . 0.0 111.205 -3.006 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 58' ' ' LEU . . . . . . . . . . . . . 29.7 tp -107.75 136.05 48.14 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-O 120.729 0.3 . . . . 0.0 110.877 -177.849 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 59' ' ' ARG . . . . . . . . . . . . . 66.5 ttt180 -101.79 122.2 43.51 Favored 'General case' 0 C--N 1.326 -0.426 0 N-CA-C 109.099 -0.704 . . . . 0.0 109.099 175.919 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 43.9 t -76.18 120.88 27.03 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.263 0 C-N-CA 120.68 -0.408 . . . . 0.0 110.639 -173.964 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 43.7 mt-10 -131.04 165.38 23.34 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 115.954 -0.566 . . . . 0.0 109.838 175.181 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 62' ' ' ASP . . . . . . . . . . . . . 9.5 p-10 -55.51 -32.55 62.97 Favored 'General case' 0 C--N 1.329 -0.311 0 N-CA-C 111.89 0.33 . . . . 0.0 111.89 -177.289 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 63' ' ' ARG . . . . . . . . . . . . . 24.3 ptt180 -79.76 -4.4 51.79 Favored 'General case' 0 CA--C 1.536 0.441 0 N-CA-C 113.753 1.02 . . . . 0.0 113.753 -174.945 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 24.6 m -75.08 136.07 41.18 Favored 'General case' 0 C--N 1.333 -0.118 0 CA-C-N 118.118 0.417 . . . . 0.0 110.453 -177.943 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 65' ' ' LYS . . . . . . . . . . . . . 3.0 mptp? -88.35 128.12 35.5 Favored 'General case' 0 C--N 1.328 -0.329 0 N-CA-C 109.689 -0.486 . . . . 0.0 109.689 -179.86 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 66' ' ' ILE . . . . . . . . . . . . . 59.2 mt -112.03 131.96 62.01 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.244 0 N-CA-C 109.807 -0.442 . . . . 0.0 109.807 -179.223 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 67' ' ' THR . . . . . . . . . . . . . 27.5 m -123.95 137.15 54.66 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.138 -0.483 . . . . 0.0 110.744 -179.142 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 68' ' ' LEU . . . . . . . . . . . . . 3.6 tt . . . . . 0 C--N 1.329 -0.302 0 N-CA-C 109.37 -0.604 . . . . 0.0 109.37 178.072 . . . . . . . . 0 0 . 1 . 006 nuclear build core ' A' A ' 74' ' ' ASP . . . . . . . . . . . . . 40.5 t0 . . . . . 0 N--CA 1.46 0.036 0 N-CA-C 110.11 -0.33 . . . . 0.0 110.11 . . . . . . . . . 0 0 . 1 . 006 nuclear build core ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 44.8 t -112.52 121.64 65.24 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.211 0 CA-C-O 121.081 0.467 . . . . 0.0 110.259 179.961 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 76' ' ' LEU . . . . . . . . . . . . . 35.1 mt -125.42 140.59 52.66 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 115.571 -0.74 . . . . 0.0 109.539 179.381 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 77' ' ' GLU . . . . . . . . . . . . . 96.8 mt-10 -133.94 143.96 48.52 Favored 'General case' 0 C--N 1.332 -0.185 0 CA-C-O 121.153 0.501 . . . . 0.0 111.622 -177.166 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 78' ' ' ALA . . . . . . . . . . . . . . . -130.62 133.64 46.32 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 115.435 -0.802 . . . . 0.0 109.886 175.574 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 79' ' ' LYS . . . . . 0.564 ' O ' HD13 ' A' ' 80' ' ' ILE . 36.6 ttpt -82.26 117.83 22.66 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.358 -0.383 . . . . 0.0 110.634 -178.019 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 80' ' ' ILE . . . . . 0.564 HD13 ' O ' ' A' ' 79' ' ' LYS . 42.7 mm -139.06 113.07 7.1 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.285 0 N-CA-C 109.156 -0.683 . . . . 0.0 109.156 -178.142 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 81' ' ' LYS . . . . . . . . . . . . . 6.3 mtmp? -100.5 124.69 46.37 Favored 'General case' 0 C--N 1.327 -0.409 0 CA-C-O 120.913 0.387 . . . . 0.0 111.116 -176.637 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . 89.25 42.05 5.66 Favored Glycine 0 CA--C 1.525 0.691 0 C-N-CA 120.961 -0.638 . . . . 0.0 111.642 176.259 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 83' ' ' ILE . . . . . . . . . . . . . 74.9 mt -68.06 132.58 32.6 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.309 0 N-CA-C 109.575 -0.528 . . . . 0.0 109.575 176.694 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 84' ' ' LYS . . . . . . . . . . . . . 39.6 ttpt -95.05 -53.41 3.82 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-O 120.986 0.422 . . . . 0.0 110.365 -177.96 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 85' ' ' ASP . . . . . . . . . . . . . 7.9 t70 -149.69 151.87 34.39 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 115.944 -0.571 . . . . 0.0 110.696 -179.131 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 86' ' ' VAL . . . . . . . . . . . . . 44.1 t -130.67 131.65 64.66 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.267 0 CA-C-N 116.339 -0.392 . . . . 0.0 110.305 179.444 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 87' ' ' ILE . . . . . 0.499 HD12 ' N ' ' A' ' 87' ' ' ILE . 5.1 mp -118.47 126.1 74.86 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.273 0 N-CA-C 109.564 -0.532 . . . . 0.0 109.564 177.027 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 88' ' ' LEU . . . . . . . . . . . . . 15.7 tp -109.79 130.41 55.52 Favored 'General case' 0 C--N 1.332 -0.191 0 CA-C-N 116.34 -0.391 . . . . 0.0 110.687 -178.534 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 89' ' ' ASP . . . . . . . . . . . . . 9.8 t70 -125.88 156.94 38.86 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 116.107 -0.497 . . . . 0.0 109.964 179.091 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 84.8 tt0 -46.48 -38.24 8.94 Favored 'General case' 0 C--N 1.33 -0.248 0 N-CA-C 113.088 0.773 . . . . 0.0 113.088 -172.068 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 91' ' ' ASN . . . . . . . . . . . . . 2.7 t-20 -132.06 20.99 4.49 Favored 'General case' 0 N--CA 1.47 0.532 0 N-CA-C 112.925 0.713 . . . . 0.0 112.925 -177.518 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 92' ' ' LEU . . . . . . . . . . . . . 28.4 mt -149.55 147.71 28.5 Favored 'General case' 0 C--N 1.331 -0.225 0 CA-C-O 120.78 0.324 . . . . 0.0 110.617 -175.938 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 93' ' ' ILE . . . . . . . . . . . . . 70.1 mt -126.22 119.47 54.21 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.264 0 N-CA-C 109.197 -0.668 . . . . 0.0 109.197 176.538 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 94' ' ' VAL . . . . . . . . . . . . . 44.1 t -120.11 127.77 75.91 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.253 0 N-CA-C 109.957 -0.386 . . . . 0.0 109.957 -179.275 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 95' ' ' VAL . . . . . . . . . . . . . 45.9 t -123.32 134.58 65.86 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.208 0 CA-C-N 116.082 -0.508 . . . . 0.0 109.939 -179.433 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 96' ' ' ILE . . . . . . . . . . . . . 63.4 mt -116.86 128.03 74.34 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.284 0 N-CA-C 109.434 -0.58 . . . . 0.0 109.434 -179.726 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 97' ' ' THR . . . . . . . . . . . . . 75.3 p -100.36 155.57 17.73 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-O 121.214 0.531 . . . . 0.0 111.286 -177.501 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 98' ' ' GLU . . . . . . . . . . . . . 84.9 tt0 -53.94 -25.84 22.48 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-N 115.954 -0.566 . . . . 0.0 112.34 179.851 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 99' ' ' GLU . . . . . . . . . . . . . 34.4 tt0 -80.41 17.95 0.99 Allowed 'General case' 0 CA--C 1.54 0.594 0 N-CA-C 112.553 0.575 . . . . 0.0 112.553 -177.164 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 100' ' ' ASN . . . . . . . . . . . . . 3.5 m-20 63.11 36.44 12.2 Favored 'General case' 0 CA--C 1.53 0.174 0 O-C-N 121.931 -0.481 . . . . 0.0 111.221 176.077 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 101' ' ' GLU . . . . . . . . . . . . . 84.8 tt0 -116.72 142.88 46.33 Favored 'General case' 0 C--N 1.332 -0.189 0 CA-C-N 116.318 -0.401 . . . . 0.0 109.942 175.788 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 102' ' ' VAL . . . . . . . . . . . . . 45.0 t -117.11 126.55 74.53 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.262 0 CA-C-N 116.193 -0.458 . . . . 0.0 109.947 -178.06 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 103' ' ' LEU . . . . . 0.407 HD12 ' N ' ' A' ' 103' ' ' LEU . 6.3 mp -118.43 133.73 55.64 Favored 'General case' 0 C--N 1.331 -0.227 0 CA-C-N 116.045 -0.525 . . . . 0.0 110.283 176.759 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 104' ' ' ILE . . . . . . . . . . . . . 70.4 mt -121.27 122.6 67.82 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.235 0 CA-C-N 116.542 -0.299 . . . . 0.0 110.21 -179.045 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 105' ' ' PHE . . . . . . . . . . . . . 39.0 m-85 -123.41 164.52 18.72 Favored 'General case' 0 C--N 1.332 -0.173 0 O-C-N 123.839 0.712 . . . . 0.0 109.809 179.754 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 106' ' ' ASN . . . . . . . . . . . . . 41.7 p-10 -97.55 -169.9 1.92 Allowed 'General case' 0 C--N 1.33 -0.254 0 N-CA-C 109.989 -0.374 . . . . 0.0 109.989 174.315 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 107' ' ' GLN . . . . . . . . . . . . . 27.5 tt0 -60.2 -27.29 67.04 Favored 'General case' 0 CA--C 1.533 0.308 0 N-CA-C 112.002 0.371 . . . . 0.0 112.002 177.925 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 108' ' ' ASN . . . . . . . . . . . . . 10.2 t-20 -81.87 4.21 23.23 Favored 'General case' 0 CA--C 1.536 0.419 0 N-CA-C 113.232 0.827 . . . . 0.0 113.232 -178.95 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 109' ' ' LEU . . . . . . . . . . . . . 12.5 tp 61.03 38.26 17.38 Favored 'General case' 0 C--O 1.234 0.26 0 CA-C-O 120.973 0.415 . . . . 0.0 111.072 179.109 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 110' ' ' GLU . . . . . . . . . . . . . 95.2 mt-10 -111.16 149.89 30.26 Favored 'General case' 0 C--N 1.332 -0.189 0 CA-C-N 116.539 -0.3 . . . . 0.0 110.332 177.086 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 111' ' ' GLU . . . . . . . . . . . . . 98.4 mt-10 -73.12 125.04 26.78 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-O 120.977 0.418 . . . . 0.0 111.48 -178.823 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 112' ' ' LEU . . . . . . . . . . . . . 21.7 mt -109.95 -45.95 3.55 Favored 'General case' 0 C--N 1.331 -0.221 0 CA-C-N 115.819 -0.628 . . . . 0.0 109.917 174.669 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 113' ' ' TYR . . . . . . . . . . . . . 63.7 t80 -141.55 142.55 33.52 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 115.877 -0.601 . . . . 0.0 110.608 178.782 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 114' ' ' ARG . . . . . . . . . . . . . 33.8 ptt-85 -149.14 124.07 9.99 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-O 121.059 0.457 . . . . 0.0 110.789 177.325 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 115' ' ' GLY . . . . . . . . . . . . . . . -150.11 163.03 29.38 Favored Glycine 0 CA--C 1.524 0.636 0 N-CA-C 110.964 -0.854 . . . . 0.0 110.964 -179.12 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 116' ' ' LYS . . . . . . . . . . . . . 34.5 ttmt -130.07 134.98 47.74 Favored 'General case' 0 C--N 1.33 -0.244 0 N-CA-C 110.088 -0.338 . . . . 0.0 110.088 177.928 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 117' ' ' PHE . . . . . 0.425 ' HE2' HD13 ' A' ' 132' ' ' ILE . 33.4 m-85 -130.93 117.39 19.17 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.403 -0.362 . . . . 0.0 110.297 -175.711 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 118' ' ' GLU . . . . . . . . . . . . . 48.9 mp0 -56.08 -43.37 77.95 Favored 'General case' 0 C--N 1.328 -0.352 0 C-N-CA 120.759 -0.376 . . . . 0.0 111.104 -175.025 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 119' ' ' ASN . . . . . . . . . . . . . 71.1 m-80 -100.26 31.08 3.52 Favored 'General case' 0 C--N 1.329 -0.299 0 N-CA-C 112.259 0.466 . . . . 0.0 112.259 -172.737 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 120' ' ' LEU . . . . . . . . . . . . . 11.1 tp -55.82 120.76 7.86 Favored 'General case' 0 C--O 1.232 0.138 0 C-N-CA 121.078 -0.249 . . . . 0.0 110.491 177.199 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 121' ' ' ASN . . . . . . . . . . . . . 33.1 m120 -114.02 -44.06 3.19 Favored 'General case' 0 N--CA 1.463 0.205 0 CA-C-N 116.654 -0.248 . . . . 0.0 111.035 -176.793 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 122' ' ' LYS . . . . . . . . . . . . . 89.0 mttt -143.58 144.89 32.12 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-O 120.942 0.401 . . . . 0.0 111.352 -177.628 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 123' ' ' VAL . . . . . . . . . . . . . 45.7 t -130.53 131.17 65.18 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.27 0 N-CA-C 109.387 -0.597 . . . . 0.0 109.387 175.27 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 124' ' ' LEU . . . . . . . . . . . . . 10.1 tp -131.43 136.27 47.84 Favored 'General case' 0 C--N 1.331 -0.199 0 CA-C-O 120.824 0.345 . . . . 0.0 111.151 -176.857 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 125' ' ' VAL . . . . . . . . . . . . . 45.0 t -127.58 129.96 70.38 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.232 0 CA-C-N 116.059 -0.519 . . . . 0.0 109.751 177.061 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 126' ' ' ARG . . . . . . . . . . . . . 63.0 ttm-85 -141.63 124.73 16.32 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-O 120.944 0.402 . . . . 0.0 110.603 179.851 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 127' ' ' ASN . . . . . . . . . . . . . 23.1 m120 50.58 -109.79 0.42 Allowed 'General case' 0 CA--C 1.545 0.754 0 CA-C-O 118.832 -0.604 . . . . 0.0 111.293 179.738 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 128' ' ' ASP . . . . . . . . . . . . . 9.9 p-10 -114.08 8.67 17.09 Favored 'General case' 0 N--CA 1.469 0.516 0 CA-C-N 119.875 1.216 . . . . 0.0 113.158 -179.124 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 129' ' ' LEU . . . . . . . . . . . . . 18.1 tp -107.75 134.99 49.92 Favored 'General case' 0 C--N 1.332 -0.166 0 CA-C-N 117.956 0.344 . . . . 0.0 110.123 179.643 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 130' ' ' VAL . . . . . . . . . . . . . 44.0 t -116.69 132.69 65.64 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.253 0 N-CA-C 109.583 -0.525 . . . . 0.0 109.583 179.617 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 131' ' ' VAL . . . . . . . . . . . . . 40.7 t -132.89 133.99 58.55 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.253 0 CA-C-O 121.034 0.445 . . . . 0.0 110.474 -179.258 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 132' ' ' ILE . . . . . 0.425 HD13 ' HE2' ' A' ' 117' ' ' PHE . 74.6 mt -118.45 130.66 72.99 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 CA-C-N 115.72 -0.673 . . . . 0.0 109.204 177.718 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 133' ' ' ILE . . . . . . . . . . . . . 40.0 mm -116.68 123.39 71.6 Favored 'Isoleucine or valine' 0 C--O 1.234 0.262 0 CA-C-O 120.933 0.397 . . . . 0.0 111.071 -174.228 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 134' ' ' ASP . . . . . . . . . . . . . 6.8 p-10 -136.45 146.33 46.23 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-N 116.006 -0.543 . . . . 0.0 109.557 175.227 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 135' ' ' GLU . . . . . . . . . . . . . 38.9 tp10 -50.32 -27.94 7.04 Favored 'General case' 0 C--N 1.328 -0.36 0 N-CA-C 112.598 0.592 . . . . 0.0 112.598 -173.592 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 136' ' ' GLN . . . . . . . . . . . . . 97.8 mt-30 -76.04 -37.23 58.59 Favored 'General case' 0 C--O 1.234 0.246 0 N-CA-C 112.34 0.496 . . . . 0.0 112.34 -177.903 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 137' ' ' LYS . . . . . . . . . . . . . 47.5 pttt -168.02 175.0 6.93 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-O 121.607 0.718 . . . . 0.0 112.19 -171.593 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 138' ' ' LEU . . . . . 0.412 ' C ' HD23 ' A' ' 138' ' ' LEU . 6.3 tt -118.94 128.57 54.54 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 115.13 -0.941 . . . . 0.0 110.039 179.247 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 139' ' ' THR . . . . . 0.403 ' N ' HD23 ' A' ' 138' ' ' LEU . 31.5 m -108.03 126.02 52.24 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.285 -0.416 . . . . 0.0 110.291 179.885 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 140' ' ' LEU . . . . . . . . . . . . . 36.5 tp -113.04 122.95 49.13 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 115.722 -0.672 . . . . 0.0 109.305 -179.364 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 141' ' ' ILE . . . . . . . . . . . . . 19.0 mt -121.84 119.82 59.81 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 CA-C-O 120.955 0.407 . . . . 0.0 110.052 -174.411 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 142' ' ' ARG . . . . . . . . . . . . . 54.8 mtp180 -105.09 123.22 47.44 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 115.583 -0.735 . . . . 0.0 110.165 178.856 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 143' ' ' THR . . . . . . . . . . . . . 31.8 p . . . . . 0 C--O 1.221 -0.446 0 CA-C-O 117.98 -1.01 . . . . 0.0 110.515 -179.672 . . . . . . . . 0 0 . 1 . 006 nuclear build core ' B' B ' 2' ' ' SER . . . . . . . . . . . . . 13.5 p . . . . . 0 C--O 1.233 0.197 0 CA-C-O 120.923 0.392 . . . . 0.0 110.9 . . . . . . . . . 0 0 . 1 . 006 nuclear build core ' B' B ' 3' ' ' GLU . . . . . . . . . . . . . 46.9 mp0 -140.65 147.37 39.21 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.181 -0.463 . . . . 0.0 111.33 -178.746 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B ' 4' ' ' LEU . . . . . . . . . . . . . 17.8 tp -127.02 127.71 45.19 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 115.702 -0.681 . . . . 0.0 109.947 174.718 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B ' 5' ' ' LYS . . . . . . . . . . . . . 92.5 mttt -109.51 121.23 44.72 Favored 'General case' 0 C--O 1.234 0.27 0 CA-C-O 120.815 0.34 . . . . 0.0 110.855 178.919 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B ' 6' ' ' LEU . . . . . . . . . . . . . 58.1 mt -115.08 147.24 40.44 Favored 'General case' 0 C--N 1.331 -0.211 0 CA-C-N 115.375 -0.83 . . . . 0.0 110.716 -179.097 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B ' 7' ' ' LYS . . . . . . . . . . . . . 69.5 tttt -134.89 138.02 28.63 Favored Pre-proline 0 CA--C 1.534 0.355 0 CA-C-O 118.955 -0.545 . . . . 0.0 109.989 175.78 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B ' 8' ' ' PRO . . . . . . . . . . . . . 75.1 Cg_endo -90.06 139.67 3.16 Favored 'Trans proline' 0 N--CA 1.489 1.249 0 C-N-CA 121.7 1.6 . . . . 0.0 111.574 178.213 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B ' 9' ' ' LEU . . . . . . . . . . . . . 26.8 mt -77.27 -51.91 1.91 Allowed Pre-proline 0 CA--C 1.531 0.239 0 CA-C-O 119.138 -0.458 . . . . 0.0 111.313 -177.488 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B ' 10' ' ' PRO . . . . . . . . . . . . . 71.7 Cg_endo -76.56 149.86 31.03 Favored 'Trans proline' 0 N--CA 1.497 1.682 0 C-N-CA 121.156 1.238 . . . . 0.0 111.399 170.671 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B ' 11' ' ' LYS . . . . . . . . . . . . . 25.1 pttm -84.91 117.02 23.66 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-O 121.45 0.643 . . . . 0.0 110.61 178.254 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B ' 12' ' ' VAL . . . . . . . . . . . . . 12.8 p -151.06 148.04 15.2 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 CA-C-N 115.653 -0.703 . . . . 0.0 110.493 -179.44 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B ' 13' ' ' GLU . . . . . . . . . . . . . 84.7 tt0 -91.03 125.5 35.84 Favored 'General case' 0 C--N 1.329 -0.321 0 N-CA-C 110.034 -0.358 . . . . 0.0 110.034 177.827 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B ' 14' ' ' LEU . . . . . . . . . . . . . 28.2 mt -97.87 149.86 36.17 Favored Pre-proline 0 CA--C 1.533 0.291 0 CA-C-N 116.357 -0.383 . . . . 0.0 110.718 -176.583 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B ' 15' ' ' PRO . . . . . . . . . . . . . 24.0 Cg_exo -63.69 161.28 32.75 Favored 'Trans proline' 0 N--CA 1.497 1.689 0 C-N-CA 121.402 1.401 . . . . 0.0 111.866 175.648 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B ' 16' ' ' PRO . . . . . . . . . . . . . 27.4 Cg_exo -60.35 -35.64 90.42 Favored 'Trans proline' 0 N--CA 1.498 1.745 0 C-N-CA 121.451 1.434 . . . . 0.0 112.789 -178.535 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B ' 17' ' ' ASP . . . . . . . . . . . . . 9.4 p-10 -89.13 8.07 31.85 Favored 'General case' 0 CA--C 1.536 0.426 0 N-CA-C 113.245 0.831 . . . . 0.0 113.245 -177.428 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B ' 18' ' ' PHE . . . . . . . . . . . . . 47.5 t80 -58.27 -44.97 88.67 Favored 'General case' 0 C--N 1.334 -0.108 0 O-C-N 122.041 -0.412 . . . . 0.0 110.031 -178.017 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B ' 19' ' ' VAL . . . . . 0.407 HG13 ' N ' ' B' ' 20' ' ' ASP . 13.8 p -55.66 -41.27 64.19 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.36 0 CA-C-N 116.283 -0.417 . . . . 0.0 111.058 -178.984 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' B' B ' 20' ' ' ASP . . . . . 0.407 ' N ' HG13 ' B' ' 19' ' ' VAL . 75.6 m-20 -60.9 -43.49 98.44 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-O 120.951 0.405 . . . . 0.0 110.888 -178.154 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' B' B ' 21' ' ' VAL . . . . . . . . . . . . . 47.4 t -65.07 -46.39 91.46 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.281 0 CA-C-N 116.331 -0.395 . . . . 0.0 110.555 -177.556 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B ' 22' ' ' ILE . . . . . 0.626 HG22 HD12 ' B' ' 26' ' ' LEU . 50.9 mm -55.15 -46.52 77.68 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.259 0 CA-C-O 120.817 0.341 . . . . 0.0 110.645 179.483 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' B' B ' 23' ' ' ARG . . . . . . . . . . . . . 26.8 ttm-85 -53.65 -54.08 42.87 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-O 121.16 0.505 . . . . 0.0 111.385 -179.727 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B ' 24' ' ' ILE . . . . . . . . . . . . . 77.3 mt -60.66 -36.72 72.47 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.373 0 CA-C-N 115.61 -0.723 . . . . 0.0 111.581 -173.675 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B ' 25' ' ' LYS . . . . . . . . . . . . . 57.5 mttm -70.71 -42.86 70.07 Favored 'General case' 0 C--N 1.33 -0.281 0 N-CA-C 112.551 0.574 . . . . 0.0 112.551 179.781 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B ' 26' ' ' LEU . . . . . 0.626 HD12 HG22 ' B' ' 22' ' ' ILE . 34.3 mt -77.75 -35.84 51.34 Favored 'General case' 0 C--N 1.331 -0.23 0 N-CA-C 113.15 0.796 . . . . 0.0 113.15 -170.748 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' B' B ' 27' ' ' GLN . . . . . . . . . . . . . 18.4 pt20 -46.97 140.91 4.44 Favored 'General case' 0 N--CA 1.468 0.462 0 N-CA-C 112.747 0.647 . . . . 0.0 112.747 -175.808 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B ' 28' ' ' GLY . . . . . . . . . . . . . . . 99.96 -24.79 30.76 Favored Glycine 0 CA--C 1.534 1.223 0 CA-C-N 115.624 -0.716 . . . . 0.0 112.261 -176.733 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B ' 29' ' ' LYS . . . . . . . . . . . . . 47.2 mtmt -98.24 155.15 17.32 Favored 'General case' 0 C--N 1.332 -0.187 0 CA-C-N 117.339 0.57 . . . . 0.0 111.269 179.64 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B ' 30' ' ' THR . . . . . . . . . . . . . 38.9 m -107.19 138.48 43.3 Favored 'General case' 0 C--N 1.331 -0.209 0 CA-C-N 115.914 -0.585 . . . . 0.0 109.901 176.62 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B ' 31' ' ' VAL . . . . . . . . . . . . . 34.1 m -131.72 155.89 42.09 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.206 0 CA-C-O 120.99 0.424 . . . . 0.0 111.551 -176.866 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B ' 32' ' ' ARG . . . . . . . . . . . . . 36.3 mtp180 -129.28 152.69 48.57 Favored 'General case' 0 C--O 1.233 0.236 0 CA-C-N 115.667 -0.697 . . . . 0.0 110.688 176.802 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B ' 33' ' ' THR . . . . . . . . . . . . . 24.6 m -53.57 139.71 30.77 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.203 -0.453 . . . . 0.0 111.253 -179.075 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B ' 34' ' ' GLY . . . . . . . . . . . . . . . 99.43 -17.13 58.18 Favored Glycine 0 CA--C 1.532 1.109 0 CA-C-O 119.486 -0.619 . . . . 0.0 113.304 177.69 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B ' 35' ' ' ASP . . . . . . . . . . . . . 76.1 m-20 -65.09 148.25 52.0 Favored 'General case' 0 C--O 1.232 0.178 0 CA-C-N 118.116 0.958 . . . . 0.0 110.97 179.346 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B ' 36' ' ' VAL . . . . . . . . . . . . . 45.7 t -122.52 131.52 73.05 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.241 0 CA-C-N 115.969 -0.559 . . . . 0.0 109.85 178.58 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B ' 37' ' ' ILE . . . . . . . . . . . . . 66.7 mt -118.68 138.52 49.12 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 CA-C-N 116.128 -0.487 . . . . 0.0 109.89 -179.462 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B ' 38' ' ' GLY . . . . . . . . . . . . . . . -109.83 128.69 9.02 Favored Glycine 0 CA--C 1.526 0.757 0 N-CA-C 110.871 -0.892 . . . . 0.0 110.871 179.5 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B ' 39' ' ' ILE . . . . . . . . . . . . . 71.7 mt -124.62 131.46 72.67 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.246 0 N-CA-C 110.047 -0.353 . . . . 0.0 110.047 179.437 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B ' 40' ' ' SER . . . . . . . . . . . . . 31.5 t -92.86 119.99 32.75 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.332 -0.395 . . . . 0.0 110.675 175.819 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B ' 41' ' ' ILE . . . . . . . . . . . . . 70.4 mt -131.54 119.99 44.23 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.202 0 N-CA-C 110.223 -0.288 . . . . 0.0 110.223 178.418 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B ' 42' ' ' LEU . . . . . . . . . . . . . 30.1 mt 56.87 33.83 23.8 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.227 -0.442 . . . . 0.0 111.84 178.729 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B ' 43' ' ' GLY . . . . . . . . . . . . . . . 81.05 -10.13 49.78 Favored Glycine 0 CA--C 1.535 1.302 0 C-N-CA 121.24 -0.505 . . . . 0.0 113.584 176.482 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B ' 44' ' ' LYS . . . . . . . . . . . . . 93.4 mttt -100.03 134.43 42.96 Favored 'General case' 0 C--N 1.333 -0.126 0 CA-C-N 117.821 0.81 . . . . 0.0 110.188 177.563 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B ' 45' ' ' GLU . . . . . . . . . . . . . 85.0 tt0 -85.71 130.5 34.55 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 116.213 -0.449 . . . . 0.0 111.217 -179.815 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B ' 46' ' ' VAL . . . . . . . . . . . . . 7.3 p -124.46 129.85 73.73 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.211 0 N-CA-C 109.605 -0.517 . . . . 0.0 109.605 175.714 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B ' 47' ' ' LYS . . . . . . . . . . . . . 79.9 mttt -101.08 130.75 47.16 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.006 -0.543 . . . . 0.0 111.171 177.674 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B ' 48' ' ' PHE . . . . . . . . . . . . . 93.5 m-85 -112.46 132.0 55.28 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 116.478 -0.328 . . . . 0.0 110.131 176.102 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B ' 49' ' ' LYS . . . . . . . . . . . . . 68.5 tttt -106.04 135.54 47.3 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.352 -0.386 . . . . 0.0 110.398 179.123 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B ' 50' ' ' VAL . . . . . . . . . . . . . 43.4 t -81.96 110.18 16.92 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.243 0 N-CA-C 109.435 -0.58 . . . . 0.0 109.435 177.001 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B ' 51' ' ' VAL . . . . . . . . . . . . . 47.5 t -75.53 -47.04 35.63 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.295 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.092 -173.964 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B ' 52' ' ' GLN . . . . . . . . . . . . . 62.8 tt0 -160.83 137.26 8.57 Favored 'General case' 0 C--N 1.332 -0.186 0 C-N-CA 120.165 -0.614 . . . . 0.0 112.193 -177.917 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B ' 53' ' ' ALA . . . . . . . . . . . . . . . -112.51 130.35 56.03 Favored 'General case' 0 C--N 1.331 -0.211 0 CA-C-N 115.741 -0.663 . . . . 0.0 109.312 172.295 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B ' 54' ' ' TYR . . . . . . . . . . . . . 47.4 t80 -129.05 110.22 18.26 Favored Pre-proline 0 C--N 1.328 -0.341 0 CA-C-O 118.22 -0.895 . . . . 0.0 110.689 -178.342 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B ' 55' ' ' PRO . . . . . . . . . . . . . 72.8 Cg_endo -77.31 170.11 72.23 Favored 'Cis proline' 0 N--CA 1.5 1.909 0 CA-C-N 121.949 1.732 . . . . 0.0 112.22 -6.177 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B ' 56' ' ' SER . . . . . . . . . . . . . 13.7 m -116.24 135.88 22.91 Favored Pre-proline 0 CA--C 1.539 0.536 0 CA-C-O 118.491 -0.766 . . . . 0.0 109.329 175.143 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B ' 57' ' ' PRO . . . . . . . . . . . . . 53.1 Cg_endo -70.34 145.57 81.06 Favored 'Cis proline' 0 N--CA 1.498 1.755 0 CA-C-N 121.795 1.677 . . . . 0.0 111.452 -1.546 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B ' 58' ' ' LEU . . . . . . . . . . . . . 29.2 tp -108.34 138.3 44.85 Favored 'General case' 0 C--N 1.331 -0.225 0 CA-C-N 116.271 -0.422 . . . . 0.0 110.866 -177.865 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B ' 59' ' ' ARG . . . . . . . . . . . . . 55.7 ttt180 -103.52 127.05 50.99 Favored 'General case' 0 C--N 1.328 -0.333 0 N-CA-C 109.341 -0.614 . . . . 0.0 109.341 174.543 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B ' 60' ' ' VAL . . . . . . . . . . . . . 42.2 t -82.2 117.27 27.88 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.285 0 C-N-CA 120.74 -0.384 . . . . 0.0 110.327 -176.486 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B ' 61' ' ' GLU . . . . . . . . . . . . . 77.5 tt0 -131.2 156.83 44.68 Favored 'General case' 0 C--N 1.329 -0.302 0 N-CA-C 109.12 -0.696 . . . . 0.0 109.12 176.158 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B ' 62' ' ' ASP . . . . . . . . . . . . . 5.6 t70 -50.11 -30.99 12.24 Favored 'General case' 0 C--N 1.328 -0.363 0 N-CA-C 112.223 0.453 . . . . 0.0 112.223 -178.987 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B ' 63' ' ' ARG . . . . . . . . . . . . . 20.5 mtp-105 -72.12 -22.08 61.38 Favored 'General case' 0 CA--C 1.533 0.311 0 N-CA-C 113.063 0.764 . . . . 0.0 113.063 -176.398 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B ' 64' ' ' THR . . . . . . . . . . . . . 27.1 m -69.55 144.05 53.21 Favored 'General case' 0 C--N 1.331 -0.209 0 CA-C-O 120.92 0.39 . . . . 0.0 111.122 -174.989 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B ' 65' ' ' LYS . . . . . . . . . . . . . 85.1 mttt -89.18 130.08 35.66 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.062 -0.517 . . . . 0.0 110.126 178.739 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B ' 66' ' ' ILE . . . . . . . . . . . . . 67.6 mt -115.53 131.94 66.4 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.223 0 N-CA-C 109.886 -0.413 . . . . 0.0 109.886 -179.762 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B ' 67' ' ' THR . . . . . . . . . . . . . 32.7 m -127.54 140.44 52.13 Favored 'General case' 0 C--N 1.331 -0.225 0 CA-C-O 121.232 0.539 . . . . 0.0 110.999 -178.235 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B ' 68' ' ' LEU . . . . . . . . . . . . . 41.5 mt . . . . . 0 C--N 1.33 -0.276 0 CA-C-N 115.768 -0.651 . . . . 0.0 109.978 177.349 . . . . . . . . 0 0 . 1 . 006 nuclear build core ' B' B ' 73' ' ' VAL . . . . . . . . . . . . . 27.7 m . . . . . 0 C--O 1.231 0.098 0 CA-C-O 120.874 0.368 . . . . 0.0 110.488 . . . . . . . . . 0 0 . 1 . 006 nuclear build core ' B' B ' 74' ' ' ASP . . . . . . . . . . . . . 31.9 t0 -102.88 116.96 33.57 Favored 'General case' 0 C--N 1.33 -0.27 0 N-CA-C 109.467 -0.568 . . . . 0.0 109.467 176.867 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B ' 75' ' ' VAL . . . . . 0.492 ' C ' HD12 ' B' ' 76' ' ' LEU . 42.1 t -114.04 124.41 70.67 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.26 0 CA-C-O 121.057 0.456 . . . . 0.0 110.704 -176.148 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' B' B ' 76' ' ' LEU . . . . . 0.492 HD12 ' C ' ' B' ' 75' ' ' VAL . 7.3 mp -122.39 144.25 49.15 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 115.71 -0.677 . . . . 0.0 109.841 175.864 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' B' B ' 77' ' ' GLU . . . . . . . . . . . . . 97.7 mt-10 -134.6 130.28 36.24 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-O 121.07 0.462 . . . . 0.0 110.837 -178.887 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B ' 78' ' ' ALA . . . . . 0.646 ' HB2' HD21 ' B' ' 109' ' ' LEU . . . -117.68 128.24 54.72 Favored 'General case' 0 C--N 1.331 -0.221 0 CA-C-N 115.8 -0.636 . . . . 0.0 109.938 177.966 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' B' B ' 79' ' ' LYS . . . . . 0.648 ' O ' HD13 ' B' ' 80' ' ' ILE . 49.0 tptt -75.65 118.75 18.81 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.306 -0.406 . . . . 0.0 110.62 -177.37 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' B' B ' 80' ' ' ILE . . . . . 0.648 HD13 ' O ' ' B' ' 79' ' ' LYS . 38.1 mm -139.11 106.24 2.84 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.325 0 N-CA-C 109.278 -0.638 . . . . 0.0 109.278 -177.588 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' B' B ' 81' ' ' LYS . . . . . . . . . . . . . 86.1 mttt -93.56 126.85 38.94 Favored 'General case' 0 C--N 1.328 -0.368 0 C-N-CA 120.709 -0.397 . . . . 0.0 111.086 -178.636 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B ' 82' ' ' GLY . . . . . . . . . . . . . . . 89.04 42.14 5.7 Favored Glycine 0 CA--C 1.525 0.71 0 C-N-CA 120.811 -0.709 . . . . 0.0 111.839 174.092 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B ' 83' ' ' ILE . . . . . . . . . . . . . 71.6 mt -70.28 131.46 34.22 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.312 0 N-CA-C 109.339 -0.615 . . . . 0.0 109.339 176.128 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B ' 84' ' ' LYS . . . . . . . . . . . . . 38.5 ttpt -99.05 -43.99 6.47 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.568 -0.287 . . . . 0.0 110.389 -178.272 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B ' 85' ' ' ASP . . . . . . . . . . . . . 9.7 t70 -155.48 154.26 31.56 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.356 -0.384 . . . . 0.0 110.792 179.348 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B ' 86' ' ' VAL . . . . . . . . . . . . . 44.5 t -132.93 134.36 58.2 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.183 0 CA-C-O 120.959 0.409 . . . . 0.0 110.502 -179.476 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B ' 87' ' ' ILE . . . . . . . . . . . . . 44.3 mm -121.03 128.47 76.07 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.274 0 CA-C-N 115.798 -0.637 . . . . 0.0 109.593 178.7 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B ' 88' ' ' LEU . . . . . . . . . . . . . 17.4 tp -115.17 133.19 56.26 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-O 120.985 0.421 . . . . 0.0 111.116 -178.04 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B ' 89' ' ' ASP . . . . . . . . . . . . . 7.0 t70 -127.42 159.9 33.08 Favored 'General case' 0 C--N 1.332 -0.17 0 CA-C-N 115.898 -0.592 . . . . 0.0 109.574 176.822 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B ' 90' ' ' GLU . . . . . . . . . . . . . 96.3 mt-10 -47.15 -38.07 11.04 Favored 'General case' 0 C--N 1.33 -0.272 0 N-CA-C 113.2 0.815 . . . . 0.0 113.2 -171.009 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B ' 91' ' ' ASN . . . . . . . . . . . . . 13.6 p-10 -132.04 20.69 4.5 Favored 'General case' 0 N--CA 1.468 0.442 0 N-CA-C 113.038 0.755 . . . . 0.0 113.038 -176.736 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B ' 92' ' ' LEU . . . . . . . . . . . . . 57.5 mt -149.01 146.93 28.0 Favored 'General case' 0 C--N 1.331 -0.204 0 CA-C-O 120.767 0.318 . . . . 0.0 110.64 -177.038 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B ' 93' ' ' ILE . . . . . . . . . . . . . 67.1 mt -123.89 119.86 58.08 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.291 0 N-CA-C 109.236 -0.653 . . . . 0.0 109.236 178.231 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B ' 94' ' ' VAL . . . . . . . . . . . . . 44.7 t -118.76 128.28 75.64 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.257 0 N-CA-C 109.829 -0.434 . . . . 0.0 109.829 -179.076 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B ' 95' ' ' VAL . . . . . . . . . . . . . 42.6 t -121.73 134.1 66.08 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.304 0 CA-C-N 116.138 -0.483 . . . . 0.0 109.829 -179.882 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B ' 96' ' ' ILE . . . . . . . . . . . . . 63.7 mt -115.13 127.1 72.82 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.21 0 N-CA-C 109.411 -0.589 . . . . 0.0 109.411 179.95 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B ' 97' ' ' THR . . . . . . . . . . . . . 66.4 p -102.6 157.71 16.75 Favored 'General case' 0 C--N 1.331 -0.222 0 CA-C-O 121.394 0.616 . . . . 0.0 111.376 -176.74 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B ' 98' ' ' GLU . . . . . . . . . . . . . 84.0 tt0 -53.9 -25.54 20.61 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 115.867 -0.606 . . . . 0.0 112.317 179.834 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B ' 99' ' ' GLU . . . . . . . . . . . . . 45.8 mp0 -77.69 14.37 1.06 Allowed 'General case' 0 CA--C 1.535 0.403 0 N-CA-C 113.161 0.8 . . . . 0.0 113.161 -177.206 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B ' 100' ' ' ASN . . . . . . . . . . . . . 3.2 m-20 62.32 38.04 13.45 Favored 'General case' 0 CA--C 1.529 0.169 0 CA-C-O 121.05 0.453 . . . . 0.0 110.747 178.699 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B ' 101' ' ' GLU . . . . . . . . . . . . . 84.7 tt0 -120.61 141.76 50.03 Favored 'General case' 0 C--N 1.332 -0.163 0 CA-C-N 116.098 -0.501 . . . . 0.0 109.75 177.214 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B ' 102' ' ' VAL . . . . . . . . . . . . . 44.9 t -114.97 127.63 72.45 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.297 0 CA-C-N 116.331 -0.395 . . . . 0.0 109.972 -178.297 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B ' 103' ' ' LEU . . . . . . . . . . . . . 6.7 mp -117.25 132.83 56.54 Favored 'General case' 0 C--N 1.331 -0.227 0 CA-C-N 115.763 -0.653 . . . . 0.0 110.273 176.988 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B ' 104' ' ' ILE . . . . . 0.556 HD13 HG21 ' B' ' 130' ' ' VAL . 67.3 mt -118.24 121.69 67.79 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.24 0 CA-C-N 116.037 -0.529 . . . . 0.0 110.031 179.662 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' B' B ' 105' ' ' PHE . . . . . . . . . . . . . 56.7 m-85 -120.37 161.72 20.71 Favored 'General case' 0 C--N 1.331 -0.219 0 O-C-N 123.98 0.8 . . . . 0.0 109.651 178.64 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B ' 106' ' ' ASN . . . . . . . . . . . . . 44.2 p-10 -93.97 -169.95 2.2 Favored 'General case' 0 C--N 1.33 -0.249 0 N-CA-C 110.053 -0.351 . . . . 0.0 110.053 175.019 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B ' 107' ' ' GLN . . . . . . . . . . . . . 61.4 tt0 -58.91 -30.03 67.51 Favored 'General case' 0 C--N 1.33 -0.258 0 N-CA-C 111.876 0.324 . . . . 0.0 111.876 179.333 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B ' 108' ' ' ASN . . . . . . . . . . . . . 3.0 t-20 -83.66 7.94 15.96 Favored 'General case' 0 CA--C 1.536 0.406 0 N-CA-C 113.193 0.812 . . . . 0.0 113.193 -177.274 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B ' 109' ' ' LEU . . . . . 0.646 HD21 ' HB2' ' B' ' 78' ' ' ALA . 12.0 tp 60.78 37.66 18.64 Favored 'General case' 0 C--O 1.232 0.181 0 CA-C-O 120.962 0.41 . . . . 0.0 111.211 179.074 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' B' B ' 110' ' ' GLU . . . . . . . . . . . . . 95.4 mt-10 -107.34 151.24 25.76 Favored 'General case' 0 C--N 1.331 -0.238 0 N-CA-C 109.925 -0.398 . . . . 0.0 109.925 176.174 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B ' 111' ' ' GLU . . . . . . . . . . . . . 84.8 tt0 -82.01 123.24 28.73 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-O 120.939 0.399 . . . . 0.0 111.175 -175.626 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B ' 112' ' ' LEU . . . . . . . . . . . . . 33.7 mt -108.36 -46.0 3.79 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 115.933 -0.576 . . . . 0.0 110.481 177.443 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B ' 113' ' ' TYR . . . . . . . . . . . . . 60.5 t80 -140.61 137.68 33.84 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.163 -0.471 . . . . 0.0 110.921 -179.053 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B ' 114' ' ' ARG . . . . . . . . . . . . . 56.9 ttp180 -147.0 124.98 12.0 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-O 120.991 0.424 . . . . 0.0 110.386 175.866 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B ' 115' ' ' GLY . . . . . . . . . . . . . . . -150.15 156.53 26.78 Favored Glycine 0 CA--C 1.526 0.737 0 N-CA-C 110.95 -0.86 . . . . 0.0 110.95 179.164 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B ' 116' ' ' LYS . . . . . . . . . . . . . 35.0 ttpt -118.69 138.45 52.62 Favored 'General case' 0 C--O 1.233 0.189 0 CA-C-O 120.73 0.3 . . . . 0.0 110.288 179.18 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B ' 117' ' ' PHE . . . . . . . . . . . . . 24.0 m-85 -135.78 114.07 11.53 Favored 'General case' 0 C--N 1.329 -0.299 0 N-CA-C 109.733 -0.469 . . . . 0.0 109.733 -178.973 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B ' 118' ' ' GLU . . . . . . . . . . . . . 96.3 mt-10 -54.97 -42.22 72.12 Favored 'General case' 0 C--N 1.329 -0.29 0 C-N-CA 120.874 -0.33 . . . . 0.0 111.223 -176.234 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B ' 119' ' ' ASN . . . . . . . . . . . . . 2.5 m120 -97.32 31.13 2.58 Favored 'General case' 0 C--N 1.33 -0.257 0 N-CA-C 112.148 0.425 . . . . 0.0 112.148 -174.97 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B ' 120' ' ' LEU . . . . . . . . . . . . . 18.7 tp -57.13 121.85 11.03 Favored 'General case' 0 C--N 1.332 -0.174 0 N-CA-C 110.278 -0.268 . . . . 0.0 110.278 177.253 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B ' 121' ' ' ASN . . . . . . . . . . . . . 57.9 m-20 -113.98 -44.17 3.18 Favored 'General case' 0 C--N 1.332 -0.186 0 CA-C-N 116.667 -0.242 . . . . 0.0 111.309 -176.766 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B ' 122' ' ' LYS . . . . . . . . . . . . . 98.3 mttt -146.67 149.76 34.09 Favored 'General case' 0 C--O 1.232 0.171 0 C-N-CA 120.442 -0.503 . . . . 0.0 112.008 -177.951 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B ' 123' ' ' VAL . . . . . . . . . . . . . 48.8 t -119.41 127.78 75.85 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.218 0 CA-C-N 115.697 -0.683 . . . . 0.0 109.163 174.326 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B ' 124' ' ' LEU . . . . . . . . . . . . . 31.6 mt -120.89 136.01 55.04 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 116.531 -0.304 . . . . 0.0 110.633 -176.255 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B ' 125' ' ' VAL . . . . . . . . . . . . . 42.6 t -131.1 131.45 63.84 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.264 0 CA-C-N 116.306 -0.406 . . . . 0.0 110.266 179.121 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B ' 126' ' ' ARG . . . . . . . . . . . . . 27.7 mtp180 -151.55 129.73 11.93 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.113 -0.494 . . . . 0.0 109.842 176.619 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B ' 127' ' ' ASN . . . . . . . . . . . . . 32.5 t30 56.2 -152.45 0.38 Allowed 'General case' 0 CA--C 1.54 0.565 0 N-CA-C 109.7 -0.481 . . . . 0.0 109.7 -179.119 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B ' 128' ' ' ASP . . . . . . . . . . . . . 15.9 p-10 -83.6 18.04 2.03 Favored 'General case' 0 CA--C 1.537 0.45 0 CA-C-N 118.526 0.603 . . . . 0.0 112.562 177.558 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B ' 129' ' ' LEU . . . . . . . . . . . . . 41.1 mt -115.24 144.92 42.99 Favored 'General case' 0 C--O 1.232 0.179 0 CA-C-N 117.956 0.344 . . . . 0.0 110.24 179.69 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B ' 130' ' ' VAL . . . . . 0.556 HG21 HD13 ' B' ' 104' ' ' ILE . 32.3 m -129.31 143.21 41.89 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.232 0 CA-C-O 120.93 0.395 . . . . 0.0 110.6 -178.512 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' B' B ' 131' ' ' VAL . . . . . 0.587 HG22 HD12 ' B' ' 140' ' ' LEU . 38.0 t -136.1 141.34 41.87 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.254 0 CA-C-O 121.079 0.466 . . . . 0.0 110.551 -178.844 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' B' B ' 132' ' ' ILE . . . . . . . . . . . . . 74.1 mt -118.39 131.38 71.34 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.262 0 CA-C-N 115.805 -0.634 . . . . 0.0 109.396 178.726 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B ' 133' ' ' ILE . . . . . . . . . . . . . 41.8 mm -117.11 125.12 73.75 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.235 0 CA-C-O 120.785 0.326 . . . . 0.0 111.158 -174.035 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B ' 134' ' ' ASP . . . . . . . . . . . . . 9.7 p-10 -136.09 148.01 48.09 Favored 'General case' 0 C--N 1.332 -0.167 0 N-CA-C 109.514 -0.55 . . . . 0.0 109.514 172.89 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B ' 135' ' ' GLU . . . . . . . . . . . . . 44.3 tp10 -49.92 -27.26 5.02 Favored 'General case' 0 C--N 1.326 -0.45 0 N-CA-C 112.873 0.694 . . . . 0.0 112.873 -172.668 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B ' 136' ' ' GLN . . . . . . . . . . . . . 53.8 mt-30 -85.23 -30.46 23.82 Favored 'General case' 0 C--N 1.33 -0.24 0 N-CA-C 112.694 0.627 . . . . 0.0 112.694 -175.113 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B ' 137' ' ' LYS . . . . . . . . . . . . . 22.9 pttm -167.62 171.18 10.44 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-O 121.518 0.675 . . . . 0.0 112.483 -173.024 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B ' 138' ' ' LEU . . . . . 0.406 HD23 ' N ' ' B' ' 139' ' ' THR . 6.4 tt -121.11 130.02 53.56 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 115.059 -0.973 . . . . 0.0 110.164 -178.521 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' B' B ' 139' ' ' THR . . . . . 0.406 ' N ' HD23 ' B' ' 138' ' ' LEU . 29.2 m -109.57 125.38 52.47 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-N 116.26 -0.427 . . . . 0.0 110.291 178.593 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' B' B ' 140' ' ' LEU . . . . . 0.587 HD12 HG22 ' B' ' 131' ' ' VAL . 15.0 tp -114.24 119.24 36.35 Favored 'General case' 0 C--N 1.328 -0.328 0 N-CA-C 109.412 -0.588 . . . . 0.0 109.412 -178.015 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' B' B ' 141' ' ' ILE . . . . . 0.518 ' HB ' HG23 ' B' ' 130' ' ' VAL . 22.1 mt -120.08 121.18 65.2 Favored 'Isoleucine or valine' 0 C--O 1.234 0.248 0 CA-C-O 121.067 0.461 . . . . 0.0 110.217 -175.731 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' B' B ' 142' ' ' ARG . . . . . . . . . . . . . 85.3 mtm180 -107.13 127.23 53.31 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 115.219 -0.9 . . . . 0.0 110.435 -178.748 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B ' 143' ' ' THR . . . . . . . . . . . . . 76.5 p . . . . . 0 C--O 1.22 -0.472 0 CA-C-O 117.976 -1.011 . . . . 0.0 110.537 179.778 . . . . . . . . 0 0 . 1 . 006 nuclear build core ' C' C ' 2' ' ' SER . . . . . . . . . . . . . 5.7 p . . . . . 0 N--CA 1.461 0.104 0 CA-C-O 121.071 0.463 . . . . 0.0 110.818 . . . . . . . . . 0 0 . 1 . 006 nuclear build core ' C' C ' 3' ' ' GLU . . . . . . . . . . . . . 85.1 tt0 -142.12 140.44 32.48 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 115.801 -0.636 . . . . 0.0 111.001 -179.832 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' C' C ' 4' ' ' LEU . . . . . 0.438 HD21 HD21 ' C' ' 6' ' ' LEU . 15.9 tp -121.89 126.53 48.9 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 115.887 -0.597 . . . . 0.0 110.093 177.171 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' C' C ' 5' ' ' LYS . . . . . . . . . . . . . 99.0 mttt -104.64 121.0 42.65 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.414 -0.357 . . . . 0.0 110.572 178.577 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' C' C ' 6' ' ' LEU . . . . . 0.438 HD21 HD21 ' C' ' 4' ' ' LEU . 75.7 mt -116.63 148.71 40.71 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 115.43 -0.804 . . . . 0.0 110.284 -178.959 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' C' C ' 7' ' ' LYS . . . . . . . . . . . . . 64.2 tttm -133.18 136.04 26.68 Favored Pre-proline 0 CA--C 1.534 0.365 0 CA-C-O 118.929 -0.558 . . . . 0.0 109.91 177.084 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' C' C ' 8' ' ' PRO . . . . . . . . . . . . . 84.7 Cg_endo -90.61 140.64 3.07 Favored 'Trans proline' 0 N--CA 1.491 1.365 0 C-N-CA 121.716 1.611 . . . . 0.0 111.571 178.063 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' C' C ' 9' ' ' LEU . . . . . . . . . . . . . 68.6 mt -75.13 -47.53 4.55 Favored Pre-proline 0 CA--C 1.534 0.345 0 CA-C-O 118.712 -0.661 . . . . 0.0 112.311 -178.689 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' C' C ' 10' ' ' PRO . . . . . . . . . . . . . 91.4 Cg_endo -81.49 152.57 17.76 Favored 'Trans proline' 0 N--CA 1.497 1.715 0 C-N-CA 121.312 1.341 . . . . 0.0 111.987 176.038 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' C' C ' 11' ' ' LYS . . . . . . . . . . . . . 50.0 tttm -89.23 102.2 14.86 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.426 -0.352 . . . . 0.0 110.373 178.282 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' C' C ' 12' ' ' VAL . . . . . . . . . . . . . 12.8 p -147.36 145.7 18.89 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.359 0 CA-C-N 116.313 -0.403 . . . . 0.0 110.802 -179.461 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' C' C ' 13' ' ' GLU . . . . . . . . . . . . . 39.6 mt-10 -83.72 122.15 28.25 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.324 -0.398 . . . . 0.0 109.99 175.613 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' C' C ' 14' ' ' LEU . . . . . . . . . . . . . 27.4 mt -94.68 153.92 40.08 Favored Pre-proline 0 C--N 1.329 -0.288 0 CA-C-N 116.456 -0.338 . . . . 0.0 110.83 -177.699 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' C' C ' 15' ' ' PRO . . . . . . . . . . . . . 36.0 Cg_exo -58.35 154.96 37.84 Favored 'Trans proline' 0 N--CA 1.495 1.588 0 C-N-CA 121.268 1.312 . . . . 0.0 111.724 178.576 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' C' C ' 16' ' ' PRO . . . . . . . . . . . . . 34.2 Cg_exo -57.85 -33.61 97.21 Favored 'Trans proline' 0 N--CA 1.497 1.701 0 C-N-CA 121.483 1.455 . . . . 0.0 112.817 -179.098 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' C' C ' 17' ' ' ASP . . . . . . . . . . . . . 20.8 p-10 -90.1 8.79 30.98 Favored 'General case' 0 CA--C 1.536 0.41 0 N-CA-C 113.45 0.907 . . . . 0.0 113.45 -176.671 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' C' C ' 18' ' ' PHE . . . . . . . . . . . . . 35.4 t80 -58.4 -45.8 87.65 Favored 'General case' 0 N--CA 1.457 -0.094 0 O-C-N 121.972 -0.455 . . . . 0.0 110.122 -177.212 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' C' C ' 19' ' ' VAL . . . . . 0.408 HG13 ' N ' ' C' ' 20' ' ' ASP . 14.2 p -56.51 -41.33 72.47 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.411 0 CA-C-N 116.269 -0.423 . . . . 0.0 110.889 -178.916 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' C' C ' 20' ' ' ASP . . . . . 0.408 ' N ' HG13 ' C' ' 19' ' ' VAL . 68.8 m-20 -60.73 -42.83 98.09 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-O 120.83 0.348 . . . . 0.0 111.076 -178.191 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' C' C ' 21' ' ' VAL . . . . . . . . . . . . . 48.7 t -64.44 -48.52 84.78 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.32 0 CA-C-N 116.311 -0.404 . . . . 0.0 110.403 -177.566 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' C' C ' 22' ' ' ILE . . . . . 0.438 HG22 HD12 ' C' ' 26' ' ' LEU . 48.8 mm -55.73 -46.37 79.64 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.221 0 CA-C-O 120.869 0.366 . . . . 0.0 110.738 -179.742 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' C' C ' 23' ' ' ARG . . . . . . . . . . . . . 59.9 ttp180 -53.48 -51.7 61.91 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-O 120.777 0.323 . . . . 0.0 111.566 -178.719 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' C' C ' 24' ' ' ILE . . . . . . . . . . . . . 74.9 mt -60.12 -41.42 86.49 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.269 0 CA-C-N 116.6 -0.273 . . . . 0.0 111.214 -176.631 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' C' C ' 25' ' ' LYS . . . . . . . . . . . . . 53.6 mmtt -63.78 -39.97 95.54 Favored 'General case' 0 C--N 1.328 -0.33 0 N-CA-C 112.107 0.41 . . . . 0.0 112.107 -179.948 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' C' C ' 26' ' ' LEU . . . . . 0.438 HD12 HG22 ' C' ' 22' ' ' ILE . 87.7 mt -78.48 -41.12 33.47 Favored 'General case' 0 C--N 1.33 -0.252 0 N-CA-C 113.539 0.94 . . . . 0.0 113.539 -170.715 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' C' C ' 27' ' ' GLN . . . . . . . . . . . . . 17.4 pt20 -47.24 139.85 5.85 Favored 'General case' 0 N--CA 1.469 0.509 0 N-CA-C 112.75 0.648 . . . . 0.0 112.75 -174.237 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' C' C ' 28' ' ' GLY . . . . . . . . . . . . . . . 99.33 -26.75 23.12 Favored Glycine 0 CA--C 1.532 1.127 0 CA-C-N 115.633 -0.712 . . . . 0.0 112.217 -177.723 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' C' C ' 29' ' ' LYS . . . . . . . . . . . . . 98.9 mttt -98.51 155.06 17.45 Favored 'General case' 0 C--O 1.232 0.181 0 CA-C-N 117.273 0.536 . . . . 0.0 111.254 179.662 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' C' C ' 30' ' ' THR . . . . . . . . . . . . . 23.5 m -103.88 137.3 42.08 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-N 115.957 -0.565 . . . . 0.0 110.092 176.392 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' C' C ' 31' ' ' VAL . . . . . . . . . . . . . 34.8 m -130.51 154.07 40.01 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.245 0 CA-C-O 120.947 0.403 . . . . 0.0 110.971 -178.523 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' C' C ' 32' ' ' ARG . . . . . . . . . . . . . 95.6 mtt180 -130.11 151.58 50.49 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 116.013 -0.539 . . . . 0.0 110.466 178.502 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' C' C ' 33' ' ' THR . . . . . . . . . . . . . 29.3 m -53.4 139.25 31.07 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-O 120.851 0.358 . . . . 0.0 111.225 -178.314 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' C' C ' 34' ' ' GLY . . . . . . . . . . . . . . . 100.63 -17.05 57.14 Favored Glycine 0 CA--C 1.532 1.136 0 CA-C-O 119.671 -0.516 . . . . 0.0 113.244 179.732 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' C' C ' 35' ' ' ASP . . . . . . . . . . . . . 64.4 m-20 -65.65 150.81 47.85 Favored 'General case' 0 C--O 1.231 0.089 0 CA-C-N 118.028 0.914 . . . . 0.0 110.891 178.461 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' C' C ' 36' ' ' VAL . . . . . . . . . . . . . 43.7 t -124.38 133.61 68.89 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.188 0 CA-C-N 116.044 -0.526 . . . . 0.0 110.027 179.056 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' C' C ' 37' ' ' ILE . . . . . . . . . . . . . 69.9 mt -119.98 139.73 46.35 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.25 0 CA-C-N 116.087 -0.506 . . . . 0.0 109.842 179.882 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' C' C ' 38' ' ' GLY . . . . . . . . . . . . . . . -114.22 128.73 8.37 Favored Glycine 0 CA--C 1.526 0.727 0 N-CA-C 111.214 -0.754 . . . . 0.0 111.214 -179.82 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' C' C ' 39' ' ' ILE . . . . . . . . . . . . . 70.8 mt -125.34 130.84 72.84 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.267 0 N-CA-C 109.791 -0.448 . . . . 0.0 109.791 178.371 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' C' C ' 40' ' ' SER . . . . . . . . . . . . . 31.3 t -93.18 113.95 26.32 Favored 'General case' 0 C--N 1.33 -0.24 0 C-N-CA 120.747 -0.381 . . . . 0.0 110.817 176.185 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' C' C ' 41' ' ' ILE . . . . . . . . . . . . . 43.9 mm -123.82 121.79 63.12 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.204 0 CA-C-N 116.484 -0.326 . . . . 0.0 110.237 -179.413 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' C' C ' 42' ' ' LEU . . . . . . . . . . . . . 72.4 mt 57.68 35.33 25.51 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-N 116.349 -0.387 . . . . 0.0 111.8 177.118 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' C' C ' 43' ' ' GLY . . . . . . . . . . . . . . . 78.3 -10.18 30.01 Favored Glycine 0 CA--C 1.533 1.169 0 C-N-CA 121.178 -0.534 . . . . 0.0 113.449 177.248 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' C' C ' 44' ' ' LYS . . . . . . . . . . . . . 68.7 mttm -100.24 131.71 46.02 Favored 'General case' 0 C--N 1.333 -0.125 0 CA-C-N 118.016 0.908 . . . . 0.0 110.078 176.51 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' C' C ' 45' ' ' GLU . . . . . . . . . . . . . 31.5 tp10 -84.37 127.02 33.75 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.396 -0.366 . . . . 0.0 110.459 -179.905 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' C' C ' 46' ' ' VAL . . . . . . . . . . . . . 7.6 p -121.09 128.15 76.0 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.243 0 CA-C-O 121.116 0.484 . . . . 0.0 109.807 178.36 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' C' C ' 47' ' ' LYS . . . . . . . . . . . . . 62.8 mttp -100.57 130.66 46.66 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 115.903 -0.59 . . . . 0.0 111.459 178.058 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' C' C ' 48' ' ' PHE . . . . . . . . . . . . . 94.9 m-85 -113.95 131.95 56.13 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 115.915 -0.584 . . . . 0.0 109.873 176.023 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' C' C ' 49' ' ' LYS . . . . . . . . . . . . . 84.4 tttt -106.53 136.53 46.14 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.471 -0.331 . . . . 0.0 110.518 179.975 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' C' C ' 50' ' ' VAL . . . . . . . . . . . . . 43.6 t -80.99 109.3 15.21 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.302 0 N-CA-C 109.311 -0.626 . . . . 0.0 109.311 177.252 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' C' C ' 51' ' ' VAL . . . . . . . . . . . . . 47.9 t -73.96 -47.55 42.24 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.39 0 CA-C-N 116.148 -0.478 . . . . 0.0 110.11 -173.781 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' C' C ' 52' ' ' GLN . . . . . . . . . . . . . 61.9 tt0 -163.86 139.43 6.31 Favored 'General case' 0 C--N 1.331 -0.222 0 C-N-CA 120.218 -0.593 . . . . 0.0 111.912 -177.724 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' C' C ' 53' ' ' ALA . . . . . 0.421 ' HB1' ' HB2' ' C' ' 58' ' ' LEU . . . -112.94 133.67 54.8 Favored 'General case' 0 C--N 1.332 -0.195 0 CA-C-N 115.66 -0.7 . . . . 0.0 109.853 175.445 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' C' C ' 54' ' ' TYR . . . . . . . . . . . . . 48.9 t80 -129.08 111.14 18.33 Favored Pre-proline 0 CA--C 1.536 0.415 0 CA-C-O 118.172 -0.918 . . . . 0.0 110.456 179.263 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' C' C ' 55' ' ' PRO . . . . . . . . . . . . . 72.5 Cg_endo -77.17 168.09 77.89 Favored 'Cis proline' 0 N--CA 1.497 1.726 0 CA-C-N 121.883 1.708 . . . . 0.0 112.213 -6.24 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' C' C ' 56' ' ' SER . . . . . . . . . . . . . 48.1 m -117.32 136.5 23.48 Favored Pre-proline 0 CA--C 1.539 0.525 0 CA-C-O 118.518 -0.754 . . . . 0.0 109.683 174.652 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' C' C ' 57' ' ' PRO . . . . . . . . . . . . . 36.8 Cg_endo -66.95 145.99 73.87 Favored 'Cis proline' 0 N--CA 1.499 1.795 0 CA-C-N 121.822 1.687 . . . . 0.0 111.383 -3.473 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' C' C ' 58' ' ' LEU . . . . . 0.421 ' HB2' ' HB1' ' C' ' 53' ' ' ALA . 20.6 tp -107.76 136.17 47.95 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.505 -0.316 . . . . 0.0 110.699 -177.796 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' C' C ' 59' ' ' ARG . . . . . . . . . . . . . 71.3 ttt180 -104.58 124.42 49.29 Favored 'General case' 0 C--N 1.328 -0.355 0 N-CA-C 109.247 -0.649 . . . . 0.0 109.247 175.462 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' C' C ' 60' ' ' VAL . . . . . . . . . . . . . 42.3 t -79.73 126.23 39.14 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.251 0 C-N-CA 120.663 -0.415 . . . . 0.0 110.492 -174.459 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' C' C ' 61' ' ' GLU . . . . . . . . . . . . . 96.4 mt-10 -131.05 160.97 33.07 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 115.712 -0.676 . . . . 0.0 109.967 178.507 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' C' C ' 62' ' ' ASP . . . . . . . . . . . . . 11.7 t70 -53.76 -32.49 52.49 Favored 'General case' 0 C--N 1.328 -0.363 0 N-CA-C 111.822 0.304 . . . . 0.0 111.822 -179.154 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' C' C ' 63' ' ' ARG . . . . . . . . . . . . . 38.0 ptt180 -88.38 6.19 38.55 Favored 'General case' 0 CA--C 1.537 0.447 0 N-CA-C 113.688 0.996 . . . . 0.0 113.688 -175.616 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' C' C ' 64' ' ' THR . . . . . . . . . . . . . 38.2 m -81.12 142.51 33.22 Favored 'General case' 0 C--N 1.331 -0.2 0 CA-C-N 118.03 0.377 . . . . 0.0 110.549 -179.404 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' C' C ' 65' ' ' LYS . . . . . . . . . . . . . 68.4 mttm -89.26 129.9 35.75 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.237 179.543 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' C' C ' 66' ' ' ILE . . . . . . . . . . . . . 64.7 mt -116.93 130.1 72.4 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.217 0 N-CA-C 109.758 -0.46 . . . . 0.0 109.758 178.86 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' C' C ' 67' ' ' THR . . . . . . . . . . . . . 36.0 m -126.47 140.23 52.63 Favored 'General case' 0 C--N 1.331 -0.22 0 CA-C-O 121.069 0.461 . . . . 0.0 111.065 -177.119 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' C' C ' 68' ' ' LEU . . . . . 0.441 HD23 ' C ' ' C' ' 68' ' ' LEU . 6.4 tt . . . . . 0 C--N 1.33 -0.276 0 CA-C-N 115.763 -0.653 . . . . 0.0 109.446 176.562 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' C' C ' 73' ' ' VAL . . . . . . . . . . . . . 18.7 m . . . . . 0 N--CA 1.461 0.12 0 CA-C-O 121.201 0.524 . . . . 0.0 110.541 . . . . . . . . . 0 0 . 1 . 006 nuclear build core ' C' C ' 74' ' ' ASP . . . . . . . . . . . . . 13.7 t0 -97.52 123.72 41.49 Favored 'General case' 0 C--N 1.326 -0.417 0 CA-C-N 115.508 -0.769 . . . . 0.0 109.34 178.262 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' C' C ' 75' ' ' VAL . . . . . 0.478 ' C ' HD12 ' C' ' 76' ' ' LEU . 42.1 t -112.65 121.23 64.56 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.257 0 CA-C-O 121.187 0.518 . . . . 0.0 110.621 -176.221 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' C' C ' 76' ' ' LEU . . . . . 0.478 HD12 ' C ' ' C' ' 75' ' ' VAL . 7.6 mp -119.09 141.32 48.87 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 115.58 -0.737 . . . . 0.0 109.496 175.673 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' C' C ' 77' ' ' GLU . . . . . . . . . . . . . 46.3 mt-10 -132.23 137.0 47.38 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-O 121.059 0.457 . . . . 0.0 110.994 -178.515 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' C' C ' 78' ' ' ALA . . . . . 0.584 ' HB2' HD21 ' C' ' 109' ' ' LEU . . . -127.39 135.68 50.81 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 115.727 -0.67 . . . . 0.0 109.889 177.152 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' C' C ' 79' ' ' LYS . . . . . 0.6 ' O ' HD13 ' C' ' 80' ' ' ILE . 54.9 pttt -83.85 120.87 26.58 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-O 121.31 0.576 . . . . 0.0 110.932 -178.516 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' C' C ' 80' ' ' ILE . . . . . 0.6 HD13 ' O ' ' C' ' 79' ' ' LYS . 39.6 mm -139.18 115.92 10.34 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.274 0 CA-C-N 115.738 -0.665 . . . . 0.0 109.359 -177.769 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' C' C ' 81' ' ' LYS . . . . . . . . . . . . . 99.3 mttt -101.09 125.48 47.71 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-O 120.828 0.347 . . . . 0.0 111.156 -178.172 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' C' C ' 82' ' ' GLY . . . . . . . . . . . . . . . 89.13 42.2 5.66 Favored Glycine 0 CA--C 1.524 0.624 0 C-N-CA 120.714 -0.755 . . . . 0.0 111.772 173.117 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' C' C ' 83' ' ' ILE . . . . . . . . . . . . . 74.8 mt -65.61 134.91 29.18 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.374 0 N-CA-C 109.606 -0.516 . . . . 0.0 109.606 176.841 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' C' C ' 84' ' ' LYS . . . . . . . . . . . . . 51.0 tttp -99.09 -53.96 3.11 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-O 121.061 0.458 . . . . 0.0 110.375 -179.148 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' C' C ' 85' ' ' ASP . . . . . . . . . . . . . 10.1 t70 -148.78 146.37 28.0 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 115.786 -0.643 . . . . 0.0 110.284 -179.082 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' C' C ' 86' ' ' VAL . . . . . . . . . . . . . 43.7 t -127.14 127.61 69.63 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.196 0 CA-C-O 120.783 0.325 . . . . 0.0 110.414 -179.558 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' C' C ' 87' ' ' ILE . . . . . . . . . . . . . 44.6 mm -120.53 126.71 75.55 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.27 0 CA-C-N 115.996 -0.547 . . . . 0.0 109.766 177.935 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' C' C ' 88' ' ' LEU . . . . . . . . . . . . . 74.6 mt -107.25 139.61 41.44 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-O 121.006 0.432 . . . . 0.0 111.037 -179.314 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' C' C ' 89' ' ' ASP . . . . . . . . . . . . . 6.0 t70 -130.3 154.06 48.01 Favored 'General case' 0 C--N 1.328 -0.328 0 N-CA-C 109.302 -0.629 . . . . 0.0 109.302 176.253 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' C' C ' 90' ' ' GLU . . . . . . . . . . . . . 84.9 tt0 -47.91 -34.79 9.53 Favored 'General case' 0 C--N 1.33 -0.253 0 N-CA-C 112.972 0.73 . . . . 0.0 112.972 -172.07 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' C' C ' 91' ' ' ASN . . . . . . . . . . . . . 86.9 m-20 -132.03 19.51 4.53 Favored 'General case' 0 N--CA 1.468 0.464 0 N-CA-C 113.124 0.787 . . . . 0.0 113.124 -178.437 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' C' C ' 92' ' ' LEU . . . . . . . . . . . . . 48.5 mt -148.66 148.55 30.21 Favored 'General case' 0 C--N 1.331 -0.218 0 CA-C-O 120.644 0.259 . . . . 0.0 110.35 -177.702 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' C' C ' 93' ' ' ILE . . . . . . . . . . . . . 70.5 mt -126.94 118.39 50.33 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.345 0 N-CA-C 109.148 -0.686 . . . . 0.0 109.148 176.42 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' C' C ' 94' ' ' VAL . . . . . . . . . . . . . 46.3 t -118.89 126.29 75.19 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.281 0 CA-C-O 121.028 0.442 . . . . 0.0 110.022 -179.035 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' C' C ' 95' ' ' VAL . . . . . . . . . . . . . 44.7 t -119.91 133.1 67.77 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.382 0 CA-C-N 115.788 -0.642 . . . . 0.0 109.648 179.386 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' C' C ' 96' ' ' ILE . . . . . . . . . . . . . 63.9 mt -111.77 127.74 68.76 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.349 0 N-CA-C 109.089 -0.708 . . . . 0.0 109.089 178.016 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' C' C ' 97' ' ' THR . . . . . . . . . . . . . 80.9 p -97.83 157.91 15.82 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-O 121.159 0.504 . . . . 0.0 110.979 -178.071 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' C' C ' 98' ' ' GLU . . . . . . . . . . . . . 82.1 tt0 -53.73 -25.53 19.02 Favored 'General case' 0 CA--C 1.533 0.323 0 CA-C-N 116.105 -0.498 . . . . 0.0 112.145 179.509 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' C' C ' 99' ' ' GLU . . . . . . . . . . . . . 95.4 mt-10 -80.12 15.34 1.54 Allowed 'General case' 0 CA--C 1.535 0.398 0 N-CA-C 113.191 0.811 . . . . 0.0 113.191 -176.714 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' C' C ' 100' ' ' ASN . . . . . . . . . . . . . 3.3 m-20 61.96 37.89 14.71 Favored 'General case' 0 N--CA 1.463 0.198 0 CA-C-O 121.105 0.479 . . . . 0.0 110.939 179.001 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' C' C ' 101' ' ' GLU . . . . . . . . . . . . . 84.5 tt0 -117.99 144.43 45.54 Favored 'General case' 0 C--N 1.332 -0.172 0 CA-C-N 116.074 -0.512 . . . . 0.0 109.755 176.764 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' C' C ' 102' ' ' VAL . . . . . . . . . . . . . 44.7 t -115.14 126.26 72.67 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.253 0 CA-C-N 116.284 -0.416 . . . . 0.0 110.14 -176.75 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' C' C ' 103' ' ' LEU . . . . . . . . . . . . . 29.5 mt -115.25 127.14 55.29 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-N 115.686 -0.688 . . . . 0.0 109.932 175.905 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' C' C ' 104' ' ' ILE . . . . . . . . . . . . . 66.7 mt -116.33 120.32 64.57 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.225 0 N-CA-C 110.15 -0.315 . . . . 0.0 110.15 179.737 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' C' C ' 105' ' ' PHE . . . . . . . . . . . . . 47.8 m-85 -119.8 166.41 13.3 Favored 'General case' 0 C--N 1.332 -0.178 0 CA-C-N 115.415 -0.812 . . . . 0.0 109.535 178.364 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' C' C ' 106' ' ' ASN . . . . . . . . . . . . . 43.0 p-10 -99.5 -170.07 1.85 Allowed 'General case' 0 C--N 1.33 -0.261 0 N-CA-C 109.993 -0.373 . . . . 0.0 109.993 174.988 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' C' C ' 107' ' ' GLN . . . . . . . . . . . . . 29.7 tt0 -58.51 -30.07 66.77 Favored 'General case' 0 C--N 1.329 -0.313 0 N-CA-C 111.984 0.365 . . . . 0.0 111.984 179.287 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' C' C ' 108' ' ' ASN . . . . . . . . . . . . . 13.5 t-20 -84.05 7.57 18.16 Favored 'General case' 0 CA--C 1.536 0.439 0 N-CA-C 113.204 0.816 . . . . 0.0 113.204 -176.903 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' C' C ' 109' ' ' LEU . . . . . 0.584 HD21 ' HB2' ' C' ' 78' ' ' ALA . 10.6 tp 61.39 38.39 16.15 Favored 'General case' 0 C--N 1.332 -0.189 0 CA-C-O 121.131 0.491 . . . . 0.0 111.19 179.192 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' C' C ' 110' ' ' GLU . . . . . . . . . . . . . 96.8 mt-10 -105.38 153.29 21.86 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.219 -0.446 . . . . 0.0 109.928 176.85 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' C' C ' 111' ' ' GLU . . . . . . . . . . . . . 83.2 tt0 -85.67 121.9 29.01 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-O 120.768 0.318 . . . . 0.0 110.587 -178.508 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' C' C ' 112' ' ' LEU . . . . . . . . . . . . . 61.6 mt -111.61 -46.14 3.29 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.258 -0.428 . . . . 0.0 110.741 179.623 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' C' C ' 113' ' ' TYR . . . . . . . . . . . . . 55.8 t80 -137.17 134.72 36.64 Favored 'General case' 0 C--N 1.331 -0.223 0 CA-C-N 116.434 -0.348 . . . . 0.0 110.966 -179.094 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' C' C ' 114' ' ' ARG . . . . . . . . . . . . . 31.6 ttp180 -135.62 124.03 23.39 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.34 -0.391 . . . . 0.0 110.164 176.604 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' C' C ' 115' ' ' GLY . . . . . . . . . . . . . . . -150.05 162.68 29.26 Favored Glycine 0 CA--C 1.523 0.567 0 N-CA-C 111.038 -0.825 . . . . 0.0 111.038 179.334 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' C' C ' 116' ' ' LYS . . . . . . . . . . . . . 30.0 ttpt -131.28 137.85 49.02 Favored 'General case' 0 C--N 1.33 -0.248 0 N-CA-C 109.941 -0.392 . . . . 0.0 109.941 178.42 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' C' C ' 117' ' ' PHE . . . . . . . . . . . . . 39.2 m-85 -135.11 113.93 11.89 Favored 'General case' 0 C--N 1.331 -0.23 0 N-CA-C 109.919 -0.4 . . . . 0.0 109.919 -178.55 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' C' C ' 118' ' ' GLU . . . . . . . . . . . . . 44.1 mt-10 -57.07 -42.12 80.07 Favored 'General case' 0 C--N 1.328 -0.34 0 C-N-CA 120.774 -0.37 . . . . 0.0 110.886 -176.324 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' C' C ' 119' ' ' ASN . . . . . . . . . . . . . 3.9 p30 -100.51 31.19 3.56 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.232 -0.44 . . . . 0.0 111.964 -175.674 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' C' C ' 120' ' ' LEU . . . . . . . . . . . . . 14.2 tp -54.03 125.9 20.6 Favored 'General case' 0 N--CA 1.463 0.195 0 CA-C-O 120.487 0.184 . . . . 0.0 110.776 177.996 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' C' C ' 121' ' ' ASN . . . . . . . . . . . . . 16.6 m120 -112.72 -44.14 3.36 Favored 'General case' 0 C--O 1.231 0.12 0 C-N-CA 121.125 -0.23 . . . . 0.0 111.415 -176.422 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' C' C ' 122' ' ' LYS . . . . . . . . . . . . . 97.7 mttt -148.3 149.38 31.75 Favored 'General case' 0 C--N 1.332 -0.189 0 C-N-CA 120.557 -0.457 . . . . 0.0 111.879 -177.593 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' C' C ' 123' ' ' VAL . . . . . . . . . . . . . 44.3 t -130.18 126.92 62.47 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.325 0 N-CA-C 109.117 -0.697 . . . . 0.0 109.117 172.908 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' C' C ' 124' ' ' LEU . . . . . . . . . . . . . 12.1 tp -127.97 138.38 52.6 Favored 'General case' 0 N--CA 1.463 0.208 0 CA-C-O 120.859 0.362 . . . . 0.0 111.371 -175.661 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' C' C ' 125' ' ' VAL . . . . . 0.489 HG12 HG23 ' C' ' 130' ' ' VAL . 35.6 m -126.19 133.02 69.82 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.241 0 CA-C-N 115.942 -0.572 . . . . 0.0 110.436 177.715 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' C' C ' 126' ' ' ARG . . . . . . . . . . . . . 24.4 mmt180 -139.38 116.48 11.05 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.312 -0.404 . . . . 0.0 110.537 178.367 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' C' C ' 127' ' ' ASN . . . . . . . . . . . . . 17.8 m-80 52.1 -105.03 0.2 Allowed 'General case' 0 CA--C 1.543 0.68 0 CA-C-O 119.173 -0.441 . . . . 0.0 111.255 178.578 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' C' C ' 128' ' ' ASP . . . . . . . . . . . . . 21.2 p-10 -113.95 1.19 14.63 Favored 'General case' 0 N--CA 1.469 0.487 0 CA-C-N 119.501 1.046 . . . . 0.0 113.423 -176.916 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' C' C ' 129' ' ' LEU . . . . . . . . . . . . . 12.1 tp -108.13 137.77 45.54 Favored 'General case' 0 C--N 1.332 -0.166 0 N-CA-C 109.728 -0.471 . . . . 0.0 109.728 179.155 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' C' C ' 130' ' ' VAL . . . . . 0.507 HG13 ' HB ' ' C' ' 141' ' ' ILE . 13.0 p -126.74 137.97 56.21 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.235 0 CA-C-O 121.035 0.445 . . . . 0.0 110.131 179.906 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' C' C ' 131' ' ' VAL . . . . . . . . . . . . . 42.3 t -135.73 141.14 42.9 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.274 0 CA-C-O 121.16 0.505 . . . . 0.0 110.495 -177.358 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' C' C ' 132' ' ' ILE . . . . . . . . . . . . . 73.6 mt -115.92 132.1 66.4 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.345 0 CA-C-N 115.477 -0.783 . . . . 0.0 109.051 177.838 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' C' C ' 133' ' ' ILE . . . . . . . . . . . . . 43.3 mm -113.36 122.21 67.04 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.242 0 CA-C-O 120.9 0.381 . . . . 0.0 110.494 -175.715 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' C' C ' 134' ' ' ASP . . . . . . . . . . . . . 7.4 p-10 -135.17 146.98 49.26 Favored 'General case' 0 C--N 1.331 -0.209 0 CA-C-N 116.045 -0.525 . . . . 0.0 109.892 178.063 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' C' C ' 135' ' ' GLU . . . . . . . . . . . . . 85.2 tt0 -50.01 -27.9 6.16 Favored 'General case' 0 C--N 1.326 -0.417 0 N-CA-C 112.738 0.644 . . . . 0.0 112.738 -174.536 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' C' C ' 136' ' ' GLN . . . . . . . . . . . . . 97.3 mt-30 -79.81 -34.23 39.71 Favored 'General case' 0 C--O 1.233 0.232 0 N-CA-C 112.456 0.539 . . . . 0.0 112.456 -176.818 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' C' C ' 137' ' ' LYS . . . . . . . . . . . . . 53.1 pttt -169.99 177.06 4.46 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-O 121.551 0.691 . . . . 0.0 112.31 -172.289 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' C' C ' 138' ' ' LEU . . . . . 0.418 HD23 ' N ' ' C' ' 139' ' ' THR . 5.7 tt -116.32 126.38 53.44 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 115.126 -0.943 . . . . 0.0 109.634 176.547 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' C' C ' 139' ' ' THR . . . . . 0.418 ' N ' HD23 ' C' ' 138' ' ' LEU . 28.4 m -106.65 123.24 47.82 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.305 -0.407 . . . . 0.0 110.158 -179.638 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' C' C ' 140' ' ' LEU . . . . . 0.457 ' C ' HD23 ' C' ' 140' ' ' LEU . 5.7 tt -108.78 120.77 43.46 Favored 'General case' 0 C--N 1.329 -0.321 0 N-CA-C 109.114 -0.699 . . . . 0.0 109.114 -178.311 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' C' C ' 141' ' ' ILE . . . . . 0.507 ' HB ' HG13 ' C' ' 130' ' ' VAL . 21.1 mt -123.38 118.91 55.98 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.286 0 CA-C-O 121.211 0.529 . . . . 0.0 109.833 -177.153 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' C' C ' 142' ' ' ARG . . . . . . . . . . . . . 47.0 ttt180 . . . . . 0 C--N 1.328 -0.333 0 CA-C-N 115.207 -0.906 . . . . 0.0 110.002 179.838 . . . . . . . . 0 0 . 1 . 006 nuclear build core ' D' D ' 2' ' ' SER . . . . . . . . . . . . . 3.2 p . . . . . 0 C--O 1.23 0.068 0 CA-C-O 120.788 0.327 . . . . 0.0 110.219 . . . . . . . . . 0 0 . 1 . 006 nuclear build core ' D' D ' 3' ' ' GLU . . . . . . . . . . . . . 95.6 mt-10 -141.02 139.67 34.17 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-O 120.971 0.415 . . . . 0.0 111.074 -178.985 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' D' D ' 4' ' ' LEU . . . . . . . . . . . . . 20.1 tp -123.55 125.21 44.46 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 115.889 -0.596 . . . . 0.0 110.108 176.402 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' D' D ' 5' ' ' LYS . . . . . . . . . . . . . 54.2 mtmt -104.22 118.06 35.72 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.156 -0.474 . . . . 0.0 110.725 179.493 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' D' D ' 6' ' ' LEU . . . . . 0.404 HD23 ' HA ' ' D' ' 50' ' ' VAL . 26.3 mt -115.15 146.0 41.81 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 115.632 -0.713 . . . . 0.0 110.087 179.877 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' D' D ' 7' ' ' LYS . . . . . . . . . . . . . 74.2 tttt -131.93 139.56 35.44 Favored Pre-proline 0 CA--C 1.534 0.347 0 CA-C-O 119.164 -0.446 . . . . 0.0 109.841 176.763 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' D' D ' 8' ' ' PRO . . . . . . . . . . . . . 84.4 Cg_endo -91.96 139.23 2.1 Favored 'Trans proline' 0 N--CA 1.49 1.306 0 C-N-CA 121.776 1.651 . . . . 0.0 111.802 177.782 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' D' D ' 9' ' ' LEU . . . . . . . . . . . . . 59.0 mt -76.14 -46.93 3.65 Favored Pre-proline 0 CA--C 1.533 0.313 0 CA-C-O 118.818 -0.611 . . . . 0.0 112.146 -179.59 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' D' D ' 10' ' ' PRO . . . . . . . . . . . . . 89.1 Cg_endo -81.88 147.06 14.98 Favored 'Trans proline' 0 N--CA 1.495 1.582 0 C-N-CA 121.269 1.313 . . . . 0.0 111.614 174.175 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' D' D ' 11' ' ' LYS . . . . . . . . . . . . . 83.9 tttt -85.07 99.81 11.28 Favored 'General case' 0 C--N 1.33 -0.263 0 C-N-CA 120.801 -0.36 . . . . 0.0 110.136 178.84 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' D' D ' 12' ' ' VAL . . . . . . . . . . . . . 12.2 p -140.84 144.38 27.03 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.257 0 CA-C-N 116.219 -0.446 . . . . 0.0 110.65 -177.788 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' D' D ' 13' ' ' GLU . . . . . . . . . . . . . 43.4 mt-10 -77.69 130.32 36.65 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.253 -0.43 . . . . 0.0 110.02 176.687 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' D' D ' 14' ' ' LEU . . . . . . . . . . . . . 27.3 mt -97.88 146.1 30.89 Favored Pre-proline 0 C--N 1.329 -0.286 0 CA-C-O 119.096 -0.478 . . . . 0.0 109.996 -179.717 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' D' D ' 15' ' ' PRO . . . . . . . . . . . . . 26.9 Cg_exo -61.83 158.69 36.73 Favored 'Trans proline' 0 N--CA 1.498 1.741 0 C-N-CA 121.261 1.307 . . . . 0.0 111.693 177.144 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' D' D ' 16' ' ' PRO . . . . . . . . . . . . . 38.7 Cg_exo -58.79 -34.06 98.79 Favored 'Trans proline' 0 N--CA 1.497 1.711 0 C-N-CA 121.516 1.477 . . . . 0.0 112.898 -178.196 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' D' D ' 17' ' ' ASP . . . . . . . . . . . . . 17.3 p-10 -92.45 9.65 33.43 Favored 'General case' 0 CA--C 1.535 0.389 0 N-CA-C 113.322 0.86 . . . . 0.0 113.322 -177.348 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' D' D ' 18' ' ' PHE . . . . . . . . . . . . . 50.7 t80 -58.15 -45.71 86.93 Favored 'General case' 0 N--CA 1.457 -0.115 0 CA-C-O 121.04 0.448 . . . . 0.0 110.219 -177.709 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' D' D ' 19' ' ' VAL . . . . . . . . . . . . . 47.3 t -56.24 -44.01 78.17 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.337 0 CA-C-N 116.085 -0.507 . . . . 0.0 110.557 -177.493 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' D' D ' 20' ' ' ASP . . . . . . . . . . . . . 44.4 t0 -59.86 -43.41 94.7 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-O 120.729 0.3 . . . . 0.0 110.95 -177.338 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' D' D ' 21' ' ' VAL . . . . . . . . . . . . . 47.5 t -63.93 -46.65 93.49 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.305 0 C-N-CA 120.702 -0.399 . . . . 0.0 110.506 -177.086 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' D' D ' 22' ' ' ILE . . . . . 0.503 HG22 HD12 ' D' ' 26' ' ' LEU . 51.4 mm -55.87 -47.95 79.01 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.275 0 C-N-CA 120.946 -0.301 . . . . 0.0 110.774 179.937 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' D' D ' 23' ' ' ARG . . . . . . . . . . . . . 60.8 ttp180 -54.93 -48.76 72.7 Favored 'General case' 0 C--N 1.331 -0.233 0 C-N-CA 121.06 -0.256 . . . . 0.0 111.347 -178.143 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' D' D ' 24' ' ' ILE . . . . . . . . . . . . . 77.0 mt -59.33 -41.96 85.85 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.357 0 C-N-CA 121.027 -0.269 . . . . 0.0 111.21 -177.126 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' D' D ' 25' ' ' LYS . . . . . . . . . . . . . 73.5 mmtt -65.49 -43.58 89.75 Favored 'General case' 0 C--N 1.329 -0.312 0 N-CA-C 112.445 0.535 . . . . 0.0 112.445 -179.54 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' D' D ' 26' ' ' LEU . . . . . 0.503 HD12 HG22 ' D' ' 22' ' ' ILE . 83.8 mt -78.26 -36.15 47.19 Favored 'General case' 0 C--N 1.329 -0.308 0 N-CA-C 113.287 0.847 . . . . 0.0 113.287 -170.181 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' D' D ' 27' ' ' GLN . . . . . . . . . . . . . 4.6 pt20 -46.3 137.08 6.61 Favored 'General case' 0 N--CA 1.467 0.391 0 N-CA-C 112.871 0.693 . . . . 0.0 112.871 -174.709 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' D' D ' 28' ' ' GLY . . . . . . . . . . . . . . . 99.43 -25.37 28.52 Favored Glycine 0 CA--C 1.533 1.186 0 CA-C-N 115.883 -0.598 . . . . 0.0 112.374 -178.383 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' D' D ' 29' ' ' LYS . . . . . . . . . . . . . 54.7 mtmt -97.88 155.2 17.18 Favored 'General case' 0 C--N 1.332 -0.187 0 CA-C-N 117.341 0.57 . . . . 0.0 111.253 179.76 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' D' D ' 30' ' ' THR . . . . . . . . . . . . . 25.0 m -106.46 138.39 42.72 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 115.908 -0.587 . . . . 0.0 109.992 176.654 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' D' D ' 31' ' ' VAL . . . . . . . . . . . . . 35.8 m -128.85 155.96 41.12 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.239 0 CA-C-N 116.303 -0.408 . . . . 0.0 110.876 -178.486 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' D' D ' 32' ' ' ARG . . . . . . . . . . . . . 77.5 mtt85 -129.46 148.09 51.34 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-N 116.06 -0.518 . . . . 0.0 110.697 178.811 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' D' D ' 33' ' ' THR . . . . . . . . . . . . . 26.7 m -53.87 140.15 31.38 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.34 -0.391 . . . . 0.0 111.27 -179.703 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' D' D ' 34' ' ' GLY . . . . . . . . . . . . . . . 100.71 -17.1 56.99 Favored Glycine 0 CA--C 1.532 1.118 0 CA-C-O 119.618 -0.545 . . . . 0.0 113.306 179.541 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' D' D ' 35' ' ' ASP . . . . . . . . . . . . . 78.7 m-20 -66.51 147.87 52.68 Favored 'General case' 0 C--O 1.232 0.167 0 CA-C-N 118.017 0.909 . . . . 0.0 111.179 178.881 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' D' D ' 36' ' ' VAL . . . . . . . . . . . . . 45.1 t -121.63 129.81 75.18 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.206 0 CA-C-N 116.003 -0.544 . . . . 0.0 109.728 177.317 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' D' D ' 37' ' ' ILE . . . . . . . . . . . . . 68.0 mt -122.64 140.14 47.35 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.264 0 CA-C-N 116.293 -0.412 . . . . 0.0 110.109 -178.332 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' D' D ' 38' ' ' GLY . . . . . . . . . . . . . . . -108.96 128.74 9.18 Favored Glycine 0 CA--C 1.526 0.719 0 N-CA-C 111.086 -0.806 . . . . 0.0 111.086 179.166 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' D' D ' 39' ' ' ILE . . . . . . . . . . . . . 74.6 mt -125.54 140.81 47.29 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.258 0 N-CA-C 110.104 -0.332 . . . . 0.0 110.104 179.445 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' D' D ' 40' ' ' SER . . . . . 0.531 ' O ' HD13 ' D' ' 41' ' ' ILE . 36.3 t -92.13 117.57 29.98 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.41 -0.359 . . . . 0.0 110.828 175.998 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' D' D ' 41' ' ' ILE . . . . . 0.531 HD13 ' O ' ' D' ' 40' ' ' SER . 48.1 mm -130.03 123.35 56.13 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.243 0 N-CA-C 110.174 -0.306 . . . . 0.0 110.174 178.852 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' D' D ' 42' ' ' LEU . . . . . . . . . . . . . 9.0 tp 58.09 33.45 23.18 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.241 -0.436 . . . . 0.0 111.68 178.674 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' D' D ' 43' ' ' GLY . . . . . . . . . . . . . . . 77.02 -10.04 21.96 Favored Glycine 0 CA--C 1.534 1.262 0 C-N-CA 121.258 -0.496 . . . . 0.0 113.517 178.152 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' D' D ' 44' ' ' LYS . . . . . . . . . . . . . 99.2 mttt -103.06 146.26 28.64 Favored 'General case' 0 C--N 1.334 -0.081 0 CA-C-N 117.884 0.842 . . . . 0.0 110.081 178.443 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' D' D ' 45' ' ' GLU . . . . . . . . . . . . . 81.8 tt0 -83.85 127.42 33.82 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.377 -0.374 . . . . 0.0 110.797 -179.51 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' D' D ' 46' ' ' VAL . . . . . . . . . . . . . 7.4 p -122.11 128.8 75.66 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.183 0 N-CA-C 109.521 -0.548 . . . . 0.0 109.521 176.393 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' D' D ' 47' ' ' LYS . . . . . . . . . . . . . 89.8 mttt -100.1 130.0 46.2 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 115.993 -0.549 . . . . 0.0 111.28 178.969 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' D' D ' 48' ' ' PHE . . . . . . . . . . . . . 92.0 m-85 -113.43 131.77 55.89 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.01 176.541 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' D' D ' 49' ' ' LYS . . . . . . . . . . . . . 80.7 tttt -108.34 137.6 46.04 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 116.309 -0.405 . . . . 0.0 110.337 178.797 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' D' D ' 50' ' ' VAL . . . . . 0.404 ' HA ' HD23 ' D' ' 6' ' ' LEU . 44.1 t -82.39 109.71 16.7 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.288 0 N-CA-C 109.521 -0.548 . . . . 0.0 109.521 176.81 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' D' D ' 51' ' ' VAL . . . . . . . . . . . . . 47.8 t -72.82 -48.79 43.91 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.326 0 CA-C-N 115.794 -0.639 . . . . 0.0 110.043 -175.228 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' D' D ' 52' ' ' GLN . . . . . . . . . . . . . 49.7 tt0 -162.96 142.09 8.7 Favored 'General case' 0 C--N 1.332 -0.168 0 C-N-CA 120.037 -0.665 . . . . 0.0 111.941 -178.663 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' D' D ' 53' ' ' ALA . . . . . 0.414 ' HB1' ' HB2' ' D' ' 58' ' ' LEU . . . -116.83 132.63 56.65 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 115.766 -0.652 . . . . 0.0 109.998 175.577 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' D' D ' 54' ' ' TYR . . . . . . . . . . . . . 67.1 t80 -129.01 111.97 18.51 Favored Pre-proline 0 CA--C 1.535 0.379 0 CA-C-O 118.204 -0.903 . . . . 0.0 110.487 179.384 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' D' D ' 55' ' ' PRO . . . . . . . . . . . . . 74.4 Cg_endo -77.2 169.32 74.5 Favored 'Cis proline' 0 N--CA 1.499 1.848 0 CA-C-N 122.027 1.76 . . . . 0.0 112.198 -5.979 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' D' D ' 56' ' ' SER . . . . . . . . . . . . . 13.6 m -115.24 128.96 25.49 Favored Pre-proline 0 CA--C 1.539 0.525 0 CA-C-O 118.388 -0.815 . . . . 0.0 109.424 176.521 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' D' D ' 57' ' ' PRO . . . . . . . . . . . . . 56.7 Cg_endo -71.77 148.13 89.82 Favored 'Cis proline' 0 N--CA 1.497 1.688 0 CA-C-N 121.958 1.735 . . . . 0.0 111.62 0.19 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' D' D ' 58' ' ' LEU . . . . . 0.414 ' HB2' ' HB1' ' D' ' 53' ' ' ALA . 14.2 tp -107.69 135.73 48.63 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 116.296 -0.411 . . . . 0.0 110.559 -178.567 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' D' D ' 59' ' ' ARG . . . . . . . . . . . . . 43.6 ttp180 -106.19 124.47 49.64 Favored 'General case' 0 C--N 1.327 -0.41 0 N-CA-C 109.324 -0.621 . . . . 0.0 109.324 175.891 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' D' D ' 60' ' ' VAL . . . . . . . . . . . . . 41.4 t -79.98 120.99 32.47 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.299 0 C-N-CA 120.741 -0.384 . . . . 0.0 110.352 -175.46 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' D' D ' 61' ' ' GLU . . . . . . . . . . . . . 42.6 mt-10 -130.97 170.22 14.77 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.066 -0.515 . . . . 0.0 110.129 178.425 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' D' D ' 62' ' ' ASP . . . . . . . . . . . . . 45.1 m-20 -54.31 -32.54 56.79 Favored 'General case' 0 C--N 1.327 -0.379 0 N-CA-C 111.847 0.314 . . . . 0.0 111.847 -178.151 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' D' D ' 63' ' ' ARG . . . . . . . . . . . . . 30.7 ptt180 -88.47 4.41 46.64 Favored 'General case' 0 CA--C 1.537 0.446 0 N-CA-C 113.751 1.019 . . . . 0.0 113.751 -175.011 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' D' D ' 64' ' ' THR . . . . . . . . . . . . . 32.3 m -85.4 136.97 33.23 Favored 'General case' 0 C--N 1.332 -0.163 0 CA-C-O 120.934 0.397 . . . . 0.0 110.628 -178.609 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' D' D ' 65' ' ' LYS . . . . . . . . . . . . . 90.5 mttt -89.61 129.79 36.01 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.096 -0.502 . . . . 0.0 110.223 179.306 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' D' D ' 66' ' ' ILE . . . . . . . . . . . . . 62.5 mt -113.55 128.6 70.33 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.26 0 N-CA-C 109.575 -0.528 . . . . 0.0 109.575 178.684 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' D' D ' 67' ' ' THR . . . . . . . . . . . . . 27.0 m -122.3 138.73 54.41 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-O 120.991 0.424 . . . . 0.0 111.118 -176.31 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' D' D ' 68' ' ' LEU . . . . . . . . . . . . . 7.3 mp . . . . . 0 C--N 1.33 -0.264 0 CA-C-N 115.863 -0.608 . . . . 0.0 110.282 177.706 . . . . . . . . 0 0 . 1 . 006 nuclear build core ' D' D ' 73' ' ' VAL . . . . . . . . . . . . . 15.6 m . . . . . 0 N--CA 1.462 0.161 0 CA-C-O 120.993 0.425 . . . . 0.0 110.667 . . . . . . . . . 0 0 . 1 . 006 nuclear build core ' D' D ' 74' ' ' ASP . . . . . . . . . . . . . 5.0 t70 -108.77 118.87 37.92 Favored 'General case' 0 C--N 1.328 -0.362 0 N-CA-C 109.288 -0.634 . . . . 0.0 109.288 174.541 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' D' D ' 75' ' ' VAL . . . . . 0.407 ' C ' HD12 ' D' ' 76' ' ' LEU . 41.9 t -113.74 125.68 71.06 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.214 0 CA-C-O 121.059 0.457 . . . . 0.0 110.898 -175.854 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' D' D ' 76' ' ' LEU . . . . . 0.407 HD12 ' C ' ' D' ' 75' ' ' VAL . 5.6 mp -125.56 146.42 49.69 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 115.581 -0.736 . . . . 0.0 109.538 174.953 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' D' D ' 77' ' ' GLU . . . . . . . . . . . . . 99.2 mt-10 -134.23 131.23 38.27 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-O 121.134 0.492 . . . . 0.0 111.291 -176.95 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' D' D ' 78' ' ' ALA . . . . . . . . . . . . . . . -118.38 121.72 41.06 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 115.69 -0.686 . . . . 0.0 109.558 176.647 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' D' D ' 79' ' ' LYS . . . . . 0.644 ' O ' HD13 ' D' ' 80' ' ' ILE . 19.2 pttp -71.77 122.65 21.04 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-O 121.134 0.492 . . . . 0.0 110.96 -178.091 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' D' D ' 80' ' ' ILE . . . . . 0.644 HD13 ' O ' ' D' ' 79' ' ' LYS . 37.4 mm -139.19 108.87 3.94 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.355 0 N-CA-C 109.023 -0.732 . . . . 0.0 109.023 -178.122 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' D' D ' 81' ' ' LYS . . . . . . . . . . . . . 50.7 pttt -97.59 123.7 41.58 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-O 120.941 0.401 . . . . 0.0 111.152 -177.617 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' D' D ' 82' ' ' GLY . . . . . . . . . . . . . . . 88.97 42.26 5.69 Favored Glycine 0 CA--C 1.525 0.699 0 C-N-CA 120.718 -0.753 . . . . 0.0 111.533 174.649 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' D' D ' 83' ' ' ILE . . . . . . . . . . . . . 75.3 mt -65.91 137.17 25.41 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.332 0 N-CA-C 109.809 -0.441 . . . . 0.0 109.809 178.106 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' D' D ' 84' ' ' LYS . . . . . . . . . . . . . 50.9 tttp -98.59 -54.18 3.1 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.246 -0.434 . . . . 0.0 110.283 -179.469 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' D' D ' 85' ' ' ASP . . . . . . . . . . . . . 13.4 t70 -151.77 150.89 30.67 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 115.902 -0.59 . . . . 0.0 110.456 -179.474 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' D' D ' 86' ' ' VAL . . . . . . . . . . . . . 42.5 t -129.86 129.79 66.18 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.248 0 CA-C-O 120.974 0.416 . . . . 0.0 110.598 -179.058 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' D' D ' 87' ' ' ILE . . . . . . . . . . . . . 45.2 mm -118.83 125.79 74.75 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.286 0 CA-C-N 115.826 -0.625 . . . . 0.0 109.373 175.31 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' D' D ' 88' ' ' LEU . . . . . . . . . . . . . 30.8 mt -118.65 138.84 52.33 Favored 'General case' 0 C--N 1.332 -0.188 0 CA-C-O 121.316 0.579 . . . . 0.0 111.941 -175.427 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' D' D ' 89' ' ' ASP . . . . . . . . . . . . . 12.2 t0 -136.09 151.72 50.11 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 115.171 -0.922 . . . . 0.0 108.764 174.725 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' D' D ' 90' ' ' GLU . . . . . . . . . . . . . 83.5 tt0 -49.0 -31.8 8.13 Favored 'General case' 0 C--N 1.329 -0.32 0 N-CA-C 112.876 0.695 . . . . 0.0 112.876 -172.829 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' D' D ' 91' ' ' ASN . . . . . . . . . . . . . 12.4 p30 -117.24 3.07 12.62 Favored 'General case' 0 N--CA 1.469 0.513 0 N-CA-C 113.815 1.043 . . . . 0.0 113.815 -174.867 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' D' D ' 92' ' ' LEU . . . . . . . . . . . . . 17.7 mt -148.47 148.45 30.29 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 118.241 0.473 . . . . 0.0 110.647 -175.421 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' D' D ' 93' ' ' ILE . . . . . . . . . . . . . 75.9 mt -129.65 118.36 44.84 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.285 0 N-CA-C 109.233 -0.654 . . . . 0.0 109.233 176.949 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' D' D ' 94' ' ' VAL . . . . . . . . . . . . . 44.7 t -118.29 125.12 74.05 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.288 0 N-CA-C 109.884 -0.413 . . . . 0.0 109.884 -178.786 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' D' D ' 95' ' ' VAL . . . . . . . . . . . . . 43.5 t -120.91 134.09 65.45 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.343 0 CA-C-N 116.133 -0.485 . . . . 0.0 109.841 -179.703 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' D' D ' 96' ' ' ILE . . . . . . . . . . . . . 68.6 mt -114.42 126.71 72.01 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.339 0 N-CA-C 109.042 -0.725 . . . . 0.0 109.042 178.439 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' D' D ' 97' ' ' THR . . . . . . . . . . . . . 79.7 p -98.82 158.15 15.82 Favored 'General case' 0 C--N 1.331 -0.239 0 CA-C-O 121.176 0.512 . . . . 0.0 111.124 -176.965 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' D' D ' 98' ' ' GLU . . . . . . . . . . . . . 83.1 tt0 -53.98 -27.3 30.61 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-N 116.093 -0.503 . . . . 0.0 112.065 179.843 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' D' D ' 99' ' ' GLU . . . . . . . . . . . . . 96.6 mt-10 -78.07 13.48 1.43 Allowed 'General case' 0 CA--C 1.536 0.421 0 N-CA-C 113.294 0.85 . . . . 0.0 113.294 -176.852 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' D' D ' 100' ' ' ASN . . . . . . . . . . . . . 3.2 m-20 62.49 32.93 16.4 Favored 'General case' 0 N--CA 1.464 0.266 0 CA-C-O 120.898 0.38 . . . . 0.0 111.637 179.155 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' D' D ' 101' ' ' GLU . . . . . . . . . . . . . 84.6 tt0 -109.59 144.4 37.95 Favored 'General case' 0 C--N 1.334 -0.105 0 N-CA-C 109.709 -0.478 . . . . 0.0 109.709 173.247 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' D' D ' 102' ' ' VAL . . . . . . . . . . . . . 45.9 t -114.94 125.88 72.37 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.331 0 CA-C-N 116.113 -0.494 . . . . 0.0 109.858 -178.181 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' D' D ' 103' ' ' LEU . . . . . . . . . . . . . 53.1 mt -117.71 129.77 55.92 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 115.998 -0.546 . . . . 0.0 110.331 177.553 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' D' D ' 104' ' ' ILE . . . . . . . . . . . . . 70.3 mt -118.15 119.58 61.83 Favored 'Isoleucine or valine' 0 C--O 1.234 0.256 0 CA-C-N 116.393 -0.367 . . . . 0.0 110.173 -179.692 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' D' D ' 105' ' ' PHE . . . . . . . . . . . . . 46.6 m-85 -121.55 168.15 12.07 Favored 'General case' 0 C--N 1.332 -0.194 0 O-C-N 123.879 0.737 . . . . 0.0 109.738 179.794 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' D' D ' 106' ' ' ASN . . . . . . . . . . . . . 44.0 p-10 -99.42 -170.2 1.87 Allowed 'General case' 0 C--N 1.331 -0.217 0 N-CA-C 109.734 -0.469 . . . . 0.0 109.734 172.036 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' D' D ' 107' ' ' GLN . . . . . . . . . . . . . 59.3 tt0 -59.37 -30.03 68.12 Favored 'General case' 0 C--N 1.329 -0.31 0 N-CA-C 111.824 0.305 . . . . 0.0 111.824 -179.724 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' D' D ' 108' ' ' ASN . . . . . . . . . . . . . 11.8 t-20 -86.56 13.53 8.34 Favored 'General case' 0 CA--C 1.535 0.399 0 N-CA-C 112.904 0.705 . . . . 0.0 112.904 -177.152 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' D' D ' 109' ' ' LEU . . . . . . . . . . . . . 21.7 mt 58.51 34.03 23.58 Favored 'General case' 0 C--O 1.233 0.198 0 CA-C-O 120.73 0.3 . . . . 0.0 111.747 177.563 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' D' D ' 110' ' ' GLU . . . . . . . . . . . . . 96.1 mt-10 -99.73 138.8 36.31 Favored 'General case' 0 C--N 1.33 -0.28 0 N-CA-C 109.455 -0.572 . . . . 0.0 109.455 175.222 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' D' D ' 111' ' ' GLU . . . . . . . . . . . . . 48.3 tt0 -79.67 121.86 25.83 Favored 'General case' 0 C--N 1.327 -0.373 0 C-N-CA 120.759 -0.376 . . . . 0.0 110.293 -176.402 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' D' D ' 112' ' ' LEU . . . . . . . . . . . . . 26.6 mt -105.79 -46.01 4.24 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.019 -0.537 . . . . 0.0 110.432 179.656 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' D' D ' 113' ' ' TYR . . . . . . . . . . . . . 61.3 t80 -135.91 138.85 42.83 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.089 -0.505 . . . . 0.0 110.838 -179.041 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' D' D ' 114' ' ' ARG . . . . . . . . . . . . . 39.6 ptt180 -141.6 126.38 18.07 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-O 120.941 0.401 . . . . 0.0 110.681 176.913 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' D' D ' 115' ' ' GLY . . . . . . . . . . . . . . . -150.06 163.08 29.38 Favored Glycine 0 CA--C 1.522 0.515 0 N-CA-C 110.604 -0.999 . . . . 0.0 110.604 -179.723 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' D' D ' 116' ' ' LYS . . . . . . . . . . . . . 72.4 tttt -134.35 134.07 41.35 Favored 'General case' 0 C--N 1.33 -0.257 0 N-CA-C 110.093 -0.336 . . . . 0.0 110.093 179.192 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' D' D ' 117' ' ' PHE . . . . . . . . . . . . . 39.2 m-85 -134.03 114.01 12.74 Favored 'General case' 0 C--N 1.331 -0.209 0 CA-C-N 116.328 -0.396 . . . . 0.0 110.124 -175.18 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' D' D ' 118' ' ' GLU . . . . . . . . . . . . . 45.0 tp10 -53.49 -43.82 68.54 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.467 -0.333 . . . . 0.0 111.526 -175.665 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' D' D ' 119' ' ' ASN . . . . . . . . . . . . . 80.4 m-20 -99.69 31.04 3.36 Favored 'General case' 0 C--N 1.332 -0.175 0 N-CA-C 112.319 0.489 . . . . 0.0 112.319 -173.875 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' D' D ' 120' ' ' LEU . . . . . . . . . . . . . 15.0 tp -57.44 122.72 13.31 Favored 'General case' 0 C--N 1.331 -0.213 0 N-CA-C 110.162 -0.31 . . . . 0.0 110.162 177.386 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' D' D ' 121' ' ' ASN . . . . . . . . . . . . . 73.8 m-20 -114.02 -44.15 3.18 Favored 'General case' 0 C--O 1.232 0.153 0 CA-C-N 116.689 -0.232 . . . . 0.0 111.378 -176.883 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' D' D ' 122' ' ' LYS . . . . . . . . . . . . . 98.0 mttt -143.83 147.02 33.5 Favored 'General case' 0 C--N 1.333 -0.15 0 CA-C-O 121.072 0.463 . . . . 0.0 111.657 -178.36 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' D' D ' 123' ' ' VAL . . . . . 0.44 ' C ' HD12 ' D' ' 124' ' ' LEU . 45.4 t -127.21 124.33 63.96 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.256 0 N-CA-C 109.302 -0.629 . . . . 0.0 109.302 174.158 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' D' D ' 124' ' ' LEU . . . . . 0.485 ' N ' HD12 ' D' ' 124' ' ' LEU . 7.2 mp -115.39 131.49 56.91 Favored 'General case' 0 C--N 1.331 -0.229 0 CA-C-N 116.306 -0.406 . . . . 0.0 110.617 -177.898 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' D' D ' 125' ' ' VAL . . . . . . . . . . . . . 45.9 t -126.72 126.83 69.39 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.243 0 CA-C-N 116.128 -0.487 . . . . 0.0 109.999 179.49 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' D' D ' 126' ' ' ARG . . . . . . . . . . . . . 69.6 ttt180 -155.22 141.13 18.22 Favored 'General case' 0 C--N 1.328 -0.356 0 N-CA-C 109.527 -0.545 . . . . 0.0 109.527 177.542 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' D' D ' 127' ' ' ASN . . . . . . . . . . . . . 9.7 p30 48.73 -151.84 0.13 Allowed 'General case' 0 CA--C 1.54 0.593 0 CA-C-O 119.299 -0.381 . . . . 0.0 110.897 178.989 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' D' D ' 128' ' ' ASP . . . . . . . . . . . . . 12.7 p-10 -84.49 22.71 1.23 Allowed 'General case' 0 CA--C 1.535 0.385 0 CA-C-N 118.61 0.641 . . . . 0.0 112.264 177.705 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' D' D ' 129' ' ' LEU . . . . . . . . . . . . . 13.4 tp -120.72 137.02 54.7 Favored 'General case' 0 C--O 1.233 0.216 0 CA-C-O 121.061 0.458 . . . . 0.0 110.508 -179.605 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' D' D ' 130' ' ' VAL . . . . . . . . . . . . . 45.0 t -123.24 136.01 61.32 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.218 0 CA-C-N 115.949 -0.569 . . . . 0.0 109.61 178.26 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' D' D ' 131' ' ' VAL . . . . . . . . . . . . . 42.2 t -134.9 136.82 51.63 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.238 0 CA-C-O 121.186 0.517 . . . . 0.0 110.516 179.957 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' D' D ' 132' ' ' ILE . . . . . . . . . . . . . 72.1 mt -117.55 133.89 62.87 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.295 0 CA-C-N 115.639 -0.71 . . . . 0.0 109.63 -179.579 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' D' D ' 133' ' ' ILE . . . . . . . . . . . . . 43.1 mm -118.55 122.21 68.92 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.19 0 CA-C-O 120.961 0.41 . . . . 0.0 110.947 -176.221 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' D' D ' 134' ' ' ASP . . . . . . . . . . . . . 8.0 p-10 -135.11 148.04 49.69 Favored 'General case' 0 C--N 1.329 -0.299 0 N-CA-C 109.3 -0.63 . . . . 0.0 109.3 173.029 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' D' D ' 135' ' ' GLU . . . . . . . . . . . . . 43.5 tp10 -49.83 -24.74 2.59 Favored 'General case' 0 C--N 1.327 -0.386 0 N-CA-C 112.768 0.655 . . . . 0.0 112.768 -171.671 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' D' D ' 136' ' ' GLN . . . . . . . . . . . . . 46.5 tt0 -102.83 -24.65 13.69 Favored 'General case' 0 CA--C 1.533 0.298 0 N-CA-C 112.96 0.726 . . . . 0.0 112.96 -173.995 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' D' D ' 137' ' ' LYS . . . . . . . . . . . . . 97.3 mttt -143.65 152.77 41.77 Favored 'General case' 0 C--N 1.331 -0.201 0 CA-C-O 121.168 0.508 . . . . 0.0 111.821 -172.574 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' D' D ' 138' ' ' LEU . . . . . . . . . . . . . 4.4 tt -120.41 121.8 39.32 Favored 'General case' 0 C--N 1.33 -0.262 0 N-CA-C 109.079 -0.712 . . . . 0.0 109.079 172.434 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' D' D ' 139' ' ' THR . . . . . . . . . . . . . 34.3 m -111.23 130.4 55.66 Favored 'General case' 0 C--N 1.332 -0.193 0 CA-C-O 120.734 0.302 . . . . 0.0 111.036 -175.683 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' D' D ' 140' ' ' LEU . . . . . 0.462 ' C ' HD23 ' D' ' 140' ' ' LEU . 5.6 tt -116.98 122.54 44.53 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 115.618 -0.719 . . . . 0.0 109.238 -179.683 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' D' D ' 141' ' ' ILE . . . . . 0.455 ' N ' HD23 ' D' ' 140' ' ' LEU . 18.8 mt -121.6 122.74 67.83 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.248 0 CA-C-O 120.888 0.375 . . . . 0.0 110.085 -175.663 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' D' D ' 142' ' ' ARG . . . . . . . . . . . . . 73.4 mtp180 -110.9 125.95 54.2 Favored 'General case' 0 C--N 1.331 -0.22 0 CA-C-N 115.682 -0.69 . . . . 0.0 110.16 -179.534 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' D' D ' 143' ' ' THR . . . . . . . . . . . . . 66.6 p . . . . . 0 C--O 1.219 -0.503 0 CA-C-O 118.074 -0.965 . . . . 0.0 110.492 -179.796 . . . . . . . . 0 0 . 1 . 006 nuclear build core ' E' E ' 2' ' ' SER . . . . . . . . . . . . . 6.4 p . . . . . 0 N--CA 1.462 0.166 0 CA-C-O 121.033 0.444 . . . . 0.0 110.994 . . . . . . . . . 0 0 . 1 . 006 nuclear build core ' E' E ' 3' ' ' GLU . . . . . . . . . . . . . 95.1 mt-10 -140.91 141.95 34.49 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 115.876 -0.602 . . . . 0.0 110.961 -179.238 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' E' E ' 4' ' ' LEU . . . . . . . . . . . . . 15.0 tp -126.77 126.16 42.95 Favored 'General case' 0 C--N 1.331 -0.206 0 CA-C-N 116.091 -0.504 . . . . 0.0 109.97 176.516 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' E' E ' 5' ' ' LYS . . . . . . . . . . . . . 68.6 mttm -106.11 122.2 45.7 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-O 120.844 0.355 . . . . 0.0 110.826 178.426 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' E' E ' 6' ' ' LEU . . . . . . . . . . . . . 74.6 mt -118.59 146.56 44.52 Favored 'General case' 0 C--N 1.331 -0.209 0 CA-C-N 115.535 -0.757 . . . . 0.0 110.311 179.765 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' E' E ' 7' ' ' LYS . . . . . . . . . . . . . 80.0 tttt -135.66 140.24 33.26 Favored Pre-proline 0 CA--C 1.534 0.335 0 CA-C-O 119.093 -0.479 . . . . 0.0 110.254 176.985 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' E' E ' 8' ' ' PRO . . . . . . . . . . . . . 88.8 Cg_endo -91.98 143.39 2.74 Favored 'Trans proline' 0 N--CA 1.49 1.311 0 C-N-CA 121.827 1.685 . . . . 0.0 111.934 177.773 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' E' E ' 9' ' ' LEU . . . . . . . . . . . . . 60.8 mt -77.37 -47.51 2.52 Favored Pre-proline 0 CA--C 1.533 0.317 0 CA-C-O 118.688 -0.673 . . . . 0.0 112.226 179.533 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' E' E ' 10' ' ' PRO . . . . . . . . . . . . . 94.8 Cg_endo -80.26 142.82 15.31 Favored 'Trans proline' 0 N--CA 1.495 1.582 0 C-N-CA 121.133 1.222 . . . . 0.0 111.518 175.905 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' E' E ' 11' ' ' LYS . . . . . . . . . . . . . 46.0 pttt -83.76 113.38 20.86 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-O 121.496 0.665 . . . . 0.0 110.879 -179.74 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' E' E ' 12' ' ' VAL . . . . . . . . . . . . . 12.2 p -151.18 148.54 14.8 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.284 0 CA-C-N 115.649 -0.705 . . . . 0.0 110.377 179.873 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' E' E ' 13' ' ' GLU . . . . . . . . . . . . . 43.0 mt-10 -83.78 116.03 22.51 Favored 'General case' 0 C--N 1.329 -0.313 0 N-CA-C 110.144 -0.317 . . . . 0.0 110.144 177.658 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' E' E ' 14' ' ' LEU . . . . . . . . . . . . . 31.1 mt -99.33 143.53 26.59 Favored Pre-proline 0 CA--C 1.533 0.309 0 CA-C-O 119.09 -0.481 . . . . 0.0 110.279 -179.439 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' E' E ' 15' ' ' PRO . . . . . . . . . . . . . 25.7 Cg_exo -62.55 157.34 47.11 Favored 'Trans proline' 0 N--CA 1.498 1.774 0 C-N-CA 121.342 1.361 . . . . 0.0 112.013 177.682 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' E' E ' 16' ' ' PRO . . . . . . . . . . . . . 31.4 Cg_exo -59.76 -34.43 95.93 Favored 'Trans proline' 0 N--CA 1.498 1.752 0 C-N-CA 121.452 1.435 . . . . 0.0 112.782 179.969 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' E' E ' 17' ' ' ASP . . . . . . . . . . . . . 9.1 p-10 -83.32 4.43 27.24 Favored 'General case' 0 CA--C 1.537 0.465 0 N-CA-C 113.26 0.837 . . . . 0.0 113.26 -177.462 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' E' E ' 18' ' ' PHE . . . . . . . . . . . . . 33.8 t80 -58.06 -44.69 87.63 Favored 'General case' 0 C--N 1.334 -0.07 0 O-C-N 121.884 -0.51 . . . . 0.0 109.898 -178.574 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' E' E ' 19' ' ' VAL . . . . . . . . . . . . . 48.5 t -58.3 -40.33 77.45 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.361 0 CA-C-N 116.037 -0.529 . . . . 0.0 110.525 -178.725 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' E' E ' 20' ' ' ASP . . . . . . . . . . . . . 11.8 t70 -58.85 -43.74 90.86 Favored 'General case' 0 C--O 1.234 0.268 0 CA-C-O 120.947 0.403 . . . . 0.0 110.772 -177.223 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' E' E ' 21' ' ' VAL . . . . . . . . . . . . . 48.4 t -65.8 -51.98 55.24 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.291 0 C-N-CA 120.662 -0.415 . . . . 0.0 110.517 -179.011 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' E' E ' 22' ' ' ILE . . . . . 0.473 HG22 HD12 ' E' ' 26' ' ' LEU . 50.4 mm -55.24 -54.09 28.29 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.295 0 C-N-CA 120.901 -0.32 . . . . 0.0 111.168 -176.665 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' E' E ' 23' ' ' ARG . . . . . . . . . . . . . 13.8 ptm180 -58.52 -44.45 89.52 Favored 'General case' 0 C--N 1.33 -0.249 0 C-N-CA 120.773 -0.371 . . . . 0.0 111.721 -172.973 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' E' E ' 24' ' ' ILE . . . . . . . . . . . . . 86.9 mt -64.18 -34.97 72.29 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.303 0 C-N-CA 120.767 -0.373 . . . . 0.0 111.355 -177.714 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' E' E ' 25' ' ' LYS . . . . . . . . . . . . . 34.4 mmtp -67.87 -44.07 77.93 Favored 'General case' 0 C--N 1.33 -0.27 0 N-CA-C 112.09 0.404 . . . . 0.0 112.09 177.365 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' E' E ' 26' ' ' LEU . . . . . 0.473 HD12 HG22 ' E' ' 22' ' ' ILE . 75.8 mt -85.49 -23.79 27.63 Favored 'General case' 0 C--N 1.329 -0.294 0 N-CA-C 114.065 1.135 . . . . 0.0 114.065 -170.266 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' E' E ' 27' ' ' GLN . . . . . . . . . . . . . 12.5 pt20 -47.63 145.66 2.58 Favored 'General case' 0 N--CA 1.47 0.535 0 N-CA-C 112.553 0.575 . . . . 0.0 112.553 -176.152 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' E' E ' 28' ' ' GLY . . . . . . . . . . . . . . . 99.77 -23.82 34.58 Favored Glycine 0 CA--C 1.532 1.121 0 CA-C-N 115.512 -0.767 . . . . 0.0 112.2 -175.28 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' E' E ' 29' ' ' LYS . . . . . . . . . . . . . 79.9 mttt -94.54 155.06 17.09 Favored 'General case' 0 C--O 1.233 0.212 0 CA-C-N 117.577 0.689 . . . . 0.0 110.518 177.153 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' E' E ' 30' ' ' THR . . . . . . . . . . . . . 26.9 m -107.48 138.5 43.57 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 116.116 -0.493 . . . . 0.0 110.128 178.056 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' E' E ' 31' ' ' VAL . . . . . . . . . . . . . 34.7 m -127.24 151.66 34.36 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.199 0 CA-C-O 121.005 0.431 . . . . 0.0 110.893 -179.161 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' E' E ' 32' ' ' ARG . . . . . . . . . . . . . 55.0 ttt180 -128.32 150.09 50.23 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 115.893 -0.594 . . . . 0.0 110.073 179.389 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' E' E ' 33' ' ' THR . . . . . . . . . . . . . 23.2 m -52.59 137.62 30.08 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-O 120.733 0.302 . . . . 0.0 111.528 -177.357 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' E' E ' 34' ' ' GLY . . . . . . . . . . . . . . . 100.03 -17.04 57.73 Favored Glycine 0 CA--C 1.533 1.183 0 CA-C-O 119.671 -0.516 . . . . 0.0 113.313 178.763 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' E' E ' 35' ' ' ASP . . . . . . . . . . . . . 76.7 m-20 -67.22 149.88 49.83 Favored 'General case' 0 N--CA 1.462 0.144 0 CA-C-N 117.983 0.891 . . . . 0.0 111.266 179.043 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' E' E ' 36' ' ' VAL . . . . . . . . . . . . . 44.8 t -121.23 130.5 74.59 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.186 0 CA-C-N 115.966 -0.561 . . . . 0.0 109.956 178.464 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' E' E ' 37' ' ' ILE . . . . . . . . . . . . . 69.9 mt -121.27 139.09 49.52 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.279 0 CA-C-N 116.139 -0.482 . . . . 0.0 109.85 179.839 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' E' E ' 38' ' ' GLY . . . . . . . . . . . . . . . -114.33 129.38 8.68 Favored Glycine 0 CA--C 1.527 0.784 0 N-CA-C 111.53 -0.628 . . . . 0.0 111.53 -177.791 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' E' E ' 39' ' ' ILE . . . . . . . . . . . . . 69.9 mt -121.85 136.76 57.71 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.189 0 N-CA-C 109.829 -0.434 . . . . 0.0 109.829 177.765 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' E' E ' 40' ' ' SER . . . . . . . . . . . . . 39.7 t -92.88 113.98 26.41 Favored 'General case' 0 C--N 1.33 -0.264 0 C-N-CA 120.935 -0.306 . . . . 0.0 110.895 176.167 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' E' E ' 41' ' ' ILE . . . . . . . . . . . . . 47.9 mm -120.87 113.2 39.01 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.167 0 N-CA-C 110.157 -0.312 . . . . 0.0 110.157 179.196 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' E' E ' 42' ' ' LEU . . . . . . . . . . . . . 7.0 mp 57.01 36.17 27.41 Favored 'General case' 0 CA--C 1.533 0.298 0 CA-C-O 120.84 0.352 . . . . 0.0 111.232 179.681 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' E' E ' 43' ' ' GLY . . . . . . . . . . . . . . . 77.74 -10.17 26.21 Favored Glycine 0 CA--C 1.535 1.29 0 C-N-CA 121.245 -0.502 . . . . 0.0 113.566 177.708 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' E' E ' 44' ' ' LYS . . . . . . . . . . . . . 49.4 tptt -94.95 132.91 39.27 Favored 'General case' 0 C--N 1.332 -0.19 0 CA-C-N 117.763 0.781 . . . . 0.0 109.695 176.821 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' E' E ' 45' ' ' GLU . . . . . . . . . . . . . 84.5 tt0 -83.49 125.82 32.14 Favored 'General case' 0 C--N 1.328 -0.359 0 C-N-CA 120.838 -0.345 . . . . 0.0 111.003 -178.796 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' E' E ' 46' ' ' VAL . . . . . . . . . . . . . 7.2 p -119.44 124.68 73.42 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.231 0 N-CA-C 109.311 -0.626 . . . . 0.0 109.311 175.268 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' E' E ' 47' ' ' LYS . . . . . . . . . . . . . 60.6 mttp -99.36 128.34 45.47 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 115.976 -0.557 . . . . 0.0 111.11 178.486 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' E' E ' 48' ' ' PHE . . . . . . . . . . . . . 95.7 m-85 -110.2 131.87 54.67 Favored 'General case' 0 C--N 1.329 -0.321 0 N-CA-C 109.687 -0.486 . . . . 0.0 109.687 175.44 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' E' E ' 49' ' ' LYS . . . . . . . . . . . . . 61.9 tttm -106.99 136.6 46.58 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.485 -0.325 . . . . 0.0 110.283 178.984 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' E' E ' 50' ' ' VAL . . . . . . . . . . . . . 45.7 t -75.4 107.29 5.98 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.34 0 N-CA-C 109.023 -0.732 . . . . 0.0 109.023 175.715 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' E' E ' 51' ' ' VAL . . . . . . . . . . . . . 47.0 t -71.34 -48.07 55.98 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.261 0 O-C-N 123.511 0.507 . . . . 0.0 109.856 -174.063 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' E' E ' 52' ' ' GLN . . . . . . . . . . . . . 48.2 tt0 -168.11 135.65 2.19 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 116.051 -0.522 . . . . 0.0 111.445 -179.142 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' E' E ' 53' ' ' ALA . . . . . . . . . . . . . . . -110.34 131.44 55.05 Favored 'General case' 0 C--N 1.331 -0.23 0 CA-C-N 115.943 -0.571 . . . . 0.0 109.865 176.114 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' E' E ' 54' ' ' TYR . . . . . . . . . . . . . 34.0 t80 -129.07 108.0 18.01 Favored Pre-proline 0 CA--C 1.535 0.389 0 CA-C-O 118.28 -0.867 . . . . 0.0 110.379 -179.735 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' E' E ' 55' ' ' PRO . . . . . . . . . . . . . 73.9 Cg_endo -77.09 170.02 72.74 Favored 'Cis proline' 0 N--CA 1.499 1.833 0 CA-C-N 121.85 1.697 . . . . 0.0 112.369 -5.351 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' E' E ' 56' ' ' SER . . . . . . . . . . . . . 48.9 m -115.9 137.12 23.1 Favored Pre-proline 0 CA--C 1.538 0.518 0 CA-C-O 118.51 -0.757 . . . . 0.0 109.565 175.547 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' E' E ' 57' ' ' PRO . . . . . . . . . . . . . 59.7 Cg_endo -73.76 146.79 87.89 Favored 'Cis proline' 0 N--CA 1.497 1.712 0 CA-C-N 121.705 1.644 . . . . 0.0 111.553 -2.481 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' E' E ' 58' ' ' LEU . . . . . . . . . . . . . 31.1 tp -108.38 138.3 44.91 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.375 -0.375 . . . . 0.0 110.762 -177.509 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' E' E ' 59' ' ' ARG . . . . . . . . . . . . . 55.8 ttp180 -102.04 128.71 48.37 Favored 'General case' 0 C--N 1.327 -0.387 0 N-CA-C 109.266 -0.642 . . . . 0.0 109.266 175.837 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' E' E ' 60' ' ' VAL . . . . . . . . . . . . . 42.3 t -84.88 116.36 28.31 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.233 0 C-N-CA 120.743 -0.383 . . . . 0.0 110.815 -173.235 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' E' E ' 61' ' ' GLU . . . . . . . . . . . . . 95.8 mt-10 -131.25 159.47 37.72 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 115.909 -0.587 . . . . 0.0 110.139 175.095 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' E' E ' 62' ' ' ASP . . . . . . . . . . . . . 81.4 m-20 -54.43 -30.79 53.75 Favored 'General case' 0 C--N 1.329 -0.319 0 N-CA-C 111.893 0.331 . . . . 0.0 111.893 179.507 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' E' E ' 63' ' ' ARG . . . . . . . . . . . . . 39.0 ptt180 -78.4 -1.18 32.2 Favored 'General case' 0 CA--C 1.538 0.487 0 N-CA-C 113.72 1.007 . . . . 0.0 113.72 -175.8 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' E' E ' 64' ' ' THR . . . . . . . . . . . . . 31.6 m -93.4 148.25 22.23 Favored 'General case' 0 C--N 1.331 -0.199 0 CA-C-N 118.168 0.44 . . . . 0.0 110.305 -179.134 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' E' E ' 65' ' ' LYS . . . . . . . . . . . . . 43.7 mtmt -86.31 122.44 30.29 Favored 'General case' 0 C--N 1.329 -0.287 0 C-N-CA 120.654 -0.419 . . . . 0.0 110.213 179.413 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' E' E ' 66' ' ' ILE . . . . . . . . . . . . . 61.0 mt -112.26 125.71 69.57 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.246 0 N-CA-C 109.393 -0.595 . . . . 0.0 109.393 179.91 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' E' E ' 67' ' ' THR . . . . . . . . . . . . . 27.8 m -119.33 138.12 53.25 Favored 'General case' 0 C--N 1.331 -0.202 0 CA-C-N 116.235 -0.439 . . . . 0.0 110.891 -175.749 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' E' E ' 68' ' ' LEU . . . . . . . . . . . . . 4.4 tt . . . . . 0 C--N 1.329 -0.31 0 CA-C-N 115.788 -0.642 . . . . 0.0 109.725 178.191 . . . . . . . . 0 0 . 1 . 006 nuclear build core ' E' E ' 73' ' ' VAL . . . . . . . . . . . . . 35.9 m . . . . . 0 C--O 1.233 0.187 0 CA-C-O 120.8 0.333 . . . . 0.0 110.667 . . . . . . . . . 0 0 . 1 . 006 nuclear build core ' E' E ' 74' ' ' ASP . . . . . . . . . . . . . 6.0 t70 -103.04 122.3 44.35 Favored 'General case' 0 C--N 1.329 -0.296 0 N-CA-C 109.614 -0.513 . . . . 0.0 109.614 -178.937 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' E' E ' 75' ' ' VAL . . . . . . . . . . . . . 40.5 t -119.37 125.73 74.68 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.241 0 CA-C-O 121.095 0.474 . . . . 0.0 110.808 -176.699 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' E' E ' 76' ' ' LEU . . . . . . . . . . . . . 6.0 mp -120.51 143.37 48.59 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 115.659 -0.7 . . . . 0.0 109.586 174.701 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' E' E ' 77' ' ' GLU . . . . . . . . . . . . . 47.1 mt-10 -134.99 129.05 33.57 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-O 121.022 0.439 . . . . 0.0 110.768 -178.563 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' E' E ' 78' ' ' ALA . . . . . 0.538 ' HB2' HD21 ' E' ' 109' ' ' LEU . . . -114.47 133.6 55.63 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 115.802 -0.635 . . . . 0.0 109.865 177.854 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' E' E ' 79' ' ' LYS . . . . . 0.58 ' O ' HD13 ' E' ' 80' ' ' ILE . 83.3 tttt -78.8 114.87 18.09 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.332 -0.395 . . . . 0.0 109.981 -179.792 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' E' E ' 80' ' ' ILE . . . . . 0.58 HD13 ' O ' ' E' ' 79' ' ' LYS . 41.9 mm -138.14 121.16 19.77 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.255 0 N-CA-C 109.864 -0.421 . . . . 0.0 109.864 -175.551 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' E' E ' 81' ' ' LYS . . . . . . . . . . . . . 9.6 mtmp? -110.92 126.9 55.22 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-O 120.962 0.41 . . . . 0.0 111.02 -178.426 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' E' E ' 82' ' ' GLY . . . . . . . . . . . . . . . 89.06 42.12 5.7 Favored Glycine 0 CA--C 1.525 0.679 0 C-N-CA 121.003 -0.618 . . . . 0.0 112.025 174.403 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' E' E ' 83' ' ' ILE . . . . . . . . . . . . . 74.7 mt -67.78 133.26 31.88 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.246 0 N-CA-C 109.719 -0.474 . . . . 0.0 109.719 177.329 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' E' E ' 84' ' ' LYS . . . . . . . . . . . . . 83.0 tttt -97.21 -54.15 3.25 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 115.999 -0.546 . . . . 0.0 110.465 -176.979 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' E' E ' 85' ' ' ASP . . . . . . . . . . . . . 13.8 t70 -152.15 149.87 29.24 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 115.604 -0.726 . . . . 0.0 110.163 -179.226 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' E' E ' 86' ' ' VAL . . . . . . . . . . . . . 44.0 t -133.5 131.08 57.31 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.297 0 CA-C-O 120.97 0.414 . . . . 0.0 110.523 -179.66 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' E' E ' 87' ' ' ILE . . . . . . . . . . . . . 46.9 mm -120.07 126.53 75.38 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.254 0 CA-C-N 115.846 -0.616 . . . . 0.0 109.585 176.241 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' E' E ' 88' ' ' LEU . . . . . . . . . . . . . 53.6 mt -110.96 135.75 51.0 Favored 'General case' 0 C--N 1.331 -0.218 0 CA-C-O 121.153 0.501 . . . . 0.0 111.375 -176.243 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' E' E ' 89' ' ' ASP . . . . . . . . . . . . . 7.8 t0 -128.84 150.52 50.3 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 115.596 -0.729 . . . . 0.0 109.034 175.045 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' E' E ' 90' ' ' GLU . . . . . . . . . . . . . 44.1 mt-10 -49.12 -32.82 10.65 Favored 'General case' 0 C--N 1.329 -0.31 0 N-CA-C 112.864 0.69 . . . . 0.0 112.864 -172.339 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' E' E ' 91' ' ' ASN . . . . . . . . . . . . . 65.7 m-80 -131.86 28.68 4.51 Favored 'General case' 0 N--CA 1.467 0.388 0 N-CA-C 112.412 0.523 . . . . 0.0 112.412 -176.208 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' E' E ' 92' ' ' LEU . . . . . . . . . . . . . 9.0 tp -166.2 145.7 6.02 Favored 'General case' 0 C--N 1.33 -0.258 0 N-CA-C 110.207 -0.294 . . . . 0.0 110.207 179.623 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' E' E ' 93' ' ' ILE . . . . . 0.409 HD11 HD11 ' D' ' 140' ' ' LEU . 69.2 mt -127.72 125.17 64.72 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.202 0 N-CA-C 109.795 -0.446 . . . . 0.0 109.795 179.857 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' E' E ' 94' ' ' VAL . . . . . . . . . . . . . 45.8 t -120.88 125.91 74.6 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.22 0 N-CA-C 109.688 -0.486 . . . . 0.0 109.688 179.255 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' E' E ' 95' ' ' VAL . . . . . . . . . . . . . 43.3 t -122.52 135.18 63.44 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.236 0 CA-C-N 116.205 -0.452 . . . . 0.0 109.979 -178.471 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' E' E ' 96' ' ' ILE . . . . . . . . . . . . . 57.1 mt -116.27 130.11 71.57 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 N-CA-C 109.372 -0.603 . . . . 0.0 109.372 179.224 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' E' E ' 97' ' ' THR . . . . . . . . . . . . . 72.9 p -102.23 154.85 18.64 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-O 121.184 0.516 . . . . 0.0 111.056 -178.778 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' E' E ' 98' ' ' GLU . . . . . . . . . . . . . 96.8 mt-10 -54.23 -23.26 14.07 Favored 'General case' 0 CA--C 1.533 0.318 0 N-CA-C 112.366 0.506 . . . . 0.0 112.366 178.932 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' E' E ' 99' ' ' GLU . . . . . . . . . . . . . 32.5 tt0 -79.09 14.69 1.35 Allowed 'General case' 0 CA--C 1.539 0.523 0 N-CA-C 112.688 0.625 . . . . 0.0 112.688 -177.97 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' E' E ' 100' ' ' ASN . . . . . . . . . . . . . 4.4 m-20 62.35 38.06 13.35 Favored 'General case' 0 C--O 1.231 0.117 0 O-C-N 121.801 -0.562 . . . . 0.0 111.002 178.817 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' E' E ' 101' ' ' GLU . . . . . . . . . . . . . 84.9 tt0 -118.01 142.64 47.16 Favored 'General case' 0 C--N 1.331 -0.212 0 CA-C-N 115.996 -0.547 . . . . 0.0 109.845 176.263 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' E' E ' 102' ' ' VAL . . . . . . . . . . . . . 45.5 t -114.97 128.51 72.09 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.306 0 N-CA-C 109.811 -0.44 . . . . 0.0 109.811 -178.688 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' E' E ' 103' ' ' LEU . . . . . . . . . . . . . 51.0 mt -120.29 134.85 55.18 Favored 'General case' 0 C--N 1.331 -0.219 0 CA-C-N 115.865 -0.607 . . . . 0.0 110.382 178.222 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' E' E ' 104' ' ' ILE . . . . . . . . . . . . . 67.8 mt -118.78 124.36 73.03 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.304 0 N-CA-C 110.077 -0.342 . . . . 0.0 110.077 -179.745 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' E' E ' 105' ' ' PHE . . . . . . . . . . . . . 92.2 m-85 -124.07 162.77 22.84 Favored 'General case' 0 C--N 1.332 -0.194 0 O-C-N 123.912 0.758 . . . . 0.0 109.984 -179.981 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' E' E ' 106' ' ' ASN . . . . . . . . . . . . . 47.7 p-10 -98.59 -170.5 1.95 Allowed 'General case' 0 C--N 1.33 -0.279 0 N-CA-C 109.871 -0.418 . . . . 0.0 109.871 174.551 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' E' E ' 107' ' ' GLN . . . . . . . . . . . . . 46.0 tt0 -60.18 -30.07 69.1 Favored 'General case' 0 C--N 1.329 -0.297 0 N-CA-C 111.987 0.366 . . . . 0.0 111.987 -178.827 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' E' E ' 108' ' ' ASN . . . . . . . . . . . . . 59.9 t30 -84.86 10.16 12.34 Favored 'General case' 0 CA--C 1.536 0.439 0 N-CA-C 113.154 0.798 . . . . 0.0 113.154 -177.632 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' E' E ' 109' ' ' LEU . . . . . 0.538 HD21 ' HB2' ' E' ' 78' ' ' ALA . 8.4 tp 58.6 37.18 25.4 Favored 'General case' 0 C--N 1.331 -0.198 0 CA-C-O 121.065 0.459 . . . . 0.0 111.232 179.476 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' E' E ' 110' ' ' GLU . . . . . . . . . . . . . 70.5 mm-40 -103.4 142.16 34.71 Favored 'General case' 0 C--N 1.329 -0.303 0 N-CA-C 109.358 -0.608 . . . . 0.0 109.358 174.908 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' E' E ' 111' ' ' GLU . . . . . . . . . . . . . 71.6 tt0 -78.36 121.77 24.9 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-O 120.94 0.4 . . . . 0.0 110.387 -175.199 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' E' E ' 112' ' ' LEU . . . . . . . . . . . . . 15.3 mt -106.21 -46.02 4.16 Favored 'General case' 0 C--N 1.331 -0.196 0 CA-C-N 116.08 -0.509 . . . . 0.0 110.778 -178.913 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' E' E ' 113' ' ' TYR . . . . . . . . . . . . . 59.0 t80 -137.31 144.38 42.58 Favored 'General case' 0 C--N 1.331 -0.223 0 CA-C-N 116.204 -0.453 . . . . 0.0 111.012 -178.4 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' E' E ' 114' ' ' ARG . . . . . . . . . . . . . 48.1 ptt85 -147.12 125.75 12.53 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.271 -0.422 . . . . 0.0 111.003 179.073 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' E' E ' 115' ' ' GLY . . . . . . . . . . . . . . . -149.98 153.95 25.4 Favored Glycine 0 CA--C 1.525 0.678 0 N-CA-C 111.231 -0.748 . . . . 0.0 111.231 178.206 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' E' E ' 116' ' ' LYS . . . . . . . . . . . . . 25.9 ttpp -124.83 132.49 53.33 Favored 'General case' 0 C--N 1.331 -0.212 0 N-CA-C 109.942 -0.392 . . . . 0.0 109.942 178.352 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' E' E ' 117' ' ' PHE . . . . . . . . . . . . . 48.5 m-85 -130.68 115.9 17.32 Favored 'General case' 0 C--N 1.331 -0.206 0 CA-C-O 120.928 0.394 . . . . 0.0 110.373 -175.568 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' E' E ' 118' ' ' GLU . . . . . . . . . . . . . 46.1 tp10 -52.84 -51.11 62.2 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.36 -0.382 . . . . 0.0 111.784 -174.734 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' E' E ' 119' ' ' ASN . . . . . . . . . . . . . 3.2 p30 -98.45 31.31 2.88 Favored 'General case' 0 C--N 1.33 -0.274 0 N-CA-C 112.197 0.443 . . . . 0.0 112.197 -174.418 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' E' E ' 120' ' ' LEU . . . . . . . . . . . . . 14.5 tp -51.71 124.81 13.24 Favored 'General case' 0 N--CA 1.464 0.237 0 CA-C-O 120.535 0.207 . . . . 0.0 111.057 178.025 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' E' E ' 121' ' ' ASN . . . . . . . . . . . . . 15.6 m120 -113.55 -44.06 3.25 Favored 'General case' 0 C--O 1.232 0.183 0 CA-C-N 116.727 -0.215 . . . . 0.0 111.285 -176.495 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' E' E ' 122' ' ' LYS . . . . . . . . . . . . . 98.8 mttt -145.36 148.53 33.48 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-O 121.049 0.452 . . . . 0.0 111.826 -176.737 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' E' E ' 123' ' ' VAL . . . . . . . . . . . . . 45.6 t -129.41 130.93 67.6 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.293 0 N-CA-C 109.396 -0.594 . . . . 0.0 109.396 175.462 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' E' E ' 124' ' ' LEU . . . . . . . . . . . . . 19.7 tp -130.26 133.97 46.9 Favored 'General case' 0 C--N 1.332 -0.163 0 CA-C-O 120.791 0.329 . . . . 0.0 110.748 -177.179 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' E' E ' 125' ' ' VAL . . . . . . . . . . . . . 11.1 p -133.67 135.49 55.49 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.25 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.303 179.776 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' E' E ' 126' ' ' ARG . . . . . . . . . . . . . 20.8 ttm180 -144.39 121.86 11.71 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.307 -0.406 . . . . 0.0 110.626 178.331 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' E' E ' 127' ' ' ASN . . . . . . . . . . . . . 4.3 m120 49.41 -106.39 0.2 Allowed 'General case' 0 CA--C 1.545 0.77 0 CA-C-O 118.957 -0.544 . . . . 0.0 111.639 178.994 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' E' E ' 128' ' ' ASP . . . . . . . . . . . . . 11.6 p-10 -114.09 4.0 15.47 Favored 'General case' 0 N--CA 1.468 0.468 0 CA-C-N 119.693 1.133 . . . . 0.0 113.408 -177.21 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' E' E ' 129' ' ' LEU . . . . . . . . . . . . . 15.5 tp -107.13 132.67 52.75 Favored 'General case' 0 C--N 1.333 -0.147 0 N-CA-C 109.561 -0.533 . . . . 0.0 109.561 178.617 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' E' E ' 130' ' ' VAL . . . . . . . . . . . . . 41.5 t -122.92 136.55 59.35 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.243 0 CA-C-O 120.668 0.271 . . . . 0.0 110.349 -177.309 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' E' E ' 131' ' ' VAL . . . . . 0.521 HG12 HD12 ' E' ' 140' ' ' LEU . 27.1 m -136.07 140.81 43.23 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.236 0 CA-C-O 121.166 0.508 . . . . 0.0 111.274 177.579 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' E' E ' 132' ' ' ILE . . . . . . . . . . . . . 75.5 mt -121.22 132.4 70.67 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.384 0 CA-C-N 115.39 -0.823 . . . . 0.0 109.171 178.125 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' E' E ' 133' ' ' ILE . . . . . . . . . . . . . 33.2 mm -115.37 121.17 66.65 Favored 'Isoleucine or valine' 0 C--O 1.234 0.251 0 CA-C-O 120.898 0.38 . . . . 0.0 111.237 -173.464 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' E' E ' 134' ' ' ASP . . . . . . . . . . . . . 7.3 p-10 -133.59 146.53 51.05 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 115.904 -0.589 . . . . 0.0 109.584 175.724 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' E' E ' 135' ' ' GLU . . . . . . . . . . . . . 39.2 tp10 -49.93 -26.8 4.49 Favored 'General case' 0 C--N 1.326 -0.422 0 N-CA-C 112.815 0.672 . . . . 0.0 112.815 -173.407 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' E' E ' 136' ' ' GLN . . . . . . . . . . . . . 49.7 tt0 -81.91 -32.99 30.66 Favored 'General case' 0 C--O 1.234 0.274 0 N-CA-C 112.328 0.492 . . . . 0.0 112.328 -175.968 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' E' E ' 137' ' ' LYS . . . . . . . . . . . . . 50.7 pttt -170.06 173.04 6.14 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-O 121.451 0.643 . . . . 0.0 112.27 -172.967 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' E' E ' 138' ' ' LEU . . . . . 0.405 ' C ' HD23 ' E' ' 138' ' ' LEU . 6.6 tt -118.33 129.13 55.26 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 115.212 -0.904 . . . . 0.0 110.055 179.521 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' E' E ' 139' ' ' THR . . . . . . . . . . . . . 24.4 m -106.87 130.25 54.58 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.439 -0.346 . . . . 0.0 110.516 -179.803 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' E' E ' 140' ' ' LEU . . . . . 0.521 HD12 HG12 ' E' ' 131' ' ' VAL . 51.2 tp -118.34 127.21 53.48 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 115.784 -0.644 . . . . 0.0 109.413 -177.766 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' E' E ' 141' ' ' ILE . . . . . . . . . . . . . 19.1 mt -123.49 122.38 64.92 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 CA-C-N 116.397 -0.365 . . . . 0.0 110.143 -174.996 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' E' E ' 142' ' ' ARG . . . . . . . . . . . . . 84.4 mtp180 -108.77 129.41 55.38 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-N 115.523 -0.762 . . . . 0.0 110.455 179.46 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' E' E ' 143' ' ' THR . . . . . . . . . . . . . 40.0 p . . . . . 0 C--O 1.221 -0.442 0 CA-C-O 117.961 -1.018 . . . . 0.0 110.605 179.145 . . . . . . . . 0 0 . 1 . 006 nuclear build core ' F' F ' 1' ' ' MET . . . . . . . . . . . . . 24.2 ptp . . . . . 0 C--O 1.231 0.125 0 CA-C-O 120.784 0.326 . . . . 0.0 110.728 . . . . . . . . . 0 0 . 1 . 006 nuclear build core ' F' F ' 2' ' ' SER . . . . . . . . . . . . . 4.5 p -115.79 131.19 57.01 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.107 -0.497 . . . . 0.0 110.098 177.249 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' F' F ' 3' ' ' GLU . . . . . . . . . . . . . 84.8 tt0 -142.75 141.07 31.67 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.054 -0.521 . . . . 0.0 111.08 -178.304 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' F' F ' 4' ' ' LEU . . . . . . . . . . . . . 18.0 tp -127.41 132.52 50.1 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 115.883 -0.599 . . . . 0.0 110.216 178.097 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' F' F ' 5' ' ' LYS . . . . . . . . . . . . . 68.6 mttm -112.03 121.06 43.95 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-N 116.338 -0.392 . . . . 0.0 110.665 179.477 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' F' F ' 6' ' ' LEU . . . . . . . . . . . . . 68.4 mt -116.61 144.76 44.0 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 115.451 -0.795 . . . . 0.0 110.158 -178.394 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' F' F ' 7' ' ' LYS . . . . . . . . . . . . . 1.7 ttmp? -130.56 135.25 27.1 Favored Pre-proline 0 CA--C 1.534 0.351 0 CA-C-O 118.848 -0.596 . . . . 0.0 110.293 177.627 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' F' F ' 8' ' ' PRO . . . . . . . . . . . . . 62.9 Cg_endo -91.03 137.91 2.26 Favored 'Trans proline' 0 N--CA 1.49 1.265 0 C-N-CA 121.715 1.61 . . . . 0.0 111.348 175.75 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' F' F ' 9' ' ' LEU . . . . . . . . . . . . . 50.6 mt -77.01 -47.45 2.72 Favored Pre-proline 0 CA--C 1.532 0.274 0 CA-C-O 118.762 -0.637 . . . . 0.0 112.241 -176.693 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' F' F ' 10' ' ' PRO . . . . . . . . . . . . . 93.0 Cg_endo -82.03 151.21 16.17 Favored 'Trans proline' 0 N--CA 1.498 1.744 0 C-N-CA 121.178 1.252 . . . . 0.0 111.607 174.956 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' F' F ' 11' ' ' LYS . . . . . . . . . . . . . 19.5 pttp -84.6 114.02 21.68 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-O 121.623 0.725 . . . . 0.0 110.682 178.166 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' F' F ' 12' ' ' VAL . . . . . . . . . . . . . 11.5 p -151.05 148.79 14.69 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.241 0 CA-C-N 115.534 -0.757 . . . . 0.0 110.059 179.918 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' F' F ' 13' ' ' GLU . . . . . . . . . . . . . 84.8 tt0 -89.58 122.87 33.15 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-O 120.822 0.344 . . . . 0.0 110.246 178.458 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' F' F ' 14' ' ' LEU . . . . . . . . . . . . . 21.1 mt -97.61 151.48 37.64 Favored Pre-proline 0 C--N 1.33 -0.266 0 CA-C-N 116.293 -0.412 . . . . 0.0 110.431 -178.342 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' F' F ' 15' ' ' PRO . . . . . . . . . . . . . 27.0 Cg_exo -61.17 156.58 44.38 Favored 'Trans proline' 0 N--CA 1.496 1.676 0 C-N-CA 121.21 1.273 . . . . 0.0 111.577 177.381 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' F' F ' 16' ' ' PRO . . . . . . . . . . . . . 39.5 Cg_exo -58.78 -35.66 98.27 Favored 'Trans proline' 0 N--CA 1.496 1.621 0 C-N-CA 121.436 1.424 . . . . 0.0 112.708 -179.62 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' F' F ' 17' ' ' ASP . . . . . . . . . . . . . 12.4 p-10 -88.24 11.17 17.2 Favored 'General case' 0 CA--C 1.536 0.427 0 N-CA-C 113.12 0.785 . . . . 0.0 113.12 -178.211 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' F' F ' 18' ' ' PHE . . . . . . . . . . . . . 61.6 t80 -58.06 -43.52 86.95 Favored 'General case' 0 C--N 1.333 -0.111 0 O-C-N 121.994 -0.441 . . . . 0.0 110.131 -178.232 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' F' F ' 19' ' ' VAL . . . . . . . . . . . . . 48.5 t -57.01 -42.06 78.54 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.308 0 CA-C-N 116.256 -0.429 . . . . 0.0 110.416 -178.568 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' F' F ' 20' ' ' ASP . . . . . . . . . . . . . 17.0 t0 -59.95 -42.59 94.36 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-O 120.872 0.368 . . . . 0.0 110.882 -178.303 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' F' F ' 21' ' ' VAL . . . . . . . . . . . . . 48.0 t -64.55 -46.23 93.23 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.285 0 C-N-CA 120.84 -0.344 . . . . 0.0 110.518 -177.988 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' F' F ' 22' ' ' ILE . . . . . 0.603 HG22 HD12 ' F' ' 26' ' ' LEU . 48.5 mm -56.34 -45.04 81.35 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.177 0 C-N-CA 120.92 -0.312 . . . . 0.0 110.583 178.968 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' F' F ' 23' ' ' ARG . . . . . . . . . . . . . 56.6 ttp180 -54.39 -48.55 71.42 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-O 120.738 0.304 . . . . 0.0 111.305 -179.27 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' F' F ' 24' ' ' ILE . . . . . . . . . . . . . 72.4 mt -59.19 -44.3 91.54 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.21 0 CA-C-N 116.493 -0.321 . . . . 0.0 110.935 -178.047 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' F' F ' 25' ' ' LYS . . . . . . . . . . . . . 44.8 mtpt -63.91 -43.31 96.33 Favored 'General case' 0 C--N 1.328 -0.347 0 N-CA-C 112.357 0.502 . . . . 0.0 112.357 -177.997 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' F' F ' 26' ' ' LEU . . . . . 0.603 HD12 HG22 ' F' ' 22' ' ' ILE . 67.7 mt -79.18 -40.95 29.55 Favored 'General case' 0 C--N 1.33 -0.273 0 N-CA-C 113.428 0.899 . . . . 0.0 113.428 -170.551 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' F' F ' 27' ' ' GLN . . . . . . . . . . . . . 15.5 pt20 -46.67 137.66 6.73 Favored 'General case' 0 N--CA 1.468 0.449 0 N-CA-C 112.871 0.693 . . . . 0.0 112.871 -174.607 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' F' F ' 28' ' ' GLY . . . . . . . . . . . . . . . 100.47 -25.85 26.76 Favored Glycine 0 CA--C 1.533 1.181 0 CA-C-N 115.571 -0.741 . . . . 0.0 112.312 -177.589 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' F' F ' 29' ' ' LYS . . . . . . . . . . . . . 55.1 mmtt -97.4 155.17 17.03 Favored 'General case' 0 C--O 1.232 0.169 0 CA-C-N 117.272 0.536 . . . . 0.0 111.304 178.253 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' F' F ' 30' ' ' THR . . . . . . . . . . . . . 26.6 m -107.09 134.28 50.45 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 115.517 -0.765 . . . . 0.0 109.577 174.802 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' F' F ' 31' ' ' VAL . . . . . . . . . . . . . 35.0 m -130.1 158.94 42.54 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.226 0 CA-C-O 120.926 0.393 . . . . 0.0 110.918 -177.086 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' F' F ' 32' ' ' ARG . . . . . . . . . . . . . 34.9 mtp180 -131.46 152.82 50.36 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-O 121.458 0.647 . . . . 0.0 110.94 179.095 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' F' F ' 33' ' ' THR . . . . . 0.41 HG23 ' O ' ' F' ' 51' ' ' VAL . 16.8 m -53.53 139.67 30.64 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 115.786 -0.643 . . . . 0.0 111.22 -179.417 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' F' F ' 34' ' ' GLY . . . . . . . . . . . . . . . 101.81 -17.05 55.45 Favored Glycine 0 CA--C 1.533 1.181 0 CA-C-O 119.635 -0.536 . . . . 0.0 113.287 179.261 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' F' F ' 35' ' ' ASP . . . . . . . . . . . . . 72.0 m-20 -64.9 148.4 51.53 Favored 'General case' 0 N--CA 1.461 0.106 0 CA-C-N 118.073 0.936 . . . . 0.0 111.19 178.98 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' F' F ' 36' ' ' VAL . . . . . . . . . . . . . 44.3 t -124.01 131.82 72.32 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.179 0 CA-C-N 115.929 -0.578 . . . . 0.0 109.906 179.844 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' F' F ' 37' ' ' ILE . . . . . . . . . . . . . 68.4 mt -122.93 139.9 48.32 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.195 0 CA-C-N 116.076 -0.511 . . . . 0.0 109.777 179.702 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' F' F ' 38' ' ' GLY . . . . . . . . . . . . . . . -115.2 128.99 8.35 Favored Glycine 0 CA--C 1.526 0.742 0 N-CA-C 110.904 -0.878 . . . . 0.0 110.904 179.508 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' F' F ' 39' ' ' ILE . . . . . . . . . . . . . 72.6 mt -123.69 136.21 60.91 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.229 0 CA-C-O 120.722 0.296 . . . . 0.0 110.359 -179.18 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' F' F ' 40' ' ' SER . . . . . . . . . . . . . 48.0 t -93.77 120.3 33.86 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.326 -0.397 . . . . 0.0 110.654 173.833 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' F' F ' 41' ' ' ILE . . . . . . . . . . . . . 72.3 mt -125.84 121.07 58.91 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.243 0 CA-C-O 120.817 0.341 . . . . 0.0 110.343 178.337 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' F' F ' 42' ' ' LEU . . . . . . . . . . . . . 7.0 mp 50.94 35.09 11.72 Favored 'General case' 0 CA--C 1.532 0.256 0 CA-C-O 121.131 0.491 . . . . 0.0 111.636 178.326 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' F' F ' 43' ' ' GLY . . . . . . . . . . . . . . . 73.03 32.84 60.18 Favored Glycine 0 CA--C 1.527 0.839 0 C-N-CA 121.132 -0.556 . . . . 0.0 112.076 177.842 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' F' F ' 44' ' ' LYS . . . . . . . . . . . . . 44.7 tttp -137.54 130.01 29.65 Favored 'General case' 0 C--N 1.329 -0.288 0 N-CA-C 109.539 -0.541 . . . . 0.0 109.539 178.318 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' F' F ' 45' ' ' GLU . . . . . . . . . . . . . 77.5 tt0 -84.15 123.59 30.25 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.529 -0.305 . . . . 0.0 111.336 -175.462 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' F' F ' 46' ' ' VAL . . . . . . . . . . . . . 7.2 p -124.7 130.31 73.44 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.207 0 CA-C-O 120.918 0.389 . . . . 0.0 109.994 176.876 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' F' F ' 47' ' ' LYS . . . . . . . . . . . . . 33.8 mmtp -99.75 132.22 45.23 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 115.906 -0.588 . . . . 0.0 111.298 177.647 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' F' F ' 48' ' ' PHE . . . . . . . . . . . . . 95.4 m-85 -115.8 131.87 56.81 Favored 'General case' 0 C--N 1.331 -0.208 0 N-CA-C 109.603 -0.517 . . . . 0.0 109.603 174.449 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' F' F ' 49' ' ' LYS . . . . . . . . . . . . . 82.4 tttt -108.92 135.88 49.38 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.338 -0.392 . . . . 0.0 110.51 179.553 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' F' F ' 50' ' ' VAL . . . . . . . . . . . . . 47.1 t -79.03 105.82 8.98 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.253 0 N-CA-C 109.127 -0.694 . . . . 0.0 109.127 176.061 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' F' F ' 51' ' ' VAL . . . . . 0.41 ' O ' HG23 ' F' ' 33' ' ' THR . 46.3 t -70.54 -53.48 22.33 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.298 0 CA-C-N 115.887 -0.597 . . . . 0.0 109.579 -174.271 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' F' F ' 52' ' ' GLN . . . . . . . . . . . . . 90.9 mt-30 -153.75 152.05 30.3 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 115.974 -0.557 . . . . 0.0 111.742 -178.114 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' F' F ' 53' ' ' ALA . . . . . 0.463 ' HB1' ' HB2' ' F' ' 58' ' ' LEU . . . -128.42 132.92 48.47 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 115.317 -0.856 . . . . 0.0 109.765 174.547 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' F' F ' 54' ' ' TYR . . . . . . . . . . . . . 82.3 t80 -129.13 111.67 18.31 Favored Pre-proline 0 CA--C 1.535 0.368 0 CA-C-O 118.298 -0.858 . . . . 0.0 110.402 179.473 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' F' F ' 55' ' ' PRO . . . . . . . . . . . . . 73.6 Cg_endo -77.05 169.6 73.93 Favored 'Cis proline' 0 N--CA 1.5 1.854 0 CA-C-N 122.023 1.758 . . . . 0.0 112.226 -6.227 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' F' F ' 56' ' ' SER . . . . . . . . . . . . . 13.6 m -116.43 124.66 29.26 Favored Pre-proline 0 CA--C 1.539 0.554 0 CA-C-O 118.37 -0.824 . . . . 0.0 109.219 176.102 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' F' F ' 57' ' ' PRO . . . . . . . . . . . . . 53.9 Cg_endo -69.55 149.32 87.88 Favored 'Cis proline' 0 N--CA 1.498 1.754 0 CA-C-N 122.063 1.773 . . . . 0.0 112.086 2.128 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' F' F ' 58' ' ' LEU . . . . . 0.463 ' HB2' ' HB1' ' F' ' 53' ' ' ALA . 21.4 tp -108.63 136.3 48.45 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.111 -0.495 . . . . 0.0 110.619 -179.569 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' F' F ' 59' ' ' ARG . . . . . . . . . . . . . 40.9 ttm180 -103.75 123.4 46.98 Favored 'General case' 0 C--N 1.329 -0.291 0 N-CA-C 109.346 -0.613 . . . . 0.0 109.346 175.867 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' F' F ' 60' ' ' VAL . . . . . . . . . . . . . 42.1 t -81.91 124.09 38.73 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.269 0 C-N-CA 120.638 -0.425 . . . . 0.0 110.362 -175.581 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' F' F ' 61' ' ' GLU . . . . . . . . . . . . . 79.3 tt0 -131.09 157.47 43.0 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 115.74 -0.664 . . . . 0.0 109.27 179.367 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' F' F ' 62' ' ' ASP . . . . . . . . . . . . . 10.5 t0 -51.56 -32.48 28.39 Favored 'General case' 0 C--N 1.328 -0.368 0 N-CA-C 112.138 0.422 . . . . 0.0 112.138 -176.692 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' F' F ' 63' ' ' ARG . . . . . . . . . . . . . 16.7 ptp180 -89.4 10.05 23.98 Favored 'General case' 0 N--CA 1.466 0.36 0 N-CA-C 113.613 0.968 . . . . 0.0 113.613 -176.157 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' F' F ' 64' ' ' THR . . . . . . . . . . . . . 22.4 m -80.15 143.34 33.95 Favored 'General case' 0 C--N 1.331 -0.21 0 CA-C-N 118.001 0.364 . . . . 0.0 110.63 -178.508 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' F' F ' 65' ' ' LYS . . . . . . . . . . . . . 95.9 mttt -87.47 126.69 35.05 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.169 -0.468 . . . . 0.0 110.008 179.372 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' F' F ' 66' ' ' ILE . . . . . . . . . . . . . 66.6 mt -118.2 129.52 74.41 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.288 0 N-CA-C 109.903 -0.406 . . . . 0.0 109.903 -179.404 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' F' F ' 67' ' ' THR . . . . . . . . . . . . . 24.4 m -121.0 138.97 53.91 Favored 'General case' 0 C--N 1.331 -0.207 0 CA-C-N 116.248 -0.433 . . . . 0.0 110.856 -178.189 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' F' F ' 68' ' ' LEU . . . . . . . . . . . . . 15.2 tp . . . . . 0 C--N 1.332 -0.172 0 CA-C-N 115.929 -0.578 . . . . 0.0 110.347 179.155 . . . . . . . . 0 0 . 1 . 006 nuclear build core ' F' F ' 73' ' ' VAL . . . . . . . . . . . . . 34.6 m . . . . . 0 C--O 1.231 0.091 0 CA-C-O 120.861 0.362 . . . . 0.0 110.193 . . . . . . . . . 0 0 . 1 . 006 nuclear build core ' F' F ' 74' ' ' ASP . . . . . . . . . . . . . 7.5 t0 -97.6 124.77 42.0 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.138 -0.483 . . . . 0.0 110.157 -177.769 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' F' F ' 75' ' ' VAL . . . . . . . . . . . . . 42.7 t -113.42 125.93 70.77 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.247 0 CA-C-O 121.078 0.466 . . . . 0.0 110.446 -178.745 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' F' F ' 76' ' ' LEU . . . . . . . . . . . . . 27.0 mt -128.78 149.54 50.68 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 115.671 -0.695 . . . . 0.0 109.727 178.737 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' F' F ' 77' ' ' GLU . . . . . . . . . . . . . 47.2 mt-10 -136.05 140.31 43.73 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-O 121.004 0.43 . . . . 0.0 111.44 -176.526 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' F' F ' 78' ' ' ALA . . . . . . . . . . . . . . . -124.03 126.62 46.58 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 115.663 -0.698 . . . . 0.0 109.56 175.906 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' F' F ' 79' ' ' LYS . . . . . 0.587 ' O ' HD13 ' F' ' 80' ' ' ILE . 53.7 pttt -80.06 123.93 28.29 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-O 121.133 0.492 . . . . 0.0 111.341 -176.714 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' F' F ' 80' ' ' ILE . . . . . 0.587 HD13 ' O ' ' F' ' 79' ' ' LYS . 39.5 mm -139.14 118.49 13.58 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.238 0 CA-C-N 115.901 -0.591 . . . . 0.0 109.692 -178.287 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' F' F ' 81' ' ' LYS . . . . . . . . . . . . . 40.2 mmtt -96.1 118.87 33.55 Favored 'General case' 0 C--N 1.327 -0.374 0 C-N-CA 120.905 -0.318 . . . . 0.0 111.205 179.667 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' F' F ' 82' ' ' GLY . . . . . . . . . . . . . . . 89.19 42.17 5.65 Favored Glycine 0 CA--C 1.526 0.747 0 C-N-CA 120.654 -0.784 . . . . 0.0 112.027 172.202 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' F' F ' 83' ' ' ILE . . . . . . . . . . . . . 73.1 mt -64.47 134.21 29.35 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.294 0 N-CA-C 109.505 -0.554 . . . . 0.0 109.505 175.835 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' F' F ' 84' ' ' LYS . . . . . . . . . . . . . 36.5 ttpt -97.73 -53.97 3.26 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-O 120.992 0.425 . . . . 0.0 110.14 -179.346 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' F' F ' 85' ' ' ASP . . . . . . . . . . . . . 9.1 t70 -149.35 151.56 34.33 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 115.745 -0.661 . . . . 0.0 110.503 -179.472 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' F' F ' 86' ' ' VAL . . . . . . . . . . . . . 44.6 t -126.67 130.58 71.63 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.218 0 CA-C-O 120.952 0.406 . . . . 0.0 110.321 -178.986 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' F' F ' 87' ' ' ILE . . . . . . . . . . . . . 43.4 mm -119.2 126.2 75.14 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.304 0 CA-C-N 115.84 -0.618 . . . . 0.0 109.388 177.961 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' F' F ' 88' ' ' LEU . . . . . . . . . . . . . 13.0 tp -116.94 135.32 53.8 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-O 120.976 0.417 . . . . 0.0 111.394 -175.943 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' F' F ' 89' ' ' ASP . . . . . . . . . . . . . 6.1 t70 -132.17 156.31 46.65 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 115.812 -0.631 . . . . 0.0 109.457 175.228 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' F' F ' 90' ' ' GLU . . . . . . . . . . . . . 96.6 mt-10 -48.03 -36.95 13.78 Favored 'General case' 0 C--N 1.33 -0.28 0 N-CA-C 113.176 0.806 . . . . 0.0 113.176 -171.123 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' F' F ' 91' ' ' ASN . . . . . . . . . . . . . 35.3 m120 -123.44 13.14 9.45 Favored 'General case' 0 N--CA 1.468 0.466 0 N-CA-C 113.555 0.946 . . . . 0.0 113.555 -174.763 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' F' F ' 92' ' ' LEU . . . . . . . . . . . . . 44.3 mt -149.73 147.98 28.69 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-N 117.925 0.33 . . . . 0.0 110.721 -176.577 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' F' F ' 93' ' ' ILE . . . . . . . . . . . . . 74.0 mt -122.71 118.3 54.62 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.268 0 N-CA-C 109.102 -0.703 . . . . 0.0 109.102 175.736 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' F' F ' 94' ' ' VAL . . . . . . . . . . . . . 45.5 t -117.42 127.28 74.91 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.249 0 N-CA-C 109.743 -0.466 . . . . 0.0 109.743 -179.054 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' F' F ' 95' ' ' VAL . . . . . . . . . . . . . 43.0 t -123.21 134.94 64.77 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.364 0 CA-C-N 116.1 -0.5 . . . . 0.0 109.964 -178.958 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' F' F ' 96' ' ' ILE . . . . . 0.406 HD11 ' HB ' ' F' ' 123' ' ' VAL . 65.8 mt -115.45 126.28 72.95 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.308 0 N-CA-C 109.259 -0.645 . . . . 0.0 109.259 178.718 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' F' F ' 97' ' ' THR . . . . . . . . . . . . . 69.4 p -99.75 155.93 17.37 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-O 121.228 0.537 . . . . 0.0 110.957 -177.341 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' F' F ' 98' ' ' GLU . . . . . . . . . . . . . 84.9 tt0 -53.87 -24.91 17.45 Favored 'General case' 0 CA--C 1.536 0.422 0 CA-C-N 116.057 -0.519 . . . . 0.0 112.267 179.658 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' F' F ' 99' ' ' GLU . . . . . . . . . . . . . 96.8 mt-10 -77.55 12.89 1.42 Allowed 'General case' 0 CA--C 1.537 0.45 0 N-CA-C 113.301 0.852 . . . . 0.0 113.301 -177.924 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' F' F ' 100' ' ' ASN . . . . . . . . . . . . . 2.2 m-20 61.84 33.62 17.55 Favored 'General case' 0 N--CA 1.464 0.262 0 CA-C-N 118.099 0.409 . . . . 0.0 111.315 -179.74 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' F' F ' 101' ' ' GLU . . . . . . . . . . . . . 54.4 tt0 -110.27 143.69 40.07 Favored 'General case' 0 C--N 1.333 -0.137 0 N-CA-C 109.571 -0.529 . . . . 0.0 109.571 174.189 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' F' F ' 102' ' ' VAL . . . . . . . . . . . . . 46.7 t -115.39 127.16 73.06 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.295 0 N-CA-C 109.84 -0.429 . . . . 0.0 109.84 -178.39 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' F' F ' 103' ' ' LEU . . . . . . . . . . . . . 19.7 mt -118.64 132.58 56.18 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 115.864 -0.607 . . . . 0.0 110.715 178.711 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' F' F ' 104' ' ' ILE . . . . . 0.575 HD13 HG11 ' F' ' 130' ' ' VAL . 63.8 mt -116.85 120.65 65.68 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.277 0 N-CA-C 109.81 -0.441 . . . . 0.0 109.81 177.921 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' F' F ' 105' ' ' PHE . . . . . . . . . . . . . 92.3 m-85 -120.43 162.78 18.95 Favored 'General case' 0 C--N 1.332 -0.157 0 O-C-N 123.859 0.724 . . . . 0.0 109.91 -179.906 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' F' F ' 106' ' ' ASN . . . . . . . . . . . . . 45.6 p-10 -97.62 -174.09 2.81 Favored 'General case' 0 C--N 1.33 -0.268 0 N-CA-C 109.593 -0.521 . . . . 0.0 109.593 172.214 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' F' F ' 107' ' ' GLN . . . . . . . . . . . . . 29.1 tt0 -62.21 -19.24 62.95 Favored 'General case' 0 CA--C 1.536 0.429 0 N-CA-C 112.586 0.588 . . . . 0.0 112.586 -178.725 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' F' F ' 108' ' ' ASN . . . . . . . . . . . . . 17.2 t30 -95.68 14.09 24.23 Favored 'General case' 0 CA--C 1.535 0.393 0 N-CA-C 113.124 0.787 . . . . 0.0 113.124 -178.259 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' F' F ' 109' ' ' LEU . . . . . . . . . . . . . 52.5 mt 58.98 38.92 24.1 Favored 'General case' 0 C--O 1.232 0.155 0 CA-C-O 121.139 0.495 . . . . 0.0 111.395 178.095 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' F' F ' 110' ' ' GLU . . . . . . . . . . . . . 96.5 mt-10 -106.14 156.9 17.97 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.15 -0.477 . . . . 0.0 109.95 176.055 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' F' F ' 111' ' ' GLU . . . . . . . . . . . . . 84.5 tt0 -86.98 121.91 30.1 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-O 120.884 0.374 . . . . 0.0 111.107 -177.258 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' F' F ' 112' ' ' LEU . . . . . . . . . . . . . 31.4 mt -108.43 -45.95 3.79 Favored 'General case' 0 C--N 1.332 -0.189 0 CA-C-N 116.054 -0.521 . . . . 0.0 110.448 176.735 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' F' F ' 113' ' ' TYR . . . . . 0.455 ' HB3' HD12 ' F' ' 104' ' ' ILE . 55.5 t80 -141.86 138.55 32.21 Favored 'General case' 0 C--N 1.331 -0.229 0 C-N-CA 120.614 -0.434 . . . . 0.0 111.319 179.947 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' F' F ' 114' ' ' ARG . . . . . . . . . . . . . 23.7 ttm180 -138.1 124.2 20.28 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.232 -0.44 . . . . 0.0 110.195 176.539 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' F' F ' 115' ' ' GLY . . . . . . . . . . . . . . . -150.17 159.64 28.2 Favored Glycine 0 CA--C 1.525 0.676 0 N-CA-C 110.798 -0.921 . . . . 0.0 110.798 178.283 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' F' F ' 116' ' ' LYS . . . . . . . . . . . . . 55.4 tttt -132.6 135.33 45.83 Favored 'General case' 0 C--N 1.329 -0.305 0 N-CA-C 110.098 -0.334 . . . . 0.0 110.098 178.714 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' F' F ' 117' ' ' PHE . . . . . . . . . . . . . 26.3 m-85 -137.72 116.31 12.11 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-O 120.799 0.333 . . . . 0.0 110.309 -174.611 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' F' F ' 118' ' ' GLU . . . . . . . . . . . . . 46.0 tp10 -53.96 -44.58 70.85 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.594 -0.276 . . . . 0.0 111.309 -177.621 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' F' F ' 119' ' ' ASN . . . . . . . . . . . . . 11.7 m120 -97.09 31.1 2.51 Favored 'General case' 0 C--N 1.329 -0.309 0 N-CA-C 112.202 0.445 . . . . 0.0 112.202 -174.497 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' F' F ' 120' ' ' LEU . . . . . . . . . . . . . 15.5 tp -57.76 122.53 13.06 Favored 'General case' 0 C--N 1.333 -0.126 0 N-CA-C 110.225 -0.287 . . . . 0.0 110.225 177.744 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' F' F ' 121' ' ' ASN . . . . . . . . . . . . . 88.6 m-20 -113.75 -43.95 3.23 Favored 'General case' 0 C--N 1.333 -0.124 0 CA-C-N 116.66 -0.246 . . . . 0.0 111.232 -176.729 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' F' F ' 122' ' ' LYS . . . . . . . . . . . . . 51.2 mttm -143.74 144.73 31.96 Favored 'General case' 0 C--N 1.33 -0.25 0 C-N-CA 120.629 -0.428 . . . . 0.0 111.669 -177.408 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' F' F ' 123' ' ' VAL . . . . . 0.406 ' HB ' HD11 ' F' ' 96' ' ' ILE . 43.9 t -127.18 127.84 69.77 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.249 0 N-CA-C 109.328 -0.619 . . . . 0.0 109.328 174.795 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' F' F ' 124' ' ' LEU . . . . . . . . . . . . . 56.5 mt -128.78 139.2 52.3 Favored 'General case' 0 C--N 1.331 -0.211 0 CA-C-O 120.792 0.33 . . . . 0.0 110.933 -176.653 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' F' F ' 125' ' ' VAL . . . . . . . . . . . . . 12.8 p -137.88 137.72 44.63 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.249 0 CA-C-N 116.344 -0.389 . . . . 0.0 110.569 178.487 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' F' F ' 126' ' ' ARG . . . . . . . . . . . . . 55.2 ttt180 -163.87 135.31 4.68 Favored 'General case' 0 C--N 1.33 -0.243 0 N-CA-C 109.803 -0.443 . . . . 0.0 109.803 177.775 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' F' F ' 127' ' ' ASN . . . . . . . . . . . . . 77.7 m-20 55.39 -153.34 0.33 Allowed 'General case' 0 CA--C 1.541 0.607 0 N-CA-C 109.974 -0.38 . . . . 0.0 109.974 -179.791 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' F' F ' 128' ' ' ASP . . . . . . . . . . . . . 10.4 p-10 -80.76 16.06 1.54 Allowed 'General case' 0 CA--C 1.535 0.386 0 N-CA-C 112.815 0.672 . . . . 0.0 112.815 179.439 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' F' F ' 129' ' ' LEU . . . . . . . . . . . . . 38.5 mt -117.51 138.32 51.97 Favored 'General case' 0 C--O 1.231 0.106 0 CA-C-N 118.131 0.423 . . . . 0.0 110.371 179.778 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' F' F ' 130' ' ' VAL . . . . . 0.575 HG11 HD13 ' F' ' 104' ' ' ILE . 12.9 p -132.07 141.0 46.59 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.217 0 N-CA-C 109.919 -0.4 . . . . 0.0 109.919 175.983 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' F' F ' 131' ' ' VAL . . . . . 0.417 HG22 HD12 ' F' ' 140' ' ' LEU . 39.4 t -134.58 140.77 45.03 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.218 0 CA-C-O 121.13 0.491 . . . . 0.0 110.636 -175.24 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' F' F ' 132' ' ' ILE . . . . . . . . . . . . . 71.4 mt -119.28 130.75 73.53 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.316 0 CA-C-N 115.526 -0.761 . . . . 0.0 109.133 177.451 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' F' F ' 133' ' ' ILE . . . . . . . . . . . . . 41.4 mm -117.87 123.49 71.75 Favored 'Isoleucine or valine' 0 C--O 1.233 0.221 0 CA-C-O 120.773 0.321 . . . . 0.0 111.041 -175.184 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' F' F ' 134' ' ' ASP . . . . . . . . . . . . . 8.5 p-10 -135.63 146.51 47.94 Favored 'General case' 0 C--N 1.33 -0.25 0 N-CA-C 109.57 -0.53 . . . . 0.0 109.57 173.268 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' F' F ' 135' ' ' GLU . . . . . . . . . . . . . 40.6 tp10 -49.87 -25.83 3.51 Favored 'General case' 0 C--N 1.327 -0.387 0 N-CA-C 112.725 0.639 . . . . 0.0 112.725 -173.259 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' F' F ' 136' ' ' GLN . . . . . . . . . . . . . 61.7 tt0 -82.39 -35.7 27.44 Favored 'General case' 0 C--O 1.233 0.236 0 N-CA-C 112.269 0.47 . . . . 0.0 112.269 -176.333 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' F' F ' 137' ' ' LYS . . . . . . . . . . . . . 45.6 pttt -165.12 167.98 17.68 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-O 121.486 0.66 . . . . 0.0 112.12 -172.315 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' F' F ' 138' ' ' LEU . . . . . 0.412 HD23 ' C ' ' F' ' 138' ' ' LEU . 7.3 tt -118.34 130.79 56.22 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 115.169 -0.923 . . . . 0.0 109.866 -179.526 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' F' F ' 139' ' ' THR . . . . . . . . . . . . . 38.0 m -113.1 126.22 55.23 Favored 'General case' 0 C--N 1.331 -0.21 0 CA-C-N 116.328 -0.396 . . . . 0.0 110.773 179.92 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' F' F ' 140' ' ' LEU . . . . . 0.417 HD12 HG22 ' F' ' 131' ' ' VAL . 18.7 tp -109.85 122.77 48.28 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 115.526 -0.761 . . . . 0.0 108.973 178.745 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' F' F ' 141' ' ' ILE . . . . . 0.535 ' HB ' HG13 ' F' ' 130' ' ' VAL . 19.6 mt -122.04 119.48 58.69 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.32 0 N-CA-C 109.594 -0.521 . . . . 0.0 109.594 -177.158 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' F' F ' 142' ' ' ARG . . . . . . . . . . . . . 66.4 ttp85 -110.92 128.85 55.96 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 115.488 -0.778 . . . . 0.0 110.57 -176.415 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' F' F ' 143' ' ' THR . . . . . . . . . . . . . 39.4 p . . . . . 0 C--O 1.222 -0.37 0 CA-C-O 117.952 -1.023 . . . . 0.0 110.558 -179.983 . . . . . . . . 0 0 . 1 . 007 nuclear build core ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 88.8 p . . . . . 0 C--O 1.231 0.107 0 CA-C-O 120.849 0.356 . . . . 0.0 110.48 . . . . . . . . . 0 0 . 1 . 007 nuclear build core ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 85.2 tt0 -140.5 142.53 35.25 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-N 116.149 -0.478 . . . . 0.0 111.057 -177.527 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 4' ' ' LEU . . . . . . . . . . . . . 19.0 tp -122.99 127.57 49.0 Favored 'General case' 0 C--N 1.331 -0.198 0 CA-C-N 115.964 -0.562 . . . . 0.0 110.148 177.046 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 5' ' ' LYS . . . . . . . . . . . . . 98.8 mttt -106.71 122.88 47.24 Favored 'General case' 0 C--O 1.234 0.244 0 CA-C-N 116.543 -0.299 . . . . 0.0 110.641 179.275 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 63.5 mt -116.08 144.65 43.85 Favored 'General case' 0 N--CA 1.464 0.235 0 CA-C-N 115.859 -0.609 . . . . 0.0 110.692 -179.241 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 85.0 tttt -125.81 131.22 23.94 Favored Pre-proline 0 CA--C 1.536 0.433 0 CA-C-O 118.583 -0.722 . . . . 0.0 109.523 175.758 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 8' ' ' PRO . . . . . . . . . . . . . 96.1 Cg_endo -83.56 137.79 8.12 Favored 'Trans proline' 0 N--CA 1.494 1.529 0 C-N-CA 121.295 1.33 . . . . 0.0 112.078 177.851 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 67.4 mt -77.95 -47.87 2.18 Favored Pre-proline 0 CA--C 1.534 0.352 0 CA-C-O 118.548 -0.739 . . . . 0.0 112.084 179.165 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 72.2 Cg_endo -77.8 151.34 27.99 Favored 'Trans proline' 0 N--CA 1.497 1.679 0 CA-C-N 120.28 1.136 . . . . 0.0 111.642 176.36 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 23.2 tptm -85.67 95.15 9.27 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.421 -0.354 . . . . 0.0 110.55 -179.336 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 12.1 p -143.7 144.33 23.29 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.319 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.552 -179.92 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 45.6 mp0 -90.4 127.23 36.14 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.334 -0.393 . . . . 0.0 109.963 177.58 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 14' ' ' LEU . . . . . . . . . . . . . 37.2 mt -97.87 146.89 32.24 Favored Pre-proline 0 CA--C 1.533 0.29 0 CA-C-O 119.19 -0.433 . . . . 0.0 110.371 -177.44 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 15' ' ' PRO . . . . . . . . . . . . . 26.2 Cg_exo -61.29 162.32 20.55 Favored 'Trans proline' 0 N--CA 1.498 1.759 0 C-N-CA 121.345 1.363 . . . . 0.0 111.939 178.148 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 16' ' ' PRO . . . . . . . . . . . . . 34.8 Cg_exo -59.34 -38.64 83.42 Favored 'Trans proline' 0 N--CA 1.496 1.629 0 C-N-CA 121.541 1.494 . . . . 0.0 112.907 -177.699 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 17' ' ' ASP . . . . . . . . . . . . . 18.9 p-10 -86.52 6.34 31.09 Favored 'General case' 0 CA--C 1.537 0.443 0 N-CA-C 113.303 0.853 . . . . 0.0 113.303 -178.161 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 18' ' ' PHE . . . . . . . . . . . . . 39.2 t80 -58.33 -43.09 88.07 Favored 'General case' 0 C--N 1.334 -0.108 0 O-C-N 121.982 -0.449 . . . . 0.0 110.103 -178.212 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 19' ' ' VAL . . . . . . . . . . . . . 47.5 t -56.69 -41.14 73.79 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.282 0 CA-C-N 116.243 -0.435 . . . . 0.0 110.468 -179.405 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 5.7 t70 -59.77 -42.0 92.33 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-O 120.873 0.368 . . . . 0.0 110.534 -179.002 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 47.9 t -63.86 -46.18 94.97 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.325 0 CA-C-N 116.242 -0.435 . . . . 0.0 110.301 -178.971 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 22' ' ' ILE . . . . . 0.558 HG22 HD12 ' A' ' 26' ' ' LEU . 51.6 mm -55.03 -47.93 76.41 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.282 0 CA-C-O 120.572 0.225 . . . . 0.0 110.819 179.241 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 23' ' ' ARG . . . . . . . . . . . . . 30.8 ttp180 -54.53 -51.5 64.97 Favored 'General case' 0 C--N 1.329 -0.307 0 C-N-CA 121.121 -0.232 . . . . 0.0 111.332 -177.813 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 24' ' ' ILE . . . . . . . . . . . . . 72.9 mt -59.53 -41.3 84.37 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.277 0 C-N-CA 121.031 -0.267 . . . . 0.0 111.232 -176.881 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 60.7 mtpt -68.67 -41.9 78.64 Favored 'General case' 0 C--N 1.328 -0.333 0 N-CA-C 112.45 0.537 . . . . 0.0 112.45 -177.324 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 26' ' ' LEU . . . . . 0.558 HD12 HG22 ' A' ' 22' ' ' ILE . 95.3 mt -79.57 -37.46 36.32 Favored 'General case' 0 C--N 1.33 -0.266 0 N-CA-C 113.152 0.797 . . . . 0.0 113.152 -171.365 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 27' ' ' GLN . . . . . . . . . . . . . 14.1 pt20 -46.33 140.48 4.09 Favored 'General case' 0 N--CA 1.47 0.544 0 N-CA-C 112.802 0.667 . . . . 0.0 112.802 -175.273 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 100.97 -25.44 28.33 Favored Glycine 0 CA--C 1.532 1.14 0 CA-C-N 115.575 -0.739 . . . . 0.0 112.229 -176.089 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 96.9 mttt -98.18 155.1 17.33 Favored 'General case' 0 C--O 1.233 0.185 0 CA-C-N 117.451 0.625 . . . . 0.0 111.192 179.267 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 30' ' ' THR . . . . . . . . . . . . . 41.5 m -100.96 138.73 37.62 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.138 -0.483 . . . . 0.0 110.273 177.154 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 34.7 m -131.3 148.52 32.81 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.247 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.79 -178.971 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 32' ' ' ARG . . . . . . . . . . . . . 23.0 ttm180 -130.06 146.69 51.74 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.163 -0.471 . . . . 0.0 110.26 178.166 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 33' ' ' THR . . . . . . . . . . . . . 29.6 m -52.39 139.18 25.36 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-O 120.777 0.323 . . . . 0.0 111.469 -178.285 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 98.91 -17.25 58.48 Favored Glycine 0 CA--C 1.534 1.23 0 CA-C-O 119.737 -0.479 . . . . 0.0 113.135 -179.907 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 78.1 m-20 -67.67 149.19 50.35 Favored 'General case' 0 C--N 1.334 -0.09 0 CA-C-N 117.948 0.874 . . . . 0.0 111.346 179.065 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 46.3 t -117.01 126.45 74.44 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.179 0 CA-C-N 115.652 -0.703 . . . . 0.0 109.441 176.513 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 37' ' ' ILE . . . . . . . . . . . . . 64.0 mt -118.36 137.15 53.25 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.297 0 N-CA-C 109.866 -0.42 . . . . 0.0 109.866 -179.118 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . -114.74 128.51 8.19 Favored Glycine 0 CA--C 1.524 0.656 0 N-CA-C 110.876 -0.889 . . . . 0.0 110.876 179.304 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 39' ' ' ILE . . . . . . . . . . . . . 70.4 mt -124.45 127.36 72.99 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.224 0 N-CA-C 110.08 -0.341 . . . . 0.0 110.08 179.223 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 40' ' ' SER . . . . . . . . . . . . . 27.5 t -92.84 119.04 31.76 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.312 -0.403 . . . . 0.0 110.931 176.727 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 41' ' ' ILE . . . . . . . . . . . . . 71.7 mt -134.02 129.13 53.92 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.211 0 CA-C-O 121.017 0.436 . . . . 0.0 110.462 178.491 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 8.3 tp 54.75 33.4 19.5 Favored 'General case' 0 CA--C 1.531 0.244 0 CA-C-N 115.958 -0.565 . . . . 0.0 111.737 177.523 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . 71.52 29.02 68.48 Favored Glycine 0 CA--C 1.53 0.996 0 C-N-CA 121.046 -0.597 . . . . 0.0 112.253 177.794 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 44' ' ' LYS . . . . . . . . . . . . . 81.3 tttt -139.1 127.4 22.75 Favored 'General case' 0 C--N 1.33 -0.255 0 N-CA-C 109.739 -0.467 . . . . 0.0 109.739 178.833 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 84.8 tt0 -85.24 125.78 33.15 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-N 116.375 -0.375 . . . . 0.0 111.423 -178.395 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 46' ' ' VAL . . . . . 0.405 ' O ' HG13 ' A' ' 46' ' ' VAL . 9.6 p -118.69 124.41 73.1 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.172 0 N-CA-C 109.434 -0.58 . . . . 0.0 109.434 173.587 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 61.9 mtpt -98.49 124.27 43.12 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 116.046 -0.525 . . . . 0.0 110.523 177.726 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 48' ' ' PHE . . . . . . . . . . . . . 38.9 m-85 -111.1 131.81 54.78 Favored 'General case' 0 C--N 1.328 -0.344 0 N-CA-C 109.555 -0.535 . . . . 0.0 109.555 177.573 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 43.0 tttp -106.42 131.92 53.06 Favored 'General case' 0 C--N 1.328 -0.345 0 N-CA-C 109.936 -0.394 . . . . 0.0 109.936 178.638 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 50' ' ' VAL . . . . . . . . . . . . . 46.0 t -75.38 106.58 5.27 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.332 0 N-CA-C 109.336 -0.616 . . . . 0.0 109.336 178.068 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 51' ' ' VAL . . . . . . . . . . . . . 44.6 t -71.17 -49.65 47.12 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.288 0 CA-C-N 116.165 -0.471 . . . . 0.0 109.79 -174.789 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 52' ' ' GLN . . . . . . . . . . . . . 43.3 tt0 -162.73 136.88 6.33 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 115.88 -0.6 . . . . 0.0 111.289 -178.102 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 53' ' ' ALA . . . . . 0.412 ' HB3' ' OG ' ' A' ' 56' ' ' SER . . . -115.9 132.84 56.53 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 115.968 -0.56 . . . . 0.0 109.999 176.119 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 54' ' ' TYR . . . . . . . . . . . . . 11.6 t80 -129.06 110.64 18.3 Favored Pre-proline 0 CA--C 1.534 0.346 0 CA-C-O 118.157 -0.925 . . . . 0.0 110.192 178.466 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 55' ' ' PRO . . . . . . . . . . . . . 72.7 Cg_endo -77.22 170.13 72.29 Favored 'Cis proline' 0 N--CA 1.501 1.931 0 CA-C-N 122.024 1.758 . . . . 0.0 112.49 -6.054 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 56' ' ' SER . . . . . 0.412 ' OG ' ' HB3' ' A' ' 53' ' ' ALA . 48.9 m -124.01 137.55 29.11 Favored Pre-proline 0 CA--C 1.538 0.514 0 CA-C-O 118.532 -0.747 . . . . 0.0 109.546 174.904 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 57' ' ' PRO . . . . . . . . . . . . . 37.8 Cg_endo -67.52 145.52 74.37 Favored 'Cis proline' 0 N--CA 1.498 1.778 0 CA-C-N 121.687 1.638 . . . . 0.0 111.487 -2.894 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 58' ' ' LEU . . . . . . . . . . . . . 20.7 tp -107.99 137.95 45.09 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.256 -0.429 . . . . 0.0 110.47 -178.768 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 59' ' ' ARG . . . . . . . . . . . . . 56.7 ttp180 -103.31 120.61 41.1 Favored 'General case' 0 C--N 1.328 -0.366 0 N-CA-C 109.133 -0.691 . . . . 0.0 109.133 174.917 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 42.2 t -72.95 118.53 18.29 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.276 0 C-N-CA 120.766 -0.374 . . . . 0.0 110.647 -173.8 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 70.6 mm-40 -131.02 159.12 38.45 Favored 'General case' 0 C--N 1.331 -0.216 0 CA-C-N 115.951 -0.568 . . . . 0.0 109.734 176.909 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 62' ' ' ASP . . . . . . . . . . . . . 11.0 p-10 -53.34 -31.43 44.3 Favored 'General case' 0 C--N 1.328 -0.343 0 N-CA-C 112.034 0.383 . . . . 0.0 112.034 -178.27 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 63' ' ' ARG . . . . . . . . . . . . . 86.2 mtt-85 -72.02 -21.94 61.48 Favored 'General case' 0 CA--C 1.533 0.324 0 N-CA-C 112.888 0.699 . . . . 0.0 112.888 -175.444 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 33.3 m -70.1 143.75 52.31 Favored 'General case' 0 C--N 1.332 -0.191 0 CA-C-O 120.988 0.423 . . . . 0.0 111.209 -174.479 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 65' ' ' LYS . . . . . . . . . . . . . 1.1 mptm? -89.54 134.8 33.95 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 115.839 -0.619 . . . . 0.0 110.013 177.827 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 66' ' ' ILE . . . . . . . . . . . . . 58.9 mt -114.82 130.36 69.39 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.27 0 N-CA-C 109.771 -0.455 . . . . 0.0 109.771 178.394 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 67' ' ' THR . . . . . . . . . . . . . 30.8 m -124.47 142.1 51.58 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-O 121.247 0.546 . . . . 0.0 111.136 -177.253 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 68' ' ' LEU . . . . . . . . . . . . . 2.6 tt . . . . . 0 C--N 1.331 -0.224 0 CA-C-N 115.544 -0.753 . . . . 0.0 109.68 178.485 . . . . . . . . 0 0 . 1 . 007 nuclear build core ' A' A ' 74' ' ' ASP . . . . . . . . . . . . . 13.0 t70 . . . . . 0 CA--C 1.521 -0.166 0 N-CA-C 110.229 -0.285 . . . . 0.0 110.229 . . . . . . . . . 0 0 . 1 . 007 nuclear build core ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 45.7 t -117.37 117.92 56.82 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 CA-C-O 121.192 0.52 . . . . 0.0 109.919 -179.439 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 76' ' ' LEU . . . . . . . . . . . . . 14.9 mt -120.9 142.92 49.25 Favored 'General case' 0 C--N 1.327 -0.403 0 CA-C-N 115.453 -0.794 . . . . 0.0 109.3 178.552 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 77' ' ' GLU . . . . . . . . . . . . . 96.8 mt-10 -135.31 128.91 32.66 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-O 121.16 0.505 . . . . 0.0 110.527 -177.548 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 78' ' ' ALA . . . . . 0.746 ' HB2' HD21 ' A' ' 109' ' ' LEU . . . -113.0 130.71 56.04 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 115.582 -0.735 . . . . 0.0 109.478 177.353 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 79' ' ' LYS . . . . . 0.581 ' O ' HD13 ' A' ' 80' ' ' ILE . 84.2 tttt -76.07 112.7 12.79 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-O 120.963 0.411 . . . . 0.0 110.532 -177.193 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 80' ' ' ILE . . . . . 0.581 HD13 ' O ' ' A' ' 79' ' ' LYS . 42.4 mm -139.08 109.95 4.7 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.346 0 CA-C-N 115.768 -0.651 . . . . 0.0 109.316 -177.727 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 81' ' ' LYS . . . . . . . . . . . . . 48.5 mtmt -108.64 130.76 55.32 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-O 120.875 0.369 . . . . 0.0 110.728 -178.321 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . 89.06 42.18 5.68 Favored Glycine 0 CA--C 1.525 0.708 0 C-N-CA 120.794 -0.717 . . . . 0.0 111.434 176.806 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 83' ' ' ILE . . . . . . . . . . . . . 73.5 mt -68.49 136.16 26.99 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.297 0 N-CA-C 109.872 -0.418 . . . . 0.0 109.872 177.423 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 84' ' ' LYS . . . . . . . . . . . . . 50.0 tttp -93.05 -50.45 5.52 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.213 -0.448 . . . . 0.0 110.18 -179.341 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 85' ' ' ASP . . . . . . . . . . . . . 6.6 t0 -157.22 154.97 30.05 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 115.908 -0.587 . . . . 0.0 110.517 179.734 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 86' ' ' VAL . . . . . . . . . . . . . 42.7 t -129.81 132.34 65.91 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.201 0 CA-C-O 120.974 0.416 . . . . 0.0 110.552 -178.862 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 87' ' ' ILE . . . . . 0.494 HD12 ' N ' ' A' ' 87' ' ' ILE . 5.0 mp -121.84 128.83 75.79 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.193 0 CA-C-N 115.957 -0.565 . . . . 0.0 109.629 176.887 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 88' ' ' LEU . . . . . . . . . . . . . 75.2 mt -112.6 135.96 52.7 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-O 120.997 0.427 . . . . 0.0 111.268 -177.826 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 89' ' ' ASP . . . . . . . . . . . . . 13.6 t70 -133.02 152.4 51.97 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 115.754 -0.657 . . . . 0.0 109.532 175.613 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 97.4 mt-10 -48.56 -36.27 15.14 Favored 'General case' 0 C--N 1.329 -0.319 0 N-CA-C 113.036 0.754 . . . . 0.0 113.036 -172.678 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 91' ' ' ASN . . . . . . . . . . . . . 81.8 m-20 -121.96 12.19 10.42 Favored 'General case' 0 N--CA 1.468 0.473 0 N-CA-C 113.379 0.881 . . . . 0.0 113.379 -176.268 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 92' ' ' LEU . . . . . . . . . . . . . 11.8 mt -148.68 145.3 27.64 Favored 'General case' 0 C--N 1.332 -0.185 0 CA-C-N 118.101 0.41 . . . . 0.0 110.455 -175.701 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 93' ' ' ILE . . . . . . . . . . . . . 66.8 mt -120.95 117.81 54.21 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.294 0 N-CA-C 108.942 -0.762 . . . . 0.0 108.942 174.499 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 94' ' ' VAL . . . . . 0.456 HG11 HG11 ' A' ' 123' ' ' VAL . 46.2 t -118.83 128.2 75.69 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.24 0 CA-C-O 120.82 0.343 . . . . 0.0 110.224 -177.097 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 95' ' ' VAL . . . . . . . . . . . . . 44.2 t -125.63 137.25 58.28 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.334 0 CA-C-N 116.115 -0.493 . . . . 0.0 109.916 179.977 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 96' ' ' ILE . . . . . . . . . . . . . 57.0 mt -116.6 128.45 73.95 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.325 0 N-CA-C 109.098 -0.705 . . . . 0.0 109.098 178.575 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 97' ' ' THR . . . . . . . . . . . . . 81.7 p -102.59 159.96 14.99 Favored 'General case' 0 C--N 1.331 -0.223 0 CA-C-O 121.099 0.476 . . . . 0.0 111.471 -175.202 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 98' ' ' GLU . . . . . . . . . . . . . 84.8 tt0 -53.86 -27.5 30.37 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.168 -0.469 . . . . 0.0 112.037 179.443 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 99' ' ' GLU . . . . . . . . . . . . . 42.8 mt-10 -79.62 15.83 1.24 Allowed 'General case' 0 CA--C 1.535 0.398 0 N-CA-C 113.07 0.767 . . . . 0.0 113.07 -178.393 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 100' ' ' ASN . . . . . . . . . . . . . 3.3 m-20 62.37 30.97 17.46 Favored 'General case' 0 CA--C 1.532 0.279 0 N-CA-C 111.832 0.308 . . . . 0.0 111.832 177.663 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 101' ' ' GLU . . . . . . . . . . . . . 98.5 mt-10 -101.28 150.58 22.84 Favored 'General case' 0 C--N 1.333 -0.128 0 CA-C-O 120.78 0.324 . . . . 0.0 110.851 171.687 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 102' ' ' VAL . . . . . . . . . . . . . 47.3 t -117.83 124.44 73.08 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.379 0 CA-C-N 115.469 -0.787 . . . . 0.0 109.208 176.442 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 103' ' ' LEU . . . . . . . . . . . . . 40.2 mt -116.44 130.06 56.56 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 115.925 -0.58 . . . . 0.0 110.261 178.602 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 104' ' ' ILE . . . . . 0.434 HD12 ' HB3' ' A' ' 113' ' ' TYR . 68.0 mt -118.76 117.94 56.13 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.291 0 N-CA-C 109.948 -0.39 . . . . 0.0 109.948 179.194 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 105' ' ' PHE . . . . . . . . . . . . . 40.1 m-85 -118.5 163.96 16.0 Favored 'General case' 0 C--N 1.332 -0.19 0 O-C-N 124.086 0.866 . . . . 0.0 110.255 179.282 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 106' ' ' ASN . . . . . . . . . . . . . 43.6 p-10 -98.69 -169.91 1.86 Allowed 'General case' 0 C--N 1.33 -0.263 0 N-CA-C 109.898 -0.408 . . . . 0.0 109.898 173.506 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 107' ' ' GLN . . . . . . . . . . . . . 41.2 tt0 -58.67 -29.89 66.93 Favored 'General case' 0 C--N 1.329 -0.322 0 N-CA-C 112.01 0.374 . . . . 0.0 112.01 179.242 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 108' ' ' ASN . . . . . . . . . . . . . 8.3 t-20 -83.55 6.61 19.91 Favored 'General case' 0 CA--C 1.537 0.458 0 N-CA-C 113.298 0.851 . . . . 0.0 113.298 -177.509 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 109' ' ' LEU . . . . . 0.746 HD21 ' HB2' ' A' ' 78' ' ' ALA . 9.1 tp 61.98 36.24 15.72 Favored 'General case' 0 CA--C 1.53 0.2 0 CA-C-O 120.877 0.37 . . . . 0.0 111.536 178.595 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 110' ' ' GLU . . . . . . . . . . . . . 70.8 mm-40 -105.6 152.27 23.31 Favored 'General case' 0 C--N 1.332 -0.189 0 CA-C-N 116.516 -0.311 . . . . 0.0 110.196 177.443 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 111' ' ' GLU . . . . . . . . . . . . . 98.6 mt-10 -80.9 122.06 26.76 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-O 120.878 0.371 . . . . 0.0 111.193 -178.486 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 112' ' ' LEU . . . . . . . . . . . . . 19.2 mt -108.55 -46.01 3.76 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 115.969 -0.56 . . . . 0.0 110.054 176.165 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 113' ' ' TYR . . . . . 0.434 ' HB3' HD12 ' A' ' 104' ' ' ILE . 57.7 t80 -134.74 133.06 39.52 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 116.284 -0.416 . . . . 0.0 110.735 179.184 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 114' ' ' ARG . . . . . . . . . . . . . 55.1 ttp180 -138.11 123.44 19.42 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.262 -0.426 . . . . 0.0 110.006 178.089 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 115' ' ' GLY . . . . . . . . . . . . . . . -150.12 162.84 29.33 Favored Glycine 0 CA--C 1.523 0.553 0 N-CA-C 110.902 -0.879 . . . . 0.0 110.902 -178.522 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 116' ' ' LYS . . . . . . . . . . . . . 76.3 tttt -131.9 131.02 42.36 Favored 'General case' 0 C--N 1.33 -0.278 0 N-CA-C 110.082 -0.34 . . . . 0.0 110.082 178.184 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 117' ' ' PHE . . . . . . . . . . . . . 47.9 m-85 -130.03 117.34 19.88 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 116.238 -0.437 . . . . 0.0 110.25 -177.196 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 118' ' ' GLU . . . . . . . . . . . . . 97.5 mt-10 -53.81 -43.69 69.57 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 116.433 -0.349 . . . . 0.0 111.363 -176.803 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 119' ' ' ASN . . . . . . . . . . . . . 2.8 m-20 -101.98 31.09 4.06 Favored 'General case' 0 C--N 1.331 -0.214 0 N-CA-C 112.089 0.403 . . . . 0.0 112.089 -174.786 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 120' ' ' LEU . . . . . . . . . . . . . 13.8 tp -55.04 120.07 6.38 Favored 'General case' 0 N--CA 1.462 0.169 0 CA-C-O 120.62 0.248 . . . . 0.0 110.666 178.65 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 121' ' ' ASN . . . . . . . . . . . . . 32.7 t-20 -110.77 -44.11 3.7 Favored 'General case' 0 C--N 1.332 -0.189 0 CA-C-N 116.565 -0.288 . . . . 0.0 111.137 -176.543 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 122' ' ' LYS . . . . . . . . . . . . . 90.6 mttt -148.23 152.03 36.49 Favored 'General case' 0 C--N 1.331 -0.204 0 CA-C-O 121.129 0.49 . . . . 0.0 111.955 -177.996 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 123' ' ' VAL . . . . . 0.456 HG11 HG11 ' A' ' 94' ' ' VAL . 42.2 t -129.45 124.66 60.24 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.268 0 CA-C-N 115.685 -0.689 . . . . 0.0 109.158 172.407 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 124' ' ' LEU . . . . . 0.496 HD12 ' N ' ' A' ' 124' ' ' LEU . 6.2 mp -118.1 141.67 48.23 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-O 120.765 0.316 . . . . 0.0 111.004 -175.65 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 125' ' ' VAL . . . . . 0.412 ' CG2' HG21 ' A' ' 94' ' ' VAL . 41.2 t -129.17 135.66 61.39 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.209 0 CA-C-N 116.24 -0.436 . . . . 0.0 110.427 -179.901 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 126' ' ' ARG . . . . . . . . . . . . . 26.3 mmt85 -139.48 109.92 6.6 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.081 -0.509 . . . . 0.0 110.215 176.712 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 127' ' ' ASN . . . . . . . . . . . . . 79.1 m-20 51.96 -104.83 0.19 Allowed 'General case' 0 CA--C 1.543 0.691 0 CA-C-O 119.1 -0.476 . . . . 0.0 111.341 179.521 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 128' ' ' ASP . . . . . . . . . . . . . 18.7 p-10 -110.3 -2.13 16.88 Favored 'General case' 0 CA--C 1.536 0.439 0 CA-C-N 119.513 1.051 . . . . 0.0 113.459 -176.105 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 129' ' ' LEU . . . . . . . . . . . . . 27.5 mt -104.99 143.89 32.56 Favored 'General case' 0 C--N 1.332 -0.17 0 N-CA-C 109.721 -0.474 . . . . 0.0 109.721 178.557 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 130' ' ' VAL . . . . . 0.525 HG13 ' HB ' ' A' ' 141' ' ' ILE . 12.2 p -132.23 142.06 43.72 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.212 0 CA-C-O 121.147 0.499 . . . . 0.0 110.507 -178.92 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 131' ' ' VAL . . . . . 0.576 HG22 HD12 ' A' ' 140' ' ' LEU . 40.9 t -134.39 138.09 50.43 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.252 0 CA-C-N 115.917 -0.583 . . . . 0.0 110.315 -178.236 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 132' ' ' ILE . . . . . . . . . . . . . 70.7 mt -113.98 131.52 65.67 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.341 0 N-CA-C 109.137 -0.69 . . . . 0.0 109.137 178.308 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 133' ' ' ILE . . . . . . . . . . . . . 40.2 mm -115.65 121.02 66.43 Favored 'Isoleucine or valine' 0 C--O 1.234 0.257 0 CA-C-O 120.665 0.269 . . . . 0.0 110.993 -174.501 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 134' ' ' ASP . . . . . . . . . . . . . 9.7 p-10 -134.72 146.39 49.39 Favored 'General case' 0 C--N 1.331 -0.215 0 CA-C-N 115.984 -0.553 . . . . 0.0 109.66 174.509 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 135' ' ' GLU . . . . . . . . . . . . . 85.2 tt0 -49.89 -26.49 4.13 Favored 'General case' 0 C--N 1.328 -0.33 0 N-CA-C 112.792 0.664 . . . . 0.0 112.792 -173.946 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 136' ' ' GLN . . . . . . . . . . . . . 43.2 tt0 -80.03 -35.19 37.58 Favored 'General case' 0 C--O 1.233 0.205 0 N-CA-C 112.124 0.416 . . . . 0.0 112.124 -176.644 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 137' ' ' LYS . . . . . . . . . . . . . 50.3 pttt -167.61 171.47 10.21 Favored 'General case' 0 C--N 1.331 -0.208 0 CA-C-O 121.527 0.68 . . . . 0.0 112.244 -172.5 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 138' ' ' LEU . . . . . 0.466 HD23 ' N ' ' A' ' 139' ' ' THR . 4.3 tt -114.83 127.34 55.66 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 115.053 -0.976 . . . . 0.0 109.821 178.269 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 139' ' ' THR . . . . . 0.466 ' N ' HD23 ' A' ' 138' ' ' LEU . 22.8 m -107.08 125.41 51.01 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.323 -0.399 . . . . 0.0 110.458 179.609 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 140' ' ' LEU . . . . . 0.576 HD12 HG22 ' A' ' 131' ' ' VAL . 14.9 tp -113.49 119.64 38.25 Favored 'General case' 0 C--N 1.328 -0.365 0 N-CA-C 109.252 -0.647 . . . . 0.0 109.252 -178.371 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 141' ' ' ILE . . . . . 0.525 ' HB ' HG13 ' A' ' 130' ' ' VAL . 19.4 mt -119.65 120.91 64.86 Favored 'Isoleucine or valine' 0 C--O 1.234 0.269 0 CA-C-O 120.949 0.404 . . . . 0.0 110.046 -175.977 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 142' ' ' ARG . . . . . . . . . . . . . 73.3 mtm180 -107.32 129.48 54.89 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 115.38 -0.827 . . . . 0.0 110.258 179.575 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 143' ' ' THR . . . . . . . . . . . . . 32.1 p . . . . . 0 C--O 1.22 -0.448 0 CA-C-O 118.045 -0.979 . . . . 0.0 110.618 179.691 . . . . . . . . 0 0 . 1 . 007 nuclear build core ' B' B ' 2' ' ' SER . . . . . . . . . . . . . 3.6 p . . . . . 0 C--O 1.232 0.183 0 CA-C-O 120.895 0.379 . . . . 0.0 110.411 . . . . . . . . . 0 0 . 1 . 007 nuclear build core ' B' B ' 3' ' ' GLU . . . . . . . . . . . . . 95.1 mt-10 -140.62 140.63 35.1 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-N 116.094 -0.503 . . . . 0.0 110.882 -178.445 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B ' 4' ' ' LEU . . . . . 0.475 HD21 HD21 ' B' ' 6' ' ' LEU . 16.5 tp -126.21 127.5 45.76 Favored 'General case' 0 C--N 1.331 -0.216 0 CA-C-N 115.971 -0.559 . . . . 0.0 110.36 177.441 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' B' B ' 5' ' ' LYS . . . . . . . . . . . . . 98.1 mttt -104.37 120.95 42.37 Favored 'General case' 0 C--O 1.234 0.237 0 CA-C-N 116.287 -0.415 . . . . 0.0 110.336 177.727 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B ' 6' ' ' LEU . . . . . 0.475 HD21 HD21 ' B' ' 4' ' ' LEU . 54.3 mt -117.14 148.0 41.94 Favored 'General case' 0 C--N 1.331 -0.227 0 CA-C-N 115.499 -0.773 . . . . 0.0 110.613 -178.501 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' B' B ' 7' ' ' LYS . . . . . . . . . . . . . 79.4 tttt -138.84 141.04 29.14 Favored Pre-proline 0 CA--C 1.534 0.344 0 CA-C-O 119.135 -0.46 . . . . 0.0 110.163 175.505 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B ' 8' ' ' PRO . . . . . . . . . . . . . 88.0 Cg_endo -92.04 142.11 2.53 Favored 'Trans proline' 0 N--CA 1.49 1.287 0 C-N-CA 121.792 1.661 . . . . 0.0 111.723 177.438 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B ' 9' ' ' LEU . . . . . . . . . . . . . 57.8 mt -77.36 -46.78 2.6 Favored Pre-proline 0 CA--C 1.534 0.348 0 CA-C-O 118.671 -0.68 . . . . 0.0 112.175 -179.736 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B ' 10' ' ' PRO . . . . . . . . . . . . . 86.5 Cg_endo -81.75 150.47 16.51 Favored 'Trans proline' 0 N--CA 1.495 1.612 0 C-N-CA 121.266 1.311 . . . . 0.0 111.79 175.232 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B ' 11' ' ' LYS . . . . . . . . . . . . . 28.2 ttpp -88.87 99.72 12.61 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-O 120.778 0.323 . . . . 0.0 110.541 179.742 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B ' 12' ' ' VAL . . . . . . . . . . . . . 12.6 p -143.68 148.02 19.39 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.29 0 CA-C-N 116.261 -0.427 . . . . 0.0 110.559 -179.398 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B ' 13' ' ' GLU . . . . . . . . . . . . . 44.5 mp0 -84.51 126.09 32.98 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.315 -0.402 . . . . 0.0 110.298 178.676 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B ' 14' ' ' LEU . . . . . . . . . . . . . 47.9 mt -98.63 148.27 34.32 Favored Pre-proline 0 CA--C 1.532 0.284 0 CA-C-O 119.168 -0.444 . . . . 0.0 110.498 -179.415 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B ' 15' ' ' PRO . . . . . . . . . . . . . 24.7 Cg_exo -63.16 159.62 38.24 Favored 'Trans proline' 0 N--CA 1.497 1.73 0 C-N-CA 121.301 1.334 . . . . 0.0 111.831 176.518 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B ' 16' ' ' PRO . . . . . . . . . . . . . 28.8 Cg_exo -60.18 -33.69 94.73 Favored 'Trans proline' 0 N--CA 1.497 1.722 0 C-N-CA 121.52 1.48 . . . . 0.0 112.677 -178.998 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B ' 17' ' ' ASP . . . . . . . . . . . . . 10.6 p-10 -82.79 1.07 40.86 Favored 'General case' 0 CA--C 1.537 0.458 0 N-CA-C 113.281 0.845 . . . . 0.0 113.281 -177.617 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B ' 18' ' ' PHE . . . . . . . . . . . . . 36.2 t80 -57.61 -45.04 85.84 Favored 'General case' 0 C--N 1.334 -0.106 0 O-C-N 121.962 -0.461 . . . . 0.0 110.23 -178.182 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B ' 19' ' ' VAL . . . . . . . . . . . . . 46.9 t -57.08 -43.99 82.24 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.349 0 CA-C-N 116.263 -0.426 . . . . 0.0 110.492 -178.407 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B ' 20' ' ' ASP . . . . . . . . . . . . . 40.8 m-20 -59.76 -42.54 93.5 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-O 120.742 0.306 . . . . 0.0 110.948 -177.467 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B ' 21' ' ' VAL . . . . . . . . . . . . . 46.8 t -63.85 -48.31 86.86 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.241 0 C-N-CA 120.724 -0.391 . . . . 0.0 110.515 -177.792 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B ' 22' ' ' ILE . . . . . 0.479 HG22 HD12 ' B' ' 26' ' ' LEU . 50.4 mm -55.57 -46.92 79.25 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.258 0 C-N-CA 120.997 -0.281 . . . . 0.0 110.798 179.639 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' B' B ' 23' ' ' ARG . . . . . . . . . . . . . 57.8 ttp180 -53.8 -50.39 66.23 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-O 120.594 0.235 . . . . 0.0 111.449 -178.152 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B ' 24' ' ' ILE . . . . . . . . . . . . . 74.8 mt -60.13 -42.96 91.89 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.317 0 CA-C-N 116.57 -0.286 . . . . 0.0 111.304 -177.462 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B ' 25' ' ' LYS . . . . . . . . . . . . . 70.7 mmtt -65.13 -38.44 90.65 Favored 'General case' 0 C--N 1.33 -0.265 0 N-CA-C 112.127 0.417 . . . . 0.0 112.127 -178.73 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B ' 26' ' ' LEU . . . . . 0.479 HD12 HG22 ' B' ' 22' ' ' ILE . 83.4 mt -77.9 -44.77 26.02 Favored 'General case' 0 C--N 1.329 -0.307 0 N-CA-C 112.747 0.647 . . . . 0.0 112.747 -172.119 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' B' B ' 27' ' ' GLN . . . . . . . . . . . . . 15.3 pt20 -46.98 137.88 7.01 Favored 'General case' 0 N--CA 1.469 0.489 0 N-CA-C 112.751 0.648 . . . . 0.0 112.751 -176.168 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B ' 28' ' ' GLY . . . . . . . . . . . . . . . 100.66 -28.82 14.15 Favored Glycine 0 CA--C 1.533 1.195 0 CA-C-N 115.619 -0.718 . . . . 0.0 111.978 -177.066 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B ' 29' ' ' LYS . . . . . . . . . . . . . 93.3 mttt -98.84 155.19 17.5 Favored 'General case' 0 C--O 1.233 0.216 0 CA-C-O 121.053 0.454 . . . . 0.0 111.133 179.285 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B ' 30' ' ' THR . . . . . . . . . . . . . 27.3 m -104.28 137.39 42.26 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.136 -0.484 . . . . 0.0 110.065 175.884 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B ' 31' ' ' VAL . . . . . . . . . . . . . 34.9 m -130.56 155.84 42.07 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.308 0 CA-C-N 116.375 -0.375 . . . . 0.0 110.927 -178.133 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B ' 32' ' ' ARG . . . . . . . . . . . . . 66.2 mtp180 -132.29 152.9 51.16 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-O 121.334 0.588 . . . . 0.0 110.835 179.084 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B ' 33' ' ' THR . . . . . . . . . . . . . 23.9 m -53.27 140.06 27.77 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 115.985 -0.552 . . . . 0.0 111.378 -178.245 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B ' 34' ' ' GLY . . . . . . . . . . . . . . . 99.28 -17.02 58.48 Favored Glycine 0 CA--C 1.532 1.121 0 CA-C-O 119.611 -0.549 . . . . 0.0 113.279 178.273 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B ' 35' ' ' ASP . . . . . . . . . . . . . 77.0 m-20 -66.1 147.71 52.92 Favored 'General case' 0 C--O 1.231 0.109 0 CA-C-N 118.06 0.93 . . . . 0.0 110.888 178.6 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B ' 36' ' ' VAL . . . . . . . . . . . . . 44.3 t -124.58 131.06 73.24 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.271 0 CA-C-N 116.07 -0.514 . . . . 0.0 109.927 178.853 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B ' 37' ' ' ILE . . . . . . . . . . . . . 64.8 mt -120.47 138.97 49.22 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.277 0 CA-C-N 116.197 -0.456 . . . . 0.0 109.951 -179.69 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B ' 38' ' ' GLY . . . . . . . . . . . . . . . -109.22 128.7 9.12 Favored Glycine 0 CA--C 1.526 0.729 0 N-CA-C 111.171 -0.772 . . . . 0.0 111.171 179.969 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B ' 39' ' ' ILE . . . . . . . . . . . . . 72.1 mt -124.38 130.12 73.7 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.256 0 N-CA-C 109.779 -0.452 . . . . 0.0 109.779 178.422 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B ' 40' ' ' SER . . . . . 0.535 ' O ' HD13 ' B' ' 41' ' ' ILE . 78.6 p -91.42 117.02 29.32 Favored 'General case' 0 C--N 1.329 -0.294 0 C-N-CA 120.973 -0.291 . . . . 0.0 111.02 178.512 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' B' B ' 41' ' ' ILE . . . . . 0.535 HD13 ' O ' ' B' ' 40' ' ' SER . 47.1 mm -130.32 125.07 58.94 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.23 0 CA-C-O 120.778 0.323 . . . . 0.0 110.191 179.512 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' B' B ' 42' ' ' LEU . . . . . . . . . . . . . 52.8 mt 57.8 34.23 24.16 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.246 -0.433 . . . . 0.0 111.782 177.802 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B ' 43' ' ' GLY . . . . . . . . . . . . . . . 77.7 -10.08 26.42 Favored Glycine 0 CA--C 1.534 1.279 0 C-N-CA 121.265 -0.493 . . . . 0.0 113.456 177.525 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B ' 44' ' ' LYS . . . . . . . . . . . . . 39.1 mtpt -104.83 133.93 48.81 Favored 'General case' 0 C--N 1.333 -0.121 0 CA-C-N 117.952 0.876 . . . . 0.0 109.855 177.086 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B ' 45' ' ' GLU . . . . . . . . . . . . . 36.3 tp10 -84.6 129.25 34.87 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.425 -0.352 . . . . 0.0 110.864 -179.475 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B ' 46' ' ' VAL . . . . . . . . . . . . . 7.5 p -116.79 129.62 73.0 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.224 0 N-CA-C 109.312 -0.625 . . . . 0.0 109.312 176.599 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B ' 47' ' ' LYS . . . . . . . . . . . . . 58.9 mtpt -99.99 126.8 46.22 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 115.912 -0.585 . . . . 0.0 111.032 179.134 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B ' 48' ' ' PHE . . . . . . . . . . . . . 92.4 m-85 -109.86 131.88 54.66 Favored 'General case' 0 C--N 1.331 -0.213 0 CA-C-N 116.318 -0.401 . . . . 0.0 110.047 176.454 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B ' 49' ' ' LYS . . . . . . . . . . . . . 62.4 tttm -107.64 137.42 45.7 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 116.276 -0.42 . . . . 0.0 110.509 179.2 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B ' 50' ' ' VAL . . . . . . . . . . . . . 45.5 t -80.29 107.42 12.65 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.286 0 N-CA-C 109.135 -0.691 . . . . 0.0 109.135 174.615 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B ' 51' ' ' VAL . . . . . . . . . . . . . 47.8 t -73.5 -47.3 45.9 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.374 0 CA-C-N 116.35 -0.386 . . . . 0.0 110.024 -173.773 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B ' 52' ' ' GLN . . . . . . . . . . . . . 43.3 tt0 -162.17 137.07 7.02 Favored 'General case' 0 C--N 1.33 -0.279 0 C-N-CA 120.418 -0.513 . . . . 0.0 111.606 -178.964 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B ' 53' ' ' ALA . . . . . . . . . . . . . . . -113.47 133.01 55.44 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 115.782 -0.645 . . . . 0.0 109.987 175.35 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B ' 54' ' ' TYR . . . . . . . . . . . . . 12.5 t80 -129.11 112.65 18.44 Favored Pre-proline 0 CA--C 1.534 0.358 0 CA-C-O 118.32 -0.848 . . . . 0.0 110.469 179.208 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B ' 55' ' ' PRO . . . . . . . . . . . . . 73.9 Cg_endo -77.07 169.61 73.87 Favored 'Cis proline' 0 N--CA 1.499 1.8 0 CA-C-N 121.934 1.726 . . . . 0.0 112.195 -6.412 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B ' 56' ' ' SER . . . . . . . . . . . . . 13.6 m -116.83 131.02 24.15 Favored Pre-proline 0 CA--C 1.54 0.559 0 CA-C-O 118.37 -0.824 . . . . 0.0 109.474 176.097 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B ' 57' ' ' PRO . . . . . . . . . . . . . 48.4 Cg_endo -69.99 148.2 86.74 Favored 'Cis proline' 0 N--CA 1.497 1.683 0 CA-C-N 121.937 1.728 . . . . 0.0 111.573 -1.349 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B ' 58' ' ' LEU . . . . . . . . . . . . . 25.8 tp -107.74 135.38 49.25 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.384 -0.371 . . . . 0.0 110.744 -178.399 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B ' 59' ' ' ARG . . . . . . . . . . . . . 55.0 ttt180 -101.96 121.15 41.6 Favored 'General case' 0 C--N 1.327 -0.382 0 N-CA-C 109.297 -0.631 . . . . 0.0 109.297 176.14 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B ' 60' ' ' VAL . . . . . . . . . . . . . 44.4 t -78.97 123.19 35.62 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.263 0 C-N-CA 120.694 -0.402 . . . . 0.0 110.36 -174.987 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B ' 61' ' ' GLU . . . . . . . . . . . . . 95.7 mt-10 -131.03 165.57 22.93 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.062 -0.517 . . . . 0.0 110.057 178.269 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B ' 62' ' ' ASP . . . . . . . . . . . . . 18.0 p-10 -54.61 -32.64 59.19 Favored 'General case' 0 C--N 1.328 -0.329 0 C-N-CA 120.975 -0.29 . . . . 0.0 111.675 179.872 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B ' 63' ' ' ARG . . . . . . . . . . . . . 10.8 ptm180 -85.21 7.29 22.52 Favored 'General case' 0 CA--C 1.537 0.452 0 N-CA-C 113.523 0.934 . . . . 0.0 113.523 -176.273 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B ' 64' ' ' THR . . . . . . . . . . . . . 33.0 m -83.84 138.48 33.19 Favored 'General case' 0 C--N 1.332 -0.17 0 CA-C-N 118.135 0.425 . . . . 0.0 110.76 -178.319 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B ' 65' ' ' LYS . . . . . . . . . . . . . 69.2 mttm -89.99 129.27 36.34 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.106 -0.497 . . . . 0.0 110.281 178.541 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B ' 66' ' ' ILE . . . . . . . . . . . . . 63.0 mt -116.84 130.37 71.83 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.292 0 N-CA-C 109.935 -0.395 . . . . 0.0 109.935 179.454 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B ' 67' ' ' THR . . . . . . . . . . . . . 25.5 m -123.3 136.69 54.81 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.596 -179.513 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B ' 68' ' ' LEU . . . . . . . . . . . . . 17.7 tp . . . . . 0 C--N 1.33 -0.275 0 CA-C-N 116.039 -0.528 . . . . 0.0 110.551 179.515 . . . . . . . . 0 0 . 1 . 007 nuclear build core ' B' B ' 73' ' ' VAL . . . . . . . . . . . . . 31.0 m . . . . . 0 C--O 1.231 0.123 0 CA-C-O 120.902 0.382 . . . . 0.0 110.668 . . . . . . . . . 0 0 . 1 . 007 nuclear build core ' B' B ' 74' ' ' ASP . . . . . . . . . . . . . 7.5 t70 -102.84 120.69 41.05 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.041 -0.527 . . . . 0.0 109.731 179.695 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B ' 75' ' ' VAL . . . . . . . . . . . . . 42.5 t -113.74 122.21 67.42 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.219 0 CA-C-O 121.087 0.47 . . . . 0.0 110.531 -177.76 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B ' 76' ' ' LEU . . . . . . . . . . . . . 32.6 mt -119.85 145.57 46.53 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 115.575 -0.739 . . . . 0.0 109.434 177.471 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B ' 77' ' ' GLU . . . . . . . . . . . . . 98.0 mt-10 -136.46 134.24 37.46 Favored 'General case' 0 C--N 1.332 -0.187 0 CA-C-O 121.189 0.518 . . . . 0.0 111.18 -178.095 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B ' 78' ' ' ALA . . . . . 0.662 ' HB2' HD21 ' B' ' 109' ' ' LEU . . . -122.22 123.76 42.22 Favored 'General case' 0 C--N 1.331 -0.224 0 CA-C-N 115.62 -0.718 . . . . 0.0 109.666 176.471 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' B' B ' 79' ' ' LYS . . . . . 0.566 ' O ' HD13 ' B' ' 80' ' ' ILE . 45.9 pttt -73.6 121.04 20.03 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-O 121.295 0.569 . . . . 0.0 110.811 -177.832 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' B' B ' 80' ' ' ILE . . . . . 0.566 HD13 ' O ' ' B' ' 79' ' ' LYS . 40.4 mm -139.33 112.49 6.22 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.267 0 CA-C-N 115.658 -0.701 . . . . 0.0 109.267 -177.799 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' B' B ' 81' ' ' LYS . . . . . . . . . . . . . 28.9 mtpt -99.46 122.31 42.38 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-O 120.845 0.355 . . . . 0.0 111.113 -177.789 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B ' 82' ' ' GLY . . . . . . . . . . . . . . . 89.22 42.2 5.63 Favored Glycine 0 CA--C 1.525 0.694 0 C-N-CA 120.738 -0.744 . . . . 0.0 111.808 174.362 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B ' 83' ' ' ILE . . . . . . . . . . . . . 68.5 mt -61.92 135.39 26.55 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.33 0 N-CA-C 109.727 -0.472 . . . . 0.0 109.727 176.938 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B ' 84' ' ' LYS . . . . . . . . . . . . . 75.6 tttt -94.39 -51.6 4.71 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.129 -0.487 . . . . 0.0 109.988 -179.312 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B ' 85' ' ' ASP . . . . . . . . . . . . . 11.6 t70 -157.86 152.14 24.57 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 115.666 -0.697 . . . . 0.0 110.347 178.979 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B ' 86' ' ' VAL . . . . . . . . . . . . . 42.6 t -127.41 129.46 70.58 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.275 0 CA-C-O 120.897 0.38 . . . . 0.0 110.313 -179.541 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B ' 87' ' ' ILE . . . . . . . . . . . . . 44.7 mm -119.55 128.95 75.88 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.312 0 CA-C-N 115.985 -0.552 . . . . 0.0 109.755 177.984 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B ' 88' ' ' LEU . . . . . 0.447 HD12 HD22 ' A' ' 124' ' ' LEU . 47.7 mt -111.85 138.12 48.88 Favored 'General case' 0 C--N 1.332 -0.185 0 CA-C-O 121.057 0.456 . . . . 0.0 111.791 -176.645 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' B' B ' 89' ' ' ASP . . . . . . . . . . . . . 13.4 t70 -132.87 155.34 49.2 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 115.401 -0.818 . . . . 0.0 109.226 174.876 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B ' 90' ' ' GLU . . . . . . . . . . . . . 35.0 tt0 -47.54 -37.21 11.72 Favored 'General case' 0 N--CA 1.465 0.301 0 N-CA-C 113.005 0.743 . . . . 0.0 113.005 -171.409 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B ' 91' ' ' ASN . . . . . . . . . . . . . 0.3 OUTLIER -129.59 20.3 5.63 Favored 'General case' 0 N--CA 1.469 0.507 0 N-CA-C 112.823 0.675 . . . . 0.0 112.823 -177.005 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' B' B ' 92' ' ' LEU . . . . . . . . . . . . . 19.6 mt -148.73 143.25 26.29 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-O 120.822 0.344 . . . . 0.0 110.288 -177.427 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B ' 93' ' ' ILE . . . . . . . . . . . . . 71.3 mt -121.54 117.0 51.2 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.331 0 N-CA-C 108.947 -0.76 . . . . 0.0 108.947 175.755 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B ' 94' ' ' VAL . . . . . . . . . . . . . 46.8 t -114.37 123.51 70.12 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.292 0 N-CA-C 109.728 -0.471 . . . . 0.0 109.728 -179.102 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B ' 95' ' ' VAL . . . . . . . . . . . . . 44.1 t -119.95 132.0 70.83 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.321 0 CA-C-N 116.032 -0.531 . . . . 0.0 109.767 -179.447 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B ' 96' ' ' ILE . . . . . . . . . . . . . 66.1 mt -114.48 127.93 71.76 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.33 0 N-CA-C 109.073 -0.714 . . . . 0.0 109.073 178.471 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B ' 97' ' ' THR . . . . . . . . . . . . . 61.3 p -102.31 154.9 18.61 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-O 121.061 0.457 . . . . 0.0 111.094 -177.644 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B ' 98' ' ' GLU . . . . . . . . . . . . . 98.0 mt-10 -53.96 -22.2 9.77 Favored 'General case' 0 CA--C 1.533 0.302 0 N-CA-C 112.355 0.502 . . . . 0.0 112.355 178.177 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B ' 99' ' ' GLU . . . . . . . . . . . . . 95.9 mt-10 -76.54 11.67 1.54 Allowed 'General case' 0 CA--C 1.537 0.468 0 N-CA-C 113.149 0.796 . . . . 0.0 113.149 -178.939 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B ' 100' ' ' ASN . . . . . . . . . . . . . 2.4 m-20 61.96 37.94 14.66 Favored 'General case' 0 CA--C 1.529 0.172 0 CA-C-O 121.077 0.465 . . . . 0.0 110.836 179.785 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B ' 101' ' ' GLU . . . . . . . . . . . . . 84.6 tt0 -120.39 142.02 49.57 Favored 'General case' 0 C--N 1.332 -0.193 0 N-CA-C 109.564 -0.532 . . . . 0.0 109.564 176.215 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B ' 102' ' ' VAL . . . . . . . . . . . . . 45.9 t -114.92 127.57 72.41 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.238 0 N-CA-C 109.976 -0.379 . . . . 0.0 109.976 -178.362 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B ' 103' ' ' LEU . . . . . . . . . . . . . 55.6 mt -116.77 131.89 56.84 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 115.641 -0.709 . . . . 0.0 110.335 177.771 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B ' 104' ' ' ILE . . . . . 0.414 HD12 ' HB3' ' B' ' 113' ' ' TYR . 66.2 mt -115.97 119.35 61.63 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.256 0 CA-C-N 116.375 -0.375 . . . . 0.0 110.03 178.511 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' B' B ' 105' ' ' PHE . . . . . . . . . . . . . 34.7 m-85 -119.59 167.1 12.33 Favored 'General case' 0 C--N 1.333 -0.142 0 O-C-N 123.995 0.809 . . . . 0.0 109.994 178.657 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B ' 106' ' ' ASN . . . . . . . . . . . . . 44.3 p-10 -104.02 -169.98 1.71 Allowed 'General case' 0 C--N 1.331 -0.232 0 N-CA-C 110.078 -0.341 . . . . 0.0 110.078 174.631 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B ' 107' ' ' GLN . . . . . . . . . . . . . 16.0 tt0 -59.64 -29.9 68.35 Favored 'General case' 0 CA--C 1.531 0.244 0 N-CA-C 111.963 0.357 . . . . 0.0 111.963 179.612 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B ' 108' ' ' ASN . . . . . . . . . . . . . 4.9 t-20 -82.87 6.77 17.34 Favored 'General case' 0 CA--C 1.537 0.45 0 N-CA-C 113.171 0.804 . . . . 0.0 113.171 -177.749 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B ' 109' ' ' LEU . . . . . 0.662 HD21 ' HB2' ' B' ' 78' ' ' ALA . 12.0 tp 61.85 37.76 15.15 Favored 'General case' 0 CA--C 1.53 0.18 0 CA-C-O 120.948 0.404 . . . . 0.0 111.294 178.188 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' B' B ' 110' ' ' GLU . . . . . . . . . . . . . 96.0 mt-10 -107.66 165.59 11.32 Favored 'General case' 0 C--N 1.331 -0.218 0 CA-C-N 116.342 -0.39 . . . . 0.0 110.123 176.9 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B ' 111' ' ' GLU . . . . . . . . . . . . . 45.4 tp10 -89.1 125.51 35.06 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-O 120.928 0.394 . . . . 0.0 111.0 -177.452 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B ' 112' ' ' LEU . . . . . . . . . . . . . 17.4 mt -109.62 -46.05 3.58 Favored 'General case' 0 C--N 1.332 -0.19 0 CA-C-N 115.991 -0.55 . . . . 0.0 110.404 177.201 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B ' 113' ' ' TYR . . . . . 0.414 ' HB3' HD12 ' B' ' 104' ' ' ILE . 64.4 t80 -145.42 140.31 27.53 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.226 -0.443 . . . . 0.0 111.382 -179.398 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' B' B ' 114' ' ' ARG . . . . . . . . . . . . . 21.3 ttm180 -132.39 127.8 36.21 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-N 116.006 -0.543 . . . . 0.0 109.842 175.627 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B ' 115' ' ' GLY . . . . . . . . . . . . . . . -150.1 131.35 3.58 Favored Glycine 0 CA--C 1.523 0.573 0 N-CA-C 111.137 -0.785 . . . . 0.0 111.137 178.334 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B ' 116' ' ' LYS . . . . . . . . . . . . . 28.4 ttpp -106.68 133.24 51.65 Favored 'General case' 0 C--N 1.331 -0.235 0 N-CA-C 109.664 -0.495 . . . . 0.0 109.664 176.85 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B ' 117' ' ' PHE . . . . . . . . . . . . . 39.4 m-85 -136.01 113.92 11.23 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-O 120.903 0.382 . . . . 0.0 110.246 -175.591 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B ' 118' ' ' GLU . . . . . . . . . . . . . 97.0 mt-10 -54.34 -44.01 71.73 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.485 -0.325 . . . . 0.0 111.279 -177.628 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B ' 119' ' ' ASN . . . . . . . . . . . . . 83.9 m-20 -96.67 31.03 2.41 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 116.182 -0.463 . . . . 0.0 112.146 -174.661 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B ' 120' ' ' LEU . . . . . . . . . . . . . 14.9 tp -57.04 120.25 7.68 Favored 'General case' 0 C--N 1.333 -0.137 0 CA-C-O 120.641 0.258 . . . . 0.0 110.33 177.447 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B ' 121' ' ' ASN . . . . . . . . . . . . . 61.1 m-80 -113.6 -44.0 3.25 Favored 'General case' 0 C--N 1.332 -0.156 0 CA-C-N 116.627 -0.26 . . . . 0.0 111.084 -177.357 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B ' 122' ' ' LYS . . . . . . . . . . . . . 88.6 mttt -147.4 149.8 33.43 Favored 'General case' 0 C--N 1.331 -0.197 0 CA-C-O 121.221 0.534 . . . . 0.0 111.744 -178.035 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B ' 123' ' ' VAL . . . . . . . . . . . . . 44.6 t -128.19 129.2 69.29 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.263 0 CA-C-N 115.71 -0.677 . . . . 0.0 109.589 175.506 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B ' 124' ' ' LEU . . . . . . . . . . . . . 83.8 mt -123.63 131.93 53.74 Favored 'General case' 0 C--N 1.331 -0.224 0 CA-C-N 116.396 -0.366 . . . . 0.0 110.573 -179.041 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B ' 125' ' ' VAL . . . . . 0.452 ' O ' HG13 ' B' ' 125' ' ' VAL . 11.2 p -131.12 122.86 52.46 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.232 0 CA-C-N 116.163 -0.471 . . . . 0.0 109.835 177.161 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' B' B ' 126' ' ' ARG . . . . . . . . . . . . . 88.8 mtt180 -147.45 128.82 14.86 Favored 'General case' 0 C--N 1.33 -0.252 0 N-CA-C 109.62 -0.511 . . . . 0.0 109.62 -179.802 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B ' 127' ' ' ASN . . . . . . . . . . . . . 32.0 m120 55.95 -151.94 0.39 Allowed 'General case' 0 CA--C 1.541 0.616 0 N-CA-C 109.784 -0.451 . . . . 0.0 109.784 -178.749 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B ' 128' ' ' ASP . . . . . . . . . . . . . 19.4 p-10 -83.69 19.73 1.59 Allowed 'General case' 0 CA--C 1.536 0.412 0 CA-C-N 118.67 0.668 . . . . 0.0 112.49 177.337 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B ' 129' ' ' LEU . . . . . . . . . . . . . 2.0 tt -116.41 131.81 56.85 Favored 'General case' 0 C--O 1.232 0.156 0 N-CA-C 109.96 -0.385 . . . . 0.0 109.96 -179.92 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B ' 130' ' ' VAL . . . . . . . . . . . . . 44.7 t -124.19 138.26 54.38 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.228 0 CA-C-O 120.765 0.317 . . . . 0.0 110.146 -178.826 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B ' 131' ' ' VAL . . . . . 0.434 HG22 HD12 ' B' ' 140' ' ' LEU . 41.2 t -136.1 137.75 48.14 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.261 0 CA-C-O 121.037 0.446 . . . . 0.0 110.444 179.851 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' B' B ' 132' ' ' ILE . . . . . . . . . . . . . 73.5 mt -119.84 133.39 66.76 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.254 0 N-CA-C 109.342 -0.614 . . . . 0.0 109.342 178.68 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B ' 133' ' ' ILE . . . . . . . . . . . . . 40.1 mm -117.44 121.71 68.22 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.29 0 CA-C-O 120.824 0.345 . . . . 0.0 111.205 -174.498 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B ' 134' ' ' ASP . . . . . . . . . . . . . 6.8 p-10 -132.07 147.25 52.43 Favored 'General case' 0 C--N 1.332 -0.178 0 CA-C-N 115.852 -0.613 . . . . 0.0 109.521 173.831 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B ' 135' ' ' GLU . . . . . . . . . . . . . 43.7 tp10 -49.9 -26.72 4.37 Favored 'General case' 0 C--N 1.328 -0.33 0 N-CA-C 112.904 0.705 . . . . 0.0 112.904 -170.756 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B ' 136' ' ' GLN . . . . . . . . . . . . . 96.9 mt-30 -92.88 -34.76 13.69 Favored 'General case' 0 C--N 1.331 -0.232 0 N-CA-C 112.381 0.511 . . . . 0.0 112.381 -175.475 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B ' 137' ' ' LYS . . . . . . . . . . . . . 55.4 mtmt -145.49 154.98 42.81 Favored 'General case' 0 C--N 1.33 -0.239 0 CA-C-O 121.474 0.654 . . . . 0.0 111.856 -170.141 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B ' 138' ' ' LEU . . . . . 0.454 HD23 ' N ' ' B' ' 139' ' ' THR . 4.2 tt -113.31 123.05 49.22 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 115.144 -0.935 . . . . 0.0 108.981 174.403 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' B' B ' 139' ' ' THR . . . . . 0.454 ' N ' HD23 ' B' ' 138' ' ' LEU . 33.1 m -107.61 128.48 54.58 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-O 120.848 0.356 . . . . 0.0 110.852 -177.218 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' B' B ' 140' ' ' LEU . . . . . 0.434 HD12 HG22 ' B' ' 131' ' ' VAL . 18.8 tp -114.08 121.53 44.09 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 115.45 -0.796 . . . . 0.0 109.355 -179.28 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' B' B ' 141' ' ' ILE . . . . . . . . . . . . . 19.5 mt -120.86 120.13 61.5 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.342 0 N-CA-C 109.855 -0.424 . . . . 0.0 109.855 -175.733 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B ' 142' ' ' ARG . . . . . . . . . . . . . 73.5 mtm180 -111.01 129.23 55.96 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 115.55 -0.75 . . . . 0.0 110.547 -179.401 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B ' 143' ' ' THR . . . . . . . . . . . . . 39.9 p . . . . . 0 C--O 1.222 -0.373 0 CA-C-O 117.959 -1.02 . . . . 0.0 110.56 179.939 . . . . . . . . 0 0 . 1 . 007 nuclear build core ' C' C ' 2' ' ' SER . . . . . . . . . . . . . 25.9 p . . . . . 0 C--O 1.231 0.086 0 CA-C-O 120.911 0.386 . . . . 0.0 110.312 . . . . . . . . . 0 0 . 1 . 007 nuclear build core ' C' C ' 3' ' ' GLU . . . . . . . . . . . . . 95.7 mt-10 -139.42 141.8 37.48 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.191 -0.459 . . . . 0.0 111.014 -178.021 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' C' C ' 4' ' ' LEU . . . . . 0.4 HD11 HG13 ' C' ' 50' ' ' VAL . 16.9 tp -125.11 125.83 44.37 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 115.724 -0.671 . . . . 0.0 110.197 177.165 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' C' C ' 5' ' ' LYS . . . . . . . . . . . . . 60.5 mttp -105.23 121.53 44.04 Favored 'General case' 0 C--O 1.234 0.25 0 CA-C-N 116.505 -0.316 . . . . 0.0 110.282 177.632 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' C' C ' 6' ' ' LEU . . . . . . . . . . . . . 53.2 mt -114.46 145.71 41.55 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-N 115.623 -0.717 . . . . 0.0 110.917 -178.058 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' C' C ' 7' ' ' LYS . . . . . . . . . . . . . 25.9 ttpt -132.7 134.53 24.77 Favored Pre-proline 0 CA--C 1.536 0.412 0 CA-C-O 118.884 -0.579 . . . . 0.0 109.64 176.449 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' C' C ' 8' ' ' PRO . . . . . . . . . . . . . 86.5 Cg_endo -90.67 133.3 1.75 Allowed 'Trans proline' 0 N--CA 1.489 1.228 0 C-N-CA 121.624 1.55 . . . . 0.0 111.343 174.095 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' C' C ' 9' ' ' LEU . . . . . . . . . . . . . 62.1 mt -69.13 -48.21 27.59 Favored Pre-proline 0 CA--C 1.533 0.325 0 CA-C-O 118.608 -0.711 . . . . 0.0 112.48 -177.085 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' C' C ' 10' ' ' PRO . . . . . . . . . . . . . 90.0 Cg_endo -78.81 146.83 21.17 Favored 'Trans proline' 0 N--CA 1.495 1.59 0 C-N-CA 121.109 1.206 . . . . 0.0 111.817 177.367 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' C' C ' 11' ' ' LYS . . . . . . . . . . . . . 62.0 tttm -78.55 91.39 4.57 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.436 -0.347 . . . . 0.0 110.424 179.185 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' C' C ' 12' ' ' VAL . . . . . . . . . . . . . 12.4 p -139.63 146.15 25.77 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.308 0 CA-C-N 116.297 -0.41 . . . . 0.0 110.485 -179.705 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' C' C ' 13' ' ' GLU . . . . . . . . . . . . . 44.7 tp10 -90.26 129.37 36.51 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.33 -0.396 . . . . 0.0 110.298 179.351 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' C' C ' 14' ' ' LEU . . . . . . . . . . . . . 27.3 mt -97.99 152.36 38.02 Favored Pre-proline 0 CA--C 1.531 0.246 0 CA-C-N 116.33 -0.395 . . . . 0.0 110.653 -178.323 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' C' C ' 15' ' ' PRO . . . . . . . . . . . . . 27.2 Cg_exo -61.31 159.01 32.77 Favored 'Trans proline' 0 N--CA 1.499 1.795 0 C-N-CA 121.307 1.338 . . . . 0.0 111.815 177.265 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' C' C ' 16' ' ' PRO . . . . . . . . . . . . . 39.8 Cg_exo -58.63 -39.37 83.27 Favored 'Trans proline' 0 N--CA 1.498 1.74 0 C-N-CA 121.483 1.455 . . . . 0.0 112.871 -178.481 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' C' C ' 17' ' ' ASP . . . . . . . . . . . . . 12.9 p-10 -85.81 8.51 19.73 Favored 'General case' 0 CA--C 1.536 0.44 0 N-CA-C 113.176 0.806 . . . . 0.0 113.176 -177.738 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' C' C ' 18' ' ' PHE . . . . . . . . . . . . . 55.0 t80 -58.1 -45.53 87.06 Favored 'General case' 0 C--N 1.333 -0.118 0 O-C-N 122.077 -0.389 . . . . 0.0 110.178 -177.925 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' C' C ' 19' ' ' VAL . . . . . 0.414 HG13 ' N ' ' C' ' 20' ' ' ASP . 13.8 p -55.88 -41.69 67.9 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.371 0 CA-C-N 116.336 -0.393 . . . . 0.0 111.006 -178.244 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' C' C ' 20' ' ' ASP . . . . . 0.414 ' N ' HG13 ' C' ' 19' ' ' VAL . 11.3 t70 -60.82 -42.03 96.91 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-O 120.977 0.418 . . . . 0.0 110.655 -178.831 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' C' C ' 21' ' ' VAL . . . . . . . . . . . . . 47.3 t -64.04 -45.47 96.58 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.248 0 CA-C-N 116.244 -0.434 . . . . 0.0 110.442 -178.138 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' C' C ' 22' ' ' ILE . . . . . 0.45 HG22 HD12 ' C' ' 26' ' ' LEU . 51.5 mm -55.4 -47.25 78.41 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.265 0 C-N-CA 121.056 -0.258 . . . . 0.0 110.661 179.037 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' C' C ' 23' ' ' ARG . . . . . . . . . . . . . 54.0 ttp180 -54.35 -49.83 68.86 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-O 120.671 0.272 . . . . 0.0 111.411 -179.068 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' C' C ' 24' ' ' ILE . . . . . . . . . . . . . 73.1 mt -59.34 -41.76 85.26 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.314 0 CA-C-N 116.566 -0.288 . . . . 0.0 111.422 -176.889 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' C' C ' 25' ' ' LYS . . . . . . . . . . . . . 49.6 mttm -67.28 -42.64 83.46 Favored 'General case' 0 C--N 1.329 -0.32 0 N-CA-C 112.351 0.5 . . . . 0.0 112.351 -178.791 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' C' C ' 26' ' ' LEU . . . . . 0.45 HD12 HG22 ' C' ' 22' ' ' ILE . 92.6 mt -78.34 -37.91 43.38 Favored 'General case' 0 C--N 1.33 -0.272 0 N-CA-C 113.116 0.784 . . . . 0.0 113.116 -170.651 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' C' C ' 27' ' ' GLN . . . . . . . . . . . . . 13.8 pt20 -46.87 139.12 5.72 Favored 'General case' 0 N--CA 1.47 0.531 0 N-CA-C 112.918 0.71 . . . . 0.0 112.918 -175.016 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' C' C ' 28' ' ' GLY . . . . . . . . . . . . . . . 100.01 -26.69 23.51 Favored Glycine 0 CA--C 1.533 1.17 0 CA-C-N 115.493 -0.776 . . . . 0.0 112.207 -177.505 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' C' C ' 29' ' ' LYS . . . . . . . . . . . . . 60.8 mttp -98.24 155.12 17.34 Favored 'General case' 0 C--O 1.232 0.169 0 CA-C-N 117.264 0.532 . . . . 0.0 111.071 179.555 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' C' C ' 30' ' ' THR . . . . . . . . . . . . . 32.8 m -110.0 133.52 53.1 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-N 116.048 -0.523 . . . . 0.0 110.186 176.823 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' C' C ' 31' ' ' VAL . . . . . . . . . . . . . 35.0 m -133.45 164.3 35.32 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.267 0 CA-C-N 116.265 -0.425 . . . . 0.0 110.364 -179.641 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' C' C ' 32' ' ' ARG . . . . . . . . . . . . . 29.9 ttp180 -132.53 153.59 50.8 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-O 121.294 0.569 . . . . 0.0 110.605 179.232 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' C' C ' 33' ' ' THR . . . . . . . . . . . . . 28.8 m -52.41 140.35 22.46 Favored 'General case' 0 C--N 1.331 -0.227 0 CA-C-N 116.127 -0.488 . . . . 0.0 111.561 -178.327 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' C' C ' 34' ' ' GLY . . . . . . . . . . . . . . . 100.02 -17.2 57.52 Favored Glycine 0 CA--C 1.533 1.181 0 CA-C-O 119.713 -0.493 . . . . 0.0 113.199 179.875 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' C' C ' 35' ' ' ASP . . . . . . . . . . . . . 60.7 m-20 -66.77 149.73 50.12 Favored 'General case' 0 C--O 1.232 0.164 0 CA-C-N 118.074 0.937 . . . . 0.0 111.2 178.918 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' C' C ' 36' ' ' VAL . . . . . . . . . . . . . 45.2 t -123.65 130.44 74.05 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.261 0 CA-C-N 115.897 -0.592 . . . . 0.0 109.825 178.905 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' C' C ' 37' ' ' ILE . . . . . . . . . . . . . 62.1 mt -122.15 139.2 49.84 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.265 0 CA-C-N 116.259 -0.428 . . . . 0.0 109.898 -178.84 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' C' C ' 38' ' ' GLY . . . . . . . . . . . . . . . -109.83 128.74 9.05 Favored Glycine 0 CA--C 1.525 0.696 0 N-CA-C 111.192 -0.763 . . . . 0.0 111.192 179.744 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' C' C ' 39' ' ' ILE . . . . . . . . . . . . . 68.8 mt -120.76 130.96 74.02 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.19 0 N-CA-C 109.944 -0.391 . . . . 0.0 109.944 178.406 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' C' C ' 40' ' ' SER . . . . . . . . . . . . . 32.8 t -93.12 122.58 35.65 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.423 -0.353 . . . . 0.0 111.099 177.324 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' C' C ' 41' ' ' ILE . . . . . . . . . . . . . 70.3 mt -129.75 120.24 49.66 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.206 0 CA-C-O 120.881 0.372 . . . . 0.0 110.325 177.405 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' C' C ' 42' ' ' LEU . . . . . . . . . . . . . 62.6 mt 52.84 36.13 20.67 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 116.02 -0.536 . . . . 0.0 111.677 177.163 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' C' C ' 43' ' ' GLY . . . . . . . . . . . . . . . 72.64 30.0 64.74 Favored Glycine 0 CA--C 1.529 0.967 0 C-N-CA 121.108 -0.567 . . . . 0.0 112.284 177.615 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' C' C ' 44' ' ' LYS . . . . . . . . . . . . . 62.3 mtpt -134.65 129.06 34.27 Favored 'General case' 0 C--N 1.331 -0.222 0 N-CA-C 109.645 -0.502 . . . . 0.0 109.645 177.809 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' C' C ' 45' ' ' GLU . . . . . . . . . . . . . 84.5 tt0 -84.23 122.2 28.55 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-O 120.871 0.367 . . . . 0.0 111.304 -178.255 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' C' C ' 46' ' ' VAL . . . . . . . . . . . . . 7.6 p -119.03 125.6 74.64 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.168 0 N-CA-C 109.06 -0.718 . . . . 0.0 109.06 173.643 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' C' C ' 47' ' ' LYS . . . . . . . . . . . . . 97.9 mttt -99.62 126.87 45.7 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.099 -0.5 . . . . 0.0 111.151 -179.843 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' C' C ' 48' ' ' PHE . . . . . . . . . . . . . 93.6 m-85 -110.39 131.78 54.75 Favored 'General case' 0 C--N 1.329 -0.289 0 N-CA-C 109.624 -0.51 . . . . 0.0 109.624 176.76 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' C' C ' 49' ' ' LYS . . . . . . . . . . . . . 71.4 tttt -108.79 136.83 47.71 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.388 -0.369 . . . . 0.0 110.459 179.075 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' C' C ' 50' ' ' VAL . . . . . 0.4 HG13 HD11 ' C' ' 4' ' ' LEU . 48.0 t -78.87 105.36 8.0 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.278 0 N-CA-C 109.087 -0.709 . . . . 0.0 109.087 175.899 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' C' C ' 51' ' ' VAL . . . . . . . . . . . . . 46.8 t -69.19 -48.96 65.75 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.291 0 CA-C-N 116.07 -0.514 . . . . 0.0 109.843 -173.922 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' C' C ' 52' ' ' GLN . . . . . . . . . . . . . 32.3 tt0 -162.43 143.23 10.12 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-N 115.949 -0.569 . . . . 0.0 111.522 -179.1 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' C' C ' 53' ' ' ALA . . . . . . . . . . . . . . . -122.58 133.85 54.54 Favored 'General case' 0 C--N 1.331 -0.212 0 CA-C-N 115.786 -0.643 . . . . 0.0 109.718 176.714 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' C' C ' 54' ' ' TYR . . . . . . . . . . . . . 14.9 t80 -129.08 113.08 18.52 Favored Pre-proline 0 CA--C 1.535 0.397 0 CA-C-O 118.041 -0.981 . . . . 0.0 110.345 179.265 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' C' C ' 55' ' ' PRO . . . . . . . . . . . . . 73.7 Cg_endo -77.08 169.15 75.09 Favored 'Cis proline' 0 N--CA 1.501 1.967 0 CA-C-N 122.017 1.756 . . . . 0.0 112.214 -6.95 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' C' C ' 56' ' ' SER . . . . . . . . . . . . . 13.5 m -117.74 135.95 23.51 Favored Pre-proline 0 CA--C 1.539 0.533 0 CA-C-O 118.549 -0.738 . . . . 0.0 109.825 175.681 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' C' C ' 57' ' ' PRO . . . . . . . . . . . . . 36.5 Cg_endo -67.22 164.68 70.47 Favored 'Cis proline' 0 N--CA 1.496 1.665 0 CA-C-N 121.743 1.658 . . . . 0.0 111.231 -4.318 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' C' C ' 58' ' ' LEU . . . . . . . . . . . . . 42.4 tp -130.71 138.4 49.99 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-O 121.126 0.489 . . . . 0.0 110.777 -178.737 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' C' C ' 59' ' ' ARG . . . . . . . . . . . . . 51.1 ttt180 -104.1 125.81 50.72 Favored 'General case' 0 C--N 1.327 -0.395 0 N-CA-C 108.939 -0.763 . . . . 0.0 108.939 173.297 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' C' C ' 60' ' ' VAL . . . . . . . . . . . . . 44.1 t -78.94 122.46 34.2 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.319 0 CA-C-O 120.937 0.398 . . . . 0.0 110.609 -174.135 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' C' C ' 61' ' ' GLU . . . . . . . . . . . . . 43.1 mt-10 -131.03 166.04 21.89 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 115.79 -0.641 . . . . 0.0 109.697 174.739 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' C' C ' 62' ' ' ASP . . . . . . . . . . . . . 81.0 m-20 -52.87 -31.85 41.69 Favored 'General case' 0 C--N 1.328 -0.369 0 N-CA-C 111.971 0.36 . . . . 0.0 111.971 -179.883 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' C' C ' 63' ' ' ARG . . . . . . . . . . . . . 21.0 mmm180 -71.17 -21.88 62.11 Favored 'General case' 0 CA--C 1.534 0.351 0 N-CA-C 112.76 0.652 . . . . 0.0 112.76 -176.128 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' C' C ' 64' ' ' THR . . . . . . . . . . . . . 25.3 m -72.12 136.3 46.49 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-O 120.933 0.397 . . . . 0.0 110.947 -175.829 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' C' C ' 65' ' ' LYS . . . . . . . . . . . . . 96.9 mttt -89.8 131.45 35.74 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.011 -0.54 . . . . 0.0 110.144 179.221 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' C' C ' 66' ' ' ILE . . . . . . . . . . . . . 64.0 mt -116.67 130.52 71.38 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.256 0 CA-C-O 120.89 0.376 . . . . 0.0 110.121 -179.892 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' C' C ' 67' ' ' THR . . . . . . . . . . . . . 21.7 m -129.19 142.5 50.85 Favored 'General case' 0 C--N 1.332 -0.185 0 CA-C-N 116.084 -0.507 . . . . 0.0 110.787 -178.846 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' C' C ' 68' ' ' LEU . . . . . 0.5 HD12 ' N ' ' C' ' 68' ' ' LEU . 7.1 mp . . . . . 0 C--N 1.33 -0.248 0 CA-C-N 116.081 -0.509 . . . . 0.0 110.417 178.631 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' C' C ' 73' ' ' VAL . . . . . . . . . . . . . 26.8 m . . . . . 0 C--O 1.231 0.121 0 N-CA-C 109.802 -0.444 . . . . 0.0 109.802 . . . . . . . . . 0 0 . 1 . 007 nuclear build core ' C' C ' 74' ' ' ASP . . . . . . . . . . . . . 14.0 t70 -91.35 115.24 27.87 Favored 'General case' 0 C--N 1.328 -0.33 0 N-CA-C 109.921 -0.4 . . . . 0.0 109.921 -178.351 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' C' C ' 75' ' ' VAL . . . . . . . . . . . . . 45.6 t -113.1 120.29 62.72 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.268 0 CA-C-O 121.094 0.473 . . . . 0.0 110.216 -178.446 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' C' C ' 76' ' ' LEU . . . . . . . . . . . . . 19.8 mt -123.18 144.94 49.02 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 115.605 -0.725 . . . . 0.0 109.585 179.452 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' C' C ' 77' ' ' GLU . . . . . . . . . . . . . 46.2 mt-10 -134.31 133.5 40.78 Favored 'General case' 0 C--N 1.332 -0.188 0 CA-C-O 121.042 0.449 . . . . 0.0 111.149 -178.804 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' C' C ' 78' ' ' ALA . . . . . . . . . . . . . . . -118.94 135.75 54.43 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 115.713 -0.676 . . . . 0.0 109.808 176.461 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' C' C ' 79' ' ' LYS . . . . . 0.664 ' O ' HD13 ' C' ' 80' ' ' ILE . 62.5 mtpt -80.7 115.3 20.13 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-O 120.813 0.34 . . . . 0.0 110.869 -177.627 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' C' C ' 80' ' ' ILE . . . . . 0.664 HD13 ' O ' ' C' ' 79' ' ' LYS . 37.2 mm -139.23 104.61 2.22 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.281 0 N-CA-C 109.284 -0.636 . . . . 0.0 109.284 -178.527 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' C' C ' 81' ' ' LYS . . . . . . . . . . . . . 93.1 mttt -97.65 128.48 44.38 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-O 120.782 0.325 . . . . 0.0 110.839 -178.766 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' C' C ' 82' ' ' GLY . . . . . . . . . . . . . . . 89.08 42.25 5.66 Favored Glycine 0 CA--C 1.524 0.655 0 N-CA-C 111.176 -0.77 . . . . 0.0 111.176 176.685 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' C' C ' 83' ' ' ILE . . . . . . . . . . . . . 73.6 mt -67.37 132.3 32.5 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.306 0 N-CA-C 109.771 -0.455 . . . . 0.0 109.771 177.689 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' C' C ' 84' ' ' LYS . . . . . . . . . . . . . 76.4 tttt -95.42 -54.06 3.53 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.22 -0.445 . . . . 0.0 110.311 -178.736 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' C' C ' 85' ' ' ASP . . . . . . . . . . . . . 7.4 t0 -149.81 146.3 27.07 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 115.806 -0.634 . . . . 0.0 110.39 -178.652 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' C' C ' 86' ' ' VAL . . . . . . . . . . . . . 42.6 t -124.31 129.5 73.96 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.216 0 CA-C-O 120.858 0.361 . . . . 0.0 110.291 -179.597 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' C' C ' 87' ' ' ILE . . . . . . . . . . . . . 45.1 mm -120.18 126.15 74.97 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.268 0 CA-C-N 115.957 -0.565 . . . . 0.0 109.738 177.637 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' C' C ' 88' ' ' LEU . . . . . . . . . . . . . 19.9 tp -115.15 134.72 54.91 Favored 'General case' 0 C--N 1.332 -0.171 0 CA-C-O 120.992 0.425 . . . . 0.0 111.222 -177.736 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' C' C ' 89' ' ' ASP . . . . . . . . . . . . . 5.6 t70 -131.53 162.23 30.77 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 115.861 -0.609 . . . . 0.0 109.562 176.43 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' C' C ' 90' ' ' GLU . . . . . . . . . . . . . 43.2 mt-10 -46.94 -41.9 16.83 Favored 'General case' 0 N--CA 1.464 0.26 0 N-CA-C 113.015 0.746 . . . . 0.0 113.015 -171.224 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' C' C ' 91' ' ' ASN . . . . . . . . . . . . . 11.3 p-10 -132.04 28.29 4.48 Favored 'General case' 0 N--CA 1.466 0.329 0 N-CA-C 112.301 0.482 . . . . 0.0 112.301 -177.773 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' C' C ' 92' ' ' LEU . . . . . . . . . . . . . 16.1 mt -148.62 142.33 25.57 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-O 120.689 0.281 . . . . 0.0 110.35 -177.38 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' C' C ' 93' ' ' ILE . . . . . . . . . . . . . 72.9 mt -125.25 116.58 47.27 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.286 0 N-CA-C 109.143 -0.688 . . . . 0.0 109.143 176.11 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' C' C ' 94' ' ' VAL . . . . . 0.588 HG21 HG11 ' C' ' 125' ' ' VAL . 45.2 t -118.54 127.73 75.53 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.29 0 CA-C-O 120.959 0.409 . . . . 0.0 109.939 -178.795 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' C' C ' 95' ' ' VAL . . . . . . . . . . . . . 44.0 t -122.59 132.78 70.53 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.373 0 CA-C-N 115.96 -0.564 . . . . 0.0 109.854 -179.524 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' C' C ' 96' ' ' ILE . . . . . . . . . . . . . 58.6 mt -113.12 125.58 70.4 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.327 0 N-CA-C 109.058 -0.719 . . . . 0.0 109.058 178.066 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' C' C ' 97' ' ' THR . . . . . . . . . . . . . 71.5 p -98.95 154.53 17.99 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-O 121.197 0.522 . . . . 0.0 111.108 -177.758 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' C' C ' 98' ' ' GLU . . . . . . . . . . . . . 85.1 tt0 -53.82 -25.48 19.62 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 115.959 -0.564 . . . . 0.0 112.341 179.771 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' C' C ' 99' ' ' GLU . . . . . . . . . . . . . 37.0 tt0 -81.07 17.96 1.14 Allowed 'General case' 0 CA--C 1.539 0.525 0 N-CA-C 112.625 0.602 . . . . 0.0 112.625 -177.436 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' C' C ' 100' ' ' ASN . . . . . . . . . . . . . 2.7 m-20 62.39 32.77 16.72 Favored 'General case' 0 N--CA 1.464 0.259 0 O-C-N 121.85 -0.531 . . . . 0.0 111.836 176.276 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' C' C ' 101' ' ' GLU . . . . . . . . . . . . . 84.8 tt0 -113.06 144.82 41.96 Favored 'General case' 0 C--N 1.332 -0.155 0 N-CA-C 109.812 -0.44 . . . . 0.0 109.812 174.14 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' C' C ' 102' ' ' VAL . . . . . . . . . . . . . 45.7 t -115.09 127.43 72.65 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.293 0 CA-C-N 116.244 -0.435 . . . . 0.0 109.926 -177.695 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' C' C ' 103' ' ' LEU . . . . . . . . . . . . . 50.6 mt -117.38 131.53 56.76 Favored 'General case' 0 C--N 1.331 -0.215 0 CA-C-N 115.881 -0.6 . . . . 0.0 110.132 178.531 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' C' C ' 104' ' ' ILE . . . . . . . . . . . . . 65.1 mt -122.56 122.65 66.61 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.227 0 CA-C-O 120.568 0.223 . . . . 0.0 110.46 -179.657 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' C' C ' 105' ' ' PHE . . . . . . . . . . . . . 47.7 m-85 -124.07 164.64 19.0 Favored 'General case' 0 C--N 1.331 -0.225 0 CA-C-N 115.596 -0.729 . . . . 0.0 109.843 178.432 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' C' C ' 106' ' ' ASN . . . . . . . . . . . . . 42.9 p-10 -96.29 -171.41 2.29 Favored 'General case' 0 C--N 1.331 -0.212 0 N-CA-C 109.992 -0.373 . . . . 0.0 109.992 174.929 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' C' C ' 107' ' ' GLN . . . . . . . . . . . . . 15.4 tt0 -60.23 -29.46 68.77 Favored 'General case' 0 C--N 1.329 -0.32 0 N-CA-C 111.96 0.355 . . . . 0.0 111.96 -179.659 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' C' C ' 108' ' ' ASN . . . . . . . . . . . . . 5.0 t-20 -83.95 6.16 22.83 Favored 'General case' 0 CA--C 1.536 0.441 0 N-CA-C 113.277 0.843 . . . . 0.0 113.277 -177.468 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' C' C ' 109' ' ' LEU . . . . . . . . . . . . . 12.0 tp 62.09 41.67 10.64 Favored 'General case' 0 C--N 1.332 -0.164 0 CA-C-O 121.383 0.611 . . . . 0.0 110.98 178.657 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' C' C ' 110' ' ' GLU . . . . . . . . . . . . . 96.2 mt-10 -108.55 155.97 20.04 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.139 -0.482 . . . . 0.0 110.014 176.094 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' C' C ' 111' ' ' GLU . . . . . . . . . . . . . 83.7 tt0 -79.97 121.93 26.09 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.394 -0.366 . . . . 0.0 110.683 -179.121 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' C' C ' 112' ' ' LEU . . . . . . . . . . . . . 17.9 mt -112.44 -46.03 3.2 Favored 'General case' 0 C--N 1.331 -0.212 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.306 177.026 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' C' C ' 113' ' ' TYR . . . . . . . . . . . . . 62.7 t80 -147.07 137.2 23.35 Favored 'General case' 0 C--N 1.33 -0.243 0 C-N-CA 120.606 -0.438 . . . . 0.0 111.462 179.991 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' C' C ' 114' ' ' ARG . . . . . . . . . . . . . 93.2 mtt180 -137.67 127.83 26.05 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.131 -0.486 . . . . 0.0 110.096 173.876 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' C' C ' 115' ' ' GLY . . . . . . . . . . . . . . . -149.99 162.89 29.31 Favored Glycine 0 CA--C 1.524 0.596 0 N-CA-C 110.682 -0.967 . . . . 0.0 110.682 179.337 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' C' C ' 116' ' ' LYS . . . . . . . . . . . . . 75.2 tttt -132.31 138.5 47.84 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-O 120.856 0.36 . . . . 0.0 110.143 179.287 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' C' C ' 117' ' ' PHE . . . . . . . . . . . . . 33.4 m-85 -136.28 116.72 13.71 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.158 -0.474 . . . . 0.0 109.812 -177.113 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' C' C ' 118' ' ' GLU . . . . . . . . . . . . . 45.7 mp0 -56.01 -40.62 73.65 Favored 'General case' 0 C--N 1.329 -0.304 0 C-N-CA 120.803 -0.359 . . . . 0.0 110.92 -175.758 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' C' C ' 119' ' ' ASN . . . . . . . . . . . . . 30.5 m120 -100.07 31.19 3.42 Favored 'General case' 0 CA--C 1.53 0.21 0 N-CA-C 112.103 0.408 . . . . 0.0 112.103 -174.912 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' C' C ' 120' ' ' LEU . . . . . . . . . . . . . 15.0 tp -57.34 119.9 7.25 Favored 'General case' 0 C--N 1.333 -0.148 0 C-N-CA 121.005 -0.278 . . . . 0.0 110.352 178.087 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' C' C ' 121' ' ' ASN . . . . . . . . . . . . . 46.8 m-80 -114.15 -44.1 3.17 Favored 'General case' 0 C--N 1.332 -0.195 0 CA-C-N 116.571 -0.286 . . . . 0.0 111.245 -177.705 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' C' C ' 122' ' ' LYS . . . . . . . . . . . . . 75.7 mttt -143.35 149.22 37.44 Favored 'General case' 0 C--N 1.331 -0.222 0 CA-C-O 121.066 0.46 . . . . 0.0 111.834 -176.312 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' C' C ' 123' ' ' VAL . . . . . . . . . . . . . 43.1 t -128.62 130.96 69.03 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.227 0 N-CA-C 109.266 -0.642 . . . . 0.0 109.266 174.847 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' C' C ' 124' ' ' LEU . . . . . . . . . . . . . 13.3 tp -130.27 138.3 50.43 Favored 'General case' 0 C--N 1.332 -0.184 0 CA-C-O 120.837 0.351 . . . . 0.0 110.916 -177.484 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' C' C ' 125' ' ' VAL . . . . . 0.588 HG11 HG21 ' C' ' 94' ' ' VAL . 34.9 m -129.74 138.82 53.19 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.229 0 CA-C-N 116.127 -0.488 . . . . 0.0 110.603 179.939 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' C' C ' 126' ' ' ARG . . . . . . . . . . . . . 77.9 mtp85 -147.17 121.88 9.87 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-O 120.868 0.366 . . . . 0.0 110.938 178.162 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' C' C ' 127' ' ' ASN . . . . . . . . . . . . . 9.5 m120 51.02 -105.11 0.19 Allowed 'General case' 0 CA--C 1.544 0.739 0 CA-C-N 116.113 -0.494 . . . . 0.0 111.437 178.684 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' C' C ' 128' ' ' ASP . . . . . . . . . . . . . 12.6 p-10 -114.13 -0.32 14.02 Favored 'General case' 0 CA--C 1.537 0.461 0 CA-C-N 119.504 1.047 . . . . 0.0 113.372 -177.37 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' C' C ' 129' ' ' LEU . . . . . . . . . . . . . 58.3 mt -105.01 143.65 32.89 Favored 'General case' 0 C--O 1.232 0.166 0 CA-C-N 118.135 0.425 . . . . 0.0 110.373 -179.465 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' C' C ' 130' ' ' VAL . . . . . . . . . . . . . 44.9 t -124.4 136.97 58.81 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.284 0 N-CA-C 109.642 -0.503 . . . . 0.0 109.642 -179.956 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' C' C ' 131' ' ' VAL . . . . . 0.496 HG22 HD12 ' C' ' 140' ' ' LEU . 41.3 t -134.55 137.62 51.0 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.248 0 CA-C-O 121.194 0.521 . . . . 0.0 110.376 179.974 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' C' C ' 132' ' ' ILE . . . . . . . . . . . . . 73.3 mt -118.85 133.71 64.82 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.29 0 CA-C-N 115.54 -0.755 . . . . 0.0 109.366 179.565 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' C' C ' 133' ' ' ILE . . . . . . . . . . . . . 37.7 mm -117.02 121.62 68.21 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.229 0 CA-C-N 116.462 -0.336 . . . . 0.0 110.889 -175.035 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' C' C ' 134' ' ' ASP . . . . . . . . . . . . . 7.9 p-10 -133.57 145.86 50.46 Favored 'General case' 0 C--N 1.332 -0.163 0 N-CA-C 109.652 -0.499 . . . . 0.0 109.652 174.067 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' C' C ' 135' ' ' GLU . . . . . . . . . . . . . 80.4 tt0 -49.75 -23.0 1.58 Allowed 'General case' 0 C--N 1.327 -0.403 0 N-CA-C 113.055 0.761 . . . . 0.0 113.055 -171.356 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' C' C ' 136' ' ' GLN . . . . . . . . . . . . . 44.6 tt0 -105.0 -22.56 13.1 Favored 'General case' 0 N--CA 1.465 0.294 0 N-CA-C 113.075 0.769 . . . . 0.0 113.075 -174.976 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' C' C ' 137' ' ' LYS . . . . . . . . . . . . . 78.4 mttt -145.37 153.09 40.85 Favored 'General case' 0 C--N 1.333 -0.143 0 CA-C-O 121.538 0.685 . . . . 0.0 112.22 -172.342 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' C' C ' 138' ' ' LEU . . . . . . . . . . . . . 14.6 tp -115.2 122.16 45.18 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 115.064 -0.971 . . . . 0.0 109.237 173.743 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' C' C ' 139' ' ' THR . . . . . . . . . . . . . 24.4 m -111.79 126.5 55.14 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-O 120.584 0.23 . . . . 0.0 111.011 -177.817 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' C' C ' 140' ' ' LEU . . . . . 0.496 HD12 HG22 ' C' ' 131' ' ' VAL . 15.0 tp -117.84 122.5 43.54 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 115.796 -0.638 . . . . 0.0 109.387 -178.976 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' C' C ' 141' ' ' ILE . . . . . . . . . . . . . 19.1 mt -121.7 123.05 68.51 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.252 0 CA-C-O 120.853 0.359 . . . . 0.0 110.127 -176.317 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' C' C ' 142' ' ' ARG . . . . . . . . . . . . . 84.2 mtp180 . . . . . 0 C--N 1.329 -0.293 0 CA-C-N 115.521 -0.763 . . . . 0.0 110.536 -178.696 . . . . . . . . 0 0 . 1 . 007 nuclear build core ' D' D ' 2' ' ' SER . . . . . . . . . . . . . 1.8 p . . . . . 0 C--O 1.231 0.119 0 CA-C-O 120.863 0.363 . . . . 0.0 110.178 . . . . . . . . . 0 0 . 1 . 007 nuclear build core ' D' D ' 3' ' ' GLU . . . . . . . . . . . . . 93.3 mt-10 -139.99 143.17 36.34 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-N 116.042 -0.526 . . . . 0.0 111.403 -175.819 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' D' D ' 4' ' ' LEU . . . . . . . . . . . . . 20.9 tp -126.53 129.52 48.77 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 115.776 -0.647 . . . . 0.0 109.751 175.49 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' D' D ' 5' ' ' LYS . . . . . . . . . . . . . 99.7 mttt -113.43 122.43 47.3 Favored 'General case' 0 C--O 1.235 0.336 0 CA-C-N 116.581 -0.281 . . . . 0.0 111.069 -178.624 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' D' D ' 6' ' ' LEU . . . . . . . . . . . . . 43.7 mt -114.0 143.34 44.91 Favored 'General case' 0 C--N 1.332 -0.19 0 CA-C-N 115.49 -0.777 . . . . 0.0 110.202 -179.958 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' D' D ' 7' ' ' LYS . . . . . . . . . . . . . 31.3 ttpt -125.88 138.57 32.32 Favored Pre-proline 0 CA--C 1.534 0.346 0 CA-C-O 118.917 -0.564 . . . . 0.0 109.637 175.601 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' D' D ' 8' ' ' PRO . . . . . . . . . . . . . 85.9 Cg_endo -91.14 135.22 1.8 Allowed 'Trans proline' 0 N--CA 1.489 1.23 0 C-N-CA 121.71 1.607 . . . . 0.0 112.049 179.537 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' D' D ' 9' ' ' LEU . . . . . . . . . . . . . 35.3 mt -73.81 -46.78 6.91 Favored Pre-proline 0 C--N 1.329 -0.313 0 CA-C-O 118.715 -0.66 . . . . 0.0 111.865 179.527 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' D' D ' 10' ' ' PRO . . . . . . . . . . . . . 89.4 Cg_endo -81.77 153.17 17.32 Favored 'Trans proline' 0 N--CA 1.495 1.588 0 C-N-CA 121.179 1.253 . . . . 0.0 111.574 174.71 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' D' D ' 11' ' ' LYS . . . . . . . . . . . . . 62.7 tttm -87.6 99.08 11.78 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-O 120.893 0.378 . . . . 0.0 110.443 178.863 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' D' D ' 12' ' ' VAL . . . . . . . . . . . . . 12.2 p -140.47 145.46 25.8 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.293 0 CA-C-N 116.108 -0.496 . . . . 0.0 110.352 179.971 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' D' D ' 13' ' ' GLU . . . . . . . . . . . . . 84.6 tt0 -90.1 125.45 35.43 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.317 -0.401 . . . . 0.0 110.029 178.588 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' D' D ' 14' ' ' LEU . . . . . 0.407 HD22 ' CD1' ' D' ' 18' ' ' PHE . 21.1 mt -96.77 151.17 37.7 Favored Pre-proline 0 C--N 1.329 -0.309 0 CA-C-N 116.404 -0.362 . . . . 0.0 110.692 -177.669 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' D' D ' 15' ' ' PRO . . . . . . . . . . . . . 26.7 Cg_exo -61.61 157.38 42.29 Favored 'Trans proline' 0 N--CA 1.497 1.697 0 C-N-CA 121.225 1.283 . . . . 0.0 111.669 176.812 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' D' D ' 16' ' ' PRO . . . . . . . . . . . . . 37.2 Cg_exo -57.59 -36.21 98.63 Favored 'Trans proline' 0 N--CA 1.496 1.66 0 C-N-CA 121.461 1.441 . . . . 0.0 112.981 -177.466 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' D' D ' 17' ' ' ASP . . . . . . . . . . . . . 22.4 p-10 -92.03 9.06 34.86 Favored 'General case' 0 CA--C 1.535 0.403 0 N-CA-C 113.418 0.896 . . . . 0.0 113.418 -175.988 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' D' D ' 18' ' ' PHE . . . . . 0.407 ' CD1' HD22 ' D' ' 14' ' ' LEU . 62.4 t80 -57.09 -47.61 80.63 Favored 'General case' 0 C--N 1.333 -0.145 0 O-C-N 121.837 -0.539 . . . . 0.0 110.483 -177.585 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' D' D ' 19' ' ' VAL . . . . . . . . . . . . . 44.3 t -55.57 -51.0 62.7 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.382 0 CA-C-N 116.281 -0.418 . . . . 0.0 111.235 -174.429 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' D' D ' 20' ' ' ASP . . . . . . . . . . . . . 2.3 p-10 -59.33 -37.27 77.39 Favored 'General case' 0 N--CA 1.464 0.228 0 C-N-CA 120.381 -0.527 . . . . 0.0 111.252 -176.32 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' D' D ' 21' ' ' VAL . . . . . . . . . . . . . 59.7 t -63.0 -45.15 99.61 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.266 0 C-N-CA 120.314 -0.555 . . . . 0.0 110.191 179.885 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' D' D ' 22' ' ' ILE . . . . . 0.534 HG22 HD12 ' D' ' 26' ' ' LEU . 46.1 mm -57.39 -39.46 68.45 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.317 0 C-N-CA 120.961 -0.296 . . . . 0.0 110.475 178.36 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' D' D ' 23' ' ' ARG . . . . . . . . . . . . . 55.5 ttp180 -57.26 -49.97 74.38 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-O 121.057 0.456 . . . . 0.0 110.437 176.751 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' D' D ' 24' ' ' ILE . . . . . . . . . . . . . 76.6 mt -60.0 -38.89 78.56 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.34 0 CA-C-N 116.028 -0.533 . . . . 0.0 111.858 -176.884 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' D' D ' 25' ' ' LYS . . . . . . . . . . . . . 25.9 pttt -76.64 -40.82 47.97 Favored 'General case' 0 CA--C 1.534 0.36 0 C-N-CA 120.343 -0.543 . . . . 0.0 112.112 -174.426 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' D' D ' 26' ' ' LEU . . . . . 0.534 HD12 HG22 ' D' ' 22' ' ' ILE . 14.7 mt -79.35 -28.39 42.0 Favored 'General case' 0 CA--C 1.53 0.211 0 N-CA-C 113.172 0.804 . . . . 0.0 113.172 -171.828 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' D' D ' 27' ' ' GLN . . . . . . . . . . . . . 17.3 pt20 -46.37 141.68 3.4 Favored 'General case' 0 N--CA 1.471 0.589 0 N-CA-C 112.931 0.715 . . . . 0.0 112.931 -175.518 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' D' D ' 28' ' ' GLY . . . . . . . . . . . . . . . 100.36 -25.85 26.74 Favored Glycine 0 CA--C 1.532 1.117 0 CA-C-N 115.58 -0.736 . . . . 0.0 112.189 -176.55 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' D' D ' 29' ' ' LYS . . . . . . . . . . . . . 53.2 mttm -97.65 155.13 17.13 Favored 'General case' 0 C--N 1.332 -0.162 0 CA-C-N 117.422 0.611 . . . . 0.0 110.854 178.45 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' D' D ' 30' ' ' THR . . . . . . . . . . . . . 33.4 m -106.19 140.64 38.83 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.235 -0.438 . . . . 0.0 110.24 176.946 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' D' D ' 31' ' ' VAL . . . . . . . . . . . . . 35.0 m -127.82 155.03 39.03 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.198 0 CA-C-O 120.819 0.342 . . . . 0.0 110.875 -178.581 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' D' D ' 32' ' ' ARG . . . . . . . . . . . . . 43.6 mtp180 -133.31 152.57 51.93 Favored 'General case' 0 C--N 1.331 -0.203 0 CA-C-N 115.854 -0.612 . . . . 0.0 110.675 177.719 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' D' D ' 33' ' ' THR . . . . . . . . . . . . . 18.8 m -53.46 139.14 31.72 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.034 -0.53 . . . . 0.0 111.387 -179.256 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' D' D ' 34' ' ' GLY . . . . . . . . . . . . . . . 99.84 -17.2 57.69 Favored Glycine 0 CA--C 1.533 1.202 0 C-N-CA 121.123 -0.56 . . . . 0.0 113.284 178.13 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' D' D ' 35' ' ' ASP . . . . . . . . . . . . . 77.3 m-20 -66.12 147.79 52.8 Favored 'General case' 0 C--O 1.231 0.112 0 CA-C-N 118.053 0.927 . . . . 0.0 111.064 179.444 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' D' D ' 36' ' ' VAL . . . . . . . . . . . . . 45.0 t -122.23 129.61 75.19 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.241 0 CA-C-N 115.933 -0.576 . . . . 0.0 109.751 177.775 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' D' D ' 37' ' ' ILE . . . . . . . . . . . . . 63.9 mt -120.14 137.91 52.44 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.254 0 CA-C-N 116.289 -0.414 . . . . 0.0 110.031 -179.381 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' D' D ' 38' ' ' GLY . . . . . . . . . . . . . . . -112.65 127.72 8.12 Favored Glycine 0 CA--C 1.526 0.746 0 N-CA-C 110.828 -0.909 . . . . 0.0 110.828 178.557 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' D' D ' 39' ' ' ILE . . . . . . . . . . . . . 70.8 mt -124.76 131.0 73.24 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.282 0 N-CA-C 110.113 -0.329 . . . . 0.0 110.113 179.58 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' D' D ' 40' ' ' SER . . . . . . . . . . . . . 53.1 p -91.94 123.05 35.02 Favored 'General case' 0 C--N 1.331 -0.2 0 CA-C-N 116.292 -0.413 . . . . 0.0 110.928 177.555 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' D' D ' 41' ' ' ILE . . . . . . . . . . . . . 72.9 mt -132.34 122.43 48.03 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.229 0 CA-C-N 116.469 -0.332 . . . . 0.0 110.344 177.756 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' D' D ' 42' ' ' LEU . . . . . . . . . . . . . 52.9 mt 53.87 35.9 22.84 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.161 -0.472 . . . . 0.0 111.742 176.821 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' D' D ' 43' ' ' GLY . . . . . . . . . . . . . . . 72.85 28.03 67.75 Favored Glycine 0 CA--C 1.53 1.031 0 C-N-CA 121.171 -0.537 . . . . 0.0 112.457 177.241 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' D' D ' 44' ' ' LYS . . . . . . . . . . . . . 48.7 mtmt -138.12 128.24 25.8 Favored 'General case' 0 C--N 1.331 -0.206 0 N-CA-C 109.778 -0.453 . . . . 0.0 109.778 177.77 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' D' D ' 45' ' ' GLU . . . . . . . . . . . . . 84.5 tt0 -84.62 125.92 32.89 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.515 -0.311 . . . . 0.0 111.444 -177.939 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' D' D ' 46' ' ' VAL . . . . . 0.417 HG13 ' O ' ' D' ' 46' ' ' VAL . 8.9 p -118.58 124.39 73.06 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.23 0 N-CA-C 109.22 -0.659 . . . . 0.0 109.22 173.553 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' D' D ' 47' ' ' LYS . . . . . . . . . . . . . 91.8 mttt -98.96 124.86 44.21 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 116.087 -0.506 . . . . 0.0 110.845 178.362 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' D' D ' 48' ' ' PHE . . . . . . . . . . . . . 31.7 m-85 -108.03 131.86 54.15 Favored 'General case' 0 C--N 1.329 -0.32 0 N-CA-C 109.626 -0.509 . . . . 0.0 109.626 176.812 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' D' D ' 49' ' ' LYS . . . . . . . . . . . . . 82.2 tttt -106.79 132.08 53.17 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.246 -0.434 . . . . 0.0 110.123 178.718 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' D' D ' 50' ' ' VAL . . . . . . . . . . . . . 45.7 t -75.65 105.02 4.24 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.323 0 N-CA-C 109.257 -0.645 . . . . 0.0 109.257 177.5 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' D' D ' 51' ' ' VAL . . . . . . . . . . . . . 47.7 t -71.61 -51.43 32.7 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.273 0 CA-C-N 116.04 -0.527 . . . . 0.0 109.774 -174.687 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' D' D ' 52' ' ' GLN . . . . . . . . . . . . . 55.0 mt-30 -155.35 147.48 23.62 Favored 'General case' 0 C--N 1.33 -0.256 0 C-N-CA 120.343 -0.543 . . . . 0.0 111.789 -177.862 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' D' D ' 53' ' ' ALA . . . . . . . . . . . . . . . -124.47 130.8 53.14 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 115.291 -0.868 . . . . 0.0 109.51 173.909 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' D' D ' 54' ' ' TYR . . . . . . . . . . . . . 16.0 t80 -128.97 108.19 18.19 Favored Pre-proline 0 CA--C 1.534 0.341 0 CA-C-O 118.272 -0.871 . . . . 0.0 110.458 -179.465 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' D' D ' 55' ' ' PRO . . . . . . . . . . . . . 74.2 Cg_endo -77.16 170.0 72.71 Favored 'Cis proline' 0 N--CA 1.499 1.845 0 CA-C-N 121.86 1.7 . . . . 0.0 112.422 -5.915 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' D' D ' 56' ' ' SER . . . . . . . . . . . . . 19.6 m -116.85 133.19 23.1 Favored Pre-proline 0 CA--C 1.539 0.533 0 CA-C-O 118.465 -0.778 . . . . 0.0 109.487 174.826 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' D' D ' 57' ' ' PRO . . . . . . . . . . . . . 49.0 Cg_endo -69.91 164.18 80.32 Favored 'Cis proline' 0 N--CA 1.497 1.726 0 CA-C-N 121.848 1.696 . . . . 0.0 111.485 -1.898 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' D' D ' 58' ' ' LEU . . . . . . . . . . . . . 37.4 tp -130.23 138.05 50.35 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-O 120.886 0.374 . . . . 0.0 110.589 -179.355 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' D' D ' 59' ' ' ARG . . . . . . . . . . . . . 30.1 ttm180 -99.66 132.51 44.96 Favored 'General case' 0 C--N 1.327 -0.396 0 CA-C-N 115.85 -0.614 . . . . 0.0 109.617 176.236 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' D' D ' 60' ' ' VAL . . . . . . . . . . . . . 42.9 t -82.34 114.79 23.78 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.259 0 C-N-CA 120.787 -0.365 . . . . 0.0 110.238 -178.092 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' D' D ' 61' ' ' GLU . . . . . . . . . . . . . 96.0 mt-10 -131.19 169.43 15.93 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.079 -0.51 . . . . 0.0 109.928 176.709 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' D' D ' 62' ' ' ASP . . . . . . . . . . . . . 10.1 p-10 -55.26 -32.58 62.45 Favored 'General case' 0 C--N 1.329 -0.3 0 C-N-CA 120.904 -0.319 . . . . 0.0 111.572 178.716 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' D' D ' 63' ' ' ARG . . . . . . . . . . . . . 16.8 ptp180 -82.51 7.66 13.82 Favored 'General case' 0 CA--C 1.536 0.407 0 N-CA-C 113.504 0.927 . . . . 0.0 113.504 -176.743 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' D' D ' 64' ' ' THR . . . . . . . . . . . . . 28.5 m -91.65 134.31 34.81 Favored 'General case' 0 C--N 1.333 -0.133 0 CA-C-N 118.167 0.439 . . . . 0.0 110.618 -179.385 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' D' D ' 65' ' ' LYS . . . . . . . . . . . . . 23.0 mtpp -89.86 127.6 36.03 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.034 -0.53 . . . . 0.0 110.268 179.589 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' D' D ' 66' ' ' ILE . . . . . . . . . . . . . 65.0 mt -117.35 132.84 65.97 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.25 0 CA-C-O 120.805 0.336 . . . . 0.0 110.291 -178.327 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' D' D ' 67' ' ' THR . . . . . . . . . . . . . 23.1 m -128.7 144.19 51.1 Favored 'General case' 0 N--CA 1.463 0.217 0 CA-C-N 116.094 -0.503 . . . . 0.0 110.941 -179.139 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' D' D ' 68' ' ' LEU . . . . . . . . . . . . . 15.8 tp . . . . . 0 C--N 1.331 -0.225 0 CA-C-N 115.916 -0.584 . . . . 0.0 110.622 179.348 . . . . . . . . 0 0 . 1 . 007 nuclear build core ' D' D ' 73' ' ' VAL . . . . . . . . . . . . . 34.7 m . . . . . 0 CA--C 1.528 0.113 0 N-CA-C 109.801 -0.444 . . . . 0.0 109.801 . . . . . . . . . 0 0 . 1 . 007 nuclear build core ' D' D ' 74' ' ' ASP . . . . . . . . . . . . . 13.7 t70 -97.75 116.88 30.83 Favored 'General case' 0 C--N 1.33 -0.259 0 C-N-CA 120.86 -0.336 . . . . 0.0 110.149 -177.257 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' D' D ' 75' ' ' VAL . . . . . . . . . . . . . 45.3 t -112.76 122.09 66.27 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.212 0 CA-C-O 121.086 0.469 . . . . 0.0 110.218 -178.617 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' D' D ' 76' ' ' LEU . . . . . . . . . . . . . 29.7 mt -126.78 143.2 51.32 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 115.623 -0.717 . . . . 0.0 109.433 179.28 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' D' D ' 77' ' ' GLU . . . . . . . . . . . . . 39.4 tt0 -138.44 138.97 38.67 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-O 121.052 0.453 . . . . 0.0 111.228 -177.156 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' D' D ' 78' ' ' ALA . . . . . . . . . . . . . . . -122.94 142.01 51.29 Favored 'General case' 0 C--N 1.331 -0.239 0 CA-C-N 115.881 -0.6 . . . . 0.0 110.063 177.613 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' D' D ' 79' ' ' LYS . . . . . 0.639 ' O ' HD13 ' D' ' 80' ' ' ILE . 84.4 tttt -84.7 119.2 24.98 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-O 120.743 0.306 . . . . 0.0 110.741 -178.263 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' D' D ' 80' ' ' ILE . . . . . 0.639 HD13 ' O ' ' D' ' 79' ' ' LYS . 38.2 mm -139.13 113.33 7.27 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.283 0 N-CA-C 109.763 -0.458 . . . . 0.0 109.763 -178.302 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' D' D ' 81' ' ' LYS . . . . . . . . . . . . . 39.2 tptt -105.12 125.56 51.11 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-O 120.734 0.302 . . . . 0.0 110.814 -178.275 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' D' D ' 82' ' ' GLY . . . . . . . . . . . . . . . 89.16 42.16 5.66 Favored Glycine 0 CA--C 1.526 0.726 0 C-N-CA 120.83 -0.7 . . . . 0.0 111.473 174.986 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' D' D ' 83' ' ' ILE . . . . . . . . . . . . . 71.5 mt -67.92 137.02 25.41 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.286 0 N-CA-C 109.897 -0.408 . . . . 0.0 109.897 177.78 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' D' D ' 84' ' ' LYS . . . . . . . . . . . . . 42.8 tttp -95.11 -52.31 4.26 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 116.139 -0.482 . . . . 0.0 110.075 -179.63 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' D' D ' 85' ' ' ASP . . . . . . . . . . . . . 10.9 t70 -158.48 154.32 26.6 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 115.694 -0.685 . . . . 0.0 110.252 178.632 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' D' D ' 86' ' ' VAL . . . . . . . . . . . . . 43.3 t -130.11 132.86 65.05 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.223 0 CA-C-O 120.935 0.398 . . . . 0.0 110.563 -178.939 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' D' D ' 87' ' ' ILE . . . . . 0.492 HD12 ' N ' ' D' ' 87' ' ' ILE . 5.0 mp -120.48 128.37 76.0 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.272 0 CA-C-N 115.851 -0.613 . . . . 0.0 109.516 176.752 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' D' D ' 88' ' ' LEU . . . . . . . . . . . . . 16.6 tp -114.17 134.46 54.89 Favored 'General case' 0 C--N 1.331 -0.218 0 CA-C-O 121.066 0.46 . . . . 0.0 110.949 -177.652 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' D' D ' 89' ' ' ASP . . . . . . . . . . . . . 7.6 t70 -130.49 160.93 32.62 Favored 'General case' 0 C--N 1.332 -0.187 0 CA-C-N 115.849 -0.614 . . . . 0.0 109.734 177.046 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' D' D ' 90' ' ' GLU . . . . . . . . . . . . . 71.0 mm-40 -46.63 -40.11 12.45 Favored 'General case' 0 C--N 1.329 -0.289 0 N-CA-C 113.117 0.784 . . . . 0.0 113.117 -171.517 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' D' D ' 91' ' ' ASN . . . . . . . . . . . . . 82.4 m-20 -132.04 25.44 4.59 Favored 'General case' 0 N--CA 1.467 0.403 0 N-CA-C 112.665 0.617 . . . . 0.0 112.665 -177.015 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' D' D ' 92' ' ' LEU . . . . . . . . . . . . . 18.1 mt -149.76 143.36 25.36 Favored 'General case' 0 C--N 1.331 -0.223 0 CA-C-O 120.622 0.249 . . . . 0.0 110.382 -177.361 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' D' D ' 93' ' ' ILE . . . . . . . . . . . . . 73.4 mt -126.19 115.1 41.39 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.345 0 N-CA-C 109.19 -0.67 . . . . 0.0 109.19 176.022 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' D' D ' 94' ' ' VAL . . . . . 0.623 HG21 HG11 ' D' ' 125' ' ' VAL . 45.1 t -117.82 126.4 74.79 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.267 0 CA-C-O 120.878 0.371 . . . . 0.0 110.049 -177.857 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' D' D ' 95' ' ' VAL . . . . . . . . . . . . . 43.4 t -120.63 134.01 65.46 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 CA-C-N 115.918 -0.583 . . . . 0.0 109.824 179.978 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' D' D ' 96' ' ' ILE . . . . . 0.459 HD11 ' HB ' ' D' ' 123' ' ' VAL . 63.3 mt -112.58 126.88 70.03 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 N-CA-C 108.951 -0.759 . . . . 0.0 108.951 178.466 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' D' D ' 97' ' ' THR . . . . . . . . . . . . . 81.7 p -99.34 156.95 16.73 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-O 121.21 0.529 . . . . 0.0 111.154 -177.036 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' D' D ' 98' ' ' GLU . . . . . . . . . . . . . 45.9 tp10 -53.85 -27.61 30.9 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.193 -0.458 . . . . 0.0 112.182 -179.529 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' D' D ' 99' ' ' GLU . . . . . . . . . . . . . 40.8 tt0 -79.78 16.31 1.17 Allowed 'General case' 0 CA--C 1.538 0.517 0 N-CA-C 112.666 0.617 . . . . 0.0 112.666 -176.808 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' D' D ' 100' ' ' ASN . . . . . . . . . . . . . 4.2 m-20 61.24 34.37 18.74 Favored 'General case' 0 CA--C 1.531 0.245 0 O-C-N 121.749 -0.595 . . . . 0.0 111.399 177.828 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' D' D ' 101' ' ' GLU . . . . . . . . . . . . . 84.9 tt0 -111.79 145.65 39.02 Favored 'General case' 0 C--N 1.331 -0.2 0 N-CA-C 109.594 -0.521 . . . . 0.0 109.594 173.604 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' D' D ' 102' ' ' VAL . . . . . . . . . . . . . 45.5 t -114.93 125.98 72.39 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.356 0 CA-C-N 116.275 -0.421 . . . . 0.0 110.125 -177.502 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' D' D ' 103' ' ' LEU . . . . . . . . . . . . . 29.8 mt -117.55 128.28 54.81 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 115.794 -0.639 . . . . 0.0 110.232 177.441 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' D' D ' 104' ' ' ILE . . . . . . . . . . . . . 67.3 mt -119.45 122.18 68.3 Favored 'Isoleucine or valine' 0 C--O 1.235 0.299 0 N-CA-C 110.403 -0.221 . . . . 0.0 110.403 -179.612 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' D' D ' 105' ' ' PHE . . . . . . . . . . . . . 62.4 m-85 -120.78 165.16 15.53 Favored 'General case' 0 C--O 1.232 0.147 0 O-C-N 123.95 0.781 . . . . 0.0 109.804 179.126 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' D' D ' 106' ' ' ASN . . . . . . . . . . . . . 43.3 p-10 -99.56 -170.1 1.85 Allowed 'General case' 0 C--N 1.33 -0.249 0 N-CA-C 109.78 -0.452 . . . . 0.0 109.78 172.708 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' D' D ' 107' ' ' GLN . . . . . . . . . . . . . 50.9 tt0 -57.65 -29.79 64.88 Favored 'General case' 0 C--N 1.328 -0.337 0 N-CA-C 112.033 0.383 . . . . 0.0 112.033 179.707 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' D' D ' 108' ' ' ASN . . . . . . . . . . . . . 15.1 t-20 -88.07 13.43 11.18 Favored 'General case' 0 CA--C 1.535 0.386 0 N-CA-C 112.917 0.71 . . . . 0.0 112.917 -176.215 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' D' D ' 109' ' ' LEU . . . . . . . . . . . . . 29.4 mt 57.64 34.81 24.97 Favored 'General case' 0 CA--C 1.53 0.182 0 O-C-N 122.108 -0.37 . . . . 0.0 111.661 177.98 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' D' D ' 110' ' ' GLU . . . . . . . . . . . . . 43.3 mt-10 -101.3 153.99 19.17 Favored 'General case' 0 C--N 1.331 -0.235 0 N-CA-C 109.984 -0.376 . . . . 0.0 109.984 176.991 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' D' D ' 111' ' ' GLU . . . . . . . . . . . . . 80.6 tt0 -82.7 121.96 27.54 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.383 -0.371 . . . . 0.0 110.589 -178.246 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' D' D ' 112' ' ' LEU . . . . . . . . . . . . . 25.5 mt -110.92 -46.05 3.39 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 116.293 -0.412 . . . . 0.0 110.444 178.354 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' D' D ' 113' ' ' TYR . . . . . . . . . . . . . 46.8 t80 -137.93 136.3 36.89 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-O 120.839 0.352 . . . . 0.0 111.061 -179.679 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' D' D ' 114' ' ' ARG . . . . . . . . . . . . . 60.1 ttt180 -138.01 121.45 17.17 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 115.931 -0.577 . . . . 0.0 110.257 177.034 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' D' D ' 115' ' ' GLY . . . . . . . . . . . . . . . -150.07 162.44 29.19 Favored Glycine 0 CA--C 1.525 0.677 0 N-CA-C 110.977 -0.849 . . . . 0.0 110.977 179.506 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' D' D ' 116' ' ' LYS . . . . . . . . . . . . . 70.3 tttt -136.72 137.5 40.0 Favored 'General case' 0 C--N 1.328 -0.36 0 N-CA-C 110.124 -0.324 . . . . 0.0 110.124 178.762 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' D' D ' 117' ' ' PHE . . . . . . . . . . . . . 26.3 m-85 -135.61 117.59 15.29 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 116.403 -0.362 . . . . 0.0 110.198 -176.135 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' D' D ' 118' ' ' GLU . . . . . . . . . . . . . 96.0 mt-10 -54.17 -44.96 71.94 Favored 'General case' 0 C--N 1.33 -0.27 0 C-N-CA 120.937 -0.305 . . . . 0.0 111.392 -176.316 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' D' D ' 119' ' ' ASN . . . . . . . . . . . . . 3.2 m-20 -97.78 31.04 2.75 Favored 'General case' 0 C--N 1.329 -0.317 0 N-CA-C 112.143 0.423 . . . . 0.0 112.143 -174.838 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' D' D ' 120' ' ' LEU . . . . . . . . . . . . . 20.3 tp -56.48 122.61 12.35 Favored 'General case' 0 C--O 1.233 0.197 0 CA-C-O 120.587 0.232 . . . . 0.0 110.407 178.01 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' D' D ' 121' ' ' ASN . . . . . . . . . . . . . 53.4 m-20 -114.11 -44.13 3.17 Favored 'General case' 0 C--N 1.332 -0.18 0 CA-C-N 116.707 -0.224 . . . . 0.0 111.394 -176.325 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' D' D ' 122' ' ' LYS . . . . . . . . . . . . . 26.1 ttmt -149.97 147.52 27.97 Favored 'General case' 0 C--N 1.332 -0.177 0 C-N-CA 120.417 -0.513 . . . . 0.0 111.563 -176.312 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' D' D ' 123' ' ' VAL . . . . . 0.459 ' HB ' HD11 ' D' ' 96' ' ' ILE . 43.9 t -126.73 134.35 66.45 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.181 0 CA-C-N 116.038 -0.528 . . . . 0.0 109.731 177.742 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' D' D ' 124' ' ' LEU . . . . . . . . . . . . . 65.7 mt -130.08 142.7 50.58 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-O 120.809 0.338 . . . . 0.0 110.986 -178.275 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' D' D ' 125' ' ' VAL . . . . . 0.623 HG11 HG21 ' D' ' 94' ' ' VAL . 35.1 m -132.79 140.25 47.84 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.243 0 CA-C-N 116.26 -0.427 . . . . 0.0 110.569 178.416 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' D' D ' 126' ' ' ARG . . . . . . . . . . . . . 95.3 mtt-85 -144.26 119.09 9.89 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.443 -0.344 . . . . 0.0 110.617 178.74 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' D' D ' 127' ' ' ASN . . . . . . . . . . . . . 84.9 m-20 51.36 -104.98 0.19 Allowed 'General case' 0 CA--C 1.543 0.697 0 CA-C-O 119.095 -0.479 . . . . 0.0 111.334 179.707 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' D' D ' 128' ' ' ASP . . . . . . . . . . . . . 18.9 p-10 -114.19 1.35 14.51 Favored 'General case' 0 N--CA 1.468 0.442 0 CA-C-N 119.548 1.067 . . . . 0.0 113.371 -177.794 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' D' D ' 129' ' ' LEU . . . . . . . . . . . . . 58.8 mt -104.96 144.84 31.24 Favored 'General case' 0 C--N 1.334 -0.108 0 O-C-N 121.961 -0.462 . . . . 0.0 110.246 179.881 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' D' D ' 130' ' ' VAL . . . . . . . . . . . . . 42.4 t -124.48 139.56 50.38 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.214 0 CA-C-N 116.375 -0.375 . . . . 0.0 110.009 -178.107 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' D' D ' 131' ' ' VAL . . . . . 0.516 HG22 HD12 ' D' ' 140' ' ' LEU . 42.6 t -134.55 135.37 53.8 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.24 0 CA-C-O 121.065 0.459 . . . . 0.0 110.271 179.275 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' D' D ' 132' ' ' ILE . . . . . . . . . . . . . 73.2 mt -118.47 130.82 72.77 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.282 0 CA-C-N 115.657 -0.701 . . . . 0.0 109.354 179.068 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' D' D ' 133' ' ' ILE . . . . . 0.412 HG21 HG21 ' E' ' 86' ' ' VAL . 43.1 mm -115.83 121.95 68.45 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.249 0 CA-C-O 120.975 0.417 . . . . 0.0 110.912 -175.992 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' D' D ' 134' ' ' ASP . . . . . . . . . . . . . 7.2 p-10 -133.43 146.08 50.86 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 115.826 -0.625 . . . . 0.0 109.507 174.615 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' D' D ' 135' ' ' GLU . . . . . . . . . . . . . 85.9 tt0 -49.8 -23.02 1.64 Allowed 'General case' 0 C--N 1.328 -0.36 0 N-CA-C 113.022 0.749 . . . . 0.0 113.022 -171.573 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' D' D ' 136' ' ' GLN . . . . . . . . . . . . . 50.2 tt0 -100.18 -31.57 11.33 Favored 'General case' 0 N--CA 1.462 0.175 0 N-CA-C 112.342 0.497 . . . . 0.0 112.342 -176.07 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' D' D ' 137' ' ' LYS . . . . . . . . . . . . . 88.4 mttt -140.45 153.11 46.16 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-O 121.288 0.566 . . . . 0.0 111.644 -171.057 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' D' D ' 138' ' ' LEU . . . . . 0.418 ' C ' HD23 ' D' ' 138' ' ' LEU . 5.5 tt -116.87 120.52 38.72 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 115.488 -0.778 . . . . 0.0 109.017 171.733 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' D' D ' 139' ' ' THR . . . . . . . . . . . . . 30.5 m -108.38 128.11 54.48 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 116.322 -0.399 . . . . 0.0 110.744 -176.451 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' D' D ' 140' ' ' LEU . . . . . 0.516 HD12 HG22 ' D' ' 131' ' ' VAL . 14.0 tp -117.54 122.6 44.1 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 115.619 -0.719 . . . . 0.0 109.354 -178.811 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' D' D ' 141' ' ' ILE . . . . . . . . . . . . . 19.1 mt -120.92 119.64 60.02 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.274 0 N-CA-C 109.964 -0.384 . . . . 0.0 109.964 -175.404 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' D' D ' 142' ' ' ARG . . . . . . . . . . . . . 74.3 mtm180 -106.93 131.31 54.15 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 115.782 -0.645 . . . . 0.0 110.481 -178.318 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' D' D ' 143' ' ' THR . . . . . . . . . . . . . 44.6 p . . . . . 0 C--O 1.22 -0.466 0 CA-C-O 117.984 -1.008 . . . . 0.0 110.591 179.798 . . . . . . . . 0 0 . 1 . 007 nuclear build core ' E' E ' 2' ' ' SER . . . . . . . . . . . . . 98.5 p . . . . . 0 C--O 1.232 0.155 0 CA-C-O 120.952 0.406 . . . . 0.0 110.664 . . . . . . . . . 0 0 . 1 . 007 nuclear build core ' E' E ' 3' ' ' GLU . . . . . . . . . . . . . 85.0 tt0 -140.33 144.73 36.48 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.107 -0.497 . . . . 0.0 111.109 -178.025 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' E' E ' 4' ' ' LEU . . . . . . . . . . . . . 16.3 tp -127.56 134.59 49.72 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 115.852 -0.613 . . . . 0.0 110.131 177.426 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' E' E ' 5' ' ' LYS . . . . . . . . . . . . . 68.9 mttm -115.23 122.67 46.7 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.635 -0.257 . . . . 0.0 110.997 -178.808 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' E' E ' 6' ' ' LEU . . . . . 0.429 HD23 ' HA ' ' E' ' 50' ' ' VAL . 58.5 mt -114.34 142.52 46.21 Favored 'General case' 0 N--CA 1.462 0.163 0 CA-C-N 115.564 -0.744 . . . . 0.0 110.095 178.601 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' E' E ' 7' ' ' LYS . . . . . . . . . . . . . 79.3 tttt -122.49 136.19 26.33 Favored Pre-proline 0 CA--C 1.534 0.348 0 CA-C-O 118.775 -0.631 . . . . 0.0 109.781 176.634 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' E' E ' 8' ' ' PRO . . . . . . . . . . . . . 89.4 Cg_endo -91.36 131.49 1.38 Allowed 'Trans proline' 0 N--CA 1.49 1.279 0 C-N-CA 121.741 1.627 . . . . 0.0 111.705 178.089 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' E' E ' 9' ' ' LEU . . . . . 0.406 HD12 ' HB2' ' E' ' 47' ' ' LYS . 59.4 mt -72.01 -47.86 11.11 Favored Pre-proline 0 CA--C 1.534 0.335 0 CA-C-O 118.563 -0.732 . . . . 0.0 112.286 -178.642 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' E' E ' 10' ' ' PRO . . . . . . . . . . . . . 95.1 Cg_endo -79.61 152.37 22.81 Favored 'Trans proline' 0 N--CA 1.497 1.713 0 C-N-CA 121.166 1.244 . . . . 0.0 111.916 177.145 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' E' E ' 11' ' ' LYS . . . . . . . . . . . . . 97.7 mttt -83.86 91.92 7.67 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.366 -0.379 . . . . 0.0 110.262 178.34 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' E' E ' 12' ' ' VAL . . . . . . . . . . . . . 12.2 p -139.0 145.15 28.05 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.257 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.476 -178.931 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' E' E ' 13' ' ' GLU . . . . . . . . . . . . . 44.6 mp0 -91.6 125.93 36.51 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.235 -0.439 . . . . 0.0 110.179 178.671 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' E' E ' 14' ' ' LEU . . . . . . . . . . . . . 20.8 mt -97.93 149.99 36.29 Favored Pre-proline 0 CA--C 1.532 0.287 0 CA-C-O 119.331 -0.366 . . . . 0.0 110.562 -178.843 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' E' E ' 15' ' ' PRO . . . . . . . . . . . . . 27.4 Cg_exo -61.02 158.74 32.76 Favored 'Trans proline' 0 N--CA 1.496 1.675 0 C-N-CA 121.317 1.345 . . . . 0.0 111.943 177.979 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' E' E ' 16' ' ' PRO . . . . . . . . . . . . . 29.8 Cg_exo -59.68 -34.85 96.15 Favored 'Trans proline' 0 N--CA 1.496 1.675 0 C-N-CA 121.403 1.402 . . . . 0.0 112.76 -178.938 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' E' E ' 17' ' ' ASP . . . . . . . . . . . . . 8.3 p-10 -85.03 4.73 32.49 Favored 'General case' 0 C--N 1.327 -0.401 0 N-CA-C 113.322 0.86 . . . . 0.0 113.322 -177.497 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' E' E ' 18' ' ' PHE . . . . . . . . . . . . . 44.0 t80 -57.95 -44.85 87.24 Favored 'General case' 0 N--CA 1.457 -0.091 0 O-C-N 121.836 -0.54 . . . . 0.0 110.187 -178.315 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' E' E ' 19' ' ' VAL . . . . . . . . . . . . . 46.6 t -56.78 -44.99 82.88 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 CA-C-N 116.152 -0.476 . . . . 0.0 110.544 -178.304 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' E' E ' 20' ' ' ASP . . . . . . . . . . . . . 80.1 m-20 -59.54 -41.9 91.12 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-O 120.772 0.32 . . . . 0.0 110.808 -177.233 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' E' E ' 21' ' ' VAL . . . . . . . . . . . . . 46.9 t -64.55 -46.79 91.6 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.284 0 C-N-CA 120.809 -0.356 . . . . 0.0 110.621 -177.801 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' E' E ' 22' ' ' ILE . . . . . 0.662 HG22 HD12 ' E' ' 26' ' ' LEU . 51.4 mm -57.26 -39.98 70.97 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.217 0 C-N-CA 120.902 -0.319 . . . . 0.0 110.774 -179.562 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' E' E ' 23' ' ' ARG . . . . . . . . . . . . . 34.2 ttp180 -56.91 -50.28 73.02 Favored 'General case' 0 N--CA 1.464 0.255 0 CA-C-O 121.08 0.466 . . . . 0.0 110.443 177.326 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' E' E ' 24' ' ' ILE . . . . . . . . . . . . . 70.6 mt -61.16 -38.65 80.17 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.327 0 CA-C-N 115.807 -0.633 . . . . 0.0 112.072 -176.739 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' E' E ' 25' ' ' LYS . . . . . . . . . . . . . 14.7 pttp -78.34 -36.42 46.29 Favored 'General case' 0 CA--C 1.534 0.348 0 C-N-CA 120.606 -0.437 . . . . 0.0 112.007 -174.049 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' E' E ' 26' ' ' LEU . . . . . 0.662 HD12 HG22 ' E' ' 22' ' ' ILE . 47.6 mt -79.74 -35.06 39.38 Favored 'General case' 0 C--N 1.33 -0.266 0 N-CA-C 113.046 0.758 . . . . 0.0 113.046 -173.022 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' E' E ' 27' ' ' GLN . . . . . . . . . . . . . 15.9 pt20 -46.82 139.75 5.18 Favored 'General case' 0 N--CA 1.468 0.465 0 N-CA-C 112.906 0.706 . . . . 0.0 112.906 -175.49 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' E' E ' 28' ' ' GLY . . . . . . . . . . . . . . . 100.54 -25.94 26.44 Favored Glycine 0 CA--C 1.533 1.166 0 CA-C-N 115.511 -0.768 . . . . 0.0 112.304 -177.991 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' E' E ' 29' ' ' LYS . . . . . . . . . . . . . 98.9 mttt -98.3 155.12 17.36 Favored 'General case' 0 C--N 1.332 -0.167 0 CA-C-N 117.423 0.611 . . . . 0.0 111.175 179.439 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' E' E ' 30' ' ' THR . . . . . . . . . . . . . 31.2 m -102.72 137.14 41.33 Favored 'General case' 0 C--N 1.331 -0.199 0 CA-C-N 116.105 -0.498 . . . . 0.0 110.204 177.069 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' E' E ' 31' ' ' VAL . . . . . . . . . . . . . 34.9 m -128.98 154.27 39.74 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.26 0 CA-C-N 116.444 -0.344 . . . . 0.0 110.816 -179.226 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' E' E ' 32' ' ' ARG . . . . . . . . . . . . . 94.8 mtt180 -131.67 149.08 52.61 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-O 121.179 0.514 . . . . 0.0 110.611 178.332 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' E' E ' 33' ' ' THR . . . . . . . . . . . . . 22.3 m -53.44 139.74 29.84 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.22 -0.446 . . . . 0.0 111.357 -179.382 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' E' E ' 34' ' ' GLY . . . . . . . . . . . . . . . 99.69 -17.12 57.94 Favored Glycine 0 CA--C 1.532 1.126 0 CA-C-O 119.62 -0.545 . . . . 0.0 113.263 179.36 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' E' E ' 35' ' ' ASP . . . . . . . . . . . . . 78.3 m-20 -66.67 148.5 51.82 Favored 'General case' 0 C--N 1.333 -0.152 0 CA-C-N 118.041 0.921 . . . . 0.0 111.078 178.934 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' E' E ' 36' ' ' VAL . . . . . . . . . . . . . 44.3 t -120.97 129.91 75.21 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.262 0 CA-C-N 115.933 -0.576 . . . . 0.0 109.785 178.236 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' E' E ' 37' ' ' ILE . . . . . . . . . . . . . 63.8 mt -119.79 136.96 55.23 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.257 0 N-CA-C 109.751 -0.463 . . . . 0.0 109.751 -179.636 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' E' E ' 38' ' ' GLY . . . . . . . . . . . . . . . -114.97 128.72 8.25 Favored Glycine 0 CA--C 1.524 0.644 0 N-CA-C 111.006 -0.838 . . . . 0.0 111.006 -179.77 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' E' E ' 39' ' ' ILE . . . . . . . . . . . . . 72.5 mt -126.47 127.67 70.63 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.232 0 N-CA-C 110.143 -0.317 . . . . 0.0 110.143 179.142 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' E' E ' 40' ' ' SER . . . . . . . . . . . . . 7.4 m -92.7 119.35 32.01 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.295 -0.411 . . . . 0.0 110.595 175.423 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' E' E ' 41' ' ' ILE . . . . . . . . . . . . . 69.3 mt -129.73 126.57 62.98 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.175 0 CA-C-O 120.951 0.405 . . . . 0.0 110.49 179.769 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' E' E ' 42' ' ' LEU . . . . . . . . . . . . . 30.7 mt 54.1 33.8 18.57 Favored 'General case' 0 C--N 1.331 -0.223 0 CA-C-N 116.033 -0.53 . . . . 0.0 111.781 177.395 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' E' E ' 43' ' ' GLY . . . . . . . . . . . . . . . 72.36 29.54 66.04 Favored Glycine 0 CA--C 1.529 0.936 0 C-N-CA 121.127 -0.559 . . . . 0.0 112.296 177.811 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' E' E ' 44' ' ' LYS . . . . . . . . . . . . . 83.6 tttt -139.43 126.92 21.61 Favored 'General case' 0 C--N 1.331 -0.225 0 N-CA-C 109.637 -0.505 . . . . 0.0 109.637 178.217 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' E' E ' 45' ' ' GLU . . . . . . . . . . . . . 47.1 tt0 -85.65 126.59 34.05 Favored 'General case' 0 C--N 1.327 -0.397 0 CA-C-N 116.229 -0.441 . . . . 0.0 111.539 -175.483 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' E' E ' 46' ' ' VAL . . . . . . . . . . . . . 9.9 p -123.21 126.08 72.9 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.198 0 N-CA-C 109.966 -0.383 . . . . 0.0 109.966 174.457 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' E' E ' 47' ' ' LYS . . . . . 0.406 ' HB2' HD12 ' E' ' 9' ' ' LEU . 33.8 mmtp -99.48 127.44 45.54 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 115.967 -0.561 . . . . 0.0 110.877 176.223 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' E' E ' 48' ' ' PHE . . . . . . . . . . . . . 34.6 m-85 -109.78 131.7 54.82 Favored 'General case' 0 C--N 1.329 -0.289 0 N-CA-C 109.444 -0.576 . . . . 0.0 109.444 175.506 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' E' E ' 49' ' ' LYS . . . . . . . . . . . . . 46.2 tttp -107.67 132.12 53.67 Favored 'General case' 0 C--N 1.327 -0.38 0 N-CA-C 110.08 -0.341 . . . . 0.0 110.08 178.081 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' E' E ' 50' ' ' VAL . . . . . 0.429 ' HA ' HD23 ' E' ' 6' ' ' LEU . 46.7 t -76.58 104.42 4.61 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.268 0 N-CA-C 109.188 -0.671 . . . . 0.0 109.188 177.022 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' E' E ' 51' ' ' VAL . . . . . . . . . . . . . 48.3 t -69.74 -52.94 27.02 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.363 0 N-CA-C 109.609 -0.515 . . . . 0.0 109.609 -174.959 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' E' E ' 52' ' ' GLN . . . . . . . . . . . . . 91.1 mt-30 -153.64 153.69 32.79 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-O 121.253 0.549 . . . . 0.0 111.783 -178.08 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' E' E ' 53' ' ' ALA . . . . . 0.444 ' HB3' ' OG ' ' E' ' 56' ' ' SER . . . -130.57 132.69 45.68 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 115.02 -0.991 . . . . 0.0 109.621 174.978 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' E' E ' 54' ' ' TYR . . . . . . . . . . . . . 40.4 t80 -129.0 107.65 18.1 Favored Pre-proline 0 CA--C 1.535 0.397 0 CA-C-O 118.138 -0.934 . . . . 0.0 110.36 179.893 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' E' E ' 55' ' ' PRO . . . . . . . . . . . . . 72.8 Cg_endo -77.17 168.07 77.94 Favored 'Cis proline' 0 N--CA 1.5 1.891 0 CA-C-N 121.783 1.672 . . . . 0.0 112.713 -5.278 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' E' E ' 56' ' ' SER . . . . . 0.444 ' OG ' ' HB3' ' E' ' 53' ' ' ALA . 68.4 m -118.2 132.89 23.54 Favored Pre-proline 0 CA--C 1.539 0.553 0 CA-C-O 118.377 -0.821 . . . . 0.0 109.463 173.77 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' E' E ' 57' ' ' PRO . . . . . . . . . . . . . 34.4 Cg_endo -66.19 163.97 66.91 Favored 'Cis proline' 0 N--CA 1.496 1.675 0 CA-C-N 121.95 1.732 . . . . 0.0 111.66 -1.788 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' E' E ' 58' ' ' LEU . . . . . . . . . . . . . 33.5 tp -130.07 136.83 49.79 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.104 -0.498 . . . . 0.0 110.281 -179.537 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' E' E ' 59' ' ' ARG . . . . . . . . . . . . . 41.8 ttm180 -102.72 123.58 46.67 Favored 'General case' 0 C--N 1.327 -0.403 0 CA-C-N 115.791 -0.64 . . . . 0.0 109.31 176.349 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' E' E ' 60' ' ' VAL . . . . . . . . . . . . . 45.8 t -71.99 116.97 14.7 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.294 0 C-N-CA 120.803 -0.359 . . . . 0.0 110.331 -174.584 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' E' E ' 61' ' ' GLU . . . . . . . . . . . . . 95.7 mt-10 -131.05 159.5 37.36 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 115.816 -0.629 . . . . 0.0 109.761 176.475 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' E' E ' 62' ' ' ASP . . . . . . . . . . . . . 13.8 t70 -52.48 -31.94 37.57 Favored 'General case' 0 C--N 1.328 -0.357 0 N-CA-C 111.953 0.353 . . . . 0.0 111.953 -179.209 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' E' E ' 63' ' ' ARG . . . . . . . . . . . . . 37.3 mtp180 -72.22 -21.89 61.34 Favored 'General case' 0 C--N 1.33 -0.281 0 N-CA-C 112.954 0.724 . . . . 0.0 112.954 -175.935 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' E' E ' 64' ' ' THR . . . . . . . . . . . . . 28.4 m -69.33 136.77 52.25 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-O 120.93 0.395 . . . . 0.0 110.865 -175.988 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' E' E ' 65' ' ' LYS . . . . . . . . . . . . . 92.1 mttt -89.31 127.91 35.83 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-N 115.97 -0.559 . . . . 0.0 109.917 177.987 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' E' E ' 66' ' ' ILE . . . . . . . . . . . . . 64.4 mt -114.49 129.33 70.73 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 N-CA-C 110.008 -0.368 . . . . 0.0 110.008 -179.705 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' E' E ' 67' ' ' THR . . . . . . . . . . . . . 30.2 m -122.74 142.27 50.89 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-O 121.16 0.505 . . . . 0.0 111.11 -177.644 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' E' E ' 68' ' ' LEU . . . . . . . . . . . . . 17.6 tp . . . . . 0 C--N 1.33 -0.25 0 CA-C-N 115.563 -0.744 . . . . 0.0 109.898 177.491 . . . . . . . . 0 0 . 1 . 007 nuclear build core ' E' E ' 73' ' ' VAL . . . . . . . . . . . . . 27.0 m . . . . . 0 C--O 1.231 0.102 0 CA-C-O 120.893 0.378 . . . . 0.0 110.752 . . . . . . . . . 0 0 . 1 . 007 nuclear build core ' E' E ' 74' ' ' ASP . . . . . . . . . . . . . 28.2 t0 -98.77 119.6 37.78 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.028 -0.533 . . . . 0.0 110.023 -178.762 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' E' E ' 75' ' ' VAL . . . . . . . . . . . . . 42.7 t -112.64 123.43 68.32 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.256 0 CA-C-O 120.987 0.422 . . . . 0.0 110.427 -178.263 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' E' E ' 76' ' ' LEU . . . . . . . . . . . . . 27.0 mt -125.02 142.64 51.36 Favored 'General case' 0 C--N 1.331 -0.239 0 CA-C-N 115.842 -0.617 . . . . 0.0 109.772 177.492 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' E' E ' 77' ' ' GLU . . . . . . . . . . . . . 97.6 mt-10 -135.22 131.24 36.42 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-O 121.005 0.431 . . . . 0.0 111.123 -177.747 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' E' E ' 78' ' ' ALA . . . . . . . . . . . . . . . -118.06 135.86 53.92 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 115.814 -0.63 . . . . 0.0 109.67 176.588 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' E' E ' 79' ' ' LYS . . . . . 0.594 ' O ' HD13 ' E' ' 80' ' ' ILE . 90.0 mttt -79.65 118.46 21.5 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-O 121.003 0.43 . . . . 0.0 110.677 -178.864 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' E' E ' 80' ' ' ILE . . . . . 0.594 HD13 ' O ' ' E' ' 79' ' ' LYS . 41.1 mm -139.12 114.09 8.15 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.376 0 N-CA-C 108.944 -0.761 . . . . 0.0 108.944 -178.502 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' E' E ' 81' ' ' LYS . . . . . . . . . . . . . 56.2 pttt -111.06 129.46 55.91 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-O 121.009 0.433 . . . . 0.0 111.628 -174.253 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' E' E ' 82' ' ' GLY . . . . . . . . . . . . . . . 89.13 42.04 5.7 Favored Glycine 0 CA--C 1.526 0.728 0 N-CA-C 111.524 -0.63 . . . . 0.0 111.524 175.974 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' E' E ' 83' ' ' ILE . . . . . . . . . . . . . 69.1 mt -74.23 138.62 20.76 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.342 0 N-CA-C 109.833 -0.432 . . . . 0.0 109.833 178.145 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' E' E ' 84' ' ' LYS . . . . . . . . . . . . . 39.4 ttpt -102.49 -47.4 4.47 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.302 -0.408 . . . . 0.0 110.163 -179.756 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' E' E ' 85' ' ' ASP . . . . . . . . . . . . . 45.5 t0 -148.91 147.06 28.21 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 115.987 -0.551 . . . . 0.0 110.608 179.876 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' E' E ' 86' ' ' VAL . . . . . 0.412 HG21 HG21 ' D' ' 133' ' ' ILE . 42.4 t -127.84 131.46 69.73 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.266 0 CA-C-O 120.902 0.382 . . . . 0.0 110.404 -179.208 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' E' E ' 87' ' ' ILE . . . . . . . . . . . . . 46.7 mm -121.4 125.12 73.26 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.271 0 CA-C-N 115.955 -0.566 . . . . 0.0 109.686 176.772 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' E' E ' 88' ' ' LEU . . . . . . . . . . . . . 18.3 tp -114.26 130.49 56.65 Favored 'General case' 0 C--N 1.332 -0.163 0 CA-C-O 120.924 0.392 . . . . 0.0 111.074 -177.445 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' E' E ' 89' ' ' ASP . . . . . . . . . . . . . 13.0 t70 -127.33 154.79 44.52 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 115.957 -0.565 . . . . 0.0 109.896 177.16 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' E' E ' 90' ' ' GLU . . . . . . . . . . . . . 96.8 mt-10 -48.1 -36.93 14.15 Favored 'General case' 0 C--N 1.329 -0.313 0 N-CA-C 112.923 0.712 . . . . 0.0 112.923 -172.722 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' E' E ' 91' ' ' ASN . . . . . . . . . . . . . 87.6 m-20 -132.0 33.76 3.89 Favored 'General case' 0 N--CA 1.465 0.31 0 N-CA-C 111.939 0.348 . . . . 0.0 111.939 -175.942 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' E' E ' 92' ' ' LEU . . . . . . . . . . . . . 17.3 tp -166.12 141.66 4.77 Favored 'General case' 0 C--N 1.329 -0.308 0 C-N-CA 121.027 -0.269 . . . . 0.0 110.719 179.46 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' E' E ' 93' ' ' ILE . . . . . . . . . . . . . 72.8 mt -121.86 120.42 61.48 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.27 0 N-CA-C 109.138 -0.69 . . . . 0.0 109.138 178.017 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' E' E ' 94' ' ' VAL . . . . . . . . . . . . . 47.1 t -121.4 125.74 74.03 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.261 0 CA-C-O 121.052 0.453 . . . . 0.0 109.986 -177.763 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' E' E ' 95' ' ' VAL . . . . . . . . . . . . . 43.0 t -121.27 132.81 69.7 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.245 0 CA-C-N 115.873 -0.603 . . . . 0.0 109.847 -179.257 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' E' E ' 96' ' ' ILE . . . . . . . . . . . . . 66.7 mt -115.48 124.19 71.72 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.273 0 N-CA-C 109.147 -0.686 . . . . 0.0 109.147 178.395 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' E' E ' 97' ' ' THR . . . . . . . . . . . . . 77.1 p -99.9 155.02 17.9 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-O 121.523 0.678 . . . . 0.0 111.595 -174.657 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' E' E ' 98' ' ' GLU . . . . . . . . . . . . . 84.7 tt0 -54.03 -26.72 27.87 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 115.548 -0.751 . . . . 0.0 112.141 179.726 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' E' E ' 99' ' ' GLU . . . . . . . . . . . . . 96.3 mt-10 -79.76 16.72 1.06 Allowed 'General case' 0 CA--C 1.537 0.454 0 N-CA-C 113.126 0.788 . . . . 0.0 113.126 -177.369 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' E' E ' 100' ' ' ASN . . . . . . . . . . . . . 4.2 m-20 62.81 37.38 12.39 Favored 'General case' 0 CA--C 1.53 0.198 0 CA-C-O 121.073 0.463 . . . . 0.0 111.048 178.168 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' E' E ' 101' ' ' GLU . . . . . . . . . . . . . 84.7 tt0 -116.46 143.98 44.89 Favored 'General case' 0 C--N 1.333 -0.139 0 CA-C-N 116.159 -0.473 . . . . 0.0 109.909 176.939 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' E' E ' 102' ' ' VAL . . . . . . . . . . . . . 46.4 t -115.0 125.68 72.38 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.27 0 N-CA-C 109.803 -0.443 . . . . 0.0 109.803 -179.468 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' E' E ' 103' ' ' LEU . . . . . . . . . . . . . 27.7 mt -118.94 128.69 54.65 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-N 115.732 -0.667 . . . . 0.0 110.251 177.783 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' E' E ' 104' ' ' ILE . . . . . 0.61 HD13 HG21 ' E' ' 130' ' ' VAL . 66.4 mt -117.66 122.67 70.36 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.2 0 N-CA-C 110.028 -0.36 . . . . 0.0 110.028 179.787 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' E' E ' 105' ' ' PHE . . . . . . . . . . . . . 91.6 m-85 -122.75 166.08 15.53 Favored 'General case' 0 N--CA 1.462 0.129 0 O-C-N 123.999 0.812 . . . . 0.0 110.131 -179.464 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' E' E ' 106' ' ' ASN . . . . . . . . . . . . . 48.7 p-10 -102.94 -172.59 2.14 Favored 'General case' 0 C--N 1.331 -0.196 0 N-CA-C 109.888 -0.412 . . . . 0.0 109.888 172.378 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' E' E ' 107' ' ' GLN . . . . . . . . . . . . . 53.3 tp60 -59.16 -27.9 66.1 Favored 'General case' 0 C--N 1.329 -0.294 0 N-CA-C 112.239 0.459 . . . . 0.0 112.239 -178.586 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' E' E ' 108' ' ' ASN . . . . . . . . . . . . . 8.4 t-20 -88.24 14.06 10.17 Favored 'General case' 0 CA--C 1.533 0.306 0 N-CA-C 112.92 0.711 . . . . 0.0 112.92 -176.918 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' E' E ' 109' ' ' LEU . . . . . . . . . . . . . 41.4 mt 57.99 34.53 24.36 Favored 'General case' 0 CA--C 1.531 0.224 0 CA-C-O 120.718 0.294 . . . . 0.0 111.643 178.514 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' E' E ' 110' ' ' GLU . . . . . . . . . . . . . 43.5 mt-10 -101.49 154.51 18.76 Favored 'General case' 0 C--N 1.33 -0.272 0 N-CA-C 109.28 -0.637 . . . . 0.0 109.28 174.968 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' E' E ' 111' ' ' GLU . . . . . . . . . . . . . 41.6 tt0 -90.96 121.83 33.12 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-O 121.048 0.451 . . . . 0.0 110.987 -175.444 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' E' E ' 112' ' ' LEU . . . . . . . . . . . . . 90.4 mt -101.23 -46.15 5.13 Favored 'General case' 0 C--N 1.332 -0.195 0 CA-C-N 115.803 -0.635 . . . . 0.0 110.388 178.675 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' E' E ' 113' ' ' TYR . . . . . 0.402 ' HB3' HD12 ' E' ' 104' ' ' ILE . 59.8 t80 -139.17 136.56 35.2 Favored 'General case' 0 C--N 1.331 -0.211 0 CA-C-N 116.174 -0.467 . . . . 0.0 111.355 -177.475 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' E' E ' 114' ' ' ARG . . . . . . . . . . . . . 57.3 ttp180 -135.05 120.15 18.75 Favored 'General case' 0 C--N 1.331 -0.22 0 CA-C-N 115.943 -0.572 . . . . 0.0 110.107 177.239 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' E' E ' 115' ' ' GLY . . . . . . . . . . . . . . . -150.07 149.39 21.29 Favored Glycine 0 CA--C 1.524 0.617 0 N-CA-C 111.073 -0.811 . . . . 0.0 111.073 178.281 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' E' E ' 116' ' ' LYS . . . . . . . . . . . . . 34.3 ttmt -125.8 136.45 53.13 Favored 'General case' 0 C--N 1.33 -0.266 0 N-CA-C 109.977 -0.379 . . . . 0.0 109.977 176.042 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' E' E ' 117' ' ' PHE . . . . . . . . . . . . . 40.1 m-85 -129.65 115.97 18.14 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.167 -0.47 . . . . 0.0 110.136 -176.584 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' E' E ' 118' ' ' GLU . . . . . . . . . . . . . 85.4 tt0 -53.7 -46.18 70.63 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.493 -0.322 . . . . 0.0 111.451 -177.133 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' E' E ' 119' ' ' ASN . . . . . . . . . . . . . 86.7 m-20 -96.99 31.07 2.49 Favored 'General case' 0 C--N 1.331 -0.2 0 N-CA-C 112.11 0.411 . . . . 0.0 112.11 -175.8 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' E' E ' 120' ' ' LEU . . . . . . . . . . . . . 10.4 tp -56.12 121.06 8.55 Favored 'General case' 0 C--N 1.332 -0.161 0 O-C-N 122.313 -0.242 . . . . 0.0 110.449 178.343 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' E' E ' 121' ' ' ASN . . . . . . . . . . . . . 31.1 m120 -113.82 -44.07 3.21 Favored 'General case' 0 C--N 1.331 -0.217 0 CA-C-N 116.734 -0.212 . . . . 0.0 111.245 -175.765 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' E' E ' 122' ' ' LYS . . . . . . . . . . . . . 97.9 mttt -146.5 147.3 31.04 Favored 'General case' 0 C--N 1.332 -0.194 0 C-N-CA 120.488 -0.485 . . . . 0.0 111.389 -177.705 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' E' E ' 123' ' ' VAL . . . . . 0.512 ' C ' HD12 ' E' ' 124' ' ' LEU . 44.6 t -130.61 129.11 64.11 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.252 0 CA-C-N 115.982 -0.554 . . . . 0.0 109.678 176.759 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' E' E ' 124' ' ' LEU . . . . . 0.512 HD12 ' C ' ' E' ' 123' ' ' VAL . 6.5 mp -126.49 131.06 51.71 Favored 'General case' 0 C--N 1.331 -0.205 0 N-CA-C 109.999 -0.371 . . . . 0.0 109.999 -179.513 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' E' E ' 125' ' ' VAL . . . . . . . . . . . . . 33.7 m -139.7 137.02 39.8 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.342 0 CA-C-O 120.766 0.317 . . . . 0.0 110.792 -179.071 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' E' E ' 126' ' ' ARG . . . . . . . . . . . . . 74.5 ttt-85 -143.91 127.73 17.28 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.708 -179.683 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' E' E ' 127' ' ' ASN . . . . . . . . . . . . . 4.6 m120 51.24 -106.62 0.26 Allowed 'General case' 0 CA--C 1.544 0.713 0 CA-C-O 118.982 -0.532 . . . . 0.0 111.594 179.064 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' E' E ' 128' ' ' ASP . . . . . . . . . . . . . 23.7 p-10 -114.16 1.86 14.69 Favored 'General case' 0 CA--C 1.536 0.406 0 CA-C-N 119.675 1.125 . . . . 0.0 113.582 -175.854 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' E' E ' 129' ' ' LEU . . . . . . . . . . . . . 13.5 tp -112.79 136.43 52.41 Favored 'General case' 0 C--N 1.333 -0.135 0 N-CA-C 109.771 -0.455 . . . . 0.0 109.771 179.605 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' E' E ' 130' ' ' VAL . . . . . 0.61 HG21 HD13 ' E' ' 104' ' ' ILE . 32.4 m -132.74 142.89 41.22 Favored 'Isoleucine or valine' 0 C--O 1.233 0.198 0 CA-C-O 121.115 0.484 . . . . 0.0 110.976 -179.18 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' E' E ' 131' ' ' VAL . . . . . . . . . . . . . 41.4 t -136.12 138.63 46.98 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.338 0 CA-C-N 115.986 -0.552 . . . . 0.0 109.981 178.37 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' E' E ' 132' ' ' ILE . . . . . . . . . . . . . 74.1 mt -113.57 133.75 58.52 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.312 0 CA-C-N 115.665 -0.698 . . . . 0.0 109.508 -179.568 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' E' E ' 133' ' ' ILE . . . . . . . . . . . . . 42.6 mm -116.04 122.62 69.99 Favored 'Isoleucine or valine' 0 C--O 1.233 0.225 0 CA-C-O 120.991 0.424 . . . . 0.0 110.928 -176.18 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' E' E ' 134' ' ' ASP . . . . . . . . . . . . . 10.5 p-10 -134.86 147.59 49.92 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 115.84 -0.618 . . . . 0.0 109.537 174.625 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' E' E ' 135' ' ' GLU . . . . . . . . . . . . . 84.6 tt0 -49.76 -26.64 4.04 Favored 'General case' 0 C--N 1.325 -0.463 0 N-CA-C 112.811 0.671 . . . . 0.0 112.811 -171.627 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' E' E ' 136' ' ' GLN . . . . . . . . . . . . . 96.8 mt-30 -83.6 -37.88 22.34 Favored 'General case' 0 C--O 1.234 0.243 0 N-CA-C 112.332 0.493 . . . . 0.0 112.332 -176.243 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' E' E ' 137' ' ' LYS . . . . . . . . . . . . . 19.5 pttp -159.91 174.09 14.93 Favored 'General case' 0 C--N 1.331 -0.209 0 CA-C-O 121.51 0.671 . . . . 0.0 112.296 -171.834 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' E' E ' 138' ' ' LEU . . . . . 0.424 ' C ' HD23 ' E' ' 138' ' ' LEU . 8.1 tt -121.91 130.5 53.39 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 114.926 -1.034 . . . . 0.0 109.732 177.599 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' E' E ' 139' ' ' THR . . . . . . . . . . . . . 40.8 m -113.07 125.51 54.46 Favored 'General case' 0 C--N 1.331 -0.23 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.716 -178.558 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' E' E ' 140' ' ' LEU . . . . . 0.484 ' C ' HD23 ' E' ' 140' ' ' LEU . 8.7 tt -107.65 122.57 46.98 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 115.636 -0.711 . . . . 0.0 109.288 -179.502 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' E' E ' 141' ' ' ILE . . . . . 0.509 ' HB ' HG23 ' E' ' 130' ' ' VAL . 19.2 mt -125.07 118.87 54.25 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.288 0 CA-C-O 121.066 0.46 . . . . 0.0 109.886 -177.692 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' E' E ' 142' ' ' ARG . . . . . . . . . . . . . 77.4 ttt-85 -110.94 119.3 38.62 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 115.474 -0.785 . . . . 0.0 109.822 -179.428 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' E' E ' 143' ' ' THR . . . . . . . . . . . . . 71.4 p . . . . . 0 C--O 1.221 -0.442 0 CA-C-O 117.951 -1.023 . . . . 0.0 110.623 -178.14 . . . . . . . . 0 0 . 1 . 007 nuclear build core ' F' F ' 1' ' ' MET . . . . . . . . . . . . . 25.3 ptp . . . . . 0 C--O 1.23 0.076 0 CA-C-O 120.687 0.279 . . . . 0.0 110.691 . . . . . . . . . 0 0 . 1 . 007 nuclear build core ' F' F ' 2' ' ' SER . . . . . . . . . . . . . 2.2 p -122.52 125.24 45.35 Favored 'General case' 0 C--N 1.331 -0.227 0 CA-C-O 121.096 0.474 . . . . 0.0 110.564 178.426 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' F' F ' 3' ' ' GLU . . . . . . . . . . . . . 85.1 tt0 -144.49 144.56 31.41 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-N 115.942 -0.572 . . . . 0.0 111.184 -178.973 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' F' F ' 4' ' ' LEU . . . . . 0.444 HD21 HD21 ' F' ' 6' ' ' LEU . 12.1 tp -126.11 135.32 51.57 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 115.782 -0.645 . . . . 0.0 110.292 178.092 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' F' F ' 5' ' ' LYS . . . . . . . . . . . . . 98.9 mttt -111.37 121.57 45.59 Favored 'General case' 0 C--O 1.235 0.316 0 CA-C-N 116.345 -0.389 . . . . 0.0 110.505 179.764 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' F' F ' 6' ' ' LEU . . . . . 0.444 HD21 HD21 ' F' ' 4' ' ' LEU . 78.7 mt -116.93 147.24 42.4 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 115.735 -0.666 . . . . 0.0 110.538 -178.981 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' F' F ' 7' ' ' LYS . . . . . . . . . . . . . 55.0 tttt -137.45 140.38 30.27 Favored Pre-proline 0 CA--C 1.534 0.328 0 CA-C-O 119.201 -0.428 . . . . 0.0 110.1 177.035 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' F' F ' 8' ' ' PRO . . . . . . . . . . . . . 93.5 Cg_endo -91.55 143.2 2.95 Favored 'Trans proline' 0 N--CA 1.49 1.303 0 C-N-CA 121.764 1.643 . . . . 0.0 111.717 177.781 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' F' F ' 9' ' ' LEU . . . . . . . . . . . . . 41.6 mt -79.81 -47.41 1.45 Allowed Pre-proline 0 CA--C 1.535 0.373 0 CA-C-O 118.686 -0.673 . . . . 0.0 112.42 -178.594 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' F' F ' 10' ' ' PRO . . . . . . . . . . . . . 86.1 Cg_endo -80.67 155.98 21.11 Favored 'Trans proline' 0 N--CA 1.496 1.638 0 C-N-CA 121.243 1.296 . . . . 0.0 111.951 176.252 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' F' F ' 11' ' ' LYS . . . . . . . . . . . . . 53.9 tptt -88.01 99.32 12.07 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.393 -0.367 . . . . 0.0 110.39 179.094 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' F' F ' 12' ' ' VAL . . . . . . . . . . . . . 11.9 p -145.94 143.21 21.51 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.305 0 CA-C-N 116.118 -0.492 . . . . 0.0 110.378 179.03 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' F' F ' 13' ' ' GLU . . . . . . . . . . . . . 43.8 mt-10 -85.91 124.27 32.19 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.373 -0.376 . . . . 0.0 110.219 177.677 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' F' F ' 14' ' ' LEU . . . . . . . . . . . . . 18.7 mt -94.76 152.19 39.59 Favored Pre-proline 0 C--N 1.329 -0.298 0 CA-C-N 116.315 -0.402 . . . . 0.0 110.544 -178.695 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' F' F ' 15' ' ' PRO . . . . . . . . . . . . . 39.7 Cg_exo -58.43 157.31 27.19 Favored 'Trans proline' 0 N--CA 1.498 1.752 0 C-N-CA 121.235 1.29 . . . . 0.0 111.796 179.586 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' F' F ' 16' ' ' PRO . . . . . . . . . . . . . 32.1 Cg_exo -59.5 -37.92 86.21 Favored 'Trans proline' 0 N--CA 1.497 1.729 0 C-N-CA 121.42 1.414 . . . . 0.0 112.672 -178.182 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' F' F ' 17' ' ' ASP . . . . . . . . . . . . . 15.2 p-10 -87.59 11.25 15.48 Favored 'General case' 0 CA--C 1.535 0.387 0 N-CA-C 113.074 0.768 . . . . 0.0 113.074 -178.149 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' F' F ' 18' ' ' PHE . . . . . . . . . . . . . 45.2 t80 -58.28 -43.33 87.92 Favored 'General case' 0 CA--C 1.522 -0.114 0 O-C-N 121.863 -0.523 . . . . 0.0 110.089 -178.524 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' F' F ' 19' ' ' VAL . . . . . . . . . . . . . 46.8 t -55.54 -42.77 69.81 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.323 0 CA-C-N 116.354 -0.384 . . . . 0.0 110.675 -178.583 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' F' F ' 20' ' ' ASP . . . . . . . . . . . . . 81.2 m-20 -60.2 -44.94 94.71 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-O 120.859 0.362 . . . . 0.0 110.857 -177.97 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' F' F ' 21' ' ' VAL . . . . . . . . . . . . . 48.7 t -64.13 -46.71 92.83 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.309 0 C-N-CA 120.788 -0.365 . . . . 0.0 110.547 -177.52 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' F' F ' 22' ' ' ILE . . . . . 0.461 HG22 HD12 ' F' ' 26' ' ' LEU . 49.4 mm -55.88 -46.63 80.25 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.257 0 CA-C-O 120.633 0.254 . . . . 0.0 110.597 179.375 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' F' F ' 23' ' ' ARG . . . . . . . . . . . . . 53.9 ttp180 -54.11 -47.91 71.32 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-O 120.607 0.242 . . . . 0.0 111.349 -178.502 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' F' F ' 24' ' ' ILE . . . . . . . . . . . . . 72.2 mt -59.12 -44.51 91.76 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.285 0 CA-C-N 116.677 -0.238 . . . . 0.0 111.098 -178.405 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' F' F ' 25' ' ' LYS . . . . . . . . . . . . . 67.6 mttm -65.05 -39.75 93.75 Favored 'General case' 0 C--N 1.328 -0.339 0 N-CA-C 112.429 0.529 . . . . 0.0 112.429 -177.977 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' F' F ' 26' ' ' LEU . . . . . 0.461 HD12 HG22 ' F' ' 22' ' ' ILE . 63.6 mt -78.62 -43.27 26.71 Favored 'General case' 0 C--N 1.331 -0.229 0 N-CA-C 112.882 0.697 . . . . 0.0 112.882 -171.824 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' F' F ' 27' ' ' GLN . . . . . . . . . . . . . 15.6 pt20 -46.73 139.4 5.33 Favored 'General case' 0 N--CA 1.467 0.41 0 N-CA-C 112.883 0.697 . . . . 0.0 112.883 -174.641 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' F' F ' 28' ' ' GLY . . . . . . . . . . . . . . . 99.82 -25.57 27.76 Favored Glycine 0 CA--C 1.533 1.199 0 CA-C-N 115.472 -0.786 . . . . 0.0 112.197 -176.154 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' F' F ' 29' ' ' LYS . . . . . . . . . . . . . 91.4 mttt -98.0 155.22 17.21 Favored 'General case' 0 C--O 1.233 0.197 0 CA-C-N 117.242 0.521 . . . . 0.0 110.929 178.091 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' F' F ' 30' ' ' THR . . . . . . . . . . . . . 26.0 m -107.28 134.57 50.16 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 115.894 -0.594 . . . . 0.0 109.565 173.9 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' F' F ' 31' ' ' VAL . . . . . . . . . . . . . 34.9 m -125.98 153.5 34.18 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.214 0 CA-C-O 120.924 0.393 . . . . 0.0 110.938 -176.978 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' F' F ' 32' ' ' ARG . . . . . . . . . . . . . 47.8 ttp180 -126.46 147.07 49.86 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 116.044 -0.525 . . . . 0.0 110.334 179.421 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' F' F ' 33' ' ' THR . . . . . . . . . . . . . 15.8 m -52.84 138.74 28.86 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.323 -0.399 . . . . 0.0 111.46 -177.514 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' F' F ' 34' ' ' GLY . . . . . . . . . . . . . . . 101.17 -17.22 56.23 Favored Glycine 0 CA--C 1.535 1.287 0 CA-C-O 119.662 -0.521 . . . . 0.0 113.253 179.248 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' F' F ' 35' ' ' ASP . . . . . . . . . . . . . 78.5 m-20 -66.06 149.06 50.85 Favored 'General case' 0 N--CA 1.461 0.11 0 CA-C-N 117.947 0.873 . . . . 0.0 110.938 178.645 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' F' F ' 36' ' ' VAL . . . . . . . . . . . . . 44.1 t -122.25 131.99 72.01 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.219 0 CA-C-N 116.034 -0.53 . . . . 0.0 109.967 179.178 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' F' F ' 37' ' ' ILE . . . . . . . . . . . . . 66.0 mt -120.76 139.3 48.43 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.247 0 CA-C-N 115.973 -0.558 . . . . 0.0 109.667 179.7 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' F' F ' 38' ' ' GLY . . . . . . . . . . . . . . . -114.49 128.9 8.41 Favored Glycine 0 CA--C 1.525 0.686 0 N-CA-C 111.371 -0.692 . . . . 0.0 111.371 -178.536 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' F' F ' 39' ' ' ILE . . . . . . . . . . . . . 72.1 mt -125.19 129.41 73.2 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.188 0 N-CA-C 109.896 -0.409 . . . . 0.0 109.896 178.014 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' F' F ' 40' ' ' SER . . . . . . . . . . . . . 28.8 t -92.47 121.82 34.31 Favored 'General case' 0 C--N 1.329 -0.301 0 C-N-CA 120.997 -0.281 . . . . 0.0 110.834 176.935 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' F' F ' 41' ' ' ILE . . . . . . . . . . . . . 72.9 mt -133.98 124.96 47.84 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.224 0 CA-C-O 120.774 0.321 . . . . 0.0 110.253 179.304 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' F' F ' 42' ' ' LEU . . . . . . . . . . . . . 60.6 mt 58.29 33.65 23.33 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-N 116.145 -0.48 . . . . 0.0 111.798 178.082 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' F' F ' 43' ' ' GLY . . . . . . . . . . . . . . . 77.66 -10.23 25.37 Favored Glycine 0 CA--C 1.536 1.361 0 C-N-CA 121.268 -0.492 . . . . 0.0 113.456 178.203 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' F' F ' 44' ' ' LYS . . . . . . . . . . . . . 27.1 mtpp -100.52 130.58 46.61 Favored 'General case' 0 C--N 1.332 -0.171 0 CA-C-N 117.852 0.826 . . . . 0.0 109.891 176.937 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' F' F ' 45' ' ' GLU . . . . . . . . . . . . . 38.2 tp10 -84.53 128.46 34.61 Favored 'General case' 0 C--N 1.33 -0.271 0 C-N-CA 120.884 -0.326 . . . . 0.0 110.808 179.877 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' F' F ' 46' ' ' VAL . . . . . . . . . . . . . 7.6 p -119.89 128.57 75.93 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.242 0 N-CA-C 109.702 -0.481 . . . . 0.0 109.702 177.543 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' F' F ' 47' ' ' LYS . . . . . . . . . . . . . 64.9 mttp -100.25 130.17 46.34 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 115.948 -0.569 . . . . 0.0 111.214 178.975 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' F' F ' 48' ' ' PHE . . . . . . . . . . . . . 92.2 m-85 -113.46 131.87 55.87 Favored 'General case' 0 C--N 1.33 -0.267 0 N-CA-C 109.721 -0.474 . . . . 0.0 109.721 176.024 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' F' F ' 49' ' ' LYS . . . . . . . . . . . . . 54.1 tttm -107.83 137.79 45.22 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.545 -0.298 . . . . 0.0 110.622 179.197 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' F' F ' 50' ' ' VAL . . . . . . . . . . . . . 44.5 t -79.17 107.23 11.39 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.282 0 N-CA-C 109.179 -0.674 . . . . 0.0 109.179 175.22 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' F' F ' 51' ' ' VAL . . . . . . . . . . . . . 46.0 t -70.52 -52.78 26.24 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.339 0 CA-C-N 115.934 -0.576 . . . . 0.0 109.585 -174.664 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' F' F ' 52' ' ' GLN . . . . . . . . . . . . . 46.9 mt-30 -155.73 153.6 30.18 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.058 -0.519 . . . . 0.0 111.669 -177.527 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' F' F ' 53' ' ' ALA . . . . . 0.446 ' HB1' ' HB2' ' F' ' 58' ' ' LEU . . . -128.97 132.44 47.57 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 115.292 -0.867 . . . . 0.0 109.889 175.546 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' F' F ' 54' ' ' TYR . . . . . . . . . . . . . 27.1 t80 -129.01 107.71 18.08 Favored Pre-proline 0 CA--C 1.535 0.378 0 CA-C-O 118.238 -0.887 . . . . 0.0 110.43 -179.849 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' F' F ' 55' ' ' PRO . . . . . . . . . . . . . 73.7 Cg_endo -77.1 170.1 72.53 Favored 'Cis proline' 0 N--CA 1.5 1.862 0 CA-C-N 121.787 1.674 . . . . 0.0 112.364 -5.812 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' F' F ' 56' ' ' SER . . . . . . . . . . . . . 45.5 m -115.61 131.44 23.65 Favored Pre-proline 0 CA--C 1.538 0.507 0 CA-C-O 118.499 -0.763 . . . . 0.0 109.448 175.74 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' F' F ' 57' ' ' PRO . . . . . . . . . . . . . 53.7 Cg_endo -70.88 149.04 90.61 Favored 'Cis proline' 0 N--CA 1.496 1.675 0 CA-C-N 121.955 1.734 . . . . 0.0 111.577 -1.899 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' F' F ' 58' ' ' LEU . . . . . 0.446 ' HB2' ' HB1' ' F' ' 53' ' ' ALA . 23.8 tp -108.29 136.43 47.95 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.219 -0.446 . . . . 0.0 110.725 -177.449 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' F' F ' 59' ' ' ARG . . . . . . . . . . . . . 70.7 ttt180 -103.02 126.12 50.06 Favored 'General case' 0 C--N 1.327 -0.384 0 N-CA-C 109.117 -0.697 . . . . 0.0 109.117 175.744 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' F' F ' 60' ' ' VAL . . . . . . . . . . . . . 41.2 t -91.07 123.21 43.12 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.303 0 C-N-CA 120.663 -0.415 . . . . 0.0 111.014 -174.059 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' F' F ' 61' ' ' GLU . . . . . . . . . . . . . 96.1 mt-10 -131.13 172.06 12.55 Favored 'General case' 0 C--N 1.329 -0.317 0 N-CA-C 109.407 -0.59 . . . . 0.0 109.407 173.055 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' F' F ' 62' ' ' ASP . . . . . . . . . . . . . 73.3 m-20 -54.22 -32.67 56.47 Favored 'General case' 0 C--N 1.328 -0.334 0 C-N-CA 121.029 -0.268 . . . . 0.0 111.583 179.299 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' F' F ' 63' ' ' ARG . . . . . . . . . . . . . 13.5 ptm180 -74.56 -11.91 60.33 Favored 'General case' 0 CA--C 1.535 0.394 0 N-CA-C 113.409 0.892 . . . . 0.0 113.409 -177.298 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' F' F ' 64' ' ' THR . . . . . . . . . . . . . 37.6 m -74.67 138.72 43.04 Favored 'General case' 0 C--O 1.233 0.193 0 O-C-N 122.096 -0.377 . . . . 0.0 110.75 -176.09 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' F' F ' 65' ' ' LYS . . . . . . . . . . . . . 55.5 mtmt -89.24 129.12 35.86 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.149 -0.478 . . . . 0.0 110.141 177.863 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' F' F ' 66' ' ' ILE . . . . . . . . . . . . . 65.3 mt -114.75 129.84 70.19 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.295 0 N-CA-C 109.899 -0.408 . . . . 0.0 109.899 -179.835 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' F' F ' 67' ' ' THR . . . . . . . . . . . . . 24.8 m -118.82 135.51 54.5 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-N 116.076 -0.511 . . . . 0.0 110.464 179.862 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' F' F ' 68' ' ' LEU . . . . . 0.479 HD23 ' C ' ' F' ' 68' ' ' LEU . 6.5 tt . . . . . 0 C--N 1.329 -0.295 0 CA-C-N 115.912 -0.586 . . . . 0.0 110.01 179.062 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' F' F ' 73' ' ' VAL . . . . . . . . . . . . . 34.4 m . . . . . 0 C--O 1.231 0.131 0 N-CA-C 110.118 -0.327 . . . . 0.0 110.118 . . . . . . . . . 0 0 . 1 . 007 nuclear build core ' F' F ' 74' ' ' ASP . . . . . . . . . . . . . 24.1 t0 -96.37 121.9 38.67 Favored 'General case' 0 C--N 1.33 -0.263 0 C-N-CA 120.941 -0.304 . . . . 0.0 110.186 -177.302 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' F' F ' 75' ' ' VAL . . . . . 0.49 ' C ' HD12 ' F' ' 76' ' ' LEU . 41.0 t -121.29 124.68 72.52 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.214 0 CA-C-O 121.039 0.447 . . . . 0.0 110.913 -177.781 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' F' F ' 76' ' ' LEU . . . . . 0.49 HD12 ' C ' ' F' ' 75' ' ' VAL . 7.5 mp -121.57 143.73 49.13 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 115.61 -0.723 . . . . 0.0 109.512 176.473 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' F' F ' 77' ' ' GLU . . . . . . . . . . . . . 98.3 mt-10 -134.78 140.83 46.2 Favored 'General case' 0 N--CA 1.463 0.186 0 CA-C-O 121.091 0.472 . . . . 0.0 111.617 -178.16 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' F' F ' 78' ' ' ALA . . . . . 0.608 ' HB2' HD21 ' F' ' 109' ' ' LEU . . . -133.95 141.2 47.21 Favored 'General case' 0 C--N 1.331 -0.223 0 CA-C-N 115.706 -0.679 . . . . 0.0 110.229 176.248 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' F' F ' 79' ' ' LYS . . . . . 0.571 ' O ' HD13 ' F' ' 80' ' ' ILE . 10.0 mtpm? -82.19 119.96 24.74 Favored 'General case' 0 C--N 1.331 -0.225 0 CA-C-O 120.934 0.397 . . . . 0.0 110.801 -178.868 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' F' F ' 80' ' ' ILE . . . . . 0.571 HD13 ' O ' ' F' ' 79' ' ' LYS . 42.2 mm -139.23 102.09 1.65 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 N-CA-C 109.165 -0.679 . . . . 0.0 109.165 -178.705 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' F' F ' 81' ' ' LYS . . . . . . . . . . . . . 54.6 mtpt -97.21 127.71 43.42 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-O 120.957 0.408 . . . . 0.0 111.133 -176.92 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' F' F ' 82' ' ' GLY . . . . . . . . . . . . . . . 89.16 42.12 5.67 Favored Glycine 0 CA--C 1.525 0.695 0 C-N-CA 120.937 -0.649 . . . . 0.0 111.522 175.793 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' F' F ' 83' ' ' ILE . . . . . . . . . . . . . 71.9 mt -67.49 138.03 23.55 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.297 0 N-CA-C 109.89 -0.411 . . . . 0.0 109.89 178.407 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' F' F ' 84' ' ' LYS . . . . . . . . . . . . . 56.3 tttp -99.63 -51.91 3.62 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.02 -0.536 . . . . 0.0 110.173 -179.726 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' F' F ' 85' ' ' ASP . . . . . . . . . . . . . 7.9 t70 -156.85 153.31 28.02 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 115.811 -0.632 . . . . 0.0 110.293 -179.914 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' F' F ' 86' ' ' VAL . . . . . . . . . . . . . 41.9 t -133.36 134.75 56.96 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.246 0 CA-C-O 121.083 0.468 . . . . 0.0 110.548 -179.128 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' F' F ' 87' ' ' ILE . . . . . . . . . . . . . 45.1 mm -119.36 128.16 75.85 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.25 0 CA-C-N 115.666 -0.697 . . . . 0.0 109.733 176.892 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' F' F ' 88' ' ' LEU . . . . . . . . . . . . . 63.9 mt -114.54 133.62 55.65 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-O 121.078 0.466 . . . . 0.0 111.173 -178.754 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' F' F ' 89' ' ' ASP . . . . . . . . . . . . . 8.8 t70 -131.89 154.62 49.03 Favored 'General case' 0 C--N 1.327 -0.385 0 CA-C-N 115.667 -0.697 . . . . 0.0 109.425 177.094 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' F' F ' 90' ' ' GLU . . . . . . . . . . . . . 83.9 tt0 -47.49 -32.98 5.73 Favored 'General case' 0 C--N 1.328 -0.33 0 N-CA-C 113.031 0.752 . . . . 0.0 113.031 -172.483 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' F' F ' 91' ' ' ASN . . . . . . . . . . . . . 35.0 m120 -124.47 7.82 8.34 Favored 'General case' 0 N--CA 1.469 0.489 0 N-CA-C 113.613 0.968 . . . . 0.0 113.613 -175.128 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' F' F ' 92' ' ' LEU . . . . . . . . . . . . . 27.5 mt -147.15 148.57 31.69 Favored 'General case' 0 C--N 1.333 -0.14 0 CA-C-N 118.247 0.476 . . . . 0.0 110.965 -175.464 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' F' F ' 93' ' ' ILE . . . . . . . . . . . . . 74.0 mt -126.52 116.45 45.26 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.286 0 N-CA-C 109.105 -0.702 . . . . 0.0 109.105 175.846 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' F' F ' 94' ' ' VAL . . . . . 0.402 HG21 HG21 ' F' ' 125' ' ' VAL . 46.1 t -118.79 128.59 75.64 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.193 0 CA-C-O 120.827 0.346 . . . . 0.0 110.101 -177.967 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' F' F ' 95' ' ' VAL . . . . . . . . . . . . . 42.1 t -123.27 134.98 64.68 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.317 0 CA-C-N 116.079 -0.509 . . . . 0.0 109.871 -179.853 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' F' F ' 96' ' ' ILE . . . . . . . . . . . . . 59.8 mt -115.25 129.22 71.85 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.282 0 N-CA-C 109.324 -0.621 . . . . 0.0 109.324 178.822 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' F' F ' 97' ' ' THR . . . . . . . . . . . . . 82.5 p -100.72 158.83 15.66 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-O 121.298 0.571 . . . . 0.0 111.157 -177.95 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' F' F ' 98' ' ' GLU . . . . . . . . . . . . . 46.4 tp10 -53.74 -27.2 27.02 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.011 -0.541 . . . . 0.0 112.259 -179.436 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' F' F ' 99' ' ' GLU . . . . . . . . . . . . . 39.4 tt0 -80.25 17.87 0.97 Allowed 'General case' 0 CA--C 1.539 0.555 0 N-CA-C 112.679 0.622 . . . . 0.0 112.679 -176.822 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' F' F ' 100' ' ' ASN . . . . . . . . . . . . . 4.1 m-20 61.05 38.0 17.52 Favored 'General case' 0 N--CA 1.462 0.166 0 O-C-N 121.857 -0.527 . . . . 0.0 111.017 176.792 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' F' F ' 101' ' ' GLU . . . . . . . . . . . . . 84.8 tt0 -117.66 143.08 46.51 Favored 'General case' 0 C--N 1.331 -0.226 0 N-CA-C 109.574 -0.528 . . . . 0.0 109.574 175.838 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' F' F ' 102' ' ' VAL . . . . . . . . . . . . . 44.9 t -116.73 126.59 74.25 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.353 0 CA-C-N 116.319 -0.4 . . . . 0.0 110.107 -176.986 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' F' F ' 103' ' ' LEU . . . . . . . . . . . . . 6.8 mp -118.42 135.31 54.42 Favored 'General case' 0 C--N 1.331 -0.215 0 CA-C-N 115.752 -0.658 . . . . 0.0 110.01 176.446 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' F' F ' 104' ' ' ILE . . . . . . . . . . . . . 72.4 mt -123.67 122.24 64.39 Favored 'Isoleucine or valine' 0 C--O 1.234 0.246 0 CA-C-N 116.503 -0.317 . . . . 0.0 110.29 -178.525 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' F' F ' 105' ' ' PHE . . . . . . . . . . . . . 47.5 m-85 -121.16 166.5 13.85 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 115.314 -0.857 . . . . 0.0 109.92 179.778 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' F' F ' 106' ' ' ASN . . . . . . . . . . . . . 42.3 p-10 -99.7 -169.89 1.81 Allowed 'General case' 0 C--N 1.33 -0.25 0 N-CA-C 109.821 -0.437 . . . . 0.0 109.821 172.992 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' F' F ' 107' ' ' GLN . . . . . . . . . . . . . 36.2 tt0 -60.44 -30.07 69.42 Favored 'General case' 0 C--N 1.329 -0.317 0 N-CA-C 111.734 0.272 . . . . 0.0 111.734 178.857 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' F' F ' 108' ' ' ASN . . . . . . . . . . . . . 10.1 t-20 -81.96 4.93 20.79 Favored 'General case' 0 CA--C 1.537 0.458 0 N-CA-C 113.305 0.854 . . . . 0.0 113.305 -178.833 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' F' F ' 109' ' ' LEU . . . . . 0.608 HD21 ' HB2' ' F' ' 78' ' ' ALA . 6.0 tp 63.4 38.51 10.02 Favored 'General case' 0 C--O 1.232 0.167 0 CA-C-O 121.107 0.479 . . . . 0.0 111.377 177.158 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' F' F ' 110' ' ' GLU . . . . . . . . . . . . . 70.7 mm-40 -107.76 152.44 24.36 Favored 'General case' 0 C--N 1.331 -0.23 0 CA-C-N 116.256 -0.429 . . . . 0.0 110.12 176.03 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' F' F ' 111' ' ' GLU . . . . . . . . . . . . . 98.6 mt-10 -78.58 125.83 29.91 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-O 120.944 0.402 . . . . 0.0 111.188 -178.542 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' F' F ' 112' ' ' LEU . . . . . . . . . . . . . 8.4 mt -111.97 -46.04 3.26 Favored 'General case' 0 C--N 1.332 -0.159 0 CA-C-N 116.012 -0.54 . . . . 0.0 109.905 176.336 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' F' F ' 113' ' ' TYR . . . . . . . . . . . . . 49.5 t80 -139.69 140.94 36.97 Favored 'General case' 0 C--N 1.332 -0.19 0 CA-C-N 116.128 -0.487 . . . . 0.0 110.773 -179.637 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' F' F ' 114' ' ' ARG . . . . . . . . . . . . . 42.4 ptt85 -150.96 118.75 6.16 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-O 121.043 0.449 . . . . 0.0 110.959 179.731 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' F' F ' 115' ' ' GLY . . . . . . . . . . . . . . . -150.28 162.98 29.41 Favored Glycine 0 CA--C 1.527 0.786 0 N-CA-C 111.177 -0.769 . . . . 0.0 111.177 -178.846 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' F' F ' 116' ' ' LYS . . . . . . . . . . . . . 26.6 ttpp -122.41 144.84 48.79 Favored 'General case' 0 C--N 1.33 -0.245 0 O-C-N 122.644 -0.327 . . . . 0.0 110.172 176.457 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' F' F ' 117' ' ' PHE . . . . . . . . . . . . . 45.4 m-85 -138.22 113.9 9.76 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-O 121.035 0.445 . . . . 0.0 110.278 179.771 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' F' F ' 118' ' ' GLU . . . . . . . . . . . . . 84.7 tt0 -52.53 -50.17 63.39 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-N 116.385 -0.371 . . . . 0.0 111.702 -176.016 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' F' F ' 119' ' ' ASN . . . . . . . . . . . . . 72.2 m-80 -95.78 30.98 2.18 Favored 'General case' 0 C--N 1.329 -0.285 0 N-CA-C 112.246 0.462 . . . . 0.0 112.246 -174.458 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' F' F ' 120' ' ' LEU . . . . . . . . . . . . . 17.3 tp -55.29 120.75 7.54 Favored 'General case' 0 C--N 1.332 -0.163 0 CA-C-O 120.703 0.287 . . . . 0.0 110.77 178.392 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' F' F ' 121' ' ' ASN . . . . . . . . . . . . . 37.2 t30 -114.16 -44.05 3.17 Favored 'General case' 0 C--N 1.333 -0.125 0 CA-C-N 116.6 -0.273 . . . . 0.0 111.039 -177.995 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' F' F ' 122' ' ' LYS . . . . . . . . . . . . . 61.2 mtpt -140.6 148.54 41.1 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-O 121.045 0.45 . . . . 0.0 111.584 -175.461 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' F' F ' 123' ' ' VAL . . . . . . . . . . . . . 45.0 t -132.6 133.19 59.76 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.274 0 N-CA-C 109.374 -0.602 . . . . 0.0 109.374 174.761 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' F' F ' 124' ' ' LEU . . . . . . . . . . . . . 66.8 mt -131.74 136.05 47.3 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-O 120.988 0.423 . . . . 0.0 111.201 -176.415 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' F' F ' 125' ' ' VAL . . . . . 0.402 HG21 HG21 ' F' ' 94' ' ' VAL . 38.7 t -129.2 135.19 62.48 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.207 0 CA-C-N 115.73 -0.668 . . . . 0.0 110.067 -179.582 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' F' F ' 126' ' ' ARG . . . . . . . . . . . . . 17.1 ptp180 -165.18 142.78 6.02 Favored 'General case' 0 C--N 1.331 -0.202 0 CA-C-O 121.004 0.431 . . . . 0.0 110.414 176.31 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' F' F ' 127' ' ' ASN . . . . . . . . . . . . . 1.3 t-20 54.74 -155.13 0.26 Allowed 'General case' 0 CA--C 1.538 0.517 0 N-CA-C 110.104 -0.332 . . . . 0.0 110.104 -179.656 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' F' F ' 128' ' ' ASP . . . . . . . . . . . . . 23.1 p-10 -84.12 20.71 1.51 Allowed 'General case' 0 CA--C 1.534 0.35 0 CA-C-N 118.325 0.511 . . . . 0.0 112.347 176.481 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' F' F ' 129' ' ' LEU . . . . . . . . . . . . . 46.2 mt -121.09 144.47 48.54 Favored 'General case' 0 C--O 1.234 0.246 0 O-C-N 122.053 -0.405 . . . . 0.0 110.438 -179.376 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' F' F ' 130' ' ' VAL . . . . . 0.532 HG13 ' HB ' ' F' ' 141' ' ' ILE . 11.1 p -134.19 139.76 47.51 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.268 0 CA-C-N 116.286 -0.415 . . . . 0.0 110.016 178.832 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' F' F ' 131' ' ' VAL . . . . . 0.554 HG12 HD12 ' F' ' 140' ' ' LEU . 34.6 m -136.06 146.49 29.23 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.254 0 CA-C-O 121.268 0.556 . . . . 0.0 111.286 -178.265 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' F' F ' 132' ' ' ILE . . . . . . . . . . . . . 68.2 mt -121.91 133.97 66.64 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.299 0 CA-C-N 115.389 -0.823 . . . . 0.0 109.497 179.645 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' F' F ' 133' ' ' ILE . . . . . . . . . . . . . 37.3 mm -115.57 117.52 55.85 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.267 0 CA-C-N 116.463 -0.335 . . . . 0.0 110.828 -175.984 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' F' F ' 134' ' ' ASP . . . . . . . . . . . . . 8.0 p-10 -129.92 146.65 51.63 Favored 'General case' 0 C--N 1.33 -0.245 0 N-CA-C 109.649 -0.501 . . . . 0.0 109.649 175.526 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' F' F ' 135' ' ' GLU . . . . . . . . . . . . . 41.5 tp10 -49.93 -23.04 1.75 Allowed 'General case' 0 C--N 1.327 -0.371 0 N-CA-C 112.799 0.666 . . . . 0.0 112.799 -172.207 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' F' F ' 136' ' ' GLN . . . . . . . . . . . . . 48.1 tt0 -101.38 -28.73 12.43 Favored 'General case' 0 CA--C 1.531 0.215 0 N-CA-C 112.481 0.549 . . . . 0.0 112.481 -174.801 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' F' F ' 137' ' ' LYS . . . . . . . . . . . . . 76.6 mttt -141.95 151.74 42.85 Favored 'General case' 0 C--O 1.233 0.22 0 CA-C-O 121.363 0.601 . . . . 0.0 112.378 -170.714 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' F' F ' 138' ' ' LEU . . . . . . . . . . . . . 24.3 tp -109.14 119.14 38.63 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 115.011 -0.995 . . . . 0.0 108.941 170.251 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' F' F ' 139' ' ' THR . . . . . . . . . . . . . 33.0 m -108.19 123.73 49.2 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-O 120.751 0.31 . . . . 0.0 110.914 -177.263 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' F' F ' 140' ' ' LEU . . . . . 0.554 HD12 HG12 ' F' ' 131' ' ' VAL . 12.4 tp -115.82 120.61 39.81 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 115.601 -0.727 . . . . 0.0 109.503 -179.219 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' F' F ' 141' ' ' ILE . . . . . 0.532 ' HB ' HG13 ' F' ' 130' ' ' VAL . 19.7 mt -118.97 121.18 66.19 Favored 'Isoleucine or valine' 0 C--O 1.235 0.302 0 N-CA-C 109.801 -0.444 . . . . 0.0 109.801 -176.676 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' F' F ' 142' ' ' ARG . . . . . . . . . . . . . 73.8 mtm180 -111.56 126.82 55.4 Favored 'General case' 0 C--N 1.332 -0.175 0 CA-C-N 115.798 -0.637 . . . . 0.0 110.125 -178.348 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' F' F ' 143' ' ' THR . . . . . . . . . . . . . 25.8 p . . . . . 0 C--O 1.221 -0.443 0 CA-C-O 118.235 -0.888 . . . . 0.0 110.998 -179.368 . . . . . . . . 0 0 . 1 . 008 nuclear build core ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 5.0 p . . . . . 0 N--CA 1.461 0.112 0 CA-C-O 120.988 0.423 . . . . 0.0 110.781 . . . . . . . . . 0 0 . 1 . 008 nuclear build core ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 41.2 mt-10 -140.4 140.74 35.53 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 115.985 -0.552 . . . . 0.0 111.029 -179.332 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 4' ' ' LEU . . . . . 0.425 HD12 HD23 ' A' ' 58' ' ' LEU . 3.0 tt -124.2 126.3 45.89 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 115.918 -0.583 . . . . 0.0 109.707 177.338 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 5' ' ' LYS . . . . . . . . . . . . . 63.9 mttp -106.91 120.24 41.51 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-O 120.69 0.281 . . . . 0.0 110.807 -179.791 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 37.2 mt -114.66 145.64 41.79 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 115.502 -0.772 . . . . 0.0 110.742 -178.573 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 53.6 tttm -137.78 140.56 30.05 Favored Pre-proline 0 CA--C 1.534 0.35 0 CA-C-O 119.104 -0.474 . . . . 0.0 109.791 174.36 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 8' ' ' PRO . . . . . . . . . . . . . 88.4 Cg_endo -91.81 144.71 3.01 Favored 'Trans proline' 0 N--CA 1.489 1.23 0 C-N-CA 121.775 1.65 . . . . 0.0 111.83 177.931 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 62.7 mt -78.64 -46.51 1.91 Allowed Pre-proline 0 CA--C 1.532 0.277 0 CA-C-O 118.859 -0.591 . . . . 0.0 111.906 179.663 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 75.5 Cg_endo -83.93 144.98 11.11 Favored 'Trans proline' 0 N--CA 1.494 1.543 0 C-N-CA 121.219 1.28 . . . . 0.0 111.516 173.362 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 22.3 pttm -74.53 116.44 15.22 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-O 121.319 0.58 . . . . 0.0 110.437 177.639 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 12.3 p -150.41 147.32 16.04 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.359 0 CA-C-N 115.682 -0.69 . . . . 0.0 110.56 -177.966 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 84.6 tt0 -95.73 121.98 38.02 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.394 -0.366 . . . . 0.0 110.099 177.881 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 14' ' ' LEU . . . . . . . . . . . . . 21.9 mt -99.14 144.03 27.48 Favored Pre-proline 0 CA--C 1.533 0.324 0 CA-C-O 119.093 -0.48 . . . . 0.0 110.521 -176.718 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 15' ' ' PRO . . . . . . . . . . . . . 23.6 Cg_exo -64.76 161.66 35.08 Favored 'Trans proline' 0 N--CA 1.498 1.754 0 C-N-CA 121.292 1.328 . . . . 0.0 111.933 175.209 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 16' ' ' PRO . . . . . . . . . . . . . 27.1 Cg_exo -60.67 -31.97 92.67 Favored 'Trans proline' 0 N--CA 1.496 1.643 0 C-N-CA 121.538 1.492 . . . . 0.0 112.79 -178.96 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 17' ' ' ASP . . . . . . . . . . . . . 10.0 p-10 -83.16 -2.41 55.42 Favored 'General case' 0 CA--C 1.535 0.386 0 N-CA-C 113.351 0.871 . . . . 0.0 113.351 -176.556 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 18' ' ' PHE . . . . . . . . . . . . . 45.5 t80 -57.45 -43.76 84.2 Favored 'General case' 0 C--O 1.23 0.035 0 O-C-N 121.913 -0.492 . . . . 0.0 110.236 -178.478 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 19' ' ' VAL . . . . . . . . . . . . . 48.5 t -57.02 -44.1 82.18 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.314 0 CA-C-N 116.269 -0.423 . . . . 0.0 110.485 -178.497 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 18.2 t70 -59.69 -41.81 91.55 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-O 120.757 0.313 . . . . 0.0 110.902 -177.651 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 43.8 t -64.32 -47.28 90.32 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.274 0 C-N-CA 120.692 -0.403 . . . . 0.0 110.459 -177.948 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 22' ' ' ILE . . . . . 0.581 HG22 HD12 ' A' ' 26' ' ' LEU . 50.2 mm -57.3 -42.05 79.48 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.244 0 C-N-CA 120.801 -0.359 . . . . 0.0 110.591 179.942 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 23' ' ' ARG . . . . . . . . . . . . . 56.5 ttp180 -55.8 -50.31 70.85 Favored 'General case' 0 C--N 1.331 -0.211 0 CA-C-O 120.928 0.394 . . . . 0.0 110.899 179.73 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 24' ' ' ILE . . . . . . . . . . . . . 77.5 mt -60.44 -41.02 86.01 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.251 0 CA-C-N 116.09 -0.505 . . . . 0.0 111.67 -176.961 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 25' ' ' LYS . . . . . 0.574 ' HE3' HD13 ' A' ' 22' ' ' ILE . 16.5 ptpt -72.49 -37.57 68.41 Favored 'General case' 0 CA--C 1.535 0.376 0 C-N-CA 120.622 -0.431 . . . . 0.0 112.115 -175.15 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 26' ' ' LEU . . . . . 0.581 HD12 HG22 ' A' ' 22' ' ' ILE . 43.9 mt -79.84 -39.5 30.52 Favored 'General case' 0 C--N 1.331 -0.209 0 N-CA-C 113.383 0.883 . . . . 0.0 113.383 -173.406 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 27' ' ' GLN . . . . . . . . . . . . . 17.5 pt20 -46.49 141.24 3.76 Favored 'General case' 0 N--CA 1.469 0.503 0 N-CA-C 112.958 0.725 . . . . 0.0 112.958 -173.492 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 97.26 -25.97 24.82 Favored Glycine 0 CA--C 1.534 1.262 0 CA-C-N 115.553 -0.749 . . . . 0.0 112.164 -177.304 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 84.0 mttt -97.94 155.14 17.22 Favored 'General case' 0 C--O 1.233 0.21 0 CA-C-N 117.232 0.516 . . . . 0.0 110.943 179.812 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 30' ' ' THR . . . . . . . . . . . . . 29.1 m -106.86 137.62 44.57 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.142 -0.481 . . . . 0.0 110.101 177.168 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 34.8 m -130.2 159.45 42.21 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.202 0 CA-C-N 116.321 -0.4 . . . . 0.0 110.84 -178.8 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 32' ' ' ARG . . . . . . . . . . . . . 82.2 mtm180 -132.82 150.93 52.11 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-O 121.31 0.576 . . . . 0.0 110.682 178.357 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 33' ' ' THR . . . . . . . . . . . . . 22.0 m -53.4 139.82 29.34 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.074 -0.512 . . . . 0.0 111.312 -178.764 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 100.11 -17.15 57.49 Favored Glycine 0 CA--C 1.532 1.119 0 CA-C-O 119.591 -0.561 . . . . 0.0 113.226 178.881 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 76.6 m-20 -66.08 147.98 52.52 Favored 'General case' 0 C--O 1.233 0.187 0 CA-C-N 118.078 0.939 . . . . 0.0 111.155 178.857 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 44.0 t -122.79 131.53 73.08 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.224 0 CA-C-N 115.937 -0.574 . . . . 0.0 109.906 178.871 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 37' ' ' ILE . . . . . . . . . . . . . 69.0 mt -120.95 139.01 49.5 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.253 0 CA-C-N 116.167 -0.469 . . . . 0.0 110.008 -179.683 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . -109.43 128.85 9.16 Favored Glycine 0 CA--C 1.527 0.785 0 N-CA-C 110.975 -0.85 . . . . 0.0 110.975 179.663 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 39' ' ' ILE . . . . . . . . . . . . . 77.6 mt -126.06 135.9 62.46 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.229 0 CA-C-O 120.765 0.317 . . . . 0.0 110.181 179.612 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 40' ' ' SER . . . . . . . . . . . . . 36.6 t -93.87 122.28 36.19 Favored 'General case' 0 C--N 1.331 -0.239 0 CA-C-N 116.309 -0.405 . . . . 0.0 110.902 175.149 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 41' ' ' ILE . . . . . . . . . . . . . 70.6 mt -133.36 127.43 53.89 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.202 0 CA-C-O 120.841 0.353 . . . . 0.0 110.376 178.662 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 83.4 mt 53.66 33.04 15.71 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 116.203 -0.453 . . . . 0.0 111.959 177.788 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . 72.39 29.37 66.22 Favored Glycine 0 CA--C 1.529 0.952 0 C-N-CA 121.112 -0.566 . . . . 0.0 112.313 177.839 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 44' ' ' LYS . . . . . . . . . . . . . 60.3 mttm -137.36 136.5 37.98 Favored 'General case' 0 C--N 1.331 -0.215 0 N-CA-C 109.862 -0.422 . . . . 0.0 109.862 178.723 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 84.4 tt0 -83.81 122.02 28.11 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.459 -0.337 . . . . 0.0 110.899 -179.688 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 46' ' ' VAL . . . . . . . . . . . . . 7.3 p -122.07 130.06 74.87 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.212 0 N-CA-C 109.547 -0.538 . . . . 0.0 109.547 176.221 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 64.3 mttp -100.66 128.4 46.72 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.011 -0.541 . . . . 0.0 110.994 178.935 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 48' ' ' PHE . . . . . . . . . . . . . 91.0 m-85 -111.12 131.89 54.72 Favored 'General case' 0 C--N 1.33 -0.272 0 N-CA-C 109.698 -0.482 . . . . 0.0 109.698 176.035 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 84.5 tttt -109.12 136.89 47.87 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.356 -0.383 . . . . 0.0 110.729 -179.558 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 50' ' ' VAL . . . . . . . . . . . . . 44.0 t -80.49 106.22 11.33 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.317 0 N-CA-C 109.178 -0.675 . . . . 0.0 109.178 175.159 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 51' ' ' VAL . . . . . . . . . . . . . 47.0 t -70.55 -53.21 23.47 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.354 0 N-CA-C 109.493 -0.558 . . . . 0.0 109.493 -175.035 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 52' ' ' GLN . . . . . . . . . . . . . 90.5 mt-30 -153.85 153.55 32.31 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-O 121.258 0.552 . . . . 0.0 111.796 -178.575 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -129.06 132.11 47.4 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 115.072 -0.967 . . . . 0.0 109.552 175.041 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 54' ' ' TYR . . . . . . . . . . . . . 25.1 t80 -129.03 110.1 18.28 Favored Pre-proline 0 CA--C 1.536 0.41 0 CA-C-O 118.197 -0.906 . . . . 0.0 110.048 179.391 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 55' ' ' PRO . . . . . . . . . . . . . 74.2 Cg_endo -77.17 170.01 72.67 Favored 'Cis proline' 0 N--CA 1.499 1.851 0 CA-C-N 121.877 1.706 . . . . 0.0 112.542 -4.103 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 56' ' ' SER . . . . . . . . . . . . . 13.6 m -115.55 127.61 26.65 Favored Pre-proline 0 CA--C 1.538 0.485 0 CA-C-O 118.344 -0.836 . . . . 0.0 109.506 176.214 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 57' ' ' PRO . . . . . . . . . . . . . 38.0 Cg_endo -66.6 168.5 50.82 Favored 'Cis proline' 0 N--CA 1.498 1.739 0 CA-C-N 122.081 1.779 . . . . 0.0 111.41 -0.657 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 58' ' ' LEU . . . . . 0.425 HD23 HD12 ' A' ' 4' ' ' LEU . 32.7 tp -130.55 136.15 48.63 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-O 120.926 0.393 . . . . 0.0 110.622 -178.997 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 59' ' ' ARG . . . . . . . . . . . . . 49.3 ttp180 -103.69 127.65 51.12 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 115.974 -0.557 . . . . 0.0 109.554 177.303 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 41.7 t -79.67 120.89 31.89 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.181 0 C-N-CA 120.57 -0.452 . . . . 0.0 110.143 -176.247 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 90.7 mt-10 -131.05 161.16 32.63 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 115.86 -0.609 . . . . 0.0 109.88 179.956 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 62' ' ' ASP . . . . . . . . . . . . . 12.7 t70 -54.34 -32.26 56.37 Favored 'General case' 0 C--N 1.328 -0.345 0 C-N-CA 120.926 -0.309 . . . . 0.0 111.714 177.728 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 63' ' ' ARG . . . . . . . . . . . . . 8.1 ptp180 -87.79 9.86 20.35 Favored 'General case' 0 CA--C 1.535 0.391 0 N-CA-C 113.568 0.951 . . . . 0.0 113.568 -175.405 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 39.5 m -92.2 141.0 29.06 Favored 'General case' 0 C--N 1.334 -0.085 0 CA-C-N 118.199 0.454 . . . . 0.0 110.437 -179.426 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 65' ' ' LYS . . . . . . . . . . . . . 67.0 mttm -88.82 127.16 35.61 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.151 -0.477 . . . . 0.0 110.258 179.915 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 66' ' ' ILE . . . . . . . . . . . . . 67.2 mt -115.18 129.13 71.93 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.236 0 N-CA-C 109.87 -0.419 . . . . 0.0 109.87 179.741 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 67' ' ' THR . . . . . . . . . . . . . 31.0 m -126.7 139.4 53.18 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-O 121.076 0.465 . . . . 0.0 111.107 -177.404 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 68' ' ' LEU . . . . . . . . . . . . . 33.8 mt . . . . . 0 C--N 1.33 -0.253 0 CA-C-N 115.825 -0.625 . . . . 0.0 110.229 176.481 . . . . . . . . 0 0 . 1 . 008 nuclear build core ' A' A ' 74' ' ' ASP . . . . . . . . . . . . . 12.1 t70 . . . . . 0 CA--C 1.523 -0.062 0 N-CA-C 109.713 -0.477 . . . . 0.0 109.713 . . . . . . . . . 0 0 . 1 . 008 nuclear build core ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 42.4 t -110.98 121.06 62.99 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.263 0 CA-C-O 121.17 0.509 . . . . 0.0 110.534 -177.671 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 76' ' ' LEU . . . . . . . . . . . . . 29.7 mt -123.9 137.48 54.63 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 115.483 -0.781 . . . . 0.0 109.083 177.149 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 77' ' ' GLU . . . . . . . . . . . . . 33.5 tt0 -136.7 135.84 38.53 Favored 'General case' 0 C--N 1.33 -0.257 0 C-N-CA 120.745 -0.382 . . . . 0.0 111.111 -175.727 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 78' ' ' ALA . . . . . 0.592 ' HB2' HD21 ' A' ' 109' ' ' LEU . . . -124.72 140.77 52.63 Favored 'General case' 0 N--CA 1.463 0.211 0 CA-C-N 116.059 -0.518 . . . . 0.0 110.281 179.064 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 79' ' ' LYS . . . . . 0.589 ' O ' HD13 ' A' ' 80' ' ' ILE . 63.6 mttp -83.25 123.66 29.81 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.358 -0.383 . . . . 0.0 110.546 -179.501 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 80' ' ' ILE . . . . . 0.589 HD13 ' O ' ' A' ' 79' ' ' LYS . 23.3 mm -139.23 114.1 7.96 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.247 0 N-CA-C 108.967 -0.753 . . . . 0.0 108.967 -178.822 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 81' ' ' LYS . . . . . . . . . . . . . 84.2 tttt -103.16 123.92 47.62 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-O 120.92 0.39 . . . . 0.0 111.35 -175.696 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . 89.1 42.17 5.68 Favored Glycine 0 CA--C 1.525 0.707 0 C-N-CA 120.95 -0.643 . . . . 0.0 111.933 173.185 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 83' ' ' ILE . . . . . . . . . . . . . 71.2 mt -68.33 136.9 25.54 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.287 0 N-CA-C 109.847 -0.427 . . . . 0.0 109.847 177.925 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 84' ' ' LYS . . . . . . . . . . . . . 28.6 ttpp -99.66 -48.29 4.78 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.086 -0.506 . . . . 0.0 109.999 179.858 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 85' ' ' ASP . . . . . . . . . . . . . 8.9 t70 -153.36 149.09 27.48 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 115.842 -0.617 . . . . 0.0 110.542 179.303 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 86' ' ' VAL . . . . . . . . . . . . . 45.0 t -128.16 130.51 69.6 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.218 0 CA-C-O 120.917 0.389 . . . . 0.0 110.245 179.558 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 87' ' ' ILE . . . . . 0.492 HD12 ' N ' ' A' ' 87' ' ' ILE . 5.1 mp -122.1 126.18 74.03 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.23 0 CA-C-N 116.007 -0.542 . . . . 0.0 109.58 177.721 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 88' ' ' LEU . . . . . . . . . . . . . 39.0 mt -113.21 137.99 50.64 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-O 121.207 0.527 . . . . 0.0 111.294 -178.104 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 89' ' ' ASP . . . . . . . . . . . . . 13.0 t70 -128.8 157.75 40.59 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 115.376 -0.829 . . . . 0.0 109.008 175.781 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 85.0 tt0 -46.79 -37.9 9.32 Favored 'General case' 0 C--N 1.33 -0.271 0 N-CA-C 112.97 0.73 . . . . 0.0 112.97 -172.07 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 91' ' ' ASN . . . . . . . . . . . . . 28.7 p30 -132.06 23.91 4.56 Favored 'General case' 0 N--CA 1.465 0.306 0 N-CA-C 112.863 0.69 . . . . 0.0 112.863 -177.89 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 92' ' ' LEU . . . . . . . . . . . . . 9.8 mt -149.24 144.45 26.54 Favored 'General case' 0 C--N 1.331 -0.206 0 N-CA-C 110.131 -0.322 . . . . 0.0 110.131 -177.547 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 93' ' ' ILE . . . . . . . . . . . . . 75.8 mt -127.69 119.0 50.63 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.247 0 N-CA-C 109.428 -0.582 . . . . 0.0 109.428 177.757 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 94' ' ' VAL . . . . . 0.427 HG21 HG21 ' A' ' 125' ' ' VAL . 45.5 t -121.39 128.3 75.87 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.261 0 CA-C-O 120.925 0.393 . . . . 0.0 110.133 179.984 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 95' ' ' VAL . . . . . . . . . . . . . 47.2 t -122.63 134.1 66.82 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.298 0 CA-C-N 115.863 -0.608 . . . . 0.0 109.754 -179.307 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 96' ' ' ILE . . . . . . . . . . . . . 60.0 mt -115.21 130.02 70.45 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.294 0 N-CA-C 109.273 -0.64 . . . . 0.0 109.273 179.127 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 97' ' ' THR . . . . . . . . . . . . . 73.1 p -103.81 156.28 17.94 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-O 121.253 0.549 . . . . 0.0 111.243 -178.107 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 98' ' ' GLU . . . . . . . . . . . . . 96.2 mt-10 -54.95 -26.89 39.45 Favored 'General case' 0 CA--C 1.532 0.276 0 CA-C-N 116.091 -0.504 . . . . 0.0 112.325 -179.041 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 99' ' ' GLU . . . . . . . . . . . . . 12.7 pt-20 -78.9 16.67 0.85 Allowed 'General case' 0 CA--C 1.535 0.382 0 N-CA-C 113.261 0.838 . . . . 0.0 113.261 -177.638 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 100' ' ' ASN . . . . . . . . . . . . . 3.1 m-20 63.53 37.59 10.35 Favored 'General case' 0 C--O 1.232 0.147 0 CA-C-O 121.072 0.463 . . . . 0.0 111.106 176.992 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 101' ' ' GLU . . . . . . . . . . . . . 85.0 tt0 -116.36 142.63 46.59 Favored 'General case' 0 C--N 1.331 -0.238 0 N-CA-C 109.709 -0.478 . . . . 0.0 109.709 175.819 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 102' ' ' VAL . . . . . . . . . . . . . 46.6 t -117.4 125.79 74.23 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.29 0 CA-C-N 116.179 -0.464 . . . . 0.0 109.908 -178.057 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 103' ' ' LEU . . . . . 0.483 HD12 ' N ' ' A' ' 103' ' ' LEU . 6.3 mp -116.5 134.57 54.7 Favored 'General case' 0 N--CA 1.463 0.185 0 CA-C-N 115.813 -0.631 . . . . 0.0 110.287 177.311 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 104' ' ' ILE . . . . . 0.43 HD12 ' HB3' ' A' ' 113' ' ' TYR . 66.0 mt -121.39 120.94 63.37 Favored 'Isoleucine or valine' 0 C--O 1.234 0.261 0 N-CA-C 110.051 -0.352 . . . . 0.0 110.051 -179.065 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 105' ' ' PHE . . . . . . . . . . . . . 66.3 m-85 -120.89 164.7 16.28 Favored 'General case' 0 C--N 1.331 -0.234 0 O-C-N 124.012 0.82 . . . . 0.0 109.688 179.593 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 106' ' ' ASN . . . . . . . . . . . . . 44.2 p-10 -100.88 -171.13 1.95 Allowed 'General case' 0 C--N 1.33 -0.276 0 N-CA-C 109.737 -0.468 . . . . 0.0 109.737 172.842 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 107' ' ' GLN . . . . . . . . . . . . . 32.6 tt0 -60.83 -27.59 68.19 Favored 'General case' 0 CA--C 1.533 0.31 0 N-CA-C 111.96 0.355 . . . . 0.0 111.96 178.785 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 108' ' ' ASN . . . . . 0.428 ' ND2' ' O ' ' A' ' 108' ' ' ASN . 0.9 OUTLIER -81.97 6.0 17.4 Favored 'General case' 0 CA--C 1.538 0.501 0 N-CA-C 113.06 0.763 . . . . 0.0 113.06 -178.693 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 109' ' ' LEU . . . . . 0.592 HD21 ' HB2' ' A' ' 78' ' ' ALA . 11.2 tp 61.58 37.52 16.17 Favored 'General case' 0 C--O 1.233 0.204 0 CA-C-O 120.952 0.406 . . . . 0.0 111.3 178.319 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 110' ' ' GLU . . . . . . . . . . . . . 43.2 mt-10 -109.02 153.97 22.87 Favored 'General case' 0 C--N 1.33 -0.245 0 N-CA-C 110.091 -0.337 . . . . 0.0 110.091 177.375 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 111' ' ' GLU . . . . . . . . . . . . . 98.3 mt-10 -81.7 121.94 27.02 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-O 120.974 0.416 . . . . 0.0 111.098 -179.814 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 112' ' ' LEU . . . . . . . . . . . . . 21.3 mt -107.45 -45.47 4.07 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 115.887 -0.597 . . . . 0.0 109.963 175.835 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 113' ' ' TYR . . . . . 0.43 ' HB3' HD12 ' A' ' 104' ' ' ILE . 50.4 t80 -139.37 140.51 37.48 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 115.944 -0.571 . . . . 0.0 110.502 179.678 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 114' ' ' ARG . . . . . . . . . . . . . 32.0 ptt180 -150.92 120.74 7.06 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-O 120.917 0.389 . . . . 0.0 110.818 178.476 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 115' ' ' GLY . . . . . . . . . . . . . . . -150.24 163.04 29.42 Favored Glycine 0 CA--C 1.525 0.7 0 N-CA-C 111.314 -0.714 . . . . 0.0 111.314 -179.309 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 116' ' ' LYS . . . . . . . . . . . . . 36.2 ttpt -122.87 136.63 54.93 Favored 'General case' 0 C--N 1.33 -0.261 0 N-CA-C 109.671 -0.492 . . . . 0.0 109.671 175.988 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 117' ' ' PHE . . . . . . . . . . . . . 43.9 m-85 -134.21 115.55 14.3 Favored 'General case' 0 C--N 1.331 -0.22 0 CA-C-O 121.006 0.431 . . . . 0.0 110.343 -176.791 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 118' ' ' GLU . . . . . . . . . . . . . 84.2 tt0 -52.31 -49.16 64.75 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.271 -0.422 . . . . 0.0 111.785 -175.574 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 119' ' ' ASN . . . . . . . . . . . . . 86.2 m-20 -97.57 31.02 2.69 Favored 'General case' 0 C--N 1.33 -0.273 0 N-CA-C 112.284 0.475 . . . . 0.0 112.284 -173.791 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 120' ' ' LEU . . . . . . . . . . . . . 14.7 tp -58.24 121.8 11.63 Favored 'General case' 0 C--N 1.332 -0.177 0 N-CA-C 110.039 -0.356 . . . . 0.0 110.039 177.354 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 121' ' ' ASN . . . . . . . . . . . . . 72.7 m-20 -113.47 -44.05 3.26 Favored 'General case' 0 C--N 1.331 -0.203 0 CA-C-N 116.537 -0.301 . . . . 0.0 111.044 -177.176 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 122' ' ' LYS . . . . . . . . . . . . . 98.9 mttt -144.62 149.07 35.12 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-O 121.068 0.461 . . . . 0.0 111.689 -177.409 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 123' ' ' VAL . . . . . . . . . . . . . 40.3 t -128.81 129.63 68.4 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.305 0 N-CA-C 109.124 -0.695 . . . . 0.0 109.124 173.723 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 124' ' ' LEU . . . . . . . . . . . . . 66.2 mt -124.6 133.68 53.19 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-O 120.892 0.377 . . . . 0.0 111.017 -176.162 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 125' ' ' VAL . . . . . 0.427 HG21 HG21 ' A' ' 94' ' ' VAL . 42.0 t -124.92 125.07 69.08 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.239 0 CA-C-N 115.866 -0.606 . . . . 0.0 109.619 177.257 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 126' ' ' ARG . . . . . . . . . . . . . 84.7 mtt180 -149.08 130.35 14.62 Favored 'General case' 0 C--N 1.328 -0.35 0 N-CA-C 110.034 -0.358 . . . . 0.0 110.034 179.058 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 127' ' ' ASN . . . . . . . . . . . . . 3.4 t-20 55.75 -151.72 0.39 Allowed 'General case' 0 CA--C 1.54 0.57 0 N-CA-C 109.841 -0.429 . . . . 0.0 109.841 -179.514 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 128' ' ' ASP . . . . . . . . . . . . . 18.8 p-10 -83.64 17.27 2.31 Favored 'General case' 0 CA--C 1.535 0.37 0 N-CA-C 112.695 0.628 . . . . 0.0 112.695 178.44 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 129' ' ' LEU . . . . . . . . . . . . . 47.4 mt -116.96 138.87 51.27 Favored 'General case' 0 C--O 1.232 0.133 0 CA-C-N 118.1 0.409 . . . . 0.0 110.697 179.563 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 130' ' ' VAL . . . . . . . . . . . . . 45.6 t -124.66 138.64 53.39 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.215 0 CA-C-N 116.127 -0.488 . . . . 0.0 109.814 179.419 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 131' ' ' VAL . . . . . 0.489 HG12 HD12 ' A' ' 140' ' ' LEU . 35.3 m -136.0 144.36 33.56 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.24 0 CA-C-O 121.236 0.541 . . . . 0.0 111.359 -179.738 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 132' ' ' ILE . . . . . . . . . . . . . 73.9 mt -117.36 133.64 63.49 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.297 0 CA-C-N 115.326 -0.852 . . . . 0.0 109.269 179.202 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 133' ' ' ILE . . . . . . . . . . . . . 40.9 mm -116.03 119.09 60.87 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.255 0 CA-C-O 120.806 0.336 . . . . 0.0 111.159 -175.204 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 134' ' ' ASP . . . . . . . . . . . . . 8.0 p-10 -133.85 145.59 49.83 Favored 'General case' 0 C--N 1.331 -0.212 0 N-CA-C 109.365 -0.605 . . . . 0.0 109.365 174.181 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 135' ' ' GLU . . . . . . . . . . . . . 43.3 tp10 -50.03 -28.01 6.38 Favored 'General case' 0 C--N 1.327 -0.375 0 N-CA-C 112.616 0.598 . . . . 0.0 112.616 -172.755 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 136' ' ' GLN . . . . . . . . . . . . . 97.4 mt-30 -78.11 -37.19 46.88 Favored 'General case' 0 C--N 1.331 -0.221 0 N-CA-C 112.35 0.5 . . . . 0.0 112.35 -177.188 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 137' ' ' LYS . . . . . . . . . . . . . 53.4 pttt -165.85 172.87 11.17 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-O 121.683 0.754 . . . . 0.0 112.271 -171.964 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 138' ' ' LEU . . . . . . . . . . . . . 6.5 tt -118.14 130.93 56.4 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 114.902 -1.045 . . . . 0.0 109.787 178.359 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 139' ' ' THR . . . . . . . . . . . . . 37.2 m -108.16 129.93 55.15 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.353 179.727 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 140' ' ' LEU . . . . . 0.489 HD12 HG12 ' A' ' 131' ' ' VAL . 36.7 tp -113.46 121.83 45.47 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 115.478 -0.783 . . . . 0.0 109.254 -178.298 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 141' ' ' ILE . . . . . . . . . . . . . 19.8 mt -119.65 116.26 50.11 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.292 0 N-CA-C 109.797 -0.446 . . . . 0.0 109.797 -176.42 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 142' ' ' ARG . . . . . . . . . . . . . 84.3 mtp180 -104.88 124.17 49.0 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 115.329 -0.851 . . . . 0.0 110.537 -178.832 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 143' ' ' THR . . . . . . . . . . . . . 37.0 p . . . . . 0 C--O 1.221 -0.412 0 CA-C-O 117.972 -1.013 . . . . 0.0 110.595 -179.912 . . . . . . . . 0 0 . 1 . 008 nuclear build core ' B' B ' 2' ' ' SER . . . . . . . . . . . . . 6.1 p . . . . . 0 C--O 1.233 0.193 0 CA-C-O 121.026 0.441 . . . . 0.0 110.481 . . . . . . . . . 0 0 . 1 . 008 nuclear build core ' B' B ' 3' ' ' GLU . . . . . . . . . . . . . 84.6 tt0 -141.24 139.35 33.74 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 115.901 -0.591 . . . . 0.0 111.188 -179.108 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B ' 4' ' ' LEU . . . . . . . . . . . . . 48.4 mt -119.75 129.77 54.65 Favored 'General case' 0 C--N 1.331 -0.212 0 CA-C-N 115.791 -0.64 . . . . 0.0 110.37 176.814 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B ' 5' ' ' LYS . . . . . . . . . . . . . 59.9 mttp -104.75 119.22 38.48 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.167 -0.47 . . . . 0.0 110.257 177.187 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B ' 6' ' ' LEU . . . . . . . . . . . . . 62.4 mt -117.46 144.16 45.3 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 115.516 -0.766 . . . . 0.0 110.075 -178.395 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B ' 7' ' ' LYS . . . . . . . . . . . . . 33.7 ttpt -132.71 140.26 37.2 Favored Pre-proline 0 CA--C 1.532 0.279 0 CA-C-O 119.176 -0.44 . . . . 0.0 110.231 176.549 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B ' 8' ' ' PRO . . . . . . . . . . . . . 91.5 Cg_endo -91.98 134.74 1.47 Allowed 'Trans proline' 0 N--CA 1.488 1.191 0 C-N-CA 121.795 1.663 . . . . 0.0 111.543 176.864 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B ' 9' ' ' LEU . . . . . 0.436 HD12 ' HB2' ' B' ' 47' ' ' LYS . 26.8 mt -70.19 -46.99 21.33 Favored Pre-proline 0 CA--C 1.533 0.308 0 CA-C-O 118.683 -0.675 . . . . 0.0 112.026 -178.855 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' B' B ' 10' ' ' PRO . . . . . . . . . . . . . 94.6 Cg_endo -81.89 155.26 17.66 Favored 'Trans proline' 0 N--CA 1.496 1.631 0 C-N-CA 121.29 1.327 . . . . 0.0 111.883 175.372 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B ' 11' ' ' LYS . . . . . . . . . . . . . 38.6 mmtm -88.18 102.6 14.96 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-O 120.793 0.33 . . . . 0.0 110.65 178.105 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B ' 12' ' ' VAL . . . . . . . . . . . . . 12.2 p -146.45 146.47 18.89 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.26 0 CA-C-N 116.207 -0.451 . . . . 0.0 110.267 178.946 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B ' 13' ' ' GLU . . . . . . . . . . . . . 80.6 tt0 -86.54 131.32 34.2 Favored 'General case' 0 C--N 1.33 -0.269 0 N-CA-C 109.941 -0.392 . . . . 0.0 109.941 178.312 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B ' 14' ' ' LEU . . . . . . . . . . . . . 29.5 mt -96.57 151.67 38.11 Favored Pre-proline 0 CA--C 1.533 0.32 0 CA-C-N 116.402 -0.363 . . . . 0.0 110.814 -176.703 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B ' 15' ' ' PRO . . . . . . . . . . . . . 25.8 Cg_exo -62.03 158.64 37.93 Favored 'Trans proline' 0 N--CA 1.497 1.735 0 C-N-CA 121.273 1.315 . . . . 0.0 111.93 176.793 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B ' 16' ' ' PRO . . . . . . . . . . . . . 37.9 Cg_exo -58.71 -38.99 86.29 Favored 'Trans proline' 0 N--CA 1.498 1.741 0 C-N-CA 121.388 1.392 . . . . 0.0 112.835 -178.899 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B ' 17' ' ' ASP . . . . . . . . . . . . . 10.7 p-10 -87.67 10.26 18.71 Favored 'General case' 0 CA--C 1.535 0.371 0 N-CA-C 113.279 0.844 . . . . 0.0 113.279 -176.951 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B ' 18' ' ' PHE . . . . . . . . . . . . . 42.7 t80 -58.0 -44.95 87.5 Favored 'General case' 0 N--CA 1.457 -0.087 0 O-C-N 121.973 -0.454 . . . . 0.0 110.26 -177.489 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B ' 19' ' ' VAL . . . . . 0.41 HG13 ' N ' ' B' ' 20' ' ' ASP . 13.6 p -56.15 -41.68 70.27 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.327 0 CA-C-N 116.62 -0.263 . . . . 0.0 110.958 -178.589 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' B' B ' 20' ' ' ASP . . . . . 0.41 ' N ' HG13 ' B' ' 19' ' ' VAL . 82.5 m-20 -60.83 -43.53 98.14 Favored 'General case' 0 C--N 1.331 -0.21 0 CA-C-O 120.799 0.333 . . . . 0.0 110.82 -178.278 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' B' B ' 21' ' ' VAL . . . . . . . . . . . . . 49.1 t -63.94 -48.46 86.05 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.285 0 C-N-CA 120.744 -0.383 . . . . 0.0 110.509 -177.347 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B ' 22' ' ' ILE . . . . . 0.496 HG22 HD12 ' B' ' 26' ' ' LEU . 49.8 mm -55.61 -47.06 79.35 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.274 0 C-N-CA 120.978 -0.289 . . . . 0.0 110.892 -179.34 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' B' B ' 23' ' ' ARG . . . . . . . . . . . . . 45.7 ttp180 -55.69 -48.94 74.25 Favored 'General case' 0 C--N 1.33 -0.255 0 C-N-CA 120.83 -0.348 . . . . 0.0 111.234 -177.841 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B ' 24' ' ' ILE . . . . . . . . . . . . . 76.3 mt -59.85 -41.63 86.39 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.215 0 C-N-CA 121.081 -0.248 . . . . 0.0 111.203 -177.407 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B ' 25' ' ' LYS . . . . . . . . . . . . . 40.3 mmtm -64.08 -43.03 96.67 Favored 'General case' 0 C--N 1.329 -0.3 0 N-CA-C 112.216 0.451 . . . . 0.0 112.216 -179.593 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B ' 26' ' ' LEU . . . . . 0.496 HD12 HG22 ' B' ' 22' ' ' ILE . 71.4 mt -78.69 -38.51 39.05 Favored 'General case' 0 C--N 1.328 -0.327 0 N-CA-C 113.502 0.927 . . . . 0.0 113.502 -169.888 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' B' B ' 27' ' ' GLN . . . . . . . . . . . . . 15.7 pt20 -47.52 140.13 6.21 Favored 'General case' 0 N--CA 1.469 0.51 0 N-CA-C 112.704 0.631 . . . . 0.0 112.704 -174.788 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B ' 28' ' ' GLY . . . . . . . . . . . . . . . 98.73 -27.46 19.64 Favored Glycine 0 CA--C 1.532 1.137 0 CA-C-N 115.53 -0.759 . . . . 0.0 112.179 -178.438 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B ' 29' ' ' LYS . . . . . . . . . . . . . 61.3 mtpt -98.25 155.03 17.38 Favored 'General case' 0 C--N 1.332 -0.181 0 CA-C-N 117.314 0.557 . . . . 0.0 111.06 179.602 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B ' 30' ' ' THR . . . . . . . . . . . . . 30.1 m -94.54 136.73 34.51 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.032 -0.531 . . . . 0.0 110.003 176.321 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B ' 31' ' ' VAL . . . . . . . . . . . . . 35.1 m -124.87 148.4 29.28 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.228 0 CA-C-N 116.308 -0.406 . . . . 0.0 110.549 -179.798 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B ' 32' ' ' ARG . . . . . . . . . . . . . 33.6 ttm180 -136.02 146.52 47.24 Favored 'General case' 0 C--N 1.331 -0.219 0 CA-C-O 121.267 0.555 . . . . 0.0 110.583 178.501 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B ' 33' ' ' THR . . . . . . . . . . . . . 22.8 m -53.04 139.93 26.72 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.206 -0.452 . . . . 0.0 111.317 -178.56 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B ' 34' ' ' GLY . . . . . . . . . . . . . . . 101.23 -17.18 56.19 Favored Glycine 0 CA--C 1.534 1.254 0 CA-C-O 119.669 -0.517 . . . . 0.0 113.172 -179.989 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B ' 35' ' ' ASP . . . . . . . . . . . . . 80.2 m-20 -66.57 146.99 53.9 Favored 'General case' 0 N--CA 1.461 0.108 0 CA-C-N 118.024 0.912 . . . . 0.0 111.086 178.421 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B ' 36' ' ' VAL . . . . . . . . . . . . . 43.6 t -123.1 130.99 74.06 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.258 0 CA-C-N 116.009 -0.541 . . . . 0.0 109.781 177.898 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B ' 37' ' ' ILE . . . . . . . . . . . . . 66.7 mt -122.17 138.84 51.02 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.289 0 CA-C-N 116.285 -0.416 . . . . 0.0 110.093 -179.401 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B ' 38' ' ' GLY . . . . . . . . . . . . . . . -108.76 128.63 9.15 Favored Glycine 0 CA--C 1.526 0.746 0 N-CA-C 110.995 -0.842 . . . . 0.0 110.995 178.878 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B ' 39' ' ' ILE . . . . . . . . . . . . . 74.6 mt -125.77 136.84 59.61 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.21 0 N-CA-C 110.16 -0.311 . . . . 0.0 110.16 179.766 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B ' 40' ' ' SER . . . . . . . . . . . . . 38.0 t -92.59 115.33 28.0 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.363 -0.38 . . . . 0.0 110.832 175.822 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B ' 41' ' ' ILE . . . . . . . . . . . . . 44.3 mm -121.48 119.1 58.03 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.198 0 CA-C-N 116.509 -0.314 . . . . 0.0 110.412 -179.905 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B ' 42' ' ' LEU . . . . . . . . . . . . . 9.6 tp 53.27 36.88 23.86 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.194 -0.457 . . . . 0.0 111.576 176.964 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B ' 43' ' ' GLY . . . . . . . . . . . . . . . 72.99 27.26 69.06 Favored Glycine 0 CA--C 1.53 0.993 0 C-N-CA 121.145 -0.55 . . . . 0.0 112.591 177.02 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B ' 44' ' ' LYS . . . . . . . . . . . . . 97.8 mttt -136.67 134.91 37.76 Favored 'General case' 0 C--N 1.331 -0.212 0 N-CA-C 109.58 -0.526 . . . . 0.0 109.58 177.47 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B ' 45' ' ' GLU . . . . . . . . . . . . . 84.3 tt0 -82.82 122.55 28.36 Favored 'General case' 0 C--N 1.329 -0.321 0 C-N-CA 120.701 -0.4 . . . . 0.0 111.066 -177.726 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B ' 46' ' ' VAL . . . . . . . . . . . . . 7.1 p -121.04 128.53 76.08 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.206 0 N-CA-C 109.391 -0.596 . . . . 0.0 109.391 175.768 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B ' 47' ' ' LYS . . . . . 0.436 ' HB2' HD12 ' B' ' 9' ' ' LEU . 68.5 mttm -100.31 126.87 46.69 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 115.979 -0.555 . . . . 0.0 110.971 178.335 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' B' B ' 48' ' ' PHE . . . . . . . . . . . . . 90.3 m-85 -109.14 131.95 54.58 Favored 'General case' 0 C--N 1.331 -0.228 0 N-CA-C 109.697 -0.483 . . . . 0.0 109.697 176.661 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B ' 49' ' ' LYS . . . . . . . . . . . . . 83.1 tttt -108.54 135.5 49.7 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.282 -0.417 . . . . 0.0 110.371 179.037 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B ' 50' ' ' VAL . . . . . . . . . . . . . 47.4 t -79.8 106.84 11.49 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.273 0 N-CA-C 109.164 -0.68 . . . . 0.0 109.164 175.906 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B ' 51' ' ' VAL . . . . . . . . . . . . . 47.9 t -72.65 -48.62 45.55 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.273 0 CA-C-N 115.961 -0.563 . . . . 0.0 110.098 -173.547 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B ' 52' ' ' GLN . . . . . . . . . . . . . 62.5 tt0 -161.83 145.58 12.4 Favored 'General case' 0 C--N 1.33 -0.246 0 C-N-CA 120.207 -0.597 . . . . 0.0 111.597 -177.341 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B ' 53' ' ' ALA . . . . . . . . . . . . . . . -122.71 134.73 54.45 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 115.877 -0.602 . . . . 0.0 109.852 175.852 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B ' 54' ' ' TYR . . . . . . . . . . . . . 31.2 t80 -129.07 111.71 18.4 Favored Pre-proline 0 CA--C 1.534 0.361 0 CA-C-O 118.331 -0.842 . . . . 0.0 110.506 -179.716 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B ' 55' ' ' PRO . . . . . . . . . . . . . 74.3 Cg_endo -77.18 168.28 77.37 Favored 'Cis proline' 0 N--CA 1.5 1.882 0 CA-C-N 121.832 1.69 . . . . 0.0 112.005 -8.089 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B ' 56' ' ' SER . . . . . . . . . . . . . 49.8 m -117.03 136.38 23.3 Favored Pre-proline 0 CA--C 1.537 0.468 0 CA-C-O 118.525 -0.75 . . . . 0.0 109.796 175.952 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B ' 57' ' ' PRO . . . . . . . . . . . . . 43.1 Cg_endo -69.61 163.52 81.22 Favored 'Cis proline' 0 N--CA 1.497 1.714 0 CA-C-N 121.794 1.677 . . . . 0.0 111.259 -4.277 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B ' 58' ' ' LEU . . . . . . . . . . . . . 20.8 tp -130.4 138.95 50.61 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-O 120.811 0.338 . . . . 0.0 110.829 -178.583 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B ' 59' ' ' ARG . . . . . . . . . . . . . 55.9 ttp180 -99.18 124.17 44.02 Favored 'General case' 0 C--N 1.328 -0.352 0 N-CA-C 109.2 -0.667 . . . . 0.0 109.2 174.035 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B ' 60' ' ' VAL . . . . . . . . . . . . . 40.7 t -73.77 125.35 32.77 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.289 0 C-N-CA 120.595 -0.442 . . . . 0.0 110.341 -175.113 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B ' 61' ' ' GLU . . . . . . . . . . . . . 95.9 mt-10 -130.26 160.9 32.48 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 115.837 -0.619 . . . . 0.0 110.092 179.699 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B ' 62' ' ' ASP . . . . . . . . . . . . . 7.3 p-10 -56.08 -32.9 64.56 Favored 'General case' 0 C--N 1.328 -0.349 0 C-N-CA 120.852 -0.339 . . . . 0.0 111.435 178.69 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B ' 63' ' ' ARG . . . . . . . . . . . . . 15.5 ptm180 -82.59 6.7 16.82 Favored 'General case' 0 CA--C 1.537 0.473 0 N-CA-C 113.52 0.933 . . . . 0.0 113.52 -177.361 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B ' 64' ' ' THR . . . . . . . . . . . . . 21.3 m -87.2 139.39 30.61 Favored 'General case' 0 C--N 1.333 -0.13 0 CA-C-N 118.119 0.418 . . . . 0.0 110.611 -178.262 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B ' 65' ' ' LYS . . . . . . . . . . . . . 48.7 mtmt -88.89 128.71 35.68 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.082 -0.508 . . . . 0.0 110.373 179.291 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B ' 66' ' ' ILE . . . . . . . . . . . . . 66.9 mt -117.73 128.31 74.94 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.261 0 N-CA-C 109.783 -0.451 . . . . 0.0 109.783 179.928 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B ' 67' ' ' THR . . . . . . . . . . . . . 25.2 m -122.2 135.88 54.83 Favored 'General case' 0 C--N 1.332 -0.172 0 CA-C-O 121.074 0.464 . . . . 0.0 110.727 -179.096 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B ' 68' ' ' LEU . . . . . 0.478 HD12 ' N ' ' B' ' 68' ' ' LEU . 8.0 mp . . . . . 0 C--N 1.33 -0.276 0 CA-C-N 115.815 -0.63 . . . . 0.0 110.344 178.781 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B ' 73' ' ' VAL . . . . . . . . . . . . . 34.9 m . . . . . 0 C--O 1.23 0.074 0 CA-C-O 121.052 0.453 . . . . 0.0 110.828 . . . . . . . . . 0 0 . 1 . 008 nuclear build core ' B' B ' 74' ' ' ASP . . . . . . . . . . . . . 12.8 t70 -94.07 121.33 35.45 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 115.679 -0.691 . . . . 0.0 109.686 178.067 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B ' 75' ' ' VAL . . . . . . . . . . . . . 45.8 t -110.29 122.57 65.06 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.236 0 CA-C-O 121.246 0.545 . . . . 0.0 110.42 -178.378 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B ' 76' ' ' LEU . . . . . . . . . . . . . 26.7 mt -126.93 146.56 50.27 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 115.39 -0.823 . . . . 0.0 109.422 178.687 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B ' 77' ' ' GLU . . . . . . . . . . . . . 97.6 mt-10 -134.35 138.8 45.18 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-O 121.089 0.471 . . . . 0.0 111.193 -177.346 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B ' 78' ' ' ALA . . . . . 0.533 ' HB2' HD21 ' B' ' 109' ' ' LEU . . . -125.29 130.54 52.22 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 115.636 -0.711 . . . . 0.0 109.607 176.203 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' B' B ' 79' ' ' LYS . . . . . 0.66 ' O ' HD13 ' B' ' 80' ' ' ILE . 79.4 tttt -78.45 119.48 21.81 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-O 120.906 0.384 . . . . 0.0 110.636 -176.508 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' B' B ' 80' ' ' ILE . . . . . 0.66 HD13 ' O ' ' B' ' 79' ' ' LYS . 37.6 mm -139.24 105.02 2.32 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.325 0 N-CA-C 108.926 -0.768 . . . . 0.0 108.926 -178.807 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' B' B ' 81' ' ' LYS . . . . . . . . . . . . . 56.1 pttt -98.54 127.98 44.68 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-O 120.936 0.398 . . . . 0.0 111.557 -176.71 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B ' 82' ' ' GLY . . . . . . . . . . . . . . . 89.14 42.12 5.67 Favored Glycine 0 CA--C 1.526 0.766 0 C-N-CA 121.036 -0.602 . . . . 0.0 111.975 175.148 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B ' 83' ' ' ILE . . . . . . . . . . . . . 74.2 mt -71.81 138.88 20.72 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 N-CA-C 109.646 -0.502 . . . . 0.0 109.646 176.478 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B ' 84' ' ' LYS . . . . . . . . . . . . . 33.1 ttpt -99.88 -52.94 3.3 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-O 120.938 0.399 . . . . 0.0 110.177 -179.802 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B ' 85' ' ' ASP . . . . . . . . . . . . . 11.1 t70 -145.88 147.43 31.77 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 115.915 -0.584 . . . . 0.0 110.518 -178.813 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B ' 86' ' ' VAL . . . . . . . . . . . . . 44.9 t -128.06 131.88 69.04 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.254 0 CA-C-O 120.81 0.338 . . . . 0.0 110.496 -179.105 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B ' 87' ' ' ILE . . . . . 0.496 ' N ' HD12 ' B' ' 87' ' ' ILE . 5.1 mp -122.26 127.15 75.1 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.168 0 N-CA-C 109.692 -0.485 . . . . 0.0 109.692 177.434 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' B' B ' 88' ' ' LEU . . . . . . . . . . . . . 17.4 tp -111.22 131.63 54.97 Favored 'General case' 0 C--N 1.331 -0.201 0 CA-C-O 120.954 0.407 . . . . 0.0 110.934 -178.471 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B ' 89' ' ' ASP . . . . . . . . . . . . . 5.9 t70 -126.09 155.33 41.77 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.014 -0.539 . . . . 0.0 109.73 178.039 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B ' 90' ' ' GLU . . . . . . . . . . . . . 84.2 tt0 -47.12 -38.52 11.68 Favored 'General case' 0 CA--C 1.531 0.248 0 N-CA-C 112.888 0.699 . . . . 0.0 112.888 -172.181 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B ' 91' ' ' ASN . . . . . . . . . . . . . 14.7 m120 -128.09 17.42 6.66 Favored 'General case' 0 N--CA 1.469 0.482 0 N-CA-C 113.007 0.743 . . . . 0.0 113.007 -177.085 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B ' 92' ' ' LEU . . . . . . . . . . . . . 35.6 mt -147.91 144.46 28.09 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-O 120.801 0.334 . . . . 0.0 110.433 -176.171 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B ' 93' ' ' ILE . . . . . . . . . . . . . 70.5 mt -122.84 115.32 45.49 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.373 0 N-CA-C 109.056 -0.72 . . . . 0.0 109.056 177.376 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B ' 94' ' ' VAL . . . . . . . . . . . . . 42.6 t -117.32 126.84 74.81 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.283 0 CA-C-O 120.901 0.381 . . . . 0.0 110.178 -177.111 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B ' 95' ' ' VAL . . . . . . . . . . . . . 46.5 t -122.39 133.18 69.41 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.337 0 CA-C-N 115.933 -0.576 . . . . 0.0 109.773 179.874 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B ' 96' ' ' ILE . . . . . 0.51 HD11 ' HB ' ' B' ' 123' ' ' VAL . 66.0 mt -115.21 125.22 72.43 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.329 0 N-CA-C 109.315 -0.624 . . . . 0.0 109.315 179.097 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' B' B ' 97' ' ' THR . . . . . . . . . . . . . 80.4 p -99.75 158.0 16.09 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-O 121.202 0.525 . . . . 0.0 111.191 -176.127 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B ' 98' ' ' GLU . . . . . . . . . . . . . 44.9 mt-10 -53.95 -26.12 24.03 Favored 'General case' 0 C--N 1.329 -0.319 0 N-CA-C 112.308 0.485 . . . . 0.0 112.308 -179.268 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B ' 99' ' ' GLU . . . . . . . . . . . . . 70.0 mm-40 -78.84 15.73 1.02 Allowed 'General case' 0 CA--C 1.535 0.371 0 N-CA-C 113.203 0.816 . . . . 0.0 113.203 -176.829 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B ' 100' ' ' ASN . . . . . . . . . . . . . 2.4 m-20 62.24 38.01 13.74 Favored 'General case' 0 N--CA 1.463 0.2 0 CA-C-O 121.118 0.485 . . . . 0.0 110.996 178.647 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B ' 101' ' ' GLU . . . . . . . . . . . . . 84.6 tt0 -116.77 142.79 46.46 Favored 'General case' 0 C--N 1.331 -0.224 0 CA-C-N 116.021 -0.536 . . . . 0.0 109.917 176.486 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B ' 102' ' ' VAL . . . . . . . . . . . . . 43.2 t -114.96 125.0 72.17 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.327 0 N-CA-C 109.738 -0.467 . . . . 0.0 109.738 -178.957 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B ' 103' ' ' LEU . . . . . . . . . . . . . 57.5 mt -115.23 131.52 56.9 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 115.637 -0.71 . . . . 0.0 109.906 177.819 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B ' 104' ' ' ILE . . . . . 0.419 HD12 ' HB3' ' B' ' 113' ' ' TYR . 67.4 mt -118.82 118.39 57.61 Favored 'Isoleucine or valine' 0 C--O 1.234 0.271 0 N-CA-C 110.096 -0.335 . . . . 0.0 110.096 -178.831 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' B' B ' 105' ' ' PHE . . . . . . . . . . . . . 68.8 m-85 -115.07 162.95 16.31 Favored 'General case' 0 C--N 1.332 -0.191 0 O-C-N 124.196 0.935 . . . . 0.0 109.893 179.265 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B ' 106' ' ' ASN . . . . . . . . . . . . . 45.0 p-10 -102.62 -170.11 1.76 Allowed 'General case' 0 C--N 1.329 -0.3 0 N-CA-C 109.801 -0.444 . . . . 0.0 109.801 174.392 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B ' 107' ' ' GLN . . . . . . . . . . . . . 60.3 tt0 -58.52 -28.27 65.28 Favored 'General case' 0 C--N 1.33 -0.248 0 N-CA-C 111.968 0.359 . . . . 0.0 111.968 177.682 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B ' 108' ' ' ASN . . . . . . . . . . . . . 10.6 t-20 -84.11 7.09 19.9 Favored 'General case' 0 CA--C 1.536 0.439 0 N-CA-C 113.235 0.828 . . . . 0.0 113.235 -177.625 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B ' 109' ' ' LEU . . . . . 0.533 HD21 ' HB2' ' B' ' 78' ' ' ALA . 6.5 tp 60.52 36.61 19.97 Favored 'General case' 0 C--O 1.233 0.197 0 CA-C-O 120.891 0.377 . . . . 0.0 111.414 178.745 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' B' B ' 110' ' ' GLU . . . . . . . . . . . . . 70.8 mm-40 -115.45 150.64 36.14 Favored 'General case' 0 C--N 1.331 -0.215 0 CA-C-O 120.723 0.297 . . . . 0.0 110.321 177.117 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B ' 111' ' ' GLU . . . . . . . . . . . . . 24.7 mm-40 -78.14 122.69 25.97 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-O 121.188 0.518 . . . . 0.0 111.762 -177.752 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B ' 112' ' ' LEU . . . . . . . . . . . . . 57.7 mt -102.94 -42.63 5.76 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 115.449 -0.796 . . . . 0.0 110.137 173.622 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B ' 113' ' ' TYR . . . . . 0.419 ' HB3' HD12 ' B' ' 104' ' ' ILE . 56.3 t80 -139.12 140.81 38.05 Favored 'General case' 0 N--CA 1.463 0.205 0 CA-C-O 120.978 0.418 . . . . 0.0 111.329 -179.677 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' B' B ' 114' ' ' ARG . . . . . . . . . . . . . 66.4 mtm180 -139.85 125.27 19.06 Favored 'General case' 0 C--N 1.331 -0.22 0 CA-C-N 115.794 -0.639 . . . . 0.0 110.247 177.515 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B ' 115' ' ' GLY . . . . . . . . . . . . . . . -150.03 153.12 24.9 Favored Glycine 0 CA--C 1.524 0.604 0 C-N-CA 120.697 -0.763 . . . . 0.0 111.581 179.46 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B ' 116' ' ' LYS . . . . . . . . . . . . . 39.8 ttpt -122.16 135.15 54.75 Favored 'General case' 0 C--N 1.33 -0.258 0 N-CA-C 109.602 -0.518 . . . . 0.0 109.602 176.104 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B ' 117' ' ' PHE . . . . . . . . . . . . . 47.1 m-85 -134.92 113.96 12.06 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-O 121.037 0.446 . . . . 0.0 110.335 -176.611 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B ' 118' ' ' GLU . . . . . . . . . . . . . 84.8 tt0 -53.41 -49.87 66.38 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.384 -0.371 . . . . 0.0 111.485 -176.771 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B ' 119' ' ' ASN . . . . . . . . . . . . . 13.3 m120 -94.21 30.99 1.77 Allowed 'General case' 0 C--N 1.329 -0.284 0 N-CA-C 112.111 0.412 . . . . 0.0 112.111 -174.591 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B ' 120' ' ' LEU . . . . . . . . . . . . . 14.9 tp -57.42 122.88 13.65 Favored 'General case' 0 C--N 1.332 -0.188 0 N-CA-C 110.28 -0.267 . . . . 0.0 110.28 178.289 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B ' 121' ' ' ASN . . . . . . . . . . . . . 80.9 m-20 -114.01 -44.07 3.19 Favored 'General case' 0 C--N 1.331 -0.204 0 CA-C-N 116.628 -0.26 . . . . 0.0 111.215 -176.617 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B ' 122' ' ' LYS . . . . . . . . . . . . . 54.0 mttm -143.34 145.71 32.92 Favored 'General case' 0 C--N 1.331 -0.199 0 C-N-CA 120.593 -0.443 . . . . 0.0 111.478 -177.406 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B ' 123' ' ' VAL . . . . . 0.51 ' HB ' HD11 ' B' ' 96' ' ' ILE . 46.3 t -126.31 128.54 71.59 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.259 0 N-CA-C 109.38 -0.6 . . . . 0.0 109.38 175.522 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' B' B ' 124' ' ' LEU . . . . . . . . . . . . . 40.4 mt -126.84 136.45 52.37 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-O 120.812 0.339 . . . . 0.0 110.773 -177.292 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B ' 125' ' ' VAL . . . . . . . . . . . . . 11.4 p -136.23 130.39 47.83 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.298 0 CA-C-N 116.338 -0.392 . . . . 0.0 110.134 177.244 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B ' 126' ' ' ARG . . . . . . . . . . . . . 29.5 mmm180 -138.17 119.91 15.2 Favored 'General case' 0 C--N 1.331 -0.201 0 CA-C-N 116.281 -0.418 . . . . 0.0 110.417 -178.977 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B ' 127' ' ' ASN . . . . . . . . . . . . . 33.7 m120 50.14 -104.85 0.16 Allowed 'General case' 0 CA--C 1.544 0.713 0 CA-C-O 119.176 -0.44 . . . . 0.0 111.794 176.622 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B ' 128' ' ' ASP . . . . . . . . . . . . . 18.1 p-10 -110.54 -0.43 17.34 Favored 'General case' 0 CA--C 1.536 0.415 0 N-CA-C 113.752 1.019 . . . . 0.0 113.752 -174.759 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B ' 129' ' ' LEU . . . . . . . . . . . . . 83.7 mt -111.01 144.22 40.47 Favored 'General case' 0 C--N 1.332 -0.175 0 O-C-N 121.972 -0.455 . . . . 0.0 110.273 179.349 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B ' 130' ' ' VAL . . . . . 0.566 HG13 ' HB ' ' B' ' 141' ' ' ILE . 13.6 p -130.81 138.58 53.25 Favored 'Isoleucine or valine' 0 C--O 1.233 0.214 0 CA-C-O 121.188 0.518 . . . . 0.0 110.423 178.706 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' B' B ' 131' ' ' VAL . . . . . . . . . . . . . 37.5 t -135.11 138.95 48.06 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.263 0 CA-C-N 115.858 -0.61 . . . . 0.0 110.47 -175.773 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B ' 132' ' ' ILE . . . . . . . . . . . . . 70.1 mt -117.22 129.77 73.21 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.283 0 CA-C-N 115.866 -0.606 . . . . 0.0 109.409 178.869 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B ' 133' ' ' ILE . . . . . . . . . . . . . 43.5 mm -114.0 119.46 61.22 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.244 0 CA-C-O 120.815 0.34 . . . . 0.0 110.652 -176.183 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B ' 134' ' ' ASP . . . . . . . . . . . . . 9.0 p-10 -134.43 143.04 47.33 Favored 'General case' 0 C--N 1.33 -0.27 0 N-CA-C 109.586 -0.524 . . . . 0.0 109.586 177.05 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B ' 135' ' ' GLU . . . . . . . . . . . . . 85.7 tt0 -49.93 -25.84 3.63 Favored 'General case' 0 C--N 1.328 -0.347 0 N-CA-C 112.594 0.59 . . . . 0.0 112.594 -174.316 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B ' 136' ' ' GLN . . . . . . . . . . . . . 53.2 mt-30 -78.95 -38.28 37.48 Favored 'General case' 0 CA--C 1.531 0.216 0 N-CA-C 112.138 0.422 . . . . 0.0 112.138 -178.016 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B ' 137' ' ' LYS . . . . . . . . . . . . . 19.6 ptpt -162.77 174.46 12.44 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-O 121.49 0.662 . . . . 0.0 111.958 -173.458 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B ' 138' ' ' LEU . . . . . . . . . . . . . 6.1 tt -117.88 126.77 53.0 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 115.098 -0.956 . . . . 0.0 109.568 177.007 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B ' 139' ' ' THR . . . . . . . . . . . . . 28.6 m -108.78 124.86 51.26 Favored 'General case' 0 C--N 1.331 -0.204 0 CA-C-N 116.372 -0.376 . . . . 0.0 110.619 -178.882 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B ' 140' ' ' LEU . . . . . . . . . . . . . 17.9 tp -112.17 119.02 36.95 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 115.579 -0.737 . . . . 0.0 109.124 -179.449 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B ' 141' ' ' ILE . . . . . 0.566 ' HB ' HG13 ' B' ' 130' ' ' VAL . 19.9 mt -119.29 121.11 65.74 Favored 'Isoleucine or valine' 0 C--O 1.235 0.309 0 CA-C-O 121.236 0.541 . . . . 0.0 110.375 -176.209 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' B' B ' 142' ' ' ARG . . . . . . . . . . . . . 7.8 mmm180 -94.75 117.34 29.97 Favored 'General case' 0 C--N 1.331 -0.224 0 CA-C-N 114.861 -1.063 . . . . 0.0 109.718 177.86 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B ' 143' ' ' THR . . . . . . . . . . . . . 6.0 p . . . . . 0 C--O 1.221 -0.444 0 CA-C-O 117.929 -1.034 . . . . 0.0 110.523 -177.914 . . . . . . . . 0 0 . 1 . 008 nuclear build core ' C' C ' 2' ' ' SER . . . . . . . . . . . . . 3.1 p . . . . . 0 C--O 1.232 0.135 0 CA-C-O 121.041 0.448 . . . . 0.0 110.41 . . . . . . . . . 0 0 . 1 . 008 nuclear build core ' C' C ' 3' ' ' GLU . . . . . . . . . . . . . 96.0 mt-10 -140.35 141.1 35.68 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 115.72 -0.673 . . . . 0.0 110.951 -177.886 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' C' C ' 4' ' ' LEU . . . . . . . . . . . . . 18.3 tp -123.19 127.06 48.12 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 115.771 -0.65 . . . . 0.0 109.799 175.795 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' C' C ' 5' ' ' LYS . . . . . . . . . . . . . 98.8 mttt -110.41 119.77 40.28 Favored 'General case' 0 C--O 1.234 0.26 0 CA-C-N 116.427 -0.352 . . . . 0.0 110.789 -179.257 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' C' C ' 6' ' ' LEU . . . . . . . . . . . . . 70.9 mt -114.8 143.98 44.23 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 115.302 -0.863 . . . . 0.0 110.277 -179.187 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' C' C ' 7' ' ' LYS . . . . . . . . . . . . . 51.3 tttm -128.26 133.29 24.99 Favored Pre-proline 0 CA--C 1.535 0.39 0 CA-C-O 118.777 -0.63 . . . . 0.0 110.102 177.442 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' C' C ' 8' ' ' PRO . . . . . . . . . . . . . 73.4 Cg_endo -89.01 136.32 2.95 Favored 'Trans proline' 0 N--CA 1.491 1.378 0 C-N-CA 121.61 1.54 . . . . 0.0 111.501 176.699 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' C' C ' 9' ' ' LEU . . . . . . . . . . . . . 75.8 mt -75.29 -52.08 3.16 Favored Pre-proline 0 CA--C 1.533 0.32 0 CA-C-O 118.712 -0.661 . . . . 0.0 112.02 -177.312 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' C' C ' 10' ' ' PRO . . . . . . . . . . . . . 60.4 Cg_endo -72.95 150.23 48.54 Favored 'Trans proline' 0 N--CA 1.5 1.866 0 C-N-CA 121.085 1.19 . . . . 0.0 111.948 174.375 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' C' C ' 11' ' ' LYS . . . . . . . . . . . . . 41.0 mtpt -89.13 100.78 13.49 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.502 -0.317 . . . . 0.0 110.825 179.391 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' C' C ' 12' ' ' VAL . . . . . . . . . . . . . 12.4 p -146.24 143.39 21.09 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.336 0 CA-C-N 116.265 -0.425 . . . . 0.0 110.579 179.223 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' C' C ' 13' ' ' GLU . . . . . . . . . . . . . 95.0 mt-10 -81.09 123.99 28.85 Favored 'General case' 0 C--N 1.33 -0.274 0 N-CA-C 109.98 -0.378 . . . . 0.0 109.98 177.916 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' C' C ' 14' ' ' LEU . . . . . . . . . . . . . 28.2 mt -98.27 152.31 37.92 Favored Pre-proline 0 CA--C 1.532 0.287 0 CA-C-N 116.425 -0.352 . . . . 0.0 110.601 -179.046 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' C' C ' 15' ' ' PRO . . . . . . . . . . . . . 34.3 Cg_exo -58.41 156.07 32.74 Favored 'Trans proline' 0 N--CA 1.497 1.693 0 C-N-CA 121.323 1.348 . . . . 0.0 111.854 178.088 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' C' C ' 16' ' ' PRO . . . . . . . . . . . . . 39.3 Cg_exo -58.85 -34.36 99.01 Favored 'Trans proline' 0 N--CA 1.496 1.64 0 C-N-CA 121.475 1.45 . . . . 0.0 112.677 -179.821 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' C' C ' 17' ' ' ASP . . . . . . . . . . . . . 19.4 p-10 -85.3 9.78 14.37 Favored 'General case' 0 CA--C 1.535 0.375 0 N-CA-C 113.081 0.771 . . . . 0.0 113.081 -177.545 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' C' C ' 18' ' ' PHE . . . . . . . . . . . . . 34.7 t80 -56.79 -42.15 78.96 Favored 'General case' 0 C--N 1.333 -0.118 0 O-C-N 121.939 -0.476 . . . . 0.0 110.365 -179.378 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' C' C ' 19' ' ' VAL . . . . . . . . . . . . . 53.1 t -56.43 -44.47 80.34 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 CA-C-N 116.361 -0.381 . . . . 0.0 110.469 -179.335 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' C' C ' 20' ' ' ASP . . . . . . . . . . . . . 82.8 m-20 -59.8 -42.5 93.55 Favored 'General case' 0 C--N 1.329 -0.308 0 C-N-CA 120.817 -0.353 . . . . 0.0 110.785 -178.271 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' C' C ' 21' ' ' VAL . . . . . . . . . . . . . 56.2 t -63.37 -47.75 90.45 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.303 0 C-N-CA 120.736 -0.385 . . . . 0.0 110.464 -177.294 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' C' C ' 22' ' ' ILE . . . . . 0.569 HG22 HD12 ' C' ' 26' ' ' LEU . 51.3 mm -55.42 -48.75 76.64 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.326 0 C-N-CA 121.077 -0.249 . . . . 0.0 110.8 -179.976 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' C' C ' 23' ' ' ARG . . . . . . . . . . . . . 55.4 ttp180 -55.66 -47.8 76.09 Favored 'General case' 0 C--N 1.33 -0.276 0 C-N-CA 120.806 -0.358 . . . . 0.0 111.415 -177.314 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' C' C ' 24' ' ' ILE . . . . . . . . . . . . . 75.8 mt -59.29 -42.01 85.87 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.311 0 C-N-CA 121.089 -0.244 . . . . 0.0 111.315 -177.284 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' C' C ' 25' ' ' LYS . . . . . . . . . . . . . 93.3 mttt -67.82 -43.79 78.78 Favored 'General case' 0 C--N 1.331 -0.219 0 N-CA-C 112.6 0.592 . . . . 0.0 112.6 -178.903 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' C' C ' 26' ' ' LEU . . . . . 0.569 HD12 HG22 ' C' ' 22' ' ' ILE . 70.6 mt -78.31 -33.96 48.98 Favored 'General case' 0 C--N 1.329 -0.313 0 N-CA-C 113.548 0.944 . . . . 0.0 113.548 -169.967 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' C' C ' 27' ' ' GLN . . . . . . . . . . . . . 20.9 pt20 -46.76 138.79 5.86 Favored 'General case' 0 N--CA 1.467 0.385 0 N-CA-C 112.971 0.73 . . . . 0.0 112.971 -173.925 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' C' C ' 28' ' ' GLY . . . . . . . . . . . . . . . 100.05 -27.18 21.51 Favored Glycine 0 CA--C 1.532 1.116 0 CA-C-N 115.614 -0.721 . . . . 0.0 112.214 -178.906 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' C' C ' 29' ' ' LYS . . . . . . . . . . . . . 61.8 mttp -97.96 155.21 17.2 Favored 'General case' 0 C--O 1.232 0.159 0 CA-C-N 117.341 0.571 . . . . 0.0 111.301 179.475 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' C' C ' 30' ' ' THR . . . . . . . . . . . . . 37.3 m -104.92 139.95 38.89 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-N 115.954 -0.566 . . . . 0.0 109.898 175.817 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' C' C ' 31' ' ' VAL . . . . . . . . . . . . . 34.7 m -127.31 152.26 35.13 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.218 0 CA-C-O 120.947 0.403 . . . . 0.0 111.077 -178.048 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' C' C ' 32' ' ' ARG . . . . . . . . . . . . . 97.1 mtt180 -126.35 149.47 49.17 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 115.834 -0.621 . . . . 0.0 110.622 177.912 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' C' C ' 33' ' ' THR . . . . . 0.401 HG23 ' O ' ' C' ' 51' ' ' VAL . 17.6 m -53.65 138.81 33.93 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-N 116.118 -0.492 . . . . 0.0 111.308 -178.658 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' C' C ' 34' ' ' GLY . . . . . . . . . . . . . . . 100.2 -17.15 57.4 Favored Glycine 0 CA--C 1.533 1.194 0 CA-C-O 119.672 -0.515 . . . . 0.0 113.333 178.967 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' C' C ' 35' ' ' ASP . . . . . . . . . . . . . 77.5 m-20 -65.53 148.35 51.88 Favored 'General case' 0 N--CA 1.462 0.142 0 CA-C-N 117.965 0.883 . . . . 0.0 110.922 178.869 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' C' C ' 36' ' ' VAL . . . . . . . . . . . . . 41.4 t -120.53 131.52 72.49 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.258 0 CA-C-N 116.007 -0.542 . . . . 0.0 109.858 178.943 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' C' C ' 37' ' ' ILE . . . . . . . . . . . . . 67.1 mt -118.68 138.11 50.46 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.225 0 CA-C-N 116.082 -0.508 . . . . 0.0 109.682 179.276 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' C' C ' 38' ' ' GLY . . . . . . . . . . . . . . . -114.85 128.75 8.28 Favored Glycine 0 CA--C 1.525 0.67 0 N-CA-C 111.006 -0.838 . . . . 0.0 111.006 -179.878 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' C' C ' 39' ' ' ILE . . . . . . . . . . . . . 73.0 mt -123.21 137.35 56.89 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.186 0 N-CA-C 110.252 -0.277 . . . . 0.0 110.252 179.585 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' C' C ' 40' ' ' SER . . . . . . . . . . . . . 99.5 p -91.69 117.71 30.0 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.329 -0.396 . . . . 0.0 110.713 175.767 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' C' C ' 41' ' ' ILE . . . . . 0.426 HD12 HG11 ' C' ' 46' ' ' VAL . 72.0 mt -127.79 121.48 56.64 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.202 0 CA-C-O 120.902 0.382 . . . . 0.0 110.397 178.82 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' C' C ' 42' ' ' LEU . . . . . . . . . . . . . 10.8 tp 52.3 35.61 17.5 Favored 'General case' 0 CA--C 1.531 0.23 0 CA-C-N 116.036 -0.529 . . . . 0.0 111.614 177.087 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' C' C ' 43' ' ' GLY . . . . . . . . . . . . . . . 72.07 31.88 63.73 Favored Glycine 0 CA--C 1.529 0.92 0 C-N-CA 121.183 -0.532 . . . . 0.0 111.972 178.047 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' C' C ' 44' ' ' LYS . . . . . . . . . . . . . 40.7 ttpt -138.79 129.75 26.58 Favored 'General case' 0 C--N 1.329 -0.313 0 N-CA-C 109.609 -0.515 . . . . 0.0 109.609 178.743 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' C' C ' 45' ' ' GLU . . . . . . . . . . . . . 84.6 tt0 -82.6 118.23 23.14 Favored 'General case' 0 C--N 1.328 -0.335 0 C-N-CA 120.753 -0.379 . . . . 0.0 110.673 -178.768 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' C' C ' 46' ' ' VAL . . . . . 0.426 HG11 HD12 ' C' ' 41' ' ' ILE . 7.5 p -114.94 127.36 72.52 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.153 0 N-CA-C 109.285 -0.635 . . . . 0.0 109.285 176.795 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' C' C ' 47' ' ' LYS . . . . . . . . . . . . . 64.2 mttp -100.45 128.15 46.59 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 115.817 -0.629 . . . . 0.0 111.306 179.724 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' C' C ' 48' ' ' PHE . . . . . . . . . . . . . 94.9 m-85 -111.83 131.86 55.07 Favored 'General case' 0 C--N 1.329 -0.283 0 N-CA-C 109.652 -0.499 . . . . 0.0 109.652 174.956 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' C' C ' 49' ' ' LYS . . . . . . . . . . . . . 41.8 tttp -107.57 136.57 47.12 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.619 -0.264 . . . . 0.0 110.427 179.287 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' C' C ' 50' ' ' VAL . . . . . . . . . . . . . 46.4 t -79.87 108.75 13.69 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.305 0 N-CA-C 109.164 -0.68 . . . . 0.0 109.164 176.273 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' C' C ' 51' ' ' VAL . . . . . 0.401 ' O ' HG23 ' C' ' 33' ' ' THR . 46.8 t -73.24 -51.63 25.13 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.293 0 CA-C-N 116.153 -0.476 . . . . 0.0 109.737 -175.336 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' C' C ' 52' ' ' GLN . . . . . . . . . . . . . 86.2 mt-30 -154.03 149.17 26.91 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-O 121.334 0.587 . . . . 0.0 112.077 -178.007 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' C' C ' 53' ' ' ALA . . . . . 0.531 ' HB3' ' OG ' ' C' ' 56' ' ' SER . . . -124.25 130.31 52.3 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 115.091 -0.958 . . . . 0.0 109.5 172.885 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' C' C ' 54' ' ' TYR . . . . . . . . . . . . . 45.5 t80 -128.97 107.08 18.1 Favored Pre-proline 0 CA--C 1.535 0.386 0 CA-C-O 118.24 -0.886 . . . . 0.0 110.593 -179.383 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' C' C ' 55' ' ' PRO . . . . . . . . . . . . . 73.3 Cg_endo -77.1 168.68 76.34 Favored 'Cis proline' 0 N--CA 1.499 1.827 0 CA-C-N 121.821 1.686 . . . . 0.0 112.243 -5.413 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' C' C ' 56' ' ' SER . . . . . 0.531 ' OG ' ' HB3' ' C' ' 53' ' ' ALA . 71.1 m -116.57 133.26 23.03 Favored Pre-proline 0 CA--C 1.537 0.472 0 CA-C-O 118.544 -0.741 . . . . 0.0 109.342 174.989 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' C' C ' 57' ' ' PRO . . . . . . . . . . . . . 55.3 Cg_endo -70.79 146.27 83.94 Favored 'Cis proline' 0 N--CA 1.498 1.745 0 CA-C-N 121.844 1.694 . . . . 0.0 111.688 -0.561 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' C' C ' 58' ' ' LEU . . . . . . . . . . . . . 31.4 tp -108.03 137.63 45.7 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.085 -0.507 . . . . 0.0 110.605 -178.7 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' C' C ' 59' ' ' ARG . . . . . . . . . . . . . 37.1 ttm180 -98.91 133.56 43.02 Favored 'General case' 0 C--N 1.328 -0.355 0 N-CA-C 109.453 -0.573 . . . . 0.0 109.453 175.273 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' C' C ' 60' ' ' VAL . . . . . . . . . . . . . 40.1 t -87.01 113.8 25.16 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.236 0 C-N-CA 120.616 -0.434 . . . . 0.0 110.386 -178.112 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' C' C ' 61' ' ' GLU . . . . . . . . . . . . . 15.7 mm-40 -131.1 163.66 27.17 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 115.944 -0.571 . . . . 0.0 109.769 174.246 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' C' C ' 62' ' ' ASP . . . . . . . . . . . . . 81.8 m-20 -52.32 -32.21 36.79 Favored 'General case' 0 C--N 1.329 -0.309 0 N-CA-C 111.802 0.297 . . . . 0.0 111.802 177.743 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' C' C ' 63' ' ' ARG . . . . . . . . . . . . . 41.4 mtp180 -72.07 -22.07 61.42 Favored 'General case' 0 CA--C 1.533 0.299 0 N-CA-C 112.884 0.698 . . . . 0.0 112.884 -176.484 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' C' C ' 64' ' ' THR . . . . . . . . . . . . . 40.5 m -72.27 138.12 47.22 Favored 'General case' 0 C--N 1.332 -0.186 0 CA-C-O 120.918 0.39 . . . . 0.0 110.657 -176.467 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' C' C ' 65' ' ' LYS . . . . . . . . . . . . . 38.8 ttpt -88.63 127.11 35.56 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 115.989 -0.551 . . . . 0.0 110.239 179.549 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' C' C ' 66' ' ' ILE . . . . . . . . . . . . . 72.5 mt -112.96 132.09 62.72 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.28 0 CA-C-O 120.892 0.377 . . . . 0.0 110.064 -178.053 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' C' C ' 67' ' ' THR . . . . . . . . . . . . . 23.4 m -125.29 137.26 54.07 Favored 'General case' 0 C--N 1.331 -0.212 0 CA-C-N 116.091 -0.504 . . . . 0.0 110.655 -179.239 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' C' C ' 68' ' ' LEU . . . . . . . . . . . . . 13.8 tp . . . . . 0 C--N 1.33 -0.245 0 CA-C-N 115.887 -0.597 . . . . 0.0 110.527 179.841 . . . . . . . . 0 0 . 1 . 008 nuclear build core ' C' C ' 73' ' ' VAL . . . . . . . . . . . . . 34.6 m . . . . . 0 N--CA 1.462 0.159 0 CA-C-O 120.752 0.31 . . . . 0.0 110.369 . . . . . . . . . 0 0 . 1 . 008 nuclear build core ' C' C ' 74' ' ' ASP . . . . . . . . . . . . . 42.3 t0 -104.55 121.52 43.66 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-N 116.332 -0.394 . . . . 0.0 110.183 -177.966 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' C' C ' 75' ' ' VAL . . . . . 0.44 ' C ' HD12 ' C' ' 76' ' ' LEU . 40.6 t -118.24 125.91 74.62 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.326 0 CA-C-O 121.107 0.479 . . . . 0.0 111.005 -176.462 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' C' C ' 76' ' ' LEU . . . . . 0.44 HD12 ' C ' ' C' ' 75' ' ' VAL . 6.8 mp -121.53 143.99 48.96 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 115.601 -0.727 . . . . 0.0 109.732 174.681 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' C' C ' 77' ' ' GLU . . . . . . . . . . . . . 97.0 mt-10 -134.47 130.67 37.06 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-O 120.988 0.423 . . . . 0.0 111.016 -177.995 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' C' C ' 78' ' ' ALA . . . . . . . . . . . . . . . -117.98 134.09 55.29 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 115.663 -0.699 . . . . 0.0 109.766 176.933 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' C' C ' 79' ' ' LYS . . . . . 0.58 ' O ' HD13 ' C' ' 80' ' ' ILE . 49.2 mtmt -77.47 120.71 22.85 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-O 120.967 0.413 . . . . 0.0 110.967 -177.956 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' C' C ' 80' ' ' ILE . . . . . 0.58 HD13 ' O ' ' C' ' 79' ' ' LYS . 42.1 mm -139.09 108.54 3.87 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.322 0 N-CA-C 108.933 -0.765 . . . . 0.0 108.933 -179.009 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' C' C ' 81' ' ' LYS . . . . . . . . . . . . . 44.0 mtmt -101.44 123.34 45.34 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-O 120.723 0.297 . . . . 0.0 111.257 -176.382 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' C' C ' 82' ' ' GLY . . . . . . . . . . . . . . . 89.07 42.43 5.62 Favored Glycine 0 CA--C 1.526 0.738 0 C-N-CA 120.652 -0.785 . . . . 0.0 111.794 174.674 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' C' C ' 83' ' ' ILE . . . . . . . . . . . . . 68.0 mt -65.29 137.03 25.73 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 CA-C-O 121.001 0.429 . . . . 0.0 109.862 177.733 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' C' C ' 84' ' ' LYS . . . . . . . . . . . . . 46.3 tttp -92.94 -52.52 4.55 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 115.942 -0.572 . . . . 0.0 109.94 179.891 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' C' C ' 85' ' ' ASP . . . . . . . . . . . . . 7.0 t70 -154.33 151.98 29.71 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 115.478 -0.783 . . . . 0.0 110.321 -179.225 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' C' C ' 86' ' ' VAL . . . . . . . . . . . . . 43.4 t -130.46 129.76 64.8 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.287 0 CA-C-N 116.47 -0.332 . . . . 0.0 110.495 -179.485 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' C' C ' 87' ' ' ILE . . . . . 0.501 ' N ' HD12 ' C' ' 87' ' ' ILE . 5.1 mp -119.37 128.78 75.85 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.285 0 N-CA-C 109.405 -0.591 . . . . 0.0 109.405 176.184 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' C' C ' 88' ' ' LEU . . . . . . . . . . . . . 23.7 tp -117.58 135.96 53.61 Favored 'General case' 0 C--N 1.331 -0.216 0 CA-C-O 121.014 0.435 . . . . 0.0 111.556 -176.126 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' C' C ' 89' ' ' ASP . . . . . . . . . . . . . 10.9 t70 -130.01 154.31 47.53 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 115.665 -0.698 . . . . 0.0 109.19 174.537 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' C' C ' 90' ' ' GLU . . . . . . . . . . . . . 96.6 mt-10 -49.81 -35.0 21.26 Favored 'General case' 0 C--N 1.33 -0.261 0 N-CA-C 112.718 0.636 . . . . 0.0 112.718 -172.277 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' C' C ' 91' ' ' ASN . . . . . . . . . . . . . 86.2 m-20 -130.29 32.61 4.44 Favored 'General case' 0 N--CA 1.465 0.294 0 N-CA-C 111.99 0.367 . . . . 0.0 111.99 -175.902 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' C' C ' 92' ' ' LEU . . . . . . . . . . . . . 8.7 tp -166.1 145.75 6.15 Favored 'General case' 0 C--N 1.331 -0.228 0 C-N-CA 120.933 -0.307 . . . . 0.0 110.782 178.67 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' C' C ' 93' ' ' ILE . . . . . . . . . . . . . 68.0 mt -125.93 124.08 65.47 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.181 0 N-CA-C 109.586 -0.524 . . . . 0.0 109.586 179.391 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' C' C ' 94' ' ' VAL . . . . . . . . . . . . . 43.3 t -122.64 125.21 72.21 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.223 0 N-CA-C 109.937 -0.394 . . . . 0.0 109.937 179.344 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' C' C ' 95' ' ' VAL . . . . . . . . . . . . . 43.8 t -124.08 134.67 65.94 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.299 0 CA-C-N 116.305 -0.407 . . . . 0.0 110.168 -179.461 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' C' C ' 96' ' ' ILE . . . . . . . . . . . . . 61.1 mt -118.99 130.52 73.7 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.238 0 N-CA-C 109.457 -0.571 . . . . 0.0 109.457 179.54 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' C' C ' 97' ' ' THR . . . . . . . . . . . . . 81.1 p -103.46 158.44 16.35 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-O 121.088 0.47 . . . . 0.0 111.44 -177.295 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' C' C ' 98' ' ' GLU . . . . . . . . . . . . . 98.1 mt-10 -53.97 -26.5 26.09 Favored 'General case' 0 CA--C 1.532 0.257 0 N-CA-C 112.392 0.516 . . . . 0.0 112.392 179.998 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' C' C ' 99' ' ' GLU . . . . . . . . . . . . . 95.8 mt-10 -77.78 14.05 1.18 Allowed 'General case' 0 CA--C 1.535 0.391 0 N-CA-C 113.302 0.853 . . . . 0.0 113.302 -177.23 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' C' C ' 100' ' ' ASN . . . . . . . . . . . . . 4.6 m-20 63.01 37.95 11.35 Favored 'General case' 0 C--O 1.232 0.142 0 CA-C-O 121.08 0.467 . . . . 0.0 111.033 178.489 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' C' C ' 101' ' ' GLU . . . . . . . . . . . . . 84.9 tt0 -117.65 140.11 50.1 Favored 'General case' 0 C--N 1.333 -0.151 0 CA-C-N 116.083 -0.508 . . . . 0.0 109.646 175.697 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' C' C ' 102' ' ' VAL . . . . . . . . . . . . . 45.7 t -115.16 128.83 72.18 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.263 0 CA-C-N 116.311 -0.404 . . . . 0.0 110.063 -178.667 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' C' C ' 103' ' ' LEU . . . . . 0.514 HD12 ' N ' ' C' ' 103' ' ' LEU . 6.1 mp -118.4 132.94 56.24 Favored 'General case' 0 C--N 1.331 -0.201 0 CA-C-N 115.695 -0.684 . . . . 0.0 110.131 176.904 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' C' C ' 104' ' ' ILE . . . . . . . . . . . . . 67.9 mt -117.92 122.48 69.82 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.228 0 CA-C-N 116.328 -0.397 . . . . 0.0 109.972 -179.766 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' C' C ' 105' ' ' PHE . . . . . . . . . . . . . 67.1 m-85 -123.16 164.67 18.24 Favored 'General case' 0 C--N 1.333 -0.132 0 O-C-N 123.916 0.76 . . . . 0.0 109.777 -179.972 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' C' C ' 106' ' ' ASN . . . . . . . . . . . . . 47.3 p-10 -102.42 -172.08 2.07 Favored 'General case' 0 C--N 1.33 -0.246 0 N-CA-C 110.151 -0.315 . . . . 0.0 110.151 174.688 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' C' C ' 107' ' ' GLN . . . . . . . . . . . . . 29.9 tt0 -58.81 -28.07 65.67 Favored 'General case' 0 C--N 1.329 -0.311 0 N-CA-C 112.086 0.402 . . . . 0.0 112.086 179.166 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' C' C ' 108' ' ' ASN . . . . . . . . . . . . . 7.9 t-20 -84.75 12.12 7.85 Favored 'General case' 0 CA--C 1.537 0.453 0 N-CA-C 112.89 0.7 . . . . 0.0 112.89 -177.956 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' C' C ' 109' ' ' LEU . . . . . . . . . . . . . 10.7 tp 53.8 37.22 25.89 Favored 'General case' 0 C--N 1.333 -0.148 0 CA-C-O 121.089 0.471 . . . . 0.0 111.315 179.409 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' C' C ' 110' ' ' GLU . . . . . . . . . . . . . 96.0 mt-10 -105.98 141.88 36.64 Favored 'General case' 0 C--N 1.33 -0.272 0 N-CA-C 109.325 -0.62 . . . . 0.0 109.325 174.528 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' C' C ' 111' ' ' GLU . . . . . . . . . . . . . 51.4 tt0 -79.61 121.92 25.87 Favored 'General case' 0 C--N 1.328 -0.332 0 C-N-CA 120.693 -0.403 . . . . 0.0 110.286 -176.478 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' C' C ' 112' ' ' LEU . . . . . . . . . . . . . 34.3 mt -102.85 -46.11 4.79 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.034 -0.53 . . . . 0.0 110.72 -179.668 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' C' C ' 113' ' ' TYR . . . . . . . . . . . . . 59.1 t80 -137.45 140.8 41.46 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.034 -0.53 . . . . 0.0 110.927 -177.824 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' C' C ' 114' ' ' ARG . . . . . . . . . . . . . 28.5 ptt180 -144.83 126.08 14.75 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-O 120.93 0.395 . . . . 0.0 110.664 176.56 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' C' C ' 115' ' ' GLY . . . . . . . . . . . . . . . -150.01 151.8 23.82 Favored Glycine 0 CA--C 1.524 0.61 0 N-CA-C 111.131 -0.788 . . . . 0.0 111.131 179.297 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' C' C ' 116' ' ' LYS . . . . . . . . . . . . . 39.7 ttpt -119.53 132.55 55.78 Favored 'General case' 0 C--N 1.329 -0.296 0 N-CA-C 110.006 -0.368 . . . . 0.0 110.006 178.185 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' C' C ' 117' ' ' PHE . . . . . . . . . . . . . 37.5 m-85 -128.93 113.8 15.66 Favored 'General case' 0 C--N 1.329 -0.286 0 N-CA-C 109.878 -0.416 . . . . 0.0 109.878 -178.257 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' C' C ' 118' ' ' GLU . . . . . . . . . . . . . 85.1 tt0 -55.54 -38.49 69.35 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-N 116.398 -0.364 . . . . 0.0 111.339 -175.308 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' C' C ' 119' ' ' ASN . . . . . . . . . . . . . 10.5 p-10 -108.73 31.14 5.87 Favored 'General case' 0 N--CA 1.463 0.196 0 N-CA-C 112.237 0.458 . . . . 0.0 112.237 -173.106 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' C' C ' 120' ' ' LEU . . . . . . . . . . . . . 15.0 tp -54.36 126.81 24.71 Favored 'General case' 0 N--CA 1.463 0.21 0 O-C-N 122.358 -0.213 . . . . 0.0 110.683 177.024 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' C' C ' 121' ' ' ASN . . . . . . . . . . . . . 27.1 m120 -110.56 -44.22 3.72 Favored 'General case' 0 C--N 1.332 -0.187 0 C-N-CA 121.169 -0.212 . . . . 0.0 111.173 -177.06 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' C' C ' 122' ' ' LYS . . . . . . . . . . . . . 95.2 mttt -148.36 148.15 30.05 Favored 'General case' 0 C--N 1.331 -0.229 0 CA-C-O 121.028 0.442 . . . . 0.0 111.44 -178.266 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' C' C ' 123' ' ' VAL . . . . . . . . . . . . . 47.0 t -127.42 128.33 69.83 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.223 0 N-CA-C 109.569 -0.53 . . . . 0.0 109.569 174.769 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' C' C ' 124' ' ' LEU . . . . . . . . . . . . . 67.9 mt -126.45 135.22 51.1 Favored 'General case' 0 C--N 1.331 -0.217 0 CA-C-N 116.494 -0.321 . . . . 0.0 110.626 -178.785 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' C' C ' 125' ' ' VAL . . . . . 0.515 HG23 HG22 ' C' ' 130' ' ' VAL . 12.4 p -138.05 137.45 44.5 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.284 0 CA-C-N 116.442 -0.345 . . . . 0.0 110.524 179.141 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' C' C ' 126' ' ' ARG . . . . . . . . . . . . . 90.6 mtt180 -143.96 123.32 13.08 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.565 178.676 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' C' C ' 127' ' ' ASN . . . . . . . . . . . . . 1.9 m-80 51.67 -105.02 0.19 Allowed 'General case' 0 CA--C 1.544 0.723 0 CA-C-O 119.134 -0.46 . . . . 0.0 111.279 -179.814 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' C' C ' 128' ' ' ASP . . . . . . . . . . . . . 8.9 p-10 -114.11 1.99 14.77 Favored 'General case' 0 CA--C 1.536 0.406 0 CA-C-N 119.538 1.063 . . . . 0.0 113.49 -176.53 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' C' C ' 129' ' ' LEU . . . . . . . . . . . . . 54.4 mt -104.97 135.49 46.21 Favored 'General case' 0 C--N 1.332 -0.185 0 CA-C-N 118.193 0.451 . . . . 0.0 110.401 179.618 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' C' C ' 130' ' ' VAL . . . . . 0.515 HG22 HG23 ' C' ' 125' ' ' VAL . 47.2 t -123.35 135.16 64.15 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.22 0 N-CA-C 109.913 -0.403 . . . . 0.0 109.913 179.991 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' C' C ' 131' ' ' VAL . . . . . 0.48 HG22 HD12 ' C' ' 140' ' ' LEU . 42.0 t -134.32 135.37 54.29 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.344 0 CA-C-O 121.125 0.488 . . . . 0.0 110.103 178.257 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' C' C ' 132' ' ' ILE . . . . . . . . . . . . . 72.5 mt -115.35 130.2 70.31 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.361 0 CA-C-N 115.498 -0.774 . . . . 0.0 109.179 -179.682 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' C' C ' 133' ' ' ILE . . . . . . . . . . . . . 44.6 mm -114.06 120.03 62.78 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.248 0 CA-C-O 120.981 0.419 . . . . 0.0 110.631 -176.226 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' C' C ' 134' ' ' ASP . . . . . . . . . . . . . 6.7 p-10 -129.58 149.51 51.31 Favored 'General case' 0 C--N 1.331 -0.23 0 CA-C-N 115.97 -0.559 . . . . 0.0 109.539 176.117 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' C' C ' 135' ' ' GLU . . . . . . . . . . . . . 41.4 tp10 -49.96 -27.05 4.81 Favored 'General case' 0 C--N 1.327 -0.378 0 N-CA-C 112.806 0.669 . . . . 0.0 112.806 -169.927 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' C' C ' 136' ' ' GLN . . . . . . . . . . . . . 30.7 tt0 -103.67 -22.82 13.51 Favored 'General case' 0 N--CA 1.465 0.282 0 N-CA-C 113.093 0.775 . . . . 0.0 113.093 -173.402 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' C' C ' 137' ' ' LYS . . . . . . . . . . . . . 54.0 mtmt -148.77 157.16 43.24 Favored 'General case' 0 C--N 1.332 -0.153 0 CA-C-O 121.212 0.529 . . . . 0.0 112.008 -170.649 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' C' C ' 138' ' ' LEU . . . . . 0.415 HD23 ' C ' ' C' ' 138' ' ' LEU . 5.5 tt -120.18 125.48 48.29 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 115.568 -0.742 . . . . 0.0 109.444 175.312 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' C' C ' 139' ' ' THR . . . . . . . . . . . . . 37.6 m -111.57 131.57 55.15 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-O 120.762 0.315 . . . . 0.0 111.126 -176.463 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' C' C ' 140' ' ' LEU . . . . . 0.48 HD12 HG22 ' C' ' 131' ' ' VAL . 14.3 tp -116.35 122.5 45.06 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 115.527 -0.761 . . . . 0.0 109.428 -179.67 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' C' C ' 141' ' ' ILE . . . . . . . . . . . . . 19.5 mt -120.77 119.45 59.59 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.29 0 N-CA-C 109.687 -0.486 . . . . 0.0 109.687 -177.258 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' C' C ' 142' ' ' ARG . . . . . . . . . . . . . 53.2 ttt180 . . . . . 0 C--N 1.328 -0.349 0 CA-C-N 115.301 -0.863 . . . . 0.0 110.501 -176.341 . . . . . . . . 0 0 . 1 . 008 nuclear build core ' D' D ' 2' ' ' SER . . . . . . . . . . . . . 4.2 p . . . . . 0 C--O 1.232 0.143 0 CA-C-O 121.167 0.508 . . . . 0.0 110.698 . . . . . . . . . 0 0 . 1 . 008 nuclear build core ' D' D ' 3' ' ' GLU . . . . . . . . . . . . . 84.8 tt0 -141.28 141.97 33.92 Favored 'General case' 0 C--N 1.326 -0.423 0 CA-C-N 115.578 -0.737 . . . . 0.0 111.121 -178.25 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' D' D ' 4' ' ' LEU . . . . . . . . . . . . . 65.2 mt -119.9 128.98 54.14 Favored 'General case' 0 C--N 1.331 -0.224 0 CA-C-N 115.739 -0.664 . . . . 0.0 110.436 176.303 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' D' D ' 5' ' ' LYS . . . . . . . . . . . . . 61.1 mttp -106.02 119.55 39.49 Favored 'General case' 0 C--O 1.235 0.322 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.303 176.62 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' D' D ' 6' ' ' LEU . . . . . . . . . . . . . 73.2 mt -118.18 152.08 36.36 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-N 115.457 -0.792 . . . . 0.0 110.726 -177.72 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' D' D ' 7' ' ' LYS . . . . . . . . . . . . . 29.2 ttpt -143.27 140.92 18.28 Favored Pre-proline 0 CA--C 1.534 0.354 0 CA-C-O 119.19 -0.434 . . . . 0.0 110.067 174.33 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' D' D ' 8' ' ' PRO . . . . . . . . . . . . . 93.9 Cg_endo -89.27 138.23 3.25 Favored 'Trans proline' 0 N--CA 1.489 1.23 0 C-N-CA 121.752 1.635 . . . . 0.0 111.555 177.875 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' D' D ' 9' ' ' LEU . . . . . . . . . . . . . 84.9 mt -70.85 -48.81 14.59 Favored Pre-proline 0 C--N 1.329 -0.306 0 CA-C-O 119.143 -0.456 . . . . 0.0 111.045 -178.824 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' D' D ' 10' ' ' PRO . . . . . . . . . . . . . 95.6 Cg_endo -79.75 138.44 13.36 Favored 'Trans proline' 0 N--CA 1.495 1.57 0 C-N-CA 121.098 1.198 . . . . 0.0 111.228 169.398 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' D' D ' 11' ' ' LYS . . . . . . . . . . . . . 82.3 tttt -87.88 102.86 15.11 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-O 120.886 0.375 . . . . 0.0 110.472 -178.923 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' D' D ' 12' ' ' VAL . . . . . . . . . . . . . 12.1 p -140.77 147.86 22.43 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.248 0 CA-C-N 116.127 -0.488 . . . . 0.0 110.518 -179.391 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' D' D ' 13' ' ' GLU . . . . . . . . . . . . . 95.2 mt-10 -78.93 123.36 27.19 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 116.3 -0.409 . . . . 0.0 110.041 178.392 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' D' D ' 14' ' ' LEU . . . . . . . . . . . . . 21.8 mt -98.55 153.88 37.76 Favored Pre-proline 0 C--N 1.33 -0.24 0 CA-C-N 116.427 -0.351 . . . . 0.0 111.103 -178.072 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' D' D ' 15' ' ' PRO . . . . . . . . . . . . . 37.9 Cg_exo -59.72 158.8 26.85 Favored 'Trans proline' 0 N--CA 1.497 1.717 0 C-N-CA 121.359 1.373 . . . . 0.0 111.83 178.295 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' D' D ' 16' ' ' PRO . . . . . . . . . . . . . 26.4 Cg_exo -60.47 -37.96 77.21 Favored 'Trans proline' 0 N--CA 1.498 1.787 0 C-N-CA 121.424 1.416 . . . . 0.0 112.911 -177.347 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' D' D ' 17' ' ' ASP . . . . . . . . . . . . . 22.6 p-10 -89.93 11.01 21.71 Favored 'General case' 0 CA--C 1.537 0.464 0 N-CA-C 113.303 0.853 . . . . 0.0 113.303 -176.47 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' D' D ' 18' ' ' PHE . . . . . . . . . . . . . 51.2 t80 -57.97 -42.81 85.83 Favored 'General case' 0 C--O 1.227 -0.081 0 O-C-N 121.996 -0.44 . . . . 0.0 110.113 -178.933 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' D' D ' 19' ' ' VAL . . . . . . . . . . . . . 48.2 t -57.34 -41.22 77.93 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.306 0 CA-C-N 116.234 -0.439 . . . . 0.0 110.391 -178.624 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' D' D ' 20' ' ' ASP . . . . . . . . . . . . . 79.7 m-20 -59.9 -43.53 94.77 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-O 120.798 0.333 . . . . 0.0 110.876 -177.916 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' D' D ' 21' ' ' VAL . . . . . . . . . . . . . 45.4 t -64.63 -46.46 92.37 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.312 0 C-N-CA 120.719 -0.392 . . . . 0.0 110.527 -177.801 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' D' D ' 22' ' ' ILE . . . . . 0.646 HG22 HD12 ' D' ' 26' ' ' LEU . 50.3 mm -56.44 -45.6 81.86 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.276 0 CA-C-O 120.727 0.299 . . . . 0.0 110.571 179.215 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' D' D ' 23' ' ' ARG . . . . . . . . . . . . . 59.4 ttp180 -53.34 -49.7 66.56 Favored 'General case' 0 C--N 1.331 -0.224 0 CA-C-O 120.835 0.35 . . . . 0.0 111.412 -178.704 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' D' D ' 24' ' ' ILE . . . . . . . . . . . . . 72.9 mt -59.61 -45.76 93.83 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.262 0 CA-C-N 116.281 -0.418 . . . . 0.0 111.136 -177.32 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' D' D ' 25' ' ' LYS . . . . . . . . . . . . . 59.4 mtpt -65.32 -37.35 86.83 Favored 'General case' 0 C--N 1.33 -0.263 0 N-CA-C 112.354 0.502 . . . . 0.0 112.354 -177.121 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' D' D ' 26' ' ' LEU . . . . . 0.646 HD12 HG22 ' D' ' 22' ' ' ILE . 25.9 mt -78.25 -45.68 22.26 Favored 'General case' 0 C--N 1.329 -0.296 0 N-CA-C 112.979 0.733 . . . . 0.0 112.979 -172.781 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' D' D ' 27' ' ' GLN . . . . . . . . . . . . . 16.2 pt20 -46.89 138.52 6.29 Favored 'General case' 0 N--CA 1.468 0.452 0 N-CA-C 112.728 0.64 . . . . 0.0 112.728 -175.68 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' D' D ' 28' ' ' GLY . . . . . . . . . . . . . . . 100.89 -26.6 24.04 Favored Glycine 0 CA--C 1.534 1.223 0 CA-C-N 115.542 -0.754 . . . . 0.0 112.274 -176.596 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' D' D ' 29' ' ' LYS . . . . . . . . . . . . . 65.8 mttm -98.74 155.12 17.51 Favored 'General case' 0 C--N 1.332 -0.154 0 CA-C-N 117.261 0.53 . . . . 0.0 111.217 179.259 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' D' D ' 30' ' ' THR . . . . . . . . . . . . . 17.7 m -102.73 137.13 41.35 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.185 -0.461 . . . . 0.0 110.084 176.128 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' D' D ' 31' ' ' VAL . . . . . . . . . . . . . 33.8 m -130.87 156.88 43.04 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.263 0 CA-C-O 120.816 0.341 . . . . 0.0 110.857 -179.158 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' D' D ' 32' ' ' ARG . . . . . . . . . . . . . 60.9 ttt180 -134.62 150.0 50.63 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 115.992 -0.549 . . . . 0.0 110.218 178.283 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' D' D ' 33' ' ' THR . . . . . . . . . . . . . 31.7 m -52.38 140.17 22.79 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-O 120.826 0.346 . . . . 0.0 111.421 -177.737 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' D' D ' 34' ' ' GLY . . . . . . . . . . . . . . . 99.68 -17.1 57.99 Favored Glycine 0 CA--C 1.531 1.053 0 C-N-CA 121.199 -0.524 . . . . 0.0 113.286 179.105 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' D' D ' 35' ' ' ASP . . . . . . . . . . . . . 72.5 m-20 -65.16 149.1 50.49 Favored 'General case' 0 C--O 1.231 0.101 0 CA-C-N 118.086 0.943 . . . . 0.0 111.141 179.427 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' D' D ' 36' ' ' VAL . . . . . . . . . . . . . 46.1 t -123.1 131.13 73.81 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.223 0 CA-C-N 115.683 -0.69 . . . . 0.0 109.798 178.409 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' D' D ' 37' ' ' ILE . . . . . . . . . . . . . 71.5 mt -119.59 139.79 45.75 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.251 0 CA-C-N 116.166 -0.47 . . . . 0.0 109.958 -179.709 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' D' D ' 38' ' ' GLY . . . . . . . . . . . . . . . -113.01 128.74 8.55 Favored Glycine 0 CA--C 1.526 0.721 0 N-CA-C 111.051 -0.82 . . . . 0.0 111.051 179.492 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' D' D ' 39' ' ' ILE . . . . . . . . . . . . . 68.3 mt -123.28 133.65 68.53 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.185 0 N-CA-C 110.103 -0.332 . . . . 0.0 110.103 179.241 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' D' D ' 40' ' ' SER . . . . . . . . . . . . . 93.4 p -92.69 122.67 35.32 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.394 -0.366 . . . . 0.0 110.729 175.859 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' D' D ' 41' ' ' ILE . . . . . . . . . . . . . 68.2 mt -129.04 119.64 49.76 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.219 0 CA-C-O 120.754 0.312 . . . . 0.0 110.482 178.218 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' D' D ' 42' ' ' LEU . . . . . . . . . . . . . 10.4 tp 51.94 37.21 20.4 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.143 -0.48 . . . . 0.0 111.594 176.907 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' D' D ' 43' ' ' GLY . . . . . . . . . . . . . . . 72.96 30.13 63.84 Favored Glycine 0 CA--C 1.528 0.886 0 C-N-CA 121.007 -0.616 . . . . 0.0 112.34 177.512 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' D' D ' 44' ' ' LYS . . . . . . . . . . . . . 81.9 mttt -136.57 129.39 30.78 Favored 'General case' 0 C--N 1.329 -0.313 0 N-CA-C 109.667 -0.494 . . . . 0.0 109.667 177.925 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' D' D ' 45' ' ' GLU . . . . . . . . . . . . . 85.2 tt0 -83.56 123.42 29.74 Favored 'General case' 0 C--N 1.329 -0.3 0 C-N-CA 120.812 -0.355 . . . . 0.0 111.141 -177.854 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' D' D ' 46' ' ' VAL . . . . . . . . . . . . . 7.7 p -120.97 128.3 76.06 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.231 0 N-CA-C 109.481 -0.563 . . . . 0.0 109.481 175.972 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' D' D ' 47' ' ' LYS . . . . . . . . . . . . . 35.3 mtmm -102.11 129.72 48.52 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 115.809 -0.632 . . . . 0.0 111.645 -179.892 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' D' D ' 48' ' ' PHE . . . . . . . . . . . . . 88.3 m-85 -112.8 131.97 55.46 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.368 -0.378 . . . . 0.0 110.37 177.224 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' D' D ' 49' ' ' LYS . . . . . . . . . . . . . 60.5 tttt -106.01 137.39 44.0 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.517 -0.31 . . . . 0.0 110.576 178.796 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' D' D ' 50' ' ' VAL . . . . . . . . . . . . . 45.5 t -84.82 107.84 16.24 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.241 0 N-CA-C 109.198 -0.667 . . . . 0.0 109.198 174.735 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' D' D ' 51' ' ' VAL . . . . . . . . . . . . . 47.2 t -73.07 -47.61 47.1 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.302 0 CA-C-N 116.153 -0.476 . . . . 0.0 110.159 -173.099 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' D' D ' 52' ' ' GLN . . . . . . . . . . . . . 62.8 tt0 -161.4 139.18 9.16 Favored 'General case' 0 C--N 1.331 -0.226 0 C-N-CA 120.231 -0.588 . . . . 0.0 111.884 -177.321 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' D' D ' 53' ' ' ALA . . . . . . . . . . . . . . . -115.96 133.61 55.85 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 115.655 -0.702 . . . . 0.0 109.609 174.144 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' D' D ' 54' ' ' TYR . . . . . . . . . . . . . 44.3 t80 -128.94 110.77 18.49 Favored Pre-proline 0 CA--C 1.537 0.449 0 CA-C-O 118.112 -0.947 . . . . 0.0 110.489 -179.531 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' D' D ' 55' ' ' PRO . . . . . . . . . . . . . 73.6 Cg_endo -77.13 169.9 73.03 Favored 'Cis proline' 0 N--CA 1.5 1.869 0 CA-C-N 121.853 1.698 . . . . 0.0 112.155 -6.987 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' D' D ' 56' ' ' SER . . . . . . . . . . . . . 49.1 m -117.79 135.01 23.19 Favored Pre-proline 0 CA--C 1.54 0.574 0 CA-C-O 118.42 -0.8 . . . . 0.0 109.949 175.901 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' D' D ' 57' ' ' PRO . . . . . . . . . . . . . 38.3 Cg_endo -68.45 163.73 77.04 Favored 'Cis proline' 0 N--CA 1.498 1.773 0 CA-C-N 121.875 1.705 . . . . 0.0 111.361 -3.754 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' D' D ' 58' ' ' LEU . . . . . . . . . . . . . 37.4 tp -129.78 137.94 50.79 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-O 120.877 0.37 . . . . 0.0 110.595 -179.866 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' D' D ' 59' ' ' ARG . . . . . . . . . . . . . 62.0 ttm-85 -100.62 121.28 41.35 Favored 'General case' 0 C--N 1.326 -0.414 0 N-CA-C 109.142 -0.688 . . . . 0.0 109.142 174.593 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' D' D ' 60' ' ' VAL . . . . . . . . . . . . . 42.3 t -74.54 124.81 32.92 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 C-N-CA 120.778 -0.369 . . . . 0.0 110.391 -173.786 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' D' D ' 61' ' ' GLU . . . . . . . . . . . . . 70.5 mm-40 -131.01 163.39 27.68 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 115.913 -0.585 . . . . 0.0 109.868 177.569 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' D' D ' 62' ' ' ASP . . . . . . . . . . . . . 14.9 p-10 -55.67 -31.64 62.56 Favored 'General case' 0 C--N 1.328 -0.346 0 N-CA-C 111.749 0.278 . . . . 0.0 111.749 -178.898 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' D' D ' 63' ' ' ARG . . . . . . . . . . . . . 10.0 ptm180 -83.68 6.75 19.81 Favored 'General case' 0 CA--C 1.536 0.438 0 N-CA-C 113.553 0.946 . . . . 0.0 113.553 -176.121 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' D' D ' 64' ' ' THR . . . . . . . . . . . . . 29.3 m -85.64 139.68 31.2 Favored 'General case' 0 C--N 1.332 -0.184 0 CA-C-N 118.192 0.451 . . . . 0.0 110.651 -179.074 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' D' D ' 65' ' ' LYS . . . . . . . . . . . . . 38.1 mtmt -89.07 132.6 34.7 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.273 -0.421 . . . . 0.0 110.419 179.657 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' D' D ' 66' ' ' ILE . . . . . . . . . . . . . 61.6 mt -120.38 128.16 75.97 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.221 0 CA-C-N 116.366 -0.379 . . . . 0.0 110.046 -177.244 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' D' D ' 67' ' ' THR . . . . . . . . . . . . . 27.8 m -130.21 142.65 50.55 Favored 'General case' 0 C--N 1.332 -0.177 0 CA-C-O 120.978 0.418 . . . . 0.0 111.234 -178.638 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' D' D ' 68' ' ' LEU . . . . . 0.456 ' N ' HD12 ' D' ' 68' ' ' LEU . 7.2 mp . . . . . 0 C--N 1.329 -0.297 0 CA-C-N 116.049 -0.523 . . . . 0.0 110.65 177.827 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' D' D ' 73' ' ' VAL . . . . . . . . . . . . . 2.5 m . . . . . 0 N--CA 1.463 0.202 0 CA-C-O 120.98 0.419 . . . . 0.0 110.262 . . . . . . . . . 0 0 . 1 . 008 nuclear build core ' D' D ' 74' ' ' ASP . . . . . . . . . . . . . 15.3 t0 -99.06 118.81 36.67 Favored 'General case' 0 C--N 1.325 -0.497 0 N-CA-C 108.829 -0.804 . . . . 0.0 108.829 173.894 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' D' D ' 75' ' ' VAL . . . . . . . . . . . . . 47.8 t -110.19 122.04 64.07 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.218 0 CA-C-O 121.132 0.491 . . . . 0.0 110.671 -176.325 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' D' D ' 76' ' ' LEU . . . . . . . . . . . . . 5.1 mp -124.08 138.66 54.41 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 115.657 -0.701 . . . . 0.0 109.28 174.5 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' D' D ' 77' ' ' GLU . . . . . . . . . . . . . 69.3 tt0 -134.37 136.9 43.71 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-O 120.955 0.407 . . . . 0.0 110.803 -177.801 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' D' D ' 78' ' ' ALA . . . . . . . . . . . . . . . -121.52 138.59 54.23 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 115.959 -0.564 . . . . 0.0 110.434 178.774 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' D' D ' 79' ' ' LYS . . . . . 0.581 ' O ' HD13 ' D' ' 80' ' ' ILE . 7.6 ttpm? -77.75 115.38 17.46 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 116.438 -0.346 . . . . 0.0 110.419 179.582 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' D' D ' 80' ' ' ILE . . . . . 0.581 HD13 ' O ' ' D' ' 79' ' ' LYS . 42.1 mm -139.06 108.09 3.68 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.273 0 N-CA-C 109.328 -0.619 . . . . 0.0 109.328 -178.369 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' D' D ' 81' ' ' LYS . . . . . . . . . . . . . 55.1 pttt -106.76 129.82 54.57 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-O 120.921 0.391 . . . . 0.0 111.518 -176.33 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' D' D ' 82' ' ' GLY . . . . . . . . . . . . . . . 88.95 42.19 5.72 Favored Glycine 0 CA--C 1.526 0.778 0 N-CA-C 111.529 -0.628 . . . . 0.0 111.529 176.752 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' D' D ' 83' ' ' ILE . . . . . . . . . . . . . 73.3 mt -71.92 138.76 20.95 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.32 0 N-CA-C 109.718 -0.475 . . . . 0.0 109.718 178.064 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' D' D ' 84' ' ' LYS . . . . . . . . . . . . . 50.4 tttp -95.7 -53.87 3.56 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 116.023 -0.535 . . . . 0.0 110.207 -178.136 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' D' D ' 85' ' ' ASP . . . . . . . . . . . . . 8.3 t70 -152.55 152.26 31.66 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 115.795 -0.639 . . . . 0.0 110.14 -179.594 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' D' D ' 86' ' ' VAL . . . . . . . . . . . . . 46.6 t -127.74 129.07 70.01 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.224 0 CA-C-O 120.883 0.373 . . . . 0.0 110.44 -179.041 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' D' D ' 87' ' ' ILE . . . . . . . . . . . . . 44.5 mm -117.97 127.5 75.2 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.217 0 CA-C-N 115.941 -0.572 . . . . 0.0 109.461 176.682 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' D' D ' 88' ' ' LEU . . . . . . . . . . . . . 12.5 tp -113.98 131.63 56.26 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-O 120.998 0.427 . . . . 0.0 111.154 -176.861 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' D' D ' 89' ' ' ASP . . . . . . . . . . . . . 13.8 t70 -123.88 152.08 42.76 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 115.78 -0.646 . . . . 0.0 109.432 176.837 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' D' D ' 90' ' ' GLU . . . . . . . . . . . . . 46.2 tp10 -47.84 -36.85 12.65 Favored 'General case' 0 CA--C 1.531 0.242 0 N-CA-C 112.735 0.643 . . . . 0.0 112.735 -172.967 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' D' D ' 91' ' ' ASN . . . . . . . . . . . . . 28.7 m120 -132.02 32.39 4.04 Favored 'General case' 0 N--CA 1.466 0.338 0 C-N-CA 120.846 -0.342 . . . . 0.0 111.916 -176.508 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' D' D ' 92' ' ' LEU . . . . . . . . . . . . . 9.7 tp -166.11 148.14 6.97 Favored 'General case' 0 C--N 1.329 -0.291 0 C-N-CA 121.008 -0.277 . . . . 0.0 110.591 -179.839 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' D' D ' 93' ' ' ILE . . . . . . . . . . . . . 64.1 mt -127.06 124.54 64.68 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.284 0 N-CA-C 109.58 -0.526 . . . . 0.0 109.58 -179.356 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' D' D ' 94' ' ' VAL . . . . . 0.624 HG21 HG11 ' D' ' 125' ' ' VAL . 46.7 t -124.08 127.74 73.64 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.234 0 CA-C-O 121.004 0.431 . . . . 0.0 110.181 179.99 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' D' D ' 95' ' ' VAL . . . . . . . . . . . . . 44.6 t -121.88 135.47 61.9 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.261 0 CA-C-N 116.054 -0.521 . . . . 0.0 109.931 179.984 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' D' D ' 96' ' ' ILE . . . . . . . . . . . . . 66.2 mt -116.3 129.49 72.64 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 N-CA-C 109.356 -0.609 . . . . 0.0 109.356 178.82 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' D' D ' 97' ' ' THR . . . . . . . . . . . . . 79.6 p -100.0 158.48 15.8 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-O 121.02 0.438 . . . . 0.0 111.105 -177.334 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' D' D ' 98' ' ' GLU . . . . . . . . . . . . . 97.1 mt-10 -54.06 -26.36 26.43 Favored 'General case' 0 C--N 1.329 -0.288 0 N-CA-C 112.219 0.451 . . . . 0.0 112.219 -179.795 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' D' D ' 99' ' ' GLU . . . . . . . . . . . . . 41.0 mt-10 -80.04 16.85 1.1 Allowed 'General case' 0 CA--C 1.536 0.412 0 N-CA-C 112.99 0.737 . . . . 0.0 112.99 -177.759 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' D' D ' 100' ' ' ASN . . . . . . . . . . . . . 3.3 m-20 63.16 37.94 10.99 Favored 'General case' 0 N--CA 1.463 0.197 0 CA-C-O 121.05 0.452 . . . . 0.0 111.085 177.453 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' D' D ' 101' ' ' GLU . . . . . . . . . . . . . 98.2 mt-10 -112.18 146.0 38.87 Favored 'General case' 0 C--N 1.332 -0.162 0 CA-C-N 116.2 -0.455 . . . . 0.0 110.419 174.981 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' D' D ' 102' ' ' VAL . . . . . 0.449 ' C ' HD12 ' D' ' 103' ' ' LEU . 45.3 t -117.01 127.18 74.69 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.363 0 CA-C-N 115.762 -0.654 . . . . 0.0 109.606 179.134 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' D' D ' 103' ' ' LEU . . . . . 0.449 HD12 ' C ' ' D' ' 102' ' ' VAL . 7.4 mp -119.45 129.76 54.92 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 115.883 -0.599 . . . . 0.0 110.207 175.716 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' D' D ' 104' ' ' ILE . . . . . . . . . . . . . 73.8 mt -114.13 122.22 67.81 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.335 0 CA-C-N 116.024 -0.534 . . . . 0.0 109.885 -179.341 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' D' D ' 105' ' ' PHE . . . . . . . . . . . . . 85.8 m-85 -119.23 160.03 22.94 Favored 'General case' 0 C--N 1.331 -0.229 0 O-C-N 124.17 0.919 . . . . 0.0 109.894 179.96 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' D' D ' 106' ' ' ASN . . . . . . . . . . . . . 42.8 p-10 -95.04 -170.22 2.15 Favored 'General case' 0 C--N 1.329 -0.321 0 N-CA-C 109.557 -0.534 . . . . 0.0 109.557 172.799 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' D' D ' 107' ' ' GLN . . . . . . . . . . . . . 58.2 tt0 -61.07 -25.57 67.03 Favored 'General case' 0 C--N 1.329 -0.314 0 N-CA-C 112.123 0.416 . . . . 0.0 112.123 178.54 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' D' D ' 108' ' ' ASN . . . . . . . . . . . . . 5.7 t-20 -83.66 3.2 33.93 Favored 'General case' 0 CA--C 1.538 0.518 0 N-CA-C 113.133 0.79 . . . . 0.0 113.133 -178.703 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' D' D ' 109' ' ' LEU . . . . . . . . . . . . . 9.1 tp 62.86 37.23 12.35 Favored 'General case' 0 C--O 1.232 0.151 0 CA-C-O 120.945 0.402 . . . . 0.0 111.36 179.39 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' D' D ' 110' ' ' GLU . . . . . . . . . . . . . 96.3 mt-10 -106.82 149.95 26.86 Favored 'General case' 0 C--N 1.331 -0.216 0 N-CA-C 110.025 -0.361 . . . . 0.0 110.025 176.458 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' D' D ' 111' ' ' GLU . . . . . . . . . . . . . 43.0 tp10 -79.67 121.98 25.98 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-O 121.114 0.483 . . . . 0.0 110.803 -176.889 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' D' D ' 112' ' ' LEU . . . . . . . . . . . . . 28.4 mt -103.93 -46.08 4.58 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 115.747 -0.661 . . . . 0.0 110.119 176.541 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' D' D ' 113' ' ' TYR . . . . . . . . . . . . . 65.2 t80 -142.53 135.5 28.37 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.226 -0.443 . . . . 0.0 111.33 -179.614 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' D' D ' 114' ' ' ARG . . . . . . . . . . . . . 79.0 ttt-85 -139.98 121.94 15.62 Favored 'General case' 0 C--N 1.331 -0.229 0 CA-C-N 116.321 -0.399 . . . . 0.0 110.121 177.17 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' D' D ' 115' ' ' GLY . . . . . . . . . . . . . . . -150.15 161.98 29.07 Favored Glycine 0 CA--C 1.525 0.656 0 N-CA-C 110.982 -0.847 . . . . 0.0 110.982 -178.761 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' D' D ' 116' ' ' LYS . . . . . . . . . . . . . 39.0 ttpt -120.08 137.32 54.2 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-O 120.741 0.305 . . . . 0.0 110.307 178.622 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' D' D ' 117' ' ' PHE . . . . . . . . . . . . . 31.6 m-85 -133.39 113.95 13.13 Favored 'General case' 0 C--N 1.33 -0.244 0 N-CA-C 109.859 -0.423 . . . . 0.0 109.859 179.224 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' D' D ' 118' ' ' GLU . . . . . . . . . . . . . 95.9 mt-10 -55.72 -44.8 77.83 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.33 -0.396 . . . . 0.0 111.228 -174.898 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' D' D ' 119' ' ' ASN . . . . . . . . . . . . . 20.2 m120 -95.89 30.93 2.23 Favored 'General case' 0 C--N 1.33 -0.275 0 N-CA-C 112.132 0.419 . . . . 0.0 112.132 -174.11 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' D' D ' 120' ' ' LEU . . . . . . . . . . . . . 13.3 tp -57.35 119.74 6.99 Favored 'General case' 0 C--N 1.334 -0.083 0 C-N-CA 120.984 -0.287 . . . . 0.0 110.259 178.078 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' D' D ' 121' ' ' ASN . . . . . . . . . . . . . 73.4 m-20 -114.12 -44.06 3.17 Favored 'General case' 0 C--N 1.332 -0.156 0 CA-C-N 116.409 -0.359 . . . . 0.0 111.118 -178.405 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' D' D ' 122' ' ' LYS . . . . . . . . . . . . . 63.1 mtpt -141.96 148.73 39.09 Favored 'General case' 0 C--N 1.331 -0.219 0 CA-C-O 121.079 0.466 . . . . 0.0 111.607 -176.611 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' D' D ' 123' ' ' VAL . . . . . . . . . . . . . 43.9 t -131.53 125.9 57.1 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.252 0 CA-C-N 115.854 -0.612 . . . . 0.0 109.512 174.565 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' D' D ' 124' ' ' LEU . . . . . . . . . . . . . 49.7 mt -122.79 137.46 54.92 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-O 120.74 0.305 . . . . 0.0 110.697 -178.157 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' D' D ' 125' ' ' VAL . . . . . 0.624 HG11 HG21 ' D' ' 94' ' ' VAL . 34.8 m -129.69 130.1 66.69 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.25 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.789 179.735 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' D' D ' 126' ' ' ARG . . . . . . . . . . . . . 83.0 mtt180 -144.94 118.96 9.37 Favored 'General case' 0 C--N 1.328 -0.348 0 N-CA-C 109.56 -0.533 . . . . 0.0 109.56 177.164 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' D' D ' 127' ' ' ASN . . . . . . . . . . . . . 30.8 m120 56.73 -149.05 0.47 Allowed 'General case' 0 CA--C 1.54 0.596 0 N-CA-C 109.648 -0.501 . . . . 0.0 109.648 -178.229 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' D' D ' 128' ' ' ASP . . . . . . . . . . . . . 23.3 p-10 -82.41 12.96 3.92 Favored 'General case' 0 CA--C 1.536 0.429 0 CA-C-N 118.773 0.715 . . . . 0.0 112.88 178.364 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' D' D ' 129' ' ' LEU . . . . . . . . . . . . . 16.1 tp -108.64 134.98 50.64 Favored 'General case' 0 C--O 1.233 0.196 0 CA-C-N 118.261 0.482 . . . . 0.0 110.088 178.637 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' D' D ' 130' ' ' VAL . . . . . . . . . . . . . 44.0 t -126.26 141.36 46.05 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.303 0 CA-C-O 120.929 0.395 . . . . 0.0 110.623 -177.539 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' D' D ' 131' ' ' VAL . . . . . . . . . . . . . 42.6 t -133.63 133.99 56.8 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.305 0 CA-C-N 116.049 -0.523 . . . . 0.0 110.126 177.994 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' D' D ' 132' ' ' ILE . . . . . . . . . . . . . 65.8 mt -118.41 134.0 63.42 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.343 0 N-CA-C 109.364 -0.606 . . . . 0.0 109.364 178.834 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' D' D ' 133' ' ' ILE . . . . . . . . . . . . . 37.6 mm -117.14 123.56 71.96 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.254 0 CA-C-O 120.619 0.247 . . . . 0.0 111.122 -174.367 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' D' D ' 134' ' ' ASP . . . . . . . . . . . . . 9.8 p-10 -135.82 147.62 48.36 Favored 'General case' 0 C--N 1.331 -0.202 0 N-CA-C 109.537 -0.542 . . . . 0.0 109.537 173.295 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' D' D ' 135' ' ' GLU . . . . . . . . . . . . . 85.2 tt0 -49.9 -27.7 5.58 Favored 'General case' 0 C--N 1.328 -0.356 0 N-CA-C 112.89 0.7 . . . . 0.0 112.89 -170.184 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' D' D ' 136' ' ' GLN . . . . . . . . . . . . . 98.0 mt-30 -82.21 -40.03 22.26 Favored 'General case' 0 C--O 1.235 0.297 0 N-CA-C 112.185 0.439 . . . . 0.0 112.185 -176.92 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' D' D ' 137' ' ' LYS . . . . . . . . . . . . . 56.6 pttt -156.73 167.04 31.66 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-O 121.523 0.678 . . . . 0.0 112.294 -169.745 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' D' D ' 138' ' ' LEU . . . . . . . . . . . . . 6.0 tt -116.24 127.74 55.01 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 115.06 -0.973 . . . . 0.0 109.664 178.156 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' D' D ' 139' ' ' THR . . . . . . . . . . . . . 29.0 m -106.71 126.62 52.52 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-N 116.281 -0.418 . . . . 0.0 110.712 -178.313 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' D' D ' 140' ' ' LEU . . . . . . . . . . . . . 21.1 tp -111.51 122.83 48.86 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 115.664 -0.698 . . . . 0.0 109.191 179.553 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' D' D ' 141' ' ' ILE . . . . . . . . . . . . . 19.5 mt -121.16 118.89 57.61 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.279 0 N-CA-C 109.87 -0.419 . . . . 0.0 109.87 -174.664 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' D' D ' 142' ' ' ARG . . . . . . . . . . . . . 48.5 mtm180 -109.0 127.97 54.55 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 115.481 -0.781 . . . . 0.0 110.098 -178.527 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' D' D ' 143' ' ' THR . . . . . . . . . . . . . 6.9 p . . . . . 0 C--O 1.22 -0.497 0 CA-C-O 117.989 -1.005 . . . . 0.0 110.61 -179.472 . . . . . . . . 0 0 . 1 . 008 nuclear build core ' E' E ' 2' ' ' SER . . . . . . . . . . . . . 2.9 p . . . . . 0 C--O 1.231 0.107 0 CA-C-O 120.99 0.424 . . . . 0.0 110.449 . . . . . . . . . 0 0 . 1 . 008 nuclear build core ' E' E ' 3' ' ' GLU . . . . . . . . . . . . . 84.7 tt0 -141.99 141.59 32.88 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.089 -0.505 . . . . 0.0 111.06 -179.302 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' E' E ' 4' ' ' LEU . . . . . . . . . . . . . 17.0 tp -126.12 126.86 44.85 Favored 'General case' 0 C--N 1.332 -0.195 0 CA-C-N 116.136 -0.483 . . . . 0.0 110.257 177.664 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' E' E ' 5' ' ' LYS . . . . . . . . . . . . . 61.6 mttp -107.06 121.39 44.39 Favored 'General case' 0 C--O 1.235 0.319 0 CA-C-N 116.251 -0.431 . . . . 0.0 110.7 178.5 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' E' E ' 6' ' ' LEU . . . . . . . . . . . . . 72.6 mt -116.84 146.25 43.02 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 115.326 -0.852 . . . . 0.0 110.46 -178.784 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' E' E ' 7' ' ' LYS . . . . . . . . . . . . . 55.6 tttm -135.24 139.75 32.55 Favored Pre-proline 0 CA--C 1.534 0.351 0 CA-C-O 119.135 -0.459 . . . . 0.0 110.361 176.927 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' E' E ' 8' ' ' PRO . . . . . . . . . . . . . 84.7 Cg_endo -91.85 139.46 2.19 Favored 'Trans proline' 0 N--CA 1.489 1.262 0 C-N-CA 121.694 1.596 . . . . 0.0 111.632 176.602 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' E' E ' 9' ' ' LEU . . . . . . . . . . . . . 38.7 mt -76.03 -48.4 3.52 Favored Pre-proline 0 CA--C 1.534 0.363 0 CA-C-O 118.631 -0.7 . . . . 0.0 112.569 -178.036 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' E' E ' 10' ' ' PRO . . . . . . . . . . . . . 91.3 Cg_endo -80.06 157.13 23.49 Favored 'Trans proline' 0 N--CA 1.497 1.723 0 C-N-CA 121.315 1.343 . . . . 0.0 111.912 178.126 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' E' E ' 11' ' ' LYS . . . . . . . . . . . . . 17.4 pttp -83.17 112.54 19.93 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-O 121.55 0.691 . . . . 0.0 110.428 176.84 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' E' E ' 12' ' ' VAL . . . . . . . . . . . . . 12.5 p -151.13 151.19 12.65 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.248 0 CA-C-N 115.629 -0.714 . . . . 0.0 110.58 -178.769 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' E' E ' 13' ' ' GLU . . . . . . . . . . . . . 96.5 mt-10 -97.71 121.68 39.9 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.3 -0.409 . . . . 0.0 110.351 177.679 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' E' E ' 14' ' ' LEU . . . . . . . . . . . . . 39.4 mt -98.45 137.65 20.72 Favored Pre-proline 0 CA--C 1.534 0.351 0 CA-C-O 118.808 -0.615 . . . . 0.0 110.213 -179.377 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' E' E ' 15' ' ' PRO . . . . . . . . . . . . . 25.3 Cg_exo -62.59 162.24 25.25 Favored 'Trans proline' 0 N--CA 1.498 1.765 0 C-N-CA 121.299 1.333 . . . . 0.0 112.013 176.942 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' E' E ' 16' ' ' PRO . . . . . . . . . . . . . 28.1 Cg_exo -59.95 -32.71 95.48 Favored 'Trans proline' 0 N--CA 1.497 1.691 0 C-N-CA 121.568 1.512 . . . . 0.0 112.931 -178.219 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' E' E ' 17' ' ' ASP . . . . . . . . . . . . . 10.1 p-10 -81.52 -3.93 54.54 Favored 'General case' 0 CA--C 1.535 0.383 0 N-CA-C 113.357 0.873 . . . . 0.0 113.357 -177.451 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' E' E ' 18' ' ' PHE . . . . . . . . . . . . . 30.0 t80 -56.62 -44.49 81.24 Favored 'General case' 0 C--N 1.334 -0.09 0 O-C-N 121.885 -0.509 . . . . 0.0 110.242 -179.182 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' E' E ' 19' ' ' VAL . . . . . . . . . . . . . 14.4 p -57.38 -40.67 75.66 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.329 0 CA-C-N 116.346 -0.388 . . . . 0.0 110.698 -179.707 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' E' E ' 20' ' ' ASP . . . . . . . . . . . . . 8.2 t70 -60.33 -42.74 96.29 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-O 120.921 0.391 . . . . 0.0 110.781 -177.827 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' E' E ' 21' ' ' VAL . . . . . . . . . . . . . 46.4 t -64.46 -47.33 89.78 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.297 0 CA-C-N 116.331 -0.395 . . . . 0.0 110.476 -177.751 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' E' E ' 22' ' ' ILE . . . . . 0.448 HG22 HD12 ' E' ' 26' ' ' LEU . 49.1 mm -57.5 -42.04 80.11 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.362 0 C-N-CA 120.934 -0.306 . . . . 0.0 110.673 -179.633 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' E' E ' 23' ' ' ARG . . . . . . . . . . . . . 61.9 ttp180 -54.8 -51.09 66.87 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-O 120.981 0.42 . . . . 0.0 110.9 178.935 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' E' E ' 24' ' ' ILE . . . . . . . . . . . . . 73.0 mt -60.85 -41.64 89.47 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.355 0 CA-C-N 115.92 -0.582 . . . . 0.0 111.764 -176.564 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' E' E ' 25' ' ' LYS . . . . . . . . . . . . . 15.1 ptpt -70.39 -39.64 74.4 Favored 'General case' 0 CA--C 1.535 0.373 0 N-CA-C 112.174 0.435 . . . . 0.0 112.174 -174.804 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' E' E ' 26' ' ' LEU . . . . . 0.448 HD12 HG22 ' E' ' 22' ' ' ILE . 15.4 mt -78.87 -39.27 35.61 Favored 'General case' 0 C--N 1.33 -0.278 0 N-CA-C 113.268 0.84 . . . . 0.0 113.268 -171.291 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' E' E ' 27' ' ' GLN . . . . . . . . . . . . . 16.1 pt20 -47.0 135.69 9.21 Favored 'General case' 0 N--CA 1.469 0.499 0 N-CA-C 112.763 0.653 . . . . 0.0 112.763 -175.13 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' E' E ' 28' ' ' GLY . . . . . . . . . . . . . . . 101.05 -24.02 33.44 Favored Glycine 0 CA--C 1.534 1.259 0 CA-C-N 115.606 -0.725 . . . . 0.0 112.378 -176.784 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' E' E ' 29' ' ' LYS . . . . . . . . . . . . . 91.8 mttt -98.82 155.17 17.51 Favored 'General case' 0 C--O 1.233 0.208 0 CA-C-N 117.443 0.622 . . . . 0.0 111.311 179.534 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' E' E ' 30' ' ' THR . . . . . . . . . . . . . 28.8 m -109.39 138.57 45.55 Favored 'General case' 0 C--N 1.331 -0.209 0 CA-C-N 116.27 -0.423 . . . . 0.0 110.005 175.841 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' E' E ' 31' ' ' VAL . . . . . . . . . . . . . 34.5 m -132.13 160.92 42.16 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.22 0 CA-C-N 116.392 -0.367 . . . . 0.0 110.857 -178.95 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' E' E ' 32' ' ' ARG . . . . . . . . . . . . . 63.5 mtt85 -130.44 149.04 52.3 Favored 'General case' 0 C--N 1.332 -0.19 0 CA-C-O 121.199 0.523 . . . . 0.0 110.667 177.303 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' E' E ' 33' ' ' THR . . . . . . . . . . . . . 31.5 m -53.59 141.38 25.91 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.129 -0.487 . . . . 0.0 111.259 -179.581 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' E' E ' 34' ' ' GLY . . . . . . . . . . . . . . . 99.28 -17.16 58.27 Favored Glycine 0 CA--C 1.533 1.2 0 CA-C-O 119.643 -0.532 . . . . 0.0 113.156 179.874 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' E' E ' 35' ' ' ASP . . . . . . . . . . . . . 78.8 m-20 -66.5 147.72 52.9 Favored 'General case' 0 C--O 1.232 0.145 0 CA-C-N 118.026 0.913 . . . . 0.0 110.999 178.163 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' E' E ' 36' ' ' VAL . . . . . . . . . . . . . 46.9 t -119.85 129.78 74.99 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.212 0 CA-C-N 115.829 -0.623 . . . . 0.0 109.829 178.611 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' E' E ' 37' ' ' ILE . . . . . . . . . . . . . 66.7 mt -120.13 138.18 51.55 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.269 0 N-CA-C 109.748 -0.464 . . . . 0.0 109.748 179.833 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' E' E ' 38' ' ' GLY . . . . . . . . . . . . . . . -113.77 128.78 8.46 Favored Glycine 0 CA--C 1.524 0.624 0 N-CA-C 111.389 -0.684 . . . . 0.0 111.389 -179.024 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' E' E ' 39' ' ' ILE . . . . . . . . . . . . . 71.2 mt -122.51 126.74 74.52 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.24 0 N-CA-C 109.747 -0.464 . . . . 0.0 109.747 177.336 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' E' E ' 40' ' ' SER . . . . . . . . . . . . . 43.1 t -92.16 119.51 31.88 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.442 -0.344 . . . . 0.0 110.786 177.162 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' E' E ' 41' ' ' ILE . . . . . . . . . . . . . 71.8 mt -131.47 123.9 53.55 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.225 0 N-CA-C 110.052 -0.351 . . . . 0.0 110.052 178.594 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' E' E ' 42' ' ' LEU . . . . . . . . . . . . . 82.6 mt 57.8 33.74 23.58 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.2 -0.455 . . . . 0.0 111.87 178.485 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' E' E ' 43' ' ' GLY . . . . . . . . . . . . . . . 77.87 -10.15 27.25 Favored Glycine 0 CA--C 1.535 1.306 0 C-N-CA 121.274 -0.489 . . . . 0.0 113.431 177.79 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' E' E ' 44' ' ' LYS . . . . . . . . . . . . . 62.8 tttm -98.78 127.24 44.65 Favored 'General case' 0 C--O 1.232 0.138 0 CA-C-N 117.808 0.804 . . . . 0.0 109.696 176.723 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' E' E ' 45' ' ' GLU . . . . . . . . . . . . . 39.2 tp10 -84.76 126.84 33.77 Favored 'General case' 0 C--N 1.328 -0.336 0 C-N-CA 120.811 -0.356 . . . . 0.0 110.662 -179.935 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' E' E ' 46' ' ' VAL . . . . . . . . . . . . . 7.6 p -117.09 128.71 74.41 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.199 0 N-CA-C 109.368 -0.604 . . . . 0.0 109.368 176.585 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' E' E ' 47' ' ' LYS . . . . . . . . . . . . . 64.6 mttp -100.32 129.35 46.29 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 115.884 -0.598 . . . . 0.0 111.142 179.052 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' E' E ' 48' ' ' PHE . . . . . . . . . . . . . 93.5 m-85 -112.19 131.86 55.23 Favored 'General case' 0 C--N 1.33 -0.27 0 N-CA-C 109.604 -0.517 . . . . 0.0 109.604 175.889 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' E' E ' 49' ' ' LYS . . . . . . . . . . . . . 52.5 tttp -108.05 135.46 49.37 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 116.434 -0.348 . . . . 0.0 110.332 179.244 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' E' E ' 50' ' ' VAL . . . . . . . . . . . . . 46.2 t -78.43 106.53 9.29 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.281 0 N-CA-C 108.954 -0.758 . . . . 0.0 108.954 175.317 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' E' E ' 51' ' ' VAL . . . . . . . . . . . . . 51.5 t -71.74 -47.05 58.89 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.319 0 CA-C-N 116.18 -0.464 . . . . 0.0 110.106 -172.98 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' E' E ' 52' ' ' GLN . . . . . . . . . . . . . 46.9 tt0 -163.5 136.86 5.6 Favored 'General case' 0 C--N 1.329 -0.297 0 C-N-CA 120.175 -0.61 . . . . 0.0 111.834 -178.281 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' E' E ' 53' ' ' ALA . . . . . . . . . . . . . . . -113.01 134.36 54.55 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 115.721 -0.672 . . . . 0.0 109.699 174.566 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' E' E ' 54' ' ' TYR . . . . . . . . . . . . . 24.8 t80 -129.03 111.28 18.4 Favored Pre-proline 0 CA--C 1.536 0.419 0 CA-C-O 118.17 -0.919 . . . . 0.0 110.555 -179.889 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' E' E ' 55' ' ' PRO . . . . . . . . . . . . . 73.6 Cg_endo -77.08 168.8 76.03 Favored 'Cis proline' 0 N--CA 1.501 1.946 0 CA-C-N 121.899 1.714 . . . . 0.0 112.068 -7.245 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' E' E ' 56' ' ' SER . . . . . . . . . . . . . 27.0 m -115.04 131.27 23.61 Favored Pre-proline 0 CA--C 1.539 0.525 0 CA-C-O 118.456 -0.783 . . . . 0.0 109.533 176.24 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' E' E ' 57' ' ' PRO . . . . . . . . . . . . . 36.5 Cg_endo -66.6 164.17 68.67 Favored 'Cis proline' 0 N--CA 1.496 1.671 0 CA-C-N 121.957 1.734 . . . . 0.0 111.503 -1.501 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' E' E ' 58' ' ' LEU . . . . . . . . . . . . . 28.7 tp -129.45 135.47 48.7 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.436 -0.347 . . . . 0.0 110.623 -179.693 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' E' E ' 59' ' ' ARG . . . . . . . . . . . . . 73.5 ttt-85 -103.21 127.2 50.59 Favored 'General case' 0 C--N 1.327 -0.4 0 N-CA-C 109.028 -0.73 . . . . 0.0 109.028 175.504 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' E' E ' 60' ' ' VAL . . . . . . . . . . . . . 40.1 t -87.41 124.39 40.75 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.305 0 C-N-CA 120.767 -0.373 . . . . 0.0 110.878 -173.071 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' E' E ' 61' ' ' GLU . . . . . . . . . . . . . 40.6 mt-10 -131.01 166.52 20.82 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.01 -0.541 . . . . 0.0 109.703 176.002 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' E' E ' 62' ' ' ASP . . . . . . . . . . . . . 5.5 t70 -53.57 -32.92 52.87 Favored 'General case' 0 C--N 1.329 -0.318 0 N-CA-C 111.746 0.276 . . . . 0.0 111.746 -179.166 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' E' E ' 63' ' ' ARG . . . . . . . . . . . . . 35.2 mmt180 -73.51 -19.07 61.02 Favored 'General case' 0 N--CA 1.465 0.318 0 N-CA-C 113.023 0.749 . . . . 0.0 113.023 -176.863 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' E' E ' 64' ' ' THR . . . . . . . . . . . . . 25.0 m -66.23 141.9 57.89 Favored 'General case' 0 C--N 1.331 -0.2 0 CA-C-O 120.862 0.363 . . . . 0.0 110.876 -174.935 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' E' E ' 65' ' ' LYS . . . . . . . . . . . . . 92.1 mttt -87.83 128.71 35.34 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 115.995 -0.548 . . . . 0.0 109.893 178.285 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' E' E ' 66' ' ' ILE . . . . . . . . . . . . . 51.7 mt -116.18 131.24 69.27 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 N-CA-C 110.036 -0.357 . . . . 0.0 110.036 179.82 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' E' E ' 67' ' ' THR . . . . . . . . . . . . . 22.5 m -127.26 135.82 51.13 Favored 'General case' 0 C--N 1.332 -0.157 0 CA-C-O 121.036 0.446 . . . . 0.0 110.948 -179.89 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' E' E ' 68' ' ' LEU . . . . . . . . . . . . . 32.8 mt . . . . . 0 C--N 1.329 -0.283 0 CA-C-N 115.938 -0.574 . . . . 0.0 110.337 176.918 . . . . . . . . 0 0 . 1 . 008 nuclear build core ' E' E ' 73' ' ' VAL . . . . . . . . . . . . . 33.5 m . . . . . 0 N--CA 1.465 0.281 0 CA-C-O 121.019 0.438 . . . . 0.0 110.784 . . . . . . . . . 0 0 . 1 . 008 nuclear build core ' E' E ' 74' ' ' ASP . . . . . . . . . . . . . 5.0 t70 -100.13 120.12 39.38 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 115.859 -0.609 . . . . 0.0 109.795 -178.613 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' E' E ' 75' ' ' VAL . . . . . . . . . . . . . 44.0 t -119.75 126.4 75.27 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.246 0 CA-C-O 121.014 0.435 . . . . 0.0 110.749 -176.262 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' E' E ' 76' ' ' LEU . . . . . . . . . . . . . 5.9 mp -124.03 149.65 45.83 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 115.671 -0.695 . . . . 0.0 109.683 175.503 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' E' E ' 77' ' ' GLU . . . . . . . . . . . . . 96.2 mt-10 -136.01 131.54 35.14 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-O 121.022 0.439 . . . . 0.0 110.989 -178.646 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' E' E ' 78' ' ' ALA . . . . . . . . . . . . . . . -115.12 140.8 48.77 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 115.71 -0.677 . . . . 0.0 109.822 177.367 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' E' E ' 79' ' ' LYS . . . . . 0.58 ' O ' HD13 ' E' ' 80' ' ' ILE . 69.4 mttm -87.99 116.73 26.36 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-O 120.846 0.355 . . . . 0.0 111.223 -176.442 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' E' E ' 80' ' ' ILE . . . . . 0.58 HD13 ' O ' ' E' ' 79' ' ' LYS . 40.1 mm -139.19 102.32 1.69 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.312 0 N-CA-C 109.074 -0.713 . . . . 0.0 109.074 179.438 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' E' E ' 81' ' ' LYS . . . . . . . . . . . . . 41.0 tttp -91.3 126.15 36.29 Favored 'General case' 0 C--N 1.328 -0.351 0 C-N-CA 120.695 -0.402 . . . . 0.0 110.892 -177.171 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' E' E ' 82' ' ' GLY . . . . . . . . . . . . . . . 89.12 42.08 5.69 Favored Glycine 0 CA--C 1.524 0.629 0 C-N-CA 120.885 -0.674 . . . . 0.0 111.721 176.038 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' E' E ' 83' ' ' ILE . . . . . . . . . . . . . 72.6 mt -69.61 137.95 23.12 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.37 0 N-CA-C 109.711 -0.478 . . . . 0.0 109.711 177.027 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' E' E ' 84' ' ' LYS . . . . . . . . . . . . . 38.9 ttpt -100.87 -49.27 4.19 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-O 120.752 0.31 . . . . 0.0 110.234 -179.378 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' E' E ' 85' ' ' ASP . . . . . . . . . . . . . 9.0 t70 -151.85 154.06 35.42 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.243 -0.435 . . . . 0.0 110.7 -178.771 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' E' E ' 86' ' ' VAL . . . . . . . . . . . . . 44.6 t -132.57 136.36 56.14 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.22 0 CA-C-O 121.003 0.43 . . . . 0.0 110.392 -179.812 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' E' E ' 87' ' ' ILE . . . . . . . . . . . . . 47.4 mm -122.74 128.14 75.15 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.289 0 CA-C-N 115.71 -0.677 . . . . 0.0 109.674 178.919 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' E' E ' 88' ' ' LEU . . . . . . . . . . . . . 70.3 mt -111.99 136.52 51.22 Favored 'General case' 0 C--N 1.332 -0.185 0 CA-C-O 121.094 0.473 . . . . 0.0 111.396 -177.759 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' E' E ' 89' ' ' ASP . . . . . . . . . . . . . 9.5 t70 -127.2 154.87 44.28 Favored 'General case' 0 C--N 1.33 -0.274 0 N-CA-C 109.067 -0.716 . . . . 0.0 109.067 175.576 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' E' E ' 90' ' ' GLU . . . . . . . . . . . . . 82.9 tt0 -48.04 -34.32 9.34 Favored 'General case' 0 C--N 1.331 -0.235 0 N-CA-C 112.933 0.716 . . . . 0.0 112.933 -171.74 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' E' E ' 91' ' ' ASN . . . . . . . . . . . . . 13.6 p30 -131.99 18.25 4.59 Favored 'General case' 0 N--CA 1.468 0.454 0 N-CA-C 113.207 0.818 . . . . 0.0 113.207 -177.717 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' E' E ' 92' ' ' LEU . . . . . . . . . . . . . 25.3 mt -146.98 151.08 36.39 Favored 'General case' 0 C--N 1.332 -0.175 0 CA-C-N 117.861 0.301 . . . . 0.0 110.404 -177.069 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' E' E ' 93' ' ' ILE . . . . . . . . . . . . . 67.1 mt -127.1 121.73 58.49 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.213 0 N-CA-C 109.43 -0.582 . . . . 0.0 109.43 178.189 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' E' E ' 94' ' ' VAL . . . . . . . . . . . . . 45.9 t -120.62 129.91 75.1 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.291 0 CA-C-O 120.889 0.376 . . . . 0.0 110.013 -179.816 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' E' E ' 95' ' ' VAL . . . . . . . . . . . . . 44.3 t -122.7 136.0 60.94 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 CA-C-N 116.015 -0.539 . . . . 0.0 109.867 -179.562 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' E' E ' 96' ' ' ILE . . . . . . . . . . . . . 63.1 mt -118.26 127.18 75.41 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.232 0 N-CA-C 109.402 -0.592 . . . . 0.0 109.402 178.896 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' E' E ' 97' ' ' THR . . . . . . . . . . . . . 77.8 p -100.75 158.52 15.9 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-O 121.083 0.468 . . . . 0.0 111.106 -177.464 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' E' E ' 98' ' ' GLU . . . . . . . . . . . . . 47.1 tp10 -53.85 -26.32 23.93 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.279 -0.419 . . . . 0.0 112.105 -179.861 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' E' E ' 99' ' ' GLU . . . . . . . . . . . . . 96.0 mt-10 -76.1 11.61 1.42 Allowed 'General case' 0 CA--C 1.535 0.381 0 N-CA-C 113.404 0.89 . . . . 0.0 113.404 -177.204 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' E' E ' 100' ' ' ASN . . . . . . . . . . . . . 4.0 m-20 63.42 37.67 10.55 Favored 'General case' 0 CA--C 1.529 0.156 0 CA-C-O 121.143 0.497 . . . . 0.0 111.023 179.792 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' E' E ' 101' ' ' GLU . . . . . . . . . . . . . 85.0 tt0 -114.97 140.07 49.32 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.025 -0.534 . . . . 0.0 109.6 175.559 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' E' E ' 102' ' ' VAL . . . . . . . . . . . . . 47.5 t -114.88 126.1 72.37 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.243 0 N-CA-C 109.795 -0.446 . . . . 0.0 109.795 -178.508 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' E' E ' 103' ' ' LEU . . . . . . . . . . . . . 45.7 mt -119.15 133.15 55.95 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 115.768 -0.651 . . . . 0.0 110.483 178.233 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' E' E ' 104' ' ' ILE . . . . . . . . . . . . . 69.4 mt -119.0 122.42 69.28 Favored 'Isoleucine or valine' 0 C--O 1.235 0.296 0 CA-C-N 116.399 -0.364 . . . . 0.0 110.41 -179.618 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' E' E ' 105' ' ' PHE . . . . . . . . . . . . . 61.9 m-85 -121.72 167.1 13.34 Favored 'General case' 0 C--N 1.333 -0.142 0 O-C-N 124.013 0.821 . . . . 0.0 109.498 178.208 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' E' E ' 106' ' ' ASN . . . . . . . . . . . . . 46.3 p-10 -101.05 -170.36 1.83 Allowed 'General case' 0 C--N 1.33 -0.261 0 N-CA-C 109.95 -0.389 . . . . 0.0 109.95 172.99 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' E' E ' 107' ' ' GLN . . . . . . . . . . . . . 58.6 tt0 -58.99 -29.82 67.5 Favored 'General case' 0 C--N 1.328 -0.327 0 N-CA-C 111.902 0.334 . . . . 0.0 111.902 -179.998 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' E' E ' 108' ' ' ASN . . . . . . . . . . . . . 51.3 t30 -84.77 11.32 9.35 Favored 'General case' 0 CA--C 1.535 0.4 0 N-CA-C 112.838 0.681 . . . . 0.0 112.838 -177.307 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' E' E ' 109' ' ' LEU . . . . . . . . . . . . . 17.8 mt 57.58 36.46 26.82 Favored 'General case' 0 CA--C 1.53 0.185 0 CA-C-O 120.898 0.38 . . . . 0.0 111.342 178.63 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' E' E ' 110' ' ' GLU . . . . . . . . . . . . . 70.4 mm-40 -101.87 138.18 39.18 Favored 'General case' 0 C--N 1.33 -0.281 0 N-CA-C 109.172 -0.677 . . . . 0.0 109.172 174.909 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' E' E ' 111' ' ' GLU . . . . . . . . . . . . . 73.1 tt0 -82.55 121.81 27.27 Favored 'General case' 0 C--N 1.33 -0.28 0 C-N-CA 120.665 -0.414 . . . . 0.0 110.029 -176.655 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' E' E ' 112' ' ' LEU . . . . . . . . . . . . . 22.5 mt -108.95 -44.76 3.92 Favored 'General case' 0 C--N 1.332 -0.195 0 CA-C-N 116.129 -0.487 . . . . 0.0 110.789 -177.655 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' E' E ' 113' ' ' TYR . . . . . . . . . . . . . 50.9 t80 -132.91 137.07 46.51 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.365 -0.38 . . . . 0.0 110.911 -177.739 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' E' E ' 114' ' ' ARG . . . . . . . . . . . . . 16.3 ptm180 -143.31 126.95 17.0 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-O 121.034 0.445 . . . . 0.0 110.664 176.57 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' E' E ' 115' ' ' GLY . . . . . . . . . . . . . . . -150.11 140.27 7.9 Favored Glycine 0 CA--C 1.524 0.64 0 N-CA-C 111.147 -0.781 . . . . 0.0 111.147 178.599 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' E' E ' 116' ' ' LYS . . . . . . . . . . . . . 39.6 ttpt -104.89 128.98 53.33 Favored 'General case' 0 C--N 1.33 -0.269 0 N-CA-C 109.721 -0.474 . . . . 0.0 109.721 175.67 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' E' E ' 117' ' ' PHE . . . . . . . . . . . . . 69.8 m-85 -125.68 114.96 19.36 Favored 'General case' 0 C--N 1.331 -0.22 0 CA-C-O 121.019 0.438 . . . . 0.0 110.129 -177.268 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' E' E ' 118' ' ' GLU . . . . . . . . . . . . . 96.0 mt-10 -54.55 -41.35 69.68 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.462 -0.336 . . . . 0.0 111.265 -175.825 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' E' E ' 119' ' ' ASN . . . . . . . . . . . . . 69.9 m-80 -104.07 31.07 4.76 Favored 'General case' 0 C--O 1.234 0.246 0 CA-C-N 116.229 -0.441 . . . . 0.0 112.111 -173.92 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' E' E ' 120' ' ' LEU . . . . . . . . . . . . . 11.7 tp -56.24 120.05 6.95 Favored 'General case' 0 N--CA 1.462 0.147 0 CA-C-O 120.715 0.293 . . . . 0.0 110.311 178.884 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' E' E ' 121' ' ' ASN . . . . . . . . . . . . . 45.7 m-80 -114.34 -44.03 3.15 Favored 'General case' 0 C--O 1.232 0.153 0 CA-C-N 116.385 -0.37 . . . . 0.0 111.169 -176.655 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' E' E ' 122' ' ' LYS . . . . . . . . . . . . . 97.8 mttt -142.59 147.62 36.16 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-O 121.021 0.439 . . . . 0.0 111.596 -175.915 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' E' E ' 123' ' ' VAL . . . . . . . . . . . . . 44.1 t -127.09 129.16 71.07 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.275 0 N-CA-C 109.278 -0.638 . . . . 0.0 109.278 174.126 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' E' E ' 124' ' ' LEU . . . . . . . . . . . . . 38.1 mt -129.52 137.06 50.58 Favored 'General case' 0 C--N 1.331 -0.202 0 CA-C-O 120.838 0.352 . . . . 0.0 110.948 -178.394 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' E' E ' 125' ' ' VAL . . . . . . . . . . . . . 12.8 p -137.55 138.22 44.88 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.255 0 CA-C-N 116.282 -0.417 . . . . 0.0 110.329 177.908 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' E' E ' 126' ' ' ARG . . . . . . . . . . . . . 37.8 mtp180 -146.2 127.67 15.01 Favored 'General case' 0 C--N 1.331 -0.229 0 CA-C-O 120.954 0.406 . . . . 0.0 110.839 179.159 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' E' E ' 127' ' ' ASN . . . . . . . . . . . . . 62.1 t30 49.55 -104.93 0.15 Allowed 'General case' 0 CA--C 1.543 0.684 0 CA-C-O 118.953 -0.546 . . . . 0.0 111.826 179.157 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' E' E ' 128' ' ' ASP . . . . . . . . . . . . . 12.0 p-10 -114.19 0.61 14.28 Favored 'General case' 0 CA--C 1.537 0.445 0 CA-C-N 119.612 1.096 . . . . 0.0 113.591 -175.148 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' E' E ' 129' ' ' LEU . . . . . . . . . . . . . 84.3 mt -112.32 145.16 40.52 Favored 'General case' 0 C--N 1.333 -0.133 0 CA-C-N 118.203 0.456 . . . . 0.0 110.03 179.839 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' E' E ' 130' ' ' VAL . . . . . 0.507 HG13 ' HB ' ' E' ' 141' ' ' ILE . 12.0 p -131.95 141.93 44.26 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.175 0 CA-C-O 121.059 0.457 . . . . 0.0 110.25 179.954 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' E' E ' 131' ' ' VAL . . . . . 0.673 HG22 HD12 ' E' ' 140' ' ' LEU . 27.0 t -135.42 139.32 46.92 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.315 0 CA-C-N 115.961 -0.563 . . . . 0.0 110.397 -177.348 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' E' E ' 132' ' ' ILE . . . . . . . . . . . . . 74.6 mt -115.97 130.45 70.65 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.332 0 N-CA-C 109.215 -0.661 . . . . 0.0 109.215 178.582 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' E' E ' 133' ' ' ILE . . . . . . . . . . . . . 39.5 mm -116.47 123.08 71.14 Favored 'Isoleucine or valine' 0 N--CA 1.462 0.159 0 CA-C-O 120.727 0.299 . . . . 0.0 110.923 -174.662 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' E' E ' 134' ' ' ASP . . . . . . . . . . . . . 12.1 p-10 -136.47 151.71 49.76 Favored 'General case' 0 C--N 1.332 -0.173 0 N-CA-C 109.883 -0.414 . . . . 0.0 109.883 174.422 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' E' E ' 135' ' ' GLU . . . . . . . . . . . . . 41.2 tp10 -50.05 -26.42 4.35 Favored 'General case' 0 C--N 1.328 -0.343 0 N-CA-C 113.025 0.75 . . . . 0.0 113.025 -171.781 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' E' E ' 136' ' ' GLN . . . . . . . . . . . . . 47.1 tt0 -91.47 -25.11 19.46 Favored 'General case' 0 C--O 1.234 0.264 0 N-CA-C 112.977 0.732 . . . . 0.0 112.977 -173.121 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' E' E ' 137' ' ' LYS . . . . . . . . . . . . . 22.6 pttm -170.06 171.36 7.02 Favored 'General case' 0 C--O 1.232 0.148 0 CA-C-O 121.501 0.667 . . . . 0.0 112.659 -172.522 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' E' E ' 138' ' ' LEU . . . . . 0.439 HD23 ' N ' ' E' ' 139' ' ' THR . 5.1 tt -122.28 129.01 51.78 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 115.009 -0.996 . . . . 0.0 109.817 179.727 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' E' E ' 139' ' ' THR . . . . . 0.439 ' N ' HD23 ' E' ' 138' ' ' LEU . 43.5 m -111.46 127.61 55.74 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.528 -0.306 . . . . 0.0 110.354 179.288 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' E' E ' 140' ' ' LEU . . . . . 0.673 HD12 HG22 ' E' ' 131' ' ' VAL . 11.9 tp -114.27 123.34 49.3 Favored 'General case' 0 C--N 1.33 -0.268 0 N-CA-C 109.554 -0.535 . . . . 0.0 109.554 -178.976 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' E' E ' 141' ' ' ILE . . . . . 0.507 ' HB ' HG13 ' E' ' 130' ' ' VAL . 19.6 mt -121.5 124.79 72.54 Favored 'Isoleucine or valine' 0 C--O 1.234 0.253 0 CA-C-O 120.943 0.401 . . . . 0.0 110.261 -174.648 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' E' E ' 142' ' ' ARG . . . . . . . . . . . . . 82.2 mtp180 -108.68 128.13 54.59 Favored 'General case' 0 C--N 1.331 -0.222 0 CA-C-N 115.229 -0.896 . . . . 0.0 110.181 -178.654 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' E' E ' 143' ' ' THR . . . . . . . . . . . . . 24.9 p . . . . . 0 C--O 1.221 -0.412 0 CA-C-O 117.964 -1.017 . . . . 0.0 110.52 -179.754 . . . . . . . . 0 0 . 1 . 008 nuclear build core ' F' F ' 1' ' ' MET . . . . . . . . . . . . . 25.2 ptp . . . . . 0 CA--C 1.527 0.084 0 CA-C-O 120.725 0.298 . . . . 0.0 110.789 . . . . . . . . . 0 0 . 1 . 008 nuclear build core ' F' F ' 2' ' ' SER . . . . . . . . . . . . . 2.5 p -131.03 125.44 33.28 Favored 'General case' 0 C--N 1.331 -0.224 0 CA-C-N 116.461 -0.336 . . . . 0.0 110.358 178.738 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' F' F ' 3' ' ' GLU . . . . . . . . . . . . . 93.9 mt-10 -139.47 139.66 37.07 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 116.144 -0.48 . . . . 0.0 111.056 -176.439 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' F' F ' 4' ' ' LEU . . . . . . . . . . . . . 20.6 tp -123.24 127.66 48.9 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 115.805 -0.634 . . . . 0.0 109.91 175.387 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' F' F ' 5' ' ' LYS . . . . . . . . . . . . . 90.9 mttt -109.76 122.25 47.07 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 116.466 -0.334 . . . . 0.0 110.829 179.891 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' F' F ' 6' ' ' LEU . . . . . . . . . . . . . 71.7 mt -116.69 147.2 42.2 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 115.551 -0.75 . . . . 0.0 110.094 179.274 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' F' F ' 7' ' ' LYS . . . . . . . . . . . . . 39.4 ttmt -137.44 142.29 36.8 Favored Pre-proline 0 CA--C 1.533 0.319 0 CA-C-O 119.298 -0.382 . . . . 0.0 110.043 175.845 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' F' F ' 8' ' ' PRO . . . . . . . . . . . . . 87.7 Cg_endo -90.51 143.89 3.75 Favored 'Trans proline' 0 N--CA 1.489 1.244 0 C-N-CA 121.761 1.641 . . . . 0.0 111.846 178.376 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' F' F ' 9' ' ' LEU . . . . . . . . . . . . . 50.4 mt -76.84 -47.97 2.81 Favored Pre-proline 0 CA--C 1.534 0.347 0 CA-C-O 118.709 -0.663 . . . . 0.0 112.27 -179.652 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' F' F ' 10' ' ' PRO . . . . . . . . . . . . . 84.5 Cg_endo -80.41 157.76 22.48 Favored 'Trans proline' 0 N--CA 1.497 1.702 0 C-N-CA 121.237 1.291 . . . . 0.0 111.967 176.561 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' F' F ' 11' ' ' LYS . . . . . . . . . . . . . 53.3 mttm -87.48 100.54 12.84 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-O 120.817 0.341 . . . . 0.0 110.539 178.049 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' F' F ' 12' ' ' VAL . . . . . . . . . . . . . 11.4 p -139.97 144.2 28.62 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.275 0 CA-C-N 116.05 -0.523 . . . . 0.0 110.071 179.281 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' F' F ' 13' ' ' GLU . . . . . . . . . . . . . 41.6 tp10 -91.01 116.67 28.97 Favored 'General case' 0 C--N 1.329 -0.325 0 N-CA-C 109.989 -0.374 . . . . 0.0 109.989 178.611 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' F' F ' 14' ' ' LEU . . . . . . . . . . . . . 23.0 mt -98.24 153.67 37.98 Favored Pre-proline 0 C--N 1.33 -0.269 0 CA-C-N 116.251 -0.431 . . . . 0.0 111.177 -176.124 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' F' F ' 15' ' ' PRO . . . . . . . . . . . . . 37.4 Cg_exo -59.7 156.88 35.11 Favored 'Trans proline' 0 N--CA 1.497 1.733 0 C-N-CA 121.332 1.355 . . . . 0.0 112.132 179.065 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' F' F ' 16' ' ' PRO . . . . . . . . . . . . . 28.1 Cg_exo -60.68 -34.34 92.17 Favored 'Trans proline' 0 N--CA 1.497 1.701 0 C-N-CA 121.404 1.403 . . . . 0.0 112.187 178.043 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' F' F ' 17' ' ' ASP . . . . . . . . . . . . . 15.1 p-10 -85.11 12.29 8.07 Favored 'General case' 0 CA--C 1.536 0.427 0 N-CA-C 113.113 0.783 . . . . 0.0 113.113 -177.939 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' F' F ' 18' ' ' PHE . . . . . . . . . . . . . 33.4 t80 -57.83 -42.36 84.2 Favored 'General case' 0 C--N 1.333 -0.115 0 O-C-N 121.988 -0.445 . . . . 0.0 110.142 -179.678 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' F' F ' 19' ' ' VAL . . . . . . . . . . . . . 49.8 t -55.89 -52.98 43.18 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.316 0 CA-C-N 116.352 -0.385 . . . . 0.0 111.102 -176.675 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' F' F ' 20' ' ' ASP . . . . . . . . . . . . . 2.5 p-10 -59.82 -36.25 76.38 Favored 'General case' 0 N--CA 1.464 0.268 0 C-N-CA 120.582 -0.447 . . . . 0.0 111.342 -176.452 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' F' F ' 21' ' ' VAL . . . . . . . . . . . . . 51.7 t -63.93 -47.13 91.96 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.239 0 C-N-CA 120.575 -0.45 . . . . 0.0 110.34 -179.853 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' F' F ' 22' ' ' ILE . . . . . 0.446 HG22 HD12 ' F' ' 26' ' ' LEU . 49.2 mm -55.54 -48.35 77.48 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.219 0 CA-C-O 120.736 0.303 . . . . 0.0 110.505 178.129 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' F' F ' 23' ' ' ARG . . . . . . . . . . . . . 53.2 ttp180 -54.41 -49.54 69.7 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.521 -0.309 . . . . 0.0 111.572 -177.109 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' F' F ' 24' ' ' ILE . . . . . . . . . . . . . 78.0 mt -59.16 -46.15 92.24 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.316 0 C-N-CA 120.971 -0.291 . . . . 0.0 111.166 -176.7 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' F' F ' 25' ' ' LYS . . . . . . . . . . . . . 90.8 mttt -64.76 -44.05 91.34 Favored 'General case' 0 C--N 1.33 -0.275 0 N-CA-C 112.54 0.57 . . . . 0.0 112.54 -177.25 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' F' F ' 26' ' ' LEU . . . . . 0.446 HD12 HG22 ' F' ' 22' ' ' ILE . 61.4 mt -83.67 -24.16 31.44 Favored 'General case' 0 C--N 1.329 -0.302 0 N-CA-C 113.467 0.914 . . . . 0.0 113.467 -171.508 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' F' F ' 27' ' ' GLN . . . . . . . . . . . . . 6.4 pt20 -46.15 136.58 6.76 Favored 'General case' 0 CA--C 1.534 0.351 0 N-CA-C 112.813 0.671 . . . . 0.0 112.813 -174.633 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' F' F ' 28' ' ' GLY . . . . . . . . . . . . . . . 100.53 -21.56 43.58 Favored Glycine 0 CA--C 1.533 1.214 0 CA-C-N 115.701 -0.681 . . . . 0.0 112.786 -178.623 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' F' F ' 29' ' ' LYS . . . . . . . . . . . . . 63.2 mttp -97.79 155.08 17.2 Favored 'General case' 0 C--N 1.331 -0.199 0 CA-C-N 117.604 0.702 . . . . 0.0 111.144 179.125 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' F' F ' 30' ' ' THR . . . . . . . . . . . . . 24.2 m -104.7 139.23 39.82 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.196 177.366 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' F' F ' 31' ' ' VAL . . . . . . . . . . . . . 34.3 m -129.33 157.45 42.1 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.19 0 CA-C-O 120.856 0.36 . . . . 0.0 110.915 -178.741 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' F' F ' 32' ' ' ARG . . . . . . . . . . . . . 93.4 mtt180 -133.74 152.33 51.85 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 115.959 -0.564 . . . . 0.0 110.779 177.934 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' F' F ' 33' ' ' THR . . . . . . . . . . . . . 28.5 m -53.31 139.97 28.33 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.133 -0.485 . . . . 0.0 111.399 -178.852 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' F' F ' 34' ' ' GLY . . . . . . . . . . . . . . . 99.21 -17.17 58.33 Favored Glycine 0 CA--C 1.532 1.118 0 C-N-CA 121.16 -0.543 . . . . 0.0 113.222 178.81 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' F' F ' 35' ' ' ASP . . . . . . . . . . . . . 76.0 m-20 -65.83 148.66 51.42 Favored 'General case' 0 C--O 1.232 0.176 0 CA-C-N 118.065 0.933 . . . . 0.0 111.188 179.092 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' F' F ' 36' ' ' VAL . . . . . . . . . . . . . 45.0 t -122.3 129.76 75.06 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.243 0 CA-C-N 115.981 -0.554 . . . . 0.0 109.874 178.468 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' F' F ' 37' ' ' ILE . . . . . . . . . . . . . 66.1 mt -119.77 138.79 49.24 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.201 0 CA-C-N 116.21 -0.45 . . . . 0.0 109.933 -179.776 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' F' F ' 38' ' ' GLY . . . . . . . . . . . . . . . -110.76 128.78 8.93 Favored Glycine 0 CA--C 1.525 0.691 0 N-CA-C 111.193 -0.763 . . . . 0.0 111.193 -179.331 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' F' F ' 39' ' ' ILE . . . . . . . . . . . . . 72.9 mt -123.85 132.69 70.96 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.216 0 N-CA-C 110.137 -0.32 . . . . 0.0 110.137 178.89 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' F' F ' 40' ' ' SER . . . . . . . . . . . . . 23.0 t -92.7 118.86 31.51 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.332 -0.394 . . . . 0.0 110.685 175.34 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' F' F ' 41' ' ' ILE . . . . . . . . . . . . . 70.5 mt -130.69 125.33 58.47 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.229 0 CA-C-O 120.884 0.374 . . . . 0.0 110.469 179.219 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' F' F ' 42' ' ' LEU . . . . . . . . . . . . . 48.3 mt 51.94 34.46 13.69 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 115.994 -0.548 . . . . 0.0 111.913 176.833 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' F' F ' 43' ' ' GLY . . . . . . . . . . . . . . . 72.92 31.36 62.18 Favored Glycine 0 CA--C 1.53 0.993 0 C-N-CA 121.076 -0.583 . . . . 0.0 112.187 177.089 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' F' F ' 44' ' ' LYS . . . . . . . . . . . . . 40.6 ttpt -138.31 130.89 29.23 Favored 'General case' 0 C--N 1.329 -0.314 0 N-CA-C 109.613 -0.514 . . . . 0.0 109.613 178.081 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' F' F ' 45' ' ' GLU . . . . . . . . . . . . . 84.6 tt0 -83.06 118.91 23.86 Favored 'General case' 0 C--N 1.328 -0.351 0 C-N-CA 120.815 -0.354 . . . . 0.0 110.847 -179.66 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' F' F ' 46' ' ' VAL . . . . . . . . . . . . . 7.6 p -119.13 126.74 75.62 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.27 0 N-CA-C 109.375 -0.602 . . . . 0.0 109.375 176.623 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' F' F ' 47' ' ' LYS . . . . . . . . . . . . . 61.0 mttm -100.12 130.61 46.28 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.033 -0.53 . . . . 0.0 111.342 177.813 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' F' F ' 48' ' ' PHE . . . . . . . . . . . . . 90.0 m-85 -111.03 131.91 54.67 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 115.969 -0.559 . . . . 0.0 109.777 175.589 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' F' F ' 49' ' ' LYS . . . . . . . . . . . . . 83.6 tttt -106.81 134.68 49.6 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 116.213 -0.448 . . . . 0.0 110.379 -179.559 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' F' F ' 50' ' ' VAL . . . . . . . . . . . . . 46.8 t -77.07 106.98 7.68 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.283 0 N-CA-C 109.142 -0.688 . . . . 0.0 109.142 176.368 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' F' F ' 51' ' ' VAL . . . . . . . . . . . . . 47.9 t -69.57 -47.95 68.76 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.325 0 CA-C-N 115.932 -0.577 . . . . 0.0 109.979 -173.278 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' F' F ' 52' ' ' GLN . . . . . . . . . . . . . 61.1 tt0 -168.22 148.39 4.8 Favored 'General case' 0 C--N 1.331 -0.22 0 C-N-CA 120.228 -0.589 . . . . 0.0 111.678 -178.838 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' F' F ' 53' ' ' ALA . . . . . . . . . . . . . . . -123.25 132.07 53.9 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 115.651 -0.704 . . . . 0.0 109.86 176.492 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' F' F ' 54' ' ' TYR . . . . . . . . . . . . . 54.3 t80 -129.04 110.11 18.27 Favored Pre-proline 0 CA--C 1.535 0.385 0 CA-C-O 118.317 -0.849 . . . . 0.0 110.166 179.92 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' F' F ' 55' ' ' PRO . . . . . . . . . . . . . 73.9 Cg_endo -77.07 170.03 72.74 Favored 'Cis proline' 0 N--CA 1.497 1.713 0 CA-C-N 121.861 1.7 . . . . 0.0 112.27 -4.661 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' F' F ' 56' ' ' SER . . . . . . . . . . . . . 13.5 m -113.93 131.91 22.91 Favored Pre-proline 0 CA--C 1.538 0.484 0 CA-C-O 118.513 -0.756 . . . . 0.0 109.326 175.652 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' F' F ' 57' ' ' PRO . . . . . . . . . . . . . 55.6 Cg_endo -71.33 166.88 76.79 Favored 'Cis proline' 0 N--CA 1.498 1.757 0 CA-C-N 121.923 1.722 . . . . 0.0 111.643 -0.321 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' F' F ' 58' ' ' LEU . . . . . . . . . . . . . 35.3 tp -129.54 137.34 50.72 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.271 -0.422 . . . . 0.0 110.152 179.491 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' F' F ' 59' ' ' ARG . . . . . . . . . . . . . 38.5 ttm180 -103.71 133.89 47.95 Favored 'General case' 0 C--N 1.327 -0.381 0 N-CA-C 109.706 -0.479 . . . . 0.0 109.706 177.836 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' F' F ' 60' ' ' VAL . . . . . . . . . . . . . 44.1 t -85.28 111.38 20.65 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.264 0 C-N-CA 120.761 -0.376 . . . . 0.0 110.36 -176.428 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' F' F ' 61' ' ' GLU . . . . . . . . . . . . . 95.5 mt-10 -131.06 165.26 23.63 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 115.835 -0.621 . . . . 0.0 109.677 176.043 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' F' F ' 62' ' ' ASP . . . . . . . . . . . . . 19.9 p-10 -53.7 -32.47 51.98 Favored 'General case' 0 C--N 1.328 -0.365 0 N-CA-C 111.85 0.315 . . . . 0.0 111.85 -179.42 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' F' F ' 63' ' ' ARG . . . . . . . . . . . . . 81.3 mtp180 -72.97 -21.93 60.78 Favored 'General case' 0 CA--C 1.533 0.299 0 N-CA-C 113.041 0.756 . . . . 0.0 113.041 -176.313 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' F' F ' 64' ' ' THR . . . . . . . . . . . . . 17.8 m -71.17 142.01 50.7 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-O 120.952 0.406 . . . . 0.0 111.09 -174.568 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' F' F ' 65' ' ' LYS . . . . . . . . . . . . . 39.7 mtpt -89.48 125.46 35.19 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 115.883 -0.599 . . . . 0.0 109.925 178.784 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' F' F ' 66' ' ' ILE . . . . . . . . . . . . . 68.1 mt -119.07 131.64 71.25 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.339 0 CA-C-O 120.874 0.368 . . . . 0.0 110.277 -178.15 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' F' F ' 67' ' ' THR . . . . . . . . . . . . . 26.1 m -123.98 136.89 54.6 Favored 'General case' 0 C--N 1.331 -0.215 0 CA-C-N 116.015 -0.539 . . . . 0.0 110.742 -179.048 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' F' F ' 68' ' ' LEU . . . . . 0.472 HD23 ' C ' ' F' ' 68' ' ' LEU . 5.7 tt . . . . . 0 C--N 1.33 -0.25 0 CA-C-N 115.968 -0.56 . . . . 0.0 110.515 179.485 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' F' F ' 73' ' ' VAL . . . . . . . . . . . . . 35.9 m . . . . . 0 C--O 1.232 0.132 0 CA-C-O 120.837 0.351 . . . . 0.0 110.686 . . . . . . . . . 0 0 . 1 . 008 nuclear build core ' F' F ' 74' ' ' ASP . . . . . . . . . . . . . 19.5 t0 -107.05 123.04 47.64 Favored 'General case' 0 C--N 1.328 -0.329 0 N-CA-C 109.584 -0.525 . . . . 0.0 109.584 179.156 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' F' F ' 75' ' ' VAL . . . . . 0.429 ' C ' HD12 ' F' ' 76' ' ' LEU . 46.2 t -117.34 126.26 74.48 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.233 0 CA-C-O 121.173 0.511 . . . . 0.0 110.771 -177.43 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' F' F ' 76' ' ' LEU . . . . . 0.429 HD12 ' C ' ' F' ' 75' ' ' VAL . 6.5 mp -122.82 143.66 49.7 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 115.463 -0.79 . . . . 0.0 109.128 174.546 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' F' F ' 77' ' ' GLU . . . . . . . . . . . . . 30.1 tt0 -135.85 140.76 44.42 Favored 'General case' 0 C--N 1.331 -0.225 0 C-N-CA 120.734 -0.386 . . . . 0.0 111.273 -174.73 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' F' F ' 78' ' ' ALA . . . . . . . . . . . . . . . -130.16 134.96 47.68 Favored 'General case' 0 C--N 1.331 -0.239 0 CA-C-N 115.933 -0.576 . . . . 0.0 110.013 176.762 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' F' F ' 79' ' ' LYS . . . . . 0.403 ' O ' HD13 ' F' ' 80' ' ' ILE . 31.1 ttmt -82.4 125.71 31.36 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-O 120.74 0.305 . . . . 0.0 110.822 -178.607 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' F' F ' 80' ' ' ILE . . . . . 0.403 HD13 ' O ' ' F' ' 79' ' ' LYS . 28.0 mm -139.12 114.81 8.98 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.265 0 N-CA-C 109.062 -0.718 . . . . 0.0 109.062 -177.8 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' F' F ' 81' ' ' LYS . . . . . . . . . . . . . 70.1 tttt -103.69 122.11 44.36 Favored 'General case' 0 C--N 1.328 -0.334 0 C-N-CA 121.027 -0.269 . . . . 0.0 111.116 -175.884 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' F' F ' 82' ' ' GLY . . . . . . . . . . . . . . . 89.09 42.18 5.68 Favored Glycine 0 CA--C 1.525 0.66 0 C-N-CA 120.715 -0.755 . . . . 0.0 111.892 174.789 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' F' F ' 83' ' ' ILE . . . . . . . . . . . . . 69.0 mt -65.27 136.49 26.6 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.243 0 N-CA-C 109.91 -0.404 . . . . 0.0 109.91 178.044 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' F' F ' 84' ' ' LYS . . . . . . . . . . . . . 29.0 ttmt -94.32 -51.78 4.64 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.088 -0.506 . . . . 0.0 109.93 179.482 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' F' F ' 85' ' ' ASP . . . . . . . . . . . . . 4.3 t70 -157.29 153.59 27.7 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 115.621 -0.718 . . . . 0.0 110.504 -179.659 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' F' F ' 86' ' ' VAL . . . . . . . . . . . . . 43.8 t -131.52 133.41 61.85 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.232 0 CA-C-O 120.98 0.419 . . . . 0.0 110.356 -179.181 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' F' F ' 87' ' ' ILE . . . . . 0.497 HD12 ' N ' ' F' ' 87' ' ' ILE . 5.0 mp -120.37 126.29 75.1 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.241 0 CA-C-N 115.943 -0.572 . . . . 0.0 109.528 177.765 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' F' F ' 88' ' ' LEU . . . . . . . . . . . . . 10.7 tp -109.5 128.2 55.0 Favored 'General case' 0 C--N 1.331 -0.226 0 CA-C-O 120.902 0.382 . . . . 0.0 110.895 -177.929 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' F' F ' 89' ' ' ASP . . . . . . . . . . . . . 4.2 t0 -120.69 158.14 28.1 Favored 'General case' 0 C--N 1.329 -0.286 0 N-CA-C 109.497 -0.557 . . . . 0.0 109.497 177.441 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' F' F ' 90' ' ' GLU . . . . . . . . . . . . . 84.0 tt0 -45.12 -46.19 11.68 Favored 'General case' 0 N--CA 1.465 0.291 0 N-CA-C 112.985 0.735 . . . . 0.0 112.985 -172.484 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' F' F ' 91' ' ' ASN . . . . . . . . . . . . . 79.4 m-20 -132.05 30.84 4.22 Favored 'General case' 0 N--CA 1.465 0.29 0 N-CA-C 112.189 0.44 . . . . 0.0 112.189 -179.608 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' F' F ' 92' ' ' LEU . . . . . . . . . . . . . 7.2 mt -150.35 140.94 22.56 Favored 'General case' 0 C--N 1.331 -0.204 0 N-CA-C 109.564 -0.532 . . . . 0.0 109.564 -178.088 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' F' F ' 93' ' ' ILE . . . . . . . . . . . . . 73.5 mt -124.01 119.45 56.87 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.289 0 N-CA-C 109.338 -0.616 . . . . 0.0 109.338 178.997 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' F' F ' 94' ' ' VAL . . . . . . . . . . . . . 44.0 t -119.55 126.59 75.46 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.198 0 CA-C-O 120.892 0.377 . . . . 0.0 109.998 -179.648 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' F' F ' 95' ' ' VAL . . . . . . . . . . . . . 44.1 t -121.58 133.14 69.01 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.298 0 CA-C-N 116.101 -0.5 . . . . 0.0 109.738 179.623 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' F' F ' 96' ' ' ILE . . . . . . . . . . . . . 64.3 mt -114.26 126.15 71.71 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.326 0 N-CA-C 109.234 -0.654 . . . . 0.0 109.234 178.88 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' F' F ' 97' ' ' THR . . . . . . . . . . . . . 64.6 p -98.62 154.8 17.67 Favored 'General case' 0 C--N 1.327 -0.385 0 CA-C-O 121.109 0.48 . . . . 0.0 110.952 -178.311 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' F' F ' 98' ' ' GLU . . . . . . . . . . . . . 83.4 tt0 -53.89 -23.5 12.91 Favored 'General case' 0 CA--C 1.535 0.371 0 N-CA-C 112.419 0.525 . . . . 0.0 112.419 179.966 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' F' F ' 99' ' ' GLU . . . . . . . . . . . . . 13.8 mm-40 -77.54 13.92 1.14 Allowed 'General case' 0 CA--C 1.536 0.431 0 N-CA-C 113.272 0.841 . . . . 0.0 113.272 -178.444 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' F' F ' 100' ' ' ASN . . . . . . . . . . . . . 2.2 m-20 63.65 37.73 9.95 Favored 'General case' 0 N--CA 1.463 0.212 0 CA-C-O 121.111 0.481 . . . . 0.0 110.948 178.322 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' F' F ' 101' ' ' GLU . . . . . . . . . . . . . 84.9 tt0 -120.09 140.93 50.3 Favored 'General case' 0 C--N 1.333 -0.151 0 CA-C-N 116.203 -0.453 . . . . 0.0 109.853 176.68 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' F' F ' 102' ' ' VAL . . . . . . . . . . . . . 43.2 t -115.03 126.74 72.7 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 CA-C-N 116.197 -0.456 . . . . 0.0 109.881 -178.32 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' F' F ' 103' ' ' LEU . . . . . 0.516 HD12 ' N ' ' F' ' 103' ' ' LEU . 6.2 mp -117.29 134.89 54.27 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 115.994 -0.548 . . . . 0.0 110.294 177.784 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' F' F ' 104' ' ' ILE . . . . . . . . . . . . . 66.3 mt -119.0 122.22 68.78 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.218 0 CA-C-N 116.422 -0.354 . . . . 0.0 110.217 -179.147 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' F' F ' 105' ' ' PHE . . . . . . . . . . . . . 79.3 m-85 -120.54 161.46 21.27 Favored 'General case' 0 C--N 1.331 -0.235 0 O-C-N 124.046 0.841 . . . . 0.0 109.987 179.614 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' F' F ' 106' ' ' ASN . . . . . . . . . . . . . 46.8 p-10 -97.4 -169.85 1.92 Allowed 'General case' 0 CA--C 1.531 0.228 0 N-CA-C 110.19 -0.3 . . . . 0.0 110.19 175.559 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' F' F ' 107' ' ' GLN . . . . . . . . . . . . . 63.0 tt0 -59.0 -30.09 67.72 Favored 'General case' 0 C--N 1.33 -0.271 0 N-CA-C 111.954 0.353 . . . . 0.0 111.954 179.618 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' F' F ' 108' ' ' ASN . . . . . . . . . . . . . 8.5 t-20 -83.98 11.76 7.32 Favored 'General case' 0 CA--C 1.536 0.428 0 N-CA-C 112.877 0.695 . . . . 0.0 112.877 -178.124 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' F' F ' 109' ' ' LEU . . . . . . . . . . . . . 10.5 tp 54.96 35.41 24.49 Favored 'General case' 0 C--N 1.331 -0.201 0 CA-C-O 120.902 0.382 . . . . 0.0 111.431 -179.602 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' F' F ' 110' ' ' GLU . . . . . . . . . . . . . 94.9 mt-10 -104.46 147.06 28.0 Favored 'General case' 0 C--N 1.331 -0.233 0 N-CA-C 109.335 -0.617 . . . . 0.0 109.335 175.38 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' F' F ' 111' ' ' GLU . . . . . . . . . . . . . 64.8 tt0 -81.47 121.95 26.92 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-O 120.913 0.387 . . . . 0.0 110.639 -174.97 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' F' F ' 112' ' ' LEU . . . . . . . . . . . . . 16.9 mt -104.7 -46.04 4.44 Favored 'General case' 0 C--N 1.331 -0.227 0 CA-C-N 116.04 -0.527 . . . . 0.0 110.623 179.513 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' F' F ' 113' ' ' TYR . . . . . . . . . . . . . 49.5 t80 -137.25 146.04 44.28 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.166 -0.47 . . . . 0.0 111.026 -177.919 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' F' F ' 114' ' ' ARG . . . . . . . . . . . . . 37.6 ptt180 -148.58 126.58 12.0 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.141 -0.481 . . . . 0.0 110.779 178.505 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' F' F ' 115' ' ' GLY . . . . . . . . . . . . . . . -150.16 142.78 9.98 Favored Glycine 0 CA--C 1.524 0.641 0 N-CA-C 111.062 -0.815 . . . . 0.0 111.062 179.159 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' F' F ' 116' ' ' LYS . . . . . . . . . . . . . 39.1 ttpt -112.37 134.09 54.09 Favored 'General case' 0 C--N 1.331 -0.236 0 N-CA-C 109.694 -0.484 . . . . 0.0 109.694 176.908 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' F' F ' 117' ' ' PHE . . . . . . . . . . . . . 28.1 m-85 -136.54 114.38 11.25 Favored 'General case' 0 C--N 1.329 -0.313 0 N-CA-C 110.055 -0.35 . . . . 0.0 110.055 -175.351 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' F' F ' 118' ' ' GLU . . . . . . . . . . . . . 43.7 mt-10 -54.94 -44.1 74.0 Favored 'General case' 0 C--N 1.33 -0.274 0 C-N-CA 120.883 -0.327 . . . . 0.0 111.348 -176.618 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' F' F ' 119' ' ' ASN . . . . . . . . . . . . . 30.6 m120 -94.87 30.49 2.07 Favored 'General case' 0 C--N 1.33 -0.263 0 N-CA-C 112.161 0.43 . . . . 0.0 112.161 -174.659 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' F' F ' 120' ' ' LEU . . . . . . . . . . . . . 22.0 tp -57.5 120.08 7.65 Favored 'General case' 0 C--N 1.331 -0.211 0 C-N-CA 120.925 -0.31 . . . . 0.0 110.293 177.577 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' F' F ' 121' ' ' ASN . . . . . . . . . . . . . 76.2 m-20 -111.63 -44.1 3.55 Favored 'General case' 0 C--N 1.331 -0.221 0 CA-C-N 116.425 -0.352 . . . . 0.0 110.711 -179.273 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' F' F ' 122' ' ' LYS . . . . . . . . . . . . . 97.0 mttt -146.93 145.08 29.67 Favored 'General case' 0 C--N 1.331 -0.216 0 C-N-CA 120.536 -0.466 . . . . 0.0 111.899 -179.316 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' F' F ' 123' ' ' VAL . . . . . . . . . . . . . 45.1 t -122.95 125.86 72.89 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.234 0 N-CA-C 108.998 -0.742 . . . . 0.0 108.998 171.531 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' F' F ' 124' ' ' LEU . . . . . 0.462 HD23 ' N ' ' F' ' 125' ' ' VAL . 3.3 tt -125.26 131.86 53.03 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.461 -0.336 . . . . 0.0 110.482 -175.28 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' F' F ' 125' ' ' VAL . . . . . 0.462 ' N ' HD23 ' F' ' 124' ' ' LEU . 11.7 p -131.14 135.95 58.78 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.224 0 CA-C-N 116.377 -0.374 . . . . 0.0 110.502 178.961 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' F' F ' 126' ' ' ARG . . . . . . . . . . . . . 96.6 mtt180 -149.43 128.37 12.63 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 116.109 -0.496 . . . . 0.0 110.873 177.333 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' F' F ' 127' ' ' ASN . . . . . . . . . . . . . 36.1 t30 50.46 -106.77 0.24 Allowed 'General case' 0 CA--C 1.543 0.677 0 CA-C-O 118.975 -0.536 . . . . 0.0 111.543 178.85 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' F' F ' 128' ' ' ASP . . . . . . . . . . . . . 18.7 p-10 -114.14 5.17 15.85 Favored 'General case' 0 N--CA 1.469 0.476 0 CA-C-N 119.667 1.121 . . . . 0.0 113.531 -176.332 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' F' F ' 129' ' ' LEU . . . . . . . . . . . . . 61.9 mt -109.39 137.52 47.12 Favored 'General case' 0 C--O 1.232 0.159 0 CA-C-N 118.155 0.434 . . . . 0.0 110.702 -179.428 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' F' F ' 130' ' ' VAL . . . . . . . . . . . . . 44.4 t -124.02 132.0 72.05 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.194 0 N-CA-C 109.609 -0.515 . . . . 0.0 109.609 177.596 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' F' F ' 131' ' ' VAL . . . . . 0.464 HG22 HD12 ' F' ' 140' ' ' LEU . 41.4 t -135.56 137.08 50.06 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.208 0 CA-C-O 121.091 0.472 . . . . 0.0 110.511 -179.452 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' F' F ' 132' ' ' ILE . . . . . . . . . . . . . 71.0 mt -118.26 132.82 66.99 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.239 0 CA-C-N 115.815 -0.629 . . . . 0.0 109.542 178.717 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' F' F ' 133' ' ' ILE . . . . . . . . . . . . . 43.1 mm -118.31 124.6 73.37 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.238 0 CA-C-N 116.519 -0.31 . . . . 0.0 111.205 -174.758 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' F' F ' 134' ' ' ASP . . . . . . . . . . . . . 13.9 p-10 -140.52 151.42 44.76 Favored 'General case' 0 C--N 1.332 -0.19 0 N-CA-C 109.737 -0.468 . . . . 0.0 109.737 172.655 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' F' F ' 135' ' ' GLU . . . . . . . . . . . . . 42.5 tp10 -50.89 -27.44 7.5 Favored 'General case' 0 C--N 1.328 -0.357 0 N-CA-C 112.971 0.73 . . . . 0.0 112.971 -171.028 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' F' F ' 136' ' ' GLN . . . . . . . . . . . . . 99.3 mm-40 -86.28 -29.62 22.93 Favored 'General case' 0 C--O 1.233 0.23 0 N-CA-C 112.705 0.631 . . . . 0.0 112.705 -174.332 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' F' F ' 137' ' ' LYS . . . . . . . . . . . . . 55.7 pttt -164.95 169.11 16.84 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-O 121.524 0.678 . . . . 0.0 112.545 -170.605 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' F' F ' 138' ' ' LEU . . . . . 0.417 HD23 ' N ' ' F' ' 139' ' ' THR . 5.3 tt -122.26 127.52 50.01 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 114.986 -1.006 . . . . 0.0 109.598 178.565 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' F' F ' 139' ' ' THR . . . . . 0.417 ' N ' HD23 ' F' ' 138' ' ' LEU . 35.0 m -108.07 124.59 50.43 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.423 -0.353 . . . . 0.0 110.333 -179.299 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' F' F ' 140' ' ' LEU . . . . . 0.464 HD12 HG22 ' F' ' 131' ' ' VAL . 14.5 tp -113.0 120.2 40.56 Favored 'General case' 0 C--N 1.329 -0.284 0 N-CA-C 109.337 -0.616 . . . . 0.0 109.337 -179.069 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' F' F ' 141' ' ' ILE . . . . . . . . . . . . . 18.9 mt -120.94 121.96 66.48 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.28 0 CA-C-O 120.961 0.41 . . . . 0.0 110.052 -175.364 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' F' F ' 142' ' ' ARG . . . . . . . . . . . . . 75.3 mtp180 -105.84 117.18 33.37 Favored 'General case' 0 C--O 1.232 0.163 0 CA-C-N 115.548 -0.751 . . . . 0.0 109.945 179.113 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' F' F ' 143' ' ' THR . . . . . . . . . . . . . 18.8 p . . . . . 0 C--O 1.219 -0.505 0 CA-C-O 118.029 -0.986 . . . . 0.0 110.663 -179.015 . . . . . . . . 0 0 . 1 . 009 nuclear build core ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 5.3 p . . . . . 0 CA--C 1.523 -0.081 0 N-CA-C 110.013 -0.365 . . . . 0.0 110.013 . . . . . . . . . 0 0 . 1 . 009 nuclear build core ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 84.9 tt0 -146.14 143.85 29.59 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.27 -0.423 . . . . 0.0 111.371 -178.232 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 4' ' ' LEU . . . . . . . . . . . . . 16.8 tp -127.54 132.84 49.84 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 115.937 -0.574 . . . . 0.0 110.079 176.934 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 5' ' ' LYS . . . . . . . . . . . . . 91.6 mttt -112.05 120.64 42.55 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.589 -179.555 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 6' ' ' LEU . . . . . 0.465 HD23 ' HA ' ' A' ' 50' ' ' VAL . 71.5 mt -115.95 142.67 46.47 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 115.471 -0.786 . . . . 0.0 110.305 -178.685 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 39.4 ttmt -122.71 138.42 29.42 Favored Pre-proline 0 CA--C 1.532 0.286 0 CA-C-O 118.991 -0.528 . . . . 0.0 109.807 176.013 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 8' ' ' PRO . . . . . . . . . . . . . 91.3 Cg_endo -91.44 131.76 1.37 Allowed 'Trans proline' 0 N--CA 1.489 1.229 0 C-N-CA 121.702 1.602 . . . . 0.0 111.803 178.688 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 41.2 mt -71.91 -46.98 11.88 Favored Pre-proline 0 C--N 1.327 -0.376 0 CA-C-O 118.648 -0.691 . . . . 0.0 112.004 -179.388 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 83.6 Cg_endo -81.05 150.42 17.93 Favored 'Trans proline' 0 N--CA 1.495 1.581 0 C-N-CA 121.213 1.276 . . . . 0.0 111.878 175.412 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 68.8 mttm -88.85 99.33 12.3 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.401 -0.363 . . . . 0.0 110.496 178.932 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 12.4 p -144.52 149.16 17.52 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.282 0 CA-C-N 116.239 -0.437 . . . . 0.0 110.522 -179.494 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 44.2 mp0 -90.48 120.61 31.72 Favored 'General case' 0 C--N 1.331 -0.208 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.436 179.064 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 14' ' ' LEU . . . . . . . . . . . . . 24.2 mt -98.24 154.23 37.74 Favored Pre-proline 0 C--N 1.329 -0.291 0 CA-C-N 116.351 -0.386 . . . . 0.0 110.867 -179.744 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 15' ' ' PRO . . . . . . . . . . . . . 37.5 Cg_exo -59.63 155.93 39.84 Favored 'Trans proline' 0 N--CA 1.497 1.729 0 C-N-CA 121.272 1.315 . . . . 0.0 111.615 177.742 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 16' ' ' PRO . . . . . . . . . . . . . 35.8 Cg_exo -58.18 -38.29 91.84 Favored 'Trans proline' 0 N--CA 1.496 1.643 0 C-N-CA 121.491 1.461 . . . . 0.0 112.697 -179.514 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 17' ' ' ASP . . . . . . . . . . . . . 15.9 p-10 -85.18 10.69 11.59 Favored 'General case' 0 CA--C 1.534 0.363 0 N-CA-C 113.215 0.82 . . . . 0.0 113.215 -177.816 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 18' ' ' PHE . . . . . . . . . . . . . 42.1 t80 -58.2 -42.3 85.86 Favored 'General case' 0 N--CA 1.458 -0.046 0 O-C-N 121.95 -0.469 . . . . 0.0 110.116 -179.158 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 19' ' ' VAL . . . . . 0.403 HG13 ' N ' ' A' ' 20' ' ' ASP . 12.6 p -55.9 -40.51 62.74 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.287 0 CA-C-N 116.436 -0.347 . . . . 0.0 110.709 179.65 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 20' ' ' ASP . . . . . 0.403 ' N ' HG13 ' A' ' 19' ' ' VAL . 53.9 m-20 -60.59 -44.0 96.74 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-O 120.83 0.348 . . . . 0.0 110.722 -179.394 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 47.0 t -63.64 -47.13 92.67 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.324 0 CA-C-N 116.358 -0.383 . . . . 0.0 110.587 -177.643 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 22' ' ' ILE . . . . . 0.581 HG22 HD12 ' A' ' 26' ' ' LEU . 50.7 mm -54.97 -49.51 70.52 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.204 0 O-C-N 122.227 -0.296 . . . . 0.0 110.835 179.3 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 23' ' ' ARG . . . . . . . . . . . . . 34.8 ttp180 -54.04 -49.32 69.21 Favored 'General case' 0 C--N 1.33 -0.247 0 C-N-CA 121.043 -0.263 . . . . 0.0 111.53 -178.339 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 24' ' ' ILE . . . . . . . . . . . . . 79.1 mt -58.85 -42.0 84.45 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.281 0 C-N-CA 121.181 -0.208 . . . . 0.0 111.428 -177.147 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 45.2 mttm -67.97 -42.13 81.33 Favored 'General case' 0 C--N 1.328 -0.347 0 N-CA-C 112.212 0.449 . . . . 0.0 112.212 -178.442 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 26' ' ' LEU . . . . . 0.581 HD12 HG22 ' A' ' 22' ' ' ILE . 81.6 mt -80.19 -34.72 37.22 Favored 'General case' 0 C--N 1.328 -0.34 0 N-CA-C 113.501 0.926 . . . . 0.0 113.501 -169.64 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 27' ' ' GLN . . . . . . . . . . . . . 15.8 pt20 -46.64 141.52 3.75 Favored 'General case' 0 N--CA 1.467 0.412 0 N-CA-C 112.876 0.695 . . . . 0.0 112.876 -174.84 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 100.25 -26.89 22.83 Favored Glycine 0 CA--C 1.534 1.225 0 CA-C-N 115.644 -0.707 . . . . 0.0 112.166 -177.485 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 49.2 mtpt -97.52 155.04 17.13 Favored 'General case' 0 C--O 1.233 0.205 0 CA-C-N 117.322 0.561 . . . . 0.0 110.976 178.802 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 30' ' ' THR . . . . . . . . . . . . . 25.6 m -106.21 137.71 43.67 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.189 -0.459 . . . . 0.0 110.007 176.436 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 34.9 m -129.14 159.21 41.43 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.275 0 CA-C-N 116.409 -0.359 . . . . 0.0 110.866 -178.286 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 32' ' ' ARG . . . . . . . . . . . . . 76.7 mtm180 -133.46 150.82 51.73 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-O 121.209 0.528 . . . . 0.0 110.564 178.391 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 33' ' ' THR . . . . . . . . . . . . . 13.6 m -52.69 140.23 24.12 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.203 -0.453 . . . . 0.0 111.416 -178.148 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 100.53 -17.16 57.08 Favored Glycine 0 CA--C 1.532 1.111 0 CA-C-O 119.805 -0.442 . . . . 0.0 113.315 179.673 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 74.1 m-20 -66.82 149.31 50.76 Favored 'General case' 0 N--CA 1.461 0.098 0 CA-C-N 118.021 0.91 . . . . 0.0 111.205 178.931 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 45.3 t -119.42 129.87 74.74 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.2 0 CA-C-N 115.915 -0.584 . . . . 0.0 109.737 178.007 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 37' ' ' ILE . . . . . . . . . . . . . 64.1 mt -120.48 138.71 50.1 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.238 0 CA-C-N 116.091 -0.504 . . . . 0.0 109.854 -179.332 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . -116.52 128.8 8.11 Favored Glycine 0 CA--C 1.525 0.701 0 N-CA-C 111.052 -0.819 . . . . 0.0 111.052 179.953 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 39' ' ' ILE . . . . . . . . . . . . . 71.1 mt -126.72 134.24 66.71 Favored 'Isoleucine or valine' 0 C--N 1.333 -0.138 0 CA-C-O 120.822 0.344 . . . . 0.0 110.219 178.988 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 40' ' ' SER . . . . . . . . . . . . . 8.6 t -92.79 114.52 27.1 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.224 -0.444 . . . . 0.0 110.938 175.139 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 41' ' ' ILE . . . . . . . . . . . . . 44.3 mm -121.79 119.37 58.57 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.232 0 CA-C-O 120.87 0.367 . . . . 0.0 110.353 179.912 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 9.4 tp 55.45 36.63 27.52 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.182 -0.463 . . . . 0.0 111.483 177.254 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . 72.43 24.9 75.53 Favored Glycine 0 CA--C 1.532 1.111 0 C-N-CA 121.14 -0.553 . . . . 0.0 112.659 177.929 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 44' ' ' LYS . . . . . . . . . . . . . 43.4 mmtm -132.02 130.9 41.98 Favored 'General case' 0 C--N 1.332 -0.174 0 CA-C-N 117.28 0.54 . . . . 0.0 109.748 178.609 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 84.0 tt0 -83.32 121.22 26.84 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.479 -0.328 . . . . 0.0 111.154 -178.286 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 46' ' ' VAL . . . . . 0.429 HG13 ' O ' ' A' ' 46' ' ' VAL . 11.2 p -119.73 121.41 66.09 Favored 'Isoleucine or valine' 0 C--O 1.232 0.166 0 N-CA-C 109.6 -0.518 . . . . 0.0 109.6 173.935 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 51.9 mtmt -98.72 126.48 44.35 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 115.968 -0.56 . . . . 0.0 110.657 178.243 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 48' ' ' PHE . . . . . . . . . . . . . 46.2 m-85 -110.99 131.85 54.7 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.201 -0.454 . . . . 0.0 109.816 178.631 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 80.9 tttt -106.43 130.89 54.16 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.362 -0.381 . . . . 0.0 110.044 178.329 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 50' ' ' VAL . . . . . 0.465 ' HA ' HD23 ' A' ' 6' ' ' LEU . 43.3 t -75.04 105.54 4.1 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.322 0 N-CA-C 109.414 -0.587 . . . . 0.0 109.414 177.785 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 51' ' ' VAL . . . . . . . . . . . . . 45.8 t -71.24 -51.95 30.54 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.363 0 CA-C-N 116.053 -0.521 . . . . 0.0 109.713 -175.015 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 52' ' ' GLN . . . . . . . . . . . . . 87.1 mt-30 -153.74 151.91 30.16 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-O 121.146 0.498 . . . . 0.0 111.44 -178.313 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -128.08 133.69 49.08 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 115.253 -0.885 . . . . 0.0 109.828 175.819 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 54' ' ' TYR . . . . . . . . . . . . . 58.1 t80 -129.03 108.81 18.15 Favored Pre-proline 0 CA--C 1.535 0.373 0 CA-C-O 118.363 -0.827 . . . . 0.0 110.324 -179.421 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 55' ' ' PRO . . . . . . . . . . . . . 73.5 Cg_endo -77.14 170.13 72.39 Favored 'Cis proline' 0 N--CA 1.499 1.845 0 CA-C-N 121.766 1.666 . . . . 0.0 112.372 -5.47 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 56' ' ' SER . . . . . . . . . . . . . 32.3 m -115.54 127.2 26.99 Favored Pre-proline 0 CA--C 1.538 0.494 0 CA-C-O 118.384 -0.817 . . . . 0.0 109.322 175.495 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 57' ' ' PRO . . . . . . . . . . . . . 36.9 Cg_endo -66.28 167.43 53.59 Favored 'Cis proline' 0 N--CA 1.497 1.682 0 CA-C-N 121.977 1.742 . . . . 0.0 111.708 0.063 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 58' ' ' LEU . . . . . . . . . . . . . 28.5 tp -130.98 137.26 49.16 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.136 -0.484 . . . . 0.0 110.447 -179.912 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 59' ' ' ARG . . . . . . . . . . . . . 70.8 ttt180 -102.44 130.94 49.38 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 116.149 -0.478 . . . . 0.0 109.791 177.163 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 40.8 t -80.43 112.39 18.39 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 CA-C-O 120.878 0.37 . . . . 0.0 110.397 -177.101 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 83.0 tt0 -131.0 155.41 46.87 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 115.84 -0.618 . . . . 0.0 109.461 177.433 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 62' ' ' ASP . . . . . . . . . . . . . 76.3 m-20 -50.5 -30.38 12.72 Favored 'General case' 0 C--N 1.328 -0.356 0 N-CA-C 112.208 0.447 . . . . 0.0 112.208 179.733 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 63' ' ' ARG . . . . . . . . . . . . . 77.2 mtp180 -71.99 -21.6 61.55 Favored 'General case' 0 CA--C 1.534 0.352 0 N-CA-C 112.843 0.682 . . . . 0.0 112.843 -176.768 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 27.5 m -71.59 139.3 49.33 Favored 'General case' 0 C--N 1.332 -0.159 0 CA-C-O 120.971 0.415 . . . . 0.0 111.0 -176.687 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 65' ' ' LYS . . . . . . . . . . . . . 55.0 mtmt -89.09 134.51 33.97 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-N 115.902 -0.59 . . . . 0.0 109.896 176.714 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 66' ' ' ILE . . . . . . . . . . . . . 63.3 mt -115.55 129.83 71.18 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.259 0 N-CA-C 109.925 -0.398 . . . . 0.0 109.925 -178.643 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 67' ' ' THR . . . . . . . . . . . . . 24.5 m -120.02 135.78 54.8 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.851 -179.148 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 68' ' ' LEU . . . . . 0.478 HD23 ' C ' ' A' ' 68' ' ' LEU . 6.6 tt . . . . . 0 C--N 1.329 -0.309 0 CA-C-N 115.701 -0.681 . . . . 0.0 110.039 178.168 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 74' ' ' ASP . . . . . . . . . . . . . 9.0 t0 . . . . . 0 C--O 1.231 0.103 0 N-CA-C 109.904 -0.406 . . . . 0.0 109.904 . . . . . . . . . 0 0 . 1 . 009 nuclear build core ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 41.0 t -114.26 121.98 67.46 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.255 0 CA-C-O 121.213 0.53 . . . . 0.0 110.521 -178.321 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 76' ' ' LEU . . . . . . . . . . . . . 29.9 mt -117.74 141.29 48.57 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 115.446 -0.797 . . . . 0.0 109.165 176.28 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 77' ' ' GLU . . . . . . . . . . . . . 16.8 tt0 -137.31 133.53 35.05 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-O 120.851 0.358 . . . . 0.0 111.135 -176.11 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 78' ' ' ALA . . . . . . . . . . . . . . . -125.99 141.06 52.13 Favored 'General case' 0 C--N 1.331 -0.202 0 CA-C-N 116.058 -0.519 . . . . 0.0 110.457 178.913 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 79' ' ' LYS . . . . . 0.638 ' O ' HD13 ' A' ' 80' ' ' ILE . 45.0 mmtt -79.63 121.89 25.85 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.382 -0.372 . . . . 0.0 110.38 177.992 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 80' ' ' ILE . . . . . 0.638 HD13 ' O ' ' A' ' 79' ' ' LYS . 38.5 mm -138.9 107.41 3.5 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.343 0 N-CA-C 109.386 -0.598 . . . . 0.0 109.386 -179.413 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 81' ' ' LYS . . . . . . . . . . . . . 28.7 ttpp -103.25 125.22 49.8 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-O 120.811 0.339 . . . . 0.0 111.64 -175.321 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . 89.19 42.05 5.68 Favored Glycine 0 CA--C 1.524 0.646 0 C-N-CA 121.102 -0.57 . . . . 0.0 112.012 172.48 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 83' ' ' ILE . . . . . . . . . . . . . 71.3 mt -72.85 136.75 24.87 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 N-CA-C 109.851 -0.426 . . . . 0.0 109.851 176.965 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 84' ' ' LYS . . . . . . . . . . . . . 39.6 ttpt -100.54 -48.14 4.64 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-O 120.966 0.412 . . . . 0.0 110.105 -179.438 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 85' ' ' ASP . . . . . . . . . . . . . 6.3 t70 -151.41 152.51 33.17 Favored 'General case' 0 C--N 1.331 -0.23 0 CA-C-N 115.891 -0.595 . . . . 0.0 110.548 179.1 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 86' ' ' VAL . . . . . . . . . . . . . 41.5 t -131.16 133.64 62.3 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.266 0 CA-C-O 121.034 0.445 . . . . 0.0 110.664 -178.461 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 87' ' ' ILE . . . . . . . . . . . . . 44.2 mm -119.75 125.48 74.36 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.247 0 CA-C-N 115.757 -0.656 . . . . 0.0 109.434 175.924 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 88' ' ' LEU . . . . . . . . . . . . . 14.5 tp -110.74 134.2 52.68 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-O 121.018 0.437 . . . . 0.0 111.309 -176.069 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 89' ' ' ASP . . . . . . . . . . . . . 12.9 t70 -127.5 155.1 44.28 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 115.875 -0.602 . . . . 0.0 109.829 177.497 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 43.1 tp10 -45.61 -44.09 12.78 Favored 'General case' 0 N--CA 1.465 0.308 0 N-CA-C 113.105 0.78 . . . . 0.0 113.105 -172.432 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 91' ' ' ASN . . . . . . . . . . . . . 66.0 m-80 -128.3 24.42 5.9 Favored 'General case' 0 N--CA 1.467 0.42 0 N-CA-C 112.547 0.573 . . . . 0.0 112.547 -178.421 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 92' ' ' LEU . . . . . . . . . . . . . 13.8 mt -149.78 145.68 26.76 Favored 'General case' 0 C--N 1.332 -0.169 0 N-CA-C 109.689 -0.486 . . . . 0.0 109.689 -176.832 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 93' ' ' ILE . . . . . . . . . . . . . 68.2 mt -128.47 118.54 48.0 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.306 0 N-CA-C 109.491 -0.559 . . . . 0.0 109.491 179.003 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 94' ' ' VAL . . . . . 0.451 HG21 HG11 ' A' ' 125' ' ' VAL . 46.4 t -118.53 126.14 74.91 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.252 0 N-CA-C 109.92 -0.4 . . . . 0.0 109.92 -179.6 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 95' ' ' VAL . . . . . . . . . . . . . 42.1 t -122.21 135.15 63.25 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.317 0 CA-C-N 116.054 -0.521 . . . . 0.0 109.988 -179.336 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 96' ' ' ILE . . . . . 0.423 HD11 ' HB ' ' A' ' 123' ' ' VAL . 67.1 mt -114.07 127.1 71.64 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.291 0 N-CA-C 109.366 -0.605 . . . . 0.0 109.366 179.075 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 97' ' ' THR . . . . . . . . . . . . . 68.0 p -100.08 156.73 17.02 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-O 121.397 0.617 . . . . 0.0 111.442 -176.879 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 98' ' ' GLU . . . . . . . . . . . . . 97.5 mt-10 -53.93 -25.79 22.13 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 115.822 -0.626 . . . . 0.0 112.312 -179.983 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 99' ' ' GLU . . . . . . . . . . . . . 41.5 mt-10 -80.4 18.11 0.96 Allowed 'General case' 0 CA--C 1.534 0.353 0 N-CA-C 113.003 0.742 . . . . 0.0 113.003 -177.148 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 100' ' ' ASN . . . . . . . . . . . . . 1.8 m120 63.87 35.48 10.95 Favored 'General case' 0 CA--C 1.531 0.222 0 CA-C-O 120.93 0.395 . . . . 0.0 111.145 176.634 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 101' ' ' GLU . . . . . . . . . . . . . 85.0 tt0 -118.47 142.33 47.68 Favored 'General case' 0 C--N 1.333 -0.14 0 N-CA-C 110.018 -0.364 . . . . 0.0 110.018 178.369 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 102' ' ' VAL . . . . . . . . . . . . . 45.6 t -116.39 126.67 73.97 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.297 0 N-CA-C 109.851 -0.425 . . . . 0.0 109.851 -178.686 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 103' ' ' LEU . . . . . . . . . . . . . 6.1 mp -118.37 133.48 55.84 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-N 115.807 -0.633 . . . . 0.0 110.458 177.95 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 104' ' ' ILE . . . . . . . . . . . . . 64.5 mt -117.88 119.54 61.85 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.22 0 CA-C-N 116.441 -0.345 . . . . 0.0 110.216 -179.761 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 105' ' ' PHE . . . . . . . . . . . . . 85.3 m-85 -114.87 165.26 13.04 Favored 'General case' 0 C--N 1.333 -0.146 0 O-C-N 124.042 0.839 . . . . 0.0 109.873 178.194 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 106' ' ' ASN . . . . . . . . . . . . . 49.3 p-10 -100.93 -170.27 1.82 Allowed 'General case' 0 C--N 1.331 -0.236 0 N-CA-C 109.636 -0.505 . . . . 0.0 109.636 171.727 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 107' ' ' GLN . . . . . . . . . . . . . 30.2 tt0 -58.06 -28.63 64.71 Favored 'General case' 0 C--N 1.328 -0.347 0 N-CA-C 112.261 0.467 . . . . 0.0 112.261 -179.201 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 108' ' ' ASN . . . . . . . . . . . . . 12.1 t-20 -90.88 14.19 14.4 Favored 'General case' 0 CA--C 1.533 0.314 0 N-CA-C 112.942 0.719 . . . . 0.0 112.942 -176.059 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 109' ' ' LEU . . . . . . . . . . . . . 63.4 mt 57.68 33.76 23.63 Favored 'General case' 0 CA--C 1.53 0.176 0 O-C-N 122.211 -0.306 . . . . 0.0 111.738 179.193 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 110' ' ' GLU . . . . . . . . . . . . . 70.6 mm-40 -99.66 140.83 33.29 Favored 'General case' 0 C--N 1.331 -0.225 0 N-CA-C 109.334 -0.617 . . . . 0.0 109.334 174.527 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 111' ' ' GLU . . . . . . . . . . . . . 47.5 tt0 -81.06 121.89 26.63 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-O 120.889 0.376 . . . . 0.0 110.714 -176.04 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 112' ' ' LEU . . . . . . . . . . . . . 30.9 mt -104.72 -46.02 4.44 Favored 'General case' 0 C--N 1.331 -0.219 0 CA-C-N 115.992 -0.549 . . . . 0.0 110.588 -179.857 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 113' ' ' TYR . . . . . . . . . . . . . 59.4 t80 -135.31 141.12 45.58 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.235 -0.439 . . . . 0.0 110.813 -178.682 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 114' ' ' ARG . . . . . . . . . . . . . 44.5 ptt85 -146.54 121.18 9.8 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.396 -0.366 . . . . 0.0 110.7 178.962 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 115' ' ' GLY . . . . . . . . . . . . . . . -150.15 160.4 28.52 Favored Glycine 0 CA--C 1.525 0.665 0 N-CA-C 111.008 -0.837 . . . . 0.0 111.008 179.296 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 116' ' ' LYS . . . . . . . . . . . . . 27.8 ttmt -125.59 137.41 53.9 Favored 'General case' 0 C--N 1.33 -0.248 0 N-CA-C 109.883 -0.414 . . . . 0.0 109.883 176.966 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 117' ' ' PHE . . . . . . . . . . . . . 44.1 m-85 -134.34 114.93 13.48 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.265 -0.425 . . . . 0.0 110.351 -175.513 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 118' ' ' GLU . . . . . . . . . . . . . 84.1 tt0 -50.62 -53.07 33.73 Favored 'General case' 0 C--N 1.329 -0.305 0 N-CA-C 111.98 0.363 . . . . 0.0 111.98 -176.019 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 119' ' ' ASN . . . . . . . . . . . . . 73.5 m-20 -94.94 31.01 1.94 Allowed 'General case' 0 C--N 1.33 -0.246 0 N-CA-C 112.308 0.484 . . . . 0.0 112.308 -173.505 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 120' ' ' LEU . . . . . . . . . . . . . 16.9 tp -56.4 123.07 13.42 Favored 'General case' 0 C--N 1.332 -0.178 0 C-N-CA 120.87 -0.332 . . . . 0.0 110.528 177.281 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 121' ' ' ASN . . . . . . . . . . . . . 9.9 m120 -114.09 -44.12 3.17 Favored 'General case' 0 C--N 1.331 -0.212 0 CA-C-N 116.55 -0.296 . . . . 0.0 110.985 -177.494 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 122' ' ' LYS . . . . . . . . . . . . . 91.4 mttt -145.15 148.78 33.97 Favored 'General case' 0 C--N 1.331 -0.209 0 CA-C-O 121.028 0.442 . . . . 0.0 111.728 -177.362 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 123' ' ' VAL . . . . . 0.423 ' HB ' HD11 ' A' ' 96' ' ' ILE . 44.6 t -128.63 125.73 64.0 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 N-CA-C 109.071 -0.714 . . . . 0.0 109.071 173.403 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 124' ' ' LEU . . . . . . . . . . . . . 5.8 mp -122.65 142.83 50.24 Favored 'General case' 0 C--N 1.332 -0.188 0 CA-C-O 120.836 0.351 . . . . 0.0 111.014 -175.68 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 125' ' ' VAL . . . . . 0.451 HG11 HG21 ' A' ' 94' ' ' VAL . 35.5 m -137.37 140.58 41.7 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.265 0 CA-C-N 115.999 -0.546 . . . . 0.0 110.581 179.053 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 126' ' ' ARG . . . . . . . . . . . . . 7.2 ptm85 -153.18 131.1 11.73 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-O 120.906 0.384 . . . . 0.0 110.577 176.068 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 127' ' ' ASN . . . . . . . . . . . . . 30.5 m120 50.6 -110.54 0.47 Allowed 'General case' 0 CA--C 1.545 0.763 0 CA-C-O 118.86 -0.591 . . . . 0.0 111.229 -179.691 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 128' ' ' ASP . . . . . . . . . . . . . 8.9 p-10 -114.11 7.79 16.8 Favored 'General case' 0 N--CA 1.468 0.428 0 CA-C-N 119.878 1.217 . . . . 0.0 113.314 -178.081 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 129' ' ' LEU . . . . . . . . . . . . . 11.8 tp -108.92 138.5 45.16 Favored 'General case' 0 C--N 1.332 -0.167 0 CA-C-N 118.153 0.433 . . . . 0.0 110.423 -178.825 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 130' ' ' VAL . . . . . . . . . . . . . 44.5 t -121.56 136.29 58.96 Favored 'Isoleucine or valine' 0 N--CA 1.462 0.169 0 N-CA-C 109.691 -0.485 . . . . 0.0 109.691 179.843 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 131' ' ' VAL . . . . . 0.512 HG22 HD12 ' A' ' 140' ' ' LEU . 39.0 t -134.46 136.31 52.95 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.235 0 CA-C-O 120.974 0.416 . . . . 0.0 110.504 -178.84 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 132' ' ' ILE . . . . . . . . . . . . . 71.0 mt -116.77 131.39 69.56 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 CA-C-N 115.746 -0.661 . . . . 0.0 109.267 178.722 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 133' ' ' ILE . . . . . . . . . . . . . 42.7 mm -119.36 122.3 68.69 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.223 0 CA-C-O 120.746 0.308 . . . . 0.0 110.987 -174.793 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 134' ' ' ASP . . . . . . . . . . . . . 16.6 p-10 -138.82 146.86 41.8 Favored 'General case' 0 C--N 1.332 -0.163 0 CA-C-N 116.272 -0.422 . . . . 0.0 109.872 173.744 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 135' ' ' GLU . . . . . . . . . . . . . 77.8 tt0 -49.9 -23.05 1.73 Allowed 'General case' 0 C--N 1.329 -0.305 0 N-CA-C 113.606 0.965 . . . . 0.0 113.606 -168.013 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 136' ' ' GLN . . . . . . . . . . . . . 22.3 pt20 -96.69 -27.21 14.88 Favored 'General case' 0 C--O 1.235 0.293 0 N-CA-C 112.551 0.574 . . . . 0.0 112.551 -174.011 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 137' ' ' LYS . . . . . . . . . . . . . 53.7 pttt -156.01 165.32 36.8 Favored 'General case' 0 C--O 1.233 0.205 0 CA-C-O 121.599 0.714 . . . . 0.0 112.125 -176.95 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 138' ' ' LEU . . . . . 0.408 ' C ' HD23 ' A' ' 138' ' ' LEU . 6.0 tt -119.58 127.04 52.6 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 115.02 -0.991 . . . . 0.0 109.416 176.375 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 139' ' ' THR . . . . . 0.407 ' N ' HD23 ' A' ' 138' ' ' LEU . 34.1 m -111.78 131.08 55.57 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.368 -0.378 . . . . 0.0 110.572 -178.458 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 140' ' ' LEU . . . . . 0.512 HD12 HG22 ' A' ' 131' ' ' VAL . 12.7 tp -117.31 123.81 47.44 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 115.657 -0.701 . . . . 0.0 109.273 -178.328 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 141' ' ' ILE . . . . . . . . . . . . . 19.5 mt -120.28 118.76 57.84 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.332 0 CA-C-O 120.983 0.42 . . . . 0.0 109.88 -174.859 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 142' ' ' ARG . . . . . . . . . . . . . 29.6 tpt85 -105.3 122.08 45.2 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 115.302 -0.863 . . . . 0.0 109.932 -178.251 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 143' ' ' THR . . . . . . . . . . . . . 57.2 p . . . . . 0 C--O 1.221 -0.445 0 CA-C-O 117.949 -1.024 . . . . 0.0 110.632 -178.721 . . . . . . . . 0 0 . 1 . 009 nuclear build core ' B' B ' 2' ' ' SER . . . . . . . . . . . . . 2.9 p . . . . . 0 N--CA 1.462 0.171 0 CA-C-O 120.881 0.372 . . . . 0.0 110.913 . . . . . . . . . 0 0 . 1 . 009 nuclear build core ' B' B ' 3' ' ' GLU . . . . . . . . . . . . . 84.9 tt0 -144.21 143.15 30.92 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.14 -0.482 . . . . 0.0 111.206 179.998 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' B' B ' 4' ' ' LEU . . . . . . . . . . . . . 15.5 tp -127.04 132.88 50.61 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 115.892 -0.595 . . . . 0.0 110.187 177.264 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' B' B ' 5' ' ' LYS . . . . . . . . . . . . . 95.8 mttt -112.61 122.25 47.13 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.326 -0.397 . . . . 0.0 110.799 -179.279 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' B' B ' 6' ' ' LEU . . . . . . . . . . . . . 38.7 mt -114.05 141.0 47.99 Favored 'General case' 0 C--N 1.332 -0.19 0 CA-C-N 115.506 -0.77 . . . . 0.0 110.266 -179.452 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' B' B ' 7' ' ' LYS . . . . . . . . . . . . . 74.6 tttt -121.97 136.26 26.08 Favored Pre-proline 0 CA--C 1.535 0.385 0 CA-C-O 118.839 -0.601 . . . . 0.0 109.697 176.304 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' B' B ' 8' ' ' PRO . . . . . . . . . . . . . 84.4 Cg_endo -90.47 135.31 2.1 Favored 'Trans proline' 0 N--CA 1.491 1.349 0 C-N-CA 121.656 1.57 . . . . 0.0 112.011 178.357 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' B' B ' 9' ' ' LEU . . . . . . . . . . . . . 53.9 mt -74.2 -47.93 5.96 Favored Pre-proline 0 CA--C 1.535 0.366 0 CA-C-O 118.628 -0.701 . . . . 0.0 112.336 -179.738 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' B' B ' 10' ' ' PRO . . . . . . . . . . . . . 97.4 Cg_endo -79.11 151.98 24.01 Favored 'Trans proline' 0 N--CA 1.497 1.677 0 C-N-CA 121.092 1.195 . . . . 0.0 111.882 177.563 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' B' B ' 11' ' ' LYS . . . . . . . . . . . . . 62.1 tttm -81.27 95.7 7.05 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.333 -0.394 . . . . 0.0 110.167 178.341 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' B' B ' 12' ' ' VAL . . . . . . . . . . . . . 12.3 p -141.69 146.43 23.09 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.321 0 CA-C-N 116.273 -0.421 . . . . 0.0 110.752 -177.629 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' B' B ' 13' ' ' GLU . . . . . . . . . . . . . 85.2 tt0 -99.5 114.61 27.69 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.067 -0.515 . . . . 0.0 109.895 176.581 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' B' B ' 14' ' ' LEU . . . . . . . . . . . . . 32.2 mt -92.46 160.6 34.48 Favored Pre-proline 0 C--N 1.328 -0.33 0 CA-C-N 116.328 -0.396 . . . . 0.0 111.115 -176.341 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' B' B ' 15' ' ' PRO . . . . . . . . . . . . . 35.3 Cg_exo -57.64 155.26 32.51 Favored 'Trans proline' 0 N--CA 1.496 1.62 0 C-N-CA 121.341 1.361 . . . . 0.0 111.874 -179.464 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' B' B ' 16' ' ' PRO . . . . . . . . . . . . . 33.7 Cg_exo -57.19 -40.91 79.22 Favored 'Trans proline' 0 N--CA 1.498 1.74 0 C-N-CA 121.347 1.364 . . . . 0.0 112.734 -178.262 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' B' B ' 17' ' ' ASP . . . . . . . . . . . . . 16.9 p-10 -89.46 15.69 8.85 Favored 'General case' 0 CA--C 1.534 0.362 0 N-CA-C 112.929 0.714 . . . . 0.0 112.929 -177.239 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' B' B ' 18' ' ' PHE . . . . . 0.447 ' CE2' HD11 ' B' ' 22' ' ' ILE . 27.3 t80 -57.14 -39.9 76.11 Favored 'General case' 0 C--O 1.227 -0.089 0 O-C-N 122.052 -0.405 . . . . 0.0 110.438 -179.07 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' B' B ' 19' ' ' VAL . . . . . . . . . . . . . 46.0 t -54.91 -44.59 73.57 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.201 0 CA-C-O 120.762 0.315 . . . . 0.0 110.584 -179.96 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' B' B ' 20' ' ' ASP . . . . . . . . . . . . . 74.8 m-20 -59.92 -40.99 90.76 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.482 -0.326 . . . . 0.0 110.631 -179.738 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' B' B ' 21' ' ' VAL . . . . . . . . . . . . . 47.5 t -62.69 -45.08 99.7 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.305 0 CA-C-N 116.448 -0.342 . . . . 0.0 110.265 -178.526 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' B' B ' 22' ' ' ILE . . . . . 0.714 HG22 HD12 ' B' ' 26' ' ' LEU . 51.0 mm -55.14 -49.74 69.52 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.332 0 C-N-CA 121.136 -0.226 . . . . 0.0 110.649 178.224 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' B' B ' 23' ' ' ARG . . . . . 0.46 ' HB2' HD12 ' B' ' 66' ' ' ILE . 58.7 ttp180 -53.83 -47.05 71.29 Favored 'General case' 0 C--N 1.33 -0.281 0 C-N-CA 121.079 -0.248 . . . . 0.0 111.538 -179.019 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' B' B ' 24' ' ' ILE . . . . . . . . . . . . . 70.9 mt -57.88 -45.42 87.53 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.322 0 C-N-CA 121.065 -0.254 . . . . 0.0 111.067 -177.224 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' B' B ' 25' ' ' LYS . . . . . . . . . . . . . 46.1 mtmt -70.21 -34.19 72.61 Favored 'General case' 0 C--N 1.328 -0.34 0 N-CA-C 112.378 0.51 . . . . 0.0 112.378 -177.607 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' B' B ' 26' ' ' LEU . . . . . 0.714 HD12 HG22 ' B' ' 22' ' ' ILE . 31.2 mt -80.87 -38.17 28.59 Favored 'General case' 0 C--N 1.331 -0.232 0 N-CA-C 113.579 0.955 . . . . 0.0 113.579 -171.514 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' B' B ' 27' ' ' GLN . . . . . . . . . . . . . 18.1 pt20 -45.39 139.42 3.64 Favored 'General case' 0 N--CA 1.47 0.557 0 N-CA-C 113.071 0.767 . . . . 0.0 113.071 -173.2 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' B' B ' 28' ' ' GLY . . . . . . . . . . . . . . . 98.27 -27.17 20.58 Favored Glycine 0 CA--C 1.532 1.124 0 CA-C-N 115.53 -0.759 . . . . 0.0 112.257 -178.003 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' B' B ' 29' ' ' LYS . . . . . . . . . . . . . 99.1 mttt -97.46 155.18 17.05 Favored 'General case' 0 C--O 1.233 0.22 0 CA-C-N 117.257 0.529 . . . . 0.0 111.066 179.159 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' B' B ' 30' ' ' THR . . . . . . . . . . . . . 34.7 m -105.26 138.57 41.25 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 115.879 -0.601 . . . . 0.0 110.035 176.108 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' B' B ' 31' ' ' VAL . . . . . . . . . . . . . 34.6 m -127.52 151.38 34.29 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.225 0 CA-C-O 120.925 0.393 . . . . 0.0 110.855 -178.634 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' B' B ' 32' ' ' ARG . . . . . . . . . . . . . 58.3 ttp180 -127.18 148.8 50.18 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.042 -0.526 . . . . 0.0 110.551 179.43 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' B' B ' 33' ' ' THR . . . . . . . . . . . . . 25.4 m -52.93 137.43 32.56 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.339 -0.391 . . . . 0.0 111.289 179.985 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' B' B ' 34' ' ' GLY . . . . . . . . . . . . . . . 100.96 -17.17 56.64 Favored Glycine 0 CA--C 1.533 1.175 0 C-N-CA 121.191 -0.528 . . . . 0.0 113.202 179.764 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' B' B ' 35' ' ' ASP . . . . . . . . . . . . . 57.3 m-20 -65.75 151.26 47.0 Favored 'General case' 0 C--O 1.232 0.168 0 CA-C-N 118.007 0.903 . . . . 0.0 111.089 179.86 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' B' B ' 36' ' ' VAL . . . . . . . . . . . . . 45.1 t -123.93 130.36 73.91 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.245 0 CA-C-N 116.048 -0.524 . . . . 0.0 109.868 178.717 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' B' B ' 37' ' ' ILE . . . . . . . . . . . . . 62.1 mt -120.09 137.63 53.29 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.206 0 CA-C-N 116.136 -0.484 . . . . 0.0 109.919 -179.969 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' B' B ' 38' ' ' GLY . . . . . . . . . . . . . . . -118.72 128.78 7.84 Favored Glycine 0 CA--C 1.525 0.712 0 N-CA-C 111.028 -0.829 . . . . 0.0 111.028 179.597 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' B' B ' 39' ' ' ILE . . . . . . . . . . . . . 70.8 mt -126.7 131.85 70.74 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.245 0 CA-C-O 120.825 0.345 . . . . 0.0 110.158 178.87 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' B' B ' 40' ' ' SER . . . . . . . . . . . . . 33.6 t -91.66 120.9 32.84 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.28 -0.418 . . . . 0.0 110.797 177.039 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' B' B ' 41' ' ' ILE . . . . . . . . . . . . . 72.7 mt -133.84 126.49 50.83 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.18 0 CA-C-O 120.884 0.373 . . . . 0.0 110.539 178.772 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' B' B ' 42' ' ' LEU . . . . . . . . . . . . . 42.7 mt 54.79 34.64 22.31 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-N 116.018 -0.537 . . . . 0.0 111.79 176.15 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' B' B ' 43' ' ' GLY . . . . . . . . . . . . . . . 71.89 29.36 67.28 Favored Glycine 0 CA--C 1.531 1.053 0 C-N-CA 121.027 -0.606 . . . . 0.0 112.311 177.683 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' B' B ' 44' ' ' LYS . . . . . . . . . . . . . 53.6 tttm -141.53 127.11 18.95 Favored 'General case' 0 C--N 1.33 -0.259 0 N-CA-C 109.754 -0.461 . . . . 0.0 109.754 178.144 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' B' B ' 45' ' ' GLU . . . . . . . . . . . . . 80.4 tt0 -84.07 123.36 29.95 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 116.441 -0.345 . . . . 0.0 111.133 -178.386 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' B' B ' 46' ' ' VAL . . . . . 0.43 ' O ' HG13 ' B' ' 46' ' ' VAL . 10.6 p -115.59 120.83 65.86 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.195 0 N-CA-C 109.473 -0.566 . . . . 0.0 109.473 175.034 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' B' B ' 47' ' ' LYS . . . . . . . . . . . . . 52.2 mtpt -99.2 126.98 45.11 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.047 -0.524 . . . . 0.0 110.968 178.248 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' B' B ' 48' ' ' PHE . . . . . . . . . . . . . 37.7 m-85 -110.12 132.0 54.55 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.049 -0.523 . . . . 0.0 109.746 176.7 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' B' B ' 49' ' ' LYS . . . . . . . . . . . . . 85.6 tttt -106.21 132.05 52.73 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.319 -0.401 . . . . 0.0 110.002 178.407 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' B' B ' 50' ' ' VAL . . . . . . . . . . . . . 44.4 t -76.19 105.46 5.12 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.392 0 N-CA-C 109.471 -0.566 . . . . 0.0 109.471 178.252 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' B' B ' 51' ' ' VAL . . . . . . . . . . . . . 50.6 t -73.41 -46.42 49.27 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.261 0 CA-C-N 116.042 -0.526 . . . . 0.0 110.089 -174.05 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' B' B ' 52' ' ' GLN . . . . . . . . . . . . . 30.6 tt0 -157.87 144.4 17.72 Favored 'General case' 0 C--N 1.332 -0.166 0 C-N-CA 120.09 -0.644 . . . . 0.0 111.894 -178.085 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' B' B ' 53' ' ' ALA . . . . . . . . . . . . . . . -123.5 130.91 53.38 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 115.442 -0.799 . . . . 0.0 109.775 176.364 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' B' B ' 54' ' ' TYR . . . . . . . . . . . . . 64.8 t80 -128.95 109.84 18.37 Favored Pre-proline 0 CA--C 1.535 0.377 0 CA-C-O 118.15 -0.928 . . . . 0.0 110.449 179.99 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' B' B ' 55' ' ' PRO . . . . . . . . . . . . . 74.1 Cg_endo -77.05 169.94 73.01 Favored 'Cis proline' 0 N--CA 1.499 1.841 0 CA-C-N 121.993 1.748 . . . . 0.0 112.436 -5.299 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' B' B ' 56' ' ' SER . . . . . . . . . . . . . 13.6 m -114.95 126.14 28.19 Favored Pre-proline 0 CA--C 1.537 0.463 0 CA-C-O 118.416 -0.802 . . . . 0.0 109.241 175.824 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' B' B ' 57' ' ' PRO . . . . . . . . . . . . . 61.3 Cg_endo -74.18 152.65 98.5 Favored 'Cis proline' 0 N--CA 1.495 1.61 0 CA-C-N 121.976 1.741 . . . . 0.0 111.873 1.36 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' B' B ' 58' ' ' LEU . . . . . . . . . . . . . 17.8 tp -109.44 136.09 49.41 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.165 -0.471 . . . . 0.0 110.819 -178.292 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' B' B ' 59' ' ' ARG . . . . . . . . . . . . . 57.4 ttp180 -105.2 126.2 51.82 Favored 'General case' 0 C--N 1.329 -0.319 0 N-CA-C 109.509 -0.552 . . . . 0.0 109.509 176.076 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' B' B ' 60' ' ' VAL . . . . . . . . . . . . . 40.4 t -83.23 121.03 35.58 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.315 0 C-N-CA 120.694 -0.402 . . . . 0.0 111.046 -174.498 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' B' B ' 61' ' ' GLU . . . . . . . . . . . . . 95.4 mt-10 -131.01 165.68 22.65 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 115.674 -0.694 . . . . 0.0 109.424 175.243 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' B' B ' 62' ' ' ASP . . . . . . . . . . . . . 79.8 m-20 -52.47 -33.45 44.6 Favored 'General case' 0 C--N 1.329 -0.324 0 N-CA-C 112.056 0.391 . . . . 0.0 112.056 -175.64 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' B' B ' 63' ' ' ARG . . . . . . . . . . . . . 65.8 mtp180 -76.58 -21.97 54.89 Favored 'General case' 0 C--N 1.329 -0.297 0 N-CA-C 113.088 0.773 . . . . 0.0 113.088 -175.512 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' B' B ' 64' ' ' THR . . . . . . . . . . . . . 29.8 m -61.1 138.28 58.21 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-O 120.915 0.388 . . . . 0.0 111.164 -175.137 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' B' B ' 65' ' ' LYS . . . . . . . . . . . . . 55.6 mttm -89.99 133.32 34.87 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 115.913 -0.585 . . . . 0.0 110.38 179.129 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' B' B ' 66' ' ' ILE . . . . . 0.46 HD12 ' HB2' ' B' ' 23' ' ' ARG . 66.8 mt -120.05 129.84 74.98 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.202 0 N-CA-C 109.93 -0.396 . . . . 0.0 109.93 178.0 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' B' B ' 67' ' ' THR . . . . . . . . . . . . . 31.4 m -121.33 140.13 52.5 Favored 'General case' 0 C--N 1.331 -0.213 0 CA-C-N 116.062 -0.517 . . . . 0.0 111.002 -178.352 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' B' B ' 68' ' ' LEU . . . . . 0.476 ' C ' HD23 ' B' ' 68' ' ' LEU . 6.1 tt . . . . . 0 C--N 1.331 -0.225 0 CA-C-N 115.863 -0.608 . . . . 0.0 110.238 178.882 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' B' B ' 73' ' ' VAL . . . . . . . . . . . . . 35.5 m . . . . . 0 C--O 1.232 0.179 0 N-CA-C 109.882 -0.414 . . . . 0.0 109.882 . . . . . . . . . 0 0 . 1 . 009 nuclear build core ' B' B ' 74' ' ' ASP . . . . . . . . . . . . . 27.6 t0 -99.86 116.46 31.98 Favored 'General case' 0 C--N 1.331 -0.217 0 C-N-CA 120.794 -0.363 . . . . 0.0 110.041 -178.804 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' B' B ' 75' ' ' VAL . . . . . . . . . . . . . 44.4 t -114.97 123.13 70.36 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.217 0 CA-C-O 120.96 0.41 . . . . 0.0 110.401 -177.658 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' B' B ' 76' ' ' LEU . . . . . . . . . . . . . 26.0 mt -125.31 146.95 49.33 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 115.775 -0.648 . . . . 0.0 109.65 178.806 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' B' B ' 77' ' ' GLU . . . . . . . . . . . . . 96.8 mt-10 -138.48 141.95 39.42 Favored 'General case' 0 C--N 1.332 -0.188 0 CA-C-O 121.016 0.436 . . . . 0.0 111.57 -177.656 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' B' B ' 78' ' ' ALA . . . . . 0.58 ' HB2' HD21 ' B' ' 109' ' ' LEU . . . -129.81 139.41 51.24 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 115.801 -0.636 . . . . 0.0 110.003 175.827 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' B' B ' 79' ' ' LYS . . . . . 0.45 ' O ' HD13 ' B' ' 80' ' ' ILE . 98.2 mttt -79.4 119.54 22.56 Favored 'General case' 0 C--N 1.331 -0.198 0 CA-C-O 120.78 0.324 . . . . 0.0 110.937 -178.128 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' B' B ' 80' ' ' ILE . . . . . 0.45 HD13 ' O ' ' B' ' 79' ' ' LYS . 25.9 mm -139.19 113.08 6.91 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 N-CA-C 109.171 -0.678 . . . . 0.0 109.171 -178.673 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' B' B ' 81' ' ' LYS . . . . . . . . . . . . . 62.4 mttm -108.99 127.27 53.93 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-O 121.04 0.448 . . . . 0.0 111.376 -177.173 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' B' B ' 82' ' ' GLY . . . . . . . . . . . . . . . 89.15 41.99 5.71 Favored Glycine 0 CA--C 1.526 0.747 0 CA-C-N 115.833 -0.621 . . . . 0.0 111.823 174.199 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' B' B ' 83' ' ' ILE . . . . . . . . . . . . . 71.0 mt -72.95 140.44 17.88 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.318 0 N-CA-C 110.099 -0.334 . . . . 0.0 110.099 178.329 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' B' B ' 84' ' ' LYS . . . . . . . . . . . . . 28.5 ttmt -97.53 -53.22 3.51 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.174 -0.466 . . . . 0.0 109.94 179.175 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' B' B ' 85' ' ' ASP . . . . . . . . . . . . . 7.0 t70 -152.38 151.51 30.92 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 115.76 -0.655 . . . . 0.0 110.556 -179.535 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' B' B ' 86' ' ' VAL . . . . . . . . . . . . . 42.8 t -128.82 130.11 68.52 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.24 0 CA-C-O 120.912 0.387 . . . . 0.0 110.289 -179.238 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' B' B ' 87' ' ' ILE . . . . . 0.498 ' N ' HD12 ' B' ' 87' ' ' ILE . 5.1 mp -119.44 128.26 75.86 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.178 0 N-CA-C 109.531 -0.544 . . . . 0.0 109.531 177.134 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' B' B ' 88' ' ' LEU . . . . . . . . . . . . . 57.0 mt -114.34 140.89 48.26 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-O 121.204 0.526 . . . . 0.0 111.263 -177.764 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' B' B ' 89' ' ' ASP . . . . . . . . . . . . . 5.0 t70 -132.27 158.94 40.53 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 115.376 -0.829 . . . . 0.0 109.457 176.517 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' B' B ' 90' ' ' GLU . . . . . . . . . . . . . 83.0 tt0 -46.33 -41.68 13.7 Favored 'General case' 0 C--N 1.331 -0.238 0 N-CA-C 112.975 0.731 . . . . 0.0 112.975 -173.19 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' B' B ' 91' ' ' ASN . . . . . . . . . . . . . 9.5 p-10 -132.19 38.01 3.52 Favored 'General case' 0 N--CA 1.464 0.231 0 CA-C-O 120.704 0.288 . . . . 0.0 111.391 -177.696 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' B' B ' 92' ' ' LEU . . . . . . . . . . . . . 11.6 tp -163.45 142.23 8.11 Favored 'General case' 0 C--N 1.331 -0.226 0 C-N-CA 120.865 -0.334 . . . . 0.0 110.89 -177.978 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' B' B ' 93' ' ' ILE . . . . . . . . . . . . . 76.9 mt -127.65 119.08 50.92 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 N-CA-C 109.284 -0.635 . . . . 0.0 109.284 177.715 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' B' B ' 94' ' ' VAL . . . . . 0.749 HG21 HG11 ' B' ' 125' ' ' VAL . 47.3 t -123.44 127.11 74.07 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.234 0 CA-C-O 120.978 0.418 . . . . 0.0 110.123 -179.8 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' B' B ' 95' ' ' VAL . . . . . . . . . . . . . 41.9 t -121.97 137.18 56.43 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.337 0 CA-C-N 115.741 -0.663 . . . . 0.0 109.91 -178.377 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' B' B ' 96' ' ' ILE . . . . . 0.522 HD11 ' HB ' ' B' ' 123' ' ' VAL . 58.0 mt -114.75 127.8 72.12 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.263 0 N-CA-C 109.362 -0.607 . . . . 0.0 109.362 179.126 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' B' B ' 97' ' ' THR . . . . . . . . . . . . . 67.6 p -102.5 154.34 19.19 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-O 121.199 0.524 . . . . 0.0 111.383 -177.626 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' B' B ' 98' ' ' GLU . . . . . . . . . . . . . 46.5 tp10 -53.95 -25.56 21.24 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 115.984 -0.553 . . . . 0.0 112.207 179.751 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' B' B ' 99' ' ' GLU . . . . . . . . . . . . . 32.6 tt0 -78.82 16.74 0.82 Allowed 'General case' 0 CA--C 1.537 0.469 0 N-CA-C 112.812 0.671 . . . . 0.0 112.812 -177.82 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' B' B ' 100' ' ' ASN . . . . . . . . . . . . . 4.1 m-20 61.67 37.94 15.59 Favored 'General case' 0 CA--C 1.53 0.181 0 O-C-N 121.894 -0.503 . . . . 0.0 110.855 178.066 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' B' B ' 101' ' ' GLU . . . . . . . . . . . . . 84.5 tt0 -116.54 143.35 45.71 Favored 'General case' 0 C--N 1.333 -0.149 0 CA-C-N 115.935 -0.575 . . . . 0.0 109.724 177.603 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' B' B ' 102' ' ' VAL . . . . . . . . . . . . . 44.7 t -114.98 125.05 72.2 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.331 0 CA-C-N 116.206 -0.452 . . . . 0.0 109.857 -178.822 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' B' B ' 103' ' ' LEU . . . . . . . . . . . . . 24.2 mt -116.84 128.26 55.09 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 115.807 -0.633 . . . . 0.0 110.348 177.84 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' B' B ' 104' ' ' ILE . . . . . . . . . . . . . 68.1 mt -120.39 121.04 64.57 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.26 0 CA-C-N 116.64 -0.254 . . . . 0.0 110.428 179.688 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' B' B ' 105' ' ' PHE . . . . . . . . . . . . . 52.5 m-85 -121.85 166.77 13.88 Favored 'General case' 0 C--N 1.333 -0.139 0 CA-C-N 115.674 -0.693 . . . . 0.0 109.678 178.611 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' B' B ' 106' ' ' ASN . . . . . . . . . . . . . 45.1 p-10 -99.57 -171.02 1.99 Allowed 'General case' 0 C--N 1.329 -0.285 0 N-CA-C 109.876 -0.416 . . . . 0.0 109.876 173.318 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' B' B ' 107' ' ' GLN . . . . . . . . . . . . . 45.4 tt0 -60.23 -29.63 68.87 Favored 'General case' 0 C--N 1.329 -0.293 0 N-CA-C 112.001 0.371 . . . . 0.0 112.001 179.979 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' B' B ' 108' ' ' ASN . . . . . . . . . . . . . 4.5 t-20 -82.49 7.34 14.64 Favored 'General case' 0 CA--C 1.536 0.431 0 N-CA-C 113.163 0.801 . . . . 0.0 113.163 -177.633 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' B' B ' 109' ' ' LEU . . . . . 0.58 HD21 ' HB2' ' B' ' 78' ' ' ALA . 12.5 tp 61.63 38.18 15.53 Favored 'General case' 0 C--N 1.333 -0.139 0 CA-C-O 121.165 0.507 . . . . 0.0 111.205 179.073 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' B' B ' 110' ' ' GLU . . . . . . . . . . . . . 95.7 mt-10 -108.07 148.13 30.21 Favored 'General case' 0 C--N 1.33 -0.281 0 N-CA-C 109.539 -0.541 . . . . 0.0 109.539 174.871 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' B' B ' 111' ' ' GLU . . . . . . . . . . . . . 49.3 tt0 -83.21 122.03 27.87 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-O 120.896 0.379 . . . . 0.0 111.023 -175.624 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' B' B ' 112' ' ' LEU . . . . . . . . . . . . . 84.8 mt -104.83 -46.03 4.41 Favored 'General case' 0 C--N 1.331 -0.203 0 CA-C-N 116.025 -0.534 . . . . 0.0 110.591 178.844 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' B' B ' 113' ' ' TYR . . . . . . . . . . . . . 42.3 t80 -137.15 136.71 38.48 Favored 'General case' 0 C--N 1.331 -0.223 0 CA-C-N 116.357 -0.383 . . . . 0.0 111.363 -177.823 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' B' B ' 114' ' ' ARG . . . . . . . . . . . . . 46.2 ttp180 -137.17 125.64 23.51 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 115.913 -0.585 . . . . 0.0 110.039 176.474 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' B' B ' 115' ' ' GLY . . . . . . . . . . . . . . . -150.03 154.71 25.85 Favored Glycine 0 CA--C 1.525 0.667 0 C-N-CA 120.756 -0.735 . . . . 0.0 111.271 178.932 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' B' B ' 116' ' ' LYS . . . . . . . . . . . . . 30.8 ttpt -128.62 130.67 47.62 Favored 'General case' 0 C--N 1.329 -0.304 0 N-CA-C 109.797 -0.446 . . . . 0.0 109.797 177.778 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' B' B ' 117' ' ' PHE . . . . . . . . . . . . . 46.1 m-85 -128.79 116.21 19.13 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-O 120.926 0.393 . . . . 0.0 110.464 -175.987 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' B' B ' 118' ' ' GLU . . . . . . . . . . . . . 95.9 mt-10 -52.65 -46.76 67.29 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.361 -0.381 . . . . 0.0 111.573 -176.942 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' B' B ' 119' ' ' ASN . . . . . . . . . . . . . 9.8 m120 -99.57 30.97 3.35 Favored 'General case' 0 C--N 1.33 -0.272 0 N-CA-C 112.22 0.452 . . . . 0.0 112.22 -174.35 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' B' B ' 120' ' ' LEU . . . . . . . . . . . . . 15.8 tp -54.21 125.78 20.47 Favored 'General case' 0 N--CA 1.462 0.17 0 CA-C-O 120.718 0.294 . . . . 0.0 110.984 179.22 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' B' B ' 121' ' ' ASN . . . . . . . . . . . . . 31.3 m120 -107.92 -44.1 4.28 Favored 'General case' 0 C--N 1.331 -0.212 0 CA-C-N 116.367 -0.379 . . . . 0.0 110.806 -177.98 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' B' B ' 122' ' ' LYS . . . . . . . . . . . . . 1.2 ptpm? -160.29 157.35 27.9 Favored 'General case' 0 C--N 1.332 -0.19 0 CA-C-O 121.231 0.538 . . . . 0.0 112.056 -179.348 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' B' B ' 123' ' ' VAL . . . . . 0.522 ' HB ' HD11 ' B' ' 96' ' ' ILE . 46.8 t -127.23 131.51 70.53 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.224 0 CA-C-N 115.587 -0.733 . . . . 0.0 109.526 176.707 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' B' B ' 124' ' ' LEU . . . . . . . . . . . . . 14.4 tp -126.8 138.81 53.41 Favored 'General case' 0 N--CA 1.463 0.19 0 CA-C-N 116.496 -0.32 . . . . 0.0 110.541 -177.988 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' B' B ' 125' ' ' VAL . . . . . 0.749 HG11 HG21 ' B' ' 94' ' ' VAL . 34.7 m -132.68 141.99 43.6 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.182 0 CA-C-O 120.835 0.35 . . . . 0.0 111.328 -177.654 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' B' B ' 126' ' ' ARG . . . . . . . . . . . . . 88.9 mtt180 -146.57 118.07 7.97 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.658 175.128 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' B' B ' 127' ' ' ASN . . . . . . . . . . . . . 75.2 m-80 52.0 -106.43 0.27 Allowed 'General case' 0 CA--C 1.544 0.715 0 CA-C-O 118.97 -0.538 . . . . 0.0 111.256 178.996 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' B' B ' 128' ' ' ASP . . . . . . . . . . . . . 15.5 p-10 -114.07 3.16 15.18 Favored 'General case' 0 N--CA 1.469 0.484 0 CA-C-N 119.649 1.113 . . . . 0.0 113.295 -177.893 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' B' B ' 129' ' ' LEU . . . . . . . . . . . . . 15.6 tp -105.34 135.48 46.65 Favored 'General case' 0 C--N 1.332 -0.184 0 N-CA-C 109.553 -0.536 . . . . 0.0 109.553 178.084 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' B' B ' 130' ' ' VAL . . . . . . . . . . . . . 41.1 t -124.63 140.46 47.79 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.235 0 N-CA-C 110.136 -0.32 . . . . 0.0 110.136 -177.751 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' B' B ' 131' ' ' VAL . . . . . 0.403 HG22 HD12 ' B' ' 140' ' ' LEU . 41.5 t -133.51 135.07 56.39 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 CA-C-O 120.963 0.411 . . . . 0.0 110.145 178.788 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' B' B ' 132' ' ' ILE . . . . . . . . . . . . . 70.1 mt -116.92 131.41 69.68 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.314 0 N-CA-C 109.197 -0.668 . . . . 0.0 109.197 178.297 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' B' B ' 133' ' ' ILE . . . . . . . . . . . . . 43.3 mm -115.94 120.94 66.3 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.316 0 CA-C-N 116.406 -0.361 . . . . 0.0 110.819 -174.901 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' B' B ' 134' ' ' ASP . . . . . . . . . . . . . 8.6 p-10 -134.37 147.48 50.52 Favored 'General case' 0 C--N 1.331 -0.2 0 N-CA-C 109.545 -0.539 . . . . 0.0 109.545 174.346 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' B' B ' 135' ' ' GLU . . . . . . . . . . . . . 84.9 tt0 -49.84 -24.36 2.39 Favored 'General case' 0 C--N 1.328 -0.357 0 N-CA-C 112.894 0.702 . . . . 0.0 112.894 -172.537 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' B' B ' 136' ' ' GLN . . . . . . . . . . . . . 96.1 mt-30 -99.81 -27.93 13.39 Favored 'General case' 0 N--CA 1.463 0.182 0 N-CA-C 112.727 0.64 . . . . 0.0 112.727 -174.672 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' B' B ' 137' ' ' LYS . . . . . . . . . . . . . 94.4 mttt -141.94 150.66 41.73 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-O 121.467 0.651 . . . . 0.0 112.296 -169.531 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' B' B ' 138' ' ' LEU . . . . . . . . . . . . . 11.3 tp -112.06 118.48 35.53 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 114.988 -1.005 . . . . 0.0 108.987 170.945 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' B' B ' 139' ' ' THR . . . . . . . . . . . . . 25.6 m -110.38 125.22 52.98 Favored 'General case' 0 C--N 1.331 -0.216 0 CA-C-O 120.644 0.259 . . . . 0.0 111.127 -177.014 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' B' B ' 140' ' ' LEU . . . . . 0.403 HD12 HG22 ' B' ' 131' ' ' VAL . 23.3 tp -114.56 122.8 47.65 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 115.652 -0.704 . . . . 0.0 109.354 179.586 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' B' B ' 141' ' ' ILE . . . . . . . . . . . . . 19.3 mt -121.87 125.16 72.86 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.247 0 CA-C-O 120.856 0.36 . . . . 0.0 110.199 -174.094 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' B' B ' 142' ' ' ARG . . . . . . . . . . . . . 79.0 mtp180 -114.53 129.38 56.66 Favored 'General case' 0 C--N 1.331 -0.212 0 CA-C-N 115.67 -0.695 . . . . 0.0 110.351 -179.34 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' B' B ' 143' ' ' THR . . . . . . . . . . . . . 26.0 p . . . . . 0 C--O 1.221 -0.424 0 CA-C-O 118.015 -0.993 . . . . 0.0 110.525 179.749 . . . . . . . . 0 0 . 1 . 009 nuclear build core ' C' C ' 2' ' ' SER . . . . . . . . . . . . . 2.3 p . . . . . 0 C--O 1.232 0.15 0 CA-C-O 121.008 0.433 . . . . 0.0 110.36 . . . . . . . . . 0 0 . 1 . 009 nuclear build core ' C' C ' 3' ' ' GLU . . . . . . . . . . . . . 85.3 tt0 -140.12 141.6 36.09 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 115.795 -0.639 . . . . 0.0 111.088 -177.001 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' C' C ' 4' ' ' LEU . . . . . 0.422 HD21 HD21 ' C' ' 6' ' ' LEU . 13.2 tp -124.11 130.39 52.46 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 115.765 -0.652 . . . . 0.0 110.116 177.497 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' C' C ' 5' ' ' LYS . . . . . . . . . . . . . 53.5 mttp -108.65 120.35 42.21 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.185 -0.462 . . . . 0.0 110.541 179.817 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' C' C ' 6' ' ' LEU . . . . . 0.422 HD21 HD21 ' C' ' 4' ' ' LEU . 55.4 mt -114.48 147.93 38.6 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 115.427 -0.806 . . . . 0.0 110.45 -178.827 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' C' C ' 7' ' ' LYS . . . . . . . . . . . . . 78.7 tttt -139.85 138.87 20.4 Favored Pre-proline 0 CA--C 1.534 0.328 0 CA-C-O 119.081 -0.485 . . . . 0.0 110.162 176.249 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' C' C ' 8' ' ' PRO . . . . . . . . . . . . . 98.2 Cg_endo -92.08 144.43 2.81 Favored 'Trans proline' 0 N--CA 1.49 1.267 0 C-N-CA 121.69 1.593 . . . . 0.0 111.812 177.482 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' C' C ' 9' ' ' LEU . . . . . . . . . . . . . 53.0 mt -74.94 -47.1 4.88 Favored Pre-proline 0 CA--C 1.534 0.353 0 CA-C-O 118.699 -0.667 . . . . 0.0 112.051 -179.524 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' C' C ' 10' ' ' PRO . . . . . . . . . . . . . 96.5 Cg_endo -82.28 156.56 17.04 Favored 'Trans proline' 0 N--CA 1.496 1.64 0 C-N-CA 121.221 1.281 . . . . 0.0 111.808 175.27 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' C' C ' 11' ' ' LYS . . . . . . . . . . . . . 59.3 tttm -88.7 106.57 18.42 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.428 -0.351 . . . . 0.0 110.24 178.32 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' C' C ' 12' ' ' VAL . . . . . . . . . . . . . 12.4 p -140.46 148.47 22.19 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.243 0 CA-C-N 116.248 -0.433 . . . . 0.0 110.632 -178.659 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' C' C ' 13' ' ' GLU . . . . . . . . . . . . . 83.2 tt0 -90.91 122.0 33.23 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 116.131 -0.486 . . . . 0.0 110.21 178.522 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' C' C ' 14' ' ' LEU . . . . . . . . . . . . . 35.5 mt -98.55 151.84 37.64 Favored Pre-proline 0 CA--C 1.532 0.282 0 CA-C-N 116.383 -0.371 . . . . 0.0 110.948 -176.706 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' C' C ' 15' ' ' PRO . . . . . . . . . . . . . 24.2 Cg_exo -63.96 158.01 49.75 Favored 'Trans proline' 0 N--CA 1.497 1.722 0 C-N-CA 121.266 1.311 . . . . 0.0 111.721 174.871 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' C' C ' 16' ' ' PRO . . . . . . . . . . . . . 39.4 Cg_exo -58.72 -38.87 86.86 Favored 'Trans proline' 0 N--CA 1.496 1.665 0 C-N-CA 121.409 1.406 . . . . 0.0 112.776 -178.965 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' C' C ' 17' ' ' ASP . . . . . . . . . . . . . 12.7 p-10 -87.95 11.94 14.54 Favored 'General case' 0 CA--C 1.536 0.424 0 N-CA-C 113.148 0.796 . . . . 0.0 113.148 -177.402 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' C' C ' 18' ' ' PHE . . . . . . . . . . . . . 44.9 t80 -57.95 -44.74 87.17 Favored 'General case' 0 C--N 1.335 -0.065 0 O-C-N 122.007 -0.433 . . . . 0.0 110.113 -178.826 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' C' C ' 19' ' ' VAL . . . . . 0.413 HG13 ' N ' ' C' ' 20' ' ' ASP . 12.7 p -56.94 -41.61 77.15 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.357 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.726 -179.145 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' C' C ' 20' ' ' ASP . . . . . 0.413 ' N ' HG13 ' C' ' 19' ' ' VAL . 79.6 m-20 -60.65 -42.93 97.97 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-O 120.843 0.354 . . . . 0.0 111.015 -177.709 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' C' C ' 21' ' ' VAL . . . . . . . . . . . . . 47.1 t -63.94 -47.98 88.18 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.338 0 C-N-CA 120.782 -0.367 . . . . 0.0 110.383 -178.076 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' C' C ' 22' ' ' ILE . . . . . 0.485 HG22 HD12 ' C' ' 26' ' ' LEU . 46.4 mm -58.11 -38.49 67.96 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.298 0 CA-C-O 120.841 0.353 . . . . 0.0 110.56 179.407 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' C' C ' 23' ' ' ARG . . . . . . . . . . . . . 56.3 ttp180 -55.53 -48.24 75.01 Favored 'General case' 0 C--N 1.33 -0.253 0 O-C-N 122.094 -0.379 . . . . 0.0 110.845 177.429 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' C' C ' 24' ' ' ILE . . . . . . . . . . . . . 67.2 mt -60.24 -41.9 88.54 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.358 0 CA-C-N 116.148 -0.478 . . . . 0.0 111.75 -177.776 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' C' C ' 25' ' ' LYS . . . . . . . . . . . . . 16.1 ptmt -72.33 -36.08 68.76 Favored 'General case' 0 CA--C 1.534 0.328 0 C-N-CA 120.561 -0.455 . . . . 0.0 112.077 -176.044 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' C' C ' 26' ' ' LEU . . . . . 0.485 HD12 HG22 ' C' ' 22' ' ' ILE . 78.3 mt -78.54 -41.78 31.19 Favored 'General case' 0 C--N 1.33 -0.247 0 N-CA-C 112.887 0.699 . . . . 0.0 112.887 -172.952 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' C' C ' 27' ' ' GLN . . . . . . . . . . . . . 14.4 pt20 -46.38 138.53 5.56 Favored 'General case' 0 N--CA 1.468 0.466 0 N-CA-C 112.812 0.671 . . . . 0.0 112.812 -175.338 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' C' C ' 28' ' ' GLY . . . . . . . . . . . . . . . 100.62 -26.65 23.82 Favored Glycine 0 CA--C 1.532 1.119 0 CA-C-N 115.55 -0.75 . . . . 0.0 112.135 -177.891 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' C' C ' 29' ' ' LYS . . . . . . . . . . . . . 59.7 mmtt -97.82 155.23 17.14 Favored 'General case' 0 C--O 1.233 0.217 0 CA-C-N 117.445 0.623 . . . . 0.0 111.019 178.699 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' C' C ' 30' ' ' THR . . . . . . . . . . . . . 40.5 m -100.08 135.79 40.97 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 115.883 -0.599 . . . . 0.0 109.688 174.24 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' C' C ' 31' ' ' VAL . . . . . . . . . . . . . 34.9 m -125.91 154.8 35.23 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.211 0 CA-C-N 116.5 -0.318 . . . . 0.0 110.602 -178.367 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' C' C ' 32' ' ' ARG . . . . . . . . . . . . . 46.3 ttt180 -135.71 149.13 49.13 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-O 121.225 0.536 . . . . 0.0 110.667 179.624 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' C' C ' 33' ' ' THR . . . . . . . . . . . . . 18.2 m -52.48 140.51 22.35 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.286 -0.415 . . . . 0.0 111.426 -178.339 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' C' C ' 34' ' ' GLY . . . . . . . . . . . . . . . 99.71 -17.04 58.03 Favored Glycine 0 CA--C 1.532 1.11 0 CA-C-O 119.656 -0.524 . . . . 0.0 113.224 179.073 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' C' C ' 35' ' ' ASP . . . . . . . . . . . . . 72.6 m-20 -64.59 149.19 49.33 Favored 'General case' 0 C--O 1.231 0.1 0 CA-C-N 118.13 0.965 . . . . 0.0 111.081 179.426 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' C' C ' 36' ' ' VAL . . . . . . . . . . . . . 45.6 t -126.01 130.69 72.24 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.249 0 CA-C-N 115.995 -0.548 . . . . 0.0 109.838 178.477 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' C' C ' 37' ' ' ILE . . . . . . . . . . . . . 66.6 mt -121.93 139.69 48.2 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.299 0 CA-C-N 116.292 -0.413 . . . . 0.0 110.194 -178.953 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' C' C ' 38' ' ' GLY . . . . . . . . . . . . . . . -108.7 128.85 9.25 Favored Glycine 0 CA--C 1.526 0.748 0 N-CA-C 110.96 -0.856 . . . . 0.0 110.96 179.285 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' C' C ' 39' ' ' ILE . . . . . . . . . . . . . 72.6 mt -125.78 132.22 71.02 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.181 0 N-CA-C 110.191 -0.3 . . . . 0.0 110.191 179.829 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' C' C ' 40' ' ' SER . . . . . . . . . . . . . 27.6 t -92.78 122.16 34.9 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.418 -0.356 . . . . 0.0 110.886 175.581 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' C' C ' 41' ' ' ILE . . . . . . . . . . . . . 72.3 mt -131.01 116.89 35.43 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.223 0 CA-C-O 121.031 0.443 . . . . 0.0 110.55 178.699 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' C' C ' 42' ' ' LEU . . . . . 0.532 ' O ' HD23 ' C' ' 42' ' ' LEU . 1.3 tt 51.46 47.4 24.89 Favored 'General case' 0 CA--C 1.531 0.217 0 CA-C-N 115.768 -0.651 . . . . 0.0 111.208 175.996 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' C' C ' 43' ' ' GLY . . . . . . . . . . . . . . . 70.17 21.38 77.09 Favored Glycine 0 CA--C 1.531 1.075 0 C-N-CA 121.081 -0.58 . . . . 0.0 112.79 175.016 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' C' C ' 44' ' ' LYS . . . . . . . . . . . . . 59.4 mtpt -131.65 128.35 38.88 Favored 'General case' 0 C--N 1.331 -0.212 0 CA-C-N 117.692 0.746 . . . . 0.0 110.098 179.068 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' C' C ' 45' ' ' GLU . . . . . . . . . . . . . 83.2 tt0 -83.8 123.14 29.58 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 116.441 -0.345 . . . . 0.0 110.997 -179.68 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' C' C ' 46' ' ' VAL . . . . . . . . . . . . . 7.2 p -123.15 128.26 74.92 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.204 0 N-CA-C 109.722 -0.473 . . . . 0.0 109.722 176.669 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' C' C ' 47' ' ' LYS . . . . . . . . . . . . . 63.2 mttp -100.19 128.65 46.23 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.085 -0.507 . . . . 0.0 111.089 177.664 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' C' C ' 48' ' ' PHE . . . . . . . . . . . . . 91.1 m-85 -110.5 131.83 54.71 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.206 -0.452 . . . . 0.0 109.863 176.346 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' C' C ' 49' ' ' LYS . . . . . . . . . . . . . 79.2 tttt -108.61 137.99 45.66 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.377 -0.374 . . . . 0.0 110.424 178.978 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' C' C ' 50' ' ' VAL . . . . . . . . . . . . . 44.9 t -79.73 106.28 10.55 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.335 0 N-CA-C 109.335 -0.617 . . . . 0.0 109.335 175.828 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' C' C ' 51' ' ' VAL . . . . . . . . . . . . . 48.2 t -69.81 -47.67 68.69 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.284 0 CA-C-N 116.052 -0.522 . . . . 0.0 109.863 -173.486 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' C' C ' 52' ' ' GLN . . . . . . . . . . . . . 21.4 pt20 -167.85 158.88 11.11 Favored 'General case' 0 C--N 1.332 -0.192 0 C-N-CA 120.165 -0.614 . . . . 0.0 111.643 179.482 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' C' C ' 53' ' ' ALA . . . . . . . . . . . . . . . -135.56 138.68 43.24 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 115.564 -0.743 . . . . 0.0 110.229 178.94 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' C' C ' 54' ' ' TYR . . . . . . . . . . . . . 63.6 t80 -128.9 110.31 18.52 Favored Pre-proline 0 CA--C 1.534 0.36 0 CA-C-O 118.156 -0.926 . . . . 0.0 110.259 179.772 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' C' C ' 55' ' ' PRO . . . . . . . . . . . . . 73.4 Cg_endo -77.17 170.06 72.55 Favored 'Cis proline' 0 N--CA 1.501 1.926 0 CA-C-N 121.908 1.717 . . . . 0.0 112.236 -7.91 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' C' C ' 56' ' ' SER . . . . . . . . . . . . . 51.1 m -121.24 134.6 24.49 Favored Pre-proline 0 CA--C 1.537 0.457 0 CA-C-O 118.582 -0.723 . . . . 0.0 109.619 175.09 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' C' C ' 57' ' ' PRO . . . . . . . . . . . . . 36.3 Cg_endo -66.41 164.68 66.05 Favored 'Cis proline' 0 N--CA 1.499 1.799 0 CA-C-N 121.841 1.693 . . . . 0.0 111.521 -2.944 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' C' C ' 58' ' ' LEU . . . . . . . . . . . . . 32.8 tp -130.77 139.68 50.25 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-O 120.947 0.403 . . . . 0.0 110.663 -178.338 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' C' C ' 59' ' ' ARG . . . . . . . . . . . . . 55.2 ttm-85 -96.1 129.5 43.37 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-N 115.762 -0.654 . . . . 0.0 109.338 174.367 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' C' C ' 60' ' ' VAL . . . . . . . . . . . . . 40.9 t -86.14 121.11 37.02 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.268 0 C-N-CA 120.624 -0.431 . . . . 0.0 110.4 -177.917 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' C' C ' 61' ' ' GLU . . . . . . . . . . . . . 71.6 tt0 -130.57 157.66 42.1 Favored 'General case' 0 C--N 1.329 -0.31 0 N-CA-C 109.113 -0.699 . . . . 0.0 109.113 177.523 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' C' C ' 62' ' ' ASP . . . . . . . . . . . . . 12.8 t70 -51.22 -32.28 23.45 Favored 'General case' 0 C--N 1.327 -0.404 0 N-CA-C 112.07 0.396 . . . . 0.0 112.07 -178.282 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' C' C ' 63' ' ' ARG . . . . . . . . . . . . . 98.2 mtt180 -77.18 -21.94 53.21 Favored 'General case' 0 CA--C 1.533 0.29 0 N-CA-C 112.857 0.688 . . . . 0.0 112.857 -177.812 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' C' C ' 64' ' ' THR . . . . . . . . . . . . . 20.0 m -57.46 141.8 46.27 Favored 'General case' 0 C--N 1.331 -0.207 0 CA-C-O 120.842 0.353 . . . . 0.0 110.642 -176.478 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' C' C ' 65' ' ' LYS . . . . . . . . . . . . . 40.2 ttpt -89.13 121.44 31.45 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.1 -0.5 . . . . 0.0 110.279 -179.63 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' C' C ' 66' ' ' ILE . . . . . . . . . . . . . 63.1 mt -113.5 129.15 69.82 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.241 0 N-CA-C 109.87 -0.418 . . . . 0.0 109.87 -179.718 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' C' C ' 67' ' ' THR . . . . . . . . . . . . . 18.8 m -129.08 143.86 51.0 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-O 121.142 0.496 . . . . 0.0 111.236 -177.433 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' C' C ' 68' ' ' LEU . . . . . . . . . . . . . 17.1 tp . . . . . 0 C--N 1.329 -0.323 0 CA-C-N 115.827 -0.624 . . . . 0.0 110.092 177.58 . . . . . . . . 0 0 . 1 . 009 nuclear build core ' C' C ' 73' ' ' VAL . . . . . . . . . . . . . 35.5 m . . . . . 0 C--O 1.232 0.15 0 N-CA-C 109.598 -0.519 . . . . 0.0 109.598 . . . . . . . . . 0 0 . 1 . 009 nuclear build core ' C' C ' 74' ' ' ASP . . . . . . . . . . . . . 27.6 t0 -98.71 119.81 38.08 Favored 'General case' 0 C--N 1.331 -0.203 0 C-N-CA 120.805 -0.358 . . . . 0.0 110.193 -176.185 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' C' C ' 75' ' ' VAL . . . . . 0.402 ' C ' HD12 ' C' ' 76' ' ' LEU . 40.6 t -119.13 121.9 67.87 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.237 0 CA-C-O 121.094 0.473 . . . . 0.0 110.63 -178.009 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' C' C ' 76' ' ' LEU . . . . . 0.402 HD12 ' C ' ' C' ' 75' ' ' VAL . 7.1 mp -117.25 139.78 50.37 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 115.669 -0.696 . . . . 0.0 109.402 175.437 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' C' C ' 77' ' ' GLU . . . . . . . . . . . . . 98.0 mt-10 -135.47 129.08 32.6 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-O 121.072 0.463 . . . . 0.0 111.007 -178.401 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' C' C ' 78' ' ' ALA . . . . . 0.481 ' HB2' HD21 ' C' ' 109' ' ' LEU . . . -117.66 136.69 53.15 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 115.638 -0.71 . . . . 0.0 109.957 177.778 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' C' C ' 79' ' ' LYS . . . . . 0.612 ' O ' HD13 ' C' ' 80' ' ' ILE . 68.4 mmtt -73.37 116.01 13.42 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.512 -0.313 . . . . 0.0 110.16 -179.107 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' C' C ' 80' ' ' ILE . . . . . 0.612 HD13 ' O ' ' C' ' 79' ' ' LYS . 39.7 mm -139.09 110.63 5.13 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.303 0 N-CA-C 109.56 -0.533 . . . . 0.0 109.56 -177.433 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' C' C ' 81' ' ' LYS . . . . . . . . . . . . . 99.5 mttt -112.56 128.73 56.44 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-O 120.95 0.405 . . . . 0.0 110.775 -178.852 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' C' C ' 82' ' ' GLY . . . . . . . . . . . . . . . 89.08 42.16 5.68 Favored Glycine 0 CA--C 1.525 0.679 0 C-N-CA 121.024 -0.608 . . . . 0.0 111.649 176.835 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' C' C ' 83' ' ' ILE . . . . . . . . . . . . . 72.0 mt -69.51 136.17 26.78 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.22 0 N-CA-C 109.718 -0.475 . . . . 0.0 109.718 177.23 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' C' C ' 84' ' ' LYS . . . . . . . . . . . . . 60.2 tttp -97.81 -53.56 3.37 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.054 -0.521 . . . . 0.0 110.195 -178.187 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' C' C ' 85' ' ' ASP . . . . . . . . . . . . . 13.1 t70 -151.17 148.67 28.54 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 115.746 -0.661 . . . . 0.0 110.232 -179.342 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' C' C ' 86' ' ' VAL . . . . . . . . . . . . . 41.4 t -129.2 129.62 67.63 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.264 0 CA-C-O 120.944 0.402 . . . . 0.0 110.397 -179.294 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' C' C ' 87' ' ' ILE . . . . . . . . . . . . . 44.6 mm -119.14 126.0 74.97 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.263 0 CA-C-N 115.923 -0.58 . . . . 0.0 109.657 177.097 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' C' C ' 88' ' ' LEU . . . . . . . . . . . . . 19.4 tp -109.82 123.4 49.49 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-O 121.005 0.431 . . . . 0.0 110.826 -178.333 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' C' C ' 89' ' ' ASP . . . . . . . . . . . . . 13.6 t70 -113.61 156.86 22.92 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 115.81 -0.632 . . . . 0.0 109.336 176.325 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' C' C ' 90' ' ' GLU . . . . . . . . . . . . . 81.8 tt0 -45.14 -42.28 8.82 Favored 'General case' 0 N--CA 1.465 0.282 0 N-CA-C 113.266 0.839 . . . . 0.0 113.266 -171.694 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' C' C ' 91' ' ' ASN . . . . . . . . . . . . . 73.1 m-20 -132.02 25.19 4.6 Favored 'General case' 0 N--CA 1.467 0.377 0 N-CA-C 112.652 0.612 . . . . 0.0 112.652 -178.539 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' C' C ' 92' ' ' LEU . . . . . . . . . . . . . 38.1 mt -148.17 142.02 25.74 Favored 'General case' 0 C--N 1.332 -0.19 0 N-CA-C 110.171 -0.307 . . . . 0.0 110.171 -177.635 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' C' C ' 93' ' ' ILE . . . . . . . . . . . . . 62.7 mt -118.62 116.9 52.72 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.266 0 N-CA-C 109.425 -0.583 . . . . 0.0 109.425 179.986 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' C' C ' 94' ' ' VAL . . . . . 0.506 HG21 HG11 ' C' ' 125' ' ' VAL . 44.2 t -119.39 124.13 72.45 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.2 0 CA-C-O 121.026 0.441 . . . . 0.0 110.075 -179.671 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' C' C ' 95' ' ' VAL . . . . . . . . . . . . . 42.7 t -121.23 135.35 61.68 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.297 0 CA-C-N 115.803 -0.635 . . . . 0.0 109.96 -179.258 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' C' C ' 96' ' ' ILE . . . . . . . . . . . . . 60.4 mt -115.9 128.86 73.04 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.288 0 N-CA-C 109.411 -0.588 . . . . 0.0 109.411 178.264 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' C' C ' 97' ' ' THR . . . . . . . . . . . . . 80.5 p -98.67 160.08 14.51 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-O 121.08 0.467 . . . . 0.0 110.828 -179.184 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' C' C ' 98' ' ' GLU . . . . . . . . . . . . . 97.6 mt-10 -53.82 -25.73 20.86 Favored 'General case' 0 CA--C 1.532 0.265 0 N-CA-C 112.257 0.465 . . . . 0.0 112.257 -179.927 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' C' C ' 99' ' ' GLU . . . . . . . . . . . . . 43.2 mt-10 -79.86 16.37 1.18 Allowed 'General case' 0 CA--C 1.535 0.375 0 N-CA-C 113.071 0.767 . . . . 0.0 113.071 -177.732 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' C' C ' 100' ' ' ASN . . . . . . . . . . . . . 3.9 m-20 61.83 38.07 15.0 Favored 'General case' 0 CA--C 1.529 0.155 0 CA-C-O 121.12 0.486 . . . . 0.0 110.91 178.27 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' C' C ' 101' ' ' GLU . . . . . . . . . . . . . 84.7 tt0 -113.18 141.42 46.96 Favored 'General case' 0 C--N 1.331 -0.199 0 CA-C-N 116.159 -0.473 . . . . 0.0 109.854 176.55 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' C' C ' 102' ' ' VAL . . . . . . . . . . . . . 46.1 t -114.86 125.08 72.09 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.272 0 CA-C-N 116.221 -0.445 . . . . 0.0 109.917 -178.55 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' C' C ' 103' ' ' LEU . . . . . . . . . . . . . 16.8 mt -116.65 129.83 56.38 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 115.616 -0.72 . . . . 0.0 110.182 177.763 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' C' C ' 104' ' ' ILE . . . . . . . . . . . . . 61.5 mt -117.7 120.71 65.53 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.286 0 N-CA-C 110.296 -0.261 . . . . 0.0 110.296 179.028 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' C' C ' 105' ' ' PHE . . . . . . . . . . . . . 46.0 m-85 -120.75 163.28 18.35 Favored 'General case' 0 C--N 1.332 -0.171 0 O-C-N 123.97 0.794 . . . . 0.0 109.654 177.86 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' C' C ' 106' ' ' ASN . . . . . . . . . . . . . 45.8 p-10 -97.42 -171.02 2.11 Favored 'General case' 0 C--N 1.331 -0.219 0 N-CA-C 109.783 -0.451 . . . . 0.0 109.783 173.719 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' C' C ' 107' ' ' GLN . . . . . . . . . . . . . 51.1 tt0 -59.67 -28.69 67.49 Favored 'General case' 0 C--N 1.329 -0.309 0 N-CA-C 112.043 0.386 . . . . 0.0 112.043 179.687 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' C' C ' 108' ' ' ASN . . . . . . . . . . . . . 6.3 t-20 -84.88 11.94 8.37 Favored 'General case' 0 CA--C 1.537 0.447 0 N-CA-C 112.955 0.724 . . . . 0.0 112.955 -178.012 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' C' C ' 109' ' ' LEU . . . . . 0.481 HD21 ' HB2' ' C' ' 78' ' ' ALA . 11.6 tp 55.76 38.19 29.79 Favored 'General case' 0 C--O 1.232 0.154 0 CA-C-O 121.099 0.476 . . . . 0.0 111.338 178.722 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' C' C ' 110' ' ' GLU . . . . . . . . . . . . . 70.7 mm-40 -101.97 148.91 24.78 Favored 'General case' 0 C--N 1.328 -0.336 0 N-CA-C 109.636 -0.505 . . . . 0.0 109.636 175.707 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' C' C ' 111' ' ' GLU . . . . . . . . . . . . . 82.8 tt0 -81.85 121.91 27.05 Favored 'General case' 0 C--N 1.326 -0.415 0 CA-C-O 120.834 0.349 . . . . 0.0 110.357 -179.45 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' C' C ' 112' ' ' LEU . . . . . . . . . . . . . 34.1 mt -111.56 -46.04 3.31 Favored 'General case' 0 C--N 1.331 -0.203 0 CA-C-N 116.107 -0.497 . . . . 0.0 110.595 -179.689 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' C' C ' 113' ' ' TYR . . . . . . . . . . . . . 56.9 t80 -138.58 135.29 34.83 Favored 'General case' 0 C--N 1.33 -0.259 0 C-N-CA 120.772 -0.371 . . . . 0.0 111.332 -179.154 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' C' C ' 114' ' ' ARG . . . . . . . . . . . . . 63.8 ttp85 -137.88 122.08 18.07 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 115.949 -0.569 . . . . 0.0 110.026 178.956 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' C' C ' 115' ' ' GLY . . . . . . . . . . . . . . . -150.12 142.81 10.02 Favored Glycine 0 CA--C 1.525 0.671 0 C-N-CA 120.79 -0.719 . . . . 0.0 111.336 178.826 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' C' C ' 116' ' ' LYS . . . . . . . . . . . . . 38.8 ttpt -111.49 132.94 54.13 Favored 'General case' 0 C--N 1.33 -0.25 0 N-CA-C 109.782 -0.451 . . . . 0.0 109.782 176.379 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' C' C ' 117' ' ' PHE . . . . . . . . . . . . . 57.8 m-85 -130.69 113.97 14.82 Favored 'General case' 0 C--N 1.332 -0.193 0 CA-C-O 120.983 0.421 . . . . 0.0 110.385 -176.631 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' C' C ' 118' ' ' GLU . . . . . . . . . . . . . 71.0 mm-40 -54.28 -47.52 72.27 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.284 -0.416 . . . . 0.0 111.283 -177.276 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' C' C ' 119' ' ' ASN . . . . . . . . . . . . . 33.3 m120 -94.63 30.99 1.87 Allowed 'General case' 0 C--N 1.33 -0.251 0 N-CA-C 112.194 0.442 . . . . 0.0 112.194 -175.043 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' C' C ' 120' ' ' LEU . . . . . . . . . . . . . 13.7 tp -57.64 121.21 9.82 Favored 'General case' 0 C--N 1.332 -0.165 0 N-CA-C 110.204 -0.295 . . . . 0.0 110.204 177.163 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' C' C ' 121' ' ' ASN . . . . . . . . . . . . . 94.2 m-20 -114.01 -43.91 3.2 Favored 'General case' 0 C--O 1.232 0.171 0 CA-C-N 116.484 -0.326 . . . . 0.0 111.338 -176.113 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' C' C ' 122' ' ' LYS . . . . . . . . . . . . . 39.5 ttpt -150.97 148.88 28.93 Favored 'General case' 0 C--N 1.331 -0.227 0 CA-C-O 121.04 0.448 . . . . 0.0 111.637 -176.617 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' C' C ' 123' ' ' VAL . . . . . . . . . . . . . 44.9 t -128.65 133.87 65.62 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.227 0 CA-C-N 116.007 -0.542 . . . . 0.0 109.737 177.417 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' C' C ' 124' ' ' LEU . . . . . . . . . . . . . 79.5 mt -128.93 139.35 52.16 Favored 'General case' 0 C--N 1.331 -0.201 0 CA-C-O 120.759 0.314 . . . . 0.0 110.942 -178.595 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' C' C ' 125' ' ' VAL . . . . . 0.506 HG11 HG21 ' C' ' 94' ' ' VAL . 35.6 m -133.17 128.93 56.58 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.206 0 CA-C-N 116.254 -0.43 . . . . 0.0 110.53 178.242 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' C' C ' 126' ' ' ARG . . . . . . . . . . . . . 91.0 mtt180 -150.78 128.33 11.48 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.419 -0.355 . . . . 0.0 110.177 178.199 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' C' C ' 127' ' ' ASN . . . . . . . . . . . . . 77.5 m-20 54.52 -151.58 0.36 Allowed 'General case' 0 CA--C 1.541 0.6 0 CA-C-O 119.449 -0.31 . . . . 0.0 110.228 178.017 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' C' C ' 128' ' ' ASP . . . . . . . . . . . . . 23.5 p-10 -81.03 18.14 1.09 Allowed 'General case' 0 CA--C 1.536 0.405 0 N-CA-C 112.881 0.697 . . . . 0.0 112.881 -179.62 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' C' C ' 129' ' ' LEU . . . . . . . . . . . . . 15.9 tp -123.92 137.02 54.69 Favored 'General case' 0 C--O 1.232 0.165 0 CA-C-N 117.983 0.356 . . . . 0.0 110.185 178.715 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' C' C ' 130' ' ' VAL . . . . . 0.496 HG23 ' HB ' ' C' ' 141' ' ' ILE . 32.1 m -131.78 145.81 34.4 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.197 0 CA-C-O 120.905 0.383 . . . . 0.0 110.327 178.575 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' C' C ' 131' ' ' VAL . . . . . 0.515 HG22 HD12 ' C' ' 140' ' ' LEU . 40.7 t -136.1 140.49 43.8 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.325 0 CA-C-O 121.058 0.456 . . . . 0.0 110.553 -177.704 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' C' C ' 132' ' ' ILE . . . . . . . . . . . . . 73.9 mt -116.8 129.68 72.92 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 CA-C-N 115.585 -0.734 . . . . 0.0 109.032 177.45 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' C' C ' 133' ' ' ILE . . . . . . . . . . . . . 40.3 mm -114.06 121.84 66.99 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.275 0 CA-C-O 120.698 0.285 . . . . 0.0 110.942 -174.428 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' C' C ' 134' ' ' ASP . . . . . . . . . . . . . 9.0 p-10 -135.23 146.54 48.72 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.116 -0.493 . . . . 0.0 109.786 175.501 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' C' C ' 135' ' ' GLU . . . . . . . . . . . . . 81.2 tt0 -49.92 -25.41 3.21 Favored 'General case' 0 CA--C 1.533 0.325 0 N-CA-C 112.77 0.656 . . . . 0.0 112.77 -175.465 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' C' C ' 136' ' ' GLN . . . . . . . . . . . . . 8.4 tp-100 -80.88 -34.28 33.7 Favored 'General case' 0 C--O 1.233 0.2 0 N-CA-C 112.036 0.384 . . . . 0.0 112.036 -176.032 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' C' C ' 137' ' ' LYS . . . . . . . . . . . . . 40.3 pttt -169.57 175.49 5.38 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-O 121.522 0.677 . . . . 0.0 112.085 -173.597 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' C' C ' 138' ' ' LEU . . . . . 0.479 HD23 ' N ' ' C' ' 139' ' ' THR . 4.8 tt -117.74 125.34 50.47 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 115.05 -0.977 . . . . 0.0 109.81 177.931 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' C' C ' 139' ' ' THR . . . . . 0.479 ' N ' HD23 ' C' ' 138' ' ' LEU . 28.6 m -105.18 124.01 48.81 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.312 -0.404 . . . . 0.0 110.497 179.701 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' C' C ' 140' ' ' LEU . . . . . 0.515 HD12 HG22 ' C' ' 131' ' ' VAL . 19.6 tp -110.68 117.89 34.71 Favored 'General case' 0 C--N 1.329 -0.302 0 N-CA-C 109.046 -0.724 . . . . 0.0 109.046 -179.496 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' C' C ' 141' ' ' ILE . . . . . 0.496 ' HB ' HG23 ' C' ' 130' ' ' VAL . 19.9 mt -118.63 121.29 66.63 Favored 'Isoleucine or valine' 0 C--O 1.234 0.25 0 CA-C-O 121.24 0.543 . . . . 0.0 109.877 -175.496 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' C' C ' 142' ' ' ARG . . . . . . . . . . . . . 70.5 mtt180 . . . . . 0 C--N 1.33 -0.274 0 CA-C-N 115.042 -0.981 . . . . 0.0 110.112 -177.952 . . . . . . . . 0 0 . 1 . 009 nuclear build core ' D' D ' 2' ' ' SER . . . . . . . . . . . . . 12.7 p . . . . . 0 N--CA 1.462 0.156 0 CA-C-O 121.164 0.507 . . . . 0.0 110.677 . . . . . . . . . 0 0 . 1 . 009 nuclear build core ' D' D ' 3' ' ' GLU . . . . . . . . . . . . . 84.9 tt0 -143.99 140.87 29.85 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 115.748 -0.66 . . . . 0.0 111.161 -178.709 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' D' D ' 4' ' ' LEU . . . . . . . . . . . . . 19.2 tp -124.56 131.74 53.47 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.014 -0.539 . . . . 0.0 110.06 177.093 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' D' D ' 5' ' ' LYS . . . . . . . . . . . . . 77.9 mttt -111.93 120.91 43.51 Favored 'General case' 0 C--O 1.234 0.259 0 CA-C-N 116.365 -0.379 . . . . 0.0 110.767 -179.406 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' D' D ' 6' ' ' LEU . . . . . . . . . . . . . 54.5 mt -114.57 142.47 46.39 Favored 'General case' 0 C--N 1.332 -0.174 0 CA-C-N 115.553 -0.749 . . . . 0.0 110.163 -179.563 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' D' D ' 7' ' ' LYS . . . . . . . . . . . . . 31.0 ttpt -122.3 136.87 26.86 Favored Pre-proline 0 CA--C 1.534 0.351 0 CA-C-O 118.84 -0.6 . . . . 0.0 109.602 175.794 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' D' D ' 8' ' ' PRO . . . . . . . . . . . . . 98.8 Cg_endo -91.22 131.78 1.44 Allowed 'Trans proline' 0 N--CA 1.489 1.255 0 C-N-CA 121.687 1.591 . . . . 0.0 111.799 178.215 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' D' D ' 9' ' ' LEU . . . . . . . . . . . . . 36.1 mt -72.8 -47.48 8.83 Favored Pre-proline 0 CA--C 1.535 0.38 0 CA-C-O 118.49 -0.767 . . . . 0.0 112.128 -178.593 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' D' D ' 10' ' ' PRO . . . . . . . . . . . . . 75.8 Cg_endo -78.62 149.1 23.53 Favored 'Trans proline' 0 N--CA 1.496 1.623 0 CA-C-N 120.347 1.159 . . . . 0.0 111.794 176.397 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' D' D ' 11' ' ' LYS . . . . . . . . . . . . . 53.7 mttp -85.51 95.85 9.43 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.481 -0.327 . . . . 0.0 110.693 -179.721 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' D' D ' 12' ' ' VAL . . . . . . . . . . . . . 12.1 p -144.35 145.19 21.79 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.278 0 CA-C-N 116.285 -0.416 . . . . 0.0 110.43 179.361 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' D' D ' 13' ' ' GLU . . . . . . . . . . . . . 95.7 mt-10 -90.11 122.09 32.76 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.254 -0.43 . . . . 0.0 110.271 178.681 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' D' D ' 14' ' ' LEU . . . . . . . . . . . . . 23.1 mt -98.07 154.34 37.77 Favored Pre-proline 0 CA--C 1.532 0.265 0 CA-C-N 116.283 -0.417 . . . . 0.0 111.174 -177.874 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' D' D ' 15' ' ' PRO . . . . . . . . . . . . . 36.6 Cg_exo -59.35 162.29 14.88 Favored 'Trans proline' 0 N--CA 1.496 1.669 0 C-N-CA 121.4 1.4 . . . . 0.0 112.079 178.581 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' D' D ' 16' ' ' PRO . . . . . . . . . . . . . 23.7 Cg_exo -63.01 -41.42 28.83 Favored 'Trans proline' 0 N--CA 1.497 1.703 0 C-N-CA 121.493 1.462 . . . . 0.0 112.815 -179.175 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' D' D ' 17' ' ' ASP . . . . . . . . . . . . . 22.8 p-10 -82.91 9.53 9.81 Favored 'General case' 0 CA--C 1.537 0.47 0 N-CA-C 113.241 0.83 . . . . 0.0 113.241 -176.859 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' D' D ' 18' ' ' PHE . . . . . . . . . . . . . 29.3 t80 -56.98 -41.81 79.09 Favored 'General case' 0 C--N 1.334 -0.09 0 O-C-N 121.986 -0.446 . . . . 0.0 110.369 -179.562 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' D' D ' 19' ' ' VAL . . . . . . . . . . . . . 46.5 t -56.23 -44.44 79.35 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.252 0 CA-C-N 116.327 -0.397 . . . . 0.0 110.599 -179.379 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' D' D ' 20' ' ' ASP . . . . . . . . . . . . . 41.6 m-20 -59.81 -41.26 90.87 Favored 'General case' 0 C--N 1.33 -0.247 0 C-N-CA 120.84 -0.344 . . . . 0.0 110.943 -178.091 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' D' D ' 21' ' ' VAL . . . . . . . . . . . . . 47.2 t -63.66 -47.54 90.78 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 C-N-CA 120.759 -0.377 . . . . 0.0 110.494 -178.357 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' D' D ' 22' ' ' ILE . . . . . 0.667 HG22 HD12 ' D' ' 26' ' ' LEU . 49.8 mm -54.78 -47.28 74.55 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.273 0 C-N-CA 120.97 -0.292 . . . . 0.0 110.798 178.907 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' D' D ' 23' ' ' ARG . . . . . . . . . . . . . 53.2 ttp180 -53.74 -52.0 61.55 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-O 120.609 0.242 . . . . 0.0 111.533 -178.953 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' D' D ' 24' ' ' ILE . . . . . . . . . . . . . 76.7 mt -58.61 -41.26 81.6 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.377 0 CA-C-N 116.749 -0.205 . . . . 0.0 111.367 -176.339 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' D' D ' 25' ' ' LYS . . . . . . . . . . . . . 73.0 mmtt -68.4 -42.29 79.23 Favored 'General case' 0 C--N 1.329 -0.292 0 N-CA-C 112.277 0.473 . . . . 0.0 112.277 -178.338 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' D' D ' 26' ' ' LEU . . . . . 0.667 HD12 HG22 ' D' ' 22' ' ' ILE . 33.1 mt -80.47 -34.31 35.99 Favored 'General case' 0 C--N 1.33 -0.258 0 N-CA-C 113.661 0.986 . . . . 0.0 113.661 -169.41 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' D' D ' 27' ' ' GLN . . . . . . . . . . . . . 13.9 pt20 -46.1 139.71 4.34 Favored 'General case' 0 N--CA 1.469 0.489 0 N-CA-C 112.853 0.686 . . . . 0.0 112.853 -175.17 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' D' D ' 28' ' ' GLY . . . . . . . . . . . . . . . 101.05 -27.01 22.54 Favored Glycine 0 CA--C 1.532 1.144 0 CA-C-N 115.657 -0.701 . . . . 0.0 112.163 -175.99 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' D' D ' 29' ' ' LYS . . . . . . . . . . . . . 64.9 mttp -97.65 155.09 17.15 Favored 'General case' 0 C--O 1.233 0.226 0 CA-C-N 117.336 0.568 . . . . 0.0 110.986 178.751 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' D' D ' 30' ' ' THR . . . . . . . . . . . . . 40.1 m -106.77 140.63 39.32 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.232 -0.44 . . . . 0.0 110.151 177.251 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' D' D ' 31' ' ' VAL . . . . . . . . . . . . . 34.9 m -128.22 156.12 40.21 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.19 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.851 -179.125 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' D' D ' 32' ' ' ARG . . . . . . . . . . . . . 67.3 ttt180 -131.65 147.0 52.48 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 115.974 -0.557 . . . . 0.0 110.314 178.285 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' D' D ' 33' ' ' THR . . . . . . . . . . . . . 22.8 m -52.52 139.22 25.94 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-O 120.762 0.315 . . . . 0.0 111.502 -178.329 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' D' D ' 34' ' ' GLY . . . . . . . . . . . . . . . 99.67 -17.05 58.07 Favored Glycine 0 CA--C 1.533 1.159 0 CA-C-O 119.762 -0.466 . . . . 0.0 113.32 179.26 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' D' D ' 35' ' ' ASP . . . . . . . . . . . . . 76.7 m-20 -66.44 149.24 50.72 Favored 'General case' 0 N--CA 1.46 0.074 0 CA-C-N 117.992 0.896 . . . . 0.0 111.17 179.787 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' D' D ' 36' ' ' VAL . . . . . . . . . . . . . 45.6 t -120.18 128.9 76.0 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.202 0 CA-C-N 115.749 -0.66 . . . . 0.0 109.687 177.439 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' D' D ' 37' ' ' ILE . . . . . . . . . . . . . 64.1 mt -121.37 138.85 50.38 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.229 0 CA-C-N 116.194 -0.457 . . . . 0.0 109.889 -179.145 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' D' D ' 38' ' ' GLY . . . . . . . . . . . . . . . -117.97 128.87 7.97 Favored Glycine 0 CA--C 1.526 0.749 0 N-CA-C 110.97 -0.852 . . . . 0.0 110.97 -179.943 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' D' D ' 39' ' ' ILE . . . . . . . . . . . . . 71.5 mt -128.05 129.83 69.64 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.198 0 N-CA-C 110.036 -0.357 . . . . 0.0 110.036 178.815 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' D' D ' 40' ' ' SER . . . . . . . . . . . . . 87.2 p -92.16 123.73 35.72 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.267 -0.424 . . . . 0.0 110.861 176.804 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' D' D ' 41' ' ' ILE . . . . . . . . . . . . . 71.9 mt -134.14 121.04 36.83 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.263 0 CA-C-O 120.993 0.425 . . . . 0.0 110.278 177.82 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' D' D ' 42' ' ' LEU . . . . . 0.546 HD23 ' O ' ' D' ' 42' ' ' LEU . 1.3 tt 57.81 44.78 19.66 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-O 121.42 0.629 . . . . 0.0 110.187 178.46 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' D' D ' 43' ' ' GLY . . . . . . . . . . . . . . . 72.36 -5.75 13.89 Favored Glycine 0 CA--C 1.534 1.276 0 C-N-CA 121.146 -0.549 . . . . 0.0 113.644 175.897 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' D' D ' 44' ' ' LYS . . . . . . . . . . . . . 22.9 tptm -109.27 126.05 52.93 Favored 'General case' 0 N--CA 1.462 0.129 0 CA-C-N 118.141 0.971 . . . . 0.0 110.183 -178.908 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' D' D ' 45' ' ' GLU . . . . . . . . . . . . . 43.6 tp10 -84.69 130.31 34.72 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-O 120.816 0.341 . . . . 0.0 111.124 -179.482 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' D' D ' 46' ' ' VAL . . . . . . . . . . . . . 10.3 p -120.3 126.99 75.86 Favored 'Isoleucine or valine' 0 N--CA 1.462 0.167 0 N-CA-C 109.818 -0.438 . . . . 0.0 109.818 175.25 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' D' D ' 47' ' ' LYS . . . . . . . . . . . . . 86.4 mttt -99.09 126.16 44.77 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 115.912 -0.585 . . . . 0.0 110.931 178.248 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' D' D ' 48' ' ' PHE . . . . . . . . . . . . . 34.2 m-85 -111.43 131.97 54.8 Favored 'General case' 0 C--N 1.331 -0.207 0 N-CA-C 109.812 -0.44 . . . . 0.0 109.812 177.665 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' D' D ' 49' ' ' LYS . . . . . . . . . . . . . 38.4 tttp -107.71 132.15 53.66 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.362 -0.381 . . . . 0.0 110.274 177.655 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' D' D ' 50' ' ' VAL . . . . . . . . . . . . . 45.5 t -76.56 104.11 4.38 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.332 0 N-CA-C 109.361 -0.607 . . . . 0.0 109.361 177.06 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' D' D ' 51' ' ' VAL . . . . . . . . . . . . . 47.5 t -69.48 -53.2 26.11 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.341 0 N-CA-C 109.554 -0.536 . . . . 0.0 109.554 -175.692 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' D' D ' 52' ' ' GLN . . . . . . . . . . . . . 81.8 mt-30 -154.86 152.45 29.79 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.053 -0.522 . . . . 0.0 111.677 -178.381 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' D' D ' 53' ' ' ALA . . . . . 0.44 ' HB3' ' OG ' ' D' ' 56' ' ' SER . . . -129.29 133.29 47.4 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 115.361 -0.836 . . . . 0.0 109.703 175.539 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' D' D ' 54' ' ' TYR . . . . . . . . . . . . . 45.8 t80 -129.0 109.69 18.28 Favored Pre-proline 0 CA--C 1.535 0.397 0 CA-C-O 118.162 -0.923 . . . . 0.0 110.463 179.217 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' D' D ' 55' ' ' PRO . . . . . . . . . . . . . 73.7 Cg_endo -77.17 167.47 79.58 Favored 'Cis proline' 0 N--CA 1.5 1.871 0 CA-C-N 121.808 1.681 . . . . 0.0 112.103 -6.676 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' D' D ' 56' ' ' SER . . . . . 0.44 ' OG ' ' HB3' ' D' ' 53' ' ' ALA . 62.7 m -117.41 133.04 23.27 Favored Pre-proline 0 CA--C 1.54 0.567 0 CA-C-O 118.437 -0.792 . . . . 0.0 109.458 174.803 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' D' D ' 57' ' ' PRO . . . . . . . . . . . . . 38.4 Cg_endo -67.7 164.5 72.51 Favored 'Cis proline' 0 N--CA 1.498 1.774 0 CA-C-N 121.881 1.707 . . . . 0.0 111.433 -1.407 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' D' D ' 58' ' ' LEU . . . . . . . . . . . . . 24.0 tp -130.73 138.05 49.8 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 116.321 -0.399 . . . . 0.0 110.612 -179.478 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' D' D ' 59' ' ' ARG . . . . . . . . . . . . . 56.7 ttp180 -103.24 127.96 50.4 Favored 'General case' 0 C--N 1.328 -0.342 0 N-CA-C 109.362 -0.607 . . . . 0.0 109.362 174.882 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' D' D ' 60' ' ' VAL . . . . . . . . . . . . . 43.5 t -78.48 119.47 27.57 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.28 0 C-N-CA 120.75 -0.38 . . . . 0.0 110.836 -174.591 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' D' D ' 61' ' ' GLU . . . . . . . . . . . . . 15.6 mm-40 -131.09 161.33 32.31 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 115.729 -0.669 . . . . 0.0 109.666 175.378 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' D' D ' 62' ' ' ASP . . . . . . . . . . . . . 54.0 m-20 -52.6 -31.65 37.51 Favored 'General case' 0 C--N 1.328 -0.343 0 N-CA-C 112.085 0.402 . . . . 0.0 112.085 -178.252 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' D' D ' 63' ' ' ARG . . . . . . . . . . . . . 79.7 mtp180 -73.2 -21.91 60.57 Favored 'General case' 0 CA--C 1.532 0.256 0 N-CA-C 112.949 0.722 . . . . 0.0 112.949 -175.41 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' D' D ' 64' ' ' THR . . . . . . . . . . . . . 25.7 m -69.31 139.96 54.33 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-O 120.951 0.405 . . . . 0.0 110.965 -175.752 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' D' D ' 65' ' ' LYS . . . . . . . . . . . . . 67.5 mttm -89.34 132.14 35.09 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 115.945 -0.57 . . . . 0.0 110.134 178.341 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' D' D ' 66' ' ' ILE . . . . . . . . . . . . . 62.7 mt -117.51 129.52 73.85 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.261 0 N-CA-C 109.893 -0.41 . . . . 0.0 109.893 179.446 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' D' D ' 67' ' ' THR . . . . . . . . . . . . . 25.5 m -122.86 137.47 54.93 Favored 'General case' 0 C--N 1.332 -0.181 0 CA-C-N 116.128 -0.487 . . . . 0.0 110.769 -178.872 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' D' D ' 68' ' ' LEU . . . . . . . . . . . . . 14.9 tp . . . . . 0 C--N 1.33 -0.241 0 CA-C-N 115.964 -0.562 . . . . 0.0 110.348 178.805 . . . . . . . . 0 0 . 1 . 009 nuclear build core ' D' D ' 73' ' ' VAL . . . . . . . . . . . . . 30.3 m . . . . . 0 C--O 1.231 0.128 0 CA-C-O 120.936 0.398 . . . . 0.0 110.404 . . . . . . . . . 0 0 . 1 . 009 nuclear build core ' D' D ' 74' ' ' ASP . . . . . . . . . . . . . 15.2 t0 -97.04 124.46 41.04 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 115.997 -0.547 . . . . 0.0 109.59 178.905 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' D' D ' 75' ' ' VAL . . . . . . . . . . . . . 41.9 t -116.75 125.29 73.62 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.211 0 CA-C-O 121.091 0.472 . . . . 0.0 110.891 -175.29 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' D' D ' 76' ' ' LEU . . . . . . . . . . . . . 5.7 mp -125.73 144.71 50.5 Favored 'General case' 0 C--N 1.331 -0.205 0 CA-C-N 115.704 -0.68 . . . . 0.0 109.55 173.896 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' D' D ' 77' ' ' GLU . . . . . . . . . . . . . 98.0 mt-10 -133.52 131.03 39.31 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-O 120.961 0.41 . . . . 0.0 111.007 -177.666 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' D' D ' 78' ' ' ALA . . . . . . . . . . . . . . . -116.13 130.95 57.04 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 115.833 -0.621 . . . . 0.0 109.697 177.516 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' D' D ' 79' ' ' LYS . . . . . 0.614 ' O ' HD13 ' D' ' 80' ' ' ILE . 88.1 mttt -77.34 123.85 27.07 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-O 120.854 0.359 . . . . 0.0 110.906 -177.059 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' D' D ' 80' ' ' ILE . . . . . 0.614 HD13 ' O ' ' D' ' 79' ' ' LYS . 39.5 mm -139.1 114.4 8.56 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.277 0 N-CA-C 109.309 -0.626 . . . . 0.0 109.309 -177.858 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' D' D ' 81' ' ' LYS . . . . . . . . . . . . . 69.3 mttm -100.48 118.93 37.68 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-O 120.793 0.33 . . . . 0.0 111.245 -177.234 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' D' D ' 82' ' ' GLY . . . . . . . . . . . . . . . 89.17 42.22 5.64 Favored Glycine 0 CA--C 1.526 0.738 0 C-N-CA 120.668 -0.777 . . . . 0.0 111.989 172.888 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' D' D ' 83' ' ' ILE . . . . . . . . . . . . . 72.3 mt -61.99 135.92 25.97 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.341 0 N-CA-C 109.835 -0.431 . . . . 0.0 109.835 176.434 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' D' D ' 84' ' ' LYS . . . . . . . . . . . . . 15.5 ttmm -95.21 -51.45 4.61 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-O 121.118 0.485 . . . . 0.0 109.744 179.115 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' D' D ' 85' ' ' ASP . . . . . . . . . . . . . 7.5 t70 -158.38 154.9 27.73 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 115.548 -0.751 . . . . 0.0 110.145 179.105 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' D' D ' 86' ' ' VAL . . . . . . . . . . . . . 44.4 t -130.56 133.98 62.81 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.176 0 CA-C-O 121.055 0.455 . . . . 0.0 110.459 -179.436 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' D' D ' 87' ' ' ILE . . . . . . . . . . . . . 44.3 mm -119.25 125.72 74.7 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.253 0 CA-C-N 115.653 -0.703 . . . . 0.0 109.664 177.657 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' D' D ' 88' ' ' LEU . . . . . . . . . . . . . 14.2 tp -108.14 127.17 53.58 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.299 -0.409 . . . . 0.0 110.848 -178.331 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' D' D ' 89' ' ' ASP . . . . . . . . . . . . . 13.6 t70 -121.22 154.41 36.32 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.002 -0.545 . . . . 0.0 109.843 178.23 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' D' D ' 90' ' ' GLU . . . . . . . . . . . . . 82.3 tt0 -46.32 -37.58 7.61 Favored 'General case' 0 C--N 1.33 -0.271 0 N-CA-C 113.079 0.77 . . . . 0.0 113.079 -172.754 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' D' D ' 91' ' ' ASN . . . . . . . . . . . . . 13.4 t-20 -132.0 22.02 4.53 Favored 'General case' 0 N--CA 1.469 0.477 0 N-CA-C 112.779 0.659 . . . . 0.0 112.779 -177.446 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' D' D ' 92' ' ' LEU . . . . . . . . . . . . . 19.9 mt -150.49 144.15 25.19 Favored 'General case' 0 C--N 1.331 -0.204 0 CA-C-O 120.773 0.321 . . . . 0.0 110.269 -176.59 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' D' D ' 93' ' ' ILE . . . . . . . . . . . . . 74.6 mt -121.78 115.08 45.33 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.276 0 N-CA-C 109.168 -0.678 . . . . 0.0 109.168 176.944 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' D' D ' 94' ' ' VAL . . . . . . . . . . . . . 46.8 t -118.06 127.04 75.32 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.217 0 CA-C-O 121.071 0.462 . . . . 0.0 110.111 -177.883 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' D' D ' 95' ' ' VAL . . . . . . . . . . . . . 41.1 t -121.42 134.55 64.41 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.277 0 CA-C-N 115.769 -0.651 . . . . 0.0 109.772 -179.678 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' D' D ' 96' ' ' ILE . . . . . . . . . . . . . 63.4 mt -113.57 127.58 70.84 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.287 0 N-CA-C 109.209 -0.663 . . . . 0.0 109.209 178.381 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' D' D ' 97' ' ' THR . . . . . . . . . . . . . 59.9 p -101.44 156.15 17.63 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-O 121.289 0.566 . . . . 0.0 111.379 -177.106 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' D' D ' 98' ' ' GLU . . . . . . . . . . . . . 45.5 tp10 -53.81 -26.65 25.1 Favored 'General case' 0 CA--C 1.533 0.32 0 CA-C-N 116.009 -0.542 . . . . 0.0 112.075 179.309 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' D' D ' 99' ' ' GLU . . . . . . . . . . . . . 96.7 mt-10 -79.97 17.49 0.96 Allowed 'General case' 0 CA--C 1.534 0.357 0 N-CA-C 113.084 0.772 . . . . 0.0 113.084 -177.217 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' D' D ' 100' ' ' ASN . . . . . . . . . . . . . 2.7 m-20 62.41 37.65 13.45 Favored 'General case' 0 C--O 1.233 0.19 0 CA-C-O 121.004 0.43 . . . . 0.0 110.959 177.456 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' D' D ' 101' ' ' GLU . . . . . . . . . . . . . 84.5 tt0 -116.27 143.64 45.26 Favored 'General case' 0 C--N 1.332 -0.173 0 CA-C-N 116.22 -0.445 . . . . 0.0 109.864 177.356 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' D' D ' 102' ' ' VAL . . . . . . . . . . . . . 45.3 t -114.93 124.37 71.52 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.267 0 CA-C-N 116.103 -0.499 . . . . 0.0 109.842 -179.122 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' D' D ' 103' ' ' LEU . . . . . . . . . . . . . 30.9 mt -115.88 131.31 56.98 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-N 115.815 -0.63 . . . . 0.0 110.464 178.075 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' D' D ' 104' ' ' ILE . . . . . 0.51 HD13 HG11 ' D' ' 130' ' ' VAL . 68.9 mt -120.77 120.1 61.49 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.302 0 N-CA-C 110.268 -0.271 . . . . 0.0 110.268 179.425 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' D' D ' 105' ' ' PHE . . . . . . . . . . . . . 59.1 m-85 -121.64 166.95 13.49 Favored 'General case' 0 C--N 1.333 -0.149 0 O-C-N 123.886 0.741 . . . . 0.0 110.043 178.494 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' D' D ' 106' ' ' ASN . . . . . . . . . . . . . 45.2 p-10 -104.1 -170.63 1.8 Allowed 'General case' 0 CA--C 1.531 0.227 0 N-CA-C 110.088 -0.338 . . . . 0.0 110.088 173.187 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' D' D ' 107' ' ' GLN . . . . . . . . . . . . . 63.3 tt0 -57.56 -29.77 64.69 Favored 'General case' 0 C--N 1.33 -0.255 0 N-CA-C 112.071 0.396 . . . . 0.0 112.071 179.338 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' D' D ' 108' ' ' ASN . . . . . . . . . . . . . 4.0 t-20 -87.3 12.62 11.46 Favored 'General case' 0 CA--C 1.536 0.415 0 N-CA-C 113.045 0.757 . . . . 0.0 113.045 -176.295 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' D' D ' 109' ' ' LEU . . . . . . . . . . . . . 24.9 mt 55.1 36.75 27.66 Favored 'General case' 0 CA--C 1.528 0.132 0 CA-C-O 120.943 0.401 . . . . 0.0 111.43 178.665 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' D' D ' 110' ' ' GLU . . . . . . . . . . . . . 95.8 mt-10 -102.28 148.86 24.93 Favored 'General case' 0 C--N 1.33 -0.251 0 N-CA-C 109.689 -0.485 . . . . 0.0 109.689 175.917 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' D' D ' 111' ' ' GLU . . . . . . . . . . . . . 79.9 tt0 -79.34 122.0 25.82 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.339 -0.392 . . . . 0.0 110.565 -178.027 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' D' D ' 112' ' ' LEU . . . . . . . . . . . . . 43.4 mt -109.05 -46.01 3.67 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-N 116.128 -0.487 . . . . 0.0 110.245 178.677 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' D' D ' 113' ' ' TYR . . . . . . . . . . . . . 60.3 t80 -140.94 137.49 33.14 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.32 -0.4 . . . . 0.0 111.147 -179.959 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' D' D ' 114' ' ' ARG . . . . . . . . . . . . . 68.5 ttp85 -140.72 119.25 12.3 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 115.881 -0.6 . . . . 0.0 109.98 177.377 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' D' D ' 115' ' ' GLY . . . . . . . . . . . . . . . -150.08 151.13 23.24 Favored Glycine 0 CA--C 1.523 0.588 0 N-CA-C 110.919 -0.872 . . . . 0.0 110.919 179.554 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' D' D ' 116' ' ' LYS . . . . . . . . . . . . . 35.2 ttmt -124.29 140.0 53.38 Favored 'General case' 0 C--N 1.329 -0.298 0 N-CA-C 109.968 -0.382 . . . . 0.0 109.968 177.449 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' D' D ' 117' ' ' PHE . . . . . . . . . . . . . 28.9 m-85 -136.16 118.89 16.08 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.04 -176.232 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' D' D ' 118' ' ' GLU . . . . . . . . . . . . . 96.1 mt-10 -53.45 -46.55 69.91 Favored 'General case' 0 C--N 1.33 -0.278 0 C-N-CA 121.041 -0.264 . . . . 0.0 111.307 -177.88 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' D' D ' 119' ' ' ASN . . . . . . . . . . . . . 24.3 m120 -95.87 31.04 2.19 Favored 'General case' 0 C--N 1.331 -0.216 0 CA-C-N 116.149 -0.478 . . . . 0.0 112.198 -175.891 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' D' D ' 120' ' ' LEU . . . . . . . . . . . . . 19.4 tp -57.59 122.04 11.78 Favored 'General case' 0 C--O 1.231 0.123 0 N-CA-C 110.077 -0.342 . . . . 0.0 110.077 177.271 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' D' D ' 121' ' ' ASN . . . . . . . . . . . . . 29.2 t-20 -113.56 -44.0 3.26 Favored 'General case' 0 C--O 1.233 0.199 0 CA-C-N 116.683 -0.235 . . . . 0.0 111.329 -175.37 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' D' D ' 122' ' ' LYS . . . . . . . . . . . . . 34.7 ttmt -150.98 141.81 22.85 Favored 'General case' 0 C--N 1.331 -0.201 0 C-N-CA 120.513 -0.475 . . . . 0.0 111.703 -177.457 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' D' D ' 123' ' ' VAL . . . . . . . . . . . . . 46.5 t -119.57 127.87 75.87 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.231 0 N-CA-C 108.972 -0.751 . . . . 0.0 108.972 173.539 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' D' D ' 124' ' ' LEU . . . . . . . . . . . . . 17.7 tp -127.16 140.72 52.05 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-O 120.867 0.365 . . . . 0.0 110.924 -175.506 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' D' D ' 125' ' ' VAL . . . . . 0.585 HG12 HG23 ' D' ' 130' ' ' VAL . 35.6 m -126.82 140.91 47.65 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.276 0 CA-C-N 116.065 -0.516 . . . . 0.0 110.629 179.787 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' D' D ' 126' ' ' ARG . . . . . . . . . . . . . 47.7 ttt180 -159.34 134.08 7.98 Favored 'General case' 0 C--N 1.329 -0.318 0 N-CA-C 109.53 -0.544 . . . . 0.0 109.53 178.287 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' D' D ' 127' ' ' ASN . . . . . . . . . . . . . 1.6 t-20 56.68 -154.0 0.35 Allowed 'General case' 0 CA--C 1.537 0.47 0 N-CA-C 109.588 -0.523 . . . . 0.0 109.588 -178.333 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' D' D ' 128' ' ' ASP . . . . . . . . . . . . . 13.7 p-10 -84.99 20.7 1.79 Allowed 'General case' 0 CA--C 1.535 0.381 0 CA-C-N 118.433 0.561 . . . . 0.0 112.346 177.178 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' D' D ' 129' ' ' LEU . . . . . . . . . . . . . 59.1 mt -122.87 150.3 43.07 Favored 'General case' 0 C--O 1.233 0.228 0 O-C-N 122.119 -0.363 . . . . 0.0 110.307 -179.699 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' D' D ' 130' ' ' VAL . . . . . 0.585 HG23 HG12 ' D' ' 125' ' ' VAL . 12.9 p -134.46 147.15 30.07 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.205 0 CA-C-O 120.891 0.377 . . . . 0.0 110.412 -179.16 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' D' D ' 131' ' ' VAL . . . . . . . . . . . . . 14.9 p -136.23 142.84 37.48 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.211 0 CA-C-O 121.121 0.486 . . . . 0.0 110.904 -179.528 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' D' D ' 132' ' ' ILE . . . . . . . . . . . . . 72.4 mt -115.63 131.41 68.09 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.231 0 CA-C-N 115.689 -0.687 . . . . 0.0 109.374 178.333 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' D' D ' 133' ' ' ILE . . . . . . . . . . . . . 42.5 mm -115.61 124.23 71.85 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.307 0 CA-C-O 120.878 0.371 . . . . 0.0 110.911 -175.597 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' D' D ' 134' ' ' ASP . . . . . . . . . . . . . 10.3 p-10 -137.46 146.33 44.17 Favored 'General case' 0 C--N 1.331 -0.201 0 CA-C-N 116.103 -0.499 . . . . 0.0 109.762 174.294 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' D' D ' 135' ' ' GLU . . . . . . . . . . . . . 84.9 tt0 -49.87 -25.95 3.63 Favored 'General case' 0 C--N 1.329 -0.309 0 N-CA-C 112.776 0.658 . . . . 0.0 112.776 -173.798 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' D' D ' 136' ' ' GLN . . . . . . . . . . . . . 48.0 tt0 -81.91 -34.04 30.12 Favored 'General case' 0 C--N 1.331 -0.231 0 N-CA-C 111.939 0.348 . . . . 0.0 111.939 -175.828 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' D' D ' 137' ' ' LYS . . . . . . . . . . . . . 53.7 pttt -167.78 175.3 6.99 Favored 'General case' 0 C--N 1.331 -0.223 0 CA-C-O 121.561 0.696 . . . . 0.0 112.079 -173.396 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' D' D ' 138' ' ' LEU . . . . . 0.454 HD23 ' N ' ' D' ' 139' ' ' THR . 5.5 tt -119.2 129.6 55.05 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 115.095 -0.957 . . . . 0.0 109.853 179.07 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' D' D ' 139' ' ' THR . . . . . 0.454 ' N ' HD23 ' D' ' 138' ' ' LEU . 39.1 m -112.49 124.22 52.02 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.289 -0.414 . . . . 0.0 110.353 178.829 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' D' D ' 140' ' ' LEU . . . . . . . . . . . . . 31.7 tp -112.07 124.97 53.57 Favored 'General case' 0 C--N 1.327 -0.378 0 N-CA-C 109.186 -0.672 . . . . 0.0 109.186 -178.663 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' D' D ' 141' ' ' ILE . . . . . 0.416 ' HB ' HG13 ' D' ' 130' ' ' VAL . 19.7 mt -121.99 117.16 51.44 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.292 0 CA-C-O 120.954 0.406 . . . . 0.0 109.983 -173.071 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' D' D ' 142' ' ' ARG . . . . . . . . . . . . . 78.6 mtp180 -107.11 125.26 50.83 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-N 115.382 -0.826 . . . . 0.0 110.445 -177.35 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' D' D ' 143' ' ' THR . . . . . . . . . . . . . 25.4 p . . . . . 0 C--O 1.219 -0.544 0 CA-C-O 118.004 -0.998 . . . . 0.0 110.61 -179.748 . . . . . . . . 0 0 . 1 . 009 nuclear build core ' E' E ' 2' ' ' SER . . . . . . . . . . . . . 2.0 p . . . . . 0 C--O 1.233 0.207 0 CA-C-O 121.014 0.435 . . . . 0.0 110.67 . . . . . . . . . 0 0 . 1 . 009 nuclear build core ' E' E ' 3' ' ' GLU . . . . . . . . . . . . . 66.3 tt0 -144.87 142.52 29.98 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-N 115.794 -0.639 . . . . 0.0 111.251 -175.29 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' E' E ' 4' ' ' LEU . . . . . . . . . . . . . 15.9 tp -123.37 135.0 53.94 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 115.918 -0.583 . . . . 0.0 110.001 175.583 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' E' E ' 5' ' ' LYS . . . . . . . . . . . . . 89.9 mttt -115.42 121.98 44.41 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.581 -0.281 . . . . 0.0 110.89 -179.125 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' E' E ' 6' ' ' LEU . . . . . . . . . . . . . 69.4 mt -114.48 145.93 41.3 Favored 'General case' 0 C--N 1.331 -0.225 0 CA-C-N 115.808 -0.633 . . . . 0.0 110.19 178.227 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' E' E ' 7' ' ' LYS . . . . . . . . . . . . . 26.3 ttpp -127.76 142.58 44.69 Favored Pre-proline 0 CA--C 1.533 0.323 0 CA-C-O 119.129 -0.462 . . . . 0.0 109.826 175.928 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' E' E ' 8' ' ' PRO . . . . . . . . . . . . . 87.2 Cg_endo -91.04 132.49 1.54 Allowed 'Trans proline' 0 N--CA 1.489 1.234 0 C-N-CA 121.652 1.568 . . . . 0.0 111.843 178.769 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' E' E ' 9' ' ' LEU . . . . . . . . . . . . . 71.6 mt -71.0 -47.17 14.73 Favored Pre-proline 0 CA--C 1.534 0.331 0 CA-C-O 118.663 -0.684 . . . . 0.0 112.111 -179.696 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' E' E ' 10' ' ' PRO . . . . . . . . . . . . . 98.3 Cg_endo -79.96 155.95 23.37 Favored 'Trans proline' 0 N--CA 1.495 1.614 0 C-N-CA 121.106 1.204 . . . . 0.0 111.878 175.573 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' E' E ' 11' ' ' LYS . . . . . . . . . . . . . 62.4 mttp -88.14 96.03 10.38 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-O 120.774 0.321 . . . . 0.0 110.695 179.696 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' E' E ' 12' ' ' VAL . . . . . . . . . . . . . 12.5 p -143.35 147.01 20.74 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.248 0 CA-C-N 116.231 -0.44 . . . . 0.0 110.37 179.228 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' E' E ' 13' ' ' GLU . . . . . . . . . . . . . 84.8 tt0 -92.06 123.59 35.53 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.321 -0.399 . . . . 0.0 110.276 179.175 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' E' E ' 14' ' ' LEU . . . . . . . . . . . . . 41.7 mt -97.9 149.01 35.28 Favored Pre-proline 0 CA--C 1.533 0.307 0 CA-C-O 119.352 -0.356 . . . . 0.0 110.6 -178.099 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' E' E ' 15' ' ' PRO . . . . . . . . . . . . . 26.1 Cg_exo -62.08 157.57 43.58 Favored 'Trans proline' 0 N--CA 1.498 1.751 0 C-N-CA 121.349 1.366 . . . . 0.0 111.906 177.412 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' E' E ' 16' ' ' PRO . . . . . . . . . . . . . 34.0 Cg_exo -59.36 -37.85 87.89 Favored 'Trans proline' 0 N--CA 1.498 1.758 0 C-N-CA 121.49 1.46 . . . . 0.0 112.875 -179.228 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' E' E ' 17' ' ' ASP . . . . . . . . . . . . . 18.2 p-10 -79.43 1.86 23.95 Favored 'General case' 0 CA--C 1.538 0.499 0 N-CA-C 113.327 0.862 . . . . 0.0 113.327 -177.34 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' E' E ' 18' ' ' PHE . . . . . . . . . . . . . 46.9 t80 -57.61 -47.18 82.88 Favored 'General case' 0 N--CA 1.458 -0.074 0 O-C-N 121.97 -0.456 . . . . 0.0 110.142 -178.605 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' E' E ' 19' ' ' VAL . . . . . 0.41 HG13 ' N ' ' E' ' 20' ' ' ASP . 13.8 p -55.34 -41.49 62.11 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.319 0 CA-C-N 116.26 -0.427 . . . . 0.0 111.095 -178.553 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' E' E ' 20' ' ' ASP . . . . . 0.41 ' N ' HG13 ' E' ' 19' ' ' VAL . 9.5 t0 -60.44 -43.16 97.11 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-O 120.925 0.393 . . . . 0.0 110.899 -177.977 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' E' E ' 21' ' ' VAL . . . . . . . . . . . . . 47.2 t -64.34 -45.98 94.45 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.287 0 CA-C-N 116.272 -0.422 . . . . 0.0 110.496 -178.177 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' E' E ' 22' ' ' ILE . . . . . 0.62 HG22 HD12 ' E' ' 26' ' ' LEU . 50.2 mm -54.63 -47.09 73.05 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.287 0 CA-C-O 120.676 0.275 . . . . 0.0 110.753 178.809 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' E' E ' 23' ' ' ARG . . . . . . . . . . . . . 25.1 ttm-85 -53.3 -54.17 40.28 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-O 121.258 0.551 . . . . 0.0 111.677 179.963 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' E' E ' 24' ' ' ILE . . . . . . . . . . . . . 76.4 mt -61.0 -36.52 72.94 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.38 0 CA-C-N 115.67 -0.696 . . . . 0.0 111.59 -172.857 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' E' E ' 25' ' ' LYS . . . . . . . . . . . . . 64.1 mttm -75.22 -40.66 58.91 Favored 'General case' 0 C--N 1.33 -0.267 0 N-CA-C 112.349 0.5 . . . . 0.0 112.349 -178.855 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' E' E ' 26' ' ' LEU . . . . . 0.62 HD12 HG22 ' E' ' 22' ' ' ILE . 75.9 mt -80.22 -25.64 39.52 Favored 'General case' 0 C--N 1.331 -0.201 0 N-CA-C 113.195 0.813 . . . . 0.0 113.195 -171.112 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' E' E ' 27' ' ' GLN . . . . . . . . . . . . . 18.4 pt20 -46.38 136.67 7.1 Favored 'General case' 0 N--CA 1.469 0.495 0 N-CA-C 112.594 0.59 . . . . 0.0 112.594 -177.368 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' E' E ' 28' ' ' GLY . . . . . . . . . . . . . . . 99.8 -21.06 46.67 Favored Glycine 0 CA--C 1.535 1.305 0 CA-C-N 115.824 -0.626 . . . . 0.0 112.661 -177.162 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' E' E ' 29' ' ' LYS . . . . . . . . . . . . . 61.1 mttp -97.02 155.14 16.91 Favored 'General case' 0 C--O 1.233 0.218 0 CA-C-N 117.471 0.636 . . . . 0.0 110.935 179.492 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' E' E ' 30' ' ' THR . . . . . . . . . . . . . 28.5 m -108.65 137.45 46.57 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.042 -0.526 . . . . 0.0 110.031 176.748 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' E' E ' 31' ' ' VAL . . . . . . . . . . . . . 35.3 m -130.35 152.77 37.98 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.223 0 CA-C-O 120.919 0.39 . . . . 0.0 110.778 -178.751 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' E' E ' 32' ' ' ARG . . . . . . . . . . . . . 37.9 ttm180 -133.23 148.23 51.99 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-O 121.246 0.546 . . . . 0.0 110.398 179.568 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' E' E ' 33' ' ' THR . . . . . . . . . . . . . 16.4 m -52.11 139.33 23.49 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.244 -0.434 . . . . 0.0 111.624 -177.145 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' E' E ' 34' ' ' GLY . . . . . . . . . . . . . . . 101.03 -17.24 56.45 Favored Glycine 0 CA--C 1.534 1.235 0 CA-C-O 119.667 -0.519 . . . . 0.0 113.201 179.051 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' E' E ' 35' ' ' ASP . . . . . . . . . . . . . 79.2 m-20 -66.78 147.3 53.43 Favored 'General case' 0 N--CA 1.462 0.163 0 CA-C-N 118.026 0.913 . . . . 0.0 111.229 179.25 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' E' E ' 36' ' ' VAL . . . . . . . . . . . . . 45.8 t -122.51 129.1 75.49 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.204 0 CA-C-N 115.779 -0.646 . . . . 0.0 109.737 177.802 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' E' E ' 37' ' ' ILE . . . . . . . . . . . . . 63.2 mt -123.16 139.23 50.53 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.256 0 CA-C-N 116.286 -0.416 . . . . 0.0 109.953 -179.011 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' E' E ' 38' ' ' GLY . . . . . . . . . . . . . . . -115.46 128.65 8.16 Favored Glycine 0 CA--C 1.524 0.605 0 N-CA-C 110.982 -0.847 . . . . 0.0 110.982 178.661 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' E' E ' 39' ' ' ILE . . . . . . . . . . . . . 68.7 mt -126.98 125.71 67.05 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.271 0 N-CA-C 110.019 -0.363 . . . . 0.0 110.019 179.501 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' E' E ' 40' ' ' SER . . . . . . . . . . . . . 24.0 t -91.99 118.66 30.99 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.388 -0.369 . . . . 0.0 110.794 176.545 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' E' E ' 41' ' ' ILE . . . . . . . . . . . . . 70.9 mt -130.35 131.05 65.63 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.227 0 CA-C-O 120.927 0.394 . . . . 0.0 110.299 179.283 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' E' E ' 42' ' ' LEU . . . . . . . . . . . . . 47.3 mt 54.94 33.47 20.15 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-N 116.039 -0.528 . . . . 0.0 111.817 177.954 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' E' E ' 43' ' ' GLY . . . . . . . . . . . . . . . 71.77 28.99 68.03 Favored Glycine 0 CA--C 1.53 0.983 0 C-N-CA 121.075 -0.583 . . . . 0.0 112.299 178.094 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' E' E ' 44' ' ' LYS . . . . . . . . . . . . . 20.0 tptm -142.43 125.92 16.75 Favored 'General case' 0 C--N 1.331 -0.205 0 N-CA-C 109.748 -0.464 . . . . 0.0 109.748 178.46 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' E' E ' 45' ' ' GLU . . . . . . . . . . . . . 41.0 tp10 -85.21 128.6 34.74 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-O 120.843 0.354 . . . . 0.0 111.589 -177.413 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' E' E ' 46' ' ' VAL . . . . . . . . . . . . . 8.9 p -120.15 127.74 75.92 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.188 0 N-CA-C 109.525 -0.546 . . . . 0.0 109.525 174.261 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' E' E ' 47' ' ' LYS . . . . . . . . . . . . . 52.7 mtpt -98.55 124.41 43.28 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.035 -0.529 . . . . 0.0 110.792 178.01 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' E' E ' 48' ' ' PHE . . . . . . . . . . . . . 37.6 m-85 -109.27 131.82 54.7 Favored 'General case' 0 C--N 1.33 -0.265 0 N-CA-C 109.782 -0.451 . . . . 0.0 109.782 178.069 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' E' E ' 49' ' ' LYS . . . . . . . . . . . . . 76.8 tttt -108.63 132.58 53.75 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.417 -0.356 . . . . 0.0 110.344 178.009 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' E' E ' 50' ' ' VAL . . . . . . . . . . . . . 45.6 t -76.29 105.07 4.83 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.367 0 N-CA-C 109.249 -0.649 . . . . 0.0 109.249 176.087 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' E' E ' 51' ' ' VAL . . . . . . . . . . . . . 47.0 t -68.64 -53.92 24.32 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.351 0 N-CA-C 109.401 -0.592 . . . . 0.0 109.401 -175.64 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' E' E ' 52' ' ' GLN . . . . . . . . . . . . . 80.8 mt-30 -155.7 154.61 31.78 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 115.967 -0.561 . . . . 0.0 111.584 -178.163 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' E' E ' 53' ' ' ALA . . . . . . . . . . . . . . . -130.9 132.17 44.97 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 115.371 -0.831 . . . . 0.0 109.667 174.91 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' E' E ' 54' ' ' TYR . . . . . . . . . . . . . 39.7 t80 -129.07 108.92 18.1 Favored Pre-proline 0 CA--C 1.534 0.353 0 CA-C-O 118.273 -0.87 . . . . 0.0 110.421 179.892 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' E' E ' 55' ' ' PRO . . . . . . . . . . . . . 73.2 Cg_endo -77.21 169.89 72.94 Favored 'Cis proline' 0 N--CA 1.5 1.866 0 CA-C-N 121.84 1.693 . . . . 0.0 112.32 -6.428 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' E' E ' 56' ' ' SER . . . . . . . . . . . . . 13.6 m -117.22 134.71 23.03 Favored Pre-proline 0 CA--C 1.539 0.528 0 CA-C-O 118.401 -0.809 . . . . 0.0 109.45 174.031 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' E' E ' 57' ' ' PRO . . . . . . . . . . . . . 50.8 Cg_endo -70.07 146.79 83.81 Favored 'Cis proline' 0 N--CA 1.496 1.672 0 CA-C-N 121.85 1.696 . . . . 0.0 111.519 -1.379 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' E' E ' 58' ' ' LEU . . . . . . . . . . . . . 33.6 tp -107.89 138.76 43.57 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-O 120.87 0.367 . . . . 0.0 110.689 -177.838 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' E' E ' 59' ' ' ARG . . . . . . . . . . . . . 72.7 ttt180 -102.66 131.59 49.34 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 115.813 -0.63 . . . . 0.0 109.679 176.952 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' E' E ' 60' ' ' VAL . . . . . . . . . . . . . 41.7 t -86.29 118.65 33.08 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.213 0 C-N-CA 120.775 -0.37 . . . . 0.0 110.602 -177.167 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' E' E ' 61' ' ' GLU . . . . . . . . . . . . . 96.6 mt-10 -131.11 158.17 41.13 Favored 'General case' 0 C--N 1.331 -0.229 0 CA-C-N 115.874 -0.603 . . . . 0.0 109.748 177.302 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' E' E ' 62' ' ' ASP . . . . . . . . . . . . . 48.5 m-20 -52.44 -32.94 41.92 Favored 'General case' 0 C--N 1.329 -0.324 0 N-CA-C 111.816 0.302 . . . . 0.0 111.816 -178.663 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' E' E ' 63' ' ' ARG . . . . . . . . . . . . . 75.5 mtp180 -78.91 -19.96 50.53 Favored 'General case' 0 CA--C 1.533 0.301 0 N-CA-C 113.153 0.797 . . . . 0.0 113.153 -176.258 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' E' E ' 64' ' ' THR . . . . . . . . . . . . . 24.9 m -66.34 149.2 50.74 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-O 120.993 0.425 . . . . 0.0 111.117 -174.739 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' E' E ' 65' ' ' LYS . . . . . . . . . . . . . 24.6 mtpp -89.67 127.26 35.9 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 115.964 -0.562 . . . . 0.0 110.651 179.997 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' E' E ' 66' ' ' ILE . . . . . . . . . . . . . 64.1 mt -117.64 128.52 74.84 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.272 0 N-CA-C 109.842 -0.429 . . . . 0.0 109.842 177.476 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' E' E ' 67' ' ' THR . . . . . . . . . . . . . 28.8 m -120.56 137.76 54.23 Favored 'General case' 0 C--N 1.331 -0.229 0 CA-C-O 121.123 0.487 . . . . 0.0 110.928 -178.587 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' E' E ' 68' ' ' LEU . . . . . . . . . . . . . 13.3 tp . . . . . 0 C--N 1.33 -0.279 0 CA-C-N 115.706 -0.679 . . . . 0.0 110.254 178.44 . . . . . . . . 0 0 . 1 . 009 nuclear build core ' E' E ' 73' ' ' VAL . . . . . . . . . . . . . 35.2 m . . . . . 0 N--CA 1.462 0.125 0 CA-C-O 120.709 0.29 . . . . 0.0 110.466 . . . . . . . . . 0 0 . 1 . 009 nuclear build core ' E' E ' 74' ' ' ASP . . . . . . . . . . . . . 10.8 t70 -98.04 118.04 33.74 Favored 'General case' 0 C--N 1.33 -0.274 0 N-CA-C 109.935 -0.394 . . . . 0.0 109.935 -178.471 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' E' E ' 75' ' ' VAL . . . . . . . . . . . . . 42.0 t -112.32 122.65 66.97 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.2 0 CA-C-O 121.09 0.471 . . . . 0.0 110.369 -178.31 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' E' E ' 76' ' ' LEU . . . . . . . . . . . . . 29.9 mt -122.79 137.62 54.87 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 115.63 -0.713 . . . . 0.0 109.432 178.398 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' E' E ' 77' ' ' GLU . . . . . . . . . . . . . 96.4 mt-10 -133.27 140.3 47.39 Favored 'General case' 0 C--N 1.331 -0.217 0 CA-C-O 121.035 0.445 . . . . 0.0 111.301 -177.29 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' E' E ' 78' ' ' ALA . . . . . 0.577 ' HB2' HD21 ' E' ' 109' ' ' LEU . . . -130.12 129.62 43.76 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 115.678 -0.692 . . . . 0.0 109.957 176.377 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' E' E ' 79' ' ' LYS . . . . . 0.583 ' O ' HD13 ' E' ' 80' ' ' ILE . 32.7 mmtp -75.24 119.09 18.9 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-O 120.949 0.404 . . . . 0.0 110.58 -179.428 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' E' E ' 80' ' ' ILE . . . . . 0.583 HD13 ' O ' ' E' ' 79' ' ' LYS . 22.7 mm -139.25 112.53 6.36 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.269 0 N-CA-C 108.947 -0.76 . . . . 0.0 108.947 -178.578 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' E' E ' 81' ' ' LYS . . . . . . . . . . . . . 40.6 mttp -99.72 126.75 45.82 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-O 120.875 0.369 . . . . 0.0 111.293 -176.07 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' E' E ' 82' ' ' GLY . . . . . . . . . . . . . . . 89.11 42.21 5.66 Favored Glycine 0 CA--C 1.526 0.744 0 C-N-CA 120.989 -0.624 . . . . 0.0 111.892 174.119 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' E' E ' 83' ' ' ILE . . . . . . . . . . . . . 69.8 mt -67.93 137.99 23.5 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.34 0 N-CA-C 109.793 -0.447 . . . . 0.0 109.793 177.099 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' E' E ' 84' ' ' LYS . . . . . . . . . . . . . 70.4 tttt -100.24 -53.63 3.08 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.165 -0.471 . . . . 0.0 110.226 -178.58 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' E' E ' 85' ' ' ASP . . . . . . . . . . . . . 8.5 t70 -151.23 148.45 28.23 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 115.837 -0.619 . . . . 0.0 110.387 -178.985 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' E' E ' 86' ' ' VAL . . . . . . . . . . . . . 43.7 t -129.47 129.42 66.93 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.269 0 CA-C-O 120.928 0.394 . . . . 0.0 110.377 -179.648 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' E' E ' 87' ' ' ILE . . . . . . . . . . . . . 4.6 mp -122.19 134.28 65.93 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.255 0 CA-C-N 115.972 -0.558 . . . . 0.0 109.709 178.593 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' E' E ' 88' ' ' LEU . . . . . . . . . . . . . 10.2 tp -111.59 134.89 52.85 Favored 'General case' 0 C--N 1.331 -0.205 0 CA-C-O 121.105 0.479 . . . . 0.0 111.059 -178.206 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' E' E ' 89' ' ' ASP . . . . . . . . . . . . . 4.7 t70 -121.53 159.12 27.01 Favored 'General case' 0 C--N 1.331 -0.205 0 CA-C-N 115.651 -0.704 . . . . 0.0 109.634 177.515 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' E' E ' 90' ' ' GLU . . . . . . . . . . . . . 84.3 tt0 -44.97 -44.37 9.8 Favored 'General case' 0 N--CA 1.465 0.301 0 N-CA-C 113.094 0.775 . . . . 0.0 113.094 -172.224 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' E' E ' 91' ' ' ASN . . . . . . . . . . . . . 23.8 m120 -132.02 26.34 4.59 Favored 'General case' 0 N--CA 1.467 0.419 0 N-CA-C 112.401 0.519 . . . . 0.0 112.401 -179.427 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' E' E ' 92' ' ' LEU . . . . . . . . . . . . . 12.8 mt -149.24 151.88 35.02 Favored 'General case' 0 C--N 1.333 -0.143 0 N-CA-C 110.105 -0.332 . . . . 0.0 110.105 -176.159 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' E' E ' 93' ' ' ILE . . . . . . . . . . . . . 72.2 mt -127.71 121.98 57.93 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.28 0 N-CA-C 109.349 -0.612 . . . . 0.0 109.349 177.812 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' E' E ' 94' ' ' VAL . . . . . 0.46 HG21 HG11 ' E' ' 125' ' ' VAL . 44.6 t -118.07 128.1 75.19 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.294 0 CA-C-O 120.813 0.34 . . . . 0.0 110.119 -178.343 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' E' E ' 95' ' ' VAL . . . . . . . . . . . . . 43.6 t -122.19 135.11 63.37 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.381 0 CA-C-N 115.986 -0.552 . . . . 0.0 109.996 -179.238 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' E' E ' 96' ' ' ILE . . . . . . . . . . . . . 62.2 mt -115.3 128.04 72.65 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.346 0 N-CA-C 109.241 -0.652 . . . . 0.0 109.241 178.392 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' E' E ' 97' ' ' THR . . . . . . . . . . . . . 66.5 p -101.32 155.74 17.86 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-O 121.056 0.455 . . . . 0.0 111.04 -177.521 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' E' E ' 98' ' ' GLU . . . . . . . . . . . . . 97.1 mt-10 -53.91 -26.22 24.08 Favored 'General case' 0 CA--C 1.532 0.265 0 N-CA-C 112.194 0.442 . . . . 0.0 112.194 179.874 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' E' E ' 99' ' ' GLU . . . . . . . . . . . . . 97.0 mt-10 -78.86 15.53 1.06 Allowed 'General case' 0 CA--C 1.535 0.37 0 N-CA-C 113.167 0.803 . . . . 0.0 113.167 -177.383 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' E' E ' 100' ' ' ASN . . . . . . . . . . . . . 3.6 m-20 61.54 37.41 16.4 Favored 'General case' 0 CA--C 1.529 0.17 0 CA-C-O 120.974 0.416 . . . . 0.0 111.124 178.728 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' E' E ' 101' ' ' GLU . . . . . . . . . . . . . 80.9 tt0 -115.23 145.45 42.41 Favored 'General case' 0 C--N 1.332 -0.173 0 CA-C-N 115.951 -0.568 . . . . 0.0 109.616 175.803 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' E' E ' 102' ' ' VAL . . . . . . . . . . . . . 43.4 t -115.59 125.98 72.97 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.335 0 CA-C-N 116.318 -0.401 . . . . 0.0 110.143 -177.043 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' E' E ' 103' ' ' LEU . . . . . . . . . . . . . 23.4 mt -117.92 130.5 56.26 Favored 'General case' 0 C--N 1.331 -0.226 0 CA-C-N 115.888 -0.596 . . . . 0.0 110.15 177.747 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' E' E ' 104' ' ' ILE . . . . . 0.556 HD13 HG21 ' E' ' 130' ' ' VAL . 68.8 mt -119.9 120.85 64.45 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.189 0 CA-C-O 120.646 0.26 . . . . 0.0 110.308 179.02 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' E' E ' 105' ' ' PHE . . . . . . . . . . . . . 55.6 m-85 -119.86 166.5 13.21 Favored 'General case' 0 C--N 1.332 -0.18 0 CA-C-N 115.352 -0.84 . . . . 0.0 109.796 178.618 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' E' E ' 106' ' ' ASN . . . . . . . . . . . . . 47.1 p-10 -97.87 -169.94 1.91 Allowed 'General case' 0 C--N 1.331 -0.231 0 N-CA-C 109.708 -0.478 . . . . 0.0 109.708 172.972 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' E' E ' 107' ' ' GLN . . . . . . . . . . . . . 5.6 tp-100 -60.89 -28.17 68.69 Favored 'General case' 0 CA--C 1.533 0.295 0 N-CA-C 112.012 0.375 . . . . 0.0 112.012 179.564 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' E' E ' 108' ' ' ASN . . . . . . . . . . . . . 15.6 t-20 -82.94 9.43 10.07 Favored 'General case' 0 CA--C 1.536 0.42 0 N-CA-C 112.94 0.718 . . . . 0.0 112.94 -179.125 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' E' E ' 109' ' ' LEU . . . . . 0.577 HD21 ' HB2' ' E' ' 78' ' ' ALA . 9.4 tp 57.78 36.92 26.94 Favored 'General case' 0 C--O 1.232 0.164 0 CA-C-O 120.877 0.37 . . . . 0.0 111.278 179.973 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' E' E ' 110' ' ' GLU . . . . . . . . . . . . . 96.6 mt-10 -102.14 150.07 23.64 Favored 'General case' 0 C--N 1.331 -0.23 0 N-CA-C 109.788 -0.449 . . . . 0.0 109.788 176.364 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' E' E ' 111' ' ' GLU . . . . . . . . . . . . . 68.0 tt0 -83.24 121.93 27.75 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 116.47 -0.332 . . . . 0.0 110.846 -176.509 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' E' E ' 112' ' ' LEU . . . . . . . . . . . . . 13.4 mt -110.47 -45.99 3.46 Favored 'General case' 0 C--N 1.332 -0.182 0 CA-C-N 116.228 -0.442 . . . . 0.0 110.553 179.685 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' E' E ' 113' ' ' TYR . . . . . . . . . . . . . 57.3 t80 -135.77 133.74 38.26 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.341 -0.391 . . . . 0.0 110.936 -178.346 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' E' E ' 114' ' ' ARG . . . . . . . . . . . . . 76.7 ttt180 -134.57 120.18 19.32 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.14 -0.482 . . . . 0.0 110.054 176.938 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' E' E ' 115' ' ' GLY . . . . . . . . . . . . . . . -148.32 162.46 28.82 Favored Glycine 0 CA--C 1.524 0.635 0 N-CA-C 110.694 -0.962 . . . . 0.0 110.694 -179.773 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' E' E ' 116' ' ' LYS . . . . . . . . . . . . . 33.6 ttmt -136.81 139.09 41.5 Favored 'General case' 0 C--N 1.327 -0.371 0 N-CA-C 110.224 -0.287 . . . . 0.0 110.224 -179.623 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' E' E ' 117' ' ' PHE . . . . . . . . . . . . . 32.9 m-85 -137.51 113.94 10.21 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-O 121.047 0.451 . . . . 0.0 110.272 -176.487 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' E' E ' 118' ' ' GLU . . . . . . . . . . . . . 96.5 mt-10 -53.59 -45.6 70.07 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.142 -0.481 . . . . 0.0 111.514 -176.425 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' E' E ' 119' ' ' ASN . . . . . . . . . . . . . 32.7 m120 -96.55 30.93 2.41 Favored 'General case' 0 C--N 1.329 -0.299 0 N-CA-C 112.306 0.484 . . . . 0.0 112.306 -174.316 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' E' E ' 120' ' ' LEU . . . . . . . . . . . . . 12.9 tp -56.24 122.94 12.94 Favored 'General case' 0 C--N 1.332 -0.191 0 C-N-CA 121.139 -0.224 . . . . 0.0 110.559 177.645 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' E' E ' 121' ' ' ASN . . . . . . . . . . . . . 44.7 t30 -114.07 -44.01 3.19 Favored 'General case' 0 C--N 1.333 -0.131 0 CA-C-N 116.684 -0.235 . . . . 0.0 111.559 -176.641 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' E' E ' 122' ' ' LYS . . . . . 0.424 ' HE3' HD11 ' E' ' 124' ' ' LEU . 33.6 ttpt -149.1 149.16 30.61 Favored 'General case' 0 C--N 1.332 -0.158 0 CA-C-O 121.077 0.465 . . . . 0.0 111.431 -174.647 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' E' E ' 123' ' ' VAL . . . . . . . . . . . . . 45.7 t -126.52 136.49 60.67 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.265 0 CA-C-N 116.11 -0.495 . . . . 0.0 109.935 179.126 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' E' E ' 124' ' ' LEU . . . . . 0.424 HD11 ' HE3' ' E' ' 122' ' ' LYS . 57.3 mt -129.86 138.32 50.91 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-O 120.714 0.292 . . . . 0.0 110.655 -178.926 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' E' E ' 125' ' ' VAL . . . . . 0.46 HG11 HG21 ' E' ' 94' ' ' VAL . 35.7 m -135.9 143.67 35.58 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.269 0 CA-C-N 116.341 -0.391 . . . . 0.0 110.644 178.509 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' E' E ' 126' ' ' ARG . . . . . . . . . . . . . 67.6 ttt180 -162.02 122.09 2.51 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 116.128 -0.487 . . . . 0.0 110.103 177.921 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' E' E ' 127' ' ' ASN . . . . . . . . . . . . . 3.7 t-20 56.02 -149.58 0.45 Allowed 'General case' 0 CA--C 1.54 0.591 0 N-CA-C 109.973 -0.38 . . . . 0.0 109.973 179.822 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' E' E ' 128' ' ' ASP . . . . . . . . . . . . . 14.2 p-10 -80.01 13.54 2.21 Favored 'General case' 0 CA--C 1.536 0.441 0 N-CA-C 112.879 0.696 . . . . 0.0 112.879 -179.792 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' E' E ' 129' ' ' LEU . . . . . . . . . . . . . 39.6 mt -110.82 138.58 47.03 Favored 'General case' 0 C--O 1.231 0.129 0 CA-C-N 118.143 0.429 . . . . 0.0 109.981 178.053 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' E' E ' 130' ' ' VAL . . . . . 0.556 HG21 HD13 ' E' ' 104' ' ' ILE . 30.6 m -132.63 140.76 46.78 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.185 0 CA-C-O 120.957 0.408 . . . . 0.0 110.377 178.478 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' E' E ' 131' ' ' VAL . . . . . 0.537 HG22 HD12 ' E' ' 140' ' ' LEU . 39.7 t -136.06 139.31 46.02 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.256 0 CA-C-O 121.166 0.507 . . . . 0.0 110.392 -178.419 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' E' E ' 132' ' ' ILE . . . . . . . . . . . . . 68.1 mt -116.63 130.95 70.62 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.325 0 CA-C-N 115.552 -0.749 . . . . 0.0 109.379 179.932 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' E' E ' 133' ' ' ILE . . . . . . . . . . . . . 41.8 mm -114.47 119.12 60.59 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.214 0 CA-C-O 121.026 0.441 . . . . 0.0 110.797 -176.07 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' E' E ' 134' ' ' ASP . . . . . . . . . . . . . 7.0 p-10 -128.18 147.44 50.57 Favored 'General case' 0 C--N 1.33 -0.259 0 N-CA-C 109.649 -0.5 . . . . 0.0 109.649 175.684 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' E' E ' 135' ' ' GLU . . . . . . . . . . . . . 85.6 tt0 -49.81 -24.21 2.28 Favored 'General case' 0 C--N 1.327 -0.371 0 N-CA-C 112.971 0.73 . . . . 0.0 112.971 -171.084 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' E' E ' 136' ' ' GLN . . . . . . . . . . . . . 63.0 tt0 -100.03 -31.16 11.58 Favored 'General case' 0 CA--C 1.529 0.165 0 N-CA-C 112.145 0.424 . . . . 0.0 112.145 -175.318 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' E' E ' 137' ' ' LYS . . . . . . . . . . . . . 74.5 mttt -142.23 155.52 45.26 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-O 121.384 0.612 . . . . 0.0 111.818 -169.66 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' E' E ' 138' ' ' LEU . . . . . 0.407 ' C ' HD23 ' E' ' 138' ' ' LEU . 4.4 tt -116.47 120.98 40.51 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 115.323 -0.853 . . . . 0.0 109.054 171.772 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' E' E ' 139' ' ' THR . . . . . . . . . . . . . 26.3 m -108.39 126.39 52.82 Favored 'General case' 0 C--N 1.331 -0.204 0 CA-C-N 116.381 -0.372 . . . . 0.0 110.974 -176.764 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' E' E ' 140' ' ' LEU . . . . . 0.537 HD12 HG22 ' E' ' 131' ' ' VAL . 15.4 tp -112.34 122.43 47.71 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 115.486 -0.779 . . . . 0.0 109.418 -179.618 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' E' E ' 141' ' ' ILE . . . . . 0.523 ' HB ' HG23 ' E' ' 130' ' ' VAL . 19.2 mt -123.14 121.36 62.83 Favored 'Isoleucine or valine' 0 C--O 1.234 0.259 0 N-CA-C 109.778 -0.452 . . . . 0.0 109.778 -177.339 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' E' E ' 142' ' ' ARG . . . . . . . . . . . . . 29.2 ttp180 -118.68 127.06 53.22 Favored 'General case' 0 C--N 1.331 -0.22 0 CA-C-N 115.437 -0.801 . . . . 0.0 110.276 -177.7 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' E' E ' 143' ' ' THR . . . . . . . . . . . . . 72.9 p . . . . . 0 C--O 1.221 -0.432 0 CA-C-O 118.108 -0.948 . . . . 0.0 110.677 -179.265 . . . . . . . . 0 0 . 1 . 009 nuclear build core ' F' F ' 1' ' ' MET . . . . . . . . . . . . . 26.2 ptt? . . . . . 0 C--O 1.231 0.082 0 CA-C-O 120.782 0.325 . . . . 0.0 110.7 . . . . . . . . . 0 0 . 1 . 009 nuclear build core ' F' F ' 2' ' ' SER . . . . . 0.566 ' HB2' HD11 ' F' ' 58' ' ' LEU . 9.1 p -126.83 147.62 50.01 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-N 116.261 -0.427 . . . . 0.0 110.684 179.985 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' F' F ' 3' ' ' GLU . . . . . . . . . . . . . 81.9 tt0 -140.78 140.13 34.71 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.068 -0.515 . . . . 0.0 111.132 -178.424 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' F' F ' 4' ' ' LEU . . . . . . . . . . . . . 18.1 tp -122.1 131.11 53.8 Favored 'General case' 0 C--N 1.332 -0.185 0 CA-C-N 115.971 -0.559 . . . . 0.0 109.907 176.418 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' F' F ' 5' ' ' LYS . . . . . . . . . . . . . 64.1 mttp -109.72 121.14 44.54 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.238 -0.437 . . . . 0.0 110.576 -179.041 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' F' F ' 6' ' ' LEU . . . . . . . . . . . . . 63.0 mt -114.0 149.33 35.51 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 115.467 -0.788 . . . . 0.0 110.811 -177.878 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' F' F ' 7' ' ' LYS . . . . . . . . . . . . . 29.6 ttpt -135.0 134.87 22.07 Favored Pre-proline 0 CA--C 1.534 0.357 0 CA-C-O 118.929 -0.558 . . . . 0.0 109.728 176.72 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' F' F ' 8' ' ' PRO . . . . . . . . . . . . . 97.1 Cg_endo -91.05 131.2 1.46 Allowed 'Trans proline' 0 N--CA 1.49 1.265 0 C-N-CA 121.73 1.62 . . . . 0.0 111.396 175.331 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' F' F ' 9' ' ' LEU . . . . . . . . . . . . . 27.9 mt -68.63 -46.84 35.11 Favored Pre-proline 0 CA--C 1.532 0.28 0 CA-C-O 118.791 -0.623 . . . . 0.0 111.509 -177.067 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' F' F ' 10' ' ' PRO . . . . . . . . . . . . . 98.4 Cg_endo -80.71 140.96 13.37 Favored 'Trans proline' 0 N--CA 1.496 1.643 0 C-N-CA 121.012 1.141 . . . . 0.0 111.25 171.542 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' F' F ' 11' ' ' LYS . . . . . . . . . . . . . 54.0 tttp -84.82 106.47 16.38 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-O 120.86 0.362 . . . . 0.0 110.586 -179.433 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' F' F ' 12' ' ' VAL . . . . . . . . . . . . . 12.2 p -142.98 148.72 19.23 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.344 0 CA-C-N 116.101 -0.5 . . . . 0.0 110.497 -179.758 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' F' F ' 13' ' ' GLU . . . . . . . . . . . . . 43.8 tp10 -82.18 117.07 22.04 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.211 -0.449 . . . . 0.0 109.984 177.74 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' F' F ' 14' ' ' LEU . . . . . . . . . . . . . 32.3 mt -89.61 149.79 43.0 Favored Pre-proline 0 C--N 1.33 -0.263 0 CA-C-O 119.326 -0.369 . . . . 0.0 110.618 -177.62 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' F' F ' 15' ' ' PRO . . . . . . . . . . . . . 26.0 Cg_exo -61.67 159.12 33.94 Favored 'Trans proline' 0 N--CA 1.496 1.631 0 C-N-CA 121.186 1.257 . . . . 0.0 111.627 176.756 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' F' F ' 16' ' ' PRO . . . . . . . . . . . . . 38.5 Cg_exo -58.52 -36.17 97.73 Favored 'Trans proline' 0 N--CA 1.497 1.712 0 C-N-CA 121.386 1.391 . . . . 0.0 112.931 -177.499 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' F' F ' 17' ' ' ASP . . . . . . . . . . . . . 7.2 p-10 -90.77 8.42 34.76 Favored 'General case' 0 CA--C 1.535 0.372 0 N-CA-C 113.393 0.886 . . . . 0.0 113.393 -176.867 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' F' F ' 18' ' ' PHE . . . . . . . . . . . . . 34.9 t80 -58.42 -45.45 88.42 Favored 'General case' 0 C--O 1.231 0.102 0 O-C-N 121.983 -0.448 . . . . 0.0 110.018 -178.187 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' F' F ' 19' ' ' VAL . . . . . 0.4 HG13 ' N ' ' F' ' 20' ' ' ASP . 13.2 p -57.22 -40.66 75.04 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.372 0 CA-C-N 116.156 -0.475 . . . . 0.0 110.571 179.939 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' F' F ' 20' ' ' ASP . . . . . 0.4 ' N ' HG13 ' F' ' 19' ' ' VAL . 65.8 m-20 -60.02 -43.12 95.48 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-O 120.798 0.333 . . . . 0.0 110.84 -178.013 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' F' F ' 21' ' ' VAL . . . . . . . . . . . . . 46.6 t -64.06 -47.33 90.76 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.284 0 CA-C-N 116.398 -0.365 . . . . 0.0 110.377 -178.183 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' F' F ' 22' ' ' ILE . . . . . 0.446 HG22 HD12 ' F' ' 26' ' ' LEU . 49.9 mm -57.73 -39.24 69.43 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.353 0 CA-C-O 120.793 0.33 . . . . 0.0 110.896 -179.941 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' F' F ' 23' ' ' ARG . . . . . . . . . . . . . 54.6 ttp180 -57.13 -50.55 72.45 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-O 120.904 0.383 . . . . 0.0 110.562 177.243 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' F' F ' 24' ' ' ILE . . . . . . . . . . . . . 72.8 mt -61.0 -40.1 84.44 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.287 0 CA-C-N 115.986 -0.552 . . . . 0.0 111.968 -176.979 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' F' F ' 25' ' ' LYS . . . . . . . . . . . . . 13.8 pttp -75.48 -35.18 60.9 Favored 'General case' 0 CA--C 1.534 0.348 0 C-N-CA 120.671 -0.412 . . . . 0.0 112.046 -174.03 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' F' F ' 26' ' ' LEU . . . . . 0.446 HD12 HG22 ' F' ' 22' ' ' ILE . 34.3 mt -80.32 -41.42 24.89 Favored 'General case' 0 C--N 1.33 -0.256 0 N-CA-C 112.841 0.682 . . . . 0.0 112.841 -174.762 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' F' F ' 27' ' ' GLN . . . . . . . . . . . . . 18.9 pt20 -46.3 139.63 4.63 Favored 'General case' 0 N--CA 1.467 0.392 0 N-CA-C 113.006 0.743 . . . . 0.0 113.006 -174.551 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' F' F ' 28' ' ' GLY . . . . . . . . . . . . . . . 99.61 -25.85 26.66 Favored Glycine 0 CA--C 1.534 1.243 0 CA-C-N 115.539 -0.755 . . . . 0.0 112.199 -175.362 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' F' F ' 29' ' ' LYS . . . . . . . . . . . . . 25.7 mtpp -98.43 155.18 17.37 Favored 'General case' 0 C--N 1.333 -0.146 0 CA-C-N 117.18 0.49 . . . . 0.0 111.167 179.648 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' F' F ' 30' ' ' THR . . . . . . . . . . . . . 29.8 m -101.17 137.73 39.14 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.036 -0.529 . . . . 0.0 109.96 175.657 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' F' F ' 31' ' ' VAL . . . . . . . . . . . . . 35.3 m -129.26 154.24 39.82 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.254 0 CA-C-O 120.94 0.4 . . . . 0.0 110.742 -179.754 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' F' F ' 32' ' ' ARG . . . . . . . . . . . . . 80.8 mtm180 -132.53 148.29 52.38 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 115.849 -0.614 . . . . 0.0 110.335 178.395 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' F' F ' 33' ' ' THR . . . . . . . . . . . . . 25.3 m -52.79 138.01 30.33 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.344 -0.389 . . . . 0.0 111.418 -178.688 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' F' F ' 34' ' ' GLY . . . . . . . . . . . . . . . 101.64 -17.14 55.56 Favored Glycine 0 CA--C 1.532 1.155 0 CA-C-O 119.697 -0.501 . . . . 0.0 113.28 179.369 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' F' F ' 35' ' ' ASP . . . . . . . . . . . . . 73.3 m-20 -65.84 149.17 50.61 Favored 'General case' 0 C--O 1.232 0.136 0 CA-C-N 117.981 0.89 . . . . 0.0 110.952 179.23 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' F' F ' 36' ' ' VAL . . . . . . . . . . . . . 45.8 t -126.0 131.61 71.54 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.289 0 CA-C-N 116.049 -0.523 . . . . 0.0 109.854 178.302 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' F' F ' 37' ' ' ILE . . . . . . . . . . . . . 65.2 mt -121.06 139.15 49.18 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.233 0 CA-C-N 116.162 -0.472 . . . . 0.0 109.891 -178.995 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' F' F ' 38' ' ' GLY . . . . . . . . . . . . . . . -110.36 128.8 9.0 Favored Glycine 0 CA--C 1.525 0.662 0 N-CA-C 111.059 -0.816 . . . . 0.0 111.059 179.916 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' F' F ' 39' ' ' ILE . . . . . . . . . . . . . 73.7 mt -123.9 133.68 68.59 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.185 0 N-CA-C 110.049 -0.352 . . . . 0.0 110.049 179.347 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' F' F ' 40' ' ' SER . . . . . . . . . . . . . 99.8 p -93.23 123.66 36.66 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.398 -0.364 . . . . 0.0 111.0 176.298 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' F' F ' 41' ' ' ILE . . . . . . . . . . . . . 70.9 mt -131.21 120.69 47.28 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.209 0 CA-C-O 120.918 0.39 . . . . 0.0 110.345 177.869 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' F' F ' 42' ' ' LEU . . . . . . . . . . . . . 48.9 mt 52.76 35.45 18.64 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.011 -0.54 . . . . 0.0 111.699 177.166 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' F' F ' 43' ' ' GLY . . . . . . . . . . . . . . . 72.31 31.48 63.55 Favored Glycine 0 CA--C 1.53 1.027 0 C-N-CA 121.139 -0.553 . . . . 0.0 112.142 178.064 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' F' F ' 44' ' ' LYS . . . . . . . . . . . . . 58.8 mtpt -135.91 131.49 35.28 Favored 'General case' 0 C--N 1.33 -0.278 0 N-CA-C 109.714 -0.476 . . . . 0.0 109.714 177.783 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' F' F ' 45' ' ' GLU . . . . . . . . . . . . . 83.8 tt0 -83.6 119.39 24.68 Favored 'General case' 0 C--N 1.328 -0.343 0 C-N-CA 120.844 -0.342 . . . . 0.0 111.219 -178.631 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' F' F ' 46' ' ' VAL . . . . . . . . . . . . . 7.7 p -118.66 122.75 70.21 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.198 0 N-CA-C 109.195 -0.669 . . . . 0.0 109.195 174.824 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' F' F ' 47' ' ' LYS . . . . . . . . . . . . . 55.5 mtmt -100.22 128.64 46.25 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 115.999 -0.546 . . . . 0.0 111.303 -179.815 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' F' F ' 48' ' ' PHE . . . . . . . . . . . . . 93.6 m-85 -110.55 131.92 54.64 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-N 116.099 -0.501 . . . . 0.0 109.872 177.529 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' F' F ' 49' ' ' LYS . . . . . . . . . . . . . 84.3 tttt -107.77 137.09 46.4 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.281 -0.418 . . . . 0.0 110.683 179.339 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' F' F ' 50' ' ' VAL . . . . . . . . . . . . . 43.5 t -82.32 106.29 13.07 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.24 0 N-CA-C 109.279 -0.637 . . . . 0.0 109.279 175.389 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' F' F ' 51' ' ' VAL . . . . . . . . . . . . . 47.7 t -71.06 -52.58 26.32 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.373 0 N-CA-C 109.707 -0.479 . . . . 0.0 109.707 -174.475 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' F' F ' 52' ' ' GLN . . . . . . . . . . . . . 88.5 mt-30 -154.81 153.67 31.56 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-O 121.206 0.527 . . . . 0.0 111.748 -176.64 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' F' F ' 53' ' ' ALA . . . . . . . . . . . . . . . -132.17 133.01 43.72 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 115.333 -0.849 . . . . 0.0 109.526 174.42 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' F' F ' 54' ' ' TYR . . . . . . . . . . . . . 17.2 t80 -129.13 111.47 18.29 Favored Pre-proline 0 CA--C 1.535 0.385 0 CA-C-O 118.16 -0.924 . . . . 0.0 110.204 179.088 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' F' F ' 55' ' ' PRO . . . . . . . . . . . . . 73.9 Cg_endo -77.14 168.88 75.76 Favored 'Cis proline' 0 N--CA 1.5 1.876 0 CA-C-N 121.872 1.704 . . . . 0.0 112.321 -6.644 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' F' F ' 56' ' ' SER . . . . . . . . . . . . . 13.4 m -117.32 135.04 23.05 Favored Pre-proline 0 CA--C 1.539 0.531 0 CA-C-O 118.477 -0.773 . . . . 0.0 109.627 175.243 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' F' F ' 57' ' ' PRO . . . . . . . . . . . . . 35.4 Cg_endo -66.38 164.68 65.91 Favored 'Cis proline' 0 N--CA 1.498 1.774 0 CA-C-N 121.809 1.682 . . . . 0.0 111.338 -3.225 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' F' F ' 58' ' ' LEU . . . . . 0.566 HD11 ' HB2' ' F' ' 2' ' ' SER . 16.4 tp -130.77 139.08 50.21 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-O 120.996 0.427 . . . . 0.0 110.38 179.738 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' F' F ' 59' ' ' ARG . . . . . . . . . . . . . 60.3 ttm-85 -104.48 127.93 52.29 Favored 'General case' 0 C--N 1.327 -0.397 0 N-CA-C 109.152 -0.685 . . . . 0.0 109.152 174.986 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' F' F ' 60' ' ' VAL . . . . . . . . . . . . . 41.6 t -81.0 119.38 30.55 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.271 0 C-N-CA 120.732 -0.387 . . . . 0.0 110.604 -174.941 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' F' F ' 61' ' ' GLU . . . . . . . . . . . . . 95.5 mt-10 -131.05 163.07 28.43 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 115.853 -0.612 . . . . 0.0 109.689 175.301 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' F' F ' 62' ' ' ASP . . . . . . . . . . . . . 41.2 m-20 -52.51 -31.64 36.35 Favored 'General case' 0 C--N 1.328 -0.354 0 N-CA-C 112.045 0.387 . . . . 0.0 112.045 -178.942 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' F' F ' 63' ' ' ARG . . . . . . . . . . . . . 79.3 mtt85 -72.94 -22.03 60.79 Favored 'General case' 0 CA--C 1.533 0.324 0 N-CA-C 112.896 0.702 . . . . 0.0 112.896 -176.205 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' F' F ' 64' ' ' THR . . . . . . . . . . . . . 20.3 m -72.54 141.48 48.47 Favored 'General case' 0 C--N 1.331 -0.206 0 CA-C-O 120.833 0.349 . . . . 0.0 110.999 -175.755 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' F' F ' 65' ' ' LYS . . . . . . . . . . . . . 67.1 mttm -90.01 137.09 32.63 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.009 -0.541 . . . . 0.0 110.49 179.578 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' F' F ' 66' ' ' ILE . . . . . . . . . . . . . 60.4 mt -119.33 130.03 74.5 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.268 0 N-CA-C 109.68 -0.489 . . . . 0.0 109.68 177.856 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' F' F ' 67' ' ' THR . . . . . . . . . . . . . 31.9 m -125.97 145.33 50.33 Favored 'General case' 0 C--N 1.331 -0.21 0 CA-C-O 121.089 0.471 . . . . 0.0 111.37 -176.81 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' F' F ' 68' ' ' LEU . . . . . 0.412 HD23 ' C ' ' F' ' 68' ' ' LEU . 4.8 tt . . . . . 0 C--N 1.33 -0.25 0 CA-C-N 115.721 -0.672 . . . . 0.0 109.786 176.553 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' F' F ' 73' ' ' VAL . . . . . . . . . . . . . 34.9 m . . . . . 0 C--O 1.232 0.162 0 N-CA-C 110.305 -0.258 . . . . 0.0 110.305 . . . . . . . . . 0 0 . 1 . 009 nuclear build core ' F' F ' 74' ' ' ASP . . . . . . . . . . . . . 47.4 t0 -84.98 114.92 22.51 Favored 'General case' 0 C--N 1.33 -0.264 0 C-N-CA 120.524 -0.47 . . . . 0.0 110.381 -171.112 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' F' F ' 75' ' ' VAL . . . . . . . . . . . . . 46.5 t -118.16 117.89 56.28 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.27 0 CA-C-O 121.178 0.513 . . . . 0.0 109.74 178.643 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' F' F ' 76' ' ' LEU . . . . . . . . . . . . . 13.9 mt -120.86 142.44 49.66 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 115.453 -0.794 . . . . 0.0 109.216 179.385 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' F' F ' 77' ' ' GLU . . . . . . . . . . . . . 97.7 mt-10 -135.49 130.05 34.08 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-O 121.225 0.536 . . . . 0.0 111.343 -176.713 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' F' F ' 78' ' ' ALA . . . . . . . . . . . . . . . -118.7 134.46 55.11 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-N 115.47 -0.786 . . . . 0.0 109.649 176.373 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' F' F ' 79' ' ' LYS . . . . . 0.512 ' O ' HD13 ' F' ' 80' ' ' ILE . 39.7 mtmt -83.81 115.44 22.24 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-O 120.958 0.408 . . . . 0.0 110.751 -178.784 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' F' F ' 80' ' ' ILE . . . . . 0.512 HD13 ' O ' ' F' ' 79' ' ' LYS . 24.0 mm -139.19 114.73 8.74 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.323 0 CA-C-N 115.722 -0.672 . . . . 0.0 109.266 -177.93 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' F' F ' 81' ' ' LYS . . . . . . . . . . . . . 75.6 mttt -101.65 126.49 48.5 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-O 120.802 0.334 . . . . 0.0 111.029 -178.086 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' F' F ' 82' ' ' GLY . . . . . . . . . . . . . . . 89.04 42.14 5.7 Favored Glycine 0 CA--C 1.525 0.718 0 C-N-CA 120.905 -0.665 . . . . 0.0 111.933 175.423 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' F' F ' 83' ' ' ILE . . . . . . . . . . . . . 74.1 mt -66.69 138.41 22.98 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 N-CA-C 109.634 -0.506 . . . . 0.0 109.634 176.461 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' F' F ' 84' ' ' LYS . . . . . . . . . . . . . 53.8 tttp -99.34 -51.85 3.68 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.597 -176.729 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' F' F ' 85' ' ' ASP . . . . . . . . . . . . . 7.3 t70 -154.7 154.81 33.49 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.024 -0.534 . . . . 0.0 110.633 -179.807 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' F' F ' 86' ' ' VAL . . . . . . . . . . . . . 41.4 t -130.68 132.6 64.2 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.258 0 CA-C-O 121.032 0.444 . . . . 0.0 110.535 -179.516 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' F' F ' 87' ' ' ILE . . . . . . . . . . . . . 45.1 mm -120.76 128.37 76.04 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.229 0 CA-C-N 115.72 -0.673 . . . . 0.0 109.582 177.738 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' F' F ' 88' ' ' LEU . . . . . . . . . . . . . 37.4 mt -109.39 138.72 45.33 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-O 121.159 0.504 . . . . 0.0 111.312 -178.389 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' F' F ' 89' ' ' ASP . . . . . . . . . . . . . 11.7 t70 -130.07 154.89 47.0 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 115.485 -0.78 . . . . 0.0 109.197 175.319 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' F' F ' 90' ' ' GLU . . . . . . . . . . . . . 84.8 tt0 -46.12 -39.1 8.98 Favored 'General case' 0 N--CA 1.465 0.276 0 N-CA-C 113.175 0.806 . . . . 0.0 113.175 -172.315 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' F' F ' 91' ' ' ASN . . . . . . . . . . . . . 14.5 p30 -132.09 25.03 4.58 Favored 'General case' 0 N--CA 1.467 0.393 0 N-CA-C 112.71 0.633 . . . . 0.0 112.71 -178.391 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' F' F ' 92' ' ' LEU . . . . . . . . . . . . . 13.6 mt -150.38 147.22 27.32 Favored 'General case' 0 C--N 1.331 -0.218 0 N-CA-C 109.963 -0.384 . . . . 0.0 109.963 -177.398 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' F' F ' 93' ' ' ILE . . . . . . . . . . . . . 71.3 mt -126.98 117.79 48.66 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.269 0 N-CA-C 109.294 -0.632 . . . . 0.0 109.294 178.705 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' F' F ' 94' ' ' VAL . . . . . . . . . . . . . 44.3 t -118.09 127.98 75.22 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.217 0 N-CA-C 109.955 -0.387 . . . . 0.0 109.955 -178.584 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' F' F ' 95' ' ' VAL . . . . . . . . . . . . . 42.7 t -124.31 134.35 66.9 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.293 0 CA-C-N 116.18 -0.463 . . . . 0.0 109.992 -179.409 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' F' F ' 96' ' ' ILE . . . . . . . . . . . . . 57.5 mt -113.27 129.9 68.18 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.284 0 N-CA-C 109.423 -0.584 . . . . 0.0 109.423 178.722 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' F' F ' 97' ' ' THR . . . . . . . . . . . . . 59.7 p -102.1 156.92 17.24 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-O 120.946 0.403 . . . . 0.0 110.782 179.958 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' F' F ' 98' ' ' GLU . . . . . . . . . . . . . 97.8 mt-10 -53.95 -24.42 16.45 Favored 'General case' 0 CA--C 1.533 0.304 0 N-CA-C 112.344 0.498 . . . . 0.0 112.344 179.854 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' F' F ' 99' ' ' GLU . . . . . . . . . . . . . 97.1 mt-10 -75.49 9.07 2.38 Favored 'General case' 0 CA--C 1.536 0.435 0 N-CA-C 113.402 0.889 . . . . 0.0 113.402 -178.22 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' F' F ' 100' ' ' ASN . . . . . . . . . . . . . 4.2 m-20 63.07 33.94 14.2 Favored 'General case' 0 CA--C 1.532 0.263 0 CA-C-N 118.131 0.423 . . . . 0.0 111.332 -178.512 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' F' F ' 101' ' ' GLU . . . . . . . . . . . . . 84.0 tt0 -110.1 142.29 41.77 Favored 'General case' 0 C--N 1.333 -0.146 0 N-CA-C 109.475 -0.565 . . . . 0.0 109.475 172.39 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' F' F ' 102' ' ' VAL . . . . . . . . . . . . . 45.6 t -114.9 124.57 71.68 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.319 0 CA-C-N 116.226 -0.443 . . . . 0.0 109.814 -179.242 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' F' F ' 103' ' ' LEU . . . . . . . . . . . . . 26.1 mt -112.27 132.55 54.89 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 115.508 -0.769 . . . . 0.0 109.798 177.245 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' F' F ' 104' ' ' ILE . . . . . . . . . . . . . 69.9 mt -123.02 117.8 52.84 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.286 0 N-CA-C 109.983 -0.377 . . . . 0.0 109.983 -178.84 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' F' F ' 105' ' ' PHE . . . . . . . . . . . . . 20.8 m-85 -120.3 165.68 14.53 Favored 'General case' 0 C--N 1.331 -0.221 0 CA-C-N 115.568 -0.742 . . . . 0.0 109.892 179.838 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' F' F ' 106' ' ' ASN . . . . . . . . . . . . . 45.8 p-10 -98.67 -169.96 1.87 Allowed 'General case' 0 C--N 1.329 -0.288 0 N-CA-C 109.702 -0.481 . . . . 0.0 109.702 173.993 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' F' F ' 107' ' ' GLN . . . . . . . . . . . . . 45.4 tt0 -58.85 -28.09 65.75 Favored 'General case' 0 C--N 1.327 -0.379 0 N-CA-C 112.168 0.433 . . . . 0.0 112.168 179.272 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' F' F ' 108' ' ' ASN . . . . . . . . . . . . . 5.1 t-20 -86.22 10.24 15.23 Favored 'General case' 0 CA--C 1.535 0.377 0 N-CA-C 113.136 0.791 . . . . 0.0 113.136 -177.72 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' F' F ' 109' ' ' LEU . . . . . . . . . . . . . 9.9 tp 59.7 35.89 22.34 Favored 'General case' 0 C--O 1.233 0.187 0 O-C-N 122.106 -0.371 . . . . 0.0 111.426 178.612 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' F' F ' 110' ' ' GLU . . . . . . . . . . . . . 70.9 mm-40 -106.79 149.9 26.88 Favored 'General case' 0 C--N 1.33 -0.275 0 N-CA-C 110.207 -0.294 . . . . 0.0 110.207 177.168 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' F' F ' 111' ' ' GLU . . . . . . . . . . . . . 98.5 mt-10 -77.85 122.11 25.01 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.264 -0.426 . . . . 0.0 111.389 -176.944 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' F' F ' 112' ' ' LEU . . . . . . . . . . . . . 17.8 mt -107.45 -44.71 4.24 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 115.928 -0.578 . . . . 0.0 109.954 176.21 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' F' F ' 113' ' ' TYR . . . . . . . . . . . . . 42.1 t80 -141.59 137.44 31.91 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.054 -0.521 . . . . 0.0 110.987 -179.3 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' F' F ' 114' ' ' ARG . . . . . . . . . . . . . 23.9 ttm180 -138.13 125.76 22.19 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.109 -0.496 . . . . 0.0 109.869 175.823 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' F' F ' 115' ' ' GLY . . . . . . . . . . . . . . . -150.12 142.07 9.36 Favored Glycine 0 CA--C 1.524 0.597 0 N-CA-C 110.756 -0.938 . . . . 0.0 110.756 178.454 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' F' F ' 116' ' ' LYS . . . . . . . . . . . . . 84.8 tttt -118.76 128.06 54.13 Favored 'General case' 0 C--N 1.33 -0.25 0 N-CA-C 109.693 -0.484 . . . . 0.0 109.693 177.754 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' F' F ' 117' ' ' PHE . . . . . . . . . . . . . 22.7 m-85 -129.57 117.48 20.49 Favored 'General case' 0 C--N 1.332 -0.166 0 CA-C-O 120.921 0.391 . . . . 0.0 110.32 -172.954 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' F' F ' 118' ' ' GLU . . . . . . . . . . . . . 43.4 mt-10 -52.35 -49.27 64.66 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.349 -0.387 . . . . 0.0 111.765 -176.242 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' F' F ' 119' ' ' ASN . . . . . . . . . . . . . 90.3 m-20 -97.32 31.06 2.6 Favored 'General case' 0 C--N 1.33 -0.24 0 N-CA-C 112.164 0.431 . . . . 0.0 112.164 -174.293 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' F' F ' 120' ' ' LEU . . . . . . . . . . . . . 12.5 tp -56.33 124.32 17.64 Favored 'General case' 0 C--N 1.331 -0.21 0 CA-C-O 120.588 0.233 . . . . 0.0 110.604 178.273 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' F' F ' 121' ' ' ASN . . . . . . . . . . . . . 31.4 m120 -114.08 -44.04 3.18 Favored 'General case' 0 C--N 1.331 -0.198 0 CA-C-N 116.524 -0.307 . . . . 0.0 111.149 -177.327 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' F' F ' 122' ' ' LYS . . . . . . . . . . . . . 98.6 mttt -144.35 148.79 35.18 Favored 'General case' 0 C--N 1.332 -0.194 0 CA-C-O 121.198 0.523 . . . . 0.0 112.028 -175.921 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' F' F ' 123' ' ' VAL . . . . . . . . . . . . . 45.6 t -127.42 124.5 63.92 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.239 0 CA-C-N 115.624 -0.716 . . . . 0.0 109.078 172.711 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' F' F ' 124' ' ' LEU . . . . . . . . . . . . . 57.9 mt -118.93 138.8 52.53 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-O 120.837 0.351 . . . . 0.0 111.078 -175.567 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' F' F ' 125' ' ' VAL . . . . . . . . . . . . . 34.3 m -130.34 129.58 64.99 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.273 0 CA-C-N 115.961 -0.563 . . . . 0.0 110.284 177.888 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' F' F ' 126' ' ' ARG . . . . . . . . . . . . . 31.1 mmt180 -135.9 108.11 7.26 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.224 -0.444 . . . . 0.0 110.29 179.074 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' F' F ' 127' ' ' ASN . . . . . . . . . . . . . 42.1 m-80 54.26 -104.81 0.23 Allowed 'General case' 0 CA--C 1.541 0.628 0 CA-C-O 119.163 -0.446 . . . . 0.0 110.934 179.403 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' F' F ' 128' ' ' ASP . . . . . . . . . . . . . 7.5 p-10 -111.41 1.6 17.1 Favored 'General case' 0 N--CA 1.468 0.437 0 CA-C-N 119.45 1.023 . . . . 0.0 113.447 -176.053 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' F' F ' 129' ' ' LEU . . . . . . . . . . . . . 38.2 mt -104.97 141.82 35.88 Favored 'General case' 0 C--O 1.231 0.131 0 CA-C-N 118.195 0.452 . . . . 0.0 110.257 178.915 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' F' F ' 130' ' ' VAL . . . . . . . . . . . . . 44.0 t -123.37 137.08 57.9 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.224 0 CA-C-N 116.268 -0.424 . . . . 0.0 109.916 -179.275 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' F' F ' 131' ' ' VAL . . . . . . . . . . . . . 42.7 t -135.69 136.44 50.35 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.29 0 CA-C-O 121.041 0.448 . . . . 0.0 110.408 179.326 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' F' F ' 132' ' ' ILE . . . . . . . . . . . . . 67.7 mt -117.71 130.2 72.96 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.232 0 CA-C-N 115.74 -0.664 . . . . 0.0 109.286 179.567 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' F' F ' 133' ' ' ILE . . . . . . . . . . . . . 41.9 mm -118.06 120.02 63.22 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.227 0 CA-C-O 120.831 0.348 . . . . 0.0 111.221 -174.329 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' F' F ' 134' ' ' ASP . . . . . . . . . . . . . 7.1 p-10 -131.58 145.59 51.78 Favored 'General case' 0 C--N 1.332 -0.173 0 N-CA-C 109.422 -0.584 . . . . 0.0 109.422 173.403 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' F' F ' 135' ' ' GLU . . . . . . . . . . . . . 73.6 tt0 -49.92 -22.97 1.71 Allowed 'General case' 0 C--N 1.329 -0.322 0 N-CA-C 113.286 0.847 . . . . 0.0 113.286 -170.615 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' F' F ' 136' ' ' GLN . . . . . . . . . . . . . 57.1 tp60 -99.04 -34.08 10.55 Favored 'General case' 0 C--N 1.331 -0.225 0 N-CA-C 111.94 0.348 . . . . 0.0 111.94 -176.135 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' F' F ' 137' ' ' LYS . . . . . . . . . . . . . 57.5 mtpt -138.77 151.84 47.43 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-O 121.13 0.491 . . . . 0.0 111.128 -169.612 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' F' F ' 138' ' ' LEU . . . . . 0.441 HD23 ' C ' ' F' ' 138' ' ' LEU . 5.2 tt -119.29 122.76 42.63 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 115.809 -0.632 . . . . 0.0 109.437 174.445 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' F' F ' 139' ' ' THR . . . . . 0.413 ' N ' HD23 ' F' ' 138' ' ' LEU . 19.8 m -110.36 130.39 55.56 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-N 116.323 -0.399 . . . . 0.0 110.838 -177.27 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' F' F ' 140' ' ' LEU . . . . . 0.476 HD23 ' C ' ' F' ' 140' ' ' LEU . 8.9 tt -118.75 123.58 45.2 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 115.821 -0.627 . . . . 0.0 109.404 -179.232 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' F' F ' 141' ' ' ILE . . . . . . . . . . . . . 19.8 mt -120.47 120.72 63.56 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.309 0 CA-C-O 121.039 0.447 . . . . 0.0 109.887 -175.698 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' F' F ' 142' ' ' ARG . . . . . . . . . . . . . 68.9 ttt180 -110.69 130.77 55.48 Favored 'General case' 0 C--N 1.331 -0.22 0 CA-C-N 115.2 -0.909 . . . . 0.0 110.717 -175.494 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' F' F ' 143' ' ' THR . . . . . . . . . . . . . 41.2 p . . . . . 0 C--O 1.22 -0.475 0 CA-C-O 118.158 -0.925 . . . . 0.0 110.958 179.469 . . . . . . . . 0 0 . 1 . 010 nuclear build core ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 10.5 p . . . . . 0 CA--C 1.523 -0.085 0 CA-C-O 120.867 0.365 . . . . 0.0 110.588 . . . . . . . . . 0 0 . 1 . 010 nuclear build core ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 95.7 mt-10 -141.06 136.8 32.37 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.111 -0.495 . . . . 0.0 110.746 179.836 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 4' ' ' LEU . . . . . 0.477 HD21 HD21 ' A' ' 6' ' ' LEU . 14.5 tp -125.42 132.05 52.81 Favored 'General case' 0 C--N 1.332 -0.176 0 CA-C-N 116.114 -0.494 . . . . 0.0 110.218 177.616 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 5' ' ' LYS . . . . . . . . . . . . . 97.9 mttt -110.26 120.88 43.87 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.145 -0.479 . . . . 0.0 110.403 179.342 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 6' ' ' LEU . . . . . 0.477 HD21 HD21 ' A' ' 4' ' ' LEU . 66.3 mt -117.44 145.81 43.89 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 115.535 -0.757 . . . . 0.0 110.157 -178.864 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 25.8 ttpp -135.69 139.78 31.86 Favored Pre-proline 0 CA--C 1.534 0.334 0 CA-C-O 119.087 -0.483 . . . . 0.0 110.156 176.929 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 8' ' ' PRO . . . . . . . . . . . . . 92.7 Cg_endo -91.84 141.12 2.49 Favored 'Trans proline' 0 N--CA 1.489 1.227 0 C-N-CA 121.806 1.67 . . . . 0.0 111.766 177.157 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 58.8 mt -75.8 -49.65 3.46 Favored Pre-proline 0 CA--C 1.533 0.324 0 CA-C-O 118.507 -0.759 . . . . 0.0 112.588 -178.588 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 74.2 Cg_endo -76.33 155.56 36.94 Favored 'Trans proline' 0 N--CA 1.498 1.751 0 C-N-CA 121.062 1.175 . . . . 0.0 112.171 -179.436 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 27.0 tptp -87.74 92.47 9.12 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.117 -0.492 . . . . 0.0 110.468 179.42 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 12.6 p -143.63 148.75 18.66 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.32 0 CA-C-O 120.889 0.376 . . . . 0.0 110.837 -179.181 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 42.4 mp0 -87.68 129.6 35.09 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.1 -0.5 . . . . 0.0 110.332 178.47 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 14' ' ' LEU . . . . . . . . . . . . . 34.5 mt -99.24 151.66 37.49 Favored Pre-proline 0 C--N 1.33 -0.281 0 CA-C-N 116.41 -0.359 . . . . 0.0 110.813 -179.38 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 15' ' ' PRO . . . . . . . . . . . . . 27.4 Cg_exo -61.24 155.67 50.13 Favored 'Trans proline' 0 N--CA 1.497 1.717 0 C-N-CA 121.348 1.365 . . . . 0.0 111.624 177.051 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 16' ' ' PRO . . . . . . . . . . . . . 39.4 Cg_exo -58.58 -38.0 91.71 Favored 'Trans proline' 0 N--CA 1.498 1.74 0 C-N-CA 121.347 1.365 . . . . 0.0 112.798 -178.398 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 17' ' ' ASP . . . . . . . . . . . . . 12.3 p-10 -87.12 10.56 16.33 Favored 'General case' 0 CA--C 1.535 0.402 0 N-CA-C 113.231 0.826 . . . . 0.0 113.231 -177.476 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 18' ' ' PHE . . . . . . . . . . . . . 44.1 t80 -57.76 -43.14 85.26 Favored 'General case' 0 C--N 1.334 -0.085 0 O-C-N 121.942 -0.474 . . . . 0.0 110.229 -178.327 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 19' ' ' VAL . . . . . . . . . . . . . 48.1 t -56.32 -43.97 78.5 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.325 0 CA-C-N 116.291 -0.413 . . . . 0.0 110.64 -178.399 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 66.4 m-20 -59.57 -42.99 93.72 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-O 121.059 0.457 . . . . 0.0 110.815 -177.681 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 46.0 t -64.21 -48.79 84.09 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.253 0 CA-C-N 116.349 -0.387 . . . . 0.0 110.669 -177.856 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 22' ' ' ILE . . . . . 0.55 HG22 HD12 ' A' ' 26' ' ' LEU . 50.1 mm -55.65 -43.66 73.99 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.211 0 C-N-CA 120.911 -0.316 . . . . 0.0 110.689 179.861 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 23' ' ' ARG . . . . . . . . . . . . . 53.8 ttp180 -52.92 -51.92 59.62 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-O 120.55 0.214 . . . . 0.0 111.554 -179.367 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 24' ' ' ILE . . . . . . . . . . . . . 73.1 mt -60.01 -41.47 86.32 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.37 0 C-N-CA 121.095 -0.242 . . . . 0.0 111.295 -178.218 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 69.6 mmtt -64.19 -40.76 96.78 Favored 'General case' 0 C--N 1.328 -0.345 0 N-CA-C 112.187 0.44 . . . . 0.0 112.187 -178.516 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 26' ' ' LEU . . . . . 0.55 HD12 HG22 ' A' ' 22' ' ' ILE . 36.1 mt -79.61 -42.45 24.89 Favored 'General case' 0 C--N 1.329 -0.307 0 N-CA-C 113.025 0.75 . . . . 0.0 113.025 -171.289 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 27' ' ' GLN . . . . . . . . . . . . . 14.8 pt20 -46.4 140.08 4.45 Favored 'General case' 0 N--CA 1.469 0.492 0 N-CA-C 112.808 0.67 . . . . 0.0 112.808 -175.447 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 101.19 -27.93 18.35 Favored Glycine 0 CA--C 1.531 1.05 0 CA-C-N 115.591 -0.731 . . . . 0.0 112.214 -177.67 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 99.2 mttt -98.57 155.06 17.48 Favored 'General case' 0 C--O 1.232 0.18 0 CA-C-N 117.338 0.569 . . . . 0.0 111.228 179.095 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 30' ' ' THR . . . . . . . . . . . . . 49.3 m -105.29 135.54 46.48 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.117 -0.492 . . . . 0.0 109.709 174.994 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 34.4 m -129.26 159.99 40.67 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.206 0 CA-C-O 120.803 0.335 . . . . 0.0 110.996 -177.768 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 32' ' ' ARG . . . . . . . . . . . . . 38.2 ttm180 -130.66 147.88 52.39 Favored 'General case' 0 C--N 1.331 -0.217 0 CA-C-N 116.008 -0.542 . . . . 0.0 110.357 179.17 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 33' ' ' THR . . . . . . . . . . . . . 30.6 m -52.2 140.73 20.51 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-O 120.849 0.357 . . . . 0.0 111.386 -179.099 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 99.65 -17.13 57.96 Favored Glycine 0 CA--C 1.533 1.207 0 C-N-CA 121.156 -0.545 . . . . 0.0 113.202 -179.455 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 60.7 m-20 -64.92 150.1 48.47 Favored 'General case' 0 C--O 1.231 0.129 0 CA-C-N 118.059 0.93 . . . . 0.0 111.205 179.686 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 45.8 t -124.44 130.88 73.43 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.221 0 CA-C-N 115.762 -0.654 . . . . 0.0 109.838 178.963 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 37' ' ' ILE . . . . . . . . . . . . . 66.9 mt -122.89 139.86 48.4 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.221 0 CA-C-N 116.181 -0.463 . . . . 0.0 109.929 -179.647 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . -108.93 128.87 9.24 Favored Glycine 0 CA--C 1.525 0.668 0 N-CA-C 111.034 -0.826 . . . . 0.0 111.034 179.456 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 39' ' ' ILE . . . . . . . . . . . . . 70.3 mt -124.93 137.67 56.79 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.282 0 N-CA-C 110.008 -0.367 . . . . 0.0 110.008 179.59 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 40' ' ' SER . . . . . . . . . . . . . 53.6 p -91.37 114.28 26.76 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.443 -0.344 . . . . 0.0 110.789 176.697 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 41' ' ' ILE . . . . . . . . . . . . . 43.3 mm -121.69 113.44 39.17 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.185 0 N-CA-C 109.939 -0.393 . . . . 0.0 109.939 179.075 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 85.6 mt 58.83 35.46 24.26 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.36 -0.382 . . . . 0.0 111.475 178.61 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . 77.57 -10.14 25.24 Favored Glycine 0 CA--C 1.534 1.264 0 C-N-CA 121.283 -0.484 . . . . 0.0 113.434 178.419 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 44' ' ' LYS . . . . . . . . . . . . . 18.7 tptm -97.13 135.17 39.48 Favored 'General case' 0 C--N 1.333 -0.149 0 CA-C-N 117.941 0.87 . . . . 0.0 109.767 176.918 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 85.9 tt0 -82.38 123.96 29.58 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-O 120.802 0.334 . . . . 0.0 110.959 -178.977 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 46' ' ' VAL . . . . . . . . . . . . . 7.4 p -118.64 127.44 75.62 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.217 0 N-CA-C 109.465 -0.568 . . . . 0.0 109.465 176.765 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 62.3 mtpt -99.57 127.73 45.66 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.027 -0.533 . . . . 0.0 110.981 179.318 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 48' ' ' PHE . . . . . . . . . . . . . 86.8 m-85 -110.65 131.85 54.7 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.41 -0.359 . . . . 0.0 110.132 177.425 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 77.7 tttt -108.93 136.59 48.23 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.115 -0.493 . . . . 0.0 110.464 179.117 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 50' ' ' VAL . . . . . . . . . . . . . 44.6 t -81.0 106.19 11.86 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.288 0 N-CA-C 109.357 -0.609 . . . . 0.0 109.357 175.612 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 51' ' ' VAL . . . . . . . . . . . . . 55.3 t -69.38 -48.29 68.15 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.255 0 CA-C-N 116.065 -0.516 . . . . 0.0 109.89 -173.896 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 52' ' ' GLN . . . . . . . . . . . . . 21.5 pt20 -164.34 158.21 18.44 Favored 'General case' 0 C--N 1.331 -0.215 0 C-N-CA 120.198 -0.601 . . . . 0.0 111.786 179.549 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -135.87 136.4 40.53 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-N 115.292 -0.867 . . . . 0.0 110.062 179.126 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 54' ' ' TYR . . . . . . . . . . . . . 41.5 t80 -129.15 113.23 18.45 Favored Pre-proline 0 CA--C 1.535 0.368 0 CA-C-O 118.164 -0.922 . . . . 0.0 110.126 177.5 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 55' ' ' PRO . . . . . . . . . . . . . 74.3 Cg_endo -77.11 167.82 78.7 Favored 'Cis proline' 0 N--CA 1.499 1.804 0 CA-C-N 122.01 1.754 . . . . 0.0 112.343 -6.878 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 56' ' ' SER . . . . . . . . . . . . . 13.7 m -117.6 131.53 24.04 Favored Pre-proline 0 CA--C 1.539 0.531 0 CA-C-O 118.389 -0.815 . . . . 0.0 109.609 175.526 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 57' ' ' PRO . . . . . . . . . . . . . 36.6 Cg_endo -66.73 167.28 56.98 Favored 'Cis proline' 0 N--CA 1.498 1.756 0 CA-C-N 121.937 1.727 . . . . 0.0 111.253 -2.472 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 58' ' ' LEU . . . . . . . . . . . . . 34.5 tp -130.47 136.48 49.04 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.348 -0.387 . . . . 0.0 110.525 -179.831 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 59' ' ' ARG . . . . . . . . . . . . . 58.2 ttp180 -101.67 121.0 41.22 Favored 'General case' 0 C--N 1.326 -0.422 0 N-CA-C 109.164 -0.68 . . . . 0.0 109.164 175.721 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 43.7 t -76.28 120.29 26.05 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.308 0 C-N-CA 120.723 -0.391 . . . . 0.0 110.637 -173.049 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 95.0 mt-10 -131.02 163.21 28.09 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 115.78 -0.646 . . . . 0.0 109.726 176.891 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 62' ' ' ASP . . . . . . . . . . . . . 77.8 m-20 -53.99 -32.27 53.57 Favored 'General case' 0 C--N 1.329 -0.318 0 C-N-CA 120.981 -0.288 . . . . 0.0 111.695 -179.793 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 63' ' ' ARG . . . . . . . . . . . . . 39.7 ptt180 -78.47 2.35 19.25 Favored 'General case' 0 CA--C 1.537 0.465 0 N-CA-C 113.682 0.993 . . . . 0.0 113.682 -175.738 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 29.0 m -89.55 139.49 30.48 Favored 'General case' 0 C--N 1.333 -0.121 0 CA-C-N 118.131 0.423 . . . . 0.0 110.91 -178.446 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 65' ' ' LYS . . . . . . . . . . . . . 98.2 mttt -88.83 129.71 35.53 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.076 -0.511 . . . . 0.0 110.2 178.579 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 66' ' ' ILE . . . . . . . . . . . . . 60.6 mt -115.27 129.75 70.99 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.275 0 N-CA-C 109.903 -0.406 . . . . 0.0 109.903 179.296 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 67' ' ' THR . . . . . . . . . . . . . 25.7 m -120.25 136.97 54.48 Favored 'General case' 0 C--N 1.331 -0.224 0 CA-C-N 116.061 -0.518 . . . . 0.0 110.674 -179.587 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 68' ' ' LEU . . . . . 0.468 HD23 ' C ' ' A' ' 68' ' ' LEU . 6.6 tt . . . . . 0 C--N 1.329 -0.312 0 CA-C-N 115.863 -0.608 . . . . 0.0 110.158 178.778 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 74' ' ' ASP . . . . . . . . . . . . . 30.7 t0 . . . . . 0 C--O 1.229 -0.019 0 N-CA-C 109.617 -0.512 . . . . 0.0 109.617 . . . . . . . . . 0 0 . 1 . 010 nuclear build core ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 39.4 t -112.71 122.76 67.51 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.207 0 CA-C-O 120.953 0.406 . . . . 0.0 110.481 -177.897 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 76' ' ' LEU . . . . . . . . . . . . . 25.0 mt -125.64 149.27 48.57 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 115.844 -0.616 . . . . 0.0 109.829 178.195 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 77' ' ' GLU . . . . . . . . . . . . . 96.8 mt-10 -137.03 138.04 40.04 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-O 121.015 0.436 . . . . 0.0 111.213 -177.986 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 78' ' ' ALA . . . . . . . . . . . . . . . -123.1 136.61 54.87 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 115.642 -0.708 . . . . 0.0 109.813 177.076 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 79' ' ' LYS . . . . . 0.62 ' O ' HD13 ' A' ' 80' ' ' ILE . 24.9 pttm -79.3 119.82 22.9 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-O 121.262 0.553 . . . . 0.0 111.018 -177.479 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 80' ' ' ILE . . . . . 0.62 HD13 ' O ' ' A' ' 79' ' ' LYS . 35.7 mm -139.28 104.67 2.21 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.252 0 CA-C-N 115.75 -0.659 . . . . 0.0 109.33 179.822 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 81' ' ' LYS . . . . . . . . . . . . . 99.3 mttt -102.21 127.03 49.33 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-O 120.958 0.409 . . . . 0.0 111.211 -176.726 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . 89.29 42.03 5.65 Favored Glycine 0 CA--C 1.525 0.673 0 N-CA-C 111.504 -0.638 . . . . 0.0 111.504 175.883 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 83' ' ' ILE . . . . . . . . . . . . . 71.0 mt -69.66 137.49 24.04 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.298 0 N-CA-C 109.77 -0.455 . . . . 0.0 109.77 176.749 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 84' ' ' LYS . . . . . . . . . . . . . 6.9 ttpm? -101.96 -48.56 4.21 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.102 179.362 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 85' ' ' ASP . . . . . . . . . . . . . 11.1 t70 -150.44 151.39 32.69 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 115.85 -0.614 . . . . 0.0 110.38 -179.721 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 86' ' ' VAL . . . . . 0.402 HG21 HG21 ' F' ' 133' ' ' ILE . 45.1 t -131.33 132.88 62.78 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.283 0 CA-C-O 120.958 0.409 . . . . 0.0 110.447 -179.134 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 87' ' ' ILE . . . . . 0.494 HD12 ' N ' ' A' ' 87' ' ' ILE . 5.1 mp -119.31 123.64 71.62 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.206 0 N-CA-C 109.169 -0.678 . . . . 0.0 109.169 175.891 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 88' ' ' LEU . . . . . 0.709 HD13 HG21 ' F' ' 131' ' ' VAL . 23.2 mt -114.0 129.71 56.59 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.164 -0.471 . . . . 0.0 111.148 -176.089 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 89' ' ' ASP . . . . . . . . . . . . . 13.6 t70 -124.02 154.6 39.64 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 115.83 -0.623 . . . . 0.0 109.677 176.709 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 41.6 mp0 -50.69 -37.33 40.66 Favored 'General case' 0 C--N 1.329 -0.316 0 N-CA-C 112.396 0.517 . . . . 0.0 112.396 -171.789 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 91' ' ' ASN . . . . . . . . . . . . . 20.2 p-10 -132.23 35.64 3.68 Favored 'General case' 0 N--CA 1.464 0.268 0 CA-C-O 120.679 0.276 . . . . 0.0 111.727 -177.112 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 92' ' ' LEU . . . . . . . . . . . . . 7.1 tp -166.12 139.76 4.24 Favored 'General case' 0 C--N 1.33 -0.282 0 N-CA-C 110.08 -0.341 . . . . 0.0 110.08 179.792 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 93' ' ' ILE . . . . . . . . . . . . . 66.7 mt -124.93 122.96 64.63 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.178 0 N-CA-C 109.749 -0.463 . . . . 0.0 109.749 -178.758 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 94' ' ' VAL . . . . . 0.486 HG11 HG11 ' A' ' 123' ' ' VAL . 41.8 t -125.6 127.84 71.9 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.181 0 CA-C-O 120.958 0.408 . . . . 0.0 110.142 179.44 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 95' ' ' VAL . . . . . . . . . . . . . 47.7 t -120.58 135.41 60.9 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.343 0 CA-C-N 115.909 -0.587 . . . . 0.0 109.875 -179.951 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 96' ' ' ILE . . . . . . . . . . . . . 65.7 mt -114.08 127.04 71.68 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.279 0 N-CA-C 109.341 -0.615 . . . . 0.0 109.341 178.388 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 97' ' ' THR . . . . . . . . . . . . . 67.8 p -97.72 162.8 13.1 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-O 121.331 0.586 . . . . 0.0 111.316 -176.918 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 98' ' ' GLU . . . . . . . . . . . . . 79.7 tt0 -53.84 -29.05 39.36 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 115.86 -0.609 . . . . 0.0 112.1 -178.993 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 99' ' ' GLU . . . . . . . . . . . . . 95.6 mt-10 -79.2 13.38 1.88 Allowed 'General case' 0 CA--C 1.534 0.365 0 N-CA-C 113.224 0.824 . . . . 0.0 113.224 -176.936 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 100' ' ' ASN . . . . . . . . . . . . . 4.0 m-20 61.18 34.41 18.88 Favored 'General case' 0 CA--C 1.53 0.179 0 CA-C-N 118.058 0.39 . . . . 0.0 111.414 -179.388 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 101' ' ' GLU . . . . . . . . . . . . . 84.0 tt0 -107.74 143.99 35.5 Favored 'General case' 0 C--N 1.333 -0.138 0 N-CA-C 109.537 -0.542 . . . . 0.0 109.537 172.993 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 102' ' ' VAL . . . . . . . . . . . . . 42.6 t -115.52 125.98 72.91 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.302 0 CA-C-N 116.273 -0.421 . . . . 0.0 110.007 -177.195 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 103' ' ' LEU . . . . . . . . . . . . . 66.2 mt -116.72 130.77 56.93 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 115.767 -0.651 . . . . 0.0 110.189 176.749 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 104' ' ' ILE . . . . . . . . . . . . . 68.6 mt -118.63 123.33 71.38 Favored 'Isoleucine or valine' 0 C--O 1.234 0.247 0 N-CA-C 110.26 -0.274 . . . . 0.0 110.26 -178.854 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 105' ' ' PHE . . . . . . . . . . . . . 67.6 m-85 -122.99 163.7 19.94 Favored 'General case' 0 C--O 1.232 0.148 0 O-C-N 124.003 0.815 . . . . 0.0 110.136 -178.176 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 106' ' ' ASN . . . . . . . . . . . . . 43.5 p-10 -97.77 -169.9 1.9 Allowed 'General case' 0 C--N 1.329 -0.283 0 N-CA-C 109.566 -0.531 . . . . 0.0 109.566 171.93 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 107' ' ' GLN . . . . . . . . . . . . . 23.5 tt0 -57.38 -29.68 64.26 Favored 'General case' 0 C--N 1.328 -0.348 0 N-CA-C 111.988 0.366 . . . . 0.0 111.988 178.983 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 108' ' ' ASN . . . . . . . . . . . . . 6.1 t-20 -86.98 11.57 13.29 Favored 'General case' 0 CA--C 1.536 0.421 0 N-CA-C 113.09 0.774 . . . . 0.0 113.09 -175.792 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 109' ' ' LEU . . . . . . . . . . . . . 41.6 mt 57.69 37.03 27.21 Favored 'General case' 0 C--N 1.332 -0.181 0 CA-C-O 120.88 0.372 . . . . 0.0 111.475 177.303 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 110' ' ' GLU . . . . . . . . . . . . . 43.5 mt-10 -104.73 146.72 28.56 Favored 'General case' 0 C--N 1.331 -0.228 0 N-CA-C 110.108 -0.33 . . . . 0.0 110.108 176.475 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 111' ' ' GLU . . . . . . . . . . . . . 99.3 mt-10 -76.89 121.98 24.19 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-O 120.92 0.39 . . . . 0.0 110.928 -178.57 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 112' ' ' LEU . . . . . . . . . . . . . 49.0 mt -110.12 -45.69 3.56 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 115.941 -0.572 . . . . 0.0 110.158 177.575 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 113' ' ' TYR . . . . . . . . . . . . . 64.8 t80 -134.15 135.86 43.4 Favored 'General case' 0 C--N 1.332 -0.187 0 CA-C-N 116.119 -0.491 . . . . 0.0 110.99 179.845 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 114' ' ' ARG . . . . . . . . . . . . . 83.3 mtp180 -135.17 123.25 22.81 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 116.043 -0.526 . . . . 0.0 110.248 177.937 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 115' ' ' GLY . . . . . . . . . . . . . . . -150.08 158.8 27.83 Favored Glycine 0 CA--C 1.524 0.625 0 N-CA-C 110.854 -0.898 . . . . 0.0 110.854 178.761 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 116' ' ' LYS . . . . . . . . . . . . . 79.8 tttt -134.18 131.76 38.99 Favored 'General case' 0 C--N 1.329 -0.32 0 N-CA-C 110.016 -0.365 . . . . 0.0 110.016 178.199 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 117' ' ' PHE . . . . . . . . . . . . . 20.0 m-85 -136.36 114.07 11.1 Favored 'General case' 0 C--N 1.331 -0.216 0 CA-C-N 116.362 -0.381 . . . . 0.0 110.066 -174.65 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 118' ' ' GLU . . . . . . . . . . . . . 96.1 mt-10 -54.5 -38.57 66.63 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.557 -0.292 . . . . 0.0 111.283 -177.945 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 119' ' ' ASN . . . . . . . . . . . . . 7.9 m-80 -100.44 30.53 3.85 Favored 'General case' 0 C--N 1.331 -0.232 0 N-CA-C 112.142 0.423 . . . . 0.0 112.142 -175.24 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 120' ' ' LEU . . . . . . . . . . . . . 16.3 tp -58.33 122.27 12.83 Favored 'General case' 0 C--N 1.331 -0.196 0 N-CA-C 110.084 -0.339 . . . . 0.0 110.084 177.322 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 121' ' ' ASN . . . . . . . . . . . . . 60.8 t30 -114.13 -44.09 3.17 Favored 'General case' 0 N--CA 1.462 0.169 0 CA-C-N 116.712 -0.222 . . . . 0.0 111.426 -176.986 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 122' ' ' LYS . . . . . . . . . . . . . 98.5 mttt -147.02 150.69 35.6 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-O 121.016 0.436 . . . . 0.0 111.665 -176.39 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 123' ' ' VAL . . . . . 0.486 HG11 HG11 ' A' ' 94' ' ' VAL . 40.9 t -128.79 129.16 68.31 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.319 0 CA-C-N 115.89 -0.596 . . . . 0.0 109.414 174.691 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 124' ' ' LEU . . . . . . . . . . . . . 52.6 mt -117.2 132.94 56.53 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-O 120.723 0.297 . . . . 0.0 110.372 -178.787 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 125' ' ' VAL . . . . . 0.473 HG12 HG23 ' A' ' 130' ' ' VAL . 34.9 m -134.32 133.75 55.19 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.252 0 CA-C-N 116.152 -0.477 . . . . 0.0 111.045 -178.092 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 126' ' ' ARG . . . . . . . . . . . . . 14.9 ptm180 -163.4 137.19 5.82 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.185 -0.461 . . . . 0.0 109.85 175.291 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 127' ' ' ASN . . . . . . . . . . . . . 69.4 m-20 55.56 -154.82 0.29 Allowed 'General case' 0 CA--C 1.539 0.531 0 N-CA-C 109.818 -0.438 . . . . 0.0 109.818 -178.77 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 128' ' ' ASP . . . . . . . . . . . . . 23.8 p-10 -84.65 22.25 1.36 Allowed 'General case' 0 CA--C 1.534 0.334 0 CA-C-N 118.383 0.538 . . . . 0.0 112.339 177.419 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 129' ' ' LEU . . . . . . . . . . . . . 16.5 tp -118.58 138.92 52.23 Favored 'General case' 0 C--O 1.234 0.249 0 O-C-N 122.112 -0.367 . . . . 0.0 110.178 178.764 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 130' ' ' VAL . . . . . 0.515 HG13 ' HB ' ' A' ' 141' ' ' ILE . 12.3 p -135.37 140.35 44.99 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.2 0 CA-C-O 120.96 0.41 . . . . 0.0 110.396 -178.773 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 131' ' ' VAL . . . . . 0.461 HG23 ' O ' ' A' ' 139' ' ' THR . 14.6 p -136.17 141.12 42.42 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.233 0 CA-C-O 120.981 0.42 . . . . 0.0 110.891 179.29 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 132' ' ' ILE . . . . . . . . . . . . . 73.4 mt -112.96 134.02 56.93 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.292 0 CA-C-N 115.859 -0.61 . . . . 0.0 109.637 179.756 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 133' ' ' ILE . . . . . . . . . . . . . 41.7 mm -117.66 124.35 72.94 Favored 'Isoleucine or valine' 0 C--O 1.233 0.198 0 CA-C-O 120.806 0.336 . . . . 0.0 110.976 -176.192 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 134' ' ' ASP . . . . . . . . . . . . . 7.1 p-10 -136.61 148.46 47.49 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.253 -0.43 . . . . 0.0 109.85 175.747 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 135' ' ' GLU . . . . . . . . . . . . . 83.0 tt0 -50.02 -26.9 4.76 Favored 'General case' 0 C--N 1.328 -0.341 0 N-CA-C 112.67 0.619 . . . . 0.0 112.67 -174.66 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 136' ' ' GLN . . . . . . . . . . . . . 94.3 mt-30 -82.67 -32.44 28.14 Favored 'General case' 0 C--N 1.33 -0.251 0 N-CA-C 112.344 0.498 . . . . 0.0 112.344 -175.596 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 137' ' ' LYS . . . . . . . . . . . . . 56.5 pttt -170.01 176.63 4.62 Favored 'General case' 0 C--N 1.333 -0.133 0 CA-C-O 121.592 0.71 . . . . 0.0 112.29 -172.795 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 138' ' ' LEU . . . . . 0.427 ' C ' HD23 ' A' ' 138' ' ' LEU . 7.5 tt -122.18 130.17 52.96 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-N 115.006 -0.997 . . . . 0.0 110.045 179.201 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 139' ' ' THR . . . . . 0.461 ' O ' HG23 ' A' ' 131' ' ' VAL . 85.2 m -115.42 124.54 51.43 Favored 'General case' 0 C--N 1.331 -0.224 0 CA-C-N 116.253 -0.431 . . . . 0.0 110.212 179.206 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 140' ' ' LEU . . . . . . . . . . . . . 21.0 tp -111.86 125.93 54.55 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.005 -0.543 . . . . 0.0 109.606 -178.979 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 141' ' ' ILE . . . . . 0.515 ' HB ' HG13 ' A' ' 130' ' ' VAL . 19.6 mt -123.31 124.56 70.14 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.252 0 CA-C-O 120.996 0.427 . . . . 0.0 110.234 -172.814 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 142' ' ' ARG . . . . . . . . . . . . . 81.1 mtp180 -111.84 125.78 54.38 Favored 'General case' 0 C--O 1.233 0.22 0 CA-C-N 115.429 -0.805 . . . . 0.0 109.843 -178.895 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 143' ' ' THR . . . . . . . . . . . . . 40.0 p . . . . . 0 C--O 1.22 -0.452 0 CA-C-O 118.014 -0.994 . . . . 0.0 110.555 -179.226 . . . . . . . . 0 0 . 1 . 010 nuclear build core ' B' B ' 2' ' ' SER . . . . . . . . . . . . . 4.9 p . . . . . 0 N--CA 1.461 0.096 0 CA-C-O 120.797 0.332 . . . . 0.0 110.585 . . . . . . . . . 0 0 . 1 . 010 nuclear build core ' B' B ' 3' ' ' GLU . . . . . . . . . . . . . 40.7 mt-10 -141.08 141.44 34.25 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.243 -0.435 . . . . 0.0 111.09 -178.962 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B ' 4' ' ' LEU . . . . . . . . . . . . . 16.4 tp -125.9 129.82 50.09 Favored 'General case' 0 C--N 1.333 -0.143 0 CA-C-N 116.011 -0.541 . . . . 0.0 109.912 176.047 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B ' 5' ' ' LYS . . . . . . . . . . . . . 57.1 mttp -108.79 123.24 48.71 Favored 'General case' 0 C--O 1.236 0.359 0 CA-C-N 116.625 -0.262 . . . . 0.0 110.891 -179.394 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B ' 6' ' ' LEU . . . . . . . . . . . . . 66.6 mt -114.62 145.88 41.48 Favored 'General case' 0 C--N 1.331 -0.223 0 CA-C-N 115.71 -0.677 . . . . 0.0 110.557 179.646 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B ' 7' ' ' LYS . . . . . . . . . . . . . 83.7 tttt -128.12 142.0 43.08 Favored Pre-proline 0 CA--C 1.533 0.303 0 CA-C-O 119.057 -0.497 . . . . 0.0 109.787 175.569 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B ' 8' ' ' PRO . . . . . . . . . . . . . 93.7 Cg_endo -90.37 136.06 2.26 Favored 'Trans proline' 0 N--CA 1.49 1.318 0 C-N-CA 121.717 1.611 . . . . 0.0 111.832 179.131 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B ' 9' ' ' LEU . . . . . . . . . . . . . 28.0 mt -82.96 -47.2 0.84 Allowed Pre-proline 0 CA--C 1.535 0.401 0 CA-C-O 118.631 -0.699 . . . . 0.0 112.061 -179.358 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B ' 10' ' ' PRO . . . . . . . . . . . . . 83.8 Cg_endo -82.53 157.03 16.52 Favored 'Trans proline' 0 N--CA 1.495 1.592 0 C-N-CA 121.29 1.326 . . . . 0.0 111.802 175.688 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B ' 11' ' ' LYS . . . . . . . . . . . . . 18.2 pttp -86.03 110.38 19.46 Favored 'General case' 0 C--N 1.331 -0.216 0 CA-C-O 121.523 0.677 . . . . 0.0 110.329 177.42 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B ' 12' ' ' VAL . . . . . . . . . . . . . 12.0 p -151.07 149.53 14.09 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.359 0 CA-C-N 115.72 -0.673 . . . . 0.0 110.329 -179.978 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B ' 13' ' ' GLU . . . . . . . . . . . . . 42.0 tp10 -95.73 120.6 36.28 Favored 'General case' 0 C--N 1.329 -0.293 0 C-N-CA 120.853 -0.339 . . . . 0.0 110.217 177.714 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B ' 14' ' ' LEU . . . . . . . . . . . . . 37.2 mt -97.94 149.05 35.32 Favored Pre-proline 0 CA--C 1.533 0.316 0 CA-C-O 119.318 -0.372 . . . . 0.0 110.592 -177.736 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B ' 15' ' ' PRO . . . . . . . . . . . . . 26.7 Cg_exo -61.8 157.11 44.55 Favored 'Trans proline' 0 N--CA 1.499 1.83 0 C-N-CA 121.286 1.324 . . . . 0.0 111.663 176.998 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B ' 16' ' ' PRO . . . . . . . . . . . . . 39.1 Cg_exo -58.97 -33.95 98.94 Favored 'Trans proline' 0 N--CA 1.497 1.685 0 C-N-CA 121.416 1.411 . . . . 0.0 112.498 179.584 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B ' 17' ' ' ASP . . . . . . . . . . . . . 18.7 p-10 -88.02 9.69 21.54 Favored 'General case' 0 CA--C 1.536 0.413 0 N-CA-C 113.234 0.828 . . . . 0.0 113.234 -177.791 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B ' 18' ' ' PHE . . . . . . . . . . . . . 43.5 t80 -58.32 -46.49 86.08 Favored 'General case' 0 CA--C 1.523 -0.06 0 O-C-N 121.965 -0.459 . . . . 0.0 109.996 -177.983 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B ' 19' ' ' VAL . . . . . 0.417 HG13 ' N ' ' B' ' 20' ' ' ASP . 12.9 p -53.91 -41.4 48.95 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.328 0 CA-C-N 116.501 -0.318 . . . . 0.0 111.188 -178.422 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' B' B ' 20' ' ' ASP . . . . . 0.417 ' N ' HG13 ' B' ' 19' ' ' VAL . 81.2 m-20 -60.82 -45.15 95.57 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-O 120.935 0.398 . . . . 0.0 110.83 -178.841 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' B' B ' 21' ' ' VAL . . . . . . . . . . . . . 40.7 t -64.16 -44.32 97.54 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.287 0 CA-C-N 116.272 -0.422 . . . . 0.0 110.654 -177.614 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B ' 22' ' ' ILE . . . . . 0.553 HG22 HD12 ' B' ' 26' ' ' LEU . 50.3 mm -59.68 -40.01 81.16 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.199 0 C-N-CA 120.816 -0.354 . . . . 0.0 110.829 -179.65 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' B' B ' 23' ' ' ARG . . . . . . . . . . . . . 57.7 ttp180 -55.16 -49.14 72.6 Favored 'General case' 0 N--CA 1.463 0.219 0 CA-C-O 121.103 0.478 . . . . 0.0 110.692 177.736 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B ' 24' ' ' ILE . . . . . . . . . . . . . 72.4 mt -60.39 -42.85 92.43 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 CA-C-N 115.729 -0.668 . . . . 0.0 111.845 -177.047 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B ' 25' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -72.01 -37.43 69.79 Favored 'General case' 0 CA--C 1.535 0.37 0 N-CA-C 112.103 0.409 . . . . 0.0 112.103 -175.157 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' B' B ' 26' ' ' LEU . . . . . 0.553 HD12 HG22 ' B' ' 22' ' ' ILE . 40.4 mt -79.54 -39.7 31.25 Favored 'General case' 0 C--N 1.331 -0.231 0 N-CA-C 112.91 0.707 . . . . 0.0 112.91 -172.569 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' B' B ' 27' ' ' GLN . . . . . . . . . . . . . 14.3 pt20 -45.78 139.03 4.36 Favored 'General case' 0 N--CA 1.469 0.523 0 N-CA-C 112.84 0.682 . . . . 0.0 112.84 -175.095 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B ' 28' ' ' GLY . . . . . . . . . . . . . . . 102.01 -26.65 23.57 Favored Glycine 0 CA--C 1.531 1.066 0 CA-C-N 115.367 -0.833 . . . . 0.0 112.191 -176.737 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B ' 29' ' ' LYS . . . . . . . . . . . . . 54.8 mtpt -98.59 155.18 17.42 Favored 'General case' 0 C--O 1.233 0.198 0 CA-C-N 117.523 0.661 . . . . 0.0 111.237 179.058 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B ' 30' ' ' THR . . . . . . . . . . . . . 53.7 m -101.03 139.43 36.73 Favored 'General case' 0 C--N 1.331 -0.216 0 CA-C-N 116.045 -0.525 . . . . 0.0 110.1 176.03 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B ' 31' ' ' VAL . . . . . . . . . . . . . 34.5 m -130.47 155.4 41.7 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.305 0 CA-C-N 116.142 -0.481 . . . . 0.0 110.413 179.394 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B ' 32' ' ' ARG . . . . . . . . . . . . . 71.5 ttt-85 -135.41 150.25 49.84 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-O 121.048 0.451 . . . . 0.0 110.24 178.211 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B ' 33' ' ' THR . . . . . . . . . . . . . 19.8 m -52.28 137.67 28.2 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-O 120.894 0.378 . . . . 0.0 111.634 -177.068 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B ' 34' ' ' GLY . . . . . . . . . . . . . . . 101.97 -17.2 54.86 Favored Glycine 0 CA--C 1.533 1.179 0 CA-C-O 119.622 -0.543 . . . . 0.0 113.21 179.087 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B ' 35' ' ' ASP . . . . . . . . . . . . . 76.3 m-20 -67.28 148.58 51.51 Favored 'General case' 0 N--CA 1.462 0.128 0 CA-C-N 118.087 0.943 . . . . 0.0 111.299 179.514 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B ' 36' ' ' VAL . . . . . . . . . . . . . 46.3 t -121.44 131.15 73.74 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.198 0 CA-C-N 115.935 -0.575 . . . . 0.0 109.873 177.737 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B ' 37' ' ' ILE . . . . . . . . . . . . . 63.8 mt -121.27 138.57 51.21 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.299 0 CA-C-N 116.26 -0.427 . . . . 0.0 109.957 -179.921 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B ' 38' ' ' GLY . . . . . . . . . . . . . . . -114.42 127.52 7.78 Favored Glycine 0 CA--C 1.524 0.636 0 N-CA-C 111.01 -0.836 . . . . 0.0 111.01 179.126 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B ' 39' ' ' ILE . . . . . . . . . . . . . 70.8 mt -128.94 130.92 68.57 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.213 0 N-CA-C 110.003 -0.369 . . . . 0.0 110.003 178.685 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B ' 40' ' ' SER . . . . . 0.428 ' O ' HD13 ' B' ' 41' ' ' ILE . 59.7 p -90.93 118.19 30.12 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.422 -0.354 . . . . 0.0 110.693 176.959 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' B' B ' 41' ' ' ILE . . . . . 0.428 HD13 ' O ' ' B' ' 40' ' ' SER . 48.2 mm -125.08 116.95 48.58 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.19 0 CA-C-O 120.974 0.416 . . . . 0.0 110.237 179.686 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' B' B ' 42' ' ' LEU . . . . . 0.542 ' O ' HD23 ' B' ' 42' ' ' LEU . 1.3 tt 56.65 45.58 21.8 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-O 121.414 0.626 . . . . 0.0 110.366 178.217 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' B' B ' 43' ' ' GLY . . . . . . . . . . . . . . . 75.16 -9.65 12.21 Favored Glycine 0 CA--C 1.534 1.238 0 CA-C-N 116.062 -0.517 . . . . 0.0 113.726 175.378 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B ' 44' ' ' LYS . . . . . . . . . . . . . 46.8 tttp -107.29 126.9 53.03 Favored 'General case' 0 C--N 1.333 -0.121 0 CA-C-N 118.064 0.932 . . . . 0.0 110.189 -179.216 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B ' 45' ' ' GLU . . . . . . . . . . . . . 42.6 tp10 -83.51 128.84 34.83 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-O 120.829 0.347 . . . . 0.0 111.222 -178.781 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B ' 46' ' ' VAL . . . . . . . . . . . . . 8.7 p -120.18 127.08 75.88 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.198 0 N-CA-C 109.574 -0.528 . . . . 0.0 109.574 176.004 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B ' 47' ' ' LYS . . . . . . . . . . . . . 87.0 mttt -98.94 124.82 44.16 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.03 -0.532 . . . . 0.0 110.603 177.092 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B ' 48' ' ' PHE . . . . . . . . . . . . . 40.5 m-85 -108.96 131.8 54.71 Favored 'General case' 0 C--N 1.327 -0.379 0 N-CA-C 109.698 -0.482 . . . . 0.0 109.698 177.145 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B ' 49' ' ' LYS . . . . . . . . . . . . . 84.3 tttt -107.89 134.71 50.44 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.452 -0.34 . . . . 0.0 110.406 178.21 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B ' 50' ' ' VAL . . . . . . . . . . . . . 43.4 t -76.34 104.86 4.72 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.303 0 N-CA-C 109.25 -0.648 . . . . 0.0 109.25 176.729 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B ' 51' ' ' VAL . . . . . . . . . . . . . 47.0 t -69.6 -49.79 55.87 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.275 0 CA-C-N 116.088 -0.505 . . . . 0.0 109.799 -174.428 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B ' 52' ' ' GLN . . . . . . . . . . . . . 34.2 tt0 -161.91 145.05 11.99 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 115.928 -0.578 . . . . 0.0 111.569 -178.458 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B ' 53' ' ' ALA . . . . . . . . . . . . . . . -120.71 133.57 55.34 Favored 'General case' 0 C--N 1.331 -0.219 0 CA-C-N 115.792 -0.64 . . . . 0.0 110.051 176.963 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B ' 54' ' ' TYR . . . . . . . . . . . . . 45.9 t80 -129.06 109.63 18.19 Favored Pre-proline 0 CA--C 1.534 0.362 0 CA-C-O 118.27 -0.871 . . . . 0.0 110.243 178.276 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B ' 55' ' ' PRO . . . . . . . . . . . . . 73.6 Cg_endo -77.11 168.24 77.54 Favored 'Cis proline' 0 N--CA 1.5 1.862 0 CA-C-N 121.818 1.685 . . . . 0.0 112.518 -5.921 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B ' 56' ' ' SER . . . . . . . . . . . . . 50.5 m -117.3 134.02 23.13 Favored Pre-proline 0 CA--C 1.539 0.532 0 CA-C-O 118.418 -0.801 . . . . 0.0 109.557 174.851 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B ' 57' ' ' PRO . . . . . . . . . . . . . 35.2 Cg_endo -66.27 164.37 66.14 Favored 'Cis proline' 0 N--CA 1.497 1.713 0 CA-C-N 121.838 1.692 . . . . 0.0 111.341 -2.547 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B ' 58' ' ' LEU . . . . . . . . . . . . . 20.7 tp -129.78 136.05 49.16 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-O 120.966 0.413 . . . . 0.0 110.321 -179.061 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B ' 59' ' ' ARG . . . . . . . . . . . . . 36.4 ttm180 -104.47 126.89 51.98 Favored 'General case' 0 C--N 1.326 -0.455 0 N-CA-C 109.169 -0.678 . . . . 0.0 109.169 175.69 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B ' 60' ' ' VAL . . . . . . . . . . . . . 49.3 t -77.3 117.51 22.43 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.243 0 C-N-CA 120.638 -0.425 . . . . 0.0 109.933 -176.159 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B ' 61' ' ' GLU . . . . . . . . . . . . . 94.9 mt-10 -130.99 167.9 18.27 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.088 -0.505 . . . . 0.0 110.247 -179.789 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B ' 62' ' ' ASP . . . . . . . . . . . . . 24.6 t0 -54.26 -32.5 56.28 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-N 116.506 -0.315 . . . . 0.0 111.799 -178.816 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B ' 63' ' ' ARG . . . . . . . . . . . . . 5.0 ptp180 -88.9 10.14 22.35 Favored 'General case' 0 CA--C 1.534 0.353 0 N-CA-C 113.499 0.926 . . . . 0.0 113.499 -175.147 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B ' 64' ' ' THR . . . . . . . . . . . . . 27.2 m -94.02 134.4 36.46 Favored 'General case' 0 C--N 1.333 -0.122 0 CA-C-N 118.199 0.454 . . . . 0.0 110.507 -179.557 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B ' 65' ' ' LYS . . . . . . . . . . . . . 67.2 mttm -90.7 133.31 35.24 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.011 -0.54 . . . . 0.0 110.616 179.706 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B ' 66' ' ' ILE . . . . . . . . . . . . . 61.5 mt -110.75 129.6 65.64 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.21 0 N-CA-C 109.737 -0.468 . . . . 0.0 109.737 178.959 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B ' 67' ' ' THR . . . . . . . . . . . . . 27.5 m -123.47 145.52 48.76 Favored 'General case' 0 C--N 1.331 -0.23 0 CA-C-N 116.055 -0.52 . . . . 0.0 110.644 -178.277 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B ' 68' ' ' LEU . . . . . . . . . . . . . 52.9 mt . . . . . 0 C--N 1.331 -0.228 0 CA-C-N 115.931 -0.577 . . . . 0.0 111.135 -178.442 . . . . . . . . 0 0 . 1 . 010 nuclear build core ' B' B ' 73' ' ' VAL . . . . . . . . . . . . . 34.5 m . . . . . 0 C--O 1.233 0.201 0 N-CA-C 109.629 -0.508 . . . . 0.0 109.629 . . . . . . . . . 0 0 . 1 . 010 nuclear build core ' B' B ' 74' ' ' ASP . . . . . . . . . . . . . 28.9 t0 -84.85 115.35 22.7 Favored 'General case' 0 C--N 1.329 -0.323 0 C-N-CA 120.474 -0.49 . . . . 0.0 110.242 -170.972 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B ' 75' ' ' VAL . . . . . . . . . . . . . 40.8 t -120.26 122.19 67.66 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.211 0 CA-C-O 121.099 0.476 . . . . 0.0 110.55 -177.842 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B ' 76' ' ' LEU . . . . . . . . . . . . . 5.9 mp -119.25 137.64 53.53 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 115.609 -0.723 . . . . 0.0 109.288 174.627 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B ' 77' ' ' GLU . . . . . . . . . . . . . 96.8 mt-10 -129.6 138.11 51.08 Favored 'General case' 0 C--N 1.331 -0.208 0 CA-C-O 121.159 0.504 . . . . 0.0 111.106 -176.405 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B ' 78' ' ' ALA . . . . . . . . . . . . . . . -127.35 129.19 47.17 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 115.591 -0.731 . . . . 0.0 109.681 176.785 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B ' 79' ' ' LYS . . . . . 0.611 ' O ' HD13 ' B' ' 80' ' ' ILE . 79.9 tttt -76.35 119.34 20.09 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.413 -0.358 . . . . 0.0 110.304 -178.294 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' B' B ' 80' ' ' ILE . . . . . 0.611 HD13 ' O ' ' B' ' 79' ' ' LYS . 40.6 mm -139.2 113.86 7.75 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.306 0 N-CA-C 109.469 -0.567 . . . . 0.0 109.469 -175.027 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' B' B ' 81' ' ' LYS . . . . . . . . . . . . . 86.9 tttt -99.33 122.89 43.1 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-O 120.82 0.343 . . . . 0.0 111.214 -177.219 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B ' 82' ' ' GLY . . . . . . . . . . . . . . . 89.15 42.18 5.66 Favored Glycine 0 CA--C 1.526 0.752 0 C-N-CA 120.683 -0.77 . . . . 0.0 112.413 171.715 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B ' 83' ' ' ILE . . . . . . . . . . . . . 71.3 mt -63.83 137.93 23.9 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.283 0 N-CA-C 109.484 -0.562 . . . . 0.0 109.484 174.818 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B ' 84' ' ' LYS . . . . . . . . . . . . . 36.7 ttpt -106.58 -51.22 2.98 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-O 120.878 0.37 . . . . 0.0 110.352 -178.152 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B ' 85' ' ' ASP . . . . . . . . . . . . . 13.1 t70 -145.25 146.16 31.58 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 115.969 -0.559 . . . . 0.0 110.54 -178.108 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B ' 86' ' ' VAL . . . . . . . . . . . . . 46.2 t -129.97 131.89 65.89 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.263 0 CA-C-O 120.996 0.427 . . . . 0.0 110.448 -179.098 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B ' 87' ' ' ILE . . . . . 0.489 ' N ' HD12 ' B' ' 87' ' ' ILE . 5.0 mp -120.47 127.29 75.9 Favored 'Isoleucine or valine' 0 C--O 1.233 0.22 0 CA-C-N 115.86 -0.609 . . . . 0.0 109.494 176.846 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' B' B ' 88' ' ' LEU . . . . . . . . . . . . . 13.7 tp -113.68 132.93 55.61 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-O 120.963 0.411 . . . . 0.0 111.284 -177.036 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B ' 89' ' ' ASP . . . . . . . . . . . . . 11.4 t70 -130.38 155.25 46.69 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 115.745 -0.661 . . . . 0.0 109.675 176.602 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B ' 90' ' ' GLU . . . . . . . . . . . . . 84.4 tt0 -45.74 -48.56 15.27 Favored 'General case' 0 N--CA 1.466 0.34 0 N-CA-C 112.798 0.666 . . . . 0.0 112.798 -173.194 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B ' 91' ' ' ASN . . . . . . . . . . . . . 2.6 p30 -126.04 39.33 3.97 Favored 'General case' 0 N--CA 1.465 0.294 0 CA-C-O 120.958 0.409 . . . . 0.0 110.966 -177.904 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B ' 92' ' ' LEU . . . . . . . . . . . . . 10.8 tp -165.5 140.17 4.87 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.312 -0.404 . . . . 0.0 110.383 -179.376 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B ' 93' ' ' ILE . . . . . . . . . . . . . 69.6 mt -128.77 122.56 57.3 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.289 0 N-CA-C 109.294 -0.632 . . . . 0.0 109.294 179.55 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B ' 94' ' ' VAL . . . . . . . . . . . . . 46.4 t -122.54 128.62 75.42 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.229 0 CA-C-O 120.947 0.403 . . . . 0.0 110.147 -178.838 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B ' 95' ' ' VAL . . . . . . . . . . . . . 42.1 t -123.16 134.28 66.67 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.283 0 CA-C-N 116.017 -0.538 . . . . 0.0 109.834 -179.785 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B ' 96' ' ' ILE . . . . . . . . . . . . . 62.1 mt -117.8 129.92 73.47 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.237 0 N-CA-C 109.464 -0.569 . . . . 0.0 109.464 179.845 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B ' 97' ' ' THR . . . . . . . . . . . . . 70.8 p -103.38 161.2 14.04 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-O 121.23 0.538 . . . . 0.0 111.547 -176.522 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B ' 98' ' ' GLU . . . . . . . . . . . . . 71.0 mm-40 -53.79 -27.42 29.06 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 115.97 -0.559 . . . . 0.0 112.149 178.679 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B ' 99' ' ' GLU . . . . . . . . . . . . . 95.5 mt-10 -76.6 11.8 1.51 Allowed 'General case' 0 CA--C 1.536 0.433 0 N-CA-C 113.235 0.828 . . . . 0.0 113.235 -178.113 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B ' 100' ' ' ASN . . . . . . . . . . . . . 6.2 m-20 61.24 37.61 17.19 Favored 'General case' 0 CA--C 1.528 0.116 0 CA-C-O 120.912 0.387 . . . . 0.0 110.984 179.524 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B ' 101' ' ' GLU . . . . . . . . . . . . . 85.0 tt0 -113.44 142.89 45.36 Favored 'General case' 0 C--N 1.331 -0.197 0 N-CA-C 109.606 -0.516 . . . . 0.0 109.606 174.321 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B ' 102' ' ' VAL . . . . . . . . . . . . . 40.3 t -115.69 125.67 72.95 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.312 0 CA-C-N 116.158 -0.474 . . . . 0.0 109.968 -178.173 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B ' 103' ' ' LEU . . . . . . . . . . . . . 23.5 mt -115.87 126.97 54.64 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 115.736 -0.665 . . . . 0.0 109.959 176.296 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B ' 104' ' ' ILE . . . . . . . . . . . . . 66.2 mt -117.38 120.26 64.32 Favored 'Isoleucine or valine' 0 C--O 1.235 0.29 0 CA-C-N 116.612 -0.267 . . . . 0.0 110.355 -179.429 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B ' 105' ' ' PHE . . . . . . . . . . . . . 17.7 m-85 -122.97 168.4 12.37 Favored 'General case' 0 C--N 1.332 -0.188 0 O-C-N 123.797 0.686 . . . . 0.0 109.949 178.686 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B ' 106' ' ' ASN . . . . . . . . . . . . . 41.7 p-10 -96.93 -169.86 1.94 Allowed 'General case' 0 C--N 1.329 -0.316 0 N-CA-C 109.627 -0.508 . . . . 0.0 109.627 173.485 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B ' 107' ' ' GLN . . . . . . . . . . . . . 60.4 tt0 -59.5 -30.04 68.28 Favored 'General case' 0 CA--C 1.532 0.274 0 C-N-CA 120.968 -0.293 . . . . 0.0 111.775 178.438 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B ' 108' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -82.0 5.76 18.22 Favored 'General case' 0 CA--C 1.537 0.47 0 N-CA-C 113.167 0.803 . . . . 0.0 113.167 -178.053 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' B' B ' 109' ' ' LEU . . . . . . . . . . . . . 10.2 tp 61.97 37.8 14.73 Favored 'General case' 0 C--N 1.332 -0.166 0 O-C-N 122.047 -0.408 . . . . 0.0 111.377 178.106 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B ' 110' ' ' GLU . . . . . . . . . . . . . 70.9 mm-40 -103.17 159.41 15.56 Favored 'General case' 0 C--N 1.33 -0.277 0 N-CA-C 109.749 -0.463 . . . . 0.0 109.749 175.688 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B ' 111' ' ' GLU . . . . . . . . . . . . . 84.0 tt0 -85.17 123.31 30.53 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-O 120.974 0.416 . . . . 0.0 111.053 -177.397 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B ' 112' ' ' LEU . . . . . . . . . . . . . 12.7 mt -110.04 -45.96 3.53 Favored 'General case' 0 C--N 1.331 -0.216 0 CA-C-N 115.884 -0.598 . . . . 0.0 110.144 176.776 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B ' 113' ' ' TYR . . . . . . . . . . . . . 63.8 t80 -141.46 138.23 32.71 Favored 'General case' 0 C--N 1.331 -0.217 0 CA-C-N 116.212 -0.449 . . . . 0.0 111.152 179.977 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B ' 114' ' ' ARG . . . . . . . . . . . . . 67.0 ttt180 -138.62 119.58 14.37 Favored 'General case' 0 C--N 1.332 -0.191 0 CA-C-N 116.015 -0.539 . . . . 0.0 110.132 178.41 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B ' 115' ' ' GLY . . . . . . . . . . . . . . . -150.15 158.04 27.49 Favored Glycine 0 CA--C 1.525 0.696 0 C-N-CA 120.666 -0.778 . . . . 0.0 111.367 179.342 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B ' 116' ' ' LYS . . . . . . . . . . . . . 29.8 ttmt -130.81 139.31 50.17 Favored 'General case' 0 C--N 1.331 -0.231 0 N-CA-C 109.898 -0.408 . . . . 0.0 109.898 176.643 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B ' 117' ' ' PHE . . . . . . . . . . . . . 30.7 m-85 -135.84 114.5 11.9 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.329 -0.396 . . . . 0.0 110.372 -176.047 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B ' 118' ' ' GLU . . . . . . . . . . . . . 96.0 mt-10 -52.82 -47.63 67.52 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.351 -0.386 . . . . 0.0 111.579 -176.473 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B ' 119' ' ' ASN . . . . . . . . . . . . . 32.4 m120 -94.91 31.03 1.93 Allowed 'General case' 0 C--N 1.331 -0.238 0 N-CA-C 112.199 0.444 . . . . 0.0 112.199 -174.553 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B ' 120' ' ' LEU . . . . . . . . . . . . . 11.8 tp -56.48 120.46 7.75 Favored 'General case' 0 C--N 1.332 -0.156 0 CA-C-O 120.728 0.299 . . . . 0.0 110.504 177.68 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B ' 121' ' ' ASN . . . . . . . . . . . . . 64.3 t30 -112.53 -44.09 3.4 Favored 'General case' 0 C--N 1.331 -0.23 0 CA-C-N 116.317 -0.401 . . . . 0.0 110.874 -176.502 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B ' 122' ' ' LYS . . . . . . . . . . . . . 34.2 mtmm -147.45 145.97 29.37 Favored 'General case' 0 C--N 1.331 -0.217 0 CA-C-O 121.08 0.467 . . . . 0.0 111.445 -178.191 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B ' 123' ' ' VAL . . . . . . . . . . . . . 46.6 t -125.92 129.64 72.39 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.24 0 CA-C-N 115.831 -0.622 . . . . 0.0 109.409 176.395 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B ' 124' ' ' LEU . . . . . . . . . . . . . 44.9 mt -118.88 128.33 54.34 Favored 'General case' 0 C--N 1.331 -0.239 0 CA-C-N 116.308 -0.405 . . . . 0.0 110.431 -179.204 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B ' 125' ' ' VAL . . . . . . . . . . . . . 47.7 t -130.61 124.35 56.78 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.324 0 CA-C-N 116.141 -0.481 . . . . 0.0 109.824 179.105 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B ' 126' ' ' ARG . . . . . . . . . . . . . 37.0 mtm105 -145.0 119.72 9.83 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-O 120.973 0.416 . . . . 0.0 110.195 178.248 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B ' 127' ' ' ASN . . . . . . . . . . . . . 89.8 m-20 55.44 -130.17 1.99 Allowed 'General case' 0 CA--C 1.545 0.759 0 CA-C-O 118.516 -0.754 . . . . 0.0 110.196 -179.398 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B ' 128' ' ' ASP . . . . . . . . . . . . . 11.5 p-10 -97.23 10.05 40.55 Favored 'General case' 0 CA--C 1.536 0.417 0 CA-C-N 120.04 1.291 . . . . 0.0 113.237 -178.1 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B ' 129' ' ' LEU . . . . . . . . . . . . . 6.2 tt -109.05 133.57 52.82 Favored 'General case' 0 C--O 1.232 0.178 0 CA-C-N 118.28 0.491 . . . . 0.0 110.065 -179.923 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B ' 130' ' ' VAL . . . . . . . . . . . . . 46.4 t -125.89 137.35 57.99 Favored 'Isoleucine or valine' 0 N--CA 1.462 0.175 0 CA-C-O 120.953 0.406 . . . . 0.0 110.453 -176.947 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B ' 131' ' ' VAL . . . . . 0.538 HG22 HD12 ' B' ' 140' ' ' LEU . 46.9 t -136.1 135.4 50.15 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.277 0 CA-C-N 116.137 -0.483 . . . . 0.0 110.187 178.414 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' B' B ' 132' ' ' ILE . . . . . . . . . . . . . 74.1 mt -120.28 131.65 71.99 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.271 0 N-CA-C 109.708 -0.479 . . . . 0.0 109.708 -179.833 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B ' 133' ' ' ILE . . . . . . . . . . . . . 39.0 mm -117.83 121.47 67.46 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.271 0 CA-C-N 116.493 -0.321 . . . . 0.0 110.868 -176.989 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B ' 134' ' ' ASP . . . . . . . . . . . . . 8.8 p-10 -132.69 149.43 52.29 Favored 'General case' 0 CA--C 1.528 0.128 0 N-CA-C 109.898 -0.408 . . . . 0.0 109.898 173.837 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B ' 135' ' ' GLU . . . . . . . . . . . . . 85.4 tt0 -49.89 -25.5 3.25 Favored 'General case' 0 C--N 1.328 -0.357 0 N-CA-C 113.083 0.771 . . . . 0.0 113.083 -170.315 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B ' 136' ' ' GLN . . . . . . . . . . . . . 97.5 mt-30 -92.86 -29.95 15.68 Favored 'General case' 0 C--N 1.33 -0.269 0 N-CA-C 112.581 0.585 . . . . 0.0 112.581 -173.932 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B ' 137' ' ' LYS . . . . . . . . . . . . . 43.8 pttt -161.11 165.69 29.22 Favored 'General case' 0 C--O 1.233 0.212 0 CA-C-O 121.475 0.655 . . . . 0.0 112.19 -173.221 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B ' 138' ' ' LEU . . . . . . . . . . . . . 7.0 tt -117.44 129.92 56.14 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 115.103 -0.953 . . . . 0.0 110.01 178.798 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B ' 139' ' ' THR . . . . . . . . . . . . . 31.0 m -112.57 128.18 56.29 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.157 -0.474 . . . . 0.0 110.51 -179.888 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B ' 140' ' ' LEU . . . . . 0.538 HD12 HG22 ' B' ' 131' ' ' VAL . 11.5 tp -117.1 120.82 39.51 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 115.814 -0.63 . . . . 0.0 109.352 -178.761 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' B' B ' 141' ' ' ILE . . . . . . . . . . . . . 19.9 mt -116.96 119.69 62.78 Favored 'Isoleucine or valine' 0 C--O 1.233 0.193 0 CA-C-O 121.037 0.446 . . . . 0.0 110.417 -173.657 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B ' 142' ' ' ARG . . . . . . . . . . . . . 84.2 mtp180 -108.06 133.77 51.89 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 115.009 -0.996 . . . . 0.0 110.507 -177.565 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B ' 143' ' ' THR . . . . . . . . . . . . . 15.1 p . . . . . 0 C--O 1.219 -0.503 0 CA-C-O 117.907 -1.044 . . . . 0.0 110.984 179.886 . . . . . . . . 0 0 . 1 . 010 nuclear build core ' C' C ' 2' ' ' SER . . . . . . . . . . . . . 3.3 p . . . . . 0 C--O 1.231 0.126 0 CA-C-O 120.935 0.398 . . . . 0.0 110.487 . . . . . . . . . 0 0 . 1 . 010 nuclear build core ' C' C ' 3' ' ' GLU . . . . . . . . . . . . . 95.3 mt-10 -140.29 139.34 35.47 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.057 -0.52 . . . . 0.0 110.953 -178.34 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' C' C ' 4' ' ' LEU . . . . . . . . . . . . . 20.2 tp -127.05 128.48 46.35 Favored 'General case' 0 C--N 1.331 -0.221 0 CA-C-N 115.891 -0.595 . . . . 0.0 109.838 176.067 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' C' C ' 5' ' ' LYS . . . . . . . . . . . . . 96.3 mttt -112.48 122.8 48.73 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-O 120.769 0.318 . . . . 0.0 110.872 -178.581 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' C' C ' 6' ' ' LEU . . . . . . . . . . . . . 47.8 mt -114.24 142.61 46.05 Favored 'General case' 0 N--CA 1.462 0.143 0 CA-C-N 115.404 -0.817 . . . . 0.0 110.271 -179.451 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' C' C ' 7' ' ' LYS . . . . . . . . . . . . . 40.1 ttmt -123.45 137.16 28.05 Favored Pre-proline 0 CA--C 1.533 0.305 0 CA-C-O 119.001 -0.523 . . . . 0.0 109.622 175.545 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' C' C ' 8' ' ' PRO . . . . . . . . . . . . . 85.4 Cg_endo -91.83 136.01 1.69 Allowed 'Trans proline' 0 N--CA 1.489 1.231 0 C-N-CA 121.692 1.595 . . . . 0.0 111.895 179.314 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' C' C ' 9' ' ' LEU . . . . . . . . . . . . . 71.1 mt -74.62 -47.65 5.3 Favored Pre-proline 0 CA--C 1.534 0.35 0 CA-C-O 118.578 -0.725 . . . . 0.0 112.283 -179.744 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' C' C ' 10' ' ' PRO . . . . . . . . . . . . . 85.4 Cg_endo -80.15 151.49 20.81 Favored 'Trans proline' 0 N--CA 1.496 1.623 0 C-N-CA 121.162 1.241 . . . . 0.0 111.898 176.82 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' C' C ' 11' ' ' LYS . . . . . . . . . . . . . 50.5 tttp -87.21 98.25 11.22 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-O 120.752 0.311 . . . . 0.0 110.444 178.813 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' C' C ' 12' ' ' VAL . . . . . . . . . . . . . 11.9 p -144.55 144.88 21.86 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.289 0 CA-C-N 116.198 -0.455 . . . . 0.0 110.433 179.954 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' C' C ' 13' ' ' GLU . . . . . . . . . . . . . 95.2 mt-10 -82.05 126.76 32.37 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-N 116.352 -0.385 . . . . 0.0 110.041 177.846 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' C' C ' 14' ' ' LEU . . . . . . . . . . . . . 46.3 mt -95.48 148.48 34.68 Favored Pre-proline 0 C--N 1.329 -0.29 0 CA-C-O 119.235 -0.412 . . . . 0.0 110.4 -179.11 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' C' C ' 15' ' ' PRO . . . . . . . . . . . . . 38.8 Cg_exo -58.65 156.86 30.03 Favored 'Trans proline' 0 N--CA 1.496 1.651 0 C-N-CA 121.187 1.258 . . . . 0.0 111.772 178.97 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' C' C ' 16' ' ' PRO . . . . . . . . . . . . . 35.5 Cg_exo -58.49 -42.84 50.97 Favored 'Trans proline' 0 N--CA 1.498 1.762 0 C-N-CA 121.315 1.344 . . . . 0.0 112.703 -177.206 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' C' C ' 17' ' ' ASP . . . . . . . . . . . . . 12.8 p-10 -86.86 13.21 9.35 Favored 'General case' 0 C--N 1.327 -0.402 0 N-CA-C 112.999 0.741 . . . . 0.0 112.999 -177.961 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' C' C ' 18' ' ' PHE . . . . . . . . . . . . . 44.2 t80 -57.63 -50.52 72.87 Favored 'General case' 0 N--CA 1.456 -0.166 0 O-C-N 121.991 -0.443 . . . . 0.0 110.459 -176.958 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' C' C ' 19' ' ' VAL . . . . . . . . . . . . . 13.9 p -54.25 -40.46 47.62 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.285 0 CA-C-N 116.493 -0.321 . . . . 0.0 111.209 -177.911 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' C' C ' 20' ' ' ASP . . . . . . . . . . . . . 82.5 m-20 -60.53 -44.75 95.75 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-O 120.969 0.414 . . . . 0.0 110.86 -178.566 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' C' C ' 21' ' ' VAL . . . . . . . . . . . . . 46.4 t -64.16 -44.48 97.56 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.319 0 CA-C-N 116.291 -0.413 . . . . 0.0 110.396 -178.141 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' C' C ' 22' ' ' ILE . . . . . 0.669 HG22 HD12 ' C' ' 26' ' ' LEU . 50.6 mm -55.9 -44.71 78.8 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.248 0 C-N-CA 121.026 -0.269 . . . . 0.0 110.712 179.019 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' C' C ' 23' ' ' ARG . . . . . . . . . . . . . 55.5 ttp180 -53.8 -50.61 65.74 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-O 120.674 0.274 . . . . 0.0 111.439 179.727 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' C' C ' 24' ' ' ILE . . . . . . . . . . . . . 66.9 mt -58.34 -42.18 83.24 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.274 0 CA-C-N 116.558 -0.292 . . . . 0.0 110.884 -178.183 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' C' C ' 25' ' ' LYS . . . . . . . . . . . . . 53.1 mtpt -66.71 -43.82 83.29 Favored 'General case' 0 C--N 1.328 -0.367 0 N-CA-C 112.531 0.567 . . . . 0.0 112.531 -177.481 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' C' C ' 26' ' ' LEU . . . . . 0.669 HD12 HG22 ' C' ' 22' ' ' ILE . 62.9 mt -80.47 -36.23 33.74 Favored 'General case' 0 C--N 1.33 -0.256 0 N-CA-C 113.542 0.941 . . . . 0.0 113.542 -169.117 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' C' C ' 27' ' ' GLN . . . . . . . . . . . . . 16.9 pt20 -46.81 141.01 4.21 Favored 'General case' 0 N--CA 1.47 0.573 0 N-CA-C 112.674 0.62 . . . . 0.0 112.674 -176.006 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' C' C ' 28' ' ' GLY . . . . . . . . . . . . . . . 101.23 -25.77 27.02 Favored Glycine 0 CA--C 1.532 1.107 0 CA-C-N 115.752 -0.658 . . . . 0.0 112.235 -175.959 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' C' C ' 29' ' ' LYS . . . . . . . . . . . . . 73.3 mmtt -97.24 155.11 17.0 Favored 'General case' 0 C--O 1.234 0.247 0 CA-C-N 117.462 0.631 . . . . 0.0 111.191 178.46 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' C' C ' 30' ' ' THR . . . . . . . . . . . . . 23.7 m -104.8 136.01 45.11 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 115.807 -0.633 . . . . 0.0 109.785 174.841 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' C' C ' 31' ' ' VAL . . . . . . . . . . . . . 34.3 m -128.34 154.79 39.53 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.254 0 CA-C-O 120.918 0.39 . . . . 0.0 111.022 -176.916 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' C' C ' 32' ' ' ARG . . . . . . . . . . . . . 94.3 mtm-85 -133.32 150.37 51.87 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-O 121.249 0.547 . . . . 0.0 110.625 178.351 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' C' C ' 33' ' ' THR . . . . . . . . . . . . . 25.9 m -52.45 139.89 23.8 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 116.188 -0.46 . . . . 0.0 111.513 -178.327 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' C' C ' 34' ' ' GLY . . . . . . . . . . . . . . . 99.29 -17.06 58.4 Favored Glycine 0 CA--C 1.532 1.143 0 CA-C-O 119.533 -0.593 . . . . 0.0 113.214 179.228 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' C' C ' 35' ' ' ASP . . . . . . . . . . . . . 59.6 m-20 -63.15 149.76 44.48 Favored 'General case' 0 C--O 1.231 0.126 0 CA-C-N 118.138 0.969 . . . . 0.0 110.911 179.205 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' C' C ' 36' ' ' VAL . . . . . . . . . . . . . 42.0 t -122.45 129.33 75.34 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.251 0 CA-C-N 115.897 -0.592 . . . . 0.0 109.766 179.068 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' C' C ' 37' ' ' ILE . . . . . . . . . . . . . 66.2 mt -122.93 138.65 52.28 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.226 0 CA-C-N 116.265 -0.425 . . . . 0.0 109.968 179.815 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' C' C ' 38' ' ' GLY . . . . . . . . . . . . . . . -118.93 129.0 7.91 Favored Glycine 0 CA--C 1.525 0.683 0 N-CA-C 110.891 -0.884 . . . . 0.0 110.891 178.978 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' C' C ' 39' ' ' ILE . . . . . . . . . . . . . 70.2 mt -125.07 134.53 66.66 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.241 0 CA-C-O 120.764 0.316 . . . . 0.0 110.297 179.269 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' C' C ' 40' ' ' SER . . . . . . . . . . . . . 36.3 t -91.3 117.87 30.02 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.078 -0.51 . . . . 0.0 110.723 176.196 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' C' C ' 41' ' ' ILE . . . . . . . . . . . . . 65.7 mt -126.5 122.25 60.63 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.164 0 CA-C-O 120.816 0.341 . . . . 0.0 110.209 179.506 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' C' C ' 42' ' ' LEU . . . . . . . . . . . . . 5.5 mp 52.9 35.88 20.25 Favored 'General case' 0 CA--C 1.532 0.279 0 CA-C-N 116.186 -0.461 . . . . 0.0 111.399 178.099 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' C' C ' 43' ' ' GLY . . . . . . . . . . . . . . . 73.87 27.99 65.73 Favored Glycine 0 CA--C 1.531 1.087 0 C-N-CA 121.15 -0.548 . . . . 0.0 112.542 176.528 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' C' C ' 44' ' ' LYS . . . . . . . . . . . . . 95.7 mttt -139.52 128.71 23.9 Favored 'General case' 0 C--N 1.33 -0.282 0 N-CA-C 109.744 -0.465 . . . . 0.0 109.744 176.971 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' C' C ' 45' ' ' GLU . . . . . . . . . . . . . 85.2 tt0 -84.08 127.75 34.11 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-O 120.882 0.372 . . . . 0.0 111.533 -177.473 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' C' C ' 46' ' ' VAL . . . . . . . . . . . . . 9.3 p -118.41 126.76 75.34 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.21 0 N-CA-C 109.569 -0.53 . . . . 0.0 109.569 174.342 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' C' C ' 47' ' ' LYS . . . . . . . . . . . . . 75.9 mttt -98.28 123.89 42.61 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.044 -0.526 . . . . 0.0 110.808 178.315 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' C' C ' 48' ' ' PHE . . . . . . . . . . . . . 34.5 m-85 -109.18 131.77 54.75 Favored 'General case' 0 C--N 1.329 -0.299 0 N-CA-C 109.691 -0.485 . . . . 0.0 109.691 176.75 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' C' C ' 49' ' ' LYS . . . . . . . . . . . . . 49.1 tttp -107.37 132.54 53.04 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.432 -0.349 . . . . 0.0 110.164 177.638 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' C' C ' 50' ' ' VAL . . . . . . . . . . . . . 44.5 t -75.6 107.25 6.19 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.327 0 N-CA-C 109.594 -0.521 . . . . 0.0 109.594 178.314 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' C' C ' 51' ' ' VAL . . . . . . . . . . . . . 47.1 t -68.94 -49.12 66.12 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.305 0 CA-C-N 116.116 -0.493 . . . . 0.0 109.721 -175.594 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' C' C ' 52' ' ' GLN . . . . . . . . . . . . . 49.1 tt0 -162.84 143.03 9.38 Favored 'General case' 0 C--N 1.329 -0.291 0 C-N-CA 120.211 -0.596 . . . . 0.0 111.773 -178.836 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' C' C ' 53' ' ' ALA . . . . . . . . . . . . . . . -114.86 130.92 56.97 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 115.32 -0.855 . . . . 0.0 109.456 174.096 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' C' C ' 54' ' ' TYR . . . . . . . . . . . . . 22.2 t80 -128.62 110.27 19.0 Favored Pre-proline 0 CA--C 1.534 0.363 0 CA-C-O 118.34 -0.838 . . . . 0.0 110.306 -178.891 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' C' C ' 55' ' ' PRO . . . . . . . . . . . . . 74.5 Cg_endo -77.23 170.06 72.46 Favored 'Cis proline' 0 N--CA 1.499 1.831 0 CA-C-N 121.827 1.688 . . . . 0.0 112.367 -5.623 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' C' C ' 56' ' ' SER . . . . . . . . . . . . . 13.8 m -114.73 129.13 25.25 Favored Pre-proline 0 CA--C 1.538 0.496 0 CA-C-O 118.451 -0.785 . . . . 0.0 109.451 175.855 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' C' C ' 57' ' ' PRO . . . . . . . . . . . . . 59.6 Cg_endo -73.61 148.95 93.29 Favored 'Cis proline' 0 N--CA 1.497 1.689 0 CA-C-N 121.99 1.747 . . . . 0.0 111.759 -0.352 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' C' C ' 58' ' ' LEU . . . . . . . . . . . . . 23.8 tp -108.3 136.6 47.68 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.376 -0.374 . . . . 0.0 110.836 -178.174 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' C' C ' 59' ' ' ARG . . . . . . . . . . . . . 60.1 ttm-85 -103.13 123.21 46.25 Favored 'General case' 0 C--N 1.329 -0.323 0 N-CA-C 109.242 -0.651 . . . . 0.0 109.242 174.779 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' C' C ' 60' ' ' VAL . . . . . . . . . . . . . 44.1 t -80.56 121.6 34.28 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.264 0 C-N-CA 120.712 -0.395 . . . . 0.0 110.246 -176.94 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' C' C ' 61' ' ' GLU . . . . . . . . . . . . . 40.3 mt-10 -130.72 172.37 12.05 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 115.958 -0.565 . . . . 0.0 109.863 178.821 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' C' C ' 62' ' ' ASP . . . . . . . . . . . . . 60.1 m-20 -54.92 -32.52 61.28 Favored 'General case' 0 C--N 1.328 -0.365 0 N-CA-C 111.773 0.286 . . . . 0.0 111.773 -178.978 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' C' C ' 63' ' ' ARG . . . . . . . . . . . . . 17.5 ptm180 -88.92 6.31 39.94 Favored 'General case' 0 CA--C 1.536 0.437 0 N-CA-C 113.507 0.929 . . . . 0.0 113.507 -176.226 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' C' C ' 64' ' ' THR . . . . . . . . . . . . . 32.8 m -82.39 131.53 35.22 Favored 'General case' 0 C--N 1.331 -0.203 0 CA-C-N 118.143 0.429 . . . . 0.0 110.559 -178.874 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' C' C ' 65' ' ' LYS . . . . . . . . . . . . . 96.6 mttt -88.77 129.34 35.58 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.155 -0.475 . . . . 0.0 110.104 179.744 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' C' C ' 66' ' ' ILE . . . . . . . . . . . . . 64.2 mt -114.17 130.36 68.52 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.252 0 N-CA-C 109.82 -0.437 . . . . 0.0 109.82 179.305 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' C' C ' 67' ' ' THR . . . . . . . . . . . . . 22.4 m -121.53 140.09 52.66 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-N 116.118 -0.492 . . . . 0.0 111.0 -177.732 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' C' C ' 68' ' ' LEU . . . . . . . . . . . . . 44.1 mt . . . . . 0 C--N 1.33 -0.267 0 CA-C-N 115.832 -0.622 . . . . 0.0 110.415 178.173 . . . . . . . . 0 0 . 1 . 010 nuclear build core ' C' C ' 73' ' ' VAL . . . . . . . . . . . . . 27.6 m . . . . . 0 C--O 1.232 0.133 0 CA-C-O 120.815 0.34 . . . . 0.0 110.191 . . . . . . . . . 0 0 . 1 . 010 nuclear build core ' C' C ' 74' ' ' ASP . . . . . 0.436 ' OD1' HD11 ' C' ' 76' ' ' LEU . 3.1 t70 -105.53 121.68 44.44 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.273 -0.421 . . . . 0.0 109.964 -178.563 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' C' C ' 75' ' ' VAL . . . . . 0.42 ' C ' HD12 ' C' ' 76' ' ' LEU . 40.4 t -117.47 123.77 72.19 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.229 0 CA-C-O 121.095 0.474 . . . . 0.0 110.566 -177.41 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' C' C ' 76' ' ' LEU . . . . . 0.455 ' N ' HD12 ' C' ' 76' ' ' LEU . 7.0 mp -117.86 142.0 47.8 Favored 'General case' 0 C--N 1.332 -0.189 0 CA-C-N 115.683 -0.689 . . . . 0.0 109.468 176.147 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' C' C ' 77' ' ' GLU . . . . . . . . . . . . . 96.5 mt-10 -133.02 136.94 46.3 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-O 121.022 0.439 . . . . 0.0 111.259 -178.261 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' C' C ' 78' ' ' ALA . . . . . . . . . . . . . . . -126.84 135.44 51.0 Favored 'General case' 0 C--N 1.331 -0.225 0 CA-C-N 115.8 -0.636 . . . . 0.0 109.877 176.428 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' C' C ' 79' ' ' LYS . . . . . 0.477 ' O ' HD13 ' C' ' 80' ' ' ILE . 90.6 mttt -74.72 122.82 23.85 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-O 120.802 0.334 . . . . 0.0 110.553 -179.678 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' C' C ' 80' ' ' ILE . . . . . 0.477 HD13 ' O ' ' C' ' 79' ' ' LYS . 26.0 mm -139.16 113.36 7.27 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.306 0 N-CA-C 109.059 -0.719 . . . . 0.0 109.059 -178.47 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' C' C ' 81' ' ' LYS . . . . . . . . . . . . . 19.5 pttp -105.88 124.69 49.97 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-O 121.02 0.438 . . . . 0.0 111.363 -176.225 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' C' C ' 82' ' ' GLY . . . . . . . . . . . . . . . 88.99 42.09 5.73 Favored Glycine 0 CA--C 1.525 0.702 0 C-N-CA 120.73 -0.748 . . . . 0.0 111.75 173.152 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' C' C ' 83' ' ' ILE . . . . . . . . . . . . . 72.9 mt -65.75 136.14 27.2 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.311 0 CA-C-O 121.001 0.429 . . . . 0.0 110.081 178.668 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' C' C ' 84' ' ' LYS . . . . . . . . . . . . . 33.8 tttp -97.42 -53.54 3.43 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 115.824 -0.625 . . . . 0.0 110.128 -178.988 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' C' C ' 85' ' ' ASP . . . . . . . . . . . . . 12.7 t70 -153.99 153.16 31.48 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 115.596 -0.729 . . . . 0.0 110.251 179.569 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' C' C ' 86' ' ' VAL . . . . . . . . . . . . . 47.2 t -129.75 131.32 66.69 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.258 0 CA-C-O 121.003 0.43 . . . . 0.0 110.552 -179.312 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' C' C ' 87' ' ' ILE . . . . . . . . . . . . . 4.8 mp -119.92 127.28 75.88 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.236 0 CA-C-N 115.738 -0.664 . . . . 0.0 109.509 175.529 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' C' C ' 88' ' ' LEU . . . . . . . . . . . . . 11.0 tp -112.66 130.19 56.13 Favored 'General case' 0 C--N 1.331 -0.198 0 CA-C-O 120.994 0.425 . . . . 0.0 111.083 -177.144 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' C' C ' 89' ' ' ASP . . . . . . . . . . . . . 6.3 t70 -128.64 154.25 46.45 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 115.884 -0.598 . . . . 0.0 109.749 177.087 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' C' C ' 90' ' ' GLU . . . . . . . . . . . . . 81.4 tt0 -47.52 -41.41 20.95 Favored 'General case' 0 N--CA 1.464 0.229 0 N-CA-C 112.915 0.709 . . . . 0.0 112.915 -172.952 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' C' C ' 91' ' ' ASN . . . . . . . . . . . . . 19.7 m120 -121.54 16.79 11.25 Favored 'General case' 0 N--CA 1.467 0.401 0 N-CA-C 113.255 0.835 . . . . 0.0 113.255 -175.938 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' C' C ' 92' ' ' LEU . . . . . . . . . . . . . 55.2 mt -150.97 142.78 23.8 Favored 'General case' 0 C--N 1.332 -0.193 0 CA-C-O 120.818 0.342 . . . . 0.0 110.33 -177.096 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' C' C ' 93' ' ' ILE . . . . . . . . . . . . . 69.1 mt -123.28 115.41 45.45 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.32 0 N-CA-C 108.904 -0.776 . . . . 0.0 108.904 175.767 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' C' C ' 94' ' ' VAL . . . . . . . . . . . . . 45.2 t -116.58 123.9 72.11 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.308 0 CA-C-O 120.886 0.374 . . . . 0.0 110.085 -176.765 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' C' C ' 95' ' ' VAL . . . . . . . . . . . . . 42.2 t -121.04 131.92 71.79 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 CA-C-N 116.001 -0.545 . . . . 0.0 109.788 -179.815 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' C' C ' 96' ' ' ILE . . . . . 0.508 HD11 ' HB ' ' C' ' 123' ' ' VAL . 62.9 mt -112.94 127.16 70.33 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.284 0 N-CA-C 109.366 -0.605 . . . . 0.0 109.366 179.439 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' C' C ' 97' ' ' THR . . . . . . . . . . . . . 81.0 p -96.89 154.36 17.34 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-O 120.896 0.379 . . . . 0.0 110.733 -178.965 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' C' C ' 98' ' ' GLU . . . . . . . . . . . . . 97.3 mt-10 -53.91 -25.85 22.27 Favored 'General case' 0 C--N 1.328 -0.329 0 N-CA-C 112.335 0.495 . . . . 0.0 112.335 -179.722 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' C' C ' 99' ' ' GLU . . . . . . . . . . . . . 94.3 mt-10 -77.11 12.27 1.5 Allowed 'General case' 0 CA--C 1.537 0.466 0 N-CA-C 113.218 0.822 . . . . 0.0 113.218 -178.147 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' C' C ' 100' ' ' ASN . . . . . . . . . . . . . 4.0 m-20 65.08 32.81 10.03 Favored 'General case' 0 CA--C 1.531 0.248 0 CA-C-N 117.998 0.363 . . . . 0.0 111.68 178.242 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' C' C ' 101' ' ' GLU . . . . . . . . . . . . . 84.6 tt0 -112.26 143.48 43.27 Favored 'General case' 0 C--O 1.232 0.162 0 N-CA-C 109.457 -0.572 . . . . 0.0 109.457 173.149 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' C' C ' 102' ' ' VAL . . . . . . . . . . . . . 45.3 t -115.52 127.76 72.99 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.336 0 CA-C-O 120.886 0.374 . . . . 0.0 110.165 -177.591 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' C' C ' 103' ' ' LEU . . . . . . . . . . . . . 42.0 mt -114.8 127.42 55.72 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 115.489 -0.778 . . . . 0.0 109.874 176.518 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' C' C ' 104' ' ' ILE . . . . . 0.464 HD12 ' HB3' ' C' ' 113' ' ' TYR . 66.7 mt -116.48 118.52 59.05 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.292 0 N-CA-C 110.054 -0.351 . . . . 0.0 110.054 179.955 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' C' C ' 105' ' ' PHE . . . . . . . . . . . . . 63.8 m-85 -118.37 164.85 14.63 Favored 'General case' 0 C--N 1.333 -0.146 0 O-C-N 123.952 0.782 . . . . 0.0 110.523 179.613 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' C' C ' 106' ' ' ASN . . . . . . . . . . . . . 45.8 p-10 -97.96 -169.97 1.91 Allowed 'General case' 0 C--N 1.33 -0.28 0 N-CA-C 109.699 -0.482 . . . . 0.0 109.699 171.868 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' C' C ' 107' ' ' GLN . . . . . . . . . . . . . 58.7 tt0 -57.66 -29.11 64.35 Favored 'General case' 0 C--N 1.329 -0.291 0 N-CA-C 112.044 0.387 . . . . 0.0 112.044 -179.682 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' C' C ' 108' ' ' ASN . . . . . . . . . . . . . 50.8 t30 -90.4 14.08 13.85 Favored 'General case' 0 CA--C 1.534 0.329 0 N-CA-C 113.103 0.779 . . . . 0.0 113.103 -175.661 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' C' C ' 109' ' ' LEU . . . . . . . . . . . . . 59.9 mt 58.43 35.69 24.89 Favored 'General case' 0 CA--C 1.529 0.165 0 CA-C-O 120.775 0.321 . . . . 0.0 111.651 176.783 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' C' C ' 110' ' ' GLU . . . . . . . . . . . . . 95.4 mt-10 -101.78 152.85 20.38 Favored 'General case' 0 C--N 1.33 -0.254 0 N-CA-C 109.566 -0.531 . . . . 0.0 109.566 175.313 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' C' C ' 111' ' ' GLU . . . . . . . . . . . . . 44.0 tp10 -82.21 121.93 27.25 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-O 120.903 0.382 . . . . 0.0 110.954 -177.673 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' C' C ' 112' ' ' LEU . . . . . . . . . . . . . 17.6 mt -106.53 -45.94 4.12 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.006 -0.543 . . . . 0.0 110.147 177.319 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' C' C ' 113' ' ' TYR . . . . . 0.464 ' HB3' HD12 ' C' ' 104' ' ' ILE . 59.6 t80 -137.88 135.56 36.26 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.079 -0.51 . . . . 0.0 110.929 179.153 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' C' C ' 114' ' ' ARG . . . . . . . . . . . . . 41.1 ttm180 -135.7 119.82 17.67 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.027 -0.533 . . . . 0.0 110.038 177.474 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' C' C ' 115' ' ' GLY . . . . . . . . . . . . . . . -150.03 159.14 27.98 Favored Glycine 0 CA--C 1.525 0.664 0 N-CA-C 111.016 -0.834 . . . . 0.0 111.016 179.168 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' C' C ' 116' ' ' LYS . . . . . . . . . . . . . 69.4 tttt -131.15 130.32 42.91 Favored 'General case' 0 C--N 1.329 -0.316 0 N-CA-C 109.963 -0.384 . . . . 0.0 109.963 178.122 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' C' C ' 117' ' ' PHE . . . . . 0.422 ' CE2' HG21 ' C' ' 132' ' ' ILE . 41.7 m-85 -125.83 117.3 23.09 Favored 'General case' 0 C--N 1.331 -0.215 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.228 -175.271 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' C' C ' 118' ' ' GLU . . . . . . . . . . . . . 81.9 tt0 -51.94 -46.68 64.82 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.428 -0.351 . . . . 0.0 111.702 -176.422 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' C' C ' 119' ' ' ASN . . . . . . . . . . . . . 83.6 m-20 -101.47 31.26 3.82 Favored 'General case' 0 C--N 1.33 -0.239 0 N-CA-C 112.174 0.435 . . . . 0.0 112.174 -173.971 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' C' C ' 120' ' ' LEU . . . . . . . . . . . . . 13.8 tp -53.53 122.97 10.83 Favored 'General case' 0 N--CA 1.464 0.254 0 CA-C-O 120.832 0.349 . . . . 0.0 111.078 179.506 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' C' C ' 121' ' ' ASN . . . . . . . . . . . . . 9.9 t-20 -112.86 -44.07 3.35 Favored 'General case' 0 C--N 1.331 -0.199 0 CA-C-N 116.257 -0.429 . . . . 0.0 110.746 -177.507 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' C' C ' 122' ' ' LYS . . . . . . . . . . . . . 98.4 mttt -147.98 148.53 30.84 Favored 'General case' 0 C--N 1.332 -0.181 0 CA-C-O 121.061 0.458 . . . . 0.0 111.855 -178.593 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' C' C ' 123' ' ' VAL . . . . . 0.508 ' HB ' HD11 ' C' ' 96' ' ' ILE . 45.1 t -129.41 124.58 60.17 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.316 0 N-CA-C 109.175 -0.676 . . . . 0.0 109.175 173.278 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' C' C ' 124' ' ' LEU . . . . . . . . . . . . . 48.0 mt -129.55 143.79 50.98 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-O 120.946 0.403 . . . . 0.0 110.988 -176.175 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' C' C ' 125' ' ' VAL . . . . . . . . . . . . . 11.4 p -135.95 138.64 47.23 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.249 0 CA-C-N 115.881 -0.599 . . . . 0.0 110.235 178.752 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' C' C ' 126' ' ' ARG . . . . . . . . . . . . . 26.8 ttm180 -144.46 127.64 16.66 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-N 116.209 -0.45 . . . . 0.0 110.224 178.557 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' C' C ' 127' ' ' ASN . . . . . . . . . . . . . 80.7 m-20 53.16 -110.4 0.53 Allowed 'General case' 0 CA--C 1.545 0.772 0 CA-C-O 118.843 -0.599 . . . . 0.0 110.927 -179.402 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' C' C ' 128' ' ' ASP . . . . . . . . . . . . . 19.0 p-10 -114.2 5.64 15.96 Favored 'General case' 0 CA--C 1.536 0.416 0 CA-C-N 119.893 1.224 . . . . 0.0 113.384 -177.819 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' C' C ' 129' ' ' LEU . . . . . . . . . . . . . 58.4 mt -108.6 141.11 41.01 Favored 'General case' 0 C--N 1.334 -0.093 0 CA-C-N 118.133 0.424 . . . . 0.0 110.351 -179.185 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' C' C ' 130' ' ' VAL . . . . . 0.403 HG11 HD13 ' C' ' 104' ' ' ILE . 42.5 t -122.69 136.73 58.54 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.246 0 N-CA-C 109.884 -0.413 . . . . 0.0 109.884 -179.806 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' C' C ' 131' ' ' VAL . . . . . 0.447 HG22 HD12 ' C' ' 140' ' ' LEU . 44.3 t -134.63 135.14 53.88 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.214 0 CA-C-O 121.066 0.46 . . . . 0.0 110.342 -179.591 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' C' C ' 132' ' ' ILE . . . . . 0.422 HG21 ' CE2' ' C' ' 117' ' ' PHE . 68.9 mt -118.43 131.21 71.86 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.264 0 CA-C-N 115.753 -0.658 . . . . 0.0 109.371 178.854 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' C' C ' 133' ' ' ILE . . . . . . . . . . . . . 40.4 mm -116.07 122.77 70.33 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.237 0 CA-C-N 116.515 -0.311 . . . . 0.0 110.913 -175.301 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' C' C ' 134' ' ' ASP . . . . . . . . . . . . . 7.1 p-10 -133.62 148.74 51.58 Favored 'General case' 0 C--N 1.331 -0.224 0 N-CA-C 110.043 -0.354 . . . . 0.0 110.043 174.934 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' C' C ' 135' ' ' GLU . . . . . . . . . . . . . 81.3 tt0 -49.72 -25.11 2.69 Favored 'General case' 0 C--N 1.327 -0.384 0 N-CA-C 112.99 0.737 . . . . 0.0 112.99 -172.206 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' C' C ' 136' ' ' GLN . . . . . . . . . . . . . 63.1 tt0 -88.51 -37.52 15.69 Favored 'General case' 0 C--O 1.234 0.24 0 N-CA-C 112.111 0.411 . . . . 0.0 112.111 -175.656 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' C' C ' 137' ' ' LYS . . . . . . . . . . . . . 45.0 pttt -159.44 169.08 24.7 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-O 121.568 0.699 . . . . 0.0 112.252 -171.34 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' C' C ' 138' ' ' LEU . . . . . 0.449 HD23 ' C ' ' C' ' 138' ' ' LEU . 6.4 tt -116.33 126.43 53.51 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 114.942 -1.027 . . . . 0.0 109.829 178.362 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' C' C ' 139' ' ' THR . . . . . 0.411 ' N ' HD23 ' C' ' 138' ' ' LEU . 49.8 m -107.73 128.4 54.54 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.178 -0.464 . . . . 0.0 110.357 179.928 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' C' C ' 140' ' ' LEU . . . . . 0.447 HD12 HG22 ' C' ' 131' ' ' VAL . 9.5 tp -114.36 122.65 47.34 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 115.736 -0.665 . . . . 0.0 109.368 -178.748 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' C' C ' 141' ' ' ILE . . . . . . . . . . . . . 19.6 mt -120.18 124.57 72.9 Favored 'Isoleucine or valine' 0 C--O 1.234 0.238 0 CA-C-O 120.912 0.387 . . . . 0.0 110.034 -173.402 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' C' C ' 142' ' ' ARG . . . . . . . . . . . . . 64.9 mtt180 . . . . . 0 C--O 1.233 0.19 0 CA-C-N 115.574 -0.739 . . . . 0.0 110.05 -175.77 . . . . . . . . 0 0 . 1 . 010 nuclear build core ' D' D ' 2' ' ' SER . . . . . . . . . . . . . 99.1 p . . . . . 0 N--CA 1.462 0.149 0 CA-C-O 120.998 0.428 . . . . 0.0 110.761 . . . . . . . . . 0 0 . 1 . 010 nuclear build core ' D' D ' 3' ' ' GLU . . . . . . . . . . . . . 95.7 mt-10 -141.65 145.28 34.77 Favored 'General case' 0 C--N 1.331 -0.223 0 CA-C-N 116.031 -0.531 . . . . 0.0 111.246 -177.56 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' D' D ' 4' ' ' LEU . . . . . . . . . . . . . 15.4 tp -125.58 129.45 49.71 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-N 116.047 -0.524 . . . . 0.0 109.936 174.828 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' D' D ' 5' ' ' LYS . . . . . . . . . . . . . 52.4 mttm -110.63 123.63 50.37 Favored 'General case' 0 C--O 1.233 0.235 0 CA-C-O 120.71 0.291 . . . . 0.0 110.857 -179.248 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' D' D ' 6' ' ' LEU . . . . . . . . . . . . . 68.9 mt -116.63 144.57 44.24 Favored 'General case' 0 C--N 1.333 -0.148 0 CA-C-N 115.739 -0.664 . . . . 0.0 110.554 179.838 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' D' D ' 7' ' ' LYS . . . . . . . . . . . . . 55.3 tttm -126.93 141.84 41.79 Favored Pre-proline 0 CA--C 1.533 0.305 0 N-CA-C 109.704 -0.48 . . . . 0.0 109.704 175.293 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' D' D ' 8' ' ' PRO . . . . . . . . . . . . . 87.5 Cg_endo -91.4 144.15 3.17 Favored 'Trans proline' 0 N--CA 1.49 1.308 0 C-N-CA 121.645 1.563 . . . . 0.0 112.271 179.577 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' D' D ' 9' ' ' LEU . . . . . . . . . . . . . 49.6 mt -85.46 -47.17 0.61 Allowed Pre-proline 0 C--N 1.328 -0.334 0 CA-C-O 118.645 -0.693 . . . . 0.0 112.024 178.131 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' D' D ' 10' ' ' PRO . . . . . . . . . . . . . 86.4 Cg_endo -81.03 154.88 19.62 Favored 'Trans proline' 0 N--CA 1.495 1.605 0 C-N-CA 121.244 1.296 . . . . 0.0 111.8 175.956 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' D' D ' 11' ' ' LYS . . . . . . . . . . . . . 60.3 mttp -87.79 95.16 9.98 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-O 120.846 0.355 . . . . 0.0 110.654 178.824 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' D' D ' 12' ' ' VAL . . . . . . . . . . . . . 11.3 p -142.08 139.07 30.51 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.268 0 CA-C-N 116.133 -0.485 . . . . 0.0 110.303 178.691 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' D' D ' 13' ' ' GLU . . . . . . . . . . . . . 42.2 mp0 -82.5 127.15 33.04 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.311 -0.404 . . . . 0.0 110.06 178.313 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' D' D ' 14' ' ' LEU . . . . . . . . . . . . . 47.0 mt -93.68 149.69 37.53 Favored Pre-proline 0 C--N 1.329 -0.288 0 CA-C-O 119.207 -0.425 . . . . 0.0 110.27 -178.917 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' D' D ' 15' ' ' PRO . . . . . . . . . . . . . 25.6 Cg_exo -61.74 159.41 33.05 Favored 'Trans proline' 0 N--CA 1.497 1.7 0 C-N-CA 121.158 1.238 . . . . 0.0 111.381 177.007 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' D' D ' 16' ' ' PRO . . . . . . . . . . . . . 26.5 Cg_exo -60.78 -31.98 92.42 Favored 'Trans proline' 0 N--CA 1.497 1.731 0 C-N-CA 121.368 1.378 . . . . 0.0 112.362 -179.343 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' D' D ' 17' ' ' ASP . . . . . . . . . . . . . 10.2 p-10 -90.38 9.19 29.94 Favored 'General case' 0 CA--C 1.536 0.423 0 N-CA-C 113.166 0.802 . . . . 0.0 113.166 -178.506 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' D' D ' 18' ' ' PHE . . . . . . . . . . . . . 41.2 t80 -57.86 -46.73 84.38 Favored 'General case' 0 CA--C 1.522 -0.108 0 O-C-N 122.006 -0.434 . . . . 0.0 110.298 -176.915 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' D' D ' 19' ' ' VAL . . . . . . . . . . . . . 45.9 t -55.33 -44.25 74.67 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.259 0 CA-C-N 116.379 -0.373 . . . . 0.0 110.8 -177.555 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' D' D ' 20' ' ' ASP . . . . . . . . . . . . . 75.6 m-20 -59.87 -43.63 94.61 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-O 120.86 0.362 . . . . 0.0 110.965 -176.918 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' D' D ' 21' ' ' VAL . . . . . . . . . . . . . 48.9 t -64.62 -47.68 87.93 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.251 0 C-N-CA 120.817 -0.353 . . . . 0.0 110.54 -177.861 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' D' D ' 22' ' ' ILE . . . . . 0.544 HG22 HD12 ' D' ' 26' ' ' LEU . 47.1 mm -56.05 -44.4 78.47 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.282 0 CA-C-O 120.796 0.332 . . . . 0.0 110.557 179.3 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' D' D ' 23' ' ' ARG . . . . . . . . . . . . . 54.6 ttp180 -53.22 -52.29 59.4 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-O 120.848 0.356 . . . . 0.0 111.378 -179.662 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' D' D ' 24' ' ' ILE . . . . . . . . . . . . . 71.8 mt -59.08 -40.94 82.02 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.268 0 CA-C-N 116.232 -0.44 . . . . 0.0 111.404 -176.561 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' D' D ' 25' ' ' LYS . . . . . . . . . . . . . 55.8 mmtt -67.89 -39.88 83.57 Favored 'General case' 0 C--N 1.33 -0.279 0 N-CA-C 112.462 0.541 . . . . 0.0 112.462 -178.796 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' D' D ' 26' ' ' LEU . . . . . 0.544 HD12 HG22 ' D' ' 22' ' ' ILE . 76.2 mt -78.29 -39.29 40.31 Favored 'General case' 0 C--N 1.329 -0.284 0 N-CA-C 113.255 0.835 . . . . 0.0 113.255 -169.825 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' D' D ' 27' ' ' GLN . . . . . . . . . . . . . 16.8 pt20 -46.6 138.67 5.74 Favored 'General case' 0 N--CA 1.47 0.559 0 N-CA-C 112.742 0.645 . . . . 0.0 112.742 -175.81 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' D' D ' 28' ' ' GLY . . . . . . . . . . . . . . . 102.34 -26.3 24.71 Favored Glycine 0 CA--C 1.533 1.174 0 CA-C-N 115.638 -0.71 . . . . 0.0 112.297 -176.767 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' D' D ' 29' ' ' LYS . . . . . . . . . . . . . 61.5 mttm -98.45 155.19 17.37 Favored 'General case' 0 CA--C 1.528 0.105 0 CA-C-N 117.364 0.582 . . . . 0.0 111.045 178.191 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' D' D ' 30' ' ' THR . . . . . . . . . . . . . 55.5 m -107.2 138.72 42.87 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-N 116.155 -0.475 . . . . 0.0 109.906 175.937 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' D' D ' 31' ' ' VAL . . . . . . . . . . . . . 34.7 m -130.43 159.07 42.78 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.232 0 CA-C-O 120.817 0.341 . . . . 0.0 111.019 -178.016 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' D' D ' 32' ' ' ARG . . . . . . . . . . . . . 96.8 mtt180 -132.58 149.07 52.37 Favored 'General case' 0 C--N 1.332 -0.176 0 CA-C-N 115.934 -0.576 . . . . 0.0 110.662 178.65 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' D' D ' 33' ' ' THR . . . . . . . . . . . . . 18.7 m -52.96 140.4 24.93 Favored 'General case' 0 C--N 1.331 -0.23 0 CA-C-N 116.33 -0.396 . . . . 0.0 111.412 -179.387 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' D' D ' 34' ' ' GLY . . . . . . . . . . . . . . . 99.17 -17.1 58.48 Favored Glycine 0 CA--C 1.532 1.13 0 CA-C-O 119.62 -0.545 . . . . 0.0 113.274 179.335 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' D' D ' 35' ' ' ASP . . . . . . . . . . . . . 77.9 m-20 -66.61 148.9 51.26 Favored 'General case' 0 C--O 1.231 0.112 0 CA-C-N 118.037 0.919 . . . . 0.0 111.131 179.076 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' D' D ' 36' ' ' VAL . . . . . . . . . . . . . 45.5 t -119.56 128.7 75.88 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.213 0 CA-C-N 115.931 -0.577 . . . . 0.0 109.734 177.962 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' D' D ' 37' ' ' ILE . . . . . . . . . . . . . 63.3 mt -120.1 138.25 51.29 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.271 0 CA-C-N 116.158 -0.474 . . . . 0.0 109.83 -179.179 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' D' D ' 38' ' ' GLY . . . . . . . . . . . . . . . -118.38 128.86 7.91 Favored Glycine 0 CA--C 1.524 0.638 0 N-CA-C 111.058 -0.817 . . . . 0.0 111.058 -179.859 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' D' D ' 39' ' ' ILE . . . . . . . . . . . . . 68.0 mt -123.88 129.78 74.2 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.196 0 N-CA-C 110.026 -0.361 . . . . 0.0 110.026 178.808 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' D' D ' 40' ' ' SER . . . . . . . . . . . . . 20.3 t -92.09 117.42 29.82 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.142 -0.481 . . . . 0.0 110.734 176.453 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' D' D ' 41' ' ' ILE . . . . . . . . . . . . . 72.6 mt -131.95 122.56 49.43 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.232 0 CA-C-O 120.813 0.34 . . . . 0.0 110.095 178.376 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' D' D ' 42' ' ' LEU . . . . . . . . . . . . . 76.3 mt 58.3 34.9 24.48 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.023 -0.535 . . . . 0.0 111.506 179.012 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' D' D ' 43' ' ' GLY . . . . . . . . . . . . . . . 77.23 -10.15 22.8 Favored Glycine 0 CA--C 1.535 1.342 0 CA-C-O 119.785 -0.453 . . . . 0.0 113.427 178.123 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' D' D ' 44' ' ' LYS . . . . . . . . . . . . . 21.4 tptm -99.86 128.21 45.97 Favored 'General case' 0 C--N 1.332 -0.175 0 CA-C-N 117.915 0.858 . . . . 0.0 110.064 178.452 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' D' D ' 45' ' ' GLU . . . . . . . . . . . . . 85.0 tt0 -85.25 129.65 34.76 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.393 -0.367 . . . . 0.0 111.239 179.911 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' D' D ' 46' ' ' VAL . . . . . 0.423 HG13 ' O ' ' D' ' 46' ' ' VAL . 10.3 p -119.14 124.19 72.69 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.16 0 N-CA-C 109.654 -0.499 . . . . 0.0 109.654 174.82 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' D' D ' 47' ' ' LYS . . . . . . . . . . . . . 63.6 mttp -98.19 125.07 43.08 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.072 -0.513 . . . . 0.0 110.614 177.24 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' D' D ' 48' ' ' PHE . . . . . . . . . . . . . 40.0 m-85 -111.4 131.83 54.9 Favored 'General case' 0 C--N 1.329 -0.29 0 N-CA-C 109.481 -0.562 . . . . 0.0 109.481 176.985 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' D' D ' 49' ' ' LYS . . . . . . . . . . . . . 42.2 tttp -107.36 132.1 53.52 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.29 -0.413 . . . . 0.0 110.206 179.08 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' D' D ' 50' ' ' VAL . . . . . . . . . . . . . 41.9 t -74.86 105.03 3.59 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.289 0 N-CA-C 109.34 -0.615 . . . . 0.0 109.34 177.495 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' D' D ' 51' ' ' VAL . . . . . . . . . . . . . 51.4 t -72.3 -48.6 47.55 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.331 0 CA-C-N 116.182 -0.463 . . . . 0.0 109.996 -174.038 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' D' D ' 52' ' ' GLN . . . . . . . . . . . . . 60.2 tt0 -162.21 148.21 13.13 Favored 'General case' 0 C--N 1.329 -0.29 0 C-N-CA 120.242 -0.583 . . . . 0.0 111.757 -179.21 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' D' D ' 53' ' ' ALA . . . . . . . . . . . . . . . -126.33 134.47 51.09 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 115.597 -0.729 . . . . 0.0 110.117 177.892 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' D' D ' 54' ' ' TYR . . . . . . . . . . . . . 59.9 t80 -129.09 111.06 18.3 Favored Pre-proline 0 CA--C 1.535 0.376 0 CA-C-O 118.198 -0.906 . . . . 0.0 110.086 177.879 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' D' D ' 55' ' ' PRO . . . . . . . . . . . . . 72.5 Cg_endo -77.19 169.93 72.86 Favored 'Cis proline' 0 N--CA 1.5 1.887 0 CA-C-N 121.932 1.726 . . . . 0.0 112.643 -4.822 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' D' D ' 56' ' ' SER . . . . . . . . . . . . . 13.6 m -118.49 130.82 24.55 Favored Pre-proline 0 CA--C 1.539 0.545 0 CA-C-O 118.431 -0.795 . . . . 0.0 109.743 174.737 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' D' D ' 57' ' ' PRO . . . . . . . . . . . . . 32.9 Cg_endo -65.16 167.65 46.12 Favored 'Cis proline' 0 N--CA 1.498 1.753 0 CA-C-N 121.953 1.733 . . . . 0.0 111.147 -2.952 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' D' D ' 58' ' ' LEU . . . . . . . . . . . . . 14.9 tp -128.38 134.79 48.9 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-O 121.069 0.461 . . . . 0.0 110.255 -179.812 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' D' D ' 59' ' ' ARG . . . . . . . . . . . . . 58.6 ttt-85 -103.05 119.58 39.11 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 115.406 -0.815 . . . . 0.0 109.133 176.817 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' D' D ' 60' ' ' VAL . . . . . . . . . . . . . 40.6 t -74.17 117.07 17.57 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.315 0 C-N-CA 120.867 -0.333 . . . . 0.0 110.731 -172.939 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' D' D ' 61' ' ' GLU . . . . . . . . . . . . . 40.5 mt-10 -131.08 161.18 32.62 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 115.982 -0.554 . . . . 0.0 109.952 175.977 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' D' D ' 62' ' ' ASP . . . . . . . . . . . . . 61.6 m-20 -52.09 -31.43 30.44 Favored 'General case' 0 C--N 1.328 -0.33 0 N-CA-C 112.157 0.428 . . . . 0.0 112.157 -177.664 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' D' D ' 63' ' ' ARG . . . . . . . . . . . . . 78.3 mtp180 -72.58 -22.04 61.05 Favored 'General case' 0 CA--C 1.532 0.268 0 N-CA-C 113.091 0.775 . . . . 0.0 113.091 -174.607 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' D' D ' 64' ' ' THR . . . . . . . . . . . . . 34.5 m -71.2 140.39 50.45 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-O 120.888 0.375 . . . . 0.0 111.244 -175.118 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' D' D ' 65' ' ' LYS . . . . . . . . . . . . . 3.9 mptp? -90.06 138.76 31.24 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 115.85 -0.614 . . . . 0.0 110.261 178.196 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' D' D ' 66' ' ' ILE . . . . . . . . . . . . . 60.6 mt -114.1 128.25 71.15 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.231 0 N-CA-C 109.658 -0.497 . . . . 0.0 109.658 178.754 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' D' D ' 67' ' ' THR . . . . . . . . . . . . . 15.5 m -122.35 146.71 47.07 Favored 'General case' 0 C--N 1.332 -0.159 0 CA-C-O 121.233 0.54 . . . . 0.0 111.133 -176.253 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' D' D ' 68' ' ' LEU . . . . . . . . . . . . . 15.1 tp . . . . . 0 C--N 1.33 -0.268 0 CA-C-N 115.647 -0.706 . . . . 0.0 110.765 -179.467 . . . . . . . . 0 0 . 1 . 010 nuclear build core ' D' D ' 73' ' ' VAL . . . . . . . . . . . . . 33.5 m . . . . . 0 C--O 1.232 0.134 0 N-CA-C 110.124 -0.324 . . . . 0.0 110.124 . . . . . . . . . 0 0 . 1 . 010 nuclear build core ' D' D ' 74' ' ' ASP . . . . . . . . . . . . . 22.4 t0 -84.56 118.36 24.29 Favored 'General case' 0 C--N 1.33 -0.258 0 C-N-CA 120.601 -0.44 . . . . 0.0 110.295 -172.538 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' D' D ' 75' ' ' VAL . . . . . . . . . . . . . 39.4 t -122.22 121.93 65.15 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.271 0 CA-C-O 120.961 0.41 . . . . 0.0 110.659 -176.948 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' D' D ' 76' ' ' LEU . . . . . . . . . . . . . 5.8 mp -122.03 149.13 43.94 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 115.735 -0.666 . . . . 0.0 109.39 174.861 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' D' D ' 77' ' ' GLU . . . . . . . . . . . . . 96.5 mt-10 -136.68 137.12 39.67 Favored 'General case' 0 C--N 1.332 -0.189 0 CA-C-O 121.16 0.505 . . . . 0.0 111.516 -176.644 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' D' D ' 78' ' ' ALA . . . . . . . . . . . . . . . -123.58 135.37 53.94 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 115.587 -0.733 . . . . 0.0 109.414 175.156 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' D' D ' 79' ' ' LYS . . . . . 0.597 ' O ' HD13 ' D' ' 80' ' ' ILE . 59.4 mtpt -82.73 120.63 25.84 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-O 120.907 0.384 . . . . 0.0 111.129 -176.42 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' D' D ' 80' ' ' ILE . . . . . 0.597 HD13 ' O ' ' D' ' 79' ' ' LYS . 40.2 mm -139.19 105.8 2.63 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.305 0 N-CA-C 109.103 -0.703 . . . . 0.0 109.103 -178.769 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' D' D ' 81' ' ' LYS . . . . . . . . . . . . . 19.2 pttp -98.14 128.69 44.77 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-O 120.869 0.366 . . . . 0.0 111.225 -176.544 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' D' D ' 82' ' ' GLY . . . . . . . . . . . . . . . 89.21 41.99 5.69 Favored Glycine 0 CA--C 1.524 0.651 0 C-N-CA 120.685 -0.769 . . . . 0.0 111.52 176.2 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' D' D ' 83' ' ' ILE . . . . . . . . . . . . . 71.7 mt -65.3 139.25 21.67 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.328 0 CA-C-O 121.009 0.433 . . . . 0.0 110.046 178.86 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' D' D ' 84' ' ' LYS . . . . . . . . . . . . . 59.5 tttm -99.17 -53.93 3.11 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 115.89 -0.595 . . . . 0.0 109.906 -179.609 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' D' D ' 85' ' ' ASP . . . . . . . . . . . . . 13.4 t70 -156.7 150.11 24.37 Favored 'General case' 0 C--N 1.326 -0.42 0 CA-C-N 115.646 -0.706 . . . . 0.0 110.187 -179.991 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' D' D ' 86' ' ' VAL . . . . . . . . . . . . . 42.8 t -128.41 128.74 68.6 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.279 0 CA-C-O 120.93 0.395 . . . . 0.0 110.41 -179.227 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' D' D ' 87' ' ' ILE . . . . . . . . . . . . . 44.1 mm -118.08 127.63 75.26 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.284 0 CA-C-N 115.824 -0.626 . . . . 0.0 109.488 176.679 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' D' D ' 88' ' ' LEU . . . . . . . . . . . . . 18.7 tp -112.74 133.65 54.65 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-O 121.137 0.494 . . . . 0.0 111.123 -177.64 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' D' D ' 89' ' ' ASP . . . . . . . . . . . . . 10.7 t70 -125.35 158.51 34.07 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 115.587 -0.733 . . . . 0.0 109.431 176.256 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' D' D ' 90' ' ' GLU . . . . . . . . . . . . . 96.0 mt-10 -46.74 -37.74 8.96 Favored 'General case' 0 C--N 1.331 -0.237 0 N-CA-C 113.17 0.804 . . . . 0.0 113.17 -172.138 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' D' D ' 91' ' ' ASN . . . . . . . . . . . . . 4.7 p-10 -132.04 23.35 4.54 Favored 'General case' 0 N--CA 1.467 0.413 0 N-CA-C 112.815 0.672 . . . . 0.0 112.815 -177.747 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' D' D ' 92' ' ' LEU . . . . . . . . . . . . . 16.5 mt -148.97 144.45 26.79 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-O 120.858 0.361 . . . . 0.0 110.56 -176.522 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' D' D ' 93' ' ' ILE . . . . . . . . . . . . . 71.4 mt -122.6 115.31 45.61 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.316 0 N-CA-C 109.224 -0.658 . . . . 0.0 109.224 176.728 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' D' D ' 94' ' ' VAL . . . . . . . . . . . . . 44.9 t -117.06 123.0 71.31 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.267 0 N-CA-C 109.867 -0.42 . . . . 0.0 109.867 -178.932 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' D' D ' 95' ' ' VAL . . . . . . . . . . . . . 42.0 t -120.18 133.75 65.89 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.236 0 CA-C-N 116.021 -0.536 . . . . 0.0 110.025 -178.039 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' D' D ' 96' ' ' ILE . . . . . . . . . . . . . 56.1 mt -113.88 130.76 67.46 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 N-CA-C 109.124 -0.695 . . . . 0.0 109.124 177.145 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' D' D ' 97' ' ' THR . . . . . . . . . . . . . 68.6 p -103.48 157.18 17.21 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-O 120.872 0.368 . . . . 0.0 110.988 -178.638 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' D' D ' 98' ' ' GLU . . . . . . . . . . . . . 97.4 mt-10 -53.89 -22.89 10.96 Favored 'General case' 0 CA--C 1.535 0.375 0 N-CA-C 112.307 0.484 . . . . 0.0 112.307 179.121 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' D' D ' 99' ' ' GLU . . . . . . . . . . . . . 95.6 mt-10 -77.49 12.55 1.54 Allowed 'General case' 0 CA--C 1.536 0.441 0 N-CA-C 113.208 0.818 . . . . 0.0 113.208 -178.714 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' D' D ' 100' ' ' ASN . . . . . . . . . . . . . 3.0 m-20 61.85 37.46 15.36 Favored 'General case' 0 CA--C 1.531 0.217 0 CA-C-O 121.023 0.439 . . . . 0.0 110.979 179.833 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' D' D ' 101' ' ' GLU . . . . . . . . . . . . . 85.4 tt0 -116.84 145.63 43.43 Favored 'General case' 0 C--N 1.333 -0.137 0 CA-C-N 116.086 -0.506 . . . . 0.0 109.886 176.239 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' D' D ' 102' ' ' VAL . . . . . . . . . . . . . 42.9 t -117.64 127.1 75.07 Favored 'Isoleucine or valine' 0 C--O 1.233 0.224 0 CA-C-N 116.277 -0.42 . . . . 0.0 109.929 -178.284 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' D' D ' 103' ' ' LEU . . . . . . . . . . . . . 63.0 mt -119.57 134.61 55.15 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 115.991 -0.549 . . . . 0.0 110.511 178.058 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' D' D ' 104' ' ' ILE . . . . . . . . . . . . . 66.1 mt -120.99 120.18 61.52 Favored 'Isoleucine or valine' 0 C--O 1.234 0.252 0 CA-C-N 116.567 -0.288 . . . . 0.0 110.513 -179.09 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' D' D ' 105' ' ' PHE . . . . . . . . . . . . . 54.2 m-85 -120.53 167.71 12.11 Favored 'General case' 0 N--CA 1.462 0.146 0 O-C-N 124.066 0.854 . . . . 0.0 109.829 177.707 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' D' D ' 106' ' ' ASN . . . . . . . . . . . . . 47.5 p-10 -104.04 -170.39 1.77 Allowed 'General case' 0 CA--C 1.532 0.264 0 N-CA-C 110.221 -0.288 . . . . 0.0 110.221 173.091 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' D' D ' 107' ' ' GLN . . . . . . . . . . . . . 61.7 tt0 -57.75 -29.85 65.12 Favored 'General case' 0 CA--C 1.532 0.286 0 N-CA-C 111.97 0.359 . . . . 0.0 111.97 178.987 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' D' D ' 108' ' ' ASN . . . . . . . . . . . . . 10.2 t-20 -86.52 12.7 9.81 Favored 'General case' 0 CA--C 1.535 0.367 0 N-CA-C 112.922 0.712 . . . . 0.0 112.922 -176.681 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' D' D ' 109' ' ' LEU . . . . . . . . . . . . . 26.4 mt 56.76 32.34 21.06 Favored 'General case' 0 CA--C 1.53 0.211 0 N-CA-C 111.75 0.278 . . . . 0.0 111.75 179.356 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' D' D ' 110' ' ' GLU . . . . . . . . . . . . . 69.3 mm-40 -98.27 143.38 28.81 Favored 'General case' 0 C--N 1.33 -0.28 0 N-CA-C 109.258 -0.645 . . . . 0.0 109.258 175.372 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' D' D ' 111' ' ' GLU . . . . . . . . . . . . . 58.9 tt0 -83.33 121.88 27.72 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-O 121.082 0.467 . . . . 0.0 110.344 -177.162 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' D' D ' 112' ' ' LEU . . . . . . . . . . . . . 23.7 mt -104.31 -45.83 4.57 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 115.816 -0.629 . . . . 0.0 110.413 -178.759 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' D' D ' 113' ' ' TYR . . . . . . . . . . . . . 61.1 t80 -140.39 140.75 35.56 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.096 -0.502 . . . . 0.0 111.008 -178.361 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' D' D ' 114' ' ' ARG . . . . . . . . . . . . . 35.6 ptt-85 -142.21 125.41 16.41 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.305 -0.407 . . . . 0.0 110.489 176.427 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' D' D ' 115' ' ' GLY . . . . . . . . . . . . . . . -150.14 159.79 28.26 Favored Glycine 0 CA--C 1.522 0.522 0 N-CA-C 110.691 -0.964 . . . . 0.0 110.691 179.203 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' D' D ' 116' ' ' LYS . . . . . . . . . . . . . 2.1 ttmp? -127.84 138.95 52.88 Favored 'General case' 0 C--N 1.329 -0.312 0 N-CA-C 110.027 -0.361 . . . . 0.0 110.027 177.566 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' D' D ' 117' ' ' PHE . . . . . . . . . . . . . 43.8 m-85 -135.68 113.89 11.43 Favored 'General case' 0 C--N 1.331 -0.23 0 CA-C-N 116.207 -0.451 . . . . 0.0 109.895 -177.032 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' D' D ' 118' ' ' GLU . . . . . . . . . . . . . 70.8 mm-40 -54.69 -42.66 71.68 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.448 -0.342 . . . . 0.0 111.294 -176.3 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' D' D ' 119' ' ' ASN . . . . . . . . . . . . . 19.9 m120 -100.94 31.03 3.75 Favored 'General case' 0 C--N 1.331 -0.227 0 N-CA-C 112.188 0.44 . . . . 0.0 112.188 -174.287 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' D' D ' 120' ' ' LEU . . . . . . . . . . . . . 16.3 tp -56.96 121.1 9.14 Favored 'General case' 0 N--CA 1.462 0.167 0 C-N-CA 121.009 -0.276 . . . . 0.0 110.345 177.727 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' D' D ' 121' ' ' ASN . . . . . . . . . . . . . 60.5 m-20 -114.2 -44.06 3.16 Favored 'General case' 0 C--N 1.332 -0.154 0 CA-C-N 116.678 -0.237 . . . . 0.0 111.26 -176.898 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' D' D ' 122' ' ' LYS . . . . . 0.446 ' HE3' HD11 ' D' ' 124' ' ' LEU . 39.0 ttpt -144.82 143.12 30.47 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-O 120.953 0.406 . . . . 0.0 111.343 -175.976 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' D' D ' 123' ' ' VAL . . . . . . . . . . . . . 43.6 t -128.77 134.23 64.8 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.219 0 CA-C-N 116.172 -0.467 . . . . 0.0 109.762 177.18 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' D' D ' 124' ' ' LEU . . . . . 0.446 HD11 ' HE3' ' D' ' 122' ' ' LYS . 59.0 mt -129.51 135.27 48.41 Favored 'General case' 0 C--N 1.331 -0.196 0 CA-C-O 120.815 0.341 . . . . 0.0 110.949 -179.048 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' D' D ' 125' ' ' VAL . . . . . . . . . . . . . 10.6 p -132.33 131.12 60.67 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.274 0 CA-C-N 116.11 -0.496 . . . . 0.0 109.958 177.526 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' D' D ' 126' ' ' ARG . . . . . . . . . . . . . 53.8 ttm-85 -143.08 116.04 8.83 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.462 -0.335 . . . . 0.0 110.815 -178.72 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' D' D ' 127' ' ' ASN . . . . . . . . . . . . . 3.1 m120 51.97 -105.0 0.2 Allowed 'General case' 0 CA--C 1.544 0.721 0 CA-C-O 119.172 -0.442 . . . . 0.0 111.323 178.214 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' D' D ' 128' ' ' ASP . . . . . . . . . . . . . 19.1 p-10 -113.9 3.95 15.62 Favored 'General case' 0 CA--C 1.538 0.496 0 CA-C-N 119.42 1.009 . . . . 0.0 113.426 -176.208 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' D' D ' 129' ' ' LEU . . . . . . . . . . . . . 21.6 tp -110.43 137.01 48.71 Favored 'General case' 0 C--N 1.331 -0.222 0 CA-C-N 118.047 0.385 . . . . 0.0 110.05 178.857 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' D' D ' 130' ' ' VAL . . . . . . . . . . . . . 54.6 t -124.99 137.25 58.2 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.284 0 CA-C-O 120.833 0.349 . . . . 0.0 110.15 -179.475 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' D' D ' 131' ' ' VAL . . . . . . . . . . . . . 42.9 t -135.98 136.27 49.84 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.274 0 CA-C-N 116.271 -0.422 . . . . 0.0 110.363 179.698 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' D' D ' 132' ' ' ILE . . . . . . . . . . . . . 74.1 mt -119.33 133.37 66.35 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.298 0 N-CA-C 109.52 -0.548 . . . . 0.0 109.52 178.784 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' D' D ' 133' ' ' ILE . . . . . . . . . . . . . 40.4 mm -119.12 124.3 72.88 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.223 0 CA-C-O 120.829 0.347 . . . . 0.0 111.315 -174.831 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' D' D ' 134' ' ' ASP . . . . . . . . . . . . . 9.7 p-10 -137.68 150.1 47.07 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-N 116.307 -0.406 . . . . 0.0 109.932 173.637 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' D' D ' 135' ' ' GLU . . . . . . . . . . . . . 86.0 tt0 -49.77 -22.93 1.57 Allowed 'General case' 0 C--N 1.328 -0.359 0 N-CA-C 113.067 0.765 . . . . 0.0 113.067 -174.21 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' D' D ' 136' ' ' GLN . . . . . . . . . . . . . 63.1 tt0 -93.16 -28.76 16.11 Favored 'General case' 0 C--O 1.234 0.265 0 N-CA-C 112.384 0.512 . . . . 0.0 112.384 -174.004 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' D' D ' 137' ' ' LYS . . . . . . . . . . . . . 47.7 pttt -166.04 170.58 13.4 Favored 'General case' 0 C--N 1.332 -0.185 0 CA-C-O 121.55 0.69 . . . . 0.0 112.317 -172.849 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' D' D ' 138' ' ' LEU . . . . . 0.406 HD23 ' N ' ' D' ' 139' ' ' THR . 5.6 tt -121.96 128.61 51.7 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 114.882 -1.053 . . . . 0.0 109.836 178.797 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' D' D ' 139' ' ' THR . . . . . 0.406 ' N ' HD23 ' D' ' 138' ' ' LEU . 26.4 m -109.69 132.65 53.95 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-N 116.198 -0.455 . . . . 0.0 110.629 -179.254 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' D' D ' 140' ' ' LEU . . . . . 0.464 HD21 ' O ' ' E' ' 107' ' ' GLN . 12.1 tp -118.58 124.14 46.74 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 115.583 -0.735 . . . . 0.0 109.381 -178.425 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' D' D ' 141' ' ' ILE . . . . . . . . . . . . . 19.6 mt -120.48 119.62 60.32 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.344 0 N-CA-C 109.87 -0.418 . . . . 0.0 109.87 -175.795 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' D' D ' 142' ' ' ARG . . . . . . . . . . . . . 7.8 mmm180 -109.03 126.13 52.81 Favored 'General case' 0 C--N 1.331 -0.227 0 CA-C-N 115.496 -0.775 . . . . 0.0 110.508 -177.857 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' D' D ' 143' ' ' THR . . . . . . . . . . . . . 49.5 p . . . . . 0 C--O 1.219 -0.501 0 CA-C-O 117.998 -1.001 . . . . 0.0 110.627 -179.864 . . . . . . . . 0 0 . 1 . 010 nuclear build core ' E' E ' 2' ' ' SER . . . . . . . . . . . . . 94.5 p . . . . . 0 C--O 1.233 0.19 0 CA-C-O 121.106 0.479 . . . . 0.0 110.637 . . . . . . . . . 0 0 . 1 . 010 nuclear build core ' E' E ' 3' ' ' GLU . . . . . . . . . . . . . 82.4 tt0 -140.63 143.99 35.49 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 115.935 -0.575 . . . . 0.0 110.851 -177.842 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' E' E ' 4' ' ' LEU . . . . . . . . . . . . . 20.6 tp -124.86 130.87 53.24 Favored 'General case' 0 C--N 1.331 -0.216 0 CA-C-N 116.016 -0.538 . . . . 0.0 110.176 177.673 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' E' E ' 5' ' ' LYS . . . . . . . . . . . . . 61.3 mttp -108.44 121.84 45.78 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-O 120.876 0.37 . . . . 0.0 110.616 178.856 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' E' E ' 6' ' ' LEU . . . . . . . . . . . . . 67.2 mt -114.05 150.21 34.31 Favored 'General case' 0 C--N 1.331 -0.217 0 CA-C-N 115.548 -0.751 . . . . 0.0 110.702 -179.982 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' E' E ' 7' ' ' LYS . . . . . . . . . . . . . 84.6 tttt -140.46 140.11 22.06 Favored Pre-proline 0 CA--C 1.534 0.354 0 CA-C-O 119.09 -0.481 . . . . 0.0 110.02 175.189 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' E' E ' 8' ' ' PRO . . . . . . . . . . . . . 95.2 Cg_endo -92.01 143.7 2.76 Favored 'Trans proline' 0 N--CA 1.49 1.315 0 C-N-CA 121.765 1.643 . . . . 0.0 111.73 177.593 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' E' E ' 9' ' ' LEU . . . . . . . . . . . . . 60.7 mt -78.36 -47.51 1.99 Allowed Pre-proline 0 CA--C 1.533 0.298 0 CA-C-O 118.715 -0.66 . . . . 0.0 112.242 -179.257 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' E' E ' 10' ' ' PRO . . . . . . . . . . . . . 92.9 Cg_endo -80.36 153.84 21.26 Favored 'Trans proline' 0 N--CA 1.496 1.63 0 C-N-CA 121.067 1.178 . . . . 0.0 111.904 176.129 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' E' E ' 11' ' ' LYS . . . . . . . . . . . . . 55.7 mtmt -88.35 98.95 11.89 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.376 -0.374 . . . . 0.0 110.604 179.312 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' E' E ' 12' ' ' VAL . . . . . . . . . . . . . 11.2 p -145.06 144.04 21.91 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.294 0 CA-C-N 116.111 -0.495 . . . . 0.0 110.357 -179.718 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' E' E ' 13' ' ' GLU . . . . . . . . . . . . . 95.4 mt-10 -85.02 121.51 27.9 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.176 -0.465 . . . . 0.0 109.972 177.774 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' E' E ' 14' ' ' LEU . . . . . . . . . . . . . 20.0 mt -93.62 156.5 39.58 Favored Pre-proline 0 C--N 1.329 -0.323 0 CA-C-N 116.349 -0.387 . . . . 0.0 110.784 -177.188 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' E' E ' 15' ' ' PRO . . . . . . . . . . . . . 27.0 Cg_exo -60.73 155.07 50.8 Favored 'Trans proline' 0 N--CA 1.496 1.625 0 C-N-CA 121.354 1.369 . . . . 0.0 111.764 179.614 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' E' E ' 16' ' ' PRO . . . . . . . . . . . . . 32.3 Cg_exo -57.63 -36.48 98.51 Favored 'Trans proline' 0 N--CA 1.497 1.689 0 C-N-CA 121.328 1.352 . . . . 0.0 112.572 179.598 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' E' E ' 17' ' ' ASP . . . . . . . . . . . . . 8.8 p-10 -88.74 13.78 11.65 Favored 'General case' 0 CA--C 1.535 0.389 0 N-CA-C 113.027 0.751 . . . . 0.0 113.027 -177.74 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' E' E ' 18' ' ' PHE . . . . . . . . . . . . . 40.8 t80 -58.43 -44.37 89.08 Favored 'General case' 0 C--N 1.333 -0.134 0 O-C-N 121.968 -0.457 . . . . 0.0 110.198 -178.599 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' E' E ' 19' ' ' VAL . . . . . 0.44 HG13 ' N ' ' E' ' 20' ' ' ASP . 14.4 p -58.42 -46.42 89.46 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.354 0 CA-C-N 116.459 -0.337 . . . . 0.0 111.807 -174.83 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' E' E ' 20' ' ' ASP . . . . . 0.44 ' N ' HG13 ' E' ' 19' ' ' VAL . 2.7 p-10 -64.75 -36.17 83.44 Favored 'General case' 0 N--CA 1.463 0.224 0 C-N-CA 120.655 -0.418 . . . . 0.0 111.169 -177.383 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' E' E ' 21' ' ' VAL . . . . . . . . . . . . . 48.2 t -63.95 -48.19 87.2 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.217 0 C-N-CA 120.632 -0.427 . . . . 0.0 110.193 179.374 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' E' E ' 22' ' ' ILE . . . . . 0.483 HG22 HD12 ' E' ' 26' ' ' LEU . 51.0 mm -56.17 -43.09 75.15 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.216 0 C-N-CA 121.019 -0.272 . . . . 0.0 110.416 177.321 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' E' E ' 23' ' ' ARG . . . . . . . . . . . . . 43.2 ttp180 -52.1 -51.11 59.84 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-O 120.723 0.297 . . . . 0.0 111.498 -179.457 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' E' E ' 24' ' ' ILE . . . . . . . . . . . . . 70.3 mt -59.78 -41.69 86.4 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.256 0 CA-C-N 116.471 -0.331 . . . . 0.0 110.963 -179.047 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' E' E ' 25' ' ' LYS . . . . . . . . . . . . . 60.6 mtpt -62.98 -41.85 99.68 Favored 'General case' 0 C--N 1.327 -0.388 0 N-CA-C 112.076 0.399 . . . . 0.0 112.076 -178.598 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' E' E ' 26' ' ' LEU . . . . . 0.483 HD12 HG22 ' E' ' 22' ' ' ILE . 72.4 mt -80.42 -39.65 27.88 Favored 'General case' 0 C--N 1.33 -0.256 0 N-CA-C 113.27 0.841 . . . . 0.0 113.27 -170.916 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' E' E ' 27' ' ' GLN . . . . . . . . . . . . . 11.5 pt20 -46.59 135.08 8.93 Favored 'General case' 0 N--CA 1.468 0.462 0 N-CA-C 113.003 0.742 . . . . 0.0 113.003 -174.768 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' E' E ' 28' ' ' GLY . . . . . . . . . . . . . . . 100.44 -21.79 42.68 Favored Glycine 0 CA--C 1.534 1.251 0 CA-C-N 115.523 -0.762 . . . . 0.0 112.719 -178.416 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' E' E ' 29' ' ' LYS . . . . . . . . . . . . . 65.6 mttm -98.79 155.12 17.52 Favored 'General case' 0 C--O 1.232 0.177 0 CA-C-N 117.512 0.656 . . . . 0.0 111.29 -179.767 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' E' E ' 30' ' ' THR . . . . . . . . . . . . . 38.1 m -104.07 133.64 48.66 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 115.901 -0.591 . . . . 0.0 109.73 175.223 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' E' E ' 31' ' ' VAL . . . . . . . . . . . . . 33.6 m -131.72 154.91 41.14 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.211 0 CA-C-O 121.03 0.443 . . . . 0.0 111.343 -176.984 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' E' E ' 32' ' ' ARG . . . . . . . . . . . . . 55.7 mtp180 -132.25 152.33 51.4 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 115.771 -0.65 . . . . 0.0 110.436 177.553 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' E' E ' 33' ' ' THR . . . . . . . . . . . . . 20.5 m -53.18 139.68 28.36 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.271 -0.422 . . . . 0.0 111.322 -179.121 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' E' E ' 34' ' ' GLY . . . . . . . . . . . . . . . 100.82 -17.28 56.61 Favored Glycine 0 CA--C 1.532 1.126 0 CA-C-O 119.608 -0.551 . . . . 0.0 113.279 179.709 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' E' E ' 35' ' ' ASP . . . . . . . . . . . . . 66.7 m-20 -65.93 149.58 49.99 Favored 'General case' 0 C--O 1.231 0.131 0 CA-C-N 118.036 0.918 . . . . 0.0 110.998 179.059 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' E' E ' 36' ' ' VAL . . . . . . . . . . . . . 46.4 t -122.1 131.75 72.48 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.196 0 CA-C-N 115.911 -0.586 . . . . 0.0 110.134 179.825 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' E' E ' 37' ' ' ILE . . . . . . . . . . . . . 67.7 mt -119.92 139.02 48.62 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.245 0 CA-C-N 116.086 -0.506 . . . . 0.0 109.797 178.637 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' E' E ' 38' ' ' GLY . . . . . . . . . . . . . . . -113.48 128.99 8.6 Favored Glycine 0 CA--C 1.526 0.741 0 N-CA-C 111.139 -0.784 . . . . 0.0 111.139 -179.614 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' E' E ' 39' ' ' ILE . . . . . . . . . . . . . 72.1 mt -123.43 135.78 62.15 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.186 0 N-CA-C 110.015 -0.365 . . . . 0.0 110.015 178.656 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' E' E ' 40' ' ' SER . . . . . . . . . . . . . 30.0 t -92.67 123.02 35.65 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.225 -0.443 . . . . 0.0 110.835 175.8 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' E' E ' 41' ' ' ILE . . . . . . . . . . . . . 71.4 mt -131.34 114.57 26.36 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.214 0 N-CA-C 110.08 -0.341 . . . . 0.0 110.08 177.69 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' E' E ' 42' ' ' LEU . . . . . . . . . . . . . 84.4 mt 58.11 33.28 23.01 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.038 -0.528 . . . . 0.0 111.797 178.893 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' E' E ' 43' ' ' GLY . . . . . . . . . . . . . . . 83.24 -10.18 59.18 Favored Glycine 0 CA--C 1.535 1.283 0 C-N-CA 121.156 -0.545 . . . . 0.0 113.497 177.018 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' E' E ' 44' ' ' LYS . . . . . . . . . . . . . 64.6 mttp -98.46 136.18 38.96 Favored 'General case' 0 C--N 1.333 -0.115 0 CA-C-N 117.892 0.846 . . . . 0.0 110.271 177.785 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' E' E ' 45' ' ' GLU . . . . . . . . . . . . . 84.3 tt0 -85.26 128.87 34.85 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-N 116.464 -0.334 . . . . 0.0 111.373 179.946 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' E' E ' 46' ' ' VAL . . . . . . . . . . . . . 7.4 p -121.8 126.33 74.47 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.18 0 N-CA-C 109.457 -0.571 . . . . 0.0 109.457 174.697 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' E' E ' 47' ' ' LYS . . . . . . . . . . . . . 61.6 mttm -100.06 129.18 46.08 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-N 116.052 -0.522 . . . . 0.0 111.162 179.004 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' E' E ' 48' ' ' PHE . . . . . . . . . . . . . 92.6 m-85 -111.43 131.93 54.83 Favored 'General case' 0 C--N 1.332 -0.182 0 CA-C-N 116.28 -0.418 . . . . 0.0 109.954 176.28 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' E' E ' 49' ' ' LYS . . . . . . . . . . . . . 54.8 tttp -107.68 137.17 46.17 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.464 -0.335 . . . . 0.0 110.564 179.368 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' E' E ' 50' ' ' VAL . . . . . . . . . . . . . 45.6 t -79.92 108.25 13.2 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.25 0 N-CA-C 109.258 -0.645 . . . . 0.0 109.258 174.894 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' E' E ' 51' ' ' VAL . . . . . . . . . . . . . 48.7 t -71.46 -47.62 57.74 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.326 0 CA-C-N 116.223 -0.444 . . . . 0.0 110.004 -173.795 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' E' E ' 52' ' ' GLN . . . . . . . . . . . . . 62.3 tt0 -166.13 143.83 5.45 Favored 'General case' 0 C--N 1.329 -0.307 0 C-N-CA 120.441 -0.504 . . . . 0.0 111.847 -178.952 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' E' E ' 53' ' ' ALA . . . . . . . . . . . . . . . -119.66 134.11 55.36 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 115.915 -0.584 . . . . 0.0 109.774 175.599 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' E' E ' 54' ' ' TYR . . . . . . . . . . . . . 10.9 t80 -129.1 112.33 18.42 Favored Pre-proline 0 CA--C 1.534 0.348 0 CA-C-O 118.191 -0.909 . . . . 0.0 110.028 177.917 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' E' E ' 55' ' ' PRO . . . . . . . . . . . . . 71.7 Cg_endo -77.2 170.17 72.2 Favored 'Cis proline' 0 N--CA 1.5 1.911 0 CA-C-N 122.002 1.751 . . . . 0.0 112.527 -5.94 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' E' E ' 56' ' ' SER . . . . . . . . . . . . . 15.8 m -123.47 139.02 31.12 Favored Pre-proline 0 CA--C 1.539 0.545 0 CA-C-O 118.553 -0.737 . . . . 0.0 109.443 174.06 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' E' E ' 57' ' ' PRO . . . . . . . . . . . . . 37.6 Cg_endo -67.45 145.2 73.48 Favored 'Cis proline' 0 N--CA 1.498 1.773 0 CA-C-N 121.616 1.613 . . . . 0.0 111.53 -3.128 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' E' E ' 58' ' ' LEU . . . . . . . . . . . . . 16.2 tp -107.99 139.05 43.19 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-O 120.999 0.428 . . . . 0.0 110.837 -177.331 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' E' E ' 59' ' ' ARG . . . . . . . . . . . . . 21.3 ttm180 -102.45 122.54 44.52 Favored 'General case' 0 C--N 1.327 -0.389 0 N-CA-C 108.985 -0.746 . . . . 0.0 108.985 173.393 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' E' E ' 60' ' ' VAL . . . . . . . . . . . . . 45.6 t -81.55 119.17 30.62 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.35 0 C-N-CA 120.689 -0.404 . . . . 0.0 110.634 -174.281 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' E' E ' 61' ' ' GLU . . . . . . . . . . . . . 95.5 mt-10 -131.19 160.96 33.3 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 115.765 -0.652 . . . . 0.0 109.71 175.422 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' E' E ' 62' ' ' ASP . . . . . . . . . . . . . 10.9 p-10 -52.77 -29.93 30.08 Favored 'General case' 0 C--N 1.328 -0.363 0 N-CA-C 112.067 0.395 . . . . 0.0 112.067 -179.302 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' E' E ' 63' ' ' ARG . . . . . . . . . . . . . 60.0 mtp180 -72.35 -22.06 61.22 Favored 'General case' 0 CA--C 1.533 0.295 0 N-CA-C 113.002 0.742 . . . . 0.0 113.002 -175.616 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' E' E ' 64' ' ' THR . . . . . . . . . . . . . 36.8 m -66.7 142.27 57.48 Favored 'General case' 0 C--N 1.331 -0.225 0 CA-C-O 120.983 0.421 . . . . 0.0 110.913 -176.444 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' E' E ' 65' ' ' LYS . . . . . . . . . . . . . 46.6 mtmt -88.4 129.52 35.4 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 115.938 -0.574 . . . . 0.0 109.912 177.684 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' E' E ' 66' ' ' ILE . . . . . . . . . . . . . 60.7 mt -113.54 126.65 71.03 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.347 0 N-CA-C 109.976 -0.379 . . . . 0.0 109.976 -178.089 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' E' E ' 67' ' ' THR . . . . . . . . . . . . . 25.8 m -127.14 149.73 49.82 Favored 'General case' 0 C--N 1.331 -0.226 0 CA-C-O 121.147 0.498 . . . . 0.0 111.112 -176.896 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' E' E ' 68' ' ' LEU . . . . . . . . . . . . . 72.3 mt . . . . . 0 C--N 1.33 -0.282 0 CA-C-N 115.909 -0.587 . . . . 0.0 110.791 179.543 . . . . . . . . 0 0 . 1 . 010 nuclear build core ' E' E ' 73' ' ' VAL . . . . . . . . . . . . . 32.6 m . . . . . 0 C--O 1.231 0.105 0 CA-C-O 120.775 0.321 . . . . 0.0 110.634 . . . . . . . . . 0 0 . 1 . 010 nuclear build core ' E' E ' 74' ' ' ASP . . . . . . . . . . . . . 42.1 t0 -93.3 122.54 35.8 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-N 116.348 -0.387 . . . . 0.0 110.264 -175.607 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' E' E ' 75' ' ' VAL . . . . . . . . . . . . . 41.3 t -116.97 123.34 71.71 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.237 0 CA-C-O 121.051 0.453 . . . . 0.0 110.345 -178.845 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' E' E ' 76' ' ' LEU . . . . . . . . . . . . . 20.4 mt -123.82 148.73 46.47 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 115.659 -0.701 . . . . 0.0 109.64 178.518 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' E' E ' 77' ' ' GLU . . . . . . . . . . . . . 46.0 mt-10 -139.1 136.39 35.14 Favored 'General case' 0 C--N 1.331 -0.208 0 CA-C-O 121.052 0.453 . . . . 0.0 111.334 -177.946 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' E' E ' 78' ' ' ALA . . . . . 0.599 ' HB2' HD21 ' E' ' 109' ' ' LEU . . . -123.42 134.82 53.91 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 115.707 -0.678 . . . . 0.0 109.724 176.28 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' E' E ' 79' ' ' LYS . . . . . 0.642 ' O ' HD13 ' E' ' 80' ' ' ILE . 77.8 mttt -77.98 121.51 24.3 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-O 120.791 0.329 . . . . 0.0 110.837 -177.065 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' E' E ' 80' ' ' ILE . . . . . 0.642 HD13 ' O ' ' E' ' 79' ' ' LYS . 38.2 mm -139.21 109.95 4.57 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.327 0 N-CA-C 109.538 -0.541 . . . . 0.0 109.538 -178.571 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' E' E ' 81' ' ' LYS . . . . . . . . . . . . . 15.4 ptpt -103.85 126.84 51.26 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-O 121.114 0.483 . . . . 0.0 111.102 -177.808 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' E' E ' 82' ' ' GLY . . . . . . . . . . . . . . . 89.13 42.11 5.68 Favored Glycine 0 CA--C 1.524 0.624 0 N-CA-C 111.512 -0.635 . . . . 0.0 111.512 175.047 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' E' E ' 83' ' ' ILE . . . . . . . . . . . . . 72.0 mt -67.63 140.24 19.57 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.293 0 CA-C-O 120.889 0.376 . . . . 0.0 110.132 179.252 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' E' E ' 84' ' ' LYS . . . . . . . . . . . . . 82.6 tttt -100.82 -53.85 2.96 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 115.895 -0.593 . . . . 0.0 110.089 -179.403 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' E' E ' 85' ' ' ASP . . . . . . . . . . . . . 5.8 t70 -157.57 155.66 30.58 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 115.731 -0.668 . . . . 0.0 110.477 -178.577 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' E' E ' 86' ' ' VAL . . . . . . . . . . . . . 42.9 t -133.27 132.67 58.26 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.258 0 CA-C-O 121.02 0.438 . . . . 0.0 110.533 -178.662 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' E' E ' 87' ' ' ILE . . . . . 0.401 HG21 ' CG1' ' E' ' 125' ' ' VAL . 43.3 mm -117.63 130.5 72.42 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.259 0 CA-C-N 115.813 -0.631 . . . . 0.0 109.503 174.714 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' E' E ' 88' ' ' LEU . . . . . . . . . . . . . 18.6 tp -114.7 134.61 54.95 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-O 121.127 0.489 . . . . 0.0 111.493 -175.995 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' E' E ' 89' ' ' ASP . . . . . . . . . . . . . 7.0 t70 -127.39 155.37 43.74 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 115.605 -0.725 . . . . 0.0 109.426 174.931 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' E' E ' 90' ' ' GLU . . . . . . . . . . . . . 96.0 mt-10 -47.49 -42.07 22.16 Favored 'General case' 0 N--CA 1.463 0.217 0 N-CA-C 112.781 0.659 . . . . 0.0 112.781 -172.862 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' E' E ' 91' ' ' ASN . . . . . . . . . . . . . 87.2 m-20 -132.02 39.9 3.39 Favored 'General case' 0 C--O 1.233 0.227 0 CA-C-O 120.871 0.367 . . . . 0.0 111.161 -178.279 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' E' E ' 92' ' ' LEU . . . . . . . . . . . . . 10.5 tp -166.11 141.77 4.82 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.517 -0.311 . . . . 0.0 110.521 -179.579 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' E' E ' 93' ' ' ILE . . . . . . . . . . . . . 65.1 mt -126.98 124.34 64.4 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.283 0 N-CA-C 109.695 -0.483 . . . . 0.0 109.695 -178.965 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' E' E ' 94' ' ' VAL . . . . . . . . . . . . . 41.9 t -121.64 124.7 72.2 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.28 0 N-CA-C 109.794 -0.447 . . . . 0.0 109.794 179.71 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' E' E ' 95' ' ' VAL . . . . . . . . . . . . . 45.6 t -122.53 135.5 62.43 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.237 0 CA-C-N 116.443 -0.344 . . . . 0.0 110.147 -178.952 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' E' E ' 96' ' ' ILE . . . . . . . . . . . . . 60.0 mt -117.54 130.99 71.56 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.294 0 CA-C-N 115.954 -0.566 . . . . 0.0 109.476 179.155 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' E' E ' 97' ' ' THR . . . . . . . . . . . . . 40.7 p -101.01 157.37 16.8 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-O 121.095 0.474 . . . . 0.0 111.127 -179.403 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' E' E ' 98' ' ' GLU . . . . . . . . . . . . . 46.0 mt-10 -54.85 -29.49 55.4 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.231 -0.44 . . . . 0.0 112.138 -179.216 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' E' E ' 99' ' ' GLU . . . . . . . . . . . . . 71.2 mm-40 -78.64 14.18 1.39 Allowed 'General case' 0 CA--C 1.536 0.409 0 N-CA-C 113.124 0.787 . . . . 0.0 113.124 -177.361 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' E' E ' 100' ' ' ASN . . . . . . . . . . . . . 38.1 m-20 63.46 36.23 11.46 Favored 'General case' 0 N--CA 1.462 0.141 0 CA-C-O 120.947 0.403 . . . . 0.0 111.585 178.728 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' E' E ' 101' ' ' GLU . . . . . . . . . . . . . 84.8 tt0 -107.38 140.21 40.67 Favored 'General case' 0 C--N 1.331 -0.201 0 N-CA-C 109.372 -0.603 . . . . 0.0 109.372 170.989 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' E' E ' 102' ' ' VAL . . . . . . . . . . . . . 47.9 t -115.1 128.53 72.24 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.269 0 CA-C-N 116.256 -0.429 . . . . 0.0 109.9 -178.187 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' E' E ' 103' ' ' LEU . . . . . . . . . . . . . 31.0 mt -120.42 131.31 54.73 Favored 'General case' 0 C--N 1.331 -0.215 0 CA-C-N 115.757 -0.656 . . . . 0.0 110.368 177.43 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' E' E ' 104' ' ' ILE . . . . . . . . . . . . . 65.8 mt -117.64 121.61 67.87 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.241 0 CA-C-N 116.346 -0.388 . . . . 0.0 110.007 179.038 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' E' E ' 105' ' ' PHE . . . . . . . . . . . . . 75.6 m-85 -121.87 165.24 16.21 Favored 'General case' 0 C--N 1.332 -0.158 0 O-C-N 123.885 0.741 . . . . 0.0 109.823 179.819 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' E' E ' 106' ' ' ASN . . . . . . . . . . . . . 46.6 p-10 -100.21 -169.99 1.81 Allowed 'General case' 0 C--N 1.329 -0.291 0 N-CA-C 109.716 -0.476 . . . . 0.0 109.716 173.437 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' E' E ' 107' ' ' GLN . . . . . 0.464 ' O ' HD21 ' D' ' 140' ' ' LEU . 46.7 tt0 -59.27 -30.06 68.02 Favored 'General case' 0 C--N 1.329 -0.301 0 N-CA-C 111.89 0.33 . . . . 0.0 111.89 179.2 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' E' E ' 108' ' ' ASN . . . . . . . . . . . . . 58.6 t30 -82.19 6.94 15.01 Favored 'General case' 0 CA--C 1.536 0.429 0 N-CA-C 113.161 0.8 . . . . 0.0 113.161 -177.536 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' E' E ' 109' ' ' LEU . . . . . 0.599 HD21 ' HB2' ' E' ' 78' ' ' ALA . 7.4 tp 59.69 34.79 22.21 Favored 'General case' 0 C--O 1.232 0.167 0 O-C-N 122.07 -0.394 . . . . 0.0 111.602 179.42 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' E' E ' 110' ' ' GLU . . . . . . . . . . . . . 42.7 mt-10 -101.9 148.67 25.05 Favored 'General case' 0 C--N 1.33 -0.282 0 N-CA-C 109.52 -0.548 . . . . 0.0 109.52 175.118 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' E' E ' 111' ' ' GLU . . . . . . . . . . . . . 53.0 tt0 -81.98 121.97 27.2 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-O 120.849 0.357 . . . . 0.0 110.759 -176.288 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' E' E ' 112' ' ' LEU . . . . . . . . . . . . . 14.5 mt -106.91 -45.89 4.07 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.071 -0.513 . . . . 0.0 110.594 -179.958 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' E' E ' 113' ' ' TYR . . . . . . . . . . . . . 49.4 t80 -134.88 134.85 41.13 Favored 'General case' 0 C--N 1.331 -0.209 0 CA-C-N 116.28 -0.418 . . . . 0.0 111.026 -178.489 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' E' E ' 114' ' ' ARG . . . . . . . . . . . . . 78.7 ttt-85 -134.06 121.74 21.97 Favored 'General case' 0 C--N 1.331 -0.2 0 CA-C-N 116.04 -0.527 . . . . 0.0 110.262 179.655 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' E' E ' 115' ' ' GLY . . . . . . . . . . . . . . . -150.11 146.67 16.06 Favored Glycine 0 CA--C 1.523 0.553 0 N-CA-C 111.114 -0.794 . . . . 0.0 111.114 179.007 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' E' E ' 116' ' ' LYS . . . . . . . . . . . . . 61.8 tttm -128.04 126.88 42.13 Favored 'General case' 0 C--N 1.33 -0.267 0 N-CA-C 109.734 -0.469 . . . . 0.0 109.734 177.087 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' E' E ' 117' ' ' PHE . . . . . . . . . . . . . 33.6 m-85 -125.22 117.28 23.5 Favored 'General case' 0 N--CA 1.463 0.203 0 CA-C-O 121.037 0.446 . . . . 0.0 110.455 -174.47 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' E' E ' 118' ' ' GLU . . . . . . . . . . . . . 84.0 tt0 -52.08 -50.76 60.93 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.367 -0.379 . . . . 0.0 111.537 -177.891 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' E' E ' 119' ' ' ASN . . . . . . . . . . . . . 23.9 m120 -94.53 31.17 1.82 Allowed 'General case' 0 C--N 1.33 -0.243 0 N-CA-C 112.2 0.444 . . . . 0.0 112.2 -174.735 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' E' E ' 120' ' ' LEU . . . . . . . . . . . . . 20.5 tp -56.4 124.51 18.34 Favored 'General case' 0 N--CA 1.462 0.136 0 C-N-CA 120.992 -0.283 . . . . 0.0 110.448 177.789 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' E' E ' 121' ' ' ASN . . . . . . . . . . . . . 33.6 m120 -113.58 -43.97 3.26 Favored 'General case' 0 C--N 1.331 -0.217 0 CA-C-N 116.588 -0.278 . . . . 0.0 111.137 -175.948 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' E' E ' 122' ' ' LYS . . . . . . . . . . . . . 39.6 ttpt -148.59 147.29 28.83 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-O 121.016 0.436 . . . . 0.0 111.419 -176.888 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' E' E ' 123' ' ' VAL . . . . . . . . . . . . . 46.2 t -132.41 135.71 57.41 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.281 0 CA-C-N 116.021 -0.536 . . . . 0.0 109.644 176.06 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' E' E ' 124' ' ' LEU . . . . . . . . . . . . . 37.8 mt -132.8 141.63 48.58 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-O 120.791 0.329 . . . . 0.0 110.973 -178.567 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' E' E ' 125' ' ' VAL . . . . . 0.653 HG23 HG22 ' E' ' 130' ' ' VAL . 10.6 p -139.26 141.54 35.55 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.23 0 CA-C-N 116.258 -0.428 . . . . 0.0 110.309 177.964 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' E' E ' 126' ' ' ARG . . . . . . . . . . . . . 35.0 ptt-85 -150.88 126.77 10.36 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.09 -0.505 . . . . 0.0 110.579 178.486 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' E' E ' 127' ' ' ASN . . . . . . . . . . . . . 39.2 m-20 49.17 -107.37 0.23 Allowed 'General case' 0 CA--C 1.546 0.807 0 CA-C-O 119.033 -0.508 . . . . 0.0 111.792 178.715 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' E' E ' 128' ' ' ASP . . . . . . . . . . . . . 11.2 p-10 -114.06 11.88 17.78 Favored 'General case' 0 N--CA 1.467 0.408 0 CA-C-N 119.627 1.103 . . . . 0.0 113.416 -175.33 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' E' E ' 129' ' ' LEU . . . . . . . . . . . . . 81.9 mt -120.04 140.74 50.53 Favored 'General case' 0 C--N 1.333 -0.143 0 CA-C-N 118.058 0.39 . . . . 0.0 110.274 178.978 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' E' E ' 130' ' ' VAL . . . . . 0.653 HG22 HG23 ' E' ' 125' ' ' VAL . 46.2 t -128.25 138.91 53.35 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.212 0 N-CA-C 109.741 -0.466 . . . . 0.0 109.741 -179.988 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' E' E ' 131' ' ' VAL . . . . . . . . . . . . . 41.6 t -134.53 138.03 50.34 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.321 0 CA-C-N 116.287 -0.415 . . . . 0.0 110.242 -179.725 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' E' E ' 132' ' ' ILE . . . . . . . . . . . . . 72.9 mt -119.55 132.61 68.85 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.306 0 N-CA-C 109.374 -0.602 . . . . 0.0 109.374 179.942 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' E' E ' 133' ' ' ILE . . . . . . . . . . . . . 39.7 mm -117.64 119.23 61.02 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.253 0 CA-C-N 116.307 -0.406 . . . . 0.0 110.883 -175.991 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' E' E ' 134' ' ' ASP . . . . . . . . . . . . . 8.1 p-10 -131.68 146.46 52.19 Favored 'General case' 0 C--N 1.331 -0.217 0 N-CA-C 109.536 -0.542 . . . . 0.0 109.536 174.504 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' E' E ' 135' ' ' GLU . . . . . . . . . . . . . 43.5 tp10 -49.88 -23.66 2.05 Favored 'General case' 0 C--N 1.328 -0.344 0 N-CA-C 112.941 0.719 . . . . 0.0 112.941 -172.061 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' E' E ' 136' ' ' GLN . . . . . . . . . . . . . 55.6 tp60 -100.97 -27.91 13.03 Favored 'General case' 0 C--O 1.233 0.237 0 N-CA-C 112.46 0.541 . . . . 0.0 112.46 -174.838 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' E' E ' 137' ' ' LYS . . . . . . . . . . . . . 86.6 mttt -142.39 151.35 41.76 Favored 'General case' 0 C--N 1.332 -0.193 0 CA-C-O 121.464 0.649 . . . . 0.0 112.188 -170.396 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' E' E ' 138' ' ' LEU . . . . . . . . . . . . . 14.3 tp -112.49 122.21 47.05 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 115.11 -0.95 . . . . 0.0 108.925 171.977 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' E' E ' 139' ' ' THR . . . . . . . . . . . . . 24.0 m -114.61 124.08 50.95 Favored 'General case' 0 C--N 1.331 -0.212 0 CA-C-O 120.82 0.343 . . . . 0.0 110.868 -177.92 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' E' E ' 140' ' ' LEU . . . . . . . . . . . . . 13.2 tp -111.48 118.48 35.88 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 115.5 -0.773 . . . . 0.0 108.926 178.73 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' E' E ' 141' ' ' ILE . . . . . . . . . . . . . 19.6 mt -119.77 114.31 43.8 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.193 0 N-CA-C 109.726 -0.472 . . . . 0.0 109.726 -176.009 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' E' E ' 142' ' ' ARG . . . . . . . . . . . . . 79.5 mtm180 -90.98 113.67 25.98 Favored 'General case' 0 C--N 1.326 -0.43 0 CA-C-N 115.882 -0.599 . . . . 0.0 110.621 178.039 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' E' E ' 143' ' ' THR . . . . . . . . . . . . . 2.4 p . . . . . 0 C--O 1.221 -0.447 0 CA-C-O 117.951 -1.023 . . . . 0.0 110.559 -179.229 . . . . . . . . 0 0 . 1 . 010 nuclear build core ' F' F ' 1' ' ' MET . . . . . . . . . . . . . 25.1 ptt? . . . . . 0 C--O 1.233 0.199 0 CA-C-O 120.835 0.35 . . . . 0.0 110.772 . . . . . . . . . 0 0 . 1 . 010 nuclear build core ' F' F ' 2' ' ' SER . . . . . . . . . . . . . 6.3 p -116.12 132.9 56.53 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 116.255 -0.429 . . . . 0.0 110.142 178.42 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' F' F ' 3' ' ' GLU . . . . . . . . . . . . . 95.7 mt-10 -140.8 138.04 33.78 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.095 -0.502 . . . . 0.0 110.829 -178.351 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' F' F ' 4' ' ' LEU . . . . . 0.485 HD21 HD21 ' F' ' 6' ' ' LEU . 23.4 tp -123.92 125.31 44.4 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 115.994 -0.548 . . . . 0.0 109.971 175.956 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' F' F ' 5' ' ' LYS . . . . . . . . . . . . . 62.2 mttp -103.78 119.14 38.31 Favored 'General case' 0 C--O 1.234 0.281 0 CA-C-N 116.32 -0.4 . . . . 0.0 110.457 178.395 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' F' F ' 6' ' ' LEU . . . . . 0.485 HD21 HD21 ' F' ' 4' ' ' LEU . 58.1 mt -115.08 141.6 47.79 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 115.398 -0.819 . . . . 0.0 110.223 -178.488 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' F' F ' 7' ' ' LYS . . . . . . . . . . . . . 35.3 ttpt -121.45 136.24 25.73 Favored Pre-proline 0 CA--C 1.534 0.359 0 CA-C-O 118.784 -0.627 . . . . 0.0 109.896 176.627 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' F' F ' 8' ' ' PRO . . . . . . . . . . . . . 95.8 Cg_endo -91.92 133.23 1.32 Allowed 'Trans proline' 0 N--CA 1.489 1.25 0 C-N-CA 121.698 1.599 . . . . 0.0 111.901 178.048 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' F' F ' 9' ' ' LEU . . . . . . . . . . . . . 57.6 mt -73.31 -47.2 7.74 Favored Pre-proline 0 CA--C 1.534 0.336 0 CA-C-O 118.616 -0.707 . . . . 0.0 112.13 -179.117 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' F' F ' 10' ' ' PRO . . . . . . . . . . . . . 97.2 Cg_endo -81.54 147.6 15.78 Favored 'Trans proline' 0 N--CA 1.496 1.622 0 C-N-CA 121.226 1.284 . . . . 0.0 111.504 175.817 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' F' F ' 11' ' ' LYS . . . . . . . . . . . . . 32.3 ttmt -86.51 90.7 8.31 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-O 120.941 0.401 . . . . 0.0 110.498 179.469 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' F' F ' 12' ' ' VAL . . . . . . . . . . . . . 12.6 p -136.11 147.57 28.04 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.252 0 CA-C-N 116.064 -0.517 . . . . 0.0 110.29 179.562 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' F' F ' 13' ' ' GLU . . . . . . . . . . . . . 84.9 tt0 -85.55 130.08 34.66 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.391 -0.368 . . . . 0.0 110.464 179.685 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' F' F ' 14' ' ' LEU . . . . . . . . . . . . . 22.9 mt -97.72 150.7 37.05 Favored Pre-proline 0 C--N 1.33 -0.252 0 CA-C-N 116.207 -0.451 . . . . 0.0 110.354 -179.506 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' F' F ' 15' ' ' PRO . . . . . . . . . . . . . 29.9 Cg_exo -60.36 158.56 30.71 Favored 'Trans proline' 0 N--CA 1.496 1.653 0 C-N-CA 121.199 1.266 . . . . 0.0 111.9 178.096 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' F' F ' 16' ' ' PRO . . . . . . . . . . . . . 39.0 Cg_exo -58.54 -44.37 37.77 Favored 'Trans proline' 0 N--CA 1.497 1.713 0 C-N-CA 121.445 1.43 . . . . 0.0 112.662 -178.373 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' F' F ' 17' ' ' ASP . . . . . . . . . . . . . 12.3 p-10 -83.29 12.89 4.74 Favored 'General case' 0 CA--C 1.536 0.426 0 N-CA-C 112.973 0.731 . . . . 0.0 112.973 -178.718 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' F' F ' 18' ' ' PHE . . . . . 0.505 ' CZ ' HD11 ' F' ' 22' ' ' ILE . 51.4 t80 -56.98 -41.18 77.93 Favored 'General case' 0 C--O 1.227 -0.108 0 O-C-N 122.016 -0.427 . . . . 0.0 110.477 -178.537 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' F' F ' 19' ' ' VAL . . . . . . . . . . . . . 47.0 t -55.78 -44.95 79.17 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.244 0 CA-C-N 116.57 -0.287 . . . . 0.0 110.649 -178.726 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' F' F ' 20' ' ' ASP . . . . . . . . . . . . . 83.1 m-20 -59.95 -41.91 92.92 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-O 120.847 0.356 . . . . 0.0 110.723 -178.851 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' F' F ' 21' ' ' VAL . . . . . . . . . . . . . 57.6 t -63.86 -46.91 92.94 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.303 0 CA-C-N 116.377 -0.374 . . . . 0.0 110.727 -177.809 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' F' F ' 22' ' ' ILE . . . . . 0.616 HG22 HD12 ' F' ' 26' ' ' LEU . 51.6 mm -55.59 -46.37 79.15 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.206 0 CA-C-O 120.694 0.283 . . . . 0.0 110.566 178.628 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' F' F ' 23' ' ' ARG . . . . . . . . . . . . . 41.6 ttp180 -54.39 -51.62 64.27 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.71 -0.223 . . . . 0.0 111.489 -179.502 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' F' F ' 24' ' ' ILE . . . . . . . . . . . . . 75.9 mt -58.65 -44.36 89.52 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.323 0 CA-C-N 116.652 -0.249 . . . . 0.0 111.433 -175.861 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' F' F ' 25' ' ' LYS . . . . . . . . . . . . . 95.3 mttt -68.14 -42.7 79.74 Favored 'General case' 0 C--N 1.328 -0.337 0 N-CA-C 112.331 0.493 . . . . 0.0 112.331 -176.928 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' F' F ' 26' ' ' LEU . . . . . 0.616 HD12 HG22 ' F' ' 22' ' ' ILE . 80.0 mt -78.81 -38.19 38.86 Favored 'General case' 0 C--N 1.329 -0.326 0 N-CA-C 112.984 0.735 . . . . 0.0 112.984 -170.636 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' F' F ' 27' ' ' GLN . . . . . . . . . . . . . 14.8 pt20 -46.97 139.42 5.62 Favored 'General case' 0 N--CA 1.47 0.547 0 N-CA-C 112.633 0.605 . . . . 0.0 112.633 -176.431 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' F' F ' 28' ' ' GLY . . . . . . . . . . . . . . . 101.05 -25.36 28.62 Favored Glycine 0 CA--C 1.533 1.202 0 CA-C-N 115.437 -0.801 . . . . 0.0 112.197 -176.058 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' F' F ' 29' ' ' LYS . . . . . . . . . . . . . 95.1 mttt -97.98 155.2 17.21 Favored 'General case' 0 C--O 1.233 0.192 0 CA-C-N 117.427 0.614 . . . . 0.0 111.01 178.5 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' F' F ' 30' ' ' THR . . . . . . . . . . . . . 21.7 m -107.13 135.93 47.83 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 115.882 -0.599 . . . . 0.0 109.913 175.41 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' F' F ' 31' ' ' VAL . . . . . . . . . . . . . 34.5 m -132.12 156.73 42.76 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.207 0 CA-C-O 120.876 0.369 . . . . 0.0 111.159 -177.107 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' F' F ' 32' ' ' ARG . . . . . . . . . . . . . 82.8 mtt180 -132.18 152.53 51.24 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-O 121.333 0.587 . . . . 0.0 110.673 179.214 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' F' F ' 33' ' ' THR . . . . . . . . . . . . . 18.3 m -52.87 139.95 25.72 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.096 -0.502 . . . . 0.0 111.311 -178.758 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' F' F ' 34' ' ' GLY . . . . . . . . . . . . . . . 100.18 -17.3 57.21 Favored Glycine 0 CA--C 1.533 1.172 0 CA-C-O 119.619 -0.545 . . . . 0.0 113.242 179.274 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' F' F ' 35' ' ' ASP . . . . . . . . . . . . . 74.3 m-20 -67.15 150.03 49.69 Favored 'General case' 0 N--CA 1.46 0.07 0 CA-C-N 118.086 0.943 . . . . 0.0 110.991 178.774 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' F' F ' 36' ' ' VAL . . . . . . . . . . . . . 44.3 t -122.47 130.3 74.62 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.205 0 CA-C-N 116.055 -0.52 . . . . 0.0 109.909 178.44 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' F' F ' 37' ' ' ILE . . . . . . . . . . . . . 69.6 mt -122.34 140.87 44.88 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.218 0 CA-C-N 116.105 -0.498 . . . . 0.0 110.017 -178.527 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' F' F ' 38' ' ' GLY . . . . . . . . . . . . . . . -115.82 128.85 8.21 Favored Glycine 0 CA--C 1.526 0.744 0 N-CA-C 111.179 -0.768 . . . . 0.0 111.179 179.736 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' F' F ' 39' ' ' ILE . . . . . . . . . . . . . 76.3 mt -127.63 140.23 49.7 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.228 0 CA-C-O 120.746 0.308 . . . . 0.0 110.218 179.247 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' F' F ' 40' ' ' SER . . . . . . . . . . . . . 52.8 p -93.32 115.85 28.42 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 116.298 -0.41 . . . . 0.0 111.19 176.229 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' F' F ' 41' ' ' ILE . . . . . . . . . . . . . 44.8 mm -122.58 118.99 56.91 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.214 0 N-CA-C 110.19 -0.3 . . . . 0.0 110.19 178.72 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' F' F ' 42' ' ' LEU . . . . . . . . . . . . . 69.2 mt 55.89 35.64 25.82 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.191 -0.458 . . . . 0.0 111.63 177.412 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' F' F ' 43' ' ' GLY . . . . . . . . . . . . . . . 73.22 23.75 76.88 Favored Glycine 0 CA--C 1.532 1.144 0 C-N-CA 121.151 -0.547 . . . . 0.0 112.795 177.818 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' F' F ' 44' ' ' LYS . . . . . . . . . . . . . 34.7 mmtp -131.5 133.81 45.49 Favored 'General case' 0 C--N 1.331 -0.206 0 CA-C-N 117.264 0.532 . . . . 0.0 109.572 177.538 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' F' F ' 45' ' ' GLU . . . . . . . . . . . . . 85.9 tt0 -82.7 120.21 25.3 Favored 'General case' 0 C--N 1.329 -0.322 0 C-N-CA 120.745 -0.382 . . . . 0.0 110.89 -179.331 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' F' F ' 46' ' ' VAL . . . . . . . . . . . . . 11.2 p -116.83 124.28 72.71 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.154 0 N-CA-C 109.647 -0.501 . . . . 0.0 109.647 175.724 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' F' F ' 47' ' ' LYS . . . . . . . . . . . . . 55.3 mttp -98.58 126.5 44.18 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-N 116.101 -0.5 . . . . 0.0 110.955 179.208 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' F' F ' 48' ' ' PHE . . . . . . . . . . . . . 29.1 m-85 -109.3 131.82 54.71 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.168 -0.469 . . . . 0.0 109.971 177.056 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' F' F ' 49' ' ' LYS . . . . . . . . . . . . . 37.5 tttp -107.66 132.31 53.46 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-N 116.24 -0.436 . . . . 0.0 110.091 177.751 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' F' F ' 50' ' ' VAL . . . . . 0.44 HG13 HD11 ' F' ' 4' ' ' LEU . 42.4 t -75.53 107.05 5.86 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.345 0 N-CA-C 109.453 -0.573 . . . . 0.0 109.453 178.151 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' F' F ' 51' ' ' VAL . . . . . . . . . . . . . 47.4 t -74.5 -48.75 34.09 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.309 0 N-CA-C 109.759 -0.46 . . . . 0.0 109.759 -175.661 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' F' F ' 52' ' ' GLN . . . . . . . . . . . . . 49.4 tt0 -160.11 137.15 9.3 Favored 'General case' 0 C--N 1.33 -0.28 0 C-N-CA 120.316 -0.553 . . . . 0.0 111.568 -179.262 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' F' F ' 53' ' ' ALA . . . . . 0.484 ' HB1' ' HB2' ' F' ' 58' ' ' LEU . . . -113.46 133.06 55.41 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 115.708 -0.678 . . . . 0.0 109.81 175.94 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' F' F ' 54' ' ' TYR . . . . . . . . . . . . . 65.3 t80 -129.18 112.63 18.35 Favored Pre-proline 0 CA--C 1.535 0.386 0 CA-C-O 118.292 -0.861 . . . . 0.0 110.294 178.219 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' F' F ' 55' ' ' PRO . . . . . . . . . . . . . 73.2 Cg_endo -77.18 168.08 77.89 Favored 'Cis proline' 0 N--CA 1.499 1.822 0 CA-C-N 121.935 1.727 . . . . 0.0 112.238 -5.903 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' F' F ' 56' ' ' SER . . . . . . . . . . . . . 13.9 m -116.66 130.51 24.49 Favored Pre-proline 0 CA--C 1.538 0.484 0 CA-C-O 118.536 -0.745 . . . . 0.0 109.413 174.906 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' F' F ' 57' ' ' PRO . . . . . . . . . . . . . 39.3 Cg_endo -67.46 146.74 76.93 Favored 'Cis proline' 0 N--CA 1.498 1.76 0 CA-C-N 121.898 1.713 . . . . 0.0 111.434 -0.786 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' F' F ' 58' ' ' LEU . . . . . 0.484 ' HB2' ' HB1' ' F' ' 53' ' ' ALA . 20.6 tp -106.12 135.82 46.91 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.409 -0.359 . . . . 0.0 110.492 -178.634 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' F' F ' 59' ' ' ARG . . . . . . . . . . . . . 39.3 ttm180 -105.76 126.55 52.29 Favored 'General case' 0 C--N 1.326 -0.438 0 N-CA-C 109.211 -0.663 . . . . 0.0 109.211 175.889 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' F' F ' 60' ' ' VAL . . . . . . . . . . . . . 46.6 t -83.58 119.6 33.15 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.27 0 C-N-CA 120.665 -0.414 . . . . 0.0 110.514 -175.624 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' F' F ' 61' ' ' GLU . . . . . . . . . . . . . 91.6 mt-10 -130.98 165.72 22.55 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 115.926 -0.579 . . . . 0.0 109.775 177.507 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' F' F ' 62' ' ' ASP . . . . . . . . . . . . . 59.7 m-20 -53.34 -32.46 49.25 Favored 'General case' 0 C--N 1.329 -0.303 0 N-CA-C 111.858 0.318 . . . . 0.0 111.858 -178.563 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' F' F ' 63' ' ' ARG . . . . . . . . . . . . . 92.7 mtt180 -74.72 -22.06 59.03 Favored 'General case' 0 C--N 1.33 -0.25 0 N-CA-C 113.02 0.748 . . . . 0.0 113.02 -176.796 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' F' F ' 64' ' ' THR . . . . . . . . . . . . . 39.5 m -65.89 136.52 56.24 Favored 'General case' 0 C--N 1.331 -0.197 0 CA-C-O 120.894 0.378 . . . . 0.0 110.95 -174.547 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' F' F ' 65' ' ' LYS . . . . . . . . . . . . . 96.8 mttt -89.75 133.01 34.92 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 115.912 -0.586 . . . . 0.0 110.153 177.512 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' F' F ' 66' ' ' ILE . . . . . 0.486 HD12 ' N ' ' F' ' 66' ' ' ILE . 4.7 mp -113.29 125.54 70.57 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.284 0 N-CA-C 109.596 -0.52 . . . . 0.0 109.596 178.65 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' F' F ' 67' ' ' THR . . . . . . . . . . . . . 25.6 m -120.59 141.89 49.89 Favored 'General case' 0 C--N 1.331 -0.204 0 CA-C-N 116.111 -0.495 . . . . 0.0 110.997 -176.235 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' F' F ' 68' ' ' LEU . . . . . . . . . . . . . 25.4 tp . . . . . 0 C--N 1.329 -0.315 0 CA-C-N 115.823 -0.626 . . . . 0.0 110.344 179.021 . . . . . . . . 0 0 . 1 . 010 nuclear build core ' F' F ' 73' ' ' VAL . . . . . . . . . . . . . 3.1 m . . . . . 0 C--O 1.232 0.154 0 CA-C-O 121.227 0.537 . . . . 0.0 111.25 . . . . . . . . . 0 0 . 1 . 010 nuclear build core ' F' F ' 74' ' ' ASP . . . . . . . . . . . . . 13.2 t0 -96.42 115.81 28.03 Favored 'General case' 0 C--N 1.325 -0.469 0 N-CA-C 108.271 -1.011 . . . . 0.0 108.271 171.175 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' F' F ' 75' ' ' VAL . . . . . . . . . . . . . 42.9 t -107.39 124.77 63.53 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.268 0 CA-C-O 121.156 0.503 . . . . 0.0 111.064 -171.235 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' F' F ' 76' ' ' LEU . . . . . . . . . . . . . 24.3 mt -125.24 133.59 52.65 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 115.399 -0.819 . . . . 0.0 109.442 176.452 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' F' F ' 77' ' ' GLU . . . . . . . . . . . . . 98.3 mt-10 -129.35 136.41 49.96 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-O 121.046 0.451 . . . . 0.0 111.126 -178.147 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' F' F ' 78' ' ' ALA . . . . . . . . . . . . . . . -128.2 138.14 52.34 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 115.748 -0.66 . . . . 0.0 109.868 177.124 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' F' F ' 79' ' ' LYS . . . . . 0.603 ' O ' HD13 ' F' ' 80' ' ' ILE . 19.9 pttp -76.07 121.9 23.47 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-O 121.193 0.52 . . . . 0.0 110.599 -179.025 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' F' F ' 80' ' ' ILE . . . . . 0.603 HD13 ' O ' ' F' ' 79' ' ' LYS . 39.1 mm -139.22 116.58 11.18 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.282 0 N-CA-C 109.25 -0.648 . . . . 0.0 109.25 -178.242 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' F' F ' 81' ' ' LYS . . . . . . . . . . . . . 83.7 tttt -112.56 126.39 55.29 Favored 'General case' 0 C--N 1.331 -0.215 0 CA-C-O 120.958 0.408 . . . . 0.0 111.206 -176.139 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' F' F ' 82' ' ' GLY . . . . . . . . . . . . . . . 89.0 42.24 5.69 Favored Glycine 0 CA--C 1.525 0.714 0 C-N-CA 120.86 -0.686 . . . . 0.0 111.569 174.652 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' F' F ' 83' ' ' ILE . . . . . . . . . . . . . 72.8 mt -69.15 141.81 16.89 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.342 0 CA-C-O 120.975 0.417 . . . . 0.0 110.001 178.446 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' F' F ' 84' ' ' LYS . . . . . . . . . . . . . 57.0 tttp -103.59 -52.57 2.96 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 115.884 -0.598 . . . . 0.0 110.356 -178.663 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' F' F ' 85' ' ' ASP . . . . . . . . . . . . . 11.1 t70 -153.55 155.56 36.4 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 115.988 -0.551 . . . . 0.0 110.587 -178.904 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' F' F ' 86' ' ' VAL . . . . . 0.45 ' O ' HD13 ' F' ' 87' ' ' ILE . 45.1 t -130.72 133.39 63.41 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.236 0 CA-C-O 120.976 0.417 . . . . 0.0 110.682 -177.765 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' F' F ' 87' ' ' ILE . . . . . 0.45 HD13 ' O ' ' F' ' 86' ' ' VAL . 46.1 mm -124.76 126.61 71.77 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.221 0 CA-C-N 115.883 -0.599 . . . . 0.0 109.748 176.432 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' F' F ' 88' ' ' LEU . . . . . . . . . . . . . 36.4 mt -116.22 136.54 52.92 Favored 'General case' 0 N--CA 1.464 0.239 0 CA-C-O 121.129 0.49 . . . . 0.0 111.504 -177.02 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' F' F ' 89' ' ' ASP . . . . . . . . . . . . . 10.6 t70 -130.01 159.33 37.04 Favored 'General case' 0 C--N 1.331 -0.221 0 CA-C-N 115.566 -0.743 . . . . 0.0 109.605 175.439 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' F' F ' 90' ' ' GLU . . . . . . . . . . . . . 95.4 mt-10 -46.7 -39.34 11.32 Favored 'General case' 0 CA--C 1.531 0.237 0 N-CA-C 113.118 0.784 . . . . 0.0 113.118 -171.68 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' F' F ' 91' ' ' ASN . . . . . . . . . . . . . 23.9 p30 -131.73 23.55 4.66 Favored 'General case' 0 N--CA 1.466 0.35 0 N-CA-C 112.725 0.639 . . . . 0.0 112.725 -177.383 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' F' F ' 92' ' ' LEU . . . . . . . . . . . . . 16.3 mt -148.7 141.13 24.24 Favored 'General case' 0 C--N 1.33 -0.243 0 N-CA-C 110.137 -0.32 . . . . 0.0 110.137 -176.691 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' F' F ' 93' ' ' ILE . . . . . . . . . . . . . 69.6 mt -124.93 117.39 50.02 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.362 0 N-CA-C 109.604 -0.517 . . . . 0.0 109.604 179.029 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' F' F ' 94' ' ' VAL . . . . . 0.428 HG21 HG21 ' F' ' 125' ' ' VAL . 46.7 t -117.13 127.07 74.78 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.242 0 CA-C-O 120.959 0.409 . . . . 0.0 110.106 179.844 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' F' F ' 95' ' ' VAL . . . . . . . . . . . . . 47.7 t -121.59 132.51 70.58 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.322 0 CA-C-N 115.844 -0.616 . . . . 0.0 109.626 178.799 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' F' F ' 96' ' ' ILE . . . . . . . . . . . . . 63.0 mt -113.71 129.09 70.18 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.269 0 N-CA-C 109.351 -0.611 . . . . 0.0 109.351 179.476 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' F' F ' 97' ' ' THR . . . . . . . . . . . . . 72.8 p -101.21 158.34 16.11 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-O 121.136 0.493 . . . . 0.0 111.121 -178.299 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' F' F ' 98' ' ' GLU . . . . . . . . . . . . . 96.9 mt-10 -54.0 -25.79 22.8 Favored 'General case' 0 CA--C 1.532 0.274 0 N-CA-C 112.316 0.487 . . . . 0.0 112.316 -179.037 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' F' F ' 99' ' ' GLU . . . . . . . . . . . . . 71.4 mm-40 -80.7 16.68 1.32 Allowed 'General case' 0 CA--C 1.535 0.385 0 N-CA-C 113.031 0.752 . . . . 0.0 113.031 -177.298 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' F' F ' 100' ' ' ASN . . . . . . . . . . . . . 3.8 m-20 62.11 37.57 14.48 Favored 'General case' 0 C--N 1.332 -0.156 0 CA-C-O 121.076 0.465 . . . . 0.0 111.088 177.847 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' F' F ' 101' ' ' GLU . . . . . . . . . . . . . 84.0 tt0 -114.79 143.12 45.59 Favored 'General case' 0 C--N 1.333 -0.111 0 N-CA-C 109.704 -0.48 . . . . 0.0 109.704 175.922 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' F' F ' 102' ' ' VAL . . . . . . . . . . . . . 43.0 t -115.22 125.02 72.37 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 CA-C-N 116.146 -0.479 . . . . 0.0 110.055 -178.184 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' F' F ' 103' ' ' LEU . . . . . . . . . . . . . 20.2 mt -114.1 128.64 56.47 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 115.695 -0.684 . . . . 0.0 109.973 176.251 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' F' F ' 104' ' ' ILE . . . . . . . . . . . . . 71.2 mt -117.49 118.97 60.31 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.253 0 N-CA-C 110.371 -0.233 . . . . 0.0 110.371 179.999 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' F' F ' 105' ' ' PHE . . . . . . . . . . . . . 66.0 m-85 -117.54 166.3 12.53 Favored 'General case' 0 C--N 1.333 -0.152 0 CA-C-N 115.455 -0.793 . . . . 0.0 109.898 178.401 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' F' F ' 106' ' ' ASN . . . . . . . . . . . . . 44.4 p-10 -100.4 -169.98 1.8 Allowed 'General case' 0 C--N 1.33 -0.275 0 N-CA-C 109.91 -0.404 . . . . 0.0 109.91 173.988 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' F' F ' 107' ' ' GLN . . . . . . . . . . . . . 30.1 tt0 -59.38 -29.99 68.1 Favored 'General case' 0 C--N 1.329 -0.298 0 N-CA-C 111.855 0.317 . . . . 0.0 111.855 178.221 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' F' F ' 108' ' ' ASN . . . . . . . . . . . . . 14.1 t-20 -81.98 5.17 20.05 Favored 'General case' 0 CA--C 1.537 0.448 0 N-CA-C 113.276 0.843 . . . . 0.0 113.276 -177.796 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' F' F ' 109' ' ' LEU . . . . . . . . . . . . . 9.9 tp 62.61 36.28 13.77 Favored 'General case' 0 CA--C 1.53 0.2 0 O-C-N 122.073 -0.392 . . . . 0.0 111.476 178.119 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' F' F ' 110' ' ' GLU . . . . . . . . . . . . . 96.0 mt-10 -108.1 156.24 19.5 Favored 'General case' 0 C--N 1.332 -0.193 0 N-CA-C 109.894 -0.41 . . . . 0.0 109.894 176.304 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' F' F ' 111' ' ' GLU . . . . . . . . . . . . . 46.2 tp10 -82.91 123.05 29.03 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-O 121.02 0.438 . . . . 0.0 110.852 -177.479 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' F' F ' 112' ' ' LEU . . . . . . . . . . . . . 12.5 mt -108.3 -46.01 3.8 Favored 'General case' 0 C--N 1.332 -0.184 0 CA-C-N 115.93 -0.577 . . . . 0.0 110.136 177.577 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' F' F ' 113' ' ' TYR . . . . . . . . . . . . . 62.3 t80 -140.67 136.54 32.75 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.443 -0.344 . . . . 0.0 110.981 179.863 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' F' F ' 114' ' ' ARG . . . . . . . . . . . . . 59.6 ttp180 -137.97 125.25 21.74 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.28 -0.418 . . . . 0.0 110.169 177.536 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' F' F ' 115' ' ' GLY . . . . . . . . . . . . . . . -150.2 161.87 29.05 Favored Glycine 0 CA--C 1.524 0.613 0 N-CA-C 111.167 -0.773 . . . . 0.0 111.167 179.94 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' F' F ' 116' ' ' LYS . . . . . . . . . . . . . 36.3 ttpt -128.27 134.55 48.97 Favored 'General case' 0 C--N 1.33 -0.273 0 N-CA-C 109.855 -0.424 . . . . 0.0 109.855 178.09 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' F' F ' 117' ' ' PHE . . . . . . . . . . . . . 39.9 m-85 -133.33 113.84 13.04 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-O 120.968 0.414 . . . . 0.0 110.404 -176.412 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' F' F ' 118' ' ' GLU . . . . . . . . . . . . . 44.0 mp0 -57.55 -44.1 84.93 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.088 -0.505 . . . . 0.0 110.71 -175.011 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' F' F ' 119' ' ' ASN . . . . . . . . . . . . . 14.8 m120 -99.12 30.99 3.2 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.201 -0.454 . . . . 0.0 112.192 -173.722 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' F' F ' 120' ' ' LEU . . . . . . . . . . . . . 14.2 tp -55.49 121.6 9.38 Favored 'General case' 0 C--O 1.232 0.16 0 O-C-N 122.235 -0.29 . . . . 0.0 110.671 177.78 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' F' F ' 121' ' ' ASN . . . . . . . . . . . . . 38.6 m-80 -113.9 -44.14 3.2 Favored 'General case' 0 C--N 1.332 -0.183 0 CA-C-N 116.544 -0.298 . . . . 0.0 111.301 -177.756 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' F' F ' 122' ' ' LYS . . . . . . . . . . . . . 33.6 ttpt -145.27 143.5 30.26 Favored 'General case' 0 C--N 1.331 -0.21 0 C-N-CA 120.66 -0.416 . . . . 0.0 111.639 -176.514 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' F' F ' 123' ' ' VAL . . . . . . . . . . . . . 42.1 t -124.86 131.65 72.34 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.237 0 N-CA-C 109.385 -0.598 . . . . 0.0 109.385 175.15 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' F' F ' 124' ' ' LEU . . . . . 0.569 HD13 HD12 ' A' ' 88' ' ' LEU . 9.6 tt -133.9 130.75 38.22 Favored 'General case' 0 C--N 1.332 -0.194 0 CA-C-O 121.073 0.464 . . . . 0.0 111.105 -178.402 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' F' F ' 125' ' ' VAL . . . . . 0.428 HG21 HG21 ' F' ' 94' ' ' VAL . 43.3 t -121.16 133.54 67.44 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.233 0 CA-C-N 115.783 -0.644 . . . . 0.0 109.543 176.867 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' F' F ' 126' ' ' ARG . . . . . . . . . . . . . 36.6 ptt-85 -142.83 125.03 15.4 Favored 'General case' 0 C--N 1.331 -0.226 0 CA-C-O 121.021 0.438 . . . . 0.0 111.087 179.759 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' F' F ' 127' ' ' ASN . . . . . . . . . . . . . 58.8 m-80 49.21 -105.06 0.15 Allowed 'General case' 0 CA--C 1.544 0.738 0 CA-C-N 116.126 -0.488 . . . . 0.0 111.748 177.42 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' F' F ' 128' ' ' ASP . . . . . . . . . . . . . 8.8 p-10 -114.15 1.79 14.67 Favored 'General case' 0 CA--C 1.534 0.359 0 CA-C-N 119.524 1.057 . . . . 0.0 113.57 -176.366 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' F' F ' 129' ' ' LEU . . . . . . . . . . . . . 82.9 mt -113.7 145.7 40.94 Favored 'General case' 0 C--N 1.333 -0.131 0 O-C-N 121.92 -0.488 . . . . 0.0 110.5 -178.805 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' F' F ' 130' ' ' VAL . . . . . . . . . . . . . 45.7 t -125.41 135.78 62.91 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.22 0 CA-C-N 116.123 -0.49 . . . . 0.0 109.769 179.955 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' F' F ' 131' ' ' VAL . . . . . 0.709 HG21 HD13 ' A' ' 88' ' ' LEU . 27.5 m -136.03 143.1 37.01 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.251 0 CA-C-O 121.356 0.598 . . . . 0.0 111.126 178.774 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' F' F ' 132' ' ' ILE . . . . . . . . . . . . . 70.7 mt -123.6 133.95 67.74 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.288 0 CA-C-N 115.219 -0.9 . . . . 0.0 109.502 -179.336 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' F' F ' 133' ' ' ILE . . . . . 0.402 HG21 HG21 ' A' ' 86' ' ' VAL . 39.6 mm -115.57 122.01 68.48 Favored 'Isoleucine or valine' 0 C--O 1.233 0.225 0 CA-C-O 120.735 0.302 . . . . 0.0 110.89 -176.165 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' F' F ' 134' ' ' ASP . . . . . . . . . . . . . 6.7 p-10 -131.98 146.39 52.06 Favored 'General case' 0 C--N 1.331 -0.216 0 N-CA-C 109.457 -0.571 . . . . 0.0 109.457 174.098 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' F' F ' 135' ' ' GLU . . . . . . . . . . . . . 42.7 tp10 -49.82 -23.9 2.12 Favored 'General case' 0 C--N 1.328 -0.348 0 N-CA-C 112.883 0.697 . . . . 0.0 112.883 -171.406 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' F' F ' 136' ' ' GLN . . . . . . . . . . . . . 94.3 mt-30 -92.73 -37.21 12.49 Favored 'General case' 0 C--N 1.332 -0.185 0 N-CA-C 112.115 0.413 . . . . 0.0 112.115 -176.284 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' F' F ' 137' ' ' LYS . . . . . . . . . . . . . 45.9 mtmt -148.48 159.17 44.31 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-O 121.512 0.672 . . . . 0.0 111.819 -168.968 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' F' F ' 138' ' ' LEU . . . . . . . . . . . . . 5.0 tt -115.43 124.74 51.93 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 115.173 -0.921 . . . . 0.0 109.365 175.737 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' F' F ' 139' ' ' THR . . . . . . . . . . . . . 27.5 m -108.27 129.52 55.21 Favored 'General case' 0 C--N 1.331 -0.22 0 CA-C-N 116.437 -0.347 . . . . 0.0 110.878 -177.523 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' F' F ' 140' ' ' LEU . . . . . 0.455 HD23 ' C ' ' F' ' 140' ' ' LEU . 5.9 tt -117.31 122.56 44.25 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 115.607 -0.724 . . . . 0.0 109.109 -178.427 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' F' F ' 141' ' ' ILE . . . . . 0.444 ' N ' HD23 ' F' ' 140' ' ' LEU . 19.3 mt -120.06 116.97 52.02 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.345 0 N-CA-C 109.815 -0.439 . . . . 0.0 109.815 -175.969 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' F' F ' 142' ' ' ARG . . . . . . . . . . . . . 56.4 ttp180 -104.67 129.04 52.9 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 115.445 -0.798 . . . . 0.0 110.638 -178.829 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' F' F ' 143' ' ' THR . . . . . . . . . . . . . 55.8 p . . . . . 0 C--O 1.221 -0.427 0 CA-C-O 117.962 -1.018 . . . . 0.0 110.467 178.603 . . . . . . . . 0 0 . 1 . 011 nuclear build core ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 2.8 p . . . . . 0 C--O 1.232 0.14 0 CA-C-O 120.867 0.365 . . . . 0.0 110.609 . . . . . . . . . 0 0 . 1 . 011 nuclear build core ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 84.9 tt0 -141.74 138.14 32.15 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.097 -0.501 . . . . 0.0 110.856 179.501 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 4' ' ' LEU . . . . . 0.445 HD21 HD21 ' A' ' 6' ' ' LEU . 12.7 tp -123.27 133.19 54.2 Favored 'General case' 0 C--N 1.332 -0.155 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.166 177.157 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 5' ' ' LYS . . . . . . . . . . . . . 95.6 mttt -108.48 120.62 42.94 Favored 'General case' 0 C--O 1.234 0.271 0 CA-C-N 116.421 -0.354 . . . . 0.0 110.417 179.737 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 6' ' ' LEU . . . . . 0.445 HD21 HD21 ' A' ' 4' ' ' LEU . 56.2 mt -115.89 148.23 40.22 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 115.457 -0.792 . . . . 0.0 110.715 -177.755 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 31.9 ttpt -138.57 140.59 28.29 Favored Pre-proline 0 CA--C 1.534 0.357 0 CA-C-O 119.164 -0.446 . . . . 0.0 110.075 175.421 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 8' ' ' PRO . . . . . . . . . . . . . 85.5 Cg_endo -92.02 141.96 2.52 Favored 'Trans proline' 0 N--CA 1.491 1.332 0 C-N-CA 121.734 1.622 . . . . 0.0 111.802 177.794 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 51.2 mt -77.4 -48.19 2.42 Favored Pre-proline 0 CA--C 1.534 0.338 0 CA-C-O 118.649 -0.691 . . . . 0.0 112.435 -179.459 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 90.1 Cg_endo -79.82 156.66 24.1 Favored 'Trans proline' 0 N--CA 1.496 1.636 0 C-N-CA 121.15 1.233 . . . . 0.0 111.812 177.292 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 61.6 tttm -87.97 95.66 10.21 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.378 -0.374 . . . . 0.0 110.281 178.292 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 12.4 p -140.14 144.57 27.68 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.263 0 CA-C-N 116.145 -0.479 . . . . 0.0 110.532 -179.43 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 95.6 mt-10 -82.18 127.13 32.85 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.234 -0.439 . . . . 0.0 110.07 177.392 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 14' ' ' LEU . . . . . . . . . . . . . 23.9 mt -97.94 139.42 21.28 Favored Pre-proline 0 CA--C 1.533 0.318 0 CA-C-O 118.796 -0.621 . . . . 0.0 109.767 179.871 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 15' ' ' PRO . . . . . . . . . . . . . 26.6 Cg_exo -60.99 160.57 25.27 Favored 'Trans proline' 0 N--CA 1.498 1.758 0 C-N-CA 121.161 1.241 . . . . 0.0 111.713 178.348 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 16' ' ' PRO . . . . . . . . . . . . . 30.7 Cg_exo -59.66 -32.71 96.29 Favored 'Trans proline' 0 N--CA 1.499 1.794 0 C-N-CA 121.396 1.397 . . . . 0.0 112.863 -177.618 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 17' ' ' ASP . . . . . . . . . . . . . 9.6 p-10 -91.56 6.1 47.0 Favored 'General case' 0 CA--C 1.538 0.498 0 N-CA-C 113.254 0.835 . . . . 0.0 113.254 -177.275 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 18' ' ' PHE . . . . . . . . . . . . . 47.1 t80 -58.54 -46.08 87.55 Favored 'General case' 0 C--N 1.333 -0.122 0 CA-C-O 120.985 0.421 . . . . 0.0 109.975 -178.356 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 19' ' ' VAL . . . . . . . . . . . . . 48.5 t -57.37 -40.9 76.95 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.328 0 CA-C-N 116.074 -0.512 . . . . 0.0 110.41 -178.784 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 9.2 t70 -60.07 -44.11 94.98 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-O 120.743 0.306 . . . . 0.0 111.099 -177.613 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 49.0 t -64.66 -46.71 91.53 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.248 0 C-N-CA 120.694 -0.402 . . . . 0.0 110.512 -177.893 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 22' ' ' ILE . . . . . 0.504 HG22 HD12 ' A' ' 26' ' ' LEU . 50.7 mm -56.19 -45.19 80.85 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.246 0 C-N-CA 120.915 -0.314 . . . . 0.0 110.626 178.912 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 23' ' ' ARG . . . . . . . . . . . . . 55.7 ttp180 -54.76 -49.82 69.92 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-O 120.658 0.266 . . . . 0.0 111.296 -178.626 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 24' ' ' ILE . . . . . . . . . . . . . 75.9 mt -59.72 -42.22 87.92 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.249 0 CA-C-N 116.574 -0.285 . . . . 0.0 111.178 -177.522 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 99.4 mttt -67.6 -38.16 83.6 Favored 'General case' 0 C--N 1.328 -0.362 0 N-CA-C 112.604 0.594 . . . . 0.0 112.604 -178.686 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 26' ' ' LEU . . . . . 0.504 HD12 HG22 ' A' ' 22' ' ' ILE . 83.1 mt -78.13 -41.27 35.55 Favored 'General case' 0 C--N 1.33 -0.261 0 N-CA-C 113.144 0.794 . . . . 0.0 113.144 -172.168 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 27' ' ' GLN . . . . . . . . . . . . . 14.8 pt20 -46.98 138.06 6.85 Favored 'General case' 0 N--CA 1.47 0.551 0 N-CA-C 112.704 0.631 . . . . 0.0 112.704 -175.675 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 101.63 -26.43 24.48 Favored Glycine 0 CA--C 1.532 1.115 0 CA-C-N 115.571 -0.74 . . . . 0.0 112.306 -177.331 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 71.6 mmtt -98.17 155.14 17.3 Favored 'General case' 0 C--N 1.331 -0.209 0 CA-C-N 117.51 0.655 . . . . 0.0 111.097 177.802 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 30' ' ' THR . . . . . . . . . . . . . 41.4 m -105.33 137.52 43.01 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 115.895 -0.593 . . . . 0.0 109.862 176.068 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 34.8 m -129.51 157.38 42.24 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.245 0 CA-C-N 116.354 -0.385 . . . . 0.0 110.798 -178.468 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 32' ' ' ARG . . . . . . . . . . . . . 73.5 mtt85 -131.37 153.13 49.97 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-O 121.282 0.563 . . . . 0.0 110.701 177.899 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 33' ' ' THR . . . . . . . . . . . . . 22.7 m -53.02 139.66 27.32 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.051 -0.522 . . . . 0.0 111.397 -177.84 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 99.13 -16.99 58.66 Favored Glycine 0 CA--C 1.533 1.17 0 CA-C-O 119.593 -0.56 . . . . 0.0 113.327 178.345 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 61.3 m-20 -62.81 148.82 45.81 Favored 'General case' 0 C--O 1.231 0.11 0 CA-C-N 118.044 0.922 . . . . 0.0 111.084 179.696 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 45.1 t -123.66 130.69 73.93 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.257 0 CA-C-N 115.585 -0.734 . . . . 0.0 109.853 179.343 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 37' ' ' ILE . . . . . . . . . . . . . 69.6 mt -122.71 139.19 50.32 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.237 0 CA-C-N 116.248 -0.433 . . . . 0.0 110.04 -179.773 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . -110.72 128.78 8.94 Favored Glycine 0 CA--C 1.525 0.665 0 N-CA-C 111.037 -0.825 . . . . 0.0 111.037 179.556 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 39' ' ' ILE . . . . . . . . . . . . . 72.1 mt -123.06 135.62 62.51 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.257 0 N-CA-C 110.109 -0.33 . . . . 0.0 110.109 179.33 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 40' ' ' SER . . . . . . . . . . . . . 41.5 t -93.6 116.91 29.44 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.394 -0.366 . . . . 0.0 111.039 176.01 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 41' ' ' ILE . . . . . . . . . . . . . 44.2 mm -121.53 115.26 45.99 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.241 0 CA-C-N 116.476 -0.329 . . . . 0.0 110.333 179.34 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 78.5 mt 54.38 37.07 26.89 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-O 120.93 0.395 . . . . 0.0 111.548 176.942 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . 74.13 24.46 73.54 Favored Glycine 0 CA--C 1.532 1.123 0 C-N-CA 121.061 -0.59 . . . . 0.0 112.797 177.622 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 44' ' ' LYS . . . . . . . . . . . . . 70.0 mmtt -130.36 132.54 45.85 Favored 'General case' 0 C--N 1.331 -0.223 0 N-CA-C 109.57 -0.529 . . . . 0.0 109.57 177.74 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 81.3 tt0 -84.02 122.5 28.87 Favored 'General case' 0 C--N 1.329 -0.308 0 C-N-CA 120.74 -0.384 . . . . 0.0 111.099 -178.142 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 46' ' ' VAL . . . . . . . . . . . . . 7.1 p -120.86 128.15 76.03 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.194 0 N-CA-C 109.356 -0.609 . . . . 0.0 109.356 175.241 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 60.3 mttp -100.48 127.78 46.73 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 115.988 -0.551 . . . . 0.0 111.015 179.277 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 48' ' ' PHE . . . . . . . . . . . . . 92.2 m-85 -110.48 131.83 54.71 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.368 -0.378 . . . . 0.0 110.099 176.44 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 45.5 tttp -108.46 136.96 47.21 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.246 -0.433 . . . . 0.0 110.598 179.158 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 50' ' ' VAL . . . . . . . . . . . . . 47.0 t -82.33 107.35 14.18 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.33 0 N-CA-C 109.161 -0.681 . . . . 0.0 109.161 175.416 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 51' ' ' VAL . . . . . . . . . . . . . 47.8 t -71.68 -52.26 26.96 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.364 0 CA-C-N 115.952 -0.567 . . . . 0.0 109.668 -174.295 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 52' ' ' GLN . . . . . . . . . . . . . 90.8 mt-30 -152.94 151.09 29.93 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-O 121.182 0.515 . . . . 0.0 111.572 -177.755 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -126.46 131.88 51.57 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 115.214 -0.903 . . . . 0.0 109.639 175.087 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 54' ' ' TYR . . . . . . . . . . . . . 51.7 t80 -128.93 108.43 18.29 Favored Pre-proline 0 CA--C 1.533 0.323 0 CA-C-O 118.294 -0.86 . . . . 0.0 110.421 -179.826 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 55' ' ' PRO . . . . . . . . . . . . . 73.4 Cg_endo -77.12 170.0 72.77 Favored 'Cis proline' 0 N--CA 1.499 1.837 0 CA-C-N 121.809 1.682 . . . . 0.0 112.501 -5.54 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 56' ' ' SER . . . . . . . . . . . . . 15.2 m -115.27 129.05 25.41 Favored Pre-proline 0 CA--C 1.539 0.554 0 CA-C-O 118.448 -0.787 . . . . 0.0 109.462 174.994 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 57' ' ' PRO . . . . . . . . . . . . . 38.4 Cg_endo -67.48 165.73 67.61 Favored 'Cis proline' 0 N--CA 1.498 1.741 0 CA-C-N 121.979 1.742 . . . . 0.0 111.517 -0.601 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 58' ' ' LEU . . . . . . . . . . . . . 27.9 tp -129.28 135.89 49.35 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.268 179.646 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 59' ' ' ARG . . . . . . . . . . . . . 74.0 ttt180 -104.72 128.69 52.89 Favored 'General case' 0 C--N 1.326 -0.421 0 N-CA-C 109.188 -0.671 . . . . 0.0 109.188 176.562 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 46.2 t -79.92 122.4 35.06 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.212 0 C-N-CA 120.566 -0.453 . . . . 0.0 109.982 -175.945 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 78.9 tt0 -130.75 157.82 41.78 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 115.713 -0.676 . . . . 0.0 109.264 -179.511 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 62' ' ' ASP . . . . . . . . . . . . . 79.9 m-20 -51.58 -32.21 27.62 Favored 'General case' 0 C--N 1.328 -0.339 0 N-CA-C 112.125 0.417 . . . . 0.0 112.125 -177.642 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 63' ' ' ARG . . . . . . . . . . . . . 46.8 ptt85 -88.97 5.11 45.69 Favored 'General case' 0 CA--C 1.538 0.518 0 N-CA-C 113.767 1.025 . . . . 0.0 113.767 -175.598 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 30.4 m -80.14 141.03 36.12 Favored 'General case' 0 C--N 1.331 -0.206 0 CA-C-N 117.981 0.355 . . . . 0.0 110.742 -178.483 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 65' ' ' LYS . . . . . . . . . . . . . 97.0 mttt -88.67 131.36 35.03 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.237 -0.438 . . . . 0.0 110.262 178.895 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 66' ' ' ILE . . . . . . . . . . . . . 59.1 mt -115.26 126.45 72.83 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.297 0 N-CA-C 109.502 -0.555 . . . . 0.0 109.502 179.061 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 67' ' ' THR . . . . . . . . . . . . . 26.4 m -117.56 136.61 53.15 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-O 121.05 0.452 . . . . 0.0 110.731 -177.756 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 68' ' ' LEU . . . . . 0.462 HD23 ' C ' ' A' ' 68' ' ' LEU . 6.3 tt . . . . . 0 C--N 1.329 -0.307 0 CA-C-N 115.782 -0.645 . . . . 0.0 109.69 178.277 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 74' ' ' ASP . . . . . . . . . . . . . 30.2 t0 . . . . . 0 C--O 1.23 0.06 0 N-CA-C 109.845 -0.428 . . . . 0.0 109.845 . . . . . . . . . 0 0 . 1 . 011 nuclear build core ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 43.5 t -115.7 124.27 71.95 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.215 0 CA-C-O 121.071 0.462 . . . . 0.0 110.467 -178.62 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 76' ' ' LEU . . . . . . . . . . . . . 6.3 mp -118.35 138.52 52.36 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 115.692 -0.685 . . . . 0.0 109.501 175.569 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 77' ' ' GLU . . . . . . . . . . . . . 96.8 mt-10 -134.15 136.3 43.71 Favored 'General case' 0 C--N 1.331 -0.204 0 CA-C-O 121.079 0.466 . . . . 0.0 111.017 -179.222 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 78' ' ' ALA . . . . . . . . . . . . . . . -124.81 141.68 51.95 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 115.632 -0.713 . . . . 0.0 110.077 177.704 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 79' ' ' LYS . . . . . 0.596 ' O ' HD13 ' A' ' 80' ' ' ILE . 11.4 mptt -81.52 109.83 16.35 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-O 120.858 0.361 . . . . 0.0 110.379 -179.922 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 80' ' ' ILE . . . . . 0.596 HD13 ' O ' ' A' ' 79' ' ' LYS . 41.5 mm -139.09 103.77 2.04 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.356 0 N-CA-C 109.2 -0.667 . . . . 0.0 109.2 -178.122 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 81' ' ' LYS . . . . . . . . . . . . . 19.7 pttp -112.38 140.39 47.15 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-O 121.002 0.429 . . . . 0.0 111.335 -176.857 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . 89.2 42.07 5.67 Favored Glycine 0 CA--C 1.526 0.724 0 N-CA-C 110.865 -0.894 . . . . 0.0 110.865 178.599 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 83' ' ' ILE . . . . . . . . . . . . . 70.7 mt -75.79 140.94 16.5 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.333 0 CA-C-O 120.88 0.372 . . . . 0.0 110.205 -179.139 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 84' ' ' LYS . . . . . . . . . . . . . 58.0 tttp -95.13 -53.4 3.82 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 115.904 -0.589 . . . . 0.0 109.991 179.597 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 85' ' ' ASP . . . . . . . . . . . . . 10.2 t70 -155.04 154.16 32.06 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 115.629 -0.714 . . . . 0.0 110.349 -179.627 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 86' ' ' VAL . . . . . . . . . . . . . 41.6 t -126.01 131.09 72.12 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.205 0 CA-C-O 120.925 0.393 . . . . 0.0 110.422 -179.197 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 87' ' ' ILE . . . . . . . . . . . . . 46.0 mm -120.33 124.75 73.19 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.285 0 CA-C-N 115.849 -0.614 . . . . 0.0 109.39 177.423 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 88' ' ' LEU . . . . . 0.458 HD13 HG21 ' F' ' 131' ' ' VAL . 30.1 mt -118.66 136.1 54.1 Favored 'General case' 0 C--N 1.331 -0.22 0 CA-C-O 121.209 0.528 . . . . 0.0 111.29 -176.147 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 89' ' ' ASP . . . . . . . . . . . . . 6.6 t0 -131.13 157.91 41.87 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 115.448 -0.796 . . . . 0.0 109.533 177.759 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 14.2 pt-20 -46.4 -36.93 6.96 Favored 'General case' 0 C--N 1.33 -0.272 0 N-CA-C 113.218 0.822 . . . . 0.0 113.218 -172.326 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 91' ' ' ASN . . . . . . . . . . . . . 11.9 t-20 -131.99 20.81 4.52 Favored 'General case' 0 N--CA 1.468 0.467 0 N-CA-C 112.93 0.715 . . . . 0.0 112.93 -177.083 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 92' ' ' LEU . . . . . . . . . . . . . 35.2 mt -147.52 142.61 27.09 Favored 'General case' 0 C--N 1.33 -0.267 0 N-CA-C 110.323 -0.251 . . . . 0.0 110.323 -177.625 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 93' ' ' ILE . . . . . . . . . . . . . 71.5 mt -125.34 116.02 45.48 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.336 0 N-CA-C 109.416 -0.587 . . . . 0.0 109.416 179.09 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 94' ' ' VAL . . . . . 0.437 HG21 HG11 ' A' ' 125' ' ' VAL . 46.7 t -119.13 126.79 75.67 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.295 0 CA-C-O 121.001 0.429 . . . . 0.0 110.114 -178.814 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 95' ' ' VAL . . . . . . . . . . . . . 47.3 t -118.66 131.16 72.26 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.376 0 CA-C-N 115.704 -0.68 . . . . 0.0 109.455 178.982 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 96' ' ' ILE . . . . . . . . . . . . . 65.6 mt -112.04 125.82 69.37 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.299 0 N-CA-C 109.127 -0.694 . . . . 0.0 109.127 178.699 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 97' ' ' THR . . . . . . . . . . . . . 71.2 p -98.25 157.1 16.37 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-O 121.216 0.532 . . . . 0.0 111.06 -177.22 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 98' ' ' GLU . . . . . . . . . . . . . 97.1 mt-10 -54.34 -24.25 18.61 Favored 'General case' 0 C--N 1.329 -0.322 0 N-CA-C 112.434 0.531 . . . . 0.0 112.434 -179.571 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 99' ' ' GLU . . . . . . . . . . . . . 35.3 tt0 -80.78 16.74 1.33 Allowed 'General case' 0 CA--C 1.538 0.51 0 N-CA-C 112.642 0.608 . . . . 0.0 112.642 -177.551 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 100' ' ' ASN . . . . . . . . . . . . . 3.4 m-20 61.83 37.91 15.1 Favored 'General case' 0 C--O 1.232 0.153 0 O-C-N 121.91 -0.494 . . . . 0.0 111.151 178.129 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 101' ' ' GLU . . . . . . . . . . . . . 84.7 tt0 -116.31 144.55 44.1 Favored 'General case' 0 C--N 1.331 -0.214 0 CA-C-N 116.165 -0.471 . . . . 0.0 109.858 176.501 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 102' ' ' VAL . . . . . . . . . . . . . 41.3 t -115.8 125.54 72.99 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.26 0 CA-C-N 116.207 -0.451 . . . . 0.0 110.177 -178.299 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 103' ' ' LEU . . . . . . . . . . . . . 22.6 mt -116.25 127.86 55.1 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 115.782 -0.645 . . . . 0.0 109.867 175.811 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 104' ' ' ILE . . . . . . . . . . . . . 62.4 mt -118.15 122.55 69.91 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.295 0 N-CA-C 110.342 -0.244 . . . . 0.0 110.342 179.639 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 105' ' ' PHE . . . . . . . . . . . . . 62.4 m-85 -120.18 163.58 17.52 Favored 'General case' 0 C--N 1.332 -0.182 0 O-C-N 124.136 0.897 . . . . 0.0 109.679 178.689 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 106' ' ' ASN . . . . . . . . . . . . . 46.8 p-10 -95.24 -170.69 2.23 Favored 'General case' 0 C--N 1.331 -0.232 0 N-CA-C 109.752 -0.462 . . . . 0.0 109.752 173.23 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 107' ' ' GLN . . . . . . . . . . . . . 12.3 tt0 -59.32 -30.1 68.12 Favored 'General case' 0 C--N 1.33 -0.278 0 N-CA-C 111.879 0.326 . . . . 0.0 111.879 179.144 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 108' ' ' ASN . . . . . . . . . . . . . 6.8 t-20 -82.23 9.68 8.31 Favored 'General case' 0 CA--C 1.536 0.438 0 N-CA-C 113.052 0.76 . . . . 0.0 113.052 -177.809 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 109' ' ' LEU . . . . . . . . . . . . . 11.1 tp 58.03 35.71 25.43 Favored 'General case' 0 CA--C 1.531 0.215 0 CA-C-O 120.965 0.412 . . . . 0.0 111.409 179.203 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 110' ' ' GLU . . . . . . . . . . . . . 70.7 mm-40 -104.98 143.53 33.05 Favored 'General case' 0 C--N 1.331 -0.222 0 N-CA-C 109.264 -0.643 . . . . 0.0 109.264 174.812 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 111' ' ' GLU . . . . . . . . . . . . . 62.6 tt0 -81.64 121.97 27.02 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-O 121.058 0.456 . . . . 0.0 110.678 -175.144 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 112' ' ' LEU . . . . . . . . . . . . . 29.5 mt -104.58 -45.62 4.57 Favored 'General case' 0 C--N 1.331 -0.211 0 CA-C-N 115.935 -0.575 . . . . 0.0 110.736 179.716 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 113' ' ' TYR . . . . . . . . . . . . . 63.6 t80 -133.02 135.69 45.57 Favored 'General case' 0 C--N 1.331 -0.218 0 CA-C-N 116.376 -0.375 . . . . 0.0 111.277 -177.604 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 114' ' ' ARG . . . . . . . . . . . . . 55.6 ttp180 -133.98 121.22 21.31 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 115.868 -0.605 . . . . 0.0 110.109 177.333 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 115' ' ' GLY . . . . . . . . . . . . . . . -150.12 160.8 28.68 Favored Glycine 0 CA--C 1.524 0.642 0 N-CA-C 111.013 -0.835 . . . . 0.0 111.013 -179.987 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 116' ' ' LYS . . . . . . . . . . . . . 33.4 ttmt -135.97 139.43 43.2 Favored 'General case' 0 C--N 1.328 -0.368 0 N-CA-C 109.971 -0.381 . . . . 0.0 109.971 177.312 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 117' ' ' PHE . . . . . . . . . . . . . 39.9 m-85 -136.88 114.68 11.28 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-O 121.053 0.454 . . . . 0.0 110.312 -175.127 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 118' ' ' GLU . . . . . . . . . . . . . 96.6 mt-10 -53.38 -45.06 69.1 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 116.287 -0.415 . . . . 0.0 111.664 -175.413 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 119' ' ' ASN . . . . . . . . . . . . . 69.5 m-80 -98.66 31.08 3.02 Favored 'General case' 0 C--N 1.33 -0.271 0 N-CA-C 112.255 0.465 . . . . 0.0 112.255 -173.035 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 120' ' ' LEU . . . . . . . . . . . . . 26.8 tp -56.44 122.53 12.15 Favored 'General case' 0 C--N 1.332 -0.171 0 C-N-CA 121.059 -0.256 . . . . 0.0 110.494 177.638 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 121' ' ' ASN . . . . . . . . . . . . . 34.9 m120 -114.0 -44.15 3.18 Favored 'General case' 0 C--O 1.232 0.149 0 CA-C-N 116.687 -0.233 . . . . 0.0 111.181 -178.373 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 122' ' ' LYS . . . . . . . . . . . . . 97.3 mttt -148.31 152.92 37.92 Favored 'General case' 0 C--N 1.332 -0.156 0 CA-C-O 121.126 0.489 . . . . 0.0 111.468 -177.896 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 123' ' ' VAL . . . . . . . . . . . . . 45.0 t -127.19 132.41 69.72 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.217 0 CA-C-N 115.897 -0.592 . . . . 0.0 109.679 176.931 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 124' ' ' LEU . . . . . . . . . . . . . 75.8 mt -126.67 131.04 51.5 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.455 -0.339 . . . . 0.0 110.307 -179.993 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 125' ' ' VAL . . . . . 0.437 HG11 HG21 ' A' ' 94' ' ' VAL . 35.3 m -136.59 138.85 46.02 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.258 0 CA-C-O 120.844 0.354 . . . . 0.0 110.829 -179.748 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 126' ' ' ARG . . . . . . . . . . . . . 14.5 ptm180 -165.96 143.55 5.53 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.066 -0.515 . . . . 0.0 110.081 177.216 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 127' ' ' ASN . . . . . . . . . . . . . 4.3 t30 55.24 -153.82 0.31 Allowed 'General case' 0 CA--C 1.539 0.539 0 N-CA-C 110.017 -0.364 . . . . 0.0 110.017 -179.844 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 128' ' ' ASP . . . . . . . . . . . . . 8.2 p-10 -83.66 18.53 1.89 Allowed 'General case' 0 CA--C 1.535 0.37 0 N-CA-C 112.679 0.622 . . . . 0.0 112.679 179.269 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 129' ' ' LEU . . . . . . . . . . . . . 15.5 tp -122.94 138.25 54.72 Favored 'General case' 0 C--O 1.232 0.157 0 O-C-N 121.983 -0.448 . . . . 0.0 110.503 -179.608 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 130' ' ' VAL . . . . . 0.478 HG23 ' HB ' ' A' ' 141' ' ' ILE . 32.7 m -131.23 141.75 45.19 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.184 0 CA-C-O 120.805 0.336 . . . . 0.0 110.449 177.578 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 131' ' ' VAL . . . . . . . . . . . . . 47.9 t -136.14 138.61 46.99 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.285 0 CA-C-O 121.274 0.559 . . . . 0.0 110.682 -179.526 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 132' ' ' ILE . . . . . . . . . . . . . 72.1 mt -111.74 133.27 57.92 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.329 0 CA-C-N 115.41 -0.814 . . . . 0.0 109.135 178.089 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 133' ' ' ILE . . . . . . . . . . . . . 43.4 mm -114.82 120.04 63.35 Favored 'Isoleucine or valine' 0 C--O 1.233 0.229 0 CA-C-O 120.884 0.373 . . . . 0.0 110.964 -175.294 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 134' ' ' ASP . . . . . . . . . . . . . 6.2 p-10 -130.46 144.83 51.65 Favored 'General case' 0 C--N 1.331 -0.227 0 N-CA-C 109.366 -0.605 . . . . 0.0 109.366 173.83 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 135' ' ' GLU . . . . . . . . . . . . . 43.4 tp10 -49.78 -24.97 2.65 Favored 'General case' 0 C--N 1.328 -0.334 0 N-CA-C 112.793 0.664 . . . . 0.0 112.793 -170.799 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 136' ' ' GLN . . . . . . . . . . . . . 96.0 mt-30 -91.53 -40.08 11.57 Favored 'General case' 0 C--N 1.331 -0.231 0 N-CA-C 112.305 0.483 . . . . 0.0 112.305 -177.389 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 137' ' ' LYS . . . . . . . . . . . . . 61.2 mtpt -141.96 155.81 45.47 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-O 121.34 0.59 . . . . 0.0 111.718 -167.989 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 138' ' ' LEU . . . . . 0.426 ' C ' HD23 ' A' ' 138' ' ' LEU . 5.9 tt -116.0 124.69 51.13 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 115.519 -0.764 . . . . 0.0 109.177 173.832 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 139' ' ' THR . . . . . . . . . . . . . 31.1 m -111.12 124.38 52.08 Favored 'General case' 0 C--N 1.331 -0.196 0 CA-C-N 116.438 -0.346 . . . . 0.0 110.794 -176.993 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 140' ' ' LEU . . . . . 0.479 HD23 ' C ' ' A' ' 140' ' ' LEU . 9.9 tt -112.07 126.85 55.62 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 115.762 -0.653 . . . . 0.0 109.591 -178.468 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 141' ' ' ILE . . . . . 0.478 ' HB ' HG23 ' A' ' 130' ' ' VAL . 19.5 mt -125.21 123.88 66.15 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.302 0 CA-C-O 121.008 0.432 . . . . 0.0 109.873 -176.543 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 142' ' ' ARG . . . . . . . . . . . . . 61.5 ttt180 -110.06 124.88 52.27 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 115.119 -0.946 . . . . 0.0 110.459 -177.794 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 143' ' ' THR . . . . . . . . . . . . . 9.3 p . . . . . 0 C--O 1.22 -0.49 0 CA-C-O 117.979 -1.01 . . . . 0.0 110.592 179.959 . . . . . . . . 0 0 . 1 . 011 nuclear build core ' B' B ' 2' ' ' SER . . . . . . . . . . . . . 11.6 p . . . . . 0 C--O 1.231 0.125 0 CA-C-O 120.953 0.406 . . . . 0.0 110.549 . . . . . . . . . 0 0 . 1 . 011 nuclear build core ' B' B ' 3' ' ' GLU . . . . . . . . . . . . . 95.0 mt-10 -140.91 140.48 34.5 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 115.941 -0.572 . . . . 0.0 111.0 -178.762 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' B' B ' 4' ' ' LEU . . . . . . . . . . . . . 18.2 tp -125.23 130.73 52.68 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 115.915 -0.584 . . . . 0.0 110.119 176.558 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' B' B ' 5' ' ' LYS . . . . . . . . . . . . . 93.6 mttt -112.19 121.43 44.9 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-O 120.843 0.354 . . . . 0.0 110.569 179.588 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' B' B ' 6' ' ' LEU . . . . . . . . . . . . . 62.7 mt -114.1 147.16 39.22 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 115.388 -0.823 . . . . 0.0 111.157 -177.869 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' B' B ' 7' ' ' LYS . . . . . . . . . . . . . 79.4 tttt -137.0 140.26 31.0 Favored Pre-proline 0 CA--C 1.534 0.333 0 CA-C-N 116.07 -0.514 . . . . 0.0 109.724 175.715 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' B' B ' 8' ' ' PRO . . . . . . . . . . . . . 89.4 Cg_endo -91.58 146.45 3.31 Favored 'Trans proline' 0 N--CA 1.491 1.333 0 C-N-CA 121.735 1.624 . . . . 0.0 111.972 178.968 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' B' B ' 9' ' ' LEU . . . . . . . . . . . . . 41.4 mt -82.57 -46.84 0.91 Allowed Pre-proline 0 CA--C 1.534 0.353 0 CA-C-O 118.78 -0.628 . . . . 0.0 111.909 179.317 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' B' B ' 10' ' ' PRO . . . . . . . . . . . . . 94.3 Cg_endo -82.05 155.84 17.42 Favored 'Trans proline' 0 N--CA 1.495 1.56 0 C-N-CA 121.253 1.302 . . . . 0.0 111.767 174.433 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' B' B ' 11' ' ' LYS . . . . . . . . . . . . . 92.2 mttt -88.53 98.43 11.64 Favored 'General case' 0 C--N 1.329 -0.316 0 C-N-CA 120.883 -0.327 . . . . 0.0 110.513 178.725 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' B' B ' 12' ' ' VAL . . . . . . . . . . . . . 12.2 p -140.34 147.4 23.34 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.302 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.433 -179.976 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' B' B ' 13' ' ' GLU . . . . . . . . . . . . . 43.0 tp10 -89.21 129.93 35.7 Favored 'General case' 0 C--N 1.329 -0.298 0 N-CA-C 109.862 -0.421 . . . . 0.0 109.862 178.298 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' B' B ' 14' ' ' LEU . . . . . . . . . . . . . 53.8 mt -97.33 147.58 33.16 Favored Pre-proline 0 CA--C 1.532 0.286 0 CA-C-O 119.196 -0.43 . . . . 0.0 110.727 -176.94 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' B' B ' 15' ' ' PRO . . . . . . . . . . . . . 24.4 Cg_exo -63.31 161.11 32.03 Favored 'Trans proline' 0 N--CA 1.498 1.738 0 C-N-CA 121.248 1.299 . . . . 0.0 111.762 175.881 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' B' B ' 16' ' ' PRO . . . . . . . . . . . . . 31.2 Cg_exo -59.24 -38.15 87.22 Favored 'Trans proline' 0 N--CA 1.497 1.721 0 C-N-CA 121.471 1.447 . . . . 0.0 112.78 -177.706 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' B' B ' 17' ' ' ASP . . . . . . . . . . . . . 18.2 p-10 -88.79 9.44 24.58 Favored 'General case' 0 CA--C 1.536 0.419 0 N-CA-C 113.243 0.831 . . . . 0.0 113.243 -177.735 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' B' B ' 18' ' ' PHE . . . . . . . . . . . . . 34.2 t80 -58.25 -43.74 88.01 Favored 'General case' 0 C--N 1.334 -0.081 0 O-C-N 122.023 -0.423 . . . . 0.0 109.9 -178.446 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' B' B ' 19' ' ' VAL . . . . . . . . . . . . . 53.9 t -56.92 -42.91 79.54 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.369 0 CA-C-N 116.18 -0.464 . . . . 0.0 110.494 -179.479 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' B' B ' 20' ' ' ASP . . . . . . . . . . . . . 10.4 t0 -60.04 -42.6 94.77 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-O 120.847 0.356 . . . . 0.0 111.049 -177.796 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' B' B ' 21' ' ' VAL . . . . . . . . . . . . . 51.3 t -64.25 -47.01 91.67 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.335 0 CA-C-N 116.448 -0.342 . . . . 0.0 110.515 -177.685 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' B' B ' 22' ' ' ILE . . . . . 0.507 HG22 HD12 ' B' ' 26' ' ' LEU . 49.7 mm -56.48 -45.42 81.97 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.252 0 C-N-CA 120.982 -0.287 . . . . 0.0 110.572 178.819 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' B' B ' 23' ' ' ARG . . . . . . . . . . . . . 24.8 ttp180 -53.8 -50.16 66.75 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-O 120.58 0.229 . . . . 0.0 111.48 -178.446 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' B' B ' 24' ' ' ILE . . . . . . . . . . . . . 73.9 mt -59.86 -45.15 95.27 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.316 0 CA-C-N 116.574 -0.284 . . . . 0.0 111.281 -176.536 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' B' B ' 25' ' ' LYS . . . . . . . . . . . . . 50.2 mttm -65.44 -39.28 91.86 Favored 'General case' 0 C--N 1.329 -0.289 0 N-CA-C 112.607 0.595 . . . . 0.0 112.607 -177.629 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' B' B ' 26' ' ' LEU . . . . . 0.507 HD12 HG22 ' B' ' 22' ' ' ILE . 26.8 mt -77.55 -43.19 32.69 Favored 'General case' 0 C--N 1.33 -0.272 0 N-CA-C 112.763 0.653 . . . . 0.0 112.763 -172.838 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' B' B ' 27' ' ' GLN . . . . . . . . . . . . . 13.3 pt20 -47.0 137.49 7.42 Favored 'General case' 0 N--CA 1.469 0.51 0 N-CA-C 112.629 0.603 . . . . 0.0 112.629 -177.071 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' B' B ' 28' ' ' GLY . . . . . . . . . . . . . . . 100.72 -26.84 23.13 Favored Glycine 0 CA--C 1.533 1.183 0 CA-C-N 115.565 -0.743 . . . . 0.0 112.209 -176.477 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' B' B ' 29' ' ' LYS . . . . . . . . . . . . . 94.8 mttt -98.38 155.13 17.38 Favored 'General case' 0 C--O 1.232 0.166 0 CA-C-N 117.219 0.509 . . . . 0.0 110.842 178.555 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' B' B ' 30' ' ' THR . . . . . . . . . . . . . 28.5 m -103.04 136.45 42.82 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.279 -0.419 . . . . 0.0 109.962 175.269 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' B' B ' 31' ' ' VAL . . . . . . . . . . . . . 35.5 m -128.99 153.39 38.52 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.216 0 CA-C-O 121.047 0.451 . . . . 0.0 111.019 -177.856 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' B' B ' 32' ' ' ARG . . . . . . . . . . . . . 90.0 mtm-85 -128.81 148.98 50.92 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 115.905 -0.589 . . . . 0.0 110.457 178.877 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' B' B ' 33' ' ' THR . . . . . . . . . . . . . 18.7 m -53.42 138.6 32.86 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.326 -0.397 . . . . 0.0 111.279 -177.978 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' B' B ' 34' ' ' GLY . . . . . . . . . . . . . . . 101.06 -17.1 56.62 Favored Glycine 0 CA--C 1.533 1.167 0 CA-C-O 119.609 -0.55 . . . . 0.0 113.284 179.574 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' B' B ' 35' ' ' ASP . . . . . . . . . . . . . 69.0 m-20 -64.26 148.88 49.18 Favored 'General case' 0 C--N 1.334 -0.106 0 CA-C-N 118.07 0.935 . . . . 0.0 111.029 179.537 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' B' B ' 36' ' ' VAL . . . . . . . . . . . . . 45.6 t -123.8 131.58 72.77 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.215 0 CA-C-N 115.774 -0.648 . . . . 0.0 109.8 178.899 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' B' B ' 37' ' ' ILE . . . . . . . . . . . . . 65.6 mt -121.2 139.23 49.04 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.217 0 CA-C-N 116.197 -0.456 . . . . 0.0 109.973 -179.925 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' B' B ' 38' ' ' GLY . . . . . . . . . . . . . . . -112.31 128.78 8.68 Favored Glycine 0 CA--C 1.526 0.767 0 N-CA-C 111.033 -0.827 . . . . 0.0 111.033 179.799 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' B' B ' 39' ' ' ILE . . . . . . . . . . . . . 71.6 mt -124.12 134.81 65.56 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.21 0 N-CA-C 110.091 -0.337 . . . . 0.0 110.091 179.199 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' B' B ' 40' ' ' SER . . . . . . . . . . . . . 95.0 p -93.64 124.49 37.66 Favored 'General case' 0 C--N 1.331 -0.225 0 CA-C-N 116.338 -0.392 . . . . 0.0 111.096 176.24 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' B' B ' 41' ' ' ILE . . . . . . . . . . . . . 75.0 mt -130.63 122.5 52.87 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.254 0 CA-C-N 116.488 -0.324 . . . . 0.0 110.331 176.749 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' B' B ' 42' ' ' LEU . . . . . . . . . . . . . 6.6 tp 52.16 36.03 18.11 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 116.279 -0.419 . . . . 0.0 111.652 176.823 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' B' B ' 43' ' ' GLY . . . . . . . . . . . . . . . 71.84 32.56 63.7 Favored Glycine 0 CA--C 1.529 0.964 0 C-N-CA 121.085 -0.578 . . . . 0.0 112.033 178.543 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' B' B ' 44' ' ' LYS . . . . . . . . . . . . . 84.8 tttt -137.19 127.18 25.87 Favored 'General case' 0 C--N 1.328 -0.356 0 N-CA-C 109.74 -0.467 . . . . 0.0 109.74 178.915 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' B' B ' 45' ' ' GLU . . . . . . . . . . . . . 84.7 tt0 -83.01 122.84 28.83 Favored 'General case' 0 C--N 1.327 -0.409 0 CA-C-O 120.802 0.334 . . . . 0.0 110.923 -178.874 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' B' B ' 46' ' ' VAL . . . . . . . . . . . . . 7.6 p -120.16 127.74 75.92 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.229 0 N-CA-C 109.35 -0.611 . . . . 0.0 109.35 175.35 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' B' B ' 47' ' ' LYS . . . . . . . . . . . . . 58.2 mtpt -101.26 128.14 47.53 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 115.798 -0.637 . . . . 0.0 111.148 -179.658 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' B' B ' 48' ' ' PHE . . . . . . . . . . . . . 95.6 m-85 -112.44 131.94 55.3 Favored 'General case' 0 C--N 1.331 -0.223 0 CA-C-N 116.335 -0.393 . . . . 0.0 110.196 176.946 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' B' B ' 49' ' ' LYS . . . . . . . . . . . . . 74.4 tttt -108.39 137.45 46.33 Favored 'General case' 0 C--N 1.331 -0.229 0 CA-C-N 116.449 -0.342 . . . . 0.0 110.664 179.022 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' B' B ' 50' ' ' VAL . . . . . . . . . . . . . 47.1 t -82.88 110.59 18.1 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.254 0 N-CA-C 109.434 -0.58 . . . . 0.0 109.434 176.265 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' B' B ' 51' ' ' VAL . . . . . . . . . . . . . 47.5 t -73.78 -51.53 24.27 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.231 0 CA-C-N 116.108 -0.496 . . . . 0.0 109.754 -174.774 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' B' B ' 52' ' ' GLN . . . . . . . . . . . . . 92.6 mt-30 -153.26 152.82 31.61 Favored 'General case' 0 C--N 1.331 -0.211 0 CA-C-O 121.176 0.513 . . . . 0.0 111.82 -177.739 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' B' B ' 53' ' ' ALA . . . . . . . . . . . . . . . -132.27 133.59 44.28 Favored 'General case' 0 C--N 1.327 -0.404 0 CA-C-N 115.113 -0.949 . . . . 0.0 109.677 174.9 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' B' B ' 54' ' ' TYR . . . . . . . . . . . . . 63.1 t80 -129.2 113.6 18.43 Favored Pre-proline 0 CA--C 1.536 0.411 0 CA-C-O 118.077 -0.963 . . . . 0.0 110.569 179.07 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' B' B ' 55' ' ' PRO . . . . . . . . . . . . . 71.8 Cg_endo -77.25 164.11 87.57 Favored 'Cis proline' 0 N--CA 1.5 1.879 0 CA-C-N 121.993 1.748 . . . . 0.0 112.123 -8.831 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' B' B ' 56' ' ' SER . . . . . . . . . . . . . 13.7 m -114.03 132.82 22.51 Favored Pre-proline 0 CA--C 1.539 0.52 0 CA-C-O 118.495 -0.764 . . . . 0.0 109.388 175.173 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' B' B ' 57' ' ' PRO . . . . . . . . . . . . . 43.5 Cg_endo -69.02 143.81 73.45 Favored 'Cis proline' 0 N--CA 1.498 1.763 0 CA-C-N 121.865 1.702 . . . . 0.0 111.439 -0.713 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' B' B ' 58' ' ' LEU . . . . . . . . . . . . . 24.2 tp -105.68 135.51 46.96 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.382 -0.372 . . . . 0.0 110.667 -178.282 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' B' B ' 59' ' ' ARG . . . . . . . . . . . . . 41.7 ttm180 -99.98 121.54 41.51 Favored 'General case' 0 C--N 1.326 -0.438 0 N-CA-C 108.983 -0.747 . . . . 0.0 108.983 174.133 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' B' B ' 60' ' ' VAL . . . . . . . . . . . . . 39.9 t -79.53 122.57 35.02 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.225 0 C-N-CA 120.587 -0.445 . . . . 0.0 110.205 -174.107 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' B' B ' 61' ' ' GLU . . . . . . . . . . . . . 34.9 tp10 -130.89 156.7 44.61 Favored 'General case' 0 C--N 1.329 -0.32 0 N-CA-C 109.071 -0.715 . . . . 0.0 109.071 179.131 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' B' B ' 62' ' ' ASP . . . . . . . . . . . . . 5.5 t70 -51.42 -32.53 26.83 Favored 'General case' 0 C--N 1.326 -0.454 0 N-CA-C 111.946 0.35 . . . . 0.0 111.946 -178.945 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' B' B ' 63' ' ' ARG . . . . . . . . . . . . . 48.0 mmm-85 -73.91 -19.17 60.78 Favored 'General case' 0 CA--C 1.536 0.431 0 N-CA-C 113.095 0.776 . . . . 0.0 113.095 -176.928 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' B' B ' 64' ' ' THR . . . . . . . . . . . . . 32.0 m -67.9 141.69 56.3 Favored 'General case' 0 C--N 1.331 -0.209 0 CA-C-O 120.978 0.418 . . . . 0.0 111.114 -175.307 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' B' B ' 65' ' ' LYS . . . . . . . . . . . . . 68.4 mttm -90.23 132.88 35.26 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 115.833 -0.621 . . . . 0.0 110.322 179.639 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' B' B ' 66' ' ' ILE . . . . . . . . . . . . . 66.4 mt -112.56 131.2 64.75 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.239 0 N-CA-C 109.865 -0.42 . . . . 0.0 109.865 179.574 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' B' B ' 67' ' ' THR . . . . . . . . . . . . . 22.6 m -126.05 142.84 51.35 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-N 115.989 -0.551 . . . . 0.0 110.917 -177.723 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' B' B ' 68' ' ' LEU . . . . . . . . . . . . . 16.5 tp . . . . . 0 C--N 1.328 -0.336 0 CA-C-N 115.845 -0.616 . . . . 0.0 109.829 177.282 . . . . . . . . 0 0 . 1 . 011 nuclear build core ' B' B ' 73' ' ' VAL . . . . . . . . . . . . . 27.6 m . . . . . 0 C--O 1.232 0.164 0 N-CA-C 109.422 -0.584 . . . . 0.0 109.422 . . . . . . . . . 0 0 . 1 . 011 nuclear build core ' B' B ' 74' ' ' ASP . . . . . . . . . . . . . 36.2 t0 -92.62 123.71 36.12 Favored 'General case' 0 C--N 1.327 -0.397 0 CA-C-N 116.252 -0.431 . . . . 0.0 110.195 -176.764 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' B' B ' 75' ' ' VAL . . . . . . . . . . . . . 43.0 t -118.23 123.64 71.92 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.267 0 CA-C-O 121.16 0.505 . . . . 0.0 110.455 -178.592 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' B' B ' 76' ' ' LEU . . . . . . . . . . . . . 5.7 mp -123.48 146.04 48.36 Favored 'General case' 0 C--N 1.331 -0.22 0 CA-C-N 115.572 -0.74 . . . . 0.0 109.554 175.812 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' B' B ' 77' ' ' GLU . . . . . . . . . . . . . 96.9 mt-10 -134.5 132.29 39.05 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-O 121.085 0.469 . . . . 0.0 111.106 -178.267 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' B' B ' 78' ' ' ALA . . . . . . . . . . . . . . . -117.18 136.81 52.77 Favored 'General case' 0 C--N 1.331 -0.229 0 CA-C-N 115.657 -0.701 . . . . 0.0 109.91 176.898 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' B' B ' 79' ' ' LYS . . . . . 0.61 ' O ' HD13 ' B' ' 80' ' ' ILE . 55.6 mtmt -85.37 112.8 21.16 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.501 -0.318 . . . . 0.0 110.721 -178.359 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' B' B ' 80' ' ' ILE . . . . . 0.61 HD13 ' O ' ' B' ' 79' ' ' LYS . 41.0 mm -139.04 104.2 2.18 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.302 0 N-CA-C 109.33 -0.619 . . . . 0.0 109.33 -178.164 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' B' B ' 81' ' ' LYS . . . . . . . . . . . . . 52.9 pttt -98.99 130.87 45.36 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-O 120.923 0.392 . . . . 0.0 111.123 -178.497 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' B' B ' 82' ' ' GLY . . . . . . . . . . . . . . . 89.22 42.1 5.66 Favored Glycine 0 CA--C 1.524 0.649 0 N-CA-C 111.191 -0.764 . . . . 0.0 111.191 178.087 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' B' B ' 83' ' ' ILE . . . . . . . . . . . . . 66.6 mt -70.23 135.55 27.94 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.342 0 N-CA-C 109.539 -0.541 . . . . 0.0 109.539 177.676 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' B' B ' 84' ' ' LYS . . . . . . . . . . . . . 16.4 ttmm -89.37 -52.24 5.14 Favored 'General case' 0 C--N 1.328 -0.36 0 N-CA-C 109.734 -0.469 . . . . 0.0 109.734 179.687 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' B' B ' 85' ' ' ASP . . . . . . . . . . . . . 8.5 t70 -160.46 154.39 22.84 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 115.615 -0.72 . . . . 0.0 110.476 178.845 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' B' B ' 86' ' ' VAL . . . . . . . . . . . . . 40.5 t -128.34 131.47 69.03 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.259 0 CA-C-O 120.89 0.376 . . . . 0.0 110.194 179.985 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' B' B ' 87' ' ' ILE . . . . . 0.491 ' N ' HD12 ' B' ' 87' ' ' ILE . 5.0 mp -120.54 127.12 75.89 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.238 0 CA-C-N 116.021 -0.536 . . . . 0.0 109.755 177.855 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' B' B ' 88' ' ' LEU . . . . . . . . . . . . . 42.4 mt -104.75 139.78 39.04 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 116.248 -0.433 . . . . 0.0 111.0 -179.842 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' B' B ' 89' ' ' ASP . . . . . . . . . . . . . 9.5 t70 -132.98 158.4 42.77 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 115.922 -0.581 . . . . 0.0 109.672 176.917 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' B' B ' 90' ' ' GLU . . . . . . . . . . . . . 43.0 mt-10 -46.83 -39.69 12.43 Favored 'General case' 0 C--N 1.329 -0.306 0 N-CA-C 113.139 0.792 . . . . 0.0 113.139 -170.469 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' B' B ' 91' ' ' ASN . . . . . . . . . . . . . 29.2 m-80 -131.99 21.33 4.52 Favored 'General case' 0 N--CA 1.468 0.444 0 N-CA-C 113.044 0.757 . . . . 0.0 113.044 -177.591 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' B' B ' 92' ' ' LEU . . . . . . . . . . . . . 34.1 mt -150.37 150.34 31.28 Favored 'General case' 0 C--N 1.331 -0.222 0 CA-C-O 120.766 0.317 . . . . 0.0 110.451 -176.923 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' B' B ' 93' ' ' ILE . . . . . . . . . . . . . 73.3 mt -127.07 121.48 57.97 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.251 0 N-CA-C 109.133 -0.691 . . . . 0.0 109.133 175.361 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' B' B ' 94' ' ' VAL . . . . . . . . . . . . . 46.9 t -118.64 126.25 75.05 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.215 0 N-CA-C 109.814 -0.439 . . . . 0.0 109.814 -179.192 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' B' B ' 95' ' ' VAL . . . . . . . . . . . . . 46.5 t -118.91 133.19 66.56 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.316 0 CA-C-N 115.901 -0.591 . . . . 0.0 109.643 -179.951 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' B' B ' 96' ' ' ILE . . . . . . . . . . . . . 64.4 mt -111.91 126.22 69.28 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.317 0 N-CA-C 109.081 -0.711 . . . . 0.0 109.081 178.982 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' B' B ' 97' ' ' THR . . . . . . . . . . . . . 74.3 p -99.34 154.12 18.44 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-O 121.192 0.52 . . . . 0.0 111.117 -176.877 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' B' B ' 98' ' ' GLU . . . . . . . . . . . . . 84.9 tt0 -53.88 -25.51 20.34 Favored 'General case' 0 CA--C 1.535 0.372 0 CA-C-N 116.069 -0.514 . . . . 0.0 112.231 -179.513 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' B' B ' 99' ' ' GLU . . . . . . . . . . . . . 45.5 mp0 -80.91 18.08 1.08 Allowed 'General case' 0 CA--C 1.535 0.386 0 N-CA-C 112.989 0.737 . . . . 0.0 112.989 -176.619 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' B' B ' 100' ' ' ASN . . . . . . . . . . . . . 3.1 m-20 62.4 37.97 13.24 Favored 'General case' 0 C--O 1.232 0.171 0 CA-C-O 121.193 0.52 . . . . 0.0 110.997 178.121 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' B' B ' 101' ' ' GLU . . . . . . . . . . . . . 84.8 tt0 -118.77 144.77 46.08 Favored 'General case' 0 C--N 1.332 -0.175 0 CA-C-N 116.211 -0.449 . . . . 0.0 109.954 177.136 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' B' B ' 102' ' ' VAL . . . . . . . . . . . . . 44.1 t -115.09 125.34 72.37 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.29 0 N-CA-C 109.797 -0.445 . . . . 0.0 109.797 -178.034 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' B' B ' 103' ' ' LEU . . . . . . . . . . . . . 34.6 mt -117.07 130.23 56.52 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-N 115.814 -0.63 . . . . 0.0 110.006 177.874 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' B' B ' 104' ' ' ILE . . . . . . . . . . . . . 69.7 mt -118.05 122.73 70.37 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.249 0 N-CA-C 110.222 -0.288 . . . . 0.0 110.222 -179.115 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' B' B ' 105' ' ' PHE . . . . . . . . . . . . . 90.9 m-85 -122.77 164.31 18.59 Favored 'General case' 0 C--N 1.332 -0.168 0 O-C-N 123.783 0.677 . . . . 0.0 110.236 -178.496 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' B' B ' 106' ' ' ASN . . . . . . . . . . . . . 49.6 p-10 -98.14 -170.74 2.02 Favored 'General case' 0 C--N 1.33 -0.28 0 N-CA-C 109.866 -0.42 . . . . 0.0 109.866 174.933 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' B' B ' 107' ' ' GLN . . . . . . . . . . . . . 58.9 tt0 -58.24 -30.01 66.2 Favored 'General case' 0 C--N 1.328 -0.332 0 N-CA-C 112.038 0.384 . . . . 0.0 112.038 -178.407 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' B' B ' 108' ' ' ASN . . . . . . . . . . . . . 10.6 t-20 -89.88 14.02 13.11 Favored 'General case' 0 CA--C 1.534 0.348 0 N-CA-C 113.098 0.777 . . . . 0.0 113.098 -176.033 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' B' B ' 109' ' ' LEU . . . . . . . . . . . . . 14.5 mt 58.61 35.38 24.49 Favored 'General case' 0 C--N 1.331 -0.201 0 CA-C-O 120.924 0.392 . . . . 0.0 111.502 179.628 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' B' B ' 110' ' ' GLU . . . . . . . . . . . . . 96.5 mt-10 -101.92 143.3 31.97 Favored 'General case' 0 C--N 1.328 -0.34 0 N-CA-C 109.189 -0.671 . . . . 0.0 109.189 174.392 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' B' B ' 111' ' ' GLU . . . . . . . . . . . . . 51.1 tt0 -81.23 121.83 26.65 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-O 120.97 0.414 . . . . 0.0 110.653 -175.299 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' B' B ' 112' ' ' LEU . . . . . . . . . . . . . 23.2 mt -103.67 -46.09 4.63 Favored 'General case' 0 C--N 1.331 -0.212 0 CA-C-N 115.88 -0.6 . . . . 0.0 110.691 179.668 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' B' B ' 113' ' ' TYR . . . . . . . . . . . . . 58.7 t80 -137.67 146.73 44.19 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.961 -178.929 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' B' B ' 114' ' ' ARG . . . . . . . . . . . . . 30.4 ptt180 -149.69 124.58 9.92 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-N 116.158 -0.473 . . . . 0.0 111.051 -178.527 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' B' B ' 115' ' ' GLY . . . . . . . . . . . . . . . -150.16 162.42 29.21 Favored Glycine 0 CA--C 1.525 0.692 0 N-CA-C 110.928 -0.869 . . . . 0.0 110.928 178.806 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' B' B ' 116' ' ' LYS . . . . . . . . . . . . . 38.3 ttpt -131.95 138.67 48.42 Favored 'General case' 0 C--N 1.33 -0.259 0 N-CA-C 109.979 -0.378 . . . . 0.0 109.979 177.13 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' B' B ' 117' ' ' PHE . . . . . . . . . . . . . 41.8 m-85 -136.37 117.31 14.23 Favored 'General case' 0 C--N 1.331 -0.227 0 C-N-CA 120.874 -0.331 . . . . 0.0 110.362 -175.716 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' B' B ' 118' ' ' GLU . . . . . . . . . . . . . 70.6 mm-40 -54.11 -45.23 71.82 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.616 -0.265 . . . . 0.0 111.246 -177.515 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' B' B ' 119' ' ' ASN . . . . . . . . . . . . . 84.1 m-20 -98.87 31.06 3.09 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.181 -0.463 . . . . 0.0 112.171 -174.479 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' B' B ' 120' ' ' LEU . . . . . . . . . . . . . 23.0 tp -56.23 120.78 8.13 Favored 'General case' 0 C--N 1.332 -0.17 0 CA-C-O 120.626 0.25 . . . . 0.0 110.393 178.512 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' B' B ' 121' ' ' ASN . . . . . . . . . . . . . 34.3 m120 -109.66 -44.21 3.9 Favored 'General case' 0 N--CA 1.462 0.152 0 CA-C-N 116.649 -0.251 . . . . 0.0 111.211 -176.118 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' B' B ' 122' ' ' LYS . . . . . . . . . . . . . 94.3 mttt -147.94 148.14 30.47 Favored 'General case' 0 C--N 1.333 -0.139 0 C-N-CA 120.392 -0.523 . . . . 0.0 111.966 -177.918 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' B' B ' 123' ' ' VAL . . . . . . . . . . . . . 48.0 t -124.09 128.17 73.88 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.255 0 N-CA-C 109.251 -0.648 . . . . 0.0 109.251 173.792 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' B' B ' 124' ' ' LEU . . . . . . . . . . . . . 12.9 tp -129.07 132.42 47.43 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-O 120.651 0.262 . . . . 0.0 110.729 -177.092 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' B' B ' 125' ' ' VAL . . . . . . . . . . . . . 12.3 p -135.45 136.08 51.17 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.23 0 CA-C-O 120.735 0.302 . . . . 0.0 110.393 179.095 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' B' B ' 126' ' ' ARG . . . . . . . . . . . . . 96.4 mtt180 -148.72 134.16 18.58 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-O 120.977 0.418 . . . . 0.0 111.052 179.583 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' B' B ' 127' ' ' ASN . . . . . . . . . . . . . 86.3 m-20 50.32 -111.52 0.52 Allowed 'General case' 0 CA--C 1.545 0.778 0 CA-C-O 118.786 -0.626 . . . . 0.0 111.398 178.827 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' B' B ' 128' ' ' ASP . . . . . . . . . . . . . 8.2 p-10 -114.12 8.62 17.01 Favored 'General case' 0 CA--C 1.536 0.423 0 CA-C-N 119.908 1.231 . . . . 0.0 113.322 -176.934 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' B' B ' 129' ' ' LEU . . . . . . . . . . . . . 42.3 mt -117.72 144.75 44.99 Favored 'General case' 0 C--O 1.232 0.134 0 CA-C-N 118.028 0.376 . . . . 0.0 110.197 179.73 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' B' B ' 130' ' ' VAL . . . . . 0.506 HG13 ' HB ' ' B' ' 141' ' ' ILE . 12.1 p -132.97 140.31 47.58 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.212 0 CA-C-O 120.967 0.413 . . . . 0.0 110.366 -179.572 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' B' B ' 131' ' ' VAL . . . . . 0.565 HG22 HD12 ' B' ' 140' ' ' LEU . 44.1 t -136.01 139.95 44.9 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.287 0 CA-C-N 116.046 -0.524 . . . . 0.0 110.337 -178.531 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' B' B ' 132' ' ' ILE . . . . . . . . . . . . . 74.4 mt -115.92 131.43 68.39 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.364 0 CA-C-N 115.548 -0.751 . . . . 0.0 109.05 177.735 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' B' B ' 133' ' ' ILE . . . . . . . . . . . . . 42.9 mm -114.86 121.07 66.2 Favored 'Isoleucine or valine' 0 C--O 1.234 0.252 0 CA-C-O 120.867 0.365 . . . . 0.0 111.027 -174.744 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' B' B ' 134' ' ' ASP . . . . . . . . . . . . . 6.3 p-10 -129.74 146.41 51.5 Favored 'General case' 0 C--N 1.332 -0.191 0 CA-C-N 115.834 -0.621 . . . . 0.0 109.485 174.605 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' B' B ' 135' ' ' GLU . . . . . . . . . . . . . 41.7 tp10 -49.9 -24.25 2.4 Favored 'General case' 0 C--N 1.328 -0.369 0 N-CA-C 112.976 0.732 . . . . 0.0 112.976 -169.808 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' B' B ' 136' ' ' GLN . . . . . . . . . . . . . 21.3 pt20 -102.4 -30.45 11.02 Favored 'General case' 0 CA--C 1.532 0.255 0 N-CA-C 112.709 0.633 . . . . 0.0 112.709 -174.603 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' B' B ' 137' ' ' LYS . . . . . . . . . . . . . 27.4 mtpp -141.48 153.86 45.2 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-O 121.278 0.561 . . . . 0.0 111.519 -172.044 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' B' B ' 138' ' ' LEU . . . . . . . . . . . . . 5.0 tt -114.94 124.43 51.66 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 115.615 -0.72 . . . . 0.0 109.382 174.72 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' B' B ' 139' ' ' THR . . . . . . . . . . . . . 44.0 m -108.04 122.97 47.96 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.471 -0.331 . . . . 0.0 110.727 -177.994 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' B' B ' 140' ' ' LEU . . . . . 0.565 HD12 HG22 ' B' ' 131' ' ' VAL . 38.8 tp -112.97 121.56 45.0 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 115.665 -0.698 . . . . 0.0 109.322 -179.294 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' B' B ' 141' ' ' ILE . . . . . 0.506 ' HB ' HG13 ' B' ' 130' ' ' VAL . 19.2 mt -123.91 125.84 71.63 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.268 0 CA-C-O 121.012 0.434 . . . . 0.0 109.937 -176.991 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' B' B ' 142' ' ' ARG . . . . . . . . . . . . . 72.7 mtp180 -108.53 124.01 49.8 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 115.304 -0.862 . . . . 0.0 110.344 179.716 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' B' B ' 143' ' ' THR . . . . . . . . . . . . . 77.2 p . . . . . 0 C--O 1.219 -0.501 0 CA-C-O 118.016 -0.992 . . . . 0.0 110.522 -179.316 . . . . . . . . 0 0 . 1 . 011 nuclear build core ' C' C ' 2' ' ' SER . . . . . . . . . . . . . 5.5 p . . . . . 0 C--O 1.231 0.09 0 CA-C-O 120.799 0.333 . . . . 0.0 110.128 . . . . . . . . . 0 0 . 1 . 011 nuclear build core ' C' C ' 3' ' ' GLU . . . . . . . . . . . . . 94.7 mt-10 -141.28 136.6 31.78 Favored 'General case' 0 C--N 1.327 -0.407 0 CA-C-N 116.129 -0.487 . . . . 0.0 111.066 -178.681 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' C' C ' 4' ' ' LEU . . . . . . . . . . . . . 15.2 tp -123.04 126.38 46.99 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 115.983 -0.553 . . . . 0.0 109.806 175.554 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' C' C ' 5' ' ' LYS . . . . . . . . . . . . . 69.2 mttm -113.49 121.49 44.41 Favored 'General case' 0 C--N 1.331 -0.221 0 CA-C-N 116.371 -0.377 . . . . 0.0 110.669 -179.267 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' C' C ' 6' ' ' LEU . . . . . . . . . . . . . 58.2 mt -115.83 143.57 45.22 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 115.415 -0.812 . . . . 0.0 110.264 -178.726 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' C' C ' 7' ' ' LYS . . . . . . . . . . . . . 82.8 tttt -124.19 135.17 26.09 Favored Pre-proline 0 CA--C 1.534 0.359 0 CA-C-O 118.792 -0.623 . . . . 0.0 109.575 175.098 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' C' C ' 8' ' ' PRO . . . . . . . . . . . . . 88.3 Cg_endo -91.27 137.99 2.18 Favored 'Trans proline' 0 N--CA 1.49 1.317 0 C-N-CA 121.665 1.577 . . . . 0.0 111.901 179.357 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' C' C ' 9' ' ' LEU . . . . . . . . . . . . . 65.1 mt -71.8 -47.44 12.02 Favored Pre-proline 0 CA--C 1.533 0.312 0 CA-C-O 118.725 -0.655 . . . . 0.0 112.071 179.628 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' C' C ' 10' ' ' PRO . . . . . . . . . . . . . 98.7 Cg_endo -79.53 151.95 22.78 Favored 'Trans proline' 0 N--CA 1.495 1.57 0 C-N-CA 121.156 1.237 . . . . 0.0 111.779 175.696 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' C' C ' 11' ' ' LYS . . . . . . . . . . . . . 64.3 mttp -88.32 91.83 8.93 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-O 120.783 0.325 . . . . 0.0 110.69 179.807 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' C' C ' 12' ' ' VAL . . . . . . . . . . . . . 12.6 p -140.47 145.93 25.13 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.325 0 CA-C-N 116.16 -0.473 . . . . 0.0 110.34 178.684 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' C' C ' 13' ' ' GLU . . . . . . . . . . . . . 13.9 pt-20 -86.81 134.07 33.59 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.784 179.828 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' C' C ' 14' ' ' LEU . . . . . . . . . . . . . 50.0 mt -97.65 149.33 35.6 Favored Pre-proline 0 CA--C 1.532 0.28 0 CA-C-O 119.244 -0.407 . . . . 0.0 110.27 179.492 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' C' C ' 15' ' ' PRO . . . . . . . . . . . . . 26.8 Cg_exo -60.7 160.23 25.49 Favored 'Trans proline' 0 N--CA 1.498 1.786 0 C-N-CA 121.321 1.347 . . . . 0.0 111.834 178.584 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' C' C ' 16' ' ' PRO . . . . . . . . . . . . . 33.7 Cg_exo -59.17 -41.99 54.81 Favored 'Trans proline' 0 N--CA 1.497 1.705 0 C-N-CA 121.5 1.467 . . . . 0.0 112.587 -178.16 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' C' C ' 17' ' ' ASP . . . . . . . . . . . . . 8.7 p-10 -85.27 11.07 10.78 Favored 'General case' 0 CA--C 1.537 0.456 0 N-CA-C 113.065 0.765 . . . . 0.0 113.065 -178.816 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' C' C ' 18' ' ' PHE . . . . . . . . . . . . . 51.3 t80 -58.21 -42.96 87.36 Favored 'General case' 0 C--N 1.333 -0.109 0 O-C-N 122.06 -0.4 . . . . 0.0 110.082 -177.54 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' C' C ' 19' ' ' VAL . . . . . . . . . . . . . 48.3 t -57.54 -42.09 80.34 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.319 0 CA-C-N 116.385 -0.37 . . . . 0.0 110.522 -177.919 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' C' C ' 20' ' ' ASP . . . . . . . . . . . . . 83.4 m-20 -59.86 -43.52 94.65 Favored 'General case' 0 C--O 1.234 0.261 0 CA-C-O 120.96 0.409 . . . . 0.0 110.848 -178.493 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' C' C ' 21' ' ' VAL . . . . . . . . . . . . . 49.1 t -64.39 -48.54 84.81 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.251 0 CA-C-N 116.376 -0.374 . . . . 0.0 110.433 -178.097 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' C' C ' 22' ' ' ILE . . . . . . . . . . . . . 51.7 mm -56.68 -43.05 78.31 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.254 0 C-N-CA 121.079 -0.248 . . . . 0.0 110.574 179.175 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' C' C ' 23' ' ' ARG . . . . . . . . . . . . . 47.3 ttp180 -55.06 -46.64 75.38 Favored 'General case' 0 C--N 1.33 -0.255 0 C-N-CA 121.065 -0.254 . . . . 0.0 111.212 -178.495 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' C' C ' 24' ' ' ILE . . . . . . . . . . . . . 72.4 mt -59.57 -42.95 89.8 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.229 0 C-N-CA 120.869 -0.333 . . . . 0.0 110.758 179.571 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' C' C ' 25' ' ' LYS . . . . . . . . . . . . . 45.9 mmtt -62.0 -43.35 99.03 Favored 'General case' 0 C--N 1.328 -0.36 0 N-CA-C 112.037 0.384 . . . . 0.0 112.037 -179.425 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' C' C ' 26' ' ' LEU . . . . . . . . . . . . . 92.8 mt -79.67 -39.28 31.73 Favored 'General case' 0 C--N 1.329 -0.288 0 N-CA-C 113.646 0.98 . . . . 0.0 113.646 -169.899 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' C' C ' 27' ' ' GLN . . . . . . . . . . . . . 14.1 pt20 -46.77 137.51 7.02 Favored 'General case' 0 N--CA 1.469 0.502 0 N-CA-C 112.925 0.713 . . . . 0.0 112.925 -173.627 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' C' C ' 28' ' ' GLY . . . . . . . . . . . . . . . 99.47 -25.53 27.9 Favored Glycine 0 CA--C 1.533 1.179 0 CA-C-N 115.45 -0.796 . . . . 0.0 112.367 -176.934 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' C' C ' 29' ' ' LYS . . . . . . . . . . . . . 68.5 mttm -98.38 155.16 17.36 Favored 'General case' 0 C--O 1.233 0.187 0 CA-C-N 117.256 0.528 . . . . 0.0 111.061 179.537 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' C' C ' 30' ' ' THR . . . . . . . . . . . . . 25.9 m -108.59 139.92 42.69 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.149 176.267 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' C' C ' 31' ' ' VAL . . . . . . . . . . . . . 34.6 m -130.06 153.92 39.63 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.277 0 CA-C-N 116.292 -0.413 . . . . 0.0 110.9 -178.738 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' C' C ' 32' ' ' ARG . . . . . . . . . . . . . 84.3 mtm180 -128.82 147.55 50.81 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-O 121.325 0.583 . . . . 0.0 110.702 179.436 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' C' C ' 33' ' ' THR . . . . . . . . . . . . . 19.0 m -53.58 139.8 30.57 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.133 -0.485 . . . . 0.0 111.329 -178.902 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' C' C ' 34' ' ' GLY . . . . . . . . . . . . . . . 98.45 -17.13 58.92 Favored Glycine 0 CA--C 1.533 1.207 0 CA-C-O 119.706 -0.496 . . . . 0.0 113.266 178.969 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' C' C ' 35' ' ' ASP . . . . . . . . . . . . . 81.9 m-20 -66.75 149.34 50.69 Favored 'General case' 0 N--CA 1.461 0.109 0 CA-C-N 118.017 0.908 . . . . 0.0 111.044 178.978 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' C' C ' 36' ' ' VAL . . . . . . . . . . . . . 43.6 t -118.71 128.27 75.6 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.211 0 CA-C-N 116.154 -0.475 . . . . 0.0 109.725 176.832 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' C' C ' 37' ' ' ILE . . . . . . . . . . . . . 61.6 mt -119.46 137.47 53.27 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.251 0 CA-C-N 116.105 -0.498 . . . . 0.0 109.867 -179.515 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' C' C ' 38' ' ' GLY . . . . . . . . . . . . . . . -115.45 127.9 7.82 Favored Glycine 0 CA--C 1.525 0.668 0 N-CA-C 110.95 -0.86 . . . . 0.0 110.95 178.971 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' C' C ' 39' ' ' ILE . . . . . . . . . . . . . 70.5 mt -126.72 127.78 70.41 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.232 0 N-CA-C 109.905 -0.405 . . . . 0.0 109.905 178.493 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' C' C ' 40' ' ' SER . . . . . . . . . . . . . 60.4 p -91.97 119.63 31.88 Favored 'General case' 0 C--N 1.33 -0.264 0 C-N-CA 120.968 -0.293 . . . . 0.0 110.667 176.463 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' C' C ' 41' ' ' ILE . . . . . . . . . . . . . 73.3 mt -131.45 130.33 62.62 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.215 0 CA-C-O 120.868 0.366 . . . . 0.0 110.367 179.708 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' C' C ' 42' ' ' LEU . . . . . . . . . . . . . 72.8 mt 57.38 33.06 22.76 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 116.105 -0.498 . . . . 0.0 111.895 177.589 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' C' C ' 43' ' ' GLY . . . . . . . . . . . . . . . 72.55 23.06 78.57 Favored Glycine 0 CA--C 1.532 1.138 0 C-N-CA 121.132 -0.556 . . . . 0.0 112.727 177.882 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' C' C ' 44' ' ' LYS . . . . . . . . . . . . . 33.4 ttmt -139.09 129.56 25.73 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 117.315 0.557 . . . . 0.0 109.746 178.379 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' C' C ' 45' ' ' GLU . . . . . . . . . . . . . 45.9 tp10 -84.14 129.66 34.89 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-O 120.836 0.35 . . . . 0.0 111.279 -177.172 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' C' C ' 46' ' ' VAL . . . . . . . . . . . . . 9.1 p -122.75 126.12 73.43 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.246 0 N-CA-C 109.409 -0.589 . . . . 0.0 109.409 174.578 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' C' C ' 47' ' ' LYS . . . . . . . . . . . . . 64.3 mttm -100.03 128.76 46.07 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.03 -0.532 . . . . 0.0 111.339 179.068 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' C' C ' 48' ' ' PHE . . . . . . . . . . . . . 28.4 m-85 -112.51 131.97 55.32 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 116.015 -0.539 . . . . 0.0 109.795 177.549 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' C' C ' 49' ' ' LYS . . . . . . . . . . . . . 46.2 tttp -105.45 132.21 51.91 Favored 'General case' 0 C--N 1.329 -0.315 0 N-CA-C 109.812 -0.44 . . . . 0.0 109.812 177.741 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' C' C ' 50' ' ' VAL . . . . . . . . . . . . . 46.2 t -72.86 106.03 2.74 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.324 0 N-CA-C 109.454 -0.573 . . . . 0.0 109.454 178.454 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' C' C ' 51' ' ' VAL . . . . . . . . . . . . . 49.0 t -68.5 -50.61 54.8 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.279 0 N-CA-C 109.5 -0.556 . . . . 0.0 109.5 -176.357 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' C' C ' 52' ' ' GLN . . . . . . . . . . . . . 21.5 pt20 -162.67 157.81 22.31 Favored 'General case' 0 C--N 1.331 -0.201 0 CA-C-N 115.908 -0.587 . . . . 0.0 111.649 179.239 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' C' C ' 53' ' ' ALA . . . . . . . . . . . . . . . -130.97 132.61 45.16 Favored 'General case' 0 C--N 1.326 -0.422 0 CA-C-N 115.176 -0.92 . . . . 0.0 109.817 178.165 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' C' C ' 54' ' ' TYR . . . . . . . . . . . . . 29.3 t80 -128.98 108.37 18.19 Favored Pre-proline 0 CA--C 1.534 0.358 0 CA-C-O 118.204 -0.903 . . . . 0.0 110.413 -179.008 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' C' C ' 55' ' ' PRO . . . . . . . . . . . . . 73.1 Cg_endo -77.16 170.03 72.63 Favored 'Cis proline' 0 N--CA 1.501 1.916 0 CA-C-N 121.833 1.69 . . . . 0.0 112.451 -5.776 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' C' C ' 56' ' ' SER . . . . . . . . . . . . . 14.5 m -114.23 128.34 25.91 Favored Pre-proline 0 CA--C 1.54 0.568 0 CA-C-O 118.368 -0.825 . . . . 0.0 109.348 175.356 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' C' C ' 57' ' ' PRO . . . . . . . . . . . . . 57.0 Cg_endo -71.97 149.5 92.95 Favored 'Cis proline' 0 N--CA 1.497 1.689 0 CA-C-N 121.98 1.743 . . . . 0.0 111.857 -0.556 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' C' C ' 58' ' ' LEU . . . . . . . . . . . . . 24.9 tp -108.64 137.03 47.26 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.294 -0.412 . . . . 0.0 110.643 -178.622 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' C' C ' 59' ' ' ARG . . . . . . . . . . . . . 57.0 ttm-85 -107.11 127.53 53.57 Favored 'General case' 0 C--N 1.329 -0.321 0 N-CA-C 109.322 -0.621 . . . . 0.0 109.322 175.95 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' C' C ' 60' ' ' VAL . . . . . . . . . . . . . 40.9 t -81.71 120.69 33.75 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.231 0 CA-C-O 121.074 0.464 . . . . 0.0 110.968 -173.733 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' C' C ' 61' ' ' GLU . . . . . . . . . . . . . 80.4 tt0 -131.15 158.21 41.08 Favored 'General case' 0 C--N 1.33 -0.275 0 N-CA-C 108.73 -0.841 . . . . 0.0 108.73 174.729 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' C' C ' 62' ' ' ASP . . . . . . . . . . . . . 52.8 m-20 -49.82 -32.2 13.56 Favored 'General case' 0 C--N 1.329 -0.294 0 N-CA-C 112.352 0.501 . . . . 0.0 112.352 -178.146 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' C' C ' 63' ' ' ARG . . . . . . . . . . . . . 26.7 mmm180 -71.25 -20.79 62.19 Favored 'General case' 0 CA--C 1.536 0.415 0 N-CA-C 112.999 0.741 . . . . 0.0 112.999 -176.357 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' C' C ' 64' ' ' THR . . . . . . . . . . . . . 36.8 m -67.87 141.76 56.31 Favored 'General case' 0 C--N 1.331 -0.239 0 CA-C-O 121.051 0.453 . . . . 0.0 111.222 -175.592 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' C' C ' 65' ' ' LYS . . . . . . . . . . . . . 63.6 mttm -89.65 132.94 34.89 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 115.749 -0.66 . . . . 0.0 109.86 177.35 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' C' C ' 66' ' ' ILE . . . . . . . . . . . . . 63.1 mt -118.59 132.04 69.61 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.22 0 N-CA-C 110.055 -0.35 . . . . 0.0 110.055 -179.276 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' C' C ' 67' ' ' THR . . . . . . . . . . . . . 25.9 m -129.24 139.08 51.97 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-O 121.048 0.451 . . . . 0.0 111.26 -178.348 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' C' C ' 68' ' ' LEU . . . . . . . . . . . . . 39.3 mt . . . . . 0 C--N 1.33 -0.248 0 CA-C-N 115.891 -0.595 . . . . 0.0 110.165 176.066 . . . . . . . . 0 0 . 1 . 011 nuclear build core ' C' C ' 73' ' ' VAL . . . . . . . . . . . . . 32.9 m . . . . . 0 C--O 1.23 0.068 0 CA-C-O 120.888 0.375 . . . . 0.0 110.782 . . . . . . . . . 0 0 . 1 . 011 nuclear build core ' C' C ' 74' ' ' ASP . . . . . . . . . . . . . 10.8 t70 -97.04 122.29 39.87 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.109 -0.496 . . . . 0.0 109.734 179.222 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' C' C ' 75' ' ' VAL . . . . . . . . . . . . . 46.0 t -116.98 125.54 73.93 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.196 0 CA-C-O 120.879 0.371 . . . . 0.0 110.698 -175.27 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' C' C ' 76' ' ' LEU . . . . . . . . . . . . . 19.4 mt -131.51 145.57 51.82 Favored 'General case' 0 C--N 1.333 -0.148 0 CA-C-N 116.012 -0.54 . . . . 0.0 110.488 179.559 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' C' C ' 77' ' ' GLU . . . . . . . . . . . . . 33.1 mp0 -135.48 141.92 45.42 Favored 'General case' 0 C--N 1.331 -0.225 0 CA-C-O 121.136 0.493 . . . . 0.0 111.046 178.345 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' C' C ' 78' ' ' ALA . . . . . 0.697 ' HB2' HD21 ' C' ' 109' ' ' LEU . . . -126.57 135.03 50.73 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 115.677 -0.692 . . . . 0.0 109.86 176.184 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' C' C ' 79' ' ' LYS . . . . . 0.58 ' O ' HD13 ' C' ' 80' ' ' ILE . 76.5 tttt -81.73 111.19 17.76 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.315 -0.402 . . . . 0.0 110.57 -177.57 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' C' C ' 80' ' ' ILE . . . . . 0.58 HD13 ' O ' ' C' ' 79' ' ' LYS . 42.8 mm -139.14 105.92 2.7 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.341 0 N-CA-C 109.15 -0.685 . . . . 0.0 109.15 -177.45 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' C' C ' 81' ' ' LYS . . . . . . . . . . . . . 32.1 ttpt -102.24 132.29 48.27 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-O 120.921 0.391 . . . . 0.0 110.845 -176.213 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' C' C ' 82' ' ' GLY . . . . . . . . . . . . . . . 89.19 42.09 5.67 Favored Glycine 0 CA--C 1.526 0.78 0 N-CA-C 111.563 -0.615 . . . . 0.0 111.563 177.623 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' C' C ' 83' ' ' ILE . . . . . 0.403 HD11 ' HB ' ' C' ' 80' ' ' ILE . 69.1 mt -79.26 141.87 14.78 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.284 0 N-CA-C 109.717 -0.475 . . . . 0.0 109.717 177.562 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' C' C ' 84' ' ' LYS . . . . . . . . . . . . . 38.8 ttpt -101.08 -54.02 2.89 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.309 -0.405 . . . . 0.0 110.464 -178.454 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' C' C ' 85' ' ' ASP . . . . . . . . . . . . . 7.2 t0 -146.46 150.61 35.94 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.097 -0.501 . . . . 0.0 110.781 -176.949 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' C' C ' 86' ' ' VAL . . . . . . . . . . . . . 44.1 t -128.12 131.2 69.58 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.259 0 CA-C-N 116.34 -0.391 . . . . 0.0 110.275 -179.065 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' C' C ' 87' ' ' ILE . . . . . . . . . . . . . 44.9 mm -118.61 126.84 75.5 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.254 0 N-CA-C 109.696 -0.483 . . . . 0.0 109.696 176.827 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' C' C ' 88' ' ' LEU . . . . . . . . . . . . . 13.7 tp -115.61 130.21 56.78 Favored 'General case' 0 C--N 1.331 -0.227 0 CA-C-O 120.964 0.411 . . . . 0.0 111.067 -177.014 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' C' C ' 89' ' ' ASP . . . . . . . . . . . . . 6.1 t0 -126.1 152.57 45.71 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 115.836 -0.62 . . . . 0.0 109.449 176.829 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' C' C ' 90' ' ' GLU . . . . . . . . . . . . . 84.8 tt0 -48.23 -35.72 12.5 Favored 'General case' 0 C--N 1.329 -0.312 0 N-CA-C 112.751 0.648 . . . . 0.0 112.751 -173.219 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' C' C ' 91' ' ' ASN . . . . . . . . . . . . . 85.1 m-20 -131.97 33.59 3.92 Favored 'General case' 0 N--CA 1.465 0.314 0 N-CA-C 111.877 0.325 . . . . 0.0 111.877 -176.804 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' C' C ' 92' ' ' LEU . . . . . . . . . . . . . 8.2 tp -166.07 142.6 5.11 Favored 'General case' 0 C--N 1.331 -0.215 0 C-N-CA 121.014 -0.274 . . . . 0.0 110.566 -179.002 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' C' C ' 93' ' ' ILE . . . . . . . . . . . . . 74.0 mt -127.14 125.17 65.8 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.26 0 N-CA-C 109.493 -0.558 . . . . 0.0 109.493 178.227 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' C' C ' 94' ' ' VAL . . . . . 0.578 HG21 HG11 ' C' ' 125' ' ' VAL . 45.2 t -127.1 129.83 71.11 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.259 0 CA-C-O 120.968 0.414 . . . . 0.0 110.197 179.914 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' C' C ' 95' ' ' VAL . . . . . . . . . . . . . 42.3 t -121.35 134.4 64.84 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.339 0 CA-C-N 115.936 -0.574 . . . . 0.0 109.76 179.324 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' C' C ' 96' ' ' ILE . . . . . . . . . . . . . 64.1 mt -116.15 128.71 73.37 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 N-CA-C 109.371 -0.604 . . . . 0.0 109.371 179.64 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' C' C ' 97' ' ' THR . . . . . . . . . . . . . 73.3 p -101.82 160.56 14.37 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-O 121.185 0.517 . . . . 0.0 111.13 -177.577 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' C' C ' 98' ' ' GLU . . . . . . . . . . . . . 12.5 pt-20 -54.04 -25.94 24.0 Favored 'General case' 0 C--N 1.328 -0.337 0 N-CA-C 112.39 0.515 . . . . 0.0 112.39 -178.108 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' C' C ' 99' ' ' GLU . . . . . . . . . . . . . 95.5 mt-10 -79.87 15.44 1.43 Allowed 'General case' 0 CA--C 1.536 0.404 0 N-CA-C 113.131 0.789 . . . . 0.0 113.131 -176.164 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' C' C ' 100' ' ' ASN . . . . . . . . . . . . . 3.5 m-20 61.82 37.35 15.54 Favored 'General case' 0 CA--C 1.531 0.245 0 CA-C-O 121.047 0.451 . . . . 0.0 110.995 179.499 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' C' C ' 101' ' ' GLU . . . . . . . . . . . . . 84.9 tt0 -114.82 141.27 48.12 Favored 'General case' 0 C--N 1.332 -0.159 0 CA-C-N 116.071 -0.513 . . . . 0.0 109.62 175.98 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' C' C ' 102' ' ' VAL . . . . . . . . . . . . . 43.7 t -116.46 127.01 74.19 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.341 0 CA-C-N 116.298 -0.41 . . . . 0.0 110.047 -178.122 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' C' C ' 103' ' ' LEU . . . . . . . . . . . . . 40.6 mt -114.85 130.14 56.83 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 115.719 -0.673 . . . . 0.0 110.071 176.496 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' C' C ' 104' ' ' ILE . . . . . . . . . . . . . 66.4 mt -114.95 122.22 68.62 Favored 'Isoleucine or valine' 0 C--O 1.234 0.254 0 N-CA-C 110.161 -0.311 . . . . 0.0 110.161 -178.693 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' C' C ' 105' ' ' PHE . . . . . . . . . . . . . 81.2 m-85 -123.24 163.57 20.41 Favored 'General case' 0 C--O 1.231 0.121 0 O-C-N 124.02 0.825 . . . . 0.0 109.591 -179.17 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' C' C ' 106' ' ' ASN . . . . . . . . . . . . . 47.4 p-10 -98.32 -170.61 1.99 Allowed 'General case' 0 C--N 1.33 -0.265 0 N-CA-C 109.828 -0.434 . . . . 0.0 109.828 173.525 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' C' C ' 107' ' ' GLN . . . . . . . . . . . . . 49.0 tt0 -59.44 -30.1 68.25 Favored 'General case' 0 C--N 1.33 -0.273 0 N-CA-C 112.128 0.418 . . . . 0.0 112.128 -179.252 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' C' C ' 108' ' ' ASN . . . . . . . . . . . . . 30.7 t30 -84.75 9.2 14.67 Favored 'General case' 0 CA--C 1.536 0.419 0 N-CA-C 113.181 0.808 . . . . 0.0 113.181 -177.009 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' C' C ' 109' ' ' LEU . . . . . 0.697 HD21 ' HB2' ' C' ' 78' ' ' ALA . 12.4 tp 61.56 37.51 16.24 Favored 'General case' 0 CA--C 1.53 0.188 0 CA-C-O 120.993 0.425 . . . . 0.0 111.249 178.573 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' C' C ' 110' ' ' GLU . . . . . . . . . . . . . 95.3 mt-10 -105.12 149.55 25.78 Favored 'General case' 0 C--N 1.33 -0.254 0 N-CA-C 109.687 -0.486 . . . . 0.0 109.687 175.584 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' C' C ' 111' ' ' GLU . . . . . . . . . . . . . 74.1 tt0 -87.45 121.92 30.52 Favored 'General case' 0 C--N 1.33 -0.272 0 C-N-CA 120.77 -0.372 . . . . 0.0 110.583 -175.31 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' C' C ' 112' ' ' LEU . . . . . . . . . . . . . 17.8 mt -108.01 -45.98 3.86 Favored 'General case' 0 C--N 1.332 -0.176 0 CA-C-N 115.992 -0.549 . . . . 0.0 110.78 -179.856 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' C' C ' 113' ' ' TYR . . . . . . . . . . . . . 46.8 t80 -135.55 141.89 45.27 Favored 'General case' 0 C--N 1.331 -0.23 0 CA-C-N 116.361 -0.381 . . . . 0.0 111.213 -178.179 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' C' C ' 114' ' ' ARG . . . . . . . . . . . . . 38.8 ptt180 -142.48 125.26 15.99 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.254 -0.43 . . . . 0.0 110.475 176.757 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' C' C ' 115' ' ' GLY . . . . . . . . . . . . . . . -150.09 162.25 29.14 Favored Glycine 0 CA--C 1.524 0.628 0 C-N-CA 120.693 -0.765 . . . . 0.0 111.55 -179.92 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' C' C ' 116' ' ' LYS . . . . . . . . . . . . . 39.1 ttpt -125.83 135.52 52.07 Favored 'General case' 0 C--N 1.332 -0.185 0 N-CA-C 109.866 -0.42 . . . . 0.0 109.866 176.994 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' C' C ' 117' ' ' PHE . . . . . . . . . . . . . 64.3 m-85 -130.65 113.81 14.64 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-O 120.856 0.36 . . . . 0.0 110.365 -178.256 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' C' C ' 118' ' ' GLU . . . . . . . . . . . . . 14.3 mm-40 -55.76 -48.19 75.71 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 116.397 -0.365 . . . . 0.0 111.056 -175.916 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' C' C ' 119' ' ' ASN . . . . . . . . . . . . . 68.1 m-80 -97.19 31.11 2.54 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.005 -0.543 . . . . 0.0 112.12 -174.185 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' C' C ' 120' ' ' LEU . . . . . . . . . . . . . 13.8 tp -52.63 119.88 5.04 Favored 'General case' 0 N--CA 1.466 0.325 0 O-C-N 122.238 -0.289 . . . . 0.0 111.029 178.999 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' C' C ' 121' ' ' ASN . . . . . . . . . . . . . 90.9 m-20 -113.93 -44.05 3.2 Favored 'General case' 0 C--N 1.331 -0.226 0 CA-C-N 116.317 -0.401 . . . . 0.0 111.242 -177.959 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' C' C ' 122' ' ' LYS . . . . . . . . . . . . . 38.4 ttpt -143.9 143.44 31.28 Favored 'General case' 0 C--N 1.333 -0.113 0 C-N-CA 120.507 -0.477 . . . . 0.0 111.577 -177.163 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' C' C ' 123' ' ' VAL . . . . . . . . . . . . . 43.9 t -126.41 127.44 70.5 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.285 0 N-CA-C 109.148 -0.686 . . . . 0.0 109.148 173.773 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' C' C ' 124' ' ' LEU . . . . . 0.652 HD13 HD12 ' D' ' 88' ' ' LEU . 8.7 tt -131.39 133.03 44.84 Favored 'General case' 0 N--CA 1.463 0.219 0 CA-C-O 120.961 0.41 . . . . 0.0 111.142 -176.377 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' C' C ' 125' ' ' VAL . . . . . 0.729 HG12 HG23 ' C' ' 130' ' ' VAL . 35.8 m -126.68 144.96 35.11 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.238 0 CA-C-N 115.798 -0.637 . . . . 0.0 110.441 179.607 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' C' C ' 126' ' ' ARG . . . . . . . . . . . . . 34.8 ttm180 -150.0 117.04 5.95 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-O 120.996 0.427 . . . . 0.0 110.412 177.819 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' C' C ' 127' ' ' ASN . . . . . . . . . . . . . 96.2 m-20 53.77 -107.6 0.37 Allowed 'General case' 0 CA--C 1.542 0.651 0 CA-C-N 116.0 -0.546 . . . . 0.0 110.859 -178.268 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' C' C ' 128' ' ' ASP . . . . . . . . . . . . . 8.4 p-10 -114.13 1.9 14.73 Favored 'General case' 0 CA--C 1.537 0.447 0 CA-C-N 119.742 1.156 . . . . 0.0 113.271 -177.994 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' C' C ' 129' ' ' LEU . . . . . . . . . . . . . 12.7 tp -105.15 139.59 39.58 Favored 'General case' 0 C--O 1.232 0.156 0 N-CA-C 109.429 -0.582 . . . . 0.0 109.429 178.789 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' C' C ' 130' ' ' VAL . . . . . 0.729 HG23 HG12 ' C' ' 125' ' ' VAL . 12.2 p -135.81 140.29 44.54 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.21 0 CA-C-O 121.295 0.569 . . . . 0.0 110.869 -177.564 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' C' C ' 131' ' ' VAL . . . . . . . . . . . . . 35.6 m -136.11 146.43 29.26 Favored 'Isoleucine or valine' 0 C--O 1.234 0.251 0 CA-C-N 115.793 -0.64 . . . . 0.0 110.935 178.782 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' C' C ' 132' ' ' ILE . . . . . . . . . . . . . 68.1 mt -122.88 134.0 67.32 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.293 0 CA-C-N 115.596 -0.729 . . . . 0.0 109.521 179.69 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' C' C ' 133' ' ' ILE . . . . . . . . . . . . . 42.7 mm -116.26 120.43 64.89 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.212 0 CA-C-N 116.548 -0.297 . . . . 0.0 110.733 -176.996 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' C' C ' 134' ' ' ASP . . . . . . . . . . . . . 6.1 p-10 -131.83 146.56 52.21 Favored 'General case' 0 C--N 1.331 -0.214 0 CA-C-N 116.21 -0.45 . . . . 0.0 109.806 176.379 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' C' C ' 135' ' ' GLU . . . . . . . . . . . . . 84.2 tt0 -50.0 -26.31 4.17 Favored 'General case' 0 C--N 1.328 -0.359 0 N-CA-C 112.937 0.718 . . . . 0.0 112.937 -170.779 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' C' C ' 136' ' ' GLN . . . . . . . . . . . . . 97.4 mt-30 -92.6 -35.47 13.53 Favored 'General case' 0 C--N 1.331 -0.196 0 N-CA-C 112.461 0.541 . . . . 0.0 112.461 -176.819 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' C' C ' 137' ' ' LYS . . . . . . . . . . . . . 54.4 mtmt -147.14 157.97 43.79 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-O 121.501 0.667 . . . . 0.0 112.048 -169.543 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' C' C ' 138' ' ' LEU . . . . . 0.444 HD23 ' C ' ' C' ' 138' ' ' LEU . 6.9 tt -116.08 126.26 53.5 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 115.203 -0.908 . . . . 0.0 109.317 174.621 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' C' C ' 139' ' ' THR . . . . . . . . . . . . . 33.8 m -111.47 127.98 55.86 Favored 'General case' 0 C--N 1.331 -0.212 0 CA-C-N 116.401 -0.363 . . . . 0.0 110.713 -177.831 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' C' C ' 140' ' ' LEU . . . . . 0.481 ' C ' HD23 ' C' ' 140' ' ' LEU . 9.0 tt -115.39 122.84 47.06 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 115.48 -0.782 . . . . 0.0 109.203 -179.781 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' C' C ' 141' ' ' ILE . . . . . 0.529 ' HB ' HG13 ' C' ' 130' ' ' VAL . 20.2 mt -120.5 117.72 54.24 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.27 0 CA-C-O 120.973 0.416 . . . . 0.0 110.046 -176.309 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' C' C ' 142' ' ' ARG . . . . . . . . . . . . . 62.6 ttp85 . . . . . 0 C--N 1.331 -0.205 0 CA-C-N 115.096 -0.956 . . . . 0.0 110.621 -177.72 . . . . . . . . 0 0 . 1 . 011 nuclear build core ' D' D ' 2' ' ' SER . . . . . . . . . . . . . 5.8 p . . . . . 0 N--CA 1.461 0.087 0 CA-C-O 120.822 0.344 . . . . 0.0 110.354 . . . . . . . . . 0 0 . 1 . 011 nuclear build core ' D' D ' 3' ' ' GLU . . . . . . . . . . . . . 94.2 mt-10 -141.28 137.92 32.82 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-N 116.072 -0.513 . . . . 0.0 111.014 -178.376 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' D' D ' 4' ' ' LEU . . . . . 0.407 HD21 HD21 ' D' ' 6' ' ' LEU . 15.5 tp -122.49 128.69 51.15 Favored 'General case' 0 C--N 1.33 -0.282 0 N-CA-C 109.86 -0.422 . . . . 0.0 109.86 175.695 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' D' D ' 5' ' ' LYS . . . . . . . . . . . . . 55.7 mttp -107.93 119.13 38.6 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.432 -0.349 . . . . 0.0 110.48 179.699 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' D' D ' 6' ' ' LEU . . . . . 0.407 HD21 HD21 ' D' ' 4' ' ' LEU . 71.3 mt -114.8 145.7 41.84 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 115.464 -0.789 . . . . 0.0 110.386 -177.698 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' D' D ' 7' ' ' LYS . . . . . . . . . . . . . 52.3 tttm -135.0 137.66 27.64 Favored Pre-proline 0 CA--C 1.534 0.329 0 CA-C-O 118.966 -0.54 . . . . 0.0 109.818 176.757 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' D' D ' 8' ' ' PRO . . . . . . . . . . . . . 94.0 Cg_endo -91.48 143.92 3.09 Favored 'Trans proline' 0 N--CA 1.49 1.322 0 C-N-CA 121.652 1.568 . . . . 0.0 111.877 178.495 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' D' D ' 9' ' ' LEU . . . . . . . . . . . . . 69.5 mt -80.31 -48.46 1.26 Allowed Pre-proline 0 C--N 1.328 -0.331 0 CA-C-O 118.467 -0.778 . . . . 0.0 112.372 -179.488 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' D' D ' 10' ' ' PRO . . . . . . . . . . . . . 77.7 Cg_endo -77.64 151.73 28.85 Favored 'Trans proline' 0 N--CA 1.496 1.635 0 C-N-CA 121.09 1.193 . . . . 0.0 112.009 177.618 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' D' D ' 11' ' ' LYS . . . . . . . . . . . . . 24.8 mtmt -88.29 92.32 9.12 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.311 -0.404 . . . . 0.0 110.616 179.965 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' D' D ' 12' ' ' VAL . . . . . . . . . . . . . 12.4 p -139.61 148.67 23.02 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.242 0 CA-C-N 116.073 -0.512 . . . . 0.0 110.454 -179.972 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' D' D ' 13' ' ' GLU . . . . . . . . . . . . . 84.6 tt0 -88.38 125.34 34.66 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.251 -0.431 . . . . 0.0 109.962 177.321 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' D' D ' 14' ' ' LEU . . . . . . . . . . . . . 38.2 mt -97.94 150.79 37.12 Favored Pre-proline 0 CA--C 1.531 0.249 0 CA-C-N 116.297 -0.41 . . . . 0.0 110.719 -176.328 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' D' D ' 15' ' ' PRO . . . . . . . . . . . . . 25.3 Cg_exo -62.66 155.61 57.88 Favored 'Trans proline' 0 N--CA 1.497 1.722 0 C-N-CA 121.347 1.365 . . . . 0.0 111.939 176.732 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' D' D ' 16' ' ' PRO . . . . . . . . . . . . . 35.4 Cg_exo -59.8 -30.65 92.47 Favored 'Trans proline' 0 N--CA 1.498 1.736 0 C-N-CA 121.345 1.363 . . . . 0.0 112.57 179.331 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' D' D ' 17' ' ' ASP . . . . . . . . . . . . . 7.9 p-10 -84.09 3.26 35.51 Favored 'General case' 0 C--N 1.327 -0.384 0 N-CA-C 113.329 0.862 . . . . 0.0 113.329 -177.448 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' D' D ' 18' ' ' PHE . . . . . . . . . . . . . 10.8 t80 -57.99 -45.98 85.93 Favored 'General case' 0 C--O 1.227 -0.118 0 O-C-N 121.871 -0.518 . . . . 0.0 110.058 -177.819 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' D' D ' 19' ' ' VAL . . . . . . . . . . . . . 48.6 t -56.23 -42.82 74.71 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.273 0 CA-C-N 116.168 -0.469 . . . . 0.0 110.61 -178.075 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' D' D ' 20' ' ' ASP . . . . . . . . . . . . . 83.3 m-20 -60.05 -44.05 94.94 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-O 120.782 0.325 . . . . 0.0 111.231 -177.338 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' D' D ' 21' ' ' VAL . . . . . . . . . . . . . 46.7 t -64.8 -45.6 94.55 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 C-N-CA 120.72 -0.392 . . . . 0.0 110.528 -177.532 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' D' D ' 22' ' ' ILE . . . . . 0.631 HG22 HD12 ' D' ' 26' ' ' LEU . 51.3 mm -56.63 -45.83 82.62 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.168 0 C-N-CA 120.87 -0.332 . . . . 0.0 110.547 179.386 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' D' D ' 23' ' ' ARG . . . . . . . . . . . . . 54.8 ttp180 -54.2 -49.52 69.18 Favored 'General case' 0 C--N 1.33 -0.258 0 C-N-CA 121.09 -0.244 . . . . 0.0 111.315 -178.165 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' D' D ' 24' ' ' ILE . . . . . . . . . . . . . 71.8 mt -60.32 -43.1 92.92 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.216 0 C-N-CA 121.059 -0.256 . . . . 0.0 111.32 -178.478 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' D' D ' 25' ' ' LYS . . . . . . . . . . . . . 62.4 mtpt -65.13 -40.99 95.22 Favored 'General case' 0 C--N 1.329 -0.323 0 N-CA-C 112.32 0.489 . . . . 0.0 112.32 -177.499 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' D' D ' 26' ' ' LEU . . . . . 0.631 HD12 HG22 ' D' ' 22' ' ' ILE . 45.2 mt -79.15 -41.61 28.09 Favored 'General case' 0 C--N 1.329 -0.324 0 N-CA-C 113.354 0.872 . . . . 0.0 113.354 -171.202 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' D' D ' 27' ' ' GLN . . . . . . . . . . . . . 15.2 pt20 -46.43 137.52 6.47 Favored 'General case' 0 N--CA 1.469 0.512 0 N-CA-C 112.823 0.675 . . . . 0.0 112.823 -174.882 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' D' D ' 28' ' ' GLY . . . . . . . . . . . . . . . 100.17 -27.27 21.12 Favored Glycine 0 CA--C 1.532 1.146 0 CA-C-N 115.591 -0.731 . . . . 0.0 112.249 -177.765 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' D' D ' 29' ' ' LYS . . . . . . . . . . . . . 97.2 mttt -98.21 155.24 17.27 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 117.142 0.471 . . . . 0.0 111.123 179.218 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' D' D ' 30' ' ' THR . . . . . . . . . . . . . 28.2 m -101.0 138.52 37.94 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 115.953 -0.567 . . . . 0.0 110.172 176.044 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' D' D ' 31' ' ' VAL . . . . . . . . . . . . . 34.9 m -131.07 152.57 37.76 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.255 0 CA-C-N 116.32 -0.4 . . . . 0.0 110.759 -179.586 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' D' D ' 32' ' ' ARG . . . . . . . . . . . . . 58.5 ttp180 -129.28 148.98 51.26 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-O 121.202 0.525 . . . . 0.0 110.673 179.676 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' D' D ' 33' ' ' THR . . . . . . . . . . . . . 27.4 m -53.52 138.96 32.65 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 116.276 -0.42 . . . . 0.0 111.24 179.964 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' D' D ' 34' ' ' GLY . . . . . . . . . . . . . . . 100.51 -17.11 57.17 Favored Glycine 0 CA--C 1.531 1.077 0 C-N-CA 121.272 -0.489 . . . . 0.0 113.225 -179.871 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' D' D ' 35' ' ' ASP . . . . . . . . . . . . . 69.3 m-20 -65.67 149.76 49.58 Favored 'General case' 0 C--O 1.232 0.147 0 CA-C-N 118.014 0.907 . . . . 0.0 111.314 179.564 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' D' D ' 36' ' ' VAL . . . . . . . . . . . . . 45.6 t -121.72 129.58 75.36 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.23 0 CA-C-N 115.774 -0.648 . . . . 0.0 109.771 177.511 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' D' D ' 37' ' ' ILE . . . . . . . . . . . . . 69.2 mt -121.41 138.98 49.97 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.282 0 CA-C-N 116.3 -0.409 . . . . 0.0 109.956 -179.504 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' D' D ' 38' ' ' GLY . . . . . . . . . . . . . . . -109.08 128.79 9.18 Favored Glycine 0 CA--C 1.526 0.762 0 N-CA-C 111.073 -0.811 . . . . 0.0 111.073 179.914 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' D' D ' 39' ' ' ILE . . . . . . . . . . . . . 71.7 mt -123.83 136.08 61.39 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.234 0 CA-C-O 120.842 0.353 . . . . 0.0 110.091 179.728 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' D' D ' 40' ' ' SER . . . . . . . . . . . . . 59.9 p -92.88 114.23 26.73 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.245 -0.434 . . . . 0.0 110.641 174.335 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' D' D ' 41' ' ' ILE . . . . . . . . . . . . . 47.0 mm -122.91 112.85 35.65 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.211 0 CA-C-O 120.724 0.297 . . . . 0.0 110.379 179.473 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' D' D ' 42' ' ' LEU . . . . . 0.529 HD23 ' O ' ' D' ' 42' ' ' LEU . 1.3 tt 55.23 45.79 25.05 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-O 121.443 0.639 . . . . 0.0 110.521 178.111 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' D' D ' 43' ' ' GLY . . . . . . . . . . . . . . . 74.99 -9.67 11.15 Favored Glycine 0 CA--C 1.535 1.324 0 C-N-CA 121.342 -0.456 . . . . 0.0 113.712 175.687 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' D' D ' 44' ' ' LYS . . . . . . . . . . . . . 22.0 tptp -100.37 134.19 43.68 Favored 'General case' 0 C--N 1.331 -0.206 0 CA-C-N 117.927 0.863 . . . . 0.0 110.153 -178.998 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' D' D ' 45' ' ' GLU . . . . . . . . . . . . . 84.8 tt0 -83.29 123.03 29.21 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 116.458 -0.337 . . . . 0.0 110.732 -179.869 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' D' D ' 46' ' ' VAL . . . . . . . . . . . . . 7.1 p -123.49 127.64 74.26 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.182 0 N-CA-C 109.715 -0.476 . . . . 0.0 109.715 177.643 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' D' D ' 47' ' ' LYS . . . . . . . . . . . . . 63.7 mttp -100.23 129.98 46.3 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 115.954 -0.566 . . . . 0.0 111.172 178.59 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' D' D ' 48' ' ' PHE . . . . . . . . . . . . . 90.7 m-85 -113.19 131.89 55.7 Favored 'General case' 0 C--N 1.331 -0.213 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.09 177.054 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' D' D ' 49' ' ' LYS . . . . . . . . . . . . . 82.5 tttt -107.92 137.14 46.44 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.489 179.262 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' D' D ' 50' ' ' VAL . . . . . . . . . . . . . 46.4 t -83.04 108.79 16.13 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.312 0 N-CA-C 109.311 -0.625 . . . . 0.0 109.311 176.219 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' D' D ' 51' ' ' VAL . . . . . . . . . . . . . 46.1 t -73.4 -50.76 28.78 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.328 0 CA-C-N 116.142 -0.481 . . . . 0.0 109.907 -174.573 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' D' D ' 52' ' ' GLN . . . . . . . . . . . . . 92.4 mt-30 -152.72 154.22 34.81 Favored 'General case' 0 C--N 1.332 -0.18 0 CA-C-O 121.285 0.564 . . . . 0.0 111.552 -178.167 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' D' D ' 53' ' ' ALA . . . . . . . . . . . . . . . -132.56 132.59 42.74 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 115.212 -0.904 . . . . 0.0 109.788 175.832 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' D' D ' 54' ' ' TYR . . . . . . . . . . . . . 41.7 t80 -129.08 109.23 18.11 Favored Pre-proline 0 CA--C 1.534 0.364 0 CA-C-O 118.251 -0.88 . . . . 0.0 110.355 179.509 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' D' D ' 55' ' ' PRO . . . . . . . . . . . . . 73.2 Cg_endo -77.18 168.91 75.62 Favored 'Cis proline' 0 N--CA 1.5 1.873 0 CA-C-N 121.839 1.692 . . . . 0.0 112.43 -6.826 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' D' D ' 56' ' ' SER . . . . . . . . . . . . . 13.6 m -116.98 129.49 25.28 Favored Pre-proline 0 CA--C 1.538 0.49 0 CA-C-O 118.459 -0.781 . . . . 0.0 109.262 173.911 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' D' D ' 57' ' ' PRO . . . . . . . . . . . . . 56.1 Cg_endo -71.65 149.4 92.36 Favored 'Cis proline' 0 N--CA 1.498 1.768 0 CA-C-N 122.002 1.751 . . . . 0.0 111.691 0.37 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' D' D ' 58' ' ' LEU . . . . . . . . . . . . . 23.7 tp -108.98 137.99 46.03 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.176 -0.466 . . . . 0.0 110.843 -177.723 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' D' D ' 59' ' ' ARG . . . . . . . . . . . . . 31.7 ttp180 -102.23 122.87 45.03 Favored 'General case' 0 C--N 1.329 -0.315 0 N-CA-C 109.158 -0.682 . . . . 0.0 109.158 175.111 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' D' D ' 60' ' ' VAL . . . . . . . . . . . . . 43.3 t -79.84 122.37 34.93 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.262 0 C-N-CA 120.703 -0.399 . . . . 0.0 110.802 -173.36 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' D' D ' 61' ' ' GLU . . . . . . . . . . . . . 84.1 mt-10 -131.1 161.18 32.66 Favored 'General case' 0 C--N 1.332 -0.184 0 CA-C-N 115.91 -0.586 . . . . 0.0 109.562 177.214 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' D' D ' 62' ' ' ASP . . . . . . . . . . . . . 79.0 m-20 -53.3 -33.16 52.15 Favored 'General case' 0 C--N 1.329 -0.291 0 N-CA-C 111.782 0.29 . . . . 0.0 111.782 178.319 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' D' D ' 63' ' ' ARG . . . . . . . . . . . . . 92.8 mtt-85 -72.97 -21.97 60.77 Favored 'General case' 0 CA--C 1.533 0.324 0 N-CA-C 113.004 0.742 . . . . 0.0 113.004 -176.004 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' D' D ' 64' ' ' THR . . . . . . . . . . . . . 30.8 m -65.2 141.72 58.56 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-O 120.974 0.416 . . . . 0.0 111.085 -174.509 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' D' D ' 65' ' ' LYS . . . . . . . . . . . . . 68.9 mttm -87.7 131.31 34.51 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 115.787 -0.642 . . . . 0.0 109.915 178.17 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' D' D ' 66' ' ' ILE . . . . . . . . . . . . . 60.0 mt -116.27 124.93 73.05 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.272 0 N-CA-C 109.552 -0.536 . . . . 0.0 109.552 179.375 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' D' D ' 67' ' ' THR . . . . . . . . . . . . . 22.7 m -121.28 144.0 48.86 Favored 'General case' 0 C--O 1.233 0.218 0 CA-C-O 121.035 0.445 . . . . 0.0 111.242 -175.307 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' D' D ' 68' ' ' LEU . . . . . . . . . . . . . 14.2 tp . . . . . 0 C--N 1.33 -0.245 0 CA-C-N 115.834 -0.621 . . . . 0.0 110.465 179.486 . . . . . . . . 0 0 . 1 . 011 nuclear build core ' D' D ' 73' ' ' VAL . . . . . . . . . . . . . 33.5 m . . . . . 0 C--O 1.233 0.196 0 CA-C-O 120.978 0.418 . . . . 0.0 111.003 . . . . . . . . . 0 0 . 1 . 011 nuclear build core ' D' D ' 74' ' ' ASP . . . . . . . . . . . . . 27.4 t0 -95.56 120.91 36.63 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 115.834 -0.621 . . . . 0.0 109.838 179.872 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' D' D ' 75' ' ' VAL . . . . . . . . . . . . . 42.9 t -112.02 122.76 66.92 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.234 0 CA-C-O 121.245 0.545 . . . . 0.0 110.337 -178.454 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' D' D ' 76' ' ' LEU . . . . . . . . . . . . . 33.7 mt -120.79 142.36 49.66 Favored 'General case' 0 C--N 1.331 -0.225 0 CA-C-N 115.555 -0.748 . . . . 0.0 109.617 177.814 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' D' D ' 77' ' ' GLU . . . . . . . . . . . . . 97.5 mt-10 -135.23 136.98 42.15 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-O 121.091 0.472 . . . . 0.0 111.382 -178.091 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' D' D ' 78' ' ' ALA . . . . . 0.534 ' HB2' HD21 ' D' ' 109' ' ' LEU . . . -124.83 138.37 54.27 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 115.706 -0.679 . . . . 0.0 109.816 176.804 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' D' D ' 79' ' ' LYS . . . . . 0.58 ' O ' HD13 ' D' ' 80' ' ' ILE . 62.0 mttp -81.54 118.07 22.45 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-O 120.871 0.367 . . . . 0.0 110.666 -178.568 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' D' D ' 80' ' ' ILE . . . . . 0.58 HD13 ' O ' ' D' ' 79' ' ' LYS . 42.3 mm -139.07 107.27 3.28 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.306 0 N-CA-C 109.264 -0.643 . . . . 0.0 109.264 -178.408 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' D' D ' 81' ' ' LYS . . . . . . . . . . . . . 38.0 ttpt -102.13 128.12 48.76 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-O 120.817 0.341 . . . . 0.0 110.932 -178.054 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' D' D ' 82' ' ' GLY . . . . . . . . . . . . . . . 89.05 42.17 5.69 Favored Glycine 0 CA--C 1.524 0.615 0 C-N-CA 120.725 -0.75 . . . . 0.0 111.444 174.817 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' D' D ' 83' ' ' ILE . . . . . . . . . . . . . 72.4 mt -68.25 134.88 29.5 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.264 0 N-CA-C 109.838 -0.43 . . . . 0.0 109.838 178.319 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' D' D ' 84' ' ' LYS . . . . . . . . . . . . . 30.8 tttp -94.15 -52.71 4.26 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 115.886 -0.597 . . . . 0.0 110.046 -178.22 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' D' D ' 85' ' ' ASP . . . . . . . . . . . . . 6.4 t70 -156.98 154.84 30.28 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 115.767 -0.651 . . . . 0.0 110.167 179.021 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' D' D ' 86' ' ' VAL . . . . . . . . . . . . . 44.5 t -128.72 133.61 66.05 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.219 0 CA-C-O 121.046 0.451 . . . . 0.0 110.791 179.964 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' D' D ' 87' ' ' ILE . . . . . . . . . . . . . 44.2 mm -114.62 122.39 68.64 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.249 0 CA-C-N 115.619 -0.718 . . . . 0.0 109.216 175.304 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' D' D ' 88' ' ' LEU . . . . . 0.652 HD12 HD13 ' C' ' 124' ' ' LEU . 34.8 mt -110.92 134.07 52.86 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-O 121.085 0.469 . . . . 0.0 111.34 -176.013 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' D' D ' 89' ' ' ASP . . . . . . . . . . . . . 9.8 t70 -131.92 154.94 48.74 Favored 'General case' 0 C--N 1.331 -0.211 0 CA-C-N 115.793 -0.639 . . . . 0.0 109.508 175.686 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' D' D ' 90' ' ' GLU . . . . . . . . . . . . . 84.7 tt0 -48.33 -38.13 18.31 Favored 'General case' 0 C--N 1.329 -0.284 0 N-CA-C 112.802 0.668 . . . . 0.0 112.802 -171.902 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' D' D ' 91' ' ' ASN . . . . . . . . . . . . . 35.0 m120 -132.0 36.74 3.64 Favored 'General case' 0 N--CA 1.466 0.328 0 N-CA-C 111.782 0.29 . . . . 0.0 111.782 -177.167 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' D' D ' 92' ' ' LEU . . . . . . . . . . . . . 12.9 tp -166.0 145.31 6.11 Favored 'General case' 0 C--N 1.332 -0.195 0 C-N-CA 120.827 -0.349 . . . . 0.0 110.91 -179.393 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' D' D ' 93' ' ' ILE . . . . . . . . . . . . . 68.1 mt -130.26 120.48 49.08 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.189 0 N-CA-C 109.579 -0.526 . . . . 0.0 109.579 -179.684 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' D' D ' 94' ' ' VAL . . . . . . . . . . . . . 46.9 t -121.66 126.13 74.31 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.253 0 N-CA-C 109.723 -0.473 . . . . 0.0 109.723 179.038 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' D' D ' 95' ' ' VAL . . . . . . . . . . . . . 44.1 t -121.16 134.79 63.4 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.236 0 CA-C-N 116.354 -0.385 . . . . 0.0 110.125 -178.902 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' D' D ' 96' ' ' ILE . . . . . . . . . . . . . 63.8 mt -113.68 128.63 70.47 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.316 0 N-CA-C 109.257 -0.646 . . . . 0.0 109.257 178.841 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' D' D ' 97' ' ' THR . . . . . . . . . . . . . 65.8 p -95.35 159.17 15.13 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-O 120.865 0.364 . . . . 0.0 110.443 179.746 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' D' D ' 98' ' ' GLU . . . . . . . . . . . . . 97.4 mt-10 -53.98 -27.5 31.91 Favored 'General case' 0 C--N 1.328 -0.36 0 N-CA-C 112.215 0.45 . . . . 0.0 112.215 -179.372 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' D' D ' 99' ' ' GLU . . . . . . . . . . . . . 45.8 mp0 -76.59 7.92 4.07 Favored 'General case' 0 CA--C 1.536 0.41 0 N-CA-C 113.502 0.927 . . . . 0.0 113.502 -176.733 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' D' D ' 100' ' ' ASN . . . . . . . . . . . . . 4.1 m-20 65.7 35.95 6.62 Favored 'General case' 0 N--CA 1.464 0.238 0 CA-C-N 118.133 0.424 . . . . 0.0 111.335 -178.064 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' D' D ' 101' ' ' GLU . . . . . . . . . . . . . 85.2 tt0 -109.93 142.68 40.94 Favored 'General case' 0 C--N 1.332 -0.179 0 N-CA-C 109.361 -0.607 . . . . 0.0 109.361 172.187 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' D' D ' 102' ' ' VAL . . . . . . . . . . . . . 44.5 t -115.02 126.86 72.72 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.312 0 CA-C-N 116.39 -0.368 . . . . 0.0 110.229 -175.84 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' D' D ' 103' ' ' LEU . . . . . . . . . . . . . 39.3 mt -116.62 129.91 56.43 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 115.678 -0.692 . . . . 0.0 109.897 175.629 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' D' D ' 104' ' ' ILE . . . . . . . . . . . . . 66.6 mt -117.7 124.41 73.02 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.259 0 N-CA-C 110.079 -0.341 . . . . 0.0 110.079 -179.996 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' D' D ' 105' ' ' PHE . . . . . . . . . . . . . 52.9 m-85 -123.72 163.54 20.91 Favored 'General case' 0 C--N 1.333 -0.142 0 O-C-N 123.963 0.79 . . . . 0.0 109.72 -179.376 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' D' D ' 106' ' ' ASN . . . . . . . . . . . . . 45.1 p-10 -97.86 -170.41 1.98 Allowed 'General case' 0 C--N 1.33 -0.281 0 N-CA-C 109.859 -0.422 . . . . 0.0 109.859 175.073 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' D' D ' 107' ' ' GLN . . . . . . . . . . . . . 62.4 tt0 -58.37 -30.04 66.46 Favored 'General case' 0 C--N 1.329 -0.297 0 N-CA-C 111.771 0.286 . . . . 0.0 111.771 179.097 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' D' D ' 108' ' ' ASN . . . . . . . . . . . . . 18.0 t30 -83.8 6.86 19.78 Favored 'General case' 0 CA--C 1.537 0.442 0 N-CA-C 113.389 0.885 . . . . 0.0 113.389 -176.53 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' D' D ' 109' ' ' LEU . . . . . 0.534 HD21 ' HB2' ' D' ' 78' ' ' ALA . 11.0 tp 62.37 37.54 13.68 Favored 'General case' 0 C--O 1.232 0.152 0 CA-C-O 120.957 0.408 . . . . 0.0 111.29 177.972 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' D' D ' 110' ' ' GLU . . . . . . . . . . . . . 95.5 mt-10 -106.44 153.99 21.47 Favored 'General case' 0 C--N 1.331 -0.198 0 CA-C-N 116.518 -0.31 . . . . 0.0 110.198 176.487 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' D' D ' 111' ' ' GLU . . . . . . . . . . . . . 85.0 tt0 -82.31 121.89 27.26 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.366 -0.379 . . . . 0.0 110.761 -177.721 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' D' D ' 112' ' ' LEU . . . . . . . . . . . . . 16.1 mt -110.44 -46.13 3.45 Favored 'General case' 0 C--N 1.331 -0.214 0 CA-C-N 116.198 -0.456 . . . . 0.0 110.723 179.367 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' D' D ' 113' ' ' TYR . . . . . . . . . . . . . 49.2 t80 -136.4 138.25 41.36 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-N 116.361 -0.381 . . . . 0.0 111.106 -179.104 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' D' D ' 114' ' ' ARG . . . . . . . . . . . . . 60.2 ttp180 -137.25 121.72 18.33 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 115.995 -0.548 . . . . 0.0 110.205 176.438 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' D' D ' 115' ' ' GLY . . . . . . . . . . . . . . . -150.05 162.2 29.12 Favored Glycine 0 CA--C 1.523 0.548 0 N-CA-C 110.481 -1.048 . . . . 0.0 110.481 178.903 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' D' D ' 116' ' ' LYS . . . . . . . . . . . . . 54.6 tttm -137.61 133.81 34.81 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.917 0.359 . . . . 0.0 110.219 -179.824 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' D' D ' 117' ' ' PHE . . . . . . . . . . . . . 38.5 m-85 -129.27 115.43 17.6 Favored 'General case' 0 C--N 1.331 -0.2 0 CA-C-O 120.901 0.381 . . . . 0.0 110.393 -175.689 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' D' D ' 118' ' ' GLU . . . . . . . . . . . . . 46.0 tp10 -52.86 -49.86 64.94 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.462 -0.336 . . . . 0.0 111.492 -176.792 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' D' D ' 119' ' ' ASN . . . . . . . . . . . . . 31.3 m120 -94.75 31.07 1.89 Allowed 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.257 -0.429 . . . . 0.0 112.138 -174.099 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' D' D ' 120' ' ' LEU . . . . . . . . . . . . . 17.9 tp -54.87 121.67 9.15 Favored 'General case' 0 C--N 1.332 -0.166 0 CA-C-O 120.698 0.285 . . . . 0.0 110.809 179.078 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' D' D ' 121' ' ' ASN . . . . . . . . . . . . . 15.0 m120 -114.03 -44.07 3.19 Favored 'General case' 0 C--N 1.331 -0.217 0 CA-C-N 116.356 -0.384 . . . . 0.0 110.909 -178.3 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' D' D ' 122' ' ' LYS . . . . . . . . . . . . . 59.9 mtpt -142.91 148.77 37.49 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-O 121.066 0.46 . . . . 0.0 111.74 -176.98 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' D' D ' 123' ' ' VAL . . . . . . . . . . . . . 44.5 t -131.33 128.2 61.11 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.246 0 CA-C-N 115.857 -0.611 . . . . 0.0 109.428 173.765 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' D' D ' 124' ' ' LEU . . . . . . . . . . . . . 60.8 mt -121.52 134.89 55.05 Favored 'General case' 0 C--N 1.331 -0.203 0 CA-C-N 116.357 -0.383 . . . . 0.0 110.558 -178.417 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' D' D ' 125' ' ' VAL . . . . . . . . . . . . . 40.8 t -130.19 131.8 65.54 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.266 0 CA-C-N 116.315 -0.402 . . . . 0.0 110.129 -179.785 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' D' D ' 126' ' ' ARG . . . . . . . . . . . . . 96.2 mtt-85 -140.08 117.69 11.55 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.333 -0.394 . . . . 0.0 110.627 178.487 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' D' D ' 127' ' ' ASN . . . . . . . . . . . . . 82.8 m-20 51.27 -104.96 0.18 Allowed 'General case' 0 CA--C 1.544 0.746 0 CA-C-O 119.032 -0.509 . . . . 0.0 111.408 178.718 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' D' D ' 128' ' ' ASP . . . . . . . . . . . . . 22.8 p-10 -114.03 1.1 14.54 Favored 'General case' 0 N--CA 1.468 0.473 0 CA-C-N 119.518 1.054 . . . . 0.0 113.489 -177.467 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' D' D ' 129' ' ' LEU . . . . . . . . . . . . . 44.7 mt -105.01 141.03 37.32 Favored 'General case' 0 C--O 1.231 0.129 0 CA-C-N 118.105 0.411 . . . . 0.0 110.078 179.245 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' D' D ' 130' ' ' VAL . . . . . . . . . . . . . 44.3 t -126.15 137.63 57.14 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.247 0 CA-C-N 116.388 -0.369 . . . . 0.0 110.153 -178.203 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' D' D ' 131' ' ' VAL . . . . . 0.463 HG21 ' CD1' ' E' ' 88' ' ' LEU . 44.2 t -134.13 134.17 55.48 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.324 0 CA-C-O 121.005 0.431 . . . . 0.0 110.011 177.629 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' D' D ' 132' ' ' ILE . . . . . . . . . . . . . 68.0 mt -117.28 133.61 63.48 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.297 0 CA-C-N 115.919 -0.582 . . . . 0.0 109.49 179.927 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' D' D ' 133' ' ' ILE . . . . . . . . . . . . . 37.1 mm -117.05 120.89 66.43 Favored 'Isoleucine or valine' 0 C--O 1.233 0.206 0 CA-C-O 120.682 0.277 . . . . 0.0 111.093 -175.218 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' D' D ' 134' ' ' ASP . . . . . . . . . . . . . 8.1 p-10 -132.91 147.06 52.29 Favored 'General case' 0 C--N 1.331 -0.234 0 N-CA-C 109.276 -0.638 . . . . 0.0 109.276 174.403 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' D' D ' 135' ' ' GLU . . . . . . . . . . . . . 84.4 tt0 -49.91 -26.42 4.11 Favored 'General case' 0 C--N 1.329 -0.316 0 N-CA-C 112.9 0.704 . . . . 0.0 112.9 -172.222 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' D' D ' 136' ' ' GLN . . . . . . . . . . . . . 31.4 tt0 -83.61 -34.29 25.15 Favored 'General case' 0 C--N 1.331 -0.224 0 N-CA-C 112.399 0.518 . . . . 0.0 112.399 -175.559 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' D' D ' 137' ' ' LYS . . . . . . . . . . . . . 20.5 pttp -168.35 172.37 8.47 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-O 121.544 0.688 . . . . 0.0 112.221 -172.076 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' D' D ' 138' ' ' LEU . . . . . 0.403 ' C ' HD23 ' D' ' 138' ' ' LEU . 7.7 tt -120.03 131.16 55.03 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 115.093 -0.958 . . . . 0.0 110.258 -178.46 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' D' D ' 139' ' ' THR . . . . . . . . . . . . . 33.8 m -109.04 130.08 55.47 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 116.133 -0.485 . . . . 0.0 110.675 -179.497 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' D' D ' 140' ' ' LEU . . . . . 0.428 HD12 HG22 ' D' ' 131' ' ' VAL . 27.1 tp -114.9 121.15 42.32 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 115.765 -0.652 . . . . 0.0 109.315 -179.201 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' D' D ' 141' ' ' ILE . . . . . . . . . . . . . 19.5 mt -119.85 121.96 67.41 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.222 0 N-CA-C 109.858 -0.423 . . . . 0.0 109.858 -175.158 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' D' D ' 142' ' ' ARG . . . . . . . . . . . . . 81.5 mtm180 -116.61 131.59 56.91 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 115.496 -0.775 . . . . 0.0 110.299 -176.823 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' D' D ' 143' ' ' THR . . . . . . . . . . . . . 59.5 p . . . . . 0 C--O 1.221 -0.421 0 CA-C-O 118.044 -0.979 . . . . 0.0 110.62 -179.819 . . . . . . . . 0 0 . 1 . 011 nuclear build core ' E' E ' 2' ' ' SER . . . . . . . . . . . . . 2.1 p . . . . . 0 C--O 1.232 0.142 0 N-CA-C 109.944 -0.391 . . . . 0.0 109.944 . . . . . . . . . 0 0 . 1 . 011 nuclear build core ' E' E ' 3' ' ' GLU . . . . . . . . . . . . . 80.4 tt0 -143.48 142.3 31.11 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 116.149 -0.478 . . . . 0.0 111.246 -175.384 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' E' E ' 4' ' ' LEU . . . . . . . . . . . . . 16.8 tp -122.26 132.24 54.33 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-N 116.079 -0.509 . . . . 0.0 110.163 176.172 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' E' E ' 5' ' ' LYS . . . . . . . . . . . . . 52.0 mttp -107.25 119.61 39.85 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.469 -0.332 . . . . 0.0 110.51 178.597 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' E' E ' 6' ' ' LEU . . . . . . . . . . . . . 37.6 mt -114.19 147.33 39.09 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 115.354 -0.839 . . . . 0.0 110.669 -178.571 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' E' E ' 7' ' ' LYS . . . . . . . . . . . . . 47.6 tttp -138.47 141.3 30.85 Favored Pre-proline 0 CA--C 1.534 0.343 0 CA-C-O 119.128 -0.463 . . . . 0.0 110.075 174.811 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' E' E ' 8' ' ' PRO . . . . . . . . . . . . . 73.7 Cg_endo -91.51 141.36 2.7 Favored 'Trans proline' 0 N--CA 1.49 1.298 0 C-N-CA 121.664 1.576 . . . . 0.0 111.561 176.047 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' E' E ' 9' ' ' LEU . . . . . . . . . . . . . 67.7 mt -77.2 -47.68 2.59 Favored Pre-proline 0 CA--C 1.533 0.322 0 CA-C-O 118.645 -0.693 . . . . 0.0 112.428 -179.288 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' E' E ' 10' ' ' PRO . . . . . . . . . . . . . 90.6 Cg_endo -79.98 155.36 23.09 Favored 'Trans proline' 0 N--CA 1.496 1.642 0 C-N-CA 121.282 1.321 . . . . 0.0 111.892 176.733 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' E' E ' 11' ' ' LYS . . . . . . . . . . . . . 28.2 ttpt -88.29 92.33 9.12 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-O 120.833 0.349 . . . . 0.0 110.532 178.876 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' E' E ' 12' ' ' VAL . . . . . . . . . . . . . 12.5 p -141.39 143.88 27.02 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.283 0 CA-C-N 116.241 -0.436 . . . . 0.0 110.343 178.68 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' E' E ' 13' ' ' GLU . . . . . . . . . . . . . 15.2 pt-20 -87.13 131.13 34.25 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.362 -0.381 . . . . 0.0 110.704 179.345 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' E' E ' 14' ' ' LEU . . . . . . . . . . . . . 17.5 mt -98.41 155.08 37.25 Favored Pre-proline 0 C--N 1.33 -0.266 0 CA-C-N 116.246 -0.433 . . . . 0.0 110.686 -179.967 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' E' E ' 15' ' ' PRO . . . . . . . . . . . . . 26.5 Cg_exo -61.57 160.07 29.62 Favored 'Trans proline' 0 N--CA 1.496 1.647 0 C-N-CA 121.363 1.375 . . . . 0.0 111.667 176.233 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' E' E ' 16' ' ' PRO . . . . . . . . . . . . . 34.7 Cg_exo -58.87 -40.76 68.97 Favored 'Trans proline' 0 N--CA 1.496 1.667 0 C-N-CA 121.4 1.4 . . . . 0.0 112.963 -177.304 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' E' E ' 17' ' ' ASP . . . . . . . . . . . . . 23.5 p-10 -89.01 11.33 18.58 Favored 'General case' 0 C--N 1.326 -0.417 0 N-CA-C 113.156 0.799 . . . . 0.0 113.156 -177.175 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' E' E ' 18' ' ' PHE . . . . . . . . . . . . . 47.1 t80 -58.04 -43.75 87.0 Favored 'General case' 0 C--N 1.334 -0.1 0 O-C-N 121.944 -0.473 . . . . 0.0 109.972 -179.619 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' E' E ' 19' ' ' VAL . . . . . . . . . . . . . 47.8 t -57.54 -39.3 68.51 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.309 0 CA-C-N 116.028 -0.533 . . . . 0.0 110.406 179.206 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' E' E ' 20' ' ' ASP . . . . . . . . . . . . . 28.3 t0 -58.94 -43.61 91.26 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-O 120.691 0.281 . . . . 0.0 110.579 -178.507 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' E' E ' 21' ' ' VAL . . . . . . . . . . . . . 52.4 t -64.22 -45.14 97.13 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.326 0 C-N-CA 120.689 -0.404 . . . . 0.0 110.354 -178.642 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' E' E ' 22' ' ' ILE . . . . . 0.687 HG22 HD12 ' E' ' 26' ' ' LEU . 49.3 mm -58.93 -41.59 83.48 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.327 0 C-N-CA 120.969 -0.292 . . . . 0.0 110.908 -179.929 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' E' E ' 23' ' ' ARG . . . . . . . . . . . . . 42.6 ttp180 -57.07 -47.02 82.01 Favored 'General case' 0 C--N 1.331 -0.209 0 C-N-CA 120.7 -0.4 . . . . 0.0 110.522 178.899 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' E' E ' 24' ' ' ILE . . . . . . . . . . . . . 79.6 mt -61.63 -44.95 99.5 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.302 0 CA-C-N 116.153 -0.476 . . . . 0.0 111.88 -178.559 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' E' E ' 25' ' ' LYS . . . . . . . . . . . . . 13.6 pttp -70.1 -36.21 74.71 Favored 'General case' 0 CA--C 1.533 0.307 0 C-N-CA 120.487 -0.485 . . . . 0.0 111.61 -173.729 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' E' E ' 26' ' ' LEU . . . . . 0.687 HD12 HG22 ' E' ' 22' ' ' ILE . 20.7 mt -79.05 -40.52 31.11 Favored 'General case' 0 C--N 1.33 -0.254 0 N-CA-C 112.86 0.689 . . . . 0.0 112.86 -174.482 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' E' E ' 27' ' ' GLN . . . . . . . . . . . . . 8.4 pt20 -47.32 139.47 6.36 Favored 'General case' 0 N--CA 1.467 0.4 0 N-CA-C 112.795 0.665 . . . . 0.0 112.795 -174.644 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' E' E ' 28' ' ' GLY . . . . . . . . . . . . . . . 98.77 -26.63 23.29 Favored Glycine 0 CA--C 1.534 1.239 0 CA-C-N 115.582 -0.736 . . . . 0.0 112.184 -176.021 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' E' E ' 29' ' ' LYS . . . . . . . . . . . . . 98.8 mttt -98.07 155.2 17.24 Favored 'General case' 0 C--O 1.233 0.202 0 CA-C-N 117.116 0.458 . . . . 0.0 111.154 179.21 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' E' E ' 30' ' ' THR . . . . . . . . . . . . . 24.6 m -104.82 137.11 43.1 Favored 'General case' 0 C--N 1.332 -0.186 0 CA-C-N 115.851 -0.613 . . . . 0.0 109.79 174.643 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' E' E ' 31' ' ' VAL . . . . . . . . . . . . . 34.9 m -127.94 159.37 39.01 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.19 0 CA-C-N 116.416 -0.356 . . . . 0.0 110.747 -178.185 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' E' E ' 32' ' ' ARG . . . . . . . . . . . . . 73.9 mtt85 -133.79 149.42 51.42 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-O 121.394 0.616 . . . . 0.0 110.773 179.241 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' E' E ' 33' ' ' THR . . . . . . . . . . . . . 18.4 m -53.54 140.09 29.47 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.143 -0.48 . . . . 0.0 111.18 -179.327 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' E' E ' 34' ' ' GLY . . . . . . . . . . . . . . . 100.69 -17.23 56.82 Favored Glycine 0 CA--C 1.533 1.164 0 CA-C-O 119.622 -0.544 . . . . 0.0 113.151 179.517 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' E' E ' 35' ' ' ASP . . . . . . . . . . . . . 77.1 m-20 -65.78 147.51 53.27 Favored 'General case' 0 C--N 1.333 -0.121 0 CA-C-N 118.058 0.929 . . . . 0.0 111.067 178.764 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' E' E ' 36' ' ' VAL . . . . . . . . . . . . . 45.3 t -125.02 131.71 72.21 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.245 0 CA-C-N 115.843 -0.617 . . . . 0.0 109.874 178.455 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' E' E ' 37' ' ' ILE . . . . . . . . . . . . . 68.1 mt -122.46 139.18 50.17 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.26 0 CA-C-N 116.331 -0.395 . . . . 0.0 109.948 -179.79 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' E' E ' 38' ' ' GLY . . . . . . . . . . . . . . . -111.79 128.63 8.7 Favored Glycine 0 CA--C 1.525 0.714 0 N-CA-C 111.243 -0.743 . . . . 0.0 111.243 179.928 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' E' E ' 39' ' ' ILE . . . . . . . . . . . . . 73.1 mt -127.74 129.94 70.14 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.229 0 N-CA-C 109.984 -0.376 . . . . 0.0 109.984 178.512 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' E' E ' 40' ' ' SER . . . . . . . . . . . . . 43.4 t -92.25 113.91 26.31 Favored 'General case' 0 C--N 1.329 -0.303 0 C-N-CA 120.997 -0.281 . . . . 0.0 110.92 177.501 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' E' E ' 41' ' ' ILE . . . . . . . . . . . . . 45.2 mm -123.06 124.45 70.24 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.207 0 N-CA-C 109.864 -0.421 . . . . 0.0 109.864 179.853 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' E' E ' 42' ' ' LEU . . . . . . . . . . . . . 55.6 mt 57.48 34.47 24.66 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.35 -0.387 . . . . 0.0 111.681 178.755 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' E' E ' 43' ' ' GLY . . . . . . . . . . . . . . . 77.6 -10.1 25.67 Favored Glycine 0 CA--C 1.535 1.314 0 C-N-CA 121.297 -0.478 . . . . 0.0 113.396 177.601 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' E' E ' 44' ' ' LYS . . . . . . . . . . . . . 60.2 tttm -101.65 130.29 47.97 Favored 'General case' 0 C--N 1.332 -0.172 0 CA-C-N 117.976 0.888 . . . . 0.0 109.814 177.396 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' E' E ' 45' ' ' GLU . . . . . . . . . . . . . 39.6 tp10 -83.8 128.72 34.74 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.389 -0.369 . . . . 0.0 110.813 -178.57 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' E' E ' 46' ' ' VAL . . . . . . . . . . . . . 7.3 p -120.64 132.24 70.72 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.277 0 N-CA-C 109.659 -0.497 . . . . 0.0 109.659 177.509 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' E' E ' 47' ' ' LYS . . . . . . . . . . . . . 62.5 mttp -100.72 127.95 46.95 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 115.929 -0.578 . . . . 0.0 111.088 177.245 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' E' E ' 48' ' ' PHE . . . . . . . . . . . . . 92.4 m-85 -109.61 131.73 54.79 Favored 'General case' 0 C--N 1.329 -0.298 0 N-CA-C 109.57 -0.53 . . . . 0.0 109.57 175.304 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' E' E ' 49' ' ' LYS . . . . . . . . . . . . . 47.5 tttp -111.57 139.12 47.28 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.661 -0.245 . . . . 0.0 110.656 -179.953 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' E' E ' 50' ' ' VAL . . . . . . . . . . . . . 45.1 t -83.49 108.42 16.03 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.307 0 N-CA-C 109.34 -0.615 . . . . 0.0 109.34 175.731 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' E' E ' 51' ' ' VAL . . . . . . . . . . . . . 46.7 t -74.2 -50.84 25.83 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.305 0 CA-C-N 116.117 -0.492 . . . . 0.0 109.955 -174.461 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' E' E ' 52' ' ' GLN . . . . . . . . . . . . . 92.2 mt-30 -152.69 152.7 32.03 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-O 121.18 0.514 . . . . 0.0 111.766 -178.54 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' E' E ' 53' ' ' ALA . . . . . . . . . . . . . . . -130.69 131.89 45.08 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 115.213 -0.903 . . . . 0.0 109.762 175.644 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' E' E ' 54' ' ' TYR . . . . . . . . . . . . . 39.5 t80 -129.07 108.96 18.09 Favored Pre-proline 0 CA--C 1.535 0.398 0 CA-C-O 118.306 -0.854 . . . . 0.0 110.277 179.348 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' E' E ' 55' ' ' PRO . . . . . . . . . . . . . 73.7 Cg_endo -77.27 169.28 74.53 Favored 'Cis proline' 0 N--CA 1.499 1.825 0 CA-C-N 121.829 1.689 . . . . 0.0 112.384 -4.473 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' E' E ' 56' ' ' SER . . . . . . . . . . . . . 14.5 m -113.88 122.62 34.44 Favored Pre-proline 0 CA--C 1.539 0.535 0 CA-C-O 118.309 -0.853 . . . . 0.0 109.372 175.275 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' E' E ' 57' ' ' PRO . . . . . . . . . . . . . 42.0 Cg_endo -67.72 167.96 59.48 Favored 'Cis proline' 0 N--CA 1.498 1.787 0 CA-C-N 122.104 1.787 . . . . 0.0 112.076 2.004 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' E' E ' 58' ' ' LEU . . . . . . . . . . . . . 25.6 tp -130.05 137.96 50.5 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-N 115.915 -0.584 . . . . 0.0 110.317 179.875 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' E' E ' 59' ' ' ARG . . . . . . . . . . . . . 66.6 ttt180 -102.36 134.34 45.82 Favored 'General case' 0 C--N 1.329 -0.298 0 N-CA-C 109.671 -0.492 . . . . 0.0 109.671 176.267 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' E' E ' 60' ' ' VAL . . . . . . . . . . . . . 41.1 t -90.34 122.53 41.81 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.192 0 C-N-CA 120.586 -0.446 . . . . 0.0 110.614 -177.851 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' E' E ' 61' ' ' GLU . . . . . . . . . . . . . 77.5 tt0 -131.06 158.14 41.17 Favored 'General case' 0 C--N 1.33 -0.269 0 N-CA-C 109.069 -0.715 . . . . 0.0 109.069 176.696 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' E' E ' 62' ' ' ASP . . . . . . . . . . . . . 64.2 m-20 -52.98 -34.3 55.46 Favored 'General case' 0 C--N 1.328 -0.355 0 N-CA-C 111.686 0.254 . . . . 0.0 111.686 -179.03 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' E' E ' 63' ' ' ARG . . . . . . . . . . . . . 22.6 mmt85 -78.67 -13.02 60.03 Favored 'General case' 0 CA--C 1.535 0.37 0 N-CA-C 113.384 0.883 . . . . 0.0 113.384 -178.549 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' E' E ' 64' ' ' THR . . . . . . . . . . . . . 18.2 m -64.58 146.71 54.23 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-O 120.977 0.417 . . . . 0.0 111.022 -175.654 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' E' E ' 65' ' ' LYS . . . . . . . . . . . . . 22.6 mtpp -86.32 127.2 34.76 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 115.736 -0.665 . . . . 0.0 110.32 -179.883 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' E' E ' 66' ' ' ILE . . . . . . . . . . . . . 60.4 mt -118.2 128.09 75.28 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.307 0 N-CA-C 109.774 -0.454 . . . . 0.0 109.774 178.458 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' E' E ' 67' ' ' THR . . . . . . . . . . . . . 30.7 m -125.88 144.16 50.78 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-O 121.052 0.453 . . . . 0.0 111.168 -176.989 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' E' E ' 68' ' ' LEU . . . . . . . . . . . . . 13.4 tp . . . . . 0 C--N 1.33 -0.255 0 CA-C-N 115.754 -0.657 . . . . 0.0 110.192 179.098 . . . . . . . . 0 0 . 1 . 011 nuclear build core ' E' E ' 73' ' ' VAL . . . . . . . . . . . . . 35.3 m . . . . . 0 CA--C 1.527 0.086 0 N-CA-C 110.315 -0.254 . . . . 0.0 110.315 . . . . . . . . . 0 0 . 1 . 011 nuclear build core ' E' E ' 74' ' ' ASP . . . . . . . . . . . . . 22.0 t0 -104.04 125.04 50.09 Favored 'General case' 0 C--N 1.332 -0.191 0 C-N-CA 121.02 -0.272 . . . . 0.0 110.27 -178.885 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' E' E ' 75' ' ' VAL . . . . . . . . . . . . . 46.3 t -121.48 124.12 71.09 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.258 0 CA-C-O 121.049 0.452 . . . . 0.0 110.691 -178.86 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' E' E ' 76' ' ' LEU . . . . . 0.438 ' N ' HD12 ' E' ' 76' ' ' LEU . 6.4 mp -121.39 149.21 43.31 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-N 115.764 -0.653 . . . . 0.0 109.787 176.027 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' E' E ' 77' ' ' GLU . . . . . . . . . . . . . 97.1 mt-10 -138.38 134.45 34.18 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-O 121.028 0.442 . . . . 0.0 111.214 -179.604 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' E' E ' 78' ' ' ALA . . . . . 0.656 ' HB2' HD21 ' E' ' 109' ' ' LEU . . . -121.33 136.18 55.0 Favored 'General case' 0 C--N 1.331 -0.21 0 CA-C-N 115.763 -0.653 . . . . 0.0 109.773 176.709 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' E' E ' 79' ' ' LYS . . . . . 0.635 ' O ' HD13 ' E' ' 80' ' ' ILE . 40.7 mttm -81.4 117.3 21.74 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-O 120.828 0.347 . . . . 0.0 110.949 -177.478 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' E' E ' 80' ' ' ILE . . . . . 0.635 HD13 ' O ' ' E' ' 79' ' ' LYS . 38.4 mm -139.28 106.07 2.68 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.27 0 N-CA-C 109.164 -0.68 . . . . 0.0 109.164 -179.475 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' E' E ' 81' ' ' LYS . . . . . . . . . . . . . 42.4 mtmt -99.61 126.74 45.66 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-O 121.041 0.448 . . . . 0.0 111.056 -177.992 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' E' E ' 82' ' ' GLY . . . . . . . . . . . . . . . 89.1 42.23 5.66 Favored Glycine 0 CA--C 1.525 0.695 0 C-N-CA 120.881 -0.676 . . . . 0.0 111.615 176.34 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' E' E ' 83' ' ' ILE . . . . . . . . . . . . . 75.3 mt -68.93 137.09 25.03 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.271 0 N-CA-C 109.734 -0.469 . . . . 0.0 109.734 177.149 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' E' E ' 84' ' ' LYS . . . . . . . . . . . . . 29.8 ttmt -92.49 -51.65 5.03 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-O 121.091 0.472 . . . . 0.0 109.8 -179.958 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' E' E ' 85' ' ' ASP . . . . . . . . . . . . . 5.8 t70 -156.19 152.26 27.63 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 115.492 -0.776 . . . . 0.0 110.234 -179.93 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' E' E ' 86' ' ' VAL . . . . . . . . . . . . . 44.1 t -128.07 130.62 69.75 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.27 0 CA-C-O 120.866 0.365 . . . . 0.0 110.258 179.718 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' E' E ' 87' ' ' ILE . . . . . . . . . . . . . 45.4 mm -117.3 124.19 72.73 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.291 0 CA-C-N 115.907 -0.588 . . . . 0.0 109.5 176.771 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' E' E ' 88' ' ' LEU . . . . . 0.463 ' CD1' HG21 ' D' ' 131' ' ' VAL . 13.4 tp -113.64 131.92 55.96 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-O 121.144 0.497 . . . . 0.0 111.218 -175.75 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' E' E ' 89' ' ' ASP . . . . . . . . . . . . . 9.5 t70 -125.94 153.92 43.58 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 115.63 -0.714 . . . . 0.0 109.312 174.679 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' E' E ' 90' ' ' GLU . . . . . . . . . . . . . 96.2 mt-10 -49.05 -34.55 13.77 Favored 'General case' 0 C--N 1.328 -0.367 0 N-CA-C 112.804 0.668 . . . . 0.0 112.804 -172.402 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' E' E ' 91' ' ' ASN . . . . . . . . . . . . . 85.1 m-20 -132.08 33.03 3.95 Favored 'General case' 0 N--CA 1.465 0.3 0 N-CA-C 112.099 0.407 . . . . 0.0 112.099 -176.285 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' E' E ' 92' ' ' LEU . . . . . . . . . . . . . 14.2 tp -166.05 143.8 5.53 Favored 'General case' 0 C--N 1.331 -0.231 0 C-N-CA 120.994 -0.282 . . . . 0.0 110.819 179.767 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' E' E ' 93' ' ' ILE . . . . . . . . . . . . . 69.9 mt -124.45 118.6 54.05 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.244 0 N-CA-C 109.577 -0.527 . . . . 0.0 109.577 179.863 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' E' E ' 94' ' ' VAL . . . . . 0.489 HG21 HG21 ' E' ' 125' ' ' VAL . 46.4 t -118.75 125.77 74.7 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.213 0 N-CA-C 109.73 -0.47 . . . . 0.0 109.73 179.333 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' E' E ' 95' ' ' VAL . . . . . . . . . . . . . 41.8 t -122.97 133.71 68.25 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.356 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.03 -179.08 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' E' E ' 96' ' ' ILE . . . . . . . . . . . . . 60.9 mt -115.42 127.79 72.87 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.324 0 N-CA-C 109.217 -0.66 . . . . 0.0 109.217 178.658 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' E' E ' 97' ' ' THR . . . . . . . . . . . . . 68.2 p -99.56 155.42 17.59 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-O 120.98 0.419 . . . . 0.0 110.678 -178.876 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' E' E ' 98' ' ' GLU . . . . . . . . . . . . . 45.2 mt-10 -55.64 -23.58 28.72 Favored 'General case' 0 CA--C 1.533 0.325 0 N-CA-C 112.366 0.506 . . . . 0.0 112.366 -179.717 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' E' E ' 99' ' ' GLU . . . . . . . . . . . . . 96.4 mt-10 -76.95 13.06 1.14 Allowed 'General case' 0 CA--C 1.536 0.431 0 N-CA-C 113.192 0.812 . . . . 0.0 113.192 -179.273 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' E' E ' 100' ' ' ASN . . . . . . . . . . . . . 4.0 m-20 63.69 38.07 9.63 Favored 'General case' 0 CA--C 1.529 0.149 0 CA-C-O 121.065 0.459 . . . . 0.0 111.076 178.129 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' E' E ' 101' ' ' GLU . . . . . . . . . . . . . 85.3 tt0 -118.58 144.15 46.3 Favored 'General case' 0 C--N 1.333 -0.134 0 CA-C-N 115.922 -0.581 . . . . 0.0 109.731 176.064 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' E' E ' 102' ' ' VAL . . . . . . . . . . . . . 47.2 t -116.13 127.58 73.69 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.238 0 CA-C-N 116.307 -0.406 . . . . 0.0 110.221 -177.244 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' E' E ' 103' ' ' LEU . . . . . . . . . . . . . 27.9 mt -117.73 132.99 56.39 Favored 'General case' 0 C--N 1.331 -0.213 0 CA-C-N 115.632 -0.713 . . . . 0.0 110.196 176.768 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' E' E ' 104' ' ' ILE . . . . . . . . . . . . . 67.6 mt -120.99 123.35 69.92 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.238 0 N-CA-C 110.198 -0.297 . . . . 0.0 110.198 179.378 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' E' E ' 105' ' ' PHE . . . . . . . . . . . . . 55.8 m-85 -124.91 165.69 17.64 Favored 'General case' 0 C--N 1.332 -0.164 0 O-C-N 123.896 0.748 . . . . 0.0 109.813 179.278 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' E' E ' 106' ' ' ASN . . . . . . . . . . . . . 47.3 p-10 -101.84 -170.96 1.9 Allowed 'General case' 0 C--N 1.331 -0.237 0 N-CA-C 109.966 -0.383 . . . . 0.0 109.966 173.568 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' E' E ' 107' ' ' GLN . . . . . . . . . . . . . 50.3 tt0 -58.57 -30.2 66.98 Favored 'General case' 0 C--N 1.329 -0.299 0 N-CA-C 111.998 0.37 . . . . 0.0 111.998 179.638 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' E' E ' 108' ' ' ASN . . . . . . . . . . . . . 58.1 t30 -83.11 10.79 7.39 Favored 'General case' 0 CA--C 1.537 0.463 0 N-CA-C 112.987 0.736 . . . . 0.0 112.987 -177.422 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' E' E ' 109' ' ' LEU . . . . . 0.656 HD21 ' HB2' ' E' ' 78' ' ' ALA . 8.6 tp 55.09 37.61 29.18 Favored 'General case' 0 C--N 1.332 -0.186 0 CA-C-O 121.039 0.447 . . . . 0.0 111.277 179.006 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' E' E ' 110' ' ' GLU . . . . . . . . . . . . . 70.6 mm-40 -102.9 154.94 18.71 Favored 'General case' 0 C--N 1.331 -0.235 0 N-CA-C 109.771 -0.455 . . . . 0.0 109.771 176.319 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' E' E ' 111' ' ' GLU . . . . . . . . . . . . . 85.0 tt0 -82.84 121.94 27.59 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-O 120.908 0.385 . . . . 0.0 110.598 -177.924 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' E' E ' 112' ' ' LEU . . . . . . . . . . . . . 18.8 mt -108.6 -45.92 3.76 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 115.964 -0.562 . . . . 0.0 110.38 178.34 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' E' E ' 113' ' ' TYR . . . . . . . . . . . . . 64.2 t80 -142.03 139.96 32.48 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.37 -0.377 . . . . 0.0 111.573 -179.9 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' E' E ' 114' ' ' ARG . . . . . . . . . . . . . 59.3 ttp180 -140.71 121.93 14.83 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.031 -0.531 . . . . 0.0 110.104 176.835 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' E' E ' 115' ' ' GLY . . . . . . . . . . . . . . . -150.06 161.35 28.87 Favored Glycine 0 CA--C 1.525 0.698 0 N-CA-C 111.296 -0.721 . . . . 0.0 111.296 178.563 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' E' E ' 116' ' ' LYS . . . . . . . . . . . . . 40.0 ttpt -130.9 140.7 50.23 Favored 'General case' 0 C--N 1.331 -0.215 0 N-CA-C 110.253 -0.277 . . . . 0.0 110.253 179.002 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' E' E ' 117' ' ' PHE . . . . . . . . . . . . . 30.3 m-85 -139.11 114.01 9.33 Favored 'General case' 0 C--N 1.331 -0.214 0 C-N-CA 120.839 -0.344 . . . . 0.0 110.188 -178.517 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' E' E ' 118' ' ' GLU . . . . . . . . . . . . . 95.9 mt-10 -54.83 -41.44 70.7 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 116.47 -0.332 . . . . 0.0 111.216 -176.401 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' E' E ' 119' ' ' ASN . . . . . . . . . . . . . 28.4 m120 -100.36 30.96 3.6 Favored 'General case' 0 C--N 1.33 -0.249 0 N-CA-C 112.176 0.435 . . . . 0.0 112.176 -174.016 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' E' E ' 120' ' ' LEU . . . . . . . . . . . . . 24.8 tp -57.57 119.98 7.51 Favored 'General case' 0 C--N 1.332 -0.155 0 C-N-CA 120.903 -0.319 . . . . 0.0 110.179 177.546 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' E' E ' 121' ' ' ASN . . . . . . . . . . . . . 21.1 m120 -114.19 -44.02 3.17 Favored 'General case' 0 N--CA 1.462 0.149 0 CA-C-N 116.553 -0.294 . . . . 0.0 111.319 -176.708 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' E' E ' 122' ' ' LYS . . . . . . . . . . . . . 35.8 mtmm -140.17 146.29 38.57 Favored 'General case' 0 C--N 1.331 -0.224 0 CA-C-O 121.032 0.444 . . . . 0.0 111.618 -175.825 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' E' E ' 123' ' ' VAL . . . . . . . . . . . . . 44.3 t -128.58 130.81 69.05 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.269 0 CA-C-N 115.998 -0.547 . . . . 0.0 109.796 177.038 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' E' E ' 124' ' ' LEU . . . . . . . . . . . . . 45.9 mt -123.39 129.7 51.66 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-N 116.49 -0.323 . . . . 0.0 110.597 179.645 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' E' E ' 125' ' ' VAL . . . . . 0.489 HG21 HG21 ' E' ' 94' ' ' VAL . 42.2 t -132.71 126.72 54.94 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.248 0 CA-C-N 116.231 -0.44 . . . . 0.0 109.982 178.68 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' E' E ' 126' ' ' ARG . . . . . . . . . . . . . 51.8 mmm-85 -140.05 125.14 18.63 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-O 120.918 0.389 . . . . 0.0 110.329 177.996 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' E' E ' 127' ' ' ASN . . . . . . . . . . . . . 67.3 m-80 51.25 -111.61 0.56 Allowed 'General case' 0 CA--C 1.546 0.794 0 CA-C-O 118.598 -0.715 . . . . 0.0 111.172 179.817 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' E' E ' 128' ' ' ASP . . . . . . . . . . . . . 11.6 p-10 -114.14 9.97 17.28 Favored 'General case' 0 CA--C 1.535 0.384 0 CA-C-N 120.089 1.313 . . . . 0.0 113.26 -178.357 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' E' E ' 129' ' ' LEU . . . . . . . . . . . . . 17.2 tp -109.52 138.33 46.05 Favored 'General case' 0 C--O 1.233 0.216 0 O-C-N 121.987 -0.445 . . . . 0.0 110.053 179.199 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' E' E ' 130' ' ' VAL . . . . . . . . . . . . . 41.2 t -125.02 137.19 58.43 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.226 0 CA-C-O 120.958 0.409 . . . . 0.0 110.494 -176.802 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' E' E ' 131' ' ' VAL . . . . . 0.517 HG22 HD12 ' E' ' 140' ' ' LEU . 41.8 t -135.82 136.68 49.9 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.259 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.242 177.39 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' E' E ' 132' ' ' ILE . . . . . . . . . . . . . 71.6 mt -118.3 132.98 66.58 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.337 0 CA-C-N 115.886 -0.597 . . . . 0.0 109.446 -179.031 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' E' E ' 133' ' ' ILE . . . . . . . . . . . . . 40.3 mm -117.16 123.77 72.22 Favored 'Isoleucine or valine' 0 C--O 1.233 0.214 0 CA-C-O 121.001 0.429 . . . . 0.0 111.053 -174.914 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' E' E ' 134' ' ' ASP . . . . . . . . . . . . . 6.7 p-10 -131.07 152.75 50.04 Favored 'General case' 0 C--N 1.332 -0.157 0 CA-C-N 116.048 -0.524 . . . . 0.0 109.786 174.723 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' E' E ' 135' ' ' GLU . . . . . . . . . . . . . 46.4 tp10 -49.93 -28.33 6.58 Favored 'General case' 0 C--N 1.328 -0.356 0 N-CA-C 112.91 0.707 . . . . 0.0 112.91 -169.263 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' E' E ' 136' ' ' GLN . . . . . . . . . . . . . 52.7 mt-30 -105.03 -24.96 12.73 Favored 'General case' 0 N--CA 1.464 0.275 0 N-CA-C 112.982 0.734 . . . . 0.0 112.982 -173.767 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' E' E ' 137' ' ' LYS . . . . . . . . . . . . . 59.6 mtpt -143.11 154.14 43.62 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-O 121.229 0.538 . . . . 0.0 111.891 -169.589 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' E' E ' 138' ' ' LEU . . . . . 0.423 ' C ' HD23 ' E' ' 138' ' ' LEU . 5.7 tt -119.09 124.18 46.27 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 115.546 -0.752 . . . . 0.0 109.378 174.587 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' E' E ' 139' ' ' THR . . . . . . . . . . . . . 30.6 m -110.39 130.54 55.53 Favored 'General case' 0 C--N 1.331 -0.229 0 CA-C-O 120.795 0.331 . . . . 0.0 110.774 -177.173 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' E' E ' 140' ' ' LEU . . . . . 0.517 HD12 HG22 ' E' ' 131' ' ' VAL . 12.6 tp -116.52 125.29 51.7 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 115.664 -0.698 . . . . 0.0 109.429 -178.093 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' E' E ' 141' ' ' ILE . . . . . . . . . . . . . 19.3 mt -122.56 117.75 52.99 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.308 0 N-CA-C 109.736 -0.468 . . . . 0.0 109.736 -177.205 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' E' E ' 142' ' ' ARG . . . . . . . . . . . . . 81.2 mtp180 -108.1 128.45 54.69 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 115.39 -0.823 . . . . 0.0 110.398 -176.473 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' E' E ' 143' ' ' THR . . . . . . . . . . . . . 77.8 p . . . . . 0 C--O 1.22 -0.459 0 CA-C-O 118.058 -0.972 . . . . 0.0 110.48 -179.994 . . . . . . . . 0 0 . 1 . 011 nuclear build core ' F' F ' 1' ' ' MET . . . . . . . . . . . . . 27.4 ptm . . . . . 0 C--O 1.231 0.116 0 CA-C-O 120.814 0.34 . . . . 0.0 110.756 . . . . . . . . . 0 0 . 1 . 011 nuclear build core ' F' F ' 2' ' ' SER . . . . . . . . . . . . . 7.4 p -118.99 133.92 55.52 Favored 'General case' 0 C--N 1.331 -0.21 0 CA-C-O 121.157 0.503 . . . . 0.0 110.356 177.9 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' F' F ' 3' ' ' GLU . . . . . . . . . . . . . 84.7 tt0 -145.19 142.32 29.46 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 115.878 -0.601 . . . . 0.0 110.965 179.951 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' F' F ' 4' ' ' LEU . . . . . . . . . . . . . 17.5 tp -121.34 128.21 52.05 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 115.84 -0.618 . . . . 0.0 109.998 176.597 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' F' F ' 5' ' ' LYS . . . . . . . . . . . . . 62.4 mttp -108.3 121.0 44.0 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.415 -0.357 . . . . 0.0 110.745 179.407 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' F' F ' 6' ' ' LEU . . . . . 0.461 HD23 ' HA ' ' F' ' 50' ' ' VAL . 23.8 mt -114.23 148.47 37.33 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 115.331 -0.85 . . . . 0.0 110.46 -179.461 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' F' F ' 7' ' ' LYS . . . . . . . . . . . . . 77.1 tttt -128.5 138.27 32.7 Favored Pre-proline 0 CA--C 1.533 0.302 0 CA-C-O 118.85 -0.595 . . . . 0.0 109.681 173.518 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' F' F ' 8' ' ' PRO . . . . . . . . . . . . . 95.7 Cg_endo -91.48 135.38 1.72 Allowed 'Trans proline' 0 N--CA 1.49 1.288 0 C-N-CA 121.727 1.618 . . . . 0.0 111.953 178.373 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' F' F ' 9' ' ' LEU . . . . . . . . . . . . . 55.6 mt -75.94 -46.98 3.85 Favored Pre-proline 0 CA--C 1.534 0.338 0 CA-C-O 118.777 -0.63 . . . . 0.0 111.725 179.639 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' F' F ' 10' ' ' PRO . . . . . . . . . . . . . 78.9 Cg_endo -82.86 149.04 13.9 Favored 'Trans proline' 0 N--CA 1.495 1.579 0 C-N-CA 121.246 1.297 . . . . 0.0 111.531 174.098 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' F' F ' 11' ' ' LYS . . . . . . . . . . . . . 53.8 pttt -86.59 112.17 21.32 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-O 121.588 0.709 . . . . 0.0 110.592 178.035 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' F' F ' 12' ' ' VAL . . . . . . . . . . . . . 12.2 p -151.15 149.22 14.32 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.253 0 CA-C-N 115.621 -0.718 . . . . 0.0 110.545 -179.673 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' F' F ' 13' ' ' GLU . . . . . . . . . . . . . 95.7 mt-10 -87.74 125.74 34.59 Favored 'General case' 0 C--N 1.329 -0.283 0 N-CA-C 109.85 -0.426 . . . . 0.0 109.85 176.224 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' F' F ' 14' ' ' LEU . . . . . . . . . . . . . 31.4 mt -97.86 150.71 37.04 Favored Pre-proline 0 C--N 1.33 -0.254 0 CA-C-O 119.407 -0.33 . . . . 0.0 110.679 -178.378 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' F' F ' 15' ' ' PRO . . . . . . . . . . . . . 28.1 Cg_exo -60.69 159.56 27.98 Favored 'Trans proline' 0 N--CA 1.497 1.702 0 C-N-CA 121.297 1.331 . . . . 0.0 112.007 177.826 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' F' F ' 16' ' ' PRO . . . . . . . . . . . . . 31.6 Cg_exo -59.76 -44.27 32.26 Favored 'Trans proline' 0 N--CA 1.497 1.689 0 C-N-CA 121.495 1.463 . . . . 0.0 112.688 -178.594 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' F' F ' 17' ' ' ASP . . . . . . . . . . . . . 9.1 p-10 -83.8 12.55 5.86 Favored 'General case' 0 CA--C 1.534 0.345 0 N-CA-C 113.156 0.799 . . . . 0.0 113.156 -177.709 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' F' F ' 18' ' ' PHE . . . . . . . . . . . . . 52.6 t80 -57.46 -43.77 84.28 Favored 'General case' 0 N--CA 1.458 -0.07 0 O-C-N 121.986 -0.447 . . . . 0.0 110.332 -178.39 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' F' F ' 19' ' ' VAL . . . . . . . . . . . . . 47.7 t -56.48 -44.06 79.5 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.302 0 CA-C-N 116.332 -0.394 . . . . 0.0 110.54 -178.11 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' F' F ' 20' ' ' ASP . . . . . . . . . . . . . 64.0 m-20 -60.01 -42.52 94.48 Favored 'General case' 0 C--N 1.329 -0.288 0 C-N-CA 120.905 -0.318 . . . . 0.0 110.951 -178.115 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' F' F ' 21' ' ' VAL . . . . . . . . . . . . . 50.6 t -64.5 -46.75 91.81 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.246 0 C-N-CA 120.745 -0.382 . . . . 0.0 110.691 -177.556 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' F' F ' 22' ' ' ILE . . . . . 0.514 HG22 HD12 ' F' ' 26' ' ' LEU . 51.4 mm -55.49 -46.79 78.95 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.224 0 C-N-CA 120.957 -0.297 . . . . 0.0 110.625 179.623 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' F' F ' 23' ' ' ARG . . . . . . . . . . . . . 55.9 ttp180 -54.8 -50.8 67.63 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-O 120.645 0.26 . . . . 0.0 111.314 -178.707 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' F' F ' 24' ' ' ILE . . . . . . . . . . . . . 75.6 mt -59.48 -41.86 86.0 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.268 0 CA-C-N 116.536 -0.302 . . . . 0.0 111.499 -176.266 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' F' F ' 25' ' ' LYS . . . . . . . . . . . . . 40.5 mmtt -66.41 -43.93 84.41 Favored 'General case' 0 C--N 1.329 -0.291 0 N-CA-C 112.468 0.544 . . . . 0.0 112.468 -178.655 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' F' F ' 26' ' ' LEU . . . . . 0.514 HD12 HG22 ' F' ' 22' ' ' ILE . 58.0 mt -78.77 -35.1 45.03 Favored 'General case' 0 C--N 1.33 -0.271 0 N-CA-C 113.77 1.026 . . . . 0.0 113.77 -169.837 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' F' F ' 27' ' ' GLN . . . . . . . . . . . . . 15.6 pt20 -47.39 139.41 6.58 Favored 'General case' 0 N--CA 1.469 0.524 0 N-CA-C 112.758 0.651 . . . . 0.0 112.758 -175.653 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' F' F ' 28' ' ' GLY . . . . . . . . . . . . . . . 101.22 -24.46 31.74 Favored Glycine 0 CA--C 1.534 1.274 0 CA-C-N 115.536 -0.756 . . . . 0.0 112.308 -176.242 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' F' F ' 29' ' ' LYS . . . . . . . . . . . . . 55.2 mttp -97.35 155.1 17.04 Favored 'General case' 0 C--O 1.231 0.129 0 CA-C-N 117.535 0.667 . . . . 0.0 111.253 178.589 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' F' F ' 30' ' ' THR . . . . . . . . . . . . . 41.2 m -106.17 137.49 44.02 Favored 'General case' 0 C--N 1.331 -0.23 0 CA-C-N 116.02 -0.536 . . . . 0.0 109.854 175.828 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' F' F ' 31' ' ' VAL . . . . . . . . . . . . . 34.6 m -130.21 153.08 38.42 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.243 0 CA-C-O 121.055 0.455 . . . . 0.0 111.192 -177.49 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' F' F ' 32' ' ' ARG . . . . . . . . . . . . . 55.5 mtp180 -128.92 152.53 48.46 Favored 'General case' 0 C--N 1.332 -0.187 0 CA-C-N 115.749 -0.66 . . . . 0.0 110.668 177.885 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' F' F ' 33' ' ' THR . . . . . . . . . . . . . 14.0 m -54.09 137.83 39.18 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 115.98 -0.554 . . . . 0.0 111.26 -179.206 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' F' F ' 34' ' ' GLY . . . . . . . . . . . . . . . 101.68 -17.17 55.44 Favored Glycine 0 CA--C 1.533 1.159 0 CA-C-O 119.59 -0.561 . . . . 0.0 113.354 178.804 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' F' F ' 35' ' ' ASP . . . . . . . . . . . . . 75.2 m-20 -65.88 148.03 52.43 Favored 'General case' 0 N--CA 1.461 0.091 0 CA-C-N 118.09 0.945 . . . . 0.0 111.192 179.469 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' F' F ' 36' ' ' VAL . . . . . . . . . . . . . 47.2 t -120.48 129.07 75.98 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.196 0 CA-C-N 115.872 -0.604 . . . . 0.0 109.829 178.789 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' F' F ' 37' ' ' ILE . . . . . . . . . . . . . 63.3 mt -122.29 138.85 51.08 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.226 0 CA-C-N 116.19 -0.459 . . . . 0.0 109.963 -178.958 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' F' F ' 38' ' ' GLY . . . . . . . . . . . . . . . -115.03 128.74 8.25 Favored Glycine 0 CA--C 1.526 0.72 0 N-CA-C 111.143 -0.783 . . . . 0.0 111.143 179.411 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' F' F ' 39' ' ' ILE . . . . . . . . . . . . . 76.6 mt -125.91 138.32 54.91 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.212 0 CA-C-O 120.808 0.337 . . . . 0.0 110.421 179.659 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' F' F ' 40' ' ' SER . . . . . . . . . . . . . 23.0 t -92.71 114.69 27.32 Favored 'General case' 0 C--N 1.332 -0.192 0 CA-C-N 116.335 -0.393 . . . . 0.0 111.059 176.131 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' F' F ' 41' ' ' ILE . . . . . . . . . . . . . 44.6 mm -121.43 122.75 68.05 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.215 0 CA-C-O 120.846 0.355 . . . . 0.0 110.303 179.274 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' F' F ' 42' ' ' LEU . . . . . . . . . . . . . 9.1 tp 52.84 35.38 18.73 Favored 'General case' 0 CA--C 1.532 0.252 0 CA-C-N 116.254 -0.43 . . . . 0.0 111.643 177.128 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' F' F ' 43' ' ' GLY . . . . . . . . . . . . . . . 72.15 30.41 65.26 Favored Glycine 0 CA--C 1.529 0.966 0 C-N-CA 121.058 -0.591 . . . . 0.0 112.165 178.066 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' F' F ' 44' ' ' LYS . . . . . . . . . . . . . 85.9 tttt -139.71 130.66 26.24 Favored 'General case' 0 C--N 1.33 -0.259 0 N-CA-C 109.564 -0.532 . . . . 0.0 109.564 178.886 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' F' F ' 45' ' ' GLU . . . . . . . . . . . . . 85.1 tt0 -82.5 121.66 27.05 Favored 'General case' 0 C--N 1.326 -0.425 0 CA-C-O 120.9 0.381 . . . . 0.0 110.985 -177.496 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' F' F ' 46' ' ' VAL . . . . . . . . . . . . . 9.7 p -118.2 125.74 74.48 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.171 0 N-CA-C 109.385 -0.598 . . . . 0.0 109.385 175.434 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' F' F ' 47' ' ' LYS . . . . . . . . . . . . . 98.8 mttt -98.84 125.56 44.26 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 115.948 -0.569 . . . . 0.0 110.705 179.1 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' F' F ' 48' ' ' PHE . . . . . . . . . . . . . 31.5 m-85 -110.56 131.89 54.66 Favored 'General case' 0 C--N 1.33 -0.267 0 N-CA-C 109.8 -0.444 . . . . 0.0 109.8 178.062 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' F' F ' 49' ' ' LYS . . . . . . . . . . . . . 46.1 tttp -107.05 132.75 52.61 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.26 -0.427 . . . . 0.0 110.081 178.337 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' F' F ' 50' ' ' VAL . . . . . 0.461 ' HA ' HD23 ' F' ' 6' ' ' LEU . 46.5 t -76.47 104.22 4.38 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.295 0 N-CA-C 109.263 -0.644 . . . . 0.0 109.263 177.215 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' F' F ' 51' ' ' VAL . . . . . . . . . . . . . 49.0 t -72.45 -52.41 23.86 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.298 0 N-CA-C 109.538 -0.541 . . . . 0.0 109.538 -175.239 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' F' F ' 52' ' ' GLN . . . . . . . . . . . . . 86.6 mt-30 -151.77 140.73 21.09 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-O 121.245 0.545 . . . . 0.0 111.675 -178.99 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' F' F ' 53' ' ' ALA . . . . . 0.424 ' HB1' ' HB2' ' F' ' 58' ' ' LEU . . . -116.22 127.58 54.88 Favored 'General case' 0 C--N 1.325 -0.46 0 CA-C-N 114.918 -1.037 . . . . 0.0 109.491 174.712 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' F' F ' 54' ' ' TYR . . . . . . . . . . . . . 27.4 t80 -125.92 109.06 25.02 Favored Pre-proline 0 CA--C 1.534 0.359 0 CA-C-O 118.21 -0.9 . . . . 0.0 110.511 -179.342 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' F' F ' 55' ' ' PRO . . . . . . . . . . . . . 73.3 Cg_endo -77.24 170.09 72.39 Favored 'Cis proline' 0 N--CA 1.501 1.914 0 CA-C-N 121.852 1.697 . . . . 0.0 112.658 -4.617 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' F' F ' 56' ' ' SER . . . . . . . . . . . . . 13.5 m -113.51 126.88 27.49 Favored Pre-proline 0 CA--C 1.54 0.585 0 CA-C-O 118.32 -0.848 . . . . 0.0 109.271 174.511 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' F' F ' 57' ' ' PRO . . . . . . . . . . . . . 57.3 Cg_endo -72.47 150.4 95.01 Favored 'Cis proline' 0 N--CA 1.496 1.66 0 CA-C-N 122.053 1.769 . . . . 0.0 111.692 0.043 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' F' F ' 58' ' ' LEU . . . . . 0.424 ' HB2' ' HB1' ' F' ' 53' ' ' ALA . 29.6 tp -107.9 137.36 46.03 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.221 -0.445 . . . . 0.0 110.659 -178.143 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' F' F ' 59' ' ' ARG . . . . . . . . . . . . . 73.6 ttt-85 -101.67 123.86 46.36 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 115.845 -0.616 . . . . 0.0 109.498 176.034 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' F' F ' 60' ' ' VAL . . . . . . . . . . . . . 44.6 t -76.51 114.9 17.38 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.239 0 C-N-CA 120.658 -0.417 . . . . 0.0 110.109 -177.426 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' F' F ' 61' ' ' GLU . . . . . . . . . . . . . 84.6 tt0 -131.11 154.21 48.54 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 115.759 -0.655 . . . . 0.0 109.503 179.532 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' F' F ' 62' ' ' ASP . . . . . . . . . . . . . 9.7 t0 -51.54 -32.59 28.6 Favored 'General case' 0 C--N 1.327 -0.376 0 N-CA-C 112.0 0.37 . . . . 0.0 112.0 -177.924 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' F' F ' 63' ' ' ARG . . . . . . . . . . . . . 27.2 mmm180 -72.4 -22.03 61.18 Favored 'General case' 0 N--CA 1.466 0.353 0 N-CA-C 112.934 0.716 . . . . 0.0 112.934 -177.627 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' F' F ' 64' ' ' THR . . . . . . . . . . . . . 21.6 m -67.84 137.87 55.65 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-O 120.825 0.345 . . . . 0.0 110.979 -175.461 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' F' F ' 65' ' ' LYS . . . . . . . . . . . . . 55.9 mtmt -88.95 140.21 29.67 Favored 'General case' 0 C--N 1.331 -0.224 0 CA-C-N 116.224 -0.444 . . . . 0.0 110.573 178.351 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' F' F ' 66' ' ' ILE . . . . . . . . . . . . . 4.3 mp -116.13 127.4 73.74 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.244 0 N-CA-C 109.755 -0.461 . . . . 0.0 109.755 -179.184 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' F' F ' 67' ' ' THR . . . . . . . . . . . . . 21.4 m -124.82 136.95 54.28 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-O 121.002 0.429 . . . . 0.0 110.873 -177.431 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' F' F ' 68' ' ' LEU . . . . . . . . . . . . . 15.9 tp . . . . . 0 C--N 1.33 -0.271 0 CA-C-N 116.099 -0.501 . . . . 0.0 110.561 178.241 . . . . . . . . 0 0 . 1 . 011 nuclear build core ' F' F ' 73' ' ' VAL . . . . . . . . . . . . . 31.1 m . . . . . 0 N--CA 1.462 0.168 0 CA-C-O 120.789 0.328 . . . . 0.0 110.165 . . . . . . . . . 0 0 . 1 . 011 nuclear build core ' F' F ' 74' ' ' ASP . . . . . . . . . . . . . 13.5 t70 -95.49 118.72 32.71 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.296 -0.411 . . . . 0.0 110.24 -177.575 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' F' F ' 75' ' ' VAL . . . . . . . . . . . . . 40.3 t -114.82 124.59 71.63 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.241 0 CA-C-O 121.043 0.449 . . . . 0.0 110.297 -178.746 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' F' F ' 76' ' ' LEU . . . . . . . . . . . . . 15.0 mt -128.78 146.15 50.99 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 115.661 -0.7 . . . . 0.0 109.723 178.88 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' F' F ' 77' ' ' GLU . . . . . . . . . . . . . 97.6 mt-10 -135.38 135.94 41.07 Favored 'General case' 0 C--N 1.331 -0.198 0 CA-C-O 121.075 0.464 . . . . 0.0 111.32 -178.502 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' F' F ' 78' ' ' ALA . . . . . . . . . . . . . . . -121.51 140.97 51.51 Favored 'General case' 0 C--N 1.332 -0.184 0 CA-C-N 115.775 -0.648 . . . . 0.0 109.735 176.09 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' F' F ' 79' ' ' LYS . . . . . 0.628 ' O ' HD13 ' F' ' 80' ' ' ILE . 96.1 mttt -85.26 115.1 22.84 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-O 120.909 0.385 . . . . 0.0 110.865 -178.3 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' F' F ' 80' ' ' ILE . . . . . 0.628 HD13 ' O ' ' F' ' 79' ' ' LYS . 39.7 mm -139.09 108.39 3.8 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.325 0 N-CA-C 109.239 -0.652 . . . . 0.0 109.239 -178.197 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' F' F ' 81' ' ' LYS . . . . . . . . . . . . . 39.2 ttpt -106.66 134.91 49.07 Favored 'General case' 0 C--N 1.331 -0.226 0 CA-C-O 120.939 0.4 . . . . 0.0 111.178 -177.242 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' F' F ' 82' ' ' GLY . . . . . . . . . . . . . . . 89.09 41.92 5.74 Favored Glycine 0 CA--C 1.523 0.556 0 N-CA-C 111.114 -0.795 . . . . 0.0 111.114 176.404 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' F' F ' 83' ' ' ILE . . . . . . . . . . . . . 68.0 mt -78.13 130.69 35.88 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.363 0 N-CA-C 109.525 -0.546 . . . . 0.0 109.525 178.398 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' F' F ' 84' ' ' LYS . . . . . . . . . . . . . 38.2 ttpt -95.73 -46.35 6.63 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-O 120.863 0.363 . . . . 0.0 110.147 -178.783 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' F' F ' 85' ' ' ASP . . . . . . . . . . . . . 7.2 t70 -152.08 149.15 28.51 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.111 -0.495 . . . . 0.0 110.629 178.581 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' F' F ' 86' ' ' VAL . . . . . . . . . . . . . 42.1 t -126.84 132.7 69.77 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.26 0 CA-C-O 120.859 0.361 . . . . 0.0 110.448 -179.524 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' F' F ' 87' ' ' ILE . . . . . . . . . . . . . 45.5 mm -119.27 124.59 73.33 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.223 0 N-CA-C 109.412 -0.588 . . . . 0.0 109.412 176.439 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' F' F ' 88' ' ' LEU . . . . . . . . . . . . . 16.8 tp -112.36 130.51 55.94 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-O 121.116 0.484 . . . . 0.0 111.19 -176.912 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' F' F ' 89' ' ' ASP . . . . . . . . . . . . . 9.1 t70 -123.64 155.15 38.27 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-N 115.754 -0.657 . . . . 0.0 109.388 175.443 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' F' F ' 90' ' ' GLU . . . . . . . . . . . . . 84.5 tt0 -47.59 -40.55 19.57 Favored 'General case' 0 C--N 1.329 -0.287 0 N-CA-C 112.818 0.673 . . . . 0.0 112.818 -172.07 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' F' F ' 91' ' ' ASN . . . . . . . . . . . . . 33.6 m120 -132.16 38.96 3.45 Favored 'General case' 0 CA--C 1.53 0.187 0 CA-C-O 120.856 0.36 . . . . 0.0 111.496 -178.208 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' F' F ' 92' ' ' LEU . . . . . . . . . . . . . 12.5 tp -166.0 139.63 4.3 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.593 -0.276 . . . . 0.0 110.325 -178.613 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' F' F ' 93' ' ' ILE . . . . . . . . . . . . . 68.2 mt -125.65 122.76 63.08 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.18 0 N-CA-C 109.588 -0.523 . . . . 0.0 109.588 179.851 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' F' F ' 94' ' ' VAL . . . . . 0.486 HG21 HG21 ' F' ' 125' ' ' VAL . 45.1 t -122.2 128.41 75.51 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.206 0 CA-C-O 120.977 0.417 . . . . 0.0 109.957 179.703 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' F' F ' 95' ' ' VAL . . . . . . . . . . . . . 41.3 t -119.91 132.93 68.26 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.323 0 CA-C-N 115.899 -0.591 . . . . 0.0 109.744 179.951 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' F' F ' 96' ' ' ILE . . . . . . . . . . . . . 69.5 mt -112.85 124.03 69.1 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 N-CA-C 108.96 -0.756 . . . . 0.0 108.96 177.912 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' F' F ' 97' ' ' THR . . . . . . . . . . . . . 43.6 p -98.51 155.89 17.05 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-O 121.544 0.688 . . . . 0.0 111.545 -175.424 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' F' F ' 98' ' ' GLU . . . . . . . . . . . . . 84.5 tt0 -54.11 -27.38 32.72 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 115.54 -0.755 . . . . 0.0 112.151 -179.864 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' F' F ' 99' ' ' GLU . . . . . . . . . . . . . 95.4 mt-10 -80.32 14.98 1.73 Allowed 'General case' 0 CA--C 1.535 0.381 0 N-CA-C 113.173 0.805 . . . . 0.0 113.173 -176.538 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' F' F ' 100' ' ' ASN . . . . . . . . . . . . . 3.6 m-20 63.0 35.38 13.22 Favored 'General case' 0 C--O 1.233 0.236 0 CA-C-N 118.126 0.421 . . . . 0.0 111.392 179.229 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' F' F ' 101' ' ' GLU . . . . . . . . . . . . . 85.0 tt0 -113.64 145.03 41.92 Favored 'General case' 0 C--N 1.331 -0.238 0 N-CA-C 109.633 -0.506 . . . . 0.0 109.633 174.393 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' F' F ' 102' ' ' VAL . . . . . . . . . . . . . 45.4 t -115.1 125.75 72.49 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.281 0 CA-C-N 116.22 -0.445 . . . . 0.0 109.929 -178.202 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' F' F ' 103' ' ' LEU . . . . . . . . . . . . . 61.2 mt -117.46 129.12 55.63 Favored 'General case' 0 C--N 1.332 -0.191 0 CA-C-N 115.743 -0.662 . . . . 0.0 110.325 177.445 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' F' F ' 104' ' ' ILE . . . . . . . . . . . . . 67.1 mt -119.04 124.49 73.25 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.181 0 N-CA-C 110.11 -0.33 . . . . 0.0 110.11 179.494 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' F' F ' 105' ' ' PHE . . . . . . . . . . . . . 88.9 m-85 -123.41 163.39 20.92 Favored 'General case' 0 C--O 1.232 0.168 0 O-C-N 123.954 0.784 . . . . 0.0 109.937 -179.497 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' F' F ' 106' ' ' ASN . . . . . . . . . . . . . 46.3 p-10 -97.66 -173.09 2.54 Favored 'General case' 0 C--N 1.33 -0.252 0 N-CA-C 109.821 -0.437 . . . . 0.0 109.821 171.821 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' F' F ' 107' ' ' GLN . . . . . . . . . . . . . 55.4 tt0 -60.12 -26.4 66.22 Favored 'General case' 0 C--N 1.328 -0.332 0 N-CA-C 112.19 0.441 . . . . 0.0 112.19 -178.823 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' F' F ' 108' ' ' ASN . . . . . . . . . . . . . 11.9 t-20 -88.68 13.99 11.08 Favored 'General case' 0 CA--C 1.535 0.389 0 N-CA-C 112.865 0.691 . . . . 0.0 112.865 -177.824 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' F' F ' 109' ' ' LEU . . . . . . . . . . . . . 43.2 mt 58.25 34.17 23.84 Favored 'General case' 0 CA--C 1.53 0.202 0 O-C-N 122.138 -0.351 . . . . 0.0 111.84 177.464 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' F' F ' 110' ' ' GLU . . . . . . . . . . . . . 70.5 mm-40 -103.14 142.95 33.27 Favored 'General case' 0 C--N 1.329 -0.31 0 N-CA-C 109.006 -0.738 . . . . 0.0 109.006 173.315 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' F' F ' 111' ' ' GLU . . . . . . . . . . . . . 51.1 tt0 -85.28 121.78 28.51 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-O 121.017 0.437 . . . . 0.0 110.538 -175.41 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' F' F ' 112' ' ' LEU . . . . . . . . . . . . . 44.8 mt -100.95 -42.96 6.21 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 115.708 -0.678 . . . . 0.0 110.68 179.636 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' F' F ' 113' ' ' TYR . . . . . . . . . . . . . 57.5 t80 -133.09 136.54 45.92 Favored 'General case' 0 C--N 1.331 -0.2 0 CA-C-N 116.329 -0.396 . . . . 0.0 111.221 -177.85 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' F' F ' 114' ' ' ARG . . . . . . . . . . . . . 69.8 ttt180 -137.53 118.61 14.41 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 115.716 -0.675 . . . . 0.0 110.142 178.197 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' F' F ' 115' ' ' GLY . . . . . . . . . . . . . . . -149.99 162.3 29.13 Favored Glycine 0 CA--C 1.524 0.605 0 C-N-CA 120.693 -0.765 . . . . 0.0 111.405 179.746 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' F' F ' 116' ' ' LYS . . . . . . . . . . . . . 74.2 tttt -136.97 140.42 42.17 Favored 'General case' 0 C--N 1.328 -0.338 0 N-CA-C 110.085 -0.339 . . . . 0.0 110.085 178.401 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' F' F ' 117' ' ' PHE . . . . . . . . . . . . . 34.8 m-85 -136.6 113.88 10.76 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.309 -0.405 . . . . 0.0 110.214 -177.45 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' F' F ' 118' ' ' GLU . . . . . . . . . . . . . 84.9 tt0 -53.79 -48.93 69.32 Favored 'General case' 0 C--N 1.329 -0.307 0 C-N-CA 121.112 -0.235 . . . . 0.0 111.292 -177.39 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' F' F ' 119' ' ' ASN . . . . . . . . . . . . . 6.0 m120 -92.98 31.12 1.46 Allowed 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 116.273 -0.421 . . . . 0.0 111.999 -175.464 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' F' F ' 120' ' ' LEU . . . . . . . . . . . . . 25.2 tp -55.56 122.77 12.05 Favored 'General case' 0 N--CA 1.462 0.173 0 CA-C-O 120.698 0.285 . . . . 0.0 110.535 178.413 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' F' F ' 121' ' ' ASN . . . . . . . . . . . . . 3.8 m-20 -113.86 -44.03 3.21 Favored 'General case' 0 C--O 1.232 0.146 0 CA-C-N 116.426 -0.352 . . . . 0.0 111.162 -176.189 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' F' F ' 122' ' ' LYS . . . . . . . . . . . . . 39.2 ttpt -146.01 141.6 27.83 Favored 'General case' 0 C--N 1.33 -0.24 0 C-N-CA 120.689 -0.404 . . . . 0.0 111.531 -175.1 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' F' F ' 123' ' ' VAL . . . . . . . . . . . . . 43.9 t -129.28 131.45 67.56 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.267 0 N-CA-C 109.486 -0.561 . . . . 0.0 109.486 174.786 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' F' F ' 124' ' ' LEU . . . . . 0.41 HD22 HD12 ' A' ' 88' ' ' LEU . 14.6 tp -127.37 131.85 50.28 Favored 'General case' 0 N--CA 1.464 0.227 0 CA-C-O 120.859 0.362 . . . . 0.0 110.919 -178.718 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' F' F ' 125' ' ' VAL . . . . . 0.522 HG22 HG23 ' F' ' 130' ' ' VAL . 45.4 t -126.13 129.43 72.17 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.218 0 CA-C-N 115.992 -0.549 . . . . 0.0 110.059 179.362 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' F' F ' 126' ' ' ARG . . . . . . . . . . . . . 42.0 ttm180 -154.22 131.26 10.99 Favored 'General case' 0 C--N 1.33 -0.27 0 N-CA-C 109.808 -0.441 . . . . 0.0 109.808 177.306 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' F' F ' 127' ' ' ASN . . . . . . . . . . . . . 3.4 t-20 56.67 -155.02 0.32 Allowed 'General case' 0 CA--C 1.538 0.507 0 N-CA-C 109.595 -0.521 . . . . 0.0 109.595 -178.319 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' F' F ' 128' ' ' ASP . . . . . . . . . . . . . 22.1 p-10 -82.5 17.24 1.81 Allowed 'General case' 0 CA--C 1.539 0.52 0 N-CA-C 112.491 0.552 . . . . 0.0 112.491 176.879 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' F' F ' 129' ' ' LEU . . . . . . . . . . . . . 16.5 tp -116.37 137.36 52.22 Favored 'General case' 0 C--O 1.232 0.18 0 N-CA-C 109.934 -0.395 . . . . 0.0 109.934 179.148 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' F' F ' 130' ' ' VAL . . . . . 0.522 HG23 HG22 ' F' ' 125' ' ' VAL . 12.6 p -136.9 143.37 35.19 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.25 0 CA-C-O 121.033 0.444 . . . . 0.0 110.663 -179.951 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' F' F ' 131' ' ' VAL . . . . . 0.458 HG21 HD13 ' A' ' 88' ' ' LEU . 32.5 m -136.09 146.94 28.42 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.275 0 CA-C-O 121.238 0.542 . . . . 0.0 110.912 178.804 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' F' F ' 132' ' ' ILE . . . . . . . . . . . . . 73.2 mt -122.36 134.01 66.88 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.228 0 CA-C-N 115.505 -0.771 . . . . 0.0 109.581 -179.572 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' F' F ' 133' ' ' ILE . . . . . . . . . . . . . 40.1 mm -115.91 122.79 70.3 Favored 'Isoleucine or valine' 0 C--O 1.234 0.262 0 CA-C-N 116.353 -0.385 . . . . 0.0 110.86 -176.304 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' F' F ' 134' ' ' ASP . . . . . . . . . . . . . 7.3 p-10 -131.88 150.97 52.0 Favored 'General case' 0 C--N 1.331 -0.23 0 CA-C-N 116.128 -0.487 . . . . 0.0 109.744 174.441 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' F' F ' 135' ' ' GLU . . . . . . . . . . . . . 85.6 tt0 -49.92 -25.86 3.62 Favored 'General case' 0 C--N 1.327 -0.378 0 N-CA-C 112.896 0.702 . . . . 0.0 112.896 -170.738 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' F' F ' 136' ' ' GLN . . . . . . . . . . . . . 97.8 mt-30 -105.05 -25.22 12.62 Favored 'General case' 0 N--CA 1.464 0.266 0 N-CA-C 113.015 0.746 . . . . 0.0 113.015 -175.081 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' F' F ' 137' ' ' LYS . . . . . . . . . . . . . 66.2 mttm -140.27 150.21 43.77 Favored 'General case' 0 C--N 1.331 -0.217 0 CA-C-O 121.587 0.708 . . . . 0.0 112.529 -167.529 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' F' F ' 138' ' ' LEU . . . . . . . . . . . . . 13.0 tp -112.99 121.55 44.98 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 114.787 -1.097 . . . . 0.0 109.003 173.103 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' F' F ' 139' ' ' THR . . . . . . . . . . . . . 31.8 m -113.95 126.96 55.73 Favored 'General case' 0 C--N 1.331 -0.215 0 CA-C-O 120.837 0.351 . . . . 0.0 110.862 -178.761 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' F' F ' 140' ' ' LEU . . . . . 0.485 HD23 ' C ' ' F' ' 140' ' ' LEU . 8.8 tt -116.34 124.13 49.34 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 115.577 -0.738 . . . . 0.0 109.354 179.913 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' F' F ' 141' ' ' ILE . . . . . 0.509 ' HB ' HG13 ' F' ' 130' ' ' VAL . 19.3 mt -121.48 120.88 63.11 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.275 0 CA-C-O 120.923 0.392 . . . . 0.0 109.971 -175.199 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' F' F ' 142' ' ' ARG . . . . . . . . . . . . . 34.7 tpt85 -110.22 127.07 54.77 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-N 115.337 -0.847 . . . . 0.0 109.965 -178.136 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' F' F ' 143' ' ' THR . . . . . . . . . . . . . 34.4 p . . . . . 0 C--O 1.22 -0.458 0 CA-C-O 118.02 -0.991 . . . . 0.0 110.656 -179.748 . . . . . . . . 0 0 . 1 . 012 nuclear build core ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 1.7 p . . . . . 0 C--O 1.233 0.19 0 CA-C-O 121.377 0.608 . . . . 0.0 110.336 . . . . . . . . . 0 0 . 1 . 012 nuclear build core ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 85.1 tt0 -143.05 142.1 31.47 Favored 'General case' 0 C--N 1.327 -0.399 0 CA-C-N 115.451 -0.795 . . . . 0.0 111.114 -178.325 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 4' ' ' LEU . . . . . . . . . . . . . 18.9 tp -123.93 128.18 49.05 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 115.887 -0.597 . . . . 0.0 109.952 176.922 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 5' ' ' LYS . . . . . . . . . . . . . 95.2 mttt -107.24 122.56 46.79 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.572 -0.285 . . . . 0.0 110.71 -179.873 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 58.1 mt -115.54 147.65 40.45 Favored 'General case' 0 C--N 1.331 -0.215 0 CA-C-N 115.577 -0.738 . . . . 0.0 110.244 -179.123 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 26.5 ttpp -125.98 139.7 34.98 Favored Pre-proline 0 CA--C 1.532 0.284 0 CA-C-O 118.983 -0.532 . . . . 0.0 109.725 174.244 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 8' ' ' PRO . . . . . . . . . . . . . 83.7 Cg_endo -91.75 133.61 1.42 Allowed 'Trans proline' 0 N--CA 1.489 1.224 0 C-N-CA 121.786 1.657 . . . . 0.0 111.808 178.275 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 73.2 mt -75.64 -47.01 4.14 Favored Pre-proline 0 CA--C 1.534 0.339 0 CA-C-O 118.527 -0.749 . . . . 0.0 111.948 179.03 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 73.9 Cg_endo -77.88 145.66 22.71 Favored 'Trans proline' 0 N--CA 1.496 1.635 0 CA-C-N 120.427 1.188 . . . . 0.0 111.656 175.154 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 58.1 mttm -84.76 89.53 7.54 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-O 120.815 0.34 . . . . 0.0 110.701 -179.781 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 12.3 p -139.55 146.24 25.72 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.293 0 CA-C-N 116.096 -0.502 . . . . 0.0 110.289 178.989 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 45.4 tp10 -89.47 129.35 35.97 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.342 -0.39 . . . . 0.0 110.254 178.554 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 14' ' ' LEU . . . . . . . . . . . . . 35.2 mt -97.36 144.88 28.69 Favored Pre-proline 0 C--N 1.329 -0.3 0 CA-C-O 119.14 -0.457 . . . . 0.0 110.05 -179.01 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 15' ' ' PRO . . . . . . . . . . . . . 24.8 Cg_exo -61.83 163.03 20.03 Favored 'Trans proline' 0 N--CA 1.498 1.783 0 C-N-CA 121.268 1.312 . . . . 0.0 111.751 178.447 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 16' ' ' PRO . . . . . . . . . . . . . 31.7 Cg_exo -59.52 -36.07 94.1 Favored 'Trans proline' 0 N--CA 1.497 1.698 0 C-N-CA 121.562 1.508 . . . . 0.0 112.971 -177.502 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 17' ' ' ASP . . . . . . . . . . . . . 7.9 p-10 -84.64 0.16 51.24 Favored 'General case' 0 CA--C 1.537 0.459 0 N-CA-C 113.274 0.842 . . . . 0.0 113.274 -177.748 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 18' ' ' PHE . . . . . . . . . . . . . 35.3 t80 -58.64 -43.75 89.85 Favored 'General case' 0 C--N 1.333 -0.128 0 O-C-N 121.95 -0.469 . . . . 0.0 109.963 -177.75 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 19' ' ' VAL . . . . . . . . . . . . . 53.3 t -57.19 -42.51 80.0 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.253 0 CA-C-N 116.155 -0.475 . . . . 0.0 110.383 -179.366 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 19.1 t0 -60.02 -42.89 95.33 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-O 120.775 0.322 . . . . 0.0 111.057 -177.869 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 45.4 t -64.38 -46.49 92.86 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.269 0 C-N-CA 120.784 -0.367 . . . . 0.0 110.361 -177.693 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 22' ' ' ILE . . . . . 0.411 HG22 HD12 ' A' ' 26' ' ' LEU . 51.9 mm -56.27 -44.23 78.97 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.223 0 CA-C-O 120.73 0.3 . . . . 0.0 110.54 178.633 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 23' ' ' ARG . . . . . . . . . . . . . 57.3 ttp180 -54.53 -47.82 72.71 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-O 120.774 0.321 . . . . 0.0 111.305 -179.934 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 24' ' ' ILE . . . . . . . . . . . . . 79.9 mt -59.15 -41.41 83.62 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.295 0 CA-C-N 116.438 -0.346 . . . . 0.0 111.022 -178.574 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 58.3 mttm -67.48 -41.0 85.31 Favored 'General case' 0 C--N 1.328 -0.343 0 N-CA-C 112.571 0.582 . . . . 0.0 112.571 -179.006 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 26' ' ' LEU . . . . . 0.411 HD12 HG22 ' A' ' 22' ' ' ILE . 79.5 mt -77.92 -38.67 45.05 Favored 'General case' 0 C--N 1.331 -0.233 0 N-CA-C 113.512 0.93 . . . . 0.0 113.512 -170.227 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 27' ' ' GLN . . . . . . . . . . . . . 17.9 pt20 -46.94 138.62 6.26 Favored 'General case' 0 N--CA 1.468 0.429 0 N-CA-C 112.796 0.665 . . . . 0.0 112.796 -174.722 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 101.13 -25.69 27.36 Favored Glycine 0 CA--C 1.533 1.165 0 CA-C-N 115.609 -0.723 . . . . 0.0 112.341 -177.865 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 69.8 mmtt -98.31 155.18 17.33 Favored 'General case' 0 C--N 1.333 -0.128 0 CA-C-N 117.4 0.6 . . . . 0.0 111.31 178.443 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 30' ' ' THR . . . . . . . . . . . . . 40.2 m -108.88 139.87 43.13 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 115.804 -0.634 . . . . 0.0 109.792 175.244 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 33.6 m -130.69 155.77 42.08 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.222 0 CA-C-O 121.032 0.444 . . . . 0.0 111.144 -177.542 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 32' ' ' ARG . . . . . . . . . . . . . 61.5 mtt85 -129.02 150.58 50.37 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-N 115.862 -0.608 . . . . 0.0 110.733 178.36 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 33' ' ' THR . . . . . . . . . . . . . 23.3 m -53.26 138.91 31.09 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.054 -0.521 . . . . 0.0 111.39 -178.087 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 100.65 -17.2 56.91 Favored Glycine 0 CA--C 1.534 1.266 0 CA-C-O 119.607 -0.552 . . . . 0.0 113.232 178.526 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 79.5 m-20 -66.44 147.31 53.48 Favored 'General case' 0 N--CA 1.461 0.097 0 CA-C-N 118.008 0.904 . . . . 0.0 111.117 178.63 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 42.1 t -121.74 130.35 74.68 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.288 0 CA-C-N 116.083 -0.508 . . . . 0.0 109.865 178.403 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 37' ' ' ILE . . . . . . . . . . . . . 68.4 mt -120.4 138.55 50.56 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.279 0 CA-C-N 116.161 -0.472 . . . . 0.0 109.877 -179.813 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . -117.48 128.72 7.96 Favored Glycine 0 CA--C 1.526 0.735 0 N-CA-C 110.636 -0.986 . . . . 0.0 110.636 178.611 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 39' ' ' ILE . . . . . . . . . . . . . 69.9 mt -123.75 132.46 71.34 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.24 0 CA-C-O 120.735 0.302 . . . . 0.0 110.3 -179.986 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 40' ' ' SER . . . . . . . . . . . . . 30.1 t -92.37 118.35 30.83 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.14 -0.482 . . . . 0.0 110.605 175.698 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 41' ' ' ILE . . . . . . . . . . . . . 69.2 mt -130.71 122.5 52.67 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.234 0 CA-C-O 120.849 0.357 . . . . 0.0 110.499 178.612 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 45.8 mt 55.12 33.91 21.45 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.033 -0.53 . . . . 0.0 111.897 176.666 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . 72.81 28.4 67.09 Favored Glycine 0 CA--C 1.531 1.046 0 C-N-CA 121.016 -0.611 . . . . 0.0 112.375 178.026 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 44' ' ' LYS . . . . . . . . . . . . . 26.4 ttpp -137.24 127.61 26.5 Favored 'General case' 0 C--N 1.331 -0.228 0 N-CA-C 109.54 -0.541 . . . . 0.0 109.54 177.288 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 67.6 tt0 -86.05 126.68 34.35 Favored 'General case' 0 C--N 1.327 -0.392 0 CA-C-N 116.336 -0.393 . . . . 0.0 111.12 -176.851 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 46' ' ' VAL . . . . . . . . . . . . . 10.2 p -119.55 126.81 75.68 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.172 0 N-CA-C 109.909 -0.404 . . . . 0.0 109.909 175.436 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 72.7 mmtt -98.2 125.54 43.29 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 115.927 -0.579 . . . . 0.0 110.752 176.148 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 48' ' ' PHE . . . . . . . . . . . . . 32.8 m-85 -112.16 131.61 55.36 Favored 'General case' 0 C--N 1.329 -0.295 0 N-CA-C 109.185 -0.672 . . . . 0.0 109.185 174.651 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 42.2 tttp -108.4 132.92 53.27 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.484 -0.325 . . . . 0.0 110.208 178.931 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 50' ' ' VAL . . . . . . . . . . . . . 41.3 t -76.23 103.99 4.04 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.332 0 N-CA-C 109.21 -0.663 . . . . 0.0 109.21 177.427 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 51' ' ' VAL . . . . . . . . . . . . . 47.8 t -69.65 -50.19 52.21 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.347 0 CA-C-N 116.086 -0.506 . . . . 0.0 109.801 -174.722 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 52' ' ' GLN . . . . . . . . . . . . . 62.2 tt0 -160.3 140.15 11.25 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 115.875 -0.602 . . . . 0.0 111.724 -177.84 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 53' ' ' ALA . . . . . 0.411 ' HB1' ' HB2' ' A' ' 58' ' ' LEU . . . -112.76 130.67 55.99 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-N 115.735 -0.666 . . . . 0.0 109.709 175.017 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 54' ' ' TYR . . . . . . . . . . . . . 59.5 t80 -129.16 107.94 17.89 Favored Pre-proline 0 CA--C 1.535 0.394 0 CA-C-O 118.324 -0.846 . . . . 0.0 110.457 -179.661 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 55' ' ' PRO . . . . . . . . . . . . . 73.7 Cg_endo -77.1 170.09 72.56 Favored 'Cis proline' 0 N--CA 1.499 1.821 0 CA-C-N 121.829 1.689 . . . . 0.0 112.339 -5.624 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 56' ' ' SER . . . . . . . . . . . . . 20.1 m -114.5 130.71 23.8 Favored Pre-proline 0 CA--C 1.539 0.526 0 CA-C-O 118.412 -0.804 . . . . 0.0 109.506 175.441 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 57' ' ' PRO . . . . . . . . . . . . . 55.2 Cg_endo -71.44 146.99 86.78 Favored 'Cis proline' 0 N--CA 1.496 1.664 0 CA-C-N 121.947 1.731 . . . . 0.0 111.622 -0.914 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 58' ' ' LEU . . . . . 0.411 ' HB2' ' HB1' ' A' ' 53' ' ' ALA . 22.3 tp -106.53 135.28 48.31 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.28 -0.418 . . . . 0.0 110.22 -179.506 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 59' ' ' ARG . . . . . . . . . . . . . 56.7 ttt85 -105.55 127.12 52.85 Favored 'General case' 0 C--N 1.326 -0.426 0 N-CA-C 109.2 -0.667 . . . . 0.0 109.2 176.639 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 43.4 t -86.03 124.1 40.01 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.234 0 C-N-CA 120.588 -0.445 . . . . 0.0 110.61 -174.528 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 96.0 mt-10 -131.02 172.48 12.04 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 115.774 -0.648 . . . . 0.0 109.877 177.999 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 62' ' ' ASP . . . . . . . . . . . . . 7.5 p-10 -55.56 -32.75 63.25 Favored 'General case' 0 C--N 1.328 -0.339 0 C-N-CA 120.922 -0.311 . . . . 0.0 111.557 179.42 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 63' ' ' ARG . . . . . . . . . . . . . 25.8 ptt180 -86.33 3.74 42.18 Favored 'General case' 0 CA--C 1.537 0.477 0 N-CA-C 113.724 1.009 . . . . 0.0 113.724 -176.94 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 30.7 m -83.51 135.29 34.71 Favored 'General case' 0 C--N 1.333 -0.135 0 CA-C-N 118.04 0.382 . . . . 0.0 110.612 -177.427 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 65' ' ' LYS . . . . . . . . . . . . . 52.1 mtmt -89.72 129.28 36.15 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.064 -0.517 . . . . 0.0 110.503 179.556 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 66' ' ' ILE . . . . . . . . . . . . . 66.4 mt -114.45 129.08 71.1 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.309 0 N-CA-C 109.41 -0.589 . . . . 0.0 109.41 177.61 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 67' ' ' THR . . . . . . . . . . . . . 22.0 m -125.74 144.64 50.54 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.215 -0.448 . . . . 0.0 111.345 -175.66 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 68' ' ' LEU . . . . . 0.425 HD23 ' C ' ' A' ' 68' ' ' LEU . 5.6 tt . . . . . 0 C--N 1.329 -0.299 0 CA-C-N 115.805 -0.634 . . . . 0.0 109.43 175.788 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 74' ' ' ASP . . . . . . . . . . . . . 25.1 t0 . . . . . 0 CA--C 1.524 -0.027 0 N-CA-C 110.507 -0.183 . . . . 0.0 110.507 . . . . . . . . . 0 0 . 1 . 012 nuclear build core ' A' A ' 75' ' ' VAL . . . . . 0.45 ' C ' HD12 ' A' ' 76' ' ' LEU . 40.0 t -118.67 121.01 65.91 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.212 0 CA-C-O 120.955 0.407 . . . . 0.0 110.52 -178.561 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 76' ' ' LEU . . . . . 0.45 HD12 ' C ' ' A' ' 75' ' ' VAL . 7.5 mp -117.3 141.31 48.46 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 115.79 -0.641 . . . . 0.0 109.502 175.608 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 77' ' ' GLU . . . . . . . . . . . . . 97.0 mt-10 -132.56 136.13 46.39 Favored 'General case' 0 C--N 1.331 -0.197 0 CA-C-O 121.151 0.5 . . . . 0.0 111.465 -177.724 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 78' ' ' ALA . . . . . . . . . . . . . . . -124.24 131.45 53.53 Favored 'General case' 0 C--N 1.332 -0.185 0 CA-C-N 115.482 -0.781 . . . . 0.0 109.7 176.079 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 79' ' ' LYS . . . . . 0.645 ' O ' HD13 ' A' ' 80' ' ' ILE . 99.2 mttt -78.31 117.48 19.6 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-O 120.918 0.39 . . . . 0.0 110.714 -177.533 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 80' ' ' ILE . . . . . 0.645 HD13 ' O ' ' A' ' 79' ' ' LYS . 38.7 mm -139.24 111.47 5.55 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.311 0 N-CA-C 109.241 -0.652 . . . . 0.0 109.241 -177.448 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 81' ' ' LYS . . . . . . . . . . . . . 20.0 pttp -106.31 127.41 53.23 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-O 121.165 0.507 . . . . 0.0 111.608 -176.721 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . 89.01 42.16 5.71 Favored Glycine 0 CA--C 1.525 0.691 0 C-N-CA 120.883 -0.675 . . . . 0.0 111.832 174.267 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 83' ' ' ILE . . . . . . . . . . . . . 71.1 mt -71.49 138.0 22.58 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.231 0 N-CA-C 109.921 -0.4 . . . . 0.0 109.921 178.314 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 84' ' ' LYS . . . . . . . . . . . . . 31.0 ttmt -88.96 -53.09 4.75 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 115.943 -0.572 . . . . 0.0 109.788 -179.605 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 85' ' ' ASP . . . . . . . . . . . . . 7.2 t0 -157.39 151.91 25.19 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 115.51 -0.768 . . . . 0.0 110.136 179.637 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 86' ' ' VAL . . . . . . . . . . . . . 41.9 t -126.59 131.7 70.99 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.187 0 CA-C-O 120.956 0.408 . . . . 0.0 110.375 -179.138 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 87' ' ' ILE . . . . . 0.494 HD12 ' N ' ' A' ' 87' ' ' ILE . 5.0 mp -117.37 124.75 73.43 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.224 0 N-CA-C 109.351 -0.611 . . . . 0.0 109.351 175.998 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 88' ' ' LEU . . . . . . . . . . . . . 10.6 tp -111.88 129.54 56.13 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-O 120.991 0.424 . . . . 0.0 111.098 -176.15 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 89' ' ' ASP . . . . . . . . . . . . . 13.4 t70 -125.22 150.55 46.9 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-N 115.789 -0.641 . . . . 0.0 109.535 175.428 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 84.4 tt0 -48.67 -34.88 12.68 Favored 'General case' 0 C--N 1.328 -0.351 0 N-CA-C 112.772 0.656 . . . . 0.0 112.772 -172.946 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 91' ' ' ASN . . . . . . . . . . . . . 25.1 m120 -130.48 29.79 4.79 Favored 'General case' 0 N--CA 1.468 0.459 0 N-CA-C 112.184 0.439 . . . . 0.0 112.184 -176.559 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 92' ' ' LEU . . . . . . . . . . . . . 12.4 tp -166.09 141.99 4.9 Favored 'General case' 0 C--N 1.33 -0.275 0 C-N-CA 121.103 -0.239 . . . . 0.0 110.384 179.569 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 93' ' ' ILE . . . . . . . . . . . . . 74.2 mt -124.79 123.49 65.93 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.23 0 N-CA-C 109.609 -0.515 . . . . 0.0 109.609 179.191 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 94' ' ' VAL . . . . . . . . . . . . . 45.5 t -122.56 126.87 74.66 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.241 0 N-CA-C 109.876 -0.416 . . . . 0.0 109.876 179.856 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 95' ' ' VAL . . . . . . . . . . . . . 47.8 t -121.46 132.53 70.47 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.292 0 CA-C-N 116.028 -0.533 . . . . 0.0 109.862 -179.293 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 96' ' ' ILE . . . . . . . . . . . . . 57.3 mt -112.83 126.42 70.22 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.337 0 N-CA-C 109.021 -0.733 . . . . 0.0 109.021 178.62 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 97' ' ' THR . . . . . . . . . . . . . 72.9 p -101.73 154.27 19.05 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-O 121.265 0.555 . . . . 0.0 111.137 -176.426 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 98' ' ' GLU . . . . . . . . . . . . . 48.0 tp10 -54.14 -25.92 24.84 Favored 'General case' 0 CA--C 1.535 0.366 0 CA-C-N 116.111 -0.495 . . . . 0.0 112.107 -179.809 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 99' ' ' GLU . . . . . . . . . . . . . 40.0 tt0 -80.13 18.11 0.91 Allowed 'General case' 0 CA--C 1.539 0.522 0 N-CA-C 112.573 0.582 . . . . 0.0 112.573 -176.688 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 100' ' ' ASN . . . . . . . . . . . . . 2.9 m-20 62.97 37.12 12.09 Favored 'General case' 0 CA--C 1.529 0.163 0 O-C-N 121.738 -0.601 . . . . 0.0 111.141 176.378 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 101' ' ' GLU . . . . . . . . . . . . . 84.5 tt0 -118.71 143.09 47.09 Favored 'General case' 0 C--N 1.332 -0.182 0 CA-C-N 116.072 -0.513 . . . . 0.0 109.925 176.231 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 102' ' ' VAL . . . . . . . . . . . . . 47.0 t -114.97 125.57 72.33 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.278 0 N-CA-C 109.761 -0.459 . . . . 0.0 109.761 179.858 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 103' ' ' LEU . . . . . . . . . . . . . 54.4 mt -116.71 135.12 54.03 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 115.732 -0.667 . . . . 0.0 109.955 178.886 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 104' ' ' ILE . . . . . . . . . . . . . 72.9 mt -122.97 123.09 67.25 Favored 'Isoleucine or valine' 0 C--O 1.234 0.246 0 N-CA-C 110.349 -0.241 . . . . 0.0 110.349 -178.674 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 105' ' ' PHE . . . . . . . . . . . . . 85.5 m-85 -123.82 165.43 17.35 Favored 'General case' 0 C--O 1.232 0.184 0 O-C-N 123.996 0.81 . . . . 0.0 110.071 -178.618 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 106' ' ' ASN . . . . . . . . . . . . . 47.4 p-10 -101.3 -169.96 1.77 Allowed 'General case' 0 C--N 1.329 -0.317 0 N-CA-C 109.577 -0.527 . . . . 0.0 109.577 171.769 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 107' ' ' GLN . . . . . . . . . . . . . 16.2 tt0 -59.01 -29.97 67.65 Favored 'General case' 0 C--N 1.329 -0.312 0 N-CA-C 112.006 0.373 . . . . 0.0 112.006 -178.975 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 108' ' ' ASN . . . . . . . . . . . . . 6.7 t-20 -87.07 12.31 11.73 Favored 'General case' 0 CA--C 1.533 0.321 0 N-CA-C 113.015 0.746 . . . . 0.0 113.015 -176.653 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 109' ' ' LEU . . . . . . . . . . . . . 24.9 mt 58.56 37.03 25.5 Favored 'General case' 0 C--O 1.233 0.191 0 CA-C-O 120.828 0.346 . . . . 0.0 111.497 177.245 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 110' ' ' GLU . . . . . . . . . . . . . 95.4 mt-10 -104.66 146.87 28.32 Favored 'General case' 0 C--N 1.329 -0.293 0 N-CA-C 110.013 -0.365 . . . . 0.0 110.013 176.513 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 111' ' ' GLU . . . . . . . . . . . . . 98.8 mt-10 -76.16 121.94 23.59 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-O 120.989 0.423 . . . . 0.0 111.204 -178.304 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 112' ' ' LEU . . . . . . . . . . . . . 50.3 mt -107.47 -45.81 3.99 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 115.767 -0.651 . . . . 0.0 110.033 175.985 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 113' ' ' TYR . . . . . . . . . . . . . 63.2 t80 -140.64 138.71 34.55 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.012 -0.54 . . . . 0.0 110.859 179.973 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 114' ' ' ARG . . . . . . . . . . . . . 36.5 mtm105 -144.03 124.15 13.67 Favored 'General case' 0 C--N 1.331 -0.221 0 CA-C-N 116.388 -0.369 . . . . 0.0 110.494 176.309 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 115' ' ' GLY . . . . . . . . . . . . . . . -150.15 143.66 10.98 Favored Glycine 0 CA--C 1.524 0.614 0 N-CA-C 110.939 -0.864 . . . . 0.0 110.939 179.345 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 116' ' ' LYS . . . . . . . . . . . . . 35.3 ttmt -114.15 140.43 48.53 Favored 'General case' 0 C--N 1.331 -0.201 0 CA-C-O 120.861 0.362 . . . . 0.0 110.054 177.032 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 117' ' ' PHE . . . . . . . . . . . . . 32.5 m-85 -137.63 115.04 11.09 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.19 -0.459 . . . . 0.0 109.889 -176.487 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 118' ' ' GLU . . . . . . . . . . . . . 96.0 mt-10 -54.64 -44.12 72.91 Favored 'General case' 0 C--N 1.328 -0.335 0 C-N-CA 120.965 -0.294 . . . . 0.0 111.321 -175.698 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 119' ' ' ASN . . . . . . . . . . . . . 25.1 m120 -96.44 30.58 2.5 Favored 'General case' 0 C--N 1.33 -0.248 0 N-CA-C 112.29 0.478 . . . . 0.0 112.29 -174.878 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 120' ' ' LEU . . . . . . . . . . . . . 28.7 tp -60.6 126.74 28.55 Favored 'General case' 0 C--N 1.332 -0.189 0 N-CA-C 109.83 -0.433 . . . . 0.0 109.83 177.287 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 121' ' ' ASN . . . . . . . . . . . . . 18.2 m120 -110.88 -44.09 3.68 Favored 'General case' 0 C--N 1.331 -0.225 0 CA-C-N 116.361 -0.381 . . . . 0.0 111.128 -176.863 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 122' ' ' LYS . . . . . . . . . . . . . 56.2 pttt -161.44 159.21 27.82 Favored 'General case' 0 C--N 1.332 -0.167 0 C-N-CA 120.428 -0.509 . . . . 0.0 111.84 -179.266 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 123' ' ' VAL . . . . . . . . . . . . . 38.0 t -131.18 135.86 58.89 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.221 0 CA-C-N 116.094 -0.503 . . . . 0.0 110.321 -179.481 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 124' ' ' LEU . . . . . . . . . . . . . 46.0 mt -119.85 130.53 54.92 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.068 -0.514 . . . . 0.0 109.788 177.773 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 125' ' ' VAL . . . . . 0.409 ' CG1' HG21 ' A' ' 87' ' ' ILE . 13.6 p -138.29 137.49 43.91 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.2 0 CA-C-O 121.073 0.464 . . . . 0.0 111.166 -179.026 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 126' ' ' ARG . . . . . . . . . . . . . 14.0 ptm180 -163.28 135.97 5.41 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 115.804 -0.634 . . . . 0.0 109.776 175.673 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 127' ' ' ASN . . . . . . . . . . . . . 78.6 m-20 55.34 -154.55 0.3 Allowed 'General case' 0 CA--C 1.539 0.544 0 N-CA-C 110.074 -0.343 . . . . 0.0 110.074 179.875 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 128' ' ' ASP . . . . . . . . . . . . . 20.0 p-10 -80.15 15.49 1.51 Allowed 'General case' 0 CA--C 1.536 0.411 0 N-CA-C 112.938 0.718 . . . . 0.0 112.938 179.394 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 129' ' ' LEU . . . . . . . . . . . . . 13.9 tp -119.68 132.42 55.67 Favored 'General case' 0 C--O 1.232 0.142 0 CA-C-N 118.154 0.434 . . . . 0.0 110.223 179.575 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 130' ' ' VAL . . . . . 0.402 HG13 ' HB ' ' A' ' 141' ' ' ILE . 14.1 p -138.87 145.36 27.88 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.292 0 CA-C-O 120.979 0.418 . . . . 0.0 110.604 178.912 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 131' ' ' VAL . . . . . . . . . . . . . 43.1 t -135.04 138.68 48.57 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.252 0 CA-C-N 116.18 -0.464 . . . . 0.0 110.223 179.3 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 132' ' ' ILE . . . . . . . . . . . . . 67.6 mt -112.52 131.68 63.36 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.331 0 N-CA-C 109.349 -0.611 . . . . 0.0 109.349 179.849 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 133' ' ' ILE . . . . . . . . . . . . . 43.8 mm -115.02 123.21 70.48 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.254 0 CA-C-O 120.667 0.27 . . . . 0.0 111.083 -174.945 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 134' ' ' ASP . . . . . . . . . . . . . 7.2 p-10 -135.93 147.64 48.2 Favored 'General case' 0 C--N 1.332 -0.186 0 N-CA-C 109.584 -0.524 . . . . 0.0 109.584 172.896 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 135' ' ' GLU . . . . . . . . . . . . . 84.6 tt0 -49.81 -27.65 5.3 Favored 'General case' 0 C--N 1.327 -0.409 0 N-CA-C 112.767 0.654 . . . . 0.0 112.767 -172.749 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 136' ' ' GLN . . . . . . . . . . . . . 48.2 tt0 -83.57 -32.76 25.63 Favored 'General case' 0 C--O 1.235 0.323 0 N-CA-C 112.34 0.496 . . . . 0.0 112.34 -174.967 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 137' ' ' LYS . . . . . . . . . . . . . 52.0 pttt -167.04 169.88 12.49 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-O 121.497 0.665 . . . . 0.0 112.098 -172.365 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 138' ' ' LEU . . . . . 0.466 ' C ' HD23 ' A' ' 138' ' ' LEU . 8.8 tt -119.87 129.25 54.3 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 115.273 -0.876 . . . . 0.0 110.065 179.439 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 139' ' ' THR . . . . . . . . . . . . . 44.4 m -110.03 127.01 54.57 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.084 -0.507 . . . . 0.0 110.294 179.657 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 140' ' ' LEU . . . . . 0.475 HD23 ' C ' ' A' ' 140' ' ' LEU . 8.7 tt -110.8 123.33 49.87 Favored 'General case' 0 C--N 1.328 -0.329 0 N-CA-C 109.421 -0.585 . . . . 0.0 109.421 179.782 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 141' ' ' ILE . . . . . 0.402 ' HB ' HG13 ' A' ' 130' ' ' VAL . 18.9 mt -124.64 123.59 66.33 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.259 0 CA-C-O 120.964 0.412 . . . . 0.0 109.933 -175.336 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 142' ' ' ARG . . . . . . . . . . . . . 69.4 ttt180 -111.59 119.73 39.69 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 115.75 -0.659 . . . . 0.0 109.587 178.598 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 143' ' ' THR . . . . . . . . . . . . . 71.0 p . . . . . 0 C--O 1.22 -0.46 0 CA-C-O 117.981 -1.009 . . . . 0.0 110.606 -178.451 . . . . . . . . 0 0 . 1 . 012 nuclear build core ' B' B ' 2' ' ' SER . . . . . . . . . . . . . 9.6 p . . . . . 0 C--O 1.233 0.212 0 CA-C-O 120.963 0.411 . . . . 0.0 110.558 . . . . . . . . . 0 0 . 1 . 012 nuclear build core ' B' B ' 3' ' ' GLU . . . . . . . . . . . . . 95.0 mt-10 -139.84 142.39 36.6 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.021 -0.536 . . . . 0.0 110.954 -178.532 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' B' B ' 4' ' ' LEU . . . . . 0.404 HD23 ' N ' ' B' ' 5' ' ' LYS . 4.3 tt -126.14 124.73 41.19 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 115.829 -0.623 . . . . 0.0 109.559 176.899 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' B' B ' 5' ' ' LYS . . . . . 0.404 ' N ' HD23 ' B' ' 4' ' ' LEU . 96.1 mttt -108.12 120.87 43.58 Favored 'General case' 0 C--O 1.234 0.265 0 CA-C-O 120.755 0.312 . . . . 0.0 110.913 -178.2 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' B' B ' 6' ' ' LEU . . . . . 0.412 HD23 ' HA ' ' B' ' 50' ' ' VAL . 54.4 mt -114.82 148.96 37.79 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 115.439 -0.8 . . . . 0.0 110.656 -178.992 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' B' B ' 7' ' ' LYS . . . . . . . . . . . . . 26.3 ttpp -136.53 140.78 33.33 Favored Pre-proline 0 CA--C 1.532 0.267 0 CA-C-O 119.166 -0.445 . . . . 0.0 109.991 174.701 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' B' B ' 8' ' ' PRO . . . . . . . . . . . . . 87.9 Cg_endo -91.88 138.98 2.09 Favored 'Trans proline' 0 N--CA 1.49 1.274 0 C-N-CA 121.756 1.638 . . . . 0.0 111.638 177.645 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' B' B ' 9' ' ' LEU . . . . . . . . . . . . . 69.0 mt -73.65 -46.99 7.2 Favored Pre-proline 0 CA--C 1.534 0.357 0 CA-C-O 118.682 -0.675 . . . . 0.0 111.961 -179.991 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' B' B ' 10' ' ' PRO . . . . . . . . . . . . . 83.1 Cg_endo -81.36 150.81 17.43 Favored 'Trans proline' 0 N--CA 1.497 1.7 0 C-N-CA 121.166 1.244 . . . . 0.0 111.824 174.738 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' B' B ' 11' ' ' LYS . . . . . . . . . . . . . 39.4 ttpt -87.6 94.26 9.67 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.442 -0.345 . . . . 0.0 110.325 178.648 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' B' B ' 12' ' ' VAL . . . . . . . . . . . . . 12.0 p -140.07 142.19 32.29 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.297 0 CA-C-N 116.211 -0.449 . . . . 0.0 110.394 179.252 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' B' B ' 13' ' ' GLU . . . . . . . . . . . . . 41.9 mt-10 -75.69 132.24 40.41 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-O 120.802 0.335 . . . . 0.0 110.251 178.623 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' B' B ' 14' ' ' LEU . . . . . . . . . . . . . 30.5 mt -98.32 153.16 38.16 Favored Pre-proline 0 C--N 1.33 -0.253 0 CA-C-N 116.346 -0.388 . . . . 0.0 110.666 -179.224 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' B' B ' 15' ' ' PRO . . . . . . . . . . . . . 27.7 Cg_exo -61.12 154.12 59.66 Favored 'Trans proline' 0 N--CA 1.496 1.667 0 C-N-CA 121.276 1.317 . . . . 0.0 111.599 177.626 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' B' B ' 16' ' ' PRO . . . . . . . . . . . . . 33.9 Cg_exo -57.74 -36.44 98.39 Favored 'Trans proline' 0 N--CA 1.498 1.751 0 C-N-CA 121.389 1.393 . . . . 0.0 112.793 -178.896 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' B' B ' 17' ' ' ASP . . . . . . . . . . . . . 18.0 p-10 -92.43 15.04 14.89 Favored 'General case' 0 C--N 1.327 -0.383 0 N-CA-C 113.02 0.748 . . . . 0.0 113.02 -177.489 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' B' B ' 18' ' ' PHE . . . . . . . . . . . . . 44.4 t80 -58.38 -44.69 89.0 Favored 'General case' 0 C--O 1.228 -0.078 0 O-C-N 122.008 -0.432 . . . . 0.0 110.057 -177.722 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' B' B ' 19' ' ' VAL . . . . . . . . . . . . . 48.4 t -56.91 -42.97 79.59 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.305 0 CA-C-N 116.055 -0.521 . . . . 0.0 110.53 -178.346 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' B' B ' 20' ' ' ASP . . . . . . . . . . . . . 32.9 t0 -59.59 -43.49 93.67 Favored 'General case' 0 C--N 1.329 -0.315 0 C-N-CA 120.887 -0.325 . . . . 0.0 111.026 -177.22 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' B' B ' 21' ' ' VAL . . . . . . . . . . . . . 45.1 t -64.88 -46.52 91.58 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.248 0 C-N-CA 120.716 -0.393 . . . . 0.0 110.43 -178.116 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' B' B ' 22' ' ' ILE . . . . . 0.632 HG22 HD12 ' B' ' 26' ' ' LEU . 50.9 mm -57.8 -38.87 67.98 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.324 0 CA-C-O 120.668 0.271 . . . . 0.0 110.407 179.272 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' B' B ' 23' ' ' ARG . . . . . . . . . . . . . 57.1 ttp180 -55.84 -49.87 72.11 Favored 'General case' 0 C--N 1.331 -0.216 0 CA-C-O 120.976 0.417 . . . . 0.0 110.558 177.861 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' B' B ' 24' ' ' ILE . . . . . . . . . . . . . 74.0 mt -60.85 -43.85 96.45 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.334 0 CA-C-N 115.834 -0.621 . . . . 0.0 111.73 -177.398 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' B' B ' 25' ' ' LYS . . . . . . . . . . . . . 14.8 pttp -72.97 -36.62 67.14 Favored 'General case' 0 CA--C 1.533 0.298 0 C-N-CA 120.526 -0.47 . . . . 0.0 111.901 -172.933 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' B' B ' 26' ' ' LEU . . . . . 0.632 HD12 HG22 ' B' ' 22' ' ' ILE . 42.0 mt -80.21 -41.78 24.53 Favored 'General case' 0 C--N 1.331 -0.22 0 N-CA-C 113.185 0.809 . . . . 0.0 113.185 -173.796 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' B' B ' 27' ' ' GLN . . . . . . . . . . . . . 19.2 pt20 -47.18 139.28 6.19 Favored 'General case' 0 N--CA 1.469 0.484 0 N-CA-C 112.73 0.641 . . . . 0.0 112.73 -174.539 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' B' B ' 28' ' ' GLY . . . . . . . . . . . . . . . 99.48 -26.0 26.08 Favored Glycine 0 CA--C 1.533 1.179 0 CA-C-N 115.687 -0.688 . . . . 0.0 112.255 -176.877 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' B' B ' 29' ' ' LYS . . . . . . . . . . . . . 56.4 mtmt -98.9 155.16 17.54 Favored 'General case' 0 C--O 1.232 0.164 0 CA-C-N 117.247 0.523 . . . . 0.0 111.103 179.425 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' B' B ' 30' ' ' THR . . . . . . . . . . . . . 31.4 m -105.38 137.73 42.72 Favored 'General case' 0 C--N 1.332 -0.195 0 CA-C-N 116.101 -0.499 . . . . 0.0 110.094 176.949 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' B' B ' 31' ' ' VAL . . . . . . . . . . . . . 34.3 m -130.71 160.41 41.93 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.236 0 CA-C-O 120.911 0.386 . . . . 0.0 110.971 -178.372 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' B' B ' 32' ' ' ARG . . . . . . . . . . . . . 80.3 mtm180 -134.24 149.26 50.95 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 115.907 -0.588 . . . . 0.0 110.477 177.844 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' B' B ' 33' ' ' THR . . . . . . . . . . . . . 24.7 m -53.41 141.63 24.11 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.443 -0.344 . . . . 0.0 111.39 -178.363 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' B' B ' 34' ' ' GLY . . . . . . . . . . . . . . . 99.49 -17.13 58.12 Favored Glycine 0 CA--C 1.533 1.194 0 CA-C-O 119.687 -0.507 . . . . 0.0 113.23 179.762 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' B' B ' 35' ' ' ASP . . . . . . . . . . . . . 76.1 m-20 -65.33 147.99 52.47 Favored 'General case' 0 C--O 1.231 0.123 0 CA-C-N 118.037 0.919 . . . . 0.0 111.041 178.739 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' B' B ' 36' ' ' VAL . . . . . . . . . . . . . 46.7 t -120.58 129.96 75.03 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.204 0 CA-C-N 115.829 -0.623 . . . . 0.0 109.887 179.099 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' B' B ' 37' ' ' ILE . . . . . . . . . . . . . 69.9 mt -120.31 139.18 48.42 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.219 0 N-CA-C 109.841 -0.429 . . . . 0.0 109.841 179.848 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' B' B ' 38' ' ' GLY . . . . . . . . . . . . . . . -114.04 128.74 8.4 Favored Glycine 0 CA--C 1.525 0.691 0 N-CA-C 111.256 -0.738 . . . . 0.0 111.256 -179.683 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' B' B ' 39' ' ' ILE . . . . . . . . . . . . . 69.4 mt -122.9 127.97 75.01 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.218 0 N-CA-C 109.64 -0.504 . . . . 0.0 109.64 177.418 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' B' B ' 40' ' ' SER . . . . . . . . . . . . . 56.3 p -91.95 118.12 30.45 Favored 'General case' 0 C--N 1.33 -0.257 0 C-N-CA 120.908 -0.317 . . . . 0.0 110.75 177.527 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' B' B ' 41' ' ' ILE . . . . . . . . . . . . . 73.8 mt -134.63 128.25 50.68 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.234 0 CA-C-O 120.732 0.301 . . . . 0.0 110.266 178.786 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' B' B ' 42' ' ' LEU . . . . . . . . . . . . . 49.3 mt 57.76 33.08 22.8 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.24 -0.436 . . . . 0.0 111.858 178.543 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' B' B ' 43' ' ' GLY . . . . . . . . . . . . . . . 77.29 -10.05 23.77 Favored Glycine 0 CA--C 1.535 1.334 0 C-N-CA 121.276 -0.487 . . . . 0.0 113.472 178.03 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' B' B ' 44' ' ' LYS . . . . . . . . . . . . . 65.3 tttm -102.22 129.91 48.75 Favored 'General case' 0 C--O 1.233 0.195 0 CA-C-N 117.948 0.874 . . . . 0.0 109.964 177.224 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' B' B ' 45' ' ' GLU . . . . . . . . . . . . . 44.7 tp10 -84.7 125.66 32.71 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.43 -0.35 . . . . 0.0 110.55 178.998 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' B' B ' 46' ' ' VAL . . . . . . . . . . . . . 7.5 p -113.74 128.77 70.48 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.258 0 N-CA-C 109.336 -0.616 . . . . 0.0 109.336 177.108 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' B' B ' 47' ' ' LYS . . . . . . . . . . . . . 93.5 mttt -100.05 126.58 46.27 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 115.849 -0.614 . . . . 0.0 111.12 178.725 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' B' B ' 48' ' ' PHE . . . . . . . . . . . . . 95.3 m-85 -109.48 131.9 54.64 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.079 -0.51 . . . . 0.0 109.679 176.358 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' B' B ' 49' ' ' LYS . . . . . . . . . . . . . 86.4 tttt -107.12 134.73 49.8 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.18 -0.463 . . . . 0.0 110.366 179.25 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' B' B ' 50' ' ' VAL . . . . . 0.412 ' HA ' HD23 ' B' ' 6' ' ' LEU . 46.2 t -79.0 106.42 9.97 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.336 0 N-CA-C 109.167 -0.679 . . . . 0.0 109.167 175.695 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' B' B ' 51' ' ' VAL . . . . . . . . . . . . . 52.5 t -69.9 -52.81 27.73 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.354 0 N-CA-C 109.613 -0.514 . . . . 0.0 109.613 -174.844 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' B' B ' 52' ' ' GLN . . . . . . . . . . . . . 90.7 mt-30 -153.75 151.64 29.82 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-O 121.274 0.559 . . . . 0.0 111.86 -178.114 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' B' B ' 53' ' ' ALA . . . . . . . . . . . . . . . -127.29 132.55 50.29 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 115.065 -0.971 . . . . 0.0 109.323 174.561 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' B' B ' 54' ' ' TYR . . . . . . . . . . . . . 39.7 t80 -129.06 109.78 18.2 Favored Pre-proline 0 CA--C 1.533 0.318 0 CA-C-O 118.183 -0.913 . . . . 0.0 110.381 -179.697 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' B' B ' 55' ' ' PRO . . . . . . . . . . . . . 73.6 Cg_endo -77.1 170.1 72.53 Favored 'Cis proline' 0 N--CA 1.502 2.006 0 CA-C-N 121.907 1.717 . . . . 0.0 112.594 -5.443 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' B' B ' 56' ' ' SER . . . . . . . . . . . . . 15.5 m -116.56 128.05 26.29 Favored Pre-proline 0 CA--C 1.539 0.537 0 CA-C-O 118.409 -0.805 . . . . 0.0 109.37 175.276 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' B' B ' 57' ' ' PRO . . . . . . . . . . . . . 36.6 Cg_endo -66.2 166.04 59.15 Favored 'Cis proline' 0 N--CA 1.499 1.799 0 CA-C-N 121.986 1.745 . . . . 0.0 111.662 -0.113 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' B' B ' 58' ' ' LEU . . . . . . . . . . . . . 29.7 tp -130.21 135.92 48.66 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.318 -0.401 . . . . 0.0 110.734 -179.716 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' B' B ' 59' ' ' ARG . . . . . . . . . . . . . 58.2 ttp180 -101.82 126.75 48.76 Favored 'General case' 0 C--N 1.328 -0.366 0 N-CA-C 109.237 -0.653 . . . . 0.0 109.237 175.815 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' B' B ' 60' ' ' VAL . . . . . . . . . . . . . 46.9 t -78.56 117.98 24.96 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.192 0 C-N-CA 120.546 -0.462 . . . . 0.0 109.915 -177.352 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' B' B ' 61' ' ' GLU . . . . . . . . . . . . . 74.4 tt0 -131.12 159.6 37.16 Favored 'General case' 0 C--N 1.328 -0.337 0 N-CA-C 109.422 -0.584 . . . . 0.0 109.422 -179.504 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' B' B ' 62' ' ' ASP . . . . . . . . . . . . . 52.2 m-20 -51.51 -32.17 26.62 Favored 'General case' 0 C--N 1.328 -0.355 0 N-CA-C 112.074 0.398 . . . . 0.0 112.074 -179.367 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' B' B ' 63' ' ' ARG . . . . . . . . . . . . . 14.5 ptm180 -85.15 5.4 30.06 Favored 'General case' 0 CA--C 1.535 0.403 0 N-CA-C 113.733 1.012 . . . . 0.0 113.733 -175.739 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' B' B ' 64' ' ' THR . . . . . . . . . . . . . 24.4 m -89.72 136.4 33.06 Favored 'General case' 0 C--N 1.332 -0.18 0 CA-C-N 118.151 0.432 . . . . 0.0 110.401 -178.647 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' B' B ' 65' ' ' LYS . . . . . . . . . . . . . 55.1 mtmt -89.1 128.38 35.76 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.299 -0.41 . . . . 0.0 110.31 -179.994 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' B' B ' 66' ' ' ILE . . . . . . . . . . . . . 66.1 mt -113.68 127.18 71.16 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.294 0 N-CA-C 109.638 -0.504 . . . . 0.0 109.638 179.998 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' B' B ' 67' ' ' THR . . . . . . . . . . . . . 23.4 m -126.97 144.09 51.11 Favored 'General case' 0 C--N 1.332 -0.185 0 CA-C-N 116.122 -0.49 . . . . 0.0 111.069 -175.903 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' B' B ' 68' ' ' LEU . . . . . . . . . . . . . 42.8 mt . . . . . 0 C--N 1.329 -0.316 0 CA-C-N 115.942 -0.572 . . . . 0.0 110.61 177.887 . . . . . . . . 0 0 . 1 . 012 nuclear build core ' B' B ' 73' ' ' VAL . . . . . . . . . . . . . 33.8 m . . . . . 0 C--O 1.23 0.058 0 CA-C-O 120.66 0.267 . . . . 0.0 110.376 . . . . . . . . . 0 0 . 1 . 012 nuclear build core ' B' B ' 74' ' ' ASP . . . . . . . . . . . . . 38.8 t0 -95.66 119.28 33.89 Favored 'General case' 0 C--N 1.329 -0.287 0 N-CA-C 110.121 -0.326 . . . . 0.0 110.121 -177.644 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' B' B ' 75' ' ' VAL . . . . . . . . . . . . . 40.6 t -122.52 125.2 72.31 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.295 0 CA-C-O 121.142 0.496 . . . . 0.0 110.818 -177.652 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' B' B ' 76' ' ' LEU . . . . . . . . . . . . . 5.9 mp -121.99 145.29 48.27 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 115.67 -0.695 . . . . 0.0 109.619 175.361 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' B' B ' 77' ' ' GLU . . . . . . . . . . . . . 97.3 mt-10 -134.38 132.06 38.97 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-O 121.061 0.458 . . . . 0.0 111.133 -178.634 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' B' B ' 78' ' ' ALA . . . . . . . . . . . . . . . -120.84 134.28 55.29 Favored 'General case' 0 C--N 1.33 -0.239 0 CA-C-N 115.761 -0.654 . . . . 0.0 109.84 177.028 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' B' B ' 79' ' ' LYS . . . . . 0.438 ' O ' HD13 ' B' ' 80' ' ' ILE . 94.4 mttt -79.1 120.79 24.14 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-O 120.809 0.337 . . . . 0.0 110.566 -178.575 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' B' B ' 80' ' ' ILE . . . . . 0.438 HD13 ' O ' ' B' ' 79' ' ' LYS . 26.8 mm -139.09 110.06 4.76 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.28 0 N-CA-C 109.148 -0.686 . . . . 0.0 109.148 -177.465 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' B' B ' 81' ' ' LYS . . . . . . . . . . . . . 49.0 pttt -99.42 123.39 43.66 Favored 'General case' 0 C--N 1.33 -0.283 0 CA-C-O 121.104 0.478 . . . . 0.0 111.419 -176.778 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' B' B ' 82' ' ' GLY . . . . . . . . . . . . . . . 88.85 42.18 5.76 Favored Glycine 0 CA--C 1.524 0.617 0 C-N-CA 120.769 -0.729 . . . . 0.0 111.664 173.404 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' B' B ' 83' ' ' ILE . . . . . . . . . . . . . 76.8 mt -64.38 135.13 28.45 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.285 0 N-CA-C 109.861 -0.422 . . . . 0.0 109.861 178.669 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' B' B ' 84' ' ' LYS . . . . . . . . . . . . . 84.7 tttt -92.63 -53.85 4.02 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 115.903 -0.589 . . . . 0.0 110.348 -177.326 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' B' B ' 85' ' ' ASP . . . . . . . . . . . . . 3.7 t70 -158.29 158.01 33.58 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 115.678 -0.692 . . . . 0.0 110.147 -178.783 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' B' B ' 86' ' ' VAL . . . . . . . . . . . . . 40.3 t -135.56 134.08 51.87 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.248 0 CA-C-O 121.023 0.44 . . . . 0.0 110.746 -177.69 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' B' B ' 87' ' ' ILE . . . . . . . . . . . . . 44.2 mm -117.48 127.68 74.88 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.226 0 CA-C-N 115.751 -0.659 . . . . 0.0 109.389 174.386 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' B' B ' 88' ' ' LEU . . . . . . . . . . . . . 17.3 tp -112.55 133.06 54.81 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-O 121.01 0.434 . . . . 0.0 111.19 -176.673 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' B' B ' 89' ' ' ASP . . . . . . . . . . . . . 9.0 t0 -128.22 150.51 50.0 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 115.743 -0.662 . . . . 0.0 109.43 176.591 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' B' B ' 90' ' ' GLU . . . . . . . . . . . . . 84.3 tt0 -48.03 -37.63 15.32 Favored 'General case' 0 CA--C 1.531 0.25 0 N-CA-C 112.612 0.597 . . . . 0.0 112.612 -173.336 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' B' B ' 91' ' ' ASN . . . . . . . . . . . . . 84.9 m-20 -131.6 35.07 3.85 Favored 'General case' 0 N--CA 1.465 0.285 0 CA-C-O 120.816 0.341 . . . . 0.0 111.639 -177.301 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' B' B ' 92' ' ' LEU . . . . . . . . . . . . . 11.6 tp -166.07 142.41 5.05 Favored 'General case' 0 C--N 1.331 -0.22 0 CA-C-O 120.673 0.273 . . . . 0.0 110.339 179.723 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' B' B ' 93' ' ' ILE . . . . . . . . . . . . . 70.1 mt -125.47 124.36 66.77 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.343 0 N-CA-C 109.622 -0.51 . . . . 0.0 109.622 -179.896 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' B' B ' 94' ' ' VAL . . . . . . . . . . . . . 41.0 t -124.79 127.33 72.58 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.252 0 N-CA-C 110.008 -0.368 . . . . 0.0 110.008 179.39 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' B' B ' 95' ' ' VAL . . . . . . . . . . . . . 40.1 t -123.37 137.67 55.88 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.293 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.036 -179.48 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' B' B ' 96' ' ' ILE . . . . . . . . . . . . . 65.1 mt -116.46 130.43 71.29 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.256 0 N-CA-C 109.158 -0.682 . . . . 0.0 109.158 178.254 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' B' B ' 97' ' ' THR . . . . . . . . . . . . . 65.4 p -103.96 155.78 18.38 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-O 121.029 0.443 . . . . 0.0 111.255 -177.324 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' B' B ' 98' ' ' GLU . . . . . . . . . . . . . 85.1 tt0 -54.04 -24.54 17.49 Favored 'General case' 0 CA--C 1.534 0.332 0 N-CA-C 112.068 0.396 . . . . 0.0 112.068 178.922 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' B' B ' 99' ' ' GLU . . . . . . . . . . . . . 70.9 mm-40 -76.4 13.49 0.94 Allowed 'General case' 0 CA--C 1.535 0.4 0 N-CA-C 113.2 0.815 . . . . 0.0 113.2 -179.333 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' B' B ' 100' ' ' ASN . . . . . . . . . . . . . 2.3 m-20 64.62 38.1 7.37 Favored 'General case' 0 C--O 1.232 0.15 0 CA-C-O 120.988 0.423 . . . . 0.0 110.788 177.813 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' B' B ' 101' ' ' GLU . . . . . . . . . . . . . 46.2 mt-10 -115.84 143.94 44.72 Favored 'General case' 0 C--N 1.332 -0.16 0 CA-C-N 116.074 -0.512 . . . . 0.0 110.399 177.078 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' B' B ' 102' ' ' VAL . . . . . 0.435 ' C ' HD12 ' B' ' 103' ' ' LEU . 47.2 t -115.11 126.46 72.7 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.357 0 N-CA-C 109.245 -0.65 . . . . 0.0 109.245 176.864 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' B' B ' 103' ' ' LEU . . . . . 0.435 HD12 ' C ' ' B' ' 102' ' ' VAL . 6.4 mp -121.9 132.88 54.8 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-N 116.008 -0.542 . . . . 0.0 110.386 177.796 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' B' B ' 104' ' ' ILE . . . . . . . . . . . . . 71.6 mt -117.62 124.77 73.5 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.315 0 CA-C-N 115.834 -0.621 . . . . 0.0 109.914 -179.092 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' B' B ' 105' ' ' PHE . . . . . . . . . . . . . 75.9 m-85 -123.46 162.23 23.25 Favored 'General case' 0 C--N 1.331 -0.222 0 O-C-N 123.985 0.803 . . . . 0.0 109.823 179.786 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' B' B ' 106' ' ' ASN . . . . . . . . . . . . . 47.9 p-10 -97.22 -170.41 2.02 Favored 'General case' 0 C--N 1.329 -0.31 0 N-CA-C 109.919 -0.4 . . . . 0.0 109.919 173.939 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' B' B ' 107' ' ' GLN . . . . . . . . . . . . . 47.5 tt0 -59.0 -30.05 67.69 Favored 'General case' 0 C--N 1.329 -0.287 0 N-CA-C 111.888 0.329 . . . . 0.0 111.888 179.607 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' B' B ' 108' ' ' ASN . . . . . . . . . . . . . 56.4 t30 -83.96 7.76 17.32 Favored 'General case' 0 CA--C 1.536 0.412 0 N-CA-C 113.259 0.837 . . . . 0.0 113.259 -177.022 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' B' B ' 109' ' ' LEU . . . . . . . . . . . . . 9.8 tp 60.52 36.35 20.0 Favored 'General case' 0 CA--C 1.529 0.165 0 CA-C-O 120.965 0.412 . . . . 0.0 111.413 178.613 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' B' B ' 110' ' ' GLU . . . . . . . . . . . . . 70.6 mm-40 -101.35 147.5 26.25 Favored 'General case' 0 C--N 1.329 -0.322 0 N-CA-C 109.685 -0.487 . . . . 0.0 109.685 175.837 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' B' B ' 111' ' ' GLU . . . . . . . . . . . . . 85.2 tt0 -79.51 121.95 25.85 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-O 120.94 0.4 . . . . 0.0 110.483 -177.508 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' B' B ' 112' ' ' LEU . . . . . . . . . . . . . 20.5 mt -108.26 -46.04 3.8 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 115.911 -0.586 . . . . 0.0 110.548 179.379 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' B' B ' 113' ' ' TYR . . . . . . . . . . . . . 64.4 t80 -140.27 135.17 32.01 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.145 -0.48 . . . . 0.0 111.364 -178.667 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' B' B ' 114' ' ' ARG . . . . . . . . . . . . . 71.6 ttt180 -142.16 125.16 16.2 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.306 -0.406 . . . . 0.0 110.158 176.141 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' B' B ' 115' ' ' GLY . . . . . . . . . . . . . . . -150.04 149.14 21.0 Favored Glycine 0 CA--C 1.523 0.582 0 N-CA-C 111.175 -0.77 . . . . 0.0 111.175 179.115 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' B' B ' 116' ' ' LYS . . . . . . . . . . . . . 35.3 ttpt -114.22 131.75 56.36 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-O 120.732 0.301 . . . . 0.0 110.422 178.283 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' B' B ' 117' ' ' PHE . . . . . 0.426 ' HE2' HD13 ' B' ' 132' ' ' ILE . 43.1 m-85 -129.46 113.94 15.52 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.279 -0.419 . . . . 0.0 109.938 -179.244 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' B' B ' 118' ' ' GLU . . . . . . . . . . . . . 84.6 tt0 -54.91 -48.5 73.0 Favored 'General case' 0 C--N 1.329 -0.318 0 C-N-CA 120.901 -0.319 . . . . 0.0 111.419 -175.601 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' B' B ' 119' ' ' ASN . . . . . . . . . . . . . 91.0 m-20 -94.44 31.2 1.79 Allowed 'General case' 0 C--N 1.33 -0.279 0 N-CA-C 112.187 0.44 . . . . 0.0 112.187 -174.199 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' B' B ' 120' ' ' LEU . . . . . . . . . . . . . 21.9 tp -53.28 123.67 12.51 Favored 'General case' 0 N--CA 1.464 0.254 0 CA-C-O 120.713 0.292 . . . . 0.0 110.953 178.221 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' B' B ' 121' ' ' ASN . . . . . . . . . . . . . 43.2 m-20 -106.37 -44.16 4.59 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-N 116.337 -0.392 . . . . 0.0 110.909 -177.533 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' B' B ' 122' ' ' LYS . . . . . . . . . . . . . 50.7 pttt -161.14 157.73 26.41 Favored 'General case' 0 C--N 1.331 -0.225 0 C-N-CA 120.454 -0.498 . . . . 0.0 112.204 -179.462 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' B' B ' 123' ' ' VAL . . . . . . . . . . . . . 44.0 t -125.6 131.16 72.4 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.246 0 CA-C-N 115.805 -0.634 . . . . 0.0 109.845 177.522 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' B' B ' 124' ' ' LEU . . . . . . . . . . . . . 76.8 mt -116.73 133.3 56.17 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.301 -0.408 . . . . 0.0 110.392 179.979 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' B' B ' 125' ' ' VAL . . . . . . . . . . . . . 47.3 t -131.74 129.51 61.27 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.215 0 CA-C-N 116.284 -0.417 . . . . 0.0 110.228 -179.057 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' B' B ' 126' ' ' ARG . . . . . . . . . . . . . 77.0 mtt180 -141.3 119.79 12.36 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-O 121.076 0.465 . . . . 0.0 110.458 176.538 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' B' B ' 127' ' ' ASN . . . . . . . . . . . . . 42.4 t-20 50.63 -106.47 0.24 Allowed 'General case' 0 CA--C 1.543 0.711 0 CA-C-O 119.003 -0.523 . . . . 0.0 111.37 -179.106 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' B' B ' 128' ' ' ASP . . . . . . . . . . . . . 11.7 p-10 -114.12 2.51 14.92 Favored 'General case' 0 N--CA 1.467 0.407 0 CA-C-N 119.642 1.11 . . . . 0.0 113.466 -177.334 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' B' B ' 129' ' ' LEU . . . . . . . . . . . . . 11.6 tp -104.96 136.85 43.68 Favored 'General case' 0 C--O 1.232 0.134 0 CA-C-N 118.267 0.485 . . . . 0.0 109.849 -179.916 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' B' B ' 130' ' ' VAL . . . . . . . . . . . . . 43.0 t -125.14 138.08 55.51 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.268 0 CA-C-O 121.061 0.457 . . . . 0.0 110.406 -176.885 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' B' B ' 131' ' ' VAL . . . . . 0.461 HG22 HD12 ' B' ' 140' ' ' LEU . 44.2 t -134.52 135.24 54.01 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.34 0 CA-C-N 115.895 -0.593 . . . . 0.0 110.008 177.915 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' B' B ' 132' ' ' ILE . . . . . 0.426 HD13 ' HE2' ' B' ' 117' ' ' PHE . 73.7 mt -115.79 132.28 65.69 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.281 0 N-CA-C 109.501 -0.555 . . . . 0.0 109.501 179.752 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' B' B ' 133' ' ' ILE . . . . . . . . . . . . . 42.7 mm -116.33 125.14 73.24 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.226 0 CA-C-N 116.569 -0.287 . . . . 0.0 111.074 -174.624 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' B' B ' 134' ' ' ASP . . . . . . . . . . . . . 10.1 p-10 -137.45 150.07 47.34 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 116.19 -0.459 . . . . 0.0 109.846 173.378 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' B' B ' 135' ' ' GLU . . . . . . . . . . . . . 40.1 tp10 -49.91 -27.2 4.91 Favored 'General case' 0 C--N 1.327 -0.371 0 N-CA-C 112.791 0.663 . . . . 0.0 112.791 -172.066 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' B' B ' 136' ' ' GLN . . . . . . . . . . . . . 63.2 tt0 -87.14 -33.72 19.32 Favored 'General case' 0 C--N 1.331 -0.221 0 N-CA-C 112.497 0.554 . . . . 0.0 112.497 -174.747 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' B' B ' 137' ' ' LYS . . . . . . . . . . . . . 48.3 pttt -162.1 171.22 17.84 Favored 'General case' 0 C--N 1.332 -0.181 0 CA-C-O 121.537 0.684 . . . . 0.0 112.525 -171.445 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' B' B ' 138' ' ' LEU . . . . . 0.427 ' C ' HD23 ' B' ' 138' ' ' LEU . 7.2 tt -121.45 128.74 52.45 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 114.918 -1.037 . . . . 0.0 109.896 178.531 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' B' B ' 139' ' ' THR . . . . . . . . . . . . . 39.4 m -108.18 127.13 53.55 Favored 'General case' 0 C--N 1.331 -0.221 0 CA-C-N 116.292 -0.413 . . . . 0.0 110.425 -179.929 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' B' B ' 140' ' ' LEU . . . . . 0.461 HD12 HG22 ' B' ' 131' ' ' VAL . 29.6 tp -112.2 120.9 43.35 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 115.788 -0.642 . . . . 0.0 109.531 -179.09 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' B' B ' 141' ' ' ILE . . . . . . . . . . . . . 19.1 mt -121.72 119.63 59.35 Favored 'Isoleucine or valine' 0 C--O 1.233 0.198 0 CA-C-O 121.09 0.471 . . . . 0.0 110.282 -175.249 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' B' B ' 142' ' ' ARG . . . . . . . . . . . . . 83.1 mtp180 -108.03 125.87 52.06 Favored 'General case' 0 C--N 1.331 -0.217 0 CA-C-N 115.206 -0.906 . . . . 0.0 110.091 179.044 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' B' B ' 143' ' ' THR . . . . . . . . . . . . . 15.2 p . . . . . 0 C--O 1.219 -0.501 0 CA-C-O 118.046 -0.978 . . . . 0.0 110.495 179.831 . . . . . . . . 0 0 . 1 . 012 nuclear build core ' C' C ' 2' ' ' SER . . . . . . . . . . . . . 4.1 p . . . . . 0 C--O 1.231 0.103 0 CA-C-O 120.85 0.357 . . . . 0.0 110.826 . . . . . . . . . 0 0 . 1 . 012 nuclear build core ' C' C ' 3' ' ' GLU . . . . . . . . . . . . . 57.0 mp0 -140.49 140.35 35.3 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.074 -0.512 . . . . 0.0 110.867 179.267 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' C' C ' 4' ' ' LEU . . . . . . . . . . . . . 14.8 tp -125.17 127.94 47.6 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.046 -0.525 . . . . 0.0 110.111 176.46 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' C' C ' 5' ' ' LYS . . . . . . . . . . . . . 87.9 mttt -109.3 122.93 48.41 Favored 'General case' 0 C--O 1.235 0.294 0 CA-C-O 120.66 0.267 . . . . 0.0 110.888 178.929 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' C' C ' 6' ' ' LEU . . . . . . . . . . . . . 67.2 mt -114.72 145.07 42.49 Favored 'General case' 0 N--CA 1.463 0.216 0 CA-C-N 115.676 -0.693 . . . . 0.0 110.362 179.491 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' C' C ' 7' ' ' LYS . . . . . . . . . . . . . 73.6 tttt -125.25 137.02 28.99 Favored Pre-proline 0 CA--C 1.534 0.335 0 CA-C-O 118.866 -0.588 . . . . 0.0 109.703 174.635 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' C' C ' 8' ' ' PRO . . . . . . . . . . . . . 83.5 Cg_endo -92.04 132.68 1.24 Allowed 'Trans proline' 0 N--CA 1.489 1.249 0 C-N-CA 121.663 1.575 . . . . 0.0 111.759 178.528 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' C' C ' 9' ' ' LEU . . . . . . . . . . . . . 55.7 mt -69.63 -46.74 25.76 Favored Pre-proline 0 CA--C 1.532 0.272 0 CA-C-O 118.742 -0.647 . . . . 0.0 112.079 -179.557 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' C' C ' 10' ' ' PRO . . . . . . . . . . . . . 88.4 Cg_endo -80.79 155.65 20.61 Favored 'Trans proline' 0 N--CA 1.495 1.611 0 C-N-CA 121.184 1.256 . . . . 0.0 111.78 174.769 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' C' C ' 11' ' ' LYS . . . . . . . . . . . . . 79.1 mttt -87.7 101.37 13.6 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.415 -0.357 . . . . 0.0 110.503 178.978 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' C' C ' 12' ' ' VAL . . . . . . . . . . . . . 12.2 p -145.33 144.36 21.45 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.299 0 CA-C-N 116.299 -0.41 . . . . 0.0 110.836 -179.251 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' C' C ' 13' ' ' GLU . . . . . . . . . . . . . 43.5 mt-10 -92.36 126.23 37.35 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.252 -0.431 . . . . 0.0 109.879 176.25 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' C' C ' 14' ' ' LEU . . . . . . . . . . . . . 17.3 mt -97.22 152.81 38.49 Favored Pre-proline 0 C--N 1.33 -0.267 0 CA-C-N 116.501 -0.318 . . . . 0.0 110.742 -177.649 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' C' C ' 15' ' ' PRO . . . . . . . . . . . . . 33.6 Cg_exo -59.77 159.23 25.44 Favored 'Trans proline' 0 N--CA 1.496 1.67 0 C-N-CA 121.311 1.341 . . . . 0.0 111.884 178.348 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' C' C ' 16' ' ' PRO . . . . . . . . . . . . . 29.6 Cg_exo -59.9 -34.84 95.15 Favored 'Trans proline' 0 N--CA 1.497 1.725 0 C-N-CA 121.383 1.389 . . . . 0.0 112.811 -177.675 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' C' C ' 17' ' ' ASP . . . . . . . . . . . . . 10.7 p-10 -90.18 8.74 31.46 Favored 'General case' 0 CA--C 1.536 0.423 0 N-CA-C 113.284 0.846 . . . . 0.0 113.284 -176.896 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' C' C ' 18' ' ' PHE . . . . . . . . . . . . . 53.6 t80 -57.8 -45.55 85.91 Favored 'General case' 0 C--N 1.334 -0.101 0 O-C-N 122.057 -0.402 . . . . 0.0 110.33 -178.516 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' C' C ' 19' ' ' VAL . . . . . . . . . . . . . 48.7 t -56.75 -42.11 76.62 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.289 0 CA-C-N 116.523 -0.308 . . . . 0.0 110.414 -178.633 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' C' C ' 20' ' ' ASP . . . . . . . . . . . . . 14.9 t0 -59.7 -44.0 93.87 Favored 'General case' 0 C--N 1.328 -0.352 0 C-N-CA 120.841 -0.343 . . . . 0.0 110.762 -177.939 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' C' C ' 21' ' ' VAL . . . . . . . . . . . . . 45.3 t -64.8 -46.28 92.51 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.279 0 C-N-CA 120.753 -0.379 . . . . 0.0 110.498 -177.636 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' C' C ' 22' ' ' ILE . . . . . 0.597 HG22 HD12 ' C' ' 26' ' ' LEU . 50.3 mm -56.9 -39.98 68.76 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.333 0 C-N-CA 120.983 -0.287 . . . . 0.0 110.637 179.957 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' C' C ' 23' ' ' ARG . . . . . . . . . . . . . 45.1 ttp180 -57.26 -50.38 73.09 Favored 'General case' 0 C--N 1.331 -0.21 0 C-N-CA 120.673 -0.411 . . . . 0.0 110.386 177.194 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' C' C ' 24' ' ' ILE . . . . . . . . . . . . . 71.8 mt -60.44 -39.84 82.35 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.335 0 CA-C-N 115.995 -0.548 . . . . 0.0 111.827 -176.824 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' C' C ' 25' ' ' LYS . . . . . . . . . . . . . 14.9 pttp -77.11 -37.28 54.56 Favored 'General case' 0 CA--C 1.534 0.33 0 C-N-CA 120.592 -0.443 . . . . 0.0 111.938 -173.597 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' C' C ' 26' ' ' LEU . . . . . 0.597 HD12 HG22 ' C' ' 22' ' ' ILE . 49.0 mt -79.43 -32.42 42.82 Favored 'General case' 0 C--N 1.333 -0.146 0 N-CA-C 113.479 0.918 . . . . 0.0 113.479 -173.083 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' C' C ' 27' ' ' GLN . . . . . . . . . . . . . 17.7 pt20 -46.32 139.54 4.72 Favored 'General case' 0 N--CA 1.47 0.538 0 N-CA-C 112.922 0.712 . . . . 0.0 112.922 -174.839 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' C' C ' 28' ' ' GLY . . . . . . . . . . . . . . . 99.86 -26.66 23.58 Favored Glycine 0 CA--C 1.531 1.084 0 CA-C-N 115.697 -0.683 . . . . 0.0 112.255 -177.528 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' C' C ' 29' ' ' LYS . . . . . . . . . . . . . 94.0 mttt -97.09 155.09 16.96 Favored 'General case' 0 C--N 1.332 -0.193 0 CA-C-N 117.351 0.575 . . . . 0.0 110.854 178.237 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' C' C ' 30' ' ' THR . . . . . . . . . . . . . 28.5 m -107.27 138.13 44.02 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 116.104 -0.498 . . . . 0.0 110.104 177.072 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' C' C ' 31' ' ' VAL . . . . . . . . . . . . . 34.4 m -127.51 151.97 34.99 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.244 0 CA-C-N 116.242 -0.435 . . . . 0.0 110.571 -179.393 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' C' C ' 32' ' ' ARG . . . . . . . . . . . . . 67.0 ttt180 -132.74 149.83 52.23 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-O 121.179 0.514 . . . . 0.0 110.267 179.809 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' C' C ' 33' ' ' THR . . . . . . . . . . . . . 26.1 m -52.82 138.4 29.56 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.368 -0.378 . . . . 0.0 111.499 -177.394 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' C' C ' 34' ' ' GLY . . . . . . . . . . . . . . . 101.42 -17.21 55.81 Favored Glycine 0 CA--C 1.534 1.278 0 CA-C-O 119.651 -0.527 . . . . 0.0 113.17 179.444 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' C' C ' 35' ' ' ASP . . . . . . . . . . . . . 75.2 m-20 -66.56 148.34 52.03 Favored 'General case' 0 N--CA 1.461 0.111 0 CA-C-N 118.072 0.936 . . . . 0.0 111.224 178.869 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' C' C ' 36' ' ' VAL . . . . . . . . . . . . . 42.5 t -121.5 129.0 75.97 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.247 0 CA-C-N 115.88 -0.6 . . . . 0.0 109.809 177.638 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' C' C ' 37' ' ' ILE . . . . . . . . . . . . . 64.5 mt -120.92 138.15 52.32 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.244 0 CA-C-N 116.237 -0.438 . . . . 0.0 109.948 -179.811 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' C' C ' 38' ' ' GLY . . . . . . . . . . . . . . . -116.47 126.93 7.25 Favored Glycine 0 CA--C 1.524 0.645 0 N-CA-C 110.828 -0.909 . . . . 0.0 110.828 178.402 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' C' C ' 39' ' ' ILE . . . . . . . . . . . . . 72.1 mt -123.71 131.18 73.45 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.247 0 N-CA-C 110.136 -0.32 . . . . 0.0 110.136 179.395 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' C' C ' 40' ' ' SER . . . . . . . . . . . . . 54.4 p -91.33 117.51 29.72 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.43 -0.35 . . . . 0.0 110.823 177.615 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' C' C ' 41' ' ' ILE . . . . . . . . . . . . . 72.6 mt -134.4 127.51 50.47 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.197 0 N-CA-C 110.067 -0.346 . . . . 0.0 110.067 177.857 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' C' C ' 42' ' ' LEU . . . . . . . . . . . . . 9.5 tp 57.73 34.72 24.8 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.163 -0.471 . . . . 0.0 111.562 178.258 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' C' C ' 43' ' ' GLY . . . . . . . . . . . . . . . 77.42 -10.08 24.52 Favored Glycine 0 CA--C 1.534 1.261 0 C-N-CA 121.334 -0.46 . . . . 0.0 113.467 177.32 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' C' C ' 44' ' ' LYS . . . . . . . . . . . . . 95.0 mttt -104.65 134.26 48.12 Favored 'General case' 0 C--N 1.333 -0.11 0 CA-C-N 117.993 0.897 . . . . 0.0 110.361 178.357 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' C' C ' 45' ' ' GLU . . . . . . . . . . . . . 84.8 tt0 -85.85 128.68 34.88 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.337 -0.392 . . . . 0.0 110.866 178.275 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' C' C ' 46' ' ' VAL . . . . . 0.403 ' O ' HG13 ' C' ' 46' ' ' VAL . 9.7 p -115.38 124.57 72.05 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.167 0 N-CA-C 109.417 -0.586 . . . . 0.0 109.417 175.219 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' C' C ' 47' ' ' LYS . . . . . . . . . . . . . 98.5 mttt -98.96 122.91 42.84 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.021 -0.536 . . . . 0.0 110.673 178.562 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' C' C ' 48' ' ' PHE . . . . . . . . . . . . . 40.2 m-85 -109.78 131.86 54.68 Favored 'General case' 0 C--N 1.329 -0.283 0 N-CA-C 109.607 -0.516 . . . . 0.0 109.607 177.5 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' C' C ' 49' ' ' LYS . . . . . . . . . . . . . 48.5 tttp -108.12 133.64 52.11 Favored 'General case' 0 C--N 1.329 -0.285 0 N-CA-C 109.96 -0.385 . . . . 0.0 109.96 178.201 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' C' C ' 50' ' ' VAL . . . . . . . . . . . . . 44.5 t -74.91 107.04 5.1 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.322 0 N-CA-C 109.261 -0.644 . . . . 0.0 109.261 177.854 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' C' C ' 51' ' ' VAL . . . . . . . . . . . . . 46.4 t -71.14 -48.91 52.29 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.252 0 CA-C-N 116.155 -0.475 . . . . 0.0 109.731 -174.735 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' C' C ' 52' ' ' GLN . . . . . . . . . . . . . 50.3 tt0 -163.73 139.49 6.49 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 115.823 -0.626 . . . . 0.0 111.442 -178.859 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' C' C ' 53' ' ' ALA . . . . . . . . . . . . . . . -116.13 132.88 56.53 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-N 115.78 -0.646 . . . . 0.0 109.728 174.863 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' C' C ' 54' ' ' TYR . . . . . . . . . . . . . 46.8 t80 -129.02 111.88 18.48 Favored Pre-proline 0 CA--C 1.535 0.397 0 CA-C-O 118.22 -0.895 . . . . 0.0 110.395 179.455 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' C' C ' 55' ' ' PRO . . . . . . . . . . . . . 73.2 Cg_endo -77.27 169.04 75.18 Favored 'Cis proline' 0 N--CA 1.501 1.912 0 CA-C-N 121.897 1.713 . . . . 0.0 112.22 -6.949 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' C' C ' 56' ' ' SER . . . . . . . . . . . . . 15.4 m -116.84 137.21 23.57 Favored Pre-proline 0 CA--C 1.538 0.495 0 CA-C-O 118.552 -0.737 . . . . 0.0 109.667 175.477 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' C' C ' 57' ' ' PRO . . . . . . . . . . . . . 48.6 Cg_endo -70.38 145.67 81.44 Favored 'Cis proline' 0 N--CA 1.497 1.701 0 CA-C-N 121.683 1.637 . . . . 0.0 111.334 -3.955 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' C' C ' 58' ' ' LEU . . . . . . . . . . . . . 19.3 tp -106.89 135.91 47.64 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.469 -0.332 . . . . 0.0 110.659 -177.402 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' C' C ' 59' ' ' ARG . . . . . . . . . . . . . 28.6 ttm180 -100.97 126.77 47.65 Favored 'General case' 0 C--N 1.327 -0.409 0 N-CA-C 109.51 -0.552 . . . . 0.0 109.51 176.134 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' C' C ' 60' ' ' VAL . . . . . . . . . . . . . 43.3 t -76.01 116.4 18.96 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.249 0 C-N-CA 120.729 -0.388 . . . . 0.0 110.047 -177.202 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' C' C ' 61' ' ' GLU . . . . . . . . . . . . . 95.8 mt-10 -131.02 167.32 19.24 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 115.84 -0.618 . . . . 0.0 110.104 178.994 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' C' C ' 62' ' ' ASP . . . . . . . . . . . . . 12.1 p-10 -55.65 -32.47 63.22 Favored 'General case' 0 C--N 1.328 -0.351 0 N-CA-C 111.837 0.31 . . . . 0.0 111.837 -178.46 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' C' C ' 63' ' ' ARG . . . . . . . . . . . . . 40.4 ptt180 -82.52 0.52 42.17 Favored 'General case' 0 CA--C 1.537 0.463 0 N-CA-C 113.749 1.018 . . . . 0.0 113.749 -175.068 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' C' C ' 64' ' ' THR . . . . . . . . . . . . . 33.2 m -82.55 134.33 35.19 Favored 'General case' 0 C--N 1.333 -0.151 0 CA-C-N 118.159 0.436 . . . . 0.0 110.903 -176.258 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' C' C ' 65' ' ' LYS . . . . . . . . . . . . . 53.6 mtmt -89.26 127.35 35.76 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 115.935 -0.575 . . . . 0.0 109.879 177.017 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' C' C ' 66' ' ' ILE . . . . . . . . . . . . . 64.5 mt -111.82 126.6 69.23 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.314 0 N-CA-C 109.656 -0.498 . . . . 0.0 109.656 -179.115 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' C' C ' 67' ' ' THR . . . . . . . . . . . . . 23.5 m -124.49 144.69 49.96 Favored 'General case' 0 C--N 1.331 -0.229 0 CA-C-O 121.281 0.562 . . . . 0.0 111.227 -175.453 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' C' C ' 68' ' ' LEU . . . . . . . . . . . . . 20.6 tp . . . . . 0 C--N 1.328 -0.352 0 CA-C-N 115.573 -0.74 . . . . 0.0 110.243 177.731 . . . . . . . . 0 0 . 1 . 012 nuclear build core ' C' C ' 73' ' ' VAL . . . . . . . . . . . . . 31.5 m . . . . . 0 N--CA 1.463 0.184 0 CA-C-O 121.077 0.465 . . . . 0.0 110.844 . . . . . . . . . 0 0 . 1 . 012 nuclear build core ' C' C ' 74' ' ' ASP . . . . . . . . . . . . . 26.0 t0 -98.47 122.07 41.2 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-N 115.571 -0.741 . . . . 0.0 109.411 177.19 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' C' C ' 75' ' ' VAL . . . . . 0.403 ' C ' HD12 ' C' ' 76' ' ' LEU . 44.3 t -114.09 123.78 70.09 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.226 0 CA-C-O 121.095 0.474 . . . . 0.0 110.742 -176.38 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' C' C ' 76' ' ' LEU . . . . . 0.403 HD12 ' C ' ' C' ' 75' ' ' VAL . 5.9 mp -124.93 144.8 50.16 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 115.669 -0.696 . . . . 0.0 109.696 175.288 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' C' C ' 77' ' ' GLU . . . . . . . . . . . . . 97.3 mt-10 -134.12 134.92 42.78 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-O 120.98 0.419 . . . . 0.0 111.141 -178.219 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' C' C ' 78' ' ' ALA . . . . . . . . . . . . . . . -120.19 135.44 54.98 Favored 'General case' 0 C--N 1.331 -0.219 0 CA-C-N 115.825 -0.625 . . . . 0.0 109.953 177.166 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' C' C ' 79' ' ' LYS . . . . . 0.606 ' O ' HD13 ' C' ' 80' ' ' ILE . 28.9 mtpp -84.0 117.1 23.17 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-O 120.81 0.338 . . . . 0.0 110.79 -177.91 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' C' C ' 80' ' ' ILE . . . . . 0.606 HD13 ' O ' ' C' ' 79' ' ' LYS . 41.6 mm -139.15 112.15 6.2 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.28 0 N-CA-C 109.355 -0.609 . . . . 0.0 109.355 -177.877 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' C' C ' 81' ' ' LYS . . . . . . . . . . . . . 49.6 pttt -98.72 125.96 44.19 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-O 120.969 0.414 . . . . 0.0 111.402 -177.922 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' C' C ' 82' ' ' GLY . . . . . . . . . . . . . . . 89.05 42.18 5.69 Favored Glycine 0 CA--C 1.526 0.73 0 C-N-CA 121.003 -0.618 . . . . 0.0 112.013 174.25 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' C' C ' 83' ' ' ILE . . . . . . . . . . . . . 72.7 mt -71.23 135.57 27.71 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.281 0 N-CA-C 109.326 -0.62 . . . . 0.0 109.326 176.038 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' C' C ' 84' ' ' LYS . . . . . . . . . . . . . 28.4 ttpp -102.68 -51.27 3.35 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-O 120.913 0.387 . . . . 0.0 110.597 -177.289 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' C' C ' 85' ' ' ASP . . . . . . . . . . . . . 8.5 t0 -143.69 144.07 31.7 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.008 -0.542 . . . . 0.0 110.545 -178.651 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' C' C ' 86' ' ' VAL . . . . . . . . . . . . . 42.9 t -125.91 131.19 72.1 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 CA-C-O 120.897 0.38 . . . . 0.0 110.24 179.742 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' C' C ' 87' ' ' ILE . . . . . 0.49 ' N ' HD12 ' C' ' 87' ' ' ILE . 5.1 mp -119.23 125.39 74.41 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.261 0 N-CA-C 109.573 -0.528 . . . . 0.0 109.573 176.808 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' C' C ' 88' ' ' LEU . . . . . . . . . . . . . 11.6 tp -115.91 131.35 56.96 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-O 120.992 0.425 . . . . 0.0 110.992 -177.159 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' C' C ' 89' ' ' ASP . . . . . . . . . . . . . 9.5 t70 -128.19 158.86 36.93 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-N 115.906 -0.588 . . . . 0.0 109.495 176.625 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' C' C ' 90' ' ' GLU . . . . . . . . . . . . . 83.7 tt0 -46.92 -38.81 11.12 Favored 'General case' 0 CA--C 1.531 0.217 0 N-CA-C 113.029 0.752 . . . . 0.0 113.029 -171.905 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' C' C ' 91' ' ' ASN . . . . . . . . . . . . . 30.5 t30 -132.09 26.36 4.56 Favored 'General case' 0 N--CA 1.467 0.416 0 N-CA-C 112.552 0.575 . . . . 0.0 112.552 -177.553 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' C' C ' 92' ' ' LEU . . . . . . . . . . . . . 9.2 mt -149.32 142.38 24.91 Favored 'General case' 0 C--N 1.331 -0.238 0 N-CA-C 109.98 -0.378 . . . . 0.0 109.98 -177.843 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' C' C ' 93' ' ' ILE . . . . . . . . . . . . . 75.3 mt -127.43 117.71 47.66 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.283 0 N-CA-C 109.38 -0.6 . . . . 0.0 109.38 177.256 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' C' C ' 94' ' ' VAL . . . . . 0.53 HG21 HG11 ' C' ' 125' ' ' VAL . 44.1 t -122.9 127.55 74.84 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.225 0 CA-C-O 120.959 0.409 . . . . 0.0 110.066 -179.229 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' C' C ' 95' ' ' VAL . . . . . . . . . . . . . 44.8 t -120.34 132.62 69.47 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.355 0 CA-C-N 115.886 -0.597 . . . . 0.0 109.688 -179.982 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' C' C ' 96' ' ' ILE . . . . . . . . . . . . . 66.3 mt -115.58 128.5 72.79 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.243 0 N-CA-C 109.218 -0.66 . . . . 0.0 109.218 178.789 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' C' C ' 97' ' ' THR . . . . . . . . . . . . . 67.6 p -101.53 160.46 14.42 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-O 121.144 0.497 . . . . 0.0 111.131 -176.949 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' C' C ' 98' ' ' GLU . . . . . . . . . . . . . 96.8 mt-10 -54.01 -26.6 27.14 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.117 -0.492 . . . . 0.0 112.284 -179.318 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' C' C ' 99' ' ' GLU . . . . . . . . . . . . . 71.0 mm-40 -79.18 15.65 1.13 Allowed 'General case' 0 CA--C 1.534 0.342 0 N-CA-C 113.183 0.808 . . . . 0.0 113.183 -177.549 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' C' C ' 100' ' ' ASN . . . . . . . . . . . . . 3.2 m-20 61.6 38.08 15.7 Favored 'General case' 0 N--CA 1.463 0.191 0 CA-C-O 121.14 0.495 . . . . 0.0 110.978 178.476 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' C' C ' 101' ' ' GLU . . . . . . . . . . . . . 84.6 tt0 -114.44 141.14 48.05 Favored 'General case' 0 C--N 1.332 -0.169 0 CA-C-N 116.108 -0.496 . . . . 0.0 109.762 176.306 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' C' C ' 102' ' ' VAL . . . . . . . . . . . . . 43.0 t -115.13 125.79 72.52 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.324 0 CA-C-N 116.17 -0.468 . . . . 0.0 109.894 -178.234 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' C' C ' 103' ' ' LEU . . . . . . . . . . . . . 34.9 mt -115.41 129.0 56.44 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 115.732 -0.667 . . . . 0.0 109.9 175.821 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' C' C ' 104' ' ' ILE . . . . . 0.609 HD13 HG11 ' C' ' 130' ' ' VAL . 65.1 mt -117.19 120.56 65.37 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.193 0 N-CA-C 110.261 -0.274 . . . . 0.0 110.261 -178.273 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' C' C ' 105' ' ' PHE . . . . . . . . . . . . . 56.9 m-85 -122.12 166.27 14.82 Favored 'General case' 0 C--N 1.333 -0.119 0 O-C-N 124.009 0.818 . . . . 0.0 109.722 178.931 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' C' C ' 106' ' ' ASN . . . . . . . . . . . . . 46.3 p-10 -101.07 -171.15 1.95 Allowed 'General case' 0 C--N 1.331 -0.203 0 N-CA-C 110.062 -0.347 . . . . 0.0 110.062 173.714 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' C' C ' 107' ' ' GLN . . . . . . . . . . . . . 46.2 tt0 -60.34 -26.97 66.98 Favored 'General case' 0 CA--C 1.533 0.31 0 N-CA-C 112.142 0.423 . . . . 0.0 112.142 179.494 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' C' C ' 108' ' ' ASN . . . . . . . . . . . . . 53.3 t30 -84.2 6.96 20.62 Favored 'General case' 0 CA--C 1.537 0.459 0 N-CA-C 113.159 0.8 . . . . 0.0 113.159 -178.343 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' C' C ' 109' ' ' LEU . . . . . . . . . . . . . 11.9 tp 61.64 36.86 16.42 Favored 'General case' 0 C--O 1.232 0.177 0 CA-C-O 120.932 0.396 . . . . 0.0 111.405 179.013 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' C' C ' 110' ' ' GLU . . . . . . . . . . . . . 95.7 mt-10 -108.01 153.46 23.06 Favored 'General case' 0 C--N 1.33 -0.262 0 N-CA-C 109.6 -0.519 . . . . 0.0 109.6 175.059 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' C' C ' 111' ' ' GLU . . . . . . . . . . . . . 55.8 tt0 -90.73 124.14 34.87 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-O 121.017 0.437 . . . . 0.0 111.146 -174.694 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' C' C ' 112' ' ' LEU . . . . . . . . . . . . . 25.6 mt -106.84 -46.07 4.04 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 115.87 -0.604 . . . . 0.0 110.914 179.787 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' C' C ' 113' ' ' TYR . . . . . 0.504 ' HB3' HD12 ' C' ' 104' ' ' ILE . 49.0 t80 -137.63 141.44 41.21 Favored 'General case' 0 C--N 1.331 -0.209 0 CA-C-N 116.319 -0.401 . . . . 0.0 110.802 -177.367 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' C' C ' 114' ' ' ARG . . . . . . . . . . . . . 36.7 ptt-85 -145.39 125.03 13.25 Favored 'General case' 0 C--N 1.331 -0.235 0 C-N-CA 120.94 -0.304 . . . . 0.0 110.825 178.002 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' C' C ' 115' ' ' GLY . . . . . . . . . . . . . . . -150.19 160.78 28.69 Favored Glycine 0 CA--C 1.525 0.666 0 C-N-CA 120.699 -0.762 . . . . 0.0 111.408 179.791 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' C' C ' 116' ' ' LYS . . . . . . . . . . . . . 36.7 ttpt -125.75 130.15 50.91 Favored 'General case' 0 C--N 1.331 -0.219 0 N-CA-C 109.412 -0.588 . . . . 0.0 109.412 174.344 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' C' C ' 117' ' ' PHE . . . . . . . . . . . . . 49.9 m-85 -130.56 114.64 15.72 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-O 120.958 0.409 . . . . 0.0 110.598 -174.215 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' C' C ' 118' ' ' GLU . . . . . . . . . . . . . 46.2 tp10 -52.88 -51.28 61.72 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.301 -0.409 . . . . 0.0 111.622 -176.086 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' C' C ' 119' ' ' ASN . . . . . . . . . . . . . 28.9 m120 -95.41 31.01 2.07 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.259 -0.428 . . . . 0.0 112.075 -174.103 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' C' C ' 120' ' ' LEU . . . . . . . . . . . . . 19.3 tp -54.94 122.54 11.09 Favored 'General case' 0 C--O 1.232 0.157 0 CA-C-O 120.729 0.299 . . . . 0.0 110.813 179.228 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' C' C ' 121' ' ' ASN . . . . . . . . . . . . . 17.3 m120 -103.26 -44.07 5.28 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.399 -0.364 . . . . 0.0 110.681 -177.316 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' C' C ' 122' ' ' LYS . . . . . . . . . . . . . 24.2 pttm -166.96 155.11 9.71 Favored 'General case' 0 C--N 1.331 -0.219 0 C-N-CA 120.572 -0.451 . . . . 0.0 111.843 -179.732 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' C' C ' 123' ' ' VAL . . . . . . . . . . . . . 43.0 t -123.33 135.26 63.82 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.284 0 CA-C-N 116.021 -0.536 . . . . 0.0 109.626 176.82 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' C' C ' 124' ' ' LEU . . . . . . . . . . . . . 31.5 mt -128.19 142.19 51.25 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-O 120.954 0.407 . . . . 0.0 110.977 -177.604 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' C' C ' 125' ' ' VAL . . . . . 0.53 HG11 HG21 ' C' ' 94' ' ' VAL . 35.9 m -133.48 141.18 45.07 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.293 0 CA-C-N 115.994 -0.548 . . . . 0.0 110.55 178.16 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' C' C ' 126' ' ' ARG . . . . . . . . . . . . . 19.6 ttm180 -162.86 127.61 3.1 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.122 -0.49 . . . . 0.0 109.72 178.196 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' C' C ' 127' ' ' ASN . . . . . . . . . . . . . 36.0 m120 56.4 -150.78 0.43 Allowed 'General case' 0 CA--C 1.541 0.627 0 N-CA-C 109.519 -0.548 . . . . 0.0 109.519 -176.494 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' C' C ' 128' ' ' ASP . . . . . . . . . . . . . 12.7 p-10 -82.35 16.32 2.1 Favored 'General case' 0 CA--C 1.535 0.393 0 CA-C-N 118.875 0.761 . . . . 0.0 112.762 178.725 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' C' C ' 129' ' ' LEU . . . . . . . . . . . . . 17.9 tp -107.22 133.31 51.98 Favored 'General case' 0 C--O 1.232 0.141 0 CA-C-N 118.084 0.402 . . . . 0.0 110.51 179.845 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' C' C ' 130' ' ' VAL . . . . . 0.609 HG11 HD13 ' C' ' 104' ' ' ILE . 45.2 t -121.71 133.25 68.72 Favored 'Isoleucine or valine' 0 C--N 1.333 -0.144 0 N-CA-C 109.374 -0.602 . . . . 0.0 109.374 177.787 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' C' C ' 131' ' ' VAL . . . . . 0.548 HG22 HD12 ' C' ' 140' ' ' LEU . 43.9 t -135.28 136.61 51.09 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.208 0 CA-C-O 121.084 0.468 . . . . 0.0 110.919 -177.904 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' C' C ' 132' ' ' ILE . . . . . . . . . . . . . 69.8 mt -116.69 128.91 73.94 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.292 0 CA-C-N 115.658 -0.701 . . . . 0.0 109.231 178.302 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' C' C ' 133' ' ' ILE . . . . . . . . . . . . . 42.1 mm -114.49 123.58 70.3 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.213 0 CA-C-O 120.741 0.305 . . . . 0.0 110.947 -175.239 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' C' C ' 134' ' ' ASP . . . . . . . . . . . . . 8.9 p-10 -135.31 146.65 48.68 Favored 'General case' 0 C--N 1.331 -0.2 0 N-CA-C 109.553 -0.536 . . . . 0.0 109.553 173.396 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' C' C ' 135' ' ' GLU . . . . . . . . . . . . . 85.4 tt0 -50.09 -26.17 4.18 Favored 'General case' 0 C--N 1.327 -0.405 0 N-CA-C 112.878 0.695 . . . . 0.0 112.878 -172.696 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' C' C ' 136' ' ' GLN . . . . . . . . . . . . . 96.1 mt-30 -85.18 -30.63 23.77 Favored 'General case' 0 C--O 1.234 0.278 0 N-CA-C 112.581 0.585 . . . . 0.0 112.581 -175.384 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' C' C ' 137' ' ' LYS . . . . . . . . . . . . . 19.8 pttp -168.19 170.14 10.41 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-O 121.513 0.673 . . . . 0.0 112.242 -173.29 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' C' C ' 138' ' ' LEU . . . . . 0.453 HD23 ' C ' ' C' ' 138' ' ' LEU . 7.4 tt -118.89 128.16 54.17 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 115.126 -0.943 . . . . 0.0 109.933 -179.9 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' C' C ' 139' ' ' THR . . . . . . . . . . . . . 39.1 m -109.03 126.11 52.78 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-N 116.246 -0.434 . . . . 0.0 110.09 178.63 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' C' C ' 140' ' ' LEU . . . . . 0.548 HD12 HG22 ' C' ' 131' ' ' VAL . 9.0 tp -112.77 123.4 50.22 Favored 'General case' 0 C--N 1.329 -0.303 0 N-CA-C 109.292 -0.633 . . . . 0.0 109.292 -178.588 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' C' C ' 141' ' ' ILE . . . . . . . . . . . . . 19.0 mt -121.9 125.53 73.33 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.29 0 CA-C-O 121.085 0.469 . . . . 0.0 110.303 -173.887 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' C' C ' 142' ' ' ARG . . . . . . . . . . . . . 23.2 mmm180 . . . . . 0 C--N 1.33 -0.27 0 CA-C-N 115.459 -0.791 . . . . 0.0 109.93 179.13 . . . . . . . . 0 0 . 1 . 012 nuclear build core ' D' D ' 2' ' ' SER . . . . . . . . . . . . . 4.4 p . . . . . 0 C--O 1.231 0.091 0 CA-C-O 121.009 0.433 . . . . 0.0 110.374 . . . . . . . . . 0 0 . 1 . 012 nuclear build core ' D' D ' 3' ' ' GLU . . . . . . . . . . . . . 85.0 tt0 -141.12 139.65 34.0 Favored 'General case' 0 C--N 1.326 -0.424 0 CA-C-N 115.873 -0.603 . . . . 0.0 111.147 -177.957 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' D' D ' 4' ' ' LEU . . . . . . . . . . . . . 18.0 tp -123.68 125.61 45.09 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 115.936 -0.575 . . . . 0.0 110.084 176.956 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' D' D ' 5' ' ' LYS . . . . . . . . . . . . . 67.1 mttm -104.22 119.91 40.0 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.218 -0.446 . . . . 0.0 110.401 178.768 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' D' D ' 6' ' ' LEU . . . . . . . . . . . . . 59.1 mt -116.32 147.31 41.69 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 115.393 -0.821 . . . . 0.0 110.324 -178.241 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' D' D ' 7' ' ' LYS . . . . . . . . . . . . . 83.7 tttt -134.67 136.23 25.03 Favored Pre-proline 0 CA--C 1.535 0.372 0 CA-C-O 118.931 -0.557 . . . . 0.0 109.844 176.254 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' D' D ' 8' ' ' PRO . . . . . . . . . . . . . 90.2 Cg_endo -91.6 140.59 2.52 Favored 'Trans proline' 0 N--CA 1.488 1.195 0 C-N-CA 121.751 1.634 . . . . 0.0 111.506 177.323 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' D' D ' 9' ' ' LEU . . . . . . . . . . . . . 62.3 mt -75.55 -47.9 4.07 Favored Pre-proline 0 CA--C 1.534 0.355 0 CA-C-O 118.586 -0.721 . . . . 0.0 112.336 -178.525 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' D' D ' 10' ' ' PRO . . . . . . . . . . . . . 88.1 Cg_endo -80.01 154.92 22.81 Favored 'Trans proline' 0 N--CA 1.497 1.689 0 C-N-CA 121.224 1.282 . . . . 0.0 112.187 177.166 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' D' D ' 11' ' ' LYS . . . . . . . . . . . . . 55.0 tptt -85.97 100.0 11.83 Favored 'General case' 0 C--N 1.328 -0.329 0 N-CA-C 109.914 -0.402 . . . . 0.0 109.914 176.767 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' D' D ' 12' ' ' VAL . . . . . . . . . . . . . 12.2 p -141.17 146.14 24.04 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.346 0 CA-C-O 120.956 0.408 . . . . 0.0 110.819 -178.386 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' D' D ' 13' ' ' GLU . . . . . . . . . . . . . 95.6 mt-10 -93.57 114.86 27.31 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 115.99 -0.55 . . . . 0.0 109.76 176.324 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' D' D ' 14' ' ' LEU . . . . . . . . . . . . . 38.8 mt -87.75 151.96 50.8 Favored Pre-proline 0 C--N 1.329 -0.304 0 CA-C-N 116.442 -0.344 . . . . 0.0 110.718 -177.164 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' D' D ' 15' ' ' PRO . . . . . . . . . . . . . 33.7 Cg_exo -57.34 158.66 18.07 Favored 'Trans proline' 0 N--CA 1.496 1.62 0 C-N-CA 121.26 1.306 . . . . 0.0 111.809 179.511 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' D' D ' 16' ' ' PRO . . . . . . . . . . . . . 30.7 Cg_exo -59.31 -36.64 94.15 Favored 'Trans proline' 0 N--CA 1.497 1.701 0 C-N-CA 121.432 1.421 . . . . 0.0 112.845 -177.776 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' D' D ' 17' ' ' ASP . . . . . . . . . . . . . 22.0 p-10 -89.96 11.29 20.94 Favored 'General case' 0 CA--C 1.537 0.46 0 N-CA-C 113.139 0.792 . . . . 0.0 113.139 -177.939 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' D' D ' 18' ' ' PHE . . . . . . . . . . . . . 47.7 t80 -58.0 -42.97 86.34 Favored 'General case' 0 N--CA 1.457 -0.108 0 O-C-N 121.983 -0.448 . . . . 0.0 110.16 -178.451 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' D' D ' 19' ' ' VAL . . . . . . . . . . . . . 48.1 t -57.51 -42.48 81.06 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.326 0 CA-C-N 116.244 -0.435 . . . . 0.0 110.376 -179.067 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' D' D ' 20' ' ' ASP . . . . . . . . . . . . . 11.7 t70 -59.62 -42.8 93.48 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-O 120.756 0.313 . . . . 0.0 110.857 -177.802 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' D' D ' 21' ' ' VAL . . . . . . . . . . . . . 46.5 t -64.42 -47.6 88.74 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.303 0 C-N-CA 120.74 -0.384 . . . . 0.0 110.507 -177.999 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' D' D ' 22' ' ' ILE . . . . . 0.72 HG22 HD12 ' D' ' 26' ' ' LEU . 49.9 mm -58.53 -38.46 70.72 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.283 0 C-N-CA 120.904 -0.319 . . . . 0.0 110.734 -179.644 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' D' D ' 23' ' ' ARG . . . . . . . . . . . . . 55.1 ttp180 -56.62 -49.23 75.56 Favored 'General case' 0 C--N 1.331 -0.22 0 CA-C-O 120.837 0.351 . . . . 0.0 110.533 178.066 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' D' D ' 24' ' ' ILE . . . . . . . . . . . . . 74.5 mt -61.26 -43.45 96.53 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.272 0 CA-C-N 116.04 -0.527 . . . . 0.0 111.968 -177.883 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' D' D ' 25' ' ' LYS . . . . . . . . . . . . . 15.1 pttp -71.65 -36.59 70.75 Favored 'General case' 0 CA--C 1.533 0.315 0 C-N-CA 120.364 -0.534 . . . . 0.0 111.702 -173.621 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' D' D ' 26' ' ' LEU . . . . . 0.72 HD12 HG22 ' D' ' 22' ' ' ILE . 18.9 mt -78.16 -43.38 28.86 Favored 'General case' 0 C--N 1.332 -0.177 0 N-CA-C 112.735 0.643 . . . . 0.0 112.735 -173.558 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' D' D ' 27' ' ' GLN . . . . . . . . . . . . . 15.5 pt20 -47.58 137.86 8.62 Favored 'General case' 0 N--CA 1.468 0.472 0 N-CA-C 112.647 0.61 . . . . 0.0 112.647 -175.946 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' D' D ' 28' ' ' GLY . . . . . . . . . . . . . . . 100.17 -27.38 20.6 Favored Glycine 0 CA--C 1.534 1.231 0 CA-C-N 115.631 -0.713 . . . . 0.0 112.013 -176.35 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' D' D ' 29' ' ' LYS . . . . . . . . . . . . . 56.1 mttm -98.52 155.16 17.41 Favored 'General case' 0 C--O 1.233 0.215 0 CA-C-N 117.144 0.472 . . . . 0.0 110.979 179.267 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' D' D ' 30' ' ' THR . . . . . . . . . . . . . 39.5 m -106.38 139.46 40.83 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 116.13 -0.486 . . . . 0.0 110.03 175.668 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' D' D ' 31' ' ' VAL . . . . . . . . . . . . . 34.5 m -128.66 158.67 40.97 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.289 0 CA-C-N 116.305 -0.407 . . . . 0.0 110.847 -178.304 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' D' D ' 32' ' ' ARG . . . . . . . . . . . . . 59.7 mtm180 -135.5 149.48 49.52 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.048 -0.523 . . . . 0.0 110.587 178.415 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' D' D ' 33' ' ' THR . . . . . . . . . . . . . 25.6 m -53.67 139.88 30.94 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.346 -0.388 . . . . 0.0 111.323 -178.186 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' D' D ' 34' ' ' GLY . . . . . . . . . . . . . . . 100.47 -17.13 57.18 Favored Glycine 0 CA--C 1.533 1.185 0 CA-C-O 119.702 -0.499 . . . . 0.0 113.304 178.672 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' D' D ' 35' ' ' ASP . . . . . . . . . . . . . 79.9 m-20 -66.2 147.88 52.66 Favored 'General case' 0 C--O 1.232 0.143 0 CA-C-N 118.053 0.926 . . . . 0.0 111.14 178.931 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' D' D ' 36' ' ' VAL . . . . . . . . . . . . . 45.1 t -123.42 131.13 73.68 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.224 0 CA-C-N 116.007 -0.542 . . . . 0.0 109.908 178.111 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' D' D ' 37' ' ' ILE . . . . . . . . . . . . . 66.4 mt -122.36 139.69 48.52 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.268 0 CA-C-N 116.28 -0.418 . . . . 0.0 110.042 -178.454 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' D' D ' 38' ' ' GLY . . . . . . . . . . . . . . . -111.81 128.77 8.76 Favored Glycine 0 CA--C 1.526 0.759 0 N-CA-C 111.08 -0.808 . . . . 0.0 111.08 179.472 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' D' D ' 39' ' ' ILE . . . . . . . . . . . . . 71.2 mt -122.54 134.18 66.5 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.187 0 N-CA-C 110.077 -0.342 . . . . 0.0 110.077 179.071 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' D' D ' 40' ' ' SER . . . . . . . . . . . . . 35.0 t -93.58 124.32 37.49 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.412 -0.358 . . . . 0.0 111.009 176.6 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' D' D ' 41' ' ' ILE . . . . . . . . . . . . . 71.3 mt -129.22 118.41 46.13 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.171 0 CA-C-O 120.826 0.346 . . . . 0.0 110.371 177.954 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' D' D ' 42' ' ' LEU . . . . . . . . . . . . . 56.2 mt 51.94 35.96 17.2 Favored 'General case' 0 C--O 1.233 0.201 0 CA-C-N 116.182 -0.463 . . . . 0.0 111.882 176.107 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' D' D ' 43' ' ' GLY . . . . . . . . . . . . . . . 73.98 31.65 59.65 Favored Glycine 0 CA--C 1.53 0.988 0 C-N-CA 121.115 -0.564 . . . . 0.0 112.123 178.162 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' D' D ' 44' ' ' LYS . . . . . . . . . . . . . 53.4 tttm -137.21 128.28 27.66 Favored 'General case' 0 C--N 1.329 -0.316 0 N-CA-C 109.536 -0.542 . . . . 0.0 109.536 177.94 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' D' D ' 45' ' ' GLU . . . . . . . . . . . . . 84.4 tt0 -83.83 123.14 29.6 Favored 'General case' 0 C--N 1.329 -0.318 0 C-N-CA 120.748 -0.381 . . . . 0.0 111.244 -177.766 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' D' D ' 46' ' ' VAL . . . . . . . . . . . . . 7.5 p -121.06 127.2 75.88 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.226 0 N-CA-C 109.342 -0.614 . . . . 0.0 109.342 175.497 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' D' D ' 47' ' ' LYS . . . . . . . . . . . . . 97.9 mttt -100.83 130.28 46.82 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.121 -0.491 . . . . 0.0 111.486 179.702 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' D' D ' 48' ' ' PHE . . . . . . . . . . . . . 93.6 m-85 -114.13 131.84 56.28 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.11 -0.495 . . . . 0.0 109.72 176.1 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' D' D ' 49' ' ' LYS . . . . . . . . . . . . . 71.5 tttt -108.66 138.66 44.62 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.628 -0.26 . . . . 0.0 110.494 179.148 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' D' D ' 50' ' ' VAL . . . . . . . . . . . . . 45.4 t -81.55 109.87 16.27 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.259 0 N-CA-C 109.443 -0.577 . . . . 0.0 109.443 177.047 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' D' D ' 51' ' ' VAL . . . . . . . . . . . . . 47.6 t -73.92 -47.63 42.11 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.304 0 CA-C-N 116.131 -0.486 . . . . 0.0 110.11 -174.322 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' D' D ' 52' ' ' GLN . . . . . . . . . . . . . 49.5 tt0 -162.65 139.09 7.54 Favored 'General case' 0 C--N 1.331 -0.219 0 C-N-CA 120.21 -0.596 . . . . 0.0 111.731 -178.126 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' D' D ' 53' ' ' ALA . . . . . . . . . . . . . . . -110.09 130.77 55.48 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 115.573 -0.739 . . . . 0.0 109.49 173.764 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' D' D ' 54' ' ' TYR . . . . . . . . . . . . . 24.9 t80 -126.76 108.09 22.67 Favored Pre-proline 0 CA--C 1.534 0.353 0 CA-C-O 118.379 -0.819 . . . . 0.0 110.553 -177.669 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' D' D ' 55' ' ' PRO . . . . . . . . . . . . . 73.3 Cg_endo -77.17 170.02 72.66 Favored 'Cis proline' 0 N--CA 1.5 1.896 0 CA-C-N 121.747 1.66 . . . . 0.0 112.139 -6.248 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' D' D ' 56' ' ' SER . . . . . . . . . . . . . 20.3 m -110.56 128.35 25.49 Favored Pre-proline 0 CA--C 1.538 0.511 0 CA-C-O 118.435 -0.793 . . . . 0.0 109.674 176.441 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' D' D ' 57' ' ' PRO . . . . . . . . . . . . . 46.6 Cg_endo -70.21 165.44 77.92 Favored 'Cis proline' 0 N--CA 1.496 1.676 0 CA-C-N 121.932 1.726 . . . . 0.0 111.677 -0.455 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' D' D ' 58' ' ' LEU . . . . . . . . . . . . . 25.0 tp -129.92 135.99 48.97 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.441 -0.345 . . . . 0.0 110.538 -179.234 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' D' D ' 59' ' ' ARG . . . . . . . . . . . . . 76.3 ttt180 -105.31 134.37 48.53 Favored 'General case' 0 C--N 1.327 -0.388 0 N-CA-C 109.419 -0.586 . . . . 0.0 109.419 175.725 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' D' D ' 60' ' ' VAL . . . . . . . . . . . . . 43.9 t -88.58 123.07 40.75 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.275 0 C-N-CA 120.644 -0.423 . . . . 0.0 110.359 -177.062 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' D' D ' 61' ' ' GLU . . . . . . . . . . . . . 94.7 mt-10 -131.09 173.42 11.03 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.077 -0.51 . . . . 0.0 109.962 177.242 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' D' D ' 62' ' ' ASP . . . . . . . . . . . . . 75.9 m-20 -54.39 -32.81 57.95 Favored 'General case' 0 C--N 1.327 -0.376 0 C-N-CA 120.964 -0.294 . . . . 0.0 111.635 179.786 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' D' D ' 63' ' ' ARG . . . . . . . . . . . . . 26.4 ptt180 -87.41 5.25 39.74 Favored 'General case' 0 CA--C 1.537 0.476 0 N-CA-C 113.652 0.982 . . . . 0.0 113.652 -176.32 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' D' D ' 64' ' ' THR . . . . . . . . . . . . . 28.5 m -82.3 133.74 35.25 Favored 'General case' 0 C--N 1.331 -0.211 0 CA-C-N 118.027 0.376 . . . . 0.0 110.602 -178.724 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' D' D ' 65' ' ' LYS . . . . . . . . . . . . . 87.1 mttt -89.71 124.62 34.77 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 116.106 -0.497 . . . . 0.0 110.02 178.75 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' D' D ' 66' ' ' ILE . . . . . . . . . . . . . 58.8 mt -113.6 129.4 69.49 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.305 0 N-CA-C 109.68 -0.489 . . . . 0.0 109.68 179.329 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' D' D ' 67' ' ' THR . . . . . . . . . . . . . 24.4 m -127.82 138.55 52.75 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-O 121.063 0.458 . . . . 0.0 111.124 -177.672 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' D' D ' 68' ' ' LEU . . . . . 0.509 ' N ' HD12 ' D' ' 68' ' ' LEU . 7.0 mp . . . . . 0 C--N 1.331 -0.206 0 CA-C-N 115.927 -0.579 . . . . 0.0 109.908 176.217 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' D' D ' 73' ' ' VAL . . . . . . . . . . . . . 26.9 m . . . . . 0 C--O 1.23 0.071 0 N-CA-C 109.815 -0.439 . . . . 0.0 109.815 . . . . . . . . . 0 0 . 1 . 012 nuclear build core ' D' D ' 74' ' ' ASP . . . . . . . . . . . . . 30.3 t0 -104.21 117.22 33.7 Favored 'General case' 0 C--N 1.33 -0.274 0 N-CA-C 109.884 -0.413 . . . . 0.0 109.884 179.466 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' D' D ' 75' ' ' VAL . . . . . . . . . . . . . 46.7 t -119.63 126.15 75.04 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.281 0 CA-C-O 121.066 0.46 . . . . 0.0 110.817 -176.91 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' D' D ' 76' ' ' LEU . . . . . . . . . . . . . 5.5 mp -125.23 143.97 50.69 Favored 'General case' 0 C--N 1.332 -0.178 0 CA-C-N 115.71 -0.677 . . . . 0.0 109.787 175.388 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' D' D ' 77' ' ' GLU . . . . . . . . . . . . . 97.1 mt-10 -133.63 136.42 44.8 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-O 120.986 0.422 . . . . 0.0 111.074 -178.31 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' D' D ' 78' ' ' ALA . . . . . . . . . . . . . . . -124.31 132.85 53.58 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 115.883 -0.598 . . . . 0.0 109.919 176.953 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' D' D ' 79' ' ' LYS . . . . . 0.578 ' O ' HD13 ' D' ' 80' ' ' ILE . 59.5 mtpt -79.26 117.09 19.94 Favored 'General case' 0 C--N 1.331 -0.225 0 CA-C-N 116.312 -0.404 . . . . 0.0 110.644 -178.027 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' D' D ' 80' ' ' ILE . . . . . 0.578 HD13 ' O ' ' D' ' 79' ' ' LYS . 43.3 mm -139.16 112.16 6.2 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.322 0 N-CA-C 109.079 -0.711 . . . . 0.0 109.079 -177.426 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' D' D ' 81' ' ' LYS . . . . . . . . . . . . . 55.4 pttt -104.6 129.44 52.71 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-O 120.995 0.426 . . . . 0.0 111.65 -175.909 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' D' D ' 82' ' ' GLY . . . . . . . . . . . . . . . 89.12 42.11 5.68 Favored Glycine 0 CA--C 1.524 0.653 0 CA-C-N 115.835 -0.621 . . . . 0.0 111.701 174.478 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' D' D ' 83' ' ' ILE . . . . . . . . . . . . . 69.2 mt -73.21 136.87 24.55 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.27 0 N-CA-C 109.526 -0.546 . . . . 0.0 109.526 177.207 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' D' D ' 84' ' ' LYS . . . . . . . . . . . . . 39.7 ttpt -102.25 -48.42 4.2 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-O 120.849 0.357 . . . . 0.0 110.517 -178.348 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' D' D ' 85' ' ' ASP . . . . . . . . . . . . . 12.8 t70 -146.8 145.2 29.83 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.7 -179.33 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' D' D ' 86' ' ' VAL . . . . . . . . . . . . . 43.7 t -126.38 129.56 71.9 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.223 0 CA-C-N 116.325 -0.398 . . . . 0.0 110.204 179.855 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' D' D ' 87' ' ' ILE . . . . . 0.498 HD12 ' N ' ' D' ' 87' ' ' ILE . 5.0 mp -122.27 128.16 75.4 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.227 0 N-CA-C 109.865 -0.42 . . . . 0.0 109.865 177.689 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' D' D ' 88' ' ' LEU . . . . . . . . . . . . . 68.4 mt -112.01 136.18 51.68 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-O 121.011 0.434 . . . . 0.0 111.211 -178.814 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' D' D ' 89' ' ' ASP . . . . . . . . . . . . . 9.1 t70 -130.12 154.28 47.65 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 115.812 -0.631 . . . . 0.0 109.55 175.334 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' D' D ' 90' ' ' GLU . . . . . . . . . . . . . 96.2 mt-10 -48.92 -37.4 19.76 Favored 'General case' 0 C--N 1.329 -0.325 0 N-CA-C 112.773 0.657 . . . . 0.0 112.773 -172.207 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' D' D ' 91' ' ' ASN . . . . . . . . . . . . . 86.5 m-20 -132.03 33.39 3.92 Favored 'General case' 0 N--CA 1.465 0.297 0 N-CA-C 111.914 0.338 . . . . 0.0 111.914 -176.966 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' D' D ' 92' ' ' LEU . . . . . . . . . . . . . 7.4 tp -166.06 142.37 5.04 Favored 'General case' 0 C--N 1.332 -0.17 0 C-N-CA 120.952 -0.299 . . . . 0.0 110.635 -179.344 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' D' D ' 93' ' ' ILE . . . . . . . . . . . . . 73.8 mt -124.05 124.81 69.72 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.261 0 N-CA-C 109.479 -0.563 . . . . 0.0 109.479 178.605 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' D' D ' 94' ' ' VAL . . . . . . . . . . . . . 43.8 t -123.34 125.89 72.45 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.188 0 CA-C-O 120.972 0.415 . . . . 0.0 109.96 -179.798 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' D' D ' 95' ' ' VAL . . . . . . . . . . . . . 44.6 t -120.78 131.46 72.8 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.261 0 CA-C-N 115.964 -0.562 . . . . 0.0 109.643 179.31 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' D' D ' 96' ' ' ILE . . . . . . . . . . . . . 63.2 mt -115.72 128.04 73.11 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.256 0 N-CA-C 109.446 -0.575 . . . . 0.0 109.446 -179.282 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' D' D ' 97' ' ' THR . . . . . . . . . . . . . 70.7 p -100.9 159.15 15.44 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-O 121.152 0.501 . . . . 0.0 111.111 -177.307 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' D' D ' 98' ' ' GLU . . . . . . . . . . . . . 46.5 tp10 -53.9 -26.53 25.55 Favored 'General case' 0 C--N 1.327 -0.392 0 CA-C-N 116.079 -0.509 . . . . 0.0 112.098 179.751 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' D' D ' 99' ' ' GLU . . . . . . . . . . . . . 19.9 tp10 -79.72 16.76 1.04 Allowed 'General case' 0 CA--C 1.539 0.524 0 N-CA-C 112.777 0.658 . . . . 0.0 112.777 -175.998 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' D' D ' 100' ' ' ASN . . . . . . . . . . . . . 3.7 m-20 60.88 30.87 19.91 Favored 'General case' 0 CA--C 1.532 0.285 0 O-C-N 121.958 -0.464 . . . . 0.0 111.682 178.424 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' D' D ' 101' ' ' GLU . . . . . . . . . . . . . 84.7 tt0 -112.53 144.21 42.39 Favored 'General case' 0 C--N 1.332 -0.157 0 N-CA-C 109.548 -0.538 . . . . 0.0 109.548 175.045 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' D' D ' 102' ' ' VAL . . . . . . . . . . . . . 44.3 t -118.71 130.12 73.99 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.252 0 CA-C-O 120.954 0.407 . . . . 0.0 110.16 -176.587 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' D' D ' 103' ' ' LEU . . . . . . . . . . . . . 21.2 mt -113.01 129.65 56.42 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 115.435 -0.802 . . . . 0.0 109.989 176.359 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' D' D ' 104' ' ' ILE . . . . . . . . . . . . . 66.3 mt -115.46 120.14 63.85 Favored 'Isoleucine or valine' 0 C--O 1.234 0.248 0 N-CA-C 110.169 -0.308 . . . . 0.0 110.169 -179.604 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' D' D ' 105' ' ' PHE . . . . . . . . . . . . . 73.5 m-85 -123.83 167.08 14.55 Favored 'General case' 0 C--N 1.333 -0.117 0 O-C-N 123.876 0.735 . . . . 0.0 109.976 -179.736 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' D' D ' 106' ' ' ASN . . . . . . . . . . . . . 48.8 p-10 -102.97 -170.81 1.85 Allowed 'General case' 0 C--N 1.33 -0.256 0 N-CA-C 109.903 -0.406 . . . . 0.0 109.903 172.762 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' D' D ' 107' ' ' GLN . . . . . . . . . . . . . 42.9 tt0 -61.23 -29.25 69.72 Favored 'General case' 0 N--CA 1.464 0.249 0 N-CA-C 111.902 0.334 . . . . 0.0 111.902 -179.893 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' D' D ' 108' ' ' ASN . . . . . . . . . . . . . 4.2 t-20 -81.9 11.7 4.77 Favored 'General case' 0 CA--C 1.538 0.511 0 N-CA-C 112.771 0.656 . . . . 0.0 112.771 -179.498 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' D' D ' 109' ' ' LEU . . . . . . . . . . . . . 10.9 tp 54.58 36.72 26.56 Favored 'General case' 0 C--O 1.233 0.202 0 CA-C-O 120.982 0.42 . . . . 0.0 111.4 178.554 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' D' D ' 110' ' ' GLU . . . . . . . . . . . . . 95.3 mt-10 -103.02 143.22 32.86 Favored 'General case' 0 C--N 1.328 -0.328 0 N-CA-C 109.369 -0.604 . . . . 0.0 109.369 175.091 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' D' D ' 111' ' ' GLU . . . . . . . . . . . . . 73.7 tt0 -82.67 121.87 27.41 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-O 121.017 0.437 . . . . 0.0 110.296 -176.479 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' D' D ' 112' ' ' LEU . . . . . . . . . . . . . 45.9 mt -107.0 -45.96 4.03 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-N 115.86 -0.609 . . . . 0.0 110.65 -179.137 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' D' D ' 113' ' ' TYR . . . . . . . . . . . . . 55.3 t80 -135.23 138.53 43.65 Favored 'General case' 0 C--N 1.332 -0.188 0 CA-C-O 120.845 0.355 . . . . 0.0 111.278 -178.567 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' D' D ' 114' ' ' ARG . . . . . . . . . . . . . 70.1 ttt180 -136.13 123.81 22.41 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 115.914 -0.584 . . . . 0.0 110.077 177.67 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' D' D ' 115' ' ' GLY . . . . . . . . . . . . . . . -149.96 157.46 27.23 Favored Glycine 0 CA--C 1.523 0.591 0 N-CA-C 111.136 -0.786 . . . . 0.0 111.136 -179.91 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' D' D ' 116' ' ' LYS . . . . . . . . . . . . . 67.3 tttt -131.77 129.79 41.02 Favored 'General case' 0 C--N 1.328 -0.352 0 N-CA-C 109.734 -0.469 . . . . 0.0 109.734 178.846 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' D' D ' 117' ' ' PHE . . . . . . . . . . . . . 49.0 m-85 -125.17 114.23 18.72 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.289 -0.414 . . . . 0.0 110.184 -174.837 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' D' D ' 118' ' ' GLU . . . . . . . . . . . . . 48.7 mp0 -56.9 -46.14 82.12 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.344 -0.389 . . . . 0.0 110.851 -175.297 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' D' D ' 119' ' ' ASN . . . . . . . . . . . . . 23.9 m120 -97.36 31.1 2.6 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.099 -0.5 . . . . 0.0 112.109 -174.678 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' D' D ' 120' ' ' LEU . . . . . 0.473 ' C ' HD23 ' D' ' 120' ' ' LEU . 7.2 tt -54.91 120.1 6.37 Favored 'General case' 0 N--CA 1.462 0.148 0 CA-C-O 120.817 0.341 . . . . 0.0 110.598 178.337 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' D' D ' 121' ' ' ASN . . . . . . . . . . . . . 43.3 m-20 -105.11 -44.03 4.88 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 116.303 -0.408 . . . . 0.0 110.874 -176.731 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' D' D ' 122' ' ' LYS . . . . . . . . . . . . . 55.8 pttt -162.41 153.89 18.14 Favored 'General case' 0 C--N 1.331 -0.204 0 C-N-CA 120.427 -0.509 . . . . 0.0 112.028 -179.118 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' D' D ' 123' ' ' VAL . . . . . . . . . . . . . 42.0 t -125.81 136.49 60.67 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.248 0 CA-C-N 115.806 -0.633 . . . . 0.0 109.948 179.663 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' D' D ' 124' ' ' LEU . . . . . . . . . . . . . 48.4 mt -125.72 131.13 52.61 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.278 -0.419 . . . . 0.0 110.133 178.782 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' D' D ' 125' ' ' VAL . . . . . . . . . . . . . 13.5 p -134.88 134.06 53.7 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.259 0 CA-C-O 121.113 0.482 . . . . 0.0 110.809 179.616 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' D' D ' 126' ' ' ARG . . . . . . . . . . . . . 79.0 mtp180 -147.6 122.69 10.13 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 115.513 -0.767 . . . . 0.0 109.301 177.969 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' D' D ' 127' ' ' ASN . . . . . . . . . . . . . 1.5 t-20 57.03 -148.65 0.49 Allowed 'General case' 0 CA--C 1.542 0.643 0 N-CA-C 109.579 -0.526 . . . . 0.0 109.579 -178.371 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' D' D ' 128' ' ' ASP . . . . . . . . . . . . . 19.7 p-10 -81.44 12.99 3.23 Favored 'General case' 0 CA--C 1.538 0.488 0 N-CA-C 113.044 0.757 . . . . 0.0 113.044 178.507 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' D' D ' 129' ' ' LEU . . . . . . . . . . . . . 32.9 mt -107.41 133.0 52.57 Favored 'General case' 0 C--O 1.231 0.128 0 N-CA-C 109.542 -0.54 . . . . 0.0 109.542 178.545 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' D' D ' 130' ' ' VAL . . . . . 0.531 HG13 ' HB ' ' D' ' 141' ' ' ILE . 14.7 p -138.32 139.69 41.31 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.204 0 CA-C-O 121.273 0.559 . . . . 0.0 111.314 -179.758 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' D' D ' 131' ' ' VAL . . . . . . . . . . . . . 46.4 t -136.08 140.16 44.43 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.237 0 CA-C-N 115.784 -0.644 . . . . 0.0 110.271 179.446 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' D' D ' 132' ' ' ILE . . . . . . . . . . . . . 72.4 mt -116.78 133.99 61.73 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.263 0 CA-C-N 115.966 -0.561 . . . . 0.0 109.754 -179.717 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' D' D ' 133' ' ' ILE . . . . . . . . . . . . . 42.8 mm -114.25 123.64 70.11 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.222 0 CA-C-N 116.603 -0.271 . . . . 0.0 110.926 -176.434 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' D' D ' 134' ' ' ASP . . . . . . . . . . . . . 7.0 p-10 -135.21 147.95 49.49 Favored 'General case' 0 C--N 1.332 -0.16 0 N-CA-C 109.637 -0.505 . . . . 0.0 109.637 174.459 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' D' D ' 135' ' ' GLU . . . . . . . . . . . . . 84.9 tt0 -50.06 -28.2 6.74 Favored 'General case' 0 C--N 1.328 -0.355 0 N-CA-C 112.923 0.712 . . . . 0.0 112.923 -171.287 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' D' D ' 136' ' ' GLN . . . . . . . . . . . . . 97.2 mt-30 -83.26 -35.11 25.59 Favored 'General case' 0 C--O 1.234 0.253 0 N-CA-C 112.538 0.569 . . . . 0.0 112.538 -175.829 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' D' D ' 137' ' ' LYS . . . . . . . . . . . . . 24.8 pttm -163.36 172.07 15.14 Favored 'General case' 0 C--N 1.331 -0.217 0 CA-C-O 121.525 0.678 . . . . 0.0 112.413 -171.455 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' D' D ' 138' ' ' LEU . . . . . 0.407 ' C ' HD23 ' D' ' 138' ' ' LEU . 5.9 tt -117.36 127.6 54.21 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 114.938 -1.028 . . . . 0.0 109.748 178.512 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' D' D ' 139' ' ' THR . . . . . . . . . . . . . 36.9 m -107.64 125.76 51.74 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.207 -0.451 . . . . 0.0 110.187 -179.414 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' D' D ' 140' ' ' LEU . . . . . 0.541 HD21 ' NE ' ' D' ' 142' ' ' ARG . 6.1 tt -113.06 119.34 37.52 Favored 'General case' 0 C--N 1.327 -0.392 0 CA-C-N 115.824 -0.626 . . . . 0.0 109.651 -176.951 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' D' D ' 141' ' ' ILE . . . . . 0.531 ' HB ' HG13 ' D' ' 130' ' ' VAL . 22.2 mt -123.05 125.48 72.21 Favored 'Isoleucine or valine' 0 C--O 1.234 0.244 0 CA-C-O 121.033 0.444 . . . . 0.0 110.396 -175.03 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' D' D ' 142' ' ' ARG . . . . . 0.541 ' NE ' HD21 ' D' ' 140' ' ' LEU . 61.4 mmt-85 -121.96 129.33 52.41 Favored 'General case' 0 C--N 1.331 -0.203 0 CA-C-N 115.548 -0.751 . . . . 0.0 110.466 -178.62 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' D' D ' 143' ' ' THR . . . . . . . . . . . . . 41.1 p . . . . . 0 C--O 1.219 -0.55 0 CA-C-O 118.046 -0.978 . . . . 0.0 110.6 -179.874 . . . . . . . . 0 0 . 1 . 012 nuclear build core ' E' E ' 2' ' ' SER . . . . . . . . . . . . . 2.4 p . . . . . 0 C--O 1.231 0.082 0 CA-C-O 120.958 0.409 . . . . 0.0 110.395 . . . . . . . . . 0 0 . 1 . 012 nuclear build core ' E' E ' 3' ' ' GLU . . . . . . . . . . . . . 84.8 tt0 -142.6 142.84 32.2 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.083 -0.508 . . . . 0.0 111.045 179.238 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' E' E ' 4' ' ' LEU . . . . . . . . . . . . . 21.4 tp -122.01 128.19 51.14 Favored 'General case' 0 C--N 1.331 -0.21 0 CA-C-N 115.875 -0.602 . . . . 0.0 110.183 177.918 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' E' E ' 5' ' ' LYS . . . . . . . . . . . . . 89.2 mttt -105.43 121.11 43.24 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.3 -0.409 . . . . 0.0 110.485 178.298 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' E' E ' 6' ' ' LEU . . . . . . . . . . . . . 29.6 mt -116.79 150.29 38.56 Favored 'General case' 0 C--N 1.332 -0.187 0 CA-C-N 115.289 -0.869 . . . . 0.0 110.735 -178.097 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' E' E ' 7' ' ' LYS . . . . . . . . . . . . . 23.7 ttmt -138.35 135.32 18.16 Favored Pre-proline 0 CA--C 1.535 0.392 0 CA-C-O 118.846 -0.597 . . . . 0.0 109.933 174.984 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' E' E ' 8' ' ' PRO . . . . . . . . . . . . . 93.1 Cg_endo -90.72 143.11 3.45 Favored 'Trans proline' 0 N--CA 1.492 1.43 0 C-N-CA 121.602 1.535 . . . . 0.0 111.837 178.394 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' E' E ' 9' ' ' LEU . . . . . . . . . . . . . 35.3 mt -78.14 -47.67 2.09 Favored Pre-proline 0 CA--C 1.533 0.307 0 CA-C-O 118.759 -0.638 . . . . 0.0 112.099 -179.179 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' E' E ' 10' ' ' PRO . . . . . . . . . . . . . 76.8 Cg_endo -82.31 145.38 13.48 Favored 'Trans proline' 0 N--CA 1.495 1.593 0 C-N-CA 121.235 1.29 . . . . 0.0 111.681 175.689 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' E' E ' 11' ' ' LYS . . . . . . . . . . . . . 53.3 pttt -85.27 114.72 22.57 Favored 'General case' 0 C--N 1.331 -0.214 0 CA-C-O 121.453 0.644 . . . . 0.0 110.326 177.426 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' E' E ' 12' ' ' VAL . . . . . . . . . . . . . 12.1 p -151.11 150.93 12.92 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.299 0 CA-C-N 115.732 -0.667 . . . . 0.0 110.83 -177.538 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' E' E ' 13' ' ' GLU . . . . . . . . . . . . . 14.6 mm-40 -86.93 122.38 30.72 Favored 'General case' 0 C--N 1.331 -0.239 0 N-CA-C 110.019 -0.363 . . . . 0.0 110.019 175.901 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' E' E ' 14' ' ' LEU . . . . . . . . . . . . . 46.3 mt -98.7 149.54 35.84 Favored Pre-proline 0 CA--C 1.533 0.308 0 CA-C-O 119.318 -0.372 . . . . 0.0 110.632 -178.533 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' E' E ' 15' ' ' PRO . . . . . . . . . . . . . 24.6 Cg_exo -62.94 161.7 28.46 Favored 'Trans proline' 0 N--CA 1.499 1.818 0 C-N-CA 121.297 1.331 . . . . 0.0 111.876 176.81 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' E' E ' 16' ' ' PRO . . . . . . . . . . . . . 25.8 Cg_exo -61.28 -37.46 73.09 Favored 'Trans proline' 0 N--CA 1.499 1.807 0 C-N-CA 121.546 1.498 . . . . 0.0 112.967 -177.719 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' E' E ' 17' ' ' ASP . . . . . . . . . . . . . 13.0 p-10 -89.34 8.2 31.81 Favored 'General case' 0 CA--C 1.536 0.406 0 N-CA-C 113.351 0.871 . . . . 0.0 113.351 -176.786 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' E' E ' 18' ' ' PHE . . . . . . . . . . . . . 42.7 t80 -58.18 -42.78 86.82 Favored 'General case' 0 C--N 1.334 -0.086 0 O-C-N 121.925 -0.485 . . . . 0.0 110.099 -178.267 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' E' E ' 19' ' ' VAL . . . . . . . . . . . . . 54.9 t -57.12 -43.09 80.8 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.352 0 CA-C-N 116.225 -0.443 . . . . 0.0 110.306 -179.678 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' E' E ' 20' ' ' ASP . . . . . . . . . . . . . 75.2 m-20 -59.83 -41.74 91.99 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-O 120.782 0.325 . . . . 0.0 110.928 -177.846 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' E' E ' 21' ' ' VAL . . . . . . . . . . . . . 44.7 t -63.81 -46.36 94.61 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 C-N-CA 120.79 -0.364 . . . . 0.0 110.328 -177.76 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' E' E ' 22' ' ' ILE . . . . . 0.62 HG22 HD12 ' E' ' 26' ' ' LEU . 49.7 mm -55.95 -47.0 80.6 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.275 0 C-N-CA 120.971 -0.292 . . . . 0.0 110.827 178.932 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' E' E ' 23' ' ' ARG . . . . . . . . . . . . . 55.5 ttp180 -54.8 -48.73 72.38 Favored 'General case' 0 C--N 1.33 -0.275 0 C-N-CA 120.982 -0.287 . . . . 0.0 111.461 -178.323 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' E' E ' 24' ' ' ILE . . . . . . . . . . . . . 81.2 mt -59.0 -44.68 91.72 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.332 0 C-N-CA 121.102 -0.239 . . . . 0.0 111.179 -177.035 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' E' E ' 25' ' ' LYS . . . . . . . . . . . . . 57.3 mttm -64.5 -40.07 94.97 Favored 'General case' 0 C--N 1.327 -0.406 0 N-CA-C 112.356 0.502 . . . . 0.0 112.356 -178.48 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' E' E ' 26' ' ' LEU . . . . . 0.62 HD12 HG22 ' E' ' 22' ' ' ILE . 47.2 mt -79.27 -40.65 29.98 Favored 'General case' 0 C--N 1.33 -0.271 0 N-CA-C 113.573 0.953 . . . . 0.0 113.573 -171.367 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' E' E ' 27' ' ' GLN . . . . . . . . . . . . . 14.3 pt20 -46.7 137.04 7.33 Favored 'General case' 0 N--CA 1.47 0.544 0 N-CA-C 112.75 0.648 . . . . 0.0 112.75 -174.591 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' E' E ' 28' ' ' GLY . . . . . . . . . . . . . . . 100.52 -25.86 26.73 Favored Glycine 0 CA--C 1.534 1.222 0 CA-C-N 115.531 -0.759 . . . . 0.0 112.252 -176.082 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' E' E ' 29' ' ' LYS . . . . . . . . . . . . . 62.2 mttp -97.94 155.22 17.19 Favored 'General case' 0 C--N 1.332 -0.175 0 CA-C-N 117.265 0.532 . . . . 0.0 111.148 179.073 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' E' E ' 30' ' ' THR . . . . . . . . . . . . . 34.4 m -105.2 140.79 37.82 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 115.78 -0.645 . . . . 0.0 110.075 176.184 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' E' E ' 31' ' ' VAL . . . . . . . . . . . . . 35.0 m -126.44 151.16 32.67 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.234 0 CA-C-O 121.004 0.43 . . . . 0.0 111.229 -177.791 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' E' E ' 32' ' ' ARG . . . . . . . . . . . . . 67.0 mtp85 -128.12 151.04 49.69 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 115.68 -0.691 . . . . 0.0 110.846 177.362 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' E' E ' 33' ' ' THR . . . . . . . . . . . . . 15.2 m -54.29 139.34 36.67 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 115.987 -0.552 . . . . 0.0 111.186 -178.817 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' E' E ' 34' ' ' GLY . . . . . . . . . . . . . . . 98.77 -17.16 58.68 Favored Glycine 0 CA--C 1.533 1.162 0 C-N-CA 121.019 -0.61 . . . . 0.0 113.306 178.27 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' E' E ' 35' ' ' ASP . . . . . . . . . . . . . 73.3 m-20 -63.88 149.86 46.16 Favored 'General case' 0 C--O 1.231 0.09 0 CA-C-N 118.081 0.941 . . . . 0.0 111.016 179.685 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' E' E ' 36' ' ' VAL . . . . . . . . . . . . . 44.6 t -124.08 130.16 73.89 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.217 0 CA-C-N 116.05 -0.523 . . . . 0.0 109.923 178.971 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' E' E ' 37' ' ' ILE . . . . . . . . . . . . . 62.6 mt -122.03 140.41 46.04 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.244 0 CA-C-N 116.378 -0.374 . . . . 0.0 110.069 -179.465 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' E' E ' 38' ' ' GLY . . . . . . . . . . . . . . . -114.06 128.84 8.44 Favored Glycine 0 CA--C 1.524 0.638 0 N-CA-C 111.086 -0.806 . . . . 0.0 111.086 178.766 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' E' E ' 39' ' ' ILE . . . . . . . . . . . . . 71.7 mt -122.59 135.87 61.25 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.217 0 N-CA-C 110.075 -0.343 . . . . 0.0 110.075 178.935 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' E' E ' 40' ' ' SER . . . . . . . . . . . . . 53.0 p -93.4 117.37 29.99 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.519 -0.31 . . . . 0.0 111.202 176.015 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' E' E ' 41' ' ' ILE . . . . . . . . . . . . . 44.4 mm -121.71 121.61 64.83 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.181 0 CA-C-N 116.469 -0.332 . . . . 0.0 110.118 178.176 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' E' E ' 42' ' ' LEU . . . . . . . . . . . . . 83.8 mt 52.53 33.66 13.87 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.43 -0.35 . . . . 0.0 111.853 177.41 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' E' E ' 43' ' ' GLY . . . . . . . . . . . . . . . 73.22 32.09 60.68 Favored Glycine 0 CA--C 1.529 0.915 0 C-N-CA 121.049 -0.596 . . . . 0.0 112.125 178.797 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' E' E ' 44' ' ' LYS . . . . . . . . . . . . . 80.2 tttt -138.72 130.37 27.61 Favored 'General case' 0 C--N 1.33 -0.257 0 N-CA-C 109.482 -0.562 . . . . 0.0 109.482 179.064 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' E' E ' 45' ' ' GLU . . . . . . . . . . . . . 82.0 tt0 -83.1 124.83 30.85 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-O 120.799 0.333 . . . . 0.0 111.248 -176.144 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' E' E ' 46' ' ' VAL . . . . . . . . . . . . . 7.3 p -122.09 128.11 75.48 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.175 0 N-CA-C 109.493 -0.558 . . . . 0.0 109.493 174.909 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' E' E ' 47' ' ' LYS . . . . . . . . . . . . . 94.6 mttt -100.27 129.56 46.29 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.035 -0.53 . . . . 0.0 111.38 179.099 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' E' E ' 48' ' ' PHE . . . . . . . . . . . . . 95.3 m-85 -113.27 132.01 55.7 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.088 -0.505 . . . . 0.0 109.826 175.383 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' E' E ' 49' ' ' LYS . . . . . . . . . . . . . 80.6 tttt -105.51 137.74 42.84 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.41 -0.359 . . . . 0.0 110.21 179.278 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' E' E ' 50' ' ' VAL . . . . . . . . . . . . . 42.1 t -78.06 107.3 9.8 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.332 0 N-CA-C 109.533 -0.543 . . . . 0.0 109.533 177.427 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' E' E ' 51' ' ' VAL . . . . . . . . . . . . . 52.1 t -71.54 -48.76 50.96 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.288 0 CA-C-N 116.082 -0.508 . . . . 0.0 109.882 -174.557 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' E' E ' 52' ' ' GLN . . . . . . . . . . . . . 62.5 tt0 -167.46 138.68 3.05 Favored 'General case' 0 C--N 1.331 -0.211 0 C-N-CA 120.323 -0.551 . . . . 0.0 111.682 -179.271 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' E' E ' 53' ' ' ALA . . . . . 0.52 ' HB1' ' HB2' ' E' ' 58' ' ' LEU . . . -107.19 130.82 54.67 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 115.669 -0.696 . . . . 0.0 109.642 175.098 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' E' E ' 54' ' ' TYR . . . . . . . . . . . . . 30.1 t80 -127.65 106.9 20.76 Favored Pre-proline 0 CA--C 1.534 0.348 0 CA-C-O 118.39 -0.814 . . . . 0.0 110.598 -177.975 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' E' E ' 55' ' ' PRO . . . . . . . . . . . . . 73.1 Cg_endo -77.19 170.07 72.49 Favored 'Cis proline' 0 N--CA 1.5 1.867 0 CA-C-N 121.725 1.652 . . . . 0.0 112.323 -5.726 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' E' E ' 56' ' ' SER . . . . . . . . . . . . . 16.3 m -111.39 129.99 23.52 Favored Pre-proline 0 CA--C 1.538 0.502 0 CA-C-O 118.414 -0.803 . . . . 0.0 109.48 175.272 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' E' E ' 57' ' ' PRO . . . . . . . . . . . . . 56.9 Cg_endo -72.36 147.7 89.56 Favored 'Cis proline' 0 N--CA 1.497 1.702 0 CA-C-N 121.956 1.734 . . . . 0.0 111.792 -0.918 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' E' E ' 58' ' ' LEU . . . . . 0.52 ' HB2' ' HB1' ' E' ' 53' ' ' ALA . 18.1 tp -108.08 136.6 47.49 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.32 -0.4 . . . . 0.0 110.534 -179.203 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' E' E ' 59' ' ' ARG . . . . . . . . . . . . . 32.2 ttm180 -106.1 130.02 54.08 Favored 'General case' 0 C--N 1.328 -0.329 0 N-CA-C 109.565 -0.532 . . . . 0.0 109.565 176.35 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' E' E ' 60' ' ' VAL . . . . . . . . . . . . . 40.4 t -86.71 123.0 39.47 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.219 0 C-N-CA 120.544 -0.463 . . . . 0.0 110.487 -176.904 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' E' E ' 61' ' ' GLU . . . . . . . . . . . . . 95.0 mt-10 -131.01 170.79 14.01 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 115.895 -0.593 . . . . 0.0 109.909 177.727 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' E' E ' 62' ' ' ASP . . . . . . . . . . . . . 60.3 m-20 -55.0 -33.63 62.73 Favored 'General case' 0 C--N 1.328 -0.361 0 N-CA-C 111.827 0.306 . . . . 0.0 111.827 -177.627 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' E' E ' 63' ' ' ARG . . . . . . . . . . . . . 40.0 ptt180 -89.55 5.28 46.25 Favored 'General case' 0 CA--C 1.536 0.438 0 N-CA-C 113.818 1.044 . . . . 0.0 113.818 -175.496 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' E' E ' 64' ' ' THR . . . . . . . . . . . . . 31.4 m -76.27 139.85 41.3 Favored 'General case' 0 C--N 1.332 -0.184 0 CA-C-O 120.851 0.358 . . . . 0.0 110.859 -177.874 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' E' E ' 65' ' ' LYS . . . . . . . . . . . . . 99.6 mttt -88.32 129.4 35.4 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.05 -0.523 . . . . 0.0 110.192 178.601 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' E' E ' 66' ' ' ILE . . . . . . . . . . . . . 57.7 mt -114.04 127.34 71.49 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.312 0 N-CA-C 109.728 -0.471 . . . . 0.0 109.728 -179.705 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' E' E ' 67' ' ' THR . . . . . . . . . . . . . 26.9 m -128.26 139.11 52.61 Favored 'General case' 0 C--N 1.331 -0.221 0 CA-C-O 121.063 0.459 . . . . 0.0 111.001 -177.426 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' E' E ' 68' ' ' LEU . . . . . 0.475 HD12 ' N ' ' E' ' 68' ' ' LEU . 7.7 mp . . . . . 0 C--N 1.328 -0.331 0 CA-C-N 115.922 -0.581 . . . . 0.0 110.28 176.778 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' E' E ' 73' ' ' VAL . . . . . . . . . . . . . 32.8 m . . . . . 0 C--O 1.231 0.121 0 CA-C-O 120.808 0.337 . . . . 0.0 110.421 . . . . . . . . . 0 0 . 1 . 012 nuclear build core ' E' E ' 74' ' ' ASP . . . . . . . . . . . . . 46.8 t0 -92.29 118.82 31.28 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.161 -0.472 . . . . 0.0 109.925 -179.615 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' E' E ' 75' ' ' VAL . . . . . . . . . . . . . 38.9 t -119.35 121.22 65.94 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.208 0 CA-C-O 120.988 0.423 . . . . 0.0 110.373 -179.756 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' E' E ' 76' ' ' LEU . . . . . . . . . . . . . 5.1 mp -122.26 146.41 47.31 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 115.851 -0.613 . . . . 0.0 109.752 176.527 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' E' E ' 77' ' ' GLU . . . . . . . . . . . . . 97.9 mt-10 -135.8 133.39 37.83 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-O 121.021 0.439 . . . . 0.0 111.125 -179.208 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' E' E ' 78' ' ' ALA . . . . . 0.632 ' HB2' HD21 ' E' ' 109' ' ' LEU . . . -121.81 133.28 54.9 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 115.729 -0.669 . . . . 0.0 109.727 176.364 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' E' E ' 79' ' ' LYS . . . . . 0.607 ' O ' HD13 ' E' ' 80' ' ' ILE . 49.1 tptt -80.01 118.04 21.39 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-O 120.899 0.38 . . . . 0.0 110.477 -177.3 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' E' E ' 80' ' ' ILE . . . . . 0.607 HD13 ' O ' ' E' ' 79' ' ' LYS . 41.2 mm -139.17 109.25 4.18 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.288 0 N-CA-C 109.235 -0.654 . . . . 0.0 109.235 -177.369 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' E' E ' 81' ' ' LYS . . . . . . . . . . . . . 57.5 pttt -102.23 127.31 49.24 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-O 120.938 0.399 . . . . 0.0 111.493 -177.283 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' E' E ' 82' ' ' GLY . . . . . . . . . . . . . . . 89.09 42.09 5.7 Favored Glycine 0 CA--C 1.526 0.735 0 C-N-CA 120.637 -0.792 . . . . 0.0 111.78 173.852 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' E' E ' 83' ' ' ILE . . . . . . . . . . . . . 74.0 mt -68.28 138.61 22.19 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.28 0 N-CA-C 109.932 -0.396 . . . . 0.0 109.932 178.203 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' E' E ' 84' ' ' LYS . . . . . . . . . . . . . 23.5 ttmt -95.92 -53.58 3.63 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.09 -0.505 . . . . 0.0 110.306 -179.721 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' E' E ' 85' ' ' ASP . . . . . . . . . . . . . 12.4 t70 -154.49 157.67 38.73 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 115.724 -0.671 . . . . 0.0 110.33 -178.401 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' E' E ' 86' ' ' VAL . . . . . . . . . . . . . 42.0 t -137.02 136.13 47.63 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.307 0 CA-C-O 120.939 0.4 . . . . 0.0 110.67 -178.172 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' E' E ' 87' ' ' ILE . . . . . 0.487 ' N ' HD12 ' E' ' 87' ' ' ILE . 5.1 mp -119.78 127.58 75.88 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 CA-C-N 115.774 -0.648 . . . . 0.0 109.42 176.608 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' E' E ' 88' ' ' LEU . . . . . . . . . . . . . 18.8 tp -115.69 136.41 53.09 Favored 'General case' 0 C--N 1.332 -0.192 0 CA-C-O 121.02 0.438 . . . . 0.0 111.406 -177.0 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' E' E ' 89' ' ' ASP . . . . . . . . . . . . . 42.0 t0 -134.87 160.75 37.26 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 115.777 -0.647 . . . . 0.0 109.729 176.532 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' E' E ' 90' ' ' GLU . . . . . . . . . . . . . 96.3 mt-10 -47.65 -37.6 13.15 Favored 'General case' 0 N--CA 1.463 0.179 0 N-CA-C 113.064 0.764 . . . . 0.0 113.064 -171.82 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' E' E ' 91' ' ' ASN . . . . . . . . . . . . . 5.2 p30 -132.06 23.89 4.56 Favored 'General case' 0 N--CA 1.469 0.483 0 N-CA-C 112.79 0.663 . . . . 0.0 112.79 -176.833 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' E' E ' 92' ' ' LEU . . . . . . . . . . . . . 44.5 mt -148.39 141.2 24.66 Favored 'General case' 0 C--N 1.331 -0.225 0 CA-C-O 120.823 0.344 . . . . 0.0 110.589 -178.556 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' E' E ' 93' ' ' ILE . . . . . . . . . . . . . 72.1 mt -123.7 114.27 40.79 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.362 0 N-CA-C 109.098 -0.705 . . . . 0.0 109.098 176.288 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' E' E ' 94' ' ' VAL . . . . . . . . . . . . . 43.7 t -116.55 127.02 74.28 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.236 0 N-CA-C 109.823 -0.436 . . . . 0.0 109.823 -178.741 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' E' E ' 95' ' ' VAL . . . . . . . . . . . . . 43.9 t -123.21 135.02 64.55 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 CA-C-N 116.217 -0.447 . . . . 0.0 109.934 -179.059 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' E' E ' 96' ' ' ILE . . . . . . . . . . . . . 65.2 mt -115.31 127.4 72.9 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.351 0 N-CA-C 109.391 -0.596 . . . . 0.0 109.391 178.506 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' E' E ' 97' ' ' THR . . . . . . . . . . . . . 66.7 p -101.8 157.29 16.95 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-O 121.05 0.452 . . . . 0.0 111.077 -177.852 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' E' E ' 98' ' ' GLU . . . . . . . . . . . . . 12.8 pt-20 -55.63 -21.7 19.1 Favored 'General case' 0 CA--C 1.533 0.314 0 N-CA-C 112.669 0.618 . . . . 0.0 112.669 -179.42 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' E' E ' 99' ' ' GLU . . . . . . . . . . . . . 48.4 mp0 -78.74 14.29 1.38 Allowed 'General case' 0 CA--C 1.537 0.463 0 N-CA-C 113.04 0.755 . . . . 0.0 113.04 -179.68 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' E' E ' 100' ' ' ASN . . . . . . . . . . . . . 3.0 m-20 62.76 37.88 12.2 Favored 'General case' 0 C--O 1.233 0.201 0 CA-C-O 121.068 0.461 . . . . 0.0 110.949 178.24 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' E' E ' 101' ' ' GLU . . . . . . . . . . . . . 84.9 tt0 -118.99 141.69 48.45 Favored 'General case' 0 C--N 1.332 -0.164 0 CA-C-N 116.014 -0.539 . . . . 0.0 109.895 177.223 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' E' E ' 102' ' ' VAL . . . . . . . . . . . . . 46.5 t -114.93 127.47 72.46 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.293 0 CA-C-N 116.324 -0.398 . . . . 0.0 110.041 -178.68 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' E' E ' 103' ' ' LEU . . . . . . . . . . . . . 25.7 mt -117.08 132.54 56.66 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 115.561 -0.745 . . . . 0.0 110.503 177.82 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' E' E ' 104' ' ' ILE . . . . . 0.434 HD13 HG11 ' E' ' 130' ' ' VAL . 65.9 mt -119.53 122.16 68.17 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.237 0 N-CA-C 110.22 -0.289 . . . . 0.0 110.22 178.782 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' E' E ' 105' ' ' PHE . . . . . . . . . . . . . 47.2 m-85 -122.26 162.3 21.71 Favored 'General case' 0 C--N 1.333 -0.146 0 O-C-N 124.005 0.815 . . . . 0.0 109.981 177.748 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' E' E ' 106' ' ' ASN . . . . . . . . . . . . . 41.4 p-10 -97.03 -169.93 1.95 Allowed 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.606 -0.27 . . . . 0.0 110.499 175.554 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' E' E ' 107' ' ' GLN . . . . . . . . . . . . . 46.4 tt0 -56.15 -30.2 61.83 Favored 'General case' 0 CA--C 1.531 0.247 0 N-CA-C 112.05 0.389 . . . . 0.0 112.05 -179.516 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' E' E ' 108' ' ' ASN . . . . . . . . . . . . . 30.6 t30 -90.79 12.9 17.82 Favored 'General case' 0 CA--C 1.535 0.373 0 N-CA-C 113.41 0.893 . . . . 0.0 113.41 -175.356 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' E' E ' 109' ' ' LEU . . . . . 0.632 HD21 ' HB2' ' E' ' 78' ' ' ALA . 11.3 tp 58.8 38.92 24.61 Favored 'General case' 0 C--N 1.331 -0.212 0 CA-C-O 121.168 0.508 . . . . 0.0 111.103 178.552 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' E' E ' 110' ' ' GLU . . . . . . . . . . . . . 96.0 mt-10 -102.64 151.93 21.78 Favored 'General case' 0 C--N 1.329 -0.292 0 N-CA-C 109.788 -0.449 . . . . 0.0 109.788 175.419 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' E' E ' 111' ' ' GLU . . . . . . . . . . . . . 85.1 tt0 -81.68 121.98 27.05 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-O 120.922 0.391 . . . . 0.0 110.507 -178.872 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' E' E ' 112' ' ' LEU . . . . . . . . . . . . . 17.5 mt -110.04 -45.98 3.53 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 115.962 -0.563 . . . . 0.0 110.518 179.185 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' E' E ' 113' ' ' TYR . . . . . . . . . . . . . 58.7 t80 -140.72 136.87 33.02 Favored 'General case' 0 C--N 1.331 -0.227 0 C-N-CA 120.771 -0.372 . . . . 0.0 111.398 -179.06 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' E' E ' 114' ' ' ARG . . . . . . . . . . . . . 22.0 ttm180 -135.69 124.77 24.36 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 115.958 -0.564 . . . . 0.0 109.721 174.979 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' E' E ' 115' ' ' GLY . . . . . . . . . . . . . . . -149.38 148.79 20.48 Favored Glycine 0 CA--C 1.525 0.701 0 N-CA-C 111.12 -0.792 . . . . 0.0 111.12 178.758 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' E' E ' 116' ' ' LYS . . . . . . . . . . . . . 40.3 ttpt -119.86 136.85 54.33 Favored 'General case' 0 C--N 1.33 -0.266 0 N-CA-C 110.096 -0.335 . . . . 0.0 110.096 179.172 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' E' E ' 117' ' ' PHE . . . . . . . . . . . . . 46.1 m-85 -134.49 116.11 14.72 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-N 116.302 -0.408 . . . . 0.0 110.229 -177.148 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' E' E ' 118' ' ' GLU . . . . . . . . . . . . . 84.8 tt0 -53.64 -45.07 70.07 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 116.597 -0.274 . . . . 0.0 111.515 -177.252 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' E' E ' 119' ' ' ASN . . . . . . . . . . . . . 4.2 m-80 -99.27 31.12 3.2 Favored 'General case' 0 C--N 1.33 -0.263 0 N-CA-C 112.156 0.428 . . . . 0.0 112.156 -175.225 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' E' E ' 120' ' ' LEU . . . . . . . . . . . . . 15.0 tp -55.22 120.69 7.42 Favored 'General case' 0 C--N 1.333 -0.151 0 O-C-N 122.308 -0.245 . . . . 0.0 110.694 178.465 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' E' E ' 121' ' ' ASN . . . . . . . . . . . . . 72.1 m-20 -108.82 -44.05 4.1 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.478 -0.328 . . . . 0.0 111.084 -176.728 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' E' E ' 122' ' ' LYS . . . . . . . . . . . . . 57.2 pttt -162.4 160.21 26.14 Favored 'General case' 0 CA--C 1.529 0.143 0 C-N-CA 120.43 -0.508 . . . . 0.0 112.064 -178.59 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' E' E ' 123' ' ' VAL . . . . . . . . . . . . . 42.1 t -129.08 137.87 55.99 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.201 0 CA-C-N 115.947 -0.57 . . . . 0.0 109.86 179.011 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' E' E ' 124' ' ' LEU . . . . . . . . . . . . . 80.9 mt -124.94 140.35 53.0 Favored 'General case' 0 C--N 1.332 -0.189 0 CA-C-O 120.87 0.367 . . . . 0.0 110.794 -179.007 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' E' E ' 125' ' ' VAL . . . . . . . . . . . . . 46.5 t -127.55 133.95 66.66 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.234 0 CA-C-N 116.105 -0.498 . . . . 0.0 109.822 178.118 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' E' E ' 126' ' ' ARG . . . . . . . . . . . . . 49.3 ttt85 -138.57 113.76 9.43 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-O 120.884 0.374 . . . . 0.0 110.28 -179.647 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' E' E ' 127' ' ' ASN . . . . . . . . . . . . . 12.1 m120 53.04 -104.82 0.21 Allowed 'General case' 0 CA--C 1.543 0.68 0 CA-C-O 119.2 -0.429 . . . . 0.0 111.196 179.513 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' E' E ' 128' ' ' ASP . . . . . . . . . . . . . 13.5 p-10 -113.57 0.78 14.76 Favored 'General case' 0 N--CA 1.467 0.422 0 CA-C-N 119.447 1.021 . . . . 0.0 113.549 -176.108 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' E' E ' 129' ' ' LEU . . . . . . . . . . . . . 71.4 mt -108.18 147.36 31.43 Favored 'General case' 0 C--N 1.332 -0.174 0 O-C-N 121.952 -0.467 . . . . 0.0 110.061 179.454 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' E' E ' 130' ' ' VAL . . . . . 0.469 HG13 ' HB ' ' E' ' 141' ' ' ILE . 12.4 p -129.42 140.05 50.15 Favored 'Isoleucine or valine' 0 C--O 1.233 0.22 0 CA-C-O 120.981 0.42 . . . . 0.0 110.595 -178.831 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' E' E ' 131' ' ' VAL . . . . . 0.589 HG22 HD12 ' E' ' 140' ' ' LEU . 40.7 t -135.94 139.28 46.25 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.25 0 CA-C-N 115.953 -0.567 . . . . 0.0 110.425 -178.506 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' E' E ' 132' ' ' ILE . . . . . . . . . . . . . 73.2 mt -114.09 133.51 59.88 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 N-CA-C 109.406 -0.59 . . . . 0.0 109.406 178.838 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' E' E ' 133' ' ' ILE . . . . . . . . . . . . . 43.3 mm -115.34 123.3 70.75 Favored 'Isoleucine or valine' 0 C--O 1.234 0.251 0 CA-C-O 120.936 0.398 . . . . 0.0 111.113 -174.36 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' E' E ' 134' ' ' ASP . . . . . . . . . . . . . 9.5 p-10 -136.18 147.41 47.66 Favored 'General case' 0 C--N 1.331 -0.224 0 N-CA-C 109.337 -0.616 . . . . 0.0 109.337 173.666 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' E' E ' 135' ' ' GLU . . . . . . . . . . . . . 43.3 tp10 -51.33 -28.06 11.28 Favored 'General case' 0 C--N 1.327 -0.408 0 N-CA-C 112.641 0.608 . . . . 0.0 112.641 -172.893 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' E' E ' 136' ' ' GLN . . . . . . . . . . . . . 97.6 mt-30 -80.48 -31.62 37.28 Favored 'General case' 0 C--N 1.33 -0.239 0 N-CA-C 112.629 0.603 . . . . 0.0 112.629 -176.63 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' E' E ' 137' ' ' LYS . . . . . . . . . . . . . 17.6 ptpt -170.08 175.26 5.1 Favored 'General case' 0 C--N 1.331 -0.227 0 CA-C-O 121.526 0.679 . . . . 0.0 112.374 -171.669 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' E' E ' 138' ' ' LEU . . . . . 0.417 ' C ' HD23 ' E' ' 138' ' ' LEU . 7.8 tt -123.16 130.16 52.39 Favored 'General case' 0 C--N 1.331 -0.199 0 CA-C-N 115.145 -0.934 . . . . 0.0 110.23 -179.524 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' E' E ' 139' ' ' THR . . . . . . . . . . . . . 35.1 m -107.26 125.88 51.71 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.245 -0.434 . . . . 0.0 110.442 179.518 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' E' E ' 140' ' ' LEU . . . . . 0.589 HD12 HG22 ' E' ' 131' ' ' VAL . 19.0 tp -113.84 121.37 43.81 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 115.788 -0.642 . . . . 0.0 109.555 -177.594 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' E' E ' 141' ' ' ILE . . . . . 0.469 ' HB ' HG13 ' E' ' 130' ' ' VAL . 19.3 mt -122.01 119.9 59.89 Favored 'Isoleucine or valine' 0 C--O 1.235 0.296 0 CA-C-O 120.974 0.416 . . . . 0.0 110.081 -177.229 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' E' E ' 142' ' ' ARG . . . . . . . . . . . . . 78.0 mtp180 -103.9 123.85 47.88 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 115.264 -0.88 . . . . 0.0 110.382 179.644 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' E' E ' 143' ' ' THR . . . . . . . . . . . . . 37.3 p . . . . . 0 C--O 1.22 -0.456 0 CA-C-O 118.028 -0.987 . . . . 0.0 110.648 -179.989 . . . . . . . . 0 0 . 1 . 012 nuclear build core ' F' F ' 1' ' ' MET . . . . . . . . . . . . . 25.6 ptp . . . . . 0 C--O 1.233 0.203 0 CA-C-O 120.803 0.335 . . . . 0.0 111.006 . . . . . . . . . 0 0 . 1 . 012 nuclear build core ' F' F ' 2' ' ' SER . . . . . . . . . . . . . 11.8 p -111.89 135.46 52.48 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.135 -0.484 . . . . 0.0 110.403 178.676 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' F' F ' 3' ' ' GLU . . . . . . . . . . . . . 95.5 mt-10 -140.81 141.87 34.7 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.117 -0.492 . . . . 0.0 110.982 -177.817 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' F' F ' 4' ' ' LEU . . . . . . . . . . . . . 28.6 tp -128.42 128.62 44.8 Favored 'General case' 0 C--N 1.331 -0.22 0 CA-C-N 115.928 -0.578 . . . . 0.0 110.22 176.869 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' F' F ' 5' ' ' LYS . . . . . . . . . . . . . 99.0 mttt -108.16 121.61 45.21 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-O 120.954 0.407 . . . . 0.0 110.538 178.376 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' F' F ' 6' ' ' LEU . . . . . . . . . . . . . 70.3 mt -116.41 148.49 40.63 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 115.364 -0.835 . . . . 0.0 110.483 -179.122 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' F' F ' 7' ' ' LYS . . . . . . . . . . . . . 78.0 tttt -139.57 139.02 21.11 Favored Pre-proline 0 CA--C 1.533 0.305 0 CA-C-O 119.086 -0.483 . . . . 0.0 109.924 175.894 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' F' F ' 8' ' ' PRO . . . . . . . . . . . . . 93.5 Cg_endo -91.41 145.11 3.3 Favored 'Trans proline' 0 N--CA 1.491 1.34 0 C-N-CA 121.724 1.616 . . . . 0.0 111.944 178.414 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' F' F ' 9' ' ' LEU . . . . . . . . . . . . . 64.4 mt -80.89 -47.67 1.15 Allowed Pre-proline 0 CA--C 1.534 0.331 0 CA-C-O 118.671 -0.68 . . . . 0.0 112.078 179.805 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' F' F ' 10' ' ' PRO . . . . . . . . . . . . . 88.5 Cg_endo -80.81 145.24 15.84 Favored 'Trans proline' 0 N--CA 1.497 1.686 0 C-N-CA 121.104 1.203 . . . . 0.0 111.555 175.995 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' F' F ' 11' ' ' LYS . . . . . . . . . . . . . 39.0 pttt -78.56 111.33 14.51 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-O 121.563 0.697 . . . . 0.0 110.382 177.873 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' F' F ' 12' ' ' VAL . . . . . . . . . . . . . 11.7 p -151.02 144.83 16.76 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.351 0 CA-C-N 115.629 -0.714 . . . . 0.0 110.512 -178.292 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' F' F ' 13' ' ' GLU . . . . . . . . . . . . . 40.1 mt-10 -86.25 124.55 32.75 Favored 'General case' 0 C--N 1.33 -0.26 0 N-CA-C 109.965 -0.383 . . . . 0.0 109.965 177.015 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' F' F ' 14' ' ' LEU . . . . . . . . . . . . . 19.3 mt -96.76 148.05 33.85 Favored Pre-proline 0 C--N 1.33 -0.273 0 CA-C-O 119.184 -0.436 . . . . 0.0 110.072 -179.263 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' F' F ' 15' ' ' PRO . . . . . . . . . . . . . 28.3 Cg_exo -60.54 159.13 28.99 Favored 'Trans proline' 0 N--CA 1.497 1.705 0 C-N-CA 121.28 1.32 . . . . 0.0 111.439 177.318 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' F' F ' 16' ' ' PRO . . . . . . . . . . . . . 38.7 Cg_exo -58.49 -35.95 98.04 Favored 'Trans proline' 0 N--CA 1.496 1.668 0 C-N-CA 121.418 1.412 . . . . 0.0 112.639 -178.617 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' F' F ' 17' ' ' ASP . . . . . . . . . . . . . 7.3 p-10 -91.66 11.55 24.06 Favored 'General case' 0 CA--C 1.535 0.396 0 N-CA-C 113.152 0.797 . . . . 0.0 113.152 -177.637 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' F' F ' 18' ' ' PHE . . . . . . . . . . . . . 52.2 t80 -58.29 -45.47 87.89 Favored 'General case' 0 C--N 1.333 -0.112 0 O-C-N 122.02 -0.425 . . . . 0.0 110.075 -177.67 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' F' F ' 19' ' ' VAL . . . . . 0.411 HG13 ' N ' ' F' ' 20' ' ' ASP . 13.7 p -55.89 -40.99 65.21 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 CA-C-N 116.114 -0.494 . . . . 0.0 110.904 -179.125 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' F' F ' 20' ' ' ASP . . . . . 0.411 ' N ' HG13 ' F' ' 19' ' ' VAL . 80.7 m-20 -61.22 -42.84 99.29 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-O 120.818 0.342 . . . . 0.0 110.975 -178.558 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' F' F ' 21' ' ' VAL . . . . . . . . . . . . . 48.1 t -63.84 -46.07 95.32 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.291 0 C-N-CA 120.759 -0.376 . . . . 0.0 110.318 -178.03 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' F' F ' 22' ' ' ILE . . . . . 0.621 HG22 HD12 ' F' ' 26' ' ' LEU . 49.2 mm -56.58 -46.02 82.47 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.258 0 C-N-CA 120.948 -0.301 . . . . 0.0 110.622 178.917 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' F' F ' 23' ' ' ARG . . . . . . . . . . . . . 25.8 ttp180 -54.33 -49.43 69.75 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-O 120.594 0.235 . . . . 0.0 111.418 -178.843 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' F' F ' 24' ' ' ILE . . . . . . . . . . . . . 77.1 mt -59.71 -44.07 92.87 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.368 0 CA-C-N 116.629 -0.259 . . . . 0.0 111.291 -177.194 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' F' F ' 25' ' ' LYS . . . . . . . . . . . . . 62.8 mttm -66.18 -38.18 87.41 Favored 'General case' 0 C--N 1.327 -0.371 0 N-CA-C 112.28 0.474 . . . . 0.0 112.28 -178.455 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' F' F ' 26' ' ' LEU . . . . . 0.621 HD12 HG22 ' F' ' 22' ' ' ILE . 58.2 mt -79.13 -40.52 30.8 Favored 'General case' 0 C--N 1.33 -0.241 0 N-CA-C 113.349 0.87 . . . . 0.0 113.349 -172.446 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' F' F ' 27' ' ' GLN . . . . . . . . . . . . . 8.3 pt20 -47.1 141.49 4.28 Favored 'General case' 0 N--CA 1.47 0.534 0 N-CA-C 112.726 0.639 . . . . 0.0 112.726 -174.359 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' F' F ' 28' ' ' GLY . . . . . . . . . . . . . . . 96.91 -25.76 25.39 Favored Glycine 0 CA--C 1.534 1.227 0 CA-C-N 115.626 -0.715 . . . . 0.0 112.1 -176.638 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' F' F ' 29' ' ' LYS . . . . . . . . . . . . . 59.1 mtpt -98.33 155.1 17.37 Favored 'General case' 0 C--O 1.233 0.217 0 CA-C-N 117.275 0.538 . . . . 0.0 111.002 179.284 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' F' F ' 30' ' ' THR . . . . . . . . . . . . . 31.4 m -111.45 139.27 47.0 Favored 'General case' 0 C--N 1.331 -0.217 0 CA-C-N 116.093 -0.503 . . . . 0.0 110.217 175.743 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' F' F ' 31' ' ' VAL . . . . . . . . . . . . . 35.2 m -134.37 164.43 34.26 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.225 0 CA-C-O 120.796 0.331 . . . . 0.0 110.981 -179.22 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' F' F ' 32' ' ' ARG . . . . . . . . . . . . . 77.9 mtp180 -131.3 153.97 49.01 Favored 'General case' 0 C--N 1.331 -0.223 0 CA-C-O 121.227 0.537 . . . . 0.0 110.735 177.908 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' F' F ' 33' ' ' THR . . . . . . . . . . . . . 32.3 m -53.78 140.94 28.41 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.221 -0.445 . . . . 0.0 111.222 -179.603 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' F' F ' 34' ' ' GLY . . . . . . . . . . . . . . . 99.9 -17.13 57.72 Favored Glycine 0 CA--C 1.531 1.068 0 C-N-CA 121.211 -0.519 . . . . 0.0 113.26 179.371 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' F' F ' 35' ' ' ASP . . . . . . . . . . . . . 65.6 m-20 -65.23 149.34 50.1 Favored 'General case' 0 C--O 1.231 0.121 0 CA-C-N 118.089 0.945 . . . . 0.0 111.188 179.044 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' F' F ' 36' ' ' VAL . . . . . . . . . . . . . 46.4 t -122.71 130.16 74.69 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.256 0 CA-C-N 115.78 -0.645 . . . . 0.0 109.867 178.909 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' F' F ' 37' ' ' ILE . . . . . . . . . . . . . 69.7 mt -122.07 139.47 48.95 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.234 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.044 -179.524 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' F' F ' 38' ' ' GLY . . . . . . . . . . . . . . . -113.86 129.17 8.64 Favored Glycine 0 CA--C 1.525 0.703 0 N-CA-C 111.115 -0.794 . . . . 0.0 111.115 -179.933 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' F' F ' 39' ' ' ILE . . . . . . . . . . . . . 67.7 mt -120.0 133.73 65.79 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.216 0 N-CA-C 110.084 -0.339 . . . . 0.0 110.084 178.964 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' F' F ' 40' ' ' SER . . . . . . . . . . . . . 53.6 p -93.4 120.04 33.21 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.343 -0.389 . . . . 0.0 110.844 175.399 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' F' F ' 41' ' ' ILE . . . . . . . . . . . . . 68.9 mt -129.81 122.55 54.94 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.179 0 CA-C-O 120.787 0.327 . . . . 0.0 110.462 177.903 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' F' F ' 42' ' ' LEU . . . . . . . . . . . . . 8.9 tp 52.23 35.11 16.0 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-N 116.131 -0.486 . . . . 0.0 111.628 177.308 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' F' F ' 43' ' ' GLY . . . . . . . . . . . . . . . 72.07 32.32 63.32 Favored Glycine 0 CA--C 1.529 0.952 0 C-N-CA 121.05 -0.595 . . . . 0.0 111.907 178.253 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' F' F ' 44' ' ' LYS . . . . . . . . . . . . . 54.4 tttp -137.94 128.79 27.02 Favored 'General case' 0 C--N 1.329 -0.296 0 N-CA-C 109.668 -0.493 . . . . 0.0 109.668 179.259 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' F' F ' 45' ' ' GLU . . . . . . . . . . . . . 84.6 tt0 -84.23 124.68 31.46 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-O 120.878 0.37 . . . . 0.0 111.298 -178.215 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' F' F ' 46' ' ' VAL . . . . . . . . . . . . . 7.1 p -121.0 127.74 75.99 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.209 0 N-CA-C 109.299 -0.63 . . . . 0.0 109.299 174.261 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' F' F ' 47' ' ' LYS . . . . . . . . . . . . . 93.1 mttt -99.98 127.24 46.21 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.062 -0.517 . . . . 0.0 111.006 179.583 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' F' F ' 48' ' ' PHE . . . . . . . . . . . . . 94.0 m-85 -111.07 131.96 54.65 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.305 -0.407 . . . . 0.0 109.951 175.961 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' F' F ' 49' ' ' LYS . . . . . . . . . . . . . 84.0 tttt -107.24 135.5 48.65 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.281 -0.418 . . . . 0.0 110.218 179.457 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' F' F ' 50' ' ' VAL . . . . . . . . . . . . . 46.4 t -79.38 108.02 12.47 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.295 0 N-CA-C 109.22 -0.659 . . . . 0.0 109.22 176.541 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' F' F ' 51' ' ' VAL . . . . . . . . . . . . . 47.8 t -70.9 -48.11 58.54 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.267 0 CA-C-N 115.991 -0.549 . . . . 0.0 109.974 -173.768 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' F' F ' 52' ' ' GLN . . . . . . . . . . . . . 63.2 tt0 -163.67 140.08 6.83 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.05 -0.523 . . . . 0.0 111.553 -178.233 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' F' F ' 53' ' ' ALA . . . . . 0.49 ' HB1' ' HB2' ' F' ' 58' ' ' LEU . . . -111.9 130.49 55.81 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-N 115.565 -0.743 . . . . 0.0 109.54 174.137 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' F' F ' 54' ' ' TYR . . . . . . . . . . . . . 41.8 t80 -129.06 110.16 18.24 Favored Pre-proline 0 C--N 1.327 -0.38 0 CA-C-O 118.358 -0.829 . . . . 0.0 110.484 -179.3 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' F' F ' 55' ' ' PRO . . . . . . . . . . . . . 73.8 Cg_endo -76.99 169.69 73.74 Favored 'Cis proline' 0 N--CA 1.498 1.783 0 CA-C-N 121.906 1.716 . . . . 0.0 112.296 -4.343 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' F' F ' 56' ' ' SER . . . . . . . . . . . . . 13.7 m -113.45 128.03 26.16 Favored Pre-proline 0 CA--C 1.539 0.553 0 CA-C-O 118.448 -0.787 . . . . 0.0 109.383 176.706 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' F' F ' 57' ' ' PRO . . . . . . . . . . . . . 38.5 Cg_endo -66.96 165.35 67.11 Favored 'Cis proline' 0 N--CA 1.497 1.693 0 CA-C-N 121.924 1.723 . . . . 0.0 111.463 0.388 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' F' F ' 58' ' ' LEU . . . . . 0.49 ' HB2' ' HB1' ' F' ' 53' ' ' ALA . 27.7 tp -129.26 135.76 49.2 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-O 120.934 0.397 . . . . 0.0 110.612 -179.31 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' F' F ' 59' ' ' ARG . . . . . . . . . . . . . 40.6 ttm180 -106.56 137.21 44.98 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-N 115.897 -0.592 . . . . 0.0 109.569 176.309 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' F' F ' 60' ' ' VAL . . . . . . . . . . . . . 44.2 t -91.0 122.7 42.66 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 C-N-CA 120.601 -0.44 . . . . 0.0 110.272 -178.178 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' F' F ' 61' ' ' GLU . . . . . . . . . . . . . 70.6 mm-40 -131.09 167.76 18.57 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 115.938 -0.574 . . . . 0.0 110.006 177.208 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' F' F ' 62' ' ' ASP . . . . . . . . . . . . . 75.1 m-20 -54.68 -32.95 60.16 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-N 116.58 -0.282 . . . . 0.0 111.748 -178.715 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' F' F ' 63' ' ' ARG . . . . . . . . . . . . . 7.0 ptp180 -89.45 8.55 30.36 Favored 'General case' 0 CA--C 1.536 0.413 0 N-CA-C 113.527 0.936 . . . . 0.0 113.527 -175.499 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' F' F ' 64' ' ' THR . . . . . . . . . . . . . 30.3 m -85.2 137.77 32.79 Favored 'General case' 0 C--O 1.232 0.155 0 CA-C-N 118.115 0.416 . . . . 0.0 110.343 -178.644 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' F' F ' 65' ' ' LYS . . . . . . . . . . . . . 97.3 mttt -88.58 125.94 35.03 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-N 116.27 -0.423 . . . . 0.0 110.041 -179.899 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' F' F ' 66' ' ' ILE . . . . . . . . . . . . . 64.9 mt -115.24 128.77 72.3 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.279 0 N-CA-C 109.812 -0.44 . . . . 0.0 109.812 -179.825 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' F' F ' 67' ' ' THR . . . . . . . . . . . . . 18.6 m -124.65 138.7 54.29 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.74 -177.726 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' F' F ' 68' ' ' LEU . . . . . 0.504 HD12 ' N ' ' F' ' 68' ' ' LEU . 7.1 mp . . . . . 0 C--N 1.329 -0.288 0 CA-C-N 115.895 -0.593 . . . . 0.0 110.226 177.218 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' F' F ' 73' ' ' VAL . . . . . . . . . . . . . 27.5 m . . . . . 0 C--O 1.232 0.172 0 CA-C-O 121.248 0.547 . . . . 0.0 111.079 . . . . . . . . . 0 0 . 1 . 012 nuclear build core ' F' F ' 74' ' ' ASP . . . . . . . . . . . . . 33.5 t0 -96.61 119.83 35.81 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 115.477 -0.783 . . . . 0.0 109.236 176.583 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' F' F ' 75' ' ' VAL . . . . . . . . . . . . . 42.0 t -109.6 123.15 65.25 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.247 0 CA-C-O 121.178 0.514 . . . . 0.0 110.521 -176.73 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' F' F ' 76' ' ' LEU . . . . . . . . . . . . . 23.8 mt -128.9 141.27 51.33 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 115.485 -0.78 . . . . 0.0 109.281 177.508 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' F' F ' 77' ' ' GLU . . . . . . . . . . . . . 45.7 tt0 -136.76 133.07 35.62 Favored 'General case' 0 C--N 1.331 -0.225 0 C-N-CA 120.736 -0.386 . . . . 0.0 110.978 -176.354 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' F' F ' 78' ' ' ALA . . . . . . . . . . . . . . . -120.6 135.55 55.07 Favored 'General case' 0 C--N 1.332 -0.177 0 CA-C-N 116.259 -0.428 . . . . 0.0 110.281 179.796 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' F' F ' 79' ' ' LYS . . . . . 0.655 ' O ' HD13 ' F' ' 80' ' ' ILE . 87.1 mttt -79.49 120.87 24.48 Favored 'General case' 0 C--N 1.331 -0.209 0 CA-C-O 120.853 0.359 . . . . 0.0 110.787 -179.242 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' F' F ' 80' ' ' ILE . . . . . 0.655 HD13 ' O ' ' F' ' 79' ' ' LYS . 37.2 mm -139.14 108.16 3.65 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.314 0 N-CA-C 108.869 -0.789 . . . . 0.0 108.869 -177.78 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' F' F ' 81' ' ' LYS . . . . . . . . . . . . . 79.5 tttt -99.96 125.79 46.02 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-O 120.837 0.351 . . . . 0.0 111.43 -174.834 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' F' F ' 82' ' ' GLY . . . . . . . . . . . . . . . 89.05 42.14 5.7 Favored Glycine 0 CA--C 1.525 0.683 0 C-N-CA 120.956 -0.64 . . . . 0.0 111.617 174.417 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' F' F ' 83' ' ' ILE . . . . . . . . . . . . . 68.5 mt -68.83 138.23 22.78 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.29 0 CA-C-O 120.921 0.391 . . . . 0.0 110.019 179.695 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' F' F ' 84' ' ' LYS . . . . . . . . . . . . . 38.2 tttp -99.91 -53.12 3.25 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 115.924 -0.58 . . . . 0.0 110.158 -179.475 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' F' F ' 85' ' ' ASP . . . . . . . . . . . . . 11.1 t0 -151.85 148.31 27.66 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 115.748 -0.66 . . . . 0.0 110.241 179.72 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' F' F ' 86' ' ' VAL . . . . . . . . . . . . . 45.3 t -125.94 130.24 72.33 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.191 0 CA-C-O 120.898 0.38 . . . . 0.0 110.308 -179.309 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' F' F ' 87' ' ' ILE . . . . . . . . . . . . . 46.2 mm -121.75 130.21 74.8 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.246 0 CA-C-N 115.926 -0.579 . . . . 0.0 109.948 177.365 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' F' F ' 88' ' ' LEU . . . . . . . . . . . . . 58.5 mt -108.17 137.25 46.47 Favored 'General case' 0 C--N 1.332 -0.194 0 CA-C-O 121.04 0.448 . . . . 0.0 111.361 -177.966 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' F' F ' 89' ' ' ASP . . . . . . . . . . . . . 13.8 t70 -126.58 153.14 45.67 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 115.653 -0.703 . . . . 0.0 109.489 176.695 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' F' F ' 90' ' ' GLU . . . . . . . . . . . . . 84.8 tt0 -47.54 -36.12 10.0 Favored 'General case' 0 C--N 1.329 -0.288 0 N-CA-C 112.851 0.686 . . . . 0.0 112.851 -172.259 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' F' F ' 91' ' ' ASN . . . . . . . . . . . . . 16.9 t30 -131.96 19.99 4.55 Favored 'General case' 0 N--CA 1.468 0.435 0 N-CA-C 112.995 0.739 . . . . 0.0 112.995 -178.411 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' F' F ' 92' ' ' LEU . . . . . . . . . . . . . 35.7 mt -150.28 152.83 35.12 Favored 'General case' 0 C--N 1.331 -0.209 0 CA-C-O 120.824 0.345 . . . . 0.0 110.513 -177.114 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' F' F ' 93' ' ' ILE . . . . . . . . . . . . . 71.9 mt -126.77 121.27 57.99 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.379 0 N-CA-C 109.319 -0.623 . . . . 0.0 109.319 177.206 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' F' F ' 94' ' ' VAL . . . . . . . . . . . . . 45.4 t -117.47 125.83 74.27 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.268 0 N-CA-C 109.829 -0.434 . . . . 0.0 109.829 -178.907 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' F' F ' 95' ' ' VAL . . . . . . . . . . . . . 46.1 t -122.16 133.03 69.72 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.291 0 CA-C-N 116.071 -0.513 . . . . 0.0 109.919 -179.468 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' F' F ' 96' ' ' ILE . . . . . . . . . . . . . 57.4 mt -114.77 127.77 72.15 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.323 0 N-CA-C 109.141 -0.689 . . . . 0.0 109.141 178.473 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' F' F ' 97' ' ' THR . . . . . . . . . . . . . 74.0 p -99.33 159.34 15.08 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-O 121.139 0.495 . . . . 0.0 111.423 -177.303 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' F' F ' 98' ' ' GLU . . . . . . . . . . . . . 12.6 pt-20 -54.69 -28.02 44.62 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.091 -0.504 . . . . 0.0 112.263 -179.135 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' F' F ' 99' ' ' GLU . . . . . . . . . . . . . 70.9 mm-40 -80.28 14.39 1.97 Allowed 'General case' 0 CA--C 1.535 0.397 0 N-CA-C 113.084 0.772 . . . . 0.0 113.084 -177.684 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' F' F ' 100' ' ' ASN . . . . . . . . . . . . . 5.3 m-20 62.09 35.25 15.91 Favored 'General case' 0 C--N 1.332 -0.164 0 CA-C-O 120.96 0.41 . . . . 0.0 111.354 179.56 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' F' F ' 101' ' ' GLU . . . . . . . . . . . . . 84.5 tt0 -106.61 143.0 35.35 Favored 'General case' 0 C--N 1.333 -0.145 0 N-CA-C 109.513 -0.551 . . . . 0.0 109.513 172.008 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' F' F ' 102' ' ' VAL . . . . . . . . . . . . . 43.2 t -115.02 125.45 72.34 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.311 0 N-CA-C 109.823 -0.436 . . . . 0.0 109.823 -177.867 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' F' F ' 103' ' ' LEU . . . . . . . . . . . . . 42.5 mt -116.81 129.13 55.9 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 115.762 -0.654 . . . . 0.0 110.17 177.508 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' F' F ' 104' ' ' ILE . . . . . . . . . . . . . 70.3 mt -118.36 119.43 61.24 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.261 0 N-CA-C 110.118 -0.327 . . . . 0.0 110.118 179.187 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' F' F ' 105' ' ' PHE . . . . . . . . . . . . . 65.8 m-85 -119.81 166.32 13.42 Favored 'General case' 0 C--N 1.331 -0.202 0 O-C-N 124.169 0.918 . . . . 0.0 109.591 178.858 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' F' F ' 106' ' ' ASN . . . . . . . . . . . . . 43.6 p-10 -99.3 -170.91 1.98 Allowed 'General case' 0 C--N 1.329 -0.284 0 N-CA-C 109.756 -0.461 . . . . 0.0 109.756 171.834 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' F' F ' 107' ' ' GLN . . . . . . . . . . . . . 5.8 tp-100 -57.82 -27.91 63.58 Favored 'General case' 0 CA--C 1.533 0.323 0 N-CA-C 112.005 0.372 . . . . 0.0 112.005 -179.815 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' F' F ' 108' ' ' ASN . . . . . . . . . . . . . 23.5 t30 -90.47 13.85 14.6 Favored 'General case' 0 CA--C 1.534 0.336 0 N-CA-C 113.067 0.766 . . . . 0.0 113.067 -175.997 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' F' F ' 109' ' ' LEU . . . . . . . . . . . . . 47.5 mt 57.95 38.0 26.85 Favored 'General case' 0 C--O 1.232 0.144 0 CA-C-O 120.975 0.416 . . . . 0.0 111.468 177.292 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' F' F ' 110' ' ' GLU . . . . . . . . . . . . . 95.7 mt-10 -102.07 155.12 18.39 Favored 'General case' 0 C--N 1.329 -0.319 0 N-CA-C 109.939 -0.393 . . . . 0.0 109.939 176.076 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' F' F ' 111' ' ' GLU . . . . . . . . . . . . . 84.9 tt0 -85.85 121.91 29.17 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-O 120.914 0.388 . . . . 0.0 110.698 -178.067 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' F' F ' 112' ' ' LEU . . . . . . . . . . . . . 32.5 mt -111.8 -45.97 3.29 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.043 -0.526 . . . . 0.0 110.414 178.297 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' F' F ' 113' ' ' TYR . . . . . . . . . . . . . 63.3 t80 -138.79 135.79 35.0 Favored 'General case' 0 C--N 1.331 -0.213 0 CA-C-N 116.43 -0.35 . . . . 0.0 111.117 179.351 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' F' F ' 114' ' ' ARG . . . . . . . . . . . . . 59.6 ttp180 -137.69 122.3 18.55 Favored 'General case' 0 C--N 1.331 -0.227 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.308 177.65 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' F' F ' 115' ' ' GLY . . . . . . . . . . . . . . . -150.08 161.1 28.79 Favored Glycine 0 CA--C 1.525 0.668 0 N-CA-C 111.053 -0.819 . . . . 0.0 111.053 177.943 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' F' F ' 116' ' ' LYS . . . . . . . . . . . . . 83.4 tttt -134.9 128.97 33.59 Favored 'General case' 0 C--N 1.33 -0.274 0 N-CA-C 109.972 -0.381 . . . . 0.0 109.972 177.703 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' F' F ' 117' ' ' PHE . . . . . . . . . . . . . 30.8 m-85 -129.03 118.85 23.23 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 116.402 -0.363 . . . . 0.0 110.047 -174.778 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' F' F ' 118' ' ' GLU . . . . . . . . . . . . . 95.9 mt-10 -55.59 -40.25 71.77 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.469 -0.332 . . . . 0.0 110.987 -177.264 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' F' F ' 119' ' ' ASN . . . . . . . . . . . . . 19.1 m120 -101.28 30.99 3.88 Favored 'General case' 0 C--N 1.33 -0.257 0 N-CA-C 112.047 0.388 . . . . 0.0 112.047 -175.022 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' F' F ' 120' ' ' LEU . . . . . . . . . . . . . 17.5 tp -58.08 124.48 19.5 Favored 'General case' 0 C--N 1.333 -0.15 0 CA-C-O 120.752 0.311 . . . . 0.0 110.221 178.781 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' F' F ' 121' ' ' ASN . . . . . . . . . . . . . 17.6 m120 -109.23 -44.19 3.99 Favored 'General case' 0 C--N 1.331 -0.222 0 CA-C-N 116.328 -0.396 . . . . 0.0 111.116 -176.962 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' F' F ' 122' ' ' LYS . . . . . . . . . . . . . 19.5 ptpt -163.65 163.15 24.42 Favored 'General case' 0 C--N 1.331 -0.199 0 CA-C-O 121.099 0.476 . . . . 0.0 111.726 -179.043 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' F' F ' 123' ' ' VAL . . . . . . . . . . . . . 42.2 t -132.95 137.15 54.38 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.251 0 CA-C-N 116.023 -0.535 . . . . 0.0 110.006 178.613 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' F' F ' 124' ' ' LEU . . . . . . . . . . . . . 80.0 mt -120.77 138.52 53.97 Favored 'General case' 0 C--N 1.331 -0.224 0 CA-C-N 116.293 -0.412 . . . . 0.0 110.535 -179.418 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' F' F ' 125' ' ' VAL . . . . . 0.53 HG23 HG12 ' F' ' 130' ' ' VAL . 12.0 p -133.63 130.28 56.25 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.246 0 CA-C-O 120.938 0.399 . . . . 0.0 110.785 179.641 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' F' F ' 126' ' ' ARG . . . . . . . . . . . . . 79.4 mtt85 -151.32 125.12 9.1 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 115.851 -0.613 . . . . 0.0 109.948 175.469 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' F' F ' 127' ' ' ASN . . . . . . . . . . . . . 17.3 m120 55.99 -149.32 0.46 Allowed 'General case' 0 CA--C 1.54 0.579 0 N-CA-C 109.897 -0.408 . . . . 0.0 109.897 178.99 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' F' F ' 128' ' ' ASP . . . . . . . . . . . . . 24.3 p-10 -82.17 13.08 3.67 Favored 'General case' 0 CA--C 1.537 0.446 0 N-CA-C 112.995 0.739 . . . . 0.0 112.995 -179.96 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' F' F ' 129' ' ' LEU . . . . . . . . . . . . . 19.9 tp -112.5 133.45 54.56 Favored 'General case' 0 C--O 1.232 0.182 0 CA-C-N 118.171 0.441 . . . . 0.0 110.104 179.196 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' F' F ' 130' ' ' VAL . . . . . 0.53 HG12 HG23 ' F' ' 125' ' ' VAL . 33.7 m -131.55 141.56 45.46 Favored 'Isoleucine or valine' 0 C--O 1.232 0.136 0 CA-C-O 120.782 0.325 . . . . 0.0 110.506 -179.651 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' F' F ' 131' ' ' VAL . . . . . 0.428 ' CG1' HD21 ' F' ' 138' ' ' LEU . 40.0 t -136.09 140.29 44.17 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.305 0 CA-C-O 120.986 0.422 . . . . 0.0 110.525 -179.104 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' F' F ' 132' ' ' ILE . . . . . . . . . . . . . 69.4 mt -115.16 133.8 60.28 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.249 0 N-CA-C 109.255 -0.646 . . . . 0.0 109.255 178.035 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' F' F ' 133' ' ' ILE . . . . . . . . . . . . . 42.7 mm -115.11 124.4 71.7 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.229 0 CA-C-N 116.568 -0.287 . . . . 0.0 110.859 -175.051 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' F' F ' 134' ' ' ASP . . . . . . . . . . . . . 7.2 p-10 -134.6 147.5 50.23 Favored 'General case' 0 C--N 1.332 -0.195 0 N-CA-C 109.605 -0.517 . . . . 0.0 109.605 174.089 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' F' F ' 135' ' ' GLU . . . . . . . . . . . . . 85.2 tt0 -50.7 -27.55 7.3 Favored 'General case' 0 C--N 1.328 -0.335 0 N-CA-C 112.822 0.675 . . . . 0.0 112.822 -173.129 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' F' F ' 136' ' ' GLN . . . . . . . . . . . . . 97.5 mt-30 -81.55 -32.47 32.2 Favored 'General case' 0 C--N 1.331 -0.239 0 N-CA-C 112.663 0.616 . . . . 0.0 112.663 -176.784 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' F' F ' 137' ' ' LYS . . . . . . . . . . . . . 53.3 pttt -169.02 173.54 6.83 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-O 121.562 0.696 . . . . 0.0 112.576 -172.458 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' F' F ' 138' ' ' LEU . . . . . 0.463 HD23 ' N ' ' F' ' 139' ' ' THR . 4.6 tt -117.07 129.74 56.19 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 115.113 -0.949 . . . . 0.0 109.923 179.622 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' F' F ' 139' ' ' THR . . . . . 0.463 ' N ' HD23 ' F' ' 138' ' ' LEU . 33.2 m -112.22 124.68 52.97 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.421 -0.354 . . . . 0.0 110.199 178.917 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' F' F ' 140' ' ' LEU . . . . . 0.482 HD23 ' C ' ' F' ' 140' ' ' LEU . 7.8 tt -113.86 125.19 53.79 Favored 'General case' 0 C--N 1.33 -0.281 0 N-CA-C 109.326 -0.62 . . . . 0.0 109.326 -178.724 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' F' F ' 141' ' ' ILE . . . . . 0.509 ' HB ' HG23 ' F' ' 130' ' ' VAL . 20.1 mt -121.98 125.32 72.97 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.272 0 CA-C-O 121.03 0.443 . . . . 0.0 110.022 -175.39 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' F' F ' 142' ' ' ARG . . . . . . . . . . . . . 39.1 tpt85 -113.8 128.04 56.25 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 115.132 -0.94 . . . . 0.0 109.944 -177.403 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' F' F ' 143' ' ' THR . . . . . . . . . . . . . 23.5 p . . . . . 0 C--O 1.22 -0.49 0 CA-C-O 117.953 -1.023 . . . . 0.0 110.516 -179.328 . . . . . . . . 0 0 . 1 . 013 nuclear build core ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 2.6 p . . . . . 0 N--CA 1.461 0.095 0 CA-C-O 120.924 0.392 . . . . 0.0 110.711 . . . . . . . . . 0 0 . 1 . 013 nuclear build core ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 82.8 tt0 -145.87 144.03 29.96 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.169 -0.469 . . . . 0.0 111.011 179.58 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 4' ' ' LEU . . . . . . . . . . . . . 14.8 tp -125.9 132.43 52.14 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.069 -0.514 . . . . 0.0 110.109 177.227 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 5' ' ' LYS . . . . . . . . . . . . . 68.3 mttm -109.75 122.74 48.18 Favored 'General case' 0 C--O 1.233 0.195 0 CA-C-N 116.345 -0.389 . . . . 0.0 110.823 179.941 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 31.2 mt -113.84 150.0 34.21 Favored 'General case' 0 C--N 1.331 -0.217 0 CA-C-N 115.349 -0.841 . . . . 0.0 110.196 -179.781 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 81.9 tttt -133.0 138.8 32.65 Favored Pre-proline 0 CA--C 1.534 0.332 0 CA-C-O 118.949 -0.548 . . . . 0.0 109.525 174.077 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 8' ' ' PRO . . . . . . . . . . . . . 88.5 Cg_endo -91.66 141.3 2.61 Favored 'Trans proline' 0 N--CA 1.489 1.253 0 C-N-CA 121.747 1.631 . . . . 0.0 112.16 179.741 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 62.5 mt -77.41 -47.4 2.51 Favored Pre-proline 0 CA--C 1.535 0.393 0 CA-C-O 118.69 -0.672 . . . . 0.0 112.074 178.729 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 97.8 Cg_endo -81.77 152.98 17.26 Favored 'Trans proline' 0 N--CA 1.495 1.604 0 C-N-CA 121.293 1.329 . . . . 0.0 111.995 176.088 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 46.3 tttp -88.68 98.08 11.49 Favored 'General case' 0 C--N 1.331 -0.237 0 C-N-CA 120.89 -0.324 . . . . 0.0 110.189 177.682 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 12.3 p -141.47 147.94 21.6 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.308 0 CA-C-N 116.283 -0.417 . . . . 0.0 110.673 -178.48 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 93.6 mt-10 -88.94 124.35 34.15 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.259 -0.428 . . . . 0.0 109.993 177.904 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 14' ' ' LEU . . . . . . . . . . . . . 26.2 mt -98.15 149.81 36.1 Favored Pre-proline 0 CA--C 1.534 0.335 0 CA-C-O 119.266 -0.397 . . . . 0.0 110.508 -179.25 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 15' ' ' PRO . . . . . . . . . . . . . 26.9 Cg_exo -62.06 158.55 38.52 Favored 'Trans proline' 0 N--CA 1.498 1.744 0 C-N-CA 121.282 1.322 . . . . 0.0 112.015 177.416 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 16' ' ' PRO . . . . . . . . . . . . . 32.9 Cg_exo -59.78 -35.66 93.64 Favored 'Trans proline' 0 N--CA 1.498 1.765 0 C-N-CA 121.384 1.389 . . . . 0.0 112.676 -179.739 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 17' ' ' ASP . . . . . . . . . . . . . 18.7 p-10 -86.91 8.81 21.5 Favored 'General case' 0 C--N 1.327 -0.376 0 N-CA-C 113.276 0.843 . . . . 0.0 113.276 -177.644 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 18' ' ' PHE . . . . . . . . . . . . . 37.9 t80 -58.12 -47.86 81.99 Favored 'General case' 0 N--CA 1.457 -0.081 0 O-C-N 121.963 -0.46 . . . . 0.0 110.194 -177.158 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 19' ' ' VAL . . . . . 0.408 HG13 ' N ' ' A' ' 20' ' ' ASP . 14.8 p -55.92 -41.3 66.79 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.339 0 CA-C-N 116.359 -0.382 . . . . 0.0 111.141 -177.614 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 20' ' ' ASP . . . . . 0.408 ' N ' HG13 ' A' ' 19' ' ' VAL . 49.8 m-20 -60.26 -44.74 95.04 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-O 120.805 0.336 . . . . 0.0 111.045 -177.387 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 47.0 t -64.78 -48.44 84.47 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.283 0 C-N-CA 120.726 -0.39 . . . . 0.0 110.495 -177.648 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 22' ' ' ILE . . . . . 0.542 HG22 HD12 ' A' ' 26' ' ' LEU . 44.5 mm -56.92 -43.86 81.3 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.247 0 CA-C-O 120.777 0.322 . . . . 0.0 110.489 179.957 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 23' ' ' ARG . . . . . . . . . . . . . 32.1 ttp180 -54.58 -49.76 69.62 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.65 -0.25 . . . . 0.0 111.283 -178.637 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 24' ' ' ILE . . . . . . . . . . . . . 75.9 mt -59.41 -41.39 84.3 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.238 0 C-N-CA 120.971 -0.291 . . . . 0.0 111.148 -177.622 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 91.9 mttt -64.97 -43.47 92.56 Favored 'General case' 0 C--N 1.329 -0.295 0 N-CA-C 112.439 0.533 . . . . 0.0 112.439 -179.437 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 26' ' ' LEU . . . . . 0.542 HD12 HG22 ' A' ' 22' ' ' ILE . 88.7 mt -79.75 -36.81 36.74 Favored 'General case' 0 C--N 1.331 -0.217 0 N-CA-C 113.589 0.959 . . . . 0.0 113.589 -170.541 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 27' ' ' GLN . . . . . . . . . . . . . 13.2 pt20 -47.13 142.17 3.9 Favored 'General case' 0 N--CA 1.469 0.508 0 N-CA-C 112.699 0.629 . . . . 0.0 112.699 -175.04 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 99.15 -24.99 30.02 Favored Glycine 0 CA--C 1.534 1.237 0 CA-C-N 115.591 -0.732 . . . . 0.0 112.251 -176.155 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 68.3 mttm -97.52 155.15 17.08 Favored 'General case' 0 C--O 1.232 0.177 0 CA-C-N 117.399 0.599 . . . . 0.0 111.028 178.635 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 30' ' ' THR . . . . . . . . . . . . . 30.2 m -103.25 137.68 41.06 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 115.887 -0.597 . . . . 0.0 109.933 176.13 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 35.2 m -126.33 153.52 34.89 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.248 0 CA-C-N 116.404 -0.362 . . . . 0.0 110.468 -179.4 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 32' ' ' ARG . . . . . . . . . . . . . 60.3 ttp180 -131.23 148.58 52.71 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.048 -0.524 . . . . 0.0 110.458 179.293 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 33' ' ' THR . . . . . . . . . . . . . 17.2 m -53.12 138.7 30.61 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.266 -0.425 . . . . 0.0 111.365 -177.936 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 99.91 -17.2 57.62 Favored Glycine 0 CA--C 1.532 1.155 0 CA-C-O 119.718 -0.49 . . . . 0.0 113.228 179.873 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 72.9 m-20 -66.2 151.73 46.35 Favored 'General case' 0 C--N 1.334 -0.107 0 CA-C-N 118.039 0.92 . . . . 0.0 111.288 179.404 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 45.2 t -122.73 130.46 74.47 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.198 0 CA-C-N 115.756 -0.656 . . . . 0.0 109.884 177.784 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 37' ' ' ILE . . . . . . . . . . . . . 65.3 mt -120.66 138.06 52.37 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.231 0 CA-C-N 116.18 -0.464 . . . . 0.0 109.834 -179.921 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . -116.04 128.55 8.05 Favored Glycine 0 CA--C 1.525 0.665 0 N-CA-C 110.991 -0.844 . . . . 0.0 110.991 179.582 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 39' ' ' ILE . . . . . . . . . . . . . 75.1 mt -126.82 134.28 66.59 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.226 0 CA-C-O 120.695 0.283 . . . . 0.0 110.285 179.445 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 40' ' ' SER . . . . . . . . . . . . . 53.2 p -92.39 114.61 27.2 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-N 116.225 -0.443 . . . . 0.0 110.758 175.949 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 41' ' ' ILE . . . . . . . . . . . . . 43.1 mm -120.47 117.42 53.26 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.26 0 CA-C-O 120.937 0.398 . . . . 0.0 110.601 179.545 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 42' ' ' LEU . . . . . 0.546 ' O ' HD23 ' A' ' 42' ' ' LEU . 1.3 tt 51.66 45.96 27.29 Favored 'General case' 0 CA--C 1.531 0.248 0 CA-C-O 121.404 0.621 . . . . 0.0 111.004 176.701 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . 70.76 21.68 78.01 Favored Glycine 0 CA--C 1.532 1.138 0 C-N-CA 121.175 -0.536 . . . . 0.0 112.851 175.523 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 44' ' ' LYS . . . . . . . . . . . . . 56.5 mttm -133.14 129.31 37.71 Favored 'General case' 0 C--N 1.332 -0.178 0 CA-C-N 117.55 0.675 . . . . 0.0 110.09 179.195 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 84.5 tt0 -83.95 123.81 30.36 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 116.552 -0.294 . . . . 0.0 111.067 -178.568 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 46' ' ' VAL . . . . . 0.415 HG13 ' O ' ' A' ' 46' ' ' VAL . 10.4 p -121.21 124.17 71.49 Favored 'Isoleucine or valine' 0 C--O 1.233 0.194 0 N-CA-C 109.687 -0.486 . . . . 0.0 109.687 174.674 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 93.8 mttt -99.6 127.18 45.69 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.095 -0.502 . . . . 0.0 110.783 177.702 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 48' ' ' PHE . . . . . . . . . . . . . 35.8 m-85 -110.81 131.95 54.61 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 115.855 -0.612 . . . . 0.0 109.666 177.593 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 84.2 tttt -106.52 135.78 47.44 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.246 -0.434 . . . . 0.0 110.215 179.058 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 50' ' ' VAL . . . . . . . . . . . . . 45.1 t -79.21 105.33 8.38 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.317 0 N-CA-C 109.549 -0.537 . . . . 0.0 109.549 177.622 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 51' ' ' VAL . . . . . . . . . . . . . 50.5 t -70.14 -54.32 19.33 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.366 0 N-CA-C 109.36 -0.607 . . . . 0.0 109.36 -176.347 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 52' ' ' GLN . . . . . . . . . . . . . 91.7 mt-30 -153.52 154.35 34.16 Favored 'General case' 0 C--N 1.331 -0.22 0 CA-C-N 115.913 -0.585 . . . . 0.0 111.595 -178.864 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -129.35 134.34 47.85 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 115.148 -0.933 . . . . 0.0 109.779 175.984 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 54' ' ' TYR . . . . . . . . . . . . . 57.3 t80 -128.75 107.24 18.54 Favored Pre-proline 0 CA--C 1.534 0.345 0 CA-C-O 118.281 -0.866 . . . . 0.0 110.449 -178.891 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 55' ' ' PRO . . . . . . . . . . . . . 73.5 Cg_endo -77.16 170.07 72.52 Favored 'Cis proline' 0 N--CA 1.5 1.854 0 CA-C-N 121.688 1.639 . . . . 0.0 112.405 -5.77 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 56' ' ' SER . . . . . . . . . . . . . 32.6 m -113.93 126.94 27.38 Favored Pre-proline 0 CA--C 1.54 0.57 0 CA-C-O 118.31 -0.852 . . . . 0.0 109.51 175.486 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 57' ' ' PRO . . . . . . . . . . . . . 52.7 Cg_endo -71.06 167.21 75.33 Favored 'Cis proline' 0 N--CA 1.497 1.677 0 CA-C-N 122.084 1.78 . . . . 0.0 111.89 -0.387 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 58' ' ' LEU . . . . . . . . . . . . . 18.9 tp -130.57 138.27 50.09 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.232 -0.44 . . . . 0.0 110.542 -179.426 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 59' ' ' ARG . . . . . . . . . . . . . 55.2 ttp180 -105.38 128.17 53.36 Favored 'General case' 0 C--N 1.329 -0.317 0 N-CA-C 109.118 -0.697 . . . . 0.0 109.118 175.031 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 40.2 t -82.84 123.12 38.22 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.196 0 C-N-CA 120.581 -0.448 . . . . 0.0 110.638 -173.835 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 95.1 mt-10 -131.07 168.76 16.87 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 115.78 -0.646 . . . . 0.0 109.998 177.958 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 62' ' ' ASP . . . . . . . . . . . . . 51.7 m-20 -54.36 -32.4 56.83 Favored 'General case' 0 C--N 1.329 -0.283 0 N-CA-C 111.747 0.277 . . . . 0.0 111.747 -179.712 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 63' ' ' ARG . . . . . . . . . . . . . 41.0 ptt180 -87.45 5.65 37.87 Favored 'General case' 0 CA--C 1.537 0.473 0 N-CA-C 113.712 1.004 . . . . 0.0 113.712 -174.999 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 28.8 m -87.4 139.14 30.85 Favored 'General case' 0 C--N 1.332 -0.179 0 CA-C-N 117.994 0.361 . . . . 0.0 110.537 -179.867 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 65' ' ' LYS . . . . . . . . . . . . . 61.8 mttm -87.63 130.44 34.77 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.096 -0.502 . . . . 0.0 110.281 179.154 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 66' ' ' ILE . . . . . . . . . . . . . 57.7 mt -115.47 124.93 72.47 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.316 0 N-CA-C 109.436 -0.579 . . . . 0.0 109.436 178.231 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 67' ' ' THR . . . . . . . . . . . . . 24.9 m -129.42 148.3 51.32 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-O 121.189 0.518 . . . . 0.0 111.531 -175.608 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 68' ' ' LEU . . . . . . . . . . . . . 4.0 tt . . . . . 0 C--N 1.329 -0.294 0 CA-C-N 115.764 -0.653 . . . . 0.0 109.589 176.52 . . . . . . . . 0 0 . 1 . 013 nuclear build core ' A' A ' 74' ' ' ASP . . . . . . . . . . . . . 5.3 t0 . . . . . 0 N--CA 1.457 -0.106 0 N-CA-C 109.655 -0.498 . . . . 0.0 109.655 . . . . . . . . . 0 0 . 1 . 013 nuclear build core ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 42.4 t -115.09 122.36 69.0 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.178 0 CA-C-O 121.038 0.446 . . . . 0.0 110.572 -177.783 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 76' ' ' LEU . . . . . . . . . . . . . 5.2 mp -121.09 142.87 49.44 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 115.623 -0.717 . . . . 0.0 109.739 176.386 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 77' ' ' GLU . . . . . . . . . . . . . 45.9 mt-10 -134.65 137.54 43.71 Favored 'General case' 0 C--N 1.331 -0.196 0 CA-C-O 120.955 0.407 . . . . 0.0 111.158 -179.355 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 78' ' ' ALA . . . . . 0.603 ' HB2' HD21 ' A' ' 109' ' ' LEU . . . -126.68 144.32 50.96 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 115.934 -0.576 . . . . 0.0 110.299 177.92 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 79' ' ' LYS . . . . . 0.624 ' O ' HD13 ' A' ' 80' ' ' ILE . 40.8 mmtm -82.99 116.04 22.09 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.392 -0.367 . . . . 0.0 110.688 -179.541 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 80' ' ' ILE . . . . . 0.624 HD13 ' O ' ' A' ' 79' ' ' LYS . 39.5 mm -139.09 110.69 5.16 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.286 0 N-CA-C 109.42 -0.585 . . . . 0.0 109.42 -179.288 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 81' ' ' LYS . . . . . . . . . . . . . 63.8 tttt -111.26 132.59 54.24 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-O 120.877 0.37 . . . . 0.0 111.064 -178.05 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . 89.04 42.11 5.71 Favored Glycine 0 CA--C 1.524 0.654 0 N-CA-C 111.432 -0.667 . . . . 0.0 111.432 175.46 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 83' ' ' ILE . . . . . . . . . . . . . 72.4 mt -76.54 137.68 22.12 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.326 0 N-CA-C 109.673 -0.491 . . . . 0.0 109.673 178.364 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 84' ' ' LYS . . . . . . . . . . . . . 39.3 ttpt -98.27 -48.14 5.18 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-N 116.241 -0.436 . . . . 0.0 110.036 -179.07 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 85' ' ' ASP . . . . . . . . . . . . . 5.5 t70 -155.12 155.77 34.58 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.089 -0.505 . . . . 0.0 110.814 179.357 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 86' ' ' VAL . . . . . . . . . . . . . 41.6 t -132.24 135.79 57.51 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.222 0 CA-C-O 120.962 0.411 . . . . 0.0 110.803 -178.423 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 87' ' ' ILE . . . . . . . . . . . . . 47.9 mm -119.22 123.59 71.6 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.308 0 CA-C-N 115.883 -0.599 . . . . 0.0 109.632 175.027 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 88' ' ' LEU . . . . . . . . . . . . . 14.2 tp -111.46 130.58 55.67 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-O 120.816 0.341 . . . . 0.0 110.89 -177.798 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 89' ' ' ASP . . . . . . . . . . . . . 6.9 t0 -130.89 156.02 45.76 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.048 -0.523 . . . . 0.0 109.704 178.328 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 79.5 tt0 -47.86 -39.61 19.12 Favored 'General case' 0 C--N 1.33 -0.27 0 N-CA-C 112.845 0.683 . . . . 0.0 112.845 -171.675 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 91' ' ' ASN . . . . . . . . . . . . . 16.4 m120 -123.58 14.98 9.52 Favored 'General case' 0 N--CA 1.467 0.406 0 N-CA-C 113.312 0.856 . . . . 0.0 113.312 -175.884 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 92' ' ' LEU . . . . . . . . . . . . . 33.4 mt -149.82 146.03 26.92 Favored 'General case' 0 C--N 1.331 -0.225 0 CA-C-N 117.93 0.332 . . . . 0.0 110.52 -176.214 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 93' ' ' ILE . . . . . . . . . . . . . 73.6 mt -127.62 116.92 45.12 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.331 0 N-CA-C 109.113 -0.699 . . . . 0.0 109.113 175.913 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 94' ' ' VAL . . . . . . . . . . . . . 45.0 t -116.7 126.87 74.36 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.278 0 N-CA-C 109.889 -0.412 . . . . 0.0 109.889 -177.941 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 95' ' ' VAL . . . . . . . . . . . . . 43.0 t -121.06 133.93 66.11 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.293 0 CA-C-N 116.177 -0.465 . . . . 0.0 109.807 179.465 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 96' ' ' ILE . . . . . 0.402 HD11 ' HB ' ' A' ' 123' ' ' VAL . 66.3 mt -113.52 126.1 70.9 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.365 0 N-CA-C 109.071 -0.714 . . . . 0.0 109.071 178.818 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 97' ' ' THR . . . . . . . . . . . . . 72.5 p -101.75 158.24 16.26 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-O 121.519 0.676 . . . . 0.0 111.593 -175.701 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 98' ' ' GLU . . . . . . . . . . . . . 82.4 tt0 -53.83 -27.3 28.73 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 115.549 -0.75 . . . . 0.0 112.295 179.991 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 99' ' ' GLU . . . . . . . . . . . . . 95.3 mt-10 -78.83 14.42 1.36 Allowed 'General case' 0 CA--C 1.535 0.369 0 N-CA-C 113.282 0.845 . . . . 0.0 113.282 -176.866 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 100' ' ' ASN . . . . . . . . . . . . . 3.2 m-20 61.03 37.5 17.92 Favored 'General case' 0 CA--C 1.53 0.211 0 CA-C-O 121.08 0.467 . . . . 0.0 110.891 -179.782 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 101' ' ' GLU . . . . . . . . . . . . . 84.3 tt0 -115.78 145.78 42.51 Favored 'General case' 0 C--O 1.232 0.16 0 CA-C-N 116.142 -0.481 . . . . 0.0 109.732 176.473 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 102' ' ' VAL . . . . . . . . . . . . . 45.7 t -114.95 125.3 72.24 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.298 0 N-CA-C 109.805 -0.442 . . . . 0.0 109.805 -177.332 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 103' ' ' LEU . . . . . . . . . . . . . 39.0 mt -116.3 126.48 53.6 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 115.634 -0.712 . . . . 0.0 110.185 177.263 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 104' ' ' ILE . . . . . 0.402 HD13 HG11 ' A' ' 130' ' ' VAL . 64.3 mt -117.59 120.11 63.75 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.214 0 N-CA-C 110.142 -0.318 . . . . 0.0 110.142 -179.993 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 105' ' ' PHE . . . . . . . . . . . . . 68.6 m-85 -119.95 165.57 14.47 Favored 'General case' 0 C--N 1.332 -0.19 0 O-C-N 123.818 0.698 . . . . 0.0 109.526 178.94 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 106' ' ' ASN . . . . . . . . . . . . . 36.7 p-10 -99.59 -170.33 1.88 Allowed 'General case' 0 C--N 1.331 -0.218 0 N-CA-C 109.952 -0.388 . . . . 0.0 109.952 174.926 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 107' ' ' GLN . . . . . . . . . . . . . 48.6 tp60 -59.47 -30.15 68.32 Favored 'General case' 0 C--N 1.328 -0.328 0 N-CA-C 111.94 0.348 . . . . 0.0 111.94 179.474 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 108' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -84.35 9.19 13.78 Favored 'General case' 0 CA--C 1.537 0.477 0 N-CA-C 113.204 0.816 . . . . 0.0 113.204 -177.326 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 109' ' ' LEU . . . . . 0.603 HD21 ' HB2' ' A' ' 78' ' ' ALA . 9.8 tp 61.67 35.04 17.23 Favored 'General case' 0 CA--C 1.531 0.222 0 CA-C-O 120.868 0.366 . . . . 0.0 111.545 178.64 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 110' ' ' GLU . . . . . . . . . . . . . 70.6 mm-40 -104.86 142.92 33.89 Favored 'General case' 0 C--N 1.33 -0.276 0 N-CA-C 109.373 -0.603 . . . . 0.0 109.373 174.719 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 111' ' ' GLU . . . . . . . . . . . . . 48.7 tt0 -83.63 121.85 27.81 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-O 120.892 0.377 . . . . 0.0 110.201 -176.725 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 112' ' ' LEU . . . . . . . . . . . . . 52.2 mt -105.1 -42.25 5.35 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 115.86 -0.609 . . . . 0.0 110.619 -179.526 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 113' ' ' TYR . . . . . . . . . . . . . 51.7 t80 -133.05 131.61 40.84 Favored 'General case' 0 C--N 1.331 -0.204 0 CA-C-O 121.01 0.433 . . . . 0.0 111.042 -179.095 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 114' ' ' ARG . . . . . . . . . . . . . 57.1 ttt180 -132.48 119.01 20.02 Favored 'General case' 0 C--N 1.331 -0.226 0 CA-C-N 115.745 -0.661 . . . . 0.0 109.812 177.242 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 115' ' ' GLY . . . . . . . . . . . . . . . -150.14 159.28 28.04 Favored Glycine 0 CA--C 1.522 0.522 0 N-CA-C 110.766 -0.934 . . . . 0.0 110.766 179.136 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 116' ' ' LYS . . . . . . . . . . . . . 34.3 ttmt -130.24 139.61 50.78 Favored 'General case' 0 C--N 1.329 -0.296 0 N-CA-C 110.03 -0.359 . . . . 0.0 110.03 177.646 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 117' ' ' PHE . . . . . . . . . . . . . 49.1 m-85 -134.87 113.96 12.09 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.288 -0.415 . . . . 0.0 110.012 -176.832 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 118' ' ' GLU . . . . . . . . . . . . . 79.6 tt0 -53.72 -43.28 68.91 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.64 -0.254 . . . . 0.0 111.263 -176.47 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 119' ' ' ASN . . . . . . . . . . . . . 32.5 m120 -99.31 30.99 3.26 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.091 -0.504 . . . . 0.0 112.119 -174.781 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 120' ' ' LEU . . . . . . . . . . . . . 15.4 tp -55.24 122.83 11.96 Favored 'General case' 0 N--CA 1.462 0.171 0 CA-C-O 120.751 0.31 . . . . 0.0 110.66 179.22 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 121' ' ' ASN . . . . . . . . . . . . . 64.9 t30 -113.33 -44.15 3.27 Favored 'General case' 0 C--N 1.331 -0.197 0 CA-C-N 116.362 -0.381 . . . . 0.0 111.046 -176.871 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 122' ' ' LYS . . . . . . . . . . . . . 93.4 mttt -144.26 148.1 34.43 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-O 121.057 0.456 . . . . 0.0 112.014 -177.869 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 123' ' ' VAL . . . . . 0.402 ' HB ' HD11 ' A' ' 96' ' ' ILE . 45.6 t -126.66 123.59 63.33 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.288 0 N-CA-C 109.066 -0.716 . . . . 0.0 109.066 172.567 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 124' ' ' LEU . . . . . . . . . . . . . 62.1 mt -125.74 136.93 53.72 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-O 120.855 0.36 . . . . 0.0 111.047 -176.954 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 125' ' ' VAL . . . . . . . . . . . . . 11.4 p -134.75 130.31 52.69 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.308 0 CA-C-N 115.967 -0.56 . . . . 0.0 110.148 178.196 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 126' ' ' ARG . . . . . . . . . . . . . 35.7 mmt180 -140.46 127.2 20.42 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.186 179.14 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 127' ' ' ASN . . . . . . . . . . . . . 12.5 t-20 52.04 -111.58 0.59 Allowed 'General case' 0 CA--C 1.544 0.742 0 CA-C-O 118.696 -0.668 . . . . 0.0 110.933 -179.969 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 128' ' ' ASP . . . . . . . . . . . . . 13.3 p-10 -114.06 8.6 17.09 Favored 'General case' 0 CA--C 1.537 0.45 0 CA-C-N 120.073 1.306 . . . . 0.0 113.23 179.918 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 129' ' ' LEU . . . . . . . . . . . . . 14.3 tp -106.41 135.61 47.61 Favored 'General case' 0 C--O 1.231 0.115 0 CA-C-N 118.037 0.38 . . . . 0.0 110.144 -179.993 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 130' ' ' VAL . . . . . 0.402 HG11 HD13 ' A' ' 104' ' ' ILE . 43.1 t -119.82 135.86 58.79 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.202 0 N-CA-C 109.831 -0.433 . . . . 0.0 109.831 -179.475 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 131' ' ' VAL . . . . . 0.498 HG12 HD12 ' A' ' 140' ' ' LEU . 21.0 m -136.04 138.8 46.88 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.239 0 CA-C-O 121.314 0.578 . . . . 0.0 110.94 177.928 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 132' ' ' ILE . . . . . . . . . . . . . 72.2 mt -118.86 131.12 72.58 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.319 0 CA-C-N 115.353 -0.84 . . . . 0.0 109.001 178.871 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 133' ' ' ILE . . . . . . . . . . . . . 39.3 mm -115.86 123.96 71.73 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.271 0 CA-C-N 116.596 -0.275 . . . . 0.0 110.747 -174.211 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 134' ' ' ASP . . . . . . . . . . . . . 13.4 p-10 -136.02 154.57 51.02 Favored 'General case' 0 C--N 1.332 -0.181 0 CA-C-N 116.295 -0.412 . . . . 0.0 110.086 176.409 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 135' ' ' GLU . . . . . . . . . . . . . 75.9 tt0 -50.02 -29.27 8.38 Favored 'General case' 0 C--N 1.328 -0.346 0 N-CA-C 113.4 0.889 . . . . 0.0 113.4 -168.815 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 136' ' ' GLN . . . . . . . . . . . . . 14.5 pt20 -99.83 -17.01 17.86 Favored 'General case' 0 C--O 1.235 0.34 0 N-CA-C 113.596 0.962 . . . . 0.0 113.596 -171.233 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 137' ' ' LYS . . . . . . . . . . . . . 19.2 pttp -168.04 172.2 9.01 Favored 'General case' 0 C--O 1.232 0.152 0 CA-C-O 121.692 0.758 . . . . 0.0 112.661 -175.41 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 138' ' ' LEU . . . . . . . . . . . . . 7.0 tt -123.26 129.55 51.52 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 114.71 -1.132 . . . . 0.0 110.01 178.985 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 139' ' ' THR . . . . . . . . . . . . . 30.4 m -108.3 127.99 54.35 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-N 116.247 -0.433 . . . . 0.0 110.579 179.69 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 140' ' ' LEU . . . . . 0.498 HD12 HG12 ' A' ' 131' ' ' VAL . 29.1 tp -111.93 123.33 50.02 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 115.61 -0.723 . . . . 0.0 109.159 -179.074 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 141' ' ' ILE . . . . . . . . . . . . . 19.6 mt -122.13 121.57 64.34 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.354 0 CA-C-O 120.911 0.386 . . . . 0.0 110.07 -174.662 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 142' ' ' ARG . . . . . . . . . . . . . 77.6 mtp180 -105.04 118.51 36.71 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 115.588 -0.733 . . . . 0.0 109.836 179.413 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 143' ' ' THR . . . . . . . . . . . . . 73.0 p . . . . . 0 C--O 1.221 -0.428 0 CA-C-O 117.976 -1.011 . . . . 0.0 110.592 -178.69 . . . . . . . . 0 0 . 1 . 013 nuclear build core ' B' B ' 2' ' ' SER . . . . . . . . . . . . . 3.1 p . . . . . 0 C--O 1.23 0.06 0 N-CA-C 110.077 -0.342 . . . . 0.0 110.077 . . . . . . . . . 0 0 . 1 . 013 nuclear build core ' B' B ' 3' ' ' GLU . . . . . . . . . . . . . 78.2 tt0 -140.64 137.57 33.7 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.622 -179.4 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' B' B ' 4' ' ' LEU . . . . . . . . . . . . . 12.6 tp -121.77 127.67 50.89 Favored 'General case' 0 C--N 1.331 -0.2 0 CA-C-N 116.096 -0.502 . . . . 0.0 110.143 177.501 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' B' B ' 5' ' ' LYS . . . . . . . . . . . . . 94.9 mttt -102.44 121.27 42.01 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.34 -0.391 . . . . 0.0 110.422 178.2 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' B' B ' 6' ' ' LEU . . . . . . . . . . . . . 59.5 mt -116.34 148.43 40.6 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-N 115.538 -0.756 . . . . 0.0 110.507 -178.98 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' B' B ' 7' ' ' LYS . . . . . . . . . . . . . 47.8 tttp -137.67 138.3 23.91 Favored Pre-proline 0 CA--C 1.534 0.341 0 CA-C-O 118.935 -0.555 . . . . 0.0 110.14 175.502 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' B' B ' 8' ' ' PRO . . . . . . . . . . . . . 98.9 Cg_endo -91.98 138.31 1.95 Allowed 'Trans proline' 0 N--CA 1.491 1.326 0 C-N-CA 121.803 1.669 . . . . 0.0 111.544 176.51 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' B' B ' 9' ' ' LEU . . . . . . . . . . . . . 65.7 mt -73.27 -47.33 7.77 Favored Pre-proline 0 CA--C 1.533 0.326 0 CA-C-O 118.751 -0.642 . . . . 0.0 112.238 -178.583 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' B' B ' 10' ' ' PRO . . . . . . . . . . . . . 87.8 Cg_endo -81.16 152.58 18.51 Favored 'Trans proline' 0 N--CA 1.496 1.672 0 C-N-CA 121.234 1.29 . . . . 0.0 111.894 175.807 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' B' B ' 11' ' ' LYS . . . . . . . . . . . . . 68.1 mttm -85.54 102.91 13.92 Favored 'General case' 0 C--N 1.33 -0.24 0 N-CA-C 110.106 -0.331 . . . . 0.0 110.106 177.459 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' B' B ' 12' ' ' VAL . . . . . . . . . . . . . 12.2 p -139.79 145.31 26.84 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.281 0 CA-C-N 116.335 -0.393 . . . . 0.0 110.722 -178.242 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' B' B ' 13' ' ' GLU . . . . . . . . . . . . . 95.5 mt-10 -87.83 121.32 30.11 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.094 -0.503 . . . . 0.0 109.887 177.13 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' B' B ' 14' ' ' LEU . . . . . . . . . . . . . 16.3 mt -97.71 153.0 38.43 Favored Pre-proline 0 C--N 1.329 -0.321 0 CA-C-N 116.498 -0.319 . . . . 0.0 110.678 -176.931 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' B' B ' 15' ' ' PRO . . . . . . . . . . . . . 26.0 Cg_exo -62.24 155.67 55.34 Favored 'Trans proline' 0 N--CA 1.497 1.713 0 C-N-CA 121.288 1.325 . . . . 0.0 111.581 176.076 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' B' B ' 16' ' ' PRO . . . . . . . . . . . . . 35.0 Cg_exo -58.0 -35.75 98.54 Favored 'Trans proline' 0 N--CA 1.498 1.742 0 C-N-CA 121.418 1.412 . . . . 0.0 112.704 -179.619 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' B' B ' 17' ' ' ASP . . . . . . . . . . . . . 17.8 p-10 -89.15 11.53 18.36 Favored 'General case' 0 C--N 1.327 -0.39 0 N-CA-C 113.202 0.816 . . . . 0.0 113.202 -177.462 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' B' B ' 18' ' ' PHE . . . . . . . . . . . . . 47.3 t80 -58.1 -42.64 86.13 Favored 'General case' 0 C--N 1.334 -0.088 0 O-C-N 121.905 -0.497 . . . . 0.0 110.023 -178.174 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' B' B ' 19' ' ' VAL . . . . . . . . . . . . . 49.1 t -58.0 -42.89 83.8 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.319 0 CA-C-N 116.438 -0.346 . . . . 0.0 110.283 -178.42 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' B' B ' 20' ' ' ASP . . . . . . . . . . . . . 81.2 m-20 -59.66 -42.16 92.19 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-O 120.796 0.331 . . . . 0.0 110.91 -177.955 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' B' B ' 21' ' ' VAL . . . . . . . . . . . . . 47.0 t -64.35 -49.31 81.53 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.321 0 CA-C-N 116.361 -0.381 . . . . 0.0 110.412 -178.215 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' B' B ' 22' ' ' ILE . . . . . 0.456 HG22 HD12 ' B' ' 26' ' ' LEU . 49.5 mm -56.89 -43.29 80.06 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.271 0 C-N-CA 120.993 -0.283 . . . . 0.0 110.542 179.592 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' B' B ' 23' ' ' ARG . . . . . . . . . . . . . 38.3 ttp180 -54.17 -49.63 68.86 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-O 120.732 0.301 . . . . 0.0 111.303 -178.73 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' B' B ' 24' ' ' ILE . . . . . . . . . . . . . 69.6 mt -60.44 -41.92 89.22 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.265 0 CA-C-N 116.416 -0.357 . . . . 0.0 110.899 -178.573 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' B' B ' 25' ' ' LYS . . . . . . . . . . . . . 88.4 mttt -64.91 -40.17 94.66 Favored 'General case' 0 C--N 1.328 -0.344 0 N-CA-C 112.469 0.544 . . . . 0.0 112.469 -179.096 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' B' B ' 26' ' ' LEU . . . . . 0.456 HD12 HG22 ' B' ' 22' ' ' ILE . 57.8 mt -77.81 -41.81 35.95 Favored 'General case' 0 C--N 1.33 -0.276 0 N-CA-C 113.141 0.793 . . . . 0.0 113.141 -171.408 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' B' B ' 27' ' ' GLN . . . . . . . . . . . . . 14.3 pt20 -46.86 135.62 9.0 Favored 'General case' 0 N--CA 1.469 0.516 0 N-CA-C 112.717 0.636 . . . . 0.0 112.717 -175.929 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' B' B ' 28' ' ' GLY . . . . . . . . . . . . . . . 101.06 -25.38 28.51 Favored Glycine 0 CA--C 1.533 1.161 0 CA-C-N 115.671 -0.695 . . . . 0.0 112.483 -177.792 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' B' B ' 29' ' ' LYS . . . . . . . . . . . . . 97.5 mttt -98.63 155.09 17.48 Favored 'General case' 0 C--N 1.331 -0.207 0 CA-C-N 117.398 0.599 . . . . 0.0 111.163 178.78 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' B' B ' 30' ' ' THR . . . . . . . . . . . . . 25.7 m -104.65 137.71 42.06 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.076 -0.511 . . . . 0.0 109.921 175.186 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' B' B ' 31' ' ' VAL . . . . . . . . . . . . . 34.5 m -128.26 155.64 40.02 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.254 0 CA-C-O 120.824 0.345 . . . . 0.0 110.894 -178.798 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' B' B ' 32' ' ' ARG . . . . . . . . . . . . . 97.1 mtt180 -133.51 149.93 51.7 Favored 'General case' 0 C--N 1.331 -0.225 0 CA-C-O 121.193 0.521 . . . . 0.0 110.654 177.823 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' B' B ' 33' ' ' THR . . . . . . . . . . . . . 23.6 m -53.21 139.64 28.65 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.237 -0.438 . . . . 0.0 111.419 -178.2 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' B' B ' 34' ' ' GLY . . . . . . . . . . . . . . . 99.4 -17.12 58.22 Favored Glycine 0 CA--C 1.531 1.092 0 C-N-CA 121.18 -0.533 . . . . 0.0 113.28 178.891 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' B' B ' 35' ' ' ASP . . . . . . . . . . . . . 75.6 m-20 -65.79 148.95 50.95 Favored 'General case' 0 C--O 1.232 0.145 0 CA-C-N 118.109 0.954 . . . . 0.0 111.152 179.631 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' B' B ' 36' ' ' VAL . . . . . . . . . . . . . 42.5 t -122.71 130.59 74.39 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.207 0 CA-C-N 115.938 -0.574 . . . . 0.0 109.966 177.7 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' B' B ' 37' ' ' ILE . . . . . . . . . . . . . 66.4 mt -121.63 139.23 49.36 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.305 0 N-CA-C 109.772 -0.455 . . . . 0.0 109.772 -179.721 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' B' B ' 38' ' ' GLY . . . . . . . . . . . . . . . -113.37 128.8 8.53 Favored Glycine 0 CA--C 1.526 0.77 0 N-CA-C 111.384 -0.686 . . . . 0.0 111.384 -178.673 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' B' B ' 39' ' ' ILE . . . . . . . . . . . . . 68.5 mt -123.89 127.91 73.95 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.204 0 N-CA-C 109.771 -0.455 . . . . 0.0 109.771 178.084 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' B' B ' 40' ' ' SER . . . . . . . . . . . . . 30.6 t -93.81 123.15 36.96 Favored 'General case' 0 C--N 1.329 -0.294 0 C-N-CA 120.923 -0.311 . . . . 0.0 111.005 176.589 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' B' B ' 41' ' ' ILE . . . . . . . . . . . . . 70.4 mt -131.73 125.67 56.09 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.233 0 CA-C-O 120.877 0.37 . . . . 0.0 110.588 178.834 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' B' B ' 42' ' ' LEU . . . . . . . . . . . . . 9.9 tp 54.62 35.45 23.69 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.067 -0.515 . . . . 0.0 111.623 176.88 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' B' B ' 43' ' ' GLY . . . . . . . . . . . . . . . 71.96 27.29 70.75 Favored Glycine 0 CA--C 1.531 1.087 0 C-N-CA 121.078 -0.582 . . . . 0.0 112.392 177.34 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' B' B ' 44' ' ' LYS . . . . . . . . . . . . . 91.4 mttt -138.05 126.84 23.82 Favored 'General case' 0 C--N 1.331 -0.211 0 N-CA-C 109.434 -0.58 . . . . 0.0 109.434 178.292 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' B' B ' 45' ' ' GLU . . . . . . . . . . . . . 29.1 tp10 -85.25 129.22 34.85 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-O 120.801 0.334 . . . . 0.0 111.233 -175.887 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' B' B ' 46' ' ' VAL . . . . . . . . . . . . . 7.4 p -122.36 129.48 75.26 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.2 0 N-CA-C 109.435 -0.58 . . . . 0.0 109.435 174.865 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' B' B ' 47' ' ' LYS . . . . . . . . . . . . . 69.0 mmtt -100.42 128.26 46.53 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.023 -0.535 . . . . 0.0 111.336 177.545 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' B' B ' 48' ' ' PHE . . . . . . . . . . . . . 91.7 m-85 -109.93 131.84 54.69 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 115.954 -0.566 . . . . 0.0 109.58 175.096 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' B' B ' 49' ' ' LYS . . . . . . . . . . . . . 41.5 tttp -108.62 137.63 46.25 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.422 -0.353 . . . . 0.0 110.365 179.638 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' B' B ' 50' ' ' VAL . . . . . . . . . . . . . 44.8 t -78.98 107.1 11.05 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.213 0 N-CA-C 109.326 -0.62 . . . . 0.0 109.326 176.352 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' B' B ' 51' ' ' VAL . . . . . . . . . . . . . 46.4 t -69.0 -48.97 67.06 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.329 0 CA-C-N 115.935 -0.575 . . . . 0.0 109.8 -174.097 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' B' B ' 52' ' ' GLN . . . . . . . . . . . . . 60.1 tt0 -170.1 147.93 3.28 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 115.838 -0.619 . . . . 0.0 111.274 -178.863 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' B' B ' 53' ' ' ALA . . . . . . . . . . . . . . . -122.77 136.78 54.98 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.085 -0.507 . . . . 0.0 110.34 178.843 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' B' B ' 54' ' ' TYR . . . . . . . . . . . . . 47.0 t80 -129.16 111.84 18.29 Favored Pre-proline 0 CA--C 1.535 0.387 0 CA-C-O 118.265 -0.874 . . . . 0.0 110.212 177.995 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' B' B ' 55' ' ' PRO . . . . . . . . . . . . . 73.4 Cg_endo -77.17 167.88 78.46 Favored 'Cis proline' 0 N--CA 1.5 1.901 0 CA-C-N 121.932 1.726 . . . . 0.0 112.127 -6.991 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' B' B ' 56' ' ' SER . . . . . . . . . . . . . 24.0 m -117.22 133.12 23.21 Favored Pre-proline 0 CA--C 1.537 0.476 0 CA-C-O 118.492 -0.766 . . . . 0.0 109.576 175.102 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' B' B ' 57' ' ' PRO . . . . . . . . . . . . . 36.4 Cg_endo -66.34 164.0 67.66 Favored 'Cis proline' 0 N--CA 1.499 1.809 0 CA-C-N 121.953 1.733 . . . . 0.0 111.375 -2.504 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' B' B ' 58' ' ' LEU . . . . . . . . . . . . . 23.0 tp -129.27 135.72 49.15 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.328 -0.396 . . . . 0.0 110.513 -179.217 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' B' B ' 59' ' ' ARG . . . . . . . . . . . . . 74.7 ttt180 -102.45 126.86 49.62 Favored 'General case' 0 C--N 1.327 -0.376 0 N-CA-C 109.241 -0.652 . . . . 0.0 109.241 175.362 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' B' B ' 60' ' ' VAL . . . . . . . . . . . . . 40.7 t -81.35 121.81 35.39 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.322 0 C-N-CA 120.634 -0.426 . . . . 0.0 110.402 -175.045 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' B' B ' 61' ' ' GLU . . . . . . . . . . . . . 95.1 mt-10 -131.11 165.38 23.4 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 115.803 -0.635 . . . . 0.0 109.634 176.698 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' B' B ' 62' ' ' ASP . . . . . . . . . . . . . 80.0 m-20 -53.82 -32.62 53.41 Favored 'General case' 0 C--N 1.328 -0.364 0 N-CA-C 111.787 0.291 . . . . 0.0 111.787 -179.852 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' B' B ' 63' ' ' ARG . . . . . . . . . . . . . 24.7 mmm180 -72.82 -18.96 61.41 Favored 'General case' 0 CA--C 1.535 0.379 0 N-CA-C 113.092 0.775 . . . . 0.0 113.092 -177.085 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' B' B ' 64' ' ' THR . . . . . . . . . . . . . 25.8 m -72.44 138.98 47.47 Favored 'General case' 0 C--N 1.331 -0.204 0 CA-C-O 120.962 0.411 . . . . 0.0 111.24 -174.642 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' B' B ' 65' ' ' LYS . . . . . . . . . . . . . 98.4 mttt -90.81 136.45 33.06 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 115.887 -0.597 . . . . 0.0 110.429 178.615 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' B' B ' 66' ' ' ILE . . . . . . . . . . . . . 60.6 mt -117.1 129.33 73.82 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.233 0 N-CA-C 109.662 -0.496 . . . . 0.0 109.662 179.147 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' B' B ' 67' ' ' THR . . . . . . . . . . . . . 28.0 m -125.74 144.85 50.45 Favored 'General case' 0 N--CA 1.463 0.205 0 CA-C-O 121.133 0.492 . . . . 0.0 111.581 -175.581 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' B' B ' 68' ' ' LEU . . . . . . . . . . . . . 4.4 tt . . . . . 0 C--N 1.33 -0.252 0 CA-C-N 115.614 -0.721 . . . . 0.0 109.559 177.026 . . . . . . . . 0 0 . 1 . 013 nuclear build core ' B' B ' 73' ' ' VAL . . . . . . . . . . . . . 33.8 m . . . . . 0 C--O 1.232 0.151 0 N-CA-C 109.616 -0.512 . . . . 0.0 109.616 . . . . . . . . . 0 0 . 1 . 013 nuclear build core ' B' B ' 74' ' ' ASP . . . . . . . . . . . . . 12.6 t70 -96.62 121.2 38.19 Favored 'General case' 0 C--N 1.33 -0.264 0 C-N-CA 120.779 -0.369 . . . . 0.0 110.346 -176.082 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' B' B ' 75' ' ' VAL . . . . . . . . . . . . . 41.3 t -115.87 126.04 73.23 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.184 0 CA-C-O 121.057 0.456 . . . . 0.0 110.66 -178.263 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' B' B ' 76' ' ' LEU . . . . . . . . . . . . . 15.6 mt -127.59 148.16 50.36 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 115.587 -0.733 . . . . 0.0 109.367 176.929 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' B' B ' 77' ' ' GLU . . . . . . . . . . . . . 98.0 mt-10 -136.87 141.44 42.78 Favored 'General case' 0 C--N 1.333 -0.125 0 CA-C-O 121.173 0.511 . . . . 0.0 111.532 -176.423 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' B' B ' 78' ' ' ALA . . . . . . . . . . . . . . . -127.01 133.5 50.52 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 115.529 -0.76 . . . . 0.0 109.794 176.394 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' B' B ' 79' ' ' LYS . . . . . 0.637 ' O ' HD13 ' B' ' 80' ' ' ILE . 85.8 tttt -78.12 116.68 18.76 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-O 120.891 0.377 . . . . 0.0 110.728 -177.608 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' B' B ' 80' ' ' ILE . . . . . 0.637 HD13 ' O ' ' B' ' 79' ' ' LYS . 37.9 mm -139.15 108.43 3.77 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.302 0 N-CA-C 109.432 -0.581 . . . . 0.0 109.432 -176.447 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' B' B ' 81' ' ' LYS . . . . . . . . . . . . . 38.6 ttpt -104.36 127.7 52.07 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-O 120.839 0.352 . . . . 0.0 110.939 -177.629 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' B' B ' 82' ' ' GLY . . . . . . . . . . . . . . . 89.05 42.13 5.7 Favored Glycine 0 CA--C 1.525 0.675 0 C-N-CA 120.847 -0.692 . . . . 0.0 111.687 175.522 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' B' B ' 83' ' ' ILE . . . . . . . . . . . . . 72.2 mt -70.12 136.05 26.9 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.339 0 N-CA-C 109.669 -0.493 . . . . 0.0 109.669 177.515 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' B' B ' 84' ' ' LYS . . . . . . . . . . . . . 81.1 tttt -94.19 -52.12 4.51 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 115.996 -0.547 . . . . 0.0 110.307 -179.025 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' B' B ' 85' ' ' ASP . . . . . . . . . . . . . 9.5 t70 -156.33 155.79 32.85 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 115.838 -0.619 . . . . 0.0 110.439 179.936 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' B' B ' 86' ' ' VAL . . . . . . . . . . . . . 42.5 t -126.35 133.67 68.21 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.18 0 CA-C-O 121.048 0.451 . . . . 0.0 110.67 -178.338 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' B' B ' 87' ' ' ILE . . . . . . . . . . . . . 44.7 mm -118.42 121.15 66.4 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.282 0 CA-C-N 115.644 -0.707 . . . . 0.0 109.245 175.264 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' B' B ' 88' ' ' LEU . . . . . 0.405 HD22 ' CG2' ' A' ' 131' ' ' VAL . 17.7 tp -109.98 132.51 54.09 Favored 'General case' 0 C--N 1.332 -0.194 0 CA-C-O 120.907 0.384 . . . . 0.0 111.428 -175.055 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' B' B ' 89' ' ' ASP . . . . . . . . . . . . . 9.8 t70 -129.49 153.33 48.09 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 115.91 -0.586 . . . . 0.0 109.56 175.869 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' B' B ' 90' ' ' GLU . . . . . . . . . . . . . 83.5 tt0 -48.21 -36.33 13.54 Favored 'General case' 0 C--N 1.329 -0.294 0 N-CA-C 112.738 0.644 . . . . 0.0 112.738 -172.641 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' B' B ' 91' ' ' ASN . . . . . . . . . . . . . 7.1 p30 -132.09 29.37 4.37 Favored 'General case' 0 N--CA 1.466 0.341 0 N-CA-C 112.301 0.482 . . . . 0.0 112.301 -177.378 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' B' B ' 92' ' ' LEU . . . . . . . . . . . . . 5.0 mt -154.78 143.16 20.48 Favored 'General case' 0 C--N 1.331 -0.213 0 N-CA-C 109.809 -0.441 . . . . 0.0 109.809 -178.474 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' B' B ' 93' ' ' ILE . . . . . . . . . . . . . 70.6 mt -123.38 112.26 32.75 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.213 0 N-CA-C 108.926 -0.768 . . . . 0.0 108.926 176.752 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' B' B ' 94' ' ' VAL . . . . . . . . . . . . . 46.3 t -116.05 125.56 73.2 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.258 0 N-CA-C 109.589 -0.523 . . . . 0.0 109.589 -179.599 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' B' B ' 95' ' ' VAL . . . . . . . . . . . . . 43.2 t -122.93 135.81 61.79 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.349 0 CA-C-N 116.127 -0.488 . . . . 0.0 109.976 -178.141 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' B' B ' 96' ' ' ILE . . . . . . . . . . . . . 63.8 mt -111.6 127.58 68.67 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.355 0 N-CA-C 109.075 -0.713 . . . . 0.0 109.075 178.145 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' B' B ' 97' ' ' THR . . . . . . . . . . . . . 78.4 p -101.18 156.79 17.22 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-O 120.967 0.413 . . . . 0.0 111.136 -177.479 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' B' B ' 98' ' ' GLU . . . . . . . . . . . . . 13.5 pt-20 -53.87 -23.62 13.16 Favored 'General case' 0 CA--C 1.533 0.319 0 N-CA-C 112.434 0.531 . . . . 0.0 112.434 -179.97 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' B' B ' 99' ' ' GLU . . . . . . . . . . . . . 95.6 mt-10 -79.24 14.5 1.48 Allowed 'General case' 0 CA--C 1.536 0.433 0 N-CA-C 112.969 0.729 . . . . 0.0 112.969 -178.212 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' B' B ' 100' ' ' ASN . . . . . . . . . . . . . 2.4 m-20 61.71 37.95 15.47 Favored 'General case' 0 CA--C 1.529 0.169 0 CA-C-O 121.081 0.467 . . . . 0.0 110.893 178.9 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' B' B ' 101' ' ' GLU . . . . . . . . . . . . . 83.5 tt0 -116.53 144.74 43.98 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-N 116.039 -0.528 . . . . 0.0 109.728 176.561 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' B' B ' 102' ' ' VAL . . . . . . . . . . . . . 46.1 t -114.94 123.6 70.78 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.314 0 N-CA-C 109.592 -0.521 . . . . 0.0 109.592 -179.942 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' B' B ' 103' ' ' LEU . . . . . . . . . . . . . 70.9 mt -114.34 131.78 56.43 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 115.806 -0.634 . . . . 0.0 110.255 178.411 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' B' B ' 104' ' ' ILE . . . . . 0.612 HD12 ' HB3' ' B' ' 113' ' ' TYR . 66.7 mt -117.9 117.54 55.26 Favored 'Isoleucine or valine' 0 C--O 1.234 0.252 0 CA-C-N 116.441 -0.345 . . . . 0.0 110.247 -178.756 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' B' B ' 105' ' ' PHE . . . . . . . . . . . . . 82.7 m-85 -117.43 163.29 16.6 Favored 'General case' 0 C--N 1.332 -0.157 0 O-C-N 124.241 0.963 . . . . 0.0 109.846 -179.906 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' B' B ' 106' ' ' ASN . . . . . . . . . . . . . 52.9 p-10 -102.41 -172.26 2.1 Favored 'General case' 0 C--N 1.331 -0.211 0 N-CA-C 109.757 -0.46 . . . . 0.0 109.757 171.256 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' B' B ' 107' ' ' GLN . . . . . . . . . . . . . 48.9 tt0 -58.45 -29.73 66.4 Favored 'General case' 0 C--N 1.328 -0.329 0 N-CA-C 112.227 0.454 . . . . 0.0 112.227 -178.066 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' B' B ' 108' ' ' ASN . . . . . . . . . . . . . 11.7 t-20 -88.74 14.16 10.8 Favored 'General case' 0 CA--C 1.535 0.385 0 N-CA-C 112.862 0.69 . . . . 0.0 112.862 -176.22 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' B' B ' 109' ' ' LEU . . . . . . . . . . . . . 71.6 mt 58.61 35.53 24.56 Favored 'General case' 0 C--O 1.234 0.238 0 CA-C-O 120.822 0.344 . . . . 0.0 111.547 178.771 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' B' B ' 110' ' ' GLU . . . . . . . . . . . . . 43.3 mt-10 -105.27 141.32 37.0 Favored 'General case' 0 C--N 1.329 -0.299 0 N-CA-C 109.771 -0.455 . . . . 0.0 109.771 176.35 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' B' B ' 111' ' ' GLU . . . . . . . . . . . . . 97.7 mt-10 -77.29 125.51 29.44 Favored 'General case' 0 C--N 1.327 -0.399 0 CA-C-N 116.331 -0.395 . . . . 0.0 111.257 -176.77 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' B' B ' 112' ' ' LEU . . . . . . . . . . . . . 11.6 mt -106.71 -45.99 4.08 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.041 -0.527 . . . . 0.0 110.176 176.889 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' B' B ' 113' ' ' TYR . . . . . 0.612 ' HB3' HD12 ' B' ' 104' ' ' ILE . 55.9 t80 -140.45 140.69 35.43 Favored 'General case' 0 C--N 1.33 -0.243 0 C-N-CA 120.74 -0.384 . . . . 0.0 110.956 -178.84 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' B' B ' 114' ' ' ARG . . . . . . . . . . . . . 21.0 mtp-105 -139.36 126.22 20.88 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.244 -0.435 . . . . 0.0 110.209 176.04 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' B' B ' 115' ' ' GLY . . . . . . . . . . . . . . . -150.07 142.81 10.03 Favored Glycine 0 CA--C 1.523 0.532 0 N-CA-C 111.229 -0.748 . . . . 0.0 111.229 179.826 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' B' B ' 116' ' ' LYS . . . . . . . . . . . . . 39.1 ttpt -112.02 132.82 54.57 Favored 'General case' 0 C--N 1.33 -0.245 0 N-CA-C 109.774 -0.454 . . . . 0.0 109.774 177.955 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' B' B ' 117' ' ' PHE . . . . . . . . . . . . . 40.9 m-85 -134.27 113.87 12.42 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-O 120.942 0.401 . . . . 0.0 110.198 -176.532 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' B' B ' 118' ' ' GLU . . . . . . . . . . . . . 95.8 mt-10 -56.34 -41.93 76.9 Favored 'General case' 0 C--N 1.326 -0.426 0 CA-C-N 116.13 -0.487 . . . . 0.0 111.196 -174.594 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' B' B ' 119' ' ' ASN . . . . . . . . . . . . . 88.5 m-20 -100.6 31.12 3.61 Favored 'General case' 0 C--N 1.329 -0.295 0 N-CA-C 112.213 0.449 . . . . 0.0 112.213 -173.853 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' B' B ' 120' ' ' LEU . . . . . . . . . . . . . 9.7 tp -55.25 122.03 10.18 Favored 'General case' 0 N--CA 1.462 0.158 0 C-N-CA 121.044 -0.262 . . . . 0.0 110.674 178.062 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' B' B ' 121' ' ' ASN . . . . . . . . . . . . . 3.5 m-20 -114.09 -44.14 3.17 Favored 'General case' 0 C--N 1.332 -0.153 0 CA-C-N 116.63 -0.259 . . . . 0.0 111.18 -176.242 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' B' B ' 122' ' ' LYS . . . . . . . . . . . . . 16.1 ttmm -151.79 142.65 22.97 Favored 'General case' 0 C--N 1.331 -0.206 0 C-N-CA 120.363 -0.535 . . . . 0.0 111.712 -176.828 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' B' B ' 123' ' ' VAL . . . . . . . . . . . . . 46.2 t -120.72 130.79 74.18 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.256 0 CA-C-N 115.825 -0.625 . . . . 0.0 109.628 177.139 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' B' B ' 124' ' ' LEU . . . . . . . . . . . . . 75.4 mt -127.83 138.48 52.72 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-O 120.831 0.348 . . . . 0.0 110.692 -178.424 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' B' B ' 125' ' ' VAL . . . . . . . . . . . . . 35.0 m -130.7 143.15 41.78 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.245 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.909 -179.567 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' B' B ' 126' ' ' ARG . . . . . . . . . . . . . 94.3 mtt-85 -148.34 117.72 6.94 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 115.832 -0.622 . . . . 0.0 109.397 176.205 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' B' B ' 127' ' ' ASN . . . . . . . . . . . . . 79.8 m-20 56.61 -143.35 0.71 Allowed 'General case' 0 CA--C 1.541 0.615 0 CA-C-O 119.138 -0.458 . . . . 0.0 109.773 -179.39 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' B' B ' 128' ' ' ASP . . . . . . . . . . . . . 12.0 p-10 -85.76 10.28 14.06 Favored 'General case' 0 CA--C 1.535 0.396 0 CA-C-N 119.248 0.931 . . . . 0.0 113.229 179.953 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' B' B ' 129' ' ' LEU . . . . . 0.47 HD13 HH21 ' B' ' 142' ' ' ARG . 28.2 mt -111.22 145.15 39.22 Favored 'General case' 0 N--CA 1.463 0.189 0 O-C-N 121.841 -0.537 . . . . 0.0 109.762 179.112 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' B' B ' 130' ' ' VAL . . . . . 0.475 HG23 ' HB ' ' B' ' 141' ' ' ILE . 32.6 m -137.13 148.09 26.53 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.262 0 CA-C-O 121.315 0.578 . . . . 0.0 111.923 -175.943 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' B' B ' 131' ' ' VAL . . . . . 0.461 HG22 HD12 ' B' ' 140' ' ' LEU . 43.9 t -136.14 137.7 48.14 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.225 0 CA-C-N 115.535 -0.757 . . . . 0.0 110.087 177.504 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' B' B ' 132' ' ' ILE . . . . . . . . . . . . . 75.3 mt -118.77 132.02 69.87 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.287 0 CA-C-N 116.028 -0.533 . . . . 0.0 109.669 -179.757 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' B' B ' 133' ' ' ILE . . . . . . . . . . . . . 41.0 mm -115.62 122.83 70.23 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.251 0 CA-C-N 116.414 -0.357 . . . . 0.0 110.883 -175.339 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' B' B ' 134' ' ' ASP . . . . . . . . . . . . . 9.3 p-10 -136.91 144.24 43.37 Favored 'General case' 0 C--N 1.331 -0.222 0 N-CA-C 109.691 -0.485 . . . . 0.0 109.691 173.282 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' B' B ' 135' ' ' GLU . . . . . . . . . . . . . 33.0 tp10 -49.91 -24.38 2.48 Favored 'General case' 0 C--N 1.326 -0.431 0 N-CA-C 112.806 0.669 . . . . 0.0 112.806 -172.394 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' B' B ' 136' ' ' GLN . . . . . . . . . . . . . 48.1 tt0 -82.51 -38.57 23.65 Favored 'General case' 0 C--N 1.332 -0.168 0 N-CA-C 112.082 0.401 . . . . 0.0 112.082 -176.934 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' B' B ' 137' ' ' LYS . . . . . . . . . . . . . 58.7 pttt -160.01 168.55 25.37 Favored 'General case' 0 C--O 1.234 0.256 0 CA-C-O 121.495 0.664 . . . . 0.0 112.119 -173.1 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' B' B ' 138' ' ' LEU . . . . . 0.445 HD23 ' N ' ' B' ' 139' ' ' THR . 5.1 tt -116.39 127.45 54.65 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 115.155 -0.93 . . . . 0.0 109.781 178.38 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' B' B ' 139' ' ' THR . . . . . 0.445 ' N ' HD23 ' B' ' 138' ' ' LEU . 31.8 m -109.79 124.83 51.96 Favored 'General case' 0 C--N 1.331 -0.217 0 CA-C-O 120.738 0.304 . . . . 0.0 110.381 179.926 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' B' B ' 140' ' ' LEU . . . . . 0.461 HD12 HG22 ' B' ' 131' ' ' VAL . 11.2 tp -114.86 117.27 30.23 Favored 'General case' 0 C--N 1.328 -0.367 0 N-CA-C 108.897 -0.779 . . . . 0.0 108.897 -179.183 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' B' B ' 141' ' ' ILE . . . . . 0.475 ' HB ' HG23 ' B' ' 130' ' ' VAL . 18.9 mt -117.22 117.01 53.85 Favored 'Isoleucine or valine' 0 C--O 1.236 0.361 0 CA-C-O 121.129 0.49 . . . . 0.0 110.069 -174.373 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' B' B ' 142' ' ' ARG . . . . . 0.47 HH21 HD13 ' B' ' 129' ' ' LEU . 2.0 mtp85 -103.72 135.01 46.09 Favored 'General case' 0 C--N 1.331 -0.201 0 CA-C-N 115.033 -0.985 . . . . 0.0 109.824 -177.353 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' B' B ' 143' ' ' THR . . . . . . . . . . . . . 72.7 p . . . . . 0 C--O 1.22 -0.478 0 CA-C-O 118.241 -0.885 . . . . 0.0 110.763 -179.722 . . . . . . . . 0 0 . 1 . 013 nuclear build core ' C' C ' 2' ' ' SER . . . . . . . . . . . . . 2.4 p . . . . . 0 N--CA 1.462 0.149 0 CA-C-O 120.902 0.382 . . . . 0.0 110.274 . . . . . . . . . 0 0 . 1 . 013 nuclear build core ' C' C ' 3' ' ' GLU . . . . . . . . . . . . . 84.2 tt0 -139.77 140.1 36.62 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 115.918 -0.583 . . . . 0.0 111.045 -177.244 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' C' C ' 4' ' ' LEU . . . . . . . . . . . . . 18.0 tp -126.7 130.16 49.83 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.028 -0.533 . . . . 0.0 110.203 177.752 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' C' C ' 5' ' ' LYS . . . . . . . . . . . . . 61.4 mttp -109.06 119.8 40.63 Favored 'General case' 0 C--O 1.233 0.22 0 CA-C-O 120.9 0.381 . . . . 0.0 110.693 179.054 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' C' C ' 6' ' ' LEU . . . . . 0.473 HD23 ' HA ' ' C' ' 50' ' ' VAL . 36.6 mt -115.04 148.82 38.38 Favored 'General case' 0 C--N 1.331 -0.211 0 CA-C-N 115.359 -0.837 . . . . 0.0 110.554 179.495 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' C' C ' 7' ' ' LYS . . . . . . . . . . . . . 25.9 ttpp -135.25 135.29 22.36 Favored Pre-proline 0 CA--C 1.535 0.392 0 CA-C-O 118.773 -0.632 . . . . 0.0 109.966 176.418 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' C' C ' 8' ' ' PRO . . . . . . . . . . . . . 89.7 Cg_endo -88.82 136.6 3.12 Favored 'Trans proline' 0 N--CA 1.492 1.383 0 C-N-CA 121.534 1.489 . . . . 0.0 111.515 176.344 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' C' C ' 9' ' ' LEU . . . . . . . . . . . . . 51.1 mt -73.32 -47.62 7.57 Favored Pre-proline 0 CA--C 1.534 0.335 0 CA-C-O 118.616 -0.707 . . . . 0.0 112.17 -178.237 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' C' C ' 10' ' ' PRO . . . . . . . . . . . . . 97.8 Cg_endo -79.8 145.57 18.06 Favored 'Trans proline' 0 N--CA 1.495 1.598 0 C-N-CA 121.104 1.202 . . . . 0.0 111.639 175.381 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' C' C ' 11' ' ' LYS . . . . . . . . . . . . . 52.9 pttt -78.43 111.88 14.9 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-O 121.601 0.715 . . . . 0.0 110.561 179.026 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' C' C ' 12' ' ' VAL . . . . . . . . . . . . . 12.4 p -151.11 148.32 14.99 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.295 0 CA-C-N 115.609 -0.723 . . . . 0.0 110.612 -179.437 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' C' C ' 13' ' ' GLU . . . . . . . . . . . . . 49.1 mp0 -91.65 120.78 32.72 Favored 'General case' 0 C--N 1.331 -0.236 0 N-CA-C 109.752 -0.462 . . . . 0.0 109.752 174.997 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' C' C ' 14' ' ' LEU . . . . . . . . . . . . . 14.7 mt -89.01 152.11 47.88 Favored Pre-proline 0 C--N 1.329 -0.287 0 CA-C-N 116.501 -0.318 . . . . 0.0 110.768 -176.984 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' C' C ' 15' ' ' PRO . . . . . . . . . . . . . 37.0 Cg_exo -59.8 162.33 16.11 Favored 'Trans proline' 0 N--CA 1.498 1.768 0 C-N-CA 121.329 1.353 . . . . 0.0 111.835 176.771 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' C' C ' 16' ' ' PRO . . . . . . . . . . . . . 37.9 Cg_exo -58.46 -44.02 41.13 Favored 'Trans proline' 0 N--CA 1.497 1.731 0 C-N-CA 121.444 1.429 . . . . 0.0 112.861 -177.242 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' C' C ' 17' ' ' ASP . . . . . . . . . . . . . 23.3 p-10 -92.44 17.05 10.53 Favored 'General case' 0 CA--C 1.536 0.433 0 N-CA-C 112.924 0.712 . . . . 0.0 112.924 -176.964 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' C' C ' 18' ' ' PHE . . . . . . . . . . . . . 52.8 t80 -57.24 -41.8 80.25 Favored 'General case' 0 C--N 1.333 -0.128 0 O-C-N 122.106 -0.371 . . . . 0.0 110.227 -179.193 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' C' C ' 19' ' ' VAL . . . . . . . . . . . . . 48.7 t -56.93 -43.41 80.51 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.303 0 CA-C-N 116.434 -0.348 . . . . 0.0 110.317 -179.468 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' C' C ' 20' ' ' ASP . . . . . . . . . . . . . 16.4 m-20 -60.1 -42.57 94.97 Favored 'General case' 0 C--N 1.33 -0.272 0 C-N-CA 120.98 -0.288 . . . . 0.0 111.173 -178.821 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' C' C ' 21' ' ' VAL . . . . . . . . . . . . . 48.3 t -63.96 -46.62 93.52 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.278 0 C-N-CA 120.794 -0.362 . . . . 0.0 110.37 -177.491 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' C' C ' 22' ' ' ILE . . . . . 0.562 HG22 HD12 ' C' ' 26' ' ' LEU . 51.4 mm -56.42 -45.82 81.88 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.208 0 CA-C-O 120.747 0.308 . . . . 0.0 110.423 178.221 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' C' C ' 23' ' ' ARG . . . . . . . . . . . . . 50.6 ttp180 -54.6 -47.83 72.9 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.589 -0.278 . . . . 0.0 111.488 -178.501 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' C' C ' 24' ' ' ILE . . . . . . . . . . . . . 76.5 mt -59.85 -44.09 93.38 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.362 0 CA-C-O 120.606 0.241 . . . . 0.0 111.045 -178.376 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' C' C ' 25' ' ' LYS . . . . . . . . . . . . . 54.7 mtmt -64.62 -41.44 96.19 Favored 'General case' 0 C--N 1.327 -0.377 0 N-CA-C 112.367 0.506 . . . . 0.0 112.367 -178.332 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' C' C ' 26' ' ' LEU . . . . . 0.562 HD12 HG22 ' C' ' 22' ' ' ILE . 79.6 mt -79.2 -40.35 31.0 Favored 'General case' 0 C--N 1.33 -0.266 0 N-CA-C 113.416 0.895 . . . . 0.0 113.416 -171.397 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' C' C ' 27' ' ' GLN . . . . . . . . . . . . . 14.3 pt20 -46.78 139.5 5.32 Favored 'General case' 0 N--CA 1.47 0.526 0 N-CA-C 112.703 0.631 . . . . 0.0 112.703 -175.041 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' C' C ' 28' ' ' GLY . . . . . . . . . . . . . . . 100.72 -26.19 25.54 Favored Glycine 0 CA--C 1.534 1.271 0 CA-C-N 115.467 -0.788 . . . . 0.0 112.179 -176.586 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' C' C ' 29' ' ' LYS . . . . . . . . . . . . . 99.1 mttt -98.6 155.12 17.46 Favored 'General case' 0 C--N 1.331 -0.198 0 CA-C-N 117.411 0.605 . . . . 0.0 111.365 179.277 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' C' C ' 30' ' ' THR . . . . . . . . . . . . . 38.1 m -103.28 135.91 44.03 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 115.886 -0.597 . . . . 0.0 109.979 175.758 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' C' C ' 31' ' ' VAL . . . . . . . . . . . . . 34.7 m -130.01 152.95 38.17 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.229 0 CA-C-O 120.934 0.397 . . . . 0.0 110.867 -178.597 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' C' C ' 32' ' ' ARG . . . . . . . . . . . . . 34.5 ttp180 -130.59 149.84 52.07 Favored 'General case' 0 C--N 1.331 -0.221 0 CA-C-N 116.027 -0.533 . . . . 0.0 110.452 179.519 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' C' C ' 33' ' ' THR . . . . . . . . . . . . . 19.1 m -52.65 139.17 26.77 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.241 -0.436 . . . . 0.0 111.498 -177.111 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' C' C ' 34' ' ' GLY . . . . . . . . . . . . . . . 100.21 -17.19 57.34 Favored Glycine 0 CA--C 1.533 1.165 0 CA-C-O 119.644 -0.531 . . . . 0.0 113.179 179.321 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' C' C ' 35' ' ' ASP . . . . . . . . . . . . . 70.9 m-20 -65.41 149.24 50.35 Favored 'General case' 0 C--O 1.231 0.083 0 CA-C-N 118.087 0.944 . . . . 0.0 111.276 179.303 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' C' C ' 36' ' ' VAL . . . . . . . . . . . . . 45.2 t -123.3 130.71 74.12 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.215 0 CA-C-N 115.735 -0.666 . . . . 0.0 109.658 178.065 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' C' C ' 37' ' ' ILE . . . . . . . . . . . . . 67.8 mt -121.06 138.57 51.04 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.24 0 CA-C-N 116.306 -0.406 . . . . 0.0 110.05 -179.609 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' C' C ' 38' ' ' GLY . . . . . . . . . . . . . . . -110.47 128.77 8.97 Favored Glycine 0 CA--C 1.525 0.703 0 N-CA-C 110.859 -0.896 . . . . 0.0 110.859 179.263 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' C' C ' 39' ' ' ILE . . . . . . . . . . . . . 73.2 mt -122.68 129.56 75.11 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.226 0 N-CA-C 110.069 -0.345 . . . . 0.0 110.069 179.812 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' C' C ' 40' ' ' SER . . . . . . . . . . . . . 87.3 p -93.15 120.34 33.34 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.425 -0.352 . . . . 0.0 110.991 176.744 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' C' C ' 41' ' ' ILE . . . . . . . . . . . . . 70.2 mt -133.3 127.49 54.17 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.258 0 CA-C-O 120.886 0.374 . . . . 0.0 110.446 177.955 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' C' C ' 42' ' ' LEU . . . . . . . . . . . . . 11.2 tp 53.23 34.53 17.85 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.035 -0.53 . . . . 0.0 111.593 177.1 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' C' C ' 43' ' ' GLY . . . . . . . . . . . . . . . 71.2 31.07 66.62 Favored Glycine 0 CA--C 1.531 1.061 0 C-N-CA 121.094 -0.574 . . . . 0.0 111.941 177.907 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' C' C ' 44' ' ' LYS . . . . . . . . . . . . . 80.5 tttt -138.43 126.83 23.14 Favored 'General case' 0 C--N 1.329 -0.296 0 N-CA-C 109.751 -0.463 . . . . 0.0 109.751 179.834 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' C' C ' 45' ' ' GLU . . . . . . . . . . . . . 81.9 tt0 -84.37 122.83 29.49 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-N 116.45 -0.341 . . . . 0.0 111.003 -178.398 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' C' C ' 46' ' ' VAL . . . . . . . . . . . . . 7.2 p -119.88 130.29 74.38 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.302 0 N-CA-C 109.449 -0.574 . . . . 0.0 109.449 175.877 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' C' C ' 47' ' ' LYS . . . . . . . . . . . . . 64.9 mttp -100.27 127.86 46.47 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 115.979 -0.555 . . . . 0.0 111.356 178.768 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' C' C ' 48' ' ' PHE . . . . . . . . . . . . . 94.6 m-85 -111.33 131.88 54.83 Favored 'General case' 0 C--N 1.33 -0.273 0 N-CA-C 109.674 -0.491 . . . . 0.0 109.674 175.495 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' C' C ' 49' ' ' LYS . . . . . . . . . . . . . 83.3 tttt -108.48 137.06 47.06 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.401 -0.363 . . . . 0.0 110.654 179.869 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' C' C ' 50' ' ' VAL . . . . . 0.473 ' HA ' HD23 ' C' ' 6' ' ' LEU . 41.0 t -83.21 107.57 15.01 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.243 0 N-CA-C 109.421 -0.585 . . . . 0.0 109.421 176.465 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' C' C ' 51' ' ' VAL . . . . . . . . . . . . . 48.9 t -72.46 -53.48 19.23 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.275 0 N-CA-C 109.581 -0.525 . . . . 0.0 109.581 -175.455 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' C' C ' 52' ' ' GLN . . . . . . . . . . . . . 90.9 mt-30 -154.07 151.6 29.5 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.02 -0.536 . . . . 0.0 111.832 -177.647 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' C' C ' 53' ' ' ALA . . . . . . . . . . . . . . . -130.12 133.78 46.88 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 115.318 -0.855 . . . . 0.0 109.827 174.463 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' C' C ' 54' ' ' TYR . . . . . . . . . . . . . 53.7 t80 -129.16 111.27 18.22 Favored Pre-proline 0 CA--C 1.535 0.377 0 CA-C-O 118.267 -0.873 . . . . 0.0 110.395 178.662 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' C' C ' 55' ' ' PRO . . . . . . . . . . . . . 73.3 Cg_endo -77.1 166.33 82.64 Favored 'Cis proline' 0 N--CA 1.499 1.84 0 CA-C-N 121.919 1.721 . . . . 0.0 112.348 -6.855 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' C' C ' 56' ' ' SER . . . . . . . . . . . . . 20.3 m -116.74 135.94 23.09 Favored Pre-proline 0 CA--C 1.538 0.519 0 CA-C-O 118.423 -0.798 . . . . 0.0 109.363 173.775 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' C' C ' 57' ' ' PRO . . . . . . . . . . . . . 49.4 Cg_endo -70.0 146.03 81.58 Favored 'Cis proline' 0 N--CA 1.497 1.733 0 CA-C-N 121.832 1.69 . . . . 0.0 111.473 -1.837 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' C' C ' 58' ' ' LEU . . . . . . . . . . . . . 31.9 tp -108.16 137.65 45.77 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.331 -0.395 . . . . 0.0 110.696 -177.704 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' C' C ' 59' ' ' ARG . . . . . . . . . . . . . 55.6 ttp180 -102.89 125.23 49.56 Favored 'General case' 0 C--N 1.327 -0.377 0 N-CA-C 109.227 -0.657 . . . . 0.0 109.227 174.653 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' C' C ' 60' ' ' VAL . . . . . . . . . . . . . 45.8 t -79.66 120.78 31.66 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.293 0 C-N-CA 120.689 -0.404 . . . . 0.0 110.65 -174.717 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' C' C ' 61' ' ' GLU . . . . . . . . . . . . . 43.3 mt-10 -131.03 163.05 28.44 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 115.747 -0.661 . . . . 0.0 109.675 176.542 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' C' C ' 62' ' ' ASP . . . . . . . . . . . . . 9.3 p-10 -53.36 -32.58 49.93 Favored 'General case' 0 C--N 1.328 -0.342 0 N-CA-C 111.894 0.331 . . . . 0.0 111.894 -178.634 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' C' C ' 63' ' ' ARG . . . . . . . . . . . . . 47.8 mtp180 -73.52 -21.5 60.37 Favored 'General case' 0 CA--C 1.534 0.335 0 N-CA-C 113.033 0.753 . . . . 0.0 113.033 -176.216 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' C' C ' 64' ' ' THR . . . . . . . . . . . . . 30.2 m -61.53 138.53 58.29 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-O 120.973 0.416 . . . . 0.0 111.341 -174.02 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' C' C ' 65' ' ' LYS . . . . . . . . . . . . . 40.5 ttpt -89.34 120.37 30.62 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 115.821 -0.627 . . . . 0.0 109.946 177.631 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' C' C ' 66' ' ' ILE . . . . . . . . . . . . . 64.0 mt -113.19 130.26 67.42 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.201 0 CA-C-O 120.894 0.378 . . . . 0.0 109.989 -178.434 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' C' C ' 67' ' ' THR . . . . . . . . . . . . . 25.5 m -129.41 147.36 51.22 Favored 'General case' 0 C--N 1.332 -0.186 0 CA-C-N 116.106 -0.497 . . . . 0.0 111.173 -177.815 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' C' C ' 68' ' ' LEU . . . . . . . . . . . . . 62.8 mt . . . . . 0 C--N 1.329 -0.303 0 CA-C-N 115.851 -0.613 . . . . 0.0 110.381 177.038 . . . . . . . . 0 0 . 1 . 013 nuclear build core ' C' C ' 73' ' ' VAL . . . . . . . . . . . . . 33.2 m . . . . . 0 C--O 1.231 0.093 0 CA-C-O 120.978 0.418 . . . . 0.0 110.718 . . . . . . . . . 0 0 . 1 . 013 nuclear build core ' C' C ' 74' ' ' ASP . . . . . . . . . . . . . 27.7 t0 -102.16 121.62 42.58 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 115.698 -0.683 . . . . 0.0 109.405 176.745 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' C' C ' 75' ' ' VAL . . . . . . . . . . . . . 43.1 t -110.82 121.32 63.33 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.249 0 CA-C-O 121.056 0.455 . . . . 0.0 110.825 -175.543 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' C' C ' 76' ' ' LEU . . . . . . . . . . . . . 21.9 mt -117.86 141.9 47.91 Favored 'General case' 0 C--N 1.331 -0.206 0 CA-C-N 115.598 -0.728 . . . . 0.0 109.693 176.114 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' C' C ' 77' ' ' GLU . . . . . . . . . . . . . 97.9 mt-10 -136.2 135.53 39.2 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-O 120.98 0.419 . . . . 0.0 111.307 -178.168 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' C' C ' 78' ' ' ALA . . . . . 0.595 ' HB2' HD21 ' C' ' 109' ' ' LEU . . . -124.61 134.56 52.88 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 115.627 -0.715 . . . . 0.0 109.882 176.801 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' C' C ' 79' ' ' LYS . . . . . 0.582 ' O ' HD13 ' C' ' 80' ' ' ILE . 66.3 mmtt -78.54 121.25 24.36 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-O 120.976 0.417 . . . . 0.0 110.597 179.851 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' C' C ' 80' ' ' ILE . . . . . 0.582 HD13 ' O ' ' C' ' 79' ' ' LYS . 42.2 mm -139.06 115.06 9.41 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.305 0 N-CA-C 109.291 -0.633 . . . . 0.0 109.291 -178.422 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' C' C ' 81' ' ' LYS . . . . . . . . . . . . . 46.7 pttt -104.11 123.37 47.13 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-O 121.085 0.469 . . . . 0.0 111.096 -178.437 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' C' C ' 82' ' ' GLY . . . . . . . . . . . . . . . 89.07 42.13 5.69 Favored Glycine 0 CA--C 1.525 0.697 0 C-N-CA 120.701 -0.761 . . . . 0.0 111.838 174.358 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' C' C ' 83' ' ' ILE . . . . . . . . . . . . . 70.6 mt -64.22 138.45 23.04 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.272 0 N-CA-C 109.73 -0.471 . . . . 0.0 109.73 177.691 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' C' C ' 84' ' ' LYS . . . . . . . . . . . . . 77.4 tttt -100.14 -51.15 3.75 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 115.995 -0.548 . . . . 0.0 110.465 -177.325 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' C' C ' 85' ' ' ASP . . . . . . . . . . . . . 5.1 t0 -156.51 152.26 27.13 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.014 -0.539 . . . . 0.0 110.319 -179.707 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' C' C ' 86' ' ' VAL . . . . . 0.42 ' O ' HD13 ' C' ' 87' ' ' ILE . 44.0 t -130.16 132.73 65.04 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.229 0 CA-C-O 121.021 0.438 . . . . 0.0 110.622 -179.461 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' C' C ' 87' ' ' ILE . . . . . 0.42 HD13 ' O ' ' C' ' 86' ' ' VAL . 43.5 mm -122.04 125.19 72.75 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.29 0 CA-C-N 115.948 -0.569 . . . . 0.0 109.604 176.098 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' C' C ' 88' ' ' LEU . . . . . . . . . . . . . 14.8 tp -111.03 129.27 55.96 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-O 120.84 0.352 . . . . 0.0 111.139 -177.145 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' C' C ' 89' ' ' ASP . . . . . . . . . . . . . 12.6 t70 -121.38 151.25 40.36 Favored 'General case' 0 C--N 1.33 -0.258 0 N-CA-C 109.555 -0.535 . . . . 0.0 109.555 176.67 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' C' C ' 90' ' ' GLU . . . . . . . . . . . . . 83.5 tt0 -48.86 -33.24 10.24 Favored 'General case' 0 C--N 1.328 -0.342 0 N-CA-C 112.64 0.607 . . . . 0.0 112.64 -173.082 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' C' C ' 91' ' ' ASN . . . . . . . . . . . . . 79.2 m-20 -131.99 28.14 4.5 Favored 'General case' 0 N--CA 1.466 0.333 0 N-CA-C 112.411 0.523 . . . . 0.0 112.411 -175.764 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' C' C ' 92' ' ' LEU . . . . . . . . . . . . . 11.7 tp -166.2 150.94 8.05 Favored 'General case' 0 C--N 1.33 -0.245 0 C-N-CA 120.835 -0.346 . . . . 0.0 110.851 -179.281 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' C' C ' 93' ' ' ILE . . . . . . . . . . . . . 69.0 mt -126.87 125.72 67.21 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.173 0 N-CA-C 109.757 -0.46 . . . . 0.0 109.757 179.629 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' C' C ' 94' ' ' VAL . . . . . . . . . . . . . 43.2 t -123.14 128.67 75.1 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.238 0 N-CA-C 110.077 -0.342 . . . . 0.0 110.077 178.957 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' C' C ' 95' ' ' VAL . . . . . . . . . . . . . 40.9 t -124.23 136.86 59.08 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.235 0 CA-C-O 120.933 0.397 . . . . 0.0 110.072 -179.406 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' C' C ' 96' ' ' ILE . . . . . . . . . . . . . 59.7 mt -114.31 130.11 69.16 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.335 0 N-CA-C 109.266 -0.642 . . . . 0.0 109.266 179.035 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' C' C ' 97' ' ' THR . . . . . . . . . . . . . 68.1 p -102.93 154.36 19.29 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-O 121.253 0.549 . . . . 0.0 111.192 -177.704 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' C' C ' 98' ' ' GLU . . . . . . . . . . . . . 84.0 tt0 -53.86 -24.61 16.41 Favored 'General case' 0 CA--C 1.533 0.322 0 N-CA-C 112.299 0.481 . . . . 0.0 112.299 179.625 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' C' C ' 99' ' ' GLU . . . . . . . . . . . . . 13.8 mm-40 -77.67 14.71 0.97 Allowed 'General case' 0 CA--C 1.535 0.391 0 N-CA-C 113.266 0.839 . . . . 0.0 113.266 -177.471 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' C' C ' 100' ' ' ASN . . . . . . . . . . . . . 2.9 m-20 62.89 38.05 11.64 Favored 'General case' 0 N--CA 1.464 0.245 0 CA-C-O 121.116 0.484 . . . . 0.0 110.757 178.686 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' C' C ' 101' ' ' GLU . . . . . . . . . . . . . 83.6 tt0 -122.36 145.97 47.77 Favored 'General case' 0 C--N 1.331 -0.217 0 CA-C-N 116.182 -0.463 . . . . 0.0 109.924 177.773 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' C' C ' 102' ' ' VAL . . . . . . . . . . . . . 44.1 t -114.95 129.26 71.44 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.232 0 CA-C-N 116.302 -0.408 . . . . 0.0 110.047 -177.396 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' C' C ' 103' ' ' LEU . . . . . . . . . . . . . 27.6 mt -119.63 131.55 55.49 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 115.59 -0.732 . . . . 0.0 110.131 177.06 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' C' C ' 104' ' ' ILE . . . . . . . . . . . . . 72.3 mt -117.15 125.07 73.73 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.276 0 N-CA-C 109.816 -0.438 . . . . 0.0 109.816 178.872 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' C' C ' 105' ' ' PHE . . . . . . . . . . . . . 93.8 m-85 -122.49 163.44 19.89 Favored 'General case' 0 C--O 1.232 0.144 0 O-C-N 123.904 0.752 . . . . 0.0 109.945 -177.909 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' C' C ' 106' ' ' ASN . . . . . . . . . . . . . 44.9 p-10 -101.08 -171.25 1.96 Allowed 'General case' 0 C--N 1.332 -0.19 0 CA-C-N 116.549 -0.296 . . . . 0.0 110.249 174.755 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' C' C ' 107' ' ' GLN . . . . . . . . . . . . . 14.0 tt0 -58.32 -29.51 65.97 Favored 'General case' 0 CA--C 1.533 0.297 0 N-CA-C 112.027 0.38 . . . . 0.0 112.027 -179.972 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' C' C ' 108' ' ' ASN . . . . . 0.42 ' O ' ' ND2' ' C' ' 108' ' ' ASN . 0.7 OUTLIER -85.27 7.9 20.51 Favored 'General case' 0 CA--C 1.538 0.506 0 N-CA-C 113.279 0.844 . . . . 0.0 113.279 -176.559 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' C' C ' 109' ' ' LEU . . . . . 0.595 HD21 ' HB2' ' C' ' 78' ' ' ALA . 10.7 tp 60.07 36.97 21.3 Favored 'General case' 0 CA--C 1.531 0.225 0 CA-C-O 120.98 0.419 . . . . 0.0 111.28 179.513 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' C' C ' 110' ' ' GLU . . . . . . . . . . . . . 70.6 mm-40 -108.83 147.96 31.3 Favored 'General case' 0 C--N 1.33 -0.269 0 N-CA-C 109.653 -0.499 . . . . 0.0 109.653 175.199 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' C' C ' 111' ' ' GLU . . . . . . . . . . . . . 55.4 tt0 -82.57 121.92 27.42 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-O 120.958 0.409 . . . . 0.0 111.022 -174.122 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' C' C ' 112' ' ' LEU . . . . . . . . . . . . . 11.8 mt -103.28 -46.2 4.67 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 115.936 -0.574 . . . . 0.0 110.888 179.47 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' C' C ' 113' ' ' TYR . . . . . . . . . . . . . 64.2 t80 -133.34 136.6 45.48 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 116.464 -0.335 . . . . 0.0 111.397 -177.444 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' C' C ' 114' ' ' ARG . . . . . . . . . . . . . 35.8 ttp180 -135.44 121.0 19.36 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 115.918 -0.583 . . . . 0.0 110.316 177.841 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' C' C ' 115' ' ' GLY . . . . . . . . . . . . . . . -150.01 145.44 13.54 Favored Glycine 0 CA--C 1.524 0.638 0 N-CA-C 111.062 -0.815 . . . . 0.0 111.062 178.122 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' C' C ' 116' ' ' LYS . . . . . . . . . . . . . 34.6 ttpt -117.16 138.34 51.73 Favored 'General case' 0 C--N 1.33 -0.249 0 N-CA-C 109.9 -0.407 . . . . 0.0 109.9 177.974 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' C' C ' 117' ' ' PHE . . . . . 0.403 ' HE2' HD13 ' C' ' 132' ' ' ILE . 46.1 m-85 -135.47 113.97 11.66 Favored 'General case' 0 C--N 1.33 -0.264 0 N-CA-C 109.941 -0.392 . . . . 0.0 109.941 -178.573 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' C' C ' 118' ' ' GLU . . . . . . . . . . . . . 45.8 tp10 -55.05 -42.66 72.98 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.391 -0.368 . . . . 0.0 111.211 -176.304 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' C' C ' 119' ' ' ASN . . . . . . . . . . . . . 4.7 m120 -99.81 31.11 3.37 Favored 'General case' 0 C--N 1.33 -0.247 0 N-CA-C 112.255 0.465 . . . . 0.0 112.255 -173.852 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' C' C ' 120' ' ' LEU . . . . . . . . . . . . . 15.9 tp -56.02 119.99 6.75 Favored 'General case' 0 N--CA 1.461 0.118 0 CA-C-O 120.783 0.325 . . . . 0.0 110.377 177.603 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' C' C ' 121' ' ' ASN . . . . . . . . . . . . . 7.8 t-20 -113.84 -44.1 3.21 Favored 'General case' 0 C--N 1.332 -0.157 0 CA-C-N 116.457 -0.338 . . . . 0.0 110.944 -176.208 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' C' C ' 122' ' ' LYS . . . . . . . . . . . . . 61.8 mtpt -140.23 146.17 38.32 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-O 121.079 0.466 . . . . 0.0 111.518 -177.682 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' C' C ' 123' ' ' VAL . . . . . . . . . . . . . 47.7 t -124.16 126.88 72.93 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.319 0 CA-C-N 115.816 -0.629 . . . . 0.0 109.582 175.557 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' C' C ' 124' ' ' LEU . . . . . . . . . . . . . 50.9 mt -114.5 127.75 55.97 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.141 -0.481 . . . . 0.0 110.126 -179.331 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' C' C ' 125' ' ' VAL . . . . . . . . . . . . . 41.4 t -135.6 121.93 32.3 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.33 0 CA-C-O 120.765 0.317 . . . . 0.0 110.259 179.478 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' C' C ' 126' ' ' ARG . . . . . . . . . . . . . 79.0 mtt85 -151.39 136.15 17.19 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 116.094 -0.503 . . . . 0.0 109.696 175.831 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' C' C ' 127' ' ' ASN . . . . . . . . . . . . . 75.6 m-20 56.13 -152.1 0.38 Allowed 'General case' 0 CA--C 1.539 0.532 0 N-CA-C 109.702 -0.481 . . . . 0.0 109.702 -178.202 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' C' C ' 128' ' ' ASP . . . . . . . . . . . . . 20.2 p-10 -88.08 21.54 2.72 Favored 'General case' 0 CA--C 1.534 0.346 0 CA-C-N 118.596 0.635 . . . . 0.0 112.377 176.806 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' C' C ' 129' ' ' LEU . . . . . . . . . . . . . 1.4 tt -115.43 134.67 54.87 Favored 'General case' 0 C--O 1.235 0.312 0 O-C-N 122.039 -0.413 . . . . 0.0 109.963 -179.338 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' C' C ' 130' ' ' VAL . . . . . . . . . . . . . 41.6 t -123.06 139.88 48.45 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.313 0 CA-C-O 121.017 0.437 . . . . 0.0 110.579 -175.788 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' C' C ' 131' ' ' VAL . . . . . 0.465 HG22 HD12 ' C' ' 140' ' ' LEU . 41.4 t -135.99 135.8 50.14 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.278 0 CA-C-N 116.097 -0.501 . . . . 0.0 110.266 178.209 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' C' C ' 132' ' ' ILE . . . . . 0.403 HD13 ' HE2' ' C' ' 117' ' ' PHE . 71.8 mt -117.44 131.53 69.88 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.314 0 N-CA-C 109.502 -0.555 . . . . 0.0 109.502 179.297 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' C' C ' 133' ' ' ILE . . . . . . . . . . . . . 35.7 mm -115.6 119.62 62.36 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.25 0 CA-C-O 120.803 0.335 . . . . 0.0 110.86 -176.387 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' C' C ' 134' ' ' ASP . . . . . . . . . . . . . 5.9 p-10 -129.71 148.81 51.63 Favored 'General case' 0 C--N 1.332 -0.193 0 CA-C-N 116.016 -0.538 . . . . 0.0 109.734 176.502 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' C' C ' 135' ' ' GLU . . . . . . . . . . . . . 75.2 tt0 -50.29 -27.55 6.31 Favored 'General case' 0 C--N 1.328 -0.333 0 N-CA-C 113.096 0.776 . . . . 0.0 113.096 -170.884 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' C' C ' 136' ' ' GLN . . . . . . . . . . . . . 13.9 pt20 -101.94 -14.65 17.11 Favored 'General case' 0 CA--C 1.535 0.378 0 N-CA-C 113.514 0.931 . . . . 0.0 113.514 -172.237 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' C' C ' 137' ' ' LYS . . . . . . . . . . . . . 13.3 ptpt -168.52 168.2 11.17 Favored 'General case' 0 N--CA 1.462 0.175 0 CA-C-O 121.622 0.725 . . . . 0.0 112.228 178.743 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' C' C ' 138' ' ' LEU . . . . . . . . . . . . . 5.8 tt -119.39 129.57 54.87 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 114.957 -1.019 . . . . 0.0 109.737 179.395 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' C' C ' 139' ' ' THR . . . . . . . . . . . . . 38.6 m -110.29 130.04 55.62 Favored 'General case' 0 C--N 1.331 -0.214 0 CA-C-N 116.449 -0.341 . . . . 0.0 110.488 -179.218 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' C' C ' 140' ' ' LEU . . . . . 0.465 HD12 HG22 ' C' ' 131' ' ' VAL . 15.2 tp -115.71 125.29 52.62 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 115.688 -0.687 . . . . 0.0 109.41 -178.661 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' C' C ' 141' ' ' ILE . . . . . . . . . . . . . 19.2 mt -122.73 117.4 51.77 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.24 0 CA-C-O 120.861 0.362 . . . . 0.0 110.032 -175.33 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' C' C ' 142' ' ' ARG . . . . . . . . . . . . . 81.3 mtm180 . . . . . 0 C--N 1.331 -0.196 0 CA-C-N 115.499 -0.773 . . . . 0.0 109.939 179.917 . . . . . . . . 0 0 . 1 . 013 nuclear build core ' D' D ' 2' ' ' SER . . . . . . . . . . . . . 2.5 p . . . . . 0 C--O 1.231 0.096 0 CA-C-O 120.897 0.379 . . . . 0.0 110.36 . . . . . . . . . 0 0 . 1 . 013 nuclear build core ' D' D ' 3' ' ' GLU . . . . . . . . . . . . . 83.7 tt0 -141.54 142.26 33.54 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-N 115.931 -0.577 . . . . 0.0 111.056 -177.123 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' D' D ' 4' ' ' LEU . . . . . . . . . . . . . 21.6 tp -124.81 129.77 51.08 Favored 'General case' 0 C--N 1.331 -0.213 0 CA-C-N 116.109 -0.496 . . . . 0.0 110.192 175.803 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' D' D ' 5' ' ' LYS . . . . . . . . . . . . . 68.7 mttm -104.7 120.08 40.51 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-N 116.25 -0.432 . . . . 0.0 110.542 178.635 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' D' D ' 6' ' ' LEU . . . . . . . . . . . . . 45.5 mt -115.22 146.76 41.12 Favored 'General case' 0 C--N 1.331 -0.223 0 CA-C-N 115.389 -0.823 . . . . 0.0 110.236 -179.872 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' D' D ' 7' ' ' LYS . . . . . . . . . . . . . 85.5 tttt -132.71 131.76 22.26 Favored Pre-proline 0 CA--C 1.537 0.453 0 CA-C-O 118.67 -0.681 . . . . 0.0 110.2 176.465 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' D' D ' 8' ' ' PRO . . . . . . . . . . . . . 95.1 Cg_endo -87.37 140.78 5.55 Favored 'Trans proline' 0 N--CA 1.491 1.362 0 C-N-CA 121.508 1.472 . . . . 0.0 111.632 175.776 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' D' D ' 9' ' ' LEU . . . . . . . . . . . . . 37.2 mt -79.98 -49.21 1.3 Allowed Pre-proline 0 CA--C 1.535 0.376 0 CA-C-O 118.566 -0.731 . . . . 0.0 112.494 -177.927 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' D' D ' 10' ' ' PRO . . . . . . . . . . . . . 85.6 Cg_endo -77.5 154.32 31.29 Favored 'Trans proline' 0 N--CA 1.498 1.752 0 C-N-CA 121.183 1.255 . . . . 0.0 112.27 179.808 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' D' D ' 11' ' ' LYS . . . . . . . . . . . . . 80.8 tttt -88.1 100.18 12.75 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 116.236 -0.438 . . . . 0.0 110.382 178.438 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' D' D ' 12' ' ' VAL . . . . . . . . . . . . . 12.3 p -143.94 147.89 19.31 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.273 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.667 -178.985 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' D' D ' 13' ' ' GLU . . . . . . . . . . . . . 70.7 mm-40 -81.55 123.14 28.4 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.229 -0.441 . . . . 0.0 109.999 177.13 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' D' D ' 14' ' ' LEU . . . . . . . . . . . . . 18.2 mt -98.12 147.02 32.51 Favored Pre-proline 0 CA--C 1.532 0.285 0 CA-C-O 119.158 -0.448 . . . . 0.0 110.444 -179.203 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' D' D ' 15' ' ' PRO . . . . . . . . . . . . . 27.1 Cg_exo -61.8 156.0 51.02 Favored 'Trans proline' 0 N--CA 1.499 1.807 0 C-N-CA 121.316 1.344 . . . . 0.0 112.004 177.489 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' D' D ' 16' ' ' PRO . . . . . . . . . . . . . 32.1 Cg_exo -59.85 -37.2 87.77 Favored 'Trans proline' 0 N--CA 1.497 1.689 0 C-N-CA 121.398 1.399 . . . . 0.0 112.55 178.962 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' D' D ' 17' ' ' ASP . . . . . . . . . . . . . 8.8 p-10 -87.53 15.77 6.29 Favored 'General case' 0 CA--C 1.536 0.419 0 N-CA-C 112.869 0.692 . . . . 0.0 112.869 -177.529 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' D' D ' 18' ' ' PHE . . . . . . . . . . . . . 35.7 t80 -56.38 -47.34 79.13 Favored 'General case' 0 C--N 1.334 -0.089 0 O-C-N 122.031 -0.418 . . . . 0.0 110.536 -178.283 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' D' D ' 19' ' ' VAL . . . . . . . . . . . . . 48.5 t -55.05 -40.89 56.28 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.259 0 C-N-CA 121.139 -0.224 . . . . 0.0 110.915 -177.337 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' D' D ' 20' ' ' ASP . . . . . . . . . . . . . 70.0 m-20 -60.06 -45.01 94.29 Favored 'General case' 0 C--N 1.331 -0.233 0 C-N-CA 120.864 -0.335 . . . . 0.0 110.959 -178.143 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' D' D ' 21' ' ' VAL . . . . . . . . . . . . . 47.5 t -65.52 -46.27 90.26 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.336 0 C-N-CA 120.631 -0.428 . . . . 0.0 110.585 -178.316 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' D' D ' 22' ' ' ILE . . . . . 0.497 HG22 HD12 ' D' ' 26' ' ' LEU . 49.4 mm -55.61 -58.67 4.01 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.295 0 C-N-CA 121.074 -0.25 . . . . 0.0 111.038 -178.101 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' D' D ' 23' ' ' ARG . . . . . . . . . . . . . 12.2 ptm180 -55.83 -42.78 76.25 Favored 'General case' 0 C--N 1.332 -0.183 0 C-N-CA 120.71 -0.396 . . . . 0.0 111.747 -174.662 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' D' D ' 24' ' ' ILE . . . . . . . . . . . . . 74.4 mt -59.78 -42.66 89.59 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.321 0 C-N-CA 120.871 -0.331 . . . . 0.0 111.314 -177.502 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' D' D ' 25' ' ' LYS . . . . . . . . . . . . . 97.5 mttt -69.08 -42.02 76.76 Favored 'General case' 0 C--N 1.329 -0.298 0 N-CA-C 112.457 0.54 . . . . 0.0 112.457 -179.808 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' D' D ' 26' ' ' LEU . . . . . 0.497 HD12 HG22 ' D' ' 22' ' ' ILE . 86.9 mt -78.87 -30.9 45.32 Favored 'General case' 0 C--N 1.329 -0.3 0 N-CA-C 113.708 1.003 . . . . 0.0 113.708 -169.851 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' D' D ' 27' ' ' GLN . . . . . . . . . . . . . 17.3 pt20 -47.45 141.4 4.98 Favored 'General case' 0 N--CA 1.469 0.497 0 N-CA-C 112.679 0.622 . . . . 0.0 112.679 -175.223 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' D' D ' 28' ' ' GLY . . . . . . . . . . . . . . . 100.07 -22.38 40.43 Favored Glycine 0 CA--C 1.533 1.158 0 CA-C-N 115.709 -0.678 . . . . 0.0 112.495 -177.109 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' D' D ' 29' ' ' LYS . . . . . . . . . . . . . 74.2 mmtt -96.59 155.02 16.95 Favored 'General case' 0 C--O 1.232 0.137 0 CA-C-N 117.588 0.694 . . . . 0.0 110.721 177.901 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' D' D ' 30' ' ' THR . . . . . . . . . . . . . 32.3 m -106.6 136.76 45.83 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.154 -0.475 . . . . 0.0 109.885 176.225 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' D' D ' 31' ' ' VAL . . . . . . . . . . . . . 34.8 m -129.47 156.27 41.8 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.203 0 CA-C-O 120.907 0.384 . . . . 0.0 110.864 -178.289 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' D' D ' 32' ' ' ARG . . . . . . . . . . . . . 54.0 ttp180 -133.99 150.82 51.28 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 115.857 -0.611 . . . . 0.0 110.384 178.652 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' D' D ' 33' ' ' THR . . . . . . . . . . . . . 27.4 m -53.06 139.99 26.66 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.419 -0.355 . . . . 0.0 111.339 -179.37 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' D' D ' 34' ' ' GLY . . . . . . . . . . . . . . . 99.74 -17.18 57.81 Favored Glycine 0 CA--C 1.533 1.181 0 CA-C-O 119.762 -0.466 . . . . 0.0 113.218 179.909 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' D' D ' 35' ' ' ASP . . . . . . . . . . . . . 73.4 m-20 -66.89 149.21 50.92 Favored 'General case' 0 C--O 1.231 0.122 0 CA-C-N 118.019 0.909 . . . . 0.0 111.3 178.609 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' D' D ' 36' ' ' VAL . . . . . . . . . . . . . 45.9 t -122.24 129.46 75.31 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.286 0 CA-C-N 115.815 -0.63 . . . . 0.0 109.692 177.463 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' D' D ' 37' ' ' ILE . . . . . . . . . . . . . 66.6 mt -119.9 138.08 51.65 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.264 0 CA-C-N 116.367 -0.379 . . . . 0.0 110.042 -178.942 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' D' D ' 38' ' ' GLY . . . . . . . . . . . . . . . -112.3 128.79 8.69 Favored Glycine 0 CA--C 1.524 0.653 0 N-CA-C 111.009 -0.836 . . . . 0.0 111.009 179.487 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' D' D ' 39' ' ' ILE . . . . . . . . . . . . . 72.1 mt -122.91 132.58 71.1 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.184 0 N-CA-C 110.039 -0.356 . . . . 0.0 110.039 179.319 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' D' D ' 40' ' ' SER . . . . . . . . . . . . . 13.6 t -92.51 119.41 31.97 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.474 -0.33 . . . . 0.0 110.647 176.153 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' D' D ' 41' ' ' ILE . . . . . . . . . . . . . 73.0 mt -131.1 115.99 31.74 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.208 0 CA-C-O 120.987 0.422 . . . . 0.0 110.691 179.51 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' D' D ' 42' ' ' LEU . . . . . 0.519 HD23 ' O ' ' D' ' 42' ' ' LEU . 1.4 tt 52.58 48.17 23.12 Favored 'General case' 0 CA--C 1.532 0.288 0 CA-C-N 115.738 -0.665 . . . . 0.0 110.989 175.9 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' D' D ' 43' ' ' GLY . . . . . . . . . . . . . . . 70.19 16.44 73.13 Favored Glycine 0 CA--C 1.534 1.266 0 C-N-CA 121.064 -0.589 . . . . 0.0 113.089 174.75 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' D' D ' 44' ' ' LYS . . . . . . . . . . . . . 53.3 mtmt -128.38 130.01 47.07 Favored 'General case' 0 C--N 1.333 -0.133 0 CA-C-N 117.788 0.794 . . . . 0.0 110.304 179.629 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' D' D ' 45' ' ' GLU . . . . . . . . . . . . . 81.4 tt0 -84.84 124.51 31.67 Favored 'General case' 0 C--N 1.327 -0.406 0 CA-C-N 116.451 -0.341 . . . . 0.0 110.737 -179.858 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' D' D ' 46' ' ' VAL . . . . . . . . . . . . . 7.3 p -122.26 127.06 75.07 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.235 0 N-CA-C 109.651 -0.5 . . . . 0.0 109.651 176.498 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' D' D ' 47' ' ' LYS . . . . . . . . . . . . . 99.3 mttt -101.03 130.66 47.07 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.008 -0.542 . . . . 0.0 111.481 178.171 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' D' D ' 48' ' ' PHE . . . . . . . . . . . . . 92.1 m-85 -113.86 131.95 56.08 Favored 'General case' 0 C--N 1.329 -0.303 0 N-CA-C 109.559 -0.534 . . . . 0.0 109.559 174.592 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' D' D ' 49' ' ' LYS . . . . . . . . . . . . . 80.6 tttt -107.99 137.44 45.98 Favored 'General case' 0 C--N 1.329 -0.309 0 N-CA-C 110.284 -0.265 . . . . 0.0 110.284 178.8 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' D' D ' 50' ' ' VAL . . . . . . . . . . . . . 45.6 t -81.69 109.2 15.61 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.252 0 N-CA-C 109.236 -0.653 . . . . 0.0 109.236 176.889 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' D' D ' 51' ' ' VAL . . . . . . . . . . . . . 48.8 t -74.35 -47.07 41.96 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.278 0 CA-C-N 115.902 -0.59 . . . . 0.0 110.213 -173.809 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' D' D ' 52' ' ' GLN . . . . . . . . . . . . . 31.2 tt0 -163.88 142.49 7.63 Favored 'General case' 0 C--N 1.332 -0.19 0 C-N-CA 120.26 -0.576 . . . . 0.0 111.789 -178.432 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' D' D ' 53' ' ' ALA . . . . . . . . . . . . . . . -118.55 132.33 56.21 Favored 'General case' 0 C--N 1.332 -0.184 0 CA-C-N 115.812 -0.631 . . . . 0.0 110.194 177.207 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' D' D ' 54' ' ' TYR . . . . . . . . . . . . . 55.0 t80 -128.98 107.92 18.14 Favored Pre-proline 0 CA--C 1.534 0.362 0 CA-C-O 118.252 -0.88 . . . . 0.0 110.557 -179.849 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' D' D ' 55' ' ' PRO . . . . . . . . . . . . . 73.8 Cg_endo -77.27 170.08 72.37 Favored 'Cis proline' 0 N--CA 1.501 1.914 0 CA-C-N 121.89 1.711 . . . . 0.0 112.274 -5.67 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' D' D ' 56' ' ' SER . . . . . . . . . . . . . 32.8 m -116.46 133.57 22.97 Favored Pre-proline 0 CA--C 1.539 0.547 0 CA-C-O 118.418 -0.801 . . . . 0.0 109.408 174.447 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' D' D ' 57' ' ' PRO . . . . . . . . . . . . . 41.9 Cg_endo -67.8 166.33 66.7 Favored 'Cis proline' 0 N--CA 1.499 1.8 0 CA-C-N 121.874 1.705 . . . . 0.0 111.524 -1.446 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' D' D ' 58' ' ' LEU . . . . . . . . . . . . . 38.5 tp -129.27 138.03 51.41 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.239 -0.437 . . . . 0.0 110.173 179.657 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' D' D ' 59' ' ' ARG . . . . . . . . . . . . . 72.7 ttt-85 -101.95 129.32 48.19 Favored 'General case' 0 C--N 1.329 -0.306 0 N-CA-C 109.405 -0.591 . . . . 0.0 109.405 178.013 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' D' D ' 60' ' ' VAL . . . . . . . . . . . . . 41.5 t -78.5 113.77 18.23 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.299 0 C-N-CA 120.782 -0.367 . . . . 0.0 110.255 -176.165 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' D' D ' 61' ' ' GLU . . . . . . . . . . . . . 82.8 tt0 -131.24 151.57 51.35 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 115.913 -0.585 . . . . 0.0 109.66 175.998 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' D' D ' 62' ' ' ASP . . . . . . . . . . . . . 50.6 m-20 -49.58 -32.08 11.92 Favored 'General case' 0 C--N 1.327 -0.396 0 N-CA-C 112.129 0.418 . . . . 0.0 112.129 179.394 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' D' D ' 63' ' ' ARG . . . . . . . . . . . . . 35.0 mtp180 -75.0 -21.75 58.95 Favored 'General case' 0 CA--C 1.533 0.32 0 N-CA-C 113.1 0.778 . . . . 0.0 113.1 -174.859 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' D' D ' 64' ' ' THR . . . . . . . . . . . . . 23.1 m -70.23 146.72 50.48 Favored 'General case' 0 C--N 1.331 -0.222 0 CA-C-O 120.726 0.298 . . . . 0.0 110.995 -175.536 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' D' D ' 65' ' ' LYS . . . . . . . . . . . . . 40.2 ttpt -88.28 121.64 30.9 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-O 121.068 0.461 . . . . 0.0 110.306 179.64 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' D' D ' 66' ' ' ILE . . . . . . . . . . . . . 69.1 mt -113.75 125.22 70.99 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.271 0 N-CA-C 109.556 -0.535 . . . . 0.0 109.556 -178.24 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' D' D ' 67' ' ' THR . . . . . . . . . . . . . 10.8 m -123.92 141.73 51.78 Favored 'General case' 0 C--N 1.331 -0.216 0 CA-C-O 121.062 0.458 . . . . 0.0 111.295 -174.57 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' D' D ' 68' ' ' LEU . . . . . 0.409 ' C ' HD23 ' D' ' 68' ' ' LEU . 5.7 tt . . . . . 0 C--N 1.329 -0.3 0 CA-C-N 115.746 -0.661 . . . . 0.0 109.735 177.132 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' D' D ' 73' ' ' VAL . . . . . . . . . . . . . 34.5 m . . . . . 0 N--CA 1.461 0.078 0 CA-C-O 120.512 0.196 . . . . 0.0 110.534 . . . . . . . . . 0 0 . 1 . 013 nuclear build core ' D' D ' 74' ' ' ASP . . . . . . . . . . . . . 15.6 t0 -100.85 116.48 32.82 Favored 'General case' 0 C--N 1.332 -0.162 0 N-CA-C 109.965 -0.383 . . . . 0.0 109.965 -178.795 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' D' D ' 75' ' ' VAL . . . . . . . . . . . . . 45.2 t -113.77 124.08 70.07 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.196 0 CA-C-O 121.057 0.456 . . . . 0.0 110.304 -177.992 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' D' D ' 76' ' ' LEU . . . . . . . . . . . . . 19.2 mt -127.85 145.51 50.91 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 115.726 -0.67 . . . . 0.0 109.872 179.014 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' D' D ' 77' ' ' GLU . . . . . . . . . . . . . 97.0 mt-10 -134.03 138.62 45.48 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-O 121.092 0.472 . . . . 0.0 111.359 -178.526 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' D' D ' 78' ' ' ALA . . . . . . . . . . . . . . . -125.2 138.83 54.13 Favored 'General case' 0 C--N 1.331 -0.226 0 CA-C-N 115.743 -0.662 . . . . 0.0 109.708 176.301 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' D' D ' 79' ' ' LYS . . . . . 0.516 ' O ' HD13 ' D' ' 80' ' ' ILE . 69.2 mttm -75.12 122.8 24.15 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-O 120.913 0.387 . . . . 0.0 110.797 -177.865 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' D' D ' 80' ' ' ILE . . . . . 0.516 HD13 ' O ' ' D' ' 79' ' ' LYS . 24.5 mm -139.11 114.42 8.54 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.263 0 N-CA-C 109.29 -0.633 . . . . 0.0 109.29 -177.09 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' D' D ' 81' ' ' LYS . . . . . . . . . . . . . 61.7 mttp -113.42 123.24 49.61 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-O 120.866 0.365 . . . . 0.0 111.493 -175.722 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' D' D ' 82' ' ' GLY . . . . . . . . . . . . . . . 89.04 42.08 5.72 Favored Glycine 0 CA--C 1.525 0.715 0 C-N-CA 121.004 -0.617 . . . . 0.0 112.006 174.201 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' D' D ' 83' ' ' ILE . . . . . . . . . . . . . 68.9 mt -68.74 137.39 24.48 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.269 0 N-CA-C 109.992 -0.373 . . . . 0.0 109.992 178.668 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' D' D ' 84' ' ' LYS . . . . . . . . . . . . . 25.6 ttpt -105.94 -47.27 3.9 Favored 'General case' 0 C--N 1.331 -0.217 0 CA-C-N 116.455 -0.339 . . . . 0.0 110.165 177.91 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' D' D ' 85' ' ' ASP . . . . . . . . . . . . . 12.0 t70 -150.34 151.04 32.27 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.043 -0.526 . . . . 0.0 110.441 -179.272 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' D' D ' 86' ' ' VAL . . . . . . . . . . . . . 40.5 t -138.13 137.01 44.7 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.235 0 CA-C-O 121.029 0.443 . . . . 0.0 110.764 -179.266 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' D' D ' 87' ' ' ILE . . . . . . . . . . . . . 46.2 mm -122.16 130.65 74.38 Favored 'Isoleucine or valine' 0 C--O 1.233 0.192 0 CA-C-N 115.781 -0.645 . . . . 0.0 109.793 177.159 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' D' D ' 88' ' ' LEU . . . . . . . . . . . . . 18.8 tp -116.85 132.16 56.77 Favored 'General case' 0 C--N 1.331 -0.201 0 CA-C-O 121.021 0.439 . . . . 0.0 111.161 -177.623 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' D' D ' 89' ' ' ASP . . . . . . . . . . . . . 5.5 t70 -130.66 156.29 45.15 Favored 'General case' 0 C--N 1.331 -0.204 0 CA-C-N 115.835 -0.621 . . . . 0.0 109.668 175.483 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' D' D ' 90' ' ' GLU . . . . . . . . . . . . . 83.9 tt0 -47.04 -39.49 12.9 Favored 'General case' 0 C--N 1.331 -0.201 0 N-CA-C 112.97 0.73 . . . . 0.0 112.97 -172.359 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' D' D ' 91' ' ' ASN . . . . . . . . . . . . . 21.6 p-10 -131.99 36.03 3.7 Favored 'General case' 0 C--O 1.233 0.22 0 N-CA-C 111.767 0.284 . . . . 0.0 111.767 -176.215 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' D' D ' 92' ' ' LEU . . . . . . . . . . . . . 16.0 tp -165.86 138.73 4.17 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-O 120.754 0.312 . . . . 0.0 110.605 -179.821 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' D' D ' 93' ' ' ILE . . . . . . . . . . . . . 73.2 mt -124.27 123.11 65.74 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.204 0 N-CA-C 109.431 -0.581 . . . . 0.0 109.431 179.55 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' D' D ' 94' ' ' VAL . . . . . . . . . . . . . 46.0 t -124.03 128.2 73.94 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.299 0 N-CA-C 109.897 -0.409 . . . . 0.0 109.897 -178.783 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' D' D ' 95' ' ' VAL . . . . . . . . . . . . . 40.7 t -123.78 135.28 63.99 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.346 0 CA-C-N 116.133 -0.485 . . . . 0.0 109.965 -178.611 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' D' D ' 96' ' ' ILE . . . . . . . . . . . . . 66.2 mt -117.13 128.47 74.49 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.237 0 N-CA-C 109.394 -0.595 . . . . 0.0 109.394 178.661 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' D' D ' 97' ' ' THR . . . . . . . . . . . . . 71.2 p -104.35 157.06 17.41 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-O 121.388 0.613 . . . . 0.0 111.502 -176.56 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' D' D ' 98' ' ' GLU . . . . . . . . . . . . . 12.8 pt-20 -54.85 -24.49 23.33 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 115.73 -0.668 . . . . 0.0 112.492 -179.444 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' D' D ' 99' ' ' GLU . . . . . . . . . . . . . 14.8 mm-40 -80.2 16.8 1.16 Allowed 'General case' 0 CA--C 1.536 0.441 0 N-CA-C 112.959 0.725 . . . . 0.0 112.959 -178.578 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' D' D ' 100' ' ' ASN . . . . . . . . . . . . . 4.2 m-20 62.47 37.84 13.13 Favored 'General case' 0 C--O 1.233 0.198 0 CA-C-O 121.019 0.437 . . . . 0.0 110.976 178.344 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' D' D ' 101' ' ' GLU . . . . . . . . . . . . . 84.4 tt0 -114.99 140.84 48.71 Favored 'General case' 0 C--N 1.331 -0.213 0 CA-C-N 116.127 -0.488 . . . . 0.0 109.912 177.364 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' D' D ' 102' ' ' VAL . . . . . . . . . . . . . 44.7 t -114.83 124.77 71.81 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.287 0 N-CA-C 109.656 -0.498 . . . . 0.0 109.656 179.282 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' D' D ' 103' ' ' LEU . . . . . . . . . . . . . 22.0 mt -116.6 133.6 55.82 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 115.805 -0.634 . . . . 0.0 110.155 179.055 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' D' D ' 104' ' ' ILE . . . . . . . . . . . . . 69.1 mt -121.73 121.92 65.59 Favored 'Isoleucine or valine' 0 C--O 1.234 0.239 0 CA-C-N 116.577 -0.283 . . . . 0.0 110.323 -178.35 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' D' D ' 105' ' ' PHE . . . . . . . . . . . . . 74.1 m-85 -123.81 165.81 16.68 Favored 'General case' 0 C--N 1.333 -0.141 0 O-C-N 123.994 0.808 . . . . 0.0 109.937 179.933 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' D' D ' 106' ' ' ASN . . . . . . . . . . . . . 49.8 p-10 -100.54 -174.03 2.55 Favored 'General case' 0 C--N 1.331 -0.209 0 N-CA-C 109.816 -0.438 . . . . 0.0 109.816 171.422 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' D' D ' 107' ' ' GLN . . . . . . . . . . . . . 5.0 tp-100 -59.21 -25.37 63.92 Favored 'General case' 0 CA--C 1.533 0.313 0 N-CA-C 112.331 0.493 . . . . 0.0 112.331 -178.016 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' D' D ' 108' ' ' ASN . . . . . . . . . . . . . 9.7 t30 -91.45 14.17 15.52 Favored 'General case' 0 CA--C 1.534 0.365 0 N-CA-C 112.9 0.704 . . . . 0.0 112.9 -176.553 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' D' D ' 109' ' ' LEU . . . . . . . . . . . . . 76.8 mt 58.77 33.57 23.15 Favored 'General case' 0 CA--C 1.529 0.172 0 CA-C-O 120.789 0.328 . . . . 0.0 111.864 179.162 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' D' D ' 110' ' ' GLU . . . . . . . . . . . . . 70.5 mm-40 -100.21 134.82 42.58 Favored 'General case' 0 C--N 1.329 -0.284 0 N-CA-C 108.932 -0.766 . . . . 0.0 108.932 173.85 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' D' D ' 111' ' ' GLU . . . . . . . . . . . . . 45.2 tt0 -82.18 121.79 27.06 Favored 'General case' 0 C--N 1.328 -0.355 0 C-N-CA 120.643 -0.423 . . . . 0.0 110.519 -174.566 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' D' D ' 112' ' ' LEU . . . . . . . . . . . . . 34.2 mt -97.85 -45.99 6.11 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 115.851 -0.613 . . . . 0.0 110.552 179.282 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' D' D ' 113' ' ' TYR . . . . . . . . . . . . . 58.6 t80 -140.84 144.7 35.49 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.072 -0.513 . . . . 0.0 111.1 -177.854 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' D' D ' 114' ' ' ARG . . . . . . . . . . . . . 33.4 ptt180 -145.89 125.11 12.95 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 115.825 -0.625 . . . . 0.0 110.21 173.617 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' D' D ' 115' ' ' GLY . . . . . . . . . . . . . . . -149.98 143.14 10.38 Favored Glycine 0 CA--C 1.523 0.536 0 N-CA-C 110.82 -0.912 . . . . 0.0 110.82 -179.706 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' D' D ' 116' ' ' LYS . . . . . . . . . . . . . 31.4 ttmt -115.86 132.53 56.62 Favored 'General case' 0 C--N 1.329 -0.318 0 N-CA-C 109.974 -0.38 . . . . 0.0 109.974 179.184 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' D' D ' 117' ' ' PHE . . . . . . . . . . . . . 52.0 m-85 -123.52 116.27 22.91 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.123 -0.49 . . . . 0.0 110.087 -177.085 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' D' D ' 118' ' ' GLU . . . . . . . . . . . . . 84.1 tt0 -53.69 -48.47 69.48 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.576 -0.284 . . . . 0.0 111.355 -176.63 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' D' D ' 119' ' ' ASN . . . . . . . . . . . . . 87.0 m-20 -95.25 31.05 2.02 Favored 'General case' 0 C--N 1.33 -0.27 0 N-CA-C 112.203 0.446 . . . . 0.0 112.203 -174.964 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' D' D ' 120' ' ' LEU . . . . . . . . . . . . . 14.6 tp -55.34 120.32 6.92 Favored 'General case' 0 C--N 1.331 -0.202 0 CA-C-O 120.714 0.292 . . . . 0.0 110.525 178.298 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' D' D ' 121' ' ' ASN . . . . . . . . . . . . . 60.3 m-80 -113.99 -44.1 3.19 Favored 'General case' 0 C--O 1.231 0.109 0 CA-C-N 116.522 -0.308 . . . . 0.0 111.332 -176.795 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' D' D ' 122' ' ' LYS . . . . . . . . . . . . . 53.3 mttm -140.86 145.7 36.54 Favored 'General case' 0 C--N 1.331 -0.219 0 CA-C-O 120.965 0.412 . . . . 0.0 111.665 -177.647 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' D' D ' 123' ' ' VAL . . . . . . . . . . . . . 45.5 t -131.58 127.51 59.48 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.258 0 CA-C-N 116.014 -0.539 . . . . 0.0 109.696 175.319 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' D' D ' 124' ' ' LEU . . . . . . . . . . . . . 14.2 tp -131.29 133.47 45.41 Favored 'General case' 0 C--N 1.33 -0.251 0 N-CA-C 110.108 -0.33 . . . . 0.0 110.108 179.13 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' D' D ' 125' ' ' VAL . . . . . 0.559 HG12 HG13 ' D' ' 130' ' ' VAL . 32.8 m -141.24 138.5 33.39 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 CA-C-O 120.883 0.373 . . . . 0.0 111.074 -178.89 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' D' D ' 126' ' ' ARG . . . . . . . . . . . . . 98.5 mtt180 -144.04 131.05 20.5 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 115.933 -0.576 . . . . 0.0 110.249 178.64 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' D' D ' 127' ' ' ASN . . . . . . . . . . . . . 56.5 t30 52.84 -113.46 0.77 Allowed 'General case' 0 CA--C 1.546 0.813 0 CA-C-O 118.626 -0.702 . . . . 0.0 110.849 179.366 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' D' D ' 128' ' ' ASP . . . . . . . . . . . . . 12.9 p-10 -114.03 12.65 18.01 Favored 'General case' 0 CA--C 1.536 0.416 0 CA-C-N 120.126 1.33 . . . . 0.0 113.144 179.929 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' D' D ' 129' ' ' LEU . . . . . . . . . . . . . 15.8 tp -107.0 131.92 53.52 Favored 'General case' 0 C--O 1.232 0.171 0 N-CA-C 110.002 -0.37 . . . . 0.0 110.002 179.095 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' D' D ' 130' ' ' VAL . . . . . 0.559 HG13 HG12 ' D' ' 125' ' ' VAL . 46.5 t -122.7 133.76 67.88 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.246 0 CA-C-O 120.773 0.321 . . . . 0.0 110.353 -177.0 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' D' D ' 131' ' ' VAL . . . . . 0.535 HG22 HD12 ' D' ' 140' ' ' LEU . 42.8 t -135.52 133.55 52.03 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.191 0 CA-C-O 121.093 0.473 . . . . 0.0 110.204 176.441 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' D' D ' 132' ' ' ILE . . . . . . . . . . . . . 72.5 mt -122.15 134.0 66.73 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.25 0 CA-C-N 115.743 -0.662 . . . . 0.0 109.606 -178.728 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' D' D ' 133' ' ' ILE . . . . . . . . . . . . . 40.3 mm -114.98 124.39 71.6 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.251 0 CA-C-O 120.693 0.282 . . . . 0.0 110.92 -175.298 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' D' D ' 134' ' ' ASP . . . . . . . . . . . . . 9.6 p-10 -134.63 147.83 50.27 Favored 'General case' 0 C--N 1.332 -0.179 0 N-CA-C 109.721 -0.474 . . . . 0.0 109.721 174.804 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' D' D ' 135' ' ' GLU . . . . . . . . . . . . . 43.2 tp10 -50.49 -29.48 10.56 Favored 'General case' 0 C--N 1.329 -0.296 0 N-CA-C 112.845 0.683 . . . . 0.0 112.845 -171.43 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' D' D ' 136' ' ' GLN . . . . . . . . . . . . . 98.7 mt-30 -81.17 -32.71 33.48 Favored 'General case' 0 C--N 1.331 -0.197 0 N-CA-C 112.63 0.604 . . . . 0.0 112.63 -176.016 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' D' D ' 137' ' ' LYS . . . . . . . . . . . . . 37.7 pttt -167.67 172.87 8.93 Favored 'General case' 0 C--N 1.331 -0.223 0 CA-C-O 121.625 0.726 . . . . 0.0 112.261 -172.234 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' D' D ' 138' ' ' LEU . . . . . . . . . . . . . 5.5 tt -115.06 127.64 55.75 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 115.029 -0.987 . . . . 0.0 109.828 179.158 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' D' D ' 139' ' ' THR . . . . . . . . . . . . . 28.1 m -106.2 124.86 50.24 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.143 -0.481 . . . . 0.0 110.145 -179.675 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' D' D ' 140' ' ' LEU . . . . . 0.535 HD12 HG22 ' D' ' 131' ' ' VAL . 11.6 tp -115.67 121.65 43.17 Favored 'General case' 0 C--N 1.327 -0.376 0 N-CA-C 109.311 -0.626 . . . . 0.0 109.311 -178.54 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' D' D ' 141' ' ' ILE . . . . . . . . . . . . . 19.5 mt -119.13 116.75 51.95 Favored 'Isoleucine or valine' 0 C--O 1.234 0.274 0 CA-C-O 120.924 0.392 . . . . 0.0 109.966 -174.847 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' D' D ' 142' ' ' ARG . . . . . . . . . . . . . 81.7 mtp180 -106.87 131.23 54.2 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-N 115.27 -0.877 . . . . 0.0 110.626 -177.751 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' D' D ' 143' ' ' THR . . . . . . . . . . . . . 33.6 p . . . . . 0 C--O 1.221 -0.441 0 CA-C-O 117.907 -1.045 . . . . 0.0 110.893 179.624 . . . . . . . . 0 0 . 1 . 013 nuclear build core ' E' E ' 2' ' ' SER . . . . . . . . . . . . . 11.1 p . . . . . 0 C--O 1.233 0.19 0 CA-C-O 120.896 0.379 . . . . 0.0 110.646 . . . . . . . . . 0 0 . 1 . 013 nuclear build core ' E' E ' 3' ' ' GLU . . . . . . . . . . . . . 77.6 tt0 -141.0 140.7 34.37 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.773 179.787 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' E' E ' 4' ' ' LEU . . . . . . . . . . . . . 5.2 tt -125.82 128.28 47.42 Favored 'General case' 0 C--N 1.331 -0.215 0 CA-C-N 116.087 -0.506 . . . . 0.0 110.124 177.79 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' E' E ' 5' ' ' LYS . . . . . . . . . . . . . 68.9 mttm -105.04 122.59 46.19 Favored 'General case' 0 C--O 1.235 0.291 0 CA-C-N 116.428 -0.351 . . . . 0.0 110.868 -179.307 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' E' E ' 6' ' ' LEU . . . . . . . . . . . . . 64.6 mt -114.61 148.99 37.3 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-N 115.633 -0.712 . . . . 0.0 110.899 -179.153 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' E' E ' 7' ' ' LYS . . . . . . . . . . . . . 79.6 tttt -138.61 134.38 17.29 Favored Pre-proline 0 CA--C 1.535 0.387 0 CA-C-O 118.893 -0.575 . . . . 0.0 109.909 174.676 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' E' E ' 8' ' ' PRO . . . . . . . . . . . . . 88.8 Cg_endo -88.63 142.29 4.9 Favored 'Trans proline' 0 N--CA 1.492 1.42 0 C-N-CA 121.536 1.49 . . . . 0.0 111.624 177.497 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' E' E ' 9' ' ' LEU . . . . . . . . . . . . . 73.7 mt -76.03 -47.27 3.71 Favored Pre-proline 0 CA--C 1.534 0.341 0 CA-C-O 118.792 -0.623 . . . . 0.0 112.058 -178.432 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' E' E ' 10' ' ' PRO . . . . . . . . . . . . . 97.7 Cg_endo -82.34 149.1 14.91 Favored 'Trans proline' 0 N--CA 1.495 1.603 0 C-N-CA 121.276 1.318 . . . . 0.0 111.712 174.463 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' E' E ' 11' ' ' LYS . . . . . . . . . . . . . 59.8 mttp -88.47 97.6 11.16 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-O 120.886 0.374 . . . . 0.0 110.558 178.648 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' E' E ' 12' ' ' VAL . . . . . . . . . . . . . 11.9 p -139.54 148.28 23.45 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.274 0 CA-C-N 115.946 -0.57 . . . . 0.0 110.216 179.79 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' E' E ' 13' ' ' GLU . . . . . . . . . . . . . 81.1 tt0 -81.95 121.72 26.86 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.35 -0.386 . . . . 0.0 109.974 179.085 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' E' E ' 14' ' ' LEU . . . . . . . . . . . . . 31.2 mt -95.89 150.48 37.38 Favored Pre-proline 0 CA--C 1.532 0.271 0 CA-C-N 116.355 -0.384 . . . . 0.0 110.466 -178.581 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' E' E ' 15' ' ' PRO . . . . . . . . . . . . . 33.1 Cg_exo -60.09 158.91 27.98 Favored 'Trans proline' 0 N--CA 1.497 1.728 0 C-N-CA 121.182 1.254 . . . . 0.0 112.024 178.9 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' E' E ' 16' ' ' PRO . . . . . . . . . . . . . 26.8 Cg_exo -60.69 -44.05 28.59 Favored 'Trans proline' 0 N--CA 1.497 1.708 0 C-N-CA 121.453 1.435 . . . . 0.0 112.962 -178.106 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' E' E ' 17' ' ' ASP . . . . . . . . . . . . . 14.3 p-10 -82.69 9.83 8.81 Favored 'General case' 0 C--N 1.327 -0.388 0 N-CA-C 113.259 0.837 . . . . 0.0 113.259 -176.772 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' E' E ' 18' ' ' PHE . . . . . . . . . . . . . 48.0 t80 -57.45 -42.95 83.49 Favored 'General case' 0 N--CA 1.457 -0.089 0 O-C-N 121.896 -0.502 . . . . 0.0 110.243 -178.539 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' E' E ' 19' ' ' VAL . . . . . . . . . . . . . 47.7 t -56.88 -44.63 82.56 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.362 0 CA-C-N 116.384 -0.371 . . . . 0.0 110.473 -177.945 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' E' E ' 20' ' ' ASP . . . . . . . . . . . . . 72.3 m-20 -59.61 -41.31 90.07 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-O 120.773 0.32 . . . . 0.0 110.78 -177.824 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' E' E ' 21' ' ' VAL . . . . . . . . . . . . . 46.4 t -64.24 -46.36 93.6 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.323 0 C-N-CA 120.725 -0.39 . . . . 0.0 110.476 -178.239 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' E' E ' 22' ' ' ILE . . . . . 0.594 HG22 HD12 ' E' ' 26' ' ' LEU . 48.6 mm -61.6 -35.58 68.03 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.266 0 C-N-CA 121.034 -0.267 . . . . 0.0 111.058 -179.852 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' E' E ' 23' ' ' ARG . . . . . . . . . . . . . 58.1 ttp180 -57.38 -47.79 80.74 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-O 120.965 0.412 . . . . 0.0 110.355 176.971 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' E' E ' 24' ' ' ILE . . . . . . . . . . . . . 76.0 mt -61.83 -46.67 96.0 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.238 0 CA-C-N 115.928 -0.578 . . . . 0.0 112.02 -178.037 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' E' E ' 25' ' ' LYS . . . . . . . . . . . . . 12.6 ptmm? -68.45 -35.17 77.21 Favored 'General case' 0 CA--C 1.532 0.283 0 C-N-CA 120.632 -0.427 . . . . 0.0 111.824 -174.05 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' E' E ' 26' ' ' LEU . . . . . 0.594 HD12 HG22 ' E' ' 22' ' ' ILE . 63.3 mt -79.19 -46.45 17.88 Favored 'General case' 0 C--N 1.331 -0.219 0 N-CA-C 112.963 0.727 . . . . 0.0 112.963 -174.918 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' E' E ' 27' ' ' GLN . . . . . . . . . . . . . 15.2 pt20 -46.52 140.84 4.05 Favored 'General case' 0 N--CA 1.468 0.466 0 N-CA-C 112.937 0.717 . . . . 0.0 112.937 -173.786 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' E' E ' 28' ' ' GLY . . . . . . . . . . . . . . . 100.72 -29.93 11.37 Favored Glycine 0 CA--C 1.53 1.01 0 CA-C-N 115.382 -0.827 . . . . 0.0 112.0 -176.776 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' E' E ' 29' ' ' LYS . . . . . . . . . . . . . 98.4 mttt -99.52 155.3 17.64 Favored 'General case' 0 C--O 1.234 0.273 0 CA-C-N 117.137 0.469 . . . . 0.0 111.58 179.435 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' E' E ' 30' ' ' THR . . . . . . . . . . . . . 32.2 m -97.12 140.03 32.23 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 115.93 -0.577 . . . . 0.0 110.266 176.203 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' E' E ' 31' ' ' VAL . . . . . . . . . . . . . 35.1 m -131.13 153.7 39.52 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.238 0 CA-C-N 116.234 -0.439 . . . . 0.0 110.711 -179.616 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' E' E ' 32' ' ' ARG . . . . . . . . . . . . . 75.9 mtt180 -132.7 150.1 52.2 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.04 -0.527 . . . . 0.0 110.489 178.476 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' E' E ' 33' ' ' THR . . . . . . . . . . . . . 26.6 m -53.17 140.56 25.71 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 116.241 -0.436 . . . . 0.0 111.416 -178.016 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' E' E ' 34' ' ' GLY . . . . . . . . . . . . . . . 99.62 -17.22 57.86 Favored Glycine 0 CA--C 1.531 1.082 0 C-N-CA 121.208 -0.52 . . . . 0.0 113.259 179.447 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' E' E ' 35' ' ' ASP . . . . . . . . . . . . . 75.9 m-20 -66.11 148.89 51.14 Favored 'General case' 0 C--N 1.334 -0.098 0 CA-C-N 118.092 0.946 . . . . 0.0 110.908 178.272 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' E' E ' 36' ' ' VAL . . . . . . . . . . . . . 44.1 t -123.76 132.52 71.24 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.214 0 CA-C-N 116.096 -0.502 . . . . 0.0 109.918 178.166 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' E' E ' 37' ' ' ILE . . . . . . . . . . . . . 66.8 mt -118.43 138.79 47.99 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.317 0 CA-C-N 116.12 -0.491 . . . . 0.0 109.766 -179.648 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' E' E ' 38' ' ' GLY . . . . . . . . . . . . . . . -110.87 128.77 8.91 Favored Glycine 0 CA--C 1.526 0.751 0 N-CA-C 111.171 -0.771 . . . . 0.0 111.171 -179.337 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' E' E ' 39' ' ' ILE . . . . . . . . . . . . . 77.0 mt -123.84 136.05 61.5 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.199 0 CA-C-O 120.791 0.329 . . . . 0.0 110.123 179.018 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' E' E ' 40' ' ' SER . . . . . . . . . . . . . 78.0 p -93.64 124.07 37.38 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.705 174.8 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' E' E ' 41' ' ' ILE . . . . . . . . . . . . . 70.7 mt -127.82 118.62 49.4 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.2 0 CA-C-O 120.919 0.39 . . . . 0.0 110.373 177.785 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' E' E ' 42' ' ' LEU . . . . . . . . . . . . . 44.4 mt 51.37 34.32 11.64 Favored 'General case' 0 CA--C 1.531 0.213 0 CA-C-N 116.202 -0.454 . . . . 0.0 111.952 177.621 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' E' E ' 43' ' ' GLY . . . . . . . . . . . . . . . 74.65 32.4 57.41 Favored Glycine 0 CA--C 1.528 0.898 0 C-N-CA 121.138 -0.553 . . . . 0.0 112.095 178.303 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' E' E ' 44' ' ' LYS . . . . . . . . . . . . . 47.8 tptt -137.14 131.32 32.43 Favored 'General case' 0 C--N 1.33 -0.253 0 N-CA-C 109.549 -0.537 . . . . 0.0 109.549 177.776 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' E' E ' 45' ' ' GLU . . . . . . . . . . . . . 69.0 tt0 -85.13 123.3 30.49 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 116.538 -0.301 . . . . 0.0 111.415 -174.666 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' E' E ' 46' ' ' VAL . . . . . . . . . . . . . 7.1 p -124.99 128.7 73.27 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.21 0 CA-C-O 120.904 0.383 . . . . 0.0 110.056 176.412 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' E' E ' 47' ' ' LYS . . . . . . . . . . . . . 34.9 mmtp -101.77 132.81 47.3 Favored 'General case' 0 C--N 1.331 -0.21 0 CA-C-N 115.934 -0.575 . . . . 0.0 111.653 177.604 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' E' E ' 48' ' ' PHE . . . . . . . . . . . . . 89.6 m-85 -114.73 131.9 56.62 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-N 115.922 -0.581 . . . . 0.0 109.734 174.258 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' E' E ' 49' ' ' LYS . . . . . . . . . . . . . 57.6 tttm -106.67 139.8 40.54 Favored 'General case' 0 C--O 1.233 0.23 0 CA-C-N 116.69 -0.232 . . . . 0.0 110.586 179.426 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' E' E ' 50' ' ' VAL . . . . . . . . . . . . . 47.2 t -80.88 108.14 13.92 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.282 0 N-CA-C 109.155 -0.683 . . . . 0.0 109.155 176.026 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' E' E ' 51' ' ' VAL . . . . . . . . . . . . . 47.8 t -71.31 -47.88 57.27 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.309 0 CA-C-N 116.158 -0.474 . . . . 0.0 110.125 -174.266 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' E' E ' 52' ' ' GLN . . . . . . . . . . . . . 48.3 tt0 -164.86 141.58 5.95 Favored 'General case' 0 C--N 1.332 -0.169 0 C-N-CA 120.128 -0.629 . . . . 0.0 111.693 -178.338 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' E' E ' 53' ' ' ALA . . . . . 0.418 ' HB3' ' OG ' ' E' ' 56' ' ' SER . . . -115.0 133.11 56.32 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 115.764 -0.653 . . . . 0.0 110.001 176.5 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' E' E ' 54' ' ' TYR . . . . . . . . . . . . . 13.7 t80 -129.19 110.89 18.14 Favored Pre-proline 0 CA--C 1.534 0.364 0 CA-C-O 118.198 -0.906 . . . . 0.0 110.358 178.556 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' E' E ' 55' ' ' PRO . . . . . . . . . . . . . 72.3 Cg_endo -77.28 170.13 72.23 Favored 'Cis proline' 0 N--CA 1.5 1.862 0 CA-C-N 122.062 1.772 . . . . 0.0 112.075 -6.444 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' E' E ' 56' ' ' SER . . . . . 0.418 ' OG ' ' HB3' ' E' ' 53' ' ' ALA . 48.8 m -123.18 139.09 30.97 Favored Pre-proline 0 CA--C 1.538 0.485 0 CA-C-O 118.501 -0.761 . . . . 0.0 109.505 174.758 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' E' E ' 57' ' ' PRO . . . . . . . . . . . . . 36.7 Cg_endo -67.07 144.29 69.51 Favored 'Cis proline' 0 N--CA 1.499 1.849 0 CA-C-N 121.764 1.666 . . . . 0.0 111.489 -3.54 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' E' E ' 58' ' ' LEU . . . . . . . . . . . . . 19.6 tp -108.37 136.33 48.18 Favored 'General case' 0 C--N 1.331 -0.239 0 CA-C-N 116.313 -0.403 . . . . 0.0 111.024 -176.905 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' E' E ' 59' ' ' ARG . . . . . . . . . . . . . 74.5 ttt180 -103.63 123.78 47.62 Favored 'General case' 0 C--N 1.329 -0.32 0 N-CA-C 108.823 -0.806 . . . . 0.0 108.823 173.04 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' E' E ' 60' ' ' VAL . . . . . . . . . . . . . 43.9 t -81.67 123.02 37.51 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.258 0 C-N-CA 120.475 -0.49 . . . . 0.0 110.58 -173.367 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' E' E ' 61' ' ' GLU . . . . . . . . . . . . . 70.6 mm-40 -131.09 165.06 24.09 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 115.824 -0.625 . . . . 0.0 109.727 176.471 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' E' E ' 62' ' ' ASP . . . . . . . . . . . . . 11.7 t0 -52.62 -30.83 33.49 Favored 'General case' 0 C--N 1.328 -0.338 0 N-CA-C 111.983 0.364 . . . . 0.0 111.983 -179.822 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' E' E ' 63' ' ' ARG . . . . . . . . . . . . . 90.8 mtt-85 -71.78 -22.01 61.64 Favored 'General case' 0 CA--C 1.533 0.302 0 N-CA-C 112.829 0.677 . . . . 0.0 112.829 -176.309 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' E' E ' 64' ' ' THR . . . . . . . . . . . . . 27.3 m -73.03 136.82 45.08 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-O 120.844 0.354 . . . . 0.0 111.203 -174.246 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' E' E ' 65' ' ' LYS . . . . . . . . . . . . . 57.2 mtmt -90.08 132.61 35.32 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 115.956 -0.566 . . . . 0.0 110.454 177.946 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' E' E ' 66' ' ' ILE . . . . . . . . . . . . . 66.4 mt -112.62 128.2 69.43 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.283 0 N-CA-C 109.571 -0.529 . . . . 0.0 109.571 178.837 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' E' E ' 67' ' ' THR . . . . . . . . . . . . . 21.9 m -122.85 144.67 49.05 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-O 121.219 0.533 . . . . 0.0 111.317 -175.425 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' E' E ' 68' ' ' LEU . . . . . 0.452 ' C ' HD23 ' E' ' 68' ' ' LEU . 6.2 tt . . . . . 0 C--N 1.33 -0.281 0 CA-C-N 115.601 -0.727 . . . . 0.0 109.96 178.698 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' E' E ' 73' ' ' VAL . . . . . . . . . . . . . 27.0 m . . . . . 0 N--CA 1.461 0.112 0 CA-C-O 121.078 0.466 . . . . 0.0 110.564 . . . . . . . . . 0 0 . 1 . 013 nuclear build core ' E' E ' 74' ' ' ASP . . . . . . . . . . . . . 19.2 t0 -98.88 117.77 34.14 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 115.729 -0.669 . . . . 0.0 109.514 178.306 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' E' E ' 75' ' ' VAL . . . . . . . . . . . . . 43.3 t -109.0 119.34 58.38 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.251 0 CA-C-O 121.034 0.445 . . . . 0.0 110.279 -178.235 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' E' E ' 76' ' ' LEU . . . . . . . . . . . . . 28.7 mt -119.77 143.24 47.93 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 115.653 -0.703 . . . . 0.0 109.731 178.254 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' E' E ' 77' ' ' GLU . . . . . . . . . . . . . 97.2 mt-10 -134.86 129.38 34.35 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-O 121.071 0.463 . . . . 0.0 111.011 -178.294 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' E' E ' 78' ' ' ALA . . . . . . . . . . . . . . . -115.1 127.11 55.39 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 115.707 -0.679 . . . . 0.0 109.531 177.121 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' E' E ' 79' ' ' LYS . . . . . 0.545 ' O ' HD13 ' E' ' 80' ' ' ILE . 95.4 mttt -75.18 117.7 17.3 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-O 121.014 0.435 . . . . 0.0 110.747 -177.793 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' E' E ' 80' ' ' ILE . . . . . 0.545 HD13 ' O ' ' E' ' 79' ' ' LYS . 25.2 mm -139.27 111.23 5.33 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.378 0 N-CA-C 108.918 -0.771 . . . . 0.0 108.918 -178.601 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' E' E ' 81' ' ' LYS . . . . . . . . . . . . . 20.4 pttp -101.55 128.48 47.79 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-O 121.179 0.514 . . . . 0.0 111.402 -176.883 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' E' E ' 82' ' ' GLY . . . . . . . . . . . . . . . 89.19 42.14 5.66 Favored Glycine 0 CA--C 1.527 0.789 0 CA-C-N 115.697 -0.683 . . . . 0.0 111.858 175.6 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' E' E ' 83' ' ' ILE . . . . . . . . . . . . . 68.6 mt -69.37 137.37 24.36 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.337 0 N-CA-C 109.675 -0.491 . . . . 0.0 109.675 176.737 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' E' E ' 84' ' ' LYS . . . . . . . . . . . . . 23.4 ttpp -104.72 -51.73 3.01 Favored 'General case' 0 C--N 1.331 -0.212 0 CA-C-O 120.935 0.398 . . . . 0.0 110.252 179.968 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' E' E ' 85' ' ' ASP . . . . . . . . . . . . . 11.3 t70 -147.88 148.73 31.16 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 115.988 -0.551 . . . . 0.0 110.525 -178.865 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' E' E ' 86' ' ' VAL . . . . . . . . . . . . . 43.3 t -130.37 133.58 63.67 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.212 0 CA-C-O 120.984 0.421 . . . . 0.0 110.621 -179.498 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' E' E ' 87' ' ' ILE . . . . . . . . . . . . . 43.3 mm -119.31 122.87 70.16 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 CA-C-N 115.769 -0.651 . . . . 0.0 109.374 176.532 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' E' E ' 88' ' ' LEU . . . . . . . . . . . . . 60.4 mt -113.4 133.06 55.37 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-O 120.962 0.41 . . . . 0.0 111.312 -176.86 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' E' E ' 89' ' ' ASP . . . . . . . . . . . . . 6.5 t0 -134.2 157.56 45.93 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 115.821 -0.627 . . . . 0.0 109.72 176.627 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' E' E ' 90' ' ' GLU . . . . . . . . . . . . . 82.6 tt0 -46.41 -39.08 9.9 Favored 'General case' 0 C--N 1.329 -0.287 0 N-CA-C 113.295 0.85 . . . . 0.0 113.295 -170.588 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' E' E ' 91' ' ' ASN . . . . . . . . . . . . . 44.2 t30 -124.54 11.64 8.6 Favored 'General case' 0 N--CA 1.469 0.499 0 N-CA-C 113.528 0.936 . . . . 0.0 113.528 -174.231 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' E' E ' 92' ' ' LEU . . . . . . . . . . . . . 18.5 mt -148.22 143.48 27.04 Favored 'General case' 0 C--N 1.333 -0.141 0 CA-C-N 117.941 0.337 . . . . 0.0 110.36 -176.322 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' E' E ' 93' ' ' ILE . . . . . . . . . . . . . 70.1 mt -123.98 117.37 50.73 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.294 0 N-CA-C 109.222 -0.658 . . . . 0.0 109.222 176.724 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' E' E ' 94' ' ' VAL . . . . . . . . . . . . . 44.5 t -116.59 125.99 73.83 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.281 0 N-CA-C 109.791 -0.448 . . . . 0.0 109.791 -179.44 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' E' E ' 95' ' ' VAL . . . . . . . . . . . . . 43.4 t -118.81 133.45 65.61 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.34 0 CA-C-N 115.987 -0.552 . . . . 0.0 109.83 -179.601 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' E' E ' 96' ' ' ILE . . . . . 0.434 HD11 ' HB ' ' E' ' 123' ' ' VAL . 68.7 mt -114.17 127.11 71.74 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.305 0 N-CA-C 109.255 -0.646 . . . . 0.0 109.255 178.085 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' E' E ' 97' ' ' THR . . . . . . . . . . . . . 76.4 p -99.59 158.94 15.4 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-O 121.207 0.527 . . . . 0.0 111.117 -177.242 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' E' E ' 98' ' ' GLU . . . . . . . . . . . . . 96.8 mt-10 -53.82 -25.69 20.65 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.079 -0.509 . . . . 0.0 112.181 179.296 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' E' E ' 99' ' ' GLU . . . . . . . . . . . . . 34.7 tt0 -79.34 15.29 1.27 Allowed 'General case' 0 CA--C 1.539 0.533 0 N-CA-C 112.623 0.601 . . . . 0.0 112.623 -177.277 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' E' E ' 100' ' ' ASN . . . . . . . . . . . . . 2.8 m-20 61.16 37.94 17.21 Favored 'General case' 0 CA--C 1.53 0.186 0 O-C-N 121.815 -0.553 . . . . 0.0 110.936 178.752 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' E' E ' 101' ' ' GLU . . . . . . . . . . . . . 84.0 tt0 -115.27 145.11 42.78 Favored 'General case' 0 C--N 1.332 -0.182 0 CA-C-N 116.023 -0.535 . . . . 0.0 109.8 176.89 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' E' E ' 102' ' ' VAL . . . . . . . . . . . . . 45.5 t -115.02 124.22 71.46 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.331 0 CA-C-N 116.121 -0.491 . . . . 0.0 109.867 -178.251 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' E' E ' 103' ' ' LEU . . . . . . . . . . . . . 22.3 mt -118.48 128.16 54.32 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 115.8 -0.636 . . . . 0.0 110.144 176.667 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' E' E ' 104' ' ' ILE . . . . . . . . . . . . . 71.5 mt -118.42 122.28 69.14 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.257 0 N-CA-C 110.284 -0.265 . . . . 0.0 110.284 -179.652 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' E' E ' 105' ' ' PHE . . . . . . . . . . . . . 71.3 m-85 -120.79 165.84 14.58 Favored 'General case' 0 C--N 1.332 -0.161 0 O-C-N 124.035 0.835 . . . . 0.0 110.265 -179.985 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' E' E ' 106' ' ' ASN . . . . . . . . . . . . . 53.4 p-10 -99.35 -169.98 1.84 Allowed 'General case' 0 C--N 1.331 -0.236 0 N-CA-C 109.826 -0.435 . . . . 0.0 109.826 172.731 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' E' E ' 107' ' ' GLN . . . . . . . . . . . . . 5.4 tp-100 -57.45 -27.77 62.75 Favored 'General case' 0 CA--C 1.534 0.334 0 N-CA-C 112.193 0.442 . . . . 0.0 112.193 -177.889 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' E' E ' 108' ' ' ASN . . . . . . . . . . . . . 9.1 t-20 -93.68 14.34 19.38 Favored 'General case' 0 CA--C 1.534 0.351 0 N-CA-C 113.136 0.791 . . . . 0.0 113.136 -175.453 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' E' E ' 109' ' ' LEU . . . . . . . . . . . . . 72.5 mt 58.72 35.81 24.57 Favored 'General case' 0 CA--C 1.53 0.176 0 CA-C-O 120.881 0.372 . . . . 0.0 111.55 179.494 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' E' E ' 110' ' ' GLU . . . . . . . . . . . . . 95.9 mt-10 -99.26 148.19 24.39 Favored 'General case' 0 C--N 1.33 -0.282 0 N-CA-C 109.774 -0.454 . . . . 0.0 109.774 175.894 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' E' E ' 111' ' ' GLU . . . . . . . . . . . . . 57.1 tt0 -79.9 122.86 27.2 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.399 -0.364 . . . . 0.0 111.016 -176.273 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' E' E ' 112' ' ' LEU . . . . . . . . . . . . . 17.0 mt -109.89 -45.98 3.55 Favored 'General case' 0 C--N 1.331 -0.202 0 CA-C-N 116.207 -0.451 . . . . 0.0 110.616 177.584 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' E' E ' 113' ' ' TYR . . . . . . . . . . . . . 53.2 t80 -138.47 135.5 35.23 Favored 'General case' 0 C--N 1.331 -0.238 0 C-N-CA 120.837 -0.345 . . . . 0.0 111.079 -179.318 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' E' E ' 114' ' ' ARG . . . . . . . . . . . . . 61.3 ttp180 -136.19 123.45 21.83 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-N 116.228 -0.442 . . . . 0.0 110.373 178.047 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' E' E ' 115' ' ' GLY . . . . . . . . . . . . . . . -150.14 158.91 27.88 Favored Glycine 0 CA--C 1.526 0.726 0 N-CA-C 111.181 -0.768 . . . . 0.0 111.181 177.956 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' E' E ' 116' ' ' LYS . . . . . . . . . . . . . 39.5 ttpt -127.75 137.46 52.44 Favored 'General case' 0 C--N 1.331 -0.238 0 N-CA-C 109.497 -0.557 . . . . 0.0 109.497 175.105 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' E' E ' 117' ' ' PHE . . . . . . . . . . . . . 37.1 m-85 -139.75 113.89 8.95 Favored 'General case' 0 C--N 1.331 -0.209 0 C-N-CA 120.697 -0.401 . . . . 0.0 110.214 -177.094 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' E' E ' 118' ' ' GLU . . . . . . . . . . . . . 96.1 mt-10 -56.86 -43.92 81.66 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.398 -0.364 . . . . 0.0 110.891 -176.67 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' E' E ' 119' ' ' ASN . . . . . . . . . . . . . 79.0 m-20 -93.87 28.66 2.32 Favored 'General case' 0 C--N 1.329 -0.299 0 N-CA-C 112.312 0.486 . . . . 0.0 112.312 -174.943 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' E' E ' 120' ' ' LEU . . . . . . . . . . . . . 18.6 tp -59.3 123.46 16.79 Favored 'General case' 0 C--N 1.333 -0.122 0 N-CA-C 109.945 -0.391 . . . . 0.0 109.945 177.645 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' E' E ' 121' ' ' ASN . . . . . . . . . . . . . 33.7 m120 -114.13 -43.92 3.19 Favored 'General case' 0 C--N 1.332 -0.19 0 CA-C-N 116.509 -0.314 . . . . 0.0 110.953 -177.526 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' E' E ' 122' ' ' LYS . . . . . . . . . . . . . 98.6 mttt -144.03 148.05 34.69 Favored 'General case' 0 C--N 1.332 -0.195 0 CA-C-O 121.089 0.471 . . . . 0.0 111.714 -177.109 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' E' E ' 123' ' ' VAL . . . . . 0.434 ' HB ' HD11 ' E' ' 96' ' ' ILE . 45.8 t -127.95 129.97 69.82 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.341 0 N-CA-C 109.183 -0.673 . . . . 0.0 109.183 173.528 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' E' E ' 124' ' ' LEU . . . . . . . . . . . . . 28.2 mt -129.31 137.74 51.19 Favored 'General case' 0 N--CA 1.463 0.206 0 CA-C-O 121.047 0.451 . . . . 0.0 111.036 -176.147 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' E' E ' 125' ' ' VAL . . . . . . . . . . . . . 41.4 t -124.71 129.46 73.63 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.225 0 CA-C-N 115.77 -0.65 . . . . 0.0 109.922 179.725 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' E' E ' 126' ' ' ARG . . . . . . . . . . . . . 43.4 mmm-85 -140.61 115.32 9.56 Favored 'General case' 0 C--N 1.329 -0.298 0 N-CA-C 109.416 -0.587 . . . . 0.0 109.416 177.869 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' E' E ' 127' ' ' ASN . . . . . . . . . . . . . 78.5 m-20 56.02 -149.84 0.45 Allowed 'General case' 0 CA--C 1.541 0.629 0 N-CA-C 109.838 -0.43 . . . . 0.0 109.838 -179.93 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' E' E ' 128' ' ' ASP . . . . . . . . . . . . . 38.4 p30 -80.01 14.19 1.93 Allowed 'General case' 0 CA--C 1.535 0.39 0 N-CA-C 112.932 0.716 . . . . 0.0 112.932 179.136 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' E' E ' 129' ' ' LEU . . . . . . . . . . . . . 14.3 tp -111.93 136.46 51.22 Favored 'General case' 0 C--O 1.232 0.141 0 N-CA-C 109.688 -0.486 . . . . 0.0 109.688 177.289 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' E' E ' 130' ' ' VAL . . . . . 0.52 HG13 ' HB ' ' E' ' 141' ' ' ILE . 11.3 p -129.09 140.75 48.4 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.254 0 CA-C-O 120.934 0.397 . . . . 0.0 110.341 -177.924 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' E' E ' 131' ' ' VAL . . . . . . . . . . . . . 35.1 m -136.05 145.1 31.56 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.252 0 CA-C-O 121.237 0.541 . . . . 0.0 111.292 -179.096 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' E' E ' 132' ' ' ILE . . . . . . . . . . . . . 72.5 mt -118.94 133.69 64.98 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.32 0 CA-C-N 115.269 -0.878 . . . . 0.0 109.243 179.986 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' E' E ' 133' ' ' ILE . . . . . . . . . . . . . 39.5 mm -115.37 119.84 62.96 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.274 0 CA-C-O 120.722 0.296 . . . . 0.0 110.885 -175.399 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' E' E ' 134' ' ' ASP . . . . . . . . . . . . . 9.5 p-10 -131.79 148.26 52.55 Favored 'General case' 0 C--N 1.332 -0.173 0 N-CA-C 109.542 -0.54 . . . . 0.0 109.542 175.221 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' E' E ' 135' ' ' GLU . . . . . . . . . . . . . 84.8 tt0 -49.87 -27.61 5.4 Favored 'General case' 0 C--N 1.326 -0.422 0 N-CA-C 112.796 0.665 . . . . 0.0 112.796 -172.567 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' E' E ' 136' ' ' GLN . . . . . . . . . . . . . 98.4 mt-30 -81.85 -34.45 30.11 Favored 'General case' 0 C--N 1.33 -0.249 0 N-CA-C 112.746 0.647 . . . . 0.0 112.746 -176.192 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' E' E ' 137' ' ' LYS . . . . . . . . . . . . . 54.1 pttt -167.93 171.53 9.71 Favored 'General case' 0 C--N 1.332 -0.196 0 CA-C-O 121.66 0.743 . . . . 0.0 112.573 -171.131 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' E' E ' 138' ' ' LEU . . . . . 0.582 HD23 ' N ' ' E' ' 139' ' ' THR . 3.4 tt -114.05 127.91 56.15 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 114.73 -1.123 . . . . 0.0 109.679 -179.958 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' E' E ' 139' ' ' THR . . . . . 0.582 ' N ' HD23 ' E' ' 138' ' ' LEU . 30.5 m -108.86 128.02 54.55 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-O 120.715 0.293 . . . . 0.0 110.401 179.219 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' E' E ' 140' ' ' LEU . . . . . 0.48 ' C ' HD23 ' E' ' 140' ' ' LEU . 8.0 tt -117.57 124.34 48.44 Favored 'General case' 0 C--N 1.329 -0.285 0 N-CA-C 109.359 -0.608 . . . . 0.0 109.359 -178.594 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' E' E ' 141' ' ' ILE . . . . . 0.52 ' HB ' HG13 ' E' ' 130' ' ' VAL . 19.5 mt -120.94 121.73 65.87 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.305 0 N-CA-C 109.714 -0.476 . . . . 0.0 109.714 -175.431 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' E' E ' 142' ' ' ARG . . . . . . . . . . . . . 73.7 ttt180 -112.7 130.21 56.13 Favored 'General case' 0 C--N 1.331 -0.208 0 CA-C-N 115.709 -0.678 . . . . 0.0 110.407 -176.89 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' E' E ' 143' ' ' THR . . . . . . . . . . . . . 50.8 p . . . . . 0 C--O 1.22 -0.475 0 CA-C-O 117.997 -1.001 . . . . 0.0 110.603 -179.81 . . . . . . . . 0 0 . 1 . 013 nuclear build core ' F' F ' 1' ' ' MET . . . . . . . . . . . . . 25.6 ptp . . . . . 0 CA--C 1.527 0.06 0 CA-C-O 120.766 0.317 . . . . 0.0 110.615 . . . . . . . . . 0 0 . 1 . 013 nuclear build core ' F' F ' 2' ' ' SER . . . . . . . . . . . . . 3.0 p -110.51 127.54 55.22 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-O 121.134 0.492 . . . . 0.0 110.449 178.916 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' F' F ' 3' ' ' GLU . . . . . . . . . . . . . 84.2 tt0 -140.17 139.14 35.66 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 115.69 -0.687 . . . . 0.0 110.771 -178.827 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' F' F ' 4' ' ' LEU . . . . . . . . . . . . . 19.1 tp -122.13 124.75 44.62 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 115.985 -0.552 . . . . 0.0 110.376 178.497 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' F' F ' 5' ' ' LYS . . . . . . . . . . . . . 97.9 mttt -101.92 118.84 37.75 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.146 -0.479 . . . . 0.0 110.28 177.261 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' F' F ' 6' ' ' LEU . . . . . . . . . . . . . 31.0 mt -114.99 148.28 38.99 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 115.486 -0.779 . . . . 0.0 110.242 -179.07 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' F' F ' 7' ' ' LYS . . . . . . . . . . . . . 52.3 tttp -137.2 140.71 31.84 Favored Pre-proline 0 CA--C 1.534 0.34 0 CA-C-O 119.124 -0.465 . . . . 0.0 110.047 175.433 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' F' F ' 8' ' ' PRO . . . . . . . . . . . . . 89.3 Cg_endo -91.85 139.37 2.17 Favored 'Trans proline' 0 N--CA 1.49 1.293 0 C-N-CA 121.736 1.624 . . . . 0.0 111.745 177.898 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' F' F ' 9' ' ' LEU . . . . . . . . . . . . . 46.1 mt -77.68 -47.66 2.34 Favored Pre-proline 0 CA--C 1.534 0.35 0 CA-C-O 118.682 -0.675 . . . . 0.0 112.237 -179.663 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' F' F ' 10' ' ' PRO . . . . . . . . . . . . . 86.2 Cg_endo -80.6 152.93 20.18 Favored 'Trans proline' 0 N--CA 1.495 1.616 0 C-N-CA 121.185 1.257 . . . . 0.0 111.89 176.064 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' F' F ' 11' ' ' LYS . . . . . . . . . . . . . 60.7 tttm -88.8 93.66 9.66 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-O 120.818 0.342 . . . . 0.0 110.456 179.038 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' F' F ' 12' ' ' VAL . . . . . . . . . . . . . 13.0 p -141.38 143.34 27.86 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.231 0 CA-C-N 116.318 -0.401 . . . . 0.0 110.701 -179.525 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' F' F ' 13' ' ' GLU . . . . . . . . . . . . . 45.9 mp0 -77.67 132.83 38.38 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.29 -0.414 . . . . 0.0 110.255 178.065 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' F' F ' 14' ' ' LEU . . . . . . . . . . . . . 31.0 mt -98.37 147.74 33.55 Favored Pre-proline 0 CA--C 1.533 0.307 0 CA-C-O 119.185 -0.436 . . . . 0.0 110.233 -179.738 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' F' F ' 15' ' ' PRO . . . . . . . . . . . . . 25.8 Cg_exo -62.17 158.95 36.94 Favored 'Trans proline' 0 N--CA 1.498 1.741 0 C-N-CA 121.335 1.356 . . . . 0.0 111.876 176.793 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' F' F ' 16' ' ' PRO . . . . . . . . . . . . . 38.7 Cg_exo -58.56 -41.17 67.31 Favored 'Trans proline' 0 N--CA 1.498 1.785 0 C-N-CA 121.497 1.465 . . . . 0.0 112.808 -177.72 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' F' F ' 17' ' ' ASP . . . . . . . . . . . . . 19.2 p-10 -85.71 9.02 17.55 Favored 'General case' 0 C--N 1.326 -0.414 0 N-CA-C 113.23 0.826 . . . . 0.0 113.23 -177.609 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' F' F ' 18' ' ' PHE . . . . . . . . . . . . . 36.7 t80 -58.34 -45.43 88.14 Favored 'General case' 0 C--N 1.333 -0.114 0 O-C-N 121.998 -0.439 . . . . 0.0 110.152 -177.594 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' F' F ' 19' ' ' VAL . . . . . 0.413 HG13 ' N ' ' F' ' 20' ' ' ASP . 13.6 p -56.69 -41.51 74.63 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.329 0 CA-C-N 116.25 -0.432 . . . . 0.0 110.954 -178.738 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' F' F ' 20' ' ' ASP . . . . . 0.413 ' N ' HG13 ' F' ' 19' ' ' VAL . 30.0 m-20 -60.53 -43.5 97.07 Favored 'General case' 0 C--N 1.331 -0.198 0 C-N-CA 120.937 -0.305 . . . . 0.0 111.12 -178.087 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' F' F ' 21' ' ' VAL . . . . . . . . . . . . . 47.0 t -64.58 -46.11 93.52 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.255 0 C-N-CA 120.834 -0.346 . . . . 0.0 110.519 -177.498 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' F' F ' 22' ' ' ILE . . . . . 0.53 HG22 HD12 ' F' ' 26' ' ' LEU . 51.5 mm -57.46 -41.05 77.93 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.288 0 C-N-CA 121.089 -0.244 . . . . 0.0 110.628 179.418 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' F' F ' 23' ' ' ARG . . . . . . . . . . . . . 32.0 ttp180 -56.14 -48.29 76.55 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-O 120.945 0.402 . . . . 0.0 110.718 178.04 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' F' F ' 24' ' ' ILE . . . . . . . . . . . . . 73.0 mt -61.66 -42.48 94.38 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.306 0 CA-C-N 116.014 -0.539 . . . . 0.0 111.941 -177.969 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' F' F ' 25' ' ' LYS . . . . . . . . . . . . . 16.4 pttp -73.58 -35.07 65.4 Favored 'General case' 0 CA--C 1.533 0.314 0 C-N-CA 120.537 -0.465 . . . . 0.0 111.801 -173.326 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' F' F ' 26' ' ' LEU . . . . . 0.53 HD12 HG22 ' F' ' 22' ' ' ILE . 64.5 mt -79.07 -43.06 24.94 Favored 'General case' 0 C--N 1.33 -0.258 0 N-CA-C 112.971 0.73 . . . . 0.0 112.971 -174.528 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' F' F ' 27' ' ' GLN . . . . . . . . . . . . . 15.1 pt20 -46.73 139.67 5.12 Favored 'General case' 0 N--CA 1.469 0.505 0 N-CA-C 112.884 0.698 . . . . 0.0 112.884 -174.54 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' F' F ' 28' ' ' GLY . . . . . . . . . . . . . . . 100.31 -29.99 11.1 Favored Glycine 0 CA--C 1.529 0.948 0 CA-C-N 115.471 -0.786 . . . . 0.0 111.971 -177.915 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' F' F ' 29' ' ' LYS . . . . . . . . . . . . . 98.1 mttt -98.09 155.2 17.25 Favored 'General case' 0 C--O 1.233 0.19 0 CA-C-O 121.061 0.458 . . . . 0.0 111.035 177.988 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' F' F ' 30' ' ' THR . . . . . . . . . . . . . 23.9 m -103.91 139.43 39.09 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.019 -0.537 . . . . 0.0 109.994 175.816 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' F' F ' 31' ' ' VAL . . . . . . . . . . . . . 34.9 m -127.34 157.61 38.93 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.288 0 CA-C-N 116.254 -0.43 . . . . 0.0 110.514 -179.125 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' F' F ' 32' ' ' ARG . . . . . . . . . . . . . 56.3 ttp180 -133.77 151.92 51.73 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-O 121.178 0.514 . . . . 0.0 110.612 179.569 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' F' F ' 33' ' ' THR . . . . . . . . . . . . . 20.7 m -53.09 138.43 31.06 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 116.221 -0.445 . . . . 0.0 111.406 -178.489 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' F' F ' 34' ' ' GLY . . . . . . . . . . . . . . . 100.84 -17.08 56.9 Favored Glycine 0 CA--C 1.534 1.223 0 CA-C-O 119.584 -0.565 . . . . 0.0 113.262 179.16 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' F' F ' 35' ' ' ASP . . . . . . . . . . . . . 63.2 m-20 -65.13 149.45 49.88 Favored 'General case' 0 N--CA 1.461 0.096 0 CA-C-N 118.006 0.903 . . . . 0.0 111.308 179.602 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' F' F ' 36' ' ' VAL . . . . . . . . . . . . . 45.8 t -125.15 129.63 73.2 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.196 0 CA-C-N 115.686 -0.688 . . . . 0.0 109.71 178.399 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' F' F ' 37' ' ' ILE . . . . . . . . . . . . . 68.4 mt -122.29 138.92 50.85 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.265 0 N-CA-C 109.839 -0.43 . . . . 0.0 109.839 -179.948 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' F' F ' 38' ' ' GLY . . . . . . . . . . . . . . . -111.07 128.87 8.93 Favored Glycine 0 CA--C 1.524 0.654 0 N-CA-C 111.191 -0.764 . . . . 0.0 111.191 -179.372 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' F' F ' 39' ' ' ILE . . . . . . . . . . . . . 72.4 mt -122.57 136.47 59.28 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.215 0 N-CA-C 109.902 -0.407 . . . . 0.0 109.902 179.014 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' F' F ' 40' ' ' SER . . . . . 0.518 ' O ' HD13 ' F' ' 41' ' ' ILE . 21.8 t -92.74 118.32 30.95 Favored 'General case' 0 C--N 1.33 -0.25 0 C-N-CA 120.956 -0.298 . . . . 0.0 110.802 176.26 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' F' F ' 41' ' ' ILE . . . . . 0.518 HD13 ' O ' ' F' ' 40' ' ' SER . 47.8 mm -128.77 115.77 38.38 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.207 0 CA-C-O 120.811 0.339 . . . . 0.0 110.273 178.331 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' F' F ' 42' ' ' LEU . . . . . . . . . . . . . 11.4 tp 57.14 37.16 28.34 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 116.137 -0.483 . . . . 0.0 111.386 178.428 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' F' F ' 43' ' ' GLY . . . . . . . . . . . . . . . 77.67 -10.09 26.21 Favored Glycine 0 CA--C 1.534 1.268 0 C-N-CA 121.316 -0.469 . . . . 0.0 113.5 177.074 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' F' F ' 44' ' ' LYS . . . . . . . . . . . . . 38.7 mmtm -97.52 135.5 39.27 Favored 'General case' 0 C--N 1.332 -0.193 0 CA-C-N 117.966 0.883 . . . . 0.0 110.17 177.277 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' F' F ' 45' ' ' GLU . . . . . . . . . . . . . 82.7 tt0 -84.65 125.99 32.96 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.358 -0.383 . . . . 0.0 110.819 179.873 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' F' F ' 46' ' ' VAL . . . . . . . . . . . . . 7.3 p -119.34 126.44 75.34 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.159 0 N-CA-C 109.437 -0.579 . . . . 0.0 109.437 176.135 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' F' F ' 47' ' ' LYS . . . . . . . . . . . . . 60.4 mttp -100.1 127.46 46.33 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 115.865 -0.607 . . . . 0.0 111.007 178.806 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' F' F ' 48' ' ' PHE . . . . . . . . . . . . . 93.9 m-85 -109.89 131.91 54.64 Favored 'General case' 0 C--N 1.33 -0.262 0 N-CA-C 109.817 -0.438 . . . . 0.0 109.817 175.925 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' F' F ' 49' ' ' LYS . . . . . . . . . . . . . 53.7 tttp -108.44 138.83 44.09 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.406 -0.361 . . . . 0.0 110.349 179.128 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' F' F ' 50' ' ' VAL . . . . . . . . . . . . . 45.2 t -81.77 108.69 15.13 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.257 0 N-CA-C 109.384 -0.598 . . . . 0.0 109.384 176.226 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' F' F ' 51' ' ' VAL . . . . . . . . . . . . . 48.5 t -74.89 -48.06 34.66 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.276 0 CA-C-N 115.988 -0.551 . . . . 0.0 110.068 -174.015 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' F' F ' 52' ' ' GLN . . . . . . . . . . . . . 62.6 tt0 -158.7 133.94 8.52 Favored 'General case' 0 C--N 1.331 -0.23 0 C-N-CA 120.241 -0.584 . . . . 0.0 111.811 -177.518 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' F' F ' 53' ' ' ALA . . . . . 0.481 ' HB1' ' HB2' ' F' ' 58' ' ' LEU . . . -108.22 127.29 53.71 Favored 'General case' 0 C--N 1.332 -0.185 0 CA-C-N 115.667 -0.697 . . . . 0.0 109.644 174.395 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' F' F ' 54' ' ' TYR . . . . . . . . . . . . . 56.5 t80 -123.38 107.45 32.24 Favored Pre-proline 0 CA--C 1.534 0.346 0 CA-C-O 118.304 -0.855 . . . . 0.0 110.643 -178.606 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' F' F ' 55' ' ' PRO . . . . . . . . . . . . . 74.0 Cg_endo -76.96 169.86 73.28 Favored 'Cis proline' 0 N--CA 1.5 1.887 0 CA-C-N 121.725 1.652 . . . . 0.0 112.434 -5.681 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' F' F ' 56' ' ' SER . . . . . . . . . . . . . 25.1 m -108.52 124.55 34.1 Favored Pre-proline 0 CA--C 1.538 0.51 0 CA-C-O 118.372 -0.823 . . . . 0.0 109.561 175.819 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' F' F ' 57' ' ' PRO . . . . . . . . . . . . . 48.1 Cg_endo -70.19 166.66 74.6 Favored 'Cis proline' 0 N--CA 1.498 1.771 0 CA-C-N 122.106 1.788 . . . . 0.0 111.824 0.391 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' F' F ' 58' ' ' LEU . . . . . 0.481 ' HB2' ' HB1' ' F' ' 53' ' ' ALA . 24.2 tp -129.09 135.37 48.81 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.137 -0.483 . . . . 0.0 110.296 -179.926 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' F' F ' 59' ' ' ARG . . . . . . . . . . . . . 52.1 ttp180 -104.56 131.87 51.46 Favored 'General case' 0 C--N 1.327 -0.4 0 N-CA-C 109.68 -0.489 . . . . 0.0 109.68 178.749 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' F' F ' 60' ' ' VAL . . . . . . . . . . . . . 45.3 t -86.2 123.22 39.45 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.214 0 C-N-CA 120.671 -0.411 . . . . 0.0 110.404 -175.469 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' F' F ' 61' ' ' GLU . . . . . . . . . . . . . 95.3 mt-10 -131.06 166.26 21.43 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 115.942 -0.572 . . . . 0.0 110.14 177.806 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' F' F ' 62' ' ' ASP . . . . . . . . . . . . . 64.0 m-20 -54.92 -32.75 61.5 Favored 'General case' 0 C--N 1.327 -0.382 0 C-N-CA 121.096 -0.242 . . . . 0.0 111.604 179.536 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' F' F ' 63' ' ' ARG . . . . . . . . . . . . . 10.3 ptm180 -87.78 6.91 32.88 Favored 'General case' 0 CA--C 1.537 0.446 0 N-CA-C 113.59 0.959 . . . . 0.0 113.59 -176.73 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' F' F ' 64' ' ' THR . . . . . . . . . . . . . 11.8 m -82.41 139.98 33.72 Favored 'General case' 0 C--N 1.333 -0.137 0 CA-C-N 118.051 0.387 . . . . 0.0 110.655 -177.967 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' F' F ' 65' ' ' LYS . . . . . . . . . . . . . 97.9 mttt -89.15 125.05 34.89 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.085 179.21 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' F' F ' 66' ' ' ILE . . . . . . . . . . . . . 59.4 mt -116.36 127.93 73.83 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.262 0 N-CA-C 109.679 -0.489 . . . . 0.0 109.679 179.0 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' F' F ' 67' ' ' THR . . . . . . . . . . . . . 25.1 m -129.13 145.63 51.25 Favored 'General case' 0 C--N 1.331 -0.214 0 CA-C-O 121.112 0.482 . . . . 0.0 111.42 -176.658 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' F' F ' 68' ' ' LEU . . . . . . . . . . . . . 15.5 tp . . . . . 0 C--N 1.33 -0.243 0 CA-C-N 115.79 -0.641 . . . . 0.0 109.527 175.899 . . . . . . . . 0 0 . 1 . 013 nuclear build core ' F' F ' 73' ' ' VAL . . . . . . . . . . . . . 35.8 m . . . . . 0 C--O 1.232 0.137 0 N-CA-C 109.694 -0.484 . . . . 0.0 109.694 . . . . . . . . . 0 0 . 1 . 013 nuclear build core ' F' F ' 74' ' ' ASP . . . . . . . . . . . . . 7.2 t70 -90.64 115.17 27.54 Favored 'General case' 0 C--N 1.331 -0.226 0 C-N-CA 120.645 -0.422 . . . . 0.0 110.31 -173.593 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' F' F ' 75' ' ' VAL . . . . . . . . . . . . . 44.5 t -114.89 120.45 64.55 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.228 0 CA-C-O 121.038 0.447 . . . . 0.0 110.085 -179.272 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' F' F ' 76' ' ' LEU . . . . . . . . . . . . . 20.6 mt -124.47 144.29 50.17 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 115.662 -0.699 . . . . 0.0 109.717 179.34 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' F' F ' 77' ' ' GLU . . . . . . . . . . . . . 46.6 mt-10 -134.11 135.86 43.48 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-O 121.073 0.463 . . . . 0.0 111.286 -177.761 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' F' F ' 78' ' ' ALA . . . . . . . . . . . . . . . -122.64 127.71 49.7 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 115.483 -0.78 . . . . 0.0 109.457 175.712 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' F' F ' 79' ' ' LYS . . . . . 0.651 ' O ' HD13 ' F' ' 80' ' ' ILE . 37.7 tttp -79.79 120.29 23.86 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-O 120.993 0.425 . . . . 0.0 110.828 -175.785 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' F' F ' 80' ' ' ILE . . . . . 0.651 HD13 ' O ' ' F' ' 79' ' ' LYS . 37.5 mm -139.3 108.85 3.84 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.291 0 N-CA-C 108.983 -0.747 . . . . 0.0 108.983 -179.289 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' F' F ' 81' ' ' LYS . . . . . . . . . . . . . 39.7 ttpt -99.26 123.69 43.74 Favored 'General case' 0 C--N 1.329 -0.298 0 C-N-CA 120.862 -0.335 . . . . 0.0 110.97 -176.236 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' F' F ' 82' ' ' GLY . . . . . . . . . . . . . . . 89.21 42.18 5.64 Favored Glycine 0 CA--C 1.525 0.708 0 C-N-CA 120.7 -0.762 . . . . 0.0 111.677 176.368 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' F' F ' 83' ' ' ILE . . . . . . . . . . . . . 75.3 mt -67.2 140.31 19.57 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.338 0 N-CA-C 109.875 -0.417 . . . . 0.0 109.875 177.603 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' F' F ' 84' ' ' LYS . . . . . . . . . . . . . 47.0 tttp -100.82 -53.94 2.94 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.029 -0.532 . . . . 0.0 110.654 -178.644 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' F' F ' 85' ' ' ASP . . . . . . . . . . . . . 13.5 t70 -146.22 149.43 33.9 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 115.916 -0.584 . . . . 0.0 110.705 -178.095 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' F' F ' 86' ' ' VAL . . . . . . . . . . . . . 41.3 t -128.51 127.56 67.09 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.221 0 CA-C-O 120.815 0.341 . . . . 0.0 110.364 -179.782 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' F' F ' 87' ' ' ILE . . . . . . . . . . . . . 44.4 mm -120.84 130.39 74.67 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.223 0 CA-C-N 116.071 -0.513 . . . . 0.0 109.923 178.674 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' F' F ' 88' ' ' LEU . . . . . . . . . . . . . 27.1 mt -115.47 137.4 52.09 Favored 'General case' 0 C--N 1.332 -0.182 0 CA-C-O 120.951 0.405 . . . . 0.0 111.069 -178.946 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' F' F ' 89' ' ' ASP . . . . . . . . . . . . . 7.4 t70 -135.31 162.19 33.28 Favored 'General case' 0 C--N 1.331 -0.239 0 CA-C-N 115.999 -0.546 . . . . 0.0 110.084 177.335 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' F' F ' 90' ' ' GLU . . . . . . . . . . . . . 96.4 mt-10 -45.15 -48.14 12.27 Favored 'General case' 0 N--CA 1.465 0.307 0 N-CA-C 113.149 0.796 . . . . 0.0 113.149 -171.263 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' F' F ' 91' ' ' ASN . . . . . . . . . . . . . 21.0 t-20 -132.04 39.91 3.39 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-O 120.974 0.416 . . . . 0.0 110.861 -177.606 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' F' F ' 92' ' ' LEU . . . . . . . . . . . . . 10.7 tp -163.45 138.01 6.14 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.355 -0.384 . . . . 0.0 110.89 -177.539 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' F' F ' 93' ' ' ILE . . . . . . . . . . . . . 69.0 mt -122.3 124.81 71.79 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.311 0 N-CA-C 109.226 -0.657 . . . . 0.0 109.226 177.29 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' F' F ' 94' ' ' VAL . . . . . . . . . . . . . 45.8 t -123.54 128.62 74.68 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.258 0 CA-C-O 120.983 0.42 . . . . 0.0 110.069 -178.931 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' F' F ' 95' ' ' VAL . . . . . . . . . . . . . 44.4 t -121.58 134.76 63.89 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.314 0 CA-C-N 115.921 -0.581 . . . . 0.0 109.724 178.958 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' F' F ' 96' ' ' ILE . . . . . . . . . . . . . 61.6 mt -114.47 127.71 71.83 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.354 0 N-CA-C 109.146 -0.687 . . . . 0.0 109.146 178.493 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' F' F ' 97' ' ' THR . . . . . . . . . . . . . 58.3 p -98.5 159.5 14.91 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-O 121.102 0.477 . . . . 0.0 111.177 -177.498 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' F' F ' 98' ' ' GLU . . . . . . . . . . . . . 80.4 tt0 -53.88 -28.16 34.55 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.171 -0.468 . . . . 0.0 112.092 -179.622 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' F' F ' 99' ' ' GLU . . . . . . . . . . . . . 95.6 mt-10 -79.96 16.5 1.17 Allowed 'General case' 0 CA--C 1.535 0.392 0 N-CA-C 113.043 0.757 . . . . 0.0 113.043 -177.263 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' F' F ' 100' ' ' ASN . . . . . . . . . . . . . 4.2 m-20 62.48 38.04 12.95 Favored 'General case' 0 CA--C 1.53 0.198 0 CA-C-O 121.009 0.433 . . . . 0.0 111.072 177.757 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' F' F ' 101' ' ' GLU . . . . . . . . . . . . . 83.6 tt0 -111.8 144.05 41.74 Favored 'General case' 0 C--N 1.332 -0.186 0 CA-C-N 116.004 -0.544 . . . . 0.0 109.775 175.891 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' F' F ' 102' ' ' VAL . . . . . . . . . . . . . 42.7 t -115.02 125.09 72.24 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.293 0 N-CA-C 109.798 -0.445 . . . . 0.0 109.798 -178.67 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' F' F ' 103' ' ' LEU . . . . . . . . . . . . . 44.1 mt -118.3 131.63 56.33 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 115.725 -0.67 . . . . 0.0 110.046 178.395 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' F' F ' 104' ' ' ILE . . . . . 0.614 HD13 HG11 ' F' ' 130' ' ' VAL . 67.3 mt -121.09 123.09 69.25 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.245 0 CA-C-O 120.66 0.266 . . . . 0.0 110.374 -179.787 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' F' F ' 105' ' ' PHE . . . . . . . . . . . . . 48.7 m-85 -123.95 167.42 14.17 Favored 'General case' 0 C--N 1.333 -0.122 0 CA-C-N 115.358 -0.837 . . . . 0.0 109.885 178.931 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' F' F ' 106' ' ' ASN . . . . . . . . . . . . . 36.8 p-10 -98.74 -169.97 1.86 Allowed 'General case' 0 C--N 1.331 -0.207 0 N-CA-C 109.866 -0.42 . . . . 0.0 109.866 172.919 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' F' F ' 107' ' ' GLN . . . . . . . . . . . . . 12.1 tt0 -58.6 -30.08 66.94 Favored 'General case' 0 C--N 1.329 -0.31 0 N-CA-C 112.048 0.388 . . . . 0.0 112.048 -179.339 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' F' F ' 108' ' ' ASN . . . . . . . . . . . . . 5.7 t30 -91.33 14.01 15.77 Favored 'General case' 0 CA--C 1.535 0.394 0 N-CA-C 113.153 0.797 . . . . 0.0 113.153 -176.631 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' F' F ' 109' ' ' LEU . . . . . . . . . . . . . 30.7 mt 59.25 34.61 23.12 Favored 'General case' 0 C--N 1.332 -0.167 0 N-CA-C 111.992 0.367 . . . . 0.0 111.992 177.019 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' F' F ' 110' ' ' GLU . . . . . . . . . . . . . 95.9 mt-10 -98.64 136.37 38.81 Favored 'General case' 0 C--N 1.328 -0.338 0 N-CA-C 109.049 -0.723 . . . . 0.0 109.049 173.187 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' F' F ' 111' ' ' GLU . . . . . . . . . . . . . 56.1 tt0 -78.64 121.9 25.27 Favored 'General case' 0 C--N 1.327 -0.401 0 CA-C-O 120.898 0.38 . . . . 0.0 110.743 -173.727 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' F' F ' 112' ' ' LEU . . . . . . . . . . . . . 15.3 mt -103.73 -45.97 4.65 Favored 'General case' 0 C--N 1.331 -0.204 0 CA-C-N 115.868 -0.606 . . . . 0.0 110.703 179.574 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' F' F ' 113' ' ' TYR . . . . . . . . . . . . . 44.5 t80 -136.26 141.88 43.93 Favored 'General case' 0 C--N 1.331 -0.239 0 CA-C-N 116.193 -0.458 . . . . 0.0 111.181 -177.174 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' F' F ' 114' ' ' ARG . . . . . . . . . . . . . 32.3 ptt180 -147.06 123.25 10.86 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.107 -0.497 . . . . 0.0 110.826 176.893 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' F' F ' 115' ' ' GLY . . . . . . . . . . . . . . . -150.09 163.02 29.37 Favored Glycine 0 CA--C 1.523 0.554 0 N-CA-C 110.789 -0.924 . . . . 0.0 110.789 179.472 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' F' F ' 116' ' ' LYS . . . . . . . . . . . . . 38.3 ttpt -130.17 135.77 48.54 Favored 'General case' 0 C--N 1.329 -0.295 0 O-C-N 122.627 -0.337 . . . . 0.0 110.123 179.066 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' F' F ' 117' ' ' PHE . . . . . . . . . . . . . 48.6 m-85 -133.58 114.85 14.01 Favored 'General case' 0 C--N 1.331 -0.206 0 CA-C-O 120.967 0.413 . . . . 0.0 110.176 -176.95 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' F' F ' 118' ' ' GLU . . . . . . . . . . . . . 70.6 mm-40 -54.54 -41.1 69.34 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 116.412 -0.358 . . . . 0.0 111.371 -176.319 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' F' F ' 119' ' ' ASN . . . . . . . . . . . . . 85.6 m-20 -100.73 31.04 3.68 Favored 'General case' 0 C--N 1.33 -0.276 0 N-CA-C 112.176 0.435 . . . . 0.0 112.176 -173.919 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' F' F ' 120' ' ' LEU . . . . . . . . . . . . . 15.0 tp -56.59 119.92 6.91 Favored 'General case' 0 C--N 1.332 -0.19 0 CA-C-O 120.707 0.289 . . . . 0.0 110.379 178.254 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' F' F ' 121' ' ' ASN . . . . . . . . . . . . . 72.9 m-20 -114.15 -44.13 3.16 Favored 'General case' 0 C--N 1.333 -0.141 0 CA-C-N 116.368 -0.378 . . . . 0.0 111.282 -177.647 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' F' F ' 122' ' ' LYS . . . . . . . . . . . . . 53.4 mtmt -145.3 151.27 38.08 Favored 'General case' 0 C--N 1.331 -0.239 0 CA-C-O 121.042 0.449 . . . . 0.0 111.749 -176.234 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' F' F ' 123' ' ' VAL . . . . . . . . . . . . . 46.7 t -130.8 127.97 62.3 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.235 0 CA-C-N 116.01 -0.541 . . . . 0.0 109.545 174.697 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' F' F ' 124' ' ' LEU . . . . . . . . . . . . . 41.2 mt -115.99 136.99 52.52 Favored 'General case' 0 C--N 1.331 -0.196 0 CA-C-N 116.307 -0.406 . . . . 0.0 110.709 -178.736 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' F' F ' 125' ' ' VAL . . . . . . . . . . . . . 35.1 m -128.43 138.16 55.4 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.209 0 CA-C-N 116.265 -0.425 . . . . 0.0 110.817 -179.359 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' F' F ' 126' ' ' ARG . . . . . . . . . . . . . 96.3 mtt-85 -143.9 111.44 5.98 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.102 -0.499 . . . . 0.0 110.38 177.155 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' F' F ' 127' ' ' ASN . . . . . . . . . . . . . 79.1 m-20 53.13 -104.95 0.22 Allowed 'General case' 0 CA--C 1.544 0.722 0 CA-C-O 119.122 -0.466 . . . . 0.0 111.057 -179.847 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' F' F ' 128' ' ' ASP . . . . . . . . . . . . . 12.3 p-10 -113.98 0.17 14.28 Favored 'General case' 0 CA--C 1.536 0.434 0 CA-C-N 119.509 1.049 . . . . 0.0 113.386 -177.531 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' F' F ' 129' ' ' LEU . . . . . 0.458 HD12 ' N ' ' F' ' 129' ' ' LEU . 9.9 mp -105.0 147.84 27.38 Favored 'General case' 0 CA--C 1.523 -0.096 0 N-CA-C 109.669 -0.493 . . . . 0.0 109.669 177.842 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' F' F ' 130' ' ' VAL . . . . . 0.614 HG11 HD13 ' F' ' 104' ' ' ILE . 13.1 p -137.37 145.19 29.88 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.245 0 CA-C-O 121.23 0.538 . . . . 0.0 110.87 -176.757 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' F' F ' 131' ' ' VAL . . . . . . . . . . . . . 44.1 t -134.61 136.97 51.97 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.294 0 CA-C-N 115.722 -0.672 . . . . 0.0 109.869 178.079 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' F' F ' 132' ' ' ILE . . . . . . . . . . . . . 71.1 mt -114.18 132.2 63.92 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.335 0 N-CA-C 109.452 -0.573 . . . . 0.0 109.452 -178.825 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' F' F ' 133' ' ' ILE . . . . . . . . . . . . . 43.0 mm -117.77 121.8 68.28 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.27 0 CA-C-O 120.791 0.329 . . . . 0.0 110.621 -176.041 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' F' F ' 134' ' ' ASP . . . . . . . . . . . . . 7.1 p-10 -132.38 148.56 52.42 Favored 'General case' 0 C--N 1.33 -0.249 0 N-CA-C 109.578 -0.527 . . . . 0.0 109.578 174.934 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' F' F ' 135' ' ' GLU . . . . . . . . . . . . . 32.3 tp10 -49.9 -24.4 2.48 Favored 'General case' 0 C--N 1.328 -0.328 0 N-CA-C 112.943 0.72 . . . . 0.0 112.943 -169.775 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' F' F ' 136' ' ' GLN . . . . . . . . . . . . . 60.7 tt0 -105.02 -26.42 12.15 Favored 'General case' 0 N--CA 1.466 0.327 0 N-CA-C 112.748 0.647 . . . . 0.0 112.748 -174.637 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' F' F ' 137' ' ' LYS . . . . . . . . . . . . . 77.3 mttt -141.7 154.0 45.02 Favored 'General case' 0 C--N 1.331 -0.198 0 CA-C-O 121.252 0.549 . . . . 0.0 111.798 -171.731 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' F' F ' 138' ' ' LEU . . . . . 0.41 HD23 ' C ' ' F' ' 138' ' ' LEU . 6.1 tt -120.29 124.97 46.9 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 115.616 -0.72 . . . . 0.0 109.299 173.765 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' F' F ' 139' ' ' THR . . . . . . . . . . . . . 31.1 m -114.21 129.83 56.63 Favored 'General case' 0 C--N 1.332 -0.191 0 CA-C-N 116.385 -0.37 . . . . 0.0 110.757 -177.362 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' F' F ' 140' ' ' LEU . . . . . 0.475 HD23 ' C ' ' F' ' 140' ' ' LEU . 7.4 tt -116.87 121.53 41.75 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 115.686 -0.688 . . . . 0.0 109.387 -179.119 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' F' F ' 141' ' ' ILE . . . . . 0.424 ' HB ' HG13 ' F' ' 130' ' ' VAL . 19.0 mt -121.37 118.5 56.2 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.253 0 N-CA-C 109.778 -0.453 . . . . 0.0 109.778 -176.764 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' F' F ' 142' ' ' ARG . . . . . . . . . . . . . 61.7 ttt180 -110.87 127.77 55.55 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 115.5 -0.773 . . . . 0.0 110.403 -176.86 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' F' F ' 143' ' ' THR . . . . . . . . . . . . . 42.3 p . . . . . 0 C--O 1.22 -0.458 0 CA-C-O 117.989 -1.005 . . . . 0.0 110.66 -179.706 . . . . . . . . 0 0 . 1 . 014 nuclear build core ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 41.1 p . . . . . 0 N--CA 1.461 0.108 0 CA-C-O 120.915 0.388 . . . . 0.0 110.485 . . . . . . . . . 0 0 . 1 . 014 nuclear build core ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 95.2 mt-10 -140.54 142.71 35.16 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.174 -0.466 . . . . 0.0 111.243 -178.162 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 4' ' ' LEU . . . . . 0.648 HD21 HD23 ' A' ' 58' ' ' LEU . 56.0 mt -119.73 130.1 54.83 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 115.819 -0.628 . . . . 0.0 110.317 175.319 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 5' ' ' LYS . . . . . . . . . . . . . 67.1 mttm -107.38 120.57 42.52 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.306 -0.406 . . . . 0.0 110.436 177.242 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 73.9 mt -116.82 150.81 37.74 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 115.532 -0.758 . . . . 0.0 110.378 -179.238 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 74.8 tttt -140.69 139.11 19.33 Favored Pre-proline 0 CA--C 1.534 0.335 0 CA-C-O 119.167 -0.444 . . . . 0.0 110.092 175.594 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 8' ' ' PRO . . . . . . . . . . . . . 86.4 Cg_endo -91.76 140.99 2.52 Favored 'Trans proline' 0 N--CA 1.49 1.267 0 C-N-CA 121.733 1.622 . . . . 0.0 111.672 176.971 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 68.8 mt -74.05 -47.93 6.22 Favored Pre-proline 0 C--N 1.328 -0.348 0 CA-C-O 118.622 -0.704 . . . . 0.0 112.243 -178.473 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 89.0 Cg_endo -80.76 146.36 16.58 Favored 'Trans proline' 0 N--CA 1.495 1.614 0 C-N-CA 121.211 1.274 . . . . 0.0 111.931 176.419 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 63.3 mttm -85.8 95.82 9.55 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-O 120.943 0.401 . . . . 0.0 110.416 178.234 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 11.7 p -139.87 149.23 22.34 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.277 0 CA-C-N 115.894 -0.594 . . . . 0.0 110.348 -179.465 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 45.5 tp10 -87.25 122.21 30.73 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 116.337 -0.392 . . . . 0.0 110.322 178.966 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 14' ' ' LEU . . . . . . . . . . . . . 44.7 mt -97.91 157.65 34.23 Favored Pre-proline 0 C--N 1.329 -0.296 0 CA-C-N 116.163 -0.471 . . . . 0.0 110.861 -179.188 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 15' ' ' PRO . . . . . . . . . . . . . 36.9 Cg_exo -59.56 158.31 28.26 Favored 'Trans proline' 0 N--CA 1.496 1.663 0 C-N-CA 121.413 1.408 . . . . 0.0 111.875 178.719 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 16' ' ' PRO . . . . . . . . . . . . . 33.4 Cg_exo -59.2 -42.65 48.27 Favored 'Trans proline' 0 N--CA 1.496 1.649 0 C-N-CA 121.516 1.478 . . . . 0.0 112.84 -177.606 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 17' ' ' ASP . . . . . . . . . . . . . 7.9 p-10 -87.43 13.42 10.01 Favored 'General case' 0 CA--C 1.536 0.414 0 N-CA-C 113.072 0.767 . . . . 0.0 113.072 -177.06 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 18' ' ' PHE . . . . . . . . . . . . . 42.0 t80 -57.16 -45.45 83.61 Favored 'General case' 0 C--N 1.334 -0.088 0 O-C-N 122.041 -0.412 . . . . 0.0 110.238 -178.994 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 19' ' ' VAL . . . . . . . . . . . . . 47.0 t -57.43 -43.37 82.53 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.262 0 CA-C-N 116.154 -0.475 . . . . 0.0 110.378 -178.451 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 32.0 m-20 -59.1 -41.96 89.37 Favored 'General case' 0 C--N 1.331 -0.224 0 C-N-CA 120.916 -0.314 . . . . 0.0 111.082 -177.634 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 46.9 t -64.55 -44.46 96.83 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.264 0 C-N-CA 120.709 -0.396 . . . . 0.0 110.427 -178.372 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 22' ' ' ILE . . . . . 0.582 HG22 HD12 ' A' ' 26' ' ' LEU . 50.9 mm -56.94 -40.14 70.11 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 C-N-CA 120.987 -0.285 . . . . 0.0 110.567 178.709 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 23' ' ' ARG . . . . . . . . . . . . . 53.4 ttp180 -57.13 -48.88 77.58 Favored 'General case' 0 C--N 1.331 -0.214 0 CA-C-O 121.018 0.437 . . . . 0.0 110.468 177.136 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 24' ' ' ILE . . . . . . . . . . . . . 72.7 mt -61.15 -39.5 82.63 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.324 0 CA-C-N 115.839 -0.619 . . . . 0.0 111.944 -177.089 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 16.6 pttp -77.35 -36.07 54.1 Favored 'General case' 0 CA--C 1.535 0.389 0 C-N-CA 120.537 -0.465 . . . . 0.0 111.806 -174.218 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 26' ' ' LEU . . . . . 0.582 HD12 HG22 ' A' ' 22' ' ' ILE . 83.4 mt -77.89 -38.55 45.57 Favored 'General case' 0 C--N 1.33 -0.275 0 N-CA-C 112.979 0.733 . . . . 0.0 112.979 -173.304 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 27' ' ' GLN . . . . . . . . . . . . . 15.5 pt20 -46.92 139.84 5.23 Favored 'General case' 0 N--CA 1.469 0.48 0 N-CA-C 112.867 0.691 . . . . 0.0 112.867 -175.265 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 100.77 -27.76 19.06 Favored Glycine 0 CA--C 1.532 1.122 0 CA-C-N 115.573 -0.739 . . . . 0.0 112.166 -177.544 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 38.0 mmtm -97.84 155.12 17.2 Favored 'General case' 0 C--O 1.232 0.169 0 CA-C-N 117.202 0.501 . . . . 0.0 111.095 178.159 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 30' ' ' THR . . . . . . . . . . . . . 32.3 m -98.92 137.0 38.11 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.107 -0.497 . . . . 0.0 109.884 175.55 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 34.7 m -126.44 151.73 33.27 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.222 0 CA-C-O 120.826 0.346 . . . . 0.0 110.655 -179.296 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 32' ' ' ARG . . . . . . . . . . . . . 76.2 ttt-85 -136.09 149.12 48.58 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.089 -0.505 . . . . 0.0 110.448 178.59 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 33' ' ' THR . . . . . . . . . . . . . 32.1 m -52.92 139.81 26.4 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.386 -0.37 . . . . 0.0 111.301 -178.448 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 100.87 -17.17 56.74 Favored Glycine 0 CA--C 1.533 1.172 0 CA-C-O 119.744 -0.476 . . . . 0.0 113.218 179.644 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 76.7 m-20 -66.69 147.94 52.59 Favored 'General case' 0 N--CA 1.461 0.099 0 CA-C-N 118.028 0.914 . . . . 0.0 111.149 178.728 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 44.6 t -124.25 130.15 73.78 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.197 0 CA-C-N 115.882 -0.599 . . . . 0.0 109.8 178.02 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 37' ' ' ILE . . . . . . . . . . . . . 66.7 mt -122.37 139.65 48.66 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.234 0 CA-C-N 116.266 -0.425 . . . . 0.0 110.126 -179.019 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . -110.18 128.78 9.02 Favored Glycine 0 CA--C 1.526 0.74 0 N-CA-C 111.053 -0.819 . . . . 0.0 111.053 179.586 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 39' ' ' ILE . . . . . . . . . . . . . 73.7 mt -123.87 135.09 64.65 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.171 0 N-CA-C 110.247 -0.279 . . . . 0.0 110.247 179.585 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 40' ' ' SER . . . . . 0.511 ' O ' HD13 ' A' ' 41' ' ' ILE . 96.6 p -92.97 120.94 33.81 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.398 -0.365 . . . . 0.0 110.984 176.07 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 41' ' ' ILE . . . . . 0.511 HD13 ' O ' ' A' ' 40' ' ' SER . 48.1 mm -128.62 115.06 35.92 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.187 0 CA-C-O 120.834 0.35 . . . . 0.0 110.371 177.698 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 42' ' ' LEU . . . . . 0.549 ' O ' HD23 ' A' ' 42' ' ' LEU . 1.3 tt 54.52 44.47 28.71 Favored 'General case' 0 CA--C 1.532 0.251 0 CA-C-O 121.392 0.615 . . . . 0.0 110.546 177.636 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . 70.64 16.28 73.96 Favored Glycine 0 CA--C 1.534 1.278 0 C-N-CA 121.093 -0.575 . . . . 0.0 113.12 175.469 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 44' ' ' LYS . . . . . . . . . . . . . 58.5 mtpt -124.05 132.61 53.7 Favored 'General case' 0 C--N 1.332 -0.17 0 CA-C-N 117.765 0.783 . . . . 0.0 109.902 179.413 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 84.8 tt0 -84.46 123.28 30.07 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 116.444 -0.344 . . . . 0.0 111.115 -179.156 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 46' ' ' VAL . . . . . . . . . . . . . 7.3 p -121.64 128.49 75.8 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.244 0 N-CA-C 109.333 -0.617 . . . . 0.0 109.333 175.731 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 66.6 mttm -100.77 128.58 46.76 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.099 -0.5 . . . . 0.0 111.259 178.602 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 48' ' ' PHE . . . . . . . . . . . . . 93.1 m-85 -110.81 131.79 54.75 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-N 116.129 -0.487 . . . . 0.0 109.811 175.603 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 78.5 tttt -108.61 137.41 46.6 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 116.314 -0.403 . . . . 0.0 110.382 179.342 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 50' ' ' VAL . . . . . . . . . . . . . 45.8 t -79.95 109.72 14.79 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.366 0 N-CA-C 109.275 -0.639 . . . . 0.0 109.275 176.326 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 51' ' ' VAL . . . . . . . . . . . . . 55.9 t -71.47 -47.31 59.39 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.324 0 CA-C-N 116.055 -0.521 . . . . 0.0 109.895 -173.795 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 52' ' ' GLN . . . . . . . . . . . . . 61.6 tt0 -171.14 142.14 1.74 Allowed 'General case' 0 C--N 1.33 -0.244 0 C-N-CA 120.145 -0.622 . . . . 0.0 111.557 -178.657 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -114.38 136.08 53.38 Favored 'General case' 0 C--N 1.331 -0.239 0 CA-C-N 115.711 -0.677 . . . . 0.0 109.99 176.135 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 54' ' ' TYR . . . . . . . . . . . . . 30.5 t80 -129.07 108.33 18.04 Favored Pre-proline 0 CA--C 1.536 0.433 0 CA-C-O 118.21 -0.9 . . . . 0.0 110.393 179.616 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 55' ' ' PRO . . . . . . . . . . . . . 73.8 Cg_endo -77.17 169.99 72.71 Favored 'Cis proline' 0 N--CA 1.5 1.873 0 CA-C-N 121.824 1.687 . . . . 0.0 112.318 -5.371 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 56' ' ' SER . . . . . . . . . . . . . 66.6 m -117.45 136.51 23.55 Favored Pre-proline 0 CA--C 1.538 0.514 0 CA-C-O 118.482 -0.771 . . . . 0.0 109.885 175.688 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 57' ' ' PRO . . . . . . . . . . . . . 50.5 Cg_endo -71.24 163.09 86.6 Favored 'Cis proline' 0 N--CA 1.497 1.706 0 CA-C-N 121.791 1.675 . . . . 0.0 111.291 -5.867 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 58' ' ' LEU . . . . . 0.648 HD23 HD21 ' A' ' 4' ' ' LEU . 39.4 tp -129.69 138.69 51.3 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-O 121.042 0.449 . . . . 0.0 110.67 -179.205 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 59' ' ' ARG . . . . . . . . . . . . . 41.6 ttm180 -95.58 125.5 40.22 Favored 'General case' 0 C--N 1.326 -0.449 0 CA-C-N 115.717 -0.674 . . . . 0.0 109.219 174.177 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 39.9 t -77.18 116.57 20.73 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.241 0 C-N-CA 120.678 -0.409 . . . . 0.0 110.332 -175.082 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 70.6 mm-40 -131.22 161.77 31.48 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.018 -0.537 . . . . 0.0 109.756 175.977 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 62' ' ' ASP . . . . . . . . . . . . . 81.4 m-20 -52.32 -28.0 17.53 Favored 'General case' 0 C--N 1.328 -0.335 0 N-CA-C 112.034 0.383 . . . . 0.0 112.034 177.816 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 63' ' ' ARG . . . . . . . . . . . . . 77.6 mtp85 -70.77 -22.01 62.44 Favored 'General case' 0 CA--C 1.534 0.331 0 N-CA-C 112.879 0.696 . . . . 0.0 112.879 -176.444 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 29.6 m -80.63 142.05 34.38 Favored 'General case' 0 C--N 1.331 -0.227 0 CA-C-O 121.041 0.448 . . . . 0.0 111.119 -175.239 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 65' ' ' LYS . . . . . . . . . . . . . 96.8 mttt -90.11 138.18 31.73 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 115.902 -0.59 . . . . 0.0 110.066 179.176 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 66' ' ' ILE . . . . . . . . . . . . . 63.9 mt -117.55 129.75 73.52 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.212 0 N-CA-C 110.03 -0.359 . . . . 0.0 110.03 179.329 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 67' ' ' THR . . . . . . . . . . . . . 33.4 m -127.19 142.34 51.51 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-O 121.091 0.472 . . . . 0.0 110.861 -178.855 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 68' ' ' LEU . . . . . . . . . . . . . 15.4 tp . . . . . 0 C--N 1.33 -0.275 0 CA-C-N 116.081 -0.509 . . . . 0.0 110.187 178.057 . . . . . . . . 0 0 . 1 . 014 nuclear build core ' A' A ' 74' ' ' ASP . . . . . . . . . . . . . 10.5 t0 . . . . . 0 CA--C 1.523 -0.084 0 N-CA-C 109.903 -0.406 . . . . 0.0 109.903 . . . . . . . . . 0 0 . 1 . 014 nuclear build core ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 43.9 t -111.63 120.67 62.62 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.254 0 CA-C-O 121.249 0.547 . . . . 0.0 110.329 -178.635 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 76' ' ' LEU . . . . . . . . . . . . . 18.3 mt -121.38 139.44 53.44 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 115.463 -0.79 . . . . 0.0 109.035 176.787 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 77' ' ' GLU . . . . . . . . . . . . . 26.0 tt0 -135.71 141.62 44.94 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-O 120.986 0.422 . . . . 0.0 111.361 -174.476 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 78' ' ' ALA . . . . . 0.58 ' HB2' HD21 ' A' ' 109' ' ' LEU . . . -132.14 135.26 46.26 Favored 'General case' 0 C--N 1.331 -0.201 0 CA-C-N 115.821 -0.627 . . . . 0.0 110.073 176.572 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 79' ' ' LYS . . . . . 0.651 ' O ' HD13 ' A' ' 80' ' ' ILE . 62.3 mtpt -77.95 123.28 26.6 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-O 120.868 0.366 . . . . 0.0 110.43 -179.616 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 80' ' ' ILE . . . . . 0.651 HD13 ' O ' ' A' ' 79' ' ' LYS . 38.1 mm -139.19 108.81 3.92 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.257 0 N-CA-C 109.018 -0.734 . . . . 0.0 109.018 -176.87 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 81' ' ' LYS . . . . . . . . . . . . . 95.0 mttt -102.48 125.63 49.27 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-O 120.897 0.379 . . . . 0.0 111.148 -176.12 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . 89.06 42.05 5.72 Favored Glycine 0 CA--C 1.524 0.618 0 C-N-CA 120.818 -0.706 . . . . 0.0 111.547 174.644 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 83' ' ' ILE . . . . . . . . . . . . . 73.5 mt -68.12 135.7 27.95 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.339 0 N-CA-C 109.674 -0.491 . . . . 0.0 109.674 177.939 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 84' ' ' LYS . . . . . . . . . . . . . 82.9 tttt -96.84 -53.51 3.51 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.025 -0.534 . . . . 0.0 110.18 -179.136 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 85' ' ' ASP . . . . . . . . . . . . . 8.7 t70 -154.52 151.74 29.26 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 115.627 -0.715 . . . . 0.0 110.327 -179.916 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 86' ' ' VAL . . . . . . . . . . . . . 44.1 t -130.15 132.22 65.37 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.298 0 CA-C-O 121.049 0.452 . . . . 0.0 110.383 179.774 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 87' ' ' ILE . . . . . 0.496 HD12 ' N ' ' A' ' 87' ' ' ILE . 5.1 mp -117.78 124.09 72.59 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.242 0 N-CA-C 108.975 -0.75 . . . . 0.0 108.975 176.255 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 88' ' ' LEU . . . . . . . . . . . . . 14.4 tp -112.39 128.45 56.31 Favored 'General case' 0 C--N 1.331 -0.226 0 CA-C-O 121.073 0.463 . . . . 0.0 111.309 -175.497 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 89' ' ' ASP . . . . . . . . . . . . . 5.9 t70 -120.65 155.47 33.75 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 115.831 -0.622 . . . . 0.0 109.415 175.833 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 44.4 mp0 -51.02 -36.35 39.07 Favored 'General case' 0 C--N 1.328 -0.33 0 N-CA-C 112.464 0.542 . . . . 0.0 112.464 -171.448 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 91' ' ' ASN . . . . . . . . . . . . . 84.8 m-20 -132.05 33.07 3.95 Favored 'General case' 0 N--CA 1.465 0.309 0 N-CA-C 111.963 0.357 . . . . 0.0 111.963 -176.729 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 92' ' ' LEU . . . . . . . . . . . . . 10.4 tp -166.09 146.63 6.48 Favored 'General case' 0 C--N 1.331 -0.217 0 C-N-CA 120.997 -0.281 . . . . 0.0 110.593 179.525 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 93' ' ' ILE . . . . . . . . . . . . . 63.8 mt -127.09 125.81 67.03 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.238 0 N-CA-C 109.724 -0.473 . . . . 0.0 109.724 -179.611 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 94' ' ' VAL . . . . . . . . . . . . . 45.1 t -122.21 126.04 73.76 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.197 0 N-CA-C 109.742 -0.466 . . . . 0.0 109.742 177.874 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 95' ' ' VAL . . . . . . . . . . . . . 43.5 t -122.61 134.95 64.27 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.235 0 N-CA-C 110.055 -0.35 . . . . 0.0 110.055 -179.047 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 96' ' ' ILE . . . . . . . . . . . . . 61.6 mt -114.43 129.86 69.76 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.322 0 N-CA-C 109.341 -0.614 . . . . 0.0 109.341 178.632 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 97' ' ' THR . . . . . . . . . . . . . 63.4 p -100.26 156.74 17.05 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-O 121.01 0.434 . . . . 0.0 110.814 -179.706 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 98' ' ' GLU . . . . . . . . . . . . . 45.6 tp10 -54.01 -28.1 36.02 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.304 -0.407 . . . . 0.0 112.071 -178.233 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 99' ' ' GLU . . . . . . . . . . . . . 96.0 mt-10 -79.78 16.89 1.02 Allowed 'General case' 0 CA--C 1.534 0.363 0 N-CA-C 113.218 0.821 . . . . 0.0 113.218 -175.465 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 100' ' ' ASN . . . . . . . . . . . . . 3.7 m-20 62.93 37.91 11.61 Favored 'General case' 0 N--CA 1.464 0.232 0 CA-C-O 121.159 0.504 . . . . 0.0 111.021 177.973 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 101' ' ' GLU . . . . . . . . . . . . . 84.5 tt0 -116.8 144.03 44.97 Favored 'General case' 0 C--N 1.332 -0.169 0 N-CA-C 109.583 -0.525 . . . . 0.0 109.583 175.262 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 102' ' ' VAL . . . . . . . . . . . . . 41.1 t -116.4 128.55 73.7 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.283 0 CA-C-O 120.923 0.392 . . . . 0.0 110.187 -176.035 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 103' ' ' LEU . . . . . . . . . . . . . 27.0 mt -118.21 130.29 55.99 Favored 'General case' 0 C--N 1.331 -0.239 0 CA-C-N 115.643 -0.708 . . . . 0.0 110.053 176.215 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 104' ' ' ILE . . . . . 0.424 HD12 ' HB3' ' A' ' 113' ' ' TYR . 70.3 mt -117.85 122.67 70.3 Favored 'Isoleucine or valine' 0 C--O 1.234 0.259 0 N-CA-C 110.136 -0.32 . . . . 0.0 110.136 179.822 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 105' ' ' PHE . . . . . . . . . . . . . 80.7 m-85 -122.11 164.19 18.17 Favored 'General case' 0 C--N 1.331 -0.208 0 O-C-N 124.037 0.836 . . . . 0.0 110.143 -178.353 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 106' ' ' ASN . . . . . 0.415 ' HB3' HD11 ' A' ' 112' ' ' LEU . 44.3 p-10 -100.54 -170.05 1.81 Allowed 'General case' 0 C--N 1.331 -0.198 0 N-CA-C 109.884 -0.413 . . . . 0.0 109.884 172.35 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 107' ' ' GLN . . . . . . . . . . . . . 30.2 tt0 -59.16 -29.99 67.84 Favored 'General case' 0 C--N 1.328 -0.329 0 N-CA-C 112.008 0.374 . . . . 0.0 112.008 -179.508 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 108' ' ' ASN . . . . . . . . . . . . . 3.0 t-20 -84.67 8.31 17.38 Favored 'General case' 0 CA--C 1.536 0.413 0 N-CA-C 113.271 0.841 . . . . 0.0 113.271 -176.751 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 109' ' ' LEU . . . . . 0.58 HD21 ' HB2' ' A' ' 78' ' ' ALA . 11.3 tp 61.6 36.51 16.74 Favored 'General case' 0 C--O 1.233 0.185 0 CA-C-O 120.89 0.376 . . . . 0.0 111.309 178.823 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 110' ' ' GLU . . . . . . . . . . . . . 16.1 mm-40 -103.35 155.46 18.46 Favored 'General case' 0 C--N 1.33 -0.282 0 N-CA-C 109.847 -0.427 . . . . 0.0 109.847 176.056 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 111' ' ' GLU . . . . . . . . . . . . . 44.6 tp10 -84.83 121.96 28.47 Favored 'General case' 0 C--N 1.331 -0.231 0 C-N-CA 120.807 -0.357 . . . . 0.0 110.791 -178.092 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 112' ' ' LEU . . . . . 0.415 HD11 ' HB3' ' A' ' 106' ' ' ASN . 49.7 mt -107.0 -46.05 4.01 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.091 -0.504 . . . . 0.0 110.397 177.735 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 113' ' ' TYR . . . . . 0.424 ' HB3' HD12 ' A' ' 104' ' ' ILE . 60.0 t80 -136.35 135.45 38.85 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.22 -0.446 . . . . 0.0 110.863 179.68 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 114' ' ' ARG . . . . . . . . . . . . . 61.5 ttp85 -135.66 119.09 16.84 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 116.086 -0.506 . . . . 0.0 110.028 178.624 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 115' ' ' GLY . . . . . . . . . . . . . . . -150.04 159.56 28.15 Favored Glycine 0 CA--C 1.523 0.586 0 C-N-CA 120.693 -0.765 . . . . 0.0 111.441 179.855 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 116' ' ' LYS . . . . . . . . . . . . . 39.3 ttpt -130.04 138.26 50.67 Favored 'General case' 0 C--N 1.33 -0.282 0 N-CA-C 109.858 -0.423 . . . . 0.0 109.858 176.47 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 117' ' ' PHE . . . . . . . . . . . . . 38.6 m-85 -137.38 114.04 10.38 Favored 'General case' 0 C--N 1.329 -0.319 0 N-CA-C 110.121 -0.325 . . . . 0.0 110.121 -176.453 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 118' ' ' GLU . . . . . . . . . . . . . 21.7 pt-20 -55.54 -39.71 70.92 Favored 'General case' 0 C--N 1.33 -0.276 0 C-N-CA 120.942 -0.303 . . . . 0.0 111.08 -176.615 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 119' ' ' ASN . . . . . . . . . . . . . 92.8 m-20 -100.01 29.98 3.97 Favored 'General case' 0 C--N 1.33 -0.251 0 N-CA-C 112.252 0.464 . . . . 0.0 112.252 -175.182 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 120' ' ' LEU . . . . . . . . . . . . . 13.8 tp -59.72 120.36 9.35 Favored 'General case' 0 C--N 1.331 -0.209 0 N-CA-C 109.775 -0.454 . . . . 0.0 109.775 177.751 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 121' ' ' ASN . . . . . . . . . . . . . 83.3 m-20 -113.31 -43.99 3.29 Favored 'General case' 0 C--N 1.332 -0.188 0 CA-C-N 116.578 -0.283 . . . . 0.0 111.027 -176.819 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 122' ' ' LYS . . . . . . . . . . . . . 93.4 mttt -144.2 146.93 33.01 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-O 121.054 0.454 . . . . 0.0 111.672 -178.354 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 123' ' ' VAL . . . . . 0.429 ' C ' HD12 ' A' ' 124' ' ' LEU . 44.2 t -123.22 123.45 67.77 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.334 0 N-CA-C 109.375 -0.602 . . . . 0.0 109.375 174.474 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 124' ' ' LEU . . . . . 0.483 HD12 ' N ' ' A' ' 124' ' ' LEU . 7.3 mp -114.03 127.23 55.85 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.308 -0.405 . . . . 0.0 110.209 -179.064 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 125' ' ' VAL . . . . . . . . . . . . . 11.4 p -135.31 134.08 52.56 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.328 0 CA-C-N 116.504 -0.316 . . . . 0.0 110.326 -179.602 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 126' ' ' ARG . . . . . . . . . . . . . 44.8 ttt180 -146.4 119.67 8.94 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.471 178.903 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 127' ' ' ASN . . . . . . . . . . . . . 33.3 t30 51.26 -104.88 0.18 Allowed 'General case' 0 CA--C 1.544 0.72 0 CA-C-O 119.121 -0.466 . . . . 0.0 111.42 179.309 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 128' ' ' ASP . . . . . . . . . . . . . 20.1 p-10 -112.12 0.35 15.87 Favored 'General case' 0 N--CA 1.468 0.45 0 CA-C-N 119.448 1.022 . . . . 0.0 113.653 -174.444 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 129' ' ' LEU . . . . . . . . . . . . . 76.3 mt -107.63 138.85 43.1 Favored 'General case' 0 C--O 1.231 0.117 0 CA-C-N 118.33 0.514 . . . . 0.0 110.358 179.676 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 130' ' ' VAL . . . . . . . . . . . . . 44.0 t -127.7 135.63 62.6 Favored 'Isoleucine or valine' 0 N--CA 1.462 0.156 0 CA-C-O 120.925 0.393 . . . . 0.0 110.248 -178.932 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 131' ' ' VAL . . . . . 0.516 ' CG1' HD21 ' A' ' 138' ' ' LEU . 40.9 t -134.01 134.16 55.78 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.283 0 CA-C-N 116.083 -0.508 . . . . 0.0 110.006 178.144 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 132' ' ' ILE . . . . . . . . . . . . . 72.2 mt -111.25 129.78 65.95 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.317 0 N-CA-C 109.363 -0.606 . . . . 0.0 109.363 179.653 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 133' ' ' ILE . . . . . . . . . . . . . 41.9 mm -113.67 118.8 59.26 Favored 'Isoleucine or valine' 0 C--O 1.234 0.265 0 CA-C-O 120.92 0.39 . . . . 0.0 110.865 -175.426 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 134' ' ' ASP . . . . . . . . . . . . . 8.6 p-10 -131.03 147.03 52.58 Favored 'General case' 0 C--N 1.331 -0.218 0 N-CA-C 109.303 -0.629 . . . . 0.0 109.303 174.823 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 135' ' ' GLU . . . . . . . . . . . . . 39.0 tp10 -49.89 -28.15 6.2 Favored 'General case' 0 C--N 1.326 -0.417 0 N-CA-C 112.662 0.616 . . . . 0.0 112.662 -172.564 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 136' ' ' GLN . . . . . . . . . . . . . 97.8 mt-30 -82.59 -33.71 27.92 Favored 'General case' 0 C--N 1.331 -0.226 0 N-CA-C 112.806 0.669 . . . . 0.0 112.806 -176.073 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 137' ' ' LYS . . . . . . . . . . . . . 53.7 pttt -166.33 172.98 10.48 Favored 'General case' 0 C--O 1.232 0.165 0 CA-C-O 121.72 0.772 . . . . 0.0 112.746 -172.458 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 138' ' ' LEU . . . . . 0.516 HD21 ' CG1' ' A' ' 131' ' ' VAL . 4.2 tt -117.83 128.88 55.28 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-N 114.767 -1.106 . . . . 0.0 109.798 179.479 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 139' ' ' THR . . . . . 0.485 ' N ' HD23 ' A' ' 138' ' ' LEU . 29.2 m -108.9 127.27 53.9 Favored 'General case' 0 C--N 1.331 -0.23 0 CA-C-N 116.422 -0.354 . . . . 0.0 110.241 178.611 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 140' ' ' LEU . . . . . 0.482 HD23 ' C ' ' A' ' 140' ' ' LEU . 7.4 tt -111.48 121.77 46.08 Favored 'General case' 0 C--N 1.327 -0.382 0 N-CA-C 109.347 -0.612 . . . . 0.0 109.347 -178.594 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 141' ' ' ILE . . . . . . . . . . . . . 19.3 mt -121.08 120.62 62.73 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 CA-C-O 120.955 0.407 . . . . 0.0 110.181 -175.275 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 142' ' ' ARG . . . . . . . . . . . . . 76.4 mtp180 -106.87 122.11 45.75 Favored 'General case' 0 C--N 1.33 -0.239 0 CA-C-N 115.258 -0.883 . . . . 0.0 109.758 179.527 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 143' ' ' THR . . . . . . . . . . . . . 27.6 p . . . . . 0 C--O 1.22 -0.468 0 CA-C-O 117.996 -1.002 . . . . 0.0 110.523 179.907 . . . . . . . . 0 0 . 1 . 014 nuclear build core ' B' B ' 2' ' ' SER . . . . . . . . . . . . . 2.8 p . . . . . 0 C--O 1.23 0.055 0 CA-C-O 120.642 0.258 . . . . 0.0 110.425 . . . . . . . . . 0 0 . 1 . 014 nuclear build core ' B' B ' 3' ' ' GLU . . . . . . . . . . . . . 84.5 tt0 -139.95 139.1 36.04 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-O 120.996 0.426 . . . . 0.0 111.114 -179.248 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' B' B ' 4' ' ' LEU . . . . . . . . . . . . . 4.7 tt -123.24 125.32 44.86 Favored 'General case' 0 C--N 1.331 -0.22 0 CA-C-N 115.689 -0.687 . . . . 0.0 109.752 177.868 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' B' B ' 5' ' ' LYS . . . . . . . . . . . . . 62.7 mttp -106.07 122.57 46.45 Favored 'General case' 0 C--O 1.234 0.269 0 CA-C-O 120.841 0.353 . . . . 0.0 110.877 -179.551 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' B' B ' 6' ' ' LEU . . . . . . . . . . . . . 79.2 mt -114.08 154.43 27.75 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 115.367 -0.833 . . . . 0.0 110.787 -179.179 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' B' B ' 7' ' ' LYS . . . . . . . . . . . . . 62.9 tttm -143.23 140.54 17.89 Favored Pre-proline 0 CA--C 1.533 0.326 0 CA-C-O 119.152 -0.452 . . . . 0.0 110.057 174.007 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' B' B ' 8' ' ' PRO . . . . . . . . . . . . . 71.8 Cg_endo -90.27 139.56 3.01 Favored 'Trans proline' 0 N--CA 1.49 1.282 0 C-N-CA 121.723 1.615 . . . . 0.0 111.407 176.959 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' B' B ' 9' ' ' LEU . . . . . . . . . . . . . 53.6 mt -77.68 -46.69 2.43 Favored Pre-proline 0 C--N 1.329 -0.308 0 CA-C-O 118.811 -0.614 . . . . 0.0 112.102 -177.486 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' B' B ' 10' ' ' PRO . . . . . . . . . . . . . 76.8 Cg_endo -84.08 157.72 13.3 Favored 'Trans proline' 0 N--CA 1.495 1.609 0 C-N-CA 121.353 1.369 . . . . 0.0 111.686 173.771 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' B' B ' 11' ' ' LYS . . . . . . . . . . . . . 24.5 pttm -86.91 114.64 23.71 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-O 121.527 0.68 . . . . 0.0 110.544 177.417 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' B' B ' 12' ' ' VAL . . . . . . . . . . . . . 12.4 p -151.01 148.67 14.79 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.289 0 CA-C-N 115.659 -0.7 . . . . 0.0 110.447 -179.886 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' B' B ' 13' ' ' GLU . . . . . . . . . . . . . 84.5 tt0 -89.06 119.58 29.7 Favored 'General case' 0 C--N 1.329 -0.326 0 N-CA-C 109.877 -0.416 . . . . 0.0 109.877 176.494 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' B' B ' 14' ' ' LEU . . . . . . . . . . . . . 21.4 mt -93.92 147.54 33.68 Favored Pre-proline 0 C--N 1.329 -0.317 0 CA-C-O 119.102 -0.475 . . . . 0.0 110.479 -176.91 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' B' B ' 15' ' ' PRO . . . . . . . . . . . . . 25.3 Cg_exo -62.65 160.41 32.58 Favored 'Trans proline' 0 N--CA 1.497 1.733 0 C-N-CA 121.284 1.322 . . . . 0.0 112.001 177.714 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' B' B ' 16' ' ' PRO . . . . . . . . . . . . . 39.0 Cg_exo -58.88 -44.13 38.07 Favored 'Trans proline' 0 N--CA 1.498 1.781 0 C-N-CA 121.365 1.377 . . . . 0.0 112.892 -178.716 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' B' B ' 17' ' ' ASP . . . . . . . . . . . . . 11.1 p-10 -83.77 10.33 9.74 Favored 'General case' 0 C--N 1.327 -0.404 0 N-CA-C 113.169 0.803 . . . . 0.0 113.169 -177.03 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' B' B ' 18' ' ' PHE . . . . . . . . . . . . . 36.1 t80 -57.91 -43.03 85.91 Favored 'General case' 0 C--N 1.334 -0.084 0 O-C-N 121.975 -0.453 . . . . 0.0 110.088 -178.746 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' B' B ' 19' ' ' VAL . . . . . . . . . . . . . 48.3 t -57.4 -43.39 82.47 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.352 0 CA-C-N 116.247 -0.433 . . . . 0.0 110.403 -179.514 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' B' B ' 20' ' ' ASP . . . . . . . . . . . . . 53.6 m-20 -59.97 -42.57 94.44 Favored 'General case' 0 C--N 1.331 -0.204 0 C-N-CA 120.979 -0.288 . . . . 0.0 110.996 -177.299 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' B' B ' 21' ' ' VAL . . . . . . . . . . . . . 48.3 t -64.53 -45.53 95.34 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.319 0 C-N-CA 120.728 -0.389 . . . . 0.0 110.433 -178.089 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' B' B ' 22' ' ' ILE . . . . . 0.556 HG22 HD12 ' B' ' 26' ' ' LEU . 50.0 mm -58.73 -40.63 80.14 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.318 0 C-N-CA 121.081 -0.247 . . . . 0.0 110.681 179.227 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' B' B ' 23' ' ' ARG . . . . . . . . . . . . . 46.2 ttp180 -56.15 -48.29 76.56 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-O 120.984 0.421 . . . . 0.0 110.585 178.503 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' B' B ' 24' ' ' ILE . . . . . . . . . . . . . 72.5 mt -61.5 -45.19 99.15 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.274 0 CA-C-N 115.94 -0.573 . . . . 0.0 111.769 -177.966 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' B' B ' 25' ' ' LYS . . . . . . . . . . . . . 15.6 pttp -71.22 -37.35 72.05 Favored 'General case' 0 CA--C 1.534 0.36 0 C-N-CA 120.615 -0.434 . . . . 0.0 111.838 -172.545 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' B' B ' 26' ' ' LEU . . . . . 0.556 HD12 HG22 ' B' ' 22' ' ' ILE . 23.7 mt -80.5 -42.23 22.86 Favored 'General case' 0 C--N 1.33 -0.245 0 N-CA-C 113.096 0.776 . . . . 0.0 113.096 -174.674 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' B' B ' 27' ' ' GLN . . . . . . . . . . . . . 14.9 pt20 -47.0 139.98 5.21 Favored 'General case' 0 N--CA 1.469 0.487 0 N-CA-C 112.751 0.649 . . . . 0.0 112.751 -174.875 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' B' B ' 28' ' ' GLY . . . . . . . . . . . . . . . 99.92 -24.51 31.85 Favored Glycine 0 CA--C 1.533 1.187 0 CA-C-N 115.525 -0.762 . . . . 0.0 112.274 -175.539 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' B' B ' 29' ' ' LYS . . . . . . . . . . . . . 65.2 mttm -98.79 155.09 17.53 Favored 'General case' 0 C--O 1.233 0.187 0 CA-C-N 117.288 0.544 . . . . 0.0 111.009 179.525 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' B' B ' 30' ' ' THR . . . . . . . . . . . . . 31.8 m -100.21 135.26 41.92 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.196 -0.457 . . . . 0.0 109.885 175.436 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' B' B ' 31' ' ' VAL . . . . . . . . . . . . . 35.0 m -127.84 154.46 38.4 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.245 0 CA-C-O 120.897 0.379 . . . . 0.0 110.967 -178.379 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' B' B ' 32' ' ' ARG . . . . . . . . . . . . . 85.6 mtm180 -133.32 151.03 51.85 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 115.823 -0.626 . . . . 0.0 110.396 178.259 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' B' B ' 33' ' ' THR . . . . . . . . . . . . . 23.7 m -53.29 138.51 32.23 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.338 -0.392 . . . . 0.0 111.362 -178.336 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' B' B ' 34' ' ' GLY . . . . . . . . . . . . . . . 101.11 -17.05 56.62 Favored Glycine 0 CA--C 1.531 1.084 0 CA-C-O 119.658 -0.523 . . . . 0.0 113.269 178.978 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' B' B ' 35' ' ' ASP . . . . . . . . . . . . . 69.2 m-20 -64.55 148.93 49.75 Favored 'General case' 0 N--CA 1.461 0.107 0 CA-C-N 118.123 0.962 . . . . 0.0 111.018 179.098 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' B' B ' 36' ' ' VAL . . . . . . . . . . . . . 45.3 t -125.47 132.02 71.49 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.217 0 CA-C-N 115.825 -0.625 . . . . 0.0 109.869 179.157 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' B' B ' 37' ' ' ILE . . . . . . . . . . . . . 68.5 mt -120.22 138.07 51.97 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.234 0 CA-C-N 116.141 -0.482 . . . . 0.0 109.853 179.624 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' B' B ' 38' ' ' GLY . . . . . . . . . . . . . . . -108.05 128.74 9.27 Favored Glycine 0 CA--C 1.524 0.61 0 N-CA-C 110.872 -0.891 . . . . 0.0 110.872 179.848 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' B' B ' 39' ' ' ILE . . . . . . . . . . . . . 75.5 mt -125.63 137.12 58.69 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.259 0 N-CA-C 110.186 -0.302 . . . . 0.0 110.186 179.994 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' B' B ' 40' ' ' SER . . . . . 0.528 ' O ' HD13 ' B' ' 41' ' ' ILE . 42.2 p -92.8 119.17 31.88 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.378 -0.374 . . . . 0.0 110.924 176.227 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' B' B ' 41' ' ' ILE . . . . . 0.528 HD13 ' O ' ' B' ' 40' ' ' SER . 47.6 mm -129.59 117.91 43.66 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.189 0 CA-C-O 120.716 0.293 . . . . 0.0 110.325 178.69 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' B' B ' 42' ' ' LEU . . . . . . . . . . . . . 51.0 mt 57.88 34.32 24.21 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.317 -0.401 . . . . 0.0 111.819 177.7 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' B' B ' 43' ' ' GLY . . . . . . . . . . . . . . . 78.74 -10.1 33.45 Favored Glycine 0 CA--C 1.534 1.236 0 C-N-CA 121.215 -0.517 . . . . 0.0 113.438 177.539 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' B' B ' 44' ' ' LYS . . . . . . . . . . . . . 72.9 mmtt -97.82 138.63 34.88 Favored 'General case' 0 C--N 1.333 -0.132 0 CA-C-N 117.854 0.827 . . . . 0.0 109.946 176.912 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' B' B ' 45' ' ' GLU . . . . . . . . . . . . . 84.8 tt0 -84.07 125.16 31.85 Favored 'General case' 0 C--N 1.328 -0.35 0 C-N-CA 120.874 -0.33 . . . . 0.0 110.76 179.447 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' B' B ' 46' ' ' VAL . . . . . . . . . . . . . 7.4 p -121.77 127.8 75.57 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.182 0 N-CA-C 109.627 -0.509 . . . . 0.0 109.627 177.603 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' B' B ' 47' ' ' LYS . . . . . . . . . . . . . 64.0 mttp -100.45 130.43 46.53 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 115.91 -0.586 . . . . 0.0 111.16 178.911 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' B' B ' 48' ' ' PHE . . . . . . . . . . . . . 93.6 m-85 -112.73 131.84 55.49 Favored 'General case' 0 C--N 1.33 -0.258 0 N-CA-C 109.889 -0.411 . . . . 0.0 109.889 175.748 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' B' B ' 49' ' ' LYS . . . . . . . . . . . . . 85.6 tttt -108.82 139.73 43.24 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.279 -0.418 . . . . 0.0 110.846 -178.499 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' B' B ' 50' ' ' VAL . . . . . . . . . . . . . 46.2 t -83.13 108.0 15.39 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.346 0 N-CA-C 109.301 -0.629 . . . . 0.0 109.301 174.852 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' B' B ' 51' ' ' VAL . . . . . . . . . . . . . 47.7 t -72.7 -48.11 47.43 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.306 0 CA-C-N 116.118 -0.492 . . . . 0.0 110.001 -173.06 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' B' B ' 52' ' ' GLN . . . . . . . . . . . . . 60.4 tt0 -165.25 146.97 7.63 Favored 'General case' 0 C--N 1.33 -0.246 0 C-N-CA 120.266 -0.574 . . . . 0.0 111.863 -177.972 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' B' B ' 53' ' ' ALA . . . . . . . . . . . . . . . -123.23 134.54 54.11 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 115.677 -0.692 . . . . 0.0 109.929 176.48 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' B' B ' 54' ' ' TYR . . . . . . . . . . . . . 33.4 t80 -129.14 112.16 18.35 Favored Pre-proline 0 CA--C 1.535 0.403 0 CA-C-O 118.184 -0.912 . . . . 0.0 110.289 178.726 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' B' B ' 55' ' ' PRO . . . . . . . . . . . . . 73.5 Cg_endo -77.11 169.22 74.86 Favored 'Cis proline' 0 N--CA 1.5 1.904 0 CA-C-N 121.99 1.747 . . . . 0.0 112.212 -6.698 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' B' B ' 56' ' ' SER . . . . . . . . . . . . . 13.8 m -117.25 137.19 23.76 Favored Pre-proline 0 CA--C 1.537 0.467 0 CA-C-O 118.537 -0.744 . . . . 0.0 109.802 175.296 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' B' B ' 57' ' ' PRO . . . . . . . . . . . . . 32.4 Cg_endo -65.71 162.94 67.82 Favored 'Cis proline' 0 N--CA 1.498 1.757 0 CA-C-N 121.761 1.665 . . . . 0.0 111.309 -4.724 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' B' B ' 58' ' ' LEU . . . . . . . . . . . . . 31.7 tp -129.18 137.52 51.2 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-O 120.945 0.402 . . . . 0.0 110.511 -178.651 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' B' B ' 59' ' ' ARG . . . . . . . . . . . . . 27.0 ttm180 -101.49 127.43 48.18 Favored 'General case' 0 C--N 1.327 -0.392 0 N-CA-C 109.301 -0.629 . . . . 0.0 109.301 176.151 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' B' B ' 60' ' ' VAL . . . . . . . . . . . . . 46.9 t -79.57 117.73 25.82 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.33 0 C-N-CA 120.677 -0.409 . . . . 0.0 110.095 -175.967 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' B' B ' 61' ' ' GLU . . . . . . . . . . . . . 70.8 mm-40 -131.06 161.83 31.17 Favored 'General case' 0 C--N 1.331 -0.208 0 CA-C-N 116.047 -0.524 . . . . 0.0 110.284 178.846 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' B' B ' 62' ' ' ASP . . . . . . . . . . . . . 67.4 m-20 -54.53 -32.45 58.22 Favored 'General case' 0 C--N 1.327 -0.396 0 CA-C-N 116.463 -0.335 . . . . 0.0 111.748 -179.901 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' B' B ' 63' ' ' ARG . . . . . . . . . . . . . 13.8 ptp180 -84.24 10.09 11.29 Favored 'General case' 0 CA--C 1.535 0.398 0 N-CA-C 113.471 0.915 . . . . 0.0 113.471 -175.854 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' B' B ' 64' ' ' THR . . . . . . . . . . . . . 32.3 m -94.92 143.0 26.82 Favored 'General case' 0 C--O 1.231 0.128 0 CA-C-N 118.02 0.373 . . . . 0.0 110.632 -179.73 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' B' B ' 65' ' ' LYS . . . . . . . . . . . . . 92.3 mttt -88.52 129.0 35.56 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.155 -0.475 . . . . 0.0 110.267 179.633 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' B' B ' 66' ' ' ILE . . . . . . . . . . . . . 59.5 mt -115.08 130.21 69.99 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.196 0 N-CA-C 109.707 -0.479 . . . . 0.0 109.707 179.479 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' B' B ' 67' ' ' THR . . . . . . . . . . . . . 28.0 m -132.49 144.68 50.61 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-O 121.111 0.482 . . . . 0.0 111.3 -177.923 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' B' B ' 68' ' ' LEU . . . . . 0.464 HD12 ' N ' ' B' ' 68' ' ' LEU . 7.3 mp . . . . . 0 C--N 1.329 -0.296 0 CA-C-N 115.96 -0.564 . . . . 0.0 109.94 174.79 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' B' B ' 73' ' ' VAL . . . . . . . . . . . . . 34.6 m . . . . . 0 C--O 1.232 0.14 0 CA-C-O 120.793 0.33 . . . . 0.0 110.603 . . . . . . . . . 0 0 . 1 . 014 nuclear build core ' B' B ' 74' ' ' ASP . . . . . . . . . . . . . 36.1 t0 -94.66 117.57 30.34 Favored 'General case' 0 C--N 1.329 -0.309 0 N-CA-C 109.669 -0.493 . . . . 0.0 109.669 -179.443 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' B' B ' 75' ' ' VAL . . . . . . . . . . . . . 44.0 t -117.9 124.66 73.4 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.287 0 CA-C-O 121.123 0.487 . . . . 0.0 110.771 -176.382 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' B' B ' 76' ' ' LEU . . . . . . . . . . . . . 5.3 mp -122.55 148.45 45.18 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 115.539 -0.755 . . . . 0.0 109.47 174.964 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' B' B ' 77' ' ' GLU . . . . . . . . . . . . . 45.8 mt-10 -135.05 139.52 44.85 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-O 120.999 0.428 . . . . 0.0 111.471 -177.645 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' B' B ' 78' ' ' ALA . . . . . 0.618 ' HB2' HD21 ' B' ' 109' ' ' LEU . . . -128.39 132.29 48.52 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 115.701 -0.681 . . . . 0.0 109.642 175.585 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' B' B ' 79' ' ' LYS . . . . . 0.565 ' O ' HD13 ' B' ' 80' ' ' ILE . 84.5 mttt -76.72 121.45 23.31 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-O 121.077 0.465 . . . . 0.0 110.851 -178.072 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' B' B ' 80' ' ' ILE . . . . . 0.565 HD13 ' O ' ' B' ' 79' ' ' LYS . 43.5 mm -139.19 109.36 4.23 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.27 0 N-CA-C 108.963 -0.754 . . . . 0.0 108.963 -177.854 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' B' B ' 81' ' ' LYS . . . . . . . . . . . . . 93.5 mttt -101.98 124.38 47.5 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-O 120.916 0.388 . . . . 0.0 111.346 -176.244 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' B' B ' 82' ' ' GLY . . . . . . . . . . . . . . . 89.07 42.16 5.69 Favored Glycine 0 CA--C 1.526 0.72 0 C-N-CA 120.956 -0.64 . . . . 0.0 111.841 174.666 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' B' B ' 83' ' ' ILE . . . . . . . . . . . . . 69.0 mt -67.39 136.86 25.85 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.28 0 N-CA-C 109.632 -0.507 . . . . 0.0 109.632 177.116 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' B' B ' 84' ' ' LYS . . . . . . . . . . . . . 38.6 ttpt -101.56 -52.4 3.23 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-O 121.022 0.439 . . . . 0.0 110.422 -178.673 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' B' B ' 85' ' ' ASP . . . . . . . . . . . . . 10.7 t70 -145.46 147.77 32.55 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 115.943 -0.571 . . . . 0.0 110.458 -178.644 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' B' B ' 86' ' ' VAL . . . . . . . . . . . . . 42.2 t -129.68 130.85 67.0 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.26 0 CA-C-O 120.905 0.383 . . . . 0.0 110.373 -179.617 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' B' B ' 87' ' ' ILE . . . . . 0.488 ' N ' HD12 ' B' ' 87' ' ' ILE . 5.0 mp -119.74 123.74 71.54 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.214 0 N-CA-C 109.313 -0.625 . . . . 0.0 109.313 176.105 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' B' B ' 88' ' ' LEU . . . . . . . . . . . . . 17.9 tp -111.01 127.77 55.64 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-O 121.038 0.447 . . . . 0.0 110.972 -177.774 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' B' B ' 89' ' ' ASP . . . . . . . . . . . . . 8.2 t70 -121.61 152.12 39.64 Favored 'General case' 0 C--N 1.331 -0.201 0 CA-C-N 115.797 -0.638 . . . . 0.0 109.6 177.005 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' B' B ' 90' ' ' GLU . . . . . . . . . . . . . 96.4 mt-10 -48.84 -36.24 16.43 Favored 'General case' 0 C--N 1.328 -0.337 0 N-CA-C 112.642 0.608 . . . . 0.0 112.642 -173.04 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' B' B ' 91' ' ' ASN . . . . . . . . . . . . . 30.5 m120 -132.21 32.87 3.93 Favored 'General case' 0 N--CA 1.466 0.336 0 N-CA-C 111.909 0.337 . . . . 0.0 111.909 -177.001 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' B' B ' 92' ' ' LEU . . . . . . . . . . . . . 15.5 tp -166.13 144.42 5.66 Favored 'General case' 0 C--N 1.331 -0.206 0 C-N-CA 121.028 -0.269 . . . . 0.0 110.574 179.722 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' B' B ' 93' ' ' ILE . . . . . . . . . . . . . 70.1 mt -123.36 122.38 65.09 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.279 0 N-CA-C 109.594 -0.521 . . . . 0.0 109.594 178.741 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' B' B ' 94' ' ' VAL . . . . . . . . . . . . . 47.3 t -120.65 125.03 73.63 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 N-CA-C 109.776 -0.453 . . . . 0.0 109.776 179.281 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' B' B ' 95' ' ' VAL . . . . . . . . . . . . . 43.5 t -124.04 134.6 66.11 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.325 0 CA-C-N 116.286 -0.415 . . . . 0.0 109.976 -178.726 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' B' B ' 96' ' ' ILE . . . . . . . . . . . . . 58.3 mt -117.6 126.96 75.04 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.255 0 N-CA-C 109.367 -0.605 . . . . 0.0 109.367 179.343 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' B' B ' 97' ' ' THR . . . . . . . . . . . . . 77.1 p -98.32 157.72 16.01 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-O 121.188 0.518 . . . . 0.0 111.137 -178.086 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' B' B ' 98' ' ' GLU . . . . . . . . . . . . . 80.2 tt0 -53.92 -29.23 41.26 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 116.1 -0.5 . . . . 0.0 112.059 -178.675 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' B' B ' 99' ' ' GLU . . . . . . . . . . . . . 39.3 tt0 -80.01 15.89 1.35 Allowed 'General case' 0 CA--C 1.541 0.61 0 N-CA-C 112.599 0.592 . . . . 0.0 112.599 -176.074 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' B' B ' 100' ' ' ASN . . . . . . . . . . . . . 4.8 m-20 63.8 33.18 12.98 Favored 'General case' 0 CA--C 1.532 0.271 0 O-C-N 121.873 -0.517 . . . . 0.0 111.703 177.859 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' B' B ' 101' ' ' GLU . . . . . . . . . . . . . 84.7 tt0 -106.47 141.94 36.95 Favored 'General case' 0 C--N 1.331 -0.215 0 N-CA-C 109.506 -0.553 . . . . 0.0 109.506 172.179 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' B' B ' 102' ' ' VAL . . . . . . . . . . . . . 45.2 t -116.89 128.18 74.35 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.299 0 N-CA-C 109.805 -0.443 . . . . 0.0 109.805 -177.813 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' B' B ' 103' ' ' LEU . . . . . . . . . . . . . 26.8 mt -118.8 131.2 56.09 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 115.839 -0.619 . . . . 0.0 110.611 178.185 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' B' B ' 104' ' ' ILE . . . . . 0.432 HD12 ' HB3' ' B' ' 113' ' ' TYR . 69.7 mt -116.17 120.12 63.93 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.245 0 N-CA-C 109.72 -0.474 . . . . 0.0 109.72 178.076 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' B' B ' 105' ' ' PHE . . . . . . . . . . . . . 70.7 m-85 -123.13 163.87 19.74 Favored 'General case' 0 C--N 1.331 -0.207 0 O-C-N 123.81 0.694 . . . . 0.0 109.722 179.867 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' B' B ' 106' ' ' ASN . . . . . . . . . . . . . 48.1 p-10 -98.87 -170.75 1.98 Allowed 'General case' 0 C--N 1.329 -0.298 0 N-CA-C 109.754 -0.461 . . . . 0.0 109.754 172.742 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' B' B ' 107' ' ' GLN . . . . . . . . . . . . . 44.7 tt0 -61.04 -30.05 70.08 Favored 'General case' 0 C--N 1.328 -0.369 0 N-CA-C 111.851 0.315 . . . . 0.0 111.851 -179.159 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' B' B ' 108' ' ' ASN . . . . . . . . . . . . . 13.7 t-20 -82.77 6.4 18.27 Favored 'General case' 0 CA--C 1.537 0.469 0 N-CA-C 113.215 0.821 . . . . 0.0 113.215 -178.421 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' B' B ' 109' ' ' LEU . . . . . 0.618 HD21 ' HB2' ' B' ' 78' ' ' ALA . 10.7 tp 61.95 39.34 13.59 Favored 'General case' 0 C--O 1.233 0.209 0 CA-C-O 121.246 0.546 . . . . 0.0 111.197 178.267 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' B' B ' 110' ' ' GLU . . . . . . . . . . . . . 70.8 mm-40 -105.77 157.83 17.17 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.105 176.419 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' B' B ' 111' ' ' GLU . . . . . . . . . . . . . 84.6 tt0 -83.17 121.99 27.8 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-O 120.901 0.381 . . . . 0.0 111.064 -176.613 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' B' B ' 112' ' ' LEU . . . . . . . . . . . . . 34.0 mt -108.29 -46.09 3.79 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-N 115.959 -0.564 . . . . 0.0 110.133 176.462 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' B' B ' 113' ' ' TYR . . . . . 0.432 ' HB3' HD12 ' B' ' 104' ' ' ILE . 63.0 t80 -143.39 135.94 27.32 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.091 -0.504 . . . . 0.0 111.182 179.141 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' B' B ' 114' ' ' ARG . . . . . . . . . . . . . 26.3 ttm180 -133.16 122.7 24.41 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.235 -0.439 . . . . 0.0 109.88 175.669 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' B' B ' 115' ' ' GLY . . . . . . . . . . . . . . . -150.08 152.34 24.27 Favored Glycine 0 CA--C 1.523 0.556 0 N-CA-C 110.69 -0.964 . . . . 0.0 110.69 179.293 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' B' B ' 116' ' ' LYS . . . . . . . . . . . . . 60.8 tttm -129.2 127.46 41.36 Favored 'General case' 0 C--N 1.328 -0.343 0 N-CA-C 109.697 -0.482 . . . . 0.0 109.697 178.351 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' B' B ' 117' ' ' PHE . . . . . 0.442 ' HE2' HD13 ' B' ' 132' ' ' ILE . 49.8 m-85 -123.27 114.06 19.72 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.258 -0.428 . . . . 0.0 110.257 -174.917 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' B' B ' 118' ' ' GLU . . . . . . . . . . . . . 84.7 tt0 -53.99 -43.29 69.86 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 116.363 -0.381 . . . . 0.0 111.357 -176.716 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' B' B ' 119' ' ' ASN . . . . . . . . . . . . . 17.7 m-80 -99.26 31.01 3.23 Favored 'General case' 0 C--N 1.33 -0.257 0 N-CA-C 112.275 0.472 . . . . 0.0 112.275 -174.203 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' B' B ' 120' ' ' LEU . . . . . . . . . . . . . 21.3 tp -56.4 120.26 7.37 Favored 'General case' 0 C--O 1.232 0.148 0 C-N-CA 121.014 -0.274 . . . . 0.0 110.445 177.877 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' B' B ' 121' ' ' ASN . . . . . . . . . . . . . 72.2 m-20 -114.16 -43.99 3.17 Favored 'General case' 0 C--O 1.232 0.181 0 CA-C-N 116.574 -0.284 . . . . 0.0 111.162 -177.283 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' B' B ' 122' ' ' LYS . . . . . . . . . . . . . 95.1 mttt -145.55 150.43 36.4 Favored 'General case' 0 C--N 1.329 -0.283 0 C-N-CA 120.69 -0.404 . . . . 0.0 111.489 -177.17 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' B' B ' 123' ' ' VAL . . . . . . . . . . . . . 43.8 t -132.77 133.26 59.36 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.235 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.107 177.896 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' B' B ' 124' ' ' LEU . . . . . . . . . . . . . 77.8 mt -120.76 130.53 54.07 Favored 'General case' 0 C--O 1.233 0.202 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.596 178.745 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' B' B ' 125' ' ' VAL . . . . . . . . . . . . . 44.8 t -128.21 128.04 68.16 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.281 0 N-CA-C 109.861 -0.422 . . . . 0.0 109.861 179.054 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' B' B ' 126' ' ' ARG . . . . . . . . . . . . . 73.3 mtp85 -140.4 115.06 9.49 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-O 120.812 0.339 . . . . 0.0 110.792 179.468 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' B' B ' 127' ' ' ASN . . . . . . . . . . . . . 21.0 t-20 51.39 -104.91 0.18 Allowed 'General case' 0 CA--C 1.544 0.718 0 CA-C-O 119.131 -0.461 . . . . 0.0 111.382 178.367 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' B' B ' 128' ' ' ASP . . . . . . . . . . . . . 18.3 p-10 -114.0 2.51 15.01 Favored 'General case' 0 N--CA 1.468 0.436 0 CA-C-N 119.562 1.074 . . . . 0.0 113.432 -177.14 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' B' B ' 129' ' ' LEU . . . . . . . . . . . . . 13.3 tp -106.45 136.89 45.41 Favored 'General case' 0 C--N 1.331 -0.218 0 CA-C-N 118.146 0.43 . . . . 0.0 109.909 178.835 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' B' B ' 130' ' ' VAL . . . . . . . . . . . . . 42.5 t -124.7 136.18 61.52 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.242 0 CA-C-O 120.881 0.372 . . . . 0.0 110.314 -177.358 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' B' B ' 131' ' ' VAL . . . . . 0.46 HG22 HD12 ' B' ' 140' ' ' LEU . 46.4 t -134.81 133.83 53.94 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.214 0 CA-C-N 116.264 -0.425 . . . . 0.0 110.187 177.984 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' B' B ' 132' ' ' ILE . . . . . 0.442 HD13 ' HE2' ' B' ' 117' ' ' PHE . 75.7 mt -117.59 133.73 63.43 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.343 0 N-CA-C 109.64 -0.504 . . . . 0.0 109.64 -179.688 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' B' B ' 133' ' ' ILE . . . . . . . . . . . . . 35.6 mm -115.76 123.25 70.93 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.242 0 CA-C-O 120.748 0.309 . . . . 0.0 111.064 -175.448 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' B' B ' 134' ' ' ASP . . . . . . . . . . . . . 9.8 p-10 -134.09 149.77 51.13 Favored 'General case' 0 C--N 1.331 -0.22 0 N-CA-C 109.621 -0.511 . . . . 0.0 109.621 174.755 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' B' B ' 135' ' ' GLU . . . . . . . . . . . . . 40.8 tp10 -50.05 -30.05 10.04 Favored 'General case' 0 C--N 1.328 -0.338 0 N-CA-C 112.651 0.612 . . . . 0.0 112.651 -170.896 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' B' B ' 136' ' ' GLN . . . . . . . . . . . . . 98.2 mt-30 -81.41 -36.4 29.54 Favored 'General case' 0 C--N 1.329 -0.3 0 N-CA-C 112.687 0.625 . . . . 0.0 112.687 -175.981 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' B' B ' 137' ' ' LYS . . . . . . . . . . . . . 20.4 pttm -163.07 172.52 14.82 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-O 121.626 0.727 . . . . 0.0 112.391 -169.706 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' B' B ' 138' ' ' LEU . . . . . . . . . . . . . 6.7 tt -118.53 129.16 55.19 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 114.94 -1.027 . . . . 0.0 109.842 178.27 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' B' B ' 139' ' ' THR . . . . . . . . . . . . . 31.5 m -108.23 128.16 54.47 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.207 -0.452 . . . . 0.0 110.328 -179.857 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' B' B ' 140' ' ' LEU . . . . . 0.46 HD12 HG22 ' B' ' 131' ' ' VAL . 9.4 tp -114.02 122.56 47.28 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 115.763 -0.653 . . . . 0.0 109.567 -178.058 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' B' B ' 141' ' ' ILE . . . . . . . . . . . . . 19.6 mt -121.37 119.71 59.85 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.34 0 N-CA-C 109.949 -0.389 . . . . 0.0 109.949 -175.322 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' B' B ' 142' ' ' ARG . . . . . . . . . . . . . 45.2 ttp180 -114.05 127.9 56.15 Favored 'General case' 0 C--N 1.331 -0.229 0 CA-C-N 115.517 -0.765 . . . . 0.0 110.314 -177.216 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' B' B ' 143' ' ' THR . . . . . . . . . . . . . 20.3 p . . . . . 0 C--O 1.22 -0.489 0 CA-C-O 118.09 -0.957 . . . . 0.0 110.625 -179.661 . . . . . . . . 0 0 . 1 . 014 nuclear build core ' C' C ' 2' ' ' SER . . . . . . . . . . . . . 5.5 p . . . . . 0 N--CA 1.461 0.123 0 CA-C-O 121.119 0.485 . . . . 0.0 110.954 . . . . . . . . . 0 0 . 1 . 014 nuclear build core ' C' C ' 3' ' ' GLU . . . . . . . . . . . . . 45.9 mp0 -139.45 142.19 37.41 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 115.785 -0.643 . . . . 0.0 110.707 179.232 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' C' C ' 4' ' ' LEU . . . . . 0.457 HD21 HD21 ' C' ' 6' ' ' LEU . 14.3 tp -124.52 127.42 47.4 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 116.085 -0.507 . . . . 0.0 110.214 176.593 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' C' C ' 5' ' ' LYS . . . . . . . . . . . . . 60.7 mttp -104.41 121.1 42.71 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.404 -0.362 . . . . 0.0 110.538 177.926 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' C' C ' 6' ' ' LEU . . . . . 0.457 HD21 HD21 ' C' ' 4' ' ' LEU . 54.8 mt -116.8 149.94 39.14 Favored 'General case' 0 C--N 1.331 -0.225 0 CA-C-N 115.603 -0.726 . . . . 0.0 110.927 -178.155 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' C' C ' 7' ' ' LYS . . . . . . . . . . . . . 59.7 tttm -138.07 142.91 37.39 Favored Pre-proline 0 CA--C 1.534 0.341 0 CA-C-N 116.28 -0.418 . . . . 0.0 109.958 175.448 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' C' C ' 8' ' ' PRO . . . . . . . . . . . . . 96.7 Cg_endo -91.46 143.39 3.02 Favored 'Trans proline' 0 N--CA 1.49 1.317 0 C-N-CA 121.763 1.642 . . . . 0.0 112.01 179.04 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' C' C ' 9' ' ' LEU . . . . . . . . . . . . . 50.5 mt -85.57 -48.19 0.58 Allowed Pre-proline 0 CA--C 1.534 0.363 0 CA-C-O 118.661 -0.685 . . . . 0.0 112.393 -179.544 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' C' C ' 10' ' ' PRO . . . . . . . . . . . . . 90.8 Cg_endo -79.97 157.97 23.93 Favored 'Trans proline' 0 N--CA 1.497 1.677 0 C-N-CA 121.17 1.247 . . . . 0.0 111.99 176.976 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' C' C ' 11' ' ' LYS . . . . . . . . . . . . . 1.9 ttmp? -88.35 95.35 10.16 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 116.333 -0.394 . . . . 0.0 110.548 179.358 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' C' C ' 12' ' ' VAL . . . . . . . . . . . . . 12.7 p -144.78 147.34 19.18 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.284 0 CA-C-N 116.296 -0.411 . . . . 0.0 110.669 -179.596 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' C' C ' 13' ' ' GLU . . . . . . . . . . . . . 84.7 tt0 -94.09 129.54 40.59 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.348 -0.387 . . . . 0.0 110.145 177.685 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' C' C ' 14' ' ' LEU . . . . . . . . . . . . . 18.3 mt -97.47 153.05 38.5 Favored Pre-proline 0 C--N 1.329 -0.304 0 CA-C-N 116.458 -0.337 . . . . 0.0 110.9 -176.575 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' C' C ' 15' ' ' PRO . . . . . . . . . . . . . 25.6 Cg_exo -62.48 162.19 25.08 Favored 'Trans proline' 0 N--CA 1.498 1.753 0 C-N-CA 121.242 1.295 . . . . 0.0 111.939 176.905 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' C' C ' 16' ' ' PRO . . . . . . . . . . . . . 25.6 Cg_exo -61.32 -36.58 78.32 Favored 'Trans proline' 0 N--CA 1.499 1.811 0 C-N-CA 121.423 1.415 . . . . 0.0 112.611 -178.488 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' C' C ' 17' ' ' ASP . . . . . . . . . . . . . 19.4 p-10 -89.5 9.72 25.51 Favored 'General case' 0 CA--C 1.535 0.4 0 N-CA-C 113.35 0.87 . . . . 0.0 113.35 -176.882 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' C' C ' 18' ' ' PHE . . . . . . . . . . . . . 47.3 t80 -58.07 -43.24 86.86 Favored 'General case' 0 C--O 1.227 -0.101 0 O-C-N 122.051 -0.406 . . . . 0.0 110.078 -178.281 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' C' C ' 19' ' ' VAL . . . . . . . . . . . . . 54.6 t -57.04 -42.17 78.85 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.321 0 CA-C-N 116.415 -0.357 . . . . 0.0 110.458 -178.751 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' C' C ' 20' ' ' ASP . . . . . . . . . . . . . 38.7 t0 -59.59 -43.52 93.66 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-O 120.874 0.369 . . . . 0.0 110.814 -178.153 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' C' C ' 21' ' ' VAL . . . . . . . . . . . . . 48.2 t -64.81 -46.01 93.3 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.326 0 CA-C-N 116.34 -0.391 . . . . 0.0 110.511 -178.23 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' C' C ' 22' ' ' ILE . . . . . 0.52 HG22 HD12 ' C' ' 26' ' ' LEU . 50.5 mm -59.77 -37.84 73.21 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.311 0 C-N-CA 120.946 -0.302 . . . . 0.0 110.779 -179.353 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' C' C ' 23' ' ' ARG . . . . . . . . . . . . . 36.7 ttp180 -57.75 -49.15 77.53 Favored 'General case' 0 C--N 1.33 -0.263 0 C-N-CA 120.689 -0.404 . . . . 0.0 110.457 178.187 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' C' C ' 24' ' ' ILE . . . . . . . . . . . . . 74.1 mt -61.45 -44.55 98.74 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.295 0 CA-C-N 116.1 -0.5 . . . . 0.0 111.952 -177.225 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' C' C ' 25' ' ' LYS . . . . . 0.472 ' HE3' HD13 ' C' ' 22' ' ' ILE . 0.7 OUTLIER -70.06 -34.52 73.31 Favored 'General case' 0 CA--C 1.534 0.361 0 C-N-CA 120.834 -0.346 . . . . 0.0 111.815 -174.676 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' C' C ' 26' ' ' LEU . . . . . 0.52 HD12 HG22 ' C' ' 22' ' ' ILE . 89.4 mt -78.78 -45.03 21.89 Favored 'General case' 0 C--N 1.331 -0.22 0 N-CA-C 113.085 0.772 . . . . 0.0 113.085 -174.18 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' C' C ' 27' ' ' GLN . . . . . . . . . . . . . 16.6 pt20 -47.29 139.78 6.03 Favored 'General case' 0 N--CA 1.469 0.517 0 N-CA-C 112.674 0.62 . . . . 0.0 112.674 -174.542 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' C' C ' 28' ' ' GLY . . . . . . . . . . . . . . . 99.75 -25.42 28.33 Favored Glycine 0 CA--C 1.535 1.286 0 CA-C-N 115.497 -0.774 . . . . 0.0 112.235 -176.535 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' C' C ' 29' ' ' LYS . . . . . . . . . . . . . 90.2 mttt -97.95 155.17 17.21 Favored 'General case' 0 C--O 1.232 0.169 0 CA-C-N 117.285 0.543 . . . . 0.0 110.963 178.755 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' C' C ' 30' ' ' THR . . . . . . . . . . . . . 24.8 m -106.65 136.63 46.13 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.034 -0.53 . . . . 0.0 109.977 175.515 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' C' C ' 31' ' ' VAL . . . . . . . . . . . . . 34.8 m -132.11 158.05 43.22 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.219 0 CA-C-O 120.889 0.375 . . . . 0.0 111.211 -177.378 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' C' C ' 32' ' ' ARG . . . . . . . . . . . . . 75.2 mtp180 -134.24 153.22 51.98 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-O 121.299 0.571 . . . . 0.0 110.809 178.656 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' C' C ' 33' ' ' THR . . . . . . . . . . . . . 28.0 m -53.52 139.74 30.39 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 116.066 -0.515 . . . . 0.0 111.317 -179.047 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' C' C ' 34' ' ' GLY . . . . . . . . . . . . . . . 99.78 -17.23 57.69 Favored Glycine 0 CA--C 1.533 1.173 0 CA-C-O 119.67 -0.517 . . . . 0.0 113.289 178.21 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' C' C ' 35' ' ' ASP . . . . . . . . . . . . . 79.2 m-20 -66.6 147.9 52.64 Favored 'General case' 0 C--O 1.232 0.172 0 CA-C-N 118.072 0.936 . . . . 0.0 111.166 178.901 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' C' C ' 36' ' ' VAL . . . . . . . . . . . . . 43.1 t -121.79 129.8 75.15 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.239 0 CA-C-N 116.039 -0.528 . . . . 0.0 109.696 177.282 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' C' C ' 37' ' ' ILE . . . . . . . . . . . . . 68.0 mt -120.84 139.57 47.69 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.322 0 CA-C-N 116.343 -0.39 . . . . 0.0 110.052 -178.726 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' C' C ' 38' ' ' GLY . . . . . . . . . . . . . . . -110.62 128.76 8.94 Favored Glycine 0 CA--C 1.526 0.728 0 N-CA-C 111.208 -0.757 . . . . 0.0 111.208 -179.953 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' C' C ' 39' ' ' ILE . . . . . . . . . . . . . 72.8 mt -123.52 137.94 55.04 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.255 0 N-CA-C 109.965 -0.383 . . . . 0.0 109.965 178.999 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' C' C ' 40' ' ' SER . . . . . . . . . . . . . 46.7 t -92.2 113.93 26.33 Favored 'General case' 0 C--N 1.329 -0.296 0 C-N-CA 120.896 -0.321 . . . . 0.0 110.742 176.479 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' C' C ' 41' ' ' ILE . . . . . . . . . . . . . 45.2 mm -122.54 114.91 44.33 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.214 0 N-CA-C 110.026 -0.361 . . . . 0.0 110.026 179.093 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' C' C ' 42' ' ' LEU . . . . . . . . . . . . . 79.5 mt 57.33 35.11 25.66 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.456 -0.338 . . . . 0.0 111.686 178.806 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' C' C ' 43' ' ' GLY . . . . . . . . . . . . . . . 77.98 -10.14 28.05 Favored Glycine 0 CA--C 1.534 1.249 0 C-N-CA 121.311 -0.471 . . . . 0.0 113.575 177.903 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' C' C ' 44' ' ' LYS . . . . . . . . . . . . . 61.9 tttm -96.1 134.2 39.44 Favored 'General case' 0 C--N 1.333 -0.111 0 CA-C-N 117.742 0.771 . . . . 0.0 109.762 176.445 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' C' C ' 45' ' ' GLU . . . . . . . . . . . . . 84.5 tt0 -83.04 123.63 29.66 Favored 'General case' 0 C--N 1.328 -0.335 0 C-N-CA 120.789 -0.365 . . . . 0.0 110.629 -179.73 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' C' C ' 46' ' ' VAL . . . . . . . . . . . . . 7.3 p -117.71 127.26 75.08 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.257 0 N-CA-C 109.448 -0.575 . . . . 0.0 109.448 177.235 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' C' C ' 47' ' ' LYS . . . . . . . . . . . . . 54.8 mtpt -99.51 127.99 45.6 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 115.848 -0.614 . . . . 0.0 110.89 178.858 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' C' C ' 48' ' ' PHE . . . . . . . . . . . . . 92.2 m-85 -110.98 131.97 54.6 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.272 -0.422 . . . . 0.0 110.017 176.153 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' C' C ' 49' ' ' LYS . . . . . . . . . . . . . 78.7 tttt -107.64 135.66 48.7 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.409 -0.36 . . . . 0.0 110.207 179.479 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' C' C ' 50' ' ' VAL . . . . . . . . . . . . . 43.9 t -81.16 109.57 15.64 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.272 0 N-CA-C 109.408 -0.59 . . . . 0.0 109.408 176.833 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' C' C ' 51' ' ' VAL . . . . . . . . . . . . . 48.8 t -70.12 -47.91 65.1 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.292 0 N-CA-C 109.785 -0.45 . . . . 0.0 109.785 -174.923 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' C' C ' 52' ' ' GLN . . . . . . . . . . . . . 46.1 tt0 -168.11 139.95 2.92 Favored 'General case' 0 C--N 1.33 -0.267 0 C-N-CA 120.278 -0.569 . . . . 0.0 111.638 -179.217 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' C' C ' 53' ' ' ALA . . . . . 0.44 ' HB1' ' HB2' ' C' ' 58' ' ' LEU . . . -110.59 133.45 53.3 Favored 'General case' 0 C--N 1.33 -0.239 0 CA-C-N 115.673 -0.694 . . . . 0.0 109.904 176.059 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' C' C ' 54' ' ' TYR . . . . . . . . . . . . . 30.3 t80 -129.08 112.12 18.42 Favored Pre-proline 0 CA--C 1.536 0.44 0 CA-C-O 118.247 -0.882 . . . . 0.0 110.551 179.396 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' C' C ' 55' ' ' PRO . . . . . . . . . . . . . 72.6 Cg_endo -77.07 165.79 84.0 Favored 'Cis proline' 0 N--CA 1.499 1.826 0 CA-C-N 121.953 1.733 . . . . 0.0 112.205 -7.299 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' C' C ' 56' ' ' SER . . . . . . . . . . . . . 41.8 m -113.82 130.8 23.49 Favored Pre-proline 0 CA--C 1.538 0.492 0 CA-C-O 118.529 -0.748 . . . . 0.0 109.337 175.072 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' C' C ' 57' ' ' PRO . . . . . . . . . . . . . 50.0 Cg_endo -69.55 145.47 79.04 Favored 'Cis proline' 0 N--CA 1.498 1.738 0 CA-C-N 121.885 1.709 . . . . 0.0 111.626 0.711 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' C' C ' 58' ' ' LEU . . . . . 0.44 ' HB2' ' HB1' ' C' ' 53' ' ' ALA . 21.8 tp -108.16 134.53 50.89 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.291 -0.413 . . . . 0.0 110.761 -178.784 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' C' C ' 59' ' ' ARG . . . . . . . . . . . . . 31.5 ttm180 -100.78 128.55 46.78 Favored 'General case' 0 C--N 1.328 -0.361 0 N-CA-C 109.325 -0.62 . . . . 0.0 109.325 175.227 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' C' C ' 60' ' ' VAL . . . . . . . . . . . . . 44.2 t -84.35 116.94 28.93 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.266 0 C-N-CA 120.613 -0.435 . . . . 0.0 110.411 -177.522 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' C' C ' 61' ' ' GLU . . . . . . . . . . . . . 65.2 mm-40 -126.14 163.68 22.59 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-N 115.744 -0.662 . . . . 0.0 109.774 176.862 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' C' C ' 62' ' ' ASP . . . . . . . . . . . . . 62.7 m-20 -52.72 -32.38 42.62 Favored 'General case' 0 C--N 1.329 -0.32 0 N-CA-C 111.794 0.294 . . . . 0.0 111.794 178.921 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' C' C ' 63' ' ' ARG . . . . . . . . . . . . . 92.6 mtt-85 -73.69 -22.08 60.04 Favored 'General case' 0 CA--C 1.533 0.312 0 N-CA-C 112.922 0.712 . . . . 0.0 112.922 -177.163 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' C' C ' 64' ' ' THR . . . . . . . . . . . . . 35.7 m -67.82 136.83 54.74 Favored 'General case' 0 C--N 1.332 -0.187 0 CA-C-O 120.982 0.42 . . . . 0.0 110.999 -173.631 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' C' C ' 65' ' ' LYS . . . . . . . . . . . . . 55.2 mtmt -90.56 132.11 35.9 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 115.807 -0.633 . . . . 0.0 110.578 178.484 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' C' C ' 66' ' ' ILE . . . . . . . . . . . . . 64.8 mt -113.65 128.55 70.48 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.258 0 N-CA-C 109.645 -0.502 . . . . 0.0 109.645 178.909 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' C' C ' 67' ' ' THR . . . . . . . . . . . . . 18.0 m -127.27 142.67 51.41 Favored 'General case' 0 C--O 1.233 0.218 0 CA-C-O 121.047 0.451 . . . . 0.0 111.11 -177.147 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' C' C ' 68' ' ' LEU . . . . . . . . . . . . . 13.7 tp . . . . . 0 C--N 1.328 -0.343 0 CA-C-N 115.912 -0.586 . . . . 0.0 109.832 176.975 . . . . . . . . 0 0 . 1 . 014 nuclear build core ' C' C ' 73' ' ' VAL . . . . . . . . . . . . . 35.9 m . . . . . 0 C--O 1.232 0.143 0 N-CA-C 110.043 -0.355 . . . . 0.0 110.043 . . . . . . . . . 0 0 . 1 . 014 nuclear build core ' C' C ' 74' ' ' ASP . . . . . . . . . . . . . 21.4 t0 -99.06 122.9 42.9 Favored 'General case' 0 C--N 1.329 -0.291 0 C-N-CA 120.896 -0.322 . . . . 0.0 110.24 -177.552 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' C' C ' 75' ' ' VAL . . . . . . . . . . . . . 41.5 t -119.96 123.33 70.6 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.2 0 CA-C-O 121.044 0.449 . . . . 0.0 110.527 -179.225 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' C' C ' 76' ' ' LEU . . . . . . . . . . . . . 5.3 mp -119.49 147.63 44.2 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 115.671 -0.695 . . . . 0.0 109.788 176.285 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' C' C ' 77' ' ' GLU . . . . . . . . . . . . . 97.8 mt-10 -136.06 134.37 38.36 Favored 'General case' 0 C--N 1.331 -0.211 0 CA-C-O 121.074 0.464 . . . . 0.0 111.327 -179.303 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' C' C ' 78' ' ' ALA . . . . . 0.743 ' HB2' HD21 ' C' ' 109' ' ' LEU . . . -124.22 133.45 53.52 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 115.696 -0.684 . . . . 0.0 109.603 176.083 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' C' C ' 79' ' ' LYS . . . . . 0.563 ' O ' HD13 ' C' ' 80' ' ' ILE . 50.0 mtpt -81.52 119.07 23.29 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-O 120.975 0.417 . . . . 0.0 110.697 -178.273 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' C' C ' 80' ' ' ILE . . . . . 0.563 HD13 ' O ' ' C' ' 79' ' ' LYS . 44.1 mm -139.18 103.09 1.83 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.338 0 N-CA-C 109.009 -0.737 . . . . 0.0 109.009 -177.1 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' C' C ' 81' ' ' LYS . . . . . . . . . . . . . 73.2 mttt -92.2 127.9 37.85 Favored 'General case' 0 C--N 1.328 -0.359 0 C-N-CA 120.644 -0.422 . . . . 0.0 111.037 -176.776 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' C' C ' 82' ' ' GLY . . . . . . . . . . . . . . . 88.98 42.18 5.71 Favored Glycine 0 CA--C 1.523 0.591 0 C-N-CA 120.889 -0.672 . . . . 0.0 112.204 173.978 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' C' C ' 83' ' ' ILE . . . . . . . . . . . . . 67.9 mt -71.26 131.89 33.96 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.217 0 N-CA-C 109.306 -0.627 . . . . 0.0 109.306 176.206 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' C' C ' 84' ' ' LYS . . . . . . . . . . . . . 28.0 ttpp -101.47 -45.73 5.21 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-O 120.724 0.297 . . . . 0.0 110.741 -176.375 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' C' C ' 85' ' ' ASP . . . . . . . . . . . . . 9.1 t70 -148.25 147.08 28.97 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.324 -0.398 . . . . 0.0 110.674 179.897 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' C' C ' 86' ' ' VAL . . . . . . . . . . . . . 44.2 t -131.74 132.41 61.96 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.229 0 CA-C-O 120.967 0.413 . . . . 0.0 110.683 -178.827 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' C' C ' 87' ' ' ILE . . . . . 0.497 ' N ' HD12 ' C' ' 87' ' ' ILE . 5.1 mp -122.9 130.42 74.48 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.256 0 CA-C-N 115.79 -0.641 . . . . 0.0 109.439 175.814 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' C' C ' 88' ' ' LEU . . . . . . . . . . . . . 23.9 tp -115.49 132.53 56.59 Favored 'General case' 0 N--CA 1.463 0.22 0 CA-C-O 120.991 0.424 . . . . 0.0 111.484 -177.086 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' C' C ' 89' ' ' ASP . . . . . . . . . . . . . 13.8 t70 -120.63 156.62 31.29 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 115.709 -0.678 . . . . 0.0 109.477 175.747 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' C' C ' 90' ' ' GLU . . . . . . . . . . . . . 70.9 mm-40 -48.05 -42.32 28.17 Favored 'General case' 0 N--CA 1.465 0.29 0 N-CA-C 112.723 0.638 . . . . 0.0 112.723 -171.629 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' C' C ' 91' ' ' ASN . . . . . . . . . . . . . 6.3 p30 -132.07 38.49 3.5 Favored 'General case' 0 C--O 1.233 0.223 0 CA-C-O 120.692 0.282 . . . . 0.0 111.488 -178.316 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' C' C ' 92' ' ' LEU . . . . . . . . . . . . . 9.9 tp -165.7 145.19 6.4 Favored 'General case' 0 C--N 1.332 -0.191 0 C-N-CA 120.754 -0.378 . . . . 0.0 110.6 -178.966 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' C' C ' 93' ' ' ILE . . . . . . . . . . . . . 55.9 mt -123.53 125.76 71.99 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.226 0 N-CA-C 109.814 -0.439 . . . . 0.0 109.814 -177.715 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' C' C ' 94' ' ' VAL . . . . . . . . . . . . . 45.8 t -124.01 126.41 72.4 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.221 0 N-CA-C 109.872 -0.418 . . . . 0.0 109.872 178.781 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' C' C ' 95' ' ' VAL . . . . . . . . . . . . . 42.4 t -126.63 137.76 56.82 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.229 0 CA-C-N 116.285 -0.416 . . . . 0.0 110.374 -178.203 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' C' C ' 96' ' ' ILE . . . . . . . . . . . . . 54.8 mt -116.65 129.44 73.14 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.28 0 N-CA-C 109.276 -0.638 . . . . 0.0 109.276 178.505 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' C' C ' 97' ' ' THR . . . . . . . . . . . . . 64.6 p -106.08 157.73 17.33 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-O 121.334 0.588 . . . . 0.0 111.628 -175.955 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' C' C ' 98' ' ' GLU . . . . . . . . . . . . . 12.8 pt-20 -53.87 -23.7 13.46 Favored 'General case' 0 CA--C 1.535 0.375 0 CA-C-N 115.818 -0.628 . . . . 0.0 112.491 179.013 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' C' C ' 99' ' ' GLU . . . . . . . . . . . . . 96.5 mt-10 -77.76 13.31 1.37 Allowed 'General case' 0 CA--C 1.536 0.433 0 N-CA-C 113.074 0.768 . . . . 0.0 113.074 -178.321 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' C' C ' 100' ' ' ASN . . . . . . . . . . . . . 1.9 m-20 61.78 37.53 15.54 Favored 'General case' 0 N--CA 1.463 0.18 0 CA-C-O 120.995 0.426 . . . . 0.0 110.759 179.599 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' C' C ' 101' ' ' GLU . . . . . . . . . . . . . 84.4 tt0 -118.92 145.21 45.94 Favored 'General case' 0 C--O 1.232 0.184 0 CA-C-N 116.058 -0.519 . . . . 0.0 109.919 179.221 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' C' C ' 102' ' ' VAL . . . . . . . . . . . . . 46.8 t -114.98 125.32 72.27 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 N-CA-C 109.646 -0.501 . . . . 0.0 109.646 -179.096 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' C' C ' 103' ' ' LEU . . . . . . . . . . . . . 37.5 mt -116.14 131.77 56.85 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-N 115.707 -0.678 . . . . 0.0 110.423 178.567 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' C' C ' 104' ' ' ILE . . . . . 0.4 HD12 ' HB3' ' C' ' 113' ' ' TYR . 66.3 mt -118.46 121.34 66.83 Favored 'Isoleucine or valine' 0 C--O 1.234 0.277 0 CA-C-N 116.332 -0.395 . . . . 0.0 110.003 177.892 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' C' C ' 105' ' ' PHE . . . . . . . . . . . . . 80.0 m-85 -120.65 162.76 19.13 Favored 'General case' 0 C--N 1.331 -0.219 0 O-C-N 123.994 0.809 . . . . 0.0 109.905 -179.749 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' C' C ' 106' ' ' ASN . . . . . . . . . . . . . 46.4 p-10 -101.09 -170.59 1.86 Allowed 'General case' 0 C--N 1.329 -0.296 0 N-CA-C 110.013 -0.366 . . . . 0.0 110.013 173.76 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' C' C ' 107' ' ' GLN . . . . . . . . . . . . . 46.2 tt0 -58.67 -29.87 66.92 Favored 'General case' 0 C--N 1.329 -0.293 0 N-CA-C 111.942 0.349 . . . . 0.0 111.942 -179.999 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' C' C ' 108' ' ' ASN . . . . . . . . . . . . . 3.7 t-20 -85.12 9.98 13.39 Favored 'General case' 0 CA--C 1.535 0.381 0 N-CA-C 113.137 0.791 . . . . 0.0 113.137 -177.177 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' C' C ' 109' ' ' LEU . . . . . 0.743 HD21 ' HB2' ' C' ' 78' ' ' ALA . 8.7 tp 59.18 36.25 23.83 Favored 'General case' 0 C--O 1.232 0.159 0 O-C-N 122.159 -0.338 . . . . 0.0 111.406 178.441 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' C' C ' 110' ' ' GLU . . . . . . . . . . . . . 95.6 mt-10 -105.17 159.81 15.57 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-O 120.758 0.313 . . . . 0.0 110.35 177.766 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' C' C ' 111' ' ' GLU . . . . . . . . . . . . . 84.6 tt0 -84.67 121.98 28.42 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.309 -0.405 . . . . 0.0 110.851 -178.402 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' C' C ' 112' ' ' LEU . . . . . . . . . . . . . 14.7 mt -109.93 -46.07 3.53 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-N 116.081 -0.509 . . . . 0.0 110.158 177.211 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' C' C ' 113' ' ' TYR . . . . . 0.4 ' HB3' HD12 ' C' ' 104' ' ' ILE . 53.2 t80 -139.33 136.94 35.34 Favored 'General case' 0 C--N 1.331 -0.224 0 CA-C-N 116.254 -0.43 . . . . 0.0 111.082 179.854 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' C' C ' 114' ' ' ARG . . . . . . . . . . . . . 71.3 ttp85 -139.09 121.11 15.63 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.054 -0.521 . . . . 0.0 110.18 177.785 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' C' C ' 115' ' ' GLY . . . . . . . . . . . . . . . -150.06 159.85 28.28 Favored Glycine 0 CA--C 1.524 0.634 0 N-CA-C 110.908 -0.877 . . . . 0.0 110.908 178.316 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' C' C ' 116' ' ' LYS . . . . . . . . . . . . . 1.4 ttmp? -131.73 142.64 49.85 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-O 120.822 0.344 . . . . 0.0 110.288 178.491 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' C' C ' 117' ' ' PHE . . . . . . . . . . . . . 31.0 m-85 -138.92 115.46 10.56 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.182 -0.463 . . . . 0.0 109.948 -177.183 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' C' C ' 118' ' ' GLU . . . . . . . . . . . . . 82.9 tt0 -52.9 -48.81 66.93 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.528 -0.305 . . . . 0.0 111.662 -176.005 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' C' C ' 119' ' ' ASN . . . . . . . . . . . . . 4.0 p30 -97.25 31.13 2.55 Favored 'General case' 0 C--N 1.33 -0.259 0 N-CA-C 112.101 0.408 . . . . 0.0 112.101 -175.349 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' C' C ' 120' ' ' LEU . . . . . . . . . . . . . 15.1 tp -52.96 126.55 20.82 Favored 'General case' 0 N--CA 1.463 0.212 0 CA-C-O 120.45 0.167 . . . . 0.0 110.862 177.813 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' C' C ' 121' ' ' ASN . . . . . . . . . . . . . 51.3 t30 -113.76 -44.2 3.21 Favored 'General case' 0 C--N 1.33 -0.258 0 C-N-CA 121.165 -0.214 . . . . 0.0 111.258 -176.133 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' C' C ' 122' ' ' LYS . . . . . . . . . . . . . 88.2 mttt -148.08 151.91 36.46 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-O 121.016 0.436 . . . . 0.0 111.81 -177.267 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' C' C ' 123' ' ' VAL . . . . . . . . . . . . . 42.9 t -131.12 128.92 62.67 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 CA-C-N 115.949 -0.569 . . . . 0.0 109.503 173.865 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' C' C ' 124' ' ' LEU . . . . . . . . . . . . . 62.0 mt -122.35 136.79 54.96 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.43 -0.35 . . . . 0.0 110.308 -178.814 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' C' C ' 125' ' ' VAL . . . . . 0.436 HG23 HG22 ' C' ' 130' ' ' VAL . 12.9 p -133.16 134.59 57.52 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.219 0 CA-C-O 120.997 0.427 . . . . 0.0 110.768 -179.463 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' C' C ' 126' ' ' ARG . . . . . . . . . . . . . 88.8 mtt180 -151.67 135.24 16.2 Favored 'General case' 0 C--N 1.327 -0.37 0 N-CA-C 109.094 -0.706 . . . . 0.0 109.094 176.123 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' C' C ' 127' ' ' ASN . . . . . . . . . . . . . 9.7 p30 48.88 -150.37 0.17 Allowed 'General case' 0 CA--C 1.541 0.62 0 CA-C-O 119.431 -0.318 . . . . 0.0 110.932 179.078 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' C' C ' 128' ' ' ASP . . . . . . . . . . . . . 10.2 p-10 -81.83 18.05 1.38 Allowed 'General case' 0 CA--C 1.535 0.4 0 N-CA-C 112.723 0.638 . . . . 0.0 112.723 179.393 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' C' C ' 129' ' ' LEU . . . . . . . . . . . . . 73.0 mt -117.6 137.66 52.46 Favored 'General case' 0 C--O 1.233 0.184 0 O-C-N 122.083 -0.386 . . . . 0.0 110.416 179.477 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' C' C ' 130' ' ' VAL . . . . . 0.436 HG22 HG23 ' C' ' 125' ' ' VAL . 43.8 t -128.72 140.45 49.21 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.212 0 CA-C-N 116.254 -0.43 . . . . 0.0 110.091 -179.151 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' C' C ' 131' ' ' VAL . . . . . 0.438 ' CG1' HD21 ' C' ' 138' ' ' LEU . 41.4 t -135.46 135.27 51.83 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.226 0 CA-C-O 121.033 0.445 . . . . 0.0 110.273 178.504 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' C' C ' 132' ' ' ILE . . . . . . . . . . . . . 70.6 mt -114.51 133.31 61.0 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.352 0 CA-C-N 115.741 -0.663 . . . . 0.0 109.399 179.263 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' C' C ' 133' ' ' ILE . . . . . . . . . . . . . 39.5 mm -114.8 122.77 69.59 Favored 'Isoleucine or valine' 0 C--O 1.234 0.237 0 CA-C-O 120.714 0.292 . . . . 0.0 110.817 -175.389 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' C' C ' 134' ' ' ASP . . . . . . . . . . . . . 8.2 p-10 -131.92 150.61 52.1 Favored 'General case' 0 C--N 1.331 -0.2 0 N-CA-C 109.855 -0.424 . . . . 0.0 109.855 176.091 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' C' C ' 135' ' ' GLU . . . . . . . . . . . . . 84.7 tt0 -49.89 -26.97 4.58 Favored 'General case' 0 C--N 1.327 -0.39 0 N-CA-C 112.902 0.704 . . . . 0.0 112.902 -172.117 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' C' C ' 136' ' ' GLN . . . . . . . . . . . . . 94.0 mt-30 -93.35 -24.71 18.01 Favored 'General case' 0 C--N 1.33 -0.281 0 N-CA-C 113.088 0.774 . . . . 0.0 113.088 -172.626 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' C' C ' 137' ' ' LYS . . . . . . . . . . . . . 55.6 pttt -170.0 173.72 5.87 Favored 'General case' 0 C--O 1.232 0.163 0 CA-C-O 121.583 0.706 . . . . 0.0 112.553 -173.432 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' C' C ' 138' ' ' LEU . . . . . 0.49 HD23 ' N ' ' C' ' 139' ' ' THR . 4.4 tt -118.51 129.75 55.54 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 114.967 -1.015 . . . . 0.0 109.937 179.592 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' C' C ' 139' ' ' THR . . . . . 0.49 ' N ' HD23 ' C' ' 138' ' ' LEU . 25.9 m -109.83 124.75 51.87 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.406 -0.361 . . . . 0.0 110.319 178.834 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' C' C ' 140' ' ' LEU . . . . . 0.484 ' C ' HD23 ' C' ' 140' ' ' LEU . 7.9 tt -111.52 125.18 53.63 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 115.705 -0.679 . . . . 0.0 109.381 -178.665 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' C' C ' 141' ' ' ILE . . . . . . . . . . . . . 19.3 mt -125.08 120.16 57.66 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.251 0 CA-C-O 120.993 0.425 . . . . 0.0 110.058 -176.011 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' C' C ' 142' ' ' ARG . . . . . . . . . . . . . 59.3 ttp180 . . . . . 0 C--N 1.331 -0.21 0 CA-C-N 115.574 -0.739 . . . . 0.0 110.19 179.352 . . . . . . . . 0 0 . 1 . 014 nuclear build core ' D' D ' 2' ' ' SER . . . . . . . . . . . . . 2.8 p . . . . . 0 N--CA 1.462 0.131 0 CA-C-O 120.801 0.334 . . . . 0.0 110.521 . . . . . . . . . 0 0 . 1 . 014 nuclear build core ' D' D ' 3' ' ' GLU . . . . . . . . . . . . . 95.8 mt-10 -141.3 140.51 33.85 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.168 -0.469 . . . . 0.0 111.166 -179.217 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' D' D ' 4' ' ' LEU . . . . . 0.4 HD21 HD21 ' D' ' 6' ' ' LEU . 17.8 tp -125.34 131.57 52.98 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 115.928 -0.578 . . . . 0.0 110.062 176.139 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' D' D ' 5' ' ' LYS . . . . . . . . . . . . . 95.2 mttt -109.8 119.93 40.88 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.424 -0.353 . . . . 0.0 110.577 179.514 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' D' D ' 6' ' ' LEU . . . . . 0.4 HD21 HD21 ' D' ' 4' ' ' LEU . 51.5 mt -115.07 145.77 41.98 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 115.365 -0.834 . . . . 0.0 110.555 -177.821 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' D' D ' 7' ' ' LYS . . . . . . . . . . . . . 61.8 tttp -132.65 134.36 24.6 Favored Pre-proline 0 CA--C 1.537 0.458 0 CA-C-O 118.7 -0.667 . . . . 0.0 109.966 177.153 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' D' D ' 8' ' ' PRO . . . . . . . . . . . . . 90.5 Cg_endo -89.54 139.39 3.39 Favored 'Trans proline' 0 N--CA 1.491 1.336 0 C-N-CA 121.437 1.425 . . . . 0.0 111.634 176.531 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' D' D ' 9' ' ' LEU . . . . . . . . . . . . . 55.0 mt -78.02 -47.8 2.15 Favored Pre-proline 0 CA--C 1.533 0.301 0 CA-C-O 118.65 -0.69 . . . . 0.0 112.417 -178.356 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' D' D ' 10' ' ' PRO . . . . . . . . . . . . . 84.2 Cg_endo -80.33 152.53 20.79 Favored 'Trans proline' 0 N--CA 1.497 1.711 0 C-N-CA 121.232 1.288 . . . . 0.0 111.83 176.725 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' D' D ' 11' ' ' LYS . . . . . . . . . . . . . 53.5 tttp -87.97 98.37 11.47 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-O 120.924 0.392 . . . . 0.0 110.373 178.767 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' D' D ' 12' ' ' VAL . . . . . . . . . . . . . 11.9 p -141.12 147.07 22.83 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.262 0 CA-C-N 116.037 -0.529 . . . . 0.0 110.432 -179.538 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' D' D ' 13' ' ' GLU . . . . . . . . . . . . . 96.1 mt-10 -84.87 124.01 31.13 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.347 -0.388 . . . . 0.0 110.371 179.06 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' D' D ' 14' ' ' LEU . . . . . . . . . . . . . 39.8 mt -98.88 144.82 28.87 Favored Pre-proline 0 CA--C 1.534 0.356 0 CA-C-O 119.005 -0.522 . . . . 0.0 110.186 -179.511 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' D' D ' 15' ' ' PRO . . . . . . . . . . . . . 25.2 Cg_exo -62.38 159.32 36.26 Favored 'Trans proline' 0 N--CA 1.497 1.728 0 C-N-CA 121.247 1.298 . . . . 0.0 111.964 177.091 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' D' D ' 16' ' ' PRO . . . . . . . . . . . . . 38.2 Cg_exo -58.32 -41.25 68.13 Favored 'Trans proline' 0 N--CA 1.498 1.758 0 C-N-CA 121.463 1.442 . . . . 0.0 112.948 -178.467 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' D' D ' 17' ' ' ASP . . . . . . . . . . . . . 14.5 p-10 -81.9 5.99 17.22 Favored 'General case' 0 C--N 1.326 -0.432 0 N-CA-C 113.208 0.818 . . . . 0.0 113.208 -177.599 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' D' D ' 18' ' ' PHE . . . . . . . . . . . . . 55.1 t80 -57.59 -42.33 82.97 Favored 'General case' 0 N--CA 1.457 -0.075 0 O-C-N 121.937 -0.477 . . . . 0.0 110.228 -179.514 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' D' D ' 19' ' ' VAL . . . . . . . . . . . . . 47.7 t -56.63 -43.26 78.45 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.263 0 CA-C-N 116.301 -0.409 . . . . 0.0 110.371 -179.358 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' D' D ' 20' ' ' ASP . . . . . . . . . . . . . 81.4 m-20 -60.48 -41.95 95.26 Favored 'General case' 0 C--N 1.33 -0.26 0 C-N-CA 120.981 -0.288 . . . . 0.0 110.895 -178.085 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' D' D ' 21' ' ' VAL . . . . . . . . . . . . . 47.2 t -64.18 -47.93 87.87 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.27 0 C-N-CA 120.742 -0.383 . . . . 0.0 110.35 -177.821 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' D' D ' 22' ' ' ILE . . . . . 0.5 HG22 HD12 ' D' ' 26' ' ' LEU . 50.7 mm -56.11 -46.36 80.96 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.25 0 CA-C-O 120.762 0.315 . . . . 0.0 110.604 179.205 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' D' D ' 23' ' ' ARG . . . . . . . . . . . . . 52.8 ttp180 -54.9 -50.53 68.53 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 116.535 -0.302 . . . . 0.0 111.518 -178.064 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' D' D ' 24' ' ' ILE . . . . . . . . . . . . . 74.9 mt -60.16 -42.17 89.23 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 C-N-CA 121.056 -0.258 . . . . 0.0 111.351 -176.397 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' D' D ' 25' ' ' LYS . . . . . . . . . . . . . 43.6 mtmt -66.85 -39.81 87.7 Favored 'General case' 0 C--N 1.329 -0.316 0 N-CA-C 112.386 0.513 . . . . 0.0 112.386 -178.72 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' D' D ' 26' ' ' LEU . . . . . 0.5 HD12 HG22 ' D' ' 22' ' ' ILE . 92.2 mt -78.48 -40.92 34.04 Favored 'General case' 0 C--N 1.331 -0.23 0 N-CA-C 112.881 0.697 . . . . 0.0 112.881 -173.096 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' D' D ' 27' ' ' GLN . . . . . . . . . . . . . 12.3 pt20 -46.61 140.39 4.46 Favored 'General case' 0 N--CA 1.469 0.496 0 N-CA-C 112.691 0.626 . . . . 0.0 112.691 -176.082 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' D' D ' 28' ' ' GLY . . . . . . . . . . . . . . . 99.51 -26.51 24.08 Favored Glycine 0 CA--C 1.532 1.126 0 CA-C-N 115.511 -0.768 . . . . 0.0 112.144 -176.394 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' D' D ' 29' ' ' LYS . . . . . . . . . . . . . 98.7 mttt -97.86 155.2 17.17 Favored 'General case' 0 C--O 1.234 0.269 0 CA-C-N 117.267 0.534 . . . . 0.0 111.134 178.59 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' D' D ' 30' ' ' THR . . . . . . . . . . . . . 18.5 m -105.8 135.58 46.96 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.002 -0.544 . . . . 0.0 109.695 174.922 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' D' D ' 31' ' ' VAL . . . . . . . . . . . . . 35.1 m -128.35 159.68 39.43 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.245 0 CA-C-N 116.382 -0.372 . . . . 0.0 110.681 -177.916 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' D' D ' 32' ' ' ARG . . . . . . . . . . . . . 57.8 ttp180 -132.75 149.8 52.24 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-O 121.22 0.533 . . . . 0.0 110.507 179.561 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' D' D ' 33' ' ' THR . . . . . . . . . . . . . 22.4 m -53.1 139.58 28.07 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 116.333 -0.394 . . . . 0.0 111.326 -178.412 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' D' D ' 34' ' ' GLY . . . . . . . . . . . . . . . 101.26 -17.05 56.36 Favored Glycine 0 CA--C 1.532 1.155 0 CA-C-O 119.645 -0.53 . . . . 0.0 113.251 179.703 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' D' D ' 35' ' ' ASP . . . . . . . . . . . . . 62.8 m-20 -64.09 148.59 49.49 Favored 'General case' 0 C--O 1.231 0.1 0 CA-C-N 118.037 0.918 . . . . 0.0 111.222 179.102 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' D' D ' 36' ' ' VAL . . . . . . . . . . . . . 45.7 t -124.71 128.82 73.62 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.234 0 CA-C-N 115.577 -0.738 . . . . 0.0 109.541 178.185 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' D' D ' 37' ' ' ILE . . . . . . . . . . . . . 66.0 mt -121.21 138.32 52.0 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.256 0 CA-C-N 116.273 -0.421 . . . . 0.0 110.02 -179.293 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' D' D ' 38' ' ' GLY . . . . . . . . . . . . . . . -108.38 128.53 9.14 Favored Glycine 0 CA--C 1.524 0.646 0 N-CA-C 110.754 -0.938 . . . . 0.0 110.754 178.408 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' D' D ' 39' ' ' ILE . . . . . . . . . . . . . 71.9 mt -123.23 138.16 54.13 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.265 0 N-CA-C 109.934 -0.395 . . . . 0.0 109.934 179.803 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' D' D ' 40' ' ' SER . . . . . 0.513 ' O ' HD13 ' D' ' 41' ' ' ILE . 79.2 p -90.32 118.47 29.84 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.316 -0.402 . . . . 0.0 110.55 176.654 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' D' D ' 41' ' ' ILE . . . . . 0.513 HD13 ' O ' ' D' ' 40' ' ' SER . 48.5 mm -129.5 116.11 37.6 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.266 0 CA-C-N 116.453 -0.339 . . . . 0.0 110.177 179.269 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' D' D ' 42' ' ' LEU . . . . . . . . . . . . . 78.1 mt 57.46 35.77 26.27 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.217 -0.447 . . . . 0.0 111.568 177.991 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' D' D ' 43' ' ' GLY . . . . . . . . . . . . . . . 77.79 -10.1 26.99 Favored Glycine 0 CA--C 1.534 1.237 0 C-N-CA 121.303 -0.475 . . . . 0.0 113.537 177.141 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' D' D ' 44' ' ' LYS . . . . . . . . . . . . . 48.5 tttp -101.52 139.8 36.68 Favored 'General case' 0 C--N 1.333 -0.128 0 CA-C-N 117.838 0.819 . . . . 0.0 109.831 177.123 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' D' D ' 45' ' ' GLU . . . . . . . . . . . . . 84.5 tt0 -83.54 127.81 34.02 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-O 120.957 0.408 . . . . 0.0 110.931 -179.201 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' D' D ' 46' ' ' VAL . . . . . . . . . . . . . 7.4 p -121.15 126.9 75.66 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.169 0 N-CA-C 109.339 -0.615 . . . . 0.0 109.339 176.294 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' D' D ' 47' ' ' LYS . . . . . . . . . . . . . 66.3 mttm -100.31 130.12 46.38 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.166 -0.47 . . . . 0.0 111.415 179.063 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' D' D ' 48' ' ' PHE . . . . . . . . . . . . . 95.4 m-85 -112.96 131.99 55.53 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 115.97 -0.559 . . . . 0.0 109.769 176.192 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' D' D ' 49' ' ' LYS . . . . . . . . . . . . . 81.6 tttt -108.31 137.81 45.65 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.297 -0.41 . . . . 0.0 110.497 179.644 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' D' D ' 50' ' ' VAL . . . . . . . . . . . . . 46.2 t -82.41 107.05 13.94 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.287 0 N-CA-C 109.169 -0.678 . . . . 0.0 109.169 175.785 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' D' D ' 51' ' ' VAL . . . . . . . . . . . . . 46.2 t -72.15 -52.38 24.85 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.318 0 CA-C-N 116.041 -0.527 . . . . 0.0 109.683 -174.442 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' D' D ' 52' ' ' GLN . . . . . . . . . . . . . 91.6 mt-30 -152.43 151.57 30.94 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-O 121.291 0.567 . . . . 0.0 111.595 -178.011 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' D' D ' 53' ' ' ALA . . . . . . . . . . . . . . . -127.01 130.66 50.45 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 115.012 -0.995 . . . . 0.0 109.871 176.658 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' D' D ' 54' ' ' TYR . . . . . . . . . . . . . 68.2 t80 -128.66 106.78 18.74 Favored Pre-proline 0 C--N 1.327 -0.384 0 CA-C-O 118.355 -0.831 . . . . 0.0 110.248 -179.776 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' D' D ' 55' ' ' PRO . . . . . . . . . . . . . 73.3 Cg_endo -77.13 170.07 72.56 Favored 'Cis proline' 0 N--CA 1.501 1.919 0 CA-C-N 121.786 1.674 . . . . 0.0 112.631 -3.156 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' D' D ' 56' ' ' SER . . . . . . . . . . . . . 13.6 m -112.15 121.35 39.55 Favored Pre-proline 0 CA--C 1.539 0.522 0 CA-C-O 118.258 -0.877 . . . . 0.0 109.447 175.584 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' D' D ' 57' ' ' PRO . . . . . . . . . . . . . 54.3 Cg_endo -70.6 170.99 59.53 Favored 'Cis proline' 0 N--CA 1.497 1.704 0 CA-C-N 122.11 1.789 . . . . 0.0 112.109 1.35 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' D' D ' 58' ' ' LEU . . . . . . . . . . . . . 19.3 tp -130.15 137.6 50.21 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 115.885 -0.598 . . . . 0.0 110.246 -179.285 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' D' D ' 59' ' ' ARG . . . . . . . . . . . . . 32.6 ttp180 -106.77 126.74 52.69 Favored 'General case' 0 C--N 1.328 -0.338 0 N-CA-C 109.367 -0.605 . . . . 0.0 109.367 176.169 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' D' D ' 60' ' ' VAL . . . . . . . . . . . . . 47.8 t -83.35 122.4 37.51 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.239 0 C-N-CA 120.667 -0.413 . . . . 0.0 110.384 -174.544 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' D' D ' 61' ' ' GLU . . . . . . . . . . . . . 93.8 mt-10 -131.09 166.94 19.97 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-N 115.794 -0.639 . . . . 0.0 110.081 179.656 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' D' D ' 62' ' ' ASP . . . . . . . . . . . . . 81.9 m-20 -55.41 -32.91 63.05 Favored 'General case' 0 C--N 1.328 -0.363 0 C-N-CA 120.951 -0.3 . . . . 0.0 111.49 179.085 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' D' D ' 63' ' ' ARG . . . . . . . . . . . . . 7.4 ptp180 -89.49 10.13 23.92 Favored 'General case' 0 CA--C 1.535 0.389 0 N-CA-C 113.408 0.892 . . . . 0.0 113.408 -176.225 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' D' D ' 64' ' ' THR . . . . . . . . . . . . . 28.6 m -90.91 137.36 32.42 Favored 'General case' 0 C--O 1.232 0.147 0 CA-C-N 118.126 0.421 . . . . 0.0 110.24 -179.732 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' D' D ' 65' ' ' LYS . . . . . . . . . . . . . 2.2 mptp? -88.52 129.25 35.51 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 116.228 -0.442 . . . . 0.0 110.303 -178.317 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' D' D ' 66' ' ' ILE . . . . . . . . . . . . . 63.6 mt -114.68 129.93 69.95 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.298 0 N-CA-C 109.713 -0.477 . . . . 0.0 109.713 178.594 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' D' D ' 67' ' ' THR . . . . . . . . . . . . . 26.7 m -121.73 136.68 54.94 Favored 'General case' 0 C--N 1.33 -0.239 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.536 -179.22 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' D' D ' 68' ' ' LEU . . . . . . . . . . . . . 19.1 tp . . . . . 0 C--N 1.33 -0.283 0 CA-C-N 115.936 -0.574 . . . . 0.0 110.218 178.819 . . . . . . . . 0 0 . 1 . 014 nuclear build core ' D' D ' 73' ' ' VAL . . . . . . . . . . . . . 30.2 m . . . . . 0 C--O 1.232 0.155 0 N-CA-C 109.566 -0.531 . . . . 0.0 109.566 . . . . . . . . . 0 0 . 1 . 014 nuclear build core ' D' D ' 74' ' ' ASP . . . . . . . . . . . . . 33.2 t0 -96.06 115.04 26.83 Favored 'General case' 0 C--N 1.329 -0.314 0 N-CA-C 109.82 -0.437 . . . . 0.0 109.82 179.384 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' D' D ' 75' ' ' VAL . . . . . . . . . . . . . 40.0 t -113.42 123.76 69.39 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.206 0 CA-C-O 121.069 0.461 . . . . 0.0 110.24 -178.721 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' D' D ' 76' ' ' LEU . . . . . . . . . . . . . 22.0 mt -126.26 140.42 52.54 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 115.706 -0.679 . . . . 0.0 109.782 179.05 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' D' D ' 77' ' ' GLU . . . . . . . . . . . . . 97.2 mt-10 -133.21 134.39 44.0 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-O 121.018 0.437 . . . . 0.0 111.242 -178.635 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' D' D ' 78' ' ' ALA . . . . . 0.502 ' HB2' HD21 ' D' ' 109' ' ' LEU . . . -124.63 132.82 53.4 Favored 'General case' 0 C--N 1.331 -0.202 0 CA-C-N 115.766 -0.652 . . . . 0.0 109.936 177.026 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' D' D ' 79' ' ' LYS . . . . . 0.597 ' O ' HD13 ' D' ' 80' ' ' ILE . 98.3 mttt -77.85 119.01 20.73 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-O 120.948 0.404 . . . . 0.0 110.924 -177.673 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' D' D ' 80' ' ' ILE . . . . . 0.597 HD13 ' O ' ' D' ' 79' ' ' LYS . 41.3 mm -139.17 110.56 4.99 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.271 0 N-CA-C 109.034 -0.728 . . . . 0.0 109.034 -177.839 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' D' D ' 81' ' ' LYS . . . . . . . . . . . . . 84.3 mttt -104.16 127.0 51.73 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-O 120.765 0.316 . . . . 0.0 111.213 -177.023 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' D' D ' 82' ' ' GLY . . . . . . . . . . . . . . . 88.21 42.2 5.98 Favored Glycine 0 CA--C 1.525 0.667 0 C-N-CA 120.621 -0.8 . . . . 0.0 111.857 173.807 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' D' D ' 83' ' ' ILE . . . . . . . . . . . . . 73.1 mt -71.01 134.27 30.31 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.323 0 N-CA-C 109.858 -0.423 . . . . 0.0 109.858 178.093 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' D' D ' 84' ' ' LYS . . . . . . . . . . . . . 53.3 tttp -89.18 -53.43 4.57 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.09 -0.505 . . . . 0.0 110.063 -179.504 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' D' D ' 85' ' ' ASP . . . . . . . . . . . . . 13.2 t70 -151.52 149.52 29.31 Favored 'General case' 0 C--N 1.327 -0.396 0 CA-C-N 115.671 -0.695 . . . . 0.0 110.529 -179.033 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' D' D ' 86' ' ' VAL . . . . . . . . . . . . . 41.0 t -127.48 128.32 69.72 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.242 0 CA-C-O 120.848 0.356 . . . . 0.0 110.069 178.971 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' D' D ' 87' ' ' ILE . . . . . . . . . . . . . 44.5 mm -116.73 126.38 74.15 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.253 0 N-CA-C 109.582 -0.525 . . . . 0.0 109.582 177.452 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' D' D ' 88' ' ' LEU . . . . . . . . . . . . . 13.0 tp -111.89 133.27 54.19 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-O 121.099 0.476 . . . . 0.0 111.108 -176.864 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' D' D ' 89' ' ' ASP . . . . . . . . . . . . . 12.3 t70 -127.34 158.15 38.03 Favored 'General case' 0 C--N 1.331 -0.23 0 CA-C-N 115.705 -0.679 . . . . 0.0 109.424 176.021 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' D' D ' 90' ' ' GLU . . . . . . . . . . . . . 96.4 mt-10 -46.94 -39.46 12.38 Favored 'General case' 0 C--N 1.33 -0.261 0 N-CA-C 113.066 0.765 . . . . 0.0 113.066 -171.342 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' D' D ' 91' ' ' ASN . . . . . . . . . . . . . 87.1 m-20 -132.04 26.05 4.58 Favored 'General case' 0 N--CA 1.467 0.424 0 N-CA-C 112.631 0.604 . . . . 0.0 112.631 -177.742 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' D' D ' 92' ' ' LEU . . . . . . . . . . . . . 10.2 mt -151.37 144.26 24.49 Favored 'General case' 0 C--N 1.329 -0.285 0 N-CA-C 109.962 -0.384 . . . . 0.0 109.962 -177.706 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' D' D ' 93' ' ' ILE . . . . . . . . . . . . . 70.9 mt -126.92 117.72 48.53 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 N-CA-C 109.241 -0.652 . . . . 0.0 109.241 178.133 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' D' D ' 94' ' ' VAL . . . . . . . . . . . . . 44.3 t -118.99 125.71 74.73 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.271 0 N-CA-C 109.77 -0.455 . . . . 0.0 109.77 -178.832 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' D' D ' 95' ' ' VAL . . . . . . . . . . . . . 45.3 t -121.04 132.8 69.59 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.294 0 CA-C-N 115.949 -0.568 . . . . 0.0 109.79 -179.411 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' D' D ' 96' ' ' ILE . . . . . 0.464 HD11 ' HB ' ' D' ' 123' ' ' VAL . 63.2 mt -113.35 125.12 70.57 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.325 0 N-CA-C 109.114 -0.698 . . . . 0.0 109.114 178.72 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' D' D ' 97' ' ' THR . . . . . . . . . . . . . 69.2 p -99.49 157.34 16.5 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-O 121.315 0.579 . . . . 0.0 111.312 -176.471 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' D' D ' 98' ' ' GLU . . . . . . . . . . . . . 78.2 tt0 -53.89 -24.37 15.82 Favored 'General case' 0 CA--C 1.534 0.364 0 CA-C-N 115.953 -0.567 . . . . 0.0 112.245 178.846 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' D' D ' 99' ' ' GLU . . . . . . . . . . . . . 36.1 tt0 -78.4 13.7 1.47 Allowed 'General case' 0 CA--C 1.54 0.586 0 N-CA-C 112.684 0.624 . . . . 0.0 112.684 -177.438 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' D' D ' 100' ' ' ASN . . . . . . . . . . . . . 3.2 m-20 61.32 38.02 16.65 Favored 'General case' 0 CA--C 1.53 0.175 0 O-C-N 121.871 -0.518 . . . . 0.0 110.974 179.651 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' D' D ' 101' ' ' GLU . . . . . . . . . . . . . 84.4 tt0 -118.79 143.94 46.61 Favored 'General case' 0 C--N 1.331 -0.2 0 CA-C-N 115.947 -0.57 . . . . 0.0 109.72 176.932 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' D' D ' 102' ' ' VAL . . . . . . . . . . . . . 47.4 t -115.0 124.65 71.87 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.323 0 CA-C-N 116.251 -0.432 . . . . 0.0 109.863 -178.537 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' D' D ' 103' ' ' LEU . . . . . . . . . . . . . 69.5 mt -114.13 129.89 56.61 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 115.842 -0.617 . . . . 0.0 109.971 176.823 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' D' D ' 104' ' ' ILE . . . . . 0.587 HD13 HG11 ' D' ' 130' ' ' VAL . 66.7 mt -120.0 119.47 60.25 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.225 0 N-CA-C 110.087 -0.338 . . . . 0.0 110.087 -178.028 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' D' D ' 105' ' ' PHE . . . . . . . . . . . . . 54.2 m-85 -121.42 162.77 19.85 Favored 'General case' 0 C--N 1.331 -0.219 0 O-C-N 123.998 0.811 . . . . 0.0 109.661 179.959 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' D' D ' 106' ' ' ASN . . . . . . . . . . . . . 41.1 p-10 -95.52 -169.99 2.07 Favored 'General case' 0 C--N 1.33 -0.272 0 N-CA-C 109.782 -0.451 . . . . 0.0 109.782 173.2 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' D' D ' 107' ' ' GLN . . . . . . . . . . . . . 13.5 tt0 -58.64 -30.04 66.99 Favored 'General case' 0 C--N 1.329 -0.313 0 N-CA-C 111.847 0.314 . . . . 0.0 111.847 178.951 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' D' D ' 108' ' ' ASN . . . . . . . . . . . . . 21.1 t-20 -84.17 6.61 21.85 Favored 'General case' 0 CA--C 1.536 0.425 0 N-CA-C 113.339 0.866 . . . . 0.0 113.339 -176.68 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' D' D ' 109' ' ' LEU . . . . . 0.502 HD21 ' HB2' ' D' ' 78' ' ' ALA . 11.6 tp 62.23 37.71 13.98 Favored 'General case' 0 CA--C 1.531 0.219 0 CA-C-O 121.013 0.435 . . . . 0.0 111.196 178.456 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' D' D ' 110' ' ' GLU . . . . . . . . . . . . . 42.9 mt-10 -107.26 151.49 25.39 Favored 'General case' 0 C--N 1.33 -0.273 0 N-CA-C 109.859 -0.423 . . . . 0.0 109.859 176.016 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' D' D ' 111' ' ' GLU . . . . . . . . . . . . . 97.7 mt-10 -79.02 121.94 25.56 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-O 121.008 0.432 . . . . 0.0 111.136 -178.575 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' D' D ' 112' ' ' LEU . . . . . . . . . . . . . 29.9 mt -106.92 -45.9 4.06 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 115.888 -0.596 . . . . 0.0 109.811 175.468 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' D' D ' 113' ' ' TYR . . . . . 0.412 ' HB3' HD12 ' D' ' 104' ' ' ILE . 53.4 t80 -141.23 142.92 33.92 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 115.858 -0.61 . . . . 0.0 110.381 179.485 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' D' D ' 114' ' ' ARG . . . . . . . . . . . . . 35.6 ptt-85 -150.58 124.06 9.01 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-O 121.128 0.49 . . . . 0.0 110.841 177.316 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' D' D ' 115' ' ' GLY . . . . . . . . . . . . . . . -150.19 163.0 29.39 Favored Glycine 0 CA--C 1.525 0.673 0 N-CA-C 111.076 -0.81 . . . . 0.0 111.076 -179.417 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' D' D ' 116' ' ' LYS . . . . . . . . . . . . . 34.0 ttpt -131.03 134.55 46.78 Favored 'General case' 0 C--N 1.33 -0.265 0 N-CA-C 109.846 -0.428 . . . . 0.0 109.846 177.717 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' D' D ' 117' ' ' PHE . . . . . . . . . . . . . 26.3 m-85 -133.07 120.44 21.31 Favored 'General case' 0 C--N 1.331 -0.218 0 CA-C-O 120.894 0.378 . . . . 0.0 110.232 -174.915 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' D' D ' 118' ' ' GLU . . . . . . . . . . . . . 46.4 tp10 -51.52 -52.08 49.84 Favored 'General case' 0 C--N 1.328 -0.351 0 N-CA-C 112.01 0.374 . . . . 0.0 112.01 -174.757 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' D' D ' 119' ' ' ASN . . . . . . . . . . . . . 3.3 p30 -100.06 31.28 3.38 Favored 'General case' 0 C--N 1.33 -0.265 0 N-CA-C 112.173 0.434 . . . . 0.0 112.173 -173.735 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' D' D ' 120' ' ' LEU . . . . . . . . . . . . . 14.1 tp -52.92 125.95 18.76 Favored 'General case' 0 N--CA 1.464 0.229 0 O-C-N 122.343 -0.223 . . . . 0.0 110.985 178.263 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' D' D ' 121' ' ' ASN . . . . . . . . . . . . . 4.3 t-20 -113.96 -44.15 3.19 Favored 'General case' 0 C--N 1.331 -0.229 0 C-N-CA 121.129 -0.229 . . . . 0.0 111.218 -176.839 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' D' D ' 122' ' ' LYS . . . . . . . . . . . . . 49.3 mttm -141.98 146.91 36.14 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-O 120.983 0.42 . . . . 0.0 111.908 -177.309 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' D' D ' 123' ' ' VAL . . . . . 0.464 ' HB ' HD11 ' D' ' 96' ' ' ILE . 43.7 t -130.44 123.28 55.01 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.261 0 N-CA-C 109.22 -0.659 . . . . 0.0 109.22 173.106 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' D' D ' 124' ' ' LEU . . . . . 0.409 HD12 ' C ' ' D' ' 123' ' ' VAL . 6.2 mp -122.97 139.31 54.21 Favored 'General case' 0 C--N 1.332 -0.173 0 CA-C-O 120.93 0.395 . . . . 0.0 111.222 -175.763 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' D' D ' 125' ' ' VAL . . . . . . . . . . . . . 11.0 p -133.15 131.99 58.52 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.194 0 CA-C-N 115.921 -0.581 . . . . 0.0 110.239 178.182 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' D' D ' 126' ' ' ARG . . . . . . . . . . . . . 55.9 mtp180 -144.49 120.91 10.98 Favored 'General case' 0 C--N 1.331 -0.23 0 CA-C-N 116.482 -0.326 . . . . 0.0 110.947 179.012 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' D' D ' 127' ' ' ASN . . . . . . . . . . . . . 75.8 m-20 49.96 -105.97 0.2 Allowed 'General case' 0 CA--C 1.543 0.696 0 CA-C-O 119.043 -0.503 . . . . 0.0 111.546 178.537 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' D' D ' 128' ' ' ASP . . . . . . . . . . . . . 12.0 p-10 -114.06 4.76 15.79 Favored 'General case' 0 N--CA 1.468 0.456 0 CA-C-N 119.684 1.129 . . . . 0.0 113.372 -178.455 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' D' D ' 129' ' ' LEU . . . . . . . . . . . . . 11.4 tp -106.01 131.27 53.5 Favored 'General case' 0 C--N 1.332 -0.19 0 N-CA-C 109.867 -0.42 . . . . 0.0 109.867 178.845 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' D' D ' 130' ' ' VAL . . . . . 0.587 HG11 HD13 ' D' ' 104' ' ' ILE . 44.1 t -119.23 134.06 64.06 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.283 0 N-CA-C 109.603 -0.517 . . . . 0.0 109.603 178.77 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' D' D ' 131' ' ' VAL . . . . . . . . . . . . . 40.4 t -136.06 135.22 50.38 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.246 0 CA-C-O 121.054 0.454 . . . . 0.0 110.504 -178.948 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' D' D ' 132' ' ' ILE . . . . . . . . . . . . . 68.4 mt -115.69 133.39 62.22 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.271 0 CA-C-N 115.75 -0.659 . . . . 0.0 109.24 177.317 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' D' D ' 133' ' ' ILE . . . . . . . . . . . . . 36.9 mm -116.67 120.69 65.76 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.308 0 CA-C-N 116.356 -0.384 . . . . 0.0 110.743 -174.093 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' D' D ' 134' ' ' ASP . . . . . . . . . . . . . 18.9 p-10 -138.93 150.87 46.4 Favored 'General case' 0 C--N 1.331 -0.202 0 N-CA-C 109.821 -0.437 . . . . 0.0 109.821 173.682 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' D' D ' 135' ' ' GLU . . . . . . . . . . . . . 39.8 tp10 -50.07 -25.92 3.91 Favored 'General case' 0 C--N 1.328 -0.356 0 N-CA-C 113.389 0.885 . . . . 0.0 113.389 -168.375 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' D' D ' 136' ' ' GLN . . . . . . . . . . . . . 20.5 pt20 -99.02 -18.15 17.91 Favored 'General case' 0 N--CA 1.464 0.262 0 N-CA-C 113.566 0.95 . . . . 0.0 113.566 -172.356 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' D' D ' 137' ' ' LYS . . . . . . . . . . . . . 54.6 pttt -161.61 166.73 26.44 Favored 'General case' 0 C--O 1.233 0.193 0 CA-C-O 121.999 0.904 . . . . 0.0 113.344 -175.146 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' D' D ' 138' ' ' LEU . . . . . . . . . . . . . 12.2 tp -117.1 125.73 51.73 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 114.143 -1.389 . . . . 0.0 109.345 176.043 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' D' D ' 139' ' ' THR . . . . . . . . . . . . . 19.4 m -108.41 123.19 48.47 Favored 'General case' 0 C--N 1.331 -0.209 0 CA-C-O 120.705 0.288 . . . . 0.0 110.485 179.289 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' D' D ' 140' ' ' LEU . . . . . 0.477 ' C ' HD23 ' D' ' 140' ' ' LEU . 7.6 tt -112.81 120.74 42.51 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 115.568 -0.742 . . . . 0.0 109.136 -179.09 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' D' D ' 141' ' ' ILE . . . . . . . . . . . . . 19.3 mt -120.91 120.24 61.76 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.367 0 CA-C-O 121.007 0.432 . . . . 0.0 109.953 -176.152 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' D' D ' 142' ' ' ARG . . . . . . . . . . . . . 71.5 ttt180 -106.89 120.28 41.61 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 115.332 -0.849 . . . . 0.0 110.188 -179.778 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' D' D ' 143' ' ' THR . . . . . . . . . . . . . 73.2 p . . . . . 0 C--O 1.22 -0.469 0 CA-C-O 118.011 -0.995 . . . . 0.0 110.63 -179.295 . . . . . . . . 0 0 . 1 . 014 nuclear build core ' E' E ' 2' ' ' SER . . . . . . . . . . . . . 6.4 p . . . . . 0 C--O 1.232 0.158 0 CA-C-O 121.038 0.447 . . . . 0.0 110.961 . . . . . . . . . 0 0 . 1 . 014 nuclear build core ' E' E ' 3' ' ' GLU . . . . . . . . . . . . . 83.5 tt0 -141.27 142.18 33.91 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 115.804 -0.634 . . . . 0.0 110.893 179.946 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' E' E ' 4' ' ' LEU . . . . . 0.518 HD23 ' N ' ' E' ' 5' ' ' LYS . 3.6 tt -123.44 123.32 40.4 Favored 'General case' 0 C--N 1.33 -0.251 0 N-CA-C 109.702 -0.481 . . . . 0.0 109.702 177.978 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' E' E ' 5' ' ' LYS . . . . . 0.518 ' N ' HD23 ' E' ' 4' ' ' LEU . 49.1 mtmt -103.31 119.62 39.21 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.205 -0.452 . . . . 0.0 111.035 -179.263 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' E' E ' 6' ' ' LEU . . . . . . . . . . . . . 15.1 mt -116.01 153.36 31.8 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 115.731 -0.668 . . . . 0.0 110.585 178.768 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' E' E ' 7' ' ' LYS . . . . . . . . . . . . . 59.5 tttp -135.02 136.89 25.86 Favored Pre-proline 0 CA--C 1.534 0.35 0 CA-C-O 119.047 -0.502 . . . . 0.0 109.987 174.609 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' E' E ' 8' ' ' PRO . . . . . . . . . . . . . 88.5 Cg_endo -91.4 137.58 2.07 Favored 'Trans proline' 0 N--CA 1.49 1.287 0 C-N-CA 121.76 1.64 . . . . 0.0 111.366 178.119 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' E' E ' 9' ' ' LEU . . . . . . . . . . . . . 27.0 mt -83.03 -47.66 0.81 Allowed Pre-proline 0 CA--C 1.533 0.309 0 CA-C-O 118.743 -0.646 . . . . 0.0 112.429 -177.133 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' E' E ' 10' ' ' PRO . . . . . . . . . . . . . 62.8 Cg_endo -83.75 156.22 13.73 Favored 'Trans proline' 0 N--CA 1.495 1.609 0 C-N-CA 121.39 1.393 . . . . 0.0 112.151 177.115 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' E' E ' 11' ' ' LYS . . . . . . . . . . . . . 20.2 pttp -78.93 116.59 19.34 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-O 121.286 0.565 . . . . 0.0 110.286 175.523 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' E' E ' 12' ' ' VAL . . . . . . . . . . . . . 12.6 p -150.65 151.99 11.95 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.28 0 CA-C-N 115.779 -0.646 . . . . 0.0 110.756 -177.192 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' E' E ' 13' ' ' GLU . . . . . . . . . . . . . 13.0 pt-20 -91.88 130.95 37.54 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.555 178.394 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' E' E ' 14' ' ' LEU . . . . . . . . . . . . . 31.4 mt -99.87 130.69 25.89 Favored Pre-proline 0 CA--C 1.536 0.437 0 CA-C-O 118.715 -0.66 . . . . 0.0 110.621 -178.341 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' E' E ' 15' ' ' PRO . . . . . . . . . . . . . 23.0 Cg_exo -65.1 161.16 38.35 Favored 'Trans proline' 0 N--CA 1.499 1.842 0 C-N-CA 121.301 1.334 . . . . 0.0 111.893 175.826 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' E' E ' 16' ' ' PRO . . . . . . . . . . . . . 30.4 Cg_exo -59.96 -32.94 95.79 Favored 'Trans proline' 0 N--CA 1.496 1.627 0 C-N-CA 121.442 1.428 . . . . 0.0 112.635 -179.096 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' E' E ' 17' ' ' ASP . . . . . . . . . . . . . 11.3 p-10 -91.13 14.44 14.16 Favored 'General case' 0 CA--C 1.535 0.38 0 N-CA-C 112.989 0.737 . . . . 0.0 112.989 -178.412 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' E' E ' 18' ' ' PHE . . . . . . . . . . . . . 47.8 t80 -55.82 -49.13 74.11 Favored 'General case' 0 C--N 1.334 -0.076 0 O-C-N 121.977 -0.452 . . . . 0.0 110.7 -177.839 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' E' E ' 19' ' ' VAL . . . . . . . . . . . . . 47.5 t -55.77 -42.33 69.6 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.304 0 CA-C-N 116.578 -0.283 . . . . 0.0 110.723 -176.703 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' E' E ' 20' ' ' ASP . . . . . . . . . . . . . 60.5 m-20 -60.12 -43.03 95.95 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-O 120.849 0.357 . . . . 0.0 110.922 -177.85 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' E' E ' 21' ' ' VAL . . . . . . . . . . . . . 44.9 t -64.98 -47.54 87.69 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.306 0 C-N-CA 120.718 -0.393 . . . . 0.0 110.415 -178.036 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' E' E ' 22' ' ' ILE . . . . . 0.565 HG22 HD12 ' E' ' 26' ' ' LEU . 50.2 mm -55.71 -58.72 3.92 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.263 0 C-N-CA 120.92 -0.312 . . . . 0.0 111.108 -178.3 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' E' E ' 23' ' ' ARG . . . . . . . . . . . . . 7.5 ptm180 -56.48 -43.44 79.63 Favored 'General case' 0 C--N 1.332 -0.177 0 C-N-CA 120.618 -0.433 . . . . 0.0 111.859 -173.783 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' E' E ' 24' ' ' ILE . . . . . . . . . . . . . 78.0 mt -60.79 -43.68 95.88 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.293 0 C-N-CA 120.996 -0.281 . . . . 0.0 111.588 -176.682 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' E' E ' 25' ' ' LYS . . . . . . . . . . . . . 98.3 mttt -71.07 -40.73 71.42 Favored 'General case' 0 C--N 1.329 -0.299 0 N-CA-C 112.421 0.526 . . . . 0.0 112.421 -178.365 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' E' E ' 26' ' ' LEU . . . . . 0.565 HD12 HG22 ' E' ' 22' ' ' ILE . 77.1 mt -80.31 -32.59 37.98 Favored 'General case' 0 C--N 1.329 -0.289 0 N-CA-C 113.708 1.003 . . . . 0.0 113.708 -170.859 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' E' E ' 27' ' ' GLN . . . . . . . . . . . . . 14.0 pt20 -47.41 142.13 4.38 Favored 'General case' 0 N--CA 1.469 0.516 0 N-CA-C 112.602 0.593 . . . . 0.0 112.602 -175.61 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' E' E ' 28' ' ' GLY . . . . . . . . . . . . . . . 99.02 -22.17 42.27 Favored Glycine 0 CA--C 1.532 1.149 0 CA-C-N 115.63 -0.714 . . . . 0.0 112.561 -177.494 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' E' E ' 29' ' ' LYS . . . . . . . . . . . . . 28.5 mmtp -96.5 154.97 16.97 Favored 'General case' 0 C--O 1.231 0.122 0 CA-C-N 117.734 0.767 . . . . 0.0 110.846 178.424 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' E' E ' 30' ' ' THR . . . . . . . . . . . . . 41.2 m -110.13 138.64 46.22 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-N 115.803 -0.635 . . . . 0.0 110.307 178.446 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' E' E ' 31' ' ' VAL . . . . . . . . . . . . . 34.7 m -133.4 159.33 42.9 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.247 0 CA-C-N 116.233 -0.44 . . . . 0.0 111.026 -179.159 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' E' E ' 32' ' ' ARG . . . . . . . . . . . . . 77.8 mtp180 -131.98 153.34 50.43 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 115.874 -0.603 . . . . 0.0 110.424 176.408 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' E' E ' 33' ' ' THR . . . . . . . . . . . . . 30.6 m -53.1 139.68 27.8 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.37 -0.377 . . . . 0.0 111.395 -177.915 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' E' E ' 34' ' ' GLY . . . . . . . . . . . . . . . 99.39 -17.14 58.2 Favored Glycine 0 CA--C 1.532 1.153 0 CA-C-O 119.601 -0.555 . . . . 0.0 113.274 178.157 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' E' E ' 35' ' ' ASP . . . . . . . . . . . . . 74.2 m-20 -65.37 148.08 52.33 Favored 'General case' 0 N--CA 1.461 0.112 0 CA-C-N 118.043 0.921 . . . . 0.0 111.211 179.318 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' E' E ' 36' ' ' VAL . . . . . . . . . . . . . 44.4 t -119.61 129.59 75.15 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 CA-C-N 115.649 -0.705 . . . . 0.0 109.705 178.875 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' E' E ' 37' ' ' ILE . . . . . . . . . . . . . 68.9 mt -121.17 139.03 49.62 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.29 0 CA-C-N 116.272 -0.422 . . . . 0.0 109.971 -179.374 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' E' E ' 38' ' ' GLY . . . . . . . . . . . . . . . -112.19 128.7 8.67 Favored Glycine 0 CA--C 1.525 0.701 0 N-CA-C 110.502 -1.039 . . . . 0.0 110.502 177.698 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' E' E ' 39' ' ' ILE . . . . . . . . . . . . . 72.1 mt -123.1 133.42 69.14 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.279 0 N-CA-C 109.944 -0.391 . . . . 0.0 109.944 -179.522 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' E' E ' 40' ' ' SER . . . . . . . . . . . . . 43.2 t -93.44 120.62 33.93 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.444 -0.344 . . . . 0.0 110.949 176.281 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' E' E ' 41' ' ' ILE . . . . . . . . . . . . . 73.6 mt -122.47 114.79 43.89 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.195 0 CA-C-O 120.955 0.407 . . . . 0.0 110.104 177.856 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' E' E ' 42' ' ' LEU . . . . . 0.542 ' O ' HD23 ' E' ' 42' ' ' LEU . 1.3 tt 51.01 44.18 28.68 Favored 'General case' 0 CA--C 1.532 0.274 0 CA-C-O 121.479 0.656 . . . . 0.0 110.829 177.866 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' E' E ' 43' ' ' GLY . . . . . . . . . . . . . . . 71.26 27.8 71.07 Favored Glycine 0 CA--C 1.531 1.084 0 C-N-CA 121.113 -0.565 . . . . 0.0 112.392 176.095 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' E' E ' 44' ' ' LYS . . . . . . . . . . . . . 61.2 tttm -133.9 129.88 36.99 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-N 117.188 0.494 . . . . 0.0 109.952 178.8 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' E' E ' 45' ' ' GLU . . . . . . . . . . . . . 82.6 tt0 -83.35 122.92 29.11 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-O 120.873 0.368 . . . . 0.0 111.274 -177.008 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' E' E ' 46' ' ' VAL . . . . . . . . . . . . . 7.4 p -122.53 128.41 75.36 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.228 0 N-CA-C 109.441 -0.577 . . . . 0.0 109.441 175.213 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' E' E ' 47' ' ' LYS . . . . . . . . . . . . . 62.5 mtpt -100.56 133.14 45.43 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 115.992 -0.549 . . . . 0.0 111.262 179.943 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' E' E ' 48' ' ' PHE . . . . . . . . . . . . . 96.0 m-85 -120.47 132.06 55.04 Favored 'General case' 0 C--N 1.331 -0.219 0 CA-C-N 116.102 -0.499 . . . . 0.0 110.075 176.897 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' E' E ' 49' ' ' LYS . . . . . . . . . . . . . 60.6 tttm -106.32 137.73 43.76 Favored 'General case' 0 C--O 1.233 0.202 0 CA-C-N 116.504 -0.316 . . . . 0.0 110.418 178.076 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' E' E ' 50' ' ' VAL . . . . . . . . . . . . . 44.0 t -80.45 105.22 9.9 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.279 0 N-CA-C 109.133 -0.692 . . . . 0.0 109.133 175.101 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' E' E ' 51' ' ' VAL . . . . . . . . . . . . . 48.0 t -70.18 -49.32 55.87 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.35 0 CA-C-N 115.956 -0.566 . . . . 0.0 109.968 -174.057 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' E' E ' 52' ' ' GLN . . . . . . . . . . . . . 60.0 tt0 -163.31 140.09 7.25 Favored 'General case' 0 C--N 1.332 -0.183 0 C-N-CA 120.179 -0.608 . . . . 0.0 111.681 -179.185 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' E' E ' 53' ' ' ALA . . . . . . . . . . . . . . . -113.64 130.96 56.31 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 115.821 -0.627 . . . . 0.0 109.907 176.238 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' E' E ' 54' ' ' TYR . . . . . . . . . . . . . 65.1 t80 -129.08 109.98 18.19 Favored Pre-proline 0 CA--C 1.535 0.385 0 CA-C-O 118.274 -0.869 . . . . 0.0 110.207 179.588 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' E' E ' 55' ' ' PRO . . . . . . . . . . . . . 73.4 Cg_endo -77.18 170.1 72.43 Favored 'Cis proline' 0 N--CA 1.499 1.838 0 CA-C-N 121.948 1.731 . . . . 0.0 112.541 -3.918 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' E' E ' 56' ' ' SER . . . . . . . . . . . . . 13.4 m -115.12 128.97 25.46 Favored Pre-proline 0 CA--C 1.539 0.546 0 CA-C-O 118.356 -0.83 . . . . 0.0 109.315 175.412 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' E' E ' 57' ' ' PRO . . . . . . . . . . . . . 44.3 Cg_endo -68.27 166.56 68.16 Favored 'Cis proline' 0 N--CA 1.497 1.722 0 CA-C-N 122.037 1.763 . . . . 0.0 111.576 0.407 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' E' E ' 58' ' ' LEU . . . . . 0.485 HD23 HD12 ' E' ' 4' ' ' LEU . 23.3 tp -129.84 138.57 51.06 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-O 121.022 0.439 . . . . 0.0 110.417 -179.148 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' E' E ' 59' ' ' ARG . . . . . . . . . . . . . 55.3 ttp180 -107.1 130.16 54.72 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 115.632 -0.713 . . . . 0.0 109.51 176.969 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' E' E ' 60' ' ' VAL . . . . . . . . . . . . . 43.7 t -77.74 119.9 27.35 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.252 0 C-N-CA 120.74 -0.384 . . . . 0.0 110.266 -177.079 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' E' E ' 61' ' ' GLU . . . . . . . . . . . . . 43.0 mt-10 -130.95 155.06 47.43 Favored 'General case' 0 C--N 1.331 -0.213 0 CA-C-N 115.944 -0.571 . . . . 0.0 110.528 179.148 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' E' E ' 62' ' ' ASP . . . . . . . . . . . . . 28.6 m-20 -54.61 -32.99 59.73 Favored 'General case' 0 C--N 1.326 -0.429 0 CA-C-N 116.491 -0.322 . . . . 0.0 111.777 179.683 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' E' E ' 63' ' ' ARG . . . . . . . . . . . . . 9.3 ptm180 -88.96 7.66 33.5 Favored 'General case' 0 CA--C 1.536 0.441 0 N-CA-C 113.652 0.982 . . . . 0.0 113.652 -175.082 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' E' E ' 64' ' ' THR . . . . . . . . . . . . . 23.3 m -89.51 146.15 24.81 Favored 'General case' 0 C--N 1.331 -0.196 0 CA-C-N 118.066 0.394 . . . . 0.0 110.319 179.648 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' E' E ' 65' ' ' LYS . . . . . . . . . . . . . 94.7 mttt -84.74 121.82 28.22 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-O 120.841 0.353 . . . . 0.0 110.211 179.914 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' E' E ' 66' ' ' ILE . . . . . . . . . . . . . 58.1 mt -112.52 122.53 66.91 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.263 0 N-CA-C 109.237 -0.653 . . . . 0.0 109.237 179.648 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' E' E ' 67' ' ' THR . . . . . . . . . . . . . 9.6 m -129.95 143.41 50.78 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-O 121.127 0.489 . . . . 0.0 111.679 -172.911 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' E' E ' 68' ' ' LEU . . . . . 0.479 HD12 ' N ' ' E' ' 68' ' ' LEU . 7.9 mp . . . . . 0 C--N 1.331 -0.239 0 CA-C-N 115.799 -0.637 . . . . 0.0 109.631 173.859 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' E' E ' 73' ' ' VAL . . . . . . . . . . . . . 32.9 m . . . . . 0 C--O 1.231 0.131 0 CA-C-O 121.0 0.428 . . . . 0.0 111.226 . . . . . . . . . 0 0 . 1 . 014 nuclear build core ' E' E ' 74' ' ' ASP . . . . . . . . . . . . . 10.6 t0 -101.07 124.11 46.28 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 115.777 -0.647 . . . . 0.0 109.882 178.366 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' E' E ' 75' ' ' VAL . . . . . . . . . . . . . 41.7 t -111.53 125.02 68.82 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.224 0 CA-C-O 121.133 0.492 . . . . 0.0 110.622 -178.111 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' E' E ' 76' ' ' LEU . . . . . . . . . . . . . 42.5 mt -121.28 143.45 49.16 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 115.593 -0.731 . . . . 0.0 109.6 177.22 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' E' E ' 77' ' ' GLU . . . . . . . . . . . . . 97.9 mt-10 -136.47 134.66 37.88 Favored 'General case' 0 C--N 1.331 -0.201 0 CA-C-O 120.996 0.427 . . . . 0.0 111.462 -178.662 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' E' E ' 78' ' ' ALA . . . . . 0.408 ' HB2' HD21 ' E' ' 109' ' ' LEU . . . -121.86 137.11 54.91 Favored 'General case' 0 C--N 1.331 -0.206 0 CA-C-N 115.728 -0.669 . . . . 0.0 109.751 175.738 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' E' E ' 79' ' ' LYS . . . . . 0.582 ' O ' HD13 ' E' ' 80' ' ' ILE . 61.5 mtpt -84.49 120.73 26.66 Favored 'General case' 0 C--N 1.331 -0.219 0 CA-C-O 120.884 0.373 . . . . 0.0 110.831 -178.166 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' E' E ' 80' ' ' ILE . . . . . 0.582 HD13 ' O ' ' E' ' 79' ' ' LYS . 22.6 mm -139.16 124.84 22.38 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.231 0 CA-C-N 115.937 -0.574 . . . . 0.0 109.688 -177.235 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' E' E ' 81' ' ' LYS . . . . . . . . . . . . . 64.8 mmtt -110.22 123.85 50.54 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-O 120.837 0.351 . . . . 0.0 111.419 -179.169 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' E' E ' 82' ' ' GLY . . . . . . . . . . . . . . . 89.06 42.15 5.69 Favored Glycine 0 CA--C 1.524 0.638 0 C-N-CA 120.698 -0.763 . . . . 0.0 112.044 171.664 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' E' E ' 83' ' ' ILE . . . . . . . . . . . . . 71.9 mt -61.66 135.92 25.73 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.335 0 CA-C-O 120.958 0.408 . . . . 0.0 109.957 178.691 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' E' E ' 84' ' ' LYS . . . . . . . . . . . . . 72.7 tttt -96.54 -50.8 4.58 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 115.739 -0.664 . . . . 0.0 110.021 -179.001 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' E' E ' 85' ' ' ASP . . . . . . . . . . . . . 6.1 t0 -156.12 150.11 25.25 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 115.54 -0.755 . . . . 0.0 110.075 179.261 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' E' E ' 86' ' ' VAL . . . . . . . . . . . . . 45.7 t -129.1 129.29 67.77 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.268 0 CA-C-O 120.92 0.391 . . . . 0.0 110.315 -179.26 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' E' E ' 87' ' ' ILE . . . . . 0.473 HG21 HG21 ' E' ' 125' ' ' VAL . 43.1 mm -118.39 125.18 74.13 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.285 0 CA-C-N 115.99 -0.55 . . . . 0.0 109.767 176.489 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' E' E ' 88' ' ' LEU . . . . . . . . . . . . . 52.1 mt -111.04 136.03 50.67 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-O 121.078 0.466 . . . . 0.0 111.437 -178.14 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' E' E ' 89' ' ' ASP . . . . . . . . . . . . . 13.8 t70 -131.42 153.56 49.58 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 115.537 -0.756 . . . . 0.0 109.319 175.384 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' E' E ' 90' ' ' GLU . . . . . . . . . . . . . 46.2 tp10 -47.28 -39.2 14.03 Favored 'General case' 0 N--CA 1.464 0.264 0 N-CA-C 112.817 0.673 . . . . 0.0 112.817 -172.872 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' E' E ' 91' ' ' ASN . . . . . . . . . . . . . 30.2 m120 -132.11 35.51 3.71 Favored 'General case' 0 N--CA 1.464 0.258 0 C-N-CA 120.974 -0.29 . . . . 0.0 111.743 -177.336 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' E' E ' 92' ' ' LEU . . . . . . . . . . . . . 11.3 tp -166.1 145.82 6.19 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-O 120.781 0.324 . . . . 0.0 110.775 -179.835 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' E' E ' 93' ' ' ILE . . . . . . . . . . . . . 72.1 mt -130.63 125.64 59.16 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.24 0 N-CA-C 109.716 -0.475 . . . . 0.0 109.716 -179.736 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' E' E ' 94' ' ' VAL . . . . . 0.462 HG21 HG11 ' E' ' 125' ' ' VAL . 44.3 t -122.89 126.39 73.73 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.292 0 N-CA-C 109.722 -0.473 . . . . 0.0 109.722 178.986 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' E' E ' 95' ' ' VAL . . . . . . . . . . . . . 45.5 t -123.71 132.73 70.89 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.207 0 N-CA-C 109.915 -0.402 . . . . 0.0 109.915 -178.863 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' E' E ' 96' ' ' ILE . . . . . . . . . . . . . 56.0 mt -118.1 134.64 61.08 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.308 0 N-CA-C 109.125 -0.694 . . . . 0.0 109.125 179.51 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' E' E ' 97' ' ' THR . . . . . . . . . . . . . 58.0 p -109.86 157.29 19.36 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-O 121.357 0.599 . . . . 0.0 111.452 -177.174 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' E' E ' 98' ' ' GLU . . . . . . . . . . . . . 96.4 mt-10 -55.13 -22.1 15.56 Favored 'General case' 0 C--N 1.329 -0.306 0 N-CA-C 112.531 0.567 . . . . 0.0 112.531 179.204 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' E' E ' 99' ' ' GLU . . . . . . . . . . . . . 38.4 tt0 -78.75 14.93 1.16 Allowed 'General case' 0 CA--C 1.54 0.57 0 N-CA-C 112.52 0.563 . . . . 0.0 112.52 -178.614 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' E' E ' 100' ' ' ASN . . . . . . . . . . . . . 2.8 m-20 61.96 37.88 14.7 Favored 'General case' 0 CA--C 1.529 0.167 0 O-C-N 121.763 -0.585 . . . . 0.0 110.857 178.537 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' E' E ' 101' ' ' GLU . . . . . . . . . . . . . 84.5 tt0 -120.57 143.57 48.55 Favored 'General case' 0 C--N 1.333 -0.134 0 CA-C-N 116.051 -0.522 . . . . 0.0 109.73 177.821 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' E' E ' 102' ' ' VAL . . . . . . . . . . . . . 41.1 t -120.94 130.85 74.22 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.267 0 CA-C-N 116.313 -0.403 . . . . 0.0 110.049 -178.247 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' E' E ' 103' ' ' LEU . . . . . . . . . . . . . 5.2 mp -121.33 136.8 54.92 Favored 'General case' 0 C--N 1.331 -0.203 0 CA-C-N 115.938 -0.574 . . . . 0.0 110.486 176.456 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' E' E ' 104' ' ' ILE . . . . . . . . . . . . . 68.2 mt -117.56 122.46 69.89 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.297 0 CA-C-N 115.639 -0.71 . . . . 0.0 109.688 -179.551 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' E' E ' 105' ' ' PHE . . . . . . . . . . . . . 55.5 m-85 -123.26 165.76 16.4 Favored 'General case' 0 C--N 1.331 -0.207 0 O-C-N 123.961 0.788 . . . . 0.0 109.455 179.421 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' E' E ' 106' ' ' ASN . . . . . . . . . . . . . 44.0 p-10 -101.65 -171.84 2.05 Favored 'General case' 0 C--N 1.331 -0.225 0 N-CA-C 109.891 -0.411 . . . . 0.0 109.891 173.746 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' E' E ' 107' ' ' GLN . . . . . . . . . . . . . 43.2 tt0 -60.27 -29.88 69.09 Favored 'General case' 0 C--N 1.328 -0.347 0 N-CA-C 111.912 0.338 . . . . 0.0 111.912 179.886 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' E' E ' 108' ' ' ASN . . . . . . . . . . . . . 60.5 t30 -81.9 6.51 15.61 Favored 'General case' 0 CA--C 1.536 0.405 0 N-CA-C 113.278 0.844 . . . . 0.0 113.278 -177.944 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' E' E ' 109' ' ' LEU . . . . . 0.408 HD21 ' HB2' ' E' ' 78' ' ' ALA . 8.8 tp 62.1 36.45 15.23 Favored 'General case' 0 C--O 1.232 0.163 0 CA-C-O 120.966 0.412 . . . . 0.0 111.533 177.905 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' E' E ' 110' ' ' GLU . . . . . . . . . . . . . 70.9 mm-40 -104.26 148.63 26.12 Favored 'General case' 0 C--N 1.329 -0.315 0 N-CA-C 109.807 -0.442 . . . . 0.0 109.807 175.796 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' E' E ' 111' ' ' GLU . . . . . . . . . . . . . 77.3 tt0 -80.22 122.03 26.35 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.429 -0.351 . . . . 0.0 110.971 -176.528 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' E' E ' 112' ' ' LEU . . . . . . . . . . . . . 26.7 mt -105.02 -46.18 4.34 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 116.29 -0.414 . . . . 0.0 110.725 178.596 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' E' E ' 113' ' ' TYR . . . . . . . . . . . . . 64.5 t80 -143.75 139.8 29.61 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.353 -0.385 . . . . 0.0 111.376 -178.875 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' E' E ' 114' ' ' ARG . . . . . . . . . . . . . 60.8 ttp180 -141.07 120.89 13.49 Favored 'General case' 0 C--N 1.33 -0.239 0 CA-C-N 116.274 -0.421 . . . . 0.0 110.165 176.008 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' E' E ' 115' ' ' GLY . . . . . . . . . . . . . . . -150.01 161.7 28.96 Favored Glycine 0 CA--C 1.524 0.652 0 N-CA-C 110.898 -0.881 . . . . 0.0 110.898 178.557 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' E' E ' 116' ' ' LYS . . . . . . . . . . . . . 32.8 ttmt -128.72 139.56 52.16 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-O 120.777 0.322 . . . . 0.0 110.411 179.462 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' E' E ' 117' ' ' PHE . . . . . . . . . . . . . 43.5 m-85 -131.6 115.48 16.14 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.233 -0.44 . . . . 0.0 110.187 -176.949 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' E' E ' 118' ' ' GLU . . . . . . . . . . . . . 96.3 mt-10 -54.64 -46.5 73.95 Favored 'General case' 0 C--N 1.329 -0.299 0 C-N-CA 121.003 -0.279 . . . . 0.0 111.408 -176.004 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' E' E ' 119' ' ' ASN . . . . . . . . . . . . . 28.6 m120 -97.4 31.04 2.63 Favored 'General case' 0 C--N 1.33 -0.269 0 N-CA-C 112.318 0.488 . . . . 0.0 112.318 -174.22 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' E' E ' 120' ' ' LEU . . . . . . . . . . . . . 19.0 tp -55.43 120.82 7.73 Favored 'General case' 0 C--O 1.232 0.175 0 C-N-CA 121.197 -0.201 . . . . 0.0 110.688 178.125 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' E' E ' 121' ' ' ASN . . . . . . . . . . . . . 31.4 m120 -114.04 -44.15 3.18 Favored 'General case' 0 C--N 1.332 -0.195 0 CA-C-N 116.689 -0.232 . . . . 0.0 111.361 -177.321 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' E' E ' 122' ' ' LYS . . . . . . . . . . . . . 93.5 mttt -146.95 154.09 40.85 Favored 'General case' 0 C--N 1.331 -0.222 0 CA-C-O 121.064 0.459 . . . . 0.0 111.895 -176.313 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' E' E ' 123' ' ' VAL . . . . . . . . . . . . . 43.3 t -132.69 133.8 59.07 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.27 0 CA-C-N 115.971 -0.559 . . . . 0.0 110.089 177.142 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' E' E ' 124' ' ' LEU . . . . . . . . . . . . . 54.4 mt -124.17 134.97 53.18 Favored 'General case' 0 C--N 1.33 -0.239 0 CA-C-N 116.591 -0.277 . . . . 0.0 110.545 179.846 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' E' E ' 125' ' ' VAL . . . . . 0.473 HG21 HG21 ' E' ' 87' ' ' ILE . 35.4 m -134.75 135.67 53.07 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.255 0 CA-C-N 116.454 -0.339 . . . . 0.0 110.836 -179.685 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' E' E ' 126' ' ' ARG . . . . . . . . . . . . . 29.9 mtp180 -148.87 124.79 10.61 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-O 121.01 0.433 . . . . 0.0 110.974 175.925 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' E' E ' 127' ' ' ASN . . . . . . . . . . . . . 23.0 t-20 49.92 -106.52 0.22 Allowed 'General case' 0 CA--C 1.543 0.708 0 CA-C-N 116.094 -0.503 . . . . 0.0 111.544 179.066 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' E' E ' 128' ' ' ASP . . . . . . . . . . . . . 23.7 p-10 -114.01 3.26 15.26 Favored 'General case' 0 N--CA 1.467 0.413 0 CA-C-N 119.63 1.105 . . . . 0.0 113.469 -177.014 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' E' E ' 129' ' ' LEU . . . . . . . . . . . . . 15.1 tp -105.23 134.94 47.51 Favored 'General case' 0 C--N 1.334 -0.106 0 N-CA-C 109.876 -0.416 . . . . 0.0 109.876 179.182 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' E' E ' 130' ' ' VAL . . . . . . . . . . . . . 44.6 t -124.29 135.58 63.26 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.246 0 N-CA-C 109.925 -0.398 . . . . 0.0 109.925 -179.532 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' E' E ' 131' ' ' VAL . . . . . 0.446 HG22 HD12 ' E' ' 140' ' ' LEU . 43.4 t -134.01 133.94 55.88 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.262 0 CA-C-O 121.037 0.446 . . . . 0.0 110.094 179.004 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' E' E ' 132' ' ' ILE . . . . . . . . . . . . . 71.0 mt -114.71 132.36 64.12 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.322 0 CA-C-N 115.808 -0.633 . . . . 0.0 109.306 179.36 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' E' E ' 133' ' ' ILE . . . . . . . . . . . . . 39.3 mm -114.93 120.0 63.32 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.231 0 CA-C-O 120.892 0.377 . . . . 0.0 110.954 -174.909 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' E' E ' 134' ' ' ASP . . . . . . . . . . . . . 9.2 p-10 -132.91 145.3 50.8 Favored 'General case' 0 C--N 1.33 -0.25 0 N-CA-C 109.35 -0.611 . . . . 0.0 109.35 174.516 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' E' E ' 135' ' ' GLU . . . . . . . . . . . . . 76.9 tt0 -49.92 -25.72 3.5 Favored 'General case' 0 C--N 1.327 -0.397 0 N-CA-C 112.859 0.688 . . . . 0.0 112.859 -171.304 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' E' E ' 136' ' ' GLN . . . . . . . . . . . . . 44.2 tt0 -82.69 -38.1 23.86 Favored 'General case' 0 C--O 1.233 0.226 0 N-CA-C 112.136 0.421 . . . . 0.0 112.136 -176.172 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' E' E ' 137' ' ' LYS . . . . . . . . . . . . . 18.2 pttp -160.74 169.25 23.14 Favored 'General case' 0 C--O 1.233 0.207 0 CA-C-O 121.451 0.643 . . . . 0.0 112.126 -173.351 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' E' E ' 138' ' ' LEU . . . . . . . . . . . . . 5.9 tt -114.6 127.4 55.76 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 115.221 -0.899 . . . . 0.0 109.63 177.446 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' E' E ' 139' ' ' THR . . . . . . . . . . . . . 23.4 m -105.21 124.03 48.84 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.275 -179.37 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' E' E ' 140' ' ' LEU . . . . . 0.446 HD12 HG22 ' E' ' 131' ' ' VAL . 35.4 tp -110.79 119.94 40.76 Favored 'General case' 0 C--N 1.327 -0.384 0 N-CA-C 109.287 -0.635 . . . . 0.0 109.287 -179.153 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' E' E ' 141' ' ' ILE . . . . . . . . . . . . . 19.3 mt -121.26 117.11 51.73 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.353 0 CA-C-O 121.002 0.43 . . . . 0.0 109.863 -176.211 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' E' E ' 142' ' ' ARG . . . . . . . . . . . . . 73.9 mtp180 -103.76 129.08 51.11 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 115.433 -0.803 . . . . 0.0 110.417 179.653 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' E' E ' 143' ' ' THR . . . . . . . . . . . . . 11.9 p . . . . . 0 C--O 1.219 -0.506 0 CA-C-O 117.997 -1.001 . . . . 0.0 110.531 179.999 . . . . . . . . 0 0 . 1 . 014 nuclear build core ' F' F ' 1' ' ' MET . . . . . . . . . . . . . 22.4 ptm . . . . . 0 N--CA 1.456 -0.152 0 CA-C-O 120.647 0.261 . . . . 0.0 110.81 . . . . . . . . . 0 0 . 1 . 014 nuclear build core ' F' F ' 2' ' ' SER . . . . . . . . . . . . . 3.5 p -121.95 129.07 52.2 Favored 'General case' 0 C--N 1.331 -0.217 0 CA-C-O 120.904 0.383 . . . . 0.0 110.624 178.75 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' F' F ' 3' ' ' GLU . . . . . . . . . . . . . 95.0 mt-10 -140.16 141.43 36.03 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.025 -0.534 . . . . 0.0 111.141 -177.573 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' F' F ' 4' ' ' LEU . . . . . . . . . . . . . 15.5 tp -125.49 126.99 45.76 Favored 'General case' 0 C--N 1.331 -0.225 0 CA-C-N 115.832 -0.622 . . . . 0.0 110.198 176.828 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' F' F ' 5' ' ' LYS . . . . . . . . . . . . . 95.4 mttt -105.35 120.97 42.92 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.412 -0.358 . . . . 0.0 110.812 178.886 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' F' F ' 6' ' ' LEU . . . . . . . . . . . . . 77.6 mt -116.09 150.27 37.61 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-N 115.495 -0.775 . . . . 0.0 110.371 -179.885 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' F' F ' 7' ' ' LYS . . . . . . . . . . . . . 58.3 tttp -140.96 137.87 17.47 Favored Pre-proline 0 CA--C 1.535 0.369 0 CA-C-O 119.025 -0.512 . . . . 0.0 110.26 176.52 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' F' F ' 8' ' ' PRO . . . . . . . . . . . . . 80.9 Cg_endo -91.73 143.76 2.93 Favored 'Trans proline' 0 N--CA 1.491 1.333 0 C-N-CA 121.69 1.593 . . . . 0.0 111.65 177.065 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' F' F ' 9' ' ' LEU . . . . . . . . . . . . . 64.7 mt -76.69 -48.67 2.86 Favored Pre-proline 0 CA--C 1.534 0.33 0 CA-C-O 118.606 -0.712 . . . . 0.0 112.529 -177.796 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' F' F ' 10' ' ' PRO . . . . . . . . . . . . . 83.7 Cg_endo -79.62 147.71 19.92 Favored 'Trans proline' 0 N--CA 1.497 1.729 0 C-N-CA 121.166 1.244 . . . . 0.0 111.627 178.033 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' F' F ' 11' ' ' LYS . . . . . . . . . . . . . 53.5 pttt -79.36 108.85 13.19 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-O 121.778 0.799 . . . . 0.0 110.315 177.563 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' F' F ' 12' ' ' VAL . . . . . . . . . . . . . 11.7 p -148.37 145.25 18.53 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.291 0 CA-C-N 115.425 -0.807 . . . . 0.0 110.12 -179.134 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' F' F ' 13' ' ' GLU . . . . . . . . . . . . . 41.0 tp10 -87.78 123.18 32.31 Favored 'General case' 0 C--N 1.329 -0.312 0 N-CA-C 109.884 -0.413 . . . . 0.0 109.884 179.165 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' F' F ' 14' ' ' LEU . . . . . . . . . . . . . 33.5 mt -98.09 149.08 35.36 Favored Pre-proline 0 CA--C 1.532 0.288 0 CA-C-N 116.404 -0.362 . . . . 0.0 110.644 -177.258 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' F' F ' 15' ' ' PRO . . . . . . . . . . . . . 25.4 Cg_exo -62.62 159.54 36.36 Favored 'Trans proline' 0 N--CA 1.498 1.791 0 C-N-CA 121.25 1.3 . . . . 0.0 111.978 176.86 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' F' F ' 16' ' ' PRO . . . . . . . . . . . . . 27.9 Cg_exo -60.47 -34.83 92.51 Favored 'Trans proline' 0 N--CA 1.496 1.639 0 C-N-CA 121.414 1.409 . . . . 0.0 112.494 -179.659 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' F' F ' 17' ' ' ASP . . . . . . . . . . . . . 22.2 p-10 -88.04 10.79 17.89 Favored 'General case' 0 CA--C 1.535 0.393 0 N-CA-C 113.024 0.75 . . . . 0.0 113.024 -178.431 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' F' F ' 18' ' ' PHE . . . . . . . . . . . . . 30.1 t80 -58.01 -42.01 84.32 Favored 'General case' 0 N--CA 1.457 -0.115 0 O-C-N 121.932 -0.48 . . . . 0.0 110.158 -178.507 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' F' F ' 19' ' ' VAL . . . . . . . . . . . . . 49.1 t -56.35 -42.86 75.61 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.282 0 CA-C-N 116.469 -0.332 . . . . 0.0 110.41 -179.676 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' F' F ' 20' ' ' ASP . . . . . . . . . . . . . 81.7 m-20 -60.15 -43.0 96.08 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.428 -0.351 . . . . 0.0 110.884 -178.049 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' F' F ' 21' ' ' VAL . . . . . . . . . . . . . 48.7 t -64.18 -48.11 87.08 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.309 0 C-N-CA 120.832 -0.347 . . . . 0.0 110.548 -177.39 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' F' F ' 22' ' ' ILE . . . . . 0.572 HG22 HD12 ' F' ' 26' ' ' LEU . 50.1 mm -55.9 -47.44 79.83 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.312 0 C-N-CA 121.036 -0.266 . . . . 0.0 110.74 -179.978 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' F' F ' 23' ' ' ARG . . . . . . . . . . . . . 54.6 ttp180 -55.38 -48.8 73.76 Favored 'General case' 0 C--N 1.33 -0.276 0 C-N-CA 121.038 -0.265 . . . . 0.0 111.337 -178.291 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' F' F ' 24' ' ' ILE . . . . . . . . . . . . . 73.9 mt -58.48 -41.98 83.18 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.281 0 CA-C-O 120.706 0.288 . . . . 0.0 110.799 -177.378 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' F' F ' 25' ' ' LYS . . . . . . . . . . . . . 51.7 mtpt -65.55 -43.66 89.21 Favored 'General case' 0 C--N 1.327 -0.382 0 N-CA-C 112.319 0.489 . . . . 0.0 112.319 -178.697 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' F' F ' 26' ' ' LEU . . . . . 0.572 HD12 HG22 ' F' ' 22' ' ' ILE . 79.5 mt -79.74 -33.2 40.97 Favored 'General case' 0 C--N 1.331 -0.201 0 N-CA-C 113.874 1.064 . . . . 0.0 113.874 -169.549 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' F' F ' 27' ' ' GLN . . . . . . . . . . . . . 17.0 pt20 -46.76 139.42 5.35 Favored 'General case' 0 N--CA 1.469 0.507 0 N-CA-C 113.027 0.751 . . . . 0.0 113.027 -173.497 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' F' F ' 28' ' ' GLY . . . . . . . . . . . . . . . 99.35 -23.61 35.58 Favored Glycine 0 CA--C 1.535 1.292 0 CA-C-N 115.442 -0.799 . . . . 0.0 112.451 -178.962 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' F' F ' 29' ' ' LYS . . . . . . . . . . . . . 61.1 mttp -97.89 155.15 17.2 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 117.527 0.664 . . . . 0.0 111.136 179.682 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' F' F ' 30' ' ' THR . . . . . . . . . . . . . 36.3 m -104.61 137.01 43.09 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 115.931 -0.577 . . . . 0.0 109.852 175.586 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' F' F ' 31' ' ' VAL . . . . . . . . . . . . . 34.9 m -129.64 153.54 38.94 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.21 0 CA-C-O 121.003 0.43 . . . . 0.0 110.953 -178.379 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' F' F ' 32' ' ' ARG . . . . . . . . . . . . . 38.9 ttm180 -133.66 149.41 51.55 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 115.991 -0.549 . . . . 0.0 110.454 -179.991 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' F' F ' 33' ' ' THR . . . . . . . . . . . . . 21.4 m -52.17 138.7 25.27 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.307 -0.406 . . . . 0.0 111.563 -176.17 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' F' F ' 34' ' ' GLY . . . . . . . . . . . . . . . 100.48 -17.1 57.21 Favored Glycine 0 CA--C 1.533 1.209 0 CA-C-O 119.64 -0.533 . . . . 0.0 113.326 178.536 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' F' F ' 35' ' ' ASP . . . . . . . . . . . . . 80.2 m-20 -66.2 147.37 53.42 Favored 'General case' 0 C--N 1.332 -0.155 0 CA-C-N 118.014 0.907 . . . . 0.0 110.953 178.856 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' F' F ' 36' ' ' VAL . . . . . . . . . . . . . 46.3 t -122.32 129.99 74.88 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.197 0 CA-C-N 115.965 -0.561 . . . . 0.0 109.849 178.225 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' F' F ' 37' ' ' ILE . . . . . . . . . . . . . 69.3 mt -121.83 139.93 47.38 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.247 0 CA-C-N 116.194 -0.457 . . . . 0.0 109.955 -179.138 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' F' F ' 38' ' ' GLY . . . . . . . . . . . . . . . -113.64 128.74 8.46 Favored Glycine 0 CA--C 1.526 0.743 0 N-CA-C 111.282 -0.727 . . . . 0.0 111.282 -179.928 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' F' F ' 39' ' ' ILE . . . . . . . . . . . . . 70.0 mt -121.03 134.94 62.8 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.171 0 N-CA-C 109.959 -0.386 . . . . 0.0 109.959 178.269 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' F' F ' 40' ' ' SER . . . . . . . . . . . . . 87.4 p -92.16 120.68 32.97 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 116.422 -0.353 . . . . 0.0 110.62 175.537 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' F' F ' 41' ' ' ILE . . . . . . . . . . . . . 72.2 mt -132.36 117.56 32.45 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.207 0 CA-C-O 120.757 0.313 . . . . 0.0 110.157 178.554 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' F' F ' 42' ' ' LEU . . . . . . . . . . . . . 8.4 tp 57.95 35.85 25.67 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.176 -0.466 . . . . 0.0 111.363 178.515 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' F' F ' 43' ' ' GLY . . . . . . . . . . . . . . . 77.41 -10.08 24.43 Favored Glycine 0 CA--C 1.535 1.326 0 C-N-CA 121.26 -0.495 . . . . 0.0 113.381 177.431 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' F' F ' 44' ' ' LYS . . . . . . . . . . . . . 59.2 tttm -98.28 134.29 41.51 Favored 'General case' 0 C--N 1.333 -0.126 0 CA-C-N 117.996 0.898 . . . . 0.0 109.897 177.905 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' F' F ' 45' ' ' GLU . . . . . . . . . . . . . 82.3 tt0 -84.53 128.14 34.43 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.325 -0.398 . . . . 0.0 110.903 -179.423 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' F' F ' 46' ' ' VAL . . . . . . . . . . . . . 7.3 p -121.87 126.84 75.1 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.211 0 N-CA-C 109.632 -0.507 . . . . 0.0 109.632 175.936 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' F' F ' 47' ' ' LYS . . . . . . . . . . . . . 59.5 mtpt -100.58 128.85 46.5 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 115.895 -0.593 . . . . 0.0 111.24 179.573 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' F' F ' 48' ' ' PHE . . . . . . . . . . . . . 95.8 m-85 -113.28 131.88 55.76 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.279 -0.419 . . . . 0.0 110.064 176.361 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' F' F ' 49' ' ' LYS . . . . . . . . . . . . . 57.0 tttm -108.66 139.69 43.09 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.47 -0.332 . . . . 0.0 110.471 178.326 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' F' F ' 50' ' ' VAL . . . . . . . . . . . . . 45.2 t -82.22 109.18 15.96 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.308 0 N-CA-C 109.137 -0.69 . . . . 0.0 109.137 175.66 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' F' F ' 51' ' ' VAL . . . . . . . . . . . . . 47.0 t -73.5 -48.4 41.48 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.294 0 CA-C-N 116.015 -0.539 . . . . 0.0 110.032 -173.81 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' F' F ' 52' ' ' GLN . . . . . . . . . . . . . 61.4 tt0 -163.82 139.48 6.38 Favored 'General case' 0 C--N 1.33 -0.239 0 C-N-CA 120.264 -0.574 . . . . 0.0 111.817 -177.604 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' F' F ' 53' ' ' ALA . . . . . . . . . . . . . . . -116.63 131.45 56.95 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 115.832 -0.622 . . . . 0.0 110.108 175.839 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' F' F ' 54' ' ' TYR . . . . . . . . . . . . . 69.0 t80 -129.12 110.63 18.22 Favored Pre-proline 0 CA--C 1.534 0.352 0 CA-C-O 118.343 -0.837 . . . . 0.0 110.393 178.959 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' F' F ' 55' ' ' PRO . . . . . . . . . . . . . 73.9 Cg_endo -77.1 170.1 72.53 Favored 'Cis proline' 0 N--CA 1.499 1.831 0 CA-C-N 121.977 1.742 . . . . 0.0 112.292 -5.93 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' F' F ' 56' ' ' SER . . . . . . . . . . . . . 14.3 m -116.16 135.55 22.83 Favored Pre-proline 0 CA--C 1.54 0.571 0 CA-C-O 118.425 -0.798 . . . . 0.0 109.678 176.155 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' F' F ' 57' ' ' PRO . . . . . . . . . . . . . 56.8 Cg_endo -72.47 148.94 92.67 Favored 'Cis proline' 0 N--CA 1.496 1.651 0 CA-C-N 121.694 1.641 . . . . 0.0 111.339 -3.024 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' F' F ' 58' ' ' LEU . . . . . . . . . . . . . 37.7 tp -107.43 137.78 44.85 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-O 120.929 0.395 . . . . 0.0 110.688 -177.096 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' F' F ' 59' ' ' ARG . . . . . . . . . . . . . 61.0 ttt180 -98.92 125.81 44.44 Favored 'General case' 0 C--N 1.325 -0.457 0 CA-C-N 115.783 -0.644 . . . . 0.0 109.292 176.527 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' F' F ' 60' ' ' VAL . . . . . . . . . . . . . 42.0 t -84.34 114.87 25.45 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.246 0 C-N-CA 120.642 -0.423 . . . . 0.0 110.352 -174.975 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' F' F ' 61' ' ' GLU . . . . . . . . . . . . . 41.0 mt-10 -131.16 160.94 33.29 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 115.931 -0.577 . . . . 0.0 109.827 177.329 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' F' F ' 62' ' ' ASP . . . . . . . . . . . . . 74.4 m-20 -53.24 -32.49 48.58 Favored 'General case' 0 C--N 1.329 -0.283 0 N-CA-C 111.858 0.318 . . . . 0.0 111.858 -179.789 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' F' F ' 63' ' ' ARG . . . . . . . . . . . . . 83.1 mtp180 -72.87 -22.03 60.84 Favored 'General case' 0 CA--C 1.533 0.306 0 N-CA-C 112.913 0.708 . . . . 0.0 112.913 -177.048 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' F' F ' 64' ' ' THR . . . . . . . . . . . . . 32.5 m -69.55 142.67 53.57 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-O 120.82 0.343 . . . . 0.0 110.815 -175.455 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' F' F ' 65' ' ' LYS . . . . . . . . . . . . . 97.7 mttt -88.73 123.22 32.95 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.066 -0.515 . . . . 0.0 110.065 179.698 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' F' F ' 66' ' ' ILE . . . . . . . . . . . . . 63.0 mt -113.58 129.35 69.54 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.295 0 N-CA-C 109.702 -0.481 . . . . 0.0 109.702 -179.916 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' F' F ' 67' ' ' THR . . . . . . . . . . . . . 28.1 m -128.26 142.65 51.09 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.144 -0.48 . . . . 0.0 111.082 -177.473 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' F' F ' 68' ' ' LEU . . . . . . . . . . . . . 4.8 tt . . . . . 0 C--N 1.33 -0.272 0 CA-C-N 115.876 -0.602 . . . . 0.0 109.484 177.135 . . . . . . . . 0 0 . 1 . 014 nuclear build core ' F' F ' 73' ' ' VAL . . . . . . . . . . . . . 29.6 m . . . . . 0 N--CA 1.461 0.077 0 CA-C-O 121.203 0.525 . . . . 0.0 111.471 . . . . . . . . . 0 0 . 1 . 014 nuclear build core ' F' F ' 74' ' ' ASP . . . . . . . . . . . . . 10.0 t70 -102.96 119.32 38.64 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 115.441 -0.8 . . . . 0.0 109.503 175.898 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' F' F ' 75' ' ' VAL . . . . . . . . . . . . . 44.9 t -111.13 123.89 67.43 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.217 0 CA-C-O 121.15 0.5 . . . . 0.0 110.556 -177.347 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' F' F ' 76' ' ' LEU . . . . . . . . . . . . . 25.9 mt -125.93 147.37 49.51 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 115.561 -0.745 . . . . 0.0 109.615 178.546 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' F' F ' 77' ' ' GLU . . . . . . . . . . . . . 98.4 mt-10 -136.24 135.6 39.18 Favored 'General case' 0 C--N 1.331 -0.204 0 CA-C-O 121.134 0.493 . . . . 0.0 111.457 -177.318 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' F' F ' 78' ' ' ALA . . . . . 0.658 ' HB2' HD21 ' F' ' 109' ' ' LEU . . . -123.34 129.2 50.98 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 115.493 -0.776 . . . . 0.0 109.699 176.14 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' F' F ' 79' ' ' LYS . . . . . 0.566 ' O ' HD13 ' F' ' 80' ' ' ILE . 96.8 mttt -76.88 119.23 20.36 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-O 120.915 0.388 . . . . 0.0 110.836 -178.585 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' F' F ' 80' ' ' ILE . . . . . 0.566 HD13 ' O ' ' F' ' 79' ' ' LYS . 42.6 mm -139.09 116.68 11.64 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.326 0 N-CA-C 108.781 -0.822 . . . . 0.0 108.781 -178.186 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' F' F ' 81' ' ' LYS . . . . . . . . . . . . . 17.6 ptpt -105.96 127.72 53.34 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-O 121.303 0.573 . . . . 0.0 111.323 -175.696 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' F' F ' 82' ' ' GLY . . . . . . . . . . . . . . . 88.75 42.17 5.8 Favored Glycine 0 CA--C 1.525 0.684 0 CA-C-N 115.725 -0.67 . . . . 0.0 111.838 173.795 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' F' F ' 83' ' ' ILE . . . . . . . . . . . . . 74.6 mt -69.88 140.91 17.86 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.292 0 CA-C-O 121.043 0.449 . . . . 0.0 110.053 179.021 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' F' F ' 84' ' ' LYS . . . . . . . . . . . . . 67.5 tttt -99.75 -53.98 3.04 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 115.868 -0.605 . . . . 0.0 110.204 -178.869 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' F' F ' 85' ' ' ASP . . . . . . . . . . . . . 5.6 t70 -155.38 155.78 34.23 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 115.817 -0.629 . . . . 0.0 110.134 -179.021 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' F' F ' 86' ' ' VAL . . . . . . . . . . . . . 44.3 t -135.6 135.66 51.18 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.238 0 CA-C-O 121.038 0.447 . . . . 0.0 110.806 -178.135 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' F' F ' 87' ' ' ILE . . . . . . . . . . . . . 44.2 mm -119.38 128.5 75.85 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.199 0 CA-C-N 115.708 -0.678 . . . . 0.0 109.466 176.139 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' F' F ' 88' ' ' LEU . . . . . 0.406 HD13 HG21 ' E' ' 131' ' ' VAL . 24.0 tp -111.98 131.51 55.35 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-O 120.89 0.376 . . . . 0.0 110.996 -177.803 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' F' F ' 89' ' ' ASP . . . . . . . . . . . . . 10.0 t70 -126.09 154.05 43.63 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 116.036 -0.529 . . . . 0.0 109.597 176.39 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' F' F ' 90' ' ' GLU . . . . . . . . . . . . . 46.5 tp10 -47.29 -38.36 12.43 Favored 'General case' 0 C--N 1.33 -0.253 0 N-CA-C 112.794 0.665 . . . . 0.0 112.794 -172.394 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' F' F ' 91' ' ' ASN . . . . . . . . . . . . . 15.0 t-20 -132.06 33.34 3.92 Favored 'General case' 0 N--CA 1.466 0.353 0 C-N-CA 120.883 -0.327 . . . . 0.0 111.855 -175.889 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' F' F ' 92' ' ' LEU . . . . . . . . . . . . . 10.1 tp -166.12 148.31 7.01 Favored 'General case' 0 C--N 1.332 -0.169 0 C-N-CA 120.705 -0.398 . . . . 0.0 111.043 179.205 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' F' F ' 93' ' ' ILE . . . . . . . . . . . . . 67.4 mt -125.55 124.49 66.9 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.211 0 N-CA-C 109.588 -0.523 . . . . 0.0 109.588 -179.883 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' F' F ' 94' ' ' VAL . . . . . . . . . . . . . 43.7 t -122.27 126.57 74.45 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.186 0 N-CA-C 109.91 -0.404 . . . . 0.0 109.91 179.466 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' F' F ' 95' ' ' VAL . . . . . . . . . . . . . 46.3 t -123.59 135.0 64.81 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.175 0 CA-C-N 116.338 -0.392 . . . . 0.0 110.103 -179.175 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' F' F ' 96' ' ' ILE . . . . . . . . . . . . . 65.1 mt -116.48 130.64 70.95 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.265 0 N-CA-C 109.38 -0.6 . . . . 0.0 109.38 178.606 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' F' F ' 97' ' ' THR . . . . . . . . . . . . . 81.5 p -101.3 159.86 14.9 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-O 121.039 0.447 . . . . 0.0 111.19 -179.154 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' F' F ' 98' ' ' GLU . . . . . . . . . . . . . 45.1 mt-10 -54.35 -26.32 29.31 Favored 'General case' 0 C--N 1.328 -0.359 0 N-CA-C 112.257 0.465 . . . . 0.0 112.257 -179.497 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' F' F ' 99' ' ' GLU . . . . . . . . . . . . . 14.3 mm-40 -78.53 14.86 1.14 Allowed 'General case' 0 CA--C 1.535 0.366 0 N-CA-C 113.183 0.808 . . . . 0.0 113.183 -178.012 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' F' F ' 100' ' ' ASN . . . . . . . . . . . . . 7.6 m-20 60.13 37.46 20.85 Favored 'General case' 0 CA--C 1.529 0.138 0 CA-C-O 121.019 0.437 . . . . 0.0 111.091 -179.845 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' F' F ' 101' ' ' GLU . . . . . . . . . . . . . 84.7 tt0 -112.04 141.03 46.22 Favored 'General case' 0 C--N 1.331 -0.223 0 CA-C-N 116.023 -0.535 . . . . 0.0 109.659 174.09 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' F' F ' 102' ' ' VAL . . . . . . . . . . . . . 42.8 t -114.98 127.8 72.39 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.293 0 N-CA-C 109.9 -0.408 . . . . 0.0 109.9 -178.848 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' F' F ' 103' ' ' LEU . . . . . 0.488 HD12 ' N ' ' F' ' 103' ' ' LEU . 6.4 mp -117.6 134.48 54.83 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 115.668 -0.696 . . . . 0.0 110.164 176.739 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' F' F ' 104' ' ' ILE . . . . . . . . . . . . . 66.2 mt -117.37 123.87 72.32 Favored 'Isoleucine or valine' 0 C--O 1.233 0.211 0 CA-C-N 116.267 -0.424 . . . . 0.0 109.957 -179.601 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' F' F ' 105' ' ' PHE . . . . . . . . . . . . . 92.3 m-85 -123.25 161.36 24.72 Favored 'General case' 0 C--N 1.332 -0.184 0 O-C-N 123.992 0.808 . . . . 0.0 109.97 -179.548 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' F' F ' 106' ' ' ASN . . . . . . . . . . . . . 44.3 p-10 -99.42 -171.74 2.13 Favored 'General case' 0 C--N 1.33 -0.277 0 N-CA-C 110.209 -0.293 . . . . 0.0 110.209 175.266 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' F' F ' 107' ' ' GLN . . . . . . . . . . . . . 50.7 tt0 -58.87 -28.21 65.92 Favored 'General case' 0 C--N 1.329 -0.316 0 N-CA-C 112.176 0.436 . . . . 0.0 112.176 179.7 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' F' F ' 108' ' ' ASN . . . . . . . . . . . . . 2.7 t-20 -85.63 7.75 22.11 Favored 'General case' 0 CA--C 1.538 0.486 0 N-CA-C 113.252 0.834 . . . . 0.0 113.252 -176.857 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' F' F ' 109' ' ' LEU . . . . . 0.658 HD21 ' HB2' ' F' ' 78' ' ' ALA . 11.7 tp 59.94 38.13 21.15 Favored 'General case' 0 CA--C 1.53 0.181 0 CA-C-O 121.086 0.47 . . . . 0.0 111.166 178.984 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' F' F ' 110' ' ' GLU . . . . . . . . . . . . . 95.7 mt-10 -108.22 148.76 29.5 Favored 'General case' 0 C--N 1.33 -0.267 0 N-CA-C 109.73 -0.47 . . . . 0.0 109.73 175.274 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' F' F ' 111' ' ' GLU . . . . . . . . . . . . . 60.0 tt0 -83.51 121.88 27.8 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-O 120.774 0.321 . . . . 0.0 110.725 -175.763 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' F' F ' 112' ' ' LEU . . . . . . . . . . . . . 27.7 mt -106.92 -46.05 4.03 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.1 -0.5 . . . . 0.0 110.814 179.673 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' F' F ' 113' ' ' TYR . . . . . . . . . . . . . 60.1 t80 -134.86 141.88 46.47 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 116.437 -0.347 . . . . 0.0 111.229 -178.227 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' F' F ' 114' ' ' ARG . . . . . . . . . . . . . 36.9 ptt180 -146.61 121.05 9.66 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.738 178.12 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' F' F ' 115' ' ' GLY . . . . . . . . . . . . . . . -150.12 149.75 21.69 Favored Glycine 0 CA--C 1.526 0.744 0 N-CA-C 111.203 -0.759 . . . . 0.0 111.203 178.332 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' F' F ' 116' ' ' LYS . . . . . . . . . . . . . 35.1 ttmt -115.35 136.77 52.75 Favored 'General case' 0 C--N 1.331 -0.233 0 N-CA-C 110.133 -0.321 . . . . 0.0 110.133 176.678 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' F' F ' 117' ' ' PHE . . . . . . . . . . . . . 44.1 m-85 -132.35 114.52 14.48 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-O 120.974 0.416 . . . . 0.0 110.137 -177.344 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' F' F ' 118' ' ' GLU . . . . . . . . . . . . . 96.2 mt-10 -53.97 -46.94 71.8 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.336 -0.393 . . . . 0.0 111.427 -175.775 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' F' F ' 119' ' ' ASN . . . . . . . . . . . . . 28.6 m120 -94.43 31.06 1.81 Allowed 'General case' 0 C--N 1.328 -0.342 0 N-CA-C 112.165 0.432 . . . . 0.0 112.165 -174.334 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' F' F ' 120' ' ' LEU . . . . . . . . . . . . . 16.0 tp -57.35 119.98 7.39 Favored 'General case' 0 C--N 1.332 -0.169 0 N-CA-C 110.175 -0.305 . . . . 0.0 110.175 177.657 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' F' F ' 121' ' ' ASN . . . . . . . . . . . . . 81.2 m-20 -114.1 -44.08 3.17 Favored 'General case' 0 C--O 1.233 0.223 0 CA-C-N 116.365 -0.379 . . . . 0.0 111.026 -178.419 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' F' F ' 122' ' ' LYS . . . . . . . . . . . . . 98.4 mttt -145.77 149.55 34.57 Favored 'General case' 0 C--N 1.333 -0.128 0 CA-C-O 121.092 0.472 . . . . 0.0 111.856 -178.319 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' F' F ' 123' ' ' VAL . . . . . . . . . . . . . 46.8 t -124.92 126.66 71.64 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.211 0 CA-C-N 115.694 -0.684 . . . . 0.0 109.497 175.043 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' F' F ' 124' ' ' LEU . . . . . 0.42 HD12 ' N ' ' F' ' 124' ' ' LEU . 6.2 mp -117.88 133.94 55.43 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.473 -0.331 . . . . 0.0 110.434 -179.314 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' F' F ' 125' ' ' VAL . . . . . . . . . . . . . 12.0 p -133.77 135.91 54.74 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.285 0 CA-C-N 116.233 -0.44 . . . . 0.0 110.522 -179.875 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' F' F ' 126' ' ' ARG . . . . . . . . . . . . . 95.9 mtt-85 -143.31 116.88 9.17 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.115 -0.493 . . . . 0.0 110.267 177.716 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' F' F ' 127' ' ' ASN . . . . . . . . . . . . . 64.3 t30 52.56 -104.98 0.21 Allowed 'General case' 0 CA--C 1.544 0.744 0 CA-C-O 118.986 -0.53 . . . . 0.0 111.357 179.74 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' F' F ' 128' ' ' ASP . . . . . . . . . . . . . 8.6 p-10 -114.08 4.43 15.64 Favored 'General case' 0 CA--C 1.537 0.463 0 CA-C-N 119.526 1.057 . . . . 0.0 113.547 -176.623 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' F' F ' 129' ' ' LEU . . . . . . . . . . . . . 14.6 tp -107.37 139.0 42.53 Favored 'General case' 0 C--N 1.332 -0.173 0 CA-C-N 118.207 0.458 . . . . 0.0 110.292 179.693 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' F' F ' 130' ' ' VAL . . . . . . . . . . . . . 41.3 t -126.71 137.14 58.73 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.233 0 CA-C-O 120.942 0.401 . . . . 0.0 110.424 -178.339 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' F' F ' 131' ' ' VAL . . . . . . . . . . . . . 43.0 t -136.02 136.46 49.63 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.271 0 CA-C-N 116.239 -0.437 . . . . 0.0 110.198 176.916 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' F' F ' 132' ' ' ILE . . . . . . . . . . . . . 77.5 mt -116.57 133.16 64.07 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.257 0 CA-C-N 115.908 -0.587 . . . . 0.0 109.605 -179.071 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' F' F ' 133' ' ' ILE . . . . . . . . . . . . . 41.2 mm -116.53 125.26 73.44 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.249 0 CA-C-N 116.377 -0.374 . . . . 0.0 111.112 -174.66 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' F' F ' 134' ' ' ASP . . . . . . . . . . . . . 11.7 p-10 -139.02 151.6 46.94 Favored 'General case' 0 C--N 1.333 -0.135 0 CA-C-N 116.198 -0.455 . . . . 0.0 109.912 174.037 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' F' F ' 135' ' ' GLU . . . . . . . . . . . . . 84.8 tt0 -50.82 -27.94 8.39 Favored 'General case' 0 C--N 1.33 -0.267 0 N-CA-C 112.862 0.69 . . . . 0.0 112.862 -172.513 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' F' F ' 136' ' ' GLN . . . . . . . . . . . . . 96.9 mt-30 -84.9 -30.02 24.73 Favored 'General case' 0 C--N 1.329 -0.291 0 N-CA-C 112.63 0.604 . . . . 0.0 112.63 -174.663 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' F' F ' 137' ' ' LYS . . . . . . . . . . . . . 56.7 pttt -169.08 173.16 7.01 Favored 'General case' 0 C--O 1.233 0.212 0 CA-C-O 121.683 0.754 . . . . 0.0 112.672 -170.267 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' F' F ' 138' ' ' LEU . . . . . 0.46 HD23 ' N ' ' F' ' 139' ' ' THR . 4.7 tt -121.73 128.9 52.29 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 114.77 -1.105 . . . . 0.0 109.673 178.862 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' F' F ' 139' ' ' THR . . . . . 0.46 ' N ' HD23 ' F' ' 138' ' ' LEU . 42.1 m -111.71 126.09 54.67 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.443 -0.344 . . . . 0.0 110.146 179.402 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' F' F ' 140' ' ' LEU . . . . . 0.471 HD23 ' C ' ' F' ' 140' ' ' LEU . 6.3 tt -113.0 124.14 51.94 Favored 'General case' 0 C--N 1.329 -0.291 0 N-CA-C 109.579 -0.526 . . . . 0.0 109.579 -178.625 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' F' F ' 141' ' ' ILE . . . . . 0.433 ' N ' HD23 ' F' ' 140' ' ' LEU . 19.4 mt -122.55 120.42 60.91 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.309 0 CA-C-O 121.014 0.435 . . . . 0.0 110.049 -175.128 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' F' F ' 142' ' ' ARG . . . . . . . . . . . . . 67.7 ttt180 -111.4 126.97 55.5 Favored 'General case' 0 C--N 1.332 -0.17 0 CA-C-N 115.376 -0.829 . . . . 0.0 110.492 -177.114 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' F' F ' 143' ' ' THR . . . . . . . . . . . . . 56.0 p . . . . . 0 C--O 1.219 -0.52 0 CA-C-O 118.12 -0.943 . . . . 0.0 110.623 179.921 . . . . . . . . 0 0 . 1 . 015 nuclear build core ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 40.9 p . . . . . 0 C--O 1.232 0.165 0 CA-C-O 120.84 0.352 . . . . 0.0 110.384 . . . . . . . . . 0 0 . 1 . 015 nuclear build core ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 95.2 mt-10 -141.32 140.56 33.83 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.194 -0.457 . . . . 0.0 111.355 -177.861 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 4' ' ' LEU . . . . . . . . . . . . . 75.9 mt -121.82 128.38 51.6 Favored 'General case' 0 C--O 1.233 0.226 0 CA-C-N 115.951 -0.568 . . . . 0.0 110.17 174.884 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 5' ' ' LYS . . . . . . . . . . . . . 68.5 mttm -107.55 122.15 46.09 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.451 -0.341 . . . . 0.0 110.259 177.769 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 6' ' ' LEU . . . . . 0.422 HD23 ' HA ' ' A' ' 50' ' ' VAL . 70.5 mt -118.14 144.29 45.8 Favored 'General case' 0 C--N 1.331 -0.224 0 CA-C-N 115.769 -0.65 . . . . 0.0 110.287 -179.105 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 59.3 tttm -121.64 135.13 24.89 Favored Pre-proline 0 CA--C 1.534 0.363 0 CA-C-O 118.675 -0.679 . . . . 0.0 109.603 175.475 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 8' ' ' PRO . . . . . . . . . . . . . 84.9 Cg_endo -90.04 131.79 1.86 Allowed 'Trans proline' 0 N--CA 1.488 1.176 0 C-N-CA 121.605 1.537 . . . . 0.0 111.735 178.054 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 28.2 mt -73.65 -47.4 7.06 Favored Pre-proline 0 CA--C 1.535 0.384 0 CA-C-O 118.604 -0.712 . . . . 0.0 111.972 -179.072 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 95.5 Cg_endo -79.76 151.04 21.66 Favored 'Trans proline' 0 N--CA 1.497 1.697 0 C-N-CA 121.056 1.171 . . . . 0.0 111.873 176.049 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 19.2 ttpp -85.65 107.06 17.37 Favored 'General case' 0 C--N 1.33 -0.27 0 C-N-CA 120.885 -0.326 . . . . 0.0 110.31 178.895 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 12.0 p -149.22 147.68 16.34 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.323 0 CA-C-N 116.352 -0.385 . . . . 0.0 110.805 -179.153 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 94.7 mt-10 -95.75 110.05 22.26 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.087 -0.506 . . . . 0.0 109.668 175.843 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 14' ' ' LEU . . . . . . . . . . . . . 51.2 mt -86.54 148.78 47.39 Favored Pre-proline 0 CA--C 1.533 0.307 0 CA-C-O 119.303 -0.379 . . . . 0.0 110.481 -176.793 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 15' ' ' PRO . . . . . . . . . . . . . 28.6 Cg_exo -61.03 159.57 29.28 Favored 'Trans proline' 0 N--CA 1.497 1.685 0 C-N-CA 121.269 1.313 . . . . 0.0 111.738 177.263 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 16' ' ' PRO . . . . . . . . . . . . . 32.7 Cg_exo -59.75 -35.89 93.14 Favored 'Trans proline' 0 N--CA 1.498 1.74 0 C-N-CA 121.374 1.383 . . . . 0.0 112.692 -178.736 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 17' ' ' ASP . . . . . . . . . . . . . 8.5 p-10 -84.03 4.85 28.14 Favored 'General case' 0 CA--C 1.536 0.423 0 N-CA-C 113.26 0.837 . . . . 0.0 113.26 -177.959 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 18' ' ' PHE . . . . . . . . . . . . . 40.2 t80 -58.47 -46.03 87.43 Favored 'General case' 0 N--CA 1.456 -0.145 0 O-C-N 121.912 -0.493 . . . . 0.0 109.978 -178.699 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 19' ' ' VAL . . . . . . . . . . . . . 47.9 t -57.12 -41.22 77.3 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.368 0 CA-C-N 116.236 -0.438 . . . . 0.0 110.479 -177.743 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 74.9 m-20 -60.34 -45.16 94.43 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-O 120.756 0.313 . . . . 0.0 111.043 -177.356 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 46.5 t -64.98 -46.46 91.52 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.276 0 C-N-CA 120.692 -0.403 . . . . 0.0 110.436 -177.761 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 22' ' ' ILE . . . . . . . . . . . . . 51.6 mm -57.32 -42.36 80.16 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.218 0 CA-C-O 120.899 0.38 . . . . 0.0 110.362 178.389 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 23' ' ' ARG . . . . . . . . . . . . . 59.7 ttp180 -53.71 -49.17 68.67 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-O 120.794 0.33 . . . . 0.0 111.278 -179.223 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 24' ' ' ILE . . . . . . . . . . . . . 70.2 mt -60.67 -41.48 88.33 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.255 0 CA-C-N 116.497 -0.32 . . . . 0.0 110.935 -179.488 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 52.9 mmtt -63.15 -37.4 87.07 Favored 'General case' 0 C--N 1.329 -0.314 0 N-CA-C 112.073 0.397 . . . . 0.0 112.073 179.239 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 58.9 mt -79.06 -42.4 26.51 Favored 'General case' 0 C--N 1.329 -0.297 0 N-CA-C 113.347 0.869 . . . . 0.0 113.347 -172.125 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 27' ' ' GLN . . . . . . . . . . . . . 10.3 pt20 -47.37 140.68 5.42 Favored 'General case' 0 N--CA 1.47 0.545 0 N-CA-C 112.716 0.636 . . . . 0.0 112.716 -174.735 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 98.09 -25.21 28.55 Favored Glycine 0 CA--C 1.532 1.147 0 CA-C-N 115.541 -0.754 . . . . 0.0 112.398 -178.627 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 69.1 mttm -97.73 155.11 17.17 Favored 'General case' 0 C--N 1.332 -0.181 0 CA-C-N 117.397 0.598 . . . . 0.0 110.81 179.375 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 30' ' ' THR . . . . . . . . . . . . . 33.1 m -102.96 137.53 41.03 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.242 -0.435 . . . . 0.0 110.076 177.297 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 35.0 m -126.67 151.4 33.28 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.251 0 CA-C-N 116.325 -0.398 . . . . 0.0 110.97 -178.998 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 32' ' ' ARG . . . . . . . . . . . . . 62.0 mtt85 -133.26 148.71 51.97 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 115.665 -0.698 . . . . 0.0 110.202 176.645 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 33' ' ' THR . . . . . . . . . . . . . 21.5 m -53.4 138.24 33.59 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-O 120.86 0.362 . . . . 0.0 111.372 -177.644 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 101.0 -17.05 56.79 Favored Glycine 0 CA--C 1.533 1.165 0 CA-C-O 119.656 -0.525 . . . . 0.0 113.359 178.587 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 80.3 m-20 -66.5 150.03 49.57 Favored 'General case' 0 N--CA 1.463 0.202 0 CA-C-N 118.043 0.922 . . . . 0.0 111.359 179.592 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 46.2 t -122.58 129.59 75.11 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.236 0 CA-C-N 116.029 -0.532 . . . . 0.0 109.852 177.524 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 37' ' ' ILE . . . . . . . . . . . . . 62.1 mt -122.08 139.83 47.87 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.235 0 CA-C-N 116.228 -0.442 . . . . 0.0 109.962 -178.495 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . -117.01 128.3 7.82 Favored Glycine 0 CA--C 1.524 0.605 0 N-CA-C 110.89 -0.884 . . . . 0.0 110.89 178.284 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 39' ' ' ILE . . . . . . . . . . . . . 75.6 mt -127.25 132.46 69.58 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.29 0 CA-C-O 120.765 0.317 . . . . 0.0 110.199 179.754 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 40' ' ' SER . . . . . . . . . . . . . 13.0 t -93.04 122.18 35.14 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.304 -0.407 . . . . 0.0 110.923 176.419 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 41' ' ' ILE . . . . . 0.492 HD12 ' N ' ' A' ' 41' ' ' ILE . 5.1 mp -128.72 120.83 53.37 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.232 0 N-CA-C 109.902 -0.407 . . . . 0.0 109.902 176.728 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 6.8 mp 56.62 35.42 26.07 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-O 121.088 0.47 . . . . 0.0 111.203 -179.704 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . 80.14 -10.14 43.27 Favored Glycine 0 CA--C 1.533 1.198 0 C-N-CA 121.255 -0.498 . . . . 0.0 113.538 176.169 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 44' ' ' LYS . . . . . . . . . . . . . 61.7 mttp -99.68 131.25 45.79 Favored 'General case' 0 C--O 1.23 0.049 0 CA-C-N 117.891 0.846 . . . . 0.0 110.207 178.419 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 83.0 tt0 -85.57 131.06 34.43 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.371 -0.377 . . . . 0.0 111.301 -178.989 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 46' ' ' VAL . . . . . 0.405 ' O ' HG13 ' A' ' 46' ' ' VAL . 10.0 p -123.09 125.06 71.51 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.167 0 N-CA-C 109.565 -0.531 . . . . 0.0 109.565 173.786 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 66.6 mttm -99.28 127.07 45.23 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.133 -0.485 . . . . 0.0 111.042 177.856 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 48' ' ' PHE . . . . . . . . . . . . . 39.4 m-85 -112.68 131.81 55.47 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 115.918 -0.583 . . . . 0.0 110.004 178.656 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 77.8 tttt -106.4 132.36 52.52 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.471 -0.331 . . . . 0.0 110.231 178.204 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 50' ' ' VAL . . . . . 0.422 ' HA ' HD23 ' A' ' 6' ' ' LEU . 45.3 t -75.63 105.16 4.34 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.244 0 N-CA-C 109.401 -0.592 . . . . 0.0 109.401 178.002 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 51' ' ' VAL . . . . . . . . . . . . . 48.5 t -69.73 -49.64 56.29 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 N-CA-C 109.751 -0.463 . . . . 0.0 109.751 -175.035 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 52' ' ' GLN . . . . . . . . . . . . . 62.7 tt0 -167.01 147.42 5.61 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 115.971 -0.559 . . . . 0.0 111.498 -178.718 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -123.11 134.99 54.19 Favored 'General case' 0 C--N 1.332 -0.19 0 CA-C-N 116.035 -0.53 . . . . 0.0 109.972 176.884 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 54' ' ' TYR . . . . . . . . . . . . . 64.0 t80 -129.11 113.88 18.58 Favored Pre-proline 0 CA--C 1.535 0.375 0 CA-C-O 118.103 -0.951 . . . . 0.0 110.246 178.443 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 55' ' ' PRO . . . . . . . . . . . . . 72.8 Cg_endo -77.16 170.15 72.31 Favored 'Cis proline' 0 N--CA 1.501 1.956 0 CA-C-N 122.154 1.805 . . . . 0.0 111.842 -8.476 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 56' ' ' SER . . . . . . . . . . . . . 14.7 m -123.67 141.91 37.8 Favored Pre-proline 0 CA--C 1.538 0.51 0 CA-C-O 118.755 -0.641 . . . . 0.0 109.81 175.483 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 57' ' ' PRO . . . . . . . . . . . . . 37.1 Cg_endo -67.27 158.39 82.78 Favored 'Cis proline' 0 N--CA 1.5 1.892 0 CA-C-N 121.466 1.559 . . . . 0.0 111.179 -5.023 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 58' ' ' LEU . . . . . . . . . . . . . 27.9 tp -128.44 137.19 51.71 Favored 'General case' 0 C--N 1.331 -0.223 0 CA-C-O 120.833 0.349 . . . . 0.0 110.808 -178.201 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 59' ' ' ARG . . . . . . . . . . . . . 57.2 ttp180 -100.34 122.92 43.88 Favored 'General case' 0 C--N 1.328 -0.357 0 N-CA-C 108.919 -0.771 . . . . 0.0 108.919 173.613 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 40.1 t -70.25 124.62 26.74 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.327 0 C-N-CA 120.718 -0.393 . . . . 0.0 110.396 -174.21 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 42.9 mt-10 -131.04 160.69 33.88 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 115.851 -0.613 . . . . 0.0 109.907 176.798 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 62' ' ' ASP . . . . . . . . . . . . . 70.6 m-20 -52.36 -31.72 35.0 Favored 'General case' 0 CA--C 1.533 0.314 0 N-CA-C 111.957 0.355 . . . . 0.0 111.957 179.137 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 63' ' ' ARG . . . . . . . . . . . . . 79.3 mtp180 -71.41 -21.74 61.95 Favored 'General case' 0 CA--C 1.532 0.281 0 N-CA-C 113.026 0.75 . . . . 0.0 113.026 -175.5 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 19.4 m -70.81 140.56 51.25 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-O 120.948 0.404 . . . . 0.0 111.288 -173.786 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 65' ' ' LYS . . . . . . . . . . . . . 97.8 mttt -89.24 136.7 32.88 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-N 115.936 -0.575 . . . . 0.0 109.972 177.407 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 66' ' ' ILE . . . . . . . . . . . . . 65.4 mt -123.02 128.8 75.27 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.264 0 N-CA-C 110.009 -0.367 . . . . 0.0 110.009 -178.575 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 67' ' ' THR . . . . . . . . . . . . . 9.3 m -124.04 144.24 49.96 Favored 'General case' 0 N--CA 1.463 0.213 0 CA-C-O 120.951 0.405 . . . . 0.0 111.421 -176.224 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 68' ' ' LEU . . . . . 0.458 HD23 ' C ' ' A' ' 68' ' ' LEU . 5.9 tt . . . . . 0 C--N 1.332 -0.158 0 CA-C-N 116.041 -0.527 . . . . 0.0 110.283 178.83 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 74' ' ' ASP . . . . . . . . . . . . . 17.9 t0 . . . . . 0 N--CA 1.457 -0.097 0 N-CA-C 109.744 -0.465 . . . . 0.0 109.744 . . . . . . . . . 0 0 . 1 . 015 nuclear build core ' A' A ' 75' ' ' VAL . . . . . 0.408 ' C ' HD12 ' A' ' 76' ' ' LEU . 40.6 t -115.75 124.48 72.21 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.311 0 CA-C-O 121.061 0.458 . . . . 0.0 110.682 -176.163 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 76' ' ' LEU . . . . . 0.408 HD12 ' C ' ' A' ' 75' ' ' VAL . 6.4 mp -122.43 142.72 50.25 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-N 115.848 -0.615 . . . . 0.0 110.007 176.358 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 77' ' ' GLU . . . . . . . . . . . . . 96.8 mt-10 -134.38 143.12 47.44 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-O 121.097 0.475 . . . . 0.0 111.242 179.739 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 78' ' ' ALA . . . . . . . . . . . . . . . -129.83 145.17 51.59 Favored 'General case' 0 C--N 1.332 -0.185 0 CA-C-N 115.712 -0.676 . . . . 0.0 109.997 176.492 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 79' ' ' LYS . . . . . 0.676 ' O ' HD13 ' A' ' 80' ' ' ILE . 33.8 mmtm -77.39 116.7 18.2 Favored 'General case' 0 C--N 1.331 -0.219 0 CA-C-N 116.374 -0.375 . . . . 0.0 110.405 179.538 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 80' ' ' ILE . . . . . 0.676 HD13 ' O ' ' A' ' 79' ' ' LYS . 35.3 mm -139.11 106.78 3.04 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.251 0 N-CA-C 109.26 -0.644 . . . . 0.0 109.26 -178.243 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 81' ' ' LYS . . . . . . . . . . . . . 38.7 tttp -109.77 130.93 55.47 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-O 120.971 0.415 . . . . 0.0 111.104 -177.135 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . 88.99 42.07 5.73 Favored Glycine 0 CA--C 1.525 0.689 0 C-N-CA 121.03 -0.605 . . . . 0.0 111.66 175.336 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 83' ' ' ILE . . . . . . . . . . . . . 67.9 mt -74.02 137.1 23.9 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.265 0 N-CA-C 110.007 -0.368 . . . . 0.0 110.007 179.307 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 84' ' ' LYS . . . . . . . . . . . . . 58.0 tttp -96.26 -52.88 3.82 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-N 116.007 -0.542 . . . . 0.0 109.875 179.035 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 85' ' ' ASP . . . . . . . . . . . . . 4.0 t70 -155.67 157.26 36.37 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 115.871 -0.604 . . . . 0.0 110.593 -179.101 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 86' ' ' VAL . . . . . . . . . . . . . 45.2 t -132.37 135.89 57.16 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.204 0 CA-C-O 120.994 0.426 . . . . 0.0 110.408 179.856 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 87' ' ' ILE . . . . . . . . . . . . . 42.3 mm -116.16 123.14 71.03 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.356 0 N-CA-C 109.161 -0.681 . . . . 0.0 109.161 176.968 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 88' ' ' LEU . . . . . . . . . . . . . 14.0 tp -109.61 130.47 55.51 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-O 121.075 0.464 . . . . 0.0 110.956 -176.597 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 89' ' ' ASP . . . . . . . . . . . . . 10.9 t70 -128.95 154.86 46.16 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-N 115.87 -0.604 . . . . 0.0 109.489 177.162 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 76.2 tt0 -48.22 -35.58 12.17 Favored 'General case' 0 C--N 1.329 -0.307 0 N-CA-C 112.808 0.669 . . . . 0.0 112.808 -172.444 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 91' ' ' ASN . . . . . . . . . . . . . 94.5 m-20 -128.43 18.3 6.4 Favored 'General case' 0 N--CA 1.469 0.487 0 N-CA-C 113.127 0.788 . . . . 0.0 113.127 -176.519 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 92' ' ' LEU . . . . . . . . . . . . . 28.5 mt -149.66 147.48 28.15 Favored 'General case' 0 C--N 1.331 -0.226 0 CA-C-O 121.0 0.429 . . . . 0.0 110.752 -177.637 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 93' ' ' ILE . . . . . . . . . . . . . 65.7 mt -127.0 113.48 32.86 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.315 0 N-CA-C 108.892 -0.781 . . . . 0.0 108.892 177.284 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 94' ' ' VAL . . . . . . . . . . . . . 45.4 t -116.08 129.42 72.5 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.241 0 N-CA-C 110.044 -0.354 . . . . 0.0 110.044 -177.93 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 95' ' ' VAL . . . . . . . . . . . . . 41.4 t -122.74 135.17 63.69 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.388 0 CA-C-N 116.111 -0.495 . . . . 0.0 110.078 -178.338 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 96' ' ' ILE . . . . . . . . . . . . . 66.0 mt -115.62 128.61 72.8 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.271 0 N-CA-C 109.364 -0.606 . . . . 0.0 109.364 178.278 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 97' ' ' THR . . . . . . . . . . . . . 79.0 p -102.43 159.51 15.36 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-O 121.132 0.492 . . . . 0.0 111.386 -177.675 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 98' ' ' GLU . . . . . . . . . . . . . 45.6 mt-10 -54.06 -25.88 23.86 Favored 'General case' 0 CA--C 1.532 0.264 0 N-CA-C 112.335 0.494 . . . . 0.0 112.335 179.736 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 99' ' ' GLU . . . . . . . . . . . . . 95.8 mt-10 -77.84 13.48 1.35 Allowed 'General case' 0 CA--C 1.535 0.37 0 N-CA-C 113.167 0.803 . . . . 0.0 113.167 -178.048 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 100' ' ' ASN . . . . . . . . . . . . . 3.3 m-20 60.87 36.59 18.93 Favored 'General case' 0 CA--C 1.529 0.173 0 CA-C-O 120.956 0.408 . . . . 0.0 110.998 -179.833 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 101' ' ' GLU . . . . . . . . . . . . . 82.9 tt0 -113.59 143.22 44.92 Favored 'General case' 0 C--N 1.332 -0.178 0 N-CA-C 109.381 -0.6 . . . . 0.0 109.381 176.348 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 102' ' ' VAL . . . . . . . . . . . . . 43.1 t -115.29 125.74 72.64 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.356 0 CA-C-O 120.909 0.385 . . . . 0.0 109.996 -177.625 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 103' ' ' LEU . . . . . . . . . . . . . 23.4 mt -114.15 130.92 56.59 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 115.518 -0.764 . . . . 0.0 109.966 176.667 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 104' ' ' ILE . . . . . 0.521 HD12 ' HB3' ' A' ' 113' ' ' TYR . 67.8 mt -119.37 118.84 58.77 Favored 'Isoleucine or valine' 0 C--O 1.234 0.27 0 N-CA-C 110.118 -0.327 . . . . 0.0 110.118 -179.846 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 105' ' ' PHE . . . . . . . . . . . . . 79.7 m-85 -117.98 164.07 15.64 Favored 'General case' 0 C--N 1.332 -0.182 0 O-C-N 123.979 0.799 . . . . 0.0 109.604 178.04 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 106' ' ' ASN . . . . . . . . . . . . . 44.2 p-10 -101.11 -170.49 1.85 Allowed 'General case' 0 C--N 1.331 -0.22 0 N-CA-C 109.992 -0.373 . . . . 0.0 109.992 173.652 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 107' ' ' GLN . . . . . . . . . . . . . 57.9 tt0 -57.43 -29.99 64.61 Favored 'General case' 0 CA--C 1.534 0.36 0 N-CA-C 111.839 0.311 . . . . 0.0 111.839 178.673 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 108' ' ' ASN . . . . . . . . . . . . . 60.3 t30 -83.94 7.42 18.37 Favored 'General case' 0 CA--C 1.536 0.434 0 N-CA-C 113.373 0.879 . . . . 0.0 113.373 -176.515 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 109' ' ' LEU . . . . . . . . . . . . . 11.2 tp 60.32 37.38 20.3 Favored 'General case' 0 CA--C 1.53 0.194 0 CA-C-O 120.955 0.407 . . . . 0.0 111.208 179.434 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 110' ' ' GLU . . . . . . . . . . . . . 70.8 mm-40 -106.88 160.95 15.13 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 116.466 -0.334 . . . . 0.0 110.169 177.85 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 111' ' ' GLU . . . . . . . . . . . . . 83.0 tt0 -85.31 122.75 29.92 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.312 -0.404 . . . . 0.0 110.801 -178.15 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 112' ' ' LEU . . . . . . . . . . . . . 17.0 mt -111.19 -46.11 3.35 Favored 'General case' 0 C--N 1.332 -0.189 0 CA-C-N 116.223 -0.444 . . . . 0.0 110.566 177.176 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 113' ' ' TYR . . . . . 0.521 ' HB3' HD12 ' A' ' 104' ' ' ILE . 46.8 t80 -141.67 139.71 33.05 Favored 'General case' 0 C--N 1.332 -0.195 0 CA-C-N 116.371 -0.377 . . . . 0.0 110.97 179.895 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 114' ' ' ARG . . . . . . . . . . . . . 58.7 ttp180 -143.09 116.02 8.81 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.068 -0.515 . . . . 0.0 110.125 178.921 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 115' ' ' GLY . . . . . . . . . . . . . . . -150.26 163.05 29.43 Favored Glycine 0 CA--C 1.525 0.678 0 N-CA-C 111.0 -0.84 . . . . 0.0 111.0 -179.506 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 116' ' ' LYS . . . . . . . . . . . . . 34.5 ttmt -128.38 137.54 51.94 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-O 120.723 0.297 . . . . 0.0 110.27 177.229 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 117' ' ' PHE . . . . . . . . . . . . . 54.4 m-85 -131.47 114.95 15.54 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.324 -0.398 . . . . 0.0 110.286 -177.007 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 118' ' ' GLU . . . . . . . . . . . . . 46.4 tp10 -53.76 -47.81 70.35 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.554 -0.294 . . . . 0.0 111.491 -176.067 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 119' ' ' ASN . . . . . . . . . . . . . 6.4 m120 -97.14 31.02 2.55 Favored 'General case' 0 C--N 1.329 -0.302 0 N-CA-C 112.088 0.403 . . . . 0.0 112.088 -174.126 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 120' ' ' LEU . . . . . 0.411 HD11 HG23 ' A' ' 132' ' ' ILE . 12.3 tp -56.63 122.22 11.55 Favored 'General case' 0 C--N 1.331 -0.224 0 C-N-CA 121.026 -0.27 . . . . 0.0 110.496 179.08 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 121' ' ' ASN . . . . . . . . . . . . . 29.2 m120 -112.78 -44.01 3.37 Favored 'General case' 0 C--O 1.232 0.157 0 CA-C-N 116.564 -0.289 . . . . 0.0 111.115 -177.299 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 122' ' ' LYS . . . . . . . . . . . . . 96.1 mttt -146.42 149.17 33.2 Favored 'General case' 0 C--N 1.331 -0.218 0 CA-C-O 120.996 0.427 . . . . 0.0 111.725 -179.544 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 123' ' ' VAL . . . . . . . . . . . . . 44.5 t -126.87 123.48 62.77 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.327 0 N-CA-C 108.971 -0.752 . . . . 0.0 108.971 171.628 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 124' ' ' LEU . . . . . . . . . . . . . 13.6 tp -120.54 137.31 54.45 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.395 -0.366 . . . . 0.0 110.537 -175.703 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 125' ' ' VAL . . . . . . . . . . . . . 43.9 t -125.36 132.76 70.67 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.243 0 CA-C-N 116.101 -0.499 . . . . 0.0 110.27 -179.412 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 126' ' ' ARG . . . . . . . . . . . . . 40.3 mmt180 -131.77 108.06 9.19 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 115.96 -0.563 . . . . 0.0 109.933 176.686 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 127' ' ' ASN . . . . . . . . . . . . . 7.8 m120 54.12 -104.83 0.23 Allowed 'General case' 0 CA--C 1.543 0.688 0 CA-C-O 119.037 -0.506 . . . . 0.0 110.935 179.85 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 128' ' ' ASP . . . . . . . . . . . . . 7.5 p-10 -113.31 4.17 16.28 Favored 'General case' 0 N--CA 1.468 0.458 0 CA-C-N 119.575 1.08 . . . . 0.0 113.387 -176.886 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 129' ' ' LEU . . . . . . . . . . . . . 76.3 mt -104.97 139.51 39.57 Favored 'General case' 0 C--N 1.332 -0.162 0 CA-C-N 118.17 0.441 . . . . 0.0 110.051 177.412 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 130' ' ' VAL . . . . . . . . . . . . . 44.8 t -120.5 135.45 60.68 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.223 0 CA-C-N 116.271 -0.422 . . . . 0.0 110.004 -177.485 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 131' ' ' VAL . . . . . 0.428 HG22 HD12 ' A' ' 140' ' ' LEU . 42.7 t -132.6 132.53 59.94 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.29 0 CA-C-O 120.985 0.421 . . . . 0.0 109.993 177.562 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 132' ' ' ILE . . . . . 0.411 HG23 HD11 ' A' ' 120' ' ' LEU . 70.8 mt -115.3 130.76 69.31 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 N-CA-C 109.251 -0.648 . . . . 0.0 109.251 178.903 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 133' ' ' ILE . . . . . . . . . . . . . 43.1 mm -115.97 121.11 66.72 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.287 0 CA-C-N 116.305 -0.407 . . . . 0.0 110.531 -175.651 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 134' ' ' ASP . . . . . . . . . . . . . 7.1 p-10 -133.0 149.98 52.19 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.045 -0.525 . . . . 0.0 109.626 175.8 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 135' ' ' GLU . . . . . . . . . . . . . 78.7 tt0 -49.79 -25.99 3.54 Favored 'General case' 0 C--N 1.327 -0.391 0 N-CA-C 113.005 0.743 . . . . 0.0 113.005 -169.244 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 136' ' ' GLN . . . . . . . . . . . . . 87.7 mt-30 -103.95 -27.43 12.17 Favored 'General case' 0 N--CA 1.465 0.32 0 N-CA-C 112.955 0.724 . . . . 0.0 112.955 -174.745 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 137' ' ' LYS . . . . . . . . . . . . . 60.5 mtpt -140.48 152.54 45.7 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-O 121.333 0.587 . . . . 0.0 111.775 -170.227 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 138' ' ' LEU . . . . . 0.4 ' C ' HD23 ' A' ' 138' ' ' LEU . 5.1 tt -117.7 121.69 41.53 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 115.504 -0.771 . . . . 0.0 109.145 172.684 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 139' ' ' THR . . . . . . . . . . . . . 26.5 m -108.5 126.63 53.13 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.425 -0.352 . . . . 0.0 110.604 -177.242 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 140' ' ' LEU . . . . . 0.428 HD12 HG22 ' A' ' 131' ' ' VAL . 12.9 tp -113.63 119.07 36.19 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 115.651 -0.704 . . . . 0.0 109.156 -179.73 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 141' ' ' ILE . . . . . . . . . . . . . 19.4 mt -119.02 120.73 64.88 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.328 0 N-CA-C 109.851 -0.426 . . . . 0.0 109.851 -174.734 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 142' ' ' ARG . . . . . . . . . . . . . 81.1 mtm180 -110.7 125.46 53.5 Favored 'General case' 0 C--N 1.331 -0.218 0 CA-C-N 115.677 -0.692 . . . . 0.0 110.203 -178.493 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 143' ' ' THR . . . . . . . . . . . . . 82.3 p . . . . . 0 C--O 1.22 -0.483 0 CA-C-O 118.04 -0.981 . . . . 0.0 110.589 -179.199 . . . . . . . . 0 0 . 1 . 015 nuclear build core ' B' B ' 2' ' ' SER . . . . . . . . . . . . . 7.0 p . . . . . 0 C--O 1.231 0.13 0 CA-C-O 120.994 0.425 . . . . 0.0 110.59 . . . . . . . . . 0 0 . 1 . 015 nuclear build core ' B' B ' 3' ' ' GLU . . . . . . . . . . . . . 92.4 mt-10 -141.74 142.02 33.26 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 115.977 -0.556 . . . . 0.0 110.821 -179.299 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' B' B ' 4' ' ' LEU . . . . . . . . . . . . . 18.6 tp -127.41 130.95 50.26 Favored 'General case' 0 C--N 1.331 -0.23 0 CA-C-N 116.37 -0.377 . . . . 0.0 110.219 176.179 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' B' B ' 5' ' ' LYS . . . . . . . . . . . . . 68.5 mttm -110.64 120.46 42.49 Favored 'General case' 0 C--N 1.331 -0.215 0 CA-C-N 116.347 -0.388 . . . . 0.0 110.581 179.393 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' B' B ' 6' ' ' LEU . . . . . . . . . . . . . 65.5 mt -114.82 147.94 39.15 Favored 'General case' 0 C--N 1.331 -0.225 0 CA-C-N 115.303 -0.862 . . . . 0.0 110.687 -178.492 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' B' B ' 7' ' ' LYS . . . . . . . . . . . . . 74.7 tttt -133.55 135.06 24.42 Favored Pre-proline 0 CA--C 1.535 0.366 0 CA-C-O 118.848 -0.596 . . . . 0.0 109.933 176.174 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' B' B ' 8' ' ' PRO . . . . . . . . . . . . . 93.9 Cg_endo -90.79 142.26 3.25 Favored 'Trans proline' 0 N--CA 1.489 1.263 0 C-N-CA 121.666 1.577 . . . . 0.0 111.721 177.579 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' B' B ' 9' ' ' LEU . . . . . . . . . . . . . 47.0 mt -81.13 -47.22 1.13 Allowed Pre-proline 0 CA--C 1.533 0.323 0 CA-C-O 118.714 -0.66 . . . . 0.0 112.258 -178.544 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' B' B ' 10' ' ' PRO . . . . . . . . . . . . . 86.5 Cg_endo -80.69 150.46 18.85 Favored 'Trans proline' 0 N--CA 1.497 1.722 0 C-N-CA 121.179 1.253 . . . . 0.0 111.879 175.17 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' B' B ' 11' ' ' LYS . . . . . . . . . . . . . 33.9 ttmt -85.65 100.04 11.7 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-O 120.879 0.371 . . . . 0.0 110.57 178.463 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' B' B ' 12' ' ' VAL . . . . . . . . . . . . . 12.1 p -143.66 138.82 25.7 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.273 0 CA-C-N 116.125 -0.489 . . . . 0.0 110.493 179.22 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' B' B ' 13' ' ' GLU . . . . . . . . . . . . . 15.0 mm-40 -74.93 129.49 37.74 Favored 'General case' 0 C--N 1.329 -0.316 0 N-CA-C 109.955 -0.387 . . . . 0.0 109.955 177.098 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' B' B ' 14' ' ' LEU . . . . . . . . . . . . . 33.2 mt -97.86 146.32 31.26 Favored Pre-proline 0 CA--C 1.533 0.304 0 CA-C-O 119.142 -0.456 . . . . 0.0 110.265 -179.379 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' B' B ' 15' ' ' PRO . . . . . . . . . . . . . 26.2 Cg_exo -61.96 160.04 31.36 Favored 'Trans proline' 0 N--CA 1.498 1.768 0 C-N-CA 121.251 1.3 . . . . 0.0 112.001 177.818 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' B' B ' 16' ' ' PRO . . . . . . . . . . . . . 27.5 Cg_exo -60.37 -35.04 92.69 Favored 'Trans proline' 0 N--CA 1.496 1.634 0 C-N-CA 121.452 1.435 . . . . 0.0 112.659 -179.446 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' B' B ' 17' ' ' ASP . . . . . . . . . . . . . 10.3 p-10 -87.61 9.49 21.07 Favored 'General case' 0 CA--C 1.535 0.399 0 N-CA-C 113.168 0.803 . . . . 0.0 113.168 -178.073 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' B' B ' 18' ' ' PHE . . . . . . . . . . . . . 28.8 t80 -57.25 -41.38 79.51 Favored 'General case' 0 CA--C 1.527 0.073 0 O-C-N 121.939 -0.476 . . . . 0.0 110.296 -178.971 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' B' B ' 19' ' ' VAL . . . . . . . . . . . . . 50.0 t -56.94 -42.73 79.28 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 CA-C-N 116.399 -0.364 . . . . 0.0 110.396 -179.983 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' B' B ' 20' ' ' ASP . . . . . 0.557 ' OD1' HD11 ' B' ' 24' ' ' ILE . 4.9 t70 -60.28 -39.68 87.76 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-O 120.849 0.357 . . . . 0.0 110.747 -178.603 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' B' B ' 21' ' ' VAL . . . . . . . . . . . . . 46.2 t -64.28 -47.99 87.37 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.314 0 C-N-CA 120.755 -0.378 . . . . 0.0 110.24 -179.316 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' B' B ' 22' ' ' ILE . . . . . 0.404 HG22 HD12 ' B' ' 26' ' ' LEU . 51.7 mm -55.59 -58.04 5.93 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.237 0 C-N-CA 120.954 -0.298 . . . . 0.0 111.171 -178.38 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' B' B ' 23' ' ' ARG . . . . . . . . . . . . . 12.0 ptm180 -55.85 -42.97 76.59 Favored 'General case' 0 CA--C 1.531 0.223 0 C-N-CA 120.527 -0.469 . . . . 0.0 111.792 -173.797 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' B' B ' 24' ' ' ILE . . . . . 0.557 HD11 ' OD1' ' B' ' 20' ' ' ASP . 75.5 mt -60.81 -44.17 96.98 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.264 0 C-N-CA 120.815 -0.354 . . . . 0.0 111.421 -177.958 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' B' B ' 25' ' ' LYS . . . . . . . . . . . . . 68.6 mttm -67.71 -42.66 81.64 Favored 'General case' 0 C--N 1.329 -0.311 0 N-CA-C 112.558 0.577 . . . . 0.0 112.558 -178.306 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' B' B ' 26' ' ' LEU . . . . . 0.404 HD12 HG22 ' B' ' 22' ' ' ILE . 29.3 mt -79.45 -35.83 39.77 Favored 'General case' 0 C--N 1.33 -0.265 0 N-CA-C 113.522 0.934 . . . . 0.0 113.522 -170.782 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' B' B ' 27' ' ' GLN . . . . . . . . . . . . . 13.9 pt20 -47.13 138.62 6.69 Favored 'General case' 0 N--CA 1.47 0.556 0 N-CA-C 112.742 0.645 . . . . 0.0 112.742 -175.502 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' B' B ' 28' ' ' GLY . . . . . . . . . . . . . . . 98.4 -23.19 37.24 Favored Glycine 0 CA--C 1.534 1.279 0 CA-C-N 115.636 -0.711 . . . . 0.0 112.386 -177.298 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' B' B ' 29' ' ' LYS . . . . . . . . . . . . . 64.6 mttp -97.64 155.1 17.14 Favored 'General case' 0 C--O 1.233 0.229 0 CA-C-N 117.382 0.591 . . . . 0.0 111.084 179.297 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' B' B ' 30' ' ' THR . . . . . . . . . . . . . 27.4 m -102.95 135.87 43.82 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.119 -0.491 . . . . 0.0 109.87 175.565 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' B' B ' 31' ' ' VAL . . . . . . . . . . . . . 34.9 m -128.48 153.85 38.51 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.212 0 CA-C-O 120.928 0.394 . . . . 0.0 110.706 -178.161 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' B' B ' 32' ' ' ARG . . . . . . . . . . . . . 91.8 mtm-85 -132.68 147.71 52.33 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-O 121.283 0.563 . . . . 0.0 110.883 179.868 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' B' B ' 33' ' ' THR . . . . . . . . . . . . . 26.4 m -53.23 140.18 27.19 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.127 -0.488 . . . . 0.0 111.344 -177.971 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' B' B ' 34' ' ' GLY . . . . . . . . . . . . . . . 100.15 -17.09 57.55 Favored Glycine 0 CA--C 1.533 1.166 0 CA-C-O 119.608 -0.551 . . . . 0.0 113.22 179.574 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' B' B ' 35' ' ' ASP . . . . . . . . . . . . . 76.9 m-20 -65.19 148.92 50.82 Favored 'General case' 0 C--N 1.333 -0.109 0 CA-C-N 118.037 0.918 . . . . 0.0 111.08 178.924 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' B' B ' 36' ' ' VAL . . . . . . . . . . . . . 46.8 t -120.53 129.95 75.02 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.275 0 CA-C-N 115.83 -0.623 . . . . 0.0 109.625 177.337 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' B' B ' 37' ' ' ILE . . . . . . . . . . . . . 70.0 mt -118.8 138.93 47.91 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.274 0 CA-C-N 116.137 -0.483 . . . . 0.0 109.867 -178.242 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' B' B ' 38' ' ' GLY . . . . . . . . . . . . . . . -115.36 128.88 8.28 Favored Glycine 0 CA--C 1.525 0.707 0 N-CA-C 110.915 -0.874 . . . . 0.0 110.915 179.596 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' B' B ' 39' ' ' ILE . . . . . . . . . . . . . 76.2 mt -125.09 137.0 59.07 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.28 0 N-CA-C 110.195 -0.298 . . . . 0.0 110.195 -179.839 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' B' B ' 40' ' ' SER . . . . . . . . . . . . . 32.0 t -93.12 122.94 36.02 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.346 -0.388 . . . . 0.0 110.726 175.181 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' B' B ' 41' ' ' ILE . . . . . . . . . . . . . 71.4 mt -129.19 118.33 45.98 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.226 0 CA-C-O 120.929 0.395 . . . . 0.0 110.344 178.367 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' B' B ' 42' ' ' LEU . . . . . 0.541 ' O ' HD23 ' B' ' 42' ' ' LEU . 1.3 tt 50.68 45.27 27.16 Favored 'General case' 0 N--CA 1.465 0.288 0 CA-C-O 121.421 0.629 . . . . 0.0 111.047 176.621 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' B' B ' 43' ' ' GLY . . . . . . . . . . . . . . . 70.43 24.7 76.56 Favored Glycine 0 CA--C 1.531 1.064 0 C-N-CA 121.093 -0.575 . . . . 0.0 112.585 175.433 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' B' B ' 44' ' ' LYS . . . . . . . . . . . . . 35.5 ttpt -136.57 133.43 36.38 Favored 'General case' 0 C--N 1.333 -0.145 0 CA-C-N 117.438 0.619 . . . . 0.0 110.213 179.672 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' B' B ' 45' ' ' GLU . . . . . . . . . . . . . 68.0 tt0 -84.08 127.8 34.14 Favored 'General case' 0 C--N 1.326 -0.419 0 CA-C-N 116.437 -0.347 . . . . 0.0 111.203 -177.096 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' B' B ' 46' ' ' VAL . . . . . . . . . . . . . 7.5 p -125.51 128.38 72.42 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.2 0 CA-C-O 121.138 0.494 . . . . 0.0 109.837 175.88 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' B' B ' 47' ' ' LYS . . . . . . . . . . . . . 34.0 mmtp -100.29 131.78 46.03 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 115.789 -0.641 . . . . 0.0 111.457 178.417 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' B' B ' 48' ' ' PHE . . . . . . . . . . . . . 96.3 m-85 -118.04 131.98 56.41 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 115.976 -0.556 . . . . 0.0 109.812 175.313 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' B' B ' 49' ' ' LYS . . . . . . . . . . . . . 83.4 tttt -106.95 138.68 42.66 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.757 -0.202 . . . . 0.0 110.468 178.984 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' B' B ' 50' ' ' VAL . . . . . . . . . . . . . 43.4 t -84.14 108.57 16.57 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.298 0 N-CA-C 109.423 -0.584 . . . . 0.0 109.423 176.768 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' B' B ' 51' ' ' VAL . . . . . . . . . . . . . 47.1 t -73.51 -51.79 23.9 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.277 0 CA-C-N 116.022 -0.536 . . . . 0.0 109.842 -174.603 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' B' B ' 52' ' ' GLN . . . . . . . . . . . . . 88.0 mt-30 -153.89 151.45 29.48 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-N 116.06 -0.518 . . . . 0.0 111.769 -177.912 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' B' B ' 53' ' ' ALA . . . . . . . . . . . . . . . -130.85 134.61 46.96 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 115.371 -0.832 . . . . 0.0 109.651 174.468 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' B' B ' 54' ' ' TYR . . . . . . . . . . . . . 35.8 t80 -129.09 114.2 18.65 Favored Pre-proline 0 CA--C 1.535 0.366 0 CA-C-O 118.062 -0.97 . . . . 0.0 110.407 178.669 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' B' B ' 55' ' ' PRO . . . . . . . . . . . . . 74.1 Cg_endo -77.2 166.19 82.81 Favored 'Cis proline' 0 N--CA 1.5 1.875 0 CA-C-N 122.181 1.815 . . . . 0.0 112.081 -7.468 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' B' B ' 56' ' ' SER . . . . . . . . . . . . . 13.7 m -115.79 127.38 26.83 Favored Pre-proline 0 CA--C 1.538 0.502 0 CA-C-O 118.436 -0.793 . . . . 0.0 109.048 175.297 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' B' B ' 57' ' ' PRO . . . . . . . . . . . . . 44.3 Cg_endo -68.09 146.95 79.3 Favored 'Cis proline' 0 N--CA 1.498 1.75 0 CA-C-N 121.981 1.743 . . . . 0.0 111.855 2.007 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' B' B ' 58' ' ' LEU . . . . . . . . . . . . . 22.7 tp -108.31 137.1 46.85 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.158 -0.473 . . . . 0.0 110.556 -179.381 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' B' B ' 59' ' ' ARG . . . . . . . . . . . . . 23.6 ttm180 -100.91 124.85 47.22 Favored 'General case' 0 C--N 1.326 -0.434 0 N-CA-C 109.341 -0.614 . . . . 0.0 109.341 176.281 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' B' B ' 60' ' ' VAL . . . . . . . . . . . . . 40.9 t -82.68 120.16 33.56 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.281 0 C-N-CA 120.739 -0.385 . . . . 0.0 110.684 -174.374 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' B' B ' 61' ' ' GLU . . . . . . . . . . . . . 71.0 mm-40 -131.17 155.98 46.1 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 115.926 -0.579 . . . . 0.0 109.845 175.138 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' B' B ' 62' ' ' ASP . . . . . . . . . . . . . 21.6 m-20 -52.25 -33.86 43.45 Favored 'General case' 0 C--N 1.328 -0.33 0 N-CA-C 111.842 0.312 . . . . 0.0 111.842 -179.998 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' B' B ' 63' ' ' ARG . . . . . . . . . . . . . 94.6 mtt180 -73.17 -21.89 60.6 Favored 'General case' 0 CA--C 1.532 0.273 0 N-CA-C 113.05 0.759 . . . . 0.0 113.05 -176.559 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' B' B ' 64' ' ' THR . . . . . . . . . . . . . 27.1 m -62.61 143.42 57.31 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-O 120.731 0.3 . . . . 0.0 110.514 -176.983 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' B' B ' 65' ' ' LYS . . . . . . . . . . . . . 54.6 mttm -85.18 124.17 31.53 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.283 -0.417 . . . . 0.0 110.097 179.38 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' B' B ' 66' ' ' ILE . . . . . . . . . . . . . 58.2 mt -115.22 124.06 71.44 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.307 0 N-CA-C 109.646 -0.502 . . . . 0.0 109.646 -179.42 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' B' B ' 67' ' ' THR . . . . . . . . . . . . . 14.4 m -127.64 144.58 51.06 Favored 'General case' 0 C--N 1.333 -0.151 0 CA-C-O 121.01 0.433 . . . . 0.0 111.118 -176.617 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' B' B ' 68' ' ' LEU . . . . . 0.451 HD12 ' N ' ' B' ' 68' ' ' LEU . 6.5 mp . . . . . 0 C--N 1.33 -0.28 0 CA-C-N 116.132 -0.485 . . . . 0.0 110.901 178.538 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' B' B ' 73' ' ' VAL . . . . . . . . . . . . . 34.7 m . . . . . 0 C--O 1.232 0.17 0 CA-C-O 120.676 0.274 . . . . 0.0 110.83 . . . . . . . . . 0 0 . 1 . 015 nuclear build core ' B' B ' 74' ' ' ASP . . . . . . . . . . . . . 19.3 t0 -104.62 123.61 47.87 Favored 'General case' 0 C--N 1.331 -0.225 0 CA-C-N 116.389 -0.368 . . . . 0.0 110.087 -179.699 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' B' B ' 75' ' ' VAL . . . . . . . . . . . . . 42.6 t -117.44 121.72 68.24 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.221 0 CA-C-O 120.993 0.425 . . . . 0.0 110.538 -178.381 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' B' B ' 76' ' ' LEU . . . . . . . . . . . . . 5.7 mp -120.99 142.09 50.11 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 115.846 -0.615 . . . . 0.0 109.904 176.012 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' B' B ' 77' ' ' GLU . . . . . . . . . . . . . 97.5 mt-10 -133.59 134.89 43.85 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-O 121.01 0.433 . . . . 0.0 110.962 -178.991 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' B' B ' 78' ' ' ALA . . . . . 0.552 ' HB2' HD21 ' B' ' 109' ' ' LEU . . . -122.82 140.88 52.45 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 115.896 -0.593 . . . . 0.0 109.977 177.26 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' B' B ' 79' ' ' LYS . . . . . 0.687 ' O ' HD13 ' B' ' 80' ' ' ILE . 70.4 mmtt -75.0 115.86 15.09 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-O 120.972 0.415 . . . . 0.0 110.442 179.905 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' B' B ' 80' ' ' ILE . . . . . 0.687 HD13 ' O ' ' B' ' 79' ' ' LYS . 35.2 mm -139.04 105.87 2.74 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.328 0 N-CA-C 109.022 -0.733 . . . . 0.0 109.022 -178.302 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' B' B ' 81' ' ' LYS . . . . . . . . . . . . . 54.6 pttt -115.44 132.29 56.67 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-O 121.1 0.476 . . . . 0.0 111.195 -177.313 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' B' B ' 82' ' ' GLY . . . . . . . . . . . . . . . 89.07 42.09 5.71 Favored Glycine 0 CA--C 1.526 0.731 0 N-CA-C 111.135 -0.786 . . . . 0.0 111.135 179.239 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' B' B ' 83' ' ' ILE . . . . . . . . . . . . . 72.6 mt -71.55 139.27 20.1 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.293 0 CA-C-O 120.827 0.346 . . . . 0.0 110.162 -179.813 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' B' B ' 84' ' ' LYS . . . . . . . . . . . . . 15.2 ttmm -96.55 -54.07 3.37 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-O 121.179 0.514 . . . . 0.0 109.939 178.2 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' B' B ' 85' ' ' ASP . . . . . . . . . . . . . 8.9 t70 -155.44 146.41 22.45 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 115.508 -0.769 . . . . 0.0 110.125 -179.425 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' B' B ' 86' ' ' VAL . . . . . . . . . . . . . 43.6 t -124.2 129.2 74.16 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.256 0 CA-C-O 120.93 0.395 . . . . 0.0 110.249 179.888 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' B' B ' 87' ' ' ILE . . . . . . . . . . . . . 44.2 mm -118.34 124.76 73.61 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.262 0 CA-C-N 115.887 -0.597 . . . . 0.0 109.496 177.297 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' B' B ' 88' ' ' LEU . . . . . . . . . . . . . 15.3 tp -114.26 124.36 51.84 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-O 121.088 0.471 . . . . 0.0 111.238 -176.898 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' B' B ' 89' ' ' ASP . . . . . . . . . . . . . 5.7 t70 -112.44 159.61 18.58 Favored 'General case' 0 C--N 1.33 -0.24 0 N-CA-C 108.99 -0.744 . . . . 0.0 108.99 175.419 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' B' B ' 90' ' ' GLU . . . . . . . . . . . . . 94.5 mt-10 -48.28 -42.61 31.3 Favored 'General case' 0 N--CA 1.465 0.291 0 N-CA-C 112.689 0.626 . . . . 0.0 112.689 -171.479 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' B' B ' 91' ' ' ASN . . . . . . . . . . . . . 33.8 p-10 -132.2 37.06 3.58 Favored 'General case' 0 N--CA 1.464 0.251 0 N-CA-C 111.753 0.279 . . . . 0.0 111.753 -178.691 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' B' B ' 92' ' ' LEU . . . . . . . . . . . . . 15.9 tp -160.6 140.1 10.82 Favored 'General case' 0 C--N 1.331 -0.237 0 C-N-CA 120.826 -0.35 . . . . 0.0 110.667 -177.877 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' B' B ' 93' ' ' ILE . . . . . . . . . . . . . 68.2 mt -122.7 123.12 67.61 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.198 0 N-CA-C 109.679 -0.489 . . . . 0.0 109.679 -178.663 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' B' B ' 94' ' ' VAL . . . . . . . . . . . . . 46.8 t -124.46 125.77 70.8 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.243 0 N-CA-C 109.718 -0.475 . . . . 0.0 109.718 177.629 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' B' B ' 95' ' ' VAL . . . . . . . . . . . . . 44.4 t -122.3 133.44 68.56 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.341 0 CA-C-N 116.022 -0.536 . . . . 0.0 109.789 -179.178 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' B' B ' 96' ' ' ILE . . . . . 0.405 HD11 ' HB ' ' B' ' 123' ' ' VAL . 51.7 mt -114.07 127.33 71.53 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.329 0 N-CA-C 108.782 -0.822 . . . . 0.0 108.782 178.301 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' B' B ' 97' ' ' THR . . . . . . . . . . . . . 82.7 p -99.0 153.76 18.61 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-O 121.292 0.568 . . . . 0.0 111.279 -176.85 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' B' B ' 98' ' ' GLU . . . . . . . . . . . . . 73.0 tt0 -53.97 -24.02 15.21 Favored 'General case' 0 C--N 1.325 -0.471 0 CA-C-N 115.811 -0.631 . . . . 0.0 112.166 179.322 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' B' B ' 99' ' ' GLU . . . . . . . . . . . . . 91.1 mt-10 -82.07 16.09 2.07 Favored 'General case' 0 CA--C 1.535 0.389 0 N-CA-C 113.082 0.771 . . . . 0.0 113.082 -176.981 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' B' B ' 100' ' ' ASN . . . . . . . . . . . . . 2.7 m-20 64.78 36.97 7.66 Favored 'General case' 0 CA--C 1.53 0.201 0 CA-C-O 121.001 0.429 . . . . 0.0 111.343 177.218 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' B' B ' 101' ' ' GLU . . . . . . . . . . . . . 82.7 tt0 -118.1 145.05 45.15 Favored 'General case' 0 C--N 1.331 -0.199 0 CA-C-N 116.147 -0.479 . . . . 0.0 110.031 175.294 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' B' B ' 102' ' ' VAL . . . . . . . . . . . . . 44.4 t -118.13 128.5 75.18 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.295 0 N-CA-C 110.137 -0.32 . . . . 0.0 110.137 -179.286 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' B' B ' 103' ' ' LEU . . . . . . . . . . . . . 6.1 mp -120.95 135.37 55.22 Favored 'General case' 0 C--N 1.331 -0.224 0 CA-C-N 115.94 -0.573 . . . . 0.0 110.489 177.642 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' B' B ' 104' ' ' ILE . . . . . . . . . . . . . 70.0 mt -121.82 124.74 72.11 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.276 0 CA-C-N 116.509 -0.314 . . . . 0.0 110.454 -179.848 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' B' B ' 105' ' ' PHE . . . . . . . . . . . . . 62.8 m-85 -123.23 166.0 15.98 Favored 'General case' 0 C--O 1.232 0.134 0 O-C-N 124.033 0.833 . . . . 0.0 109.873 -179.534 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' B' B ' 106' ' ' ASN . . . . . . . . . . . . . 43.7 p-10 -102.52 -170.66 1.84 Allowed 'General case' 0 CA--C 1.53 0.197 0 N-CA-C 110.164 -0.309 . . . . 0.0 110.164 173.894 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' B' B ' 107' ' ' GLN . . . . . . . . . . . . . 40.4 tt0 -59.05 -30.09 67.79 Favored 'General case' 0 C--N 1.33 -0.267 0 N-CA-C 112.085 0.402 . . . . 0.0 112.085 -179.265 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' B' B ' 108' ' ' ASN . . . . . . . . . . . . . 5.3 t30 -85.53 11.03 11.42 Favored 'General case' 0 CA--C 1.536 0.412 0 N-CA-C 113.052 0.76 . . . . 0.0 113.052 -176.915 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' B' B ' 109' ' ' LEU . . . . . 0.552 HD21 ' HB2' ' B' ' 78' ' ' ALA . 9.0 tp 60.59 34.81 20.15 Favored 'General case' 0 C--N 1.331 -0.215 0 CA-C-O 120.758 0.313 . . . . 0.0 111.558 178.905 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' B' B ' 110' ' ' GLU . . . . . . . . . . . . . 95.7 mt-10 -103.01 147.02 27.47 Favored 'General case' 0 C--N 1.33 -0.258 0 N-CA-C 109.68 -0.489 . . . . 0.0 109.68 176.205 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' B' B ' 111' ' ' GLU . . . . . . . . . . . . . 55.5 tt0 -85.49 121.88 28.83 Favored 'General case' 0 C--N 1.328 -0.362 0 C-N-CA 120.831 -0.348 . . . . 0.0 110.68 -177.273 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' B' B ' 112' ' ' LEU . . . . . . . . . . . . . 37.3 mt -104.39 -46.03 4.5 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.122 -0.49 . . . . 0.0 110.88 179.151 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' B' B ' 113' ' ' TYR . . . . . 0.418 ' CE1' HG21 ' C' ' 75' ' ' VAL . 66.3 t80 -136.5 144.9 44.55 Favored 'General case' 0 N--CA 1.464 0.23 0 CA-C-O 120.969 0.414 . . . . 0.0 111.132 -179.053 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' B' B ' 114' ' ' ARG . . . . . . . . . . . . . 14.3 ptt180 -146.55 124.39 11.94 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 115.621 -0.718 . . . . 0.0 110.365 178.765 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' B' B ' 115' ' ' GLY . . . . . . . . . . . . . . . -150.16 155.26 26.14 Favored Glycine 0 CA--C 1.523 0.539 0 N-CA-C 110.908 -0.877 . . . . 0.0 110.908 -179.948 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' B' B ' 116' ' ' LYS . . . . . . . . . . . . . 19.8 ttmt -126.66 140.46 52.4 Favored 'General case' 0 C--N 1.331 -0.228 0 N-CA-C 109.638 -0.504 . . . . 0.0 109.638 178.667 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' B' B ' 117' ' ' PHE . . . . . . . . . . . . . 32.2 m-85 -138.51 114.02 9.68 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-O 120.935 0.398 . . . . 0.0 110.258 -176.35 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' B' B ' 118' ' ' GLU . . . . . . . . . . . . . 75.1 tt0 -53.42 -49.73 66.7 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 116.528 -0.306 . . . . 0.0 111.432 -176.638 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' B' B ' 119' ' ' ASN . . . . . . . . . . . . . 33.7 m120 -91.45 30.47 1.3 Allowed 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.081 -0.508 . . . . 0.0 112.213 -174.324 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' B' B ' 120' ' ' LEU . . . . . . . . . . . . . 14.2 tp -56.73 122.14 11.42 Favored 'General case' 0 C--N 1.332 -0.154 0 CA-C-O 120.666 0.27 . . . . 0.0 110.459 178.579 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' B' B ' 121' ' ' ASN . . . . . . . . . . . . . 44.8 m-20 -114.01 -44.08 3.19 Favored 'General case' 0 C--N 1.332 -0.174 0 CA-C-N 116.485 -0.325 . . . . 0.0 110.956 -176.844 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' B' B ' 122' ' ' LYS . . . . . . . . . . . . . 99.1 mttt -143.76 148.64 35.91 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-O 121.027 0.441 . . . . 0.0 111.448 -177.765 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' B' B ' 123' ' ' VAL . . . . . 0.405 ' HB ' HD11 ' B' ' 96' ' ' ILE . 45.2 t -125.0 125.85 70.21 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.292 0 CA-C-N 115.885 -0.598 . . . . 0.0 109.572 175.605 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' B' B ' 124' ' ' LEU . . . . . . . . . . . . . 28.2 mt -112.08 125.44 54.1 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 116.239 -0.437 . . . . 0.0 110.333 -179.448 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' B' B ' 125' ' ' VAL . . . . . . . . . . . . . 44.2 t -133.54 126.4 51.71 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.276 0 CA-C-N 116.495 -0.32 . . . . 0.0 110.365 -179.124 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' B' B ' 126' ' ' ARG . . . . . . . . . . . . . 69.2 ttt-85 -162.61 141.67 9.0 Favored 'General case' 0 C--N 1.329 -0.32 0 N-CA-C 109.611 -0.515 . . . . 0.0 109.611 175.094 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' B' B ' 127' ' ' ASN . . . . . . . . . . . . . 10.1 p30 48.88 -151.99 0.13 Allowed 'General case' 0 CA--C 1.54 0.563 0 CA-C-O 119.373 -0.346 . . . . 0.0 111.001 178.988 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' B' B ' 128' ' ' ASP . . . . . . . . . . . . . 13.7 p-10 -83.55 21.54 1.19 Allowed 'General case' 0 CA--C 1.533 0.307 0 CA-C-N 118.512 0.596 . . . . 0.0 112.517 179.271 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' B' B ' 129' ' ' LEU . . . . . . . . . . . . . 17.1 tp -119.66 135.23 54.9 Favored 'General case' 0 C--O 1.233 0.235 0 CA-C-O 120.969 0.414 . . . . 0.0 110.327 179.541 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' B' B ' 130' ' ' VAL . . . . . . . . . . . . . 44.6 t -128.58 135.65 61.88 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.233 0 CA-C-N 115.961 -0.563 . . . . 0.0 109.802 179.322 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' B' B ' 131' ' ' VAL . . . . . 0.44 HG22 HD12 ' B' ' 140' ' ' LEU . 43.1 t -133.82 135.59 55.05 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.285 0 CA-C-O 120.924 0.392 . . . . 0.0 110.16 179.705 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' B' B ' 132' ' ' ILE . . . . . . . . . . . . . 72.8 mt -116.22 129.76 72.1 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.327 0 N-CA-C 109.341 -0.614 . . . . 0.0 109.341 -179.958 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' B' B ' 133' ' ' ILE . . . . . . . . . . . . . 41.9 mm -116.72 120.51 65.22 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.21 0 CA-C-O 120.807 0.337 . . . . 0.0 110.859 -175.779 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' B' B ' 134' ' ' ASP . . . . . . . . . . . . . 7.7 p-10 -134.22 145.59 49.31 Favored 'General case' 0 C--N 1.33 -0.265 0 N-CA-C 109.601 -0.518 . . . . 0.0 109.601 175.11 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' B' B ' 135' ' ' GLU . . . . . . . . . . . . . 73.9 tt0 -49.96 -25.45 3.3 Favored 'General case' 0 C--N 1.329 -0.309 0 N-CA-C 112.975 0.731 . . . . 0.0 112.975 -170.578 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' B' B ' 136' ' ' GLN . . . . . . . . . . . . . 97.1 mt-30 -96.81 -31.83 12.42 Favored 'General case' 0 C--O 1.234 0.276 0 N-CA-C 112.256 0.465 . . . . 0.0 112.256 -176.291 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' B' B ' 137' ' ' LYS . . . . . . . . . . . . . 92.5 mttt -139.53 152.87 47.27 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-O 121.172 0.511 . . . . 0.0 111.48 -170.408 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' B' B ' 138' ' ' LEU . . . . . 0.469 ' C ' HD23 ' B' ' 138' ' ' LEU . 6.2 tt -119.34 119.55 34.33 Favored 'General case' 0 C--N 1.327 -0.4 0 N-CA-C 108.977 -0.749 . . . . 0.0 108.977 172.682 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' B' B ' 139' ' ' THR . . . . . . . . . . . . . 28.3 m -111.16 130.32 55.67 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-O 120.655 0.264 . . . . 0.0 110.803 -175.899 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' B' B ' 140' ' ' LEU . . . . . 0.44 HD12 HG22 ' B' ' 131' ' ' VAL . 10.6 tp -115.28 120.62 40.28 Favored 'General case' 0 C--N 1.328 -0.353 0 N-CA-C 109.299 -0.63 . . . . 0.0 109.299 -179.526 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' B' B ' 141' ' ' ILE . . . . . . . . . . . . . 19.5 mt -119.88 124.92 73.69 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.242 0 CA-C-O 121.077 0.465 . . . . 0.0 110.158 -175.044 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' B' B ' 142' ' ' ARG . . . . . . . . . . . . . 82.1 mtp180 -108.35 121.66 45.38 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 115.404 -0.816 . . . . 0.0 110.004 179.472 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' B' B ' 143' ' ' THR . . . . . . . . . . . . . 81.2 p . . . . . 0 C--O 1.219 -0.516 0 CA-C-O 117.932 -1.032 . . . . 0.0 110.747 -178.885 . . . . . . . . 0 0 . 1 . 015 nuclear build core ' C' C ' 2' ' ' SER . . . . . . . . . . . . . 8.0 p . . . . . 0 C--O 1.232 0.179 0 CA-C-O 121.094 0.473 . . . . 0.0 111.146 . . . . . . . . . 0 0 . 1 . 015 nuclear build core ' C' C ' 3' ' ' GLU . . . . . . . . . . . . . 47.7 mp0 -137.72 140.44 40.71 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 115.81 -0.632 . . . . 0.0 110.578 179.789 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' C' C ' 4' ' ' LEU . . . . . . . . . . . . . 13.4 tp -123.19 128.66 50.34 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 115.813 -0.63 . . . . 0.0 109.923 178.259 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' C' C ' 5' ' ' LYS . . . . . . . . . . . . . 61.3 mttp -108.89 119.61 40.07 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.538 -0.301 . . . . 0.0 110.922 -179.801 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' C' C ' 6' ' ' LEU . . . . . . . . . . . . . 38.8 mt -114.04 147.68 38.28 Favored 'General case' 0 C--N 1.331 -0.227 0 CA-C-N 115.279 -0.873 . . . . 0.0 110.232 179.286 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' C' C ' 7' ' ' LYS . . . . . . . . . . . . . 75.1 tttt -136.87 137.15 22.48 Favored Pre-proline 0 CA--C 1.534 0.33 0 CA-C-O 118.999 -0.524 . . . . 0.0 110.113 176.763 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' C' C ' 8' ' ' PRO . . . . . . . . . . . . . 98.5 Cg_endo -90.86 139.67 2.7 Favored 'Trans proline' 0 N--CA 1.491 1.328 0 C-N-CA 121.646 1.564 . . . . 0.0 111.813 177.839 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' C' C ' 9' ' ' LEU . . . . . . . . . . . . . 37.9 mt -76.3 -48.09 3.31 Favored Pre-proline 0 CA--C 1.533 0.307 0 CA-C-O 118.649 -0.691 . . . . 0.0 112.288 -179.242 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' C' C ' 10' ' ' PRO . . . . . . . . . . . . . 81.4 Cg_endo -78.26 147.36 23.11 Favored 'Trans proline' 0 N--CA 1.496 1.666 0 C-N-CA 121.003 1.135 . . . . 0.0 111.648 176.714 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' C' C ' 11' ' ' LYS . . . . . . . . . . . . . 7.3 ttpm? -86.56 87.69 7.5 Favored 'General case' 0 C--N 1.33 -0.273 0 C-N-CA 120.846 -0.342 . . . . 0.0 110.428 -179.652 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' C' C ' 12' ' ' VAL . . . . . . . . . . . . . 11.6 p -136.32 143.45 35.68 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.271 0 CA-C-N 116.03 -0.532 . . . . 0.0 110.324 179.776 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' C' C ' 13' ' ' GLU . . . . . . . . . . . . . 94.8 mt-10 -79.03 131.03 36.14 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.349 -0.387 . . . . 0.0 110.581 -179.664 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' C' C ' 14' ' ' LEU . . . . . . . . . . . . . 21.2 mt -99.42 152.52 37.83 Favored Pre-proline 0 CA--C 1.532 0.276 0 CA-C-N 116.275 -0.421 . . . . 0.0 110.787 179.236 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' C' C ' 15' ' ' PRO . . . . . . . . . . . . . 26.6 Cg_exo -61.91 157.28 44.26 Favored 'Trans proline' 0 N--CA 1.498 1.738 0 C-N-CA 121.312 1.341 . . . . 0.0 111.793 175.961 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' C' C ' 16' ' ' PRO . . . . . . . . . . . . . 33.1 Cg_exo -57.47 -41.62 70.01 Favored 'Trans proline' 0 N--CA 1.497 1.694 0 C-N-CA 121.418 1.412 . . . . 0.0 112.901 -178.478 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' C' C ' 17' ' ' ASP . . . . . . . . . . . . . 19.8 p-10 -86.35 11.93 11.21 Favored 'General case' 0 CA--C 1.536 0.433 0 N-CA-C 113.105 0.78 . . . . 0.0 113.105 -177.64 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' C' C ' 18' ' ' PHE . . . . . . . . . . . . . 51.7 t80 -57.59 -43.33 84.53 Favored 'General case' 0 C--N 1.334 -0.08 0 O-C-N 121.986 -0.446 . . . . 0.0 110.171 -178.431 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' C' C ' 19' ' ' VAL . . . . . 0.402 HG13 ' N ' ' C' ' 20' ' ' ASP . 14.9 p -56.59 -41.94 74.89 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.243 0 CA-C-N 116.29 -0.414 . . . . 0.0 110.919 -178.732 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' C' C ' 20' ' ' ASP . . . . . 0.402 ' N ' HG13 ' C' ' 19' ' ' VAL . 34.7 m-20 -60.44 -41.59 94.36 Favored 'General case' 0 C--N 1.331 -0.222 0 CA-C-O 120.831 0.348 . . . . 0.0 110.9 -178.758 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' C' C ' 21' ' ' VAL . . . . . . . . . . . . . 48.6 t -63.69 -46.96 93.23 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.287 0 CA-C-N 116.343 -0.389 . . . . 0.0 110.261 -178.828 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' C' C ' 22' ' ' ILE . . . . . 0.402 HG22 HD12 ' C' ' 26' ' ' LEU . 50.3 mm -56.68 -45.31 82.64 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.243 0 CA-C-O 120.822 0.344 . . . . 0.0 110.577 178.851 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' C' C ' 23' ' ' ARG . . . . . . . . . . . . . 49.1 ttp180 -54.22 -49.0 70.45 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.649 -0.25 . . . . 0.0 111.374 -178.018 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' C' C ' 24' ' ' ILE . . . . . . . . . . . . . 73.2 mt -59.49 -43.8 91.48 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.321 0 CA-C-O 120.864 0.364 . . . . 0.0 110.842 -178.751 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' C' C ' 25' ' ' LYS . . . . . . . . . . . . . 60.6 mtpt -62.61 -40.52 97.19 Favored 'General case' 0 C--N 1.327 -0.409 0 N-CA-C 112.113 0.412 . . . . 0.0 112.113 -178.298 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' C' C ' 26' ' ' LEU . . . . . 0.402 HD12 HG22 ' C' ' 22' ' ' ILE . 89.8 mt -79.86 -43.43 22.32 Favored 'General case' 0 C--N 1.33 -0.246 0 N-CA-C 113.352 0.871 . . . . 0.0 113.352 -171.759 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' C' C ' 27' ' ' GLN . . . . . . . . . . . . . 15.4 pt20 -46.78 138.62 6.05 Favored 'General case' 0 N--CA 1.468 0.468 0 N-CA-C 112.822 0.675 . . . . 0.0 112.822 -173.813 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' C' C ' 28' ' ' GLY . . . . . . . . . . . . . . . 100.22 -25.87 26.66 Favored Glycine 0 CA--C 1.533 1.174 0 CA-C-N 115.402 -0.817 . . . . 0.0 112.359 -177.338 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' C' C ' 29' ' ' LYS . . . . . . . . . . . . . 63.0 mttp -98.71 155.09 17.51 Favored 'General case' 0 C--N 1.332 -0.194 0 CA-C-N 117.396 0.598 . . . . 0.0 111.367 179.779 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' C' C ' 30' ' ' THR . . . . . . . . . . . . . 28.6 m -96.87 136.4 37.48 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 115.985 -0.552 . . . . 0.0 110.012 175.445 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' C' C ' 31' ' ' VAL . . . . . . . . . . . . . 34.9 m -128.94 148.76 33.26 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.316 0 CA-C-N 116.282 -0.417 . . . . 0.0 110.654 -179.368 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' C' C ' 32' ' ' ARG . . . . . . . . . . . . . 53.9 ttp180 -131.34 147.78 52.61 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-O 121.191 0.52 . . . . 0.0 110.332 178.661 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' C' C ' 33' ' ' THR . . . . . . . . . . . . . 17.5 m -52.99 138.82 29.47 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.383 -0.371 . . . . 0.0 111.46 -177.4 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' C' C ' 34' ' ' GLY . . . . . . . . . . . . . . . 101.51 -17.2 55.68 Favored Glycine 0 CA--C 1.533 1.214 0 CA-C-O 119.66 -0.522 . . . . 0.0 113.135 -179.782 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' C' C ' 35' ' ' ASP . . . . . . . . . . . . . 67.2 m-20 -65.14 149.84 49.2 Favored 'General case' 0 C--O 1.231 0.127 0 CA-C-N 118.046 0.923 . . . . 0.0 111.249 179.127 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' C' C ' 36' ' ' VAL . . . . . . . . . . . . . 46.0 t -123.3 131.46 73.13 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.239 0 CA-C-N 115.788 -0.642 . . . . 0.0 109.835 177.784 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' C' C ' 37' ' ' ILE . . . . . . . . . . . . . 69.7 mt -120.57 139.36 48.08 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.234 0 CA-C-N 116.254 -0.43 . . . . 0.0 109.984 -179.115 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' C' C ' 38' ' ' GLY . . . . . . . . . . . . . . . -113.83 128.84 8.48 Favored Glycine 0 CA--C 1.526 0.721 0 N-CA-C 111.095 -0.802 . . . . 0.0 111.095 -179.972 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' C' C ' 39' ' ' ILE . . . . . . . . . . . . . 72.8 mt -123.18 133.44 69.09 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.265 0 N-CA-C 110.026 -0.361 . . . . 0.0 110.026 179.116 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' C' C ' 40' ' ' SER . . . . . . . . . . . . . 85.8 p -92.11 122.64 34.8 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.454 -0.339 . . . . 0.0 110.684 176.222 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' C' C ' 41' ' ' ILE . . . . . . . . . . . . . 73.3 mt -135.39 118.13 22.65 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.176 0 CA-C-O 120.95 0.405 . . . . 0.0 110.467 178.738 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' C' C ' 42' ' ' LEU . . . . . 0.533 ' O ' HD23 ' C' ' 42' ' ' LEU . 1.4 tt 55.17 45.48 25.87 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-O 121.496 0.665 . . . . 0.0 110.424 177.79 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' C' C ' 43' ' ' GLY . . . . . . . . . . . . . . . 74.99 -10.01 10.4 Favored Glycine 0 CA--C 1.535 1.31 0 C-N-CA 121.239 -0.505 . . . . 0.0 113.761 174.679 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' C' C ' 44' ' ' LYS . . . . . . . . . . . . . 93.1 mttt -104.79 137.61 42.32 Favored 'General case' 0 C--N 1.334 -0.103 0 CA-C-N 118.116 0.958 . . . . 0.0 110.6 -179.464 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' C' C ' 45' ' ' GLU . . . . . . . . . . . . . 79.5 tt0 -85.58 130.0 34.68 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.247 -0.433 . . . . 0.0 111.002 179.453 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' C' C ' 46' ' ' VAL . . . . . . . . . . . . . 7.4 p -123.24 127.96 74.69 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.247 0 N-CA-C 109.587 -0.523 . . . . 0.0 109.587 175.369 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' C' C ' 47' ' ' LYS . . . . . . . . . . . . . 57.3 mtmt -101.47 129.71 47.58 Favored 'General case' 0 C--N 1.331 -0.201 0 CA-C-N 115.888 -0.596 . . . . 0.0 111.626 179.824 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' C' C ' 48' ' ' PHE . . . . . . . . . . . . . 93.1 m-85 -113.85 132.07 56.03 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.079 -0.509 . . . . 0.0 110.154 176.861 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' C' C ' 49' ' ' LYS . . . . . . . . . . . . . 77.8 tttt -106.18 139.56 40.5 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.558 -0.292 . . . . 0.0 110.635 178.978 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' C' C ' 50' ' ' VAL . . . . . . . . . . . . . 44.9 t -83.64 105.61 13.38 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.252 0 N-CA-C 109.194 -0.669 . . . . 0.0 109.194 174.64 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' C' C ' 51' ' ' VAL . . . . . . . . . . . . . 48.7 t -69.65 -54.89 17.13 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.39 0 CA-C-N 115.791 -0.64 . . . . 0.0 109.513 -175.041 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' C' C ' 52' ' ' GLN . . . . . . . . . . . . . 88.5 mt-30 -155.26 154.36 32.04 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 115.882 -0.599 . . . . 0.0 111.906 -177.561 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' C' C ' 53' ' ' ALA . . . . . 0.639 ' HB3' ' OG ' ' C' ' 56' ' ' SER . . . -131.6 132.49 44.11 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 115.334 -0.848 . . . . 0.0 109.782 174.1 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' C' C ' 54' ' ' TYR . . . . . . . . . . . . . 19.8 t80 -129.11 110.45 18.21 Favored Pre-proline 0 CA--C 1.533 0.32 0 CA-C-O 118.142 -0.932 . . . . 0.0 110.092 177.224 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' C' C ' 55' ' ' PRO . . . . . . . . . . . . . 72.7 Cg_endo -77.1 170.1 72.51 Favored 'Cis proline' 0 N--CA 1.5 1.869 0 CA-C-N 121.983 1.744 . . . . 0.0 112.326 -4.973 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' C' C ' 56' ' ' SER . . . . . 0.639 ' OG ' ' HB3' ' C' ' 53' ' ' ALA . 67.2 m -128.19 138.9 33.98 Favored Pre-proline 0 CA--C 1.536 0.429 0 CA-C-O 118.585 -0.721 . . . . 0.0 109.32 174.039 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' C' C ' 57' ' ' PRO . . . . . . . . . . . . . 40.4 Cg_endo -68.53 143.12 70.03 Favored 'Cis proline' 0 N--CA 1.498 1.789 0 CA-C-N 121.662 1.629 . . . . 0.0 111.678 -1.093 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' C' C ' 58' ' ' LEU . . . . . . . . . . . . . 27.8 tp -107.58 138.03 44.54 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.055 -0.52 . . . . 0.0 110.764 -176.085 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' C' C ' 59' ' ' ARG . . . . . . . . . . . . . 43.1 ttp180 -101.44 119.31 38.57 Favored 'General case' 0 C--N 1.328 -0.354 0 N-CA-C 108.894 -0.78 . . . . 0.0 108.894 173.698 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' C' C ' 60' ' ' VAL . . . . . . . . . . . . . 45.0 t -72.25 120.04 19.97 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.258 0 C-N-CA 120.644 -0.423 . . . . 0.0 110.3 -173.677 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' C' C ' 61' ' ' GLU . . . . . . . . . . . . . 42.8 mt-10 -131.04 162.61 29.42 Favored 'General case' 0 C--N 1.331 -0.23 0 CA-C-N 116.03 -0.532 . . . . 0.0 110.284 178.411 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' C' C ' 62' ' ' ASP . . . . . . . . . . . . . 7.7 p-10 -56.19 -32.54 64.46 Favored 'General case' 0 C--N 1.329 -0.304 0 N-CA-C 111.922 0.342 . . . . 0.0 111.922 -178.412 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' C' C ' 63' ' ' ARG . . . . . . . . . . . . . 40.4 ptt180 -81.4 3.83 23.05 Favored 'General case' 0 CA--C 1.537 0.452 0 N-CA-C 113.746 1.017 . . . . 0.0 113.746 -175.582 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' C' C ' 64' ' ' THR . . . . . . . . . . . . . 26.4 m -87.99 138.75 31.17 Favored 'General case' 0 C--N 1.332 -0.166 0 CA-C-N 118.103 0.41 . . . . 0.0 110.48 -179.061 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' C' C ' 65' ' ' LYS . . . . . . . . . . . . . 95.4 mttt -87.93 128.31 35.37 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.373 -0.376 . . . . 0.0 110.127 -179.755 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' C' C ' 66' ' ' ILE . . . . . . . . . . . . . 59.1 mt -115.64 131.62 67.48 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.215 0 N-CA-C 109.936 -0.394 . . . . 0.0 109.936 -179.329 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' C' C ' 67' ' ' THR . . . . . . . . . . . . . 26.3 m -124.69 138.21 54.31 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-N 116.151 -0.477 . . . . 0.0 110.723 -179.689 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' C' C ' 68' ' ' LEU . . . . . . . . . . . . . 48.2 mt . . . . . 0 C--N 1.33 -0.248 0 CA-C-N 115.902 -0.59 . . . . 0.0 110.297 177.367 . . . . . . . . 0 0 . 1 . 015 nuclear build core ' C' C ' 73' ' ' VAL . . . . . . . . . . . . . 30.4 m . . . . . 0 C--O 1.231 0.125 0 N-CA-C 110.138 -0.319 . . . . 0.0 110.138 . . . . . . . . . 0 0 . 1 . 015 nuclear build core ' C' C ' 74' ' ' ASP . . . . . 0.407 ' OD1' HD11 ' C' ' 76' ' ' LEU . 13.6 t0 -96.38 119.04 34.15 Favored 'General case' 0 C--N 1.33 -0.253 0 N-CA-C 109.919 -0.401 . . . . 0.0 109.919 -177.498 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' C' C ' 75' ' ' VAL . . . . . 0.418 HG21 ' CE1' ' B' ' 113' ' ' TYR . 43.2 t -119.44 122.95 70.25 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.208 0 CA-C-O 121.125 0.488 . . . . 0.0 110.811 -176.954 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' C' C ' 76' ' ' LEU . . . . . 0.48 ' N ' HD12 ' C' ' 76' ' ' LEU . 5.8 mp -121.05 141.48 50.72 Favored 'General case' 0 C--N 1.331 -0.205 0 CA-C-N 115.647 -0.706 . . . . 0.0 109.12 174.112 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' C' C ' 77' ' ' GLU . . . . . . . . . . . . . 31.3 tt0 -132.08 132.13 43.02 Favored 'General case' 0 C--N 1.331 -0.209 0 CA-C-O 120.841 0.353 . . . . 0.0 110.902 -176.161 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' C' C ' 78' ' ' ALA . . . . . . . . . . . . . . . -119.1 142.44 47.9 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 116.002 -0.545 . . . . 0.0 109.869 177.454 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' C' C ' 79' ' ' LYS . . . . . 0.565 ' O ' HD13 ' C' ' 80' ' ' ILE . 81.3 tttt -84.45 119.73 25.47 Favored 'General case' 0 C--N 1.328 -0.332 0 C-N-CA 120.934 -0.307 . . . . 0.0 110.58 -178.69 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' C' C ' 80' ' ' ILE . . . . . 0.565 HD13 ' O ' ' C' ' 79' ' ' LYS . 44.8 mm -138.26 117.94 14.96 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.27 0 N-CA-C 109.533 -0.543 . . . . 0.0 109.533 -177.486 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' C' C ' 81' ' ' LYS . . . . . . . . . . . . . 59.4 mtmt -112.83 125.69 54.62 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.407 -0.361 . . . . 0.0 111.37 -176.298 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' C' C ' 82' ' ' GLY . . . . . . . . . . . . . . . 89.13 42.11 5.68 Favored Glycine 0 CA--C 1.524 0.595 0 C-N-CA 120.865 -0.683 . . . . 0.0 111.458 175.485 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' C' C ' 83' ' ' ILE . . . . . . . . . . . . . 70.1 mt -67.59 132.77 32.34 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.291 0 N-CA-C 109.835 -0.431 . . . . 0.0 109.835 178.909 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' C' C ' 84' ' ' LYS . . . . . . . . . . . . . 59.4 tttp -93.5 -49.25 6.0 Favored 'General case' 0 C--N 1.327 -0.407 0 CA-C-N 116.011 -0.54 . . . . 0.0 109.837 179.967 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' C' C ' 85' ' ' ASP . . . . . . . . . . . . . 5.1 t0 -159.84 153.14 22.15 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 115.71 -0.677 . . . . 0.0 110.28 179.031 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' C' C ' 86' ' ' VAL . . . . . . . . . . . . . 42.6 t -125.92 131.75 71.46 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.274 0 CA-C-O 120.868 0.366 . . . . 0.0 110.199 -179.939 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' C' C ' 87' ' ' ILE . . . . . . . . . . . . . 44.2 mm -120.13 129.27 75.68 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.264 0 CA-C-N 116.027 -0.533 . . . . 0.0 109.632 178.981 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' C' C ' 88' ' ' LEU . . . . . . . . . . . . . 12.4 tp -112.31 130.77 55.84 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-O 120.985 0.421 . . . . 0.0 111.296 -175.857 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' C' C ' 89' ' ' ASP . . . . . . . . . . . . . 13.1 t70 -125.27 152.01 45.2 Favored 'General case' 0 C--N 1.33 -0.249 0 N-CA-C 109.272 -0.64 . . . . 0.0 109.272 175.016 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' C' C ' 90' ' ' GLU . . . . . . . . . . . . . 95.4 mt-10 -48.92 -37.8 20.93 Favored 'General case' 0 C--N 1.329 -0.324 0 N-CA-C 112.754 0.649 . . . . 0.0 112.754 -171.804 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' C' C ' 91' ' ' ASN . . . . . . . . . . . . . 14.7 m-80 -125.49 16.7 8.23 Favored 'General case' 0 N--CA 1.468 0.474 0 N-CA-C 113.21 0.819 . . . . 0.0 113.21 -177.352 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' C' C ' 92' ' ' LEU . . . . . . . . . . . . . 12.5 mt -148.86 143.26 26.15 Favored 'General case' 0 C--N 1.333 -0.114 0 N-CA-C 110.112 -0.329 . . . . 0.0 110.112 -176.605 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' C' C ' 93' ' ' ILE . . . . . . . . . . . . . 73.7 mt -121.23 119.27 58.7 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.353 0 N-CA-C 109.157 -0.683 . . . . 0.0 109.157 177.55 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' C' C ' 94' ' ' VAL . . . . . . . . . . . . . 45.3 t -118.73 127.16 75.68 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.201 0 CA-C-O 121.023 0.439 . . . . 0.0 110.061 -178.314 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' C' C ' 95' ' ' VAL . . . . . . . . . . . . . 44.9 t -118.97 132.91 67.5 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.357 0 CA-C-N 115.784 -0.644 . . . . 0.0 109.519 178.681 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' C' C ' 96' ' ' ILE . . . . . . . . . . . . . 68.3 mt -112.67 126.06 70.01 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.346 0 N-CA-C 109.214 -0.662 . . . . 0.0 109.214 178.775 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' C' C ' 97' ' ' THR . . . . . . . . . . . . . 60.6 p -99.76 158.27 15.91 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-O 121.313 0.578 . . . . 0.0 111.386 -176.904 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' C' C ' 98' ' ' GLU . . . . . . . . . . . . . 83.8 tt0 -53.88 -26.71 26.17 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.049 -0.523 . . . . 0.0 112.23 179.73 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' C' C ' 99' ' ' GLU . . . . . . . . . . . . . 71.0 mm-40 -78.87 15.35 1.1 Allowed 'General case' 0 CA--C 1.534 0.353 0 N-CA-C 113.185 0.809 . . . . 0.0 113.185 -177.691 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' C' C ' 100' ' ' ASN . . . . . . . . . . . . . 4.1 m-20 60.88 38.16 17.97 Favored 'General case' 0 C--O 1.232 0.146 0 CA-C-O 121.101 0.477 . . . . 0.0 110.823 179.833 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' C' C ' 101' ' ' GLU . . . . . . . . . . . . . 83.7 tt0 -114.83 144.36 43.65 Favored 'General case' 0 C--N 1.332 -0.16 0 CA-C-N 116.001 -0.545 . . . . 0.0 109.64 177.016 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' C' C ' 102' ' ' VAL . . . . . . . . . . . . . 44.4 t -114.93 124.84 71.98 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.306 0 N-CA-C 109.919 -0.401 . . . . 0.0 109.919 -178.156 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' C' C ' 103' ' ' LEU . . . . . . . . . . . . . 28.7 mt -113.64 131.28 56.2 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 115.717 -0.674 . . . . 0.0 110.198 176.6 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' C' C ' 104' ' ' ILE . . . . . . . . . . . . . 73.5 mt -120.36 119.06 58.76 Favored 'Isoleucine or valine' 0 C--O 1.235 0.325 0 N-CA-C 110.295 -0.261 . . . . 0.0 110.295 -179.79 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' C' C ' 105' ' ' PHE . . . . . . . . . . . . . 79.7 m-85 -120.19 167.37 12.32 Favored 'General case' 0 C--N 1.331 -0.217 0 O-C-N 124.205 0.941 . . . . 0.0 109.766 178.956 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' C' C ' 106' ' ' ASN . . . . . . . . . . . . . 39.7 p-10 -103.77 -169.91 1.7 Allowed 'General case' 0 CA--C 1.53 0.181 0 N-CA-C 109.703 -0.48 . . . . 0.0 109.703 171.394 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' C' C ' 107' ' ' GLN . . . . . . . . . . . . . 50.0 tt0 -58.69 -30.12 67.15 Favored 'General case' 0 C--N 1.329 -0.302 0 N-CA-C 111.862 0.319 . . . . 0.0 111.862 179.361 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' C' C ' 108' ' ' ASN . . . . . . . . . . . . . 45.7 t30 -89.21 12.88 14.66 Favored 'General case' 0 CA--C 1.535 0.393 0 N-CA-C 113.048 0.759 . . . . 0.0 113.048 -176.855 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' C' C ' 109' ' ' LEU . . . . . . . . . . . . . 63.3 mt 58.28 35.72 25.12 Favored 'General case' 0 C--N 1.332 -0.182 0 CA-C-O 120.755 0.312 . . . . 0.0 111.767 175.934 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' C' C ' 110' ' ' GLU . . . . . . . . . . . . . 70.3 mm-40 -103.91 135.28 45.74 Favored 'General case' 0 C--N 1.33 -0.264 0 N-CA-C 110.014 -0.365 . . . . 0.0 110.014 175.238 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' C' C ' 111' ' ' GLU . . . . . . . . . . . . . 98.1 mt-10 -67.14 123.62 20.78 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-O 121.044 0.45 . . . . 0.0 111.071 -178.39 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' C' C ' 112' ' ' LEU . . . . . . . . . . . . . 13.9 mt -105.99 -43.88 4.74 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-N 115.793 -0.64 . . . . 0.0 109.946 175.78 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' C' C ' 113' ' ' TYR . . . . . . . . . . . . . 65.0 t80 -143.86 140.76 29.96 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.236 -0.438 . . . . 0.0 111.637 -179.315 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' C' C ' 114' ' ' ARG . . . . . . . . . . . . . 37.2 ttm180 -136.31 128.1 29.16 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 115.797 -0.638 . . . . 0.0 109.96 174.026 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' C' C ' 115' ' ' GLY . . . . . . . . . . . . . . . -150.04 159.41 28.09 Favored Glycine 0 CA--C 1.526 0.774 0 N-CA-C 111.169 -0.772 . . . . 0.0 111.169 177.441 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' C' C ' 116' ' ' LYS . . . . . . . . . . . . . 33.7 ttpt -130.81 136.6 48.85 Favored 'General case' 0 C--N 1.33 -0.244 0 N-CA-C 109.974 -0.38 . . . . 0.0 109.974 177.555 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' C' C ' 117' ' ' PHE . . . . . . . . . . . . . 40.8 m-85 -135.14 117.14 15.3 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-O 120.703 0.287 . . . . 0.0 110.39 -176.672 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' C' C ' 118' ' ' GLU . . . . . . . . . . . . . 70.6 mm-40 -54.65 -46.32 73.96 Favored 'General case' 0 C--N 1.329 -0.29 0 C-N-CA 120.996 -0.282 . . . . 0.0 111.38 -177.014 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' C' C ' 119' ' ' ASN . . . . . . . . . . . . . 6.0 m120 -95.99 30.99 2.24 Favored 'General case' 0 C--N 1.329 -0.322 0 N-CA-C 112.046 0.387 . . . . 0.0 112.046 -175.457 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' C' C ' 120' ' ' LEU . . . . . . . . . . . . . 14.0 tp -57.82 120.93 9.3 Favored 'General case' 0 C--O 1.232 0.154 0 CA-C-O 120.679 0.276 . . . . 0.0 110.39 179.008 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' C' C ' 121' ' ' ASN . . . . . . . . . . . . . 93.9 m-20 -114.16 -43.96 3.18 Favored 'General case' 0 C--N 1.331 -0.217 0 CA-C-N 116.38 -0.373 . . . . 0.0 111.311 -178.304 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' C' C ' 122' ' ' LYS . . . . . . . . . . . . . 97.2 mttt -144.28 151.11 38.93 Favored 'General case' 0 C--N 1.331 -0.215 0 C-N-CA 120.647 -0.421 . . . . 0.0 111.848 -175.993 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' C' C ' 123' ' ' VAL . . . . . . . . . . . . . 46.1 t -132.08 128.59 59.4 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.311 0 N-CA-C 109.259 -0.645 . . . . 0.0 109.259 172.159 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' C' C ' 124' ' ' LEU . . . . . . . . . . . . . 8.7 tp -128.31 143.27 51.0 Favored 'General case' 0 N--CA 1.464 0.245 0 CA-C-O 120.726 0.298 . . . . 0.0 110.91 -175.845 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' C' C ' 125' ' ' VAL . . . . . 0.474 HG12 HG23 ' C' ' 130' ' ' VAL . 35.0 m -130.19 143.84 39.78 Favored 'Isoleucine or valine' 0 C--O 1.232 0.177 0 CA-C-N 116.35 -0.386 . . . . 0.0 111.254 -178.637 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' C' C ' 126' ' ' ARG . . . . . . . . . . . . . 96.0 mtt-85 -149.73 124.9 10.08 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 116.246 -0.434 . . . . 0.0 110.781 175.634 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' C' C ' 127' ' ' ASN . . . . . . . . . . . . . 24.8 m120 49.63 -109.18 0.35 Allowed 'General case' 0 CA--C 1.545 0.764 0 CA-C-O 118.828 -0.606 . . . . 0.0 111.649 178.938 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' C' C ' 128' ' ' ASP . . . . . . . . . . . . . 19.5 p-10 -114.09 7.3 16.68 Favored 'General case' 0 N--CA 1.469 0.482 0 CA-C-N 119.891 1.223 . . . . 0.0 113.371 -177.442 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' C' C ' 129' ' ' LEU . . . . . . . . . . . . . 42.1 mt -113.7 147.88 37.4 Favored 'General case' 0 C--O 1.232 0.14 0 N-CA-C 109.795 -0.446 . . . . 0.0 109.795 178.723 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' C' C ' 130' ' ' VAL . . . . . 0.49 HG13 ' HB ' ' C' ' 141' ' ' ILE . 12.9 p -133.62 143.18 39.55 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.222 0 CA-C-O 121.166 0.508 . . . . 0.0 110.511 -179.758 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' C' C ' 131' ' ' VAL . . . . . 0.476 HG22 HD12 ' C' ' 140' ' ' LEU . 41.1 t -132.92 138.4 51.82 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.248 0 CA-C-N 115.848 -0.614 . . . . 0.0 110.234 -178.068 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' C' C ' 132' ' ' ILE . . . . . . . . . . . . . 72.2 mt -116.8 133.86 62.15 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.331 0 N-CA-C 109.308 -0.627 . . . . 0.0 109.308 179.471 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' C' C ' 133' ' ' ILE . . . . . . . . . . . . . 40.1 mm -117.02 122.89 71.08 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.245 0 CA-C-N 116.673 -0.239 . . . . 0.0 110.81 -174.756 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' C' C ' 134' ' ' ASP . . . . . . . . . . . . . 7.2 p-10 -135.59 150.28 49.63 Favored 'General case' 0 C--N 1.331 -0.225 0 N-CA-C 110.003 -0.369 . . . . 0.0 110.003 175.55 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' C' C ' 135' ' ' GLU . . . . . . . . . . . . . 44.8 tp10 -50.67 -28.08 8.26 Favored 'General case' 0 C--N 1.328 -0.361 0 N-CA-C 112.756 0.65 . . . . 0.0 112.756 -173.218 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' C' C ' 136' ' ' GLN . . . . . . . . . . . . . 96.9 mt-30 -86.17 -29.22 23.41 Favored 'General case' 0 C--N 1.33 -0.253 0 N-CA-C 112.805 0.669 . . . . 0.0 112.805 -174.98 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' C' C ' 137' ' ' LYS . . . . . . . . . . . . . 43.1 pttt -170.14 173.67 5.77 Favored 'General case' 0 C--N 1.332 -0.189 0 CA-C-O 121.53 0.681 . . . . 0.0 112.503 -172.544 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' C' C ' 138' ' ' LEU . . . . . 0.42 HD23 ' N ' ' C' ' 139' ' ' THR . 5.5 tt -118.55 128.62 54.74 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 114.967 -1.015 . . . . 0.0 109.766 179.168 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' C' C ' 139' ' ' THR . . . . . 0.42 ' N ' HD23 ' C' ' 138' ' ' LEU . 31.9 m -107.09 128.16 54.13 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.43 -0.35 . . . . 0.0 110.281 179.798 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' C' C ' 140' ' ' LEU . . . . . 0.476 HD12 HG22 ' C' ' 131' ' ' VAL . 11.0 tp -114.6 121.42 43.38 Favored 'General case' 0 C--N 1.328 -0.339 0 N-CA-C 109.23 -0.655 . . . . 0.0 109.23 -178.718 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' C' C ' 141' ' ' ILE . . . . . 0.49 ' HB ' HG13 ' C' ' 130' ' ' VAL . 20.1 mt -119.28 121.6 66.97 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 CA-C-O 121.032 0.444 . . . . 0.0 110.04 -175.803 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' C' C ' 142' ' ' ARG . . . . . . . . . . . . . 69.5 mtt180 . . . . . 0 C--N 1.329 -0.312 0 CA-C-N 114.989 -1.005 . . . . 0.0 109.849 -175.263 . . . . . . . . 0 0 . 1 . 015 nuclear build core ' D' D ' 2' ' ' SER . . . . . . . . . . . . . 25.2 p . . . . . 0 N--CA 1.461 0.082 0 CA-C-O 120.913 0.387 . . . . 0.0 110.574 . . . . . . . . . 0 0 . 1 . 015 nuclear build core ' D' D ' 3' ' ' GLU . . . . . . . . . . . . . 95.3 mt-10 -141.13 138.78 33.72 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.1 -0.5 . . . . 0.0 111.489 -177.498 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' D' D ' 4' ' ' LEU . . . . . . . . . . . . . 70.1 mt -118.96 127.74 53.75 Favored 'General case' 0 C--N 1.331 -0.214 0 CA-C-N 115.953 -0.567 . . . . 0.0 110.079 174.392 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' D' D ' 5' ' ' LYS . . . . . . . . . . . . . 98.7 mttt -109.67 122.4 47.38 Favored 'General case' 0 C--O 1.235 0.311 0 CA-C-O 120.673 0.273 . . . . 0.0 110.659 177.225 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' D' D ' 6' ' ' LEU . . . . . . . . . . . . . 46.8 mt -113.94 146.55 39.93 Favored 'General case' 0 C--N 1.331 -0.219 0 CA-C-N 115.435 -0.802 . . . . 0.0 109.919 179.786 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' D' D ' 7' ' ' LYS . . . . . . . . . . . . . 76.4 tttt -131.28 137.63 31.01 Favored Pre-proline 0 CA--C 1.533 0.318 0 CA-C-O 118.935 -0.555 . . . . 0.0 109.732 175.74 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' D' D ' 8' ' ' PRO . . . . . . . . . . . . . 85.9 Cg_endo -90.96 135.18 1.86 Allowed 'Trans proline' 0 N--CA 1.489 1.225 0 C-N-CA 121.705 1.603 . . . . 0.0 111.825 179.316 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' D' D ' 9' ' ' LEU . . . . . . . . . . . . . 38.0 mt -73.3 -45.13 7.86 Favored Pre-proline 0 CA--C 1.533 0.311 0 CA-C-O 119.019 -0.515 . . . . 0.0 111.036 179.79 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' D' D ' 10' ' ' PRO . . . . . . . . . . . . . 64.5 Cg_endo -86.11 152.82 9.6 Favored 'Trans proline' 0 N--CA 1.492 1.425 0 C-N-CA 121.241 1.294 . . . . 0.0 111.066 169.041 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' D' D ' 11' ' ' LYS . . . . . . . . . . . . . 25.5 pttm -86.1 119.86 26.86 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-O 121.291 0.567 . . . . 0.0 110.461 177.084 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' D' D ' 12' ' ' VAL . . . . . . . . . . . . . 13.1 p -150.47 143.29 17.22 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.327 0 CA-C-N 115.928 -0.578 . . . . 0.0 110.523 -179.966 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' D' D ' 13' ' ' GLU . . . . . . . . . . . . . 43.3 mt-10 -90.36 110.47 21.55 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.296 -0.411 . . . . 0.0 110.04 177.808 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' D' D ' 14' ' ' LEU . . . . . . . . . . . . . 15.8 mt -88.08 153.05 51.47 Favored Pre-proline 0 C--N 1.33 -0.281 0 CA-C-N 116.345 -0.389 . . . . 0.0 110.646 -178.154 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' D' D ' 15' ' ' PRO . . . . . . . . . . . . . 25.4 Cg_exo -62.58 155.16 60.19 Favored 'Trans proline' 0 N--CA 1.497 1.679 0 C-N-CA 121.267 1.311 . . . . 0.0 111.35 175.17 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' D' D ' 16' ' ' PRO . . . . . . . . . . . . . 36.5 Cg_exo -58.02 -35.64 98.61 Favored 'Trans proline' 0 N--CA 1.497 1.723 0 C-N-CA 121.318 1.345 . . . . 0.0 112.923 -178.68 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' D' D ' 17' ' ' ASP . . . . . . . . . . . . . 10.8 p-10 -85.48 5.96 28.99 Favored 'General case' 0 CA--C 1.536 0.411 0 N-CA-C 113.336 0.865 . . . . 0.0 113.336 -176.508 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' D' D ' 18' ' ' PHE . . . . . . . . . . . . . 42.3 t80 -58.37 -44.49 88.9 Favored 'General case' 0 C--N 1.334 -0.101 0 O-C-N 121.939 -0.475 . . . . 0.0 109.892 -179.251 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' D' D ' 19' ' ' VAL . . . . . . . . . . . . . 47.6 t -56.76 -42.6 77.79 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.284 0 CA-C-N 116.243 -0.435 . . . . 0.0 110.316 -179.423 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' D' D ' 20' ' ' ASP . . . . . . . . . . . . . 9.6 t70 -59.47 -42.59 92.39 Favored 'General case' 0 C--N 1.33 -0.278 0 C-N-CA 120.853 -0.339 . . . . 0.0 110.72 -177.522 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' D' D ' 21' ' ' VAL . . . . . . . . . . . . . 47.3 t -64.42 -46.37 93.12 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 C-N-CA 120.754 -0.378 . . . . 0.0 110.646 -177.611 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' D' D ' 22' ' ' ILE . . . . . 0.551 HG22 HD12 ' D' ' 26' ' ' LEU . 45.4 mm -58.57 -40.27 78.38 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.267 0 C-N-CA 121.05 -0.26 . . . . 0.0 110.758 -179.449 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' D' D ' 23' ' ' ARG . . . . . . . . . . . . . 35.4 ttp180 -57.73 -49.64 75.88 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-O 121.148 0.499 . . . . 0.0 110.32 177.285 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' D' D ' 24' ' ' ILE . . . . . . . . . . . . . 66.0 mt -60.96 -38.41 79.32 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.304 0 CA-C-N 115.737 -0.665 . . . . 0.0 111.841 -176.781 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' D' D ' 25' ' ' LYS . . . . . . . . . . . . . 35.5 pttt -77.21 -37.57 53.14 Favored 'General case' 0 CA--C 1.534 0.341 0 C-N-CA 120.396 -0.521 . . . . 0.0 111.864 -174.952 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' D' D ' 26' ' ' LEU . . . . . 0.551 HD12 HG22 ' D' ' 22' ' ' ILE . 72.0 mt -77.7 -32.42 52.99 Favored 'General case' 0 C--N 1.331 -0.238 0 N-CA-C 113.237 0.828 . . . . 0.0 113.237 -172.354 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' D' D ' 27' ' ' GLN . . . . . . . . . . . . . 20.4 pt20 -45.71 135.71 6.58 Favored 'General case' 0 N--CA 1.469 0.517 0 N-CA-C 112.951 0.723 . . . . 0.0 112.951 -175.49 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' D' D ' 28' ' ' GLY . . . . . . . . . . . . . . . 99.37 -24.76 30.93 Favored Glycine 0 CA--C 1.534 1.223 0 CA-C-N 115.62 -0.718 . . . . 0.0 112.441 -177.713 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' D' D ' 29' ' ' LYS . . . . . . . . . . . . . 69.0 mttm -98.05 155.17 17.25 Favored 'General case' 0 C--N 1.333 -0.12 0 CA-C-N 117.29 0.545 . . . . 0.0 111.002 179.599 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' D' D ' 30' ' ' THR . . . . . . . . . . . . . 21.6 m -101.1 140.19 35.74 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.36 -0.382 . . . . 0.0 110.465 178.206 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' D' D ' 31' ' ' VAL . . . . . . . . . . . . . 34.9 m -130.14 150.4 34.58 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.232 0 CA-C-N 116.232 -0.44 . . . . 0.0 110.992 -179.418 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' D' D ' 32' ' ' ARG . . . . . . . . . . . . . 82.0 mtm180 -135.42 151.09 50.1 Favored 'General case' 0 C--N 1.331 -0.23 0 CA-C-O 121.258 0.551 . . . . 0.0 110.672 178.275 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' D' D ' 33' ' ' THR . . . . . . . . . . . . . 29.3 m -53.65 139.93 30.6 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.273 -0.421 . . . . 0.0 111.193 -179.49 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' D' D ' 34' ' ' GLY . . . . . . . . . . . . . . . 101.01 -17.02 56.82 Favored Glycine 0 CA--C 1.532 1.131 0 CA-C-O 119.703 -0.498 . . . . 0.0 113.244 179.609 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' D' D ' 35' ' ' ASP . . . . . . . . . . . . . 67.5 m-20 -65.15 148.63 51.33 Favored 'General case' 0 C--O 1.232 0.133 0 CA-C-N 118.103 0.951 . . . . 0.0 110.999 178.739 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' D' D ' 36' ' ' VAL . . . . . . . . . . . . . 45.4 t -126.75 131.76 70.79 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.232 0 CA-C-N 116.044 -0.525 . . . . 0.0 109.935 179.444 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' D' D ' 37' ' ' ILE . . . . . . . . . . . . . 63.0 mt -124.89 139.78 50.01 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.215 0 CA-C-N 116.226 -0.443 . . . . 0.0 110.173 -179.09 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' D' D ' 38' ' ' GLY . . . . . . . . . . . . . . . -113.83 128.41 8.28 Favored Glycine 0 CA--C 1.526 0.724 0 N-CA-C 110.741 -0.944 . . . . 0.0 110.741 177.73 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' D' D ' 39' ' ' ILE . . . . . . . . . . . . . 70.6 mt -126.92 137.72 57.0 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.282 0 CA-C-O 120.654 0.264 . . . . 0.0 110.297 -179.758 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' D' D ' 40' ' ' SER . . . . . . . . . . . . . 42.9 t -92.11 120.8 33.06 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.307 -0.406 . . . . 0.0 110.755 176.058 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' D' D ' 41' ' ' ILE . . . . . . . . . . . . . 67.7 mt -126.57 117.51 48.4 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.193 0 CA-C-O 120.707 0.289 . . . . 0.0 110.268 178.672 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' D' D ' 42' ' ' LEU . . . . . . . . . . . . . 8.2 mp 50.94 39.13 22.05 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-O 121.094 0.474 . . . . 0.0 111.729 177.262 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' D' D ' 43' ' ' GLY . . . . . . . . . . . . . . . 75.36 26.57 65.55 Favored Glycine 0 CA--C 1.531 1.077 0 C-N-CA 121.218 -0.515 . . . . 0.0 112.669 175.742 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' D' D ' 44' ' ' LYS . . . . . . . . . . . . . 98.8 mttt -136.56 129.35 30.76 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 117.142 0.471 . . . . 0.0 109.798 176.606 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' D' D ' 45' ' ' GLU . . . . . . . . . . . . . 73.0 tt0 -84.16 123.38 30.02 Favored 'General case' 0 C--N 1.329 -0.314 0 C-N-CA 120.788 -0.365 . . . . 0.0 110.8 -178.102 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' D' D ' 46' ' ' VAL . . . . . . . . . . . . . 11.3 p -117.22 127.29 74.79 Favored 'Isoleucine or valine' 0 C--O 1.233 0.196 0 N-CA-C 109.832 -0.433 . . . . 0.0 109.832 176.368 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' D' D ' 47' ' ' LYS . . . . . . . . . . . . . 34.3 mmtp -98.23 122.91 41.96 Favored 'General case' 0 C--N 1.327 -0.404 0 CA-C-N 115.927 -0.578 . . . . 0.0 110.659 177.165 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' D' D ' 48' ' ' PHE . . . . . . . . . . . . . 30.6 m-85 -108.32 131.79 54.37 Favored 'General case' 0 C--N 1.33 -0.276 0 N-CA-C 109.668 -0.493 . . . . 0.0 109.668 175.693 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' D' D ' 49' ' ' LYS . . . . . . . . . . . . . 60.1 tttm -108.82 136.12 48.9 Favored 'General case' 0 C--N 1.329 -0.316 0 N-CA-C 110.04 -0.355 . . . . 0.0 110.04 175.858 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' D' D ' 50' ' ' VAL . . . . . . . . . . . . . 45.3 t -77.63 107.05 8.71 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.343 0 N-CA-C 109.176 -0.675 . . . . 0.0 109.176 176.487 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' D' D ' 51' ' ' VAL . . . . . . . . . . . . . 45.0 t -70.96 -48.75 54.27 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.315 0 CA-C-N 116.132 -0.486 . . . . 0.0 109.781 -174.221 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' D' D ' 52' ' ' GLN . . . . . . . . . . . . . 62.2 tt0 -164.66 139.8 5.55 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 115.983 -0.553 . . . . 0.0 111.187 -176.614 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' D' D ' 53' ' ' ALA . . . . . . . . . . . . . . . -120.37 135.87 54.89 Favored 'General case' 0 C--N 1.332 -0.191 0 CA-C-N 116.009 -0.541 . . . . 0.0 109.868 174.342 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' D' D ' 54' ' ' TYR . . . . . . . . . . . . . 43.7 t80 -129.11 116.58 18.9 Favored Pre-proline 0 CA--C 1.536 0.413 0 CA-C-O 118.091 -0.957 . . . . 0.0 110.338 178.226 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' D' D ' 55' ' ' PRO . . . . . . . . . . . . . 73.8 Cg_endo -77.13 170.07 72.57 Favored 'Cis proline' 0 N--CA 1.501 1.94 0 CA-C-N 122.015 1.756 . . . . 0.0 111.56 -9.836 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' D' D ' 56' ' ' SER . . . . . . . . . . . . . 13.7 m -128.03 141.72 42.15 Favored Pre-proline 0 CA--C 1.536 0.41 0 CA-C-O 118.625 -0.702 . . . . 0.0 109.575 174.777 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' D' D ' 57' ' ' PRO . . . . . . . . . . . . . 49.8 Cg_endo -69.94 141.71 67.49 Favored 'Cis proline' 0 N--CA 1.5 1.859 0 CA-C-N 121.489 1.567 . . . . 0.0 111.689 -1.082 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' D' D ' 58' ' ' LEU . . . . . . . . . . . . . 28.1 tp -108.53 138.74 44.34 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-N 116.381 -0.372 . . . . 0.0 110.881 -177.989 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' D' D ' 59' ' ' ARG . . . . . . . . . . . . . 66.9 ttp85 -99.67 124.14 44.61 Favored 'General case' 0 C--N 1.328 -0.332 0 N-CA-C 109.099 -0.704 . . . . 0.0 109.099 173.323 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' D' D ' 60' ' ' VAL . . . . . . . . . . . . . 41.1 t -72.78 120.28 21.12 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.254 0 CA-C-O 120.964 0.411 . . . . 0.0 110.51 -175.066 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' D' D ' 61' ' ' GLU . . . . . . . . . . . . . 74.7 tt0 -131.09 156.79 44.62 Favored 'General case' 0 C--N 1.328 -0.331 0 N-CA-C 108.874 -0.787 . . . . 0.0 108.874 175.991 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' D' D ' 62' ' ' ASP . . . . . . . . . . . . . 53.1 m-20 -49.6 -30.37 8.67 Favored 'General case' 0 CA--C 1.534 0.336 0 N-CA-C 112.378 0.51 . . . . 0.0 112.378 -179.169 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' D' D ' 63' ' ' ARG . . . . . . . . . . . . . 94.2 mtt180 -72.5 -21.96 61.12 Favored 'General case' 0 CA--C 1.533 0.3 0 N-CA-C 113.118 0.784 . . . . 0.0 113.118 -175.217 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' D' D ' 64' ' ' THR . . . . . . . . . . . . . 34.2 m -66.57 139.78 57.93 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-O 120.871 0.367 . . . . 0.0 110.913 -176.257 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' D' D ' 65' ' ' LYS . . . . . . . . . . . . . 99.4 mttt -89.09 130.69 35.49 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.093 -0.503 . . . . 0.0 109.906 176.971 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' D' D ' 66' ' ' ILE . . . . . . . . . . . . . 4.0 mp -112.39 124.14 68.79 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.229 0 N-CA-C 109.518 -0.549 . . . . 0.0 109.518 178.517 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' D' D ' 67' ' ' THR . . . . . . . . . . . . . 24.4 m -119.94 137.34 54.11 Favored 'General case' 0 C--N 1.331 -0.208 0 CA-C-O 121.102 0.477 . . . . 0.0 110.877 -176.985 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' D' D ' 68' ' ' LEU . . . . . . . . . . . . . 17.3 tp . . . . . 0 C--N 1.328 -0.326 0 CA-C-N 115.831 -0.622 . . . . 0.0 109.99 178.084 . . . . . . . . 0 0 . 1 . 015 nuclear build core ' D' D ' 73' ' ' VAL . . . . . . . . . . . . . 35.2 m . . . . . 0 C--O 1.231 0.103 0 CA-C-O 120.684 0.278 . . . . 0.0 110.254 . . . . . . . . . 0 0 . 1 . 015 nuclear build core ' D' D ' 74' ' ' ASP . . . . . . . . . . . . . 17.9 t0 -99.85 123.73 44.4 Favored 'General case' 0 C--N 1.331 -0.233 0 N-CA-C 110.04 -0.356 . . . . 0.0 110.04 -178.242 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' D' D ' 75' ' ' VAL . . . . . 0.55 ' C ' HD12 ' D' ' 76' ' ' LEU . 43.3 t -117.96 122.82 70.62 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.197 0 CA-C-O 120.922 0.391 . . . . 0.0 110.494 -177.862 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' D' D ' 76' ' ' LEU . . . . . 0.55 HD12 ' C ' ' D' ' 75' ' ' VAL . 8.0 mp -124.42 149.33 46.87 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 115.848 -0.615 . . . . 0.0 109.737 176.25 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' D' D ' 77' ' ' GLU . . . . . . . . . . . . . 97.2 mt-10 -136.3 136.6 39.9 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-O 121.049 0.452 . . . . 0.0 111.138 -178.476 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' D' D ' 78' ' ' ALA . . . . . . . . . . . . . . . -119.23 128.75 54.49 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 115.707 -0.679 . . . . 0.0 109.803 176.511 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' D' D ' 79' ' ' LYS . . . . . 0.652 ' O ' HD13 ' D' ' 80' ' ' ILE . 32.9 ttmt -79.46 118.05 20.98 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-O 120.963 0.411 . . . . 0.0 110.986 -176.348 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' D' D ' 80' ' ' ILE . . . . . 0.652 HD13 ' O ' ' D' ' 79' ' ' LYS . 37.1 mm -139.2 104.37 2.16 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.272 0 N-CA-C 109.067 -0.716 . . . . 0.0 109.067 -178.848 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' D' D ' 81' ' ' LYS . . . . . . . . . . . . . 84.5 tttt -95.0 125.56 39.75 Favored 'General case' 0 C--N 1.329 -0.287 0 C-N-CA 120.758 -0.377 . . . . 0.0 110.944 -177.277 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' D' D ' 82' ' ' GLY . . . . . . . . . . . . . . . 89.03 42.2 5.69 Favored Glycine 0 CA--C 1.524 0.594 0 N-CA-C 111.237 -0.745 . . . . 0.0 111.237 176.401 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' D' D ' 83' ' ' ILE . . . . . . . . . . . . . 71.1 mt -65.4 131.51 31.18 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.273 0 N-CA-C 109.68 -0.489 . . . . 0.0 109.68 177.521 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' D' D ' 84' ' ' LYS . . . . . . . . . . . . . 48.6 tttp -89.97 -50.54 5.96 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.025 -0.534 . . . . 0.0 109.947 -179.117 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' D' D ' 85' ' ' ASP . . . . . . . . . . . . . 10.0 t70 -159.85 153.12 22.1 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 115.653 -0.703 . . . . 0.0 110.173 178.366 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' D' D ' 86' ' ' VAL . . . . . . . . . . . . . 41.3 t -127.4 132.63 69.23 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.244 0 CA-C-O 120.965 0.412 . . . . 0.0 110.48 -179.328 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' D' D ' 87' ' ' ILE . . . . . 0.492 HD12 ' N ' ' D' ' 87' ' ' ILE . 5.0 mp -119.95 122.83 69.55 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.238 0 N-CA-C 109.329 -0.619 . . . . 0.0 109.329 176.471 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' D' D ' 88' ' ' LEU . . . . . . . . . . . . . 86.1 mt -109.49 137.18 47.72 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-O 121.157 0.503 . . . . 0.0 111.307 -177.73 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' D' D ' 89' ' ' ASP . . . . . . . . . . . . . 8.6 t70 -131.48 156.47 45.6 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 115.598 -0.728 . . . . 0.0 109.29 176.499 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' D' D ' 90' ' ' GLU . . . . . . . . . . . . . 48.1 mp0 -50.85 -29.07 10.85 Favored 'General case' 0 C--N 1.327 -0.387 0 N-CA-C 112.544 0.572 . . . . 0.0 112.544 -171.177 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' D' D ' 91' ' ' ASN . . . . . . . . . . . . . 54.0 t30 -131.61 13.74 4.94 Favored 'General case' 0 N--CA 1.468 0.464 0 N-CA-C 113.307 0.854 . . . . 0.0 113.307 -176.228 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' D' D ' 92' ' ' LEU . . . . . . . . . . . . . 41.8 mt -147.82 148.72 31.2 Favored 'General case' 0 C--N 1.331 -0.204 0 CA-C-N 118.04 0.382 . . . . 0.0 110.55 -176.85 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' D' D ' 93' ' ' ILE . . . . . . . . . . . . . 72.3 mt -126.09 114.08 37.03 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.357 0 N-CA-C 109.063 -0.717 . . . . 0.0 109.063 175.845 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' D' D ' 94' ' ' VAL . . . . . . . . . . . . . 42.3 t -115.29 125.49 72.56 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.24 0 N-CA-C 109.816 -0.438 . . . . 0.0 109.816 -178.945 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' D' D ' 95' ' ' VAL . . . . . . . . . . . . . 44.6 t -119.29 133.24 66.77 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.283 0 CA-C-N 116.056 -0.52 . . . . 0.0 109.813 -179.83 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' D' D ' 96' ' ' ILE . . . . . . . . . . . . . 64.2 mt -111.7 126.0 69.05 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.358 0 N-CA-C 108.804 -0.813 . . . . 0.0 108.804 177.239 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' D' D ' 97' ' ' THR . . . . . . . . . . . . . 60.3 p -99.82 159.89 14.72 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-O 121.215 0.531 . . . . 0.0 111.388 -176.315 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' D' D ' 98' ' ' GLU . . . . . . . . . . . . . 81.0 tt0 -53.89 -26.28 24.23 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.043 -0.526 . . . . 0.0 112.12 179.254 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' D' D ' 99' ' ' GLU . . . . . . . . . . . . . 95.6 mt-10 -78.01 13.07 1.53 Allowed 'General case' 0 CA--C 1.536 0.432 0 N-CA-C 113.146 0.795 . . . . 0.0 113.146 -177.794 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' D' D ' 100' ' ' ASN . . . . . . . . . . . . . 3.0 m-20 60.47 37.74 19.61 Favored 'General case' 0 CA--C 1.529 0.167 0 CA-C-O 121.126 0.489 . . . . 0.0 110.961 -179.443 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' D' D ' 101' ' ' GLU . . . . . . . . . . . . . 83.4 tt0 -113.74 145.5 41.28 Favored 'General case' 0 C--N 1.332 -0.169 0 N-CA-C 109.45 -0.574 . . . . 0.0 109.45 176.097 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' D' D ' 102' ' ' VAL . . . . . . . . . . . . . 46.3 t -114.82 121.44 66.91 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.319 0 N-CA-C 109.615 -0.513 . . . . 0.0 109.615 -178.817 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' D' D ' 103' ' ' LEU . . . . . . . . . . . . . 39.0 mt -115.31 127.59 55.54 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 115.705 -0.68 . . . . 0.0 109.925 177.593 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' D' D ' 104' ' ' ILE . . . . . 0.417 HD13 HG11 ' D' ' 130' ' ' VAL . 68.4 mt -118.87 120.5 64.24 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.271 0 N-CA-C 110.164 -0.31 . . . . 0.0 110.164 -178.627 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' D' D ' 105' ' ' PHE . . . . . . . . . . . . . 54.8 m-85 -119.72 165.91 13.9 Favored 'General case' 0 C--N 1.331 -0.202 0 O-C-N 123.978 0.798 . . . . 0.0 109.542 179.268 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' D' D ' 106' ' ' ASN . . . . . . . . . . . . . 39.2 p-10 -97.32 -173.0 2.54 Favored 'General case' 0 C--N 1.329 -0.294 0 N-CA-C 109.683 -0.488 . . . . 0.0 109.683 172.597 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' D' D ' 107' ' ' GLN . . . . . . . . . . . . . 43.3 tp60 -58.77 -27.68 65.2 Favored 'General case' 0 CA--C 1.534 0.355 0 N-CA-C 111.78 0.289 . . . . 0.0 111.78 178.382 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' D' D ' 108' ' ' ASN . . . . . . . . . . . . . 9.2 t30 -84.54 9.6 13.15 Favored 'General case' 0 CA--C 1.536 0.415 0 N-CA-C 113.147 0.795 . . . . 0.0 113.147 -177.17 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' D' D ' 109' ' ' LEU . . . . . . . . . . . . . 18.8 mt 58.89 34.34 23.6 Favored 'General case' 0 CA--C 1.53 0.21 0 CA-C-O 120.942 0.401 . . . . 0.0 111.804 178.777 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' D' D ' 110' ' ' GLU . . . . . . . . . . . . . 70.7 mm-40 -107.25 141.52 38.44 Favored 'General case' 0 C--N 1.33 -0.275 0 N-CA-C 108.998 -0.742 . . . . 0.0 108.998 173.14 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' D' D ' 111' ' ' GLU . . . . . . . . . . . . . 52.1 tt0 -85.04 123.38 30.51 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-O 121.186 0.517 . . . . 0.0 111.07 -173.369 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' D' D ' 112' ' ' LEU . . . . . . . . . . . . . 30.4 mt -101.35 -43.23 6.02 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 115.625 -0.716 . . . . 0.0 110.89 178.852 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' D' D ' 113' ' ' TYR . . . . . . . . . . . . . 43.9 t80 -133.01 135.98 45.76 Favored 'General case' 0 C--N 1.332 -0.164 0 CA-C-O 120.784 0.326 . . . . 0.0 111.548 -176.367 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' D' D ' 114' ' ' ARG . . . . . . . . . . . . . 32.3 ttm180 -134.19 120.26 19.84 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-N 115.892 -0.594 . . . . 0.0 110.067 176.664 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' D' D ' 115' ' ' GLY . . . . . . . . . . . . . . . -150.01 159.73 28.22 Favored Glycine 0 CA--C 1.523 0.555 0 N-CA-C 110.825 -0.91 . . . . 0.0 110.825 178.659 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' D' D ' 116' ' ' LYS . . . . . . . . . . . . . 32.9 ttmt -136.05 139.7 43.27 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-O 120.817 0.341 . . . . 0.0 110.288 178.067 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' D' D ' 117' ' ' PHE . . . . . . . . . . . . . 20.4 m-85 -138.19 119.97 15.25 Favored 'General case' 0 C--N 1.331 -0.236 0 N-CA-C 109.911 -0.404 . . . . 0.0 109.911 -177.427 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' D' D ' 118' ' ' GLU . . . . . . . . . . . . . 96.1 mt-10 -55.51 -40.17 71.42 Favored 'General case' 0 C--N 1.329 -0.326 0 C-N-CA 120.916 -0.313 . . . . 0.0 110.915 -178.224 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' D' D ' 119' ' ' ASN . . . . . . . . . . . . . 78.3 m-20 -97.23 28.94 3.38 Favored 'General case' 0 C--N 1.331 -0.218 0 N-CA-C 112.35 0.5 . . . . 0.0 112.35 -174.795 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' D' D ' 120' ' ' LEU . . . . . . . . . . . . . 16.7 tp -58.18 119.97 7.81 Favored 'General case' 0 C--N 1.333 -0.131 0 N-CA-C 110.125 -0.324 . . . . 0.0 110.125 178.237 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' D' D ' 121' ' ' ASN . . . . . . . . . . . . . 66.2 t30 -114.01 -44.22 3.17 Favored 'General case' 0 C--N 1.331 -0.227 0 CA-C-N 116.511 -0.313 . . . . 0.0 111.273 -177.053 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' D' D ' 122' ' ' LYS . . . . . . . . . . . . . 59.8 mttm -146.7 154.5 41.5 Favored 'General case' 0 C--N 1.33 -0.241 0 C-N-CA 120.653 -0.419 . . . . 0.0 111.739 -176.434 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' D' D ' 123' ' ' VAL . . . . . . . . . . . . . 43.8 t -131.71 129.95 61.66 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.243 0 CA-C-N 115.971 -0.559 . . . . 0.0 109.731 175.221 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' D' D ' 124' ' ' LEU . . . . . . . . . . . . . 30.3 mt -118.92 133.7 55.66 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-N 116.31 -0.405 . . . . 0.0 110.623 -179.164 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' D' D ' 125' ' ' VAL . . . . . 0.426 HG22 HG23 ' D' ' 130' ' ' VAL . 45.3 t -129.01 124.41 60.81 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 N-CA-C 109.895 -0.409 . . . . 0.0 109.895 178.153 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' D' D ' 126' ' ' ARG . . . . . . . . . . . . . 44.1 mtp180 -148.87 130.92 15.33 Favored 'General case' 0 C--N 1.329 -0.296 0 N-CA-C 109.69 -0.485 . . . . 0.0 109.69 179.189 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' D' D ' 127' ' ' ASN . . . . . . . . . . . . . 37.2 t30 56.32 -152.54 0.38 Allowed 'General case' 0 CA--C 1.539 0.527 0 N-CA-C 109.742 -0.466 . . . . 0.0 109.742 -179.943 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' D' D ' 128' ' ' ASP . . . . . . . . . . . . . 12.3 p-10 -84.05 18.67 2.01 Favored 'General case' 0 CA--C 1.536 0.428 0 CA-C-N 118.506 0.594 . . . . 0.0 112.602 177.936 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' D' D ' 129' ' ' LEU . . . . . . . . . . . . . 15.3 tp -117.82 138.83 51.82 Favored 'General case' 0 C--O 1.232 0.181 0 O-C-N 122.172 -0.33 . . . . 0.0 110.164 179.632 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' D' D ' 130' ' ' VAL . . . . . 0.487 HG13 ' HB ' ' D' ' 141' ' ' ILE . 12.5 p -129.11 141.18 47.27 Favored 'Isoleucine or valine' 0 N--CA 1.462 0.171 0 CA-C-O 121.133 0.492 . . . . 0.0 110.248 179.891 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' D' D ' 131' ' ' VAL . . . . . . . . . . . . . 58.8 t -136.06 137.56 48.47 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.276 0 CA-C-N 115.85 -0.614 . . . . 0.0 110.555 -177.197 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' D' D ' 132' ' ' ILE . . . . . . . . . . . . . 74.4 mt -114.14 133.94 58.59 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.243 0 CA-C-N 115.881 -0.599 . . . . 0.0 109.441 179.296 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' D' D ' 133' ' ' ILE . . . . . . . . . . . . . 42.9 mm -116.29 122.23 69.27 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.243 0 CA-C-O 120.822 0.344 . . . . 0.0 110.8 -175.323 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' D' D ' 134' ' ' ASP . . . . . . . . . . . . . 7.2 p-10 -136.03 146.04 46.69 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.148 -0.478 . . . . 0.0 109.838 175.248 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' D' D ' 135' ' ' GLU . . . . . . . . . . . . . 80.6 tt0 -49.85 -22.97 1.65 Allowed 'General case' 0 C--N 1.328 -0.344 0 N-CA-C 113.076 0.769 . . . . 0.0 113.076 -171.464 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' D' D ' 136' ' ' GLN . . . . . . . . . . . . . 13.3 pt20 -100.9 -30.44 11.66 Favored 'General case' 0 N--CA 1.464 0.249 0 N-CA-C 112.674 0.62 . . . . 0.0 112.674 -175.587 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' D' D ' 137' ' ' LYS . . . . . . . . . . . . . 87.3 mttt -142.6 158.05 44.07 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-O 121.407 0.622 . . . . 0.0 112.129 -173.019 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' D' D ' 138' ' ' LEU . . . . . . . . . . . . . 4.6 tt -118.48 122.13 41.96 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-N 115.174 -0.921 . . . . 0.0 108.883 171.459 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' D' D ' 139' ' ' THR . . . . . . . . . . . . . 28.0 m -111.16 125.06 53.39 Favored 'General case' 0 C--N 1.332 -0.162 0 CA-C-O 120.644 0.259 . . . . 0.0 110.899 -176.71 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' D' D ' 140' ' ' LEU . . . . . 0.479 ' C ' HD23 ' D' ' 140' ' ' LEU . 7.7 tt -114.03 125.68 54.27 Favored 'General case' 0 C--N 1.327 -0.388 0 N-CA-C 109.294 -0.632 . . . . 0.0 109.294 -179.265 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' D' D ' 141' ' ' ILE . . . . . 0.487 ' HB ' HG13 ' D' ' 130' ' ' VAL . 19.7 mt -123.28 120.37 60.08 Favored 'Isoleucine or valine' 0 C--O 1.235 0.311 0 N-CA-C 109.715 -0.476 . . . . 0.0 109.715 -176.146 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' D' D ' 142' ' ' ARG . . . . . . . . . . . . . 61.2 ttt180 -114.51 127.24 55.7 Favored 'General case' 0 C--N 1.332 -0.177 0 CA-C-N 115.448 -0.796 . . . . 0.0 110.327 -176.347 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' D' D ' 143' ' ' THR . . . . . . . . . . . . . 28.7 p . . . . . 0 C--O 1.219 -0.516 0 CA-C-O 118.018 -0.992 . . . . 0.0 110.597 -179.68 . . . . . . . . 0 0 . 1 . 015 nuclear build core ' E' E ' 2' ' ' SER . . . . . . . . . . . . . 4.9 p . . . . . 0 N--CA 1.462 0.164 0 CA-C-O 121.103 0.478 . . . . 0.0 110.67 . . . . . . . . . 0 0 . 1 . 015 nuclear build core ' E' E ' 3' ' ' GLU . . . . . . . . . . . . . 79.8 tt0 -145.83 143.06 29.4 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 115.884 -0.598 . . . . 0.0 111.021 -178.003 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' E' E ' 4' ' ' LEU . . . . . 0.509 HD21 HD21 ' E' ' 6' ' ' LEU . 15.1 tp -123.59 135.37 53.93 Favored 'General case' 0 C--N 1.331 -0.217 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.281 177.359 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' E' E ' 5' ' ' LYS . . . . . . . . . . . . . 90.3 mttt -109.09 120.04 41.34 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.23 -0.441 . . . . 0.0 110.38 178.87 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' E' E ' 6' ' ' LEU . . . . . 0.509 HD21 HD21 ' E' ' 4' ' ' LEU . 59.4 mt -116.58 142.89 46.3 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 115.63 -0.713 . . . . 0.0 111.096 -177.815 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' E' E ' 7' ' ' LYS . . . . . . . . . . . . . 60.3 tttm -133.89 140.6 36.92 Favored Pre-proline 0 CA--C 1.534 0.338 0 CA-C-O 119.015 -0.517 . . . . 0.0 110.033 176.522 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' E' E ' 8' ' ' PRO . . . . . . . . . . . . . 98.1 Cg_endo -90.78 143.73 3.5 Favored 'Trans proline' 0 N--CA 1.49 1.314 0 C-N-CA 121.804 1.669 . . . . 0.0 111.866 178.247 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' E' E ' 9' ' ' LEU . . . . . . . . . . . . . 43.6 mt -84.08 -48.26 0.7 Allowed Pre-proline 0 CA--C 1.534 0.342 0 CA-C-O 118.683 -0.675 . . . . 0.0 112.389 -179.205 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' E' E ' 10' ' ' PRO . . . . . . . . . . . . . 88.1 Cg_endo -79.91 158.02 24.13 Favored 'Trans proline' 0 N--CA 1.496 1.642 0 C-N-CA 121.258 1.305 . . . . 0.0 111.845 177.408 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' E' E ' 11' ' ' LYS . . . . . . . . . . . . . 39.3 ttpt -88.0 94.84 9.91 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-O 120.863 0.363 . . . . 0.0 110.422 179.47 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' E' E ' 12' ' ' VAL . . . . . . . . . . . . . 12.4 p -143.15 143.47 24.86 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.286 0 CA-C-N 116.23 -0.441 . . . . 0.0 110.583 179.099 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' E' E ' 13' ' ' GLU . . . . . . . . . . . . . 70.6 mm-40 -84.4 132.62 34.56 Favored 'General case' 0 C--N 1.33 -0.254 0 N-CA-C 109.951 -0.388 . . . . 0.0 109.951 177.263 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' E' E ' 14' ' ' LEU . . . . . . . . . . . . . 48.8 mt -97.97 147.7 33.43 Favored Pre-proline 0 CA--C 1.532 0.278 0 CA-C-O 119.309 -0.376 . . . . 0.0 110.381 -178.151 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' E' E ' 15' ' ' PRO . . . . . . . . . . . . . 24.9 Cg_exo -62.69 161.72 27.49 Favored 'Trans proline' 0 N--CA 1.498 1.749 0 C-N-CA 121.25 1.3 . . . . 0.0 111.825 175.98 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' E' E ' 16' ' ' PRO . . . . . . . . . . . . . 31.2 Cg_exo -59.38 -39.51 76.21 Favored 'Trans proline' 0 N--CA 1.497 1.691 0 C-N-CA 121.422 1.414 . . . . 0.0 112.661 -178.219 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' E' E ' 17' ' ' ASP . . . . . . . . . . . . . 22.8 p-10 -88.71 11.28 18.03 Favored 'General case' 0 CA--C 1.535 0.387 0 N-CA-C 113.172 0.805 . . . . 0.0 113.172 -177.646 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' E' E ' 18' ' ' PHE . . . . . . . . . . . . . 43.5 t80 -57.82 -44.53 86.46 Favored 'General case' 0 C--N 1.335 -0.056 0 O-C-N 122.014 -0.429 . . . . 0.0 110.121 -178.059 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' E' E ' 19' ' ' VAL . . . . . . . . . . . . . 47.6 t -58.16 -41.52 80.99 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.336 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.309 -179.069 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' E' E ' 20' ' ' ASP . . . . . . . . . . . . . 76.2 m-20 -59.72 -42.35 92.89 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-O 120.851 0.358 . . . . 0.0 110.805 -177.655 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' E' E ' 21' ' ' VAL . . . . . . . . . . . . . 47.0 t -64.6 -47.87 87.2 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.294 0 CA-C-N 116.36 -0.382 . . . . 0.0 110.42 -178.194 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' E' E ' 22' ' ' ILE . . . . . 0.581 HG22 HD12 ' E' ' 26' ' ' LEU . 49.6 mm -56.05 -45.03 80.32 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.256 0 CA-C-O 120.727 0.299 . . . . 0.0 110.662 179.102 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' E' E ' 23' ' ' ARG . . . . . . . . . . . . . 59.4 ttp180 -54.09 -49.94 67.94 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-O 120.694 0.283 . . . . 0.0 111.388 -178.313 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' E' E ' 24' ' ' ILE . . . . . . . . . . . . . 71.2 mt -60.06 -44.59 95.25 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.271 0 CA-C-N 116.626 -0.261 . . . . 0.0 111.105 -178.044 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' E' E ' 25' ' ' LYS . . . . . . . . . . . . . 83.4 mttt -64.84 -37.91 89.21 Favored 'General case' 0 C--N 1.329 -0.308 0 N-CA-C 112.394 0.516 . . . . 0.0 112.394 -177.694 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' E' E ' 26' ' ' LEU . . . . . 0.581 HD12 HG22 ' E' ' 22' ' ' ILE . 50.0 mt -79.27 -42.19 26.42 Favored 'General case' 0 C--N 1.331 -0.221 0 N-CA-C 113.53 0.937 . . . . 0.0 113.53 -172.046 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' E' E ' 27' ' ' GLN . . . . . . . . . . . . . 11.1 pt20 -46.83 141.88 3.71 Favored 'General case' 0 N--CA 1.469 0.491 0 N-CA-C 112.905 0.705 . . . . 0.0 112.905 -173.772 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' E' E ' 28' ' ' GLY . . . . . . . . . . . . . . . 97.75 -26.26 23.96 Favored Glycine 0 CA--C 1.531 1.086 0 CA-C-N 115.418 -0.81 . . . . 0.0 112.184 -177.818 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' E' E ' 29' ' ' LYS . . . . . . . . . . . . . 69.5 mttm -97.77 155.12 17.18 Favored 'General case' 0 C--N 1.331 -0.222 0 CA-C-N 117.365 0.583 . . . . 0.0 110.976 178.249 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' E' E ' 30' ' ' THR . . . . . . . . . . . . . 19.2 m -106.79 137.12 45.42 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 115.931 -0.577 . . . . 0.0 109.727 175.149 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' E' E ' 31' ' ' VAL . . . . . . . . . . . . . 35.0 m -128.17 154.97 39.5 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.253 0 CA-C-O 120.973 0.416 . . . . 0.0 110.862 -177.691 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' E' E ' 32' ' ' ARG . . . . . . . . . . . . . 59.1 ttm-85 -127.24 146.1 50.54 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.04 -0.527 . . . . 0.0 110.327 -179.972 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' E' E ' 33' ' ' THR . . . . . . . . . . . . . 18.6 m -53.08 139.26 28.91 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.469 -0.332 . . . . 0.0 111.355 -177.861 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' E' E ' 34' ' ' GLY . . . . . . . . . . . . . . . 101.13 -17.13 56.44 Favored Glycine 0 CA--C 1.532 1.156 0 CA-C-O 119.674 -0.514 . . . . 0.0 113.243 -179.826 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' E' E ' 35' ' ' ASP . . . . . . . . . . . . . 78.8 m-20 -66.51 149.03 51.05 Favored 'General case' 0 C--O 1.23 0.071 0 CA-C-N 118.018 0.909 . . . . 0.0 111.198 178.542 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' E' E ' 36' ' ' VAL . . . . . . . . . . . . . 44.0 t -123.38 131.95 72.25 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.18 0 CA-C-N 115.865 -0.607 . . . . 0.0 109.786 177.985 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' E' E ' 37' ' ' ILE . . . . . . . . . . . . . 67.8 mt -121.91 140.65 45.21 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.21 0 CA-C-N 116.256 -0.429 . . . . 0.0 109.952 -178.936 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' E' E ' 38' ' ' GLY . . . . . . . . . . . . . . . -110.71 128.81 8.95 Favored Glycine 0 CA--C 1.527 0.802 0 N-CA-C 111.348 -0.701 . . . . 0.0 111.348 -179.528 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' E' E ' 39' ' ' ILE . . . . . . . . . . . . . 72.8 mt -123.83 134.25 67.0 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.207 0 N-CA-C 110.135 -0.32 . . . . 0.0 110.135 179.134 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' E' E ' 40' ' ' SER . . . . . . . . . . . . . 19.5 p -93.57 114.19 26.47 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.508 -0.314 . . . . 0.0 110.993 176.214 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' E' E ' 41' ' ' ILE . . . . . . . . . . . . . 44.7 mm -121.58 124.46 71.75 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.269 0 CA-C-O 120.789 0.328 . . . . 0.0 110.334 179.074 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' E' E ' 42' ' ' LEU . . . . . . . . . . . . . 57.7 mt 52.0 33.06 11.11 Favored 'General case' 0 C--N 1.331 -0.23 0 CA-C-N 116.254 -0.43 . . . . 0.0 111.933 177.359 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' E' E ' 43' ' ' GLY . . . . . . . . . . . . . . . 72.4 33.65 61.22 Favored Glycine 0 CA--C 1.529 0.932 0 C-N-CA 121.091 -0.576 . . . . 0.0 111.749 178.747 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' E' E ' 44' ' ' LYS . . . . . . . . . . . . . 21.1 tptm -138.86 131.23 28.54 Favored 'General case' 0 C--N 1.329 -0.3 0 N-CA-C 109.463 -0.569 . . . . 0.0 109.463 179.539 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' E' E ' 45' ' ' GLU . . . . . . . . . . . . . 80.9 tt0 -82.52 119.25 23.99 Favored 'General case' 0 C--N 1.328 -0.359 0 C-N-CA 120.795 -0.362 . . . . 0.0 110.941 -177.267 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' E' E ' 46' ' ' VAL . . . . . . . . . . . . . 7.4 p -119.97 126.44 75.29 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.18 0 N-CA-C 109.451 -0.574 . . . . 0.0 109.451 176.26 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' E' E ' 47' ' ' LYS . . . . . . . . . . . . . 63.2 mttp -99.97 129.53 46.05 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 115.898 -0.592 . . . . 0.0 111.206 178.916 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' E' E ' 48' ' ' PHE . . . . . . . . . . . . . 87.4 m-85 -112.01 131.8 55.18 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.062 -0.517 . . . . 0.0 110.191 177.162 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' E' E ' 49' ' ' LYS . . . . . . . . . . . . . 79.0 tttt -107.71 135.71 48.68 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.343 -0.39 . . . . 0.0 110.63 -179.666 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' E' E ' 50' ' ' VAL . . . . . . . . . . . . . 45.9 t -81.41 107.55 13.72 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.242 0 N-CA-C 109.123 -0.695 . . . . 0.0 109.123 175.406 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' E' E ' 51' ' ' VAL . . . . . . . . . . . . . 42.9 t -73.14 -50.85 29.01 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.346 0 CA-C-N 115.994 -0.548 . . . . 0.0 109.791 -174.399 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' E' E ' 52' ' ' GLN . . . . . . . . . . . . . 70.2 mt-30 -154.92 155.1 33.69 Favored 'General case' 0 C--N 1.331 -0.218 0 CA-C-O 121.135 0.493 . . . . 0.0 111.699 -179.332 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' E' E ' 53' ' ' ALA . . . . . 0.501 ' HB1' ' HB2' ' E' ' 58' ' ' LEU . . . -131.68 133.78 45.24 Favored 'General case' 0 C--N 1.33 -0.283 0 CA-C-N 115.364 -0.835 . . . . 0.0 109.886 175.629 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' E' E ' 54' ' ' TYR . . . . . . . . . . . . . 57.7 t80 -129.13 109.08 18.03 Favored Pre-proline 0 CA--C 1.534 0.344 0 CA-C-O 118.284 -0.865 . . . . 0.0 110.439 179.399 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' E' E ' 55' ' ' PRO . . . . . . . . . . . . . 72.8 Cg_endo -77.1 169.8 73.32 Favored 'Cis proline' 0 N--CA 1.498 1.746 0 CA-C-N 121.911 1.718 . . . . 0.0 112.356 -5.457 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' E' E ' 56' ' ' SER . . . . . . . . . . . . . 30.7 m -116.6 129.03 25.57 Favored Pre-proline 0 CA--C 1.538 0.516 0 CA-C-O 118.368 -0.825 . . . . 0.0 109.404 175.244 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' E' E ' 57' ' ' PRO . . . . . . . . . . . . . 42.6 Cg_endo -68.97 148.93 85.87 Favored 'Cis proline' 0 N--CA 1.498 1.771 0 CA-C-N 122.052 1.768 . . . . 0.0 111.815 -0.586 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' E' E ' 58' ' ' LEU . . . . . 0.501 ' HB2' ' HB1' ' E' ' 53' ' ' ALA . 23.5 tp -108.2 138.53 44.32 Favored 'General case' 0 C--N 1.331 -0.222 0 CA-C-N 116.101 -0.499 . . . . 0.0 110.667 -178.304 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' E' E ' 59' ' ' ARG . . . . . . . . . . . . . 60.6 ttt180 -103.44 131.33 50.63 Favored 'General case' 0 C--N 1.328 -0.346 0 N-CA-C 109.404 -0.591 . . . . 0.0 109.404 175.872 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' E' E ' 60' ' ' VAL . . . . . . . . . . . . . 42.1 t -89.71 119.0 36.1 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.287 0 C-N-CA 120.669 -0.412 . . . . 0.0 110.516 -176.483 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' E' E ' 61' ' ' GLU . . . . . . . . . . . . . 95.1 mt-10 -131.18 167.46 19.12 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.104 -0.498 . . . . 0.0 110.002 176.525 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' E' E ' 62' ' ' ASP . . . . . . . . . . . . . 80.5 m-20 -54.4 -32.71 57.77 Favored 'General case' 0 C--N 1.328 -0.365 0 N-CA-C 111.678 0.251 . . . . 0.0 111.678 -179.712 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' E' E ' 63' ' ' ARG . . . . . . . . . . . . . 11.1 ptm180 -85.7 6.41 27.81 Favored 'General case' 0 CA--C 1.536 0.423 0 N-CA-C 113.551 0.945 . . . . 0.0 113.551 -175.505 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' E' E ' 64' ' ' THR . . . . . . . . . . . . . 23.8 m -85.66 138.68 31.98 Favored 'General case' 0 C--N 1.332 -0.155 0 CA-C-N 118.237 0.472 . . . . 0.0 110.591 -179.09 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' E' E ' 65' ' ' LYS . . . . . . . . . . . . . 48.7 mtmt -87.68 129.78 35.02 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-O 120.949 0.404 . . . . 0.0 110.322 178.565 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' E' E ' 66' ' ' ILE . . . . . . . . . . . . . 58.8 mt -113.11 124.87 70.18 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.316 0 N-CA-C 109.504 -0.554 . . . . 0.0 109.504 179.73 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' E' E ' 67' ' ' THR . . . . . . . . . . . . . 17.8 m -115.48 137.78 51.7 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-O 121.077 0.465 . . . . 0.0 110.663 -177.582 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' E' E ' 68' ' ' LEU . . . . . . . . . . . . . 15.8 tp . . . . . 0 C--N 1.329 -0.319 0 CA-C-N 115.817 -0.628 . . . . 0.0 110.772 -178.333 . . . . . . . . 0 0 . 1 . 015 nuclear build core ' E' E ' 73' ' ' VAL . . . . . . . . . . . . . 30.1 m . . . . . 0 C--O 1.231 0.13 0 CA-C-O 120.905 0.383 . . . . 0.0 111.143 . . . . . . . . . 0 0 . 1 . 015 nuclear build core ' E' E ' 74' ' ' ASP . . . . . . . . . . . . . 12.3 t70 -91.28 122.78 34.19 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 115.882 -0.599 . . . . 0.0 110.48 -174.048 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' E' E ' 75' ' ' VAL . . . . . . . . . . . . . 44.3 t -116.99 120.71 65.92 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.248 0 CA-C-O 121.14 0.495 . . . . 0.0 110.134 178.98 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' E' E ' 76' ' ' LEU . . . . . . . . . . . . . 16.5 mt -122.31 143.23 49.75 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 115.603 -0.726 . . . . 0.0 109.75 178.098 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' E' E ' 77' ' ' GLU . . . . . . . . . . . . . 96.0 mt-10 -136.89 135.51 37.88 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-O 121.048 0.451 . . . . 0.0 111.112 -177.804 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' E' E ' 78' ' ' ALA . . . . . . . . . . . . . . . -119.93 139.69 52.05 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 115.643 -0.708 . . . . 0.0 109.795 176.678 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' E' E ' 79' ' ' LYS . . . . . 0.707 ' O ' HD13 ' E' ' 80' ' ' ILE . 54.7 mttp -87.94 114.5 24.62 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.412 -0.358 . . . . 0.0 110.774 -177.058 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' E' E ' 80' ' ' ILE . . . . . 0.707 HD13 ' O ' ' E' ' 79' ' ' LYS . 33.4 mm -139.05 103.7 2.04 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.325 0 N-CA-C 109.252 -0.647 . . . . 0.0 109.252 -178.703 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' E' E ' 81' ' ' LYS . . . . . . . . . . . . . 37.9 ttpt -98.12 130.51 44.89 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-O 120.93 0.395 . . . . 0.0 110.547 -178.5 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' E' E ' 82' ' ' GLY . . . . . . . . . . . . . . . 89.15 42.13 5.67 Favored Glycine 0 CA--C 1.523 0.563 0 N-CA-C 111.142 -0.783 . . . . 0.0 111.142 178.053 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' E' E ' 83' ' ' ILE . . . . . . . . . . . . . 71.8 mt -72.43 135.38 27.91 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.291 0 N-CA-C 109.323 -0.621 . . . . 0.0 109.323 176.459 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' E' E ' 84' ' ' LYS . . . . . . . . . . . . . 31.4 ttpt -100.0 -50.67 3.92 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-O 120.888 0.375 . . . . 0.0 110.528 -177.062 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' E' E ' 85' ' ' ASP . . . . . . . . . . . . . 8.1 t70 -147.24 150.17 34.32 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.109 -0.496 . . . . 0.0 110.655 -178.783 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' E' E ' 86' ' ' VAL . . . . . . . . . . . . . 42.5 t -131.28 130.71 63.33 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.202 0 CA-C-O 120.993 0.425 . . . . 0.0 110.527 -179.333 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' E' E ' 87' ' ' ILE . . . . . . . . . . . . . 43.6 mm -118.59 125.59 74.5 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.189 0 N-CA-C 109.444 -0.576 . . . . 0.0 109.444 175.843 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' E' E ' 88' ' ' LEU . . . . . . . . . . . . . 17.2 tp -112.98 128.83 56.6 Favored 'General case' 0 C--N 1.331 -0.201 0 CA-C-O 120.924 0.392 . . . . 0.0 111.135 -176.949 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' E' E ' 89' ' ' ASP . . . . . . . . . . . . . 6.7 t70 -125.95 156.28 40.03 Favored 'General case' 0 C--N 1.331 -0.22 0 CA-C-N 115.988 -0.551 . . . . 0.0 109.927 177.172 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' E' E ' 90' ' ' GLU . . . . . . . . . . . . . 64.0 tt0 -45.73 -46.19 14.88 Favored 'General case' 0 N--CA 1.464 0.238 0 N-CA-C 112.988 0.736 . . . . 0.0 112.988 -172.166 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' E' E ' 91' ' ' ASN . . . . . . . . . . . . . 41.0 t30 -132.17 39.98 3.37 Favored 'General case' 0 C--N 1.332 -0.173 0 CA-C-O 121.124 0.488 . . . . 0.0 110.882 -177.647 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' E' E ' 92' ' ' LEU . . . . . . . . . . . . . 11.9 tp -165.39 138.14 4.36 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.243 -0.435 . . . . 0.0 110.168 -178.453 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' E' E ' 93' ' ' ILE . . . . . . . . . . . . . 70.8 mt -126.08 125.17 67.47 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.29 0 N-CA-C 109.905 -0.406 . . . . 0.0 109.905 -178.531 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' E' E ' 94' ' ' VAL . . . . . 0.631 HG21 HG21 ' E' ' 125' ' ' VAL . 43.7 t -122.87 126.61 74.06 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.187 0 N-CA-C 109.938 -0.393 . . . . 0.0 109.938 179.369 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' E' E ' 95' ' ' VAL . . . . . . . . . . . . . 43.7 t -121.43 133.79 66.83 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.317 0 CA-C-N 116.1 -0.5 . . . . 0.0 109.699 179.555 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' E' E ' 96' ' ' ILE . . . . . . . . . . . . . 68.4 mt -117.36 129.63 73.54 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.283 0 N-CA-C 109.348 -0.612 . . . . 0.0 109.348 -179.778 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' E' E ' 97' ' ' THR . . . . . . . . . . . . . 61.6 p -105.31 162.42 13.44 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-O 121.549 0.69 . . . . 0.0 111.896 -174.53 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' E' E ' 98' ' ' GLU . . . . . . . . . . . . . 13.1 mm-40 -53.8 -28.91 38.0 Favored 'General case' 0 CA--C 1.531 0.241 0 CA-C-N 115.727 -0.669 . . . . 0.0 112.121 179.254 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' E' E ' 99' ' ' GLU . . . . . . . . . . . . . 95.2 mt-10 -79.53 16.92 0.95 Allowed 'General case' 0 CA--C 1.535 0.402 0 N-CA-C 113.164 0.801 . . . . 0.0 113.164 -175.032 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' E' E ' 100' ' ' ASN . . . . . . . . . . . . . 4.0 m-20 62.11 38.12 14.07 Favored 'General case' 0 N--CA 1.463 0.208 0 CA-C-O 121.094 0.473 . . . . 0.0 110.84 177.935 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' E' E ' 101' ' ' GLU . . . . . . . . . . . . . 83.3 tt0 -120.41 143.04 48.67 Favored 'General case' 0 C--N 1.331 -0.203 0 CA-C-N 116.184 -0.462 . . . . 0.0 109.979 178.242 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' E' E ' 102' ' ' VAL . . . . . . . . . . . . . 43.1 t -115.03 127.71 72.48 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.282 0 CA-C-N 116.262 -0.426 . . . . 0.0 109.938 179.135 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' E' E ' 103' ' ' LEU . . . . . 0.507 HD12 ' N ' ' E' ' 103' ' ' LEU . 6.3 mp -116.34 131.53 56.92 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-N 115.676 -0.693 . . . . 0.0 109.786 175.954 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' E' E ' 104' ' ' ILE . . . . . . . . . . . . . 69.7 mt -118.74 123.69 71.94 Favored 'Isoleucine or valine' 0 C--O 1.234 0.269 0 N-CA-C 110.118 -0.327 . . . . 0.0 110.118 -179.004 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' E' E ' 105' ' ' PHE . . . . . . . . . . . . . 57.5 m-85 -124.6 164.28 20.17 Favored 'General case' 0 C--N 1.332 -0.191 0 O-C-N 124.07 0.856 . . . . 0.0 109.774 -179.725 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' E' E ' 106' ' ' ASN . . . . . . . . . . . . . 44.1 p-10 -96.71 -169.87 1.96 Allowed 'General case' 0 C--N 1.331 -0.199 0 N-CA-C 110.114 -0.328 . . . . 0.0 110.114 173.749 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' E' E ' 107' ' ' GLN . . . . . . . . . . . . . 46.5 tt0 -58.2 -30.04 66.15 Favored 'General case' 0 C--N 1.33 -0.279 0 N-CA-C 111.927 0.344 . . . . 0.0 111.927 -179.897 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' E' E ' 108' ' ' ASN . . . . . . . . . . . . . 11.9 t-20 -88.58 13.29 12.43 Favored 'General case' 0 CA--C 1.535 0.389 0 N-CA-C 113.037 0.754 . . . . 0.0 113.037 -176.578 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' E' E ' 109' ' ' LEU . . . . . . . . . . . . . 21.2 mt 57.06 33.81 23.92 Favored 'General case' 0 CA--C 1.53 0.196 0 N-CA-C 111.812 0.301 . . . . 0.0 111.812 179.01 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' E' E ' 110' ' ' GLU . . . . . . . . . . . . . 96.0 mt-10 -100.19 132.7 45.41 Favored 'General case' 0 C--N 1.329 -0.311 0 N-CA-C 109.171 -0.677 . . . . 0.0 109.171 174.688 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' E' E ' 111' ' ' GLU . . . . . . . . . . . . . 52.6 tt0 -74.79 121.84 22.39 Favored 'General case' 0 C--N 1.327 -0.385 0 CA-C-O 121.017 0.437 . . . . 0.0 110.875 -173.606 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' E' E ' 112' ' ' LEU . . . . . . . . . . . . . 73.4 mt -100.64 -46.12 5.28 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 115.872 -0.603 . . . . 0.0 110.61 179.519 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' E' E ' 113' ' ' TYR . . . . . . . . . . . . . 64.2 t80 -140.89 143.66 34.8 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.121 -0.491 . . . . 0.0 111.277 -177.237 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' E' E ' 114' ' ' ARG . . . . . . . . . . . . . 47.0 ptt85 -144.25 126.14 15.32 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.09 -0.504 . . . . 0.0 110.603 176.417 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' E' E ' 115' ' ' GLY . . . . . . . . . . . . . . . -150.03 147.52 17.83 Favored Glycine 0 CA--C 1.524 0.646 0 N-CA-C 111.11 -0.796 . . . . 0.0 111.11 179.203 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' E' E ' 116' ' ' LYS . . . . . . . . . . . . . 37.1 ttpt -118.72 135.53 54.44 Favored 'General case' 0 C--N 1.33 -0.264 0 N-CA-C 109.92 -0.4 . . . . 0.0 109.92 177.64 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' E' E ' 117' ' ' PHE . . . . . . . . . . . . . 43.0 m-85 -127.25 115.42 19.03 Favored 'General case' 0 C--N 1.331 -0.211 0 CA-C-N 116.215 -0.448 . . . . 0.0 109.914 -177.2 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' E' E ' 118' ' ' GLU . . . . . . . . . . . . . 96.1 mt-10 -53.99 -48.26 70.58 Favored 'General case' 0 C--N 1.33 -0.282 0 C-N-CA 121.005 -0.278 . . . . 0.0 111.344 -176.364 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' E' E ' 119' ' ' ASN . . . . . . . . . . . . . 65.7 m-80 -95.69 31.13 2.12 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 115.964 -0.562 . . . . 0.0 112.074 -174.828 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' E' E ' 120' ' ' LEU . . . . . . . . . . . . . 17.5 tp -53.23 119.92 5.34 Favored 'General case' 0 N--CA 1.463 0.215 0 CA-C-O 120.795 0.331 . . . . 0.0 110.909 179.421 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' E' E ' 121' ' ' ASN . . . . . . . . . . . . . 43.2 m-80 -114.13 -44.13 3.17 Favored 'General case' 0 C--N 1.333 -0.15 0 CA-C-N 116.273 -0.421 . . . . 0.0 111.102 -177.581 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' E' E ' 122' ' ' LYS . . . . . . . . . . . . . 18.7 mtpp -139.79 142.5 36.7 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.33 -0.395 . . . . 0.0 111.706 -174.876 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' E' E ' 123' ' ' VAL . . . . . . . . . . . . . 46.4 t -132.81 126.16 53.7 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.377 0 N-CA-C 109.339 -0.615 . . . . 0.0 109.339 172.953 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' E' E ' 124' ' ' LEU . . . . . . . . . . . . . 7.4 tp -129.09 130.94 47.13 Favored 'General case' 0 C--O 1.232 0.179 0 CA-C-O 120.939 0.4 . . . . 0.0 110.538 -178.114 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' E' E ' 125' ' ' VAL . . . . . 0.631 HG21 HG21 ' E' ' 94' ' ' VAL . 41.5 t -124.75 133.17 70.12 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.218 0 CA-C-N 116.014 -0.539 . . . . 0.0 109.884 179.345 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' E' E ' 126' ' ' ARG . . . . . . . . . . . . . 34.7 ttm180 -155.68 124.04 5.88 Favored 'General case' 0 C--N 1.328 -0.327 0 N-CA-C 109.619 -0.512 . . . . 0.0 109.619 179.06 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' E' E ' 127' ' ' ASN . . . . . . . . . . . . . 32.1 t30 57.97 -154.44 0.36 Allowed 'General case' 0 CA--C 1.538 0.487 0 N-CA-C 109.296 -0.631 . . . . 0.0 109.296 -175.936 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' E' E ' 128' ' ' ASP . . . . . . . . . . . . . 9.0 p-10 -80.94 16.5 1.45 Allowed 'General case' 0 CA--C 1.536 0.424 0 N-CA-C 112.51 0.559 . . . . 0.0 112.51 176.635 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' E' E ' 129' ' ' LEU . . . . . . . . . . . . . 26.3 tp -107.7 131.28 54.59 Favored 'General case' 0 C--O 1.232 0.155 0 O-C-N 122.019 -0.426 . . . . 0.0 110.014 177.865 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' E' E ' 130' ' ' VAL . . . . . . . . . . . . . 44.6 t -125.3 134.93 65.58 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.27 0 N-CA-C 109.843 -0.428 . . . . 0.0 109.843 -179.352 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' E' E ' 131' ' ' VAL . . . . . 0.437 HG22 HD12 ' E' ' 140' ' ' LEU . 43.4 t -134.05 133.42 56.01 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.252 0 CA-C-O 121.137 0.494 . . . . 0.0 110.252 178.388 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' E' E ' 132' ' ' ILE . . . . . . . . . . . . . 73.1 mt -119.63 132.96 67.95 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.252 0 CA-C-N 115.601 -0.727 . . . . 0.0 109.411 179.648 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' E' E ' 133' ' ' ILE . . . . . . . . . . . . . 42.8 mm -118.03 123.27 71.41 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.277 0 CA-C-O 120.886 0.374 . . . . 0.0 111.2 -174.029 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' E' E ' 134' ' ' ASP . . . . . . . . . . . . . 5.3 p-10 -127.38 151.6 48.58 Favored 'General case' 0 C--N 1.331 -0.227 0 CA-C-N 115.843 -0.617 . . . . 0.0 109.6 173.397 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' E' E ' 135' ' ' GLU . . . . . . . . . . . . . 43.2 tp10 -49.73 -26.38 3.76 Favored 'General case' 0 C--N 1.329 -0.314 0 N-CA-C 112.86 0.689 . . . . 0.0 112.86 -169.859 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' E' E ' 136' ' ' GLN . . . . . . . . . . . . . 97.3 mt-30 -102.9 -31.12 10.41 Favored 'General case' 0 N--CA 1.464 0.228 0 N-CA-C 112.851 0.686 . . . . 0.0 112.851 -174.345 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' E' E ' 137' ' ' LYS . . . . . . . . . . . . . 27.7 ttpp -144.17 153.91 42.59 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-O 121.223 0.535 . . . . 0.0 111.673 -166.689 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' E' E ' 138' ' ' LEU . . . . . 0.41 ' C ' HD23 ' E' ' 138' ' ' LEU . 6.8 tt -118.73 126.31 51.61 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 115.616 -0.72 . . . . 0.0 110.056 178.388 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' E' E ' 139' ' ' THR . . . . . . . . . . . . . 33.4 m -107.45 125.44 51.25 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.095 -179.901 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' E' E ' 140' ' ' LEU . . . . . 0.437 HD12 HG22 ' E' ' 131' ' ' VAL . 7.5 tp -113.91 120.25 40.06 Favored 'General case' 0 C--N 1.329 -0.299 0 N-CA-C 109.065 -0.717 . . . . 0.0 109.065 -179.948 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' E' E ' 141' ' ' ILE . . . . . . . . . . . . . 18.3 mt -120.99 126.09 74.8 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.268 0 CA-C-O 120.894 0.378 . . . . 0.0 110.459 -172.779 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' E' E ' 142' ' ' ARG . . . . . . . . . . . . . 77.9 mtp180 -109.12 130.65 55.48 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 115.651 -0.704 . . . . 0.0 109.977 176.571 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' E' E ' 143' ' ' THR . . . . . . . . . . . . . 58.9 p . . . . . 0 C--O 1.22 -0.453 0 CA-C-O 118.025 -0.988 . . . . 0.0 110.452 -179.937 . . . . . . . . 0 0 . 1 . 015 nuclear build core ' F' F ' 1' ' ' MET . . . . . . . . . . . . . 26.1 ptt? . . . . . 0 C--O 1.232 0.14 0 CA-C-O 120.914 0.388 . . . . 0.0 111.126 . . . . . . . . . 0 0 . 1 . 015 nuclear build core ' F' F ' 2' ' ' SER . . . . . . . . . . . . . 7.6 p -111.57 139.94 46.6 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.028 -0.533 . . . . 0.0 110.31 178.26 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' F' F ' 3' ' ' GLU . . . . . . . . . . . . . 81.1 tt0 -143.79 143.89 31.55 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.333 -0.394 . . . . 0.0 111.356 -176.836 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' F' F ' 4' ' ' LEU . . . . . . . . . . . . . 24.1 tp -124.52 129.87 51.42 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 115.872 -0.604 . . . . 0.0 109.87 175.305 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' F' F ' 5' ' ' LYS . . . . . . . . . . . . . 99.3 mttt -110.58 122.08 46.88 Favored 'General case' 0 C--O 1.234 0.26 0 CA-C-N 116.395 -0.366 . . . . 0.0 110.901 -179.513 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' F' F ' 6' ' ' LEU . . . . . . . . . . . . . 32.8 mt -114.52 146.69 40.42 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 115.342 -0.845 . . . . 0.0 110.263 -179.264 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' F' F ' 7' ' ' LYS . . . . . . . . . . . . . 36.7 ttmt -132.92 137.76 30.35 Favored Pre-proline 0 CA--C 1.534 0.338 0 CA-C-O 118.974 -0.536 . . . . 0.0 109.805 174.758 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' F' F ' 8' ' ' PRO . . . . . . . . . . . . . 83.6 Cg_endo -91.52 141.65 2.74 Favored 'Trans proline' 0 N--CA 1.49 1.305 0 C-N-CA 121.773 1.649 . . . . 0.0 112.014 179.359 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' F' F ' 9' ' ' LEU . . . . . . . . . . . . . 37.6 mt -78.44 -46.59 2.01 Favored Pre-proline 0 CA--C 1.534 0.328 0 CA-C-O 118.765 -0.636 . . . . 0.0 111.735 179.056 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' F' F ' 10' ' ' PRO . . . . . . . . . . . . . 91.1 Cg_endo -83.08 145.96 12.54 Favored 'Trans proline' 0 N--CA 1.494 1.54 0 C-N-CA 121.218 1.279 . . . . 0.0 111.52 173.452 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' F' F ' 11' ' ' LYS . . . . . . . . . . . . . 19.8 pttp -84.01 116.78 23.0 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-O 121.324 0.583 . . . . 0.0 110.545 177.988 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' F' F ' 12' ' ' VAL . . . . . . . . . . . . . 11.9 p -151.06 143.88 16.71 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.306 0 CA-C-N 115.662 -0.699 . . . . 0.0 110.274 -179.662 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' F' F ' 13' ' ' GLU . . . . . . . . . . . . . 43.3 mt-10 -83.13 117.16 22.69 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.517 -0.311 . . . . 0.0 110.26 178.53 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' F' F ' 14' ' ' LEU . . . . . . . . . . . . . 34.7 mt -98.41 142.31 24.38 Favored Pre-proline 0 CA--C 1.534 0.358 0 CA-C-O 118.997 -0.525 . . . . 0.0 109.853 -179.695 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' F' F ' 15' ' ' PRO . . . . . . . . . . . . . 26.4 Cg_exo -61.22 160.93 24.79 Favored 'Trans proline' 0 N--CA 1.497 1.724 0 C-N-CA 121.202 1.268 . . . . 0.0 111.828 178.282 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' F' F ' 16' ' ' PRO . . . . . . . . . . . . . 32.7 Cg_exo -59.55 -37.52 88.23 Favored 'Trans proline' 0 N--CA 1.497 1.684 0 C-N-CA 121.508 1.472 . . . . 0.0 112.633 -178.303 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' F' F ' 17' ' ' ASP . . . . . . . . . . . . . 13.6 p-10 -86.44 7.94 23.83 Favored 'General case' 0 CA--C 1.536 0.423 0 N-CA-C 113.132 0.79 . . . . 0.0 113.132 -177.989 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' F' F ' 18' ' ' PHE . . . . . . . . . . . . . 52.0 t80 -58.26 -43.8 88.05 Favored 'General case' 0 N--CA 1.457 -0.102 0 O-C-N 121.985 -0.447 . . . . 0.0 109.991 -179.55 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' F' F ' 19' ' ' VAL . . . . . . . . . . . . . 47.1 t -57.33 -40.86 76.65 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.324 0 CA-C-N 116.112 -0.494 . . . . 0.0 110.322 -179.626 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' F' F ' 20' ' ' ASP . . . . . . . . . . . . . 36.6 t0 -60.37 -43.56 96.46 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-O 120.769 0.319 . . . . 0.0 110.974 -178.258 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' F' F ' 21' ' ' VAL . . . . . . . . . . . . . 47.3 t -64.35 -45.94 94.53 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.279 0 C-N-CA 120.821 -0.352 . . . . 0.0 110.361 -178.382 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' F' F ' 22' ' ' ILE . . . . . 0.669 HG22 HD12 ' F' ' 26' ' ' LEU . 50.9 mm -56.21 -43.36 76.15 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.271 0 CA-C-O 120.768 0.318 . . . . 0.0 110.49 177.957 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' F' F ' 23' ' ' ARG . . . . . . . . . . . . . 58.8 ttp180 -55.26 -49.09 72.94 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-O 120.723 0.296 . . . . 0.0 111.182 179.693 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' F' F ' 24' ' ' ILE . . . . . . . . . . . . . 73.7 mt -59.32 -41.34 83.88 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.293 0 CA-C-N 116.447 -0.342 . . . . 0.0 111.042 -177.608 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' F' F ' 25' ' ' LYS . . . . . . . . . . . . . 48.0 mttm -69.04 -42.53 76.2 Favored 'General case' 0 C--N 1.328 -0.344 0 N-CA-C 112.696 0.628 . . . . 0.0 112.696 -178.056 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' F' F ' 26' ' ' LEU . . . . . 0.669 HD12 HG22 ' F' ' 22' ' ' ILE . 53.6 mt -79.47 -34.58 41.34 Favored 'General case' 0 C--N 1.331 -0.225 0 N-CA-C 113.72 1.007 . . . . 0.0 113.72 -170.451 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' F' F ' 27' ' ' GLN . . . . . . . . . . . . . 19.4 pt20 -46.67 138.37 6.1 Favored 'General case' 0 N--CA 1.469 0.486 0 N-CA-C 112.998 0.74 . . . . 0.0 112.998 -174.18 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' F' F ' 28' ' ' GLY . . . . . . . . . . . . . . . 100.23 -24.58 31.55 Favored Glycine 0 CA--C 1.533 1.163 0 CA-C-N 115.528 -0.76 . . . . 0.0 112.525 -177.963 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' F' F ' 29' ' ' LYS . . . . . . . . . . . . . 68.7 mttm -98.04 155.08 17.28 Favored 'General case' 0 C--O 1.232 0.177 0 CA-C-N 117.387 0.594 . . . . 0.0 111.337 179.637 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' F' F ' 30' ' ' THR . . . . . . . . . . . . . 29.5 m -105.92 139.43 40.49 Favored 'General case' 0 C--N 1.331 -0.218 0 CA-C-N 115.928 -0.578 . . . . 0.0 110.345 177.989 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' F' F ' 31' ' ' VAL . . . . . . . . . . . . . 34.4 m -129.9 156.71 42.33 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.271 0 CA-C-N 116.357 -0.383 . . . . 0.0 110.616 179.918 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' F' F ' 32' ' ' ARG . . . . . . . . . . . . . 68.1 mtm180 -131.68 152.41 50.89 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-O 121.099 0.476 . . . . 0.0 110.853 177.55 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' F' F ' 33' ' ' THR . . . . . . . . . . . . . 19.8 m -53.39 138.69 32.46 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.304 -0.407 . . . . 0.0 111.175 -179.534 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' F' F ' 34' ' ' GLY . . . . . . . . . . . . . . . 99.59 -17.21 57.91 Favored Glycine 0 CA--C 1.532 1.151 0 C-N-CA 121.211 -0.519 . . . . 0.0 113.268 178.869 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' F' F ' 35' ' ' ASP . . . . . . . . . . . . . 74.3 m-20 -66.83 149.87 49.95 Favored 'General case' 0 N--CA 1.462 0.145 0 CA-C-N 118.076 0.938 . . . . 0.0 111.191 178.98 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' F' F ' 36' ' ' VAL . . . . . . . . . . . . . 43.9 t -121.83 130.0 74.97 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.209 0 N-CA-C 109.607 -0.516 . . . . 0.0 109.607 177.018 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' F' F ' 37' ' ' ILE . . . . . . . . . . . . . 66.2 mt -121.29 138.48 51.52 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.245 0 CA-C-N 116.186 -0.461 . . . . 0.0 109.978 -178.627 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' F' F ' 38' ' ' GLY . . . . . . . . . . . . . . . -113.61 128.02 8.12 Favored Glycine 0 CA--C 1.524 0.652 0 N-CA-C 110.936 -0.866 . . . . 0.0 110.936 179.219 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' F' F ' 39' ' ' ILE . . . . . . . . . . . . . 78.4 mt -127.9 140.49 49.02 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.186 0 CA-C-O 120.789 0.328 . . . . 0.0 110.265 179.2 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' F' F ' 40' ' ' SER . . . . . . . . . . . . . 42.7 t -91.26 115.5 28.07 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.226 -0.443 . . . . 0.0 110.649 176.392 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' F' F ' 41' ' ' ILE . . . . . . . . . . . . . 44.8 mm -119.62 113.22 40.24 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.231 0 N-CA-C 109.961 -0.385 . . . . 0.0 109.961 178.439 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' F' F ' 42' ' ' LEU . . . . . . . . . . . . . 69.1 mt 57.62 36.1 26.39 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.415 -0.357 . . . . 0.0 111.498 179.5 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' F' F ' 43' ' ' GLY . . . . . . . . . . . . . . . 80.34 -10.2 44.35 Favored Glycine 0 CA--C 1.533 1.197 0 C-N-CA 121.289 -0.482 . . . . 0.0 113.517 177.306 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' F' F ' 44' ' ' LYS . . . . . . . . . . . . . 42.8 tttp -99.6 134.68 42.14 Favored 'General case' 0 C--N 1.333 -0.132 0 CA-C-N 117.831 0.816 . . . . 0.0 110.007 177.339 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' F' F ' 45' ' ' GLU . . . . . . . . . . . . . 83.8 tt0 -82.61 127.99 33.89 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-O 120.797 0.332 . . . . 0.0 110.838 -179.014 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' F' F ' 46' ' ' VAL . . . . . . . . . . . . . 10.7 p -121.63 126.11 74.32 Favored 'Isoleucine or valine' 0 C--N 1.333 -0.15 0 N-CA-C 109.639 -0.504 . . . . 0.0 109.639 175.759 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' F' F ' 47' ' ' LYS . . . . . . . . . . . . . 97.7 mttt -99.23 124.82 44.6 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.044 -0.525 . . . . 0.0 110.807 178.235 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' F' F ' 48' ' ' PHE . . . . . . . . . . . . . 32.6 m-85 -108.84 131.89 54.54 Favored 'General case' 0 C--N 1.33 -0.277 0 N-CA-C 109.798 -0.445 . . . . 0.0 109.798 176.548 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' F' F ' 49' ' ' LYS . . . . . . . . . . . . . 34.6 tttp -106.86 135.51 48.29 Favored 'General case' 0 C--N 1.328 -0.355 0 N-CA-C 109.849 -0.426 . . . . 0.0 109.849 177.518 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' F' F ' 50' ' ' VAL . . . . . . . . . . . . . 45.2 t -76.99 106.82 7.37 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.308 0 N-CA-C 109.438 -0.579 . . . . 0.0 109.438 178.027 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' F' F ' 51' ' ' VAL . . . . . . . . . . . . . 47.0 t -73.91 -47.87 41.19 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.324 0 CA-C-N 116.22 -0.446 . . . . 0.0 109.982 -175.009 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' F' F ' 52' ' ' GLN . . . . . . . . . . . . . 63.0 tt0 -159.75 143.85 14.7 Favored 'General case' 0 C--N 1.33 -0.275 0 C-N-CA 120.422 -0.511 . . . . 0.0 111.447 -177.874 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' F' F ' 53' ' ' ALA . . . . . . . . . . . . . . . -123.64 132.9 53.97 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 115.747 -0.66 . . . . 0.0 109.778 175.004 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' F' F ' 54' ' ' TYR . . . . . . . . . . . . . 25.9 t80 -129.2 111.59 18.21 Favored Pre-proline 0 CA--C 1.536 0.416 0 CA-C-O 118.13 -0.938 . . . . 0.0 110.386 178.931 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' F' F ' 55' ' ' PRO . . . . . . . . . . . . . 73.6 Cg_endo -77.26 161.25 93.12 Favored 'Cis proline' 0 N--CA 1.499 1.821 0 CA-C-N 121.943 1.729 . . . . 0.0 112.407 -6.835 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' F' F ' 56' ' ' SER . . . . . . . . . . . . . 60.8 m -108.76 130.78 22.32 Favored Pre-proline 0 CA--C 1.539 0.557 0 CA-C-O 118.434 -0.793 . . . . 0.0 109.487 175.304 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' F' F ' 57' ' ' PRO . . . . . . . . . . . . . 36.5 Cg_endo -66.31 163.13 70.1 Favored 'Cis proline' 0 N--CA 1.498 1.78 0 CA-C-N 121.972 1.74 . . . . 0.0 111.601 -1.3 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' F' F ' 58' ' ' LEU . . . . . . . . . . . . . 15.7 tp -129.37 138.98 51.84 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-O 121.026 0.441 . . . . 0.0 110.405 -178.131 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' F' F ' 59' ' ' ARG . . . . . . . . . . . . . 74.2 ttt180 -104.68 136.31 44.44 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 115.836 -0.62 . . . . 0.0 109.683 176.244 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' F' F ' 60' ' ' VAL . . . . . . . . . . . . . 43.3 t -85.35 116.72 29.14 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.262 0 C-N-CA 120.662 -0.415 . . . . 0.0 110.234 -178.345 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' F' F ' 61' ' ' GLU . . . . . . . . . . . . . 39.1 tp10 -131.06 155.54 46.72 Favored 'General case' 0 C--N 1.328 -0.362 0 N-CA-C 109.005 -0.739 . . . . 0.0 109.005 176.856 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' F' F ' 62' ' ' ASP . . . . . . . . . . . . . 13.9 t70 -51.04 -32.37 21.55 Favored 'General case' 0 C--N 1.327 -0.391 0 N-CA-C 112.011 0.374 . . . . 0.0 112.011 -178.868 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' F' F ' 63' ' ' ARG . . . . . . . . . . . . . 87.6 mtt180 -73.21 -22.06 60.52 Favored 'General case' 0 CA--C 1.534 0.335 0 N-CA-C 112.908 0.707 . . . . 0.0 112.908 -176.801 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' F' F ' 64' ' ' THR . . . . . . . . . . . . . 18.9 m -71.8 143.02 49.65 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-O 120.929 0.395 . . . . 0.0 110.88 -175.3 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' F' F ' 65' ' ' LYS . . . . . . . . . . . . . 91.4 mttt -87.71 129.91 34.99 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 115.973 -0.558 . . . . 0.0 110.049 178.809 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' F' F ' 66' ' ' ILE . . . . . . . . . . . . . 58.2 mt -115.9 125.57 73.08 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.226 0 N-CA-C 109.579 -0.526 . . . . 0.0 109.579 178.32 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' F' F ' 67' ' ' THR . . . . . . . . . . . . . 24.6 m -121.79 142.3 50.35 Favored 'General case' 0 C--N 1.331 -0.227 0 CA-C-O 121.008 0.432 . . . . 0.0 111.215 -176.246 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' F' F ' 68' ' ' LEU . . . . . . . . . . . . . 4.9 tt . . . . . 0 C--N 1.328 -0.346 0 CA-C-N 115.743 -0.662 . . . . 0.0 109.85 178.173 . . . . . . . . 0 0 . 1 . 015 nuclear build core ' F' F ' 73' ' ' VAL . . . . . . . . . . . . . 35.6 m . . . . . 0 N--CA 1.461 0.115 0 CA-C-O 120.902 0.382 . . . . 0.0 110.702 . . . . . . . . . 0 0 . 1 . 015 nuclear build core ' F' F ' 74' ' ' ASP . . . . . . . . . . . . . 14.4 t0 -104.47 118.42 36.57 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.017 -0.538 . . . . 0.0 109.784 179.341 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' F' F ' 75' ' ' VAL . . . . . 0.568 ' C ' HD12 ' F' ' 76' ' ' LEU . 42.9 t -115.55 124.17 71.76 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.301 0 CA-C-O 120.965 0.412 . . . . 0.0 110.658 -177.466 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' F' F ' 76' ' ' LEU . . . . . 0.568 HD12 ' C ' ' F' ' 75' ' ' VAL . 8.7 mp -122.61 150.73 42.25 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-N 115.74 -0.664 . . . . 0.0 109.687 175.945 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' F' F ' 77' ' ' GLU . . . . . . . . . . . . . 98.9 mt-10 -135.59 141.47 45.14 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-O 121.183 0.516 . . . . 0.0 111.816 -175.984 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' F' F ' 78' ' ' ALA . . . . . . . . . . . . . . . -127.81 143.83 51.11 Favored 'General case' 0 C--N 1.331 -0.204 0 CA-C-N 115.518 -0.764 . . . . 0.0 109.82 175.868 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' F' F ' 79' ' ' LYS . . . . . 0.625 ' O ' HD13 ' F' ' 80' ' ' ILE . 37.8 mtmt -95.26 112.33 24.05 Favored 'General case' 0 C--N 1.33 -0.239 0 CA-C-O 120.738 0.304 . . . . 0.0 111.074 -176.89 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' F' F ' 80' ' ' ILE . . . . . 0.625 HD13 ' O ' ' F' ' 79' ' ' LYS . 39.3 mm -139.23 112.67 6.5 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.238 0 N-CA-C 109.404 -0.591 . . . . 0.0 109.404 -179.265 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' F' F ' 81' ' ' LYS . . . . . . . . . . . . . 56.3 pttt -106.67 131.48 53.76 Favored 'General case' 0 N--CA 1.464 0.242 0 CA-C-O 120.961 0.41 . . . . 0.0 111.389 -178.223 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' F' F ' 82' ' ' GLY . . . . . . . . . . . . . . . 89.13 41.95 5.72 Favored Glycine 0 CA--C 1.527 0.804 0 C-N-CA 121.018 -0.61 . . . . 0.0 111.813 176.154 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' F' F ' 83' ' ' ILE . . . . . . . . . . . . . 74.5 mt -77.13 137.9 21.55 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 N-CA-C 109.351 -0.611 . . . . 0.0 109.351 176.329 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' F' F ' 84' ' ' LYS . . . . . . . . . . . . . 19.3 ttpt -101.47 -46.85 4.86 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.431 -0.35 . . . . 0.0 110.527 -176.897 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' F' F ' 85' ' ' ASP . . . . . . . . . . . . . 13.7 t70 -143.72 146.6 33.29 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.448 -0.342 . . . . 0.0 110.479 -179.176 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' F' F ' 86' ' ' VAL . . . . . . . . . . . . . 44.7 t -128.96 128.86 67.81 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.215 0 CA-C-O 120.91 0.386 . . . . 0.0 110.405 -178.847 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' F' F ' 87' ' ' ILE . . . . . . . . . . . . . 44.7 mm -121.35 128.36 75.91 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.235 0 N-CA-C 109.359 -0.608 . . . . 0.0 109.359 177.903 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' F' F ' 88' ' ' LEU . . . . . . . . . . . . . 62.1 mt -120.21 139.26 52.92 Favored 'General case' 0 C--N 1.332 -0.194 0 CA-C-O 121.207 0.527 . . . . 0.0 111.882 -175.277 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' F' F ' 89' ' ' ASP . . . . . . . . . . . . . 13.4 t70 -133.61 154.92 50.52 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 115.423 -0.808 . . . . 0.0 109.436 175.394 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' F' F ' 90' ' ' GLU . . . . . . . . . . . . . 44.2 mt-10 -49.46 -36.78 23.7 Favored 'General case' 0 C--N 1.329 -0.294 0 N-CA-C 112.832 0.678 . . . . 0.0 112.832 -171.805 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' F' F ' 91' ' ' ASN . . . . . . . . . . . . . 9.1 m120 -127.1 22.11 6.69 Favored 'General case' 0 N--CA 1.468 0.449 0 N-CA-C 112.869 0.692 . . . . 0.0 112.869 -176.651 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' F' F ' 92' ' ' LEU . . . . . . . . . . . . . 5.8 mt -153.49 144.4 22.79 Favored 'General case' 0 C--N 1.331 -0.199 0 N-CA-C 109.573 -0.528 . . . . 0.0 109.573 -177.894 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' F' F ' 93' ' ' ILE . . . . . . . . . . . . . 71.2 mt -127.28 122.25 59.34 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.288 0 N-CA-C 109.407 -0.59 . . . . 0.0 109.407 178.41 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' F' F ' 94' ' ' VAL . . . . . . . . . . . . . 43.5 t -121.95 126.97 75.22 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.242 0 CA-C-O 120.911 0.386 . . . . 0.0 110.014 -179.821 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' F' F ' 95' ' ' VAL . . . . . . . . . . . . . 44.0 t -120.47 133.25 67.78 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.384 0 CA-C-N 115.963 -0.562 . . . . 0.0 109.662 179.671 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' F' F ' 96' ' ' ILE . . . . . . . . . . . . . 66.9 mt -114.99 124.54 71.75 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.231 0 N-CA-C 109.121 -0.696 . . . . 0.0 109.121 178.726 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' F' F ' 97' ' ' THR . . . . . . . . . . . . . 45.3 p -98.28 156.75 16.56 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-O 121.114 0.483 . . . . 0.0 111.474 -176.139 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' F' F ' 98' ' ' GLU . . . . . . . . . . . . . 96.7 mt-10 -54.09 -26.35 26.68 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 116.037 -0.529 . . . . 0.0 112.027 178.307 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' F' F ' 99' ' ' GLU . . . . . . . . . . . . . 34.6 tt0 -79.33 17.03 0.88 Allowed 'General case' 0 CA--C 1.538 0.51 0 N-CA-C 112.582 0.586 . . . . 0.0 112.582 -176.83 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' F' F ' 100' ' ' ASN . . . . . . . . . . . . . 2.0 m120 64.18 36.2 9.68 Favored 'General case' 0 CA--C 1.531 0.224 0 O-C-N 121.84 -0.538 . . . . 0.0 110.984 176.002 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' F' F ' 101' ' ' GLU . . . . . . . . . . . . . 79.1 tt0 -117.15 142.88 46.46 Favored 'General case' 0 C--O 1.231 0.099 0 N-CA-C 109.917 -0.401 . . . . 0.0 109.917 178.248 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' F' F ' 102' ' ' VAL . . . . . . . . . . . . . 43.4 t -115.56 125.16 72.66 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.312 0 N-CA-C 109.728 -0.471 . . . . 0.0 109.728 -179.848 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' F' F ' 103' ' ' LEU . . . . . . . . . . . . . 40.0 mt -117.08 131.06 57.01 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 115.972 -0.558 . . . . 0.0 110.606 178.256 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' F' F ' 104' ' ' ILE . . . . . 0.468 HD12 ' HB3' ' F' ' 113' ' ' TYR . 67.0 mt -117.19 120.08 63.87 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.221 0 CA-C-N 116.405 -0.361 . . . . 0.0 110.314 -179.477 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' F' F ' 105' ' ' PHE . . . . . . . . . . . . . 76.1 m-85 -121.58 167.4 12.93 Favored 'General case' 0 C--O 1.231 0.128 0 O-C-N 124.092 0.87 . . . . 0.0 109.688 178.238 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' F' F ' 106' ' ' ASN . . . . . . . . . . . . . 43.0 p-10 -104.09 -170.99 1.85 Allowed 'General case' 0 C--N 1.332 -0.172 0 N-CA-C 109.657 -0.497 . . . . 0.0 109.657 170.653 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' F' F ' 107' ' ' GLN . . . . . . . . . . . . . 50.3 tt0 -58.41 -29.98 66.51 Favored 'General case' 0 C--N 1.328 -0.338 0 N-CA-C 111.925 0.343 . . . . 0.0 111.925 179.735 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' F' F ' 108' ' ' ASN . . . . . . . . . . . . . 47.1 t30 -88.22 13.7 10.89 Favored 'General case' 0 CA--C 1.534 0.359 0 N-CA-C 112.91 0.707 . . . . 0.0 112.91 -176.484 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' F' F ' 109' ' ' LEU . . . . . . . . . . . . . 82.1 mt 57.2 33.6 23.55 Favored 'General case' 0 CA--C 1.529 0.173 0 N-CA-C 111.823 0.305 . . . . 0.0 111.823 176.875 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' F' F ' 110' ' ' GLU . . . . . . . . . . . . . 95.8 mt-10 -100.0 138.61 36.84 Favored 'General case' 0 C--N 1.331 -0.239 0 N-CA-C 109.339 -0.615 . . . . 0.0 109.339 175.616 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' F' F ' 111' ' ' GLU . . . . . . . . . . . . . 56.7 tt0 -75.49 121.9 23.05 Favored 'General case' 0 C--N 1.328 -0.338 0 C-N-CA 120.64 -0.424 . . . . 0.0 110.532 -175.727 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' F' F ' 112' ' ' LEU . . . . . . . . . . . . . 32.4 mt -104.36 -46.02 4.51 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.065 -0.516 . . . . 0.0 110.657 179.715 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' F' F ' 113' ' ' TYR . . . . . 0.468 ' HB3' HD12 ' F' ' 104' ' ' ILE . 58.8 t80 -143.16 141.06 31.06 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 116.247 -0.433 . . . . 0.0 111.295 -179.35 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' F' F ' 114' ' ' ARG . . . . . . . . . . . . . 39.0 ptt180 -137.81 123.76 20.16 Favored 'General case' 0 C--N 1.331 -0.203 0 CA-C-N 115.837 -0.619 . . . . 0.0 110.252 178.124 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' F' F ' 115' ' ' GLY . . . . . . . . . . . . . . . -150.08 160.94 28.74 Favored Glycine 0 CA--C 1.523 0.582 0 C-N-CA 120.565 -0.826 . . . . 0.0 111.472 -179.289 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' F' F ' 116' ' ' LYS . . . . . . . . . . . . . 32.5 ttpt -127.18 141.4 51.75 Favored 'General case' 0 C--N 1.33 -0.249 0 N-CA-C 109.838 -0.431 . . . . 0.0 109.838 176.487 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' F' F ' 117' ' ' PHE . . . . . . . . . . . . . 43.0 m-85 -141.17 113.82 8.28 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.408 -0.36 . . . . 0.0 110.061 -179.545 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' F' F ' 118' ' ' GLU . . . . . . . . . . . . . 95.9 mt-10 -55.6 -44.13 76.7 Favored 'General case' 0 C--N 1.329 -0.321 0 C-N-CA 120.867 -0.333 . . . . 0.0 111.093 -176.252 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' F' F ' 119' ' ' ASN . . . . . . . . . . . . . 3.5 m120 -98.72 31.11 3.03 Favored 'General case' 0 C--N 1.33 -0.246 0 N-CA-C 112.216 0.45 . . . . 0.0 112.216 -174.387 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' F' F ' 120' ' ' LEU . . . . . . . . . . . . . 17.5 tp -57.04 121.03 9.04 Favored 'General case' 0 N--CA 1.463 0.206 0 N-CA-C 110.092 -0.336 . . . . 0.0 110.092 177.475 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' F' F ' 121' ' ' ASN . . . . . . . . . . . . . 5.3 t30 -114.08 -44.11 3.18 Favored 'General case' 0 C--N 1.332 -0.182 0 C-N-CA 121.208 -0.197 . . . . 0.0 111.25 -176.75 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' F' F ' 122' ' ' LYS . . . . . . . . . . . . . 86.3 mttt -142.97 147.87 35.9 Favored 'General case' 0 C--N 1.332 -0.19 0 CA-C-O 121.164 0.507 . . . . 0.0 111.788 -178.986 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' F' F ' 123' ' ' VAL . . . . . . . . . . . . . 42.9 t -128.74 129.56 68.49 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.186 0 CA-C-N 115.729 -0.668 . . . . 0.0 109.553 174.823 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' F' F ' 124' ' ' LEU . . . . . . . . . . . . . 21.7 mt -123.81 135.32 53.71 Favored 'General case' 0 C--N 1.331 -0.212 0 CA-C-O 120.81 0.338 . . . . 0.0 110.679 -178.841 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' F' F ' 125' ' ' VAL . . . . . 0.439 ' O ' HG13 ' F' ' 125' ' ' VAL . 11.7 p -136.86 123.95 30.91 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.273 0 CA-C-N 116.233 -0.44 . . . . 0.0 110.214 178.0 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' F' F ' 126' ' ' ARG . . . . . . . . . . . . . 89.6 mtt180 -152.94 132.92 13.33 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.053 -0.521 . . . . 0.0 109.873 178.938 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' F' F ' 127' ' ' ASN . . . . . . . . . . . . . 3.9 m120 55.58 -151.76 0.38 Allowed 'General case' 0 CA--C 1.541 0.602 0 N-CA-C 109.898 -0.408 . . . . 0.0 109.898 179.38 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' F' F ' 128' ' ' ASP . . . . . . . . . . . . . 19.7 p-10 -81.35 15.3 2.05 Favored 'General case' 0 CA--C 1.536 0.417 0 CA-C-N 118.643 0.656 . . . . 0.0 112.764 178.675 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' F' F ' 129' ' ' LEU . . . . . . . . . . . . . 31.7 mt -111.05 131.14 55.31 Favored 'General case' 0 C--O 1.233 0.213 0 O-C-N 121.936 -0.477 . . . . 0.0 110.651 179.588 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' F' F ' 130' ' ' VAL . . . . . . . . . . . . . 41.2 t -122.15 133.64 67.85 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.223 0 N-CA-C 109.115 -0.698 . . . . 0.0 109.115 176.839 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' F' F ' 131' ' ' VAL . . . . . 0.417 HG22 HD12 ' F' ' 140' ' ' LEU . 42.6 t -135.73 137.4 49.3 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.213 0 CA-C-O 121.049 0.452 . . . . 0.0 110.694 -176.852 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' F' F ' 132' ' ' ILE . . . . . . . . . . . . . 67.7 mt -120.55 133.42 67.29 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.242 0 CA-C-N 115.748 -0.66 . . . . 0.0 109.604 179.732 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' F' F ' 133' ' ' ILE . . . . . . . . . . . . . 40.5 mm -119.8 120.6 63.79 Favored 'Isoleucine or valine' 0 C--O 1.234 0.269 0 CA-C-O 120.876 0.37 . . . . 0.0 110.949 -177.294 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' F' F ' 134' ' ' ASP . . . . . . . . . . . . . 7.2 p-10 -134.16 146.9 50.62 Favored 'General case' 0 C--N 1.329 -0.285 0 N-CA-C 109.497 -0.556 . . . . 0.0 109.497 174.562 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' F' F ' 135' ' ' GLU . . . . . . . . . . . . . 52.6 tt0 -49.86 -25.96 3.62 Favored 'General case' 0 C--N 1.328 -0.358 0 N-CA-C 112.948 0.722 . . . . 0.0 112.948 -170.145 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' F' F ' 136' ' ' GLN . . . . . . . . . . . . . 60.8 tp60 -99.2 -31.2 11.85 Favored 'General case' 0 C--N 1.332 -0.183 0 N-CA-C 112.384 0.512 . . . . 0.0 112.384 -174.767 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' F' F ' 137' ' ' LYS . . . . . . . . . . . . . 89.4 mttt -139.85 153.9 47.16 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-O 121.214 0.53 . . . . 0.0 111.532 -170.515 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' F' F ' 138' ' ' LEU . . . . . . . . . . . . . 4.3 tt -121.37 126.85 50.43 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 115.625 -0.716 . . . . 0.0 109.32 174.171 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' F' F ' 139' ' ' THR . . . . . . . . . . . . . 31.8 m -116.67 134.21 55.09 Favored 'General case' 0 N--CA 1.462 0.144 0 CA-C-O 120.891 0.377 . . . . 0.0 111.385 -176.338 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' F' F ' 140' ' ' LEU . . . . . 0.417 HD12 HG22 ' F' ' 131' ' ' VAL . 24.0 tp -120.99 122.65 40.6 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 115.387 -0.824 . . . . 0.0 109.167 179.721 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' F' F ' 141' ' ' ILE . . . . . . . . . . . . . 19.2 mt -119.87 125.24 74.09 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.323 0 CA-C-O 120.974 0.416 . . . . 0.0 110.278 -175.638 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' F' F ' 142' ' ' ARG . . . . . . . . . . . . . 43.1 mtm180 -107.59 124.67 50.29 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 115.205 -0.907 . . . . 0.0 110.134 178.948 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' F' F ' 143' ' ' THR . . . . . . . . . . . . . 21.5 p . . . . . 0 C--O 1.221 -0.443 0 CA-C-O 117.991 -1.004 . . . . 0.0 110.584 179.852 . . . . . . . . 0 0 . 1 . 016 nuclear build core ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 5.0 p . . . . . 0 C--O 1.231 0.08 0 CA-C-O 120.932 0.396 . . . . 0.0 110.362 . . . . . . . . . 0 0 . 1 . 016 nuclear build core ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 95.5 mt-10 -141.85 142.42 33.12 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.115 -0.493 . . . . 0.0 111.242 -178.061 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 4' ' ' LEU . . . . . . . . . . . . . 18.1 tp -124.32 124.45 42.41 Favored 'General case' 0 C--N 1.331 -0.218 0 CA-C-N 115.757 -0.656 . . . . 0.0 109.848 175.718 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 5' ' ' LYS . . . . . . . . . . . . . 98.0 mttt -105.09 120.55 41.79 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.65 -179.7 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 37.8 mt -115.37 148.81 38.86 Favored 'General case' 0 C--N 1.332 -0.183 0 CA-C-N 115.624 -0.716 . . . . 0.0 110.237 -178.414 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 21.3 ttpt -129.83 135.53 27.64 Favored Pre-proline 0 CA--C 1.534 0.339 0 CA-C-O 118.851 -0.595 . . . . 0.0 109.443 174.276 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 8' ' ' PRO . . . . . . . . . . . . . 76.8 Cg_endo -91.54 135.54 1.72 Allowed 'Trans proline' 0 N--CA 1.489 1.239 0 C-N-CA 121.694 1.596 . . . . 0.0 111.683 177.52 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 48.6 mt -72.15 -47.24 10.99 Favored Pre-proline 0 CA--C 1.533 0.309 0 CA-C-O 118.594 -0.717 . . . . 0.0 112.171 -178.988 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 83.4 Cg_endo -80.8 148.65 17.75 Favored 'Trans proline' 0 N--CA 1.496 1.666 0 C-N-CA 121.217 1.278 . . . . 0.0 111.753 175.905 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 51.2 tptt -85.2 96.05 9.36 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.466 -0.334 . . . . 0.0 110.275 179.234 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 12.5 p -142.52 149.65 18.98 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.243 0 CA-C-N 116.25 -0.432 . . . . 0.0 110.692 -178.326 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 83.1 tt0 -89.92 129.48 36.27 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-N 116.163 -0.471 . . . . 0.0 110.551 179.378 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 14' ' ' LEU . . . . . . . . . . . . . 48.3 mt -98.44 153.06 38.16 Favored Pre-proline 0 CA--C 1.532 0.282 0 CA-C-N 116.425 -0.352 . . . . 0.0 110.888 -178.872 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 15' ' ' PRO . . . . . . . . . . . . . 30.1 Cg_exo -61.19 159.88 28.78 Favored 'Trans proline' 0 N--CA 1.497 1.705 0 C-N-CA 121.356 1.371 . . . . 0.0 111.963 176.627 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 16' ' ' PRO . . . . . . . . . . . . . 31.6 Cg_exo -59.72 -42.17 48.8 Favored 'Trans proline' 0 N--CA 1.495 1.613 0 C-N-CA 121.475 1.45 . . . . 0.0 112.648 -179.068 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 17' ' ' ASP . . . . . . . . . . . . . 13.1 p-10 -84.13 11.65 7.72 Favored 'General case' 0 CA--C 1.535 0.383 0 N-CA-C 113.129 0.789 . . . . 0.0 113.129 -177.676 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 18' ' ' PHE . . . . . 0.466 ' HE1' HD13 ' A' ' 41' ' ' ILE . 31.2 t80 -57.12 -45.04 83.81 Favored 'General case' 0 N--CA 1.458 -0.074 0 O-C-N 121.917 -0.489 . . . . 0.0 110.433 -178.408 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 19' ' ' VAL . . . . . . . . . . . . . 48.0 t -57.06 -41.06 76.85 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.245 0 CA-C-N 116.371 -0.377 . . . . 0.0 110.534 -178.711 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 68.8 m-20 -59.79 -43.38 94.43 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-O 120.899 0.381 . . . . 0.0 110.703 -178.342 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 45.4 t -64.34 -46.56 92.77 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.321 0 CA-C-N 116.281 -0.418 . . . . 0.0 110.56 -178.231 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 22' ' ' ILE . . . . . 0.63 HG22 HD12 ' A' ' 26' ' ' LEU . 50.6 mm -55.11 -47.07 77.63 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.222 0 C-N-CA 120.99 -0.284 . . . . 0.0 110.828 179.272 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 23' ' ' ARG . . . . . . . . . . . . . 56.5 ttp180 -54.12 -50.03 67.82 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-O 120.697 0.284 . . . . 0.0 111.329 -179.021 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 24' ' ' ILE . . . . . . . . . . . . . 74.0 mt -58.91 -42.31 85.52 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.239 0 CA-C-N 116.432 -0.349 . . . . 0.0 111.25 -178.157 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 61.9 mtpt -67.76 -41.77 82.8 Favored 'General case' 0 C--N 1.328 -0.354 0 N-CA-C 112.404 0.52 . . . . 0.0 112.404 -177.405 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 26' ' ' LEU . . . . . 0.63 HD12 HG22 ' A' ' 22' ' ' ILE . 49.2 mt -79.43 -37.38 37.21 Favored 'General case' 0 C--N 1.33 -0.28 0 N-CA-C 113.368 0.877 . . . . 0.0 113.368 -169.495 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 27' ' ' GLN . . . . . . . . . . . . . 15.9 pt20 -46.84 136.19 8.39 Favored 'General case' 0 N--CA 1.47 0.553 0 N-CA-C 112.728 0.64 . . . . 0.0 112.728 -176.09 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 99.72 -23.99 33.94 Favored Glycine 0 CA--C 1.534 1.252 0 CA-C-N 115.624 -0.716 . . . . 0.0 112.448 -176.633 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 28.8 mtpp -97.91 155.17 17.2 Favored 'General case' 0 C--O 1.233 0.209 0 CA-C-N 117.344 0.572 . . . . 0.0 111.005 179.983 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 30' ' ' THR . . . . . . . . . . . . . 33.8 m -105.53 138.03 42.39 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.143 -0.481 . . . . 0.0 110.118 176.848 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 35.2 m -129.95 149.48 33.65 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.271 0 CA-C-O 121.018 0.437 . . . . 0.0 110.933 -179.27 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 32' ' ' ARG . . . . . . . . . . . . . 29.5 ttm105 -130.05 148.01 51.86 Favored 'General case' 0 C--N 1.331 -0.239 0 CA-C-N 115.905 -0.589 . . . . 0.0 110.233 178.9 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 33' ' ' THR . . . . . . . . . . . . . 25.4 m -52.24 138.07 27.08 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.397 -0.365 . . . . 0.0 111.496 -177.58 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 100.28 -17.1 57.41 Favored Glycine 0 CA--C 1.533 1.161 0 CA-C-O 119.649 -0.528 . . . . 0.0 113.288 178.862 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 72.6 m-20 -65.85 149.85 49.52 Favored 'General case' 0 C--O 1.231 0.128 0 CA-C-N 118.053 0.927 . . . . 0.0 111.199 -179.965 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 45.6 t -119.8 129.3 75.57 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.275 0 CA-C-N 115.904 -0.589 . . . . 0.0 109.701 177.548 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 37' ' ' ILE . . . . . . . . . . . . . 63.8 mt -120.0 137.24 54.49 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.266 0 CA-C-N 116.162 -0.472 . . . . 0.0 109.797 -179.647 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . -116.45 128.86 8.14 Favored Glycine 0 CA--C 1.525 0.672 0 N-CA-C 110.848 -0.901 . . . . 0.0 110.848 179.948 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 39' ' ' ILE . . . . . . . . . . . . . 68.3 mt -126.66 129.94 71.62 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.169 0 N-CA-C 110.056 -0.349 . . . . 0.0 110.056 179.238 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 40' ' ' SER . . . . . . . . . . . . . 16.8 p -91.31 119.0 30.98 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.1 -0.5 . . . . 0.0 110.4 175.49 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 41' ' ' ILE . . . . . 0.466 HD13 ' HE1' ' A' ' 18' ' ' PHE . 70.2 mt -127.26 113.74 33.5 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.197 0 N-CA-C 110.113 -0.329 . . . . 0.0 110.113 -179.546 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 7.8 mp 56.62 39.25 29.89 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-O 121.247 0.546 . . . . 0.0 110.913 179.184 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . 79.38 -10.23 37.33 Favored Glycine 0 CA--C 1.533 1.172 0 C-N-CA 121.252 -0.499 . . . . 0.0 113.653 175.952 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 44' ' ' LYS . . . . . . . . . . . . . 78.7 tttt -98.27 126.49 43.78 Favored 'General case' 0 C--N 1.333 -0.11 0 CA-C-N 117.913 0.856 . . . . 0.0 110.094 177.882 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 77.3 tt0 -84.9 127.45 34.16 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.372 -0.376 . . . . 0.0 111.081 -179.427 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 46' ' ' VAL . . . . . . . . . . . . . 10.9 p -123.07 125.18 71.73 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.187 0 N-CA-C 110.085 -0.339 . . . . 0.0 110.085 175.874 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 99.1 mttt -99.34 127.88 45.41 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.057 -0.52 . . . . 0.0 111.024 177.248 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 48' ' ' PHE . . . . . . . . . . . . . 34.2 m-85 -112.49 131.91 55.34 Favored 'General case' 0 C--N 1.33 -0.279 0 N-CA-C 109.605 -0.517 . . . . 0.0 109.605 176.913 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 85.9 tttt -105.07 134.36 48.29 Favored 'General case' 0 C--N 1.328 -0.363 0 N-CA-C 110.084 -0.339 . . . . 0.0 110.084 177.562 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 50' ' ' VAL . . . . . . . . . . . . . 43.2 t -77.84 105.09 6.41 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.371 0 N-CA-C 109.491 -0.559 . . . . 0.0 109.491 177.908 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 51' ' ' VAL . . . . . . . . . . . . . 46.9 t -72.88 -47.99 46.81 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.335 0 CA-C-N 116.018 -0.537 . . . . 0.0 110.075 -174.145 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 52' ' ' GLN . . . . . . . . . . . . . 44.4 tt0 -158.44 135.53 9.91 Favored 'General case' 0 C--N 1.33 -0.27 0 C-N-CA 120.274 -0.571 . . . . 0.0 111.796 -177.954 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 53' ' ' ALA . . . . . 0.613 ' HB3' ' OG ' ' A' ' 56' ' ' SER . . . -110.23 129.44 55.72 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 115.839 -0.619 . . . . 0.0 109.649 175.032 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 54' ' ' TYR . . . . . . . . . . . . . 60.2 t80 -129.03 106.64 18.02 Favored Pre-proline 0 CA--C 1.535 0.378 0 CA-C-O 118.373 -0.823 . . . . 0.0 110.546 -178.437 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 55' ' ' PRO . . . . . . . . . . . . . 73.0 Cg_endo -77.13 168.94 75.59 Favored 'Cis proline' 0 N--CA 1.499 1.81 0 CA-C-N 121.67 1.632 . . . . 0.0 112.458 -5.766 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 56' ' ' SER . . . . . 0.613 ' OG ' ' HB3' ' A' ' 53' ' ' ALA . 74.3 m -118.01 134.42 23.31 Favored Pre-proline 0 CA--C 1.539 0.556 0 CA-C-O 118.486 -0.769 . . . . 0.0 109.473 174.494 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 57' ' ' PRO . . . . . . . . . . . . . 51.7 Cg_endo -70.78 146.98 85.78 Favored 'Cis proline' 0 N--CA 1.497 1.699 0 CA-C-N 121.88 1.707 . . . . 0.0 111.347 -1.911 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 58' ' ' LEU . . . . . . . . . . . . . 20.6 tp -108.0 136.3 47.93 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 116.39 -0.368 . . . . 0.0 110.86 -177.944 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 59' ' ' ARG . . . . . . . . . . . . . 55.8 ttp180 -104.31 117.94 35.42 Favored 'General case' 0 C--N 1.327 -0.389 0 N-CA-C 109.052 -0.721 . . . . 0.0 109.052 174.018 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 42.4 t -71.55 122.13 23.08 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.353 0 CA-C-N 116.353 -0.385 . . . . 0.0 110.698 -173.114 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 95.4 mt-10 -131.07 165.32 23.51 Favored 'General case' 0 C--N 1.331 -0.225 0 CA-C-N 115.795 -0.639 . . . . 0.0 110.033 177.28 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 62' ' ' ASP . . . . . . . . . . . . . 14.9 m-20 -55.19 -32.68 62.39 Favored 'General case' 0 C--N 1.329 -0.315 0 N-CA-C 111.758 0.281 . . . . 0.0 111.758 -179.252 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 63' ' ' ARG . . . . . . . . . . . . . 17.6 ptm180 -81.35 6.56 13.99 Favored 'General case' 0 CA--C 1.535 0.399 0 N-CA-C 113.524 0.935 . . . . 0.0 113.524 -176.512 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 34.4 m -91.41 136.16 33.31 Favored 'General case' 0 C--O 1.232 0.147 0 CA-C-N 118.26 0.482 . . . . 0.0 110.751 -179.754 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 65' ' ' LYS . . . . . . . . . . . . . 68.7 mttm -89.51 135.42 33.61 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.005 -0.543 . . . . 0.0 110.319 179.473 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 66' ' ' ILE . . . . . 0.475 HD12 ' N ' ' A' ' 66' ' ' ILE . 4.3 mp -116.45 127.42 74.06 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.282 0 N-CA-C 109.552 -0.536 . . . . 0.0 109.552 178.76 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 67' ' ' THR . . . . . . . . . . . . . 25.0 m -131.38 148.66 52.68 Favored 'General case' 0 N--CA 1.464 0.237 0 CA-C-O 121.137 0.494 . . . . 0.0 111.944 -175.376 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 68' ' ' LEU . . . . . 0.425 ' N ' HD12 ' A' ' 68' ' ' LEU . 8.5 mp . . . . . 0 C--N 1.331 -0.219 0 CA-C-N 115.629 -0.714 . . . . 0.0 109.909 175.356 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 74' ' ' ASP . . . . . . . . . . . . . 13.3 t70 . . . . . 0 N--CA 1.458 -0.07 0 N-CA-C 110.432 -0.21 . . . . 0.0 110.432 . . . . . . . . . 0 0 . 1 . 016 nuclear build core ' A' A ' 75' ' ' VAL . . . . . 0.417 ' C ' HD12 ' A' ' 76' ' ' LEU . 41.4 t -124.91 124.11 67.08 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.206 0 CA-C-O 121.141 0.496 . . . . 0.0 110.691 -176.481 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 76' ' ' LEU . . . . . 0.417 HD12 ' C ' ' A' ' 75' ' ' VAL . 6.4 mp -122.1 150.14 42.58 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 115.586 -0.734 . . . . 0.0 109.22 173.841 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 77' ' ' GLU . . . . . . . . . . . . . 97.0 mt-10 -137.86 137.07 37.74 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-O 121.126 0.489 . . . . 0.0 111.237 -178.073 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 78' ' ' ALA . . . . . 0.485 ' HB2' HD21 ' A' ' 109' ' ' LEU . . . -125.06 129.61 50.6 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 115.708 -0.678 . . . . 0.0 109.532 175.803 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 79' ' ' LYS . . . . . 0.695 ' O ' HD13 ' A' ' 80' ' ' ILE . 39.2 ttpt -73.69 120.15 18.89 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-O 120.795 0.331 . . . . 0.0 110.575 -177.848 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 80' ' ' ILE . . . . . 0.695 HD13 ' O ' ' A' ' 79' ' ' LYS . 25.9 mm -139.34 98.48 1.15 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.326 0 N-CA-C 109.268 -0.642 . . . . 0.0 109.268 -178.238 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 81' ' ' LYS . . . . . . . . . . . . . 56.2 mtmt -95.75 127.22 41.59 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-O 120.982 0.42 . . . . 0.0 110.97 -177.896 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . 89.18 42.08 5.67 Favored Glycine 0 CA--C 1.525 0.675 0 N-CA-C 111.566 -0.614 . . . . 0.0 111.566 176.43 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 83' ' ' ILE . . . . . . . . . . . . . 69.0 mt -67.26 137.86 23.94 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.289 0 N-CA-C 109.657 -0.497 . . . . 0.0 109.657 176.871 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 84' ' ' LYS . . . . . . . . . . . . . 54.5 tttp -95.46 -49.91 5.22 Favored 'General case' 0 C--N 1.327 -0.395 0 CA-C-N 116.15 -0.477 . . . . 0.0 109.868 -179.031 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 85' ' ' ASP . . . . . . . . . . . . . 10.4 t70 -159.16 149.95 19.77 Favored 'General case' 0 C--N 1.327 -0.401 0 CA-C-N 115.589 -0.732 . . . . 0.0 110.239 178.605 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 86' ' ' VAL . . . . . . . . . . . . . 42.1 t -130.12 131.32 65.94 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.275 0 CA-C-O 120.898 0.38 . . . . 0.0 110.237 179.241 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 87' ' ' ILE . . . . . 0.49 HD12 ' N ' ' A' ' 87' ' ' ILE . 5.1 mp -119.07 129.01 75.77 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.281 0 CA-C-N 115.89 -0.596 . . . . 0.0 109.395 178.383 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 88' ' ' LEU . . . . . . . . . . . . . 13.3 tp -118.58 133.24 56.01 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-O 121.069 0.461 . . . . 0.0 111.302 -176.078 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 89' ' ' ASP . . . . . . . . . . . . . 12.8 t70 -130.92 159.03 38.63 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 115.637 -0.71 . . . . 0.0 109.38 175.109 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 95.8 mt-10 -47.41 -37.69 11.92 Favored 'General case' 0 C--N 1.33 -0.241 0 N-CA-C 113.029 0.751 . . . . 0.0 113.029 -172.362 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 91' ' ' ASN . . . . . . . . . . . . . 69.7 m-80 -132.11 36.38 3.65 Favored 'General case' 0 N--CA 1.464 0.235 0 N-CA-C 111.877 0.325 . . . . 0.0 111.877 -175.443 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 92' ' ' LEU . . . . . . . . . . . . . 19.3 tp -166.07 139.68 4.26 Favored 'General case' 0 C--N 1.332 -0.181 0 C-N-CA 120.836 -0.346 . . . . 0.0 110.99 -179.288 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 93' ' ' ILE . . . . . . . . . . . . . 68.9 mt -126.27 118.03 50.22 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.164 0 N-CA-C 109.089 -0.708 . . . . 0.0 109.089 177.625 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 94' ' ' VAL . . . . . . . . . . . . . 42.9 t -120.25 127.0 75.87 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.289 0 N-CA-C 109.903 -0.406 . . . . 0.0 109.903 -179.004 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 95' ' ' VAL . . . . . . . . . . . . . 42.7 t -120.89 134.04 65.6 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.311 0 CA-C-N 116.131 -0.486 . . . . 0.0 109.983 -179.435 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 96' ' ' ILE . . . . . . . . . . . . . 57.5 mt -115.42 127.62 72.92 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.324 0 N-CA-C 109.155 -0.683 . . . . 0.0 109.155 178.105 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 97' ' ' THR . . . . . . . . . . . . . 59.4 p -101.95 153.31 19.98 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-O 121.015 0.436 . . . . 0.0 110.955 -177.752 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 98' ' ' GLU . . . . . . . . . . . . . 96.4 mt-10 -53.9 -23.4 12.62 Favored 'General case' 0 CA--C 1.534 0.36 0 N-CA-C 112.297 0.481 . . . . 0.0 112.297 179.426 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 99' ' ' GLU . . . . . . . . . . . . . 95.0 mt-10 -78.79 15.27 1.1 Allowed 'General case' 0 CA--C 1.536 0.419 0 N-CA-C 113.121 0.785 . . . . 0.0 113.121 -177.536 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 100' ' ' ASN . . . . . . . . . . . . . 3.6 m-20 64.01 38.07 8.86 Favored 'General case' 0 N--CA 1.463 0.188 0 CA-C-O 120.972 0.415 . . . . 0.0 110.965 177.435 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 101' ' ' GLU . . . . . . . . . . . . . 83.4 tt0 -119.22 142.82 47.68 Favored 'General case' 0 C--N 1.332 -0.165 0 CA-C-N 116.177 -0.465 . . . . 0.0 109.876 176.551 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 102' ' ' VAL . . . . . . . . . . . . . 45.5 t -115.77 126.46 73.31 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.283 0 CA-C-N 116.117 -0.492 . . . . 0.0 109.759 -178.845 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 103' ' ' LEU . . . . . . . . . . . . . 46.6 mt -120.48 132.41 55.19 Favored 'General case' 0 C--N 1.331 -0.202 0 CA-C-N 115.992 -0.549 . . . . 0.0 110.517 178.313 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 104' ' ' ILE . . . . . . . . . . . . . 67.7 mt -118.95 122.43 69.33 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.256 0 CA-C-N 116.332 -0.395 . . . . 0.0 110.324 -178.48 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 105' ' ' PHE . . . . . . . . . . . . . 85.8 m-85 -123.99 165.06 18.1 Favored 'General case' 0 C--O 1.232 0.17 0 O-C-N 123.895 0.747 . . . . 0.0 109.892 -179.527 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 106' ' ' ASN . . . . . . . . . . . . . 46.8 p-10 -100.63 -171.36 2.0 Favored 'General case' 0 C--N 1.331 -0.21 0 N-CA-C 109.742 -0.466 . . . . 0.0 109.742 172.665 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 107' ' ' GLN . . . . . . . . . . . . . 29.4 tt0 -61.09 -29.85 70.0 Favored 'General case' 0 C--N 1.329 -0.285 0 N-CA-C 111.974 0.361 . . . . 0.0 111.974 -178.642 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 108' ' ' ASN . . . . . . . . . . . . . 3.8 t-20 -83.54 10.69 8.44 Favored 'General case' 0 CA--C 1.537 0.457 0 N-CA-C 113.014 0.746 . . . . 0.0 113.014 -178.303 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 109' ' ' LEU . . . . . 0.485 HD21 ' HB2' ' A' ' 78' ' ' ALA . 7.6 tp 57.72 37.72 27.32 Favored 'General case' 0 CA--C 1.529 0.172 0 CA-C-O 121.206 0.527 . . . . 0.0 111.341 179.277 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 110' ' ' GLU . . . . . . . . . . . . . 70.8 mm-40 -103.93 142.7 33.97 Favored 'General case' 0 C--N 1.33 -0.266 0 N-CA-C 109.33 -0.619 . . . . 0.0 109.33 174.071 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 111' ' ' GLU . . . . . . . . . . . . . 48.6 tt0 -79.14 121.94 25.63 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-N 116.454 -0.339 . . . . 0.0 110.893 -176.062 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 112' ' ' LEU . . . . . . . . . . . . . 44.1 mt -102.93 -46.12 4.76 Favored 'General case' 0 C--N 1.33 -0.239 0 CA-C-N 116.128 -0.487 . . . . 0.0 110.515 179.589 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 113' ' ' TYR . . . . . . . . . . . . . 63.9 t80 -140.59 145.02 36.17 Favored 'General case' 0 C--N 1.332 -0.182 0 CA-C-N 116.397 -0.365 . . . . 0.0 111.061 -179.682 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 114' ' ' ARG . . . . . . . . . . . . . 39.0 ptt180 -144.59 126.7 15.58 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.085 -0.507 . . . . 0.0 110.462 178.807 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 115' ' ' GLY . . . . . . . . . . . . . . . -150.05 150.75 22.85 Favored Glycine 0 CA--C 1.524 0.602 0 C-N-CA 120.682 -0.77 . . . . 0.0 111.192 179.654 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 116' ' ' LYS . . . . . . . . . . . . . 27.5 ttpp -123.45 135.77 54.26 Favored 'General case' 0 C--N 1.33 -0.274 0 N-CA-C 109.687 -0.486 . . . . 0.0 109.687 177.27 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 117' ' ' PHE . . . . . . . . . . . . . 36.2 m-85 -134.07 113.92 12.62 Favored 'General case' 0 C--N 1.33 -0.262 0 N-CA-C 110.037 -0.357 . . . . 0.0 110.037 -177.291 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 118' ' ' GLU . . . . . . . . . . . . . 83.5 tt0 -55.09 -44.72 75.16 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.383 -0.371 . . . . 0.0 111.185 -177.123 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 119' ' ' ASN . . . . . . . . . . . . . 85.2 m-20 -95.48 30.99 2.1 Favored 'General case' 0 C--N 1.33 -0.264 0 N-CA-C 112.214 0.45 . . . . 0.0 112.214 -175.649 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 120' ' ' LEU . . . . . . . . . . . . . 24.8 tp -57.63 122.16 12.08 Favored 'General case' 0 C--N 1.333 -0.132 0 N-CA-C 110.141 -0.318 . . . . 0.0 110.141 176.656 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 121' ' ' ASN . . . . . . . . . . . . . 61.5 m-20 -114.05 -43.99 3.19 Favored 'General case' 0 C--N 1.332 -0.187 0 CA-C-N 116.647 -0.251 . . . . 0.0 110.998 -176.773 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 122' ' ' LYS . . . . . . . . . . . . . 98.1 mttt -145.91 150.87 36.91 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-O 121.061 0.457 . . . . 0.0 111.505 -177.596 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 123' ' ' VAL . . . . . . . . . . . . . 43.5 t -128.75 131.16 68.72 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.253 0 CA-C-N 115.955 -0.566 . . . . 0.0 109.695 176.516 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 124' ' ' LEU . . . . . . . . . . . . . 34.0 mt -121.76 128.75 52.1 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.277 -0.419 . . . . 0.0 110.16 -179.547 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 125' ' ' VAL . . . . . 0.459 ' CG2' HG21 ' A' ' 87' ' ' ILE . 35.6 m -140.07 141.45 33.71 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 CA-C-O 120.862 0.363 . . . . 0.0 110.81 179.688 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 126' ' ' ARG . . . . . . . . . . . . . 51.0 ttp180 -161.29 129.66 4.4 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.07 -0.514 . . . . 0.0 110.622 177.502 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 127' ' ' ASN . . . . . . . . . . . . . 6.1 m120 52.77 -111.24 0.58 Allowed 'General case' 0 CA--C 1.544 0.741 0 CA-C-O 118.871 -0.585 . . . . 0.0 111.024 179.347 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 128' ' ' ASP . . . . . . . . . . . . . 11.9 p-10 -114.04 12.21 17.89 Favored 'General case' 0 N--CA 1.466 0.337 0 CA-C-N 119.892 1.224 . . . . 0.0 113.244 -177.747 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 129' ' ' LEU . . . . . . . . . . . . . 30.5 mt -107.7 134.11 51.15 Favored 'General case' 0 C--N 1.333 -0.147 0 O-C-N 121.968 -0.457 . . . . 0.0 110.136 178.013 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 130' ' ' VAL . . . . . . . . . . . . . 45.5 t -125.08 131.02 73.03 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.229 0 N-CA-C 109.58 -0.526 . . . . 0.0 109.58 178.759 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 131' ' ' VAL . . . . . 0.523 HG22 HD12 ' A' ' 140' ' ' LEU . 42.2 t -135.61 133.81 51.75 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.307 0 CA-C-O 120.999 0.428 . . . . 0.0 110.192 178.514 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 132' ' ' ILE . . . . . . . . . . . . . 74.6 mt -114.48 130.63 68.47 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.378 0 CA-C-N 115.81 -0.632 . . . . 0.0 109.308 179.44 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 133' ' ' ILE . . . . . . . . . . . . . 42.9 mm -114.56 119.24 60.96 Favored 'Isoleucine or valine' 0 C--O 1.234 0.263 0 CA-C-O 120.874 0.368 . . . . 0.0 110.748 -175.353 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 134' ' ' ASP . . . . . . . . . . . . . 9.6 p-10 -133.94 147.95 51.12 Favored 'General case' 0 C--N 1.331 -0.225 0 N-CA-C 109.678 -0.489 . . . . 0.0 109.678 176.282 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 135' ' ' GLU . . . . . . . . . . . . . 78.8 tt0 -49.9 -27.84 5.81 Favored 'General case' 0 C--N 1.328 -0.368 0 N-CA-C 112.833 0.679 . . . . 0.0 112.833 -173.698 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 136' ' ' GLN . . . . . . . . . . . . . 48.2 tt0 -79.05 -37.39 39.11 Favored 'General case' 0 C--O 1.233 0.229 0 N-CA-C 111.973 0.361 . . . . 0.0 111.973 -176.064 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 137' ' ' LYS . . . . . . . . . . . . . 51.8 pttt -166.32 175.46 8.22 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-O 121.689 0.756 . . . . 0.0 112.197 -171.129 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 138' ' ' LEU . . . . . 0.41 HD23 ' N ' ' A' ' 139' ' ' THR . 4.8 tt -119.46 128.45 54.02 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 114.877 -1.056 . . . . 0.0 109.757 178.7 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 139' ' ' THR . . . . . 0.41 ' N ' HD23 ' A' ' 138' ' ' LEU . 19.5 m -109.12 124.08 50.23 Favored 'General case' 0 C--N 1.331 -0.205 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.598 -179.496 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 140' ' ' LEU . . . . . 0.523 HD12 HG22 ' A' ' 131' ' ' VAL . 48.0 tp -112.09 120.43 41.82 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 115.982 -0.554 . . . . 0.0 109.574 -179.166 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 141' ' ' ILE . . . . . . . . . . . . . 19.1 mt -122.95 120.65 61.18 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.278 0 CA-C-O 120.993 0.425 . . . . 0.0 110.088 -176.198 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 142' ' ' ARG . . . . . . . . . . . . . 22.3 mtp-105 -97.59 121.23 39.25 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 115.463 -0.79 . . . . 0.0 109.976 176.49 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 143' ' ' THR . . . . . . . . . . . . . 48.2 p . . . . . 0 C--O 1.22 -0.459 0 CA-C-O 118.051 -0.976 . . . . 0.0 110.423 179.339 . . . . . . . . 0 0 . 1 . 016 nuclear build core ' B' B ' 2' ' ' SER . . . . . . . . . . . . . 2.3 p . . . . . 0 C--O 1.23 0.066 0 N-CA-C 110.017 -0.364 . . . . 0.0 110.017 . . . . . . . . . 0 0 . 1 . 016 nuclear build core ' B' B ' 3' ' ' GLU . . . . . . . . . . . . . 81.3 tt0 -140.94 142.46 34.36 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-N 116.172 -0.467 . . . . 0.0 111.158 -176.266 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' B' B ' 4' ' ' LEU . . . . . . . . . . . . . 11.4 tp -123.6 130.95 53.43 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 115.946 -0.57 . . . . 0.0 109.744 176.298 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' B' B ' 5' ' ' LYS . . . . . . . . . . . . . 91.5 mttt -110.87 121.43 45.33 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 116.31 -0.405 . . . . 0.0 110.729 -178.307 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' B' B ' 6' ' ' LEU . . . . . . . . . . . . . 55.9 mt -116.54 151.27 36.51 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 115.569 -0.741 . . . . 0.0 110.653 -178.856 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' B' B ' 7' ' ' LYS . . . . . . . . . . . . . 59.1 tttt -139.04 135.42 17.46 Favored Pre-proline 0 CA--C 1.535 0.396 0 CA-C-O 118.966 -0.54 . . . . 0.0 110.152 175.936 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' B' B ' 8' ' ' PRO . . . . . . . . . . . . . 94.7 Cg_endo -92.04 144.79 2.89 Favored 'Trans proline' 0 N--CA 1.49 1.274 0 C-N-CA 121.814 1.676 . . . . 0.0 111.632 177.359 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' B' B ' 9' ' ' LEU . . . . . . . . . . . . . 47.3 mt -86.54 -47.91 0.52 Allowed Pre-proline 0 CA--C 1.534 0.345 0 CA-C-O 118.701 -0.666 . . . . 0.0 112.646 -177.981 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' B' B ' 10' ' ' PRO . . . . . . . . . . . . . 97.3 Cg_endo -81.91 160.77 18.54 Favored 'Trans proline' 0 N--CA 1.495 1.616 0 C-N-CA 121.421 1.414 . . . . 0.0 112.063 177.802 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' B' B ' 11' ' ' LYS . . . . . . . . . . . . . 52.5 pttt -85.67 121.67 28.67 Favored 'General case' 0 C--N 1.331 -0.196 0 CA-C-O 120.953 0.406 . . . . 0.0 110.377 178.145 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' B' B ' 12' ' ' VAL . . . . . . . . . . . . . 12.5 p -151.09 144.81 16.7 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.251 0 CA-C-N 116.226 -0.443 . . . . 0.0 110.705 -179.971 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' B' B ' 13' ' ' GLU . . . . . . . . . . . . . 81.4 tt0 -91.88 108.98 20.32 Favored 'General case' 0 C--N 1.329 -0.325 0 N-CA-C 109.718 -0.475 . . . . 0.0 109.718 176.263 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' B' B ' 14' ' ' LEU . . . . . . . . . . . . . 81.2 mt -84.44 143.41 41.56 Favored Pre-proline 0 CA--C 1.534 0.343 0 CA-C-O 119.168 -0.444 . . . . 0.0 110.666 -175.923 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' B' B ' 15' ' ' PRO . . . . . . . . . . . . . 24.8 Cg_exo -63.06 163.33 22.97 Favored 'Trans proline' 0 N--CA 1.497 1.703 0 C-N-CA 121.301 1.334 . . . . 0.0 111.879 175.608 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' B' B ' 16' ' ' PRO . . . . . . . . . . . . . 29.6 Cg_exo -60.17 -39.17 71.28 Favored 'Trans proline' 0 N--CA 1.496 1.671 0 C-N-CA 121.478 1.452 . . . . 0.0 112.846 -178.105 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' B' B ' 17' ' ' ASP . . . . . . . . . . . . . 20.1 p-10 -90.74 12.5 18.96 Favored 'General case' 0 CA--C 1.536 0.423 0 N-CA-C 113.161 0.8 . . . . 0.0 113.161 -176.814 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' B' B ' 18' ' ' PHE . . . . . . . . . . . . . 33.9 t80 -56.21 -46.0 79.66 Favored 'General case' 0 C--N 1.334 -0.104 0 O-C-N 121.937 -0.477 . . . . 0.0 110.671 -178.364 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' B' B ' 19' ' ' VAL . . . . . . . . . . . . . 46.6 t -55.48 -43.54 72.64 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.277 0 CA-C-N 116.61 -0.268 . . . . 0.0 110.858 -177.931 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' B' B ' 20' ' ' ASP . . . . . . . . . . . . . 50.7 m-20 -60.01 -43.79 94.99 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-O 120.988 0.423 . . . . 0.0 111.017 -177.682 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' B' B ' 21' ' ' VAL . . . . . . . . . . . . . 45.1 t -64.38 -46.6 92.54 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.259 0 CA-C-N 116.401 -0.363 . . . . 0.0 110.573 -177.554 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' B' B ' 22' ' ' ILE . . . . . 0.45 HG22 HD12 ' B' ' 26' ' ' LEU . 50.7 mm -56.27 -44.5 79.7 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.206 0 C-N-CA 120.926 -0.31 . . . . 0.0 110.564 178.678 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' B' B ' 23' ' ' ARG . . . . . . . . . . . . . 55.7 ttp180 -53.36 -48.08 68.85 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-O 120.722 0.296 . . . . 0.0 111.396 -179.76 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' B' B ' 24' ' ' ILE . . . . . . . . . . . . . 71.4 mt -58.97 -44.53 91.27 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.251 0 CA-C-N 116.496 -0.32 . . . . 0.0 110.938 -179.228 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' B' B ' 25' ' ' LYS . . . . . . . . . . . . . 53.0 mttm -65.59 -35.27 80.33 Favored 'General case' 0 C--N 1.327 -0.404 0 N-CA-C 112.3 0.482 . . . . 0.0 112.3 -178.051 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' B' B ' 26' ' ' LEU . . . . . 0.45 HD12 HG22 ' B' ' 22' ' ' ILE . 56.1 mt -80.01 -46.02 17.36 Favored 'General case' 0 C--N 1.329 -0.31 0 N-CA-C 112.943 0.72 . . . . 0.0 112.943 -172.896 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' B' B ' 27' ' ' GLN . . . . . . . . . . . . . 15.5 pt20 -46.56 138.74 5.63 Favored 'General case' 0 N--CA 1.468 0.464 0 N-CA-C 112.677 0.621 . . . . 0.0 112.677 -174.909 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' B' B ' 28' ' ' GLY . . . . . . . . . . . . . . . 100.09 -24.92 30.24 Favored Glycine 0 CA--C 1.533 1.195 0 CA-C-N 115.599 -0.728 . . . . 0.0 112.412 -177.869 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' B' B ' 29' ' ' LYS . . . . . . . . . . . . . 67.9 mttm -97.72 155.08 17.18 Favored 'General case' 0 C--N 1.331 -0.198 0 CA-C-N 117.402 0.601 . . . . 0.0 111.145 179.656 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' B' B ' 30' ' ' THR . . . . . . . . . . . . . 28.9 m -106.04 133.34 50.9 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 115.861 -0.609 . . . . 0.0 109.778 175.008 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' B' B ' 31' ' ' VAL . . . . . . . . . . . . . 35.2 m -128.63 156.1 40.86 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.214 0 CA-C-N 116.437 -0.347 . . . . 0.0 110.693 -178.619 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' B' B ' 32' ' ' ARG . . . . . . . . . . . . . 72.2 ttt180 -132.73 148.03 52.33 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.036 -0.529 . . . . 0.0 110.351 178.929 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' B' B ' 33' ' ' THR . . . . . . . . . . . . . 19.6 m -52.64 138.09 29.27 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-O 120.858 0.361 . . . . 0.0 111.396 -178.25 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' B' B ' 34' ' ' GLY . . . . . . . . . . . . . . . 102.13 -17.24 54.51 Favored Glycine 0 CA--C 1.534 1.23 0 CA-C-N 116.074 -0.512 . . . . 0.0 113.235 179.286 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' B' B ' 35' ' ' ASP . . . . . . . . . . . . . 78.6 m-20 -66.91 151.17 48.09 Favored 'General case' 0 N--CA 1.462 0.158 0 CA-C-N 117.972 0.886 . . . . 0.0 111.052 178.715 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' B' B ' 36' ' ' VAL . . . . . . . . . . . . . 44.4 t -124.25 132.73 70.91 Favored 'Isoleucine or valine' 0 C--N 1.333 -0.145 0 CA-C-N 115.959 -0.564 . . . . 0.0 109.902 178.234 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' B' B ' 37' ' ' ILE . . . . . . . . . . . . . 68.5 mt -119.66 140.16 44.58 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.189 0 CA-C-N 116.063 -0.517 . . . . 0.0 109.96 -179.258 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' B' B ' 38' ' ' GLY . . . . . . . . . . . . . . . -116.95 128.84 8.07 Favored Glycine 0 CA--C 1.525 0.714 0 N-CA-C 111.043 -0.823 . . . . 0.0 111.043 179.598 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' B' B ' 39' ' ' ILE . . . . . . . . . . . . . 76.9 mt -128.89 139.68 51.26 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.248 0 N-CA-C 110.147 -0.316 . . . . 0.0 110.147 179.245 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' B' B ' 40' ' ' SER . . . . . . . . . . . . . 53.7 p -93.22 126.01 38.12 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.263 -0.426 . . . . 0.0 110.863 175.26 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' B' B ' 41' ' ' ILE . . . . . . . . . . . . . 68.6 mt -134.99 113.94 16.62 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.247 0 CA-C-O 120.826 0.346 . . . . 0.0 110.534 177.702 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' B' B ' 42' ' ' LEU . . . . . 0.516 ' O ' HD23 ' B' ' 42' ' ' LEU . 1.5 tt 56.33 47.84 18.3 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-O 121.52 0.676 . . . . 0.0 110.358 177.604 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' B' B ' 43' ' ' GLY . . . . . . . . . . . . . . . 72.2 -5.49 14.05 Favored Glycine 0 CA--C 1.536 1.351 0 C-N-CA 121.162 -0.542 . . . . 0.0 113.724 175.118 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' B' B ' 44' ' ' LYS . . . . . . . . . . . . . 80.6 tttt -108.85 135.04 50.71 Favored 'General case' 0 C--N 1.332 -0.181 0 CA-C-N 118.049 0.924 . . . . 0.0 110.19 -179.212 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' B' B ' 45' ' ' GLU . . . . . . . . . . . . . 84.1 tt0 -83.73 130.65 34.95 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-N 116.458 -0.337 . . . . 0.0 111.079 -179.075 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' B' B ' 46' ' ' VAL . . . . . . . . . . . . . 7.3 p -124.04 125.06 70.25 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.189 0 CA-C-O 121.002 0.43 . . . . 0.0 109.875 175.616 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' B' B ' 47' ' ' LYS . . . . . . . . . . . . . 91.9 mttt -100.08 131.46 46.02 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 115.951 -0.568 . . . . 0.0 111.031 176.529 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' B' B ' 48' ' ' PHE . . . . . . . . . . . . . 94.6 m-85 -113.08 131.88 55.64 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.057 -0.52 . . . . 0.0 109.644 175.341 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' B' B ' 49' ' ' LYS . . . . . . . . . . . . . 76.1 tttt -107.22 135.46 48.71 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.605 -0.27 . . . . 0.0 110.302 178.094 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' B' B ' 50' ' ' VAL . . . . . . . . . . . . . 43.9 t -81.16 107.48 13.48 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.315 0 N-CA-C 109.219 -0.66 . . . . 0.0 109.219 176.268 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' B' B ' 51' ' ' VAL . . . . . . . . . . . . . 40.4 t -74.88 -49.65 28.29 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.337 0 CA-C-N 115.982 -0.554 . . . . 0.0 110.14 -172.716 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' B' B ' 52' ' ' GLN . . . . . . . . . . . . . 85.8 mt-30 -154.34 152.98 30.87 Favored 'General case' 0 C--N 1.331 -0.199 0 C-N-CA 120.449 -0.5 . . . . 0.0 111.797 -177.304 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' B' B ' 53' ' ' ALA . . . . . 0.413 ' HB3' ' OG ' ' B' ' 56' ' ' SER . . . -130.35 130.5 44.51 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 115.339 -0.846 . . . . 0.0 109.643 175.016 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' B' B ' 54' ' ' TYR . . . . . . . . . . . . . 19.1 t80 -129.13 105.91 17.95 Favored Pre-proline 0 CA--C 1.534 0.357 0 CA-C-O 118.357 -0.83 . . . . 0.0 110.464 -179.572 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' B' B ' 55' ' ' PRO . . . . . . . . . . . . . 73.8 Cg_endo -77.2 170.06 72.49 Favored 'Cis proline' 0 N--CA 1.5 1.912 0 CA-C-N 121.673 1.633 . . . . 0.0 112.474 -5.98 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' B' B ' 56' ' ' SER . . . . . 0.413 ' OG ' ' HB3' ' B' ' 53' ' ' ALA . 36.0 m -116.42 134.16 22.89 Favored Pre-proline 0 CA--C 1.539 0.524 0 CA-C-O 118.461 -0.781 . . . . 0.0 109.606 175.17 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' B' B ' 57' ' ' PRO . . . . . . . . . . . . . 36.2 Cg_endo -67.07 166.53 62.35 Favored 'Cis proline' 0 N--CA 1.497 1.732 0 CA-C-N 121.856 1.698 . . . . 0.0 111.349 -3.727 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' B' B ' 58' ' ' LEU . . . . . . . . . . . . . 31.4 tp -130.77 138.04 49.75 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.239 -0.437 . . . . 0.0 110.512 -179.324 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' B' B ' 59' ' ' ARG . . . . . . . . . . . . . 59.8 ttm-85 -105.47 127.34 52.95 Favored 'General case' 0 C--N 1.327 -0.37 0 N-CA-C 109.148 -0.686 . . . . 0.0 109.148 175.0 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' B' B ' 60' ' ' VAL . . . . . . . . . . . . . 40.1 t -81.2 123.99 38.33 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.338 0 C-N-CA 120.651 -0.42 . . . . 0.0 110.872 -173.788 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' B' B ' 61' ' ' GLU . . . . . . . . . . . . . 95.7 mt-10 -131.0 162.55 29.52 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 115.691 -0.686 . . . . 0.0 109.666 176.251 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' B' B ' 62' ' ' ASP . . . . . . . . . . . . . 78.7 m-20 -54.85 -33.96 62.35 Favored 'General case' 0 C--N 1.328 -0.329 0 C-N-CA 121.015 -0.274 . . . . 0.0 111.646 -178.86 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' B' B ' 63' ' ' ARG . . . . . . . . . . . . . 7.3 mmm180 -76.18 -10.3 59.3 Favored 'General case' 0 CA--C 1.537 0.446 0 N-CA-C 113.186 0.81 . . . . 0.0 113.186 -176.74 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' B' B ' 64' ' ' THR . . . . . . . . . . . . . 30.0 m -72.27 145.32 47.98 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-O 121.004 0.43 . . . . 0.0 111.246 -175.915 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' B' B ' 65' ' ' LYS . . . . . . . . . . . . . 23.9 mtpp -89.58 127.52 35.9 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 115.878 -0.601 . . . . 0.0 110.265 178.491 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' B' B ' 66' ' ' ILE . . . . . . . . . . . . . 55.7 mt -114.77 129.93 70.07 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.245 0 N-CA-C 109.779 -0.452 . . . . 0.0 109.779 179.59 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' B' B ' 67' ' ' THR . . . . . . . . . . . . . 25.9 m -127.76 143.63 51.12 Favored 'General case' 0 C--N 1.332 -0.176 0 CA-C-O 121.171 0.51 . . . . 0.0 111.586 -176.842 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' B' B ' 68' ' ' LEU . . . . . . . . . . . . . 16.0 tp . . . . . 0 C--N 1.33 -0.255 0 CA-C-N 115.59 -0.732 . . . . 0.0 109.622 175.666 . . . . . . . . 0 0 . 1 . 016 nuclear build core ' B' B ' 73' ' ' VAL . . . . . . . . . . . . . 35.4 m . . . . . 0 C--O 1.232 0.146 0 CA-C-O 120.854 0.359 . . . . 0.0 110.697 . . . . . . . . . 0 0 . 1 . 016 nuclear build core ' B' B ' 74' ' ' ASP . . . . . . . . . . . . . 18.6 t0 -104.09 115.43 30.42 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.001 -0.545 . . . . 0.0 109.893 179.245 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' B' B ' 75' ' ' VAL . . . . . . . . . . . . . 40.8 t -116.69 123.58 71.82 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.291 0 CA-C-O 121.086 0.47 . . . . 0.0 110.738 -176.271 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' B' B ' 76' ' ' LEU . . . . . . . . . . . . . 4.9 mp -125.19 146.63 49.42 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 115.635 -0.712 . . . . 0.0 109.516 176.273 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' B' B ' 77' ' ' GLU . . . . . . . . . . . . . 46.4 mt-10 -134.22 141.11 46.91 Favored 'General case' 0 C--N 1.331 -0.227 0 CA-C-O 120.944 0.402 . . . . 0.0 111.119 -178.513 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' B' B ' 78' ' ' ALA . . . . . 0.788 ' HB2' HD21 ' B' ' 109' ' ' LEU . . . -129.81 135.34 48.3 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 115.879 -0.601 . . . . 0.0 109.925 176.289 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' B' B ' 79' ' ' LYS . . . . . 0.553 ' O ' HD13 ' B' ' 80' ' ' ILE . 43.3 pttt -80.36 121.59 25.88 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-O 121.123 0.487 . . . . 0.0 111.18 -176.951 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' B' B ' 80' ' ' ILE . . . . . 0.553 HD13 ' O ' ' B' ' 79' ' ' LYS . 23.7 mm -139.45 112.26 5.87 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.327 0 N-CA-C 109.119 -0.697 . . . . 0.0 109.119 -179.018 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' B' B ' 81' ' ' LYS . . . . . . . . . . . . . 36.2 ttpt -100.45 123.08 44.2 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-O 120.911 0.386 . . . . 0.0 111.148 -178.363 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' B' B ' 82' ' ' GLY . . . . . . . . . . . . . . . 89.17 42.07 5.68 Favored Glycine 0 CA--C 1.527 0.792 0 C-N-CA 120.859 -0.686 . . . . 0.0 112.225 173.732 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' B' B ' 83' ' ' ILE . . . . . . . . . . . . . 69.2 mt -67.46 136.1 27.26 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.321 0 N-CA-C 109.689 -0.486 . . . . 0.0 109.689 175.993 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' B' B ' 84' ' ' LYS . . . . . . . . . . . . . 38.6 ttpt -104.48 -48.21 3.88 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-O 120.873 0.368 . . . . 0.0 110.584 -178.266 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' B' B ' 85' ' ' ASP . . . . . . . . . . . . . 13.8 t70 -143.37 146.64 33.68 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.06 -0.518 . . . . 0.0 110.631 -178.594 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' B' B ' 86' ' ' VAL . . . . . . . . . . . . . 44.7 t -131.08 132.69 63.42 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.268 0 CA-C-O 120.863 0.363 . . . . 0.0 110.389 -179.285 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' B' B ' 87' ' ' ILE . . . . . 0.496 ' N ' HD12 ' B' ' 87' ' ' ILE . 5.2 mp -123.97 128.09 73.95 Favored 'Isoleucine or valine' 0 C--O 1.233 0.187 0 CA-C-N 115.945 -0.571 . . . . 0.0 109.762 177.527 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' B' B ' 88' ' ' LEU . . . . . . . . . . . . . 18.8 tp -113.62 133.14 55.46 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.284 -0.416 . . . . 0.0 110.953 -177.901 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' B' B ' 89' ' ' ASP . . . . . . . . . . . . . 6.4 t0 -132.33 160.5 36.1 Favored 'General case' 0 C--N 1.331 -0.199 0 CA-C-N 116.171 -0.468 . . . . 0.0 109.848 177.955 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' B' B ' 90' ' ' GLU . . . . . . . . . . . . . 95.7 mt-10 -44.95 -47.29 11.38 Favored 'General case' 0 N--CA 1.465 0.28 0 N-CA-C 113.328 0.862 . . . . 0.0 113.328 -171.785 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' B' B ' 91' ' ' ASN . . . . . . . . . . . . . 77.7 m-20 -124.26 21.48 8.76 Favored 'General case' 0 N--CA 1.468 0.428 0 N-CA-C 112.809 0.67 . . . . 0.0 112.809 -176.237 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' B' B ' 92' ' ' LEU . . . . . . . . . . . . . 26.6 mt -148.23 145.96 28.46 Favored 'General case' 0 C--N 1.331 -0.208 0 CA-C-O 120.757 0.313 . . . . 0.0 110.872 -174.861 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' B' B ' 93' ' ' ILE . . . . . . . . . . . . . 71.7 mt -125.58 115.93 44.86 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.319 0 N-CA-C 108.898 -0.779 . . . . 0.0 108.898 176.683 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' B' B ' 94' ' ' VAL . . . . . . . . . . . . . 43.6 t -116.45 127.06 74.16 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.322 0 N-CA-C 109.95 -0.389 . . . . 0.0 109.95 -177.283 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' B' B ' 95' ' ' VAL . . . . . . . . . . . . . 43.7 t -122.56 134.4 65.86 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.265 0 CA-C-N 116.099 -0.5 . . . . 0.0 109.91 -179.318 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' B' B ' 96' ' ' ILE . . . . . . . . . . . . . 68.8 mt -118.07 126.75 75.15 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.287 0 N-CA-C 109.349 -0.611 . . . . 0.0 109.349 178.981 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' B' B ' 97' ' ' THR . . . . . . . . . . . . . 69.6 p -99.39 157.08 16.66 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-O 121.274 0.559 . . . . 0.0 111.495 -176.029 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' B' B ' 98' ' ' GLU . . . . . . . . . . . . . 12.1 pt-20 -53.82 -25.23 18.45 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 115.966 -0.561 . . . . 0.0 112.489 -179.275 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' B' B ' 99' ' ' GLU . . . . . . . . . . . . . 95.6 mt-10 -81.97 17.85 1.47 Allowed 'General case' 0 CA--C 1.535 0.366 0 N-CA-C 113.021 0.748 . . . . 0.0 113.021 -177.529 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' B' B ' 100' ' ' ASN . . . . . . . . . . . . . 3.2 m-20 61.75 37.96 15.34 Favored 'General case' 0 C--O 1.232 0.175 0 CA-C-O 120.955 0.407 . . . . 0.0 110.98 177.86 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' B' B ' 101' ' ' GLU . . . . . . . . . . . . . 83.9 tt0 -115.2 142.97 45.94 Favored 'General case' 0 C--N 1.331 -0.208 0 N-CA-C 109.709 -0.478 . . . . 0.0 109.709 176.35 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' B' B ' 102' ' ' VAL . . . . . . . . . . . . . 44.4 t -116.04 127.06 73.75 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.34 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.037 -177.247 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' B' B ' 103' ' ' LEU . . . . . . . . . . . . . 45.3 mt -120.44 131.12 54.63 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 115.828 -0.624 . . . . 0.0 110.243 177.081 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' B' B ' 104' ' ' ILE . . . . . 0.663 HD13 HG21 ' B' ' 130' ' ' VAL . 67.5 mt -119.68 121.47 66.3 Favored 'Isoleucine or valine' 0 C--O 1.234 0.285 0 CA-C-N 116.471 -0.331 . . . . 0.0 110.182 -178.791 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' B' B ' 105' ' ' PHE . . . . . . . . . . . . . 51.2 m-85 -123.38 163.95 19.81 Favored 'General case' 0 C--N 1.334 -0.089 0 O-C-N 123.838 0.711 . . . . 0.0 109.769 178.7 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' B' B ' 106' ' ' ASN . . . . . . . . . . . . . 43.3 p-10 -97.06 -169.95 1.95 Allowed 'General case' 0 C--N 1.331 -0.221 0 N-CA-C 110.096 -0.335 . . . . 0.0 110.096 174.845 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' B' B ' 107' ' ' GLN . . . . . . . . . . . . . 50.7 tt0 -59.55 -30.0 68.31 Favored 'General case' 0 C--N 1.328 -0.327 0 N-CA-C 111.886 0.328 . . . . 0.0 111.886 179.029 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' B' B ' 108' ' ' ASN . . . . . . . . . . . . . 65.9 t30 -82.56 7.09 15.52 Favored 'General case' 0 CA--C 1.536 0.421 0 N-CA-C 113.283 0.846 . . . . 0.0 113.283 -177.864 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' B' B ' 109' ' ' LEU . . . . . 0.788 HD21 ' HB2' ' B' ' 78' ' ' ALA . 11.9 tp 60.21 37.49 20.57 Favored 'General case' 0 C--N 1.331 -0.2 0 CA-C-O 121.112 0.482 . . . . 0.0 111.218 179.464 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' B' B ' 110' ' ' GLU . . . . . . . . . . . . . 70.9 mm-40 -103.61 148.43 26.01 Favored 'General case' 0 C--N 1.33 -0.264 0 N-CA-C 109.639 -0.504 . . . . 0.0 109.639 175.199 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' B' B ' 111' ' ' GLU . . . . . . . . . . . . . 62.6 tt0 -84.97 122.04 28.64 Favored 'General case' 0 C--N 1.327 -0.396 0 CA-C-O 120.893 0.377 . . . . 0.0 110.586 -176.75 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' B' B ' 112' ' ' LEU . . . . . . . . . . . . . 45.5 mt -109.57 -45.99 3.6 Favored 'General case' 0 C--N 1.332 -0.171 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.722 179.963 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' B' B ' 113' ' ' TYR . . . . . . . . . . . . . 55.5 t80 -133.33 139.12 46.68 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.328 -0.396 . . . . 0.0 110.872 -178.861 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' B' B ' 114' ' ' ARG . . . . . . . . . . . . . 34.7 ptt-85 -145.12 121.01 10.63 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.235 -0.438 . . . . 0.0 110.726 179.624 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' B' B ' 115' ' ' GLY . . . . . . . . . . . . . . . -150.24 159.2 28.01 Favored Glycine 0 CA--C 1.524 0.646 0 C-N-CA 120.871 -0.681 . . . . 0.0 111.439 178.88 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' B' B ' 116' ' ' LYS . . . . . . . . . . . . . 38.6 ttpt -125.59 130.71 52.2 Favored 'General case' 0 C--N 1.33 -0.251 0 N-CA-C 109.525 -0.546 . . . . 0.0 109.525 175.524 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' B' B ' 117' ' ' PHE . . . . . . . . . . . . . 44.5 m-85 -132.43 116.31 16.64 Favored 'General case' 0 C--N 1.331 -0.224 0 CA-C-O 120.934 0.397 . . . . 0.0 110.481 -174.535 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' B' B ' 118' ' ' GLU . . . . . . . . . . . . . 95.8 mt-10 -53.46 -45.03 69.37 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.374 -0.376 . . . . 0.0 111.503 -177.228 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' B' B ' 119' ' ' ASN . . . . . . . . . . . . . 4.6 m120 -97.12 29.72 3.03 Favored 'General case' 0 C--N 1.33 -0.249 0 N-CA-C 112.403 0.52 . . . . 0.0 112.403 -173.958 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' B' B ' 120' ' ' LEU . . . . . . . . . . . . . 17.8 tp -59.07 119.89 8.13 Favored 'General case' 0 C--N 1.331 -0.205 0 N-CA-C 110.067 -0.346 . . . . 0.0 110.067 177.647 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' B' B ' 121' ' ' ASN . . . . . . . . . . . . . 72.8 m-20 -114.07 -44.03 3.18 Favored 'General case' 0 C--N 1.332 -0.167 0 CA-C-N 116.493 -0.321 . . . . 0.0 111.162 -177.521 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' B' B ' 122' ' ' LYS . . . . . . . . . . . . . 97.8 mttt -143.77 151.37 39.9 Favored 'General case' 0 C--N 1.332 -0.162 0 CA-C-O 121.184 0.516 . . . . 0.0 111.748 -176.353 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' B' B ' 123' ' ' VAL . . . . . . . . . . . . . 45.1 t -128.38 126.71 66.19 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.22 0 CA-C-N 115.83 -0.623 . . . . 0.0 109.515 175.225 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' B' B ' 124' ' ' LEU . . . . . 0.425 ' N ' HD12 ' B' ' 124' ' ' LEU . 7.0 mp -114.36 131.61 56.49 Favored 'General case' 0 C--N 1.332 -0.186 0 CA-C-N 116.373 -0.376 . . . . 0.0 110.772 -178.179 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' B' B ' 125' ' ' VAL . . . . . . . . . . . . . 9.2 p -131.94 131.33 61.68 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.215 0 CA-C-N 116.151 -0.477 . . . . 0.0 109.855 178.024 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' B' B ' 126' ' ' ARG . . . . . . . . . . . . . 48.2 ttt180 -151.44 128.77 11.28 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-O 120.951 0.405 . . . . 0.0 110.772 178.74 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' B' B ' 127' ' ' ASN . . . . . . . . . . . . . 6.9 m120 52.1 -112.73 0.69 Allowed 'General case' 0 CA--C 1.545 0.756 0 CA-C-O 118.837 -0.601 . . . . 0.0 111.029 179.242 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' B' B ' 128' ' ' ASP . . . . . . . . . . . . . 10.9 p-10 -114.17 10.16 17.27 Favored 'General case' 0 N--CA 1.468 0.447 0 CA-C-N 119.934 1.243 . . . . 0.0 113.216 -177.288 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' B' B ' 129' ' ' LEU . . . . . . . . . . . . . 77.9 mt -118.43 149.81 40.62 Favored 'General case' 0 C--O 1.233 0.235 0 CA-C-N 118.212 0.46 . . . . 0.0 110.445 -178.605 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' B' B ' 130' ' ' VAL . . . . . 0.663 HG21 HD13 ' B' ' 104' ' ' ILE . 32.9 m -135.43 144.6 33.57 Favored 'Isoleucine or valine' 0 C--O 1.232 0.182 0 CA-C-O 121.326 0.584 . . . . 0.0 111.042 -179.876 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' B' B ' 131' ' ' VAL . . . . . 0.557 HG22 HD12 ' B' ' 140' ' ' LEU . 45.7 t -136.03 137.88 48.11 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.324 0 CA-C-N 115.595 -0.73 . . . . 0.0 109.901 179.013 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' B' B ' 132' ' ' ILE . . . . . . . . . . . . . 71.6 mt -112.32 130.35 66.19 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.337 0 N-CA-C 109.317 -0.623 . . . . 0.0 109.317 179.452 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' B' B ' 133' ' ' ILE . . . . . . . . . . . . . 38.9 mm -114.48 120.09 63.22 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.255 0 CA-C-O 120.752 0.31 . . . . 0.0 111.007 -174.513 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' B' B ' 134' ' ' ASP . . . . . . . . . . . . . 6.9 p-10 -130.93 146.3 52.3 Favored 'General case' 0 C--N 1.332 -0.194 0 N-CA-C 109.465 -0.568 . . . . 0.0 109.465 175.048 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' B' B ' 135' ' ' GLU . . . . . . . . . . . . . 33.6 tt0 -49.95 -27.49 5.41 Favored 'General case' 0 C--N 1.329 -0.323 0 N-CA-C 112.731 0.641 . . . . 0.0 112.731 -173.262 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' B' B ' 136' ' ' GLN . . . . . . . . . . . . . 98.7 mt-30 -79.4 -36.2 39.51 Favored 'General case' 0 C--N 1.331 -0.202 0 N-CA-C 112.175 0.435 . . . . 0.0 112.175 -176.86 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' B' B ' 137' ' ' LYS . . . . . . . . . . . . . 45.6 pttt -169.45 175.39 5.51 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-O 121.448 0.642 . . . . 0.0 112.148 -172.137 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' B' B ' 138' ' ' LEU . . . . . 0.429 ' C ' HD23 ' B' ' 138' ' ' LEU . 7.7 tt -118.18 129.5 55.55 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 115.266 -0.879 . . . . 0.0 110.355 -179.459 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' B' B ' 139' ' ' THR . . . . . . . . . . . . . 32.7 m -107.35 126.45 52.48 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 115.923 -0.58 . . . . 0.0 110.238 178.191 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' B' B ' 140' ' ' LEU . . . . . 0.557 HD12 HG22 ' B' ' 131' ' ' VAL . 12.3 tp -111.63 119.11 37.59 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 115.904 -0.589 . . . . 0.0 109.652 -176.602 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' B' B ' 141' ' ' ILE . . . . . 0.529 ' HB ' HG23 ' B' ' 130' ' ' VAL . 27.2 mt -121.71 121.47 64.47 Favored 'Isoleucine or valine' 0 C--O 1.234 0.245 0 CA-C-O 121.351 0.596 . . . . 0.0 110.525 -173.969 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' B' B ' 142' ' ' ARG . . . . . . . . . . . . . 0.5 OUTLIER -108.25 123.99 49.62 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 114.903 -1.044 . . . . 0.0 110.068 -179.794 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' B' B ' 143' ' ' THR . . . . . . . . . . . . . 40.3 p . . . . . 0 C--O 1.219 -0.516 0 CA-C-O 118.002 -0.999 . . . . 0.0 110.574 179.443 . . . . . . . . 0 0 . 1 . 016 nuclear build core ' C' C ' 2' ' ' SER . . . . . . . . . . . . . 2.9 p . . . . . 0 C--O 1.231 0.094 0 CA-C-O 120.937 0.399 . . . . 0.0 110.691 . . . . . . . . . 0 0 . 1 . 016 nuclear build core ' C' C ' 3' ' ' GLU . . . . . . . . . . . . . 45.0 mt-10 -140.12 143.1 36.05 Favored 'General case' 0 C--N 1.331 -0.227 0 CA-C-N 116.027 -0.533 . . . . 0.0 110.981 -179.656 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' C' C ' 4' ' ' LEU . . . . . 0.595 HD12 HD23 ' C' ' 58' ' ' LEU . 2.4 tt -124.57 124.35 42.05 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 115.65 -0.705 . . . . 0.0 109.535 177.075 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' C' C ' 5' ' ' LYS . . . . . . . . . . . . . 78.6 mttt -103.87 118.77 37.48 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.721 -178.564 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' C' C ' 6' ' ' LEU . . . . . . . . . . . . . 27.3 mt -116.79 147.96 41.61 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 115.566 -0.743 . . . . 0.0 110.317 -179.172 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' C' C ' 7' ' ' LYS . . . . . . . . . . . . . 81.2 tttt -134.87 139.87 33.49 Favored Pre-proline 0 CA--C 1.533 0.308 0 CA-C-O 119.124 -0.465 . . . . 0.0 109.957 175.643 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' C' C ' 8' ' ' PRO . . . . . . . . . . . . . 88.4 Cg_endo -91.34 137.74 2.12 Favored 'Trans proline' 0 N--CA 1.489 1.236 0 C-N-CA 121.722 1.615 . . . . 0.0 111.555 177.813 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' C' C ' 9' ' ' LEU . . . . . . . . . . . . . 68.0 mt -77.73 -47.79 2.3 Favored Pre-proline 0 CA--C 1.535 0.396 0 CA-C-O 118.634 -0.698 . . . . 0.0 112.444 -178.25 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' C' C ' 10' ' ' PRO . . . . . . . . . . . . . 88.9 Cg_endo -80.28 152.84 21.08 Favored 'Trans proline' 0 N--CA 1.497 1.678 0 C-N-CA 121.135 1.223 . . . . 0.0 112.03 177.006 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' C' C ' 11' ' ' LYS . . . . . . . . . . . . . 33.9 mmtp -85.65 97.57 10.19 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.354 -0.384 . . . . 0.0 110.396 177.851 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' C' C ' 12' ' ' VAL . . . . . . . . . . . . . 11.8 p -140.03 145.17 26.76 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.288 0 CA-C-N 116.107 -0.497 . . . . 0.0 110.308 179.778 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' C' C ' 13' ' ' GLU . . . . . . . . . . . . . 70.5 tt0 -84.27 116.16 22.83 Favored 'General case' 0 C--N 1.328 -0.333 0 N-CA-C 109.756 -0.461 . . . . 0.0 109.756 178.179 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' C' C ' 14' ' ' LEU . . . . . . . . . . . . . 19.0 mt -87.21 152.24 52.55 Favored Pre-proline 0 C--N 1.328 -0.33 0 CA-C-N 116.421 -0.354 . . . . 0.0 111.079 -175.131 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' C' C ' 15' ' ' PRO . . . . . . . . . . . . . 26.8 Cg_exo -61.95 161.61 25.2 Favored 'Trans proline' 0 N--CA 1.496 1.65 0 C-N-CA 121.443 1.428 . . . . 0.0 111.698 176.451 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' C' C ' 16' ' ' PRO . . . . . . . . . . . . . 24.0 Cg_exo -62.81 -38.14 50.74 Favored 'Trans proline' 0 N--CA 1.497 1.729 0 C-N-CA 121.485 1.457 . . . . 0.0 112.75 -179.248 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' C' C ' 17' ' ' ASP . . . . . . . . . . . . . 9.4 p-10 -93.88 15.84 15.7 Favored 'General case' 0 C--N 1.327 -0.388 0 N-CA-C 113.154 0.798 . . . . 0.0 113.154 -175.688 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' C' C ' 18' ' ' PHE . . . . . . . . . . . . . 38.2 t80 -57.06 -47.03 81.97 Favored 'General case' 0 C--N 1.334 -0.076 0 O-C-N 122.06 -0.4 . . . . 0.0 110.595 -176.998 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' C' C ' 19' ' ' VAL . . . . . . . . . . . . . 46.3 t -56.33 -46.28 81.69 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.323 0 CA-C-N 116.464 -0.335 . . . . 0.0 110.852 -176.261 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' C' C ' 20' ' ' ASP . . . . . . . . . . . . . 77.2 m-20 -60.08 -41.55 92.7 Favored 'General case' 0 C--N 1.329 -0.298 0 C-N-CA 120.939 -0.304 . . . . 0.0 111.159 -177.066 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' C' C ' 21' ' ' VAL . . . . . . . . . . . . . 44.5 t -64.04 -46.75 92.95 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.29 0 C-N-CA 120.759 -0.376 . . . . 0.0 110.383 -177.968 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' C' C ' 22' ' ' ILE . . . . . 0.597 HG22 HD12 ' C' ' 26' ' ' LEU . 51.5 mm -56.36 -46.32 81.8 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.218 0 C-N-CA 120.951 -0.3 . . . . 0.0 110.567 178.352 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' C' C ' 23' ' ' ARG . . . . . . . . . . . . . 56.4 ttp180 -52.88 -49.05 66.64 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-O 120.652 0.263 . . . . 0.0 111.558 -178.798 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' C' C ' 24' ' ' ILE . . . . . . . . . . . . . 71.3 mt -58.32 -47.75 86.84 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.341 0 CA-C-N 116.661 -0.245 . . . . 0.0 110.802 -178.187 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' C' C ' 25' ' ' LYS . . . . . . . . . . . . . 40.4 mmtt -60.76 -43.96 97.34 Favored 'General case' 0 C--N 1.329 -0.315 0 N-CA-C 112.129 0.418 . . . . 0.0 112.129 -177.959 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' C' C ' 26' ' ' LEU . . . . . 0.597 HD12 HG22 ' C' ' 22' ' ' ILE . 81.8 mt -80.88 -29.21 35.75 Favored 'General case' 0 C--N 1.33 -0.273 0 N-CA-C 113.392 0.886 . . . . 0.0 113.392 -170.721 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' C' C ' 27' ' ' GLN . . . . . . . . . . . . . 4.4 pt20 -45.87 134.53 7.78 Favored 'General case' 0 N--CA 1.467 0.423 0 N-CA-C 112.856 0.687 . . . . 0.0 112.856 -174.931 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' C' C ' 28' ' ' GLY . . . . . . . . . . . . . . . 101.11 -20.21 48.45 Favored Glycine 0 CA--C 1.533 1.191 0 CA-C-N 115.948 -0.569 . . . . 0.0 112.863 -179.038 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' C' C ' 29' ' ' LYS . . . . . . . . . . . . . 59.9 mtpt -97.53 155.08 17.11 Favored 'General case' 0 C--N 1.332 -0.17 0 CA-C-N 117.78 0.79 . . . . 0.0 111.153 179.84 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' C' C ' 30' ' ' THR . . . . . . . . . . . . . 42.6 m -107.38 138.41 43.63 Favored 'General case' 0 C--N 1.332 -0.164 0 CA-C-N 116.157 -0.474 . . . . 0.0 110.038 176.262 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' C' C ' 31' ' ' VAL . . . . . . . . . . . . . 35.0 m -131.33 160.61 42.19 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.252 0 CA-C-N 116.38 -0.373 . . . . 0.0 110.771 -178.928 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' C' C ' 32' ' ' ARG . . . . . . . . . . . . . 21.1 mtp-105 -132.99 153.3 51.6 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-O 121.37 0.605 . . . . 0.0 110.552 178.236 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' C' C ' 33' ' ' THR . . . . . . . . . . . . . 17.9 m -52.98 139.72 26.97 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.022 -0.536 . . . . 0.0 111.457 -177.817 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' C' C ' 34' ' ' GLY . . . . . . . . . . . . . . . 99.85 -17.06 57.87 Favored Glycine 0 CA--C 1.532 1.108 0 CA-C-O 119.623 -0.543 . . . . 0.0 113.447 177.678 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' C' C ' 35' ' ' ASP . . . . . . . . . . . . . 70.9 m-20 -64.23 148.85 49.19 Favored 'General case' 0 C--O 1.232 0.167 0 CA-C-N 118.004 0.902 . . . . 0.0 111.17 -179.833 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' C' C ' 36' ' ' VAL . . . . . . . . . . . . . 45.9 t -122.63 129.69 75.03 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.241 0 CA-C-N 115.794 -0.639 . . . . 0.0 109.629 178.117 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' C' C ' 37' ' ' ILE . . . . . . . . . . . . . 67.7 mt -121.82 140.23 46.44 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.278 0 CA-C-N 116.396 -0.365 . . . . 0.0 110.129 -178.146 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' C' C ' 38' ' ' GLY . . . . . . . . . . . . . . . -113.2 128.96 8.62 Favored Glycine 0 CA--C 1.526 0.745 0 N-CA-C 111.082 -0.807 . . . . 0.0 111.082 -179.845 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' C' C ' 39' ' ' ILE . . . . . . . . . . . . . 76.2 mt -124.24 142.64 40.35 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.205 0 N-CA-C 110.025 -0.361 . . . . 0.0 110.025 179.564 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' C' C ' 40' ' ' SER . . . . . 0.536 ' O ' HD13 ' C' ' 41' ' ' ILE . 89.7 p -91.3 120.47 32.22 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.361 -0.381 . . . . 0.0 111.067 177.888 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' C' C ' 41' ' ' ILE . . . . . 0.536 HD13 ' O ' ' C' ' 40' ' ' SER . 46.3 mm -130.16 114.96 30.9 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.242 0 CA-C-N 116.435 -0.348 . . . . 0.0 110.098 177.904 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' C' C ' 42' ' ' LEU . . . . . . . . . . . . . 49.0 mt 58.03 35.16 24.97 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.391 -0.368 . . . . 0.0 111.566 178.248 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' C' C ' 43' ' ' GLY . . . . . . . . . . . . . . . 77.89 -10.08 27.74 Favored Glycine 0 CA--C 1.533 1.203 0 C-N-CA 121.316 -0.469 . . . . 0.0 113.499 177.81 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' C' C ' 44' ' ' LYS . . . . . . . . . . . . . 68.4 mmtt -98.04 139.47 33.81 Favored 'General case' 0 C--N 1.333 -0.11 0 CA-C-N 117.96 0.88 . . . . 0.0 109.869 176.057 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' C' C ' 45' ' ' GLU . . . . . . . . . . . . . 82.2 tt0 -83.3 123.81 29.99 Favored 'General case' 0 C--N 1.329 -0.315 0 C-N-CA 120.936 -0.306 . . . . 0.0 110.713 179.536 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' C' C ' 46' ' ' VAL . . . . . . . . . . . . . 7.7 p -115.5 128.37 72.74 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.167 0 N-CA-C 109.511 -0.552 . . . . 0.0 109.511 177.441 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' C' C ' 47' ' ' LYS . . . . . . . . . . . . . 67.4 mttm -100.24 130.74 46.4 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 115.97 -0.559 . . . . 0.0 111.56 -179.927 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' C' C ' 48' ' ' PHE . . . . . . . . . . . . . 91.1 m-85 -115.31 131.91 56.78 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.079 -0.509 . . . . 0.0 109.714 175.813 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' C' C ' 49' ' ' LYS . . . . . . . . . . . . . 82.8 tttt -107.92 137.18 46.37 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.498 -0.319 . . . . 0.0 110.716 -179.478 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' C' C ' 50' ' ' VAL . . . . . . . . . . . . . 44.3 t -82.29 105.64 12.36 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.262 0 N-CA-C 109.543 -0.54 . . . . 0.0 109.543 176.288 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' C' C ' 51' ' ' VAL . . . . . . . . . . . . . 46.4 t -71.0 -52.89 24.08 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.333 0 CA-C-N 115.926 -0.579 . . . . 0.0 109.75 -174.914 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' C' C ' 52' ' ' GLN . . . . . . . . . . . . . 81.9 mt-30 -154.57 149.92 27.19 Favored 'General case' 0 C--N 1.331 -0.198 0 C-N-CA 120.41 -0.516 . . . . 0.0 111.58 -177.418 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' C' C ' 53' ' ' ALA . . . . . . . . . . . . . . . -122.89 130.69 53.17 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 115.41 -0.813 . . . . 0.0 109.43 174.833 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' C' C ' 54' ' ' TYR . . . . . . . . . . . . . 67.9 t80 -129.0 107.41 18.08 Favored Pre-proline 0 CA--C 1.533 0.318 0 CA-C-O 118.215 -0.898 . . . . 0.0 110.493 -179.416 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' C' C ' 55' ' ' PRO . . . . . . . . . . . . . 73.1 Cg_endo -77.09 170.05 72.67 Favored 'Cis proline' 0 N--CA 1.5 1.907 0 CA-C-N 121.726 1.652 . . . . 0.0 112.583 -5.07 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' C' C ' 56' ' ' SER . . . . . . . . . . . . . 32.5 m -115.71 132.12 23.33 Favored Pre-proline 0 CA--C 1.538 0.516 0 CA-C-O 118.429 -0.796 . . . . 0.0 109.515 175.428 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' C' C ' 57' ' ' PRO . . . . . . . . . . . . . 33.5 Cg_endo -65.76 166.26 55.41 Favored 'Cis proline' 0 N--CA 1.498 1.785 0 CA-C-N 121.971 1.74 . . . . 0.0 111.378 -2.583 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' C' C ' 58' ' ' LEU . . . . . 0.595 HD23 HD12 ' C' ' 4' ' ' LEU . 19.4 tp -130.5 138.58 50.31 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-O 121.018 0.437 . . . . 0.0 110.662 -179.919 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' C' C ' 59' ' ' ARG . . . . . . . . . . . . . 78.6 ttt-85 -103.61 128.4 50.9 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 115.579 -0.737 . . . . 0.0 109.47 175.767 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' C' C ' 60' ' ' VAL . . . . . . . . . . . . . 43.2 t -78.86 112.93 17.48 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.344 0 CA-C-O 120.817 0.342 . . . . 0.0 110.378 -177.114 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' C' C ' 61' ' ' GLU . . . . . . . . . . . . . 72.9 tt0 -130.95 157.01 44.11 Favored 'General case' 0 C--N 1.329 -0.314 0 N-CA-C 109.359 -0.608 . . . . 0.0 109.359 177.936 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' C' C ' 62' ' ' ASP . . . . . . . . . . . . . 9.5 t0 -51.7 -30.79 23.51 Favored 'General case' 0 C--N 1.326 -0.414 0 N-CA-C 112.213 0.449 . . . . 0.0 112.213 -177.479 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' C' C ' 63' ' ' ARG . . . . . . . . . . . . . 73.8 mtp180 -72.66 -22.06 60.99 Favored 'General case' 0 CA--C 1.532 0.288 0 N-CA-C 112.966 0.728 . . . . 0.0 112.966 -175.38 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' C' C ' 64' ' ' THR . . . . . . . . . . . . . 32.3 m -73.69 140.58 46.14 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-O 120.895 0.379 . . . . 0.0 110.829 -176.226 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' C' C ' 65' ' ' LYS . . . . . . . . . . . . . 42.1 mtmt -89.22 127.79 35.78 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.099 -0.501 . . . . 0.0 110.12 177.868 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' C' C ' 66' ' ' ILE . . . . . . . . . . . . . 64.8 mt -109.48 125.73 66.62 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.32 0 N-CA-C 109.427 -0.583 . . . . 0.0 109.427 179.152 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' C' C ' 67' ' ' THR . . . . . . . . . . . . . 23.1 m -124.81 142.29 51.53 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-O 121.277 0.56 . . . . 0.0 111.358 -174.9 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' C' C ' 68' ' ' LEU . . . . . . . . . . . . . 43.8 mt . . . . . 0 C--N 1.33 -0.25 0 CA-C-N 115.59 -0.732 . . . . 0.0 109.894 176.123 . . . . . . . . 0 0 . 1 . 016 nuclear build core ' C' C ' 73' ' ' VAL . . . . . . . . . . . . . 34.8 m . . . . . 0 N--CA 1.462 0.146 0 CA-C-O 120.717 0.294 . . . . 0.0 110.799 . . . . . . . . . 0 0 . 1 . 016 nuclear build core ' C' C ' 74' ' ' ASP . . . . . . . . . . . . . 35.6 t0 -102.83 118.06 36.0 Favored 'General case' 0 C--N 1.331 -0.199 0 N-CA-C 109.455 -0.572 . . . . 0.0 109.455 177.835 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' C' C ' 75' ' ' VAL . . . . . . . . . . . . . 39.9 t -118.63 123.88 72.25 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.245 0 CA-C-O 121.141 0.496 . . . . 0.0 110.795 -176.634 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' C' C ' 76' ' ' LEU . . . . . . . . . . . . . 6.7 mp -117.62 150.39 39.11 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 115.503 -0.771 . . . . 0.0 109.613 176.184 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' C' C ' 77' ' ' GLU . . . . . . . . . . . . . 47.2 mt-10 -134.62 132.32 38.85 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-O 120.963 0.411 . . . . 0.0 111.019 179.916 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' C' C ' 78' ' ' ALA . . . . . 0.776 ' HB2' HD21 ' C' ' 109' ' ' LEU . . . -124.66 127.76 47.8 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 115.838 -0.619 . . . . 0.0 109.919 177.05 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' C' C ' 79' ' ' LYS . . . . . 0.559 ' O ' HD13 ' C' ' 80' ' ' ILE . 14.4 ptpt -72.81 119.29 16.85 Favored 'General case' 0 C--N 1.331 -0.239 0 CA-C-O 121.239 0.543 . . . . 0.0 110.589 -178.772 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' C' C ' 80' ' ' ILE . . . . . 0.559 HD13 ' O ' ' C' ' 79' ' ' LYS . 24.1 mm -139.44 105.59 2.43 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.285 0 N-CA-C 109.213 -0.662 . . . . 0.0 109.213 -177.781 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' C' C ' 81' ' ' LYS . . . . . . . . . . . . . 55.9 pttt -98.91 126.83 44.68 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-O 121.032 0.444 . . . . 0.0 111.26 -177.205 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' C' C ' 82' ' ' GLY . . . . . . . . . . . . . . . 89.16 42.03 5.69 Favored Glycine 0 CA--C 1.526 0.754 0 CA-C-N 115.838 -0.619 . . . . 0.0 111.834 175.05 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' C' C ' 83' ' ' ILE . . . . . . . . . . . . . 67.3 mt -71.99 139.35 19.88 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.391 0 N-CA-C 109.551 -0.537 . . . . 0.0 109.551 176.57 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' C' C ' 84' ' ' LYS . . . . . . . . . . . . . 20.2 ttpp -102.28 -50.21 3.68 Favored 'General case' 0 C--N 1.331 -0.215 0 CA-C-O 120.895 0.378 . . . . 0.0 110.317 -178.857 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' C' C ' 85' ' ' ASP . . . . . . . . . . . . . 11.1 t70 -150.95 150.0 30.29 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.034 -0.53 . . . . 0.0 110.641 -179.184 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' C' C ' 86' ' ' VAL . . . . . . . . . . . . . 44.7 t -132.93 131.12 59.06 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.275 0 CA-C-O 120.89 0.376 . . . . 0.0 110.3 179.779 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' C' C ' 87' ' ' ILE . . . . . . . . . . . . . 40.3 mm -119.5 127.08 75.86 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.233 0 N-CA-C 109.359 -0.608 . . . . 0.0 109.359 177.457 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' C' C ' 88' ' ' LEU . . . . . . . . . . . . . 20.4 tp -113.03 132.15 55.5 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-O 120.973 0.416 . . . . 0.0 111.119 -177.209 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' C' C ' 89' ' ' ASP . . . . . . . . . . . . . 8.6 t70 -125.1 156.5 38.19 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 115.77 -0.65 . . . . 0.0 109.587 176.272 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' C' C ' 90' ' ' GLU . . . . . . . . . . . . . 95.4 mt-10 -47.02 -39.28 12.34 Favored 'General case' 0 C--N 1.329 -0.301 0 N-CA-C 113.007 0.743 . . . . 0.0 113.007 -172.167 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' C' C ' 91' ' ' ASN . . . . . . . . . . . . . 3.7 t-20 -132.09 34.8 3.77 Favored 'General case' 0 N--CA 1.464 0.251 0 N-CA-C 111.832 0.308 . . . . 0.0 111.832 -175.862 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' C' C ' 92' ' ' LEU . . . . . . . . . . . . . 11.4 tp -166.09 146.03 6.27 Favored 'General case' 0 C--N 1.332 -0.187 0 C-N-CA 120.755 -0.378 . . . . 0.0 111.058 -179.335 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' C' C ' 93' ' ' ILE . . . . . . . . . . . . . 64.4 mt -125.3 123.42 65.05 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.18 0 N-CA-C 109.575 -0.528 . . . . 0.0 109.575 178.622 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' C' C ' 94' ' ' VAL . . . . . 0.452 HG21 HG11 ' C' ' 125' ' ' VAL . 47.0 t -122.64 125.02 71.92 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.218 0 N-CA-C 109.887 -0.412 . . . . 0.0 109.887 178.806 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' C' C ' 95' ' ' VAL . . . . . . . . . . . . . 44.3 t -121.61 135.8 60.6 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.273 0 CA-C-N 116.068 -0.515 . . . . 0.0 110.049 -178.38 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' C' C ' 96' ' ' ILE . . . . . . . . . . . . . 64.9 mt -117.87 127.31 75.17 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.307 0 N-CA-C 109.647 -0.501 . . . . 0.0 109.647 -179.949 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' C' C ' 97' ' ' THR . . . . . . . . . . . . . 81.2 p -98.94 156.41 16.91 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-O 121.021 0.439 . . . . 0.0 110.984 -178.965 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' C' C ' 98' ' ' GLU . . . . . . . . . . . . . 14.2 pt-20 -55.58 -22.18 20.83 Favored 'General case' 0 CA--C 1.534 0.343 0 N-CA-C 112.603 0.594 . . . . 0.0 112.603 -178.736 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' C' C ' 99' ' ' GLU . . . . . . . . . . . . . 51.0 mp0 -81.22 15.49 1.92 Allowed 'General case' 0 CA--C 1.535 0.399 0 N-CA-C 112.95 0.722 . . . . 0.0 112.95 -178.881 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' C' C ' 100' ' ' ASN . . . . . . . . . . . . . 22.3 m-20 59.66 37.37 22.42 Favored 'General case' 0 C--N 1.332 -0.153 0 CA-C-O 121.026 0.441 . . . . 0.0 111.159 -179.428 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' C' C ' 101' ' ' GLU . . . . . . . . . . . . . 84.4 tt0 -111.91 142.35 44.41 Favored 'General case' 0 C--N 1.333 -0.132 0 N-CA-C 109.575 -0.528 . . . . 0.0 109.575 173.198 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' C' C ' 102' ' ' VAL . . . . . . . . . . . . . 44.3 t -114.95 127.93 72.31 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.249 0 CA-C-N 116.27 -0.423 . . . . 0.0 109.998 -177.025 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' C' C ' 103' ' ' LEU . . . . . . . . . . . . . 39.8 mt -117.01 131.56 56.92 Favored 'General case' 0 C--N 1.331 -0.216 0 CA-C-N 115.604 -0.726 . . . . 0.0 110.224 177.087 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' C' C ' 104' ' ' ILE . . . . . 0.5 HD12 ' HB3' ' C' ' 113' ' ' TYR . 66.8 mt -118.44 122.9 70.66 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.255 0 CA-C-N 116.491 -0.322 . . . . 0.0 110.155 -179.865 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' C' C ' 105' ' ' PHE . . . . . . . . . . . . . 89.7 m-85 -124.85 162.66 23.88 Favored 'General case' 0 N--CA 1.462 0.135 0 O-C-N 123.983 0.802 . . . . 0.0 110.3 -178.3 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' C' C ' 106' ' ' ASN . . . . . . . . . . . . . 41.3 p-10 -100.27 -169.95 1.8 Allowed 'General case' 0 C--N 1.331 -0.21 0 CA-C-N 116.309 -0.405 . . . . 0.0 109.934 174.018 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' C' C ' 107' ' ' GLN . . . . . . . . . . . . . 32.3 tt0 -58.49 -30.01 66.68 Favored 'General case' 0 CA--C 1.532 0.252 0 N-CA-C 111.998 0.37 . . . . 0.0 111.998 179.553 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' C' C ' 108' ' ' ASN . . . . . . . . . . . . . 10.7 t-20 -84.24 9.62 12.46 Favored 'General case' 0 CA--C 1.536 0.407 0 N-CA-C 113.114 0.783 . . . . 0.0 113.114 -176.787 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' C' C ' 109' ' ' LEU . . . . . 0.776 HD21 ' HB2' ' C' ' 78' ' ' ALA . 11.1 tp 56.13 35.85 26.39 Favored 'General case' 0 CA--C 1.531 0.225 0 CA-C-O 120.898 0.38 . . . . 0.0 111.266 -179.97 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' C' C ' 110' ' ' GLU . . . . . . . . . . . . . 42.8 mt-10 -103.17 147.62 26.79 Favored 'General case' 0 C--N 1.331 -0.22 0 N-CA-C 109.522 -0.547 . . . . 0.0 109.522 175.613 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' C' C ' 111' ' ' GLU . . . . . . . . . . . . . 50.9 tt0 -79.68 121.9 25.88 Favored 'General case' 0 C--N 1.327 -0.396 0 CA-C-O 120.822 0.344 . . . . 0.0 110.877 -175.838 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' C' C ' 112' ' ' LEU . . . . . . . . . . . . . 22.9 mt -106.03 -45.89 4.23 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-N 116.029 -0.532 . . . . 0.0 110.42 178.805 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' C' C ' 113' ' ' TYR . . . . . 0.5 ' HB3' HD12 ' C' ' 104' ' ' ILE . 53.4 t80 -136.26 138.79 42.17 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-O 120.905 0.383 . . . . 0.0 111.294 -178.849 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' C' C ' 114' ' ' ARG . . . . . . . . . . . . . 58.8 ttp180 -137.08 121.62 18.37 Favored 'General case' 0 C--N 1.331 -0.197 0 CA-C-N 115.775 -0.648 . . . . 0.0 110.221 178.164 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' C' C ' 115' ' ' GLY . . . . . . . . . . . . . . . -150.0 151.13 23.25 Favored Glycine 0 CA--C 1.523 0.584 0 N-CA-C 111.094 -0.802 . . . . 0.0 111.094 178.033 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' C' C ' 116' ' ' LYS . . . . . . . . . . . . . 72.6 tttt -130.01 133.19 46.6 Favored 'General case' 0 C--N 1.33 -0.261 0 N-CA-C 109.793 -0.447 . . . . 0.0 109.793 178.013 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' C' C ' 117' ' ' PHE . . . . . . . . . . . . . 23.1 m-85 -133.5 113.94 13.04 Favored 'General case' 0 C--N 1.331 -0.226 0 CA-C-O 120.884 0.373 . . . . 0.0 110.339 -174.136 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' C' C ' 118' ' ' GLU . . . . . . . . . . . . . 95.7 mt-10 -54.15 -50.43 66.98 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.396 -0.365 . . . . 0.0 111.179 -177.736 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' C' C ' 119' ' ' ASN . . . . . . . . . . . . . 35.6 m120 -89.67 29.64 1.13 Allowed 'General case' 0 C--N 1.33 -0.278 0 N-CA-C 112.261 0.467 . . . . 0.0 112.261 -174.922 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' C' C ' 120' ' ' LEU . . . . . . . . . . . . . 30.6 tp -57.95 121.22 10.05 Favored 'General case' 0 C--N 1.332 -0.162 0 N-CA-C 110.161 -0.311 . . . . 0.0 110.161 177.313 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' C' C ' 121' ' ' ASN . . . . . . . . . . . . . 32.1 m120 -114.11 -43.41 3.24 Favored 'General case' 0 C--N 1.331 -0.209 0 CA-C-N 116.326 -0.397 . . . . 0.0 111.017 -177.155 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' C' C ' 122' ' ' LYS . . . . . . . . . . . . . 67.9 mttm -138.68 144.34 39.57 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-O 121.152 0.501 . . . . 0.0 111.614 -175.909 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' C' C ' 123' ' ' VAL . . . . . . . . . . . . . 45.7 t -124.55 126.23 71.41 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.21 0 CA-C-N 115.715 -0.675 . . . . 0.0 109.448 176.146 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' C' C ' 124' ' ' LEU . . . . . . . . . . . . . 27.3 mt -123.18 131.0 53.52 Favored 'General case' 0 C--N 1.332 -0.166 0 CA-C-O 120.642 0.258 . . . . 0.0 110.683 -178.212 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' C' C ' 125' ' ' VAL . . . . . 0.452 HG11 HG21 ' C' ' 94' ' ' VAL . 35.1 m -136.31 134.41 49.84 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.288 0 CA-C-N 116.321 -0.4 . . . . 0.0 110.752 179.896 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' C' C ' 126' ' ' ARG . . . . . . . . . . . . . 95.7 mtt-85 -146.28 118.17 8.19 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.325 -0.398 . . . . 0.0 110.671 178.053 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' C' C ' 127' ' ' ASN . . . . . . . . . . . . . 34.8 m120 49.84 -104.97 0.16 Allowed 'General case' 0 CA--C 1.544 0.718 0 CA-C-O 119.202 -0.428 . . . . 0.0 111.78 177.599 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' C' C ' 128' ' ' ASP . . . . . . . . . . . . . 13.0 p-10 -114.23 13.5 17.94 Favored 'General case' 0 N--CA 1.467 0.408 0 CA-C-N 119.406 1.003 . . . . 0.0 113.263 -175.112 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' C' C ' 129' ' ' LEU . . . . . . . . . . . . . 24.4 tp -118.32 136.83 53.48 Favored 'General case' 0 C--N 1.332 -0.161 0 O-C-N 122.029 -0.42 . . . . 0.0 110.046 177.592 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' C' C ' 130' ' ' VAL . . . . . . . . . . . . . 42.4 t -125.09 136.56 60.47 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.196 0 CA-C-O 120.926 0.393 . . . . 0.0 110.025 -179.347 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' C' C ' 131' ' ' VAL . . . . . 0.485 HG22 HD12 ' C' ' 140' ' ' LEU . 41.8 t -136.02 135.26 50.46 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.291 0 CA-C-O 121.131 0.491 . . . . 0.0 110.167 178.022 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' C' C ' 132' ' ' ILE . . . . . . . . . . . . . 73.1 mt -117.08 129.85 72.95 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.323 0 CA-C-N 115.717 -0.674 . . . . 0.0 109.388 -179.295 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' C' C ' 133' ' ' ILE . . . . . . . . . . . . . 37.6 mm -115.46 120.3 64.31 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.301 0 CA-C-O 120.608 0.242 . . . . 0.0 111.047 -174.494 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' C' C ' 134' ' ' ASP . . . . . . . . . . . . . 7.5 p-10 -130.42 149.87 51.9 Favored 'General case' 0 C--N 1.333 -0.138 0 N-CA-C 109.944 -0.391 . . . . 0.0 109.944 174.655 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' C' C ' 135' ' ' GLU . . . . . . . . . . . . . 58.0 tt0 -49.92 -25.93 3.69 Favored 'General case' 0 C--N 1.327 -0.375 0 N-CA-C 113.088 0.773 . . . . 0.0 113.088 -170.889 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' C' C ' 136' ' ' GLN . . . . . . . . . . . . . 30.1 tt0 -95.38 -26.87 15.71 Favored 'General case' 0 CA--C 1.531 0.221 0 N-CA-C 112.765 0.654 . . . . 0.0 112.765 -172.472 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' C' C ' 137' ' ' LYS . . . . . . . . . . . . . 58.3 pttt -163.86 167.46 20.72 Favored 'General case' 0 C--O 1.233 0.193 0 CA-C-O 121.576 0.703 . . . . 0.0 112.162 -175.114 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' C' C ' 138' ' ' LEU . . . . . 0.413 HD23 ' C ' ' C' ' 138' ' ' LEU . 6.3 tt -117.12 128.43 55.12 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 115.029 -0.987 . . . . 0.0 109.928 179.712 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' C' C ' 139' ' ' THR . . . . . . . . . . . . . 27.7 m -108.24 124.83 50.9 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.156 -0.474 . . . . 0.0 110.402 179.236 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' C' C ' 140' ' ' LEU . . . . . 0.485 HD12 HG22 ' C' ' 131' ' ' VAL . 10.5 tp -111.21 120.47 42.38 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 115.853 -0.612 . . . . 0.0 109.355 -178.977 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' C' C ' 141' ' ' ILE . . . . . . . . . . . . . 18.9 mt -123.21 118.28 54.18 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.269 0 CA-C-O 121.118 0.485 . . . . 0.0 110.081 -174.862 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' C' C ' 142' ' ' ARG . . . . . . . . . . . . . 72.1 mtp180 . . . . . 0 C--N 1.328 -0.349 0 CA-C-N 115.435 -0.802 . . . . 0.0 110.176 176.736 . . . . . . . . 0 0 . 1 . 016 nuclear build core ' D' D ' 2' ' ' SER . . . . . . . . . . . . . 3.9 p . . . . . 0 N--CA 1.462 0.168 0 CA-C-O 120.951 0.405 . . . . 0.0 110.613 . . . . . . . . . 0 0 . 1 . 016 nuclear build core ' D' D ' 3' ' ' GLU . . . . . . . . . . . . . 80.7 tt0 -146.6 142.93 28.45 Favored 'General case' 0 C--N 1.327 -0.396 0 CA-C-N 115.987 -0.551 . . . . 0.0 111.019 -178.658 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' D' D ' 4' ' ' LEU . . . . . . . . . . . . . 17.2 tp -124.3 132.27 53.56 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.01 -0.541 . . . . 0.0 110.056 177.171 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' D' D ' 5' ' ' LYS . . . . . . . . . . . . . 66.4 mttm -111.13 121.76 46.14 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 116.331 -0.395 . . . . 0.0 110.513 -179.176 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' D' D ' 6' ' ' LEU . . . . . . . . . . . . . 71.1 mt -117.2 151.43 36.9 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 115.668 -0.696 . . . . 0.0 110.94 -177.384 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' D' D ' 7' ' ' LYS . . . . . . . . . . . . . 74.9 tttt -142.5 141.72 21.47 Favored Pre-proline 0 CA--C 1.532 0.278 0 CA-C-N 116.18 -0.464 . . . . 0.0 109.952 174.005 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' D' D ' 8' ' ' PRO . . . . . . . . . . . . . 84.1 Cg_endo -90.76 144.8 3.7 Favored 'Trans proline' 0 N--CA 1.491 1.325 0 C-N-CA 121.74 1.627 . . . . 0.0 112.081 179.039 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' D' D ' 9' ' ' LEU . . . . . . . . . . . . . 40.9 mt -81.07 -47.18 1.14 Allowed Pre-proline 0 CA--C 1.533 0.292 0 CA-C-O 118.71 -0.662 . . . . 0.0 112.048 179.784 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' D' D ' 10' ' ' PRO . . . . . . . . . . . . . 88.1 Cg_endo -81.34 154.3 18.68 Favored 'Trans proline' 0 N--CA 1.497 1.711 0 C-N-CA 121.149 1.233 . . . . 0.0 111.643 175.223 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' D' D ' 11' ' ' LYS . . . . . . . . . . . . . 61.6 tttm -88.71 100.41 13.1 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.473 -0.331 . . . . 0.0 110.513 179.392 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' D' D ' 12' ' ' VAL . . . . . . . . . . . . . 12.3 p -144.92 146.44 19.98 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.233 0 CA-C-N 116.22 -0.446 . . . . 0.0 110.679 -179.516 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' D' D ' 13' ' ' GLU . . . . . . . . . . . . . 95.1 mt-10 -82.57 130.56 35.14 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 116.28 -0.418 . . . . 0.0 109.97 176.782 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' D' D ' 14' ' ' LEU . . . . . . . . . . . . . 16.8 mt -97.52 146.93 32.25 Favored Pre-proline 0 CA--C 1.533 0.303 0 CA-C-O 119.223 -0.418 . . . . 0.0 110.238 -178.476 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' D' D ' 15' ' ' PRO . . . . . . . . . . . . . 30.5 Cg_exo -60.43 159.36 27.68 Favored 'Trans proline' 0 N--CA 1.497 1.721 0 C-N-CA 121.328 1.352 . . . . 0.0 111.783 177.176 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' D' D ' 16' ' ' PRO . . . . . . . . . . . . . 39.4 Cg_exo -58.4 -41.04 69.67 Favored 'Trans proline' 0 N--CA 1.497 1.683 0 C-N-CA 121.472 1.448 . . . . 0.0 112.676 -178.261 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' D' D ' 17' ' ' ASP . . . . . . . . . . . . . 12.6 p-10 -87.82 13.01 11.55 Favored 'General case' 0 CA--C 1.535 0.404 0 N-CA-C 113.086 0.772 . . . . 0.0 113.086 -178.084 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' D' D ' 18' ' ' PHE . . . . . . . . . . . . . 46.6 t80 -58.26 -45.01 88.61 Favored 'General case' 0 C--N 1.334 -0.079 0 CA-C-O 120.935 0.398 . . . . 0.0 110.078 -178.542 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' D' D ' 19' ' ' VAL . . . . . . . . . . . . . 47.7 t -56.87 -41.2 75.64 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.249 0 CA-C-N 116.142 -0.481 . . . . 0.0 110.438 -178.805 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' D' D ' 20' ' ' ASP . . . . . . . . . . . . . 71.1 m-20 -60.39 -44.0 96.1 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-O 120.811 0.339 . . . . 0.0 111.071 -178.074 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' D' D ' 21' ' ' VAL . . . . . . . . . . . . . 46.1 t -64.22 -48.6 84.89 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 CA-C-N 116.353 -0.385 . . . . 0.0 110.484 -177.844 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' D' D ' 22' ' ' ILE . . . . . 0.666 HG22 HD12 ' D' ' 26' ' ' LEU . 50.6 mm -55.09 -47.92 76.62 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.241 0 CA-C-O 120.687 0.279 . . . . 0.0 110.829 179.356 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' D' D ' 23' ' ' ARG . . . . . . . . . . . . . 3.7 tmm_? -53.5 -53.38 52.33 Favored 'General case' 0 C--N 1.329 -0.313 0 N-CA-C 111.605 0.224 . . . . 0.0 111.605 -177.719 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' D' D ' 24' ' ' ILE . . . . . . . . . . . . . 72.2 mt -60.31 -41.86 88.64 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.28 0 N-CA-C 111.659 0.244 . . . . 0.0 111.659 -175.711 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' D' D ' 25' ' ' LYS . . . . . . . . . . . . . 53.0 mttm -67.79 -36.95 81.37 Favored 'General case' 0 C--N 1.328 -0.334 0 N-CA-C 112.147 0.425 . . . . 0.0 112.147 -177.707 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' D' D ' 26' ' ' LEU . . . . . 0.666 HD12 HG22 ' D' ' 22' ' ' ILE . 26.5 mt -79.46 -41.94 26.41 Favored 'General case' 0 C--N 1.33 -0.275 0 N-CA-C 112.798 0.666 . . . . 0.0 112.798 -173.617 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' D' D ' 27' ' ' GLN . . . . . . . . . . . . . 10.8 pt20 -46.0 138.57 4.99 Favored 'General case' 0 N--CA 1.47 0.554 0 N-CA-C 112.686 0.625 . . . . 0.0 112.686 -175.669 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' D' D ' 28' ' ' GLY . . . . . . . . . . . . . . . 100.79 -27.86 18.59 Favored Glycine 0 CA--C 1.53 1.02 0 CA-C-N 115.334 -0.848 . . . . 0.0 112.073 -176.086 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' D' D ' 29' ' ' LYS . . . . . . . . . . . . . 94.4 mttt -97.91 155.14 17.22 Favored 'General case' 0 C--O 1.232 0.164 0 CA-C-N 117.186 0.493 . . . . 0.0 111.01 178.796 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' D' D ' 30' ' ' THR . . . . . . . . . . . . . 25.2 m -103.96 139.39 39.18 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.167 -0.47 . . . . 0.0 110.33 176.935 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' D' D ' 31' ' ' VAL . . . . . . . . . . . . . 35.1 m -128.76 151.05 35.0 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.278 0 CA-C-O 121.047 0.451 . . . . 0.0 110.91 -178.922 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' D' D ' 32' ' ' ARG . . . . . . . . . . . . . 26.3 ttm180 -129.05 146.25 51.06 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 115.971 -0.559 . . . . 0.0 110.212 178.895 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' D' D ' 33' ' ' THR . . . . . . . . . . . . . 16.9 m -52.5 139.07 26.2 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.455 -0.339 . . . . 0.0 111.488 -177.301 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' D' D ' 34' ' ' GLY . . . . . . . . . . . . . . . 101.1 -17.21 56.38 Favored Glycine 0 CA--C 1.532 1.151 0 CA-C-O 119.702 -0.499 . . . . 0.0 113.242 179.962 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' D' D ' 35' ' ' ASP . . . . . . . . . . . . . 74.3 m-20 -66.08 149.65 49.94 Favored 'General case' 0 N--CA 1.461 0.095 0 CA-C-N 118.033 0.916 . . . . 0.0 111.15 179.176 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' D' D ' 36' ' ' VAL . . . . . . . . . . . . . 45.9 t -122.12 130.74 74.31 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.193 0 CA-C-N 115.838 -0.619 . . . . 0.0 109.776 177.947 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' D' D ' 37' ' ' ILE . . . . . . . . . . . . . 71.9 mt -121.13 140.13 46.2 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.218 0 CA-C-N 116.299 -0.409 . . . . 0.0 109.994 -179.149 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' D' D ' 38' ' ' GLY . . . . . . . . . . . . . . . -114.26 128.91 8.44 Favored Glycine 0 CA--C 1.526 0.767 0 N-CA-C 111.297 -0.721 . . . . 0.0 111.297 -178.685 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' D' D ' 39' ' ' ILE . . . . . . . . . . . . . 72.2 mt -123.51 135.63 62.69 Favored 'Isoleucine or valine' 0 C--N 1.333 -0.135 0 N-CA-C 109.963 -0.384 . . . . 0.0 109.963 178.268 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' D' D ' 40' ' ' SER . . . . . . . . . . . . . 23.1 t -92.71 123.12 35.76 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-N 116.521 -0.309 . . . . 0.0 111.018 176.786 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' D' D ' 41' ' ' ILE . . . . . . . . . . . . . 73.2 mt -132.21 112.9 20.49 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.167 0 CA-C-O 120.844 0.355 . . . . 0.0 110.315 177.511 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' D' D ' 42' ' ' LEU . . . . . 0.527 HD23 ' O ' ' D' ' 42' ' ' LEU . 1.4 tt 54.5 47.35 22.97 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-O 121.53 0.681 . . . . 0.0 110.647 178.237 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' D' D ' 43' ' ' GLY . . . . . . . . . . . . . . . 75.23 -10.1 11.51 Favored Glycine 0 CA--C 1.535 1.289 0 CA-C-O 119.692 -0.504 . . . . 0.0 113.796 175.274 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' D' D ' 44' ' ' LYS . . . . . . . . . . . . . 35.8 mmtm -99.79 132.65 45.01 Favored 'General case' 0 C--N 1.332 -0.165 0 CA-C-N 118.066 0.933 . . . . 0.0 110.378 -179.981 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' D' D ' 45' ' ' GLU . . . . . . . . . . . . . 80.3 tt0 -84.45 122.83 29.52 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.22 -0.446 . . . . 0.0 110.806 178.635 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' D' D ' 46' ' ' VAL . . . . . . . . . . . . . 7.7 p -117.19 124.27 72.81 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.199 0 N-CA-C 109.542 -0.54 . . . . 0.0 109.542 176.09 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' D' D ' 47' ' ' LYS . . . . . . . . . . . . . 57.7 mtmt -99.94 129.58 46.03 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 115.812 -0.631 . . . . 0.0 111.18 179.515 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' D' D ' 48' ' ' PHE . . . . . . . . . . . . . 91.3 m-85 -112.34 132.36 55.03 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-N 116.166 -0.47 . . . . 0.0 109.982 177.277 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' D' D ' 49' ' ' LYS . . . . . . . . . . . . . 76.1 tttt -105.84 135.54 47.09 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.348 -0.387 . . . . 0.0 110.41 179.581 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' D' D ' 50' ' ' VAL . . . . . . . . . . . . . 44.1 t -79.47 107.2 11.64 Favored 'Isoleucine or valine' 0 C--O 1.232 0.177 0 N-CA-C 109.324 -0.621 . . . . 0.0 109.324 175.717 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' D' D ' 51' ' ' VAL . . . . . . . . . . . . . 48.2 t -71.21 -51.69 32.54 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.344 0 CA-C-N 115.998 -0.547 . . . . 0.0 109.787 -174.376 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' D' D ' 52' ' ' GLN . . . . . . . . . . . . . 45.1 mt-30 -155.53 150.73 26.83 Favored 'General case' 0 C--N 1.331 -0.221 0 CA-C-O 121.18 0.514 . . . . 0.0 111.74 -177.467 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' D' D ' 53' ' ' ALA . . . . . . . . . . . . . . . -125.19 127.27 46.53 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 115.216 -0.902 . . . . 0.0 109.604 175.907 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' D' D ' 54' ' ' TYR . . . . . . . . . . . . . 62.6 t80 -126.37 107.32 24.02 Favored Pre-proline 0 CA--C 1.535 0.392 0 CA-C-O 118.321 -0.847 . . . . 0.0 110.689 -178.242 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' D' D ' 55' ' ' PRO . . . . . . . . . . . . . 74.1 Cg_endo -77.12 170.02 72.71 Favored 'Cis proline' 0 N--CA 1.499 1.836 0 CA-C-N 121.697 1.642 . . . . 0.0 112.355 -6.022 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' D' D ' 56' ' ' SER . . . . . . . . . . . . . 14.5 m -110.59 128.69 24.93 Favored Pre-proline 0 CA--C 1.539 0.526 0 CA-C-O 118.407 -0.806 . . . . 0.0 109.384 175.739 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' D' D ' 57' ' ' PRO . . . . . . . . . . . . . 61.2 Cg_endo -74.84 149.09 93.3 Favored 'Cis proline' 0 N--CA 1.496 1.639 0 CA-C-N 121.96 1.736 . . . . 0.0 111.716 -0.714 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' D' D ' 58' ' ' LEU . . . . . . . . . . . . . 27.9 tp -108.19 137.52 46.02 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.227 -0.442 . . . . 0.0 110.454 -179.04 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' D' D ' 59' ' ' ARG . . . . . . . . . . . . . 25.5 ttm180 -103.82 126.59 51.06 Favored 'General case' 0 C--N 1.327 -0.383 0 N-CA-C 109.394 -0.595 . . . . 0.0 109.394 176.029 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' D' D ' 60' ' ' VAL . . . . . . . . . . . . . 45.6 t -78.8 116.63 22.96 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.231 0 C-N-CA 120.684 -0.407 . . . . 0.0 110.409 -174.833 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' D' D ' 61' ' ' GLU . . . . . . . . . . . . . 94.7 mt-10 -131.06 163.1 28.36 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 116.0 -0.545 . . . . 0.0 109.849 177.795 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' D' D ' 62' ' ' ASP . . . . . . . . . . . . . 14.2 t0 -52.81 -32.99 47.06 Favored 'General case' 0 C--N 1.329 -0.296 0 N-CA-C 111.864 0.32 . . . . 0.0 111.864 -178.67 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' D' D ' 63' ' ' ARG . . . . . . . . . . . . . 77.2 mtt85 -73.64 -21.97 60.13 Favored 'General case' 0 C--N 1.33 -0.258 0 N-CA-C 113.076 0.769 . . . . 0.0 113.076 -176.061 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' D' D ' 64' ' ' THR . . . . . . . . . . . . . 31.4 m -66.14 138.39 57.69 Favored 'General case' 0 C--N 1.331 -0.211 0 CA-C-O 120.955 0.407 . . . . 0.0 111.14 -175.14 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' D' D ' 65' ' ' LYS . . . . . . . . . . . . . 93.2 mttt -89.01 136.62 32.92 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 115.763 -0.653 . . . . 0.0 109.827 176.969 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' D' D ' 66' ' ' ILE . . . . . . . . . . . . . 58.1 mt -115.8 127.21 73.46 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.294 0 N-CA-C 109.852 -0.425 . . . . 0.0 109.852 -179.181 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' D' D ' 67' ' ' THR . . . . . . . . . . . . . 26.5 m -126.45 147.57 49.78 Favored 'General case' 0 N--CA 1.463 0.215 0 CA-C-O 121.148 0.499 . . . . 0.0 111.362 -175.928 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' D' D ' 68' ' ' LEU . . . . . 0.473 ' N ' HD12 ' D' ' 68' ' ' LEU . 8.9 mp . . . . . 0 C--N 1.329 -0.292 0 CA-C-N 115.869 -0.605 . . . . 0.0 110.454 177.389 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' D' D ' 73' ' ' VAL . . . . . . . . . . . . . 3.5 m . . . . . 0 CA--C 1.522 -0.128 0 CA-C-O 121.138 0.494 . . . . 0.0 110.992 . . . . . . . . . 0 0 . 1 . 016 nuclear build core ' D' D ' 74' ' ' ASP . . . . . . . . . . . . . 6.0 t70 -93.1 118.77 31.59 Favored 'General case' 0 C--N 1.327 -0.409 0 N-CA-C 108.691 -0.855 . . . . 0.0 108.691 173.136 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' D' D ' 75' ' ' VAL . . . . . 0.427 ' C ' HD12 ' D' ' 76' ' ' LEU . 36.6 t -111.44 126.8 68.86 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.313 0 CA-C-O 121.241 0.543 . . . . 0.0 111.312 -171.754 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' D' D ' 76' ' ' LEU . . . . . 0.427 HD12 ' C ' ' D' ' 75' ' ' VAL . 5.9 mp -125.97 145.53 50.25 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 115.363 -0.835 . . . . 0.0 109.531 174.672 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' D' D ' 77' ' ' GLU . . . . . . . . . . . . . 97.7 mt-10 -135.26 137.81 42.91 Favored 'General case' 0 N--CA 1.463 0.202 0 CA-C-O 120.982 0.42 . . . . 0.0 111.183 -179.468 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' D' D ' 78' ' ' ALA . . . . . 0.528 ' HB2' HD21 ' D' ' 109' ' ' LEU . . . -131.41 142.12 49.97 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 115.885 -0.598 . . . . 0.0 110.199 177.492 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' D' D ' 79' ' ' LYS . . . . . 0.558 ' O ' HD13 ' D' ' 80' ' ' ILE . 71.2 mmtt -82.05 122.2 27.52 Favored 'General case' 0 C--N 1.331 -0.239 0 CA-C-O 121.058 0.456 . . . . 0.0 111.276 -178.031 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' D' D ' 80' ' ' ILE . . . . . 0.558 HD13 ' O ' ' D' ' 79' ' ' LYS . 41.6 mm -139.17 118.94 13.97 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.304 0 N-CA-C 108.926 -0.768 . . . . 0.0 108.926 179.889 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' D' D ' 81' ' ' LYS . . . . . . . . . . . . . 47.5 pttt -112.28 125.56 54.29 Favored 'General case' 0 N--CA 1.464 0.269 0 CA-C-O 121.051 0.453 . . . . 0.0 111.381 -177.051 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' D' D ' 82' ' ' GLY . . . . . . . . . . . . . . . 88.52 42.22 5.86 Favored Glycine 0 CA--C 1.525 0.677 0 C-N-CA 120.825 -0.702 . . . . 0.0 111.689 173.659 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' D' D ' 83' ' ' ILE . . . . . . . . . . . . . 70.1 mt -63.55 138.64 22.63 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.33 0 CA-C-O 121.017 0.437 . . . . 0.0 110.206 179.343 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' D' D ' 84' ' ' LYS . . . . . . . . . . . . . 83.7 tttt -96.96 -50.3 4.68 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 115.792 -0.64 . . . . 0.0 109.718 179.306 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' D' D ' 85' ' ' ASP . . . . . . . . . . . . . 9.8 t70 -158.63 152.52 23.57 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 115.636 -0.711 . . . . 0.0 110.182 179.214 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' D' D ' 86' ' ' VAL . . . . . . . . . . . . . 43.4 t -130.48 130.13 64.93 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.297 0 CA-C-O 120.863 0.364 . . . . 0.0 110.429 -178.991 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' D' D ' 87' ' ' ILE . . . . . 0.493 HD12 ' N ' ' D' ' 87' ' ' ILE . 5.0 mp -119.6 126.13 75.02 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.261 0 N-CA-C 109.43 -0.582 . . . . 0.0 109.43 176.696 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' D' D ' 88' ' ' LEU . . . . . 0.452 ' CD1' HG21 ' C' ' 131' ' ' VAL . 12.9 tp -113.45 126.19 55.06 Favored 'General case' 0 C--N 1.331 -0.23 0 CA-C-O 120.987 0.422 . . . . 0.0 111.29 -176.636 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' D' D ' 89' ' ' ASP . . . . . . . . . . . . . 9.3 t0 -118.52 151.42 37.88 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 115.871 -0.604 . . . . 0.0 109.524 175.77 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' D' D ' 90' ' ' GLU . . . . . . . . . . . . . 95.4 mt-10 -48.63 -36.85 16.72 Favored 'General case' 0 C--N 1.33 -0.263 0 N-CA-C 112.782 0.66 . . . . 0.0 112.782 -173.054 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' D' D ' 91' ' ' ASN . . . . . . . . . . . . . 36.2 m120 -130.95 31.58 4.45 Favored 'General case' 0 N--CA 1.465 0.307 0 N-CA-C 112.022 0.378 . . . . 0.0 112.022 -176.711 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' D' D ' 92' ' ' LEU . . . . . . . . . . . . . 13.1 tp -166.14 139.38 4.12 Favored 'General case' 0 C--N 1.33 -0.274 0 N-CA-C 110.06 -0.348 . . . . 0.0 110.06 -179.818 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' D' D ' 93' ' ' ILE . . . . . . . . . . . . . 66.2 mt -125.01 124.15 67.02 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.255 0 N-CA-C 109.698 -0.482 . . . . 0.0 109.698 -178.435 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' D' D ' 94' ' ' VAL . . . . . 0.422 HG21 HG11 ' D' ' 125' ' ' VAL . 43.0 t -125.72 127.15 71.2 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.256 0 CA-C-O 121.023 0.44 . . . . 0.0 110.169 -179.367 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' D' D ' 95' ' ' VAL . . . . . . . . . . . . . 43.7 t -122.17 135.4 62.39 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.262 0 CA-C-N 115.893 -0.594 . . . . 0.0 109.856 179.845 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' D' D ' 96' ' ' ILE . . . . . . . . . . . . . 58.5 mt -115.43 129.29 71.95 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.323 0 N-CA-C 109.24 -0.652 . . . . 0.0 109.24 179.631 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' D' D ' 97' ' ' THR . . . . . . . . . . . . . 69.7 p -103.92 157.71 16.91 Favored 'General case' 0 C--N 1.331 -0.211 0 CA-C-O 121.381 0.61 . . . . 0.0 111.631 -176.522 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' D' D ' 98' ' ' GLU . . . . . . . . . . . . . 44.6 tp10 -53.77 -29.05 38.31 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 115.832 -0.622 . . . . 0.0 112.16 -178.871 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' D' D ' 99' ' ' GLU . . . . . . . . . . . . . 12.9 pt-20 -80.1 18.07 0.91 Allowed 'General case' 0 CA--C 1.534 0.359 0 N-CA-C 113.12 0.785 . . . . 0.0 113.12 -176.419 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' D' D ' 100' ' ' ASN . . . . . . . . . . . . . 4.6 m-20 62.91 38.13 11.53 Favored 'General case' 0 CA--C 1.529 0.151 0 CA-C-O 121.039 0.447 . . . . 0.0 110.897 177.773 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' D' D ' 101' ' ' GLU . . . . . . . . . . . . . 82.8 tt0 -114.71 142.07 46.99 Favored 'General case' 0 C--N 1.332 -0.173 0 CA-C-N 116.111 -0.495 . . . . 0.0 109.743 176.707 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' D' D ' 102' ' ' VAL . . . . . . . . . . . . . 44.8 t -115.84 125.97 73.18 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.312 0 N-CA-C 109.754 -0.462 . . . . 0.0 109.754 -179.49 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' D' D ' 103' ' ' LEU . . . . . . . . . . . . . 47.7 mt -117.15 130.31 56.53 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 115.746 -0.661 . . . . 0.0 110.295 177.777 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' D' D ' 104' ' ' ILE . . . . . 0.4 HD13 HG21 ' D' ' 130' ' ' VAL . 68.9 mt -120.06 121.35 65.64 Favored 'Isoleucine or valine' 0 C--O 1.235 0.316 0 N-CA-C 110.095 -0.335 . . . . 0.0 110.095 -179.139 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' D' D ' 105' ' ' PHE . . . . . . . . . . . . . 62.5 m-85 -122.69 162.65 21.57 Favored 'General case' 0 C--N 1.332 -0.159 0 O-C-N 123.924 0.765 . . . . 0.0 110.099 -178.902 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' D' D ' 106' ' ' ASN . . . . . 0.401 ' HB3' HD11 ' D' ' 112' ' ' LEU . 43.5 p30 -96.03 -171.63 2.37 Favored 'General case' 0 C--N 1.328 -0.348 0 N-CA-C 109.368 -0.604 . . . . 0.0 109.368 172.174 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' D' D ' 107' ' ' GLN . . . . . . . . . . . . . 45.8 tt0 -60.97 -29.9 69.94 Favored 'General case' 0 C--N 1.329 -0.325 0 N-CA-C 112.027 0.38 . . . . 0.0 112.027 -178.634 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' D' D ' 108' ' ' ASN . . . . . . . . . . . . . 6.7 t-20 -82.58 8.59 11.42 Favored 'General case' 0 CA--C 1.537 0.463 0 N-CA-C 113.15 0.796 . . . . 0.0 113.15 -178.069 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' D' D ' 109' ' ' LEU . . . . . 0.528 HD21 ' HB2' ' D' ' 78' ' ' ALA . 11.7 tp 61.67 37.92 15.61 Favored 'General case' 0 CA--C 1.53 0.182 0 CA-C-O 121.089 0.471 . . . . 0.0 111.324 178.122 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' D' D ' 110' ' ' GLU . . . . . . . . . . . . . 70.7 mm-40 -105.72 154.5 20.38 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.272 -0.422 . . . . 0.0 110.058 175.98 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' D' D ' 111' ' ' GLU . . . . . . . . . . . . . 44.4 mt-10 -83.61 122.19 28.25 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-O 120.852 0.358 . . . . 0.0 111.336 -177.88 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' D' D ' 112' ' ' LEU . . . . . 0.401 HD11 ' HB3' ' D' ' 106' ' ' ASN . 95.0 mt -106.25 -45.92 4.18 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.054 -0.521 . . . . 0.0 109.903 175.516 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' D' D ' 113' ' ' TYR . . . . . . . . . . . . . 59.9 t80 -140.0 139.95 36.14 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-N 116.26 -0.427 . . . . 0.0 110.808 179.602 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' D' D ' 114' ' ' ARG . . . . . . . . . . . . . 34.2 ptt180 -145.31 123.01 11.84 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.222 -0.445 . . . . 0.0 110.536 178.579 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' D' D ' 115' ' ' GLY . . . . . . . . . . . . . . . -150.12 156.91 26.97 Favored Glycine 0 CA--C 1.525 0.717 0 C-N-CA 120.694 -0.765 . . . . 0.0 111.641 179.516 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' D' D ' 116' ' ' LYS . . . . . . . . . . . . . 27.1 ttpp -128.44 133.13 48.48 Favored 'General case' 0 C--N 1.33 -0.259 0 N-CA-C 109.826 -0.435 . . . . 0.0 109.826 176.849 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' D' D ' 117' ' ' PHE . . . . . 0.439 ' HE2' HD13 ' D' ' 132' ' ' ILE . 31.4 m-85 -130.41 113.94 14.95 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-O 120.85 0.357 . . . . 0.0 110.237 -175.896 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' D' D ' 118' ' ' GLU . . . . . . . . . . . . . 95.9 mt-10 -52.97 -47.88 67.84 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.477 -0.328 . . . . 0.0 111.491 -176.981 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' D' D ' 119' ' ' ASN . . . . . . . . . . . . . 3.6 m-20 -94.96 31.01 1.95 Allowed 'General case' 0 C--N 1.329 -0.326 0 N-CA-C 112.338 0.496 . . . . 0.0 112.338 -174.131 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' D' D ' 120' ' ' LEU . . . . . . . . . . . . . 18.6 tp -55.96 124.5 17.91 Favored 'General case' 0 C--N 1.333 -0.146 0 CA-C-O 120.565 0.222 . . . . 0.0 110.507 176.86 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' D' D ' 121' ' ' ASN . . . . . . . . . . . . . 35.1 m120 -111.94 -44.0 3.51 Favored 'General case' 0 C--N 1.331 -0.222 0 CA-C-N 116.596 -0.275 . . . . 0.0 110.959 -177.605 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' D' D ' 122' ' ' LYS . . . . . . . . . . . . . 97.9 mttt -144.73 146.1 32.02 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-O 121.001 0.429 . . . . 0.0 111.621 -178.112 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' D' D ' 123' ' ' VAL . . . . . . . . . . . . . 45.6 t -125.69 125.28 68.25 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.26 0 N-CA-C 109.446 -0.575 . . . . 0.0 109.446 175.162 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' D' D ' 124' ' ' LEU . . . . . . . . . . . . . 49.3 mt -124.07 131.05 53.51 Favored 'General case' 0 C--N 1.331 -0.227 0 CA-C-O 120.676 0.274 . . . . 0.0 110.737 -178.169 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' D' D ' 125' ' ' VAL . . . . . 0.449 ' CG2' HG21 ' D' ' 87' ' ' ILE . 34.8 m -132.09 131.48 61.26 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.294 0 CA-C-N 116.274 -0.421 . . . . 0.0 110.389 179.285 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' D' D ' 126' ' ' ARG . . . . . . . . . . . . . 94.3 mtt180 -144.13 125.44 14.71 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-O 121.068 0.461 . . . . 0.0 111.12 -179.555 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' D' D ' 127' ' ' ASN . . . . . . . . . . . . . 6.7 m120 49.98 -109.53 0.38 Allowed 'General case' 0 CA--C 1.545 0.772 0 CA-C-O 118.972 -0.537 . . . . 0.0 111.685 177.334 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' D' D ' 128' ' ' ASP . . . . . . . . . . . . . 11.3 p-10 -114.15 8.72 17.01 Favored 'General case' 0 N--CA 1.469 0.479 0 CA-C-N 119.71 1.141 . . . . 0.0 113.224 -176.194 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' D' D ' 129' ' ' LEU . . . . . . . . . . . . . 58.4 mt -121.98 143.63 49.36 Favored 'General case' 0 C--N 1.333 -0.145 0 N-CA-C 109.483 -0.562 . . . . 0.0 109.483 177.357 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' D' D ' 130' ' ' VAL . . . . . 0.4 HG21 HD13 ' D' ' 104' ' ' ILE . 34.9 m -134.8 146.04 31.38 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.288 0 CA-C-O 121.229 0.537 . . . . 0.0 110.644 179.848 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' D' D ' 131' ' ' VAL . . . . . . . . . . . . . 43.1 t -136.03 139.84 45.09 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.396 0 CA-C-N 115.758 -0.655 . . . . 0.0 110.112 -179.789 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' D' D ' 132' ' ' ILE . . . . . 0.439 HD13 ' HE2' ' D' ' 117' ' ' PHE . 71.6 mt -114.59 130.95 68.08 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.322 0 N-CA-C 109.209 -0.663 . . . . 0.0 109.209 178.89 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' D' D ' 133' ' ' ILE . . . . . . . . . . . . . 40.3 mm -112.45 118.94 59.09 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.263 0 CA-C-N 116.438 -0.346 . . . . 0.0 110.763 -174.767 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' D' D ' 134' ' ' ASP . . . . . . . . . . . . . 6.6 p-10 -129.0 145.27 51.29 Favored 'General case' 0 C--N 1.331 -0.214 0 N-CA-C 109.396 -0.594 . . . . 0.0 109.396 175.984 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' D' D ' 135' ' ' GLU . . . . . . . . . . . . . 39.7 tp10 -49.95 -27.32 5.19 Favored 'General case' 0 C--O 1.235 0.315 0 N-CA-C 112.63 0.604 . . . . 0.0 112.63 -174.155 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' D' D ' 136' ' ' GLN . . . . . . . . . . . . . 95.4 mt-30 -76.88 -39.5 50.81 Favored 'General case' 0 C--O 1.235 0.319 0 CA-C-O 120.814 0.34 . . . . 0.0 111.893 -177.884 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' D' D ' 137' ' ' LYS . . . . . . . . . . . . . 55.0 pttt -170.01 176.91 4.51 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-O 121.475 0.655 . . . . 0.0 112.328 -171.825 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' D' D ' 138' ' ' LEU . . . . . 0.411 ' C ' HD23 ' D' ' 138' ' ' LEU . 6.8 tt -117.23 129.3 55.84 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 115.065 -0.97 . . . . 0.0 110.317 -178.515 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' D' D ' 139' ' ' THR . . . . . . . . . . . . . 35.6 m -109.08 124.88 51.47 Favored 'General case' 0 C--N 1.331 -0.219 0 CA-C-N 116.024 -0.535 . . . . 0.0 110.179 178.577 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' D' D ' 140' ' ' LEU . . . . . 0.457 ' C ' HD23 ' D' ' 140' ' ' LEU . 5.8 tt -111.29 122.14 47.08 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 115.781 -0.645 . . . . 0.0 109.308 -178.145 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' D' D ' 141' ' ' ILE . . . . . 0.43 ' N ' HD23 ' D' ' 140' ' ' LEU . 19.6 mt -122.79 118.55 55.37 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.221 0 CA-C-O 121.177 0.513 . . . . 0.0 110.201 -175.993 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' D' D ' 142' ' ' ARG . . . . . . . . . . . . . 92.6 mtt180 -92.77 120.45 33.16 Favored 'General case' 0 C--O 1.234 0.24 0 CA-C-N 115.223 -0.899 . . . . 0.0 109.823 176.865 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' D' D ' 143' ' ' THR . . . . . . . . . . . . . 67.1 p . . . . . 0 C--O 1.221 -0.428 0 CA-C-O 118.006 -0.997 . . . . 0.0 110.464 179.724 . . . . . . . . 0 0 . 1 . 016 nuclear build core ' E' E ' 2' ' ' SER . . . . . . . . . . . . . 13.1 p . . . . . 0 N--CA 1.462 0.136 0 CA-C-O 121.087 0.47 . . . . 0.0 110.809 . . . . . . . . . 0 0 . 1 . 016 nuclear build core ' E' E ' 3' ' ' GLU . . . . . . . . . . . . . 46.8 tt0 -152.46 145.63 24.65 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 116.059 -0.519 . . . . 0.0 111.152 -177.227 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' E' E ' 4' ' ' LEU . . . . . . . . . . . . . 18.4 tp -124.04 129.4 50.84 Favored 'General case' 0 C--N 1.331 -0.198 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.281 177.397 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' E' E ' 5' ' ' LYS . . . . . . . . . . . . . 67.6 mttm -108.24 123.1 48.26 Favored 'General case' 0 C--N 1.331 -0.215 0 CA-C-N 116.339 -0.391 . . . . 0.0 110.888 179.047 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' E' E ' 6' ' ' LEU . . . . . . . . . . . . . 33.7 mt -115.83 146.3 42.1 Favored 'General case' 0 N--CA 1.464 0.227 0 CA-C-N 115.641 -0.709 . . . . 0.0 110.155 179.132 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' E' E ' 7' ' ' LYS . . . . . . . . . . . . . 31.2 ttmt -128.32 136.76 29.57 Favored Pre-proline 0 CA--C 1.534 0.329 0 CA-C-O 118.88 -0.581 . . . . 0.0 109.585 174.912 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' E' E ' 8' ' ' PRO . . . . . . . . . . . . . 83.1 Cg_endo -92.0 141.51 2.47 Favored 'Trans proline' 0 N--CA 1.49 1.271 0 C-N-CA 121.719 1.613 . . . . 0.0 112.126 178.53 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' E' E ' 9' ' ' LEU . . . . . . . . . . . . . 20.3 mt -78.95 -46.91 1.72 Allowed Pre-proline 0 CA--C 1.534 0.359 0 CA-C-O 118.628 -0.701 . . . . 0.0 111.712 178.419 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' E' E ' 10' ' ' PRO . . . . . . . . . . . . . 91.5 Cg_endo -81.79 150.79 16.54 Favored 'Trans proline' 0 N--CA 1.495 1.615 0 C-N-CA 121.156 1.237 . . . . 0.0 111.539 174.645 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' E' E ' 11' ' ' LYS . . . . . . . . . . . . . 25.1 pttm -86.91 115.84 24.58 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-O 121.389 0.614 . . . . 0.0 110.742 179.423 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' E' E ' 12' ' ' VAL . . . . . . . . . . . . . 12.4 p -151.16 144.77 16.64 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.295 0 CA-C-N 115.822 -0.627 . . . . 0.0 110.341 177.496 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' E' E ' 13' ' ' GLU . . . . . . . . . . . . . 81.5 tt0 -92.83 114.18 26.67 Favored 'General case' 0 C--N 1.329 -0.32 0 N-CA-C 109.749 -0.463 . . . . 0.0 109.749 176.13 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' E' E ' 14' ' ' LEU . . . . . . . . . . . . . 27.9 mt -86.29 144.22 37.96 Favored Pre-proline 0 CA--C 1.533 0.301 0 CA-C-O 119.075 -0.488 . . . . 0.0 110.238 -176.508 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' E' E ' 15' ' ' PRO . . . . . . . . . . . . . 29.4 Cg_exo -60.34 162.62 16.83 Favored 'Trans proline' 0 N--CA 1.498 1.758 0 C-N-CA 121.271 1.314 . . . . 0.0 111.667 178.221 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' E' E ' 16' ' ' PRO . . . . . . . . . . . . . 33.0 Cg_exo -59.09 -38.86 84.7 Favored 'Trans proline' 0 N--CA 1.497 1.711 0 C-N-CA 121.511 1.474 . . . . 0.0 112.904 -176.892 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' E' E ' 17' ' ' ASP . . . . . . . . . . . . . 14.8 p-10 -83.94 1.67 42.41 Favored 'General case' 0 C--N 1.327 -0.383 0 N-CA-C 113.326 0.861 . . . . 0.0 113.326 -177.376 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' E' E ' 18' ' ' PHE . . . . . 0.405 ' CZ ' HD11 ' E' ' 22' ' ' ILE . 61.5 t80 -58.15 -46.4 85.73 Favored 'General case' 0 N--CA 1.457 -0.088 0 O-C-N 121.899 -0.5 . . . . 0.0 110.255 -178.048 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' E' E ' 19' ' ' VAL . . . . . . . . . . . . . 46.6 t -55.45 -43.02 70.39 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.264 0 CA-C-N 116.269 -0.423 . . . . 0.0 110.639 -178.082 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' E' E ' 20' ' ' ASP . . . . . . . . . . . . . 9.5 t0 -60.31 -43.15 96.61 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-O 120.803 0.335 . . . . 0.0 110.844 -178.588 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' E' E ' 21' ' ' VAL . . . . . . . . . . . . . 47.5 t -64.19 -45.88 95.06 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.299 0 C-N-CA 120.882 -0.327 . . . . 0.0 110.603 -177.851 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' E' E ' 22' ' ' ILE . . . . . 0.608 HG22 HD12 ' E' ' 26' ' ' LEU . 51.5 mm -55.53 -46.27 78.89 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.251 0 CA-C-O 120.822 0.344 . . . . 0.0 110.521 178.372 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' E' E ' 23' ' ' ARG . . . . . . . . . . . . . 60.0 ttp180 -53.31 -50.88 64.01 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.65 -0.25 . . . . 0.0 111.509 179.744 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' E' E ' 24' ' ' ILE . . . . . . . . . . . . . 73.7 mt -58.81 -42.9 86.87 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.27 0 CA-C-N 116.546 -0.297 . . . . 0.0 111.332 -176.737 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' E' E ' 25' ' ' LYS . . . . . . . . . . . . . 93.1 mttt -68.88 -38.59 79.79 Favored 'General case' 0 C--N 1.328 -0.332 0 N-CA-C 112.379 0.511 . . . . 0.0 112.379 -177.639 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' E' E ' 26' ' ' LEU . . . . . 0.608 HD12 HG22 ' E' ' 22' ' ' ILE . 78.3 mt -79.85 -38.81 31.96 Favored 'General case' 0 C--N 1.331 -0.236 0 N-CA-C 113.311 0.856 . . . . 0.0 113.311 -170.947 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' E' E ' 27' ' ' GLN . . . . . . . . . . . . . 17.0 pt20 -46.79 140.03 4.93 Favored 'General case' 0 N--CA 1.47 0.559 0 N-CA-C 112.643 0.609 . . . . 0.0 112.643 -175.376 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' E' E ' 28' ' ' GLY . . . . . . . . . . . . . . . 101.4 -26.02 26.06 Favored Glycine 0 CA--C 1.533 1.201 0 CA-C-N 115.57 -0.741 . . . . 0.0 112.174 -175.811 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' E' E ' 29' ' ' LYS . . . . . . . . . . . . . 88.0 mttt -97.51 155.06 17.11 Favored 'General case' 0 C--O 1.232 0.178 0 CA-C-N 117.374 0.587 . . . . 0.0 111.147 178.713 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' E' E ' 30' ' ' THR . . . . . . . . . . . . . 20.8 m -102.57 140.72 36.48 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 115.947 -0.57 . . . . 0.0 110.28 176.735 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' E' E ' 31' ' ' VAL . . . . . . . . . . . . . 34.9 m -128.4 147.48 32.94 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.25 0 CA-C-O 120.901 0.381 . . . . 0.0 110.64 -179.566 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' E' E ' 32' ' ' ARG . . . . . . . . . . . . . 68.8 ttt-85 -130.12 147.16 51.82 Favored 'General case' 0 C--N 1.331 -0.21 0 CA-C-N 116.07 -0.514 . . . . 0.0 110.415 179.541 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' E' E ' 33' ' ' THR . . . . . . . . . . . . . 22.9 m -52.46 139.36 25.28 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 116.458 -0.337 . . . . 0.0 111.594 -177.958 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' E' E ' 34' ' ' GLY . . . . . . . . . . . . . . . 97.48 -17.13 59.52 Favored Glycine 0 CA--C 1.533 1.179 0 C-N-CA 121.176 -0.535 . . . . 0.0 113.322 178.837 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' E' E ' 35' ' ' ASP . . . . . . . . . . . . . 77.1 m-20 -66.16 151.17 47.53 Favored 'General case' 0 C--O 1.231 0.087 0 CA-C-N 118.032 0.916 . . . . 0.0 111.057 179.838 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' E' E ' 36' ' ' VAL . . . . . . . . . . . . . 44.1 t -123.95 128.05 73.95 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.236 0 N-CA-C 109.678 -0.49 . . . . 0.0 109.678 177.038 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' E' E ' 37' ' ' ILE . . . . . . . . . . . . . 60.7 mt -120.78 137.5 54.31 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.26 0 CA-C-N 116.023 -0.535 . . . . 0.0 109.87 -179.473 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' E' E ' 38' ' ' GLY . . . . . . . . . . . . . . . -113.91 127.35 7.77 Favored Glycine 0 CA--C 1.526 0.748 0 N-CA-C 110.854 -0.898 . . . . 0.0 110.854 178.867 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' E' E ' 39' ' ' ILE . . . . . . . . . . . . . 72.7 mt -126.23 126.53 69.57 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.237 0 N-CA-C 110.005 -0.368 . . . . 0.0 110.005 179.451 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' E' E ' 40' ' ' SER . . . . . . . . . . . . . 80.2 p -93.33 123.1 36.38 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.398 -0.364 . . . . 0.0 111.052 176.423 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' E' E ' 41' ' ' ILE . . . . . . . . . . . . . 71.4 mt -137.3 127.97 39.38 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.215 0 CA-C-O 120.943 0.401 . . . . 0.0 110.21 177.11 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' E' E ' 42' ' ' LEU . . . . . . . . . . . . . 8.7 tp 58.47 35.15 24.5 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.045 -0.525 . . . . 0.0 111.522 179.257 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' E' E ' 43' ' ' GLY . . . . . . . . . . . . . . . 72.48 14.61 77.37 Favored Glycine 0 CA--C 1.535 1.285 0 C-N-CA 121.246 -0.502 . . . . 0.0 113.222 176.933 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' E' E ' 44' ' ' LYS . . . . . . . . . . . . . 72.0 mmtt -124.45 130.28 52.18 Favored 'General case' 0 N--CA 1.462 0.172 0 CA-C-N 117.89 0.845 . . . . 0.0 110.203 178.129 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' E' E ' 45' ' ' GLU . . . . . . . . . . . . . 79.1 tt0 -85.34 122.78 30.0 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 115.954 -0.567 . . . . 0.0 111.11 -179.812 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' E' E ' 46' ' ' VAL . . . . . 0.406 ' O ' HG13 ' E' ' 46' ' ' VAL . 10.9 p -118.82 123.0 70.79 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.197 0 N-CA-C 109.555 -0.535 . . . . 0.0 109.555 174.376 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' E' E ' 47' ' ' LYS . . . . . . . . . . . . . 68.1 mttm -99.33 126.93 45.28 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 115.984 -0.553 . . . . 0.0 111.014 179.114 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' E' E ' 48' ' ' PHE . . . . . . . . . . . . . 29.1 m-85 -111.09 131.82 54.77 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.116 -0.493 . . . . 0.0 109.944 177.446 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' E' E ' 49' ' ' LYS . . . . . . . . . . . . . 80.9 tttt -107.11 137.19 45.64 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.374 -0.376 . . . . 0.0 110.284 177.557 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' E' E ' 50' ' ' VAL . . . . . . . . . . . . . 42.9 t -74.15 106.72 4.19 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.345 0 N-CA-C 109.812 -0.44 . . . . 0.0 109.812 178.682 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' E' E ' 51' ' ' VAL . . . . . . . . . . . . . 46.1 t -70.75 -50.34 44.73 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.277 0 O-C-N 123.65 0.594 . . . . 0.0 109.704 -176.104 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' E' E ' 52' ' ' GLN . . . . . . . . . . . . . 56.3 tt0 -168.02 138.19 2.66 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 115.908 -0.587 . . . . 0.0 111.145 -179.19 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' E' E ' 53' ' ' ALA . . . . . . . . . . . . . . . -112.15 132.4 54.9 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 115.873 -0.603 . . . . 0.0 110.135 177.04 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' E' E ' 54' ' ' TYR . . . . . . . . . . . . . 22.9 t80 -127.97 107.22 20.1 Favored Pre-proline 0 CA--C 1.534 0.345 0 CA-C-O 118.285 -0.864 . . . . 0.0 110.364 179.778 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' E' E ' 55' ' ' PRO . . . . . . . . . . . . . 73.3 Cg_endo -77.06 170.05 72.7 Favored 'Cis proline' 0 N--CA 1.5 1.888 0 CA-C-N 121.682 1.637 . . . . 0.0 112.488 -5.286 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' E' E ' 56' ' ' SER . . . . . . . . . . . . . 70.5 m -115.54 129.93 24.73 Favored Pre-proline 0 CA--C 1.539 0.538 0 CA-C-O 118.427 -0.796 . . . . 0.0 109.35 175.391 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' E' E ' 57' ' ' PRO . . . . . . . . . . . . . 60.8 Cg_endo -74.34 150.61 95.81 Favored 'Cis proline' 0 N--CA 1.497 1.684 0 CA-C-N 121.952 1.733 . . . . 0.0 111.722 -0.31 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' E' E ' 58' ' ' LEU . . . . . . . . . . . . . 21.4 tp -109.02 138.11 45.88 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 116.299 -0.409 . . . . 0.0 110.85 -177.84 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' E' E ' 59' ' ' ARG . . . . . . . . . . . . . 78.0 ttt180 -101.75 125.88 48.5 Favored 'General case' 0 C--N 1.328 -0.339 0 N-CA-C 109.244 -0.65 . . . . 0.0 109.244 173.537 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' E' E ' 60' ' ' VAL . . . . . . . . . . . . . 46.8 t -77.81 114.64 18.6 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.308 0 C-N-CA 120.72 -0.392 . . . . 0.0 110.378 -176.88 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' E' E ' 61' ' ' GLU . . . . . . . . . . . . . 44.2 mt-10 -131.01 161.19 32.51 Favored 'General case' 0 C--N 1.332 -0.167 0 CA-C-N 115.933 -0.576 . . . . 0.0 110.012 177.663 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' E' E ' 62' ' ' ASP . . . . . . . . . . . . . 77.9 m-20 -54.4 -33.71 59.86 Favored 'General case' 0 C--N 1.328 -0.352 0 N-CA-C 112.088 0.403 . . . . 0.0 112.088 -175.798 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' E' E ' 63' ' ' ARG . . . . . . . . . . . . . 25.0 mmm180 -74.87 -17.21 60.62 Favored 'General case' 0 CA--C 1.535 0.391 0 N-CA-C 113.125 0.787 . . . . 0.0 113.125 -175.427 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' E' E ' 64' ' ' THR . . . . . . . . . . . . . 11.4 m -75.77 142.93 42.24 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-O 120.852 0.358 . . . . 0.0 110.865 -176.131 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' E' E ' 65' ' ' LYS . . . . . . . . . . . . . 95.6 mttt -89.63 139.76 30.23 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.111 -0.495 . . . . 0.0 110.531 179.938 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' E' E ' 66' ' ' ILE . . . . . . . . . . . . . 55.3 mt -113.81 133.37 59.99 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.287 0 N-CA-C 109.837 -0.431 . . . . 0.0 109.837 178.256 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' E' E ' 67' ' ' THR . . . . . . . . . . . . . 25.3 m -128.34 139.14 52.56 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-O 121.056 0.455 . . . . 0.0 111.166 -178.191 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' E' E ' 68' ' ' LEU . . . . . 0.489 HD12 ' N ' ' E' ' 68' ' ' LEU . 7.2 mp . . . . . 0 C--N 1.328 -0.336 0 CA-C-N 115.826 -0.625 . . . . 0.0 109.853 176.411 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' E' E ' 73' ' ' VAL . . . . . . . . . . . . . 34.7 m . . . . . 0 N--CA 1.462 0.138 0 CA-C-O 120.98 0.419 . . . . 0.0 110.616 . . . . . . . . . 0 0 . 1 . 016 nuclear build core ' E' E ' 74' ' ' ASP . . . . . . . . . . . . . 9.7 t0 -104.33 120.39 41.09 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.025 -0.534 . . . . 0.0 109.822 179.104 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' E' E ' 75' ' ' VAL . . . . . . . . . . . . . 40.5 t -114.39 123.05 69.68 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.18 0 CA-C-O 121.055 0.455 . . . . 0.0 110.955 -175.4 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' E' E ' 76' ' ' LEU . . . . . . . . . . . . . 6.0 mp -123.34 146.71 47.72 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 115.657 -0.701 . . . . 0.0 109.591 175.632 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' E' E ' 77' ' ' GLU . . . . . . . . . . . . . 97.1 mt-10 -134.03 140.84 46.95 Favored 'General case' 0 N--CA 1.463 0.207 0 CA-C-O 121.167 0.508 . . . . 0.0 111.383 -178.418 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' E' E ' 78' ' ' ALA . . . . . . . . . . . . . . . -130.51 129.51 42.98 Favored 'General case' 0 C--N 1.332 -0.193 0 CA-C-N 115.684 -0.689 . . . . 0.0 109.751 175.849 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' E' E ' 79' ' ' LYS . . . . . 0.714 ' O ' HD13 ' E' ' 80' ' ' ILE . 37.3 mmtm -71.74 119.54 16.04 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-O 120.886 0.374 . . . . 0.0 110.981 -178.234 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' E' E ' 80' ' ' ILE . . . . . 0.714 HD13 ' O ' ' E' ' 79' ' ' LYS . 32.1 mm -139.31 99.91 1.32 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.259 0 N-CA-C 109.089 -0.708 . . . . 0.0 109.089 -178.213 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' E' E ' 81' ' ' LYS . . . . . . . . . . . . . 53.0 pttt -101.51 128.13 47.89 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-O 121.103 0.478 . . . . 0.0 111.31 -176.639 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' E' E ' 82' ' ' GLY . . . . . . . . . . . . . . . 89.21 41.95 5.7 Favored Glycine 0 CA--C 1.526 0.777 0 CA-C-N 115.799 -0.637 . . . . 0.0 111.66 177.2 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' E' E ' 83' ' ' ILE . . . . . . . . . . . . . 73.7 mt -68.94 144.66 13.95 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 CA-C-O 121.034 0.445 . . . . 0.0 110.234 179.078 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' E' E ' 84' ' ' LYS . . . . . . . . . . . . . 87.6 tttt -100.99 -51.77 3.46 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 115.792 -0.64 . . . . 0.0 109.993 -179.905 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' E' E ' 85' ' ' ASP . . . . . . . . . . . . . 7.9 t70 -160.44 154.69 23.33 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 115.597 -0.729 . . . . 0.0 110.057 179.459 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' E' E ' 86' ' ' VAL . . . . . . . . . . . . . 40.6 t -132.95 131.61 59.04 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.212 0 CA-C-O 121.06 0.457 . . . . 0.0 110.576 -178.588 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' E' E ' 87' ' ' ILE . . . . . . . . . . . . . 44.9 mm -119.45 128.23 75.86 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.208 0 CA-C-N 115.804 -0.634 . . . . 0.0 109.556 176.515 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' E' E ' 88' ' ' LEU . . . . . . . . . . . . . 84.2 mt -110.29 137.82 47.5 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-O 121.111 0.481 . . . . 0.0 111.499 -177.363 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' E' E ' 89' ' ' ASP . . . . . . . . . . . . . 10.9 t70 -127.07 153.23 46.24 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 115.502 -0.772 . . . . 0.0 109.074 174.436 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' E' E ' 90' ' ' GLU . . . . . . . . . . . . . 95.8 mt-10 -48.06 -36.91 13.9 Favored 'General case' 0 C--N 1.33 -0.244 0 N-CA-C 112.903 0.705 . . . . 0.0 112.903 -172.605 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' E' E ' 91' ' ' ASN . . . . . . . . . . . . . 27.6 m120 -132.06 32.03 4.08 Favored 'General case' 0 N--CA 1.465 0.277 0 N-CA-C 112.102 0.408 . . . . 0.0 112.102 -176.848 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' E' E ' 92' ' ' LEU . . . . . . . . . . . . . 8.1 tp -166.09 152.94 9.59 Favored 'General case' 0 C--N 1.33 -0.247 0 C-N-CA 120.897 -0.321 . . . . 0.0 110.81 -179.44 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' E' E ' 93' ' ' ILE . . . . . . . . . . . . . 73.0 mt -130.37 129.91 65.08 Favored 'Isoleucine or valine' 0 N--CA 1.462 0.166 0 N-CA-C 109.971 -0.381 . . . . 0.0 109.971 179.171 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' E' E ' 94' ' ' VAL . . . . . . . . . . . . . 44.7 t -122.56 125.0 71.97 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.246 0 N-CA-C 109.597 -0.52 . . . . 0.0 109.597 176.942 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' E' E ' 95' ' ' VAL . . . . . . . . . . . . . 43.5 t -120.66 134.52 63.82 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.295 0 CA-C-N 116.285 -0.416 . . . . 0.0 110.145 -177.929 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' E' E ' 96' ' ' ILE . . . . . . . . . . . . . 66.9 mt -115.83 129.4 72.25 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 N-CA-C 109.361 -0.607 . . . . 0.0 109.361 178.985 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' E' E ' 97' ' ' THR . . . . . . . . . . . . . 77.8 p -101.28 155.89 17.76 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-O 121.033 0.444 . . . . 0.0 111.111 -178.028 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' E' E ' 98' ' ' GLU . . . . . . . . . . . . . 12.8 pt-20 -54.05 -22.14 10.07 Favored 'General case' 0 CA--C 1.535 0.393 0 N-CA-C 112.613 0.598 . . . . 0.0 112.613 -179.256 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' E' E ' 99' ' ' GLU . . . . . . . . . . . . . 31.2 tt0 -83.38 18.15 1.9 Allowed 'General case' 0 CA--C 1.536 0.417 0 N-CA-C 112.79 0.663 . . . . 0.0 112.79 -177.333 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' E' E ' 100' ' ' ASN . . . . . . . . . . . . . 2.6 m-20 62.16 37.98 14.03 Favored 'General case' 0 CA--C 1.53 0.198 0 CA-C-O 121.011 0.434 . . . . 0.0 110.828 177.961 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' E' E ' 101' ' ' GLU . . . . . . . . . . . . . 81.4 tt0 -119.75 141.55 49.35 Favored 'General case' 0 C--N 1.332 -0.195 0 N-CA-C 109.765 -0.457 . . . . 0.0 109.765 177.684 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' E' E ' 102' ' ' VAL . . . . . . . . . . . . . 41.0 t -115.12 128.69 72.2 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.271 0 N-CA-C 110.216 -0.29 . . . . 0.0 110.216 -178.238 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' E' E ' 103' ' ' LEU . . . . . . . . . . . . . 7.0 mp -116.5 136.69 52.77 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 115.559 -0.746 . . . . 0.0 109.93 176.864 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' E' E ' 104' ' ' ILE . . . . . 0.498 HD12 ' HB3' ' E' ' 113' ' ' TYR . 68.2 mt -116.02 121.82 68.26 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.259 0 N-CA-C 109.766 -0.457 . . . . 0.0 109.766 179.742 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' E' E ' 105' ' ' PHE . . . . . . . . . . . . . 93.0 m-85 -123.33 165.76 16.44 Favored 'General case' 0 C--N 1.332 -0.163 0 O-C-N 124.281 0.988 . . . . 0.0 109.997 -177.713 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' E' E ' 106' ' ' ASN . . . . . . . . . . . . . 46.0 p-10 -104.0 -171.61 1.96 Allowed 'General case' 0 C--N 1.331 -0.197 0 N-CA-C 109.61 -0.515 . . . . 0.0 109.61 171.205 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' E' E ' 107' ' ' GLN . . . . . . . . . . . . . 25.4 tt0 -60.55 -24.37 65.35 Favored 'General case' 0 CA--C 1.534 0.35 0 N-CA-C 112.221 0.452 . . . . 0.0 112.221 179.831 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' E' E ' 108' ' ' ASN . . . . . . . . . . . . . 26.1 t30 -90.19 13.66 14.57 Favored 'General case' 0 CA--C 1.534 0.356 0 N-CA-C 112.978 0.733 . . . . 0.0 112.978 -178.609 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' E' E ' 109' ' ' LEU . . . . . . . . . . . . . 46.0 mt 56.73 35.24 25.91 Favored 'General case' 0 CA--C 1.53 0.206 0 CA-C-N 117.866 0.303 . . . . 0.0 111.557 177.511 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' E' E ' 110' ' ' GLU . . . . . . . . . . . . . 71.0 mm-40 -102.38 146.8 27.53 Favored 'General case' 0 C--N 1.33 -0.269 0 N-CA-C 109.906 -0.405 . . . . 0.0 109.906 176.926 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' E' E ' 111' ' ' GLU . . . . . . . . . . . . . 79.6 tt0 -82.29 124.73 30.23 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-O 120.953 0.406 . . . . 0.0 111.254 -175.993 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' E' E ' 112' ' ' LEU . . . . . . . . . . . . . 15.4 mt -108.38 -46.05 3.78 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 115.915 -0.584 . . . . 0.0 110.061 176.569 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' E' E ' 113' ' ' TYR . . . . . 0.498 ' HB3' HD12 ' E' ' 104' ' ' ILE . 48.3 t80 -142.55 145.06 33.22 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.169 -0.469 . . . . 0.0 111.317 -178.915 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' E' E ' 114' ' ' ARG . . . . . . . . . . . . . 55.1 ttp180 -151.02 125.26 9.38 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-O 121.065 0.459 . . . . 0.0 110.448 174.798 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' E' E ' 115' ' ' GLY . . . . . . . . . . . . . . . -150.13 155.65 26.34 Favored Glycine 0 CA--C 1.524 0.64 0 N-CA-C 110.67 -0.972 . . . . 0.0 110.67 178.374 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' E' E ' 116' ' ' LYS . . . . . . . . . . . . . 38.8 ttpt -114.9 140.29 49.1 Favored 'General case' 0 C--N 1.331 -0.197 0 O-C-N 122.593 -0.357 . . . . 0.0 110.338 179.14 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' E' E ' 117' ' ' PHE . . . . . . . . . . . . . 41.4 m-85 -133.95 114.59 13.43 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.2 -0.455 . . . . 0.0 110.17 -177.778 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' E' E ' 118' ' ' GLU . . . . . . . . . . . . . 70.8 mm-40 -51.28 -53.16 38.34 Favored 'General case' 0 C--N 1.33 -0.27 0 N-CA-C 111.837 0.31 . . . . 0.0 111.837 -175.925 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' E' E ' 119' ' ' ASN . . . . . . . . . . . . . 25.2 m120 -94.22 31.07 1.76 Allowed 'General case' 0 C--N 1.328 -0.334 0 N-CA-C 112.176 0.436 . . . . 0.0 112.176 -174.128 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' E' E ' 120' ' ' LEU . . . . . . . . . . . . . 12.9 tp -54.33 119.82 5.7 Favored 'General case' 0 N--CA 1.464 0.257 0 CA-C-O 120.749 0.309 . . . . 0.0 110.854 179.156 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' E' E ' 121' ' ' ASN . . . . . . . . . . . . . 88.8 m-20 -114.1 -44.03 3.18 Favored 'General case' 0 C--N 1.332 -0.176 0 CA-C-N 116.356 -0.384 . . . . 0.0 111.141 -178.036 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' E' E ' 122' ' ' LYS . . . . . . . . . . . . . 63.2 mtpt -140.63 148.61 41.14 Favored 'General case' 0 C--N 1.331 -0.211 0 CA-C-O 121.137 0.494 . . . . 0.0 111.682 -175.754 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' E' E ' 123' ' ' VAL . . . . . . . . . . . . . 43.5 t -131.27 126.45 58.81 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.261 0 CA-C-N 115.79 -0.641 . . . . 0.0 109.359 174.052 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' E' E ' 124' ' ' LEU . . . . . . . . . . . . . 41.1 mt -121.61 135.61 54.98 Favored 'General case' 0 C--N 1.331 -0.22 0 CA-C-N 116.496 -0.32 . . . . 0.0 110.565 -177.898 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' E' E ' 125' ' ' VAL . . . . . . . . . . . . . 11.6 p -134.0 129.26 54.11 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.277 0 CA-C-N 116.257 -0.429 . . . . 0.0 110.249 179.151 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' E' E ' 126' ' ' ARG . . . . . . . . . . . . . 52.1 mmm-85 -137.33 116.16 12.27 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.348 179.32 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' E' E ' 127' ' ' ASN . . . . . . . . . . . . . 7.1 m-80 52.65 -104.85 0.21 Allowed 'General case' 0 CA--C 1.543 0.689 0 CA-C-O 119.205 -0.426 . . . . 0.0 111.273 178.956 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' E' E ' 128' ' ' ASP . . . . . . . . . . . . . 10.9 p-10 -114.1 2.25 14.86 Favored 'General case' 0 N--CA 1.468 0.468 0 CA-C-N 119.48 1.036 . . . . 0.0 113.464 -176.458 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' E' E ' 129' ' ' LEU . . . . . . . . . . . . . 14.5 tp -105.36 135.1 47.36 Favored 'General case' 0 C--N 1.333 -0.146 0 CA-C-N 118.233 0.469 . . . . 0.0 110.012 179.018 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' E' E ' 130' ' ' VAL . . . . . . . . . . . . . 43.1 t -121.32 135.58 61.03 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.192 0 CA-C-O 120.897 0.379 . . . . 0.0 110.003 -178.288 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' E' E ' 131' ' ' VAL . . . . . . . . . . . . . 43.5 t -135.64 134.14 51.65 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.202 0 CA-C-O 120.991 0.424 . . . . 0.0 110.176 178.541 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' E' E ' 132' ' ' ILE . . . . . . . . . . . . . 71.5 mt -116.86 132.32 66.94 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.352 0 CA-C-N 115.713 -0.676 . . . . 0.0 109.357 179.748 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' E' E ' 133' ' ' ILE . . . . . . . . . . . . . 39.9 mm -116.0 119.26 61.37 Favored 'Isoleucine or valine' 0 C--O 1.234 0.25 0 CA-C-O 120.79 0.329 . . . . 0.0 111.029 -173.862 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' E' E ' 134' ' ' ASP . . . . . . . . . . . . . 10.4 p-10 -131.11 144.98 51.81 Favored 'General case' 0 C--N 1.332 -0.18 0 N-CA-C 109.454 -0.573 . . . . 0.0 109.454 174.584 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' E' E ' 135' ' ' GLU . . . . . . . . . . . . . 80.0 tt0 -49.8 -26.07 3.62 Favored 'General case' 0 C--N 1.328 -0.334 0 N-CA-C 112.95 0.722 . . . . 0.0 112.95 -171.656 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' E' E ' 136' ' ' GLN . . . . . . . . . . . . . 35.0 tt0 -80.9 -38.33 28.15 Favored 'General case' 0 C--O 1.234 0.256 0 N-CA-C 111.887 0.328 . . . . 0.0 111.887 -176.417 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' E' E ' 137' ' ' LYS . . . . . . . . . . . . . 15.3 pttp -162.02 171.56 17.37 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-O 121.602 0.715 . . . . 0.0 112.119 -172.423 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' E' E ' 138' ' ' LEU . . . . . 0.484 HD23 ' N ' ' E' ' 139' ' ' THR . 3.6 tt -114.07 126.51 55.19 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 114.864 -1.062 . . . . 0.0 109.744 179.171 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' E' E ' 139' ' ' THR . . . . . 0.484 ' N ' HD23 ' E' ' 138' ' ' LEU . 26.2 m -105.32 123.39 47.78 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.338 -0.392 . . . . 0.0 110.529 -179.858 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' E' E ' 140' ' ' LEU . . . . . 0.472 ' C ' HD23 ' E' ' 140' ' ' LEU . 7.6 tt -110.67 122.28 47.41 Favored 'General case' 0 C--N 1.327 -0.401 0 N-CA-C 109.251 -0.648 . . . . 0.0 109.251 -179.35 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' E' E ' 141' ' ' ILE . . . . . . . . . . . . . 19.7 mt -122.46 113.89 40.28 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.264 0 N-CA-C 109.786 -0.45 . . . . 0.0 109.786 -176.45 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' E' E ' 142' ' ' ARG . . . . . . . . . . . . . 67.8 ttp85 -103.05 129.7 49.94 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 115.416 -0.811 . . . . 0.0 110.831 -177.934 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' E' E ' 143' ' ' THR . . . . . . . . . . . . . 81.3 p . . . . . 0 C--O 1.22 -0.47 0 CA-C-O 117.873 -1.06 . . . . 0.0 110.834 179.463 . . . . . . . . 0 0 . 1 . 016 nuclear build core ' F' F ' 1' ' ' MET . . . . . . . . . . . . . 23.5 ptp . . . . . 0 C--O 1.232 0.169 0 CA-C-O 120.733 0.301 . . . . 0.0 110.685 . . . . . . . . . 0 0 . 1 . 016 nuclear build core ' F' F ' 2' ' ' SER . . . . . . . . . . . . . 6.8 p -114.45 132.55 56.22 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.252 -0.431 . . . . 0.0 110.723 -179.566 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' F' F ' 3' ' ' GLU . . . . . . . . . . . . . 81.8 tt0 -141.35 141.06 33.87 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 115.963 -0.562 . . . . 0.0 111.032 -179.07 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' F' F ' 4' ' ' LEU . . . . . . . . . . . . . 15.2 tp -125.58 132.02 52.61 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.049 -0.523 . . . . 0.0 110.01 176.618 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' F' F ' 5' ' ' LYS . . . . . . . . . . . . . 65.1 mttm -111.61 120.18 41.21 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.249 -0.432 . . . . 0.0 110.606 -179.673 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' F' F ' 6' ' ' LEU . . . . . . . . . . . . . 67.1 mt -114.35 150.34 34.72 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 115.477 -0.783 . . . . 0.0 110.279 -178.609 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' F' F ' 7' ' ' LYS . . . . . . . . . . . . . 40.9 tttp -137.65 139.72 27.8 Favored Pre-proline 0 CA--C 1.534 0.353 0 CA-C-O 119.048 -0.501 . . . . 0.0 110.145 176.758 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' F' F ' 8' ' ' PRO . . . . . . . . . . . . . 94.0 Cg_endo -90.21 139.92 3.13 Favored 'Trans proline' 0 N--CA 1.489 1.263 0 C-N-CA 121.746 1.63 . . . . 0.0 111.662 177.575 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' F' F ' 9' ' ' LEU . . . . . . . . . . . . . 46.8 mt -78.7 -47.64 1.81 Allowed Pre-proline 0 CA--C 1.533 0.3 0 CA-C-O 118.652 -0.689 . . . . 0.0 112.181 -178.963 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' F' F ' 10' ' ' PRO . . . . . . . . . . . . . 92.1 Cg_endo -79.47 150.18 21.9 Favored 'Trans proline' 0 N--CA 1.496 1.647 0 C-N-CA 121.139 1.226 . . . . 0.0 111.766 175.95 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' F' F ' 11' ' ' LYS . . . . . . . . . . . . . 82.9 tttt -86.31 101.43 13.07 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.295 -0.411 . . . . 0.0 110.371 179.256 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' F' F ' 12' ' ' VAL . . . . . . . . . . . . . 12.5 p -146.64 149.84 15.55 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.255 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.76 -178.526 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' F' F ' 13' ' ' GLU . . . . . . . . . . . . . 70.7 mm-40 -79.87 126.64 31.25 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.152 -0.477 . . . . 0.0 110.098 177.112 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' F' F ' 14' ' ' LEU . . . . . . . . . . . . . 37.8 mt -97.53 144.48 28.03 Favored Pre-proline 0 CA--C 1.533 0.291 0 CA-C-O 119.012 -0.518 . . . . 0.0 110.038 179.464 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' F' F ' 15' ' ' PRO . . . . . . . . . . . . . 25.7 Cg_exo -62.01 153.97 65.23 Favored 'Trans proline' 0 N--CA 1.497 1.72 0 C-N-CA 121.204 1.27 . . . . 0.0 111.442 177.133 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' F' F ' 16' ' ' PRO . . . . . . . . . . . . . 31.2 Cg_exo -57.2 -38.84 94.14 Favored 'Trans proline' 0 N--CA 1.497 1.715 0 C-N-CA 121.412 1.408 . . . . 0.0 112.856 -179.244 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' F' F ' 17' ' ' ASP . . . . . . . . . . . . . 21.7 p-10 -85.98 9.63 16.45 Favored 'General case' 0 CA--C 1.537 0.444 0 N-CA-C 113.319 0.859 . . . . 0.0 113.319 -177.138 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' F' F ' 18' ' ' PHE . . . . . . . . . . . . . 43.3 t80 -58.47 -48.51 80.51 Favored 'General case' 0 N--CA 1.457 -0.109 0 O-C-N 121.971 -0.455 . . . . 0.0 110.153 -177.239 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' F' F ' 19' ' ' VAL . . . . . . . . . . . . . 14.0 p -54.46 -41.36 53.58 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.256 0 CA-C-N 116.378 -0.374 . . . . 0.0 111.284 -177.611 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' F' F ' 20' ' ' ASP . . . . . . . . . . . . . 73.3 m-20 -60.87 -45.95 92.52 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-O 120.823 0.344 . . . . 0.0 111.039 -177.806 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' F' F ' 21' ' ' VAL . . . . . . . . . . . . . 46.4 t -64.34 -46.92 91.71 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 C-N-CA 120.76 -0.376 . . . . 0.0 110.573 -177.103 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' F' F ' 22' ' ' ILE . . . . . 0.488 HG22 HD12 ' F' ' 26' ' ' LEU . 49.1 mm -56.21 -46.72 81.39 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.221 0 C-N-CA 120.917 -0.313 . . . . 0.0 110.647 179.347 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' F' F ' 23' ' ' ARG . . . . . . . . . . . . . 50.9 ttp180 -53.51 -48.42 69.02 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-O 120.639 0.257 . . . . 0.0 111.468 -178.477 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' F' F ' 24' ' ' ILE . . . . . . . . . . . . . 73.1 mt -59.58 -43.38 90.84 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.337 0 C-N-CA 121.072 -0.251 . . . . 0.0 111.05 -178.984 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' F' F ' 25' ' ' LYS . . . . . . . . . . . . . 53.5 mtmt -64.61 -39.1 93.11 Favored 'General case' 0 C--N 1.329 -0.307 0 N-CA-C 112.255 0.465 . . . . 0.0 112.255 -178.409 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' F' F ' 26' ' ' LEU . . . . . 0.488 HD12 HG22 ' F' ' 22' ' ' ILE . 63.3 mt -79.8 -40.59 28.27 Favored 'General case' 0 C--N 1.329 -0.298 0 N-CA-C 113.501 0.926 . . . . 0.0 113.501 -170.591 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' F' F ' 27' ' ' GLN . . . . . . . . . . . . . 18.2 pt20 -46.38 138.4 5.66 Favored 'General case' 0 N--CA 1.469 0.506 0 N-CA-C 112.995 0.739 . . . . 0.0 112.995 -173.821 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' F' F ' 28' ' ' GLY . . . . . . . . . . . . . . . 100.92 -26.88 23.05 Favored Glycine 0 CA--C 1.533 1.201 0 CA-C-N 115.611 -0.722 . . . . 0.0 112.185 -177.379 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' F' F ' 29' ' ' LYS . . . . . . . . . . . . . 83.1 mttt -97.98 155.12 17.25 Favored 'General case' 0 C--O 1.233 0.187 0 CA-C-N 117.329 0.564 . . . . 0.0 111.227 179.6 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' F' F ' 30' ' ' THR . . . . . . . . . . . . . 40.9 m -101.19 140.54 35.34 Favored 'General case' 0 C--N 1.33 -0.239 0 CA-C-N 116.01 -0.541 . . . . 0.0 110.375 177.755 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' F' F ' 31' ' ' VAL . . . . . . . . . . . . . 35.4 m -129.79 152.97 38.14 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.164 0 CA-C-N 116.313 -0.403 . . . . 0.0 110.327 178.673 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' F' F ' 32' ' ' ARG . . . . . . . . . . . . . 50.1 ttt180 -132.04 149.08 52.51 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-O 121.185 0.517 . . . . 0.0 110.277 178.529 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' F' F ' 33' ' ' THR . . . . . . . . . . . . . 19.5 m -52.46 137.63 29.34 Favored 'General case' 0 C--N 1.331 -0.212 0 CA-C-N 116.369 -0.378 . . . . 0.0 111.44 -178.218 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' F' F ' 34' ' ' GLY . . . . . . . . . . . . . . . 100.51 -17.15 57.11 Favored Glycine 0 CA--C 1.534 1.238 0 C-N-CA 121.172 -0.537 . . . . 0.0 113.188 179.532 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' F' F ' 35' ' ' ASP . . . . . . . . . . . . . 52.2 m-20 -64.54 151.04 45.59 Favored 'General case' 0 C--N 1.333 -0.115 0 CA-C-N 118.034 0.917 . . . . 0.0 111.19 -179.817 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' F' F ' 36' ' ' VAL . . . . . . . . . . . . . 44.7 t -127.85 130.92 70.12 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.199 0 CA-C-N 115.815 -0.629 . . . . 0.0 109.858 178.685 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' F' F ' 37' ' ' ILE . . . . . . . . . . . . . 66.0 mt -124.37 142.76 40.1 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.231 0 CA-C-N 116.282 -0.417 . . . . 0.0 110.033 -178.73 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' F' F ' 38' ' ' GLY . . . . . . . . . . . . . . . -111.98 128.84 8.77 Favored Glycine 0 CA--C 1.526 0.75 0 N-CA-C 111.036 -0.826 . . . . 0.0 111.036 179.133 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' F' F ' 39' ' ' ILE . . . . . . . . . . . . . 76.2 mt -125.14 135.68 63.26 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.224 0 N-CA-C 110.107 -0.331 . . . . 0.0 110.107 179.469 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' F' F ' 40' ' ' SER . . . . . . . . . . . . . 60.0 p -92.86 116.41 29.01 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.307 -0.406 . . . . 0.0 111.046 176.431 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' F' F ' 41' ' ' ILE . . . . . . . . . . . . . 44.5 mm -121.54 121.52 64.76 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.205 0 CA-C-O 120.86 0.362 . . . . 0.0 110.235 178.865 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' F' F ' 42' ' ' LEU . . . . . . . . . . . . . 60.3 mt 52.28 34.69 15.24 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.166 -0.47 . . . . 0.0 111.819 176.961 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' F' F ' 43' ' ' GLY . . . . . . . . . . . . . . . 72.98 32.56 60.61 Favored Glycine 0 CA--C 1.529 0.939 0 C-N-CA 121.047 -0.597 . . . . 0.0 112.064 177.869 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' F' F ' 44' ' ' LYS . . . . . . . . . . . . . 28.0 ttpp -139.92 132.96 29.51 Favored 'General case' 0 C--N 1.329 -0.322 0 N-CA-C 109.635 -0.506 . . . . 0.0 109.635 177.657 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' F' F ' 45' ' ' GLU . . . . . . . . . . . . . 79.5 tt0 -82.25 121.11 26.23 Favored 'General case' 0 C--N 1.328 -0.326 0 C-N-CA 120.928 -0.309 . . . . 0.0 111.134 -177.025 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' F' F ' 46' ' ' VAL . . . . . . . . . . . . . 7.5 p -120.88 127.03 75.89 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.254 0 N-CA-C 109.454 -0.572 . . . . 0.0 109.454 175.384 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' F' F ' 47' ' ' LYS . . . . . . . . . . . . . 69.0 mttm -100.02 129.93 46.13 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 115.96 -0.564 . . . . 0.0 111.159 179.338 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' F' F ' 48' ' ' PHE . . . . . . . . . . . . . 92.0 m-85 -113.18 131.81 55.73 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.233 -0.439 . . . . 0.0 110.002 177.489 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' F' F ' 49' ' ' LYS . . . . . . . . . . . . . 76.5 tttt -109.52 139.33 44.64 Favored 'General case' 0 C--N 1.331 -0.205 0 CA-C-N 116.409 -0.359 . . . . 0.0 110.581 178.839 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' F' F ' 50' ' ' VAL . . . . . . . . . . . . . 43.6 t -82.59 108.85 15.87 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.212 0 N-CA-C 109.528 -0.545 . . . . 0.0 109.528 176.251 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' F' F ' 51' ' ' VAL . . . . . . . . . . . . . 46.9 t -71.64 -53.68 19.74 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.338 0 CA-C-N 115.91 -0.586 . . . . 0.0 109.536 -175.316 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' F' F ' 52' ' ' GLN . . . . . . . . . . . . . 85.2 mt-30 -154.63 152.55 30.12 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-O 121.114 0.483 . . . . 0.0 111.481 -177.31 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' F' F ' 53' ' ' ALA . . . . . . . . . . . . . . . -129.79 133.3 46.89 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 115.496 -0.774 . . . . 0.0 109.858 175.156 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' F' F ' 54' ' ' TYR . . . . . . . . . . . . . 29.7 t80 -129.08 107.91 18.0 Favored Pre-proline 0 C--N 1.328 -0.331 0 CA-C-O 118.27 -0.871 . . . . 0.0 110.211 179.218 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' F' F ' 55' ' ' PRO . . . . . . . . . . . . . 73.9 Cg_endo -77.2 170.07 72.48 Favored 'Cis proline' 0 N--CA 1.501 1.916 0 CA-C-N 121.881 1.707 . . . . 0.0 112.549 -4.245 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' F' F ' 56' ' ' SER . . . . . . . . . . . . . 60.6 m -117.2 130.74 24.42 Favored Pre-proline 0 CA--C 1.538 0.495 0 CA-C-O 118.413 -0.803 . . . . 0.0 109.602 175.494 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' F' F ' 57' ' ' PRO . . . . . . . . . . . . . 31.3 Cg_endo -65.06 167.32 46.71 Favored 'Cis proline' 0 N--CA 1.498 1.749 0 CA-C-N 121.953 1.733 . . . . 0.0 111.542 -2.848 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' F' F ' 58' ' ' LEU . . . . . . . . . . . . . 18.2 tp -130.77 139.06 50.21 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.081 -0.509 . . . . 0.0 110.203 -179.81 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' F' F ' 59' ' ' ARG . . . . . . . . . . . . . 41.4 ttm180 -101.77 134.35 45.08 Favored 'General case' 0 C--N 1.326 -0.445 0 N-CA-C 109.276 -0.638 . . . . 0.0 109.276 174.523 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' F' F ' 60' ' ' VAL . . . . . . . . . . . . . 42.2 t -84.53 119.29 33.21 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.299 0 C-N-CA 120.569 -0.452 . . . . 0.0 110.161 -178.631 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' F' F ' 61' ' ' GLU . . . . . . . . . . . . . 70.5 tt0 -131.14 155.57 46.77 Favored 'General case' 0 C--N 1.327 -0.373 0 N-CA-C 109.094 -0.706 . . . . 0.0 109.094 176.276 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' F' F ' 62' ' ' ASP . . . . . . . . . . . . . 10.4 p-10 -52.49 -29.78 26.68 Favored 'General case' 0 C--N 1.326 -0.438 0 N-CA-C 112.064 0.394 . . . . 0.0 112.064 -177.72 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' F' F ' 63' ' ' ARG . . . . . . . . . . . . . 84.5 mtt-85 -75.5 -21.97 57.57 Favored 'General case' 0 CA--C 1.532 0.26 0 N-CA-C 113.092 0.775 . . . . 0.0 113.092 -175.902 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' F' F ' 64' ' ' THR . . . . . . . . . . . . . 31.5 m -67.07 146.47 54.28 Favored 'General case' 0 C--N 1.331 -0.227 0 CA-C-O 120.903 0.382 . . . . 0.0 111.195 -174.148 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' F' F ' 65' ' ' LYS . . . . . . . . . . . . . 68.3 mttm -88.63 127.65 35.57 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 115.954 -0.566 . . . . 0.0 110.036 177.691 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' F' F ' 66' ' ' ILE . . . . . . . . . . . . . 60.6 mt -115.02 127.43 72.58 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.322 0 N-CA-C 109.637 -0.505 . . . . 0.0 109.637 179.343 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' F' F ' 67' ' ' THR . . . . . . . . . . . . . 26.0 m -124.73 143.54 50.71 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-O 121.166 0.508 . . . . 0.0 111.357 -176.435 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' F' F ' 68' ' ' LEU . . . . . 0.474 HD23 ' C ' ' F' ' 68' ' ' LEU . 6.3 tt . . . . . 0 C--N 1.328 -0.333 0 CA-C-N 115.557 -0.747 . . . . 0.0 109.525 175.473 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' F' F ' 73' ' ' VAL . . . . . . . . . . . . . 33.5 m . . . . . 0 C--O 1.232 0.138 0 CA-C-O 121.044 0.449 . . . . 0.0 110.929 . . . . . . . . . 0 0 . 1 . 016 nuclear build core ' F' F ' 74' ' ' ASP . . . . . . . . . . . . . 12.9 t70 -98.75 118.35 35.29 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 115.697 -0.683 . . . . 0.0 109.463 176.505 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' F' F ' 75' ' ' VAL . . . . . . . . . . . . . 38.5 t -111.5 125.44 68.81 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.298 0 CA-C-O 121.083 0.468 . . . . 0.0 110.619 -176.351 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' F' F ' 76' ' ' LEU . . . . . . . . . . . . . 21.1 mt -129.5 147.98 51.36 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 115.575 -0.739 . . . . 0.0 109.765 178.793 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' F' F ' 77' ' ' GLU . . . . . . . . . . . . . 43.9 mp0 -135.57 136.49 41.16 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-O 120.981 0.419 . . . . 0.0 111.01 -179.301 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' F' F ' 78' ' ' ALA . . . . . 0.722 ' HB2' HD21 ' F' ' 109' ' ' LEU . . . -123.12 135.25 54.28 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 115.701 -0.681 . . . . 0.0 109.935 176.903 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' F' F ' 79' ' ' LYS . . . . . 0.724 ' O ' HD13 ' F' ' 80' ' ' ILE . 99.0 mttt -74.93 120.25 20.22 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-O 120.85 0.357 . . . . 0.0 110.801 -177.565 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' F' F ' 80' ' ' ILE . . . . . 0.724 HD13 ' O ' ' F' ' 79' ' ' LYS . 31.6 mm -139.19 104.6 2.23 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.241 0 N-CA-C 108.956 -0.757 . . . . 0.0 108.956 -178.635 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' F' F ' 81' ' ' LYS . . . . . . . . . . . . . 60.4 tttm -99.11 121.55 41.15 Favored 'General case' 0 C--N 1.327 -0.403 0 CA-C-O 120.881 0.372 . . . . 0.0 111.318 -175.47 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' F' F ' 82' ' ' GLY . . . . . . . . . . . . . . . 89.17 42.17 5.65 Favored Glycine 0 CA--C 1.525 0.681 0 C-N-CA 121.026 -0.607 . . . . 0.0 111.99 174.705 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' F' F ' 83' ' ' ILE . . . . . . . . . . . . . 71.7 mt -66.3 137.38 24.99 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.314 0 N-CA-C 109.65 -0.5 . . . . 0.0 109.65 175.909 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' F' F ' 84' ' ' LYS . . . . . . . . . . . . . 24.1 ttpp -102.38 -50.6 3.56 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-O 120.863 0.363 . . . . 0.0 110.464 -179.758 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' F' F ' 85' ' ' ASP . . . . . . . . . . . . . 8.6 t70 -149.41 151.33 33.86 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 115.976 -0.556 . . . . 0.0 110.648 -179.59 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' F' F ' 86' ' ' VAL . . . . . . . . . . . . . 44.0 t -131.34 132.84 62.76 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.248 0 CA-C-O 120.895 0.379 . . . . 0.0 110.547 -178.645 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' F' F ' 87' ' ' ILE . . . . . 0.497 HD12 ' N ' ' F' ' 87' ' ' ILE . 5.1 mp -121.94 129.93 75.01 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.289 0 N-CA-C 109.364 -0.606 . . . . 0.0 109.364 176.315 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' F' F ' 88' ' ' LEU . . . . . . . . . . . . . 13.9 tp -115.29 134.58 55.0 Favored 'General case' 0 C--N 1.332 -0.182 0 CA-C-O 121.182 0.515 . . . . 0.0 111.693 -175.366 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' F' F ' 89' ' ' ASP . . . . . . . . . . . . . 7.4 t0 -126.53 148.9 49.66 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 115.465 -0.788 . . . . 0.0 109.0 174.067 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' F' F ' 90' ' ' GLU . . . . . . . . . . . . . 93.5 mt-10 -49.38 -34.08 15.28 Favored 'General case' 0 C--N 1.329 -0.286 0 N-CA-C 112.625 0.602 . . . . 0.0 112.625 -173.769 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' F' F ' 91' ' ' ASN . . . . . . . . . . . . . 21.9 m120 -128.05 30.32 5.26 Favored 'General case' 0 N--CA 1.465 0.323 0 N-CA-C 112.187 0.44 . . . . 0.0 112.187 -176.974 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' F' F ' 92' ' ' LEU . . . . . . . . . . . . . 13.4 tp -166.19 147.57 6.68 Favored 'General case' 0 C--N 1.332 -0.179 0 CA-C-O 120.609 0.242 . . . . 0.0 110.52 -179.993 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' F' F ' 93' ' ' ILE . . . . . . . . . . . . . 70.4 mt -128.83 123.39 59.02 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.254 0 N-CA-C 109.541 -0.54 . . . . 0.0 109.541 179.416 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' F' F ' 94' ' ' VAL . . . . . 0.541 HG21 HG11 ' F' ' 125' ' ' VAL . 44.0 t -122.05 129.21 75.57 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.253 0 CA-C-O 120.884 0.373 . . . . 0.0 110.137 -179.424 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' F' F ' 95' ' ' VAL . . . . . . . . . . . . . 43.9 t -124.63 136.1 61.76 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.275 0 CA-C-N 116.04 -0.527 . . . . 0.0 110.054 -179.452 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' F' F ' 96' ' ' ILE . . . . . . . . . . . . . 59.6 mt -116.05 128.48 73.33 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.274 0 N-CA-C 109.255 -0.646 . . . . 0.0 109.255 178.783 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' F' F ' 97' ' ' THR . . . . . . . . . . . . . 82.6 p -102.89 156.63 17.53 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-O 121.156 0.503 . . . . 0.0 111.559 -175.845 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' F' F ' 98' ' ' GLU . . . . . . . . . . . . . 45.0 mt-10 -53.93 -26.04 23.39 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 116.099 -0.5 . . . . 0.0 112.179 179.395 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' F' F ' 99' ' ' GLU . . . . . . . . . . . . . 71.2 mm-40 -79.36 16.32 1.04 Allowed 'General case' 0 CA--C 1.535 0.377 0 N-CA-C 113.158 0.799 . . . . 0.0 113.158 -176.973 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' F' F ' 100' ' ' ASN . . . . . . . . . . . . . 2.1 m-20 62.11 32.78 17.35 Favored 'General case' 0 CA--C 1.531 0.232 0 CA-C-N 117.996 0.362 . . . . 0.0 111.555 178.412 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' F' F ' 101' ' ' GLU . . . . . . . . . . . . . 84.1 tt0 -112.56 144.71 41.59 Favored 'General case' 0 C--O 1.232 0.164 0 N-CA-C 109.735 -0.469 . . . . 0.0 109.735 175.412 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' F' F ' 102' ' ' VAL . . . . . . . . . . . . . 46.5 t -117.21 127.19 74.8 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.367 0 N-CA-C 109.67 -0.493 . . . . 0.0 109.67 -179.087 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' F' F ' 103' ' ' LEU . . . . . . . . . . . . . 27.9 mt -118.99 133.69 55.66 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 115.919 -0.582 . . . . 0.0 110.275 179.561 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' F' F ' 104' ' ' ILE . . . . . . . . . . . . . 70.5 mt -120.2 121.94 67.04 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.205 0 CA-C-N 116.469 -0.332 . . . . 0.0 110.295 -179.791 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' F' F ' 105' ' ' PHE . . . . . . . . . . . . . 81.4 m-85 -120.17 164.03 16.84 Favored 'General case' 0 C--N 1.332 -0.194 0 O-C-N 124.043 0.84 . . . . 0.0 109.681 179.504 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' F' F ' 106' ' ' ASN . . . . . . . . . . . . . 38.8 p-10 -97.41 -171.75 2.27 Favored 'General case' 0 C--N 1.331 -0.216 0 N-CA-C 109.957 -0.386 . . . . 0.0 109.957 174.091 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' F' F ' 107' ' ' GLN . . . . . . . . . . . . . 29.5 tt0 -60.01 -30.07 68.9 Favored 'General case' 0 C--N 1.33 -0.263 0 N-CA-C 111.986 0.365 . . . . 0.0 111.986 179.73 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' F' F ' 108' ' ' ASN . . . . . . . . . . . . . 44.6 t30 -82.71 6.04 19.3 Favored 'General case' 0 CA--C 1.536 0.433 0 N-CA-C 113.246 0.832 . . . . 0.0 113.246 -177.354 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' F' F ' 109' ' ' LEU . . . . . 0.722 HD21 ' HB2' ' F' ' 78' ' ' ALA . 12.6 tp 63.13 40.84 8.61 Favored 'General case' 0 C--O 1.233 0.189 0 CA-C-O 121.229 0.537 . . . . 0.0 111.091 178.107 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' F' F ' 110' ' ' GLU . . . . . . . . . . . . . 43.8 mt-10 -111.67 150.68 29.82 Favored 'General case' 0 C--N 1.33 -0.271 0 N-CA-C 109.814 -0.439 . . . . 0.0 109.814 174.639 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' F' F ' 111' ' ' GLU . . . . . . . . . . . . . 62.8 tt0 -84.75 121.98 28.46 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.389 -0.369 . . . . 0.0 110.956 -176.292 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' F' F ' 112' ' ' LEU . . . . . . . . . . . . . 57.7 mt -109.83 -46.02 3.55 Favored 'General case' 0 C--N 1.333 -0.144 0 CA-C-N 116.277 -0.419 . . . . 0.0 110.796 179.771 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' F' F ' 113' ' ' TYR . . . . . 0.415 ' HE2' HG21 ' A' ' 75' ' ' VAL . 61.0 t80 -132.99 140.56 47.83 Favored 'General case' 0 N--CA 1.464 0.271 0 CA-C-O 120.852 0.358 . . . . 0.0 110.745 -179.551 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' F' F ' 114' ' ' ARG . . . . . . . . . . . . . 36.0 ptt180 -143.99 123.46 13.17 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 115.848 -0.615 . . . . 0.0 110.347 178.384 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' F' F ' 115' ' ' GLY . . . . . . . . . . . . . . . -150.13 160.82 28.69 Favored Glycine 0 CA--C 1.525 0.661 0 N-CA-C 111.196 -0.762 . . . . 0.0 111.196 179.58 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' F' F ' 116' ' ' LYS . . . . . . . . . . . . . 76.8 tttt -130.5 140.6 50.51 Favored 'General case' 0 C--N 1.329 -0.287 0 N-CA-C 109.846 -0.428 . . . . 0.0 109.846 177.597 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' F' F ' 117' ' ' PHE . . . . . . . . . . . . . 30.8 m-85 -139.28 114.02 9.26 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.11 -0.495 . . . . 0.0 109.975 -177.222 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' F' F ' 118' ' ' GLU . . . . . . . . . . . . . 44.9 tp10 -52.05 -45.81 64.86 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.534 -0.303 . . . . 0.0 111.565 -176.927 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' F' F ' 119' ' ' ASN . . . . . . . . . . . . . 86.4 m-20 -98.52 31.14 2.96 Favored 'General case' 0 C--N 1.329 -0.299 0 N-CA-C 112.185 0.439 . . . . 0.0 112.185 -174.608 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' F' F ' 120' ' ' LEU . . . . . . . . . . . . . 17.5 tp -55.33 120.12 6.61 Favored 'General case' 0 N--CA 1.462 0.146 0 O-C-N 122.266 -0.271 . . . . 0.0 110.608 178.067 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' F' F ' 121' ' ' ASN . . . . . . . . . . . . . 89.1 m-20 -112.49 -44.09 3.41 Favored 'General case' 0 C--O 1.232 0.167 0 CA-C-N 116.579 -0.282 . . . . 0.0 111.219 -176.491 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' F' F ' 122' ' ' LYS . . . . . . . . . . . . . 92.4 mttt -146.68 150.24 35.02 Favored 'General case' 0 C--N 1.333 -0.138 0 C-N-CA 120.389 -0.524 . . . . 0.0 111.978 -177.862 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' F' F ' 123' ' ' VAL . . . . . . . . . . . . . 46.1 t -125.62 126.05 69.63 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.224 0 CA-C-N 115.726 -0.67 . . . . 0.0 109.53 175.471 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' F' F ' 124' ' ' LEU . . . . . . . . . . . . . 48.3 mt -115.97 132.99 56.49 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.399 -0.364 . . . . 0.0 110.363 -178.685 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' F' F ' 125' ' ' VAL . . . . . 0.541 HG11 HG21 ' F' ' 94' ' ' VAL . 34.9 m -131.73 137.1 55.83 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.211 0 CA-C-O 120.868 0.366 . . . . 0.0 111.074 -177.902 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' F' F ' 126' ' ' ARG . . . . . . . . . . . . . 96.7 mtt-85 -145.43 111.37 5.55 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.151 -0.477 . . . . 0.0 110.575 176.179 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' F' F ' 127' ' ' ASN . . . . . . . . . . . . . 6.2 m120 53.29 -104.91 0.22 Allowed 'General case' 0 CA--C 1.542 0.651 0 CA-C-O 119.07 -0.49 . . . . 0.0 111.193 178.869 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' F' F ' 128' ' ' ASP . . . . . . . . . . . . . 13.3 p-10 -113.66 3.22 15.53 Favored 'General case' 0 N--CA 1.469 0.495 0 CA-C-N 119.454 1.025 . . . . 0.0 113.378 -176.239 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' F' F ' 129' ' ' LEU . . . . . . . . . . . . . 17.2 tp -106.82 139.66 40.89 Favored 'General case' 0 C--N 1.334 -0.104 0 N-CA-C 109.787 -0.449 . . . . 0.0 109.787 177.853 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' F' F ' 130' ' ' VAL . . . . . . . . . . . . . 41.8 t -129.36 139.79 50.85 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.231 0 CA-C-O 121.064 0.459 . . . . 0.0 110.339 -177.565 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' F' F ' 131' ' ' VAL . . . . . . . . . . . . . 44.6 t -136.1 135.61 50.01 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.319 0 CA-C-N 116.015 -0.539 . . . . 0.0 109.838 176.915 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' F' F ' 132' ' ' ILE . . . . . . . . . . . . . 71.3 mt -117.57 134.05 62.4 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.292 0 CA-C-N 116.141 -0.481 . . . . 0.0 109.709 -178.681 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' F' F ' 133' ' ' ILE . . . . . . . . . . . . . 43.0 mm -115.3 123.24 70.67 Favored 'Isoleucine or valine' 0 C--O 1.233 0.217 0 CA-C-N 116.277 -0.42 . . . . 0.0 111.003 -175.054 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' F' F ' 134' ' ' ASP . . . . . . . . . . . . . 8.1 p-10 -134.87 145.48 48.32 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 115.892 -0.595 . . . . 0.0 109.505 173.952 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' F' F ' 135' ' ' GLU . . . . . . . . . . . . . 40.1 tp10 -49.9 -24.83 2.72 Favored 'General case' 0 CA--C 1.534 0.346 0 N-CA-C 112.737 0.643 . . . . 0.0 112.737 -173.901 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' F' F ' 136' ' ' GLN . . . . . . . . . . . . . 60.1 tt0 -81.91 -36.76 27.74 Favored 'General case' 0 C--O 1.234 0.243 0 N-CA-C 111.859 0.318 . . . . 0.0 111.859 -176.533 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' F' F ' 137' ' ' LYS . . . . . . . . . . . . . 20.0 pttp -168.18 175.36 6.59 Favored 'General case' 0 C--N 1.331 -0.201 0 CA-C-O 121.503 0.668 . . . . 0.0 111.984 -173.0 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' F' F ' 138' ' ' LEU . . . . . 0.418 HD23 ' C ' ' F' ' 138' ' ' LEU . 7.3 tt -118.94 129.79 55.36 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 115.107 -0.951 . . . . 0.0 110.15 179.563 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' F' F ' 139' ' ' THR . . . . . . . . . . . . . 37.7 m -110.39 130.02 55.64 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.104 -0.498 . . . . 0.0 110.508 -179.984 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' F' F ' 140' ' ' LEU . . . . . 0.446 HD23 ' N ' ' F' ' 141' ' ' ILE . 5.2 tt -115.38 123.98 50.04 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 115.855 -0.611 . . . . 0.0 109.755 -178.091 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' F' F ' 141' ' ' ILE . . . . . 0.446 ' N ' HD23 ' F' ' 140' ' ' LEU . 18.8 mt -123.4 124.69 70.32 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.184 0 N-CA-C 110.015 -0.365 . . . . 0.0 110.015 -174.379 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' F' F ' 142' ' ' ARG . . . . . . . . . . . . . 77.1 ttt180 -120.91 134.57 55.3 Favored 'General case' 0 C--O 1.234 0.259 0 CA-C-N 116.106 -0.497 . . . . 0.0 110.297 -178.823 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' F' F ' 143' ' ' THR . . . . . . . . . . . . . 21.5 p . . . . . 0 C--O 1.219 -0.533 0 CA-C-O 117.99 -1.005 . . . . 0.0 110.567 -179.607 . . . . . . . . 0 0 . 1 . 017 nuclear build core ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 7.1 p . . . . . 0 C--O 1.232 0.154 0 CA-C-O 121.084 0.469 . . . . 0.0 110.598 . . . . . . . . . 0 0 . 1 . 017 nuclear build core ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 95.6 mt-10 -141.23 141.41 34.03 Favored 'General case' 0 C--N 1.327 -0.406 0 CA-C-N 115.861 -0.609 . . . . 0.0 110.876 -179.096 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 4' ' ' LEU . . . . . 0.488 HD23 ' N ' ' A' ' 5' ' ' LYS . 3.7 tt -128.19 124.95 38.04 Favored 'General case' 0 C--N 1.33 -0.268 0 N-CA-C 109.679 -0.489 . . . . 0.0 109.679 176.887 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 5' ' ' LYS . . . . . 0.488 ' N ' HD23 ' A' ' 4' ' ' LEU . 63.0 mttp -107.7 122.61 47.08 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-O 120.625 0.25 . . . . 0.0 111.087 -179.189 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 25.2 mt -114.0 144.51 42.97 Favored 'General case' 0 C--O 1.232 0.145 0 CA-C-N 115.542 -0.754 . . . . 0.0 110.525 179.419 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 24.8 ttmt -126.52 139.38 34.56 Favored Pre-proline 0 CA--C 1.531 0.247 0 N-CA-C 109.537 -0.542 . . . . 0.0 109.537 173.224 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 8' ' ' PRO . . . . . . . . . . . . . 98.3 Cg_endo -91.5 141.76 2.76 Favored 'Trans proline' 0 N--CA 1.491 1.335 0 C-N-CA 121.715 1.61 . . . . 0.0 112.156 -179.674 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 56.3 mt -80.07 -47.22 1.39 Allowed Pre-proline 0 CA--C 1.534 0.364 0 CA-C-O 118.64 -0.695 . . . . 0.0 112.222 178.799 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 89.8 Cg_endo -80.98 153.79 19.36 Favored 'Trans proline' 0 N--CA 1.496 1.644 0 C-N-CA 121.168 1.245 . . . . 0.0 111.749 176.142 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 19.4 tptp -88.23 99.09 11.95 Favored 'General case' 0 C--N 1.33 -0.274 0 N-CA-C 110.005 -0.369 . . . . 0.0 110.005 179.303 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 12.7 p -142.34 148.54 20.09 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.258 0 CA-C-N 116.326 -0.397 . . . . 0.0 110.928 -177.766 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 84.2 tt0 -93.69 121.1 34.78 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.05 -0.523 . . . . 0.0 110.04 176.628 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 14' ' ' LEU . . . . . . . . . . . . . 46.6 mt -98.58 152.3 37.84 Favored Pre-proline 0 CA--C 1.533 0.29 0 CA-C-N 116.468 -0.333 . . . . 0.0 110.843 -178.309 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 15' ' ' PRO . . . . . . . . . . . . . 28.6 Cg_exo -61.03 158.65 33.24 Favored 'Trans proline' 0 N--CA 1.498 1.74 0 C-N-CA 121.3 1.333 . . . . 0.0 112.013 177.706 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 16' ' ' PRO . . . . . . . . . . . . . 29.5 Cg_exo -59.99 -36.08 91.04 Favored 'Trans proline' 0 N--CA 1.497 1.677 0 C-N-CA 121.443 1.429 . . . . 0.0 112.689 -179.919 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 17' ' ' ASP . . . . . . . . . . . . . 21.7 p-10 -85.84 8.72 19.02 Favored 'General case' 0 CA--C 1.536 0.406 0 N-CA-C 113.295 0.85 . . . . 0.0 113.295 -177.172 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 18' ' ' PHE . . . . . . . . . . . . . 41.9 t80 -58.09 -44.01 87.36 Favored 'General case' 0 N--CA 1.457 -0.087 0 O-C-N 122.03 -0.419 . . . . 0.0 110.102 -178.713 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 19' ' ' VAL . . . . . . . . . . . . . 48.5 t -56.15 -42.66 73.64 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.291 0 CA-C-N 116.275 -0.42 . . . . 0.0 110.457 -178.81 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 73.0 m-20 -59.89 -43.68 94.67 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-O 120.791 0.329 . . . . 0.0 110.885 -177.907 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 45.8 t -64.35 -45.57 95.61 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.292 0 C-N-CA 120.715 -0.394 . . . . 0.0 110.574 -177.466 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 22' ' ' ILE . . . . . 0.687 HG22 HD12 ' A' ' 26' ' ' LEU . 51.1 mm -55.36 -47.61 77.83 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.254 0 C-N-CA 120.921 -0.312 . . . . 0.0 110.73 179.26 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 23' ' ' ARG . . . . . . . . . . . . . 55.6 ttp180 -55.44 -49.1 73.34 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-O 120.704 0.288 . . . . 0.0 111.207 -178.48 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 24' ' ' ILE . . . . . . . . . . . . . 71.6 mt -58.99 -41.72 84.06 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.258 0 CA-C-N 116.529 -0.305 . . . . 0.0 111.351 -176.419 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 83.6 mttt -71.75 -41.1 68.86 Favored 'General case' 0 C--N 1.328 -0.346 0 N-CA-C 112.714 0.635 . . . . 0.0 112.714 -178.02 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 26' ' ' LEU . . . . . 0.687 HD12 HG22 ' A' ' 22' ' ' ILE . 34.2 mt -78.53 -32.58 48.03 Favored 'General case' 0 C--N 1.328 -0.343 0 N-CA-C 113.697 0.999 . . . . 0.0 113.697 -170.332 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 27' ' ' GLN . . . . . . . . . . . . . 16.5 pt20 -47.11 140.76 4.81 Favored 'General case' 0 N--CA 1.468 0.463 0 N-CA-C 112.771 0.656 . . . . 0.0 112.771 -175.873 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 99.62 -24.11 33.49 Favored Glycine 0 CA--C 1.534 1.222 0 CA-C-N 115.696 -0.684 . . . . 0.0 112.399 -178.047 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 57.2 mtpt -97.62 155.06 17.15 Favored 'General case' 0 C--N 1.333 -0.13 0 CA-C-N 117.531 0.666 . . . . 0.0 111.125 179.312 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 30' ' ' THR . . . . . . . . . . . . . 41.0 m -105.18 137.32 43.14 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 115.89 -0.595 . . . . 0.0 110.036 176.273 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 31' ' ' VAL . . . . . 0.429 HG21 HD11 ' A' ' 4' ' ' LEU . 34.7 m -129.08 152.27 36.96 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.213 0 CA-C-O 120.932 0.396 . . . . 0.0 110.932 -178.402 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 32' ' ' ARG . . . . . . . . . . . . . 68.3 ttp85 -130.28 148.51 52.12 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 115.94 -0.573 . . . . 0.0 110.477 179.924 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 33' ' ' THR . . . . . . . . . . . . . 25.0 m -52.99 139.3 28.17 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.308 -0.405 . . . . 0.0 111.435 -178.024 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 100.16 -17.12 57.49 Favored Glycine 0 CA--C 1.532 1.137 0 CA-C-O 119.698 -0.501 . . . . 0.0 113.342 179.437 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 77.8 m-20 -66.43 149.58 50.2 Favored 'General case' 0 C--N 1.334 -0.102 0 CA-C-N 118.055 0.927 . . . . 0.0 111.228 179.122 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 47.4 t -122.35 130.55 74.44 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.199 0 CA-C-N 115.881 -0.6 . . . . 0.0 109.729 177.922 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 37' ' ' ILE . . . . . . . . . . . . . 65.4 mt -122.56 140.24 46.98 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.282 0 CA-C-N 116.063 -0.517 . . . . 0.0 109.998 -178.196 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . -113.89 128.45 8.28 Favored Glycine 0 CA--C 1.525 0.71 0 N-CA-C 110.983 -0.847 . . . . 0.0 110.983 178.343 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 39' ' ' ILE . . . . . . . . . . . . . 73.9 mt -127.95 136.63 59.77 Favored 'Isoleucine or valine' 0 N--CA 1.462 0.175 0 N-CA-C 110.069 -0.345 . . . . 0.0 110.069 178.928 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 40' ' ' SER . . . . . . . . . . . . . 88.3 p -92.69 118.99 31.64 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.481 -0.327 . . . . 0.0 111.15 177.014 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 41' ' ' ILE . . . . . . . . . . . . . 45.2 mm -121.66 121.99 65.84 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.214 0 CA-C-N 116.438 -0.346 . . . . 0.0 110.232 178.327 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 38.1 mt 53.25 34.25 17.27 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.265 -0.425 . . . . 0.0 111.918 176.602 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . 75.72 27.51 62.81 Favored Glycine 0 CA--C 1.53 1.016 0 C-N-CA 121.077 -0.583 . . . . 0.0 112.594 176.646 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 44' ' ' LYS . . . . . . . . . . . . . 24.7 ttpp -140.33 133.44 29.51 Favored 'General case' 0 C--N 1.33 -0.25 0 N-CA-C 109.427 -0.583 . . . . 0.0 109.427 176.582 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 84.3 tt0 -82.85 126.12 32.09 Favored 'General case' 0 C--N 1.329 -0.318 0 C-N-CA 120.796 -0.361 . . . . 0.0 111.327 -176.325 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 46' ' ' VAL . . . . . . . . . . . . . 9.2 p -120.29 125.67 74.44 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.199 0 N-CA-C 109.166 -0.679 . . . . 0.0 109.166 173.975 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 95.5 mttt -99.2 127.67 45.21 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.085 -0.507 . . . . 0.0 110.807 179.076 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 48' ' ' PHE . . . . . . . . . . . . . 37.7 m-85 -111.39 131.89 54.85 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.075 -0.511 . . . . 0.0 109.998 178.486 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 80.4 tttt -106.61 134.86 49.09 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.45 -0.341 . . . . 0.0 110.164 177.469 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 50' ' ' VAL . . . . . . . . . . . . . 44.4 t -78.16 106.14 8.29 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.285 0 N-CA-C 109.559 -0.534 . . . . 0.0 109.559 177.949 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 51' ' ' VAL . . . . . . . . . . . . . 48.7 t -71.25 -49.96 44.61 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.303 0 CA-C-N 115.946 -0.57 . . . . 0.0 109.83 -175.457 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 52' ' ' GLN . . . . . . . . . . . . . 62.0 tt0 -158.55 139.63 13.09 Favored 'General case' 0 C--N 1.33 -0.28 0 C-N-CA 120.278 -0.569 . . . . 0.0 111.764 -177.82 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -115.5 131.52 56.91 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 115.569 -0.741 . . . . 0.0 109.739 174.976 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 54' ' ' TYR . . . . . . . . . . . . . 43.6 t80 -129.03 110.21 18.29 Favored Pre-proline 0 CA--C 1.535 0.397 0 CA-C-O 118.208 -0.901 . . . . 0.0 110.52 -179.334 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 55' ' ' PRO . . . . . . . . . . . . . 72.9 Cg_endo -77.1 169.95 72.9 Favored 'Cis proline' 0 N--CA 1.498 1.781 0 CA-C-N 121.913 1.719 . . . . 0.0 112.228 -5.067 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 56' ' ' SER . . . . . . . . . . . . . 15.0 m -113.64 127.88 26.34 Favored Pre-proline 0 CA--C 1.539 0.529 0 CA-C-O 118.446 -0.788 . . . . 0.0 109.633 176.616 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 57' ' ' PRO . . . . . . . . . . . . . 60.4 Cg_endo -74.11 149.55 94.17 Favored 'Cis proline' 0 N--CA 1.498 1.739 0 CA-C-N 122.002 1.751 . . . . 0.0 111.685 0.063 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 58' ' ' LEU . . . . . . . . . . . . . 32.0 tp -108.16 137.09 46.74 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.229 -0.441 . . . . 0.0 110.606 -178.253 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 59' ' ' ARG . . . . . . . . . . . . . 52.8 ttp180 -104.4 127.94 52.17 Favored 'General case' 0 C--N 1.328 -0.338 0 N-CA-C 109.24 -0.652 . . . . 0.0 109.24 175.345 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 42.2 t -83.5 121.26 36.01 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.259 0 C-N-CA 120.731 -0.388 . . . . 0.0 110.771 -173.758 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 95.8 mt-10 -131.12 165.02 24.18 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 115.667 -0.697 . . . . 0.0 109.627 175.749 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 62' ' ' ASP . . . . . . . . . . . . . 19.0 p-10 -53.78 -32.49 52.69 Favored 'General case' 0 C--N 1.329 -0.322 0 C-N-CA 121.035 -0.266 . . . . 0.0 111.663 179.428 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 63' ' ' ARG . . . . . . . . . . . . . 67.7 mtp180 -72.52 -22.08 61.09 Favored 'General case' 0 CA--C 1.532 0.282 0 N-CA-C 112.963 0.727 . . . . 0.0 112.963 -176.814 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 25.8 m -69.18 138.97 54.54 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-O 120.981 0.42 . . . . 0.0 110.876 -174.982 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 65' ' ' LYS . . . . . . . . . . . . . 90.8 mttt -88.56 127.78 35.55 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 115.964 -0.562 . . . . 0.0 109.854 178.673 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 66' ' ' ILE . . . . . . . . . . . . . 63.4 mt -112.47 129.01 68.79 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.189 0 N-CA-C 109.62 -0.511 . . . . 0.0 109.62 178.718 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 67' ' ' THR . . . . . . . . . . . . . 19.4 m -121.03 136.29 55.02 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.09 -0.504 . . . . 0.0 110.689 -177.311 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 68' ' ' LEU . . . . . . . . . . . . . 17.7 tp . . . . . 0 C--N 1.33 -0.261 0 CA-C-N 115.938 -0.574 . . . . 0.0 110.342 178.753 . . . . . . . . 0 0 . 1 . 017 nuclear build core ' A' A ' 74' ' ' ASP . . . . . . . . . . . . . 7.2 t70 . . . . . 0 C--O 1.231 0.096 0 N-CA-C 109.71 -0.478 . . . . 0.0 109.71 . . . . . . . . . 0 0 . 1 . 017 nuclear build core ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 42.7 t -119.19 128.84 75.81 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.322 0 CA-C-O 121.188 0.518 . . . . 0.0 110.899 -176.342 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 76' ' ' LEU . . . . . . . . . . . . . 5.0 mp -124.56 145.63 49.48 Favored 'General case' 0 C--N 1.332 -0.161 0 CA-C-N 115.643 -0.708 . . . . 0.0 109.818 174.679 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 77' ' ' GLU . . . . . . . . . . . . . 97.5 mt-10 -136.15 133.04 36.78 Favored 'General case' 0 C--N 1.331 -0.226 0 CA-C-O 120.927 0.394 . . . . 0.0 111.3 -179.935 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 78' ' ' ALA . . . . . . . . . . . . . . . -121.53 139.62 53.26 Favored 'General case' 0 C--N 1.331 -0.197 0 CA-C-N 115.82 -0.627 . . . . 0.0 109.698 176.105 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 79' ' ' LYS . . . . . 0.622 ' O ' HD13 ' A' ' 80' ' ' ILE . 32.8 ttpt -76.96 119.85 21.27 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-O 120.889 0.376 . . . . 0.0 110.247 -179.919 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 80' ' ' ILE . . . . . 0.622 HD13 ' O ' ' A' ' 79' ' ' LYS . 22.9 mm -139.24 111.86 5.86 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.327 0 N-CA-C 109.007 -0.738 . . . . 0.0 109.007 -178.544 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 81' ' ' LYS . . . . . . . . . . . . . 79.0 tttt -115.77 129.09 56.31 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-O 120.902 0.382 . . . . 0.0 110.657 -177.138 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . 89.11 41.98 5.72 Favored Glycine 0 CA--C 1.525 0.704 0 N-CA-C 111.342 -0.703 . . . . 0.0 111.342 178.085 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 83' ' ' ILE . . . . . . . . . . . . . 75.9 mt -67.33 140.21 19.7 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.309 0 CA-C-O 120.902 0.382 . . . . 0.0 109.993 178.593 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 84' ' ' LYS . . . . . . . . . . . . . 71.6 tttt -99.71 -52.03 3.57 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.043 -0.526 . . . . 0.0 110.074 -179.901 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 85' ' ' ASP . . . . . . . . . . . . . 5.0 t70 -159.86 156.73 27.86 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 115.758 -0.656 . . . . 0.0 110.365 179.809 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 86' ' ' VAL . . . . . . . . . . . . . 40.7 t -131.13 132.87 63.22 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.228 0 CA-C-O 120.983 0.42 . . . . 0.0 110.744 -178.94 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 87' ' ' ILE . . . . . . . . . . . . . 43.9 mm -120.07 126.82 75.68 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.268 0 CA-C-N 115.771 -0.649 . . . . 0.0 109.361 177.08 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 88' ' ' LEU . . . . . . . . . . . . . 19.1 tp -114.84 134.33 55.22 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-O 120.944 0.402 . . . . 0.0 111.423 -176.8 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 89' ' ' ASP . . . . . . . . . . . . . 13.5 t70 -129.38 157.17 42.67 Favored 'General case' 0 C--N 1.331 -0.226 0 CA-C-N 115.787 -0.642 . . . . 0.0 109.606 176.719 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 60.2 mp0 -48.51 -35.96 14.24 Favored 'General case' 0 C--N 1.332 -0.192 0 N-CA-C 113.06 0.763 . . . . 0.0 113.06 -171.154 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 91' ' ' ASN . . . . . . . . . . . . . 27.6 t30 -130.65 18.35 5.21 Favored 'General case' 0 N--CA 1.47 0.534 0 N-CA-C 113.15 0.796 . . . . 0.0 113.15 -177.238 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 92' ' ' LEU . . . . . . . . . . . . . 22.6 mt -146.99 142.52 27.59 Favored 'General case' 0 C--N 1.331 -0.216 0 N-CA-C 110.221 -0.288 . . . . 0.0 110.221 -177.595 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 93' ' ' ILE . . . . . . . . . . . . . 71.9 mt -123.21 117.86 52.89 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.354 0 N-CA-C 109.312 -0.625 . . . . 0.0 109.312 177.695 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 94' ' ' VAL . . . . . . . . . . . . . 41.9 t -120.24 128.75 76.0 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.25 0 CA-C-O 120.959 0.409 . . . . 0.0 110.102 -178.987 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 95' ' ' VAL . . . . . . . . . . . . . 42.5 t -123.24 135.56 62.79 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.367 0 CA-C-N 115.933 -0.576 . . . . 0.0 109.77 179.616 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 96' ' ' ILE . . . . . . . . . . . . . 66.9 mt -114.17 130.94 67.53 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.36 0 N-CA-C 109.425 -0.583 . . . . 0.0 109.425 179.259 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 97' ' ' THR . . . . . . . . . . . . . 60.4 p -104.65 158.09 16.73 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-O 121.04 0.447 . . . . 0.0 111.267 -177.825 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 98' ' ' GLU . . . . . . . . . . . . . 97.3 mt-10 -53.98 -26.03 23.89 Favored 'General case' 0 C--N 1.328 -0.355 0 N-CA-C 112.371 0.508 . . . . 0.0 112.371 -179.763 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 99' ' ' GLU . . . . . . . . . . . . . 95.6 mt-10 -78.56 14.62 1.22 Allowed 'General case' 0 CA--C 1.536 0.417 0 N-CA-C 113.171 0.804 . . . . 0.0 113.171 -177.343 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 100' ' ' ASN . . . . . . . . . . . . . 3.6 m-20 62.17 37.94 14.02 Favored 'General case' 0 N--CA 1.462 0.172 0 CA-C-O 121.125 0.488 . . . . 0.0 110.894 178.818 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 101' ' ' GLU . . . . . . . . . . . . . 84.6 tt0 -115.36 144.24 44.07 Favored 'General case' 0 C--O 1.233 0.2 0 CA-C-N 116.047 -0.524 . . . . 0.0 109.807 176.584 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 102' ' ' VAL . . . . . . . . . . . . . 45.1 t -115.03 124.69 71.93 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.338 0 CA-C-N 116.067 -0.515 . . . . 0.0 109.94 -178.339 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 103' ' ' LEU . . . . . . . . . . . . . 23.2 mt -115.13 126.82 55.09 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 115.753 -0.658 . . . . 0.0 110.168 176.449 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 104' ' ' ILE . . . . . . . . . . . . . 72.6 mt -118.21 120.42 64.37 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.232 0 N-CA-C 109.983 -0.377 . . . . 0.0 109.983 179.438 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 105' ' ' PHE . . . . . . . . . . . . . 53.5 m-85 -120.32 162.33 19.63 Favored 'General case' 0 C--N 1.332 -0.178 0 CA-C-N 115.5 -0.773 . . . . 0.0 110.052 179.955 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 106' ' ' ASN . . . . . . . . . . . . . 43.1 p-10 -93.8 -169.83 2.19 Favored 'General case' 0 C--N 1.329 -0.311 0 N-CA-C 109.785 -0.45 . . . . 0.0 109.785 173.375 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 107' ' ' GLN . . . . . . . . . . . . . 48.6 tt0 -57.64 -30.03 65.06 Favored 'General case' 0 CA--C 1.532 0.268 0 N-CA-C 112.061 0.393 . . . . 0.0 112.061 179.37 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 108' ' ' ASN . . . . . . . . . . . . . 49.4 t30 -84.72 9.48 13.87 Favored 'General case' 0 CA--C 1.536 0.412 0 N-CA-C 113.251 0.834 . . . . 0.0 113.251 -177.131 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 109' ' ' LEU . . . . . . . . . . . . . 10.9 tp 58.28 37.03 26.03 Favored 'General case' 0 C--N 1.331 -0.23 0 CA-C-O 120.983 0.421 . . . . 0.0 111.28 179.167 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 110' ' ' GLU . . . . . . . . . . . . . 95.7 mt-10 -106.64 159.48 16.16 Favored 'General case' 0 C--N 1.332 -0.174 0 CA-C-O 120.811 0.338 . . . . 0.0 110.166 176.846 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 111' ' ' GLU . . . . . . . . . . . . . 80.4 tt0 -81.58 121.92 26.93 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.282 -0.417 . . . . 0.0 111.213 -175.646 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 112' ' ' LEU . . . . . . . . . . . . . 15.3 mt -110.29 -46.08 3.48 Favored 'General case' 0 C--N 1.331 -0.227 0 CA-C-N 116.064 -0.516 . . . . 0.0 109.829 175.238 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 113' ' ' TYR . . . . . 0.423 ' CE2' HG21 ' B' ' 75' ' ' VAL . 58.7 t80 -139.24 136.6 35.13 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.145 -0.48 . . . . 0.0 110.931 178.849 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 114' ' ' ARG . . . . . . . . . . . . . 63.3 ttt180 -140.3 122.06 15.4 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 116.095 -0.502 . . . . 0.0 110.187 178.117 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 115' ' ' GLY . . . . . . . . . . . . . . . -150.08 161.66 28.96 Favored Glycine 0 CA--C 1.525 0.703 0 C-N-CA 120.732 -0.747 . . . . 0.0 111.391 179.676 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 116' ' ' LYS . . . . . . . . . . . . . 39.8 ttpt -128.88 136.17 50.07 Favored 'General case' 0 C--N 1.33 -0.27 0 N-CA-C 109.869 -0.419 . . . . 0.0 109.869 177.179 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 117' ' ' PHE . . . . . . . . . . . . . 39.3 m-85 -134.55 113.88 12.23 Favored 'General case' 0 C--N 1.329 -0.285 0 N-CA-C 109.878 -0.416 . . . . 0.0 109.878 -178.012 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 118' ' ' GLU . . . . . . . . . . . . . 12.9 pt-20 -57.06 -39.29 74.64 Favored 'General case' 0 C--N 1.329 -0.313 0 C-N-CA 120.726 -0.39 . . . . 0.0 111.084 -176.415 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 119' ' ' ASN . . . . . . . . . . . . . 32.7 m120 -94.81 26.0 3.79 Favored 'General case' 0 C--N 1.331 -0.207 0 N-CA-C 112.644 0.609 . . . . 0.0 112.644 -174.558 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 120' ' ' LEU . . . . . . . . . . . . . 17.5 tp -58.55 125.01 21.58 Favored 'General case' 0 C--N 1.333 -0.139 0 CA-C-O 120.816 0.341 . . . . 0.0 110.227 178.973 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 121' ' ' ASN . . . . . . . . . . . . . 2.7 m-80 -113.96 -44.16 3.19 Favored 'General case' 0 C--N 1.332 -0.186 0 CA-C-N 116.262 -0.426 . . . . 0.0 110.581 -179.141 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 122' ' ' LYS . . . . . . . . . . . . . 56.6 pttt -159.71 157.93 30.41 Favored 'General case' 0 C--N 1.332 -0.186 0 C-N-CA 120.525 -0.47 . . . . 0.0 111.671 -179.624 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 123' ' ' VAL . . . . . . . . . . . . . 43.7 t -129.99 136.78 58.11 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.229 0 CA-C-N 116.022 -0.535 . . . . 0.0 110.09 179.956 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 124' ' ' LEU . . . . . . . . . . . . . 78.4 mt -119.82 133.96 55.41 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.152 -0.476 . . . . 0.0 110.81 -178.93 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 125' ' ' VAL . . . . . . . . . . . . . 48.3 t -126.91 127.25 69.67 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.218 0 N-CA-C 109.482 -0.562 . . . . 0.0 109.482 176.671 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 126' ' ' ARG . . . . . . . . . . . . . 41.7 ttt180 -144.01 124.4 13.89 Favored 'General case' 0 C--N 1.33 -0.242 0 C-N-CA 120.763 -0.375 . . . . 0.0 110.834 -179.192 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 127' ' ' ASN . . . . . . . . . . . . . 3.5 m120 51.2 -106.63 0.26 Allowed 'General case' 0 CA--C 1.544 0.726 0 CA-C-O 118.934 -0.555 . . . . 0.0 111.311 179.916 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 128' ' ' ASP . . . . . . . . . . . . . 10.9 p-10 -114.09 0.4 14.28 Favored 'General case' 0 N--CA 1.467 0.407 0 CA-C-N 119.754 1.161 . . . . 0.0 113.463 -177.883 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 129' ' ' LEU . . . . . . . . . . . . . 30.6 mt -104.91 141.73 36.02 Favored 'General case' 0 C--O 1.232 0.161 0 CA-C-N 118.249 0.477 . . . . 0.0 110.668 -178.429 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 130' ' ' VAL . . . . . . . . . . . . . 46.2 t -123.42 133.59 68.73 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.274 0 CA-C-N 115.973 -0.558 . . . . 0.0 109.574 178.422 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 131' ' ' VAL . . . . . 0.445 HG22 HD12 ' A' ' 140' ' ' LEU . 44.4 t -133.86 135.8 54.69 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.27 0 CA-C-O 121.119 0.485 . . . . 0.0 110.162 179.451 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 132' ' ' ILE . . . . . . . . . . . . . 73.8 mt -113.41 130.94 66.5 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.289 0 CA-C-N 115.668 -0.696 . . . . 0.0 109.249 179.423 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 133' ' ' ILE . . . . . . . . . . . . . 42.1 mm -114.2 120.33 63.66 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.277 0 CA-C-O 120.888 0.375 . . . . 0.0 110.727 -176.356 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 134' ' ' ASP . . . . . . . . . . . . . 7.1 p-10 -132.36 145.96 51.62 Favored 'General case' 0 C--N 1.33 -0.255 0 N-CA-C 109.104 -0.702 . . . . 0.0 109.104 174.003 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 135' ' ' GLU . . . . . . . . . . . . . 41.8 tp10 -49.69 -24.66 2.39 Favored 'General case' 0 C--N 1.328 -0.34 0 N-CA-C 112.881 0.697 . . . . 0.0 112.881 -170.961 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 136' ' ' GLN . . . . . . . . . . . . . 54.1 tp60 -96.53 -34.08 11.59 Favored 'General case' 0 CA--C 1.53 0.18 0 N-CA-C 112.223 0.453 . . . . 0.0 112.223 -175.871 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 137' ' ' LYS . . . . . . . . . . . . . 65.3 mttt -141.22 156.57 45.89 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-O 121.31 0.576 . . . . 0.0 111.905 -169.551 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 138' ' ' LEU . . . . . 0.497 HD23 ' N ' ' A' ' 139' ' ' THR . 5.1 tt -119.41 122.9 42.81 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 115.392 -0.822 . . . . 0.0 109.042 172.028 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 139' ' ' THR . . . . . 0.497 ' N ' HD23 ' A' ' 138' ' ' LEU . 24.8 m -107.06 128.11 54.08 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.552 -0.295 . . . . 0.0 110.548 -178.107 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 140' ' ' LEU . . . . . 0.445 HD12 HG22 ' A' ' 131' ' ' VAL . 44.4 tp -113.32 119.73 38.69 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 115.74 -0.664 . . . . 0.0 109.417 -179.08 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 141' ' ' ILE . . . . . . . . . . . . . 19.3 mt -119.89 118.11 55.96 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.264 0 CA-C-O 121.006 0.431 . . . . 0.0 109.88 -176.713 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 142' ' ' ARG . . . . . . . . . . . . . 78.1 mtm180 -104.47 129.7 52.45 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 115.285 -0.871 . . . . 0.0 110.549 -178.693 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 143' ' ' THR . . . . . . . . . . . . . 77.1 p . . . . . 0 C--O 1.22 -0.466 0 CA-C-O 117.944 -1.027 . . . . 0.0 110.482 179.501 . . . . . . . . 0 0 . 1 . 017 nuclear build core ' B' B ' 2' ' ' SER . . . . . . . . . . . . . 12.5 p . . . . . 0 C--O 1.231 0.083 0 CA-C-O 121.009 0.433 . . . . 0.0 110.37 . . . . . . . . . 0 0 . 1 . 017 nuclear build core ' B' B ' 3' ' ' GLU . . . . . . . . . . . . . 43.6 mt-10 -140.52 145.02 36.28 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-N 115.751 -0.658 . . . . 0.0 110.999 -176.989 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' B' B ' 4' ' ' LEU . . . . . . . . . . . . . 23.1 tp -124.28 128.25 48.87 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.063 -0.517 . . . . 0.0 110.131 174.747 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' B' B ' 5' ' ' LYS . . . . . . . . . . . . . 63.8 mmtt -105.45 113.8 27.58 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 115.988 -0.551 . . . . 0.0 111.121 -179.202 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' B' B ' 6' ' ' LEU . . . . . . . . . . . . . 28.7 mt -113.71 137.48 51.55 Favored 'General case' 0 C--N 1.333 -0.147 0 O-C-N 124.034 0.834 . . . . 0.0 109.659 178.214 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' B' B ' 7' ' ' LYS . . . . . . . . . . . . . 57.7 tttp -123.2 137.95 29.14 Favored Pre-proline 0 CA--C 1.533 0.32 0 CA-C-O 118.853 -0.594 . . . . 0.0 109.862 177.333 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' B' B ' 8' ' ' PRO . . . . . . . . . . . . . 85.0 Cg_endo -90.41 137.2 2.44 Favored 'Trans proline' 0 N--CA 1.491 1.377 0 C-N-CA 121.625 1.55 . . . . 0.0 111.872 179.062 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' B' B ' 9' ' ' LEU . . . . . . . . . . . . . 39.5 mt -80.43 -48.57 1.23 Allowed Pre-proline 0 CA--C 1.535 0.374 0 CA-C-O 118.555 -0.736 . . . . 0.0 112.441 -179.69 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' B' B ' 10' ' ' PRO . . . . . . . . . . . . . 90.0 Cg_endo -78.88 156.21 27.0 Favored 'Trans proline' 0 N--CA 1.497 1.694 0 C-N-CA 121.183 1.256 . . . . 0.0 112.051 178.727 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' B' B ' 11' ' ' LYS . . . . . . . . . . . . . 60.6 mttp -82.71 93.13 7.32 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.353 -0.385 . . . . 0.0 110.333 178.476 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' B' B ' 12' ' ' VAL . . . . . . . . . . . . . 12.7 p -140.16 146.91 24.05 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.303 0 CA-C-N 116.296 -0.411 . . . . 0.0 110.718 -179.262 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' B' B ' 13' ' ' GLU . . . . . . . . . . . . . 84.7 tt0 -97.66 129.04 44.77 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.345 -0.389 . . . . 0.0 110.057 177.823 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' B' B ' 14' ' ' LEU . . . . . . . . . . . . . 27.3 mt -98.37 149.91 36.2 Favored Pre-proline 0 CA--C 1.532 0.282 0 CA-C-O 119.298 -0.382 . . . . 0.0 110.65 -177.12 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' B' B ' 15' ' ' PRO . . . . . . . . . . . . . 24.2 Cg_exo -63.68 160.57 35.87 Favored 'Trans proline' 0 N--CA 1.498 1.737 0 C-N-CA 121.366 1.377 . . . . 0.0 111.733 175.36 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' B' B ' 16' ' ' PRO . . . . . . . . . . . . . 30.4 Cg_exo -59.84 -35.81 92.86 Favored 'Trans proline' 0 N--CA 1.498 1.737 0 C-N-CA 121.47 1.447 . . . . 0.0 112.688 -178.589 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' B' B ' 17' ' ' ASP . . . . . . . . . . . . . 38.1 p30 -90.2 9.6 27.87 Favored 'General case' 0 CA--C 1.535 0.391 0 N-CA-C 113.367 0.877 . . . . 0.0 113.367 -177.553 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' B' B ' 18' ' ' PHE . . . . . . . . . . . . . 37.4 t80 -58.43 -46.38 86.61 Favored 'General case' 0 N--CA 1.458 -0.059 0 O-C-N 121.965 -0.459 . . . . 0.0 110.017 -177.598 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' B' B ' 19' ' ' VAL . . . . . . . . . . . . . 48.5 t -56.86 -41.72 76.63 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.399 0 CA-C-N 116.228 -0.442 . . . . 0.0 110.392 -178.176 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' B' B ' 20' ' ' ASP . . . . . . . . . . . . . 78.3 m-20 -60.14 -44.0 95.29 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-O 120.784 0.326 . . . . 0.0 111.0 -177.399 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' B' B ' 21' ' ' VAL . . . . . . . . . . . . . 48.0 t -64.5 -46.13 93.65 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.294 0 C-N-CA 120.765 -0.374 . . . . 0.0 110.468 -177.648 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' B' B ' 22' ' ' ILE . . . . . 0.536 HG22 HD12 ' B' ' 26' ' ' LEU . 50.1 mm -56.31 -44.73 80.48 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.25 0 C-N-CA 120.857 -0.337 . . . . 0.0 110.582 179.083 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' B' B ' 23' ' ' ARG . . . . . . . . . . . . . 59.6 ttp180 -54.49 -48.81 71.4 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-O 120.763 0.316 . . . . 0.0 111.17 -179.549 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' B' B ' 24' ' ' ILE . . . . . . . . . . . . . 74.2 mt -59.52 -41.1 83.69 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.247 0 CA-C-N 116.336 -0.393 . . . . 0.0 111.424 -176.66 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' B' B ' 25' ' ' LYS . . . . . . . . . . . . . 97.7 mttt -70.07 -43.33 71.38 Favored 'General case' 0 C--N 1.33 -0.273 0 N-CA-C 112.719 0.637 . . . . 0.0 112.719 -178.625 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' B' B ' 26' ' ' LEU . . . . . 0.536 HD12 HG22 ' B' ' 22' ' ' ILE . 92.2 mt -78.11 -34.23 50.12 Favored 'General case' 0 C--N 1.33 -0.26 0 N-CA-C 113.444 0.905 . . . . 0.0 113.444 -170.336 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' B' B ' 27' ' ' GLN . . . . . . . . . . . . . 20.2 pt20 -46.98 139.38 5.66 Favored 'General case' 0 N--CA 1.468 0.47 0 N-CA-C 112.755 0.65 . . . . 0.0 112.755 -175.95 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' B' B ' 28' ' ' GLY . . . . . . . . . . . . . . . 100.8 -23.95 33.79 Favored Glycine 0 CA--C 1.535 1.283 0 CA-C-N 115.671 -0.695 . . . . 0.0 112.384 -176.232 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' B' B ' 29' ' ' LYS . . . . . . . . . . . . . 45.4 mtmt -97.99 155.16 17.23 Favored 'General case' 0 C--O 1.231 0.1 0 CA-C-N 117.396 0.598 . . . . 0.0 111.037 178.804 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' B' B ' 30' ' ' THR . . . . . . . . . . . . . 32.0 m -105.05 137.7 42.39 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 116.043 -0.526 . . . . 0.0 110.236 177.978 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' B' B ' 31' ' ' VAL . . . . . . . . . . . . . 35.2 m -131.35 158.26 43.29 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.22 0 CA-C-O 120.865 0.364 . . . . 0.0 110.898 -179.153 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' B' B ' 32' ' ' ARG . . . . . . . . . . . . . 98.1 mtt180 -135.63 153.15 51.74 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-O 121.284 0.564 . . . . 0.0 110.77 178.245 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' B' B ' 33' ' ' THR . . . . . . . . . . . . . 19.8 m -53.6 140.67 28.05 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.153 -0.476 . . . . 0.0 111.441 -178.478 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' B' B ' 34' ' ' GLY . . . . . . . . . . . . . . . 99.29 -17.11 58.34 Favored Glycine 0 CA--C 1.532 1.109 0 CA-C-N 116.09 -0.505 . . . . 0.0 113.309 178.996 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' B' B ' 35' ' ' ASP . . . . . . . . . . . . . 78.2 m-20 -67.02 149.14 51.03 Favored 'General case' 0 N--CA 1.462 0.13 0 CA-C-N 118.036 0.918 . . . . 0.0 111.194 178.946 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' B' B ' 36' ' ' VAL . . . . . . . . . . . . . 45.7 t -119.48 129.84 74.8 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.197 0 CA-C-N 115.895 -0.593 . . . . 0.0 109.668 176.768 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' B' B ' 37' ' ' ILE . . . . . . . . . . . . . 65.1 mt -119.08 137.71 52.17 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.275 0 CA-C-N 116.125 -0.489 . . . . 0.0 109.968 -178.93 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' B' B ' 38' ' ' GLY . . . . . . . . . . . . . . . -113.34 127.77 8.04 Favored Glycine 0 CA--C 1.526 0.725 0 N-CA-C 110.873 -0.891 . . . . 0.0 110.873 179.43 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' B' B ' 39' ' ' ILE . . . . . . . . . . . . . 72.2 mt -125.6 131.55 71.94 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.27 0 N-CA-C 110.127 -0.323 . . . . 0.0 110.127 179.254 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' B' B ' 40' ' ' SER . . . . . . . . . . . . . 26.7 p -92.15 114.68 27.28 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.418 -0.356 . . . . 0.0 110.997 176.875 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' B' B ' 41' ' ' ILE . . . . . 0.443 HG22 HD13 ' B' ' 42' ' ' LEU . 44.1 mm -121.44 123.43 69.62 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.236 0 CA-C-N 116.483 -0.326 . . . . 0.0 110.33 179.714 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' B' B ' 42' ' ' LEU . . . . . 0.443 HD13 HG22 ' B' ' 41' ' ' ILE . 6.7 mp 52.94 34.53 17.02 Favored 'General case' 0 CA--C 1.533 0.29 0 CA-C-N 116.292 -0.413 . . . . 0.0 111.505 177.92 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' B' B ' 43' ' ' GLY . . . . . . . . . . . . . . . 72.67 30.48 63.96 Favored Glycine 0 CA--C 1.53 0.999 0 C-N-CA 121.199 -0.524 . . . . 0.0 112.211 177.888 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' B' B ' 44' ' ' LYS . . . . . . . . . . . . . 61.5 tttm -138.21 128.94 26.69 Favored 'General case' 0 C--N 1.329 -0.288 0 N-CA-C 109.585 -0.524 . . . . 0.0 109.585 178.132 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' B' B ' 45' ' ' GLU . . . . . . . . . . . . . 84.7 tt0 -83.28 122.0 27.85 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-O 120.817 0.342 . . . . 0.0 111.019 -177.153 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' B' B ' 46' ' ' VAL . . . . . . . . . . . . . 10.6 p -119.98 125.03 73.85 Favored 'Isoleucine or valine' 0 C--O 1.232 0.147 0 N-CA-C 109.444 -0.576 . . . . 0.0 109.444 174.651 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' B' B ' 47' ' ' LYS . . . . . . . . . . . . . 99.3 mttt -99.91 128.31 46.01 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.145 -0.479 . . . . 0.0 111.025 179.094 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' B' B ' 48' ' ' PHE . . . . . . . . . . . . . 26.7 m-85 -110.74 131.84 54.7 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 115.946 -0.57 . . . . 0.0 109.588 175.489 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' B' B ' 49' ' ' LYS . . . . . . . . . . . . . 60.8 tttm -105.62 135.42 47.05 Favored 'General case' 0 C--N 1.327 -0.37 0 N-CA-C 109.867 -0.42 . . . . 0.0 109.867 177.047 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' B' B ' 50' ' ' VAL . . . . . . . . . . . . . 47.3 t -79.99 104.99 8.93 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.326 0 N-CA-C 109.563 -0.532 . . . . 0.0 109.563 178.509 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' B' B ' 51' ' ' VAL . . . . . . . . . . . . . 46.4 t -69.88 -51.86 36.49 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.335 0 CA-C-N 115.945 -0.57 . . . . 0.0 109.8 -176.721 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' B' B ' 52' ' ' GLN . . . . . . . . . . . . . 92.4 mt-30 -151.88 151.36 31.18 Favored 'General case' 0 C--N 1.334 -0.105 0 C-N-CA 120.244 -0.582 . . . . 0.0 111.957 -179.456 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' B' B ' 53' ' ' ALA . . . . . . . . . . . . . . . -126.8 131.11 51.34 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 115.092 -0.958 . . . . 0.0 109.555 174.402 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' B' B ' 54' ' ' TYR . . . . . . . . . . . . . 30.2 t80 -129.12 109.67 18.1 Favored Pre-proline 0 C--N 1.328 -0.351 0 CA-C-O 118.201 -0.904 . . . . 0.0 110.31 178.902 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' B' B ' 55' ' ' PRO . . . . . . . . . . . . . 73.7 Cg_endo -77.28 168.3 77.18 Favored 'Cis proline' 0 N--CA 1.5 1.911 0 CA-C-N 121.985 1.745 . . . . 0.0 112.634 -3.558 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' B' B ' 56' ' ' SER . . . . . . . . . . . . . 13.5 m -114.63 125.84 28.64 Favored Pre-proline 0 CA--C 1.538 0.516 0 CA-C-O 118.368 -0.825 . . . . 0.0 109.241 174.907 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' B' B ' 57' ' ' PRO . . . . . . . . . . . . . 44.8 Cg_endo -68.67 168.38 63.03 Favored 'Cis proline' 0 N--CA 1.496 1.66 0 CA-C-N 122.041 1.764 . . . . 0.0 111.573 1.325 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' B' B ' 58' ' ' LEU . . . . . . . . . . . . . 26.9 tp -129.23 135.64 49.07 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.137 179.28 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' B' B ' 59' ' ' ARG . . . . . . . . . . . . . 69.8 ttt180 -104.16 124.27 48.8 Favored 'General case' 0 C--N 1.327 -0.388 0 N-CA-C 109.277 -0.638 . . . . 0.0 109.277 177.413 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' B' B ' 60' ' ' VAL . . . . . . . . . . . . . 46.5 t -73.2 115.45 14.1 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.234 0 C-N-CA 120.61 -0.436 . . . . 0.0 110.078 -175.488 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' B' B ' 61' ' ' GLU . . . . . . . . . . . . . 75.0 tt0 -131.02 155.08 47.46 Favored 'General case' 0 C--N 1.329 -0.314 0 N-CA-C 109.152 -0.685 . . . . 0.0 109.152 177.897 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' B' B ' 62' ' ' ASP . . . . . . . . . . . . . 13.6 t70 -52.0 -32.79 35.37 Favored 'General case' 0 C--N 1.327 -0.405 0 N-CA-C 111.946 0.351 . . . . 0.0 111.946 -177.732 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' B' B ' 63' ' ' ARG . . . . . . . . . . . . . 98.6 mtt180 -74.16 -22.14 59.56 Favored 'General case' 0 C--N 1.33 -0.272 0 N-CA-C 113.04 0.756 . . . . 0.0 113.04 -177.185 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' B' B ' 64' ' ' THR . . . . . . . . . . . . . 31.0 m -64.84 136.85 57.34 Favored 'General case' 0 C--N 1.331 -0.226 0 CA-C-O 120.725 0.298 . . . . 0.0 110.57 -176.843 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' B' B ' 65' ' ' LYS . . . . . . . . . . . . . 40.3 ttpt -88.66 124.6 34.24 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-O 121.079 0.466 . . . . 0.0 110.176 -179.976 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' B' B ' 66' ' ' ILE . . . . . . . . . . . . . 69.9 mt -108.09 126.59 64.66 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.298 0 N-CA-C 109.815 -0.439 . . . . 0.0 109.815 -177.906 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' B' B ' 67' ' ' THR . . . . . . . . . . . . . 42.1 m -120.69 139.93 52.34 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.039 -0.528 . . . . 0.0 110.769 -176.422 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' B' B ' 68' ' ' LEU . . . . . . . . . . . . . 19.8 tp . . . . . 0 C--N 1.329 -0.303 0 CA-C-N 115.796 -0.638 . . . . 0.0 110.463 179.749 . . . . . . . . 0 0 . 1 . 017 nuclear build core ' B' B ' 73' ' ' VAL . . . . . . . . . . . . . 17.2 m . . . . . 0 C--O 1.231 0.081 0 CA-C-O 121.171 0.51 . . . . 0.0 110.78 . . . . . . . . . 0 0 . 1 . 017 nuclear build core ' B' B ' 74' ' ' ASP . . . . . . . . . . . . . 18.1 t0 -103.43 121.42 42.76 Favored 'General case' 0 C--N 1.328 -0.36 0 N-CA-C 108.955 -0.757 . . . . 0.0 108.955 175.441 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' B' B ' 75' ' ' VAL . . . . . 0.423 HG21 ' CE2' ' A' ' 113' ' ' TYR . 41.8 t -114.86 124.99 72.05 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.225 0 CA-C-O 121.135 0.493 . . . . 0.0 110.954 -175.017 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' B' B ' 76' ' ' LEU . . . . . . . . . . . . . 5.6 mp -125.13 147.37 49.05 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 115.394 -0.821 . . . . 0.0 109.492 175.069 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' B' B ' 77' ' ' GLU . . . . . . . . . . . . . 97.6 mt-10 -133.35 131.23 39.85 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-O 121.053 0.454 . . . . 0.0 111.165 -178.444 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' B' B ' 78' ' ' ALA . . . . . . . . . . . . . . . -117.67 139.08 51.5 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 115.67 -0.696 . . . . 0.0 109.662 176.822 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' B' B ' 79' ' ' LYS . . . . . 0.515 ' O ' HD13 ' B' ' 80' ' ' ILE . 9.4 mtpm? -87.34 117.88 26.41 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-O 120.948 0.404 . . . . 0.0 110.707 -178.501 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' B' B ' 80' ' ' ILE . . . . . 0.515 HD13 ' O ' ' B' ' 79' ' ' LYS . 25.2 mm -139.08 114.29 8.45 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.268 0 N-CA-C 108.979 -0.749 . . . . 0.0 108.979 -177.958 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' B' B ' 81' ' ' LYS . . . . . . . . . . . . . 53.8 tttp -103.92 127.3 51.45 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-O 120.812 0.339 . . . . 0.0 111.402 -175.718 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' B' B ' 82' ' ' GLY . . . . . . . . . . . . . . . 89.19 41.98 5.7 Favored Glycine 0 CA--C 1.527 0.843 0 C-N-CA 120.839 -0.696 . . . . 0.0 112.258 173.271 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' B' B ' 83' ' ' ILE . . . . . . . . . . . . . 69.7 mt -73.57 138.91 20.31 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.347 0 N-CA-C 109.571 -0.529 . . . . 0.0 109.571 176.961 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' B' B ' 84' ' ' LYS . . . . . . . . . . . . . 38.5 ttpt -103.52 -49.08 3.78 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-N 116.294 -0.412 . . . . 0.0 110.606 -177.828 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' B' B ' 85' ' ' ASP . . . . . . . . . . . . . 12.2 t70 -144.49 148.51 34.62 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.091 -0.504 . . . . 0.0 110.603 -178.532 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' B' B ' 86' ' ' VAL . . . . . . . . . . . . . 46.4 t -130.38 133.12 64.33 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.247 0 CA-C-O 120.87 0.367 . . . . 0.0 110.428 -179.189 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' B' B ' 87' ' ' ILE . . . . . 0.489 ' N ' HD12 ' B' ' 87' ' ' ILE . 5.0 mp -122.64 124.38 70.52 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.195 0 CA-C-N 115.935 -0.575 . . . . 0.0 109.522 176.617 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' B' B ' 88' ' ' LEU . . . . . . . . . . . . . 16.0 tp -109.74 129.61 55.6 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-O 120.866 0.365 . . . . 0.0 110.709 -178.629 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' B' B ' 89' ' ' ASP . . . . . . . . . . . . . 13.4 t70 -128.23 155.68 44.16 Favored 'General case' 0 C--N 1.331 -0.215 0 CA-C-N 116.12 -0.491 . . . . 0.0 110.031 178.122 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' B' B ' 90' ' ' GLU . . . . . . . . . . . . . 96.2 mt-10 -47.5 -36.84 10.84 Favored 'General case' 0 C--N 1.328 -0.357 0 N-CA-C 113.055 0.761 . . . . 0.0 113.055 -171.457 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' B' B ' 91' ' ' ASN . . . . . . . . . . . . . 66.0 m-80 -129.01 16.54 6.22 Favored 'General case' 0 N--CA 1.469 0.502 0 N-CA-C 113.285 0.846 . . . . 0.0 113.285 -176.435 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' B' B ' 92' ' ' LEU . . . . . . . . . . . . . 11.4 mt -148.73 144.89 27.37 Favored 'General case' 0 C--N 1.331 -0.198 0 CA-C-O 120.818 0.342 . . . . 0.0 110.248 -176.265 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' B' B ' 93' ' ' ILE . . . . . . . . . . . . . 72.3 mt -121.59 116.43 49.48 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.224 0 N-CA-C 108.838 -0.801 . . . . 0.0 108.838 174.946 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' B' B ' 94' ' ' VAL . . . . . . . . . . . . . 43.9 t -115.7 125.8 73.0 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.294 0 N-CA-C 109.68 -0.489 . . . . 0.0 109.68 -178.084 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' B' B ' 95' ' ' VAL . . . . . . . . . . . . . 41.9 t -120.8 132.74 69.55 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.315 0 CA-C-N 116.065 -0.516 . . . . 0.0 109.681 -179.636 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' B' B ' 96' ' ' ILE . . . . . . . . . . . . . 70.7 mt -114.31 125.27 71.57 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.353 0 N-CA-C 109.228 -0.656 . . . . 0.0 109.228 178.577 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' B' B ' 97' ' ' THR . . . . . . . . . . . . . 54.6 p -96.2 155.29 16.82 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-O 121.164 0.506 . . . . 0.0 111.115 -177.583 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' B' B ' 98' ' ' GLU . . . . . . . . . . . . . 12.6 pt-20 -55.4 -20.67 12.82 Favored 'General case' 0 C--N 1.328 -0.338 0 N-CA-C 112.707 0.632 . . . . 0.0 112.707 -179.396 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' B' B ' 99' ' ' GLU . . . . . . . . . . . . . 12.8 pt-20 -84.56 17.61 2.62 Favored 'General case' 0 CA--C 1.535 0.377 0 N-CA-C 113.117 0.784 . . . . 0.0 113.117 -178.7 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' B' B ' 100' ' ' ASN . . . . . . . . . . . . . 3.1 m-20 62.86 37.95 11.8 Favored 'General case' 0 N--CA 1.462 0.171 0 CA-C-O 121.084 0.468 . . . . 0.0 111.129 177.29 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' B' B ' 101' ' ' GLU . . . . . . . . . . . . . 84.6 tt0 -117.72 141.01 48.88 Favored 'General case' 0 C--N 1.332 -0.158 0 N-CA-C 109.77 -0.456 . . . . 0.0 109.77 175.358 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' B' B ' 102' ' ' VAL . . . . . . . . . . . . . 45.2 t -114.96 127.67 72.42 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.329 0 N-CA-C 109.991 -0.374 . . . . 0.0 109.991 -178.134 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' B' B ' 103' ' ' LEU . . . . . . . . . . . . . 29.4 mt -119.27 133.99 55.45 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 115.762 -0.653 . . . . 0.0 110.19 177.599 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' B' B ' 104' ' ' ILE . . . . . 0.409 ' CD1' HG11 ' B' ' 130' ' ' VAL . 69.8 mt -118.73 121.48 67.05 Favored 'Isoleucine or valine' 0 C--O 1.233 0.215 0 CA-C-N 116.52 -0.309 . . . . 0.0 110.272 -179.449 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' B' B ' 105' ' ' PHE . . . . . . . . . . . . . 90.1 m-85 -118.57 163.31 16.98 Favored 'General case' 0 C--O 1.232 0.143 0 O-C-N 124.116 0.885 . . . . 0.0 109.692 178.442 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' B' B ' 106' ' ' ASN . . . . . . . . . . . . . 44.6 p-10 -101.21 -170.64 1.87 Allowed 'General case' 0 C--N 1.33 -0.276 0 N-CA-C 110.185 -0.302 . . . . 0.0 110.185 174.1 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' B' B ' 107' ' ' GLN . . . . . . . . . . . . . 16.5 tt0 -57.49 -26.89 61.98 Favored 'General case' 0 C--N 1.328 -0.331 0 N-CA-C 112.325 0.491 . . . . 0.0 112.325 179.526 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' B' B ' 108' ' ' ASN . . . . . . . . . . . . . 21.4 t-20 -92.41 13.53 19.26 Favored 'General case' 0 CA--C 1.535 0.396 0 N-CA-C 113.144 0.794 . . . . 0.0 113.144 -176.43 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' B' B ' 109' ' ' LEU . . . . . 0.4 HD11 ' HB3' ' A' ' 140' ' ' LEU . 38.9 mt 57.26 32.92 22.54 Favored 'General case' 0 C--O 1.233 0.22 0 N-CA-C 112.013 0.375 . . . . 0.0 112.013 178.332 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' B' B ' 110' ' ' GLU . . . . . . . . . . . . . 70.7 mm-40 -103.21 140.19 37.69 Favored 'General case' 0 C--N 1.329 -0.303 0 N-CA-C 109.497 -0.557 . . . . 0.0 109.497 175.203 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' B' B ' 111' ' ' GLU . . . . . . . . . . . . . 52.7 tt0 -76.95 121.72 23.87 Favored 'General case' 0 C--N 1.326 -0.418 0 CA-C-N 116.426 -0.352 . . . . 0.0 110.512 -175.698 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' B' B ' 112' ' ' LEU . . . . . . . . . . . . . 85.6 mt -103.09 -45.77 4.83 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.13 -0.487 . . . . 0.0 110.522 178.841 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' B' B ' 113' ' ' TYR . . . . . . . . . . . . . 65.0 t80 -137.87 144.06 41.21 Favored 'General case' 0 C--N 1.331 -0.2 0 CA-C-N 116.188 -0.46 . . . . 0.0 111.29 -178.105 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' B' B ' 114' ' ' ARG . . . . . . . . . . . . . 37.3 ptt180 -145.59 125.47 13.52 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 115.994 -0.548 . . . . 0.0 110.513 177.429 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' B' B ' 115' ' ' GLY . . . . . . . . . . . . . . . -150.22 149.22 21.07 Favored Glycine 0 CA--C 1.525 0.668 0 N-CA-C 111.12 -0.792 . . . . 0.0 111.12 179.467 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' B' B ' 116' ' ' LYS . . . . . . . . . . . . . 7.4 ttpm? -114.49 137.6 51.65 Favored 'General case' 0 C--N 1.33 -0.265 0 N-CA-C 109.661 -0.496 . . . . 0.0 109.661 176.288 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' B' B ' 117' ' ' PHE . . . . . . . . . . . . . 39.0 m-85 -137.02 113.79 10.37 Favored 'General case' 0 C--N 1.329 -0.305 0 N-CA-C 109.962 -0.384 . . . . 0.0 109.962 -179.036 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' B' B ' 118' ' ' GLU . . . . . . . . . . . . . 96.3 mt-10 -57.91 -42.42 84.69 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.332 -0.395 . . . . 0.0 110.742 -176.371 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' B' B ' 119' ' ' ASN . . . . . . . . . . . . . 69.1 m-80 -97.22 31.1 2.55 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.207 -0.451 . . . . 0.0 112.094 -174.707 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' B' B ' 120' ' ' LEU . . . . . . . . . . . . . 24.2 tp -57.1 121.23 9.54 Favored 'General case' 0 C--N 1.333 -0.136 0 C-N-CA 120.944 -0.302 . . . . 0.0 110.429 177.969 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' B' B ' 121' ' ' ASN . . . . . . . . . . . . . 27.2 m-80 -103.43 -43.56 5.38 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.356 -0.384 . . . . 0.0 110.287 -179.556 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' B' B ' 122' ' ' LYS . . . . . . . . . . . . . 53.6 pttt -165.95 152.98 9.87 Favored 'General case' 0 C--N 1.331 -0.222 0 CA-C-O 121.186 0.517 . . . . 0.0 111.892 179.047 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' B' B ' 123' ' ' VAL . . . . . . . . . . . . . 45.1 t -119.71 132.46 69.39 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.261 0 CA-C-N 115.852 -0.613 . . . . 0.0 109.538 177.911 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' B' B ' 124' ' ' LEU . . . . . . . . . . . . . 6.5 mp -119.36 136.42 54.28 Favored 'General case' 0 C--N 1.332 -0.193 0 CA-C-N 116.156 -0.474 . . . . 0.0 110.673 -177.757 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' B' B ' 125' ' ' VAL . . . . . . . . . . . . . 46.0 t -119.2 131.89 70.62 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.273 0 CA-C-N 116.002 -0.545 . . . . 0.0 109.833 178.36 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' B' B ' 126' ' ' ARG . . . . . . . . . . . . . 40.7 mmt180 -133.27 99.14 4.44 Favored 'General case' 0 C--N 1.331 -0.21 0 CA-C-N 116.25 -0.432 . . . . 0.0 110.278 179.12 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' B' B ' 127' ' ' ASN . . . . . . . . . . . . . 34.3 t-20 53.42 -104.89 0.22 Allowed 'General case' 0 CA--C 1.542 0.65 0 CA-C-O 119.02 -0.514 . . . . 0.0 111.157 178.793 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' B' B ' 128' ' ' ASP . . . . . . . . . . . . . 19.5 p-10 -105.86 -3.09 22.3 Favored 'General case' 0 CA--C 1.537 0.468 0 CA-C-N 119.562 1.074 . . . . 0.0 113.684 -175.971 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' B' B ' 129' ' ' LEU . . . . . . . . . . . . . 60.2 mt -105.09 142.84 34.16 Favored 'General case' 0 C--N 1.332 -0.157 0 O-C-N 122.102 -0.374 . . . . 0.0 110.116 178.571 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' B' B ' 130' ' ' VAL . . . . . 0.409 HG11 ' CD1' ' B' ' 104' ' ' ILE . 42.9 t -121.27 135.88 60.02 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.213 0 N-CA-C 110.016 -0.365 . . . . 0.0 110.016 -178.582 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' B' B ' 131' ' ' VAL . . . . . . . . . . . . . 39.6 t -133.13 133.34 58.47 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.278 0 CA-C-O 120.932 0.396 . . . . 0.0 110.275 179.479 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' B' B ' 132' ' ' ILE . . . . . . . . . . . . . 73.1 mt -114.06 130.17 68.73 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.363 0 N-CA-C 109.263 -0.643 . . . . 0.0 109.263 178.604 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' B' B ' 133' ' ' ILE . . . . . . . . . . . . . 42.3 mm -111.98 119.61 60.46 Favored 'Isoleucine or valine' 0 C--O 1.234 0.247 0 CA-C-O 120.877 0.37 . . . . 0.0 110.878 -176.095 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' B' B ' 134' ' ' ASP . . . . . . . . . . . . . 7.4 p-10 -132.88 143.56 49.59 Favored 'General case' 0 C--N 1.33 -0.246 0 N-CA-C 109.312 -0.625 . . . . 0.0 109.312 175.449 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' B' B ' 135' ' ' GLU . . . . . . . . . . . . . 77.7 tt0 -49.99 -25.77 3.64 Favored 'General case' 0 C--N 1.327 -0.389 0 N-CA-C 112.697 0.629 . . . . 0.0 112.697 -174.599 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' B' B ' 136' ' ' GLN . . . . . . . . . . . . . 47.7 tt0 -85.54 -31.42 22.71 Favored 'General case' 0 C--O 1.233 0.192 0 N-CA-C 112.386 0.513 . . . . 0.0 112.386 -175.388 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' B' B ' 137' ' ' LYS . . . . . . . . . . . . . 18.2 ptpt -164.7 174.06 11.17 Favored 'General case' 0 C--O 1.233 0.205 0 CA-C-O 121.64 0.733 . . . . 0.0 112.193 -175.359 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' B' B ' 138' ' ' LEU . . . . . 0.409 HD23 ' N ' ' B' ' 139' ' ' THR . 6.5 tt -119.5 128.87 54.37 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 114.938 -1.028 . . . . 0.0 109.504 176.418 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' B' B ' 139' ' ' THR . . . . . 0.409 ' N ' HD23 ' B' ' 138' ' ' LEU . 25.4 m -108.1 126.0 52.24 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.315 -0.402 . . . . 0.0 110.467 -179.933 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' B' B ' 140' ' ' LEU . . . . . . . . . . . . . 17.2 tp -112.95 119.9 39.55 Favored 'General case' 0 C--N 1.331 -0.209 0 CA-C-N 115.791 -0.64 . . . . 0.0 109.304 -178.926 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' B' B ' 141' ' ' ILE . . . . . . . . . . . . . 19.2 mt -119.16 123.19 70.93 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.289 0 CA-C-O 120.884 0.373 . . . . 0.0 110.118 -173.845 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' B' B ' 142' ' ' ARG . . . . . . . . . . . . . 72.7 mtt180 -108.79 127.58 54.14 Favored 'General case' 0 C--N 1.331 -0.239 0 CA-C-N 115.439 -0.801 . . . . 0.0 110.027 -176.301 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' B' B ' 143' ' ' THR . . . . . . . . . . . . . 52.9 p . . . . . 0 C--O 1.221 -0.442 0 CA-C-O 117.992 -1.004 . . . . 0.0 110.576 179.804 . . . . . . . . 0 0 . 1 . 017 nuclear build core ' C' C ' 2' ' ' SER . . . . . . . . . . . . . 55.2 p . . . . . 0 N--CA 1.461 0.112 0 CA-C-O 120.888 0.375 . . . . 0.0 110.554 . . . . . . . . . 0 0 . 1 . 017 nuclear build core ' C' C ' 3' ' ' GLU . . . . . . . . . . . . . 42.7 mt-10 -140.37 141.07 35.64 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.039 -0.528 . . . . 0.0 111.013 -178.458 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' C' C ' 4' ' ' LEU . . . . . . . . . . . . . 19.0 tp -124.27 128.28 48.92 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 115.808 -0.633 . . . . 0.0 109.976 176.19 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' C' C ' 5' ' ' LYS . . . . . . . . . . . . . 99.1 mttt -110.36 123.43 49.83 Favored 'General case' 0 C--O 1.234 0.254 0 CA-C-O 120.672 0.272 . . . . 0.0 110.929 179.877 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' C' C ' 6' ' ' LEU . . . . . . . . . . . . . 52.4 mt -114.61 145.62 41.77 Favored 'General case' 0 C--N 1.332 -0.185 0 CA-C-N 115.559 -0.746 . . . . 0.0 110.146 178.586 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' C' C ' 7' ' ' LYS . . . . . . . . . . . . . 35.7 ttpt -127.36 141.41 40.78 Favored Pre-proline 0 CA--C 1.533 0.319 0 CA-C-O 119.071 -0.49 . . . . 0.0 109.711 175.286 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' C' C ' 8' ' ' PRO . . . . . . . . . . . . . 91.7 Cg_endo -91.69 138.56 2.1 Favored 'Trans proline' 0 N--CA 1.489 1.211 0 C-N-CA 121.718 1.612 . . . . 0.0 112.129 179.255 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' C' C ' 9' ' ' LEU . . . . . . . . . . . . . 67.8 mt -78.19 -47.16 2.12 Favored Pre-proline 0 C--N 1.329 -0.312 0 CA-C-O 118.714 -0.66 . . . . 0.0 111.826 178.189 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' C' C ' 10' ' ' PRO . . . . . . . . . . . . . 85.5 Cg_endo -81.14 151.61 18.19 Favored 'Trans proline' 0 N--CA 1.495 1.613 0 C-N-CA 121.14 1.226 . . . . 0.0 111.536 174.58 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' C' C ' 11' ' ' LYS . . . . . . . . . . . . . 66.7 tttt -88.33 98.85 11.82 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-O 120.836 0.351 . . . . 0.0 110.194 178.712 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' C' C ' 12' ' ' VAL . . . . . . . . . . . . . 13.2 p -140.03 147.14 23.93 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.285 0 CA-C-N 116.29 -0.414 . . . . 0.0 110.727 -178.463 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' C' C ' 13' ' ' GLU . . . . . . . . . . . . . 84.1 tt0 -88.96 123.82 33.66 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.21 -0.45 . . . . 0.0 109.908 176.978 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' C' C ' 14' ' ' LEU . . . . . . . . . . . . . 22.2 mt -98.14 152.29 37.94 Favored Pre-proline 0 C--N 1.329 -0.299 0 CA-C-N 116.402 -0.363 . . . . 0.0 110.84 -177.189 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' C' C ' 15' ' ' PRO . . . . . . . . . . . . . 25.6 Cg_exo -62.31 157.02 47.6 Favored 'Trans proline' 0 N--CA 1.498 1.761 0 C-N-CA 121.261 1.308 . . . . 0.0 111.713 176.116 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' C' C ' 16' ' ' PRO . . . . . . . . . . . . . 39.5 Cg_exo -58.72 -36.47 97.08 Favored 'Trans proline' 0 N--CA 1.498 1.776 0 C-N-CA 121.389 1.393 . . . . 0.0 112.65 -179.533 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' C' C ' 17' ' ' ASP . . . . . . . . . . . . . 16.6 p-10 -85.66 7.94 21.46 Favored 'General case' 0 CA--C 1.535 0.393 0 N-CA-C 113.23 0.826 . . . . 0.0 113.23 -177.641 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' C' C ' 18' ' ' PHE . . . . . . . . . . . . . 43.9 t80 -58.09 -46.8 84.89 Favored 'General case' 0 N--CA 1.456 -0.126 0 O-C-N 121.983 -0.448 . . . . 0.0 110.285 -176.876 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' C' C ' 19' ' ' VAL . . . . . 0.4 HG13 ' N ' ' C' ' 20' ' ' ASP . 14.7 p -55.48 -41.76 64.72 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.288 0 CA-C-N 116.523 -0.308 . . . . 0.0 111.029 -178.019 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' C' C ' 20' ' ' ASP . . . . . 0.4 ' N ' HG13 ' C' ' 19' ' ' VAL . 78.3 m-20 -61.4 -44.44 97.14 Favored 'General case' 0 C--N 1.329 -0.286 0 C-N-CA 120.935 -0.306 . . . . 0.0 111.231 -178.198 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' C' C ' 21' ' ' VAL . . . . . . . . . . . . . 47.6 t -64.11 -45.22 97.12 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.287 0 C-N-CA 120.715 -0.394 . . . . 0.0 110.447 -176.953 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' C' C ' 22' ' ' ILE . . . . . 0.41 HG22 HD12 ' C' ' 26' ' ' LEU . 51.0 mm -56.5 -46.25 82.27 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.227 0 C-N-CA 120.872 -0.331 . . . . 0.0 110.55 178.614 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' C' C ' 23' ' ' ARG . . . . . . . . . . . . . 56.1 ttp180 -54.89 -46.75 74.84 Favored 'General case' 0 C--N 1.329 -0.302 0 C-N-CA 121.057 -0.257 . . . . 0.0 111.384 -179.269 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' C' C ' 24' ' ' ILE . . . . . . . . . . . . . 79.7 mt -59.58 -43.87 91.97 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.303 0 C-N-CA 121.075 -0.25 . . . . 0.0 111.246 -177.987 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' C' C ' 25' ' ' LYS . . . . . . . . . . . . . 97.4 mttt -66.01 -42.1 90.12 Favored 'General case' 0 C--N 1.328 -0.361 0 N-CA-C 112.504 0.557 . . . . 0.0 112.504 -178.878 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' C' C ' 26' ' ' LEU . . . . . 0.41 HD12 HG22 ' C' ' 22' ' ' ILE . 93.0 mt -77.91 -38.79 44.88 Favored 'General case' 0 C--N 1.33 -0.254 0 N-CA-C 113.216 0.821 . . . . 0.0 113.216 -170.833 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' C' C ' 27' ' ' GLN . . . . . . . . . . . . . 14.0 pt20 -47.19 139.94 5.66 Favored 'General case' 0 N--CA 1.469 0.521 0 N-CA-C 112.709 0.633 . . . . 0.0 112.709 -176.137 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' C' C ' 28' ' ' GLY . . . . . . . . . . . . . . . 100.61 -26.15 25.69 Favored Glycine 0 CA--C 1.534 1.269 0 CA-C-N 115.598 -0.728 . . . . 0.0 112.14 -176.3 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' C' C ' 29' ' ' LYS . . . . . . . . . . . . . 37.9 mtmm -98.79 155.02 17.57 Favored 'General case' 0 C--N 1.332 -0.181 0 CA-C-N 117.295 0.547 . . . . 0.0 111.292 179.115 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' C' C ' 30' ' ' THR . . . . . . . . . . . . . 50.1 m -107.84 136.45 47.55 Favored 'General case' 0 C--N 1.332 -0.19 0 CA-C-N 116.147 -0.479 . . . . 0.0 109.991 176.349 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' C' C ' 31' ' ' VAL . . . . . . . . . . . . . 34.9 m -132.2 162.16 40.16 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.247 0 CA-C-N 116.302 -0.408 . . . . 0.0 111.036 -178.347 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' C' C ' 32' ' ' ARG . . . . . . . . . . . . . 81.6 mtt180 -132.29 152.43 51.38 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 115.989 -0.551 . . . . 0.0 110.591 178.654 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' C' C ' 33' ' ' THR . . . . . . . . . . . . . 28.8 m -53.61 140.18 29.63 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.299 -0.41 . . . . 0.0 111.237 -179.313 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' C' C ' 34' ' ' GLY . . . . . . . . . . . . . . . 100.49 -17.16 57.12 Favored Glycine 0 CA--C 1.532 1.139 0 CA-C-O 119.589 -0.562 . . . . 0.0 113.17 179.755 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' C' C ' 35' ' ' ASP . . . . . . . . . . . . . 72.1 m-20 -65.98 149.69 49.83 Favored 'General case' 0 N--CA 1.461 0.123 0 CA-C-N 118.127 0.963 . . . . 0.0 111.151 178.79 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' C' C ' 36' ' ' VAL . . . . . . . . . . . . . 43.5 t -122.6 130.82 74.23 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.213 0 CA-C-N 115.968 -0.56 . . . . 0.0 109.934 178.9 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' C' C ' 37' ' ' ILE . . . . . . . . . . . . . 69.3 mt -122.53 140.55 45.99 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.205 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.093 -178.928 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' C' C ' 38' ' ' GLY . . . . . . . . . . . . . . . -115.7 128.73 8.17 Favored Glycine 0 CA--C 1.525 0.708 0 N-CA-C 111.177 -0.769 . . . . 0.0 111.177 179.42 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' C' C ' 39' ' ' ILE . . . . . . . . . . . . . 72.9 mt -125.9 135.69 63.12 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.306 0 N-CA-C 110.136 -0.32 . . . . 0.0 110.136 179.245 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' C' C ' 40' ' ' SER . . . . . . . . . . . . . 9.7 t -93.32 114.08 26.43 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.343 -0.389 . . . . 0.0 111.132 177.268 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' C' C ' 41' ' ' ILE . . . . . . . . . . . . . 45.8 mm -122.58 119.55 58.46 Favored 'Isoleucine or valine' 0 CA--C 1.529 0.153 0 N-CA-C 110.07 -0.344 . . . . 0.0 110.07 178.758 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' C' C ' 42' ' ' LEU . . . . . . . . . . . . . 41.3 mt 57.39 34.06 24.15 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.394 -0.366 . . . . 0.0 111.916 177.479 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' C' C ' 43' ' ' GLY . . . . . . . . . . . . . . . 79.32 -10.13 37.37 Favored Glycine 0 CA--C 1.535 1.325 0 C-N-CA 121.271 -0.49 . . . . 0.0 113.485 177.312 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' C' C ' 44' ' ' LYS . . . . . . . . . . . . . 64.0 mmtt -100.46 134.72 42.99 Favored 'General case' 0 C--N 1.332 -0.156 0 CA-C-N 117.887 0.844 . . . . 0.0 110.079 175.878 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' C' C ' 45' ' ' GLU . . . . . . . . . . . . . 84.0 tt0 -85.18 131.57 34.41 Favored 'General case' 0 C--N 1.326 -0.425 0 CA-C-N 116.455 -0.339 . . . . 0.0 111.159 -179.279 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' C' C ' 46' ' ' VAL . . . . . . . . . . . . . 9.5 p -120.97 125.77 74.41 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.189 0 N-CA-C 109.585 -0.524 . . . . 0.0 109.585 174.428 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' C' C ' 47' ' ' LYS . . . . . . . . . . . . . 82.8 mttt -98.8 125.96 44.31 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 115.993 -0.549 . . . . 0.0 110.524 177.83 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' C' C ' 48' ' ' PHE . . . . . . . . . . . . . 31.0 m-85 -110.53 131.91 54.64 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.359 -0.382 . . . . 0.0 110.175 178.293 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' C' C ' 49' ' ' LYS . . . . . . . . . . . . . 58.5 tttt -105.92 132.42 52.05 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.251 -0.431 . . . . 0.0 109.97 177.677 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' C' C ' 50' ' ' VAL . . . . . . . . . . . . . 46.0 t -75.74 104.98 4.29 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.247 0 N-CA-C 109.14 -0.689 . . . . 0.0 109.14 176.552 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' C' C ' 51' ' ' VAL . . . . . . . . . . . . . 47.3 t -69.17 -48.51 68.43 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.324 0 CA-C-N 116.085 -0.507 . . . . 0.0 109.925 -173.418 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' C' C ' 52' ' ' GLN . . . . . . . . . . . . . 46.9 tt0 -168.33 146.83 4.34 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 115.95 -0.568 . . . . 0.0 111.381 -178.706 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' C' C ' 53' ' ' ALA . . . . . . . . . . . . . . . -122.61 136.54 54.91 Favored 'General case' 0 C--N 1.331 -0.209 0 CA-C-N 115.842 -0.617 . . . . 0.0 110.109 177.032 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' C' C ' 54' ' ' TYR . . . . . . . . . . . . . 58.3 t80 -129.12 112.11 18.37 Favored Pre-proline 0 CA--C 1.534 0.329 0 CA-C-O 118.081 -0.961 . . . . 0.0 110.202 177.55 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' C' C ' 55' ' ' PRO . . . . . . . . . . . . . 72.8 Cg_endo -77.31 170.14 72.16 Favored 'Cis proline' 0 N--CA 1.499 1.829 0 CA-C-N 122.015 1.755 . . . . 0.0 112.337 -6.283 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' C' C ' 56' ' ' SER . . . . . . . . . . . . . 25.5 m -122.25 135.65 25.67 Favored Pre-proline 0 CA--C 1.538 0.491 0 CA-C-O 118.513 -0.756 . . . . 0.0 109.537 175.049 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' C' C ' 57' ' ' PRO . . . . . . . . . . . . . 34.9 Cg_endo -66.29 160.85 75.13 Favored 'Cis proline' 0 N--CA 1.499 1.799 0 CA-C-N 121.864 1.701 . . . . 0.0 111.525 -2.839 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' C' C ' 58' ' ' LEU . . . . . . . . . . . . . 30.3 tp -127.57 136.4 51.64 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-O 121.118 0.485 . . . . 0.0 110.713 -178.101 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' C' C ' 59' ' ' ARG . . . . . . . . . . . . . 20.7 ttm180 -103.01 122.52 44.78 Favored 'General case' 0 C--N 1.327 -0.411 0 N-CA-C 108.919 -0.771 . . . . 0.0 108.919 173.936 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' C' C ' 60' ' ' VAL . . . . . . . . . . . . . 39.9 t -77.72 120.81 29.09 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.323 0 C-N-CA 120.561 -0.456 . . . . 0.0 110.349 -173.647 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' C' C ' 61' ' ' GLU . . . . . . . . . . . . . 96.3 mt-10 -131.13 165.5 23.15 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 115.679 -0.691 . . . . 0.0 109.567 176.807 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' C' C ' 62' ' ' ASP . . . . . . . . . . . . . 7.8 p-10 -53.09 -31.25 40.9 Favored 'General case' 0 C--N 1.329 -0.325 0 N-CA-C 111.912 0.338 . . . . 0.0 111.912 179.816 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' C' C ' 63' ' ' ARG . . . . . . . . . . . . . 87.6 mtt180 -71.77 -22.1 61.64 Favored 'General case' 0 CA--C 1.533 0.293 0 N-CA-C 112.962 0.727 . . . . 0.0 112.962 -176.307 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' C' C ' 64' ' ' THR . . . . . . . . . . . . . 32.9 m -74.48 136.6 42.26 Favored 'General case' 0 C--N 1.332 -0.192 0 CA-C-O 120.918 0.389 . . . . 0.0 110.832 -175.956 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' C' C ' 65' ' ' LYS . . . . . . . . . . . . . 96.0 mttt -89.36 133.88 34.31 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.023 -0.535 . . . . 0.0 109.977 179.013 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' C' C ' 66' ' ' ILE . . . . . . . . . . . . . 65.3 mt -115.48 130.56 69.87 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.266 0 N-CA-C 109.976 -0.379 . . . . 0.0 109.976 179.739 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' C' C ' 67' ' ' THR . . . . . . . . . . . . . 23.8 m -122.54 138.42 54.58 Favored 'General case' 0 C--N 1.331 -0.214 0 CA-C-N 115.929 -0.578 . . . . 0.0 110.516 -179.071 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' C' C ' 68' ' ' LEU . . . . . 0.437 HD23 ' C ' ' C' ' 68' ' ' LEU . 5.8 tt . . . . . 0 C--N 1.33 -0.267 0 CA-C-N 115.959 -0.564 . . . . 0.0 110.173 178.795 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' C' C ' 73' ' ' VAL . . . . . . . . . . . . . 34.0 m . . . . . 0 C--O 1.231 0.094 0 CA-C-O 120.894 0.378 . . . . 0.0 110.871 . . . . . . . . . 0 0 . 1 . 017 nuclear build core ' C' C ' 74' ' ' ASP . . . . . . . . . . . . . 8.0 t70 -103.84 126.03 50.68 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.105 -0.498 . . . . 0.0 109.737 179.993 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' C' C ' 75' ' ' VAL . . . . . . . . . . . . . 40.5 t -121.13 127.95 75.95 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.345 0 CA-C-O 121.169 0.509 . . . . 0.0 110.957 -176.633 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' C' C ' 76' ' ' LEU . . . . . . . . . . . . . 5.2 mp -121.47 144.67 48.56 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 115.488 -0.778 . . . . 0.0 109.523 174.244 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' C' C ' 77' ' ' GLU . . . . . . . . . . . . . 47.1 mt-10 -133.92 137.84 45.15 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-O 121.033 0.444 . . . . 0.0 111.127 -177.629 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' C' C ' 78' ' ' ALA . . . . . 0.643 ' HB2' HD21 ' C' ' 109' ' ' LEU . . . -125.79 128.61 47.96 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 115.78 -0.646 . . . . 0.0 109.707 176.477 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' C' C ' 79' ' ' LYS . . . . . 0.622 ' O ' HD13 ' C' ' 80' ' ' ILE . 54.1 mtmt -77.45 122.72 25.59 Favored 'General case' 0 C--N 1.331 -0.214 0 CA-C-O 121.044 0.449 . . . . 0.0 110.667 -178.327 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' C' C ' 80' ' ' ILE . . . . . 0.622 HD13 ' O ' ' C' ' 79' ' ' LYS . 39.4 mm -139.05 114.16 8.36 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.356 0 N-CA-C 109.178 -0.675 . . . . 0.0 109.178 -177.779 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' C' C ' 81' ' ' LYS . . . . . . . . . . . . . 31.8 ttpt -101.4 121.99 42.92 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-O 120.821 0.343 . . . . 0.0 111.002 -177.461 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' C' C ' 82' ' ' GLY . . . . . . . . . . . . . . . 89.12 42.23 5.65 Favored Glycine 0 CA--C 1.527 0.786 0 C-N-CA 120.683 -0.77 . . . . 0.0 111.91 174.246 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' C' C ' 83' ' ' ILE . . . . . . . . . . . . . 73.4 mt -67.74 131.91 32.87 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.341 0 N-CA-C 109.468 -0.567 . . . . 0.0 109.468 175.944 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' C' C ' 84' ' ' LYS . . . . . . . . . . . . . 72.8 tttt -88.84 -53.26 4.69 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-O 121.046 0.451 . . . . 0.0 110.181 -178.22 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' C' C ' 85' ' ' ASP . . . . . . . . . . . . . 11.5 t70 -155.85 152.96 29.0 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 115.626 -0.715 . . . . 0.0 110.146 179.201 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' C' C ' 86' ' ' VAL . . . . . . . . . . . . . 46.6 t -128.65 130.59 68.9 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.252 0 CA-C-O 120.961 0.41 . . . . 0.0 110.564 -178.475 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' C' C ' 87' ' ' ILE . . . . . . . . . . . . . 45.0 mm -119.58 126.54 75.42 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.303 0 CA-C-N 115.781 -0.645 . . . . 0.0 109.612 177.453 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' C' C ' 88' ' ' LEU . . . . . . . . . . . . . 86.5 mt -111.15 139.34 46.61 Favored 'General case' 0 C--N 1.331 -0.214 0 CA-C-O 121.152 0.501 . . . . 0.0 111.286 -178.151 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' C' C ' 89' ' ' ASP . . . . . . . . . . . . . 46.8 t0 -130.57 162.94 28.18 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 115.462 -0.79 . . . . 0.0 109.457 176.864 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' C' C ' 90' ' ' GLU . . . . . . . . . . . . . 45.5 tp10 -44.99 -44.51 9.96 Favored 'General case' 0 N--CA 1.465 0.293 0 N-CA-C 113.222 0.823 . . . . 0.0 113.222 -170.874 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' C' C ' 91' ' ' ASN . . . . . . . . . . . . . 31.0 m120 -132.12 26.41 4.55 Favored 'General case' 0 N--CA 1.467 0.381 0 N-CA-C 112.473 0.546 . . . . 0.0 112.473 -178.478 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' C' C ' 92' ' ' LEU . . . . . . . . . . . . . 36.5 mt -146.58 144.87 29.86 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-O 120.736 0.303 . . . . 0.0 110.51 -176.931 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' C' C ' 93' ' ' ILE . . . . . . . . . . . . . 65.3 mt -124.18 115.07 43.75 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.311 0 N-CA-C 109.104 -0.702 . . . . 0.0 109.104 177.505 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' C' C ' 94' ' ' VAL . . . . . 0.516 HG11 HG11 ' C' ' 123' ' ' VAL . 46.6 t -115.89 126.4 73.39 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.218 0 N-CA-C 109.763 -0.458 . . . . 0.0 109.763 -179.382 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' C' C ' 95' ' ' VAL . . . . . . . . . . . . . 43.2 t -121.18 133.72 66.86 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.372 0 CA-C-N 116.047 -0.524 . . . . 0.0 109.935 -178.893 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' C' C ' 96' ' ' ILE . . . . . . . . . . . . . 67.8 mt -110.14 124.52 66.95 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.317 0 N-CA-C 108.939 -0.763 . . . . 0.0 108.939 177.637 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' C' C ' 97' ' ' THR . . . . . . . . . . . . . 82.7 p -97.8 155.01 17.23 Favored 'General case' 0 C--N 1.327 -0.395 0 CA-C-O 121.059 0.457 . . . . 0.0 111.025 -177.176 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' C' C ' 98' ' ' GLU . . . . . . . . . . . . . 84.2 tt0 -53.79 -23.22 11.36 Favored 'General case' 0 C--N 1.327 -0.399 0 N-CA-C 112.379 0.511 . . . . 0.0 112.379 -179.835 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' C' C ' 99' ' ' GLU . . . . . . . . . . . . . 68.9 mm-40 -82.26 15.05 2.58 Favored 'General case' 0 CA--C 1.536 0.412 0 N-CA-C 113.2 0.815 . . . . 0.0 113.2 -176.569 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' C' C ' 100' ' ' ASN . . . . . . . . . . . . . 3.0 m-20 62.83 33.5 15.18 Favored 'General case' 0 N--CA 1.465 0.276 0 CA-C-O 120.914 0.387 . . . . 0.0 111.535 179.336 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' C' C ' 101' ' ' GLU . . . . . . . . . . . . . 84.9 tt0 -113.12 145.88 40.17 Favored 'General case' 0 C--N 1.331 -0.225 0 N-CA-C 109.639 -0.504 . . . . 0.0 109.639 174.144 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' C' C ' 102' ' ' VAL . . . . . . . . . . . . . 44.9 t -114.87 123.56 70.68 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.316 0 N-CA-C 109.717 -0.475 . . . . 0.0 109.717 -178.484 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' C' C ' 103' ' ' LEU . . . . . . . . . . . . . 35.5 mt -115.29 132.74 56.52 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 115.804 -0.634 . . . . 0.0 109.82 178.888 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' C' C ' 104' ' ' ILE . . . . . . . . . . . . . 64.6 mt -123.86 121.56 62.54 Favored 'Isoleucine or valine' 0 C--O 1.234 0.248 0 N-CA-C 110.432 -0.21 . . . . 0.0 110.432 -179.241 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' C' C ' 105' ' ' PHE . . . . . . . . . . . . . 61.8 m-85 -118.91 165.29 14.25 Favored 'General case' 0 C--N 1.33 -0.254 0 O-C-N 124.104 0.878 . . . . 0.0 109.617 178.561 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' C' C ' 106' ' ' ASN . . . . . . . . . . . . . 40.9 p-10 -101.21 -169.9 1.76 Allowed 'General case' 0 C--N 1.33 -0.25 0 N-CA-C 109.857 -0.423 . . . . 0.0 109.857 173.627 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' C' C ' 107' ' ' GLN . . . . . . . . . . . . . 49.2 tt0 -56.42 -29.69 61.89 Favored 'General case' 0 CA--C 1.534 0.332 0 N-CA-C 111.823 0.305 . . . . 0.0 111.823 176.744 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' C' C ' 108' ' ' ASN . . . . . . . . . . . . . 8.0 t-20 -84.35 9.57 12.81 Favored 'General case' 0 CA--C 1.536 0.43 0 N-CA-C 113.205 0.816 . . . . 0.0 113.205 -176.684 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' C' C ' 109' ' ' LEU . . . . . 0.643 HD21 ' HB2' ' C' ' 78' ' ' ALA . 8.0 tp 56.05 36.55 27.59 Favored 'General case' 0 C--N 1.332 -0.167 0 CA-C-O 120.923 0.392 . . . . 0.0 111.339 179.442 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' C' C ' 110' ' ' GLU . . . . . . . . . . . . . 70.5 mm-40 -107.79 150.29 27.17 Favored 'General case' 0 C--N 1.333 -0.141 0 N-CA-C 110.07 -0.344 . . . . 0.0 110.07 176.876 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' C' C ' 111' ' ' GLU . . . . . . . . . . . . . 98.0 mt-10 -77.16 122.29 24.8 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-O 120.876 0.37 . . . . 0.0 111.051 -178.296 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' C' C ' 112' ' ' LEU . . . . . . . . . . . . . 17.9 mt -108.62 -46.0 3.75 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 115.988 -0.551 . . . . 0.0 110.388 177.08 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' C' C ' 113' ' ' TYR . . . . . . . . . . . . . 59.6 t80 -136.75 137.68 40.13 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.359 -0.382 . . . . 0.0 111.048 179.943 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' C' C ' 114' ' ' ARG . . . . . . . . . . . . . 72.4 mtm180 -141.44 122.08 14.25 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 115.998 -0.546 . . . . 0.0 110.482 178.111 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' C' C ' 115' ' ' GLY . . . . . . . . . . . . . . . -150.11 160.91 28.73 Favored Glycine 0 CA--C 1.525 0.708 0 N-CA-C 111.03 -0.828 . . . . 0.0 111.03 178.572 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' C' C ' 116' ' ' LYS . . . . . . . . . . . . . 72.5 tttt -134.27 133.43 40.79 Favored 'General case' 0 C--N 1.33 -0.266 0 N-CA-C 110.021 -0.363 . . . . 0.0 110.021 179.27 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' C' C ' 117' ' ' PHE . . . . . . . . . . . . . 31.2 m-85 -133.06 123.15 25.25 Favored 'General case' 0 C--N 1.331 -0.202 0 CA-C-O 120.932 0.396 . . . . 0.0 110.363 -174.457 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' C' C ' 118' ' ' GLU . . . . . . . . . . . . . 43.4 mt-10 -53.77 -48.54 69.65 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.459 -0.337 . . . . 0.0 111.4 -176.49 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' C' C ' 119' ' ' ASN . . . . . . . . . . . . . 67.5 m-80 -98.57 31.03 3.01 Favored 'General case' 0 C--N 1.329 -0.321 0 N-CA-C 112.255 0.465 . . . . 0.0 112.255 -174.098 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' C' C ' 120' ' ' LEU . . . . . . . . . . . . . 18.4 tp -56.6 120.27 7.49 Favored 'General case' 0 N--CA 1.462 0.15 0 C-N-CA 121.04 -0.264 . . . . 0.0 110.325 177.888 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' C' C ' 121' ' ' ASN . . . . . . . . . . . . . 9.8 t-20 -109.42 -44.03 3.98 Favored 'General case' 0 C--N 1.331 -0.219 0 CA-C-N 116.58 -0.282 . . . . 0.0 111.192 -175.646 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' C' C ' 122' ' ' LYS . . . . . . . . . . . . . 15.9 ptpt -154.77 153.54 31.39 Favored 'General case' 0 C--N 1.332 -0.187 0 CA-C-O 121.286 0.565 . . . . 0.0 112.019 -178.291 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' C' C ' 123' ' ' VAL . . . . . 0.516 HG11 HG11 ' C' ' 94' ' ' VAL . 45.6 t -121.68 130.89 74.2 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.224 0 CA-C-N 115.698 -0.683 . . . . 0.0 109.474 176.223 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' C' C ' 124' ' ' LEU . . . . . 0.429 HD12 ' N ' ' C' ' 124' ' ' LEU . 6.2 mp -121.4 140.02 52.69 Favored 'General case' 0 C--N 1.331 -0.215 0 CA-C-N 116.319 -0.401 . . . . 0.0 110.635 -178.05 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' C' C ' 125' ' ' VAL . . . . . 0.436 HG11 HG21 ' C' ' 94' ' ' VAL . 35.2 m -134.78 140.12 46.16 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.258 0 CA-C-N 116.334 -0.394 . . . . 0.0 110.453 178.237 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' C' C ' 126' ' ' ARG . . . . . . . . . . . . . 52.5 ttt85 -149.13 118.69 6.95 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-O 120.907 0.384 . . . . 0.0 110.615 178.322 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' C' C ' 127' ' ' ASN . . . . . . . . . . . . . 35.7 t30 50.83 -104.95 0.18 Allowed 'General case' 0 CA--C 1.542 0.668 0 CA-C-N 116.144 -0.48 . . . . 0.0 111.572 179.862 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' C' C ' 128' ' ' ASP . . . . . . . . . . . . . 11.8 p-10 -110.61 -0.17 17.34 Favored 'General case' 0 CA--C 1.536 0.413 0 CA-C-N 119.501 1.046 . . . . 0.0 113.658 -175.043 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' C' C ' 129' ' ' LEU . . . . . . . . . . . . . 88.0 mt -106.35 142.73 35.54 Favored 'General case' 0 C--O 1.232 0.138 0 CA-C-N 118.186 0.448 . . . . 0.0 110.838 -179.451 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' C' C ' 130' ' ' VAL . . . . . . . . . . . . . 47.0 t -122.04 135.91 60.63 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.302 0 N-CA-C 109.619 -0.511 . . . . 0.0 109.619 178.625 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' C' C ' 131' ' ' VAL . . . . . . . . . . . . . 42.9 t -133.48 137.1 53.64 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.269 0 CA-C-O 121.018 0.437 . . . . 0.0 110.624 -178.726 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' C' C ' 132' ' ' ILE . . . . . . . . . . . . . 74.3 mt -115.61 130.46 70.21 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.304 0 CA-C-N 115.642 -0.708 . . . . 0.0 109.262 178.762 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' C' C ' 133' ' ' ILE . . . . . . . . . . . . . 43.7 mm -116.62 121.32 67.4 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.215 0 CA-C-O 120.774 0.321 . . . . 0.0 111.04 -175.447 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' C' C ' 134' ' ' ASP . . . . . . . . . . . . . 8.2 p-10 -136.11 144.3 45.03 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 115.878 -0.601 . . . . 0.0 109.443 173.756 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' C' C ' 135' ' ' GLU . . . . . . . . . . . . . 42.2 tp10 -49.81 -23.85 2.08 Favored 'General case' 0 C--N 1.327 -0.395 0 N-CA-C 112.724 0.639 . . . . 0.0 112.724 -172.226 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' C' C ' 136' ' ' GLN . . . . . . . . . . . . . 50.5 tt0 -93.13 -36.77 12.48 Favored 'General case' 0 C--O 1.233 0.2 0 N-CA-C 112.082 0.401 . . . . 0.0 112.082 -176.468 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' C' C ' 137' ' ' LYS . . . . . . . . . . . . . 89.9 mttt -140.12 155.06 47.15 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-O 121.251 0.548 . . . . 0.0 111.648 -171.185 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' C' C ' 138' ' ' LEU . . . . . . . . . . . . . 5.2 tt -117.8 123.54 46.22 Favored 'General case' 0 C--N 1.329 -0.321 0 N-CA-C 108.881 -0.785 . . . . 0.0 108.881 171.544 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' C' C ' 139' ' ' THR . . . . . . . . . . . . . 31.2 m -113.35 131.11 56.09 Favored 'General case' 0 C--N 1.331 -0.215 0 CA-C-O 120.875 0.369 . . . . 0.0 111.05 -176.353 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' C' C ' 140' ' ' LEU . . . . . 0.476 ' C ' HD23 ' C' ' 140' ' ' LEU . 6.8 tt -116.61 122.67 45.3 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 115.333 -0.849 . . . . 0.0 108.914 -179.407 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' C' C ' 141' ' ' ILE . . . . . . . . . . . . . 19.5 mt -119.81 120.41 63.21 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.276 0 CA-C-O 120.929 0.395 . . . . 0.0 110.02 -176.239 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' C' C ' 142' ' ' ARG . . . . . . . . . . . . . 57.6 mtp180 . . . . . 0 C--N 1.331 -0.212 0 CA-C-N 115.431 -0.804 . . . . 0.0 110.014 179.319 . . . . . . . . 0 0 . 1 . 017 nuclear build core ' D' D ' 2' ' ' SER . . . . . . . . . . . . . 2.9 p . . . . . 0 C--O 1.232 0.137 0 CA-C-O 120.833 0.349 . . . . 0.0 110.616 . . . . . . . . . 0 0 . 1 . 017 nuclear build core ' D' D ' 3' ' ' GLU . . . . . . . . . . . . . 94.3 mt-10 -141.19 139.82 33.91 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.12 -0.491 . . . . 0.0 111.158 -178.798 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' D' D ' 4' ' ' LEU . . . . . . . . . . . . . 21.7 tp -123.27 128.96 50.69 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 115.869 -0.605 . . . . 0.0 109.763 174.799 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' D' D ' 5' ' ' LYS . . . . . . . . . . . . . 94.8 mttt -112.75 121.6 45.2 Favored 'General case' 0 C--O 1.235 0.302 0 CA-C-O 120.897 0.38 . . . . 0.0 111.014 -177.95 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' D' D ' 6' ' ' LEU . . . . . 0.454 HD23 ' HA ' ' D' ' 50' ' ' VAL . 61.9 mt -114.94 142.17 46.97 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-N 115.225 -0.898 . . . . 0.0 110.274 -179.185 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' D' D ' 7' ' ' LYS . . . . . . . . . . . . . 44.7 tttm -122.35 140.48 32.72 Favored Pre-proline 0 CA--C 1.533 0.291 0 CA-C-O 119.017 -0.516 . . . . 0.0 109.993 176.056 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' D' D ' 8' ' ' PRO . . . . . . . . . . . . . 96.9 Cg_endo -91.72 137.76 1.97 Allowed 'Trans proline' 0 N--CA 1.49 1.316 0 C-N-CA 121.83 1.687 . . . . 0.0 111.964 179.45 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' D' D ' 9' ' ' LEU . . . . . . . . . . . . . 26.3 mt -77.54 -48.28 2.34 Favored Pre-proline 0 CA--C 1.535 0.371 0 CA-C-O 118.675 -0.678 . . . . 0.0 112.341 -179.991 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' D' D ' 10' ' ' PRO . . . . . . . . . . . . . 87.0 Cg_endo -80.23 159.35 23.29 Favored 'Trans proline' 0 N--CA 1.497 1.685 0 C-N-CA 121.308 1.339 . . . . 0.0 112.219 177.961 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' D' D ' 11' ' ' LYS . . . . . . . . . . . . . 82.5 mttt -86.54 95.69 9.82 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.51 -0.314 . . . . 0.0 110.318 177.543 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' D' D ' 12' ' ' VAL . . . . . . . . . . . . . 12.4 p -142.2 147.55 21.26 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.324 0 CA-C-N 116.238 -0.437 . . . . 0.0 110.443 179.928 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' D' D ' 13' ' ' GLU . . . . . . . . . . . . . 45.5 tp10 -92.09 121.83 34.01 Favored 'General case' 0 C--N 1.328 -0.336 0 N-CA-C 109.985 -0.376 . . . . 0.0 109.985 177.797 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' D' D ' 14' ' ' LEU . . . . . . . . . . . . . 41.0 mt -93.02 138.15 23.41 Favored Pre-proline 0 C--N 1.329 -0.305 0 CA-C-O 118.88 -0.581 . . . . 0.0 110.073 -178.666 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' D' D ' 15' ' ' PRO . . . . . . . . . . . . . 28.7 Cg_exo -60.47 158.55 31.25 Favored 'Trans proline' 0 N--CA 1.498 1.782 0 C-N-CA 121.268 1.312 . . . . 0.0 111.953 178.995 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' D' D ' 16' ' ' PRO . . . . . . . . . . . . . 39.3 Cg_exo -58.91 -35.52 98.47 Favored 'Trans proline' 0 N--CA 1.498 1.766 0 C-N-CA 121.527 1.485 . . . . 0.0 112.894 -179.469 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' D' D ' 17' ' ' ASP . . . . . . . . . . . . . 15.8 p-10 -82.18 2.65 30.62 Favored 'General case' 0 CA--C 1.537 0.454 0 N-CA-C 113.296 0.85 . . . . 0.0 113.296 -177.682 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' D' D ' 18' ' ' PHE . . . . . . . . . . . . . 36.7 t80 -58.15 -47.08 84.45 Favored 'General case' 0 C--N 1.333 -0.115 0 O-C-N 121.933 -0.48 . . . . 0.0 110.019 -178.242 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' D' D ' 19' ' ' VAL . . . . . 0.425 HG13 ' N ' ' D' ' 20' ' ' ASP . 12.7 p -55.19 -41.73 62.03 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 CA-C-N 116.353 -0.385 . . . . 0.0 111.197 -178.094 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' D' D ' 20' ' ' ASP . . . . . 0.425 ' N ' HG13 ' D' ' 19' ' ' VAL . 7.7 t0 -60.91 -44.31 97.36 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-O 120.9 0.381 . . . . 0.0 110.827 -177.811 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' D' D ' 21' ' ' VAL . . . . . . . . . . . . . 45.5 t -64.62 -45.71 94.61 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.324 0 CA-C-N 116.326 -0.397 . . . . 0.0 110.41 -177.486 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' D' D ' 22' ' ' ILE . . . . . 0.671 HG22 HD12 ' D' ' 26' ' ' LEU . 49.5 mm -55.55 -47.73 78.31 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.264 0 C-N-CA 121.096 -0.242 . . . . 0.0 110.672 179.533 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' D' D ' 23' ' ' ARG . . . . . . . . . . . . . 47.0 ttp180 -55.15 -49.05 72.8 Favored 'General case' 0 C--N 1.331 -0.219 0 C-N-CA 121.042 -0.263 . . . . 0.0 111.155 -178.33 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' D' D ' 24' ' ' ILE . . . . . . . . . . . . . 71.4 mt -58.93 -43.97 89.85 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.281 0 C-N-CA 121.05 -0.26 . . . . 0.0 111.251 -176.308 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' D' D ' 25' ' ' LYS . . . . . . . . . . . . . 49.2 mttm -68.18 -41.05 82.05 Favored 'General case' 0 C--N 1.328 -0.332 0 N-CA-C 112.582 0.586 . . . . 0.0 112.582 -177.86 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' D' D ' 26' ' ' LEU . . . . . 0.671 HD12 HG22 ' D' ' 22' ' ' ILE . 36.1 mt -79.46 -33.49 42.32 Favored 'General case' 0 C--N 1.329 -0.311 0 N-CA-C 113.837 1.051 . . . . 0.0 113.837 -170.421 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' D' D ' 27' ' ' GLN . . . . . . . . . . . . . 18.3 pt20 -46.84 140.76 4.43 Favored 'General case' 0 N--CA 1.469 0.514 0 N-CA-C 112.956 0.725 . . . . 0.0 112.956 -174.247 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' D' D ' 28' ' ' GLY . . . . . . . . . . . . . . . 98.14 -24.15 33.05 Favored Glycine 0 CA--C 1.532 1.141 0 CA-C-N 115.571 -0.74 . . . . 0.0 112.427 -178.355 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' D' D ' 29' ' ' LYS . . . . . . . . . . . . . 48.9 mtpt -97.45 155.11 17.07 Favored 'General case' 0 C--N 1.333 -0.126 0 CA-C-N 117.425 0.612 . . . . 0.0 110.783 179.101 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' D' D ' 30' ' ' THR . . . . . . . . . . . . . 23.5 m -104.51 139.84 38.83 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.196 -0.456 . . . . 0.0 110.338 178.876 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' D' D ' 31' ' ' VAL . . . . . . . . . . . . . 34.4 m -130.98 150.28 34.44 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.303 0 CA-C-N 116.101 -0.5 . . . . 0.0 110.783 -179.176 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' D' D ' 32' ' ' ARG . . . . . . . . . . . . . 83.0 mtm180 -128.67 150.34 50.29 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 115.913 -0.585 . . . . 0.0 110.475 178.324 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' D' D ' 33' ' ' THR . . . . . . . . . . . . . 15.0 m -53.64 138.53 34.51 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.305 -0.407 . . . . 0.0 111.385 -178.036 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' D' D ' 34' ' ' GLY . . . . . . . . . . . . . . . 100.43 -17.23 57.07 Favored Glycine 0 CA--C 1.532 1.145 0 CA-C-O 119.67 -0.517 . . . . 0.0 113.192 179.589 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' D' D ' 35' ' ' ASP . . . . . . . . . . . . . 75.1 m-20 -66.35 149.8 49.84 Favored 'General case' 0 N--CA 1.461 0.085 0 CA-C-N 118.015 0.907 . . . . 0.0 111.087 178.838 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' D' D ' 36' ' ' VAL . . . . . . . . . . . . . 44.2 t -118.77 130.75 73.17 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.244 0 CA-C-N 115.908 -0.587 . . . . 0.0 109.839 178.08 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' D' D ' 37' ' ' ILE . . . . . . . . . . . . . 64.7 mt -119.72 138.12 51.38 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.233 0 N-CA-C 109.854 -0.425 . . . . 0.0 109.854 -179.723 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' D' D ' 38' ' ' GLY . . . . . . . . . . . . . . . -113.54 127.89 8.07 Favored Glycine 0 CA--C 1.525 0.661 0 N-CA-C 110.782 -0.927 . . . . 0.0 110.782 179.064 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' D' D ' 39' ' ' ILE . . . . . . . . . . . . . 78.0 mt -128.25 137.46 57.39 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.237 0 CA-C-O 120.814 0.34 . . . . 0.0 110.313 179.626 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' D' D ' 40' ' ' SER . . . . . . . . . . . . . 32.4 t -91.54 116.53 28.94 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.248 -0.433 . . . . 0.0 110.598 175.285 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' D' D ' 41' ' ' ILE . . . . . . . . . . . . . 44.0 mm -119.83 114.34 43.86 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.216 0 CA-C-O 120.886 0.374 . . . . 0.0 110.177 178.823 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' D' D ' 42' ' ' LEU . . . . . 0.545 HD23 ' O ' ' D' ' 42' ' ' LEU . 1.3 tt 52.27 46.23 27.02 Favored 'General case' 0 CA--C 1.532 0.262 0 CA-C-O 121.399 0.618 . . . . 0.0 111.036 177.527 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' D' D ' 43' ' ' GLY . . . . . . . . . . . . . . . 70.9 25.79 75.14 Favored Glycine 0 CA--C 1.532 1.109 0 C-N-CA 121.1 -0.571 . . . . 0.0 112.532 175.398 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' D' D ' 44' ' ' LYS . . . . . . . . . . . . . 85.9 tttt -136.01 129.65 32.35 Favored 'General case' 0 C--N 1.331 -0.221 0 CA-C-N 117.274 0.537 . . . . 0.0 109.975 179.323 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' D' D ' 45' ' ' GLU . . . . . . . . . . . . . 84.7 tt0 -82.47 119.33 24.07 Favored 'General case' 0 C--N 1.328 -0.355 0 C-N-CA 120.816 -0.354 . . . . 0.0 110.842 -179.275 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' D' D ' 46' ' ' VAL . . . . . . . . . . . . . 10.0 p -118.57 125.17 74.16 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.179 0 N-CA-C 109.425 -0.583 . . . . 0.0 109.425 175.391 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' D' D ' 47' ' ' LYS . . . . . . . . . . . . . 39.6 mtmt -98.73 126.77 44.45 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 115.953 -0.567 . . . . 0.0 110.729 177.809 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' D' D ' 48' ' ' PHE . . . . . . . . . . . . . 45.9 m-85 -111.2 131.95 54.71 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 115.747 -0.66 . . . . 0.0 109.928 178.532 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' D' D ' 49' ' ' LYS . . . . . . . . . . . . . 38.2 tttp -104.48 131.78 51.46 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.334 -0.394 . . . . 0.0 110.09 178.531 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' D' D ' 50' ' ' VAL . . . . . 0.454 ' HA ' HD23 ' D' ' 6' ' ' LEU . 45.7 t -77.04 105.33 5.79 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.33 0 N-CA-C 109.204 -0.665 . . . . 0.0 109.204 177.623 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' D' D ' 51' ' ' VAL . . . . . . . . . . . . . 48.8 t -71.27 -52.5 26.37 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.317 0 CA-C-N 116.064 -0.516 . . . . 0.0 109.683 -174.93 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' D' D ' 52' ' ' GLN . . . . . . . . . . . . . 89.4 mt-30 -153.7 151.17 29.33 Favored 'General case' 0 C--N 1.331 -0.239 0 CA-C-N 115.995 -0.548 . . . . 0.0 111.845 -178.308 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' D' D ' 53' ' ' ALA . . . . . . . . . . . . . . . -129.74 133.24 46.91 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 115.145 -0.934 . . . . 0.0 109.561 174.057 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' D' D ' 54' ' ' TYR . . . . . . . . . . . . . 44.0 t80 -129.08 112.04 18.42 Favored Pre-proline 0 CA--C 1.536 0.419 0 CA-C-O 118.107 -0.949 . . . . 0.0 110.124 178.122 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' D' D ' 55' ' ' PRO . . . . . . . . . . . . . 73.3 Cg_endo -77.19 167.56 79.31 Favored 'Cis proline' 0 N--CA 1.5 1.857 0 CA-C-N 121.907 1.717 . . . . 0.0 112.585 -5.875 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' D' D ' 56' ' ' SER . . . . . . . . . . . . . 13.6 m -117.34 134.09 23.14 Favored Pre-proline 0 CA--C 1.539 0.549 0 CA-C-O 118.483 -0.77 . . . . 0.0 109.292 174.204 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' D' D ' 57' ' ' PRO . . . . . . . . . . . . . 56.0 Cg_endo -70.68 147.7 87.16 Favored 'Cis proline' 0 N--CA 1.498 1.785 0 CA-C-N 121.844 1.694 . . . . 0.0 111.415 -1.608 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' D' D ' 58' ' ' LEU . . . . . . . . . . . . . 24.2 tp -107.84 138.14 44.62 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-O 120.896 0.379 . . . . 0.0 110.495 -179.139 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' D' D ' 59' ' ' ARG . . . . . . . . . . . . . 61.2 ttt180 -103.04 120.25 40.32 Favored 'General case' 0 C--N 1.327 -0.397 0 N-CA-C 108.981 -0.748 . . . . 0.0 108.981 174.812 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' D' D ' 60' ' ' VAL . . . . . . . . . . . . . 42.4 t -71.93 119.7 18.93 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.277 0 C-N-CA 120.615 -0.434 . . . . 0.0 110.198 -174.276 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' D' D ' 61' ' ' GLU . . . . . . . . . . . . . 81.3 tt0 -131.14 152.15 50.72 Favored 'General case' 0 C--N 1.328 -0.33 0 N-CA-C 109.268 -0.641 . . . . 0.0 109.268 178.166 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' D' D ' 62' ' ' ASP . . . . . . . . . . . . . 19.3 p-10 -54.48 -31.97 56.89 Favored 'General case' 0 N--CA 1.465 0.301 0 C-N-CA 120.751 -0.38 . . . . 0.0 111.835 -176.405 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' D' D ' 63' ' ' ARG . . . . . . . . . . . . . 77.6 mtp180 -72.32 -21.24 61.36 Favored 'General case' 0 CA--C 1.535 0.38 0 N-CA-C 112.816 0.673 . . . . 0.0 112.816 -177.514 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' D' D ' 64' ' ' THR . . . . . . . . . . . . . 33.1 m -72.26 146.91 46.92 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-O 120.926 0.393 . . . . 0.0 110.905 -176.238 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' D' D ' 65' ' ' LYS . . . . . . . . . . . . . 68.8 mttm -90.14 131.67 35.86 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.018 -0.537 . . . . 0.0 110.819 -179.229 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' D' D ' 66' ' ' ILE . . . . . . . . . . . . . 68.3 mt -118.2 130.52 72.94 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.24 0 N-CA-C 109.655 -0.498 . . . . 0.0 109.655 178.391 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' D' D ' 67' ' ' THR . . . . . . . . . . . . . 29.5 m -126.48 139.65 53.07 Favored 'General case' 0 C--N 1.332 -0.194 0 CA-C-O 121.169 0.509 . . . . 0.0 111.253 -177.537 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' D' D ' 68' ' ' LEU . . . . . . . . . . . . . 51.0 mt . . . . . 0 C--N 1.33 -0.253 0 CA-C-N 115.733 -0.667 . . . . 0.0 110.121 176.62 . . . . . . . . 0 0 . 1 . 017 nuclear build core ' D' D ' 73' ' ' VAL . . . . . . . . . . . . . 34.8 m . . . . . 0 C--O 1.232 0.176 0 CA-C-O 120.819 0.343 . . . . 0.0 110.716 . . . . . . . . . 0 0 . 1 . 017 nuclear build core ' D' D ' 74' ' ' ASP . . . . . . . . . . . . . 39.7 t0 -101.77 119.03 38.14 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.309 -0.405 . . . . 0.0 110.126 -179.836 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' D' D ' 75' ' ' VAL . . . . . . . . . . . . . 44.3 t -114.0 123.04 69.27 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.25 0 CA-C-O 121.131 0.491 . . . . 0.0 110.268 -179.451 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' D' D ' 76' ' ' LEU . . . . . . . . . . . . . 33.9 mt -123.4 141.58 51.85 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 115.616 -0.72 . . . . 0.0 109.511 178.535 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' D' D ' 77' ' ' GLU . . . . . . . . . . . . . 96.7 mt-10 -134.75 138.6 44.47 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-O 121.211 0.529 . . . . 0.0 111.375 -177.849 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' D' D ' 78' ' ' ALA . . . . . . . . . . . . . . . -125.11 137.31 54.18 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 115.556 -0.747 . . . . 0.0 109.581 175.809 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' D' D ' 79' ' ' LYS . . . . . 0.616 ' O ' HD13 ' D' ' 80' ' ' ILE . 65.0 mttp -80.17 117.91 21.39 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-O 120.864 0.364 . . . . 0.0 110.65 -179.017 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' D' D ' 80' ' ' ILE . . . . . 0.616 HD13 ' O ' ' D' ' 79' ' ' LYS . 40.7 mm -138.96 102.82 1.84 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.32 0 N-CA-C 109.135 -0.691 . . . . 0.0 109.135 -178.052 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' D' D ' 81' ' ' LYS . . . . . . . . . . . . . 78.1 tttt -99.49 128.37 45.6 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-O 120.889 0.376 . . . . 0.0 110.92 -176.195 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' D' D ' 82' ' ' GLY . . . . . . . . . . . . . . . 89.07 42.21 5.67 Favored Glycine 0 CA--C 1.526 0.743 0 C-N-CA 120.987 -0.625 . . . . 0.0 111.862 175.791 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' D' D ' 83' ' ' ILE . . . . . . . . . . . . . 70.1 mt -70.17 137.77 23.36 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.311 0 N-CA-C 109.358 -0.608 . . . . 0.0 109.358 175.874 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' D' D ' 84' ' ' LYS . . . . . . . . . . . . . 38.5 ttpt -99.57 -46.59 5.4 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.343 -0.39 . . . . 0.0 110.243 -178.541 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' D' D ' 85' ' ' ASP . . . . . . . . . . . . . 8.0 t70 -155.11 152.66 29.76 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.072 -0.513 . . . . 0.0 110.663 179.21 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' D' D ' 86' ' ' VAL . . . . . . . . . . . . . 44.0 t -128.57 134.82 63.87 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.19 0 CA-C-O 120.91 0.386 . . . . 0.0 110.347 179.843 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' D' D ' 87' ' ' ILE . . . . . . . . . . . . . 43.7 mm -119.73 125.34 74.23 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.228 0 CA-C-N 115.909 -0.587 . . . . 0.0 109.719 178.152 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' D' D ' 88' ' ' LEU . . . . . . . . . . . . . 14.7 tp -111.05 131.46 55.04 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-O 120.835 0.35 . . . . 0.0 110.96 -177.622 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' D' D ' 89' ' ' ASP . . . . . . . . . . . . . 13.6 t70 -133.1 157.44 45.28 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 116.151 -0.477 . . . . 0.0 110.039 177.737 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' D' D ' 90' ' ' GLU . . . . . . . . . . . . . 82.6 tt0 -46.18 -39.11 9.19 Favored 'General case' 0 C--N 1.331 -0.23 0 N-CA-C 113.127 0.788 . . . . 0.0 113.127 -172.146 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' D' D ' 91' ' ' ASN . . . . . . . . . . . . . 82.8 m-20 -130.75 22.76 5.01 Favored 'General case' 0 N--CA 1.469 0.488 0 N-CA-C 112.762 0.653 . . . . 0.0 112.762 -176.785 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' D' D ' 92' ' ' LEU . . . . . . . . . . . . . 37.6 mt -149.05 141.22 23.97 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-O 120.826 0.346 . . . . 0.0 110.581 -176.931 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' D' D ' 93' ' ' ILE . . . . . . . . . . . . . 69.5 mt -122.08 113.11 37.52 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.255 0 N-CA-C 108.638 -0.875 . . . . 0.0 108.638 174.895 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' D' D ' 94' ' ' VAL . . . . . 0.453 HG21 HG11 ' D' ' 125' ' ' VAL . 41.4 t -116.57 128.93 73.79 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.291 0 CA-C-O 120.949 0.404 . . . . 0.0 110.013 -176.955 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' D' D ' 95' ' ' VAL . . . . . . . . . . . . . 46.1 t -121.65 132.58 70.46 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.282 0 CA-C-N 116.021 -0.536 . . . . 0.0 109.808 -179.826 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' D' D ' 96' ' ' ILE . . . . . . . . . . . . . 62.8 mt -113.29 126.41 70.71 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.322 0 N-CA-C 109.074 -0.713 . . . . 0.0 109.074 178.482 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' D' D ' 97' ' ' THR . . . . . . . . . . . . . 81.0 p -101.79 156.91 17.22 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-O 121.085 0.469 . . . . 0.0 111.44 -175.262 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' D' D ' 98' ' ' GLU . . . . . . . . . . . . . 46.1 mt-10 -55.62 -25.35 38.29 Favored 'General case' 0 CA--C 1.533 0.298 0 N-CA-C 112.324 0.49 . . . . 0.0 112.324 178.783 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' D' D ' 99' ' ' GLU . . . . . . . . . . . . . 14.1 mm-40 -76.12 11.92 1.33 Allowed 'General case' 0 CA--C 1.537 0.467 0 N-CA-C 113.161 0.8 . . . . 0.0 113.161 -179.708 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' D' D ' 100' ' ' ASN . . . . . . . . . . . . . 3.2 m-20 62.72 38.0 12.22 Favored 'General case' 0 CA--C 1.529 0.147 0 CA-C-O 121.039 0.447 . . . . 0.0 110.949 179.113 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' D' D ' 101' ' ' GLU . . . . . . . . . . . . . 84.8 tt0 -117.69 145.29 44.51 Favored 'General case' 0 C--N 1.332 -0.155 0 N-CA-C 109.505 -0.554 . . . . 0.0 109.505 176.658 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' D' D ' 102' ' ' VAL . . . . . . . . . . . . . 42.2 t -115.8 124.45 72.22 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.337 0 CA-C-N 116.272 -0.422 . . . . 0.0 109.98 -178.406 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' D' D ' 103' ' ' LEU . . . . . . . . . . . . . 19.3 mt -115.17 127.85 55.8 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 115.69 -0.686 . . . . 0.0 110.129 176.87 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' D' D ' 104' ' ' ILE . . . . . 0.433 HD12 ' HB3' ' D' ' 113' ' ' TYR . 65.6 mt -119.95 120.32 62.83 Favored 'Isoleucine or valine' 0 C--O 1.233 0.223 0 N-CA-C 110.136 -0.32 . . . . 0.0 110.136 -179.496 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' D' D ' 105' ' ' PHE . . . . . . . . . . . . . 46.3 m-85 -120.44 164.2 16.75 Favored 'General case' 0 C--N 1.334 -0.109 0 O-C-N 123.885 0.741 . . . . 0.0 109.977 179.61 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' D' D ' 106' ' ' ASN . . . . . . . . . . . . . 43.4 p-10 -99.24 -169.79 1.81 Allowed 'General case' 0 C--N 1.332 -0.192 0 N-CA-C 110.1 -0.333 . . . . 0.0 110.1 174.883 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' D' D ' 107' ' ' GLN . . . . . . . . . . . . . 62.3 tt0 -57.37 -30.16 64.64 Favored 'General case' 0 C--N 1.33 -0.243 0 N-CA-C 112.121 0.415 . . . . 0.0 112.121 -179.581 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' D' D ' 108' ' ' ASN . . . . . . . . . . . . . 5.4 t30 -88.43 11.24 17.48 Favored 'General case' 0 CA--C 1.536 0.424 0 N-CA-C 113.304 0.853 . . . . 0.0 113.304 -176.405 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' D' D ' 109' ' ' LEU . . . . . . . . . . . . . 9.5 tp 60.63 36.07 19.76 Favored 'General case' 0 CA--C 1.531 0.213 0 O-C-N 122.141 -0.349 . . . . 0.0 111.446 178.452 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' D' D ' 110' ' ' GLU . . . . . . . . . . . . . 95.5 mt-10 -107.84 152.22 24.69 Favored 'General case' 0 C--N 1.331 -0.237 0 N-CA-C 109.836 -0.431 . . . . 0.0 109.836 176.495 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' D' D ' 111' ' ' GLU . . . . . . . . . . . . . 97.3 mt-10 -78.48 126.87 31.36 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-O 121.102 0.477 . . . . 0.0 111.661 -176.359 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' D' D ' 112' ' ' LEU . . . . . . . . . . . . . 30.9 mt -108.93 -46.03 3.69 Favored 'General case' 0 C--N 1.332 -0.181 0 CA-C-N 115.573 -0.74 . . . . 0.0 109.952 174.736 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' D' D ' 113' ' ' TYR . . . . . 0.433 ' HB3' HD12 ' D' ' 104' ' ' ILE . 50.8 t80 -140.45 137.45 33.92 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.095 -0.502 . . . . 0.0 110.91 -179.813 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' D' D ' 114' ' ' ARG . . . . . . . . . . . . . 60.2 ttp180 -142.15 119.09 11.24 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.262 -0.426 . . . . 0.0 110.416 178.701 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' D' D ' 115' ' ' GLY . . . . . . . . . . . . . . . -150.19 162.59 29.27 Favored Glycine 0 CA--C 1.525 0.687 0 N-CA-C 111.021 -0.832 . . . . 0.0 111.021 179.3 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' D' D ' 116' ' ' LYS . . . . . . . . . . . . . 35.0 ttmt -131.66 135.44 46.9 Favored 'General case' 0 C--N 1.33 -0.251 0 N-CA-C 110.024 -0.362 . . . . 0.0 110.024 177.221 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' D' D ' 117' ' ' PHE . . . . . . . . . . . . . 39.8 m-85 -132.2 120.78 22.69 Favored 'General case' 0 C--N 1.331 -0.211 0 CA-C-O 120.86 0.362 . . . . 0.0 110.46 -174.532 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' D' D ' 118' ' ' GLU . . . . . . . . . . . . . 95.9 mt-10 -53.97 -48.53 70.25 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.413 -0.358 . . . . 0.0 111.571 -175.438 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' D' D ' 119' ' ' ASN . . . . . . . . . . . . . 9.4 m120 -99.28 31.11 3.2 Favored 'General case' 0 C--N 1.329 -0.288 0 N-CA-C 112.201 0.445 . . . . 0.0 112.201 -173.771 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' D' D ' 120' ' ' LEU . . . . . . . . . . . . . 23.7 tp -54.88 127.7 29.83 Favored 'General case' 0 C--N 1.332 -0.169 0 CA-C-O 120.805 0.336 . . . . 0.0 110.8 179.544 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' D' D ' 121' ' ' ASN . . . . . . . . . . . . . 95.1 m-20 -111.11 -44.05 3.65 Favored 'General case' 0 C--O 1.233 0.211 0 CA-C-N 116.287 -0.415 . . . . 0.0 111.109 -177.496 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' D' D ' 122' ' ' LYS . . . . . . . . . . . . . 19.0 ptpt -164.34 166.99 20.28 Favored 'General case' 0 N--CA 1.463 0.176 0 CA-C-O 121.277 0.56 . . . . 0.0 112.149 -178.285 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' D' D ' 123' ' ' VAL . . . . . . . . . . . . . 45.5 t -131.49 139.36 50.89 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.207 0 CA-C-N 115.584 -0.735 . . . . 0.0 110.121 179.749 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' D' D ' 124' ' ' LEU . . . . . . . . . . . . . 37.2 mt -121.55 138.9 54.11 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-N 116.313 -0.403 . . . . 0.0 110.737 -179.151 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' D' D ' 125' ' ' VAL . . . . . 0.453 HG11 HG21 ' D' ' 94' ' ' VAL . 35.6 m -135.06 134.12 53.23 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.211 0 CA-C-N 116.585 -0.28 . . . . 0.0 110.939 178.922 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' D' D ' 126' ' ' ARG . . . . . . . . . . . . . 22.3 mtp-105 -148.87 118.31 6.92 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 116.523 -0.308 . . . . 0.0 111.048 177.0 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' D' D ' 127' ' ' ASN . . . . . . . . . . . . . 34.6 m120 48.97 -104.89 0.14 Allowed 'General case' 0 CA--C 1.545 0.76 0 CA-C-O 119.193 -0.432 . . . . 0.0 111.976 175.604 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' D' D ' 128' ' ' ASP . . . . . . . . . . . . . 19.2 p-10 -114.05 14.61 18.38 Favored 'General case' 0 N--CA 1.468 0.463 0 CA-C-N 119.407 1.003 . . . . 0.0 113.28 -174.968 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' D' D ' 129' ' ' LEU . . . . . . . . . . . . . 19.1 tp -123.62 139.22 54.22 Favored 'General case' 0 C--N 1.331 -0.233 0 N-CA-C 109.736 -0.468 . . . . 0.0 109.736 177.458 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' D' D ' 130' ' ' VAL . . . . . 0.549 HG13 ' HB ' ' D' ' 141' ' ' ILE . 13.4 p -131.91 140.54 47.78 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.202 0 CA-C-O 121.173 0.511 . . . . 0.0 110.317 179.523 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' D' D ' 131' ' ' VAL . . . . . . . . . . . . . 40.7 t -135.99 140.46 43.98 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.241 0 CA-C-N 115.864 -0.607 . . . . 0.0 110.493 -177.013 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' D' D ' 132' ' ' ILE . . . . . . . . . . . . . 73.4 mt -115.8 131.33 68.52 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.283 0 N-CA-C 109.188 -0.671 . . . . 0.0 109.188 177.501 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' D' D ' 133' ' ' ILE . . . . . . . . . . . . . 43.6 mm -115.12 119.63 62.32 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.191 0 CA-C-O 120.716 0.293 . . . . 0.0 110.752 -175.904 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' D' D ' 134' ' ' ASP . . . . . . . . . . . . . 8.0 p-10 -133.01 144.25 49.96 Favored 'General case' 0 C--N 1.331 -0.233 0 N-CA-C 109.425 -0.583 . . . . 0.0 109.425 175.896 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' D' D ' 135' ' ' GLU . . . . . . . . . . . . . 83.4 tt0 -49.93 -26.86 4.55 Favored 'General case' 0 C--N 1.327 -0.391 0 N-CA-C 112.779 0.659 . . . . 0.0 112.779 -173.63 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' D' D ' 136' ' ' GLN . . . . . . . . . . . . . 97.3 mt-30 -79.01 -36.89 40.44 Favored 'General case' 0 C--O 1.233 0.225 0 N-CA-C 112.448 0.536 . . . . 0.0 112.448 -178.122 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' D' D ' 137' ' ' LYS . . . . . . . . . . . . . 1.2 ptpm? -164.39 174.11 11.41 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-O 121.671 0.748 . . . . 0.0 112.223 -173.206 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' D' D ' 138' ' ' LEU . . . . . 0.413 HD23 ' N ' ' D' ' 139' ' ' THR . 5.7 tt -117.89 127.3 53.72 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 114.905 -1.043 . . . . 0.0 109.553 177.637 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' D' D ' 139' ' ' THR . . . . . 0.413 ' N ' HD23 ' D' ' 138' ' ' LEU . 42.4 m -106.42 123.61 48.34 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.354 -0.385 . . . . 0.0 110.152 179.301 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' D' D ' 140' ' ' LEU . . . . . . . . . . . . . 14.1 tp -110.61 118.41 36.13 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-N 115.723 -0.672 . . . . 0.0 109.33 -177.901 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' D' D ' 141' ' ' ILE . . . . . 0.549 ' HB ' HG13 ' D' ' 130' ' ' VAL . 19.4 mt -120.11 118.25 56.27 Favored 'Isoleucine or valine' 0 C--O 1.234 0.279 0 CA-C-O 121.045 0.45 . . . . 0.0 110.042 -176.632 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' D' D ' 142' ' ' ARG . . . . . . . . . . . . . 81.3 mtp180 -92.03 128.98 38.08 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 115.433 -0.803 . . . . 0.0 110.009 177.459 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' D' D ' 143' ' ' THR . . . . . 0.58 HG22 HG12 ' E' ' 73' ' ' VAL . 63.6 p . . . . . 0 C--O 1.221 -0.431 0 CA-C-O 117.965 -1.017 . . . . 0.0 110.424 -179.701 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' E' E ' 2' ' ' SER . . . . . . . . . . . . . 2.7 p . . . . . 0 N--CA 1.462 0.155 0 CA-C-O 121.138 0.494 . . . . 0.0 110.856 . . . . . . . . . 0 0 . 1 . 017 nuclear build core ' E' E ' 3' ' ' GLU . . . . . . . . . . . . . 84.2 tt0 -141.53 138.23 32.58 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 115.699 -0.682 . . . . 0.0 110.882 -179.911 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' E' E ' 4' ' ' LEU . . . . . . . . . . . . . 13.6 tp -123.47 127.13 47.95 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.113 -0.494 . . . . 0.0 109.983 176.78 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' E' E ' 5' ' ' LYS . . . . . . . . . . . . . 91.5 mttt -107.2 121.24 44.14 Favored 'General case' 0 C--N 1.331 -0.23 0 CA-C-N 116.442 -0.345 . . . . 0.0 110.627 178.844 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' E' E ' 6' ' ' LEU . . . . . . . . . . . . . 30.6 mt -115.97 147.05 41.59 Favored 'General case' 0 C--N 1.331 -0.222 0 CA-C-N 115.529 -0.76 . . . . 0.0 110.385 -179.147 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' E' E ' 7' ' ' LYS . . . . . . . . . . . . . 36.9 ttmt -133.18 137.93 30.48 Favored Pre-proline 0 CA--C 1.535 0.384 0 CA-C-O 119.028 -0.51 . . . . 0.0 109.928 176.246 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' E' E ' 8' ' ' PRO . . . . . . . . . . . . . 85.9 Cg_endo -90.63 143.97 3.67 Favored 'Trans proline' 0 N--CA 1.49 1.314 0 C-N-CA 121.798 1.665 . . . . 0.0 111.84 178.805 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' E' E ' 9' ' ' LEU . . . . . . . . . . . . . 57.8 mt -81.15 -48.47 1.07 Allowed Pre-proline 0 CA--C 1.534 0.335 0 CA-C-O 118.669 -0.682 . . . . 0.0 112.385 -178.915 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' E' E ' 10' ' ' PRO . . . . . . . . . . . . . 86.0 Cg_endo -80.41 154.24 21.27 Favored 'Trans proline' 0 N--CA 1.496 1.637 0 C-N-CA 121.281 1.321 . . . . 0.0 111.934 177.169 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' E' E ' 11' ' ' LYS . . . . . . . . . . . . . 46.8 pttt -85.06 111.01 19.35 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-O 121.543 0.687 . . . . 0.0 110.426 177.415 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' E' E ' 12' ' ' VAL . . . . . . . . . . . . . 12.7 p -151.09 151.0 12.86 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.276 0 CA-C-N 115.769 -0.65 . . . . 0.0 110.858 -179.196 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' E' E ' 13' ' ' GLU . . . . . . . . . . . . . 95.2 mt-10 -94.26 120.93 35.22 Favored 'General case' 0 C--N 1.329 -0.32 0 N-CA-C 109.827 -0.434 . . . . 0.0 109.827 175.842 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' E' E ' 14' ' ' LEU . . . . . . . . . . . . . 27.4 mt -97.35 150.96 37.37 Favored Pre-proline 0 CA--C 1.532 0.265 0 CA-C-O 119.333 -0.365 . . . . 0.0 110.735 -177.916 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' E' E ' 15' ' ' PRO . . . . . . . . . . . . . 28.0 Cg_exo -60.86 159.5 28.9 Favored 'Trans proline' 0 N--CA 1.497 1.735 0 C-N-CA 121.339 1.359 . . . . 0.0 111.977 178.055 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' E' E ' 16' ' ' PRO . . . . . . . . . . . . . 27.5 Cg_exo -60.14 -37.22 85.2 Favored 'Trans proline' 0 N--CA 1.496 1.661 0 C-N-CA 121.464 1.443 . . . . 0.0 112.497 -179.006 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' E' E ' 17' ' ' ASP . . . . . . . . . . . . . 19.6 p-10 -86.84 10.26 16.61 Favored 'General case' 0 CA--C 1.537 0.455 0 N-CA-C 113.144 0.794 . . . . 0.0 113.144 -177.89 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' E' E ' 18' ' ' PHE . . . . . . . . . . . . . 59.7 t80 -57.56 -45.66 84.89 Favored 'General case' 0 N--CA 1.458 -0.059 0 O-C-N 122.059 -0.401 . . . . 0.0 110.275 -178.075 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' E' E ' 19' ' ' VAL . . . . . . . . . . . . . 14.4 p -56.35 -41.46 71.4 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.307 0 CA-C-N 116.499 -0.318 . . . . 0.0 110.858 -178.832 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' E' E ' 20' ' ' ASP . . . . . . . . . . . . . 67.0 m-20 -60.78 -41.17 94.99 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-O 120.762 0.315 . . . . 0.0 110.7 -179.54 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' E' E ' 21' ' ' VAL . . . . . . . . . . . . . 50.0 t -64.02 -43.91 97.69 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.323 0 CA-C-N 116.346 -0.388 . . . . 0.0 110.148 -178.359 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' E' E ' 22' ' ' ILE . . . . . 0.641 HG22 HD12 ' E' ' 26' ' ' LEU . 46.2 mm -55.8 -49.15 76.45 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.227 0 C-N-CA 120.889 -0.324 . . . . 0.0 110.705 178.373 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' E' E ' 23' ' ' ARG . . . . . . . . . . . . . 30.7 ttp180 -54.86 -50.28 69.04 Favored 'General case' 0 C--N 1.33 -0.261 0 C-N-CA 121.013 -0.275 . . . . 0.0 111.466 -178.452 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' E' E ' 24' ' ' ILE . . . . . 0.428 ' O ' ' NE2' ' E' ' 27' ' ' GLN . 75.0 mt -58.77 -46.43 90.79 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.293 0 C-N-CA 120.988 -0.285 . . . . 0.0 111.132 -176.308 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' E' E ' 25' ' ' LYS . . . . . . . . . . . . . 8.5 mtpm? -67.17 -42.31 84.5 Favored 'General case' 0 C--N 1.328 -0.366 0 N-CA-C 112.283 0.475 . . . . 0.0 112.283 -176.607 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' E' E ' 26' ' ' LEU . . . . . 0.641 HD12 HG22 ' E' ' 22' ' ' ILE . 42.3 mt -80.11 -29.72 39.0 Favored 'General case' 0 C--N 1.33 -0.252 0 N-CA-C 113.326 0.861 . . . . 0.0 113.326 -171.957 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' E' E ' 27' ' ' GLN . . . . . 0.428 ' NE2' ' O ' ' E' ' 24' ' ' ILE . 18.8 pt20 -45.99 134.49 8.06 Favored 'General case' 0 N--CA 1.467 0.406 0 N-CA-C 112.78 0.659 . . . . 0.0 112.78 -174.38 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' E' E ' 28' ' ' GLY . . . . . . . . . . . . . . . 99.78 -21.94 42.67 Favored Glycine 0 CA--C 1.535 1.325 0 CA-C-N 115.815 -0.629 . . . . 0.0 112.477 -177.428 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' E' E ' 29' ' ' LYS . . . . . . . . . . . . . 9.1 mtpm? -97.39 155.16 17.03 Favored 'General case' 0 C--N 1.331 -0.2 0 CA-C-N 117.542 0.671 . . . . 0.0 110.875 179.63 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' E' E ' 30' ' ' THR . . . . . . . . . . . . . 37.8 m -102.42 139.03 38.57 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 115.929 -0.578 . . . . 0.0 110.424 177.997 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' E' E ' 31' ' ' VAL . . . . . . . . . . . . . 35.4 m -126.26 150.3 31.76 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.266 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.127 179.028 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' E' E ' 32' ' ' ARG . . . . . . . . . . . . . 66.9 ttt-85 -136.04 148.4 48.34 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-O 121.06 0.457 . . . . 0.0 110.332 179.377 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' E' E ' 33' ' ' THR . . . . . . . . . . . . . 28.0 m -52.84 138.27 29.95 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.35 -0.386 . . . . 0.0 111.515 -177.195 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' E' E ' 34' ' ' GLY . . . . . . . . . . . . . . . 98.44 -17.04 59.06 Favored Glycine 0 CA--C 1.533 1.189 0 CA-C-N 116.141 -0.482 . . . . 0.0 113.316 178.536 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' E' E ' 35' ' ' ASP . . . . . . . . . . . . . 81.2 m-20 -66.66 149.31 50.7 Favored 'General case' 0 C--O 1.231 0.131 0 CA-C-N 117.976 0.888 . . . . 0.0 111.312 179.85 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' E' E ' 36' ' ' VAL . . . . . . . . . . . . . 47.0 t -118.79 129.41 75.04 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.233 0 CA-C-N 115.745 -0.661 . . . . 0.0 109.674 176.679 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' E' E ' 37' ' ' ILE . . . . . . . . . . . . . 70.3 mt -120.17 138.46 50.64 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.26 0 N-CA-C 109.82 -0.437 . . . . 0.0 109.82 179.909 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' E' E ' 38' ' ' GLY . . . . . . . . . . . . . . . -111.9 128.57 8.65 Favored Glycine 0 CA--C 1.525 0.689 0 N-CA-C 111.055 -0.818 . . . . 0.0 111.055 179.384 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' E' E ' 39' ' ' ILE . . . . . . . . . . . . . 73.8 mt -127.59 135.98 61.72 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.189 0 CA-C-O 120.731 0.3 . . . . 0.0 110.267 179.186 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' E' E ' 40' ' ' SER . . . . . . . . . . . . . 91.0 p -92.99 116.24 28.87 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.278 -0.419 . . . . 0.0 110.733 174.429 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' E' E ' 41' ' ' ILE . . . . . . . . . . . . . 44.0 mm -121.1 123.17 69.43 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.216 0 CA-C-N 116.552 -0.294 . . . . 0.0 110.431 179.588 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' E' E ' 42' ' ' LEU . . . . . . . . . . . . . 47.0 mt 52.27 33.27 12.29 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.303 -0.408 . . . . 0.0 111.951 176.919 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' E' E ' 43' ' ' GLY . . . . . . . . . . . . . . . 74.15 31.69 59.27 Favored Glycine 0 CA--C 1.528 0.88 0 C-N-CA 121.135 -0.555 . . . . 0.0 112.159 177.711 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' E' E ' 44' ' ' LYS . . . . . . . . . . . . . 67.6 tttt -139.58 135.54 33.48 Favored 'General case' 0 C--N 1.329 -0.308 0 N-CA-C 109.674 -0.491 . . . . 0.0 109.674 177.747 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' E' E ' 45' ' ' GLU . . . . . . . . . . . . . 83.6 tt0 -82.16 120.92 25.95 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-O 120.861 0.362 . . . . 0.0 110.971 -177.098 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' E' E ' 46' ' ' VAL . . . . . . . . . . . . . 7.6 p -124.58 125.04 69.46 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.179 0 N-CA-C 109.41 -0.589 . . . . 0.0 109.41 176.277 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' E' E ' 47' ' ' LYS . . . . . . . . . . . . . 96.1 mttt -101.08 134.5 43.99 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.019 -0.537 . . . . 0.0 111.31 177.768 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' E' E ' 48' ' ' PHE . . . . . . . . . . . . . 88.5 m-85 -115.19 132.89 56.46 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 115.88 -0.6 . . . . 0.0 109.965 176.553 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' E' E ' 49' ' ' LYS . . . . . . . . . . . . . 83.3 tttt -105.33 136.91 43.99 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 116.347 -0.388 . . . . 0.0 109.987 177.303 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' E' E ' 50' ' ' VAL . . . . . . . . . . . . . 43.1 t -80.42 109.92 15.42 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.277 0 N-CA-C 109.353 -0.61 . . . . 0.0 109.353 176.821 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' E' E ' 51' ' ' VAL . . . . . . . . . . . . . 53.4 t -68.91 -47.33 76.46 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.24 0 CA-C-N 115.898 -0.592 . . . . 0.0 109.889 -174.777 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' E' E ' 52' ' ' GLN . . . . . . . . . . . . . 48.7 tt0 -167.85 141.77 3.46 Favored 'General case' 0 C--N 1.331 -0.219 0 C-N-CA 120.342 -0.543 . . . . 0.0 111.672 -179.688 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' E' E ' 53' ' ' ALA . . . . . . . . . . . . . . . -111.58 131.49 55.22 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 115.55 -0.75 . . . . 0.0 109.675 175.742 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' E' E ' 54' ' ' TYR . . . . . . . . . . . . . 50.6 t80 -127.67 106.48 20.8 Favored Pre-proline 0 CA--C 1.536 0.418 0 CA-C-O 118.319 -0.848 . . . . 0.0 110.438 -179.61 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' E' E ' 55' ' ' PRO . . . . . . . . . . . . . 73.4 Cg_endo -77.02 170.02 72.83 Favored 'Cis proline' 0 N--CA 1.499 1.836 0 CA-C-N 121.696 1.641 . . . . 0.0 112.607 -2.91 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' E' E ' 56' ' ' SER . . . . . . . . . . . . . 13.6 m -109.49 121.19 43.1 Favored Pre-proline 0 CA--C 1.539 0.537 0 CA-C-O 118.381 -0.819 . . . . 0.0 109.563 177.22 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' E' E ' 57' ' ' PRO . . . . . . . . . . . . . 61.1 Cg_endo -74.36 169.3 74.38 Favored 'Cis proline' 0 N--CA 1.497 1.686 0 CA-C-N 122.049 1.767 . . . . 0.0 112.073 0.97 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' E' E ' 58' ' ' LEU . . . . . . . . . . . . . 26.3 tp -128.13 136.16 50.78 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 115.999 -0.546 . . . . 0.0 110.014 179.755 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' E' E ' 59' ' ' ARG . . . . . . . . . . . . . 39.4 ttm180 -101.2 124.99 47.77 Favored 'General case' 0 C--N 1.326 -0.425 0 CA-C-N 115.89 -0.595 . . . . 0.0 109.467 178.512 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' E' E ' 60' ' ' VAL . . . . . . . . . . . . . 42.9 t -80.04 116.56 24.36 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.207 0 C-N-CA 120.57 -0.452 . . . . 0.0 110.353 -175.691 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' E' E ' 61' ' ' GLU . . . . . . . . . . . . . 95.6 mt-10 -131.04 166.07 21.85 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 115.792 -0.64 . . . . 0.0 110.045 178.765 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' E' E ' 62' ' ' ASP . . . . . . . . . . . . . 81.1 m-20 -54.94 -32.6 61.46 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.505 -0.316 . . . . 0.0 111.763 -179.991 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' E' E ' 63' ' ' ARG . . . . . . . . . . . . . 16.8 ptp180 -85.5 7.71 21.88 Favored 'General case' 0 CA--C 1.535 0.402 0 N-CA-C 113.536 0.939 . . . . 0.0 113.536 -175.751 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' E' E ' 64' ' ' THR . . . . . . . . . . . . . 34.0 m -94.35 141.79 28.16 Favored 'General case' 0 C--N 1.332 -0.166 0 CA-C-N 118.156 0.435 . . . . 0.0 110.587 -177.969 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' E' E ' 65' ' ' LYS . . . . . . . . . . . . . 98.3 mttt -88.87 126.8 35.54 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.09 -0.504 . . . . 0.0 110.195 179.234 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' E' E ' 66' ' ' ILE . . . . . . . . . . . . . 59.4 mt -114.23 126.45 71.75 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.292 0 N-CA-C 109.542 -0.54 . . . . 0.0 109.542 178.23 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' E' E ' 67' ' ' THR . . . . . . . . . . . . . 20.6 m -119.46 134.83 55.03 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-O 120.944 0.402 . . . . 0.0 110.481 -178.497 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' E' E ' 68' ' ' LEU . . . . . 0.481 ' C ' HD23 ' E' ' 68' ' ' LEU . 6.4 tt . . . . . 0 C--N 1.328 -0.345 0 CA-C-N 115.886 -0.597 . . . . 0.0 110.113 179.247 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' E' E ' 73' ' ' VAL . . . . . 0.58 HG12 HG22 ' D' ' 143' ' ' THR . 26.7 m . . . . . 0 C--O 1.232 0.136 0 CA-C-O 121.06 0.457 . . . . 0.0 110.968 . . . . . . . . . 1 1 . 1 . 017 nuclear build core ' E' E ' 74' ' ' ASP . . . . . . . . . . . . . 19.6 t0 -112.33 119.13 37.23 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 115.738 -0.665 . . . . 0.0 109.521 177.646 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' E' E ' 75' ' ' VAL . . . . . . . . . . . . . 43.8 t -110.63 126.53 67.96 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.258 0 CA-C-O 121.141 0.496 . . . . 0.0 111.0 -174.983 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' E' E ' 76' ' ' LEU . . . . . . . . . . . . . 23.0 mt -128.76 144.52 51.19 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 115.456 -0.793 . . . . 0.0 109.475 176.379 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' E' E ' 77' ' ' GLU . . . . . . . . . . . . . 98.0 mt-10 -131.72 139.33 48.97 Favored 'General case' 0 C--N 1.332 -0.163 0 CA-C-O 121.117 0.484 . . . . 0.0 111.622 -177.07 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' E' E ' 78' ' ' ALA . . . . . . . . . . . . . . . -126.68 129.41 48.39 Favored 'General case' 0 C--N 1.331 -0.196 0 CA-C-N 115.573 -0.74 . . . . 0.0 109.685 175.693 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' E' E ' 79' ' ' LYS . . . . . 0.602 ' O ' HD13 ' E' ' 80' ' ' ILE . 51.8 pttt -75.85 121.09 22.11 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-O 121.471 0.653 . . . . 0.0 110.997 -177.996 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' E' E ' 80' ' ' ILE . . . . . 0.602 HD13 ' O ' ' E' ' 79' ' ' LYS . 41.2 mm -139.28 107.52 3.26 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.224 0 CA-C-N 115.531 -0.759 . . . . 0.0 109.111 -177.131 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' E' E ' 81' ' ' LYS . . . . . . . . . . . . . 31.7 ttpt -103.61 126.94 51.06 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-O 120.838 0.351 . . . . 0.0 111.111 -177.199 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' E' E ' 82' ' ' GLY . . . . . . . . . . . . . . . 89.03 42.01 5.74 Favored Glycine 0 CA--C 1.526 0.722 0 C-N-CA 120.8 -0.714 . . . . 0.0 111.716 174.977 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' E' E ' 83' ' ' ILE . . . . . . . . . . . . . 70.8 mt -65.48 138.97 22.11 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.356 0 CA-C-O 120.931 0.396 . . . . 0.0 110.033 179.194 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' E' E ' 84' ' ' LYS . . . . . . . . . . . . . 57.0 tttp -98.72 -50.27 4.3 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 115.964 -0.562 . . . . 0.0 109.893 179.043 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' E' E ' 85' ' ' ASP . . . . . . . . . . . . . 5.3 t70 -157.92 153.4 26.16 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 115.647 -0.706 . . . . 0.0 110.228 178.696 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' E' E ' 86' ' ' VAL . . . . . . . . . . . . . 44.6 t -128.39 131.77 68.7 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.208 0 CA-C-O 121.014 0.435 . . . . 0.0 110.559 -178.838 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' E' E ' 87' ' ' ILE . . . . . . . . . . . . . 4.9 mp -117.99 123.3 71.46 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.253 0 CA-C-N 115.743 -0.662 . . . . 0.0 109.245 175.149 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' E' E ' 88' ' ' LEU . . . . . . . . . . . . . 13.0 tp -111.08 130.98 55.44 Favored 'General case' 0 C--N 1.331 -0.198 0 CA-C-O 120.99 0.424 . . . . 0.0 111.032 -177.328 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' E' E ' 89' ' ' ASP . . . . . . . . . . . . . 13.2 t70 -126.65 153.12 45.81 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 115.867 -0.606 . . . . 0.0 109.451 176.51 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' E' E ' 90' ' ' GLU . . . . . . . . . . . . . 80.4 tt0 -47.81 -33.42 7.25 Favored 'General case' 0 C--N 1.331 -0.23 0 N-CA-C 112.866 0.691 . . . . 0.0 112.866 -172.271 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' E' E ' 91' ' ' ASN . . . . . . . . . . . . . 3.8 p30 -129.14 14.55 6.22 Favored 'General case' 0 N--CA 1.469 0.509 0 N-CA-C 113.349 0.87 . . . . 0.0 113.349 -175.905 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' E' E ' 92' ' ' LEU . . . . . . . . . . . . . 34.9 mt -149.42 147.17 27.95 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-O 120.796 0.331 . . . . 0.0 110.508 -176.355 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' E' E ' 93' ' ' ILE . . . . . . . . . . . . . 71.7 mt -125.07 117.17 49.25 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.274 0 N-CA-C 109.319 -0.623 . . . . 0.0 109.319 177.696 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' E' E ' 94' ' ' VAL . . . . . . . . . . . . . 46.6 t -116.39 125.85 73.6 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.273 0 N-CA-C 109.753 -0.462 . . . . 0.0 109.753 -179.897 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' E' E ' 95' ' ' VAL . . . . . . . . . . . . . 38.7 t -122.74 132.93 70.32 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.293 0 CA-C-N 116.113 -0.494 . . . . 0.0 109.838 -179.097 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' E' E ' 96' ' ' ILE . . . . . . . . . . . . . 59.4 mt -114.53 129.57 70.37 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.327 0 N-CA-C 109.224 -0.658 . . . . 0.0 109.224 178.451 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' E' E ' 97' ' ' THR . . . . . . . . . . . . . 68.1 p -101.51 157.79 16.56 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-O 121.001 0.429 . . . . 0.0 110.968 -177.762 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' E' E ' 98' ' ' GLU . . . . . . . . . . . . . 44.6 mt-10 -53.81 -25.01 17.34 Favored 'General case' 0 C--N 1.329 -0.298 0 N-CA-C 112.489 0.551 . . . . 0.0 112.489 179.982 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' E' E ' 99' ' ' GLU . . . . . . . . . . . . . 96.4 mt-10 -78.1 14.69 1.08 Allowed 'General case' 0 CA--C 1.536 0.42 0 N-CA-C 113.331 0.863 . . . . 0.0 113.331 -177.052 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' E' E ' 100' ' ' ASN . . . . . . . . . . . . . 2.2 m-20 63.06 34.43 13.82 Favored 'General case' 0 N--CA 1.464 0.264 0 CA-C-N 117.909 0.322 . . . . 0.0 111.352 178.032 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' E' E ' 101' ' ' GLU . . . . . . . . . . . . . 81.4 tt0 -116.49 144.23 44.59 Favored 'General case' 0 C--N 1.332 -0.189 0 N-CA-C 109.582 -0.525 . . . . 0.0 109.582 175.195 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' E' E ' 102' ' ' VAL . . . . . . . . . . . . . 46.2 t -118.94 127.47 75.79 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.257 0 N-CA-C 109.864 -0.421 . . . . 0.0 109.864 -178.269 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' E' E ' 103' ' ' LEU . . . . . 0.506 HD12 ' N ' ' E' ' 103' ' ' LEU . 6.1 mp -118.39 135.8 54.12 Favored 'General case' 0 C--N 1.332 -0.188 0 CA-C-N 115.829 -0.623 . . . . 0.0 110.112 177.26 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' E' E ' 104' ' ' ILE . . . . . 0.408 HD13 HG21 ' E' ' 130' ' ' VAL . 66.2 mt -119.46 122.0 67.84 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.265 0 N-CA-C 110.147 -0.316 . . . . 0.0 110.147 -179.723 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' E' E ' 105' ' ' PHE . . . . . . . . . . . . . 73.7 m-85 -118.84 163.67 16.55 Favored 'General case' 0 C--N 1.33 -0.245 0 O-C-N 123.991 0.807 . . . . 0.0 109.405 179.353 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' E' E ' 106' ' ' ASN . . . . . . . . . . . . . 47.6 p-10 -96.64 -170.93 2.15 Favored 'General case' 0 C--N 1.331 -0.201 0 N-CA-C 109.803 -0.443 . . . . 0.0 109.803 172.714 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' E' E ' 107' ' ' GLN . . . . . . . . . . . . . 42.1 tt0 -59.73 -27.62 66.64 Favored 'General case' 0 C--N 1.327 -0.373 0 N-CA-C 112.104 0.409 . . . . 0.0 112.104 -179.963 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' E' E ' 108' ' ' ASN . . . . . . . . . . . . . 6.9 t-20 -88.14 13.9 10.33 Favored 'General case' 0 CA--C 1.536 0.418 0 N-CA-C 112.874 0.694 . . . . 0.0 112.874 -178.161 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' E' E ' 109' ' ' LEU . . . . . . . . . . . . . 42.0 mt 57.25 32.3 21.51 Favored 'General case' 0 CA--C 1.529 0.172 0 N-CA-C 112.013 0.375 . . . . 0.0 112.013 178.697 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' E' E ' 110' ' ' GLU . . . . . . . . . . . . . 95.1 mt-10 -101.18 140.02 36.05 Favored 'General case' 0 C--N 1.33 -0.261 0 N-CA-C 109.125 -0.694 . . . . 0.0 109.125 174.269 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' E' E ' 111' ' ' GLU . . . . . . . . . . . . . 44.7 tt0 -82.43 121.91 27.34 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-O 120.948 0.404 . . . . 0.0 110.69 -174.605 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' E' E ' 112' ' ' LEU . . . . . . . . . . . . . 14.0 mt -102.12 -45.18 5.23 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 115.909 -0.587 . . . . 0.0 110.547 179.338 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' E' E ' 113' ' ' TYR . . . . . . . . . . . . . 57.4 t80 -134.8 143.51 47.12 Favored 'General case' 0 C--N 1.331 -0.218 0 CA-C-N 116.387 -0.37 . . . . 0.0 111.078 -177.536 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' E' E ' 114' ' ' ARG . . . . . . . . . . . . . 35.1 ptt180 -147.06 125.49 12.36 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.18 -0.463 . . . . 0.0 110.727 177.863 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' E' E ' 115' ' ' GLY . . . . . . . . . . . . . . . -150.15 162.97 29.38 Favored Glycine 0 CA--C 1.523 0.572 0 N-CA-C 110.834 -0.907 . . . . 0.0 110.834 -179.927 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' E' E ' 116' ' ' LYS . . . . . . . . . . . . . 30.7 ttmt -132.06 138.97 48.37 Favored 'General case' 0 C--N 1.329 -0.305 0 O-C-N 122.59 -0.359 . . . . 0.0 110.051 177.922 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' E' E ' 117' ' ' PHE . . . . . . . . . . . . . 28.0 m-85 -137.09 114.78 11.22 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-O 120.875 0.369 . . . . 0.0 110.038 -175.938 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' E' E ' 118' ' ' GLU . . . . . . . . . . . . . 96.8 mt-10 -54.27 -43.03 70.64 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.458 -0.337 . . . . 0.0 111.333 -176.679 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' E' E ' 119' ' ' ASN . . . . . . . . . . . . . 59.2 m-80 -98.9 31.06 3.1 Favored 'General case' 0 C--N 1.331 -0.215 0 CA-C-N 116.222 -0.444 . . . . 0.0 112.159 -174.257 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' E' E ' 120' ' ' LEU . . . . . . . . . . . . . 25.1 tp -57.03 119.82 6.96 Favored 'General case' 0 C--N 1.333 -0.127 0 C-N-CA 121.028 -0.269 . . . . 0.0 110.322 177.937 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' E' E ' 121' ' ' ASN . . . . . . . . . . . . . 9.9 t-20 -114.14 -44.14 3.16 Favored 'General case' 0 C--N 1.332 -0.182 0 CA-C-N 116.545 -0.298 . . . . 0.0 111.192 -177.28 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' E' E ' 122' ' ' LYS . . . . . . . . . . . . . 61.8 mtpt -144.29 152.59 41.0 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-O 121.048 0.451 . . . . 0.0 111.561 -176.814 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' E' E ' 123' ' ' VAL . . . . . . . . . . . . . 43.5 t -132.32 131.89 60.64 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.238 0 CA-C-N 116.01 -0.541 . . . . 0.0 109.808 175.983 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' E' E ' 124' ' ' LEU . . . . . . . . . . . . . 52.6 mt -120.15 133.12 55.58 Favored 'General case' 0 C--N 1.331 -0.213 0 CA-C-N 116.275 -0.421 . . . . 0.0 110.624 -179.339 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' E' E ' 125' ' ' VAL . . . . . . . . . . . . . 43.3 t -127.83 120.34 53.8 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.188 0 N-CA-C 109.788 -0.449 . . . . 0.0 109.788 177.818 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' E' E ' 126' ' ' ARG . . . . . . . . . . . . . 51.2 mtp180 -148.87 138.86 22.16 Favored 'General case' 0 C--N 1.329 -0.323 0 N-CA-C 109.661 -0.496 . . . . 0.0 109.661 179.615 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' E' E ' 127' ' ' ASN . . . . . . . . . . . . . 4.9 p-10 48.67 -151.13 0.14 Allowed 'General case' 0 CA--C 1.54 0.585 0 CA-C-O 119.434 -0.317 . . . . 0.0 111.024 177.353 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' E' E ' 128' ' ' ASP . . . . . . . . . . . . . 13.3 p-10 -84.14 22.84 1.14 Allowed 'General case' 0 CA--C 1.534 0.332 0 CA-C-N 118.541 0.61 . . . . 0.0 112.416 178.653 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' E' E ' 129' ' ' LEU . . . . . . . . . . . . . 15.0 tp -127.08 140.4 52.31 Favored 'General case' 0 C--O 1.233 0.2 0 O-C-N 122.072 -0.393 . . . . 0.0 110.354 -179.398 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' E' E ' 130' ' ' VAL . . . . . 0.495 HG23 ' HB ' ' E' ' 141' ' ' ILE . 30.9 m -129.5 142.81 42.98 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.218 0 CA-C-O 121.001 0.429 . . . . 0.0 110.468 179.297 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' E' E ' 131' ' ' VAL . . . . . 0.525 HG22 HD12 ' E' ' 140' ' ' LEU . 39.8 t -136.1 138.92 46.65 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.234 0 CA-C-N 116.118 -0.492 . . . . 0.0 110.545 -177.77 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' E' E ' 132' ' ' ILE . . . . . . . . . . . . . 73.8 mt -117.18 132.22 67.61 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.289 0 N-CA-C 109.347 -0.612 . . . . 0.0 109.347 177.761 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' E' E ' 133' ' ' ILE . . . . . . . . . . . . . 35.2 mm -115.65 122.39 69.32 Favored 'Isoleucine or valine' 0 C--O 1.234 0.278 0 CA-C-O 120.656 0.265 . . . . 0.0 111.06 -174.766 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' E' E ' 134' ' ' ASP . . . . . . . . . . . . . 7.5 p-10 -135.15 146.44 48.78 Favored 'General case' 0 C--N 1.329 -0.31 0 N-CA-C 109.374 -0.602 . . . . 0.0 109.374 174.812 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' E' E ' 135' ' ' GLU . . . . . . . . . . . . . 84.4 tt0 -49.91 -26.37 4.06 Favored 'General case' 0 CA--C 1.532 0.285 0 N-CA-C 112.721 0.637 . . . . 0.0 112.721 -174.242 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' E' E ' 136' ' ' GLN . . . . . . . . . . . . . 24.9 tt0 -77.64 -38.56 47.63 Favored 'General case' 0 C--O 1.234 0.28 0 CA-C-O 120.896 0.379 . . . . 0.0 111.933 -177.01 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' E' E ' 137' ' ' LYS . . . . . . . . . . . . . 17.4 ptpt -166.83 176.47 7.05 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-O 121.496 0.665 . . . . 0.0 111.621 -173.364 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' E' E ' 138' ' ' LEU . . . . . 0.425 ' C ' HD23 ' E' ' 138' ' ' LEU . 7.4 tt -119.62 128.07 53.53 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 115.243 -0.89 . . . . 0.0 109.954 177.83 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' E' E ' 139' ' ' THR . . . . . . . . . . . . . 36.9 m -105.94 125.85 51.49 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.245 -0.434 . . . . 0.0 110.372 179.869 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' E' E ' 140' ' ' LEU . . . . . 0.525 HD12 HG22 ' E' ' 131' ' ' VAL . 21.3 tp -113.08 119.52 38.12 Favored 'General case' 0 C--N 1.329 -0.306 0 N-CA-C 109.018 -0.734 . . . . 0.0 109.018 -179.137 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' E' E ' 141' ' ' ILE . . . . . 0.495 ' HB ' HG23 ' E' ' 130' ' ' VAL . 19.5 mt -119.17 121.64 67.18 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.309 0 CA-C-O 121.042 0.449 . . . . 0.0 110.012 -175.944 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' E' E ' 142' ' ' ARG . . . . . . . . . . . . . 78.9 mtp180 -109.97 115.76 30.38 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 115.126 -0.943 . . . . 0.0 109.901 -177.748 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' E' E ' 143' ' ' THR . . . . . . . . . . . . . 34.9 p . . . . . 0 C--O 1.219 -0.51 0 CA-C-O 118.037 -0.983 . . . . 0.0 110.649 -178.24 . . . . . . . . 0 0 . 1 . 017 nuclear build core ' F' F ' 1' ' ' MET . . . . . . . . . . . . . 24.6 ptp . . . . . 0 C--O 1.232 0.147 0 CA-C-O 120.686 0.279 . . . . 0.0 110.683 . . . . . . . . . 0 0 . 1 . 017 nuclear build core ' F' F ' 2' ' ' SER . . . . . . . . . . . . . 50.6 p -123.7 141.06 52.37 Favored 'General case' 0 C--N 1.332 -0.184 0 CA-C-O 120.986 0.422 . . . . 0.0 110.534 178.968 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' F' F ' 3' ' ' GLU . . . . . . . . . . . . . 84.7 tt0 -142.01 140.45 32.67 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.041 -0.527 . . . . 0.0 111.376 -178.777 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' F' F ' 4' ' ' LEU . . . . . . . . . . . . . 67.9 mt -120.16 134.0 55.36 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.042 -0.526 . . . . 0.0 110.2 176.253 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' F' F ' 5' ' ' LYS . . . . . . . . . . . . . 68.1 mttm -109.97 119.85 40.6 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.303 -0.408 . . . . 0.0 110.275 178.194 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' F' F ' 6' ' ' LEU . . . . . . . . . . . . . 57.1 mt -114.51 147.51 39.28 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 115.382 -0.826 . . . . 0.0 110.472 -178.109 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' F' F ' 7' ' ' LYS . . . . . . . . . . . . . 56.4 tttm -136.84 137.14 22.52 Favored Pre-proline 0 CA--C 1.534 0.34 0 CA-C-O 118.901 -0.571 . . . . 0.0 109.962 176.78 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' F' F ' 8' ' ' PRO . . . . . . . . . . . . . 97.3 Cg_endo -91.97 141.98 2.55 Favored 'Trans proline' 0 N--CA 1.488 1.2 0 C-N-CA 121.688 1.592 . . . . 0.0 111.776 177.397 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' F' F ' 9' ' ' LEU . . . . . . . . . . . . . 21.9 mt -79.79 -47.3 1.46 Allowed Pre-proline 0 CA--C 1.532 0.274 0 CA-C-O 118.697 -0.668 . . . . 0.0 111.92 -178.94 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' F' F ' 10' ' ' PRO . . . . . . . . . . . . . 96.0 Cg_endo -81.66 140.61 11.83 Favored 'Trans proline' 0 N--CA 1.494 1.55 0 C-N-CA 121.188 1.258 . . . . 0.0 111.509 175.254 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' F' F ' 11' ' ' LYS . . . . . . . . . . . . . 46.3 tptt -79.94 98.09 7.01 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-O 120.863 0.363 . . . . 0.0 110.184 179.726 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' F' F ' 12' ' ' VAL . . . . . . . . . . . . . 12.7 p -138.16 145.81 27.98 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.245 0 CA-C-N 116.132 -0.485 . . . . 0.0 110.542 -179.357 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' F' F ' 13' ' ' GLU . . . . . . . . . . . . . 84.6 tt0 -83.56 126.13 32.49 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.353 -0.385 . . . . 0.0 110.403 179.515 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' F' F ' 14' ' ' LEU . . . . . . . . . . . . . 15.5 mt -98.13 149.86 36.15 Favored Pre-proline 0 CA--C 1.532 0.284 0 CA-C-N 116.338 -0.392 . . . . 0.0 110.352 -178.593 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' F' F ' 15' ' ' PRO . . . . . . . . . . . . . 25.8 Cg_exo -62.51 164.11 19.03 Favored 'Trans proline' 0 N--CA 1.496 1.628 0 C-N-CA 121.277 1.318 . . . . 0.0 111.916 176.001 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' F' F ' 16' ' ' PRO . . . . . . . . . . . . . 27.6 Cg_exo -60.32 -41.84 46.86 Favored 'Trans proline' 0 N--CA 1.498 1.748 0 C-N-CA 121.439 1.426 . . . . 0.0 112.842 -177.974 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' F' F ' 17' ' ' ASP . . . . . . . . . . . . . 7.9 p-10 -88.67 11.09 18.45 Favored 'General case' 0 C--N 1.327 -0.376 0 N-CA-C 113.249 0.833 . . . . 0.0 113.249 -176.679 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' F' F ' 18' ' ' PHE . . . . . . . . . . . . . 49.2 t80 -57.18 -42.72 81.69 Favored 'General case' 0 C--N 1.334 -0.07 0 O-C-N 121.922 -0.486 . . . . 0.0 110.25 -178.816 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' F' F ' 19' ' ' VAL . . . . . . . . . . . . . 47.7 t -57.52 -43.05 82.3 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.321 0 CA-C-N 116.144 -0.48 . . . . 0.0 110.36 -179.092 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' F' F ' 20' ' ' ASP . . . . . . . . . . . . . 8.6 t70 -59.85 -41.13 90.74 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-O 120.873 0.368 . . . . 0.0 110.726 -178.217 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' F' F ' 21' ' ' VAL . . . . . . . . . . . . . 51.1 t -64.36 -47.2 90.58 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.332 0 CA-C-N 116.323 -0.398 . . . . 0.0 110.392 -178.2 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' F' F ' 22' ' ' ILE . . . . . 0.446 HG22 HD12 ' F' ' 26' ' ' LEU . 50.5 mm -55.93 -45.37 80.0 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.202 0 C-N-CA 120.928 -0.309 . . . . 0.0 110.662 179.201 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' F' F ' 23' ' ' ARG . . . . . . . . . . . . . 36.1 ttp180 -53.83 -50.7 65.62 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-O 120.675 0.274 . . . . 0.0 111.428 -178.999 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' F' F ' 24' ' ' ILE . . . . . . . . . . . . . 71.5 mt -60.31 -41.36 86.83 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.264 0 CA-C-N 116.514 -0.312 . . . . 0.0 111.314 -177.18 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' F' F ' 25' ' ' LYS . . . . . . . . . . . . . 82.3 mttt -66.39 -39.02 88.81 Favored 'General case' 0 C--N 1.33 -0.265 0 N-CA-C 112.354 0.502 . . . . 0.0 112.354 -178.674 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' F' F ' 26' ' ' LEU . . . . . 0.446 HD12 HG22 ' F' ' 22' ' ' ILE . 75.7 mt -78.42 -41.9 31.64 Favored 'General case' 0 C--N 1.33 -0.278 0 N-CA-C 113.005 0.742 . . . . 0.0 113.005 -173.39 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' F' F ' 27' ' ' GLN . . . . . . . . . . . . . 10.8 pt20 -46.91 142.1 3.66 Favored 'General case' 0 N--CA 1.47 0.538 0 N-CA-C 112.694 0.627 . . . . 0.0 112.694 -175.377 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' F' F ' 28' ' ' GLY . . . . . . . . . . . . . . . 98.94 -29.77 11.09 Favored Glycine 0 CA--C 1.531 1.087 0 CA-C-N 115.514 -0.766 . . . . 0.0 111.96 -177.477 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' F' F ' 29' ' ' LYS . . . . . . . . . . . . . 8.7 mtpm? -98.66 155.14 17.47 Favored 'General case' 0 C--O 1.232 0.167 0 CA-C-O 121.013 0.435 . . . . 0.0 110.955 179.264 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' F' F ' 30' ' ' THR . . . . . . . . . . . . . 29.7 m -97.28 138.4 34.82 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.151 -0.477 . . . . 0.0 109.947 175.682 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' F' F ' 31' ' ' VAL . . . . . . . . . . . . . 35.3 m -124.94 151.45 30.56 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.257 0 CA-C-N 116.289 -0.414 . . . . 0.0 110.82 -178.47 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' F' F ' 32' ' ' ARG . . . . . . . . . . . . . 61.5 mtp180 -135.3 152.19 51.26 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-O 121.398 0.618 . . . . 0.0 110.717 176.82 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' F' F ' 33' ' ' THR . . . . . . . . . . . . . 8.4 m -54.0 138.3 37.48 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 115.973 -0.558 . . . . 0.0 111.18 -179.085 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' F' F ' 34' ' ' GLY . . . . . . . . . . . . . . . 101.57 -17.08 55.79 Favored Glycine 0 CA--C 1.532 1.139 0 CA-C-O 119.539 -0.59 . . . . 0.0 113.293 178.768 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' F' F ' 35' ' ' ASP . . . . . . . . . . . . . 74.2 m-20 -65.27 148.81 51.04 Favored 'General case' 0 N--CA 1.461 0.113 0 CA-C-N 118.134 0.967 . . . . 0.0 111.25 179.869 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' F' F ' 36' ' ' VAL . . . . . . . . . . . . . 44.8 t -122.48 129.84 74.96 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.16 0 CA-C-N 115.741 -0.663 . . . . 0.0 109.793 178.308 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' F' F ' 37' ' ' ILE . . . . . . . . . . . . . 70.4 mt -122.71 140.18 47.28 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.185 0 CA-C-N 116.233 -0.439 . . . . 0.0 109.96 -179.813 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' F' F ' 38' ' ' GLY . . . . . . . . . . . . . . . -114.0 128.78 8.42 Favored Glycine 0 CA--C 1.525 0.679 0 N-CA-C 111.211 -0.756 . . . . 0.0 111.211 -179.973 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' F' F ' 39' ' ' ILE . . . . . . . . . . . . . 72.4 mt -126.25 130.27 72.03 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.214 0 N-CA-C 109.746 -0.465 . . . . 0.0 109.746 178.539 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' F' F ' 40' ' ' SER . . . . . 0.558 ' O ' HD13 ' F' ' 41' ' ' ILE . 83.7 p -93.45 121.62 35.04 Favored 'General case' 0 C--N 1.331 -0.227 0 C-N-CA 120.945 -0.302 . . . . 0.0 111.456 178.826 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' F' F ' 41' ' ' ILE . . . . . 0.558 HD13 ' O ' ' F' ' 40' ' ' SER . 44.5 mm -133.4 129.13 55.99 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.181 0 CA-C-N 116.427 -0.351 . . . . 0.0 110.163 177.813 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' F' F ' 42' ' ' LEU . . . . . 0.481 ' HG ' HG22 ' F' ' 41' ' ' ILE . 70.3 mt 57.6 32.99 22.67 Favored 'General case' 0 C--N 1.33 -0.249 0 N-CA-C 112.023 0.379 . . . . 0.0 112.023 176.93 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' F' F ' 43' ' ' GLY . . . . . . . . . . . . . . . 77.46 -10.12 24.6 Favored Glycine 0 CA--C 1.533 1.205 0 C-N-CA 121.108 -0.568 . . . . 0.0 113.553 177.502 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' F' F ' 44' ' ' LYS . . . . . . . . . . . . . 37.6 mmtm -103.25 136.31 43.26 Favored 'General case' 0 C--O 1.232 0.173 0 CA-C-N 117.988 0.894 . . . . 0.0 110.051 176.638 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' F' F ' 45' ' ' GLU . . . . . . . . . . . . . 35.1 tp10 -84.58 127.56 34.13 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.344 -0.389 . . . . 0.0 110.628 -179.805 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' F' F ' 46' ' ' VAL . . . . . . . . . . . . . 5.8 p -115.22 126.67 72.85 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.223 0 N-CA-C 109.212 -0.662 . . . . 0.0 109.212 176.23 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' F' F ' 47' ' ' LYS . . . . . . . . . . . . . 63.4 mttm -100.14 128.99 46.12 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 115.791 -0.641 . . . . 0.0 110.924 -179.482 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' F' F ' 48' ' ' PHE . . . . . . . . . . . . . 95.6 m-85 -113.73 131.83 56.04 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.358 -0.383 . . . . 0.0 110.324 177.884 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' F' F ' 49' ' ' LYS . . . . . . . . . . . . . 80.0 tttt -108.06 139.01 43.34 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.357 -0.383 . . . . 0.0 110.633 178.214 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' F' F ' 50' ' ' VAL . . . . . . . . . . . . . 45.0 t -82.11 107.33 14.0 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.343 0 N-CA-C 109.224 -0.658 . . . . 0.0 109.224 175.011 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' F' F ' 51' ' ' VAL . . . . . . . . . . . . . 50.3 t -72.25 -51.87 27.42 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.258 0 CA-C-N 116.103 -0.499 . . . . 0.0 109.757 -174.753 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' F' F ' 52' ' ' GLN . . . . . . . . . . . . . 90.7 mt-30 -153.84 153.23 31.73 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-O 121.296 0.57 . . . . 0.0 111.722 -178.564 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' F' F ' 53' ' ' ALA . . . . . . . . . . . . . . . -129.98 132.64 46.37 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 115.252 -0.885 . . . . 0.0 109.635 173.825 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' F' F ' 54' ' ' TYR . . . . . . . . . . . . . 41.1 t80 -129.09 110.58 18.24 Favored Pre-proline 0 CA--C 1.536 0.406 0 CA-C-O 118.231 -0.89 . . . . 0.0 110.555 179.974 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' F' F ' 55' ' ' PRO . . . . . . . . . . . . . 74.4 Cg_endo -77.21 169.37 74.35 Favored 'Cis proline' 0 N--CA 1.5 1.869 0 CA-C-N 121.823 1.687 . . . . 0.0 112.165 -7.971 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' F' F ' 56' ' ' SER . . . . . . . . . . . . . 13.6 m -117.84 135.03 23.22 Favored Pre-proline 0 CA--C 1.538 0.487 0 CA-C-O 118.515 -0.755 . . . . 0.0 109.599 174.809 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' F' F ' 57' ' ' PRO . . . . . . . . . . . . . 58.8 Cg_endo -73.18 162.01 92.69 Favored 'Cis proline' 0 N--CA 1.498 1.736 0 CA-C-N 121.898 1.714 . . . . 0.0 111.412 -2.656 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' F' F ' 58' ' ' LEU . . . . . . . . . . . . . 23.9 tp -130.88 139.64 50.13 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-O 121.003 0.43 . . . . 0.0 110.936 -179.673 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' F' F ' 59' ' ' ARG . . . . . . . . . . . . . 35.7 ttm180 -97.84 125.22 42.59 Favored 'General case' 0 C--N 1.327 -0.399 0 N-CA-C 109.087 -0.708 . . . . 0.0 109.087 173.052 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' F' F ' 60' ' ' VAL . . . . . . . . . . . . . 43.4 t -79.44 119.86 29.59 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.262 0 C-N-CA 120.599 -0.44 . . . . 0.0 110.426 -175.144 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' F' F ' 61' ' ' GLU . . . . . . . . . . . . . 95.2 mt-10 -131.08 169.93 15.21 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 115.792 -0.64 . . . . 0.0 109.742 176.592 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' F' F ' 62' ' ' ASP . . . . . . . . . . . . . 80.1 m-20 -52.8 -32.37 43.66 Favored 'General case' 0 C--N 1.329 -0.305 0 N-CA-C 111.948 0.351 . . . . 0.0 111.948 -178.417 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' F' F ' 63' ' ' ARG . . . . . . . . . . . . . 85.4 mtt180 -72.29 -22.06 61.26 Favored 'General case' 0 CA--C 1.533 0.308 0 N-CA-C 113.019 0.748 . . . . 0.0 113.019 -175.661 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' F' F ' 64' ' ' THR . . . . . . . . . . . . . 33.1 m -68.72 135.43 51.29 Favored 'General case' 0 C--N 1.331 -0.229 0 CA-C-O 120.995 0.426 . . . . 0.0 111.049 -175.099 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' F' F ' 65' ' ' LYS . . . . . . . . . . . . . 63.3 mttm -89.95 136.47 33.02 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 115.912 -0.585 . . . . 0.0 110.064 177.922 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' F' F ' 66' ' ' ILE . . . . . . . . . . . . . 60.1 mt -118.29 129.95 73.86 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.185 0 N-CA-C 109.851 -0.426 . . . . 0.0 109.851 179.06 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' F' F ' 67' ' ' THR . . . . . . . . . . . . . 24.2 m -124.88 142.26 51.57 Favored 'General case' 0 C--N 1.332 -0.186 0 CA-C-O 121.103 0.477 . . . . 0.0 110.9 -178.878 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' F' F ' 68' ' ' LEU . . . . . 0.478 HD23 ' C ' ' F' ' 68' ' ' LEU . 7.1 tt . . . . . 0 C--N 1.33 -0.24 0 CA-C-N 115.944 -0.571 . . . . 0.0 109.822 177.396 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' F' F ' 73' ' ' VAL . . . . . . . . . . . . . 33.1 m . . . . . 0 C--O 1.23 0.066 0 N-CA-C 110.112 -0.329 . . . . 0.0 110.112 . . . . . . . . . 0 0 . 1 . 017 nuclear build core ' F' F ' 74' ' ' ASP . . . . . . . . . . . . . 14.4 t0 -92.85 117.49 30.08 Favored 'General case' 0 C--N 1.331 -0.227 0 C-N-CA 120.735 -0.386 . . . . 0.0 110.3 -173.729 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' F' F ' 75' ' ' VAL . . . . . . . . . . . . . 41.8 t -113.72 120.43 63.56 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.287 0 CA-C-O 121.101 0.477 . . . . 0.0 110.075 -179.785 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' F' F ' 76' ' ' LEU . . . . . . . . . . . . . 15.4 mt -125.17 144.17 50.58 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 115.728 -0.669 . . . . 0.0 109.686 178.129 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' F' F ' 77' ' ' GLU . . . . . . . . . . . . . 97.4 mt-10 -134.6 132.69 39.35 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-O 121.151 0.501 . . . . 0.0 110.981 -176.855 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' F' F ' 78' ' ' ALA . . . . . . . . . . . . . . . -116.33 127.29 54.56 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 115.658 -0.701 . . . . 0.0 109.719 177.309 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' F' F ' 79' ' ' LYS . . . . . 0.623 ' O ' HD13 ' F' ' 80' ' ' ILE . 52.5 mtmt -78.39 116.31 18.71 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-O 120.85 0.357 . . . . 0.0 110.691 -177.586 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' F' F ' 80' ' ' ILE . . . . . 0.623 HD13 ' O ' ' F' ' 79' ' ' LYS . 40.1 mm -139.14 106.25 2.83 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.295 0 N-CA-C 109.003 -0.74 . . . . 0.0 109.003 -177.313 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' F' F ' 81' ' ' LYS . . . . . . . . . . . . . 44.3 tptt -98.05 124.17 42.42 Favored 'General case' 0 C--N 1.328 -0.355 0 C-N-CA 120.788 -0.365 . . . . 0.0 110.806 -175.95 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' F' F ' 82' ' ' GLY . . . . . . . . . . . . . . . 89.09 42.24 5.66 Favored Glycine 0 CA--C 1.524 0.648 0 C-N-CA 120.756 -0.735 . . . . 0.0 111.798 175.423 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' F' F ' 83' ' ' ILE . . . . . . . . . . . . . 75.7 mt -66.45 141.09 18.45 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.286 0 N-CA-C 109.815 -0.439 . . . . 0.0 109.815 177.122 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' F' F ' 84' ' ' LYS . . . . . . . . . . . . . 41.6 tttp -95.4 -53.42 3.77 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 115.93 -0.577 . . . . 0.0 110.361 -178.775 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' F' F ' 85' ' ' ASP . . . . . . . . . . . . . 12.9 t70 -153.21 151.98 30.69 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 115.714 -0.675 . . . . 0.0 110.419 -179.711 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' F' F ' 86' ' ' VAL . . . . . . . . . . . . . 44.6 t -127.22 130.68 71.01 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.266 0 CA-C-O 120.951 0.405 . . . . 0.0 110.406 -179.113 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' F' F ' 87' ' ' ILE . . . . . 0.498 HD12 ' N ' ' F' ' 87' ' ' ILE . 5.0 mp -122.03 129.02 75.74 Favored 'Isoleucine or valine' 0 C--O 1.233 0.206 0 CA-C-N 115.932 -0.576 . . . . 0.0 109.604 176.954 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' F' F ' 88' ' ' LEU . . . . . . . . . . . . . 18.5 tp -112.32 128.36 56.26 Favored 'General case' 0 C--N 1.332 -0.183 0 CA-C-O 121.03 0.443 . . . . 0.0 110.983 -179.0 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' F' F ' 89' ' ' ASP . . . . . . . . . . . . . 6.5 t0 -117.28 152.1 35.56 Favored 'General case' 0 C--N 1.329 -0.3 0 N-CA-C 109.093 -0.706 . . . . 0.0 109.093 175.63 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' F' F ' 90' ' ' GLU . . . . . . . . . . . . . 84.3 tt0 -48.86 -30.57 5.96 Favored 'General case' 0 C--N 1.329 -0.299 0 N-CA-C 112.83 0.678 . . . . 0.0 112.83 -172.534 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' F' F ' 91' ' ' ASN . . . . . . . . . . . . . 7.3 m120 -130.55 15.78 5.43 Favored 'General case' 0 N--CA 1.468 0.468 0 N-CA-C 113.308 0.855 . . . . 0.0 113.308 -177.051 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' F' F ' 92' ' ' LEU . . . . . . . . . . . . . 55.7 mt -149.96 149.59 30.62 Favored 'General case' 0 C--N 1.332 -0.195 0 CA-C-N 117.964 0.347 . . . . 0.0 110.764 -176.396 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' F' F ' 93' ' ' ILE . . . . . . . . . . . . . 68.2 mt -122.16 119.63 59.01 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.244 0 N-CA-C 108.985 -0.746 . . . . 0.0 108.985 176.631 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' F' F ' 94' ' ' VAL . . . . . 0.452 HG21 HG21 ' F' ' 125' ' ' VAL . 47.6 t -120.67 127.31 75.91 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.254 0 CA-C-O 121.008 0.432 . . . . 0.0 110.016 -178.785 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' F' F ' 95' ' ' VAL . . . . . . . . . . . . . 40.4 t -122.87 134.84 64.84 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.342 0 CA-C-N 115.809 -0.632 . . . . 0.0 109.876 -179.754 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' F' F ' 96' ' ' ILE . . . . . 0.528 HD11 ' HB ' ' F' ' 123' ' ' VAL . 59.1 mt -114.48 125.65 71.83 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.379 0 N-CA-C 108.947 -0.76 . . . . 0.0 108.947 178.266 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' F' F ' 97' ' ' THR . . . . . . . . . . . . . 73.9 p -98.91 155.23 17.51 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-O 121.221 0.534 . . . . 0.0 111.438 -175.585 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' F' F ' 98' ' ' GLU . . . . . . . . . . . . . 22.1 pt-20 -54.26 -21.76 10.01 Favored 'General case' 0 CA--C 1.534 0.353 0 N-CA-C 112.568 0.581 . . . . 0.0 112.568 179.339 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' F' F ' 99' ' ' GLU . . . . . . . . . . . . . 34.7 tt0 -83.74 18.11 2.07 Favored 'General case' 0 CA--C 1.539 0.542 0 N-CA-C 112.394 0.516 . . . . 0.0 112.394 -177.548 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' F' F ' 100' ' ' ASN . . . . . . . . . . . . . 3.6 m-20 62.04 37.98 14.37 Favored 'General case' 0 C--O 1.232 0.183 0 CA-C-O 121.161 0.505 . . . . 0.0 111.029 177.247 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' F' F ' 101' ' ' GLU . . . . . . . . . . . . . 84.2 tt0 -118.13 143.36 46.55 Favored 'General case' 0 C--N 1.331 -0.219 0 CA-C-N 116.147 -0.479 . . . . 0.0 109.998 176.836 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' F' F ' 102' ' ' VAL . . . . . . . . . . . . . 44.8 t -114.9 125.54 72.25 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.345 0 N-CA-C 109.822 -0.436 . . . . 0.0 109.822 -179.268 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' F' F ' 103' ' ' LEU . . . . . . . . . . . . . 21.2 mt -118.79 129.45 55.25 Favored 'General case' 0 C--N 1.331 -0.223 0 CA-C-N 115.791 -0.64 . . . . 0.0 110.28 178.116 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' F' F ' 104' ' ' ILE . . . . . . . . . . . . . 67.4 mt -118.63 121.56 67.3 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.251 0 N-CA-C 109.974 -0.38 . . . . 0.0 109.974 178.575 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' F' F ' 105' ' ' PHE . . . . . . . . . . . . . 52.7 m-85 -120.74 163.59 17.88 Favored 'General case' 0 C--N 1.332 -0.176 0 O-C-N 123.978 0.799 . . . . 0.0 109.623 179.647 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' F' F ' 106' ' ' ASN . . . . . . . . . . . . . 48.7 p-10 -97.67 -173.45 2.63 Favored 'General case' 0 C--N 1.328 -0.34 0 N-CA-C 109.618 -0.512 . . . . 0.0 109.618 171.887 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' F' F ' 107' ' ' GLN . . . . . . . . . . . . . 47.2 tt0 -58.57 -26.56 63.72 Favored 'General case' 0 C--N 1.329 -0.317 0 N-CA-C 112.349 0.5 . . . . 0.0 112.349 -178.543 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' F' F ' 108' ' ' ASN . . . . . . . . . . . . . 8.3 t-20 -89.63 14.07 12.55 Favored 'General case' 0 CA--C 1.535 0.379 0 N-CA-C 112.96 0.726 . . . . 0.0 112.96 -176.725 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' F' F ' 109' ' ' LEU . . . . . . . . . . . . . 48.9 mt 57.56 38.98 28.08 Favored 'General case' 0 C--N 1.332 -0.154 0 CA-C-O 121.163 0.506 . . . . 0.0 111.504 178.01 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' F' F ' 110' ' ' GLU . . . . . . . . . . . . . 95.9 mt-10 -104.05 161.03 14.34 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.076 -0.511 . . . . 0.0 109.958 176.466 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' F' F ' 111' ' ' GLU . . . . . . . . . . . . . 84.6 tt0 -89.64 122.33 32.67 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-O 120.905 0.383 . . . . 0.0 110.922 -177.869 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' F' F ' 112' ' ' LEU . . . . . . . . . . . . . 14.0 mt -112.1 -46.04 3.24 Favored 'General case' 0 C--N 1.332 -0.195 0 CA-C-N 116.071 -0.513 . . . . 0.0 110.419 178.029 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' F' F ' 113' ' ' TYR . . . . . . . . . . . . . 54.3 t80 -140.84 134.61 30.37 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.286 -0.416 . . . . 0.0 110.921 179.85 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' F' F ' 114' ' ' ARG . . . . . . . . . . . . . 43.4 ttp180 -141.71 122.49 14.37 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.489 -0.323 . . . . 0.0 110.479 177.782 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' F' F ' 115' ' ' GLY . . . . . . . . . . . . . . . -150.16 146.94 16.6 Favored Glycine 0 CA--C 1.526 0.72 0 N-CA-C 111.193 -0.763 . . . . 0.0 111.193 178.998 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' F' F ' 116' ' ' LYS . . . . . . . . . . . . . 33.2 ttpt -115.2 133.76 55.75 Favored 'General case' 0 C--N 1.33 -0.24 0 N-CA-C 109.776 -0.453 . . . . 0.0 109.776 176.228 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' F' F ' 117' ' ' PHE . . . . . . . . . . . . . 52.3 m-85 -131.77 114.59 14.92 Favored 'General case' 0 C--N 1.332 -0.184 0 CA-C-O 120.924 0.392 . . . . 0.0 110.279 -176.298 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' F' F ' 118' ' ' GLU . . . . . . . . . . . . . 84.4 tt0 -54.26 -45.39 72.4 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.443 -0.344 . . . . 0.0 111.539 -176.015 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' F' F ' 119' ' ' ASN . . . . . . . . . . . . . 9.2 m120 -97.54 30.94 2.7 Favored 'General case' 0 C--N 1.33 -0.281 0 N-CA-C 112.178 0.436 . . . . 0.0 112.178 -174.934 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' F' F ' 120' ' ' LEU . . . . . . . . . . . . . 23.9 tp -58.01 126.95 29.68 Favored 'General case' 0 C--N 1.333 -0.148 0 CA-C-O 120.76 0.314 . . . . 0.0 110.304 178.411 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' F' F ' 121' ' ' ASN . . . . . . . . . . . . . 20.8 t-20 -109.77 -44.0 3.92 Favored 'General case' 0 C--N 1.332 -0.181 0 CA-C-N 116.376 -0.374 . . . . 0.0 110.946 -177.987 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' F' F ' 122' ' ' LYS . . . . . . . . . . . . . 18.8 ptpt -161.29 159.72 28.91 Favored 'General case' 0 C--N 1.333 -0.136 0 CA-C-O 121.141 0.496 . . . . 0.0 111.82 -179.33 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' F' F ' 123' ' ' VAL . . . . . 0.528 ' HB ' HD11 ' F' ' 96' ' ' ILE . 45.8 t -127.27 135.59 63.02 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.199 0 CA-C-N 115.867 -0.606 . . . . 0.0 109.749 177.15 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' F' F ' 124' ' ' LEU . . . . . . . . . . . . . 6.5 mp -118.53 130.41 55.9 Favored 'General case' 0 C--N 1.331 -0.22 0 CA-C-N 116.37 -0.377 . . . . 0.0 110.636 -179.22 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' F' F ' 125' ' ' VAL . . . . . 0.568 HG22 HG23 ' F' ' 130' ' ' VAL . 44.6 t -131.69 127.71 59.4 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.236 0 CA-C-N 116.331 -0.395 . . . . 0.0 110.17 179.371 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' F' F ' 126' ' ' ARG . . . . . . . . . . . . . 78.7 mtt180 -149.98 133.63 16.72 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-O 120.95 0.405 . . . . 0.0 110.889 177.154 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' F' F ' 127' ' ' ASN . . . . . . . . . . . . . 9.4 m120 52.48 -118.28 1.29 Allowed 'General case' 0 CA--C 1.545 0.77 0 CA-C-O 118.657 -0.687 . . . . 0.0 110.798 178.826 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' F' F ' 128' ' ' ASP . . . . . . . . . . . . . 8.2 p-10 -113.26 13.55 19.17 Favored 'General case' 0 N--CA 1.469 0.477 0 CA-C-N 120.107 1.321 . . . . 0.0 112.838 -179.624 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' F' F ' 129' ' ' LEU . . . . . . . . . . . . . 13.5 tp -116.26 139.2 50.62 Favored 'General case' 0 C--O 1.233 0.187 0 N-CA-C 109.832 -0.433 . . . . 0.0 109.832 179.121 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' F' F ' 130' ' ' VAL . . . . . 0.568 HG23 HG22 ' F' ' 125' ' ' VAL . 13.0 p -134.06 141.22 44.44 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.196 0 CA-C-O 121.1 0.476 . . . . 0.0 110.554 -179.326 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' F' F ' 131' ' ' VAL . . . . . . . . . . . . . 35.3 m -136.06 147.45 28.16 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.362 0 CA-C-N 115.963 -0.562 . . . . 0.0 110.801 179.212 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' F' F ' 132' ' ' ILE . . . . . . . . . . . . . 71.0 mt -118.43 131.05 72.33 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.373 0 CA-C-N 115.736 -0.665 . . . . 0.0 109.285 -179.873 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' F' F ' 133' ' ' ILE . . . . . . . . . . . . . 43.4 mm -115.6 121.81 68.08 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.241 0 CA-C-O 120.753 0.311 . . . . 0.0 110.708 -175.979 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' F' F ' 134' ' ' ASP . . . . . . . . . . . . . 7.6 p-10 -133.88 149.15 51.32 Favored 'General case' 0 C--N 1.331 -0.212 0 N-CA-C 109.586 -0.524 . . . . 0.0 109.586 174.562 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' F' F ' 135' ' ' GLU . . . . . . . . . . . . . 84.9 tt0 -49.84 -24.33 2.38 Favored 'General case' 0 C--N 1.326 -0.423 0 N-CA-C 112.949 0.722 . . . . 0.0 112.949 -170.869 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' F' F ' 136' ' ' GLN . . . . . . . . . . . . . 48.5 tt0 -104.68 -25.57 12.65 Favored 'General case' 0 N--CA 1.465 0.297 0 N-CA-C 112.846 0.684 . . . . 0.0 112.846 -174.484 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' F' F ' 137' ' ' LYS . . . . . . . . . . . . . 88.5 mttt -141.62 151.72 43.36 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-O 121.169 0.509 . . . . 0.0 111.777 -171.23 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' F' F ' 138' ' ' LEU . . . . . . . . . . . . . 5.0 tt -120.04 120.27 35.81 Favored 'General case' 0 C--N 1.329 -0.29 0 N-CA-C 109.151 -0.685 . . . . 0.0 109.151 172.502 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' F' F ' 139' ' ' THR . . . . . . . . . . . . . 40.6 m -110.92 131.15 55.29 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.416 -0.356 . . . . 0.0 110.792 -176.956 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' F' F ' 140' ' ' LEU . . . . . 0.485 HD23 ' C ' ' F' ' 140' ' ' LEU . 8.0 tt -116.26 123.77 48.53 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 115.769 -0.651 . . . . 0.0 109.309 -179.671 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' F' F ' 141' ' ' ILE . . . . . 0.566 ' HB ' HG13 ' F' ' 130' ' ' VAL . 19.2 mt -122.54 121.1 62.77 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.295 0 CA-C-O 121.08 0.467 . . . . 0.0 110.072 -175.811 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' F' F ' 142' ' ' ARG . . . . . . . . . . . . . 65.8 ttt180 -109.98 129.23 55.7 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 115.318 -0.855 . . . . 0.0 110.364 -178.992 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' F' F ' 143' ' ' THR . . . . . . . . . . . . . 81.3 p . . . . . 0 C--O 1.219 -0.505 0 CA-C-O 117.915 -1.04 . . . . 0.0 110.484 178.927 . . . . . . . . 0 0 . 1 . 018 nuclear build core ' A' A ' 2' ' ' SER . . . . . 0.415 ' HB2' HD11 ' A' ' 58' ' ' LEU . 79.0 p . . . . . 0 N--CA 1.462 0.126 0 CA-C-O 120.936 0.398 . . . . 0.0 110.625 . . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 44.5 mp0 -138.2 141.26 40.01 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.098 -0.501 . . . . 0.0 110.882 -178.523 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 4' ' ' LEU . . . . . . . . . . . . . 15.1 tp -126.77 131.05 51.38 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 115.939 -0.573 . . . . 0.0 110.077 177.274 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 5' ' ' LYS . . . . . . . . . . . . . 68.9 mttm -114.04 121.52 44.12 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-O 120.901 0.381 . . . . 0.0 110.923 -179.164 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 6' ' ' LEU . . . . . 0.433 HD23 ' HA ' ' A' ' 50' ' ' VAL . 63.7 mt -115.45 141.05 48.57 Favored 'General case' 0 C--N 1.331 -0.227 0 CA-C-N 115.237 -0.892 . . . . 0.0 110.046 179.686 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 86.3 tttt -121.0 136.87 25.95 Favored Pre-proline 0 CA--C 1.533 0.308 0 CA-C-O 118.867 -0.587 . . . . 0.0 109.751 177.032 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 8' ' ' PRO . . . . . . . . . . . . . 93.0 Cg_endo -89.03 131.91 2.25 Favored 'Trans proline' 0 N--CA 1.491 1.327 0 C-N-CA 121.699 1.599 . . . . 0.0 111.921 179.088 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 57.1 mt -70.95 -47.91 14.57 Favored Pre-proline 0 CA--C 1.533 0.321 0 CA-C-O 118.575 -0.726 . . . . 0.0 112.211 -179.985 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 71.5 Cg_endo -77.77 153.13 29.5 Favored 'Trans proline' 0 N--CA 1.496 1.626 0 C-N-CA 121.14 1.227 . . . . 0.0 111.913 176.528 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 58.7 tttm -87.18 89.71 8.09 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-O 120.842 0.353 . . . . 0.0 110.266 179.634 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 12.1 p -139.34 148.01 23.93 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.245 0 CA-C-N 116.231 -0.441 . . . . 0.0 110.707 -178.072 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 95.6 mt-10 -90.89 128.53 36.79 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.141 -0.481 . . . . 0.0 110.026 177.248 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 14' ' ' LEU . . . . . . . . . . . . . 24.0 mt -98.0 152.55 38.11 Favored Pre-proline 0 CA--C 1.532 0.267 0 CA-C-O 119.512 -0.28 . . . . 0.0 110.801 -178.586 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 15' ' ' PRO . . . . . . . . . . . . . 25.5 Cg_exo -62.09 159.06 36.07 Favored 'Trans proline' 0 N--CA 1.497 1.727 0 C-N-CA 121.281 1.321 . . . . 0.0 112.165 177.513 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 16' ' ' PRO . . . . . . . . . . . . . 37.5 Cg_exo -58.35 -45.02 33.37 Favored 'Trans proline' 0 N--CA 1.498 1.792 0 C-N-CA 121.437 1.425 . . . . 0.0 112.866 -178.863 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 17' ' ' ASP . . . . . . . . . . . . . 19.8 p-10 -85.32 12.9 7.28 Favored 'General case' 0 C--N 1.326 -0.435 0 N-CA-C 113.14 0.793 . . . . 0.0 113.14 -177.016 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 18' ' ' PHE . . . . . . . . . . . . . 42.6 t80 -58.36 -46.79 85.61 Favored 'General case' 0 CA--C 1.523 -0.078 0 O-C-N 122.096 -0.378 . . . . 0.0 110.162 -177.963 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 19' ' ' VAL . . . . . . . . . . . . . 14.0 p -55.92 -40.23 61.43 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.347 0 CA-C-N 116.227 -0.442 . . . . 0.0 111.104 -178.345 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 78.3 m-20 -61.15 -45.18 95.69 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-O 120.783 0.325 . . . . 0.0 111.093 -177.977 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 60.7 t -64.66 -47.02 90.6 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 C-N-CA 120.781 -0.368 . . . . 0.0 110.591 -177.919 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 22' ' ' ILE . . . . . 0.53 HG22 HD12 ' A' ' 26' ' ' LEU . 50.5 mm -56.89 -43.35 80.18 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.189 0 C-N-CA 120.829 -0.348 . . . . 0.0 110.483 179.142 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 23' ' ' ARG . . . . . . . . . . . . . 43.2 ttp180 -54.71 -49.38 70.86 Favored 'General case' 0 C--N 1.33 -0.257 0 C-N-CA 121.143 -0.223 . . . . 0.0 111.309 -178.727 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 24' ' ' ILE . . . . . . . . . . . . . 73.2 mt -59.25 -39.84 79.78 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.244 0 C-N-CA 120.869 -0.332 . . . . 0.0 110.751 -178.699 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 8.3 mtpm? -66.05 -41.82 90.33 Favored 'General case' 0 C--N 1.327 -0.385 0 N-CA-C 112.276 0.473 . . . . 0.0 112.276 -179.253 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 26' ' ' LEU . . . . . 0.53 HD12 HG22 ' A' ' 22' ' ' ILE . 67.0 mt -80.75 -36.07 32.46 Favored 'General case' 0 C--N 1.331 -0.228 0 N-CA-C 113.881 1.067 . . . . 0.0 113.881 -171.134 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 27' ' ' GLN . . . . . . . . . . . . . 11.5 pt20 -46.85 141.49 3.97 Favored 'General case' 0 N--CA 1.47 0.527 0 N-CA-C 112.81 0.67 . . . . 0.0 112.81 -175.17 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 98.64 -24.21 33.07 Favored Glycine 0 CA--C 1.533 1.201 0 CA-C-N 115.673 -0.694 . . . . 0.0 112.354 -176.886 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 60.5 mttp -98.07 155.22 17.23 Favored 'General case' 0 C--O 1.232 0.16 0 CA-C-N 117.45 0.625 . . . . 0.0 110.901 179.167 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 30' ' ' THR . . . . . . . . . . . . . 30.9 m -104.51 136.71 43.56 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.161 -0.472 . . . . 0.0 109.88 176.25 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 33.9 m -129.27 152.51 37.35 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.194 0 CA-C-O 120.987 0.423 . . . . 0.0 110.975 -178.683 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 32' ' ' ARG . . . . . . . . . . . . . 94.2 mtt180 -129.34 152.3 49.05 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-O 121.32 0.581 . . . . 0.0 110.614 179.943 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 33' ' ' THR . . . . . . . . . . . . . 21.4 m -53.63 139.75 31.01 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-N 116.162 -0.472 . . . . 0.0 111.202 -179.297 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 98.62 -17.09 58.88 Favored Glycine 0 CA--C 1.534 1.263 0 C-N-CA 121.106 -0.569 . . . . 0.0 113.269 178.844 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 58.7 m-20 -64.14 149.7 47.18 Favored 'General case' 0 C--O 1.231 0.11 0 CA-C-N 117.997 0.898 . . . . 0.0 111.369 -179.609 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 45.6 t -119.46 126.55 75.44 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.288 0 CA-C-N 115.458 -0.792 . . . . 0.0 109.538 177.896 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 37' ' ' ILE . . . . . . . . . . . . . 69.4 mt -120.71 138.34 51.52 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.226 0 CA-C-N 116.397 -0.365 . . . . 0.0 110.05 -179.072 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . -118.67 128.77 7.84 Favored Glycine 0 CA--C 1.525 0.66 0 N-CA-C 110.98 -0.848 . . . . 0.0 110.98 179.467 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 39' ' ' ILE . . . . . . . . . . . . . 70.8 mt -123.21 134.58 65.8 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.184 0 N-CA-C 109.938 -0.393 . . . . 0.0 109.938 178.228 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 40' ' ' SER . . . . . . . . . . . . . 23.2 t -91.49 120.54 32.4 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 116.272 -0.422 . . . . 0.0 111.04 178.72 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 41' ' ' ILE . . . . . . . . . . . . . 71.4 mt -127.5 116.38 43.39 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.234 0 CA-C-N 116.41 -0.359 . . . . 0.0 110.16 177.392 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 42' ' ' LEU . . . . . 0.532 ' O ' HD23 ' A' ' 42' ' ' LEU . 1.3 tt 49.58 47.65 22.41 Favored 'General case' 0 CA--C 1.533 0.311 0 CA-C-O 121.468 0.652 . . . . 0.0 111.43 177.166 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . 71.24 21.73 78.51 Favored Glycine 0 CA--C 1.532 1.094 0 C-N-CA 121.102 -0.571 . . . . 0.0 112.862 174.632 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 44' ' ' LYS . . . . . . . . . . . . . 85.3 tttt -135.14 126.43 28.3 Favored 'General case' 0 C--N 1.331 -0.222 0 CA-C-N 117.636 0.718 . . . . 0.0 109.881 178.959 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 84.9 tt0 -84.72 125.82 32.86 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.485 -0.325 . . . . 0.0 111.176 -178.682 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 46' ' ' VAL . . . . . 0.425 HG13 ' O ' ' A' ' 46' ' ' VAL . 10.3 p -113.34 123.25 68.8 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.252 0 N-CA-C 109.144 -0.687 . . . . 0.0 109.144 174.072 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 88.6 mttt -98.98 122.94 42.9 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 115.92 -0.582 . . . . 0.0 110.857 179.726 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 48' ' ' PHE . . . . . . . . . . . . . 31.0 m-85 -108.76 131.87 54.53 Favored 'General case' 0 C--N 1.329 -0.3 0 N-CA-C 109.71 -0.478 . . . . 0.0 109.71 176.924 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 76.6 tttt -106.57 130.62 54.3 Favored 'General case' 0 C--N 1.328 -0.33 0 N-CA-C 109.964 -0.384 . . . . 0.0 109.964 178.239 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 50' ' ' VAL . . . . . 0.433 ' HA ' HD23 ' A' ' 6' ' ' LEU . 45.5 t -74.82 105.29 3.75 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.305 0 N-CA-C 109.366 -0.605 . . . . 0.0 109.366 178.433 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 51' ' ' VAL . . . . . . . . . . . . . 48.2 t -70.35 -54.01 20.42 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.303 0 N-CA-C 109.475 -0.565 . . . . 0.0 109.475 -175.916 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 52' ' ' GLN . . . . . . . . . . . . . 89.9 mt-30 -153.73 150.15 28.23 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 115.856 -0.611 . . . . 0.0 111.79 -178.129 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -127.21 131.57 50.61 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 115.041 -0.981 . . . . 0.0 109.524 173.5 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 54' ' ' TYR . . . . . . . . . . . . . 14.5 t80 -129.06 110.24 18.25 Favored Pre-proline 0 C--N 1.329 -0.304 0 CA-C-O 118.198 -0.906 . . . . 0.0 110.234 177.453 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 55' ' ' PRO . . . . . . . . . . . . . 75.4 Cg_endo -77.31 170.22 71.94 Favored 'Cis proline' 0 N--CA 1.5 1.861 0 CA-C-N 121.958 1.735 . . . . 0.0 112.492 -5.927 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 56' ' ' SER . . . . . . . . . . . . . 14.1 m -123.91 138.9 31.34 Favored Pre-proline 0 CA--C 1.537 0.462 0 CA-C-O 118.499 -0.762 . . . . 0.0 109.401 173.532 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 57' ' ' PRO . . . . . . . . . . . . . 39.3 Cg_endo -67.67 144.28 71.07 Favored 'Cis proline' 0 N--CA 1.499 1.797 0 CA-C-N 121.695 1.641 . . . . 0.0 111.61 -2.627 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 58' ' ' LEU . . . . . 0.415 HD11 ' HB2' ' A' ' 2' ' ' SER . 15.7 tp -107.16 136.92 46.17 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-O 120.934 0.397 . . . . 0.0 110.629 -176.841 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 59' ' ' ARG . . . . . . . . . . . . . 56.5 ttp180 -103.73 124.9 49.73 Favored 'General case' 0 C--N 1.327 -0.378 0 N-CA-C 109.272 -0.64 . . . . 0.0 109.272 176.229 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 43.9 t -77.87 116.42 21.39 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 C-N-CA 120.73 -0.388 . . . . 0.0 110.745 -173.306 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 95.2 mt-10 -131.02 161.1 32.72 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 115.699 -0.682 . . . . 0.0 109.531 175.028 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 62' ' ' ASP . . . . . . . . . . . . . 70.0 m-20 -52.36 -31.67 34.77 Favored 'General case' 0 C--N 1.328 -0.349 0 N-CA-C 112.179 0.437 . . . . 0.0 112.179 -178.001 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 63' ' ' ARG . . . . . . . . . . . . . 87.5 mtt180 -70.92 -22.07 62.29 Favored 'General case' 0 CA--C 1.533 0.301 0 N-CA-C 113.038 0.755 . . . . 0.0 113.038 -174.942 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 27.8 m -68.43 137.16 54.28 Favored 'General case' 0 C--N 1.332 -0.188 0 CA-C-O 120.925 0.393 . . . . 0.0 111.061 -175.482 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 65' ' ' LYS . . . . . . . . . . . . . 90.5 mttt -88.92 127.62 35.66 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 115.984 -0.553 . . . . 0.0 109.772 177.832 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 66' ' ' ILE . . . . . . . . . . . . . 65.4 mt -118.06 130.24 73.22 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.278 0 CA-C-O 120.773 0.32 . . . . 0.0 110.236 -177.502 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 67' ' ' THR . . . . . . . . . . . . . 31.4 m -125.55 139.82 53.27 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-O 121.064 0.459 . . . . 0.0 110.967 -178.844 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 68' ' ' LEU . . . . . 0.499 ' N ' HD12 ' A' ' 68' ' ' LEU . 7.1 mp . . . . . 0 C--N 1.331 -0.211 0 CA-C-N 115.941 -0.572 . . . . 0.0 110.442 177.264 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 74' ' ' ASP . . . . . . . . . . . . . 31.6 t0 . . . . . 0 C--O 1.23 0.058 0 N-CA-C 109.717 -0.475 . . . . 0.0 109.717 . . . . . . . . . 0 0 . 1 . 018 nuclear build core ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 40.9 t -114.74 123.87 70.84 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.249 0 CA-C-O 121.083 0.468 . . . . 0.0 110.776 -177.253 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 76' ' ' LEU . . . . . . . . . . . . . 5.5 mp -120.96 144.35 48.53 Favored 'General case' 0 C--N 1.331 -0.226 0 CA-C-N 115.667 -0.697 . . . . 0.0 109.59 175.185 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 77' ' ' GLU . . . . . . . . . . . . . 97.8 mt-10 -133.96 138.01 45.19 Favored 'General case' 0 C--N 1.331 -0.213 0 CA-C-O 121.112 0.482 . . . . 0.0 111.445 -178.95 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 78' ' ' ALA . . . . . . . . . . . . . . . -127.12 142.05 51.61 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 115.579 -0.737 . . . . 0.0 109.745 177.314 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 79' ' ' LYS . . . . . 0.645 ' O ' HD13 ' A' ' 80' ' ' ILE . 47.3 pttt -85.79 120.78 27.58 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-O 121.23 0.538 . . . . 0.0 110.967 -178.218 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 80' ' ' ILE . . . . . 0.645 HD13 ' O ' ' A' ' 79' ' ' LYS . 37.0 mm -139.2 114.9 8.9 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.312 0 CA-C-N 115.768 -0.651 . . . . 0.0 109.411 -179.159 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 81' ' ' LYS . . . . . . . . . . . . . 97.7 mttt -107.4 126.96 53.14 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-O 120.804 0.335 . . . . 0.0 111.011 -179.178 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . 89.05 42.17 5.69 Favored Glycine 0 CA--C 1.525 0.683 0 C-N-CA 120.845 -0.693 . . . . 0.0 111.65 175.526 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 83' ' ' ILE . . . . . . . . . . . . . 69.7 mt -69.91 138.2 22.56 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.309 0 CA-C-O 120.901 0.381 . . . . 0.0 110.042 178.514 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 84' ' ' LYS . . . . . . . . . . . . . 63.4 tttm -94.5 -54.05 3.67 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-N 115.945 -0.57 . . . . 0.0 110.07 -179.104 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 85' ' ' ASP . . . . . . . . . . . . . 7.2 t70 -158.01 154.95 28.52 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 115.652 -0.704 . . . . 0.0 110.412 -179.969 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 86' ' ' VAL . . . . . . . . . . . . . 40.0 t -131.94 132.32 61.5 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.259 0 CA-C-O 120.914 0.388 . . . . 0.0 110.576 179.473 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 87' ' ' ILE . . . . . 0.493 HD12 ' N ' ' A' ' 87' ' ' ILE . 5.1 mp -118.9 128.37 75.73 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.281 0 CA-C-N 115.816 -0.629 . . . . 0.0 109.414 176.044 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 88' ' ' LEU . . . . . . . . . . . . . 16.9 tp -110.95 134.6 52.45 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-O 121.138 0.494 . . . . 0.0 111.414 -176.234 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 89' ' ' ASP . . . . . . . . . . . . . 12.9 t70 -127.14 149.75 49.81 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 115.602 -0.727 . . . . 0.0 109.36 175.129 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 83.6 tt0 -48.89 -32.57 9.15 Favored 'General case' 0 C--N 1.33 -0.264 0 N-CA-C 112.606 0.595 . . . . 0.0 112.606 -173.357 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 91' ' ' ASN . . . . . . . . . . . . . 79.2 m-20 -131.18 29.67 4.62 Favored 'General case' 0 N--CA 1.465 0.316 0 N-CA-C 112.216 0.45 . . . . 0.0 112.216 -176.368 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 92' ' ' LEU . . . . . . . . . . . . . 8.1 tp -166.21 148.83 7.07 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-O 120.784 0.326 . . . . 0.0 110.602 179.299 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 93' ' ' ILE . . . . . . . . . . . . . 69.9 mt -126.74 122.99 61.92 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.277 0 N-CA-C 109.487 -0.56 . . . . 0.0 109.487 178.931 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 94' ' ' VAL . . . . . . . . . . . . . 42.8 t -121.27 127.6 75.81 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.265 0 N-CA-C 110.084 -0.339 . . . . 0.0 110.084 -179.442 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 95' ' ' VAL . . . . . . . . . . . . . 43.4 t -125.66 136.0 62.19 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.239 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.228 -179.294 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 96' ' ' ILE . . . . . . . . . . . . . 51.6 mt -115.86 129.42 72.25 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 N-CA-C 109.112 -0.699 . . . . 0.0 109.112 178.495 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 97' ' ' THR . . . . . . . . . . . . . 81.7 p -101.21 159.06 15.57 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-O 121.105 0.479 . . . . 0.0 111.16 -178.024 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 98' ' ' GLU . . . . . . . . . . . . . 84.8 tt0 -53.85 -28.37 35.47 Favored 'General case' 0 CA--C 1.533 0.312 0 CA-C-N 116.208 -0.451 . . . . 0.0 112.152 -178.797 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 99' ' ' GLU . . . . . . . . . . . . . 96.0 mt-10 -79.04 14.61 1.35 Allowed 'General case' 0 CA--C 1.535 0.375 0 N-CA-C 113.22 0.822 . . . . 0.0 113.22 -176.316 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 100' ' ' ASN . . . . . . . . . . . . . 3.3 m-20 61.54 33.23 18.51 Favored 'General case' 0 N--CA 1.464 0.24 0 CA-C-N 118.067 0.394 . . . . 0.0 111.639 -179.833 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 101' ' ' GLU . . . . . . . . . . . . . 84.9 tt0 -107.61 144.2 34.99 Favored 'General case' 0 C--O 1.232 0.143 0 N-CA-C 109.607 -0.516 . . . . 0.0 109.607 173.08 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 102' ' ' VAL . . . . . . . . . . . . . 42.7 t -114.93 126.07 72.41 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.304 0 CA-C-N 116.294 -0.412 . . . . 0.0 110.009 -177.627 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 103' ' ' LEU . . . . . . . . . . . . . 21.2 mt -115.72 129.7 56.57 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 115.79 -0.641 . . . . 0.0 109.889 177.324 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 104' ' ' ILE . . . . . 0.612 HD13 HG11 ' A' ' 130' ' ' VAL . 68.3 mt -118.49 121.51 67.24 Favored 'Isoleucine or valine' 0 C--O 1.235 0.297 0 N-CA-C 110.13 -0.322 . . . . 0.0 110.13 179.274 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 105' ' ' PHE . . . . . . . . . . . . . 78.3 m-85 -118.92 164.47 15.4 Favored 'General case' 0 C--N 1.333 -0.126 0 O-C-N 124.129 0.893 . . . . 0.0 109.757 -179.499 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 106' ' ' ASN . . . . . . . . . . . . . 42.3 p-10 -101.66 -170.83 1.88 Allowed 'General case' 0 C--N 1.331 -0.221 0 N-CA-C 110.039 -0.356 . . . . 0.0 110.039 173.54 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 107' ' ' GLN . . . . . . . . . . . . . 59.4 tt0 -57.67 -28.69 64.0 Favored 'General case' 0 CA--C 1.534 0.341 0 N-CA-C 111.894 0.331 . . . . 0.0 111.894 177.243 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 108' ' ' ASN . . . . . . . . . . . . . 50.1 t30 -82.94 3.28 30.61 Favored 'General case' 0 CA--C 1.536 0.415 0 N-CA-C 113.353 0.872 . . . . 0.0 113.353 -176.447 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 109' ' ' LEU . . . . . . . . . . . . . 11.5 tp 62.66 39.6 11.09 Favored 'General case' 0 CA--C 1.529 0.172 0 CA-C-O 121.115 0.483 . . . . 0.0 111.051 178.378 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 110' ' ' GLU . . . . . . . . . . . . . 95.5 mt-10 -114.28 150.32 34.61 Favored 'General case' 0 C--N 1.331 -0.198 0 CA-C-N 116.366 -0.379 . . . . 0.0 110.278 176.31 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 111' ' ' GLU . . . . . . . . . . . . . 45.6 mt-10 -76.07 123.62 26.08 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 116.359 -0.382 . . . . 0.0 110.894 -179.739 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 112' ' ' LEU . . . . . . . . . . . . . 16.3 mt -110.04 -46.05 3.52 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.142 -0.481 . . . . 0.0 110.178 176.665 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 113' ' ' TYR . . . . . . . . . . . . . 41.0 t80 -134.79 136.73 42.77 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.235 -0.439 . . . . 0.0 110.659 -179.682 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 114' ' ' ARG . . . . . . . . . . . . . 65.8 ttp85 -141.37 123.25 15.36 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.406 -0.361 . . . . 0.0 110.569 178.014 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 115' ' ' GLY . . . . . . . . . . . . . . . -150.14 163.04 29.39 Favored Glycine 0 CA--C 1.523 0.556 0 N-CA-C 111.054 -0.819 . . . . 0.0 111.054 -179.192 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 116' ' ' LYS . . . . . . . . . . . . . 57.1 tttm -131.56 136.63 47.98 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-O 120.781 0.324 . . . . 0.0 110.188 178.656 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 117' ' ' PHE . . . . . . . . . . . . . 36.2 m-85 -136.34 115.58 12.55 Favored 'General case' 0 C--N 1.331 -0.209 0 CA-C-N 116.245 -0.434 . . . . 0.0 110.283 -176.062 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 118' ' ' GLU . . . . . . . . . . . . . 45.4 mp0 -56.48 -44.46 80.64 Favored 'General case' 0 C--N 1.327 -0.381 0 C-N-CA 120.781 -0.368 . . . . 0.0 111.098 -175.194 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 119' ' ' ASN . . . . . . . . . . . . . 11.4 m120 -98.01 30.97 2.85 Favored 'General case' 0 C--N 1.33 -0.259 0 N-CA-C 112.194 0.442 . . . . 0.0 112.194 -174.011 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 120' ' ' LEU . . . . . . . . . . . . . 21.9 tp -57.64 123.29 15.11 Favored 'General case' 0 C--N 1.332 -0.163 0 C-N-CA 120.854 -0.338 . . . . 0.0 110.379 177.941 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 121' ' ' ASN . . . . . . . . . . . . . 34.6 m120 -114.09 -44.08 3.18 Favored 'General case' 0 C--O 1.233 0.191 0 CA-C-N 116.548 -0.296 . . . . 0.0 111.002 -177.561 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 122' ' ' LYS . . . . . . . . . . . . . 98.3 mttt -144.49 149.16 35.49 Favored 'General case' 0 C--N 1.331 -0.198 0 CA-C-O 121.152 0.501 . . . . 0.0 111.621 -176.365 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 123' ' ' VAL . . . . . . . . . . . . . 47.3 t -129.67 128.55 65.77 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.276 0 CA-C-N 115.733 -0.667 . . . . 0.0 109.538 175.952 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 124' ' ' LEU . . . . . . . . . . . . . 75.0 mt -119.72 134.83 55.08 Favored 'General case' 0 C--N 1.331 -0.219 0 CA-C-N 116.48 -0.327 . . . . 0.0 110.443 -178.213 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 125' ' ' VAL . . . . . . . . . . . . . 12.4 p -140.13 130.93 30.6 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.223 0 CA-C-O 120.878 0.37 . . . . 0.0 110.97 -179.76 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 126' ' ' ARG . . . . . . . . . . . . . 72.8 mtt180 -152.55 134.1 14.53 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 115.822 -0.626 . . . . 0.0 109.674 175.848 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 127' ' ' ASN . . . . . . . . . . . . . 31.5 m120 55.74 -147.77 0.51 Allowed 'General case' 0 CA--C 1.542 0.647 0 N-CA-C 109.729 -0.471 . . . . 0.0 109.729 -178.855 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 128' ' ' ASP . . . . . . . . . . . . . 9.3 p-10 -87.23 14.62 7.45 Favored 'General case' 0 CA--C 1.536 0.409 0 CA-C-N 118.809 0.732 . . . . 0.0 112.934 178.641 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 129' ' ' LEU . . . . . . . . . . . . . 80.5 mt -110.89 138.21 47.57 Favored 'General case' 0 C--O 1.233 0.216 0 O-C-N 121.974 -0.454 . . . . 0.0 110.273 179.575 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 130' ' ' VAL . . . . . 0.612 HG11 HD13 ' A' ' 104' ' ' ILE . 14.4 p -134.03 142.14 41.97 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.176 0 CA-C-O 121.177 0.513 . . . . 0.0 110.847 -178.937 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 131' ' ' VAL . . . . . 0.558 HG22 HD12 ' A' ' 140' ' ' LEU . 44.5 t -135.76 138.51 47.7 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.228 0 CA-C-N 115.876 -0.602 . . . . 0.0 110.243 -178.923 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 132' ' ' ILE . . . . . . . . . . . . . 72.6 mt -115.87 132.39 65.48 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.298 0 CA-C-N 115.948 -0.569 . . . . 0.0 109.488 -179.856 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 133' ' ' ILE . . . . . . . . . . . . . 39.0 mm -116.9 117.37 55.18 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.21 0 CA-C-N 116.5 -0.318 . . . . 0.0 110.624 -176.333 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 134' ' ' ASP . . . . . . . . . . . . . 7.2 p-10 -128.63 151.43 49.5 Favored 'General case' 0 C--N 1.331 -0.204 0 N-CA-C 109.629 -0.508 . . . . 0.0 109.629 175.252 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 135' ' ' GLU . . . . . . . . . . . . . 45.8 tp10 -49.92 -28.16 6.31 Favored 'General case' 0 C--N 1.327 -0.398 0 N-CA-C 112.748 0.647 . . . . 0.0 112.748 -171.056 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 136' ' ' GLN . . . . . . . . . . . . . 76.9 mt-30 -103.45 -22.95 13.58 Favored 'General case' 0 N--CA 1.464 0.254 0 N-CA-C 113.144 0.794 . . . . 0.0 113.144 -173.874 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 137' ' ' LYS . . . . . . . . . . . . . 94.9 mttt -141.93 147.19 36.65 Favored 'General case' 0 C--N 1.331 -0.224 0 CA-C-O 121.376 0.608 . . . . 0.0 112.007 -168.695 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 138' ' ' LEU . . . . . . . . . . . . . 10.5 tp -111.66 118.3 35.29 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 115.193 -0.912 . . . . 0.0 108.863 172.326 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 139' ' ' THR . . . . . . . . . . . . . 24.9 m -111.98 125.61 54.25 Favored 'General case' 0 N--CA 1.463 0.21 0 CA-C-O 120.695 0.283 . . . . 0.0 110.882 -176.819 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 140' ' ' LEU . . . . . 0.558 HD12 HG22 ' A' ' 131' ' ' VAL . 11.6 tp -114.03 122.96 48.51 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 115.664 -0.698 . . . . 0.0 109.23 179.534 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 141' ' ' ILE . . . . . 0.515 ' HB ' HG13 ' A' ' 130' ' ' VAL . 20.3 mt -123.15 122.66 66.01 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.243 0 CA-C-O 120.997 0.427 . . . . 0.0 110.3 -175.778 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 142' ' ' ARG . . . . . . . . . . . . . 84.2 mtp180 -106.91 123.22 47.86 Favored 'General case' 0 C--N 1.331 -0.22 0 CA-C-N 115.264 -0.88 . . . . 0.0 110.068 179.252 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 143' ' ' THR . . . . . . . . . . . . . 26.6 p . . . . . 0 C--O 1.221 -0.428 0 CA-C-O 117.939 -1.029 . . . . 0.0 110.58 179.742 . . . . . . . . 0 0 . 1 . 018 nuclear build core ' B' B ' 2' ' ' SER . . . . . . . . . . . . . 2.8 p . . . . . 0 N--CA 1.462 0.152 0 CA-C-O 120.901 0.382 . . . . 0.0 110.606 . . . . . . . . . 0 0 . 1 . 018 nuclear build core ' B' B ' 3' ' ' GLU . . . . . . . . . . . . . 84.6 tt0 -142.64 142.55 32.1 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 115.981 -0.554 . . . . 0.0 111.193 -178.297 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' B' B ' 4' ' ' LEU . . . . . . . . . . . . . 13.4 tp -123.05 131.01 53.52 Favored 'General case' 0 C--N 1.331 -0.209 0 CA-C-N 115.757 -0.656 . . . . 0.0 110.143 177.109 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' B' B ' 5' ' ' LYS . . . . . . . . . . . . . 94.6 mttt -107.72 121.8 45.44 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.232 -0.44 . . . . 0.0 110.433 178.727 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' B' B ' 6' ' ' LEU . . . . . . . . . . . . . 44.4 mt -115.88 148.18 40.25 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 115.554 -0.748 . . . . 0.0 110.195 -179.283 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' B' B ' 7' ' ' LYS . . . . . . . . . . . . . 83.4 tttt -135.35 140.31 34.02 Favored Pre-proline 0 CA--C 1.535 0.388 0 CA-C-O 119.092 -0.48 . . . . 0.0 110.118 176.335 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' B' B ' 8' ' ' PRO . . . . . . . . . . . . . 88.8 Cg_endo -92.04 143.71 2.74 Favored 'Trans proline' 0 N--CA 1.491 1.345 0 C-N-CA 121.718 1.612 . . . . 0.0 111.653 177.689 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' B' B ' 9' ' ' LEU . . . . . . . . . . . . . 75.3 mt -81.8 -47.67 1.0 Allowed Pre-proline 0 CA--C 1.535 0.384 0 CA-C-O 118.611 -0.709 . . . . 0.0 112.303 -179.321 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' B' B ' 10' ' ' PRO . . . . . . . . . . . . . 95.1 Cg_endo -79.61 154.48 23.84 Favored 'Trans proline' 0 N--CA 1.496 1.662 0 C-N-CA 121.125 1.217 . . . . 0.0 111.869 176.412 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' B' B ' 11' ' ' LYS . . . . . . . . . . . . . 62.2 tttm -88.46 102.79 15.25 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-N 116.378 -0.374 . . . . 0.0 110.439 179.058 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' B' B ' 12' ' ' VAL . . . . . . . . . . . . . 12.8 p -149.67 144.29 17.82 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.319 0 CA-C-N 116.294 -0.412 . . . . 0.0 110.875 179.945 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' B' B ' 13' ' ' GLU . . . . . . . . . . . . . 95.8 mt-10 -79.62 131.99 36.14 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.14 -0.482 . . . . 0.0 110.062 177.468 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' B' B ' 14' ' ' LEU . . . . . . . . . . . . . 26.6 mt -98.67 147.97 33.91 Favored Pre-proline 0 CA--C 1.534 0.337 0 CA-C-O 119.252 -0.404 . . . . 0.0 110.623 -177.955 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' B' B ' 15' ' ' PRO . . . . . . . . . . . . . 24.7 Cg_exo -62.88 158.26 43.88 Favored 'Trans proline' 0 N--CA 1.498 1.772 0 C-N-CA 121.328 1.352 . . . . 0.0 111.779 176.828 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' B' B ' 16' ' ' PRO . . . . . . . . . . . . . 33.6 Cg_exo -59.2 -39.31 79.87 Favored 'Trans proline' 0 N--CA 1.498 1.748 0 C-N-CA 121.508 1.472 . . . . 0.0 112.714 -177.581 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' B' B ' 17' ' ' ASP . . . . . . . . . . . . . 24.1 p-10 -89.12 11.9 17.25 Favored 'General case' 0 C--N 1.328 -0.358 0 N-CA-C 113.154 0.798 . . . . 0.0 113.154 -177.411 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' B' B ' 18' ' ' PHE . . . . . . . . . . . . . 44.2 t80 -58.09 -45.82 86.53 Favored 'General case' 0 C--N 1.335 -0.056 0 O-C-N 121.993 -0.442 . . . . 0.0 110.081 -178.458 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' B' B ' 19' ' ' VAL . . . . . . . . . . . . . 13.7 p -56.57 -40.52 69.23 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.297 0 CA-C-N 116.15 -0.477 . . . . 0.0 110.878 -179.219 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' B' B ' 20' ' ' ASP . . . . . . . . . . . . . 9.8 t70 -60.53 -44.78 95.71 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-O 120.768 0.318 . . . . 0.0 111.032 -177.766 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' B' B ' 21' ' ' VAL . . . . . . . . . . . . . 46.9 t -64.3 -47.83 88.04 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.282 0 C-N-CA 120.676 -0.41 . . . . 0.0 110.377 -177.891 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' B' B ' 22' ' ' ILE . . . . . 0.468 HG22 HD12 ' B' ' 26' ' ' LEU . 51.1 mm -55.92 -46.16 80.23 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.261 0 CA-C-O 120.672 0.273 . . . . 0.0 110.589 179.813 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' B' B ' 23' ' ' ARG . . . . . . . . . . . . . 60.4 ttp180 -54.38 -50.88 66.48 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.779 -0.191 . . . . 0.0 111.39 -178.281 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' B' B ' 24' ' ' ILE . . . . . . . . . . . . . 75.6 mt -59.8 -42.47 89.05 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.298 0 C-N-CA 121.036 -0.266 . . . . 0.0 110.939 -177.686 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' B' B ' 25' ' ' LYS . . . . . . . . . . . . . 60.3 mtpt -64.6 -39.38 93.62 Favored 'General case' 0 C--N 1.328 -0.333 0 N-CA-C 112.232 0.456 . . . . 0.0 112.232 -177.898 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' B' B ' 26' ' ' LEU . . . . . 0.468 HD12 HG22 ' B' ' 22' ' ' ILE . 55.7 mt -79.0 -43.5 24.23 Favored 'General case' 0 C--N 1.33 -0.268 0 N-CA-C 113.089 0.774 . . . . 0.0 113.089 -172.454 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' B' B ' 27' ' ' GLN . . . . . . . . . . . . . 14.2 pt20 -46.55 139.31 5.17 Favored 'General case' 0 N--CA 1.469 0.475 0 N-CA-C 112.841 0.682 . . . . 0.0 112.841 -174.084 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' B' B ' 28' ' ' GLY . . . . . . . . . . . . . . . 100.23 -28.06 17.47 Favored Glycine 0 CA--C 1.533 1.192 0 CA-C-N 115.43 -0.805 . . . . 0.0 112.083 -176.215 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' B' B ' 29' ' ' LYS . . . . . . . . . . . . . 55.5 mtmt -98.88 155.16 17.53 Favored 'General case' 0 C--O 1.233 0.226 0 CA-C-N 117.085 0.442 . . . . 0.0 111.248 178.494 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' B' B ' 30' ' ' THR . . . . . . . . . . . . . 35.2 m -104.35 140.39 37.96 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.13 -0.486 . . . . 0.0 110.115 176.305 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' B' B ' 31' ' ' VAL . . . . . . . . . . . . . 35.2 m -129.08 156.61 41.78 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.274 0 CA-C-N 116.321 -0.399 . . . . 0.0 110.627 -179.575 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' B' B ' 32' ' ' ARG . . . . . . . . . . . . . 62.7 ttt180 -133.37 148.64 51.85 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.066 -0.516 . . . . 0.0 110.143 179.076 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' B' B ' 33' ' ' THR . . . . . . . . . . . . . 18.0 m -53.05 139.11 29.14 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.43 -0.35 . . . . 0.0 111.414 -177.248 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' B' B ' 34' ' ' GLY . . . . . . . . . . . . . . . 100.94 -17.19 56.64 Favored Glycine 0 CA--C 1.532 1.142 0 CA-C-O 119.571 -0.572 . . . . 0.0 113.281 179.085 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' B' B ' 35' ' ' ASP . . . . . . . . . . . . . 79.4 m-20 -66.28 149.3 50.56 Favored 'General case' 0 C--N 1.334 -0.09 0 CA-C-N 118.119 0.959 . . . . 0.0 111.077 179.04 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' B' B ' 36' ' ' VAL . . . . . . . . . . . . . 44.3 t -121.71 129.88 75.1 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.204 0 CA-C-N 115.92 -0.582 . . . . 0.0 109.826 178.523 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' B' B ' 37' ' ' ILE . . . . . . . . . . . . . 65.8 mt -120.8 138.69 50.43 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.254 0 N-CA-C 109.982 -0.377 . . . . 0.0 109.982 -179.534 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' B' B ' 38' ' ' GLY . . . . . . . . . . . . . . . -111.61 128.87 8.84 Favored Glycine 0 CA--C 1.526 0.723 0 N-CA-C 111.07 -0.812 . . . . 0.0 111.07 -179.94 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' B' B ' 39' ' ' ILE . . . . . . . . . . . . . 72.3 mt -123.11 138.52 52.82 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.188 0 N-CA-C 110.165 -0.309 . . . . 0.0 110.165 179.161 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' B' B ' 40' ' ' SER . . . . . 0.465 ' O ' HD13 ' B' ' 41' ' ' ILE . 32.9 t -93.22 117.13 29.71 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.481 -0.327 . . . . 0.0 110.981 175.636 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' B' B ' 41' ' ' ILE . . . . . 0.465 HD13 ' O ' ' B' ' 40' ' ' SER . 47.7 mm -125.68 122.96 63.49 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.262 0 CA-C-O 120.844 0.354 . . . . 0.0 110.586 178.694 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' B' B ' 42' ' ' LEU . . . . . . . . . . . . . 65.3 mt 52.61 33.63 14.06 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.185 -0.462 . . . . 0.0 111.881 177.368 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' B' B ' 43' ' ' GLY . . . . . . . . . . . . . . . 73.19 31.19 61.79 Favored Glycine 0 CA--C 1.529 0.963 0 C-N-CA 121.09 -0.576 . . . . 0.0 112.194 177.951 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' B' B ' 44' ' ' LYS . . . . . . . . . . . . . 40.3 ttpt -138.57 133.72 32.91 Favored 'General case' 0 C--N 1.329 -0.303 0 N-CA-C 109.663 -0.495 . . . . 0.0 109.663 178.098 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' B' B ' 45' ' ' GLU . . . . . . . . . . . . . 78.0 tt0 -83.2 118.55 23.68 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-O 120.918 0.39 . . . . 0.0 110.814 -177.598 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' B' B ' 46' ' ' VAL . . . . . . . . . . . . . 7.4 p -117.18 128.08 74.6 Favored 'Isoleucine or valine' 0 N--CA 1.462 0.159 0 N-CA-C 109.611 -0.514 . . . . 0.0 109.611 177.917 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' B' B ' 47' ' ' LYS . . . . . . . . . . . . . 32.3 mmtp -98.93 129.5 45.26 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 115.96 -0.564 . . . . 0.0 111.357 178.721 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' B' B ' 48' ' ' PHE . . . . . . . . . . . . . 90.5 m-85 -114.08 131.83 56.25 Favored 'General case' 0 C--N 1.329 -0.296 0 N-CA-C 109.378 -0.601 . . . . 0.0 109.378 173.966 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' B' B ' 49' ' ' LYS . . . . . . . . . . . . . 59.5 tttm -108.28 138.54 44.39 Favored 'General case' 0 C--N 1.329 -0.308 0 N-CA-C 110.315 -0.254 . . . . 0.0 110.315 179.359 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' B' B ' 50' ' ' VAL . . . . . . . . . . . . . 44.8 t -78.99 107.88 11.96 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.299 0 N-CA-C 109.226 -0.657 . . . . 0.0 109.226 176.529 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' B' B ' 51' ' ' VAL . . . . . . . . . . . . . 52.9 t -73.04 -48.17 45.14 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.271 0 CA-C-N 115.938 -0.574 . . . . 0.0 110.225 -173.573 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' B' B ' 52' ' ' GLN . . . . . . . . . . . . . 45.3 tt0 -162.62 145.17 10.87 Favored 'General case' 0 C--N 1.332 -0.192 0 C-N-CA 120.303 -0.559 . . . . 0.0 111.554 -177.711 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' B' B ' 53' ' ' ALA . . . . . . . . . . . . . . . -121.1 133.89 55.23 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 115.821 -0.627 . . . . 0.0 110.044 176.76 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' B' B ' 54' ' ' TYR . . . . . . . . . . . . . 33.9 t80 -129.01 106.97 18.02 Favored Pre-proline 0 CA--C 1.534 0.342 0 CA-C-O 118.303 -0.856 . . . . 0.0 110.355 179.435 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' B' B ' 55' ' ' PRO . . . . . . . . . . . . . 73.8 Cg_endo -77.13 169.27 74.69 Favored 'Cis proline' 0 N--CA 1.5 1.858 0 CA-C-N 121.812 1.683 . . . . 0.0 112.503 -4.478 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' B' B ' 56' ' ' SER . . . . . . . . . . . . . 67.4 m -115.3 128.07 26.26 Favored Pre-proline 0 CA--C 1.539 0.543 0 CA-C-O 118.454 -0.784 . . . . 0.0 109.466 175.891 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' B' B ' 57' ' ' PRO . . . . . . . . . . . . . 40.0 Cg_endo -67.84 167.38 62.69 Favored 'Cis proline' 0 N--CA 1.496 1.666 0 CA-C-N 121.984 1.744 . . . . 0.0 111.648 -0.845 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' B' B ' 58' ' ' LEU . . . . . . . . . . . . . 31.4 tp -129.85 136.71 49.87 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.187 -0.46 . . . . 0.0 110.334 179.674 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' B' B ' 59' ' ' ARG . . . . . . . . . . . . . 53.6 ttp180 -103.06 128.3 49.98 Favored 'General case' 0 C--N 1.326 -0.417 0 N-CA-C 109.16 -0.682 . . . . 0.0 109.16 176.898 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' B' B ' 60' ' ' VAL . . . . . . . . . . . . . 42.1 t -84.05 127.64 39.6 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.185 0 C-N-CA 120.533 -0.467 . . . . 0.0 110.622 -174.139 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' B' B ' 61' ' ' GLU . . . . . . . . . . . . . 96.0 mt-10 -129.9 159.13 37.55 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 115.558 -0.747 . . . . 0.0 109.611 176.969 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' B' B ' 62' ' ' ASP . . . . . . . . . . . . . 6.8 t0 -53.5 -32.47 50.49 Favored 'General case' 0 C--N 1.328 -0.363 0 N-CA-C 111.88 0.326 . . . . 0.0 111.88 -178.58 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' B' B ' 63' ' ' ARG . . . . . . . . . . . . . 28.7 ptt180 -90.04 6.23 43.24 Favored 'General case' 0 CA--C 1.537 0.476 0 N-CA-C 113.878 1.066 . . . . 0.0 113.878 -175.633 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' B' B ' 64' ' ' THR . . . . . . . . . . . . . 25.7 m -75.11 147.23 40.74 Favored 'General case' 0 C--N 1.331 -0.206 0 CA-C-O 121.006 0.432 . . . . 0.0 111.069 -177.854 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' B' B ' 65' ' ' LYS . . . . . . . . . . . . . 25.2 mtpp -84.94 126.71 33.74 Favored 'General case' 0 C--N 1.331 -0.227 0 CA-C-N 115.893 -0.594 . . . . 0.0 110.208 179.453 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' B' B ' 66' ' ' ILE . . . . . . . . . . . . . 60.4 mt -121.94 132.17 71.51 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.235 0 N-CA-C 110.151 -0.314 . . . . 0.0 110.151 -179.426 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' B' B ' 67' ' ' THR . . . . . . . . . . . . . 29.6 m -130.11 141.55 50.68 Favored 'General case' 0 C--N 1.332 -0.154 0 CA-C-O 121.02 0.438 . . . . 0.0 111.184 -179.458 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' B' B ' 68' ' ' LEU . . . . . 0.488 HD12 ' N ' ' B' ' 68' ' ' LEU . 7.0 mp . . . . . 0 C--N 1.332 -0.195 0 CA-C-N 115.942 -0.572 . . . . 0.0 110.427 177.013 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' B' B ' 73' ' ' VAL . . . . . . . . . . . . . 27.1 m . . . . . 0 C--O 1.232 0.135 0 CA-C-O 120.754 0.312 . . . . 0.0 110.365 . . . . . . . . . 0 0 . 1 . 018 nuclear build core ' B' B ' 74' ' ' ASP . . . . . . . . . . . . . 36.3 t0 -97.78 116.26 29.65 Favored 'General case' 0 C--N 1.329 -0.289 0 N-CA-C 109.732 -0.47 . . . . 0.0 109.732 -179.28 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' B' B ' 75' ' ' VAL . . . . . . . . . . . . . 42.0 t -112.38 122.15 66.07 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.171 0 CA-C-O 121.112 0.482 . . . . 0.0 110.388 -177.97 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' B' B ' 76' ' ' LEU . . . . . . . . . . . . . 14.7 mt -124.82 133.7 53.02 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 115.537 -0.756 . . . . 0.0 109.2 177.422 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' B' B ' 77' ' ' GLU . . . . . . . . . . . . . 35.9 tt0 -131.91 136.89 47.73 Favored 'General case' 0 C--N 1.331 -0.222 0 CA-C-O 121.013 0.435 . . . . 0.0 110.98 -176.25 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' B' B ' 78' ' ' ALA . . . . . . . . . . . . . . . -123.87 139.81 53.6 Favored 'General case' 0 C--N 1.331 -0.219 0 CA-C-N 115.947 -0.57 . . . . 0.0 110.214 178.08 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' B' B ' 79' ' ' LYS . . . . . 0.626 ' O ' HD13 ' B' ' 80' ' ' ILE . 50.0 pttt -73.37 118.15 15.98 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-O 121.292 0.567 . . . . 0.0 110.453 179.402 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' B' B ' 80' ' ' ILE . . . . . 0.626 HD13 ' O ' ' B' ' 79' ' ' LYS . 38.0 mm -139.22 109.68 4.4 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.346 0 CA-C-N 115.906 -0.588 . . . . 0.0 109.718 -177.734 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' B' B ' 81' ' ' LYS . . . . . . . . . . . . . 67.6 mttm -110.76 130.6 55.53 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-O 120.948 0.404 . . . . 0.0 110.927 -179.67 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' B' B ' 82' ' ' GLY . . . . . . . . . . . . . . . 89.05 42.22 5.68 Favored Glycine 0 CA--C 1.525 0.698 0 C-N-CA 120.971 -0.633 . . . . 0.0 111.655 175.527 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' B' B ' 83' ' ' ILE . . . . . . . . . . . . . 71.9 mt -66.91 132.35 32.27 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.317 0 N-CA-C 109.672 -0.492 . . . . 0.0 109.672 177.688 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' B' B ' 84' ' ' LYS . . . . . . . . . . . . . 44.9 tttp -96.37 -52.72 3.87 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-O 121.091 0.472 . . . . 0.0 110.227 -178.742 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' B' B ' 85' ' ' ASP . . . . . . . . . . . . . 7.3 t70 -150.98 149.41 29.56 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 115.647 -0.706 . . . . 0.0 110.118 179.422 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' B' B ' 86' ' ' VAL . . . . . . . . . . . . . 43.2 t -128.6 128.77 68.31 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.292 0 CA-C-O 120.887 0.375 . . . . 0.0 110.529 -178.307 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' B' B ' 87' ' ' ILE . . . . . . . . . . . . . 43.7 mm -120.3 125.2 73.93 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.224 0 CA-C-N 116.002 -0.545 . . . . 0.0 109.968 176.251 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' B' B ' 88' ' ' LEU . . . . . . . . . . . . . 19.2 tp -109.64 130.04 55.54 Favored 'General case' 0 C--N 1.331 -0.225 0 CA-C-O 120.967 0.413 . . . . 0.0 111.141 -178.086 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' B' B ' 89' ' ' ASP . . . . . . . . . . . . . 12.7 t70 -123.12 151.6 41.91 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 115.827 -0.624 . . . . 0.0 109.583 176.0 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' B' B ' 90' ' ' GLU . . . . . . . . . . . . . 96.8 mt-10 -47.08 -36.56 8.32 Favored 'General case' 0 C--N 1.33 -0.253 0 N-CA-C 112.993 0.738 . . . . 0.0 112.993 -173.061 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' B' B ' 91' ' ' ASN . . . . . . . . . . . . . 8.6 p30 -130.47 19.69 5.23 Favored 'General case' 0 N--CA 1.467 0.421 0 N-CA-C 113.051 0.76 . . . . 0.0 113.051 -177.668 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' B' B ' 92' ' ' LEU . . . . . . . . . . . . . 16.5 mt -148.89 143.16 26.05 Favored 'General case' 0 C--N 1.332 -0.169 0 N-CA-C 109.982 -0.377 . . . . 0.0 109.982 -177.336 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' B' B ' 93' ' ' ILE . . . . . . . . . . . . . 70.7 mt -120.09 118.03 55.55 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.328 0 N-CA-C 109.314 -0.624 . . . . 0.0 109.314 178.003 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' B' B ' 94' ' ' VAL . . . . . . . . . . . . . 48.4 t -119.22 123.5 71.44 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.207 0 N-CA-C 109.901 -0.407 . . . . 0.0 109.901 -179.304 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' B' B ' 95' ' ' VAL . . . . . . . . . . . . . 44.3 t -122.4 132.83 70.32 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.397 0 CA-C-N 115.916 -0.584 . . . . 0.0 109.876 -179.439 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' B' B ' 96' ' ' ILE . . . . . . . . . . . . . 67.0 mt -112.78 126.77 70.22 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.287 0 N-CA-C 109.12 -0.696 . . . . 0.0 109.12 178.265 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' B' B ' 97' ' ' THR . . . . . . . . . . . . . 68.2 p -99.6 152.72 19.72 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-O 120.877 0.37 . . . . 0.0 110.929 -178.543 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' B' B ' 98' ' ' GLU . . . . . . . . . . . . . 45.0 mt-10 -53.87 -24.23 15.19 Favored 'General case' 0 CA--C 1.533 0.324 0 N-CA-C 112.346 0.498 . . . . 0.0 112.346 179.927 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' B' B ' 99' ' ' GLU . . . . . . . . . . . . . 31.1 tt0 -79.27 15.54 1.19 Allowed 'General case' 0 CA--C 1.539 0.549 0 N-CA-C 112.697 0.629 . . . . 0.0 112.697 -177.306 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' B' B ' 100' ' ' ASN . . . . . . . . . . . . . 3.8 m-20 63.56 38.0 9.99 Favored 'General case' 0 CA--C 1.531 0.213 0 CA-C-O 121.006 0.432 . . . . 0.0 111.107 177.366 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' B' B ' 101' ' ' GLU . . . . . . . . . . . . . 85.0 tt0 -118.95 143.26 47.13 Favored 'General case' 0 C--N 1.331 -0.202 0 CA-C-N 116.042 -0.526 . . . . 0.0 109.909 176.014 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' B' B ' 102' ' ' VAL . . . . . . . . . . . . . 45.0 t -114.99 126.29 72.53 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.273 0 CA-C-N 116.262 -0.427 . . . . 0.0 109.946 -177.534 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' B' B ' 103' ' ' LEU . . . . . . . . . . . . . 21.2 mt -116.0 129.38 56.35 Favored 'General case' 0 C--N 1.331 -0.201 0 CA-C-N 115.848 -0.614 . . . . 0.0 110.555 178.263 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' B' B ' 104' ' ' ILE . . . . . . . . . . . . . 66.9 mt -118.82 119.55 61.37 Favored 'Isoleucine or valine' 0 C--O 1.233 0.215 0 CA-C-N 116.443 -0.344 . . . . 0.0 110.109 179.216 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' B' B ' 105' ' ' PHE . . . . . . . . . . . . . 66.8 m-85 -120.72 164.69 16.17 Favored 'General case' 0 C--N 1.331 -0.212 0 O-C-N 123.972 0.795 . . . . 0.0 109.878 178.741 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' B' B ' 106' ' ' ASN . . . . . . . . . . . . . 46.0 p-10 -101.08 -171.49 2.01 Favored 'General case' 0 N--CA 1.463 0.215 0 N-CA-C 110.267 -0.272 . . . . 0.0 110.267 174.605 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' B' B ' 107' ' ' GLN . . . . . . . . . . . . . 60.3 tt0 -59.47 -29.37 67.77 Favored 'General case' 0 CA--C 1.531 0.225 0 N-CA-C 112.021 0.378 . . . . 0.0 112.021 -179.347 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' B' B ' 108' ' ' ASN . . . . . . . . . . . . . 17.9 t30 -86.59 10.01 16.78 Favored 'General case' 0 CA--C 1.536 0.426 0 N-CA-C 113.189 0.811 . . . . 0.0 113.189 -177.115 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' B' B ' 109' ' ' LEU . . . . . . . . . . . . . 12.9 tp 59.68 41.65 18.24 Favored 'General case' 0 C--N 1.331 -0.198 0 CA-C-O 121.25 0.548 . . . . 0.0 110.897 178.318 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' B' B ' 110' ' ' GLU . . . . . . . . . . . . . 70.9 mm-40 -108.07 156.79 18.88 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.138 -0.483 . . . . 0.0 109.866 176.133 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' B' B ' 111' ' ' GLU . . . . . . . . . . . . . 84.9 tt0 -84.39 121.96 28.28 Favored 'General case' 0 C--N 1.329 -0.298 0 C-N-CA 120.845 -0.342 . . . . 0.0 110.79 -178.566 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' B' B ' 112' ' ' LEU . . . . . . . . . . . . . 28.4 mt -110.58 -46.18 3.42 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 116.16 -0.473 . . . . 0.0 110.547 178.169 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' B' B ' 113' ' ' TYR . . . . . . . . . . . . . 54.0 t80 -142.17 134.24 27.44 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.357 -0.383 . . . . 0.0 111.249 -179.941 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' B' B ' 114' ' ' ARG . . . . . . . . . . . . . 29.9 ttm180 -135.28 124.27 24.21 Favored 'General case' 0 C--N 1.329 -0.292 0 N-CA-C 109.839 -0.43 . . . . 0.0 109.839 175.44 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' B' B ' 115' ' ' GLY . . . . . . . . . . . . . . . -150.03 151.64 23.67 Favored Glycine 0 CA--C 1.523 0.569 0 C-N-CA 120.754 -0.736 . . . . 0.0 111.325 179.213 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' B' B ' 116' ' ' LYS . . . . . . . . . . . . . 39.1 ttpt -121.94 136.43 54.92 Favored 'General case' 0 C--N 1.328 -0.333 0 N-CA-C 109.662 -0.495 . . . . 0.0 109.662 177.744 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' B' B ' 117' ' ' PHE . . . . . . . . . . . . . 40.6 m-85 -135.2 113.76 11.66 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-O 121.082 0.468 . . . . 0.0 110.074 -176.861 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' B' B ' 118' ' ' GLU . . . . . . . . . . . . . 97.0 mt-10 -53.86 -43.78 69.82 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.073 -0.512 . . . . 0.0 111.662 -174.256 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' B' B ' 119' ' ' ASN . . . . . . . . . . . . . 5.6 p30 -104.63 31.13 4.91 Favored 'General case' 0 C--N 1.33 -0.257 0 N-CA-C 112.244 0.461 . . . . 0.0 112.244 -173.942 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' B' B ' 120' ' ' LEU . . . . . . . . . . . . . 13.7 tp -53.48 126.05 20.14 Favored 'General case' 0 N--CA 1.464 0.238 0 CA-C-O 120.469 0.176 . . . . 0.0 110.8 177.72 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' B' B ' 121' ' ' ASN . . . . . . . . . . . . . 77.3 m-20 -114.1 -44.12 3.17 Favored 'General case' 0 N--CA 1.462 0.173 0 C-N-CA 121.195 -0.202 . . . . 0.0 111.283 -176.843 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' B' B ' 122' ' ' LYS . . . . . . . . . . . . . 62.2 mtpt -142.1 145.69 34.57 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-O 121.121 0.486 . . . . 0.0 111.727 -176.775 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' B' B ' 123' ' ' VAL . . . . . . . . . . . . . 44.0 t -127.24 127.52 69.35 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.264 0 N-CA-C 109.21 -0.663 . . . . 0.0 109.21 174.909 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' B' B ' 124' ' ' LEU . . . . . . . . . . . . . 51.1 mt -128.03 136.38 51.18 Favored 'General case' 0 C--N 1.331 -0.196 0 CA-C-O 120.853 0.358 . . . . 0.0 111.097 -177.216 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' B' B ' 125' ' ' VAL . . . . . . . . . . . . . 11.1 p -133.97 133.65 56.11 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.249 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.027 177.304 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' B' B ' 126' ' ' ARG . . . . . . . . . . . . . 77.0 mtp85 -146.64 126.47 13.52 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-O 120.86 0.362 . . . . 0.0 111.073 -179.275 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' B' B ' 127' ' ' ASN . . . . . . . . . . . . . 7.6 m-80 49.23 -105.21 0.15 Allowed 'General case' 0 CA--C 1.545 0.76 0 CA-C-O 119.036 -0.507 . . . . 0.0 111.784 178.162 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' B' B ' 128' ' ' ASP . . . . . . . . . . . . . 15.9 p-10 -114.09 3.02 15.11 Favored 'General case' 0 CA--C 1.535 0.396 0 CA-C-N 119.552 1.069 . . . . 0.0 113.546 -176.36 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' B' B ' 129' ' ' LEU . . . . . . . . . . . . . 52.8 mt -111.48 140.85 45.73 Favored 'General case' 0 C--N 1.333 -0.114 0 O-C-N 121.972 -0.455 . . . . 0.0 110.522 -179.078 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' B' B ' 130' ' ' VAL . . . . . . . . . . . . . 46.5 t -122.98 134.85 64.9 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.326 0 N-CA-C 109.401 -0.592 . . . . 0.0 109.401 177.839 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' B' B ' 131' ' ' VAL . . . . . . . . . . . . . 39.3 t -134.36 138.06 50.53 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.223 0 CA-C-O 121.187 0.518 . . . . 0.0 110.45 -179.002 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' B' B ' 132' ' ' ILE . . . . . . . . . . . . . 70.7 mt -116.76 130.19 72.04 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.339 0 CA-C-N 115.556 -0.747 . . . . 0.0 109.388 179.508 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' B' B ' 133' ' ' ILE . . . . . . . . . . . . . 40.4 mm -112.2 119.25 59.72 Favored 'Isoleucine or valine' 0 C--O 1.233 0.221 0 CA-C-O 120.855 0.36 . . . . 0.0 110.67 -177.241 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' B' B ' 134' ' ' ASP . . . . . . . . . . . . . 7.2 p-10 -134.13 148.78 51.01 Favored 'General case' 0 C--N 1.331 -0.206 0 CA-C-N 116.103 -0.499 . . . . 0.0 109.76 177.156 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' B' B ' 135' ' ' GLU . . . . . . . . . . . . . 42.8 tp10 -49.9 -30.0 9.33 Favored 'General case' 0 C--N 1.328 -0.36 0 N-CA-C 112.576 0.584 . . . . 0.0 112.576 -173.523 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' B' B ' 136' ' ' GLN . . . . . . . . . . . . . 43.2 tp60 -80.18 -34.91 37.13 Favored 'General case' 0 C--N 1.33 -0.251 0 N-CA-C 112.282 0.475 . . . . 0.0 112.282 -175.046 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' B' B ' 137' ' ' LYS . . . . . . . . . . . . . 40.0 pttt -170.0 174.2 5.64 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-O 121.452 0.644 . . . . 0.0 112.179 -170.512 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' B' B ' 138' ' ' LEU . . . . . . . . . . . . . 6.1 tt -118.0 128.21 54.56 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 115.186 -0.915 . . . . 0.0 109.9 178.969 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' B' B ' 139' ' ' THR . . . . . . . . . . . . . 34.0 m -106.27 127.76 53.48 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.261 -0.427 . . . . 0.0 110.396 -179.87 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' B' B ' 140' ' ' LEU . . . . . 0.461 ' C ' HD23 ' B' ' 140' ' ' LEU . 5.5 tt -113.88 121.02 42.71 Favored 'General case' 0 C--N 1.328 -0.351 0 N-CA-C 109.149 -0.686 . . . . 0.0 109.149 -178.922 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' B' B ' 141' ' ' ILE . . . . . 0.416 ' N ' HD23 ' B' ' 140' ' ' LEU . 19.1 mt -119.88 116.81 51.65 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.303 0 N-CA-C 109.814 -0.439 . . . . 0.0 109.814 -176.604 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' B' B ' 142' ' ' ARG . . . . . . . . . . . . . 68.5 ttt180 -108.18 131.97 54.11 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 115.417 -0.81 . . . . 0.0 110.463 -177.092 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' B' B ' 143' ' ' THR . . . . . . . . . . . . . 35.2 p . . . . . 0 C--O 1.22 -0.45 0 CA-C-O 117.936 -1.03 . . . . 0.0 110.522 179.092 . . . . . . . . 0 0 . 1 . 018 nuclear build core ' C' C ' 2' ' ' SER . . . . . . . . . . . . . 12.6 p . . . . . 0 N--CA 1.463 0.181 0 CA-C-O 121.024 0.44 . . . . 0.0 110.906 . . . . . . . . . 0 0 . 1 . 018 nuclear build core ' C' C ' 3' ' ' GLU . . . . . . . . . . . . . 95.8 mt-10 -141.0 142.44 34.26 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 115.863 -0.608 . . . . 0.0 110.961 -178.356 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' C' C ' 4' ' ' LEU . . . . . . . . . . . . . 16.2 tp -122.73 127.05 48.7 Favored 'General case' 0 C--N 1.331 -0.207 0 CA-C-N 116.103 -0.499 . . . . 0.0 109.719 175.402 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' C' C ' 5' ' ' LYS . . . . . . . . . . . . . 52.5 mttp -108.07 122.12 46.23 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-O 120.763 0.315 . . . . 0.0 110.995 -179.109 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' C' C ' 6' ' ' LEU . . . . . . . . . . . . . 27.6 mt -116.21 151.81 34.98 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 115.543 -0.753 . . . . 0.0 110.522 179.863 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' C' C ' 7' ' ' LYS . . . . . . . . . . . . . 74.2 tttt -144.02 139.56 16.11 Favored Pre-proline 0 CA--C 1.534 0.331 0 CA-C-O 119.124 -0.465 . . . . 0.0 109.949 173.569 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' C' C ' 8' ' ' PRO . . . . . . . . . . . . . 80.3 Cg_endo -90.65 141.54 3.23 Favored 'Trans proline' 0 N--CA 1.491 1.364 0 C-N-CA 121.66 1.573 . . . . 0.0 111.72 176.764 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' C' C ' 9' ' ' LEU . . . . . . . . . . . . . 54.6 mt -73.78 -47.97 6.66 Favored Pre-proline 0 CA--C 1.535 0.392 0 CA-C-O 118.665 -0.683 . . . . 0.0 112.472 -178.519 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' C' C ' 10' ' ' PRO . . . . . . . . . . . . . 88.1 Cg_endo -80.66 152.3 19.73 Favored 'Trans proline' 0 N--CA 1.497 1.677 0 C-N-CA 121.313 1.342 . . . . 0.0 111.99 177.422 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' C' C ' 11' ' ' LYS . . . . . . . . . . . . . 73.8 mmtt -82.49 102.0 11.06 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-O 120.929 0.395 . . . . 0.0 110.222 177.524 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' C' C ' 12' ' ' VAL . . . . . . . . . . . . . 12.9 p -141.31 146.4 23.53 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 CA-C-N 116.136 -0.483 . . . . 0.0 110.466 -179.225 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' C' C ' 13' ' ' GLU . . . . . . . . . . . . . 85.0 tt0 -85.19 124.44 31.84 Favored 'General case' 0 C--N 1.329 -0.306 0 N-CA-C 109.93 -0.396 . . . . 0.0 109.93 177.429 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' C' C ' 14' ' ' LEU . . . . . . . . . . . . . 48.8 mt -93.12 142.8 25.81 Favored Pre-proline 0 CA--C 1.533 0.314 0 CA-C-O 119.072 -0.49 . . . . 0.0 110.379 -177.453 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' C' C ' 15' ' ' PRO . . . . . . . . . . . . . 35.6 Cg_exo -60.22 162.1 17.94 Favored 'Trans proline' 0 N--CA 1.496 1.665 0 C-N-CA 121.353 1.369 . . . . 0.0 112.034 176.887 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' C' C ' 16' ' ' PRO . . . . . . . . . . . . . 38.3 Cg_exo -58.2 -42.33 57.87 Favored 'Trans proline' 0 N--CA 1.496 1.632 0 C-N-CA 121.507 1.472 . . . . 0.0 112.897 -176.399 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' C' C ' 17' ' ' ASP . . . . . . . . . . . . . 15.2 p-10 -92.87 13.03 21.68 Favored 'General case' 0 C--N 1.327 -0.383 0 N-CA-C 113.239 0.829 . . . . 0.0 113.239 -175.966 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' C' C ' 18' ' ' PHE . . . . . . . . . . . . . 41.8 t80 -57.71 -43.98 85.59 Favored 'General case' 0 C--O 1.231 0.1 0 CA-C-O 121.073 0.463 . . . . 0.0 110.08 -178.188 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' C' C ' 19' ' ' VAL . . . . . . . . . . . . . 44.9 t -59.47 -42.39 87.66 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.346 0 CA-C-N 116.122 -0.49 . . . . 0.0 110.21 -179.259 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' C' C ' 20' ' ' ASP . . . . . . . . . . . . . 78.5 m-20 -59.69 -42.66 93.46 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-O 120.732 0.301 . . . . 0.0 110.951 -177.361 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' C' C ' 21' ' ' VAL . . . . . . . . . . . . . 43.7 t -64.58 -46.8 91.46 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.318 0 C-N-CA 120.79 -0.364 . . . . 0.0 110.315 -177.755 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' C' C ' 22' ' ' ILE . . . . . 0.488 HG22 HD12 ' C' ' 26' ' ' LEU . 24.5 mm -59.32 -40.1 80.58 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.276 0 C-N-CA 120.869 -0.332 . . . . 0.0 110.362 -179.017 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' C' C ' 23' ' ' ARG . . . . . . . . . . . . . 55.8 ttp180 -55.36 -50.04 70.72 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-O 121.038 0.447 . . . . 0.0 110.736 178.335 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' C' C ' 24' ' ' ILE . . . . . . . . . . . . . 78.0 mt -60.21 -46.06 95.2 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.327 0 CA-C-N 116.005 -0.543 . . . . 0.0 111.595 -177.379 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' C' C ' 25' ' ' LYS . . . . . . . . . . . . . 17.7 ptpt -67.47 -39.15 85.28 Favored 'General case' 0 CA--C 1.534 0.358 0 C-N-CA 120.584 -0.446 . . . . 0.0 111.94 -173.71 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' C' C ' 26' ' ' LEU . . . . . 0.488 HD12 HG22 ' C' ' 22' ' ' ILE . 21.8 mt -79.49 -31.66 42.33 Favored 'General case' 0 C--N 1.33 -0.255 0 N-CA-C 113.045 0.757 . . . . 0.0 113.045 -174.765 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' C' C ' 27' ' ' GLN . . . . . . . . . . . . . 4.5 pt20 -45.9 135.48 7.14 Favored 'General case' 0 CA--C 1.536 0.436 0 N-CA-C 112.78 0.659 . . . . 0.0 112.78 -175.083 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' C' C ' 28' ' ' GLY . . . . . . . . . . . . . . . 97.06 -21.14 47.83 Favored Glycine 0 CA--C 1.534 1.264 0 CA-C-N 115.985 -0.552 . . . . 0.0 112.683 -177.822 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' C' C ' 29' ' ' LYS . . . . . . . . . . . . . 61.7 mttp -97.53 155.14 17.08 Favored 'General case' 0 C--N 1.331 -0.213 0 CA-C-N 117.522 0.661 . . . . 0.0 110.963 -178.984 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' C' C ' 30' ' ' THR . . . . . . . . . . . . . 13.9 m -104.02 139.72 38.74 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.337 177.989 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' C' C ' 31' ' ' VAL . . . . . . . . . . . . . 34.0 m -131.61 157.35 43.15 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.206 0 CA-C-N 116.234 -0.439 . . . . 0.0 110.856 -179.151 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' C' C ' 32' ' ' ARG . . . . . . . . . . . . . 81.7 mtt85 -133.65 150.7 51.57 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-N 115.957 -0.565 . . . . 0.0 110.744 176.828 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' C' C ' 33' ' ' THR . . . . . . . . . . . . . 33.5 m -53.41 139.98 28.95 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.206 -0.452 . . . . 0.0 111.282 -178.944 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' C' C ' 34' ' ' GLY . . . . . . . . . . . . . . . 98.65 -16.98 59.02 Favored Glycine 0 CA--C 1.532 1.125 0 CA-C-O 119.638 -0.535 . . . . 0.0 113.329 178.332 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' C' C ' 35' ' ' ASP . . . . . . . . . . . . . 76.9 m-20 -64.3 149.08 48.86 Favored 'General case' 0 C--O 1.231 0.125 0 CA-C-N 118.054 0.927 . . . . 0.0 111.225 -179.865 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' C' C ' 36' ' ' VAL . . . . . . . . . . . . . 46.2 t -121.07 129.66 75.46 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.211 0 CA-C-N 115.777 -0.647 . . . . 0.0 109.816 178.644 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' C' C ' 37' ' ' ILE . . . . . . . . . . . . . 72.1 mt -123.23 139.98 48.27 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.276 0 CA-C-N 116.182 -0.463 . . . . 0.0 109.994 -179.77 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' C' C ' 38' ' ' GLY . . . . . . . . . . . . . . . -108.91 128.67 9.15 Favored Glycine 0 CA--C 1.526 0.736 0 N-CA-C 111.317 -0.713 . . . . 0.0 111.317 -179.302 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' C' C ' 39' ' ' ILE . . . . . . . . . . . . . 77.7 mt -128.34 135.36 62.82 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.187 0 CA-C-O 120.757 0.313 . . . . 0.0 110.185 178.535 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' C' C ' 40' ' ' SER . . . . . . . . . . . . . 32.6 p -92.78 117.03 29.57 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.324 -0.398 . . . . 0.0 110.822 175.377 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' C' C ' 41' ' ' ILE . . . . . . . . . . . . . 45.7 mm -121.12 112.91 37.66 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.21 0 CA-C-O 120.794 0.331 . . . . 0.0 110.186 178.686 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' C' C ' 42' ' ' LEU . . . . . 0.424 ' O ' HD23 ' C' ' 42' ' ' LEU . 2.0 tt 55.58 48.56 18.4 Favored 'General case' 0 CA--C 1.533 0.307 0 CA-C-O 121.538 0.685 . . . . 0.0 110.098 178.643 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' C' C ' 43' ' ' GLY . . . . . . . . . . . . . . . 71.77 -5.48 11.92 Favored Glycine 0 CA--C 1.536 1.359 0 C-N-CA 121.125 -0.559 . . . . 0.0 113.766 175.642 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' C' C ' 44' ' ' LYS . . . . . . . . . . . . . 25.6 tptp -103.34 132.97 49.17 Favored 'General case' 0 C--O 1.231 0.126 0 CA-C-N 117.975 0.888 . . . . 0.0 110.031 -178.716 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' C' C ' 45' ' ' GLU . . . . . . . . . . . . . 82.5 tt0 -82.34 119.7 24.48 Favored 'General case' 0 C--N 1.329 -0.32 0 C-N-CA 120.808 -0.357 . . . . 0.0 110.78 -178.476 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' C' C ' 46' ' ' VAL . . . . . . . . . . . . . 7.2 p -122.8 124.52 70.65 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.21 0 N-CA-C 109.42 -0.585 . . . . 0.0 109.42 177.283 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' C' C ' 47' ' ' LYS . . . . . . . . . . . . . 53.7 mtmt -100.88 132.0 46.49 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.073 -0.512 . . . . 0.0 111.124 177.201 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' C' C ' 48' ' ' PHE . . . . . . . . . . . . . 84.3 m-85 -109.42 134.17 52.17 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 115.87 -0.605 . . . . 0.0 110.417 179.741 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' C' C ' 49' ' ' LYS . . . . . . . . . . . . . 87.5 tttt -105.3 134.36 48.54 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 115.844 -0.616 . . . . 0.0 110.05 178.589 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' C' C ' 50' ' ' VAL . . . . . . . . . . . . . 44.6 t -77.87 106.69 8.62 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.243 0 N-CA-C 109.147 -0.686 . . . . 0.0 109.147 174.873 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' C' C ' 51' ' ' VAL . . . . . . . . . . . . . 45.8 t -68.71 -46.63 79.37 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.308 0 CA-C-N 116.107 -0.497 . . . . 0.0 110.018 -172.59 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' C' C ' 52' ' ' GLN . . . . . . . . . . . . . 45.0 tt0 -171.39 145.25 2.09 Favored 'General case' 0 C--N 1.331 -0.207 0 C-N-CA 120.229 -0.588 . . . . 0.0 111.662 -179.361 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' C' C ' 53' ' ' ALA . . . . . . . . . . . . . . . -116.63 132.1 56.77 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 115.766 -0.652 . . . . 0.0 110.013 176.459 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' C' C ' 54' ' ' TYR . . . . . . . . . . . . . 48.2 t80 -129.11 108.87 18.03 Favored Pre-proline 0 CA--C 1.535 0.39 0 CA-C-O 118.264 -0.874 . . . . 0.0 110.242 177.983 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' C' C ' 55' ' ' PRO . . . . . . . . . . . . . 72.4 Cg_endo -77.11 168.5 76.83 Favored 'Cis proline' 0 N--CA 1.498 1.774 0 CA-C-N 121.865 1.702 . . . . 0.0 112.504 -3.823 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' C' C ' 56' ' ' SER . . . . . . . . . . . . . 50.2 m -115.71 130.49 24.31 Favored Pre-proline 0 CA--C 1.538 0.501 0 CA-C-O 118.456 -0.783 . . . . 0.0 109.373 174.446 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' C' C ' 57' ' ' PRO . . . . . . . . . . . . . 54.8 Cg_endo -70.0 165.3 77.7 Favored 'Cis proline' 0 N--CA 1.497 1.732 0 CA-C-N 121.918 1.721 . . . . 0.0 111.432 0.606 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' C' C ' 58' ' ' LEU . . . . . . . . . . . . . 29.3 tp -129.73 137.51 50.61 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-O 120.908 0.385 . . . . 0.0 110.419 -179.957 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' C' C ' 59' ' ' ARG . . . . . . . . . . . . . 64.7 ttp85 -106.98 125.72 51.38 Favored 'General case' 0 C--N 1.328 -0.332 0 N-CA-C 109.328 -0.619 . . . . 0.0 109.328 176.917 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' C' C ' 60' ' ' VAL . . . . . . . . . . . . . 45.0 t -75.48 115.97 17.66 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.288 0 CA-C-O 120.878 0.37 . . . . 0.0 110.656 -173.884 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' C' C ' 61' ' ' GLU . . . . . . . . . . . . . 39.1 tp10 -131.05 154.76 47.89 Favored 'General case' 0 C--N 1.33 -0.263 0 N-CA-C 109.062 -0.718 . . . . 0.0 109.062 176.77 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' C' C ' 62' ' ' ASP . . . . . . . . . . . . . 83.4 m-20 -50.86 -32.33 20.01 Favored 'General case' 0 C--N 1.326 -0.444 0 N-CA-C 112.162 0.43 . . . . 0.0 112.162 -176.612 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' C' C ' 63' ' ' ARG . . . . . . . . . . . . . 75.4 mtt85 -72.37 -22.19 61.18 Favored 'General case' 0 C--N 1.33 -0.261 0 N-CA-C 113.154 0.798 . . . . 0.0 113.154 -175.627 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' C' C ' 64' ' ' THR . . . . . . . . . . . . . 33.3 m -68.81 140.36 55.26 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-O 120.86 0.362 . . . . 0.0 110.697 -176.778 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' C' C ' 65' ' ' LYS . . . . . . . . . . . . . 97.2 mttt -88.08 134.64 33.71 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.045 -0.525 . . . . 0.0 109.989 179.159 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' C' C ' 66' ' ' ILE . . . . . . . . . . . . . 53.7 mt -111.09 129.84 65.64 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.238 0 N-CA-C 109.607 -0.516 . . . . 0.0 109.607 -178.248 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' C' C ' 67' ' ' THR . . . . . . . . . . . . . 34.6 m -123.69 140.24 53.19 Favored 'General case' 0 C--N 1.331 -0.223 0 CA-C-O 121.079 0.466 . . . . 0.0 111.295 -175.724 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' C' C ' 68' ' ' LEU . . . . . 0.465 HD12 ' N ' ' C' ' 68' ' ' LEU . 8.2 mp . . . . . 0 C--N 1.328 -0.353 0 CA-C-N 115.667 -0.697 . . . . 0.0 110.1 176.077 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' C' C ' 73' ' ' VAL . . . . . . . . . . . . . 21.1 m . . . . . 0 C--O 1.232 0.134 0 CA-C-O 121.137 0.494 . . . . 0.0 111.038 . . . . . . . . . 0 0 . 1 . 018 nuclear build core ' C' C ' 74' ' ' ASP . . . . . . . . . . . . . 7.0 t0 -107.95 122.92 47.81 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 115.572 -0.74 . . . . 0.0 109.371 175.251 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' C' C ' 75' ' ' VAL . . . . . . . . . . . . . 40.1 t -112.52 121.32 64.63 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.231 0 CA-C-O 121.128 0.49 . . . . 0.0 110.676 -177.69 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' C' C ' 76' ' ' LEU . . . . . 0.469 ' N ' HD12 ' C' ' 76' ' ' LEU . 6.4 mp -119.57 148.48 43.26 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 115.573 -0.74 . . . . 0.0 109.621 176.309 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' C' C ' 77' ' ' GLU . . . . . . . . . . . . . 98.0 mt-10 -137.84 133.58 34.1 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-O 121.108 0.48 . . . . 0.0 111.129 -177.988 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' C' C ' 78' ' ' ALA . . . . . 0.663 ' HB2' HD21 ' C' ' 109' ' ' LEU . . . -118.74 128.0 54.08 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 115.674 -0.693 . . . . 0.0 109.672 176.724 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' C' C ' 79' ' ' LYS . . . . . 0.563 ' O ' HD13 ' C' ' 80' ' ' ILE . 61.7 mttp -83.87 114.94 22.01 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-O 121.05 0.452 . . . . 0.0 110.897 -176.072 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' C' C ' 80' ' ' ILE . . . . . 0.563 HD13 ' O ' ' C' ' 79' ' ' LYS . 43.7 mm -139.26 107.33 3.19 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.28 0 N-CA-C 109.025 -0.731 . . . . 0.0 109.025 -178.023 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' C' C ' 81' ' ' LYS . . . . . . . . . . . . . 77.4 tttt -95.34 127.41 41.37 Favored 'General case' 0 C--N 1.328 -0.369 0 C-N-CA 120.676 -0.409 . . . . 0.0 110.687 -177.837 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' C' C ' 82' ' ' GLY . . . . . . . . . . . . . . . 89.29 42.03 5.65 Favored Glycine 0 CA--C 1.524 0.645 0 C-N-CA 120.749 -0.738 . . . . 0.0 111.744 176.426 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' C' C ' 83' ' ' ILE . . . . . . . . . . . . . 67.9 mt -68.39 139.28 20.92 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.324 0 N-CA-C 109.47 -0.567 . . . . 0.0 109.47 176.586 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' C' C ' 84' ' ' LYS . . . . . . . . . . . . . 68.5 tttt -98.42 -54.14 3.13 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.112 -0.495 . . . . 0.0 110.704 -176.009 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' C' C ' 85' ' ' ASP . . . . . . . . . . . . . 6.9 t70 -152.14 155.31 37.6 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 115.885 -0.598 . . . . 0.0 110.353 -177.883 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' C' C ' 86' ' ' VAL . . . . . . . . . . . . . 40.3 t -133.17 132.23 58.48 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.254 0 CA-C-O 121.017 0.437 . . . . 0.0 110.729 -178.485 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' C' C ' 87' ' ' ILE . . . . . . . . . . . . . 45.1 mm -117.63 122.28 69.47 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.276 0 CA-C-N 115.776 -0.647 . . . . 0.0 109.325 174.431 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' C' C ' 88' ' ' LEU . . . . . . . . . . . . . 13.4 tp -113.04 130.75 56.04 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-O 120.992 0.425 . . . . 0.0 110.998 -176.219 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' C' C ' 89' ' ' ASP . . . . . . . . . . . . . 11.7 t70 -128.65 160.24 33.06 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 115.888 -0.597 . . . . 0.0 109.863 178.38 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' C' C ' 90' ' ' GLU . . . . . . . . . . . . . 83.3 tt0 -46.23 -41.13 12.45 Favored 'General case' 0 CA--C 1.532 0.282 0 N-CA-C 113.073 0.768 . . . . 0.0 113.073 -172.041 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' C' C ' 91' ' ' ASN . . . . . . . . . . . . . 25.6 m120 -132.05 27.55 4.53 Favored 'General case' 0 N--CA 1.467 0.409 0 N-CA-C 112.44 0.533 . . . . 0.0 112.44 -177.451 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' C' C ' 92' ' ' LEU . . . . . . . . . . . . . 12.2 mt -149.98 141.17 23.11 Favored 'General case' 0 C--N 1.33 -0.265 0 N-CA-C 110.221 -0.288 . . . . 0.0 110.221 -177.43 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' C' C ' 93' ' ' ILE . . . . . . . . . . . . . 73.0 mt -124.5 113.63 37.22 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.284 0 N-CA-C 109.075 -0.713 . . . . 0.0 109.075 176.887 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' C' C ' 94' ' ' VAL . . . . . . . . . . . . . 45.0 t -116.6 126.49 74.08 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.247 0 N-CA-C 109.806 -0.442 . . . . 0.0 109.806 -179.388 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' C' C ' 95' ' ' VAL . . . . . . . . . . . . . 40.2 t -124.38 136.63 59.89 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.325 0 CA-C-N 116.28 -0.418 . . . . 0.0 110.056 -178.687 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' C' C ' 96' ' ' ILE . . . . . . . . . . . . . 61.4 mt -116.55 130.55 71.19 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.361 0 N-CA-C 109.221 -0.659 . . . . 0.0 109.221 179.112 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' C' C ' 97' ' ' THR . . . . . . . . . . . . . 71.4 p -98.37 159.99 14.58 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-O 120.908 0.385 . . . . 0.0 110.619 -178.346 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' C' C ' 98' ' ' GLU . . . . . . . . . . . . . 12.8 pt-20 -53.99 -19.27 4.45 Favored 'General case' 0 CA--C 1.535 0.367 0 N-CA-C 112.801 0.667 . . . . 0.0 112.801 -179.266 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' C' C ' 99' ' ' GLU . . . . . . . . . . . . . 37.1 tt0 -85.67 16.34 4.02 Favored 'General case' 0 CA--C 1.539 0.545 0 N-CA-C 112.567 0.58 . . . . 0.0 112.567 -177.259 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' C' C ' 100' ' ' ASN . . . . . . . . . . . . . 3.4 m-20 61.14 38.06 17.18 Favored 'General case' 0 CA--C 1.529 0.17 0 O-C-N 121.818 -0.551 . . . . 0.0 110.971 178.564 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' C' C ' 101' ' ' GLU . . . . . . . . . . . . . 82.0 tt0 -116.12 143.24 45.74 Favored 'General case' 0 C--N 1.331 -0.207 0 N-CA-C 109.444 -0.576 . . . . 0.0 109.444 175.831 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' C' C ' 102' ' ' VAL . . . . . . . . . . . . . 44.4 t -117.66 128.41 74.87 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.263 0 CA-C-O 120.972 0.415 . . . . 0.0 110.098 -177.609 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' C' C ' 103' ' ' LEU . . . . . . . . . . . . . 25.0 mt -118.38 136.35 53.8 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 115.564 -0.743 . . . . 0.0 109.752 176.164 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' C' C ' 104' ' ' ILE . . . . . . . . . . . . . 69.2 mt -118.19 121.34 66.99 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.244 0 N-CA-C 109.844 -0.428 . . . . 0.0 109.844 179.725 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' C' C ' 105' ' ' PHE . . . . . . . . . . . . . 53.9 m-85 -118.11 161.31 20.06 Favored 'General case' 0 C--N 1.333 -0.139 0 O-C-N 124.183 0.927 . . . . 0.0 109.836 -179.328 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' C' C ' 106' ' ' ASN . . . . . . . . . . . . . 44.7 p-10 -98.82 -171.04 2.03 Favored 'General case' 0 C--N 1.33 -0.246 0 N-CA-C 110.049 -0.352 . . . . 0.0 110.049 175.427 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' C' C ' 107' ' ' GLN . . . . . . . . . . . . . 41.0 tt0 -58.29 -30.13 66.39 Favored 'General case' 0 C--N 1.329 -0.284 0 N-CA-C 111.968 0.358 . . . . 0.0 111.968 -179.459 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' C' C ' 108' ' ' ASN . . . . . . . . . . . . . 12.9 t30 -86.17 8.78 19.68 Favored 'General case' 0 CA--C 1.535 0.398 0 N-CA-C 113.475 0.917 . . . . 0.0 113.475 -175.954 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' C' C ' 109' ' ' LEU . . . . . 0.663 HD21 ' HB2' ' C' ' 78' ' ' ALA . 11.9 tp 62.96 38.55 11.06 Favored 'General case' 0 CA--C 1.53 0.185 0 CA-C-O 121.073 0.464 . . . . 0.0 111.301 177.752 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' C' C ' 110' ' ' GLU . . . . . . . . . . . . . 70.7 mm-40 -109.16 157.43 18.78 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 116.37 -0.377 . . . . 0.0 110.114 176.211 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' C' C ' 111' ' ' GLU . . . . . . . . . . . . . 98.5 mt-10 -86.35 124.24 32.48 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-O 120.806 0.336 . . . . 0.0 111.263 -178.401 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' C' C ' 112' ' ' LEU . . . . . . . . . . . . . 13.5 mt -111.14 -45.99 3.37 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 115.982 -0.554 . . . . 0.0 110.711 178.479 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' C' C ' 113' ' ' TYR . . . . . . . . . . . . . 61.6 t80 -135.85 142.45 44.79 Favored 'General case' 0 N--CA 1.464 0.256 0 C-N-CA 120.749 -0.381 . . . . 0.0 111.532 -178.224 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' C' C ' 114' ' ' ARG . . . . . . . . . . . . . 51.3 mtt85 -135.75 125.88 26.2 Favored 'General case' 0 C--N 1.331 -0.21 0 CA-C-N 115.996 -0.547 . . . . 0.0 109.937 179.684 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' C' C ' 115' ' ' GLY . . . . . . . . . . . . . . . -150.13 155.06 26.04 Favored Glycine 0 CA--C 1.524 0.65 0 C-N-CA 120.643 -0.789 . . . . 0.0 111.296 177.886 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' C' C ' 116' ' ' LYS . . . . . . . . . . . . . 36.1 ttpt -129.98 136.07 49.02 Favored 'General case' 0 C--N 1.331 -0.224 0 N-CA-C 109.64 -0.504 . . . . 0.0 109.64 175.875 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' C' C ' 117' ' ' PHE . . . . . . . . . . . . . 40.0 m-85 -137.7 113.92 10.08 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-O 120.927 0.394 . . . . 0.0 110.313 -176.033 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' C' C ' 118' ' ' GLU . . . . . . . . . . . . . 95.7 mt-10 -56.0 -46.4 78.74 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.388 -0.369 . . . . 0.0 110.976 -176.321 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' C' C ' 119' ' ' ASN . . . . . . . . . . . . . 71.0 m-80 -95.86 31.03 2.19 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.102 -0.499 . . . . 0.0 112.002 -174.99 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' C' C ' 120' ' ' LEU . . . . . . . . . . . . . 12.2 tp -56.7 119.96 7.02 Favored 'General case' 0 C--N 1.333 -0.144 0 C-N-CA 120.993 -0.283 . . . . 0.0 110.278 178.284 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' C' C ' 121' ' ' ASN . . . . . . . . . . . . . 56.3 m-20 -114.08 -44.2 3.17 Favored 'General case' 0 C--N 1.331 -0.226 0 CA-C-N 116.491 -0.322 . . . . 0.0 110.983 -176.883 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' C' C ' 122' ' ' LYS . . . . . . . . . . . . . 92.5 mttt -143.26 145.21 32.54 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-O 121.126 0.489 . . . . 0.0 111.688 -178.133 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' C' C ' 123' ' ' VAL . . . . . . . . . . . . . 43.8 t -124.75 126.2 71.11 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.262 0 CA-C-N 115.735 -0.666 . . . . 0.0 109.325 174.997 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' C' C ' 124' ' ' LEU . . . . . . . . . . . . . 74.4 mt -115.13 129.45 56.67 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.507 -0.315 . . . . 0.0 110.379 -177.122 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' C' C ' 125' ' ' VAL . . . . . . . . . . . . . 43.6 t -127.9 122.6 58.99 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.225 0 CA-C-N 116.282 -0.417 . . . . 0.0 109.898 178.851 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' C' C ' 126' ' ' ARG . . . . . . . . . . . . . 80.9 mtt85 -151.99 135.6 16.18 Favored 'General case' 0 C--N 1.33 -0.255 0 N-CA-C 109.748 -0.464 . . . . 0.0 109.748 178.267 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' C' C ' 127' ' ' ASN . . . . . . . . . . . . . 3.1 m120 55.99 -154.99 0.3 Allowed 'General case' 0 CA--C 1.539 0.549 0 N-CA-C 109.644 -0.502 . . . . 0.0 109.644 -179.282 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' C' C ' 128' ' ' ASP . . . . . . . . . . . . . 9.3 p-10 -84.88 21.47 1.58 Allowed 'General case' 0 CA--C 1.535 0.384 0 CA-C-N 118.432 0.56 . . . . 0.0 112.199 175.831 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' C' C ' 129' ' ' LEU . . . . . . . . . . . . . 12.8 tp -116.42 137.76 51.9 Favored 'General case' 0 C--O 1.234 0.254 0 CA-C-O 120.91 0.386 . . . . 0.0 110.381 -179.676 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' C' C ' 130' ' ' VAL . . . . . . . . . . . . . 42.8 t -124.33 136.8 59.32 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.204 0 CA-C-N 116.079 -0.509 . . . . 0.0 110.049 -178.864 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' C' C ' 131' ' ' VAL . . . . . . . . . . . . . 44.6 t -136.02 137.79 48.24 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.292 0 CA-C-O 120.946 0.403 . . . . 0.0 110.329 179.181 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' C' C ' 132' ' ' ILE . . . . . . . . . . . . . 72.4 mt -121.26 134.09 65.74 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.247 0 CA-C-N 116.064 -0.516 . . . . 0.0 109.795 -179.027 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' C' C ' 133' ' ' ILE . . . . . . . . . . . . . 42.9 mm -117.2 121.56 67.97 Favored 'Isoleucine or valine' 0 C--O 1.233 0.228 0 CA-C-O 120.834 0.349 . . . . 0.0 111.156 -176.275 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' C' C ' 134' ' ' ASP . . . . . . . . . . . . . 6.9 p-10 -133.47 147.12 51.65 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 115.78 -0.645 . . . . 0.0 109.52 174.003 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' C' C ' 135' ' ' GLU . . . . . . . . . . . . . 83.3 tt0 -50.05 -25.05 3.05 Favored 'General case' 0 C--N 1.327 -0.373 0 N-CA-C 112.96 0.726 . . . . 0.0 112.96 -171.247 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' C' C ' 136' ' ' GLN . . . . . . . . . . . . . 95.6 mm-40 -93.46 -35.03 13.17 Favored 'General case' 0 C--N 1.33 -0.267 0 N-CA-C 112.633 0.605 . . . . 0.0 112.633 -176.379 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' C' C ' 137' ' ' LYS . . . . . . . . . . . . . 50.0 mtmt -146.2 154.74 42.1 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-O 121.303 0.573 . . . . 0.0 112.056 -169.13 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' C' C ' 138' ' ' LEU . . . . . 0.423 HD23 ' C ' ' C' ' 138' ' ' LEU . 5.5 tt -116.81 123.45 47.15 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 115.349 -0.841 . . . . 0.0 109.16 175.151 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' C' C ' 139' ' ' THR . . . . . . . . . . . . . 30.7 m -111.57 129.71 55.98 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 116.483 -0.326 . . . . 0.0 110.97 -175.939 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' C' C ' 140' ' ' LEU . . . . . 0.473 ' C ' HD23 ' C' ' 140' ' ' LEU . 7.4 tt -117.77 124.36 48.24 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 115.747 -0.66 . . . . 0.0 109.449 -179.624 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' C' C ' 141' ' ' ILE . . . . . . . . . . . . . 19.0 mt -122.43 120.54 61.35 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.277 0 N-CA-C 109.909 -0.404 . . . . 0.0 109.909 -175.972 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' C' C ' 142' ' ' ARG . . . . . . . . . . . . . 78.3 ttt-85 . . . . . 0 C--N 1.33 -0.248 0 CA-C-N 115.84 -0.618 . . . . 0.0 110.099 -178.086 . . . . . . . . 0 0 . 1 . 018 nuclear build core ' D' D ' 2' ' ' SER . . . . . . . . . . . . . 79.5 p . . . . . 0 C--O 1.232 0.183 0 CA-C-O 120.92 0.39 . . . . 0.0 110.522 . . . . . . . . . 0 0 . 1 . 018 nuclear build core ' D' D ' 3' ' ' GLU . . . . . . . . . . . . . 84.9 tt0 -140.22 138.4 35.06 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.063 -0.517 . . . . 0.0 110.987 -178.647 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' D' D ' 4' ' ' LEU . . . . . 0.491 HD21 HG13 ' D' ' 50' ' ' VAL . 4.9 tt -124.25 130.23 52.15 Favored 'General case' 0 C--N 1.332 -0.187 0 CA-C-N 115.96 -0.564 . . . . 0.0 110.137 178.309 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' D' D ' 5' ' ' LYS . . . . . 0.415 ' N ' HD23 ' D' ' 4' ' ' LEU . 67.6 mttm -109.65 122.58 47.78 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.455 -0.339 . . . . 0.0 111.017 -178.739 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' D' D ' 6' ' ' LEU . . . . . 0.453 HD23 ' HA ' ' D' ' 50' ' ' VAL . 79.6 mt -115.38 149.78 37.41 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 115.369 -0.832 . . . . 0.0 110.331 179.793 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' D' D ' 7' ' ' LYS . . . . . . . . . . . . . 64.1 tttm -137.45 137.07 21.29 Favored Pre-proline 0 CA--C 1.534 0.338 0 CA-C-O 119.014 -0.517 . . . . 0.0 110.087 176.587 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' D' D ' 8' ' ' PRO . . . . . . . . . . . . . 93.1 Cg_endo -92.01 141.73 2.49 Favored 'Trans proline' 0 N--CA 1.49 1.3 0 C-N-CA 121.823 1.682 . . . . 0.0 111.491 176.701 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' D' D ' 9' ' ' LEU . . . . . . . . . . . . . 66.7 mt -75.86 -47.48 3.84 Favored Pre-proline 0 CA--C 1.533 0.292 0 CA-C-O 118.74 -0.648 . . . . 0.0 112.219 -178.439 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' D' D ' 10' ' ' PRO . . . . . . . . . . . . . 98.6 Cg_endo -81.74 149.04 16.04 Favored 'Trans proline' 0 N--CA 1.495 1.612 0 C-N-CA 121.184 1.256 . . . . 0.0 111.852 175.542 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' D' D ' 11' ' ' LYS . . . . . . . . . . . . . 24.3 tptp -88.86 100.53 13.24 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-O 120.764 0.316 . . . . 0.0 110.399 179.539 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' D' D ' 12' ' ' VAL . . . . . . . . . . . . . 11.4 p -139.62 142.23 33.19 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.233 0 CA-C-N 116.358 -0.383 . . . . 0.0 110.548 -179.206 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' D' D ' 13' ' ' GLU . . . . . . . . . . . . . 43.1 mp0 -78.17 122.44 25.65 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 116.3 -0.409 . . . . 0.0 110.165 178.041 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' D' D ' 14' ' ' LEU . . . . . . . . . . . . . 35.8 mt -98.4 153.44 38.02 Favored Pre-proline 0 CA--C 1.532 0.285 0 CA-C-N 116.462 -0.336 . . . . 0.0 110.51 -179.283 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' D' D ' 15' ' ' PRO . . . . . . . . . . . . . 33.5 Cg_exo -60.56 157.41 36.92 Favored 'Trans proline' 0 N--CA 1.496 1.653 0 C-N-CA 121.256 1.304 . . . . 0.0 111.792 176.801 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' D' D ' 16' ' ' PRO . . . . . . . . . . . . . 36.2 Cg_exo -58.83 -37.39 94.05 Favored 'Trans proline' 0 N--CA 1.498 1.737 0 C-N-CA 121.376 1.384 . . . . 0.0 112.654 -178.177 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' D' D ' 17' ' ' ASP . . . . . . . . . . . . . 7.1 p-10 -88.46 9.94 21.9 Favored 'General case' 0 CA--C 1.534 0.355 0 N-CA-C 113.284 0.846 . . . . 0.0 113.284 -176.832 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' D' D ' 18' ' ' PHE . . . . . . . . . . . . . 19.8 t80 -57.72 -45.06 86.25 Favored 'General case' 0 C--N 1.334 -0.091 0 O-C-N 121.916 -0.49 . . . . 0.0 110.041 -177.653 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' D' D ' 19' ' ' VAL . . . . . . . . . . . . . 48.0 t -57.61 -43.15 82.82 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.286 0 CA-C-N 116.273 -0.421 . . . . 0.0 110.548 -178.521 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' D' D ' 20' ' ' ASP . . . . . . . . . . . . . 82.5 m-20 -60.15 -42.56 95.15 Favored 'General case' 0 C--N 1.33 -0.258 0 C-N-CA 120.837 -0.345 . . . . 0.0 111.112 -176.789 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' D' D ' 21' ' ' VAL . . . . . . . . . . . . . 45.6 t -64.73 -46.28 92.67 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.33 0 C-N-CA 120.807 -0.357 . . . . 0.0 110.347 -177.863 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' D' D ' 22' ' ' ILE . . . . . . . . . . . . . 50.5 mm -56.91 -42.98 79.61 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.229 0 C-N-CA 120.815 -0.354 . . . . 0.0 110.441 178.379 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' D' D ' 23' ' ' ARG . . . . . . . . . . . . . 54.7 ttp180 -53.5 -47.39 69.9 Favored 'General case' 0 C--N 1.33 -0.266 0 O-C-N 122.32 -0.237 . . . . 0.0 111.339 -179.208 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' D' D ' 24' ' ' ILE . . . . . . . . . . . . . 71.7 mt -60.02 -43.41 92.52 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.342 0 C-N-CA 120.933 -0.307 . . . . 0.0 110.698 179.541 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' D' D ' 25' ' ' LYS . . . . . . . . . . . . . 89.0 mttt -61.73 -38.09 86.62 Favored 'General case' 0 C--N 1.328 -0.343 0 N-CA-C 112.379 0.511 . . . . 0.0 112.379 -179.564 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' D' D ' 26' ' ' LEU . . . . . . . . . . . . . 86.3 mt -77.99 -46.63 20.52 Favored 'General case' 0 C--N 1.329 -0.32 0 N-CA-C 112.702 0.63 . . . . 0.0 112.702 -171.719 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' D' D ' 27' ' ' GLN . . . . . . . . . . . . . 15.2 pt20 -47.03 137.76 7.25 Favored 'General case' 0 N--CA 1.47 0.556 0 N-CA-C 112.75 0.648 . . . . 0.0 112.75 -175.839 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' D' D ' 28' ' ' GLY . . . . . . . . . . . . . . . 101.14 -26.86 23.1 Favored Glycine 0 CA--C 1.531 1.092 0 CA-C-N 115.591 -0.731 . . . . 0.0 112.312 -178.454 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' D' D ' 29' ' ' LYS . . . . . . . . . . . . . 87.4 mttt -99.67 155.14 17.77 Favored 'General case' 0 C--N 1.332 -0.182 0 CA-C-N 117.398 0.599 . . . . 0.0 111.385 179.707 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' D' D ' 30' ' ' THR . . . . . . . . . . . . . 22.2 m -101.07 135.38 42.63 Favored 'General case' 0 C--N 1.33 -0.239 0 CA-C-N 116.099 -0.501 . . . . 0.0 109.662 174.119 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' D' D ' 31' ' ' VAL . . . . . . . . . . . . . 34.3 m -127.48 156.33 39.12 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.226 0 CA-C-O 120.866 0.365 . . . . 0.0 111.14 -177.644 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' D' D ' 32' ' ' ARG . . . . . . . . . . . . . 72.8 mtt85 -132.93 149.35 52.25 Favored 'General case' 0 C--O 1.233 0.186 0 CA-C-N 115.724 -0.671 . . . . 0.0 110.838 178.864 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' D' D ' 33' ' ' THR . . . . . 0.432 HG23 ' HA ' ' D' ' 52' ' ' GLN . 23.7 m -53.8 140.46 29.97 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.07 -0.514 . . . . 0.0 111.146 -179.784 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' D' D ' 34' ' ' GLY . . . . . . . . . . . . . . . 99.7 -17.08 57.99 Favored Glycine 0 CA--C 1.531 1.047 0 C-N-CA 121.105 -0.569 . . . . 0.0 113.31 178.753 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' D' D ' 35' ' ' ASP . . . . . . . . . . . . . 75.8 m-20 -62.15 147.63 47.03 Favored 'General case' 0 N--CA 1.461 0.125 0 CA-C-N 118.054 0.927 . . . . 0.0 111.156 179.683 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' D' D ' 36' ' ' VAL . . . . . . . . . . . . . 46.5 t -124.63 129.12 73.79 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.234 0 CA-C-N 115.659 -0.7 . . . . 0.0 109.721 178.883 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' D' D ' 37' ' ' ILE . . . . . . . . . . . . . 68.0 mt -120.74 137.6 53.95 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.229 0 N-CA-C 109.857 -0.423 . . . . 0.0 109.857 -179.706 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' D' D ' 38' ' ' GLY . . . . . . . . . . . . . . . -111.5 128.74 8.8 Favored Glycine 0 CA--C 1.525 0.666 0 N-CA-C 111.018 -0.833 . . . . 0.0 111.018 179.606 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' D' D ' 39' ' ' ILE . . . . . . . . . . . . . 69.6 mt -125.44 126.64 70.89 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.228 0 N-CA-C 109.849 -0.426 . . . . 0.0 109.849 178.782 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' D' D ' 40' ' ' SER . . . . . . . . . . . . . 46.6 t -93.4 120.45 33.69 Favored 'General case' 0 C--N 1.33 -0.262 0 C-N-CA 120.825 -0.35 . . . . 0.0 110.88 176.158 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' D' D ' 41' ' ' ILE . . . . . . . . . . . . . 71.1 mt -132.88 125.47 52.32 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.186 0 CA-C-O 120.749 0.309 . . . . 0.0 110.316 178.589 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' D' D ' 42' ' ' LEU . . . . . . . . . . . . . 61.4 mt 57.5 34.39 24.54 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.098 -0.501 . . . . 0.0 111.891 177.296 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' D' D ' 43' ' ' GLY . . . . . . . . . . . . . . . 78.52 -10.11 31.88 Favored Glycine 0 CA--C 1.535 1.295 0 C-N-CA 121.192 -0.528 . . . . 0.0 113.463 176.975 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' D' D ' 44' ' ' LYS . . . . . . . . . . . . . 52.7 mtmt -101.76 130.25 48.13 Favored 'General case' 0 C--N 1.333 -0.14 0 CA-C-N 117.884 0.842 . . . . 0.0 110.066 176.65 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' D' D ' 45' ' ' GLU . . . . . . . . . . . . . 38.9 tp10 -85.53 130.33 34.6 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.4 -0.364 . . . . 0.0 110.777 -179.924 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' D' D ' 46' ' ' VAL . . . . . . . . . . . . . 7.2 p -121.61 129.46 75.5 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.235 0 N-CA-C 109.631 -0.507 . . . . 0.0 109.631 176.298 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' D' D ' 47' ' ' LYS . . . . . . . . . . . . . 98.5 mttt -101.03 130.44 47.03 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 115.892 -0.595 . . . . 0.0 111.119 178.387 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' D' D ' 48' ' ' PHE . . . . . . . . . . . . . 95.3 m-85 -113.41 131.83 55.85 Favored 'General case' 0 C--N 1.33 -0.244 0 N-CA-C 109.831 -0.433 . . . . 0.0 109.831 176.211 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' D' D ' 49' ' ' LYS . . . . . . . . . . . . . 81.8 tttt -110.5 139.11 46.05 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.402 -0.363 . . . . 0.0 110.63 179.454 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' D' D ' 50' ' ' VAL . . . . . 0.491 HG13 HD21 ' D' ' 4' ' ' LEU . 42.5 t -83.53 108.13 15.76 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.276 0 N-CA-C 109.4 -0.593 . . . . 0.0 109.4 175.59 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' D' D ' 51' ' ' VAL . . . . . . . . . . . . . 48.8 t -70.37 -48.26 61.36 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.314 0 CA-C-N 116.039 -0.528 . . . . 0.0 109.851 -173.816 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' D' D ' 52' ' ' GLN . . . . . 0.432 ' HA ' HG23 ' D' ' 33' ' ' THR . 14.0 pt20 -167.79 157.6 10.24 Favored 'General case' 0 C--N 1.331 -0.201 0 C-N-CA 120.115 -0.634 . . . . 0.0 112.017 -179.864 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' D' D ' 53' ' ' ALA . . . . . 0.656 ' HB3' ' OG ' ' D' ' 56' ' ' SER . . . -133.85 135.28 43.62 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 115.314 -0.857 . . . . 0.0 109.97 177.317 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' D' D ' 54' ' ' TYR . . . . . . . . . . . . . 13.8 t80 -129.01 111.69 18.47 Favored Pre-proline 0 CA--C 1.535 0.39 0 CA-C-O 118.24 -0.886 . . . . 0.0 110.133 179.163 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' D' D ' 55' ' ' PRO . . . . . . . . . . . . . 73.4 Cg_endo -77.12 170.21 72.21 Favored 'Cis proline' 0 N--CA 1.501 1.93 0 CA-C-N 121.899 1.714 . . . . 0.0 112.127 -7.587 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' D' D ' 56' ' ' SER . . . . . 0.656 ' OG ' ' HB3' ' D' ' 53' ' ' ALA . 66.0 m -129.71 140.64 39.23 Favored Pre-proline 0 CA--C 1.538 0.499 0 CA-C-O 118.71 -0.662 . . . . 0.0 109.489 174.52 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' D' D ' 57' ' ' PRO . . . . . . . . . . . . . 38.3 Cg_endo -68.05 156.31 87.46 Favored 'Cis proline' 0 N--CA 1.499 1.836 0 CA-C-N 121.559 1.592 . . . . 0.0 111.723 -2.018 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' D' D ' 58' ' ' LEU . . . . . . . . . . . . . 32.4 tp -128.75 138.86 52.34 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.252 -0.431 . . . . 0.0 110.778 -176.664 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' D' D ' 59' ' ' ARG . . . . . . . . . . . . . 60.1 ttt180 -100.48 120.36 39.88 Favored 'General case' 0 C--N 1.327 -0.4 0 N-CA-C 108.904 -0.776 . . . . 0.0 108.904 173.413 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' D' D ' 60' ' ' VAL . . . . . . . . . . . . . 43.3 t -72.63 126.38 33.12 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.252 0 C-N-CA 120.67 -0.412 . . . . 0.0 110.279 -174.084 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' D' D ' 61' ' ' GLU . . . . . . . . . . . . . 95.5 mt-10 -130.39 162.88 28.12 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 115.85 -0.613 . . . . 0.0 109.687 178.567 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' D' D ' 62' ' ' ASP . . . . . . . . . . . . . 5.2 t70 -53.34 -32.08 47.44 Favored 'General case' 0 C--N 1.328 -0.353 0 N-CA-C 111.782 0.29 . . . . 0.0 111.782 -179.638 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' D' D ' 63' ' ' ARG . . . . . . . . . . . . . 34.4 ptt180 -84.07 4.26 30.98 Favored 'General case' 0 CA--C 1.537 0.456 0 N-CA-C 113.779 1.029 . . . . 0.0 113.779 -174.926 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' D' D ' 64' ' ' THR . . . . . . . . . . . . . 35.4 m -86.93 139.61 30.45 Favored 'General case' 0 C--N 1.332 -0.186 0 CA-C-N 118.211 0.46 . . . . 0.0 110.713 -178.659 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' D' D ' 65' ' ' LYS . . . . . . . . . . . . . 67.5 mttm -90.14 134.05 34.51 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.252 -0.431 . . . . 0.0 110.581 -179.443 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' D' D ' 66' ' ' ILE . . . . . . . . . . . . . 58.8 mt -116.35 134.32 60.15 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.201 0 CA-C-O 120.897 0.379 . . . . 0.0 110.002 -179.719 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' D' D ' 67' ' ' THR . . . . . . . . . . . . . 34.6 m -125.31 141.46 52.07 Favored 'General case' 0 C--N 1.332 -0.17 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.92 -178.344 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' D' D ' 68' ' ' LEU . . . . . 0.426 ' C ' HD23 ' D' ' 68' ' ' LEU . 5.3 tt . . . . . 0 C--N 1.33 -0.257 0 CA-C-N 116.002 -0.544 . . . . 0.0 110.128 178.468 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' D' D ' 73' ' ' VAL . . . . . . . . . . . . . 27.7 m . . . . . 0 C--O 1.232 0.134 0 CA-C-O 120.628 0.251 . . . . 0.0 110.468 . . . . . . . . . 0 0 . 1 . 018 nuclear build core ' D' D ' 74' ' ' ASP . . . . . . . . . . . . . 10.3 t0 -103.68 117.98 35.66 Favored 'General case' 0 C--N 1.33 -0.242 0 N-CA-C 109.796 -0.446 . . . . 0.0 109.796 179.821 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' D' D ' 75' ' ' VAL . . . . . . . . . . . . . 45.4 t -113.52 122.86 68.46 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.227 0 CA-C-O 121.173 0.511 . . . . 0.0 110.474 -178.756 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' D' D ' 76' ' ' LEU . . . . . . . . . . . . . 24.5 mt -122.71 138.04 54.73 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 115.398 -0.819 . . . . 0.0 109.035 176.451 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' D' D ' 77' ' ' GLU . . . . . . . . . . . . . 58.6 tt0 -136.84 135.34 37.83 Favored 'General case' 0 C--N 1.331 -0.197 0 CA-C-O 121.027 0.441 . . . . 0.0 110.995 -177.133 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' D' D ' 78' ' ' ALA . . . . . 0.576 ' HB2' HD21 ' D' ' 109' ' ' LEU . . . -122.47 137.67 54.8 Favored 'General case' 0 C--N 1.331 -0.203 0 CA-C-N 115.862 -0.608 . . . . 0.0 109.926 178.517 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' D' D ' 79' ' ' LYS . . . . . 0.59 ' O ' HD13 ' D' ' 80' ' ' ILE . 54.2 mtmt -81.97 120.41 25.21 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-O 120.884 0.374 . . . . 0.0 110.483 179.831 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' D' D ' 80' ' ' ILE . . . . . 0.59 HD13 ' O ' ' D' ' 79' ' ' LYS . 42.6 mm -138.99 112.55 6.76 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.344 0 N-CA-C 109.254 -0.647 . . . . 0.0 109.254 -177.423 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' D' D ' 81' ' ' LYS . . . . . . . . . . . . . 9.3 mtmp? -103.33 126.88 50.72 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-O 120.91 0.386 . . . . 0.0 111.259 -177.158 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' D' D ' 82' ' ' GLY . . . . . . . . . . . . . . . 89.18 42.06 5.68 Favored Glycine 0 CA--C 1.525 0.712 0 C-N-CA 120.989 -0.624 . . . . 0.0 111.645 174.795 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' D' D ' 83' ' ' ILE . . . . . . . . . . . . . 72.5 mt -69.92 134.71 29.65 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.331 0 N-CA-C 109.501 -0.555 . . . . 0.0 109.501 176.347 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' D' D ' 84' ' ' LYS . . . . . . . . . . . . . 35.7 ttpt -98.65 -54.11 3.12 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-O 121.057 0.456 . . . . 0.0 110.423 -178.811 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' D' D ' 85' ' ' ASP . . . . . . . . . . . . . 10.6 t70 -148.53 149.94 32.5 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 115.758 -0.656 . . . . 0.0 110.387 -178.168 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' D' D ' 86' ' ' VAL . . . . . . . . . . . . . 40.7 t -127.41 129.51 70.58 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.252 0 CA-C-O 120.813 0.339 . . . . 0.0 110.474 -178.906 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' D' D ' 87' ' ' ILE . . . . . . . . . . . . . 43.7 mm -119.49 130.87 73.48 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.255 0 CA-C-N 115.98 -0.554 . . . . 0.0 109.61 177.305 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' D' D ' 88' ' ' LEU . . . . . . . . . . . . . 19.3 tp -115.42 135.79 53.75 Favored 'General case' 0 C--N 1.331 -0.205 0 CA-C-O 120.952 0.406 . . . . 0.0 111.544 -175.797 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' D' D ' 89' ' ' ASP . . . . . . . . . . . . . 13.3 t70 -128.67 156.97 42.6 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-N 115.755 -0.657 . . . . 0.0 109.537 176.091 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' D' D ' 90' ' ' GLU . . . . . . . . . . . . . 70.8 mm-40 -46.96 -38.53 10.79 Favored 'General case' 0 N--CA 1.465 0.305 0 N-CA-C 113.035 0.754 . . . . 0.0 113.035 -171.102 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' D' D ' 91' ' ' ASN . . . . . . . . . . . . . 59.7 m-80 -131.97 20.0 4.54 Favored 'General case' 0 N--CA 1.467 0.413 0 N-CA-C 112.968 0.729 . . . . 0.0 112.968 -177.421 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' D' D ' 92' ' ' LEU . . . . . 0.408 HD21 HG21 ' D' ' 143' ' ' THR . 15.8 mt -147.04 143.93 28.73 Favored 'General case' 0 C--N 1.331 -0.213 0 N-CA-C 110.141 -0.318 . . . . 0.0 110.141 -176.654 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' D' D ' 93' ' ' ILE . . . . . . . . . . . . . 75.2 mt -123.55 119.5 57.44 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.285 0 N-CA-C 109.294 -0.632 . . . . 0.0 109.294 179.035 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' D' D ' 94' ' ' VAL . . . . . 0.475 HG21 HG11 ' D' ' 125' ' ' VAL . 46.5 t -118.35 125.09 74.04 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.208 0 CA-C-O 120.988 0.423 . . . . 0.0 109.912 -178.57 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' D' D ' 95' ' ' VAL . . . . . . . . . . . . . 47.0 t -118.72 131.98 69.91 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.344 0 CA-C-N 115.862 -0.608 . . . . 0.0 109.643 -179.564 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' D' D ' 96' ' ' ILE . . . . . . . . . . . . . 68.7 mt -112.61 126.79 70.04 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.328 0 N-CA-C 109.184 -0.672 . . . . 0.0 109.184 178.354 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' D' D ' 97' ' ' THR . . . . . . . . . . . . . 78.4 p -97.63 159.64 14.8 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-O 121.28 0.562 . . . . 0.0 111.214 -176.678 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' D' D ' 98' ' ' GLU . . . . . . . . . . . . . 85.4 tt0 -53.96 -27.48 31.5 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 115.906 -0.588 . . . . 0.0 112.202 -179.061 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' D' D ' 99' ' ' GLU . . . . . . . . . . . . . 95.2 mt-10 -82.32 15.4 2.47 Favored 'General case' 0 CA--C 1.535 0.403 0 N-CA-C 113.14 0.793 . . . . 0.0 113.14 -176.581 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' D' D ' 100' ' ' ASN . . . . . . . . . . . . . 4.1 m-20 62.2 35.63 15.41 Favored 'General case' 0 C--N 1.331 -0.212 0 CA-C-O 120.949 0.404 . . . . 0.0 111.441 179.675 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' D' D ' 101' ' ' GLU . . . . . . . . . . . . . 84.2 tt0 -109.04 143.83 37.84 Favored 'General case' 0 C--N 1.331 -0.203 0 N-CA-C 109.595 -0.521 . . . . 0.0 109.595 173.227 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' D' D ' 102' ' ' VAL . . . . . . . . . . . . . 43.0 t -114.94 125.24 72.21 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.292 0 CA-C-N 116.206 -0.452 . . . . 0.0 109.944 -177.399 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' D' D ' 103' ' ' LEU . . . . . . . . . . . . . 16.8 mt -116.13 130.18 56.68 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 115.877 -0.601 . . . . 0.0 110.256 177.532 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' D' D ' 104' ' ' ILE . . . . . . . . . . . . . 70.9 mt -116.98 121.94 68.92 Favored 'Isoleucine or valine' 0 C--O 1.235 0.299 0 N-CA-C 110.286 -0.265 . . . . 0.0 110.286 179.83 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' D' D ' 105' ' ' PHE . . . . . . . . . . . . . 86.7 m-85 -121.67 163.47 18.95 Favored 'General case' 0 CA--C 1.528 0.134 0 O-C-N 124.052 0.845 . . . . 0.0 109.885 179.0 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' D' D ' 106' ' ' ASN . . . . . . . . . . . . . 40.6 p-10 -96.72 -169.94 1.97 Allowed 'General case' 0 C--N 1.33 -0.274 0 N-CA-C 109.913 -0.403 . . . . 0.0 109.913 173.075 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' D' D ' 107' ' ' GLN . . . . . . . . . . . . . 34.3 tt0 -60.59 -30.09 69.6 Favored 'General case' 0 CA--C 1.532 0.269 0 C-N-CA 121.014 -0.275 . . . . 0.0 111.628 179.565 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' D' D ' 108' ' ' ASN . . . . . . . . . . . . . 4.0 t-20 -82.67 4.79 23.5 Favored 'General case' 0 CA--C 1.536 0.421 0 N-CA-C 113.355 0.872 . . . . 0.0 113.355 -178.454 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' D' D ' 109' ' ' LEU . . . . . 0.576 HD21 ' HB2' ' D' ' 78' ' ' ALA . 7.4 tp 63.87 36.69 10.13 Favored 'General case' 0 CA--C 1.53 0.185 0 O-C-N 122.13 -0.356 . . . . 0.0 111.467 177.492 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' D' D ' 110' ' ' GLU . . . . . . . . . . . . . 95.5 mt-10 -105.13 154.49 20.11 Favored 'General case' 0 C--N 1.331 -0.222 0 N-CA-C 109.887 -0.412 . . . . 0.0 109.887 176.401 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' D' D ' 111' ' ' GLU . . . . . . . . . . . . . 83.6 tt0 -80.46 124.87 29.29 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-O 120.952 0.406 . . . . 0.0 110.928 -176.506 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' D' D ' 112' ' ' LEU . . . . . . . . . . . . . 31.8 mt -111.89 -46.08 3.27 Favored 'General case' 0 C--N 1.331 -0.216 0 CA-C-N 115.995 -0.548 . . . . 0.0 110.511 178.355 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' D' D ' 113' ' ' TYR . . . . . . . . . . . . . 58.1 t80 -142.21 140.35 32.3 Favored 'General case' 0 C--N 1.328 -0.331 0 C-N-CA 120.792 -0.363 . . . . 0.0 111.242 -179.644 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' D' D ' 114' ' ' ARG . . . . . . . . . . . . . 33.6 ttp180 -136.82 126.48 25.4 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.202 -0.454 . . . . 0.0 110.419 176.975 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' D' D ' 115' ' ' GLY . . . . . . . . . . . . . . . -150.05 158.93 27.89 Favored Glycine 0 CA--C 1.524 0.636 0 N-CA-C 110.78 -0.928 . . . . 0.0 110.78 178.164 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' D' D ' 116' ' ' LYS . . . . . . . . . . . . . 79.3 tttt -136.02 131.75 35.38 Favored 'General case' 0 C--N 1.328 -0.331 0 N-CA-C 109.925 -0.398 . . . . 0.0 109.925 178.879 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' D' D ' 117' ' ' PHE . . . . . . . . . . . . . 32.4 m-85 -132.72 117.56 18.0 Favored 'General case' 0 N--CA 1.463 0.214 0 CA-C-O 120.929 0.395 . . . . 0.0 110.599 -173.72 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' D' D ' 118' ' ' GLU . . . . . . . . . . . . . 46.5 tp10 -52.88 -50.96 62.79 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.296 -0.411 . . . . 0.0 111.393 -177.577 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' D' D ' 119' ' ' ASN . . . . . . . . . . . . . 79.4 m-20 -93.61 31.07 1.62 Allowed 'General case' 0 C--N 1.33 -0.27 0 N-CA-C 112.202 0.445 . . . . 0.0 112.202 -173.783 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' D' D ' 120' ' ' LEU . . . . . . . . . . . . . 20.2 tp -58.36 124.58 20.01 Favored 'General case' 0 C--N 1.332 -0.195 0 N-CA-C 110.075 -0.343 . . . . 0.0 110.075 177.474 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' D' D ' 121' ' ' ASN . . . . . . . . . . . . . 4.4 m-20 -114.03 -44.09 3.18 Favored 'General case' 0 C--N 1.331 -0.213 0 CA-C-N 116.56 -0.291 . . . . 0.0 110.963 -178.143 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' D' D ' 122' ' ' LYS . . . . . . . . . . . . . 85.1 mttt -146.45 149.98 34.74 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-O 121.156 0.503 . . . . 0.0 111.902 -176.414 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' D' D ' 123' ' ' VAL . . . . . 0.433 ' C ' HD12 ' D' ' 124' ' ' LEU . 44.1 t -124.91 128.88 73.47 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.299 0 N-CA-C 109.211 -0.663 . . . . 0.0 109.211 172.873 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' D' D ' 124' ' ' LEU . . . . . 0.433 HD12 ' C ' ' D' ' 123' ' ' VAL . 6.6 mp -121.89 135.96 54.91 Favored 'General case' 0 C--N 1.332 -0.176 0 CA-C-N 116.609 -0.269 . . . . 0.0 110.732 -176.273 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' D' D ' 125' ' ' VAL . . . . . 0.475 HG11 HG21 ' D' ' 94' ' ' VAL . 35.5 m -136.72 130.21 45.96 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.193 0 CA-C-O 120.955 0.407 . . . . 0.0 110.983 178.734 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' D' D ' 126' ' ' ARG . . . . . . . . . . . . . 95.2 mtt180 -151.69 130.19 12.19 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 115.911 -0.586 . . . . 0.0 109.802 176.901 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' D' D ' 127' ' ' ASN . . . . . . . . . . . . . 4.1 m120 56.6 -152.38 0.39 Allowed 'General case' 0 CA--C 1.539 0.536 0 N-CA-C 109.764 -0.458 . . . . 0.0 109.764 179.68 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' D' D ' 128' ' ' ASP . . . . . . . . . . . . . 15.4 p-10 -80.47 14.59 1.96 Allowed 'General case' 0 CA--C 1.536 0.423 0 N-CA-C 112.876 0.695 . . . . 0.0 112.876 178.662 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' D' D ' 129' ' ' LEU . . . . . 0.541 HD13 ' NE ' ' D' ' 142' ' ' ARG . 11.6 tp -114.17 132.63 56.02 Favored 'General case' 0 N--CA 1.46 0.045 0 CA-C-N 118.09 0.404 . . . . 0.0 109.911 179.049 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' D' D ' 130' ' ' VAL . . . . . 0.404 HG23 ' HB ' ' D' ' 141' ' ' ILE . 34.5 m -132.07 142.39 42.97 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.193 0 CA-C-O 121.086 0.469 . . . . 0.0 110.157 176.763 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' D' D ' 131' ' ' VAL . . . . . . . . . . . . . 34.4 m -136.14 148.79 27.41 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 CA-C-O 121.191 0.519 . . . . 0.0 111.21 -179.255 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' D' D ' 132' ' ' ILE . . . . . . . . . . . . . 75.2 mt -115.44 130.66 69.65 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.383 0 CA-C-N 115.4 -0.818 . . . . 0.0 109.024 178.307 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' D' D ' 133' ' ' ILE . . . . . . . . . . . . . 42.3 mm -115.27 115.2 48.66 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.197 0 CA-C-O 120.884 0.373 . . . . 0.0 110.753 -175.993 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' D' D ' 134' ' ' ASP . . . . . . . . . . . . . 6.1 p-10 -125.88 145.51 50.22 Favored 'General case' 0 C--N 1.333 -0.12 0 N-CA-C 109.371 -0.603 . . . . 0.0 109.371 174.95 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' D' D ' 135' ' ' GLU . . . . . . . . . . . . . 46.2 tp10 -49.75 -26.58 3.98 Favored 'General case' 0 C--N 1.327 -0.388 0 N-CA-C 112.761 0.652 . . . . 0.0 112.761 -169.318 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' D' D ' 136' ' ' GLN . . . . . . . . . . . . . 99.1 mm-40 -92.95 -39.74 10.97 Favored 'General case' 0 C--N 1.332 -0.179 0 N-CA-C 112.293 0.479 . . . . 0.0 112.293 -177.126 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' D' D ' 137' ' ' LYS . . . . . . . . . . . . . 28.0 mtpp -137.99 155.02 49.28 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-O 121.277 0.56 . . . . 0.0 111.698 -170.015 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' D' D ' 138' ' ' LEU . . . . . . . . . . . . . 5.3 tt -116.06 125.34 52.29 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 115.547 -0.752 . . . . 0.0 109.286 174.407 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' D' D ' 139' ' ' THR . . . . . . . . . . . . . 39.9 m -110.67 129.65 55.77 Favored 'General case' 0 C--N 1.332 -0.183 0 CA-C-N 116.406 -0.361 . . . . 0.0 110.993 -177.6 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' D' D ' 140' ' ' LEU . . . . . 0.469 ' C ' HD23 ' D' ' 140' ' ' LEU . 6.5 tt -111.17 123.59 50.5 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 115.499 -0.773 . . . . 0.0 109.322 -179.502 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' D' D ' 141' ' ' ILE . . . . . 0.415 ' N ' HD23 ' D' ' 140' ' ' LEU . 18.8 mt -125.36 118.38 52.4 Favored 'Isoleucine or valine' 0 C--O 1.234 0.255 0 CA-C-O 120.964 0.411 . . . . 0.0 110.404 -177.199 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' D' D ' 142' ' ' ARG . . . . . 0.541 ' NE ' HD13 ' D' ' 129' ' ' LEU . 15.9 mmt180 -102.91 122.75 45.19 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 115.425 -0.807 . . . . 0.0 109.777 175.079 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' D' D ' 143' ' ' THR . . . . . 0.408 HG21 HD21 ' D' ' 92' ' ' LEU . 2.5 p . . . . . 0 C--O 1.22 -0.487 0 CA-C-O 117.983 -1.008 . . . . 0.0 110.568 179.898 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' E' E ' 2' ' ' SER . . . . . . . . . . . . . 3.9 p . . . . . 0 C--O 1.23 0.06 0 CA-C-O 120.744 0.307 . . . . 0.0 110.287 . . . . . . . . . 0 0 . 1 . 018 nuclear build core ' E' E ' 3' ' ' GLU . . . . . . . . . . . . . 30.4 tp10 -139.14 139.75 37.71 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.244 -0.435 . . . . 0.0 110.79 -176.215 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' E' E ' 4' ' ' LEU . . . . . . . . . . . . . 18.1 tp -126.01 130.79 51.88 Favored 'General case' 0 C--N 1.332 -0.184 0 N-CA-C 109.881 -0.415 . . . . 0.0 109.881 174.809 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' E' E ' 5' ' ' LYS . . . . . . . . . . . . . 99.3 mttt -116.33 123.98 48.99 Favored 'General case' 0 C--O 1.235 0.297 0 CA-C-O 120.734 0.302 . . . . 0.0 111.192 -178.236 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' E' E ' 6' ' ' LEU . . . . . 0.404 HD23 ' HA ' ' E' ' 50' ' ' VAL . 50.8 mt -113.98 147.11 39.14 Favored 'General case' 0 N--CA 1.461 0.117 0 CA-C-N 115.437 -0.801 . . . . 0.0 110.272 178.837 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' E' E ' 7' ' ' LYS . . . . . . . . . . . . . 82.2 tttt -129.37 141.02 40.36 Favored Pre-proline 0 CA--C 1.533 0.302 0 CA-C-O 119.137 -0.459 . . . . 0.0 109.883 175.031 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' E' E ' 8' ' ' PRO . . . . . . . . . . . . . 90.0 Cg_endo -91.84 146.17 3.13 Favored 'Trans proline' 0 N--CA 1.49 1.272 0 C-N-CA 121.916 1.744 . . . . 0.0 112.163 179.392 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' E' E ' 9' ' ' LEU . . . . . . . . . . . . . 37.1 mt -86.79 -49.23 0.48 Allowed Pre-proline 0 CA--C 1.535 0.376 0 CA-C-O 118.682 -0.675 . . . . 0.0 112.562 178.818 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' E' E ' 10' ' ' PRO . . . . . . . . . . . . . 97.2 Cg_endo -77.93 161.65 29.87 Favored 'Trans proline' 0 N--CA 1.497 1.725 0 C-N-CA 121.256 1.304 . . . . 0.0 112.444 -179.665 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' E' E ' 11' ' ' LYS . . . . . . . . . . . . . 25.1 tptp -86.93 95.44 9.9 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-N 116.231 -0.441 . . . . 0.0 110.085 177.536 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' E' E ' 12' ' ' VAL . . . . . . . . . . . . . 12.5 p -142.18 147.63 21.2 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 CA-C-N 116.313 -0.403 . . . . 0.0 110.838 -179.008 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' E' E ' 13' ' ' GLU . . . . . . . . . . . . . 95.9 mt-10 -93.81 122.6 36.45 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.029 -0.532 . . . . 0.0 110.128 177.507 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' E' E ' 14' ' ' LEU . . . . . . . . . . . . . 22.3 mt -97.65 151.26 37.51 Favored Pre-proline 0 CA--C 1.533 0.301 0 CA-C-O 119.329 -0.367 . . . . 0.0 110.464 -178.714 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' E' E ' 15' ' ' PRO . . . . . . . . . . . . . 37.8 Cg_exo -59.46 156.06 38.25 Favored 'Trans proline' 0 N--CA 1.498 1.775 0 C-N-CA 121.241 1.294 . . . . 0.0 111.835 178.391 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' E' E ' 16' ' ' PRO . . . . . . . . . . . . . 31.4 Cg_exo -56.83 -38.99 94.57 Favored 'Trans proline' 0 N--CA 1.497 1.711 0 C-N-CA 121.333 1.355 . . . . 0.0 112.475 -179.856 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' E' E ' 17' ' ' ASP . . . . . . . . . . . . . 23.1 p-10 -93.48 20.18 7.56 Favored 'General case' 0 C--N 1.329 -0.324 0 N-CA-C 112.665 0.617 . . . . 0.0 112.665 -178.242 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' E' E ' 18' ' ' PHE . . . . . 0.53 ' CZ ' HD11 ' E' ' 22' ' ' ILE . 62.5 t80 -57.11 -41.6 79.28 Favored 'General case' 0 C--O 1.227 -0.101 0 O-C-N 122.051 -0.405 . . . . 0.0 110.308 -178.329 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' E' E ' 19' ' ' VAL . . . . . . . . . . . . . 52.2 t -54.91 -45.82 75.84 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.289 0 CA-C-N 116.396 -0.365 . . . . 0.0 110.815 -178.912 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' E' E ' 20' ' ' ASP . . . . . . . . . . . . . 80.8 m-20 -60.28 -41.4 93.25 Favored 'General case' 0 C--N 1.331 -0.222 0 C-N-CA 120.905 -0.318 . . . . 0.0 110.886 -178.165 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' E' E ' 21' ' ' VAL . . . . . . . . . . . . . 47.9 t -63.92 -47.15 91.89 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.306 0 C-N-CA 120.736 -0.386 . . . . 0.0 110.398 -177.931 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' E' E ' 22' ' ' ILE . . . . . 0.615 HG22 HD12 ' E' ' 26' ' ' LEU . 51.3 mm -57.18 -43.83 82.4 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.197 0 C-N-CA 120.856 -0.338 . . . . 0.0 110.529 179.158 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' E' E ' 23' ' ' ARG . . . . . . . . . . . . . 28.7 ttp180 -54.56 -48.24 72.3 Favored 'General case' 0 C--N 1.331 -0.201 0 C-N-CA 121.082 -0.247 . . . . 0.0 111.286 -179.472 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' E' E ' 24' ' ' ILE . . . . . . . . . . . . . 72.9 mt -58.52 -44.44 89.18 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.377 0 C-N-CA 120.959 -0.297 . . . . 0.0 110.708 -177.92 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' E' E ' 25' ' ' LYS . . . . . . . . . . . . . 24.5 mtpp -64.68 -44.01 91.71 Favored 'General case' 0 C--N 1.329 -0.291 0 N-CA-C 112.456 0.539 . . . . 0.0 112.456 -178.046 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' E' E ' 26' ' ' LEU . . . . . 0.615 HD12 HG22 ' E' ' 22' ' ' ILE . 79.1 mt -84.03 -25.29 30.02 Favored 'General case' 0 C--N 1.329 -0.289 0 N-CA-C 113.388 0.884 . . . . 0.0 113.388 -171.667 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' E' E ' 27' ' ' GLN . . . . . . . . . . . . . 6.1 pt20 -46.13 135.84 7.32 Favored 'General case' 0 N--CA 1.467 0.416 0 N-CA-C 112.757 0.651 . . . . 0.0 112.757 -174.41 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' E' E ' 28' ' ' GLY . . . . . . . . . . . . . . . 98.86 -22.3 41.67 Favored Glycine 0 CA--C 1.535 1.291 0 CA-C-N 115.792 -0.64 . . . . 0.0 112.516 -177.474 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' E' E ' 29' ' ' LYS . . . . . . . . . . . . . 8.2 mtpm? -97.53 155.08 17.11 Favored 'General case' 0 C--N 1.331 -0.2 0 CA-C-N 117.474 0.637 . . . . 0.0 110.925 179.523 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' E' E ' 30' ' ' THR . . . . . . . . . . . . . 22.3 m -109.77 139.27 45.02 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.337 177.115 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' E' E ' 31' ' ' VAL . . . . . . . . . . . . . 35.1 m -128.35 157.7 40.67 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.266 0 CA-C-N 116.254 -0.43 . . . . 0.0 110.505 -179.528 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' E' E ' 32' ' ' ARG . . . . . . . . . . . . . 53.0 ttp180 -132.21 150.92 52.04 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-O 121.198 0.523 . . . . 0.0 110.579 179.139 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' E' E ' 33' ' ' THR . . . . . . . . . . . . . 27.6 m -52.81 138.88 28.37 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.264 -0.425 . . . . 0.0 111.471 -177.812 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' E' E ' 34' ' ' GLY . . . . . . . . . . . . . . . 99.36 -17.23 58.1 Favored Glycine 0 CA--C 1.532 1.142 0 CA-C-N 116.151 -0.477 . . . . 0.0 113.2 179.087 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' E' E ' 35' ' ' ASP . . . . . . . . . . . . . 78.7 m-20 -67.46 149.39 50.27 Favored 'General case' 0 C--N 1.334 -0.085 0 CA-C-N 118.059 0.929 . . . . 0.0 111.204 178.539 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' E' E ' 36' ' ' VAL . . . . . . . . . . . . . 43.4 t -119.27 129.1 75.69 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.216 0 CA-C-N 115.945 -0.57 . . . . 0.0 109.582 176.785 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' E' E ' 37' ' ' ILE . . . . . . . . . . . . . 64.3 mt -118.19 138.35 49.19 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 CA-C-N 116.178 -0.464 . . . . 0.0 109.76 -178.967 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' E' E ' 38' ' ' GLY . . . . . . . . . . . . . . . -116.51 127.64 7.57 Favored Glycine 0 CA--C 1.523 0.567 0 N-CA-C 110.88 -0.888 . . . . 0.0 110.88 179.097 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' E' E ' 39' ' ' ILE . . . . . . . . . . . . . 72.0 mt -127.22 126.78 68.49 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.214 0 N-CA-C 110.136 -0.32 . . . . 0.0 110.136 179.135 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' E' E ' 40' ' ' SER . . . . . . . . . . . . . 53.8 p -92.52 122.41 34.93 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.374 -0.375 . . . . 0.0 110.826 176.632 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' E' E ' 41' ' ' ILE . . . . . . . . . . . . . 70.6 mt -132.22 130.55 60.64 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.228 0 CA-C-O 120.808 0.337 . . . . 0.0 110.22 177.502 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' E' E ' 42' ' ' LEU . . . . . . . . . . . . . 64.7 mt 56.87 32.94 22.32 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 116.144 -0.48 . . . . 0.0 111.959 178.176 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' E' E ' 43' ' ' GLY . . . . . . . . . . . . . . . 72.95 23.69 77.39 Favored Glycine 0 CA--C 1.531 1.039 0 C-N-CA 121.067 -0.587 . . . . 0.0 112.71 177.717 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' E' E ' 44' ' ' LYS . . . . . . . . . . . . . 99.4 mttt -138.66 128.65 25.34 Favored 'General case' 0 C--N 1.331 -0.206 0 CA-C-N 117.404 0.602 . . . . 0.0 109.861 178.051 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' E' E ' 45' ' ' GLU . . . . . . . . . . . . . 44.0 tp10 -85.55 132.36 34.2 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.42 -0.354 . . . . 0.0 111.539 -176.835 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' E' E ' 46' ' ' VAL . . . . . . . . . . . . . 8.8 p -121.92 127.93 75.52 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.186 0 N-CA-C 109.343 -0.614 . . . . 0.0 109.343 172.81 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' E' E ' 47' ' ' LYS . . . . . . . . . . . . . 55.4 mtmt -98.42 127.21 44.25 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.142 -0.481 . . . . 0.0 110.833 177.781 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' E' E ' 48' ' ' PHE . . . . . . . . . . . . . 43.0 m-85 -114.21 131.9 56.3 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 115.925 -0.58 . . . . 0.0 109.683 177.333 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' E' E ' 49' ' ' LYS . . . . . . . . . . . . . 75.8 tttt -105.81 134.81 48.33 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 116.417 -0.356 . . . . 0.0 110.102 178.483 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' E' E ' 50' ' ' VAL . . . . . 0.404 ' HA ' HD23 ' E' ' 6' ' ' LEU . 45.8 t -78.7 107.15 10.64 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.339 0 N-CA-C 109.245 -0.65 . . . . 0.0 109.245 177.752 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' E' E ' 51' ' ' VAL . . . . . . . . . . . . . 48.4 t -73.56 -51.11 26.43 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.316 0 CA-C-N 116.152 -0.476 . . . . 0.0 109.769 -174.567 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' E' E ' 52' ' ' GLN . . . . . . . . . . . . . 90.4 mt-30 -152.77 149.61 28.53 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-O 121.249 0.547 . . . . 0.0 111.963 -177.803 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' E' E ' 53' ' ' ALA . . . . . . . . . . . . . . . -130.46 130.63 44.48 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 114.978 -1.01 . . . . 0.0 109.243 173.143 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' E' E ' 54' ' ' TYR . . . . . . . . . . . . . 6.9 t80 -129.14 109.33 18.03 Favored Pre-proline 0 CA--C 1.534 0.361 0 CA-C-O 118.203 -0.903 . . . . 0.0 110.138 179.011 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' E' E ' 55' ' ' PRO . . . . . . . . . . . . . 74.1 Cg_endo -77.07 170.08 72.61 Favored 'Cis proline' 0 N--CA 1.5 1.895 0 CA-C-N 122.012 1.754 . . . . 0.0 112.593 -4.795 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' E' E ' 56' ' ' SER . . . . . . . . . . . . . 13.6 m -116.39 132.67 23.2 Favored Pre-proline 0 CA--C 1.539 0.546 0 CA-C-O 118.359 -0.829 . . . . 0.0 109.579 176.058 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' E' E ' 57' ' ' PRO . . . . . . . . . . . . . 48.3 Cg_endo -70.57 165.34 79.21 Favored 'Cis proline' 0 N--CA 1.496 1.663 0 CA-C-N 121.975 1.741 . . . . 0.0 111.536 -2.572 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' E' E ' 58' ' ' LEU . . . . . . . . . . . . . 22.5 tp -129.9 138.19 50.79 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.2 -0.455 . . . . 0.0 110.273 -179.563 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' E' E ' 59' ' ' ARG . . . . . . . . . . . . . 53.9 ttp180 -105.83 136.24 45.83 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-N 115.924 -0.58 . . . . 0.0 109.463 176.684 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' E' E ' 60' ' ' VAL . . . . . . . . . . . . . 39.9 t -89.62 116.34 30.88 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.264 0 CA-C-O 121.04 0.448 . . . . 0.0 110.638 -175.172 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' E' E ' 61' ' ' GLU . . . . . . . . . . . . . 95.6 mt-10 -131.05 173.28 11.16 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 115.552 -0.749 . . . . 0.0 109.455 175.501 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' E' E ' 62' ' ' ASP . . . . . . . . . . . . . 58.8 m-20 -53.72 -33.96 57.33 Favored 'General case' 0 C--N 1.328 -0.347 0 N-CA-C 111.778 0.288 . . . . 0.0 111.778 -178.821 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' E' E ' 63' ' ' ARG . . . . . . . . . . . . . 26.2 mmm180 -76.57 -17.81 59.01 Favored 'General case' 0 CA--C 1.533 0.317 0 N-CA-C 113.224 0.824 . . . . 0.0 113.224 -176.28 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' E' E ' 64' ' ' THR . . . . . . . . . . . . . 19.0 m -68.95 136.16 52.11 Favored 'General case' 0 C--N 1.331 -0.208 0 CA-C-O 120.896 0.379 . . . . 0.0 110.707 -174.919 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' E' E ' 65' ' ' LYS . . . . . . . . . . . . . 43.4 mtpt -90.06 122.33 32.95 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.098 -0.501 . . . . 0.0 109.9 179.946 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' E' E ' 66' ' ' ILE . . . . . . . . . . . . . 62.3 mt -113.83 131.95 64.23 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.234 0 CA-C-O 120.896 0.379 . . . . 0.0 110.35 -176.975 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' E' E ' 67' ' ' THR . . . . . . . . . . . . . 41.4 m -126.84 139.42 53.1 Favored 'General case' 0 C--O 1.234 0.24 0 CA-C-N 115.923 -0.58 . . . . 0.0 110.59 179.137 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' E' E ' 68' ' ' LEU . . . . . 0.429 ' C ' HD23 ' E' ' 68' ' ' LEU . 5.4 tt . . . . . 0 C--N 1.327 -0.397 0 CA-C-N 115.787 -0.642 . . . . 0.0 109.894 177.461 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' E' E ' 73' ' ' VAL . . . . . . . . . . . . . 35.1 m . . . . . 0 C--O 1.231 0.125 0 N-CA-C 109.882 -0.414 . . . . 0.0 109.882 . . . . . . . . . 0 0 . 1 . 018 nuclear build core ' E' E ' 74' ' ' ASP . . . . . . . . . . . . . 19.5 t0 -95.41 115.05 26.89 Favored 'General case' 0 C--N 1.332 -0.191 0 N-CA-C 109.764 -0.458 . . . . 0.0 109.764 -178.493 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' E' E ' 75' ' ' VAL . . . . . 0.452 ' C ' HD12 ' E' ' 76' ' ' LEU . 38.4 t -118.6 126.39 75.14 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.218 0 CA-C-O 121.0 0.428 . . . . 0.0 110.655 -176.547 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' E' E ' 76' ' ' LEU . . . . . 0.452 HD12 ' C ' ' E' ' 75' ' ' VAL . 5.8 mp -127.32 147.48 50.25 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 115.646 -0.707 . . . . 0.0 109.863 177.125 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' E' E ' 77' ' ' GLU . . . . . . . . . . . . . 96.3 mt-10 -134.21 133.33 40.77 Favored 'General case' 0 C--N 1.332 -0.19 0 CA-C-O 121.078 0.466 . . . . 0.0 111.27 -178.748 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' E' E ' 78' ' ' ALA . . . . . 0.441 ' HB2' HD21 ' E' ' 109' ' ' LEU . . . -122.3 141.29 51.68 Favored 'General case' 0 C--N 1.331 -0.221 0 CA-C-N 115.7 -0.682 . . . . 0.0 109.739 176.347 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' E' E ' 79' ' ' LYS . . . . . 0.588 ' O ' HD13 ' E' ' 80' ' ' ILE . 82.3 tttt -84.5 117.51 23.73 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-O 120.889 0.376 . . . . 0.0 110.641 -178.262 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' E' E ' 80' ' ' ILE . . . . . 0.588 HD13 ' O ' ' E' ' 79' ' ' LYS . 42.9 mm -137.95 110.74 7.15 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.381 0 N-CA-C 108.953 -0.758 . . . . 0.0 108.953 -178.858 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' E' E ' 81' ' ' LYS . . . . . . . . . . . . . 55.3 pttt -100.18 125.91 46.38 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-O 120.895 0.378 . . . . 0.0 111.336 -176.589 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' E' E ' 82' ' ' GLY . . . . . . . . . . . . . . . 87.85 42.17 6.11 Favored Glycine 0 CA--C 1.525 0.683 0 C-N-CA 120.825 -0.702 . . . . 0.0 111.714 175.072 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' E' E ' 83' ' ' ILE . . . . . . . . . . . . . 73.4 mt -66.77 127.35 28.07 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.271 0 N-CA-C 109.508 -0.552 . . . . 0.0 109.508 177.548 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' E' E ' 84' ' ' LYS . . . . . . . . . . . . . 59.8 tttt -82.58 -48.44 10.97 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 115.928 -0.578 . . . . 0.0 110.145 -178.25 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' E' E ' 85' ' ' ASP . . . . . . . . . . . . . 33.2 t0 -163.94 159.03 20.4 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 115.851 -0.613 . . . . 0.0 110.653 179.022 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' E' E ' 86' ' ' VAL . . . . . 0.446 ' O ' HD13 ' E' ' 87' ' ' ILE . 43.2 t -129.33 136.25 59.86 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.27 0 CA-C-O 121.031 0.443 . . . . 0.0 110.55 -179.606 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' E' E ' 87' ' ' ILE . . . . . 0.446 HD13 ' O ' ' E' ' 86' ' ' VAL . 44.0 mm -123.18 128.55 75.01 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.227 0 CA-C-N 115.821 -0.627 . . . . 0.0 109.685 176.605 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' E' E ' 88' ' ' LEU . . . . . . . . . . . . . 17.4 tp -111.89 133.84 53.83 Favored 'General case' 0 N--CA 1.464 0.227 0 CA-C-O 121.052 0.453 . . . . 0.0 111.43 -175.539 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' E' E ' 89' ' ' ASP . . . . . . . . . . . . . 13.8 t70 -125.66 157.49 37.13 Favored 'General case' 0 C--N 1.331 -0.222 0 CA-C-N 115.688 -0.687 . . . . 0.0 109.679 176.252 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' E' E ' 90' ' ' GLU . . . . . . . . . . . . . 84.1 tt0 -45.56 -42.71 11.31 Favored 'General case' 0 N--CA 1.465 0.314 0 N-CA-C 113.087 0.773 . . . . 0.0 113.087 -171.632 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' E' E ' 91' ' ' ASN . . . . . . . . . . . . . 3.3 t-20 -132.16 25.78 4.55 Favored 'General case' 0 N--CA 1.468 0.446 0 N-CA-C 112.464 0.542 . . . . 0.0 112.464 -178.703 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' E' E ' 92' ' ' LEU . . . . . . . . . . . . . 28.5 mt -149.34 145.22 26.9 Favored 'General case' 0 C--N 1.331 -0.213 0 CA-C-O 120.721 0.296 . . . . 0.0 110.202 -177.376 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' E' E ' 93' ' ' ILE . . . . . . . . . . . . . 66.0 mt -123.71 121.12 61.64 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.292 0 N-CA-C 109.327 -0.62 . . . . 0.0 109.327 178.798 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' E' E ' 94' ' ' VAL . . . . . . . . . . . . . 46.8 t -117.52 126.67 74.82 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.282 0 N-CA-C 109.655 -0.498 . . . . 0.0 109.655 179.956 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' E' E ' 95' ' ' VAL . . . . . . . . . . . . . 38.8 t -121.47 134.15 65.73 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.331 0 CA-C-N 116.102 -0.499 . . . . 0.0 109.731 -178.872 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' E' E ' 96' ' ' ILE . . . . . 0.581 HD11 ' HB ' ' E' ' 123' ' ' VAL . 65.3 mt -113.81 127.07 71.36 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.33 0 N-CA-C 109.267 -0.642 . . . . 0.0 109.267 178.674 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' E' E ' 97' ' ' THR . . . . . . . . . . . . . 68.5 p -98.09 152.38 19.38 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-O 121.108 0.48 . . . . 0.0 111.102 -178.311 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' E' E ' 98' ' ' GLU . . . . . . . . . . . . . 85.0 tt0 -53.95 -23.44 13.08 Favored 'General case' 0 CA--C 1.535 0.377 0 N-CA-C 112.313 0.486 . . . . 0.0 112.313 179.738 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' E' E ' 99' ' ' GLU . . . . . . . . . . . . . 36.6 tt0 -80.94 18.08 1.08 Allowed 'General case' 0 CA--C 1.54 0.571 0 N-CA-C 112.5 0.556 . . . . 0.0 112.5 -177.012 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' E' E ' 100' ' ' ASN . . . . . . . . . . . . . 2.5 m-20 61.54 37.92 16.02 Favored 'General case' 0 CA--C 1.53 0.206 0 O-C-N 121.869 -0.519 . . . . 0.0 110.997 178.365 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' E' E ' 101' ' ' GLU . . . . . . . . . . . . . 85.1 tt0 -119.71 140.71 50.25 Favored 'General case' 0 C--N 1.332 -0.19 0 CA-C-N 116.099 -0.5 . . . . 0.0 109.66 176.703 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' E' E ' 102' ' ' VAL . . . . . . . . . . . . . 41.7 t -115.58 127.86 73.01 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.257 0 N-CA-C 109.732 -0.47 . . . . 0.0 109.732 -177.581 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' E' E ' 103' ' ' LEU . . . . . . . . . . . . . 5.0 mp -124.1 137.94 54.5 Favored 'General case' 0 C--N 1.331 -0.216 0 CA-C-N 116.33 -0.396 . . . . 0.0 110.607 177.506 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' E' E ' 104' ' ' ILE . . . . . . . . . . . . . 64.3 mt -117.63 126.3 74.63 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.274 0 CA-C-N 115.892 -0.594 . . . . 0.0 109.927 -178.893 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' E' E ' 105' ' ' PHE . . . . . . . . . . . . . 98.9 m-85 -120.86 161.35 21.69 Favored 'General case' 0 C--N 1.332 -0.18 0 O-C-N 124.046 0.841 . . . . 0.0 110.275 -179.008 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' E' E ' 106' ' ' ASN . . . . . . . . . . . . . 43.6 p-10 -99.0 -169.8 1.83 Allowed 'General case' 0 CA--C 1.532 0.284 0 CA-C-N 116.351 -0.386 . . . . 0.0 110.123 175.128 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' E' E ' 107' ' ' GLN . . . . . . . . . . . . . 11.9 tt0 -56.33 -30.05 62.1 Favored 'General case' 0 C--N 1.329 -0.303 0 N-CA-C 111.811 0.3 . . . . 0.0 111.811 179.732 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' E' E ' 108' ' ' ASN . . . . . . . . . . . . . 4.8 t-20 -90.72 14.1 14.36 Favored 'General case' 0 CA--C 1.535 0.396 0 N-CA-C 113.197 0.814 . . . . 0.0 113.197 -175.889 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' E' E ' 109' ' ' LEU . . . . . 0.441 HD21 ' HB2' ' E' ' 78' ' ' ALA . 11.0 tp 54.88 36.0 25.64 Favored 'General case' 0 C--N 1.332 -0.191 0 CA-C-O 120.829 0.347 . . . . 0.0 111.506 178.501 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' E' E ' 110' ' ' GLU . . . . . . . . . . . . . 70.6 mm-40 -101.29 151.33 22.02 Favored 'General case' 0 C--N 1.33 -0.271 0 N-CA-C 109.808 -0.442 . . . . 0.0 109.808 176.514 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' E' E ' 111' ' ' GLU . . . . . . . . . . . . . 44.0 tp10 -78.52 122.03 25.35 Favored 'General case' 0 C--N 1.329 -0.296 0 C-N-CA 120.698 -0.401 . . . . 0.0 110.825 -176.901 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' E' E ' 112' ' ' LEU . . . . . . . . . . . . . 15.3 mt -110.58 -45.97 3.45 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.115 -0.493 . . . . 0.0 110.428 177.837 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' E' E ' 113' ' ' TYR . . . . . . . . . . . . . 55.7 t80 -137.27 137.22 38.8 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 116.402 -0.363 . . . . 0.0 110.862 -179.585 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' E' E ' 114' ' ' ARG . . . . . . . . . . . . . 56.0 ttp180 -143.45 119.71 10.85 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.422 -0.354 . . . . 0.0 110.413 179.03 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' E' E ' 115' ' ' GLY . . . . . . . . . . . . . . . -150.16 153.75 25.26 Favored Glycine 0 CA--C 1.525 0.704 0 N-CA-C 111.075 -0.81 . . . . 0.0 111.075 178.376 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' E' E ' 116' ' ' LYS . . . . . . . . . . . . . 27.5 ttpp -116.97 143.7 45.42 Favored 'General case' 0 C--N 1.33 -0.262 0 N-CA-C 109.955 -0.387 . . . . 0.0 109.955 177.662 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' E' E ' 117' ' ' PHE . . . . . . . . . . . . . 51.2 m-85 -139.19 114.63 9.78 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-O 120.935 0.397 . . . . 0.0 110.204 -178.24 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' E' E ' 118' ' ' GLU . . . . . . . . . . . . . 95.6 mt-10 -53.61 -50.15 66.28 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.472 -0.331 . . . . 0.0 111.411 -175.558 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' E' E ' 119' ' ' ASN . . . . . . . . . . . . . 2.6 m120 -93.63 31.02 1.63 Allowed 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.192 -0.458 . . . . 0.0 112.158 -175.222 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' E' E ' 120' ' ' LEU . . . . . . . . . . . . . 16.2 tp -57.11 122.89 13.46 Favored 'General case' 0 C--N 1.333 -0.14 0 CA-C-O 120.721 0.296 . . . . 0.0 110.277 178.563 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' E' E ' 121' ' ' ASN . . . . . . . . . . . . . 13.7 m120 -112.13 -44.17 3.45 Favored 'General case' 0 C--N 1.332 -0.185 0 CA-C-N 116.395 -0.366 . . . . 0.0 110.991 -177.183 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' E' E ' 122' ' ' LYS . . . . . . . . . . . . . 80.2 mttt -146.2 145.7 30.53 Favored 'General case' 0 C--N 1.332 -0.194 0 C-N-CA 120.575 -0.45 . . . . 0.0 111.832 -177.282 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' E' E ' 123' ' ' VAL . . . . . 0.581 ' HB ' HD11 ' E' ' 96' ' ' ILE . 46.9 t -127.89 123.83 61.66 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.291 0 N-CA-C 108.883 -0.784 . . . . 0.0 108.883 171.96 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' E' E ' 124' ' ' LEU . . . . . . . . . . . . . 69.0 mt -132.66 145.9 51.44 Favored 'General case' 0 C--N 1.331 -0.2 0 CA-C-O 121.048 0.451 . . . . 0.0 111.492 -175.036 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' E' E ' 125' ' ' VAL . . . . . 0.565 HG23 HG22 ' E' ' 130' ' ' VAL . 11.9 p -135.17 137.41 50.33 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.238 0 CA-C-N 115.834 -0.621 . . . . 0.0 110.395 178.915 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' E' E ' 126' ' ' ARG . . . . . . . . . . . . . 25.3 mmt180 -140.35 124.64 17.73 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 115.976 -0.556 . . . . 0.0 110.206 178.605 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' E' E ' 127' ' ' ASN . . . . . . . . . . . . . 14.9 m-80 51.4 -106.67 0.27 Allowed 'General case' 0 CA--C 1.543 0.695 0 CA-C-O 118.976 -0.535 . . . . 0.0 111.36 179.739 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' E' E ' 128' ' ' ASP . . . . . . . . . . . . . 14.8 p-10 -114.07 5.93 16.21 Favored 'General case' 0 N--CA 1.468 0.43 0 CA-C-N 119.723 1.147 . . . . 0.0 113.468 -176.948 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' E' E ' 129' ' ' LEU . . . . . . . . . . . . . 15.8 tp -111.56 134.5 53.09 Favored 'General case' 0 C--N 1.333 -0.138 0 CA-C-N 118.261 0.482 . . . . 0.0 110.472 -179.492 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' E' E ' 130' ' ' VAL . . . . . 0.565 HG22 HG23 ' E' ' 125' ' ' VAL . 45.0 t -118.66 134.84 60.99 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.183 0 N-CA-C 109.523 -0.547 . . . . 0.0 109.523 178.657 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' E' E ' 131' ' ' VAL . . . . . . . . . . . . . 39.4 t -136.05 141.01 42.87 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.258 0 CA-C-O 121.119 0.485 . . . . 0.0 110.704 -178.525 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' E' E ' 132' ' ' ILE . . . . . . . . . . . . . 71.5 mt -117.96 132.54 67.5 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.279 0 CA-C-N 115.457 -0.792 . . . . 0.0 109.413 178.669 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' E' E ' 133' ' ' ILE . . . . . . . . . . . . . 44.0 mm -115.8 121.97 68.5 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.246 0 CA-C-O 120.747 0.308 . . . . 0.0 110.675 -176.769 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' E' E ' 134' ' ' ASP . . . . . . . . . . . . . 7.3 p-10 -134.37 149.68 50.84 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.02 -0.536 . . . . 0.0 109.795 175.47 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' E' E ' 135' ' ' GLU . . . . . . . . . . . . . 42.9 tp10 -49.78 -26.71 4.13 Favored 'General case' 0 C--N 1.327 -0.383 0 N-CA-C 112.85 0.685 . . . . 0.0 112.85 -170.442 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' E' E ' 136' ' ' GLN . . . . . . . . . . . . . 55.3 mt-30 -102.78 -25.67 13.43 Favored 'General case' 0 N--CA 1.466 0.367 0 N-CA-C 112.888 0.699 . . . . 0.0 112.888 -174.532 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' E' E ' 137' ' ' LYS . . . . . . . . . . . . . 82.7 mttt -143.21 153.31 42.7 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-O 121.23 0.538 . . . . 0.0 111.714 -170.239 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' E' E ' 138' ' ' LEU . . . . . 0.426 ' C ' HD23 ' E' ' 138' ' ' LEU . 5.8 tt -118.29 121.15 39.7 Favored 'General case' 0 C--N 1.328 -0.352 0 N-CA-C 108.744 -0.836 . . . . 0.0 108.744 171.667 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' E' E ' 139' ' ' THR . . . . . . . . . . . . . 23.8 m -109.27 128.19 54.88 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.452 -0.34 . . . . 0.0 110.54 -176.344 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' E' E ' 140' ' ' LEU . . . . . 0.478 ' C ' HD23 ' E' ' 140' ' ' LEU . 7.1 tt -114.37 122.12 45.69 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 115.724 -0.671 . . . . 0.0 109.494 -178.835 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' E' E ' 141' ' ' ILE . . . . . . . . . . . . . 19.1 mt -122.84 116.81 49.9 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.288 0 N-CA-C 109.601 -0.518 . . . . 0.0 109.601 -176.897 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' E' E ' 142' ' ' ARG . . . . . . . . . . . . . 71.5 ttt180 -101.52 120.67 40.67 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 115.671 -0.695 . . . . 0.0 110.458 -179.107 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' E' E ' 143' ' ' THR . . . . . 0.497 HG22 HG12 ' F' ' 73' ' ' VAL . 16.4 p . . . . . 0 C--O 1.22 -0.472 0 CA-C-O 118.009 -0.996 . . . . 0.0 110.469 179.678 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' F' F ' 1' ' ' MET . . . . . . . . . . . . . 25.5 ptp . . . . . 0 CA--C 1.529 0.149 0 CA-C-O 120.644 0.259 . . . . 0.0 110.371 . . . . . . . . . 0 0 . 1 . 018 nuclear build core ' F' F ' 2' ' ' SER . . . . . . . . . . . . . 4.9 p -124.28 132.8 53.59 Favored 'General case' 0 C--N 1.332 -0.188 0 CA-C-O 120.908 0.385 . . . . 0.0 110.803 179.754 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' F' F ' 3' ' ' GLU . . . . . . . . . . . . . 85.2 tt0 -142.61 140.38 31.64 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.155 -0.475 . . . . 0.0 111.225 -179.119 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' F' F ' 4' ' ' LEU . . . . . 0.446 HD21 HD21 ' F' ' 6' ' ' LEU . 14.9 tp -125.55 135.09 51.88 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.03 -0.532 . . . . 0.0 110.049 177.163 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' F' F ' 5' ' ' LYS . . . . . . . . . . . . . 69.0 mttm -112.43 120.73 42.65 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.237 -0.438 . . . . 0.0 110.58 178.764 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' F' F ' 6' ' ' LEU . . . . . 0.446 HD21 HD21 ' F' ' 4' ' ' LEU . 73.4 mt -114.93 146.06 41.56 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 115.294 -0.866 . . . . 0.0 110.043 -179.968 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' F' F ' 7' ' ' LYS . . . . . . . . . . . . . 53.4 tttm -133.88 140.2 35.71 Favored Pre-proline 0 CA--C 1.534 0.334 0 CA-C-O 119.115 -0.469 . . . . 0.0 110.245 177.576 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' F' F ' 8' ' ' PRO . . . . . . . . . . . . . 94.4 Cg_endo -91.95 139.07 2.07 Favored 'Trans proline' 0 N--CA 1.489 1.22 0 C-N-CA 121.668 1.578 . . . . 0.0 111.537 176.798 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' F' F ' 9' ' ' LEU . . . . . . . . . . . . . 56.5 mt -71.57 -47.9 12.46 Favored Pre-proline 0 C--N 1.329 -0.315 0 CA-C-O 118.613 -0.708 . . . . 0.0 112.176 -178.889 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' F' F ' 10' ' ' PRO . . . . . . . . . . . . . 97.4 Cg_endo -79.46 157.9 25.55 Favored 'Trans proline' 0 N--CA 1.495 1.616 0 C-N-CA 121.197 1.264 . . . . 0.0 112.291 177.061 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' F' F ' 11' ' ' LYS . . . . . . . . . . . . . 6.6 tmtm? -87.21 97.28 10.68 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.256 178.756 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' F' F ' 12' ' ' VAL . . . . . . . . . . . . . 13.0 p -143.63 146.62 20.93 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.23 0 CA-C-N 116.301 -0.408 . . . . 0.0 110.778 179.607 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' F' F ' 13' ' ' GLU . . . . . . . . . . . . . 94.5 mt-10 -82.71 135.12 35.1 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.079 -0.509 . . . . 0.0 110.256 178.23 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' F' F ' 14' ' ' LEU . . . . . . . . . . . . . 15.2 mt -98.18 141.59 23.21 Favored Pre-proline 0 CA--C 1.534 0.328 0 CA-C-O 118.887 -0.578 . . . . 0.0 110.099 179.536 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' F' F ' 15' ' ' PRO . . . . . . . . . . . . . 26.0 Cg_exo -62.24 159.92 33.09 Favored 'Trans proline' 0 N--CA 1.496 1.658 0 C-N-CA 121.297 1.331 . . . . 0.0 111.711 176.113 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' F' F ' 16' ' ' PRO . . . . . . . . . . . . . 39.6 Cg_exo -58.42 -41.23 67.64 Favored 'Trans proline' 0 N--CA 1.496 1.657 0 C-N-CA 121.499 1.466 . . . . 0.0 112.907 -177.313 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' F' F ' 17' ' ' ASP . . . . . . . . . . . . . 24.2 p-10 -84.71 6.99 22.06 Favored 'General case' 0 CA--C 1.538 0.498 0 N-CA-C 113.261 0.837 . . . . 0.0 113.261 -177.38 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' F' F ' 18' ' ' PHE . . . . . . . . . . . . . 41.2 t80 -57.83 -45.72 85.78 Favored 'General case' 0 C--N 1.334 -0.099 0 O-C-N 122.012 -0.43 . . . . 0.0 110.161 -177.798 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' F' F ' 19' ' ' VAL . . . . . . . . . . . . . 48.7 t -56.71 -44.37 81.28 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.304 0 CA-C-N 116.298 -0.41 . . . . 0.0 110.559 -178.101 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' F' F ' 20' ' ' ASP . . . . . . . . . . . . . 29.2 m-20 -59.67 -42.06 92.01 Favored 'General case' 0 C--N 1.329 -0.296 0 C-N-CA 120.896 -0.322 . . . . 0.0 111.089 -177.711 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' F' F ' 21' ' ' VAL . . . . . . . . . . . . . 46.9 t -63.48 -45.63 97.34 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.285 0 C-N-CA 120.824 -0.35 . . . . 0.0 110.17 -177.738 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' F' F ' 22' ' ' ILE . . . . . 0.611 HG22 HD12 ' F' ' 26' ' ' LEU . 51.7 mm -55.56 -48.2 77.73 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 C-N-CA 121.085 -0.246 . . . . 0.0 110.679 178.568 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' F' F ' 23' ' ' ARG . . . . . . . . . . . . . 41.5 ttp180 -54.97 -47.46 74.53 Favored 'General case' 0 C--N 1.328 -0.339 0 C-N-CA 121.074 -0.25 . . . . 0.0 111.395 -177.937 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' F' F ' 24' ' ' ILE . . . . . . . . . . . . . 82.5 mt -58.8 -45.72 91.25 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.29 0 C-N-CA 121.144 -0.222 . . . . 0.0 111.341 -177.442 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' F' F ' 25' ' ' LYS . . . . . . . . . . . . . 93.0 mttt -67.78 -42.68 81.3 Favored 'General case' 0 C--N 1.328 -0.333 0 N-CA-C 112.538 0.57 . . . . 0.0 112.538 -177.56 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' F' F ' 26' ' ' LEU . . . . . 0.611 HD12 HG22 ' F' ' 22' ' ' ILE . 94.6 mt -77.68 -37.76 49.0 Favored 'General case' 0 C--N 1.329 -0.287 0 N-CA-C 113.288 0.848 . . . . 0.0 113.288 -170.128 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' F' F ' 27' ' ' GLN . . . . . . . . . . . . . 15.4 pt20 -47.19 137.95 7.49 Favored 'General case' 0 N--CA 1.468 0.451 0 N-CA-C 112.698 0.629 . . . . 0.0 112.698 -174.917 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' F' F ' 28' ' ' GLY . . . . . . . . . . . . . . . 100.77 -26.21 25.47 Favored Glycine 0 CA--C 1.533 1.184 0 CA-C-N 115.533 -0.758 . . . . 0.0 112.26 -177.435 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' F' F ' 29' ' ' LYS . . . . . . . . . . . . . 91.4 mttt -97.79 155.06 17.21 Favored 'General case' 0 C--N 1.332 -0.167 0 CA-C-N 117.375 0.588 . . . . 0.0 110.946 178.101 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' F' F ' 30' ' ' THR . . . . . . . . . . . . . 26.2 m -106.06 138.44 42.25 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.006 -0.543 . . . . 0.0 110.152 177.244 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' F' F ' 31' ' ' VAL . . . . . . . . . . . . . 34.1 m -128.64 157.1 41.34 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.267 0 CA-C-N 116.343 -0.39 . . . . 0.0 110.722 -178.792 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' F' F ' 32' ' ' ARG . . . . . . . . . . . . . 98.6 mtt180 -130.15 150.28 51.48 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-O 121.243 0.544 . . . . 0.0 110.654 177.824 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' F' F ' 33' ' ' THR . . . . . . . . . . . . . 15.2 m -53.66 138.34 35.09 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.217 -0.447 . . . . 0.0 111.187 -178.787 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' F' F ' 34' ' ' GLY . . . . . . . . . . . . . . . 100.88 -17.05 56.91 Favored Glycine 0 CA--C 1.532 1.15 0 CA-C-O 119.614 -0.548 . . . . 0.0 113.287 179.381 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' F' F ' 35' ' ' ASP . . . . . . . . . . . . . 73.5 m-20 -65.25 149.43 49.95 Favored 'General case' 0 C--O 1.231 0.13 0 CA-C-N 118.049 0.924 . . . . 0.0 111.264 179.49 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' F' F ' 36' ' ' VAL . . . . . . . . . . . . . 46.6 t -123.13 131.91 72.36 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.171 0 CA-C-N 115.88 -0.6 . . . . 0.0 110.038 178.884 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' F' F ' 37' ' ' ILE . . . . . . . . . . . . . 67.5 mt -123.67 142.66 39.58 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.28 0 CA-C-N 116.156 -0.475 . . . . 0.0 109.811 -179.959 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' F' F ' 38' ' ' GLY . . . . . . . . . . . . . . . -113.09 128.78 8.56 Favored Glycine 0 CA--C 1.527 0.791 0 N-CA-C 111.335 -0.706 . . . . 0.0 111.335 -179.574 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' F' F ' 39' ' ' ILE . . . . . . . . . . . . . 72.0 mt -126.61 127.3 70.1 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.18 0 N-CA-C 109.829 -0.434 . . . . 0.0 109.829 177.862 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' F' F ' 40' ' ' SER . . . . . . . . . . . . . 42.3 t -93.42 116.43 28.97 Favored 'General case' 0 C--N 1.329 -0.29 0 C-N-CA 120.918 -0.313 . . . . 0.0 110.836 175.815 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' F' F ' 41' ' ' ILE . . . . . . . . . . . . . 44.2 mm -122.78 121.91 64.55 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.188 0 CA-C-O 120.934 0.397 . . . . 0.0 110.362 179.853 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' F' F ' 42' ' ' LEU . . . . . 0.541 ' O ' HD23 ' F' ' 42' ' ' LEU . 1.3 tt 54.94 46.44 24.37 Favored 'General case' 0 C--N 1.331 -0.211 0 CA-C-O 121.366 0.603 . . . . 0.0 110.686 177.118 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' F' F ' 43' ' ' GLY . . . . . . . . . . . . . . . 70.5 10.05 65.99 Favored Glycine 0 CA--C 1.534 1.259 0 C-N-CA 121.232 -0.509 . . . . 0.0 113.32 174.522 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' F' F ' 44' ' ' LYS . . . . . . . . . . . . . 43.1 tptt -124.83 127.18 46.76 Favored 'General case' 0 C--N 1.333 -0.146 0 CA-C-N 117.986 0.893 . . . . 0.0 109.767 -178.715 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' F' F ' 45' ' ' GLU . . . . . . . . . . . . . 36.9 tp10 -83.43 127.43 33.68 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-O 120.875 0.369 . . . . 0.0 110.943 -177.148 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' F' F ' 46' ' ' VAL . . . . . . . . . . . . . 7.5 p -124.32 130.59 73.59 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.194 0 N-CA-C 109.491 -0.559 . . . . 0.0 109.491 176.191 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' F' F ' 47' ' ' LYS . . . . . . . . . . . . . 30.0 mtpp -100.7 131.21 46.71 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.054 -0.521 . . . . 0.0 111.221 178.292 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' F' F ' 48' ' ' PHE . . . . . . . . . . . . . 89.1 m-85 -113.26 131.91 55.73 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.242 -0.435 . . . . 0.0 110.367 178.118 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' F' F ' 49' ' ' LYS . . . . . . . . . . . . . 82.1 tttt -107.31 137.21 45.78 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.169 -0.469 . . . . 0.0 110.412 178.492 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' F' F ' 50' ' ' VAL . . . . . 0.404 ' HA ' HD23 ' F' ' 6' ' ' LEU . 47.6 t -80.32 106.89 12.08 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.316 0 N-CA-C 109.138 -0.689 . . . . 0.0 109.138 175.061 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' F' F ' 51' ' ' VAL . . . . . . . . . . . . . 55.2 t -70.51 -48.22 60.58 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.286 0 CA-C-N 116.114 -0.494 . . . . 0.0 109.932 -173.373 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' F' F ' 52' ' ' GLN . . . . . . . . . . . . . 21.4 pt20 -164.64 158.92 18.42 Favored 'General case' 0 C--N 1.331 -0.229 0 C-N-CA 120.156 -0.618 . . . . 0.0 111.859 -179.505 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' F' F ' 53' ' ' ALA . . . . . . . . . . . . . . . -135.46 135.86 40.85 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 115.361 -0.836 . . . . 0.0 110.495 179.347 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' F' F ' 54' ' ' TYR . . . . . . . . . . . . . 59.6 t80 -128.98 110.52 18.4 Favored Pre-proline 0 CA--C 1.534 0.345 0 CA-C-O 118.225 -0.893 . . . . 0.0 110.211 177.232 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' F' F ' 55' ' ' PRO . . . . . . . . . . . . . 72.6 Cg_endo -77.15 166.27 82.72 Favored 'Cis proline' 0 N--CA 1.5 1.859 0 CA-C-N 121.988 1.746 . . . . 0.0 112.322 -6.0 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' F' F ' 56' ' ' SER . . . . . . . . . . . . . 43.5 m -116.03 130.09 24.69 Favored Pre-proline 0 CA--C 1.538 0.488 0 CA-C-O 118.387 -0.816 . . . . 0.0 109.293 174.059 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' F' F ' 57' ' ' PRO . . . . . . . . . . . . . 37.6 Cg_endo -66.72 163.64 70.72 Favored 'Cis proline' 0 N--CA 1.498 1.788 0 CA-C-N 122.054 1.769 . . . . 0.0 111.701 -0.172 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' F' F ' 58' ' ' LEU . . . . . . . . . . . . . 24.7 tp -129.37 137.38 50.92 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.349 -179.025 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' F' F ' 59' ' ' ARG . . . . . . . . . . . . . 74.8 ttt180 -105.18 128.59 53.47 Favored 'General case' 0 C--N 1.327 -0.391 0 N-CA-C 109.272 -0.64 . . . . 0.0 109.272 175.657 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' F' F ' 60' ' ' VAL . . . . . . . . . . . . . 45.5 t -79.01 123.09 35.52 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.306 0 C-N-CA 120.686 -0.405 . . . . 0.0 110.347 -175.432 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' F' F ' 61' ' ' GLU . . . . . . . . . . . . . 95.4 mt-10 -131.09 162.75 29.17 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 115.732 -0.667 . . . . 0.0 109.949 177.894 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' F' F ' 62' ' ' ASP . . . . . . . . . . . . . 16.7 p-10 -56.8 -32.84 66.08 Favored 'General case' 0 C--N 1.328 -0.342 0 C-N-CA 120.941 -0.304 . . . . 0.0 111.522 179.329 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' F' F ' 63' ' ' ARG . . . . . . . . . . . . . 17.0 ptm180 -82.9 5.4 21.98 Favored 'General case' 0 CA--C 1.537 0.462 0 N-CA-C 113.558 0.947 . . . . 0.0 113.558 -176.602 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' F' F ' 64' ' ' THR . . . . . . . . . . . . . 19.4 m -88.53 141.97 28.09 Favored 'General case' 0 C--O 1.231 0.126 0 CA-C-N 118.235 0.471 . . . . 0.0 110.753 -177.66 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' F' F ' 65' ' ' LYS . . . . . . . . . . . . . 97.7 mttt -87.4 125.64 34.39 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.264 -0.425 . . . . 0.0 109.918 178.514 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' F' F ' 66' ' ' ILE . . . . . . . . . . . . . 59.0 mt -116.36 124.92 73.11 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.336 0 N-CA-C 109.712 -0.477 . . . . 0.0 109.712 179.708 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' F' F ' 67' ' ' THR . . . . . . . . . . . . . 19.6 m -123.8 146.03 48.64 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-O 121.043 0.449 . . . . 0.0 111.247 -176.231 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' F' F ' 68' ' ' LEU . . . . . . . . . . . . . 49.8 mt . . . . . 0 C--N 1.329 -0.317 0 CA-C-N 115.77 -0.65 . . . . 0.0 110.486 177.637 . . . . . . . . 0 0 . 1 . 018 nuclear build core ' F' F ' 73' ' ' VAL . . . . . 0.497 HG12 HG22 ' E' ' 143' ' ' THR . 31.0 m . . . . . 0 C--O 1.231 0.122 0 CA-C-O 121.096 0.474 . . . . 0.0 111.213 . . . . . . . . . 1 1 . 1 . 018 nuclear build core ' F' F ' 74' ' ' ASP . . . . . . . . . . . . . 9.6 t0 -101.9 120.86 41.07 Favored 'General case' 0 C--N 1.327 -0.383 0 N-CA-C 109.042 -0.725 . . . . 0.0 109.042 174.724 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' F' F ' 75' ' ' VAL . . . . . . . . . . . . . 40.5 t -109.39 123.16 65.06 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.288 0 CA-C-O 121.207 0.527 . . . . 0.0 110.779 -175.939 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' F' F ' 76' ' ' LEU . . . . . . . . . . . . . 15.4 mt -129.55 144.25 51.19 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 115.477 -0.783 . . . . 0.0 109.127 177.101 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' F' F ' 77' ' ' GLU . . . . . . . . . . . . . 56.2 tt0 -138.86 139.99 38.31 Favored 'General case' 0 C--N 1.332 -0.184 0 C-N-CA 120.671 -0.411 . . . . 0.0 111.269 -175.148 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' F' F ' 78' ' ' ALA . . . . . 0.481 ' HB2' HD21 ' F' ' 109' ' ' LEU . . . -124.4 140.02 53.35 Favored 'General case' 0 C--N 1.331 -0.229 0 CA-C-N 115.947 -0.57 . . . . 0.0 110.308 178.217 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' F' F ' 79' ' ' LYS . . . . . 0.624 ' O ' HD13 ' F' ' 80' ' ' ILE . 3.9 mptp? -82.75 116.36 22.07 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-N 116.427 -0.351 . . . . 0.0 110.685 -178.529 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' F' F ' 80' ' ' ILE . . . . . 0.624 HD13 ' O ' ' F' ' 79' ' ' LYS . 40.0 mm -139.2 107.04 3.08 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.279 0 N-CA-C 109.391 -0.596 . . . . 0.0 109.391 -178.855 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' F' F ' 81' ' ' LYS . . . . . . . . . . . . . 99.3 mttt -105.19 133.61 49.68 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-O 120.902 0.382 . . . . 0.0 110.975 -179.037 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' F' F ' 82' ' ' GLY . . . . . . . . . . . . . . . 88.9 42.23 5.73 Favored Glycine 0 CA--C 1.524 0.63 0 N-CA-C 111.228 -0.749 . . . . 0.0 111.228 176.549 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' F' F ' 83' ' ' ILE . . . . . . . . . . . . . 72.8 mt -72.56 135.91 26.74 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.336 0 N-CA-C 109.964 -0.384 . . . . 0.0 109.964 179.382 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' F' F ' 84' ' ' LYS . . . . . . . . . . . . . 54.7 tttp -98.4 -53.96 3.19 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 115.971 -0.559 . . . . 0.0 110.329 -178.535 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' F' F ' 85' ' ' ASP . . . . . . . . . . . . . 7.4 t0 -149.6 148.31 29.18 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 115.85 -0.613 . . . . 0.0 110.327 -178.808 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' F' F ' 86' ' ' VAL . . . . . . . . . . . . . 42.3 t -129.79 129.39 66.18 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.274 0 CA-C-O 120.906 0.384 . . . . 0.0 110.456 -179.527 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' F' F ' 87' ' ' ILE . . . . . . . . . . . . . 45.6 mm -118.66 125.96 74.82 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.268 0 CA-C-N 116.006 -0.543 . . . . 0.0 109.734 175.809 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' F' F ' 88' ' ' LEU . . . . . . . . . . . . . 38.5 mt -113.02 136.82 52.27 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-O 121.12 0.486 . . . . 0.0 111.303 -177.973 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' F' F ' 89' ' ' ASP . . . . . . . . . . . . . 7.6 t70 -134.85 155.29 50.92 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 115.687 -0.688 . . . . 0.0 109.618 175.538 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' F' F ' 90' ' ' GLU . . . . . . . . . . . . . 95.7 mt-10 -48.78 -33.15 9.82 Favored 'General case' 0 C--N 1.329 -0.324 0 N-CA-C 112.927 0.714 . . . . 0.0 112.927 -172.542 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' F' F ' 91' ' ' ASN . . . . . . . . . . . . . 27.9 t30 -130.44 18.86 5.29 Favored 'General case' 0 N--CA 1.469 0.493 0 N-CA-C 113.063 0.764 . . . . 0.0 113.063 -176.056 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' F' F ' 92' ' ' LEU . . . . . . . . . . . . . 12.0 mt -151.66 143.63 23.83 Favored 'General case' 0 C--N 1.333 -0.151 0 N-CA-C 109.976 -0.379 . . . . 0.0 109.976 -177.225 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' F' F ' 93' ' ' ILE . . . . . . . . . . . . . 71.9 mt -128.82 118.11 46.24 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 N-CA-C 109.278 -0.638 . . . . 0.0 109.278 176.086 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' F' F ' 94' ' ' VAL . . . . . . . . . . . . . 44.5 t -120.84 127.02 75.89 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.344 0 N-CA-C 109.998 -0.371 . . . . 0.0 109.998 -178.538 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' F' F ' 95' ' ' VAL . . . . . . . . . . . . . 44.0 t -123.14 134.11 67.16 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.33 0 CA-C-N 116.064 -0.516 . . . . 0.0 109.95 -179.593 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' F' F ' 96' ' ' ILE . . . . . . . . . . . . . 52.8 mt -113.61 127.54 70.9 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.345 0 N-CA-C 109.006 -0.738 . . . . 0.0 109.006 178.391 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' F' F ' 97' ' ' THR . . . . . . . . . . . . . 66.1 p -99.42 157.15 16.62 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-O 121.204 0.526 . . . . 0.0 111.069 -177.142 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' F' F ' 98' ' ' GLU . . . . . . . . . . . . . 81.9 tt0 -53.98 -27.87 34.22 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 116.127 -0.488 . . . . 0.0 112.056 179.909 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' F' F ' 99' ' ' GLU . . . . . . . . . . . . . 95.9 mt-10 -76.92 12.54 1.32 Allowed 'General case' 0 CA--C 1.536 0.404 0 N-CA-C 113.329 0.863 . . . . 0.0 113.329 -176.737 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' F' F ' 100' ' ' ASN . . . . . . . . . . . . . 3.9 m-20 63.57 34.61 12.37 Favored 'General case' 0 CA--C 1.531 0.248 0 CA-C-O 120.964 0.412 . . . . 0.0 111.369 179.328 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' F' F ' 101' ' ' GLU . . . . . . . . . . . . . 84.0 tt0 -113.96 145.6 41.29 Favored 'General case' 0 C--N 1.333 -0.133 0 N-CA-C 109.52 -0.548 . . . . 0.0 109.52 173.607 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' F' F ' 102' ' ' VAL . . . . . . . . . . . . . 43.9 t -118.12 128.93 75.13 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.253 0 CA-C-O 120.849 0.356 . . . . 0.0 110.096 -177.802 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' F' F ' 103' ' ' LEU . . . . . . . . . . . . . 48.4 mt -115.84 130.43 56.83 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 115.479 -0.782 . . . . 0.0 109.823 178.372 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' F' F ' 104' ' ' ILE . . . . . . . . . . . . . 62.5 mt -119.87 121.59 66.43 Favored 'Isoleucine or valine' 0 C--O 1.233 0.23 0 N-CA-C 110.152 -0.314 . . . . 0.0 110.152 179.597 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' F' F ' 105' ' ' PHE . . . . . . . . . . . . . 30.8 m-85 -124.25 165.78 17.03 Favored 'General case' 0 C--N 1.333 -0.149 0 O-C-N 123.936 0.773 . . . . 0.0 109.521 178.152 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' F' F ' 106' ' ' ASN . . . . . . . . . . . . . 44.1 p-10 -96.99 -170.0 1.96 Allowed 'General case' 0 C--N 1.329 -0.29 0 N-CA-C 109.861 -0.422 . . . . 0.0 109.861 172.858 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' F' F ' 107' ' ' GLN . . . . . . . . . . . . . 47.8 tt0 -60.1 -30.14 69.05 Favored 'General case' 0 CA--C 1.532 0.286 0 N-CA-C 111.873 0.323 . . . . 0.0 111.873 179.532 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' F' F ' 108' ' ' ASN . . . . . . . . . . . . . 7.1 t-20 -82.5 8.19 12.34 Favored 'General case' 0 CA--C 1.537 0.457 0 N-CA-C 113.219 0.822 . . . . 0.0 113.219 -178.31 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' F' F ' 109' ' ' LEU . . . . . 0.481 HD21 ' HB2' ' F' ' 78' ' ' ALA . 11.0 tp 59.76 37.45 22.07 Favored 'General case' 0 CA--C 1.529 0.17 0 CA-C-O 120.977 0.418 . . . . 0.0 111.294 178.255 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' F' F ' 110' ' ' GLU . . . . . . . . . . . . . 70.7 mm-40 -104.04 163.68 12.22 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.416 -0.356 . . . . 0.0 110.109 177.228 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' F' F ' 111' ' ' GLU . . . . . . . . . . . . . 83.6 tt0 -84.86 124.18 31.31 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-N 116.328 -0.397 . . . . 0.0 111.053 -177.215 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' F' F ' 112' ' ' LEU . . . . . . . . . . . . . 15.3 mt -112.64 -46.06 3.18 Favored 'General case' 0 C--N 1.331 -0.197 0 CA-C-N 116.051 -0.522 . . . . 0.0 110.014 175.163 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' F' F ' 113' ' ' TYR . . . . . . . . . . . . . 57.7 t80 -148.25 137.91 22.28 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.228 -0.442 . . . . 0.0 111.036 179.775 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' F' F ' 114' ' ' ARG . . . . . . . . . . . . . 31.1 mtp180 -137.13 123.77 21.05 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.346 -0.388 . . . . 0.0 109.995 174.713 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' F' F ' 115' ' ' GLY . . . . . . . . . . . . . . . -149.46 160.15 28.34 Favored Glycine 0 CA--C 1.523 0.544 0 N-CA-C 110.832 -0.907 . . . . 0.0 110.832 -179.658 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' F' F ' 116' ' ' LYS . . . . . . . . . . . . . 72.5 tttt -133.32 133.64 42.79 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-O 120.844 0.354 . . . . 0.0 110.184 179.622 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' F' F ' 117' ' ' PHE . . . . . . . . . . . . . 23.6 m-85 -132.1 115.64 16.01 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.192 -0.458 . . . . 0.0 109.843 -175.459 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' F' F ' 118' ' ' GLU . . . . . . . . . . . . . 85.2 tt0 -55.4 -40.09 70.99 Favored 'General case' 0 C--N 1.329 -0.324 0 C-N-CA 120.902 -0.319 . . . . 0.0 111.213 -177.152 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' F' F ' 119' ' ' ASN . . . . . . . . . . . . . 4.5 m-80 -97.8 30.99 2.77 Favored 'General case' 0 C--N 1.33 -0.282 0 N-CA-C 112.173 0.434 . . . . 0.0 112.173 -176.084 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' F' F ' 120' ' ' LEU . . . . . . . . . . . . . 11.7 tp -56.54 122.31 11.7 Favored 'General case' 0 C--N 1.333 -0.146 0 C-N-CA 121.065 -0.254 . . . . 0.0 110.641 178.991 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' F' F ' 121' ' ' ASN . . . . . . . . . . . . . 10.5 t-20 -108.16 -44.14 4.22 Favored 'General case' 0 C--O 1.233 0.192 0 CA-C-N 116.578 -0.283 . . . . 0.0 111.05 -177.859 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' F' F ' 122' ' ' LYS . . . . . . . . . . . . . 55.7 pttt -165.94 161.73 17.73 Favored 'General case' 0 C--N 1.332 -0.17 0 C-N-CA 120.398 -0.521 . . . . 0.0 112.218 -179.223 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' F' F ' 123' ' ' VAL . . . . . . . . . . . . . 44.1 t -131.36 137.38 55.61 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.202 0 CA-C-N 115.809 -0.632 . . . . 0.0 109.956 178.959 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' F' F ' 124' ' ' LEU . . . . . . . . . . . . . 88.4 mt -122.38 136.8 54.97 Favored 'General case' 0 C--N 1.331 -0.223 0 CA-C-N 116.498 -0.319 . . . . 0.0 110.944 -179.47 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' F' F ' 125' ' ' VAL . . . . . . . . . . . . . 44.3 t -126.12 129.27 72.19 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.217 0 CA-C-N 116.096 -0.502 . . . . 0.0 109.849 178.576 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' F' F ' 126' ' ' ARG . . . . . . . . . . . . . 27.3 mmt85 -139.85 118.12 12.03 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.408 -0.36 . . . . 0.0 110.701 179.122 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' F' F ' 127' ' ' ASN . . . . . . . . . . . . . 4.9 m-20 49.66 -105.0 0.16 Allowed 'General case' 0 CA--C 1.545 0.759 0 CA-C-O 119.052 -0.499 . . . . 0.0 111.678 178.438 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' F' F ' 128' ' ' ASP . . . . . . . . . . . . . 17.5 p-10 -114.0 1.21 14.6 Favored 'General case' 0 N--CA 1.468 0.429 0 CA-C-N 119.571 1.078 . . . . 0.0 113.401 -178.046 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' F' F ' 129' ' ' LEU . . . . . . . . . . . . . 62.1 mt -107.32 142.86 36.44 Favored 'General case' 0 C--N 1.333 -0.131 0 N-CA-C 109.782 -0.451 . . . . 0.0 109.782 179.508 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' F' F ' 130' ' ' VAL . . . . . . . . . . . . . 41.9 t -129.5 140.31 49.43 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.287 0 CA-C-O 120.911 0.386 . . . . 0.0 110.066 -179.12 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' F' F ' 131' ' ' VAL . . . . . 0.426 HG12 HD12 ' F' ' 140' ' ' LEU . 34.8 m -135.93 142.0 40.23 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.267 0 CA-C-O 121.151 0.5 . . . . 0.0 110.838 178.882 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' F' F ' 132' ' ' ILE . . . . . . . . . . . . . 73.7 mt -118.61 134.0 63.64 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.259 0 CA-C-N 115.649 -0.705 . . . . 0.0 109.37 -179.78 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' F' F ' 133' ' ' ILE . . . . . . . . . . . . . 38.7 mm -116.79 122.51 70.11 Favored 'Isoleucine or valine' 0 C--O 1.234 0.278 0 CA-C-O 120.828 0.347 . . . . 0.0 111.077 -175.161 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' F' F ' 134' ' ' ASP . . . . . . . . . . . . . 6.1 p-10 -134.2 147.24 50.7 Favored 'General case' 0 C--N 1.332 -0.183 0 CA-C-N 115.87 -0.605 . . . . 0.0 109.577 172.693 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' F' F ' 135' ' ' GLU . . . . . . . . . . . . . 81.9 tt0 -49.94 -23.91 2.25 Favored 'General case' 0 C--N 1.328 -0.369 0 N-CA-C 113.088 0.773 . . . . 0.0 113.088 -170.147 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' F' F ' 136' ' ' GLN . . . . . . . . . . . . . 47.6 tt0 -104.69 -26.27 12.37 Favored 'General case' 0 CA--C 1.531 0.238 0 N-CA-C 112.748 0.648 . . . . 0.0 112.748 -174.625 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' F' F ' 137' ' ' LYS . . . . . . . . . . . . . 7.2 ttpm? -143.87 150.14 37.99 Favored 'General case' 0 C--N 1.332 -0.167 0 CA-C-O 121.36 0.6 . . . . 0.0 111.781 -170.5 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' F' F ' 138' ' ' LEU . . . . . . . . . . . . . 5.7 tt -116.87 126.62 53.29 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 115.466 -0.788 . . . . 0.0 109.241 175.183 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' F' F ' 139' ' ' THR . . . . . . . . . . . . . 26.4 m -112.44 128.27 56.27 Favored 'General case' 0 C--N 1.331 -0.208 0 CA-C-N 116.592 -0.276 . . . . 0.0 110.82 -178.106 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' F' F ' 140' ' ' LEU . . . . . 0.426 HD12 HG12 ' F' ' 131' ' ' VAL . 36.5 tp -112.71 120.24 40.85 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 115.573 -0.739 . . . . 0.0 109.263 179.783 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' F' F ' 141' ' ' ILE . . . . . . . . . . . . . 19.3 mt -119.83 119.73 61.17 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.28 0 N-CA-C 109.863 -0.421 . . . . 0.0 109.863 -175.009 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' F' F ' 142' ' ' ARG . . . . . . . . . . . . . 78.9 mtp180 -108.9 130.11 55.43 Favored 'General case' 0 C--N 1.331 -0.23 0 CA-C-N 115.556 -0.747 . . . . 0.0 110.624 -177.948 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' F' F ' 143' ' ' THR . . . . . . . . . . . . . 26.5 p . . . . . 0 C--O 1.22 -0.485 0 CA-C-O 118.106 -0.95 . . . . 0.0 110.532 -179.238 . . . . . . . . 0 0 . 1 . 019 nuclear build core ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 3.9 p . . . . . 0 N--CA 1.462 0.152 0 CA-C-O 121.149 0.5 . . . . 0.0 110.692 . . . . . . . . . 0 0 . 1 . 019 nuclear build core ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 95.7 mt-10 -141.26 144.36 34.63 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 115.593 -0.731 . . . . 0.0 110.996 -176.55 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 4' ' ' LEU . . . . . . . . . . . . . 21.8 tp -122.46 125.6 46.15 Favored 'General case' 0 C--N 1.331 -0.206 0 CA-C-N 115.919 -0.582 . . . . 0.0 109.758 174.431 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 5' ' ' LYS . . . . . . . . . . . . . 90.5 mttt -104.64 120.95 42.52 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.341 -0.391 . . . . 0.0 110.685 -179.51 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 65.9 mt -117.82 147.27 43.19 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 115.575 -0.739 . . . . 0.0 110.7 -178.08 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 56.6 tttt -140.31 139.37 20.66 Favored Pre-proline 0 CA--C 1.533 0.314 0 CA-C-O 119.066 -0.492 . . . . 0.0 109.953 175.103 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 8' ' ' PRO . . . . . . . . . . . . . 94.1 Cg_endo -91.81 146.63 3.18 Favored 'Trans proline' 0 N--CA 1.49 1.319 0 C-N-CA 121.623 1.549 . . . . 0.0 111.834 178.119 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 59.1 mt -78.64 -47.18 1.87 Allowed Pre-proline 0 CA--C 1.534 0.359 0 CA-C-O 118.724 -0.655 . . . . 0.0 112.029 179.96 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 87.8 Cg_endo -81.34 151.37 17.68 Favored 'Trans proline' 0 N--CA 1.495 1.609 0 C-N-CA 121.195 1.264 . . . . 0.0 111.939 175.774 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 34.4 mmtp -84.26 100.43 11.21 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.445 -0.343 . . . . 0.0 110.347 177.703 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 12.5 p -140.28 143.73 29.02 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.275 0 CA-C-N 116.233 -0.439 . . . . 0.0 110.545 -179.794 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 15.0 pt-20 -89.62 130.84 35.86 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.198 -0.455 . . . . 0.0 110.224 177.72 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 14' ' ' LEU . . . . . . . . . . . . . 35.0 mt -98.24 153.72 37.95 Favored Pre-proline 0 C--O 1.234 0.241 0 CA-C-N 116.377 -0.374 . . . . 0.0 111.16 -176.5 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 15' ' ' PRO . . . . . . . . . . . . . 24.8 Cg_exo -63.0 165.44 16.59 Favored 'Trans proline' 0 N--CA 1.496 1.667 0 C-N-CA 121.37 1.38 . . . . 0.0 111.806 174.657 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 16' ' ' PRO . . . . . . . . . . . . . 26.5 Cg_exo -60.71 -46.32 17.36 Favored 'Trans proline' 0 N--CA 1.498 1.763 0 C-N-CA 121.48 1.454 . . . . 0.0 112.912 -177.649 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 17' ' ' ASP . . . . . . . . . . . . . 22.4 p-10 -86.06 11.31 11.96 Favored 'General case' 0 C--N 1.327 -0.412 0 N-CA-C 113.207 0.817 . . . . 0.0 113.207 -176.508 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 18' ' ' PHE . . . . . . . . . . . . . 37.5 t80 -57.03 -40.5 76.86 Favored 'General case' 0 C--N 1.334 -0.091 0 O-C-N 121.877 -0.514 . . . . 0.0 110.461 -179.215 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 19' ' ' VAL . . . . . . . . . . . . . 47.7 t -56.91 -44.06 81.63 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.285 0 CA-C-N 116.344 -0.389 . . . . 0.0 110.412 -179.683 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 18.1 t70 -59.79 -41.55 91.42 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-O 120.892 0.377 . . . . 0.0 110.702 -178.031 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 47.5 t -63.76 -47.74 89.63 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.308 0 CA-C-N 116.422 -0.353 . . . . 0.0 110.487 -178.021 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 22' ' ' ILE . . . . . 0.53 HG22 HD12 ' A' ' 26' ' ' LEU . 50.6 mm -56.16 -44.61 79.58 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.201 0 C-N-CA 120.863 -0.335 . . . . 0.0 110.656 179.07 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 23' ' ' ARG . . . . . . . . . . . . . 51.2 ttp180 -53.62 -49.1 68.59 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-O 120.715 0.293 . . . . 0.0 111.462 -179.393 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 24' ' ' ILE . . . . . . . . . . . . . 71.8 mt -59.24 -44.63 92.45 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.268 0 CA-C-N 116.441 -0.345 . . . . 0.0 111.157 -178.329 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 79.3 mttt -64.06 -41.38 97.37 Favored 'General case' 0 C--N 1.329 -0.318 0 N-CA-C 112.377 0.51 . . . . 0.0 112.377 -177.554 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 26' ' ' LEU . . . . . 0.53 HD12 HG22 ' A' ' 22' ' ' ILE . 65.2 mt -79.48 -42.34 25.51 Favored 'General case' 0 C--N 1.329 -0.307 0 N-CA-C 113.147 0.795 . . . . 0.0 113.147 -171.108 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 27' ' ' GLN . . . . . . . . . . . . . 15.3 pt20 -46.58 138.43 5.91 Favored 'General case' 0 N--CA 1.469 0.491 0 N-CA-C 112.816 0.673 . . . . 0.0 112.816 -175.533 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 100.77 -25.65 27.56 Favored Glycine 0 CA--C 1.531 1.086 0 CA-C-N 115.498 -0.774 . . . . 0.0 112.387 -178.515 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 85.6 mttt -98.68 155.22 17.43 Favored 'General case' 0 C--O 1.233 0.197 0 CA-C-N 117.428 0.614 . . . . 0.0 111.467 179.47 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 30' ' ' THR . . . . . . . . . . . . . 29.9 m -100.79 137.14 39.57 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 115.836 -0.62 . . . . 0.0 109.748 175.125 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 34.0 m -128.81 151.77 36.04 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.24 0 CA-C-O 120.829 0.347 . . . . 0.0 111.076 -177.602 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 32' ' ' ARG . . . . . . . . . . . . . 75.5 mtp180 -131.08 150.23 52.24 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-O 121.294 0.569 . . . . 0.0 110.541 177.241 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 33' ' ' THR . . . . . . . . . . . . . 17.6 m -53.17 138.2 32.2 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.163 -0.471 . . . . 0.0 111.471 -178.611 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 102.07 -17.23 54.63 Favored Glycine 0 CA--C 1.531 1.06 0 CA-C-O 119.67 -0.517 . . . . 0.0 113.333 178.06 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 79.7 m-20 -65.82 146.07 55.2 Favored 'General case' 0 C--O 1.231 0.107 0 CA-C-N 118.075 0.938 . . . . 0.0 110.98 179.268 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 46.9 t -121.19 129.19 75.9 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.197 0 CA-C-N 115.943 -0.571 . . . . 0.0 109.806 178.603 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 37' ' ' ILE . . . . . . . . . . . . . 67.7 mt -119.62 138.23 50.92 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.228 0 CA-C-N 116.211 -0.45 . . . . 0.0 109.835 -179.522 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . -112.15 128.68 8.66 Favored Glycine 0 CA--C 1.525 0.682 0 N-CA-C 111.034 -0.826 . . . . 0.0 111.034 179.963 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 39' ' ' ILE . . . . . . . . . . . . . 72.3 mt -127.41 127.18 68.72 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.206 0 N-CA-C 109.848 -0.427 . . . . 0.0 109.848 178.453 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 40' ' ' SER . . . . . . . . . . . . . 45.7 t -92.72 124.88 37.05 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.476 -0.329 . . . . 0.0 110.79 177.0 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 41' ' ' ILE . . . . . . . . . . . . . 73.9 mt -128.67 116.41 41.22 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.158 0 CA-C-O 120.92 0.391 . . . . 0.0 110.186 178.261 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 42' ' ' LEU . . . . . 0.538 ' O ' HD23 ' A' ' 42' ' ' LEU . 1.3 tt 54.91 46.71 23.83 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-O 121.441 0.639 . . . . 0.0 110.616 177.835 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . 75.97 -10.05 15.87 Favored Glycine 0 CA--C 1.533 1.194 0 CA-C-N 116.042 -0.526 . . . . 0.0 113.667 174.35 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 44' ' ' LYS . . . . . . . . . . . . . 46.6 mtmt -104.41 126.92 51.94 Favored 'General case' 0 C--N 1.332 -0.175 0 CA-C-N 118.178 0.989 . . . . 0.0 110.328 179.224 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 39.5 tp10 -84.83 134.25 34.3 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-O 120.96 0.409 . . . . 0.0 111.34 -177.699 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 46' ' ' VAL . . . . . . . . . . . . . 7.4 p -127.81 130.65 70.14 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.175 0 CA-C-N 116.085 -0.507 . . . . 0.0 109.851 176.075 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 97.7 mttt -100.89 131.54 46.72 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.146 -0.479 . . . . 0.0 111.452 177.59 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 48' ' ' PHE . . . . . . . . . . . . . 90.4 m-85 -113.9 131.77 56.17 Favored 'General case' 0 C--N 1.33 -0.278 0 N-CA-C 109.535 -0.542 . . . . 0.0 109.535 175.246 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 45.3 tttp -108.07 137.23 46.41 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-O 120.715 0.293 . . . . 0.0 110.736 179.405 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 50' ' ' VAL . . . . . . . . . . . . . 45.0 t -78.91 107.04 10.87 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.236 0 N-CA-C 109.157 -0.683 . . . . 0.0 109.157 175.163 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 51' ' ' VAL . . . . . . . . . . . . . 47.5 t -73.23 -47.68 45.94 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.356 0 CA-C-N 116.263 -0.426 . . . . 0.0 110.053 -173.555 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 52' ' ' GLN . . . . . . . . . . . . . 62.0 tt0 -162.69 141.96 9.04 Favored 'General case' 0 C--N 1.331 -0.201 0 C-N-CA 120.158 -0.617 . . . . 0.0 111.838 -178.129 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -114.92 130.7 56.96 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 115.65 -0.705 . . . . 0.0 109.9 176.057 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 54' ' ' TYR . . . . . . . . . . . . . 37.9 t80 -129.15 107.44 17.85 Favored Pre-proline 0 CA--C 1.534 0.338 0 CA-C-O 118.292 -0.861 . . . . 0.0 110.52 -179.726 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 55' ' ' PRO . . . . . . . . . . . . . 72.4 Cg_endo -77.2 169.98 72.71 Favored 'Cis proline' 0 N--CA 1.499 1.85 0 CA-C-N 121.778 1.671 . . . . 0.0 112.562 -5.145 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 56' ' ' SER . . . . . . . . . . . . . 16.1 m -115.34 133.21 22.76 Favored Pre-proline 0 CA--C 1.538 0.506 0 CA-C-O 118.457 -0.782 . . . . 0.0 109.494 174.764 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 57' ' ' PRO . . . . . . . . . . . . . 56.0 Cg_endo -71.62 147.98 89.3 Favored 'Cis proline' 0 N--CA 1.497 1.71 0 CA-C-N 121.851 1.697 . . . . 0.0 111.502 -2.171 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 58' ' ' LEU . . . . . . . . . . . . . 22.2 tp -108.05 137.11 46.61 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-O 120.926 0.393 . . . . 0.0 110.74 -177.952 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 59' ' ' ARG . . . . . . . . . . . . . 77.2 ttt180 -102.89 122.05 43.76 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-N 115.882 -0.599 . . . . 0.0 109.401 175.714 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 43.3 t -79.31 119.81 29.33 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.254 0 C-N-CA 120.633 -0.427 . . . . 0.0 110.331 -176.3 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 75.3 tt0 -130.88 158.72 39.45 Favored 'General case' 0 C--N 1.328 -0.33 0 N-CA-C 109.059 -0.719 . . . . 0.0 109.059 177.435 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 62' ' ' ASP . . . . . . . . . . . . . 68.4 m-20 -50.98 -31.11 16.93 Favored 'General case' 0 C--N 1.327 -0.381 0 N-CA-C 112.211 0.448 . . . . 0.0 112.211 -178.65 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 63' ' ' ARG . . . . . . . . . . . . . 7.1 ptp180 -86.25 4.63 38.01 Favored 'General case' 0 CA--C 1.535 0.383 0 N-CA-C 113.728 1.01 . . . . 0.0 113.728 -175.579 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 17.9 m -86.65 141.85 28.65 Favored 'General case' 0 C--N 1.332 -0.162 0 CA-C-N 118.188 0.449 . . . . 0.0 110.371 -178.667 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 65' ' ' LYS . . . . . . . . . . . . . 37.3 ttpt -89.08 130.74 35.48 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-O 121.0 0.428 . . . . 0.0 110.607 -177.94 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 66' ' ' ILE . . . . . . . . . . . . . 64.7 mt -111.78 131.52 62.93 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.288 0 N-CA-C 109.857 -0.423 . . . . 0.0 109.857 -179.104 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 67' ' ' THR . . . . . . . . . . . . . 28.5 m -125.7 138.25 53.87 Favored 'General case' 0 C--N 1.332 -0.166 0 CA-C-O 121.059 0.457 . . . . 0.0 110.865 -177.928 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 68' ' ' LEU . . . . . 0.496 ' N ' HD12 ' A' ' 68' ' ' LEU . 6.8 mp . . . . . 0 C--N 1.33 -0.239 0 CA-C-N 115.889 -0.596 . . . . 0.0 110.332 178.132 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 74' ' ' ASP . . . . . . . . . . . . . 23.9 t0 . . . . . 0 C--O 1.23 0.064 0 N-CA-C 109.839 -0.43 . . . . 0.0 109.839 . . . . . . . . . 0 0 . 1 . 019 nuclear build core ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 42.3 t -115.78 124.54 72.29 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.204 0 CA-C-O 121.073 0.463 . . . . 0.0 110.906 -175.712 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 76' ' ' LEU . . . . . . . . . . . . . 5.0 mp -121.08 137.17 54.78 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 115.625 -0.716 . . . . 0.0 109.336 174.162 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 77' ' ' GLU . . . . . 0.442 ' HG2' HG23 ' F' ' 139' ' ' THR . 96.9 mt-10 -131.75 133.11 44.42 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-O 120.967 0.413 . . . . 0.0 111.141 -178.568 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 78' ' ' ALA . . . . . . . . . . . . . . . -122.39 137.74 54.76 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 115.813 -0.631 . . . . 0.0 109.923 176.971 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 79' ' ' LYS . . . . . 0.577 ' O ' HD13 ' A' ' 80' ' ' ILE . 99.2 mttt -75.92 117.25 17.45 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-O 120.983 0.421 . . . . 0.0 110.285 179.541 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 80' ' ' ILE . . . . . 0.577 HD13 ' O ' ' A' ' 79' ' ' LYS . 42.8 mm -139.1 102.6 1.76 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.394 0 N-CA-C 109.382 -0.599 . . . . 0.0 109.382 -176.888 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 81' ' ' LYS . . . . . . . . . . . . . 97.1 mttt -99.7 131.35 45.74 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-O 120.981 0.42 . . . . 0.0 111.198 -177.704 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . 89.02 42.1 5.72 Favored Glycine 0 CA--C 1.526 0.742 0 CA-C-N 115.893 -0.594 . . . . 0.0 111.779 174.866 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 83' ' ' ILE . . . . . . . . . . . . . 70.5 mt -69.3 136.62 25.89 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.354 0 N-CA-C 109.833 -0.432 . . . . 0.0 109.833 178.068 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 84' ' ' LYS . . . . . . . . . . . . . 59.5 tttt -99.11 -53.7 3.18 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.115 -0.493 . . . . 0.0 110.285 -178.395 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 85' ' ' ASP . . . . . . . . . . . . . 8.6 t70 -155.12 154.65 32.69 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 115.857 -0.611 . . . . 0.0 110.4 179.841 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 86' ' ' VAL . . . . . . . . . . . . . 42.2 t -129.41 132.0 66.9 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.225 0 CA-C-O 120.942 0.401 . . . . 0.0 110.642 -178.756 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 87' ' ' ILE . . . . . 0.496 HD12 ' N ' ' A' ' 87' ' ' ILE . 5.0 mp -119.62 126.81 75.68 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.219 0 CA-C-N 115.975 -0.557 . . . . 0.0 109.566 176.81 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 88' ' ' LEU . . . . . . . . . . . . . 66.8 mt -107.02 135.29 48.83 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-O 121.075 0.464 . . . . 0.0 111.322 -177.949 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 89' ' ' ASP . . . . . . . . . . . . . 13.1 t70 -127.89 152.15 48.2 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 115.758 -0.655 . . . . 0.0 109.536 175.532 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 83.3 tt0 -47.28 -39.68 15.06 Favored 'General case' 0 C--N 1.33 -0.266 0 N-CA-C 112.792 0.664 . . . . 0.0 112.792 -172.978 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 91' ' ' ASN . . . . . . . . . . . . . 29.0 p30 -132.03 34.95 3.77 Favored 'General case' 0 N--CA 1.464 0.245 0 N-CA-C 111.695 0.257 . . . . 0.0 111.695 -177.673 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 92' ' ' LEU . . . . . . . . . . . . . 8.0 tp -166.11 147.0 6.59 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-O 120.73 0.3 . . . . 0.0 110.533 -178.718 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 93' ' ' ILE . . . . . . . . . . . . . 74.6 mt -129.72 122.92 55.99 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.267 0 N-CA-C 109.545 -0.539 . . . . 0.0 109.545 179.881 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 94' ' ' VAL . . . . . . . . . . . . . 40.3 t -121.06 128.06 76.0 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.271 0 CA-C-O 120.854 0.359 . . . . 0.0 110.051 -179.519 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 95' ' ' VAL . . . . . . . . . . . . . 42.0 t -120.12 134.29 64.12 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.314 0 CA-C-N 116.031 -0.531 . . . . 0.0 109.804 179.695 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 96' ' ' ILE . . . . . . . . . . . . . 63.3 mt -111.18 128.77 67.42 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.409 0 N-CA-C 109.166 -0.679 . . . . 0.0 109.166 178.856 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 97' ' ' THR . . . . . . . . . . . . . 75.8 p -100.82 157.63 16.57 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-O 121.343 0.592 . . . . 0.0 111.283 -177.412 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 98' ' ' GLU . . . . . . . . . . . . . 84.7 tt0 -53.92 -28.16 35.12 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.001 -0.545 . . . . 0.0 112.066 -179.478 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 99' ' ' GLU . . . . . . . . . . . . . 44.9 mp0 -80.58 17.73 1.07 Allowed 'General case' 0 CA--C 1.534 0.34 0 N-CA-C 112.984 0.735 . . . . 0.0 112.984 -176.339 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 100' ' ' ASN . . . . . . . . . . . . . 4.1 m-20 61.51 37.97 16.08 Favored 'General case' 0 CA--C 1.529 0.157 0 CA-C-O 121.063 0.459 . . . . 0.0 110.938 178.459 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 101' ' ' GLU . . . . . . . . . . . . . 84.9 tt0 -117.83 144.72 45.13 Favored 'General case' 0 C--N 1.331 -0.232 0 N-CA-C 109.671 -0.492 . . . . 0.0 109.671 176.307 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 102' ' ' VAL . . . . . . . . . . . . . 45.6 t -114.98 126.2 72.51 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.257 0 CA-C-O 120.887 0.375 . . . . 0.0 110.152 -177.483 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 103' ' ' LEU . . . . . . . . . . . . . 42.5 mt -114.3 130.98 56.67 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-N 115.592 -0.731 . . . . 0.0 109.822 176.614 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 104' ' ' ILE . . . . . 0.675 HD13 HG11 ' A' ' 130' ' ' VAL . 67.7 mt -122.37 120.96 62.55 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.236 0 N-CA-C 110.436 -0.209 . . . . 0.0 110.436 -177.312 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 105' ' ' PHE . . . . . . . . . . . . . 43.8 m-85 -123.83 166.63 15.28 Favored 'General case' 0 C--N 1.332 -0.193 0 O-C-N 124.041 0.838 . . . . 0.0 109.798 179.64 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 106' ' ' ASN . . . . . . . . . . . . . 41.2 p-10 -96.21 -169.91 2.0 Favored 'General case' 0 C--N 1.329 -0.302 0 N-CA-C 109.377 -0.601 . . . . 0.0 109.377 171.545 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 107' ' ' GLN . . . . . . . . . . . . . 48.0 tt0 -59.61 -30.04 68.42 Favored 'General case' 0 CA--C 1.532 0.256 0 C-N-CA 120.74 -0.384 . . . . 0.0 111.644 177.688 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 108' ' ' ASN . . . . . . . . . . . . . 5.0 t-20 -81.89 6.32 16.18 Favored 'General case' 0 CA--C 1.537 0.476 0 N-CA-C 113.178 0.807 . . . . 0.0 113.178 -178.145 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 109' ' ' LEU . . . . . . . . . . . . . 8.9 tp 61.88 36.94 15.65 Favored 'General case' 0 C--O 1.232 0.155 0 O-C-N 122.123 -0.36 . . . . 0.0 111.526 176.567 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 110' ' ' GLU . . . . . . . . . . . . . 96.0 mt-10 -104.99 149.61 25.62 Favored 'General case' 0 C--N 1.33 -0.267 0 N-CA-C 110.032 -0.358 . . . . 0.0 110.032 176.018 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 111' ' ' GLU . . . . . . . . . . . . . 98.8 mt-10 -76.61 122.62 24.9 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-O 120.99 0.424 . . . . 0.0 111.222 -178.101 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 112' ' ' LEU . . . . . . . . . . . . . 16.1 mt -110.78 -45.94 3.42 Favored 'General case' 0 C--N 1.332 -0.177 0 CA-C-N 115.953 -0.567 . . . . 0.0 110.188 176.986 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 113' ' ' TYR . . . . . 0.412 ' HB3' HD12 ' A' ' 104' ' ' ILE . 34.5 t80 -138.65 140.69 38.96 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.859 179.381 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 114' ' ' ARG . . . . . . . . . . . . . 78.3 mtp180 -143.05 122.4 13.07 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.078 -0.51 . . . . 0.0 110.355 179.074 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 115' ' ' GLY . . . . . . . . . . . . . . . -150.12 153.79 25.29 Favored Glycine 0 CA--C 1.525 0.67 0 N-CA-C 111.22 -0.752 . . . . 0.0 111.22 179.73 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 116' ' ' LYS . . . . . . . . . . . . . 40.3 ttpt -126.47 129.46 48.73 Favored 'General case' 0 C--N 1.331 -0.226 0 N-CA-C 109.72 -0.474 . . . . 0.0 109.72 178.778 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 117' ' ' PHE . . . . . 0.412 ' HE2' HD13 ' A' ' 132' ' ' ILE . 41.6 m-85 -130.56 114.96 16.11 Favored 'General case' 0 C--N 1.333 -0.15 0 CA-C-O 120.851 0.358 . . . . 0.0 110.631 -174.155 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 118' ' ' GLU . . . . . . . . . . . . . 84.7 tt0 -53.93 -46.69 71.6 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.418 -0.355 . . . . 0.0 111.379 -177.875 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 119' ' ' ASN . . . . . . . . . . . . . 33.0 m120 -94.77 30.44 2.06 Favored 'General case' 0 C--N 1.329 -0.299 0 N-CA-C 112.241 0.46 . . . . 0.0 112.241 -175.197 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 120' ' ' LEU . . . . . . . . . . . . . 17.1 tp -58.47 123.4 16.06 Favored 'General case' 0 C--N 1.332 -0.153 0 N-CA-C 110.204 -0.295 . . . . 0.0 110.204 177.575 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 121' ' ' ASN . . . . . . . . . . . . . 14.7 m120 -113.77 -44.19 3.21 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-N 116.678 -0.237 . . . . 0.0 110.989 -178.399 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 122' ' ' LYS . . . . . . . . . . . . . 97.3 mttt -148.28 150.31 33.42 Favored 'General case' 0 C--N 1.331 -0.236 0 C-N-CA 120.549 -0.46 . . . . 0.0 111.523 -178.04 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 123' ' ' VAL . . . . . . . . . . . . . 43.9 t -130.13 132.23 65.4 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.185 0 CA-C-N 115.967 -0.561 . . . . 0.0 109.55 175.825 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 124' ' ' LEU . . . . . . . . . . . . . 17.6 tp -127.62 136.9 52.27 Favored 'General case' 0 C--N 1.332 -0.162 0 CA-C-O 120.808 0.337 . . . . 0.0 110.621 -178.188 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 125' ' ' VAL . . . . . . . . . . . . . 11.4 p -125.59 128.05 72.07 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.22 0 CA-C-N 116.112 -0.495 . . . . 0.0 110.252 178.978 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 126' ' ' ARG . . . . . . . . . . . . . 51.8 mmm-85 -140.84 123.9 16.46 Favored 'General case' 0 C--N 1.33 -0.269 0 N-CA-C 109.19 -0.67 . . . . 0.0 109.19 178.909 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 127' ' ' ASN . . . . . . . . . . . . . 37.1 t30 57.25 -150.99 0.43 Allowed 'General case' 0 CA--C 1.539 0.546 0 N-CA-C 109.56 -0.533 . . . . 0.0 109.56 -179.074 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 128' ' ' ASP . . . . . . . . . . . . . 19.5 p-10 -83.57 14.75 3.54 Favored 'General case' 0 CA--C 1.537 0.46 0 CA-C-N 118.637 0.653 . . . . 0.0 112.694 177.024 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 129' ' ' LEU . . . . . . . . . . . . . 40.2 mt -114.1 145.09 42.1 Favored 'General case' 0 C--O 1.231 0.119 0 O-C-N 121.975 -0.453 . . . . 0.0 109.83 179.06 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 130' ' ' VAL . . . . . 0.675 HG11 HD13 ' A' ' 104' ' ' ILE . 12.3 p -133.73 144.98 34.24 Favored 'Isoleucine or valine' 0 C--O 1.233 0.206 0 CA-C-O 121.248 0.547 . . . . 0.0 110.756 -176.914 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 131' ' ' VAL . . . . . 0.548 HG22 HD12 ' A' ' 140' ' ' LEU . 45.3 t -134.36 137.35 51.74 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.303 0 CA-C-N 115.707 -0.679 . . . . 0.0 110.063 179.695 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 132' ' ' ILE . . . . . 0.412 HD13 ' HE2' ' A' ' 117' ' ' PHE . 72.1 mt -116.53 132.82 65.05 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.367 0 CA-C-N 115.757 -0.656 . . . . 0.0 109.336 179.47 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 133' ' ' ILE . . . . . . . . . . . . . 42.6 mm -114.55 120.18 63.52 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.259 0 CA-C-O 120.693 0.282 . . . . 0.0 110.879 -175.356 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 134' ' ' ASP . . . . . . . . . . . . . 8.4 p-10 -130.62 143.25 50.62 Favored 'General case' 0 C--N 1.33 -0.244 0 N-CA-C 109.351 -0.611 . . . . 0.0 109.351 174.732 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 135' ' ' GLU . . . . . . . . . . . . . 39.6 tp10 -50.0 -26.32 4.18 Favored 'General case' 0 C--N 1.328 -0.328 0 N-CA-C 112.89 0.7 . . . . 0.0 112.89 -171.939 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 136' ' ' GLN . . . . . . . . . . . . . 97.0 mt-30 -80.43 -35.1 35.52 Favored 'General case' 0 C--N 1.331 -0.218 0 N-CA-C 112.022 0.378 . . . . 0.0 112.022 -176.962 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 137' ' ' LYS . . . . . . . . . . . . . 49.7 pttt -167.64 172.61 9.19 Favored 'General case' 0 C--N 1.331 -0.219 0 CA-C-O 121.478 0.656 . . . . 0.0 112.052 -173.828 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 138' ' ' LEU . . . . . 0.411 HD23 ' N ' ' A' ' 139' ' ' THR . 6.1 tt -113.99 129.81 56.58 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 115.164 -0.925 . . . . 0.0 110.114 -179.48 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 139' ' ' THR . . . . . 0.411 ' N ' HD23 ' A' ' 138' ' ' LEU . 24.8 m -108.63 126.41 52.93 Favored 'General case' 0 C--N 1.332 -0.179 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.568 179.964 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 140' ' ' LEU . . . . . 0.548 HD12 HG22 ' A' ' 131' ' ' VAL . 11.1 tp -114.26 122.89 48.14 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-N 115.753 -0.658 . . . . 0.0 109.404 -178.846 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 141' ' ' ILE . . . . . 0.473 ' HB ' HG13 ' A' ' 130' ' ' VAL . 19.9 mt -121.48 120.38 61.69 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.273 0 CA-C-O 120.954 0.407 . . . . 0.0 109.94 -176.41 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 142' ' ' ARG . . . . . . . . . . . . . 72.0 mtp180 -110.61 118.03 35.12 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 115.327 -0.851 . . . . 0.0 110.64 -177.405 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 143' ' ' THR . . . . . . . . . . . . . 33.7 p . . . . . 0 C--O 1.219 -0.502 0 CA-C-O 117.891 -1.052 . . . . 0.0 110.533 179.929 . . . . . . . . 0 0 . 1 . 019 nuclear build core ' B' B ' 2' ' ' SER . . . . . . . . . . . . . 7.3 p . . . . . 0 C--O 1.23 0.074 0 CA-C-O 120.818 0.342 . . . . 0.0 110.358 . . . . . . . . . 0 0 . 1 . 019 nuclear build core ' B' B ' 3' ' ' GLU . . . . . . . . . . . . . 94.5 mt-10 -140.71 142.96 34.79 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.112 -0.495 . . . . 0.0 111.022 -177.943 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' B' B ' 4' ' ' LEU . . . . . . . . . . . . . 17.7 tp -127.85 127.86 44.2 Favored 'General case' 0 C--N 1.331 -0.205 0 CA-C-N 116.087 -0.506 . . . . 0.0 109.865 175.538 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' B' B ' 5' ' ' LYS . . . . . . . . . . . . . 98.6 mttt -109.02 122.74 47.89 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-O 120.487 0.184 . . . . 0.0 110.87 -179.673 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' B' B ' 6' ' ' LEU . . . . . . . . . . . . . 53.6 mt -114.94 143.89 44.44 Favored 'General case' 0 N--CA 1.463 0.215 0 O-C-N 123.8 0.688 . . . . 0.0 110.946 179.679 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' B' B ' 7' ' ' LYS . . . . . . . . . . . . . 84.3 tttt -129.88 135.47 27.55 Favored Pre-proline 0 CA--C 1.535 0.366 0 CA-C-O 118.811 -0.614 . . . . 0.0 109.643 175.226 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' B' B ' 8' ' ' PRO . . . . . . . . . . . . . 71.8 Cg_endo -90.48 142.85 3.59 Favored 'Trans proline' 0 N--CA 1.492 1.396 0 C-N-CA 121.578 1.519 . . . . 0.0 112.421 179.726 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' B' B ' 9' ' ' LEU . . . . . . . . . . . . . 19.5 mt -87.08 -49.64 0.46 Allowed Pre-proline 0 CA--C 1.535 0.386 0 CA-C-O 118.669 -0.682 . . . . 0.0 112.477 -179.399 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' B' B ' 10' ' ' PRO . . . . . . . . . . . . . 95.7 Cg_endo -79.12 163.03 25.64 Favored 'Trans proline' 0 N--CA 1.496 1.657 0 C-N-CA 121.317 1.344 . . . . 0.0 112.315 -178.995 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' B' B ' 11' ' ' LYS . . . . . . . . . . . . . 26.5 tptp -87.09 104.06 15.98 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.404 178.604 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' B' B ' 12' ' ' VAL . . . . . . . . . . . . . 12.5 p -147.83 147.09 17.57 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.231 0 CA-C-N 116.31 -0.404 . . . . 0.0 110.684 -179.661 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' B' B ' 13' ' ' GLU . . . . . . . . . . . . . 84.7 tt0 -100.34 124.57 45.99 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.158 -0.474 . . . . 0.0 110.079 177.447 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' B' B ' 14' ' ' LEU . . . . . 0.404 HD13 ' CD2' ' B' ' 18' ' ' PHE . 30.3 mt -98.93 151.46 37.4 Favored Pre-proline 0 CA--C 1.533 0.291 0 CA-C-O 119.311 -0.376 . . . . 0.0 111.228 -176.329 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' B' B ' 15' ' ' PRO . . . . . . . . . . . . . 24.2 Cg_exo -63.84 162.25 29.46 Favored 'Trans proline' 0 N--CA 1.498 1.792 0 C-N-CA 121.372 1.382 . . . . 0.0 111.97 175.625 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' B' B ' 16' ' ' PRO . . . . . . . . . . . . . 24.7 Cg_exo -62.41 -37.91 56.82 Favored 'Trans proline' 0 N--CA 1.497 1.694 0 C-N-CA 121.409 1.406 . . . . 0.0 112.469 179.235 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' B' B ' 17' ' ' ASP . . . . . . . . . . . . . 10.0 p-10 -85.25 12.33 8.28 Favored 'General case' 0 CA--C 1.536 0.423 0 N-CA-C 113.012 0.745 . . . . 0.0 113.012 -178.303 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' B' B ' 18' ' ' PHE . . . . . 0.404 ' CD2' HD13 ' B' ' 14' ' ' LEU . 18.7 t80 -56.8 -41.55 77.94 Favored 'General case' 0 C--N 1.334 -0.095 0 O-C-N 121.899 -0.5 . . . . 0.0 110.358 -179.183 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' B' B ' 19' ' ' VAL . . . . . . . . . . . . . 46.8 t -55.63 -41.08 62.99 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.205 0 CA-C-N 116.5 -0.318 . . . . 0.0 110.577 -179.45 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' B' B ' 20' ' ' ASP . . . . . . . . . . . . . 74.6 m-20 -59.33 -41.49 89.26 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-O 121.015 0.436 . . . . 0.0 110.427 179.942 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' B' B ' 21' ' ' VAL . . . . . . . . . . . . . 47.9 t -64.11 -46.0 94.92 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.306 0 CA-C-N 116.136 -0.484 . . . . 0.0 110.386 179.936 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' B' B ' 22' ' ' ILE . . . . . 0.468 HG22 HD12 ' B' ' 26' ' ' LEU . 51.2 mm -53.98 -60.02 1.66 Allowed 'Isoleucine or valine' 0 CA--C 1.53 0.191 0 C-N-CA 120.959 -0.296 . . . . 0.0 111.42 -178.324 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' B' B ' 23' ' ' ARG . . . . . . . . . . . . . 6.0 ptm180 -54.84 -44.75 74.2 Favored 'General case' 0 CA--C 1.53 0.184 0 C-N-CA 120.513 -0.475 . . . . 0.0 111.853 -174.244 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' B' B ' 24' ' ' ILE . . . . . . . . . . . . . 81.0 mt -61.03 -45.12 99.18 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.268 0 C-N-CA 120.836 -0.346 . . . . 0.0 111.663 -176.67 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' B' B ' 25' ' ' LYS . . . . . . . . . . . . . 72.1 mmtt -68.78 -42.56 77.22 Favored 'General case' 0 C--N 1.33 -0.267 0 N-CA-C 112.355 0.502 . . . . 0.0 112.355 -177.186 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' B' B ' 26' ' ' LEU . . . . . 0.468 HD12 HG22 ' B' ' 22' ' ' ILE . 83.0 mt -79.4 -33.97 42.26 Favored 'General case' 0 C--N 1.33 -0.275 0 N-CA-C 113.679 0.992 . . . . 0.0 113.679 -168.571 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' B' B ' 27' ' ' GLN . . . . . . . . . . . . . 17.6 pt20 -46.7 141.27 3.95 Favored 'General case' 0 N--CA 1.469 0.504 0 N-CA-C 112.785 0.661 . . . . 0.0 112.785 -175.577 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' B' B ' 28' ' ' GLY . . . . . . . . . . . . . . . 101.59 -27.16 21.73 Favored Glycine 0 CA--C 1.531 1.077 0 CA-C-N 115.612 -0.722 . . . . 0.0 112.205 -177.389 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' B' B ' 29' ' ' LYS . . . . . . . . . . . . . 68.0 mttm -97.48 155.09 17.09 Favored 'General case' 0 C--O 1.232 0.155 0 CA-C-N 117.451 0.625 . . . . 0.0 111.07 178.051 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' B' B ' 30' ' ' THR . . . . . . . . . . . . . 29.8 m -107.38 139.63 41.57 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.032 -0.531 . . . . 0.0 110.294 177.719 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' B' B ' 31' ' ' VAL . . . . . . . . . . . . . 34.5 m -129.25 152.97 38.0 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.212 0 CA-C-N 116.211 -0.45 . . . . 0.0 110.658 -179.256 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' B' B ' 32' ' ' ARG . . . . . . . . . . . . . 57.8 ttt180 -130.78 151.11 51.58 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-O 121.119 0.485 . . . . 0.0 110.243 178.798 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' B' B ' 33' ' ' THR . . . . . . . . . . . . . 21.6 m -52.12 137.16 28.39 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.366 -0.379 . . . . 0.0 111.676 -176.705 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' B' B ' 34' ' ' GLY . . . . . . . . . . . . . . . 100.61 -17.21 56.92 Favored Glycine 0 CA--C 1.532 1.154 0 CA-C-N 116.042 -0.526 . . . . 0.0 113.39 178.283 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' B' B ' 35' ' ' ASP . . . . . . . . . . . . . 78.3 m-20 -67.4 151.22 47.8 Favored 'General case' 0 C--O 1.231 0.129 0 CA-C-N 118.002 0.901 . . . . 0.0 111.244 179.141 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' B' B ' 36' ' ' VAL . . . . . . . . . . . . . 45.8 t -120.66 130.12 74.88 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.252 0 CA-C-N 115.996 -0.547 . . . . 0.0 109.806 177.429 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' B' B ' 37' ' ' ILE . . . . . . . . . . . . . 63.0 mt -119.53 138.24 50.81 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.256 0 CA-C-N 116.16 -0.473 . . . . 0.0 109.743 -179.132 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' B' B ' 38' ' ' GLY . . . . . . . . . . . . . . . -116.02 128.72 8.13 Favored Glycine 0 CA--C 1.526 0.724 0 N-CA-C 111.096 -0.802 . . . . 0.0 111.096 -179.765 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' B' B ' 39' ' ' ILE . . . . . . . . . . . . . 74.8 mt -130.58 131.0 65.16 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.237 0 N-CA-C 110.134 -0.321 . . . . 0.0 110.134 178.878 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' B' B ' 40' ' ' SER . . . . . . . . . . . . . 68.2 p -92.79 115.22 27.91 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 116.418 -0.355 . . . . 0.0 110.911 176.47 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' B' B ' 41' ' ' ILE . . . . . . . . . . . . . 44.0 mm -122.07 128.86 75.7 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.232 0 CA-C-N 116.476 -0.329 . . . . 0.0 110.276 -179.934 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' B' B ' 42' ' ' LEU . . . . . . . . . . . . . 49.9 mt 55.32 33.52 20.91 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.24 -0.436 . . . . 0.0 111.825 177.263 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' B' B ' 43' ' ' GLY . . . . . . . . . . . . . . . 72.56 27.62 69.09 Favored Glycine 0 CA--C 1.531 1.052 0 C-N-CA 121.203 -0.522 . . . . 0.0 112.393 177.646 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' B' B ' 44' ' ' LYS . . . . . . . . . . . . . 49.4 tptt -141.9 128.32 20.05 Favored 'General case' 0 C--N 1.331 -0.227 0 N-CA-C 109.65 -0.5 . . . . 0.0 109.65 177.832 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' B' B ' 45' ' ' GLU . . . . . . . . . . . . . 44.1 tp10 -82.93 128.06 34.1 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-O 120.891 0.377 . . . . 0.0 111.323 -176.147 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' B' B ' 46' ' ' VAL . . . . . . . . . . . . . 8.5 p -121.86 128.08 75.59 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.255 0 N-CA-C 109.5 -0.556 . . . . 0.0 109.5 174.765 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' B' B ' 47' ' ' LYS . . . . . . . . . . . . . 52.0 mtpt -98.86 127.26 44.74 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.011 -0.54 . . . . 0.0 110.616 177.41 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' B' B ' 48' ' ' PHE . . . . . . . . . . . . . 46.1 m-85 -111.05 131.84 54.74 Favored 'General case' 0 C--N 1.329 -0.309 0 N-CA-C 109.667 -0.494 . . . . 0.0 109.667 177.082 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' B' B ' 49' ' ' LYS . . . . . . . . . . . . . 77.5 tttt -104.71 133.32 49.75 Favored 'General case' 0 C--N 1.328 -0.327 0 N-CA-C 109.926 -0.398 . . . . 0.0 109.926 178.225 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' B' B ' 50' ' ' VAL . . . . . . . . . . . . . 42.3 t -77.76 105.45 6.8 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.28 0 N-CA-C 109.38 -0.6 . . . . 0.0 109.38 178.169 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' B' B ' 51' ' ' VAL . . . . . . . . . . . . . 49.8 t -73.02 -47.28 48.7 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.372 0 CA-C-N 116.061 -0.518 . . . . 0.0 109.879 -174.693 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' B' B ' 52' ' ' GLN . . . . . . . . . . . . . 62.1 tt0 -158.97 138.43 11.59 Favored 'General case' 0 C--N 1.33 -0.274 0 C-N-CA 120.417 -0.513 . . . . 0.0 111.486 -178.241 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' B' B ' 53' ' ' ALA . . . . . . . . . . . . . . . -117.13 130.7 56.8 Favored 'General case' 0 C--N 1.332 -0.193 0 CA-C-N 115.687 -0.688 . . . . 0.0 109.632 172.058 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' B' B ' 54' ' ' TYR . . . . . . . . . . . . . 57.9 t80 -129.18 112.17 18.29 Favored Pre-proline 0 CA--C 1.536 0.432 0 CA-C-O 118.189 -0.91 . . . . 0.0 110.359 178.933 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' B' B ' 55' ' ' PRO . . . . . . . . . . . . . 74.3 Cg_endo -77.11 168.89 75.76 Favored 'Cis proline' 0 N--CA 1.5 1.9 0 CA-C-N 121.973 1.74 . . . . 0.0 112.156 -6.002 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' B' B ' 56' ' ' SER . . . . . . . . . . . . . 13.5 m -116.6 134.88 22.84 Favored Pre-proline 0 CA--C 1.538 0.492 0 CA-C-O 118.478 -0.772 . . . . 0.0 109.456 175.881 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' B' B ' 57' ' ' PRO . . . . . . . . . . . . . 56.0 Cg_endo -72.11 146.73 86.87 Favored 'Cis proline' 0 N--CA 1.497 1.728 0 CA-C-N 121.842 1.694 . . . . 0.0 111.496 -2.229 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' B' B ' 58' ' ' LEU . . . . . . . . . . . . . 25.0 tp -108.35 136.81 47.36 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.378 -0.374 . . . . 0.0 110.832 -177.667 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' B' B ' 59' ' ' ARG . . . . . . . . . . . . . 29.0 ttm180 -100.51 125.9 46.89 Favored 'General case' 0 C--N 1.328 -0.34 0 N-CA-C 109.371 -0.603 . . . . 0.0 109.371 175.521 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' B' B ' 60' ' ' VAL . . . . . . . . . . . . . 40.8 t -78.04 121.73 31.44 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.247 0 C-N-CA 120.828 -0.349 . . . . 0.0 110.848 -174.798 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' B' B ' 61' ' ' GLU . . . . . . . . . . . . . 42.9 mt-10 -130.96 154.05 48.55 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 115.744 -0.662 . . . . 0.0 109.822 175.308 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' B' B ' 62' ' ' ASP . . . . . . . . . . . . . 19.8 p-10 -53.72 -33.64 56.26 Favored 'General case' 0 C--N 1.327 -0.397 0 N-CA-C 111.843 0.312 . . . . 0.0 111.843 -177.792 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' B' B ' 63' ' ' ARG . . . . . . . . . . . . . 36.5 mmt180 -75.66 -18.61 59.59 Favored 'General case' 0 CA--C 1.535 0.371 0 N-CA-C 113.099 0.778 . . . . 0.0 113.099 -175.969 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' B' B ' 64' ' ' THR . . . . . . . . . . . . . 24.0 m -67.2 147.91 52.46 Favored 'General case' 0 C--N 1.332 -0.172 0 CA-C-N 117.724 0.238 . . . . 0.0 110.48 -177.06 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' B' B ' 65' ' ' LYS . . . . . . . . . . . . . 98.4 mttt -87.61 122.95 31.95 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-O 120.937 0.398 . . . . 0.0 110.116 -179.648 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' B' B ' 66' ' ' ILE . . . . . . . . . . . . . 63.4 mt -108.57 120.27 59.64 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.26 0 N-CA-C 109.581 -0.526 . . . . 0.0 109.581 179.183 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' B' B ' 67' ' ' THR . . . . . . . . . . . . . 4.6 m -109.36 140.69 42.73 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-O 121.338 0.59 . . . . 0.0 111.132 -173.511 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' B' B ' 68' ' ' LEU . . . . . . . . . . . . . 7.0 tt . . . . . 0 C--N 1.329 -0.283 0 CA-C-N 115.202 -0.908 . . . . 0.0 110.121 -178.926 . . . . . . . . 0 0 . 1 . 019 nuclear build core ' B' B ' 73' ' ' VAL . . . . . . . . . . . . . 34.2 m . . . . . 0 CA--C 1.527 0.065 0 CA-C-O 120.755 0.312 . . . . 0.0 110.377 . . . . . . . . . 0 0 . 1 . 019 nuclear build core ' B' B ' 74' ' ' ASP . . . . . . . . . . . . . 26.4 t0 -78.85 123.89 27.68 Favored 'General case' 0 C--N 1.331 -0.205 0 CA-C-N 116.259 -0.428 . . . . 0.0 111.156 -165.058 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' B' B ' 75' ' ' VAL . . . . . . . . . . . . . 47.0 t -119.7 118.83 58.5 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.218 0 CA-C-N 116.138 -0.483 . . . . 0.0 110.098 -179.571 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' B' B ' 76' ' ' LEU . . . . . . . . . . . . . 23.8 mt -124.33 145.37 49.46 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 115.63 -0.714 . . . . 0.0 109.688 -179.966 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' B' B ' 77' ' ' GLU . . . . . . . . . . . . . 96.0 mt-10 -136.42 134.94 38.28 Favored 'General case' 0 C--N 1.331 -0.227 0 CA-C-O 121.056 0.455 . . . . 0.0 111.184 -178.606 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' B' B ' 78' ' ' ALA . . . . . . . . . . . . . . . -123.57 131.23 53.57 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 115.611 -0.722 . . . . 0.0 109.701 176.462 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' B' B ' 79' ' ' LYS . . . . . 0.608 ' O ' HD13 ' B' ' 80' ' ' ILE . 97.3 mttt -77.32 120.33 22.19 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-O 121.043 0.449 . . . . 0.0 111.266 -175.389 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' B' B ' 80' ' ' ILE . . . . . 0.608 HD13 ' O ' ' B' ' 79' ' ' LYS . 25.9 mm -139.27 101.14 1.49 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.256 0 N-CA-C 109.015 -0.735 . . . . 0.0 109.015 179.11 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' B' B ' 81' ' ' LYS . . . . . . . . . . . . . 68.6 tttt -93.06 124.6 37.15 Favored 'General case' 0 C--N 1.328 -0.332 0 C-N-CA 120.776 -0.37 . . . . 0.0 110.993 -177.01 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' B' B ' 82' ' ' GLY . . . . . . . . . . . . . . . 89.2 42.14 5.65 Favored Glycine 0 CA--C 1.524 0.641 0 C-N-CA 120.738 -0.744 . . . . 0.0 111.416 176.288 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' B' B ' 83' ' ' ILE . . . . . . . . . . . . . 72.1 mt -64.45 137.76 24.31 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.352 0 N-CA-C 109.91 -0.404 . . . . 0.0 109.91 177.884 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' B' B ' 84' ' ' LYS . . . . . . . . . . . . . 80.2 tttt -93.51 -51.38 4.98 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 115.932 -0.576 . . . . 0.0 110.001 -179.426 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' B' B ' 85' ' ' ASP . . . . . . . . . . . . . 9.9 t70 -159.87 153.59 22.78 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 115.514 -0.766 . . . . 0.0 110.062 179.558 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' B' B ' 86' ' ' VAL . . . . . . . . . . . . . 43.9 t -129.94 132.15 65.8 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.212 0 CA-C-O 121.021 0.438 . . . . 0.0 110.479 -179.166 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' B' B ' 87' ' ' ILE . . . . . . . . . . . . . 43.5 mm -120.12 125.38 74.17 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.265 0 CA-C-N 115.665 -0.698 . . . . 0.0 109.221 177.132 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' B' B ' 88' ' ' LEU . . . . . . . . . . . . . 12.0 tp -114.51 127.92 56.06 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-O 121.021 0.439 . . . . 0.0 111.254 -176.788 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' B' B ' 89' ' ' ASP . . . . . . . . . . . . . 11.2 t70 -117.81 153.66 33.1 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 115.702 -0.681 . . . . 0.0 109.407 175.931 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' B' B ' 90' ' ' GLU . . . . . . . . . . . . . 84.6 tt0 -47.78 -35.5 10.12 Favored 'General case' 0 C--N 1.33 -0.282 0 N-CA-C 112.869 0.692 . . . . 0.0 112.869 -172.836 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' B' B ' 91' ' ' ASN . . . . . . . . . . . . . 18.3 p-10 -132.06 31.36 4.16 Favored 'General case' 0 N--CA 1.466 0.326 0 N-CA-C 112.256 0.465 . . . . 0.0 112.256 -175.808 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' B' B ' 92' ' ' LEU . . . . . . . . . . . . . 6.7 tp -166.13 145.1 5.9 Favored 'General case' 0 C--N 1.331 -0.213 0 C-N-CA 120.934 -0.307 . . . . 0.0 110.54 -179.619 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' B' B ' 93' ' ' ILE . . . . . . . . . . . . . 68.8 mt -123.14 123.36 67.67 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.264 0 N-CA-C 109.704 -0.48 . . . . 0.0 109.704 -179.413 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' B' B ' 94' ' ' VAL . . . . . . . . . . . . . 43.5 t -121.38 124.96 73.04 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.239 0 CA-C-O 120.967 0.413 . . . . 0.0 110.024 179.689 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' B' B ' 95' ' ' VAL . . . . . . . . . . . . . 45.9 t -119.68 133.4 66.58 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.283 0 CA-C-N 115.917 -0.583 . . . . 0.0 109.928 -179.071 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' B' B ' 96' ' ' ILE . . . . . 0.666 HD11 ' HB ' ' B' ' 123' ' ' VAL . 61.8 mt -114.59 126.38 72.12 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.366 0 N-CA-C 109.467 -0.568 . . . . 0.0 109.467 178.988 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' B' B ' 97' ' ' THR . . . . . . . . . . . . . 67.4 p -95.94 156.21 16.43 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-O 120.99 0.424 . . . . 0.0 110.812 -179.267 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' B' B ' 98' ' ' GLU . . . . . . . . . . . . . 40.1 tp10 -53.92 -28.66 38.19 Favored 'General case' 0 C--N 1.329 -0.287 0 N-CA-C 112.144 0.424 . . . . 0.0 112.144 -178.401 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' B' B ' 99' ' ' GLU . . . . . . . . . . . . . 14.7 pt-20 -81.54 17.25 1.45 Allowed 'General case' 0 CA--C 1.535 0.373 0 N-CA-C 113.326 0.862 . . . . 0.0 113.326 -176.19 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' B' B ' 100' ' ' ASN . . . . . . . . . . . . . 4.9 m-20 64.89 34.65 9.0 Favored 'General case' 0 N--CA 1.463 0.216 0 CA-C-O 120.793 0.33 . . . . 0.0 111.678 176.959 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' B' B ' 101' ' ' GLU . . . . . . . . . . . . . 84.5 tt0 -108.84 141.78 40.38 Favored 'General case' 0 C--N 1.331 -0.2 0 N-CA-C 109.642 -0.503 . . . . 0.0 109.642 172.226 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' B' B ' 102' ' ' VAL . . . . . . . . . . . . . 46.3 t -114.96 125.9 72.41 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.308 0 N-CA-C 109.967 -0.382 . . . . 0.0 109.967 -177.846 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' B' B ' 103' ' ' LEU . . . . . . . . . . . . . 57.4 mt -117.26 129.79 56.14 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 115.845 -0.616 . . . . 0.0 110.13 177.944 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' B' B ' 104' ' ' ILE . . . . . 0.57 HD13 HG11 ' B' ' 130' ' ' VAL . 67.8 mt -118.31 120.84 65.6 Favored 'Isoleucine or valine' 0 C--O 1.234 0.289 0 N-CA-C 110.161 -0.311 . . . . 0.0 110.161 -178.976 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' B' B ' 105' ' ' PHE . . . . . . . . . . . . . 74.6 m-85 -123.53 165.16 17.6 Favored 'General case' 0 C--N 1.333 -0.15 0 O-C-N 123.92 0.763 . . . . 0.0 109.836 -179.252 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' B' B ' 106' ' ' ASN . . . . . . . . . . . . . 46.7 p-10 -99.51 -170.77 1.95 Allowed 'General case' 0 C--N 1.33 -0.274 0 N-CA-C 109.788 -0.449 . . . . 0.0 109.788 171.832 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' B' B ' 107' ' ' GLN . . . . . . . . . . . . . 51.0 tt0 -57.58 -27.64 62.87 Favored 'General case' 0 C--N 1.327 -0.373 0 N-CA-C 112.305 0.483 . . . . 0.0 112.305 -178.944 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' B' B ' 108' ' ' ASN . . . . . . . . . . . . . 14.4 t30 -93.5 14.31 19.11 Favored 'General case' 0 CA--C 1.535 0.379 0 N-CA-C 113.0 0.741 . . . . 0.0 113.0 -175.43 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' B' B ' 109' ' ' LEU . . . . . . . . . . . . . 71.1 mt 59.12 37.7 24.04 Favored 'General case' 0 C--N 1.332 -0.189 0 CA-C-O 121.067 0.461 . . . . 0.0 111.377 177.596 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' B' B ' 110' ' ' GLU . . . . . . . . . . . . . 43.4 mt-10 -103.46 163.43 12.29 Favored 'General case' 0 C--N 1.331 -0.225 0 CA-C-N 116.388 -0.369 . . . . 0.0 110.223 177.331 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' B' B ' 111' ' ' GLU . . . . . . . . . . . . . 82.6 tt0 -84.58 124.9 31.94 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-O 120.94 0.4 . . . . 0.0 111.243 -177.22 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' B' B ' 112' ' ' LEU . . . . . . . . . . . . . 20.0 mt -113.02 -45.99 3.14 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 115.905 -0.589 . . . . 0.0 109.6 172.84 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' B' B ' 113' ' ' TYR . . . . . 0.487 ' HB3' HD12 ' B' ' 104' ' ' ILE . 34.9 t80 -150.64 137.04 18.72 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.02 -0.536 . . . . 0.0 110.821 179.097 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' B' B ' 114' ' ' ARG . . . . . . . . . . . . . 57.0 mtm180 -140.39 124.4 17.46 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-O 120.733 0.302 . . . . 0.0 110.306 175.242 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' B' B ' 115' ' ' GLY . . . . . . . . . . . . . . . -150.15 162.9 29.36 Favored Glycine 0 CA--C 1.523 0.566 0 N-CA-C 110.632 -0.987 . . . . 0.0 110.632 -179.555 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' B' B ' 116' ' ' LYS . . . . . . . . . . . . . 82.7 tttt -133.37 130.83 39.32 Favored 'General case' 0 C--N 1.33 -0.278 0 N-CA-C 109.918 -0.401 . . . . 0.0 109.918 178.553 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' B' B ' 117' ' ' PHE . . . . . . . . . . . . . 46.5 m-85 -125.79 118.43 25.51 Favored 'General case' 0 C--N 1.331 -0.227 0 CA-C-O 121.015 0.436 . . . . 0.0 110.49 -174.862 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' B' B ' 118' ' ' GLU . . . . . . . . . . . . . 44.5 tp10 -52.83 -49.38 65.82 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.397 -0.365 . . . . 0.0 111.572 -176.979 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' B' B ' 119' ' ' ASN . . . . . . . . . . . . . 20.4 m120 -95.76 31.21 2.12 Favored 'General case' 0 C--N 1.33 -0.253 0 N-CA-C 112.11 0.411 . . . . 0.0 112.11 -174.803 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' B' B ' 120' ' ' LEU . . . . . . . . . . . . . 13.7 tp -55.04 123.38 13.4 Favored 'General case' 0 N--CA 1.462 0.134 0 CA-C-O 120.711 0.291 . . . . 0.0 110.769 178.282 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' B' B ' 121' ' ' ASN . . . . . . . . . . . . . 60.5 t30 -113.58 -44.01 3.25 Favored 'General case' 0 C--N 1.332 -0.184 0 CA-C-N 116.337 -0.392 . . . . 0.0 110.822 -177.742 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' B' B ' 122' ' ' LYS . . . . . . . . . . . . . 97.8 mttt -148.53 150.72 33.87 Favored 'General case' 0 C--N 1.331 -0.229 0 CA-C-O 121.119 0.485 . . . . 0.0 111.562 -178.434 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' B' B ' 123' ' ' VAL . . . . . 0.666 ' HB ' HD11 ' B' ' 96' ' ' ILE . 47.4 t -131.74 129.35 61.19 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.224 0 N-CA-C 109.325 -0.62 . . . . 0.0 109.325 174.812 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' B' B ' 124' ' ' LEU . . . . . . . . . . . . . 67.3 mt -130.87 142.65 50.39 Favored 'General case' 0 C--N 1.331 -0.203 0 CA-C-O 120.959 0.409 . . . . 0.0 110.769 -177.438 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' B' B ' 125' ' ' VAL . . . . . . . . . . . . . 12.1 p -135.7 138.32 48.07 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.255 0 CA-C-N 116.005 -0.543 . . . . 0.0 110.555 179.946 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' B' B ' 126' ' ' ARG . . . . . . . . . . . . . 75.3 mtt180 -148.08 121.95 9.35 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 115.838 -0.619 . . . . 0.0 109.393 178.04 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' B' B ' 127' ' ' ASN . . . . . . . . . . . . . 71.6 m-80 57.04 -147.44 0.52 Allowed 'General case' 0 CA--C 1.541 0.614 0 N-CA-C 109.602 -0.518 . . . . 0.0 109.602 -178.278 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' B' B ' 128' ' ' ASP . . . . . . . . . . . . . 23.1 p-10 -83.44 12.62 5.3 Favored 'General case' 0 CA--C 1.537 0.464 0 CA-C-N 118.845 0.748 . . . . 0.0 112.989 179.199 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' B' B ' 129' ' ' LEU . . . . . . . . . . . . . 19.6 tp -109.03 136.45 48.53 Favored 'General case' 0 C--O 1.231 0.084 0 N-CA-C 109.747 -0.464 . . . . 0.0 109.747 178.32 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' B' B ' 130' ' ' VAL . . . . . 0.57 HG11 HD13 ' B' ' 104' ' ' ILE . 12.3 p -131.3 141.76 45.12 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.213 0 CA-C-O 120.982 0.42 . . . . 0.0 110.637 -178.806 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' B' B ' 131' ' ' VAL . . . . . 0.553 HG22 HD12 ' B' ' 140' ' ' LEU . 41.5 t -136.14 138.37 47.3 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 CA-C-N 116.021 -0.536 . . . . 0.0 110.495 -178.741 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' B' B ' 132' ' ' ILE . . . . . . . . . . . . . 73.1 mt -116.79 133.64 62.82 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.323 0 CA-C-N 115.591 -0.731 . . . . 0.0 109.244 178.448 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' B' B ' 133' ' ' ILE . . . . . . . . . . . . . 41.1 mm -115.94 120.81 65.9 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.268 0 CA-C-O 120.714 0.293 . . . . 0.0 111.018 -175.521 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' B' B ' 134' ' ' ASP . . . . . . . . . . . . . 7.5 p-10 -131.98 144.98 51.19 Favored 'General case' 0 C--N 1.33 -0.262 0 N-CA-C 109.433 -0.58 . . . . 0.0 109.433 175.124 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' B' B ' 135' ' ' GLU . . . . . . . . . . . . . 83.7 tt0 -50.06 -26.23 4.2 Favored 'General case' 0 C--N 1.328 -0.348 0 N-CA-C 112.861 0.689 . . . . 0.0 112.861 -173.682 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' B' B ' 136' ' ' GLN . . . . . . . . . . . . . 97.1 mt-30 -78.51 -35.8 45.81 Favored 'General case' 0 C--O 1.234 0.245 0 N-CA-C 112.058 0.392 . . . . 0.0 112.058 -177.465 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' B' B ' 137' ' ' LYS . . . . . . . . . . . . . 56.2 pttt -170.0 173.66 5.89 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-O 121.426 0.631 . . . . 0.0 111.907 -172.613 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' B' B ' 138' ' ' LEU . . . . . 0.422 ' C ' HD23 ' B' ' 138' ' ' LEU . 8.2 tt -116.31 130.14 56.63 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 115.415 -0.811 . . . . 0.0 110.136 179.557 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' B' B ' 139' ' ' THR . . . . . . . . . . . . . 25.8 m -108.07 124.35 50.07 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.069 -0.514 . . . . 0.0 110.501 179.995 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' B' B ' 140' ' ' LEU . . . . . 0.553 HD12 HG22 ' B' ' 131' ' ' VAL . 49.7 tp -113.08 121.07 43.48 Favored 'General case' 0 C--N 1.328 -0.351 0 N-CA-C 109.094 -0.706 . . . . 0.0 109.094 -179.241 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' B' B ' 141' ' ' ILE . . . . . 0.494 ' HB ' HG13 ' B' ' 130' ' ' VAL . 19.0 mt -121.23 121.1 63.95 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.309 0 CA-C-O 120.985 0.422 . . . . 0.0 110.189 -175.261 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' B' B ' 142' ' ' ARG . . . . . . . . . . . . . 61.4 mtp180 -105.21 120.81 42.45 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 115.15 -0.932 . . . . 0.0 109.985 179.363 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' B' B ' 143' ' ' THR . . . . . . . . . . . . . 35.9 p . . . . . 0 C--O 1.22 -0.486 0 CA-C-O 118.065 -0.969 . . . . 0.0 110.604 -179.697 . . . . . . . . 0 0 . 1 . 019 nuclear build core ' C' C ' 2' ' ' SER . . . . . . . . . . . . . 3.1 p . . . . . 0 C--O 1.232 0.149 0 CA-C-O 121.043 0.449 . . . . 0.0 110.351 . . . . . . . . . 0 0 . 1 . 019 nuclear build core ' C' C ' 3' ' ' GLU . . . . . . . . . . . . . 84.8 tt0 -141.24 141.61 33.99 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 115.89 -0.595 . . . . 0.0 110.954 -178.891 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' C' C ' 4' ' ' LEU . . . . . . . . . . . . . 19.2 tp -126.14 129.08 48.35 Favored 'General case' 0 C--N 1.331 -0.216 0 CA-C-N 115.866 -0.606 . . . . 0.0 110.257 177.73 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' C' C ' 5' ' ' LYS . . . . . . . . . . . . . 66.9 mttm -105.35 120.96 42.88 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.255 -0.429 . . . . 0.0 110.543 178.728 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' C' C ' 6' ' ' LEU . . . . . . . . . . . . . 55.1 mt -116.56 146.53 42.57 Favored 'General case' 0 C--N 1.331 -0.23 0 O-C-N 123.831 0.707 . . . . 0.0 110.109 -179.703 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' C' C ' 7' ' ' LYS . . . . . . . . . . . . . 49.8 tttp -126.83 137.67 30.99 Favored Pre-proline 0 CA--C 1.534 0.329 0 CA-C-O 118.901 -0.571 . . . . 0.0 109.912 175.664 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' C' C ' 8' ' ' PRO . . . . . . . . . . . . . 89.8 Cg_endo -92.1 131.72 1.17 Allowed 'Trans proline' 0 N--CA 1.489 1.257 0 C-N-CA 121.661 1.574 . . . . 0.0 111.673 178.016 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' C' C ' 9' ' ' LEU . . . . . . . . . . . . . 64.8 mt -70.98 -46.59 15.0 Favored Pre-proline 0 CA--C 1.533 0.303 0 CA-C-O 118.808 -0.615 . . . . 0.0 112.191 -179.053 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' C' C ' 10' ' ' PRO . . . . . . . . . . . . . 85.8 Cg_endo -81.79 147.89 15.47 Favored 'Trans proline' 0 N--CA 1.495 1.617 0 C-N-CA 121.237 1.291 . . . . 0.0 111.574 174.26 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' C' C ' 11' ' ' LYS . . . . . . . . . . . . . 60.7 tttm -88.14 96.54 10.57 Favored 'General case' 0 C--N 1.33 -0.254 0 C-N-CA 120.862 -0.335 . . . . 0.0 110.455 179.145 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' C' C ' 12' ' ' VAL . . . . . . . . . . . . . 12.5 p -140.06 146.78 24.35 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.321 0 CA-C-N 116.241 -0.436 . . . . 0.0 110.512 -179.79 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' C' C ' 13' ' ' GLU . . . . . . . . . . . . . 81.4 tt0 -85.86 125.8 33.57 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.243 -0.435 . . . . 0.0 110.008 177.949 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' C' C ' 14' ' ' LEU . . . . . . . . . . . . . 17.6 mt -96.94 149.63 35.94 Favored Pre-proline 0 CA--C 1.532 0.263 0 CA-C-O 119.262 -0.399 . . . . 0.0 110.366 -178.708 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' C' C ' 15' ' ' PRO . . . . . . . . . . . . . 26.1 Cg_exo -61.76 160.65 28.01 Favored 'Trans proline' 0 N--CA 1.497 1.732 0 C-N-CA 121.23 1.287 . . . . 0.0 111.852 177.496 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' C' C ' 16' ' ' PRO . . . . . . . . . . . . . 34.0 Cg_exo -59.5 -34.01 97.07 Favored 'Trans proline' 0 N--CA 1.498 1.754 0 C-N-CA 121.437 1.425 . . . . 0.0 112.714 -178.127 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' C' C ' 17' ' ' ASP . . . . . . . . . . . . . 18.5 p-10 -87.88 3.58 47.91 Favored 'General case' 0 CA--C 1.536 0.435 0 N-CA-C 113.409 0.892 . . . . 0.0 113.409 -177.042 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' C' C ' 18' ' ' PHE . . . . . . . . . . . . . 43.3 t80 -58.18 -46.5 85.64 Favored 'General case' 0 C--N 1.334 -0.091 0 O-C-N 122.046 -0.409 . . . . 0.0 110.098 -177.689 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' C' C ' 19' ' ' VAL . . . . . . . . . . . . . 47.8 t -56.75 -43.0 78.59 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.372 0 CA-C-N 116.27 -0.423 . . . . 0.0 110.608 -177.895 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' C' C ' 20' ' ' ASP . . . . . . . . . . . . . 67.7 m-20 -59.66 -43.0 94.11 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-O 120.786 0.327 . . . . 0.0 110.813 -177.549 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' C' C ' 21' ' ' VAL . . . . . . . . . . . . . 46.2 t -64.01 -45.41 96.78 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.32 0 C-N-CA 120.818 -0.353 . . . . 0.0 110.425 -177.848 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' C' C ' 22' ' ' ILE . . . . . 0.547 HG22 HD12 ' C' ' 26' ' ' LEU . 51.8 mm -54.96 -48.44 75.26 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.276 0 C-N-CA 120.993 -0.283 . . . . 0.0 110.743 179.032 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' C' C ' 23' ' ' ARG . . . . . . . . . . . . . 54.3 ttp180 -54.65 -47.93 72.93 Favored 'General case' 0 C--N 1.33 -0.258 0 C-N-CA 121.022 -0.271 . . . . 0.0 111.355 -178.328 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' C' C ' 24' ' ' ILE . . . . . . . . . . . . . 74.2 mt -59.11 -42.89 87.98 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.34 0 C-N-CA 121.184 -0.206 . . . . 0.0 111.208 -177.901 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' C' C ' 25' ' ' LYS . . . . . . . . . . . . . 73.9 mmtt -66.68 -41.37 88.21 Favored 'General case' 0 C--N 1.328 -0.335 0 N-CA-C 112.253 0.464 . . . . 0.0 112.253 -178.428 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' C' C ' 26' ' ' LEU . . . . . 0.547 HD12 HG22 ' C' ' 22' ' ' ILE . 83.1 mt -79.22 -38.76 34.9 Favored 'General case' 0 C--N 1.328 -0.332 0 N-CA-C 113.283 0.845 . . . . 0.0 113.283 -169.872 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' C' C ' 27' ' ' GLN . . . . . . . . . . . . . 17.2 pt20 -47.06 140.05 5.28 Favored 'General case' 0 N--CA 1.468 0.444 0 N-CA-C 112.78 0.659 . . . . 0.0 112.78 -175.831 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' C' C ' 28' ' ' GLY . . . . . . . . . . . . . . . 99.15 -25.7 27.21 Favored Glycine 0 CA--C 1.533 1.159 0 CA-C-N 115.687 -0.688 . . . . 0.0 112.297 -177.013 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' C' C ' 29' ' ' LYS . . . . . . . . . . . . . 87.5 mttt -97.89 155.11 17.22 Favored 'General case' 0 C--N 1.331 -0.199 0 CA-C-N 117.357 0.579 . . . . 0.0 111.053 179.362 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' C' C ' 30' ' ' THR . . . . . . . . . . . . . 26.2 m -103.79 138.3 40.59 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.133 -0.485 . . . . 0.0 110.1 176.696 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' C' C ' 31' ' ' VAL . . . . . . . . . . . . . 34.4 m -129.85 151.14 35.39 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.201 0 CA-C-O 120.868 0.366 . . . . 0.0 110.986 -178.429 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' C' C ' 32' ' ' ARG . . . . . . . . . . . . . 71.3 mtt85 -127.91 149.19 50.42 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 115.971 -0.558 . . . . 0.0 110.489 178.743 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' C' C ' 33' ' ' THR . . . . . . . . . . . . . 30.3 m -53.18 138.76 30.85 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.43 -0.35 . . . . 0.0 111.375 -179.175 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' C' C ' 34' ' ' GLY . . . . . . . . . . . . . . . 100.23 -17.2 57.32 Favored Glycine 0 CA--C 1.533 1.159 0 C-N-CA 121.307 -0.473 . . . . 0.0 113.223 179.266 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' C' C ' 35' ' ' ASP . . . . . . . . . . . . . 76.2 m-20 -66.63 149.3 50.69 Favored 'General case' 0 N--CA 1.462 0.151 0 CA-C-N 117.967 0.883 . . . . 0.0 111.155 179.361 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' C' C ' 36' ' ' VAL . . . . . . . . . . . . . 44.6 t -119.3 128.99 75.83 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.26 0 CA-C-N 115.845 -0.616 . . . . 0.0 109.674 177.929 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' C' C ' 37' ' ' ILE . . . . . . . . . . . . . 65.6 mt -119.83 138.28 50.95 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.271 0 CA-C-N 116.151 -0.477 . . . . 0.0 109.804 -179.466 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' C' C ' 38' ' ' GLY . . . . . . . . . . . . . . . -116.9 128.71 8.02 Favored Glycine 0 CA--C 1.525 0.667 0 N-CA-C 111.121 -0.792 . . . . 0.0 111.121 -179.653 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' C' C ' 39' ' ' ILE . . . . . . . . . . . . . 70.7 mt -127.0 127.05 69.35 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.256 0 N-CA-C 109.961 -0.385 . . . . 0.0 109.961 178.268 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' C' C ' 40' ' ' SER . . . . . . . . . . . . . 59.6 p -91.41 113.94 26.34 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.561 -0.29 . . . . 0.0 110.988 177.773 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' C' C ' 41' ' ' ILE . . . . . . . . . . . . . 45.5 mm -123.3 128.14 74.69 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.248 0 CA-C-N 116.408 -0.36 . . . . 0.0 110.063 179.694 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' C' C ' 42' ' ' LEU . . . . . . . . . . . . . 69.8 mt 58.02 33.86 23.63 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 116.194 -0.457 . . . . 0.0 111.779 176.934 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' C' C ' 43' ' ' GLY . . . . . . . . . . . . . . . 73.11 21.81 79.5 Favored Glycine 0 CA--C 1.533 1.195 0 C-N-CA 121.227 -0.511 . . . . 0.0 112.89 177.623 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' C' C ' 44' ' ' LYS . . . . . . . . . . . . . 67.6 mttm -138.25 130.54 28.88 Favored 'General case' 0 C--N 1.332 -0.16 0 CA-C-N 117.41 0.605 . . . . 0.0 109.919 177.548 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' C' C ' 45' ' ' GLU . . . . . . . . . . . . . 43.5 tp10 -84.06 127.26 33.78 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.367 -0.379 . . . . 0.0 111.413 -177.545 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' C' C ' 46' ' ' VAL . . . . . . . . . . . . . 8.9 p -116.06 127.3 73.7 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.282 0 N-CA-C 109.249 -0.648 . . . . 0.0 109.249 173.312 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' C' C ' 47' ' ' LYS . . . . . . . . . . . . . 64.8 mttp -98.07 126.16 43.38 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 116.104 -0.498 . . . . 0.0 110.787 178.715 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' C' C ' 48' ' ' PHE . . . . . . . . . . . . . 34.2 m-85 -110.82 131.88 54.67 Favored 'General case' 0 C--N 1.328 -0.345 0 N-CA-C 109.453 -0.573 . . . . 0.0 109.453 177.159 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' C' C ' 49' ' ' LYS . . . . . . . . . . . . . 45.2 tttp -105.65 133.27 50.67 Favored 'General case' 0 C--N 1.328 -0.354 0 N-CA-C 110.085 -0.339 . . . . 0.0 110.085 178.831 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' C' C ' 50' ' ' VAL . . . . . . . . . . . . . 46.2 t -75.79 102.4 2.83 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.324 0 N-CA-C 109.189 -0.671 . . . . 0.0 109.189 176.669 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' C' C ' 51' ' ' VAL . . . . . . . . . . . . . 47.0 t -70.03 -48.18 64.22 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.279 0 CA-C-N 116.005 -0.543 . . . . 0.0 109.895 -174.293 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' C' C ' 52' ' ' GLN . . . . . . . . . . . . . 62.0 tt0 -160.14 138.92 10.54 Favored 'General case' 0 C--N 1.33 -0.252 0 C-N-CA 120.382 -0.527 . . . . 0.0 111.631 -178.8 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' C' C ' 53' ' ' ALA . . . . . 0.447 ' HB3' ' OG ' ' C' ' 56' ' ' SER . . . -111.55 130.97 55.57 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 115.665 -0.698 . . . . 0.0 109.806 176.012 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' C' C ' 54' ' ' TYR . . . . . . . . . . . . . 45.7 t80 -128.93 107.32 18.19 Favored Pre-proline 0 CA--C 1.535 0.395 0 CA-C-O 118.335 -0.841 . . . . 0.0 110.54 -179.04 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' C' C ' 55' ' ' PRO . . . . . . . . . . . . . 73.7 Cg_endo -77.12 170.04 72.65 Favored 'Cis proline' 0 N--CA 1.499 1.81 0 CA-C-N 121.784 1.673 . . . . 0.0 112.355 -6.158 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' C' C ' 56' ' ' SER . . . . . 0.447 ' OG ' ' HB3' ' C' ' 53' ' ' ALA . 69.8 m -117.06 132.33 23.52 Favored Pre-proline 0 CA--C 1.539 0.544 0 CA-C-O 118.492 -0.766 . . . . 0.0 109.476 175.371 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' C' C ' 57' ' ' PRO . . . . . . . . . . . . . 44.2 Cg_endo -69.35 147.4 83.72 Favored 'Cis proline' 0 N--CA 1.498 1.767 0 CA-C-N 121.909 1.718 . . . . 0.0 111.335 -1.46 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' C' C ' 58' ' ' LEU . . . . . . . . . . . . . 27.0 tp -107.06 136.63 46.59 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.372 -0.377 . . . . 0.0 110.68 -178.017 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' C' C ' 59' ' ' ARG . . . . . . . . . . . . . 75.4 ttt180 -102.12 120.79 41.02 Favored 'General case' 0 C--N 1.325 -0.482 0 N-CA-C 109.364 -0.606 . . . . 0.0 109.364 176.27 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' C' C ' 60' ' ' VAL . . . . . . . . . . . . . 40.8 t -74.31 122.09 26.9 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.268 0 C-N-CA 120.633 -0.427 . . . . 0.0 110.09 -176.021 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' C' C ' 61' ' ' GLU . . . . . . . . . . . . . 32.4 tp10 -130.72 157.78 41.87 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 115.994 -0.548 . . . . 0.0 109.759 -178.409 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' C' C ' 62' ' ' ASP . . . . . . . . . . . . . 35.7 m-20 -53.22 -32.5 48.51 Favored 'General case' 0 C--N 1.326 -0.417 0 N-CA-C 111.762 0.282 . . . . 0.0 111.762 179.947 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' C' C ' 63' ' ' ARG . . . . . . . . . . . . . 9.5 ptm180 -86.25 6.56 29.07 Favored 'General case' 0 CA--C 1.535 0.397 0 N-CA-C 113.551 0.945 . . . . 0.0 113.551 -177.522 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' C' C ' 64' ' ' THR . . . . . . . . . . . . . 37.6 m -83.58 137.87 33.64 Favored 'General case' 0 C--N 1.332 -0.166 0 CA-C-N 118.095 0.407 . . . . 0.0 110.569 -178.144 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' C' C ' 65' ' ' LYS . . . . . . . . . . . . . 53.4 mtmt -89.67 127.27 35.9 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 116.016 -0.538 . . . . 0.0 110.279 178.232 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' C' C ' 66' ' ' ILE . . . . . . . . . . . . . 64.1 mt -113.52 125.72 70.84 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.288 0 N-CA-C 109.413 -0.588 . . . . 0.0 109.413 178.957 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' C' C ' 67' ' ' THR . . . . . . . . . . . . . 20.9 m -125.21 143.67 50.83 Favored 'General case' 0 C--N 1.331 -0.208 0 CA-C-O 121.139 0.495 . . . . 0.0 111.221 -175.858 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' C' C ' 68' ' ' LEU . . . . . 0.433 HD12 ' N ' ' C' ' 68' ' ' LEU . 7.8 mp . . . . . 0 C--N 1.329 -0.295 0 CA-C-N 115.738 -0.665 . . . . 0.0 110.129 176.471 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' C' C ' 73' ' ' VAL . . . . . . . . . . . . . 35.8 m . . . . . 0 C--O 1.231 0.088 0 CA-C-O 120.828 0.347 . . . . 0.0 110.354 . . . . . . . . . 0 0 . 1 . 019 nuclear build core ' C' C ' 74' ' ' ASP . . . . . . . . . . . . . 29.4 t0 -101.06 117.53 35.2 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.253 -0.43 . . . . 0.0 110.071 -178.802 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' C' C ' 75' ' ' VAL . . . . . . . . . . . . . 43.5 t -111.48 120.95 63.13 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.241 0 CA-C-O 120.992 0.425 . . . . 0.0 110.315 -179.266 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' C' C ' 76' ' ' LEU . . . . . . . . . . . . . 29.5 mt -123.42 145.41 48.81 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 115.869 -0.605 . . . . 0.0 109.604 179.212 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' C' C ' 77' ' ' GLU . . . . . . . . . . . . . 45.4 mt-10 -136.83 135.47 37.96 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-O 121.035 0.445 . . . . 0.0 111.149 -177.25 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' C' C ' 78' ' ' ALA . . . . . 0.573 ' HB2' HD21 ' C' ' 109' ' ' LEU . . . -122.17 125.84 47.0 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 115.615 -0.721 . . . . 0.0 109.465 176.862 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' C' C ' 79' ' ' LYS . . . . . 0.58 ' O ' HD13 ' C' ' 80' ' ' ILE . 47.4 pttt -78.63 119.86 22.49 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-O 121.437 0.637 . . . . 0.0 111.208 -175.781 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' C' C ' 80' ' ' ILE . . . . . 0.58 HD13 ' O ' ' C' ' 79' ' ' LYS . 38.8 mm -139.39 110.25 4.57 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.246 0 CA-C-N 115.478 -0.783 . . . . 0.0 108.993 -179.832 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' C' C ' 81' ' ' LYS . . . . . . . . . . . . . 25.1 mtpp -97.77 123.99 41.94 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-O 120.894 0.378 . . . . 0.0 111.097 -177.977 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' C' C ' 82' ' ' GLY . . . . . . . . . . . . . . . 89.19 42.22 5.63 Favored Glycine 0 CA--C 1.527 0.839 0 C-N-CA 120.85 -0.691 . . . . 0.0 111.604 175.8 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' C' C ' 83' ' ' ILE . . . . . . . . . . . . . 69.2 mt -65.24 136.58 26.45 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.35 0 N-CA-C 109.732 -0.469 . . . . 0.0 109.732 177.477 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' C' C ' 84' ' ' LYS . . . . . . . . . . . . . 26.9 ttmt -88.64 -48.74 7.33 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.136 -0.484 . . . . 0.0 110.114 -179.508 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' C' C ' 85' ' ' ASP . . . . . . . . . . . . . 4.6 t70 -162.97 157.69 21.34 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 115.799 -0.637 . . . . 0.0 110.537 179.311 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' C' C ' 86' ' ' VAL . . . . . . . . . . . . . 41.1 t -130.22 133.81 63.56 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.277 0 CA-C-O 120.984 0.421 . . . . 0.0 110.469 -178.535 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' C' C ' 87' ' ' ILE . . . . . 0.498 ' N ' HD12 ' C' ' 87' ' ' ILE . 5.0 mp -119.36 125.97 74.91 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.257 0 CA-C-N 115.848 -0.615 . . . . 0.0 109.474 176.993 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' C' C ' 88' ' ' LEU . . . . . . . . . . . . . 54.5 mt -110.52 135.6 50.94 Favored 'General case' 0 C--N 1.332 -0.187 0 CA-C-O 120.998 0.427 . . . . 0.0 111.495 -176.776 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' C' C ' 89' ' ' ASP . . . . . . . . . . . . . 9.0 t70 -131.46 153.16 50.04 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 115.777 -0.647 . . . . 0.0 109.554 174.802 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' C' C ' 90' ' ' GLU . . . . . . . . . . . . . 95.4 mt-10 -48.33 -38.58 19.46 Favored 'General case' 0 C--N 1.33 -0.274 0 N-CA-C 112.666 0.617 . . . . 0.0 112.666 -172.858 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' C' C ' 91' ' ' ASN . . . . . . . . . . . . . 0.8 OUTLIER -132.02 36.82 3.64 Favored 'General case' 0 N--CA 1.463 0.221 0 CA-C-O 120.807 0.336 . . . . 0.0 111.404 -177.294 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' C' C ' 92' ' ' LEU . . . . . . . . . . . . . 13.1 tp -166.07 142.85 5.18 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.578 -0.283 . . . . 0.0 110.626 -179.155 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' C' C ' 93' ' ' ILE . . . . . . . . . . . . . 67.0 mt -127.47 122.16 58.79 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.262 0 N-CA-C 109.461 -0.57 . . . . 0.0 109.461 178.741 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' C' C ' 94' ' ' VAL . . . . . 0.423 HG21 HG21 ' C' ' 125' ' ' VAL . 44.9 t -120.8 125.47 74.1 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.228 0 N-CA-C 109.757 -0.46 . . . . 0.0 109.757 179.252 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' C' C ' 95' ' ' VAL . . . . . . . . . . . . . 45.1 t -119.87 132.61 69.13 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.264 0 CA-C-N 116.015 -0.538 . . . . 0.0 109.77 -179.642 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' C' C ' 96' ' ' ILE . . . . . . . . . . . . . 65.9 mt -113.48 125.19 70.71 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.34 0 N-CA-C 109.106 -0.702 . . . . 0.0 109.106 179.025 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' C' C ' 97' ' ' THR . . . . . . . . . . . . . 73.0 p -99.74 151.43 21.24 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-O 121.118 0.485 . . . . 0.0 111.183 -177.185 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' C' C ' 98' ' ' GLU . . . . . . . . . . . . . 85.6 tt0 -53.87 -24.98 17.69 Favored 'General case' 0 C--N 1.33 -0.265 0 N-CA-C 112.343 0.497 . . . . 0.0 112.343 -179.603 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' C' C ' 99' ' ' GLU . . . . . . . . . . . . . 71.1 mm-40 -79.31 16.35 1.02 Allowed 'General case' 0 CA--C 1.534 0.356 0 N-CA-C 113.033 0.753 . . . . 0.0 113.033 -178.102 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' C' C ' 100' ' ' ASN . . . . . . . . . . . . . 4.5 m-20 64.19 37.95 8.49 Favored 'General case' 0 C--O 1.233 0.222 0 CA-C-O 121.0 0.428 . . . . 0.0 111.076 177.326 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' C' C ' 101' ' ' GLU . . . . . . . . . . . . . 84.2 tt0 -118.29 143.65 46.43 Favored 'General case' 0 C--N 1.333 -0.145 0 CA-C-N 116.1 -0.5 . . . . 0.0 109.795 176.711 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' C' C ' 102' ' ' VAL . . . . . . . . . . . . . 42.8 t -115.04 126.11 72.54 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.335 0 CA-C-N 116.434 -0.348 . . . . 0.0 110.063 -178.689 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' C' C ' 103' ' ' LEU . . . . . 0.434 HD23 ' HG3' ' C' ' 114' ' ' ARG . 15.1 mt -115.57 126.87 54.76 Favored 'General case' 0 C--N 1.331 -0.205 0 CA-C-N 115.484 -0.78 . . . . 0.0 110.028 176.873 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' C' C ' 104' ' ' ILE . . . . . . . . . . . . . 68.4 mt -119.22 121.11 65.8 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.275 0 N-CA-C 110.293 -0.262 . . . . 0.0 110.293 -179.973 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' C' C ' 105' ' ' PHE . . . . . . . . . . . . . 35.7 m-85 -125.35 167.05 15.47 Favored 'General case' 0 C--N 1.334 -0.105 0 O-C-N 123.838 0.711 . . . . 0.0 110.166 179.788 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' C' C ' 106' ' ' ASN . . . . . . . . . . . . . 41.3 p-10 -99.95 -169.79 1.79 Allowed 'General case' 0 C--N 1.33 -0.254 0 N-CA-C 110.01 -0.367 . . . . 0.0 110.01 174.399 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' C' C ' 107' ' ' GLN . . . . . . . . . . . . . 46.5 tt0 -58.36 -29.46 66.01 Favored 'General case' 0 C--N 1.329 -0.318 0 N-CA-C 112.006 0.373 . . . . 0.0 112.006 179.421 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' C' C ' 108' ' ' ASN . . . . . . . . . . . . . 10.3 t30 -86.75 13.01 9.51 Favored 'General case' 0 CA--C 1.536 0.435 0 N-CA-C 113.051 0.76 . . . . 0.0 113.051 -177.977 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' C' C ' 109' ' ' LEU . . . . . 0.573 HD21 ' HB2' ' C' ' 78' ' ' ALA . 7.9 tp 55.67 37.83 29.37 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-O 120.947 0.403 . . . . 0.0 111.36 178.277 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' C' C ' 110' ' ' GLU . . . . . . . . . . . . . 96.0 mt-10 -103.04 156.85 17.39 Favored 'General case' 0 C--N 1.33 -0.255 0 N-CA-C 109.832 -0.433 . . . . 0.0 109.832 175.947 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' C' C ' 111' ' ' GLU . . . . . . . . . . . . . 84.6 tt0 -84.31 121.99 28.29 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-O 120.952 0.406 . . . . 0.0 111.127 -176.852 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' C' C ' 112' ' ' LEU . . . . . . . . . . . . . 27.2 mt -105.72 -46.11 4.23 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-N 115.979 -0.555 . . . . 0.0 110.057 176.586 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' C' C ' 113' ' ' TYR . . . . . . . . . . . . . 59.6 t80 -145.49 138.88 26.42 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.048 -0.523 . . . . 0.0 110.856 -179.689 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' C' C ' 114' ' ' ARG . . . . . 0.434 ' HG3' HD23 ' C' ' 103' ' ' LEU . 27.1 ttm180 -141.88 126.29 17.7 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.32 -0.4 . . . . 0.0 110.266 176.965 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' C' C ' 115' ' ' GLY . . . . . . . . . . . . . . . -150.21 160.82 28.7 Favored Glycine 0 CA--C 1.524 0.597 0 N-CA-C 111.101 -0.799 . . . . 0.0 111.101 179.333 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' C' C ' 116' ' ' LYS . . . . . . . . . . . . . 38.9 ttpt -130.39 134.18 46.95 Favored 'General case' 0 C--N 1.33 -0.253 0 N-CA-C 110.035 -0.357 . . . . 0.0 110.035 177.24 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' C' C ' 117' ' ' PHE . . . . . 0.414 ' HE2' HD13 ' C' ' 132' ' ' ILE . 47.5 m-85 -126.99 118.64 24.9 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.333 -0.394 . . . . 0.0 110.464 -176.337 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' C' C ' 118' ' ' GLU . . . . . . . . . . . . . 95.9 mt-10 -51.86 -51.61 55.48 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.39 -0.368 . . . . 0.0 111.697 -175.629 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' C' C ' 119' ' ' ASN . . . . . . . . . . . . . 70.5 m-80 -98.03 31.01 2.84 Favored 'General case' 0 C--N 1.329 -0.294 0 N-CA-C 112.19 0.441 . . . . 0.0 112.19 -173.485 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' C' C ' 120' ' ' LEU . . . . . 0.477 HD23 ' C ' ' C' ' 120' ' ' LEU . 6.5 tt -56.27 121.3 9.2 Favored 'General case' 0 C--N 1.333 -0.129 0 CA-C-O 120.727 0.299 . . . . 0.0 110.562 178.751 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' C' C ' 121' ' ' ASN . . . . . . . . . . . . . 30.9 m120 -114.03 -44.12 3.18 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 116.364 -0.38 . . . . 0.0 111.159 -176.44 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' C' C ' 122' ' ' LYS . . . . . . . . . . . . . 55.2 mtmt -142.87 150.73 40.24 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-O 121.149 0.499 . . . . 0.0 111.513 -176.379 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' C' C ' 123' ' ' VAL . . . . . . . . . . . . . 45.8 t -130.38 133.46 63.84 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.228 0 CA-C-N 115.863 -0.608 . . . . 0.0 109.653 177.812 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' C' C ' 124' ' ' LEU . . . . . . . . . . . . . 30.1 mt -125.14 127.78 47.38 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.468 -0.333 . . . . 0.0 110.416 -179.852 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' C' C ' 125' ' ' VAL . . . . . 0.423 HG21 HG21 ' C' ' 94' ' ' VAL . 43.0 t -132.57 131.09 60.04 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.262 0 CA-C-N 116.183 -0.462 . . . . 0.0 109.97 -179.829 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' C' C ' 126' ' ' ARG . . . . . . . . . . . . . 78.1 mtt180 -145.95 119.77 9.28 Favored 'General case' 0 C--N 1.331 -0.22 0 CA-C-N 116.348 -0.387 . . . . 0.0 110.79 178.88 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' C' C ' 127' ' ' ASN . . . . . . . . . . . . . 64.1 t30 51.12 -105.75 0.22 Allowed 'General case' 0 CA--C 1.543 0.696 0 CA-C-O 119.023 -0.513 . . . . 0.0 111.476 179.188 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' C' C ' 128' ' ' ASP . . . . . . . . . . . . . 16.1 p-10 -114.08 5.27 15.96 Favored 'General case' 0 N--CA 1.469 0.483 0 CA-C-N 119.602 1.092 . . . . 0.0 113.442 -177.084 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' C' C ' 129' ' ' LEU . . . . . 0.47 HD22 ' NH1' ' C' ' 142' ' ' ARG . 26.1 mt -105.01 133.22 50.17 Favored 'General case' 0 C--N 1.332 -0.184 0 N-CA-C 109.555 -0.535 . . . . 0.0 109.555 177.703 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' C' C ' 130' ' ' VAL . . . . . . . . . . . . . 46.3 t -128.11 132.02 68.85 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.287 0 CA-C-O 120.881 0.372 . . . . 0.0 110.218 -178.508 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' C' C ' 131' ' ' VAL . . . . . 0.472 HG12 HD12 ' C' ' 140' ' ' LEU . 35.2 m -136.15 138.69 46.86 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.228 0 CA-C-O 121.15 0.5 . . . . 0.0 111.059 177.246 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' C' C ' 132' ' ' ILE . . . . . 0.414 HD13 ' HE2' ' C' ' 117' ' ' PHE . 71.4 mt -116.4 131.55 68.62 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.303 0 CA-C-N 115.67 -0.695 . . . . 0.0 109.26 179.189 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' C' C ' 133' ' ' ILE . . . . . . . . . . . . . 33.3 mm -115.09 120.66 65.24 Favored 'Isoleucine or valine' 0 C--O 1.234 0.255 0 CA-C-O 120.762 0.315 . . . . 0.0 111.316 -173.958 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' C' C ' 134' ' ' ASP . . . . . . . . . . . . . 10.0 p-10 -132.94 148.43 52.28 Favored 'General case' 0 C--N 1.33 -0.255 0 N-CA-C 109.538 -0.542 . . . . 0.0 109.538 175.066 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' C' C ' 135' ' ' GLU . . . . . . . . . . . . . 85.3 tt0 -49.94 -25.37 3.21 Favored 'General case' 0 C--N 1.328 -0.355 0 N-CA-C 112.864 0.691 . . . . 0.0 112.864 -172.281 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' C' C ' 136' ' ' GLN . . . . . . . . . . . . . 97.5 mt-30 -84.16 -37.83 21.43 Favored 'General case' 0 C--O 1.234 0.245 0 N-CA-C 112.305 0.483 . . . . 0.0 112.305 -176.588 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' C' C ' 137' ' ' LYS . . . . . . . . . . . . . 22.7 pttm -162.16 174.71 12.55 Favored 'General case' 0 C--N 1.331 -0.224 0 CA-C-O 121.507 0.67 . . . . 0.0 112.402 -170.634 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' C' C ' 138' ' ' LEU . . . . . . . . . . . . . 7.0 tt -122.6 128.1 50.25 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 114.903 -1.044 . . . . 0.0 109.918 178.558 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' C' C ' 139' ' ' THR . . . . . . . . . . . . . 30.1 m -104.15 124.05 48.39 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.121 -0.491 . . . . 0.0 110.236 179.012 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' C' C ' 140' ' ' LEU . . . . . 0.476 HD11 ' NH2' ' C' ' 142' ' ' ARG . 19.4 tp -109.25 119.56 39.87 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 115.719 -0.673 . . . . 0.0 109.674 -177.808 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' C' C ' 141' ' ' ILE . . . . . . . . . . . . . 19.0 mt -121.15 120.93 63.55 Favored 'Isoleucine or valine' 0 C--O 1.235 0.297 0 CA-C-O 120.986 0.422 . . . . 0.0 110.235 -175.093 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' C' C ' 142' ' ' ARG . . . . . 0.476 ' NH2' HD11 ' C' ' 140' ' ' LEU . 1.1 mpt_? . . . . . 0 C--N 1.33 -0.272 0 CA-C-N 115.312 -0.858 . . . . 0.0 110.08 -179.296 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' D' D ' 2' ' ' SER . . . . . . . . . . . . . 7.6 p . . . . . 0 C--O 1.232 0.16 0 CA-C-O 121.124 0.488 . . . . 0.0 110.917 . . . . . . . . . 0 0 . 1 . 019 nuclear build core ' D' D ' 3' ' ' GLU . . . . . . . . . . . . . 43.6 mp0 -137.85 142.19 40.75 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 115.619 -0.719 . . . . 0.0 110.571 -178.991 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' D' D ' 4' ' ' LEU . . . . . . . . . . . . . 4.2 tt -123.9 123.13 39.74 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 115.753 -0.658 . . . . 0.0 109.78 177.24 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' D' D ' 5' ' ' LYS . . . . . . . . . . . . . 63.6 mttp -102.63 121.51 42.54 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-O 120.77 0.319 . . . . 0.0 110.825 -179.984 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' D' D ' 6' ' ' LEU . . . . . . . . . . . . . 64.7 mt -114.37 148.3 37.84 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 115.553 -0.748 . . . . 0.0 110.614 179.836 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' D' D ' 7' ' ' LYS . . . . . . . . . . . . . 22.7 ttmm -139.82 141.32 27.17 Favored Pre-proline 0 CA--C 1.534 0.339 0 N-CA-C 109.811 -0.44 . . . . 0.0 109.811 174.826 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' D' D ' 8' ' ' PRO . . . . . . . . . . . . . 96.4 Cg_endo -91.22 139.16 2.41 Favored 'Trans proline' 0 N--CA 1.49 1.316 0 C-N-CA 121.694 1.596 . . . . 0.0 111.663 177.988 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' D' D ' 9' ' ' LEU . . . . . . . . . . . . . 49.2 mt -78.28 -45.84 2.13 Favored Pre-proline 0 CA--C 1.533 0.313 0 CA-C-O 118.838 -0.601 . . . . 0.0 111.788 -179.655 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' D' D ' 10' ' ' PRO . . . . . . . . . . . . . 74.7 Cg_endo -84.63 150.75 11.51 Favored 'Trans proline' 0 N--CA 1.495 1.604 0 C-N-CA 121.224 1.283 . . . . 0.0 111.364 171.804 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' D' D ' 11' ' ' LYS . . . . . . . . . . . . . 19.8 pttp -83.47 117.28 22.98 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-O 121.385 0.612 . . . . 0.0 110.423 178.4 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' D' D ' 12' ' ' VAL . . . . . . . . . . . . . 12.3 p -151.05 148.58 14.84 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.271 0 CA-C-N 115.837 -0.62 . . . . 0.0 110.625 -179.965 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' D' D ' 13' ' ' GLU . . . . . . . . . . . . . 44.7 mp0 -91.07 121.59 33.0 Favored 'General case' 0 C--N 1.328 -0.346 0 N-CA-C 109.866 -0.42 . . . . 0.0 109.866 176.663 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' D' D ' 14' ' ' LEU . . . . . 0.42 HD22 ' CD1' ' D' ' 18' ' ' PHE . 15.7 mt -98.09 147.8 33.6 Favored Pre-proline 0 CA--C 1.533 0.3 0 CA-C-O 119.23 -0.414 . . . . 0.0 110.627 -177.801 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' D' D ' 15' ' ' PRO . . . . . . . . . . . . . 24.4 Cg_exo -63.33 162.41 27.11 Favored 'Trans proline' 0 N--CA 1.497 1.685 0 C-N-CA 121.39 1.393 . . . . 0.0 111.813 175.877 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' D' D ' 16' ' ' PRO . . . . . . . . . . . . . 27.8 Cg_exo -60.27 -33.94 94.21 Favored 'Trans proline' 0 N--CA 1.497 1.723 0 C-N-CA 121.495 1.463 . . . . 0.0 112.687 -178.724 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' D' D ' 17' ' ' ASP . . . . . . . . . . . . . 23.1 p-10 -90.07 6.73 41.11 Favored 'General case' 0 CA--C 1.536 0.421 0 N-CA-C 113.447 0.906 . . . . 0.0 113.447 -176.936 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' D' D ' 18' ' ' PHE . . . . . 0.42 ' CD1' HD22 ' D' ' 14' ' ' LEU . 53.4 t80 -58.04 -42.87 86.31 Favored 'General case' 0 C--N 1.335 -0.036 0 O-C-N 122.045 -0.409 . . . . 0.0 110.171 -178.777 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' D' D ' 19' ' ' VAL . . . . . . . . . . . . . 47.3 t -56.6 -43.46 78.74 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 CA-C-N 116.236 -0.438 . . . . 0.0 110.514 -179.27 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' D' D ' 20' ' ' ASP . . . . . . . . . . . . . 79.3 m-20 -60.26 -42.02 94.48 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-O 120.696 0.284 . . . . 0.0 110.923 -178.276 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' D' D ' 21' ' ' VAL . . . . . . . . . . . . . 46.3 t -64.12 -48.38 86.04 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.294 0 C-N-CA 120.854 -0.339 . . . . 0.0 110.517 -177.871 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' D' D ' 22' ' ' ILE . . . . . 0.502 HG22 HD12 ' D' ' 26' ' ' LEU . 50.3 mm -55.97 -45.45 80.15 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.218 0 CA-C-O 120.867 0.365 . . . . 0.0 110.577 179.087 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' D' D ' 23' ' ' ARG . . . . . . . . . . . . . 53.7 ttp180 -54.13 -49.93 68.07 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.602 -0.272 . . . . 0.0 111.427 -178.86 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' D' D ' 24' ' ' ILE . . . . . . . . . . . . . 77.5 mt -59.78 -41.5 85.73 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.267 0 C-N-CA 121.172 -0.211 . . . . 0.0 111.253 -178.065 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' D' D ' 25' ' ' LYS . . . . . . . . . . . . . 73.2 mmtt -63.51 -42.56 98.48 Favored 'General case' 0 C--N 1.328 -0.346 0 N-CA-C 112.015 0.376 . . . . 0.0 112.015 -179.695 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' D' D ' 26' ' ' LEU . . . . . 0.502 HD12 HG22 ' D' ' 22' ' ' ILE . 74.5 mt -79.87 -40.19 28.88 Favored 'General case' 0 C--N 1.329 -0.311 0 N-CA-C 113.344 0.868 . . . . 0.0 113.344 -170.856 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' D' D ' 27' ' ' GLN . . . . . . . . . . . . . 12.6 pt20 -46.67 140.94 4.12 Favored 'General case' 0 N--CA 1.47 0.526 0 N-CA-C 112.785 0.661 . . . . 0.0 112.785 -174.923 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' D' D ' 28' ' ' GLY . . . . . . . . . . . . . . . 98.57 -27.6 18.84 Favored Glycine 0 CA--C 1.533 1.186 0 CA-C-N 115.527 -0.761 . . . . 0.0 112.123 -177.87 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' D' D ' 29' ' ' LYS . . . . . . . . . . . . . 67.3 mttm -98.39 155.14 17.38 Favored 'General case' 0 C--O 1.232 0.181 0 CA-C-N 117.229 0.515 . . . . 0.0 111.044 179.636 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' D' D ' 30' ' ' THR . . . . . . . . . . . . . 37.9 m -100.7 137.65 38.81 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.075 -0.511 . . . . 0.0 110.062 176.095 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' D' D ' 31' ' ' VAL . . . . . . . . . . . . . 34.6 m -128.4 157.31 40.88 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.282 0 CA-C-O 120.992 0.425 . . . . 0.0 110.716 -178.953 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' D' D ' 32' ' ' ARG . . . . . . . . . . . . . 94.2 mtt180 -133.72 151.26 51.57 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 115.74 -0.664 . . . . 0.0 110.446 177.832 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' D' D ' 33' ' ' THR . . . . . . . . . . . . . 30.0 m -53.12 138.52 31.03 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.496 -0.32 . . . . 0.0 111.317 -179.339 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' D' D ' 34' ' ' GLY . . . . . . . . . . . . . . . 101.28 -17.13 56.19 Favored Glycine 0 CA--C 1.533 1.17 0 CA-C-O 119.593 -0.559 . . . . 0.0 113.305 179.124 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' D' D ' 35' ' ' ASP . . . . . . . . . . . . . 67.9 m-20 -65.26 148.95 50.79 Favored 'General case' 0 N--CA 1.461 0.122 0 CA-C-N 118.039 0.92 . . . . 0.0 110.987 179.332 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' D' D ' 36' ' ' VAL . . . . . . . . . . . . . 44.7 t -124.23 130.86 73.54 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.25 0 CA-C-N 115.858 -0.61 . . . . 0.0 109.916 179.49 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' D' D ' 37' ' ' ILE . . . . . . . . . . . . . 65.4 mt -119.7 138.19 51.12 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.267 0 CA-C-N 116.195 -0.457 . . . . 0.0 109.787 179.396 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' D' D ' 38' ' ' GLY . . . . . . . . . . . . . . . -114.33 128.72 8.34 Favored Glycine 0 CA--C 1.524 0.637 0 N-CA-C 111.096 -0.801 . . . . 0.0 111.096 -179.699 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' D' D ' 39' ' ' ILE . . . . . . . . . . . . . 72.7 mt -127.34 131.03 70.84 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.282 0 N-CA-C 109.863 -0.421 . . . . 0.0 109.863 178.373 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' D' D ' 40' ' ' SER . . . . . . . . . . . . . 51.8 p -91.92 121.1 33.2 Favored 'General case' 0 C--N 1.329 -0.292 0 C-N-CA 120.894 -0.322 . . . . 0.0 110.81 176.348 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' D' D ' 41' ' ' ILE . . . . . . . . . . . . . 71.9 mt -130.02 119.29 46.68 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.201 0 CA-C-O 120.833 0.349 . . . . 0.0 110.295 179.918 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' D' D ' 42' ' ' LEU . . . . . . . . . . . . . 83.5 mt 58.15 33.41 23.14 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.073 -0.512 . . . . 0.0 111.874 177.551 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' D' D ' 43' ' ' GLY . . . . . . . . . . . . . . . 82.57 -10.1 56.8 Favored Glycine 0 CA--C 1.533 1.216 0 C-N-CA 121.22 -0.514 . . . . 0.0 113.468 176.746 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' D' D ' 44' ' ' LYS . . . . . . . . . . . . . 68.2 tttt -103.34 129.51 50.39 Favored 'General case' 0 C--N 1.332 -0.167 0 CA-C-N 117.948 0.874 . . . . 0.0 109.851 176.885 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' D' D ' 45' ' ' GLU . . . . . . . . . . . . . 39.9 tp10 -84.22 131.14 34.78 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-O 120.816 0.341 . . . . 0.0 110.99 -179.47 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' D' D ' 46' ' ' VAL . . . . . . . . . . . . . 7.3 p -120.99 129.03 76.13 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.191 0 N-CA-C 109.69 -0.485 . . . . 0.0 109.69 176.793 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' D' D ' 47' ' ' LYS . . . . . . . . . . . . . 65.2 mmtt -99.59 126.6 45.61 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 115.87 -0.605 . . . . 0.0 110.931 177.075 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' D' D ' 48' ' ' PHE . . . . . . . . . . . . . 95.8 m-85 -108.78 131.74 54.66 Favored 'General case' 0 C--N 1.328 -0.328 0 N-CA-C 109.399 -0.593 . . . . 0.0 109.399 175.193 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' D' D ' 49' ' ' LYS . . . . . . . . . . . . . 74.3 tttt -109.01 135.48 50.11 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.467 -0.333 . . . . 0.0 110.501 179.934 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' D' D ' 50' ' ' VAL . . . . . . . . . . . . . 43.7 t -78.72 106.05 8.95 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.293 0 N-CA-C 109.187 -0.671 . . . . 0.0 109.187 175.73 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' D' D ' 51' ' ' VAL . . . . . . . . . . . . . 52.9 t -68.8 -47.63 75.23 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.315 0 CA-C-N 116.077 -0.511 . . . . 0.0 109.992 -173.251 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' D' D ' 52' ' ' GLN . . . . . . . . . . . . . 62.8 tt0 -170.18 144.2 2.57 Favored 'General case' 0 C--N 1.33 -0.271 0 C-N-CA 120.262 -0.575 . . . . 0.0 111.839 -178.996 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' D' D ' 53' ' ' ALA . . . . . . . . . . . . . . . -116.46 134.32 55.0 Favored 'General case' 0 C--N 1.331 -0.213 0 CA-C-N 115.641 -0.709 . . . . 0.0 109.831 175.948 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' D' D ' 54' ' ' TYR . . . . . . . . . . . . . 48.7 t80 -129.06 112.82 18.52 Favored Pre-proline 0 CA--C 1.534 0.343 0 CA-C-O 118.194 -0.908 . . . . 0.0 110.442 178.578 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' D' D ' 55' ' ' PRO . . . . . . . . . . . . . 74.0 Cg_endo -77.18 167.86 78.5 Favored 'Cis proline' 0 N--CA 1.499 1.84 0 CA-C-N 122.002 1.751 . . . . 0.0 112.14 -7.727 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' D' D ' 56' ' ' SER . . . . . . . . . . . . . 13.6 m -117.11 140.64 27.34 Favored Pre-proline 0 CA--C 1.537 0.454 0 CA-C-O 118.674 -0.679 . . . . 0.0 109.741 174.802 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' D' D ' 57' ' ' PRO . . . . . . . . . . . . . 38.2 Cg_endo -68.0 159.95 82.92 Favored 'Cis proline' 0 N--CA 1.498 1.786 0 CA-C-N 121.596 1.606 . . . . 0.0 111.139 -3.544 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' D' D ' 58' ' ' LEU . . . . . . . . . . . . . 20.7 tp -129.6 137.16 50.55 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-O 120.995 0.426 . . . . 0.0 110.473 -178.136 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' D' D ' 59' ' ' ARG . . . . . . . . . . . . . 41.7 ttp180 -104.57 126.6 51.81 Favored 'General case' 0 C--N 1.327 -0.379 0 N-CA-C 109.24 -0.652 . . . . 0.0 109.24 175.342 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' D' D ' 60' ' ' VAL . . . . . . . . . . . . . 41.4 t -80.06 123.45 36.87 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.291 0 C-N-CA 120.676 -0.409 . . . . 0.0 110.649 -173.411 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' D' D ' 61' ' ' GLU . . . . . . . . . . . . . 95.9 mt-10 -131.05 164.19 25.97 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 115.782 -0.645 . . . . 0.0 109.78 177.34 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' D' D ' 62' ' ' ASP . . . . . . . . . . . . . 76.4 m-20 -53.19 -32.5 48.29 Favored 'General case' 0 C--N 1.328 -0.345 0 N-CA-C 111.81 0.3 . . . . 0.0 111.81 -179.981 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' D' D ' 63' ' ' ARG . . . . . . . . . . . . . 95.7 mtt180 -74.48 -21.99 59.3 Favored 'General case' 0 CA--C 1.533 0.294 0 N-CA-C 112.945 0.72 . . . . 0.0 112.945 -176.986 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' D' D ' 64' ' ' THR . . . . . . . . . . . . . 26.8 m -64.84 137.17 57.61 Favored 'General case' 0 C--N 1.331 -0.223 0 CA-C-O 120.965 0.412 . . . . 0.0 110.572 -175.599 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' D' D ' 65' ' ' LYS . . . . . . . . . . . . . 39.8 ttpt -89.14 123.78 33.72 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 115.903 -0.589 . . . . 0.0 110.317 -179.721 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' D' D ' 66' ' ' ILE . . . . . . . . . . . . . 62.7 mt -111.48 130.2 65.46 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.261 0 N-CA-C 109.94 -0.393 . . . . 0.0 109.94 -178.564 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' D' D ' 67' ' ' THR . . . . . . . . . . . . . 8.1 m -130.1 146.97 51.79 Favored 'General case' 0 C--N 1.332 -0.192 0 CA-C-O 121.068 0.461 . . . . 0.0 111.231 -176.663 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' D' D ' 68' ' ' LEU . . . . . . . . . . . . . 54.0 mt . . . . . 0 C--N 1.33 -0.247 0 CA-C-N 115.836 -0.62 . . . . 0.0 110.266 177.47 . . . . . . . . 0 0 . 1 . 019 nuclear build core ' D' D ' 73' ' ' VAL . . . . . . . . . . . . . 34.6 m . . . . . 0 C--O 1.231 0.1 0 CA-C-O 120.795 0.331 . . . . 0.0 110.874 . . . . . . . . . 0 0 . 1 . 019 nuclear build core ' D' D ' 74' ' ' ASP . . . . . . . . . . . . . 23.6 t0 -96.84 124.66 40.88 Favored 'General case' 0 C--N 1.33 -0.264 0 N-CA-C 109.548 -0.538 . . . . 0.0 109.548 178.516 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' D' D ' 75' ' ' VAL . . . . . . . . . . . . . 40.6 t -114.31 122.88 69.31 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.258 0 CA-C-O 121.064 0.459 . . . . 0.0 110.7 -177.524 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' D' D ' 76' ' ' LEU . . . . . . . . . . . . . 5.5 mp -124.76 152.41 43.86 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 115.653 -0.703 . . . . 0.0 109.608 175.951 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' D' D ' 77' ' ' GLU . . . . . . . . . . . . . 98.4 mt-10 -137.35 139.66 40.95 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-O 121.068 0.461 . . . . 0.0 111.34 -177.669 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' D' D ' 78' ' ' ALA . . . . . 0.723 ' HB2' HD21 ' D' ' 109' ' ' LEU . . . -125.58 137.99 53.92 Favored 'General case' 0 C--N 1.331 -0.217 0 CA-C-N 115.711 -0.677 . . . . 0.0 109.841 176.778 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' D' D ' 79' ' ' LYS . . . . . 0.652 ' O ' HD13 ' D' ' 80' ' ' ILE . 68.8 mttm -88.94 115.82 26.77 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.39 -0.368 . . . . 0.0 110.848 -177.747 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' D' D ' 80' ' ' ILE . . . . . 0.652 HD13 ' O ' ' D' ' 79' ' ' LYS . 36.2 mm -139.18 111.7 5.8 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.267 0 N-CA-C 109.153 -0.684 . . . . 0.0 109.153 -177.863 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' D' D ' 81' ' ' LYS . . . . . . . . . . . . . 39.7 ttpt -100.7 126.85 47.27 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-O 120.928 0.394 . . . . 0.0 111.279 -176.558 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' D' D ' 82' ' ' GLY . . . . . . . . . . . . . . . 89.18 42.15 5.65 Favored Glycine 0 CA--C 1.526 0.746 0 N-CA-C 111.534 -0.626 . . . . 0.0 111.534 175.548 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' D' D ' 83' ' ' ILE . . . . . . . . . . . . . 67.8 mt -68.26 139.4 20.77 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.348 0 CA-C-O 120.849 0.357 . . . . 0.0 110.111 179.008 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' D' D ' 84' ' ' LYS . . . . . . . . . . . . . 30.3 ttmt -96.66 -53.64 3.49 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.041 -0.527 . . . . 0.0 109.949 179.467 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' D' D ' 85' ' ' ASP . . . . . . . . . . . . . 7.1 t70 -155.41 152.63 29.27 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 115.507 -0.77 . . . . 0.0 110.117 -179.53 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' D' D ' 86' ' ' VAL . . . . . . . . . . . . . 41.6 t -130.13 132.52 65.22 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.215 0 CA-C-O 120.879 0.371 . . . . 0.0 110.533 -179.476 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' D' D ' 87' ' ' ILE . . . . . . . . . . . . . 45.0 mm -119.37 127.61 75.85 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.263 0 CA-C-N 115.902 -0.59 . . . . 0.0 109.643 177.271 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' D' D ' 88' ' ' LEU . . . . . . . . . . . . . 14.7 tp -110.45 131.3 55.17 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.377 -0.374 . . . . 0.0 110.967 -178.16 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' D' D ' 89' ' ' ASP . . . . . . . . . . . . . 13.3 t70 -124.82 152.2 44.22 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.033 -0.531 . . . . 0.0 109.821 177.611 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' D' D ' 90' ' ' GLU . . . . . . . . . . . . . 96.2 mt-10 -48.56 -34.65 11.82 Favored 'General case' 0 C--N 1.328 -0.368 0 N-CA-C 112.605 0.595 . . . . 0.0 112.605 -173.878 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' D' D ' 91' ' ' ASN . . . . . . . . . . . . . 33.6 m120 -132.05 30.99 4.21 Favored 'General case' 0 CA--C 1.531 0.219 0 N-CA-C 112.167 0.432 . . . . 0.0 112.167 -176.179 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' D' D ' 92' ' ' LEU . . . . . . . . . . . . . 10.8 tp -166.06 149.35 7.49 Favored 'General case' 0 C--N 1.331 -0.215 0 CA-C-O 120.795 0.331 . . . . 0.0 111.089 -179.749 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' D' D ' 93' ' ' ILE . . . . . . . . . . . . . 72.6 mt -126.25 120.23 56.13 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.22 0 N-CA-C 109.298 -0.63 . . . . 0.0 109.298 177.426 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' D' D ' 94' ' ' VAL . . . . . 0.711 HG21 HG11 ' D' ' 125' ' ' VAL . 45.1 t -120.39 127.19 75.89 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.233 0 CA-C-O 120.818 0.342 . . . . 0.0 110.092 -178.637 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' D' D ' 95' ' ' VAL . . . . . . . . . . . . . 43.9 t -122.91 134.22 66.7 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.341 0 CA-C-N 116.123 -0.489 . . . . 0.0 109.98 -179.062 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' D' D ' 96' ' ' ILE . . . . . . . . . . . . . 60.9 mt -115.97 128.15 73.34 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.317 0 N-CA-C 109.478 -0.564 . . . . 0.0 109.478 179.143 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' D' D ' 97' ' ' THR . . . . . . . . . . . . . 66.9 p -100.98 154.01 19.05 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-O 121.138 0.494 . . . . 0.0 111.011 -178.171 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' D' D ' 98' ' ' GLU . . . . . . . . . . . . . 96.4 mt-10 -56.94 -23.86 48.5 Favored 'General case' 0 CA--C 1.533 0.325 0 N-CA-C 112.469 0.544 . . . . 0.0 112.469 -178.736 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' D' D ' 99' ' ' GLU . . . . . . . . . . . . . 71.1 mm-40 -80.5 18.08 0.99 Allowed 'General case' 0 CA--C 1.533 0.324 0 N-CA-C 112.961 0.726 . . . . 0.0 112.961 -178.699 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' D' D ' 100' ' ' ASN . . . . . . . . . . . . . 3.8 m-20 64.09 38.12 8.62 Favored 'General case' 0 N--CA 1.463 0.191 0 CA-C-O 121.063 0.459 . . . . 0.0 111.049 176.899 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' D' D ' 101' ' ' GLU . . . . . . . . . . . . . 84.5 tt0 -116.68 143.07 46.08 Favored 'General case' 0 C--N 1.332 -0.162 0 CA-C-N 116.068 -0.515 . . . . 0.0 109.884 177.125 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' D' D ' 102' ' ' VAL . . . . . . . . . . . . . 43.5 t -114.99 126.93 72.71 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.287 0 CA-C-N 116.275 -0.42 . . . . 0.0 109.891 -178.801 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' D' D ' 103' ' ' LEU . . . . . . . . . . . . . 44.9 mt -118.16 134.28 55.14 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 115.668 -0.696 . . . . 0.0 109.632 179.532 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' D' D ' 104' ' ' ILE . . . . . . . . . . . . . 73.2 mt -126.11 122.81 62.48 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.266 0 C-N-CA 121.213 -0.195 . . . . 0.0 110.562 -176.819 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' D' D ' 105' ' ' PHE . . . . . . . . . . . . . 49.7 m-85 -127.36 165.94 18.79 Favored 'General case' 0 C--N 1.333 -0.112 0 O-C-N 123.993 0.808 . . . . 0.0 110.075 -179.781 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' D' D ' 106' ' ' ASN . . . . . . . . . . . . . 45.7 p-10 -101.85 -170.01 1.76 Allowed 'General case' 0 C--N 1.331 -0.227 0 N-CA-C 109.94 -0.392 . . . . 0.0 109.94 174.379 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' D' D ' 107' ' ' GLN . . . . . . . . . . . . . 39.0 tt0 -58.72 -30.1 67.19 Favored 'General case' 0 C--N 1.33 -0.269 0 N-CA-C 111.996 0.369 . . . . 0.0 111.996 179.73 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' D' D ' 108' ' ' ASN . . . . . . . . . . . . . 11.3 t-20 -83.55 7.99 15.5 Favored 'General case' 0 CA--C 1.534 0.357 0 N-CA-C 113.238 0.829 . . . . 0.0 113.238 -176.836 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' D' D ' 109' ' ' LEU . . . . . 0.723 HD21 ' HB2' ' D' ' 78' ' ' ALA . 12.8 tp 61.29 38.55 16.35 Favored 'General case' 0 CA--C 1.529 0.154 0 CA-C-O 120.999 0.428 . . . . 0.0 111.028 178.388 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' D' D ' 110' ' ' GLU . . . . . . . . . . . . . 95.5 mt-10 -108.21 152.81 24.09 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 116.396 -0.365 . . . . 0.0 110.373 177.937 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' D' D ' 111' ' ' GLU . . . . . . . . . . . . . 94.9 mt-10 -77.69 125.31 29.14 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-O 120.913 0.387 . . . . 0.0 111.123 -179.543 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' D' D ' 112' ' ' LEU . . . . . . . . . . . . . 83.4 mt -107.99 -45.36 3.99 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 115.975 -0.557 . . . . 0.0 109.664 173.297 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' D' D ' 113' ' ' TYR . . . . . . . . . . . . . 64.6 t80 -147.31 141.55 26.21 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.133 -0.485 . . . . 0.0 111.555 -179.252 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' D' D ' 114' ' ' ARG . . . . . . . . . . . . . 65.3 mtt180 -139.36 124.65 19.07 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 115.874 -0.603 . . . . 0.0 110.3 173.69 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' D' D ' 115' ' ' GLY . . . . . . . . . . . . . . . -150.06 157.43 27.21 Favored Glycine 0 CA--C 1.525 0.683 0 N-CA-C 110.862 -0.895 . . . . 0.0 110.862 178.69 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' D' D ' 116' ' ' LYS . . . . . . . . . . . . . 39.7 ttpt -129.12 139.04 52.12 Favored 'General case' 0 C--N 1.329 -0.322 0 N-CA-C 110.103 -0.332 . . . . 0.0 110.103 178.195 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' D' D ' 117' ' ' PHE . . . . . . . . . . . . . 47.9 m-85 -132.15 116.01 16.46 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.283 -0.417 . . . . 0.0 110.489 -176.196 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' D' D ' 118' ' ' GLU . . . . . . . . . . . . . 84.7 tt0 -51.95 -52.93 46.88 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.407 -0.36 . . . . 0.0 111.659 -176.853 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' D' D ' 119' ' ' ASN . . . . . . . . . . . . . 96.3 m-20 -93.65 31.14 1.62 Allowed 'General case' 0 C--N 1.329 -0.29 0 N-CA-C 112.227 0.454 . . . . 0.0 112.227 -174.525 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' D' D ' 120' ' ' LEU . . . . . . . . . . . . . 15.8 tp -54.08 122.1 9.48 Favored 'General case' 0 N--CA 1.464 0.231 0 O-C-N 122.289 -0.257 . . . . 0.0 110.671 177.562 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' D' D ' 121' ' ' ASN . . . . . . . . . . . . . 26.7 m120 -114.09 -44.02 3.18 Favored 'General case' 0 C--O 1.232 0.166 0 CA-C-N 116.595 -0.275 . . . . 0.0 111.188 -175.977 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' D' D ' 122' ' ' LYS . . . . . . . . . . . . . 44.4 mtmt -145.68 146.52 31.32 Favored 'General case' 0 C--N 1.331 -0.215 0 C-N-CA 120.538 -0.465 . . . . 0.0 111.665 -176.471 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' D' D ' 123' ' ' VAL . . . . . . . . . . . . . 44.0 t -129.02 130.5 68.31 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.275 0 CA-C-N 115.849 -0.614 . . . . 0.0 109.53 176.096 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' D' D ' 124' ' ' LEU . . . . . . . . . . . . . 14.9 tp -128.34 135.34 49.45 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-O 120.78 0.324 . . . . 0.0 110.612 -178.555 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' D' D ' 125' ' ' VAL . . . . . 0.711 HG11 HG21 ' D' ' 94' ' ' VAL . 34.9 m -133.61 141.0 45.44 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.195 0 CA-C-N 116.328 -0.396 . . . . 0.0 111.031 -178.719 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' D' D ' 126' ' ' ARG . . . . . . . . . . . . . 78.2 mtt180 -149.41 125.19 10.49 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.554 176.267 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' D' D ' 127' ' ' ASN . . . . . . . . . . . . . 18.8 t-20 52.51 -111.37 0.58 Allowed 'General case' 0 CA--C 1.545 0.755 0 CA-C-O 118.734 -0.65 . . . . 0.0 111.046 178.849 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' D' D ' 128' ' ' ASP . . . . . . . . . . . . . 21.5 p-10 -114.15 10.7 17.4 Favored 'General case' 0 N--CA 1.468 0.454 0 CA-C-N 120.044 1.293 . . . . 0.0 113.081 -179.747 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' D' D ' 129' ' ' LEU . . . . . . . . . . . . . 13.1 tp -107.29 135.77 48.25 Favored 'General case' 0 C--N 1.332 -0.165 0 N-CA-C 109.877 -0.416 . . . . 0.0 109.877 178.914 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' D' D ' 130' ' ' VAL . . . . . . . . . . . . . 44.3 t -123.79 136.16 61.12 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.239 0 CA-C-O 120.869 0.366 . . . . 0.0 110.023 -178.127 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' D' D ' 131' ' ' VAL . . . . . . . . . . . . . 43.4 t -133.87 133.71 56.35 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.258 0 CA-C-O 121.027 0.441 . . . . 0.0 110.059 177.561 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' D' D ' 132' ' ' ILE . . . . . . . . . . . . . 71.6 mt -118.01 131.51 70.55 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.335 0 CA-C-N 115.724 -0.671 . . . . 0.0 109.604 -179.273 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' D' D ' 133' ' ' ILE . . . . . . . . . . . . . 36.8 mm -116.19 124.33 72.35 Favored 'Isoleucine or valine' 0 C--O 1.233 0.197 0 CA-C-O 120.804 0.335 . . . . 0.0 111.106 -175.062 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' D' D ' 134' ' ' ASP . . . . . . . . . . . . . 11.6 p-10 -135.22 151.33 50.52 Favored 'General case' 0 C--N 1.332 -0.18 0 CA-C-N 116.104 -0.498 . . . . 0.0 109.916 174.603 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' D' D ' 135' ' ' GLU . . . . . . . . . . . . . 84.6 tt0 -49.95 -26.24 4.01 Favored 'General case' 0 C--O 1.236 0.354 0 N-CA-C 113.571 0.952 . . . . 0.0 113.571 -168.493 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' D' D ' 136' ' ' GLN . . . . . . . . . . . . . 14.3 pt20 -100.15 -19.55 16.39 Favored 'General case' 0 N--CA 1.466 0.352 0 N-CA-C 113.314 0.857 . . . . 0.0 113.314 -172.491 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' D' D ' 137' ' ' LYS . . . . . . . . . . . . . 56.8 pttt -165.88 170.54 13.69 Favored 'General case' 0 C--O 1.232 0.139 0 CA-C-O 121.645 0.736 . . . . 0.0 112.344 -176.693 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' D' D ' 138' ' ' LEU . . . . . . . . . . . . . 7.2 tt -121.23 127.67 51.67 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 114.919 -1.037 . . . . 0.0 109.827 178.938 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' D' D ' 139' ' ' THR . . . . . . . . . . . . . 42.1 m -106.18 126.71 52.55 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.089 -0.505 . . . . 0.0 110.331 179.895 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' D' D ' 140' ' ' LEU . . . . . 0.464 ' C ' HD23 ' D' ' 140' ' ' LEU . 5.7 tt -110.74 122.49 47.94 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 115.748 -0.66 . . . . 0.0 109.27 -179.203 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' D' D ' 141' ' ' ILE . . . . . 0.438 ' N ' HD23 ' D' ' 140' ' ' LEU . 19.1 mt -122.21 116.16 48.32 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.294 0 N-CA-C 109.867 -0.42 . . . . 0.0 109.867 -175.176 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' D' D ' 142' ' ' ARG . . . . . . . . . . . . . 58.9 ttp180 -108.75 129.29 55.37 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 115.64 -0.709 . . . . 0.0 110.507 -178.784 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' D' D ' 143' ' ' THR . . . . . . . . . . . . . 70.2 p . . . . . 0 C--O 1.22 -0.475 0 CA-C-O 118.223 -0.894 . . . . 0.0 110.894 179.695 . . . . . . . . 0 0 . 1 . 019 nuclear build core ' E' E ' 2' ' ' SER . . . . . . . . . . . . . 2.1 p . . . . . 0 C--O 1.231 0.08 0 N-CA-C 110.026 -0.361 . . . . 0.0 110.026 . . . . . . . . . 0 0 . 1 . 019 nuclear build core ' E' E ' 3' ' ' GLU . . . . . . . . . . . . . 89.2 mt-10 -139.29 140.75 37.71 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.016 -0.538 . . . . 0.0 111.103 -175.374 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' E' E ' 4' ' ' LEU . . . . . . . . . . . . . 16.0 tp -122.89 124.93 44.35 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 115.785 -0.643 . . . . 0.0 109.506 173.979 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' E' E ' 5' ' ' LYS . . . . . . . . . . . . . 60.7 mttp -108.83 120.26 41.98 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 116.397 -0.365 . . . . 0.0 110.573 -179.265 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' E' E ' 6' ' ' LEU . . . . . . . . . . . . . 54.1 mt -113.91 143.43 44.71 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 115.402 -0.817 . . . . 0.0 110.041 -178.796 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' E' E ' 7' ' ' LYS . . . . . . . . . . . . . 78.4 tttt -122.71 135.77 26.04 Favored Pre-proline 0 CA--C 1.535 0.388 0 CA-C-O 118.84 -0.6 . . . . 0.0 109.542 176.087 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' E' E ' 8' ' ' PRO . . . . . . . . . . . . . 72.4 Cg_endo -88.9 131.54 2.27 Favored 'Trans proline' 0 N--CA 1.49 1.309 0 C-N-CA 121.566 1.511 . . . . 0.0 111.814 178.938 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' E' E ' 9' ' ' LEU . . . . . . . . . . . . . 73.9 mt -70.36 -51.22 13.55 Favored Pre-proline 0 C--N 1.329 -0.313 0 CA-C-O 118.694 -0.67 . . . . 0.0 111.817 -178.703 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' E' E ' 10' ' ' PRO . . . . . . . . . . . . . 70.3 Cg_endo -74.66 151.24 41.08 Favored 'Trans proline' 0 N--CA 1.497 1.713 0 C-N-CA 121.076 1.184 . . . . 0.0 111.891 175.226 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' E' E ' 11' ' ' LYS . . . . . . . . . . . . . 70.6 mmtt -83.92 89.11 7.16 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-O 120.879 0.371 . . . . 0.0 110.42 178.511 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' E' E ' 12' ' ' VAL . . . . . . . . . . . . . 12.2 p -140.06 144.81 27.32 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.276 0 CA-C-N 116.024 -0.535 . . . . 0.0 110.359 179.877 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' E' E ' 13' ' ' GLU . . . . . . . . . . . . . 84.9 tt0 -91.79 130.62 37.53 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.275 -0.42 . . . . 0.0 110.241 178.626 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' E' E ' 14' ' ' LEU . . . . . . . . . . . . . 19.9 mt -97.65 152.98 38.45 Favored Pre-proline 0 C--N 1.33 -0.251 0 CA-C-N 116.258 -0.428 . . . . 0.0 110.796 -177.509 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' E' E ' 15' ' ' PRO . . . . . . . . . . . . . 27.9 Cg_exo -60.81 159.28 29.51 Favored 'Trans proline' 0 N--CA 1.497 1.692 0 C-N-CA 121.334 1.356 . . . . 0.0 111.795 176.833 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' E' E ' 16' ' ' PRO . . . . . . . . . . . . . 38.6 Cg_exo -58.48 -37.04 96.58 Favored 'Trans proline' 0 N--CA 1.497 1.727 0 C-N-CA 121.362 1.374 . . . . 0.0 112.704 -178.211 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' E' E ' 17' ' ' ASP . . . . . . . . . . . . . 10.5 p-10 -94.47 15.43 17.83 Favored 'General case' 0 C--N 1.328 -0.345 0 N-CA-C 113.063 0.764 . . . . 0.0 113.063 -177.088 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' E' E ' 18' ' ' PHE . . . . . . . . . . . . . 51.9 t80 -58.03 -44.34 87.28 Favored 'General case' 0 N--CA 1.46 0.06 0 O-C-N 122.0 -0.437 . . . . 0.0 110.085 -178.788 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' E' E ' 19' ' ' VAL . . . . . . . . . . . . . 47.4 t -56.61 -40.83 71.52 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.344 0 CA-C-N 116.255 -0.43 . . . . 0.0 110.35 -179.764 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' E' E ' 20' ' ' ASP . . . . . . . . . . . . . 70.1 m-20 -60.07 -42.69 95.09 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-O 120.801 0.334 . . . . 0.0 110.85 -178.274 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' E' E ' 21' ' ' VAL . . . . . . . . . . . . . 47.5 t -65.38 -52.02 57.0 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.278 0 C-N-CA 120.828 -0.349 . . . . 0.0 110.613 -178.334 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' E' E ' 22' ' ' ILE . . . . . . . . . . . . . 48.7 mm -54.32 -54.57 20.49 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.231 0 CA-C-O 120.743 0.306 . . . . 0.0 111.24 -177.493 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' E' E ' 23' ' ' ARG . . . . . . . . . . . . . 14.4 ptm180 -61.34 -45.29 95.04 Favored 'General case' 0 CA--C 1.532 0.275 0 N-CA-C 112.166 0.432 . . . . 0.0 112.166 -173.656 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' E' E ' 24' ' ' ILE . . . . . . . . . . . . . 73.0 mt -61.85 -38.53 80.78 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.209 0 O-C-N 122.138 -0.352 . . . . 0.0 111.224 -175.474 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' E' E ' 25' ' ' LYS . . . . . . . . . . . . . 66.6 mttm -72.33 -43.81 63.56 Favored 'General case' 0 C--N 1.331 -0.237 0 N-CA-C 112.077 0.399 . . . . 0.0 112.077 -178.971 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' E' E ' 26' ' ' LEU . . . . . . . . . . . . . 56.4 mt -87.03 -8.19 57.38 Favored 'General case' 0 CA--C 1.533 0.303 0 N-CA-C 113.835 1.05 . . . . 0.0 113.835 -173.627 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' E' E ' 27' ' ' GLN . . . . . . . . . . . . . 15.3 pt20 -46.59 143.13 2.82 Favored 'General case' 0 N--CA 1.467 0.412 0 O-C-N 121.592 -0.692 . . . . 0.0 112.451 -179.706 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' E' E ' 28' ' ' GLY . . . . . . . . . . . . . . . 100.07 -22.49 39.92 Favored Glycine 0 CA--C 1.533 1.212 0 CA-C-N 115.885 -0.598 . . . . 0.0 112.467 -177.953 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' E' E ' 29' ' ' LYS . . . . . . . . . . . . . 34.8 mmtp -89.6 154.98 19.55 Favored 'General case' 0 C--O 1.233 0.186 0 CA-C-N 117.599 0.699 . . . . 0.0 110.632 177.994 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' E' E ' 30' ' ' THR . . . . . . . . . . . . . 9.1 m -107.95 139.77 42.07 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.093 -0.503 . . . . 0.0 110.17 178.269 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' E' E ' 31' ' ' VAL . . . . . . . . . . . . . 35.0 m -127.91 152.87 36.55 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.263 0 CA-C-O 120.929 0.395 . . . . 0.0 110.755 -178.963 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' E' E ' 32' ' ' ARG . . . . . . . . . . . . . 83.5 mtt180 -131.68 150.31 52.19 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.025 -0.534 . . . . 0.0 110.366 177.565 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' E' E ' 33' ' ' THR . . . . . . . . . . . . . 22.0 m -52.8 138.64 28.88 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.366 -0.379 . . . . 0.0 111.457 -178.383 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' E' E ' 34' ' ' GLY . . . . . . . . . . . . . . . 100.16 -17.13 57.47 Favored Glycine 0 CA--C 1.532 1.101 0 CA-C-N 116.18 -0.464 . . . . 0.0 113.28 179.485 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' E' E ' 35' ' ' ASP . . . . . . . . . . . . . 77.0 m-20 -67.97 149.51 49.65 Favored 'General case' 0 N--CA 1.462 0.125 0 CA-C-N 117.989 0.894 . . . . 0.0 111.183 178.683 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' E' E ' 36' ' ' VAL . . . . . . . . . . . . . 44.6 t -120.95 128.81 76.13 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.219 0 CA-C-N 116.063 -0.517 . . . . 0.0 109.688 176.775 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' E' E ' 37' ' ' ILE . . . . . . . . . . . . . 62.9 mt -119.08 138.4 49.93 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 CA-C-N 116.089 -0.505 . . . . 0.0 109.923 -178.539 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' E' E ' 38' ' ' GLY . . . . . . . . . . . . . . . -116.42 128.14 7.81 Favored Glycine 0 CA--C 1.526 0.757 0 N-CA-C 110.937 -0.865 . . . . 0.0 110.937 179.285 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' E' E ' 39' ' ' ILE . . . . . . . . . . . . . 73.5 mt -128.82 131.07 68.7 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.216 0 N-CA-C 110.066 -0.346 . . . . 0.0 110.066 178.893 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' E' E ' 40' ' ' SER . . . . . . . . . . . . . 46.8 t -91.79 113.94 26.34 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.392 -0.367 . . . . 0.0 110.965 177.908 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' E' E ' 41' ' ' ILE . . . . . . . . . . . . . 45.9 mm -123.24 123.45 67.76 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.22 0 N-CA-C 109.835 -0.431 . . . . 0.0 109.835 179.467 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' E' E ' 42' ' ' LEU . . . . . . . . . . . . . 68.7 mt 57.85 34.85 24.84 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.307 -0.406 . . . . 0.0 111.683 177.94 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' E' E ' 43' ' ' GLY . . . . . . . . . . . . . . . 78.94 -10.22 34.22 Favored Glycine 0 CA--C 1.534 1.219 0 C-N-CA 121.248 -0.501 . . . . 0.0 113.43 177.094 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' E' E ' 44' ' ' LYS . . . . . . . . . . . . . 30.4 ttmt -102.83 129.36 49.48 Favored 'General case' 0 N--CA 1.461 0.078 0 CA-C-N 117.982 0.891 . . . . 0.0 110.157 177.103 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' E' E ' 45' ' ' GLU . . . . . . . . . . . . . 39.9 tp10 -84.18 127.54 34.0 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 116.283 -0.417 . . . . 0.0 110.93 -179.662 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' E' E ' 46' ' ' VAL . . . . . . . . . . . . . 9.2 p -119.27 125.9 74.86 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.22 0 N-CA-C 109.675 -0.491 . . . . 0.0 109.675 176.468 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' E' E ' 47' ' ' LYS . . . . . . . . . . . . . 62.8 mttp -99.23 126.81 45.12 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.023 -0.535 . . . . 0.0 110.889 177.266 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' E' E ' 48' ' ' PHE . . . . . . . . . . . . . 41.1 m-85 -110.55 131.87 54.68 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.035 -0.529 . . . . 0.0 109.805 177.138 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' E' E ' 49' ' ' LYS . . . . . . . . . . . . . 78.9 tttt -105.95 132.24 52.29 Favored 'General case' 0 C--N 1.328 -0.351 0 N-CA-C 110.074 -0.343 . . . . 0.0 110.074 177.887 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' E' E ' 50' ' ' VAL . . . . . . . . . . . . . 46.6 t -77.1 107.55 8.68 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.331 0 N-CA-C 109.449 -0.574 . . . . 0.0 109.449 178.023 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' E' E ' 51' ' ' VAL . . . . . . . . . . . . . 46.6 t -71.55 -52.71 24.22 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.339 0 N-CA-C 109.545 -0.539 . . . . 0.0 109.545 -175.943 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' E' E ' 52' ' ' GLN . . . . . . . . . . . . . 83.3 mt-30 -154.74 152.5 29.96 Favored 'General case' 0 C--N 1.331 -0.207 0 CA-C-O 121.252 0.549 . . . . 0.0 111.66 -178.105 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' E' E ' 53' ' ' ALA . . . . . . . . . . . . . . . -130.2 131.96 45.8 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 115.313 -0.858 . . . . 0.0 109.545 174.141 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' E' E ' 54' ' ' TYR . . . . . . . . . . . . . 59.8 t80 -129.04 110.29 18.28 Favored Pre-proline 0 CA--C 1.535 0.374 0 CA-C-O 118.205 -0.902 . . . . 0.0 110.32 179.457 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' E' E ' 55' ' ' PRO . . . . . . . . . . . . . 73.9 Cg_endo -77.16 169.82 73.18 Favored 'Cis proline' 0 N--CA 1.5 1.865 0 CA-C-N 121.987 1.745 . . . . 0.0 112.153 -5.638 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' E' E ' 56' ' ' SER . . . . . . . . . . . . . 13.7 m -115.89 132.44 23.2 Favored Pre-proline 0 CA--C 1.538 0.488 0 CA-C-O 118.458 -0.782 . . . . 0.0 109.155 175.416 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' E' E ' 57' ' ' PRO . . . . . . . . . . . . . 50.9 Cg_endo -69.75 164.12 80.01 Favored 'Cis proline' 0 N--CA 1.498 1.753 0 CA-C-N 121.928 1.724 . . . . 0.0 111.684 0.166 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' E' E ' 58' ' ' LEU . . . . . . . . . . . . . 36.8 tp -129.82 139.4 51.24 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.079 179.821 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' E' E ' 59' ' ' ARG . . . . . . . . . . . . . 26.6 ttm180 -103.83 139.11 39.47 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.246 -0.434 . . . . 0.0 110.05 178.983 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' E' E ' 60' ' ' VAL . . . . . . . . . . . . . 42.9 t -86.64 111.22 21.18 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.196 0 CA-C-O 120.84 0.352 . . . . 0.0 110.34 -177.991 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' E' E ' 61' ' ' GLU . . . . . . . . . . . . . 81.3 tt0 -131.17 154.44 48.37 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 115.845 -0.616 . . . . 0.0 109.58 177.407 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' E' E ' 62' ' ' ASP . . . . . . . . . . . . . 9.4 p-10 -52.82 -23.74 7.55 Favored 'General case' 0 C--N 1.326 -0.433 0 N-CA-C 112.467 0.543 . . . . 0.0 112.467 -179.579 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' E' E ' 63' ' ' ARG . . . . . . . . . . . . . 23.8 mmm180 -84.72 -14.22 49.03 Favored 'General case' 0 CA--C 1.534 0.349 0 N-CA-C 113.443 0.905 . . . . 0.0 113.443 -177.066 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' E' E ' 64' ' ' THR . . . . . . . . . . . . . 14.0 m -76.58 151.84 36.15 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-O 120.937 0.399 . . . . 0.0 111.05 -176.066 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' E' E ' 65' ' ' LYS . . . . . . . . . . . . . 45.7 mtpt -90.49 118.7 30.16 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.134 179.063 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' E' E ' 66' ' ' ILE . . . . . . . . . . . . . 72.0 mt -117.62 124.67 73.37 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.219 0 N-CA-C 109.741 -0.466 . . . . 0.0 109.741 -178.344 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' E' E ' 67' ' ' THR . . . . . . . . . . . . . 27.4 m -132.1 151.06 51.98 Favored 'General case' 0 C--N 1.332 -0.182 0 CA-C-O 121.269 0.557 . . . . 0.0 111.876 -173.437 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' E' E ' 68' ' ' LEU . . . . . . . . . . . . . 78.9 mt . . . . . 0 C--N 1.331 -0.237 0 CA-C-N 115.548 -0.751 . . . . 0.0 110.126 175.474 . . . . . . . . 0 0 . 1 . 019 nuclear build core ' E' E ' 73' ' ' VAL . . . . . . . . . . . . . 31.5 m . . . . . 0 C--O 1.233 0.213 0 CA-C-O 121.174 0.511 . . . . 0.0 111.097 . . . . . . . . . 0 0 . 1 . 019 nuclear build core ' E' E ' 74' ' ' ASP . . . . . . . . . . . . . 16.6 t0 -106.94 122.55 46.64 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 115.496 -0.775 . . . . 0.0 109.232 174.273 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' E' E ' 75' ' ' VAL . . . . . 0.492 ' C ' HD12 ' E' ' 76' ' ' LEU . 41.2 t -117.83 125.68 74.31 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.294 0 CA-C-O 121.112 0.482 . . . . 0.0 110.809 -176.916 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' E' E ' 76' ' ' LEU . . . . . 0.492 HD12 ' C ' ' E' ' 75' ' ' VAL . 6.1 mp -127.37 151.11 49.21 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-N 115.566 -0.743 . . . . 0.0 109.62 176.437 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' E' E ' 77' ' ' GLU . . . . . . . . . . . . . 97.0 mt-10 -136.48 136.03 39.1 Favored 'General case' 0 C--N 1.332 -0.171 0 CA-C-O 121.068 0.461 . . . . 0.0 111.26 -177.4 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' E' E ' 78' ' ' ALA . . . . . . . . . . . . . . . -121.05 138.85 53.98 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-N 115.737 -0.665 . . . . 0.0 109.819 176.838 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' E' E ' 79' ' ' LYS . . . . . 0.576 ' O ' HD13 ' E' ' 80' ' ' ILE . 99.7 mttt -83.59 118.85 24.09 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-O 120.951 0.405 . . . . 0.0 111.0 -176.982 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' E' E ' 80' ' ' ILE . . . . . 0.576 HD13 ' O ' ' E' ' 79' ' ' LYS . 42.0 mm -139.25 115.43 9.5 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.2 0 N-CA-C 109.346 -0.613 . . . . 0.0 109.346 -178.229 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' E' E ' 81' ' ' LYS . . . . . . . . . . . . . 64.7 mttm -109.44 125.51 52.51 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-O 120.854 0.359 . . . . 0.0 111.09 -177.705 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' E' E ' 82' ' ' GLY . . . . . . . . . . . . . . . 89.09 42.12 5.69 Favored Glycine 0 CA--C 1.523 0.582 0 C-N-CA 120.774 -0.727 . . . . 0.0 111.419 175.994 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' E' E ' 83' ' ' ILE . . . . . . . . . . . . . 72.9 mt -66.06 133.31 31.14 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.297 0 CA-C-O 120.942 0.401 . . . . 0.0 110.01 178.181 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' E' E ' 84' ' ' LYS . . . . . . . . . . . . . 85.9 tttt -91.67 -53.14 4.42 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-N 115.936 -0.574 . . . . 0.0 109.97 -179.633 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' E' E ' 85' ' ' ASP . . . . . . . . . . . . . 13.3 t70 -156.24 151.02 26.03 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 115.553 -0.749 . . . . 0.0 110.059 179.402 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' E' E ' 86' ' ' VAL . . . . . . . . . . . . . 43.3 t -125.87 129.63 72.44 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.287 0 CA-C-O 120.937 0.399 . . . . 0.0 110.439 -178.986 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' E' E ' 87' ' ' ILE . . . . . . . . . . . . . 44.5 mm -118.28 126.15 74.82 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.208 0 CA-C-N 115.979 -0.555 . . . . 0.0 109.714 177.008 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' E' E ' 88' ' ' LEU . . . . . . . . . . . . . 14.2 tp -108.8 131.08 55.32 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-O 120.972 0.415 . . . . 0.0 111.004 -177.591 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' E' E ' 89' ' ' ASP . . . . . . . . . . . . . 7.7 t70 -119.61 154.07 34.52 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 115.787 -0.642 . . . . 0.0 109.5 176.781 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' E' E ' 90' ' ' GLU . . . . . . . . . . . . . 82.4 tt0 -46.28 -43.57 15.8 Favored 'General case' 0 N--CA 1.464 0.263 0 N-CA-C 112.871 0.693 . . . . 0.0 112.871 -173.106 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' E' E ' 91' ' ' ASN . . . . . . . . . . . . . 16.0 t-20 -132.15 39.11 3.44 Favored 'General case' 0 C--N 1.331 -0.217 0 CA-C-O 120.907 0.384 . . . . 0.0 111.195 -178.815 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' E' E ' 92' ' ' LEU . . . . . . . . . . . . . 10.5 tp -166.08 147.26 6.72 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 116.526 -0.307 . . . . 0.0 110.386 -178.708 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' E' E ' 93' ' ' ILE . . . . . . . . . . . . . 65.8 mt -128.78 123.49 59.31 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.214 0 N-CA-C 109.483 -0.562 . . . . 0.0 109.483 -178.972 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' E' E ' 94' ' ' VAL . . . . . 0.647 HG21 HG11 ' E' ' 125' ' ' VAL . 44.1 t -124.24 129.36 74.07 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.216 0 CA-C-O 121.021 0.438 . . . . 0.0 110.035 -179.841 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' E' E ' 95' ' ' VAL . . . . . . . . . . . . . 42.5 t -122.04 135.83 60.89 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.328 0 CA-C-N 115.881 -0.599 . . . . 0.0 109.926 -178.906 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' E' E ' 96' ' ' ILE . . . . . . . . . . . . . 62.0 mt -111.92 126.7 69.33 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.355 0 N-CA-C 109.215 -0.661 . . . . 0.0 109.215 178.068 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' E' E ' 97' ' ' THR . . . . . . . . . . . . . 68.3 p -97.16 155.91 16.63 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-O 121.168 0.509 . . . . 0.0 111.134 -178.176 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' E' E ' 98' ' ' GLU . . . . . . . . . . . . . 82.6 tt0 -53.86 -25.88 21.89 Favored 'General case' 0 C--N 1.327 -0.372 0 N-CA-C 112.304 0.483 . . . . 0.0 112.304 -178.941 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' E' E ' 99' ' ' GLU . . . . . . . . . . . . . 71.2 mm-40 -81.56 16.16 1.83 Allowed 'General case' 0 CA--C 1.536 0.413 0 N-CA-C 113.137 0.791 . . . . 0.0 113.137 -176.74 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' E' E ' 100' ' ' ASN . . . . . . . . . . . . . 3.5 m-20 62.89 34.33 14.37 Favored 'General case' 0 CA--C 1.531 0.227 0 CA-C-O 120.909 0.385 . . . . 0.0 111.519 178.644 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' E' E ' 101' ' ' GLU . . . . . . . . . . . . . 84.6 tt0 -112.65 143.63 43.52 Favored 'General case' 0 C--N 1.334 -0.093 0 N-CA-C 109.69 -0.485 . . . . 0.0 109.69 173.422 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' E' E ' 102' ' ' VAL . . . . . . . . . . . . . 45.6 t -115.21 129.43 71.47 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.322 0 CA-C-N 116.49 -0.323 . . . . 0.0 110.297 -177.414 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' E' E ' 103' ' ' LEU . . . . . . . . . . . . . 51.1 mt -117.85 130.75 56.45 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-N 115.7 -0.682 . . . . 0.0 110.415 177.31 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' E' E ' 104' ' ' ILE . . . . . . . . . . . . . 70.7 mt -117.45 122.86 70.88 Favored 'Isoleucine or valine' 0 C--O 1.233 0.226 0 N-CA-C 110.154 -0.313 . . . . 0.0 110.154 178.373 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' E' E ' 105' ' ' PHE . . . . . . . . . . . . . 74.3 m-85 -123.6 164.36 19.19 Favored 'General case' 0 C--O 1.232 0.132 0 O-C-N 123.905 0.753 . . . . 0.0 109.876 -179.781 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' E' E ' 106' ' ' ASN . . . . . 0.415 ' HB3' HD11 ' E' ' 112' ' ' LEU . 43.5 p-10 -99.07 -170.02 1.86 Allowed 'General case' 0 C--N 1.33 -0.254 0 N-CA-C 109.738 -0.467 . . . . 0.0 109.738 172.381 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' E' E ' 107' ' ' GLN . . . . . . . . . . . . . 48.8 tt0 -57.91 -29.8 65.4 Favored 'General case' 0 C--N 1.329 -0.298 0 N-CA-C 112.025 0.38 . . . . 0.0 112.025 179.982 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' E' E ' 108' ' ' ASN . . . . . . . . . . . . . 22.5 t30 -88.69 13.14 12.99 Favored 'General case' 0 CA--C 1.535 0.388 0 N-CA-C 113.094 0.776 . . . . 0.0 113.094 -176.024 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' E' E ' 109' ' ' LEU . . . . . . . . . . . . . 38.4 mt 57.43 36.18 26.77 Favored 'General case' 0 C--N 1.333 -0.149 0 CA-C-O 120.941 0.4 . . . . 0.0 111.566 177.811 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' E' E ' 110' ' ' GLU . . . . . . . . . . . . . 95.6 mt-10 -100.56 155.26 17.95 Favored 'General case' 0 C--N 1.33 -0.258 0 N-CA-C 109.72 -0.474 . . . . 0.0 109.72 176.191 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' E' E ' 111' ' ' GLU . . . . . . . . . . . . . 84.4 tt0 -82.26 121.91 27.25 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-O 120.883 0.373 . . . . 0.0 110.92 -177.707 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' E' E ' 112' ' ' LEU . . . . . 0.415 HD11 ' HB3' ' E' ' 106' ' ' ASN . 75.2 mt -107.9 -45.99 3.87 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.017 -0.538 . . . . 0.0 110.047 176.416 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' E' E ' 113' ' ' TYR . . . . . . . . . . . . . 63.3 t80 -143.28 135.76 27.32 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.153 -0.476 . . . . 0.0 111.52 -179.395 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' E' E ' 114' ' ' ARG . . . . . . . . . . . . . 21.4 ttm180 -131.13 123.88 29.52 Favored 'General case' 0 C--N 1.331 -0.201 0 CA-C-N 115.775 -0.648 . . . . 0.0 109.623 173.529 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' E' E ' 115' ' ' GLY . . . . . . . . . . . . . . . -150.0 156.41 26.73 Favored Glycine 0 CA--C 1.523 0.539 0 N-CA-C 110.85 -0.9 . . . . 0.0 110.85 178.531 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' E' E ' 116' ' ' LYS . . . . . . . . . . . . . 55.6 tttt -132.68 140.31 48.08 Favored 'General case' 0 C--N 1.329 -0.309 0 O-C-N 122.646 -0.326 . . . . 0.0 110.16 179.245 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' E' E ' 117' ' ' PHE . . . . . . . . . . . . . 18.2 m-85 -139.63 113.82 8.95 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-O 120.887 0.375 . . . . 0.0 110.091 -176.194 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' E' E ' 118' ' ' GLU . . . . . . . . . . . . . 83.2 tt0 -53.3 -47.43 69.22 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.453 -0.339 . . . . 0.0 111.573 -175.84 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' E' E ' 119' ' ' ASN . . . . . . . . . . . . . 74.4 m-20 -95.15 31.12 1.98 Allowed 'General case' 0 C--N 1.332 -0.196 0 N-CA-C 112.265 0.468 . . . . 0.0 112.265 -174.45 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' E' E ' 120' ' ' LEU . . . . . . . . . . . . . 22.1 tp -55.85 122.95 12.66 Favored 'General case' 0 C--N 1.333 -0.136 0 CA-C-O 120.724 0.297 . . . . 0.0 110.52 177.146 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' E' E ' 121' ' ' ASN . . . . . . . . . . . . . 62.7 t30 -112.2 -44.08 3.46 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-N 116.362 -0.381 . . . . 0.0 110.718 -177.977 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' E' E ' 122' ' ' LYS . . . . . . . . . . . . . 98.0 mttt -143.45 144.76 32.15 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-O 120.96 0.409 . . . . 0.0 111.661 -177.476 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' E' E ' 123' ' ' VAL . . . . . . . . . . . . . 46.7 t -123.61 122.37 64.77 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.284 0 N-CA-C 109.136 -0.69 . . . . 0.0 109.136 173.826 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' E' E ' 124' ' ' LEU . . . . . 0.512 HD12 ' N ' ' E' ' 124' ' ' LEU . 5.6 mp -120.59 132.3 55.08 Favored 'General case' 0 C--N 1.331 -0.203 0 CA-C-N 116.483 -0.326 . . . . 0.0 110.389 -177.155 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' E' E ' 125' ' ' VAL . . . . . 0.647 HG11 HG21 ' E' ' 94' ' ' VAL . 35.1 m -135.56 138.74 47.7 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.314 0 CA-C-N 116.379 -0.373 . . . . 0.0 110.736 179.279 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' E' E ' 126' ' ' ARG . . . . . . . . . . . . . 32.8 ptt-85 -150.19 125.23 9.95 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 116.088 -0.506 . . . . 0.0 110.178 177.926 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' E' E ' 127' ' ' ASN . . . . . . . . . . . . . 85.5 m-20 55.07 -123.38 2.03 Favored 'General case' 0 CA--C 1.546 0.804 0 CA-C-O 118.529 -0.748 . . . . 0.0 110.209 -178.191 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' E' E ' 128' ' ' ASP . . . . . . . . . . . . . 23.3 p-10 -106.07 12.29 30.51 Favored 'General case' 0 CA--C 1.536 0.431 0 CA-C-N 120.235 1.379 . . . . 0.0 113.088 179.349 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' E' E ' 129' ' ' LEU . . . . . 0.442 HD23 ' N ' ' E' ' 130' ' ' VAL . 5.0 tt -106.14 132.63 51.98 Favored 'General case' 0 C--O 1.231 0.121 0 N-CA-C 109.653 -0.499 . . . . 0.0 109.653 179.079 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' E' E ' 130' ' ' VAL . . . . . 0.478 HG13 HG12 ' E' ' 125' ' ' VAL . 46.4 t -122.05 136.32 59.3 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.248 0 CA-C-O 120.894 0.378 . . . . 0.0 110.185 -177.926 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' E' E ' 131' ' ' VAL . . . . . 0.515 HG22 HD12 ' E' ' 140' ' ' LEU . 42.1 t -135.11 135.5 52.46 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.19 0 CA-C-O 121.128 0.49 . . . . 0.0 110.076 177.668 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' E' E ' 132' ' ' ILE . . . . . . . . . . . . . 74.7 mt -118.1 132.34 68.21 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.338 0 CA-C-N 115.746 -0.661 . . . . 0.0 109.532 -178.86 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' E' E ' 133' ' ' ILE . . . . . . . . . . . . . 37.5 mm -116.88 121.9 68.78 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.205 0 CA-C-O 120.78 0.324 . . . . 0.0 111.075 -174.694 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' E' E ' 134' ' ' ASP . . . . . . . . . . . . . 10.2 p-10 -135.23 149.84 49.96 Favored 'General case' 0 C--N 1.331 -0.221 0 CA-C-N 116.03 -0.532 . . . . 0.0 109.767 175.225 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' E' E ' 135' ' ' GLU . . . . . . . . . . . . . 85.1 tt0 -49.92 -26.67 4.36 Favored 'General case' 0 C--N 1.329 -0.318 0 N-CA-C 113.019 0.748 . . . . 0.0 113.019 -172.159 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' E' E ' 136' ' ' GLN . . . . . . . . . . . . . 99.7 mm-40 -85.55 -32.11 22.33 Favored 'General case' 0 C--O 1.235 0.299 0 N-CA-C 112.401 0.519 . . . . 0.0 112.401 -174.935 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' E' E ' 137' ' ' LYS . . . . . . . . . . . . . 55.7 pttt -168.54 174.07 7.04 Favored 'General case' 0 C--N 1.332 -0.186 0 CA-C-O 121.5 0.667 . . . . 0.0 112.257 -171.008 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' E' E ' 138' ' ' LEU . . . . . 0.438 ' C ' HD23 ' E' ' 138' ' ' LEU . 8.7 tt -121.88 130.1 53.09 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 115.032 -0.985 . . . . 0.0 110.264 179.8 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' E' E ' 139' ' ' THR . . . . . . . . . . . . . 38.0 m -108.3 130.27 55.19 Favored 'General case' 0 C--N 1.331 -0.23 0 CA-C-N 116.163 -0.471 . . . . 0.0 110.653 -179.546 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' E' E ' 140' ' ' LEU . . . . . 0.515 HD12 HG22 ' E' ' 131' ' ' VAL . 12.3 tp -116.34 121.8 43.02 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 115.724 -0.671 . . . . 0.0 109.332 -179.271 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' E' E ' 141' ' ' ILE . . . . . . . . . . . . . 18.9 mt -120.57 121.65 65.98 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.288 0 CA-C-O 120.976 0.417 . . . . 0.0 110.296 -175.152 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' E' E ' 142' ' ' ARG . . . . . . . . . . . . . 66.4 mtp180 -108.93 130.86 55.46 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 115.264 -0.88 . . . . 0.0 110.438 179.906 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' E' E ' 143' ' ' THR . . . . . . . . . . . . . 19.1 p . . . . . 0 C--O 1.221 -0.417 0 CA-C-O 117.988 -1.006 . . . . 0.0 110.492 178.782 . . . . . . . . 0 0 . 1 . 019 nuclear build core ' F' F ' 1' ' ' MET . . . . . . . . . . . . . 16.0 ptm . . . . . 0 CA--C 1.528 0.128 0 CA-C-O 120.679 0.276 . . . . 0.0 110.594 . . . . . . . . . 0 0 . 1 . 019 nuclear build core ' F' F ' 2' ' ' SER . . . . . . . . . . . . . 11.7 p -118.77 132.77 56.15 Favored 'General case' 0 C--N 1.332 -0.182 0 CA-C-O 121.006 0.431 . . . . 0.0 110.824 -179.335 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' F' F ' 3' ' ' GLU . . . . . . . . . . . . . 95.6 mt-10 -141.3 141.08 33.94 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 115.779 -0.646 . . . . 0.0 110.823 -179.284 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' F' F ' 4' ' ' LEU . . . . . . . . . . . . . 12.5 tp -129.38 131.05 46.74 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.235 -0.439 . . . . 0.0 110.267 177.115 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' F' F ' 5' ' ' LYS . . . . . . . . . . . . . 98.7 mttt -113.77 121.62 44.62 Favored 'General case' 0 C--O 1.234 0.247 0 CA-C-N 116.505 -0.316 . . . . 0.0 110.825 -179.708 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' F' F ' 6' ' ' LEU . . . . . 0.442 HD23 ' HA ' ' F' ' 50' ' ' VAL . 66.7 mt -114.05 145.08 42.08 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-N 115.478 -0.783 . . . . 0.0 110.007 179.372 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' F' F ' 7' ' ' LYS . . . . . . . . . . . . . 27.2 ttpp -126.72 141.22 39.7 Favored Pre-proline 0 CA--C 1.534 0.329 0 CA-C-O 119.059 -0.496 . . . . 0.0 109.804 176.134 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' F' F ' 8' ' ' PRO . . . . . . . . . . . . . 97.8 Cg_endo -92.07 137.2 1.76 Allowed 'Trans proline' 0 N--CA 1.49 1.295 0 C-N-CA 121.799 1.666 . . . . 0.0 111.897 178.801 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' F' F ' 9' ' ' LEU . . . . . . . . . . . . . 63.0 mt -75.64 -46.93 4.15 Favored Pre-proline 0 CA--C 1.535 0.384 0 CA-C-O 118.764 -0.636 . . . . 0.0 112.076 179.255 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' F' F ' 10' ' ' PRO . . . . . . . . . . . . . 71.1 Cg_endo -83.44 158.29 14.64 Favored 'Trans proline' 0 N--CA 1.497 1.691 0 C-N-CA 121.294 1.329 . . . . 0.0 112.179 175.583 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' F' F ' 11' ' ' LYS . . . . . . . . . . . . . 37.0 mmtm -79.19 105.33 10.44 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.396 -0.365 . . . . 0.0 110.167 176.044 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' F' F ' 12' ' ' VAL . . . . . . . . . . . . . 12.7 p -145.58 141.18 22.22 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.312 0 CA-C-O 120.833 0.349 . . . . 0.0 110.863 -179.602 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' F' F ' 13' ' ' GLU . . . . . . . . . . . . . 15.2 mm-40 -95.45 124.82 39.67 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.202 -0.454 . . . . 0.0 109.874 175.378 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' F' F ' 14' ' ' LEU . . . . . . . . . . . . . 44.6 mt -96.79 151.49 37.88 Favored Pre-proline 0 C--N 1.328 -0.332 0 CA-C-N 116.411 -0.359 . . . . 0.0 110.497 -177.131 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' F' F ' 15' ' ' PRO . . . . . . . . . . . . . 35.4 Cg_exo -59.3 158.49 26.37 Favored 'Trans proline' 0 N--CA 1.497 1.716 0 C-N-CA 121.27 1.313 . . . . 0.0 111.795 178.715 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' F' F ' 16' ' ' PRO . . . . . . . . . . . . . 37.1 Cg_exo -59.03 -37.75 91.42 Favored 'Trans proline' 0 N--CA 1.497 1.677 0 C-N-CA 121.472 1.448 . . . . 0.0 112.516 -179.485 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' F' F ' 17' ' ' ASP . . . . . . . . . . . . . 18.2 p-10 -89.04 14.02 11.63 Favored 'General case' 0 CA--C 1.536 0.406 0 N-CA-C 112.984 0.735 . . . . 0.0 112.984 -178.77 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' F' F ' 18' ' ' PHE . . . . . 0.502 ' CZ ' HD11 ' F' ' 22' ' ' ILE . 53.0 t80 -58.4 -45.25 88.74 Favored 'General case' 0 N--CA 1.457 -0.082 0 O-C-N 121.975 -0.453 . . . . 0.0 110.122 -177.487 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' F' F ' 19' ' ' VAL . . . . . 0.402 HG13 ' N ' ' F' ' 20' ' ' ASP . 14.6 p -55.15 -41.39 59.89 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.243 0 CA-C-N 116.512 -0.313 . . . . 0.0 111.066 -177.96 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' F' F ' 20' ' ' ASP . . . . . 0.402 ' N ' HG13 ' F' ' 19' ' ' VAL . 68.5 m-20 -60.5 -44.47 95.95 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-O 120.83 0.348 . . . . 0.0 110.852 -179.19 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' F' F ' 21' ' ' VAL . . . . . . . . . . . . . 50.4 t -64.07 -48.37 86.2 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.308 0 CA-C-N 116.43 -0.35 . . . . 0.0 110.568 -177.478 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' F' F ' 22' ' ' ILE . . . . . 0.72 HG22 HD12 ' F' ' 26' ' ' LEU . 49.0 mm -58.01 -43.55 85.21 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.288 0 C-N-CA 120.926 -0.309 . . . . 0.0 110.754 -178.885 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' F' F ' 23' ' ' ARG . . . . . . . . . . . . . 55.7 ttp180 -55.92 -47.56 77.29 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-O 120.654 0.264 . . . . 0.0 110.832 -179.98 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' F' F ' 24' ' ' ILE . . . . . . . . . . . . . 69.0 mt -60.49 -41.03 86.17 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.29 0 CA-C-N 116.578 -0.283 . . . . 0.0 111.643 -178.473 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' F' F ' 25' ' ' LYS . . . . . 0.621 ' HE3' HD13 ' F' ' 22' ' ' ILE . 14.9 ptpt -74.13 -35.14 64.08 Favored 'General case' 0 CA--C 1.534 0.327 0 N-CA-C 112.317 0.488 . . . . 0.0 112.317 -175.063 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' F' F ' 26' ' ' LEU . . . . . 0.72 HD12 HG22 ' F' ' 22' ' ' ILE . 22.7 mt -80.66 -38.89 28.27 Favored 'General case' 0 C--N 1.327 -0.378 0 N-CA-C 113.31 0.855 . . . . 0.0 113.31 -173.662 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' F' F ' 27' ' ' GLN . . . . . . . . . . . . . 16.6 pt20 -46.47 141.23 3.74 Favored 'General case' 0 N--CA 1.47 0.528 0 N-CA-C 112.784 0.661 . . . . 0.0 112.784 -174.411 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' F' F ' 28' ' ' GLY . . . . . . . . . . . . . . . 101.14 -25.92 26.52 Favored Glycine 0 CA--C 1.532 1.122 0 CA-C-N 115.464 -0.789 . . . . 0.0 112.262 -176.477 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' F' F ' 29' ' ' LYS . . . . . . . . . . . . . 55.5 mtpt -98.04 155.04 17.31 Favored 'General case' 0 C--N 1.332 -0.161 0 CA-C-N 117.483 0.642 . . . . 0.0 111.183 178.827 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' F' F ' 30' ' ' THR . . . . . . . . . . . . . 29.9 m -103.63 138.97 39.56 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 115.988 -0.551 . . . . 0.0 109.964 176.127 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' F' F ' 31' ' ' VAL . . . . . . . . . . . . . 35.0 m -129.46 156.25 41.78 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.235 0 CA-C-N 116.382 -0.372 . . . . 0.0 110.972 -178.26 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' F' F ' 32' ' ' ARG . . . . . . . . . . . . . 93.6 mtm-85 -133.31 148.41 51.9 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 115.731 -0.668 . . . . 0.0 110.248 177.439 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' F' F ' 33' ' ' THR . . . . . . . . . . . . . 19.0 m -53.03 140.03 26.35 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.411 -0.359 . . . . 0.0 111.372 -178.442 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' F' F ' 34' ' ' GLY . . . . . . . . . . . . . . . 100.33 -17.14 57.3 Favored Glycine 0 CA--C 1.532 1.144 0 CA-C-O 119.609 -0.55 . . . . 0.0 113.251 179.765 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' F' F ' 35' ' ' ASP . . . . . . . . . . . . . 73.3 m-20 -65.66 149.28 50.36 Favored 'General case' 0 N--CA 1.462 0.151 0 CA-C-N 118.04 0.92 . . . . 0.0 111.094 179.435 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' F' F ' 36' ' ' VAL . . . . . . . . . . . . . 45.6 t -124.83 131.31 72.8 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.174 0 CA-C-N 115.963 -0.562 . . . . 0.0 109.801 178.335 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' F' F ' 37' ' ' ILE . . . . . . . . . . . . . 65.1 mt -122.09 140.0 47.35 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.224 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.027 -178.678 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' F' F ' 38' ' ' GLY . . . . . . . . . . . . . . . -113.76 128.63 8.39 Favored Glycine 0 CA--C 1.524 0.639 0 N-CA-C 110.888 -0.885 . . . . 0.0 110.888 178.329 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' F' F ' 39' ' ' ILE . . . . . . . . . . . . . 71.8 mt -127.52 133.97 66.64 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.197 0 N-CA-C 110.093 -0.336 . . . . 0.0 110.093 179.439 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' F' F ' 40' ' ' SER . . . . . . . . . . . . . 20.4 t -92.35 124.26 36.28 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.376 -0.375 . . . . 0.0 111.298 178.381 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' F' F ' 41' ' ' ILE . . . . . . . . . . . . . 68.9 mt -134.35 121.9 38.46 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.236 0 N-CA-C 110.058 -0.349 . . . . 0.0 110.058 176.436 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' F' F ' 42' ' ' LEU . . . . . . . . . . . . . 45.0 mt 58.84 35.13 24.11 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.087 -0.506 . . . . 0.0 111.694 177.942 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' F' F ' 43' ' ' GLY . . . . . . . . . . . . . . . 74.35 13.13 81.78 Favored Glycine 0 CA--C 1.534 1.231 0 C-N-CA 121.135 -0.555 . . . . 0.0 113.371 176.964 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' F' F ' 44' ' ' LYS . . . . . . . . . . . . . 94.9 mttt -126.21 130.98 52.03 Favored 'General case' 0 C--N 1.332 -0.155 0 CA-C-N 117.847 0.824 . . . . 0.0 109.785 177.191 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' F' F ' 45' ' ' GLU . . . . . . . . . . . . . 83.9 tt0 -84.81 130.5 34.66 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-O 120.887 0.375 . . . . 0.0 111.39 -178.391 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' F' F ' 46' ' ' VAL . . . . . . . . . . . . . 9.8 p -117.96 128.26 75.09 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.236 0 N-CA-C 109.566 -0.531 . . . . 0.0 109.566 174.508 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' F' F ' 47' ' ' LYS . . . . . . . . . . . . . 92.3 mttt -98.13 124.29 42.61 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.157 -0.474 . . . . 0.0 110.693 177.846 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' F' F ' 48' ' ' PHE . . . . . . . . . . . . . 33.5 m-85 -108.43 131.79 54.43 Favored 'General case' 0 C--N 1.329 -0.32 0 N-CA-C 109.571 -0.529 . . . . 0.0 109.571 175.866 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' F' F ' 49' ' ' LYS . . . . . . . . . . . . . 46.6 tttm -108.58 134.2 51.67 Favored 'General case' 0 C--N 1.331 -0.227 0 CA-C-N 116.342 -0.39 . . . . 0.0 110.202 177.678 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' F' F ' 50' ' ' VAL . . . . . 0.442 ' HA ' HD23 ' F' ' 6' ' ' LEU . 45.0 t -78.74 105.68 8.38 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.342 0 N-CA-C 109.368 -0.604 . . . . 0.0 109.368 177.227 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' F' F ' 51' ' ' VAL . . . . . . . . . . . . . 47.8 t -69.68 -52.78 28.65 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.276 0 N-CA-C 109.534 -0.543 . . . . 0.0 109.534 -175.903 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' F' F ' 52' ' ' GLN . . . . . . . . . . . . . 87.8 mt-30 -153.54 151.12 29.42 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 115.889 -0.596 . . . . 0.0 111.544 -178.634 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' F' F ' 53' ' ' ALA . . . . . . . . . . . . . . . -128.82 134.17 48.25 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 115.021 -0.99 . . . . 0.0 109.493 175.089 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' F' F ' 54' ' ' TYR . . . . . . . . . . . . . 84.3 t80 -129.12 111.47 18.31 Favored Pre-proline 0 CA--C 1.535 0.401 0 CA-C-O 118.15 -0.929 . . . . 0.0 110.387 -179.862 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' F' F ' 55' ' ' PRO . . . . . . . . . . . . . 73.4 Cg_endo -77.07 169.18 75.01 Favored 'Cis proline' 0 N--CA 1.5 1.879 0 CA-C-N 121.94 1.729 . . . . 0.0 112.303 -5.952 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' F' F ' 56' ' ' SER . . . . . . . . . . . . . 13.7 m -116.76 128.16 26.21 Favored Pre-proline 0 CA--C 1.538 0.509 0 CA-C-O 118.366 -0.826 . . . . 0.0 109.274 174.686 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' F' F ' 57' ' ' PRO . . . . . . . . . . . . . 37.2 Cg_endo -66.68 165.44 64.93 Favored 'Cis proline' 0 N--CA 1.496 1.647 0 CA-C-N 122.023 1.758 . . . . 0.0 111.78 0.259 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' F' F ' 58' ' ' LEU . . . . . . . . . . . . . 26.6 tp -130.08 135.85 48.69 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.155 -0.475 . . . . 0.0 110.276 179.296 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' F' F ' 59' ' ' ARG . . . . . . . . . . . . . 58.2 ttt-85 -103.82 125.02 49.97 Favored 'General case' 0 C--N 1.327 -0.406 0 N-CA-C 109.278 -0.638 . . . . 0.0 109.278 175.39 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' F' F ' 60' ' ' VAL . . . . . . . . . . . . . 47.6 t -76.86 117.81 22.36 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.318 0 C-N-CA 120.756 -0.378 . . . . 0.0 110.362 -175.127 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' F' F ' 61' ' ' GLU . . . . . . . . . . . . . 95.6 mt-10 -130.95 166.44 20.95 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 115.728 -0.669 . . . . 0.0 109.661 177.917 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' F' F ' 62' ' ' ASP . . . . . . . . . . . . . 82.0 m-20 -53.97 -32.58 54.41 Favored 'General case' 0 C--N 1.329 -0.312 0 C-N-CA 121.012 -0.275 . . . . 0.0 111.688 179.651 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' F' F ' 63' ' ' ARG . . . . . . . . . . . . . 49.8 ptt85 -78.41 -1.0 31.38 Favored 'General case' 0 CA--C 1.537 0.46 0 N-CA-C 113.781 1.03 . . . . 0.0 113.781 -175.838 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' F' F ' 64' ' ' THR . . . . . . . . . . . . . 34.3 m -86.6 134.75 33.61 Favored 'General case' 0 C--O 1.232 0.161 0 CA-C-N 118.164 0.438 . . . . 0.0 110.808 -177.158 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' F' F ' 65' ' ' LYS . . . . . . . . . . . . . 90.9 mttt -90.01 128.11 36.2 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.01 -0.541 . . . . 0.0 110.211 178.208 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' F' F ' 66' ' ' ILE . . . . . . . . . . . . . 63.3 mt -114.04 130.93 67.38 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.252 0 N-CA-C 109.886 -0.412 . . . . 0.0 109.886 -179.682 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' F' F ' 67' ' ' THR . . . . . . . . . . . . . 30.5 m -125.5 143.57 50.94 Favored 'General case' 0 C--N 1.331 -0.227 0 CA-C-N 116.013 -0.54 . . . . 0.0 111.113 -177.977 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' F' F ' 68' ' ' LEU . . . . . . . . . . . . . 20.6 tp . . . . . 0 C--N 1.33 -0.269 0 CA-C-N 115.687 -0.688 . . . . 0.0 110.118 177.431 . . . . . . . . 0 0 . 1 . 019 nuclear build core ' F' F ' 73' ' ' VAL . . . . . . . . . . . . . 34.3 m . . . . . 0 N--CA 1.462 0.164 0 CA-C-O 120.893 0.378 . . . . 0.0 111.002 . . . . . . . . . 0 0 . 1 . 019 nuclear build core ' F' F ' 74' ' ' ASP . . . . . . . . . . . . . 33.0 t0 -100.79 124.08 45.92 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 115.842 -0.617 . . . . 0.0 110.233 -178.923 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' F' F ' 75' ' ' VAL . . . . . . . . . . . . . 42.5 t -118.1 123.17 71.25 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.24 0 CA-C-O 121.027 0.441 . . . . 0.0 110.594 -178.294 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' F' F ' 76' ' ' LEU . . . . . 0.516 HD12 ' N ' ' F' ' 76' ' ' LEU . 5.5 mp -121.94 147.89 45.47 Favored 'General case' 0 C--N 1.331 -0.217 0 CA-C-N 115.744 -0.662 . . . . 0.0 109.686 175.661 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' F' F ' 77' ' ' GLU . . . . . . . . . . . . . 96.4 mt-10 -137.63 132.17 32.61 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-O 121.005 0.431 . . . . 0.0 111.165 -178.712 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' F' F ' 78' ' ' ALA . . . . . . . . . . . . . . . -115.33 131.01 57.07 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 115.744 -0.662 . . . . 0.0 109.859 177.17 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' F' F ' 79' ' ' LYS . . . . . 0.623 ' O ' HD13 ' F' ' 80' ' ' ILE . 34.3 tptt -85.75 117.42 24.62 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-O 120.798 0.332 . . . . 0.0 110.955 -176.71 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' F' F ' 80' ' ' ILE . . . . . 0.623 HD13 ' O ' ' F' ' 79' ' ' LYS . 39.1 mm -139.23 107.46 3.26 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.272 0 N-CA-C 109.227 -0.657 . . . . 0.0 109.227 -179.314 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' F' F ' 81' ' ' LYS . . . . . . . . . . . . . 38.8 ttpt -89.08 121.47 31.45 Favored 'General case' 0 C--N 1.328 -0.334 0 C-N-CA 120.865 -0.334 . . . . 0.0 111.084 -177.207 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' F' F ' 82' ' ' GLY . . . . . . . . . . . . . . . 89.21 42.19 5.64 Favored Glycine 0 CA--C 1.525 0.698 0 C-N-CA 120.561 -0.828 . . . . 0.0 111.651 174.239 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' F' F ' 83' ' ' ILE . . . . . . . . . . . . . 73.9 mt -65.45 139.79 20.75 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.306 0 N-CA-C 109.623 -0.51 . . . . 0.0 109.623 176.997 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' F' F ' 84' ' ' LYS . . . . . . . . . . . . . 84.3 tttt -94.72 -53.27 3.93 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.028 -0.533 . . . . 0.0 110.49 -176.773 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' F' F ' 85' ' ' ASP . . . . . . . . . . . . . 9.3 t70 -154.12 153.1 31.25 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 115.787 -0.642 . . . . 0.0 110.313 -179.39 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' F' F ' 86' ' ' VAL . . . . . . . . . . . . . 44.4 t -130.79 131.12 64.66 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.247 0 CA-C-O 120.846 0.355 . . . . 0.0 110.616 -179.009 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' F' F ' 87' ' ' ILE . . . . . 0.497 HD12 ' N ' ' F' ' 87' ' ' ILE . 5.1 mp -123.13 126.57 73.76 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.249 0 CA-C-N 115.992 -0.549 . . . . 0.0 109.566 176.892 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' F' F ' 88' ' ' LEU . . . . . . . . . . . . . 53.7 mt -113.18 137.76 50.98 Favored 'General case' 0 C--N 1.331 -0.224 0 CA-C-O 121.12 0.486 . . . . 0.0 111.649 -175.963 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' F' F ' 89' ' ' ASP . . . . . . . . . . . . . 12.3 t0 -133.23 150.76 51.93 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 115.592 -0.731 . . . . 0.0 109.279 174.973 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' F' F ' 90' ' ' GLU . . . . . . . . . . . . . 82.9 tt0 -48.18 -38.01 17.15 Favored 'General case' 0 C--N 1.33 -0.258 0 N-CA-C 112.827 0.677 . . . . 0.0 112.827 -173.385 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' F' F ' 91' ' ' ASN . . . . . . . . . . . . . 26.5 m120 -128.44 32.93 4.77 Favored 'General case' 0 N--CA 1.466 0.361 0 N-CA-C 111.794 0.294 . . . . 0.0 111.794 -177.077 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' F' F ' 92' ' ' LEU . . . . . . . . . . . . . 19.3 tp -166.13 138.9 4.01 Favored 'General case' 0 C--N 1.33 -0.259 0 N-CA-C 110.2 -0.296 . . . . 0.0 110.2 -179.438 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' F' F ' 93' ' ' ILE . . . . . . . . . . . . . 71.0 mt -126.36 122.46 61.3 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.279 0 N-CA-C 109.666 -0.494 . . . . 0.0 109.666 178.368 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' F' F ' 94' ' ' VAL . . . . . 0.558 HG21 HG11 ' F' ' 125' ' ' VAL . 43.8 t -120.78 126.25 75.01 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.265 0 N-CA-C 109.887 -0.412 . . . . 0.0 109.887 179.995 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' F' F ' 95' ' ' VAL . . . . . . . . . . . . . 42.7 t -121.45 133.77 66.92 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.282 0 CA-C-N 115.939 -0.573 . . . . 0.0 109.665 179.849 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' F' F ' 96' ' ' ILE . . . . . . . . . . . . . 60.9 mt -115.5 126.66 73.12 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.323 0 N-CA-C 109.363 -0.606 . . . . 0.0 109.363 179.039 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' F' F ' 97' ' ' THR . . . . . . . . . . . . . 80.8 p -96.5 156.52 16.31 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-O 120.863 0.363 . . . . 0.0 110.765 -179.191 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' F' F ' 98' ' ' GLU . . . . . . . . . . . . . 40.8 tp10 -53.82 -25.54 19.97 Favored 'General case' 0 CA--C 1.533 0.317 0 N-CA-C 112.111 0.411 . . . . 0.0 112.111 -179.461 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' F' F ' 99' ' ' GLU . . . . . . . . . . . . . 18.1 tp10 -80.05 17.42 1.0 Allowed 'General case' 0 CA--C 1.538 0.503 0 N-CA-C 112.858 0.688 . . . . 0.0 112.858 -177.732 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' F' F ' 100' ' ' ASN . . . . . . . . . . . . . 3.6 m-20 63.1 35.59 12.83 Favored 'General case' 0 CA--C 1.531 0.233 0 CA-C-O 120.882 0.372 . . . . 0.0 111.435 176.39 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' F' F ' 101' ' ' GLU . . . . . . . . . . . . . 83.9 tt0 -113.19 142.06 46.23 Favored 'General case' 0 C--N 1.332 -0.173 0 N-CA-C 109.866 -0.42 . . . . 0.0 109.866 175.355 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' F' F ' 102' ' ' VAL . . . . . . . . . . . . . 45.8 t -115.01 126.17 72.53 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.266 0 N-CA-C 109.896 -0.409 . . . . 0.0 109.896 -178.537 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' F' F ' 103' ' ' LEU . . . . . . . . . . . . . 58.2 mt -116.1 133.85 55.57 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 115.685 -0.689 . . . . 0.0 109.796 177.798 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' F' F ' 104' ' ' ILE . . . . . . . . . . . . . 73.8 mt -121.53 119.41 58.87 Favored 'Isoleucine or valine' 0 C--O 1.233 0.23 0 N-CA-C 110.211 -0.292 . . . . 0.0 110.211 -178.939 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' F' F ' 105' ' ' PHE . . . . . . . . . . . . . 35.5 m-85 -121.79 168.2 12.11 Favored 'General case' 0 C--N 1.332 -0.153 0 O-C-N 124.222 0.951 . . . . 0.0 109.907 -179.968 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' F' F ' 106' ' ' ASN . . . . . . . . . . . . . 45.5 p-10 -102.56 -170.03 1.75 Allowed 'General case' 0 C--N 1.33 -0.273 0 N-CA-C 109.509 -0.552 . . . . 0.0 109.509 171.917 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' F' F ' 107' ' ' GLN . . . . . . . . . . . . . 57.1 tt0 -58.21 -26.1 62.4 Favored 'General case' 0 CA--C 1.534 0.337 0 N-CA-C 112.162 0.43 . . . . 0.0 112.162 179.024 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' F' F ' 108' ' ' ASN . . . . . 0.409 ' O ' ' ND2' ' F' ' 108' ' ' ASN . 1.2 t30 -91.16 13.29 17.43 Favored 'General case' 0 CA--C 1.536 0.426 0 N-CA-C 112.974 0.731 . . . . 0.0 112.974 -176.729 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' F' F ' 109' ' ' LEU . . . . . . . . . . . . . 67.7 mt 57.17 35.44 26.24 Favored 'General case' 0 CA--C 1.53 0.178 0 CA-C-O 120.714 0.292 . . . . 0.0 111.543 177.795 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' F' F ' 110' ' ' GLU . . . . . . . . . . . . . 70.8 mm-40 -102.75 149.27 24.63 Favored 'General case' 0 C--N 1.33 -0.282 0 N-CA-C 109.897 -0.409 . . . . 0.0 109.897 176.249 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' F' F ' 111' ' ' GLU . . . . . . . . . . . . . 98.6 mt-10 -81.47 121.97 26.94 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-O 120.997 0.427 . . . . 0.0 111.38 -176.644 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' F' F ' 112' ' ' LEU . . . . . . . . . . . . . 44.7 mt -105.52 -45.69 4.38 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 115.852 -0.613 . . . . 0.0 109.905 175.94 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' F' F ' 113' ' ' TYR . . . . . . . . . . . . . 61.5 t80 -141.92 140.86 32.91 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 115.976 -0.556 . . . . 0.0 110.761 179.928 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' F' F ' 114' ' ' ARG . . . . . . . . . . . . . 71.7 mtm180 -145.17 121.0 10.59 Favored 'General case' 0 C--N 1.331 -0.226 0 CA-C-N 116.358 -0.383 . . . . 0.0 110.557 177.65 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' F' F ' 115' ' ' GLY . . . . . . . . . . . . . . . -150.13 162.67 29.28 Favored Glycine 0 CA--C 1.525 0.677 0 N-CA-C 110.908 -0.877 . . . . 0.0 110.908 -179.603 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' F' F ' 116' ' ' LYS . . . . . . . . . . . . . 1.9 ttmp? -126.43 136.0 52.1 Favored 'General case' 0 C--N 1.33 -0.267 0 N-CA-C 109.933 -0.395 . . . . 0.0 109.933 176.47 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' F' F ' 117' ' ' PHE . . . . . . . . . . . . . 60.6 m-85 -128.91 115.13 17.38 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.237 -0.438 . . . . 0.0 110.264 -176.519 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' F' F ' 118' ' ' GLU . . . . . . . . . . . . . 84.5 tt0 -51.83 -49.16 63.38 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 116.431 -0.349 . . . . 0.0 111.742 -175.718 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' F' F ' 119' ' ' ASN . . . . . . . . . . . . . 5.2 m120 -98.8 31.08 3.06 Favored 'General case' 0 C--N 1.33 -0.249 0 N-CA-C 112.126 0.417 . . . . 0.0 112.126 -174.053 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' F' F ' 120' ' ' LEU . . . . . . . . . . . . . 19.1 tp -54.5 121.29 8.07 Favored 'General case' 0 N--CA 1.462 0.157 0 CA-C-O 120.671 0.272 . . . . 0.0 110.959 179.056 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' F' F ' 121' ' ' ASN . . . . . . . . . . . . . 6.6 t-20 -113.97 -44.08 3.19 Favored 'General case' 0 C--N 1.333 -0.113 0 CA-C-N 116.536 -0.302 . . . . 0.0 111.008 -177.352 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' F' F ' 122' ' ' LYS . . . . . . . . . . . . . 95.8 mttt -146.9 151.36 36.93 Favored 'General case' 0 C--N 1.331 -0.209 0 CA-C-O 121.064 0.459 . . . . 0.0 111.734 -178.416 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' F' F ' 123' ' ' VAL . . . . . . . . . . . . . 46.1 t -129.52 124.41 59.54 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.325 0 N-CA-C 109.181 -0.674 . . . . 0.0 109.181 173.058 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' F' F ' 124' ' ' LEU . . . . . 0.5 HD12 ' N ' ' F' ' 124' ' ' LEU . 6.1 mp -117.1 138.79 51.4 Favored 'General case' 0 C--N 1.331 -0.215 0 CA-C-O 120.818 0.342 . . . . 0.0 110.492 -176.699 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' F' F ' 125' ' ' VAL . . . . . 0.652 HG12 HG23 ' F' ' 130' ' ' VAL . 35.2 m -135.16 140.06 45.84 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.238 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.996 -179.514 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' F' F ' 126' ' ' ARG . . . . . . . . . . . . . 6.7 ptm85 -139.86 118.98 12.69 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 115.938 -0.574 . . . . 0.0 109.966 176.052 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' F' F ' 127' ' ' ASN . . . . . . . . . . . . . 29.9 m120 52.55 -107.65 0.35 Allowed 'General case' 0 CA--C 1.544 0.747 0 CA-C-O 118.968 -0.539 . . . . 0.0 111.053 -178.221 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' F' F ' 128' ' ' ASP . . . . . . . . . . . . . 9.5 p-10 -114.17 3.9 15.36 Favored 'General case' 0 N--CA 1.467 0.4 0 CA-C-N 119.746 1.157 . . . . 0.0 113.476 -178.378 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' F' F ' 129' ' ' LEU . . . . . . . . . . . . . 10.4 tp -105.04 141.81 35.94 Favored 'General case' 0 C--O 1.232 0.142 0 N-CA-C 109.619 -0.512 . . . . 0.0 109.619 179.413 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' F' F ' 130' ' ' VAL . . . . . 0.652 HG23 HG12 ' F' ' 125' ' ' VAL . 14.5 p -133.12 143.4 39.44 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.249 0 CA-C-O 121.312 0.577 . . . . 0.0 111.5 -175.538 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' F' F ' 131' ' ' VAL . . . . . . . . . . . . . 43.8 t -136.06 137.58 48.45 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.232 0 CA-C-N 115.591 -0.732 . . . . 0.0 109.949 177.882 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' F' F ' 132' ' ' ILE . . . . . . . . . . . . . 69.6 mt -114.21 134.08 58.23 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.257 0 CA-C-N 116.075 -0.511 . . . . 0.0 109.628 -179.215 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' F' F ' 133' ' ' ILE . . . . . . . . . . . . . 43.2 mm -117.92 119.53 61.79 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.238 0 CA-C-O 121.007 0.432 . . . . 0.0 110.819 -176.549 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' F' F ' 134' ' ' ASP . . . . . . . . . . . . . 7.3 p-10 -132.84 144.68 50.37 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 115.77 -0.65 . . . . 0.0 109.329 174.834 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' F' F ' 135' ' ' GLU . . . . . . . . . . . . . 85.5 tt0 -49.86 -25.04 2.8 Favored 'General case' 0 C--N 1.328 -0.332 0 N-CA-C 112.942 0.719 . . . . 0.0 112.942 -170.745 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' F' F ' 136' ' ' GLN . . . . . . . . . . . . . 97.4 mt-30 -94.09 -34.47 12.97 Favored 'General case' 0 C--N 1.331 -0.221 0 N-CA-C 112.112 0.412 . . . . 0.0 112.112 -176.953 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' F' F ' 137' ' ' LYS . . . . . . . . . . . . . 78.6 mttt -139.91 153.21 46.91 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-O 121.247 0.546 . . . . 0.0 111.702 -170.149 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' F' F ' 138' ' ' LEU . . . . . 0.441 HD23 ' C ' ' F' ' 138' ' ' LEU . 6.6 tt -117.56 123.07 45.35 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 115.53 -0.759 . . . . 0.0 108.973 170.94 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' F' F ' 139' ' ' THR . . . . . 0.442 HG23 ' HG2' ' A' ' 77' ' ' GLU . 31.3 m -114.55 128.58 56.4 Favored 'General case' 0 C--N 1.331 -0.218 0 CA-C-N 116.327 -0.397 . . . . 0.0 111.053 -175.537 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' F' F ' 140' ' ' LEU . . . . . 0.479 HD23 ' C ' ' F' ' 140' ' ' LEU . 7.3 tt -114.18 125.08 53.53 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 115.619 -0.719 . . . . 0.0 109.308 179.634 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' F' F ' 141' ' ' ILE . . . . . 0.49 ' HB ' HG13 ' F' ' 130' ' ' VAL . 19.0 mt -124.72 119.78 57.07 Favored 'Isoleucine or valine' 0 C--O 1.235 0.31 0 CA-C-O 121.005 0.431 . . . . 0.0 110.52 -175.301 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' F' F ' 142' ' ' ARG . . . . . . . . . . . . . 94.1 mtt180 -94.69 125.25 39.22 Favored 'General case' 0 C--N 1.332 -0.182 0 CA-C-N 115.249 -0.887 . . . . 0.0 109.387 174.527 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' F' F ' 143' ' ' THR . . . . . . . . . . . . . 45.1 p . . . . . 0 C--O 1.221 -0.437 0 CA-C-O 117.982 -1.009 . . . . 0.0 110.61 179.58 . . . . . . . . 0 0 . 1 . 020 nuclear build core ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 59.9 p . . . . . 0 C--O 1.231 0.103 0 N-CA-C 110.063 -0.347 . . . . 0.0 110.063 . . . . . . . . . 0 0 . 1 . 020 nuclear build core ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 95.6 mt-10 -139.95 142.75 36.36 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-O 121.08 0.467 . . . . 0.0 111.385 -177.423 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 4' ' ' LEU . . . . . 0.423 HD21 HD23 ' A' ' 58' ' ' LEU . 39.0 mt -120.86 127.52 51.96 Favored 'General case' 0 C--N 1.331 -0.215 0 CA-C-N 115.603 -0.726 . . . . 0.0 110.043 174.978 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 5' ' ' LYS . . . . . . . . . . . . . 88.8 mttt -108.9 119.43 39.54 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-O 120.862 0.363 . . . . 0.0 110.498 176.364 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 45.6 mt -115.55 146.73 41.47 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 115.297 -0.865 . . . . 0.0 110.234 -179.199 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 75.4 tttt -135.91 136.25 22.93 Favored Pre-proline 0 CA--C 1.534 0.328 0 CA-C-O 118.981 -0.533 . . . . 0.0 110.247 176.125 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 8' ' ' PRO . . . . . . . . . . . . . 89.1 Cg_endo -90.81 141.86 3.17 Favored 'Trans proline' 0 N--CA 1.491 1.361 0 C-N-CA 121.553 1.502 . . . . 0.0 111.526 176.281 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 65.1 mt -73.4 -47.42 7.5 Favored Pre-proline 0 CA--C 1.533 0.313 0 CA-C-O 118.711 -0.661 . . . . 0.0 112.235 -178.266 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 83.2 Cg_endo -80.95 153.11 19.21 Favored 'Trans proline' 0 N--CA 1.495 1.608 0 C-N-CA 121.268 1.312 . . . . 0.0 111.767 175.558 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 24.7 ttpp -86.99 102.57 14.52 Favored 'General case' 0 C--N 1.329 -0.295 0 C-N-CA 120.772 -0.371 . . . . 0.0 110.174 178.588 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 11.8 p -141.33 144.05 26.86 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.291 0 CA-C-N 116.275 -0.42 . . . . 0.0 110.368 -179.412 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 95.3 mt-10 -84.5 129.84 34.81 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.062 178.635 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 14' ' ' LEU . . . . . . . . . . . . . 34.7 mt -98.66 148.54 34.69 Favored Pre-proline 0 CA--C 1.533 0.327 0 CA-C-O 119.229 -0.415 . . . . 0.0 110.629 -177.938 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 15' ' ' PRO . . . . . . . . . . . . . 24.5 Cg_exo -63.51 163.64 23.34 Favored 'Trans proline' 0 N--CA 1.498 1.758 0 C-N-CA 121.382 1.388 . . . . 0.0 111.978 175.992 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 16' ' ' PRO . . . . . . . . . . . . . 25.6 Cg_exo -61.29 -39.91 53.79 Favored 'Trans proline' 0 N--CA 1.496 1.651 0 C-N-CA 121.544 1.496 . . . . 0.0 112.836 -178.511 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 17' ' ' ASP . . . . . . . . . . . . . 7.9 p-10 -83.64 4.57 27.88 Favored 'General case' 0 CA--C 1.535 0.394 0 N-CA-C 113.344 0.868 . . . . 0.0 113.344 -176.973 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 18' ' ' PHE . . . . . . . . . . . . . 39.7 t80 -57.28 -46.66 82.89 Favored 'General case' 0 N--CA 1.457 -0.098 0 O-C-N 121.943 -0.473 . . . . 0.0 110.471 -176.494 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 19' ' ' VAL . . . . . . . . . . . . . 45.9 t -56.05 -47.15 80.71 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.362 0 CA-C-N 116.477 -0.328 . . . . 0.0 110.831 -176.527 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 49.3 m-20 -60.13 -41.09 91.95 Favored 'General case' 0 C--N 1.329 -0.302 0 C-N-CA 120.921 -0.312 . . . . 0.0 111.158 -176.954 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 56.1 t -64.74 -45.3 95.56 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.255 0 C-N-CA 120.746 -0.382 . . . . 0.0 110.504 -177.78 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 22' ' ' ILE . . . . . 0.583 HG22 HD12 ' A' ' 26' ' ' LEU . 51.2 mm -56.49 -45.05 81.89 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.235 0 C-N-CA 121.031 -0.268 . . . . 0.0 110.385 178.027 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 23' ' ' ARG . . . . . . . . . . . . . 45.3 ttp180 -53.99 -48.8 70.02 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-O 120.611 0.243 . . . . 0.0 111.375 -179.629 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 24' ' ' ILE . . . . . . . . . . . . . 70.7 mt -60.55 -43.26 94.09 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.349 0 CA-C-O 120.634 0.254 . . . . 0.0 111.025 -178.217 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 74.5 mttt -64.97 -36.48 84.52 Favored 'General case' 0 C--N 1.328 -0.367 0 N-CA-C 112.069 0.396 . . . . 0.0 112.069 -178.804 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 26' ' ' LEU . . . . . 0.583 HD12 HG22 ' A' ' 22' ' ' ILE . 42.6 mt -79.72 -44.19 21.23 Favored 'General case' 0 C--N 1.33 -0.269 0 N-CA-C 113.413 0.894 . . . . 0.0 113.413 -173.396 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 27' ' ' GLN . . . . . . . . . . . . . 16.9 pt20 -46.95 140.08 5.08 Favored 'General case' 0 N--CA 1.469 0.48 0 N-CA-C 112.833 0.679 . . . . 0.0 112.833 -173.619 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 97.55 -26.65 22.18 Favored Glycine 0 CA--C 1.534 1.24 0 CA-C-N 115.525 -0.761 . . . . 0.0 112.169 -176.062 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 65.5 mttm -97.58 155.17 17.09 Favored 'General case' 0 C--O 1.233 0.214 0 CA-C-N 117.108 0.454 . . . . 0.0 110.939 179.009 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 30' ' ' THR . . . . . . . . . . . . . 29.0 m -95.58 136.3 36.15 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.06 -0.518 . . . . 0.0 110.293 176.669 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 35.5 m -121.24 138.87 50.21 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.239 0 CA-C-N 116.352 -0.386 . . . . 0.0 110.612 -179.79 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 32' ' ' ARG . . . . . . . . . . . . . 48.0 tpt85 -134.08 139.11 45.75 Favored 'General case' 0 C--N 1.326 -0.428 0 CA-C-N 115.878 -0.601 . . . . 0.0 110.086 -178.822 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 33' ' ' THR . . . . . . . . . . . . . 19.7 m -51.67 140.58 18.42 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-O 120.922 0.391 . . . . 0.0 111.642 -175.475 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 99.13 -17.34 58.17 Favored Glycine 0 CA--C 1.533 1.181 0 CA-C-N 116.006 -0.543 . . . . 0.0 113.024 -179.372 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 82.0 m-20 -64.95 147.97 52.41 Favored 'General case' 0 C--O 1.231 0.096 0 CA-C-N 118.02 0.91 . . . . 0.0 111.088 179.079 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 46.0 t -120.39 128.18 75.97 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.166 0 CA-C-N 115.712 -0.676 . . . . 0.0 109.66 177.835 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 37' ' ' ILE . . . . . . . . . . . . . 66.9 mt -120.74 138.47 51.09 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.273 0 N-CA-C 109.782 -0.451 . . . . 0.0 109.782 -179.572 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . -114.29 128.68 8.33 Favored Glycine 0 CA--C 1.526 0.762 0 N-CA-C 110.935 -0.866 . . . . 0.0 110.935 179.53 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 39' ' ' ILE . . . . . . . . . . . . . 73.3 mt -126.62 127.01 69.83 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.246 0 N-CA-C 109.936 -0.394 . . . . 0.0 109.936 179.05 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 40' ' ' SER . . . . . . . . . . . . . 45.8 t -93.12 123.24 36.25 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.558 -0.292 . . . . 0.0 110.996 177.31 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 41' ' ' ILE . . . . . . . . . . . . . 73.0 mt -131.16 123.01 52.67 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.21 0 CA-C-O 120.92 0.391 . . . . 0.0 110.059 177.715 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 10.9 tp 56.35 36.8 28.1 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.072 -0.513 . . . . 0.0 111.339 178.847 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . 79.01 -10.08 35.39 Favored Glycine 0 CA--C 1.534 1.227 0 C-N-CA 121.21 -0.519 . . . . 0.0 113.641 175.963 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 44' ' ' LYS . . . . . . . . . . . . . 83.4 tttt -101.15 128.3 47.3 Favored 'General case' 0 C--N 1.334 -0.091 0 CA-C-N 117.968 0.884 . . . . 0.0 109.975 177.699 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 41.2 tp10 -84.94 130.63 34.61 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.373 -0.376 . . . . 0.0 110.921 -178.995 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 46' ' ' VAL . . . . . . . . . . . . . 7.4 p -121.82 132.07 71.69 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.199 0 N-CA-C 109.651 -0.5 . . . . 0.0 109.651 176.419 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 94.1 mttt -100.88 131.1 46.92 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.083 -0.508 . . . . 0.0 111.281 178.982 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 48' ' ' PHE . . . . . . . . . . . . . 92.1 m-85 -115.5 131.88 56.8 Favored 'General case' 0 C--N 1.33 -0.244 0 N-CA-C 109.759 -0.46 . . . . 0.0 109.759 175.598 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 54.4 tttm -108.32 139.32 43.19 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.693 -0.23 . . . . 0.0 110.425 178.022 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 50' ' ' VAL . . . . . . . . . . . . . 44.9 t -79.04 107.84 11.96 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.355 0 N-CA-C 109.262 -0.644 . . . . 0.0 109.262 175.909 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 51' ' ' VAL . . . . . . . . . . . . . 49.2 t -72.06 -48.62 48.82 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.324 0 CA-C-N 116.023 -0.535 . . . . 0.0 109.909 -174.324 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 52' ' ' GLN . . . . . . . . . . . . . 61.8 tt0 -162.95 144.45 9.95 Favored 'General case' 0 C--N 1.331 -0.238 0 C-N-CA 120.345 -0.542 . . . . 0.0 111.917 -178.52 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -121.66 132.61 54.75 Favored 'General case' 0 C--N 1.331 -0.196 0 CA-C-N 115.717 -0.674 . . . . 0.0 109.827 175.913 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 54' ' ' TYR . . . . . . . . . . . . . 22.5 t80 -129.16 110.94 18.2 Favored Pre-proline 0 CA--C 1.535 0.396 0 CA-C-O 118.101 -0.952 . . . . 0.0 110.656 177.787 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 55' ' ' PRO . . . . . . . . . . . . . 71.1 Cg_endo -75.94 170.04 72.86 Favored 'Cis proline' 0 N--CA 1.501 1.929 0 CA-C-N 121.898 1.714 . . . . 0.0 112.578 -7.908 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 56' ' ' SER . . . . . . . . . . . . . 66.3 m -118.36 132.53 23.75 Favored Pre-proline 0 CA--C 1.54 0.58 0 CA-C-O 118.439 -0.791 . . . . 0.0 110.079 178.257 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 57' ' ' PRO . . . . . . . . . . . . . 75.9 Cg_endo -79.22 149.73 84.03 Favored 'Cis proline' 0 N--CA 1.495 1.601 0 CA-C-N 121.932 1.726 . . . . 0.0 111.535 -4.922 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 58' ' ' LEU . . . . . 0.423 HD23 HD21 ' A' ' 4' ' ' LEU . 30.6 tp -108.84 140.89 41.66 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.303 -0.408 . . . . 0.0 110.929 -177.817 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 59' ' ' ARG . . . . . . . . . . . . . 78.2 ttt180 -94.06 119.02 32.34 Favored 'General case' 0 C--N 1.328 -0.331 0 N-CA-C 108.809 -0.812 . . . . 0.0 108.809 170.862 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 45.8 t -72.87 120.3 21.28 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.322 0 C-N-CA 120.55 -0.46 . . . . 0.0 110.667 -173.462 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 95.3 mt-10 -131.14 162.68 29.36 Favored 'General case' 0 C--N 1.331 -0.239 0 CA-C-N 115.63 -0.714 . . . . 0.0 109.78 176.945 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 62' ' ' ASP . . . . . . . . . . . . . 12.6 p-10 -54.28 -31.4 53.69 Favored 'General case' 0 C--N 1.329 -0.315 0 N-CA-C 112.185 0.439 . . . . 0.0 112.185 -177.693 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 63' ' ' ARG . . . . . . . . . . . . . 15.2 mmm180 -71.01 -21.81 62.24 Favored 'General case' 0 C--N 1.329 -0.285 0 N-CA-C 113.02 0.748 . . . . 0.0 113.02 -175.787 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 30.3 m -69.76 140.36 53.41 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-O 120.788 0.327 . . . . 0.0 110.997 -175.679 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 65' ' ' LYS . . . . . . . . . . . . . 12.1 mptt -88.91 134.7 33.87 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.154 -0.475 . . . . 0.0 109.836 179.731 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 66' ' ' ILE . . . . . . . . . . . . . 61.1 mt -117.91 131.81 69.57 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.302 0 CA-C-O 120.844 0.354 . . . . 0.0 110.321 -179.067 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 67' ' ' THR . . . . . . . . . . . . . 19.1 m -128.01 135.5 49.98 Favored 'General case' 0 C--N 1.331 -0.23 0 CA-C-N 116.112 -0.495 . . . . 0.0 110.507 178.517 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 68' ' ' LEU . . . . . 0.484 ' N ' HD12 ' A' ' 68' ' ' LEU . 8.5 mp . . . . . 0 C--N 1.329 -0.293 0 CA-C-N 115.939 -0.573 . . . . 0.0 110.296 177.731 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 74' ' ' ASP . . . . . . . . . . . . . 36.1 t0 . . . . . 0 N--CA 1.46 0.028 0 N-CA-C 109.998 -0.371 . . . . 0.0 109.998 . . . . . . . . . 0 0 . 1 . 020 nuclear build core ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 40.2 t -118.26 122.64 70.08 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.262 0 CA-C-O 120.922 0.392 . . . . 0.0 110.791 -176.745 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 76' ' ' LEU . . . . . . . . . . . . . 5.6 mp -122.54 146.43 47.42 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 115.869 -0.605 . . . . 0.0 109.832 175.572 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 77' ' ' GLU . . . . . . . . . . . . . 97.9 mt-10 -134.94 141.59 46.31 Favored 'General case' 0 C--N 1.331 -0.218 0 CA-C-O 121.04 0.448 . . . . 0.0 111.419 -179.241 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 78' ' ' ALA . . . . . . . . . . . . . . . -130.62 140.27 50.41 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-N 115.682 -0.69 . . . . 0.0 109.858 175.581 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 79' ' ' LYS . . . . . 0.589 ' O ' HD13 ' A' ' 80' ' ' ILE . 53.0 mttm -87.49 122.77 31.64 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-O 120.994 0.426 . . . . 0.0 111.239 -177.606 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 80' ' ' ILE . . . . . 0.589 HD13 ' O ' ' A' ' 79' ' ' LYS . 39.8 mm -139.2 109.26 4.16 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.298 0 N-CA-C 108.994 -0.743 . . . . 0.0 108.994 179.37 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 81' ' ' LYS . . . . . . . . . . . . . 78.2 tttt -97.8 123.37 41.73 Favored 'General case' 0 C--N 1.329 -0.3 0 C-N-CA 120.788 -0.365 . . . . 0.0 110.935 -176.949 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . 89.17 42.21 5.64 Favored Glycine 0 CA--C 1.526 0.741 0 C-N-CA 120.759 -0.734 . . . . 0.0 111.705 175.292 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 83' ' ' ILE . . . . . . . . . . . . . 71.1 mt -66.12 138.52 22.86 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.218 0 N-CA-C 109.736 -0.468 . . . . 0.0 109.736 177.178 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 84' ' ' LYS . . . . . . . . . . . . . 78.5 tttt -96.17 -52.9 3.83 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.031 -0.531 . . . . 0.0 110.405 -179.192 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 85' ' ' ASP . . . . . . . . . . . . . 7.1 t70 -154.19 153.7 32.23 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 115.906 -0.588 . . . . 0.0 110.567 -178.977 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 86' ' ' VAL . . . . . . . . . . . . . 42.6 t -131.77 131.32 62.13 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.242 0 CA-C-O 120.984 0.421 . . . . 0.0 110.468 -179.821 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 87' ' ' ILE . . . . . 0.498 HD12 ' N ' ' A' ' 87' ' ' ILE . 5.0 mp -119.06 127.91 75.82 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.224 0 N-CA-C 109.301 -0.629 . . . . 0.0 109.301 176.25 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 88' ' ' LEU . . . . . . . . . . . . . 84.8 mt -117.32 138.82 51.52 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-O 121.149 0.499 . . . . 0.0 111.857 -177.071 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 89' ' ' ASP . . . . . . . . . . . . . 13.7 t70 -134.13 157.75 45.4 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-N 115.375 -0.829 . . . . 0.0 109.19 175.014 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 74.0 tt0 -47.5 -38.13 13.28 Favored 'General case' 0 C--N 1.33 -0.244 0 N-CA-C 112.772 0.656 . . . . 0.0 112.772 -172.785 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 91' ' ' ASN . . . . . . . . . . . . . 13.5 p-10 -132.09 35.97 3.68 Favored 'General case' 0 C--N 1.331 -0.207 0 N-CA-C 111.866 0.321 . . . . 0.0 111.866 -176.604 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 92' ' ' LEU . . . . . . . . . . . . . 13.1 tp -163.73 141.72 7.49 Favored 'General case' 0 C--N 1.332 -0.168 0 C-N-CA 120.85 -0.34 . . . . 0.0 110.934 -179.051 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 93' ' ' ILE . . . . . . . . . . . . . 74.8 mt -126.59 120.83 57.19 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.245 0 N-CA-C 109.461 -0.57 . . . . 0.0 109.461 178.268 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 94' ' ' VAL . . . . . 0.48 HG21 HG11 ' A' ' 125' ' ' VAL . 43.7 t -120.96 127.17 75.91 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.271 0 N-CA-C 109.873 -0.418 . . . . 0.0 109.873 179.306 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 95' ' ' VAL . . . . . . . . . . . . . 44.4 t -123.42 134.79 65.29 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.283 0 CA-C-N 116.137 -0.483 . . . . 0.0 109.92 -178.908 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 96' ' ' ILE . . . . . . . . . . . . . 65.3 mt -116.51 128.69 73.79 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.294 0 N-CA-C 109.286 -0.635 . . . . 0.0 109.286 179.157 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 97' ' ' THR . . . . . . . . . . . . . 74.1 p -100.7 156.07 17.54 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-O 121.206 0.527 . . . . 0.0 111.177 -177.606 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 98' ' ' GLU . . . . . . . . . . . . . 79.8 tt0 -54.02 -26.26 25.47 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.166 -0.47 . . . . 0.0 112.129 -178.808 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 99' ' ' GLU . . . . . . . . . . . . . 95.4 mt-10 -81.83 16.62 1.76 Allowed 'General case' 0 CA--C 1.535 0.374 0 N-CA-C 113.232 0.826 . . . . 0.0 113.232 -175.814 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 100' ' ' ASN . . . . . . . . . . . . . 3.7 m-20 62.97 36.03 12.87 Favored 'General case' 0 N--CA 1.464 0.243 0 CA-C-O 120.906 0.384 . . . . 0.0 111.345 178.548 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 101' ' ' GLU . . . . . . . . . . . . . 84.2 tt0 -112.33 144.4 41.82 Favored 'General case' 0 C--N 1.332 -0.188 0 CA-C-N 116.126 -0.488 . . . . 0.0 109.858 173.549 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 102' ' ' VAL . . . . . . . . . . . . . 48.1 t -116.19 128.05 73.61 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.283 0 CA-C-N 116.325 -0.398 . . . . 0.0 110.128 -178.324 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 103' ' ' LEU . . . . . . . . . . . . . 21.3 mt -118.97 131.86 56.04 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 115.693 -0.685 . . . . 0.0 110.094 177.475 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 104' ' ' ILE . . . . . 0.494 ' CD1' HG11 ' A' ' 130' ' ' VAL . 70.1 mt -120.76 123.39 70.17 Favored 'Isoleucine or valine' 0 C--O 1.234 0.248 0 N-CA-C 110.398 -0.223 . . . . 0.0 110.398 -179.735 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 105' ' ' PHE . . . . . . . . . . . . . 66.5 m-85 -122.92 166.15 15.52 Favored 'General case' 0 C--O 1.232 0.162 0 O-C-N 123.915 0.759 . . . . 0.0 109.942 -179.486 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 106' ' ' ASN . . . . . . . . . . . . . 38.0 p-10 -103.71 -171.08 1.88 Allowed 'General case' 0 C--N 1.331 -0.235 0 N-CA-C 109.951 -0.389 . . . . 0.0 109.951 172.662 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 107' ' ' GLN . . . . . . . . . . . . . 62.0 tt0 -59.85 -24.83 64.54 Favored 'General case' 0 CA--C 1.533 0.324 0 N-CA-C 112.156 0.428 . . . . 0.0 112.156 177.199 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 108' ' ' ASN . . . . . . . . . . . . . 28.5 t30 -84.51 4.16 33.18 Favored 'General case' 0 CA--C 1.538 0.498 0 N-CA-C 113.16 0.8 . . . . 0.0 113.16 -178.022 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 109' ' ' LEU . . . . . . . . . . . . . 12.0 tp 60.88 37.68 18.28 Favored 'General case' 0 CA--C 1.531 0.232 0 CA-C-O 120.943 0.401 . . . . 0.0 111.209 179.669 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 110' ' ' GLU . . . . . . . . . . . . . 15.1 mm-40 -106.55 150.14 26.44 Favored 'General case' 0 C--N 1.329 -0.294 0 N-CA-C 109.958 -0.386 . . . . 0.0 109.958 176.598 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 111' ' ' GLU . . . . . . . . . . . . . 43.3 tp10 -80.16 121.91 26.16 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-O 120.889 0.376 . . . . 0.0 110.043 179.776 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 112' ' ' LEU . . . . . . . . . . . . . 14.8 mt -108.34 -45.62 3.87 Favored 'General case' 0 C--N 1.331 -0.201 0 CA-C-N 116.07 -0.514 . . . . 0.0 110.142 178.511 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 113' ' ' TYR . . . . . . . . . . . . . 64.0 t80 -137.29 139.36 40.87 Favored 'General case' 0 C--N 1.331 -0.211 0 CA-C-N 116.248 -0.433 . . . . 0.0 111.221 -179.805 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 114' ' ' ARG . . . . . . . . . . . . . 32.4 ttm180 -140.95 124.26 16.61 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 115.888 -0.596 . . . . 0.0 110.275 177.509 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 115' ' ' GLY . . . . . . . . . . . . . . . -149.98 158.39 27.64 Favored Glycine 0 CA--C 1.524 0.61 0 N-CA-C 110.938 -0.865 . . . . 0.0 110.938 178.967 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 116' ' ' LYS . . . . . . . . . . . . . 77.5 tttt -136.65 133.61 36.42 Favored 'General case' 0 C--N 1.329 -0.311 0 N-CA-C 110.097 -0.335 . . . . 0.0 110.097 178.636 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 117' ' ' PHE . . . . . . . . . . . . . 9.7 m-85 -138.08 118.98 14.23 Favored 'General case' 0 C--N 1.33 -0.25 0 C-N-CA 120.754 -0.379 . . . . 0.0 110.103 -174.208 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 118' ' ' GLU . . . . . . . . . . . . . 70.6 mm-40 -55.18 -43.65 74.53 Favored 'General case' 0 C--N 1.33 -0.279 0 C-N-CA 120.847 -0.341 . . . . 0.0 111.027 -177.935 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 119' ' ' ASN . . . . . . . . . . . . . 65.7 m-80 -93.71 28.41 2.36 Favored 'General case' 0 C--N 1.329 -0.288 0 N-CA-C 112.414 0.524 . . . . 0.0 112.414 -174.248 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 120' ' ' LEU . . . . . . . . . . . . . 19.2 tp -58.65 120.25 8.57 Favored 'General case' 0 C--N 1.333 -0.128 0 N-CA-C 110.028 -0.36 . . . . 0.0 110.028 177.263 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 121' ' ' ASN . . . . . . . . . . . . . 10.4 t-20 -112.46 -44.13 3.41 Favored 'General case' 0 C--O 1.232 0.148 0 CA-C-N 116.655 -0.248 . . . . 0.0 111.058 -176.274 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 122' ' ' LYS . . . . . . . . . . . . . 82.8 mttt -144.52 147.46 33.26 Favored 'General case' 0 C--N 1.332 -0.162 0 CA-C-O 121.177 0.513 . . . . 0.0 111.793 -177.928 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 123' ' ' VAL . . . . . . . . . . . . . 45.8 t -123.24 128.64 74.98 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.193 0 CA-C-N 115.759 -0.655 . . . . 0.0 109.459 175.139 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 124' ' ' LEU . . . . . . . . . . . . . 52.5 mt -123.6 141.09 52.35 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-O 120.798 0.332 . . . . 0.0 110.854 -177.063 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 125' ' ' VAL . . . . . 0.48 HG11 HG21 ' A' ' 94' ' ' VAL . 34.8 m -135.11 140.93 44.2 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.259 0 CA-C-N 116.287 -0.415 . . . . 0.0 110.992 179.446 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 126' ' ' ARG . . . . . . . . . . . . . 77.6 mtp85 -144.91 111.01 5.5 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 115.975 -0.557 . . . . 0.0 110.396 176.47 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 127' ' ' ASN . . . . . . . . . . . . . 55.8 t30 52.3 -108.54 0.4 Allowed 'General case' 0 CA--C 1.545 0.765 0 CA-C-O 118.83 -0.605 . . . . 0.0 111.344 179.691 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 128' ' ' ASP . . . . . . . . . . . . . 22.9 p-10 -108.09 5.8 26.34 Favored 'General case' 0 N--CA 1.468 0.464 0 CA-C-N 119.876 1.216 . . . . 0.0 113.485 -177.79 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 129' ' ' LEU . . . . . . . . . . . . . 12.1 tp -104.99 138.33 41.37 Favored 'General case' 0 C--N 1.332 -0.175 0 N-CA-C 109.883 -0.414 . . . . 0.0 109.883 178.692 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 130' ' ' VAL . . . . . 0.494 HG11 ' CD1' ' A' ' 104' ' ' ILE . 41.5 t -121.76 137.99 53.53 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.23 0 N-CA-C 110.081 -0.34 . . . . 0.0 110.081 -178.584 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 131' ' ' VAL . . . . . 0.5 HG22 HD12 ' A' ' 140' ' ' LEU . 40.0 t -134.71 136.23 52.58 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.248 0 CA-C-O 121.036 0.446 . . . . 0.0 110.45 -179.476 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 132' ' ' ILE . . . . . . . . . . . . . 75.0 mt -118.21 130.69 72.69 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.273 0 CA-C-N 115.738 -0.665 . . . . 0.0 109.49 179.436 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 133' ' ' ILE . . . . . . . . . . . . . 43.0 mm -117.75 123.33 71.55 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.261 0 CA-C-O 120.985 0.422 . . . . 0.0 111.063 -175.907 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 134' ' ' ASP . . . . . . . . . . . . . 7.7 p-10 -135.01 148.18 49.88 Favored 'General case' 0 C--N 1.331 -0.223 0 CA-C-N 115.849 -0.614 . . . . 0.0 109.517 173.92 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 135' ' ' GLU . . . . . . . . . . . . . 43.6 tp10 -49.89 -24.71 2.64 Favored 'General case' 0 C--N 1.326 -0.416 0 N-CA-C 112.797 0.665 . . . . 0.0 112.797 -172.01 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 136' ' ' GLN . . . . . . . . . . . . . 59.7 tp60 -101.11 -27.49 13.22 Favored 'General case' 0 CA--C 1.53 0.211 0 N-CA-C 112.668 0.618 . . . . 0.0 112.668 -174.863 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 137' ' ' LYS . . . . . . . . . . . . . 81.5 mttt -142.36 152.99 43.43 Favored 'General case' 0 C--N 1.332 -0.188 0 CA-C-O 121.17 0.51 . . . . 0.0 111.685 -171.661 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 138' ' ' LEU . . . . . . . . . . . . . 4.7 tt -120.22 122.27 40.56 Favored 'General case' 0 C--N 1.328 -0.346 0 N-CA-C 109.011 -0.737 . . . . 0.0 109.011 171.675 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 139' ' ' THR . . . . . . . . . . . . . 32.8 m -112.62 128.6 56.42 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 116.376 -0.374 . . . . 0.0 110.787 -176.835 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 140' ' ' LEU . . . . . 0.5 HD12 HG22 ' A' ' 131' ' ' VAL . 15.0 tp -115.85 121.63 42.96 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 115.522 -0.763 . . . . 0.0 109.264 -179.292 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 141' ' ' ILE . . . . . . . . . . . . . 19.3 mt -119.29 120.15 62.87 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.266 0 CA-C-O 120.888 0.375 . . . . 0.0 110.354 -174.613 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 142' ' ' ARG . . . . . . . . . . . . . 73.1 mtm180 -106.48 127.51 53.36 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-N 115.498 -0.774 . . . . 0.0 110.166 179.629 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 143' ' ' THR . . . . . . . . . . . . . 77.3 p . . . . . 0 C--O 1.221 -0.398 0 CA-C-O 117.922 -1.037 . . . . 0.0 110.577 -179.419 . . . . . . . . 0 0 . 1 . 020 nuclear build core ' B' B ' 2' ' ' SER . . . . . . . . . . . . . 36.4 p . . . . . 0 C--O 1.231 0.125 0 CA-C-O 120.896 0.379 . . . . 0.0 110.687 . . . . . . . . . 0 0 . 1 . 020 nuclear build core ' B' B ' 3' ' ' GLU . . . . . . . . . . . . . 95.2 mt-10 -140.52 145.96 37.52 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-O 121.026 0.441 . . . . 0.0 111.484 -177.106 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' B' B ' 4' ' ' LEU . . . . . . . . . . . . . 17.2 tp -125.47 131.03 52.93 Favored 'General case' 0 C--N 1.332 -0.191 0 CA-C-N 115.82 -0.627 . . . . 0.0 109.859 175.264 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' B' B ' 5' ' ' LYS . . . . . . . . . . . . . 98.6 mttt -108.55 120.86 43.67 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.42 -0.354 . . . . 0.0 110.837 -179.256 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' B' B ' 6' ' ' LEU . . . . . . . . . . . . . 55.2 mt -114.64 148.71 37.76 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 115.35 -0.841 . . . . 0.0 110.225 -179.728 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' B' B ' 7' ' ' LYS . . . . . . . . . . . . . 58.9 tttp -138.47 140.86 29.38 Favored Pre-proline 0 CA--C 1.535 0.379 0 CA-C-O 119.132 -0.461 . . . . 0.0 110.015 175.139 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' B' B ' 8' ' ' PRO . . . . . . . . . . . . . 90.1 Cg_endo -91.98 142.27 2.58 Favored 'Trans proline' 0 N--CA 1.489 1.247 0 C-N-CA 121.76 1.64 . . . . 0.0 111.922 178.229 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' B' B ' 9' ' ' LEU . . . . . . . . . . . . . 68.8 mt -74.22 -47.35 6.09 Favored Pre-proline 0 CA--C 1.533 0.316 0 CA-C-O 118.64 -0.695 . . . . 0.0 112.105 179.244 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' B' B ' 10' ' ' PRO . . . . . . . . . . . . . 84.0 Cg_endo -80.77 150.39 18.61 Favored 'Trans proline' 0 N--CA 1.495 1.6 0 C-N-CA 121.242 1.295 . . . . 0.0 111.816 175.49 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' B' B ' 11' ' ' LYS . . . . . . . . . . . . . 62.3 mtpt -86.67 97.46 10.58 Favored 'General case' 0 C--N 1.331 -0.229 0 CA-C-O 120.82 0.343 . . . . 0.0 110.362 178.74 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' B' B ' 12' ' ' VAL . . . . . . . . . . . . . 12.6 p -142.67 148.91 19.36 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.259 0 CA-C-N 116.102 -0.499 . . . . 0.0 110.568 -179.186 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' B' B ' 13' ' ' GLU . . . . . . . . . . . . . 82.3 tt0 -87.29 131.5 34.22 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 116.307 -0.406 . . . . 0.0 110.09 178.144 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' B' B ' 14' ' ' LEU . . . . . . . . . . . . . 28.0 mt -96.23 150.9 37.76 Favored Pre-proline 0 CA--C 1.532 0.263 0 CA-C-O 119.376 -0.345 . . . . 0.0 110.62 -178.225 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' B' B ' 15' ' ' PRO . . . . . . . . . . . . . 28.4 Cg_exo -60.75 159.43 28.71 Favored 'Trans proline' 0 N--CA 1.497 1.702 0 C-N-CA 121.307 1.338 . . . . 0.0 111.832 177.228 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' B' B ' 16' ' ' PRO . . . . . . . . . . . . . 38.5 Cg_exo -57.94 -45.0 35.2 Favored 'Trans proline' 0 N--CA 1.498 1.776 0 C-N-CA 121.452 1.435 . . . . 0.0 113.061 -176.73 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' B' B ' 17' ' ' ASP . . . . . . . . . . . . . 22.7 p-10 -87.64 12.47 12.54 Favored 'General case' 0 CA--C 1.536 0.413 0 N-CA-C 113.138 0.792 . . . . 0.0 113.138 -177.303 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' B' B ' 18' ' ' PHE . . . . . . . . . . . . . 48.2 t80 -58.26 -42.69 86.99 Favored 'General case' 0 N--CA 1.457 -0.092 0 O-C-N 122.054 -0.404 . . . . 0.0 110.178 -178.297 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' B' B ' 19' ' ' VAL . . . . . . . . . . . . . 46.3 t -56.94 -43.83 81.33 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 CA-C-N 116.308 -0.405 . . . . 0.0 110.533 -178.384 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' B' B ' 20' ' ' ASP . . . . . . . . . . . . . 36.8 m-20 -59.94 -41.95 92.94 Favored 'General case' 0 C--N 1.33 -0.276 0 C-N-CA 120.924 -0.31 . . . . 0.0 110.908 -177.964 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' B' B ' 21' ' ' VAL . . . . . . . . . . . . . 48.9 t -64.29 -46.65 92.63 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.27 0 C-N-CA 120.661 -0.416 . . . . 0.0 110.376 -177.78 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' B' B ' 22' ' ' ILE . . . . . 0.511 HG22 HD12 ' B' ' 26' ' ' LEU . 51.3 mm -56.32 -45.28 81.37 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.275 0 C-N-CA 120.955 -0.298 . . . . 0.0 110.577 179.036 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' B' B ' 23' ' ' ARG . . . . . . . . . . . . . 51.7 ttp180 -54.65 -48.58 72.14 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-O 120.584 0.23 . . . . 0.0 111.224 -178.472 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' B' B ' 24' ' ' ILE . . . . . . . . . . . . . 72.0 mt -59.96 -44.38 94.43 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.268 0 CA-C-N 116.599 -0.273 . . . . 0.0 111.293 -177.675 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' B' B ' 25' ' ' LYS . . . . . . . . . . . . . 35.9 mttm -63.99 -42.16 97.27 Favored 'General case' 0 C--N 1.33 -0.277 0 N-CA-C 112.341 0.496 . . . . 0.0 112.341 -178.82 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' B' B ' 26' ' ' LEU . . . . . 0.511 HD12 HG22 ' B' ' 22' ' ' ILE . 92.0 mt -78.42 -42.2 30.82 Favored 'General case' 0 C--N 1.328 -0.35 0 N-CA-C 113.162 0.801 . . . . 0.0 113.162 -170.911 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' B' B ' 27' ' ' GLN . . . . . . . . . . . . . 4.1 pt20 -47.51 140.93 5.45 Favored 'General case' 0 N--CA 1.468 0.459 0 N-CA-C 112.708 0.633 . . . . 0.0 112.708 -174.726 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' B' B ' 28' ' ' GLY . . . . . . . . . . . . . . . 100.7 -26.93 22.8 Favored Glycine 0 CA--C 1.533 1.168 0 CA-C-N 115.564 -0.744 . . . . 0.0 112.205 -177.521 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' B' B ' 29' ' ' LYS . . . . . . . . . . . . . 99.5 mttt -98.71 155.08 17.51 Favored 'General case' 0 C--N 1.332 -0.168 0 CA-C-N 117.379 0.59 . . . . 0.0 111.269 179.32 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' B' B ' 30' ' ' THR . . . . . . . . . . . . . 34.6 m -103.57 135.65 44.77 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 115.75 -0.659 . . . . 0.0 109.763 174.925 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' B' B ' 31' ' ' VAL . . . . . . . . . . . . . 35.4 m -130.86 161.21 41.25 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.245 0 CA-C-N 116.379 -0.373 . . . . 0.0 110.775 -178.805 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' B' B ' 32' ' ' ARG . . . . . . . . . . . . . 70.5 mtm180 -133.75 151.98 51.75 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 115.848 -0.615 . . . . 0.0 110.981 179.748 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' B' B ' 33' ' ' THR . . . . . . . . . . . . . 20.7 m -53.5 139.53 30.87 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.199 -0.455 . . . . 0.0 111.29 -178.758 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' B' B ' 34' ' ' GLY . . . . . . . . . . . . . . . 100.5 -17.01 57.34 Favored Glycine 0 CA--C 1.531 1.086 0 CA-C-O 119.584 -0.565 . . . . 0.0 113.224 178.9 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' B' B ' 35' ' ' ASP . . . . . . . . . . . . . 71.9 m-20 -64.78 148.29 51.5 Favored 'General case' 0 C--O 1.232 0.147 0 CA-C-N 118.183 0.992 . . . . 0.0 111.251 179.639 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' B' B ' 36' ' ' VAL . . . . . . . . . . . . . 46.3 t -117.92 128.41 75.05 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.22 0 CA-C-N 115.527 -0.76 . . . . 0.0 109.739 178.52 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' B' B ' 37' ' ' ILE . . . . . . . . . . . . . 69.8 mt -121.91 138.99 50.32 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.26 0 CA-C-N 116.259 -0.428 . . . . 0.0 109.977 -179.306 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' B' B ' 38' ' ' GLY . . . . . . . . . . . . . . . -114.22 128.97 8.48 Favored Glycine 0 CA--C 1.526 0.742 0 N-CA-C 111.176 -0.769 . . . . 0.0 111.176 -179.203 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' B' B ' 39' ' ' ILE . . . . . . . . . . . . . 75.6 mt -124.06 134.54 66.29 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.253 0 CA-C-O 120.765 0.317 . . . . 0.0 110.164 179.077 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' B' B ' 40' ' ' SER . . . . . . . . . . . . . 53.3 p -92.88 115.95 28.59 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 116.39 -0.368 . . . . 0.0 111.052 176.345 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' B' B ' 41' ' ' ILE . . . . . . . . . . . . . 44.7 mm -121.42 120.78 62.91 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.257 0 CA-C-O 120.775 0.321 . . . . 0.0 110.305 178.461 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' B' B ' 42' ' ' LEU . . . . . . . . . . . . . 62.6 mt 51.75 35.39 15.13 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-N 116.252 -0.431 . . . . 0.0 111.799 176.688 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' B' B ' 43' ' ' GLY . . . . . . . . . . . . . . . 73.88 31.79 59.7 Favored Glycine 0 CA--C 1.528 0.872 0 C-N-CA 121.073 -0.584 . . . . 0.0 112.141 177.706 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' B' B ' 44' ' ' LYS . . . . . . . . . . . . . 23.6 tptm -136.85 128.0 27.9 Favored 'General case' 0 C--N 1.329 -0.293 0 N-CA-C 109.397 -0.594 . . . . 0.0 109.397 177.736 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' B' B ' 45' ' ' GLU . . . . . . . . . . . . . 81.8 tt0 -82.73 117.42 22.64 Favored 'General case' 0 C--N 1.327 -0.373 0 C-N-CA 120.917 -0.313 . . . . 0.0 110.702 -178.356 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' B' B ' 46' ' ' VAL . . . . . . . . . . . . . 7.3 p -115.84 128.58 73.06 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.192 0 N-CA-C 109.412 -0.588 . . . . 0.0 109.412 176.284 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' B' B ' 47' ' ' LYS . . . . . . . . . . . . . 68.6 mttm -99.55 126.93 45.6 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 115.788 -0.642 . . . . 0.0 110.991 179.451 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' B' B ' 48' ' ' PHE . . . . . . . . . . . . . 91.1 m-85 -111.3 131.93 54.77 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-N 116.078 -0.51 . . . . 0.0 109.816 176.996 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' B' B ' 49' ' ' LYS . . . . . . . . . . . . . 83.5 tttt -106.56 134.97 48.88 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-N 116.365 -0.379 . . . . 0.0 110.269 178.6 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' B' B ' 50' ' ' VAL . . . . . . . . . . . . . 45.3 t -78.92 105.59 8.45 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.329 0 N-CA-C 108.993 -0.743 . . . . 0.0 108.993 175.328 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' B' B ' 51' ' ' VAL . . . . . . . . . . . . . 49.0 t -70.1 -53.42 23.58 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.387 0 N-CA-C 109.479 -0.563 . . . . 0.0 109.479 -174.208 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' B' B ' 52' ' ' GLN . . . . . . . . . . . . . 91.7 mt-30 -153.88 152.51 30.72 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 115.947 -0.57 . . . . 0.0 111.695 -177.617 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' B' B ' 53' ' ' ALA . . . . . . . . . . . . . . . -128.2 132.93 48.81 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 115.313 -0.858 . . . . 0.0 109.62 174.87 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' B' B ' 54' ' ' TYR . . . . . . . . . . . . . 58.2 t80 -129.05 107.61 18.01 Favored Pre-proline 0 CA--C 1.534 0.33 0 CA-C-O 118.219 -0.896 . . . . 0.0 110.354 179.767 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' B' B ' 55' ' ' PRO . . . . . . . . . . . . . 73.8 Cg_endo -77.22 169.75 73.32 Favored 'Cis proline' 0 N--CA 1.501 1.926 0 CA-C-N 121.839 1.692 . . . . 0.0 112.863 -4.419 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' B' B ' 56' ' ' SER . . . . . . . . . . . . . 50.6 m -117.59 132.0 23.81 Favored Pre-proline 0 CA--C 1.539 0.537 0 CA-C-O 118.352 -0.832 . . . . 0.0 109.548 174.361 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' B' B ' 57' ' ' PRO . . . . . . . . . . . . . 32.4 Cg_endo -65.21 164.99 57.4 Favored 'Cis proline' 0 N--CA 1.498 1.769 0 CA-C-N 122.027 1.76 . . . . 0.0 111.554 -2.615 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' B' B ' 58' ' ' LEU . . . . . . . . . . . . . 25.0 tp -129.4 137.51 50.96 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-O 120.997 0.427 . . . . 0.0 110.518 -178.284 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' B' B ' 59' ' ' ARG . . . . . . . . . . . . . 75.0 ttt180 -103.4 127.71 50.7 Favored 'General case' 0 C--N 1.326 -0.443 0 CA-C-N 115.731 -0.668 . . . . 0.0 109.225 175.169 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' B' B ' 60' ' ' VAL . . . . . . . . . . . . . 45.6 t -82.07 116.77 26.9 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.232 0 C-N-CA 120.553 -0.459 . . . . 0.0 110.39 -175.928 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' B' B ' 61' ' ' GLU . . . . . . . . . . . . . 70.6 mm-40 -131.14 162.14 30.57 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 115.905 -0.589 . . . . 0.0 109.877 176.618 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' B' B ' 62' ' ' ASP . . . . . . . . . . . . . 43.7 m-20 -53.15 -32.36 47.22 Favored 'General case' 0 C--N 1.328 -0.331 0 N-CA-C 111.807 0.299 . . . . 0.0 111.807 -179.694 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' B' B ' 63' ' ' ARG . . . . . . . . . . . . . 23.7 mmt180 -71.14 -21.94 62.13 Favored 'General case' 0 CA--C 1.532 0.282 0 N-CA-C 112.858 0.688 . . . . 0.0 112.858 -175.99 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' B' B ' 64' ' ' THR . . . . . . . . . . . . . 26.1 m -77.4 140.95 40.01 Favored 'General case' 0 C--N 1.331 -0.226 0 CA-C-O 121.0 0.429 . . . . 0.0 110.877 -175.315 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' B' B ' 65' ' ' LYS . . . . . . . . . . . . . 3.0 mptp? -89.75 134.67 34.05 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 115.976 -0.556 . . . . 0.0 110.233 179.753 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' B' B ' 66' ' ' ILE . . . . . . . . . . . . . 58.9 mt -114.28 129.0 71.04 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.229 0 N-CA-C 109.649 -0.5 . . . . 0.0 109.649 178.083 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' B' B ' 67' ' ' THR . . . . . . . . . . . . . 32.6 m -124.79 139.65 53.65 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-O 121.001 0.429 . . . . 0.0 111.014 -177.128 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' B' B ' 68' ' ' LEU . . . . . . . . . . . . . 6.8 mp . . . . . 0 C--N 1.329 -0.285 0 CA-C-N 115.886 -0.597 . . . . 0.0 110.171 176.196 . . . . . . . . 0 0 . 1 . 020 nuclear build core ' B' B ' 73' ' ' VAL . . . . . . . . . . . . . 30.4 m . . . . . 0 C--O 1.231 0.112 0 N-CA-C 110.06 -0.348 . . . . 0.0 110.06 . . . . . . . . . 0 0 . 1 . 020 nuclear build core ' B' B ' 74' ' ' ASP . . . . . . . . . . . . . 25.2 t0 -103.44 116.42 32.36 Favored 'General case' 0 C--N 1.33 -0.273 0 N-CA-C 109.819 -0.438 . . . . 0.0 109.819 -178.691 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' B' B ' 75' ' ' VAL . . . . . . . . . . . . . 41.7 t -111.34 122.23 65.39 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.243 0 CA-C-O 121.042 0.448 . . . . 0.0 110.355 -178.354 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' B' B ' 76' ' ' LEU . . . . . . . . . . . . . 35.8 mt -119.09 138.69 52.7 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 115.665 -0.698 . . . . 0.0 109.39 177.341 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' B' B ' 77' ' ' GLU . . . . . . . . . . . . . 46.3 mt-10 -134.32 136.37 43.43 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-O 121.14 0.495 . . . . 0.0 111.265 -176.914 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' B' B ' 78' ' ' ALA . . . . . . . . . . . . . . . -125.87 137.55 53.75 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 115.602 -0.726 . . . . 0.0 109.768 176.258 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' B' B ' 79' ' ' LYS . . . . . . . . . . . . . 93.5 mttt -81.73 119.1 23.43 Favored 'General case' 0 C--N 1.329 -0.311 0 C-N-CA 120.811 -0.356 . . . . 0.0 110.438 -179.16 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' B' B ' 80' ' ' ILE . . . . . . . . . . . . . 29.5 mm -134.65 118.46 26.04 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.292 0 CA-C-N 115.721 -0.672 . . . . 0.0 109.234 -176.652 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' B' B ' 81' ' ' LYS . . . . . . . . . . . . . 17.8 ttpt -108.67 123.92 49.73 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-O 120.818 0.342 . . . . 0.0 111.13 -177.073 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' B' B ' 82' ' ' GLY . . . . . . . . . . . . . . . 89.08 42.19 5.68 Favored Glycine 0 CA--C 1.526 0.779 0 C-N-CA 120.838 -0.696 . . . . 0.0 111.816 173.88 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' B' B ' 83' ' ' ILE . . . . . . . . . . . . . 69.9 mt -67.55 138.41 22.78 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.369 0 N-CA-C 109.883 -0.414 . . . . 0.0 109.883 177.969 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' B' B ' 84' ' ' LYS . . . . . . . . . . . . . 39.8 ttpt -100.39 -52.09 3.46 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-O 121.103 0.477 . . . . 0.0 110.046 179.643 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' B' B ' 85' ' ' ASP . . . . . . . . . . . . . 6.5 t70 -153.04 152.35 31.26 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 115.69 -0.687 . . . . 0.0 110.393 -179.955 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' B' B ' 86' ' ' VAL . . . . . . . . . . . . . 41.2 t -129.07 131.73 67.75 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.207 0 CA-C-O 120.871 0.367 . . . . 0.0 110.426 -179.61 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' B' B ' 87' ' ' ILE . . . . . . . . . . . . . 44.3 mm -119.28 126.37 75.28 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.238 0 N-CA-C 109.301 -0.629 . . . . 0.0 109.301 176.251 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' B' B ' 88' ' ' LEU . . . . . 0.434 HD13 HG21 ' A' ' 131' ' ' VAL . 81.3 mt -120.95 137.22 54.72 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-O 121.236 0.541 . . . . 0.0 111.706 -176.23 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' B' B ' 89' ' ' ASP . . . . . . . . . . . . . 5.2 t0 -133.09 154.83 50.2 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 115.452 -0.795 . . . . 0.0 109.054 174.823 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' B' B ' 90' ' ' GLU . . . . . . . . . . . . . 84.2 tt0 -48.84 -30.92 6.33 Favored 'General case' 0 C--N 1.33 -0.273 0 N-CA-C 112.804 0.668 . . . . 0.0 112.804 -172.891 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' B' B ' 91' ' ' ASN . . . . . . . . . . . . . 78.2 m-20 -131.54 28.78 4.6 Favored 'General case' 0 N--CA 1.466 0.343 0 N-CA-C 112.521 0.563 . . . . 0.0 112.521 -174.46 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' B' B ' 92' ' ' LEU . . . . . . . . . . . . . 16.9 tp -166.11 143.07 5.22 Favored 'General case' 0 C--N 1.331 -0.217 0 C-N-CA 120.765 -0.374 . . . . 0.0 110.923 179.794 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' B' B ' 93' ' ' ILE . . . . . . . . . . . . . 72.3 mt -125.13 123.83 66.17 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.242 0 N-CA-C 109.633 -0.506 . . . . 0.0 109.633 178.548 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' B' B ' 94' ' ' VAL . . . . . 0.591 HG21 HG11 ' B' ' 125' ' ' VAL . 44.1 t -125.41 127.54 71.92 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.238 0 CA-C-O 121.016 0.436 . . . . 0.0 109.996 178.126 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' B' B ' 95' ' ' VAL . . . . . . . . . . . . . 46.1 t -120.7 134.87 62.76 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.312 0 CA-C-N 115.944 -0.571 . . . . 0.0 109.765 179.872 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' B' B ' 96' ' ' ILE . . . . . . . . . . . . . 67.9 mt -115.46 128.46 72.67 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.273 0 N-CA-C 109.416 -0.587 . . . . 0.0 109.416 178.898 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' B' B ' 97' ' ' THR . . . . . . . . . . . . . 74.5 p -102.7 159.11 15.75 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-O 121.283 0.563 . . . . 0.0 111.308 -177.103 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' B' B ' 98' ' ' GLU . . . . . . . . . . . . . 45.0 mt-10 -53.95 -25.01 18.53 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.049 -0.523 . . . . 0.0 112.276 179.736 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' B' B ' 99' ' ' GLU . . . . . . . . . . . . . 33.7 tt0 -80.69 17.37 1.15 Allowed 'General case' 0 CA--C 1.538 0.494 0 N-CA-C 112.519 0.563 . . . . 0.0 112.519 -176.485 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' B' B ' 100' ' ' ASN . . . . . . . . . . . . . 2.4 m-20 60.72 37.97 18.61 Favored 'General case' 0 N--CA 1.463 0.181 0 O-C-N 121.801 -0.562 . . . . 0.0 110.883 179.392 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' B' B ' 101' ' ' GLU . . . . . . . . . . . . . 84.7 tt0 -116.19 144.13 44.59 Favored 'General case' 0 C--N 1.332 -0.169 0 CA-C-N 116.215 -0.448 . . . . 0.0 109.895 178.133 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' B' B ' 102' ' ' VAL . . . . . . . . . . . . . 44.8 t -116.51 127.07 74.22 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.234 0 CA-C-O 120.963 0.411 . . . . 0.0 109.907 -178.724 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' B' B ' 103' ' ' LEU . . . . . . . . . . . . . 51.1 mt -113.33 129.95 56.4 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 115.431 -0.804 . . . . 0.0 110.063 178.2 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' B' B ' 104' ' ' ILE . . . . . 0.41 HD12 ' HB3' ' B' ' 113' ' ' TYR . 67.7 mt -118.82 120.08 62.99 Favored 'Isoleucine or valine' 0 C--O 1.234 0.249 0 N-CA-C 110.213 -0.291 . . . . 0.0 110.213 -179.418 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' B' B ' 105' ' ' PHE . . . . . . . . . . . . . 38.6 m-85 -124.04 163.69 20.91 Favored 'General case' 0 C--N 1.332 -0.168 0 CA-C-N 115.537 -0.756 . . . . 0.0 109.55 178.404 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' B' B ' 106' ' ' ASN . . . . . . . . . . . . . 41.5 p-10 -95.92 -171.68 2.4 Favored 'General case' 0 C--N 1.33 -0.262 0 N-CA-C 109.955 -0.387 . . . . 0.0 109.955 173.949 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' B' B ' 107' ' ' GLN . . . . . . . . . . . . . 39.3 tt0 -59.86 -30.05 68.71 Favored 'General case' 0 C--N 1.328 -0.341 0 N-CA-C 111.806 0.299 . . . . 0.0 111.806 179.782 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' B' B ' 108' ' ' ASN . . . . . . . . . . . . . 3.7 t-20 -83.66 7.54 17.15 Favored 'General case' 0 CA--C 1.535 0.398 0 N-CA-C 113.275 0.843 . . . . 0.0 113.275 -177.366 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' B' B ' 109' ' ' LEU . . . . . . . . . . . . . 12.2 tp 63.01 39.88 9.75 Favored 'General case' 0 C--O 1.232 0.179 0 CA-C-O 121.116 0.484 . . . . 0.0 111.371 176.971 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' B' B ' 110' ' ' GLU . . . . . . . . . . . . . 95.9 mt-10 -108.88 163.44 13.28 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.28 -0.418 . . . . 0.0 110.381 177.064 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' B' B ' 111' ' ' GLU . . . . . . . . . . . . . 82.6 tt0 -84.65 123.63 30.57 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.193 -0.458 . . . . 0.0 111.037 -178.552 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' B' B ' 112' ' ' LEU . . . . . . . . . . . . . 22.7 mt -113.08 -46.02 3.13 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.094 -0.503 . . . . 0.0 110.257 174.374 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' B' B ' 113' ' ' TYR . . . . . 0.41 ' HB3' HD12 ' B' ' 104' ' ' ILE . 53.7 t80 -146.72 140.22 25.74 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.333 -0.394 . . . . 0.0 111.199 -179.998 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' B' B ' 114' ' ' ARG . . . . . . . . . . . . . 33.6 mtp180 -141.7 123.25 15.03 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.381 -0.372 . . . . 0.0 110.276 175.483 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' B' B ' 115' ' ' GLY . . . . . . . . . . . . . . . -150.08 161.08 28.79 Favored Glycine 0 CA--C 1.523 0.576 0 C-N-CA 120.7 -0.762 . . . . 0.0 111.364 179.922 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' B' B ' 116' ' ' LYS . . . . . . . . . . . . . 38.6 ttpt -126.9 138.08 53.25 Favored 'General case' 0 C--N 1.33 -0.25 0 N-CA-C 109.929 -0.397 . . . . 0.0 109.929 177.661 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' B' B ' 117' ' ' PHE . . . . . . . . . . . . . 35.7 m-85 -136.35 113.81 10.86 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-O 120.752 0.311 . . . . 0.0 110.347 -176.556 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' B' B ' 118' ' ' GLU . . . . . . . . . . . . . 44.2 mt-10 -54.83 -45.63 74.49 Favored 'General case' 0 C--N 1.329 -0.29 0 C-N-CA 120.942 -0.303 . . . . 0.0 111.27 -176.986 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' B' B ' 119' ' ' ASN . . . . . . . . . . . . . 34.7 m120 -93.78 28.78 2.25 Favored 'General case' 0 C--N 1.329 -0.287 0 O-C-N 123.554 0.534 . . . . 0.0 112.381 -173.688 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' B' B ' 120' ' ' LEU . . . . . . . . . . . . . 17.9 tp -57.37 119.9 7.26 Favored 'General case' 0 C--N 1.333 -0.141 0 C-N-CA 120.957 -0.297 . . . . 0.0 110.317 177.82 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' B' B ' 121' ' ' ASN . . . . . . . . . . . . . 45.8 t-20 -113.32 -44.06 3.28 Favored 'General case' 0 C--N 1.332 -0.19 0 CA-C-N 116.651 -0.25 . . . . 0.0 111.191 -177.164 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' B' B ' 122' ' ' LYS . . . . . . . . . . . . . 98.7 mttt -143.89 146.37 32.95 Favored 'General case' 0 C--N 1.332 -0.182 0 CA-C-O 121.087 0.47 . . . . 0.0 111.698 -178.351 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' B' B ' 123' ' ' VAL . . . . . . . . . . . . . 47.4 t -127.85 126.08 66.1 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.234 0 CA-C-N 115.756 -0.657 . . . . 0.0 109.375 175.075 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' B' B ' 124' ' ' LEU . . . . . . . . . . . . . 31.2 mt -125.6 134.7 51.83 Favored 'General case' 0 C--N 1.331 -0.212 0 CA-C-O 120.799 0.333 . . . . 0.0 110.675 -178.604 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' B' B ' 125' ' ' VAL . . . . . 0.721 HG12 HG23 ' B' ' 130' ' ' VAL . 35.1 m -132.15 144.22 37.74 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.244 0 CA-C-N 116.075 -0.511 . . . . 0.0 110.801 -179.213 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' B' B ' 126' ' ' ARG . . . . . 0.583 ' NH2' HD23 ' B' ' 129' ' ' LEU . 34.3 ptt-85 -152.51 120.49 6.18 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-O 121.328 0.585 . . . . 0.0 111.147 176.0 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' B' B ' 127' ' ' ASN . . . . . . . . . . . . . 82.3 m-20 52.82 -106.24 0.28 Allowed 'General case' 0 CA--C 1.542 0.637 0 CA-C-N 115.457 -0.792 . . . . 0.0 111.284 -179.439 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' B' B ' 128' ' ' ASP . . . . . . . . . . . . . 16.3 p-10 -114.1 0.87 14.42 Favored 'General case' 0 N--CA 1.468 0.445 0 CA-C-N 119.585 1.084 . . . . 0.0 113.372 -176.239 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' B' B ' 129' ' ' LEU . . . . . 0.583 HD23 ' NH2' ' B' ' 126' ' ' ARG . 18.0 tp -109.71 139.8 44.32 Favored 'General case' 0 C--N 1.332 -0.159 0 N-CA-C 109.699 -0.482 . . . . 0.0 109.699 -179.513 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' B' B ' 130' ' ' VAL . . . . . 0.721 HG23 HG12 ' B' ' 125' ' ' VAL . 13.2 p -134.39 143.1 38.94 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.2 0 CA-C-O 121.229 0.537 . . . . 0.0 110.9 -177.958 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' B' B ' 131' ' ' VAL . . . . . . . . . . . . . 42.9 t -135.97 139.79 45.27 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.246 0 CA-C-N 115.753 -0.658 . . . . 0.0 110.319 179.024 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' B' B ' 132' ' ' ILE . . . . . . . . . . . . . 72.9 mt -117.29 133.85 62.74 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.264 0 CA-C-N 115.599 -0.728 . . . . 0.0 109.481 179.7 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' B' B ' 133' ' ' ILE . . . . . . . . . . . . . 37.3 mm -115.47 124.21 71.74 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.224 0 CA-C-O 120.681 0.277 . . . . 0.0 110.965 -175.877 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' B' B ' 134' ' ' ASP . . . . . . . . . . . . . 9.6 p-10 -136.13 150.68 49.18 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-N 115.996 -0.547 . . . . 0.0 109.837 174.975 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' B' B ' 135' ' ' GLU . . . . . . . . . . . . . 46.7 tp10 -49.88 -28.95 7.26 Favored 'General case' 0 C--N 1.327 -0.393 0 N-CA-C 112.675 0.62 . . . . 0.0 112.675 -172.111 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' B' B ' 136' ' ' GLN . . . . . . . . . . . . . 58.7 tt0 -86.74 -31.55 20.89 Favored 'General case' 0 C--N 1.331 -0.233 0 N-CA-C 112.562 0.579 . . . . 0.0 112.562 -173.394 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' B' B ' 137' ' ' LYS . . . . . . . . . . . . . 56.9 pttt -166.09 174.66 9.12 Favored 'General case' 0 C--O 1.232 0.143 0 CA-C-O 121.545 0.688 . . . . 0.0 112.498 -172.649 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' B' B ' 138' ' ' LEU . . . . . 0.416 HD23 ' N ' ' B' ' 139' ' ' THR . 5.9 tt -120.54 129.84 53.98 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 114.932 -1.031 . . . . 0.0 109.811 179.048 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' B' B ' 139' ' ' THR . . . . . 0.416 ' N ' HD23 ' B' ' 138' ' ' LEU . 28.2 m -108.51 125.85 52.27 Favored 'General case' 0 C--N 1.331 -0.22 0 CA-C-N 116.272 -0.422 . . . . 0.0 110.357 179.446 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' B' B ' 140' ' ' LEU . . . . . 0.482 ' C ' HD23 ' B' ' 140' ' ' LEU . 8.0 tt -113.94 121.7 44.72 Favored 'General case' 0 C--N 1.329 -0.315 0 N-CA-C 109.156 -0.683 . . . . 0.0 109.156 -179.171 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' B' B ' 141' ' ' ILE . . . . . 0.421 ' HB ' HG13 ' B' ' 130' ' ' VAL . 19.0 mt -121.64 119.66 59.5 Favored 'Isoleucine or valine' 0 C--O 1.234 0.26 0 CA-C-O 120.949 0.404 . . . . 0.0 110.074 -176.193 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' B' B ' 142' ' ' ARG . . . . . . . . . . . . . 46.2 ttp180 -107.48 129.79 54.91 Favored 'General case' 0 C--N 1.332 -0.163 0 CA-C-N 115.198 -0.91 . . . . 0.0 110.772 -178.779 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' B' B ' 143' ' ' THR . . . . . . . . . . . . . 38.1 p . . . . . 0 C--O 1.22 -0.468 0 CA-C-O 118.044 -0.979 . . . . 0.0 110.516 178.969 . . . . . . . . 0 0 . 1 . 020 nuclear build core ' C' C ' 2' ' ' SER . . . . . . . . . . . . . 16.6 p . . . . . 0 N--CA 1.461 0.089 0 CA-C-O 121.014 0.435 . . . . 0.0 110.52 . . . . . . . . . 0 0 . 1 . 020 nuclear build core ' C' C ' 3' ' ' GLU . . . . . . . . . . . . . 95.5 mt-10 -141.48 141.29 33.65 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 115.978 -0.555 . . . . 0.0 111.089 -179.078 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' C' C ' 4' ' ' LEU . . . . . . . . . . . . . 15.3 tp -126.0 127.53 46.04 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 115.931 -0.577 . . . . 0.0 110.032 176.892 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' C' C ' 5' ' ' LYS . . . . . . . . . . . . . 86.8 mttt -106.5 120.57 42.26 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 116.438 -0.347 . . . . 0.0 110.776 178.162 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' C' C ' 6' ' ' LEU . . . . . 0.437 HD23 ' HA ' ' C' ' 50' ' ' VAL . 27.9 mt -115.05 148.82 38.4 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-N 115.295 -0.866 . . . . 0.0 110.381 179.772 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' C' C ' 7' ' ' LYS . . . . . . . . . . . . . 25.7 ttpp -134.62 133.18 21.13 Favored Pre-proline 0 CA--C 1.534 0.331 0 CA-C-O 118.791 -0.623 . . . . 0.0 110.04 176.875 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' C' C ' 8' ' ' PRO . . . . . . . . . . . . . 59.1 Cg_endo -89.7 135.81 2.53 Favored 'Trans proline' 0 N--CA 1.489 1.229 0 C-N-CA 121.69 1.593 . . . . 0.0 111.586 176.656 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' C' C ' 9' ' ' LEU . . . . . . . . . . . . . 34.2 mt -75.36 -47.47 4.33 Favored Pre-proline 0 CA--C 1.534 0.345 0 CA-C-O 118.581 -0.724 . . . . 0.0 112.085 -177.234 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' C' C ' 10' ' ' PRO . . . . . . . . . . . . . 71.8 Cg_endo -78.65 146.82 21.58 Favored 'Trans proline' 0 N--CA 1.495 1.609 0 C-N-CA 121.052 1.168 . . . . 0.0 111.684 175.143 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' C' C ' 11' ' ' LYS . . . . . . . . . . . . . 21.3 tptm -85.92 99.62 11.54 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-O 120.84 0.352 . . . . 0.0 110.349 -178.625 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' C' C ' 12' ' ' VAL . . . . . . . . . . . . . 12.6 p -143.65 150.12 17.5 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.264 0 CA-C-N 116.207 -0.451 . . . . 0.0 110.665 -179.172 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' C' C ' 13' ' ' GLU . . . . . . . . . . . . . 81.2 tt0 -84.55 127.67 34.18 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.281 -0.418 . . . . 0.0 110.13 178.582 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' C' C ' 14' ' ' LEU . . . . . . . . . . . . . 43.7 mt -96.63 150.03 36.51 Favored Pre-proline 0 CA--C 1.532 0.284 0 CA-C-O 119.368 -0.349 . . . . 0.0 110.627 -178.136 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' C' C ' 15' ' ' PRO . . . . . . . . . . . . . 28.0 Cg_exo -61.23 158.95 32.7 Favored 'Trans proline' 0 N--CA 1.497 1.701 0 C-N-CA 121.26 1.307 . . . . 0.0 111.97 177.754 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' C' C ' 16' ' ' PRO . . . . . . . . . . . . . 26.4 Cg_exo -60.79 -39.34 63.47 Favored 'Trans proline' 0 N--CA 1.496 1.671 0 C-N-CA 121.433 1.422 . . . . 0.0 112.732 -179.128 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' C' C ' 17' ' ' ASP . . . . . . . . . . . . . 19.3 p-10 -87.84 12.76 12.22 Favored 'General case' 0 CA--C 1.535 0.385 0 N-CA-C 113.171 0.804 . . . . 0.0 113.171 -177.006 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' C' C ' 18' ' ' PHE . . . . . . . . . . . . . 42.7 t80 -58.29 -45.39 88.05 Favored 'General case' 0 C--N 1.333 -0.117 0 O-C-N 122.135 -0.353 . . . . 0.0 110.089 -177.754 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' C' C ' 19' ' ' VAL . . . . . . . . . . . . . 47.8 t -55.87 -43.25 73.84 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.355 0 CA-C-N 116.523 -0.308 . . . . 0.0 110.779 -177.356 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' C' C ' 20' ' ' ASP . . . . . . . . . . . . . 7.5 t70 -60.09 -47.29 86.5 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-O 120.799 0.333 . . . . 0.0 111.009 -176.676 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' C' C ' 21' ' ' VAL . . . . . . . . . . . . . 46.4 t -64.4 -43.06 96.99 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.259 0 C-N-CA 120.663 -0.415 . . . . 0.0 110.408 -177.1 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' C' C ' 22' ' ' ILE . . . . . . . . . . . . . 43.9 mm -55.76 -48.31 78.2 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.346 0 N-CA-C 110.438 -0.208 . . . . 0.0 110.438 178.488 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' C' C ' 23' ' ' ARG . . . . . . . . . . . . . 53.8 ttp180 -54.97 -44.48 74.43 Favored 'General case' 0 C--N 1.332 -0.175 0 C-N-CA 120.911 -0.316 . . . . 0.0 111.221 -177.988 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' C' C ' 24' ' ' ILE . . . . . . . . . . . . . 75.0 mt -59.23 -46.9 91.89 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.253 0 CA-C-O 120.721 0.296 . . . . 0.0 110.938 -179.658 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' C' C ' 25' ' ' LYS . . . . . . . . . . . . . 44.2 mtmt -64.63 -38.62 91.63 Favored 'General case' 0 C--N 1.328 -0.331 0 N-CA-C 112.483 0.549 . . . . 0.0 112.483 -177.61 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' C' C ' 26' ' ' LEU . . . . . . . . . . . . . 81.1 mt -79.02 -44.74 21.62 Favored 'General case' 0 C--N 1.33 -0.259 0 N-CA-C 113.268 0.84 . . . . 0.0 113.268 -172.282 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' C' C ' 27' ' ' GLN . . . . . . . . . . . . . 18.2 pt20 -47.01 140.39 4.92 Favored 'General case' 0 N--CA 1.467 0.423 0 N-CA-C 112.812 0.671 . . . . 0.0 112.812 -173.548 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' C' C ' 28' ' ' GLY . . . . . . . . . . . . . . . 98.21 -27.09 20.91 Favored Glycine 0 CA--C 1.533 1.199 0 CA-C-N 115.513 -0.767 . . . . 0.0 112.103 -176.774 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' C' C ' 29' ' ' LYS . . . . . . . . . . . . . 29.2 mtpp -98.0 155.18 17.22 Favored 'General case' 0 C--O 1.232 0.154 0 CA-C-N 117.149 0.474 . . . . 0.0 111.072 179.246 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' C' C ' 30' ' ' THR . . . . . . . . . . . . . 28.7 m -100.37 139.59 35.82 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 115.991 -0.55 . . . . 0.0 110.361 177.307 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' C' C ' 31' ' ' VAL . . . . . . . . . . . . . 35.0 m -130.41 149.84 33.99 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.285 0 CA-C-N 116.319 -0.401 . . . . 0.0 110.759 -179.619 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' C' C ' 32' ' ' ARG . . . . . . . . . . . . . 72.2 mtp180 -132.68 154.09 50.48 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-O 121.198 0.523 . . . . 0.0 110.821 177.07 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' C' C ' 33' ' ' THR . . . . . 0.437 HG23 ' HA ' ' C' ' 52' ' ' GLN . 15.3 m -53.5 136.96 37.32 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-N 116.022 -0.536 . . . . 0.0 111.239 -179.026 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' C' C ' 34' ' ' GLY . . . . . . . . . . . . . . . 101.15 -16.99 56.63 Favored Glycine 0 CA--C 1.532 1.142 0 CA-C-O 119.641 -0.533 . . . . 0.0 113.346 178.24 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' C' C ' 35' ' ' ASP . . . . . . . . . . . . . 61.5 m-20 -64.53 149.61 48.35 Favored 'General case' 0 N--CA 1.461 0.116 0 CA-C-N 118.081 0.941 . . . . 0.0 111.1 179.599 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' C' C ' 36' ' ' VAL . . . . . . . . . . . . . 46.0 t -126.34 130.69 71.93 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.277 0 CA-C-N 115.82 -0.627 . . . . 0.0 109.812 178.682 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' C' C ' 37' ' ' ILE . . . . . . . . . . . . . 68.3 mt -122.2 139.39 49.3 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.259 0 CA-C-N 116.137 -0.483 . . . . 0.0 109.952 -179.458 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' C' C ' 38' ' ' GLY . . . . . . . . . . . . . . . -113.34 128.84 8.55 Favored Glycine 0 CA--C 1.527 0.782 0 N-CA-C 110.908 -0.877 . . . . 0.0 110.908 179.294 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' C' C ' 39' ' ' ILE . . . . . . . . . . . . . 72.7 mt -125.07 129.56 73.3 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.212 0 N-CA-C 109.828 -0.434 . . . . 0.0 109.828 179.091 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' C' C ' 40' ' ' SER . . . . . . . . . . . . . 85.7 p -92.97 121.13 33.99 Favored 'General case' 0 C--N 1.329 -0.294 0 C-N-CA 120.915 -0.314 . . . . 0.0 110.946 176.803 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' C' C ' 41' ' ' ILE . . . . . . . . . . . . . 74.5 mt -131.78 122.47 49.73 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.19 0 CA-C-O 120.756 0.312 . . . . 0.0 110.179 178.363 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' C' C ' 42' ' ' LEU . . . . . . . . . . . . . 82.2 mt 57.5 34.18 24.25 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.146 -0.479 . . . . 0.0 111.756 178.59 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' C' C ' 43' ' ' GLY . . . . . . . . . . . . . . . 80.39 -10.14 45.11 Favored Glycine 0 CA--C 1.534 1.264 0 C-N-CA 121.262 -0.494 . . . . 0.0 113.447 176.879 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' C' C ' 44' ' ' LYS . . . . . . . . . . . . . 96.6 mttt -99.19 129.16 45.41 Favored 'General case' 0 C--N 1.333 -0.127 0 CA-C-N 117.917 0.858 . . . . 0.0 110.052 177.327 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' C' C ' 45' ' ' GLU . . . . . . . . . . . . . 37.7 tp10 -85.18 126.92 34.04 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.414 -0.357 . . . . 0.0 110.481 179.321 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' C' C ' 46' ' ' VAL . . . . . . . . . . . . . 7.4 p -119.23 130.69 73.59 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.227 0 CA-C-O 121.203 0.525 . . . . 0.0 109.824 177.484 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' C' C ' 47' ' ' LYS . . . . . . . . . . . . . 44.6 mmtm -99.09 128.4 45.22 Favored 'General case' 0 C--N 1.331 -0.23 0 CA-C-N 115.719 -0.673 . . . . 0.0 111.281 177.746 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' C' C ' 48' ' ' PHE . . . . . . . . . . . . . 95.5 m-85 -112.3 131.8 55.31 Favored 'General case' 0 C--N 1.33 -0.251 0 N-CA-C 109.634 -0.506 . . . . 0.0 109.634 174.676 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' C' C ' 49' ' ' LYS . . . . . . . . . . . . . 79.7 tttt -107.94 137.53 45.77 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.417 -0.356 . . . . 0.0 110.222 179.103 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' C' C ' 50' ' ' VAL . . . . . 0.437 ' HA ' HD23 ' C' ' 6' ' ' LEU . 44.8 t -82.04 107.72 14.35 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.289 0 N-CA-C 109.389 -0.597 . . . . 0.0 109.389 177.065 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' C' C ' 51' ' ' VAL . . . . . . . . . . . . . 51.8 t -69.58 -47.45 71.51 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.335 0 CA-C-N 116.029 -0.532 . . . . 0.0 109.893 -174.335 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' C' C ' 52' ' ' GLN . . . . . 0.437 ' HA ' HG23 ' C' ' 33' ' ' THR . 61.3 tt0 -169.74 144.43 2.86 Favored 'General case' 0 C--N 1.331 -0.217 0 C-N-CA 120.288 -0.565 . . . . 0.0 111.648 -179.978 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' C' C ' 53' ' ' ALA . . . . . . . . . . . . . . . -114.51 134.85 54.71 Favored 'General case' 0 C--N 1.331 -0.227 0 CA-C-N 115.627 -0.715 . . . . 0.0 110.117 176.429 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' C' C ' 54' ' ' TYR . . . . . . . . . . . . . 51.0 t80 -128.99 112.08 18.55 Favored Pre-proline 0 CA--C 1.536 0.408 0 CA-C-O 118.189 -0.91 . . . . 0.0 110.453 178.809 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' C' C ' 55' ' ' PRO . . . . . . . . . . . . . 72.7 Cg_endo -77.15 169.36 74.43 Favored 'Cis proline' 0 N--CA 1.5 1.9 0 CA-C-N 122.053 1.769 . . . . 0.0 112.2 -6.336 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' C' C ' 56' ' ' SER . . . . . . . . . . . . . 14.7 m -117.23 135.87 23.25 Favored Pre-proline 0 CA--C 1.538 0.509 0 CA-C-O 118.591 -0.718 . . . . 0.0 109.605 175.272 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' C' C ' 57' ' ' PRO . . . . . . . . . . . . . 49.1 Cg_endo -70.17 146.76 83.92 Favored 'Cis proline' 0 N--CA 1.496 1.653 0 CA-C-N 121.724 1.651 . . . . 0.0 111.355 -3.484 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' C' C ' 58' ' ' LEU . . . . . . . . . . . . . 17.2 tp -107.81 135.87 48.49 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-O 120.847 0.356 . . . . 0.0 110.798 -177.329 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' C' C ' 59' ' ' ARG . . . . . . . . . . . . . 42.4 ttp180 -102.44 119.85 39.51 Favored 'General case' 0 C--N 1.328 -0.349 0 N-CA-C 108.971 -0.752 . . . . 0.0 108.971 174.418 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' C' C ' 60' ' ' VAL . . . . . . . . . . . . . 41.2 t -76.2 122.73 30.97 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.238 0 C-N-CA 120.661 -0.415 . . . . 0.0 110.674 -173.289 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' C' C ' 61' ' ' GLU . . . . . . . . . . . . . 88.3 mt-10 -131.09 163.13 28.32 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 115.938 -0.573 . . . . 0.0 109.749 175.962 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' C' C ' 62' ' ' ASP . . . . . . . . . . . . . 11.4 p-10 -53.87 -30.4 45.59 Favored 'General case' 0 C--N 1.328 -0.339 0 N-CA-C 111.85 0.315 . . . . 0.0 111.85 178.751 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' C' C ' 63' ' ' ARG . . . . . . . . . . . . . 77.8 mtp180 -71.58 -22.08 61.78 Favored 'General case' 0 CA--C 1.533 0.308 0 N-CA-C 112.952 0.723 . . . . 0.0 112.952 -175.958 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' C' C ' 64' ' ' THR . . . . . . . . . . . . . 31.0 m -71.46 141.79 50.22 Favored 'General case' 0 C--N 1.331 -0.213 0 CA-C-O 120.859 0.362 . . . . 0.0 111.381 -174.173 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' C' C ' 65' ' ' LYS . . . . . . . . . . . . . 2.4 mptp? -88.96 129.66 35.59 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 115.925 -0.579 . . . . 0.0 109.849 177.416 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' C' C ' 66' ' ' ILE . . . . . . . . . . . . . 66.8 mt -116.68 127.84 74.2 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.268 0 N-CA-C 109.913 -0.402 . . . . 0.0 109.913 179.615 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' C' C ' 67' ' ' THR . . . . . . . . . . . . . 32.2 m -127.89 143.69 51.1 Favored 'General case' 0 C--N 1.332 -0.164 0 CA-C-N 116.16 -0.473 . . . . 0.0 111.0 -177.25 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' C' C ' 68' ' ' LEU . . . . . . . . . . . . . 28.2 mt . . . . . 0 C--N 1.33 -0.246 0 CA-C-N 115.877 -0.602 . . . . 0.0 110.404 177.435 . . . . . . . . 0 0 . 1 . 020 nuclear build core ' C' C ' 73' ' ' VAL . . . . . . . . . . . . . 31.5 m . . . . . 0 C--O 1.231 0.127 0 CA-C-O 121.069 0.462 . . . . 0.0 110.741 . . . . . . . . . 0 0 . 1 . 020 nuclear build core ' C' C ' 74' ' ' ASP . . . . . . . . . . . . . 13.7 t0 -97.46 119.64 36.37 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 115.58 -0.736 . . . . 0.0 109.437 178.436 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' C' C ' 75' ' ' VAL . . . . . . . . . . . . . 43.0 t -109.75 122.52 64.49 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.221 0 CA-C-O 121.036 0.446 . . . . 0.0 110.402 -177.906 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' C' C ' 76' ' ' LEU . . . . . . . . . . . . . 28.7 mt -123.1 140.53 52.93 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 115.612 -0.722 . . . . 0.0 109.678 178.568 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' C' C ' 77' ' ' GLU . . . . . . . . . . . . . 97.2 mt-10 -132.83 135.67 45.78 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-O 121.082 0.468 . . . . 0.0 111.12 -179.267 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' C' C ' 78' ' ' ALA . . . . . . . . . . . . . . . -124.55 133.92 53.15 Favored 'General case' 0 C--O 1.233 0.221 0 CA-C-N 115.807 -0.633 . . . . 0.0 109.903 177.013 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' C' C ' 79' ' ' LYS . . . . . 0.683 ' O ' HD13 ' C' ' 80' ' ' ILE . 61.3 mtpt -79.15 118.31 20.98 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-O 120.874 0.369 . . . . 0.0 110.747 -178.068 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' C' C ' 80' ' ' ILE . . . . . 0.683 HD13 ' O ' ' C' ' 79' ' ' LYS . 34.7 mm -139.18 105.98 2.7 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.285 0 N-CA-C 108.886 -0.783 . . . . 0.0 108.886 -178.462 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' C' C ' 81' ' ' LYS . . . . . . . . . . . . . 23.2 tptm -98.99 126.52 44.71 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-O 120.849 0.357 . . . . 0.0 111.137 -175.715 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' C' C ' 82' ' ' GLY . . . . . . . . . . . . . . . 89.17 42.07 5.68 Favored Glycine 0 CA--C 1.526 0.758 0 C-N-CA 120.755 -0.736 . . . . 0.0 111.798 174.816 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' C' C ' 83' ' ' ILE . . . . . . . . . . . . . 72.5 mt -69.73 136.22 26.62 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.338 0 N-CA-C 109.648 -0.501 . . . . 0.0 109.648 177.182 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' C' C ' 84' ' ' LYS . . . . . . . . . . . . . 22.9 ttmt -94.7 -54.1 3.62 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-O 121.123 0.487 . . . . 0.0 110.121 -179.759 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' C' C ' 85' ' ' ASP . . . . . . . . . . . . . 7.6 t70 -152.31 148.09 27.11 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 115.604 -0.725 . . . . 0.0 110.352 -179.005 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' C' C ' 86' ' ' VAL . . . . . . . . . . . . . 45.3 t -126.9 129.32 71.34 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.275 0 CA-C-O 120.976 0.417 . . . . 0.0 110.225 179.999 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' C' C ' 87' ' ' ILE . . . . . 0.498 ' N ' HD12 ' C' ' 87' ' ' ILE . 5.1 mp -118.32 129.41 74.67 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.239 0 CA-C-N 115.898 -0.592 . . . . 0.0 109.524 177.403 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' C' C ' 88' ' ' LEU . . . . . . . . . . . . . 26.9 mt -111.14 140.15 45.92 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-O 120.96 0.409 . . . . 0.0 111.312 -177.277 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' C' C ' 89' ' ' ASP . . . . . . . . . . . . . 36.0 t0 -132.16 157.39 44.4 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 115.811 -0.631 . . . . 0.0 109.542 177.314 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' C' C ' 90' ' ' GLU . . . . . . . . . . . . . 40.5 mp0 -49.66 -34.09 17.45 Favored 'General case' 0 C--N 1.331 -0.222 0 N-CA-C 112.914 0.709 . . . . 0.0 112.914 -171.448 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' C' C ' 91' ' ' ASN . . . . . . . . . . . . . 26.2 m120 -130.23 16.22 5.58 Favored 'General case' 0 N--CA 1.469 0.492 0 N-CA-C 113.256 0.836 . . . . 0.0 113.256 -177.225 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' C' C ' 92' ' ' LEU . . . . . . . . . . . . . 28.9 mt -148.12 149.76 32.61 Favored 'General case' 0 C--N 1.332 -0.188 0 CA-C-O 120.798 0.332 . . . . 0.0 110.763 -175.568 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' C' C ' 93' ' ' ILE . . . . . . . . . . . . . 68.1 mt -126.01 118.25 51.18 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.292 0 N-CA-C 109.041 -0.725 . . . . 0.0 109.041 175.648 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' C' C ' 94' ' ' VAL . . . . . 0.542 HG21 HG11 ' C' ' 125' ' ' VAL . 44.5 t -117.61 125.54 74.15 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.255 0 CA-C-O 121.034 0.445 . . . . 0.0 109.956 -178.727 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' C' C ' 95' ' ' VAL . . . . . . . . . . . . . 42.3 t -120.1 134.64 62.93 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.307 0 CA-C-N 115.859 -0.61 . . . . 0.0 109.852 -178.94 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' C' C ' 96' ' ' ILE . . . . . . . . . . . . . 64.9 mt -114.17 126.03 71.59 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.279 0 N-CA-C 109.016 -0.735 . . . . 0.0 109.016 177.432 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' C' C ' 97' ' ' THR . . . . . . . . . . . . . 76.2 p -100.87 157.49 16.68 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-O 120.908 0.385 . . . . 0.0 111.093 -176.317 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' C' C ' 98' ' ' GLU . . . . . . . . . . . . . 13.0 pt-20 -53.96 -22.57 10.61 Favored 'General case' 0 CA--C 1.535 0.366 0 N-CA-C 112.279 0.474 . . . . 0.0 112.279 178.019 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' C' C ' 99' ' ' GLU . . . . . . . . . . . . . 95.3 mt-10 -78.18 12.51 1.83 Allowed 'General case' 0 CA--C 1.536 0.434 0 N-CA-C 113.022 0.749 . . . . 0.0 113.022 179.605 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' C' C ' 100' ' ' ASN . . . . . . . . . . . . . 2.1 m-20 61.87 38.07 14.86 Favored 'General case' 0 CA--C 1.53 0.207 0 CA-C-O 121.028 0.442 . . . . 0.0 110.923 179.48 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' C' C ' 101' ' ' GLU . . . . . . . . . . . . . 42.0 mt-10 -111.17 148.71 32.17 Favored 'General case' 0 CA--C 1.521 -0.17 0 CA-C-N 115.988 -0.551 . . . . 0.0 110.494 176.019 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' C' C ' 102' ' ' VAL . . . . . . . . . . . . . 46.6 t -114.85 120.9 65.76 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.293 0 CA-C-N 115.487 -0.779 . . . . 0.0 109.126 177.114 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' C' C ' 103' ' ' LEU . . . . . . . . . . . . . 22.1 mt -111.56 126.12 54.65 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 115.68 -0.691 . . . . 0.0 109.994 177.851 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' C' C ' 104' ' ' ILE . . . . . 0.543 HD12 ' HB3' ' C' ' 113' ' ' TYR . 68.4 mt -111.94 114.21 46.39 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.325 0 N-CA-C 109.58 -0.526 . . . . 0.0 109.58 179.318 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' C' C ' 105' ' ' PHE . . . . . . . . . . . . . 95.6 m-85 -117.23 163.12 16.78 Favored 'General case' 0 C--N 1.332 -0.169 0 O-C-N 124.056 0.847 . . . . 0.0 109.956 -179.796 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' C' C ' 106' ' ' ASN . . . . . . . . . . . . . 51.1 p-10 -104.05 -170.73 1.82 Allowed 'General case' 0 C--N 1.328 -0.362 0 N-CA-C 109.661 -0.496 . . . . 0.0 109.661 171.805 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' C' C ' 107' ' ' GLN . . . . . . . . . . . . . 45.4 tt0 -58.39 -28.9 65.6 Favored 'General case' 0 C--N 1.328 -0.35 0 N-CA-C 112.071 0.397 . . . . 0.0 112.071 178.513 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' C' C ' 108' ' ' ASN . . . . . . . . . . . . . 48.6 t30 -89.49 6.86 39.01 Favored 'General case' 0 CA--C 1.536 0.427 0 N-CA-C 113.202 0.815 . . . . 0.0 113.202 -175.857 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' C' C ' 109' ' ' LEU . . . . . . . . . . . . . 89.0 mt 59.09 31.94 21.74 Favored 'General case' 0 C--N 1.332 -0.157 0 N-CA-C 112.034 0.383 . . . . 0.0 112.034 175.968 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' C' C ' 110' ' ' GLU . . . . . . . . . . . . . 14.0 pt-20 -106.09 144.22 33.11 Favored 'General case' 0 C--N 1.332 -0.165 0 N-CA-C 109.616 -0.513 . . . . 0.0 109.616 173.867 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' C' C ' 111' ' ' GLU . . . . . . . . . . . . . 54.5 tt0 -66.79 121.95 16.59 Favored 'General case' 0 C--N 1.327 -0.412 0 CA-C-N 116.12 -0.491 . . . . 0.0 111.528 -172.281 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' C' C ' 112' ' ' LEU . . . . . . . . . . . . . 10.7 mt -101.41 -46.16 5.09 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.039 -0.528 . . . . 0.0 109.653 174.009 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' C' C ' 113' ' ' TYR . . . . . 0.543 ' HB3' HD12 ' C' ' 104' ' ' ILE . 64.0 t80 -148.48 140.55 23.98 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.059 -0.519 . . . . 0.0 111.133 178.023 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' C' C ' 114' ' ' ARG . . . . . . . . . . . . . 29.6 ttm180 -137.61 126.12 23.54 Favored 'General case' 0 C--N 1.329 -0.289 0 N-CA-C 109.819 -0.438 . . . . 0.0 109.819 175.803 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' C' C ' 115' ' ' GLY . . . . . . . . . . . . . . . -150.12 161.56 28.94 Favored Glycine 0 CA--C 1.522 0.505 0 N-CA-C 110.753 -0.939 . . . . 0.0 110.753 -179.089 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' C' C ' 116' ' ' LYS . . . . . . . . . . . . . 26.4 ttpp -127.84 134.35 49.42 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-O 120.755 0.312 . . . . 0.0 110.363 -179.614 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' C' C ' 117' ' ' PHE . . . . . . . . . . . . . 59.2 m-85 -134.37 113.91 12.39 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.249 -0.432 . . . . 0.0 109.982 -178.932 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' C' C ' 118' ' ' GLU . . . . . . . . . . . . . 44.4 mp0 -58.06 -39.47 78.56 Favored 'General case' 0 C--N 1.328 -0.332 0 C-N-CA 120.629 -0.429 . . . . 0.0 110.745 -175.649 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' C' C ' 119' ' ' ASN . . . . . . . . . . . . . 3.5 m120 -100.06 30.73 3.62 Favored 'General case' 0 C--N 1.329 -0.286 0 N-CA-C 112.169 0.433 . . . . 0.0 112.169 -175.341 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' C' C ' 120' ' ' LEU . . . . . . . . . . . . . 18.5 tp -58.85 119.85 7.94 Favored 'General case' 0 C--N 1.332 -0.157 0 N-CA-C 110.029 -0.36 . . . . 0.0 110.029 178.279 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' C' C ' 121' ' ' ASN . . . . . . . . . . . . . 87.0 m-20 -114.16 -44.16 3.16 Favored 'General case' 0 C--N 1.333 -0.137 0 CA-C-N 116.493 -0.322 . . . . 0.0 111.302 -178.272 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' C' C ' 122' ' ' LYS . . . . . . . . . . . . . 62.1 mtpt -143.51 151.27 40.07 Favored 'General case' 0 C--N 1.33 -0.239 0 CA-C-O 120.973 0.416 . . . . 0.0 111.532 -175.258 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' C' C ' 123' ' ' VAL . . . . . . . . . . . . . 43.6 t -135.2 135.16 52.55 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.245 0 CA-C-N 116.143 -0.48 . . . . 0.0 109.866 176.059 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' C' C ' 124' ' ' LEU . . . . . . . . . . . . . 55.8 mt -126.0 141.88 51.77 Favored 'General case' 0 C--N 1.331 -0.221 0 CA-C-O 120.897 0.38 . . . . 0.0 110.839 -177.962 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' C' C ' 125' ' ' VAL . . . . . 0.542 HG11 HG21 ' C' ' 94' ' ' VAL . 34.9 m -135.93 138.72 47.17 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.201 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.74 179.039 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' C' C ' 126' ' ' ARG . . . . . . . . . . . . . 46.6 ptt85 -152.53 131.08 12.23 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-O 120.849 0.357 . . . . 0.0 110.774 175.873 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' C' C ' 127' ' ' ASN . . . . . . . . . . . . . 89.7 m-20 50.71 -115.43 0.86 Allowed 'General case' 0 CA--C 1.546 0.797 0 CA-C-O 118.67 -0.681 . . . . 0.0 111.177 -179.77 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' C' C ' 128' ' ' ASP . . . . . . . . . . . . . 8.7 p-10 -114.11 16.06 18.19 Favored 'General case' 0 CA--C 1.536 0.433 0 CA-C-N 120.17 1.35 . . . . 0.0 112.848 -179.884 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' C' C ' 129' ' ' LEU . . . . . . . . . . . . . 5.7 tt -111.96 136.75 50.89 Favored 'General case' 0 C--O 1.234 0.252 0 N-CA-C 110.024 -0.361 . . . . 0.0 110.024 -179.617 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' C' C ' 130' ' ' VAL . . . . . . . . . . . . . 43.2 t -117.99 135.88 56.97 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.185 0 CA-C-N 116.39 -0.368 . . . . 0.0 110.109 -177.442 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' C' C ' 131' ' ' VAL . . . . . . . . . . . . . 43.4 t -133.79 133.78 56.51 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.214 0 CA-C-O 120.938 0.399 . . . . 0.0 110.289 178.513 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' C' C ' 132' ' ' ILE . . . . . . . . . . . . . 70.6 mt -119.82 133.31 66.99 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.233 0 N-CA-C 109.513 -0.551 . . . . 0.0 109.513 -179.567 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' C' C ' 133' ' ' ILE . . . . . . . . . . . . . 40.9 mm -117.77 120.78 65.7 Favored 'Isoleucine or valine' 0 C--O 1.234 0.266 0 CA-C-O 120.801 0.334 . . . . 0.0 111.102 -175.301 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' C' C ' 134' ' ' ASP . . . . . . . . . . . . . 6.9 p-10 -132.43 148.0 52.39 Favored 'General case' 0 C--N 1.33 -0.251 0 N-CA-C 109.708 -0.478 . . . . 0.0 109.708 176.322 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' C' C ' 135' ' ' GLU . . . . . . . . . . . . . 41.6 tp10 -49.98 -29.42 8.5 Favored 'General case' 0 C--N 1.327 -0.387 0 N-CA-C 112.648 0.61 . . . . 0.0 112.648 -173.667 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' C' C ' 136' ' ' GLN . . . . . . . . . . . . . 93.9 mt-30 -79.96 -33.32 39.63 Favored 'General case' 0 C--O 1.234 0.268 0 N-CA-C 112.321 0.489 . . . . 0.0 112.321 -175.302 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' C' C ' 137' ' ' LYS . . . . . . . . . . . . . 46.8 pttt -169.93 174.65 5.49 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-O 121.403 0.621 . . . . 0.0 112.31 -172.451 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' C' C ' 138' ' ' LEU . . . . . 0.411 HD23 ' N ' ' C' ' 139' ' ' THR . 5.2 tt -116.12 129.88 56.54 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 115.116 -0.947 . . . . 0.0 109.951 179.499 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' C' C ' 139' ' ' THR . . . . . 0.411 ' N ' HD23 ' C' ' 138' ' ' LEU . 27.0 m -108.39 126.61 53.07 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-N 116.318 -0.401 . . . . 0.0 110.366 179.855 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' C' C ' 140' ' ' LEU . . . . . . . . . . . . . 14.3 tp -114.44 121.37 43.33 Favored 'General case' 0 C--N 1.33 -0.273 0 N-CA-C 109.048 -0.723 . . . . 0.0 109.048 -179.463 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' C' C ' 141' ' ' ILE . . . . . . . . . . . . . 19.5 mt -119.91 115.6 47.91 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.279 0 CA-C-O 120.978 0.418 . . . . 0.0 109.906 -175.888 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' C' C ' 142' ' ' ARG . . . . . . . . . . . . . 84.2 mtm180 . . . . . 0 C--N 1.33 -0.25 0 CA-C-N 115.243 -0.889 . . . . 0.0 110.841 -175.933 . . . . . . . . 0 0 . 1 . 020 nuclear build core ' D' D ' 2' ' ' SER . . . . . . . . . . . . . 6.8 p . . . . . 0 C--O 1.231 0.119 0 CA-C-O 120.859 0.362 . . . . 0.0 110.718 . . . . . . . . . 0 0 . 1 . 020 nuclear build core ' D' D ' 3' ' ' GLU . . . . . . . . . . . . . 95.6 mt-10 -140.22 138.23 34.92 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.03 -0.532 . . . . 0.0 110.897 179.236 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' D' D ' 4' ' ' LEU . . . . . 0.414 HD21 HD21 ' D' ' 6' ' ' LEU . 17.2 tp -122.86 128.33 50.21 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 115.911 -0.586 . . . . 0.0 110.249 178.095 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' D' D ' 5' ' ' LYS . . . . . . . . . . . . . 67.6 mttm -105.54 121.4 43.88 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.382 -0.372 . . . . 0.0 110.468 178.219 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' D' D ' 6' ' ' LEU . . . . . 0.414 HD21 HD21 ' D' ' 4' ' ' LEU . 73.8 mt -117.65 149.46 40.68 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 115.622 -0.717 . . . . 0.0 110.778 -178.78 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' D' D ' 7' ' ' LYS . . . . . . . . . . . . . 35.5 ttpt -139.55 139.41 22.29 Favored Pre-proline 0 CA--C 1.535 0.376 0 CA-C-O 119.136 -0.459 . . . . 0.0 110.135 175.704 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' D' D ' 8' ' ' PRO . . . . . . . . . . . . . 94.0 Cg_endo -92.09 144.06 2.76 Favored 'Trans proline' 0 N--CA 1.49 1.267 0 C-N-CA 121.778 1.652 . . . . 0.0 111.659 177.053 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' D' D ' 9' ' ' LEU . . . . . . . . . . . . . 45.1 mt -80.25 -48.23 1.29 Allowed Pre-proline 0 CA--C 1.534 0.349 0 CA-C-O 118.665 -0.683 . . . . 0.0 112.445 -178.602 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' D' D ' 10' ' ' PRO . . . . . . . . . . . . . 86.1 Cg_endo -79.75 152.61 22.52 Favored 'Trans proline' 0 N--CA 1.496 1.632 0 C-N-CA 121.213 1.276 . . . . 0.0 112.055 177.318 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' D' D ' 11' ' ' LYS . . . . . . . . . . . . . 90.2 mttt -85.38 97.85 10.22 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.483 -0.326 . . . . 0.0 110.534 178.374 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' D' D ' 12' ' ' VAL . . . . . . . . . . . . . 12.1 p -144.32 143.12 23.57 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.288 0 CA-C-N 116.222 -0.445 . . . . 0.0 110.524 179.743 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' D' D ' 13' ' ' GLU . . . . . . . . . . . . . 45.8 mp0 -81.89 127.01 32.57 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.342 -0.39 . . . . 0.0 110.037 176.956 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' D' D ' 14' ' ' LEU . . . . . . . . . . . . . 22.5 mt -97.28 144.79 28.53 Favored Pre-proline 0 CA--C 1.533 0.311 0 CA-C-O 119.019 -0.515 . . . . 0.0 110.11 -179.688 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' D' D ' 15' ' ' PRO . . . . . . . . . . . . . 29.8 Cg_exo -59.95 160.32 22.38 Favored 'Trans proline' 0 N--CA 1.497 1.709 0 C-N-CA 121.241 1.294 . . . . 0.0 112.085 179.079 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' D' D ' 16' ' ' PRO . . . . . . . . . . . . . 31.6 Cg_exo -59.3 -37.83 88.56 Favored 'Trans proline' 0 N--CA 1.497 1.691 0 C-N-CA 121.452 1.434 . . . . 0.0 112.905 -177.424 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' D' D ' 17' ' ' ASP . . . . . . . . . . . . . 13.7 p-10 -85.33 4.17 36.34 Favored 'General case' 0 CA--C 1.537 0.46 0 N-CA-C 113.301 0.852 . . . . 0.0 113.301 -177.204 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' D' D ' 18' ' ' PHE . . . . . . . . . . . . . 48.2 t80 -58.29 -47.17 84.52 Favored 'General case' 0 C--N 1.334 -0.102 0 O-C-N 122.03 -0.419 . . . . 0.0 110.151 -177.275 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' D' D ' 19' ' ' VAL . . . . . . . . . . . . . 47.5 t -56.72 -42.94 78.26 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.356 0 CA-C-N 116.335 -0.393 . . . . 0.0 110.504 -177.789 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' D' D ' 20' ' ' ASP . . . . . . . . . . . . . 53.4 m-20 -59.82 -41.79 92.07 Favored 'General case' 0 C--N 1.328 -0.333 0 C-N-CA 120.913 -0.315 . . . . 0.0 110.896 -177.851 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' D' D ' 21' ' ' VAL . . . . . . . . . . . . . 47.7 t -64.63 -46.26 92.97 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.275 0 C-N-CA 120.811 -0.356 . . . . 0.0 110.491 -178.06 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' D' D ' 22' ' ' ILE . . . . . 0.45 HG22 HD12 ' D' ' 26' ' ' LEU . 46.8 mm -57.75 -40.44 75.69 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.317 0 C-N-CA 120.745 -0.382 . . . . 0.0 110.615 179.726 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' D' D ' 23' ' ' ARG . . . . . . . . . . . . . 59.1 ttp180 -55.69 -49.97 71.55 Favored 'General case' 0 C--N 1.331 -0.219 0 CA-C-O 120.969 0.414 . . . . 0.0 110.843 178.11 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' D' D ' 24' ' ' ILE . . . . . . . . . . . . . 74.1 mt -61.36 -40.26 85.57 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.324 0 CA-C-N 115.918 -0.583 . . . . 0.0 111.925 -176.666 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' D' D ' 25' ' ' LYS . . . . . . . . . . . . . 7.7 ptmm? -72.19 -36.46 69.23 Favored 'General case' 0 CA--C 1.531 0.239 0 C-N-CA 120.534 -0.466 . . . . 0.0 111.882 -176.145 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' D' D ' 26' ' ' LEU . . . . . 0.45 HD12 HG22 ' D' ' 22' ' ' ILE . 77.0 mt -77.7 -40.25 41.96 Favored 'General case' 0 C--N 1.33 -0.243 0 N-CA-C 113.194 0.813 . . . . 0.0 113.194 -173.23 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' D' D ' 27' ' ' GLN . . . . . . . . . . . . . 14.7 pt20 -47.53 137.12 9.26 Favored 'General case' 0 N--CA 1.471 0.58 0 N-CA-C 112.661 0.615 . . . . 0.0 112.661 -175.901 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' D' D ' 28' ' ' GLY . . . . . . . . . . . . . . . 99.63 -24.84 30.58 Favored Glycine 0 CA--C 1.533 1.21 0 CA-C-N 115.545 -0.752 . . . . 0.0 112.304 -176.345 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' D' D ' 29' ' ' LYS . . . . . . . . . . . . . 72.9 mmtt -98.11 155.18 17.26 Favored 'General case' 0 C--N 1.331 -0.218 0 CA-C-N 117.318 0.559 . . . . 0.0 111.232 179.352 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' D' D ' 30' ' ' THR . . . . . . . . . . . . . 24.4 m -105.79 135.85 46.47 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 115.784 -0.643 . . . . 0.0 109.859 175.342 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' D' D ' 31' ' ' VAL . . . . . . . . . . . . . 34.8 m -130.83 155.52 41.96 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.276 0 CA-C-O 120.994 0.426 . . . . 0.0 110.926 -178.225 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' D' D ' 32' ' ' ARG . . . . . . . . . . . . . 84.8 mtm180 -131.65 150.78 52.03 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.012 -0.54 . . . . 0.0 110.863 179.143 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' D' D ' 33' ' ' THR . . . . . . . . . . . . . 20.8 m -53.5 140.37 28.36 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.111 -0.495 . . . . 0.0 111.293 -179.09 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' D' D ' 34' ' ' GLY . . . . . . . . . . . . . . . 98.99 -17.17 58.55 Favored Glycine 0 CA--C 1.533 1.189 0 C-N-CA 121.103 -0.57 . . . . 0.0 113.207 179.699 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' D' D ' 35' ' ' ASP . . . . . . . . . . . . . 69.1 m-20 -65.47 148.87 50.99 Favored 'General case' 0 C--O 1.232 0.138 0 CA-C-N 118.013 0.907 . . . . 0.0 111.122 178.99 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' D' D ' 36' ' ' VAL . . . . . . . . . . . . . 45.7 t -122.97 130.03 74.72 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.251 0 CA-C-N 115.774 -0.648 . . . . 0.0 109.704 178.594 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' D' D ' 37' ' ' ILE . . . . . . . . . . . . . 69.7 mt -120.12 137.93 52.33 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.276 0 N-CA-C 109.767 -0.457 . . . . 0.0 109.767 179.442 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' D' D ' 38' ' ' GLY . . . . . . . . . . . . . . . -112.52 128.79 8.65 Favored Glycine 0 CA--C 1.526 0.724 0 N-CA-C 111.11 -0.796 . . . . 0.0 111.11 -179.078 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' D' D ' 39' ' ' ILE . . . . . . . . . . . . . 75.8 mt -124.23 135.55 63.33 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.261 0 CA-C-O 120.795 0.331 . . . . 0.0 110.164 178.999 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' D' D ' 40' ' ' SER . . . . . . . . . . . . . 23.0 t -92.71 120.74 33.41 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.321 -0.399 . . . . 0.0 110.723 176.142 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' D' D ' 41' ' ' ILE . . . . . . . . . . . . . 70.3 mt -132.09 118.16 35.89 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.23 0 N-CA-C 110.107 -0.331 . . . . 0.0 110.107 178.272 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' D' D ' 42' ' ' LEU . . . . . . . . . . . . . 5.4 mp 56.11 36.96 28.32 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.179 -0.464 . . . . 0.0 111.326 179.315 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' D' D ' 43' ' ' GLY . . . . . . . . . . . . . . . 77.48 -10.07 24.99 Favored Glycine 0 CA--C 1.533 1.209 0 C-N-CA 121.279 -0.486 . . . . 0.0 113.531 176.54 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' D' D ' 44' ' ' LYS . . . . . . . . . . . . . 61.9 mttp -97.19 135.96 38.39 Favored 'General case' 0 C--N 1.333 -0.123 0 CA-C-N 117.993 0.897 . . . . 0.0 110.151 177.398 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' D' D ' 45' ' ' GLU . . . . . . . . . . . . . 80.8 tt0 -85.2 126.9 34.03 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.282 -0.417 . . . . 0.0 110.758 179.817 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' D' D ' 46' ' ' VAL . . . . . . . . . . . . . 7.1 p -121.15 127.13 75.81 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.224 0 N-CA-C 109.597 -0.52 . . . . 0.0 109.597 175.895 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' D' D ' 47' ' ' LYS . . . . . . . . . . . . . 58.4 mttm -100.63 129.48 46.56 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 115.862 -0.608 . . . . 0.0 111.139 178.051 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' D' D ' 48' ' ' PHE . . . . . . . . . . . . . 92.5 m-85 -111.12 131.75 54.84 Favored 'General case' 0 C--N 1.329 -0.319 0 N-CA-C 109.61 -0.515 . . . . 0.0 109.61 174.807 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' D' D ' 49' ' ' LYS . . . . . . . . . . . . . 83.3 tttt -108.82 138.15 45.62 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.414 -0.357 . . . . 0.0 110.486 179.76 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' D' D ' 50' ' ' VAL . . . . . . . . . . . . . 44.9 t -80.3 109.56 14.93 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.285 0 N-CA-C 109.292 -0.632 . . . . 0.0 109.292 176.141 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' D' D ' 51' ' ' VAL . . . . . . . . . . . . . 51.2 t -71.81 -47.14 57.94 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.273 0 CA-C-N 115.988 -0.551 . . . . 0.0 109.97 -174.084 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' D' D ' 52' ' ' GLN . . . . . . . . . . . . . 47.6 tt0 -170.93 145.09 2.29 Favored 'General case' 0 C--N 1.33 -0.28 0 C-N-CA 120.433 -0.507 . . . . 0.0 111.439 -179.8 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' D' D ' 53' ' ' ALA . . . . . . . . . . . . . . . -121.14 136.18 55.02 Favored 'General case' 0 C--N 1.331 -0.227 0 CA-C-N 115.903 -0.589 . . . . 0.0 110.474 178.499 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' D' D ' 54' ' ' TYR . . . . . . . . . . . . . 35.6 t80 -129.16 113.59 18.49 Favored Pre-proline 0 CA--C 1.536 0.406 0 CA-C-O 118.24 -0.886 . . . . 0.0 110.117 176.142 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' D' D ' 55' ' ' PRO . . . . . . . . . . . . . 72.8 Cg_endo -77.29 170.08 72.35 Favored 'Cis proline' 0 N--CA 1.499 1.825 0 CA-C-N 122.037 1.763 . . . . 0.0 112.057 -6.089 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' D' D ' 56' ' ' SER . . . . . . . . . . . . . 17.5 m -122.51 134.1 24.74 Favored Pre-proline 0 CA--C 1.538 0.508 0 CA-C-O 118.519 -0.753 . . . . 0.0 109.496 175.204 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' D' D ' 57' ' ' PRO . . . . . . . . . . . . . 38.4 Cg_endo -67.2 145.54 73.63 Favored 'Cis proline' 0 N--CA 1.498 1.777 0 CA-C-N 121.834 1.691 . . . . 0.0 111.562 -1.67 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' D' D ' 58' ' ' LEU . . . . . . . . . . . . . 23.7 tp -106.25 136.05 46.65 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.263 -0.426 . . . . 0.0 110.736 -177.626 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' D' D ' 59' ' ' ARG . . . . . . . . . . . . . 42.1 ttm180 -103.28 127.83 50.5 Favored 'General case' 0 C--N 1.328 -0.367 0 N-CA-C 109.247 -0.649 . . . . 0.0 109.247 174.945 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' D' D ' 60' ' ' VAL . . . . . . . . . . . . . 45.5 t -84.18 120.28 34.73 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.242 0 C-N-CA 120.689 -0.404 . . . . 0.0 110.37 -175.916 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' D' D ' 61' ' ' GLU . . . . . . . . . . . . . 43.9 mt-10 -131.11 167.19 19.53 Favored 'General case' 0 C--N 1.331 -0.214 0 CA-C-N 115.735 -0.666 . . . . 0.0 109.858 177.391 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' D' D ' 62' ' ' ASP . . . . . . . . . . . . . 13.3 t70 -53.81 -32.57 53.19 Favored 'General case' 0 C--N 1.327 -0.377 0 N-CA-C 111.776 0.287 . . . . 0.0 111.776 -179.879 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' D' D ' 63' ' ' ARG . . . . . . . . . . . . . 26.5 ptt180 -82.99 3.79 28.65 Favored 'General case' 0 CA--C 1.536 0.434 0 N-CA-C 113.793 1.034 . . . . 0.0 113.793 -175.629 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' D' D ' 64' ' ' THR . . . . . . . . . . . . . 38.0 m -86.98 135.12 33.4 Favored 'General case' 0 C--N 1.333 -0.148 0 CA-C-N 118.117 0.417 . . . . 0.0 110.584 -178.343 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' D' D ' 65' ' ' LYS . . . . . . . . . . . . . 93.4 mttt -90.24 129.54 36.48 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.066 -0.515 . . . . 0.0 110.237 178.917 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' D' D ' 66' ' ' ILE . . . . . . . . . . . . . 63.4 mt -112.67 129.52 68.12 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.314 0 N-CA-C 109.725 -0.472 . . . . 0.0 109.725 179.641 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' D' D ' 67' ' ' THR . . . . . . . . . . . . . 29.3 m -124.02 138.11 54.5 Favored 'General case' 0 C--N 1.331 -0.204 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.807 -178.267 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' D' D ' 68' ' ' LEU . . . . . 0.496 ' N ' HD12 ' D' ' 68' ' ' LEU . 7.8 mp . . . . . 0 C--N 1.327 -0.386 0 CA-C-N 115.845 -0.616 . . . . 0.0 110.219 178.2 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' D' D ' 73' ' ' VAL . . . . . . . . . . . . . 30.7 m . . . . . 0 C--O 1.231 0.088 0 CA-C-O 121.067 0.46 . . . . 0.0 111.253 . . . . . . . . . 0 0 . 1 . 020 nuclear build core ' D' D ' 74' ' ' ASP . . . . . . . . . . . . . 8.3 t0 -101.54 118.42 36.91 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 115.696 -0.684 . . . . 0.0 109.598 178.539 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' D' D ' 75' ' ' VAL . . . . . . . . . . . . . 40.8 t -110.2 123.71 66.33 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.244 0 CA-C-O 120.99 0.424 . . . . 0.0 110.481 -177.179 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' D' D ' 76' ' ' LEU . . . . . . . . . . . . . 30.0 mt -128.49 147.41 50.68 Favored 'General case' 0 C--N 1.331 -0.22 0 CA-C-N 115.794 -0.639 . . . . 0.0 110.066 178.854 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' D' D ' 77' ' ' GLU . . . . . . . . . . . . . 97.1 mt-10 -136.75 140.65 42.73 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-O 120.98 0.419 . . . . 0.0 110.99 -177.95 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' D' D ' 78' ' ' ALA . . . . . 0.674 ' HB2' HD21 ' D' ' 109' ' ' LEU . . . -125.67 127.39 46.19 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 115.799 -0.637 . . . . 0.0 109.748 176.878 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' D' D ' 79' ' ' LYS . . . . . 0.581 ' O ' HD13 ' D' ' 80' ' ' ILE . 48.8 mmtm -71.59 119.37 15.66 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-O 120.849 0.357 . . . . 0.0 110.848 -178.096 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' D' D ' 80' ' ' ILE . . . . . 0.581 HD13 ' O ' ' D' ' 79' ' ' LYS . 41.3 mm -139.09 112.73 6.75 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.289 0 N-CA-C 108.885 -0.783 . . . . 0.0 108.885 -179.298 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' D' D ' 81' ' ' LYS . . . . . . . . . . . . . 83.2 tttt -102.65 123.67 46.79 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-O 120.833 0.349 . . . . 0.0 111.205 -174.534 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' D' D ' 82' ' ' GLY . . . . . . . . . . . . . . . 89.22 41.99 5.68 Favored Glycine 0 CA--C 1.526 0.747 0 C-N-CA 120.824 -0.703 . . . . 0.0 112.064 173.702 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' D' D ' 83' ' ' ILE . . . . . . . . . . . . . 67.6 mt -68.25 139.63 20.39 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.311 0 N-CA-C 109.802 -0.444 . . . . 0.0 109.802 177.249 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' D' D ' 84' ' ' LYS . . . . . . . . . . . . . 39.7 ttpt -102.62 -47.9 4.29 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.165 -0.47 . . . . 0.0 110.295 -179.081 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' D' D ' 85' ' ' ASP . . . . . . . . . . . . . 7.5 t70 -152.31 151.04 30.4 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.068 -0.515 . . . . 0.0 110.552 179.903 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' D' D ' 86' ' ' VAL . . . . . . . . . . . . . 42.0 t -129.04 131.5 68.02 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.241 0 CA-C-O 120.917 0.389 . . . . 0.0 110.394 179.513 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' D' D ' 87' ' ' ILE . . . . . 0.499 HD12 ' N ' ' D' ' 87' ' ' ILE . 5.1 mp -118.64 127.35 75.62 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.245 0 N-CA-C 109.472 -0.566 . . . . 0.0 109.472 177.506 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' D' D ' 88' ' ' LEU . . . . . . . . . . . . . 20.6 tp -111.66 123.45 50.26 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.382 -0.372 . . . . 0.0 110.691 -176.963 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' D' D ' 89' ' ' ASP . . . . . . . . . . . . . 12.8 t70 -121.23 156.14 33.1 Favored 'General case' 0 C--N 1.332 -0.184 0 CA-C-N 116.419 -0.355 . . . . 0.0 110.235 -179.983 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' D' D ' 90' ' ' GLU . . . . . . . . . . . . . 68.1 tt0 -46.04 -45.7 16.22 Favored 'General case' 0 N--CA 1.465 0.291 0 N-CA-C 112.972 0.73 . . . . 0.0 112.972 -171.832 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' D' D ' 91' ' ' ASN . . . . . . . . . . . . . 8.4 t-20 -129.59 34.76 4.29 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-O 120.709 0.29 . . . . 0.0 111.665 -176.039 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' D' D ' 92' ' ' LEU . . . . . . . . . . . . . 7.0 tp -166.14 146.38 6.33 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-O 120.944 0.402 . . . . 0.0 110.554 179.68 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' D' D ' 93' ' ' ILE . . . . . . . . . . . . . 66.7 mt -122.26 123.0 67.8 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.366 0 N-CA-C 109.13 -0.693 . . . . 0.0 109.13 179.146 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' D' D ' 94' ' ' VAL . . . . . . . . . . . . . 43.1 t -119.33 128.19 75.84 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.246 0 CA-C-O 120.839 0.352 . . . . 0.0 110.053 -178.122 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' D' D ' 95' ' ' VAL . . . . . . . . . . . . . 42.4 t -123.12 132.59 71.11 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.302 0 CA-C-N 116.043 -0.526 . . . . 0.0 109.882 179.474 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' D' D ' 96' ' ' ILE . . . . . . . . . . . . . 67.5 mt -116.2 127.87 73.67 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.312 0 N-CA-C 109.268 -0.642 . . . . 0.0 109.268 179.077 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' D' D ' 97' ' ' THR . . . . . . . . . . . . . 70.0 p -99.76 158.27 15.91 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-O 121.029 0.442 . . . . 0.0 111.026 -177.664 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' D' D ' 98' ' ' GLU . . . . . . . . . . . . . 44.8 tp10 -54.03 -26.13 24.89 Favored 'General case' 0 CA--C 1.534 0.34 0 CA-C-N 116.224 -0.444 . . . . 0.0 111.916 179.058 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' D' D ' 99' ' ' GLU . . . . . . . . . . . . . 34.5 tt0 -76.3 11.47 1.54 Allowed 'General case' 0 CA--C 1.539 0.533 0 N-CA-C 112.765 0.654 . . . . 0.0 112.765 -177.512 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' D' D ' 100' ' ' ASN . . . . . . . . . . . . . 2.1 m-20 62.81 32.15 16.07 Favored 'General case' 0 CA--C 1.532 0.277 0 O-C-N 121.705 -0.622 . . . . 0.0 111.555 178.983 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' D' D ' 101' ' ' GLU . . . . . . . . . . . . . 78.5 tt0 -109.75 144.66 37.85 Favored 'General case' 0 C--O 1.234 0.241 0 N-CA-C 109.631 -0.507 . . . . 0.0 109.631 172.887 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' D' D ' 102' ' ' VAL . . . . . . . . . . . . . 44.6 t -116.13 128.2 73.5 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.248 0 CA-C-N 116.432 -0.349 . . . . 0.0 110.134 -178.592 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' D' D ' 103' ' ' LEU . . . . . . . . . . . . . 21.1 mt -116.2 130.52 56.83 Favored 'General case' 0 C--N 1.331 -0.208 0 CA-C-N 115.717 -0.674 . . . . 0.0 110.163 176.973 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' D' D ' 104' ' ' ILE . . . . . 0.58 HD13 HG21 ' D' ' 130' ' ' VAL . 66.9 mt -116.82 120.5 65.22 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.299 0 N-CA-C 110.018 -0.364 . . . . 0.0 110.018 179.621 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' D' D ' 105' ' ' PHE . . . . . . . . . . . . . 62.8 m-85 -120.8 165.12 15.59 Favored 'General case' 0 C--N 1.333 -0.123 0 O-C-N 123.893 0.746 . . . . 0.0 109.807 178.777 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' D' D ' 106' ' ' ASN . . . . . . . . . . . . . 42.9 p-10 -98.94 -170.05 1.87 Allowed 'General case' 0 C--N 1.331 -0.229 0 N-CA-C 109.936 -0.394 . . . . 0.0 109.936 173.549 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' D' D ' 107' ' ' GLN . . . . . . . . . . . . . 48.7 tt0 -60.5 -30.03 69.46 Favored 'General case' 0 C--N 1.329 -0.289 0 N-CA-C 111.955 0.354 . . . . 0.0 111.955 179.946 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' D' D ' 108' ' ' ASN . . . . . . . . . . . . . 6.6 t-20 -83.27 6.78 18.46 Favored 'General case' 0 CA--C 1.536 0.425 0 N-CA-C 113.223 0.824 . . . . 0.0 113.223 -178.371 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' D' D ' 109' ' ' LEU . . . . . 0.674 HD21 ' HB2' ' D' ' 78' ' ' ALA . 10.2 tp 62.41 37.69 13.41 Favored 'General case' 0 CA--C 1.529 0.167 0 O-C-N 122.087 -0.383 . . . . 0.0 111.377 178.244 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' D' D ' 110' ' ' GLU . . . . . . . . . . . . . 70.7 mm-40 -105.89 162.24 13.75 Favored 'General case' 0 C--N 1.33 -0.255 0 N-CA-C 109.765 -0.457 . . . . 0.0 109.765 176.014 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' D' D ' 111' ' ' GLU . . . . . . . . . . . . . 83.9 tt0 -86.67 127.45 34.95 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-O 120.938 0.399 . . . . 0.0 111.208 -176.357 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' D' D ' 112' ' ' LEU . . . . . . . . . . . . . 15.6 mt -113.03 -46.09 3.13 Favored 'General case' 0 C--N 1.331 -0.197 0 CA-C-N 115.953 -0.567 . . . . 0.0 110.418 176.579 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' D' D ' 113' ' ' TYR . . . . . 0.563 ' HB3' HD12 ' D' ' 104' ' ' ILE . 38.2 t80 -143.06 138.73 30.13 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.269 -0.423 . . . . 0.0 111.26 -179.295 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' D' D ' 114' ' ' ARG . . . . . . . . . . . . . 27.4 ttm180 -137.42 122.61 19.24 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.338 -0.392 . . . . 0.0 109.968 174.908 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' D' D ' 115' ' ' GLY . . . . . . . . . . . . . . . -150.07 163.1 29.38 Favored Glycine 0 CA--C 1.526 0.775 0 N-CA-C 111.115 -0.794 . . . . 0.0 111.115 179.031 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' D' D ' 116' ' ' LYS . . . . . . . . . . . . . 88.2 tttt -131.69 138.19 48.59 Favored 'General case' 0 C--N 1.33 -0.241 0 N-CA-C 110.046 -0.353 . . . . 0.0 110.046 178.628 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' D' D ' 117' ' ' PHE . . . . . 0.423 ' HE2' HD13 ' D' ' 132' ' ' ILE . 27.6 m-85 -139.05 113.96 9.32 Favored 'General case' 0 C--N 1.331 -0.205 0 CA-C-N 116.26 -0.427 . . . . 0.0 109.963 -176.657 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' D' D ' 118' ' ' GLU . . . . . . . . . . . . . 70.7 mm-40 -54.5 -47.78 72.65 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.564 -0.289 . . . . 0.0 111.542 -174.982 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' D' D ' 119' ' ' ASN . . . . . . . . . . . . . 29.5 m120 -93.59 31.06 1.61 Allowed 'General case' 0 C--N 1.329 -0.315 0 N-CA-C 112.15 0.426 . . . . 0.0 112.15 -174.319 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' D' D ' 120' ' ' LEU . . . . . . . . . . . . . 10.3 tp -56.06 120.69 7.89 Favored 'General case' 0 C--N 1.333 -0.139 0 C-N-CA 121.078 -0.249 . . . . 0.0 110.584 177.864 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' D' D ' 121' ' ' ASN . . . . . . . . . . . . . 36.2 m120 -113.78 -44.05 3.22 Favored 'General case' 0 C--O 1.233 0.204 0 CA-C-N 116.575 -0.284 . . . . 0.0 111.178 -177.582 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' D' D ' 122' ' ' LYS . . . . . . . . . . . . . 98.3 mttt -145.72 150.11 35.65 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-O 121.081 0.467 . . . . 0.0 111.945 -177.978 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' D' D ' 123' ' ' VAL . . . . . . . . . . . . . 44.0 t -127.67 127.56 68.6 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.166 0 CA-C-N 115.811 -0.631 . . . . 0.0 109.485 175.292 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' D' D ' 124' ' ' LEU . . . . . 0.429 HD13 ' HB2' ' E' ' 88' ' ' LEU . 35.6 mt -118.02 136.59 53.44 Favored 'General case' 0 C--N 1.332 -0.161 0 CA-C-N 116.426 -0.352 . . . . 0.0 110.606 -179.231 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' D' D ' 125' ' ' VAL . . . . . . . . . . . . . 34.9 m -121.82 141.95 40.16 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.223 0 CA-C-N 116.128 -0.487 . . . . 0.0 110.608 -179.293 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' D' D ' 126' ' ' ARG . . . . . . . . . . . . . 36.5 ptt180 -148.05 114.78 6.04 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-O 121.292 0.567 . . . . 0.0 110.462 177.725 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' D' D ' 127' ' ' ASN . . . . . . . . . . . . . 60.6 t30 49.48 -107.74 0.26 Allowed 'General case' 0 CA--C 1.546 0.823 0 CA-C-O 118.967 -0.539 . . . . 0.0 111.432 -178.516 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' D' D ' 128' ' ' ASP . . . . . . . . . . . . . 20.4 p-10 -114.08 4.98 15.85 Favored 'General case' 0 N--CA 1.469 0.482 0 CA-C-N 119.813 1.188 . . . . 0.0 113.264 179.726 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' D' D ' 129' ' ' LEU . . . . . . . . . . . . . 25.1 mt -108.82 152.75 24.46 Favored 'General case' 0 C--O 1.233 0.222 0 N-CA-C 109.349 -0.612 . . . . 0.0 109.349 178.332 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' D' D ' 130' ' ' VAL . . . . . 0.58 HG21 HD13 ' D' ' 104' ' ' ILE . 33.3 m -139.34 150.17 22.84 Favored 'Isoleucine or valine' 0 N--CA 1.462 0.153 0 CA-C-O 121.462 0.649 . . . . 0.0 111.804 -177.756 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' D' D ' 131' ' ' VAL . . . . . 0.753 HG22 HD12 ' D' ' 140' ' ' LEU . 43.4 t -136.09 138.49 47.21 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.267 0 CA-C-N 115.321 -0.854 . . . . 0.0 109.891 177.277 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' D' D ' 132' ' ' ILE . . . . . 0.423 HD13 ' HE2' ' D' ' 117' ' ' PHE . 70.6 mt -118.03 133.97 63.14 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.305 0 CA-C-N 116.086 -0.506 . . . . 0.0 109.702 -178.538 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' D' D ' 133' ' ' ILE . . . . . . . . . . . . . 42.9 mm -115.07 124.06 71.34 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.287 0 CA-C-N 116.399 -0.364 . . . . 0.0 110.846 -175.643 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' D' D ' 134' ' ' ASP . . . . . . . . . . . . . 8.9 p-10 -136.6 146.58 46.23 Favored 'General case' 0 C--N 1.332 -0.166 0 N-CA-C 109.651 -0.5 . . . . 0.0 109.651 174.227 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' D' D ' 135' ' ' GLU . . . . . . . . . . . . . 45.7 tp10 -49.9 -28.4 6.58 Favored 'General case' 0 C--N 1.328 -0.346 0 N-CA-C 112.874 0.694 . . . . 0.0 112.874 -172.05 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' D' D ' 136' ' ' GLN . . . . . . . . . . . . . 36.5 tt0 -80.48 -35.6 34.56 Favored 'General case' 0 C--N 1.331 -0.21 0 N-CA-C 112.236 0.458 . . . . 0.0 112.236 -176.048 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' D' D ' 137' ' ' LYS . . . . . . . . . . . . . 58.5 pttt -167.05 172.59 9.98 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-O 121.61 0.719 . . . . 0.0 112.193 -171.994 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' D' D ' 138' ' ' LEU . . . . . . . . . . . . . 5.0 tt -115.8 128.39 55.8 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 115.046 -0.979 . . . . 0.0 109.847 179.749 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' D' D ' 139' ' ' THR . . . . . . . . . . . . . 38.5 m -109.62 130.25 55.53 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.303 -0.408 . . . . 0.0 110.377 -179.459 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' D' D ' 140' ' ' LEU . . . . . 0.753 HD12 HG22 ' D' ' 131' ' ' VAL . 10.0 tp -118.46 127.54 53.75 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.025 -0.534 . . . . 0.0 109.914 -178.26 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' D' D ' 141' ' ' ILE . . . . . 0.475 ' HB ' HG23 ' D' ' 130' ' ' VAL . 19.0 mt -125.71 121.64 60.41 Favored 'Isoleucine or valine' 0 C--O 1.234 0.28 0 N-CA-C 109.898 -0.408 . . . . 0.0 109.898 -176.043 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' D' D ' 142' ' ' ARG . . . . . . . . . . . . . 73.9 mtm180 -115.42 123.48 48.73 Favored 'General case' 0 N--CA 1.463 0.179 0 CA-C-N 116.132 -0.485 . . . . 0.0 109.872 -179.463 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' D' D ' 143' ' ' THR . . . . . . . . . . . . . 25.2 p . . . . . 0 C--O 1.219 -0.526 0 CA-C-O 118.047 -0.977 . . . . 0.0 110.57 -179.263 . . . . . . . . 0 0 . 1 . 020 nuclear build core ' E' E ' 2' ' ' SER . . . . . 0.432 ' OG ' HG23 ' E' ' 64' ' ' THR . 87.3 p . . . . . 0 N--CA 1.463 0.2 0 CA-C-O 121.042 0.449 . . . . 0.0 111.173 . . . . . . . . . 1 1 . 1 . 020 nuclear build core ' E' E ' 3' ' ' GLU . . . . . . . . . . . . . 47.6 mp0 -138.74 144.7 39.6 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 115.855 -0.611 . . . . 0.0 110.986 -178.468 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' E' E ' 4' ' ' LEU . . . . . . . . . . . . . 16.8 tp -125.02 125.13 43.38 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 115.809 -0.632 . . . . 0.0 109.931 176.298 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' E' E ' 5' ' ' LYS . . . . . . . . . . . . . 69.2 mttm -106.39 121.71 44.79 Favored 'General case' 0 C--N 1.331 -0.224 0 CA-C-N 116.362 -0.381 . . . . 0.0 110.634 179.078 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' E' E ' 6' ' ' LEU . . . . . . . . . . . . . 77.1 mt -118.65 147.87 43.32 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 115.492 -0.776 . . . . 0.0 110.522 179.768 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' E' E ' 7' ' ' LYS . . . . . . . . . . . . . 84.9 tttt -140.25 142.46 29.93 Favored Pre-proline 0 C--N 1.329 -0.316 0 N-CA-C 109.666 -0.494 . . . . 0.0 109.666 175.687 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' E' E ' 8' ' ' PRO . . . . . . . . . . . . . 85.1 Cg_endo -90.86 147.45 3.87 Favored 'Trans proline' 0 N--CA 1.492 1.391 0 C-N-CA 121.779 1.653 . . . . 0.0 112.081 179.584 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' E' E ' 9' ' ' LEU . . . . . . . . . . . . . 37.4 mt -84.03 -47.69 0.72 Allowed Pre-proline 0 C--N 1.329 -0.301 0 CA-C-O 118.598 -0.715 . . . . 0.0 112.012 178.929 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' E' E ' 10' ' ' PRO . . . . . . . . . . . . . 97.3 Cg_endo -80.76 154.42 20.27 Favored 'Trans proline' 0 N--CA 1.495 1.602 0 C-N-CA 121.124 1.216 . . . . 0.0 111.667 176.052 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' E' E ' 11' ' ' LYS . . . . . . . . . . . . . 58.2 mtpt -88.71 100.99 13.56 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-O 120.804 0.335 . . . . 0.0 110.471 -179.969 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' E' E ' 12' ' ' VAL . . . . . . . . . . . . . 12.3 p -139.6 143.94 29.67 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.224 0 CA-C-N 116.18 -0.464 . . . . 0.0 110.62 -179.225 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' E' E ' 13' ' ' GLU . . . . . . . . . . . . . 45.5 mp0 -90.98 117.41 29.55 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.31 -0.405 . . . . 0.0 110.018 177.254 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' E' E ' 14' ' ' LEU . . . . . 0.46 HD22 ' CE1' ' E' ' 18' ' ' PHE . 25.3 mt -97.93 155.3 37.23 Favored Pre-proline 0 C--N 1.329 -0.283 0 CA-C-N 116.334 -0.394 . . . . 0.0 111.03 -176.832 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' E' E ' 15' ' ' PRO . . . . . . . . . . . . . 32.9 Cg_exo -60.46 161.27 21.0 Favored 'Trans proline' 0 N--CA 1.496 1.676 0 C-N-CA 121.316 1.344 . . . . 0.0 112.048 177.067 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' E' E ' 16' ' ' PRO . . . . . . . . . . . . . 24.6 Cg_exo -61.82 -34.88 81.45 Favored 'Trans proline' 0 N--CA 1.497 1.725 0 C-N-CA 121.472 1.448 . . . . 0.0 112.753 -178.954 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' E' E ' 17' ' ' ASP . . . . . . . . . . . . . 15.7 p-10 -88.38 11.65 16.27 Favored 'General case' 0 CA--C 1.534 0.336 0 N-CA-C 113.24 0.829 . . . . 0.0 113.24 -176.408 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' E' E ' 18' ' ' PHE . . . . . 0.46 ' CE1' HD22 ' E' ' 14' ' ' LEU . 37.3 t80 -56.91 -45.53 82.57 Favored 'General case' 0 C--O 1.231 0.118 0 O-C-N 122.024 -0.423 . . . . 0.0 110.334 -178.377 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' E' E ' 19' ' ' VAL . . . . . 0.408 HG13 ' N ' ' E' ' 20' ' ' ASP . 13.2 p -56.55 -41.57 73.58 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.317 0 CA-C-N 116.544 -0.298 . . . . 0.0 110.898 -179.013 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' E' E ' 20' ' ' ASP . . . . . 0.408 ' N ' HG13 ' E' ' 19' ' ' VAL . 78.1 m-20 -61.05 -43.12 99.37 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-O 120.837 0.351 . . . . 0.0 110.889 -178.545 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' E' E ' 21' ' ' VAL . . . . . . . . . . . . . 48.8 t -64.3 -44.86 97.34 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.319 0 C-N-CA 120.797 -0.361 . . . . 0.0 110.448 -176.952 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' E' E ' 22' ' ' ILE . . . . . 0.609 HG22 HD12 ' E' ' 26' ' ' LEU . 49.8 mm -55.2 -50.62 62.74 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.247 0 C-N-CA 121.151 -0.22 . . . . 0.0 110.716 178.72 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' E' E ' 23' ' ' ARG . . . . . . . . . . . . . 37.8 ttp180 -55.21 -48.65 73.57 Favored 'General case' 0 C--N 1.329 -0.311 0 C-N-CA 120.949 -0.3 . . . . 0.0 111.567 -177.778 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' E' E ' 24' ' ' ILE . . . . . . . . . . . . . 75.4 mt -58.91 -43.72 89.21 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 C-N-CA 121.054 -0.258 . . . . 0.0 111.368 -176.126 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' E' E ' 25' ' ' LYS . . . . . . . . . . . . . 93.1 mttt -69.34 -39.62 78.04 Favored 'General case' 0 C--N 1.33 -0.268 0 N-CA-C 112.556 0.576 . . . . 0.0 112.556 -178.302 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' E' E ' 26' ' ' LEU . . . . . 0.609 HD12 HG22 ' E' ' 22' ' ' ILE . 79.2 mt -78.98 -33.49 45.07 Favored 'General case' 0 C--N 1.331 -0.219 0 N-CA-C 113.673 0.99 . . . . 0.0 113.673 -170.745 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' E' E ' 27' ' ' GLN . . . . . . . . . . . . . 21.0 pt20 -46.4 137.42 6.5 Favored 'General case' 0 N--CA 1.469 0.5 0 N-CA-C 112.861 0.689 . . . . 0.0 112.861 -174.406 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' E' E ' 28' ' ' GLY . . . . . . . . . . . . . . . 99.99 -23.73 34.89 Favored Glycine 0 CA--C 1.533 1.198 0 CA-C-N 115.68 -0.691 . . . . 0.0 112.53 -177.448 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' E' E ' 29' ' ' LYS . . . . . . . . . . . . . 97.7 mttt -97.59 155.13 17.11 Favored 'General case' 0 C--O 1.233 0.235 0 CA-C-N 117.459 0.63 . . . . 0.0 111.132 179.512 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' E' E ' 30' ' ' THR . . . . . . . . . . . . . 27.0 m -103.28 138.52 39.95 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.085 -0.507 . . . . 0.0 110.272 177.545 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' E' E ' 31' ' ' VAL . . . . . . . . . . . . . 34.9 m -130.23 156.73 42.54 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.239 0 CA-C-N 116.385 -0.371 . . . . 0.0 110.879 -178.923 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' E' E ' 32' ' ' ARG . . . . . . . . . . . . . 79.0 mtm180 -136.1 150.4 49.1 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-O 121.32 0.581 . . . . 0.0 110.819 178.112 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' E' E ' 33' ' ' THR . . . . . . . . . . . . . 17.6 m -53.55 141.43 25.54 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.128 -0.487 . . . . 0.0 111.27 -178.625 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' E' E ' 34' ' ' GLY . . . . . . . . . . . . . . . 99.64 -17.08 58.06 Favored Glycine 0 CA--C 1.532 1.149 0 CA-C-O 119.699 -0.501 . . . . 0.0 113.275 179.609 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' E' E ' 35' ' ' ASP . . . . . . . . . . . . . 76.6 m-20 -66.03 147.69 52.95 Favored 'General case' 0 C--O 1.23 0.071 0 CA-C-N 118.054 0.927 . . . . 0.0 111.152 179.054 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' E' E ' 36' ' ' VAL . . . . . . . . . . . . . 46.4 t -122.54 127.97 75.2 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.204 0 CA-C-N 115.83 -0.623 . . . . 0.0 109.649 177.803 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' E' E ' 37' ' ' ILE . . . . . . . . . . . . . 68.2 mt -119.31 138.66 49.28 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.239 0 CA-C-N 116.247 -0.433 . . . . 0.0 109.928 -179.499 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' E' E ' 38' ' ' GLY . . . . . . . . . . . . . . . -110.34 128.58 8.9 Favored Glycine 0 CA--C 1.525 0.7 0 N-CA-C 111.025 -0.83 . . . . 0.0 111.025 179.891 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' E' E ' 39' ' ' ILE . . . . . . . . . . . . . 75.4 mt -126.13 139.34 51.83 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.2 0 N-CA-C 110.027 -0.36 . . . . 0.0 110.027 178.835 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' E' E ' 40' ' ' SER . . . . . 0.432 ' O ' HD13 ' E' ' 41' ' ' ILE . 31.0 t -92.28 116.66 29.16 Favored 'General case' 0 C--N 1.329 -0.297 0 C-N-CA 120.935 -0.306 . . . . 0.0 110.936 176.107 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' E' E ' 41' ' ' ILE . . . . . 0.432 HD13 ' O ' ' E' ' 40' ' ' SER . 46.0 mm -124.59 115.96 46.06 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.157 0 N-CA-C 110.112 -0.329 . . . . 0.0 110.112 178.584 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' E' E ' 42' ' ' LEU . . . . . . . . . . . . . 70.4 mt 57.58 33.43 23.24 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-N 116.196 -0.457 . . . . 0.0 111.793 179.437 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' E' E ' 43' ' ' GLY . . . . . . . . . . . . . . . 81.78 -10.05 53.44 Favored Glycine 0 CA--C 1.534 1.261 0 C-N-CA 121.26 -0.495 . . . . 0.0 113.435 177.043 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' E' E ' 44' ' ' LYS . . . . . . . . . . . . . 53.1 mtpt -100.45 140.45 34.68 Favored 'General case' 0 C--N 1.333 -0.134 0 CA-C-N 117.892 0.846 . . . . 0.0 110.198 178.321 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' E' E ' 45' ' ' GLU . . . . . . . . . . . . . 80.7 tt0 -83.98 126.05 32.65 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.464 -0.334 . . . . 0.0 110.985 -178.752 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' E' E ' 46' ' ' VAL . . . . . . . . . . . . . 7.6 p -120.68 124.37 72.27 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.224 0 N-CA-C 109.409 -0.589 . . . . 0.0 109.409 175.836 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' E' E ' 47' ' ' LYS . . . . . . . . . . . . . 93.1 mttt -100.51 128.5 46.55 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.011 -0.54 . . . . 0.0 111.132 178.027 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' E' E ' 48' ' ' PHE . . . . . . . . . . . . . 93.5 m-85 -109.56 131.96 54.58 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.249 -0.432 . . . . 0.0 110.015 176.499 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' E' E ' 49' ' ' LYS . . . . . . . . . . . . . 80.0 tttt -107.49 134.59 50.3 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.312 -0.403 . . . . 0.0 110.293 179.53 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' E' E ' 50' ' ' VAL . . . . . . . . . . . . . 46.2 t -77.13 110.01 12.31 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.304 0 N-CA-C 109.287 -0.635 . . . . 0.0 109.287 176.393 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' E' E ' 51' ' ' VAL . . . . . . . . . . . . . 48.4 t -74.28 -47.08 42.29 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.278 0 CA-C-N 116.073 -0.512 . . . . 0.0 110.233 -173.852 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' E' E ' 52' ' ' GLN . . . . . . . . . . . . . 61.9 tt0 -168.01 140.08 3.0 Favored 'General case' 0 C--N 1.331 -0.228 0 C-N-CA 120.409 -0.516 . . . . 0.0 111.351 -177.942 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' E' E ' 53' ' ' ALA . . . . . . . . . . . . . . . -117.18 134.46 54.75 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 115.798 -0.637 . . . . 0.0 110.179 175.62 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' E' E ' 54' ' ' TYR . . . . . . . . . . . . . 55.5 t80 -129.05 112.69 18.53 Favored Pre-proline 0 CA--C 1.535 0.375 0 CA-C-O 118.146 -0.93 . . . . 0.0 110.378 177.877 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' E' E ' 55' ' ' PRO . . . . . . . . . . . . . 74.0 Cg_endo -77.09 168.13 77.89 Favored 'Cis proline' 0 N--CA 1.5 1.902 0 CA-C-N 122.14 1.8 . . . . 0.0 112.273 -6.925 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' E' E ' 56' ' ' SER . . . . . . . . . . . . . 15.5 m -116.89 133.79 23.04 Favored Pre-proline 0 CA--C 1.538 0.506 0 CA-C-O 118.414 -0.803 . . . . 0.0 109.572 175.198 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' E' E ' 57' ' ' PRO . . . . . . . . . . . . . 39.4 Cg_endo -67.54 161.11 79.13 Favored 'Cis proline' 0 N--CA 1.497 1.716 0 CA-C-N 121.864 1.701 . . . . 0.0 111.29 -1.695 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' E' E ' 58' ' ' LEU . . . . . . . . . . . . . 21.3 tp -125.99 138.39 53.74 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-O 120.969 0.414 . . . . 0.0 110.46 -178.967 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' E' E ' 59' ' ' ARG . . . . . . . . . . . . . 74.6 ttt180 -103.25 127.0 50.7 Favored 'General case' 0 C--N 1.327 -0.4 0 CA-C-N 115.737 -0.665 . . . . 0.0 109.355 176.249 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' E' E ' 60' ' ' VAL . . . . . . . . . . . . . 41.8 t -77.35 116.74 21.21 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.26 0 C-N-CA 120.672 -0.411 . . . . 0.0 110.156 -176.441 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' E' E ' 61' ' ' GLU . . . . . . . . . . . . . 95.7 mt-10 -131.15 162.17 30.5 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 115.907 -0.588 . . . . 0.0 110.145 178.423 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' E' E ' 62' ' ' ASP . . . . . . . . . . . . . 79.3 m-20 -54.79 -32.67 60.5 Favored 'General case' 0 C--N 1.328 -0.346 0 C-N-CA 121.065 -0.254 . . . . 0.0 111.667 -179.851 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' E' E ' 63' ' ' ARG . . . . . . . . . . . . . 10.8 ptm180 -82.6 6.82 16.47 Favored 'General case' 0 CA--C 1.534 0.354 0 N-CA-C 113.744 1.016 . . . . 0.0 113.744 -175.887 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' E' E ' 64' ' ' THR . . . . . 0.432 HG23 ' OG ' ' E' ' 2' ' ' SER . 27.6 m -93.43 140.14 29.91 Favored 'General case' 0 C--O 1.232 0.133 0 CA-C-N 118.16 0.436 . . . . 0.0 110.486 -179.62 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' E' E ' 65' ' ' LYS . . . . . . . . . . . . . 68.3 mttm -88.62 124.2 33.83 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.277 -0.42 . . . . 0.0 110.008 179.558 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' E' E ' 66' ' ' ILE . . . . . . . . . . . . . 56.5 mt -113.58 129.8 68.74 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.253 0 N-CA-C 109.815 -0.439 . . . . 0.0 109.815 -179.814 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' E' E ' 67' ' ' THR . . . . . . . . . . . . . 19.0 m -127.21 133.97 50.18 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-O 121.245 0.545 . . . . 0.0 110.767 179.949 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' E' E ' 68' ' ' LEU . . . . . . . . . . . . . 21.7 tp . . . . . 0 C--N 1.33 -0.269 0 CA-C-N 115.737 -0.665 . . . . 0.0 109.72 176.55 . . . . . . . . 0 0 . 1 . 020 nuclear build core ' E' E ' 73' ' ' VAL . . . . . . . . . . . . . 34.3 m . . . . . 0 C--O 1.232 0.132 0 N-CA-C 110.293 -0.262 . . . . 0.0 110.293 . . . . . . . . . 0 0 . 1 . 020 nuclear build core ' E' E ' 74' ' ' ASP . . . . . . . . . . . . . 13.9 t70 -77.35 114.98 16.73 Favored 'General case' 0 C--N 1.328 -0.338 0 C-N-CA 120.362 -0.535 . . . . 0.0 110.274 -168.414 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' E' E ' 75' ' ' VAL . . . . . . . . . . . . . 46.8 t -119.38 117.91 55.63 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.273 0 CA-C-O 121.16 0.505 . . . . 0.0 109.733 -179.654 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' E' E ' 76' ' ' LEU . . . . . . . . . . . . . 15.2 mt -124.59 148.57 47.78 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 115.459 -0.791 . . . . 0.0 109.613 -178.329 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' E' E ' 77' ' ' GLU . . . . . . . . . . . . . 45.3 mt-10 -138.77 135.46 34.7 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-O 121.15 0.5 . . . . 0.0 111.266 -177.604 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' E' E ' 78' ' ' ALA . . . . . 0.569 ' HB2' HD21 ' E' ' 109' ' ' LEU . . . -121.78 129.24 52.52 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 115.562 -0.745 . . . . 0.0 109.622 175.708 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' E' E ' 79' ' ' LYS . . . . . 0.652 ' O ' HD13 ' E' ' 80' ' ' ILE . 48.7 mttm -75.83 117.84 18.0 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-O 121.008 0.433 . . . . 0.0 110.875 -178.55 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' E' E ' 80' ' ' ILE . . . . . 0.652 HD13 ' O ' ' E' ' 79' ' ' LYS . 38.4 mm -139.14 102.5 1.73 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.261 0 N-CA-C 108.908 -0.775 . . . . 0.0 108.908 -177.95 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' E' E ' 81' ' ' LYS . . . . . . . . . . . . . 53.5 mttp -96.31 127.82 42.66 Favored 'General case' 0 C--N 1.327 -0.397 0 C-N-CA 120.783 -0.367 . . . . 0.0 111.305 -176.489 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' E' E ' 82' ' ' GLY . . . . . . . . . . . . . . . 89.14 42.18 5.66 Favored Glycine 0 CA--C 1.525 0.703 0 C-N-CA 120.714 -0.755 . . . . 0.0 111.867 173.588 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' E' E ' 83' ' ' ILE . . . . . . . . . . . . . 70.7 mt -70.95 135.0 28.98 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.358 0 N-CA-C 109.477 -0.564 . . . . 0.0 109.477 177.186 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' E' E ' 84' ' ' LYS . . . . . . . . . . . . . 31.1 ttpt -94.34 -51.64 4.7 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-O 121.023 0.44 . . . . 0.0 110.212 -177.521 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' E' E ' 85' ' ' ASP . . . . . . . . . . . . . 8.9 t70 -149.49 149.31 30.57 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 115.696 -0.684 . . . . 0.0 110.068 -179.383 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' E' E ' 86' ' ' VAL . . . . . . . . . . . . . 39.6 t -132.3 133.65 59.99 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.244 0 CA-C-O 120.959 0.409 . . . . 0.0 110.502 -179.671 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' E' E ' 87' ' ' ILE . . . . . 0.5 ' N ' HD12 ' E' ' 87' ' ' ILE . 5.0 mp -118.94 123.48 71.56 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 N-CA-C 109.206 -0.665 . . . . 0.0 109.206 176.717 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' E' E ' 88' ' ' LEU . . . . . 0.429 ' HB2' HD13 ' D' ' 124' ' ' LEU . 14.0 tp -109.43 119.52 39.72 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.401 -0.363 . . . . 0.0 110.475 -179.068 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' E' E ' 89' ' ' ASP . . . . . . . . . . . . . 6.6 t70 -112.28 153.92 26.43 Favored 'General case' 0 C--N 1.33 -0.28 0 N-CA-C 109.628 -0.508 . . . . 0.0 109.628 178.249 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' E' E ' 90' ' ' GLU . . . . . . . . . . . . . 82.0 tt0 -47.76 -36.86 12.22 Favored 'General case' 0 C--N 1.329 -0.296 0 N-CA-C 112.685 0.624 . . . . 0.0 112.685 -173.364 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' E' E ' 91' ' ' ASN . . . . . . . . . . . . . 13.2 p30 -131.97 32.19 4.08 Favored 'General case' 0 N--CA 1.465 0.285 0 N-CA-C 112.29 0.478 . . . . 0.0 112.29 -175.79 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' E' E ' 92' ' ' LEU . . . . . . . . . . . . . 6.4 tp -166.02 144.68 5.87 Favored 'General case' 0 C--N 1.332 -0.183 0 C-N-CA 120.686 -0.406 . . . . 0.0 111.016 -179.656 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' E' E ' 93' ' ' ILE . . . . . . . . . . . . . 62.3 mt -119.82 119.87 61.59 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.24 0 N-CA-C 109.346 -0.613 . . . . 0.0 109.346 -179.787 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' E' E ' 94' ' ' VAL . . . . . . . . . . . . . 45.5 t -122.22 126.44 74.3 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.293 0 CA-C-O 120.849 0.357 . . . . 0.0 110.212 -178.984 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' E' E ' 95' ' ' VAL . . . . . . . . . . . . . 42.9 t -123.65 134.23 66.99 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.209 0 CA-C-N 116.109 -0.496 . . . . 0.0 110.093 -179.356 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' E' E ' 96' ' ' ILE . . . . . . . . . . . . . 66.6 mt -117.13 127.54 74.69 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.257 0 N-CA-C 109.509 -0.552 . . . . 0.0 109.509 178.634 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' E' E ' 97' ' ' THR . . . . . . . . . . . . . 82.0 p -99.28 157.33 16.46 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-O 121.13 0.491 . . . . 0.0 111.282 -177.433 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' E' E ' 98' ' ' GLU . . . . . . . . . . . . . 96.7 mt-10 -54.62 -26.45 32.89 Favored 'General case' 0 C--N 1.328 -0.328 0 N-CA-C 112.236 0.458 . . . . 0.0 112.236 -179.829 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' E' E ' 99' ' ' GLU . . . . . . . . . . . . . 95.7 mt-10 -78.22 14.7 1.11 Allowed 'General case' 0 CA--C 1.536 0.43 0 N-CA-C 113.1 0.778 . . . . 0.0 113.1 -177.425 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' E' E ' 100' ' ' ASN . . . . . . . . . . . . . 4.5 m-20 63.47 38.03 10.19 Favored 'General case' 0 C--O 1.232 0.149 0 CA-C-O 121.055 0.455 . . . . 0.0 110.951 178.11 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' E' E ' 101' ' ' GLU . . . . . . . . . . . . . 83.3 tt0 -119.24 141.31 49.03 Favored 'General case' 0 C--N 1.332 -0.192 0 N-CA-C 109.601 -0.518 . . . . 0.0 109.601 176.178 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' E' E ' 102' ' ' VAL . . . . . . . . . . . . . 41.8 t -115.03 130.9 68.76 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.271 0 CA-C-O 120.812 0.339 . . . . 0.0 110.407 -177.527 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' E' E ' 103' ' ' LEU . . . . . . . . . . . . . 27.1 mt -119.29 130.89 55.64 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 115.454 -0.794 . . . . 0.0 109.992 176.725 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' E' E ' 104' ' ' ILE . . . . . 0.456 HD11 HG11 ' E' ' 130' ' ' VAL . 72.4 mt -119.65 123.56 71.26 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.252 0 N-CA-C 110.096 -0.335 . . . . 0.0 110.096 179.506 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' E' E ' 105' ' ' PHE . . . . . . . . . . . . . 66.9 m-85 -124.86 162.99 23.16 Favored 'General case' 0 C--N 1.332 -0.159 0 O-C-N 123.735 0.647 . . . . 0.0 110.482 -177.792 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' E' E ' 106' ' ' ASN . . . . . . . . . . . . . 40.6 p-10 -100.7 -169.98 1.79 Allowed 'General case' 0 CA--C 1.531 0.218 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.263 175.592 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' E' E ' 107' ' ' GLN . . . . . . . . . . . . . 47.2 tt0 -59.09 -29.97 67.74 Favored 'General case' 0 CA--C 1.531 0.232 0 N-CA-C 112.017 0.377 . . . . 0.0 112.017 179.917 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' E' E ' 108' ' ' ASN . . . . . . . . . . . . . 12.2 t-20 -86.01 9.62 16.57 Favored 'General case' 0 CA--C 1.534 0.348 0 N-CA-C 113.275 0.842 . . . . 0.0 113.275 -177.087 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' E' E ' 109' ' ' LEU . . . . . 0.569 HD21 ' HB2' ' E' ' 78' ' ' ALA . 12.1 tp 57.76 40.11 26.55 Favored 'General case' 0 CA--C 1.529 0.169 0 CA-C-O 121.206 0.527 . . . . 0.0 111.012 178.33 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' E' E ' 110' ' ' GLU . . . . . . . . . . . . . 95.5 mt-10 -108.32 156.93 18.83 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.202 -0.454 . . . . 0.0 109.99 175.953 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' E' E ' 111' ' ' GLU . . . . . . . . . . . . . 35.5 tt0 -81.61 122.08 27.15 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-O 120.892 0.377 . . . . 0.0 110.744 -177.304 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' E' E ' 112' ' ' LEU . . . . . . . . . . . . . 16.8 mt -107.74 -45.94 3.91 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 115.991 -0.549 . . . . 0.0 110.219 175.996 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' E' E ' 113' ' ' TYR . . . . . . . . . . . . . 63.2 t80 -139.5 135.08 33.13 Favored 'General case' 0 C--N 1.332 -0.19 0 C-N-CA 120.814 -0.355 . . . . 0.0 111.456 179.624 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' E' E ' 114' ' ' ARG . . . . . . . . . . . . . 19.4 ttm180 -133.76 123.85 25.61 Favored 'General case' 0 C--N 1.331 -0.224 0 CA-C-N 115.811 -0.631 . . . . 0.0 109.72 175.58 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' E' E ' 115' ' ' GLY . . . . . . . . . . . . . . . -150.11 141.36 8.72 Favored Glycine 0 CA--C 1.524 0.655 0 N-CA-C 111.272 -0.731 . . . . 0.0 111.272 178.906 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' E' E ' 116' ' ' LYS . . . . . . . . . . . . . 17.1 ttpp -116.57 130.72 56.9 Favored 'General case' 0 C--N 1.332 -0.194 0 N-CA-C 109.748 -0.464 . . . . 0.0 109.748 177.443 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' E' E ' 117' ' ' PHE . . . . . . . . . . . . . 38.6 m-85 -130.58 114.04 14.96 Favored 'General case' 0 C--N 1.331 -0.213 0 CA-C-O 120.782 0.325 . . . . 0.0 110.211 -175.696 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' E' E ' 118' ' ' GLU . . . . . . . . . . . . . 96.0 mt-10 -55.54 -41.49 73.29 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.406 -0.361 . . . . 0.0 111.102 -176.695 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' E' E ' 119' ' ' ASN . . . . . . . . . . . . . 34.7 m-80 -99.57 30.96 3.36 Favored 'General case' 0 C--N 1.33 -0.268 0 N-CA-C 112.121 0.415 . . . . 0.0 112.121 -174.123 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' E' E ' 120' ' ' LEU . . . . . . . . . . . . . 13.7 tp -55.33 121.3 8.61 Favored 'General case' 0 C--N 1.333 -0.115 0 CA-C-O 120.747 0.308 . . . . 0.0 110.736 178.382 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' E' E ' 121' ' ' ASN . . . . . . . . . . . . . 30.4 m120 -112.51 -44.13 3.4 Favored 'General case' 0 C--N 1.332 -0.175 0 CA-C-N 116.316 -0.402 . . . . 0.0 110.841 -178.145 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' E' E ' 122' ' ' LYS . . . . . . . . . . . . . 35.4 mtmm -147.47 147.05 29.78 Favored 'General case' 0 C--N 1.331 -0.231 0 C-N-CA 120.6 -0.44 . . . . 0.0 111.783 -177.985 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' E' E ' 123' ' ' VAL . . . . . . . . . . . . . 45.5 t -123.94 127.27 73.54 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.233 0 CA-C-N 115.88 -0.6 . . . . 0.0 109.562 176.133 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' E' E ' 124' ' ' LEU . . . . . . . . . . . . . 51.5 mt -119.73 136.36 54.46 Favored 'General case' 0 C--N 1.331 -0.23 0 CA-C-N 116.355 -0.384 . . . . 0.0 110.673 -177.743 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' E' E ' 125' ' ' VAL . . . . . . . . . . . . . 12.1 p -133.31 135.25 56.58 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.265 0 CA-C-O 120.749 0.309 . . . . 0.0 110.392 178.505 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' E' E ' 126' ' ' ARG . . . . . . . . . . . . . 95.8 mtt-85 -144.5 120.9 10.97 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-N 116.093 -0.503 . . . . 0.0 110.566 179.139 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' E' E ' 127' ' ' ASN . . . . . . . . . . . . . 94.9 m-20 50.4 -108.02 0.31 Allowed 'General case' 0 CA--C 1.544 0.721 0 CA-C-O 118.854 -0.593 . . . . 0.0 111.428 179.662 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' E' E ' 128' ' ' ASP . . . . . . . . . . . . . 11.0 p-10 -114.08 6.85 16.54 Favored 'General case' 0 CA--C 1.536 0.436 0 CA-C-N 119.796 1.18 . . . . 0.0 113.417 -177.776 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' E' E ' 129' ' ' LEU . . . . . . . . . . . . . 6.1 mp -110.75 150.04 29.66 Favored 'General case' 0 C--O 1.233 0.189 0 CA-C-N 118.206 0.457 . . . . 0.0 110.435 178.666 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' E' E ' 130' ' ' VAL . . . . . 0.456 HG11 HD11 ' E' ' 104' ' ' ILE . 40.6 t -130.86 140.98 47.35 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.237 0 CA-C-N 116.271 -0.422 . . . . 0.0 110.406 -178.213 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' E' E ' 131' ' ' VAL . . . . . . . . . . . . . 41.3 t -134.92 135.88 52.51 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 CA-C-N 116.096 -0.502 . . . . 0.0 109.806 177.835 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' E' E ' 132' ' ' ILE . . . . . . . . . . . . . 71.3 mt -119.29 133.68 65.32 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.25 0 N-CA-C 109.737 -0.468 . . . . 0.0 109.737 -179.842 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' E' E ' 133' ' ' ILE . . . . . . . . . . . . . 41.8 mm -115.9 123.58 71.35 Favored 'Isoleucine or valine' 0 C--O 1.233 0.223 0 CA-C-N 116.39 -0.368 . . . . 0.0 110.663 -176.867 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' E' E ' 134' ' ' ASP . . . . . . . . . . . . . 10.1 p-10 -134.88 150.14 50.4 Favored 'General case' 0 C--N 1.331 -0.237 0 N-CA-C 109.75 -0.463 . . . . 0.0 109.75 175.332 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' E' E ' 135' ' ' GLU . . . . . . . . . . . . . 40.6 tp10 -49.95 -27.29 5.14 Favored 'General case' 0 C--N 1.328 -0.347 0 N-CA-C 112.809 0.67 . . . . 0.0 112.809 -171.581 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' E' E ' 136' ' ' GLN . . . . . . . . . . . . . 43.4 tt0 -89.99 -29.97 18.09 Favored 'General case' 0 C--O 1.234 0.266 0 N-CA-C 112.619 0.6 . . . . 0.0 112.619 -173.388 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' E' E ' 137' ' ' LYS . . . . . . . . . . . . . 52.2 pttt -163.86 173.02 13.23 Favored 'General case' 0 C--N 1.332 -0.179 0 CA-C-O 121.528 0.68 . . . . 0.0 112.448 -173.238 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' E' E ' 138' ' ' LEU . . . . . . . . . . . . . 6.4 tt -121.15 129.94 53.49 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 115.03 -0.986 . . . . 0.0 109.928 178.579 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' E' E ' 139' ' ' THR . . . . . . . . . . . . . 27.9 m -111.78 129.49 56.11 Favored 'General case' 0 C--N 1.331 -0.211 0 CA-C-N 116.315 -0.402 . . . . 0.0 110.676 -178.856 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' E' E ' 140' ' ' LEU . . . . . . . . . . . . . 8.7 tp -117.14 120.7 39.1 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 115.748 -0.66 . . . . 0.0 109.363 -177.989 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' E' E ' 141' ' ' ILE . . . . . . . . . . . . . 19.4 mt -119.49 121.42 66.33 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.239 0 CA-C-O 120.818 0.342 . . . . 0.0 110.219 -175.701 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' E' E ' 142' ' ' ARG . . . . . . . . . . . . . 75.1 mtp180 -111.85 130.4 55.83 Favored 'General case' 0 C--N 1.331 -0.222 0 CA-C-N 115.556 -0.747 . . . . 0.0 110.185 -178.666 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' E' E ' 143' ' ' THR . . . . . . . . . . . . . 39.9 p . . . . . 0 C--O 1.219 -0.506 0 CA-C-O 118.011 -0.995 . . . . 0.0 110.598 179.953 . . . . . . . . 0 0 . 1 . 020 nuclear build core ' F' F ' 1' ' ' MET . . . . . . . . . . . . . 26.1 ptt? . . . . . 0 CA--C 1.527 0.094 0 CA-C-O 120.849 0.356 . . . . 0.0 110.441 . . . . . . . . . 0 0 . 1 . 020 nuclear build core ' F' F ' 2' ' ' SER . . . . . . . . . . . . . 6.2 p -108.34 139.38 43.13 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-N 116.1 -0.5 . . . . 0.0 110.805 -178.536 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' F' F ' 3' ' ' GLU . . . . . . . . . . . . . 33.1 tp10 -139.18 133.58 31.6 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 115.723 -0.671 . . . . 0.0 110.194 -178.102 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' F' F ' 4' ' ' LEU . . . . . . . . . . . . . 19.7 tp -125.15 127.59 47.08 Favored 'General case' 0 C--N 1.331 -0.196 0 N-CA-C 110.071 -0.344 . . . . 0.0 110.071 175.23 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' F' F ' 5' ' ' LYS . . . . . . . . . . . . . 98.7 mttt -111.14 121.39 45.18 Favored 'General case' 0 C--O 1.235 0.302 0 CA-C-O 120.831 0.348 . . . . 0.0 110.827 179.378 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' F' F ' 6' ' ' LEU . . . . . . . . . . . . . 60.4 mt -114.46 143.31 45.15 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 115.369 -0.832 . . . . 0.0 109.898 179.549 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' F' F ' 7' ' ' LYS . . . . . . . . . . . . . 80.6 tttt -123.43 134.23 25.08 Favored Pre-proline 0 CA--C 1.534 0.339 0 CA-C-O 118.893 -0.575 . . . . 0.0 109.812 175.96 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' F' F ' 8' ' ' PRO . . . . . . . . . . . . . 94.4 Cg_endo -92.03 136.57 1.69 Allowed 'Trans proline' 0 N--CA 1.489 1.261 0 C-N-CA 121.607 1.538 . . . . 0.0 111.703 177.722 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' F' F ' 9' ' ' LEU . . . . . . . . . . . . . 63.0 mt -79.32 -47.53 1.57 Allowed Pre-proline 0 CA--C 1.533 0.301 0 CA-C-O 118.61 -0.71 . . . . 0.0 112.1 -179.486 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' F' F ' 10' ' ' PRO . . . . . . . . . . . . . 90.1 Cg_endo -80.9 149.82 18.04 Favored 'Trans proline' 0 N--CA 1.496 1.63 0 C-N-CA 121.207 1.271 . . . . 0.0 111.87 176.502 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' F' F ' 11' ' ' LYS . . . . . . . . . . . . . 45.3 tttp -88.25 111.2 21.39 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-O 120.753 0.311 . . . . 0.0 110.371 178.99 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' F' F ' 12' ' ' VAL . . . . . . . . . . . . . 12.4 p -145.52 146.78 19.24 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.299 0 CA-C-O 120.898 0.38 . . . . 0.0 110.801 -178.645 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' F' F ' 13' ' ' GLU . . . . . . . . . . . . . 70.3 mm-40 -88.22 108.95 19.55 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.084 -0.507 . . . . 0.0 110.382 175.384 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' F' F ' 14' ' ' LEU . . . . . . . . . . . . . 38.9 mt -91.75 147.04 34.23 Favored Pre-proline 0 C--N 1.328 -0.361 0 CA-C-N 116.125 -0.489 . . . . 0.0 110.012 -179.439 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' F' F ' 15' ' ' PRO . . . . . . . . . . . . . 36.3 Cg_exo -58.37 157.42 26.51 Favored 'Trans proline' 0 N--CA 1.497 1.705 0 C-N-CA 121.237 1.291 . . . . 0.0 111.823 179.024 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' F' F ' 16' ' ' PRO . . . . . . . . . . . . . 36.9 Cg_exo -58.22 -36.79 97.45 Favored 'Trans proline' 0 N--CA 1.497 1.73 0 C-N-CA 121.384 1.389 . . . . 0.0 112.876 -178.505 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' F' F ' 17' ' ' ASP . . . . . . . . . . . . . 8.7 p-10 -83.51 12.19 5.98 Favored 'General case' 0 CA--C 1.536 0.412 0 N-CA-C 113.146 0.795 . . . . 0.0 113.146 -177.803 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' F' F ' 18' ' ' PHE . . . . . . . . . . . . . 45.6 t80 -56.78 -45.86 81.88 Favored 'General case' 0 N--CA 1.457 -0.096 0 O-C-N 122.007 -0.433 . . . . 0.0 110.424 -178.566 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' F' F ' 19' ' ' VAL . . . . . . . . . . . . . 15.0 p -54.85 -41.04 55.24 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.273 0 CA-C-N 116.549 -0.296 . . . . 0.0 111.175 -178.176 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' F' F ' 20' ' ' ASP . . . . . . . . . . . . . 73.7 m-20 -60.72 -45.25 94.99 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-O 120.814 0.34 . . . . 0.0 111.075 -178.429 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' F' F ' 21' ' ' VAL . . . . . . . . . . . . . 47.6 t -64.64 -46.97 90.83 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.328 0 C-N-CA 120.65 -0.42 . . . . 0.0 110.574 -177.273 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' F' F ' 22' ' ' ILE . . . . . 0.622 HG22 HD12 ' F' ' 26' ' ' LEU . 50.8 mm -56.46 -45.73 81.97 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.271 0 CA-C-O 120.875 0.369 . . . . 0.0 110.462 179.443 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' F' F ' 23' ' ' ARG . . . . . . . . . . . . . 32.3 ttp180 -53.64 -49.03 68.78 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.655 -0.248 . . . . 0.0 111.369 -179.076 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' F' F ' 24' ' ' ILE . . . . . . . . . . . . . 67.8 mt -59.27 -48.27 87.55 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.336 0 C-N-CA 121.039 -0.265 . . . . 0.0 111.193 -177.361 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' F' F ' 25' ' ' LYS . . . . . . . . . . . . . 98.8 mttt -64.35 -36.23 83.45 Favored 'General case' 0 C--N 1.329 -0.286 0 N-CA-C 112.538 0.57 . . . . 0.0 112.538 -177.029 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' F' F ' 26' ' ' LEU . . . . . 0.622 HD12 HG22 ' F' ' 22' ' ' ILE . 53.4 mt -77.47 -43.77 31.19 Favored 'General case' 0 C--N 1.33 -0.259 0 N-CA-C 112.869 0.692 . . . . 0.0 112.869 -173.169 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' F' F ' 27' ' ' GLN . . . . . . . . . . . . . 3.7 pt20 -47.4 137.91 8.1 Favored 'General case' 0 N--CA 1.468 0.439 0 N-CA-C 112.714 0.635 . . . . 0.0 112.714 -175.424 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' F' F ' 28' ' ' GLY . . . . . . . . . . . . . . . 101.02 -26.45 24.63 Favored Glycine 0 CA--C 1.533 1.165 0 CA-C-N 115.587 -0.733 . . . . 0.0 112.235 -176.998 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' F' F ' 29' ' ' LYS . . . . . . . . . . . . . 66.7 mmtt -98.14 155.1 17.31 Favored 'General case' 0 C--O 1.233 0.217 0 CA-C-N 117.311 0.556 . . . . 0.0 111.26 178.792 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' F' F ' 30' ' ' THR . . . . . . . . . . . . . 26.9 m -107.95 139.8 42.04 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 115.882 -0.599 . . . . 0.0 110.152 176.741 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' F' F ' 31' ' ' VAL . . . . . . . . . . . . . 34.7 m -129.5 157.67 42.19 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.267 0 CA-C-N 116.373 -0.376 . . . . 0.0 111.08 -178.121 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' F' F ' 32' ' ' ARG . . . . . . . . . . . . . 88.7 mtt180 -131.03 149.02 52.8 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 115.7 -0.682 . . . . 0.0 110.34 177.01 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' F' F ' 33' ' ' THR . . . . . . . . . . . . . 14.1 m -53.5 138.47 33.72 Favored 'General case' 0 C--N 1.332 -0.189 0 CA-C-N 116.489 -0.323 . . . . 0.0 111.271 -177.949 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' F' F ' 34' ' ' GLY . . . . . . . . . . . . . . . 100.72 -17.04 57.06 Favored Glycine 0 CA--C 1.532 1.139 0 CA-C-O 119.632 -0.538 . . . . 0.0 113.298 179.326 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' F' F ' 35' ' ' ASP . . . . . . . . . . . . . 54.1 m-20 -63.0 150.63 41.93 Favored 'General case' 0 C--O 1.233 0.206 0 CA-C-N 118.121 0.961 . . . . 0.0 111.316 -179.926 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' F' F ' 36' ' ' VAL . . . . . . . . . . . . . 45.3 t -123.33 129.48 74.79 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.232 0 CA-C-N 115.76 -0.655 . . . . 0.0 109.822 178.582 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' F' F ' 37' ' ' ILE . . . . . . . . . . . . . 67.5 mt -124.84 140.41 48.08 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.257 0 CA-C-N 116.304 -0.407 . . . . 0.0 110.183 -179.096 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' F' F ' 38' ' ' GLY . . . . . . . . . . . . . . . -118.65 128.71 7.81 Favored Glycine 0 CA--C 1.525 0.689 0 N-CA-C 111.181 -0.768 . . . . 0.0 111.181 179.322 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' F' F ' 39' ' ' ILE . . . . . . . . . . . . . 77.4 mt -127.36 141.25 46.83 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.276 0 N-CA-C 110.234 -0.284 . . . . 0.0 110.234 179.218 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' F' F ' 40' ' ' SER . . . . . . . . . . . . . 76.8 p -92.48 119.11 31.66 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.445 -0.343 . . . . 0.0 110.995 176.068 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' F' F ' 41' ' ' ILE . . . . . . . . . . . . . 43.8 mm -121.05 118.74 57.22 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.195 0 CA-C-N 116.463 -0.335 . . . . 0.0 110.141 178.125 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' F' F ' 42' ' ' LEU . . . . . . . . . . . . . 64.5 mt 52.05 34.42 13.97 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.308 -0.405 . . . . 0.0 111.907 177.194 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' F' F ' 43' ' ' GLY . . . . . . . . . . . . . . . 76.74 28.8 58.52 Favored Glycine 0 CA--C 1.53 1.028 0 C-N-CA 121.185 -0.531 . . . . 0.0 112.523 176.693 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' F' F ' 44' ' ' LYS . . . . . . . . . . . . . 7.8 ttpm? -140.52 131.28 25.79 Favored 'General case' 0 C--N 1.33 -0.242 0 N-CA-C 109.289 -0.634 . . . . 0.0 109.289 176.316 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' F' F ' 45' ' ' GLU . . . . . . . . . . . . . 81.3 tt0 -82.4 126.71 32.5 Favored 'General case' 0 C--N 1.328 -0.332 0 C-N-CA 120.865 -0.334 . . . . 0.0 111.263 -175.806 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' F' F ' 46' ' ' VAL . . . . . . . . . . . . . 10.4 p -118.2 124.96 73.88 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.2 0 N-CA-C 109.532 -0.544 . . . . 0.0 109.532 175.091 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' F' F ' 47' ' ' LYS . . . . . . . . . . . . . 62.0 mttp -99.14 125.53 44.71 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 115.866 -0.606 . . . . 0.0 110.942 178.105 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' F' F ' 48' ' ' PHE . . . . . . . . . . . . . 33.7 m-85 -110.26 131.91 54.64 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.037 -0.529 . . . . 0.0 109.921 177.384 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' F' F ' 49' ' ' LYS . . . . . . . . . . . . . 43.0 tttp -107.67 132.99 52.74 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 116.31 -0.404 . . . . 0.0 109.975 176.402 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' F' F ' 50' ' ' VAL . . . . . . . . . . . . . 44.0 t -76.81 107.82 8.71 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.312 0 N-CA-C 109.483 -0.562 . . . . 0.0 109.483 178.701 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' F' F ' 51' ' ' VAL . . . . . . . . . . . . . 44.7 t -72.43 -50.42 35.31 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.289 0 CA-C-N 116.022 -0.535 . . . . 0.0 109.825 -174.747 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' F' F ' 52' ' ' GLN . . . . . . . . . . . . . 62.8 tt0 -159.06 144.61 16.25 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 115.836 -0.62 . . . . 0.0 111.501 -176.908 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' F' F ' 53' ' ' ALA . . . . . . . . . . . . . . . -123.25 132.43 54.02 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 115.524 -0.762 . . . . 0.0 109.931 175.971 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' F' F ' 54' ' ' TYR . . . . . . . . . . . . . 67.7 t80 -129.13 112.81 18.43 Favored Pre-proline 0 CA--C 1.536 0.407 0 CA-C-O 118.154 -0.927 . . . . 0.0 110.261 177.351 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' F' F ' 55' ' ' PRO . . . . . . . . . . . . . 74.4 Cg_endo -77.05 166.97 81.17 Favored 'Cis proline' 0 N--CA 1.501 1.919 0 CA-C-N 122.09 1.782 . . . . 0.0 112.467 -5.4 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' F' F ' 56' ' ' SER . . . . . . . . . . . . . 13.7 m -114.05 124.99 29.96 Favored Pre-proline 0 CA--C 1.539 0.535 0 CA-C-O 118.369 -0.824 . . . . 0.0 109.381 176.506 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' F' F ' 57' ' ' PRO . . . . . . . . . . . . . 39.5 Cg_endo -67.16 166.24 64.07 Favored 'Cis proline' 0 N--CA 1.498 1.751 0 CA-C-N 122.065 1.773 . . . . 0.0 111.556 0.939 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' F' F ' 58' ' ' LEU . . . . . . . . . . . . . 24.0 tp -127.46 135.0 49.81 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.227 -0.442 . . . . 0.0 110.365 179.958 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' F' F ' 59' ' ' ARG . . . . . . . . . . . . . 57.4 ttp180 -106.63 123.1 47.61 Favored 'General case' 0 C--N 1.328 -0.358 0 N-CA-C 109.244 -0.65 . . . . 0.0 109.244 177.129 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' F' F ' 60' ' ' VAL . . . . . . . . . . . . . 44.5 t -78.12 122.22 32.57 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.347 0 C-N-CA 120.753 -0.379 . . . . 0.0 110.546 -174.049 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' F' F ' 61' ' ' GLU . . . . . . . . . . . . . 95.5 mt-10 -131.06 164.92 24.36 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-N 115.804 -0.635 . . . . 0.0 109.784 176.293 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' F' F ' 62' ' ' ASP . . . . . . . . . . . . . 80.5 m-20 -53.94 -32.66 54.4 Favored 'General case' 0 C--N 1.328 -0.342 0 C-N-CA 121.027 -0.269 . . . . 0.0 111.646 -179.663 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' F' F ' 63' ' ' ARG . . . . . . . . . . . . . 24.4 mmt180 -73.07 -21.39 60.79 Favored 'General case' 0 CA--C 1.533 0.32 0 N-CA-C 113.034 0.753 . . . . 0.0 113.034 -177.519 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' F' F ' 64' ' ' THR . . . . . . . . . . . . . 30.9 m -68.08 137.35 54.91 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-O 120.882 0.373 . . . . 0.0 111.009 -174.201 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' F' F ' 65' ' ' LYS . . . . . . . . . . . . . 97.9 mttt -90.36 132.17 35.73 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.038 -0.528 . . . . 0.0 109.992 178.525 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' F' F ' 66' ' ' ILE . . . . . . . . . . . . . 64.2 mt -119.51 131.39 72.25 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.264 0 CA-C-O 120.934 0.397 . . . . 0.0 110.071 -179.822 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' F' F ' 67' ' ' THR . . . . . . . . . . . . . 22.9 m -123.39 139.03 54.45 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 115.96 -0.563 . . . . 0.0 110.651 -179.412 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' F' F ' 68' ' ' LEU . . . . . 0.478 HD23 ' C ' ' F' ' 68' ' ' LEU . 6.3 tt . . . . . 0 C--N 1.331 -0.225 0 CA-C-N 116.108 -0.496 . . . . 0.0 110.506 179.673 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' F' F ' 73' ' ' VAL . . . . . . . . . . . . . 35.6 m . . . . . 0 N--CA 1.462 0.15 0 N-CA-C 109.747 -0.464 . . . . 0.0 109.747 . . . . . . . . . 0 0 . 1 . 020 nuclear build core ' F' F ' 74' ' ' ASP . . . . . . . . . . . . . 12.0 t0 -96.43 117.19 30.37 Favored 'General case' 0 C--N 1.332 -0.192 0 C-N-CA 120.743 -0.383 . . . . 0.0 110.065 -176.284 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' F' F ' 75' ' ' VAL . . . . . . . . . . . . . 41.9 t -116.99 122.21 69.54 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.253 0 CA-C-O 120.985 0.421 . . . . 0.0 110.522 -178.043 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' F' F ' 76' ' ' LEU . . . . . . . . . . . . . 6.2 mp -119.85 144.96 47.08 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 115.675 -0.693 . . . . 0.0 109.782 176.51 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' F' F ' 77' ' ' GLU . . . . . . . . . . . . . 46.3 mt-10 -136.11 136.75 40.38 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-O 121.082 0.468 . . . . 0.0 111.351 -179.278 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' F' F ' 78' ' ' ALA . . . . . . . . . . . . . . . -123.97 132.27 53.68 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-N 115.68 -0.691 . . . . 0.0 109.7 175.873 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' F' F ' 79' ' ' LYS . . . . . 0.618 ' O ' HD13 ' F' ' 80' ' ' ILE . 62.1 mttp -81.17 117.37 21.66 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-O 120.925 0.393 . . . . 0.0 110.669 -178.814 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' F' F ' 80' ' ' ILE . . . . . 0.618 HD13 ' O ' ' F' ' 79' ' ' LYS . 40.3 mm -139.04 112.25 6.44 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.37 0 N-CA-C 109.13 -0.693 . . . . 0.0 109.13 -177.002 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' F' F ' 81' ' ' LYS . . . . . . . . . . . . . 79.0 tttt -102.08 127.49 48.96 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-O 120.852 0.358 . . . . 0.0 111.071 -177.668 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' F' F ' 82' ' ' GLY . . . . . . . . . . . . . . . 89.07 42.15 5.69 Favored Glycine 0 CA--C 1.525 0.691 0 C-N-CA 120.872 -0.68 . . . . 0.0 112.037 174.481 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' F' F ' 83' ' ' ILE . . . . . . . . . . . . . 68.7 mt -71.6 136.93 24.73 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.351 0 N-CA-C 109.281 -0.637 . . . . 0.0 109.281 175.684 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' F' F ' 84' ' ' LYS . . . . . . . . . . . . . 27.7 ttpp -94.94 -48.92 5.79 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-O 121.03 0.443 . . . . 0.0 110.047 -178.717 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' F' F ' 85' ' ' ASP . . . . . . . . . . . . . 10.0 t70 -154.57 153.38 31.32 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 115.756 -0.656 . . . . 0.0 110.562 -179.682 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' F' F ' 86' ' ' VAL . . . . . . . . . . . . . 41.9 t -128.98 133.47 66.01 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.202 0 CA-C-O 121.043 0.449 . . . . 0.0 110.243 179.201 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' F' F ' 87' ' ' ILE . . . . . . . . . . . . . 43.9 mm -117.77 123.69 72.04 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.263 0 CA-C-N 115.777 -0.647 . . . . 0.0 109.277 177.21 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' F' F ' 88' ' ' LEU . . . . . . . . . . . . . 14.7 tp -115.02 125.28 53.4 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-O 121.147 0.498 . . . . 0.0 111.44 -175.701 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' F' F ' 89' ' ' ASP . . . . . . . . . . . . . 13.2 t70 -118.4 154.78 31.86 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 115.525 -0.761 . . . . 0.0 109.147 174.185 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' F' F ' 90' ' ' GLU . . . . . . . . . . . . . 96.0 mt-10 -48.7 -39.92 26.35 Favored 'General case' 0 C--N 1.329 -0.302 0 N-CA-C 112.717 0.636 . . . . 0.0 112.717 -172.187 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' F' F ' 91' ' ' ASN . . . . . . . . . . . . . 21.8 p30 -132.15 38.09 3.52 Favored 'General case' 0 N--CA 1.464 0.259 0 CA-C-O 120.815 0.341 . . . . 0.0 111.477 -178.291 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' F' F ' 92' ' ' LEU . . . . . . . . . . . . . 18.4 tp -165.64 137.99 4.15 Favored 'General case' 0 C--N 1.329 -0.298 0 N-CA-C 110.25 -0.278 . . . . 0.0 110.25 -179.996 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' F' F ' 93' ' ' ILE . . . . . . . . . . . . . 71.5 mt -125.02 126.49 71.24 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.23 0 N-CA-C 109.91 -0.404 . . . . 0.0 109.91 -176.956 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' F' F ' 94' ' ' VAL . . . . . 0.472 HG21 HG11 ' F' ' 125' ' ' VAL . 44.0 t -125.05 128.47 73.04 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.207 0 N-CA-C 109.915 -0.402 . . . . 0.0 109.915 178.212 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' F' F ' 95' ' ' VAL . . . . . . . . . . . . . 44.0 t -120.14 133.4 67.0 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.302 0 CA-C-N 116.096 -0.502 . . . . 0.0 109.749 179.001 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' F' F ' 96' ' ' ILE . . . . . . . . . . . . . 64.3 mt -115.66 128.11 73.02 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.293 0 N-CA-C 109.462 -0.57 . . . . 0.0 109.462 179.545 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' F' F ' 97' ' ' THR . . . . . . . . . . . . . 72.7 p -103.74 157.76 16.85 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-O 121.331 0.586 . . . . 0.0 111.516 -176.392 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' F' F ' 98' ' ' GLU . . . . . . . . . . . . . 70.8 mm-40 -53.9 -26.02 23.04 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 115.994 -0.548 . . . . 0.0 112.397 179.709 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' F' F ' 99' ' ' GLU . . . . . . . . . . . . . 36.1 tt0 -79.99 16.99 1.05 Allowed 'General case' 0 CA--C 1.538 0.51 0 N-CA-C 112.588 0.588 . . . . 0.0 112.588 -176.441 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' F' F ' 100' ' ' ASN . . . . . . . . . . . . . 2.6 m-20 60.85 37.76 18.34 Favored 'General case' 0 C--O 1.232 0.165 0 O-C-N 121.761 -0.587 . . . . 0.0 110.95 178.454 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' F' F ' 101' ' ' GLU . . . . . . . . . . . . . 84.2 tt0 -116.37 144.38 44.34 Favored 'General case' 0 C--N 1.331 -0.225 0 CA-C-N 115.99 -0.55 . . . . 0.0 109.679 176.852 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' F' F ' 102' ' ' VAL . . . . . . . . . . . . . 44.6 t -117.63 126.37 74.68 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.357 0 CA-C-N 116.24 -0.436 . . . . 0.0 109.839 -178.257 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' F' F ' 103' ' ' LEU . . . . . . . . . . . . . 40.7 mt -116.39 129.22 56.13 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 115.717 -0.674 . . . . 0.0 110.121 176.692 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' F' F ' 104' ' ' ILE . . . . . . . . . . . . . 72.2 mt -116.62 122.08 69.09 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.257 0 N-CA-C 110.136 -0.32 . . . . 0.0 110.136 -179.596 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' F' F ' 105' ' ' PHE . . . . . . . . . . . . . 58.6 m-85 -121.21 166.38 14.07 Favored 'General case' 0 C--N 1.332 -0.162 0 O-C-N 124.087 0.867 . . . . 0.0 109.837 -178.968 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' F' F ' 106' ' ' ASN . . . . . . . . . . . . . 42.1 p-10 -102.79 -170.83 1.85 Allowed 'General case' 0 C--N 1.331 -0.231 0 N-CA-C 110.011 -0.366 . . . . 0.0 110.011 172.501 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' F' F ' 107' ' ' GLN . . . . . . . . . . . . . 45.4 tt0 -59.58 -30.16 68.46 Favored 'General case' 0 C--N 1.328 -0.358 0 N-CA-C 111.903 0.335 . . . . 0.0 111.903 179.106 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' F' F ' 108' ' ' ASN . . . . . . . . . . . . . 12.3 t-20 -81.84 6.19 16.45 Favored 'General case' 0 CA--C 1.537 0.467 0 N-CA-C 113.221 0.822 . . . . 0.0 113.221 -177.768 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' F' F ' 109' ' ' LEU . . . . . . . . . . . . . 9.7 tp 61.6 36.82 16.59 Favored 'General case' 0 CA--C 1.53 0.178 0 CA-C-O 120.905 0.383 . . . . 0.0 111.369 178.816 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' F' F ' 110' ' ' GLU . . . . . . . . . . . . . 43.0 mt-10 -106.36 158.44 16.88 Favored 'General case' 0 C--N 1.33 -0.264 0 N-CA-C 109.623 -0.51 . . . . 0.0 109.623 175.805 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' F' F ' 111' ' ' GLU . . . . . . . . . . . . . 44.1 mp0 -87.07 121.97 30.26 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-O 121.106 0.479 . . . . 0.0 111.212 -177.985 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' F' F ' 112' ' ' LEU . . . . . . . . . . . . . 42.9 mt -101.19 -45.95 5.2 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 115.611 -0.722 . . . . 0.0 110.095 175.768 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' F' F ' 113' ' ' TYR . . . . . . . . . . . . . 64.3 t80 -141.79 137.28 31.44 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.049 -0.523 . . . . 0.0 111.613 -178.054 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' F' F ' 114' ' ' ARG . . . . . . . . . . . . . 92.3 mtt180 -129.06 123.65 32.84 Favored 'General case' 0 C--N 1.331 -0.23 0 N-CA-C 109.3 -0.63 . . . . 0.0 109.3 175.245 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' F' F ' 115' ' ' GLY . . . . . . . . . . . . . . . -150.06 157.68 27.33 Favored Glycine 0 CA--C 1.525 0.661 0 C-N-CA 120.447 -0.882 . . . . 0.0 111.807 -179.835 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' F' F ' 116' ' ' LYS . . . . . . . . . . . . . 39.7 ttpt -128.72 140.7 51.61 Favored 'General case' 0 C--N 1.33 -0.263 0 N-CA-C 109.848 -0.427 . . . . 0.0 109.848 176.695 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' F' F ' 117' ' ' PHE . . . . . . . . . . . . . 47.2 m-85 -139.56 114.28 9.33 Favored 'General case' 0 C--N 1.329 -0.283 0 C-N-CA 120.836 -0.346 . . . . 0.0 110.334 -178.257 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' F' F ' 118' ' ' GLU . . . . . . . . . . . . . 84.4 tt0 -53.58 -45.87 70.13 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.523 -0.308 . . . . 0.0 111.405 -176.489 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' F' F ' 119' ' ' ASN . . . . . . . . . . . . . 85.4 m-20 -97.51 31.03 2.66 Favored 'General case' 0 C--N 1.331 -0.22 0 N-CA-C 112.182 0.438 . . . . 0.0 112.182 -174.86 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' F' F ' 120' ' ' LEU . . . . . . . . . . . . . 22.8 tp -57.51 120.44 8.28 Favored 'General case' 0 C--N 1.332 -0.174 0 CA-C-O 120.638 0.256 . . . . 0.0 110.326 178.146 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' F' F ' 121' ' ' ASN . . . . . . . . . . . . . 35.1 m120 -114.13 -44.13 3.17 Favored 'General case' 0 C--N 1.332 -0.188 0 CA-C-N 116.62 -0.263 . . . . 0.0 111.159 -177.521 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' F' F ' 122' ' ' LYS . . . . . . . . . . . . . 92.8 mttt -144.43 150.16 37.23 Favored 'General case' 0 C--N 1.332 -0.189 0 C-N-CA 120.598 -0.441 . . . . 0.0 111.646 -177.448 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' F' F ' 123' ' ' VAL . . . . . . . . . . . . . 42.5 t -132.91 129.32 57.76 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.267 0 N-CA-C 109.526 -0.546 . . . . 0.0 109.526 174.044 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' F' F ' 124' ' ' LEU . . . . . . . . . . . . . 80.4 mt -127.92 144.28 51.1 Favored 'General case' 0 C--N 1.331 -0.209 0 CA-C-O 120.754 0.311 . . . . 0.0 111.23 -176.87 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' F' F ' 125' ' ' VAL . . . . . 0.63 HG12 HG23 ' F' ' 130' ' ' VAL . 34.6 m -132.49 143.95 38.3 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.182 0 CA-C-N 116.173 -0.467 . . . . 0.0 111.18 -179.584 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' F' F ' 126' ' ' ARG . . . . . . . . . . . . . 76.7 mtp85 -145.58 116.49 7.78 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 116.006 -0.543 . . . . 0.0 110.408 176.406 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' F' F ' 127' ' ' ASN . . . . . . . . . . . . . 88.2 m-20 51.52 -104.84 0.19 Allowed 'General case' 0 CA--C 1.544 0.729 0 CA-C-O 119.087 -0.483 . . . . 0.0 111.283 179.824 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' F' F ' 128' ' ' ASP . . . . . . . . . . . . . 11.7 p-10 -114.03 0.19 14.25 Favored 'General case' 0 N--CA 1.468 0.463 0 CA-C-N 119.619 1.1 . . . . 0.0 113.318 -178.079 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' F' F ' 129' ' ' LEU . . . . . . . . . . . . . 17.2 tp -104.93 140.32 38.34 Favored 'General case' 0 C--N 1.332 -0.187 0 N-CA-C 109.565 -0.531 . . . . 0.0 109.565 178.463 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' F' F ' 130' ' ' VAL . . . . . 0.63 HG23 HG12 ' F' ' 125' ' ' VAL . 13.1 p -133.71 143.37 38.91 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.236 0 CA-C-O 121.257 0.551 . . . . 0.0 110.663 -179.357 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' F' F ' 131' ' ' VAL . . . . . 0.498 HG22 HD12 ' F' ' 140' ' ' LEU . 43.4 t -134.67 138.86 48.76 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.259 0 CA-C-N 115.766 -0.652 . . . . 0.0 110.162 -179.372 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' F' F ' 132' ' ' ILE . . . . . . . . . . . . . 69.5 mt -115.26 133.02 62.83 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.345 0 CA-C-N 115.625 -0.716 . . . . 0.0 109.078 179.003 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' F' F ' 133' ' ' ILE . . . . . . . . . . . . . 41.5 mm -117.13 123.55 71.95 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.211 0 CA-C-O 120.727 0.299 . . . . 0.0 110.949 -174.664 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' F' F ' 134' ' ' ASP . . . . . . . . . . . . . 8.1 p-10 -136.68 147.24 46.71 Favored 'General case' 0 C--N 1.331 -0.202 0 N-CA-C 109.654 -0.498 . . . . 0.0 109.654 174.13 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' F' F ' 135' ' ' GLU . . . . . . . . . . . . . 38.6 tp10 -49.89 -26.42 4.08 Favored 'General case' 0 C--N 1.328 -0.334 0 N-CA-C 112.709 0.633 . . . . 0.0 112.709 -172.348 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' F' F ' 136' ' ' GLN . . . . . . . . . . . . . 65.5 tp60 -81.9 -39.07 24.36 Favored 'General case' 0 C--O 1.233 0.21 0 N-CA-C 112.077 0.399 . . . . 0.0 112.077 -176.764 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' F' F ' 137' ' ' LYS . . . . . . . . . . . . . 50.4 pttt -161.48 172.24 16.78 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-O 121.484 0.659 . . . . 0.0 112.2 -171.303 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' F' F ' 138' ' ' LEU . . . . . 0.4 ' C ' HD23 ' F' ' 138' ' ' LEU . 7.2 tt -119.58 129.82 54.83 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 115.111 -0.949 . . . . 0.0 109.664 178.584 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' F' F ' 139' ' ' THR . . . . . . . . . . . . . 21.6 m -109.34 126.64 53.6 Favored 'General case' 0 C--N 1.331 -0.21 0 CA-C-N 116.24 -0.436 . . . . 0.0 110.4 -179.677 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' F' F ' 140' ' ' LEU . . . . . 0.498 HD12 HG22 ' F' ' 131' ' ' VAL . 25.6 tp -112.09 120.06 40.56 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 115.73 -0.668 . . . . 0.0 109.417 -178.665 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' F' F ' 141' ' ' ILE . . . . . 0.499 ' HB ' HG13 ' F' ' 130' ' ' VAL . 19.5 mt -120.91 122.95 69.11 Favored 'Isoleucine or valine' 0 C--O 1.235 0.307 0 CA-C-O 121.022 0.439 . . . . 0.0 110.108 -175.591 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' F' F ' 142' ' ' ARG . . . . . . . . . . . . . 76.9 mtt180 -113.24 131.96 55.7 Favored 'General case' 0 C--O 1.233 0.206 0 CA-C-N 115.302 -0.863 . . . . 0.0 109.961 -175.969 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' F' F ' 143' ' ' THR . . . . . . . . . . . . . 52.0 p . . . . . 0 C--O 1.221 -0.418 0 CA-C-O 118.024 -0.989 . . . . 0.0 110.408 178.275 . . . . . . . . 0 0 . 1 . 001 nuclear build full ' A' A ' -3' ' ' GLU . . . . . . . . . . . . . 48.2 mt-10 . . . . . 0 N--CA 1.491 1.581 0 N-CA-C 109.567 -0.531 . . . . 32.38 109.567 . . . . . . . . . 0 0 . 1 . 001 nuclear build full ' A' A ' -2' ' ' GLY . . . . . . . . . . . . . . . -69.3 141.34 35.4 Favored Glycine 0 CA--C 1.525 0.671 0 N-CA-C 110.484 -1.046 . . . . 28.94 110.484 177.692 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' -1' ' ' VAL . . . . . . . . . . . . . 43.2 t -96.01 136.32 27.3 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.315 0 CA-C-O 120.815 0.341 . . . . 26.21 110.246 -178.457 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 0' ' ' ILE . . . . . . . . . . . . . 75.1 mt -107.64 130.62 59.65 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.266 0 CA-C-N 116.141 -0.481 . . . . 24.64 109.751 178.537 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 26.1 ptt? -79.17 169.78 17.64 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.25 -0.432 . . . . 20.97 111.111 -177.219 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 1.9 p -120.37 125.95 49.26 Favored 'General case' 0 C--N 1.331 -0.22 0 CA-C-N 115.963 -0.562 . . . . 18.2 110.564 178.464 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 84.7 tt0 -143.85 141.64 30.43 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 116.023 -0.535 . . . . 15.68 111.114 -179.308 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 4' ' ' LEU . . . . . . . . . . . . . 19.0 tp -122.62 127.84 49.89 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-N 116.019 -0.537 . . . . 13.41 110.087 177.485 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 5' ' ' LYS . . . . . . . . . . . . . 72.6 mttt -109.81 121.44 45.23 Favored 'General case' 0 C--O 1.234 0.246 0 CA-C-O 120.916 0.389 . . . . 11.98 110.709 178.94 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 31.1 mt -114.33 149.18 36.41 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 115.205 -0.907 . . . . 10.99 110.371 -178.719 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 19.5 ttmm -133.85 139.41 33.35 Favored Pre-proline 0 CA--C 1.536 0.418 0 CA-C-O 119.095 -0.479 . . . . 9.31 109.799 175.17 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 8' ' ' PRO . . . . . . . . . . . . . 90.3 Cg_endo -91.82 134.47 1.49 Allowed 'Trans proline' 0 N--CA 1.49 1.293 0 C-N-CA 121.718 1.612 . . . . 9.35 111.649 177.427 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 59.0 mt -71.78 -46.54 12.3 Favored Pre-proline 0 C--N 1.329 -0.295 0 CA-C-O 118.723 -0.656 . . . . 13.42 111.838 -179.703 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 92.4 Cg_endo -80.47 146.85 17.5 Favored 'Trans proline' 0 N--CA 1.494 1.556 0 C-N-CA 121.077 1.185 . . . . 13.21 111.582 173.071 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 93.4 mttt -87.09 92.21 8.97 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-O 120.872 0.367 . . . . 12.71 110.561 -179.942 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 12.4 p -138.63 143.74 31.6 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.292 0 CA-C-N 116.111 -0.495 . . . . 13.83 110.414 179.672 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 94.8 mt-10 -82.24 131.35 35.23 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.298 -0.41 . . . . 13.84 110.126 178.055 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 14' ' ' LEU . . . . . . . . . . . . . 30.8 mt -93.92 150.32 38.38 Favored Pre-proline 0 C--N 1.328 -0.328 0 CA-C-N 116.358 -0.383 . . . . 13.0 110.164 -179.483 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 15' ' ' PRO . . . . . . . . . . . . . 39.2 Cg_exo -57.9 159.92 16.59 Favored 'Trans proline' 0 N--CA 1.497 1.684 0 C-N-CA 121.213 1.275 . . . . 15.42 111.624 179.515 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 16' ' ' PRO . . . . . . . . . . . . . 39.7 Cg_exo -58.54 -39.78 80.12 Favored 'Trans proline' 0 N--CA 1.497 1.698 0 C-N-CA 121.479 1.453 . . . . 16.07 112.866 -177.39 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 17' ' ' ASP . . . . . . . . . . . . . 19.5 p-10 -88.4 9.11 24.61 Favored 'General case' 0 C--N 1.326 -0.415 0 N-CA-C 113.22 0.822 . . . . 16.69 113.22 -178.168 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 18' ' ' PHE . . . . . . . . . . . . . 50.3 t80 -58.27 -48.05 81.68 Favored 'General case' 0 N--CA 1.457 -0.103 0 O-C-N 121.91 -0.494 . . . . 13.52 110.19 -176.316 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 19' ' ' VAL . . . . . . . . . . . . . 46.4 t -54.8 -47.95 73.93 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.345 0 CA-C-N 116.446 -0.343 . . . . 12.65 111.167 -175.077 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 2.6 p30 -62.71 -38.24 89.65 Favored 'General case' 0 C--N 1.332 -0.175 0 C-N-CA 120.572 -0.451 . . . . 15.76 111.336 -176.245 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 54.7 t -64.34 -46.79 92.09 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.181 0 C-N-CA 120.582 -0.447 . . . . 15.45 110.213 -179.775 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 22' ' ' ILE . . . . . 0.615 HG22 HD12 ' A' ' 26' ' ' LEU . 51.6 mm -56.71 -45.26 82.72 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.248 0 C-N-CA 121.036 -0.266 . . . . 13.87 110.454 178.96 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 23' ' ' ARG . . . . . . . . . . . . . 59.5 ttp180 -53.98 -48.43 70.36 Favored 'General case' 0 C--N 1.329 -0.295 0 C-N-CA 121.179 -0.208 . . . . 16.33 111.32 -179.273 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 24' ' ' ILE . . . . . . . . . . . . . 76.1 mt -58.97 -46.58 91.47 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.339 0 C-N-CA 120.877 -0.329 . . . . 17.1 110.86 -177.965 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 99.6 mttt -64.25 -38.08 89.77 Favored 'General case' 0 C--N 1.329 -0.324 0 N-CA-C 112.546 0.572 . . . . 16.69 112.546 -177.948 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 26' ' ' LEU . . . . . 0.615 HD12 HG22 ' A' ' 22' ' ' ILE . 49.7 mt -77.89 -41.6 36.09 Favored 'General case' 0 C--N 1.33 -0.247 0 N-CA-C 113.093 0.775 . . . . 16.62 113.093 -172.015 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 27' ' ' GLN . . . . . . . . . . . . . 14.3 pt20 -47.69 139.35 7.33 Favored 'General case' 0 N--CA 1.468 0.462 0 N-CA-C 112.77 0.656 . . . . 18.08 112.77 -174.426 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 100.29 -24.11 33.35 Favored Glycine 0 CA--C 1.535 1.287 0 CA-C-N 115.532 -0.758 . . . . 19.92 112.259 -175.698 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 98.0 mttt -97.78 155.19 17.14 Favored 'General case' 0 C--O 1.233 0.228 0 CA-C-N 117.369 0.585 . . . . 19.41 110.993 178.568 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 30' ' ' THR . . . . . . . . . . . . . 29.5 m -104.01 139.2 39.46 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 115.907 -0.588 . . . . 20.61 110.034 176.141 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 34.8 m -126.34 150.58 32.06 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.221 0 CA-C-N 116.408 -0.36 . . . . 17.93 110.719 -178.997 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 32' ' ' ARG . . . . . . . . . . . . . 32.4 ttm105 -134.94 147.33 49.75 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-O 121.16 0.505 . . . . 23.02 110.31 177.519 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 33' ' ' THR . . . . . . . . . . . . . 15.9 m -52.18 137.93 27.07 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.214 -0.448 . . . . 17.9 111.534 -177.355 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 100.71 -17.0 57.13 Favored Glycine 0 CA--C 1.532 1.147 0 CA-C-O 119.663 -0.52 . . . . 17.01 113.301 178.819 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 78.6 m-20 -65.8 147.8 52.8 Favored 'General case' 0 N--CA 1.462 0.146 0 CA-C-N 118.022 0.911 . . . . 18.86 111.125 179.135 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 44.8 t -123.25 129.76 74.7 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.173 0 CA-C-N 115.927 -0.579 . . . . 17.24 109.852 177.888 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 37' ' ' ILE . . . . . . . . . . . . . 65.0 mt -122.57 139.02 50.74 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.279 0 CA-C-N 116.345 -0.389 . . . . 15.76 109.961 -179.749 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . -112.9 128.79 8.59 Favored Glycine 0 CA--C 1.527 0.787 0 N-CA-C 111.013 -0.835 . . . . 17.43 111.013 179.281 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 39' ' ' ILE . . . . . . . . . . . . . 76.7 mt -123.9 136.25 60.89 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.22 0 N-CA-C 109.994 -0.373 . . . . 17.07 109.994 179.046 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 40' ' ' SER . . . . . . . . . . . . . 34.5 t -91.91 118.16 30.48 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-O 120.696 0.284 . . . . 20.45 111.09 178.181 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 41' ' ' ILE . . . . . . . . . . . . . 45.2 mm -120.93 116.71 50.67 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.237 0 CA-C-N 116.283 -0.417 . . . . 18.94 110.23 178.881 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 7.5 mp 50.92 35.62 12.95 Favored 'General case' 0 N--CA 1.464 0.228 0 CA-C-N 116.345 -0.389 . . . . 21.68 111.751 177.708 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . 76.05 31.13 56.2 Favored Glycine 0 CA--C 1.529 0.946 0 C-N-CA 121.082 -0.58 . . . . 22.22 112.274 177.57 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 44' ' ' LYS . . . . . . . . . . . . . 59.6 tttp -136.64 129.11 30.22 Favored 'General case' 0 C--N 1.33 -0.262 0 N-CA-C 109.484 -0.561 . . . . 20.38 109.484 176.862 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 82.1 tt0 -81.73 115.08 20.8 Favored 'General case' 0 C--N 1.329 -0.324 0 C-N-CA 120.75 -0.38 . . . . 20.21 110.663 -178.22 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 46' ' ' VAL . . . . . . . . . . . . . 6.8 p -110.86 125.17 68.16 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.24 0 N-CA-C 109.061 -0.718 . . . . 16.13 109.061 175.967 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 9.5 mtmp? -99.9 125.61 45.91 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 115.702 -0.681 . . . . 18.68 111.282 -178.568 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 48' ' ' PHE . . . . . . . . . . . . . 96.0 m-85 -111.26 131.9 54.78 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-N 116.188 -0.46 . . . . 13.1 109.899 177.268 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 49.1 tttm -108.31 139.07 43.55 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.357 -0.383 . . . . 14.45 110.513 178.941 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 50' ' ' VAL . . . . . . . . . . . . . 44.2 t -82.46 111.47 18.9 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.298 0 N-CA-C 109.505 -0.554 . . . . 13.58 109.505 176.683 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 51' ' ' VAL . . . . . . . . . . . . . 45.9 t -77.74 -46.54 26.98 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.321 0 CA-C-N 116.129 -0.487 . . . . 13.24 110.27 -174.014 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 52' ' ' GLN . . . . . . . . . . . . . 59.9 tt0 -157.82 135.35 10.43 Favored 'General case' 0 C--N 1.33 -0.276 0 C-N-CA 120.413 -0.515 . . . . 15.29 111.526 -177.0 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -113.2 118.78 35.63 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 115.401 -0.818 . . . . 16.95 109.596 173.497 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 54' ' ' TYR . . . . . . . . . . . . . 16.9 t80 -116.91 107.14 46.53 Favored Pre-proline 0 CA--C 1.534 0.351 0 CA-C-O 118.246 -0.883 . . . . 21.06 110.613 -177.757 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 55' ' ' PRO . . . . . . . . . . . . . 73.0 Cg_endo -76.98 169.98 72.96 Favored 'Cis proline' 0 N--CA 1.499 1.828 0 CA-C-N 121.758 1.664 . . . . 20.7 112.605 -3.775 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 56' ' ' SER . . . . . . . . . . . . . 13.6 m -105.2 117.73 57.7 Favored Pre-proline 0 CA--C 1.538 0.513 0 CA-C-O 118.41 -0.805 . . . . 21.83 109.546 176.92 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 57' ' ' PRO . . . . . . . . . . . . . 72.1 Cg_endo -77.84 171.05 68.85 Favored 'Cis proline' 0 N--CA 1.495 1.604 0 CA-C-N 121.968 1.738 . . . . 22.39 112.422 2.164 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 58' ' ' LEU . . . . . . . . . . . . . 25.6 tp -128.18 138.14 52.35 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 115.789 -0.641 . . . . 18.81 110.348 -178.735 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 59' ' ' ARG . . . . . . . . . . . . . 59.9 ttt85 -101.12 129.74 47.06 Favored 'General case' 0 C--N 1.326 -0.419 0 CA-C-N 115.949 -0.569 . . . . 22.37 109.549 176.441 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 42.1 t -88.79 116.7 30.86 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.229 0 C-N-CA 120.572 -0.451 . . . . 17.4 110.496 -176.631 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 94.8 mt-10 -131.14 168.76 16.9 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 115.967 -0.56 . . . . 20.44 109.581 174.953 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 62' ' ' ASP . . . . . . . . . . . . . 2.1 m-20 -53.91 -34.34 59.25 Favored 'General case' 0 C--N 1.329 -0.312 0 C-N-CA 121.046 -0.262 . . . . 18.68 111.693 -177.783 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 63' ' ' ARG . . . . . . . . . . . . . 28.2 mmm180 -73.87 -17.65 61.02 Favored 'General case' 0 CA--C 1.533 0.313 0 N-CA-C 113.234 0.827 . . . . 22.37 113.234 -176.169 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 18.0 m -69.94 141.72 53.02 Favored 'General case' 0 C--N 1.332 -0.191 0 CA-C-O 120.838 0.351 . . . . 16.58 111.014 -174.887 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 65' ' ' LYS . . . . . . . . . . . . . 93.8 mttt -88.5 132.66 34.41 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.098 -0.501 . . . . 17.07 109.988 178.732 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 66' ' ' ILE . . . . . . . . . . . . . 53.7 mt -117.56 131.91 68.9 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.233 0 N-CA-C 110.012 -0.366 . . . . 12.48 110.012 179.921 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 67' ' ' THR . . . . . . . . . . . . . 18.8 m -130.96 135.86 48.03 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-O 121.011 0.434 . . . . 10.9 110.788 178.796 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 68' ' ' LEU . . . . . 0.497 ' N ' HD12 ' A' ' 68' ' ' LEU . 6.7 mp -108.0 129.58 55.11 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.124 -0.489 . . . . 8.22 110.43 176.685 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 69' ' ' VAL . . . . . . . . . . . . . 43.2 t -102.22 131.77 49.6 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.312 0 CA-C-N 116.225 -0.443 . . . . 7.13 110.37 -179.046 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 70' ' ' THR . . . . . . . . . . . . . 3.4 m -99.09 -55.1 2.79 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.107 -0.497 . . . . 5.72 110.552 178.101 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 71' ' ' HIS . . . . . . . . . . . . . 62.2 m80 -140.02 155.78 70.65 Favored Pre-proline 0 C--N 1.331 -0.221 0 CA-C-N 116.213 -0.449 . . . . 6.72 110.763 -179.6 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 72' ' ' PRO . . . . . . . . . . . . . 91.0 Cg_endo -85.01 -29.3 0.7 Allowed 'Trans proline' 0 N--CA 1.493 1.446 0 C-N-CA 121.649 1.566 . . . . 3.4 112.644 178.843 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 73' ' ' VAL . . . . . . . . . . . . . 35.3 m -127.17 166.32 24.12 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.202 0 CA-C-N 116.474 -0.33 . . . . 1.24 110.303 -179.837 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 74' ' ' ASP . . . . . . . . . . . . . 29.6 t70 -99.33 119.52 38.07 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.471 -0.332 . . . . 0.96 110.217 -177.849 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 44.7 t -112.72 122.7 67.39 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.228 0 CA-C-O 121.148 0.499 . . . . 0.71 110.243 -179.551 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 76' ' ' LEU . . . . . . . . . . . . . 36.0 mt -124.12 139.24 54.13 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 115.56 -0.745 . . . . 1.13 109.403 177.802 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 77' ' ' GLU . . . . . . . . . . . . . 96.8 mt-10 -129.99 142.24 50.66 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-O 121.136 0.493 . . . . 1.42 111.142 -177.224 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 78' ' ' ALA . . . . . . . . . . . . . . . -131.64 136.56 47.83 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 115.479 -0.782 . . . . 0.57 109.937 177.334 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 79' ' ' LYS . . . . . 0.58 ' O ' HD13 ' A' ' 80' ' ' ILE . 38.0 tttp -81.23 119.57 23.79 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-O 120.91 0.386 . . . . 2.96 110.939 -176.537 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 80' ' ' ILE . . . . . 0.58 HD13 ' O ' ' A' ' 79' ' ' LYS . 42.0 mm -139.13 108.45 3.8 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.324 0 N-CA-C 109.089 -0.708 . . . . 0.56 109.089 -178.347 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 81' ' ' LYS . . . . . . . . . . . . . 37.9 tttp -102.78 125.44 49.52 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-O 120.95 0.405 . . . . 2.85 111.114 -176.818 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . 89.01 42.13 5.71 Favored Glycine 0 CA--C 1.526 0.757 0 C-N-CA 121.057 -0.592 . . . . 0.57 111.93 174.993 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 83' ' ' ILE . . . . . . . . . . . . . 72.2 mt -68.14 136.35 26.68 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 N-CA-C 109.641 -0.503 . . . . 0.55 109.641 177.01 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 84' ' ' LYS . . . . . . . . . . . . . 40.2 ttpt -104.93 -46.94 4.15 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.35 -0.387 . . . . 1.44 110.306 -178.432 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 85' ' ' ASP . . . . . . . . . . . . . 20.7 t70 -149.49 148.48 29.46 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.068 -0.514 . . . . 0.79 110.455 179.319 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 86' ' ' VAL . . . . . . . . . . . . . 43.2 t -130.89 133.31 63.24 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.227 0 CA-C-O 120.955 0.407 . . . . 0.54 110.375 -179.887 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 87' ' ' ILE . . . . . . . . . . . . . 45.1 mm -120.55 127.74 75.95 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.231 0 CA-C-N 115.821 -0.627 . . . . 1.41 109.781 178.537 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 88' ' ' LEU . . . . . . . . . . . . . 54.5 mt -107.82 135.49 49.14 Favored 'General case' 0 C--N 1.331 -0.221 0 CA-C-N 116.276 -0.42 . . . . 1.56 110.974 -179.659 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 89' ' ' ASP . . . . . . . . . . . . . 12.2 t70 -130.78 155.48 46.6 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.005 -0.543 . . . . 0.97 109.655 176.988 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 96.8 mt-10 -48.69 -36.35 15.95 Favored 'General case' 0 C--N 1.329 -0.3 0 N-CA-C 112.818 0.673 . . . . 2.49 112.818 -171.478 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 91' ' ' ASN . . . . . . . . . . . . . 12.6 t-20 -131.99 22.2 4.54 Favored 'General case' 0 N--CA 1.468 0.452 0 N-CA-C 112.781 0.659 . . . . 2.35 112.781 -177.572 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 92' ' ' LEU . . . . . . . . . . . . . 23.1 mt -150.06 147.1 27.4 Favored 'General case' 0 C--N 1.332 -0.153 0 CA-C-O 120.799 0.333 . . . . 1.35 110.395 -177.348 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 93' ' ' ILE . . . . . . . . . . . . . 70.6 mt -124.24 117.94 52.24 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.272 0 N-CA-C 109.104 -0.702 . . . . 0.52 109.104 175.964 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 94' ' ' VAL . . . . . . . . . . . . . 46.4 t -118.96 127.08 75.82 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.268 0 CA-C-O 120.91 0.386 . . . . 0.46 110.028 -178.427 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 95' ' ' VAL . . . . . . . . . . . . . 43.7 t -120.88 132.7 69.72 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.308 0 CA-C-N 115.945 -0.571 . . . . 0.42 109.733 179.912 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 96' ' ' ILE . . . . . . . . . . . . . 67.5 mt -114.21 126.94 71.83 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.24 0 N-CA-C 109.215 -0.661 . . . . 0.51 109.215 178.859 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 97' ' ' THR . . . . . . . . . . . . . 69.6 p -102.6 155.64 18.15 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-O 121.241 0.543 . . . . 0.53 111.228 -176.41 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 98' ' ' GLU . . . . . . . . . . . . . 48.6 mt-10 -54.27 -23.54 15.32 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.017 -0.538 . . . . 2.42 112.275 178.279 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 99' ' ' GLU . . . . . . . . . . . . . 95.0 mt-10 -76.82 13.28 1.07 Allowed 'General case' 0 CA--C 1.536 0.406 0 N-CA-C 113.24 0.829 . . . . 2.34 113.24 -178.278 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 100' ' ' ASN . . . . . . . . . . . . . 1.7 m120 64.35 36.28 9.2 Favored 'General case' 0 CA--C 1.53 0.19 0 CA-C-O 120.944 0.402 . . . . 0.6 110.922 177.545 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 101' ' ' GLU . . . . . . . . . . . . . 84.3 tt0 -122.43 143.93 49.37 Favored 'General case' 0 C--N 1.333 -0.139 0 CA-C-N 116.239 -0.437 . . . . 0.54 109.916 178.586 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 102' ' ' VAL . . . . . . . . . . . . . 45.4 t -115.09 126.79 72.77 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.231 0 N-CA-C 109.811 -0.441 . . . . 0.41 109.811 -179.713 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 103' ' ' LEU . . . . . . . . . . . . . 27.6 mt -114.69 130.11 56.77 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 115.723 -0.671 . . . . 0.77 110.051 177.308 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 104' ' ' ILE . . . . . . . . . . . . . 72.4 mt -116.63 121.44 67.67 Favored 'Isoleucine or valine' 0 C--O 1.234 0.279 0 CA-C-N 116.552 -0.295 . . . . 0.43 110.321 -179.193 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 105' ' ' PHE . . . . . . . . . . . . . 88.3 m-85 -120.9 161.26 21.86 Favored 'General case' 0 C--N 1.333 -0.134 0 O-C-N 123.953 0.783 . . . . 0.48 109.884 -179.856 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 106' ' ' ASN . . . . . . . . . . . . . 39.0 p30 -95.87 -173.19 2.77 Favored 'General case' 0 C--N 1.33 -0.276 0 N-CA-C 110.065 -0.346 . . . . 0.63 110.065 175.314 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 107' ' ' GLN . . . . . . . . . . . . . 61.1 tt0 -60.17 -30.06 69.09 Favored 'General case' 0 C--N 1.329 -0.29 0 N-CA-C 111.936 0.347 . . . . 1.47 111.936 -179.98 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 108' ' ' ASN . . . . . . . . . . . . . 50.7 t30 -82.33 8.66 10.71 Favored 'General case' 0 CA--C 1.537 0.446 0 N-CA-C 113.043 0.757 . . . . 1.35 113.043 -177.831 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 109' ' ' LEU . . . . . . . . . . . . . 13.0 tp 61.47 39.83 14.53 Favored 'General case' 0 C--O 1.233 0.193 0 CA-C-O 121.324 0.583 . . . . 1.14 110.975 179.229 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 110' ' ' GLU . . . . . . . . . . . . . 95.2 mt-10 -109.97 152.2 26.17 Favored 'General case' 0 C--N 1.33 -0.244 0 N-CA-C 109.532 -0.544 . . . . 1.92 109.532 175.535 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 111' ' ' GLU . . . . . . . . . . . . . 81.2 tt0 -88.02 122.3 31.45 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-O 120.828 0.347 . . . . 1.78 110.941 -175.555 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 112' ' ' LEU . . . . . . . . . . . . . 51.8 mt -106.09 -46.1 4.17 Favored 'General case' 0 C--N 1.332 -0.186 0 CA-C-N 116.14 -0.482 . . . . 0.56 111.139 179.539 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 113' ' ' TYR . . . . . . . . . . . . . 61.4 t80 -136.76 138.23 40.71 Favored 'General case' 0 C--N 1.331 -0.213 0 CA-C-O 120.912 0.386 . . . . 0.5 111.545 -176.148 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 114' ' ' ARG . . . . . . . . . . . . . 38.9 ttm180 -132.54 122.89 25.52 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 115.878 -0.601 . . . . 2.76 109.773 175.612 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 115' ' ' GLY . . . . . . . . . . . . . . . -150.1 138.62 6.84 Favored Glycine 0 CA--C 1.523 0.543 0 N-CA-C 111.07 -0.812 . . . . 0.43 111.07 178.779 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 116' ' ' LYS . . . . . . . . . . . . . 34.0 ttmt -114.95 140.22 49.19 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-O 120.818 0.342 . . . . 1.57 110.079 177.256 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 117' ' ' PHE . . . . . . . . . . . . . 32.4 m-85 -136.89 114.93 11.49 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.147 -0.479 . . . . 0.49 109.892 -176.724 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 118' ' ' GLU . . . . . . . . . . . . . 84.2 tt0 -51.39 -49.4 61.61 Favored 'General case' 0 C--N 1.328 -0.358 0 N-CA-C 111.869 0.322 . . . . 2.77 111.869 -176.221 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 119' ' ' ASN . . . . . . . . . . . . . 97.7 m-20 -98.07 31.29 2.77 Favored 'General case' 0 C--N 1.328 -0.335 0 N-CA-C 112.221 0.452 . . . . 1.35 112.221 -174.321 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 120' ' ' LEU . . . . . . . . . . . . . 21.8 tp -54.57 120.74 7.12 Favored 'General case' 0 N--CA 1.463 0.19 0 O-C-N 122.243 -0.286 . . . . 0.56 110.71 178.727 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 121' ' ' ASN . . . . . . . . . . . . . 85.9 m-20 -113.81 -44.0 3.22 Favored 'General case' 0 C--N 1.332 -0.181 0 CA-C-N 116.459 -0.337 . . . . 1.74 111.07 -176.465 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 122' ' ' LYS . . . . . . . . . . . . . 84.9 mttt -142.93 145.3 32.9 Favored 'General case' 0 C--N 1.331 -0.227 0 CA-C-O 121.148 0.499 . . . . 1.94 111.705 -178.129 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 123' ' ' VAL . . . . . . . . . . . . . 46.4 t -121.8 122.57 67.21 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.249 0 N-CA-C 108.978 -0.749 . . . . 0.55 108.978 173.363 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 124' ' ' LEU . . . . . 0.511 HD12 ' N ' ' A' ' 124' ' ' LEU . 6.8 mp -108.9 122.97 48.32 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 116.272 -0.422 . . . . 1.63 110.349 -177.301 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 125' ' ' VAL . . . . . . . . . . . . . 44.2 t -126.16 125.37 67.69 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.307 0 N-CA-C 109.608 -0.516 . . . . 1.58 109.608 178.825 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 126' ' ' ARG . . . . . . . . . . . . . 81.2 mtt-85 -143.94 123.84 13.5 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-O 121.045 0.45 . . . . 3.09 110.774 -179.535 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 127' ' ' ASN . . . . . . . . . . . . . 18.9 t-20 50.91 -105.23 0.19 Allowed 'General case' 0 CA--C 1.543 0.709 0 CA-C-O 118.965 -0.54 . . . . 2.33 111.398 179.764 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 128' ' ' ASP . . . . . . . . . . . . . 9.1 p-10 -114.16 -1.51 13.65 Favored 'General case' 0 CA--C 1.537 0.452 0 CA-C-N 119.697 1.135 . . . . 1.17 113.522 -177.425 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 129' ' ' LEU . . . . . . . . . . . . . 79.3 mt -105.58 144.24 32.62 Favored 'General case' 0 C--O 1.232 0.162 0 CA-C-N 118.207 0.458 . . . . 1.96 110.876 -177.398 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 130' ' ' VAL . . . . . . . . . . . . . 45.1 t -127.35 134.99 64.6 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.169 0 CA-C-O 121.075 0.464 . . . . 1.37 110.251 -179.354 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 131' ' ' VAL . . . . . 0.455 HG22 HD12 ' A' ' 140' ' ' LEU . 45.5 t -133.02 135.35 57.04 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.287 0 CA-C-N 116.088 -0.505 . . . . 1.07 109.906 177.517 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 132' ' ' ILE . . . . . . . . . . . . . 68.5 mt -113.46 131.17 65.97 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.304 0 N-CA-C 109.381 -0.6 . . . . 0.42 109.381 -179.976 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 133' ' ' ILE . . . . . . . . . . . . . 41.9 mm -118.55 120.77 65.26 Favored 'Isoleucine or valine' 0 C--O 1.233 0.22 0 CA-C-O 120.954 0.407 . . . . 0.5 111.111 -175.384 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 134' ' ' ASP . . . . . . . . . . . . . 3.6 p30 -135.59 146.73 48.26 Favored 'General case' 0 C--N 1.332 -0.196 0 N-CA-C 109.362 -0.607 . . . . 0.55 109.362 173.19 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 135' ' ' GLU . . . . . . . . . . . . . 85.9 tt0 -49.88 -23.76 2.1 Favored 'General case' 0 C--N 1.326 -0.454 0 N-CA-C 112.85 0.685 . . . . 2.04 112.85 -172.658 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 136' ' ' GLN . . . . . . . . . . . . . 52.0 mt-30 -87.57 -36.27 17.65 Favored 'General case' 0 C--O 1.234 0.251 0 N-CA-C 112.586 0.587 . . . . 2.11 112.586 -176.203 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 137' ' ' LYS . . . . . . . . . . . . . 40.7 pttt -157.44 167.45 30.18 Favored 'General case' 0 C--N 1.331 -0.197 0 CA-C-O 121.514 0.673 . . . . 1.56 112.277 -172.87 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 138' ' ' LEU . . . . . 0.415 HD23 ' N ' ' A' ' 139' ' ' THR . 6.1 tt -121.31 128.74 52.62 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 115.084 -0.962 . . . . 0.97 109.701 178.006 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 139' ' ' THR . . . . . 0.415 ' N ' HD23 ' A' ' 138' ' ' LEU . 28.6 m -111.78 129.9 55.98 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.41 -0.359 . . . . 0.44 110.46 -179.411 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 140' ' ' LEU . . . . . 0.455 HD12 HG22 ' A' ' 131' ' ' VAL . 21.6 tp -111.75 118.82 36.64 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 115.679 -0.691 . . . . 1.03 109.165 179.734 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 141' ' ' ILE . . . . . . . . . . . . . 19.5 mt -119.09 118.02 56.22 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.314 0 N-CA-C 109.569 -0.53 . . . . 0.5 109.569 -176.794 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 142' ' ' ARG . . . . . . . . . . . . . 49.5 ttp180 -110.84 124.81 52.78 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 115.354 -0.839 . . . . 2.87 110.174 -176.6 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 143' ' ' THR . . . . . . . . . . . . . 27.6 p . . . . . 0 C--O 1.219 -0.525 0 CA-C-O 117.977 -1.011 . . . . 1.48 110.6 -179.242 . . . . . . . . 0 0 . 1 . 001 nuclear build full ' B' B ' -3' ' ' GLU . . . . . . . . . . . . . 47.3 mt-10 . . . . . 0 N--CA 1.491 1.587 0 N-CA-C 109.31 -0.626 . . . . 33.38 109.31 . . . . . . . . . 0 0 . 1 . 001 nuclear build full ' B' B ' -2' ' ' GLY . . . . . . . . . . . . . . . -65.61 138.63 38.22 Favored Glycine 0 CA--C 1.525 0.676 0 N-CA-C 110.874 -0.89 . . . . 29.16 110.874 179.9 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' -1' ' ' VAL . . . . . 0.444 ' O ' HD13 ' B' ' 0' ' ' ILE . 42.9 t -96.96 126.5 49.69 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.294 0 N-CA-C 110.081 -0.34 . . . . 26.67 110.081 -179.857 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 0' ' ' ILE . . . . . 0.444 HD13 ' O ' ' B' ' -1' ' ' VAL . 44.8 mm -124.53 118.7 54.28 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.235 0 CA-C-N 116.354 -0.385 . . . . 24.73 110.117 179.489 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 1' ' ' MET . . . . . . . . . . . . . 24.6 ptt? -95.94 156.39 16.35 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.12 -0.491 . . . . 21.58 110.57 179.57 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 2' ' ' SER . . . . . . . . . . . . . 2.0 p -114.68 123.14 48.53 Favored 'General case' 0 C--O 1.232 0.183 0 CA-C-O 121.125 0.488 . . . . 19.08 110.598 178.492 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 3' ' ' GLU . . . . . . . . . . . . . 93.2 mt-10 -140.71 141.86 34.9 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-N 115.781 -0.645 . . . . 16.48 110.956 -178.157 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 4' ' ' LEU . . . . . 0.503 HD21 HD21 ' B' ' 6' ' ' LEU . 12.7 tp -125.6 130.05 50.87 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 115.986 -0.552 . . . . 14.28 109.874 176.336 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 5' ' ' LYS . . . . . . . . . . . . . 94.8 mttt -106.73 119.77 40.22 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.37 -0.377 . . . . 12.15 110.285 179.839 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 6' ' ' LEU . . . . . 0.503 HD21 HD21 ' B' ' 4' ' ' LEU . 75.7 mt -117.13 148.68 41.34 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 115.477 -0.783 . . . . 11.97 110.257 -176.982 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 7' ' ' LYS . . . . . . . . . . . . . 34.1 ttmt -132.76 134.83 25.08 Favored Pre-proline 0 CA--C 1.535 0.385 0 CA-C-O 118.853 -0.594 . . . . 9.81 110.118 177.578 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 8' ' ' PRO . . . . . . . . . . . . . 74.3 Cg_endo -91.61 131.87 1.33 Allowed 'Trans proline' 0 N--CA 1.491 1.329 0 C-N-CA 121.668 1.578 . . . . 9.83 111.606 176.537 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 9' ' ' LEU . . . . . . . . . . . . . 72.8 mt -70.95 -52.12 10.1 Favored Pre-proline 0 CA--C 1.533 0.295 0 CA-C-O 118.591 -0.718 . . . . 13.18 112.106 -177.526 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 10' ' ' PRO . . . . . . . . . . . . . 38.4 Cg_endo -68.59 141.8 51.45 Favored 'Trans proline' 0 N--CA 1.498 1.78 0 CA-C-N 120.287 1.138 . . . . 13.3 111.613 175.072 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 11' ' ' LYS . . . . . . . . . . . . . 69.1 mttm -87.04 97.38 10.69 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.408 -0.36 . . . . 12.9 110.645 -179.921 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 12' ' ' VAL . . . . . . . . . . . . . 11.8 p -139.38 142.08 34.05 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.325 0 CA-C-N 116.021 -0.536 . . . . 14.63 110.385 -179.902 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 13' ' ' GLU . . . . . . . . . . . . . 47.7 mt-10 -73.48 120.44 19.08 Favored 'General case' 0 C--N 1.329 -0.317 0 N-CA-C 110.007 -0.368 . . . . 14.92 110.007 177.64 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 14' ' ' LEU . . . . . . . . . . . . . 26.3 mt -95.84 143.16 25.65 Favored Pre-proline 0 CA--C 1.533 0.303 0 CA-C-O 118.928 -0.558 . . . . 14.87 109.752 179.953 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 15' ' ' PRO . . . . . . . . . . . . . 29.6 Cg_exo -59.82 159.82 23.63 Favored 'Trans proline' 0 N--CA 1.497 1.682 0 C-N-CA 121.253 1.302 . . . . 17.71 111.545 178.764 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 16' ' ' PRO . . . . . . . . . . . . . 37.4 Cg_exo -58.88 -40.11 75.04 Favored 'Trans proline' 0 N--CA 1.498 1.791 0 C-N-CA 121.429 1.419 . . . . 18.26 112.799 -177.813 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 17' ' ' ASP . . . . . . . . . . . . . 3.1 p30 -87.5 10.88 16.26 Favored 'General case' 0 CA--C 1.536 0.409 0 N-CA-C 113.05 0.759 . . . . 19.81 113.05 -178.61 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 18' ' ' PHE . . . . . . . . . . . . . 50.2 t80 -58.62 -44.97 90.13 Favored 'General case' 0 CA--C 1.523 -0.095 0 O-C-N 121.902 -0.499 . . . . 16.3 109.883 -178.348 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 19' ' ' VAL . . . . . . . . . . . . . 13.7 p -56.0 -39.04 55.58 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.283 0 CA-C-N 116.121 -0.491 . . . . 15.53 110.827 179.838 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 20' ' ' ASP . . . . . . . . . . . . . 31.0 t0 -60.11 -44.91 94.51 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-O 120.767 0.318 . . . . 19.22 110.717 -179.032 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 21' ' ' VAL . . . . . . . . . . . . . 47.7 t -64.24 -45.82 95.14 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.293 0 C-N-CA 120.757 -0.377 . . . . 18.61 110.43 -177.813 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 22' ' ' ILE . . . . . 0.659 HG22 HD12 ' B' ' 26' ' ' LEU . 51.0 mm -55.82 -47.3 79.75 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.224 0 C-N-CA 121.002 -0.279 . . . . 16.42 110.651 179.525 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 23' ' ' ARG . . . . . . . . . . . . . 43.7 ttp180 -55.25 -48.11 74.46 Favored 'General case' 0 C--N 1.329 -0.291 0 C-N-CA 121.064 -0.254 . . . . 19.83 111.346 -178.354 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 24' ' ' ILE . . . . . . . . . . . . . 72.9 mt -59.26 -41.28 83.52 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.297 0 C-N-CA 121.076 -0.25 . . . . 20.56 110.96 -177.964 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 25' ' ' LYS . . . . . . . . . . . . . 8.3 mtpm? -69.45 -38.91 78.01 Favored 'General case' 0 C--N 1.328 -0.356 0 N-CA-C 112.274 0.472 . . . . 19.42 112.274 -178.122 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 26' ' ' LEU . . . . . 0.659 HD12 HG22 ' B' ' 22' ' ' ILE . 37.9 mt -79.35 -38.08 35.94 Favored 'General case' 0 C--N 1.329 -0.291 0 N-CA-C 113.587 0.958 . . . . 18.5 113.587 -171.457 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 27' ' ' GLN . . . . . . . . . . . . . 14.9 pt20 -46.77 141.08 4.13 Favored 'General case' 0 N--CA 1.47 0.554 0 N-CA-C 112.747 0.647 . . . . 21.33 112.747 -175.189 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 28' ' ' GLY . . . . . . . . . . . . . . . 100.26 -23.68 34.97 Favored Glycine 0 CA--C 1.533 1.17 0 CA-C-N 115.481 -0.781 . . . . 21.4 112.289 -176.152 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 29' ' ' LYS . . . . . . . . . . . . . 68.5 mttm -98.06 155.11 17.27 Favored 'General case' 0 C--O 1.233 0.194 0 CA-C-N 117.559 0.679 . . . . 20.58 111.212 178.986 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 30' ' ' THR . . . . . . . . . . . . . 30.7 m -104.93 139.46 39.62 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 115.953 -0.567 . . . . 21.06 109.936 176.303 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 31' ' ' VAL . . . . . . . . . . . . . 34.8 m -129.78 149.09 33.28 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.252 0 CA-C-O 120.954 0.407 . . . . 18.25 111.167 -177.957 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 32' ' ' ARG . . . . . . . . . . . . . 75.2 mtt85 -124.69 149.15 47.52 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 115.823 -0.626 . . . . 22.16 110.166 177.427 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 33' ' ' THR . . . . . . . . . . . . . 23.6 m -53.83 136.7 39.94 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.369 -0.378 . . . . 17.28 111.356 -179.053 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 34' ' ' GLY . . . . . . . . . . . . . . . 100.0 -17.11 57.65 Favored Glycine 0 CA--C 1.531 1.053 0 CA-C-O 119.585 -0.564 . . . . 16.47 113.386 177.457 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 35' ' ' ASP . . . . . . . . . . . . . 81.8 m-20 -66.0 146.93 54.11 Favored 'General case' 0 C--O 1.231 0.117 0 CA-C-N 118.111 0.956 . . . . 18.38 111.17 -179.366 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 36' ' ' VAL . . . . . . . . . . . . . 44.5 t -121.17 128.83 76.07 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.235 0 CA-C-N 115.999 -0.546 . . . . 17.19 109.698 176.982 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 37' ' ' ILE . . . . . . . . . . . . . 64.6 mt -120.57 138.81 49.84 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.305 0 CA-C-N 116.238 -0.437 . . . . 16.42 110.019 -178.138 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 38' ' ' GLY . . . . . . . . . . . . . . . -106.63 127.24 8.79 Favored Glycine 0 CA--C 1.524 0.615 0 N-CA-C 110.927 -0.869 . . . . 18.22 110.927 178.424 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 39' ' ' ILE . . . . . . . . . . . . . 76.8 mt -127.72 141.48 46.29 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.264 0 N-CA-C 110.048 -0.353 . . . . 18.12 110.048 179.583 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 40' ' ' SER . . . . . 0.427 ' O ' HD13 ' B' ' 41' ' ' ILE . 40.6 t -91.8 118.83 31.06 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-O 120.813 0.34 . . . . 21.59 110.96 177.189 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 41' ' ' ILE . . . . . 0.438 HG22 HD13 ' B' ' 42' ' ' LEU . 47.3 mm -124.7 120.0 57.65 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.213 0 CA-C-N 116.149 -0.478 . . . . 20.26 110.487 178.989 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 42' ' ' LEU . . . . . 0.438 HD13 HG22 ' B' ' 41' ' ' ILE . 7.8 mp 52.06 35.87 17.37 Favored 'General case' 0 C--N 1.331 -0.2 0 CA-C-N 116.301 -0.409 . . . . 22.74 111.638 177.848 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 43' ' ' GLY . . . . . . . . . . . . . . . 72.8 31.5 62.31 Favored Glycine 0 CA--C 1.529 0.956 0 C-N-CA 121.131 -0.557 . . . . 23.04 112.101 178.375 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 44' ' ' LYS . . . . . . . . . . . . . 85.1 tttt -137.71 131.46 31.39 Favored 'General case' 0 C--N 1.329 -0.311 0 N-CA-C 109.57 -0.53 . . . . 21.05 109.57 178.416 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 45' ' ' GLU . . . . . . . . . . . . . 81.7 tt0 -80.17 111.0 16.12 Favored 'General case' 0 C--N 1.328 -0.337 0 C-N-CA 120.657 -0.417 . . . . 20.06 110.238 -179.222 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 46' ' ' VAL . . . . . . . . . . . . . 7.0 p -109.86 128.2 66.16 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.188 0 N-CA-C 109.332 -0.618 . . . . 16.65 109.332 178.954 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 47' ' ' LYS . . . . . . . . . . . . . 44.0 mttm -98.54 124.28 43.2 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 115.781 -0.645 . . . . 18.21 110.666 178.409 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 48' ' ' PHE . . . . . . . . . . . . . 96.4 m-85 -108.99 131.79 54.73 Favored 'General case' 0 C--N 1.328 -0.351 0 N-CA-C 109.679 -0.489 . . . . 13.38 109.679 176.013 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 49' ' ' LYS . . . . . . . . . . . . . 42.6 tttp -109.18 137.97 46.26 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.484 -0.326 . . . . 14.08 110.593 178.246 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 50' ' ' VAL . . . . . 0.433 ' HA ' HD23 ' B' ' 6' ' ' LEU . 48.1 t -82.41 106.85 13.73 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.369 0 N-CA-C 109.156 -0.683 . . . . 13.85 109.156 175.527 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 51' ' ' VAL . . . . . . . . . . . . . 48.2 t -69.92 -52.35 31.85 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.354 0 N-CA-C 109.476 -0.564 . . . . 12.96 109.476 -176.113 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 52' ' ' GLN . . . . . . . . . . . . . 46.6 mt-30 -155.14 152.72 29.8 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 115.914 -0.584 . . . . 14.9 111.61 -179.401 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 53' ' ' ALA . . . . . . . . . . . . . . . -127.27 131.31 50.56 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 115.327 -0.851 . . . . 16.72 109.847 176.473 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 54' ' ' TYR . . . . . . . . . . . . . 9.8 t80 -129.1 107.5 17.93 Favored Pre-proline 0 CA--C 1.535 0.367 0 CA-C-O 118.337 -0.839 . . . . 20.83 110.496 -179.829 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 55' ' ' PRO . . . . . . . . . . . . . 73.2 Cg_endo -77.11 170.0 72.77 Favored 'Cis proline' 0 N--CA 1.5 1.882 0 CA-C-N 121.781 1.672 . . . . 20.51 112.397 -5.952 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 56' ' ' SER . . . . . . . . . . . . . 18.7 m -116.54 133.21 23.03 Favored Pre-proline 0 CA--C 1.538 0.494 0 CA-C-O 118.445 -0.788 . . . . 21.17 109.433 174.37 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 57' ' ' PRO . . . . . . . . . . . . . 55.4 Cg_endo -71.72 149.04 91.86 Favored 'Cis proline' 0 N--CA 1.497 1.728 0 CA-C-N 121.967 1.738 . . . . 21.75 111.566 -1.057 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 58' ' ' LEU . . . . . . . . . . . . . 26.7 tp -107.63 136.24 47.73 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.438 -0.347 . . . . 18.89 110.467 -178.873 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 59' ' ' ARG . . . . . . . . . . . . . 71.3 ttt-85 -106.64 119.23 38.74 Favored 'General case' 0 C--N 1.327 -0.371 0 N-CA-C 109.131 -0.692 . . . . 23.48 109.131 177.239 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 60' ' ' VAL . . . . . . . . . . . . . 44.7 t -78.05 122.27 32.6 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.286 0 C-N-CA 120.753 -0.379 . . . . 19.33 110.428 -173.96 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 61' ' ' GLU . . . . . . . . . . . . . 46.9 mt-10 -131.0 174.31 10.13 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.065 -0.516 . . . . 21.74 109.882 176.923 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 62' ' ' ASP . . . . . . . . . . . . . 10.9 t70 -54.29 -32.71 57.06 Favored 'General case' 0 C--N 1.327 -0.381 0 C-N-CA 121.037 -0.265 . . . . 21.65 111.668 -178.812 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 63' ' ' ARG . . . . . . . . . . . . . 39.9 ptt180 -89.49 5.14 46.75 Favored 'General case' 0 CA--C 1.537 0.452 0 N-CA-C 113.715 1.006 . . . . 24.12 113.715 -176.152 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 64' ' ' THR . . . . . . . . . . . . . 38.7 m -81.1 130.7 35.14 Favored 'General case' 0 C--N 1.331 -0.2 0 CA-C-N 118.134 0.425 . . . . 18.66 110.386 -179.717 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 65' ' ' LYS . . . . . . . . . . . . . 91.0 mttt -90.47 130.37 36.54 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.353 -0.385 . . . . 18.71 110.469 -179.715 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 66' ' ' ILE . . . . . . . . . . . . . 65.1 mt -116.48 132.35 66.37 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.232 0 CA-C-O 120.923 0.392 . . . . 14.83 110.006 179.456 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 67' ' ' THR . . . . . . . . . . . . . 30.4 m -120.4 139.37 52.91 Favored 'General case' 0 C--N 1.331 -0.22 0 CA-C-N 116.04 -0.527 . . . . 12.49 110.637 -178.938 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 68' ' ' LEU . . . . . . . . . . . . . 6.8 mp -101.24 116.32 32.53 Favored 'General case' 0 C--N 1.332 -0.193 0 CA-C-N 116.209 -0.45 . . . . 10.14 110.781 179.692 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 69' ' ' VAL . . . . . . . . . . . . . 44.1 t -103.57 139.29 24.92 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.322 0 CA-C-N 115.926 -0.579 . . . . 7.78 109.933 178.5 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 70' ' ' THR . . . . . . . . . . . . . 3.2 p -136.88 45.46 2.27 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-O 121.325 0.583 . . . . 6.56 110.619 179.983 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 71' ' ' HIS . . . . . . . . . . . . . 18.5 t60 -125.71 80.62 66.38 Favored Pre-proline 0 CA--C 1.535 0.371 0 CA-C-N 116.063 -0.517 . . . . 6.6 110.595 -179.372 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 72' ' ' PRO . . . . . . . . . . . . . 16.8 Cg_exo -65.0 -30.04 56.94 Favored 'Trans proline' 0 N--CA 1.496 1.656 0 C-N-CA 121.429 1.42 . . . . 2.94 112.443 -179.436 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 73' ' ' VAL . . . . . . . . . . . . . 34.5 m -147.93 172.12 2.5 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.36 0 CA-C-N 116.515 -0.311 . . . . 1.07 110.53 -179.831 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 74' ' ' ASP . . . . . . . . . . . . . 29.8 t0 -94.01 120.23 33.98 Favored 'General case' 0 C--N 1.331 -0.229 0 CA-C-N 116.446 -0.343 . . . . 0.93 110.159 -179.631 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 75' ' ' VAL . . . . . . . . . . . . . 43.4 t -118.76 121.77 67.75 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.212 0 CA-C-O 121.046 0.45 . . . . 0.66 110.688 -177.86 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 76' ' ' LEU . . . . . . . . . . . . . 6.0 mp -123.66 146.49 48.18 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-N 115.82 -0.627 . . . . 1.16 109.672 175.284 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 77' ' ' GLU . . . . . . . . . . . . . 98.1 mt-10 -135.54 139.74 44.18 Favored 'General case' 0 N--CA 1.462 0.161 0 CA-C-O 121.015 0.436 . . . . 1.33 111.582 -177.642 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 78' ' ' ALA . . . . . . . . . . . . . . . -127.73 137.79 52.56 Favored 'General case' 0 C--N 1.331 -0.223 0 CA-C-N 115.639 -0.71 . . . . 0.63 109.69 175.474 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 79' ' ' LYS . . . . . 0.605 ' O ' HD13 ' B' ' 80' ' ' ILE . 49.8 pttt -84.64 123.15 30.03 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-O 121.073 0.464 . . . . 3.1 110.937 -179.019 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 80' ' ' ILE . . . . . 0.605 HD13 ' O ' ' B' ' 79' ' ' LYS . 40.0 mm -139.16 117.54 12.51 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.28 0 N-CA-C 109.421 -0.585 . . . . 0.65 109.421 -177.659 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 81' ' ' LYS . . . . . . . . . . . . . 85.4 tttt -104.14 121.79 43.97 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-O 120.795 0.331 . . . . 2.96 111.122 -177.292 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 82' ' ' GLY . . . . . . . . . . . . . . . 89.11 42.2 5.67 Favored Glycine 0 CA--C 1.526 0.733 0 C-N-CA 120.648 -0.786 . . . . 0.68 112.069 173.618 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 83' ' ' ILE . . . . . . . . . . . . . 69.3 mt -67.43 137.92 23.78 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.282 0 N-CA-C 109.669 -0.493 . . . . 0.62 109.669 176.625 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 84' ' ' LYS . . . . . . . . . . . . . 80.5 tttt -93.46 -54.07 3.82 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.078 -0.51 . . . . 1.62 110.379 -178.388 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 85' ' ' ASP . . . . . . . . . . . . . 19.5 t70 -156.43 152.92 28.07 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 115.63 -0.714 . . . . 0.7 110.138 -179.085 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 86' ' ' VAL . . . . . . . . . . . . . 45.1 t -127.5 131.07 70.57 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.25 0 CA-C-O 121.096 0.474 . . . . 0.48 110.543 -179.092 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 87' ' ' ILE . . . . . 0.491 ' N ' HD12 ' B' ' 87' ' ' ILE . 5.1 mp -118.94 125.13 74.23 Favored 'Isoleucine or valine' 0 C--O 1.233 0.23 0 CA-C-N 115.668 -0.696 . . . . 1.38 109.276 176.64 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 88' ' ' LEU . . . . . . . . . . . . . 16.6 tp -110.05 127.28 54.75 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-O 120.926 0.393 . . . . 1.67 110.958 -177.415 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 89' ' ' ASP . . . . . . . . . . . . . 14.6 t70 -118.89 158.17 26.21 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 115.813 -0.631 . . . . 0.85 109.408 177.09 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 90' ' ' GLU . . . . . . . . . . . . . 95.1 mt-10 -47.31 -40.35 16.83 Favored 'General case' 0 C--N 1.33 -0.265 0 N-CA-C 113.0 0.741 . . . . 2.51 113.0 -171.33 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 91' ' ' ASN . . . . . . . . . . . . . 69.9 m-80 -132.09 26.51 4.56 Favored 'General case' 0 N--CA 1.466 0.373 0 N-CA-C 112.469 0.544 . . . . 2.35 112.469 -178.023 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 92' ' ' LEU . . . . . . . . . . . . . 84.9 mt -150.51 143.22 24.57 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-O 120.748 0.308 . . . . 1.45 110.448 -178.731 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 93' ' ' ILE . . . . . . . . . . . . . 74.5 mt -118.53 113.37 41.63 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.346 0 N-CA-C 109.257 -0.646 . . . . 0.54 109.257 178.181 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 94' ' ' VAL . . . . . . . . . . . . . 46.1 t -115.35 124.95 72.41 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.201 0 CA-C-O 120.939 0.4 . . . . 0.45 109.99 -178.43 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 95' ' ' VAL . . . . . . . . . . . . . 42.7 t -121.91 134.34 65.49 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.285 0 CA-C-N 116.07 -0.514 . . . . 0.43 109.881 -179.122 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 96' ' ' ILE . . . . . . . . . . . . . 64.6 mt -112.89 128.71 69.48 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.365 0 N-CA-C 109.075 -0.713 . . . . 0.5 109.075 177.831 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 97' ' ' THR . . . . . . . . . . . . . 69.6 p -98.37 158.72 15.4 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-O 121.153 0.501 . . . . 0.56 111.082 -178.043 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 98' ' ' GLU . . . . . . . . . . . . . 83.6 tt0 -53.93 -27.66 32.18 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.148 -0.478 . . . . 3.05 112.081 -179.819 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 99' ' ' GLU . . . . . . . . . . . . . 95.5 mt-10 -81.31 16.78 1.49 Allowed 'General case' 0 CA--C 1.534 0.363 0 N-CA-C 113.152 0.797 . . . . 2.29 113.152 -176.588 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 100' ' ' ASN . . . . . . . . . . . . . 4.3 m-20 62.89 38.05 11.65 Favored 'General case' 0 N--CA 1.462 0.158 0 CA-C-O 121.073 0.464 . . . . 0.66 111.158 177.265 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 101' ' ' GLU . . . . . . . . . . . . . 84.6 tt0 -115.18 144.46 43.65 Favored 'General case' 0 C--N 1.333 -0.132 0 CA-C-N 116.1 -0.5 . . . . 0.69 109.738 174.937 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 102' ' ' VAL . . . . . . . . . . . . . 45.0 t -115.5 126.23 72.98 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 CA-C-N 116.257 -0.429 . . . . 0.48 110.083 -177.812 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 103' ' ' LEU . . . . . . . . . . . . . 55.6 mt -119.23 132.48 55.93 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 115.789 -0.641 . . . . 1.28 110.014 177.15 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 104' ' ' ILE . . . . . . . . . . . . . 66.7 mt -121.34 121.61 65.18 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.236 0 N-CA-C 110.369 -0.234 . . . . 0.51 110.369 179.047 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 105' ' ' PHE . . . . . . . . . . . . . 76.0 m-85 -115.81 166.32 12.09 Favored 'General case' 0 C--N 1.332 -0.175 0 O-C-N 124.205 0.941 . . . . 0.55 109.643 177.911 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 106' ' ' ASN . . . . . . . . . . . . . 52.0 p-10 -100.08 -171.57 2.07 Favored 'General case' 0 C--N 1.331 -0.213 0 N-CA-C 110.086 -0.338 . . . . 0.71 110.086 173.546 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 107' ' ' GLN . . . . . . . . . . . . . 50.2 tt0 -58.37 -30.15 66.56 Favored 'General case' 0 CA--C 1.532 0.286 0 N-CA-C 111.901 0.334 . . . . 1.83 111.901 178.574 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 108' ' ' ASN . . . . . . . . . . . . . 63.6 t30 -83.03 8.16 13.63 Favored 'General case' 0 CA--C 1.535 0.388 0 N-CA-C 113.212 0.819 . . . . 1.5 113.212 -177.147 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 109' ' ' LEU . . . . . . . . . . . . . 11.9 tp 60.92 37.43 18.33 Favored 'General case' 0 CA--C 1.53 0.186 0 CA-C-O 120.99 0.424 . . . . 1.18 111.197 179.028 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 110' ' ' GLU . . . . . . . . . . . . . 47.6 mt-10 -110.09 153.09 25.16 Favored 'General case' 0 C--N 1.33 -0.24 0 N-CA-C 109.751 -0.463 . . . . 1.97 109.751 176.436 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 111' ' ' GLU . . . . . . . . . . . . . 73.7 tt0 -86.76 123.17 31.61 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-O 120.855 0.359 . . . . 1.84 110.926 -174.931 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 112' ' ' LEU . . . . . . . . . . . . . 32.9 mt -108.9 -46.06 3.69 Favored 'General case' 0 C--N 1.332 -0.186 0 CA-C-N 116.198 -0.455 . . . . 0.75 111.27 -179.55 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 113' ' ' TYR . . . . . . . . . . . . . 71.6 t80 -136.83 142.3 42.87 Favored 'General case' 0 N--CA 1.464 0.244 0 CA-C-O 120.778 0.323 . . . . 0.68 111.064 -178.202 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 114' ' ' ARG . . . . . . . . . . . . . 25.0 ptt180 -144.52 127.25 16.21 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.05 -0.523 . . . . 3.02 110.927 -179.989 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 115' ' ' GLY . . . . . . . . . . . . . . . -150.19 160.46 28.55 Favored Glycine 0 CA--C 1.525 0.659 0 N-CA-C 111.242 -0.743 . . . . 0.53 111.242 178.614 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 116' ' ' LYS . . . . . . . . . . . . . 7.9 ttpm? -129.65 134.45 47.69 Favored 'General case' 0 C--N 1.33 -0.267 0 N-CA-C 109.782 -0.451 . . . . 1.72 109.782 175.911 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 117' ' ' PHE . . . . . . . . . . . . . 38.3 m-85 -134.46 113.97 12.39 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-O 120.815 0.34 . . . . 0.56 110.258 -176.939 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 118' ' ' GLU . . . . . . . . . . . . . 95.9 mt-10 -55.29 -40.94 71.66 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.424 -0.353 . . . . 2.56 111.129 -176.371 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 119' ' ' ASN . . . . . . . . . . . . . 7.2 m120 -102.84 31.12 4.33 Favored 'General case' 0 C--N 1.331 -0.227 0 CA-C-N 116.272 -0.422 . . . . 1.35 112.136 -174.431 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 120' ' ' LEU . . . . . . . . . . . . . 18.8 tp -56.23 120.46 7.6 Favored 'General case' 0 N--CA 1.462 0.156 0 C-N-CA 120.971 -0.292 . . . . 0.57 110.403 178.418 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 121' ' ' ASN . . . . . . . . . . . . . 64.2 t30 -114.08 -44.1 3.18 Favored 'General case' 0 C--O 1.233 0.186 0 CA-C-N 116.504 -0.316 . . . . 1.95 111.239 -175.891 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 122' ' ' LYS . . . . . . . . . . . . . 91.0 mttt -146.22 150.32 35.61 Favored 'General case' 0 C--N 1.331 -0.197 0 CA-C-O 121.192 0.52 . . . . 1.8 111.981 -176.339 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 123' ' ' VAL . . . . . . . . . . . . . 45.4 t -124.73 128.86 73.64 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.245 0 CA-C-N 115.651 -0.704 . . . . 0.57 109.391 174.723 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 124' ' ' LEU . . . . . . . . . . . . . 72.5 mt -120.8 132.43 55.02 Favored 'General case' 0 C--N 1.33 -0.273 0 N-CA-C 110.181 -0.303 . . . . 1.68 110.181 -178.194 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 125' ' ' VAL . . . . . . . . . . . . . 35.1 m -138.43 132.44 41.61 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.25 0 CA-C-O 120.971 0.415 . . . . 1.73 111.085 -179.754 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 126' ' ' ARG . . . . . . . . . . . . . 89.3 mtt-85 -151.58 132.92 14.57 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 115.777 -0.647 . . . . 2.53 109.714 176.605 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 127' ' ' ASN . . . . . . . . . . . . . 32.0 t30 56.67 -147.82 0.51 Allowed 'General case' 0 CA--C 1.541 0.623 0 N-CA-C 109.686 -0.487 . . . . 2.3 109.686 -179.415 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 128' ' ' ASP . . . . . . . . . . . . . 4.5 p30 -88.04 16.89 5.46 Favored 'General case' 0 CA--C 1.536 0.433 0 CA-C-N 118.75 0.705 . . . . 1.02 112.725 178.446 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 129' ' ' LEU . . . . . . . . . . . . . 15.0 tp -115.37 136.08 53.46 Favored 'General case' 0 C--O 1.232 0.167 0 O-C-N 122.118 -0.364 . . . . 1.86 110.073 179.389 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 130' ' ' VAL . . . . . 0.496 HG23 ' HB ' ' B' ' 141' ' ' ILE . 32.6 m -131.53 144.0 38.81 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.27 0 CA-C-O 120.995 0.426 . . . . 1.48 111.0 -178.546 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 131' ' ' VAL . . . . . 0.43 HG13 ' O ' ' B' ' 139' ' ' THR . 42.8 t -136.04 140.07 44.65 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 CA-C-N 116.022 -0.536 . . . . 0.7 110.34 179.796 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 132' ' ' ILE . . . . . . . . . . . . . 72.4 mt -112.95 133.88 57.37 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.323 0 N-CA-C 109.422 -0.584 . . . . 0.45 109.422 178.256 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 133' ' ' ILE . . . . . . . . . . . . . 38.5 mm -114.68 116.97 54.18 Favored 'Isoleucine or valine' 0 C--O 1.233 0.232 0 CA-C-N 116.534 -0.303 . . . . 0.54 110.767 -176.118 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 134' ' ' ASP . . . . . . . . . . . . . 7.6 p-10 -129.61 149.79 51.22 Favored 'General case' 0 C--N 1.331 -0.215 0 N-CA-C 109.594 -0.521 . . . . 0.56 109.594 174.963 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 135' ' ' GLU . . . . . . . . . . . . . 85.0 tt0 -49.9 -25.94 3.65 Favored 'General case' 0 C--N 1.327 -0.372 0 N-CA-C 112.719 0.637 . . . . 1.64 112.719 -172.113 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 136' ' ' GLN . . . . . . . . . . . . . 53.0 mt-30 -101.82 -25.68 13.73 Favored 'General case' 0 C--O 1.233 0.218 0 N-CA-C 112.892 0.701 . . . . 2.0 112.892 -173.939 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 137' ' ' LYS . . . . . . . . . . . . . 86.5 mttt -144.84 150.67 37.52 Favored 'General case' 0 C--N 1.331 -0.227 0 CA-C-O 121.482 0.658 . . . . 1.9 112.559 -168.503 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 138' ' ' LEU . . . . . . . . . . . . . 12.5 tp -112.65 117.6 32.71 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 114.888 -1.051 . . . . 0.74 108.78 172.64 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 139' ' ' THR . . . . . 0.43 ' O ' HG13 ' B' ' 131' ' ' VAL . 22.1 m -110.54 124.97 52.83 Favored 'General case' 0 C--N 1.332 -0.182 0 CA-C-O 120.596 0.236 . . . . 0.47 110.753 -177.266 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 140' ' ' LEU . . . . . 0.464 ' C ' HD23 ' B' ' 140' ' ' LEU . 6.5 tt -116.1 122.73 45.99 Favored 'General case' 0 C--N 1.33 -0.249 0 N-CA-C 109.484 -0.561 . . . . 0.86 109.484 -178.261 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 141' ' ' ILE . . . . . 0.496 ' HB ' HG23 ' B' ' 130' ' ' VAL . 19.8 mt -120.71 122.95 69.26 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.298 0 CA-C-O 120.949 0.404 . . . . 0.56 110.015 -175.397 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 142' ' ' ARG . . . . . . . . . . . . . 67.5 mtm180 -104.4 126.38 51.45 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 115.281 -0.872 . . . . 3.56 109.938 179.78 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 143' ' ' THR . . . . . . . . . . . . . 23.0 p . . . . . 0 C--O 1.22 -0.497 0 CA-C-O 117.963 -1.018 . . . . 1.46 110.645 -179.576 . . . . . . . . 0 0 . 1 . 001 nuclear build full ' C' C ' -3' ' ' GLU . . . . . . . . . . . . . 21.9 pt-20 . . . . . 0 N--CA 1.492 1.643 0 N-CA-C 110.322 -0.251 . . . . 36.63 110.322 . . . . . . . . . 0 0 . 1 . 001 nuclear build full ' C' C ' -2' ' ' GLY . . . . . . . . . . . . . . . -73.3 94.0 0.71 Allowed Glycine 0 CA--C 1.524 0.603 0 N-CA-C 111.245 -0.742 . . . . 32.08 111.245 -178.441 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' C' C ' -1' ' ' VAL . . . . . . . . . . . . . 45.1 t -93.84 126.69 46.23 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.337 0 N-CA-C 109.018 -0.734 . . . . 29.13 109.018 175.43 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' C' C ' 0' ' ' ILE . . . . . . . . . . . . . 44.6 mm -99.44 117.86 45.2 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.316 0 CA-C-O 120.944 0.402 . . . . 27.62 110.588 -175.998 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' C' C ' 1' ' ' MET . . . . . . . . . . . . . 24.9 ptm -90.72 141.11 29.13 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-N 115.815 -0.63 . . . . 23.77 110.079 178.21 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' C' C ' 2' ' ' SER . . . . . . . . . . . . . 51.0 p -104.93 140.09 38.68 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-O 120.996 0.427 . . . . 21.19 110.875 -178.159 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' C' C ' 3' ' ' GLU . . . . . . . . . . . . . 95.2 mt-10 -140.02 142.57 36.22 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 115.832 -0.622 . . . . 18.63 110.711 -179.463 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' C' C ' 4' ' ' LEU . . . . . 0.409 HD12 HD23 ' C' ' 58' ' ' LEU . 4.0 tt -123.78 124.02 41.78 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.083 -0.508 . . . . 16.59 109.788 176.63 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' C' C ' 5' ' ' LYS . . . . . . . . . . . . . 57.3 mttm -100.12 121.7 41.81 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.298 -0.41 . . . . 14.18 110.866 -179.314 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' C' C ' 6' ' ' LEU . . . . . . . . . . . . . 60.6 mt -117.59 146.3 43.72 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 115.557 -0.747 . . . . 13.76 110.67 -179.437 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' C' C ' 7' ' ' LYS . . . . . . . . . . . . . 38.5 ttmt -138.89 139.14 22.8 Favored Pre-proline 0 CA--C 1.533 0.318 0 CA-C-O 119.115 -0.469 . . . . 11.14 109.998 174.779 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' C' C ' 8' ' ' PRO . . . . . . . . . . . . . 94.1 Cg_endo -91.95 146.12 3.05 Favored 'Trans proline' 0 N--CA 1.489 1.258 0 C-N-CA 121.82 1.68 . . . . 10.45 112.098 178.817 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' C' C ' 9' ' ' LEU . . . . . . . . . . . . . 70.2 mt -75.89 -46.34 3.93 Favored Pre-proline 0 CA--C 1.533 0.31 0 CA-C-O 118.742 -0.647 . . . . 14.46 111.596 178.035 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' C' C ' 10' ' ' PRO . . . . . . . . . . . . . 84.6 Cg_endo -81.76 142.68 12.85 Favored 'Trans proline' 0 N--CA 1.495 1.574 0 C-N-CA 121.024 1.15 . . . . 13.28 111.227 172.308 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' C' C ' 11' ' ' LYS . . . . . . . . . . . . . 53.7 tttm -86.33 109.94 19.33 Favored 'General case' 0 C--N 1.331 -0.223 0 C-N-CA 120.68 -0.408 . . . . 12.2 110.524 -179.254 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' C' C ' 12' ' ' VAL . . . . . . . . . . . . . 11.6 p -147.38 145.62 18.95 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.299 0 CA-C-N 116.003 -0.544 . . . . 13.43 110.402 -179.294 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' C' C ' 13' ' ' GLU . . . . . . . . . . . . . 46.1 mt-10 -81.15 130.28 34.95 Favored 'General case' 0 C--N 1.329 -0.286 0 N-CA-C 110.096 -0.335 . . . . 13.26 110.096 177.91 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' C' C ' 14' ' ' LEU . . . . . . . . . . . . . 17.3 mt -98.78 143.94 27.27 Favored Pre-proline 0 CA--C 1.533 0.326 0 CA-C-O 118.987 -0.53 . . . . 13.07 110.336 -178.215 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' C' C ' 15' ' ' PRO . . . . . . . . . . . . . 23.2 Cg_exo -64.49 161.09 36.49 Favored 'Trans proline' 0 N--CA 1.498 1.754 0 C-N-CA 121.36 1.373 . . . . 15.43 111.733 176.333 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' C' C ' 16' ' ' PRO . . . . . . . . . . . . . 35.7 Cg_exo -59.12 -35.32 98.18 Favored 'Trans proline' 0 N--CA 1.498 1.748 0 C-N-CA 121.508 1.472 . . . . 15.95 112.979 -178.545 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' C' C ' 17' ' ' ASP . . . . . . . . . . . . . 11.6 p-10 -83.3 -0.71 50.9 Favored 'General case' 0 CA--C 1.537 0.452 0 N-CA-C 113.35 0.87 . . . . 17.37 113.35 -177.397 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' C' C ' 18' ' ' PHE . . . . . . . . . . . . . 29.2 t80 -58.34 -44.26 88.65 Favored 'General case' 0 C--N 1.334 -0.107 0 O-C-N 121.972 -0.455 . . . . 14.54 110.082 -177.343 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' C' C ' 19' ' ' VAL . . . . . . . . . . . . . 49.7 t -57.14 -43.96 82.47 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.288 0 CA-C-N 116.132 -0.485 . . . . 15.03 110.423 -177.737 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' C' C ' 20' ' ' ASP . . . . . . . . . . . . . 2.0 m-20 -60.07 -43.31 95.54 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.551 -0.295 . . . . 17.45 111.029 -177.653 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' C' C ' 21' ' ' VAL . . . . . . . . . . . . . 46.4 t -63.84 -45.49 96.94 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.289 0 C-N-CA 120.707 -0.397 . . . . 17.27 110.545 -176.94 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' C' C ' 22' ' ' ILE . . . . . 0.599 HG22 HD12 ' C' ' 26' ' ' LEU . 50.6 mm -55.9 -48.58 78.25 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.226 0 C-N-CA 121.038 -0.265 . . . . 16.84 110.71 179.014 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' C' C ' 23' ' ' ARG . . . . . . . . . . . . . 49.3 ttp180 -54.84 -45.76 74.55 Favored 'General case' 0 C--N 1.331 -0.234 0 C-N-CA 120.92 -0.312 . . . . 19.12 111.347 -178.245 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' C' C ' 24' ' ' ILE . . . . . . . . . . . . . 75.5 mt -58.94 -45.33 92.03 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.253 0 C-N-CA 121.013 -0.275 . . . . 20.12 111.073 -178.696 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' C' C ' 25' ' ' LYS . . . . . . . . . . . . . 53.6 mttm -65.81 -38.1 88.04 Favored 'General case' 0 C--N 1.328 -0.349 0 N-CA-C 112.418 0.525 . . . . 20.06 112.418 -178.325 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' C' C ' 26' ' ' LEU . . . . . 0.599 HD12 HG22 ' C' ' 22' ' ' ILE . 62.8 mt -78.51 -39.82 36.99 Favored 'General case' 0 C--N 1.33 -0.25 0 N-CA-C 113.697 0.999 . . . . 20.37 113.697 -170.443 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' C' C ' 27' ' ' GLN . . . . . . . . . . . . . 18.5 pt20 -47.39 138.66 7.29 Favored 'General case' 0 N--CA 1.469 0.478 0 N-CA-C 112.827 0.677 . . . . 21.9 112.827 -174.772 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' C' C ' 28' ' ' GLY . . . . . . . . . . . . . . . 98.62 -22.05 42.86 Favored Glycine 0 CA--C 1.534 1.234 0 CA-C-N 115.772 -0.649 . . . . 24.11 112.683 -177.737 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' C' C ' 29' ' ' LYS . . . . . . . . . . . . . 63.3 mttp -98.26 155.07 17.37 Favored 'General case' 0 C--N 1.333 -0.129 0 CA-C-N 117.521 0.661 . . . . 22.95 111.02 -179.964 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' C' C ' 30' ' ' THR . . . . . . . . . . . . . 41.7 m -105.73 135.25 47.49 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.165 -0.47 . . . . 24.58 109.826 175.33 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' C' C ' 31' ' ' VAL . . . . . . . . . . . . . 34.9 m -130.56 150.5 34.68 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.289 0 CA-C-O 120.979 0.419 . . . . 21.44 111.171 -177.815 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' C' C ' 32' ' ' ARG . . . . . . . . . . . . . 56.0 ttp180 -131.71 151.0 51.97 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 115.772 -0.649 . . . . 25.8 110.182 177.674 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' C' C ' 33' ' ' THR . . . . . . . . . . . . . 23.5 m -52.92 138.82 29.09 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.423 -0.353 . . . . 20.32 111.436 -177.761 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' C' C ' 34' ' ' GLY . . . . . . . . . . . . . . . 101.25 -17.23 56.08 Favored Glycine 0 CA--C 1.533 1.177 0 CA-C-O 119.695 -0.503 . . . . 19.11 113.276 179.24 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' C' C ' 35' ' ' ASP . . . . . . . . . . . . . 75.1 m-20 -67.0 152.48 45.7 Favored 'General case' 0 N--CA 1.461 0.103 0 CA-C-N 118.046 0.923 . . . . 21.47 111.417 178.984 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' C' C ' 36' ' ' VAL . . . . . . . . . . . . . 44.9 t -121.03 130.98 74.12 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.227 0 CA-C-N 115.969 -0.56 . . . . 19.32 109.99 178.423 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' C' C ' 37' ' ' ILE . . . . . . . . . . . . . 71.9 mt -123.61 140.87 45.83 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.23 0 CA-C-N 116.158 -0.474 . . . . 17.81 109.858 179.972 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' C' C ' 38' ' ' GLY . . . . . . . . . . . . . . . -113.42 128.93 8.58 Favored Glycine 0 CA--C 1.528 0.851 0 N-CA-C 111.272 -0.731 . . . . 18.91 111.272 -179.548 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' C' C ' 39' ' ' ILE . . . . . . . . . . . . . 68.7 mt -124.83 132.37 71.41 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.199 0 N-CA-C 109.911 -0.403 . . . . 17.92 109.911 178.395 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' C' C ' 40' ' ' SER . . . . . 0.52 ' O ' HD13 ' C' ' 41' ' ' ILE . 15.7 t -92.78 117.92 30.53 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-N 116.546 -0.297 . . . . 20.9 111.009 177.093 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' C' C ' 41' ' ' ILE . . . . . 0.52 HD13 ' O ' ' C' ' 40' ' ' SER . 47.4 mm -130.89 128.2 62.36 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.217 0 CA-C-O 120.711 0.291 . . . . 18.73 110.223 178.847 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' C' C ' 42' ' ' LEU . . . . . . . . . . . . . 23.1 mt 57.33 33.53 23.42 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.196 -0.456 . . . . 20.86 111.873 177.985 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' C' C ' 43' ' ' GLY . . . . . . . . . . . . . . . 77.64 -10.1 25.89 Favored Glycine 0 CA--C 1.535 1.311 0 C-N-CA 121.188 -0.529 . . . . 21.69 113.421 177.341 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' C' C ' 44' ' ' LYS . . . . . . . . . . . . . 65.6 tttt -104.87 135.46 46.19 Favored 'General case' 0 C--N 1.332 -0.162 0 CA-C-N 117.938 0.869 . . . . 19.99 110.105 177.58 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' C' C ' 45' ' ' GLU . . . . . . . . . . . . . 84.6 tt0 -83.72 131.14 34.95 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.36 -0.382 . . . . 20.5 110.91 -179.734 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' C' C ' 46' ' ' VAL . . . . . . . . . . . . . 7.3 p -120.76 130.64 74.36 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.229 0 N-CA-C 109.369 -0.604 . . . . 16.54 109.369 175.99 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' C' C ' 47' ' ' LYS . . . . . . . . . . . . . 66.8 mttm -99.26 126.89 45.17 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 115.877 -0.601 . . . . 19.31 110.709 178.949 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' C' C ' 48' ' ' PHE . . . . . . . . . . . . . 85.2 m-85 -111.27 131.96 54.74 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.366 -0.379 . . . . 15.05 110.085 177.921 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' C' C ' 49' ' ' LYS . . . . . . . . . . . . . 78.9 tttt -105.16 136.09 45.3 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.228 -0.442 . . . . 16.18 109.913 178.156 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' C' C ' 50' ' ' VAL . . . . . . . . . . . . . 46.6 t -78.22 107.85 10.81 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.312 0 N-CA-C 109.161 -0.681 . . . . 16.26 109.161 177.174 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' C' C ' 51' ' ' VAL . . . . . . . . . . . . . 48.9 t -70.22 -47.87 64.71 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.304 0 CA-C-N 115.964 -0.562 . . . . 15.45 109.956 -174.298 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' C' C ' 52' ' ' GLN . . . . . . . . . . . . . 48.4 tt0 -168.99 140.1 2.43 Favored 'General case' 0 C--N 1.33 -0.255 0 C-N-CA 120.389 -0.524 . . . . 17.03 111.581 -179.004 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' C' C ' 53' ' ' ALA . . . . . . . . . . . . . . . -109.65 133.3 53.28 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 115.85 -0.614 . . . . 19.6 109.799 174.922 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' C' C ' 54' ' ' TYR . . . . . . . . . . . . . 10.0 t80 -129.03 107.39 18.03 Favored Pre-proline 0 CA--C 1.534 0.35 0 CA-C-O 118.27 -0.871 . . . . 23.17 110.389 -179.942 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' C' C ' 55' ' ' PRO . . . . . . . . . . . . . 72.7 Cg_endo -77.21 170.03 72.59 Favored 'Cis proline' 0 N--CA 1.501 1.932 0 CA-C-N 121.798 1.678 . . . . 23.64 112.558 -6.009 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' C' C ' 56' ' ' SER . . . . . . . . . . . . . 20.0 m -116.59 140.21 26.44 Favored Pre-proline 0 CA--C 1.539 0.524 0 CA-C-O 118.616 -0.707 . . . . 24.73 109.737 174.763 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' C' C ' 57' ' ' PRO . . . . . . . . . . . . . 57.0 Cg_endo -73.36 148.01 91.04 Favored 'Cis proline' 0 N--CA 1.499 1.809 0 CA-C-N 121.621 1.615 . . . . 25.61 111.161 -6.123 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' C' C ' 58' ' ' LEU . . . . . 0.409 HD23 HD12 ' C' ' 4' ' ' LEU . 25.1 tp -107.47 139.3 42.18 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-O 120.986 0.422 . . . . 22.18 110.759 -177.487 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' C' C ' 59' ' ' ARG . . . . . . . . . . . . . 54.3 ttp180 -103.91 119.42 38.89 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 115.543 -0.753 . . . . 26.61 109.016 174.598 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' C' C ' 60' ' ' VAL . . . . . . . . . . . . . 40.9 t -72.58 120.18 20.67 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.286 0 C-N-CA 120.872 -0.331 . . . . 21.45 110.726 -173.092 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' C' C ' 61' ' ' GLU . . . . . . . . . . . . . 94.8 mt-10 -131.03 164.9 24.39 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 115.774 -0.648 . . . . 24.7 109.764 175.979 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' C' C ' 62' ' ' ASP . . . . . . . . . . . . . 39.4 m-20 -53.87 -32.49 53.32 Favored 'General case' 0 C--N 1.328 -0.349 0 C-N-CA 120.982 -0.287 . . . . 22.78 111.763 -179.865 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' C' C ' 63' ' ' ARG . . . . . . . . . . . . . 28.5 ptt180 -78.77 0.23 27.73 Favored 'General case' 0 CA--C 1.537 0.468 0 N-CA-C 113.799 1.037 . . . . 25.71 113.799 -175.445 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' C' C ' 64' ' ' THR . . . . . . . . . . . . . 32.5 m -86.28 136.4 33.17 Favored 'General case' 0 C--N 1.333 -0.148 0 CA-C-N 118.146 0.43 . . . . 20.03 110.797 -177.926 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' C' C ' 65' ' ' LYS . . . . . . . . . . . . . 62.8 mttm -89.67 131.08 35.83 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.166 -0.47 . . . . 19.19 110.192 178.924 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' C' C ' 66' ' ' ILE . . . . . . . . . . . . . 58.2 mt -112.2 130.18 66.35 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.254 0 N-CA-C 109.631 -0.507 . . . . 15.6 109.631 -179.808 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' C' C ' 67' ' ' THR . . . . . . . . . . . . . 26.5 m -124.78 137.34 54.33 Favored 'General case' 0 C--N 1.332 -0.167 0 CA-C-O 121.01 0.433 . . . . 13.36 111.022 -177.307 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' C' C ' 68' ' ' LEU . . . . . . . . . . . . . 53.9 mt -105.02 127.45 52.88 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 115.859 -0.61 . . . . 10.54 110.209 177.806 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' C' C ' 69' ' ' VAL . . . . . . . . . . . . . 44.1 t -102.4 117.25 47.47 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.275 0 CA-C-O 120.836 0.35 . . . . 9.48 110.245 179.434 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' C' C ' 70' ' ' THR . . . . . . . . . . . . . 27.3 p -150.07 161.68 41.89 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.045 -0.525 . . . . 6.72 110.425 178.391 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' C' C ' 71' ' ' HIS . . . . . . . . . . . . . 15.8 t60 -135.81 68.33 65.05 Favored Pre-proline 0 CA--C 1.535 0.396 0 CA-C-N 116.352 -0.386 . . . . 7.9 110.38 177.924 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' C' C ' 72' ' ' PRO . . . . . . . . . . . . . 93.8 Cg_endo -90.89 160.04 4.03 Favored 'Trans proline' 0 N--CA 1.489 1.211 0 C-N-CA 121.936 1.758 . . . . 3.33 112.222 179.049 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' C' C ' 73' ' ' VAL . . . . . . . . . . . . . 33.8 m -111.61 154.59 13.14 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.214 0 CA-C-O 120.87 0.367 . . . . 1.13 110.48 179.322 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' C' C ' 74' ' ' ASP . . . . . 0.408 ' OD2' HD11 ' C' ' 76' ' ' LEU . 6.7 t70 -103.36 128.33 50.48 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 115.978 -0.555 . . . . 0.81 109.778 -179.514 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' C' C ' 75' ' ' VAL . . . . . 0.422 ' C ' HD12 ' C' ' 76' ' ' LEU . 41.0 t -114.63 122.9 69.67 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.209 0 CA-C-O 121.063 0.458 . . . . 0.61 110.745 -176.878 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' C' C ' 76' ' ' LEU . . . . . 0.433 ' N ' HD12 ' C' ' 76' ' ' LEU . 6.8 mp -119.88 139.56 52.2 Favored 'General case' 0 C--N 1.33 -0.277 0 N-CA-C 108.875 -0.787 . . . . 1.07 108.875 173.831 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' C' C ' 77' ' ' GLU . . . . . . . . . . . . . 59.6 tt0 -137.29 136.25 37.86 Favored 'General case' 0 C--N 1.333 -0.14 0 C-N-CA 120.496 -0.482 . . . . 1.18 111.416 -174.237 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' C' C ' 78' ' ' ALA . . . . . 0.516 ' HB2' HD21 ' C' ' 109' ' ' LEU . . . -124.07 137.43 54.57 Favored 'General case' 0 C--N 1.331 -0.199 0 CA-C-N 115.771 -0.65 . . . . 0.56 109.835 177.45 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' C' C ' 79' ' ' LYS . . . . . 0.58 ' O ' HD13 ' C' ' 80' ' ' ILE . 68.1 mttm -79.84 120.27 23.85 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-O 120.976 0.417 . . . . 3.18 110.621 -179.542 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' C' C ' 80' ' ' ILE . . . . . 0.58 HD13 ' O ' ' C' ' 79' ' ' LYS . 43.4 mm -139.11 114.05 8.13 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.311 0 N-CA-C 109.13 -0.693 . . . . 0.53 109.13 -176.95 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' C' C ' 81' ' ' LYS . . . . . . . . . . . . . 41.6 tttp -110.22 130.42 55.55 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-O 120.974 0.416 . . . . 2.98 111.247 -176.362 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' C' C ' 82' ' ' GLY . . . . . . . . . . . . . . . 89.13 42.08 5.69 Favored Glycine 0 CA--C 1.526 0.722 0 CA-C-N 115.857 -0.61 . . . . 0.52 111.692 175.694 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' C' C ' 83' ' ' ILE . . . . . . . . . . . . . 67.7 mt -69.95 138.34 22.26 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.279 0 N-CA-C 109.833 -0.432 . . . . 0.54 109.833 178.54 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' C' C ' 84' ' ' LYS . . . . . . . . . . . . . 35.3 tttp -101.01 -54.03 2.9 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.068 -0.515 . . . . 1.68 110.366 -178.658 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' C' C ' 85' ' ' ASP . . . . . . . . . . . . . 13.3 t70 -151.97 151.33 31.06 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 115.862 -0.608 . . . . 0.76 110.353 -179.7 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' C' C ' 86' ' ' VAL . . . . . . . . . . . . . 44.6 t -131.06 130.43 63.77 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.235 0 CA-C-O 120.93 0.395 . . . . 0.54 110.596 -178.657 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' C' C ' 87' ' ' ILE . . . . . . . . . . . . . 46.1 mm -119.88 127.29 75.88 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.221 0 CA-C-N 115.883 -0.599 . . . . 1.38 109.71 176.297 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' C' C ' 88' ' ' LEU . . . . . . . . . . . . . 14.1 tp -110.02 131.5 55.0 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-O 120.869 0.366 . . . . 1.66 110.969 -178.228 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' C' C ' 89' ' ' ASP . . . . . . . . . . . . . 21.8 t70 -123.42 156.68 35.01 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-N 116.087 -0.506 . . . . 0.95 109.939 178.389 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' C' C ' 90' ' ' GLU . . . . . . . . . . . . . 81.2 tt0 -46.33 -40.17 11.38 Favored 'General case' 0 C--N 1.33 -0.255 0 N-CA-C 113.048 0.758 . . . . 2.43 113.048 -171.738 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' C' C ' 91' ' ' ASN . . . . . . . . . . . . . 6.3 p-10 -132.1 23.03 4.51 Favored 'General case' 0 N--CA 1.468 0.434 0 N-CA-C 112.779 0.659 . . . . 2.22 112.779 -178.546 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' C' C ' 92' ' ' LEU . . . . . . . . . . . . . 15.1 mt -149.26 148.79 29.98 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-O 120.734 0.302 . . . . 1.45 110.262 -176.504 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' C' C ' 93' ' ' ILE . . . . . . . . . . . . . 75.7 mt -125.84 120.23 56.75 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.262 0 N-CA-C 109.41 -0.589 . . . . 0.48 109.41 177.005 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' C' C ' 94' ' ' VAL . . . . . 0.679 HG21 HG21 ' C' ' 125' ' ' VAL . 46.4 t -118.65 124.97 74.01 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.244 0 N-CA-C 109.765 -0.457 . . . . 0.47 109.765 -179.603 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' C' C ' 95' ' ' VAL . . . . . . . . . . . . . 41.6 t -122.02 134.49 65.13 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.328 0 CA-C-N 116.038 -0.528 . . . . 0.41 109.946 -178.226 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' C' C ' 96' ' ' ILE . . . . . . . . . . . . . 62.6 mt -115.85 127.73 73.35 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.341 0 N-CA-C 109.004 -0.739 . . . . 0.46 109.004 178.039 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' C' C ' 97' ' ' THR . . . . . . . . . . . . . 81.4 p -99.56 157.45 16.44 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-O 121.199 0.523 . . . . 0.43 111.1 -178.262 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' C' C ' 98' ' ' GLU . . . . . . . . . . . . . 85.0 tt0 -54.01 -27.82 34.23 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.065 -0.516 . . . . 2.33 112.043 179.771 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' C' C ' 99' ' ' GLU . . . . . . . . . . . . . 94.6 mt-10 -77.49 12.14 1.71 Allowed 'General case' 0 CA--C 1.537 0.458 0 N-CA-C 113.162 0.801 . . . . 2.1 113.162 -177.676 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' C' C ' 100' ' ' ASN . . . . . . . . . . . . . 3.4 m-20 63.57 33.59 13.22 Favored 'General case' 0 CA--C 1.532 0.262 0 CA-C-O 120.904 0.383 . . . . 0.51 111.565 179.174 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' C' C ' 101' ' ' GLU . . . . . . . . . . . . . 85.1 tt0 -107.71 144.74 34.4 Favored 'General case' 0 C--N 1.333 -0.15 0 N-CA-C 109.715 -0.476 . . . . 0.45 109.715 172.833 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' C' C ' 102' ' ' VAL . . . . . . . . . . . . . 45.7 t -115.35 127.08 73.05 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.317 0 CA-C-N 116.255 -0.429 . . . . 0.41 109.851 -177.876 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' C' C ' 103' ' ' LEU . . . . . . . . . . . . . 27.0 mt -117.78 131.41 56.59 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-N 115.883 -0.599 . . . . 0.59 110.407 178.526 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' C' C ' 104' ' ' ILE . . . . . . . . . . . . . 68.9 mt -117.34 119.79 62.92 Favored 'Isoleucine or valine' 0 C--O 1.233 0.219 0 N-CA-C 110.132 -0.321 . . . . 0.45 110.132 178.308 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' C' C ' 105' ' ' PHE . . . . . . . . . . . . . 95.8 m-85 -120.65 166.9 13.04 Favored 'General case' 0 C--N 1.332 -0.158 0 O-C-N 124.136 0.897 . . . . 0.46 110.038 179.676 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' C' C ' 106' ' ' ASN . . . . . . . . . . . . . 35.5 p30 -101.11 -171.94 2.08 Favored 'General case' 0 C--N 1.33 -0.265 0 N-CA-C 110.17 -0.307 . . . . 0.56 110.17 173.073 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' C' C ' 107' ' ' GLN . . . . . . . . . . . . . 63.0 tt0 -60.56 -30.29 69.7 Favored 'General case' 0 CA--C 1.531 0.236 0 N-CA-C 111.803 0.298 . . . . 1.49 111.803 179.633 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' C' C ' 108' ' ' ASN . . . . . . . . . . . . . 3.6 t-20 -82.94 9.28 10.39 Favored 'General case' 0 CA--C 1.536 0.426 0 N-CA-C 112.976 0.732 . . . . 1.39 112.976 -178.375 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' C' C ' 109' ' ' LEU . . . . . 0.516 HD21 ' HB2' ' C' ' 78' ' ' ALA . 7.6 tp 61.24 32.99 19.33 Favored 'General case' 0 CA--C 1.53 0.193 0 O-C-N 122.228 -0.295 . . . . 0.96 111.741 179.14 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' C' C ' 110' ' ' GLU . . . . . . . . . . . . . 94.9 mt-10 -100.89 142.3 32.55 Favored 'General case' 0 C--N 1.33 -0.265 0 N-CA-C 109.319 -0.623 . . . . 1.9 109.319 174.724 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' C' C ' 111' ' ' GLU . . . . . . . . . . . . . 60.6 tt0 -85.05 121.99 28.61 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-O 120.893 0.378 . . . . 1.86 110.807 -175.14 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' C' C ' 112' ' ' LEU . . . . . . . . . . . . . 60.3 mt -99.71 -46.13 5.52 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 115.94 -0.573 . . . . 0.63 110.877 179.256 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' C' C ' 113' ' ' TYR . . . . . . . . . . . . . 85.5 t80 -137.15 140.0 41.55 Favored 'General case' 0 N--CA 1.464 0.242 0 CA-C-O 121.078 0.466 . . . . 0.53 111.59 -178.1 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' C' C ' 114' ' ' ARG . . . . . . . . . . . . . 41.1 ttm180 -130.5 124.57 32.24 Favored 'General case' 0 C--N 1.331 -0.23 0 CA-C-N 115.361 -0.836 . . . . 2.7 109.862 175.993 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' C' C ' 115' ' ' GLY . . . . . . . . . . . . . . . -147.18 159.02 27.91 Favored Glycine 0 CA--C 1.523 0.572 0 N-CA-C 110.56 -1.016 . . . . 0.45 110.56 178.474 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' C' C ' 116' ' ' LYS . . . . . . . . . . . . . 77.3 tttt -137.49 133.12 34.25 Favored 'General case' 0 C--N 1.329 -0.305 0 N-CA-C 109.996 -0.372 . . . . 1.58 109.996 179.385 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' C' C ' 117' ' ' PHE . . . . . . . . . . . . . 35.6 m-85 -134.18 115.75 14.56 Favored 'General case' 0 C--N 1.331 -0.223 0 CA-C-N 116.386 -0.37 . . . . 0.56 110.226 -174.82 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' C' C ' 118' ' ' GLU . . . . . . . . . . . . . 95.2 mt-10 -54.64 -40.88 69.43 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.472 -0.331 . . . . 2.11 111.498 -175.623 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' C' C ' 119' ' ' ASN . . . . . . . . . . . . . 30.6 m120 -100.53 31.16 3.58 Favored 'General case' 0 C--N 1.33 -0.244 0 N-CA-C 112.266 0.469 . . . . 1.52 112.266 -173.187 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' C' C ' 120' ' ' LEU . . . . . . . . . . . . . 14.2 tp -53.79 120.03 5.73 Favored 'General case' 0 N--CA 1.464 0.267 0 CA-C-O 120.676 0.274 . . . . 0.49 110.907 178.048 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' C' C ' 121' ' ' ASN . . . . . . . . . . . . . 19.9 m120 -113.92 -44.15 3.19 Favored 'General case' 0 C--N 1.331 -0.2 0 CA-C-N 116.441 -0.345 . . . . 1.98 110.992 -177.699 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' C' C ' 122' ' ' LYS . . . . . . . . . . . . . 97.9 mttt -146.44 150.31 35.38 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-O 121.059 0.457 . . . . 1.85 111.644 -178.022 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' C' C ' 123' ' ' VAL . . . . . . . . . . . . . 44.7 t -129.78 127.58 64.31 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.303 0 N-CA-C 109.383 -0.599 . . . . 0.62 109.383 174.536 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' C' C ' 124' ' ' LEU . . . . . . . . . . . . . 71.0 mt -117.18 132.34 56.67 Favored 'General case' 0 N--CA 1.463 0.223 0 CA-C-N 116.547 -0.297 . . . . 1.7 110.663 -178.066 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' C' C ' 125' ' ' VAL . . . . . 0.679 HG21 HG21 ' C' ' 94' ' ' VAL . 43.7 t -132.63 121.8 45.81 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.206 0 CA-C-N 116.234 -0.439 . . . . 1.65 110.283 -179.411 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' C' C ' 126' ' ' ARG . . . . . . . . . . . . . 80.5 mtt85 -152.69 137.31 16.89 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.287 -0.415 . . . . 3.27 110.152 176.647 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' C' C ' 127' ' ' ASN . . . . . . . . . . . . . 20.1 m120 54.82 -154.44 0.28 Allowed 'General case' 0 CA--C 1.539 0.53 0 N-CA-C 110.102 -0.332 . . . . 2.28 110.102 178.562 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' C' C ' 128' ' ' ASP . . . . . . . . . . . . . 4.2 p30 -82.9 19.71 1.32 Allowed 'General case' 0 CA--C 1.534 0.332 0 N-CA-C 112.483 0.549 . . . . 1.11 112.483 178.543 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' C' C ' 129' ' ' LEU . . . . . . . . . . . . . 15.5 tp -122.75 137.09 55.02 Favored 'General case' 0 C--O 1.233 0.193 0 O-C-N 122.019 -0.426 . . . . 2.08 110.381 179.935 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' C' C ' 130' ' ' VAL . . . . . 0.553 HG23 ' HB ' ' C' ' 141' ' ' ILE . 32.1 m -132.8 143.68 38.89 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.215 0 CA-C-O 120.957 0.408 . . . . 1.44 110.379 178.527 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' C' C ' 131' ' ' VAL . . . . . 0.503 HG12 HD22 ' D' ' 88' ' ' LEU . 14.1 p -136.05 141.15 42.48 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.283 0 CA-C-N 116.349 -0.387 . . . . 0.91 110.683 179.9 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' C' C ' 132' ' ' ILE . . . . . . . . . . . . . 74.1 mt -114.64 131.84 65.57 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.354 0 N-CA-C 109.196 -0.668 . . . . 0.49 109.196 178.751 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' C' C ' 133' ' ' ILE . . . . . . . . . . . . . 42.7 mm -117.37 120.14 63.98 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.232 0 CA-C-O 120.946 0.403 . . . . 0.47 110.901 -175.659 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' C' C ' 134' ' ' ASP . . . . . . . . . . . . . 7.2 p-10 -130.79 144.29 51.34 Favored 'General case' 0 C--N 1.33 -0.257 0 N-CA-C 109.072 -0.714 . . . . 0.53 109.072 173.689 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' C' C ' 135' ' ' GLU . . . . . . . . . . . . . 84.4 tt0 -49.78 -25.35 2.97 Favored 'General case' 0 C--N 1.327 -0.379 0 N-CA-C 112.852 0.686 . . . . 2.0 112.852 -170.559 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' C' C ' 136' ' ' GLN . . . . . . . . . . . . . 94.7 mt-30 -92.78 -36.97 12.59 Favored 'General case' 0 C--N 1.332 -0.183 0 N-CA-C 112.105 0.409 . . . . 2.24 112.105 -177.499 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' C' C ' 137' ' ' LYS . . . . . . . . . . . . . 41.6 mttp -136.83 151.53 49.24 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-O 121.03 0.443 . . . . 1.48 111.1 -168.453 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' C' C ' 138' ' ' LEU . . . . . . . . . . . . . 5.2 tt -118.91 121.47 40.05 Favored 'General case' 0 C--N 1.332 -0.19 0 N-CA-C 109.047 -0.723 . . . . 0.81 109.047 173.133 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' C' C ' 139' ' ' THR . . . . . 0.454 ' O ' HG23 ' C' ' 131' ' ' VAL . 33.1 m -114.19 127.38 55.87 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-O 120.711 0.291 . . . . 0.54 111.066 -176.565 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' C' C ' 140' ' ' LEU . . . . . . . . . . . . . 21.6 tp -111.03 123.84 50.98 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 115.599 -0.728 . . . . 1.11 109.158 179.922 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' C' C ' 141' ' ' ILE . . . . . 0.553 ' HB ' HG23 ' C' ' 130' ' ' VAL . 19.5 mt -122.19 121.61 64.38 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.298 0 CA-C-O 120.981 0.419 . . . . 0.65 110.073 -173.906 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' C' C ' 142' ' ' ARG . . . . . . . . . . . . . 59.3 mtp180 -100.88 122.29 43.19 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 115.419 -0.809 . . . . 4.0 110.001 178.762 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' C' C ' 143' ' ' THR . . . . . . . . . . . . . 37.4 p . . . . . 0 C--O 1.219 -0.505 0 CA-C-O 117.871 -1.061 . . . . 1.67 110.599 -179.28 . . . . . . . . 0 0 . 1 . 001 nuclear build full ' D' D ' -3' ' ' GLU . . . . . . . . . . . . . 95.2 mt-10 . . . . . 0 N--CA 1.49 1.544 0 N-CA-C 109.439 -0.578 . . . . 32.38 109.439 . . . . . . . . . 0 0 . 1 . 001 nuclear build full ' D' D ' -2' ' ' GLY . . . . . . . . . . . . . . . -111.62 128.36 8.59 Favored Glycine 0 CA--C 1.526 0.721 0 N-CA-C 111.015 -0.834 . . . . 30.2 111.015 179.987 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' D' D ' -1' ' ' VAL . . . . . . . . . . . . . 44.2 t -97.2 134.12 36.22 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.323 0 CA-C-O 120.767 0.318 . . . . 27.44 110.148 179.313 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' D' D ' 0' ' ' ILE . . . . . . . . . . . . . 68.7 mt -115.45 143.98 24.08 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.26 0 CA-C-N 116.18 -0.464 . . . . 25.56 109.959 -179.462 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' D' D ' 1' ' ' MET . . . . . . . . . . . . . 25.6 ptm -143.16 149.93 38.72 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.196 -0.456 . . . . 22.18 110.903 -179.53 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' D' D ' 2' ' ' SER . . . . . . . . . . . . . 3.6 p -125.02 134.76 52.44 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 116.153 -0.476 . . . . 19.86 110.477 178.286 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' D' D ' 3' ' ' GLU . . . . . . . . . . . . . 84.7 tt0 -139.71 139.57 36.6 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.137 -0.483 . . . . 17.06 110.807 -179.434 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' D' D ' 4' ' ' LEU . . . . . 0.426 HD21 HD21 ' D' ' 6' ' ' LEU . 15.3 tp -124.42 126.09 45.36 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 115.912 -0.585 . . . . 14.92 110.117 177.695 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' D' D ' 5' ' ' LYS . . . . . . . . . . . . . 46.5 mttm -102.49 120.48 40.59 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.328 -0.396 . . . . 12.31 110.389 177.795 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' D' D ' 6' ' ' LEU . . . . . 0.426 HD21 HD21 ' D' ' 4' ' ' LEU . 78.4 mt -117.63 149.25 41.01 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 115.564 -0.744 . . . . 12.66 110.663 -179.145 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' D' D ' 7' ' ' LYS . . . . . . . . . . . . . 77.5 tttt -136.77 135.68 20.54 Favored Pre-proline 0 CA--C 1.534 0.359 0 CA-C-O 118.764 -0.636 . . . . 10.07 109.792 176.266 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' D' D ' 8' ' ' PRO . . . . . . . . . . . . . 86.9 Cg_endo -87.83 143.91 6.17 Favored 'Trans proline' 0 N--CA 1.492 1.395 0 C-N-CA 121.546 1.497 . . . . 10.15 111.635 178.43 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' D' D ' 9' ' ' LEU . . . . . . . . . . . . . 21.7 mt -79.86 -46.99 1.46 Allowed Pre-proline 0 CA--C 1.533 0.305 0 CA-C-O 118.746 -0.645 . . . . 13.43 111.91 -178.884 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' D' D ' 10' ' ' PRO . . . . . . . . . . . . . 92.3 Cg_endo -80.69 148.9 18.14 Favored 'Trans proline' 0 N--CA 1.495 1.603 0 C-N-CA 121.194 1.263 . . . . 13.55 111.646 174.127 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' D' D ' 11' ' ' LYS . . . . . . . . . . . . . 96.0 mttt -88.71 102.1 14.65 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-O 120.886 0.374 . . . . 13.05 110.767 179.961 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' D' D ' 12' ' ' VAL . . . . . . . . . . . . . 12.2 p -141.03 143.85 27.61 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 CA-C-N 116.108 -0.496 . . . . 14.73 110.391 179.145 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' D' D ' 13' ' ' GLU . . . . . . . . . . . . . 45.9 mt-10 -79.72 124.65 28.78 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.408 -0.36 . . . . 15.06 110.38 179.245 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' D' D ' 14' ' ' LEU . . . . . . . . . . . . . 22.7 mt -99.52 147.78 33.81 Favored Pre-proline 0 CA--C 1.534 0.332 0 CA-C-O 119.185 -0.436 . . . . 15.04 110.534 -178.139 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' D' D ' 15' ' ' PRO . . . . . . . . . . . . . 23.8 Cg_exo -64.1 160.82 36.28 Favored 'Trans proline' 0 N--CA 1.499 1.821 0 C-N-CA 121.298 1.332 . . . . 17.83 111.816 175.018 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' D' D ' 16' ' ' PRO . . . . . . . . . . . . . 28.1 Cg_exo -60.02 -36.76 88.53 Favored 'Trans proline' 0 N--CA 1.496 1.64 0 C-N-CA 121.486 1.457 . . . . 18.35 112.795 -178.408 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' D' D ' 17' ' ' ASP . . . . . . . . . . . . . 2.9 p30 -88.27 9.22 23.85 Favored 'General case' 0 CA--C 1.535 0.402 0 N-CA-C 113.189 0.811 . . . . 20.13 113.189 -177.775 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' D' D ' 18' ' ' PHE . . . . . . . . . . . . . 61.8 t80 -57.53 -42.44 82.87 Favored 'General case' 0 N--CA 1.46 0.042 0 O-C-N 121.983 -0.448 . . . . 16.67 110.172 -179.443 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' D' D ' 19' ' ' VAL . . . . . . . . . . . . . 48.0 t -56.91 -42.53 78.67 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.321 0 CA-C-N 116.264 -0.426 . . . . 16.27 110.428 -179.353 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' D' D ' 20' ' ' ASP . . . . . . . . . . . . . 18.4 t70 -59.98 -42.16 93.57 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-O 120.8 0.333 . . . . 19.6 110.89 -178.12 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' D' D ' 21' ' ' VAL . . . . . . . . . . . . . 46.2 t -64.26 -46.61 92.82 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.269 0 C-N-CA 120.793 -0.363 . . . . 19.26 110.452 -177.938 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' D' D ' 22' ' ' ILE . . . . . 0.503 HG22 HD12 ' D' ' 26' ' ' LEU . 49.0 mm -56.23 -44.41 79.25 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.211 0 C-N-CA 120.962 -0.295 . . . . 17.48 110.565 178.651 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' D' D ' 23' ' ' ARG . . . . . . . . . . . . . 55.9 ttp180 -54.15 -49.38 69.39 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-O 120.673 0.273 . . . . 20.79 111.444 -179.689 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' D' D ' 24' ' ' ILE . . . . . . . . . . . . . 76.9 mt -58.88 -43.01 87.45 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.308 0 CA-C-N 116.48 -0.327 . . . . 21.9 111.135 -177.474 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' D' D ' 25' ' ' LYS . . . . . . . . . . . . . 63.4 mttm -66.39 -43.25 86.36 Favored 'General case' 0 C--N 1.328 -0.355 0 N-CA-C 112.619 0.6 . . . . 20.64 112.619 -178.438 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' D' D ' 26' ' ' LEU . . . . . 0.503 HD12 HG22 ' D' ' 22' ' ' ILE . 92.8 mt -78.71 -37.54 41.29 Favored 'General case' 0 C--N 1.331 -0.228 0 N-CA-C 113.55 0.944 . . . . 19.88 113.55 -170.385 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' D' D ' 27' ' ' GLN . . . . . . . . . . . . . 15.1 pt20 -46.75 138.99 5.67 Favored 'General case' 0 N--CA 1.469 0.488 0 N-CA-C 112.765 0.654 . . . . 22.91 112.765 -175.305 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' D' D ' 28' ' ' GLY . . . . . . . . . . . . . . . 100.3 -23.42 35.94 Favored Glycine 0 CA--C 1.534 1.263 0 CA-C-N 115.606 -0.725 . . . . 23.12 112.393 -176.572 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' D' D ' 29' ' ' LYS . . . . . . . . . . . . . 68.8 mttm -98.44 155.11 17.41 Favored 'General case' 0 C--O 1.233 0.2 0 CA-C-N 117.441 0.621 . . . . 21.77 111.253 179.436 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' D' D ' 30' ' ' THR . . . . . . . . . . . . . 40.8 m -102.98 137.88 40.58 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.034 -0.53 . . . . 22.51 109.938 175.362 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' D' D ' 31' ' ' VAL . . . . . . . . . . . . . 34.8 m -128.19 154.38 38.79 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.249 0 CA-C-O 120.911 0.386 . . . . 19.36 110.854 -178.708 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' D' D ' 32' ' ' ARG . . . . . . . . . . . . . 43.6 mtm180 -133.46 151.53 51.8 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 115.742 -0.663 . . . . 23.0 110.307 177.908 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' D' D ' 33' ' ' THR . . . . . . . . . . . . . 31.9 m -53.2 137.77 33.47 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.498 -0.319 . . . . 17.54 111.458 -178.155 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' D' D ' 34' ' ' GLY . . . . . . . . . . . . . . . 98.91 -17.02 58.8 Favored Glycine 0 CA--C 1.532 1.147 0 CA-C-O 119.65 -0.528 . . . . 16.71 113.365 177.927 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' D' D ' 35' ' ' ASP . . . . . . . . . . . . . 75.2 m-20 -65.72 149.69 49.72 Favored 'General case' 0 C--O 1.231 0.108 0 CA-C-N 118.012 0.906 . . . . 19.02 111.198 179.96 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' D' D ' 36' ' ' VAL . . . . . . . . . . . . . 46.3 t -118.66 130.11 73.96 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.251 0 CA-C-N 115.847 -0.615 . . . . 17.79 109.682 177.304 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' D' D ' 37' ' ' ILE . . . . . . . . . . . . . 64.1 mt -115.55 136.98 50.62 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.298 0 CA-C-N 116.11 -0.496 . . . . 17.21 109.764 179.912 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' D' D ' 38' ' ' GLY . . . . . . . . . . . . . . . -109.53 127.61 8.55 Favored Glycine 0 CA--C 1.524 0.635 0 N-CA-C 110.73 -0.948 . . . . 18.84 110.73 178.945 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' D' D ' 39' ' ' ILE . . . . . . . . . . . . . 72.2 mt -121.19 130.73 74.37 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.206 0 N-CA-C 109.911 -0.403 . . . . 18.53 109.911 179.222 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' D' D ' 40' ' ' SER . . . . . . . . . . . . . 78.0 p -92.24 119.18 31.6 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.233 -0.44 . . . . 21.82 110.74 176.506 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' D' D ' 41' ' ' ILE . . . . . . . . . . . . . 72.6 mt -129.59 116.91 40.53 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.244 0 N-CA-C 109.954 -0.387 . . . . 20.47 109.954 177.938 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' D' D ' 42' ' ' LEU . . . . . . . . . . . . . 69.8 mt 58.08 33.23 22.96 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.269 -0.423 . . . . 22.9 111.698 179.173 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' D' D ' 43' ' ' GLY . . . . . . . . . . . . . . . 80.9 -10.13 48.82 Favored Glycine 0 CA--C 1.535 1.293 0 C-N-CA 121.188 -0.53 . . . . 23.16 113.433 177.303 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' D' D ' 44' ' ' LYS . . . . . . . . . . . . . 94.6 mttt -99.05 137.33 37.73 Favored 'General case' 0 C--N 1.332 -0.173 0 CA-C-N 117.966 0.883 . . . . 21.23 110.285 178.622 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' D' D ' 45' ' ' GLU . . . . . . . . . . . . . 84.7 tt0 -85.21 130.61 34.57 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.257 -0.429 . . . . 20.64 111.474 -178.686 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' D' D ' 46' ' ' VAL . . . . . . . . . . . . . 7.4 p -125.37 126.2 70.26 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.22 0 N-CA-C 109.275 -0.639 . . . . 16.96 109.275 173.333 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' D' D ' 47' ' ' LYS . . . . . . . . . . . . . 9.7 mtmp? -101.46 131.27 47.67 Favored 'General case' 0 C--N 1.331 -0.23 0 CA-C-N 116.165 -0.47 . . . . 18.29 111.688 179.204 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' D' D ' 48' ' ' PHE . . . . . . . . . . . . . 92.2 m-85 -114.58 133.63 55.67 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 115.893 -0.594 . . . . 13.84 109.985 176.32 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' D' D ' 49' ' ' LYS . . . . . . . . . . . . . 60.7 tttm -105.33 137.61 42.86 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.743 -0.208 . . . . 13.73 110.559 179.065 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' D' D ' 50' ' ' VAL . . . . . . . . . . . . . 44.2 t -81.04 108.35 14.28 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.268 0 N-CA-C 109.275 -0.639 . . . . 14.42 109.275 175.862 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' D' D ' 51' ' ' VAL . . . . . . . . . . . . . 48.4 t -73.23 -47.35 47.23 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.351 0 CA-C-N 116.224 -0.443 . . . . 12.84 110.107 -173.821 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' D' D ' 52' ' ' GLN . . . . . . . . . . . . . 48.4 tt0 -162.54 136.82 6.5 Favored 'General case' 0 C--N 1.331 -0.234 0 C-N-CA 120.354 -0.538 . . . . 14.45 111.648 -178.378 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' D' D ' 53' ' ' ALA . . . . . . . . . . . . . . . -110.06 131.3 55.18 Favored 'General case' 0 C--N 1.332 -0.19 0 CA-C-N 115.852 -0.613 . . . . 16.93 109.891 175.482 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' D' D ' 54' ' ' TYR . . . . . . . . . . . . . 8.9 t80 -129.02 108.34 18.12 Favored Pre-proline 0 CA--C 1.534 0.361 0 CA-C-O 118.333 -0.842 . . . . 20.68 110.47 179.8 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' D' D ' 55' ' ' PRO . . . . . . . . . . . . . 74.2 Cg_endo -77.14 170.05 72.6 Favored 'Cis proline' 0 N--CA 1.5 1.858 0 CA-C-N 121.831 1.689 . . . . 21.15 112.481 -5.288 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' D' D ' 56' ' ' SER . . . . . . . . . . . . . 50.1 m -117.29 133.62 23.17 Favored Pre-proline 0 CA--C 1.538 0.515 0 CA-C-O 118.511 -0.757 . . . . 21.68 109.714 175.307 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' D' D ' 57' ' ' PRO . . . . . . . . . . . . . 38.0 Cg_endo -68.09 165.15 72.06 Favored 'Cis proline' 0 N--CA 1.496 1.666 0 CA-C-N 121.828 1.689 . . . . 22.71 111.217 -3.535 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' D' D ' 58' ' ' LEU . . . . . . . . . . . . . 25.0 tp -130.2 136.29 49.08 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-O 120.937 0.399 . . . . 19.85 110.891 -179.001 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' D' D ' 59' ' ' ARG . . . . . . . . . . . . . 55.8 ttp180 -101.73 124.39 47.3 Favored 'General case' 0 C--N 1.327 -0.377 0 N-CA-C 109.08 -0.711 . . . . 25.3 109.08 174.383 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' D' D ' 60' ' ' VAL . . . . . . . . . . . . . 41.3 t -82.12 122.49 36.96 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.304 0 C-N-CA 120.677 -0.409 . . . . 20.84 110.491 -174.538 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' D' D ' 61' ' ' GLU . . . . . . . . . . . . . 45.2 mt-10 -131.13 169.72 15.51 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 115.972 -0.558 . . . . 23.88 109.74 177.415 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' D' D ' 62' ' ' ASP . . . . . . . . . . . . . 6.9 p-10 -55.3 -32.32 62.34 Favored 'General case' 0 C--N 1.328 -0.366 0 N-CA-C 111.743 0.275 . . . . 23.34 111.743 -179.123 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' D' D ' 63' ' ' ARG . . . . . . . . . . . . . 40.2 ptt180 -77.63 -8.44 57.88 Favored 'General case' 0 CA--C 1.537 0.451 0 N-CA-C 113.669 0.988 . . . . 25.78 113.669 -176.415 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' D' D ' 64' ' ' THR . . . . . . . . . . . . . 36.9 m -77.29 136.68 38.51 Favored 'General case' 0 C--N 1.333 -0.116 0 CA-C-O 120.902 0.382 . . . . 19.75 110.73 -176.149 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' D' D ' 65' ' ' LYS . . . . . . . . . . . . . 61.2 mttm -89.51 127.6 35.88 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.026 -0.534 . . . . 18.76 110.031 178.043 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' D' D ' 66' ' ' ILE . . . . . . . . . . . . . 62.5 mt -113.31 127.78 70.44 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.284 0 N-CA-C 109.66 -0.496 . . . . 15.71 109.66 179.376 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' D' D ' 67' ' ' THR . . . . . . . . . . . . . 18.3 m -124.37 141.74 51.83 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.226 -0.443 . . . . 12.72 110.825 -176.925 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' D' D ' 68' ' ' LEU . . . . . . . . . . . . . 16.6 tp -102.08 130.16 48.6 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 115.938 -0.574 . . . . 10.78 110.038 178.545 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' D' D ' 69' ' ' VAL . . . . . . . . . . . . . 40.9 t -96.3 136.51 26.93 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.317 0 CA-C-N 116.321 -0.399 . . . . 7.93 110.507 -177.822 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' D' D ' 70' ' ' THR . . . . . . . . . . . . . 29.6 p -139.23 -47.89 0.48 Allowed 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 115.93 -0.577 . . . . 7.09 110.558 179.299 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' D' D ' 71' ' ' HIS . . . . . . . . . . . . . 32.3 m-70 -127.05 99.08 29.15 Favored Pre-proline 0 CA--C 1.533 0.305 0 CA-C-N 116.044 -0.526 . . . . 7.29 110.324 -178.833 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' D' D ' 72' ' ' PRO . . . . . . . . . . . . . 19.3 Cg_exo -64.93 -29.93 57.7 Favored 'Trans proline' 0 N--CA 1.497 1.691 0 C-N-CA 121.277 1.318 . . . . 2.9 112.328 -177.689 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' D' D ' 73' ' ' VAL . . . . . . . . . . . . . 34.9 m -136.38 158.56 38.05 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.232 0 CA-C-O 120.841 0.353 . . . . 1.1 110.578 177.377 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' D' D ' 74' ' ' ASP . . . . . . . . . . . . . 21.5 t70 -100.57 118.49 36.85 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.088 -0.506 . . . . 0.93 109.947 179.648 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' D' D ' 75' ' ' VAL . . . . . . . . . . . . . 43.9 t -113.97 122.38 67.97 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.213 0 CA-C-O 121.118 0.485 . . . . 0.71 110.555 -177.654 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' D' D ' 76' ' ' LEU . . . . . . . . . . . . . 14.1 mt -125.92 138.26 53.76 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 115.52 -0.764 . . . . 1.2 109.059 175.77 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' D' D ' 77' ' ' GLU . . . . . . . . . . . . . 73.3 tt0 -136.43 141.93 43.62 Favored 'General case' 0 C--N 1.332 -0.17 0 CA-C-O 121.118 0.485 . . . . 1.29 111.591 -173.762 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' D' D ' 78' ' ' ALA . . . . . . . . . . . . . . . -127.88 145.12 51.05 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 115.52 -0.764 . . . . 0.68 109.94 177.476 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' D' D ' 79' ' ' LYS . . . . . 0.563 ' O ' HD13 ' D' ' 80' ' ' ILE . 45.8 mttm -81.48 123.86 28.97 Favored 'General case' 0 C--N 1.331 -0.234 0 C-N-CA 120.753 -0.379 . . . . 3.12 110.688 178.913 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' D' D ' 80' ' ' ILE . . . . . 0.563 HD13 ' O ' ' D' ' 79' ' ' LYS . 42.8 mm -138.46 113.7 9.23 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.343 0 N-CA-C 109.212 -0.662 . . . . 0.59 109.212 -179.15 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' D' D ' 81' ' ' LYS . . . . . . . . . . . . . 58.6 mttp -102.04 121.94 43.14 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-O 120.784 0.326 . . . . 3.19 111.243 -176.536 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' D' D ' 82' ' ' GLY . . . . . . . . . . . . . . . 89.07 42.14 5.69 Favored Glycine 0 CA--C 1.525 0.702 0 C-N-CA 120.935 -0.65 . . . . 0.48 112.006 173.702 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' D' D ' 83' ' ' ILE . . . . . . . . . . . . . 76.3 mt -65.69 136.93 25.88 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.257 0 N-CA-C 109.765 -0.457 . . . . 0.52 109.765 177.113 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' D' D ' 84' ' ' LYS . . . . . . . . . . . . . 55.2 tttp -98.66 -53.63 3.25 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.21 -0.45 . . . . 1.6 110.275 -178.757 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' D' D ' 85' ' ' ASP . . . . . . . . . . . . . 20.9 t0 -152.86 149.72 28.57 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 115.755 -0.657 . . . . 0.83 110.28 -179.756 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' D' D ' 86' ' ' VAL . . . . . . . . . . . . . 40.5 t -133.79 131.16 56.42 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.286 0 CA-C-O 120.973 0.416 . . . . 0.47 110.56 -179.702 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' D' D ' 87' ' ' ILE . . . . . . . . . . . . . 45.3 mm -119.85 129.54 75.27 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.243 0 CA-C-N 115.795 -0.639 . . . . 1.31 109.695 176.857 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' D' D ' 88' ' ' LEU . . . . . 0.503 HD22 HG12 ' C' ' 131' ' ' VAL . 17.0 tp -112.6 135.75 52.96 Favored 'General case' 0 C--N 1.331 -0.203 0 CA-C-O 121.083 0.468 . . . . 1.72 111.289 -177.354 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' D' D ' 89' ' ' ASP . . . . . . . . . . . . . 20.6 t70 -128.62 155.11 45.48 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 115.545 -0.752 . . . . 0.88 109.253 174.587 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' D' D ' 90' ' ' GLU . . . . . . . . . . . . . 82.6 tt0 -46.97 -39.95 13.43 Favored 'General case' 0 C--N 1.33 -0.243 0 N-CA-C 112.964 0.727 . . . . 2.54 112.964 -171.887 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' D' D ' 91' ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER -132.07 37.85 3.55 Favored 'General case' 0 N--CA 1.463 0.189 0 CA-C-O 120.836 0.351 . . . . 2.21 111.437 -177.223 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' D' D ' 92' ' ' LEU . . . . . . . . . . . . . 11.7 tp -166.09 140.37 4.43 Favored 'General case' 0 C--N 1.33 -0.246 0 C-N-CA 121.01 -0.276 . . . . 1.41 110.602 -179.038 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' D' D ' 93' ' ' ILE . . . . . . . . . . . . . 71.3 mt -124.14 122.62 64.75 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.188 0 N-CA-C 109.653 -0.499 . . . . 0.47 109.653 178.679 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' D' D ' 94' ' ' VAL . . . . . 0.706 HG21 HG11 ' D' ' 125' ' ' VAL . 42.9 t -120.77 125.07 73.64 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.214 0 N-CA-C 109.901 -0.407 . . . . 0.44 109.901 179.52 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' D' D ' 95' ' ' VAL . . . . . . . . . . . . . 42.9 t -123.88 135.16 64.42 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.25 0 CA-C-N 116.097 -0.502 . . . . 0.38 110.109 -178.448 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' D' D ' 96' ' ' ILE . . . . . . . . . . . . . 58.3 mt -116.59 128.49 73.94 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.28 0 N-CA-C 109.256 -0.646 . . . . 0.51 109.256 178.37 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' D' D ' 97' ' ' THR . . . . . . . . . . . . . 81.2 p -103.7 155.79 18.3 Favored 'General case' 0 C--N 1.331 -0.222 0 CA-C-O 121.356 0.598 . . . . 0.48 111.561 -176.74 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' D' D ' 98' ' ' GLU . . . . . . . . . . . . . 84.8 tt0 -54.0 -27.26 30.6 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 115.836 -0.62 . . . . 2.67 112.191 179.504 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' D' D ' 99' ' ' GLU . . . . . . . . . . . . . 46.0 mp0 -78.93 16.2 0.94 Allowed 'General case' 0 CA--C 1.536 0.406 0 N-CA-C 113.123 0.786 . . . . 2.3 113.123 -177.474 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' D' D ' 100' ' ' ASN . . . . . . . . . . . . . 1.8 m-20 63.59 37.34 10.37 Favored 'General case' 0 CA--C 1.529 0.147 0 CA-C-O 121.007 0.432 . . . . 0.62 110.945 176.757 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' D' D ' 101' ' ' GLU . . . . . . . . . . . . . 84.9 tt0 -116.52 144.69 44.03 Favored 'General case' 0 C--N 1.332 -0.157 0 CA-C-N 116.187 -0.461 . . . . 1.1 109.892 176.88 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' D' D ' 102' ' ' VAL . . . . . . . . . . . . . 46.7 t -114.98 125.36 72.28 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.32 0 CA-C-N 116.116 -0.493 . . . . 0.43 109.815 -179.206 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' D' D ' 103' ' ' LEU . . . . . 0.408 HD23 ' HG3' ' D' ' 114' ' ' ARG . 19.2 mt -117.36 128.93 55.52 Favored 'General case' 0 C--N 1.331 -0.219 0 CA-C-N 115.789 -0.642 . . . . 0.97 110.19 178.08 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' D' D ' 104' ' ' ILE . . . . . . . . . . . . . 71.9 mt -119.09 120.69 64.68 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.278 0 N-CA-C 110.042 -0.355 . . . . 0.39 110.042 177.807 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' D' D ' 105' ' ' PHE . . . . . . . . . . . . . 97.4 m-85 -118.47 161.23 20.34 Favored 'General case' 0 C--N 1.332 -0.187 0 O-C-N 124.084 0.865 . . . . 0.42 110.129 -178.627 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' D' D ' 106' ' ' ASN . . . . . . . . . . . . . 18.4 p-10 -93.26 -170.63 2.44 Favored 'General case' 0 C--N 1.329 -0.315 0 N-CA-C 109.805 -0.443 . . . . 0.53 109.805 172.278 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' D' D ' 107' ' ' GLN . . . . . . . . . . . . . 48.8 tt0 -59.63 -30.2 68.54 Favored 'General case' 0 C--N 1.328 -0.336 0 N-CA-C 112.0 0.37 . . . . 1.77 112.0 -179.849 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' D' D ' 108' ' ' ASN . . . . . . . . . . . . . 5.5 t-20 -85.55 8.29 19.86 Favored 'General case' 0 CA--C 1.536 0.428 0 N-CA-C 113.293 0.849 . . . . 1.37 113.293 -177.292 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' D' D ' 109' ' ' LEU . . . . . . . . . . . . . 13.6 tp 61.97 43.76 8.84 Favored 'General case' 0 C--N 1.332 -0.18 0 CA-C-O 121.377 0.608 . . . . 1.37 110.854 178.797 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' D' D ' 110' ' ' GLU . . . . . . . . . . . . . 77.7 mm-40 -114.23 143.66 44.48 Favored 'General case' 0 C--N 1.331 -0.224 0 CA-C-N 116.035 -0.53 . . . . 2.08 109.998 176.557 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' D' D ' 111' ' ' GLU . . . . . . . . . . . . . 96.3 mt-10 -72.03 123.02 21.9 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-O 120.908 0.385 . . . . 1.92 111.197 -177.392 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' D' D ' 112' ' ' LEU . . . . . . . . . . . . . 12.3 mt -108.09 -44.89 4.06 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 115.932 -0.576 . . . . 0.62 109.795 175.0 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' D' D ' 113' ' ' TYR . . . . . . . . . . . . . 71.9 t80 -136.62 132.32 34.9 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 115.969 -0.56 . . . . 0.58 110.549 178.785 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' D' D ' 114' ' ' ARG . . . . . 0.408 ' HG3' HD23 ' D' ' 103' ' ' LEU . 56.3 ttp180 -139.74 121.75 15.66 Favored 'General case' 0 C--N 1.331 -0.225 0 CA-C-O 120.823 0.344 . . . . 3.47 110.498 178.662 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' D' D ' 115' ' ' GLY . . . . . . . . . . . . . . . -150.12 163.07 29.39 Favored Glycine 0 CA--C 1.524 0.604 0 N-CA-C 110.949 -0.86 . . . . 0.52 110.949 179.779 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' D' D ' 116' ' ' LYS . . . . . . . . . . . . . 40.2 ttpt -128.84 138.1 51.86 Favored 'General case' 0 C--N 1.331 -0.237 0 N-CA-C 110.098 -0.334 . . . . 1.54 110.098 177.84 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' D' D ' 117' ' ' PHE . . . . . . . . . . . . . 42.6 m-85 -135.81 113.89 11.34 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-N 116.334 -0.394 . . . . 0.55 110.148 -177.757 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' D' D ' 118' ' ' GLU . . . . . . . . . . . . . 96.9 mt-10 -56.97 -43.74 81.93 Favored 'General case' 0 C--N 1.328 -0.338 0 C-N-CA 120.883 -0.327 . . . . 2.59 110.832 -177.0 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' D' D ' 119' ' ' ASN . . . . . . . . . . . . . 10.1 m120 -96.44 30.98 2.36 Favored 'General case' 0 C--N 1.328 -0.349 0 N-CA-C 112.116 0.413 . . . . 1.6 112.116 -174.765 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' D' D ' 120' ' ' LEU . . . . . . . . . . . . . 20.2 tp -57.7 120.0 7.61 Favored 'General case' 0 N--CA 1.461 0.104 0 N-CA-C 110.009 -0.367 . . . . 0.63 110.009 176.854 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' D' D ' 121' ' ' ASN . . . . . . . . . . . . . 8.4 t-20 -111.95 -44.1 3.5 Favored 'General case' 0 C--N 1.332 -0.156 0 CA-C-N 116.597 -0.274 . . . . 2.02 111.132 -175.423 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' D' D ' 122' ' ' LYS . . . . . . . . . . . . . 98.4 mttt -143.82 145.17 32.15 Favored 'General case' 0 C--N 1.33 -0.274 0 C-N-CA 120.691 -0.404 . . . . 1.81 111.728 -177.316 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' D' D ' 123' ' ' VAL . . . . . . . . . . . . . 45.0 t -127.92 128.73 69.41 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.295 0 N-CA-C 109.383 -0.599 . . . . 0.62 109.383 175.318 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' D' D ' 124' ' ' LEU . . . . . . . . . . . . . 8.2 tp -130.81 134.73 47.09 Favored 'General case' 0 C--N 1.332 -0.179 0 CA-C-O 120.932 0.396 . . . . 1.62 110.367 -178.292 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' D' D ' 125' ' ' VAL . . . . . 0.706 HG11 HG21 ' D' ' 94' ' ' VAL . 35.1 m -130.66 137.53 55.87 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.208 0 CA-C-N 116.251 -0.431 . . . . 1.73 110.991 -178.551 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' D' D ' 126' ' ' ARG . . . . . . . . . . . . . 96.7 mtt-85 -148.71 119.21 7.4 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 115.947 -0.57 . . . . 3.32 109.934 176.097 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' D' D ' 127' ' ' ASN . . . . . . . . . . . . . 2.0 t30 56.29 -149.06 0.47 Allowed 'General case' 0 CA--C 1.541 0.632 0 N-CA-C 109.723 -0.473 . . . . 2.38 109.723 179.669 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' D' D ' 128' ' ' ASP . . . . . . . . . . . . . 11.8 p-10 -80.43 13.06 2.61 Favored 'General case' 0 CA--C 1.537 0.444 0 CA-C-N 118.78 0.718 . . . . 1.18 112.93 -179.993 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' D' D ' 129' ' ' LEU . . . . . . . . . . . . . 15.7 tp -110.02 133.15 53.5 Favored 'General case' 0 C--O 1.232 0.175 0 CA-C-N 118.217 0.462 . . . . 1.83 110.085 178.423 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' D' D ' 130' ' ' VAL . . . . . . . . . . . . . 41.4 t -122.65 139.81 48.37 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.308 0 CA-C-N 116.578 -0.283 . . . . 1.36 110.498 -176.987 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' D' D ' 131' ' ' VAL . . . . . 0.413 HG22 HD12 ' D' ' 140' ' ' LEU . 40.7 t -133.93 134.86 55.62 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.192 0 CA-C-O 121.087 0.47 . . . . 0.64 110.484 177.536 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' D' D ' 132' ' ' ILE . . . . . . . . . . . . . 72.3 mt -117.95 134.07 62.74 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.269 0 CA-C-N 115.61 -0.723 . . . . 0.49 109.424 179.294 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' D' D ' 133' ' ' ILE . . . . . . . . . . . . . 29.7 mm -115.35 120.57 65.06 Favored 'Isoleucine or valine' 0 C--O 1.234 0.262 0 CA-C-N 116.5 -0.318 . . . . 0.52 110.763 -175.254 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' D' D ' 134' ' ' ASP . . . . . . . . . . . . . 5.6 p-10 -136.41 148.14 47.63 Favored 'General case' 0 C--N 1.331 -0.203 0 CA-C-N 116.327 -0.397 . . . . 0.59 109.946 176.331 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' D' D ' 135' ' ' GLU . . . . . . . . . . . . . 84.6 tt0 -49.85 -28.46 6.51 Favored 'General case' 0 C--O 1.236 0.352 0 N-CA-C 112.582 0.586 . . . . 1.68 112.582 -175.277 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' D' D ' 136' ' ' GLN . . . . . . . . . . . . . 94.8 mt-30 -78.26 -36.12 47.29 Favored 'General case' 0 C--N 1.331 -0.223 0 N-CA-C 112.414 0.524 . . . . 2.43 112.414 -176.458 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' D' D ' 137' ' ' LYS . . . . . . . . . . . . . 35.3 pttt -170.06 177.0 4.44 Favored 'General case' 0 C--O 1.233 0.217 0 CA-C-O 121.827 0.822 . . . . 1.39 113.117 -170.821 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' D' D ' 138' ' ' LEU . . . . . . . . . . . . . 9.5 tp -113.18 129.2 56.59 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 114.233 -1.348 . . . . 0.76 109.797 178.311 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' D' D ' 139' ' ' THR . . . . . . . . . . . . . 36.9 m -112.09 126.02 54.73 Favored 'General case' 0 C--N 1.331 -0.22 0 CA-C-O 120.673 0.273 . . . . 0.47 110.616 179.197 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' D' D ' 140' ' ' LEU . . . . . 0.413 HD12 HG22 ' D' ' 131' ' ' VAL . 17.1 tp -115.01 124.28 51.23 Favored 'General case' 0 C--N 1.329 -0.299 0 N-CA-C 108.905 -0.776 . . . . 1.08 108.905 179.261 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' D' D ' 141' ' ' ILE . . . . . . . . . . . . . 20.0 mt -119.91 118.54 57.37 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.375 0 N-CA-C 109.808 -0.441 . . . . 0.53 109.808 -175.796 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' D' D ' 142' ' ' ARG . . . . . . . . . . . . . 74.3 ttt180 -109.75 124.02 50.53 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-N 115.141 -0.936 . . . . 2.96 110.453 -175.472 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' D' D ' 143' ' ' THR . . . . . . . . . . . . . 22.6 p . . . . . 0 C--O 1.22 -0.485 0 CA-C-O 118.015 -0.993 . . . . 1.86 110.601 -179.75 . . . . . . . . 0 0 . 1 . 001 nuclear build full ' E' E ' -3' ' ' GLU . . . . . . . . . . . . . 95.1 mt-10 . . . . . 0 N--CA 1.491 1.592 0 N-CA-C 109.16 -0.682 . . . . 32.09 109.16 . . . . . . . . . 0 0 . 1 . 001 nuclear build full ' E' E ' -2' ' ' GLY . . . . . . . . . . . . . . . -72.83 133.67 19.28 Favored Glycine 0 CA--C 1.523 0.58 0 N-CA-C 110.641 -0.984 . . . . 28.09 110.641 178.247 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' E' E ' -1' ' ' VAL . . . . . . . . . . . . . 46.3 t -90.46 130.88 38.98 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.363 0 CA-C-O 120.916 0.389 . . . . 25.41 110.088 -178.953 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' E' E ' 0' ' ' ILE . . . . . . . . . . . . . 72.7 mt -115.85 127.19 73.53 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.278 0 CA-C-N 115.959 -0.564 . . . . 24.25 109.511 178.588 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' E' E ' 1' ' ' MET . . . . . . . . . . . . . 16.3 ptt? -84.01 153.5 23.82 Favored 'General case' 0 C--N 1.329 -0.305 0 C-N-CA 120.818 -0.353 . . . . 20.31 110.586 -178.3 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' E' E ' 2' ' ' SER . . . . . . . . . . . . . 2.0 p -113.04 122.96 49.17 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-O 121.075 0.464 . . . . 17.92 110.299 177.715 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' E' E ' 3' ' ' GLU . . . . . . . . . . . . . 85.0 tt0 -140.33 139.14 35.37 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-N 115.711 -0.677 . . . . 15.6 110.869 -178.485 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' E' E ' 4' ' ' LEU . . . . . 0.428 HD21 HD21 ' E' ' 6' ' ' LEU . 18.8 tp -122.56 126.34 47.55 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 115.987 -0.551 . . . . 14.43 110.154 177.248 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' E' E ' 5' ' ' LYS . . . . . . . . . . . . . 91.4 mttt -103.43 120.31 40.58 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.238 -0.437 . . . . 11.5 110.319 178.028 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' E' E ' 6' ' ' LEU . . . . . 0.43 HD23 ' HA ' ' E' ' 50' ' ' VAL . 69.6 mt -118.32 149.9 40.4 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 115.565 -0.743 . . . . 12.06 110.437 -178.68 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' E' E ' 7' ' ' LYS . . . . . . . . . . . . . 59.8 tttm -135.67 141.69 38.06 Favored Pre-proline 0 CA--C 1.534 0.351 0 CA-C-O 119.192 -0.432 . . . . 10.04 110.039 176.976 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' E' E ' 8' ' ' PRO . . . . . . . . . . . . . 75.1 Cg_endo -88.52 136.97 3.39 Favored 'Trans proline' 0 N--CA 1.49 1.295 0 C-N-CA 121.643 1.562 . . . . 9.88 111.568 178.924 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' E' E ' 9' ' ' LEU . . . . . . . . . . . . . 81.8 mt -77.72 -52.17 1.7 Allowed Pre-proline 0 C--N 1.33 -0.258 0 CA-C-O 119.057 -0.497 . . . . 13.89 111.587 -177.95 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' E' E ' 10' ' ' PRO . . . . . . . . . . . . . 57.2 Cg_endo -73.19 148.3 43.9 Favored 'Trans proline' 0 N--CA 1.496 1.67 0 C-N-CA 121.049 1.166 . . . . 13.57 111.439 172.399 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' E' E ' 11' ' ' LYS . . . . . . . . . . . . . 63.9 mttp -82.91 97.34 8.63 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-O 120.84 0.352 . . . . 12.82 110.853 -179.124 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' E' E ' 12' ' ' VAL . . . . . . . . . . . . . 12.3 p -142.72 144.25 24.6 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.334 0 CA-C-N 116.09 -0.505 . . . . 14.34 110.422 178.802 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' E' E ' 13' ' ' GLU . . . . . . . . . . . . . 85.0 tt0 -87.0 129.39 34.9 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.312 -0.403 . . . . 14.37 109.947 177.539 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' E' E ' 14' ' ' LEU . . . . . . . . . . . . . 21.3 mt -91.36 148.19 37.07 Favored Pre-proline 0 CA--C 1.533 0.309 0 C-N-CA 120.804 -0.358 . . . . 13.43 110.51 -176.701 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' E' E ' 15' ' ' PRO . . . . . . . . . . . . . 26.5 Cg_exo -62.22 161.2 27.62 Favored 'Trans proline' 0 N--CA 1.496 1.632 0 C-N-CA 121.321 1.348 . . . . 15.98 111.84 175.497 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' E' E ' 16' ' ' PRO . . . . . . . . . . . . . 35.7 Cg_exo -59.08 -31.88 96.38 Favored 'Trans proline' 0 N--CA 1.496 1.673 0 C-N-CA 121.45 1.433 . . . . 15.78 112.704 -178.779 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' E' E ' 17' ' ' ASP . . . . . . . . . . . . . 3.0 p30 -93.58 8.5 40.54 Favored 'General case' 0 CA--C 1.535 0.403 0 N-CA-C 113.302 0.853 . . . . 17.13 113.302 -176.847 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' E' E ' 18' ' ' PHE . . . . . . . . . . . . . 47.4 t80 -57.93 -44.47 86.93 Favored 'General case' 0 C--N 1.334 -0.105 0 CA-C-N 118.098 0.408 . . . . 14.38 110.184 -178.074 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' E' E ' 19' ' ' VAL . . . . . . . . . . . . . 47.8 t -57.35 -42.95 81.44 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 CA-C-N 116.311 -0.404 . . . . 13.57 110.345 -178.624 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' E' E ' 20' ' ' ASP . . . . . . . . . . . . . 8.5 m-20 -59.2 -41.98 89.86 Favored 'General case' 0 C--N 1.329 -0.32 0 C-N-CA 120.85 -0.34 . . . . 15.68 110.554 -178.268 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' E' E ' 21' ' ' VAL . . . . . . . . . . . . . 47.1 t -64.78 -46.78 91.03 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.347 0 C-N-CA 120.829 -0.348 . . . . 17.06 110.612 -178.079 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' E' E ' 22' ' ' ILE . . . . . 0.655 HG22 HD12 ' E' ' 26' ' ' LEU . 48.3 mm -61.22 -34.65 61.48 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 C-N-CA 120.981 -0.287 . . . . 15.74 111.253 -178.303 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' E' E ' 23' ' ' ARG . . . . . . . . . . . . . 58.3 ttp180 -60.52 -51.58 68.82 Favored 'General case' 0 C--N 1.331 -0.235 0 C-N-CA 120.537 -0.465 . . . . 16.75 110.164 176.135 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' E' E ' 24' ' ' ILE . . . . . . . . . . . . . 78.5 mt -60.76 -39.3 81.3 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.323 0 CA-C-N 115.968 -0.56 . . . . 18.88 111.985 -176.467 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' E' E ' 25' ' ' LYS . . . . . . . . . . . . . 11.7 ptmm? -76.67 -39.39 52.28 Favored 'General case' 0 CA--C 1.535 0.37 0 N-CA-C 112.003 0.371 . . . . 19.21 112.003 -174.615 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' E' E ' 26' ' ' LEU . . . . . 0.655 HD12 HG22 ' E' ' 22' ' ' ILE . 30.6 mt -78.82 -32.34 46.19 Favored 'General case' 0 C--N 1.332 -0.183 0 N-CA-C 113.51 0.93 . . . . 18.9 113.51 -172.267 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' E' E ' 27' ' ' GLN . . . . . . . . . . . . . 17.3 pt20 -46.69 139.02 5.57 Favored 'General case' 0 N--CA 1.471 0.593 0 N-CA-C 112.862 0.689 . . . . 20.23 112.862 -175.481 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' E' E ' 28' ' ' GLY . . . . . . . . . . . . . . . 97.17 -22.17 42.2 Favored Glycine 0 CA--C 1.534 1.245 0 CA-C-N 115.554 -0.748 . . . . 22.39 112.554 -177.284 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' E' E ' 29' ' ' LYS . . . . . . . . . . . . . 93.1 mttt -98.29 155.14 17.34 Favored 'General case' 0 C--O 1.232 0.176 0 CA-C-N 117.419 0.609 . . . . 22.36 111.136 -179.469 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' E' E ' 30' ' ' THR . . . . . . . . . . . . . 30.5 m -105.68 139.33 40.44 Favored 'General case' 0 C--N 1.332 -0.191 0 CA-C-N 116.029 -0.532 . . . . 22.55 110.341 177.659 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' E' E ' 31' ' ' VAL . . . . . . . . . . . . . 34.8 m -131.15 154.11 40.15 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.21 0 CA-C-N 116.33 -0.395 . . . . 19.56 110.821 -179.766 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' E' E ' 32' ' ' ARG . . . . . . . . . . . . . 22.2 ttp180 -136.15 151.32 49.63 Favored 'General case' 0 C--N 1.331 -0.219 0 CA-C-O 121.225 0.535 . . . . 24.48 110.439 177.004 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' E' E ' 33' ' ' THR . . . . . . . . . . . . . 41.9 m -52.78 138.64 28.75 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 116.258 -0.428 . . . . 18.58 111.417 -179.228 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' E' E ' 34' ' ' GLY . . . . . . . . . . . . . . . 98.68 -17.1 58.84 Favored Glycine 0 CA--C 1.531 1.092 0 CA-C-N 116.048 -0.524 . . . . 17.78 113.369 177.312 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' E' E ' 35' ' ' ASP . . . . . . . . . . . . . 80.9 m-20 -66.6 147.39 53.34 Favored 'General case' 0 C--O 1.231 0.129 0 CA-C-N 118.015 0.907 . . . . 20.26 111.232 179.488 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' E' E ' 36' ' ' VAL . . . . . . . . . . . . . 44.1 t -121.13 128.2 75.99 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.264 0 N-CA-C 109.443 -0.577 . . . . 18.85 109.443 175.96 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' E' E ' 37' ' ' ILE . . . . . . . . . . . . . 66.4 mt -120.32 139.72 46.71 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.271 0 CA-C-N 116.328 -0.396 . . . . 17.65 110.156 -177.96 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' E' E ' 38' ' ' GLY . . . . . . . . . . . . . . . -108.22 128.57 9.18 Favored Glycine 0 CA--C 1.524 0.653 0 N-CA-C 110.884 -0.887 . . . . 19.38 110.884 177.739 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' E' E ' 39' ' ' ILE . . . . . . . . . . . . . 74.4 mt -124.48 135.31 64.22 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.193 0 N-CA-C 110.085 -0.339 . . . . 18.73 110.085 179.479 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' E' E ' 40' ' ' SER . . . . . 0.51 ' O ' HD13 ' E' ' 41' ' ' ILE . 34.6 t -92.56 116.96 29.46 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.433 -0.349 . . . . 22.11 110.86 176.241 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' E' E ' 41' ' ' ILE . . . . . 0.51 HD13 ' O ' ' E' ' 40' ' ' SER . 48.5 mm -128.94 128.16 67.03 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.19 0 CA-C-O 120.778 0.323 . . . . 20.19 110.407 179.37 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' E' E ' 42' ' ' LEU . . . . . . . . . . . . . 56.7 mt 54.59 33.03 18.24 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.194 -0.457 . . . . 22.67 111.856 177.824 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' E' E ' 43' ' ' GLY . . . . . . . . . . . . . . . 71.16 28.74 69.68 Favored Glycine 0 CA--C 1.532 1.106 0 C-N-CA 121.109 -0.567 . . . . 23.39 112.176 177.872 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' E' E ' 44' ' ' LYS . . . . . . . . . . . . . 45.9 tttp -141.75 137.7 31.81 Favored 'General case' 0 C--N 1.33 -0.263 0 N-CA-C 109.773 -0.454 . . . . 21.45 109.773 179.464 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' E' E ' 45' ' ' GLU . . . . . . . . . . . . . 83.7 tt0 -82.36 126.64 32.4 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-O 120.934 0.397 . . . . 21.32 111.18 -176.993 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' E' E ' 46' ' ' VAL . . . . . . . . . . . . . 7.6 p -124.32 129.83 73.84 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.222 0 N-CA-C 109.367 -0.605 . . . . 17.3 109.367 175.822 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' E' E ' 47' ' ' LYS . . . . . . . . . . . . . 98.7 mttt -101.07 132.61 46.43 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.087 -0.506 . . . . 19.29 111.364 179.799 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' E' E ' 48' ' ' PHE . . . . . . . . . . . . . 92.3 m-85 -117.01 132.02 56.8 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.267 -0.424 . . . . 14.33 110.364 176.952 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' E' E ' 49' ' ' LYS . . . . . . . . . . . . . 84.6 tttt -106.78 137.28 45.11 Favored 'General case' 0 C--N 1.331 -0.23 0 CA-C-N 116.503 -0.317 . . . . 14.41 110.45 178.045 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' E' E ' 50' ' ' VAL . . . . . 0.43 ' HA ' HD23 ' E' ' 6' ' ' LEU . 44.7 t -84.29 111.13 19.68 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.258 0 N-CA-C 109.245 -0.65 . . . . 14.75 109.245 175.701 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' E' E ' 51' ' ' VAL . . . . . . . . . . . . . 46.8 t -72.66 -46.72 53.37 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.317 0 CA-C-N 116.265 -0.425 . . . . 13.28 110.053 -174.269 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' E' E ' 52' ' ' GLN . . . . . . . . . . . . . 46.9 tt0 -169.04 142.6 2.87 Favored 'General case' 0 C--N 1.331 -0.205 0 C-N-CA 120.295 -0.562 . . . . 14.71 111.776 -178.922 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' E' E ' 53' ' ' ALA . . . . . . . . . . . . . . . -116.13 135.41 53.95 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-N 115.714 -0.675 . . . . 17.09 110.106 176.589 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' E' E ' 54' ' ' TYR . . . . . . . . . . . . . 62.5 t80 -128.94 109.23 18.34 Favored Pre-proline 0 CA--C 1.536 0.427 0 CA-C-O 118.26 -0.876 . . . . 20.27 110.181 178.688 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' E' E ' 55' ' ' PRO . . . . . . . . . . . . . 74.0 Cg_endo -77.09 170.06 72.65 Favored 'Cis proline' 0 N--CA 1.499 1.826 0 CA-C-N 121.81 1.682 . . . . 20.84 112.445 -4.544 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' E' E ' 56' ' ' SER . . . . . . . . . . . . . 13.6 m -113.99 126.96 27.34 Favored Pre-proline 0 CA--C 1.538 0.498 0 CA-C-O 118.405 -0.807 . . . . 22.33 109.476 176.28 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' E' E ' 57' ' ' PRO . . . . . . . . . . . . . 56.9 Cg_endo -72.64 169.04 73.39 Favored 'Cis proline' 0 N--CA 1.497 1.704 0 CA-C-N 122.083 1.78 . . . . 23.32 111.848 -0.096 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' E' E ' 58' ' ' LEU . . . . . . . . . . . . . 28.9 tp -130.0 137.7 50.42 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.139 -0.482 . . . . 19.78 110.294 179.95 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' E' E ' 59' ' ' ARG . . . . . . . . . . . . . 52.2 ttp180 -105.19 128.75 53.55 Favored 'General case' 0 C--N 1.328 -0.35 0 N-CA-C 109.239 -0.652 . . . . 24.23 109.239 176.106 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' E' E ' 60' ' ' VAL . . . . . . . . . . . . . 41.9 t -85.39 119.08 33.38 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.272 0 C-N-CA 120.607 -0.437 . . . . 18.94 110.919 -173.992 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' E' E ' 61' ' ' GLU . . . . . . . . . . . . . 47.2 mt-10 -131.03 170.11 14.94 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 115.703 -0.68 . . . . 21.28 109.492 174.29 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' E' E ' 62' ' ' ASP . . . . . . . . . . . . . 4.5 m-20 -53.23 -32.67 49.46 Favored 'General case' 0 C--N 1.329 -0.308 0 N-CA-C 111.925 0.343 . . . . 19.55 111.925 -177.609 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' E' E ' 63' ' ' ARG . . . . . . . . . . . . . 98.2 mtt180 -73.13 -22.0 60.62 Favored 'General case' 0 CA--C 1.533 0.289 0 N-CA-C 113.038 0.755 . . . . 21.98 113.038 -176.188 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' E' E ' 64' ' ' THR . . . . . . . . . . . . . 26.7 m -66.42 137.24 56.71 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-O 120.983 0.42 . . . . 17.14 111.061 -174.692 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' E' E ' 65' ' ' LYS . . . . . . . . . . . . . 67.5 mttm -89.71 129.79 36.08 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 115.927 -0.579 . . . . 16.15 109.967 177.207 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' E' E ' 66' ' ' ILE . . . . . . . . . . . . . 63.2 mt -118.83 129.57 74.86 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.287 0 N-CA-C 109.849 -0.426 . . . . 13.46 109.849 -179.775 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' E' E ' 67' ' ' THR . . . . . . . . . . . . . 25.9 m -127.38 139.82 52.59 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-O 120.95 0.405 . . . . 10.58 110.994 -178.165 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' E' E ' 68' ' ' LEU . . . . . . . . . . . . . 65.4 mt -104.95 131.32 52.6 Favored 'General case' 0 C--N 1.331 -0.226 0 CA-C-N 116.056 -0.52 . . . . 8.76 110.528 177.912 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' E' E ' 69' ' ' VAL . . . . . . . . . . . . . 42.0 t -102.83 125.64 57.16 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.334 0 CA-C-N 116.33 -0.396 . . . . 7.11 110.205 179.024 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' E' E ' 70' ' ' THR . . . . . . . . . . . . . 10.2 t -150.05 149.78 30.81 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.042 -0.527 . . . . 5.99 110.319 177.711 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' E' E ' 71' ' ' HIS . . . . . . . . . . . . . 53.6 t-80 -141.88 69.79 24.22 Favored Pre-proline 0 CA--C 1.535 0.4 0 C-N-CA 120.858 -0.337 . . . . 6.64 111.135 -179.447 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' E' E ' 72' ' ' PRO . . . . . . . . . . . . . 64.8 Cg_endo -91.38 160.04 3.68 Favored 'Trans proline' 0 N--CA 1.488 1.194 0 C-N-CA 121.861 1.707 . . . . 2.87 111.606 174.16 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' E' E ' 73' ' ' VAL . . . . . . . . . . . . . 26.9 m -105.0 154.59 6.43 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.163 0 CA-C-O 120.972 0.415 . . . . 1.03 110.452 179.161 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' E' E ' 74' ' ' ASP . . . . . . . . . . . . . 21.6 t0 -96.08 119.91 35.42 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 115.907 -0.588 . . . . 0.96 109.544 179.853 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' E' E ' 75' ' ' VAL . . . . . . . . . . . . . 41.8 t -107.54 119.32 56.93 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.268 0 CA-C-O 121.071 0.462 . . . . 0.72 110.233 -178.973 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' E' E ' 76' ' ' LEU . . . . . . . . . . . . . 34.8 mt -115.11 137.86 51.54 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 115.592 -0.731 . . . . 1.25 109.435 177.232 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' E' E ' 77' ' ' GLU . . . . . . . . . . . . . 98.0 mt-10 -134.06 131.45 38.84 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-O 121.064 0.459 . . . . 1.17 111.061 -177.769 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' E' E ' 78' ' ' ALA . . . . . . . . . . . . . . . -119.1 124.07 45.99 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 115.654 -0.703 . . . . 0.61 109.625 176.419 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' E' E ' 79' ' ' LYS . . . . . 0.606 ' O ' HD13 ' E' ' 80' ' ' ILE . 7.8 ttpm? -74.58 122.82 23.73 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-O 120.876 0.369 . . . . 2.97 110.615 -177.162 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' E' E ' 80' ' ' ILE . . . . . 0.606 HD13 ' O ' ' E' ' 79' ' ' LYS . 39.6 mm -139.06 113.72 7.84 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.298 0 N-CA-C 109.009 -0.737 . . . . 0.63 109.009 -178.443 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' E' E ' 81' ' ' LYS . . . . . . . . . . . . . 29.2 tttp -98.94 118.12 35.0 Favored 'General case' 0 C--N 1.327 -0.397 0 CA-C-N 116.524 -0.307 . . . . 2.98 110.646 -175.381 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' E' E ' 82' ' ' GLY . . . . . . . . . . . . . . . 89.16 42.32 5.62 Favored Glycine 0 CA--C 1.527 0.818 0 C-N-CA 120.421 -0.895 . . . . 0.62 112.058 175.282 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' E' E ' 83' ' ' ILE . . . . . . . . . . . . . 77.1 mt -61.67 142.37 16.37 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.293 0 N-CA-C 109.704 -0.48 . . . . 0.62 109.704 175.994 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' E' E ' 84' ' ' LYS . . . . . . . . . . . . . 84.9 tttt -98.68 -54.02 3.14 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.11 -0.495 . . . . 1.64 110.536 -178.293 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' E' E ' 85' ' ' ASP . . . . . . . . . . . . . 11.6 t70 -156.37 155.67 32.58 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 115.769 -0.651 . . . . 0.83 110.254 -178.912 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' E' E ' 86' ' ' VAL . . . . . . . . . . . . . 43.5 t -129.28 130.86 67.86 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.268 0 CA-C-O 121.048 0.451 . . . . 0.58 110.622 -178.308 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' E' E ' 87' ' ' ILE . . . . . . . . . . . . . 44.1 mm -118.74 122.81 70.34 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.281 0 CA-C-N 115.651 -0.704 . . . . 1.46 109.249 175.653 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' E' E ' 88' ' ' LEU . . . . . . . . . . . . . 14.4 tp -115.03 131.7 56.84 Favored 'General case' 0 C--N 1.331 -0.217 0 CA-C-O 121.014 0.435 . . . . 1.69 111.256 -176.072 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' E' E ' 89' ' ' ASP . . . . . . . . . . . . . 21.3 t70 -125.5 154.41 42.12 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 115.788 -0.642 . . . . 0.91 109.472 175.427 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' E' E ' 90' ' ' GLU . . . . . . . . . . . . . 48.1 mt-10 -49.46 -34.43 16.79 Favored 'General case' 0 C--N 1.328 -0.336 0 N-CA-C 112.845 0.683 . . . . 2.25 112.845 -171.653 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' E' E ' 91' ' ' ASN . . . . . . . . . . . . . 37.6 p-10 -132.0 32.2 4.07 Favored 'General case' 0 N--CA 1.466 0.33 0 N-CA-C 112.17 0.433 . . . . 2.37 112.17 -176.096 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' E' E ' 92' ' ' LEU . . . . . . . . . . . . . 16.0 tp -166.04 141.75 4.87 Favored 'General case' 0 C--N 1.329 -0.292 0 C-N-CA 120.886 -0.326 . . . . 1.45 110.668 179.56 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' E' E ' 93' ' ' ILE . . . . . . . . . . . . . 69.1 mt -121.45 121.75 65.43 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.217 0 N-CA-C 109.722 -0.473 . . . . 0.57 109.722 -179.583 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' E' E ' 94' ' ' VAL . . . . . . . . . . . . . 45.1 t -122.74 126.64 74.21 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.202 0 N-CA-C 109.969 -0.382 . . . . 0.53 109.969 179.212 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' E' E ' 95' ' ' VAL . . . . . . . . . . . . . 42.2 t -124.0 135.88 62.15 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.307 0 CA-C-N 116.276 -0.42 . . . . 0.75 110.01 -179.377 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' E' E ' 96' ' ' ILE . . . . . . . . . . . . . 59.2 mt -115.38 132.46 64.66 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.248 0 N-CA-C 109.429 -0.582 . . . . 0.54 109.429 179.408 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' E' E ' 97' ' ' THR . . . . . . . . . . . . . 68.9 p -103.56 158.92 16.03 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-O 120.906 0.384 . . . . 0.59 110.782 -179.579 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' E' E ' 98' ' ' GLU . . . . . . . . . . . . . 96.9 mt-10 -53.85 -24.21 15.04 Favored 'General case' 0 CA--C 1.533 0.327 0 N-CA-C 112.413 0.523 . . . . 2.63 112.413 -179.983 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' E' E ' 99' ' ' GLU . . . . . . . . . . . . . 95.3 mt-10 -78.43 14.36 1.27 Allowed 'General case' 0 CA--C 1.535 0.385 0 N-CA-C 113.218 0.821 . . . . 2.62 113.218 -176.7 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' E' E ' 100' ' ' ASN . . . . . . . . . . . . . 2.7 m-20 61.8 38.03 15.11 Favored 'General case' 0 N--CA 1.463 0.193 0 CA-C-O 121.148 0.499 . . . . 0.76 110.922 179.221 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' E' E ' 101' ' ' GLU . . . . . . . . . . . . . 61.2 tt0 -119.98 142.35 48.86 Favored 'General case' 0 C--N 1.331 -0.217 0 CA-C-N 116.093 -0.503 . . . . 0.85 109.673 176.404 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' E' E ' 102' ' ' VAL . . . . . . . . . . . . . 46.3 t -115.25 130.19 70.22 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.291 0 CA-C-N 116.227 -0.442 . . . . 0.49 110.162 -178.521 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' E' E ' 103' ' ' LEU . . . . . . . . . . . . . 20.0 mt -117.35 133.93 55.41 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 115.502 -0.772 . . . . 1.1 110.066 176.221 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' E' E ' 104' ' ' ILE . . . . . 0.604 HD13 HG11 ' E' ' 130' ' ' VAL . 67.0 mt -119.48 124.91 73.81 Favored 'Isoleucine or valine' 0 C--O 1.234 0.284 0 N-CA-C 110.192 -0.299 . . . . 0.49 110.192 179.912 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' E' E ' 105' ' ' PHE . . . . . . . . . . . . . 67.4 m-85 -123.92 163.4 21.39 Favored 'General case' 0 C--O 1.232 0.151 0 O-C-N 124.013 0.821 . . . . 0.56 110.182 -179.444 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' E' E ' 106' ' ' ASN . . . . . . . . . . . . . 40.1 p30 -98.39 -171.94 2.23 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.421 -0.354 . . . . 0.71 110.327 175.651 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' E' E ' 107' ' ' GLN . . . . . . . . . . . . . 59.5 tt0 -58.37 -29.53 66.08 Favored 'General case' 0 CA--C 1.534 0.329 0 N-CA-C 111.858 0.318 . . . . 1.69 111.858 178.774 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' E' E ' 108' ' ' ASN . . . . . . . . . . . . . 7.5 t-20 -83.24 10.95 7.29 Favored 'General case' 0 CA--C 1.536 0.422 0 N-CA-C 112.933 0.716 . . . . 1.39 112.933 -177.729 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' E' E ' 109' ' ' LEU . . . . . . . . . . . . . 12.5 tp 54.82 37.66 28.91 Favored 'General case' 0 C--N 1.332 -0.169 0 CA-C-O 121.023 0.44 . . . . 1.41 111.08 -179.509 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' E' E ' 110' ' ' GLU . . . . . . . . . . . . . 95.4 mt-10 -104.78 145.91 29.7 Favored 'General case' 0 C--N 1.331 -0.224 0 N-CA-C 109.704 -0.48 . . . . 1.89 109.704 175.275 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' E' E ' 111' ' ' GLU . . . . . . . . . . . . . 80.2 tt0 -83.69 122.15 28.24 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.401 -0.363 . . . . 1.32 110.747 -175.783 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' E' E ' 112' ' ' LEU . . . . . . . . . . . . . 49.4 mt -109.14 -45.26 3.79 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-N 116.095 -0.502 . . . . 0.64 111.128 -179.275 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' E' E ' 113' ' ' TYR . . . . . . . . . . . . . 58.0 t80 -132.96 137.58 46.62 Favored 'General case' 0 N--CA 1.464 0.238 0 CA-C-O 120.839 0.352 . . . . 0.47 111.36 -176.828 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' E' E ' 114' ' ' ARG . . . . . . . . . . . . . 47.5 ttp180 -138.73 123.66 18.88 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 115.831 -0.622 . . . . 2.83 110.123 177.361 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' E' E ' 115' ' ' GLY . . . . . . . . . . . . . . . -150.14 140.09 7.78 Favored Glycine 0 CA--C 1.526 0.719 0 C-N-CA 120.737 -0.744 . . . . 0.48 111.356 178.732 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' E' E ' 116' ' ' LYS . . . . . . . . . . . . . 27.5 ttpp -110.37 134.59 52.15 Favored 'General case' 0 C--N 1.33 -0.24 0 N-CA-C 109.748 -0.464 . . . . 1.84 109.748 176.618 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' E' E ' 117' ' ' PHE . . . . . . . . . . . . . 31.7 m-85 -135.57 113.9 11.52 Favored 'General case' 0 C--N 1.332 -0.191 0 C-N-CA 120.871 -0.331 . . . . 0.59 110.158 -176.817 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' E' E ' 118' ' ' GLU . . . . . . . . . . . . . 96.3 mt-10 -55.59 -45.71 77.36 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.519 -0.31 . . . . 2.45 111.176 -176.191 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' E' E ' 119' ' ' ASN . . . . . . . . . . . . . 68.3 m-80 -95.99 30.0 2.56 Favored 'General case' 0 C--N 1.329 -0.287 0 N-CA-C 112.22 0.452 . . . . 1.54 112.22 -174.172 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' E' E ' 120' ' ' LEU . . . . . . . . . . . . . 22.0 tp -58.39 122.13 12.54 Favored 'General case' 0 C--N 1.333 -0.149 0 N-CA-C 110.027 -0.36 . . . . 0.64 110.027 177.509 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' E' E ' 121' ' ' ASN . . . . . . . . . . . . . 68.2 m-20 -113.99 -44.07 3.19 Favored 'General case' 0 C--O 1.232 0.147 0 CA-C-N 116.534 -0.303 . . . . 1.89 111.094 -178.081 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' E' E ' 122' ' ' LYS . . . . . . . . . . . . . 60.7 mttm -145.1 149.51 35.16 Favored 'General case' 0 C--N 1.332 -0.18 0 CA-C-O 121.28 0.562 . . . . 1.81 112.064 -177.028 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' E' E ' 123' ' ' VAL . . . . . . . . . . . . . 47.3 t -126.68 129.66 71.59 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.239 0 CA-C-N 115.627 -0.715 . . . . 0.54 109.461 175.536 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' E' E ' 124' ' ' LEU . . . . . . . . . . . . . 57.6 mt -121.98 139.56 53.53 Favored 'General case' 0 N--CA 1.463 0.212 0 CA-C-N 116.551 -0.295 . . . . 1.39 110.792 -178.114 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' E' E ' 125' ' ' VAL . . . . . 0.585 HG12 HG23 ' E' ' 130' ' ' VAL . 34.3 m -137.23 139.87 43.25 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.239 0 CA-C-O 121.042 0.448 . . . . 1.56 111.603 -178.723 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' E' E ' 126' ' ' ARG . . . . . . . . . . . . . 93.4 mtt-85 -147.77 115.57 6.41 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 115.687 -0.688 . . . . 3.5 110.19 174.207 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' E' E ' 127' ' ' ASN . . . . . . . . . . . . . 93.4 m-20 53.79 -129.92 2.21 Favored 'General case' 0 CA--C 1.545 0.786 0 CA-C-O 118.557 -0.735 . . . . 2.24 110.552 179.578 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' E' E ' 128' ' ' ASP . . . . . . . . . . . . . 5.1 p30 -91.82 5.78 48.6 Favored 'General case' 0 CA--C 1.536 0.42 0 CA-C-N 120.078 1.308 . . . . 1.0 113.457 -178.216 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' E' E ' 129' ' ' LEU . . . . . . . . . . . . . 15.3 tp -105.41 134.51 48.41 Favored 'General case' 0 C--N 1.333 -0.115 0 CA-C-N 118.17 0.441 . . . . 1.81 109.834 178.555 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' E' E ' 130' ' ' VAL . . . . . 0.604 HG11 HD13 ' E' ' 104' ' ' ILE . 12.4 p -132.17 143.32 40.37 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.165 0 CA-C-O 121.019 0.438 . . . . 1.29 110.705 -177.943 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' E' E ' 131' ' ' VAL . . . . . 0.581 HG22 HD12 ' E' ' 140' ' ' LEU . 38.9 t -136.0 140.09 44.66 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.278 0 CA-C-N 116.034 -0.53 . . . . 0.91 110.437 -179.086 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' E' E ' 132' ' ' ILE . . . . . . . . . . . . . 76.3 mt -114.98 133.88 59.78 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.288 0 CA-C-N 115.67 -0.695 . . . . 0.53 109.472 179.515 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' E' E ' 133' ' ' ILE . . . . . . . . . . . . . 38.0 mm -116.57 119.16 61.14 Favored 'Isoleucine or valine' 0 C--O 1.236 0.345 0 CA-C-N 116.537 -0.301 . . . . 0.46 110.989 -175.58 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' E' E ' 134' ' ' ASP . . . . . . . . . . . . . 5.8 p-10 -135.21 148.5 49.65 Favored 'General case' 0 C--N 1.332 -0.167 0 N-CA-C 109.809 -0.441 . . . . 0.56 109.809 174.753 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' E' E ' 135' ' ' GLU . . . . . . . . . . . . . 44.6 tp10 -50.01 -28.06 6.41 Favored 'General case' 0 C--N 1.329 -0.323 0 N-CA-C 112.702 0.63 . . . . 2.01 112.702 -172.222 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' E' E ' 136' ' ' GLN . . . . . . . . . . . . . 95.9 mt-30 -81.98 -37.63 26.33 Favored 'General case' 0 C--O 1.234 0.272 0 N-CA-C 112.683 0.623 . . . . 2.44 112.683 -175.694 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' E' E ' 137' ' ' LYS . . . . . . . . . . . . . 20.3 pttp -160.47 169.52 22.85 Favored 'General case' 0 C--O 1.234 0.251 0 CA-C-O 121.825 0.821 . . . . 1.77 113.192 -169.801 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' E' E ' 138' ' ' LEU . . . . . . . . . . . . . 7.7 tp -111.96 127.83 55.98 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 114.085 -1.416 . . . . 0.51 109.459 177.859 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' E' E ' 139' ' ' THR . . . . . . . . . . . . . 27.3 m -113.59 123.59 50.33 Favored 'General case' 0 C--N 1.331 -0.221 0 CA-C-O 120.614 0.245 . . . . 0.42 110.39 178.699 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' E' E ' 140' ' ' LEU . . . . . 0.581 HD12 HG22 ' E' ' 131' ' ' VAL . 8.1 tp -113.36 121.39 44.21 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 115.884 -0.598 . . . . 1.01 109.44 -179.439 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' E' E ' 141' ' ' ILE . . . . . 0.514 ' HB ' HG13 ' E' ' 130' ' ' VAL . 19.4 mt -121.14 122.79 68.46 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.307 0 CA-C-O 121.053 0.454 . . . . 0.49 109.791 -176.218 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' E' E ' 142' ' ' ARG . . . . . . . . . . . . . 50.6 ttp180 -117.35 129.46 55.89 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 115.382 -0.826 . . . . 3.09 110.587 -175.51 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' E' E ' 143' ' ' THR . . . . . . . . . . . . . 11.6 p . . . . . 0 C--O 1.22 -0.458 0 CA-C-O 117.938 -1.03 . . . . 1.57 110.603 179.642 . . . . . . . . 0 0 . 1 . 001 nuclear build full ' F' F ' -3' ' ' GLU . . . . . . . . . . . . . 13.8 pt-20 . . . . . 0 N--CA 1.49 1.543 0 N-CA-C 109.502 -0.555 . . . . 33.38 109.502 . . . . . . . . . 0 0 . 1 . 001 nuclear build full ' F' F ' -2' ' ' GLY . . . . . . . . . . . . . . . -99.3 135.17 11.99 Favored Glycine 0 CA--C 1.525 0.669 0 N-CA-C 110.715 -0.954 . . . . 31.12 110.715 178.438 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' F' F ' -1' ' ' VAL . . . . . . . . . . . . . 44.1 t -96.07 132.83 39.32 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.333 0 CA-C-O 120.868 0.366 . . . . 28.28 110.117 -179.099 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' F' F ' 0' ' ' ILE . . . . . . . . . . . . . 73.8 mt -117.61 136.65 54.08 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.215 0 CA-C-N 116.076 -0.511 . . . . 26.64 109.941 -179.942 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' F' F ' 1' ' ' MET . . . . . . . . . . . . . 26.2 ptt? -80.82 137.41 36.2 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.083 -0.508 . . . . 22.8 111.283 -177.55 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' F' F ' 2' ' ' SER . . . . . . . . . . . . . 4.4 p -121.85 135.71 54.91 Favored 'General case' 0 C--N 1.332 -0.187 0 CA-C-N 116.001 -0.545 . . . . 20.13 110.4 177.243 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' F' F ' 3' ' ' GLU . . . . . . . . . . . . . 46.0 mt-10 -141.25 142.74 33.9 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.218 -0.446 . . . . 17.46 111.133 -178.055 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' F' F ' 4' ' ' LEU . . . . . . . . . . . . . 13.5 tp -127.24 133.25 50.24 Favored 'General case' 0 C--N 1.331 -0.202 0 CA-C-N 115.886 -0.597 . . . . 15.24 109.989 176.813 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' F' F ' 5' ' ' LYS . . . . . . . . . . . . . 92.6 mttt -112.99 120.68 42.22 Favored 'General case' 0 C--O 1.234 0.273 0 CA-C-N 116.409 -0.359 . . . . 13.01 110.952 -179.573 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' F' F ' 6' ' ' LEU . . . . . . . . . . . . . 35.6 mt -113.91 149.06 35.73 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 115.289 -0.869 . . . . 12.6 110.23 179.713 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' F' F ' 7' ' ' LYS . . . . . . . . . . . . . 42.6 tttt -139.71 142.01 29.9 Favored Pre-proline 0 CA--C 1.533 0.307 0 CA-C-O 119.176 -0.44 . . . . 10.04 110.248 174.553 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' F' F ' 8' ' ' PRO . . . . . . . . . . . . . 85.5 Cg_endo -91.62 139.58 2.32 Favored 'Trans proline' 0 N--CA 1.489 1.241 0 C-N-CA 121.838 1.692 . . . . 9.67 111.782 177.997 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' F' F ' 9' ' ' LEU . . . . . . . . . . . . . 83.6 mt -70.1 -47.57 21.38 Favored Pre-proline 0 CA--C 1.533 0.293 0 CA-C-O 118.656 -0.688 . . . . 13.6 111.975 179.612 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' F' F ' 10' ' ' PRO . . . . . . . . . . . . . 84.4 Cg_endo -80.52 151.52 19.79 Favored 'Trans proline' 0 N--CA 1.495 1.586 0 C-N-CA 121.172 1.248 . . . . 13.17 111.859 175.615 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' F' F ' 11' ' ' LYS . . . . . . . . . . . . . 28.0 ttpt -83.69 103.75 13.25 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-O 120.81 0.338 . . . . 12.33 110.183 178.286 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' F' F ' 12' ' ' VAL . . . . . . . . . . . . . 12.7 p -141.02 147.41 22.59 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.258 0 CA-C-N 116.164 -0.471 . . . . 14.09 110.574 -178.589 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' F' F ' 13' ' ' GLU . . . . . . . . . . . . . 95.2 mt-10 -85.92 124.89 32.89 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 116.349 -0.387 . . . . 14.23 110.376 179.152 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' F' F ' 14' ' ' LEU . . . . . . . . . . . . . 30.9 mt -99.48 147.37 33.25 Favored Pre-proline 0 CA--C 1.532 0.284 0 CA-C-O 119.163 -0.446 . . . . 14.0 110.471 -179.186 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' F' F ' 15' ' ' PRO . . . . . . . . . . . . . 24.0 Cg_exo -63.85 154.65 68.55 Favored 'Trans proline' 0 N--CA 1.499 1.836 0 C-N-CA 121.354 1.369 . . . . 16.72 112.07 176.964 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' F' F ' 16' ' ' PRO . . . . . . . . . . . . . 39.8 Cg_exo -59.45 -35.58 95.78 Favored 'Trans proline' 0 N--CA 1.498 1.738 0 C-N-CA 121.368 1.379 . . . . 17.12 112.381 177.836 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' F' F ' 17' ' ' ASP . . . . . . . . . . . . . 6.1 p-10 -82.92 11.87 5.59 Favored 'General case' 0 C--N 1.327 -0.398 0 N-CA-C 112.95 0.722 . . . . 18.76 112.95 -179.341 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' F' F ' 18' ' ' PHE . . . . . . . . . . . . . 36.7 t80 -57.34 -44.17 84.05 Favored 'General case' 0 C--O 1.227 -0.11 0 O-C-N 121.914 -0.491 . . . . 15.4 110.196 -178.523 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' F' F ' 19' ' ' VAL . . . . . . . . . . . . . 47.4 t -55.55 -42.1 66.84 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.29 0 CA-C-N 116.417 -0.356 . . . . 15.15 110.786 -177.825 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' F' F ' 20' ' ' ASP . . . . . . . . . . . . . 5.2 t70 -60.14 -44.1 95.2 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-O 120.9 0.381 . . . . 18.08 110.969 -177.498 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' F' F ' 21' ' ' VAL . . . . . . . . . . . . . 47.5 t -65.6 -47.91 84.58 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.307 0 C-N-CA 120.576 -0.449 . . . . 18.15 110.593 -178.625 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' F' F ' 22' ' ' ILE . . . . . 0.456 ' CG2' HD12 ' F' ' 26' ' ' LEU . 49.1 mm -55.45 -58.46 4.53 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.315 0 C-N-CA 121.119 -0.232 . . . . 16.72 111.151 -177.976 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' F' F ' 23' ' ' ARG . . . . . . . . . . . . . 6.1 ptm180 -54.99 -44.0 74.06 Favored 'General case' 0 CA--C 1.53 0.189 0 C-N-CA 120.54 -0.464 . . . . 19.2 111.632 -173.696 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' F' F ' 24' ' ' ILE . . . . . . . . . . . . . 85.0 mt -60.06 -43.46 92.76 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.223 0 C-N-CA 120.796 -0.361 . . . . 20.65 111.404 -177.362 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' F' F ' 25' ' ' LYS . . . . . . . . . . . . . 93.3 mttt -71.55 -43.85 65.63 Favored 'General case' 0 C--N 1.33 -0.281 0 N-CA-C 112.823 0.675 . . . . 19.9 112.823 -177.933 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' F' F ' 26' ' ' LEU . . . . . 0.456 HD12 ' CG2' ' F' ' 22' ' ' ILE . 79.0 mt -79.04 -27.36 43.16 Favored 'General case' 0 C--N 1.329 -0.289 0 N-CA-C 113.777 1.029 . . . . 19.69 113.777 -169.301 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' F' F ' 27' ' ' GLN . . . . . . . . . . . . . 18.0 pt20 -46.78 139.83 5.07 Favored 'General case' 0 N--CA 1.469 0.523 0 N-CA-C 112.894 0.702 . . . . 21.81 112.894 -175.741 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' F' F ' 28' ' ' GLY . . . . . . . . . . . . . . . 100.66 -20.41 48.28 Favored Glycine 0 CA--C 1.534 1.221 0 CA-C-N 115.501 -0.772 . . . . 23.21 112.744 -179.0 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' F' F ' 29' ' ' LYS . . . . . . . . . . . . . 62.0 mttp -96.34 155.08 16.91 Favored 'General case' 0 C--O 1.231 0.101 0 CA-C-N 117.843 0.821 . . . . 22.44 110.99 177.726 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' F' F ' 30' ' ' THR . . . . . . . . . . . . . 30.1 m -107.02 138.97 42.17 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 115.96 -0.564 . . . . 23.24 109.948 177.584 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' F' F ' 31' ' ' VAL . . . . . . . . . . . . . 35.1 m -128.33 152.61 36.68 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.172 0 CA-C-N 116.352 -0.386 . . . . 20.1 110.779 -179.045 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' F' F ' 32' ' ' ARG . . . . . . . . . . . . . 2.8 mpt_? -131.37 150.72 52.04 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.009 -0.541 . . . . 24.75 109.976 177.195 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' F' F ' 33' ' ' THR . . . . . . . . . . . . . 14.6 m -53.68 137.39 37.53 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.426 -0.352 . . . . 18.77 111.394 -177.953 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' F' F ' 34' ' ' GLY . . . . . . . . . . . . . . . 99.88 -17.08 57.81 Favored Glycine 0 CA--C 1.533 1.198 0 C-N-CA 121.186 -0.531 . . . . 17.72 113.348 178.869 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' F' F ' 35' ' ' ASP . . . . . . . . . . . . . 60.1 m-20 -64.92 150.71 47.37 Favored 'General case' 0 C--O 1.231 0.091 0 CA-C-N 117.977 0.888 . . . . 20.13 111.487 -179.253 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' F' F ' 36' ' ' VAL . . . . . . . . . . . . . 47.7 t -121.91 129.14 75.68 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.205 0 CA-C-N 115.641 -0.709 . . . . 18.53 109.844 178.037 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' F' F ' 37' ' ' ILE . . . . . . . . . . . . . 73.9 mt -122.09 140.48 45.89 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.245 0 CA-C-N 116.299 -0.41 . . . . 17.49 110.068 -179.731 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' F' F ' 38' ' ' GLY . . . . . . . . . . . . . . . -110.52 128.68 8.92 Favored Glycine 0 CA--C 1.526 0.761 0 N-CA-C 111.092 -0.803 . . . . 19.07 111.092 179.476 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' F' F ' 39' ' ' ILE . . . . . . . . . . . . . 74.7 mt -123.47 133.35 69.43 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.262 0 N-CA-C 110.087 -0.338 . . . . 18.48 110.087 178.845 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' F' F ' 40' ' ' SER . . . . . . . . . . . . . 25.0 t -93.46 123.03 36.49 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.509 -0.314 . . . . 21.9 111.352 177.584 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' F' F ' 41' ' ' ILE . . . . . . . . . . . . . 73.2 mt -123.79 116.41 48.03 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.214 0 CA-C-N 116.348 -0.387 . . . . 20.06 110.136 176.667 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' F' F ' 42' ' ' LEU . . . . . . . . . . . . . 8.7 mp 51.06 37.08 16.98 Favored 'General case' 0 N--CA 1.465 0.313 0 CA-C-O 121.174 0.511 . . . . 22.47 111.507 178.694 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' F' F ' 43' ' ' GLY . . . . . . . . . . . . . . . 74.06 32.21 58.82 Favored Glycine 0 CA--C 1.529 0.948 0 C-N-CA 121.163 -0.541 . . . . 23.1 112.016 178.95 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' F' F ' 44' ' ' LYS . . . . . . . . . . . . . 87.6 tttt -130.62 125.9 35.27 Favored 'General case' 0 C--N 1.331 -0.232 0 N-CA-C 109.535 -0.543 . . . . 21.12 109.535 177.227 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' F' F ' 45' ' ' GLU . . . . . . . . . . . . . 82.1 tt0 -84.39 115.6 22.61 Favored 'General case' 0 C--N 1.328 -0.369 0 C-N-CA 120.811 -0.356 . . . . 20.71 110.966 -178.891 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' F' F ' 46' ' ' VAL . . . . . . . . . . . . . 7.3 p -115.25 130.36 69.93 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.243 0 N-CA-C 109.191 -0.67 . . . . 16.87 109.191 175.38 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' F' F ' 47' ' ' LYS . . . . . . . . . . . . . 63.5 mttp -99.48 125.81 45.3 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 115.97 -0.559 . . . . 18.86 111.119 179.089 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' F' F ' 48' ' ' PHE . . . . . . . . . . . . . 87.6 m-85 -108.9 131.95 54.53 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.078 -0.51 . . . . 14.18 109.899 176.735 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' F' F ' 49' ' ' LYS . . . . . . . . . . . . . 46.8 tttm -106.31 137.34 44.44 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.222 -0.445 . . . . 14.73 110.326 179.483 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' F' F ' 50' ' ' VAL . . . . . . . . . . . . . 47.6 t -81.04 107.09 13.0 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.333 0 N-CA-C 109.324 -0.621 . . . . 14.98 109.324 175.769 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' F' F ' 51' ' ' VAL . . . . . . . . . . . . . 56.6 t -70.57 -53.49 22.22 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.312 0 CA-C-N 115.864 -0.607 . . . . 13.92 109.452 -175.282 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' F' F ' 52' ' ' GLN . . . . . . . . . . . . . 88.1 mt-30 -154.34 151.96 29.68 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 115.99 -0.55 . . . . 15.71 111.822 -178.31 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' F' F ' 53' ' ' ALA . . . . . . . . . . . . . . . -129.68 130.79 45.98 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 115.21 -0.905 . . . . 18.15 109.552 174.06 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' F' F ' 54' ' ' TYR . . . . . . . . . . . . . 8.3 t80 -129.18 110.55 18.12 Favored Pre-proline 0 CA--C 1.535 0.383 0 CA-C-O 118.214 -0.898 . . . . 22.12 110.038 177.652 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' F' F ' 55' ' ' PRO . . . . . . . . . . . . . 74.0 Cg_endo -77.16 169.75 73.37 Favored 'Cis proline' 0 N--CA 1.5 1.857 0 CA-C-N 121.999 1.75 . . . . 22.21 112.666 -2.796 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' F' F ' 56' ' ' SER . . . . . . . . . . . . . 13.6 m -116.82 127.95 26.37 Favored Pre-proline 0 CA--C 1.539 0.554 0 CA-C-O 118.383 -0.818 . . . . 23.18 109.474 176.643 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' F' F ' 57' ' ' PRO . . . . . . . . . . . . . 37.6 Cg_endo -66.95 167.94 55.24 Favored 'Cis proline' 0 N--CA 1.497 1.726 0 CA-C-N 121.994 1.748 . . . . 24.03 111.466 -1.103 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' F' F ' 58' ' ' LEU . . . . . . . . . . . . . 33.5 tp -129.43 135.82 49.15 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-O 120.935 0.398 . . . . 20.69 110.507 -179.834 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' F' F ' 59' ' ' ARG . . . . . . . . . . . . . 52.5 ttt85 -97.56 127.23 43.35 Favored 'General case' 0 C--N 1.326 -0.417 0 N-CA-C 109.259 -0.645 . . . . 25.29 109.259 177.237 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' F' F ' 60' ' ' VAL . . . . . . . . . . . . . 42.6 t -82.52 114.68 23.77 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.208 0 C-N-CA 120.564 -0.454 . . . . 20.51 110.2 -176.169 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' F' F ' 61' ' ' GLU . . . . . . . . . . . . . 95.7 mt-10 -131.14 158.15 41.24 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 115.806 -0.634 . . . . 23.66 110.117 177.844 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' F' F ' 62' ' ' ASP . . . . . . . . . . . . . 4.6 p-10 -55.51 -32.46 62.91 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-N 116.511 -0.313 . . . . 21.75 111.513 177.951 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' F' F ' 63' ' ' ARG . . . . . . . . . . . . . 14.4 ptp180 -75.59 -4.94 42.84 Favored 'General case' 0 CA--C 1.535 0.389 0 N-CA-C 113.578 0.955 . . . . 25.02 113.578 -177.177 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' F' F ' 64' ' ' THR . . . . . . . . . . . . . 30.5 m -91.76 145.97 24.14 Favored 'General case' 0 C--N 1.332 -0.156 0 CA-C-N 118.271 0.487 . . . . 19.14 110.376 -178.036 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' F' F ' 65' ' ' LYS . . . . . . . . . . . . . 51.9 mtmt -87.55 124.9 33.97 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-O 121.109 0.481 . . . . 19.04 110.328 179.998 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' F' F ' 66' ' ' ILE . . . . . . . . . . . . . 71.5 mt -116.29 124.38 72.46 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.289 0 N-CA-C 109.704 -0.48 . . . . 15.12 109.704 -179.555 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' F' F ' 67' ' ' THR . . . . . . . . . . . . . 25.3 m -123.59 146.27 48.28 Favored 'General case' 0 C--N 1.331 -0.223 0 CA-C-O 121.054 0.455 . . . . 12.47 111.201 -175.776 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' F' F ' 68' ' ' LEU . . . . . 0.49 HD12 ' N ' ' F' ' 68' ' ' LEU . 8.2 mp -106.46 130.29 54.28 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 115.902 -0.59 . . . . 9.77 110.664 178.796 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' F' F ' 69' ' ' VAL . . . . . . . . . . . . . 45.8 t -101.75 138.26 26.6 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.287 0 CA-C-N 115.977 -0.556 . . . . 8.23 109.896 178.574 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' F' F ' 70' ' ' THR . . . . . . . . . . . . . 21.7 p -131.69 -46.3 0.96 Allowed 'General case' 0 C--N 1.331 -0.231 0 CA-C-N 116.503 -0.317 . . . . 6.29 110.966 -178.272 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' F' F ' 71' ' ' HIS . . . . . . . . . . . . . 51.3 m-70 -134.42 154.65 79.92 Favored Pre-proline 0 C--N 1.33 -0.258 0 CA-C-N 116.686 -0.234 . . . . 7.28 110.802 -179.157 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' F' F ' 72' ' ' PRO . . . . . . . . . . . . . 59.5 Cg_endo -74.99 -29.97 7.66 Favored 'Trans proline' 0 N--CA 1.495 1.577 0 C-N-CA 121.356 1.371 . . . . 3.42 112.608 -179.888 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' F' F ' 73' ' ' VAL . . . . . . . . . . . . . 33.4 m -132.99 168.62 23.82 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.192 0 CA-C-O 120.88 0.371 . . . . 1.16 110.737 179.815 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' F' F ' 74' ' ' ASP . . . . . 0.431 ' OD1' HD11 ' F' ' 76' ' ' LEU . 2.5 t70 -101.35 127.96 47.74 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 115.954 -0.567 . . . . 1.06 109.947 179.825 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' F' F ' 75' ' ' VAL . . . . . . . . . . . . . 42.2 t -119.59 124.31 72.68 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.277 0 CA-C-O 120.935 0.398 . . . . 0.62 110.607 -178.273 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' F' F ' 76' ' ' LEU . . . . . 0.431 HD11 ' OD1' ' F' ' 74' ' ' ASP . 5.8 mp -122.48 140.72 52.42 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 115.825 -0.625 . . . . 1.06 109.79 175.689 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' F' F ' 77' ' ' GLU . . . . . . . . . . . . . 98.2 mt-10 -133.69 140.75 47.23 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-O 121.075 0.464 . . . . 1.24 111.324 -178.442 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' F' F ' 78' ' ' ALA . . . . . . . . . . . . . . . -130.9 130.2 43.21 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 115.8 -0.636 . . . . 0.61 109.971 176.326 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' F' F ' 79' ' ' LYS . . . . . 0.584 ' O ' HD13 ' F' ' 80' ' ' ILE . 35.5 mmtt -76.55 119.43 20.37 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-O 121.05 0.452 . . . . 2.99 110.847 179.334 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' F' F ' 80' ' ' ILE . . . . . 0.584 HD13 ' O ' ' F' ' 79' ' ' LYS . 41.1 mm -139.26 100.86 1.45 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.285 0 N-CA-C 108.814 -0.81 . . . . 0.65 108.814 -179.093 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' F' F ' 81' ' ' LYS . . . . . . . . . . . . . 81.3 tttt -91.41 127.5 36.88 Favored 'General case' 0 C--N 1.327 -0.388 0 C-N-CA 120.804 -0.358 . . . . 3.19 111.085 -174.967 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' F' F ' 82' ' ' GLY . . . . . . . . . . . . . . . 89.16 42.16 5.66 Favored Glycine 0 CA--C 1.525 0.715 0 C-N-CA 120.772 -0.728 . . . . 0.65 111.974 174.961 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' F' F ' 83' ' ' ILE . . . . . . . . . . . . . 70.4 mt -72.78 138.02 22.28 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.241 0 N-CA-C 109.611 -0.514 . . . . 0.6 109.611 175.802 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' F' F ' 84' ' ' LYS . . . . . . . . . . . . . 55.7 tttp -97.89 -53.99 3.23 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.13 -0.486 . . . . 1.54 110.377 -178.325 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' F' F ' 85' ' ' ASP . . . . . . . . . . . . . 22.5 t70 -148.88 148.5 29.93 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 115.92 -0.582 . . . . 0.75 110.54 -177.381 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' F' F ' 86' ' ' VAL . . . . . . . . . . . . . 43.8 t -129.77 130.25 66.58 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.259 0 CA-C-O 120.924 0.393 . . . . 0.48 110.49 -179.518 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' F' F ' 87' ' ' ILE . . . . . 0.496 HD12 ' N ' ' F' ' 87' ' ' ILE . 5.1 mp -115.59 125.66 72.86 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.283 0 CA-C-N 115.8 -0.636 . . . . 1.33 109.352 176.51 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' F' F ' 88' ' ' LEU . . . . . . . . . . . . . 18.1 tp -111.49 131.2 55.39 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-O 121.056 0.455 . . . . 1.67 111.297 -176.465 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' F' F ' 89' ' ' ASP . . . . . . . . . . . . . 31.4 t0 -130.99 153.97 48.66 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 115.718 -0.674 . . . . 0.83 109.546 176.225 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' F' F ' 90' ' ' GLU . . . . . . . . . . . . . 95.9 mt-10 -49.34 -37.98 26.49 Favored 'General case' 0 C--N 1.328 -0.331 0 N-CA-C 112.749 0.648 . . . . 2.21 112.749 -171.959 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' F' F ' 91' ' ' ASN . . . . . . . . . . . . . 25.6 m120 -122.57 14.54 10.23 Favored 'General case' 0 N--CA 1.469 0.5 0 N-CA-C 113.193 0.812 . . . . 2.27 113.193 -176.84 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' F' F ' 92' ' ' LEU . . . . . . . . . . . . . 49.0 mt -148.74 141.52 24.6 Favored 'General case' 0 C--N 1.332 -0.195 0 CA-C-O 120.838 0.351 . . . . 1.42 110.516 -175.919 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' F' F ' 93' ' ' ILE . . . . . . . . . . . . . 73.2 mt -124.65 116.17 46.63 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.37 0 N-CA-C 109.063 -0.717 . . . . 0.46 109.063 176.256 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' F' F ' 94' ' ' VAL . . . . . 0.558 HG11 HG11 ' F' ' 123' ' ' VAL . 45.0 t -117.36 125.16 73.84 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.249 0 N-CA-C 109.907 -0.405 . . . . 0.46 109.907 -178.439 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' F' F ' 95' ' ' VAL . . . . . . . . . . . . . 42.2 t -120.84 133.41 67.6 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.344 0 CA-C-N 116.055 -0.52 . . . . 0.42 109.766 -179.739 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' F' F ' 96' ' ' ILE . . . . . . . . . . . . . 59.1 mt -114.01 128.11 71.12 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.297 0 N-CA-C 109.124 -0.695 . . . . 0.46 109.124 178.353 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' F' F ' 97' ' ' THR . . . . . . . . . . . . . 62.7 p -101.1 161.37 13.65 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-O 121.034 0.445 . . . . 0.5 110.999 -177.65 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' F' F ' 98' ' ' GLU . . . . . . . . . . . . . 97.3 mt-10 -54.03 -26.09 24.71 Favored 'General case' 0 CA--C 1.532 0.284 0 N-CA-C 112.345 0.498 . . . . 2.47 112.345 179.958 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' F' F ' 99' ' ' GLU . . . . . . . . . . . . . 95.1 mt-10 -77.69 13.08 1.4 Allowed 'General case' 0 CA--C 1.535 0.384 0 N-CA-C 113.24 0.829 . . . . 2.06 113.24 -177.748 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' F' F ' 100' ' ' ASN . . . . . . . . . . . . . 2.9 m-20 61.23 37.61 17.22 Favored 'General case' 0 CA--C 1.529 0.169 0 CA-C-O 121.106 0.479 . . . . 0.74 110.955 179.442 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' F' F ' 101' ' ' GLU . . . . . . . . . . . . . 84.0 tt0 -115.93 144.72 43.67 Favored 'General case' 0 C--N 1.334 -0.108 0 CA-C-N 116.062 -0.517 . . . . 0.54 109.606 176.182 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' F' F ' 102' ' ' VAL . . . . . . . . . . . . . 45.5 t -114.97 125.35 72.27 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.261 0 CA-C-N 116.291 -0.413 . . . . 0.44 109.963 -178.092 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' F' F ' 103' ' ' LEU . . . . . . . . . . . . . 26.4 mt -113.44 128.84 56.59 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 115.621 -0.718 . . . . 0.86 109.909 175.883 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' F' F ' 104' ' ' ILE . . . . . . . . . . . . . 65.3 mt -118.42 119.16 60.37 Favored 'Isoleucine or valine' 0 C--O 1.233 0.229 0 N-CA-C 110.308 -0.256 . . . . 0.45 110.308 -179.25 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' F' F ' 105' ' ' PHE . . . . . . . . . . . . . 49.0 m-85 -118.99 169.45 9.89 Favored 'General case' 0 C--N 1.332 -0.157 0 CA-C-N 115.423 -0.808 . . . . 0.49 109.71 177.152 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' F' F ' 106' ' ' ASN . . . . . . . . . . . . . 51.2 p-10 -102.03 -170.15 1.78 Allowed 'General case' 0 C--N 1.33 -0.277 0 N-CA-C 109.886 -0.413 . . . . 0.62 109.886 172.987 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' F' F ' 107' ' ' GLN . . . . . 0.423 ' O ' HD21 ' E' ' 140' ' ' LEU . 48.5 tt0 -59.79 -29.96 68.58 Favored 'General case' 0 C--N 1.33 -0.264 0 N-CA-C 111.766 0.284 . . . . 1.17 111.766 178.535 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' F' F ' 108' ' ' ASN . . . . . . . . . . . . . 3.6 t-20 -81.9 9.88 7.39 Favored 'General case' 0 CA--C 1.537 0.459 0 N-CA-C 112.976 0.732 . . . . 1.23 112.976 -178.496 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' F' F ' 109' ' ' LEU . . . . . . . . . . . . . 8.1 tp 58.12 36.38 25.85 Favored 'General case' 0 CA--C 1.529 0.164 0 CA-C-O 120.874 0.369 . . . . 1.33 111.461 177.9 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' F' F ' 110' ' ' GLU . . . . . . . . . . . . . 47.2 mt-10 -105.1 151.22 24.28 Favored 'General case' 0 C--N 1.33 -0.241 0 N-CA-C 109.781 -0.451 . . . . 1.71 109.781 176.67 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' F' F ' 111' ' ' GLU . . . . . . . . . . . . . 83.1 tt0 -83.92 121.92 28.03 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-O 120.858 0.361 . . . . 1.71 110.73 -176.634 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' F' F ' 112' ' ' LEU . . . . . . . . . . . . . 37.4 mt -107.77 -46.2 3.85 Favored 'General case' 0 C--N 1.332 -0.181 0 CA-C-N 116.112 -0.494 . . . . 0.69 110.809 179.241 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' F' F ' 113' ' ' TYR . . . . . . . . . . . . . 42.9 t80 -138.82 139.66 38.27 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-N 116.385 -0.37 . . . . 0.57 111.377 -178.249 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' F' F ' 114' ' ' ARG . . . . . . . . . . . . . 23.7 ttp-105 -136.15 123.75 22.29 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 115.913 -0.585 . . . . 2.6 110.167 176.234 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' F' F ' 115' ' ' GLY . . . . . . . . . . . . . . . -150.06 155.4 26.22 Favored Glycine 0 CA--C 1.521 0.446 0 N-CA-C 110.855 -0.898 . . . . 0.53 110.855 178.677 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' F' F ' 116' ' ' LYS . . . . . . . . . . . . . 33.9 ttmt -127.44 137.78 52.8 Favored 'General case' 0 C--N 1.329 -0.284 0 N-CA-C 109.925 -0.398 . . . . 1.66 109.925 177.009 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' F' F ' 117' ' ' PHE . . . . . . . . . . . . . 31.9 m-85 -137.42 114.51 10.77 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.254 -0.43 . . . . 0.53 109.932 -176.002 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' F' F ' 118' ' ' GLU . . . . . . . . . . . . . 84.4 tt0 -53.77 -42.36 68.16 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.557 -0.292 . . . . 2.71 111.349 -177.134 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' F' F ' 119' ' ' ASN . . . . . . . . . . . . . 30.8 m-80 -99.51 31.14 3.26 Favored 'General case' 0 C--N 1.33 -0.272 0 N-CA-C 112.075 0.398 . . . . 1.32 112.075 -175.062 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' F' F ' 120' ' ' LEU . . . . . . . . . . . . . 25.8 tp -58.53 119.94 7.94 Favored 'General case' 0 C--N 1.332 -0.171 0 N-CA-C 110.033 -0.358 . . . . 0.48 110.033 178.34 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' F' F ' 121' ' ' ASN . . . . . . . . . . . . . 48.3 t30 -114.16 -43.98 3.18 Favored 'General case' 0 C--N 1.332 -0.173 0 CA-C-N 116.372 -0.376 . . . . 1.85 110.909 -178.146 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' F' F ' 122' ' ' LYS . . . . . . . . . . . . . 57.1 mttm -141.62 146.81 36.66 Favored 'General case' 0 C--N 1.331 -0.227 0 CA-C-O 121.111 0.481 . . . . 1.96 111.577 -176.011 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' F' F ' 123' ' ' VAL . . . . . 0.558 HG11 HG11 ' F' ' 94' ' ' VAL . 46.7 t -130.12 129.53 65.47 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.307 0 N-CA-C 109.177 -0.675 . . . . 0.49 109.177 173.82 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' F' F ' 124' ' ' LEU . . . . . . . . . . . . . 81.8 mt -130.95 139.81 50.09 Favored 'General case' 0 C--N 1.332 -0.192 0 CA-C-O 121.086 0.469 . . . . 1.57 111.322 -175.613 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' F' F ' 125' ' ' VAL . . . . . 0.619 HG12 HG23 ' F' ' 130' ' ' VAL . 35.8 m -128.0 131.54 69.43 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.216 0 CA-C-N 115.696 -0.683 . . . . 1.64 110.213 177.689 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' F' F ' 126' ' ' ARG . . . . . . . . . . . . . 77.6 mtt180 -147.39 124.29 11.3 Favored 'General case' 0 C--N 1.327 -0.372 0 N-CA-C 109.656 -0.498 . . . . 3.24 109.656 178.639 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' F' F ' 127' ' ' ASN . . . . . . . . . . . . . 18.4 t30 56.85 -152.3 0.39 Allowed 'General case' 0 CA--C 1.54 0.565 0 N-CA-C 109.57 -0.53 . . . . 2.21 109.57 -178.828 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' F' F ' 128' ' ' ASP . . . . . . . . . . . . . 20.7 p-10 -81.13 14.65 2.22 Favored 'General case' 0 CA--C 1.537 0.46 0 N-CA-C 112.772 0.656 . . . . 1.07 112.772 178.235 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' F' F ' 129' ' ' LEU . . . . . . . . . . . . . 16.5 tp -114.33 137.24 52.06 Favored 'General case' 0 C--O 1.232 0.166 0 O-C-N 122.027 -0.42 . . . . 1.85 109.953 179.315 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' F' F ' 130' ' ' VAL . . . . . 0.619 HG23 HG12 ' F' ' 125' ' ' VAL . 12.3 p -130.22 141.81 45.39 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.268 0 CA-C-O 120.842 0.353 . . . . 1.29 110.528 -178.18 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' F' F ' 131' ' ' VAL . . . . . 0.401 ' CG2' HD21 ' F' ' 138' ' ' LEU . 14.7 p -136.17 143.01 37.1 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.207 0 CA-C-O 121.063 0.458 . . . . 0.89 111.386 -179.584 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' F' F ' 132' ' ' ILE . . . . . . . . . . . . . 70.2 mt -116.15 132.68 64.97 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.32 0 CA-C-N 115.577 -0.738 . . . . 0.41 109.044 176.188 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' F' F ' 133' ' ' ILE . . . . . . . . . . . . . 37.3 mm -116.05 121.75 68.12 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.296 0 CA-C-O 120.785 0.326 . . . . 0.39 111.386 -173.601 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' F' F ' 134' ' ' ASP . . . . . . . . . . . . . 2.8 p30 -130.68 148.64 52.49 Favored 'General case' 0 C--N 1.331 -0.219 0 N-CA-C 109.534 -0.543 . . . . 0.51 109.534 174.294 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' F' F ' 135' ' ' GLU . . . . . . . . . . . . . 84.4 tt0 -50.96 -27.53 7.86 Favored 'General case' 0 C--N 1.326 -0.424 0 N-CA-C 112.955 0.724 . . . . 1.83 112.955 -171.939 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' F' F ' 136' ' ' GLN . . . . . . . . . . . . . 98.1 mt-30 -86.18 -27.82 24.31 Favored 'General case' 0 C--O 1.234 0.24 0 N-CA-C 112.845 0.683 . . . . 1.86 112.845 -175.251 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' F' F ' 137' ' ' LYS . . . . . . . . . . . . . 33.2 pttt -170.01 172.72 6.35 Favored 'General case' 0 C--N 1.331 -0.208 0 CA-C-O 121.588 0.708 . . . . 1.76 112.378 -173.178 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' F' F ' 138' ' ' LEU . . . . . 0.401 HD21 ' CG2' ' F' ' 131' ' ' VAL . 7.1 tt -120.06 130.17 54.56 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 114.998 -1.001 . . . . 0.78 110.048 -179.428 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' F' F ' 139' ' ' THR . . . . . . . . . . . . . 46.5 m -108.51 120.59 42.88 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 116.207 -0.451 . . . . 0.45 109.92 177.786 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' F' F ' 140' ' ' LEU . . . . . . . . . . . . . 17.6 tp -109.71 125.85 53.08 Favored 'General case' 0 C--N 1.329 -0.291 0 N-CA-C 109.31 -0.626 . . . . 1.13 109.31 -178.015 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' F' F ' 141' ' ' ILE . . . . . 0.538 ' HB ' HG13 ' F' ' 130' ' ' VAL . 19.4 mt -123.46 122.76 65.89 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.275 0 CA-C-O 120.843 0.354 . . . . 0.53 110.19 -172.918 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' F' F ' 142' ' ' ARG . . . . . . . . . . . . . 80.6 mtp180 -108.04 126.64 52.97 Favored 'General case' 0 C--N 1.331 -0.219 0 CA-C-N 115.491 -0.777 . . . . 3.85 110.269 -179.466 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' F' F ' 143' ' ' THR . . . . . . . . . . . . . 66.5 p . . . . . 0 C--O 1.22 -0.472 0 CA-C-O 118.09 -0.957 . . . . 1.61 110.493 179.749 . . . . . . . . 0 0 . 1 . 002 nuclear build full ' A' A ' -3' ' ' GLU . . . . . . . . . . . . . 84.8 tt0 . . . . . 0 N--CA 1.49 1.551 0 N-CA-C 109.297 -0.631 . . . . 0.0 109.297 . . . . . . . . . 0 0 . 1 . 002 nuclear build full ' A' A ' -2' ' ' GLY . . . . . . . . . . . . . . . -81.47 135.23 14.13 Favored Glycine 0 CA--C 1.525 0.664 0 N-CA-C 111.102 -0.799 . . . . 0.0 111.102 -179.437 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' -1' ' ' VAL . . . . . . . . . . . . . 46.7 t -96.01 129.43 46.1 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.285 0 N-CA-C 109.898 -0.408 . . . . 0.0 109.898 178.938 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 0' ' ' ILE . . . . . . . . . . . . . 73.7 mt -114.28 128.17 71.41 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.243 0 CA-C-N 116.241 -0.436 . . . . 0.0 109.995 -179.137 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 25.5 ptp -85.36 140.3 30.88 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.142 -0.481 . . . . 0.0 110.924 -178.679 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 2.8 p -117.6 139.24 51.24 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-N 116.047 -0.524 . . . . 0.0 110.479 179.359 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 84.4 tt0 -140.17 143.36 36.08 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.187 -0.46 . . . . 0.0 110.988 -178.721 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 4' ' ' LEU . . . . . 0.437 HD12 HD23 ' A' ' 58' ' ' LEU . 4.9 tt -127.88 127.24 43.06 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 115.864 -0.607 . . . . 0.0 109.997 177.964 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 5' ' ' LYS . . . . . 0.418 ' N ' HD23 ' A' ' 4' ' ' LEU . 98.0 mttt -108.7 122.8 47.87 Favored 'General case' 0 C--O 1.234 0.249 0 CA-C-O 120.771 0.32 . . . . 0.0 110.909 -179.586 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 22.4 mt -113.99 150.06 34.4 Favored 'General case' 0 C--N 1.332 -0.177 0 CA-C-N 115.393 -0.821 . . . . 0.0 110.065 179.552 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 61.0 tttt -137.95 137.2 20.8 Favored Pre-proline 0 CA--C 1.535 0.377 0 CA-C-O 118.942 -0.552 . . . . 0.0 110.007 175.852 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 8' ' ' PRO . . . . . . . . . . . . . 85.9 Cg_endo -87.61 141.7 5.66 Favored 'Trans proline' 0 N--CA 1.492 1.386 0 C-N-CA 121.541 1.494 . . . . 0.0 111.792 177.575 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 46.7 mt -78.23 -47.07 2.11 Favored Pre-proline 0 CA--C 1.533 0.305 0 CA-C-O 118.745 -0.645 . . . . 0.0 112.275 -179.118 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 92.4 Cg_endo -81.98 153.9 17.05 Favored 'Trans proline' 0 N--CA 1.496 1.655 0 C-N-CA 121.269 1.313 . . . . 0.0 111.901 175.353 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 59.8 mttp -89.38 99.93 12.83 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.458 -0.337 . . . . 0.0 110.82 179.513 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 12.0 p -145.76 143.08 21.78 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.268 0 CA-C-N 116.236 -0.438 . . . . 0.0 110.493 179.198 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 43.9 mp0 -79.88 125.87 30.27 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.379 -0.373 . . . . 0.0 110.148 177.687 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 14' ' ' LEU . . . . . . . . . . . . . 29.5 mt -97.89 154.59 37.75 Favored Pre-proline 0 C--N 1.329 -0.284 0 CA-C-N 116.487 -0.324 . . . . 0.0 111.02 -177.651 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 15' ' ' PRO . . . . . . . . . . . . . 35.4 Cg_exo -59.88 160.6 21.17 Favored 'Trans proline' 0 N--CA 1.497 1.686 0 C-N-CA 121.364 1.376 . . . . 0.0 111.872 177.957 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 16' ' ' PRO . . . . . . . . . . . . . 25.7 Cg_exo -61.33 -43.19 29.74 Favored 'Trans proline' 0 N--CA 1.497 1.686 0 C-N-CA 121.571 1.514 . . . . 0.0 112.571 -179.031 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 17' ' ' ASP . . . . . . . . . . . . . 17.9 p-10 -88.34 17.0 5.57 Favored 'General case' 0 CA--C 1.535 0.371 0 N-CA-C 112.953 0.723 . . . . 0.0 112.953 -177.219 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 18' ' ' PHE . . . . . . . . . . . . . 42.7 t80 -58.27 -45.87 87.07 Favored 'General case' 0 C--N 1.334 -0.087 0 O-C-N 122.142 -0.349 . . . . 0.0 110.081 -178.489 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 19' ' ' VAL . . . . . . . . . . . . . 13.3 p -55.59 -39.69 55.72 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 CA-C-N 116.423 -0.353 . . . . 0.0 110.937 -179.532 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 77.5 m-20 -60.42 -46.65 89.27 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-O 120.926 0.393 . . . . 0.0 110.876 -178.378 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 46.4 t -64.27 -47.25 90.59 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.347 0 CA-C-N 116.365 -0.38 . . . . 0.0 110.561 -177.229 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 22' ' ' ILE . . . . . 0.506 HG22 HD12 ' A' ' 26' ' ' LEU . 50.9 mm -56.36 -45.33 81.5 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.218 0 C-N-CA 120.947 -0.301 . . . . 0.0 110.58 179.335 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 23' ' ' ARG . . . . . . . . . . . . . 59.2 ttp180 -54.24 -46.5 72.57 Favored 'General case' 0 C--N 1.33 -0.27 0 C-N-CA 121.164 -0.215 . . . . 0.0 111.366 -179.062 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 24' ' ' ILE . . . . . . . . . . . . . 74.7 mt -58.91 -45.09 92.03 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 C-N-CA 121.137 -0.225 . . . . 0.0 111.057 -179.467 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 93.8 mttt -65.22 -40.66 94.39 Favored 'General case' 0 C--N 1.329 -0.302 0 N-CA-C 112.352 0.501 . . . . 0.0 112.352 -177.89 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 26' ' ' LEU . . . . . 0.506 HD12 HG22 ' A' ' 22' ' ' ILE . 80.1 mt -79.64 -42.19 25.37 Favored 'General case' 0 C--N 1.33 -0.274 0 N-CA-C 112.898 0.703 . . . . 0.0 112.898 -171.575 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 27' ' ' GLN . . . . . . . . . . . . . 14.2 pt20 -46.05 139.51 4.41 Favored 'General case' 0 N--CA 1.469 0.49 0 N-CA-C 112.79 0.663 . . . . 0.0 112.79 -175.292 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 101.33 -28.61 15.21 Favored Glycine 0 CA--C 1.531 1.058 0 CA-C-N 115.483 -0.781 . . . . 0.0 111.973 -176.779 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 90.4 mttt -98.16 155.23 17.26 Favored 'General case' 0 C--O 1.233 0.203 0 CA-C-N 117.267 0.533 . . . . 0.0 111.055 178.452 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 30' ' ' THR . . . . . . . . . . . . . 38.0 m -101.6 138.36 38.69 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.235 -0.438 . . . . 0.0 109.831 175.026 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 34.5 m -126.31 156.45 36.8 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.191 0 CA-C-N 116.45 -0.341 . . . . 0.0 110.675 -178.822 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 32' ' ' ARG . . . . . . . . . . . . . 90.4 mtt180 -132.93 150.39 52.16 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.0 -0.545 . . . . 0.0 110.683 178.858 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 33' ' ' THR . . . . . . . . . . . . . 24.5 m -52.5 139.07 26.24 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.177 -0.465 . . . . 0.0 111.453 -178.643 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 99.47 -17.14 58.13 Favored Glycine 0 CA--C 1.533 1.175 0 CA-C-O 119.631 -0.538 . . . . 0.0 113.29 178.598 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 74.7 m-20 -65.6 148.72 51.27 Favored 'General case' 0 C--N 1.334 -0.073 0 CA-C-N 118.081 0.941 . . . . 0.0 110.954 179.463 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 46.9 t -123.13 130.1 74.58 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.249 0 CA-C-N 115.87 -0.605 . . . . 0.0 109.797 178.241 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 37' ' ' ILE . . . . . . . . . . . . . 63.3 mt -117.57 137.97 49.76 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.275 0 N-CA-C 109.844 -0.428 . . . . 0.0 109.844 -179.742 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . -108.3 128.75 9.25 Favored Glycine 0 CA--C 1.525 0.701 0 N-CA-C 110.957 -0.857 . . . . 0.0 110.957 179.885 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 39' ' ' ILE . . . . . . . . . . . . . 75.8 mt -127.02 135.51 63.41 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.244 0 N-CA-C 110.12 -0.326 . . . . 0.0 110.12 179.4 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 40' ' ' SER . . . . . . . . . . . . . 11.1 p -92.04 115.15 27.82 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.218 -0.447 . . . . 0.0 110.751 176.085 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 41' ' ' ILE . . . . . . . . . . . . . 43.7 mm -120.82 116.78 50.98 Favored 'Isoleucine or valine' 0 N--CA 1.462 0.171 0 CA-C-O 120.772 0.32 . . . . 0.0 110.498 -179.81 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 6.8 mp 50.9 37.12 16.51 Favored 'General case' 0 C--N 1.331 -0.219 0 CA-C-O 121.081 0.467 . . . . 0.0 111.656 177.301 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . 75.16 30.71 58.52 Favored Glycine 0 CA--C 1.528 0.886 0 C-N-CA 121.072 -0.585 . . . . 0.0 112.345 176.67 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 44' ' ' LYS . . . . . . . . . . . . . 16.5 ttmm -136.04 132.69 36.56 Favored 'General case' 0 C--N 1.33 -0.274 0 N-CA-C 109.861 -0.422 . . . . 0.0 109.861 176.652 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 79.0 tt0 -81.79 113.34 19.68 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.408 -0.36 . . . . 0.0 110.747 -178.844 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 46' ' ' VAL . . . . . . . . . . . . . 7.3 p -116.01 125.92 73.31 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.195 0 N-CA-C 109.628 -0.508 . . . . 0.0 109.628 177.936 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 97.1 mttt -100.48 130.0 46.5 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 115.965 -0.561 . . . . 0.0 111.287 178.445 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 48' ' ' PHE . . . . . . . . . . . . . 80.7 m-85 -111.2 131.95 54.71 Favored 'General case' 0 C--N 1.329 -0.296 0 N-CA-C 109.749 -0.463 . . . . 0.0 109.749 175.902 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 85.5 tttt -107.04 137.01 45.92 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.288 -0.415 . . . . 0.0 110.674 -179.172 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 50' ' ' VAL . . . . . . . . . . . . . 42.9 t -81.26 108.78 14.86 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.262 0 N-CA-C 109.462 -0.57 . . . . 0.0 109.462 176.094 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 51' ' ' VAL . . . . . . . . . . . . . 45.2 t -70.2 -49.29 55.97 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.288 0 CA-C-N 115.971 -0.559 . . . . 0.0 109.924 -174.116 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 52' ' ' GLN . . . . . . . . . . . . . 46.6 tt0 -168.13 142.5 3.45 Favored 'General case' 0 C--N 1.33 -0.273 0 C-N-CA 120.082 -0.647 . . . . 0.0 112.009 -177.378 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 53' ' ' ALA . . . . . 0.453 ' HB3' ' OG ' ' A' ' 56' ' ' SER . . . -113.08 133.39 55.02 Favored 'General case' 0 C--N 1.331 -0.215 0 CA-C-N 115.395 -0.82 . . . . 0.0 109.81 175.496 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 54' ' ' TYR . . . . . . . . . . . . . 50.5 t80 -129.03 107.29 18.02 Favored Pre-proline 0 CA--C 1.534 0.351 0 CA-C-O 118.314 -0.85 . . . . 0.0 110.41 179.709 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 55' ' ' PRO . . . . . . . . . . . . . 72.6 Cg_endo -77.14 169.19 74.92 Favored 'Cis proline' 0 N--CA 1.5 1.884 0 CA-C-N 121.764 1.666 . . . . 0.0 112.291 -4.827 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 56' ' ' SER . . . . . 0.453 ' OG ' ' HB3' ' A' ' 53' ' ' ALA . 74.7 m -117.3 137.31 23.9 Favored Pre-proline 0 CA--C 1.538 0.49 0 CA-C-O 118.494 -0.765 . . . . 0.0 109.691 175.114 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 57' ' ' PRO . . . . . . . . . . . . . 36.5 Cg_endo -66.72 161.66 75.03 Favored 'Cis proline' 0 N--CA 1.499 1.797 0 CA-C-N 121.746 1.659 . . . . 0.0 111.388 -3.385 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 58' ' ' LEU . . . . . 0.437 HD23 HD12 ' A' ' 4' ' ' LEU . 28.8 tp -130.03 137.29 50.18 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-O 120.945 0.403 . . . . 0.0 110.676 -178.785 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 59' ' ' ARG . . . . . . . . . . . . . 73.8 ttt180 -99.11 135.4 40.56 Favored 'General case' 0 C--N 1.327 -0.394 0 N-CA-C 109.513 -0.551 . . . . 0.0 109.513 175.395 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 40.3 t -84.93 116.33 28.28 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.287 0 C-N-CA 120.652 -0.419 . . . . 0.0 110.453 -177.398 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 34.6 tp10 -131.03 155.49 46.78 Favored 'General case' 0 C--N 1.329 -0.288 0 N-CA-C 109.088 -0.708 . . . . 0.0 109.088 177.138 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 62' ' ' ASP . . . . . . . . . . . . . 77.4 m-20 -51.68 -32.26 29.15 Favored 'General case' 0 C--N 1.326 -0.438 0 N-CA-C 112.134 0.42 . . . . 0.0 112.134 -175.787 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 63' ' ' ARG . . . . . . . . . . . . . 34.5 mmt180 -74.48 -21.61 59.49 Favored 'General case' 0 C--N 1.33 -0.281 0 N-CA-C 113.022 0.749 . . . . 0.0 113.022 -175.447 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 20.8 m -63.29 141.44 58.76 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-O 120.849 0.357 . . . . 0.0 110.824 -176.148 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 65' ' ' LYS . . . . . . . . . . . . . 94.4 mttt -84.06 123.96 30.59 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.191 -0.459 . . . . 0.0 109.796 178.013 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 66' ' ' ILE . . . . . . . . . . . . . 54.9 mt -113.83 129.7 69.25 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.247 0 N-CA-C 109.994 -0.373 . . . . 0.0 109.994 -178.803 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 67' ' ' THR . . . . . . . . . . . . . 12.0 m -125.16 136.63 53.78 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-N 116.234 -0.439 . . . . 0.0 110.736 -179.058 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 68' ' ' LEU . . . . . 0.433 ' N ' HD12 ' A' ' 68' ' ' LEU . 7.4 mp -108.27 123.1 48.27 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-N 116.04 -0.527 . . . . 0.0 110.906 179.397 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 69' ' ' VAL . . . . . . . . . . . . . 45.5 t -101.67 139.06 23.79 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.344 0 N-CA-C 109.394 -0.595 . . . . 0.0 109.394 176.959 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 70' ' ' THR . . . . . 0.486 HG23 ' N ' ' A' ' 71' ' ' HIS . 4.5 t -133.4 -53.24 0.89 Allowed 'General case' 0 N--CA 1.463 0.213 0 N-CA-C 112.062 0.393 . . . . 0.0 112.062 -176.248 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 71' ' ' HIS . . . . . 0.486 ' N ' HG23 ' A' ' 70' ' ' THR . 32.0 m80 -150.03 93.39 3.92 Favored Pre-proline 0 CA--C 1.531 0.244 0 C-N-CA 120.562 -0.455 . . . . 0.0 111.993 -174.571 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 72' ' ' PRO . . . . . . . . . . . . . 57.1 Cg_endo -75.19 -30.06 7.29 Favored 'Trans proline' 0 N--CA 1.495 1.583 0 C-N-CA 121.154 1.236 . . . . 0.0 111.869 170.039 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 73' ' ' VAL . . . . . . . . . . . . . 32.0 m -144.36 179.7 1.31 Allowed 'Isoleucine or valine' 0 C--N 1.332 -0.182 0 N-CA-C 109.322 -0.621 . . . . 0.0 109.322 174.483 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 74' ' ' ASP . . . . . . . . . . . . . 15.9 t0 -99.08 115.34 28.78 Favored 'General case' 0 C--N 1.331 -0.215 0 N-CA-C 109.93 -0.396 . . . . 0.0 109.93 179.929 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 40.9 t -112.98 122.52 67.28 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.271 0 CA-C-O 121.164 0.507 . . . . 0.0 110.432 -178.877 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 76' ' ' LEU . . . . . . . . . . . . . 23.4 mt -119.77 140.52 50.61 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 115.507 -0.77 . . . . 0.0 109.242 178.44 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 77' ' ' GLU . . . . . . . . . . . . . 98.4 mt-10 -136.18 136.96 40.42 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-O 121.102 0.477 . . . . 0.0 111.492 -177.204 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 78' ' ' ALA . . . . . 0.571 ' HB2' HD21 ' A' ' 109' ' ' LEU . . . -125.76 136.15 52.84 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 115.554 -0.748 . . . . 0.0 109.947 176.842 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 79' ' ' LYS . . . . . 0.601 ' O ' HD13 ' A' ' 80' ' ' ILE . 43.3 mmtm -81.52 113.62 19.69 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.405 -0.361 . . . . 0.0 110.562 -179.48 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 80' ' ' ILE . . . . . 0.601 HD13 ' O ' ' A' ' 79' ' ' LYS . 28.5 mm -139.22 104.12 2.09 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.355 0 N-CA-C 109.26 -0.644 . . . . 0.0 109.26 -179.633 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 81' ' ' LYS . . . . . . . . . . . . . 60.4 mtpt -99.71 131.42 45.71 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-O 120.851 0.357 . . . . 0.0 110.81 -177.307 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . 89.2 42.07 5.67 Favored Glycine 0 CA--C 1.525 0.707 0 N-CA-C 111.194 -0.762 . . . . 0.0 111.194 178.34 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 83' ' ' ILE . . . . . . . . . . . . . 70.1 mt -71.08 137.54 23.59 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.308 0 N-CA-C 109.486 -0.561 . . . . 0.0 109.486 176.801 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 84' ' ' LYS . . . . . . . . . . . . . 38.1 ttpt -98.91 -52.62 3.51 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-O 120.843 0.354 . . . . 0.0 110.379 -178.687 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 85' ' ' ASP . . . . . . . . . . . . . 12.6 t70 -151.76 153.16 33.77 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.039 -0.528 . . . . 0.0 110.692 -179.167 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 86' ' ' VAL . . . . . . . . . . . . . 41.9 t -131.4 132.97 62.59 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.248 0 CA-C-O 120.964 0.412 . . . . 0.0 110.421 -178.763 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 87' ' ' ILE . . . . . 0.494 HD12 ' N ' ' A' ' 87' ' ' ILE . 5.1 mp -122.31 129.66 75.13 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.225 0 CA-C-N 115.819 -0.628 . . . . 0.0 109.358 177.351 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 88' ' ' LEU . . . . . . . . . . . . . 25.5 tp -116.28 132.52 56.64 Favored 'General case' 0 C--N 1.331 -0.219 0 CA-C-O 120.995 0.426 . . . . 0.0 111.433 -176.4 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 89' ' ' ASP . . . . . . . . . . . . . 13.4 t70 -127.04 154.84 44.14 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 115.764 -0.653 . . . . 0.0 109.511 175.668 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 96.1 mt-10 -46.72 -39.36 11.42 Favored 'General case' 0 C--N 1.329 -0.288 0 N-CA-C 113.222 0.823 . . . . 0.0 113.222 -171.735 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 91' ' ' ASN . . . . . . . . . . . . . 12.8 m120 -129.56 22.25 5.52 Favored 'General case' 0 N--CA 1.469 0.496 0 N-CA-C 112.802 0.667 . . . . 0.0 112.802 -177.409 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 92' ' ' LEU . . . . . . . . . . . . . 10.1 mt -150.09 141.91 23.74 Favored 'General case' 0 C--N 1.331 -0.209 0 N-CA-C 109.564 -0.532 . . . . 0.0 109.564 -178.094 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 93' ' ' ILE . . . . . . . . . . . . . 72.2 mt -123.99 121.28 61.73 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 N-CA-C 109.412 -0.588 . . . . 0.0 109.412 178.382 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 94' ' ' VAL . . . . . . . . . . . . . 46.3 t -120.3 126.86 75.72 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.264 0 CA-C-O 120.853 0.359 . . . . 0.0 110.145 -178.215 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 95' ' ' VAL . . . . . . . . . . . . . 41.5 t -122.48 134.3 66.1 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.316 0 CA-C-N 116.001 -0.545 . . . . 0.0 109.801 -179.731 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 96' ' ' ILE . . . . . . . . . . . . . 64.4 mt -115.9 126.73 73.53 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.255 0 N-CA-C 109.405 -0.591 . . . . 0.0 109.405 179.221 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 97' ' ' THR . . . . . . . . . . . . . 70.9 p -103.26 157.34 17.08 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-O 121.356 0.598 . . . . 0.0 111.639 -175.505 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 98' ' ' GLU . . . . . . . . . . . . . 81.5 tt0 -53.96 -26.83 27.63 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 115.893 -0.594 . . . . 0.0 112.303 -178.832 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 99' ' ' GLU . . . . . . . . . . . . . 43.2 mt-10 -80.33 17.62 1.03 Allowed 'General case' 0 CA--C 1.533 0.317 0 N-CA-C 113.069 0.766 . . . . 0.0 113.069 -177.096 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 100' ' ' ASN . . . . . . . . . . . . . 3.2 m-20 61.65 37.37 16.08 Favored 'General case' 0 CA--C 1.53 0.174 0 CA-C-O 121.09 0.472 . . . . 0.0 111.014 178.292 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 101' ' ' GLU . . . . . . . . . . . . . 84.2 tt0 -113.12 143.5 44.25 Favored 'General case' 0 C--O 1.232 0.139 0 CA-C-N 116.083 -0.508 . . . . 0.0 109.966 176.52 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 102' ' ' VAL . . . . . . . . . . . . . 46.2 t -114.98 123.8 71.03 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.27 0 N-CA-C 109.658 -0.497 . . . . 0.0 109.658 -179.653 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 103' ' ' LEU . . . . . . . . . . . . . 22.4 mt -115.98 129.51 56.41 Favored 'General case' 0 C--N 1.331 -0.199 0 CA-C-N 115.696 -0.684 . . . . 0.0 110.355 178.36 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 104' ' ' ILE . . . . . 0.519 HD13 HG21 ' A' ' 130' ' ' VAL . 70.5 mt -118.29 120.27 63.87 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.246 0 CA-C-N 116.446 -0.343 . . . . 0.0 110.189 179.081 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 105' ' ' PHE . . . . . . . . . . . . . 57.9 m-85 -121.3 165.4 15.55 Favored 'General case' 0 C--N 1.332 -0.168 0 O-C-N 123.932 0.77 . . . . 0.0 110.155 179.478 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 106' ' ' ASN . . . . . . . . . . . . . 40.9 p-10 -96.88 -169.93 1.96 Allowed 'General case' 0 C--N 1.331 -0.205 0 N-CA-C 109.913 -0.403 . . . . 0.0 109.913 173.636 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 107' ' ' GLN . . . . . . . . . . . . . 63.3 tt0 -58.96 -30.1 67.66 Favored 'General case' 0 C--N 1.329 -0.306 0 N-CA-C 111.781 0.289 . . . . 0.0 111.781 178.38 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 108' ' ' ASN . . . . . . . . . . . . . 52.2 t30 -83.47 7.22 17.59 Favored 'General case' 0 CA--C 1.536 0.437 0 N-CA-C 113.304 0.853 . . . . 0.0 113.304 -177.698 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 109' ' ' LEU . . . . . 0.571 HD21 ' HB2' ' A' ' 78' ' ' ALA . 11.4 tp 59.6 37.24 22.65 Favored 'General case' 0 C--N 1.332 -0.165 0 CA-C-O 121.017 0.437 . . . . 0.0 111.349 178.409 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 110' ' ' GLU . . . . . . . . . . . . . 70.7 mm-40 -103.55 152.12 22.09 Favored 'General case' 0 C--N 1.331 -0.216 0 N-CA-C 109.886 -0.413 . . . . 0.0 109.886 176.019 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 111' ' ' GLU . . . . . . . . . . . . . 83.4 tt0 -79.35 121.98 25.8 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-O 120.944 0.402 . . . . 0.0 110.73 -177.598 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 112' ' ' LEU . . . . . . . . . . . . . 28.8 mt -111.32 -46.04 3.34 Favored 'General case' 0 C--N 1.331 -0.229 0 CA-C-N 116.063 -0.517 . . . . 0.0 110.145 178.1 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 113' ' ' TYR . . . . . . . . . . . . . 59.8 t80 -138.99 133.43 31.73 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-N 116.115 -0.493 . . . . 0.0 111.009 179.59 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 114' ' ' ARG . . . . . . . . . . . . . 60.1 ttp180 -137.19 122.91 19.9 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.167 -0.469 . . . . 0.0 110.179 176.692 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 115' ' ' GLY . . . . . . . . . . . . . . . -150.07 146.66 16.06 Favored Glycine 0 CA--C 1.524 0.618 0 N-CA-C 110.91 -0.876 . . . . 0.0 110.91 178.974 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 116' ' ' LYS . . . . . . . . . . . . . 14.1 ttmm -116.42 134.93 54.3 Favored 'General case' 0 C--N 1.33 -0.271 0 N-CA-C 109.932 -0.396 . . . . 0.0 109.932 178.663 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 117' ' ' PHE . . . . . . . . . . . . . 48.8 m-85 -132.55 116.92 17.32 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-O 121.01 0.433 . . . . 0.0 110.331 -176.123 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 118' ' ' GLU . . . . . . . . . . . . . 43.8 mp0 -55.22 -45.06 75.96 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 116.246 -0.434 . . . . 0.0 111.133 -175.529 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 119' ' ' ASN . . . . . . . . . . . . . 35.1 m120 -98.71 31.0 3.06 Favored 'General case' 0 C--N 1.33 -0.24 0 N-CA-C 112.208 0.447 . . . . 0.0 112.208 -174.331 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 120' ' ' LEU . . . . . . . . . . . . . 31.5 tp -56.79 121.4 9.76 Favored 'General case' 0 C--N 1.333 -0.14 0 CA-C-O 120.752 0.31 . . . . 0.0 110.471 178.028 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 121' ' ' ASN . . . . . . . . . . . . . 20.3 m120 -114.05 -44.12 3.18 Favored 'General case' 0 C--N 1.333 -0.146 0 CA-C-N 116.414 -0.357 . . . . 0.0 111.204 -177.328 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 122' ' ' LYS . . . . . . . . . . . . . 96.1 mttt -144.1 149.85 37.2 Favored 'General case' 0 C--N 1.331 -0.205 0 CA-C-O 121.01 0.433 . . . . 0.0 111.72 -175.609 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 123' ' ' VAL . . . . . . . . . . . . . 47.1 t -129.69 130.4 66.81 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.27 0 N-CA-C 109.399 -0.593 . . . . 0.0 109.399 174.658 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 124' ' ' LEU . . . . . . . . . . . . . 69.9 mt -125.07 140.04 53.25 Favored 'General case' 0 N--CA 1.464 0.267 0 CA-C-O 120.782 0.325 . . . . 0.0 111.094 -177.237 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 125' ' ' VAL . . . . . . . . . . . . . 10.4 p -132.22 131.21 60.97 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.19 0 CA-C-N 116.009 -0.541 . . . . 0.0 110.332 -179.928 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 126' ' ' ARG . . . . . . . . . . . . . 35.3 mmt180 -142.3 118.03 10.45 Favored 'General case' 0 C--N 1.332 -0.192 0 CA-C-O 120.841 0.353 . . . . 0.0 110.733 178.44 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 127' ' ' ASN . . . . . . . . . . . . . 18.3 t-20 50.07 -104.89 0.16 Allowed 'General case' 0 CA--C 1.543 0.702 0 CA-C-O 119.098 -0.477 . . . . 0.0 111.664 178.017 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 128' ' ' ASP . . . . . . . . . . . . . 22.6 p-10 -114.08 3.8 15.41 Favored 'General case' 0 CA--C 1.537 0.478 0 CA-C-N 119.562 1.074 . . . . 0.0 113.451 -176.689 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 129' ' ' LEU . . . . . . . . . . . . . 14.4 tp -110.91 139.76 45.96 Favored 'General case' 0 C--N 1.332 -0.191 0 N-CA-C 109.673 -0.491 . . . . 0.0 109.673 178.374 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 130' ' ' VAL . . . . . 0.519 HG21 HD13 ' A' ' 104' ' ' ILE . 30.1 m -128.64 140.75 48.4 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.226 0 CA-C-O 120.892 0.377 . . . . 0.0 110.176 178.792 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 131' ' ' VAL . . . . . . . . . . . . . 43.8 t -136.06 140.52 43.78 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 CA-C-O 121.257 0.551 . . . . 0.0 110.458 -178.754 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 132' ' ' ILE . . . . . . . . . . . . . 71.8 mt -114.87 132.17 64.88 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.336 0 CA-C-N 115.415 -0.811 . . . . 0.0 109.302 179.28 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 133' ' ' ILE . . . . . . . . . . . . . 39.0 mm -114.25 118.76 59.44 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.236 0 CA-C-N 116.53 -0.304 . . . . 0.0 110.74 -175.604 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 134' ' ' ASP . . . . . . . . . . . . . 8.1 p-10 -133.63 146.31 50.79 Favored 'General case' 0 C--N 1.33 -0.254 0 N-CA-C 109.587 -0.523 . . . . 0.0 109.587 174.95 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 135' ' ' GLU . . . . . . . . . . . . . 80.1 tt0 -49.85 -24.21 2.32 Favored 'General case' 0 C--N 1.328 -0.359 0 N-CA-C 112.782 0.66 . . . . 0.0 112.782 -172.644 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 136' ' ' GLN . . . . . . . . . . . . . 98.7 mt-30 -93.73 -35.35 12.83 Favored 'General case' 0 C--N 1.333 -0.126 0 N-CA-C 112.294 0.479 . . . . 0.0 112.294 -176.243 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 137' ' ' LYS . . . . . . . . . . . . . 88.6 mttt -142.32 153.62 44.02 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-O 121.59 0.709 . . . . 0.0 112.622 -167.788 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 138' ' ' LEU . . . . . . . . . . . . . 14.3 tp -110.7 116.87 32.06 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 114.725 -1.125 . . . . 0.0 108.76 170.725 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 139' ' ' THR . . . . . . . . . . . . . 31.7 m -107.68 121.14 44.09 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-O 120.558 0.218 . . . . 0.0 110.775 -178.165 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 140' ' ' LEU . . . . . 0.475 HD23 ' C ' ' A' ' 140' ' ' LEU . 7.4 tt -112.85 122.83 48.82 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 115.885 -0.598 . . . . 0.0 109.426 -179.372 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 141' ' ' ILE . . . . . 0.514 ' HB ' HG23 ' A' ' 130' ' ' VAL . 18.9 mt -124.09 122.57 64.7 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.254 0 CA-C-O 121.007 0.432 . . . . 0.0 109.891 -175.863 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 142' ' ' ARG . . . . . . . . . . . . . 71.4 ttt180 -108.86 125.24 51.78 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 115.443 -0.799 . . . . 0.0 110.468 -179.196 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 143' ' ' THR . . . . . . . . . . . . . 5.6 p . . . . . 0 C--O 1.219 -0.536 0 CA-C-O 118.028 -0.986 . . . . 0.0 110.457 179.799 . . . . . . . . 0 0 . 1 . 002 nuclear build full ' B' B ' -3' ' ' GLU . . . . . . . . . . . . . 84.8 tt0 . . . . . 0 N--CA 1.49 1.574 0 N-CA-C 109.362 -0.606 . . . . 0.0 109.362 . . . . . . . . . 0 0 . 1 . 002 nuclear build full ' B' B ' -2' ' ' GLY . . . . . . . . . . . . . . . -71.21 144.26 37.34 Favored Glycine 0 CA--C 1.526 0.722 0 N-CA-C 111.031 -0.828 . . . . 0.0 111.031 -179.975 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' -1' ' ' VAL . . . . . . . . . . . . . 43.3 t -96.5 138.79 20.78 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.332 0 CA-C-O 120.789 0.328 . . . . 0.0 110.272 179.922 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 0' ' ' ILE . . . . . . . . . . . . . 72.3 mt -110.04 131.15 61.82 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.236 0 CA-C-N 116.214 -0.448 . . . . 0.0 109.941 179.074 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 1' ' ' MET . . . . . . . . . . . . . 25.6 ptm -80.81 136.22 36.08 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.229 -0.442 . . . . 0.0 110.626 179.62 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 2' ' ' SER . . . . . . . . . . . . . 90.2 p -126.56 153.72 44.84 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 116.155 -0.475 . . . . 0.0 110.269 179.341 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 3' ' ' GLU . . . . . . . . . . . . . 95.2 mt-10 -140.41 143.74 35.8 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.274 -0.421 . . . . 0.0 111.147 -177.712 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 4' ' ' LEU . . . . . . . . . . . . . 38.9 mt -121.32 127.01 50.88 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 115.811 -0.631 . . . . 0.0 110.037 175.939 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 5' ' ' LYS . . . . . . . . . . . . . 91.8 mttt -104.64 120.46 41.37 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.29 -0.414 . . . . 0.0 110.468 178.843 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 6' ' ' LEU . . . . . . . . . . . . . 57.8 mt -115.46 148.03 39.91 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 115.564 -0.744 . . . . 0.0 110.406 -179.171 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 7' ' ' LYS . . . . . . . . . . . . . 82.2 tttt -139.95 137.85 18.84 Favored Pre-proline 0 CA--C 1.534 0.357 0 CA-C-O 119.046 -0.502 . . . . 0.0 109.976 176.86 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 8' ' ' PRO . . . . . . . . . . . . . 98.0 Cg_endo -91.44 142.48 2.9 Favored 'Trans proline' 0 N--CA 1.49 1.295 0 C-N-CA 121.734 1.623 . . . . 0.0 111.718 177.719 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 9' ' ' LEU . . . . . . . . . . . . . 52.8 mt -79.23 -46.71 1.64 Allowed Pre-proline 0 CA--C 1.532 0.278 0 CA-C-O 118.847 -0.597 . . . . 0.0 112.105 -179.055 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 10' ' ' PRO . . . . . 0.443 ' HG2' HG23 ' B' ' 46' ' ' VAL . 65.7 Cg_endo -84.36 156.57 12.63 Favored 'Trans proline' 0 N--CA 1.496 1.663 0 C-N-CA 121.309 1.339 . . . . 0.0 111.631 174.488 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' B' B ' 11' ' ' LYS . . . . . . . . . . . . . 20.0 pttm -86.16 120.85 27.97 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-O 120.998 0.428 . . . . 0.0 110.045 176.494 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 12' ' ' VAL . . . . . . . . . . . . . 12.0 p -151.02 148.79 14.7 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.327 0 CA-C-N 116.081 -0.509 . . . . 0.0 110.637 -178.26 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 13' ' ' GLU . . . . . . . . . . . . . 84.7 tt0 -91.62 116.58 28.99 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.279 -0.419 . . . . 0.0 110.132 177.464 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 14' ' ' LEU . . . . . . . . . . . . . 29.5 mt -98.15 146.52 31.66 Favored Pre-proline 0 CA--C 1.532 0.287 0 CA-C-O 119.171 -0.442 . . . . 0.0 110.425 -177.491 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 15' ' ' PRO . . . . . . . . . . . . . 24.0 Cg_exo -64.01 162.18 30.3 Favored 'Trans proline' 0 N--CA 1.498 1.769 0 C-N-CA 121.335 1.357 . . . . 0.0 111.86 176.409 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 16' ' ' PRO . . . . . . . . . . . . . 27.0 Cg_exo -61.14 -35.34 86.64 Favored 'Trans proline' 0 N--CA 1.497 1.699 0 C-N-CA 121.484 1.456 . . . . 0.0 112.511 -179.585 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 17' ' ' ASP . . . . . . . . . . . . . 7.1 p-10 -85.86 6.27 28.98 Favored 'General case' 0 CA--C 1.535 0.388 0 N-CA-C 113.302 0.852 . . . . 0.0 113.302 -177.226 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 18' ' ' PHE . . . . . . . . . . . . . 51.5 t80 -57.48 -43.41 84.07 Favored 'General case' 0 C--N 1.334 -0.105 0 O-C-N 121.891 -0.506 . . . . 0.0 110.152 -179.038 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 19' ' ' VAL . . . . . 0.412 HG13 ' N ' ' B' ' 20' ' ' ASP . 12.3 p -56.85 -41.76 76.62 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.345 0 CA-C-N 116.304 -0.407 . . . . 0.0 110.763 -179.509 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' B' B ' 20' ' ' ASP . . . . . 0.412 ' N ' HG13 ' B' ' 19' ' ' VAL . 71.5 m-20 -60.68 -42.04 96.32 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-O 120.893 0.378 . . . . 0.0 110.881 -178.203 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' B' B ' 21' ' ' VAL . . . . . . . . . . . . . 50.6 t -64.42 -47.17 90.56 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.332 0 CA-C-N 116.314 -0.403 . . . . 0.0 110.512 -178.488 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 22' ' ' ILE . . . . . 0.586 HG22 HD12 ' B' ' 26' ' ' LEU . 50.5 mm -57.5 -40.21 73.43 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.281 0 C-N-CA 120.916 -0.313 . . . . 0.0 110.675 179.95 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' B' B ' 23' ' ' ARG . . . . . . . . . . . . . 46.4 ttp180 -55.95 -50.75 69.92 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-O 120.927 0.394 . . . . 0.0 110.774 177.571 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 24' ' ' ILE . . . . . . . . . . . . . 67.7 mt -62.17 -41.23 90.52 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.278 0 CA-C-N 116.047 -0.524 . . . . 0.0 112.078 -176.667 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 25' ' ' LYS . . . . . 0.469 ' HE2' HD11 ' B' ' 39' ' ' ILE . 14.9 pttp -73.32 -34.88 65.93 Favored 'General case' 0 CA--C 1.533 0.324 0 C-N-CA 120.687 -0.405 . . . . 0.0 111.79 -174.125 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' B' B ' 26' ' ' LEU . . . . . 0.586 HD12 HG22 ' B' ' 22' ' ' ILE . 75.6 mt -79.86 -43.09 22.94 Favored 'General case' 0 C--N 1.33 -0.255 0 N-CA-C 112.426 0.528 . . . . 0.0 112.426 -174.912 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' B' B ' 27' ' ' GLN . . . . . . . . . . . . . 14.2 pt20 -46.36 139.21 5.0 Favored 'General case' 0 N--CA 1.469 0.478 0 N-CA-C 112.838 0.681 . . . . 0.0 112.838 -175.554 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 28' ' ' GLY . . . . . . . . . . . . . . . 101.35 -29.53 12.32 Favored Glycine 0 CA--C 1.531 1.078 0 CA-C-N 115.355 -0.838 . . . . 0.0 112.031 -177.289 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 29' ' ' LYS . . . . . . . . . . . . . 73.7 mmtt -98.16 155.17 17.29 Favored 'General case' 0 C--N 1.332 -0.196 0 CA-C-N 117.194 0.497 . . . . 0.0 110.964 178.466 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 30' ' ' THR . . . . . . . . . . . . . 27.9 m -92.2 135.43 34.01 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.081 -0.509 . . . . 0.0 109.906 175.107 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 31' ' ' VAL . . . . . . . . . . . . . 34.9 m -122.51 145.09 29.84 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.227 0 CA-C-O 120.896 0.379 . . . . 0.0 110.57 -179.152 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 32' ' ' ARG . . . . . . . . . . . . . 73.1 ttt-85 -136.0 148.86 48.61 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 115.863 -0.608 . . . . 0.0 110.383 178.436 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 33' ' ' THR . . . . . . . . . . . . . 26.8 m -52.62 140.7 22.5 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.357 -0.383 . . . . 0.0 111.493 -178.543 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 34' ' ' GLY . . . . . . . . . . . . . . . 100.17 -17.3 57.23 Favored Glycine 0 CA--C 1.533 1.187 0 CA-C-O 119.675 -0.514 . . . . 0.0 113.159 179.678 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 35' ' ' ASP . . . . . . . . . . . . . 75.5 m-20 -65.96 148.87 51.12 Favored 'General case' 0 C--O 1.231 0.092 0 CA-C-N 118.091 0.946 . . . . 0.0 111.054 178.648 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 36' ' ' VAL . . . . . . . . . . . . . 43.4 t -126.44 130.92 71.85 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.2 0 CA-C-N 116.199 -0.455 . . . . 0.0 109.91 178.414 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 37' ' ' ILE . . . . . . . . . . . . . 65.5 mt -122.73 139.69 48.79 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.237 0 CA-C-N 116.174 -0.466 . . . . 0.0 109.984 -179.758 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 38' ' ' GLY . . . . . . . . . . . . . . . -109.31 128.76 9.13 Favored Glycine 0 CA--C 1.526 0.738 0 N-CA-C 111.086 -0.805 . . . . 0.0 111.086 179.518 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 39' ' ' ILE . . . . . 0.469 HD11 ' HE2' ' B' ' 25' ' ' LYS . 65.5 mt -125.69 126.82 70.82 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.249 0 N-CA-C 109.802 -0.444 . . . . 0.0 109.802 178.621 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' B' B ' 40' ' ' SER . . . . . 0.55 ' O ' HD13 ' B' ' 41' ' ' ILE . 41.2 t -92.44 117.32 29.81 Favored 'General case' 0 C--N 1.329 -0.307 0 C-N-CA 120.961 -0.296 . . . . 0.0 110.914 177.075 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' B' B ' 41' ' ' ILE . . . . . 0.55 HD13 ' O ' ' B' ' 40' ' ' SER . 45.3 mm -130.32 124.64 58.08 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.227 0 CA-C-O 120.722 0.296 . . . . 0.0 110.288 179.45 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' B' B ' 42' ' ' LEU . . . . . . . . . . . . . 77.9 mt 58.54 35.1 24.4 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.19 -0.459 . . . . 0.0 111.678 177.307 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 43' ' ' GLY . . . . . . . . . . . . . . . 77.54 -10.12 25.09 Favored Glycine 0 CA--C 1.534 1.261 0 C-N-CA 121.212 -0.518 . . . . 0.0 113.479 177.586 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 44' ' ' LYS . . . . . . . . . . . . . 60.3 mttp -102.49 130.13 49.21 Favored 'General case' 0 C--O 1.232 0.154 0 CA-C-N 117.977 0.888 . . . . 0.0 110.175 177.505 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 45' ' ' GLU . . . . . . . . . . . . . 38.1 tp10 -84.48 128.14 34.42 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-O 120.797 0.332 . . . . 0.0 110.887 179.552 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 46' ' ' VAL . . . . . 0.443 HG23 ' HG2' ' B' ' 10' ' ' PRO . 7.3 p -119.56 129.44 75.32 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.235 0 N-CA-C 109.617 -0.512 . . . . 0.0 109.617 176.741 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' B' B ' 47' ' ' LYS . . . . . . . . . . . . . 35.0 mmtp -99.78 126.91 45.93 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.074 -0.512 . . . . 0.0 110.885 177.833 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 48' ' ' PHE . . . . . . . . . . . . . 91.2 m-85 -108.68 131.81 54.54 Favored 'General case' 0 C--N 1.33 -0.247 0 N-CA-C 109.824 -0.435 . . . . 0.0 109.824 176.461 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 49' ' ' LYS . . . . . . . . . . . . . 85.0 tttt -108.29 136.83 47.29 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.274 -0.421 . . . . 0.0 110.276 178.698 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 50' ' ' VAL . . . . . . . . . . . . . 44.2 t -78.37 108.47 11.83 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.368 0 N-CA-C 109.318 -0.623 . . . . 0.0 109.318 176.304 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 51' ' ' VAL . . . . . . . . . . . . . 48.0 t -69.68 -48.32 65.9 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.298 0 CA-C-N 116.044 -0.525 . . . . 0.0 109.898 -174.27 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 52' ' ' GLN . . . . . . . . . . . . . 47.5 tt0 -169.2 142.56 2.78 Favored 'General case' 0 C--N 1.33 -0.266 0 C-N-CA 120.256 -0.578 . . . . 0.0 111.774 -178.551 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 53' ' ' ALA . . . . . . . . . . . . . . . -111.83 134.17 53.57 Favored 'General case' 0 C--N 1.332 -0.191 0 CA-C-N 115.594 -0.73 . . . . 0.0 109.867 175.572 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 54' ' ' TYR . . . . . . . . . . . . . 41.8 t80 -129.04 108.01 18.07 Favored Pre-proline 0 CA--C 1.534 0.36 0 CA-C-O 118.279 -0.867 . . . . 0.0 110.387 179.823 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 55' ' ' PRO . . . . . . . . . . . . . 73.7 Cg_endo -77.16 170.11 72.4 Favored 'Cis proline' 0 N--CA 1.5 1.863 0 CA-C-N 121.826 1.688 . . . . 0.0 112.396 -6.059 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 56' ' ' SER . . . . . . . . . . . . . 20.9 m -116.1 135.19 22.74 Favored Pre-proline 0 CA--C 1.539 0.544 0 CA-C-O 118.489 -0.767 . . . . 0.0 109.709 175.874 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 57' ' ' PRO . . . . . . . . . . . . . 60.8 Cg_endo -75.15 161.62 94.38 Favored 'Cis proline' 0 N--CA 1.497 1.714 0 CA-C-N 121.792 1.676 . . . . 0.0 111.346 -4.982 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 58' ' ' LEU . . . . . . . . . . . . . 40.4 tp -129.98 138.54 50.88 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-O 120.922 0.392 . . . . 0.0 110.335 -179.791 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 59' ' ' ARG . . . . . . . . . . . . . 74.3 ttt180 -95.52 125.99 40.5 Favored 'General case' 0 C--N 1.326 -0.456 0 N-CA-C 109.229 -0.656 . . . . 0.0 109.229 175.235 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 60' ' ' VAL . . . . . . . . . . . . . 49.9 t -74.76 114.49 14.76 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.331 0 C-N-CA 120.709 -0.396 . . . . 0.0 110.392 -174.587 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 61' ' ' GLU . . . . . . . . . . . . . 70.9 mm-40 -131.1 164.53 25.26 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 115.901 -0.59 . . . . 0.0 110.021 176.542 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 62' ' ' ASP . . . . . . . . . . . . . 13.4 t70 -52.34 -30.32 27.97 Favored 'General case' 0 C--N 1.328 -0.345 0 N-CA-C 112.149 0.426 . . . . 0.0 112.149 -179.408 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 63' ' ' ARG . . . . . . . . . . . . . 39.9 mmt180 -72.05 -20.8 61.62 Favored 'General case' 0 CA--C 1.533 0.301 0 N-CA-C 112.968 0.729 . . . . 0.0 112.968 -174.837 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 64' ' ' THR . . . . . . . . . . . . . 32.9 m -75.66 139.44 41.98 Favored 'General case' 0 C--N 1.331 -0.207 0 CA-C-O 120.947 0.403 . . . . 0.0 111.0 -175.896 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 65' ' ' LYS . . . . . . . . . . . . . 2.3 mptm? -89.4 137.56 32.22 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 115.882 -0.599 . . . . 0.0 109.994 177.457 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 66' ' ' ILE . . . . . . . . . . . . . 60.3 mt -116.51 130.88 70.59 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.29 0 N-CA-C 110.047 -0.353 . . . . 0.0 110.047 179.602 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 67' ' ' THR . . . . . . . . . . . . . 25.5 m -125.06 137.76 54.2 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 116.241 -0.436 . . . . 0.0 110.932 -178.631 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 68' ' ' LEU . . . . . 0.417 HD12 ' N ' ' B' ' 68' ' ' LEU . 8.4 mp -103.65 121.16 42.37 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 115.99 -0.55 . . . . 0.0 110.588 178.835 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' B' B ' 69' ' ' VAL . . . . . . . . . . . . . 44.8 t -102.28 129.16 54.17 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.323 0 CA-C-N 116.146 -0.479 . . . . 0.0 109.878 178.007 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 70' ' ' THR . . . . . . . . . . . . . 8.5 t -139.37 135.12 33.36 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-O 120.849 0.357 . . . . 0.0 110.597 179.448 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 71' ' ' HIS . . . . . . . . . . . . . 94.6 m-70 -147.71 80.73 8.82 Favored Pre-proline 0 C--N 1.329 -0.318 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.456 179.72 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 72' ' ' PRO . . . . . . . . . . . . . 72.9 Cg_endo -86.69 150.14 8.67 Favored 'Trans proline' 0 N--CA 1.489 1.248 0 C-N-CA 121.665 1.577 . . . . 0.0 112.272 179.721 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 73' ' ' VAL . . . . . . . . . . . . . 28.9 m -103.19 171.4 1.6 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.262 0 CA-C-N 116.166 -0.47 . . . . 0.0 109.909 177.445 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 74' ' ' ASP . . . . . . . . . . . . . 8.8 t70 -97.28 115.01 26.86 Favored 'General case' 0 C--N 1.329 -0.292 0 N-CA-C 109.803 -0.443 . . . . 0.0 109.803 -178.924 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 75' ' ' VAL . . . . . . . . . . . . . 46.3 t -113.08 120.29 62.71 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.242 0 CA-C-O 121.059 0.457 . . . . 0.0 110.223 -178.164 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 76' ' ' LEU . . . . . . . . . . . . . 26.9 mt -123.45 139.74 53.72 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 115.586 -0.734 . . . . 0.0 109.588 178.739 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 77' ' ' GLU . . . . . . . . . . . . . 97.5 mt-10 -134.61 130.97 37.25 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-O 121.101 0.477 . . . . 0.0 111.18 -178.134 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 78' ' ' ALA . . . . . 0.588 ' HB2' HD21 ' B' ' 109' ' ' LEU . . . -120.97 130.46 53.83 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 115.582 -0.736 . . . . 0.0 109.702 177.005 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' B' B ' 79' ' ' LYS . . . . . 0.646 ' O ' HD13 ' B' ' 80' ' ' ILE . 9.1 ptpp? -73.7 120.97 20.04 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-O 121.201 0.524 . . . . 0.0 110.381 -179.306 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' B' B ' 80' ' ' ILE . . . . . 0.646 HD13 ' O ' ' B' ' 79' ' ' LYS . 36.8 mm -139.12 108.66 3.9 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.288 0 N-CA-C 109.133 -0.691 . . . . 0.0 109.133 -177.648 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' B' B ' 81' ' ' LYS . . . . . . . . . . . . . 45.6 tttm -107.52 125.93 51.89 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-O 120.877 0.37 . . . . 0.0 111.205 -175.827 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 82' ' ' GLY . . . . . . . . . . . . . . . 89.18 42.0 5.69 Favored Glycine 0 CA--C 1.525 0.665 0 C-N-CA 120.773 -0.727 . . . . 0.0 111.811 175.005 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 83' ' ' ILE . . . . . . . . . . . . . 69.7 mt -69.15 139.94 19.64 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.315 0 N-CA-C 109.936 -0.394 . . . . 0.0 109.936 178.206 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 84' ' ' LYS . . . . . . . . . . . . . 53.1 tttp -96.74 -51.98 4.09 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.158 -0.474 . . . . 0.0 110.221 -179.199 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 85' ' ' ASP . . . . . . . . . . . . . 3.8 t70 -155.62 155.13 32.73 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 115.784 -0.644 . . . . 0.0 110.386 -179.902 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 86' ' ' VAL . . . . . . . . . . . . . 44.2 t -133.51 132.33 57.53 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.198 0 CA-C-O 121.05 0.452 . . . . 0.0 110.715 -177.957 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 87' ' ' ILE . . . . . . . . . . . . . 46.5 mm -121.26 128.12 75.91 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.194 0 CA-C-N 115.693 -0.685 . . . . 0.0 109.439 175.361 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 88' ' ' LEU . . . . . . . . . . . . . 12.8 tp -113.84 133.17 55.58 Favored 'General case' 0 C--N 1.331 -0.212 0 CA-C-O 120.997 0.427 . . . . 0.0 111.298 -176.793 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 89' ' ' ASP . . . . . . . . . . . . . 6.8 t70 -124.96 157.88 34.99 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-N 115.863 -0.608 . . . . 0.0 109.684 176.375 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 90' ' ' GLU . . . . . . . . . . . . . 44.3 mt-10 -44.99 -45.87 10.83 Favored 'General case' 0 N--CA 1.465 0.285 0 N-CA-C 113.272 0.841 . . . . 0.0 113.272 -172.025 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 91' ' ' ASN . . . . . . . . . . . . . 7.7 p-10 -131.97 37.7 3.58 Favored 'General case' 0 N--CA 1.463 0.22 0 CA-C-O 120.801 0.334 . . . . 0.0 111.373 -176.836 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 92' ' ' LEU . . . . . . . . . . . . . 4.3 tp -166.0 144.09 5.68 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-O 120.812 0.339 . . . . 0.0 110.33 179.916 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 93' ' ' ILE . . . . . . . . . . . . . 62.9 mt -125.42 124.74 67.65 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.279 0 N-CA-C 109.709 -0.478 . . . . 0.0 109.709 -177.658 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 94' ' ' VAL . . . . . . . . . . . . . 46.5 t -122.4 125.92 73.43 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.242 0 N-CA-C 109.917 -0.401 . . . . 0.0 109.917 179.527 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 95' ' ' VAL . . . . . . . . . . . . . 45.4 t -124.01 138.09 54.84 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.32 0 CA-C-N 116.131 -0.486 . . . . 0.0 110.113 -178.749 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 96' ' ' ILE . . . . . . . . . . . . . 61.8 mt -116.44 128.51 73.76 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.315 0 N-CA-C 109.255 -0.646 . . . . 0.0 109.255 178.556 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 97' ' ' THR . . . . . . . . . . . . . 71.8 p -102.9 159.61 15.34 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-O 121.265 0.555 . . . . 0.0 111.436 -175.888 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 98' ' ' GLU . . . . . . . . . . . . . 84.9 tt0 -53.91 -25.73 21.64 Favored 'General case' 0 CA--C 1.532 0.272 0 CA-C-N 116.083 -0.508 . . . . 0.0 112.161 179.327 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 99' ' ' GLU . . . . . . . . . . . . . 41.2 mt-10 -78.66 14.93 1.14 Allowed 'General case' 0 CA--C 1.535 0.39 0 N-CA-C 113.097 0.777 . . . . 0.0 113.097 -177.773 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 100' ' ' ASN . . . . . . . . . . . . . 2.4 m-20 60.63 38.01 18.89 Favored 'General case' 0 CA--C 1.529 0.167 0 CA-C-O 121.018 0.437 . . . . 0.0 110.713 179.481 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 101' ' ' GLU . . . . . . . . . . . . . 84.9 tt0 -117.29 146.31 43.41 Favored 'General case' 0 C--N 1.332 -0.173 0 CA-C-N 116.078 -0.51 . . . . 0.0 109.795 178.189 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 102' ' ' VAL . . . . . . . . . . . . . 44.9 t -114.95 124.74 71.91 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.275 0 CA-C-N 116.258 -0.428 . . . . 0.0 109.85 -178.158 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 103' ' ' LEU . . . . . . . . . . . . . 50.9 mt -115.15 132.69 56.52 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 115.715 -0.675 . . . . 0.0 109.996 178.594 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 104' ' ' ILE . . . . . 0.449 HD12 ' HB3' ' B' ' 113' ' ' TYR . 66.6 mt -123.22 119.59 58.02 Favored 'Isoleucine or valine' 0 C--O 1.233 0.2 0 N-CA-C 110.375 -0.231 . . . . 0.0 110.375 -178.334 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' B' B ' 105' ' ' PHE . . . . . . . . . . . . . 47.1 m-85 -121.17 164.61 16.62 Favored 'General case' 0 C--N 1.331 -0.211 0 CA-C-N 115.471 -0.786 . . . . 0.0 109.809 178.841 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 106' ' ' ASN . . . . . . . . . . . . . 47.4 p-10 -97.67 -169.98 1.92 Allowed 'General case' 0 C--N 1.33 -0.282 0 N-CA-C 109.652 -0.499 . . . . 0.0 109.652 172.851 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 107' ' ' GLN . . . . . . . . . . . . . 62.6 tt0 -59.67 -30.07 68.5 Favored 'General case' 0 C--N 1.33 -0.27 0 N-CA-C 111.879 0.325 . . . . 0.0 111.879 179.81 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 108' ' ' ASN . . . . . . . . . . . . . 3.1 t-20 -83.24 8.76 12.39 Favored 'General case' 0 CA--C 1.536 0.432 0 N-CA-C 113.148 0.796 . . . . 0.0 113.148 -177.535 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 109' ' ' LEU . . . . . 0.588 HD21 ' HB2' ' B' ' 78' ' ' ALA . 11.1 tp 60.99 36.21 18.71 Favored 'General case' 0 CA--C 1.53 0.198 0 CA-C-O 120.838 0.351 . . . . 0.0 111.434 178.845 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' B' B ' 110' ' ' GLU . . . . . . . . . . . . . 95.3 mt-10 -105.9 151.2 24.86 Favored 'General case' 0 C--N 1.33 -0.264 0 N-CA-C 109.898 -0.408 . . . . 0.0 109.898 176.884 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 111' ' ' GLU . . . . . . . . . . . . . 99.4 mt-10 -79.77 121.97 26.03 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-O 120.961 0.41 . . . . 0.0 111.34 -177.107 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 112' ' ' LEU . . . . . . . . . . . . . 16.3 mt -106.6 -45.74 4.16 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 115.894 -0.593 . . . . 0.0 110.086 176.418 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 113' ' ' TYR . . . . . 0.449 ' HB3' HD12 ' B' ' 104' ' ' ILE . 61.1 t80 -141.16 142.92 34.0 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 116.104 -0.498 . . . . 0.0 111.006 -179.488 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' B' B ' 114' ' ' ARG . . . . . . . . . . . . . 83.7 mtp180 -144.86 122.12 11.55 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.097 -0.502 . . . . 0.0 110.285 177.388 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 115' ' ' GLY . . . . . . . . . . . . . . . -150.05 162.59 29.23 Favored Glycine 0 CA--C 1.524 0.646 0 N-CA-C 111.006 -0.837 . . . . 0.0 111.006 179.881 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 116' ' ' LYS . . . . . . . . . . . . . 21.6 ttpt -129.1 140.8 51.42 Favored 'General case' 0 C--N 1.33 -0.267 0 N-CA-C 110.204 -0.295 . . . . 0.0 110.204 179.376 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 117' ' ' PHE . . . . . . . . . . . . . 29.1 m-85 -140.8 113.91 8.48 Favored 'General case' 0 C--N 1.331 -0.215 0 N-CA-C 109.927 -0.397 . . . . 0.0 109.927 -178.919 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 118' ' ' GLU . . . . . . . . . . . . . 70.8 mm-40 -56.19 -40.1 73.44 Favored 'General case' 0 C--N 1.329 -0.304 0 C-N-CA 120.912 -0.315 . . . . 0.0 110.944 -177.164 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 119' ' ' ASN . . . . . . . . . . . . . 80.7 m-20 -98.02 30.73 2.95 Favored 'General case' 0 C--N 1.33 -0.261 0 N-CA-C 112.168 0.432 . . . . 0.0 112.168 -175.502 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 120' ' ' LEU . . . . . . . . . . . . . 15.3 tp -58.29 123.69 16.92 Favored 'General case' 0 C--N 1.332 -0.184 0 N-CA-C 110.177 -0.305 . . . . 0.0 110.177 177.051 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 121' ' ' ASN . . . . . . . . . . . . . 77.7 m-20 -114.09 -44.08 3.18 Favored 'General case' 0 C--N 1.332 -0.195 0 CA-C-N 116.545 -0.298 . . . . 0.0 110.866 -178.475 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 122' ' ' LYS . . . . . . . . . . . . . 97.2 mttt -148.58 153.69 38.71 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-O 121.052 0.453 . . . . 0.0 111.569 -178.288 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 123' ' ' VAL . . . . . . . . . . . . . 46.1 t -133.91 130.87 55.9 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.228 0 CA-C-N 115.95 -0.568 . . . . 0.0 109.658 175.13 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 124' ' ' LEU . . . . . . . . . . . . . 64.5 mt -120.56 138.67 53.74 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.176 -0.465 . . . . 0.0 110.476 -178.206 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 125' ' ' VAL . . . . . . . . . . . . . 11.9 p -133.19 127.35 54.36 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.254 0 CA-C-N 116.463 -0.335 . . . . 0.0 110.266 178.413 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 126' ' ' ARG . . . . . . . . . . . . . 40.8 mmt180 -136.84 116.11 12.61 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.3 -0.409 . . . . 0.0 110.339 -179.707 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 127' ' ' ASN . . . . . . . . . . . . . 47.8 t30 52.67 -106.27 0.28 Allowed 'General case' 0 CA--C 1.543 0.71 0 CA-C-O 119.039 -0.505 . . . . 0.0 111.058 -179.986 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 128' ' ' ASP . . . . . . . . . . . . . 19.0 p-10 -114.09 2.92 15.07 Favored 'General case' 0 CA--C 1.536 0.426 0 CA-C-N 119.665 1.12 . . . . 0.0 113.422 -178.449 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 129' ' ' LEU . . . . . 0.547 HD23 ' N ' ' B' ' 130' ' ' VAL . 2.5 tt -104.86 135.72 45.7 Favored 'General case' 0 C--N 1.332 -0.17 0 N-CA-C 109.583 -0.525 . . . . 0.0 109.583 179.324 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' B' B ' 130' ' ' VAL . . . . . 0.547 ' N ' HD23 ' B' ' 129' ' ' LEU . 42.0 t -123.13 139.64 49.25 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.298 0 CA-C-O 120.799 0.333 . . . . 0.0 110.176 -177.678 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' B' B ' 131' ' ' VAL . . . . . . . . . . . . . 39.9 t -135.8 135.17 51.07 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.284 0 CA-C-N 116.235 -0.438 . . . . 0.0 110.162 179.561 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 132' ' ' ILE . . . . . . . . . . . . . 71.1 mt -117.52 132.45 67.3 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 N-CA-C 109.37 -0.604 . . . . 0.0 109.37 178.493 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 133' ' ' ILE . . . . . . . . . . . . . 37.7 mm -117.79 122.31 69.46 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.268 0 CA-C-O 120.617 0.246 . . . . 0.0 111.09 -174.272 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 134' ' ' ASP . . . . . . . . . . . . . 9.1 p-10 -137.38 147.82 45.76 Favored 'General case' 0 C--N 1.331 -0.207 0 CA-C-N 116.179 -0.464 . . . . 0.0 109.794 174.862 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 135' ' ' GLU . . . . . . . . . . . . . 85.5 tt0 -49.78 -24.67 2.5 Favored 'General case' 0 C--N 1.328 -0.333 0 N-CA-C 112.875 0.695 . . . . 0.0 112.875 -173.239 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 136' ' ' GLN . . . . . . . . . . . . . 56.1 tp60 -83.91 -37.64 22.11 Favored 'General case' 0 C--O 1.235 0.316 0 N-CA-C 111.959 0.355 . . . . 0.0 111.959 -175.762 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 137' ' ' LYS . . . . . . . . . . . . . 54.0 pttt -161.28 171.92 17.53 Favored 'General case' 0 C--N 1.331 -0.239 0 CA-C-O 121.558 0.694 . . . . 0.0 112.072 -172.394 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 138' ' ' LEU . . . . . . . . . . . . . 4.7 tt -118.36 126.21 51.62 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 114.962 -1.017 . . . . 0.0 109.649 177.425 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 139' ' ' THR . . . . . . . . . . . . . 16.9 m -106.88 126.19 51.99 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-N 116.24 -0.436 . . . . 0.0 110.616 -178.735 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 140' ' ' LEU . . . . . . . . . . . . . 30.8 tp -114.98 122.51 46.46 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 115.655 -0.702 . . . . 0.0 109.456 -178.405 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 141' ' ' ILE . . . . . . . . . . . . . 19.3 mt -121.86 119.79 59.71 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.282 0 N-CA-C 110.142 -0.318 . . . . 0.0 110.142 -175.039 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 142' ' ' ARG . . . . . . . . . . . . . 82.0 mtm180 -110.18 127.45 54.94 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 115.661 -0.699 . . . . 0.0 110.286 -179.585 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 143' ' ' THR . . . . . . . . . . . . . 41.6 p . . . . . 0 C--O 1.22 -0.467 0 CA-C-O 118.037 -0.982 . . . . 0.0 110.68 -179.436 . . . . . . . . 0 0 . 1 . 002 nuclear build full ' C' C ' -3' ' ' GLU . . . . . . . . . . . . . 95.7 mt-10 . . . . . 0 N--CA 1.49 1.557 0 N-CA-C 109.441 -0.577 . . . . 0.0 109.441 . . . . . . . . . 0 0 . 1 . 002 nuclear build full ' C' C ' -2' ' ' GLY . . . . . . . . . . . . . . . -72.98 113.2 4.23 Favored Glycine 0 CA--C 1.526 0.771 0 N-CA-C 110.783 -0.927 . . . . 0.0 110.783 178.899 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' C' C ' -1' ' ' VAL . . . . . . . . . . . . . 43.1 t -95.68 139.82 18.23 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 CA-C-O 120.822 0.344 . . . . 0.0 110.11 -179.322 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' C' C ' 0' ' ' ILE . . . . . . . . . . . . . 43.9 mm -100.92 139.32 22.52 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.293 0 CA-C-N 116.15 -0.477 . . . . 0.0 110.205 -179.59 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' C' C ' 1' ' ' MET . . . . . . . . . . . . . 21.5 ptm -77.69 136.84 38.24 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.088 -0.506 . . . . 0.0 110.661 179.939 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' C' C ' 2' ' ' SER . . . . . . . . . . . . . 2.6 p -123.44 127.07 47.89 Favored 'General case' 0 C--N 1.331 -0.239 0 CA-C-N 116.123 -0.489 . . . . 0.0 110.336 178.778 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' C' C ' 3' ' ' GLU . . . . . . . . . . . . . 95.5 mt-10 -140.99 140.34 34.33 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 116.049 -0.523 . . . . 0.0 111.063 -177.9 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' C' C ' 4' ' ' LEU . . . . . . . . . . . . . 16.1 tp -126.62 128.52 46.91 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 115.996 -0.547 . . . . 0.0 110.098 176.508 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' C' C ' 5' ' ' LYS . . . . . . . . . . . . . 97.4 mttt -109.27 121.5 45.31 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.4 -0.363 . . . . 0.0 110.478 179.531 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' C' C ' 6' ' ' LEU . . . . . . . . . . . . . 62.1 mt -116.21 148.8 40.05 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 115.616 -0.72 . . . . 0.0 110.293 -178.398 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' C' C ' 7' ' ' LYS . . . . . . . . . . . . . 75.6 tttt -136.4 138.54 27.16 Favored Pre-proline 0 CA--C 1.535 0.374 0 CA-C-O 118.996 -0.526 . . . . 0.0 110.2 176.774 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' C' C ' 8' ' ' PRO . . . . . . . . . . . . . 94.2 Cg_endo -91.81 142.76 2.74 Favored 'Trans proline' 0 N--CA 1.489 1.263 0 C-N-CA 121.725 1.617 . . . . 0.0 111.664 176.959 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' C' C ' 9' ' ' LEU . . . . . . . . . . . . . 36.9 mt -82.52 -47.83 0.88 Allowed Pre-proline 0 CA--C 1.534 0.343 0 CA-C-O 118.74 -0.647 . . . . 0.0 112.495 -177.681 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' C' C ' 10' ' ' PRO . . . . . . . . . . . . . 94.5 Cg_endo -81.65 161.13 19.2 Favored 'Trans proline' 0 N--CA 1.497 1.694 0 C-N-CA 121.24 1.293 . . . . 0.0 111.969 177.101 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' C' C ' 11' ' ' LYS . . . . . . . . . . . . . 91.0 mttt -86.52 103.11 14.73 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.389 -0.368 . . . . 0.0 110.38 177.825 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' C' C ' 12' ' ' VAL . . . . . . . . . . . . . 11.9 p -141.71 143.61 26.93 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.276 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.371 179.847 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' C' C ' 13' ' ' GLU . . . . . . . . . . . . . 82.5 tt0 -90.82 122.81 33.86 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 116.323 -0.399 . . . . 0.0 109.987 177.967 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' C' C ' 14' ' ' LEU . . . . . . . . . . . . . 25.3 mt -96.9 152.38 38.36 Favored Pre-proline 0 C--N 1.329 -0.311 0 CA-C-N 116.458 -0.337 . . . . 0.0 111.03 -175.973 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' C' C ' 15' ' ' PRO . . . . . . . . . . . . . 26.6 Cg_exo -61.72 163.11 19.48 Favored 'Trans proline' 0 N--CA 1.497 1.711 0 C-N-CA 121.255 1.303 . . . . 0.0 111.892 176.634 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' C' C ' 16' ' ' PRO . . . . . . . . . . . . . 25.2 Cg_exo -61.64 -44.44 21.77 Favored 'Trans proline' 0 N--CA 1.497 1.713 0 C-N-CA 121.516 1.478 . . . . 0.0 112.668 -178.472 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' C' C ' 17' ' ' ASP . . . . . . . . . . . . . 22.3 p-10 -88.72 16.23 7.07 Favored 'General case' 0 C--N 1.327 -0.385 0 N-CA-C 112.994 0.738 . . . . 0.0 112.994 -177.13 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' C' C ' 18' ' ' PHE . . . . . 0.522 ' CZ ' HD11 ' C' ' 22' ' ' ILE . 63.4 t80 -57.6 -41.53 81.43 Favored 'General case' 0 C--N 1.335 -0.064 0 O-C-N 122.053 -0.404 . . . . 0.0 110.315 -178.59 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' C' C ' 19' ' ' VAL . . . . . . . . . . . . . 44.3 t -56.26 -45.56 81.22 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.338 0 CA-C-N 116.47 -0.332 . . . . 0.0 110.624 -178.173 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' C' C ' 20' ' ' ASP . . . . . . . . . . . . . 51.4 m-20 -60.6 -40.43 91.77 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-O 120.763 0.316 . . . . 0.0 111.021 -178.295 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' C' C ' 21' ' ' VAL . . . . . . . . . . . . . 48.2 t -64.0 -48.46 85.91 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.328 0 C-N-CA 120.769 -0.373 . . . . 0.0 110.421 -178.373 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' C' C ' 22' ' ' ILE . . . . . 0.542 HG22 HD12 ' C' ' 26' ' ' LEU . 51.5 mm -55.61 -44.37 76.41 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.299 0 CA-C-O 120.895 0.379 . . . . 0.0 110.461 178.29 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' C' C ' 23' ' ' ARG . . . . . . . . . . . . . 56.6 ttp180 -52.51 -52.26 55.44 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-O 120.717 0.294 . . . . 0.0 111.609 -179.955 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' C' C ' 24' ' ' ILE . . . . . . . . . . . . . 71.1 mt -59.4 -40.63 82.12 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.294 0 CA-C-N 116.407 -0.361 . . . . 0.0 111.389 -176.338 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' C' C ' 25' ' ' LYS . . . . . . . . . . . . . 91.3 mttt -67.2 -37.83 84.31 Favored 'General case' 0 C--N 1.329 -0.288 0 N-CA-C 112.179 0.437 . . . . 0.0 112.179 -179.53 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' C' C ' 26' ' ' LEU . . . . . 0.542 HD12 HG22 ' C' ' 22' ' ' ILE . 68.2 mt -79.13 -41.18 29.15 Favored 'General case' 0 C--N 1.329 -0.295 0 N-CA-C 113.125 0.787 . . . . 0.0 113.125 -171.297 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' C' C ' 27' ' ' GLN . . . . . . . . . . . . . 13.8 pt20 -46.68 139.0 5.57 Favored 'General case' 0 N--CA 1.47 0.558 0 N-CA-C 112.659 0.614 . . . . 0.0 112.659 -176.151 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' C' C ' 28' ' ' GLY . . . . . . . . . . . . . . . 101.13 -26.87 23.07 Favored Glycine 0 CA--C 1.532 1.114 0 CA-C-N 115.536 -0.756 . . . . 0.0 112.213 -177.441 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' C' C ' 29' ' ' LYS . . . . . . . . . . . . . 61.7 mtpt -98.22 155.2 17.29 Favored 'General case' 0 C--N 1.333 -0.138 0 CA-C-N 117.32 0.56 . . . . 0.0 111.2 179.595 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' C' C ' 30' ' ' THR . . . . . . . . . . . . . 36.0 m -105.91 135.63 47.0 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 115.962 -0.563 . . . . 0.0 109.939 175.705 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' C' C ' 31' ' ' VAL . . . . . . . . . . . . . 34.5 m -132.87 158.32 43.24 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.271 0 CA-C-O 120.947 0.403 . . . . 0.0 111.019 -177.587 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' C' C ' 32' ' ' ARG . . . . . . . . . . . . . 50.7 mtp180 -134.89 152.71 51.97 Favored 'General case' 0 C--N 1.331 -0.219 0 CA-C-O 121.353 0.597 . . . . 0.0 110.706 178.736 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' C' C ' 33' ' ' THR . . . . . . . . . . . . . 22.1 m -52.57 140.17 23.68 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 115.997 -0.547 . . . . 0.0 111.509 -178.347 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' C' C ' 34' ' ' GLY . . . . . . . . . . . . . . . 100.0 -17.22 57.51 Favored Glycine 0 CA--C 1.532 1.117 0 CA-C-O 119.553 -0.582 . . . . 0.0 113.258 178.092 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' C' C ' 35' ' ' ASP . . . . . . . . . . . . . 77.5 m-20 -66.06 148.08 52.36 Favored 'General case' 0 N--CA 1.461 0.109 0 CA-C-N 118.148 0.974 . . . . 0.0 110.897 178.836 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' C' C ' 36' ' ' VAL . . . . . . . . . . . . . 44.2 t -124.92 132.8 70.85 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.238 0 CA-C-N 116.169 -0.468 . . . . 0.0 109.955 178.648 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' C' C ' 37' ' ' ILE . . . . . . . . . . . . . 67.8 mt -123.43 141.64 42.97 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.286 0 CA-C-N 116.072 -0.513 . . . . 0.0 110.04 -178.714 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' C' C ' 38' ' ' GLY . . . . . . . . . . . . . . . -111.56 129.0 8.91 Favored Glycine 0 CA--C 1.525 0.673 0 N-CA-C 111.021 -0.832 . . . . 0.0 111.021 179.667 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' C' C ' 39' ' ' ILE . . . . . . . . . . . . . 76.3 mt -125.39 137.34 57.96 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.193 0 CA-C-O 120.731 0.3 . . . . 0.0 110.205 179.805 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' C' C ' 40' ' ' SER . . . . . . . . . . . . . 35.8 t -93.4 124.6 37.5 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.273 -0.421 . . . . 0.0 110.903 175.643 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' C' C ' 41' ' ' ILE . . . . . 0.432 HD12 HG11 ' C' ' 46' ' ' VAL . 73.1 mt -130.56 119.59 46.21 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.181 0 CA-C-O 120.845 0.355 . . . . 0.0 110.336 177.757 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' C' C ' 42' ' ' LEU . . . . . . . . . . . . . 7.3 mp 51.71 37.24 19.66 Favored 'General case' 0 C--N 1.331 -0.221 0 CA-C-N 116.06 -0.518 . . . . 0.0 111.489 177.306 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' C' C ' 43' ' ' GLY . . . . . . . . . . . . . . . 72.58 30.88 63.58 Favored Glycine 0 CA--C 1.528 0.892 0 C-N-CA 121.07 -0.586 . . . . 0.0 112.309 176.837 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' C' C ' 44' ' ' LYS . . . . . . . . . . . . . 82.4 tttt -137.75 131.62 31.56 Favored 'General case' 0 C--N 1.33 -0.265 0 N-CA-C 109.692 -0.484 . . . . 0.0 109.692 177.085 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' C' C ' 45' ' ' GLU . . . . . . . . . . . . . 81.2 tt0 -82.91 123.08 29.07 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-O 120.725 0.298 . . . . 0.0 111.179 -177.345 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' C' C ' 46' ' ' VAL . . . . . 0.432 HG11 HD12 ' C' ' 41' ' ' ILE . 7.3 p -121.58 128.24 75.77 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.223 0 N-CA-C 109.624 -0.51 . . . . 0.0 109.624 176.212 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' C' C ' 47' ' ' LYS . . . . . . . . . . . . . 66.8 mttm -99.45 129.99 45.68 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.008 -0.542 . . . . 0.0 111.138 178.668 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' C' C ' 48' ' ' PHE . . . . . . . . . . . . . 91.6 m-85 -113.82 131.86 56.09 Favored 'General case' 0 C--N 1.33 -0.269 0 N-CA-C 109.873 -0.418 . . . . 0.0 109.873 176.255 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' C' C ' 49' ' ' LYS . . . . . . . . . . . . . 63.6 tttm -109.28 139.23 44.48 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.528 -0.305 . . . . 0.0 110.7 178.323 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' C' C ' 50' ' ' VAL . . . . . . . . . . . . . 45.7 t -81.17 108.54 14.56 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.352 0 N-CA-C 109.327 -0.62 . . . . 0.0 109.327 175.614 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' C' C ' 51' ' ' VAL . . . . . . . . . . . . . 46.7 t -70.04 -48.66 61.37 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.316 0 CA-C-N 116.131 -0.486 . . . . 0.0 109.8 -174.494 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' C' C ' 52' ' ' GLN . . . . . . . . . . . . . 61.6 tt0 -165.72 148.21 7.51 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.063 -0.517 . . . . 0.0 111.691 -178.964 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' C' C ' 53' ' ' ALA . . . . . . . . . . . . . . . -123.35 133.55 54.11 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 115.655 -0.702 . . . . 0.0 110.01 177.928 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' C' C ' 54' ' ' TYR . . . . . . . . . . . . . 10.3 t80 -129.02 111.98 18.5 Favored Pre-proline 0 CA--C 1.536 0.409 0 CA-C-O 118.179 -0.915 . . . . 0.0 110.483 178.977 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' C' C ' 55' ' ' PRO . . . . . . . . . . . . . 73.2 Cg_endo -77.23 168.27 77.32 Favored 'Cis proline' 0 N--CA 1.501 1.918 0 CA-C-N 122.028 1.76 . . . . 0.0 112.278 -6.782 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' C' C ' 56' ' ' SER . . . . . . . . . . . . . 13.5 m -117.35 132.33 23.59 Favored Pre-proline 0 CA--C 1.539 0.533 0 CA-C-O 118.453 -0.784 . . . . 0.0 109.292 174.21 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' C' C ' 57' ' ' PRO . . . . . . . . . . . . . 54.2 Cg_endo -70.08 147.15 84.72 Favored 'Cis proline' 0 N--CA 1.497 1.735 0 CA-C-N 121.834 1.691 . . . . 0.0 111.573 -0.109 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' C' C ' 58' ' ' LEU . . . . . . . . . . . . . 24.6 tp -108.51 136.51 48.0 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.409 -0.359 . . . . 0.0 110.843 -178.427 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' C' C ' 59' ' ' ARG . . . . . . . . . . . . . 59.2 ttt85 -102.95 121.11 41.86 Favored 'General case' 0 C--N 1.326 -0.421 0 N-CA-C 109.288 -0.634 . . . . 0.0 109.288 175.15 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' C' C ' 60' ' ' VAL . . . . . . . . . . . . . 42.5 t -76.42 118.42 22.78 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.28 0 C-N-CA 120.728 -0.389 . . . . 0.0 110.559 -174.881 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' C' C ' 61' ' ' GLU . . . . . . . . . . . . . 71.0 mm-40 -130.99 162.7 29.18 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 115.984 -0.553 . . . . 0.0 109.779 176.377 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' C' C ' 62' ' ' ASP . . . . . . . . . . . . . 80.3 m-20 -52.41 -30.5 29.66 Favored 'General case' 0 C--N 1.329 -0.302 0 N-CA-C 112.05 0.389 . . . . 0.0 112.05 179.758 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' C' C ' 63' ' ' ARG . . . . . . . . . . . . . 77.1 mtp85 -72.61 -21.85 61.05 Favored 'General case' 0 CA--C 1.533 0.294 0 N-CA-C 112.894 0.702 . . . . 0.0 112.894 -175.956 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' C' C ' 64' ' ' THR . . . . . . . . . . . . . 26.4 m -69.52 137.7 52.72 Favored 'General case' 0 C--N 1.331 -0.215 0 CA-C-O 120.993 0.425 . . . . 0.0 111.292 -174.683 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' C' C ' 65' ' ' LYS . . . . . . . . . . . . . 98.7 mttt -90.08 135.61 33.55 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 115.832 -0.622 . . . . 0.0 110.111 177.561 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' C' C ' 66' ' ' ILE . . . . . . . . . . . . . 64.4 mt -117.66 132.89 66.14 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.224 0 CA-C-O 120.868 0.366 . . . . 0.0 110.166 -179.787 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' C' C ' 67' ' ' THR . . . . . . . . . . . . . 30.1 m -122.39 139.61 53.64 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 115.988 -0.551 . . . . 0.0 110.813 -179.188 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' C' C ' 68' ' ' LEU . . . . . . . . . . . . . 4.1 tt -103.63 121.74 43.56 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 115.982 -0.554 . . . . 0.0 110.29 178.971 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' C' C ' 69' ' ' VAL . . . . . . . . . . . . . 42.0 t -101.63 129.13 53.29 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.257 0 CA-C-N 116.363 -0.381 . . . . 0.0 110.581 -178.031 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' C' C ' 70' ' ' THR . . . . . . . . . . . . . 12.0 m -144.76 132.7 21.35 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 115.992 -0.549 . . . . 0.0 110.128 177.114 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' C' C ' 71' ' ' HIS . . . . . . . . . . . . . 61.0 m-70 -129.4 84.79 60.97 Favored Pre-proline 0 CA--C 1.533 0.31 0 CA-C-N 116.5 -0.318 . . . . 0.0 110.577 -178.585 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' C' C ' 72' ' ' PRO . . . . . . . . . . . . . 74.1 Cg_endo -81.88 160.05 18.58 Favored 'Trans proline' 0 N--CA 1.493 1.465 0 C-N-CA 121.474 1.45 . . . . 0.0 112.429 -179.551 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' C' C ' 73' ' ' VAL . . . . . . . . . . . . . 30.2 m -116.53 171.22 5.48 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.229 0 CA-C-N 115.981 -0.554 . . . . 0.0 110.382 -179.973 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' C' C ' 74' ' ' ASP . . . . . . . . . . . . . 25.8 t0 -98.59 119.91 38.13 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.463 -0.335 . . . . 0.0 110.243 -177.552 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' C' C ' 75' ' ' VAL . . . . . . . . . . . . . 44.2 t -114.84 121.79 67.64 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.222 0 CA-C-O 121.176 0.513 . . . . 0.0 110.379 -179.277 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' C' C ' 76' ' ' LEU . . . . . . . . . . . . . 24.3 mt -118.92 146.58 44.83 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 115.553 -0.749 . . . . 0.0 109.628 178.119 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' C' C ' 77' ' ' GLU . . . . . . . . . . . . . 97.6 mt-10 -138.62 129.35 26.39 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-O 121.051 0.453 . . . . 0.0 111.204 -179.214 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' C' C ' 78' ' ' ALA . . . . . 0.746 ' HB2' HD21 ' C' ' 109' ' ' LEU . . . -116.94 136.5 52.9 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 115.797 -0.638 . . . . 0.0 109.787 177.345 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' C' C ' 79' ' ' LYS . . . . . 0.627 ' O ' HD13 ' C' ' 80' ' ' ILE . 52.2 pttt -84.79 119.4 25.26 Favored 'General case' 0 C--N 1.331 -0.218 0 CA-C-O 121.237 0.541 . . . . 0.0 111.006 -177.247 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' C' C ' 80' ' ' ILE . . . . . 0.627 HD13 ' O ' ' C' ' 79' ' ' LYS . 36.0 mm -139.43 117.98 12.26 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.212 0 N-CA-C 109.277 -0.638 . . . . 0.0 109.277 179.946 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' C' C ' 81' ' ' LYS . . . . . . . . . . . . . 57.2 tttm -103.36 122.54 45.05 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-O 120.777 0.322 . . . . 0.0 111.031 -178.037 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' C' C ' 82' ' ' GLY . . . . . . . . . . . . . . . 89.24 42.13 5.64 Favored Glycine 0 CA--C 1.526 0.719 0 C-N-CA 120.819 -0.705 . . . . 0.0 111.831 175.044 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' C' C ' 83' ' ' ILE . . . . . . . . . . . . . 75.3 mt -66.97 137.42 24.87 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.312 0 N-CA-C 109.858 -0.423 . . . . 0.0 109.858 177.318 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' C' C ' 84' ' ' LYS . . . . . . . . . . . . . 80.0 tttt -96.74 -54.02 3.36 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 115.971 -0.558 . . . . 0.0 110.326 -177.727 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' C' C ' 85' ' ' ASP . . . . . . . . . . . . . 8.1 t70 -151.14 150.01 30.15 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 115.748 -0.66 . . . . 0.0 110.407 -177.648 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' C' C ' 86' ' ' VAL . . . . . . . . . . . . . 44.6 t -129.04 129.18 67.87 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.266 0 CA-C-O 120.896 0.379 . . . . 0.0 110.435 -179.483 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' C' C ' 87' ' ' ILE . . . . . 0.497 ' N ' HD12 ' C' ' 87' ' ' ILE . 5.0 mp -117.45 125.56 74.11 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.288 0 CA-C-N 115.909 -0.587 . . . . 0.0 109.481 176.872 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' C' C ' 88' ' ' LEU . . . . . . . . . . . . . 16.7 tp -110.5 129.68 55.73 Favored 'General case' 0 C--N 1.331 -0.221 0 CA-C-N 116.373 -0.376 . . . . 0.0 110.719 -179.025 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' C' C ' 89' ' ' ASP . . . . . . . . . . . . . 11.9 t70 -126.63 154.75 43.58 Favored 'General case' 0 C--N 1.331 -0.222 0 CA-C-N 116.119 -0.491 . . . . 0.0 109.945 178.0 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' C' C ' 90' ' ' GLU . . . . . . . . . . . . . 77.8 tt0 -45.73 -35.14 4.04 Favored 'General case' 0 C--N 1.329 -0.299 0 N-CA-C 113.332 0.864 . . . . 0.0 113.332 -172.218 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' C' C ' 91' ' ' ASN . . . . . . . . . . . . . 56.7 m-80 -130.87 15.27 5.28 Favored 'General case' 0 N--CA 1.469 0.488 0 N-CA-C 113.309 0.855 . . . . 0.0 113.309 -175.587 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' C' C ' 92' ' ' LEU . . . . . . . . . . . . . 8.5 mt -150.34 151.97 33.71 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 118.131 0.423 . . . . 0.0 110.33 -176.414 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' C' C ' 93' ' ' ILE . . . . . . . . . . . . . 70.1 mt -129.15 119.29 48.63 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.316 0 N-CA-C 109.172 -0.677 . . . . 0.0 109.172 177.342 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' C' C ' 94' ' ' VAL . . . . . 0.56 HG21 HG11 ' C' ' 125' ' ' VAL . 45.7 t -119.91 127.98 75.91 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.252 0 CA-C-O 120.875 0.369 . . . . 0.0 110.08 -178.364 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' C' C ' 95' ' ' VAL . . . . . . . . . . . . . 42.5 t -122.46 134.02 66.93 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.25 0 CA-C-N 116.045 -0.525 . . . . 0.0 109.899 -179.984 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' C' C ' 96' ' ' ILE . . . . . . . . . . . . . 64.9 mt -114.54 127.65 71.93 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.386 0 N-CA-C 109.384 -0.599 . . . . 0.0 109.384 179.435 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' C' C ' 97' ' ' THR . . . . . . . . . . . . . 68.1 p -97.8 156.46 16.57 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-O 120.92 0.391 . . . . 0.0 110.732 -179.495 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' C' C ' 98' ' ' GLU . . . . . . . . . . . . . 45.6 tp10 -53.82 -26.5 24.44 Favored 'General case' 0 CA--C 1.534 0.336 0 N-CA-C 112.1 0.407 . . . . 0.0 112.1 -179.531 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' C' C ' 99' ' ' GLU . . . . . . . . . . . . . 28.3 tt0 -79.74 17.26 0.95 Allowed 'General case' 0 CA--C 1.536 0.417 0 N-CA-C 113.004 0.742 . . . . 0.0 113.004 -176.467 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' C' C ' 100' ' ' ASN . . . . . . . . . . . . . 3.0 m-20 62.74 31.39 16.6 Favored 'General case' 0 CA--C 1.532 0.272 0 O-C-N 122.11 -0.369 . . . . 0.0 111.908 176.765 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' C' C ' 101' ' ' GLU . . . . . . . . . . . . . 84.8 tt0 -111.92 142.55 44.18 Favored 'General case' 0 C--N 1.332 -0.165 0 N-CA-C 109.594 -0.521 . . . . 0.0 109.594 173.762 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' C' C ' 102' ' ' VAL . . . . . . . . . . . . . 43.3 t -115.42 129.33 71.87 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.306 0 CA-C-N 116.368 -0.378 . . . . 0.0 110.213 -177.449 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' C' C ' 103' ' ' LEU . . . . . . . . . . . . . 39.9 mt -115.96 129.7 56.5 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 115.601 -0.727 . . . . 0.0 109.822 176.9 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' C' C ' 104' ' ' ILE . . . . . . . . . . . . . 67.4 mt -117.97 121.19 66.73 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.228 0 N-CA-C 110.343 -0.243 . . . . 0.0 110.343 -178.784 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' C' C ' 105' ' ' PHE . . . . . . . . . . . . . 52.7 m-85 -122.66 166.95 14.06 Favored 'General case' 0 C--N 1.333 -0.139 0 O-C-N 123.872 0.732 . . . . 0.0 109.948 179.625 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' C' C ' 106' ' ' ASN . . . . . . . . . . . . . 43.9 p-10 -102.23 -169.97 1.75 Allowed 'General case' 0 C--N 1.33 -0.245 0 N-CA-C 109.972 -0.381 . . . . 0.0 109.972 174.883 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' C' C ' 107' ' ' GLN . . . . . . . . . . . . . 43.2 tt0 -57.19 -29.52 63.75 Favored 'General case' 0 C--N 1.33 -0.274 0 N-CA-C 111.915 0.339 . . . . 0.0 111.915 178.19 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' C' C ' 108' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER -84.67 11.5 8.85 Favored 'General case' 0 CA--C 1.535 0.384 0 N-CA-C 113.009 0.744 . . . . 0.0 113.009 -176.96 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' C' C ' 109' ' ' LEU . . . . . 0.746 HD21 ' HB2' ' C' ' 78' ' ' ALA . 9.7 tp 53.65 37.23 25.56 Favored 'General case' 0 C--O 1.233 0.19 0 CA-C-O 121.064 0.459 . . . . 0.0 111.254 -179.809 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' C' C ' 110' ' ' GLU . . . . . . . . . . . . . 95.8 mt-10 -104.8 145.36 30.48 Favored 'General case' 0 C--N 1.33 -0.25 0 N-CA-C 109.566 -0.531 . . . . 0.0 109.566 175.499 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' C' C ' 111' ' ' GLU . . . . . . . . . . . . . 71.0 tt0 -80.01 121.93 26.1 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-O 120.893 0.377 . . . . 0.0 110.576 -176.738 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' C' C ' 112' ' ' LEU . . . . . . . . . . . . . 10.8 mt -107.66 -46.05 3.9 Favored 'General case' 0 C--N 1.331 -0.218 0 CA-C-N 116.066 -0.515 . . . . 0.0 110.386 -179.54 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' C' C ' 113' ' ' TYR . . . . . . . . . . . . . 55.6 t80 -136.79 142.2 42.94 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-N 116.336 -0.393 . . . . 0.0 111.085 -178.784 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' C' C ' 114' ' ' ARG . . . . . . . . . . . . . 35.9 ptt-85 -142.52 124.59 15.34 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.063 -0.517 . . . . 0.0 110.363 177.507 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' C' C ' 115' ' ' GLY . . . . . . . . . . . . . . . -150.11 162.6 29.25 Favored Glycine 0 CA--C 1.524 0.629 0 N-CA-C 111.123 -0.791 . . . . 0.0 111.123 -179.765 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' C' C ' 116' ' ' LYS . . . . . . . . . . . . . 69.2 tttt -132.09 136.73 47.38 Favored 'General case' 0 C--N 1.329 -0.319 0 N-CA-C 109.797 -0.445 . . . . 0.0 109.797 177.266 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' C' C ' 117' ' ' PHE . . . . . . . . . . . . . 38.2 m-85 -133.67 114.8 13.88 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-O 120.905 0.383 . . . . 0.0 110.179 -175.595 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' C' C ' 118' ' ' GLU . . . . . . . . . . . . . 71.0 mm-40 -51.07 -52.42 43.59 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.454 -0.339 . . . . 0.0 111.792 -176.042 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' C' C ' 119' ' ' ASN . . . . . . . . . . . . . 3.2 m120 -95.63 31.18 2.09 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.274 -0.421 . . . . 0.0 112.024 -174.193 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' C' C ' 120' ' ' LEU . . . . . . . . . . . . . 18.3 tp -53.57 121.24 7.36 Favored 'General case' 0 N--CA 1.463 0.22 0 O-C-N 122.234 -0.291 . . . . 0.0 110.929 178.704 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' C' C ' 121' ' ' ASN . . . . . . . . . . . . . 69.2 m-20 -113.75 -43.85 3.25 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.341 -0.391 . . . . 0.0 110.929 -177.096 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' C' C ' 122' ' ' LYS . . . . . . . . . . . . . 97.1 mttt -144.69 147.47 33.05 Favored 'General case' 0 C--N 1.332 -0.177 0 CA-C-O 121.154 0.502 . . . . 0.0 111.946 -176.993 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' C' C ' 123' ' ' VAL . . . . . . . . . . . . . 45.6 t -125.82 125.43 68.31 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.259 0 N-CA-C 109.079 -0.711 . . . . 0.0 109.079 173.351 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' C' C ' 124' ' ' LEU . . . . . . . . . . . . . 59.9 mt -123.9 138.76 54.43 Favored 'General case' 0 C--N 1.331 -0.216 0 CA-C-O 120.877 0.37 . . . . 0.0 110.99 -176.232 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' C' C ' 125' ' ' VAL . . . . . 0.56 HG11 HG21 ' C' ' 94' ' ' VAL . 35.7 m -133.97 140.51 46.16 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.28 0 CA-C-N 116.018 -0.537 . . . . 0.0 110.365 178.399 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' C' C ' 126' ' ' ARG . . . . . . . . . . . . . 38.9 ttt180 -151.09 122.66 7.95 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-O 120.98 0.419 . . . . 0.0 110.67 177.634 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' C' C ' 127' ' ' ASN . . . . . . . . . . . . . 20.3 t-20 52.08 -107.29 0.32 Allowed 'General case' 0 CA--C 1.543 0.687 0 CA-C-O 118.968 -0.539 . . . . 0.0 111.177 -179.048 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' C' C ' 128' ' ' ASP . . . . . . . . . . . . . 17.7 p-10 -114.17 5.07 15.78 Favored 'General case' 0 N--CA 1.467 0.413 0 CA-C-N 119.654 1.116 . . . . 0.0 113.468 -177.223 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' C' C ' 129' ' ' LEU . . . . . . . . . . . . . 18.3 tp -106.66 138.62 42.49 Favored 'General case' 0 C--O 1.232 0.147 0 O-C-N 122.008 -0.432 . . . . 0.0 110.362 -179.419 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' C' C ' 130' ' ' VAL . . . . . . . . . . . . . 40.4 t -121.33 135.36 61.75 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.227 0 N-CA-C 109.724 -0.472 . . . . 0.0 109.724 179.938 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' C' C ' 131' ' ' VAL . . . . . 0.436 HG22 HD12 ' C' ' 140' ' ' LEU . 43.0 t -136.01 136.82 49.42 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.24 0 CA-C-O 120.997 0.427 . . . . 0.0 110.419 179.985 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' C' C ' 132' ' ' ILE . . . . . . . . . . . . . 68.5 mt -118.42 133.87 63.86 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.314 0 CA-C-N 115.853 -0.612 . . . . 0.0 109.491 179.058 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' C' C ' 133' ' ' ILE . . . . . . . . . . . . . 37.6 mm -116.78 119.31 61.62 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.231 0 CA-C-N 116.52 -0.309 . . . . 0.0 110.941 -175.361 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' C' C ' 134' ' ' ASP . . . . . . . . . . . . . 7.4 p-10 -130.13 148.95 52.03 Favored 'General case' 0 C--N 1.332 -0.182 0 N-CA-C 109.727 -0.471 . . . . 0.0 109.727 174.258 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' C' C ' 135' ' ' GLU . . . . . . . . . . . . . 39.2 tp10 -49.95 -24.57 2.63 Favored 'General case' 0 C--N 1.329 -0.302 0 N-CA-C 112.996 0.739 . . . . 0.0 112.996 -170.471 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' C' C ' 136' ' ' GLN . . . . . . . . . . . . . 52.8 mt-30 -104.76 -26.63 12.19 Favored 'General case' 0 N--CA 1.464 0.248 0 N-CA-C 112.773 0.657 . . . . 0.0 112.773 -174.113 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' C' C ' 137' ' ' LYS . . . . . . . . . . . . . 56.6 mtpt -141.15 150.0 42.23 Favored 'General case' 0 C--N 1.332 -0.194 0 CA-C-O 121.404 0.621 . . . . 0.0 112.099 -169.038 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' C' C ' 138' ' ' LEU . . . . . . . . . . . . . 18.1 tp -111.12 120.6 42.86 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 115.054 -0.975 . . . . 0.0 109.045 173.259 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' C' C ' 139' ' ' THR . . . . . . . . . . . . . 27.0 m -109.82 126.02 53.36 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-O 120.82 0.343 . . . . 0.0 110.973 -178.23 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' C' C ' 140' ' ' LEU . . . . . 0.436 HD12 HG22 ' C' ' 131' ' ' VAL . 17.7 tp -115.61 122.71 46.42 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 115.471 -0.786 . . . . 0.0 109.309 -179.361 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' C' C ' 141' ' ' ILE . . . . . . . . . . . . . 19.5 mt -121.76 119.42 58.74 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 N-CA-C 109.763 -0.458 . . . . 0.0 109.763 -176.37 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' C' C ' 142' ' ' ARG . . . . . . . . . . . . . 82.6 mtm180 -111.92 122.93 49.14 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 115.691 -0.686 . . . . 0.0 110.721 -177.769 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' C' C ' 143' ' ' THR . . . . . . . . . . . . . 41.1 p . . . . . 0 C--O 1.22 -0.477 0 CA-C-O 118.06 -0.971 . . . . 0.0 110.606 -179.52 . . . . . . . . 0 0 . 1 . 002 nuclear build full ' D' D ' -3' ' ' GLU . . . . . . . . . . . . . 44.3 mp0 . . . . . 0 N--CA 1.489 1.524 0 N-CA-C 109.317 -0.623 . . . . 0.0 109.317 . . . . . . . . . 0 0 . 1 . 002 nuclear build full ' D' D ' -2' ' ' GLY . . . . . . . . . . . . . . . -69.92 140.14 32.44 Favored Glycine 0 CA--C 1.525 0.692 0 N-CA-C 111.123 -0.791 . . . . 0.0 111.123 -179.54 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' D' D ' -1' ' ' VAL . . . . . . . . . . . . . 46.9 t -141.47 131.61 25.57 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.348 0 N-CA-C 109.607 -0.516 . . . . 0.0 109.607 178.451 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' D' D ' 0' ' ' ILE . . . . . . . . . . . . . 69.9 mt -111.77 126.92 69.2 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.266 0 CA-C-N 116.249 -0.432 . . . . 0.0 110.227 -178.173 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' D' D ' 1' ' ' MET . . . . . . . . . . . . . 18.2 ptp -80.39 119.82 23.6 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.049 -0.523 . . . . 0.0 110.134 177.655 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' D' D ' 2' ' ' SER . . . . . . . . . . . . . 92.7 p -113.95 154.55 27.39 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-O 121.01 0.433 . . . . 0.0 110.742 -177.836 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' D' D ' 3' ' ' GLU . . . . . . . . . . . . . 47.1 mp0 -139.41 144.58 38.17 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 115.933 -0.576 . . . . 0.0 111.227 -176.669 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' D' D ' 4' ' ' LEU . . . . . . . . . . . . . 16.4 tp -123.32 126.8 47.54 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 115.777 -0.647 . . . . 0.0 109.685 175.187 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' D' D ' 5' ' ' LYS . . . . . . . . . . . . . 88.3 mttt -109.02 121.0 44.21 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.384 -0.371 . . . . 0.0 110.642 -178.542 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' D' D ' 6' ' ' LEU . . . . . . . . . . . . . 47.8 mt -115.48 144.5 43.75 Favored 'General case' 0 C--N 1.331 -0.21 0 CA-C-N 115.87 -0.605 . . . . 0.0 110.256 -179.844 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' D' D ' 7' ' ' LYS . . . . . . . . . . . . . 45.4 tttp -127.37 136.89 29.59 Favored Pre-proline 0 CA--C 1.532 0.278 0 CA-C-O 118.886 -0.578 . . . . 0.0 109.465 175.17 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' D' D ' 8' ' ' PRO . . . . . . . . . . . . . 71.9 Cg_endo -90.41 132.99 1.82 Allowed 'Trans proline' 0 N--CA 1.49 1.319 0 C-N-CA 121.619 1.546 . . . . 0.0 111.858 178.548 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' D' D ' 9' ' ' LEU . . . . . . . . . . . . . 43.0 mt -72.26 -46.99 10.77 Favored Pre-proline 0 C--N 1.329 -0.313 0 CA-C-O 118.69 -0.671 . . . . 0.0 111.963 -179.956 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' D' D ' 10' ' ' PRO . . . . . . . . . . . . . 93.2 Cg_endo -82.37 146.63 13.94 Favored 'Trans proline' 0 N--CA 1.496 1.62 0 C-N-CA 121.178 1.252 . . . . 0.0 111.635 174.978 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' D' D ' 11' ' ' LYS . . . . . . . . . . . . . 25.1 pttm -71.67 119.2 15.49 Favored 'General case' 0 C--N 1.331 -0.203 0 N-CA-C 109.692 -0.484 . . . . 0.0 109.692 177.19 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' D' D ' 12' ' ' VAL . . . . . . . . . . . . . 12.2 p -151.17 149.51 14.07 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.288 0 CA-C-N 116.094 -0.503 . . . . 0.0 111.127 -176.414 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' D' D ' 13' ' ' GLU . . . . . . . . . . . . . 42.5 mt-10 -108.46 109.98 21.38 Favored 'General case' 0 C--N 1.331 -0.227 0 CA-C-N 115.985 -0.552 . . . . 0.0 109.81 175.466 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' D' D ' 14' ' ' LEU . . . . . . . . . . . . . 16.1 mt -97.6 152.1 37.98 Favored Pre-proline 0 CA--C 1.532 0.282 0 CA-C-O 119.398 -0.334 . . . . 0.0 110.915 -176.724 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' D' D ' 15' ' ' PRO . . . . . . . . . . . . . 25.5 Cg_exo -62.36 160.41 31.39 Favored 'Trans proline' 0 N--CA 1.498 1.769 0 C-N-CA 121.337 1.358 . . . . 0.0 111.894 176.999 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' D' D ' 16' ' ' PRO . . . . . . . . . . . . . 27.2 Cg_exo -60.98 -37.79 73.91 Favored 'Trans proline' 0 N--CA 1.498 1.758 0 C-N-CA 121.479 1.453 . . . . 0.0 112.643 -179.7 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' D' D ' 17' ' ' ASP . . . . . . . . . . . . . 11.1 p-10 -81.63 4.9 19.93 Favored 'General case' 0 CA--C 1.536 0.429 0 N-CA-C 113.303 0.853 . . . . 0.0 113.303 -177.501 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' D' D ' 18' ' ' PHE . . . . . . . . . . . . . 52.4 t80 -57.5 -44.26 84.85 Favored 'General case' 0 C--N 1.335 -0.059 0 O-C-N 121.929 -0.482 . . . . 0.0 110.272 -178.286 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' D' D ' 19' ' ' VAL . . . . . . . . . . . . . 44.0 t -55.52 -44.16 75.17 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.289 0 CA-C-N 116.396 -0.365 . . . . 0.0 110.804 -178.144 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' D' D ' 20' ' ' ASP . . . . . . . . . . . . . 13.4 t70 -59.8 -42.2 92.93 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-O 120.888 0.375 . . . . 0.0 110.809 -177.761 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' D' D ' 21' ' ' VAL . . . . . . . . . . . . . 45.2 t -64.31 -46.48 93.08 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.28 0 C-N-CA 120.742 -0.383 . . . . 0.0 110.534 -178.3 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' D' D ' 22' ' ' ILE . . . . . 0.604 HG22 HD12 ' D' ' 26' ' ' LEU . 51.4 mm -55.12 -47.38 77.32 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.232 0 C-N-CA 121.087 -0.245 . . . . 0.0 110.662 178.931 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' D' D ' 23' ' ' ARG . . . . . . . . . . . . . 52.6 ttp180 -53.74 -51.92 61.81 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-O 120.659 0.266 . . . . 0.0 111.418 -178.792 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' D' D ' 24' ' ' ILE . . . . . . . . . . . . . 71.2 mt -58.54 -43.15 86.45 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.344 0 C-N-CA 121.034 -0.266 . . . . 0.0 111.451 -175.705 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' D' D ' 25' ' ' LYS . . . . . . . . . . . . . 60.1 mttm -66.67 -43.68 83.82 Favored 'General case' 0 C--N 1.33 -0.269 0 N-CA-C 112.183 0.438 . . . . 0.0 112.183 -177.768 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' D' D ' 26' ' ' LEU . . . . . 0.604 HD12 HG22 ' D' ' 22' ' ' ILE . 27.1 mt -81.73 -25.95 34.98 Favored 'General case' 0 C--N 1.329 -0.298 0 N-CA-C 113.1 0.778 . . . . 0.0 113.1 -172.825 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' D' D ' 27' ' ' GLN . . . . . . . . . . . . . 5.8 pt20 -45.76 139.28 4.19 Favored 'General case' 0 N--CA 1.467 0.412 0 N-CA-C 112.819 0.674 . . . . 0.0 112.819 -174.666 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' D' D ' 28' ' ' GLY . . . . . . . . . . . . . . . 100.43 -26.95 22.63 Favored Glycine 0 CA--C 1.532 1.14 0 CA-C-N 115.755 -0.657 . . . . 0.0 112.116 -177.671 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' D' D ' 29' ' ' LYS . . . . . . . . . . . . . 64.0 mttp -96.72 155.09 16.92 Favored 'General case' 0 C--N 1.332 -0.175 0 CA-C-N 117.376 0.588 . . . . 0.0 110.788 178.525 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' D' D ' 30' ' ' THR . . . . . . . . . . . . . 35.3 m -108.11 141.24 40.11 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.196 -0.456 . . . . 0.0 110.489 178.993 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' D' D ' 31' ' ' VAL . . . . . . . . . . . . . 35.4 m -127.96 156.5 39.99 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.234 0 CA-C-N 116.097 -0.501 . . . . 0.0 110.32 179.147 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' D' D ' 32' ' ' ARG . . . . . . . . . . . . . 72.9 ttt-85 -130.17 150.28 51.49 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-O 121.116 0.484 . . . . 0.0 110.456 179.703 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' D' D ' 33' ' ' THR . . . . . . . . . . . . . 14.9 m -52.39 137.15 30.03 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.376 -0.375 . . . . 0.0 111.478 -178.148 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' D' D ' 34' ' ' GLY . . . . . . . . . . . . . . . 100.84 -17.17 56.77 Favored Glycine 0 CA--C 1.533 1.175 0 CA-C-O 119.691 -0.505 . . . . 0.0 113.241 179.021 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' D' D ' 35' ' ' ASP . . . . . . . . . . . . . 73.4 m-20 -66.58 150.96 48.24 Favored 'General case' 0 C--O 1.231 0.124 0 CA-C-N 118.083 0.941 . . . . 0.0 111.364 179.992 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' D' D ' 36' ' ' VAL . . . . . . . . . . . . . 41.9 t -122.01 127.81 75.44 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.228 0 CA-C-N 115.934 -0.575 . . . . 0.0 109.684 177.652 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' D' D ' 37' ' ' ILE . . . . . . . . . . . . . 61.8 mt -121.33 138.53 51.39 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.256 0 N-CA-C 109.882 -0.414 . . . . 0.0 109.882 -179.253 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' D' D ' 38' ' ' GLY . . . . . . . . . . . . . . . -117.52 128.85 8.01 Favored Glycine 0 CA--C 1.526 0.764 0 N-CA-C 111.123 -0.791 . . . . 0.0 111.123 -179.892 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' D' D ' 39' ' ' ILE . . . . . . . . . . . . . 74.5 mt -126.21 136.62 60.29 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.176 0 CA-C-O 120.785 0.326 . . . . 0.0 110.179 178.903 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' D' D ' 40' ' ' SER . . . . . . . . . . . . . 63.7 p -91.59 122.44 34.16 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.219 -0.446 . . . . 0.0 110.816 176.216 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' D' D ' 41' ' ' ILE . . . . . . . . . . . . . 68.3 mt -130.46 117.55 39.78 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.231 0 CA-C-O 120.89 0.376 . . . . 0.0 110.244 178.262 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' D' D ' 42' ' ' LEU . . . . . 0.555 HD23 ' O ' ' D' ' 42' ' ' LEU . 1.3 tt 54.62 43.73 29.75 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-O 121.419 0.628 . . . . 0.0 110.401 177.603 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' D' D ' 43' ' ' GLY . . . . . . . . . . . . . . . 71.12 19.0 76.96 Favored Glycine 0 CA--C 1.533 1.157 0 C-N-CA 121.211 -0.519 . . . . 0.0 113.089 175.411 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' D' D ' 44' ' ' LYS . . . . . . . . . . . . . 53.1 mttm -131.05 130.5 43.33 Favored 'General case' 0 C--N 1.333 -0.137 0 CA-C-N 117.774 0.787 . . . . 0.0 110.342 178.836 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' D' D ' 45' ' ' GLU . . . . . . . . . . . . . 84.8 tt0 -84.1 124.93 31.63 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 116.499 -0.319 . . . . 0.0 111.258 -178.917 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' D' D ' 46' ' ' VAL . . . . . 0.412 HG13 ' O ' ' D' ' 46' ' ' VAL . 10.1 p -117.84 124.71 73.46 Favored 'Isoleucine or valine' 0 N--CA 1.462 0.172 0 N-CA-C 109.577 -0.527 . . . . 0.0 109.577 174.549 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' D' D ' 47' ' ' LYS . . . . . . . . . . . . . 64.7 mttp -98.52 124.11 43.07 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.076 -0.511 . . . . 0.0 110.859 178.529 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' D' D ' 48' ' ' PHE . . . . . . . . . . . . . 34.3 m-85 -108.49 131.87 54.39 Favored 'General case' 0 C--N 1.329 -0.324 0 N-CA-C 109.563 -0.532 . . . . 0.0 109.563 176.545 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' D' D ' 49' ' ' LYS . . . . . . . . . . . . . 46.6 tttp -107.48 133.65 51.66 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.367 -0.379 . . . . 0.0 110.137 178.202 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' D' D ' 50' ' ' VAL . . . . . . . . . . . . . 44.1 t -76.63 104.4 4.64 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.325 0 N-CA-C 109.414 -0.587 . . . . 0.0 109.414 177.802 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' D' D ' 51' ' ' VAL . . . . . . . . . . . . . 52.5 t -69.83 -53.38 24.38 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.324 0 CA-C-N 115.985 -0.552 . . . . 0.0 109.646 -175.732 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' D' D ' 52' ' ' GLN . . . . . . . . . . . . . 87.9 mt-30 -153.73 152.2 30.49 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 115.949 -0.569 . . . . 0.0 111.377 -177.752 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' D' D ' 53' ' ' ALA . . . . . . . . . . . . . . . -131.04 129.9 42.58 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 115.231 -0.895 . . . . 0.0 109.55 175.198 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' D' D ' 54' ' ' TYR . . . . . . . . . . . . . 54.3 t80 -128.35 108.01 19.36 Favored Pre-proline 0 CA--C 1.534 0.339 0 CA-C-O 118.179 -0.915 . . . . 0.0 110.276 -179.536 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' D' D ' 55' ' ' PRO . . . . . . . . . . . . . 74.0 Cg_endo -77.09 170.08 72.59 Favored 'Cis proline' 0 N--CA 1.5 1.859 0 CA-C-N 121.754 1.662 . . . . 0.0 112.608 -3.981 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' D' D ' 56' ' ' SER . . . . . . . . . . . . . 13.6 m -112.88 131.72 22.64 Favored Pre-proline 0 CA--C 1.539 0.53 0 CA-C-O 118.438 -0.791 . . . . 0.0 109.666 176.17 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' D' D ' 57' ' ' PRO . . . . . . . . . . . . . 42.2 Cg_endo -69.42 168.17 67.25 Favored 'Cis proline' 0 N--CA 1.496 1.66 0 CA-C-N 121.929 1.725 . . . . 0.0 111.374 -3.732 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' D' D ' 58' ' ' LEU . . . . . . . . . . . . . 44.9 tp -130.24 137.67 50.15 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-O 120.955 0.407 . . . . 0.0 110.256 -179.804 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' D' D ' 59' ' ' ARG . . . . . . . . . . . . . 74.0 ttt180 -104.2 134.47 47.38 Favored 'General case' 0 C--N 1.327 -0.396 0 CA-C-N 115.918 -0.583 . . . . 0.0 109.767 178.033 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' D' D ' 60' ' ' VAL . . . . . . . . . . . . . 42.6 t -76.98 112.91 15.43 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.316 0 C-N-CA 120.821 -0.351 . . . . 0.0 110.183 -177.545 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' D' D ' 61' ' ' GLU . . . . . . . . . . . . . 96.0 mt-10 -131.08 162.05 30.69 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.001 -0.545 . . . . 0.0 110.077 178.944 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' D' D ' 62' ' ' ASP . . . . . . . . . . . . . 6.4 t70 -53.63 -31.86 48.98 Favored 'General case' 0 C--N 1.327 -0.375 0 N-CA-C 111.862 0.319 . . . . 0.0 111.862 -179.092 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' D' D ' 63' ' ' ARG . . . . . . . . . . . . . 39.4 ptt180 -84.66 3.91 34.9 Favored 'General case' 0 CA--C 1.537 0.449 0 N-CA-C 113.774 1.027 . . . . 0.0 113.774 -174.555 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' D' D ' 64' ' ' THR . . . . . . . . . . . . . 25.7 m -92.02 138.84 31.21 Favored 'General case' 0 C--N 1.333 -0.152 0 CA-C-N 118.155 0.434 . . . . 0.0 110.854 -177.805 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' D' D ' 65' ' ' LYS . . . . . . . . . . . . . 68.0 mttm -88.62 127.84 35.57 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.069 -0.514 . . . . 0.0 109.894 177.834 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' D' D ' 66' ' ' ILE . . . . . . . . . . . . . 59.8 mt -115.65 126.43 73.18 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.228 0 N-CA-C 109.684 -0.487 . . . . 0.0 109.684 179.314 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' D' D ' 67' ' ' THR . . . . . . . . . . . . . 28.4 m -126.8 145.04 50.78 Favored 'General case' 0 C--O 1.233 0.216 0 CA-C-O 121.271 0.558 . . . . 0.0 111.637 -175.448 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' D' D ' 68' ' ' LEU . . . . . 0.464 ' C ' HD23 ' D' ' 68' ' ' LEU . 6.1 tt -97.18 124.07 41.14 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 115.435 -0.802 . . . . 0.0 109.528 175.366 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' D' D ' 69' ' ' VAL . . . . . 0.421 ' N ' HD23 ' D' ' 68' ' ' LEU . 44.7 t -100.14 137.22 28.33 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.315 0 CA-C-O 121.102 0.477 . . . . 0.0 110.902 -175.008 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' D' D ' 70' ' ' THR . . . . . . . . . . . . . 3.6 t -137.27 63.0 1.57 Allowed 'General case' 0 C--N 1.33 -0.244 0 CA-C-O 121.625 0.726 . . . . 0.0 110.129 178.134 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' D' D ' 71' ' ' HIS . . . . . . . . . . . . . 6.1 m-70 -109.82 175.34 1.97 Allowed Pre-proline 0 CA--C 1.534 0.362 0 CA-C-N 115.688 -0.687 . . . . 0.0 110.476 -176.705 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' D' D ' 72' ' ' PRO . . . . . . . . . . . . . 21.7 Cg_exo -64.92 160.03 43.22 Favored 'Trans proline' 0 N--CA 1.496 1.63 0 C-N-CA 121.569 1.512 . . . . 0.0 112.148 179.836 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' D' D ' 73' ' ' VAL . . . . . . . . . . . . . 35.1 m -69.82 172.32 0.89 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.298 0 CA-C-N 115.881 -0.6 . . . . 0.0 111.18 -174.557 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' D' D ' 74' ' ' ASP . . . . . . . . . . . . . 12.5 t0 -94.89 123.24 38.24 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 115.893 -0.594 . . . . 0.0 110.294 -176.873 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' D' D ' 75' ' ' VAL . . . . . . . . . . . . . 47.1 t -116.33 121.9 68.57 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.209 0 CA-C-O 121.143 0.496 . . . . 0.0 110.204 -179.323 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' D' D ' 76' ' ' LEU . . . . . . . . . . . . . 36.8 mt -123.67 144.6 49.54 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 115.547 -0.751 . . . . 0.0 109.68 -179.54 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' D' D ' 77' ' ' GLU . . . . . . . . . . . . . 97.2 mt-10 -137.74 131.29 31.09 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-O 121.096 0.474 . . . . 0.0 111.274 -178.946 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' D' D ' 78' ' ' ALA . . . . . . . . . . . . . . . -118.94 139.82 51.02 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 115.693 -0.685 . . . . 0.0 109.974 177.183 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' D' D ' 79' ' ' LYS . . . . . 0.603 ' O ' HD13 ' D' ' 80' ' ' ILE . 35.2 tptt -80.47 116.43 20.51 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.513 -0.312 . . . . 0.0 110.818 -177.586 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' D' D ' 80' ' ' ILE . . . . . 0.603 HD13 ' O ' ' D' ' 79' ' ' LYS . 40.7 mm -139.11 108.18 3.69 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.237 0 CA-C-N 116.325 -0.398 . . . . 0.0 109.971 -176.542 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' D' D ' 81' ' ' LYS . . . . . . . . . . . . . 51.1 mttm -103.56 129.09 50.71 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-O 120.761 0.315 . . . . 0.0 111.18 -179.088 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' D' D ' 82' ' ' GLY . . . . . . . . . . . . . . . 89.05 42.16 5.69 Favored Glycine 0 CA--C 1.524 0.656 0 C-N-CA 120.828 -0.701 . . . . 0.0 111.545 173.64 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' D' D ' 83' ' ' ILE . . . . . . . . . . . . . 72.7 mt -67.15 131.1 32.93 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.365 0 N-CA-C 109.915 -0.402 . . . . 0.0 109.915 178.646 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' D' D ' 84' ' ' LYS . . . . . . . . . . . . . 76.3 tttt -91.15 -50.45 5.83 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-O 121.198 0.523 . . . . 0.0 109.665 179.619 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' D' D ' 85' ' ' ASP . . . . . . . . . . . . . 5.1 t70 -160.43 155.3 24.25 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 115.448 -0.796 . . . . 0.0 110.193 178.939 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' D' D ' 86' ' ' VAL . . . . . . . . . . . . . 40.1 t -131.54 133.31 61.91 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.285 0 CA-C-O 121.039 0.447 . . . . 0.0 110.175 179.699 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' D' D ' 87' ' ' ILE . . . . . . . . . . . . . 44.7 mm -119.05 128.46 75.8 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.294 0 CA-C-N 115.79 -0.641 . . . . 0.0 109.584 178.659 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' D' D ' 88' ' ' LEU . . . . . . . . . . . . . 21.8 tp -108.53 130.14 55.29 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-N 116.282 -0.417 . . . . 0.0 111.117 -177.638 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' D' D ' 89' ' ' ASP . . . . . . . . . . . . . 13.6 t70 -121.68 150.89 41.1 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 115.846 -0.616 . . . . 0.0 109.352 175.691 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' D' D ' 90' ' ' GLU . . . . . . . . . . . . . 43.8 tp10 -47.29 -36.34 9.07 Favored 'General case' 0 C--N 1.331 -0.206 0 N-CA-C 112.868 0.692 . . . . 0.0 112.868 -173.327 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' D' D ' 91' ' ' ASN . . . . . . . . . . . . . 86.9 m-20 -132.14 32.4 4.01 Favored 'General case' 0 N--CA 1.463 0.209 0 N-CA-C 112.097 0.406 . . . . 0.0 112.097 -176.332 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' D' D ' 92' ' ' LEU . . . . . . . . . . . . . 9.0 tp -166.15 151.23 8.32 Favored 'General case' 0 C--N 1.331 -0.223 0 C-N-CA 120.871 -0.332 . . . . 0.0 111.016 179.929 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' D' D ' 93' ' ' ILE . . . . . . . . . . . . . 71.2 mt -125.84 122.7 62.64 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.234 0 N-CA-C 109.429 -0.582 . . . . 0.0 109.429 179.707 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' D' D ' 94' ' ' VAL . . . . . . . . . . . . . 41.9 t -120.1 127.59 75.9 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.186 0 N-CA-C 110.09 -0.337 . . . . 0.0 110.09 -179.201 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' D' D ' 95' ' ' VAL . . . . . . . . . . . . . 44.4 t -123.27 133.47 69.02 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.275 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.042 -179.797 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' D' D ' 96' ' ' ILE . . . . . . . . . . . . . 65.5 mt -115.61 127.52 73.16 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.225 0 N-CA-C 109.559 -0.534 . . . . 0.0 109.559 179.231 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' D' D ' 97' ' ' THR . . . . . . . . . . . . . 66.4 p -100.47 153.58 19.24 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-O 121.081 0.467 . . . . 0.0 110.882 -178.656 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' D' D ' 98' ' ' GLU . . . . . . . . . . . . . 12.7 pt-20 -53.96 -21.71 8.65 Favored 'General case' 0 CA--C 1.534 0.362 0 N-CA-C 112.532 0.567 . . . . 0.0 112.532 -179.409 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' D' D ' 99' ' ' GLU . . . . . . . . . . . . . 96.2 mt-10 -81.34 14.99 2.16 Favored 'General case' 0 CA--C 1.534 0.364 0 N-CA-C 113.077 0.769 . . . . 0.0 113.077 -177.071 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' D' D ' 100' ' ' ASN . . . . . . . . . . . . . 4.7 m-20 62.18 34.86 15.91 Favored 'General case' 0 CA--C 1.53 0.203 0 CA-C-N 118.085 0.402 . . . . 0.0 111.182 -179.904 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' D' D ' 101' ' ' GLU . . . . . . . . . . . . . 83.5 tt0 -112.37 142.04 45.38 Favored 'General case' 0 C--N 1.333 -0.148 0 N-CA-C 109.534 -0.543 . . . . 0.0 109.534 174.552 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' D' D ' 102' ' ' VAL . . . . . . . . . . . . . 46.7 t -115.0 126.57 72.62 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.277 0 N-CA-C 109.847 -0.427 . . . . 0.0 109.847 -178.239 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' D' D ' 103' ' ' LEU . . . . . . . . . . . . . 26.0 mt -116.64 127.87 54.84 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 115.658 -0.701 . . . . 0.0 110.022 177.703 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' D' D ' 104' ' ' ILE . . . . . . . . . . . . . 67.9 mt -117.61 122.68 70.39 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.262 0 CA-C-N 116.408 -0.36 . . . . 0.0 110.219 -179.336 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' D' D ' 105' ' ' PHE . . . . . . . . . . . . . 66.2 m-85 -124.5 163.16 22.45 Favored 'General case' 0 C--N 1.331 -0.202 0 O-C-N 123.804 0.69 . . . . 0.0 109.757 179.521 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' D' D ' 106' ' ' ASN . . . . . . . . . . . . . 45.8 p-10 -96.83 -173.11 2.62 Favored 'General case' 0 C--N 1.329 -0.308 0 N-CA-C 109.59 -0.522 . . . . 0.0 109.59 173.889 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' D' D ' 107' ' ' GLN . . . . . . . . . . . . . 28.6 tt0 -60.85 -23.99 65.55 Favored 'General case' 0 CA--C 1.534 0.337 0 N-CA-C 112.312 0.486 . . . . 0.0 112.312 179.862 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' D' D ' 108' ' ' ASN . . . . . . . . . . . . . 60.6 t30 -86.53 10.22 16.0 Favored 'General case' 0 CA--C 1.536 0.43 0 N-CA-C 113.037 0.754 . . . . 0.0 113.037 -178.737 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' D' D ' 109' ' ' LEU . . . . . . . . . . . . . 12.3 tp 57.04 38.94 29.54 Favored 'General case' 0 C--N 1.332 -0.194 0 CA-C-O 121.152 0.501 . . . . 0.0 111.206 178.885 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' D' D ' 110' ' ' GLU . . . . . . . . . . . . . 70.9 mm-40 -107.1 148.82 28.32 Favored 'General case' 0 C--N 1.33 -0.265 0 N-CA-C 109.832 -0.432 . . . . 0.0 109.832 175.566 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' D' D ' 111' ' ' GLU . . . . . . . . . . . . . 83.1 tt0 -78.16 121.89 24.92 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.27 -0.423 . . . . 0.0 110.821 -177.683 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' D' D ' 112' ' ' LEU . . . . . . . . . . . . . 31.4 mt -109.6 -46.05 3.58 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-N 116.256 -0.429 . . . . 0.0 110.686 179.564 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' D' D ' 113' ' ' TYR . . . . . . . . . . . . . 58.0 t80 -140.71 135.31 31.45 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 116.264 -0.425 . . . . 0.0 110.927 -179.2 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' D' D ' 114' ' ' ARG . . . . . . . . . . . . . 69.6 ttp85 -136.42 122.03 19.65 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.138 -0.483 . . . . 0.0 110.117 178.035 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' D' D ' 115' ' ' GLY . . . . . . . . . . . . . . . -150.03 153.14 24.91 Favored Glycine 0 CA--C 1.524 0.652 0 N-CA-C 110.996 -0.842 . . . . 0.0 110.996 179.015 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' D' D ' 116' ' ' LYS . . . . . . . . . . . . . 63.4 tttt -129.5 132.13 46.82 Favored 'General case' 0 C--N 1.329 -0.321 0 N-CA-C 109.825 -0.435 . . . . 0.0 109.825 177.941 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' D' D ' 117' ' ' PHE . . . . . . . . . . . . . 37.3 m-85 -128.13 117.25 21.27 Favored 'General case' 0 C--N 1.332 -0.187 0 CA-C-O 120.963 0.411 . . . . 0.0 110.232 -175.11 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' D' D ' 118' ' ' GLU . . . . . . . . . . . . . 44.9 tp10 -51.67 -51.21 57.68 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.403 -0.362 . . . . 0.0 111.61 -177.078 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' D' D ' 119' ' ' ASN . . . . . . . . . . . . . 3.6 m120 -94.48 30.95 1.85 Allowed 'General case' 0 C--N 1.329 -0.287 0 N-CA-C 112.249 0.463 . . . . 0.0 112.249 -174.927 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' D' D ' 120' ' ' LEU . . . . . . . . . . . . . 15.6 tp -56.7 121.09 8.97 Favored 'General case' 0 C--N 1.332 -0.167 0 CA-C-O 120.597 0.237 . . . . 0.0 110.41 178.032 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' D' D ' 121' ' ' ASN . . . . . . . . . . . . . 33.1 m120 -114.08 -44.0 3.19 Favored 'General case' 0 C--O 1.232 0.171 0 CA-C-N 116.723 -0.217 . . . . 0.0 111.147 -176.649 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' D' D ' 122' ' ' LYS . . . . . . . . . . . . . 61.4 mtpt -139.13 138.58 37.13 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-O 120.92 0.391 . . . . 0.0 111.314 -176.674 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' D' D ' 123' ' ' VAL . . . . . . . . . . . . . 45.1 t -126.93 126.2 67.98 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.326 0 N-CA-C 109.375 -0.602 . . . . 0.0 109.375 175.26 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' D' D ' 124' ' ' LEU . . . . . . . . . . . . . 59.5 mt -131.21 136.43 48.24 Favored 'General case' 0 C--N 1.332 -0.194 0 CA-C-O 120.95 0.405 . . . . 0.0 110.781 -177.444 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' D' D ' 125' ' ' VAL . . . . . 0.413 HG23 HG22 ' D' ' 130' ' ' VAL . 11.6 p -133.95 138.57 50.17 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.284 0 CA-C-N 116.113 -0.494 . . . . 0.0 110.355 178.863 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' D' D ' 126' ' ' ARG . . . . . . . . . . . . . 96.7 mtt180 -149.1 126.82 11.74 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 115.769 -0.65 . . . . 0.0 109.425 177.778 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' D' D ' 127' ' ' ASN . . . . . . . . . . . . . 1.8 t-20 57.63 -147.47 0.51 Allowed 'General case' 0 CA--C 1.541 0.62 0 N-CA-C 109.418 -0.586 . . . . 0.0 109.418 -178.352 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' D' D ' 128' ' ' ASP . . . . . . . . . . . . . 8.7 p-10 -87.32 17.38 4.44 Favored 'General case' 0 CA--C 1.534 0.36 0 CA-C-N 118.892 0.769 . . . . 0.0 112.657 178.03 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' D' D ' 129' ' ' LEU . . . . . . . . . . . . . 13.3 tp -112.5 136.16 52.35 Favored 'General case' 0 C--O 1.231 0.098 0 O-C-N 122.003 -0.435 . . . . 0.0 109.988 179.001 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' D' D ' 130' ' ' VAL . . . . . 0.413 HG22 HG23 ' D' ' 125' ' ' VAL . 39.0 t -124.89 140.05 49.19 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.338 0 CA-C-O 120.768 0.318 . . . . 0.0 110.354 -176.646 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' D' D ' 131' ' ' VAL . . . . . . . . . . . . . 44.2 t -136.07 136.48 49.52 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.206 0 CA-C-O 121.144 0.497 . . . . 0.0 110.309 177.459 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' D' D ' 132' ' ' ILE . . . . . . . . . . . . . 71.3 mt -120.41 134.16 64.78 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.229 0 CA-C-N 115.69 -0.686 . . . . 0.0 109.645 -179.105 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' D' D ' 133' ' ' ILE . . . . . . . . . . . . . 43.5 mm -117.44 120.96 66.44 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.215 0 CA-C-O 121.142 0.496 . . . . 0.0 111.045 -175.915 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' D' D ' 134' ' ' ASP . . . . . . . . . . . . . 6.7 p-10 -131.71 145.82 51.84 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 115.671 -0.695 . . . . 0.0 109.449 174.216 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' D' D ' 135' ' ' GLU . . . . . . . . . . . . . 41.2 tp10 -49.74 -24.63 2.43 Favored 'General case' 0 C--N 1.328 -0.361 0 N-CA-C 112.872 0.693 . . . . 0.0 112.872 -171.584 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' D' D ' 136' ' ' GLN . . . . . . . . . . . . . 96.9 mt-30 -94.25 -33.23 13.33 Favored 'General case' 0 C--O 1.232 0.166 0 N-CA-C 112.356 0.502 . . . . 0.0 112.356 -175.932 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' D' D ' 137' ' ' LYS . . . . . . . . . . . . . 54.4 mtmt -148.17 158.11 43.89 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-O 121.388 0.613 . . . . 0.0 112.114 -170.445 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' D' D ' 138' ' ' LEU . . . . . 0.412 ' C ' HD23 ' D' ' 138' ' ' LEU . 5.6 tt -116.6 124.77 50.62 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 115.219 -0.9 . . . . 0.0 109.323 174.783 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' D' D ' 139' ' ' THR . . . . . . . . . . . . . 34.5 m -110.12 131.1 55.36 Favored 'General case' 0 C--N 1.331 -0.208 0 CA-C-N 116.366 -0.379 . . . . 0.0 110.863 -176.735 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' D' D ' 140' ' ' LEU . . . . . 0.472 ' C ' HD23 ' D' ' 140' ' ' LEU . 6.1 tt -119.79 124.02 45.12 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 115.543 -0.753 . . . . 0.0 109.303 -178.735 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' D' D ' 141' ' ' ILE . . . . . 0.437 ' N ' HD23 ' D' ' 140' ' ' LEU . 19.1 mt -121.28 120.25 61.49 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.314 0 CA-C-O 120.779 0.323 . . . . 0.0 110.131 -174.723 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' D' D ' 142' ' ' ARG . . . . . . . . . . . . . 82.8 mtp180 -110.32 127.66 55.15 Favored 'General case' 0 C--N 1.331 -0.226 0 CA-C-N 115.613 -0.722 . . . . 0.0 110.426 -179.039 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' D' D ' 143' ' ' THR . . . . . . . . . . . . . 59.8 p . . . . . 0 C--O 1.22 -0.463 0 CA-C-O 117.942 -1.028 . . . . 0.0 110.575 179.73 . . . . . . . . 0 0 . 1 . 002 nuclear build full ' E' E ' -3' ' ' GLU . . . . . . . . . . . . . 95.6 mt-10 . . . . . 0 N--CA 1.489 1.525 0 N-CA-C 109.281 -0.637 . . . . 0.0 109.281 . . . . . . . . . 0 0 . 1 . 002 nuclear build full ' E' E ' -2' ' ' GLY . . . . . . . . . . . . . . . -76.79 149.61 36.67 Favored Glycine 0 CA--C 1.525 0.702 0 N-CA-C 110.958 -0.857 . . . . 0.0 110.958 179.828 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' E' E ' -1' ' ' VAL . . . . . . . . . . . . . 46.5 t -95.71 133.1 38.03 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.368 0 N-CA-C 109.992 -0.373 . . . . 0.0 109.992 179.505 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' E' E ' 0' ' ' ILE . . . . . . . . . . . . . 70.0 mt -119.32 134.18 63.76 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.191 0 CA-C-N 116.207 -0.451 . . . . 0.0 110.105 -179.204 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' E' E ' 1' ' ' MET . . . . . . . . . . . . . 25.6 ptm -78.08 132.83 37.89 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.078 -0.51 . . . . 0.0 110.464 178.398 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' E' E ' 2' ' ' SER . . . . . . . . . . . . . 3.6 p -129.11 127.13 40.83 Favored 'General case' 0 C--N 1.331 -0.218 0 CA-C-O 120.955 0.407 . . . . 0.0 110.46 -179.617 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' E' E ' 3' ' ' GLU . . . . . . . . . . . . . 28.6 tp10 -139.44 137.55 35.71 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 115.745 -0.661 . . . . 0.0 110.503 -176.511 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' E' E ' 4' ' ' LEU . . . . . . . . . . . . . 17.8 tp -124.12 126.15 45.71 Favored 'General case' 0 C--N 1.33 -0.244 0 N-CA-C 109.564 -0.532 . . . . 0.0 109.564 174.525 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' E' E ' 5' ' ' LYS . . . . . . . . . . . . . 66.4 mttm -112.85 122.13 46.75 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-O 120.948 0.404 . . . . 0.0 110.87 -177.668 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' E' E ' 6' ' ' LEU . . . . . 0.461 HD23 ' HA ' ' E' ' 50' ' ' VAL . 59.2 mt -113.89 143.87 43.97 Favored 'General case' 0 C--N 1.331 -0.23 0 CA-C-N 115.199 -0.909 . . . . 0.0 110.161 -179.421 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' E' E ' 7' ' ' LYS . . . . . . . . . . . . . 84.8 tttt -121.05 135.22 24.68 Favored Pre-proline 0 CA--C 1.535 0.398 0 CA-C-O 118.858 -0.591 . . . . 0.0 109.529 176.167 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' E' E ' 8' ' ' PRO . . . . . . . . . . . . . 97.6 Cg_endo -91.19 132.65 1.5 Allowed 'Trans proline' 0 N--CA 1.49 1.275 0 C-N-CA 121.683 1.589 . . . . 0.0 111.765 178.484 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' E' E ' 9' ' ' LEU . . . . . . . . . . . . . 46.9 mt -74.31 -47.02 6.02 Favored Pre-proline 0 CA--C 1.533 0.32 0 CA-C-O 118.709 -0.662 . . . . 0.0 112.176 -177.55 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' E' E ' 10' ' ' PRO . . . . . . . . . . . . . 84.4 Cg_endo -81.41 153.37 18.2 Favored 'Trans proline' 0 N--CA 1.496 1.671 0 C-N-CA 121.158 1.239 . . . . 0.0 111.726 174.95 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' E' E ' 11' ' ' LYS . . . . . . . . . . . . . 57.1 tttm -86.77 99.44 11.8 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.418 -0.356 . . . . 0.0 110.3 178.747 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' E' E ' 12' ' ' VAL . . . . . . . . . . . . . 12.0 p -141.5 147.54 21.98 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.254 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.571 -178.59 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' E' E ' 13' ' ' GLU . . . . . . . . . . . . . 43.1 tp10 -93.76 122.36 36.15 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.059 -0.519 . . . . 0.0 110.045 177.61 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' E' E ' 14' ' ' LEU . . . . . . . . . . . . . 20.7 mt -95.94 148.94 35.33 Favored Pre-proline 0 C--N 1.329 -0.292 0 CA-C-O 119.328 -0.368 . . . . 0.0 110.465 -178.161 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' E' E ' 15' ' ' PRO . . . . . . . . . . . . . 24.8 Cg_exo -62.46 160.25 32.54 Favored 'Trans proline' 0 N--CA 1.497 1.731 0 C-N-CA 121.214 1.276 . . . . 0.0 111.722 177.404 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' E' E ' 16' ' ' PRO . . . . . . . . . . . . . 29.9 Cg_exo -60.06 -32.37 94.7 Favored 'Trans proline' 0 N--CA 1.497 1.685 0 C-N-CA 121.385 1.39 . . . . 0.0 112.718 -178.659 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' E' E ' 17' ' ' ASP . . . . . . . . . . . . . 18.1 p-10 -88.39 4.73 45.25 Favored 'General case' 0 CA--C 1.536 0.422 0 N-CA-C 113.326 0.861 . . . . 0.0 113.326 -177.414 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' E' E ' 18' ' ' PHE . . . . . . . . . . . . . 52.4 t80 -58.23 -43.2 87.64 Favored 'General case' 0 C--N 1.334 -0.077 0 O-C-N 121.998 -0.439 . . . . 0.0 110.042 -178.606 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' E' E ' 19' ' ' VAL . . . . . . . . . . . . . 47.2 t -55.54 -42.81 69.99 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.28 0 CA-C-N 116.33 -0.395 . . . . 0.0 110.585 -179.425 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' E' E ' 20' ' ' ASP . . . . . . . . . . . . . 76.7 m-20 -60.57 -42.99 97.76 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-O 120.801 0.334 . . . . 0.0 110.926 -178.485 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' E' E ' 21' ' ' VAL . . . . . . . . . . . . . 45.7 t -64.01 -46.32 94.24 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.265 0 C-N-CA 120.792 -0.363 . . . . 0.0 110.463 -177.757 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' E' E ' 22' ' ' ILE . . . . . 0.68 HG22 HD12 ' E' ' 26' ' ' LEU . 51.5 mm -55.67 -46.29 79.4 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.234 0 CA-C-O 120.788 0.328 . . . . 0.0 110.548 178.45 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' E' E ' 23' ' ' ARG . . . . . . . . . . . . . 54.6 ttp180 -53.1 -50.97 63.35 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-O 120.669 0.271 . . . . 0.0 111.569 -179.887 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' E' E ' 24' ' ' ILE . . . . . . . . . . . . . 74.6 mt -58.35 -47.28 88.22 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.312 0 CA-C-N 116.505 -0.316 . . . . 0.0 111.452 -176.3 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' E' E ' 25' ' ' LYS . . . . . . . . . . . . . 76.0 mttt -65.49 -40.59 93.26 Favored 'General case' 0 C--N 1.329 -0.298 0 N-CA-C 112.428 0.529 . . . . 0.0 112.428 -176.613 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' E' E ' 26' ' ' LEU . . . . . 0.68 HD12 HG22 ' E' ' 22' ' ' ILE . 40.6 mt -79.65 -38.6 33.35 Favored 'General case' 0 C--N 1.33 -0.245 0 N-CA-C 113.19 0.811 . . . . 0.0 113.19 -171.143 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' E' E ' 27' ' ' GLN . . . . . . . . . . . . . 13.1 pt20 -46.88 139.46 5.47 Favored 'General case' 0 N--CA 1.468 0.443 0 N-CA-C 112.785 0.661 . . . . 0.0 112.785 -174.976 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' E' E ' 28' ' ' GLY . . . . . . . . . . . . . . . 99.61 -25.54 27.86 Favored Glycine 0 CA--C 1.534 1.229 0 CA-C-N 115.559 -0.746 . . . . 0.0 112.178 -176.209 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' E' E ' 29' ' ' LYS . . . . . . . . . . . . . 95.6 mttt -97.21 155.19 16.95 Favored 'General case' 0 C--O 1.233 0.186 0 CA-C-N 117.324 0.562 . . . . 0.0 110.918 178.935 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' E' E ' 30' ' ' THR . . . . . . . . . . . . . 23.6 m -104.68 137.66 42.16 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 115.922 -0.581 . . . . 0.0 110.035 175.83 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' E' E ' 31' ' ' VAL . . . . . . . . . . . . . 35.2 m -127.82 155.69 39.36 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.235 0 CA-C-N 116.381 -0.372 . . . . 0.0 110.685 -179.235 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' E' E ' 32' ' ' ARG . . . . . . . . . . . . . 78.2 mtt85 -132.6 150.49 52.15 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.079 -0.51 . . . . 0.0 110.402 177.821 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' E' E ' 33' ' ' THR . . . . . . . . . . . . . 22.3 m -52.8 139.1 27.71 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.302 -0.408 . . . . 0.0 111.419 -179.194 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' E' E ' 34' ' ' GLY . . . . . . . . . . . . . . . 101.03 -17.21 56.49 Favored Glycine 0 CA--C 1.532 1.141 0 CA-C-O 119.69 -0.505 . . . . 0.0 113.165 179.751 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' E' E ' 35' ' ' ASP . . . . . . . . . . . . . 73.5 m-20 -66.95 149.64 50.33 Favored 'General case' 0 C--O 1.231 0.104 0 CA-C-N 118.08 0.94 . . . . 0.0 111.147 178.859 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' E' E ' 36' ' ' VAL . . . . . . . . . . . . . 43.1 t -121.83 130.89 74.19 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.24 0 CA-C-N 116.107 -0.497 . . . . 0.0 109.843 178.188 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' E' E ' 37' ' ' ILE . . . . . . . . . . . . . 65.1 mt -121.32 139.18 49.28 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.194 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.0 -178.971 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' E' E ' 38' ' ' GLY . . . . . . . . . . . . . . . -116.66 129.0 8.18 Favored Glycine 0 CA--C 1.525 0.676 0 N-CA-C 111.137 -0.785 . . . . 0.0 111.137 -179.873 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' E' E ' 39' ' ' ILE . . . . . . . . . . . . . 76.5 mt -127.26 139.96 50.44 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.224 0 CA-C-O 120.755 0.312 . . . . 0.0 110.243 179.351 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' E' E ' 40' ' ' SER . . . . . . . . . . . . . 13.3 t -92.6 126.02 37.5 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.288 -0.414 . . . . 0.0 111.059 177.0 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' E' E ' 41' ' ' ILE . . . . . . . . . . . . . 65.5 mt -129.53 117.0 41.12 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.193 0 CA-C-O 120.863 0.363 . . . . 0.0 110.126 177.088 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' E' E ' 42' ' ' LEU . . . . . . . . . . . . . 7.2 mp 51.78 38.18 22.44 Favored 'General case' 0 CA--C 1.53 0.195 0 CA-C-N 116.101 -0.499 . . . . 0.0 111.598 176.747 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' E' E ' 43' ' ' GLY . . . . . . . . . . . . . . . 74.17 29.1 62.96 Favored Glycine 0 CA--C 1.529 0.969 0 C-N-CA 121.156 -0.545 . . . . 0.0 112.51 176.663 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' E' E ' 44' ' ' LYS . . . . . . . . . . . . . 30.0 ttpt -139.13 128.39 24.07 Favored 'General case' 0 C--N 1.33 -0.281 0 N-CA-C 109.523 -0.547 . . . . 0.0 109.523 176.578 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' E' E ' 45' ' ' GLU . . . . . . . . . . . . . 84.3 tt0 -83.1 125.66 31.73 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-O 120.799 0.333 . . . . 0.0 111.305 -177.111 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' E' E ' 46' ' ' VAL . . . . . 0.402 HG13 ' O ' ' E' ' 46' ' ' VAL . 9.2 p -117.38 124.96 73.7 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.183 0 N-CA-C 109.558 -0.534 . . . . 0.0 109.558 174.852 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' E' E ' 47' ' ' LYS . . . . . . . . . . . . . 62.5 mttp -98.16 126.46 43.64 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.06 -0.518 . . . . 0.0 110.904 177.973 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' E' E ' 48' ' ' PHE . . . . . . . . . . . . . 33.0 m-85 -110.13 131.86 54.68 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.025 -0.534 . . . . 0.0 109.679 176.568 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' E' E ' 49' ' ' LYS . . . . . . . . . . . . . 70.2 tttt -106.53 130.55 54.29 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.378 -0.373 . . . . 0.0 110.159 178.581 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' E' E ' 50' ' ' VAL . . . . . 0.461 ' HA ' HD23 ' E' ' 6' ' ' LEU . 46.4 t -74.73 103.16 2.52 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.258 0 N-CA-C 109.151 -0.685 . . . . 0.0 109.151 176.821 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' E' E ' 51' ' ' VAL . . . . . . . . . . . . . 47.3 t -69.58 -52.97 27.12 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.289 0 N-CA-C 109.478 -0.564 . . . . 0.0 109.478 -174.687 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' E' E ' 52' ' ' GLN . . . . . . . . . . . . . 81.3 mt-30 -154.49 149.93 27.27 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 115.986 -0.552 . . . . 0.0 111.624 -178.101 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' E' E ' 53' ' ' ALA . . . . . . . . . . . . . . . -128.26 133.21 48.75 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 115.305 -0.861 . . . . 0.0 109.542 175.046 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' E' E ' 54' ' ' TYR . . . . . . . . . . . . . 58.8 t80 -129.03 110.44 18.32 Favored Pre-proline 0 C--N 1.327 -0.372 0 CA-C-O 118.202 -0.904 . . . . 0.0 110.191 179.123 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' E' E ' 55' ' ' PRO . . . . . . . . . . . . . 73.7 Cg_endo -77.21 168.36 77.08 Favored 'Cis proline' 0 N--CA 1.5 1.865 0 CA-C-N 121.828 1.689 . . . . 0.0 112.511 -5.453 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' E' E ' 56' ' ' SER . . . . . . . . . . . . . 17.7 m -116.76 131.36 23.96 Favored Pre-proline 0 CA--C 1.537 0.479 0 CA-C-O 118.392 -0.813 . . . . 0.0 109.361 174.104 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' E' E ' 57' ' ' PRO . . . . . . . . . . . . . 38.6 Cg_endo -67.13 164.98 69.45 Favored 'Cis proline' 0 N--CA 1.497 1.72 0 CA-C-N 121.96 1.736 . . . . 0.0 111.522 -0.919 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' E' E ' 58' ' ' LEU . . . . . . . . . . . . . 27.0 tp -130.44 137.0 49.59 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.218 -0.447 . . . . 0.0 110.316 -179.535 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' E' E ' 59' ' ' ARG . . . . . . . . . . . . . 41.1 ttm180 -103.05 132.67 49.14 Favored 'General case' 0 C--N 1.327 -0.373 0 N-CA-C 109.525 -0.546 . . . . 0.0 109.525 176.65 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' E' E ' 60' ' ' VAL . . . . . . . . . . . . . 45.8 t -83.24 115.44 25.65 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.284 0 C-N-CA 120.751 -0.379 . . . . 0.0 110.532 -176.9 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' E' E ' 61' ' ' GLU . . . . . . . . . . . . . 15.6 mm-40 -131.06 163.54 27.41 Favored 'General case' 0 C--N 1.331 -0.23 0 CA-C-N 115.75 -0.659 . . . . 0.0 109.714 175.165 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' E' E ' 62' ' ' ASP . . . . . . . . . . . . . 78.4 m-20 -53.13 -32.35 47.1 Favored 'General case' 0 C--N 1.328 -0.35 0 N-CA-C 111.917 0.34 . . . . 0.0 111.917 -178.95 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' E' E ' 63' ' ' ARG . . . . . . . . . . . . . 84.0 mtt180 -74.03 -22.02 59.72 Favored 'General case' 0 C--N 1.33 -0.26 0 N-CA-C 112.992 0.738 . . . . 0.0 112.992 -176.619 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' E' E ' 64' ' ' THR . . . . . . . . . . . . . 37.8 m -64.78 140.07 58.83 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-O 120.913 0.387 . . . . 0.0 110.835 -175.947 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' E' E ' 65' ' ' LYS . . . . . . . . . . . . . 25.0 mtpp -90.05 123.17 33.7 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.061 -0.518 . . . . 0.0 109.995 179.567 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' E' E ' 66' ' ' ILE . . . . . . . . . . . . . 57.3 mt -113.79 131.13 66.53 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.241 0 CA-C-O 120.85 0.357 . . . . 0.0 110.351 -177.623 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' E' E ' 67' ' ' THR . . . . . . . . . . . . . 30.9 m -132.49 139.84 48.12 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.127 -0.488 . . . . 0.0 111.012 -179.122 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' E' E ' 68' ' ' LEU . . . . . 0.446 HD12 ' N ' ' E' ' 68' ' ' LEU . 8.1 mp -107.36 135.48 48.78 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.039 -0.528 . . . . 0.0 110.203 176.836 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' E' E ' 69' ' ' VAL . . . . . . . . . . . . . 43.8 t -98.32 132.62 43.0 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.346 0 CA-C-N 116.064 -0.516 . . . . 0.0 110.197 -179.036 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' E' E ' 70' ' ' THR . . . . . . . . . . . . . 19.8 m -135.0 -50.89 0.77 Allowed 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.491 -179.916 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' E' E ' 71' ' ' HIS . . . . . . . . . . . . . 81.2 m-70 -108.53 153.17 42.28 Favored Pre-proline 0 CA--C 1.532 0.279 0 CA-C-N 116.282 -0.417 . . . . 0.0 110.419 -179.913 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' E' E ' 72' ' ' PRO . . . . . . . . . . . . . 97.7 Cg_endo -85.01 -21.34 3.17 Favored 'Trans proline' 0 N--CA 1.493 1.475 0 C-N-CA 121.589 1.526 . . . . 0.0 113.238 179.744 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' E' E ' 73' ' ' VAL . . . . . . . . . . . . . 34.6 m -126.11 167.48 20.52 Favored 'Isoleucine or valine' 0 C--O 1.232 0.155 0 CA-C-O 120.804 0.335 . . . . 0.0 110.663 -178.464 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' E' E ' 74' ' ' ASP . . . . . . . . . . . . . 26.4 t0 -99.33 120.57 39.78 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.222 -0.445 . . . . 0.0 109.998 -178.901 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' E' E ' 75' ' ' VAL . . . . . . . . . . . . . 46.8 t -112.61 121.3 64.66 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.19 0 CA-C-O 121.031 0.443 . . . . 0.0 110.358 -178.477 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' E' E ' 76' ' ' LEU . . . . . . . . . . . . . 41.2 mt -118.42 144.75 45.72 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 115.626 -0.716 . . . . 0.0 109.737 178.713 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' E' E ' 77' ' ' GLU . . . . . . . . . . . . . 97.3 mt-10 -139.43 130.2 26.07 Favored 'General case' 0 C--N 1.331 -0.205 0 CA-C-O 120.999 0.428 . . . . 0.0 111.327 -179.416 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' E' E ' 78' ' ' ALA . . . . . 0.557 ' HB2' HD21 ' E' ' 109' ' ' LEU . . . -119.16 135.28 54.74 Favored 'General case' 0 C--N 1.331 -0.212 0 CA-C-N 115.797 -0.638 . . . . 0.0 109.775 176.689 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' E' E ' 79' ' ' LYS . . . . . 0.591 ' O ' HD13 ' E' ' 80' ' ' ILE . 91.0 mttt -77.13 118.62 19.85 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-O 120.882 0.373 . . . . 0.0 110.711 -179.452 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' E' E ' 80' ' ' ILE . . . . . 0.591 HD13 ' O ' ' E' ' 79' ' ' LYS . 41.1 mm -139.13 106.04 2.75 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.39 0 N-CA-C 109.138 -0.69 . . . . 0.0 109.138 -178.077 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' E' E ' 81' ' ' LYS . . . . . . . . . . . . . 76.0 tttt -105.24 127.34 52.88 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-O 120.895 0.379 . . . . 0.0 111.164 -176.0 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' E' E ' 82' ' ' GLY . . . . . . . . . . . . . . . 89.13 42.09 5.69 Favored Glycine 0 CA--C 1.524 0.638 0 N-CA-C 111.615 -0.594 . . . . 0.0 111.615 176.346 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' E' E ' 83' ' ' ILE . . . . . . . . . . . . . 72.4 mt -69.64 140.18 19.1 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.294 0 N-CA-C 109.836 -0.431 . . . . 0.0 109.836 177.446 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' E' E ' 84' ' ' LYS . . . . . . . . . . . . . 49.4 tttp -98.17 -51.06 4.14 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 115.9 -0.591 . . . . 0.0 110.263 -178.733 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' E' E ' 85' ' ' ASP . . . . . . . . . . . . . 6.5 t70 -155.27 151.72 28.39 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 115.764 -0.653 . . . . 0.0 110.316 179.67 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' E' E ' 86' ' ' VAL . . . . . . . . . . . . . 44.2 t -130.44 131.41 65.24 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.221 0 CA-C-O 120.931 0.395 . . . . 0.0 110.553 -178.719 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' E' E ' 87' ' ' ILE . . . . . 0.49 ' N ' HD12 ' E' ' 87' ' ' ILE . 5.0 mp -120.6 126.65 75.49 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.22 0 CA-C-N 115.889 -0.596 . . . . 0.0 109.494 176.382 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' E' E ' 88' ' ' LEU . . . . . . . . . . . . . 47.2 mt -116.0 137.76 51.82 Favored 'General case' 0 N--CA 1.462 0.167 0 CA-C-O 121.045 0.45 . . . . 0.0 111.468 -176.88 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' E' E ' 89' ' ' ASP . . . . . . . . . . . . . 8.7 t70 -136.14 156.73 48.27 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 115.655 -0.702 . . . . 0.0 109.584 175.202 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' E' E ' 90' ' ' GLU . . . . . . . . . . . . . 40.8 mp0 -51.23 -34.01 30.45 Favored 'General case' 0 C--N 1.328 -0.326 0 N-CA-C 112.507 0.558 . . . . 0.0 112.507 -171.919 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' E' E ' 91' ' ' ASN . . . . . . . . . . . . . 7.8 m120 -130.28 32.01 4.54 Favored 'General case' 0 N--CA 1.465 0.313 0 N-CA-C 112.062 0.393 . . . . 0.0 112.062 -175.897 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' E' E ' 92' ' ' LEU . . . . . . . . . . . . . 13.8 tp -166.11 141.77 4.82 Favored 'General case' 0 C--N 1.331 -0.239 0 C-N-CA 120.945 -0.302 . . . . 0.0 110.526 179.242 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' E' E ' 93' ' ' ILE . . . . . . . . . . . . . 71.9 mt -128.73 119.48 49.94 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.207 0 N-CA-C 109.121 -0.696 . . . . 0.0 109.121 176.686 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' E' E ' 94' ' ' VAL . . . . . . . . . . . . . 47.6 t -123.53 128.27 74.52 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.286 0 CA-C-O 121.037 0.446 . . . . 0.0 110.019 -178.898 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' E' E ' 95' ' ' VAL . . . . . . . . . . . . . 41.6 t -121.04 135.5 61.02 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.347 0 CA-C-N 115.807 -0.633 . . . . 0.0 109.821 -179.831 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' E' E ' 96' ' ' ILE . . . . . . . . . . . . . 49.9 mt -111.18 126.31 68.56 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.36 0 N-CA-C 108.959 -0.756 . . . . 0.0 108.959 178.041 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' E' E ' 97' ' ' THR . . . . . . . . . . . . . 74.7 p -96.27 155.73 16.64 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-O 121.114 0.483 . . . . 0.0 111.005 -177.747 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' E' E ' 98' ' ' GLU . . . . . . . . . . . . . 79.2 tt0 -53.84 -27.37 29.29 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.153 -0.476 . . . . 0.0 112.1 -179.143 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' E' E ' 99' ' ' GLU . . . . . . . . . . . . . 12.7 pt-20 -81.08 18.01 1.14 Allowed 'General case' 0 CA--C 1.535 0.374 0 N-CA-C 113.181 0.808 . . . . 0.0 113.181 -176.946 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' E' E ' 100' ' ' ASN . . . . . . . . . . . . . 3.4 m-20 63.52 37.43 10.49 Favored 'General case' 0 N--CA 1.463 0.179 0 CA-C-O 121.063 0.459 . . . . 0.0 111.204 176.831 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' E' E ' 101' ' ' GLU . . . . . . . . . . . . . 84.6 tt0 -116.22 146.02 42.67 Favored 'General case' 0 C--N 1.333 -0.131 0 CA-C-N 116.202 -0.454 . . . . 0.0 109.982 175.981 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' E' E ' 102' ' ' VAL . . . . . . . . . . . . . 46.8 t -115.08 126.1 72.57 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.346 0 CA-C-N 116.34 -0.391 . . . . 0.0 110.144 -177.668 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' E' E ' 103' ' ' LEU . . . . . . . . . . . . . 35.1 mt -117.82 128.54 54.95 Favored 'General case' 0 C--N 1.332 -0.169 0 CA-C-N 115.777 -0.647 . . . . 0.0 110.083 176.832 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' E' E ' 104' ' ' ILE . . . . . 0.599 HD13 HG11 ' E' ' 130' ' ' VAL . 68.9 mt -119.13 122.71 69.9 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.225 0 CA-C-N 116.722 -0.217 . . . . 0.0 110.422 -179.072 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' E' E ' 105' ' ' PHE . . . . . . . . . . . . . 55.5 m-85 -122.8 166.8 14.39 Favored 'General case' 0 C--O 1.232 0.137 0 O-C-N 123.917 0.76 . . . . 0.0 109.753 179.494 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' E' E ' 106' ' ' ASN . . . . . . . . . . . . . 45.9 p-10 -99.11 -170.04 1.86 Allowed 'General case' 0 C--N 1.33 -0.276 0 N-CA-C 109.758 -0.46 . . . . 0.0 109.758 173.079 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' E' E ' 107' ' ' GLN . . . . . . . . . . . . . 46.9 tt0 -60.61 -30.0 69.57 Favored 'General case' 0 C--N 1.329 -0.289 0 N-CA-C 111.932 0.345 . . . . 0.0 111.932 -179.675 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' E' E ' 108' ' ' ASN . . . . . . . . . . . . . 3.2 t-20 -81.96 7.84 12.05 Favored 'General case' 0 CA--C 1.536 0.416 0 N-CA-C 113.108 0.781 . . . . 0.0 113.108 -177.891 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' E' E ' 109' ' ' LEU . . . . . 0.557 HD21 ' HB2' ' E' ' 78' ' ' ALA . 11.4 tp 61.42 35.97 17.53 Favored 'General case' 0 CA--C 1.53 0.19 0 O-C-N 122.106 -0.371 . . . . 0.0 111.442 178.724 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' E' E ' 110' ' ' GLU . . . . . . . . . . . . . 42.8 mt-10 -104.9 143.15 33.55 Favored 'General case' 0 C--N 1.33 -0.256 0 N-CA-C 109.586 -0.524 . . . . 0.0 109.586 175.288 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' E' E ' 111' ' ' GLU . . . . . . . . . . . . . 61.0 tt0 -79.72 121.98 26.01 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-O 120.877 0.37 . . . . 0.0 110.727 -176.661 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' E' E ' 112' ' ' LEU . . . . . . . . . . . . . 20.3 mt -105.98 -46.13 4.18 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 116.123 -0.489 . . . . 0.0 110.665 179.864 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' E' E ' 113' ' ' TYR . . . . . . . . . . . . . 57.1 t80 -134.31 138.26 44.83 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-O 120.901 0.382 . . . . 0.0 111.26 -178.077 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' E' E ' 114' ' ' ARG . . . . . . . . . . . . . 52.7 ttp180 -136.09 123.49 22.0 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 115.842 -0.617 . . . . 0.0 110.325 177.494 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' E' E ' 115' ' ' GLY . . . . . . . . . . . . . . . -150.0 157.98 27.46 Favored Glycine 0 CA--C 1.524 0.601 0 N-CA-C 110.915 -0.874 . . . . 0.0 110.915 179.0 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' E' E ' 116' ' ' LYS . . . . . . . . . . . . . 31.9 ttmt -131.83 138.95 48.7 Favored 'General case' 0 C--N 1.329 -0.303 0 N-CA-C 109.886 -0.413 . . . . 0.0 109.886 177.317 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' E' E ' 117' ' ' PHE . . . . . . . . . . . . . 39.1 m-85 -137.74 114.61 10.65 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-O 120.867 0.365 . . . . 0.0 110.208 -175.769 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' E' E ' 118' ' ' GLU . . . . . . . . . . . . . 81.2 tt0 -52.81 -44.51 66.7 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.493 -0.321 . . . . 0.0 111.503 -177.078 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' E' E ' 119' ' ' ASN . . . . . . . . . . . . . 36.5 m120 -95.77 30.69 2.27 Favored 'General case' 0 C--N 1.33 -0.248 0 N-CA-C 112.262 0.467 . . . . 0.0 112.262 -174.938 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' E' E ' 120' ' ' LEU . . . . . . . . . . . . . 13.9 tp -57.35 121.02 9.19 Favored 'General case' 0 C--N 1.332 -0.169 0 CA-C-O 120.631 0.253 . . . . 0.0 110.385 178.068 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' E' E ' 121' ' ' ASN . . . . . . . . . . . . . 66.7 m-20 -114.09 -44.12 3.17 Favored 'General case' 0 C--N 1.332 -0.188 0 CA-C-N 116.471 -0.331 . . . . 0.0 111.101 -178.794 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' E' E ' 122' ' ' LYS . . . . . . . . . . . . . 63.2 mtpt -145.5 152.12 39.27 Favored 'General case' 0 C--N 1.332 -0.171 0 CA-C-O 121.041 0.448 . . . . 0.0 111.714 -176.447 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' E' E ' 123' ' ' VAL . . . . . . . . . . . . . 47.2 t -130.85 131.95 64.19 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.252 0 CA-C-N 115.943 -0.571 . . . . 0.0 109.482 174.461 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' E' E ' 124' ' ' LEU . . . . . . . . . . . . . 83.0 mt -125.72 140.48 52.66 Favored 'General case' 0 C--N 1.332 -0.181 0 CA-C-O 120.827 0.346 . . . . 0.0 110.911 -177.549 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' E' E ' 125' ' ' VAL . . . . . . . . . . . . . 34.5 m -132.89 142.79 41.37 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.182 0 CA-C-N 116.127 -0.488 . . . . 0.0 110.764 179.878 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' E' E ' 126' ' ' ARG . . . . . . . . . . . . . 96.2 mtt-85 -148.05 112.15 5.18 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.443 177.105 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' E' E ' 127' ' ' ASN . . . . . . . . . . . . . 17.1 m120 53.85 -104.93 0.23 Allowed 'General case' 0 CA--C 1.543 0.699 0 CA-C-O 119.078 -0.487 . . . . 0.0 111.017 179.542 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' E' E ' 128' ' ' ASP . . . . . . . . . . . . . 18.7 p-10 -113.98 3.5 15.38 Favored 'General case' 0 N--CA 1.468 0.453 0 CA-C-N 119.508 1.049 . . . . 0.0 113.473 -177.487 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' E' E ' 129' ' ' LEU . . . . . . . . . . . . . 12.4 tp -104.92 140.47 38.1 Favored 'General case' 0 C--N 1.331 -0.215 0 N-CA-C 109.609 -0.515 . . . . 0.0 109.609 178.034 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' E' E ' 130' ' ' VAL . . . . . 0.599 HG11 HD13 ' E' ' 104' ' ' ILE . 13.4 p -132.92 139.2 50.14 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.184 0 CA-C-O 121.132 0.491 . . . . 0.0 110.742 -178.28 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' E' E ' 131' ' ' VAL . . . . . 0.589 HG22 HD12 ' E' ' 140' ' ' LEU . 38.4 t -136.11 140.85 43.11 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.267 0 CA-C-N 115.96 -0.564 . . . . 0.0 110.565 -179.792 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' E' E ' 132' ' ' ILE . . . . . . . . . . . . . 70.0 mt -116.17 133.08 63.8 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.27 0 CA-C-N 115.747 -0.66 . . . . 0.0 109.433 178.957 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' E' E ' 133' ' ' ILE . . . . . . . . . . . . . 39.0 mm -116.1 123.26 71.13 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.228 0 CA-C-O 120.678 0.275 . . . . 0.0 111.1 -174.898 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' E' E ' 134' ' ' ASP . . . . . . . . . . . . . 9.3 p-10 -136.18 149.73 48.72 Favored 'General case' 0 C--N 1.331 -0.226 0 CA-C-N 116.253 -0.431 . . . . 0.0 110.101 175.428 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' E' E ' 135' ' ' GLU . . . . . . . . . . . . . 81.5 tt0 -49.96 -27.33 5.22 Favored 'General case' 0 C--N 1.329 -0.299 0 N-CA-C 112.878 0.696 . . . . 0.0 112.878 -173.753 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' E' E ' 136' ' ' GLN . . . . . . . . . . . . . 94.8 mt-30 -83.24 -34.48 25.83 Favored 'General case' 0 C--O 1.233 0.232 0 N-CA-C 112.304 0.483 . . . . 0.0 112.304 -175.621 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' E' E ' 137' ' ' LYS . . . . . . . . . . . . . 15.2 pttp -167.51 174.23 8.04 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-O 121.597 0.713 . . . . 0.0 112.194 -170.941 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' E' E ' 138' ' ' LEU . . . . . 0.427 ' C ' HD23 ' E' ' 138' ' ' LEU . 6.3 tt -119.42 126.65 51.86 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 114.951 -1.022 . . . . 0.0 109.923 178.652 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' E' E ' 139' ' ' THR . . . . . . . . . . . . . 25.9 m -105.82 122.91 47.06 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.139 -0.482 . . . . 0.0 110.217 179.367 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' E' E ' 140' ' ' LEU . . . . . 0.589 HD12 HG22 ' E' ' 131' ' ' VAL . 10.6 tp -111.91 121.48 45.14 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 115.94 -0.573 . . . . 0.0 109.619 -177.428 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' E' E ' 141' ' ' ILE . . . . . 0.522 ' HB ' HG13 ' E' ' 130' ' ' VAL . 19.4 mt -122.0 118.68 56.31 Favored 'Isoleucine or valine' 0 C--O 1.234 0.265 0 CA-C-O 121.168 0.509 . . . . 0.0 110.121 -176.799 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' E' E ' 142' ' ' ARG . . . . . . . . . . . . . 78.6 mtp180 -102.75 110.13 21.96 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 115.058 -0.973 . . . . 0.0 110.114 178.985 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' E' E ' 143' ' ' THR . . . . . . . . . . . . . 69.6 p . . . . . 0 C--O 1.219 -0.538 0 CA-C-O 118.041 -0.98 . . . . 0.0 110.558 -178.561 . . . . . . . . 0 0 . 1 . 002 nuclear build full ' F' F ' -3' ' ' GLU . . . . . . . . . . . . . 95.9 mt-10 . . . . . 0 N--CA 1.49 1.528 0 N-CA-C 109.458 -0.571 . . . . 0.0 109.458 . . . . . . . . . 0 0 . 1 . 002 nuclear build full ' F' F ' -2' ' ' GLY . . . . . . . . . . . . . . . -75.58 150.0 39.31 Favored Glycine 0 CA--C 1.525 0.676 0 N-CA-C 110.906 -0.878 . . . . 0.0 110.906 179.86 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' F' F ' -1' ' ' VAL . . . . . . . . . . . . . 44.4 t -90.68 131.43 37.87 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.261 0 CA-C-O 120.842 0.353 . . . . 0.0 110.055 179.98 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' F' F ' 0' ' ' ILE . . . . . . . . . . . . . 44.1 mm -116.65 130.59 71.23 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.224 0 CA-C-N 116.121 -0.49 . . . . 0.0 109.996 179.224 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' F' F ' 1' ' ' MET . . . . . . . . . . . . . 25.3 ptp -83.05 134.8 35.01 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.246 -0.434 . . . . 0.0 110.778 -179.509 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' F' F ' 2' ' ' SER . . . . . . . . . . . . . 10.1 p -112.22 134.47 53.75 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.562 179.319 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' F' F ' 3' ' ' GLU . . . . . . . . . . . . . 40.6 mt-10 -139.61 141.6 37.11 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 115.991 -0.55 . . . . 0.0 110.653 -179.544 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' F' F ' 4' ' ' LEU . . . . . 0.427 HD12 HD23 ' F' ' 58' ' ' LEU . 3.1 tt -128.01 125.63 39.77 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-N 115.896 -0.593 . . . . 0.0 109.945 179.11 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' F' F ' 5' ' ' LYS . . . . . . . . . . . . . 97.9 mttt -106.28 120.05 40.84 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.297 -0.411 . . . . 0.0 110.655 -179.811 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' F' F ' 6' ' ' LEU . . . . . . . . . . . . . 64.1 mt -114.01 150.06 34.46 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 115.538 -0.756 . . . . 0.0 110.485 -178.88 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' F' F ' 7' ' ' LYS . . . . . . . . . . . . . 82.3 tttt -137.15 134.74 19.03 Favored Pre-proline 0 CA--C 1.534 0.365 0 CA-C-O 118.806 -0.616 . . . . 0.0 109.676 175.021 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' F' F ' 8' ' ' PRO . . . . . . . . . . . . . 71.8 Cg_endo -89.6 135.97 2.61 Favored 'Trans proline' 0 N--CA 1.49 1.319 0 C-N-CA 121.615 1.544 . . . . 0.0 111.483 177.838 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' F' F ' 9' ' ' LEU . . . . . . . . . . . . . 37.9 mt -72.93 -47.1 8.54 Favored Pre-proline 0 CA--C 1.533 0.325 0 CA-C-O 118.689 -0.672 . . . . 0.0 112.318 -177.538 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' F' F ' 10' ' ' PRO . . . . . . . . . . . . . 92.5 Cg_endo -80.68 149.87 18.61 Favored 'Trans proline' 0 N--CA 1.495 1.576 0 C-N-CA 121.104 1.203 . . . . 0.0 111.757 175.586 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' F' F ' 11' ' ' LYS . . . . . . . . . . . . . 83.6 tttt -84.1 96.9 9.06 Favored 'General case' 0 C--N 1.33 -0.275 0 C-N-CA 120.836 -0.346 . . . . 0.0 110.49 179.358 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' F' F ' 12' ' ' VAL . . . . . . . . . . . . . 12.1 p -142.77 144.39 24.36 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.364 0 CA-C-N 116.123 -0.49 . . . . 0.0 110.434 179.678 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' F' F ' 13' ' ' GLU . . . . . . . . . . . . . 43.7 mp0 -85.67 125.37 33.12 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.224 -0.444 . . . . 0.0 110.045 177.666 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' F' F ' 14' ' ' LEU . . . . . . . . . . . . . 45.7 mt -95.15 153.52 39.73 Favored Pre-proline 0 C--N 1.329 -0.303 0 CA-C-N 116.444 -0.344 . . . . 0.0 110.81 -177.8 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' F' F ' 15' ' ' PRO . . . . . . . . . . . . . 36.8 Cg_exo -59.33 160.14 20.67 Favored 'Trans proline' 0 N--CA 1.497 1.7 0 C-N-CA 121.296 1.331 . . . . 0.0 111.704 177.743 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' F' F ' 16' ' ' PRO . . . . . . . . . . . . . 27.5 Cg_exo -60.25 -43.13 36.98 Favored 'Trans proline' 0 N--CA 1.498 1.737 0 C-N-CA 121.381 1.388 . . . . 0.0 112.802 -177.628 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' F' F ' 17' ' ' ASP . . . . . . . . . . . . . 16.3 p-10 -87.72 12.5 12.65 Favored 'General case' 0 C--N 1.326 -0.422 0 N-CA-C 113.182 0.808 . . . . 0.0 113.182 -176.377 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' F' F ' 18' ' ' PHE . . . . . . . . . . . . . 48.1 t80 -58.0 -44.64 87.33 Favored 'General case' 0 C--N 1.334 -0.074 0 O-C-N 122.04 -0.413 . . . . 0.0 110.151 -178.241 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' F' F ' 19' ' ' VAL . . . . . 0.41 HG13 ' N ' ' F' ' 20' ' ' ASP . 14.6 p -56.46 -42.08 74.18 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.333 0 CA-C-N 116.36 -0.382 . . . . 0.0 110.941 -178.474 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' F' F ' 20' ' ' ASP . . . . . 0.41 ' N ' HG13 ' F' ' 19' ' ' VAL . 79.9 m-20 -60.98 -42.12 97.77 Favored 'General case' 0 C--O 1.233 0.234 0 CA-C-O 120.884 0.373 . . . . 0.0 110.957 -178.051 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' F' F ' 21' ' ' VAL . . . . . . . . . . . . . 46.9 t -64.0 -47.37 90.74 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 CA-C-N 116.343 -0.39 . . . . 0.0 110.406 -178.395 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' F' F ' 22' ' ' ILE . . . . . 0.51 HG22 HD12 ' F' ' 26' ' ' LEU . 50.1 mm -55.96 -43.96 76.67 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.182 0 CA-C-O 120.774 0.321 . . . . 0.0 110.66 178.769 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' F' F ' 23' ' ' ARG . . . . . . . . . . . . . 56.0 ttp180 -52.86 -52.36 57.57 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-O 120.709 0.29 . . . . 0.0 111.519 179.986 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' F' F ' 24' ' ' ILE . . . . . . . . . . . . . 69.3 mt -59.63 -40.62 82.68 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.268 0 CA-C-N 116.414 -0.357 . . . . 0.0 111.273 -177.051 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' F' F ' 25' ' ' LYS . . . . . . . . . . . . . 46.4 mttm -65.46 -42.06 92.7 Favored 'General case' 0 C--N 1.327 -0.377 0 N-CA-C 112.192 0.442 . . . . 0.0 112.192 -178.626 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' F' F ' 26' ' ' LEU . . . . . 0.51 HD12 HG22 ' F' ' 22' ' ' ILE . 74.4 mt -80.58 -38.03 30.21 Favored 'General case' 0 C--N 1.33 -0.261 0 N-CA-C 113.39 0.885 . . . . 0.0 113.39 -170.841 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' F' F ' 27' ' ' GLN . . . . . . . . . . . . . 12.4 pt20 -46.48 139.78 4.74 Favored 'General case' 0 N--CA 1.469 0.479 0 N-CA-C 112.871 0.693 . . . . 0.0 112.871 -174.946 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' F' F ' 28' ' ' GLY . . . . . . . . . . . . . . . 99.29 -25.4 28.37 Favored Glycine 0 CA--C 1.533 1.193 0 CA-C-N 115.507 -0.77 . . . . 0.0 112.264 -177.035 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' F' F ' 29' ' ' LYS . . . . . . . . . . . . . 33.5 mmtp -97.61 155.15 17.1 Favored 'General case' 0 C--O 1.233 0.198 0 CA-C-N 117.335 0.568 . . . . 0.0 110.771 178.982 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' F' F ' 30' ' ' THR . . . . . . . . . . . . . 25.2 m -107.21 136.65 46.68 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 115.928 -0.578 . . . . 0.0 109.827 175.428 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' F' F ' 31' ' ' VAL . . . . . . . . . . . . . 35.0 m -129.78 161.15 39.94 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.267 0 CA-C-N 116.473 -0.33 . . . . 0.0 110.814 -177.959 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' F' F ' 32' ' ' ARG . . . . . . . . . . . . . 92.7 mtt180 -132.56 151.22 52.0 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-O 121.307 0.575 . . . . 0.0 110.595 178.88 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' F' F ' 33' ' ' THR . . . . . . . . . . . . . 24.1 m -52.45 140.54 22.18 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.112 -0.494 . . . . 0.0 111.396 -178.467 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' F' F ' 34' ' ' GLY . . . . . . . . . . . . . . . 99.28 -17.09 58.39 Favored Glycine 0 CA--C 1.532 1.135 0 CA-C-O 119.596 -0.558 . . . . 0.0 113.218 178.977 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' F' F ' 35' ' ' ASP . . . . . . . . . . . . . 54.3 m-20 -63.3 150.48 43.18 Favored 'General case' 0 C--O 1.232 0.142 0 CA-C-N 118.09 0.945 . . . . 0.0 111.0 179.365 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' F' F ' 36' ' ' VAL . . . . . . . . . . . . . 42.4 t -125.72 130.44 72.53 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.293 0 CA-C-N 115.801 -0.636 . . . . 0.0 109.706 178.763 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' F' F ' 37' ' ' ILE . . . . . . . . . . . . . 65.2 mt -120.66 138.92 49.57 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.294 0 CA-C-N 116.336 -0.393 . . . . 0.0 110.098 -178.921 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' F' F ' 38' ' ' GLY . . . . . . . . . . . . . . . -109.13 128.86 9.21 Favored Glycine 0 CA--C 1.525 0.689 0 N-CA-C 110.872 -0.891 . . . . 0.0 110.872 179.02 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' F' F ' 39' ' ' ILE . . . . . . . . . . . . . 74.4 mt -123.57 134.91 65.03 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.256 0 N-CA-C 110.176 -0.305 . . . . 0.0 110.176 179.828 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' F' F ' 40' ' ' SER . . . . . . . . . . . . . 88.0 p -92.65 118.63 31.24 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.895 176.383 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' F' F ' 41' ' ' ILE . . . . . . . . . . . . . 44.5 mm -120.48 113.01 38.68 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.263 0 CA-C-O 120.751 0.31 . . . . 0.0 110.247 178.799 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' F' F ' 42' ' ' LEU . . . . . 0.409 HD12 ' N ' ' F' ' 42' ' ' LEU . 7.9 mp 51.21 37.4 18.37 Favored 'General case' 0 C--N 1.331 -0.223 0 CA-C-N 116.151 -0.477 . . . . 0.0 111.748 177.006 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' F' F ' 43' ' ' GLY . . . . . . . . . . . . . . . 75.95 29.84 58.4 Favored Glycine 0 CA--C 1.53 1.03 0 C-N-CA 121.151 -0.547 . . . . 0.0 112.33 177.606 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' F' F ' 44' ' ' LYS . . . . . . . . . . . . . 60.0 mtpt -135.29 127.88 30.76 Favored 'General case' 0 C--N 1.329 -0.295 0 N-CA-C 109.65 -0.5 . . . . 0.0 109.65 177.062 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' F' F ' 45' ' ' GLU . . . . . . . . . . . . . 84.2 tt0 -82.73 123.42 29.29 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-O 120.822 0.344 . . . . 0.0 111.322 -176.738 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' F' F ' 46' ' ' VAL . . . . . . . . . . . . . 7.1 p -123.23 128.4 74.89 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.202 0 N-CA-C 109.592 -0.521 . . . . 0.0 109.592 175.386 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' F' F ' 47' ' ' LYS . . . . . . . . . . . . . 63.6 mttp -99.53 128.79 45.65 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.125 -0.489 . . . . 0.0 111.229 178.099 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' F' F ' 48' ' ' PHE . . . . . . . . . . . . . 91.5 m-85 -111.64 131.9 54.96 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.023 -0.535 . . . . 0.0 109.746 176.196 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' F' F ' 49' ' ' LYS . . . . . . . . . . . . . 71.9 tttt -106.6 136.18 46.83 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.4 -0.364 . . . . 0.0 110.455 -179.654 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' F' F ' 50' ' ' VAL . . . . . . . . . . . . . 45.4 t -81.11 105.62 11.25 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.292 0 N-CA-C 109.53 -0.544 . . . . 0.0 109.53 176.691 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' F' F ' 51' ' ' VAL . . . . . . . . . . . . . 47.6 t -70.21 -51.96 34.34 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.33 0 CA-C-N 115.879 -0.6 . . . . 0.0 109.73 -174.387 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' F' F ' 52' ' ' GLN . . . . . . . . . . . . . 77.8 mt-30 -154.62 147.67 24.68 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-O 121.175 0.512 . . . . 0.0 111.756 -177.261 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' F' F ' 53' ' ' ALA . . . . . 0.456 ' HB1' ' HB2' ' F' ' 58' ' ' LEU . . . -122.39 128.84 51.46 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 115.19 -0.914 . . . . 0.0 109.317 175.282 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' F' F ' 54' ' ' TYR . . . . . . . . . . . . . 45.7 t80 -126.77 109.53 22.51 Favored Pre-proline 0 CA--C 1.534 0.335 0 CA-C-O 118.383 -0.817 . . . . 0.0 110.443 -178.479 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' F' F ' 55' ' ' PRO . . . . . . . . . . . . . 74.4 Cg_endo -77.09 170.04 72.69 Favored 'Cis proline' 0 N--CA 1.5 1.902 0 CA-C-N 121.768 1.667 . . . . 0.0 112.536 -5.091 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' F' F ' 56' ' ' SER . . . . . . . . . . . . . 13.7 m -112.27 126.91 27.6 Favored Pre-proline 0 CA--C 1.539 0.542 0 CA-C-O 118.409 -0.805 . . . . 0.0 109.642 176.52 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' F' F ' 57' ' ' PRO . . . . . . . . . . . . . 33.7 Cg_endo -65.27 169.15 41.16 Favored 'Cis proline' 0 N--CA 1.498 1.791 0 CA-C-N 122.083 1.78 . . . . 0.0 111.475 -1.543 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' F' F ' 58' ' ' LEU . . . . . 0.456 ' HB2' ' HB1' ' F' ' 53' ' ' ALA . 34.0 tp -130.61 137.05 49.45 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-O 120.971 0.415 . . . . 0.0 110.574 -179.313 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' F' F ' 59' ' ' ARG . . . . . . . . . . . . . 71.1 ttt180 -104.68 129.24 52.88 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 115.773 -0.648 . . . . 0.0 109.575 177.695 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' F' F ' 60' ' ' VAL . . . . . . . . . . . . . 42.3 t -86.74 119.17 34.23 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.272 0 C-N-CA 120.744 -0.382 . . . . 0.0 110.353 -176.131 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' F' F ' 61' ' ' GLU . . . . . . . . . . . . . 95.3 mt-10 -131.08 168.04 18.07 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.329 178.28 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' F' F ' 62' ' ' ASP . . . . . . . . . . . . . 55.8 m-20 -54.01 -32.51 54.43 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.641 -0.254 . . . . 0.0 111.641 179.259 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' F' F ' 63' ' ' ARG . . . . . . . . . . . . . 6.8 ptp180 -85.5 9.08 16.85 Favored 'General case' 0 CA--C 1.537 0.447 0 N-CA-C 113.508 0.929 . . . . 0.0 113.508 -175.892 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' F' F ' 64' ' ' THR . . . . . . . . . . . . . 30.1 m -85.43 134.81 34.05 Favored 'General case' 0 C--N 1.333 -0.124 0 CA-C-N 118.085 0.402 . . . . 0.0 110.813 -178.749 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' F' F ' 65' ' ' LYS . . . . . . . . . . . . . 52.4 mtmt -88.74 124.6 34.28 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.234 -0.439 . . . . 0.0 109.932 177.426 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' F' F ' 66' ' ' ILE . . . . . . . . . . . . . 62.3 mt -112.51 128.54 69.12 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.325 0 N-CA-C 109.835 -0.431 . . . . 0.0 109.835 -178.572 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' F' F ' 67' ' ' THR . . . . . . . . . . . . . 28.5 m -126.15 141.82 51.78 Favored 'General case' 0 C--N 1.331 -0.222 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.972 -177.05 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' F' F ' 68' ' ' LEU . . . . . 0.476 HD12 ' N ' ' F' ' 68' ' ' LEU . 8.5 mp -104.46 122.95 46.59 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 115.966 -0.561 . . . . 0.0 110.104 178.061 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' F' F ' 69' ' ' VAL . . . . . . . . . . . . . 46.8 t -101.12 102.84 14.02 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.262 0 CA-C-O 120.852 0.358 . . . . 0.0 110.206 -179.119 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' F' F ' 70' ' ' THR . . . . . . . . . . . . . 10.0 t -150.07 157.62 43.32 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.129 -0.487 . . . . 0.0 110.513 177.511 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' F' F ' 71' ' ' HIS . . . . . . . . . . . . . 83.3 m-70 -137.92 65.76 45.91 Favored Pre-proline 0 CA--C 1.536 0.426 0 C-N-CA 121.048 -0.261 . . . . 0.0 110.626 176.4 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' F' F ' 72' ' ' PRO . . . . . . . . . . . . . 69.5 Cg_endo -95.0 158.58 1.73 Allowed 'Trans proline' 0 N--CA 1.489 1.253 0 C-N-CA 121.989 1.793 . . . . 0.0 111.996 177.781 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' F' F ' 73' ' ' VAL . . . . . . . . . . . . . 35.6 m -96.19 145.19 8.97 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.305 0 N-CA-C 109.681 -0.489 . . . . 0.0 109.681 174.812 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' F' F ' 74' ' ' ASP . . . . . . . . . . . . . 39.7 t0 -88.85 114.91 25.98 Favored 'General case' 0 C--N 1.328 -0.343 0 N-CA-C 109.982 -0.377 . . . . 0.0 109.982 -177.596 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' F' F ' 75' ' ' VAL . . . . . . . . . . . . . 41.4 t -111.05 120.79 62.47 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.287 0 CA-C-O 121.07 0.462 . . . . 0.0 110.242 -178.784 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' F' F ' 76' ' ' LEU . . . . . . . . . . . . . 15.3 mt -128.55 143.81 51.03 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 115.732 -0.667 . . . . 0.0 109.692 179.097 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' F' F ' 77' ' ' GLU . . . . . . . . . . . . . 97.3 mt-10 -131.94 131.26 42.5 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-O 120.989 0.424 . . . . 0.0 111.093 -177.153 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' F' F ' 78' ' ' ALA . . . . . . . . . . . . . . . -117.94 128.38 54.75 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 115.747 -0.661 . . . . 0.0 109.621 177.148 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' F' F ' 79' ' ' LYS . . . . . 0.595 ' O ' HD13 ' F' ' 80' ' ' ILE . 95.2 mttt -79.93 120.63 24.41 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-O 120.904 0.383 . . . . 0.0 110.857 -177.085 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' F' F ' 80' ' ' ILE . . . . . 0.595 HD13 ' O ' ' F' ' 79' ' ' LYS . 41.4 mm -139.1 108.68 3.93 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.309 0 N-CA-C 109.072 -0.714 . . . . 0.0 109.072 -177.322 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' F' F ' 81' ' ' LYS . . . . . . . . . . . . . 82.7 tttt -97.53 123.79 41.54 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-O 120.868 0.366 . . . . 0.0 111.239 -175.913 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' F' F ' 82' ' ' GLY . . . . . . . . . . . . . . . 89.22 42.02 5.68 Favored Glycine 0 CA--C 1.526 0.724 0 C-N-CA 120.884 -0.674 . . . . 0.0 111.907 174.647 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' F' F ' 83' ' ' ILE . . . . . . . . . . . . . 71.4 mt -68.7 136.71 25.85 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.304 0 N-CA-C 109.661 -0.496 . . . . 0.0 109.661 176.571 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' F' F ' 84' ' ' LYS . . . . . . . . . . . . . 36.7 ttpt -101.36 -51.31 3.52 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-O 120.868 0.366 . . . . 0.0 110.262 -178.908 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' F' F ' 85' ' ' ASP . . . . . . . . . . . . . 11.9 t70 -148.22 148.65 30.74 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 115.874 -0.603 . . . . 0.0 110.385 -179.752 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' F' F ' 86' ' ' VAL . . . . . . . . . . . . . 46.3 t -133.56 132.95 57.52 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.269 0 CA-C-O 121.0 0.429 . . . . 0.0 110.494 -178.98 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' F' F ' 87' ' ' ILE . . . . . 0.498 HD12 ' N ' ' F' ' 87' ' ' ILE . 5.0 mp -119.82 127.25 75.87 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.202 0 CA-C-N 115.859 -0.61 . . . . 0.0 109.474 175.901 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' F' F ' 88' ' ' LEU . . . . . . . . . . . . . 12.8 tp -112.6 129.94 56.2 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.3 -0.409 . . . . 0.0 111.022 -177.453 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' F' F ' 89' ' ' ASP . . . . . . . . . . . . . 6.2 t70 -123.94 156.36 36.49 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 115.868 -0.606 . . . . 0.0 109.747 176.794 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' F' F ' 90' ' ' GLU . . . . . . . . . . . . . 96.3 mt-10 -46.15 -41.93 13.21 Favored 'General case' 0 C--N 1.332 -0.192 0 N-CA-C 113.15 0.796 . . . . 0.0 113.15 -172.58 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' F' F ' 91' ' ' ASN . . . . . . . . . . . . . 54.0 m-80 -132.09 36.6 3.64 Favored 'General case' 0 N--CA 1.464 0.259 0 CA-C-O 120.732 0.301 . . . . 0.0 111.569 -176.575 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' F' F ' 92' ' ' LEU . . . . . . . . . . . . . 12.6 tp -166.07 144.98 5.91 Favored 'General case' 0 C--N 1.331 -0.232 0 C-N-CA 120.927 -0.309 . . . . 0.0 110.746 -179.752 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' F' F ' 93' ' ' ILE . . . . . . . . . . . . . 68.7 mt -127.3 123.63 62.31 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.253 0 N-CA-C 109.584 -0.524 . . . . 0.0 109.584 179.795 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' F' F ' 94' ' ' VAL . . . . . 0.446 HG21 HG11 ' F' ' 125' ' ' VAL . 47.2 t -123.09 125.4 72.02 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.27 0 N-CA-C 109.907 -0.405 . . . . 0.0 109.907 -179.92 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' F' F ' 95' ' ' VAL . . . . . . . . . . . . . 43.4 t -121.16 135.81 60.13 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.325 0 CA-C-N 115.902 -0.59 . . . . 0.0 109.97 -177.877 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' F' F ' 96' ' ' ILE . . . . . . . . . . . . . 60.3 mt -117.62 126.51 74.76 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.286 0 N-CA-C 109.258 -0.645 . . . . 0.0 109.258 178.58 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' F' F ' 97' ' ' THR . . . . . . . . . . . . . 64.0 p -102.6 157.61 16.81 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-O 121.081 0.467 . . . . 0.0 111.36 -176.432 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' F' F ' 98' ' ' GLU . . . . . . . . . . . . . 12.5 pt-20 -53.88 -22.17 9.33 Favored 'General case' 0 CA--C 1.534 0.345 0 N-CA-C 112.51 0.559 . . . . 0.0 112.51 -179.936 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' F' F ' 99' ' ' GLU . . . . . . . . . . . . . 16.9 tt0 -78.94 14.56 1.34 Allowed 'General case' 0 CA--C 1.537 0.444 0 N-CA-C 112.855 0.687 . . . . 0.0 112.855 -178.061 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' F' F ' 100' ' ' ASN . . . . . . . . . . . . . 3.6 m-20 59.92 38.09 21.23 Favored 'General case' 0 CA--C 1.531 0.214 0 CA-C-O 121.027 0.441 . . . . 0.0 110.599 -179.536 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' F' F ' 101' ' ' GLU . . . . . . . . . . . . . 84.7 tt0 -118.24 143.49 46.51 Favored 'General case' 0 C--N 1.332 -0.163 0 CA-C-N 116.014 -0.539 . . . . 0.0 109.776 178.429 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' F' F ' 102' ' ' VAL . . . . . . . . . . . . . 43.6 t -114.95 126.75 72.61 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.269 0 CA-C-N 116.182 -0.463 . . . . 0.0 109.946 -177.862 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' F' F ' 103' ' ' LEU . . . . . . . . . . . . . 27.0 mt -116.53 130.78 56.94 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 115.665 -0.698 . . . . 0.0 110.267 177.704 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' F' F ' 104' ' ' ILE . . . . . . . . . . . . . 66.5 mt -118.38 120.75 65.28 Favored 'Isoleucine or valine' 0 C--O 1.234 0.25 0 N-CA-C 110.053 -0.351 . . . . 0.0 110.053 179.669 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' F' F ' 105' ' ' PHE . . . . . . . . . . . . . 84.3 m-85 -123.47 164.87 18.08 Favored 'General case' 0 C--N 1.333 -0.15 0 O-C-N 123.928 0.768 . . . . 0.0 109.91 179.742 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' F' F ' 106' ' ' ASN . . . . . . . . . . . . . 45.4 p-10 -100.07 -171.31 2.02 Favored 'General case' 0 C--N 1.331 -0.229 0 N-CA-C 109.88 -0.415 . . . . 0.0 109.88 172.934 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' F' F ' 107' ' ' GLN . . . . . . . . . . . . . 48.7 tt0 -58.67 -28.23 65.54 Favored 'General case' 0 C--N 1.328 -0.365 0 N-CA-C 112.278 0.473 . . . . 0.0 112.278 -178.693 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' F' F ' 108' ' ' ASN . . . . . . . . . . . . . 14.0 t30 -91.4 14.11 15.59 Favored 'General case' 0 CA--C 1.534 0.359 0 N-CA-C 113.177 0.806 . . . . 0.0 113.177 -176.336 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' F' F ' 109' ' ' LEU . . . . . . . . . . . . . 28.2 mt 59.15 37.2 24.09 Favored 'General case' 0 CA--C 1.529 0.144 0 CA-C-O 121.03 0.443 . . . . 0.0 111.551 177.122 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' F' F ' 110' ' ' GLU . . . . . . . . . . . . . 95.7 mt-10 -100.6 150.15 23.01 Favored 'General case' 0 C--N 1.329 -0.285 0 N-CA-C 109.818 -0.438 . . . . 0.0 109.818 176.058 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' F' F ' 111' ' ' GLU . . . . . . . . . . . . . 84.9 tt0 -82.38 122.01 27.45 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-O 120.918 0.389 . . . . 0.0 110.713 -178.255 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' F' F ' 112' ' ' LEU . . . . . . . . . . . . . 60.6 mt -110.91 -46.02 3.39 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.029 -0.532 . . . . 0.0 110.334 178.872 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' F' F ' 113' ' ' TYR . . . . . . . . . . . . . 52.6 t80 -140.96 138.58 33.87 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-O 120.874 0.368 . . . . 0.0 111.393 -179.791 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' F' F ' 114' ' ' ARG . . . . . . . . . . . . . 31.4 ttp180 -138.61 123.02 18.34 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 115.863 -0.608 . . . . 0.0 109.955 176.29 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' F' F ' 115' ' ' GLY . . . . . . . . . . . . . . . -150.08 157.78 27.37 Favored Glycine 0 CA--C 1.523 0.581 0 C-N-CA 120.794 -0.717 . . . . 0.0 111.35 179.002 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' F' F ' 116' ' ' LYS . . . . . . . . . . . . . 39.8 ttpt -127.7 140.74 51.88 Favored 'General case' 0 C--N 1.331 -0.228 0 N-CA-C 110.139 -0.319 . . . . 0.0 110.139 178.446 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' F' F ' 117' ' ' PHE . . . . . 0.472 ' HE2' HD13 ' F' ' 132' ' ' ILE . 44.2 m-85 -136.16 115.01 12.13 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-O 120.865 0.364 . . . . 0.0 110.292 -178.331 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' F' F ' 118' ' ' GLU . . . . . . . . . . . . . 84.9 tt0 -52.23 -46.9 65.89 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.43 -0.35 . . . . 0.0 111.561 -177.515 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' F' F ' 119' ' ' ASN . . . . . . . . . . . . . 18.0 m120 -97.01 31.02 2.51 Favored 'General case' 0 C--N 1.329 -0.285 0 N-CA-C 112.105 0.409 . . . . 0.0 112.105 -175.213 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' F' F ' 120' ' ' LEU . . . . . . . . . . . . . 15.5 tp -56.29 120.11 7.07 Favored 'General case' 0 C--N 1.331 -0.202 0 CA-C-O 120.694 0.283 . . . . 0.0 110.543 178.392 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' F' F ' 121' ' ' ASN . . . . . . . . . . . . . 12.5 m120 -114.06 -44.02 3.19 Favored 'General case' 0 C--N 1.332 -0.181 0 CA-C-N 116.499 -0.319 . . . . 0.0 111.225 -177.53 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' F' F ' 122' ' ' LYS . . . . . . . . . . . . . 88.4 mttt -144.7 153.84 42.14 Favored 'General case' 0 C--N 1.332 -0.195 0 CA-C-O 121.096 0.474 . . . . 0.0 111.912 -176.104 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' F' F ' 123' ' ' VAL . . . . . . . . . . . . . 44.3 t -129.29 129.04 67.23 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.261 0 CA-C-N 115.735 -0.666 . . . . 0.0 109.621 175.428 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' F' F ' 124' ' ' LEU . . . . . . . . . . . . . 34.0 mt -116.69 133.25 56.24 Favored 'General case' 0 C--N 1.331 -0.208 0 CA-C-N 116.305 -0.407 . . . . 0.0 110.275 -179.251 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' F' F ' 125' ' ' VAL . . . . . 0.446 HG11 HG21 ' F' ' 94' ' ' VAL . 34.3 m -136.21 139.03 46.33 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.298 0 CA-C-N 116.506 -0.315 . . . . 0.0 110.831 -179.032 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' F' F ' 126' ' ' ARG . . . . . . . . . . . . . 19.2 ttm180 -157.63 127.46 6.11 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-O 120.974 0.416 . . . . 0.0 110.88 175.913 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' F' F ' 127' ' ' ASN . . . . . . . . . . . . . 78.8 m-20 52.9 -113.09 0.74 Allowed 'General case' 0 CA--C 1.544 0.73 0 CA-C-O 118.748 -0.644 . . . . 0.0 110.858 -179.77 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' F' F ' 128' ' ' ASP . . . . . . . . . . . . . 18.9 p-10 -114.17 9.84 17.21 Favored 'General case' 0 CA--C 1.536 0.42 0 CA-C-N 119.978 1.263 . . . . 0.0 113.074 -178.233 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' F' F ' 129' ' ' LEU . . . . . . . . . . . . . 15.1 tp -109.02 138.69 44.97 Favored 'General case' 0 C--O 1.233 0.211 0 O-C-N 122.056 -0.403 . . . . 0.0 109.93 179.123 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' F' F ' 130' ' ' VAL . . . . . . . . . . . . . 43.0 t -125.36 139.49 51.1 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.24 0 CA-C-N 116.311 -0.404 . . . . 0.0 110.002 -178.968 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' F' F ' 131' ' ' VAL . . . . . . . . . . . . . 43.6 t -135.62 135.62 51.14 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.338 0 CA-C-N 116.239 -0.437 . . . . 0.0 109.959 178.287 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' F' F ' 132' ' ' ILE . . . . . 0.472 HD13 ' HE2' ' F' ' 117' ' ' PHE . 69.3 mt -114.41 134.13 58.31 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.323 0 N-CA-C 109.41 -0.589 . . . . 0.0 109.41 -179.926 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' F' F ' 133' ' ' ILE . . . . . . . . . . . . . 39.2 mm -116.22 117.88 56.97 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.211 0 CA-C-N 116.295 -0.411 . . . . 0.0 111.006 -174.594 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' F' F ' 134' ' ' ASP . . . . . . . . . . . . . 7.0 p-10 -129.81 149.64 51.47 Favored 'General case' 0 C--N 1.332 -0.177 0 N-CA-C 109.582 -0.525 . . . . 0.0 109.582 174.085 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' F' F ' 135' ' ' GLU . . . . . . . . . . . . . 39.7 tp10 -49.87 -26.17 3.83 Favored 'General case' 0 C--N 1.327 -0.39 0 N-CA-C 112.988 0.736 . . . . 0.0 112.988 -169.676 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' F' F ' 136' ' ' GLN . . . . . . . . . . . . . 96.9 mt-30 -105.09 -24.27 12.8 Favored 'General case' 0 N--CA 1.466 0.353 0 N-CA-C 113.178 0.807 . . . . 0.0 113.178 -174.654 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' F' F ' 137' ' ' LYS . . . . . . . . . . . . . 38.6 ttpt -140.86 147.75 39.44 Favored 'General case' 0 C--N 1.331 -0.21 0 CA-C-O 121.515 0.674 . . . . 0.0 112.35 -168.32 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' F' F ' 138' ' ' LEU . . . . . . . . . . . . . 16.3 tp -111.67 121.19 44.46 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 114.863 -1.062 . . . . 0.0 109.069 173.567 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' F' F ' 139' ' ' THR . . . . . . . . . . . . . 21.7 m -110.88 126.39 54.64 Favored 'General case' 0 C--N 1.332 -0.179 0 CA-C-O 120.689 0.28 . . . . 0.0 110.963 -178.328 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' F' F ' 140' ' ' LEU . . . . . 0.479 HD23 ' C ' ' F' ' 140' ' ' LEU . 7.8 tt -114.56 123.45 49.38 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 115.592 -0.731 . . . . 0.0 109.247 179.701 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' F' F ' 141' ' ' ILE . . . . . . . . . . . . . 19.5 mt -122.09 121.42 63.99 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.326 0 CA-C-O 120.988 0.423 . . . . 0.0 109.929 -175.545 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' F' F ' 142' ' ' ARG . . . . . . . . . . . . . 72.3 ttt-85 -113.91 131.43 56.3 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 115.268 -0.878 . . . . 0.0 110.452 -176.917 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' F' F ' 143' ' ' THR . . . . . . . . . . . . . 20.1 p . . . . . 0 C--O 1.221 -0.422 0 CA-C-O 117.991 -1.005 . . . . 0.0 110.522 179.458 . . . . . . . . 0 0 . 1 . 003 nuclear build full ' A' A ' -3' ' ' GLU . . . . . . . . . . . . . 95.7 mt-10 . . . . . 0 N--CA 1.49 1.539 0 N-CA-C 109.281 -0.637 . . . . 0.0 109.281 . . . . . . . . . 0 0 . 1 . 003 nuclear build full ' A' A ' -2' ' ' GLY . . . . . . . . . . . . . . . -61.18 150.01 44.44 Favored Glycine 0 CA--C 1.525 0.66 0 N-CA-C 110.764 -0.934 . . . . 0.0 110.764 179.694 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' -1' ' ' VAL . . . . . . . . . . . . . 45.6 t -95.22 125.23 47.94 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.273 0 CA-C-O 120.939 0.4 . . . . 0.0 110.108 -179.546 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 0' ' ' ILE . . . . . . . . . . . . . 74.2 mt -124.03 131.15 73.36 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.235 0 CA-C-N 116.037 -0.529 . . . . 0.0 109.675 178.844 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 24.6 ptp -90.57 131.86 36.05 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.241 -0.436 . . . . 0.0 110.604 -178.905 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 6.7 p -112.07 135.3 52.9 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.287 -0.415 . . . . 0.0 110.96 -179.254 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 53.7 mp0 -140.96 141.48 34.45 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.065 -0.516 . . . . 0.0 111.005 179.04 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 4' ' ' LEU . . . . . . . . . . . . . 15.8 tp -128.22 130.44 47.97 Favored 'General case' 0 C--N 1.331 -0.206 0 CA-C-N 116.067 -0.515 . . . . 0.0 110.106 175.833 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 5' ' ' LYS . . . . . . . . . . . . . 66.8 mttm -113.71 121.58 44.54 Favored 'General case' 0 C--O 1.235 0.308 0 CA-C-N 116.356 -0.384 . . . . 0.0 110.845 -179.765 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 45.1 mt -114.17 145.46 41.64 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 115.413 -0.812 . . . . 0.0 110.3 -179.271 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 78.6 tttt -131.75 136.96 29.27 Favored Pre-proline 0 CA--C 1.535 0.374 0 CA-C-O 119.011 -0.519 . . . . 0.0 109.934 176.573 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 8' ' ' PRO . . . . . . . . . . . . . 85.5 Cg_endo -91.9 143.32 2.77 Favored 'Trans proline' 0 N--CA 1.491 1.358 0 C-N-CA 121.786 1.657 . . . . 0.0 111.864 178.623 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 43.4 mt -77.94 -47.79 2.19 Favored Pre-proline 0 CA--C 1.534 0.349 0 CA-C-O 118.657 -0.687 . . . . 0.0 112.22 179.787 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 95.0 Cg_endo -81.19 156.21 19.66 Favored 'Trans proline' 0 N--CA 1.496 1.649 0 C-N-CA 121.253 1.302 . . . . 0.0 112.128 177.075 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 62.9 tttm -88.96 107.33 18.96 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.358 -0.383 . . . . 0.0 110.435 177.908 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 12.7 p -147.83 146.29 18.16 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.336 0 CA-C-O 120.814 0.34 . . . . 0.0 110.763 -179.855 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 70.7 mm-40 -84.47 130.28 34.78 Favored 'General case' 0 C--N 1.33 -0.275 0 N-CA-C 109.874 -0.417 . . . . 0.0 109.874 177.033 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 14' ' ' LEU . . . . . . . . . . . . . 32.9 mt -98.56 145.04 29.21 Favored Pre-proline 0 CA--C 1.534 0.357 0 CA-C-O 119.042 -0.504 . . . . 0.0 110.472 -178.653 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 15' ' ' PRO . . . . . . . . . . . . . 24.7 Cg_exo -62.85 160.37 33.61 Favored 'Trans proline' 0 N--CA 1.497 1.722 0 C-N-CA 121.359 1.373 . . . . 0.0 112.053 176.749 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 16' ' ' PRO . . . . . . . . . . . . . 27.8 Cg_exo -60.4 -33.04 94.58 Favored 'Trans proline' 0 N--CA 1.497 1.7 0 C-N-CA 121.556 1.504 . . . . 0.0 112.693 -179.637 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 17' ' ' ASP . . . . . . . . . . . . . 11.0 p-10 -86.16 4.42 38.54 Favored 'General case' 0 CA--C 1.536 0.42 0 N-CA-C 113.264 0.839 . . . . 0.0 113.264 -177.583 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 18' ' ' PHE . . . . . . . . . . . . . 23.0 t80 -57.45 -44.79 85.05 Favored 'General case' 0 N--CA 1.457 -0.093 0 O-C-N 121.878 -0.514 . . . . 0.0 110.252 -177.374 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 19' ' ' VAL . . . . . . . . . . . . . 48.4 t -55.9 -46.07 80.12 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.36 0 CA-C-N 116.449 -0.342 . . . . 0.0 110.823 -177.532 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 79.8 m-20 -59.59 -42.01 91.57 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-O 120.771 0.319 . . . . 0.0 110.951 -176.855 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 48.0 t -64.13 -47.48 89.93 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.25 0 C-N-CA 120.645 -0.422 . . . . 0.0 110.495 -177.701 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 22' ' ' ILE . . . . . 0.528 HG22 HD12 ' A' ' 26' ' ' LEU . 51.6 mm -55.82 -47.05 80.1 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.237 0 C-N-CA 120.978 -0.289 . . . . 0.0 110.684 179.631 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 23' ' ' ARG . . . . . . . . . . . . . 50.9 ttp180 -54.35 -49.39 69.89 Favored 'General case' 0 C--N 1.329 -0.286 0 C-N-CA 121.005 -0.278 . . . . 0.0 111.419 -177.626 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 24' ' ' ILE . . . . . . . . . . . . . 74.0 mt -60.32 -45.12 96.87 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.235 0 C-N-CA 121.117 -0.233 . . . . 0.0 111.26 -177.197 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 56.2 mmtt -64.67 -38.7 91.91 Favored 'General case' 0 C--N 1.328 -0.334 0 N-CA-C 112.259 0.466 . . . . 0.0 112.259 -177.571 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 26' ' ' LEU . . . . . 0.528 HD12 HG22 ' A' ' 22' ' ' ILE . 91.2 mt -78.33 -44.8 24.25 Favored 'General case' 0 C--N 1.33 -0.273 0 N-CA-C 112.983 0.734 . . . . 0.0 112.983 -172.27 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 27' ' ' GLN . . . . . . . . . . . . . 15.4 pt20 -47.23 139.41 6.2 Favored 'General case' 0 N--CA 1.469 0.492 0 N-CA-C 112.714 0.635 . . . . 0.0 112.714 -175.495 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 99.37 -26.34 24.74 Favored Glycine 0 CA--C 1.533 1.17 0 CA-C-N 115.613 -0.721 . . . . 0.0 112.245 -177.744 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 89.9 mttt -98.5 155.1 17.43 Favored 'General case' 0 C--O 1.233 0.191 0 CA-C-N 117.248 0.524 . . . . 0.0 111.439 179.756 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 30' ' ' THR . . . . . . . . . . . . . 24.2 m -105.78 135.17 47.68 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 115.717 -0.674 . . . . 0.0 109.774 174.906 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 34.8 m -131.73 157.13 43.1 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.276 0 CA-C-N 116.353 -0.385 . . . . 0.0 111.006 -177.739 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 32' ' ' ARG . . . . . . . . . . . . . 91.6 mtm-85 -130.61 150.42 51.82 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-O 121.289 0.566 . . . . 0.0 110.902 179.43 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 33' ' ' THR . . . . . . . . . . . . . 20.3 m -53.47 140.63 27.43 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.076 -0.511 . . . . 0.0 111.299 -178.634 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 99.63 -17.08 58.06 Favored Glycine 0 CA--C 1.534 1.278 0 C-N-CA 121.116 -0.564 . . . . 0.0 113.155 179.252 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 73.0 m-20 -64.68 148.46 50.96 Favored 'General case' 0 C--O 1.232 0.136 0 CA-C-N 118.081 0.941 . . . . 0.0 111.127 179.278 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 46.5 t -118.94 129.43 75.14 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.208 0 CA-C-N 115.721 -0.672 . . . . 0.0 109.686 178.529 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 37' ' ' ILE . . . . . . . . . . . . . 69.0 mt -121.22 138.73 50.63 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.265 0 CA-C-N 116.14 -0.482 . . . . 0.0 109.907 -179.158 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . -113.53 128.94 8.57 Favored Glycine 0 CA--C 1.526 0.758 0 N-CA-C 110.989 -0.844 . . . . 0.0 110.989 -179.976 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 39' ' ' ILE . . . . . . . . . . . . . 70.7 mt -123.43 136.99 58.22 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.218 0 N-CA-C 110.041 -0.355 . . . . 0.0 110.041 179.478 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 40' ' ' SER . . . . . . . . . . . . . 13.4 p -92.83 121.68 34.45 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.344 -0.389 . . . . 0.0 110.961 176.406 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 41' ' ' ILE . . . . . 0.413 HG22 HD13 ' A' ' 42' ' ' LEU . 70.6 mt -129.42 114.1 30.19 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.218 0 N-CA-C 109.756 -0.461 . . . . 0.0 109.756 177.136 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 42' ' ' LEU . . . . . 0.413 HD13 HG22 ' A' ' 41' ' ' ILE . 8.6 mp 57.22 35.29 25.98 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-O 120.954 0.407 . . . . 0.0 111.337 -178.973 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . 77.79 -10.13 26.77 Favored Glycine 0 CA--C 1.536 1.359 0 C-N-CA 121.275 -0.488 . . . . 0.0 113.414 178.218 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 44' ' ' LYS . . . . . . . . . . . . . 25.5 ttpt -91.77 129.97 37.64 Favored 'General case' 0 C--N 1.331 -0.226 0 CA-C-N 117.915 0.858 . . . . 0.0 109.811 176.693 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 84.4 tt0 -84.05 125.97 32.61 Favored 'General case' 0 C--N 1.327 -0.392 0 C-N-CA 120.874 -0.33 . . . . 0.0 110.805 -179.731 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 46' ' ' VAL . . . . . . . . . . . . . 7.5 p -119.4 129.25 75.52 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.187 0 N-CA-C 109.553 -0.536 . . . . 0.0 109.553 176.147 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 59.0 mtpt -100.34 126.39 46.68 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 115.704 -0.68 . . . . 0.0 111.059 179.238 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 48' ' ' PHE . . . . . . . . . . . . . 94.0 m-85 -111.33 131.9 54.81 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.198 -0.456 . . . . 0.0 109.918 176.361 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 78.4 tttt -107.28 135.61 48.5 Favored 'General case' 0 C--N 1.329 -0.322 0 N-CA-C 110.155 -0.313 . . . . 0.0 110.155 178.265 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 50' ' ' VAL . . . . . . . . . . . . . 45.0 t -79.7 109.56 14.41 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.285 0 N-CA-C 109.333 -0.617 . . . . 0.0 109.333 177.047 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 51' ' ' VAL . . . . . . . . . . . . . 49.1 t -72.4 -52.37 24.18 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.321 0 CA-C-N 115.993 -0.548 . . . . 0.0 109.626 -174.885 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 52' ' ' GLN . . . . . . . . . . . . . 90.8 mt-30 -153.42 150.27 28.64 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.061 -0.518 . . . . 0.0 111.769 -177.821 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -130.16 132.81 46.22 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 115.208 -0.905 . . . . 0.0 109.611 174.725 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 54' ' ' TYR . . . . . . . . . . . . . 37.4 t80 -129.07 113.02 18.53 Favored Pre-proline 0 CA--C 1.535 0.392 0 CA-C-O 118.144 -0.931 . . . . 0.0 110.496 179.092 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 55' ' ' PRO . . . . . . . . . . . . . 74.4 Cg_endo -77.11 167.37 79.96 Favored 'Cis proline' 0 N--CA 1.5 1.854 0 CA-C-N 121.97 1.739 . . . . 0.0 112.475 -6.872 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 56' ' ' SER . . . . . . . . . . . . . 13.6 m -116.09 127.02 27.09 Favored Pre-proline 0 CA--C 1.538 0.502 0 CA-C-O 118.427 -0.797 . . . . 0.0 109.239 175.859 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 57' ' ' PRO . . . . . . . . . . . . . 46.7 Cg_endo -69.7 148.65 87.03 Favored 'Cis proline' 0 N--CA 1.498 1.741 0 CA-C-N 122.067 1.774 . . . . 0.0 111.862 0.497 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 58' ' ' LEU . . . . . . . . . . . . . 23.2 tp -107.52 137.18 46.02 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.014 -0.539 . . . . 0.0 110.742 -178.898 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 59' ' ' ARG . . . . . . . . . . . . . 56.9 ttp180 -104.04 120.12 40.39 Favored 'General case' 0 C--N 1.327 -0.383 0 N-CA-C 109.205 -0.665 . . . . 0.0 109.205 174.513 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 40.3 t -81.37 122.35 36.28 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.232 0 C-N-CA 120.626 -0.429 . . . . 0.0 110.74 -173.453 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 91.1 mt-10 -131.07 164.15 26.06 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 115.96 -0.564 . . . . 0.0 109.675 176.567 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 62' ' ' ASP . . . . . . . . . . . . . 44.5 m-20 -53.04 -32.8 48.79 Favored 'General case' 0 C--N 1.328 -0.347 0 N-CA-C 111.852 0.316 . . . . 0.0 111.852 -179.739 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 63' ' ' ARG . . . . . . . . . . . . . 68.4 mtp180 -72.47 -21.79 61.16 Favored 'General case' 0 CA--C 1.534 0.335 0 N-CA-C 112.907 0.706 . . . . 0.0 112.907 -176.354 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 31.1 m -68.77 140.14 55.32 Favored 'General case' 0 C--N 1.331 -0.2 0 CA-C-O 120.86 0.362 . . . . 0.0 111.057 -175.675 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 65' ' ' LYS . . . . . . . . . . . . . 50.3 mtmt -89.5 134.24 34.2 Favored 'General case' 0 C--N 1.331 -0.23 0 CA-C-N 116.11 -0.496 . . . . 0.0 110.444 178.316 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 66' ' ' ILE . . . . . . . . . . . . . 61.0 mt -118.27 132.59 67.67 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.254 0 N-CA-C 109.98 -0.378 . . . . 0.0 109.98 179.917 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 67' ' ' THR . . . . . . . . . . . . . 20.5 m -124.18 136.81 54.46 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-O 121.028 0.442 . . . . 0.0 110.918 -179.362 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 68' ' ' LEU . . . . . . . . . . . . . 30.6 mt -106.16 123.02 47.37 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 115.881 -0.599 . . . . 0.0 110.431 177.498 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 69' ' ' VAL . . . . . . . . . . . . . 46.3 t -102.68 130.64 52.37 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.245 0 CA-C-N 116.159 -0.473 . . . . 0.0 109.928 178.337 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 70' ' ' THR . . . . . . . . . . . . . 24.1 m -145.28 -57.74 0.33 Allowed 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.308 -0.405 . . . . 0.0 110.466 179.685 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 71' ' ' HIS . . . . . . . . . . . . . 32.4 m80 -110.12 153.79 43.08 Favored Pre-proline 0 C--N 1.329 -0.302 0 CA-C-N 116.259 -0.428 . . . . 0.0 110.366 179.623 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 72' ' ' PRO . . . . . . . . . . . . . 38.0 Cg_endo -66.17 -15.78 49.61 Favored 'Trans proline' 0 N--CA 1.499 1.821 0 C-N-CA 121.298 1.332 . . . . 0.0 113.218 178.379 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 73' ' ' VAL . . . . . . . . . . . . . 35.6 m -120.25 161.5 19.76 Favored 'Isoleucine or valine' 0 N--CA 1.462 0.133 0 CA-C-O 120.913 0.387 . . . . 0.0 110.545 -178.802 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 74' ' ' ASP . . . . . 0.509 ' OD1' HD11 ' A' ' 76' ' ' LEU . 4.9 t70 -98.57 124.07 43.11 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.082 -0.508 . . . . 0.0 110.275 -178.243 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 42.8 t -117.8 123.65 71.98 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.26 0 CA-C-O 120.931 0.396 . . . . 0.0 110.646 -177.937 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 76' ' ' LEU . . . . . 0.509 HD11 ' OD1' ' A' ' 74' ' ' ASP . 5.8 mp -121.81 148.48 44.63 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 115.848 -0.615 . . . . 0.0 109.679 175.537 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 77' ' ' GLU . . . . . . . . . . . . . 96.6 mt-10 -137.68 134.93 35.99 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-O 120.991 0.424 . . . . 0.0 111.354 -178.308 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 78' ' ' ALA . . . . . . . . . . . . . . . -119.95 135.44 54.9 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 115.718 -0.674 . . . . 0.0 109.679 176.266 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 79' ' ' LYS . . . . . 0.612 ' O ' HD13 ' A' ' 80' ' ' ILE . 62.0 mttp -84.78 115.56 22.79 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-O 120.816 0.341 . . . . 0.0 111.078 -176.578 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 80' ' ' ILE . . . . . 0.612 HD13 ' O ' ' A' ' 79' ' ' LYS . 39.6 mm -139.3 108.56 3.71 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.27 0 N-CA-C 109.301 -0.629 . . . . 0.0 109.301 -178.082 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 81' ' ' LYS . . . . . . . . . . . . . 63.6 mttp -94.53 126.25 39.69 Favored 'General case' 0 C--N 1.33 -0.249 0 C-N-CA 120.629 -0.428 . . . . 0.0 111.175 -179.734 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . 89.08 42.1 5.7 Favored Glycine 0 CA--C 1.527 0.821 0 C-N-CA 120.679 -0.772 . . . . 0.0 112.119 173.798 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 83' ' ' ILE . . . . . . . . . . . . . 72.9 mt -68.84 137.91 23.42 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.291 0 N-CA-C 109.597 -0.52 . . . . 0.0 109.597 176.19 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 84' ' ' LYS . . . . . . . . . . . . . 14.2 ttmm -93.08 -54.05 3.88 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-O 121.104 0.478 . . . . 0.0 110.216 -178.029 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 85' ' ' ASP . . . . . . . . . . . . . 13.1 t70 -151.22 151.41 31.83 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 115.611 -0.722 . . . . 0.0 110.55 -178.725 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 86' ' ' VAL . . . . . . . . . . . . . 44.1 t -128.58 129.43 68.72 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.255 0 CA-C-O 121.016 0.436 . . . . 0.0 110.083 178.914 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 87' ' ' ILE . . . . . 0.493 HD12 ' N ' ' A' ' 87' ' ' ILE . 5.1 mp -119.33 124.04 72.31 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.207 0 N-CA-C 109.229 -0.656 . . . . 0.0 109.229 178.22 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 88' ' ' LEU . . . . . . . . . . . . . 15.9 tp -113.79 126.74 55.54 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-O 121.077 0.465 . . . . 0.0 111.259 -175.758 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 89' ' ' ASP . . . . . . . . . . . . . 13.0 t70 -121.87 152.45 39.57 Favored 'General case' 0 C--N 1.331 -0.223 0 N-CA-C 109.232 -0.655 . . . . 0.0 109.232 174.994 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 44.4 mt-10 -49.83 -35.18 22.08 Favored 'General case' 0 C--N 1.328 -0.348 0 N-CA-C 112.812 0.671 . . . . 0.0 112.812 -172.179 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 91' ' ' ASN . . . . . . . . . . . . . 87.9 m-20 -126.87 26.77 6.11 Favored 'General case' 0 N--CA 1.467 0.391 0 N-CA-C 112.596 0.591 . . . . 0.0 112.596 -175.272 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 92' ' ' LEU . . . . . . . . . . . . . 7.2 tp -166.2 141.39 4.61 Favored 'General case' 0 C--N 1.33 -0.239 0 CA-C-O 120.728 0.299 . . . . 0.0 110.387 178.233 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 93' ' ' ILE . . . . . . . . . . . . . 68.1 mt -120.61 122.4 67.9 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.267 0 N-CA-C 109.407 -0.59 . . . . 0.0 109.407 179.327 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 94' ' ' VAL . . . . . . . . . . . . . 48.0 t -120.92 125.81 74.47 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.267 0 CA-C-O 120.981 0.419 . . . . 0.0 109.993 -179.864 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 95' ' ' VAL . . . . . . . . . . . . . 44.9 t -119.81 132.25 70.04 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.249 0 CA-C-N 115.867 -0.606 . . . . 0.0 109.543 178.872 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 96' ' ' ILE . . . . . . . . . . . . . 63.3 mt -114.0 125.56 71.31 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.293 0 N-CA-C 109.077 -0.712 . . . . 0.0 109.077 179.069 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 97' ' ' THR . . . . . . . . . . . . . 80.3 p -97.66 156.46 16.53 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-O 121.011 0.434 . . . . 0.0 110.864 -177.78 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 98' ' ' GLU . . . . . . . . . . . . . 84.4 tt0 -53.88 -24.32 15.61 Favored 'General case' 0 CA--C 1.534 0.343 0 N-CA-C 112.163 0.431 . . . . 0.0 112.163 179.348 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 99' ' ' GLU . . . . . . . . . . . . . 96.0 mt-10 -76.4 11.69 1.49 Allowed 'General case' 0 CA--C 1.537 0.451 0 N-CA-C 113.227 0.825 . . . . 0.0 113.227 -178.597 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 100' ' ' ASN . . . . . . . . . . . . . 2.1 m-20 63.2 37.16 11.45 Favored 'General case' 0 CA--C 1.53 0.203 0 CA-C-O 121.005 0.431 . . . . 0.0 111.093 178.601 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 101' ' ' GLU . . . . . . . . . . . . . 68.5 tt0 -117.08 145.41 43.76 Favored 'General case' 0 C--N 1.332 -0.173 0 N-CA-C 109.386 -0.598 . . . . 0.0 109.386 175.654 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 102' ' ' VAL . . . . . . . . . . . . . 43.6 t -117.19 126.2 74.38 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.249 0 N-CA-C 109.869 -0.419 . . . . 0.0 109.869 -178.308 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 103' ' ' LEU . . . . . . . . . . . . . 28.7 mt -115.68 130.53 56.89 Favored 'General case' 0 C--N 1.331 -0.225 0 CA-C-N 115.552 -0.749 . . . . 0.0 110.157 176.409 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 104' ' ' ILE . . . . . 0.418 HD13 HG11 ' A' ' 130' ' ' VAL . 67.2 mt -116.78 120.45 65.08 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.294 0 N-CA-C 109.972 -0.381 . . . . 0.0 109.972 179.606 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 105' ' ' PHE . . . . . . . . . . . . . 66.3 m-85 -120.03 166.34 13.51 Favored 'General case' 0 C--N 1.333 -0.143 0 CA-C-N 115.323 -0.853 . . . . 0.0 109.622 179.754 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 106' ' ' ASN . . . . . . . . . . . . . 51.9 p-10 -101.49 -170.96 1.9 Allowed 'General case' 0 C--N 1.33 -0.257 0 N-CA-C 109.976 -0.379 . . . . 0.0 109.976 174.159 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 107' ' ' GLN . . . . . . . . . . . . . 13.8 tt0 -59.6 -28.02 66.81 Favored 'General case' 0 CA--C 1.533 0.301 0 N-CA-C 112.131 0.419 . . . . 0.0 112.131 179.997 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 108' ' ' ASN . . . . . . . . . . . . . 6.0 t-20 -85.22 13.37 6.46 Favored 'General case' 0 CA--C 1.536 0.418 0 N-CA-C 112.81 0.671 . . . . 0.0 112.81 -178.891 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 109' ' ' LEU . . . . . . . . . . . . . 7.1 tp 54.64 37.03 27.42 Favored 'General case' 0 CA--C 1.529 0.161 0 CA-C-O 120.935 0.398 . . . . 0.0 111.385 179.212 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 110' ' ' GLU . . . . . . . . . . . . . 95.6 mt-10 -104.33 148.6 26.2 Favored 'General case' 0 C--N 1.331 -0.216 0 N-CA-C 109.742 -0.466 . . . . 0.0 109.742 175.717 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 111' ' ' GLU . . . . . . . . . . . . . 61.3 tt0 -85.06 121.86 28.45 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-O 120.798 0.332 . . . . 0.0 110.611 -176.434 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 112' ' ' LEU . . . . . . . . . . . . . 15.0 mt -107.48 -46.13 3.91 Favored 'General case' 0 C--N 1.331 -0.225 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.699 179.886 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 113' ' ' TYR . . . . . . . . . . . . . 57.5 t80 -133.05 139.28 47.1 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.399 -0.364 . . . . 0.0 110.802 -178.101 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 114' ' ' ARG . . . . . . . . . . . . . 26.4 ptt180 -141.36 123.07 15.21 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.769 -179.923 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 115' ' ' GLY . . . . . . . . . . . . . . . -150.13 158.81 27.84 Favored Glycine 0 CA--C 1.522 0.471 0 N-CA-C 110.931 -0.868 . . . . 0.0 110.931 179.892 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 116' ' ' LYS . . . . . . . . . . . . . 33.0 ttmt -131.44 135.85 47.48 Favored 'General case' 0 C--N 1.327 -0.379 0 N-CA-C 109.868 -0.419 . . . . 0.0 109.868 177.464 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 117' ' ' PHE . . . . . . . . . . . . . 25.2 m-85 -137.91 113.86 9.9 Favored 'General case' 0 C--N 1.329 -0.319 0 N-CA-C 109.8 -0.444 . . . . 0.0 109.8 -175.805 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 118' ' ' GLU . . . . . . . . . . . . . 84.7 tt0 -56.31 -40.5 74.47 Favored 'General case' 0 C--N 1.33 -0.272 0 C-N-CA 120.787 -0.365 . . . . 0.0 110.959 -177.362 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 119' ' ' ASN . . . . . . . . . . . . . 5.4 m120 -97.5 30.62 2.82 Favored 'General case' 0 C--N 1.33 -0.263 0 N-CA-C 112.251 0.463 . . . . 0.0 112.251 -175.034 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 120' ' ' LEU . . . . . . . . . . . . . 23.9 tp -59.21 120.26 8.89 Favored 'General case' 0 C--N 1.332 -0.167 0 N-CA-C 109.859 -0.422 . . . . 0.0 109.859 176.545 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 121' ' ' ASN . . . . . . . . . . . . . 31.8 m120 -113.49 -44.18 3.24 Favored 'General case' 0 C--N 1.331 -0.223 0 CA-C-N 116.609 -0.268 . . . . 0.0 111.032 -177.162 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 122' ' ' LYS . . . . . . . . . . . . . 60.6 mtpt -143.52 144.42 31.96 Favored 'General case' 0 C--N 1.331 -0.22 0 CA-C-O 121.015 0.435 . . . . 0.0 111.383 -178.46 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 123' ' ' VAL . . . . . . . . . . . . . 47.7 t -128.9 127.53 66.35 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.297 0 N-CA-C 109.298 -0.63 . . . . 0.0 109.298 174.897 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 124' ' ' LEU . . . . . . . . . . . . . 51.8 mt -126.23 132.58 51.71 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-O 120.791 0.329 . . . . 0.0 110.654 -178.636 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 125' ' ' VAL . . . . . . . . . . . . . 11.6 p -134.45 136.0 53.3 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.34 0 CA-C-N 116.111 -0.495 . . . . 0.0 110.375 179.32 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 126' ' ' ARG . . . . . . . . . . . . . 76.2 mtt180 -143.91 127.79 17.35 Favored 'General case' 0 C--N 1.327 -0.395 0 CA-C-N 115.846 -0.615 . . . . 0.0 109.365 178.158 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 127' ' ' ASN . . . . . . . . . . . . . 79.9 m-20 56.83 -134.72 1.24 Allowed 'General case' 0 CA--C 1.544 0.743 0 CA-C-O 118.679 -0.677 . . . . 0.0 109.65 -178.285 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 128' ' ' ASP . . . . . . . . . . . . . 8.4 p-10 -99.06 15.81 24.64 Favored 'General case' 0 CA--C 1.535 0.389 0 CA-C-N 119.923 1.238 . . . . 0.0 113.057 178.641 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 129' ' ' LEU . . . . . 0.512 HD12 ' N ' ' A' ' 129' ' ' LEU . 7.0 mp -114.27 141.23 47.84 Favored 'General case' 0 N--CA 1.463 0.224 0 N-CA-C 109.874 -0.417 . . . . 0.0 109.874 178.346 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 130' ' ' VAL . . . . . 0.479 HG13 ' HB ' ' A' ' 141' ' ' ILE . 14.6 p -140.06 146.47 24.81 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.234 0 CA-C-O 121.312 0.577 . . . . 0.0 111.682 -176.432 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 131' ' ' VAL . . . . . 0.463 HG22 HD12 ' A' ' 140' ' ' LEU . 44.2 t -136.02 139.52 45.7 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.264 0 CA-C-N 115.712 -0.677 . . . . 0.0 110.196 177.105 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 132' ' ' ILE . . . . . . . . . . . . . 70.9 mt -115.58 132.68 64.25 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.335 0 CA-C-N 115.998 -0.547 . . . . 0.0 109.673 -179.82 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 133' ' ' ILE . . . . . . . . . . . . . 41.1 mm -116.94 123.43 71.79 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.241 0 CA-C-O 120.781 0.324 . . . . 0.0 111.078 -175.127 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 134' ' ' ASP . . . . . . . . . . . . . 10.3 p-10 -136.61 149.4 48.0 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-N 116.227 -0.442 . . . . 0.0 109.981 175.255 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 135' ' ' GLU . . . . . . . . . . . . . 41.8 tp10 -49.95 -28.36 6.66 Favored 'General case' 0 C--N 1.327 -0.385 0 N-CA-C 112.673 0.62 . . . . 0.0 112.673 -171.986 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 136' ' ' GLN . . . . . . . . . . . . . 97.6 mt-30 -83.47 -34.96 25.27 Favored 'General case' 0 C--O 1.234 0.242 0 N-CA-C 112.707 0.632 . . . . 0.0 112.707 -175.96 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 137' ' ' LYS . . . . . . . . . . . . . 56.3 pttt -164.08 174.51 11.24 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-O 121.6 0.714 . . . . 0.0 112.529 -171.055 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 138' ' ' LEU . . . . . 0.409 ' C ' HD23 ' A' ' 138' ' ' LEU . 6.9 tt -121.33 128.43 52.28 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 114.889 -1.05 . . . . 0.0 109.881 177.716 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 139' ' ' THR . . . . . . . . . . . . . 47.0 m -109.26 127.98 54.7 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-N 116.117 -0.492 . . . . 0.0 109.882 178.282 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 140' ' ' LEU . . . . . 0.463 HD12 HG22 ' A' ' 131' ' ' VAL . 6.9 tp -114.56 121.36 43.24 Favored 'General case' 0 C--N 1.327 -0.395 0 CA-C-N 115.983 -0.553 . . . . 0.0 109.608 -176.574 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 141' ' ' ILE . . . . . 0.479 ' HB ' HG13 ' A' ' 130' ' ' VAL . 18.9 mt -121.75 118.49 55.91 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.245 0 N-CA-C 109.885 -0.413 . . . . 0.0 109.885 -175.817 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 142' ' ' ARG . . . . . . . . . . . . . 34.4 mmt180 -116.21 134.81 54.51 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 115.557 -0.747 . . . . 0.0 110.054 -178.248 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 143' ' ' THR . . . . . . . . . . . . . 48.8 p . . . . . 0 C--O 1.221 -0.444 0 CA-C-O 118.041 -0.98 . . . . 0.0 110.775 179.363 . . . . . . . . 0 0 . 1 . 003 nuclear build full ' B' B ' -3' ' ' GLU . . . . . . . . . . . . . 95.6 mt-10 . . . . . 0 N--CA 1.49 1.55 0 N-CA-C 109.3 -0.629 . . . . 0.0 109.3 . . . . . . . . . 0 0 . 1 . 003 nuclear build full ' B' B ' -2' ' ' GLY . . . . . . . . . . . . . . . -60.4 146.17 46.42 Favored Glycine 0 CA--C 1.524 0.617 0 N-CA-C 110.771 -0.931 . . . . 0.0 110.771 179.635 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' -1' ' ' VAL . . . . . . . . . . . . . 42.7 t -95.56 133.92 34.87 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.349 0 CA-C-O 120.829 0.347 . . . . 0.0 110.149 -179.908 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 0' ' ' ILE . . . . . . . . . . . . . 42.9 mm -113.47 143.31 23.43 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.249 0 CA-C-N 116.118 -0.492 . . . . 0.0 109.916 -179.977 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 1' ' ' MET . . . . . . . . . . . . . 24.0 ptm -141.94 138.98 32.35 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.233 -0.44 . . . . 0.0 110.523 -178.748 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 2' ' ' SER . . . . . . . . . . . . . 96.8 p -129.27 151.18 50.21 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.238 -0.437 . . . . 0.0 110.627 -179.089 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 3' ' ' GLU . . . . . . . . . . . . . 95.3 mt-10 -139.4 141.27 37.54 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 115.879 -0.6 . . . . 0.0 110.804 -179.223 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 4' ' ' LEU . . . . . . . . . . . . . 5.2 tt -126.14 128.01 46.64 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.131 -0.486 . . . . 0.0 109.803 177.342 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 5' ' ' LYS . . . . . . . . . . . . . 92.5 mttt -110.19 122.28 47.27 Favored 'General case' 0 C--O 1.235 0.315 0 CA-C-O 120.873 0.368 . . . . 0.0 111.034 -178.313 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 6' ' ' LEU . . . . . . . . . . . . . 48.9 mt -114.02 148.42 37.02 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 115.296 -0.866 . . . . 0.0 110.536 -179.5 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 7' ' ' LYS . . . . . . . . . . . . . 35.8 ttpt -134.63 139.5 32.7 Favored Pre-proline 0 CA--C 1.534 0.356 0 CA-C-O 119.023 -0.513 . . . . 0.0 110.022 175.683 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 8' ' ' PRO . . . . . . . . . . . . . 84.9 Cg_endo -91.76 141.72 2.62 Favored 'Trans proline' 0 N--CA 1.489 1.257 0 C-N-CA 121.754 1.636 . . . . 0.0 111.61 177.731 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 9' ' ' LEU . . . . . . . . . . . . . 24.1 mt -79.35 -47.62 1.56 Allowed Pre-proline 0 CA--C 1.534 0.343 0 CA-C-O 118.696 -0.669 . . . . 0.0 112.203 -178.397 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 10' ' ' PRO . . . . . . . . . . . . . 89.6 Cg_endo -81.22 155.53 19.37 Favored 'Trans proline' 0 N--CA 1.495 1.581 0 C-N-CA 121.213 1.275 . . . . 0.0 111.95 176.059 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 11' ' ' LYS . . . . . . . . . . . . . 85.5 tttt -83.71 96.02 8.58 Favored 'General case' 0 C--N 1.33 -0.282 0 C-N-CA 120.832 -0.347 . . . . 0.0 110.099 177.465 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 12' ' ' VAL . . . . . . . . . . . . . 12.1 p -136.28 145.64 30.39 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.276 0 CA-C-N 116.1 -0.5 . . . . 0.0 110.411 -178.64 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 13' ' ' GLU . . . . . . . . . . . . . 81.9 tt0 -91.72 126.32 36.76 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.152 -0.476 . . . . 0.0 110.109 178.562 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 14' ' ' LEU . . . . . . . . . . . . . 27.5 mt -98.1 145.25 29.47 Favored Pre-proline 0 CA--C 1.532 0.281 0 CA-C-O 119.167 -0.444 . . . . 0.0 110.365 -177.932 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 15' ' ' PRO . . . . . . . . . . . . . 24.0 Cg_exo -63.71 160.0 38.68 Favored 'Trans proline' 0 N--CA 1.497 1.695 0 C-N-CA 121.331 1.354 . . . . 0.0 111.694 176.144 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 16' ' ' PRO . . . . . . . . . . . . . 37.5 Cg_exo -59.22 -31.6 95.53 Favored 'Trans proline' 0 N--CA 1.495 1.613 0 C-N-CA 121.474 1.45 . . . . 0.0 112.737 -179.747 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 17' ' ' ASP . . . . . . . . . . . . . 10.0 p-10 -88.1 3.97 47.11 Favored 'General case' 0 CA--C 1.536 0.404 0 N-CA-C 113.319 0.859 . . . . 0.0 113.319 -177.323 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 18' ' ' PHE . . . . . . . . . . . . . 39.2 t80 -58.26 -47.03 84.86 Favored 'General case' 0 C--N 1.334 -0.107 0 O-C-N 121.931 -0.481 . . . . 0.0 110.121 -177.64 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 19' ' ' VAL . . . . . . . . . . . . . 47.3 t -56.6 -40.83 71.5 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 CA-C-N 116.249 -0.432 . . . . 0.0 110.54 -178.236 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 20' ' ' ASP . . . . . . . . . . . . . 74.3 m-20 -59.63 -44.79 93.35 Favored 'General case' 0 C--N 1.33 -0.269 0 C-N-CA 120.919 -0.312 . . . . 0.0 110.797 -177.398 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 21' ' ' VAL . . . . . . . . . . . . . 46.9 t -64.69 -45.48 95.14 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.255 0 C-N-CA 120.702 -0.399 . . . . 0.0 110.522 -177.61 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 22' ' ' ILE . . . . . 0.588 HG22 HD12 ' B' ' 26' ' ' LEU . 50.7 mm -58.71 -40.59 79.96 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.299 0 C-N-CA 120.98 -0.288 . . . . 0.0 110.826 -179.803 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' B' B ' 23' ' ' ARG . . . . . . . . . . . . . 52.2 ttp180 -56.73 -47.07 80.82 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-O 120.891 0.377 . . . . 0.0 110.515 178.713 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 24' ' ' ILE . . . . . . . . . . . . . 77.3 mt -60.87 -44.8 98.51 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.261 0 CA-C-N 115.979 -0.555 . . . . 0.0 111.822 -178.852 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 25' ' ' LYS . . . . . . . . . . . . . 12.5 pttp -71.69 -36.56 70.63 Favored 'General case' 0 CA--C 1.533 0.309 0 C-N-CA 120.372 -0.531 . . . . 0.0 111.851 -173.042 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 26' ' ' LEU . . . . . 0.588 HD12 HG22 ' B' ' 22' ' ' ILE . 24.8 mt -78.94 -42.68 26.33 Favored 'General case' 0 C--N 1.331 -0.228 0 N-CA-C 113.186 0.81 . . . . 0.0 113.186 -173.435 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' B' B ' 27' ' ' GLN . . . . . . . . . . . . . 16.7 pt20 -47.17 138.24 7.16 Favored 'General case' 0 N--CA 1.47 0.553 0 N-CA-C 112.696 0.628 . . . . 0.0 112.696 -175.356 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 28' ' ' GLY . . . . . . . . . . . . . . . 101.5 -25.95 26.26 Favored Glycine 0 CA--C 1.532 1.122 0 CA-C-N 115.669 -0.696 . . . . 0.0 112.295 -176.391 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 29' ' ' LYS . . . . . . . . . . . . . 63.8 mttp -98.14 155.15 17.28 Favored 'General case' 0 C--O 1.232 0.175 0 CA-C-N 117.5 0.65 . . . . 0.0 111.256 178.219 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 30' ' ' THR . . . . . . . . . . . . . 41.3 m -100.49 136.23 40.68 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.015 -0.539 . . . . 0.0 109.83 175.157 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 31' ' ' VAL . . . . . . . . . . . . . 35.2 m -125.78 153.72 33.98 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.314 0 CA-C-O 120.902 0.382 . . . . 0.0 110.622 -178.738 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 32' ' ' ARG . . . . . . . . . . . . . 34.2 ttp180 -132.39 147.55 52.39 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 115.897 -0.592 . . . . 0.0 110.242 178.118 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 33' ' ' THR . . . . . . . . . . . . . 17.0 m -53.42 139.37 30.8 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.394 -0.366 . . . . 0.0 111.355 -178.342 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 34' ' ' GLY . . . . . . . . . . . . . . . 101.1 -17.18 56.42 Favored Glycine 0 CA--C 1.534 1.219 0 CA-C-O 119.69 -0.505 . . . . 0.0 113.274 179.842 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 35' ' ' ASP . . . . . . . . . . . . . 70.5 m-20 -64.46 149.34 48.71 Favored 'General case' 0 C--O 1.232 0.148 0 CA-C-N 118.017 0.908 . . . . 0.0 111.478 179.506 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 36' ' ' VAL . . . . . . . . . . . . . 44.9 t -121.4 130.25 74.82 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.216 0 CA-C-N 115.752 -0.658 . . . . 0.0 109.791 178.148 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 37' ' ' ILE . . . . . . . . . . . . . 69.7 mt -121.7 139.59 48.3 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.267 0 CA-C-N 116.294 -0.412 . . . . 0.0 110.095 -179.548 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 38' ' ' GLY . . . . . . . . . . . . . . . -111.52 128.85 8.85 Favored Glycine 0 CA--C 1.525 0.712 0 N-CA-C 111.017 -0.833 . . . . 0.0 111.017 179.634 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 39' ' ' ILE . . . . . . . . . . . . . 73.9 mt -123.3 137.12 57.71 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.201 0 N-CA-C 110.072 -0.344 . . . . 0.0 110.072 179.521 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 40' ' ' SER . . . . . . . . . . . . . 59.6 p -91.78 115.91 28.45 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.559 -0.291 . . . . 0.0 111.117 177.612 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 41' ' ' ILE . . . . . . . . . . . . . 44.7 mm -121.39 114.2 42.27 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.231 0 N-CA-C 109.772 -0.455 . . . . 0.0 109.772 178.159 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 42' ' ' LEU . . . . . . . . . . . . . 6.4 mp 56.9 35.5 26.44 Favored 'General case' 0 CA--C 1.532 0.26 0 CA-C-O 120.973 0.416 . . . . 0.0 111.342 -179.378 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 43' ' ' GLY . . . . . . . . . . . . . . . 77.91 -10.06 27.93 Favored Glycine 0 CA--C 1.534 1.276 0 C-N-CA 121.249 -0.5 . . . . 0.0 113.472 177.725 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 44' ' ' LYS . . . . . . . . . . . . . 61.1 tttm -96.32 134.33 39.6 Favored 'General case' 0 C--N 1.331 -0.197 0 CA-C-N 117.901 0.851 . . . . 0.0 109.819 176.651 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 45' ' ' GLU . . . . . . . . . . . . . 82.9 tt0 -83.5 127.94 34.11 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-O 120.867 0.365 . . . . 0.0 111.084 -177.863 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 46' ' ' VAL . . . . . . . . . . . . . 7.3 p -120.53 130.07 74.89 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.265 0 N-CA-C 109.315 -0.624 . . . . 0.0 109.315 175.541 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 47' ' ' LYS . . . . . . . . . . . . . 79.8 mttt -100.4 128.64 46.41 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.076 -0.511 . . . . 0.0 111.366 179.317 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 48' ' ' PHE . . . . . . . . . . . . . 92.1 m-85 -112.89 131.91 55.53 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 115.88 -0.6 . . . . 0.0 109.78 176.705 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 49' ' ' LYS . . . . . . . . . . . . . 66.8 tttt -107.19 137.45 45.22 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.48 -0.327 . . . . 0.0 110.64 179.68 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 50' ' ' VAL . . . . . . . . . . . . . 45.0 t -80.71 107.22 12.82 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.241 0 N-CA-C 109.17 -0.678 . . . . 0.0 109.17 175.613 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 51' ' ' VAL . . . . . . . . . . . . . 49.4 t -71.47 -54.14 18.29 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.292 0 N-CA-C 109.493 -0.558 . . . . 0.0 109.493 -174.516 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 52' ' ' GLN . . . . . . . . . . . . . 90.8 mt-30 -154.7 154.07 32.31 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 115.93 -0.577 . . . . 0.0 112.097 -176.74 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 53' ' ' ALA . . . . . 0.518 ' HB3' ' OG ' ' B' ' 56' ' ' SER . . . -132.6 134.37 44.83 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 115.191 -0.913 . . . . 0.0 109.784 174.421 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' B' B ' 54' ' ' TYR . . . . . . . . . . . . . 58.6 t80 -129.21 111.31 18.16 Favored Pre-proline 0 CA--C 1.533 0.309 0 CA-C-O 118.147 -0.93 . . . . 0.0 110.344 178.007 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 55' ' ' PRO . . . . . . . . . . . . . 74.4 Cg_endo -77.14 170.15 72.34 Favored 'Cis proline' 0 N--CA 1.5 1.907 0 CA-C-N 121.996 1.749 . . . . 0.0 111.957 -6.859 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 56' ' ' SER . . . . . 0.518 ' OG ' ' HB3' ' B' ' 53' ' ' ALA . 68.8 m -125.02 136.24 27.85 Favored Pre-proline 0 CA--C 1.538 0.491 0 CA-C-O 118.556 -0.735 . . . . 0.0 109.457 175.969 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' B' B ' 57' ' ' PRO . . . . . . . . . . . . . 37.2 Cg_endo -67.32 160.67 79.1 Favored 'Cis proline' 0 N--CA 1.499 1.852 0 CA-C-N 121.771 1.668 . . . . 0.0 111.689 -2.129 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 58' ' ' LEU . . . . . . . . . . . . . 29.4 tp -129.27 138.07 51.42 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-O 120.993 0.425 . . . . 0.0 110.593 -178.558 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 59' ' ' ARG . . . . . . . . . . . . . 57.2 ttp180 -101.02 121.22 41.39 Favored 'General case' 0 C--N 1.327 -0.38 0 N-CA-C 109.12 -0.696 . . . . 0.0 109.12 174.325 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 60' ' ' VAL . . . . . . . . . . . . . 47.4 t -72.14 122.07 23.77 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.361 0 C-N-CA 120.848 -0.341 . . . . 0.0 110.365 -173.969 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 61' ' ' GLU . . . . . . . . . . . . . 95.4 mt-10 -131.04 165.73 22.57 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.0 -0.546 . . . . 0.0 110.206 179.213 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 62' ' ' ASP . . . . . . . . . . . . . 48.2 m-20 -55.01 -32.61 61.94 Favored 'General case' 0 C--N 1.329 -0.324 0 N-CA-C 111.766 0.284 . . . . 0.0 111.766 -179.25 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 63' ' ' ARG . . . . . . . . . . . . . 32.5 ptt180 -83.35 3.36 31.95 Favored 'General case' 0 CA--C 1.538 0.487 0 N-CA-C 113.583 0.957 . . . . 0.0 113.583 -175.36 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 64' ' ' THR . . . . . . . . . . . . . 40.1 m -85.01 135.29 34.08 Favored 'General case' 0 C--N 1.331 -0.217 0 CA-C-N 118.137 0.426 . . . . 0.0 110.258 -178.997 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 65' ' ' LYS . . . . . . . . . . . . . 99.1 mttt -88.97 127.36 35.66 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.012 179.245 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 66' ' ' ILE . . . . . . . . . . . . . 58.4 mt -112.74 129.48 68.27 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.328 0 N-CA-C 109.859 -0.422 . . . . 0.0 109.859 -178.531 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 67' ' ' THR . . . . . . . . . . . . . 23.9 m -124.46 138.7 54.33 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-O 121.045 0.45 . . . . 0.0 110.801 -177.527 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 68' ' ' LEU . . . . . 0.415 HD12 ' N ' ' B' ' 68' ' ' LEU . 7.6 mp -107.28 131.15 54.52 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 115.972 -0.558 . . . . 0.0 110.242 177.025 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' B' B ' 69' ' ' VAL . . . . . . . . . . . . . 43.2 t -87.37 130.53 37.03 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.294 0 CA-C-N 116.424 -0.353 . . . . 0.0 110.067 179.132 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 70' ' ' THR . . . . . . . . . . . . . 5.7 p -99.52 -60.02 1.61 Allowed 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 116.11 -0.495 . . . . 0.0 111.092 -178.253 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 71' ' ' HIS . . . . . . . . . . . . . 83.3 m-70 -69.57 131.4 89.85 Favored Pre-proline 0 CA--C 1.536 0.412 0 CA-C-O 118.563 -0.732 . . . . 0.0 110.237 -177.768 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 72' ' ' PRO . . . . . . . . . . . . . 13.2 Cg_exo -66.37 -30.0 45.17 Favored 'Trans proline' 0 N--CA 1.498 1.759 0 C-N-CA 121.161 1.241 . . . . 0.0 112.252 177.785 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 73' ' ' VAL . . . . . . . . . . . . . 33.1 m -137.25 169.88 18.78 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.218 0 CA-C-O 121.018 0.437 . . . . 0.0 110.983 -177.711 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 74' ' ' ASP . . . . . . . . . . . . . 4.8 t0 -98.93 125.59 44.39 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 115.828 -0.623 . . . . 0.0 110.101 -179.601 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 75' ' ' VAL . . . . . . . . . . . . . 42.9 t -119.14 123.35 71.23 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.286 0 CA-C-O 121.084 0.468 . . . . 0.0 110.509 -179.402 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 76' ' ' LEU . . . . . . . . . . . . . 6.6 mp -120.39 148.38 43.84 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-N 115.691 -0.686 . . . . 0.0 109.741 176.043 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 77' ' ' GLU . . . . . . . . . . . . . 98.5 mt-10 -137.86 138.3 38.97 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-O 121.015 0.436 . . . . 0.0 111.577 -179.024 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 78' ' ' ALA . . . . . 0.613 ' HB2' HD21 ' B' ' 109' ' ' LEU . . . -130.47 134.29 46.97 Favored 'General case' 0 C--N 1.331 -0.227 0 CA-C-N 115.755 -0.657 . . . . 0.0 109.728 175.541 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' B' B ' 79' ' ' LYS . . . . . 0.603 ' O ' HD13 ' B' ' 80' ' ' ILE . 30.0 ttmt -81.2 119.53 23.72 Favored 'General case' 0 C--N 1.331 -0.204 0 CA-C-O 120.925 0.393 . . . . 0.0 110.603 -179.38 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' B' B ' 80' ' ' ILE . . . . . 0.603 HD13 ' O ' ' B' ' 79' ' ' LYS . 41.7 mm -139.15 108.43 3.77 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.367 0 N-CA-C 109.201 -0.666 . . . . 0.0 109.201 -177.439 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' B' B ' 81' ' ' LYS . . . . . . . . . . . . . 55.6 mtpt -100.49 129.16 46.4 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-O 120.941 0.4 . . . . 0.0 111.257 -176.642 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 82' ' ' GLY . . . . . . . . . . . . . . . 89.16 42.11 5.67 Favored Glycine 0 CA--C 1.526 0.725 0 C-N-CA 120.956 -0.64 . . . . 0.0 111.726 174.344 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 83' ' ' ILE . . . . . . . . . . . . . 68.2 mt -69.13 136.02 27.16 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.407 0 N-CA-C 109.563 -0.532 . . . . 0.0 109.563 177.625 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 84' ' ' LYS . . . . . . . . . . . . . 25.2 ttpp -100.5 -51.66 3.56 Favored 'General case' 0 C--N 1.332 -0.195 0 CA-C-O 121.002 0.429 . . . . 0.0 110.082 179.938 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 85' ' ' ASP . . . . . . . . . . . . . 13.4 t70 -149.16 147.16 28.11 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 115.812 -0.631 . . . . 0.0 110.358 179.754 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 86' ' ' VAL . . . . . . . . . . . . . 42.7 t -129.34 130.29 67.53 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.24 0 CA-C-O 120.969 0.414 . . . . 0.0 110.251 179.427 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 87' ' ' ILE . . . . . . . . . . . . . 44.6 mm -118.25 125.04 73.99 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.28 0 CA-C-N 115.847 -0.615 . . . . 0.0 109.555 177.347 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 88' ' ' LEU . . . . . . . . . . . . . 44.5 mt -116.84 135.56 53.64 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-O 121.292 0.568 . . . . 0.0 111.688 -177.025 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 89' ' ' ASP . . . . . . . . . . . . . 7.3 t0 -128.58 155.96 44.1 Favored 'General case' 0 C--N 1.327 -0.403 0 CA-C-N 115.156 -0.929 . . . . 0.0 108.642 174.78 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 90' ' ' GLU . . . . . . . . . . . . . 76.9 tt0 -48.67 -36.09 15.27 Favored 'General case' 0 C--N 1.329 -0.285 0 N-CA-C 112.562 0.578 . . . . 0.0 112.562 -172.749 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 91' ' ' ASN . . . . . . . . . . . . . 26.3 m120 -132.07 37.23 3.6 Favored 'General case' 0 CA--C 1.531 0.248 0 N-CA-C 111.757 0.281 . . . . 0.0 111.757 -176.953 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 92' ' ' LEU . . . . . 0.41 HD21 ' CG2' ' B' ' 130' ' ' VAL . 26.3 tp -166.06 139.72 4.28 Favored 'General case' 0 C--N 1.33 -0.265 0 C-N-CA 121.005 -0.278 . . . . 0.0 110.801 -179.377 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' B' B ' 93' ' ' ILE . . . . . . . . . . . . . 72.3 mt -126.39 122.48 61.31 Favored 'Isoleucine or valine' 0 N--CA 1.462 0.157 0 N-CA-C 109.648 -0.501 . . . . 0.0 109.648 178.605 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 94' ' ' VAL . . . . . 0.428 HG21 HG11 ' B' ' 125' ' ' VAL . 43.8 t -124.61 126.19 71.28 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.239 0 N-CA-C 109.774 -0.454 . . . . 0.0 109.774 177.994 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' B' B ' 95' ' ' VAL . . . . . . . . . . . . . 44.6 t -120.73 133.59 66.9 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.336 0 CA-C-N 116.009 -0.541 . . . . 0.0 109.806 -179.165 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 96' ' ' ILE . . . . . . . . . . . . . 61.1 mt -115.4 128.29 72.66 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.25 0 N-CA-C 109.257 -0.646 . . . . 0.0 109.257 178.788 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 97' ' ' THR . . . . . . . . . . . . . 82.1 p -102.96 155.62 18.23 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-O 121.279 0.561 . . . . 0.0 111.343 -176.368 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 98' ' ' GLU . . . . . . . . . . . . . 13.2 pt-20 -55.08 -17.02 3.43 Favored 'General case' 0 CA--C 1.535 0.382 0 N-CA-C 112.814 0.672 . . . . 0.0 112.814 179.277 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 99' ' ' GLU . . . . . . . . . . . . . 41.7 mt-10 -85.36 16.29 3.81 Favored 'General case' 0 CA--C 1.535 0.402 0 N-CA-C 112.952 0.723 . . . . 0.0 112.952 -178.674 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 100' ' ' ASN . . . . . . . . . . . . . 3.6 m-20 62.36 38.02 13.34 Favored 'General case' 0 CA--C 1.529 0.166 0 CA-C-O 121.046 0.451 . . . . 0.0 110.869 178.505 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 101' ' ' GLU . . . . . . . . . . . . . 84.3 tt0 -121.26 143.63 49.05 Favored 'General case' 0 C--N 1.332 -0.187 0 CA-C-N 116.2 -0.455 . . . . 0.0 110.045 177.955 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 102' ' ' VAL . . . . . . . . . . . . . 43.9 t -116.73 127.59 74.31 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.28 0 CA-C-N 116.341 -0.39 . . . . 0.0 110.102 -178.671 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 103' ' ' LEU . . . . . 0.511 ' N ' HD12 ' B' ' 103' ' ' LEU . 6.2 mp -116.86 134.31 54.93 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 115.747 -0.66 . . . . 0.0 110.285 176.745 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' B' B ' 104' ' ' ILE . . . . . . . . . . . . . 71.3 mt -120.87 123.24 69.78 Favored 'Isoleucine or valine' 0 C--O 1.234 0.285 0 CA-C-N 116.612 -0.267 . . . . 0.0 110.56 -178.885 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 105' ' ' PHE . . . . . . . . . . . . . 60.0 m-85 -124.98 167.24 14.99 Favored 'General case' 0 C--O 1.232 0.178 0 O-C-N 124.07 0.856 . . . . 0.0 109.736 -179.665 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 106' ' ' ASN . . . . . . . . . . . . . 44.8 p-10 -104.11 -170.23 1.74 Allowed 'General case' 0 C--N 1.331 -0.237 0 N-CA-C 110.15 -0.315 . . . . 0.0 110.15 174.218 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 107' ' ' GLN . . . . . . . . . . . . . 37.9 tt0 -58.64 -30.11 67.04 Favored 'General case' 0 C--N 1.33 -0.278 0 N-CA-C 112.047 0.388 . . . . 0.0 112.047 -179.603 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 108' ' ' ASN . . . . . . . . . . . . . 5.4 t30 -86.02 10.6 13.74 Favored 'General case' 0 CA--C 1.536 0.43 0 N-CA-C 113.116 0.784 . . . . 0.0 113.116 -176.699 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 109' ' ' LEU . . . . . 0.613 HD21 ' HB2' ' B' ' 78' ' ' ALA . 8.5 tp 59.38 37.63 23.21 Favored 'General case' 0 C--N 1.332 -0.173 0 CA-C-O 121.034 0.445 . . . . 0.0 111.315 178.69 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' B' B ' 110' ' ' GLU . . . . . . . . . . . . . 94.9 mt-10 -105.18 138.5 41.28 Favored 'General case' 0 C--N 1.329 -0.3 0 N-CA-C 109.222 -0.659 . . . . 0.0 109.222 173.718 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 111' ' ' GLU . . . . . . . . . . . . . 47.8 tt0 -85.54 121.77 28.7 Favored 'General case' 0 C--N 1.329 -0.308 0 C-N-CA 120.708 -0.397 . . . . 0.0 110.249 -176.492 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 112' ' ' LEU . . . . . . . . . . . . . 58.2 mt -103.06 -42.89 5.65 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.074 -0.512 . . . . 0.0 110.527 179.687 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 113' ' ' TYR . . . . . . . . . . . . . 64.3 t80 -133.02 141.23 48.16 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.297 -0.411 . . . . 0.0 111.254 -177.1 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 114' ' ' ARG . . . . . . . . . . . . . 36.5 ptt180 -149.27 124.09 9.91 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.092 -0.504 . . . . 0.0 110.541 177.407 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 115' ' ' GLY . . . . . . . . . . . . . . . -150.02 158.9 27.87 Favored Glycine 0 CA--C 1.524 0.601 0 N-CA-C 111.254 -0.739 . . . . 0.0 111.254 179.933 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 116' ' ' LYS . . . . . . . . . . . . . 34.4 ttpt -125.07 134.92 52.32 Favored 'General case' 0 C--N 1.33 -0.257 0 N-CA-C 110.02 -0.363 . . . . 0.0 110.02 178.491 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 117' ' ' PHE . . . . . . . . . . . . . 51.5 m-85 -129.08 115.21 17.38 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-O 120.97 0.414 . . . . 0.0 110.155 -177.064 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 118' ' ' GLU . . . . . . . . . . . . . 95.8 mt-10 -53.6 -49.79 67.03 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.387 -0.37 . . . . 0.0 111.526 -175.633 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 119' ' ' ASN . . . . . . . . . . . . . 87.2 m-20 -96.7 31.13 2.4 Favored 'General case' 0 C--N 1.328 -0.342 0 N-CA-C 112.207 0.447 . . . . 0.0 112.207 -174.169 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 120' ' ' LEU . . . . . . . . . . . . . 17.1 tp -53.44 121.84 8.48 Favored 'General case' 0 N--CA 1.464 0.271 0 CA-C-O 120.599 0.238 . . . . 0.0 110.88 178.062 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 121' ' ' ASN . . . . . . . . . . . . . 34.4 m120 -114.07 -44.17 3.17 Favored 'General case' 0 N--CA 1.463 0.203 0 CA-C-N 116.547 -0.297 . . . . 0.0 111.213 -176.289 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 122' ' ' LYS . . . . . . . . . . . . . 97.2 mttt -144.61 150.7 37.88 Favored 'General case' 0 C--N 1.331 -0.206 0 CA-C-O 120.982 0.42 . . . . 0.0 111.591 -177.386 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 123' ' ' VAL . . . . . . . . . . . . . 45.9 t -130.44 127.94 63.13 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.298 0 N-CA-C 109.437 -0.579 . . . . 0.0 109.437 174.929 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 124' ' ' LEU . . . . . . . . . . . . . 52.7 mt -127.35 138.09 52.94 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-O 120.871 0.367 . . . . 0.0 110.633 -178.067 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 125' ' ' VAL . . . . . 0.428 HG11 HG21 ' B' ' 94' ' ' VAL . 34.7 m -135.73 140.09 45.01 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.24 0 CA-C-N 116.221 -0.445 . . . . 0.0 110.885 -179.53 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' B' B ' 126' ' ' ARG . . . . . . . . . . . . . 90.5 mtt-85 -140.69 112.12 7.36 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 115.889 -0.596 . . . . 0.0 110.199 177.117 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 127' ' ' ASN . . . . . . . . . . . . . 26.2 m-20 48.96 -105.01 0.14 Allowed 'General case' 0 CA--C 1.541 0.618 0 CA-C-O 119.299 -0.381 . . . . 0.0 111.79 -179.964 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 128' ' ' ASP . . . . . . . . . . . . . 13.0 p-10 -106.08 1.02 26.01 Favored 'General case' 0 CA--C 1.536 0.414 0 N-CA-C 113.692 0.997 . . . . 0.0 113.692 -174.957 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 129' ' ' LEU . . . . . . . . . . . . . 14.5 tp -104.94 131.82 51.96 Favored 'General case' 0 C--N 1.332 -0.188 0 CA-C-N 118.125 0.421 . . . . 0.0 109.996 178.479 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 130' ' ' VAL . . . . . 0.41 ' CG2' HD21 ' B' ' 92' ' ' LEU . 46.8 t -118.95 132.97 67.3 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.252 0 N-CA-C 109.828 -0.434 . . . . 0.0 109.828 -179.618 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' B' B ' 131' ' ' VAL . . . . . . . . . . . . . 42.1 t -134.96 134.37 53.44 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.196 0 CA-C-O 121.042 0.449 . . . . 0.0 110.416 179.396 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 132' ' ' ILE . . . . . . . . . . . . . 74.0 mt -117.25 133.78 62.91 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 CA-C-N 115.773 -0.649 . . . . 0.0 109.294 -179.799 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 133' ' ' ILE . . . . . . . . . . . . . 43.0 mm -117.62 123.86 72.29 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.224 0 CA-C-O 121.031 0.443 . . . . 0.0 111.086 -173.931 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 134' ' ' ASP . . . . . . . . . . . . . 9.1 p-10 -135.03 144.67 47.43 Favored 'General case' 0 C--N 1.33 -0.242 0 N-CA-C 109.228 -0.656 . . . . 0.0 109.228 173.777 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 135' ' ' GLU . . . . . . . . . . . . . 38.0 tp10 -49.93 -25.56 3.36 Favored 'General case' 0 C--N 1.326 -0.439 0 N-CA-C 112.719 0.637 . . . . 0.0 112.719 -174.553 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 136' ' ' GLN . . . . . . . . . . . . . 47.6 tt0 -80.43 -33.77 36.62 Favored 'General case' 0 C--O 1.233 0.212 0 N-CA-C 112.364 0.505 . . . . 0.0 112.364 -176.705 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 137' ' ' LYS . . . . . . . . . . . . . 57.7 pttt -169.98 175.3 5.16 Favored 'General case' 0 C--N 1.332 -0.182 0 CA-C-O 121.461 0.648 . . . . 0.0 112.182 -174.901 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 138' ' ' LEU . . . . . . . . . . . . . 6.1 tt -120.28 129.47 54.04 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-N 115.221 -0.9 . . . . 0.0 110.188 -179.96 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 139' ' ' THR . . . . . . . . . . . . . 36.2 m -110.19 128.21 55.36 Favored 'General case' 0 C--N 1.332 -0.181 0 CA-C-N 116.341 -0.391 . . . . 0.0 110.656 179.995 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 140' ' ' LEU . . . . . 0.477 ' C ' HD23 ' B' ' 140' ' ' LEU . 7.4 tt -112.27 124.36 52.29 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 115.656 -0.702 . . . . 0.0 109.2 -179.428 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' B' B ' 141' ' ' ILE . . . . . . . . . . . . . 19.5 mt -124.08 117.46 50.92 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.36 0 CA-C-O 121.053 0.454 . . . . 0.0 109.959 -176.439 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 142' ' ' ARG . . . . . . . . . . . . . 60.0 ttt-85 -107.54 126.51 52.62 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 115.594 -0.73 . . . . 0.0 110.698 -179.195 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 143' ' ' THR . . . . . . . . . . . . . 25.3 p . . . . . 0 C--O 1.221 -0.409 0 CA-C-O 118.248 -0.882 . . . . 0.0 110.938 179.138 . . . . . . . . 0 0 . 1 . 003 nuclear build full ' C' C ' -3' ' ' GLU . . . . . . . . . . . . . 83.6 tt0 . . . . . 0 N--CA 1.491 1.596 0 N-CA-C 109.25 -0.648 . . . . 0.0 109.25 . . . . . . . . . 0 0 . 1 . 003 nuclear build full ' C' C ' -2' ' ' GLY . . . . . . . . . . . . . . . -71.58 150.04 46.03 Favored Glycine 0 CA--C 1.525 0.659 0 N-CA-C 111.019 -0.832 . . . . 0.0 111.019 179.627 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' C' C ' -1' ' ' VAL . . . . . . . . . . . . . 44.0 t -94.28 140.95 15.69 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.359 0 N-CA-C 110.086 -0.338 . . . . 0.0 110.086 179.883 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' C' C ' 0' ' ' ILE . . . . . . . . . . . . . 43.8 mm -98.57 141.87 15.63 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.38 0 CA-C-N 116.228 -0.442 . . . . 0.0 110.256 -178.272 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' C' C ' 1' ' ' MET . . . . . . . . . . . . . 24.8 ptp -83.59 142.16 31.04 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.067 -0.515 . . . . 0.0 110.789 -179.684 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' C' C ' 2' ' ' SER . . . . . . . . . . . . . 6.9 p -116.61 132.96 56.55 Favored 'General case' 0 C--N 1.331 -0.211 0 CA-C-N 116.128 -0.487 . . . . 0.0 110.054 176.88 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' C' C ' 3' ' ' GLU . . . . . . . . . . . . . 95.6 mt-10 -140.77 141.14 34.85 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.107 -0.497 . . . . 0.0 111.134 -177.388 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' C' C ' 4' ' ' LEU . . . . . . . . . . . . . 19.7 tp -125.38 130.38 51.8 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 115.713 -0.676 . . . . 0.0 110.122 176.799 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' C' C ' 5' ' ' LYS . . . . . . . . . . . . . 61.4 mttp -108.4 120.16 41.6 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.483 -0.326 . . . . 0.0 110.66 179.534 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' C' C ' 6' ' ' LEU . . . . . . . . . . . . . 46.6 mt -114.36 147.17 39.57 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 115.499 -0.773 . . . . 0.0 110.459 -178.642 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' C' C ' 7' ' ' LYS . . . . . . . . . . . . . 83.2 tttt -135.15 135.97 23.82 Favored Pre-proline 0 CA--C 1.535 0.402 0 CA-C-O 118.87 -0.586 . . . . 0.0 109.88 175.901 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' C' C ' 8' ' ' PRO . . . . . . . . . . . . . 79.1 Cg_endo -90.5 143.25 3.65 Favored 'Trans proline' 0 N--CA 1.49 1.313 0 C-N-CA 121.745 1.63 . . . . 0.0 111.794 178.255 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' C' C ' 9' ' ' LEU . . . . . . . . . . . . . 41.2 mt -81.59 -48.75 0.99 Allowed Pre-proline 0 CA--C 1.534 0.359 0 CA-C-O 118.706 -0.664 . . . . 0.0 112.527 -178.601 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' C' C ' 10' ' ' PRO . . . . . . . . . . . . . 91.5 Cg_endo -78.97 154.68 25.96 Favored 'Trans proline' 0 N--CA 1.498 1.755 0 C-N-CA 121.113 1.209 . . . . 0.0 111.983 178.161 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' C' C ' 11' ' ' LYS . . . . . . . . . . . . . 72.4 tttt -88.46 94.26 9.81 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-N 116.345 -0.389 . . . . 0.0 110.499 179.47 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' C' C ' 12' ' ' VAL . . . . . . . . . . . . . 13.0 p -141.96 147.99 21.05 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.282 0 CA-C-N 116.236 -0.438 . . . . 0.0 110.533 -179.989 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' C' C ' 13' ' ' GLU . . . . . . . . . . . . . 84.3 tt0 -87.98 128.76 35.39 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.246 -0.434 . . . . 0.0 110.403 179.151 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' C' C ' 14' ' ' LEU . . . . . . . . . . . . . 19.2 mt -98.5 151.39 37.45 Favored Pre-proline 0 CA--C 1.533 0.296 0 CA-C-N 116.467 -0.333 . . . . 0.0 110.677 -178.438 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' C' C ' 15' ' ' PRO . . . . . . . . . . . . . 27.4 Cg_exo -61.84 161.25 26.02 Favored 'Trans proline' 0 N--CA 1.497 1.714 0 C-N-CA 121.395 1.397 . . . . 0.0 112.042 177.298 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' C' C ' 16' ' ' PRO . . . . . . . . . . . . . 26.0 Cg_exo -61.51 -38.55 62.13 Favored 'Trans proline' 0 N--CA 1.497 1.705 0 C-N-CA 121.412 1.408 . . . . 0.0 112.699 179.97 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' C' C ' 17' ' ' ASP . . . . . . . . . . . . . 21.3 p-10 -84.84 9.26 14.71 Favored 'General case' 0 CA--C 1.535 0.403 0 N-CA-C 113.232 0.827 . . . . 0.0 113.232 -176.951 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' C' C ' 18' ' ' PHE . . . . . . . . . . . . . 45.1 t80 -56.83 -48.06 78.89 Favored 'General case' 0 N--CA 1.456 -0.14 0 O-C-N 121.978 -0.451 . . . . 0.0 110.662 -177.287 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' C' C ' 19' ' ' VAL . . . . . 0.416 HG13 ' N ' ' C' ' 20' ' ' ASP . 14.9 p -54.82 -43.15 66.19 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.259 0 C-N-CA 121.007 -0.277 . . . . 0.0 111.441 -176.404 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' C' C ' 20' ' ' ASP . . . . . 0.416 ' N ' HG13 ' C' ' 19' ' ' VAL . 42.1 m-20 -62.37 -43.28 99.19 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-O 120.759 0.314 . . . . 0.0 111.217 -177.637 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' C' C ' 21' ' ' VAL . . . . . . . . . . . . . 47.9 t -64.63 -44.38 96.7 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.288 0 C-N-CA 120.637 -0.425 . . . . 0.0 110.534 -177.199 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' C' C ' 22' ' ' ILE . . . . . 0.684 HG22 HD12 ' C' ' 26' ' ' LEU . 50.8 mm -56.16 -46.7 81.23 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.21 0 C-N-CA 121.029 -0.268 . . . . 0.0 110.477 178.313 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' C' C ' 23' ' ' ARG . . . . . . . . . . . . . 55.3 ttp180 -54.21 -48.45 71.02 Favored 'General case' 0 C--N 1.33 -0.28 0 C-N-CA 121.06 -0.256 . . . . 0.0 111.336 -178.754 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' C' C ' 24' ' ' ILE . . . . . . . . . . . . . 73.8 mt -59.89 -43.93 93.21 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.331 0 CA-C-N 116.685 -0.234 . . . . 0.0 111.249 -177.815 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' C' C ' 25' ' ' LYS . . . . . . . . . . . . . 80.6 mttt -67.66 -40.43 84.49 Favored 'General case' 0 C--N 1.328 -0.352 0 N-CA-C 112.666 0.617 . . . . 0.0 112.666 -177.164 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' C' C ' 26' ' ' LEU . . . . . 0.684 HD12 HG22 ' C' ' 22' ' ' ILE . 36.8 mt -79.19 -39.43 33.38 Favored 'General case' 0 C--N 1.33 -0.274 0 N-CA-C 113.303 0.853 . . . . 0.0 113.303 -171.849 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' C' C ' 27' ' ' GLN . . . . . . . . . . . . . 14.1 pt20 -46.62 140.76 4.2 Favored 'General case' 0 N--CA 1.47 0.533 0 N-CA-C 112.732 0.641 . . . . 0.0 112.732 -175.088 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' C' C ' 28' ' ' GLY . . . . . . . . . . . . . . . 100.97 -24.82 30.61 Favored Glycine 0 CA--C 1.532 1.136 0 CA-C-N 115.388 -0.824 . . . . 0.0 112.31 -177.2 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' C' C ' 29' ' ' LYS . . . . . . . . . . . . . 69.0 mttm -97.42 155.07 17.08 Favored 'General case' 0 C--N 1.331 -0.202 0 CA-C-N 117.609 0.705 . . . . 0.0 110.904 177.317 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' C' C ' 30' ' ' THR . . . . . . . . . . . . . 13.8 m -106.6 133.69 50.9 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.07 -0.514 . . . . 0.0 109.624 175.257 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' C' C ' 31' ' ' VAL . . . . . . . . . . . . . 34.4 m -130.2 156.63 42.45 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.278 0 CA-C-O 120.982 0.42 . . . . 0.0 110.94 -176.823 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' C' C ' 32' ' ' ARG . . . . . . . . . . . . . 36.0 mtp180 -129.77 153.59 48.07 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-O 121.433 0.635 . . . . 0.0 110.84 179.476 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' C' C ' 33' ' ' THR . . . . . . . . . . . . . 24.5 m -53.84 138.85 35.09 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-N 115.907 -0.588 . . . . 0.0 111.231 -179.664 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' C' C ' 34' ' ' GLY . . . . . . . . . . . . . . . 100.95 -17.04 56.85 Favored Glycine 0 CA--C 1.532 1.136 0 CA-C-O 119.678 -0.512 . . . . 0.0 113.307 179.411 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' C' C ' 35' ' ' ASP . . . . . . . . . . . . . 62.7 m-20 -65.58 149.9 49.32 Favored 'General case' 0 C--O 1.232 0.155 0 CA-C-N 118.036 0.918 . . . . 0.0 111.315 179.496 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' C' C ' 36' ' ' VAL . . . . . . . . . . . . . 46.3 t -119.01 128.97 75.78 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.232 0 CA-C-N 115.779 -0.646 . . . . 0.0 109.686 177.836 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' C' C ' 37' ' ' ILE . . . . . . . . . . . . . 70.1 mt -120.35 139.42 47.7 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.255 0 CA-C-N 116.274 -0.421 . . . . 0.0 109.939 -178.568 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' C' C ' 38' ' ' GLY . . . . . . . . . . . . . . . -113.03 128.88 8.61 Favored Glycine 0 CA--C 1.526 0.763 0 N-CA-C 110.977 -0.849 . . . . 0.0 110.977 -179.924 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' C' C ' 39' ' ' ILE . . . . . . . . . . . . . 75.1 mt -123.24 136.97 58.18 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.243 0 N-CA-C 110.085 -0.339 . . . . 0.0 110.085 179.16 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' C' C ' 40' ' ' SER . . . . . . . . . . . . . 84.0 p -93.13 124.24 36.97 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.359 -0.382 . . . . 0.0 110.95 175.883 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' C' C ' 41' ' ' ILE . . . . . . . . . . . . . 72.7 mt -127.5 113.1 30.25 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.225 0 CA-C-O 120.925 0.393 . . . . 0.0 110.213 177.262 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' C' C ' 42' ' ' LEU . . . . . 0.535 ' O ' HD23 ' C' ' 42' ' ' LEU . 1.3 tt 49.4 47.46 22.38 Favored 'General case' 0 CA--C 1.533 0.318 0 CA-C-O 121.529 0.68 . . . . 0.0 111.357 177.73 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' C' C ' 43' ' ' GLY . . . . . . . . . . . . . . . 70.68 24.16 77.16 Favored Glycine 0 CA--C 1.53 1.01 0 C-N-CA 121.116 -0.564 . . . . 0.0 112.563 175.946 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' C' C ' 44' ' ' LYS . . . . . . . . . . . . . 17.0 ttmm -132.14 129.5 39.93 Favored 'General case' 0 C--N 1.331 -0.215 0 CA-C-N 117.515 0.658 . . . . 0.0 109.956 179.049 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' C' C ' 45' ' ' GLU . . . . . . . . . . . . . 81.6 tt0 -84.07 125.79 32.45 Favored 'General case' 0 C--N 1.327 -0.381 0 C-N-CA 120.856 -0.338 . . . . 0.0 111.148 -177.787 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' C' C ' 46' ' ' VAL . . . . . . . . . . . . . 7.4 p -123.22 129.68 74.76 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.19 0 N-CA-C 109.614 -0.513 . . . . 0.0 109.614 174.773 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' C' C ' 47' ' ' LYS . . . . . . . . . . . . . 64.1 mttp -99.67 129.98 45.85 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.117 -0.492 . . . . 0.0 111.157 177.757 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' C' C ' 48' ' ' PHE . . . . . . . . . . . . . 92.8 m-85 -113.04 132.05 55.55 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 115.792 -0.64 . . . . 0.0 109.769 175.276 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' C' C ' 49' ' ' LYS . . . . . . . . . . . . . 84.1 tttt -106.13 135.43 47.61 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.412 -0.358 . . . . 0.0 110.142 179.359 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' C' C ' 50' ' ' VAL . . . . . . . . . . . . . 44.9 t -81.41 108.13 14.31 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.321 0 N-CA-C 109.304 -0.628 . . . . 0.0 109.304 176.749 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' C' C ' 51' ' ' VAL . . . . . . . . . . . . . 44.0 t -73.31 -51.23 26.6 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.333 0 CA-C-N 116.079 -0.51 . . . . 0.0 109.843 -174.302 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' C' C ' 52' ' ' GLN . . . . . . . . . . . . . 91.3 mt-30 -152.9 151.84 30.83 Favored 'General case' 0 C--N 1.333 -0.148 0 CA-C-O 121.095 0.474 . . . . 0.0 111.743 -178.104 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' C' C ' 53' ' ' ALA . . . . . . . . . . . . . . . -130.05 131.95 46.0 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 115.374 -0.83 . . . . 0.0 109.841 174.525 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' C' C ' 54' ' ' TYR . . . . . . . . . . . . . 15.5 t80 -129.16 111.34 18.24 Favored Pre-proline 0 CA--C 1.536 0.41 0 CA-C-O 118.159 -0.924 . . . . 0.0 110.33 177.423 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' C' C ' 55' ' ' PRO . . . . . . . . . . . . . 73.4 Cg_endo -77.26 167.0 80.73 Favored 'Cis proline' 0 N--CA 1.501 1.92 0 CA-C-N 122.03 1.761 . . . . 0.0 112.356 -6.056 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' C' C ' 56' ' ' SER . . . . . . . . . . . . . 13.6 m -116.89 130.73 24.37 Favored Pre-proline 0 CA--C 1.538 0.503 0 CA-C-O 118.384 -0.817 . . . . 0.0 109.158 174.086 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' C' C ' 57' ' ' PRO . . . . . . . . . . . . . 42.7 Cg_endo -68.42 146.99 80.38 Favored 'Cis proline' 0 N--CA 1.497 1.706 0 CA-C-N 122.011 1.754 . . . . 0.0 111.527 -0.353 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' C' C ' 58' ' ' LEU . . . . . . . . . . . . . 22.7 tp -107.36 135.44 48.84 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.145 -0.479 . . . . 0.0 110.403 -178.876 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' C' C ' 59' ' ' ARG . . . . . . . . . . . . . 48.6 ttt180 -102.08 122.92 45.05 Favored 'General case' 0 C--N 1.326 -0.433 0 N-CA-C 109.134 -0.691 . . . . 0.0 109.134 176.707 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' C' C ' 60' ' ' VAL . . . . . . . . . . . . . 43.8 t -78.26 117.53 23.77 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.207 0 C-N-CA 120.633 -0.427 . . . . 0.0 110.084 -175.565 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' C' C ' 61' ' ' GLU . . . . . . . . . . . . . 95.8 mt-10 -131.06 162.92 28.77 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.025 -0.534 . . . . 0.0 109.992 178.355 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' C' C ' 62' ' ' ASP . . . . . . . . . . . . . 10.0 t0 -53.55 -32.16 49.58 Favored 'General case' 0 C--N 1.327 -0.402 0 N-CA-C 111.834 0.309 . . . . 0.0 111.834 -179.117 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' C' C ' 63' ' ' ARG . . . . . . . . . . . . . 33.6 ptt180 -84.11 3.43 34.81 Favored 'General case' 0 CA--C 1.536 0.424 0 N-CA-C 113.762 1.023 . . . . 0.0 113.762 -174.972 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' C' C ' 64' ' ' THR . . . . . . . . . . . . . 34.8 m -86.53 139.26 31.03 Favored 'General case' 0 C--O 1.232 0.144 0 CA-C-N 118.171 0.442 . . . . 0.0 110.742 -178.003 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' C' C ' 65' ' ' LYS . . . . . . . . . . . . . 98.7 mttt -89.35 127.67 35.83 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.157 -0.474 . . . . 0.0 110.205 178.918 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' C' C ' 66' ' ' ILE . . . . . . . . . . . . . 63.8 mt -114.06 127.46 71.46 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.269 0 N-CA-C 109.638 -0.505 . . . . 0.0 109.638 179.995 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' C' C ' 67' ' ' THR . . . . . . . . . . . . . 22.6 m -123.5 139.24 54.22 Favored 'General case' 0 C--N 1.331 -0.216 0 CA-C-N 116.223 -0.444 . . . . 0.0 110.818 -177.459 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' C' C ' 68' ' ' LEU . . . . . . . . . . . . . 30.4 mt -102.22 126.68 49.27 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 115.881 -0.6 . . . . 0.0 110.124 178.126 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' C' C ' 69' ' ' VAL . . . . . . . . . . . . . 43.8 t -101.27 104.11 15.82 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.334 0 N-CA-C 109.765 -0.458 . . . . 0.0 109.765 179.253 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' C' C ' 70' ' ' THR . . . . . 0.442 HG23 ' O ' ' C' ' 70' ' ' THR . 9.9 t -149.98 123.86 9.3 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 116.055 -0.52 . . . . 0.0 110.586 179.402 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' C' C ' 71' ' ' HIS . . . . . . . . . . . . . 91.0 m-70 -147.21 67.17 10.65 Favored Pre-proline 0 C--N 1.328 -0.348 0 C-N-CA 120.848 -0.341 . . . . 0.0 110.855 178.164 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' C' C ' 72' ' ' PRO . . . . . . . . . . . . . 82.0 Cg_endo -93.46 156.91 2.47 Favored 'Trans proline' 0 N--CA 1.487 1.116 0 C-N-CA 121.955 1.77 . . . . 0.0 111.731 176.751 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' C' C ' 73' ' ' VAL . . . . . . . . . . . . . 27.6 m -80.73 140.25 16.93 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.258 0 CA-C-O 121.118 0.485 . . . . 0.0 110.348 178.577 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' C' C ' 74' ' ' ASP . . . . . . . . . . . . . 13.6 t70 -89.76 119.85 30.51 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 115.743 -0.662 . . . . 0.0 109.717 179.854 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' C' C ' 75' ' ' VAL . . . . . . . . . . . . . 45.1 t -110.43 121.15 62.72 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.203 0 CA-C-O 121.204 0.526 . . . . 0.0 110.327 -178.56 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' C' C ' 76' ' ' LEU . . . . . . . . . . . . . 18.6 mt -121.08 141.69 50.54 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 115.377 -0.829 . . . . 0.0 109.192 177.468 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' C' C ' 77' ' ' GLU . . . . . . . . . . . . . 97.9 mt-10 -134.14 134.02 41.71 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-O 121.204 0.526 . . . . 0.0 111.338 -177.425 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' C' C ' 78' ' ' ALA . . . . . 0.517 ' HB2' HD21 ' C' ' 109' ' ' LEU . . . -122.9 129.51 51.7 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 115.455 -0.793 . . . . 0.0 109.654 176.593 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' C' C ' 79' ' ' LYS . . . . . 0.676 ' O ' HD13 ' C' ' 80' ' ' ILE . 80.6 tttt -73.98 119.7 18.55 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.477 -0.328 . . . . 0.0 110.241 -179.013 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' C' C ' 80' ' ' ILE . . . . . 0.676 HD13 ' O ' ' C' ' 79' ' ' LYS . 35.7 mm -139.13 116.21 10.86 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.304 0 N-CA-C 109.403 -0.591 . . . . 0.0 109.403 -176.279 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' C' C ' 81' ' ' LYS . . . . . . . . . . . . . 21.1 pttp -110.73 124.18 51.47 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-O 121.246 0.546 . . . . 0.0 111.284 -177.033 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' C' C ' 82' ' ' GLY . . . . . . . . . . . . . . . 89.2 42.09 5.67 Favored Glycine 0 CA--C 1.528 0.854 0 CA-C-N 115.675 -0.693 . . . . 0.0 112.053 175.677 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' C' C ' 83' ' ' ILE . . . . . . . . . . . . . 68.2 mt -69.56 137.09 24.87 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.248 0 N-CA-C 109.487 -0.56 . . . . 0.0 109.487 176.498 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' C' C ' 84' ' ' LYS . . . . . . . . . . . . . 28.1 ttpp -103.68 -52.13 3.04 Favored 'General case' 0 C--N 1.331 -0.201 0 CA-C-O 120.852 0.358 . . . . 0.0 110.524 -179.104 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' C' C ' 85' ' ' ASP . . . . . . . . . . . . . 13.3 t70 -143.54 145.31 32.44 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.077 -0.511 . . . . 0.0 110.653 -178.597 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' C' C ' 86' ' ' VAL . . . . . . . . . . . . . 44.4 t -127.66 129.2 70.15 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.234 0 CA-C-O 120.871 0.367 . . . . 0.0 110.382 179.89 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' C' C ' 87' ' ' ILE . . . . . . . . . . . . . 43.9 mm -118.5 123.98 72.41 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.26 0 CA-C-N 116.041 -0.527 . . . . 0.0 109.604 176.598 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' C' C ' 88' ' ' LEU . . . . . . . . . . . . . 68.2 mt -113.66 137.22 51.91 Favored 'General case' 0 C--N 1.331 -0.201 0 CA-C-O 121.081 0.467 . . . . 0.0 111.687 -176.347 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' C' C ' 89' ' ' ASP . . . . . . . . . . . . . 10.2 t70 -132.62 156.35 47.08 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 115.631 -0.713 . . . . 0.0 109.204 174.352 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' C' C ' 90' ' ' GLU . . . . . . . . . . . . . 82.0 tt0 -47.4 -41.62 20.35 Favored 'General case' 0 N--CA 1.464 0.228 0 N-CA-C 112.95 0.722 . . . . 0.0 112.95 -171.633 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' C' C ' 91' ' ' ASN . . . . . . . . . . . . . 15.7 p-10 -132.14 38.49 3.49 Favored 'General case' 0 N--CA 1.465 0.298 0 CA-C-O 120.821 0.343 . . . . 0.0 111.345 -177.934 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' C' C ' 92' ' ' LEU . . . . . . . . . . . . . 20.7 tp -164.74 139.88 5.5 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.59 -0.277 . . . . 0.0 110.258 -178.872 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' C' C ' 93' ' ' ILE . . . . . . . . . . . . . 66.3 mt -130.18 124.2 57.53 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.221 0 N-CA-C 109.576 -0.527 . . . . 0.0 109.576 -177.886 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' C' C ' 94' ' ' VAL . . . . . 0.579 HG21 HG11 ' C' ' 125' ' ' VAL . 46.7 t -125.81 127.91 71.69 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.265 0 N-CA-C 109.848 -0.427 . . . . 0.0 109.848 178.551 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' C' C ' 95' ' ' VAL . . . . . . . . . . . . . 42.4 t -122.08 136.09 60.06 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.283 0 CA-C-N 115.979 -0.555 . . . . 0.0 109.852 -179.089 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' C' C ' 96' ' ' ILE . . . . . . . . . . . . . 60.4 mt -116.12 127.61 73.66 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.328 0 N-CA-C 109.348 -0.612 . . . . 0.0 109.348 179.51 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' C' C ' 97' ' ' THR . . . . . . . . . . . . . 80.6 p -99.3 157.7 16.22 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-O 120.983 0.42 . . . . 0.0 110.952 -177.81 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' C' C ' 98' ' ' GLU . . . . . . . . . . . . . 96.2 mt-10 -53.98 -25.54 21.41 Favored 'General case' 0 CA--C 1.534 0.336 0 N-CA-C 112.306 0.484 . . . . 0.0 112.306 -179.03 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' C' C ' 99' ' ' GLU . . . . . . . . . . . . . 95.7 mt-10 -79.39 15.79 1.17 Allowed 'General case' 0 CA--C 1.535 0.379 0 N-CA-C 113.197 0.814 . . . . 0.0 113.197 -177.541 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' C' C ' 100' ' ' ASN . . . . . . . . . . . . . 2.6 m-20 62.05 37.27 14.87 Favored 'General case' 0 C--O 1.233 0.216 0 CA-C-O 121.076 0.465 . . . . 0.0 111.064 178.948 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' C' C ' 101' ' ' GLU . . . . . . . . . . . . . 83.6 tt0 -111.96 143.04 43.6 Favored 'General case' 0 C--N 1.333 -0.147 0 N-CA-C 109.611 -0.514 . . . . 0.0 109.611 176.436 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' C' C ' 102' ' ' VAL . . . . . . . . . . . . . 43.7 t -114.97 123.76 70.97 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.275 0 CA-C-N 116.123 -0.489 . . . . 0.0 109.833 -178.753 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' C' C ' 103' ' ' LEU . . . . . . . . . . . . . 69.1 mt -116.58 127.53 54.58 Favored 'General case' 0 C--N 1.331 -0.207 0 CA-C-N 115.76 -0.654 . . . . 0.0 109.902 176.086 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' C' C ' 104' ' ' ILE . . . . . . . . . . . . . 65.2 mt -114.84 123.41 70.49 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.289 0 N-CA-C 109.855 -0.424 . . . . 0.0 109.855 -179.665 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' C' C ' 105' ' ' PHE . . . . . . . . . . . . . 81.9 m-85 -123.53 162.1 23.58 Favored 'General case' 0 C--N 1.331 -0.226 0 O-C-N 123.864 0.728 . . . . 0.0 109.788 -178.333 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' C' C ' 106' ' ' ASN . . . . . . . . . . . . . 38.9 p30 -98.03 -173.98 2.74 Favored 'General case' 0 C--N 1.328 -0.334 0 N-CA-C 109.553 -0.536 . . . . 0.0 109.553 173.942 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' C' C ' 107' ' ' GLN . . . . . . . . . . . . . 45.7 tt0 -59.37 -29.06 67.42 Favored 'General case' 0 CA--C 1.532 0.264 0 N-CA-C 112.004 0.372 . . . . 0.0 112.004 -179.836 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' C' C ' 108' ' ' ASN . . . . . . . . . . . . . 52.9 t30 -81.94 8.59 10.07 Favored 'General case' 0 CA--C 1.537 0.472 0 N-CA-C 113.14 0.792 . . . . 0.0 113.14 -177.485 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' C' C ' 109' ' ' LEU . . . . . 0.517 HD21 ' HB2' ' C' ' 78' ' ' ALA . 13.2 tp 58.9 40.45 22.63 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-O 121.293 0.568 . . . . 0.0 110.981 178.425 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' C' C ' 110' ' ' GLU . . . . . . . . . . . . . 95.9 mt-10 -110.26 147.39 33.92 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.05 -0.523 . . . . 0.0 109.711 174.089 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' C' C ' 111' ' ' GLU . . . . . . . . . . . . . 55.5 tt0 -82.58 121.96 27.48 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.402 -0.363 . . . . 0.0 110.497 -176.043 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' C' C ' 112' ' ' LEU . . . . . . . . . . . . . 24.3 mt -105.37 -46.09 4.3 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.079 -0.51 . . . . 0.0 110.892 -179.549 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' C' C ' 113' ' ' TYR . . . . . . . . . . . . . 55.3 t80 -135.54 140.45 44.73 Favored 'General case' 0 C--N 1.331 -0.239 0 CA-C-N 116.221 -0.445 . . . . 0.0 110.805 -178.881 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' C' C ' 114' ' ' ARG . . . . . . . . . . . . . 36.1 ptt180 -143.61 120.88 11.56 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-O 121.183 0.516 . . . . 0.0 110.902 178.327 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' C' C ' 115' ' ' GLY . . . . . . . . . . . . . . . -150.19 163.04 29.4 Favored Glycine 0 CA--C 1.524 0.631 0 N-CA-C 110.866 -0.894 . . . . 0.0 110.866 -179.328 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' C' C ' 116' ' ' LYS . . . . . . . . . . . . . 40.0 ttpt -128.75 136.13 50.15 Favored 'General case' 0 C--N 1.33 -0.266 0 O-C-N 122.616 -0.343 . . . . 0.0 110.082 177.439 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' C' C ' 117' ' ' PHE . . . . . . . . . . . . . 61.9 m-85 -132.2 114.24 14.24 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-O 120.902 0.382 . . . . 0.0 110.448 -176.263 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' C' C ' 118' ' ' GLU . . . . . . . . . . . . . 70.8 mm-40 -53.47 -50.88 64.38 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.447 -0.342 . . . . 0.0 111.499 -176.205 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' C' C ' 119' ' ' ASN . . . . . . . . . . . . . 83.1 m-20 -94.73 31.06 1.88 Allowed 'General case' 0 C--N 1.329 -0.31 0 N-CA-C 112.187 0.44 . . . . 0.0 112.187 -174.083 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' C' C ' 120' ' ' LEU . . . . . . . . . . . . . 16.7 tp -56.46 124.71 19.1 Favored 'General case' 0 C--O 1.232 0.161 0 CA-C-O 120.659 0.266 . . . . 0.0 110.556 178.484 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' C' C ' 121' ' ' ASN . . . . . . . . . . . . . 35.5 m120 -114.03 -43.97 3.2 Favored 'General case' 0 C--N 1.332 -0.167 0 CA-C-N 116.483 -0.326 . . . . 0.0 111.044 -177.871 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' C' C ' 122' ' ' LYS . . . . . . . . . . . . . 55.5 mttm -145.3 148.09 33.06 Favored 'General case' 0 C--N 1.33 -0.239 0 CA-C-O 121.071 0.463 . . . . 0.0 111.815 -176.937 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' C' C ' 123' ' ' VAL . . . . . . . . . . . . . 45.4 t -128.0 124.23 62.29 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 N-CA-C 108.909 -0.774 . . . . 0.0 108.909 171.965 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' C' C ' 124' ' ' LEU . . . . . . . . . . . . . 11.3 tp -123.29 135.66 54.33 Favored 'General case' 0 C--N 1.332 -0.185 0 CA-C-O 120.765 0.317 . . . . 0.0 110.914 -174.941 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' C' C ' 125' ' ' VAL . . . . . 0.773 HG12 HG23 ' C' ' 130' ' ' VAL . 35.7 m -131.34 139.18 51.46 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.229 0 CA-C-N 116.225 -0.443 . . . . 0.0 110.886 -179.507 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' C' C ' 126' ' ' ARG . . . . . . . . . . . . . 89.0 mtt180 -146.6 125.07 12.37 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.167 -0.469 . . . . 0.0 110.51 175.83 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' C' C ' 127' ' ' ASN . . . . . . . . . . . . . 29.2 t30 51.62 -109.31 0.43 Allowed 'General case' 0 CA--C 1.545 0.753 0 CA-C-O 118.824 -0.608 . . . . 0.0 111.199 -179.989 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' C' C ' 128' ' ' ASP . . . . . . . . . . . . . 14.3 p-10 -114.01 5.76 16.22 Favored 'General case' 0 N--CA 1.468 0.438 0 CA-C-N 119.818 1.19 . . . . 0.0 113.413 -177.918 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' C' C ' 129' ' ' LEU . . . . . . . . . . . . . 13.2 tp -109.89 136.6 48.93 Favored 'General case' 0 C--N 1.334 -0.108 0 N-CA-C 109.718 -0.475 . . . . 0.0 109.718 179.445 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' C' C ' 130' ' ' VAL . . . . . 0.773 HG23 HG12 ' C' ' 125' ' ' VAL . 12.9 p -129.54 140.7 48.42 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.205 0 CA-C-O 121.047 0.451 . . . . 0.0 110.46 -179.521 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' C' C ' 131' ' ' VAL . . . . . . . . . . . . . 43.0 t -135.72 138.29 48.07 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.314 0 CA-C-O 121.125 0.488 . . . . 0.0 110.18 179.689 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' C' C ' 132' ' ' ILE . . . . . . . . . . . . . 69.2 mt -110.64 131.23 62.34 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.328 0 CA-C-N 115.527 -0.76 . . . . 0.0 109.11 179.335 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' C' C ' 133' ' ' ILE . . . . . . . . . . . . . 42.4 mm -115.22 119.75 62.69 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.222 0 CA-C-O 120.859 0.361 . . . . 0.0 110.893 -174.716 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' C' C ' 134' ' ' ASP . . . . . . . . . . . . . 8.0 p-10 -132.17 144.24 50.53 Favored 'General case' 0 C--N 1.33 -0.253 0 N-CA-C 109.271 -0.64 . . . . 0.0 109.271 174.7 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' C' C ' 135' ' ' GLU . . . . . . . . . . . . . 84.2 tt0 -49.97 -26.41 4.2 Favored 'General case' 0 C--N 1.327 -0.395 0 N-CA-C 112.774 0.657 . . . . 0.0 112.774 -173.643 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' C' C ' 136' ' ' GLN . . . . . . . . . . . . . 62.8 tt0 -78.95 -36.59 41.39 Favored 'General case' 0 CA--C 1.531 0.217 0 N-CA-C 112.196 0.443 . . . . 0.0 112.196 -177.237 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' C' C ' 137' ' ' LYS . . . . . . . . . . . . . 34.5 pttt -167.27 172.29 9.96 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-O 121.482 0.658 . . . . 0.0 112.025 -173.258 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' C' C ' 138' ' ' LEU . . . . . 0.433 HD23 ' C ' ' C' ' 138' ' ' LEU . 7.1 tt -117.01 128.78 55.52 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 115.223 -0.899 . . . . 0.0 109.953 179.213 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' C' C ' 139' ' ' THR . . . . . . . . . . . . . 32.7 m -110.46 123.47 49.97 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.164 178.885 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' C' C ' 140' ' ' LEU . . . . . 0.479 ' C ' HD23 ' C' ' 140' ' ' LEU . 7.0 tt -107.95 123.11 48.13 Favored 'General case' 0 C--N 1.327 -0.408 0 N-CA-C 108.947 -0.76 . . . . 0.0 108.947 -179.49 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' C' C ' 141' ' ' ILE . . . . . 0.456 ' HB ' HG13 ' C' ' 130' ' ' VAL . 20.0 mt -124.96 118.64 53.71 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.248 0 CA-C-O 121.205 0.526 . . . . 0.0 109.944 -176.448 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' C' C ' 142' ' ' ARG . . . . . . . . . . . . . 67.1 ttt-85 -103.7 118.46 36.77 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 115.221 -0.9 . . . . 0.0 109.929 178.919 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' C' C ' 143' ' ' THR . . . . . . . . . . . . . 70.7 p . . . . . 0 C--O 1.22 -0.493 0 CA-C-O 117.975 -1.012 . . . . 0.0 110.565 -179.19 . . . . . . . . 0 0 . 1 . 003 nuclear build full ' D' D ' -3' ' ' GLU . . . . . . . . . . . . . 84.7 tt0 . . . . . 0 N--CA 1.49 1.571 0 N-CA-C 109.35 -0.611 . . . . 0.0 109.35 . . . . . . . . . 0 0 . 1 . 003 nuclear build full ' D' D ' -2' ' ' GLY . . . . . . . . . . . . . . . -67.21 134.92 31.49 Favored Glycine 0 CA--C 1.525 0.716 0 N-CA-C 110.999 -0.841 . . . . 0.0 110.999 -179.935 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' D' D ' -1' ' ' VAL . . . . . . . . . . . . . 42.8 t -96.82 139.79 18.77 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.358 0 N-CA-C 110.063 -0.347 . . . . 0.0 110.063 179.556 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' D' D ' 0' ' ' ILE . . . . . . . . . . . . . 45.0 mm -103.17 133.34 47.27 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.251 0 CA-C-N 116.334 -0.394 . . . . 0.0 110.197 -179.817 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' D' D ' 1' ' ' MET . . . . . . . . . . . . . 25.4 ptm -94.89 156.35 16.39 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.055 -0.52 . . . . 0.0 110.747 -178.922 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' D' D ' 2' ' ' SER . . . . . . . . . . . . . 2.3 p -130.13 124.46 32.74 Favored 'General case' 0 C--N 1.331 -0.22 0 CA-C-N 116.124 -0.489 . . . . 0.0 110.271 178.217 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' D' D ' 3' ' ' GLU . . . . . . . . . . . . . 84.3 tt0 -140.03 141.24 36.3 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 115.778 -0.646 . . . . 0.0 110.983 -176.666 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' D' D ' 4' ' ' LEU . . . . . . . . . . . . . 12.6 tp -125.38 127.64 46.9 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-N 115.927 -0.579 . . . . 0.0 110.18 176.568 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' D' D ' 5' ' ' LYS . . . . . . . . . . . . . 98.8 mttt -108.8 121.58 45.38 Favored 'General case' 0 C--O 1.235 0.322 0 CA-C-N 116.532 -0.304 . . . . 0.0 110.905 179.931 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' D' D ' 6' ' ' LEU . . . . . . . . . . . . . 40.5 mt -114.02 148.32 37.19 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-N 115.352 -0.84 . . . . 0.0 110.289 179.989 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' D' D ' 7' ' ' LYS . . . . . . . . . . . . . 57.8 tttm -128.72 137.04 30.1 Favored Pre-proline 0 CA--C 1.535 0.383 0 CA-C-O 118.831 -0.604 . . . . 0.0 109.703 173.62 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' D' D ' 8' ' ' PRO . . . . . . . . . . . . . 90.8 Cg_endo -90.84 134.05 1.77 Allowed 'Trans proline' 0 N--CA 1.491 1.344 0 C-N-CA 121.7 1.6 . . . . 0.0 111.694 178.081 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' D' D ' 9' ' ' LEU . . . . . . . . . . . . . 35.5 mt -73.38 -46.98 7.69 Favored Pre-proline 0 CA--C 1.532 0.277 0 CA-C-O 118.701 -0.666 . . . . 0.0 112.056 -178.845 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' D' D ' 10' ' ' PRO . . . . . . . . . . . . . 91.7 Cg_endo -81.78 150.38 16.42 Favored 'Trans proline' 0 N--CA 1.495 1.614 0 C-N-CA 121.267 1.311 . . . . 0.0 111.64 174.61 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' D' D ' 11' ' ' LYS . . . . . . . . . . . . . 49.9 pttt -85.38 111.29 19.79 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-O 121.626 0.727 . . . . 0.0 110.606 178.367 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' D' D ' 12' ' ' VAL . . . . . . . . . . . . . 12.3 p -151.12 148.28 15.01 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.309 0 CA-C-N 115.57 -0.741 . . . . 0.0 110.348 179.339 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' D' D ' 13' ' ' GLU . . . . . . . . . . . . . 45.5 tp10 -94.0 122.16 36.23 Favored 'General case' 0 C--N 1.33 -0.282 0 N-CA-C 110.002 -0.37 . . . . 0.0 110.002 177.584 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' D' D ' 14' ' ' LEU . . . . . . . . . . . . . 46.4 mt -98.02 152.44 38.05 Favored Pre-proline 0 CA--C 1.532 0.272 0 CA-C-O 119.439 -0.315 . . . . 0.0 110.758 -177.558 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' D' D ' 15' ' ' PRO . . . . . . . . . . . . . 27.8 Cg_exo -61.13 159.84 28.69 Favored 'Trans proline' 0 N--CA 1.497 1.684 0 C-N-CA 121.315 1.343 . . . . 0.0 111.977 177.499 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' D' D ' 16' ' ' PRO . . . . . . . . . . . . . 29.8 Cg_exo -59.96 -36.36 90.31 Favored 'Trans proline' 0 N--CA 1.497 1.692 0 C-N-CA 121.434 1.423 . . . . 0.0 112.742 -178.536 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' D' D ' 17' ' ' ASP . . . . . . . . . . . . . 8.2 p-10 -88.18 8.88 24.95 Favored 'General case' 0 CA--C 1.536 0.404 0 N-CA-C 113.24 0.829 . . . . 0.0 113.24 -177.388 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' D' D ' 18' ' ' PHE . . . . . . . . . . . . . 43.6 t80 -58.16 -46.13 86.22 Favored 'General case' 0 CA--C 1.524 -0.031 0 O-C-N 121.887 -0.508 . . . . 0.0 109.973 -178.391 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' D' D ' 19' ' ' VAL . . . . . . . . . . . . . 13.8 p -57.47 -40.6 75.58 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.34 0 CA-C-N 116.121 -0.49 . . . . 0.0 110.723 -179.519 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' D' D ' 20' ' ' ASP . . . . . . . . . . . . . 22.2 m-20 -59.49 -43.14 93.39 Favored 'General case' 0 C--N 1.331 -0.228 0 C-N-CA 120.88 -0.328 . . . . 0.0 110.846 -178.143 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' D' D ' 21' ' ' VAL . . . . . . . . . . . . . 47.7 t -64.92 -46.3 92.14 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.246 0 C-N-CA 120.717 -0.393 . . . . 0.0 110.472 -178.192 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' D' D ' 22' ' ' ILE . . . . . 0.51 HG22 HD12 ' D' ' 26' ' ' LEU . 45.2 mm -59.33 -35.82 60.4 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.256 0 C-N-CA 120.843 -0.343 . . . . 0.0 110.98 -179.872 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' D' D ' 23' ' ' ARG . . . . . . . . . . . . . 33.1 ttp180 -59.45 -49.74 76.63 Favored 'General case' 0 C--N 1.33 -0.242 0 C-N-CA 120.621 -0.432 . . . . 0.0 110.19 176.789 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' D' D ' 24' ' ' ILE . . . . . . . . . . . . . 75.6 mt -61.34 -39.8 83.94 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.322 0 CA-C-N 116.155 -0.475 . . . . 0.0 112.085 -177.034 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' D' D ' 25' ' ' LYS . . . . . . . . . . . . . 10.2 ptmt -75.06 -40.43 60.29 Favored 'General case' 0 CA--C 1.535 0.38 0 C-N-CA 120.537 -0.465 . . . . 0.0 111.98 -175.144 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' D' D ' 26' ' ' LEU . . . . . 0.51 HD12 HG22 ' D' ' 22' ' ' ILE . 24.2 mt -79.04 -33.92 44.32 Favored 'General case' 0 C--N 1.331 -0.225 0 N-CA-C 113.337 0.866 . . . . 0.0 113.337 -172.978 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' D' D ' 27' ' ' GLN . . . . . . . . . . . . . 12.9 pt20 -46.55 139.66 4.91 Favored 'General case' 0 N--CA 1.47 0.527 0 N-CA-C 112.726 0.639 . . . . 0.0 112.726 -176.3 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' D' D ' 28' ' ' GLY . . . . . . . . . . . . . . . 100.24 -24.59 31.53 Favored Glycine 0 CA--C 1.534 1.231 0 CA-C-N 115.688 -0.687 . . . . 0.0 112.134 -174.287 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' D' D ' 29' ' ' LYS . . . . . . . . . . . . . 99.4 mttt -97.83 155.22 17.15 Favored 'General case' 0 C--N 1.333 -0.113 0 CA-C-N 117.334 0.567 . . . . 0.0 110.985 178.791 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' D' D ' 30' ' ' THR . . . . . . . . . . . . . 17.8 m -105.56 140.52 38.52 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 115.949 -0.569 . . . . 0.0 110.179 176.447 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' D' D ' 31' ' ' VAL . . . . . . . . . . . . . 35.1 m -126.66 149.51 31.73 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.224 0 CA-C-N 116.398 -0.365 . . . . 0.0 110.793 -179.393 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' D' D ' 32' ' ' ARG . . . . . . . . . . . . . 93.1 mtt180 -129.91 149.18 51.75 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-O 121.29 0.567 . . . . 0.0 110.431 179.348 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' D' D ' 33' ' ' THR . . . . . . . . . . . . . 21.2 m -53.24 137.49 34.37 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.169 -0.468 . . . . 0.0 111.546 -176.671 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' D' D ' 34' ' ' GLY . . . . . . . . . . . . . . . 99.31 -16.98 58.5 Favored Glycine 0 CA--C 1.531 1.067 0 C-N-CA 121.243 -0.503 . . . . 0.0 113.358 177.278 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' D' D ' 35' ' ' ASP . . . . . . . . . . . . . 81.3 m-20 -65.89 147.98 52.51 Favored 'General case' 0 C--O 1.231 0.117 0 CA-C-N 118.045 0.923 . . . . 0.0 111.127 -179.879 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' D' D ' 36' ' ' VAL . . . . . . . . . . . . . 46.4 t -119.95 129.5 75.36 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.266 0 CA-C-N 115.971 -0.559 . . . . 0.0 109.646 176.891 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' D' D ' 37' ' ' ILE . . . . . . . . . . . . . 63.0 mt -119.33 138.02 51.38 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.267 0 N-CA-C 109.864 -0.421 . . . . 0.0 109.864 -178.306 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' D' D ' 38' ' ' GLY . . . . . . . . . . . . . . . -115.77 128.2 7.92 Favored Glycine 0 CA--C 1.526 0.763 0 N-CA-C 110.881 -0.888 . . . . 0.0 110.881 179.04 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' D' D ' 39' ' ' ILE . . . . . . . . . . . . . 68.7 mt -126.15 127.42 70.85 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.223 0 N-CA-C 110.011 -0.366 . . . . 0.0 110.011 179.036 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' D' D ' 40' ' ' SER . . . . . . . . . . . . . 42.5 t -93.12 119.92 32.85 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.509 -0.314 . . . . 0.0 111.03 176.935 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' D' D ' 41' ' ' ILE . . . . . . . . . . . . . 71.6 mt -132.93 129.96 58.21 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.206 0 CA-C-O 120.795 0.331 . . . . 0.0 110.441 178.144 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' D' D ' 42' ' ' LEU . . . . . . . . . . . . . 74.0 mt 56.74 33.01 22.24 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.204 -0.453 . . . . 0.0 111.853 177.401 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' D' D ' 43' ' ' GLY . . . . . . . . . . . . . . . 72.85 24.81 75.34 Favored Glycine 0 CA--C 1.532 1.129 0 C-N-CA 121.149 -0.548 . . . . 0.0 112.55 177.712 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' D' D ' 44' ' ' LYS . . . . . . . . . . . . . 67.3 mttm -136.85 127.01 26.2 Favored 'General case' 0 C--N 1.331 -0.214 0 CA-C-N 117.162 0.481 . . . . 0.0 109.899 178.001 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' D' D ' 45' ' ' GLU . . . . . . . . . . . . . 39.2 tp10 -85.53 126.29 33.74 Favored 'General case' 0 C--N 1.328 -0.349 0 C-N-CA 120.776 -0.369 . . . . 0.0 110.968 -178.979 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' D' D ' 46' ' ' VAL . . . . . . . . . . . . . 9.0 p -118.14 126.43 74.96 Favored 'Isoleucine or valine' 0 C--O 1.233 0.224 0 N-CA-C 109.417 -0.586 . . . . 0.0 109.417 174.778 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' D' D ' 47' ' ' LYS . . . . . . . . . . . . . 62.0 mttp -98.89 125.62 44.35 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 116.111 -0.495 . . . . 0.0 110.886 177.762 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' D' D ' 48' ' ' PHE . . . . . . . . . . . . . 38.4 m-85 -111.22 131.86 54.79 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 115.79 -0.641 . . . . 0.0 109.458 177.166 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' D' D ' 49' ' ' LYS . . . . . . . . . . . . . 46.0 tttp -105.44 133.33 50.37 Favored 'General case' 0 C--N 1.328 -0.355 0 N-CA-C 110.174 -0.306 . . . . 0.0 110.174 178.823 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' D' D ' 50' ' ' VAL . . . . . . . . . . . . . 44.0 t -77.94 103.44 5.01 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.299 0 N-CA-C 109.243 -0.651 . . . . 0.0 109.243 177.894 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' D' D ' 51' ' ' VAL . . . . . . . . . . . . . 48.1 t -72.21 -48.36 49.19 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.324 0 CA-C-N 116.105 -0.498 . . . . 0.0 110.068 -173.664 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' D' D ' 52' ' ' GLN . . . . . . . . . . . . . 62.6 tt0 -159.13 141.44 13.86 Favored 'General case' 0 C--N 1.33 -0.27 0 C-N-CA 120.298 -0.561 . . . . 0.0 111.749 -178.542 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' D' D ' 53' ' ' ALA . . . . . . . . . . . . . . . -120.66 132.41 55.09 Favored 'General case' 0 C--N 1.331 -0.2 0 CA-C-N 115.96 -0.564 . . . . 0.0 109.889 175.172 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' D' D ' 54' ' ' TYR . . . . . . . . . . . . . 71.5 t80 -129.05 111.17 18.37 Favored Pre-proline 0 CA--C 1.534 0.355 0 CA-C-O 118.231 -0.89 . . . . 0.0 110.522 179.522 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' D' D ' 55' ' ' PRO . . . . . . . . . . . . . 72.7 Cg_endo -77.24 169.9 72.89 Favored 'Cis proline' 0 N--CA 1.5 1.872 0 CA-C-N 121.945 1.73 . . . . 0.0 112.086 -7.417 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' D' D ' 56' ' ' SER . . . . . . . . . . . . . 13.7 m -119.27 134.32 23.73 Favored Pre-proline 0 CA--C 1.538 0.507 0 CA-C-O 118.51 -0.757 . . . . 0.0 109.403 174.219 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' D' D ' 57' ' ' PRO . . . . . . . . . . . . . 48.7 Cg_endo -69.85 144.7 77.56 Favored 'Cis proline' 0 N--CA 1.498 1.745 0 CA-C-N 121.857 1.699 . . . . 0.0 111.496 -0.695 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' D' D ' 58' ' ' LEU . . . . . . . . . . . . . 19.6 tp -106.75 134.55 49.72 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.369 -0.378 . . . . 0.0 110.57 -178.756 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' D' D ' 59' ' ' ARG . . . . . . . . . . . . . 19.9 ttm180 -103.59 125.52 50.17 Favored 'General case' 0 C--N 1.327 -0.395 0 N-CA-C 109.158 -0.682 . . . . 0.0 109.158 175.823 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' D' D ' 60' ' ' VAL . . . . . . . . . . . . . 43.1 t -82.23 123.51 38.29 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.25 0 C-N-CA 120.557 -0.457 . . . . 0.0 110.491 -175.659 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' D' D ' 61' ' ' GLU . . . . . . . . . . . . . 95.3 mt-10 -129.71 172.3 11.77 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 115.721 -0.672 . . . . 0.0 109.36 176.689 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' D' D ' 62' ' ' ASP . . . . . . . . . . . . . 69.2 m-20 -53.89 -32.37 53.11 Favored 'General case' 0 C--N 1.328 -0.332 0 C-N-CA 121.068 -0.253 . . . . 0.0 111.636 178.595 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' D' D ' 63' ' ' ARG . . . . . . . . . . . . . 40.7 ptt180 -83.86 -0.38 50.97 Favored 'General case' 0 CA--C 1.537 0.475 0 N-CA-C 113.754 1.02 . . . . 0.0 113.754 -176.037 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' D' D ' 64' ' ' THR . . . . . . . . . . . . . 25.3 m -76.31 132.11 39.61 Favored 'General case' 0 C--N 1.333 -0.127 0 CA-C-N 118.158 0.435 . . . . 0.0 110.733 -176.234 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' D' D ' 65' ' ' LYS . . . . . . . . . . . . . 36.5 ttpt -89.78 122.62 33.03 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.191 -0.459 . . . . 0.0 110.136 179.249 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' D' D ' 66' ' ' ILE . . . . . . . . . . . . . 61.9 mt -112.8 131.98 62.85 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.268 0 N-CA-C 109.918 -0.401 . . . . 0.0 109.918 -178.229 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' D' D ' 67' ' ' THR . . . . . . . . . . . . . 24.4 m -130.05 143.82 51.0 Favored 'General case' 0 C--O 1.234 0.268 0 CA-C-O 121.172 0.51 . . . . 0.0 111.496 -177.835 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' D' D ' 68' ' ' LEU . . . . . 0.475 ' C ' HD23 ' D' ' 68' ' ' LEU . 8.2 tt -101.09 127.02 47.82 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 115.656 -0.702 . . . . 0.0 109.553 175.908 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' D' D ' 69' ' ' VAL . . . . . . . . . . . . . 41.5 t -89.05 116.71 31.05 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.294 0 CA-C-O 121.124 0.488 . . . . 0.0 110.639 -177.036 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' D' D ' 70' ' ' THR . . . . . . . . . . . . . 10.0 t -150.1 143.83 25.34 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 115.643 -0.708 . . . . 0.0 109.833 175.565 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' D' D ' 71' ' ' HIS . . . . . . . . . . . . . 75.6 m80 -144.44 73.22 15.76 Favored Pre-proline 0 CA--C 1.535 0.391 0 C-N-CA 120.85 -0.34 . . . . 0.0 111.132 -178.326 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' D' D ' 72' ' ' PRO . . . . . . . . . . . . . 91.2 Cg_endo -88.21 146.93 6.48 Favored 'Trans proline' 0 N--CA 1.491 1.367 0 C-N-CA 121.635 1.557 . . . . 0.0 111.625 175.575 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' D' D ' 73' ' ' VAL . . . . . . . . . . . . . 27.4 m -69.92 147.6 11.64 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.209 0 CA-C-O 120.85 0.357 . . . . 0.0 110.41 179.278 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' D' D ' 74' ' ' ASP . . . . . . . . . . . . . 42.6 t0 -90.87 115.08 27.64 Favored 'General case' 0 C--N 1.326 -0.44 0 CA-C-N 115.981 -0.554 . . . . 0.0 109.719 179.471 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' D' D ' 75' ' ' VAL . . . . . . . . . . . . . 46.0 t -112.27 120.11 61.77 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.264 0 CA-C-O 121.238 0.542 . . . . 0.0 110.279 -178.943 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' D' D ' 76' ' ' LEU . . . . . . . . . . . . . 23.4 mt -122.67 144.33 49.21 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 115.408 -0.815 . . . . 0.0 109.446 179.53 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' D' D ' 77' ' ' GLU . . . . . . . . . . . . . 45.9 mt-10 -135.64 137.31 41.74 Favored 'General case' 0 N--CA 1.463 0.212 0 CA-C-O 121.219 0.533 . . . . 0.0 111.688 -176.914 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' D' D ' 78' ' ' ALA . . . . . 0.606 ' HB2' HD21 ' D' ' 109' ' ' LEU . . . -126.52 131.6 51.56 Favored 'General case' 0 C--N 1.332 -0.184 0 CA-C-N 115.507 -0.77 . . . . 0.0 109.725 175.558 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' D' D ' 79' ' ' LYS . . . . . 0.522 ' O ' HD13 ' D' ' 80' ' ' ILE . 64.7 mttp -81.32 118.46 22.66 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-O 120.832 0.349 . . . . 0.0 110.718 -177.913 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' D' D ' 80' ' ' ILE . . . . . 0.522 HD13 ' O ' ' D' ' 79' ' ' LYS . 24.8 mm -139.26 114.71 8.57 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.306 0 N-CA-C 109.57 -0.53 . . . . 0.0 109.57 -177.91 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' D' D ' 81' ' ' LYS . . . . . . . . . . . . . 97.9 mttt -98.64 123.71 43.0 Favored 'General case' 0 C--N 1.33 -0.28 0 C-N-CA 120.907 -0.317 . . . . 0.0 110.993 -179.938 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' D' D ' 82' ' ' GLY . . . . . . . . . . . . . . . 89.21 42.18 5.64 Favored Glycine 0 CA--C 1.524 0.654 0 C-N-CA 120.676 -0.773 . . . . 0.0 112.168 173.057 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' D' D ' 83' ' ' ILE . . . . . . . . . . . . . 73.5 mt -65.4 133.23 30.85 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.279 0 N-CA-C 109.314 -0.625 . . . . 0.0 109.314 175.194 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' D' D ' 84' ' ' LYS . . . . . . . . . . . . . 28.2 ttpp -97.71 -53.14 3.51 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-O 120.981 0.42 . . . . 0.0 110.51 -176.734 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' D' D ' 85' ' ' ASP . . . . . . . . . . . . . 13.9 t70 -147.54 146.67 29.53 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 115.868 -0.606 . . . . 0.0 110.396 -179.475 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' D' D ' 86' ' ' VAL . . . . . . . . . . . . . 45.0 t -128.91 129.39 68.17 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.299 0 CA-C-O 121.01 0.433 . . . . 0.0 110.545 -179.53 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' D' D ' 87' ' ' ILE . . . . . . . . . . . . . 43.6 mm -116.46 121.87 68.55 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.274 0 N-CA-C 109.087 -0.709 . . . . 0.0 109.087 175.451 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' D' D ' 88' ' ' LEU . . . . . . . . . . . . . 10.0 tp -114.93 131.58 56.84 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-O 121.047 0.451 . . . . 0.0 111.327 -174.907 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' D' D ' 89' ' ' ASP . . . . . . . . . . . . . 12.8 t70 -129.62 152.28 49.3 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 115.697 -0.683 . . . . 0.0 109.358 175.359 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' D' D ' 90' ' ' GLU . . . . . . . . . . . . . 95.9 mt-10 -50.65 -31.61 16.72 Favored 'General case' 0 C--N 1.328 -0.366 0 N-CA-C 112.477 0.547 . . . . 0.0 112.477 -173.115 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' D' D ' 91' ' ' ASN . . . . . . . . . . . . . 23.6 p30 -128.54 27.69 5.51 Favored 'General case' 0 N--CA 1.465 0.32 0 N-CA-C 112.607 0.595 . . . . 0.0 112.607 -175.779 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' D' D ' 92' ' ' LEU . . . . . . . . . . . . . 15.1 tp -166.11 143.11 5.24 Favored 'General case' 0 C--N 1.331 -0.196 0 C-N-CA 121.074 -0.25 . . . . 0.0 110.662 179.445 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' D' D ' 93' ' ' ILE . . . . . . . . . . . . . 75.6 mt -126.17 119.66 54.78 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.263 0 N-CA-C 109.552 -0.536 . . . . 0.0 109.552 178.082 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' D' D ' 94' ' ' VAL . . . . . . . . . . . . . 43.8 t -118.3 124.16 72.69 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.255 0 N-CA-C 109.627 -0.509 . . . . 0.0 109.627 178.954 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' D' D ' 95' ' ' VAL . . . . . . . . . . . . . 44.7 t -121.38 132.65 70.15 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.275 0 CA-C-N 116.233 -0.44 . . . . 0.0 109.934 -178.586 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' D' D ' 96' ' ' ILE . . . . . . . . . . . . . 67.7 mt -115.58 127.36 73.18 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 N-CA-C 109.244 -0.65 . . . . 0.0 109.244 179.128 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' D' D ' 97' ' ' THR . . . . . . . . . . . . . 80.5 p -101.47 159.68 15.08 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-O 121.364 0.602 . . . . 0.0 111.48 -176.18 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' D' D ' 98' ' ' GLU . . . . . . . . . . . . . 84.4 tt0 -53.95 -26.46 25.75 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 115.836 -0.62 . . . . 0.0 112.264 179.965 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' D' D ' 99' ' ' GLU . . . . . . . . . . . . . 43.3 mt-10 -79.49 15.64 1.24 Allowed 'General case' 0 CA--C 1.534 0.35 0 N-CA-C 113.115 0.783 . . . . 0.0 113.115 -177.169 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' D' D ' 100' ' ' ASN . . . . . . . . . . . . . 3.2 m-20 61.3 38.02 16.7 Favored 'General case' 0 N--CA 1.463 0.183 0 CA-C-O 121.16 0.505 . . . . 0.0 110.962 178.948 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' D' D ' 101' ' ' GLU . . . . . . . . . . . . . 84.1 tt0 -117.47 142.1 47.55 Favored 'General case' 0 C--N 1.333 -0.14 0 N-CA-C 109.636 -0.505 . . . . 0.0 109.636 176.308 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' D' D ' 102' ' ' VAL . . . . . . . . . . . . . 43.0 t -114.94 126.15 72.44 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.351 0 N-CA-C 109.947 -0.39 . . . . 0.0 109.947 -179.149 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' D' D ' 103' ' ' LEU . . . . . . . . . . . . . 45.7 mt -115.95 133.34 56.13 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 115.728 -0.669 . . . . 0.0 109.948 177.179 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' D' D ' 104' ' ' ILE . . . . . 0.641 HD13 HG11 ' D' ' 130' ' ' VAL . 68.2 mt -118.35 120.71 65.18 Favored 'Isoleucine or valine' 0 C--O 1.233 0.221 0 N-CA-C 110.112 -0.329 . . . . 0.0 110.112 -179.475 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' D' D ' 105' ' ' PHE . . . . . . . . . . . . . 55.8 m-85 -122.8 167.35 13.62 Favored 'General case' 0 C--N 1.332 -0.158 0 O-C-N 124.011 0.82 . . . . 0.0 109.933 -179.694 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' D' D ' 106' ' ' ASN . . . . . . . . . . . . . 41.2 p-10 -101.48 -170.84 1.89 Allowed 'General case' 0 C--N 1.331 -0.205 0 N-CA-C 109.95 -0.389 . . . . 0.0 109.95 172.922 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' D' D ' 107' ' ' GLN . . . . . . . . . . . . . 47.4 tt0 -60.57 -29.99 69.51 Favored 'General case' 0 C--N 1.33 -0.273 0 N-CA-C 111.904 0.335 . . . . 0.0 111.904 179.754 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' D' D ' 108' ' ' ASN . . . . . . . . . . . . . 4.0 t-20 -82.18 7.41 13.7 Favored 'General case' 0 CA--C 1.537 0.443 0 N-CA-C 113.143 0.794 . . . . 0.0 113.143 -178.026 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' D' D ' 109' ' ' LEU . . . . . 0.606 HD21 ' HB2' ' D' ' 78' ' ' ALA . 10.0 tp 62.31 36.67 14.45 Favored 'General case' 0 CA--C 1.53 0.204 0 CA-C-O 120.881 0.372 . . . . 0.0 111.393 178.082 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' D' D ' 110' ' ' GLU . . . . . . . . . . . . . 70.7 mm-40 -104.57 155.55 18.73 Favored 'General case' 0 C--N 1.33 -0.243 0 N-CA-C 109.503 -0.554 . . . . 0.0 109.503 175.348 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' D' D ' 111' ' ' GLU . . . . . . . . . . . . . 66.2 tt0 -91.07 124.68 35.48 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-O 120.982 0.42 . . . . 0.0 111.0 -176.003 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' D' D ' 112' ' ' LEU . . . . . . . . . . . . . 23.8 mt -108.77 -45.93 3.73 Favored 'General case' 0 C--N 1.331 -0.204 0 CA-C-N 116.097 -0.501 . . . . 0.0 110.861 179.264 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' D' D ' 113' ' ' TYR . . . . . 0.463 ' HB3' HD12 ' D' ' 104' ' ' ILE . 51.1 t80 -138.32 143.18 39.83 Favored 'General case' 0 N--CA 1.462 0.174 0 C-N-CA 120.835 -0.346 . . . . 0.0 111.074 -178.027 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' D' D ' 114' ' ' ARG . . . . . . . . . . . . . 36.2 ptt-85 -142.57 127.8 18.7 Favored 'General case' 0 C--N 1.331 -0.217 0 CA-C-N 116.274 -0.421 . . . . 0.0 110.85 177.094 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' D' D ' 115' ' ' GLY . . . . . . . . . . . . . . . -150.15 141.72 9.04 Favored Glycine 0 CA--C 1.524 0.621 0 N-CA-C 111.439 -0.665 . . . . 0.0 111.439 178.559 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' D' D ' 116' ' ' LYS . . . . . . . . . . . . . 39.5 ttpt -111.74 134.38 53.34 Favored 'General case' 0 C--N 1.331 -0.198 0 N-CA-C 109.485 -0.561 . . . . 0.0 109.485 175.101 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' D' D ' 117' ' ' PHE . . . . . . . . . . . . . 42.1 m-85 -135.79 113.95 11.4 Favored 'General case' 0 C--N 1.331 -0.225 0 CA-C-O 120.967 0.413 . . . . 0.0 110.394 -175.912 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' D' D ' 118' ' ' GLU . . . . . . . . . . . . . 70.7 mm-40 -55.13 -48.76 73.2 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.313 -0.403 . . . . 0.0 111.257 -175.811 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' D' D ' 119' ' ' ASN . . . . . . . . . . . . . 11.7 m-80 -96.01 31.05 2.23 Favored 'General case' 0 C--N 1.328 -0.344 0 N-CA-C 112.149 0.426 . . . . 0.0 112.149 -174.04 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' D' D ' 120' ' ' LEU . . . . . . . . . . . . . 15.7 tp -56.48 122.23 11.48 Favored 'General case' 0 C--N 1.332 -0.175 0 CA-C-O 120.686 0.279 . . . . 0.0 110.391 177.538 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' D' D ' 121' ' ' ASN . . . . . . . . . . . . . 12.5 t-20 -112.17 -44.12 3.46 Favored 'General case' 0 C--N 1.332 -0.18 0 CA-C-N 116.488 -0.323 . . . . 0.0 110.846 -176.027 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' D' D ' 122' ' ' LYS . . . . . . . . . . . . . 98.3 mttt -146.37 149.61 34.1 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-O 121.112 0.482 . . . . 0.0 111.51 -178.489 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' D' D ' 123' ' ' VAL . . . . . . . . . . . . . 46.4 t -130.31 126.33 61.14 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.289 0 N-CA-C 109.25 -0.648 . . . . 0.0 109.25 172.928 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' D' D ' 124' ' ' LEU . . . . . 0.453 HD22 HD12 ' E' ' 88' ' ' LEU . 6.2 mp -114.71 137.09 52.34 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-O 120.824 0.345 . . . . 0.0 111.0 -176.52 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' D' D ' 125' ' ' VAL . . . . . . . . . . . . . 44.3 t -122.83 132.15 71.88 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.179 0 CA-C-N 115.911 -0.586 . . . . 0.0 109.939 179.861 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' D' D ' 126' ' ' ARG . . . . . . . . . . . . . 25.7 mmt180 -134.86 104.66 6.08 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 116.124 -0.489 . . . . 0.0 110.215 178.021 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' D' D ' 127' ' ' ASN . . . . . . . . . . . . . 35.0 m120 53.98 -104.98 0.23 Allowed 'General case' 0 CA--C 1.544 0.733 0 CA-C-O 119.053 -0.499 . . . . 0.0 110.922 179.75 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' D' D ' 128' ' ' ASP . . . . . . . . . . . . . 13.8 p-10 -112.33 2.65 16.6 Favored 'General case' 0 CA--C 1.536 0.431 0 CA-C-N 119.579 1.081 . . . . 0.0 113.498 -177.574 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' D' D ' 129' ' ' LEU . . . . . . . . . . . . . 26.1 mt -105.01 148.66 26.51 Favored 'General case' 0 C--O 1.231 0.124 0 N-CA-C 109.726 -0.472 . . . . 0.0 109.726 177.263 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' D' D ' 130' ' ' VAL . . . . . 0.641 HG11 HD13 ' D' ' 104' ' ' ILE . 12.7 p -133.04 141.03 45.87 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.233 0 CA-C-O 121.301 0.572 . . . . 0.0 110.784 -177.682 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' D' D ' 131' ' ' VAL . . . . . 0.571 HG22 HD12 ' D' ' 140' ' ' LEU . 38.9 t -134.43 135.96 53.4 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 CA-C-N 115.716 -0.675 . . . . 0.0 109.924 178.909 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' D' D ' 132' ' ' ILE . . . . . . . . . . . . . 70.6 mt -113.87 132.21 63.53 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.366 0 N-CA-C 109.394 -0.595 . . . . 0.0 109.394 -178.717 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' D' D ' 133' ' ' ILE . . . . . . . . . . . . . 35.4 mm -117.31 120.39 64.78 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.261 0 CA-C-O 120.837 0.351 . . . . 0.0 110.78 -176.06 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' D' D ' 134' ' ' ASP . . . . . . . . . . . . . 9.3 p-10 -129.89 148.95 51.81 Favored 'General case' 0 C--N 1.329 -0.284 0 N-CA-C 109.419 -0.586 . . . . 0.0 109.419 175.179 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' D' D ' 135' ' ' GLU . . . . . . . . . . . . . 54.6 tt0 -50.03 -25.43 3.38 Favored 'General case' 0 C--N 1.327 -0.39 0 N-CA-C 112.746 0.647 . . . . 0.0 112.746 -172.414 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' D' D ' 136' ' ' GLN . . . . . . . . . . . . . 43.0 tt0 -89.86 -31.1 17.49 Favored 'General case' 0 C--O 1.233 0.208 0 N-CA-C 112.542 0.571 . . . . 0.0 112.542 -174.058 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' D' D ' 137' ' ' LYS . . . . . . . . . . . . . 25.1 pttm -164.07 174.09 11.74 Favored 'General case' 0 C--O 1.232 0.176 0 CA-C-O 121.434 0.635 . . . . 0.0 112.57 -174.373 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' D' D ' 138' ' ' LEU . . . . . 0.401 ' C ' HD23 ' D' ' 138' ' ' LEU . 7.4 tt -122.44 130.33 52.98 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 115.197 -0.91 . . . . 0.0 110.109 179.564 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' D' D ' 139' ' ' THR . . . . . 0.407 HG23 ' HG2' ' E' ' 77' ' ' GLU . 34.9 m -112.68 129.77 56.28 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-N 116.341 -0.39 . . . . 0.0 110.677 179.914 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' D' D ' 140' ' ' LEU . . . . . 0.571 HD12 HG22 ' D' ' 131' ' ' VAL . 19.5 tp -113.98 120.41 40.55 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 115.567 -0.742 . . . . 0.0 109.462 -178.241 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' D' D ' 141' ' ' ILE . . . . . 0.482 ' HB ' HG13 ' D' ' 130' ' ' VAL . 20.1 mt -120.3 119.49 60.07 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.281 0 CA-C-O 121.193 0.52 . . . . 0.0 109.93 -177.589 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' D' D ' 142' ' ' ARG . . . . . . . . . . . . . 84.6 mtm180 -111.17 133.29 53.64 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 114.941 -1.027 . . . . 0.0 110.689 -174.699 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' D' D ' 143' ' ' THR . . . . . . . . . . . . . 48.7 p . . . . . 0 C--O 1.22 -0.465 0 CA-C-O 118.03 -0.986 . . . . 0.0 110.371 179.588 . . . . . . . . 0 0 . 1 . 003 nuclear build full ' E' E ' -3' ' ' GLU . . . . . . . . . . . . . 84.5 tt0 . . . . . 0 N--CA 1.49 1.538 0 N-CA-C 109.515 -0.55 . . . . 0.0 109.515 . . . . . . . . . 0 0 . 1 . 003 nuclear build full ' E' E ' -2' ' ' GLY . . . . . . . . . . . . . . . -76.4 121.68 6.19 Favored Glycine 0 CA--C 1.525 0.712 0 N-CA-C 111.117 -0.793 . . . . 0.0 111.117 -179.432 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' E' E ' -1' ' ' VAL . . . . . . . . . . . . . 45.1 t -97.07 134.78 33.53 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.283 0 N-CA-C 110.053 -0.351 . . . . 0.0 110.053 178.684 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' E' E ' 0' ' ' ILE . . . . . . . . . . . . . 73.4 mt -115.14 132.44 64.4 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.203 0 CA-C-N 116.244 -0.435 . . . . 0.0 109.998 -179.683 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' E' E ' 1' ' ' MET . . . . . . . . . . . . . 25.6 ptt? -81.13 150.68 28.61 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.433 179.277 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' E' E ' 2' ' ' SER . . . . . . . . . . . . . 15.9 p -130.33 148.87 52.2 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.338 -0.392 . . . . 0.0 110.949 -178.997 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' E' E ' 3' ' ' GLU . . . . . . . . . . . . . 95.7 mt-10 -140.61 139.33 34.88 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 115.992 -0.549 . . . . 0.0 110.927 -179.864 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' E' E ' 4' ' ' LEU . . . . . . . . . . . . . 17.4 tp -122.94 126.76 47.84 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-N 116.071 -0.513 . . . . 0.0 110.155 176.533 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' E' E ' 5' ' ' LYS . . . . . . . . . . . . . 86.4 mttt -106.96 121.6 44.76 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.3 -0.409 . . . . 0.0 110.711 179.024 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' E' E ' 6' ' ' LEU . . . . . . . . . . . . . 75.9 mt -116.78 151.3 36.74 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 115.46 -0.791 . . . . 0.0 110.58 -179.394 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' E' E ' 7' ' ' LYS . . . . . . . . . . . . . 33.9 ttpt -140.32 142.14 28.58 Favored Pre-proline 0 CA--C 1.534 0.338 0 N-CA-C 109.764 -0.458 . . . . 0.0 109.764 175.088 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' E' E ' 8' ' ' PRO . . . . . . . . . . . . . 92.2 Cg_endo -89.03 147.91 5.6 Favored 'Trans proline' 0 N--CA 1.491 1.372 0 C-N-CA 121.654 1.569 . . . . 0.0 112.024 -179.896 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' E' E ' 9' ' ' LEU . . . . . . . . . . . . . 84.3 mt -84.23 -52.07 0.56 Allowed Pre-proline 0 C--N 1.329 -0.284 0 CA-C-O 118.855 -0.593 . . . . 0.0 111.551 -179.94 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' E' E ' 10' ' ' PRO . . . . . . . . . . . . . 61.6 Cg_endo -73.43 155.66 50.56 Favored 'Trans proline' 0 N--CA 1.498 1.762 0 C-N-CA 121.093 1.196 . . . . 0.0 111.898 173.469 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' E' E ' 11' ' ' LYS . . . . . . . . . . . . . 62.1 mtpt -89.07 98.93 12.04 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.433 -0.349 . . . . 0.0 110.749 179.207 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' E' E ' 12' ' ' VAL . . . . . . . . . . . . . 12.6 p -142.68 142.58 26.5 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.288 0 CA-C-N 116.335 -0.393 . . . . 0.0 110.667 179.809 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' E' E ' 13' ' ' GLU . . . . . . . . . . . . . 45.1 mp0 -84.74 128.28 34.53 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 116.267 -0.424 . . . . 0.0 109.86 176.754 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' E' E ' 14' ' ' LEU . . . . . . . . . . . . . 32.3 mt -98.5 148.99 35.29 Favored Pre-proline 0 CA--C 1.533 0.293 0 CA-C-O 119.197 -0.43 . . . . 0.0 110.499 -177.585 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' E' E ' 15' ' ' PRO . . . . . . . . . . . . . 26.3 Cg_exo -62.37 159.96 33.44 Favored 'Trans proline' 0 N--CA 1.497 1.71 0 C-N-CA 121.245 1.296 . . . . 0.0 111.478 174.869 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' E' E ' 16' ' ' PRO . . . . . . . . . . . . . 38.6 Cg_exo -58.68 -34.34 98.86 Favored 'Trans proline' 0 N--CA 1.496 1.666 0 C-N-CA 121.413 1.409 . . . . 0.0 112.899 -178.32 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' E' E ' 17' ' ' ASP . . . . . . . . . . . . . 22.9 p-10 -91.4 8.43 36.3 Favored 'General case' 0 CA--C 1.534 0.362 0 N-CA-C 113.341 0.867 . . . . 0.0 113.341 -177.193 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' E' E ' 18' ' ' PHE . . . . . . . . . . . . . 52.3 t80 -58.19 -43.85 87.77 Favored 'General case' 0 N--CA 1.457 -0.093 0 O-C-N 121.944 -0.472 . . . . 0.0 110.058 -178.162 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' E' E ' 19' ' ' VAL . . . . . . . . . . . . . 48.7 t -58.17 -42.52 83.51 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.304 0 CA-C-N 116.207 -0.452 . . . . 0.0 110.234 -178.909 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' E' E ' 20' ' ' ASP . . . . . . . . . . . . . 7.5 t70 -59.92 -42.09 93.15 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-O 120.833 0.349 . . . . 0.0 110.83 -177.92 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' E' E ' 21' ' ' VAL . . . . . . . . . . . . . 48.3 t -64.73 -46.18 92.94 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.332 0 CA-C-N 116.405 -0.361 . . . . 0.0 110.483 -177.723 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' E' E ' 22' ' ' ILE . . . . . 0.627 HG22 HD12 ' E' ' 26' ' ' LEU . 29.3 mm -57.0 -45.13 83.74 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.257 0 N-CA-C 110.172 -0.307 . . . . 0.0 110.172 179.266 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' E' E ' 23' ' ' ARG . . . . . . . . . . . . . 2.3 tmm_? -54.39 -48.77 71.18 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-O 120.573 0.225 . . . . 0.0 111.246 -178.935 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' E' E ' 24' ' ' ILE . . . . . . . . . . . . . 72.8 mt -59.02 -42.98 87.91 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.316 0 C-N-CA 120.943 -0.303 . . . . 0.0 110.963 -177.828 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' E' E ' 25' ' ' LYS . . . . . . . . . . . . . 96.2 mttt -66.34 -41.7 89.21 Favored 'General case' 0 C--N 1.329 -0.293 0 N-CA-C 112.759 0.652 . . . . 0.0 112.759 -178.874 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' E' E ' 26' ' ' LEU . . . . . 0.627 HD12 HG22 ' E' ' 22' ' ' ILE . 48.6 mt -78.48 -37.31 43.65 Favored 'General case' 0 C--N 1.327 -0.372 0 N-CA-C 113.689 0.996 . . . . 0.0 113.689 -169.812 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' E' E ' 27' ' ' GLN . . . . . . . . . . . . . 16.1 pt20 -47.23 138.85 6.7 Favored 'General case' 0 N--CA 1.467 0.422 0 N-CA-C 112.765 0.654 . . . . 0.0 112.765 -175.261 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' E' E ' 28' ' ' GLY . . . . . . . . . . . . . . . 101.17 -24.53 31.52 Favored Glycine 0 CA--C 1.532 1.139 0 CA-C-N 115.552 -0.749 . . . . 0.0 112.405 -177.182 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' E' E ' 29' ' ' LYS . . . . . . . . . . . . . 86.5 mttt -98.4 155.06 17.42 Favored 'General case' 0 C--O 1.233 0.198 0 CA-C-N 117.594 0.697 . . . . 0.0 111.381 179.376 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' E' E ' 30' ' ' THR . . . . . . . . . . . . . 30.5 m -104.39 136.7 43.49 Favored 'General case' 0 C--N 1.331 -0.226 0 CA-C-N 116.011 -0.54 . . . . 0.0 110.268 177.42 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' E' E ' 31' ' ' VAL . . . . . . . . . . . . . 35.0 m -132.29 157.06 43.0 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.329 0 CA-C-N 116.327 -0.397 . . . . 0.0 110.831 -179.123 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' E' E ' 32' ' ' ARG . . . . . . . . . . . . . 96.9 mtt180 -132.12 154.84 49.08 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 115.954 -0.566 . . . . 0.0 110.44 176.673 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' E' E ' 33' ' ' THR . . . . . . . . . . . . . 29.1 m -53.53 138.13 34.71 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.307 -0.406 . . . . 0.0 111.279 -178.978 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' E' E ' 34' ' ' GLY . . . . . . . . . . . . . . . 100.16 -17.11 57.51 Favored Glycine 0 CA--C 1.532 1.107 0 CA-C-O 119.616 -0.547 . . . . 0.0 113.295 178.744 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' E' E ' 35' ' ' ASP . . . . . . . . . . . . . 54.1 m-20 -65.37 150.18 48.73 Favored 'General case' 0 C--N 1.334 -0.077 0 CA-C-N 118.019 0.909 . . . . 0.0 111.137 179.818 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' E' E ' 36' ' ' VAL . . . . . . . . . . . . . 44.6 t -121.56 130.0 75.02 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.233 0 CA-C-N 115.67 -0.696 . . . . 0.0 109.76 178.536 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' E' E ' 37' ' ' ILE . . . . . . . . . . . . . 69.7 mt -119.31 138.66 49.27 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.29 0 CA-C-N 116.275 -0.421 . . . . 0.0 109.923 -179.636 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' E' E ' 38' ' ' GLY . . . . . . . . . . . . . . . -112.27 128.95 8.77 Favored Glycine 0 CA--C 1.526 0.77 0 N-CA-C 111.086 -0.806 . . . . 0.0 111.086 -179.505 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' E' E ' 39' ' ' ILE . . . . . . . . . . . . . 71.1 mt -122.03 134.14 66.21 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.275 0 N-CA-C 109.899 -0.408 . . . . 0.0 109.899 178.895 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' E' E ' 40' ' ' SER . . . . . . . . . . . . . 53.8 p -93.39 122.71 36.08 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.323 -0.398 . . . . 0.0 110.857 175.509 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' E' E ' 41' ' ' ILE . . . . . . . . . . . . . 71.4 mt -131.85 114.37 24.57 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.225 0 N-CA-C 110.021 -0.363 . . . . 0.0 110.021 177.678 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' E' E ' 42' ' ' LEU . . . . . . . . . . . . . 7.9 mp 56.6 37.57 28.92 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-O 121.086 0.47 . . . . 0.0 111.074 -179.707 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' E' E ' 43' ' ' GLY . . . . . . . . . . . . . . . 77.42 -10.08 24.53 Favored Glycine 0 CA--C 1.534 1.219 0 C-N-CA 121.296 -0.478 . . . . 0.0 113.473 177.043 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' E' E ' 44' ' ' LYS . . . . . . . . . . . . . 68.7 mttm -93.99 132.97 37.93 Favored 'General case' 0 C--N 1.333 -0.121 0 CA-C-N 118.005 0.903 . . . . 0.0 110.069 178.093 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' E' E ' 45' ' ' GLU . . . . . . . . . . . . . 69.3 tt0 -86.46 127.28 34.83 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.172 -0.467 . . . . 0.0 111.04 -177.816 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' E' E ' 46' ' ' VAL . . . . . . . . . . . . . 7.2 p -124.84 128.13 73.04 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.198 0 CA-C-O 120.943 0.401 . . . . 0.0 109.98 176.627 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' E' E ' 47' ' ' LYS . . . . . . . . . . . . . 72.6 mmtt -100.08 133.91 43.78 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-N 115.972 -0.558 . . . . 0.0 111.525 177.631 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' E' E ' 48' ' ' PHE . . . . . . . . . . . . . 91.1 m-85 -116.34 131.98 56.79 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 115.907 -0.588 . . . . 0.0 109.782 174.046 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' E' E ' 49' ' ' LYS . . . . . . . . . . . . . 82.4 tttt -105.73 136.34 45.53 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.488 -0.324 . . . . 0.0 110.527 -179.927 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' E' E ' 50' ' ' VAL . . . . . . . . . . . . . 45.0 t -80.53 108.67 14.16 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.331 0 N-CA-C 109.196 -0.668 . . . . 0.0 109.196 176.089 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' E' E ' 51' ' ' VAL . . . . . . . . . . . . . 47.5 t -74.63 -47.21 39.75 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.289 0 CA-C-N 116.139 -0.482 . . . . 0.0 110.174 -172.968 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' E' E ' 52' ' ' GLN . . . . . . . . . . . . . 48.2 tt0 -164.85 138.49 4.9 Favored 'General case' 0 C--N 1.331 -0.236 0 C-N-CA 120.155 -0.618 . . . . 0.0 111.749 -177.954 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' E' E ' 53' ' ' ALA . . . . . . . . . . . . . . . -116.46 133.6 55.82 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 115.9 -0.591 . . . . 0.0 110.169 176.835 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' E' E ' 54' ' ' TYR . . . . . . . . . . . . . 38.5 t80 -129.13 112.47 18.4 Favored Pre-proline 0 CA--C 1.535 0.398 0 CA-C-O 118.154 -0.927 . . . . 0.0 110.171 177.607 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' E' E ' 55' ' ' PRO . . . . . . . . . . . . . 72.2 Cg_endo -77.09 168.72 76.23 Favored 'Cis proline' 0 N--CA 1.5 1.904 0 CA-C-N 122.082 1.779 . . . . 0.0 112.426 -5.346 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' E' E ' 56' ' ' SER . . . . . . . . . . . . . 13.6 m -117.57 134.08 23.21 Favored Pre-proline 0 CA--C 1.54 0.562 0 CA-C-O 118.455 -0.783 . . . . 0.0 109.595 174.764 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' E' E ' 57' ' ' PRO . . . . . . . . . . . . . 36.0 Cg_endo -66.36 164.7 65.68 Favored 'Cis proline' 0 N--CA 1.498 1.751 0 CA-C-N 121.862 1.701 . . . . 0.0 111.299 -3.177 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' E' E ' 58' ' ' LEU . . . . . . . . . . . . . 23.4 tp -129.96 138.82 51.06 Favored 'General case' 0 C--N 1.331 -0.222 0 CA-C-O 121.081 0.467 . . . . 0.0 110.584 179.61 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' E' E ' 59' ' ' ARG . . . . . . . . . . . . . 75.1 ttt180 -106.06 123.31 47.8 Favored 'General case' 0 C--N 1.329 -0.295 0 N-CA-C 109.084 -0.71 . . . . 0.0 109.084 174.115 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' E' E ' 60' ' ' VAL . . . . . . . . . . . . . 44.3 t -73.52 118.95 19.69 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.351 0 C-N-CA 120.735 -0.386 . . . . 0.0 110.166 -175.198 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' E' E ' 61' ' ' GLU . . . . . . . . . . . . . 95.0 mt-10 -131.05 162.43 29.84 Favored 'General case' 0 C--N 1.331 -0.222 0 CA-C-N 116.107 -0.497 . . . . 0.0 110.109 178.455 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' E' E ' 62' ' ' ASP . . . . . . . . . . . . . 65.2 m-20 -53.57 -32.84 52.58 Favored 'General case' 0 C--N 1.326 -0.427 0 N-CA-C 111.751 0.278 . . . . 0.0 111.751 -178.898 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' E' E ' 63' ' ' ARG . . . . . . . . . . . . . 27.6 mmm180 -72.69 -21.35 61.07 Favored 'General case' 0 C--N 1.33 -0.267 0 N-CA-C 113.054 0.761 . . . . 0.0 113.054 -176.159 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' E' E ' 64' ' ' THR . . . . . . . . . . . . . 29.6 m -72.56 139.37 47.47 Favored 'General case' 0 C--N 1.331 -0.21 0 CA-C-O 120.869 0.366 . . . . 0.0 111.183 -174.409 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' E' E ' 65' ' ' LYS . . . . . . . . . . . . . 13.1 mptt -89.04 134.34 34.03 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.009 -0.541 . . . . 0.0 109.982 178.68 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' E' E ' 66' ' ' ILE . . . . . . . . . . . . . 64.4 mt -116.96 131.75 68.72 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.326 0 CA-C-O 120.885 0.374 . . . . 0.0 110.076 -179.772 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' E' E ' 67' ' ' THR . . . . . . . . . . . . . 32.5 m -127.6 140.44 52.1 Favored 'General case' 0 C--N 1.332 -0.19 0 CA-C-N 116.047 -0.524 . . . . 0.0 110.821 -178.559 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' E' E ' 68' ' ' LEU . . . . . 0.428 ' C ' HD23 ' E' ' 68' ' ' LEU . 5.0 tt -102.85 120.97 41.54 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 115.994 -0.548 . . . . 0.0 109.649 177.044 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' E' E ' 69' ' ' VAL . . . . . . . . . . . . . 42.3 t -102.0 135.14 40.24 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.29 0 CA-C-O 120.982 0.42 . . . . 0.0 110.635 -176.091 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' E' E ' 70' ' ' THR . . . . . . . . . . . . . 11.4 m -147.18 92.42 2.11 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 115.857 -0.61 . . . . 0.0 109.976 177.934 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' E' E ' 71' ' ' HIS . . . . . . . . . . . . . 86.1 m-70 -145.8 153.0 49.78 Favored Pre-proline 0 CA--C 1.534 0.327 0 C-N-CA 120.746 -0.382 . . . . 0.0 111.029 -178.268 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' E' E ' 72' ' ' PRO . . . . . . . . . . . . . 93.8 Cg_endo -93.03 160.12 2.64 Favored 'Trans proline' 0 N--CA 1.488 1.187 0 C-N-CA 121.988 1.792 . . . . 0.0 111.511 173.483 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' E' E ' 73' ' ' VAL . . . . . . . . . . . . . 33.9 m -69.87 154.05 8.36 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.224 0 C-N-CA 120.739 -0.384 . . . . 0.0 110.41 -179.477 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' E' E ' 74' ' ' ASP . . . . . . . . . . . . . 7.3 t0 -95.34 126.44 40.65 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.009 -0.542 . . . . 0.0 110.228 -176.924 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' E' E ' 75' ' ' VAL . . . . . 0.444 ' C ' HD12 ' E' ' 76' ' ' LEU . 40.4 t -119.17 123.79 71.96 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.205 0 CA-C-O 121.025 0.44 . . . . 0.0 110.583 -178.514 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' E' E ' 76' ' ' LEU . . . . . 0.444 HD12 ' C ' ' E' ' 75' ' ' VAL . 6.3 mp -123.94 146.24 48.6 Favored 'General case' 0 C--N 1.331 -0.224 0 CA-C-N 115.828 -0.624 . . . . 0.0 109.908 176.195 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' E' E ' 77' ' ' GLU . . . . . 0.407 ' HG2' HG23 ' D' ' 139' ' ' THR . 45.9 mt-10 -135.69 136.86 41.22 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-O 121.011 0.434 . . . . 0.0 111.22 -178.883 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' E' E ' 78' ' ' ALA . . . . . 0.424 ' HB2' HD21 ' E' ' 109' ' ' LEU . . . -125.95 133.44 51.83 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 115.816 -0.629 . . . . 0.0 109.674 176.145 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' E' E ' 79' ' ' LYS . . . . . 0.565 ' O ' HD13 ' E' ' 80' ' ' ILE . 84.0 mttt -80.51 120.3 24.31 Favored 'General case' 0 C--N 1.331 -0.215 0 CA-C-O 121.091 0.472 . . . . 0.0 110.754 -178.199 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' E' E ' 80' ' ' ILE . . . . . 0.565 HD13 ' O ' ' E' ' 79' ' ' LYS . 43.1 mm -139.18 108.68 3.86 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.335 0 N-CA-C 108.961 -0.755 . . . . 0.0 108.961 -176.991 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' E' E ' 81' ' ' LYS . . . . . . . . . . . . . 68.8 mttm -97.84 126.73 43.36 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-O 120.877 0.37 . . . . 0.0 111.199 -176.265 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' E' E ' 82' ' ' GLY . . . . . . . . . . . . . . . 89.08 42.14 5.69 Favored Glycine 0 CA--C 1.527 0.791 0 C-N-CA 120.911 -0.662 . . . . 0.0 111.725 174.992 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' E' E ' 83' ' ' ILE . . . . . . . . . . . . . 75.5 mt -66.83 138.52 22.75 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.314 0 CA-C-O 120.945 0.402 . . . . 0.0 109.94 178.34 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' E' E ' 84' ' ' LYS . . . . . . . . . . . . . 83.8 tttt -99.22 -53.97 3.09 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 115.989 -0.55 . . . . 0.0 110.34 -178.815 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' E' E ' 85' ' ' ASP . . . . . . . . . . . . . 5.9 t0 -154.69 151.4 28.71 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-N 115.746 -0.661 . . . . 0.0 110.044 -178.943 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' E' E ' 86' ' ' VAL . . . . . . . . . . . . . 42.8 t -131.9 130.77 61.7 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.233 0 CA-C-O 120.961 0.41 . . . . 0.0 110.537 -179.181 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' E' E ' 87' ' ' ILE . . . . . . . . . . . . . 44.5 mm -119.04 128.89 75.78 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.221 0 CA-C-N 115.863 -0.608 . . . . 0.0 109.705 177.011 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' E' E ' 88' ' ' LEU . . . . . 0.453 HD12 HD22 ' D' ' 124' ' ' LEU . 27.5 mt -114.54 139.33 49.67 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-O 121.151 0.501 . . . . 0.0 111.463 -177.635 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' E' E ' 89' ' ' ASP . . . . . . . . . . . . . 11.6 t70 -132.96 156.83 46.56 Favored 'General case' 0 C--N 1.331 -0.23 0 CA-C-N 115.517 -0.765 . . . . 0.0 109.388 175.39 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' E' E ' 90' ' ' GLU . . . . . . . . . . . . . 96.0 mt-10 -48.44 -38.52 20.0 Favored 'General case' 0 C--N 1.327 -0.371 0 N-CA-C 112.796 0.665 . . . . 0.0 112.796 -171.507 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' E' E ' 91' ' ' ASN . . . . . . . . . . . . . 33.5 m120 -132.11 34.73 3.77 Favored 'General case' 0 N--CA 1.465 0.278 0 C-N-CA 120.961 -0.296 . . . . 0.0 111.703 -176.494 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' E' E ' 92' ' ' LEU . . . . . . . . . . . . . 9.7 tp -166.16 145.55 6.02 Favored 'General case' 0 C--N 1.33 -0.258 0 C-N-CA 120.885 -0.326 . . . . 0.0 110.717 -179.66 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' E' E ' 93' ' ' ILE . . . . . . . . . . . . . 67.7 mt -127.79 125.96 65.98 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.222 0 N-CA-C 109.711 -0.477 . . . . 0.0 109.711 178.989 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' E' E ' 94' ' ' VAL . . . . . . . . . . . . . 47.1 t -122.99 127.14 74.62 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.267 0 N-CA-C 109.797 -0.446 . . . . 0.0 109.797 178.868 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' E' E ' 95' ' ' VAL . . . . . . . . . . . . . 44.2 t -122.93 135.38 63.18 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.294 0 CA-C-N 116.328 -0.396 . . . . 0.0 110.061 -179.252 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' E' E ' 96' ' ' ILE . . . . . . . . . . . . . 61.9 mt -116.31 128.75 73.54 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.326 0 N-CA-C 109.304 -0.628 . . . . 0.0 109.304 179.341 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' E' E ' 97' ' ' THR . . . . . . . . . . . . . 75.7 p -101.67 157.09 17.08 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-O 121.191 0.52 . . . . 0.0 111.371 -177.353 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' E' E ' 98' ' ' GLU . . . . . . . . . . . . . 84.6 tt0 -53.99 -26.66 27.14 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-N 116.008 -0.542 . . . . 0.0 112.133 -179.793 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' E' E ' 99' ' ' GLU . . . . . . . . . . . . . 45.7 mp0 -79.14 16.25 0.99 Allowed 'General case' 0 CA--C 1.536 0.426 0 N-CA-C 113.013 0.746 . . . . 0.0 113.013 -177.931 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' E' E ' 100' ' ' ASN . . . . . . . . . . . . . 3.8 m-20 62.95 38.08 11.44 Favored 'General case' 0 C--O 1.233 0.186 0 CA-C-O 120.952 0.406 . . . . 0.0 110.939 177.397 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' E' E ' 101' ' ' GLU . . . . . . . . . . . . . 84.5 tt0 -116.49 142.5 46.78 Favored 'General case' 0 C--N 1.331 -0.221 0 CA-C-N 116.078 -0.51 . . . . 0.0 109.801 177.124 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' E' E ' 102' ' ' VAL . . . . . . . . . . . . . 46.4 t -115.12 126.46 72.71 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.22 0 N-CA-C 109.87 -0.419 . . . . 0.0 109.87 -178.615 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' E' E ' 103' ' ' LEU . . . . . . . . . . . . . 42.5 mt -118.29 133.43 55.9 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-N 115.692 -0.685 . . . . 0.0 110.249 177.098 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' E' E ' 104' ' ' ILE . . . . . . . . . . . . . 68.5 mt -118.1 123.36 71.53 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.316 0 N-CA-C 109.986 -0.375 . . . . 0.0 109.986 179.632 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' E' E ' 105' ' ' PHE . . . . . . . . . . . . . 75.4 m-85 -122.43 165.69 15.94 Favored 'General case' 0 C--N 1.332 -0.157 0 O-C-N 124.047 0.842 . . . . 0.0 109.607 -179.964 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' E' E ' 106' ' ' ASN . . . . . . . . . . . . . 50.5 p-10 -101.54 -171.23 1.95 Allowed 'General case' 0 C--N 1.331 -0.204 0 N-CA-C 110.002 -0.37 . . . . 0.0 110.002 174.996 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' E' E ' 107' ' ' GLN . . . . . . . . . . . . . 45.8 tt0 -59.13 -29.3 67.29 Favored 'General case' 0 C--N 1.329 -0.3 0 N-CA-C 112.003 0.372 . . . . 0.0 112.003 -179.733 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' E' E ' 108' ' ' ASN . . . . . . . . . . . . . 14.4 t-20 -84.55 10.48 10.89 Favored 'General case' 0 CA--C 1.536 0.42 0 N-CA-C 113.035 0.754 . . . . 0.0 113.035 -177.508 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' E' E ' 109' ' ' LEU . . . . . 0.424 HD21 ' HB2' ' E' ' 78' ' ' ALA . 8.7 tp 58.33 36.77 25.79 Favored 'General case' 0 CA--C 1.531 0.226 0 CA-C-O 121.046 0.45 . . . . 0.0 111.373 179.711 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' E' E ' 110' ' ' GLU . . . . . . . . . . . . . 43.4 mt-10 -103.65 152.84 21.31 Favored 'General case' 0 C--N 1.33 -0.244 0 N-CA-C 109.662 -0.496 . . . . 0.0 109.662 175.676 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' E' E ' 111' ' ' GLU . . . . . . . . . . . . . 58.9 tt0 -87.29 121.91 30.36 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-O 120.914 0.387 . . . . 0.0 110.763 -176.315 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' E' E ' 112' ' ' LEU . . . . . . . . . . . . . 13.8 mt -105.18 -46.06 4.34 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 115.978 -0.556 . . . . 0.0 110.834 -179.895 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' E' E ' 113' ' ' TYR . . . . . 0.413 ' CE1' HG21 ' F' ' 75' ' ' VAL . 65.3 t80 -139.91 143.75 36.79 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.299 -0.41 . . . . 0.0 111.221 -178.431 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' E' E ' 114' ' ' ARG . . . . . . . . . . . . . 38.8 ptt180 -144.55 123.28 12.59 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.096 -0.502 . . . . 0.0 110.796 178.128 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' E' E ' 115' ' ' GLY . . . . . . . . . . . . . . . -150.13 158.81 27.84 Favored Glycine 0 CA--C 1.525 0.703 0 N-CA-C 110.934 -0.866 . . . . 0.0 110.934 178.205 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' E' E ' 116' ' ' LYS . . . . . . . . . . . . . 37.4 ttpt -127.87 139.01 52.88 Favored 'General case' 0 C--N 1.331 -0.224 0 O-C-N 122.634 -0.333 . . . . 0.0 110.29 178.118 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' E' E ' 117' ' ' PHE . . . . . . . . . . . . . 39.8 m-85 -133.75 114.96 13.99 Favored 'General case' 0 C--N 1.329 -0.296 0 N-CA-C 110.0 -0.37 . . . . 0.0 110.0 -178.153 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' E' E ' 118' ' ' GLU . . . . . . . . . . . . . 84.3 tt0 -53.57 -43.2 68.33 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.64 -0.255 . . . . 0.0 111.542 -175.97 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' E' E ' 119' ' ' ASN . . . . . . . . . . . . . 82.3 m-20 -100.17 31.0 3.53 Favored 'General case' 0 C--N 1.33 -0.24 0 N-CA-C 112.154 0.428 . . . . 0.0 112.154 -174.185 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' E' E ' 120' ' ' LEU . . . . . 0.421 HD11 HG23 ' E' ' 132' ' ' ILE . 13.9 tp -54.97 121.04 7.82 Favored 'General case' 0 C--N 1.331 -0.207 0 CA-C-O 120.663 0.268 . . . . 0.0 110.745 178.716 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' E' E ' 121' ' ' ASN . . . . . . . . . . . . . 46.1 t30 -114.03 -43.93 3.2 Favored 'General case' 0 C--O 1.232 0.167 0 CA-C-N 116.598 -0.273 . . . . 0.0 111.516 -176.184 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' E' E ' 122' ' ' LYS . . . . . . . . . . . . . 57.9 mtpt -140.08 144.55 36.88 Favored 'General case' 0 C--N 1.332 -0.159 0 CA-C-O 120.938 0.399 . . . . 0.0 111.741 -176.084 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' E' E ' 123' ' ' VAL . . . . . . . . . . . . . 46.7 t -127.1 124.9 65.34 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 N-CA-C 109.381 -0.6 . . . . 0.0 109.381 174.078 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' E' E ' 124' ' ' LEU . . . . . . . . . . . . . 51.6 mt -126.73 139.32 53.23 Favored 'General case' 0 C--N 1.331 -0.201 0 CA-C-O 120.95 0.405 . . . . 0.0 110.967 -177.186 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' E' E ' 125' ' ' VAL . . . . . . . . . . . . . 34.9 m -132.01 139.03 51.28 Favored 'Isoleucine or valine' 0 C--N 1.333 -0.145 0 CA-C-N 116.017 -0.538 . . . . 0.0 110.911 -179.871 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' E' E ' 126' ' ' ARG . . . . . . . . . . . . . 77.1 mtp85 -140.52 109.41 6.04 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 115.958 -0.565 . . . . 0.0 110.29 175.422 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' E' E ' 127' ' ' ASN . . . . . . . . . . . . . 94.5 m-20 53.32 -104.9 0.22 Allowed 'General case' 0 CA--C 1.542 0.663 0 CA-C-O 119.067 -0.492 . . . . 0.0 111.136 -179.897 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' E' E ' 128' ' ' ASP . . . . . . . . . . . . . 14.6 p-10 -113.69 5.41 16.44 Favored 'General case' 0 CA--C 1.537 0.447 0 CA-C-N 119.496 1.044 . . . . 0.0 113.393 -177.334 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' E' E ' 129' ' ' LEU . . . . . . . . . . . . . 3.9 tt -105.11 131.51 52.51 Favored 'General case' 0 C--N 1.332 -0.154 0 N-CA-C 109.367 -0.605 . . . . 0.0 109.367 177.809 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' E' E ' 130' ' ' VAL . . . . . . . . . . . . . 44.2 t -120.6 137.05 55.64 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.218 0 CA-C-O 120.765 0.317 . . . . 0.0 110.165 -177.236 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' E' E ' 131' ' ' VAL . . . . . . . . . . . . . 41.8 t -135.95 138.07 48.0 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.249 0 CA-C-O 121.203 0.525 . . . . 0.0 110.459 178.926 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' E' E ' 132' ' ' ILE . . . . . 0.421 HG23 HD11 ' E' ' 120' ' ' LEU . 76.4 mt -119.93 134.0 64.87 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.324 0 CA-C-N 115.513 -0.767 . . . . 0.0 109.51 -179.739 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' E' E ' 133' ' ' ILE . . . . . . . . . . . . . 42.8 mm -117.21 125.32 73.89 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.23 0 CA-C-O 120.798 0.332 . . . . 0.0 110.865 -176.142 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' E' E ' 134' ' ' ASP . . . . . . . . . . . . . 7.7 p-10 -137.03 148.72 47.0 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.0 -0.545 . . . . 0.0 109.568 174.187 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' E' E ' 135' ' ' GLU . . . . . . . . . . . . . 43.5 tp10 -49.81 -25.88 3.48 Favored 'General case' 0 C--N 1.327 -0.377 0 N-CA-C 112.792 0.664 . . . . 0.0 112.792 -171.585 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' E' E ' 136' ' ' GLN . . . . . . . . . . . . . 97.3 mt-30 -96.5 -33.06 11.98 Favored 'General case' 0 CA--C 1.53 0.178 0 N-CA-C 112.476 0.547 . . . . 0.0 112.476 -175.995 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' E' E ' 137' ' ' LYS . . . . . . . . . . . . . 84.5 mttt -141.37 154.56 45.72 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-O 121.233 0.54 . . . . 0.0 111.697 -168.427 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' E' E ' 138' ' ' LEU . . . . . 0.407 ' C ' HD23 ' E' ' 138' ' ' LEU . 4.5 tt -117.56 119.68 35.74 Favored 'General case' 0 C--N 1.33 -0.246 0 N-CA-C 108.965 -0.754 . . . . 0.0 108.965 171.071 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' E' E ' 139' ' ' THR . . . . . . . . . . . . . 25.3 m -106.05 128.8 54.1 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.454 -0.339 . . . . 0.0 110.712 -176.53 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' E' E ' 140' ' ' LEU . . . . . 0.468 HD23 ' N ' ' E' ' 141' ' ' ILE . 5.4 tt -116.56 122.85 45.88 Favored 'General case' 0 C--N 1.329 -0.322 0 N-CA-C 109.068 -0.716 . . . . 0.0 109.068 -179.221 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' E' E ' 141' ' ' ILE . . . . . 0.468 ' N ' HD23 ' E' ' 140' ' ' LEU . 18.9 mt -121.99 118.79 56.69 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.288 0 CA-C-O 121.025 0.44 . . . . 0.0 109.981 -176.757 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' E' E ' 142' ' ' ARG . . . . . . . . . . . . . 84.4 mtp180 -103.7 125.27 50.08 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 115.285 -0.871 . . . . 0.0 110.341 -179.576 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' E' E ' 143' ' ' THR . . . . . . . . . . . . . 43.2 p . . . . . 0 C--O 1.22 -0.472 0 CA-C-O 118.015 -0.993 . . . . 0.0 110.527 -179.781 . . . . . . . . 0 0 . 1 . 003 nuclear build full ' F' F ' -3' ' ' GLU . . . . . . . . . . . . . 95.6 mt-10 . . . . . 0 N--CA 1.49 1.554 0 N-CA-C 109.466 -0.568 . . . . 0.0 109.466 . . . . . . . . . 0 0 . 1 . 003 nuclear build full ' F' F ' -2' ' ' GLY . . . . . . . . . . . . . . . -105.79 149.29 16.67 Favored Glycine 0 CA--C 1.525 0.659 0 N-CA-C 110.641 -0.984 . . . . 0.0 110.641 178.279 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' F' F ' -1' ' ' VAL . . . . . . . . . . . . . 46.6 t -95.1 134.16 33.45 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.347 0 N-CA-C 109.776 -0.453 . . . . 0.0 109.776 179.289 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' F' F ' 0' ' ' ILE . . . . . . . . . . . . . 70.7 mt -101.85 130.91 50.8 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.286 0 CA-C-N 116.211 -0.45 . . . . 0.0 110.073 -178.03 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' F' F ' 1' ' ' MET . . . . . . . . . . . . . 27.3 ptm -81.86 133.87 35.36 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 115.872 -0.604 . . . . 0.0 110.564 178.876 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' F' F ' 2' ' ' SER . . . . . . . . . . . . . 4.5 p -117.78 130.1 56.09 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.135 177.686 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' F' F ' 3' ' ' GLU . . . . . . . . . . . . . 83.3 tt0 -142.08 137.74 31.23 Favored 'General case' 0 C--N 1.327 -0.4 0 CA-C-N 115.988 -0.551 . . . . 0.0 111.062 -177.928 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' F' F ' 4' ' ' LEU . . . . . . . . . . . . . 17.1 tp -124.54 131.1 53.49 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.059 176.816 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' F' F ' 5' ' ' LYS . . . . . . . . . . . . . 69.0 mttm -110.28 122.29 47.3 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.305 -0.407 . . . . 0.0 110.602 179.962 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' F' F ' 6' ' ' LEU . . . . . . . . . . . . . 30.3 mt -113.88 149.44 35.12 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 115.234 -0.893 . . . . 0.0 109.954 -178.895 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' F' F ' 7' ' ' LYS . . . . . . . . . . . . . 52.4 tttp -137.11 137.15 22.03 Favored Pre-proline 0 CA--C 1.534 0.34 0 CA-C-O 118.857 -0.592 . . . . 0.0 109.994 175.569 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' F' F ' 8' ' ' PRO . . . . . . . . . . . . . 74.3 Cg_endo -91.45 138.41 2.18 Favored 'Trans proline' 0 N--CA 1.49 1.276 0 C-N-CA 121.675 1.583 . . . . 0.0 111.708 177.259 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' F' F ' 9' ' ' LEU . . . . . . . . . . . . . 58.1 mt -74.78 -48.18 4.92 Favored Pre-proline 0 CA--C 1.534 0.336 0 CA-C-O 118.629 -0.7 . . . . 0.0 112.277 -178.881 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' F' F ' 10' ' ' PRO . . . . . . . . . . . . . 95.3 Cg_endo -78.79 156.8 27.6 Favored 'Trans proline' 0 N--CA 1.496 1.653 0 C-N-CA 121.081 1.187 . . . . 0.0 112.008 177.381 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' F' F ' 11' ' ' LYS . . . . . . . . . . . . . 81.8 tttt -87.92 101.76 14.06 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.396 -0.365 . . . . 0.0 110.266 179.32 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' F' F ' 12' ' ' VAL . . . . . . . . . . . . . 12.3 p -143.57 149.3 18.2 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.295 0 CA-C-N 116.2 -0.454 . . . . 0.0 110.744 -178.313 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' F' F ' 13' ' ' GLU . . . . . . . . . . . . . 84.0 tt0 -91.43 127.6 36.94 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.302 -0.408 . . . . 0.0 109.989 177.598 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' F' F ' 14' ' ' LEU . . . . . . . . . . . . . 29.9 mt -98.83 146.04 30.97 Favored Pre-proline 0 CA--C 1.534 0.333 0 CA-C-O 119.183 -0.437 . . . . 0.0 110.632 -177.711 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' F' F ' 15' ' ' PRO . . . . . . . . . . . . . 23.8 Cg_exo -64.44 158.61 48.44 Favored 'Trans proline' 0 N--CA 1.497 1.707 0 C-N-CA 121.401 1.4 . . . . 0.0 111.777 174.309 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' F' F ' 16' ' ' PRO . . . . . . . . . . . . . 37.8 Cg_exo -57.98 -43.51 47.93 Favored 'Trans proline' 0 N--CA 1.496 1.648 0 C-N-CA 121.477 1.451 . . . . 0.0 112.97 -177.834 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' F' F ' 17' ' ' ASP . . . . . . . . . . . . . 23.2 p-10 -82.42 7.73 13.41 Favored 'General case' 0 CA--C 1.536 0.429 0 N-CA-C 113.252 0.834 . . . . 0.0 113.252 -177.615 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' F' F ' 18' ' ' PHE . . . . . . . . . . . . . 45.7 t80 -58.05 -45.11 87.57 Favored 'General case' 0 N--CA 1.458 -0.069 0 O-C-N 121.996 -0.44 . . . . 0.0 110.183 -178.179 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' F' F ' 19' ' ' VAL . . . . . 0.407 HG13 ' N ' ' F' ' 20' ' ' ASP . 14.4 p -56.98 -41.96 78.12 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.35 0 CA-C-N 116.34 -0.391 . . . . 0.0 110.935 -178.585 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' F' F ' 20' ' ' ASP . . . . . 0.407 ' N ' HG13 ' F' ' 19' ' ' VAL . 67.6 m-20 -60.85 -42.13 97.23 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-O 120.884 0.373 . . . . 0.0 110.9 -178.125 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' F' F ' 21' ' ' VAL . . . . . . . . . . . . . 52.9 t -64.36 -47.37 89.84 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.32 0 CA-C-N 116.374 -0.376 . . . . 0.0 110.353 -178.107 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' F' F ' 22' ' ' ILE . . . . . . . . . . . . . 51.0 mm -56.72 -43.49 79.47 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.283 0 CA-C-O 120.773 0.32 . . . . 0.0 110.479 178.764 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' F' F ' 23' ' ' ARG . . . . . . . . . . . . . 42.2 ttp180 -54.4 -49.12 70.66 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.632 -0.258 . . . . 0.0 111.432 -179.003 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' F' F ' 24' ' ' ILE . . . . . . . . . . . . . 73.4 mt -59.37 -43.72 90.88 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.284 0 C-N-CA 121.072 -0.251 . . . . 0.0 111.019 -178.071 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' F' F ' 25' ' ' LYS . . . . . . . . . . . . . 99.0 mttt -63.79 -41.8 97.87 Favored 'General case' 0 C--N 1.327 -0.382 0 N-CA-C 112.526 0.565 . . . . 0.0 112.526 -178.255 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' F' F ' 26' ' ' LEU . . . . . . . . . . . . . 93.3 mt -79.49 -41.64 26.98 Favored 'General case' 0 C--N 1.329 -0.318 0 N-CA-C 113.14 0.793 . . . . 0.0 113.14 -172.511 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' F' F ' 27' ' ' GLN . . . . . . . . . . . . . 14.1 pt20 -46.41 142.16 3.19 Favored 'General case' 0 N--CA 1.469 0.482 0 N-CA-C 112.9 0.704 . . . . 0.0 112.9 -173.581 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' F' F ' 28' ' ' GLY . . . . . . . . . . . . . . . 101.26 -29.85 11.64 Favored Glycine 0 CA--C 1.529 0.953 0 CA-C-N 115.15 -0.932 . . . . 0.0 111.941 -177.182 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' F' F ' 29' ' ' LYS . . . . . . . . . . . . . 93.3 mttt -98.62 155.18 17.43 Favored 'General case' 0 C--N 1.332 -0.173 0 CA-C-N 117.329 0.564 . . . . 0.0 111.129 177.981 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' F' F ' 30' ' ' THR . . . . . . . . . . . . . 34.8 m -102.58 138.91 38.86 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.163 -0.471 . . . . 0.0 110.063 176.657 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' F' F ' 31' ' ' VAL . . . . . . . . . . . . . 34.9 m -128.91 158.6 41.47 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.186 0 CA-C-N 116.413 -0.358 . . . . 0.0 110.808 -178.8 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' F' F ' 32' ' ' ARG . . . . . . . . . . . . . 96.9 mtt180 -130.79 151.74 50.89 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 115.922 -0.581 . . . . 0.0 110.5 178.735 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' F' F ' 33' ' ' THR . . . . . . . . . . . . . 18.4 m -53.97 138.78 36.13 Favored 'General case' 0 C--N 1.331 -0.239 0 CA-C-N 116.19 -0.459 . . . . 0.0 111.153 -179.519 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' F' F ' 34' ' ' GLY . . . . . . . . . . . . . . . 101.82 -17.12 55.29 Favored Glycine 0 CA--C 1.534 1.225 0 CA-C-O 119.618 -0.546 . . . . 0.0 113.191 -179.915 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' F' F ' 35' ' ' ASP . . . . . . . . . . . . . 56.7 m-20 -64.71 149.57 48.89 Favored 'General case' 0 C--O 1.232 0.14 0 CA-C-N 118.146 0.973 . . . . 0.0 111.29 179.434 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' F' F ' 36' ' ' VAL . . . . . . . . . . . . . 46.3 t -124.32 130.07 73.76 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.303 0 CA-C-N 115.698 -0.683 . . . . 0.0 109.845 179.565 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' F' F ' 37' ' ' ILE . . . . . . . . . . . . . 69.1 mt -121.97 139.42 49.05 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.219 0 CA-C-N 116.216 -0.447 . . . . 0.0 109.835 179.95 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' F' F ' 38' ' ' GLY . . . . . . . . . . . . . . . -114.41 128.88 8.41 Favored Glycine 0 CA--C 1.526 0.75 0 N-CA-C 110.943 -0.863 . . . . 0.0 110.943 -179.974 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' F' F ' 39' ' ' ILE . . . . . . . . . . . . . 70.8 mt -119.37 129.89 74.69 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.245 0 N-CA-C 109.929 -0.397 . . . . 0.0 109.929 179.059 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' F' F ' 40' ' ' SER . . . . . . . . . . . . . 22.8 t -93.74 118.9 32.03 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.437 -0.347 . . . . 0.0 110.788 175.732 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' F' F ' 41' ' ' ILE . . . . . . . . . . . . . 71.4 mt -124.76 117.06 49.2 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.269 0 CA-C-O 120.787 0.327 . . . . 0.0 110.315 178.808 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' F' F ' 42' ' ' LEU . . . . . . . . . . . . . 6.9 mp 51.04 36.93 16.52 Favored 'General case' 0 N--CA 1.463 0.21 0 CA-C-O 121.143 0.497 . . . . 0.0 111.548 178.17 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' F' F ' 43' ' ' GLY . . . . . . . . . . . . . . . 73.88 30.79 60.95 Favored Glycine 0 CA--C 1.529 0.941 0 C-N-CA 121.184 -0.531 . . . . 0.0 112.324 177.636 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' F' F ' 44' ' ' LYS . . . . . . . . . . . . . 64.1 mttp -132.5 127.21 34.71 Favored 'General case' 0 C--N 1.331 -0.233 0 N-CA-C 109.679 -0.489 . . . . 0.0 109.679 177.231 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' F' F ' 45' ' ' GLU . . . . . . . . . . . . . 80.2 tt0 -84.79 122.77 29.61 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-O 120.843 0.354 . . . . 0.0 111.215 -177.535 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' F' F ' 46' ' ' VAL . . . . . . . . . . . . . 7.6 p -122.2 126.45 74.34 Favored 'Isoleucine or valine' 0 C--O 1.233 0.186 0 N-CA-C 109.329 -0.619 . . . . 0.0 109.329 174.625 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' F' F ' 47' ' ' LYS . . . . . . . . . . . . . 93.7 mttt -100.33 130.48 46.44 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.123 -0.49 . . . . 0.0 111.342 179.871 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' F' F ' 48' ' ' PHE . . . . . . . . . . . . . 91.7 m-85 -114.21 131.79 56.34 Favored 'General case' 0 C--N 1.33 -0.267 0 N-CA-C 109.637 -0.505 . . . . 0.0 109.637 175.095 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' F' F ' 49' ' ' LYS . . . . . . . . . . . . . 37.2 tttp -109.38 139.9 43.76 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.452 -0.34 . . . . 0.0 110.542 179.846 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' F' F ' 50' ' ' VAL . . . . . . . . . . . . . 43.4 t -82.96 108.22 15.5 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.225 0 N-CA-C 109.267 -0.642 . . . . 0.0 109.267 175.513 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' F' F ' 51' ' ' VAL . . . . . . . . . . . . . 48.0 t -73.08 -53.08 19.48 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.32 0 CA-C-N 115.926 -0.579 . . . . 0.0 109.615 -174.404 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' F' F ' 52' ' ' GLN . . . . . . . . . . . . . 88.7 mt-30 -154.09 151.44 29.29 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.022 -0.535 . . . . 0.0 111.972 -177.493 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' F' F ' 53' ' ' ALA . . . . . . . . . . . . . . . -128.18 132.96 48.84 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 115.214 -0.903 . . . . 0.0 109.683 174.975 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' F' F ' 54' ' ' TYR . . . . . . . . . . . . . 25.7 t80 -129.07 108.41 18.06 Favored Pre-proline 0 CA--C 1.535 0.4 0 CA-C-O 118.327 -0.844 . . . . 0.0 110.256 179.07 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' F' F ' 55' ' ' PRO . . . . . . . . . . . . . 73.2 Cg_endo -77.16 169.0 75.4 Favored 'Cis proline' 0 N--CA 1.501 1.919 0 CA-C-N 121.853 1.698 . . . . 0.0 112.453 -5.205 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' F' F ' 56' ' ' SER . . . . . . . . . . . . . 54.3 m -116.72 130.42 24.56 Favored Pre-proline 0 CA--C 1.539 0.536 0 CA-C-O 118.413 -0.803 . . . . 0.0 109.229 174.819 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' F' F ' 57' ' ' PRO . . . . . . . . . . . . . 38.1 Cg_endo -67.15 164.65 70.31 Favored 'Cis proline' 0 N--CA 1.498 1.741 0 CA-C-N 121.991 1.747 . . . . 0.0 111.584 -0.282 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' F' F ' 58' ' ' LEU . . . . . . . . . . . . . 29.7 tp -129.75 136.2 49.35 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-N 116.26 -0.427 . . . . 0.0 110.297 179.702 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' F' F ' 59' ' ' ARG . . . . . . . . . . . . . 70.5 ttt180 -100.42 128.57 46.44 Favored 'General case' 0 C--N 1.326 -0.423 0 N-CA-C 109.188 -0.671 . . . . 0.0 109.188 176.244 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' F' F ' 60' ' ' VAL . . . . . . . . . . . . . 46.9 t -80.65 115.01 22.45 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.254 0 C-N-CA 120.588 -0.445 . . . . 0.0 110.096 -175.075 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' F' F ' 61' ' ' GLU . . . . . . . . . . . . . 95.3 mt-10 -130.99 160.53 34.29 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 115.841 -0.618 . . . . 0.0 109.758 178.221 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' F' F ' 62' ' ' ASP . . . . . . . . . . . . . 15.0 p-10 -53.25 -31.45 43.56 Favored 'General case' 0 C--N 1.327 -0.387 0 N-CA-C 111.925 0.343 . . . . 0.0 111.925 179.944 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' F' F ' 63' ' ' ARG . . . . . . . . . . . . . 39.7 mtp180 -71.86 -22.11 61.57 Favored 'General case' 0 CA--C 1.532 0.27 0 N-CA-C 112.894 0.701 . . . . 0.0 112.894 -176.095 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' F' F ' 64' ' ' THR . . . . . . . . . . . . . 34.2 m -72.73 141.13 48.16 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-O 121.013 0.435 . . . . 0.0 111.013 -175.612 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' F' F ' 65' ' ' LYS . . . . . . . . . . . . . 97.5 mttt -89.18 131.2 35.42 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 115.851 -0.613 . . . . 0.0 109.84 177.635 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' F' F ' 66' ' ' ILE . . . . . . . . . . . . . 59.9 mt -116.01 129.03 73.06 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.228 0 N-CA-C 109.798 -0.445 . . . . 0.0 109.798 179.37 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' F' F ' 67' ' ' THR . . . . . . . . . . . . . 23.8 m -127.05 142.63 51.49 Favored 'General case' 0 C--N 1.331 -0.227 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.892 -178.148 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' F' F ' 68' ' ' LEU . . . . . . . . . . . . . 6.7 mp -102.3 125.72 49.09 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.023 -0.535 . . . . 0.0 110.321 176.948 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' F' F ' 69' ' ' VAL . . . . . . . . . . . . . 44.2 t -102.07 123.73 55.48 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 CA-C-N 116.11 -0.496 . . . . 0.0 110.111 -179.889 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' F' F ' 70' ' ' THR . . . . . . . . . . . . . 78.0 p -150.07 120.34 7.32 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 115.944 -0.571 . . . . 0.0 110.088 178.401 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' F' F ' 71' ' ' HIS . . . . . . . . . . . . . 54.6 m-70 -132.43 60.04 47.88 Favored Pre-proline 0 CA--C 1.538 0.517 0 C-N-CA 120.945 -0.302 . . . . 0.0 111.449 179.711 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' F' F ' 72' ' ' PRO . . . . . . . . . . . . . 77.9 Cg_endo -88.36 144.93 5.92 Favored 'Trans proline' 0 N--CA 1.491 1.379 0 C-N-CA 121.569 1.513 . . . . 0.0 110.839 170.363 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' F' F ' 73' ' ' VAL . . . . . . . . . . . . . 24.5 m -83.51 130.55 35.62 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.231 0 CA-C-O 121.356 0.598 . . . . 0.0 110.933 -179.323 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' F' F ' 74' ' ' ASP . . . . . . . . . . . . . 12.3 t0 -99.41 124.1 44.25 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 115.404 -0.816 . . . . 0.0 108.981 176.053 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' F' F ' 75' ' ' VAL . . . . . 0.413 HG21 ' CE1' ' E' ' 113' ' ' TYR . 41.8 t -112.83 124.08 69.13 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.245 0 CA-C-O 121.072 0.463 . . . . 0.0 110.839 -174.35 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' F' F ' 76' ' ' LEU . . . . . . . . . . . . . 5.8 mp -125.76 146.87 49.59 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 115.549 -0.75 . . . . 0.0 109.638 175.394 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' F' F ' 77' ' ' GLU . . . . . . . . . . . . . 97.7 mt-10 -134.22 130.88 37.84 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-O 120.977 0.418 . . . . 0.0 110.889 -178.075 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' F' F ' 78' ' ' ALA . . . . . . . . . . . . . . . -114.47 134.21 55.18 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 115.709 -0.678 . . . . 0.0 109.502 176.806 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' F' F ' 79' ' ' LYS . . . . . 0.648 ' O ' HD13 ' F' ' 80' ' ' ILE . 25.7 pttm -77.55 119.31 20.95 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-O 121.472 0.653 . . . . 0.0 110.792 -178.644 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' F' F ' 80' ' ' ILE . . . . . 0.648 HD13 ' O ' ' F' ' 79' ' ' LYS . 36.6 mm -139.26 113.87 7.66 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.282 0 CA-C-N 115.546 -0.752 . . . . 0.0 109.103 -178.795 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' F' F ' 81' ' ' LYS . . . . . . . . . . . . . 24.5 pttm -114.32 128.01 56.14 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-O 120.991 0.424 . . . . 0.0 111.269 -177.252 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' F' F ' 82' ' ' GLY . . . . . . . . . . . . . . . 88.89 42.21 5.73 Favored Glycine 0 CA--C 1.527 0.794 0 N-CA-C 111.483 -0.647 . . . . 0.0 111.483 177.078 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' F' F ' 83' ' ' ILE . . . . . . . . . . . . . 72.9 mt -69.88 140.95 17.79 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 CA-C-O 120.871 0.367 . . . . 0.0 110.197 179.633 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' F' F ' 84' ' ' LYS . . . . . . . . . . . . . 54.7 tttp -101.6 -50.88 3.59 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-N 115.951 -0.568 . . . . 0.0 109.984 178.746 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' F' F ' 85' ' ' ASP . . . . . . . . . . . . . 6.5 t0 -153.71 149.26 27.31 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 115.792 -0.64 . . . . 0.0 110.402 -179.543 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' F' F ' 86' ' ' VAL . . . . . . . . . . . . . 42.1 t -132.2 129.73 60.13 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.185 0 CA-C-O 120.882 0.372 . . . . 0.0 110.319 -179.852 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' F' F ' 87' ' ' ILE . . . . . 0.494 HD12 ' N ' ' F' ' 87' ' ' ILE . 4.9 mp -120.1 126.65 75.5 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.245 0 N-CA-C 109.548 -0.538 . . . . 0.0 109.548 176.321 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' F' F ' 88' ' ' LEU . . . . . . . . . . . . . 59.0 mt -111.59 136.9 50.17 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-O 121.103 0.478 . . . . 0.0 111.263 -177.798 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' F' F ' 89' ' ' ASP . . . . . . . . . . . . . 12.6 t70 -129.49 153.66 47.77 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 115.646 -0.706 . . . . 0.0 109.285 175.742 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' F' F ' 90' ' ' GLU . . . . . . . . . . . . . 43.6 tp10 -48.47 -33.99 10.33 Favored 'General case' 0 C--N 1.329 -0.326 0 N-CA-C 112.918 0.71 . . . . 0.0 112.918 -172.011 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' F' F ' 91' ' ' ASN . . . . . . . . . . . . . 83.3 m-20 -131.25 27.54 4.79 Favored 'General case' 0 N--CA 1.466 0.343 0 N-CA-C 112.514 0.561 . . . . 0.0 112.514 -175.381 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' F' F ' 92' ' ' LEU . . . . . . . . . . . . . 6.6 tp -166.13 150.46 7.94 Favored 'General case' 0 C--N 1.331 -0.199 0 C-N-CA 120.83 -0.348 . . . . 0.0 110.752 -179.981 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' F' F ' 93' ' ' ILE . . . . . . . . . . . . . 71.8 mt -129.03 126.14 63.95 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.216 0 N-CA-C 109.693 -0.484 . . . . 0.0 109.693 178.927 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' F' F ' 94' ' ' VAL . . . . . . . . . . . . . 44.8 t -121.8 127.16 75.39 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.258 0 N-CA-C 109.735 -0.468 . . . . 0.0 109.735 178.8 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' F' F ' 95' ' ' VAL . . . . . . . . . . . . . 42.4 t -124.16 136.3 60.86 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.25 0 CA-C-N 116.091 -0.504 . . . . 0.0 110.054 -178.361 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' F' F ' 96' ' ' ILE . . . . . 0.559 HD11 ' HB ' ' F' ' 123' ' ' VAL . 47.3 mt -118.27 130.93 72.41 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.235 0 N-CA-C 109.37 -0.604 . . . . 0.0 109.37 179.306 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' F' F ' 97' ' ' THR . . . . . . . . . . . . . 67.3 p -103.16 157.21 17.16 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-O 121.1 0.476 . . . . 0.0 111.101 -178.586 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' F' F ' 98' ' ' GLU . . . . . . . . . . . . . 96.5 mt-10 -53.84 -26.01 22.35 Favored 'General case' 0 C--N 1.328 -0.354 0 N-CA-C 112.424 0.527 . . . . 0.0 112.424 -178.79 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' F' F ' 99' ' ' GLU . . . . . . . . . . . . . 95.7 mt-10 -79.62 16.8 1.0 Allowed 'General case' 0 CA--C 1.534 0.352 0 N-CA-C 113.213 0.82 . . . . 0.0 113.213 -176.126 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' F' F ' 100' ' ' ASN . . . . . . . . . . . . . 3.6 m-20 62.72 37.4 12.68 Favored 'General case' 0 C--O 1.234 0.24 0 CA-C-O 121.212 0.53 . . . . 0.0 111.038 178.136 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' F' F ' 101' ' ' GLU . . . . . . . . . . . . . 84.5 tt0 -117.65 139.85 50.44 Favored 'General case' 0 C--N 1.333 -0.142 0 N-CA-C 109.378 -0.601 . . . . 0.0 109.378 176.217 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' F' F ' 102' ' ' VAL . . . . . . . . . . . . . 45.0 t -117.57 129.89 73.32 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 N-CA-C 109.847 -0.427 . . . . 0.0 109.847 -177.377 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' F' F ' 103' ' ' LEU . . . . . . . . . . . . . 4.7 mp -123.09 137.99 54.78 Favored 'General case' 0 C--N 1.331 -0.219 0 CA-C-N 116.144 -0.48 . . . . 0.0 110.715 178.288 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' F' F ' 104' ' ' ILE . . . . . . . . . . . . . 65.5 mt -117.8 124.7 73.44 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.255 0 CA-C-N 115.802 -0.635 . . . . 0.0 109.882 179.989 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' F' F ' 105' ' ' PHE . . . . . . . . . . . . . 89.9 m-85 -122.43 161.47 23.45 Favored 'General case' 0 C--N 1.332 -0.187 0 O-C-N 123.969 0.793 . . . . 0.0 109.817 179.458 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' F' F ' 106' ' ' ASN . . . . . . . . . . . . . 47.2 p-10 -97.5 -171.35 2.17 Favored 'General case' 0 C--N 1.331 -0.209 0 N-CA-C 109.932 -0.396 . . . . 0.0 109.932 173.132 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' F' F ' 107' ' ' GLN . . . . . . . . . . . . . 48.4 tt0 -57.3 -30.12 64.47 Favored 'General case' 0 C--N 1.328 -0.348 0 N-CA-C 112.043 0.386 . . . . 0.0 112.043 -179.188 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' F' F ' 108' ' ' ASN . . . . . . . . . . . . . 13.0 t-20 -88.73 14.02 11.09 Favored 'General case' 0 CA--C 1.534 0.349 0 N-CA-C 112.973 0.731 . . . . 0.0 112.973 -175.612 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' F' F ' 109' ' ' LEU . . . . . . . . . . . . . 33.5 mt 57.97 33.4 23.15 Favored 'General case' 0 C--O 1.233 0.19 0 N-CA-C 111.756 0.28 . . . . 0.0 111.756 179.247 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' F' F ' 110' ' ' GLU . . . . . . . . . . . . . 43.3 mt-10 -98.05 145.24 26.73 Favored 'General case' 0 C--N 1.33 -0.277 0 N-CA-C 109.594 -0.521 . . . . 0.0 109.594 175.924 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' F' F ' 111' ' ' GLU . . . . . . . . . . . . . 53.7 tt0 -81.24 122.02 26.89 Favored 'General case' 0 C--N 1.328 -0.351 0 C-N-CA 120.725 -0.39 . . . . 0.0 110.487 -176.992 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' F' F ' 112' ' ' LEU . . . . . . . . . . . . . 58.2 mt -106.53 -46.09 4.09 Favored 'General case' 0 C--N 1.331 -0.226 0 CA-C-N 116.135 -0.484 . . . . 0.0 110.42 178.178 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' F' F ' 113' ' ' TYR . . . . . . . . . . . . . 64.6 t80 -138.36 137.08 36.98 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.134 -0.485 . . . . 0.0 111.169 -179.017 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' F' F ' 114' ' ' ARG . . . . . . . . . . . . . 56.1 ttp180 -141.45 121.29 13.55 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.277 -0.419 . . . . 0.0 109.949 174.848 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' F' F ' 115' ' ' GLY . . . . . . . . . . . . . . . -148.52 160.96 28.54 Favored Glycine 0 CA--C 1.524 0.595 0 N-CA-C 111.069 -0.812 . . . . 0.0 111.069 179.826 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' F' F ' 116' ' ' LYS . . . . . . . . . . . . . 40.2 ttpt -124.36 141.93 51.69 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-O 120.64 0.257 . . . . 0.0 110.385 -179.901 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' F' F ' 117' ' ' PHE . . . . . . . . . . . . . 47.4 m-85 -135.24 113.9 11.76 Favored 'General case' 0 C--N 1.332 -0.184 0 CA-C-O 120.907 0.384 . . . . 0.0 110.019 179.459 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' F' F ' 118' ' ' GLU . . . . . . . . . . . . . 82.1 tt0 -53.95 -51.69 63.03 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.457 -0.338 . . . . 0.0 111.376 -176.348 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' F' F ' 119' ' ' ASN . . . . . . . . . . . . . 87.6 m-20 -93.84 31.19 1.65 Allowed 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.052 -0.522 . . . . 0.0 112.19 -174.712 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' F' F ' 120' ' ' LEU . . . . . . . . . . . . . 12.9 tp -54.2 124.08 14.69 Favored 'General case' 0 N--CA 1.462 0.153 0 CA-C-O 120.624 0.249 . . . . 0.0 110.738 178.348 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' F' F ' 121' ' ' ASN . . . . . . . . . . . . . 12.4 m120 -112.15 -44.06 3.47 Favored 'General case' 0 C--O 1.232 0.137 0 CA-C-N 116.62 -0.264 . . . . 0.0 110.944 -176.679 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' F' F ' 122' ' ' LYS . . . . . . . . . . . . . 98.2 mttt -146.66 143.16 28.57 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-O 120.917 0.389 . . . . 0.0 111.387 -178.875 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' F' F ' 123' ' ' VAL . . . . . 0.559 ' HB ' HD11 ' F' ' 96' ' ' ILE . 46.5 t -126.77 127.43 70.01 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.314 0 N-CA-C 109.19 -0.67 . . . . 0.0 109.19 175.049 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' F' F ' 124' ' ' LEU . . . . . . . . . . . . . 13.9 tp -134.05 140.05 46.41 Favored 'General case' 0 C--N 1.331 -0.227 0 CA-C-O 120.947 0.403 . . . . 0.0 110.805 -176.797 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' F' F ' 125' ' ' VAL . . . . . . . . . . . . . 12.2 p -131.51 140.03 49.26 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.215 0 CA-C-N 116.239 -0.437 . . . . 0.0 110.335 178.492 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' F' F ' 126' ' ' ARG . . . . . . . . . . . . . 96.6 mtt-85 -136.97 124.24 21.85 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.064 -0.516 . . . . 0.0 110.402 179.297 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' F' F ' 127' ' ' ASN . . . . . . . . . . . . . 67.7 m-80 52.02 -106.46 0.27 Allowed 'General case' 0 CA--C 1.544 0.73 0 CA-C-O 119.044 -0.503 . . . . 0.0 111.104 179.997 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' F' F ' 128' ' ' ASP . . . . . . . . . . . . . 8.1 p-10 -114.09 1.67 14.68 Favored 'General case' 0 CA--C 1.536 0.414 0 CA-C-N 119.629 1.104 . . . . 0.0 113.459 -177.86 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' F' F ' 129' ' ' LEU . . . . . . . . . . . . . 29.3 mt -107.35 145.12 33.26 Favored 'General case' 0 C--N 1.333 -0.11 0 O-C-N 121.962 -0.461 . . . . 0.0 110.383 -178.571 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' F' F ' 130' ' ' VAL . . . . . . . . . . . . . 43.3 t -122.18 136.31 59.44 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.231 0 CA-C-O 120.909 0.385 . . . . 0.0 110.072 -178.109 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' F' F ' 131' ' ' VAL . . . . . . . . . . . . . 42.4 t -131.69 133.61 61.27 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.247 0 CA-C-N 116.209 -0.451 . . . . 0.0 109.812 177.651 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' F' F ' 132' ' ' ILE . . . . . . . . . . . . . 71.0 mt -119.68 132.14 70.25 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.317 0 CA-C-N 115.966 -0.561 . . . . 0.0 109.536 -179.143 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' F' F ' 133' ' ' ILE . . . . . . . . . . . . . 37.4 mm -116.84 123.39 71.69 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.331 0 CA-C-O 120.916 0.388 . . . . 0.0 110.855 -175.274 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' F' F ' 134' ' ' ASP . . . . . . . . . . . . . 9.3 p-10 -134.07 149.12 51.12 Favored 'General case' 0 C--N 1.329 -0.298 0 N-CA-C 109.606 -0.516 . . . . 0.0 109.606 174.661 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' F' F ' 135' ' ' GLU . . . . . . . . . . . . . 84.3 tt0 -49.87 -26.58 4.19 Favored 'General case' 0 C--N 1.327 -0.386 0 N-CA-C 112.71 0.633 . . . . 0.0 112.71 -173.283 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' F' F ' 136' ' ' GLN . . . . . . . . . . . . . 36.3 tt0 -84.72 -36.47 21.8 Favored 'General case' 0 C--O 1.234 0.289 0 N-CA-C 112.19 0.441 . . . . 0.0 112.19 -174.729 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' F' F ' 137' ' ' LYS . . . . . . . . . . . . . 20.4 pttp -163.08 171.7 16.02 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-O 121.539 0.685 . . . . 0.0 112.375 -171.32 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' F' F ' 138' ' ' LEU . . . . . 0.513 HD23 ' N ' ' F' ' 139' ' ' THR . 3.9 tt -116.33 127.64 54.86 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 114.995 -1.002 . . . . 0.0 109.661 178.808 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' F' F ' 139' ' ' THR . . . . . 0.513 ' N ' HD23 ' F' ' 138' ' ' LEU . 28.4 m -108.46 127.82 54.25 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-O 120.772 0.32 . . . . 0.0 110.676 -179.88 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' F' F ' 140' ' ' LEU . . . . . . . . . . . . . 10.0 tp -113.57 120.48 41.11 Favored 'General case' 0 C--N 1.328 -0.339 0 N-CA-C 109.175 -0.676 . . . . 0.0 109.175 -179.367 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' F' F ' 141' ' ' ILE . . . . . . . . . . . . . 18.9 mt -120.56 118.36 56.29 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.299 0 CA-C-O 120.986 0.422 . . . . 0.0 109.966 -174.76 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' F' F ' 142' ' ' ARG . . . . . . . . . . . . . 83.9 mtm180 -108.86 128.18 54.69 Favored 'General case' 0 C--N 1.332 -0.19 0 CA-C-N 115.543 -0.753 . . . . 0.0 110.318 -179.255 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' F' F ' 143' ' ' THR . . . . . . . . . . . . . 22.6 p . . . . . 0 C--O 1.22 -0.462 0 CA-C-O 117.94 -1.028 . . . . 0.0 110.669 -179.42 . . . . . . . . 0 0 . 1 . 004 nuclear build full ' A' A ' -3' ' ' GLU . . . . . . . . . . . . . 42.4 mp0 . . . . . 0 N--CA 1.489 1.52 0 N-CA-C 109.361 -0.607 . . . . 0.0 109.361 . . . . . . . . . 0 0 . 1 . 004 nuclear build full ' A' A ' -2' ' ' GLY . . . . . . . . . . . . . . . -97.81 142.01 15.91 Favored Glycine 0 CA--C 1.525 0.715 0 N-CA-C 111.099 -0.801 . . . . 0.0 111.099 -179.616 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' -1' ' ' VAL . . . . . . . . . . . . . 42.7 t -142.32 147.8 20.88 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.4 0 N-CA-C 109.929 -0.397 . . . . 0.0 109.929 179.652 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 0' ' ' ILE . . . . . . . . . . . . . 42.9 mm -96.67 131.93 42.27 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.284 0 CA-C-N 116.256 -0.429 . . . . 0.0 110.282 -179.604 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 24.9 ptp -80.27 146.85 31.44 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.136 -0.484 . . . . 0.0 110.636 -179.953 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 3.8 p -122.93 130.14 52.46 Favored 'General case' 0 N--CA 1.463 0.206 0 CA-C-O 121.065 0.459 . . . . 0.0 110.875 -179.202 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 95.6 mt-10 -140.32 139.57 35.46 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 115.737 -0.665 . . . . 0.0 110.904 -179.974 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 4' ' ' LEU . . . . . . . . . . . . . 18.6 tp -125.91 129.54 49.52 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 115.922 -0.581 . . . . 0.0 110.19 177.641 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 5' ' ' LYS . . . . . . . . . . . . . 64.0 mttp -111.65 121.12 44.29 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.393 -0.367 . . . . 0.0 110.784 179.892 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 18.8 mt -114.09 148.17 37.55 Favored 'General case' 0 C--N 1.332 -0.193 0 CA-C-N 115.52 -0.764 . . . . 0.0 109.771 179.449 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 48.4 tttp -126.09 137.88 31.06 Favored Pre-proline 0 CA--C 1.533 0.3 0 CA-C-O 118.863 -0.589 . . . . 0.0 109.842 174.954 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 8' ' ' PRO . . . . . . . . . . . . . 91.6 Cg_endo -90.51 134.93 2.02 Favored 'Trans proline' 0 N--CA 1.489 1.219 0 C-N-CA 121.729 1.619 . . . . 0.0 111.791 179.182 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 22.1 mt -80.16 -47.92 1.33 Allowed Pre-proline 0 CA--C 1.533 0.307 0 CA-C-O 118.654 -0.688 . . . . 0.0 112.238 -178.844 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 90.8 Cg_endo -79.53 152.26 22.98 Favored 'Trans proline' 0 N--CA 1.497 1.677 0 C-N-CA 121.065 1.176 . . . . 0.0 111.914 176.977 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 22.9 tptm -84.35 92.38 8.01 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.39 -0.368 . . . . 0.0 110.312 178.841 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 12.0 p -139.97 144.11 28.77 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.339 0 CA-C-N 116.151 -0.477 . . . . 0.0 110.441 179.957 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 95.5 mt-10 -89.18 122.23 32.26 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.339 -0.391 . . . . 0.0 110.194 178.063 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 14' ' ' LEU . . . . . . . . . . . . . 28.5 mt -93.91 144.77 28.67 Favored Pre-proline 0 C--N 1.329 -0.29 0 CA-C-O 118.971 -0.538 . . . . 0.0 109.99 -179.354 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 15' ' ' PRO . . . . . . . . . . . . . 31.0 Cg_exo -59.53 159.92 22.19 Favored 'Trans proline' 0 N--CA 1.498 1.757 0 C-N-CA 121.256 1.304 . . . . 0.0 111.713 179.095 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 16' ' ' PRO . . . . . . . . . . . . . 37.0 Cg_exo -58.59 -41.21 66.64 Favored 'Trans proline' 0 N--CA 1.496 1.648 0 C-N-CA 121.477 1.451 . . . . 0.0 112.757 -178.226 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 17' ' ' ASP . . . . . . . . . . . . . 19.1 p-10 -82.34 6.14 18.0 Favored 'General case' 0 CA--C 1.536 0.434 0 N-CA-C 113.274 0.842 . . . . 0.0 113.274 -178.008 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 18' ' ' PHE . . . . . . . . . . . . . 58.1 t80 -57.99 -45.18 87.22 Favored 'General case' 0 C--N 1.334 -0.084 0 O-C-N 121.938 -0.476 . . . . 0.0 110.119 -178.389 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 19' ' ' VAL . . . . . . . . . . . . . 48.3 t -56.33 -43.77 77.98 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.297 0 CA-C-N 116.291 -0.413 . . . . 0.0 110.628 -177.959 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 80.6 m-20 -60.31 -42.61 95.93 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.497 -0.32 . . . . 0.0 110.964 -178.068 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 45.6 t -64.01 -46.48 93.79 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.282 0 C-N-CA 120.846 -0.342 . . . . 0.0 110.56 -177.711 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 22' ' ' ILE . . . . . 0.517 HG22 HD12 ' A' ' 26' ' ' LEU . 50.8 mm -55.54 -46.02 78.85 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.241 0 CA-C-O 120.727 0.299 . . . . 0.0 110.549 178.649 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 23' ' ' ARG . . . . . . . . . . . . . 53.7 ttp180 -53.36 -49.15 67.74 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-O 120.711 0.291 . . . . 0.0 111.412 179.959 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 24' ' ' ILE . . . . . . . . . . . . . 73.9 mt -58.81 -40.54 80.18 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.306 0 CA-C-N 116.483 -0.326 . . . . 0.0 111.133 -178.345 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 51.4 mttm -70.91 -37.54 72.94 Favored 'General case' 0 C--N 1.329 -0.308 0 N-CA-C 112.511 0.56 . . . . 0.0 112.511 -178.272 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 26' ' ' LEU . . . . . 0.517 HD12 HG22 ' A' ' 22' ' ' ILE . 67.6 mt -78.73 -35.85 44.14 Favored 'General case' 0 C--N 1.33 -0.265 0 N-CA-C 113.199 0.814 . . . . 0.0 113.199 -170.062 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 27' ' ' GLN . . . . . . . . . . . . . 21.2 pt20 -46.57 135.98 8.07 Favored 'General case' 0 N--CA 1.468 0.426 0 N-CA-C 112.822 0.675 . . . . 0.0 112.822 -176.319 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 101.15 -20.69 46.35 Favored Glycine 0 CA--C 1.535 1.294 0 CA-C-N 115.759 -0.655 . . . . 0.0 112.644 -177.84 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 56.5 mtpt -97.12 155.11 16.96 Favored 'General case' 0 C--O 1.233 0.196 0 CA-C-N 117.695 0.747 . . . . 0.0 111.061 178.84 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 30' ' ' THR . . . . . . . . . . . . . 44.5 m -106.96 133.76 51.13 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 115.95 -0.568 . . . . 0.0 109.613 174.356 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 34.7 m -128.81 153.19 38.02 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.241 0 CA-C-O 121.017 0.437 . . . . 0.0 110.961 -177.43 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 32' ' ' ARG . . . . . . . . . . . . . 96.9 mtt180 -132.81 150.92 52.11 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 115.897 -0.592 . . . . 0.0 110.623 179.365 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 33' ' ' THR . . . . . . . . . . . . . 12.5 m -53.03 139.01 29.23 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.232 -0.44 . . . . 0.0 111.295 -178.638 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 100.65 -17.14 56.99 Favored Glycine 0 CA--C 1.532 1.109 0 C-N-CA 121.205 -0.521 . . . . 0.0 113.232 179.275 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 54.4 m-20 -64.48 151.07 45.3 Favored 'General case' 0 C--O 1.232 0.136 0 CA-C-N 118.099 0.949 . . . . 0.0 111.308 -179.621 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 47.5 t -125.04 128.33 72.96 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.258 0 CA-C-N 115.767 -0.651 . . . . 0.0 109.621 178.223 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 37' ' ' ILE . . . . . . . . . . . . . 64.1 mt -123.41 140.43 47.03 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.173 0 CA-C-N 116.29 -0.414 . . . . 0.0 110.039 -178.656 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . -115.07 128.77 8.26 Favored Glycine 0 CA--C 1.526 0.752 0 N-CA-C 110.815 -0.914 . . . . 0.0 110.815 178.179 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 39' ' ' ILE . . . . . . . . . . . . . 74.5 mt -126.42 138.08 55.79 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.221 0 CA-C-O 120.75 0.31 . . . . 0.0 110.205 -179.907 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 40' ' ' SER . . . . . . . . . . . . . 35.1 t -91.51 113.94 26.34 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.616 175.491 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 41' ' ' ILE . . . . . . . . . . . . . 45.3 mm -119.66 119.99 62.08 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.214 0 CA-C-O 120.76 0.314 . . . . 0.0 110.415 -179.852 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 37.3 mt 52.74 35.08 17.62 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.192 -0.458 . . . . 0.0 111.744 177.007 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . 73.25 31.0 61.91 Favored Glycine 0 CA--C 1.529 0.947 0 C-N-CA 121.106 -0.569 . . . . 0.0 112.264 177.976 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 44' ' ' LYS . . . . . . . . . . . . . 21.0 tptp -141.36 130.8 23.79 Favored 'General case' 0 C--N 1.329 -0.315 0 N-CA-C 109.548 -0.538 . . . . 0.0 109.548 178.142 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 82.7 tt0 -81.53 121.62 26.53 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-O 120.883 0.373 . . . . 0.0 111.277 -176.397 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 46' ' ' VAL . . . . . . . . . . . . . 9.0 p -119.61 124.5 73.02 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.175 0 N-CA-C 109.564 -0.532 . . . . 0.0 109.564 175.754 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 97.7 mttt -98.83 128.71 45.11 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 116.09 -0.505 . . . . 0.0 110.843 178.326 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 48' ' ' PHE . . . . . . . . . . . . . 30.1 m-85 -113.63 131.81 55.99 Favored 'General case' 0 C--N 1.33 -0.267 0 N-CA-C 109.86 -0.422 . . . . 0.0 109.86 177.862 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 83.1 tttt -107.24 135.79 48.16 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 116.39 -0.368 . . . . 0.0 110.193 177.629 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 50' ' ' VAL . . . . . . . . . . . . . 43.9 t -79.52 107.64 12.17 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.33 0 N-CA-C 109.682 -0.488 . . . . 0.0 109.682 178.228 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 51' ' ' VAL . . . . . . . . . . . . . 47.5 t -72.51 -51.95 26.07 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.354 0 CA-C-N 115.872 -0.604 . . . . 0.0 109.619 -176.046 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 52' ' ' GLN . . . . . . . . . . . . . 63.0 mt-30 -155.59 147.62 23.44 Favored 'General case' 0 C--N 1.331 -0.225 0 C-N-CA 120.346 -0.541 . . . . 0.0 111.698 -177.672 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -124.38 132.08 53.52 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 115.231 -0.895 . . . . 0.0 109.419 174.512 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 54' ' ' TYR . . . . . . . . . . . . . 38.3 t80 -129.03 110.69 18.34 Favored Pre-proline 0 CA--C 1.535 0.368 0 CA-C-O 118.181 -0.914 . . . . 0.0 110.353 179.836 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 55' ' ' PRO . . . . . . . . . . . . . 73.8 Cg_endo -77.15 170.01 72.71 Favored 'Cis proline' 0 N--CA 1.501 1.914 0 CA-C-N 121.947 1.731 . . . . 0.0 112.335 -6.405 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 56' ' ' SER . . . . . . . . . . . . . 13.6 m -117.48 132.73 23.43 Favored Pre-proline 0 CA--C 1.539 0.555 0 CA-C-O 118.476 -0.773 . . . . 0.0 109.487 175.185 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 57' ' ' PRO . . . . . . . . . . . . . 43.5 Cg_endo -69.53 148.59 86.52 Favored 'Cis proline' 0 N--CA 1.498 1.785 0 CA-C-N 121.823 1.687 . . . . 0.0 111.348 -2.082 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 58' ' ' LEU . . . . . . . . . . . . . 19.0 tp -107.65 135.83 48.44 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.327 -0.397 . . . . 0.0 110.591 -178.168 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 59' ' ' ARG . . . . . . . . . . . . . 23.0 ttm180 -102.83 123.54 46.68 Favored 'General case' 0 C--N 1.327 -0.4 0 N-CA-C 109.293 -0.632 . . . . 0.0 109.293 175.751 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 40.5 t -82.14 119.8 32.38 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.359 0 CA-C-O 120.933 0.396 . . . . 0.0 110.807 -174.067 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 95.6 mt-10 -130.98 165.33 23.41 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 115.817 -0.629 . . . . 0.0 109.417 175.12 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 62' ' ' ASP . . . . . . . . . . . . . 64.1 m-20 -52.37 -32.01 36.44 Favored 'General case' 0 C--N 1.328 -0.332 0 N-CA-C 111.948 0.351 . . . . 0.0 111.948 -178.548 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 63' ' ' ARG . . . . . . . . . . . . . 74.4 mtt180 -73.41 -21.96 60.35 Favored 'General case' 0 CA--C 1.533 0.291 0 N-CA-C 112.84 0.682 . . . . 0.0 112.84 -175.719 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 30.6 m -69.52 134.58 49.04 Favored 'General case' 0 C--N 1.331 -0.208 0 CA-C-O 120.787 0.327 . . . . 0.0 110.952 -175.823 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 65' ' ' LYS . . . . . . . . . . . . . 57.6 mtmt -90.55 133.77 34.85 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.52 179.206 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 66' ' ' ILE . . . . . . . . . . . . . 65.4 mt -117.12 131.14 70.7 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.234 0 N-CA-C 109.995 -0.372 . . . . 0.0 109.995 -179.84 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 67' ' ' THR . . . . . . . . . . . . . 31.6 m -127.19 143.55 51.23 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.876 -178.645 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 68' ' ' LEU . . . . . . . . . . . . . 15.4 tp -105.71 131.36 53.16 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 116.119 -0.491 . . . . 0.0 110.127 177.596 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 69' ' ' VAL . . . . . . . . . . . . . 42.3 t -86.01 135.18 25.56 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.364 0 CA-C-N 116.128 -0.487 . . . . 0.0 110.488 -178.109 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 70' ' ' THR . . . . . 0.466 HG22 ' H ' ' A' ' 71' ' ' HIS . 4.0 m -87.86 167.42 13.8 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 115.833 -0.621 . . . . 0.0 109.943 177.316 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 71' ' ' HIS . . . . . 0.466 ' H ' HG22 ' A' ' 70' ' ' THR . 44.3 m80 -64.93 145.63 98.98 Favored Pre-proline 0 CA--C 1.534 0.328 0 N-CA-C 109.814 -0.439 . . . . 0.0 109.814 -179.959 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 72' ' ' PRO . . . . . . . . . . . . . 72.9 Cg_endo -77.39 -27.63 6.27 Favored 'Trans proline' 0 N--CA 1.493 1.498 0 C-N-CA 121.326 1.35 . . . . 0.0 112.707 -178.644 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 73' ' ' VAL . . . . . . . . . . . . . 35.7 m -130.27 162.89 37.27 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.184 0 CA-C-O 121.046 0.45 . . . . 0.0 110.887 -178.68 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 74' ' ' ASP . . . . . . . . . . . . . 7.1 t70 -101.64 125.87 48.38 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 115.741 -0.663 . . . . 0.0 109.806 178.939 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 42.7 t -113.94 125.04 71.15 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.268 0 CA-C-O 121.154 0.502 . . . . 0.0 110.508 -177.424 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 76' ' ' LEU . . . . . . . . . . . . . 37.7 mt -125.77 140.08 52.98 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 115.578 -0.737 . . . . 0.0 109.73 177.787 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 77' ' ' GLU . . . . . . . . . . . . . 45.9 mt-10 -132.75 136.41 46.34 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-O 120.983 0.42 . . . . 0.0 111.193 -178.751 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 78' ' ' ALA . . . . . . . . . . . . . . . -124.92 136.96 54.25 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-N 115.76 -0.654 . . . . 0.0 110.01 177.128 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 79' ' ' LYS . . . . . 0.511 ' O ' HD13 ' A' ' 80' ' ' ILE . 74.6 mmtt -78.86 119.55 22.22 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-O 120.808 0.337 . . . . 0.0 110.516 -178.54 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 80' ' ' ILE . . . . . 0.511 HD13 ' O ' ' A' ' 79' ' ' LYS . 24.2 mm -139.27 113.33 7.05 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.267 0 N-CA-C 109.303 -0.629 . . . . 0.0 109.303 -177.237 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 81' ' ' LYS . . . . . . . . . . . . . 38.5 ttpt -105.86 124.24 49.26 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-O 120.855 0.36 . . . . 0.0 111.226 -177.809 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . 89.12 42.16 5.67 Favored Glycine 0 CA--C 1.525 0.663 0 C-N-CA 120.758 -0.734 . . . . 0.0 111.886 173.655 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 83' ' ' ILE . . . . . . . . . . . . . 72.1 mt -65.64 132.79 31.26 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 CA-C-O 120.973 0.416 . . . . 0.0 110.019 178.185 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 84' ' ' LYS . . . . . . . . . . . . . 30.3 ttmt -91.87 -50.67 5.6 Favored 'General case' 0 C--N 1.331 -0.204 0 CA-C-N 116.067 -0.515 . . . . 0.0 109.883 179.493 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 85' ' ' ASP . . . . . . . . . . . . . 5.7 t70 -159.75 157.0 28.6 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 115.715 -0.675 . . . . 0.0 110.474 179.73 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 86' ' ' VAL . . . . . . . . . . . . . 42.1 t -127.86 132.46 68.78 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.221 0 CA-C-O 121.049 0.452 . . . . 0.0 110.457 -179.038 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 87' ' ' ILE . . . . . . . . . . . . . 43.2 mm -119.64 124.4 72.82 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.216 0 CA-C-N 115.863 -0.608 . . . . 0.0 109.731 177.463 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 88' ' ' LEU . . . . . . . . . . . . . 50.5 mt -108.42 136.68 47.64 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-O 120.986 0.422 . . . . 0.0 111.286 -178.521 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 89' ' ' ASP . . . . . . . . . . . . . 6.5 t70 -130.41 155.36 46.53 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 115.72 -0.673 . . . . 0.0 109.546 176.177 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 96.2 mt-10 -47.29 -36.66 9.51 Favored 'General case' 0 C--N 1.33 -0.253 0 N-CA-C 113.099 0.777 . . . . 0.0 113.099 -172.148 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 91' ' ' ASN . . . . . . . . . . . . . 35.9 t30 -132.1 21.24 4.48 Favored 'General case' 0 N--CA 1.467 0.417 0 N-CA-C 112.95 0.722 . . . . 0.0 112.95 -177.429 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 92' ' ' LEU . . . . . . . . . . . . . 20.2 mt -151.25 150.43 30.56 Favored 'General case' 0 C--N 1.333 -0.152 0 N-CA-C 110.138 -0.319 . . . . 0.0 110.138 -176.597 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 93' ' ' ILE . . . . . . . . . . . . . 76.2 mt -129.09 120.41 51.57 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.186 0 N-CA-C 109.325 -0.62 . . . . 0.0 109.325 176.159 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 94' ' ' VAL . . . . . . . . . . . . . 43.2 t -118.02 127.01 75.3 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.282 0 N-CA-C 109.68 -0.489 . . . . 0.0 109.68 -179.863 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 95' ' ' VAL . . . . . . . . . . . . . 42.8 t -120.78 135.08 62.11 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.36 0 CA-C-N 116.171 -0.468 . . . . 0.0 109.819 -179.258 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 96' ' ' ILE . . . . . . . . . . . . . 58.6 mt -113.99 128.23 71.03 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.338 0 N-CA-C 109.258 -0.645 . . . . 0.0 109.258 179.594 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 97' ' ' THR . . . . . . . . . . . . . 70.6 p -99.67 154.12 18.54 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-O 120.856 0.36 . . . . 0.0 110.686 -179.09 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 98' ' ' GLU . . . . . . . . . . . . . 96.0 mt-10 -54.76 -23.21 16.86 Favored 'General case' 0 CA--C 1.533 0.319 0 N-CA-C 112.451 0.537 . . . . 0.0 112.451 -179.701 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 99' ' ' GLU . . . . . . . . . . . . . 43.0 mt-10 -79.6 16.14 1.16 Allowed 'General case' 0 CA--C 1.535 0.379 0 N-CA-C 113.05 0.759 . . . . 0.0 113.05 -179.458 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 100' ' ' ASN . . . . . . . . . . . . . 3.6 m-20 63.57 37.97 9.97 Favored 'General case' 0 CA--C 1.529 0.144 0 CA-C-O 121.05 0.452 . . . . 0.0 110.967 177.694 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 101' ' ' GLU . . . . . . . . . . . . . 83.0 tt0 -114.38 142.36 46.45 Favored 'General case' 0 C--N 1.332 -0.162 0 CA-C-N 116.118 -0.492 . . . . 0.0 109.731 176.618 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 102' ' ' VAL . . . . . . . . . . . . . 43.6 t -115.14 123.72 71.04 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 N-CA-C 109.693 -0.484 . . . . 0.0 109.693 -179.731 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 103' ' ' LEU . . . . . . . . . . . . . 36.4 mt -116.57 130.6 56.84 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 115.877 -0.601 . . . . 0.0 110.05 178.294 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 104' ' ' ILE . . . . . 0.595 HD13 HG11 ' A' ' 130' ' ' VAL . 65.5 mt -115.35 118.95 60.41 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.324 0 N-CA-C 109.934 -0.395 . . . . 0.0 109.934 -179.591 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 105' ' ' PHE . . . . . . . . . . . . . 96.9 m-85 -118.29 162.86 17.57 Favored 'General case' 0 C--O 1.233 0.192 0 O-C-N 124.061 0.851 . . . . 0.0 110.079 -178.643 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 106' ' ' ASN . . . . . . . . . . . . . 53.2 p-10 -96.36 -169.95 2.0 Favored 'General case' 0 C--N 1.329 -0.285 0 N-CA-C 109.297 -0.631 . . . . 0.0 109.297 170.664 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 107' ' ' GLN . . . . . . . . . . . . . 44.1 tt0 -57.82 -27.53 63.25 Favored 'General case' 0 C--N 1.328 -0.335 0 N-CA-C 112.405 0.52 . . . . 0.0 112.405 -178.067 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 108' ' ' ASN . . . . . . . . . . . . . 19.6 t30 -94.63 14.25 21.65 Favored 'General case' 0 CA--C 1.534 0.333 0 N-CA-C 113.033 0.753 . . . . 0.0 113.033 -175.149 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 109' ' ' LEU . . . . . . . . . . . . . 91.4 mt 60.4 34.65 20.6 Favored 'General case' 0 CA--C 1.529 0.162 0 CA-C-O 120.756 0.312 . . . . 0.0 111.679 178.169 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 110' ' ' GLU . . . . . . . . . . . . . 96.2 mt-10 -101.47 141.16 34.75 Favored 'General case' 0 C--N 1.33 -0.265 0 N-CA-C 109.717 -0.475 . . . . 0.0 109.717 175.973 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 111' ' ' GLU . . . . . . . . . . . . . 96.4 mt-10 -73.13 121.86 20.91 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-O 120.945 0.402 . . . . 0.0 111.242 -176.719 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 112' ' ' LEU . . . . . . . . . . . . . 17.3 mt -103.43 -45.04 4.98 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 115.861 -0.608 . . . . 0.0 109.737 173.718 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 113' ' ' TYR . . . . . 0.432 ' HB3' HD12 ' A' ' 104' ' ' ILE . 61.8 t80 -142.03 142.48 32.89 Favored 'General case' 0 C--N 1.331 -0.224 0 CA-C-N 115.8 -0.636 . . . . 0.0 110.158 178.251 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 114' ' ' ARG . . . . . . . . . . . . . 33.6 ptt180 -150.65 123.59 8.71 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-O 120.957 0.408 . . . . 0.0 110.966 178.699 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 115' ' ' GLY . . . . . . . . . . . . . . . -150.2 163.03 29.4 Favored Glycine 0 CA--C 1.524 0.624 0 N-CA-C 110.664 -0.974 . . . . 0.0 110.664 -179.385 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 116' ' ' LYS . . . . . . . . . . . . . 29.8 ttmt -127.51 136.23 51.46 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-O 120.883 0.373 . . . . 0.0 110.185 178.604 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 117' ' ' PHE . . . . . . . . . . . . . 43.0 m-85 -131.44 115.15 15.81 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.12 -0.491 . . . . 0.0 110.161 -177.051 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 118' ' ' GLU . . . . . . . . . . . . . 96.2 mt-10 -54.0 -42.08 68.65 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.564 -0.289 . . . . 0.0 111.356 -176.895 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 119' ' ' ASN . . . . . . . . . . . . . 33.6 m120 -99.75 31.02 3.38 Favored 'General case' 0 CA--C 1.531 0.215 0 N-CA-C 112.132 0.419 . . . . 0.0 112.132 -174.809 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 120' ' ' LEU . . . . . . . . . . . . . 13.4 tp -56.83 121.19 9.28 Favored 'General case' 0 C--N 1.332 -0.177 0 CA-C-O 120.756 0.312 . . . . 0.0 110.562 178.41 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 121' ' ' ASN . . . . . . . . . . . . . 6.2 m120 -113.97 -44.01 3.2 Favored 'General case' 0 C--N 1.331 -0.204 0 CA-C-N 116.324 -0.398 . . . . 0.0 110.876 -178.981 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 122' ' ' LYS . . . . . . . . . . . . . 63.9 mtpt -139.68 144.54 37.64 Favored 'General case' 0 C--N 1.331 -0.211 0 CA-C-O 120.972 0.415 . . . . 0.0 111.631 -175.989 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 123' ' ' VAL . . . . . . . . . . . . . 45.2 t -131.36 122.52 51.02 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.305 0 N-CA-C 109.126 -0.694 . . . . 0.0 109.126 172.788 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 124' ' ' LEU . . . . . . . . . . . . . 14.3 tp -127.87 136.04 50.85 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-O 120.82 0.343 . . . . 0.0 110.813 -176.057 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 125' ' ' VAL . . . . . . . . . . . . . 12.6 p -134.03 137.01 52.88 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.205 0 CA-C-N 116.288 -0.414 . . . . 0.0 110.412 178.938 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 126' ' ' ARG . . . . . . . . . . . . . 26.3 mmt180 -141.77 124.99 16.39 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.118 -0.492 . . . . 0.0 110.368 179.43 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 127' ' ' ASN . . . . . . . . . . . . . 81.8 m-20 51.87 -105.02 0.2 Allowed 'General case' 0 CA--C 1.543 0.691 0 CA-C-N 115.982 -0.554 . . . . 0.0 111.356 178.949 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 128' ' ' ASP . . . . . . . . . . . . . 10.3 p-10 -114.21 0.45 14.22 Favored 'General case' 0 N--CA 1.466 0.368 0 CA-C-N 119.506 1.048 . . . . 0.0 113.656 -175.77 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 129' ' ' LEU . . . . . . . . . . . . . 47.4 mt -111.85 145.71 38.99 Favored 'General case' 0 C--O 1.231 0.117 0 CA-C-N 118.166 0.439 . . . . 0.0 110.344 -179.417 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 130' ' ' VAL . . . . . 0.595 HG11 HD13 ' A' ' 104' ' ' ILE . 12.5 p -134.16 141.21 44.38 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.217 0 CA-C-O 121.15 0.5 . . . . 0.0 110.559 -179.843 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 131' ' ' VAL . . . . . . . . . . . . . 44.3 t -135.84 139.6 45.78 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.271 0 CA-C-N 115.985 -0.552 . . . . 0.0 110.109 -179.784 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 132' ' ' ILE . . . . . . . . . . . . . 74.4 mt -118.65 133.42 65.54 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.268 0 CA-C-N 115.708 -0.678 . . . . 0.0 109.49 179.883 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 133' ' ' ILE . . . . . . . . . . . . . 38.1 mm -116.2 121.37 67.35 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.256 0 CA-C-N 116.39 -0.368 . . . . 0.0 110.78 -175.156 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 134' ' ' ASP . . . . . . . . . . . . . 8.4 p-10 -131.94 147.93 52.49 Favored 'General case' 0 C--N 1.332 -0.183 0 N-CA-C 109.871 -0.418 . . . . 0.0 109.871 175.33 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 135' ' ' GLU . . . . . . . . . . . . . 78.8 tt0 -49.86 -26.64 4.22 Favored 'General case' 0 C--N 1.328 -0.336 0 N-CA-C 113.02 0.748 . . . . 0.0 113.02 -172.742 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 136' ' ' GLN . . . . . . . . . . . . . 98.5 mt-30 -85.43 -32.04 22.54 Favored 'General case' 0 C--O 1.234 0.243 0 N-CA-C 112.425 0.528 . . . . 0.0 112.425 -175.428 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 137' ' ' LYS . . . . . . . . . . . . . 48.3 pttt -168.31 173.24 7.86 Favored 'General case' 0 C--N 1.332 -0.161 0 CA-C-O 121.646 0.736 . . . . 0.0 112.417 -173.226 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 138' ' ' LEU . . . . . 0.459 HD23 ' N ' ' A' ' 139' ' ' THR . 3.6 tt -115.7 129.11 56.35 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 114.831 -1.077 . . . . 0.0 109.996 -179.572 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 139' ' ' THR . . . . . 0.459 ' N ' HD23 ' A' ' 138' ' ' LEU . 39.0 m -110.67 123.51 50.16 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 116.221 -0.445 . . . . 0.0 110.223 179.358 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 140' ' ' LEU . . . . . 0.477 HD23 ' C ' ' A' ' 140' ' ' LEU . 6.1 tt -113.28 122.33 47.09 Favored 'General case' 0 C--N 1.328 -0.351 0 N-CA-C 109.567 -0.531 . . . . 0.0 109.567 -178.961 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 141' ' ' ILE . . . . . 0.542 ' HB ' HG13 ' A' ' 130' ' ' VAL . 19.6 mt -121.67 118.5 55.98 Favored 'Isoleucine or valine' 0 C--O 1.235 0.303 0 CA-C-O 121.104 0.478 . . . . 0.0 109.899 -175.938 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 142' ' ' ARG . . . . . . . . . . . . . 58.9 ttt180 -108.31 132.28 53.87 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 115.298 -0.864 . . . . 0.0 110.734 -177.198 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 143' ' ' THR . . . . . . . . . . . . . 56.0 p . . . . . 0 C--O 1.22 -0.483 0 CA-C-O 118.026 -0.988 . . . . 0.0 110.601 178.934 . . . . . . . . 0 0 . 1 . 004 nuclear build full ' B' B ' -3' ' ' GLU . . . . . . . . . . . . . 95.8 mt-10 . . . . . 0 N--CA 1.491 1.606 0 N-CA-C 109.385 -0.598 . . . . 0.0 109.385 . . . . . . . . . 0 0 . 1 . 004 nuclear build full ' B' B ' -2' ' ' GLY . . . . . . . . . . . . . . . -66.62 140.26 38.43 Favored Glycine 0 CA--C 1.525 0.714 0 N-CA-C 111.062 -0.815 . . . . 0.0 111.062 -179.901 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' -1' ' ' VAL . . . . . . . . . . . . . 44.5 t -96.1 132.28 40.75 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.372 0 CA-C-O 120.845 0.355 . . . . 0.0 110.07 179.454 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 0' ' ' ILE . . . . . . . . . . . . . 70.6 mt -117.68 134.48 61.13 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.178 0 CA-C-N 116.301 -0.409 . . . . 0.0 110.129 -179.759 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 1' ' ' MET . . . . . . . . . . . . . 26.6 ptt? -91.59 139.64 30.5 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.032 -0.531 . . . . 0.0 110.315 178.222 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 2' ' ' SER . . . . . . . . . . . . . 6.7 p -114.32 131.72 56.43 Favored 'General case' 0 C--N 1.331 -0.23 0 CA-C-O 121.072 0.463 . . . . 0.0 110.88 -178.519 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 3' ' ' GLU . . . . . . . . . . . . . 95.5 mt-10 -141.15 141.56 34.14 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 115.79 -0.641 . . . . 0.0 110.897 -179.226 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 4' ' ' LEU . . . . . . . . . . . . . 18.8 tp -127.15 128.33 45.99 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 115.955 -0.566 . . . . 0.0 110.12 177.056 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 5' ' ' LYS . . . . . . . . . . . . . 83.1 mttt -104.93 119.62 39.45 Favored 'General case' 0 C--O 1.234 0.267 0 CA-C-N 116.084 -0.507 . . . . 0.0 110.462 178.828 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 6' ' ' LEU . . . . . . . . . . . . . 45.1 mt -116.57 144.38 44.44 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 115.458 -0.792 . . . . 0.0 110.313 -178.967 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 7' ' ' LYS . . . . . . . . . . . . . 82.9 tttt -133.05 138.36 31.59 Favored Pre-proline 0 CA--C 1.534 0.328 0 CA-C-O 119.007 -0.521 . . . . 0.0 109.988 177.247 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 8' ' ' PRO . . . . . . . . . . . . . 89.7 Cg_endo -92.09 144.19 2.78 Favored 'Trans proline' 0 N--CA 1.489 1.223 0 C-N-CA 121.717 1.611 . . . . 0.0 111.97 178.155 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 9' ' ' LEU . . . . . . . . . . . . . 62.4 mt -81.09 -47.65 1.11 Allowed Pre-proline 0 CA--C 1.534 0.36 0 CA-C-O 118.637 -0.697 . . . . 0.0 112.319 -179.946 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 10' ' ' PRO . . . . . . . . . . . . . 86.8 Cg_endo -80.3 151.43 20.36 Favored 'Trans proline' 0 N--CA 1.496 1.656 0 C-N-CA 121.125 1.217 . . . . 0.0 111.888 176.999 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 11' ' ' LYS . . . . . . . . . . . . . 96.5 mttt -87.47 96.98 10.58 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.432 -0.349 . . . . 0.0 110.492 178.79 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 12' ' ' VAL . . . . . . . . . . . . . 12.6 p -142.06 147.07 21.9 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.328 0 CA-C-N 116.237 -0.438 . . . . 0.0 110.5 -179.932 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 13' ' ' GLU . . . . . . . . . . . . . 84.4 tt0 -84.92 127.9 34.37 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.253 -0.43 . . . . 0.0 110.055 178.069 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 14' ' ' LEU . . . . . . . . . . . . . 36.5 mt -96.41 149.96 36.51 Favored Pre-proline 0 CA--C 1.533 0.309 0 CA-C-O 119.311 -0.376 . . . . 0.0 110.713 -177.154 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 15' ' ' PRO . . . . . . . . . . . . . 27.8 Cg_exo -60.99 158.39 34.27 Favored 'Trans proline' 0 N--CA 1.499 1.797 0 C-N-CA 121.269 1.313 . . . . 0.0 111.964 178.272 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 16' ' ' PRO . . . . . . . . . . . . . 35.7 Cg_exo -59.09 -41.02 64.85 Favored 'Trans proline' 0 N--CA 1.497 1.692 0 C-N-CA 121.439 1.426 . . . . 0.0 112.714 -179.218 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 17' ' ' ASP . . . . . . . . . . . . . 15.8 p-10 -84.73 11.59 8.79 Favored 'General case' 0 CA--C 1.535 0.388 0 N-CA-C 113.155 0.798 . . . . 0.0 113.155 -178.183 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 18' ' ' PHE . . . . . . . . . . . . . 44.9 t80 -57.6 -45.73 84.94 Favored 'General case' 0 C--N 1.335 -0.064 0 O-C-N 121.949 -0.47 . . . . 0.0 110.305 -177.833 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 19' ' ' VAL . . . . . 0.413 HG13 ' N ' ' B' ' 20' ' ' ASP . 15.0 p -55.88 -42.21 69.98 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.326 0 CA-C-N 116.475 -0.329 . . . . 0.0 111.075 -177.599 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' B' B ' 20' ' ' ASP . . . . . 0.413 ' N ' HG13 ' B' ' 19' ' ' VAL . 32.8 m-20 -60.76 -42.85 98.27 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-O 120.9 0.381 . . . . 0.0 110.923 -178.397 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' B' B ' 21' ' ' VAL . . . . . . . . . . . . . 46.9 t -63.8 -45.41 97.25 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.264 0 C-N-CA 120.735 -0.386 . . . . 0.0 110.4 -178.52 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 22' ' ' ILE . . . . . 0.566 HG22 HD12 ' B' ' 26' ' ' LEU . 50.7 mm -55.7 -47.13 79.57 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.262 0 C-N-CA 121.001 -0.28 . . . . 0.0 110.592 178.366 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' B' B ' 23' ' ' ARG . . . . . . . . . . . . . 47.0 ttp180 -53.41 -51.66 61.87 Favored 'General case' 0 C--N 1.329 -0.292 0 C-N-CA 121.13 -0.228 . . . . 0.0 111.534 -178.615 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 24' ' ' ILE . . . . . . . . . . . . . 71.9 mt -59.52 -44.24 92.56 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.319 0 C-N-CA 121.112 -0.235 . . . . 0.0 111.163 -177.293 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 25' ' ' LYS . . . . . . . . . . . . . 8.7 mtpm? -64.94 -40.1 94.51 Favored 'General case' 0 C--N 1.328 -0.357 0 N-CA-C 112.178 0.436 . . . . 0.0 112.178 -176.946 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 26' ' ' LEU . . . . . 0.566 HD12 HG22 ' B' ' 22' ' ' ILE . 74.6 mt -80.09 -43.41 21.8 Favored 'General case' 0 C--N 1.33 -0.276 0 N-CA-C 112.945 0.72 . . . . 0.0 112.945 -172.106 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' B' B ' 27' ' ' GLN . . . . . . . . . . . . . 15.4 pt20 -46.39 137.67 6.27 Favored 'General case' 0 N--CA 1.469 0.487 0 N-CA-C 112.81 0.67 . . . . 0.0 112.81 -174.996 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 28' ' ' GLY . . . . . . . . . . . . . . . 100.85 -26.31 25.11 Favored Glycine 0 CA--C 1.533 1.196 0 CA-C-N 115.518 -0.765 . . . . 0.0 112.216 -176.575 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 29' ' ' LYS . . . . . . . . . . . . . 35.2 mmtp -97.79 155.08 17.2 Favored 'General case' 0 C--N 1.332 -0.159 0 CA-C-N 117.251 0.526 . . . . 0.0 111.012 179.28 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 30' ' ' THR . . . . . . . . . . . . . 43.5 m -108.01 134.4 50.97 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 115.934 -0.576 . . . . 0.0 109.869 175.202 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 31' ' ' VAL . . . . . . . . . . . . . 34.5 m -129.39 155.56 41.31 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.251 0 CA-C-O 120.9 0.381 . . . . 0.0 111.049 -177.363 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 32' ' ' ARG . . . . . . . . . . . . . 92.5 mtt180 -129.9 152.9 48.87 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-O 121.291 0.567 . . . . 0.0 110.604 179.16 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 33' ' ' THR . . . . . . . . . . . . . 18.2 m -52.82 139.02 28.03 Favored 'General case' 0 C--N 1.331 -0.225 0 CA-C-N 116.228 -0.442 . . . . 0.0 111.39 -179.001 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 34' ' ' GLY . . . . . . . . . . . . . . . 100.31 -17.12 57.34 Favored Glycine 0 CA--C 1.533 1.172 0 C-N-CA 121.219 -0.515 . . . . 0.0 113.224 179.346 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 35' ' ' ASP . . . . . . . . . . . . . 56.1 m-20 -66.04 150.5 48.59 Favored 'General case' 0 C--O 1.23 0.041 0 CA-C-N 118.043 0.922 . . . . 0.0 111.055 179.443 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 36' ' ' VAL . . . . . . . . . . . . . 46.5 t -123.06 129.72 74.86 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.207 0 CA-C-N 115.748 -0.66 . . . . 0.0 109.677 178.39 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 37' ' ' ILE . . . . . . . . . . . . . 64.8 mt -120.1 138.34 50.98 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.297 0 N-CA-C 109.755 -0.461 . . . . 0.0 109.755 179.816 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 38' ' ' GLY . . . . . . . . . . . . . . . -112.36 128.86 8.71 Favored Glycine 0 CA--C 1.525 0.716 0 N-CA-C 110.731 -0.948 . . . . 0.0 110.731 179.552 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 39' ' ' ILE . . . . . . . . . . . . . 73.4 mt -121.12 136.18 58.91 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.277 0 N-CA-C 110.043 -0.354 . . . . 0.0 110.043 179.831 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 40' ' ' SER . . . . . 0.527 ' O ' HD13 ' B' ' 41' ' ' ILE . 74.6 p -91.65 116.16 28.64 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.246 -0.434 . . . . 0.0 110.78 176.185 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' B' B ' 41' ' ' ILE . . . . . 0.527 HD13 ' O ' ' B' ' 40' ' ' SER . 48.1 mm -128.74 118.13 46.42 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.165 0 N-CA-C 110.063 -0.347 . . . . 0.0 110.063 178.711 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' B' B ' 42' ' ' LEU . . . . . . . . . . . . . 38.7 mt 58.1 34.53 24.29 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.212 -0.449 . . . . 0.0 111.52 179.325 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 43' ' ' GLY . . . . . . . . . . . . . . . 77.47 -10.14 24.54 Favored Glycine 0 CA--C 1.535 1.286 0 C-N-CA 121.315 -0.469 . . . . 0.0 113.424 178.047 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 44' ' ' LYS . . . . . . . . . . . . . 47.7 mtmt -98.85 137.47 37.38 Favored 'General case' 0 C--N 1.333 -0.144 0 CA-C-N 117.897 0.848 . . . . 0.0 110.198 177.965 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 45' ' ' GLU . . . . . . . . . . . . . 83.8 tt0 -84.46 128.18 34.44 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.293 -0.412 . . . . 0.0 111.287 -179.409 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 46' ' ' VAL . . . . . . . . . . . . . 7.2 p -120.61 129.14 75.93 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.197 0 N-CA-C 109.508 -0.553 . . . . 0.0 109.508 175.465 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 47' ' ' LYS . . . . . . . . . . . . . 98.8 mttt -99.4 128.32 45.51 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.009 -0.541 . . . . 0.0 111.007 179.001 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 48' ' ' PHE . . . . . . . . . . . . . 93.2 m-85 -113.08 131.85 55.65 Favored 'General case' 0 C--N 1.331 -0.232 0 N-CA-C 109.67 -0.493 . . . . 0.0 109.67 175.041 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 49' ' ' LYS . . . . . . . . . . . . . 79.2 tttt -106.98 136.14 47.35 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.304 -0.407 . . . . 0.0 110.426 -179.777 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 50' ' ' VAL . . . . . . . . . . . . . 42.2 t -80.08 106.99 11.99 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 N-CA-C 109.433 -0.58 . . . . 0.0 109.433 176.799 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 51' ' ' VAL . . . . . . . . . . . . . 46.7 t -75.15 -48.21 32.83 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.286 0 CA-C-N 116.064 -0.516 . . . . 0.0 110.077 -174.044 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 52' ' ' GLN . . . . . . . . . . . . . 62.6 tt0 -159.46 137.05 9.96 Favored 'General case' 0 C--N 1.33 -0.251 0 C-N-CA 120.475 -0.49 . . . . 0.0 111.397 -177.692 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 53' ' ' ALA . . . . . 0.484 ' HB1' ' HB2' ' B' ' 58' ' ' LEU . . . -114.23 130.76 56.63 Favored 'General case' 0 C--N 1.331 -0.23 0 CA-C-N 115.783 -0.644 . . . . 0.0 109.755 174.561 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' B' B ' 54' ' ' TYR . . . . . . . . . . . . . 30.2 t80 -129.08 110.76 18.29 Favored Pre-proline 0 CA--C 1.535 0.399 0 CA-C-O 118.334 -0.841 . . . . 0.0 110.329 179.495 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 55' ' ' PRO . . . . . . . . . . . . . 73.9 Cg_endo -77.11 170.08 72.56 Favored 'Cis proline' 0 N--CA 1.499 1.823 0 CA-C-N 121.918 1.721 . . . . 0.0 112.44 -4.554 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 56' ' ' SER . . . . . . . . . . . . . 13.7 m -116.18 129.46 25.2 Favored Pre-proline 0 CA--C 1.539 0.548 0 CA-C-O 118.347 -0.835 . . . . 0.0 109.37 175.96 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 57' ' ' PRO . . . . . . . . . . . . . 50.8 Cg_endo -69.99 148.18 86.7 Favored 'Cis proline' 0 N--CA 1.497 1.735 0 CA-C-N 122.053 1.769 . . . . 0.0 111.561 -0.771 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 58' ' ' LEU . . . . . 0.484 ' HB2' ' HB1' ' B' ' 53' ' ' ALA . 22.4 tp -106.48 135.44 47.97 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-O 120.851 0.357 . . . . 0.0 110.454 -178.994 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' B' B ' 59' ' ' ARG . . . . . . . . . . . . . 52.9 ttp180 -105.82 121.85 44.9 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-N 115.873 -0.603 . . . . 0.0 109.377 177.307 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 60' ' ' VAL . . . . . . . . . . . . . 42.6 t -79.09 122.92 35.31 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.287 0 C-N-CA 120.807 -0.357 . . . . 0.0 110.591 -173.848 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 61' ' ' GLU . . . . . . . . . . . . . 95.5 mt-10 -131.03 165.62 22.8 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.021 -0.536 . . . . 0.0 110.149 178.195 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 62' ' ' ASP . . . . . . . . . . . . . 14.9 p-10 -55.87 -32.59 63.8 Favored 'General case' 0 C--N 1.329 -0.324 0 N-CA-C 111.781 0.289 . . . . 0.0 111.781 -179.147 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 63' ' ' ARG . . . . . . . . . . . . . 11.0 ptm180 -86.41 4.58 38.87 Favored 'General case' 0 CA--C 1.537 0.47 0 N-CA-C 113.527 0.936 . . . . 0.0 113.527 -176.15 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 64' ' ' THR . . . . . . . . . . . . . 31.5 m -83.54 137.86 33.66 Favored 'General case' 0 C--N 1.332 -0.166 0 CA-C-N 118.231 0.469 . . . . 0.0 110.443 -178.22 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 65' ' ' LYS . . . . . . . . . . . . . 67.7 mttm -88.24 123.72 33.15 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.219 -179.911 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 66' ' ' ILE . . . . . . . . . . . . . 62.6 mt -111.94 126.59 69.35 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.283 0 N-CA-C 109.574 -0.528 . . . . 0.0 109.574 179.63 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 67' ' ' THR . . . . . . . . . . . . . 18.4 m -122.08 139.32 53.86 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 116.176 -0.465 . . . . 0.0 110.908 -177.119 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 68' ' ' LEU . . . . . . . . . . . . . 15.7 tp -103.77 129.9 51.23 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 115.841 -0.618 . . . . 0.0 110.236 178.624 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 69' ' ' VAL . . . . . . . . . . . . . 43.0 t -96.25 135.06 31.59 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.286 0 CA-C-N 116.252 -0.431 . . . . 0.0 110.45 -179.101 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 70' ' ' THR . . . . . . . . . . . . . 74.9 p -107.25 -174.33 2.51 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.117 -0.492 . . . . 0.0 110.597 -179.932 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 71' ' ' HIS . . . . . . . . . . . . . 48.7 m-70 -112.03 87.51 8.88 Favored Pre-proline 0 CA--C 1.533 0.304 0 CA-C-N 116.276 -0.42 . . . . 0.0 110.911 -178.557 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 72' ' ' PRO . . . . . . . . . . . . . 90.5 Cg_endo -85.28 159.98 11.26 Favored 'Trans proline' 0 N--CA 1.492 1.435 0 C-N-CA 121.566 1.511 . . . . 0.0 112.105 178.072 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 73' ' ' VAL . . . . . . . . . . . . . 34.2 m -87.19 164.45 2.32 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.335 0 CA-C-N 116.303 -0.408 . . . . 0.0 110.703 179.741 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 74' ' ' ASP . . . . . . . . . . . . . 13.8 t0 -99.53 123.52 43.87 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.152 -0.476 . . . . 0.0 110.051 -179.444 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 75' ' ' VAL . . . . . . . . . . . . . 41.5 t -115.24 123.89 71.28 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.261 0 CA-C-O 120.905 0.383 . . . . 0.0 110.617 -177.788 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 76' ' ' LEU . . . . . . . . . . . . . 4.4 mp -124.84 144.99 50.01 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 115.934 -0.576 . . . . 0.0 109.697 176.261 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 77' ' ' GLU . . . . . . . . . . . . . 97.4 mt-10 -134.96 138.53 44.13 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-O 121.0 0.429 . . . . 0.0 111.243 -178.068 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 78' ' ' ALA . . . . . . . . . . . . . . . -125.76 130.5 51.61 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 115.697 -0.683 . . . . 0.0 109.674 176.229 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 79' ' ' LYS . . . . . 0.597 ' O ' HD13 ' B' ' 80' ' ' ILE . 62.1 mtpt -79.02 119.44 22.17 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-O 120.865 0.364 . . . . 0.0 110.898 -177.481 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' B' B ' 80' ' ' ILE . . . . . 0.597 HD13 ' O ' ' B' ' 79' ' ' LYS . 41.6 mm -139.19 109.31 4.2 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.311 0 N-CA-C 109.138 -0.69 . . . . 0.0 109.138 -177.721 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' B' B ' 81' ' ' LYS . . . . . . . . . . . . . 60.6 tttm -101.81 126.55 48.71 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-O 120.842 0.353 . . . . 0.0 111.223 -176.642 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 82' ' ' GLY . . . . . . . . . . . . . . . 89.2 42.11 5.66 Favored Glycine 0 CA--C 1.527 0.784 0 C-N-CA 120.885 -0.674 . . . . 0.0 112.017 174.193 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 83' ' ' ILE . . . . . . . . . . . . . 72.5 mt -70.13 136.34 26.29 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.269 0 N-CA-C 109.676 -0.49 . . . . 0.0 109.676 176.407 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 84' ' ' LYS . . . . . . . . . . . . . 19.7 ttpp -101.0 -50.14 3.9 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-O 120.9 0.381 . . . . 0.0 110.461 -178.176 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 85' ' ' ASP . . . . . . . . . . . . . 10.8 t70 -147.1 148.13 31.29 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 115.987 -0.551 . . . . 0.0 110.348 -179.729 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 86' ' ' VAL . . . . . . . . . . . . . 42.2 t -130.71 132.62 64.12 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.232 0 CA-C-O 121.05 0.452 . . . . 0.0 110.578 -178.365 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 87' ' ' ILE . . . . . 0.5 ' N ' HD12 ' B' ' 87' ' ' ILE . 5.1 mp -122.62 123.02 67.47 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.217 0 N-CA-C 109.208 -0.664 . . . . 0.0 109.208 176.102 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' B' B ' 88' ' ' LEU . . . . . . . . . . . . . 33.8 mt -111.66 136.29 51.08 Favored 'General case' 0 C--N 1.332 -0.182 0 CA-C-O 121.223 0.535 . . . . 0.0 111.352 -176.129 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 89' ' ' ASP . . . . . . . . . . . . . 11.3 t70 -129.19 146.25 51.15 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 115.511 -0.768 . . . . 0.0 109.296 175.333 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 90' ' ' GLU . . . . . . . . . . . . . 12.8 pt-20 -51.09 -28.8 11.42 Favored 'General case' 0 C--N 1.328 -0.347 0 N-CA-C 112.522 0.564 . . . . 0.0 112.522 -174.017 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 91' ' ' ASN . . . . . . . . . . . . . 92.1 m-20 -127.26 22.67 6.54 Favored 'General case' 0 N--CA 1.469 0.486 0 N-CA-C 112.8 0.667 . . . . 0.0 112.8 -176.558 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 92' ' ' LEU . . . . . . . . . . . . . 7.4 tp -166.24 148.54 6.94 Favored 'General case' 0 C--N 1.331 -0.237 0 N-CA-C 110.302 -0.258 . . . . 0.0 110.302 179.471 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 93' ' ' ILE . . . . . . . . . . . . . 71.0 mt -128.18 123.97 61.42 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.285 0 N-CA-C 109.848 -0.427 . . . . 0.0 109.848 179.145 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 94' ' ' VAL . . . . . . . . . . . . . 40.8 t -122.13 125.88 73.61 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.182 0 N-CA-C 109.98 -0.378 . . . . 0.0 109.98 179.038 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 95' ' ' VAL . . . . . . . . . . . . . 41.8 t -120.82 134.66 63.54 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.329 0 CA-C-N 116.026 -0.533 . . . . 0.0 109.815 -179.959 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 96' ' ' ILE . . . . . 0.418 HD11 ' HB ' ' B' ' 123' ' ' VAL . 67.4 mt -115.76 126.15 73.18 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.209 0 N-CA-C 109.381 -0.6 . . . . 0.0 109.381 179.071 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' B' B ' 97' ' ' THR . . . . . . . . . . . . . 73.5 p -99.89 158.36 15.86 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-O 121.307 0.575 . . . . 0.0 111.326 -176.404 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 98' ' ' GLU . . . . . . . . . . . . . 43.7 tp10 -53.83 -26.62 25.21 Favored 'General case' 0 CA--C 1.533 0.311 0 CA-C-N 116.052 -0.522 . . . . 0.0 112.267 -179.174 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 99' ' ' GLU . . . . . . . . . . . . . 95.7 mt-10 -79.91 17.6 0.94 Allowed 'General case' 0 CA--C 1.535 0.377 0 N-CA-C 113.151 0.797 . . . . 0.0 113.151 -176.212 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 100' ' ' ASN . . . . . . . . . . . . . 4.2 m-20 62.42 38.1 13.1 Favored 'General case' 0 N--CA 1.463 0.175 0 CA-C-O 121.115 0.484 . . . . 0.0 110.894 177.954 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 101' ' ' GLU . . . . . . . . . . . . . 84.4 tt0 -119.04 141.86 48.34 Favored 'General case' 0 C--N 1.332 -0.184 0 CA-C-N 116.208 -0.451 . . . . 0.0 109.869 177.562 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 102' ' ' VAL . . . . . . . . . . . . . 46.2 t -115.08 127.54 72.6 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.264 0 N-CA-C 109.895 -0.409 . . . . 0.0 109.895 -178.915 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 103' ' ' LEU . . . . . . . . . . . . . 28.8 mt -118.58 131.9 56.2 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-N 115.78 -0.646 . . . . 0.0 110.306 177.845 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 104' ' ' ILE . . . . . . . . . . . . . 71.4 mt -119.52 121.85 67.39 Favored 'Isoleucine or valine' 0 C--O 1.234 0.283 0 CA-C-N 116.606 -0.27 . . . . 0.0 110.426 -179.106 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 105' ' ' PHE . . . . . . . . . . . . . 53.2 m-85 -123.18 168.44 12.42 Favored 'General case' 0 C--N 1.333 -0.122 0 O-C-N 124.115 0.885 . . . . 0.0 109.901 179.499 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 106' ' ' ASN . . . . . . . . . . . . . 44.0 p-10 -100.38 -170.61 1.89 Allowed 'General case' 0 CA--C 1.531 0.217 0 N-CA-C 109.789 -0.448 . . . . 0.0 109.789 171.754 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 107' ' ' GLN . . . . . . . . . . . . . 63.3 tt0 -58.55 -30.06 66.83 Favored 'General case' 0 C--N 1.328 -0.339 0 N-CA-C 111.858 0.318 . . . . 0.0 111.858 179.567 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 108' ' ' ASN . . . . . . . . . . . . . 59.8 t30 -86.85 14.06 7.88 Favored 'General case' 0 CA--C 1.534 0.343 0 N-CA-C 112.923 0.712 . . . . 0.0 112.923 -176.757 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 109' ' ' LEU . . . . . . . . . . . . . 34.5 mt 58.35 33.19 22.91 Favored 'General case' 0 C--N 1.332 -0.188 0 N-CA-C 111.877 0.325 . . . . 0.0 111.877 177.262 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 110' ' ' GLU . . . . . . . . . . . . . 70.5 mm-40 -98.97 138.82 35.52 Favored 'General case' 0 C--N 1.331 -0.226 0 N-CA-C 109.21 -0.663 . . . . 0.0 109.21 174.426 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 111' ' ' GLU . . . . . . . . . . . . . 42.2 tt0 -85.72 121.81 28.91 Favored 'General case' 0 C--N 1.327 -0.408 0 CA-C-O 120.942 0.401 . . . . 0.0 110.574 -176.243 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 112' ' ' LEU . . . . . . . . . . . . . 38.6 mt -105.73 -42.4 5.18 Favored 'General case' 0 C--N 1.331 -0.227 0 CA-C-N 116.007 -0.542 . . . . 0.0 110.466 179.745 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 113' ' ' TYR . . . . . . . . . . . . . 63.9 t80 -132.89 138.7 47.07 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-N 116.274 -0.421 . . . . 0.0 110.883 -178.452 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 114' ' ' ARG . . . . . . . . . . . . . 24.6 ptt180 -147.89 122.22 9.65 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.3 -0.409 . . . . 0.0 110.619 179.126 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 115' ' ' GLY . . . . . . . . . . . . . . . -150.13 148.15 19.1 Favored Glycine 0 CA--C 1.525 0.701 0 C-N-CA 120.682 -0.77 . . . . 0.0 111.451 179.761 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 116' ' ' LYS . . . . . . . . . . . . . 21.3 ttpp -116.44 131.93 56.81 Favored 'General case' 0 C--N 1.33 -0.26 0 N-CA-C 109.717 -0.475 . . . . 0.0 109.717 176.517 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 117' ' ' PHE . . . . . 0.477 ' HE2' HD13 ' B' ' 132' ' ' ILE . 47.5 m-85 -127.12 116.85 21.29 Favored 'General case' 0 C--N 1.331 -0.216 0 CA-C-O 120.945 0.403 . . . . 0.0 110.243 -176.47 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' B' B ' 118' ' ' GLU . . . . . . . . . . . . . 95.8 mt-10 -52.97 -47.03 68.47 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.309 -0.405 . . . . 0.0 111.476 -176.293 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 119' ' ' ASN . . . . . . . . . . . . . 82.6 m-20 -98.16 31.02 2.88 Favored 'General case' 0 C--N 1.33 -0.256 0 N-CA-C 112.173 0.435 . . . . 0.0 112.173 -173.805 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 120' ' ' LEU . . . . . . . . . . . . . 21.4 tp -56.72 121.82 10.69 Favored 'General case' 0 C--N 1.332 -0.184 0 CA-C-O 120.677 0.275 . . . . 0.0 110.466 177.778 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 121' ' ' ASN . . . . . . . . . . . . . 31.4 m120 -113.98 -44.14 3.19 Favored 'General case' 0 N--CA 1.462 0.155 0 CA-C-N 116.554 -0.294 . . . . 0.0 111.323 -176.684 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 122' ' ' LYS . . . . . . . . . . . . . 55.4 mtmt -147.67 152.7 38.28 Favored 'General case' 0 C--N 1.332 -0.172 0 C-N-CA 120.651 -0.42 . . . . 0.0 111.62 -177.701 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 123' ' ' VAL . . . . . 0.418 ' HB ' HD11 ' B' ' 96' ' ' ILE . 46.2 t -132.77 132.18 59.52 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.243 0 CA-C-N 115.919 -0.582 . . . . 0.0 109.862 177.715 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' B' B ' 124' ' ' LEU . . . . . . . . . . . . . 23.9 mt -121.15 136.13 55.03 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.231 -0.44 . . . . 0.0 110.548 -179.059 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 125' ' ' VAL . . . . . . . . . . . . . 43.5 t -130.46 130.73 65.28 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.262 0 CA-C-N 116.335 -0.393 . . . . 0.0 110.019 179.078 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 126' ' ' ARG . . . . . . . . . . . . . 89.8 mtt-85 -142.05 121.14 12.93 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-O 120.935 0.398 . . . . 0.0 110.642 178.578 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 127' ' ' ASN . . . . . . . . . . . . . 58.4 m-80 51.46 -107.75 0.33 Allowed 'General case' 0 CA--C 1.545 0.761 0 CA-C-O 118.881 -0.581 . . . . 0.0 111.146 179.404 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 128' ' ' ASP . . . . . . . . . . . . . 14.7 p-10 -114.19 4.26 15.47 Favored 'General case' 0 CA--C 1.537 0.445 0 CA-C-N 119.802 1.183 . . . . 0.0 113.257 -178.111 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 129' ' ' LEU . . . . . . . . . . . . . 72.6 mt -107.75 144.93 34.21 Favored 'General case' 0 C--O 1.231 0.109 0 CA-C-N 118.142 0.428 . . . . 0.0 110.09 -179.916 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 130' ' ' VAL . . . . . . . . . . . . . 41.4 t -127.67 140.22 49.73 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.185 0 CA-C-O 120.98 0.419 . . . . 0.0 110.156 -177.739 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 131' ' ' VAL . . . . . 0.505 HG22 HD12 ' B' ' 140' ' ' LEU . 41.0 t -135.01 134.84 53.23 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.277 0 CA-C-N 116.15 -0.477 . . . . 0.0 110.025 178.317 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' B' B ' 132' ' ' ILE . . . . . 0.477 HD13 ' HE2' ' B' ' 117' ' ' PHE . 69.9 mt -118.07 132.84 66.72 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.274 0 CA-C-N 115.984 -0.553 . . . . 0.0 109.606 -179.468 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' B' B ' 133' ' ' ILE . . . . . . . . . . . . . 34.0 mm -116.0 123.49 71.32 Favored 'Isoleucine or valine' 0 C--O 1.234 0.262 0 CA-C-N 116.511 -0.313 . . . . 0.0 110.894 -175.598 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 134' ' ' ASP . . . . . . . . . . . . . 7.9 p-10 -132.61 155.11 49.31 Favored 'General case' 0 C--N 1.332 -0.196 0 CA-C-N 116.434 -0.348 . . . . 0.0 110.089 174.371 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 135' ' ' GLU . . . . . . . . . . . . . 80.7 tt0 -49.83 -28.66 6.71 Favored 'General case' 0 C--N 1.328 -0.364 0 N-CA-C 113.17 0.804 . . . . 0.0 113.17 -169.951 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 136' ' ' GLN . . . . . . . . . . . . . 97.5 mt-30 -99.22 -24.78 14.73 Favored 'General case' 0 C--O 1.233 0.227 0 N-CA-C 113.096 0.776 . . . . 0.0 113.096 -171.761 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 137' ' ' LYS . . . . . . . . . . . . . 57.0 pttt -161.01 168.25 24.89 Favored 'General case' 0 C--O 1.232 0.163 0 CA-C-O 121.619 0.723 . . . . 0.0 112.56 -173.23 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 138' ' ' LEU . . . . . 0.413 ' C ' HD23 ' B' ' 138' ' ' LEU . 6.9 tt -120.07 128.36 53.41 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 114.848 -1.069 . . . . 0.0 110.009 178.219 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' B' B ' 139' ' ' THR . . . . . . . . . . . . . 43.1 m -106.49 127.82 53.6 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.068 -0.515 . . . . 0.0 110.28 179.562 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 140' ' ' LEU . . . . . 0.505 HD12 HG22 ' B' ' 131' ' ' VAL . 19.3 tp -114.92 119.26 35.95 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 115.795 -0.639 . . . . 0.0 109.674 -177.969 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' B' B ' 141' ' ' ILE . . . . . . . . . . . . . 19.3 mt -119.35 119.91 62.07 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.221 0 CA-C-O 120.95 0.405 . . . . 0.0 110.015 -174.516 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 142' ' ' ARG . . . . . . . . . . . . . 76.2 mtm180 -113.77 126.21 54.96 Favored 'General case' 0 C--N 1.332 -0.166 0 CA-C-N 115.44 -0.8 . . . . 0.0 110.369 -177.97 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 143' ' ' THR . . . . . . . . . . . . . 52.0 p . . . . . 0 C--O 1.22 -0.493 0 CA-C-O 118.123 -0.942 . . . . 0.0 110.527 -179.564 . . . . . . . . 0 0 . 1 . 004 nuclear build full ' C' C ' -3' ' ' GLU . . . . . . . . . . . . . 96.0 mt-10 . . . . . 0 N--CA 1.49 1.54 0 N-CA-C 109.437 -0.579 . . . . 0.0 109.437 . . . . . . . . . 0 0 . 1 . 004 nuclear build full ' C' C ' -2' ' ' GLY . . . . . . . . . . . . . . . -71.11 131.54 20.5 Favored Glycine 0 CA--C 1.524 0.638 0 N-CA-C 110.676 -0.969 . . . . 0.0 110.676 178.7 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' C' C ' -1' ' ' VAL . . . . . . . . . . . . . 43.7 t -95.51 139.38 19.01 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.323 0 CA-C-O 120.948 0.404 . . . . 0.0 110.14 -179.04 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' C' C ' 0' ' ' ILE . . . . . . . . . . . . . 69.4 mt -103.52 131.76 51.34 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.208 0 CA-C-N 116.051 -0.522 . . . . 0.0 110.127 -179.108 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' C' C ' 1' ' ' MET . . . . . . . . . . . . . 25.2 ptp -82.88 141.05 32.51 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.309 -0.405 . . . . 0.0 110.608 179.82 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' C' C ' 2' ' ' SER . . . . . 0.435 ' HB2' HD11 ' C' ' 58' ' ' LEU . 3.9 p -124.14 133.53 53.56 Favored 'General case' 0 C--N 1.331 -0.212 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.597 179.925 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' C' C ' 3' ' ' GLU . . . . . . . . . . . . . 93.6 mt-10 -141.04 140.9 34.33 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 115.974 -0.557 . . . . 0.0 110.879 -179.292 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' C' C ' 4' ' ' LEU . . . . . . . . . . . . . 15.5 tp -125.21 130.29 51.8 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 116.151 -0.477 . . . . 0.0 110.01 175.629 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' C' C ' 5' ' ' LYS . . . . . . . . . . . . . 96.5 mttt -111.77 121.85 46.21 Favored 'General case' 0 C--N 1.332 -0.192 0 CA-C-N 116.686 -0.234 . . . . 0.0 110.939 -178.512 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' C' C ' 6' ' ' LEU . . . . . . . . . . . . . 27.7 mt -114.3 140.91 48.23 Favored 'General case' 0 C--O 1.234 0.27 0 CA-C-N 115.504 -0.771 . . . . 0.0 110.591 -179.506 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' C' C ' 7' ' ' LYS . . . . . . . . . . . . . 41.1 tttp -121.54 137.88 27.6 Favored Pre-proline 0 CA--C 1.534 0.351 0 CA-C-O 118.935 -0.555 . . . . 0.0 109.592 174.934 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' C' C ' 8' ' ' PRO . . . . . . . . . . . . . 86.9 Cg_endo -91.93 134.68 1.49 Allowed 'Trans proline' 0 N--CA 1.488 1.193 0 C-N-CA 121.682 1.588 . . . . 0.0 111.831 178.858 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' C' C ' 9' ' ' LEU . . . . . . . . . . . . . 49.0 mt -76.66 -46.26 3.15 Favored Pre-proline 0 CA--C 1.533 0.319 0 CA-C-O 118.791 -0.623 . . . . 0.0 111.764 -179.908 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' C' C ' 10' ' ' PRO . . . . . . . . . . . . . 79.2 Cg_endo -83.78 140.46 9.19 Favored 'Trans proline' 0 N--CA 1.495 1.575 0 C-N-CA 121.288 1.325 . . . . 0.0 111.408 173.259 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' C' C ' 11' ' ' LYS . . . . . . . . . . . . . 48.8 pttt -78.96 111.34 15.05 Favored 'General case' 0 C--N 1.331 -0.214 0 CA-C-O 121.449 0.642 . . . . 0.0 110.174 178.414 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' C' C ' 12' ' ' VAL . . . . . . . . . . . . . 11.6 p -151.1 151.99 11.79 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.373 0 CA-C-N 115.711 -0.677 . . . . 0.0 110.589 -178.553 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' C' C ' 13' ' ' GLU . . . . . . . . . . . . . 80.6 tt0 -91.04 124.51 35.33 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.303 -0.408 . . . . 0.0 110.082 177.241 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' C' C ' 14' ' ' LEU . . . . . . . . . . . . . 23.8 mt -95.16 150.87 38.29 Favored Pre-proline 0 C--N 1.329 -0.284 0 CA-C-O 119.332 -0.366 . . . . 0.0 110.511 -179.141 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' C' C ' 15' ' ' PRO . . . . . . . . . . . . . 28.2 Cg_exo -60.51 157.86 34.56 Favored 'Trans proline' 0 N--CA 1.496 1.673 0 C-N-CA 121.257 1.305 . . . . 0.0 111.65 177.623 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' C' C ' 16' ' ' PRO . . . . . . . . . . . . . 38.4 Cg_exo -58.27 -39.79 81.52 Favored 'Trans proline' 0 N--CA 1.497 1.722 0 C-N-CA 121.428 1.419 . . . . 0.0 112.634 -178.718 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' C' C ' 17' ' ' ASP . . . . . . . . . . . . . 19.5 p-10 -87.79 12.76 12.13 Favored 'General case' 0 CA--C 1.536 0.421 0 N-CA-C 113.027 0.751 . . . . 0.0 113.027 -177.896 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' C' C ' 18' ' ' PHE . . . . . . . . . . . . . 45.9 t80 -57.85 -41.29 82.05 Favored 'General case' 0 C--O 1.228 -0.046 0 O-C-N 122.008 -0.432 . . . . 0.0 110.271 -178.664 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' C' C ' 19' ' ' VAL . . . . . . . . . . . . . 48.5 t -56.49 -43.83 79.0 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.271 0 CA-C-N 116.529 -0.305 . . . . 0.0 110.429 -179.484 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' C' C ' 20' ' ' ASP . . . . . . . . . . . . . 35.3 m-20 -60.31 -41.18 92.95 Favored 'General case' 0 C--N 1.33 -0.282 0 C-N-CA 120.872 -0.331 . . . . 0.0 110.719 -178.935 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' C' C ' 21' ' ' VAL . . . . . . . . . . . . . 47.9 t -63.33 -49.23 83.77 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 C-N-CA 120.836 -0.346 . . . . 0.0 110.344 -178.232 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' C' C ' 22' ' ' ILE . . . . . 0.478 HG22 HD12 ' C' ' 26' ' ' LEU . 50.6 mm -55.63 -47.57 78.79 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.268 0 CA-C-O 120.696 0.284 . . . . 0.0 110.828 179.482 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' C' C ' 23' ' ' ARG . . . . . . . . . . . . . 50.8 ttp180 -53.97 -50.65 66.06 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-O 120.619 0.247 . . . . 0.0 111.444 -177.832 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' C' C ' 24' ' ' ILE . . . . . . . . . . . . . 75.5 mt -58.66 -43.0 86.58 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.286 0 CA-C-N 116.688 -0.233 . . . . 0.0 111.139 -177.454 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' C' C ' 25' ' ' LYS . . . . . . . . . . . . . 42.8 mttm -65.37 -40.88 94.08 Favored 'General case' 0 C--N 1.328 -0.348 0 N-CA-C 112.223 0.453 . . . . 0.0 112.223 -178.264 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' C' C ' 26' ' ' LEU . . . . . 0.478 HD12 HG22 ' C' ' 22' ' ' ILE . 91.9 mt -79.98 -39.4 30.16 Favored 'General case' 0 C--N 1.33 -0.253 0 N-CA-C 113.546 0.943 . . . . 0.0 113.546 -170.061 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' C' C ' 27' ' ' GLN . . . . . . . . . . . . . 17.3 pt20 -46.35 138.71 5.36 Favored 'General case' 0 N--CA 1.47 0.527 0 N-CA-C 112.922 0.712 . . . . 0.0 112.922 -174.162 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' C' C ' 28' ' ' GLY . . . . . . . . . . . . . . . 99.95 -27.27 21.06 Favored Glycine 0 CA--C 1.534 1.263 0 CA-C-N 115.47 -0.786 . . . . 0.0 112.175 -177.074 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' C' C ' 29' ' ' LYS . . . . . . . . . . . . . 99.0 mttt -97.83 155.15 17.18 Favored 'General case' 0 C--O 1.234 0.272 0 CA-C-O 121.107 0.48 . . . . 0.0 111.26 179.457 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' C' C ' 30' ' ' THR . . . . . . . . . . . . . 36.2 m -104.82 138.93 40.33 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 115.903 -0.59 . . . . 0.0 110.057 176.14 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' C' C ' 31' ' ' VAL . . . . . . . . . . . . . 35.3 m -126.76 149.94 32.2 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.197 0 CA-C-O 120.878 0.37 . . . . 0.0 110.814 -178.702 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' C' C ' 32' ' ' ARG . . . . . . . . . . . . . 73.8 mtt85 -128.28 148.1 50.63 Favored 'General case' 0 C--N 1.331 -0.239 0 CA-C-N 116.041 -0.527 . . . . 0.0 110.481 178.788 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' C' C ' 33' ' ' THR . . . . . . . . . . . . . 11.2 m -52.68 137.89 29.96 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.292 -0.413 . . . . 0.0 111.497 -177.763 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' C' C ' 34' ' ' GLY . . . . . . . . . . . . . . . 101.31 -17.16 56.09 Favored Glycine 0 CA--C 1.532 1.134 0 CA-C-O 119.643 -0.532 . . . . 0.0 113.241 179.221 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' C' C ' 35' ' ' ASP . . . . . . . . . . . . . 77.9 m-20 -66.47 150.49 48.87 Favored 'General case' 0 N--CA 1.462 0.168 0 CA-C-N 118.062 0.931 . . . . 0.0 110.912 178.917 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' C' C ' 36' ' ' VAL . . . . . . . . . . . . . 43.9 t -124.49 132.57 71.15 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.264 0 CA-C-N 116.107 -0.497 . . . . 0.0 109.908 178.503 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' C' C ' 37' ' ' ILE . . . . . . . . . . . . . 64.3 mt -120.82 139.21 48.79 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.187 0 CA-C-N 116.065 -0.516 . . . . 0.0 109.863 -179.53 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' C' C ' 38' ' ' GLY . . . . . . . . . . . . . . . -116.16 128.7 8.1 Favored Glycine 0 CA--C 1.526 0.752 0 N-CA-C 110.922 -0.871 . . . . 0.0 110.922 178.826 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' C' C ' 39' ' ' ILE . . . . . . . . . . . . . 71.2 mt -124.53 135.27 64.4 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.215 0 CA-C-O 120.733 0.302 . . . . 0.0 110.209 179.806 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' C' C ' 40' ' ' SER . . . . . . . . . . . . . 78.9 p -92.05 121.99 34.12 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.2 -0.455 . . . . 0.0 110.885 176.942 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' C' C ' 41' ' ' ILE . . . . . . . . . . . . . 71.0 mt -130.68 120.69 48.62 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.166 0 CA-C-O 120.772 0.32 . . . . 0.0 110.461 178.07 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' C' C ' 42' ' ' LEU . . . . . . . . . . . . . 76.4 mt 53.21 35.32 19.66 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.141 -0.481 . . . . 0.0 111.703 177.349 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' C' C ' 43' ' ' GLY . . . . . . . . . . . . . . . 72.47 30.44 64.49 Favored Glycine 0 CA--C 1.53 0.994 0 C-N-CA 121.051 -0.595 . . . . 0.0 112.173 178.015 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' C' C ' 44' ' ' LYS . . . . . . . . . . . . . 29.5 ttmt -138.78 128.7 25.16 Favored 'General case' 0 C--N 1.33 -0.258 0 N-CA-C 109.616 -0.513 . . . . 0.0 109.616 178.195 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' C' C ' 45' ' ' GLU . . . . . . . . . . . . . 83.1 tt0 -83.8 124.25 30.73 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-O 120.705 0.288 . . . . 0.0 111.41 -177.566 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' C' C ' 46' ' ' VAL . . . . . 0.417 ' O ' HG13 ' C' ' 46' ' ' VAL . 10.2 p -115.89 123.1 70.84 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.245 0 N-CA-C 109.485 -0.561 . . . . 0.0 109.485 173.618 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' C' C ' 47' ' ' LYS . . . . . . . . . . . . . 61.9 mtpt -98.3 124.35 42.88 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.03 -0.532 . . . . 0.0 110.76 179.016 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' C' C ' 48' ' ' PHE . . . . . . . . . . . . . 32.7 m-85 -110.78 131.84 54.71 Favored 'General case' 0 C--N 1.33 -0.247 0 N-CA-C 109.659 -0.497 . . . . 0.0 109.659 177.178 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' C' C ' 49' ' ' LYS . . . . . . . . . . . . . 82.8 tttt -106.51 132.36 52.61 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.224 179.068 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' C' C ' 50' ' ' VAL . . . . . . . . . . . . . 42.7 t -75.92 103.54 3.52 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.335 0 N-CA-C 109.432 -0.581 . . . . 0.0 109.432 178.021 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' C' C ' 51' ' ' VAL . . . . . . . . . . . . . 44.9 t -69.47 -54.07 21.56 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 CA-C-N 115.898 -0.592 . . . . 0.0 109.449 -175.437 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' C' C ' 52' ' ' GLN . . . . . . . . . . . . . 89.1 mt-30 -153.27 150.73 29.26 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.007 -0.542 . . . . 0.0 111.531 -177.961 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' C' C ' 53' ' ' ALA . . . . . . . . . . . . . . . -126.92 131.65 51.06 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 115.157 -0.929 . . . . 0.0 109.478 174.637 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' C' C ' 54' ' ' TYR . . . . . . . . . . . . . 78.0 t80 -129.1 109.62 18.13 Favored Pre-proline 0 CA--C 1.534 0.359 0 CA-C-O 118.281 -0.866 . . . . 0.0 110.464 -179.17 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' C' C ' 55' ' ' PRO . . . . . . . . . . . . . 73.6 Cg_endo -77.15 170.02 72.68 Favored 'Cis proline' 0 N--CA 1.501 1.936 0 CA-C-N 121.895 1.713 . . . . 0.0 112.269 -6.057 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' C' C ' 56' ' ' SER . . . . . . . . . . . . . 13.6 m -116.28 131.15 23.96 Favored Pre-proline 0 CA--C 1.538 0.487 0 CA-C-O 118.46 -0.781 . . . . 0.0 109.36 174.972 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' C' C ' 57' ' ' PRO . . . . . . . . . . . . . 55.3 Cg_endo -71.38 146.83 86.3 Favored 'Cis proline' 0 N--CA 1.497 1.73 0 CA-C-N 121.996 1.749 . . . . 0.0 111.531 -1.055 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' C' C ' 58' ' ' LEU . . . . . 0.435 HD11 ' HB2' ' C' ' 2' ' ' SER . 14.4 tp -105.97 136.59 45.36 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.286 -0.416 . . . . 0.0 110.651 -178.422 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' C' C ' 59' ' ' ARG . . . . . . . . . . . . . 78.6 ttt180 -103.58 122.46 45.02 Favored 'General case' 0 C--N 1.327 -0.394 0 N-CA-C 109.308 -0.627 . . . . 0.0 109.308 175.788 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' C' C ' 60' ' ' VAL . . . . . . . . . . . . . 42.2 t -80.09 123.71 37.21 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.315 0 C-N-CA 120.704 -0.398 . . . . 0.0 110.48 -175.346 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' C' C ' 61' ' ' GLU . . . . . . . . . . . . . 95.6 mt-10 -130.84 164.25 25.62 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 115.705 -0.679 . . . . 0.0 109.745 177.645 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' C' C ' 62' ' ' ASP . . . . . . . . . . . . . 48.1 m-20 -53.37 -32.1 47.76 Favored 'General case' 0 C--N 1.327 -0.371 0 N-CA-C 111.895 0.331 . . . . 0.0 111.895 -179.178 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' C' C ' 63' ' ' ARG . . . . . . . . . . . . . 35.9 ptt180 -88.5 5.17 43.86 Favored 'General case' 0 CA--C 1.537 0.46 0 N-CA-C 113.676 0.991 . . . . 0.0 113.676 -174.929 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' C' C ' 64' ' ' THR . . . . . . . . . . . . . 26.0 m -84.59 141.66 30.52 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-N 118.19 0.45 . . . . 0.0 110.653 -178.7 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' C' C ' 65' ' ' LYS . . . . . . . . . . . . . 98.8 mttt -89.52 133.53 34.54 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-O 121.092 0.473 . . . . 0.0 110.646 -179.195 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' C' C ' 66' ' ' ILE . . . . . . . . . . . . . 60.4 mt -114.15 127.26 71.66 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.237 0 N-CA-C 109.579 -0.526 . . . . 0.0 109.579 179.482 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' C' C ' 67' ' ' THR . . . . . . . . . . . . . 15.1 m -120.5 142.66 49.1 Favored 'General case' 0 C--N 1.331 -0.214 0 CA-C-O 121.176 0.512 . . . . 0.0 111.149 -175.597 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' C' C ' 68' ' ' LEU . . . . . . . . . . . . . 34.2 mt -104.82 145.75 29.94 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 115.761 -0.654 . . . . 0.0 110.534 179.605 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' C' C ' 69' ' ' VAL . . . . . . . . . . . . . 46.9 t -82.97 155.02 3.84 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.351 0 N-CA-C 109.757 -0.46 . . . . 0.0 109.757 176.394 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' C' C ' 70' ' ' THR . . . . . . . . . . . . . 66.1 p -83.16 171.0 14.14 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-O 121.226 0.536 . . . . 0.0 111.701 -172.502 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' C' C ' 71' ' ' HIS . . . . . . . . . . . . . 69.5 m80 -69.57 161.14 76.21 Favored Pre-proline 0 CA--C 1.533 0.308 0 CA-C-N 115.343 -0.844 . . . . 0.0 111.561 -176.464 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' C' C ' 72' ' ' PRO . . . . . . . . . . . . . 28.6 Cg_endo -64.98 160.23 42.46 Favored 'Trans proline' 0 N--CA 1.495 1.601 0 C-N-CA 121.537 1.492 . . . . 0.0 111.97 175.909 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' C' C ' 73' ' ' VAL . . . . . . . . . . . . . 34.6 m -69.91 -178.72 0.26 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.25 0 CA-C-N 116.174 -0.466 . . . . 0.0 110.618 -176.128 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' C' C ' 74' ' ' ASP . . . . . . . . . . . . . 15.7 t0 -96.06 122.75 39.22 Favored 'General case' 0 C--N 1.333 -0.147 0 C-N-CA 120.753 -0.379 . . . . 0.0 110.489 -174.094 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' C' C ' 75' ' ' VAL . . . . . . . . . . . . . 41.2 t -121.07 121.17 64.28 Favored 'Isoleucine or valine' 0 N--CA 1.462 0.166 0 CA-C-O 121.119 0.485 . . . . 0.0 110.498 -179.364 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' C' C ' 76' ' ' LEU . . . . . . . . . . . . . 5.4 mp -118.01 150.78 38.71 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 115.651 -0.704 . . . . 0.0 109.501 175.833 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' C' C ' 77' ' ' GLU . . . . . . . . . . . . . 97.7 mt-10 -136.87 136.59 38.84 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-O 121.042 0.449 . . . . 0.0 111.214 -177.769 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' C' C ' 78' ' ' ALA . . . . . 0.618 ' HB2' HD21 ' C' ' 109' ' ' LEU . . . -124.77 135.91 53.39 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 115.669 -0.696 . . . . 0.0 109.712 176.353 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' C' C ' 79' ' ' LYS . . . . . 0.664 ' O ' HD13 ' C' ' 80' ' ' ILE . 99.0 mttt -81.73 119.04 23.35 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-O 120.913 0.387 . . . . 0.0 110.757 -178.498 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' C' C ' 80' ' ' ILE . . . . . 0.664 HD13 ' O ' ' C' ' 79' ' ' LYS . 35.5 mm -139.1 105.6 2.61 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.334 0 N-CA-C 109.22 -0.659 . . . . 0.0 109.22 -178.013 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' C' C ' 81' ' ' LYS . . . . . . . . . . . . . 53.4 mtmt -98.12 125.24 43.04 Favored 'General case' 0 C--N 1.329 -0.314 0 C-N-CA 120.95 -0.3 . . . . 0.0 111.167 -176.934 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' C' C ' 82' ' ' GLY . . . . . . . . . . . . . . . 89.17 42.04 5.69 Favored Glycine 0 CA--C 1.526 0.728 0 C-N-CA 120.786 -0.721 . . . . 0.0 112.048 174.816 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' C' C ' 83' ' ' ILE . . . . . . . . . . . . . 76.5 mt -69.8 138.3 22.38 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.336 0 N-CA-C 109.676 -0.491 . . . . 0.0 109.676 176.749 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' C' C ' 84' ' ' LYS . . . . . . . . . . . . . 38.0 ttpt -101.58 -50.56 3.69 Favored 'General case' 0 C--N 1.331 -0.23 0 CA-C-O 120.942 0.401 . . . . 0.0 110.381 -178.77 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' C' C ' 85' ' ' ASP . . . . . . . . . . . . . 6.6 t0 -149.65 147.51 28.19 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 115.938 -0.574 . . . . 0.0 110.509 -178.572 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' C' C ' 86' ' ' VAL . . . . . . . . . . . . . 43.7 t -129.35 133.64 65.12 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.215 0 CA-C-O 120.925 0.393 . . . . 0.0 110.414 -179.043 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' C' C ' 87' ' ' ILE . . . . . 0.502 ' N ' HD12 ' C' ' 87' ' ' ILE . 4.9 mp -121.94 127.6 75.42 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.215 0 CA-C-N 115.854 -0.612 . . . . 0.0 109.449 176.62 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' C' C ' 88' ' ' LEU . . . . . . . . . . . . . 22.3 tp -118.07 131.52 56.44 Favored 'General case' 0 C--N 1.331 -0.221 0 CA-C-O 121.078 0.466 . . . . 0.0 111.339 -177.279 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' C' C ' 89' ' ' ASP . . . . . . . . . . . . . 14.0 t70 -130.84 152.02 50.63 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 115.616 -0.72 . . . . 0.0 109.293 174.987 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' C' C ' 90' ' ' GLU . . . . . . . . . . . . . 84.9 tt0 -47.81 -35.73 10.62 Favored 'General case' 0 C--N 1.329 -0.286 0 N-CA-C 113.079 0.77 . . . . 0.0 113.079 -172.299 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' C' C ' 91' ' ' ASN . . . . . . . . . . . . . 35.9 m120 -115.4 2.88 14.03 Favored 'General case' 0 N--CA 1.468 0.462 0 N-CA-C 113.734 1.012 . . . . 0.0 113.734 -174.664 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' C' C ' 92' ' ' LEU . . . . . . . . . . . . . 40.7 mt -148.77 147.31 28.66 Favored 'General case' 0 C--N 1.332 -0.196 0 CA-C-N 118.305 0.502 . . . . 0.0 110.972 -175.228 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' C' C ' 93' ' ' ILE . . . . . . . . . . . . . 69.4 mt -125.18 122.05 62.16 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.278 0 N-CA-C 109.383 -0.599 . . . . 0.0 109.383 176.998 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' C' C ' 94' ' ' VAL . . . . . 0.433 HG21 HG21 ' C' ' 125' ' ' VAL . 42.9 t -121.87 127.12 75.34 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.267 0 CA-C-O 120.802 0.334 . . . . 0.0 110.155 -179.448 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' C' C ' 95' ' ' VAL . . . . . . . . . . . . . 45.8 t -122.7 132.64 70.86 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.249 0 CA-C-N 116.094 -0.503 . . . . 0.0 109.786 179.151 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' C' C ' 96' ' ' ILE . . . . . . . . . . . . . 62.7 mt -115.77 128.37 73.05 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.247 0 N-CA-C 109.433 -0.581 . . . . 0.0 109.433 179.75 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' C' C ' 97' ' ' THR . . . . . . . . . . . . . 64.9 p -105.3 163.16 12.82 Favored 'General case' 0 N--CA 1.464 0.233 0 CA-C-O 121.244 0.545 . . . . 0.0 111.68 -174.636 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' C' C ' 98' ' ' GLU . . . . . . . . . . . . . 14.9 mm-40 -53.78 -27.29 28.11 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 115.933 -0.576 . . . . 0.0 112.203 177.676 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' C' C ' 99' ' ' GLU . . . . . . . . . . . . . 71.1 mm-40 -75.26 9.74 1.93 Allowed 'General case' 0 CA--C 1.535 0.395 0 N-CA-C 113.284 0.846 . . . . 0.0 113.284 -177.681 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' C' C ' 100' ' ' ASN . . . . . . . . . . . . . 3.1 m-20 61.03 31.63 19.86 Favored 'General case' 0 CA--C 1.534 0.342 0 CA-C-N 118.268 0.485 . . . . 0.0 111.302 -178.611 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' C' C ' 101' ' ' GLU . . . . . . . . . . . . . 84.5 tt0 -109.63 145.14 36.95 Favored 'General case' 0 C--O 1.233 0.199 0 N-CA-C 109.729 -0.471 . . . . 0.0 109.729 174.569 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' C' C ' 102' ' ' VAL . . . . . . . . . . . . . 45.2 t -114.99 124.12 71.34 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.302 0 CA-C-N 116.137 -0.483 . . . . 0.0 109.783 -179.834 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' C' C ' 103' ' ' LEU . . . . . . . . . . . . . 21.5 mt -112.26 127.69 56.05 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 115.845 -0.616 . . . . 0.0 109.982 176.902 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' C' C ' 104' ' ' ILE . . . . . . . . . . . . . 66.3 mt -116.88 119.74 62.92 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.261 0 N-CA-C 110.268 -0.271 . . . . 0.0 110.268 -179.728 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' C' C ' 105' ' ' PHE . . . . . . . . . . . . . 44.7 m-85 -119.83 168.87 10.66 Favored 'General case' 0 C--N 1.332 -0.158 0 CA-C-N 115.421 -0.809 . . . . 0.0 110.078 179.183 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' C' C ' 106' ' ' ASN . . . . . . . . . . . . . 46.9 p-10 -103.02 -170.48 1.8 Allowed 'General case' 0 CA--C 1.53 0.187 0 N-CA-C 110.018 -0.364 . . . . 0.0 110.018 174.46 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' C' C ' 107' ' ' GLN . . . . . . . . . . . . . 57.0 tt0 -60.94 -23.2 65.12 Favored 'General case' 0 CA--C 1.532 0.272 0 N-CA-C 112.52 0.563 . . . . 0.0 112.52 -179.803 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' C' C ' 108' ' ' ASN . . . . . . . . . . . . . 37.5 t30 -89.88 14.02 13.12 Favored 'General case' 0 CA--C 1.536 0.406 0 N-CA-C 112.89 0.7 . . . . 0.0 112.89 -179.413 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' C' C ' 109' ' ' LEU . . . . . 0.618 HD21 ' HB2' ' C' ' 78' ' ' ALA . 10.4 tp 54.96 37.95 29.68 Favored 'General case' 0 C--O 1.232 0.144 0 CA-C-O 121.036 0.446 . . . . 0.0 111.225 178.732 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' C' C ' 110' ' ' GLU . . . . . . . . . . . . . 70.7 mm-40 -107.98 155.93 19.79 Favored 'General case' 0 C--N 1.331 -0.237 0 N-CA-C 109.921 -0.4 . . . . 0.0 109.921 175.423 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' C' C ' 111' ' ' GLU . . . . . . . . . . . . . 65.8 tt0 -84.56 122.02 28.43 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-N 116.278 -0.419 . . . . 0.0 111.053 -176.245 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' C' C ' 112' ' ' LEU . . . . . . . . . . . . . 36.2 mt -105.44 -46.04 4.3 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.343 -0.39 . . . . 0.0 110.376 177.58 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' C' C ' 113' ' ' TYR . . . . . . . . . . . . . 56.8 t80 -143.68 141.35 30.5 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.301 -0.409 . . . . 0.0 110.966 -179.487 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' C' C ' 114' ' ' ARG . . . . . . . . . . . . . 58.2 ttp180 -139.45 125.27 19.6 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.248 -0.433 . . . . 0.0 110.332 177.642 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' C' C ' 115' ' ' GLY . . . . . . . . . . . . . . . -149.97 151.11 23.23 Favored Glycine 0 CA--C 1.524 0.624 0 N-CA-C 110.905 -0.878 . . . . 0.0 110.905 -179.963 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' C' C ' 116' ' ' LYS . . . . . . . . . . . . . 53.3 tttt -122.09 134.85 54.76 Favored 'General case' 0 C--N 1.328 -0.355 0 N-CA-C 110.021 -0.363 . . . . 0.0 110.021 179.03 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' C' C ' 117' ' ' PHE . . . . . . . . . . . . . 40.9 m-85 -132.31 114.95 15.01 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-N 116.256 -0.429 . . . . 0.0 110.2 -175.921 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' C' C ' 118' ' ' GLU . . . . . . . . . . . . . 43.2 mt-10 -53.32 -44.95 68.8 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.478 -0.328 . . . . 0.0 111.599 -176.625 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' C' C ' 119' ' ' ASN . . . . . . . . . . . . . 30.4 m120 -100.06 31.07 3.46 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.238 -0.437 . . . . 0.0 112.098 -174.271 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' C' C ' 120' ' ' LEU . . . . . . . . . . . . . 13.2 tp -55.39 119.83 6.19 Favored 'General case' 0 N--CA 1.462 0.174 0 C-N-CA 120.984 -0.286 . . . . 0.0 110.696 178.456 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' C' C ' 121' ' ' ASN . . . . . . . . . . . . . 8.2 t-20 -113.98 -44.07 3.19 Favored 'General case' 0 C--N 1.331 -0.209 0 CA-C-N 116.477 -0.329 . . . . 0.0 111.257 -175.884 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' C' C ' 122' ' ' LYS . . . . . . . . . . . . . 95.1 mttt -142.13 148.74 38.8 Favored 'General case' 0 C--N 1.331 -0.216 0 CA-C-O 121.055 0.455 . . . . 0.0 111.602 -176.255 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' C' C ' 123' ' ' VAL . . . . . . . . . . . . . 47.1 t -132.04 124.58 53.21 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.267 0 CA-C-N 115.846 -0.616 . . . . 0.0 109.418 174.222 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' C' C ' 124' ' ' LEU . . . . . . . . . . . . . 6.3 mp -119.71 134.72 55.12 Favored 'General case' 0 N--CA 1.463 0.191 0 CA-C-N 116.453 -0.34 . . . . 0.0 110.711 -178.118 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' C' C ' 125' ' ' VAL . . . . . 0.519 HG22 HG23 ' C' ' 130' ' ' VAL . 43.5 t -132.58 124.23 50.95 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.254 0 CA-C-N 116.144 -0.48 . . . . 0.0 110.183 -179.82 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' C' C ' 126' ' ' ARG . . . . . . . . . . . . . 59.9 mtm180 -151.86 135.74 16.42 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.32 -0.4 . . . . 0.0 109.95 176.7 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' C' C ' 127' ' ' ASN . . . . . . . . . . . . . 5.5 m120 55.0 -154.22 0.3 Allowed 'General case' 0 CA--C 1.54 0.559 0 N-CA-C 110.073 -0.343 . . . . 0.0 110.073 177.852 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' C' C ' 128' ' ' ASP . . . . . . . . . . . . . 15.1 p-10 -83.05 20.74 1.16 Allowed 'General case' 0 CA--C 1.533 0.309 0 N-CA-C 112.509 0.559 . . . . 0.0 112.509 178.13 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' C' C ' 129' ' ' LEU . . . . . . . . . . . . . 14.5 tp -123.15 137.1 54.99 Favored 'General case' 0 C--O 1.234 0.269 0 O-C-N 122.052 -0.405 . . . . 0.0 110.311 179.091 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' C' C ' 130' ' ' VAL . . . . . 0.519 HG23 HG22 ' C' ' 125' ' ' VAL . 12.3 p -132.74 143.29 40.07 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.255 0 CA-C-O 120.999 0.428 . . . . 0.0 110.2 179.412 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' C' C ' 131' ' ' VAL . . . . . . . . . . . . . 41.5 t -136.04 138.93 46.72 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.37 0 CA-C-N 116.032 -0.531 . . . . 0.0 110.339 -178.436 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' C' C ' 132' ' ' ILE . . . . . . . . . . . . . 71.3 mt -116.09 132.45 65.59 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.323 0 CA-C-N 115.614 -0.721 . . . . 0.0 109.141 177.683 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' C' C ' 133' ' ' ILE . . . . . . . . . . . . . 41.4 mm -116.8 121.61 68.12 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.237 0 CA-C-O 120.753 0.311 . . . . 0.0 110.927 -174.464 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' C' C ' 134' ' ' ASP . . . . . . . . . . . . . 8.1 p-10 -135.42 146.48 48.31 Favored 'General case' 0 C--N 1.332 -0.18 0 CA-C-N 116.006 -0.543 . . . . 0.0 109.589 175.316 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' C' C ' 135' ' ' GLU . . . . . . . . . . . . . 83.2 tt0 -50.53 -27.67 7.09 Favored 'General case' 0 C--N 1.329 -0.321 0 N-CA-C 112.827 0.677 . . . . 0.0 112.827 -172.967 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' C' C ' 136' ' ' GLN . . . . . . . . . . . . . 98.4 mt-30 -79.7 -33.24 41.19 Favored 'General case' 0 C--N 1.331 -0.203 0 N-CA-C 112.263 0.468 . . . . 0.0 112.263 -176.226 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' C' C ' 137' ' ' LYS . . . . . . . . . . . . . 56.1 pttt -169.74 174.7 5.61 Favored 'General case' 0 C--N 1.331 -0.21 0 CA-C-O 121.524 0.678 . . . . 0.0 112.257 -172.894 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' C' C ' 138' ' ' LEU . . . . . 0.41 HD23 ' N ' ' C' ' 139' ' ' THR . 6.0 tt -119.14 130.38 55.51 Favored 'General case' 0 C--N 1.331 -0.226 0 CA-C-N 114.973 -1.012 . . . . 0.0 110.236 -179.109 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' C' C ' 139' ' ' THR . . . . . 0.41 ' N ' HD23 ' C' ' 138' ' ' LEU . 21.7 m -108.52 121.76 45.65 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.141 -0.482 . . . . 0.0 110.755 179.551 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' C' C ' 140' ' ' LEU . . . . . . . . . . . . . 33.3 tp -109.59 118.9 37.8 Favored 'General case' 0 C--N 1.329 -0.283 0 N-CA-C 109.058 -0.719 . . . . 0.0 109.058 -179.975 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' C' C ' 141' ' ' ILE . . . . . 0.516 ' HB ' HG13 ' C' ' 130' ' ' VAL . 22.1 mt -121.82 121.61 64.72 Favored 'Isoleucine or valine' 0 C--O 1.234 0.259 0 CA-C-O 121.089 0.471 . . . . 0.0 110.225 -175.627 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' C' C ' 142' ' ' ARG . . . . . . . . . . . . . 80.6 mtp180 -103.6 116.56 32.58 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 115.273 -0.876 . . . . 0.0 110.111 178.265 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' C' C ' 143' ' ' THR . . . . . . . . . . . . . 71.4 p . . . . . 0 C--O 1.219 -0.519 0 CA-C-O 117.992 -1.004 . . . . 0.0 110.528 -179.453 . . . . . . . . 0 0 . 1 . 004 nuclear build full ' D' D ' -3' ' ' GLU . . . . . . . . . . . . . 96.0 mt-10 . . . . . 0 N--CA 1.489 1.524 0 N-CA-C 109.446 -0.576 . . . . 0.0 109.446 . . . . . . . . . 0 0 . 1 . 004 nuclear build full ' D' D ' -2' ' ' GLY . . . . . . . . . . . . . . . -97.81 121.76 7.23 Favored Glycine 0 CA--C 1.526 0.767 0 N-CA-C 110.733 -0.947 . . . . 0.0 110.733 179.271 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' D' D ' -1' ' ' VAL . . . . . . . . . . . . . 43.7 t -95.85 134.33 33.74 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.317 0 CA-C-O 120.78 0.324 . . . . 0.0 110.163 -179.642 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' D' D ' 0' ' ' ILE . . . . . . . . . . . . . 43.9 mm -113.66 138.19 44.22 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.237 0 CA-C-N 116.265 -0.425 . . . . 0.0 110.15 -179.529 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' D' D ' 1' ' ' MET . . . . . . . . . . . . . 24.9 ptp -84.04 132.24 34.74 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.701 179.974 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' D' D ' 2' ' ' SER . . . . . . . . . . . . . 18.2 p -125.83 136.97 53.7 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.125 -0.489 . . . . 0.0 110.274 178.582 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' D' D ' 3' ' ' GLU . . . . . . . . . . . . . 75.4 tt0 -148.0 139.23 23.46 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.235 -0.439 . . . . 0.0 111.305 -176.816 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' D' D ' 4' ' ' LEU . . . . . . . . . . . . . 16.1 tp -124.01 130.2 52.18 Favored 'General case' 0 C--N 1.331 -0.214 0 CA-C-N 116.051 -0.522 . . . . 0.0 110.031 176.477 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' D' D ' 5' ' ' LYS . . . . . . . . . . . . . 65.3 mttm -112.66 123.22 49.81 Favored 'General case' 0 C--O 1.233 0.215 0 CA-C-N 116.516 -0.311 . . . . 0.0 110.944 -179.734 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' D' D ' 6' ' ' LEU . . . . . . . . . . . . . 55.0 mt -115.72 143.19 45.72 Favored 'General case' 0 N--CA 1.463 0.206 0 CA-C-N 115.609 -0.723 . . . . 0.0 110.63 -179.299 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' D' D ' 7' ' ' LYS . . . . . . . . . . . . . 52.1 tttm -124.36 139.37 32.77 Favored Pre-proline 0 CA--C 1.536 0.409 0 CA-C-O 118.88 -0.581 . . . . 0.0 109.434 175.474 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' D' D ' 8' ' ' PRO . . . . . . . . . . . . . 86.4 Cg_endo -91.72 143.07 2.84 Favored 'Trans proline' 0 N--CA 1.491 1.363 0 C-N-CA 121.707 1.605 . . . . 0.0 112.026 179.647 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' D' D ' 9' ' ' LEU . . . . . . . . . . . . . 48.9 mt -81.98 -46.59 1.01 Allowed Pre-proline 0 CA--C 1.533 0.302 0 CA-C-O 118.757 -0.64 . . . . 0.0 112.113 178.595 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' D' D ' 10' ' ' PRO . . . . . . . . . . . . . 83.6 Cg_endo -83.46 151.5 13.43 Favored 'Trans proline' 0 N--CA 1.495 1.57 0 C-N-CA 121.316 1.344 . . . . 0.0 111.693 174.928 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' D' D ' 11' ' ' LYS . . . . . . . . . . . . . 53.4 pttt -84.98 116.68 23.51 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-O 121.234 0.54 . . . . 0.0 110.144 177.41 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' D' D ' 12' ' ' VAL . . . . . . . . . . . . . 12.1 p -151.06 149.63 14.01 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.223 0 CA-C-N 116.023 -0.535 . . . . 0.0 110.777 -178.457 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' D' D ' 13' ' ' GLU . . . . . . . . . . . . . 84.7 tt0 -99.16 111.69 24.02 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.262 -0.426 . . . . 0.0 110.225 177.164 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' D' D ' 14' ' ' LEU . . . . . . . . . . . . . 20.0 mt -98.37 158.05 33.32 Favored Pre-proline 0 C--N 1.33 -0.274 0 CA-C-N 116.513 -0.312 . . . . 0.0 111.27 -177.469 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' D' D ' 15' ' ' PRO . . . . . . . . . . . . . 23.1 Cg_exo -64.72 161.53 35.48 Favored 'Trans proline' 0 N--CA 1.496 1.671 0 C-N-CA 121.424 1.416 . . . . 0.0 111.876 176.973 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' D' D ' 16' ' ' PRO . . . . . . . . . . . . . 24.6 Cg_exo -62.2 -39.8 45.81 Favored 'Trans proline' 0 N--CA 1.496 1.667 0 C-N-CA 121.53 1.487 . . . . 0.0 112.622 -179.182 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' D' D ' 17' ' ' ASP . . . . . . . . . . . . . 16.2 p-10 -84.66 9.58 13.46 Favored 'General case' 0 CA--C 1.537 0.446 0 N-CA-C 113.175 0.805 . . . . 0.0 113.175 -177.109 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' D' D ' 18' ' ' PHE . . . . . 0.434 ' HE1' HD13 ' D' ' 41' ' ' ILE . 48.0 t80 -56.64 -46.47 81.0 Favored 'General case' 0 C--N 1.334 -0.097 0 O-C-N 121.983 -0.448 . . . . 0.0 110.465 -178.397 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' D' D ' 19' ' ' VAL . . . . . . . . . . . . . 48.0 t -56.65 -42.7 77.22 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.338 0 CA-C-N 116.354 -0.385 . . . . 0.0 110.595 -178.006 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' D' D ' 20' ' ' ASP . . . . . . . . . . . . . 9.9 t0 -59.63 -42.46 92.76 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-O 120.79 0.329 . . . . 0.0 110.839 -177.82 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' D' D ' 21' ' ' VAL . . . . . . . . . . . . . 46.5 t -64.02 -45.96 95.21 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.257 0 C-N-CA 120.806 -0.358 . . . . 0.0 110.479 -178.524 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' D' D ' 22' ' ' ILE . . . . . 0.446 HG22 HD12 ' D' ' 26' ' ' LEU . 51.4 mm -54.33 -48.49 67.86 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.258 0 O-C-N 122.289 -0.257 . . . . 0.0 110.812 178.812 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' D' D ' 23' ' ' ARG . . . . . . . . . . . . . 54.1 ttp180 -54.24 -52.12 62.35 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-O 120.793 0.33 . . . . 0.0 111.43 -178.905 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' D' D ' 24' ' ' ILE . . . . . . . . . . . . . 71.4 mt -56.85 -44.2 81.58 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.315 0 CA-C-N 116.541 -0.299 . . . . 0.0 111.271 -174.703 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' D' D ' 25' ' ' LYS . . . . . . . . . . . . . 80.9 mttt -69.34 -43.95 72.64 Favored 'General case' 0 C--N 1.329 -0.311 0 N-CA-C 112.428 0.529 . . . . 0.0 112.428 -177.466 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' D' D ' 26' ' ' LEU . . . . . 0.446 HD12 HG22 ' D' ' 22' ' ' ILE . 59.3 mt -83.35 -16.15 47.17 Favored 'General case' 0 C--N 1.329 -0.307 0 N-CA-C 113.786 1.032 . . . . 0.0 113.786 -170.12 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' D' D ' 27' ' ' GLN . . . . . . . . . . . . . 20.5 pt20 -46.65 151.44 0.58 Allowed 'General case' 0 N--CA 1.468 0.439 0 N-CA-C 112.837 0.68 . . . . 0.0 112.837 -177.013 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' D' D ' 28' ' ' GLY . . . . . . . . . . . . . . . 84.74 -18.18 27.07 Favored Glycine 0 CA--C 1.537 1.438 0 CA-C-N 114.937 -1.029 . . . . 0.0 113.055 -173.636 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' D' D ' 29' ' ' LYS . . . . . . . . . . . . . 51.7 mttm -86.5 134.81 33.64 Favored 'General case' 0 CA--C 1.535 0.371 0 CA-C-N 118.273 1.037 . . . . 0.0 112.596 179.343 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' D' D ' 30' ' ' THR . . . . . . . . . . . . . 26.7 m -88.73 132.77 34.46 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 115.531 -0.759 . . . . 0.0 109.593 175.791 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' D' D ' 31' ' ' VAL . . . . . . . . . . . . . 35.0 m -126.46 148.8 31.14 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.29 0 CA-C-O 120.767 0.318 . . . . 0.0 111.066 -177.532 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' D' D ' 32' ' ' ARG . . . . . . . . . . . . . 75.6 mtt180 -131.29 151.07 51.85 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 116.056 -0.52 . . . . 0.0 110.381 177.764 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' D' D ' 33' ' ' THR . . . . . . . . . . . . . 12.6 m -52.93 137.63 32.02 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.243 -0.435 . . . . 0.0 111.43 -178.49 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' D' D ' 34' ' ' GLY . . . . . . . . . . . . . . . 100.74 -17.1 56.97 Favored Glycine 0 CA--C 1.533 1.177 0 CA-C-O 119.642 -0.532 . . . . 0.0 113.228 178.779 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' D' D ' 35' ' ' ASP . . . . . . . . . . . . . 62.1 m-20 -65.34 150.32 48.48 Favored 'General case' 0 C--O 1.232 0.156 0 CA-C-N 118.038 0.919 . . . . 0.0 111.224 -179.733 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' D' D ' 36' ' ' VAL . . . . . . . . . . . . . 46.8 t -121.22 128.27 75.95 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.272 0 CA-C-N 115.776 -0.647 . . . . 0.0 109.682 178.031 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' D' D ' 37' ' ' ILE . . . . . . . . . . . . . 65.2 mt -122.25 139.24 49.8 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.243 0 CA-C-N 116.159 -0.473 . . . . 0.0 109.807 -179.29 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' D' D ' 38' ' ' GLY . . . . . . . . . . . . . . . -118.47 128.9 7.92 Favored Glycine 0 CA--C 1.526 0.721 0 N-CA-C 111.2 -0.76 . . . . 0.0 111.2 -179.613 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' D' D ' 39' ' ' ILE . . . . . . . . . . . . . 70.3 mt -124.7 130.51 73.39 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.179 0 N-CA-C 109.881 -0.414 . . . . 0.0 109.881 178.196 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' D' D ' 40' ' ' SER . . . . . . . . . . . . . 18.4 m -92.47 124.83 36.8 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.301 -0.409 . . . . 0.0 111.116 177.634 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' D' D ' 41' ' ' ILE . . . . . 0.434 HD13 ' HE1' ' D' ' 18' ' ' PHE . 66.8 mt -135.65 122.84 34.97 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.204 0 N-CA-C 110.02 -0.363 . . . . 0.0 110.02 177.749 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' D' D ' 42' ' ' LEU . . . . . . . . . . . . . 68.2 mt 58.2 35.2 24.83 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.176 -0.465 . . . . 0.0 111.522 178.124 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' D' D ' 43' ' ' GLY . . . . . . . . . . . . . . . 77.88 -10.19 27.05 Favored Glycine 0 CA--C 1.534 1.261 0 C-N-CA 121.235 -0.507 . . . . 0.0 113.418 177.278 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' D' D ' 44' ' ' LYS . . . . . . . . . . . . . 57.7 tttm -102.91 131.52 49.78 Favored 'General case' 0 C--N 1.334 -0.071 0 CA-C-N 118.007 0.903 . . . . 0.0 110.144 177.857 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' D' D ' 45' ' ' GLU . . . . . . . . . . . . . 83.6 tt0 -85.77 133.23 34.01 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.328 -0.396 . . . . 0.0 111.539 -179.318 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' D' D ' 46' ' ' VAL . . . . . . . . . . . . . 9.6 p -120.24 123.96 71.67 Favored 'Isoleucine or valine' 0 C--O 1.233 0.208 0 N-CA-C 109.42 -0.585 . . . . 0.0 109.42 173.206 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' D' D ' 47' ' ' LYS . . . . . . . . . . . . . 98.2 mttt -98.72 127.73 44.74 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.092 -0.504 . . . . 0.0 110.79 178.594 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' D' D ' 48' ' ' PHE . . . . . . . . . . . . . 35.9 m-85 -112.17 131.92 55.19 Favored 'General case' 0 C--N 1.33 -0.263 0 N-CA-C 109.714 -0.476 . . . . 0.0 109.714 177.362 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' D' D ' 49' ' ' LYS . . . . . . . . . . . . . 79.5 tttt -107.07 133.04 52.29 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.325 -0.398 . . . . 0.0 109.967 177.531 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' D' D ' 50' ' ' VAL . . . . . . . . . . . . . 43.2 t -76.71 109.83 11.49 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.339 0 N-CA-C 109.631 -0.507 . . . . 0.0 109.631 179.001 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' D' D ' 51' ' ' VAL . . . . . . . . . . . . . 47.3 t -74.17 -48.37 37.65 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.35 0 CA-C-N 116.057 -0.52 . . . . 0.0 109.918 -175.179 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' D' D ' 52' ' ' GLN . . . . . . . . . . . . . 48.4 tt0 -160.72 137.75 9.03 Favored 'General case' 0 C--N 1.33 -0.266 0 C-N-CA 120.299 -0.56 . . . . 0.0 111.595 -178.121 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' D' D ' 53' ' ' ALA . . . . . . . . . . . . . . . -116.64 132.12 56.77 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 115.975 -0.557 . . . . 0.0 109.744 174.619 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' D' D ' 54' ' ' TYR . . . . . . . . . . . . . 50.7 t80 -129.01 112.02 18.51 Favored Pre-proline 0 CA--C 1.535 0.385 0 CA-C-O 118.166 -0.921 . . . . 0.0 110.346 179.12 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' D' D ' 55' ' ' PRO . . . . . . . . . . . . . 73.8 Cg_endo -77.18 168.73 76.1 Favored 'Cis proline' 0 N--CA 1.499 1.822 0 CA-C-N 122.061 1.772 . . . . 0.0 112.368 -6.223 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' D' D ' 56' ' ' SER . . . . . . . . . . . . . 13.5 m -117.11 126.57 27.34 Favored Pre-proline 0 CA--C 1.538 0.505 0 CA-C-O 118.347 -0.835 . . . . 0.0 109.108 174.732 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' D' D ' 57' ' ' PRO . . . . . . . . . . . . . 49.6 Cg_endo -69.55 146.66 82.37 Favored 'Cis proline' 0 N--CA 1.497 1.683 0 CA-C-N 122.063 1.772 . . . . 0.0 112.044 1.934 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' D' D ' 58' ' ' LEU . . . . . . . . . . . . . 17.5 tp -106.28 135.09 48.38 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 115.99 -0.55 . . . . 0.0 110.641 179.745 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' D' D ' 59' ' ' ARG . . . . . . . . . . . . . 1.5 tpm_? -104.58 107.59 18.6 Favored 'General case' 0 C--N 1.327 -0.401 0 N-CA-C 109.01 -0.737 . . . . 0.0 109.01 178.473 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' D' D ' 60' ' ' VAL . . . . . . . . . . . . . 43.1 t -72.69 108.72 4.25 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.378 0 CA-C-O 121.449 0.642 . . . . 0.0 112.005 -174.643 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' D' D ' 61' ' ' GLU . . . . . . . . . . . . . 95.7 mt-10 -125.16 167.21 15.13 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.269 -0.423 . . . . 0.0 109.892 175.624 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' D' D ' 62' ' ' ASP . . . . . . . . . . . . . 7.6 t0 -52.85 -32.36 44.12 Favored 'General case' 0 C--N 1.328 -0.36 0 N-CA-C 112.066 0.395 . . . . 0.0 112.066 -177.035 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' D' D ' 63' ' ' ARG . . . . . . . . . . . . . 34.5 ptt180 -73.66 -17.32 61.16 Favored 'General case' 0 CA--C 1.535 0.38 0 N-CA-C 113.282 0.845 . . . . 0.0 113.282 -175.743 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' D' D ' 64' ' ' THR . . . . . . . . . . . . . 32.6 m -77.54 143.75 38.16 Favored 'General case' 0 C--N 1.331 -0.229 0 CA-C-O 120.872 0.368 . . . . 0.0 111.048 -175.511 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' D' D ' 65' ' ' LYS . . . . . . . . . . . . . 99.1 mttt -89.17 134.62 33.95 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 115.977 -0.556 . . . . 0.0 110.313 178.591 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' D' D ' 66' ' ' ILE . . . . . . . . . . . . . 69.2 mt -118.7 127.66 75.64 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.228 0 N-CA-C 109.733 -0.469 . . . . 0.0 109.733 178.625 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' D' D ' 67' ' ' THR . . . . . . . . . . . . . 20.2 m -116.02 135.87 53.56 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.113 -0.494 . . . . 0.0 110.948 -176.72 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' D' D ' 68' ' ' LEU . . . . . . . . . . . . . 16.7 tp -106.33 121.53 44.42 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 115.726 -0.67 . . . . 0.0 110.319 178.553 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' D' D ' 69' ' ' VAL . . . . . . . . . . . . . 44.1 t -100.24 135.14 37.36 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.321 0 N-CA-C 109.904 -0.406 . . . . 0.0 109.904 179.334 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' D' D ' 70' ' ' THR . . . . . . . . . . . . . 19.9 m -132.32 107.12 8.33 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-N 116.281 -0.418 . . . . 0.0 110.601 -178.668 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' D' D ' 71' ' ' HIS . . . . . . . . . . . . . 31.7 m80 -150.01 65.56 7.52 Favored Pre-proline 0 CA--C 1.536 0.436 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.549 177.89 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' D' D ' 72' ' ' PRO . . . . . . . . . . . . . 98.5 Cg_endo -89.92 159.05 4.98 Favored 'Trans proline' 0 N--CA 1.49 1.269 0 C-N-CA 121.896 1.73 . . . . 0.0 112.052 178.106 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' D' D ' 73' ' ' VAL . . . . . . . . . . . . . 36.0 m -102.7 151.34 6.09 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.241 0 CA-C-O 120.743 0.306 . . . . 0.0 110.182 177.686 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' D' D ' 74' ' ' ASP . . . . . . . . . . . . . 18.5 t0 -95.21 116.66 29.04 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.152 -0.477 . . . . 0.0 109.831 -178.45 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' D' D ' 75' ' ' VAL . . . . . . . . . . . . . 44.6 t -111.68 121.95 65.15 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.227 0 CA-C-O 121.164 0.507 . . . . 0.0 110.547 -177.02 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' D' D ' 76' ' ' LEU . . . . . . . . . . . . . 21.7 mt -122.13 140.47 52.5 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 115.563 -0.744 . . . . 0.0 109.514 177.543 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' D' D ' 77' ' ' GLU . . . . . . . . . . . . . 46.7 mt-10 -133.77 135.88 44.19 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-O 120.92 0.39 . . . . 0.0 111.126 -178.136 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' D' D ' 78' ' ' ALA . . . . . 0.403 ' HB2' HD21 ' D' ' 109' ' ' LEU . . . -124.59 127.18 46.98 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 115.729 -0.669 . . . . 0.0 109.998 177.771 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' D' D ' 79' ' ' LYS . . . . . 0.619 ' O ' HD13 ' D' ' 80' ' ' ILE . 37.0 tptt -75.9 115.72 15.88 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-O 120.864 0.364 . . . . 0.0 110.535 -177.89 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' D' D ' 80' ' ' ILE . . . . . 0.619 HD13 ' O ' ' D' ' 79' ' ' LYS . 40.4 mm -139.26 111.59 5.62 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.287 0 N-CA-C 109.493 -0.558 . . . . 0.0 109.493 -176.355 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' D' D ' 81' ' ' LYS . . . . . . . . . . . . . 99.1 mttt -101.14 123.82 45.89 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-O 120.855 0.36 . . . . 0.0 110.96 -178.091 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' D' D ' 82' ' ' GLY . . . . . . . . . . . . . . . 89.0 42.35 5.66 Favored Glycine 0 CA--C 1.524 0.647 0 C-N-CA 120.791 -0.718 . . . . 0.0 111.826 175.05 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' D' D ' 83' ' ' ILE . . . . . . . . . . . . . 71.8 mt -63.77 136.73 25.89 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.33 0 N-CA-C 109.607 -0.516 . . . . 0.0 109.607 176.338 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' D' D ' 84' ' ' LYS . . . . . . . . . . . . . 76.7 tttt -95.78 -53.95 3.52 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.107 -0.497 . . . . 0.0 110.412 -177.567 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' D' D ' 85' ' ' ASP . . . . . . . . . . . . . 12.9 t70 -151.43 148.87 28.62 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 115.878 -0.601 . . . . 0.0 110.379 -179.21 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' D' D ' 86' ' ' VAL . . . . . . . . . . . . . 42.2 t -127.84 128.17 68.96 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.28 0 CA-C-O 120.886 0.374 . . . . 0.0 110.379 -179.078 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' D' D ' 87' ' ' ILE . . . . . 0.493 HD12 ' N ' ' D' ' 87' ' ' ILE . 4.9 mp -122.36 127.39 75.11 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.153 0 CA-C-N 115.994 -0.548 . . . . 0.0 109.634 176.993 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' D' D ' 88' ' ' LEU . . . . . . . . . . . . . 58.5 mt -110.22 134.96 51.7 Favored 'General case' 0 C--N 1.331 -0.204 0 CA-C-O 121.025 0.441 . . . . 0.0 110.802 -179.784 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' D' D ' 89' ' ' ASP . . . . . . . . . . . . . 4.4 t70 -123.82 163.12 21.85 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 115.775 -0.648 . . . . 0.0 109.526 178.265 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' D' D ' 90' ' ' GLU . . . . . . . . . . . . . 43.6 tp10 -44.92 -46.02 10.72 Favored 'General case' 0 N--CA 1.464 0.255 0 N-CA-C 113.158 0.799 . . . . 0.0 113.158 -171.495 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' D' D ' 91' ' ' ASN . . . . . . . . . . . . . 25.5 p30 -132.1 26.93 4.55 Favored 'General case' 0 N--CA 1.465 0.276 0 N-CA-C 112.408 0.521 . . . . 0.0 112.408 -178.837 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' D' D ' 92' ' ' LEU . . . . . . . . . . . . . 15.3 mt -147.72 150.44 34.32 Favored 'General case' 0 C--N 1.332 -0.164 0 CA-C-O 120.738 0.304 . . . . 0.0 110.493 -176.352 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' D' D ' 93' ' ' ILE . . . . . . . . . . . . . 69.0 mt -126.38 119.55 54.2 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.272 0 N-CA-C 109.363 -0.606 . . . . 0.0 109.363 177.785 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' D' D ' 94' ' ' VAL . . . . . 0.468 HG21 HG11 ' D' ' 125' ' ' VAL . 45.2 t -119.69 126.28 75.16 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.282 0 CA-C-O 120.99 0.424 . . . . 0.0 109.892 -179.743 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' D' D ' 95' ' ' VAL . . . . . . . . . . . . . 45.6 t -124.15 136.22 61.1 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.265 0 CA-C-N 116.003 -0.544 . . . . 0.0 110.046 -179.392 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' D' D ' 96' ' ' ILE . . . . . . . . . . . . . 54.4 mt -114.75 128.52 71.82 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.343 0 N-CA-C 108.979 -0.749 . . . . 0.0 108.979 178.539 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' D' D ' 97' ' ' THR . . . . . . . . . . . . . 55.1 p -101.11 160.53 14.31 Favored 'General case' 0 C--N 1.331 -0.216 0 CA-C-O 121.115 0.484 . . . . 0.0 111.416 -175.824 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' D' D ' 98' ' ' GLU . . . . . . . . . . . . . 84.2 tt0 -53.86 -26.97 27.12 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.192 -0.458 . . . . 0.0 112.094 178.399 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' D' D ' 99' ' ' GLU . . . . . . . . . . . . . 43.6 mt-10 -77.83 14.34 1.11 Allowed 'General case' 0 CA--C 1.536 0.409 0 N-CA-C 113.01 0.744 . . . . 0.0 113.01 -178.921 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' D' D ' 100' ' ' ASN . . . . . . . . . . . . . 1.9 m120 63.58 37.87 10.03 Favored 'General case' 0 CA--C 1.529 0.155 0 CA-C-N 118.103 0.411 . . . . 0.0 110.731 177.288 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' D' D ' 101' ' ' GLU . . . . . . . . . . . . . 96.7 mt-10 -113.12 148.21 35.76 Favored 'General case' 0 C--O 1.232 0.152 0 CA-C-N 116.268 -0.424 . . . . 0.0 110.377 177.356 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' D' D ' 102' ' ' VAL . . . . . . . . . . . . . 45.5 t -114.88 121.73 67.55 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.367 0 CA-C-N 115.662 -0.699 . . . . 0.0 109.412 177.811 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' D' D ' 103' ' ' LEU . . . . . . . . . . . . . 21.1 mt -115.0 125.66 53.85 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 115.811 -0.631 . . . . 0.0 109.889 177.531 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' D' D ' 104' ' ' ILE . . . . . 0.401 HD12 ' HB3' ' D' ' 113' ' ' TYR . 69.5 mt -114.77 118.77 59.7 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 N-CA-C 110.038 -0.356 . . . . 0.0 110.038 -179.648 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' D' D ' 105' ' ' PHE . . . . . . . . . . . . . 27.9 m-85 -119.88 166.1 13.74 Favored 'General case' 0 C--N 1.331 -0.216 0 O-C-N 123.972 0.795 . . . . 0.0 109.929 178.513 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' D' D ' 106' ' ' ASN . . . . . . . . . . . . . 41.3 p-10 -98.27 -170.33 1.95 Allowed 'General case' 0 C--N 1.329 -0.313 0 N-CA-C 109.791 -0.448 . . . . 0.0 109.791 174.614 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' D' D ' 107' ' ' GLN . . . . . . . . . . . . . 58.1 tt0 -59.77 -29.79 68.42 Favored 'General case' 0 CA--C 1.532 0.285 0 N-CA-C 111.827 0.306 . . . . 0.0 111.827 178.675 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' D' D ' 108' ' ' ASN . . . . . . . . . . . . . 5.1 t-20 -81.99 3.19 27.49 Favored 'General case' 0 CA--C 1.536 0.442 0 N-CA-C 113.283 0.846 . . . . 0.0 113.283 -177.443 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' D' D ' 109' ' ' LEU . . . . . 0.403 HD21 ' HB2' ' D' ' 78' ' ' ALA . 9.5 tp 64.48 40.94 5.91 Favored 'General case' 0 CA--C 1.53 0.182 0 CA-C-O 121.13 0.491 . . . . 0.0 111.364 177.543 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' D' D ' 110' ' ' GLU . . . . . . . . . . . . . 70.7 mm-40 -111.11 160.97 16.4 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-N 116.226 -0.443 . . . . 0.0 109.954 175.243 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' D' D ' 111' ' ' GLU . . . . . . . . . . . . . 45.1 tp10 -84.55 127.14 33.89 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-O 120.881 0.372 . . . . 0.0 111.065 -177.113 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' D' D ' 112' ' ' LEU . . . . . . . . . . . . . 18.9 mt -113.05 -46.11 3.12 Favored 'General case' 0 C--O 1.233 0.213 0 CA-C-N 116.017 -0.538 . . . . 0.0 110.388 176.825 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' D' D ' 113' ' ' TYR . . . . . 0.401 ' HB3' HD12 ' D' ' 104' ' ' ILE . 59.3 t80 -141.13 140.32 34.1 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.303 -0.408 . . . . 0.0 111.003 -179.939 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' D' D ' 114' ' ' ARG . . . . . . . . . . . . . 36.5 ttp180 -141.83 125.1 16.46 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 116.443 -0.344 . . . . 0.0 110.543 177.95 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' D' D ' 115' ' ' GLY . . . . . . . . . . . . . . . -150.1 160.95 28.75 Favored Glycine 0 CA--C 1.523 0.56 0 N-CA-C 111.124 -0.79 . . . . 0.0 111.124 178.867 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' D' D ' 116' ' ' LYS . . . . . . . . . . . . . 39.4 ttpt -127.25 134.34 50.09 Favored 'General case' 0 C--N 1.33 -0.281 0 N-CA-C 110.119 -0.326 . . . . 0.0 110.119 177.287 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' D' D ' 117' ' ' PHE . . . . . . . . . . . . . 31.5 m-85 -138.32 113.89 9.69 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.241 -0.436 . . . . 0.0 110.059 -176.739 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' D' D ' 118' ' ' GLU . . . . . . . . . . . . . 41.6 mp0 -55.18 -49.22 72.43 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-N 116.45 -0.341 . . . . 0.0 111.436 -174.504 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' D' D ' 119' ' ' ASN . . . . . . . . . . . . . 2.7 p30 -94.5 31.16 1.81 Allowed 'General case' 0 C--N 1.331 -0.216 0 N-CA-C 112.168 0.433 . . . . 0.0 112.168 -175.337 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' D' D ' 120' ' ' LEU . . . . . . . . . . . . . 26.8 tp -55.7 119.91 6.46 Favored 'General case' 0 C--N 1.332 -0.175 0 N-CA-C 110.344 -0.243 . . . . 0.0 110.344 175.831 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' D' D ' 121' ' ' ASN . . . . . . . . . . . . . 86.6 m-20 -114.19 -44.0 3.17 Favored 'General case' 0 N--CA 1.463 0.202 0 N-CA-C 111.569 0.211 . . . . 0.0 111.569 -175.37 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' D' D ' 122' ' ' LYS . . . . . . . . . . . . . 53.4 mtpt -138.59 149.02 44.83 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-O 121.11 0.481 . . . . 0.0 111.534 -175.419 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' D' D ' 123' ' ' VAL . . . . . 0.431 ' C ' HD12 ' D' ' 124' ' ' LEU . 46.4 t -133.92 126.49 50.55 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.268 0 CA-C-N 116.0 -0.545 . . . . 0.0 109.588 174.108 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' D' D ' 124' ' ' LEU . . . . . 0.431 HD12 ' C ' ' D' ' 123' ' ' VAL . 7.2 mp -116.99 134.44 54.73 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.311 -0.404 . . . . 0.0 110.571 -177.48 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' D' D ' 125' ' ' VAL . . . . . 0.468 HG11 HG21 ' D' ' 94' ' ' VAL . 34.8 m -131.32 125.85 57.65 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.283 0 CA-C-N 116.389 -0.368 . . . . 0.0 110.36 178.492 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' D' D ' 126' ' ' ARG . . . . . . . . . . . . . 91.2 mtt-85 -150.42 126.44 10.51 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.258 -0.428 . . . . 0.0 110.003 179.468 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' D' D ' 127' ' ' ASN . . . . . . . . . . . . . 10.9 t30 55.57 -148.94 0.47 Allowed 'General case' 0 CA--C 1.54 0.575 0 N-CA-C 110.001 -0.37 . . . . 0.0 110.001 179.502 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' D' D ' 128' ' ' ASP . . . . . . . . . . . . . 17.3 p-10 -82.84 15.35 2.73 Favored 'General case' 0 CA--C 1.535 0.388 0 CA-C-N 118.782 0.719 . . . . 0.0 112.931 179.459 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' D' D ' 129' ' ' LEU . . . . . . . . . . . . . 58.6 mt -112.49 138.2 49.59 Favored 'General case' 0 C--O 1.233 0.216 0 CA-C-N 118.171 0.441 . . . . 0.0 110.7 -179.991 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' D' D ' 130' ' ' VAL . . . . . . . . . . . . . 44.7 t -124.16 136.18 61.25 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.217 0 CA-C-N 115.924 -0.58 . . . . 0.0 109.744 179.638 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' D' D ' 131' ' ' VAL . . . . . 0.43 HG22 HD12 ' D' ' 140' ' ' LEU . 42.6 t -134.71 134.21 54.09 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.215 0 CA-C-O 120.964 0.411 . . . . 0.0 110.339 179.645 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' D' D ' 132' ' ' ILE . . . . . . . . . . . . . 73.6 mt -115.86 132.83 64.15 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.321 0 CA-C-N 115.963 -0.562 . . . . 0.0 109.509 -179.805 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' D' D ' 133' ' ' ILE . . . . . . . . . . . . . 35.7 mm -118.46 120.04 63.05 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.247 0 CA-C-O 120.847 0.356 . . . . 0.0 110.943 -174.043 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' D' D ' 134' ' ' ASP . . . . . . . . . . . . . 8.1 p-10 -133.11 147.95 52.14 Favored 'General case' 0 C--N 1.332 -0.185 0 N-CA-C 109.801 -0.444 . . . . 0.0 109.801 174.789 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' D' D ' 135' ' ' GLU . . . . . . . . . . . . . 84.1 tt0 -49.76 -23.86 2.04 Favored 'General case' 0 C--N 1.329 -0.32 0 N-CA-C 113.049 0.759 . . . . 0.0 113.049 -170.962 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' D' D ' 136' ' ' GLN . . . . . . . . . . . . . 39.3 tp60 -89.4 -37.68 14.66 Favored 'General case' 0 C--N 1.33 -0.241 0 N-CA-C 112.146 0.425 . . . . 0.0 112.146 -175.366 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' D' D ' 137' ' ' LYS . . . . . . . . . . . . . 57.0 pttt -156.41 166.0 34.69 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-O 121.525 0.679 . . . . 0.0 112.077 -171.185 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' D' D ' 138' ' ' LEU . . . . . 0.455 HD23 ' N ' ' D' ' 139' ' ' THR . 4.8 tt -117.7 128.4 54.86 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 115.065 -0.97 . . . . 0.0 109.793 178.115 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' D' D ' 139' ' ' THR . . . . . 0.455 ' N ' HD23 ' D' ' 138' ' ' LEU . 29.8 m -110.43 127.4 55.1 Favored 'General case' 0 C--N 1.331 -0.224 0 CA-C-N 116.421 -0.354 . . . . 0.0 110.809 -179.59 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' D' D ' 140' ' ' LEU . . . . . 0.43 HD12 HG22 ' D' ' 131' ' ' VAL . 9.9 tp -112.61 120.12 40.47 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 115.567 -0.742 . . . . 0.0 109.056 -179.912 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' D' D ' 141' ' ' ILE . . . . . . . . . . . . . 19.6 mt -119.66 117.12 52.77 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.283 0 CA-C-O 121.077 0.465 . . . . 0.0 109.933 -175.823 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' D' D ' 142' ' ' ARG . . . . . . . . . . . . . 58.8 ttp180 -108.85 119.1 38.55 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 115.28 -0.873 . . . . 0.0 110.13 -178.344 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' D' D ' 143' ' ' THR . . . . . . . . . . . . . 54.6 p . . . . . 0 C--O 1.22 -0.465 0 CA-C-O 117.983 -1.008 . . . . 0.0 110.749 -178.596 . . . . . . . . 0 0 . 1 . 004 nuclear build full ' E' E ' -3' ' ' GLU . . . . . . . . . . . . . 96.0 mt-10 . . . . . 0 N--CA 1.49 1.57 0 N-CA-C 109.387 -0.597 . . . . 0.0 109.387 . . . . . . . . . 0 0 . 1 . 004 nuclear build full ' E' E ' -2' ' ' GLY . . . . . . . . . . . . . . . -63.12 145.04 49.93 Favored Glycine 0 CA--C 1.525 0.681 0 N-CA-C 111.139 -0.785 . . . . 0.0 111.139 -179.305 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' E' E ' -1' ' ' VAL . . . . . . . . . . . . . 45.0 t -96.41 136.72 26.34 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.269 0 N-CA-C 110.1 -0.333 . . . . 0.0 110.1 179.703 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' E' E ' 0' ' ' ILE . . . . . . . . . . . . . 70.2 mt -112.27 135.52 51.35 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.202 0 CA-C-N 116.294 -0.412 . . . . 0.0 109.994 179.935 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' E' E ' 1' ' ' MET . . . . . . . . . . . . . 25.0 ptm -78.44 144.12 36.11 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 115.956 -0.565 . . . . 0.0 111.129 -178.519 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' E' E ' 2' ' ' SER . . . . . . . . . . . . . 3.0 p -126.79 129.01 47.49 Favored 'General case' 0 C--N 1.331 -0.207 0 CA-C-N 116.249 -0.432 . . . . 0.0 110.629 178.933 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' E' E ' 3' ' ' GLU . . . . . . . . . . . . . 83.4 tt0 -142.27 142.35 32.57 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.034 -0.53 . . . . 0.0 111.203 -178.579 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' E' E ' 4' ' ' LEU . . . . . . . . . . . . . 14.4 tp -123.24 128.58 50.19 Favored 'General case' 0 C--N 1.332 -0.187 0 CA-C-N 115.958 -0.565 . . . . 0.0 110.281 176.85 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' E' E ' 5' ' ' LYS . . . . . . . . . . . . . 75.1 mttt -105.86 121.4 44.0 Favored 'General case' 0 C--O 1.235 0.293 0 CA-C-N 116.306 -0.406 . . . . 0.0 110.57 178.065 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' E' E ' 6' ' ' LEU . . . . . . . . . . . . . 29.3 mt -115.3 149.82 37.22 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 115.531 -0.759 . . . . 0.0 110.251 -179.735 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' E' E ' 7' ' ' LYS . . . . . . . . . . . . . 58.4 tttm -139.6 138.08 19.66 Favored Pre-proline 0 CA--C 1.533 0.305 0 CA-C-O 119.031 -0.509 . . . . 0.0 110.086 175.088 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' E' E ' 8' ' ' PRO . . . . . . . . . . . . . 98.7 Cg_endo -91.44 139.28 2.34 Favored 'Trans proline' 0 N--CA 1.489 1.258 0 C-N-CA 121.716 1.611 . . . . 0.0 111.728 177.396 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' E' E ' 9' ' ' LEU . . . . . . . . . . . . . 57.5 mt -71.46 -46.65 13.36 Favored Pre-proline 0 CA--C 1.533 0.312 0 CA-C-O 118.644 -0.693 . . . . 0.0 112.033 -179.026 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' E' E ' 10' ' ' PRO . . . . . . . . . . . . . 89.9 Cg_endo -82.31 147.36 14.35 Favored 'Trans proline' 0 N--CA 1.495 1.596 0 C-N-CA 121.147 1.231 . . . . 0.0 111.509 174.419 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' E' E ' 11' ' ' LYS . . . . . . . . . . . . . 50.3 pttt -86.51 115.06 23.76 Favored 'General case' 0 C--N 1.331 -0.222 0 CA-C-O 121.383 0.611 . . . . 0.0 110.217 178.122 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' E' E ' 12' ' ' VAL . . . . . . . . . . . . . 11.6 p -151.11 146.59 16.06 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 CA-C-N 115.879 -0.6 . . . . 0.0 110.544 -178.89 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' E' E ' 13' ' ' GLU . . . . . . . . . . . . . 95.8 mt-10 -83.23 118.03 23.35 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.347 -0.388 . . . . 0.0 110.042 177.126 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' E' E ' 14' ' ' LEU . . . . . . . . . . . . . 48.6 mt -96.53 148.8 35.01 Favored Pre-proline 0 C--N 1.33 -0.265 0 CA-C-O 119.282 -0.39 . . . . 0.0 110.665 -177.881 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' E' E ' 15' ' ' PRO . . . . . . . . . . . . . 27.9 Cg_exo -61.31 163.61 16.98 Favored 'Trans proline' 0 N--CA 1.497 1.704 0 C-N-CA 121.339 1.36 . . . . 0.0 112.093 177.015 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' E' E ' 16' ' ' PRO . . . . . . . . . . . . . 24.4 Cg_exo -62.25 -39.58 46.82 Favored 'Trans proline' 0 N--CA 1.497 1.69 0 C-N-CA 121.561 1.508 . . . . 0.0 112.987 -178.296 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' E' E ' 17' ' ' ASP . . . . . . . . . . . . . 22.1 p-10 -85.39 8.42 18.94 Favored 'General case' 0 CA--C 1.535 0.396 0 N-CA-C 113.302 0.853 . . . . 0.0 113.302 -176.304 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' E' E ' 18' ' ' PHE . . . . . . . . . . . . . 32.4 t80 -55.97 -47.87 76.86 Favored 'General case' 0 C--N 1.334 -0.107 0 O-C-N 121.904 -0.498 . . . . 0.0 110.506 -179.359 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' E' E ' 19' ' ' VAL . . . . . . . . . . . . . 14.0 p -56.3 -40.77 68.13 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.272 0 CA-C-N 116.227 -0.442 . . . . 0.0 111.037 -178.985 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' E' E ' 20' ' ' ASP . . . . . . . . . . . . . 20.2 t0 -60.54 -43.78 96.81 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-O 120.793 0.33 . . . . 0.0 111.15 -177.312 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' E' E ' 21' ' ' VAL . . . . . . . . . . . . . 49.1 t -63.67 -46.33 95.0 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.332 0 C-N-CA 120.834 -0.346 . . . . 0.0 110.296 -178.488 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' E' E ' 22' ' ' ILE . . . . . 0.677 HG22 HD12 ' E' ' 26' ' ' LEU . 49.3 mm -55.54 -45.79 78.77 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.227 0 C-N-CA 120.956 -0.298 . . . . 0.0 110.707 178.377 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' E' E ' 23' ' ' ARG . . . . . . . . . . . . . 54.7 ttp180 -53.33 -51.0 63.79 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-O 120.584 0.23 . . . . 0.0 111.538 -178.544 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' E' E ' 24' ' ' ILE . . . . . . . . . . . . . 68.5 mt -59.64 -43.71 91.82 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.287 0 C-N-CA 121.138 -0.225 . . . . 0.0 111.349 -177.221 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' E' E ' 25' ' ' LYS . . . . . . . . . . . . . 97.9 mttt -64.85 -38.45 91.02 Favored 'General case' 0 C--N 1.329 -0.314 0 N-CA-C 112.208 0.447 . . . . 0.0 112.208 -178.247 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' E' E ' 26' ' ' LEU . . . . . 0.677 HD12 HG22 ' E' ' 22' ' ' ILE . 37.5 mt -80.47 -41.77 23.79 Favored 'General case' 0 C--N 1.329 -0.302 0 N-CA-C 113.258 0.836 . . . . 0.0 113.258 -171.675 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' E' E ' 27' ' ' GLN . . . . . . . . . . . . . 12.1 pt20 -46.42 142.68 2.91 Favored 'General case' 0 N--CA 1.469 0.486 0 N-CA-C 112.869 0.692 . . . . 0.0 112.869 -174.325 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' E' E ' 28' ' ' GLY . . . . . . . . . . . . . . . 98.75 -28.68 13.98 Favored Glycine 0 CA--C 1.531 1.066 0 CA-C-N 115.479 -0.782 . . . . 0.0 112.02 -177.467 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' E' E ' 29' ' ' LYS . . . . . . . . . . . . . 87.7 mttt -98.07 155.08 17.29 Favored 'General case' 0 C--N 1.331 -0.224 0 CA-C-N 117.235 0.517 . . . . 0.0 111.08 178.808 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' E' E ' 30' ' ' THR . . . . . . . . . . . . . 40.1 m -102.4 137.39 40.71 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.002 -0.544 . . . . 0.0 109.949 175.679 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' E' E ' 31' ' ' VAL . . . . . . . . . . . . . 34.6 m -127.92 152.81 36.48 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.256 0 CA-C-O 120.939 0.4 . . . . 0.0 110.729 -178.23 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' E' E ' 32' ' ' ARG . . . . . . . . . . . . . 61.1 ttt180 -131.09 147.82 52.66 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-O 121.215 0.531 . . . . 0.0 110.628 -179.527 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' E' E ' 33' ' ' THR . . . . . . . . . . . . . 31.4 m -52.56 140.7 22.25 Favored 'General case' 0 C--N 1.331 -0.23 0 CA-C-N 116.293 -0.412 . . . . 0.0 111.453 -178.552 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' E' E ' 34' ' ' GLY . . . . . . . . . . . . . . . 99.51 -17.2 58.01 Favored Glycine 0 CA--C 1.531 1.087 0 CA-C-O 119.681 -0.511 . . . . 0.0 113.247 179.502 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' E' E ' 35' ' ' ASP . . . . . . . . . . . . . 80.0 m-20 -66.88 147.52 53.13 Favored 'General case' 0 C--O 1.232 0.138 0 CA-C-N 118.013 0.906 . . . . 0.0 111.028 178.531 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' E' E ' 36' ' ' VAL . . . . . . . . . . . . . 44.2 t -120.9 129.31 75.81 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.208 0 CA-C-N 116.082 -0.508 . . . . 0.0 109.713 177.527 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' E' E ' 37' ' ' ILE . . . . . . . . . . . . . 67.2 mt -121.01 138.83 50.16 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.289 0 CA-C-N 116.246 -0.434 . . . . 0.0 109.937 -178.951 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' E' E ' 38' ' ' GLY . . . . . . . . . . . . . . . -109.78 128.86 9.11 Favored Glycine 0 CA--C 1.524 0.656 0 N-CA-C 111.159 -0.776 . . . . 0.0 111.159 -179.64 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' E' E ' 39' ' ' ILE . . . . . . . . . . . . . 74.4 mt -123.61 133.73 68.38 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.203 0 N-CA-C 109.976 -0.379 . . . . 0.0 109.976 179.017 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' E' E ' 40' ' ' SER . . . . . . . . . . . . . 59.7 p -92.87 117.4 30.0 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.284 -0.417 . . . . 0.0 110.797 175.465 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' E' E ' 41' ' ' ILE . . . . . . . . . . . . . 43.8 mm -121.05 118.0 54.76 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.224 0 CA-C-O 120.802 0.334 . . . . 0.0 110.379 -179.864 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' E' E ' 42' ' ' LEU . . . . . . . . . . . . . 61.1 mt 52.65 36.3 20.51 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 116.194 -0.457 . . . . 0.0 111.604 176.646 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' E' E ' 43' ' ' GLY . . . . . . . . . . . . . . . 73.04 30.51 63.08 Favored Glycine 0 CA--C 1.529 0.911 0 C-N-CA 121.135 -0.555 . . . . 0.0 112.275 177.816 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' E' E ' 44' ' ' LYS . . . . . . . . . . . . . 68.7 mttm -138.31 134.27 34.08 Favored 'General case' 0 C--N 1.331 -0.234 0 N-CA-C 109.759 -0.46 . . . . 0.0 109.759 177.757 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' E' E ' 45' ' ' GLU . . . . . . . . . . . . . 80.6 tt0 -83.02 124.46 30.44 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-O 120.839 0.352 . . . . 0.0 111.6 -176.192 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' E' E ' 46' ' ' VAL . . . . . . . . . . . . . 7.2 p -124.61 126.44 71.68 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.19 0 N-CA-C 109.478 -0.564 . . . . 0.0 109.478 173.863 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' E' E ' 47' ' ' LYS . . . . . . . . . . . . . 98.9 mttt -99.91 129.66 46.01 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.064 -0.516 . . . . 0.0 111.081 178.994 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' E' E ' 48' ' ' PHE . . . . . . . . . . . . . 91.1 m-85 -112.69 131.9 55.44 Favored 'General case' 0 C--N 1.33 -0.271 0 N-CA-C 109.872 -0.418 . . . . 0.0 109.872 177.035 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' E' E ' 49' ' ' LYS . . . . . . . . . . . . . 80.0 tttt -106.96 135.99 47.57 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.294 -0.412 . . . . 0.0 110.279 179.067 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' E' E ' 50' ' ' VAL . . . . . . . . . . . . . 46.0 t -77.14 105.02 5.56 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.218 0 N-CA-C 109.192 -0.67 . . . . 0.0 109.192 175.585 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' E' E ' 51' ' ' VAL . . . . . . . . . . . . . 48.6 t -68.71 -47.97 73.75 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.362 0 O-C-N 123.563 0.539 . . . . 0.0 109.744 -173.179 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' E' E ' 52' ' ' GLN . . . . . . . . . . . . . 43.2 tt0 -171.03 142.12 1.78 Allowed 'General case' 0 C--N 1.329 -0.318 0 C-N-CA 120.313 -0.555 . . . . 0.0 111.423 -179.709 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' E' E ' 53' ' ' ALA . . . . . . . . . . . . . . . -114.41 136.03 53.45 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 115.697 -0.683 . . . . 0.0 110.14 177.517 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' E' E ' 54' ' ' TYR . . . . . . . . . . . . . 37.0 t80 -128.99 108.6 18.18 Favored Pre-proline 0 CA--C 1.535 0.374 0 CA-C-O 118.245 -0.883 . . . . 0.0 110.206 178.558 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' E' E ' 55' ' ' PRO . . . . . . . . . . . . . 73.4 Cg_endo -77.15 170.01 72.71 Favored 'Cis proline' 0 N--CA 1.499 1.841 0 CA-C-N 121.769 1.667 . . . . 0.0 112.486 -5.025 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' E' E ' 56' ' ' SER . . . . . . . . . . . . . 41.2 m -117.21 131.39 24.03 Favored Pre-proline 0 CA--C 1.539 0.524 0 CA-C-O 118.399 -0.81 . . . . 0.0 109.509 174.768 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' E' E ' 57' ' ' PRO . . . . . . . . . . . . . 57.0 Cg_endo -72.36 148.26 90.9 Favored 'Cis proline' 0 N--CA 1.497 1.719 0 CA-C-N 121.917 1.72 . . . . 0.0 111.54 -1.173 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' E' E ' 58' ' ' LEU . . . . . . . . . . . . . 23.8 tp -108.26 137.11 46.79 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.561 -178.622 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' E' E ' 59' ' ' ARG . . . . . . . . . . . . . 54.0 ttp180 -99.92 126.06 46.01 Favored 'General case' 0 C--N 1.328 -0.341 0 N-CA-C 109.334 -0.617 . . . . 0.0 109.334 174.92 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' E' E ' 60' ' ' VAL . . . . . . . . . . . . . 40.5 t -83.03 120.43 34.36 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.269 0 C-N-CA 120.599 -0.44 . . . . 0.0 110.578 -174.955 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' E' E ' 61' ' ' GLU . . . . . . . . . . . . . 74.7 tt0 -130.8 156.01 45.72 Favored 'General case' 0 C--N 1.329 -0.326 0 N-CA-C 108.989 -0.745 . . . . 0.0 108.989 176.252 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' E' E ' 62' ' ' ASP . . . . . . . . . . . . . 9.8 p-10 -51.01 -30.62 15.78 Favored 'General case' 0 C--N 1.327 -0.385 0 N-CA-C 112.369 0.507 . . . . 0.0 112.369 -175.312 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' E' E ' 63' ' ' ARG . . . . . . . . . . . . . 76.0 mtt180 -77.89 -22.07 50.3 Favored 'General case' 0 CA--C 1.533 0.322 0 N-CA-C 113.149 0.796 . . . . 0.0 113.149 -174.987 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' E' E ' 64' ' ' THR . . . . . . . . . . . . . 28.3 m -63.37 146.16 54.1 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-O 120.872 0.367 . . . . 0.0 110.964 -175.841 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' E' E ' 65' ' ' LYS . . . . . . . . . . . . . 67.5 mttm -89.2 134.37 34.06 Favored 'General case' 0 C--N 1.331 -0.212 0 CA-C-N 116.121 -0.49 . . . . 0.0 110.662 -179.733 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' E' E ' 66' ' ' ILE . . . . . . . . . . . . . 62.4 mt -120.9 130.97 74.08 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.238 0 N-CA-C 109.993 -0.373 . . . . 0.0 109.993 179.224 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' E' E ' 67' ' ' THR . . . . . . . . . . . . . 19.1 m -129.72 142.82 50.64 Favored 'General case' 0 C--N 1.332 -0.175 0 CA-C-O 120.979 0.418 . . . . 0.0 111.042 -178.403 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' E' E ' 68' ' ' LEU . . . . . 0.506 HD12 ' N ' ' E' ' 68' ' ' LEU . 6.7 mp -105.98 128.69 53.99 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 116.106 -0.497 . . . . 0.0 110.601 177.702 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' E' E ' 69' ' ' VAL . . . . . . . . . . . . . 43.7 t -102.39 137.44 30.37 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.314 0 CA-C-N 116.163 -0.471 . . . . 0.0 110.09 179.306 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' E' E ' 70' ' ' THR . . . . . . . . . . . . . 28.8 m -134.23 114.95 13.59 Favored 'General case' 0 C--N 1.331 -0.213 0 CA-C-O 120.87 0.367 . . . . 0.0 110.875 179.598 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' E' E ' 71' ' ' HIS . . . . . . . . . . . . . 64.5 t60 -150.03 79.46 7.65 Favored Pre-proline 0 C--N 1.328 -0.347 0 CA-C-N 116.077 -0.51 . . . . 0.0 110.156 177.167 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' E' E ' 72' ' ' PRO . . . . . . . . . . . . . 55.5 Cg_endo -89.17 160.01 5.73 Favored 'Trans proline' 0 N--CA 1.489 1.213 0 C-N-CA 121.769 1.646 . . . . 0.0 112.42 -177.733 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' E' E ' 73' ' ' VAL . . . . . . . . . . . . . 36.0 m -116.32 168.87 7.39 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.216 0 CA-C-N 115.855 -0.611 . . . . 0.0 110.008 178.355 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' E' E ' 74' ' ' ASP . . . . . . . . . . . . . 18.9 t0 -93.85 118.78 31.91 Favored 'General case' 0 C--N 1.328 -0.331 0 N-CA-C 109.978 -0.378 . . . . 0.0 109.978 -177.84 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' E' E ' 75' ' ' VAL . . . . . 0.419 ' C ' HD12 ' E' ' 76' ' ' LEU . 42.2 t -116.57 121.0 66.66 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.224 0 CA-C-O 121.055 0.455 . . . . 0.0 110.468 -178.445 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' E' E ' 76' ' ' LEU . . . . . 0.419 HD12 ' C ' ' E' ' 75' ' ' VAL . 7.0 mp -119.01 149.06 42.28 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 115.778 -0.646 . . . . 0.0 109.788 176.961 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' E' E ' 77' ' ' GLU . . . . . . . . . . . . . 96.3 mt-10 -136.97 134.63 36.89 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-O 121.006 0.432 . . . . 0.0 111.333 -178.975 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' E' E ' 78' ' ' ALA . . . . . . . . . . . . . . . -121.28 136.63 54.94 Favored 'General case' 0 C--N 1.331 -0.225 0 CA-C-N 115.671 -0.695 . . . . 0.0 109.85 176.959 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' E' E ' 79' ' ' LYS . . . . . 0.452 ' O ' HD13 ' E' ' 80' ' ' ILE . 46.3 mmtm -78.48 119.25 21.51 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-O 120.798 0.332 . . . . 0.0 110.611 179.859 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' E' E ' 80' ' ' ILE . . . . . 0.452 HD13 ' O ' ' E' ' 79' ' ' LYS . 26.4 mm -139.25 110.45 4.85 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.28 0 N-CA-C 108.967 -0.753 . . . . 0.0 108.967 -179.351 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' E' E ' 81' ' ' LYS . . . . . . . . . . . . . 54.8 pttt -103.24 124.56 48.85 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-O 120.948 0.404 . . . . 0.0 111.194 -176.753 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' E' E ' 82' ' ' GLY . . . . . . . . . . . . . . . 88.94 42.2 5.72 Favored Glycine 0 CA--C 1.525 0.695 0 C-N-CA 120.713 -0.756 . . . . 0.0 111.616 174.622 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' E' E ' 83' ' ' ILE . . . . . . . . . . . . . 68.2 mt -66.35 139.7 20.74 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.362 0 N-CA-C 109.779 -0.452 . . . . 0.0 109.779 178.247 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' E' E ' 84' ' ' LYS . . . . . . . . . . . . . 87.6 tttt -101.05 -53.96 2.91 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-N 116.011 -0.54 . . . . 0.0 110.311 -178.217 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' E' E ' 85' ' ' ASP . . . . . . . . . . . . . 9.6 t70 -149.97 146.98 27.33 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 115.754 -0.657 . . . . 0.0 110.187 -178.373 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' E' E ' 86' ' ' VAL . . . . . . . . . . . . . 43.0 t -131.69 129.78 61.61 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.228 0 CA-C-O 121.006 0.431 . . . . 0.0 110.476 -178.495 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' E' E ' 87' ' ' ILE . . . . . 0.495 ' N ' HD12 ' E' ' 87' ' ' ILE . 4.9 mp -119.94 125.05 73.88 Favored 'Isoleucine or valine' 0 C--O 1.233 0.198 0 CA-C-N 115.943 -0.571 . . . . 0.0 109.481 176.2 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' E' E ' 88' ' ' LEU . . . . . . . . . . . . . 16.8 tp -110.54 129.19 55.85 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-O 120.911 0.386 . . . . 0.0 110.737 -179.185 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' E' E ' 89' ' ' ASP . . . . . . . . . . . . . 9.5 t70 -123.79 154.18 39.92 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-N 116.01 -0.541 . . . . 0.0 109.815 178.709 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' E' E ' 90' ' ' GLU . . . . . . . . . . . . . 43.1 mt-10 -47.82 -38.43 15.89 Favored 'General case' 0 C--N 1.33 -0.241 0 N-CA-C 112.71 0.633 . . . . 0.0 112.71 -172.643 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' E' E ' 91' ' ' ASN . . . . . . . . . . . . . 6.6 t-20 -132.1 34.58 3.79 Favored 'General case' 0 N--CA 1.463 0.217 0 N-CA-C 111.738 0.273 . . . . 0.0 111.738 -176.455 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' E' E ' 92' ' ' LEU . . . . . . . . . . . . . 12.5 tp -166.16 148.76 7.11 Favored 'General case' 0 C--N 1.329 -0.286 0 C-N-CA 120.937 -0.305 . . . . 0.0 110.906 -178.991 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' E' E ' 93' ' ' ILE . . . . . . . . . . . . . 72.9 mt -128.18 123.28 59.98 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.178 0 N-CA-C 109.491 -0.559 . . . . 0.0 109.491 178.222 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' E' E ' 94' ' ' VAL . . . . . . . . . . . . . 44.8 t -123.96 126.12 72.0 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.277 0 CA-C-O 120.875 0.369 . . . . 0.0 110.035 -179.66 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' E' E ' 95' ' ' VAL . . . . . . . . . . . . . 41.8 t -123.77 134.73 65.64 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.252 0 CA-C-N 116.104 -0.498 . . . . 0.0 110.21 -178.419 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' E' E ' 96' ' ' ILE . . . . . . . . . . . . . 58.1 mt -115.51 130.06 70.75 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 N-CA-C 109.287 -0.634 . . . . 0.0 109.287 178.359 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' E' E ' 97' ' ' THR . . . . . . . . . . . . . 80.3 p -102.09 158.44 16.16 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-O 121.257 0.551 . . . . 0.0 111.324 -177.034 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' E' E ' 98' ' ' GLU . . . . . . . . . . . . . 83.5 tt0 -53.86 -27.05 27.61 Favored 'General case' 0 CA--C 1.533 0.313 0 N-CA-C 112.3 0.481 . . . . 0.0 112.3 -179.529 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' E' E ' 99' ' ' GLU . . . . . . . . . . . . . 34.7 tt0 -80.77 18.06 1.05 Allowed 'General case' 0 CA--C 1.536 0.418 0 N-CA-C 112.728 0.64 . . . . 0.0 112.728 -176.619 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' E' E ' 100' ' ' ASN . . . . . . . . . . . . . 3.2 m-20 61.06 37.96 17.52 Favored 'General case' 0 N--CA 1.463 0.176 0 O-C-N 121.955 -0.466 . . . . 0.0 110.819 178.366 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' E' E ' 101' ' ' GLU . . . . . . . . . . . . . 84.2 tt0 -116.74 143.11 46.05 Favored 'General case' 0 C--N 1.331 -0.203 0 CA-C-N 116.159 -0.473 . . . . 0.0 109.75 177.379 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' E' E ' 102' ' ' VAL . . . . . . . . . . . . . 44.0 t -115.52 127.55 73.05 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.367 0 CA-C-N 116.419 -0.355 . . . . 0.0 110.132 -177.804 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' E' E ' 103' ' ' LEU . . . . . . . . . . . . . 28.9 mt -117.96 131.14 56.53 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-N 115.677 -0.692 . . . . 0.0 109.889 177.123 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' E' E ' 104' ' ' ILE . . . . . . . . . . . . . 67.4 mt -117.66 122.17 69.19 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.26 0 N-CA-C 110.107 -0.331 . . . . 0.0 110.107 -178.336 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' E' E ' 105' ' ' PHE . . . . . . . . . . . . . 91.5 m-85 -124.11 166.4 15.86 Favored 'General case' 0 C--O 1.232 0.151 0 O-C-N 123.985 0.803 . . . . 0.0 110.131 -178.52 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' E' E ' 106' ' ' ASN . . . . . . . . . . . . . 45.6 p-10 -104.04 -172.51 2.12 Favored 'General case' 0 C--N 1.332 -0.172 0 N-CA-C 109.755 -0.461 . . . . 0.0 109.755 171.131 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' E' E ' 107' ' ' GLN . . . . . . . . . . . . . 14.9 tt0 -58.76 -29.99 67.18 Favored 'General case' 0 CA--C 1.532 0.255 0 N-CA-C 112.065 0.394 . . . . 0.0 112.065 -179.72 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' E' E ' 108' ' ' ASN . . . . . . . . . . . . . 48.4 t30 -86.72 12.7 10.15 Favored 'General case' 0 CA--C 1.534 0.34 0 N-CA-C 113.001 0.741 . . . . 0.0 113.001 -176.384 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' E' E ' 109' ' ' LEU . . . . . . . . . . . . . 34.4 mt 58.2 33.34 23.06 Favored 'General case' 0 C--O 1.232 0.168 0 N-CA-C 111.998 0.37 . . . . 0.0 111.998 176.912 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' E' E ' 110' ' ' GLU . . . . . . . . . . . . . 95.5 mt-10 -101.86 129.94 48.21 Favored 'General case' 0 C--N 1.33 -0.25 0 N-CA-C 109.182 -0.673 . . . . 0.0 109.182 174.582 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' E' E ' 111' ' ' GLU . . . . . . . . . . . . . 45.5 tt0 -74.11 121.99 22.02 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-O 121.073 0.463 . . . . 0.0 110.352 -176.108 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' E' E ' 112' ' ' LEU . . . . . . . . . . . . . 35.4 mt -99.62 -46.07 5.57 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 115.795 -0.639 . . . . 0.0 110.461 -179.612 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' E' E ' 113' ' ' TYR . . . . . . . . . . . . . 57.8 t80 -139.22 145.66 39.53 Favored 'General case' 0 C--N 1.331 -0.208 0 CA-C-N 116.317 -0.402 . . . . 0.0 111.197 -178.166 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' E' E ' 114' ' ' ARG . . . . . . . . . . . . . 45.3 ptt85 -147.35 125.27 11.98 Favored 'General case' 0 C--N 1.33 -0.239 0 CA-C-N 116.07 -0.514 . . . . 0.0 110.663 179.062 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' E' E ' 115' ' ' GLY . . . . . . . . . . . . . . . -150.07 159.11 27.96 Favored Glycine 0 CA--C 1.523 0.538 0 N-CA-C 111.105 -0.798 . . . . 0.0 111.105 178.96 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' E' E ' 116' ' ' LYS . . . . . . . . . . . . . 38.4 ttpt -127.07 132.46 50.66 Favored 'General case' 0 C--N 1.33 -0.268 0 N-CA-C 109.809 -0.441 . . . . 0.0 109.809 178.077 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' E' E ' 117' ' ' PHE . . . . . . . . . . . . . 36.6 m-85 -132.14 113.82 13.77 Favored 'General case' 0 C--N 1.331 -0.213 0 CA-C-O 121.014 0.435 . . . . 0.0 110.376 -175.582 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' E' E ' 118' ' ' GLU . . . . . . . . . . . . . 96.3 mt-10 -54.77 -46.93 74.45 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 116.268 -0.424 . . . . 0.0 111.254 -176.728 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' E' E ' 119' ' ' ASN . . . . . . . . . . . . . 24.4 m120 -95.62 31.01 2.13 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.165 -0.471 . . . . 0.0 112.139 -173.523 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' E' E ' 120' ' ' LEU . . . . . . . . . . . . . 14.7 tp -54.92 119.94 6.14 Favored 'General case' 0 N--CA 1.463 0.191 0 C-N-CA 121.019 -0.272 . . . . 0.0 110.752 177.449 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' E' E ' 121' ' ' ASN . . . . . . . . . . . . . 33.3 t-20 -114.09 -43.97 3.19 Favored 'General case' 0 C--N 1.331 -0.22 0 CA-C-N 116.599 -0.273 . . . . 0.0 111.359 -175.181 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' E' E ' 122' ' ' LYS . . . . . . . . . . . . . 36.5 mtmm -143.3 145.22 32.53 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-O 121.121 0.486 . . . . 0.0 111.63 -176.628 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' E' E ' 123' ' ' VAL . . . . . . . . . . . . . 46.8 t -126.67 127.54 70.25 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.22 0 CA-C-N 115.873 -0.603 . . . . 0.0 109.63 176.525 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' E' E ' 124' ' ' LEU . . . . . . . . . . . . . 50.2 mt -130.33 123.56 30.27 Favored 'General case' 0 C--N 1.331 -0.222 0 CA-C-N 116.441 -0.345 . . . . 0.0 110.186 179.751 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' E' E ' 125' ' ' VAL . . . . . 0.486 HG12 HG13 ' E' ' 130' ' ' VAL . 33.0 m -143.14 136.43 25.58 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.305 0 CA-C-O 120.816 0.341 . . . . 0.0 111.125 -178.937 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' E' E ' 126' ' ' ARG . . . . . . . . . . . . . 63.3 mtm180 -151.02 131.15 13.49 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-O 121.152 0.501 . . . . 0.0 110.876 177.82 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' E' E ' 127' ' ' ASN . . . . . . . . . . . . . 3.7 m120 52.01 -105.05 0.2 Allowed 'General case' 0 CA--C 1.543 0.677 0 CA-C-N 115.827 -0.624 . . . . 0.0 111.489 178.629 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' E' E ' 128' ' ' ASP . . . . . . . . . . . . . 22.8 p-10 -114.13 1.45 14.59 Favored 'General case' 0 N--CA 1.467 0.409 0 CA-C-N 119.345 0.975 . . . . 0.0 113.461 -174.895 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' E' E ' 129' ' ' LEU . . . . . . . . . . . . . 68.7 mt -105.55 128.91 53.86 Favored 'General case' 0 C--N 1.333 -0.126 0 CA-C-N 118.28 0.491 . . . . 0.0 110.301 179.215 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' E' E ' 130' ' ' VAL . . . . . 0.486 HG13 HG12 ' E' ' 125' ' ' VAL . 60.3 t -122.06 128.75 75.67 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.273 0 CA-C-N 115.95 -0.568 . . . . 0.0 109.544 -179.571 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' E' E ' 131' ' ' VAL . . . . . . . . . . . . . 41.8 t -136.03 132.38 50.13 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.227 0 CA-C-O 121.186 0.517 . . . . 0.0 110.288 177.493 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' E' E ' 132' ' ' ILE . . . . . . . . . . . . . 73.5 mt -117.25 131.78 68.96 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.316 0 CA-C-N 115.625 -0.716 . . . . 0.0 109.393 179.784 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' E' E ' 133' ' ' ILE . . . . . . . . . . . . . 36.9 mm -113.04 121.07 64.56 Favored 'Isoleucine or valine' 0 C--O 1.233 0.206 0 CA-C-O 120.741 0.305 . . . . 0.0 111.009 -174.935 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' E' E ' 134' ' ' ASP . . . . . . . . . . . . . 9.7 p-10 -131.73 148.23 52.56 Favored 'General case' 0 C--N 1.332 -0.18 0 N-CA-C 109.727 -0.472 . . . . 0.0 109.727 175.2 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' E' E ' 135' ' ' GLU . . . . . . . . . . . . . 78.2 tt0 -49.9 -26.61 4.27 Favored 'General case' 0 C--N 1.328 -0.331 0 N-CA-C 113.019 0.748 . . . . 0.0 113.019 -171.515 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' E' E ' 136' ' ' GLN . . . . . . . . . . . . . 99.4 mm-40 -86.26 -32.07 21.32 Favored 'General case' 0 C--N 1.331 -0.234 0 N-CA-C 112.411 0.522 . . . . 0.0 112.411 -174.932 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' E' E ' 137' ' ' LYS . . . . . . . . . . . . . 23.8 pttm -167.21 174.04 8.51 Favored 'General case' 0 C--O 1.233 0.191 0 CA-C-O 121.472 0.653 . . . . 0.0 112.429 -172.488 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' E' E ' 138' ' ' LEU . . . . . 0.401 ' C ' HD23 ' E' ' 138' ' ' LEU . 5.6 tt -118.52 127.32 53.51 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 114.925 -1.034 . . . . 0.0 110.033 179.867 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' E' E ' 139' ' ' THR . . . . . . . . . . . . . 28.4 m -104.51 120.39 41.15 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.042 -0.526 . . . . 0.0 110.257 179.439 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' E' E ' 140' ' ' LEU . . . . . 0.473 ' C ' HD23 ' E' ' 140' ' ' LEU . 7.7 tt -108.65 120.65 43.08 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 115.824 -0.626 . . . . 0.0 109.427 -179.974 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' E' E ' 141' ' ' ILE . . . . . . . . . . . . . 18.4 mt -123.84 121.2 61.69 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.265 0 CA-C-O 121.012 0.434 . . . . 0.0 109.833 -175.041 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' E' E ' 142' ' ' ARG . . . . . . . . . . . . . 64.5 ttt180 -109.11 124.12 50.29 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 115.689 -0.687 . . . . 0.0 110.22 179.218 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' E' E ' 143' ' ' THR . . . . . . . . . . . . . 55.9 p . . . . . 0 C--O 1.22 -0.467 0 CA-C-O 118.19 -0.909 . . . . 0.0 110.822 -179.542 . . . . . . . . 0 0 . 1 . 004 nuclear build full ' F' F ' -3' ' ' GLU . . . . . . . . . . . . . 82.8 tt0 . . . . . 0 N--CA 1.491 1.61 0 N-CA-C 109.252 -0.647 . . . . 0.0 109.252 . . . . . . . . . 0 0 . 1 . 004 nuclear build full ' F' F ' -2' ' ' GLY . . . . . . . . . . . . . . . -71.33 136.55 25.12 Favored Glycine 0 CA--C 1.526 0.767 0 N-CA-C 111.281 -0.728 . . . . 0.0 111.281 -178.178 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' F' F ' -1' ' ' VAL . . . . . . . . . . . . . 43.5 t -142.38 138.3 29.32 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.292 0 N-CA-C 110.03 -0.359 . . . . 0.0 110.03 178.94 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' F' F ' 0' ' ' ILE . . . . . . . . . . . . . 72.3 mt -112.27 135.73 50.71 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.273 0 CA-C-N 116.209 -0.45 . . . . 0.0 109.884 179.69 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' F' F ' 1' ' ' MET . . . . . . . . . . . . . 27.6 ptm -92.11 147.73 22.72 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.084 -0.507 . . . . 0.0 110.638 -179.31 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' F' F ' 2' ' ' SER . . . . . . . . . . . . . 2.5 p -129.32 128.1 42.45 Favored 'General case' 0 C--N 1.331 -0.198 0 CA-C-N 116.113 -0.494 . . . . 0.0 110.596 179.59 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' F' F ' 3' ' ' GLU . . . . . . . . . . . . . 83.8 tt0 -142.29 141.24 32.41 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.151 -0.477 . . . . 0.0 111.293 -179.984 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' F' F ' 4' ' ' LEU . . . . . . . . . . . . . 17.5 tp -127.31 133.23 50.14 Favored 'General case' 0 C--N 1.331 -0.201 0 CA-C-N 116.04 -0.527 . . . . 0.0 110.272 177.782 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' F' F ' 5' ' ' LYS . . . . . . . . . . . . . 98.5 mttt -112.06 121.32 44.66 Favored 'General case' 0 C--N 1.331 -0.212 0 CA-C-N 116.241 -0.436 . . . . 0.0 110.638 179.829 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' F' F ' 6' ' ' LEU . . . . . . . . . . . . . 69.8 mt -115.02 145.86 41.85 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 115.446 -0.797 . . . . 0.0 110.058 179.948 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' F' F ' 7' ' ' LYS . . . . . . . . . . . . . 40.2 ttmt -128.45 138.58 33.36 Favored Pre-proline 0 CA--C 1.533 0.295 0 CA-C-O 119.052 -0.499 . . . . 0.0 109.879 176.166 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' F' F ' 8' ' ' PRO . . . . . . . . . . . . . 94.4 Cg_endo -92.03 139.38 2.09 Favored 'Trans proline' 0 N--CA 1.488 1.197 0 C-N-CA 121.786 1.658 . . . . 0.0 111.963 178.694 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' F' F ' 9' ' ' LEU . . . . . . . . . . . . . 66.3 mt -74.46 -46.6 5.77 Favored Pre-proline 0 CA--C 1.533 0.314 0 CA-C-O 118.691 -0.671 . . . . 0.0 111.967 178.942 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' F' F ' 10' ' ' PRO . . . . . . . . . . . . . 90.0 Cg_endo -81.04 142.29 13.6 Favored 'Trans proline' 0 N--CA 1.496 1.635 0 C-N-CA 121.076 1.184 . . . . 0.0 111.561 174.035 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' F' F ' 11' ' ' LYS . . . . . . . . . . . . . 80.6 tttt -80.98 101.95 9.84 Favored 'General case' 0 C--N 1.329 -0.295 0 C-N-CA 120.802 -0.359 . . . . 0.0 110.441 179.317 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' F' F ' 12' ' ' VAL . . . . . . . . . . . . . 11.9 p -145.35 147.57 18.55 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.291 0 CA-C-N 116.233 -0.439 . . . . 0.0 110.715 -178.592 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' F' F ' 13' ' ' GLU . . . . . . . . . . . . . 70.7 mm-40 -92.9 123.74 36.38 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.033 176.687 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' F' F ' 14' ' ' LEU . . . . . . . . . . . . . 26.1 mt -96.81 154.48 38.32 Favored Pre-proline 0 C--N 1.329 -0.322 0 CA-C-N 116.426 -0.352 . . . . 0.0 110.69 -178.689 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' F' F ' 15' ' ' PRO . . . . . . . . . . . . . 31.3 Cg_exo -57.04 156.2 25.33 Favored 'Trans proline' 0 N--CA 1.496 1.659 0 C-N-CA 121.335 1.356 . . . . 0.0 111.777 179.636 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' F' F ' 16' ' ' PRO . . . . . . . . . . . . . 35.0 Cg_exo -57.81 -37.76 95.24 Favored 'Trans proline' 0 N--CA 1.497 1.677 0 C-N-CA 121.46 1.44 . . . . 0.0 112.802 -178.627 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' F' F ' 17' ' ' ASP . . . . . . . . . . . . . 19.1 p-10 -90.29 13.36 15.54 Favored 'General case' 0 CA--C 1.537 0.445 0 N-CA-C 113.116 0.784 . . . . 0.0 113.116 -177.38 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' F' F ' 18' ' ' PHE . . . . . . . . . . . . . 46.1 t80 -58.11 -45.32 87.46 Favored 'General case' 0 C--N 1.333 -0.126 0 CA-C-O 120.876 0.37 . . . . 0.0 110.089 -178.512 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' F' F ' 19' ' ' VAL . . . . . . . . . . . . . 48.4 t -57.18 -39.67 68.54 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.322 0 CA-C-N 116.25 -0.432 . . . . 0.0 110.505 -178.131 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' F' F ' 20' ' ' ASP . . . . . . . . . . . . . 10.2 t70 -59.85 -46.46 89.2 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-O 121.095 0.474 . . . . 0.0 110.875 -178.315 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' F' F ' 21' ' ' VAL . . . . . . . . . . . . . 49.5 t -64.19 -48.74 84.34 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.305 0 CA-C-N 116.207 -0.451 . . . . 0.0 110.624 -177.925 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' F' F ' 22' ' ' ILE . . . . . 0.565 HG22 HD12 ' F' ' 26' ' ' LEU . 51.0 mm -56.36 -43.45 77.35 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.297 0 CA-C-O 120.888 0.375 . . . . 0.0 110.51 179.135 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' F' F ' 23' ' ' ARG . . . . . . . . . . . . . 41.0 ttp180 -54.2 -47.52 72.0 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.545 -0.298 . . . . 0.0 111.337 -178.535 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' F' F ' 24' ' ' ILE . . . . . . . . . . . . . 73.8 mt -58.68 -44.17 89.26 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.307 0 CA-C-N 116.578 -0.283 . . . . 0.0 111.082 -179.068 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' F' F ' 25' ' ' LYS . . . . . . . . . . . . . 55.8 mttp -64.81 -39.33 93.41 Favored 'General case' 0 N--CA 1.464 0.24 0 N-CA-C 112.461 0.541 . . . . 0.0 112.461 -179.632 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' F' F ' 26' ' ' LEU . . . . . 0.565 HD12 HG22 ' F' ' 22' ' ' ILE . 49.7 mt -78.9 -41.72 29.0 Favored 'General case' 0 C--N 1.33 -0.28 0 N-CA-C 113.299 0.851 . . . . 0.0 113.299 -170.114 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' F' F ' 27' ' ' GLN . . . . . . . . . . . . . 17.9 pt20 -46.66 139.65 5.05 Favored 'General case' 0 N--CA 1.469 0.508 0 N-CA-C 112.817 0.673 . . . . 0.0 112.817 -175.11 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' F' F ' 28' ' ' GLY . . . . . . . . . . . . . . . 100.63 -27.97 18.04 Favored Glycine 0 CA--C 1.53 0.995 0 CA-C-N 115.494 -0.775 . . . . 0.0 112.218 -177.382 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' F' F ' 29' ' ' LYS . . . . . . . . . . . . . 98.2 mttt -97.9 155.07 17.24 Favored 'General case' 0 C--O 1.232 0.18 0 CA-C-N 117.33 0.565 . . . . 0.0 111.247 179.056 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' F' F ' 30' ' ' THR . . . . . . . . . . . . . 42.0 m -103.67 140.28 37.8 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 115.892 -0.594 . . . . 0.0 110.162 176.839 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' F' F ' 31' ' ' VAL . . . . . . . . . . . . . 35.5 m -127.48 155.06 38.53 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.303 0 CA-C-N 116.272 -0.422 . . . . 0.0 110.374 179.429 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' F' F ' 32' ' ' ARG . . . . . . . . . . . . . 35.9 ttp180 -134.03 149.31 51.17 Favored 'General case' 0 C--N 1.331 -0.207 0 CA-C-O 121.305 0.574 . . . . 0.0 110.603 178.678 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' F' F ' 33' ' ' THR . . . . . 0.417 HG23 ' HA ' ' F' ' 52' ' ' GLN . 16.3 m -52.51 139.61 24.85 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-N 116.073 -0.512 . . . . 0.0 111.544 -177.939 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' F' F ' 34' ' ' GLY . . . . . . . . . . . . . . . 98.75 -17.23 58.61 Favored Glycine 0 CA--C 1.533 1.175 0 C-N-CA 121.236 -0.507 . . . . 0.0 113.366 178.947 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' F' F ' 35' ' ' ASP . . . . . . . . . . . . . 76.3 m-20 -65.79 150.17 48.97 Favored 'General case' 0 N--CA 1.462 0.161 0 CA-C-N 117.942 0.871 . . . . 0.0 111.291 -179.891 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' F' F ' 36' ' ' VAL . . . . . . . . . . . . . 44.3 t -119.73 128.93 75.91 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.222 0 CA-C-N 115.798 -0.637 . . . . 0.0 109.725 177.882 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' F' F ' 37' ' ' ILE . . . . . . . . . . . . . 68.8 mt -122.22 139.19 49.94 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.248 0 CA-C-N 116.261 -0.427 . . . . 0.0 109.928 -179.275 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' F' F ' 38' ' ' GLY . . . . . . . . . . . . . . . -115.3 128.35 8.04 Favored Glycine 0 CA--C 1.525 0.693 0 N-CA-C 110.859 -0.896 . . . . 0.0 110.859 178.853 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' F' F ' 39' ' ' ILE . . . . . . . . . . . . . 76.3 mt -127.44 138.6 54.29 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.217 0 CA-C-O 120.74 0.305 . . . . 0.0 110.197 179.921 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' F' F ' 40' ' ' SER . . . . . . . . . . . . . 42.6 t -91.96 114.05 26.48 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.274 -0.421 . . . . 0.0 110.981 176.849 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' F' F ' 41' ' ' ILE . . . . . . . . . . . . . 44.3 mm -122.94 121.06 62.3 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.234 0 N-CA-C 109.665 -0.494 . . . . 0.0 109.665 178.645 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' F' F ' 42' ' ' LEU . . . . . . . . . . . . . 84.2 mt 57.71 33.67 23.51 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 116.454 -0.339 . . . . 0.0 111.662 179.606 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' F' F ' 43' ' ' GLY . . . . . . . . . . . . . . . 77.64 -10.2 25.37 Favored Glycine 0 CA--C 1.535 1.288 0 C-N-CA 121.311 -0.471 . . . . 0.0 113.47 178.114 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' F' F ' 44' ' ' LYS . . . . . . . . . . . . . 98.3 mttt -101.05 138.76 37.66 Favored 'General case' 0 C--N 1.334 -0.108 0 CA-C-N 117.898 0.849 . . . . 0.0 110.05 177.436 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' F' F ' 45' ' ' GLU . . . . . . . . . . . . . 80.9 tt0 -83.75 130.08 34.95 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.431 -0.35 . . . . 0.0 111.263 -178.945 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' F' F ' 46' ' ' VAL . . . . . . . . . . . . . 10.4 p -120.55 125.87 74.61 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.209 0 N-CA-C 109.653 -0.499 . . . . 0.0 109.653 174.512 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' F' F ' 47' ' ' LYS . . . . . . . . . . . . . 29.2 mtpp -98.0 124.98 42.74 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 115.984 -0.553 . . . . 0.0 110.622 177.979 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' F' F ' 48' ' ' PHE . . . . . . . . . . . . . 40.8 m-85 -110.15 131.89 54.65 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.251 -0.431 . . . . 0.0 109.893 177.534 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' F' F ' 49' ' ' LYS . . . . . . . . . . . . . 85.6 tttt -106.34 131.39 53.61 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.209 -0.451 . . . . 0.0 109.811 177.158 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' F' F ' 50' ' ' VAL . . . . . . . . . . . . . 43.8 t -75.59 105.92 4.95 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.335 0 N-CA-C 109.384 -0.598 . . . . 0.0 109.384 177.911 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' F' F ' 51' ' ' VAL . . . . . . . . . . . . . 48.1 t -69.17 -48.01 71.23 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.27 0 CA-C-N 116.062 -0.517 . . . . 0.0 109.761 -174.354 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' F' F ' 52' ' ' GLN . . . . . 0.417 ' HA ' HG23 ' F' ' 33' ' ' THR . 21.4 pt20 -167.01 158.56 12.47 Favored 'General case' 0 C--N 1.331 -0.199 0 C-N-CA 120.249 -0.58 . . . . 0.0 111.79 179.167 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' F' F ' 53' ' ' ALA . . . . . . . . . . . . . . . -133.5 137.04 45.44 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 115.485 -0.779 . . . . 0.0 110.243 179.07 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' F' F ' 54' ' ' TYR . . . . . . . . . . . . . 38.4 t80 -128.98 109.43 18.29 Favored Pre-proline 0 CA--C 1.535 0.372 0 CA-C-O 118.274 -0.87 . . . . 0.0 110.359 -179.425 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' F' F ' 55' ' ' PRO . . . . . . . . . . . . . 74.0 Cg_endo -77.17 169.97 72.77 Favored 'Cis proline' 0 N--CA 1.502 2.002 0 CA-C-N 121.855 1.698 . . . . 0.0 112.145 -7.375 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' F' F ' 56' ' ' SER . . . . . . . . . . . . . 49.0 m -117.82 132.8 23.48 Favored Pre-proline 0 CA--C 1.538 0.483 0 CA-C-O 118.492 -0.766 . . . . 0.0 109.616 175.057 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' F' F ' 57' ' ' PRO . . . . . . . . . . . . . 40.4 Cg_endo -68.56 165.45 72.8 Favored 'Cis proline' 0 N--CA 1.497 1.731 0 CA-C-N 121.88 1.707 . . . . 0.0 111.328 -1.657 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' F' F ' 58' ' ' LEU . . . . . . . . . . . . . 23.4 tp -130.62 137.45 49.63 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-O 120.871 0.367 . . . . 0.0 110.691 -178.049 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' F' F ' 59' ' ' ARG . . . . . . . . . . . . . 57.6 ttt85 -104.05 128.4 51.65 Favored 'General case' 0 C--N 1.328 -0.35 0 N-CA-C 109.464 -0.569 . . . . 0.0 109.464 176.35 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' F' F ' 60' ' ' VAL . . . . . . . . . . . . . 41.1 t -81.48 122.61 36.77 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.267 0 C-N-CA 120.769 -0.372 . . . . 0.0 110.69 -175.159 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' F' F ' 61' ' ' GLU . . . . . . . . . . . . . 44.3 mt-10 -131.12 168.0 18.18 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 115.842 -0.617 . . . . 0.0 109.77 176.892 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' F' F ' 62' ' ' ASP . . . . . . . . . . . . . 10.0 p-10 -55.91 -32.67 63.97 Favored 'General case' 0 C--N 1.329 -0.316 0 N-CA-C 111.803 0.297 . . . . 0.0 111.803 -178.484 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' F' F ' 63' ' ' ARG . . . . . . . . . . . . . 24.5 mmt180 -78.77 -9.33 59.4 Favored 'General case' 0 N--CA 1.467 0.383 0 N-CA-C 113.347 0.869 . . . . 0.0 113.347 -176.772 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' F' F ' 64' ' ' THR . . . . . . . . . . . . . 31.4 m -70.85 138.93 50.67 Favored 'General case' 0 C--N 1.332 -0.165 0 CA-C-O 121.007 0.432 . . . . 0.0 111.148 -175.356 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' F' F ' 65' ' ' LYS . . . . . . . . . . . . . 62.2 mttm -88.95 123.12 32.99 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 115.862 -0.608 . . . . 0.0 109.881 176.425 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' F' F ' 66' ' ' ILE . . . . . . . . . . . . . 61.7 mt -115.2 126.61 72.82 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 N-CA-C 109.779 -0.452 . . . . 0.0 109.779 179.758 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' F' F ' 67' ' ' THR . . . . . . . . . . . . . 28.4 m -125.38 138.76 54.04 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-O 121.126 0.488 . . . . 0.0 111.175 -177.351 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' F' F ' 68' ' ' LEU . . . . . . . . . . . . . 46.3 mt -103.24 127.89 50.42 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 115.753 -0.658 . . . . 0.0 109.959 176.161 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' F' F ' 69' ' ' VAL . . . . . . . . . . . . . 42.8 t -100.59 133.49 43.57 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.345 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.189 -178.69 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' F' F ' 70' ' ' THR . . . . . . . . . . . . . 21.6 p -103.69 152.22 22.06 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.488 179.616 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' F' F ' 71' ' ' HIS . . . . . . . . . . . . . 6.8 t60 -94.79 145.22 29.2 Favored Pre-proline 0 CA--C 1.534 0.353 0 CA-C-O 119.075 -0.488 . . . . 0.0 109.846 -179.904 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' F' F ' 72' ' ' PRO . . . . . . . . . . . . . 59.2 Cg_endo -75.24 -23.95 12.92 Favored 'Trans proline' 0 N--CA 1.495 1.606 0 C-N-CA 121.284 1.323 . . . . 0.0 112.867 -179.85 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' F' F ' 73' ' ' VAL . . . . . . . . . . . . . 35.9 m -130.95 167.85 25.12 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.161 0 CA-C-O 121.027 0.441 . . . . 0.0 110.814 -179.862 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' F' F ' 74' ' ' ASP . . . . . . . . . . . . . 13.5 t0 -105.11 117.9 35.18 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 115.849 -0.614 . . . . 0.0 109.741 177.748 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' F' F ' 75' ' ' VAL . . . . . 0.429 ' C ' HD12 ' F' ' 76' ' ' LEU . 40.1 t -118.06 125.61 74.34 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.267 0 CA-C-O 121.048 0.451 . . . . 0.0 110.61 -178.08 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' F' F ' 76' ' ' LEU . . . . . 0.429 HD12 ' C ' ' F' ' 75' ' ' VAL . 5.7 mp -126.3 145.42 50.43 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 115.672 -0.695 . . . . 0.0 109.559 176.206 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' F' F ' 77' ' ' GLU . . . . . . . . . . . . . 96.7 mt-10 -132.04 129.11 39.62 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-O 121.02 0.438 . . . . 0.0 110.715 -178.064 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' F' F ' 78' ' ' ALA . . . . . . . . . . . . . . . -115.4 132.62 56.56 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 115.75 -0.659 . . . . 0.0 109.999 178.869 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' F' F ' 79' ' ' LYS . . . . . 0.584 ' O ' HD13 ' F' ' 80' ' ' ILE . 20.2 tptm -76.91 116.38 17.52 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-O 120.916 0.389 . . . . 0.0 110.791 -177.424 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' F' F ' 80' ' ' ILE . . . . . 0.584 HD13 ' O ' ' F' ' 79' ' ' LYS . 42.3 mm -139.28 98.45 1.16 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.282 0 N-CA-C 109.152 -0.684 . . . . 0.0 109.152 -176.938 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' F' F ' 81' ' ' LYS . . . . . . . . . . . . . 17.8 pttp -98.4 131.26 44.82 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-O 120.956 0.408 . . . . 0.0 111.454 -175.72 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' F' F ' 82' ' ' GLY . . . . . . . . . . . . . . . 89.12 41.98 5.72 Favored Glycine 0 CA--C 1.524 0.643 0 CA-C-N 115.82 -0.627 . . . . 0.0 111.57 176.076 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' F' F ' 83' ' ' ILE . . . . . . . . . . . . . 65.8 mt -74.59 135.5 27.24 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 N-CA-C 109.453 -0.573 . . . . 0.0 109.453 176.719 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' F' F ' 84' ' ' LYS . . . . . . . . . . . . . 38.0 ttpt -106.94 -42.48 4.91 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-O 120.782 0.325 . . . . 0.0 110.634 -177.805 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' F' F ' 85' ' ' ASP . . . . . . . . . . . . . 9.2 t70 -149.23 149.83 31.6 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.311 -0.404 . . . . 0.0 110.433 179.336 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' F' F ' 86' ' ' VAL . . . . . . . . . . . . . 41.9 t -137.64 136.76 45.9 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.231 0 CA-C-O 120.936 0.398 . . . . 0.0 110.74 -178.915 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' F' F ' 87' ' ' ILE . . . . . . . . . . . . . 4.9 mp -123.83 126.86 73.32 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.251 0 CA-C-N 115.828 -0.624 . . . . 0.0 109.522 176.171 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' F' F ' 88' ' ' LEU . . . . . . . . . . . . . 19.2 tp -114.89 130.26 56.86 Favored 'General case' 0 N--CA 1.463 0.184 0 CA-C-O 121.088 0.47 . . . . 0.0 111.187 -177.525 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' F' F ' 89' ' ' ASP . . . . . . . . . . . . . 4.2 t0 -125.42 156.58 38.6 Favored 'General case' 0 C--N 1.331 -0.207 0 CA-C-N 115.638 -0.71 . . . . 0.0 109.388 175.399 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' F' F ' 90' ' ' GLU . . . . . . . . . . . . . 81.9 tt0 -46.53 -40.89 13.39 Favored 'General case' 0 N--CA 1.463 0.211 0 N-CA-C 113.11 0.781 . . . . 0.0 113.11 -172.445 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' F' F ' 91' ' ' ASN . . . . . . . . . . . . . 71.1 m-80 -132.14 37.75 3.55 Favored 'General case' 0 N--CA 1.465 0.28 0 CA-C-O 120.785 0.326 . . . . 0.0 111.554 -176.479 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' F' F ' 92' ' ' LEU . . . . . . . . . . . . . 17.3 tp -166.08 138.85 4.04 Favored 'General case' 0 C--N 1.33 -0.281 0 C-N-CA 120.931 -0.308 . . . . 0.0 110.589 -179.563 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' F' F ' 93' ' ' ILE . . . . . . . . . . . . . 67.0 mt -124.02 122.42 64.42 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.187 0 N-CA-C 109.769 -0.456 . . . . 0.0 109.769 179.724 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' F' F ' 94' ' ' VAL . . . . . . . . . . . . . 44.8 t -120.92 125.18 73.73 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.222 0 N-CA-C 109.789 -0.448 . . . . 0.0 109.789 178.59 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' F' F ' 95' ' ' VAL . . . . . . . . . . . . . 43.1 t -120.11 134.04 64.88 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.379 0 CA-C-N 116.071 -0.513 . . . . 0.0 109.746 -179.422 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' F' F ' 96' ' ' ILE . . . . . 0.432 HD11 HG21 ' F' ' 123' ' ' VAL . 68.4 mt -116.6 127.88 74.1 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.232 0 N-CA-C 109.458 -0.571 . . . . 0.0 109.458 179.31 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' F' F ' 97' ' ' THR . . . . . . . . . . . . . 77.8 p -101.92 162.23 13.06 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-O 121.5 0.667 . . . . 0.0 111.704 -175.362 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' F' F ' 98' ' ' GLU . . . . . . . . . . . . . 82.1 tt0 -53.82 -28.51 35.92 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 115.442 -0.799 . . . . 0.0 112.361 -178.947 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' F' F ' 99' ' ' GLU . . . . . . . . . . . . . 96.0 mt-10 -81.97 18.04 1.42 Allowed 'General case' 0 CA--C 1.534 0.354 0 N-CA-C 113.116 0.784 . . . . 0.0 113.116 -176.356 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' F' F ' 100' ' ' ASN . . . . . . . . . . . . . 2.7 m-20 62.22 37.65 14.07 Favored 'General case' 0 CA--C 1.53 0.185 0 CA-C-O 121.036 0.446 . . . . 0.0 111.047 177.591 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' F' F ' 101' ' ' GLU . . . . . . . . . . . . . 84.7 tt0 -117.1 144.61 44.48 Favored 'General case' 0 C--N 1.332 -0.193 0 N-CA-C 109.719 -0.475 . . . . 0.0 109.719 177.342 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' F' F ' 102' ' ' VAL . . . . . . . . . . . . . 42.4 t -117.47 127.29 74.94 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.23 0 N-CA-C 109.962 -0.385 . . . . 0.0 109.962 -178.446 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' F' F ' 103' ' ' LEU . . . . . . . . . . . . . 31.5 mt -116.33 132.07 56.77 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 115.572 -0.74 . . . . 0.0 110.036 176.699 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' F' F ' 104' ' ' ILE . . . . . 0.528 HD13 HG11 ' F' ' 130' ' ' VAL . 66.4 mt -117.73 122.21 69.26 Favored 'Isoleucine or valine' 0 C--O 1.234 0.265 0 N-CA-C 110.238 -0.282 . . . . 0.0 110.238 -178.939 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' F' F ' 105' ' ' PHE . . . . . . . . . . . . . 86.5 m-85 -123.48 164.27 19.27 Favored 'General case' 0 C--N 1.332 -0.165 0 O-C-N 123.936 0.773 . . . . 0.0 110.3 -178.857 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' F' F ' 106' ' ' ASN . . . . . . . . . . . . . 46.0 p-10 -99.73 -169.92 1.82 Allowed 'General case' 0 CA--C 1.53 0.2 0 N-CA-C 109.655 -0.498 . . . . 0.0 109.655 171.849 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' F' F ' 107' ' ' GLN . . . . . . . . . . . . . 41.4 tt0 -57.86 -30.06 65.49 Favored 'General case' 0 C--N 1.327 -0.379 0 N-CA-C 112.117 0.414 . . . . 0.0 112.117 -178.767 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' F' F ' 108' ' ' ASN . . . . . . . . . . . . . 4.0 t-20 -91.24 14.11 15.29 Favored 'General case' 0 CA--C 1.535 0.398 0 N-CA-C 113.106 0.78 . . . . 0.0 113.106 -175.558 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' F' F ' 109' ' ' LEU . . . . . . . . . . . . . 40.8 mt 58.12 34.01 23.75 Favored 'General case' 0 CA--C 1.53 0.204 0 CA-C-O 120.718 0.294 . . . . 0.0 111.723 177.914 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' F' F ' 110' ' ' GLU . . . . . . . . . . . . . 96.0 mt-10 -98.92 134.75 41.33 Favored 'General case' 0 C--N 1.329 -0.288 0 N-CA-C 109.408 -0.59 . . . . 0.0 109.408 175.434 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' F' F ' 111' ' ' GLU . . . . . . . . . . . . . 48.4 tt0 -71.7 121.97 19.8 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-O 121.009 0.433 . . . . 0.0 110.729 -175.751 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' F' F ' 112' ' ' LEU . . . . . . . . . . . . . 25.6 mt -105.87 -46.04 4.22 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-N 115.898 -0.592 . . . . 0.0 110.327 178.994 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' F' F ' 113' ' ' TYR . . . . . 0.405 ' HB3' HD12 ' F' ' 104' ' ' ILE . 31.2 t80 -137.95 141.54 40.53 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.11 -0.495 . . . . 0.0 111.05 -179.036 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' F' F ' 114' ' ' ARG . . . . . . . . . . . . . 32.7 ptt180 -141.69 123.58 15.31 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.247 -0.433 . . . . 0.0 110.392 177.206 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' F' F ' 115' ' ' GLY . . . . . . . . . . . . . . . -150.14 160.08 28.38 Favored Glycine 0 CA--C 1.524 0.601 0 N-CA-C 111.16 -0.776 . . . . 0.0 111.16 179.821 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' F' F ' 116' ' ' LYS . . . . . . . . . . . . . 33.4 ttpt -128.96 136.91 50.99 Favored 'General case' 0 C--N 1.33 -0.276 0 N-CA-C 109.908 -0.405 . . . . 0.0 109.908 177.333 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' F' F ' 117' ' ' PHE . . . . . . . . . . . . . 43.4 m-85 -134.1 113.79 12.45 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-O 120.971 0.415 . . . . 0.0 110.238 -177.124 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' F' F ' 118' ' ' GLU . . . . . . . . . . . . . 45.7 tp10 -54.69 -48.88 71.89 Favored 'General case' 0 C--N 1.326 -0.449 0 CA-C-N 116.289 -0.414 . . . . 0.0 111.277 -176.188 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' F' F ' 119' ' ' ASN . . . . . . . . . . . . . 73.3 m-20 -95.17 31.1 1.99 Allowed 'General case' 0 C--N 1.33 -0.275 0 N-CA-C 112.155 0.428 . . . . 0.0 112.155 -173.836 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' F' F ' 120' ' ' LEU . . . . . . . . . . . . . 20.0 tp -54.18 119.91 5.76 Favored 'General case' 0 N--CA 1.464 0.233 0 O-C-N 122.207 -0.308 . . . . 0.0 110.738 177.29 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' F' F ' 121' ' ' ASN . . . . . . . . . . . . . 13.6 t-20 -114.11 -44.03 3.18 Favored 'General case' 0 C--N 1.331 -0.214 0 CA-C-N 116.455 -0.339 . . . . 0.0 110.962 -177.009 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' F' F ' 122' ' ' LYS . . . . . . . . . . . . . 61.9 mtpt -142.0 147.29 36.67 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-O 121.168 0.509 . . . . 0.0 111.233 -177.059 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' F' F ' 123' ' ' VAL . . . . . 0.432 HG21 HD11 ' F' ' 96' ' ' ILE . 44.2 t -128.66 125.98 64.39 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.191 0 N-CA-C 109.312 -0.625 . . . . 0.0 109.312 174.679 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' F' F ' 124' ' ' LEU . . . . . 0.517 HD12 ' N ' ' F' ' 124' ' ' LEU . 6.0 mp -118.17 132.82 56.3 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-O 120.766 0.317 . . . . 0.0 110.696 -177.019 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' F' F ' 125' ' ' VAL . . . . . . . . . . . . . 43.9 t -125.57 127.51 71.69 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.241 0 CA-C-N 116.051 -0.522 . . . . 0.0 110.178 179.918 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' F' F ' 126' ' ' ARG . . . . . . . . . . . . . 40.8 mmt180 -145.22 119.88 9.8 Favored 'General case' 0 C--N 1.328 -0.336 0 N-CA-C 109.478 -0.564 . . . . 0.0 109.478 177.193 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' F' F ' 127' ' ' ASN . . . . . . . . . . . . . 13.8 m120 56.38 -152.73 0.37 Allowed 'General case' 0 CA--C 1.54 0.564 0 N-CA-C 109.737 -0.468 . . . . 0.0 109.737 -179.164 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' F' F ' 128' ' ' ASP . . . . . . . . . . . . . 23.3 p-10 -79.95 14.29 1.87 Allowed 'General case' 0 CA--C 1.537 0.448 0 N-CA-C 112.759 0.652 . . . . 0.0 112.759 177.799 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' F' F ' 129' ' ' LEU . . . . . . . . . . . . . 60.9 mt -109.37 139.75 43.93 Favored 'General case' 0 C--O 1.232 0.181 0 O-C-N 121.955 -0.465 . . . . 0.0 109.747 178.254 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' F' F ' 130' ' ' VAL . . . . . 0.528 HG11 HD13 ' F' ' 104' ' ' ILE . 12.1 p -132.34 141.75 44.45 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.235 0 CA-C-O 121.202 0.525 . . . . 0.0 110.562 -177.746 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' F' F ' 131' ' ' VAL . . . . . . . . . . . . . 42.8 t -135.99 135.2 50.58 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.299 0 CA-C-N 115.794 -0.639 . . . . 0.0 110.035 178.63 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' F' F ' 132' ' ' ILE . . . . . . . . . . . . . 69.0 mt -113.52 130.76 66.98 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.332 0 CA-C-N 115.815 -0.629 . . . . 0.0 109.348 -179.784 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' F' F ' 133' ' ' ILE . . . . . . . . . . . . . 36.8 mm -114.59 120.41 64.19 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.216 0 CA-C-O 120.989 0.423 . . . . 0.0 110.914 -175.044 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' F' F ' 134' ' ' ASP . . . . . . . . . . . . . 6.9 p-10 -132.56 147.45 52.35 Favored 'General case' 0 C--N 1.332 -0.181 0 N-CA-C 109.519 -0.549 . . . . 0.0 109.519 176.007 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' F' F ' 135' ' ' GLU . . . . . . . . . . . . . 84.5 tt0 -49.94 -27.57 5.51 Favored 'General case' 0 C--N 1.329 -0.298 0 N-CA-C 112.703 0.631 . . . . 0.0 112.703 -173.008 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' F' F ' 136' ' ' GLN . . . . . . . . . . . . . 98.5 mt-30 -81.36 -34.48 31.71 Favored 'General case' 0 C--O 1.232 0.183 0 N-CA-C 112.181 0.438 . . . . 0.0 112.181 -176.158 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' F' F ' 137' ' ' LYS . . . . . . . . . . . . . 56.3 pttt -168.01 175.04 6.92 Favored 'General case' 0 C--N 1.332 -0.188 0 CA-C-O 121.506 0.669 . . . . 0.0 112.14 -172.482 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' F' F ' 138' ' ' LEU . . . . . 0.462 HD23 ' C ' ' F' ' 138' ' ' LEU . 8.5 tt -120.13 128.59 53.58 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 115.174 -0.921 . . . . 0.0 110.135 179.205 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' F' F ' 139' ' ' THR . . . . . . . . . . . . . 33.2 m -107.64 122.41 46.65 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-N 116.116 -0.493 . . . . 0.0 110.239 178.906 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' F' F ' 140' ' ' LEU . . . . . 0.463 HD23 ' C ' ' F' ' 140' ' ' LEU . 6.2 tt -111.03 122.27 47.47 Favored 'General case' 0 C--N 1.329 -0.326 0 N-CA-C 109.189 -0.671 . . . . 0.0 109.189 -179.432 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' F' F ' 141' ' ' ILE . . . . . 0.456 ' HB ' HG13 ' F' ' 130' ' ' VAL . 19.8 mt -121.63 116.36 49.25 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.275 0 CA-C-O 121.086 0.47 . . . . 0.0 109.927 -176.113 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' F' F ' 142' ' ' ARG . . . . . . . . . . . . . 61.6 ttt180 -106.07 127.46 53.2 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 114.921 -1.036 . . . . 0.0 110.619 -176.259 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' F' F ' 143' ' ' THR . . . . . . . . . . . . . 75.8 p . . . . . 0 C--O 1.22 -0.46 0 CA-C-O 118.001 -1.0 . . . . 0.0 110.589 179.192 . . . . . . . . 0 0 . 1 . 005 nuclear build full ' A' A ' -3' ' ' GLU . . . . . . . . . . . . . 11.8 pt-20 . . . . . 0 N--CA 1.49 1.557 0 N-CA-C 109.501 -0.555 . . . . 0.0 109.501 . . . . . . . . . 0 0 . 1 . 005 nuclear build full ' A' A ' -2' ' ' GLY . . . . . . . . . . . . . . . -62.93 115.13 7.63 Favored Glycine 0 CA--C 1.525 0.695 0 N-CA-C 110.843 -0.903 . . . . 0.0 110.843 -179.86 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' -1' ' ' VAL . . . . . . . . . . . . . 41.0 t -97.35 128.64 48.43 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 CA-C-O 120.83 0.348 . . . . 0.0 110.233 -179.518 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 0' ' ' ILE . . . . . . . . . . . . . 74.8 mt -122.58 133.51 68.54 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.234 0 N-CA-C 109.741 -0.466 . . . . 0.0 109.741 177.773 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 26.8 ptm -143.66 166.83 23.75 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.264 -0.426 . . . . 0.0 110.909 -178.52 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 13.7 p -114.74 135.41 54.2 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.01 -0.541 . . . . 0.0 110.618 177.934 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 84.9 tt0 -140.02 138.94 35.84 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-N 115.724 -0.671 . . . . 0.0 110.676 179.64 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 4' ' ' LEU . . . . . 0.49 HD23 ' N ' ' A' ' 5' ' ' LYS . 3.0 tt -125.7 126.51 44.76 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 115.734 -0.666 . . . . 0.0 109.698 178.579 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 5' ' ' LYS . . . . . 0.49 ' N ' HD23 ' A' ' 4' ' ' LEU . 87.8 mttt -108.99 124.34 50.56 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-O 120.655 0.265 . . . . 0.0 110.864 -179.119 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 6' ' ' LEU . . . . . 0.475 HD23 ' HA ' ' A' ' 50' ' ' VAL . 18.3 mt -122.01 150.29 42.28 Favored 'General case' 0 C--O 1.232 0.163 0 CA-C-N 115.811 -0.631 . . . . 0.0 111.254 -178.879 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 49.3 tttm -138.27 143.47 39.1 Favored Pre-proline 0 C--N 1.329 -0.304 0 CA-C-N 115.757 -0.656 . . . . 0.0 109.792 175.199 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 8' ' ' PRO . . . . . . . . . . . . . 97.5 Cg_endo -89.8 136.72 2.65 Favored 'Trans proline' 0 N--CA 1.489 1.234 0 C-N-CA 121.741 1.628 . . . . 0.0 111.766 178.537 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 40.9 mt -75.9 -45.68 3.93 Favored Pre-proline 0 CA--C 1.532 0.285 0 CA-C-O 119.064 -0.493 . . . . 0.0 111.524 -179.253 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 71.1 Cg_endo -85.1 152.12 10.93 Favored 'Trans proline' 0 N--CA 1.494 1.519 0 C-N-CA 121.234 1.289 . . . . 0.0 111.31 170.534 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 27.5 ttpp -86.23 109.78 19.16 Favored 'General case' 0 C--N 1.33 -0.271 0 C-N-CA 120.702 -0.399 . . . . 0.0 110.235 178.692 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 11.8 p -142.77 145.09 23.55 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.291 0 CA-C-N 116.092 -0.504 . . . . 0.0 110.62 -178.576 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 84.8 tt0 -88.47 121.32 30.72 Favored 'General case' 0 C--N 1.328 -0.344 0 N-CA-C 109.913 -0.403 . . . . 0.0 109.913 176.886 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 14' ' ' LEU . . . . . . . . . . . . . 29.6 mt -98.01 151.56 37.61 Favored Pre-proline 0 C--N 1.33 -0.268 0 CA-C-N 116.354 -0.384 . . . . 0.0 110.976 -176.277 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 15' ' ' PRO . . . . . . . . . . . . . 24.5 Cg_exo -63.31 161.13 31.95 Favored 'Trans proline' 0 N--CA 1.497 1.723 0 C-N-CA 121.322 1.348 . . . . 0.0 111.666 175.436 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 16' ' ' PRO . . . . . . . . . . . . . 26.6 Cg_exo -60.73 -34.0 92.39 Favored 'Trans proline' 0 N--CA 1.496 1.646 0 C-N-CA 121.478 1.452 . . . . 0.0 112.966 -177.722 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 17' ' ' ASP . . . . . . . . . . . . . 18.8 p-10 -90.62 6.6 43.17 Favored 'General case' 0 CA--C 1.537 0.465 0 N-CA-C 113.402 0.89 . . . . 0.0 113.402 -176.833 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 18' ' ' PHE . . . . . . . . . . . . . 49.6 t80 -57.59 -42.93 84.18 Favored 'General case' 0 C--N 1.334 -0.105 0 CA-C-O 120.952 0.406 . . . . 0.0 110.291 -178.021 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 19' ' ' VAL . . . . . . . . . . . . . 47.8 t -57.16 -43.57 81.84 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.346 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.358 -178.827 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 4.2 m-20 -60.15 -41.33 92.54 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.525 -0.307 . . . . 0.0 110.882 -178.381 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 47.0 t -63.58 -46.17 95.66 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 C-N-CA 120.85 -0.34 . . . . 0.0 110.296 -177.385 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 22' ' ' ILE . . . . . 0.564 HG22 HD12 ' A' ' 26' ' ' LEU . 51.0 mm -55.54 -48.63 77.13 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.237 0 CA-C-O 120.81 0.338 . . . . 0.0 110.714 178.778 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 23' ' ' ARG . . . . . . . . . . . . . 55.9 ttp180 -54.31 -48.77 70.93 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.629 -0.26 . . . . 0.0 111.568 -178.057 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 24' ' ' ILE . . . . . . . . . . . . . 78.5 mt -60.11 -42.7 90.92 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.269 0 C-N-CA 121.052 -0.259 . . . . 0.0 111.54 -176.791 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 51.1 mttm -65.13 -40.49 94.52 Favored 'General case' 0 C--N 1.328 -0.327 0 N-CA-C 112.21 0.448 . . . . 0.0 112.21 -179.12 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 26' ' ' LEU . . . . . 0.564 HD12 HG22 ' A' ' 22' ' ' ILE . 37.6 mt -78.96 -40.06 32.83 Favored 'General case' 0 C--N 1.33 -0.271 0 N-CA-C 113.526 0.935 . . . . 0.0 113.526 -171.366 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 27' ' ' GLN . . . . . . . . . . . . . 12.9 pt20 -46.88 141.91 3.75 Favored 'General case' 0 N--CA 1.47 0.545 0 N-CA-C 112.82 0.674 . . . . 0.0 112.82 -175.207 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 97.72 -30.0 10.06 Favored Glycine 0 CA--C 1.531 1.044 0 CA-C-N 115.652 -0.703 . . . . 0.0 111.984 -177.529 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 48.8 mtmt -99.3 155.3 17.58 Favored 'General case' 0 C--O 1.233 0.227 0 CA-C-O 120.993 0.425 . . . . 0.0 111.324 179.304 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 30' ' ' THR . . . . . . . . . . . . . 20.8 m -105.57 140.55 38.49 Favored 'General case' 0 C--N 1.331 -0.212 0 CA-C-N 115.91 -0.586 . . . . 0.0 110.166 176.657 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 35.5 m -129.54 161.43 39.08 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.187 0 CA-C-N 116.41 -0.359 . . . . 0.0 110.848 -179.138 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 32' ' ' ARG . . . . . . . . . . . . . 79.7 mtt85 -127.28 147.37 50.23 Favored 'General case' 0 C--N 1.331 -0.212 0 CA-C-O 121.291 0.567 . . . . 0.0 110.776 179.093 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 33' ' ' THR . . . . . . . . . . . . . 29.2 m -53.91 140.69 29.98 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.248 -0.433 . . . . 0.0 111.146 -179.879 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 98.83 -17.13 58.69 Favored Glycine 0 CA--C 1.532 1.144 0 C-N-CA 121.131 -0.557 . . . . 0.0 113.232 179.33 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 76.1 m-20 -64.63 150.26 47.37 Favored 'General case' 0 C--O 1.232 0.147 0 CA-C-N 118.096 0.948 . . . . 0.0 111.241 179.813 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 45.0 t -119.07 129.65 74.91 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.247 0 CA-C-N 115.713 -0.676 . . . . 0.0 109.81 178.85 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 37' ' ' ILE . . . . . . . . . . . . . 69.2 mt -119.94 138.28 51.03 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.273 0 CA-C-N 116.171 -0.468 . . . . 0.0 109.759 179.414 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . -113.74 128.98 8.56 Favored Glycine 0 CA--C 1.525 0.707 0 N-CA-C 111.029 -0.828 . . . . 0.0 111.029 -179.255 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 39' ' ' ILE . . . . . . . . . . . . . 72.4 mt -123.55 133.97 67.69 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.231 0 N-CA-C 110.188 -0.301 . . . . 0.0 110.188 179.079 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 40' ' ' SER . . . . . . . . . . . . . 45.2 t -93.0 113.93 26.34 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.455 -0.338 . . . . 0.0 110.776 175.597 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 41' ' ' ILE . . . . . . . . . . . . . 44.9 mm -121.51 123.44 69.59 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.265 0 CA-C-O 120.778 0.323 . . . . 0.0 110.45 179.997 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 34.5 mt 52.57 34.09 14.91 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.235 -0.438 . . . . 0.0 111.791 177.292 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . 72.52 32.16 62.28 Favored Glycine 0 CA--C 1.53 0.988 0 C-N-CA 121.113 -0.565 . . . . 0.0 111.889 178.747 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 44' ' ' LYS . . . . . . . . . . . . . 33.7 ttmt -139.21 130.48 26.82 Favored 'General case' 0 C--N 1.329 -0.314 0 N-CA-C 109.767 -0.457 . . . . 0.0 109.767 179.188 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 84.0 tt0 -82.62 122.38 28.03 Favored 'General case' 0 C--N 1.329 -0.29 0 C-N-CA 120.755 -0.378 . . . . 0.0 111.003 -177.848 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 46' ' ' VAL . . . . . . . . . . . . . 7.1 p -120.64 129.1 75.98 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.227 0 N-CA-C 109.338 -0.616 . . . . 0.0 109.338 174.682 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 59.7 mtpt -100.32 127.05 46.71 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 115.748 -0.66 . . . . 0.0 110.858 179.624 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 48' ' ' PHE . . . . . . . . . . . . . 89.5 m-85 -110.44 131.87 54.68 Favored 'General case' 0 C--N 1.33 -0.275 0 N-CA-C 110.017 -0.364 . . . . 0.0 110.017 176.919 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 86.2 tttt -106.33 133.94 50.24 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.258 -0.428 . . . . 0.0 110.415 179.892 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 50' ' ' VAL . . . . . 0.475 ' HA ' HD23 ' A' ' 6' ' ' LEU . 42.1 t -77.76 105.38 6.7 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.236 0 N-CA-C 109.165 -0.68 . . . . 0.0 109.165 176.177 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 51' ' ' VAL . . . . . . . . . . . . . 48.9 t -69.79 -48.52 63.97 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.295 0 CA-C-N 116.022 -0.535 . . . . 0.0 110.146 -173.16 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 52' ' ' GLN . . . . . . . . . . . . . 61.8 tt0 -163.96 144.62 8.51 Favored 'General case' 0 C--N 1.329 -0.296 0 C-N-CA 120.288 -0.565 . . . . 0.0 111.811 -177.911 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 53' ' ' ALA . . . . . 0.442 ' HB1' ' HB2' ' A' ' 58' ' ' LEU . . . -115.18 133.04 56.39 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 115.559 -0.746 . . . . 0.0 109.79 176.016 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 54' ' ' TYR . . . . . . . . . . . . . 9.5 t80 -129.04 108.41 18.09 Favored Pre-proline 0 CA--C 1.535 0.379 0 CA-C-O 118.182 -0.914 . . . . 0.0 110.464 178.499 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 55' ' ' PRO . . . . . . . . . . . . . 72.0 Cg_endo -76.96 168.89 75.87 Favored 'Cis proline' 0 N--CA 1.501 1.952 0 CA-C-N 121.941 1.729 . . . . 0.0 112.408 -4.945 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 56' ' ' SER . . . . . . . . . . . . . 14.4 m -112.33 128.0 26.1 Favored Pre-proline 0 CA--C 1.539 0.535 0 CA-C-O 118.366 -0.826 . . . . 0.0 109.673 176.961 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 57' ' ' PRO . . . . . . . . . . . . . 35.2 Cg_endo -65.72 168.86 44.6 Favored 'Cis proline' 0 N--CA 1.497 1.715 0 CA-C-N 122.029 1.76 . . . . 0.0 111.45 -2.862 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 58' ' ' LEU . . . . . 0.442 ' HB2' ' HB1' ' A' ' 53' ' ' ALA . 30.0 tp -129.95 135.71 48.63 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-O 120.887 0.375 . . . . 0.0 110.707 -179.41 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 59' ' ' ARG . . . . . . . . . . . . . 52.9 ttt180 -106.99 129.12 54.83 Favored 'General case' 0 C--N 1.328 -0.335 0 N-CA-C 108.688 -0.856 . . . . 0.0 108.688 176.521 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 40.6 t -89.85 126.23 42.75 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.183 0 C-N-CA 120.385 -0.526 . . . . 0.0 111.36 -172.607 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 49.8 mp0 -131.07 168.55 17.21 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 115.58 -0.737 . . . . 0.0 109.077 171.917 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 62' ' ' ASP . . . . . . . . . . . . . 18.2 p-10 -53.87 -32.6 53.72 Favored 'General case' 0 C--N 1.329 -0.323 0 C-N-CA 120.931 -0.308 . . . . 0.0 111.815 -178.449 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 63' ' ' ARG . . . . . . . . . . . . . 98.4 mtt180 -71.97 -22.14 61.49 Favored 'General case' 0 CA--C 1.532 0.273 0 N-CA-C 112.896 0.702 . . . . 0.0 112.896 -177.299 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 50.9 m -67.37 130.24 42.43 Favored 'General case' 0 C--N 1.332 -0.193 0 N-CA-C 110.125 -0.324 . . . . 0.0 110.125 -178.275 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 65' ' ' LYS . . . . . . . . . . . . . 50.3 mtmt -89.23 135.79 33.38 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.222 -0.445 . . . . 0.0 110.538 179.825 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 66' ' ' ILE . . . . . . . . . . . . . 65.1 mt -114.8 130.95 68.36 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.229 0 N-CA-C 109.736 -0.468 . . . . 0.0 109.736 -178.408 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 67' ' ' THR . . . . . . . . . . . . . 23.4 m -117.63 134.73 54.57 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.123 -0.49 . . . . 0.0 110.608 -178.524 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 68' ' ' LEU . . . . . . . . . . . . . 15.4 tp -108.4 127.72 54.14 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 115.891 -0.595 . . . . 0.0 110.472 179.585 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 69' ' ' VAL . . . . . . . . . . . . . 43.0 t -97.61 136.2 29.31 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.272 0 CA-C-O 120.877 0.37 . . . . 0.0 110.284 178.318 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 70' ' ' THR . . . . . . . . . . . . . 69.7 p -92.2 173.65 7.71 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.031 -0.531 . . . . 0.0 110.748 179.927 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 71' ' ' HIS . . . . . . . . . . . . . 40.5 t-80 -65.07 141.14 98.25 Favored Pre-proline 0 CA--C 1.533 0.321 0 CA-C-N 116.239 -0.437 . . . . 0.0 110.365 -178.462 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 72' ' ' PRO . . . . . . . . . . . . . 64.1 Cg_endo -94.49 159.91 1.95 Allowed 'Trans proline' 0 N--CA 1.491 1.362 0 C-N-CA 121.891 1.727 . . . . 0.0 112.903 179.771 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 73' ' ' VAL . . . . . . . . . . . . . 35.4 m -79.68 -170.26 0.11 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.271 0 CA-C-N 115.934 -0.575 . . . . 0.0 109.773 175.255 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 74' ' ' ASP . . . . . . . . . . . . . 13.6 t70 -86.18 114.97 23.45 Favored 'General case' 0 C--N 1.33 -0.247 0 N-CA-C 109.557 -0.535 . . . . 0.0 109.557 -179.088 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 41.4 t -122.59 124.26 70.28 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.203 0 CA-C-O 121.077 0.465 . . . . 0.0 110.909 -175.203 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 76' ' ' LEU . . . . . . . . . . . . . 5.1 mp -126.38 147.05 49.83 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 115.664 -0.698 . . . . 0.0 109.603 174.852 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 77' ' ' GLU . . . . . . . . . . . . . 45.9 mt-10 -135.1 140.52 45.55 Favored 'General case' 0 C--N 1.331 -0.207 0 CA-C-O 121.015 0.436 . . . . 0.0 111.425 -178.443 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 78' ' ' ALA . . . . . 0.42 ' HB2' HD21 ' A' ' 109' ' ' LEU . . . -129.92 131.33 45.96 Favored 'General case' 0 C--N 1.331 -0.22 0 CA-C-N 115.774 -0.648 . . . . 0.0 109.842 176.513 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 79' ' ' LYS . . . . . 0.583 ' O ' HD13 ' A' ' 80' ' ' ILE . 16.3 ptpt -74.94 122.57 23.65 Favored 'General case' 0 C--N 1.331 -0.222 0 CA-C-O 121.281 0.562 . . . . 0.0 111.087 -176.801 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 80' ' ' ILE . . . . . 0.583 HD13 ' O ' ' A' ' 79' ' ' LYS . 41.2 mm -139.22 110.57 4.95 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.318 0 CA-C-N 115.779 -0.646 . . . . 0.0 109.289 -177.875 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 81' ' ' LYS . . . . . . . . . . . . . 60.6 mttp -101.37 125.56 48.03 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-O 120.914 0.388 . . . . 0.0 111.293 -178.234 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . 89.15 42.07 5.69 Favored Glycine 0 CA--C 1.525 0.702 0 C-N-CA 121.105 -0.569 . . . . 0.0 111.894 174.254 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 83' ' ' ILE . . . . . . . . . . . . . 71.4 mt -69.55 133.3 32.09 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.33 0 N-CA-C 109.489 -0.56 . . . . 0.0 109.489 175.999 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 84' ' ' LYS . . . . . . . . . . . . . 35.7 ttpt -101.58 -49.58 3.97 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-O 120.742 0.306 . . . . 0.0 110.398 -177.881 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 85' ' ' ASP . . . . . . . . . . . . . 5.6 t70 -150.87 151.26 31.97 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.242 -0.435 . . . . 0.0 110.483 -179.972 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 86' ' ' VAL . . . . . . . . . . . . . 41.0 t -133.89 137.62 52.0 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.261 0 CA-C-O 121.014 0.435 . . . . 0.0 110.537 -179.061 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 87' ' ' ILE . . . . . 0.497 HD12 ' N ' ' A' ' 87' ' ' ILE . 5.0 mp -121.0 130.69 74.42 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.21 0 CA-C-N 115.701 -0.681 . . . . 0.0 109.699 178.134 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 88' ' ' LEU . . . . . . . . . . . . . 15.9 tp -111.79 132.83 54.4 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-O 120.858 0.361 . . . . 0.0 110.743 -178.893 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 89' ' ' ASP . . . . . . . . . . . . . 46.4 t0 -130.6 160.31 34.58 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.161 178.584 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 84.6 tt0 -45.77 -43.1 12.83 Favored 'General case' 0 CA--C 1.532 0.257 0 N-CA-C 113.06 0.763 . . . . 0.0 113.06 -171.392 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 91' ' ' ASN . . . . . . . . . . . . . 3.0 m120 -131.96 26.49 4.6 Favored 'General case' 0 N--CA 1.467 0.394 0 N-CA-C 112.471 0.545 . . . . 0.0 112.471 -178.286 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 92' ' ' LEU . . . . . . . . . . . . . 18.6 mt -148.58 144.47 27.28 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-O 120.759 0.314 . . . . 0.0 110.508 -176.693 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 93' ' ' ILE . . . . . . . . . . . . . 69.3 mt -125.23 116.69 47.65 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.306 0 N-CA-C 108.822 -0.807 . . . . 0.0 108.822 175.694 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 94' ' ' VAL . . . . . . . . . . . . . 44.3 t -117.62 127.85 74.93 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.286 0 N-CA-C 109.904 -0.406 . . . . 0.0 109.904 -177.807 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 95' ' ' VAL . . . . . . . . . . . . . 43.1 t -121.38 133.94 66.31 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.339 0 CA-C-N 116.027 -0.533 . . . . 0.0 109.813 -179.822 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 96' ' ' ILE . . . . . 0.52 HD11 ' HB ' ' A' ' 123' ' ' VAL . 66.8 mt -114.57 125.17 71.82 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.355 0 N-CA-C 109.254 -0.647 . . . . 0.0 109.254 178.63 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 97' ' ' THR . . . . . . . . . . . . . 74.7 p -97.37 156.29 16.52 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-O 121.401 0.62 . . . . 0.0 111.091 -177.388 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 98' ' ' GLU . . . . . . . . . . . . . 84.9 tt0 -53.86 -27.25 28.84 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 115.831 -0.622 . . . . 0.0 112.242 -179.163 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 99' ' ' GLU . . . . . . . . . . . . . 18.8 tp10 -80.8 16.71 1.34 Allowed 'General case' 0 CA--C 1.538 0.491 0 N-CA-C 112.741 0.645 . . . . 0.0 112.741 -176.538 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 100' ' ' ASN . . . . . . . . . . . . . 4.5 m-20 63.43 33.33 13.79 Favored 'General case' 0 C--O 1.233 0.233 0 O-C-N 122.013 -0.43 . . . . 0.0 111.694 177.478 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 101' ' ' GLU . . . . . . . . . . . . . 84.6 tt0 -111.3 142.72 43.16 Favored 'General case' 0 C--N 1.333 -0.147 0 N-CA-C 109.654 -0.498 . . . . 0.0 109.654 173.754 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 102' ' ' VAL . . . . . . . . . . . . . 46.7 t -115.06 127.3 72.67 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.294 0 CA-C-N 116.167 -0.47 . . . . 0.0 109.942 -177.711 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 103' ' ' LEU . . . . . . . . . . . . . 30.5 mt -117.8 129.55 55.74 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 115.809 -0.632 . . . . 0.0 110.279 177.267 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 104' ' ' ILE . . . . . . . . . . . . . 70.9 mt -118.35 120.86 65.65 Favored 'Isoleucine or valine' 0 C--O 1.234 0.244 0 N-CA-C 110.198 -0.297 . . . . 0.0 110.198 179.927 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 105' ' ' PHE . . . . . . . . . . . . . 54.3 m-85 -121.99 164.8 17.03 Favored 'General case' 0 C--N 1.333 -0.15 0 O-C-N 123.87 0.731 . . . . 0.0 109.781 179.377 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 106' ' ' ASN . . . . . 0.414 ' HB3' HD11 ' A' ' 112' ' ' LEU . 45.9 p-10 -99.04 -169.95 1.85 Allowed 'General case' 0 C--N 1.331 -0.219 0 N-CA-C 110.021 -0.363 . . . . 0.0 110.021 174.563 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 107' ' ' GLN . . . . . . . . . . . . . 17.0 tt0 -59.73 -30.1 68.59 Favored 'General case' 0 C--N 1.33 -0.268 0 N-CA-C 111.988 0.366 . . . . 0.0 111.988 -179.744 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 108' ' ' ASN . . . . . . . . . . . . . 7.4 t-20 -82.85 8.83 11.29 Favored 'General case' 0 CA--C 1.536 0.425 0 N-CA-C 113.19 0.811 . . . . 0.0 113.19 -178.0 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 109' ' ' LEU . . . . . 0.42 HD21 ' HB2' ' A' ' 78' ' ' ALA . 12.2 tp 58.98 39.02 24.06 Favored 'General case' 0 C--N 1.332 -0.184 0 CA-C-O 121.162 0.506 . . . . 0.0 111.009 178.966 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 110' ' ' GLU . . . . . . . . . . . . . 70.7 mm-40 -106.91 155.41 19.79 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 116.299 -0.41 . . . . 0.0 109.998 176.595 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 111' ' ' GLU . . . . . . . . . . . . . 84.4 tt0 -83.54 121.92 27.87 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-O 120.835 0.35 . . . . 0.0 110.787 -177.364 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 112' ' ' LEU . . . . . 0.414 HD11 ' HB3' ' A' ' 106' ' ' ASN . 38.5 mt -109.02 -46.0 3.68 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 116.178 -0.465 . . . . 0.0 110.495 177.949 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 113' ' ' TYR . . . . . . . . . . . . . 63.0 t80 -140.29 138.01 34.63 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-O 120.804 0.335 . . . . 0.0 111.388 -179.383 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 114' ' ' ARG . . . . . . . . . . . . . 68.9 ttp85 -136.37 124.82 23.46 Favored 'General case' 0 C--N 1.331 -0.239 0 CA-C-N 115.946 -0.57 . . . . 0.0 110.274 177.535 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 115' ' ' GLY . . . . . . . . . . . . . . . -150.03 157.12 27.08 Favored Glycine 0 CA--C 1.522 0.524 0 N-CA-C 110.784 -0.926 . . . . 0.0 110.784 179.099 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 116' ' ' LYS . . . . . . . . . . . . . 69.8 tttt -134.68 132.23 38.65 Favored 'General case' 0 C--N 1.329 -0.305 0 N-CA-C 109.958 -0.386 . . . . 0.0 109.958 177.641 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 117' ' ' PHE . . . . . . . . . . . . . 39.9 m-85 -127.41 120.6 28.8 Favored 'General case' 0 N--CA 1.463 0.2 0 CA-C-N 116.308 -0.406 . . . . 0.0 110.073 -174.761 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 118' ' ' GLU . . . . . . . . . . . . . 95.6 mt-10 -54.35 -45.89 72.82 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 116.421 -0.354 . . . . 0.0 111.314 -175.851 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 119' ' ' ASN . . . . . . . . . . . . . 88.3 m-20 -101.31 31.11 3.84 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.137 -0.483 . . . . 0.0 112.076 -174.285 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 120' ' ' LEU . . . . . . . . . . . . . 15.0 tp -54.98 119.97 6.21 Favored 'General case' 0 N--CA 1.463 0.214 0 O-C-N 122.264 -0.272 . . . . 0.0 110.615 179.724 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 121' ' ' ASN . . . . . . . . . . . . . 23.9 t-20 -114.18 -44.07 3.17 Favored 'General case' 0 C--O 1.232 0.143 0 CA-C-N 116.487 -0.324 . . . . 0.0 111.151 -177.072 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 122' ' ' LYS . . . . . . . . . . . . . 63.6 mtpt -139.26 142.16 37.78 Favored 'General case' 0 C--N 1.331 -0.225 0 CA-C-O 120.99 0.424 . . . . 0.0 111.594 -175.59 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 123' ' ' VAL . . . . . 0.52 ' HB ' HD11 ' A' ' 96' ' ' ILE . 48.0 t -126.17 125.75 68.32 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 N-CA-C 109.01 -0.737 . . . . 0.0 109.01 173.001 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 124' ' ' LEU . . . . . . . . . . . . . 78.5 mt -121.42 131.13 53.99 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-O 120.843 0.354 . . . . 0.0 110.77 -175.853 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 125' ' ' VAL . . . . . . . . . . . . . 44.5 t -126.15 126.29 69.27 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.239 0 CA-C-N 115.98 -0.555 . . . . 0.0 109.742 178.52 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 126' ' ' ARG . . . . . 0.494 HH11 HD23 ' B' ' 88' ' ' LEU . 82.4 mtt85 -150.9 129.24 12.03 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.299 -0.41 . . . . 0.0 110.045 177.729 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 127' ' ' ASN . . . . . . . . . . . . . 8.8 t-20 56.21 -152.42 0.38 Allowed 'General case' 0 CA--C 1.54 0.581 0 N-CA-C 109.736 -0.468 . . . . 0.0 109.736 179.755 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 128' ' ' ASP . . . . . . . . . . . . . 23.4 p-10 -83.06 18.13 1.76 Allowed 'General case' 0 CA--C 1.536 0.414 0 N-CA-C 112.628 0.603 . . . . 0.0 112.628 178.303 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 129' ' ' LEU . . . . . . . . . . . . . 11.7 tp -117.35 137.2 52.61 Favored 'General case' 0 C--O 1.234 0.241 0 O-C-N 122.079 -0.388 . . . . 0.0 110.472 179.765 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 130' ' ' VAL . . . . . . . . . . . . . 42.0 t -125.84 138.73 53.59 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.188 0 CA-C-N 116.276 -0.42 . . . . 0.0 109.963 -179.424 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 131' ' ' VAL . . . . . . . . . . . . . 35.1 m -136.1 143.98 34.49 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.282 0 CA-C-O 121.152 0.501 . . . . 0.0 111.163 178.143 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 132' ' ' ILE . . . . . . . . . . . . . 69.9 mt -120.9 134.03 65.63 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 CA-C-N 115.657 -0.702 . . . . 0.0 109.606 179.966 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 133' ' ' ILE . . . . . . . . . . . . . 40.8 mm -116.68 117.83 56.75 Favored 'Isoleucine or valine' 0 C--O 1.233 0.224 0 CA-C-O 120.965 0.412 . . . . 0.0 110.711 -176.684 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 134' ' ' ASP . . . . . . . . . . . . . 8.0 p-10 -131.49 148.47 52.64 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 115.844 -0.616 . . . . 0.0 109.408 174.717 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 135' ' ' GLU . . . . . . . . . . . . . 84.8 tt0 -49.76 -24.44 2.35 Favored 'General case' 0 C--N 1.327 -0.399 0 N-CA-C 112.835 0.68 . . . . 0.0 112.835 -171.947 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 136' ' ' GLN . . . . . . . . . . . . . 51.2 tt0 -101.67 -27.72 12.9 Favored 'General case' 0 C--O 1.233 0.212 0 N-CA-C 112.58 0.585 . . . . 0.0 112.58 -173.789 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 137' ' ' LYS . . . . . . . . . . . . . 49.6 mttm -142.13 149.23 39.53 Favored 'General case' 0 C--N 1.332 -0.17 0 N-CA-C 112.766 0.654 . . . . 0.0 112.766 -170.51 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 138' ' ' LEU . . . . . . . . . . . . . 9.9 tp -110.4 118.66 36.87 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 114.891 -1.049 . . . . 0.0 108.732 170.973 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 139' ' ' THR . . . . . . . . . . . . . 31.5 m -111.05 127.47 55.55 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-O 120.67 0.271 . . . . 0.0 110.86 -177.283 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 140' ' ' LEU . . . . . 0.48 HD23 ' C ' ' A' ' 140' ' ' LEU . 7.3 tt -116.05 122.66 45.84 Favored 'General case' 0 C--N 1.329 -0.292 0 N-CA-C 109.251 -0.648 . . . . 0.0 109.251 179.913 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 141' ' ' ILE . . . . . . . . . . . . . 19.0 mt -120.6 123.45 70.41 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.273 0 CA-C-O 120.87 0.367 . . . . 0.0 110.112 -174.378 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 142' ' ' ARG . . . . . . . . . . . . . 76.4 mtp180 -110.94 127.61 55.54 Favored 'General case' 0 C--N 1.331 -0.229 0 CA-C-N 115.521 -0.763 . . . . 0.0 110.164 -178.507 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 143' ' ' THR . . . . . . . . . . . . . 42.0 p . . . . . 0 C--O 1.219 -0.505 0 CA-C-O 118.024 -0.988 . . . . 0.0 110.593 -179.524 . . . . . . . . 0 0 . 1 . 005 nuclear build full ' B' B ' -3' ' ' GLU . . . . . . . . . . . . . 70.3 mm-40 . . . . . 0 N--CA 1.489 1.518 0 N-CA-C 109.32 -0.622 . . . . 0.0 109.32 . . . . . . . . . 0 0 . 1 . 005 nuclear build full ' B' B ' -2' ' ' GLY . . . . . . . . . . . . . . . -109.36 125.42 7.66 Favored Glycine 0 CA--C 1.526 0.76 0 N-CA-C 110.889 -0.885 . . . . 0.0 110.889 -179.886 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' -1' ' ' VAL . . . . . . . . . . . . . 44.4 t -141.21 135.28 31.99 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.299 0 N-CA-C 109.988 -0.375 . . . . 0.0 109.988 179.696 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 0' ' ' ILE . . . . . . . . . . . . . 69.3 mt -113.5 133.64 58.77 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.21 0 CA-C-N 116.395 -0.366 . . . . 0.0 110.026 179.622 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 1' ' ' MET . . . . . . . . . . . . . 25.9 ptt? -78.55 137.98 38.16 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.092 -0.504 . . . . 0.0 110.677 -179.611 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 2' ' ' SER . . . . . . . . . . . . . 5.2 p -111.78 139.87 46.9 Favored 'General case' 0 C--O 1.233 0.191 0 CA-C-N 116.187 -0.46 . . . . 0.0 111.03 -178.769 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 3' ' ' GLU . . . . . . . . . . . . . 33.8 tp10 -139.55 136.4 34.43 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 115.786 -0.643 . . . . 0.0 110.402 -178.52 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 4' ' ' LEU . . . . . . . . . . . . . 21.3 tp -124.49 128.77 49.48 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-O 120.714 0.292 . . . . 0.0 110.355 176.028 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 5' ' ' LYS . . . . . . . . . . . . . 98.3 mttt -105.5 120.94 42.89 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.344 -0.389 . . . . 0.0 110.539 179.074 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 6' ' ' LEU . . . . . . . . . . . . . 79.8 mt -118.21 147.62 43.2 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 115.587 -0.733 . . . . 0.0 110.549 -179.474 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 7' ' ' LYS . . . . . . . . . . . . . 73.5 tttt -134.79 140.11 34.3 Favored Pre-proline 0 CA--C 1.534 0.332 0 CA-C-O 118.985 -0.531 . . . . 0.0 110.038 176.193 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 8' ' ' PRO . . . . . . . . . . . . . 88.1 Cg_endo -91.79 137.17 1.86 Allowed 'Trans proline' 0 N--CA 1.489 1.25 0 C-N-CA 121.649 1.566 . . . . 0.0 111.559 177.804 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 9' ' ' LEU . . . . . . . . . . . . . 68.3 mt -72.32 -46.21 10.55 Favored Pre-proline 0 CA--C 1.533 0.32 0 CA-C-O 118.937 -0.554 . . . . 0.0 111.905 -178.682 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 10' ' ' PRO . . . . . . . . . . . . . 78.1 Cg_endo -84.37 152.09 12.08 Favored 'Trans proline' 0 N--CA 1.495 1.575 0 C-N-CA 121.318 1.345 . . . . 0.0 111.734 172.597 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 11' ' ' LYS . . . . . . . . . . . . . 67.5 mttm -88.91 99.9 12.76 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-O 120.81 0.338 . . . . 0.0 110.614 178.104 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 12' ' ' VAL . . . . . . . . . . . . . 12.6 p -140.91 142.42 30.09 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.28 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.362 179.239 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 13' ' ' GLU . . . . . . . . . . . . . 96.1 mt-10 -78.62 129.26 34.56 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.365 -0.379 . . . . 0.0 110.168 178.166 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 14' ' ' LEU . . . . . . . . . . . . . 29.9 mt -98.03 148.66 34.8 Favored Pre-proline 0 C--N 1.329 -0.301 0 CA-C-O 119.223 -0.417 . . . . 0.0 110.282 -179.016 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 15' ' ' PRO . . . . . . . . . . . . . 30.0 Cg_exo -60.67 160.46 24.55 Favored 'Trans proline' 0 N--CA 1.497 1.681 0 C-N-CA 121.322 1.348 . . . . 0.0 111.492 176.117 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 16' ' ' PRO . . . . . . . . . . . . . 38.8 Cg_exo -58.72 -33.81 98.57 Favored 'Trans proline' 0 N--CA 1.497 1.704 0 C-N-CA 121.375 1.384 . . . . 0.0 112.795 -177.993 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 17' ' ' ASP . . . . . . . . . . . . . 11.6 p-10 -93.76 9.83 35.5 Favored 'General case' 0 CA--C 1.535 0.381 0 N-CA-C 113.287 0.847 . . . . 0.0 113.287 -177.147 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 18' ' ' PHE . . . . . . . . . . . . . 44.4 t80 -58.49 -47.21 84.82 Favored 'General case' 0 C--N 1.334 -0.082 0 CA-C-O 120.963 0.411 . . . . 0.0 110.084 -177.961 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 19' ' ' VAL . . . . . . . . . . . . . 49.0 t -57.41 -40.65 75.66 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.339 0 CA-C-N 116.277 -0.42 . . . . 0.0 110.361 -178.737 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 20' ' ' ASP . . . . . . . . . . . . . 79.8 m-20 -60.4 -43.73 96.38 Favored 'General case' 0 C--N 1.331 -0.205 0 C-N-CA 120.936 -0.306 . . . . 0.0 110.968 -178.272 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 21' ' ' VAL . . . . . . . . . . . . . 49.1 t -64.4 -47.35 89.88 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.262 0 C-N-CA 120.753 -0.379 . . . . 0.0 110.359 -177.448 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 22' ' ' ILE . . . . . . . . . . . . . 48.9 mm -56.29 -46.53 81.61 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.258 0 CA-C-O 120.813 0.34 . . . . 0.0 110.598 179.501 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 23' ' ' ARG . . . . . . . . . . . . . 47.9 ttp180 -54.64 -50.61 67.74 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.532 -0.304 . . . . 0.0 111.391 -178.6 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 24' ' ' ILE . . . . . . . . . . . . . 76.1 mt -60.06 -40.5 83.43 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.268 0 C-N-CA 121.073 -0.251 . . . . 0.0 111.432 -176.78 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 25' ' ' LYS . . . . . . . . . . . . . 52.2 mtmt -66.9 -38.93 87.17 Favored 'General case' 0 C--N 1.328 -0.329 0 N-CA-C 112.114 0.413 . . . . 0.0 112.114 -179.833 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 26' ' ' LEU . . . . . . . . . . . . . 93.3 mt -78.49 -40.49 35.22 Favored 'General case' 0 C--N 1.331 -0.21 0 N-CA-C 113.175 0.806 . . . . 0.0 113.175 -172.441 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 27' ' ' GLN . . . . . . . . . . . . . 13.9 pt20 -46.83 139.06 5.71 Favored 'General case' 0 N--CA 1.471 0.591 0 N-CA-C 112.635 0.605 . . . . 0.0 112.635 -175.467 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 28' ' ' GLY . . . . . . . . . . . . . . . 97.68 -23.08 37.48 Favored Glycine 0 CA--C 1.535 1.283 0 CA-C-N 115.573 -0.74 . . . . 0.0 112.319 -175.931 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 29' ' ' LYS . . . . . . . . . . . . . 96.3 mttt -98.41 155.08 17.41 Favored 'General case' 0 C--O 1.233 0.234 0 CA-C-N 117.486 0.643 . . . . 0.0 111.143 179.135 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 30' ' ' THR . . . . . . . . . . . . . 38.6 m -98.38 137.88 36.44 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-N 116.073 -0.512 . . . . 0.0 110.07 176.091 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 31' ' ' VAL . . . . . . . . . . . . . 34.7 m -128.04 148.48 32.6 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.267 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.902 -178.349 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 32' ' ' ARG . . . . . . . . . . . . . 80.3 mtt180 -133.4 150.72 51.79 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-O 121.326 0.584 . . . . 0.0 110.627 177.83 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 33' ' ' THR . . . . . . . . . . . . . 23.1 m -53.39 138.57 32.77 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.034 -0.53 . . . . 0.0 111.279 -178.369 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 34' ' ' GLY . . . . . . . . . . . . . . . 100.35 -17.22 57.17 Favored Glycine 0 CA--C 1.533 1.178 0 CA-C-O 119.537 -0.591 . . . . 0.0 113.243 178.252 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 35' ' ' ASP . . . . . . . . . . . . . 77.7 m-20 -65.33 148.26 52.0 Favored 'General case' 0 C--N 1.333 -0.132 0 CA-C-N 118.131 0.965 . . . . 0.0 111.043 179.808 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 36' ' ' VAL . . . . . . . . . . . . . 44.5 t -121.06 129.72 75.41 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.228 0 CA-C-N 115.852 -0.613 . . . . 0.0 109.842 178.387 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 37' ' ' ILE . . . . . . . . . . . . . 65.3 mt -117.82 137.84 50.44 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.261 0 CA-C-N 116.19 -0.459 . . . . 0.0 109.843 -179.83 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 38' ' ' GLY . . . . . . . . . . . . . . . -110.6 128.58 8.86 Favored Glycine 0 CA--C 1.526 0.764 0 N-CA-C 110.986 -0.845 . . . . 0.0 110.986 179.561 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 39' ' ' ILE . . . . . . . . . . . . . 73.6 mt -124.34 134.66 66.06 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.178 0 N-CA-C 110.015 -0.365 . . . . 0.0 110.015 179.039 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 40' ' ' SER . . . . . . . . . . . . . 43.0 t -92.62 117.56 30.1 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.535 -0.302 . . . . 0.0 110.873 176.201 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 41' ' ' ILE . . . . . . . . . . . . . 45.3 mm -122.75 114.38 42.06 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.159 0 CA-C-O 120.897 0.38 . . . . 0.0 110.546 179.261 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 42' ' ' LEU . . . . . . . . . . . . . 9.2 tp 53.58 37.84 26.82 Favored 'General case' 0 C--N 1.331 -0.216 0 CA-C-N 116.094 -0.503 . . . . 0.0 111.399 176.862 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 43' ' ' GLY . . . . . . . . . . . . . . . 74.62 25.28 70.38 Favored Glycine 0 CA--C 1.531 1.075 0 C-N-CA 121.126 -0.559 . . . . 0.0 112.725 177.563 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 44' ' ' LYS . . . . . . . . . . . . . 34.6 mmtp -130.18 129.31 43.28 Favored 'General case' 0 C--N 1.331 -0.207 0 N-CA-C 109.546 -0.538 . . . . 0.0 109.546 177.682 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 45' ' ' GLU . . . . . . . . . . . . . 81.1 tt0 -83.1 118.98 23.93 Favored 'General case' 0 C--N 1.329 -0.295 0 C-N-CA 120.762 -0.375 . . . . 0.0 110.762 -179.173 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 46' ' ' VAL . . . . . . . . . . . . . 7.4 p -118.6 126.75 75.42 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.216 0 N-CA-C 109.288 -0.634 . . . . 0.0 109.288 176.489 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 47' ' ' LYS . . . . . . . . . . . . . 56.3 mtmt -100.67 128.73 46.61 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 115.84 -0.618 . . . . 0.0 111.304 178.85 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 48' ' ' PHE . . . . . . . . . . . . . 94.3 m-85 -110.73 131.87 54.68 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 115.999 -0.546 . . . . 0.0 109.774 176.089 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 49' ' ' LYS . . . . . . . . . . . . . 36.1 tttp -106.58 135.64 47.75 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.407 -0.36 . . . . 0.0 110.407 -179.498 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 50' ' ' VAL . . . . . . . . . . . . . 43.7 t -80.18 108.76 13.96 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.207 0 N-CA-C 109.257 -0.646 . . . . 0.0 109.257 176.488 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 51' ' ' VAL . . . . . . . . . . . . . 46.0 t -73.39 -47.94 43.93 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.273 0 CA-C-N 116.141 -0.481 . . . . 0.0 110.11 -174.125 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 52' ' ' GLN . . . . . . . . . . . . . 59.8 tt0 -162.6 140.84 8.57 Favored 'General case' 0 C--N 1.33 -0.262 0 C-N-CA 120.401 -0.52 . . . . 0.0 111.343 -177.37 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 53' ' ' ALA . . . . . . . . . . . . . . . -114.82 131.67 56.74 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 115.45 -0.795 . . . . 0.0 109.971 175.56 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 54' ' ' TYR . . . . . . . . . . . . . 30.9 t80 -129.12 111.54 18.31 Favored Pre-proline 0 CA--C 1.535 0.386 0 CA-C-O 118.302 -0.856 . . . . 0.0 110.232 177.598 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 55' ' ' PRO . . . . . . . . . . . . . 73.5 Cg_endo -77.18 167.94 78.3 Favored 'Cis proline' 0 N--CA 1.499 1.835 0 CA-C-N 121.985 1.745 . . . . 0.0 112.373 -5.955 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 56' ' ' SER . . . . . . . . . . . . . 13.6 m -117.34 134.87 23.06 Favored Pre-proline 0 CA--C 1.538 0.51 0 CA-C-O 118.574 -0.727 . . . . 0.0 109.493 174.049 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 57' ' ' PRO . . . . . . . . . . . . . 39.8 Cg_endo -68.11 146.66 78.64 Favored 'Cis proline' 0 N--CA 1.498 1.744 0 CA-C-N 121.87 1.704 . . . . 0.0 111.329 -3.06 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 58' ' ' LEU . . . . . . . . . . . . . 16.3 tp -107.2 136.8 46.41 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.282 -0.417 . . . . 0.0 110.584 -177.599 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 59' ' ' ARG . . . . . . . . . . . . . 51.2 ttp180 -104.64 119.9 40.07 Favored 'General case' 0 C--N 1.328 -0.342 0 N-CA-C 109.315 -0.624 . . . . 0.0 109.315 175.975 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 60' ' ' VAL . . . . . . . . . . . . . 48.7 t -73.37 122.53 26.47 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.252 0 C-N-CA 120.662 -0.415 . . . . 0.0 110.154 -175.214 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 61' ' ' GLU . . . . . . . . . . . . . 95.8 mt-10 -131.05 163.39 27.71 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 115.934 -0.575 . . . . 0.0 110.422 -179.21 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 62' ' ' ASP . . . . . . . . . . . . . 12.5 t70 -55.15 -32.73 62.34 Favored 'General case' 0 C--N 1.327 -0.401 0 CA-C-N 116.426 -0.352 . . . . 0.0 111.523 178.59 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 63' ' ' ARG . . . . . . . . . . . . . 13.1 ptp180 -89.84 9.6 26.86 Favored 'General case' 0 CA--C 1.534 0.337 0 N-CA-C 113.522 0.934 . . . . 0.0 113.522 -176.016 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 64' ' ' THR . . . . . . . . . . . . . 39.4 m -91.41 133.41 35.49 Favored 'General case' 0 C--N 1.332 -0.16 0 CA-C-N 118.198 0.454 . . . . 0.0 110.087 179.667 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 65' ' ' LYS . . . . . . . . . . . . . 57.6 mtmt -90.0 132.55 35.3 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-O 120.987 0.422 . . . . 0.0 110.648 -177.664 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 66' ' ' ILE . . . . . . . . . . . . . 60.7 mt -114.84 127.84 72.21 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.358 0 N-CA-C 109.755 -0.461 . . . . 0.0 109.755 -179.269 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 67' ' ' THR . . . . . . . . . . . . . 30.6 m -119.12 138.84 52.63 Favored 'General case' 0 C--N 1.332 -0.186 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.941 -176.91 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 68' ' ' LEU . . . . . . . . . . . . . 14.8 tp -103.14 125.57 49.9 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 115.913 -0.585 . . . . 0.0 110.065 178.223 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 69' ' ' VAL . . . . . . . . . . . . . 44.1 t -96.82 117.94 42.27 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.344 0 CA-C-O 120.968 0.413 . . . . 0.0 110.324 -178.774 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 70' ' ' THR . . . . . . . . . . . . . 17.4 p -150.04 75.22 1.24 Allowed 'General case' 0 C--N 1.331 -0.238 0 CA-C-N 116.007 -0.542 . . . . 0.0 110.496 178.317 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 71' ' ' HIS . . . . . . . . . . . . . 81.5 m-70 -135.71 84.41 33.09 Favored Pre-proline 0 CA--C 1.534 0.332 0 CA-C-N 116.335 -0.393 . . . . 0.0 110.59 -179.203 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 72' ' ' PRO . . . . . . . . . . . . . 61.8 Cg_endo -74.97 -26.35 11.07 Favored 'Trans proline' 0 N--CA 1.496 1.637 0 C-N-CA 121.472 1.448 . . . . 0.0 113.075 -178.069 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 73' ' ' VAL . . . . . . . . . . . . . 35.1 m -130.5 168.65 22.94 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.214 0 CA-C-O 120.859 0.361 . . . . 0.0 111.091 -176.893 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 74' ' ' ASP . . . . . . . . . . . . . 38.7 t0 -99.11 122.95 43.02 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 115.963 -0.562 . . . . 0.0 109.94 -178.975 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 75' ' ' VAL . . . . . . . . . . . . . 40.0 t -119.9 124.13 72.18 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.264 0 CA-C-O 121.063 0.459 . . . . 0.0 110.802 -177.609 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 76' ' ' LEU . . . . . . . . . . . . . 5.7 mp -119.65 142.12 48.74 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 115.687 -0.688 . . . . 0.0 109.426 174.696 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 77' ' ' GLU . . . . . . . . . . . . . 97.4 mt-10 -135.6 130.75 34.93 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-O 121.117 0.484 . . . . 0.0 111.011 -177.789 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 78' ' ' ALA . . . . . . . . . . . . . . . -117.46 134.93 54.29 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 115.619 -0.718 . . . . 0.0 109.725 177.007 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 79' ' ' LYS . . . . . 0.568 ' O ' HD13 ' B' ' 80' ' ' ILE . 90.0 mttt -75.49 115.87 15.61 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-O 120.903 0.382 . . . . 0.0 110.236 -179.041 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' B' B ' 80' ' ' ILE . . . . . 0.568 HD13 ' O ' ' B' ' 79' ' ' LYS . 44.0 mm -139.09 119.35 14.69 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.328 0 N-CA-C 109.346 -0.613 . . . . 0.0 109.346 -176.836 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' B' B ' 81' ' ' LYS . . . . . . . . . . . . . 60.0 tttm -117.92 129.67 55.76 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-O 120.924 0.392 . . . . 0.0 111.088 -176.964 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 82' ' ' GLY . . . . . . . . . . . . . . . 88.96 42.13 5.73 Favored Glycine 0 CA--C 1.524 0.651 0 CA-C-N 115.883 -0.599 . . . . 0.0 112.089 175.687 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 83' ' ' ILE . . . . . . . . . . . . . 73.9 mt -73.72 133.01 32.52 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.249 0 N-CA-C 109.229 -0.656 . . . . 0.0 109.229 175.398 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 84' ' ' LYS . . . . . . . . . . . . . 38.4 ttpt -102.47 -45.1 5.17 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.567 -0.288 . . . . 0.0 110.567 -176.94 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 85' ' ' ASP . . . . . . . . . . . . . 9.1 t70 -147.68 149.44 32.46 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.293 -0.412 . . . . 0.0 110.518 -179.914 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 86' ' ' VAL . . . . . . . . . . . . . 40.3 t -130.79 134.55 61.71 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.251 0 CA-C-O 121.002 0.429 . . . . 0.0 110.485 -179.208 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 87' ' ' ILE . . . . . 0.494 ' N ' HD12 ' B' ' 87' ' ' ILE . 5.0 mp -121.8 125.89 73.89 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.214 0 CA-C-N 115.841 -0.618 . . . . 0.0 109.385 176.51 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' B' B ' 88' ' ' LEU . . . . . 0.494 HD23 HH11 ' A' ' 126' ' ' ARG . 8.3 tp -117.91 134.19 55.18 Favored 'General case' 0 C--N 1.331 -0.224 0 CA-C-O 120.9 0.381 . . . . 0.0 111.088 -176.058 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' B' B ' 89' ' ' ASP . . . . . . . . . . . . . 12.4 t70 -134.84 160.12 39.24 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 115.948 -0.569 . . . . 0.0 109.859 177.943 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 90' ' ' GLU . . . . . . . . . . . . . 95.6 mt-10 -48.14 -37.75 16.25 Favored 'General case' 0 C--N 1.331 -0.226 0 N-CA-C 112.991 0.737 . . . . 0.0 112.991 -171.637 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 91' ' ' ASN . . . . . . . . . . . . . 12.2 m120 -130.01 22.35 5.33 Favored 'General case' 0 N--CA 1.468 0.468 0 N-CA-C 112.813 0.672 . . . . 0.0 112.813 -176.621 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 92' ' ' LEU . . . . . . . . . . . . . 51.0 mt -148.45 141.23 24.63 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-O 120.773 0.32 . . . . 0.0 110.599 -178.237 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 93' ' ' ILE . . . . . . . . . . . . . 73.2 mt -124.42 112.78 33.65 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.322 0 N-CA-C 108.858 -0.793 . . . . 0.0 108.858 176.195 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 94' ' ' VAL . . . . . 0.432 HG21 HG21 ' B' ' 125' ' ' VAL . 46.1 t -116.58 127.85 74.09 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.284 0 CA-C-O 120.923 0.392 . . . . 0.0 110.038 -177.681 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' B' B ' 95' ' ' VAL . . . . . . . . . . . . . 42.3 t -121.08 132.7 69.86 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.388 0 CA-C-N 115.885 -0.598 . . . . 0.0 109.595 -179.556 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 96' ' ' ILE . . . . . . . . . . . . . 72.4 mt -115.11 125.16 72.33 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.251 0 N-CA-C 109.192 -0.67 . . . . 0.0 109.192 178.259 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 97' ' ' THR . . . . . . . . . . . . . 80.7 p -98.67 160.42 14.29 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-O 121.33 0.586 . . . . 0.0 111.302 -175.868 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 98' ' ' GLU . . . . . . . . . . . . . 84.3 tt0 -53.84 -26.72 25.77 Favored 'General case' 0 C--N 1.327 -0.385 0 CA-C-N 115.683 -0.69 . . . . 0.0 112.249 179.843 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 99' ' ' GLU . . . . . . . . . . . . . 69.4 mm-40 -79.04 11.59 2.67 Favored 'General case' 0 CA--C 1.536 0.432 0 N-CA-C 113.227 0.825 . . . . 0.0 113.227 -177.36 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 100' ' ' ASN . . . . . . . . . . . . . 3.3 m-20 62.71 32.31 16.2 Favored 'General case' 0 CA--C 1.533 0.29 0 CA-C-N 118.233 0.469 . . . . 0.0 111.756 -179.796 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 101' ' ' GLU . . . . . . . . . . . . . 84.2 tt0 -107.79 144.18 35.31 Favored 'General case' 0 C--N 1.332 -0.187 0 N-CA-C 109.714 -0.476 . . . . 0.0 109.714 171.559 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 102' ' ' VAL . . . . . . . . . . . . . 44.5 t -116.28 126.49 73.78 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.246 0 N-CA-C 110.055 -0.35 . . . . 0.0 110.055 -178.957 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 103' ' ' LEU . . . . . . . . . . . . . 63.7 mt -114.48 131.77 56.51 Favored 'General case' 0 C--N 1.331 -0.23 0 CA-C-N 115.641 -0.709 . . . . 0.0 109.58 178.112 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 104' ' ' ILE . . . . . 0.476 HD12 ' HB3' ' B' ' 113' ' ' TYR . 62.3 mt -122.17 118.64 56.07 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.242 0 N-CA-C 110.293 -0.262 . . . . 0.0 110.293 -178.857 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' B' B ' 105' ' ' PHE . . . . . . . . . . . . . 41.3 m-85 -119.84 165.31 14.76 Favored 'General case' 0 C--N 1.331 -0.196 0 O-C-N 123.986 0.804 . . . . 0.0 109.717 178.032 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 106' ' ' ASN . . . . . . . . . . . . . 46.8 p-10 -98.07 -169.89 1.89 Allowed 'General case' 0 C--N 1.329 -0.313 0 N-CA-C 109.664 -0.495 . . . . 0.0 109.664 172.591 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 107' ' ' GLN . . . . . . . . . . . . . 28.6 tt0 -59.83 -30.21 68.78 Favored 'General case' 0 C--N 1.329 -0.29 0 N-CA-C 111.938 0.347 . . . . 0.0 111.938 -179.905 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 108' ' ' ASN . . . . . . . . . . . . . 14.8 t-20 -83.59 9.32 11.74 Favored 'General case' 0 CA--C 1.538 0.515 0 N-CA-C 113.09 0.774 . . . . 0.0 113.09 -178.354 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 109' ' ' LEU . . . . . . . . . . . . . 9.2 tp 60.38 36.32 20.41 Favored 'General case' 0 C--N 1.332 -0.179 0 CA-C-O 120.918 0.39 . . . . 0.0 111.495 178.921 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 110' ' ' GLU . . . . . . . . . . . . . 70.7 mm-40 -105.65 149.82 26.0 Favored 'General case' 0 C--N 1.33 -0.24 0 N-CA-C 109.978 -0.378 . . . . 0.0 109.978 177.094 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 111' ' ' GLU . . . . . . . . . . . . . 47.2 mp0 -76.86 126.41 30.93 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-O 121.035 0.445 . . . . 0.0 111.357 -177.249 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 112' ' ' LEU . . . . . . . . . . . . . 39.5 mt -110.07 -46.05 3.51 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 115.821 -0.627 . . . . 0.0 109.967 174.974 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 113' ' ' TYR . . . . . 0.476 ' HB3' HD12 ' B' ' 104' ' ' ILE . 65.5 t80 -143.62 140.52 30.17 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 115.975 -0.557 . . . . 0.0 111.134 179.752 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' B' B ' 114' ' ' ARG . . . . . . . . . . . . . 93.2 mtt180 -139.51 125.66 19.98 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.54 173.665 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 115' ' ' GLY . . . . . . . . . . . . . . . -150.16 162.92 29.36 Favored Glycine 0 CA--C 1.524 0.623 0 N-CA-C 111.083 -0.807 . . . . 0.0 111.083 179.491 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 116' ' ' LYS . . . . . . . . . . . . . 87.6 tttt -131.22 135.14 47.12 Favored 'General case' 0 C--N 1.33 -0.277 0 N-CA-C 109.832 -0.432 . . . . 0.0 109.832 177.412 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 117' ' ' PHE . . . . . . . . . . . . . 33.4 m-85 -136.46 114.16 11.12 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.327 -0.397 . . . . 0.0 110.393 -174.789 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 118' ' ' GLU . . . . . . . . . . . . . 83.4 tt0 -52.3 -47.68 65.8 Favored 'General case' 0 C--N 1.327 -0.408 0 CA-C-N 116.475 -0.33 . . . . 0.0 111.618 -176.999 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 119' ' ' ASN . . . . . . . . . . . . . 50.3 m-80 -97.4 30.94 2.66 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.192 -0.458 . . . . 0.0 112.175 -173.826 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 120' ' ' LEU . . . . . . . . . . . . . 12.8 tp -57.15 122.31 12.11 Favored 'General case' 0 C--N 1.332 -0.19 0 C-N-CA 120.987 -0.285 . . . . 0.0 110.318 177.98 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 121' ' ' ASN . . . . . . . . . . . . . 26.3 m120 -113.29 -44.2 3.27 Favored 'General case' 0 C--O 1.232 0.162 0 CA-C-N 116.652 -0.249 . . . . 0.0 111.101 -176.965 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 122' ' ' LYS . . . . . . . . . . . . . 97.1 mttt -148.22 150.65 34.11 Favored 'General case' 0 C--N 1.331 -0.208 0 CA-C-O 121.061 0.458 . . . . 0.0 111.701 -178.684 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 123' ' ' VAL . . . . . . . . . . . . . 43.9 t -127.38 129.09 70.58 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.233 0 N-CA-C 109.447 -0.575 . . . . 0.0 109.447 174.716 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 124' ' ' LEU . . . . . 0.403 ' N ' HD12 ' B' ' 124' ' ' LEU . 6.1 mp -122.06 134.57 54.78 Favored 'General case' 0 C--N 1.332 -0.184 0 CA-C-O 120.863 0.363 . . . . 0.0 110.757 -178.538 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' B' B ' 125' ' ' VAL . . . . . 0.432 HG21 HG21 ' B' ' 94' ' ' VAL . 43.2 t -125.28 128.23 72.59 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.283 0 CA-C-N 115.933 -0.576 . . . . 0.0 109.765 178.21 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' B' B ' 126' ' ' ARG . . . . . . . . . . . . . 30.5 ttm180 -149.15 122.01 8.74 Favored 'General case' 0 C--N 1.33 -0.276 0 N-CA-C 109.809 -0.441 . . . . 0.0 109.809 178.368 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 127' ' ' ASN . . . . . . . . . . . . . 76.9 m-20 56.37 -151.55 0.4 Allowed 'General case' 0 CA--C 1.541 0.609 0 N-CA-C 109.771 -0.455 . . . . 0.0 109.771 179.742 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 128' ' ' ASP . . . . . . . . . . . . . 19.7 p-10 -80.18 15.43 1.54 Allowed 'General case' 0 CA--C 1.535 0.383 0 N-CA-C 112.861 0.689 . . . . 0.0 112.861 178.797 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 129' ' ' LEU . . . . . . . . . . . . . 15.6 tp -111.84 133.66 53.9 Favored 'General case' 0 C--O 1.232 0.133 0 O-C-N 122.0 -0.438 . . . . 0.0 110.287 179.158 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 130' ' ' VAL . . . . . . . . . . . . . 47.7 t -121.91 135.3 62.47 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.222 0 N-CA-C 109.759 -0.46 . . . . 0.0 109.759 -179.953 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 131' ' ' VAL . . . . . . . . . . . . . 42.8 t -134.83 135.62 52.95 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.253 0 CA-C-O 121.029 0.442 . . . . 0.0 110.594 -179.533 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 132' ' ' ILE . . . . . . . . . . . . . 73.1 mt -117.51 132.69 66.57 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.26 0 CA-C-N 115.676 -0.693 . . . . 0.0 109.392 178.84 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 133' ' ' ILE . . . . . . . . . . . . . 44.6 mm -116.34 122.32 69.49 Favored 'Isoleucine or valine' 0 C--O 1.234 0.251 0 CA-C-N 116.55 -0.296 . . . . 0.0 110.931 -176.014 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 134' ' ' ASP . . . . . . . . . . . . . 7.2 p-10 -133.0 146.7 52.01 Favored 'General case' 0 C--N 1.33 -0.258 0 N-CA-C 109.714 -0.476 . . . . 0.0 109.714 174.628 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 135' ' ' GLU . . . . . . . . . . . . . 84.7 tt0 -49.87 -26.27 3.91 Favored 'General case' 0 C--N 1.326 -0.445 0 N-CA-C 112.916 0.71 . . . . 0.0 112.916 -173.321 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 136' ' ' GLN . . . . . . . . . . . . . 61.4 tt0 -84.55 -32.4 23.86 Favored 'General case' 0 C--N 1.331 -0.231 0 N-CA-C 112.42 0.526 . . . . 0.0 112.42 -175.488 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 137' ' ' LYS . . . . . . . . . . . . . 18.1 pttp -168.64 172.74 7.81 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-O 121.436 0.636 . . . . 0.0 112.245 -172.536 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 138' ' ' LEU . . . . . 0.426 HD23 ' N ' ' B' ' 139' ' ' THR . 5.3 tt -117.72 130.1 56.11 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 115.113 -0.948 . . . . 0.0 110.025 -179.217 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' B' B ' 139' ' ' THR . . . . . 0.426 ' N ' HD23 ' B' ' 138' ' ' LEU . 42.2 m -111.53 126.74 55.3 Favored 'General case' 0 C--N 1.331 -0.223 0 CA-C-N 116.147 -0.479 . . . . 0.0 110.384 179.833 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' B' B ' 140' ' ' LEU . . . . . 0.473 HD23 ' N ' ' B' ' 141' ' ' ILE . 5.6 tt -114.18 124.02 51.03 Favored 'General case' 0 C--N 1.329 -0.322 0 N-CA-C 109.261 -0.644 . . . . 0.0 109.261 -179.65 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' B' B ' 141' ' ' ILE . . . . . 0.473 ' N ' HD23 ' B' ' 140' ' ' LEU . 19.1 mt -121.94 125.71 73.53 Favored 'Isoleucine or valine' 0 C--O 1.234 0.266 0 CA-C-O 120.818 0.342 . . . . 0.0 110.15 -173.783 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' B' B ' 142' ' ' ARG . . . . . . . . . . . . . 72.0 mtm180 -114.23 133.94 55.27 Favored 'General case' 0 C--O 1.233 0.233 0 CA-C-N 115.66 -0.7 . . . . 0.0 109.82 -179.267 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 143' ' ' THR . . . . . . . . . . . . . 60.6 p . . . . . 0 C--O 1.219 -0.514 0 CA-C-O 117.957 -1.02 . . . . 0.0 110.449 179.207 . . . . . . . . 0 0 . 1 . 005 nuclear build full ' C' C ' -3' ' ' GLU . . . . . . . . . . . . . 95.7 mt-10 . . . . . 0 N--CA 1.49 1.568 0 N-CA-C 109.376 -0.602 . . . . 0.0 109.376 . . . . . . . . . 0 0 . 1 . 005 nuclear build full ' C' C ' -2' ' ' GLY . . . . . . . . . . . . . . . -61.7 149.74 46.1 Favored Glycine 0 CA--C 1.524 0.627 0 N-CA-C 110.871 -0.891 . . . . 0.0 110.871 179.75 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' C' C ' -1' ' ' VAL . . . . . . . . . . . . . 43.5 t -95.88 137.8 23.0 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.317 0 N-CA-C 110.022 -0.362 . . . . 0.0 110.022 -179.895 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' C' C ' 0' ' ' ILE . . . . . . . . . . . . . 43.4 mm -107.63 129.02 62.31 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.27 0 CA-C-N 116.258 -0.428 . . . . 0.0 110.166 -178.93 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' C' C ' 1' ' ' MET . . . . . . . . . . . . . 25.0 ptp -79.85 142.87 34.85 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.072 -0.513 . . . . 0.0 110.413 178.956 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' C' C ' 2' ' ' SER . . . . . . . . . . . . . 2.9 p -127.61 126.53 42.23 Favored 'General case' 0 C--N 1.331 -0.203 0 CA-C-N 116.356 -0.384 . . . . 0.0 110.329 -179.71 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' C' C ' 3' ' ' GLU . . . . . . . . . . . . . 94.2 mt-10 -138.51 141.54 39.36 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 115.902 -0.59 . . . . 0.0 110.721 -176.769 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' C' C ' 4' ' ' LEU . . . . . . . . . . . . . 25.2 tp -126.37 126.73 44.36 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.054 -0.521 . . . . 0.0 110.039 176.198 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' C' C ' 5' ' ' LYS . . . . . . . . . . . . . 62.7 mttp -103.83 120.96 42.07 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.508 -0.315 . . . . 0.0 110.647 179.354 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' C' C ' 6' ' ' LEU . . . . . . . . . . . . . 43.1 mt -116.79 143.03 46.16 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 115.536 -0.756 . . . . 0.0 110.556 -178.598 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' C' C ' 7' ' ' LYS . . . . . . . . . . . . . 54.8 tttm -134.3 139.58 33.31 Favored Pre-proline 0 CA--C 1.534 0.349 0 CA-C-O 119.117 -0.468 . . . . 0.0 109.997 176.164 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' C' C ' 8' ' ' PRO . . . . . . . . . . . . . 88.7 Cg_endo -91.94 143.79 2.81 Favored 'Trans proline' 0 N--CA 1.491 1.35 0 C-N-CA 121.721 1.614 . . . . 0.0 111.888 177.812 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' C' C ' 9' ' ' LEU . . . . . . . . . . . . . 63.9 mt -79.2 -48.28 1.55 Allowed Pre-proline 0 CA--C 1.535 0.385 0 CA-C-O 118.638 -0.696 . . . . 0.0 112.242 -179.93 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' C' C ' 10' ' ' PRO . . . . . . . . . . . . . 94.0 Cg_endo -79.51 153.78 23.82 Favored 'Trans proline' 0 N--CA 1.497 1.697 0 C-N-CA 121.149 1.232 . . . . 0.0 111.819 176.949 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' C' C ' 11' ' ' LYS . . . . . . . . . . . . . 51.6 tptt -87.19 96.64 10.39 Favored 'General case' 0 C--N 1.331 -0.226 0 CA-C-N 116.373 -0.376 . . . . 0.0 110.315 178.861 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' C' C ' 12' ' ' VAL . . . . . . . . . . . . . 12.0 p -143.86 143.44 23.93 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.284 0 CA-C-N 116.219 -0.446 . . . . 0.0 110.462 179.019 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' C' C ' 13' ' ' GLU . . . . . . . . . . . . . 12.8 pt-20 -88.09 128.15 35.42 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.351 -0.386 . . . . 0.0 110.296 177.751 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' C' C ' 14' ' ' LEU . . . . . . . . . . . . . 24.4 mt -98.22 153.01 38.26 Favored Pre-proline 0 C--N 1.329 -0.291 0 CA-C-N 116.232 -0.44 . . . . 0.0 110.369 -178.473 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' C' C ' 15' ' ' PRO . . . . . . . . . . . . . 33.6 Cg_exo -59.66 159.97 22.52 Favored 'Trans proline' 0 N--CA 1.495 1.616 0 C-N-CA 121.31 1.34 . . . . 0.0 111.621 178.082 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' C' C ' 16' ' ' PRO . . . . . . . . . . . . . 32.2 Cg_exo -59.42 -32.56 96.68 Favored 'Trans proline' 0 N--CA 1.498 1.743 0 C-N-CA 121.435 1.423 . . . . 0.0 112.714 -177.855 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' C' C ' 17' ' ' ASP . . . . . . . . . . . . . 9.5 p-10 -94.13 9.96 35.7 Favored 'General case' 0 CA--C 1.535 0.388 0 N-CA-C 113.211 0.819 . . . . 0.0 113.211 -177.301 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' C' C ' 18' ' ' PHE . . . . . . . . . . . . . 48.9 t80 -58.13 -42.67 86.33 Favored 'General case' 0 C--O 1.231 0.091 0 O-C-N 121.987 -0.446 . . . . 0.0 110.111 -178.511 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' C' C ' 19' ' ' VAL . . . . . . . . . . . . . 48.7 t -57.7 -42.13 80.96 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.352 0 CA-C-N 116.332 -0.395 . . . . 0.0 110.311 -179.311 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' C' C ' 20' ' ' ASP . . . . . . . . . . . . . 13.6 t70 -60.64 -42.09 96.22 Favored 'General case' 0 C--N 1.329 -0.304 0 C-N-CA 120.988 -0.285 . . . . 0.0 110.99 -178.642 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' C' C ' 21' ' ' VAL . . . . . . . . . . . . . 47.5 t -64.04 -47.56 89.8 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.284 0 C-N-CA 120.713 -0.395 . . . . 0.0 110.38 -177.973 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' C' C ' 22' ' ' ILE . . . . . 0.507 HG22 HD12 ' C' ' 26' ' ' LEU . 51.0 mm -56.67 -43.99 80.28 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.279 0 CA-C-O 120.668 0.27 . . . . 0.0 110.456 178.689 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' C' C ' 23' ' ' ARG . . . . . . . . . . . . . 60.3 ttp180 -54.11 -49.03 70.08 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-O 120.627 0.251 . . . . 0.0 111.419 -179.373 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' C' C ' 24' ' ' ILE . . . . . . . . . . . . . 75.7 mt -59.96 -42.35 89.2 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.295 0 CA-C-N 116.592 -0.276 . . . . 0.0 111.003 -178.348 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' C' C ' 25' ' ' LYS . . . . . . . . . . . . . 54.9 mtmt -67.2 -36.49 81.85 Favored 'General case' 0 C--N 1.328 -0.355 0 N-CA-C 112.299 0.481 . . . . 0.0 112.299 -179.088 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' C' C ' 26' ' ' LEU . . . . . 0.507 HD12 HG22 ' C' ' 22' ' ' ILE . 46.9 mt -77.74 -43.62 30.33 Favored 'General case' 0 C--N 1.33 -0.26 0 N-CA-C 112.899 0.703 . . . . 0.0 112.899 -172.373 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' C' C ' 27' ' ' GLN . . . . . . . . . . . . . 15.0 pt20 -46.91 138.13 6.68 Favored 'General case' 0 N--CA 1.47 0.539 0 N-CA-C 112.564 0.579 . . . . 0.0 112.564 -175.673 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' C' C ' 28' ' ' GLY . . . . . . . . . . . . . . . 100.6 -26.12 25.79 Favored Glycine 0 CA--C 1.533 1.172 0 CA-C-N 115.645 -0.707 . . . . 0.0 112.174 -176.652 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' C' C ' 29' ' ' LYS . . . . . . . . . . . . . 60.3 mmtt -98.06 155.17 17.25 Favored 'General case' 0 C--O 1.232 0.145 0 CA-C-N 117.257 0.529 . . . . 0.0 111.174 178.327 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' C' C ' 30' ' ' THR . . . . . . . . . . . . . 37.7 m -105.94 136.4 45.66 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 115.807 -0.633 . . . . 0.0 109.561 174.26 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' C' C ' 31' ' ' VAL . . . . . . . . . . . . . 34.9 m -127.4 153.75 36.97 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.234 0 CA-C-O 121.172 0.51 . . . . 0.0 111.169 -176.442 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' C' C ' 32' ' ' ARG . . . . . . . . . . . . . 78.2 mtm180 -130.53 150.07 51.91 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 115.537 -0.756 . . . . 0.0 110.26 178.663 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' C' C ' 33' ' ' THR . . . . . . . . . . . . . 24.3 m -53.68 138.95 33.74 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-N 116.453 -0.34 . . . . 0.0 111.285 -178.863 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' C' C ' 34' ' ' GLY . . . . . . . . . . . . . . . 101.0 -17.14 56.66 Favored Glycine 0 CA--C 1.532 1.154 0 CA-C-O 119.621 -0.544 . . . . 0.0 113.306 179.209 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' C' C ' 35' ' ' ASP . . . . . . . . . . . . . 72.5 m-20 -65.25 148.41 51.73 Favored 'General case' 0 C--O 1.232 0.166 0 CA-C-N 118.054 0.927 . . . . 0.0 111.069 179.421 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' C' C ' 36' ' ' VAL . . . . . . . . . . . . . 43.8 t -122.42 131.68 72.69 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.237 0 CA-C-N 115.933 -0.576 . . . . 0.0 109.871 179.111 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' C' C ' 37' ' ' ILE . . . . . . . . . . . . . 67.1 mt -121.06 138.16 52.4 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 CA-C-N 116.114 -0.494 . . . . 0.0 109.902 179.794 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' C' C ' 38' ' ' GLY . . . . . . . . . . . . . . . -112.42 128.63 8.59 Favored Glycine 0 CA--C 1.525 0.692 0 N-CA-C 111.071 -0.812 . . . . 0.0 111.071 179.562 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' C' C ' 39' ' ' ILE . . . . . . . . . . . . . 74.7 mt -124.85 137.13 58.53 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.184 0 N-CA-C 110.128 -0.323 . . . . 0.0 110.128 179.449 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' C' C ' 40' ' ' SER . . . . . . . . . . . . . 41.4 t -92.44 114.06 26.51 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 116.445 -0.343 . . . . 0.0 110.755 176.213 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' C' C ' 41' ' ' ILE . . . . . . . . . . . . . 42.7 mm -119.99 120.67 63.84 Favored 'Isoleucine or valine' 0 N--CA 1.462 0.167 0 CA-C-O 120.737 0.304 . . . . 0.0 110.59 179.879 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' C' C ' 42' ' ' LEU . . . . . . . . . . . . . 47.3 mt 51.85 34.84 14.17 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-N 116.308 -0.405 . . . . 0.0 111.856 176.435 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' C' C ' 43' ' ' GLY . . . . . . . . . . . . . . . 72.88 33.24 60.17 Favored Glycine 0 CA--C 1.529 0.907 0 C-N-CA 121.017 -0.611 . . . . 0.0 111.961 178.665 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' C' C ' 44' ' ' LYS . . . . . . . . . . . . . 55.6 tptt -140.7 129.61 23.2 Favored 'General case' 0 C--N 1.33 -0.268 0 N-CA-C 109.4 -0.593 . . . . 0.0 109.4 178.622 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' C' C ' 45' ' ' GLU . . . . . . . . . . . . . 83.6 tt0 -81.71 119.39 23.78 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-O 120.928 0.394 . . . . 0.0 110.658 -177.782 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' C' C ' 46' ' ' VAL . . . . . . . . . . . . . 7.4 p -117.56 127.06 75.03 Favored 'Isoleucine or valine' 0 C--N 1.333 -0.12 0 N-CA-C 109.303 -0.629 . . . . 0.0 109.303 176.765 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' C' C ' 47' ' ' LYS . . . . . . . . . . . . . 68.0 mttm -100.37 127.36 46.7 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 115.827 -0.624 . . . . 0.0 111.001 179.312 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' C' C ' 48' ' ' PHE . . . . . . . . . . . . . 93.8 m-85 -109.94 131.92 54.62 Favored 'General case' 0 C--N 1.328 -0.347 0 N-CA-C 109.81 -0.441 . . . . 0.0 109.81 175.632 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' C' C ' 49' ' ' LYS . . . . . . . . . . . . . 85.6 tttt -107.75 135.63 48.84 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.437 -0.347 . . . . 0.0 110.385 178.857 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' C' C ' 50' ' ' VAL . . . . . . . . . . . . . 44.6 t -79.76 107.25 11.97 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 N-CA-C 109.198 -0.668 . . . . 0.0 109.198 176.261 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' C' C ' 51' ' ' VAL . . . . . . . . . . . . . 48.4 t -70.36 -46.96 68.97 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.316 0 N-CA-C 109.856 -0.424 . . . . 0.0 109.856 -174.339 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' C' C ' 52' ' ' GLN . . . . . . . . . . . . . 37.4 tt0 -167.14 142.44 4.09 Favored 'General case' 0 C--N 1.33 -0.241 0 C-N-CA 120.314 -0.554 . . . . 0.0 111.711 -179.887 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' C' C ' 53' ' ' ALA . . . . . . . . . . . . . . . -114.69 133.79 55.6 Favored 'General case' 0 C--N 1.331 -0.227 0 CA-C-N 115.761 -0.654 . . . . 0.0 109.745 175.113 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' C' C ' 54' ' ' TYR . . . . . . . . . . . . . 64.2 t80 -129.08 112.81 18.5 Favored Pre-proline 0 CA--C 1.534 0.348 0 CA-C-O 118.259 -0.877 . . . . 0.0 110.52 -179.963 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' C' C ' 55' ' ' PRO . . . . . . . . . . . . . 73.4 Cg_endo -77.18 168.19 77.58 Favored 'Cis proline' 0 N--CA 1.501 1.964 0 CA-C-N 122.05 1.768 . . . . 0.0 112.083 -7.607 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' C' C ' 56' ' ' SER . . . . . . . . . . . . . 14.0 m -117.22 140.42 27.16 Favored Pre-proline 0 CA--C 1.539 0.52 0 CA-C-O 118.599 -0.715 . . . . 0.0 109.828 174.518 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' C' C ' 57' ' ' PRO . . . . . . . . . . . . . 51.5 Cg_endo -70.82 144.2 78.18 Favored 'Cis proline' 0 N--CA 1.498 1.742 0 CA-C-N 121.575 1.598 . . . . 0.0 111.2 -3.742 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' C' C ' 58' ' ' LEU . . . . . . . . . . . . . 16.9 tp -107.49 135.88 48.22 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-O 120.796 0.331 . . . . 0.0 110.981 -176.199 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' C' C ' 59' ' ' ARG . . . . . . . . . . . . . 55.7 ttt180 -101.68 126.06 48.45 Favored 'General case' 0 C--N 1.327 -0.405 0 N-CA-C 109.15 -0.685 . . . . 0.0 109.15 174.254 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' C' C ' 60' ' ' VAL . . . . . . . . . . . . . 42.5 t -83.65 124.48 39.69 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.264 0 C-N-CA 120.64 -0.424 . . . . 0.0 110.549 -175.426 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' C' C ' 61' ' ' GLU . . . . . . . . . . . . . 95.6 mt-10 -129.02 170.74 13.1 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 115.68 -0.691 . . . . 0.0 109.881 177.238 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' C' C ' 62' ' ' ASP . . . . . . . . . . . . . 81.6 m-20 -54.81 -32.51 60.45 Favored 'General case' 0 C--N 1.327 -0.372 0 C-N-CA 121.048 -0.261 . . . . 0.0 111.695 -178.877 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' C' C ' 63' ' ' ARG . . . . . . . . . . . . . 9.2 ptm180 -86.73 6.21 32.47 Favored 'General case' 0 CA--C 1.536 0.415 0 N-CA-C 113.623 0.972 . . . . 0.0 113.623 -175.474 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' C' C ' 64' ' ' THR . . . . . . . . . . . . . 19.8 m -73.36 135.91 44.34 Favored 'General case' 0 C--N 1.332 -0.186 0 CA-C-N 118.138 0.427 . . . . 0.0 110.799 -177.814 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' C' C ' 65' ' ' LYS . . . . . . . . . . . . . 25.3 mtpp -89.94 119.21 30.11 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.098 -0.501 . . . . 0.0 110.001 178.062 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' C' C ' 66' ' ' ILE . . . . . . . . . . . . . 65.6 mt -114.56 131.18 67.41 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.277 0 CA-C-O 120.83 0.348 . . . . 0.0 110.07 -178.681 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' C' C ' 67' ' ' THR . . . . . . . . . . . . . 21.3 m -123.01 134.65 54.3 Favored 'General case' 0 C--N 1.331 -0.224 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.478 -179.253 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' C' C ' 68' ' ' LEU . . . . . . . . . . . . . 21.5 tp -108.63 130.48 55.32 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 115.876 -0.602 . . . . 0.0 110.802 -179.809 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' C' C ' 69' ' ' VAL . . . . . . . . . . . . . 45.8 t -89.45 133.41 31.6 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.292 0 N-CA-C 109.768 -0.456 . . . . 0.0 109.768 177.476 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' C' C ' 70' ' ' THR . . . . . . . . . . . . . 3.3 m -144.44 32.28 1.19 Allowed 'General case' 0 C--N 1.331 -0.236 0 N-CA-C 111.95 0.352 . . . . 0.0 111.95 -177.944 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' C' C ' 71' ' ' HIS . . . . . . . . . . . . . 27.2 t-80 -134.18 81.8 49.45 Favored Pre-proline 0 C--O 1.234 0.238 0 N-CA-C 110.364 -0.236 . . . . 0.0 110.364 178.458 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' C' C ' 72' ' ' PRO . . . . . . . . . . . . . 90.2 Cg_endo -90.17 154.64 4.7 Favored 'Trans proline' 0 N--CA 1.49 1.274 0 C-N-CA 121.837 1.691 . . . . 0.0 113.254 -176.657 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' C' C ' 73' ' ' VAL . . . . . . . . . . . . . 33.0 m -120.52 -171.37 0.62 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 CA-C-N 115.365 -0.834 . . . . 0.0 109.243 174.896 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' C' C ' 74' ' ' ASP . . . . . . . . . . . . . 7.4 t0 -89.13 114.88 26.2 Favored 'General case' 0 C--N 1.331 -0.211 0 N-CA-C 109.09 -0.707 . . . . 0.0 109.09 -178.753 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' C' C ' 75' ' ' VAL . . . . . . . . . . . . . 42.3 t -124.52 122.0 62.85 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.266 0 CA-C-O 121.054 0.454 . . . . 0.0 110.652 -175.109 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' C' C ' 76' ' ' LEU . . . . . 0.455 ' N ' HD12 ' C' ' 76' ' ' LEU . 6.4 mp -118.92 144.54 46.37 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 115.584 -0.735 . . . . 0.0 109.378 175.332 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' C' C ' 77' ' ' GLU . . . . . . . . . . . . . 96.3 mt-10 -134.07 137.49 44.68 Favored 'General case' 0 C--N 1.331 -0.219 0 CA-C-O 120.998 0.428 . . . . 0.0 111.081 -177.653 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' C' C ' 78' ' ' ALA . . . . . 0.579 ' HB2' HD21 ' C' ' 109' ' ' LEU . . . -125.1 135.69 52.93 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 115.738 -0.665 . . . . 0.0 109.79 176.568 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' C' C ' 79' ' ' LYS . . . . . 0.598 ' O ' HD13 ' C' ' 80' ' ' ILE . 61.6 mmtt -78.0 118.5 20.35 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-O 121.002 0.43 . . . . 0.0 110.949 -177.815 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' C' C ' 80' ' ' ILE . . . . . 0.598 HD13 ' O ' ' C' ' 79' ' ' LYS . 41.5 mm -139.1 106.55 2.96 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.327 0 N-CA-C 109.107 -0.701 . . . . 0.0 109.107 -178.951 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' C' C ' 81' ' ' LYS . . . . . . . . . . . . . 99.4 mttt -100.2 127.34 46.48 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-O 120.928 0.394 . . . . 0.0 110.949 -178.145 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' C' C ' 82' ' ' GLY . . . . . . . . . . . . . . . 89.04 42.1 5.71 Favored Glycine 0 CA--C 1.524 0.634 0 C-N-CA 120.968 -0.634 . . . . 0.0 111.722 176.057 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' C' C ' 83' ' ' ILE . . . . . . . . . . . . . 72.5 mt -66.47 137.26 25.21 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.321 0 N-CA-C 109.634 -0.506 . . . . 0.0 109.634 176.339 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' C' C ' 84' ' ' LYS . . . . . . . . . . . . . 39.6 ttpt -101.02 -50.66 3.74 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-O 120.894 0.378 . . . . 0.0 110.389 -179.066 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' C' C ' 85' ' ' ASP . . . . . . . . . . . . . 12.7 t70 -152.44 151.1 30.37 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.078 -0.51 . . . . 0.0 110.783 -179.894 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' C' C ' 86' ' ' VAL . . . . . . . . . . . . . 42.4 t -128.15 131.19 69.54 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.222 0 CA-C-O 120.895 0.379 . . . . 0.0 110.261 179.362 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' C' C ' 87' ' ' ILE . . . . . 0.5 ' N ' HD12 ' C' ' 87' ' ' ILE . 5.0 mp -122.98 131.58 73.01 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.251 0 CA-C-N 116.178 -0.464 . . . . 0.0 109.781 178.884 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' C' C ' 88' ' ' LEU . . . . . . . . . . . . . 80.8 mt -109.31 139.61 44.04 Favored 'General case' 0 C--N 1.331 -0.212 0 CA-C-O 121.03 0.443 . . . . 0.0 111.181 -179.354 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' C' C ' 89' ' ' ASP . . . . . . . . . . . . . 13.6 t70 -129.23 156.25 44.26 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 115.667 -0.697 . . . . 0.0 109.624 177.562 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' C' C ' 90' ' ' GLU . . . . . . . . . . . . . 85.3 tt0 -45.93 -38.77 7.93 Favored 'General case' 0 CA--C 1.532 0.265 0 N-CA-C 113.101 0.778 . . . . 0.0 113.101 -172.151 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' C' C ' 91' ' ' ASN . . . . . . . . . . . . . 78.9 m-20 -132.07 21.48 4.49 Favored 'General case' 0 N--CA 1.469 0.485 0 N-CA-C 112.799 0.666 . . . . 0.0 112.799 -178.035 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' C' C ' 92' ' ' LEU . . . . . . . . . . . . . 40.4 mt -150.59 152.26 33.81 Favored 'General case' 0 C--N 1.331 -0.217 0 CA-C-O 120.997 0.427 . . . . 0.0 110.678 -176.423 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' C' C ' 93' ' ' ILE . . . . . . . . . . . . . 69.8 mt -125.35 123.33 64.79 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.335 0 N-CA-C 109.141 -0.689 . . . . 0.0 109.141 175.727 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' C' C ' 94' ' ' VAL . . . . . . . . . . . . . 42.3 t -119.74 128.78 75.91 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.284 0 CA-C-O 120.964 0.411 . . . . 0.0 110.079 -179.192 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' C' C ' 95' ' ' VAL . . . . . . . . . . . . . 45.5 t -120.48 134.18 64.78 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.322 0 CA-C-N 115.94 -0.573 . . . . 0.0 109.655 179.89 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' C' C ' 96' ' ' ILE . . . . . . . . . . . . . 66.9 mt -115.59 127.05 73.3 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.309 0 N-CA-C 109.283 -0.636 . . . . 0.0 109.283 178.845 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' C' C ' 97' ' ' THR . . . . . . . . . . . . . 68.6 p -100.87 158.22 16.14 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-O 121.139 0.495 . . . . 0.0 111.115 -176.819 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' C' C ' 98' ' ' GLU . . . . . . . . . . . . . 84.6 tt0 -53.85 -26.31 23.87 Favored 'General case' 0 CA--C 1.534 0.335 0 CA-C-N 116.22 -0.445 . . . . 0.0 112.172 179.861 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' C' C ' 99' ' ' GLU . . . . . . . . . . . . . 18.2 tp10 -76.8 9.97 2.52 Favored 'General case' 0 CA--C 1.538 0.517 0 N-CA-C 113.007 0.743 . . . . 0.0 113.007 -177.929 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' C' C ' 100' ' ' ASN . . . . . . . . . . . . . 3.6 m-20 63.32 33.48 13.96 Favored 'General case' 0 N--CA 1.464 0.258 0 O-C-N 121.984 -0.447 . . . . 0.0 111.57 -179.812 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' C' C ' 101' ' ' GLU . . . . . . . . . . . . . 84.7 tt0 -108.64 143.99 36.97 Favored 'General case' 0 C--N 1.332 -0.167 0 N-CA-C 109.666 -0.494 . . . . 0.0 109.666 172.038 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' C' C ' 102' ' ' VAL . . . . . . . . . . . . . 46.9 t -115.61 126.1 73.03 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.27 0 N-CA-C 109.72 -0.474 . . . . 0.0 109.72 -177.958 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' C' C ' 103' ' ' LEU . . . . . . . . . . . . . 30.9 mt -117.3 130.77 56.76 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-N 115.856 -0.611 . . . . 0.0 110.334 177.845 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' C' C ' 104' ' ' ILE . . . . . 0.449 HD13 HG21 ' C' ' 130' ' ' VAL . 64.0 mt -118.28 121.29 66.82 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.207 0 N-CA-C 110.07 -0.345 . . . . 0.0 110.07 179.383 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' C' C ' 105' ' ' PHE . . . . . . . . . . . . . 45.4 m-85 -121.63 167.55 12.78 Favored 'General case' 0 C--N 1.332 -0.182 0 O-C-N 123.851 0.719 . . . . 0.0 109.883 177.993 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' C' C ' 106' ' ' ASN . . . . . . . . . . . . . 45.2 p-10 -97.29 -169.93 1.93 Allowed 'General case' 0 C--N 1.331 -0.209 0 N-CA-C 109.879 -0.415 . . . . 0.0 109.879 173.677 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' C' C ' 107' ' ' GLN . . . . . . . . . . . . . 48.9 tt0 -59.57 -30.13 68.43 Favored 'General case' 0 CA--C 1.532 0.251 0 N-CA-C 111.9 0.333 . . . . 0.0 111.9 179.84 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' C' C ' 108' ' ' ASN . . . . . . . . . . . . . 51.6 t30 -83.78 9.85 10.91 Favored 'General case' 0 CA--C 1.536 0.424 0 N-CA-C 113.062 0.764 . . . . 0.0 113.062 -178.195 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' C' C ' 109' ' ' LEU . . . . . 0.579 HD21 ' HB2' ' C' ' 78' ' ' ALA . 8.0 tp 59.85 36.29 21.93 Favored 'General case' 0 C--N 1.331 -0.223 0 CA-C-O 120.853 0.359 . . . . 0.0 111.366 179.085 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' C' C ' 110' ' ' GLU . . . . . . . . . . . . . 96.0 mt-10 -103.38 150.1 24.13 Favored 'General case' 0 C--N 1.33 -0.26 0 N-CA-C 109.957 -0.386 . . . . 0.0 109.957 176.06 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' C' C ' 111' ' ' GLU . . . . . . . . . . . . . 71.6 tt0 -81.98 121.99 27.21 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-O 120.886 0.374 . . . . 0.0 111.111 -174.713 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' C' C ' 112' ' ' LEU . . . . . . . . . . . . . 34.1 mt -107.08 -46.09 3.99 Favored 'General case' 0 C--N 1.331 -0.21 0 CA-C-N 116.16 -0.473 . . . . 0.0 110.76 178.049 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' C' C ' 113' ' ' TYR . . . . . . . . . . . . . 60.7 t80 -139.34 139.72 37.33 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.201 -0.454 . . . . 0.0 111.14 -178.047 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' C' C ' 114' ' ' ARG . . . . . . . . . . . . . 59.1 ttp180 -137.6 125.53 22.69 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 115.956 -0.565 . . . . 0.0 110.224 177.321 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' C' C ' 115' ' ' GLY . . . . . . . . . . . . . . . -149.98 153.25 24.98 Favored Glycine 0 CA--C 1.523 0.573 0 N-CA-C 110.262 -1.135 . . . . 0.0 110.262 178.505 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' C' C ' 116' ' ' LYS . . . . . . . . . . . . . 59.0 tttm -131.5 128.98 40.48 Favored 'General case' 0 C--N 1.329 -0.325 0 N-CA-C 109.65 -0.5 . . . . 0.0 109.65 179.388 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' C' C ' 117' ' ' PHE . . . . . . . . . . . . . 26.1 m-85 -132.91 117.64 17.94 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.329 -0.396 . . . . 0.0 110.029 -173.153 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' C' C ' 118' ' ' GLU . . . . . . . . . . . . . 95.8 mt-10 -55.18 -39.46 69.58 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.521 -0.308 . . . . 0.0 111.043 -177.774 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' C' C ' 119' ' ' ASN . . . . . . . . . . . . . 29.5 m120 -100.7 30.98 3.7 Favored 'General case' 0 C--N 1.33 -0.271 0 N-CA-C 112.229 0.455 . . . . 0.0 112.229 -173.896 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' C' C ' 120' ' ' LEU . . . . . . . . . . . . . 17.1 tp -57.76 122.56 13.14 Favored 'General case' 0 N--CA 1.462 0.16 0 C-N-CA 120.845 -0.342 . . . . 0.0 110.121 177.462 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' C' C ' 121' ' ' ASN . . . . . . . . . . . . . 21.9 t-20 -112.79 -44.03 3.36 Favored 'General case' 0 C--N 1.332 -0.183 0 CA-C-N 116.554 -0.294 . . . . 0.0 111.41 -175.968 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' C' C ' 122' ' ' LYS . . . . . . . . . . . . . 31.4 ttmt -158.57 151.04 21.84 Favored 'General case' 0 C--N 1.332 -0.188 0 C-N-CA 120.546 -0.462 . . . . 0.0 111.156 -176.721 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' C' C ' 123' ' ' VAL . . . . . 0.439 ' C ' HD12 ' C' ' 124' ' ' LEU . 41.9 t -122.42 131.91 72.22 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.218 0 CA-C-N 116.19 -0.459 . . . . 0.0 109.957 177.687 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' C' C ' 124' ' ' LEU . . . . . 0.463 HD12 ' N ' ' C' ' 124' ' ' LEU . 7.2 mp -116.76 133.67 55.74 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-N 116.147 -0.479 . . . . 0.0 109.999 179.28 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' C' C ' 125' ' ' VAL . . . . . . . . . . . . . 35.2 m -135.25 139.68 46.46 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.289 0 CA-C-O 120.843 0.354 . . . . 0.0 110.922 -179.479 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' C' C ' 126' ' ' ARG . . . . . . . . . . . . . 38.8 ttt180 -163.32 133.63 4.44 Favored 'General case' 0 C--N 1.329 -0.298 0 N-CA-C 109.525 -0.546 . . . . 0.0 109.525 177.015 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' C' C ' 127' ' ' ASN . . . . . . . . . . . . . 33.4 m120 56.85 -155.13 0.32 Allowed 'General case' 0 CA--C 1.538 0.503 0 N-CA-C 109.627 -0.508 . . . . 0.0 109.627 -177.843 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' C' C ' 128' ' ' ASP . . . . . . . . . . . . . 11.6 p-10 -82.31 16.92 1.84 Allowed 'General case' 0 CA--C 1.536 0.421 0 N-CA-C 112.642 0.608 . . . . 0.0 112.642 177.705 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' C' C ' 129' ' ' LEU . . . . . . . . . . . . . 49.3 mt -115.74 142.45 46.73 Favored 'General case' 0 C--O 1.231 0.116 0 O-C-N 122.077 -0.39 . . . . 0.0 110.279 179.723 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' C' C ' 130' ' ' VAL . . . . . 0.498 HG23 ' HB ' ' C' ' 141' ' ' ILE . 32.5 m -134.77 146.8 30.12 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.249 0 CA-C-O 120.986 0.422 . . . . 0.0 110.947 -179.333 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' C' C ' 131' ' ' VAL . . . . . 0.401 ' CG1' HD21 ' C' ' 138' ' ' LEU . 39.1 t -135.99 137.86 48.2 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.299 0 CA-C-N 116.087 -0.506 . . . . 0.0 110.157 178.43 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' C' C ' 132' ' ' ILE . . . . . . . . . . . . . 70.2 mt -112.96 131.75 63.68 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.357 0 N-CA-C 109.341 -0.614 . . . . 0.0 109.341 179.933 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' C' C ' 133' ' ' ILE . . . . . . . . . . . . . 36.6 mm -113.64 122.33 67.57 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.256 0 CA-C-O 120.837 0.351 . . . . 0.0 110.79 -176.15 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' C' C ' 134' ' ' ASP . . . . . . . . . . . . . 9.4 p-10 -132.97 150.06 52.19 Favored 'General case' 0 C--N 1.331 -0.222 0 CA-C-N 116.107 -0.497 . . . . 0.0 109.66 174.741 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' C' C ' 135' ' ' GLU . . . . . . . . . . . . . 40.3 tp10 -50.0 -29.02 7.79 Favored 'General case' 0 C--N 1.327 -0.398 0 N-CA-C 112.715 0.635 . . . . 0.0 112.715 -171.873 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' C' C ' 136' ' ' GLN . . . . . . . . . . . . . 99.6 mm-40 -85.87 -29.52 23.62 Favored 'General case' 0 C--N 1.33 -0.247 0 N-CA-C 112.896 0.702 . . . . 0.0 112.896 -174.086 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' C' C ' 137' ' ' LYS . . . . . . . . . . . . . 21.0 pttm -168.97 173.16 7.12 Favored 'General case' 0 C--O 1.234 0.242 0 CA-C-O 121.496 0.665 . . . . 0.0 112.477 -171.975 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' C' C ' 138' ' ' LEU . . . . . 0.431 HD23 ' C ' ' C' ' 138' ' ' LEU . 7.3 tt -120.71 129.38 53.63 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 115.088 -0.96 . . . . 0.0 109.869 179.594 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' C' C ' 139' ' ' THR . . . . . . . . . . . . . 38.0 m -109.76 128.5 55.33 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 116.112 -0.495 . . . . 0.0 110.444 179.703 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' C' C ' 140' ' ' LEU . . . . . 0.464 ' C ' HD23 ' C' ' 140' ' ' LEU . 5.9 tt -112.01 122.64 48.33 Favored 'General case' 0 C--N 1.329 -0.305 0 N-CA-C 109.039 -0.726 . . . . 0.0 109.039 -179.39 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' C' C ' 141' ' ' ILE . . . . . 0.498 ' HB ' HG23 ' C' ' 130' ' ' VAL . 19.5 mt -121.86 121.39 64.13 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.333 0 CA-C-O 120.98 0.419 . . . . 0.0 109.93 -176.298 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' C' C ' 142' ' ' ARG . . . . . . . . . . . . . 78.9 mtm180 -111.14 125.13 53.46 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 115.463 -0.79 . . . . 0.0 110.169 -178.379 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' C' C ' 143' ' ' THR . . . . . . . . . . . . . 41.9 p . . . . . 0 C--O 1.221 -0.447 0 CA-C-O 117.905 -1.045 . . . . 0.0 110.618 -179.436 . . . . . . . . 0 0 . 1 . 005 nuclear build full ' D' D ' -3' ' ' GLU . . . . . . . . . . . . . 95.6 mt-10 . . . . . 0 N--CA 1.489 1.52 0 N-CA-C 109.34 -0.615 . . . . 0.0 109.34 . . . . . . . . . 0 0 . 1 . 005 nuclear build full ' D' D ' -2' ' ' GLY . . . . . . . . . . . . . . . -91.56 115.57 4.77 Favored Glycine 0 CA--C 1.525 0.697 0 N-CA-C 111.065 -0.814 . . . . 0.0 111.065 -179.804 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' D' D ' -1' ' ' VAL . . . . . . . . . . . . . 41.5 t -140.98 140.48 32.66 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.351 0 N-CA-C 110.138 -0.319 . . . . 0.0 110.138 179.483 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' D' D ' 0' ' ' ILE . . . . . . . . . . . . . 73.3 mt -105.58 136.38 39.94 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.223 0 CA-C-N 116.25 -0.432 . . . . 0.0 109.977 -179.849 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' D' D ' 1' ' ' MET . . . . . . . . . . . . . 26.3 ptt? -88.2 151.78 22.44 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 115.982 -0.554 . . . . 0.0 110.796 -179.059 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' D' D ' 2' ' ' SER . . . . . . . . . . . . . 6.5 p -121.1 134.0 55.24 Favored 'General case' 0 C--N 1.332 -0.187 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.752 179.703 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' D' D ' 3' ' ' GLU . . . . . . . . . . . . . 94.9 mt-10 -140.54 140.14 35.15 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.14 -0.482 . . . . 0.0 110.986 -179.044 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' D' D ' 4' ' ' LEU . . . . . . . . . . . . . 21.0 tp -126.31 128.01 46.46 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 116.129 -0.487 . . . . 0.0 110.223 176.912 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' D' D ' 5' ' ' LYS . . . . . . . . . . . . . 64.1 mttp -107.39 122.19 46.11 Favored 'General case' 0 C--O 1.234 0.274 0 CA-C-N 116.456 -0.338 . . . . 0.0 110.696 178.726 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' D' D ' 6' ' ' LEU . . . . . . . . . . . . . 73.3 mt -118.32 144.12 46.1 Favored 'General case' 0 C--N 1.331 -0.223 0 CA-C-N 115.683 -0.69 . . . . 0.0 110.778 -178.947 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' D' D ' 7' ' ' LYS . . . . . . . . . . . . . 59.3 tttm -133.95 141.76 40.91 Favored Pre-proline 0 CA--C 1.535 0.382 0 CA-C-O 119.12 -0.466 . . . . 0.0 110.158 176.727 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' D' D ' 8' ' ' PRO . . . . . . . . . . . . . 87.5 Cg_endo -91.52 140.64 2.57 Favored 'Trans proline' 0 N--CA 1.49 1.273 0 C-N-CA 121.748 1.632 . . . . 0.0 111.711 177.759 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' D' D ' 9' ' ' LEU . . . . . . . . . . . . . 53.5 mt -77.08 -48.06 2.6 Favored Pre-proline 0 CA--C 1.533 0.301 0 CA-C-O 118.799 -0.619 . . . . 0.0 112.464 -178.707 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' D' D ' 10' ' ' PRO . . . . . 0.42 ' CG ' HG23 ' D' ' 46' ' ' VAL . 85.2 Cg_endo -80.3 160.54 23.03 Favored 'Trans proline' 0 N--CA 1.495 1.605 0 C-N-CA 121.187 1.258 . . . . 0.0 112.071 176.92 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' D' D ' 11' ' ' LYS . . . . . . . . . . . . . 52.6 mttm -88.69 100.62 13.26 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.317 -0.402 . . . . 0.0 110.151 178.241 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' D' D ' 12' ' ' VAL . . . . . . . . . . . . . 12.9 p -145.77 147.34 18.53 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.263 0 CA-C-N 116.363 -0.38 . . . . 0.0 110.882 -178.888 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' D' D ' 13' ' ' GLU . . . . . . . . . . . . . 70.7 mm-40 -92.12 124.0 35.88 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.069 177.526 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' D' D ' 14' ' ' LEU . . . . . . . . . . . . . 36.4 mt -98.02 154.73 37.63 Favored Pre-proline 0 C--N 1.33 -0.258 0 CA-C-N 116.426 -0.352 . . . . 0.0 110.958 -177.88 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' D' D ' 15' ' ' PRO . . . . . . . . . . . . . 28.7 Cg_exo -60.6 154.82 51.74 Favored 'Trans proline' 0 N--CA 1.496 1.661 0 C-N-CA 121.405 1.403 . . . . 0.0 111.857 177.941 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' D' D ' 16' ' ' PRO . . . . . . . . . . . . . 36.4 Cg_exo -58.21 -37.13 96.72 Favored 'Trans proline' 0 N--CA 1.496 1.65 0 C-N-CA 121.4 1.4 . . . . 0.0 112.703 179.749 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' D' D ' 17' ' ' ASP . . . . . . . . . . . . . 15.0 p-10 -87.38 13.46 9.84 Favored 'General case' 0 CA--C 1.536 0.414 0 N-CA-C 112.981 0.734 . . . . 0.0 112.981 -178.384 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' D' D ' 18' ' ' PHE . . . . . . . . . . . . . 48.3 t80 -58.24 -45.09 88.39 Favored 'General case' 0 C--N 1.334 -0.104 0 O-C-N 122.145 -0.347 . . . . 0.0 110.14 -177.997 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' D' D ' 19' ' ' VAL . . . . . 0.402 HG13 ' N ' ' D' ' 20' ' ' ASP . 14.6 p -55.7 -41.38 64.99 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.305 0 CA-C-N 116.478 -0.328 . . . . 0.0 111.073 -178.364 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' D' D ' 20' ' ' ASP . . . . . 0.402 ' N ' HG13 ' D' ' 19' ' ' VAL . 71.5 m-20 -61.09 -43.76 98.4 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-O 120.818 0.342 . . . . 0.0 111.06 -178.329 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' D' D ' 21' ' ' VAL . . . . . . . . . . . . . 46.8 t -65.04 -46.78 90.36 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.318 0 C-N-CA 120.71 -0.396 . . . . 0.0 110.565 -177.285 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' D' D ' 22' ' ' ILE . . . . . 0.686 HG22 HD12 ' D' ' 26' ' ' LEU . 50.1 mm -56.7 -43.69 79.77 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.207 0 C-N-CA 120.959 -0.297 . . . . 0.0 110.493 179.378 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' D' D ' 23' ' ' ARG . . . . . . . . . . . . . 26.8 ttm-85 -52.93 -53.96 41.84 Favored 'General case' 0 C--N 1.331 -0.213 0 CA-C-O 121.413 0.625 . . . . 0.0 111.393 179.293 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' D' D ' 24' ' ' ILE . . . . . . . . . . . . . 78.8 mt -59.34 -41.06 83.06 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.356 0 CA-C-N 115.282 -0.872 . . . . 0.0 111.368 -173.524 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' D' D ' 25' ' ' LYS . . . . . . . . . . . . . 68.0 mttm -69.55 -41.63 75.66 Favored 'General case' 0 C--N 1.33 -0.278 0 N-CA-C 112.651 0.611 . . . . 0.0 112.651 -179.434 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' D' D ' 26' ' ' LEU . . . . . 0.686 HD12 HG22 ' D' ' 22' ' ' ILE . 60.4 mt -78.62 -33.86 47.05 Favored 'General case' 0 C--N 1.33 -0.262 0 N-CA-C 113.674 0.99 . . . . 0.0 113.674 -170.323 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' D' D ' 27' ' ' GLN . . . . . . . . . . . . . 17.5 pt20 -46.74 139.95 4.93 Favored 'General case' 0 N--CA 1.469 0.505 0 N-CA-C 112.863 0.69 . . . . 0.0 112.863 -174.884 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' D' D ' 28' ' ' GLY . . . . . . . . . . . . . . . 96.82 -21.39 46.27 Favored Glycine 0 CA--C 1.534 1.239 0 CA-C-N 115.728 -0.669 . . . . 0.0 112.531 -177.458 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' D' D ' 29' ' ' LYS . . . . . . . . . . . . . 35.1 mmtp -97.34 155.07 17.05 Favored 'General case' 0 C--O 1.232 0.16 0 CA-C-N 117.605 0.703 . . . . 0.0 110.783 179.407 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' D' D ' 30' ' ' THR . . . . . . . . . . . . . 32.0 m -106.0 137.1 44.49 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.043 -0.526 . . . . 0.0 109.868 176.165 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' D' D ' 31' ' ' VAL . . . . . . . . . . . . . 35.1 m -128.5 152.78 37.11 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.243 0 CA-C-O 121.026 0.441 . . . . 0.0 111.057 -178.088 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' D' D ' 32' ' ' ARG . . . . . . . . . . . . . 76.5 mtm180 -130.6 149.37 52.29 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 115.767 -0.652 . . . . 0.0 110.44 178.084 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' D' D ' 33' ' ' THR . . . . . . . . . . . . . 19.4 m -53.44 139.16 31.53 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.449 -0.342 . . . . 0.0 111.392 -178.238 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' D' D ' 34' ' ' GLY . . . . . . . . . . . . . . . 99.58 -17.02 58.2 Favored Glycine 0 CA--C 1.531 1.084 0 CA-C-O 119.684 -0.509 . . . . 0.0 113.296 179.378 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' D' D ' 35' ' ' ASP . . . . . . . . . . . . . 76.7 m-20 -66.17 148.74 51.38 Favored 'General case' 0 N--CA 1.461 0.107 0 CA-C-N 118.056 0.928 . . . . 0.0 111.074 179.145 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' D' D ' 36' ' ' VAL . . . . . . . . . . . . . 44.4 t -120.19 130.56 74.19 Favored 'Isoleucine or valine' 0 C--N 1.333 -0.133 0 CA-C-N 115.811 -0.631 . . . . 0.0 109.981 179.042 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' D' D ' 37' ' ' ILE . . . . . . . . . . . . . 68.3 mt -119.75 137.76 52.56 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.262 0 N-CA-C 109.721 -0.474 . . . . 0.0 109.721 179.103 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' D' D ' 38' ' ' GLY . . . . . . . . . . . . . . . -111.05 128.57 8.79 Favored Glycine 0 CA--C 1.524 0.633 0 N-CA-C 111.394 -0.682 . . . . 0.0 111.394 -178.955 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' D' D ' 39' ' ' ILE . . . . . . . . . . . . . 73.9 mt -129.99 130.47 66.18 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.217 0 N-CA-C 109.817 -0.438 . . . . 0.0 109.817 177.838 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' D' D ' 40' ' ' SER . . . . . . . . . . . . . 59.6 p -92.28 115.19 27.86 Favored 'General case' 0 C--N 1.33 -0.281 0 C-N-CA 120.912 -0.315 . . . . 0.0 110.875 176.968 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' D' D ' 41' ' ' ILE . . . . . . . . . . . . . 44.1 mm -123.39 124.48 69.85 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.223 0 N-CA-C 109.996 -0.372 . . . . 0.0 109.996 -179.754 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' D' D ' 42' ' ' LEU . . . . . . . . . . . . . 56.1 mt 57.67 34.16 24.14 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.362 -0.381 . . . . 0.0 111.729 178.274 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' D' D ' 43' ' ' GLY . . . . . . . . . . . . . . . 77.94 -10.05 28.25 Favored Glycine 0 CA--C 1.535 1.308 0 C-N-CA 121.28 -0.486 . . . . 0.0 113.407 177.713 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' D' D ' 44' ' ' LYS . . . . . . . . . . . . . 61.0 tttm -101.31 130.99 47.57 Favored 'General case' 0 C--N 1.331 -0.211 0 CA-C-N 117.914 0.857 . . . . 0.0 109.846 176.869 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' D' D ' 45' ' ' GLU . . . . . . . . . . . . . 43.3 tp10 -83.23 128.17 34.26 Favored 'General case' 0 C--N 1.329 -0.293 0 C-N-CA 120.817 -0.353 . . . . 0.0 110.727 -179.113 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' D' D ' 46' ' ' VAL . . . . . 0.42 HG23 ' CG ' ' D' ' 10' ' ' PRO . 7.3 p -121.67 131.2 73.63 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.227 0 CA-C-O 121.11 0.481 . . . . 0.0 109.704 177.363 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' D' D ' 47' ' ' LYS . . . . . . . . . . . . . 37.1 mtmm -100.47 128.06 46.64 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 115.879 -0.601 . . . . 0.0 111.069 176.349 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' D' D ' 48' ' ' PHE . . . . . . . . . . . . . 89.9 m-85 -107.97 131.96 54.0 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.077 -0.51 . . . . 0.0 109.75 176.125 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' D' D ' 49' ' ' LYS . . . . . . . . . . . . . 82.8 tttt -107.17 134.57 50.09 Favored 'General case' 0 C--N 1.327 -0.385 0 CA-C-N 116.289 -0.414 . . . . 0.0 110.379 179.856 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' D' D ' 50' ' ' VAL . . . . . . . . . . . . . 46.8 t -76.95 108.68 10.39 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.297 0 N-CA-C 109.037 -0.727 . . . . 0.0 109.037 175.709 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' D' D ' 51' ' ' VAL . . . . . . . . . . . . . 51.0 t -70.67 -47.16 65.82 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.329 0 CA-C-N 116.131 -0.486 . . . . 0.0 109.868 -174.338 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' D' D ' 52' ' ' GLN . . . . . . . . . . . . . 49.6 tt0 -167.94 142.08 3.47 Favored 'General case' 0 C--N 1.33 -0.275 0 C-N-CA 120.308 -0.557 . . . . 0.0 111.567 -179.907 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' D' D ' 53' ' ' ALA . . . . . 0.478 ' HB1' ' HB2' ' D' ' 58' ' ' LEU . . . -115.76 132.87 56.51 Favored 'General case' 0 C--N 1.331 -0.196 0 CA-C-N 115.745 -0.661 . . . . 0.0 110.024 176.255 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' D' D ' 54' ' ' TYR . . . . . . . . . . . . . 75.4 t80 -129.14 112.19 18.35 Favored Pre-proline 0 CA--C 1.536 0.413 0 CA-C-O 118.291 -0.861 . . . . 0.0 110.319 178.503 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' D' D ' 55' ' ' PRO . . . . . . . . . . . . . 73.0 Cg_endo -77.21 170.01 72.62 Favored 'Cis proline' 0 N--CA 1.499 1.836 0 CA-C-N 121.995 1.748 . . . . 0.0 112.119 -5.61 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' D' D ' 56' ' ' SER . . . . . . . . . . . . . 13.5 m -117.2 132.05 23.7 Favored Pre-proline 0 CA--C 1.538 0.502 0 CA-C-O 118.464 -0.779 . . . . 0.0 109.454 175.666 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' D' D ' 57' ' ' PRO . . . . . . . . . . . . . 45.3 Cg_endo -69.37 146.86 82.54 Favored 'Cis proline' 0 N--CA 1.496 1.667 0 CA-C-N 121.902 1.715 . . . . 0.0 111.532 -0.835 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' D' D ' 58' ' ' LEU . . . . . 0.478 ' HB2' ' HB1' ' D' ' 53' ' ' ALA . 27.2 tp -107.61 135.23 49.4 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.275 -0.421 . . . . 0.0 110.527 -179.035 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' D' D ' 59' ' ' ARG . . . . . . . . . . . . . 52.7 ttp180 -102.43 125.28 49.09 Favored 'General case' 0 C--N 1.328 -0.356 0 N-CA-C 109.482 -0.562 . . . . 0.0 109.482 177.101 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' D' D ' 60' ' ' VAL . . . . . . . . . . . . . 41.2 t -81.44 121.37 34.74 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.2 0 C-N-CA 120.745 -0.382 . . . . 0.0 110.505 -174.917 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' D' D ' 61' ' ' GLU . . . . . . . . . . . . . 96.1 mt-10 -131.13 159.92 36.25 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 115.73 -0.668 . . . . 0.0 109.929 177.213 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' D' D ' 62' ' ' ASP . . . . . . . . . . . . . 10.8 t70 -53.66 -32.3 51.02 Favored 'General case' 0 C--N 1.327 -0.376 0 N-CA-C 111.722 0.268 . . . . 0.0 111.722 179.648 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' D' D ' 63' ' ' ARG . . . . . . . . . . . . . 27.8 ptt180 -85.78 5.05 34.19 Favored 'General case' 0 CA--C 1.537 0.459 0 N-CA-C 113.771 1.026 . . . . 0.0 113.771 -175.634 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' D' D ' 64' ' ' THR . . . . . . . . . . . . . 39.9 m -86.19 143.67 27.86 Favored 'General case' 0 C--N 1.332 -0.184 0 CA-C-N 118.002 0.365 . . . . 0.0 110.411 -179.728 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' D' D ' 65' ' ' LYS . . . . . . . . . . . . . 98.7 mttt -87.21 126.08 34.58 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.438 -0.346 . . . . 0.0 110.104 179.968 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' D' D ' 66' ' ' ILE . . . . . . . . . . . . . 65.5 mt -117.71 128.33 74.91 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.295 0 N-CA-C 109.862 -0.422 . . . . 0.0 109.862 -178.969 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' D' D ' 67' ' ' THR . . . . . . . . . . . . . 25.4 m -121.86 136.8 54.94 Favored 'General case' 0 C--N 1.331 -0.202 0 CA-C-O 121.05 0.452 . . . . 0.0 110.981 -177.65 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' D' D ' 68' ' ' LEU . . . . . . . . . . . . . 19.0 tp -107.77 134.09 51.23 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-N 115.914 -0.585 . . . . 0.0 110.635 179.593 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' D' D ' 69' ' ' VAL . . . . . . . . . . . . . 43.1 t -83.77 138.02 19.95 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.29 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.238 178.326 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' D' D ' 70' ' ' THR . . . . . . . . . . . . . 9.1 t -96.4 177.87 5.55 Favored 'General case' 0 C--N 1.331 -0.2 0 CA-C-N 116.198 -0.456 . . . . 0.0 110.749 -179.424 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' D' D ' 71' ' ' HIS . . . . . . . . . . . . . 95.9 m-70 -65.1 151.13 94.34 Favored Pre-proline 0 C--N 1.331 -0.23 0 CA-C-N 116.238 -0.437 . . . . 0.0 110.882 -178.282 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' D' D ' 72' ' ' PRO . . . . . . . . . . . . . 93.2 Cg_endo -92.2 160.01 3.16 Favored 'Trans proline' 0 N--CA 1.489 1.221 0 C-N-CA 121.864 1.709 . . . . 0.0 112.38 178.774 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' D' D ' 73' ' ' VAL . . . . . . . . . . . . . 35.4 m -87.51 -176.85 0.33 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.246 0 CA-C-N 116.206 -0.452 . . . . 0.0 109.984 177.229 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' D' D ' 74' ' ' ASP . . . . . . . . . . . . . 12.8 t70 -91.47 118.56 30.67 Favored 'General case' 0 C--N 1.331 -0.217 0 N-CA-C 109.953 -0.388 . . . . 0.0 109.953 -178.832 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' D' D ' 75' ' ' VAL . . . . . . . . . . . . . 45.8 t -117.36 123.67 72.06 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.239 0 CA-C-O 121.184 0.516 . . . . 0.0 110.507 -177.328 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' D' D ' 76' ' ' LEU . . . . . . . . . . . . . 14.6 mt -125.85 144.61 50.59 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-N 115.463 -0.79 . . . . 0.0 109.347 177.726 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' D' D ' 77' ' ' GLU . . . . . . . . . . . . . 97.0 mt-10 -135.67 138.33 42.7 Favored 'General case' 0 C--N 1.332 -0.183 0 CA-C-O 121.029 0.443 . . . . 0.0 111.583 -176.739 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' D' D ' 78' ' ' ALA . . . . . 0.559 ' HB2' HD21 ' D' ' 109' ' ' LEU . . . -127.14 135.28 50.49 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 115.627 -0.715 . . . . 0.0 109.675 175.772 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' D' D ' 79' ' ' LYS . . . . . 0.568 ' O ' HD13 ' D' ' 80' ' ' ILE . 22.7 tptm -78.08 121.83 24.8 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-O 120.914 0.388 . . . . 0.0 110.647 -177.604 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' D' D ' 80' ' ' ILE . . . . . 0.568 HD13 ' O ' ' D' ' 79' ' ' LYS . 43.2 mm -139.22 113.21 7.0 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.325 0 N-CA-C 108.995 -0.743 . . . . 0.0 108.995 -178.358 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' D' D ' 81' ' ' LYS . . . . . . . . . . . . . 76.2 tttt -103.09 123.24 46.27 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-O 120.749 0.309 . . . . 0.0 111.134 -175.809 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' D' D ' 82' ' ' GLY . . . . . . . . . . . . . . . 89.15 42.19 5.65 Favored Glycine 0 CA--C 1.528 0.871 0 C-N-CA 120.925 -0.655 . . . . 0.0 112.356 173.422 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' D' D ' 83' ' ' ILE . . . . . . . . . . . . . 71.4 mt -70.84 139.43 19.99 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.245 0 N-CA-C 109.706 -0.479 . . . . 0.0 109.706 176.359 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' D' D ' 84' ' ' LYS . . . . . . . . . . . . . 38.9 ttpt -107.16 -47.28 3.71 Favored 'General case' 0 C--N 1.331 -0.197 0 CA-C-N 116.451 -0.34 . . . . 0.0 110.631 -178.316 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' D' D ' 85' ' ' ASP . . . . . . . . . . . . . 9.9 t70 -148.35 148.13 30.02 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.253 -0.43 . . . . 0.0 110.489 -179.439 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' D' D ' 86' ' ' VAL . . . . . . . . . . . . . 42.4 t -133.25 134.48 57.39 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.252 0 CA-C-O 121.032 0.444 . . . . 0.0 110.425 179.442 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' D' D ' 87' ' ' ILE . . . . . . . . . . . . . 46.0 mm -120.09 127.52 75.9 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.29 0 CA-C-N 115.799 -0.637 . . . . 0.0 109.658 178.403 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' D' D ' 88' ' ' LEU . . . . . . . . . . . . . 18.2 tp -109.66 127.06 54.3 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-O 120.937 0.398 . . . . 0.0 110.898 -178.612 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' D' D ' 89' ' ' ASP . . . . . . . . . . . . . 13.7 t70 -117.96 154.68 31.54 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 115.926 -0.579 . . . . 0.0 109.559 177.124 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' D' D ' 90' ' ' GLU . . . . . . . . . . . . . 96.3 mt-10 -49.0 -38.63 23.95 Favored 'General case' 0 C--N 1.329 -0.311 0 N-CA-C 112.748 0.648 . . . . 0.0 112.748 -172.195 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' D' D ' 91' ' ' ASN . . . . . . . . . . . . . 37.5 t30 -132.06 35.64 3.71 Favored 'General case' 0 N--CA 1.464 0.258 0 C-N-CA 120.91 -0.316 . . . . 0.0 111.654 -177.797 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' D' D ' 92' ' ' LEU . . . . . . . . . . . . . 9.2 tp -166.06 146.66 6.53 Favored 'General case' 0 C--N 1.33 -0.244 0 C-N-CA 120.8 -0.36 . . . . 0.0 110.815 -179.304 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' D' D ' 93' ' ' ILE . . . . . . . . . . . . . 71.2 mt -125.71 123.66 64.93 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.262 0 N-CA-C 109.501 -0.555 . . . . 0.0 109.501 179.975 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' D' D ' 94' ' ' VAL . . . . . 0.516 HG21 HG11 ' D' ' 125' ' ' VAL . 46.4 t -124.41 129.69 73.82 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.24 0 CA-C-O 121.011 0.434 . . . . 0.0 110.236 179.893 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' D' D ' 95' ' ' VAL . . . . . . . . . . . . . 42.8 t -121.8 135.68 61.14 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.294 0 CA-C-N 115.86 -0.609 . . . . 0.0 109.821 -179.255 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' D' D ' 96' ' ' ILE . . . . . . . . . . . . . 67.8 mt -117.93 128.03 75.11 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.239 0 N-CA-C 109.561 -0.533 . . . . 0.0 109.561 179.043 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' D' D ' 97' ' ' THR . . . . . . . . . . . . . 65.8 p -100.12 159.53 15.03 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-O 121.102 0.477 . . . . 0.0 111.067 -178.16 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' D' D ' 98' ' ' GLU . . . . . . . . . . . . . 44.4 mt-10 -54.49 -26.32 30.71 Favored 'General case' 0 C--N 1.329 -0.319 0 N-CA-C 112.296 0.48 . . . . 0.0 112.296 -179.89 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' D' D ' 99' ' ' GLU . . . . . . . . . . . . . 95.4 mt-10 -76.08 10.77 1.74 Allowed 'General case' 0 CA--C 1.536 0.427 0 N-CA-C 113.326 0.862 . . . . 0.0 113.326 -177.557 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' D' D ' 100' ' ' ASN . . . . . . . . . . . . . 4.4 m-20 64.16 34.64 10.86 Favored 'General case' 0 N--CA 1.463 0.22 0 CA-C-O 120.971 0.415 . . . . 0.0 111.418 179.836 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' D' D ' 101' ' ' GLU . . . . . . . . . . . . . 84.7 tt0 -112.38 141.8 45.67 Favored 'General case' 0 C--N 1.334 -0.102 0 N-CA-C 109.778 -0.453 . . . . 0.0 109.778 173.72 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' D' D ' 102' ' ' VAL . . . . . . . . . . . . . 44.1 t -116.62 128.95 73.85 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.336 0 N-CA-C 109.988 -0.375 . . . . 0.0 109.988 -178.643 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' D' D ' 103' ' ' LEU . . . . . . . . . . . . . 52.9 mt -117.7 134.43 54.91 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 115.747 -0.661 . . . . 0.0 110.202 177.509 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' D' D ' 104' ' ' ILE . . . . . 0.5 HD13 HG21 ' D' ' 130' ' ' VAL . 67.9 mt -119.67 123.41 70.96 Favored 'Isoleucine or valine' 0 C--O 1.234 0.288 0 N-CA-C 110.35 -0.241 . . . . 0.0 110.35 -179.39 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' D' D ' 105' ' ' PHE . . . . . . . . . . . . . 63.9 m-85 -123.69 166.56 15.32 Favored 'General case' 0 C--N 1.333 -0.133 0 O-C-N 123.913 0.758 . . . . 0.0 109.666 179.577 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' D' D ' 106' ' ' ASN . . . . . . . . . . . . . 44.7 p-10 -101.45 -169.97 1.77 Allowed 'General case' 0 C--N 1.331 -0.235 0 N-CA-C 109.82 -0.437 . . . . 0.0 109.82 174.474 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' D' D ' 107' ' ' GLN . . . . . . . . . . . . . 62.2 tt0 -59.73 -30.14 68.63 Favored 'General case' 0 C--N 1.33 -0.273 0 N-CA-C 111.887 0.329 . . . . 0.0 111.887 179.82 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' D' D ' 108' ' ' ASN . . . . . . . . . . . . . 13.1 t-20 -82.05 7.02 14.41 Favored 'General case' 0 CA--C 1.537 0.46 0 N-CA-C 113.067 0.766 . . . . 0.0 113.067 -177.723 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' D' D ' 109' ' ' LEU . . . . . 0.559 HD21 ' HB2' ' D' ' 78' ' ' ALA . 8.0 tp 60.29 36.28 20.67 Favored 'General case' 0 C--N 1.332 -0.163 0 CA-C-O 120.878 0.371 . . . . 0.0 111.488 179.246 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' D' D ' 110' ' ' GLU . . . . . . . . . . . . . 43.1 mt-10 -104.83 150.77 24.54 Favored 'General case' 0 C--N 1.332 -0.176 0 N-CA-C 109.603 -0.517 . . . . 0.0 109.603 175.424 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' D' D ' 111' ' ' GLU . . . . . . . . . . . . . 67.8 tt0 -84.68 121.87 28.28 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-O 120.907 0.384 . . . . 0.0 110.722 -175.774 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' D' D ' 112' ' ' LEU . . . . . . . . . . . . . 11.4 mt -104.29 -46.07 4.51 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.016 -0.538 . . . . 0.0 110.489 179.36 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' D' D ' 113' ' ' TYR . . . . . . . . . . . . . 64.9 t80 -140.95 145.01 35.47 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.189 -0.46 . . . . 0.0 111.319 -178.236 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' D' D ' 114' ' ' ARG . . . . . . . . . . . . . 39.0 ptt85 -142.5 127.75 18.71 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 115.994 -0.548 . . . . 0.0 110.615 177.134 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' D' D ' 115' ' ' GLY . . . . . . . . . . . . . . . -150.06 151.79 23.8 Favored Glycine 0 CA--C 1.522 0.48 0 N-CA-C 110.724 -0.95 . . . . 0.0 110.724 178.788 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' D' D ' 116' ' ' LYS . . . . . . . . . . . . . 79.1 tttt -128.37 128.82 45.24 Favored 'General case' 0 C--N 1.328 -0.335 0 N-CA-C 109.842 -0.429 . . . . 0.0 109.842 178.531 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' D' D ' 117' ' ' PHE . . . . . . . . . . . . . 33.3 m-85 -125.86 117.97 24.48 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.283 -0.417 . . . . 0.0 110.154 -174.302 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' D' D ' 118' ' ' GLU . . . . . . . . . . . . . 96.0 mt-10 -55.02 -43.01 73.3 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.558 -0.292 . . . . 0.0 111.144 -176.615 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' D' D ' 119' ' ' ASN . . . . . . . . . . . . . 66.3 m-80 -99.93 30.98 3.46 Favored 'General case' 0 C--N 1.331 -0.235 0 N-CA-C 112.176 0.435 . . . . 0.0 112.176 -174.273 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' D' D ' 120' ' ' LEU . . . . . . . . . . . . . 17.3 tp -56.11 119.87 6.6 Favored 'General case' 0 C--O 1.232 0.136 0 C-N-CA 120.925 -0.31 . . . . 0.0 110.613 178.539 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' D' D ' 121' ' ' ASN . . . . . . . . . . . . . 15.8 t-20 -114.16 -44.09 3.17 Favored 'General case' 0 C--N 1.332 -0.183 0 CA-C-N 116.592 -0.276 . . . . 0.0 111.416 -177.648 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' D' D ' 122' ' ' LYS . . . . . . . . . . . . . 96.5 mttt -145.23 150.38 36.59 Favored 'General case' 0 C--N 1.332 -0.153 0 C-N-CA 120.54 -0.464 . . . . 0.0 111.828 -176.671 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' D' D ' 123' ' ' VAL . . . . . . . . . . . . . 43.8 t -130.59 130.46 64.86 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.275 0 CA-C-N 115.951 -0.568 . . . . 0.0 109.753 176.318 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' D' D ' 124' ' ' LEU . . . . . . . . . . . . . 75.5 mt -131.1 135.61 47.65 Favored 'General case' 0 C--N 1.331 -0.208 0 CA-C-N 116.628 -0.26 . . . . 0.0 110.536 -179.643 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' D' D ' 125' ' ' VAL . . . . . 0.516 HG11 HG21 ' D' ' 94' ' ' VAL . 34.2 m -141.66 151.32 19.18 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.306 0 CA-C-O 121.007 0.432 . . . . 0.0 111.337 -179.09 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' D' D ' 126' ' ' ARG . . . . . 0.499 ' NH1' HD21 ' E' ' 88' ' ' LEU . 35.8 ptt-85 -154.15 129.75 9.97 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 115.873 -0.603 . . . . 0.0 110.549 175.965 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' D' D ' 127' ' ' ASN . . . . . . . . . . . . . 6.8 m120 51.91 -109.39 0.44 Allowed 'General case' 0 CA--C 1.546 0.809 0 CA-C-O 118.925 -0.559 . . . . 0.0 111.154 -179.927 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' D' D ' 128' ' ' ASP . . . . . . . . . . . . . 18.5 p-10 -114.13 2.92 15.04 Favored 'General case' 0 N--CA 1.468 0.438 0 CA-C-N 119.755 1.161 . . . . 0.0 113.443 -177.998 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' D' D ' 129' ' ' LEU . . . . . . . . . . . . . 48.7 mt -106.82 139.26 41.52 Favored 'General case' 0 C--N 1.333 -0.115 0 N-CA-C 109.558 -0.534 . . . . 0.0 109.558 179.12 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' D' D ' 130' ' ' VAL . . . . . 0.5 HG21 HD13 ' D' ' 104' ' ' ILE . 32.7 m -137.25 144.26 32.29 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.246 0 CA-C-O 121.167 0.508 . . . . 0.0 111.263 -178.322 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' D' D ' 131' ' ' VAL . . . . . . . . . . . . . 41.7 t -136.04 139.69 45.34 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.286 0 CA-C-N 115.878 -0.601 . . . . 0.0 110.243 178.199 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' D' D ' 132' ' ' ILE . . . . . . . . . . . . . 73.7 mt -117.14 133.31 64.28 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 CA-C-N 115.496 -0.774 . . . . 0.0 109.28 179.997 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' D' D ' 133' ' ' ILE . . . . . . . . . . . . . 40.8 mm -115.73 124.27 71.98 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.236 0 CA-C-O 120.72 0.295 . . . . 0.0 110.966 -175.034 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' D' D ' 134' ' ' ASP . . . . . . . . . . . . . 9.5 p-10 -136.46 146.4 46.29 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 115.972 -0.558 . . . . 0.0 109.719 175.548 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' D' D ' 135' ' ' GLU . . . . . . . . . . . . . 86.2 tt0 -50.27 -24.63 3.03 Favored 'General case' 0 C--N 1.327 -0.379 0 N-CA-C 112.85 0.685 . . . . 0.0 112.85 -175.014 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' D' D ' 136' ' ' GLN . . . . . . . . . . . . . 41.6 mt-30 -82.89 -32.48 27.32 Favored 'General case' 0 C--O 1.234 0.241 0 N-CA-C 112.384 0.512 . . . . 0.0 112.384 -177.15 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' D' D ' 137' ' ' LYS . . . . . . . . . . . . . 52.5 pttt -170.09 175.63 4.95 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-O 121.474 0.654 . . . . 0.0 112.295 -173.567 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' D' D ' 138' ' ' LEU . . . . . 0.45 ' C ' HD23 ' D' ' 138' ' ' LEU . 7.5 tt -119.68 127.5 52.95 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 115.184 -0.916 . . . . 0.0 109.944 177.65 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' D' D ' 139' ' ' THR . . . . . . . . . . . . . 44.6 m -110.16 127.3 54.84 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 116.243 -0.435 . . . . 0.0 110.129 -179.896 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' D' D ' 140' ' ' LEU . . . . . 0.469 ' C ' HD23 ' D' ' 140' ' ' LEU . 8.1 tt -117.07 126.23 52.53 Favored 'General case' 0 C--N 1.329 -0.311 0 N-CA-C 109.498 -0.556 . . . . 0.0 109.498 -178.708 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' D' D ' 141' ' ' ILE . . . . . 0.494 ' HB ' HG23 ' D' ' 130' ' ' VAL . 19.1 mt -123.37 121.4 62.67 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.281 0 N-CA-C 109.733 -0.469 . . . . 0.0 109.733 -175.627 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' D' D ' 142' ' ' ARG . . . . . . . . . . . . . 29.5 ttp180 -115.66 128.07 55.64 Favored 'General case' 0 C--N 1.331 -0.212 0 CA-C-N 115.696 -0.683 . . . . 0.0 110.331 -177.205 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' D' D ' 143' ' ' THR . . . . . . . . . . . . . 35.4 p . . . . . 0 C--O 1.22 -0.487 0 CA-C-O 117.976 -1.011 . . . . 0.0 110.53 -179.7 . . . . . . . . 0 0 . 1 . 005 nuclear build full ' E' E ' -3' ' ' GLU . . . . . . . . . . . . . 83.5 tt0 . . . . . 0 N--CA 1.491 1.599 0 N-CA-C 109.387 -0.597 . . . . 0.0 109.387 . . . . . . . . . 0 0 . 1 . 005 nuclear build full ' E' E ' -2' ' ' GLY . . . . . . . . . . . . . . . -105.18 146.25 16.04 Favored Glycine 0 CA--C 1.525 0.708 0 N-CA-C 111.038 -0.825 . . . . 0.0 111.038 -179.639 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' E' E ' -1' ' ' VAL . . . . . . . . . . . . . 41.0 t -141.12 139.23 33.56 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.35 0 CA-C-O 120.854 0.359 . . . . 0.0 110.118 179.475 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' E' E ' 0' ' ' ILE . . . . . . . . . . . . . 69.4 mt -111.03 135.62 49.62 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.262 0 CA-C-N 116.09 -0.505 . . . . 0.0 109.779 -179.947 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' E' E ' 1' ' ' MET . . . . . . . . . . . . . 25.4 ptp -78.81 134.97 36.95 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-O 120.892 0.377 . . . . 0.0 110.909 -178.969 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' E' E ' 2' ' ' SER . . . . . . . . . . . . . 5.3 p -123.09 132.22 54.01 Favored 'General case' 0 C--N 1.331 -0.2 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.129 176.721 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' E' E ' 3' ' ' GLU . . . . . . . . . . . . . 84.9 tt0 -144.41 141.35 29.58 Favored 'General case' 0 C--N 1.327 -0.409 0 CA-C-N 116.198 -0.456 . . . . 0.0 111.182 -178.63 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' E' E ' 4' ' ' LEU . . . . . . . . . . . . . 20.1 tp -122.73 132.07 54.07 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-N 116.04 -0.527 . . . . 0.0 110.102 176.235 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' E' E ' 5' ' ' LYS . . . . . . . . . . . . . 50.2 mtmt -108.27 119.02 38.28 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 116.353 -0.385 . . . . 0.0 110.69 -179.604 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' E' E ' 6' ' ' LEU . . . . . . . . . . . . . 54.8 mt -114.15 142.19 46.55 Favored 'General case' 0 C--N 1.331 -0.229 0 O-C-N 123.86 0.725 . . . . 0.0 111.169 -178.165 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' E' E ' 7' ' ' LYS . . . . . . . . . . . . . 65.5 tttt -132.97 138.48 31.94 Favored Pre-proline 0 CA--C 1.534 0.356 0 CA-C-O 118.922 -0.561 . . . . 0.0 109.672 176.152 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' E' E ' 8' ' ' PRO . . . . . . . . . . . . . 78.1 Cg_endo -90.99 146.55 3.68 Favored 'Trans proline' 0 N--CA 1.49 1.317 0 C-N-CA 121.691 1.594 . . . . 0.0 112.083 178.671 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' E' E ' 9' ' ' LEU . . . . . . . . . . . . . 54.8 mt -86.0 -48.55 0.55 Allowed Pre-proline 0 CA--C 1.535 0.392 0 CA-C-O 118.518 -0.753 . . . . 0.0 112.499 -179.845 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' E' E ' 10' ' ' PRO . . . . . . . . . . . . . 95.6 Cg_endo -78.41 157.13 29.14 Favored 'Trans proline' 0 N--CA 1.496 1.645 0 C-N-CA 121.22 1.28 . . . . 0.0 112.002 178.651 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' E' E ' 11' ' ' LYS . . . . . . . . . . . . . 92.5 mttt -85.18 92.2 8.34 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.311 -0.404 . . . . 0.0 110.539 179.383 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' E' E ' 12' ' ' VAL . . . . . . . . . . . . . 12.6 p -142.5 143.42 25.93 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.281 0 CA-C-N 116.372 -0.376 . . . . 0.0 110.61 179.819 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' E' E ' 13' ' ' GLU . . . . . . . . . . . . . 41.7 mt-10 -93.28 132.49 37.42 Favored 'General case' 0 C--N 1.329 -0.307 0 N-CA-C 109.926 -0.398 . . . . 0.0 109.926 177.349 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' E' E ' 14' ' ' LEU . . . . . . . . . . . . . 21.2 mt -98.5 149.76 36.05 Favored Pre-proline 0 CA--C 1.534 0.342 0 CA-C-O 119.318 -0.373 . . . . 0.0 110.737 -176.351 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' E' E ' 15' ' ' PRO . . . . . . . . . . . . . 23.5 Cg_exo -64.26 161.21 35.16 Favored 'Trans proline' 0 N--CA 1.498 1.791 0 C-N-CA 121.291 1.328 . . . . 0.0 111.971 175.841 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' E' E ' 16' ' ' PRO . . . . . . . . . . . . . 29.7 Cg_exo -59.9 -34.81 95.16 Favored 'Trans proline' 0 N--CA 1.498 1.774 0 C-N-CA 121.451 1.434 . . . . 0.0 112.938 -178.536 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' E' E ' 17' ' ' ASP . . . . . . . . . . . . . 16.5 p-10 -83.91 0.99 45.53 Favored 'General case' 0 CA--C 1.538 0.488 0 N-CA-C 113.375 0.88 . . . . 0.0 113.375 -177.738 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' E' E ' 18' ' ' PHE . . . . . . . . . . . . . 45.9 t80 -57.92 -42.27 84.46 Favored 'General case' 0 C--N 1.333 -0.124 0 O-C-N 121.938 -0.476 . . . . 0.0 110.228 -177.426 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' E' E ' 19' ' ' VAL . . . . . . . . . . . . . 46.7 t -56.19 -45.74 81.05 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.244 0 CA-C-N 116.44 -0.346 . . . . 0.0 110.62 -178.003 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' E' E ' 20' ' ' ASP . . . . . . . . . . . . . 81.3 m-20 -60.14 -40.18 88.92 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-O 120.833 0.349 . . . . 0.0 110.936 -178.217 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' E' E ' 21' ' ' VAL . . . . . . . . . . . . . 46.2 t -63.78 -47.02 92.8 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.265 0 C-N-CA 120.675 -0.41 . . . . 0.0 110.381 -178.262 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' E' E ' 22' ' ' ILE . . . . . 0.642 HG22 HD12 ' E' ' 26' ' ' LEU . 51.7 mm -55.28 -46.74 78.22 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.274 0 C-N-CA 121.131 -0.228 . . . . 0.0 110.771 179.304 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' E' E ' 23' ' ' ARG . . . . . . . . . . . . . 34.6 ttp180 -54.42 -49.36 70.14 Favored 'General case' 0 C--N 1.33 -0.267 0 C-N-CA 121.023 -0.271 . . . . 0.0 111.454 -178.841 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' E' E ' 24' ' ' ILE . . . . . . . . . . . . . 70.3 mt -59.88 -44.13 93.6 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.257 0 CA-C-N 116.549 -0.296 . . . . 0.0 111.223 -177.172 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' E' E ' 25' ' ' LYS . . . . . . . . . . . . . 50.9 mmtt -64.46 -41.85 96.28 Favored 'General case' 0 C--N 1.328 -0.336 0 N-CA-C 112.406 0.521 . . . . 0.0 112.406 -178.027 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' E' E ' 26' ' ' LEU . . . . . 0.642 HD12 HG22 ' E' ' 22' ' ' ILE . 28.8 mt -78.54 -41.59 31.76 Favored 'General case' 0 C--N 1.33 -0.269 0 N-CA-C 113.252 0.834 . . . . 0.0 113.252 -171.181 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' E' E ' 27' ' ' GLN . . . . . . . . . . . . . 14.7 pt20 -46.58 139.03 5.4 Favored 'General case' 0 N--CA 1.469 0.502 0 N-CA-C 112.787 0.662 . . . . 0.0 112.787 -175.056 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' E' E ' 28' ' ' GLY . . . . . . . . . . . . . . . 98.77 -27.04 21.61 Favored Glycine 0 CA--C 1.533 1.174 0 CA-C-N 115.528 -0.76 . . . . 0.0 112.226 -177.247 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' E' E ' 29' ' ' LYS . . . . . . . . . . . . . 46.0 mtmt -98.12 155.16 17.28 Favored 'General case' 0 C--N 1.331 -0.203 0 CA-C-N 117.168 0.484 . . . . 0.0 111.182 179.35 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' E' E ' 30' ' ' THR . . . . . . . . . . . . . 28.8 m -104.15 137.71 41.7 Favored 'General case' 0 C--N 1.331 -0.222 0 CA-C-N 115.908 -0.587 . . . . 0.0 110.149 175.957 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' E' E ' 31' ' ' VAL . . . . . . . . . . . . . 35.2 m -130.6 153.51 39.18 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 CA-C-N 116.361 -0.381 . . . . 0.0 110.94 -178.709 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' E' E ' 32' ' ' ARG . . . . . . . . . . . . . 87.8 mtm-85 -128.1 149.21 50.51 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.138 -0.483 . . . . 0.0 110.653 179.432 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' E' E ' 33' ' ' THR . . . . . . . . . . . . . 29.9 m -53.46 139.22 31.51 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.372 -0.376 . . . . 0.0 111.376 -178.524 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' E' E ' 34' ' ' GLY . . . . . . . . . . . . . . . 99.35 -17.14 58.24 Favored Glycine 0 CA--C 1.532 1.111 0 CA-C-O 119.707 -0.496 . . . . 0.0 113.312 179.217 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' E' E ' 35' ' ' ASP . . . . . . . . . . . . . 77.8 m-20 -66.3 148.62 51.58 Favored 'General case' 0 C--O 1.231 0.129 0 CA-C-N 118.02 0.91 . . . . 0.0 111.078 179.189 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' E' E ' 36' ' ' VAL . . . . . . . . . . . . . 43.9 t -119.91 129.68 75.13 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.2 0 CA-C-N 115.78 -0.645 . . . . 0.0 109.822 178.267 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' E' E ' 37' ' ' ILE . . . . . . . . . . . . . 67.5 mt -116.88 137.51 50.53 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.272 0 N-CA-C 109.739 -0.467 . . . . 0.0 109.739 179.437 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' E' E ' 38' ' ' GLY . . . . . . . . . . . . . . . -114.72 128.67 8.26 Favored Glycine 0 CA--C 1.525 0.672 0 N-CA-C 111.143 -0.783 . . . . 0.0 111.143 -179.164 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' E' E ' 39' ' ' ILE . . . . . . . . . . . . . 77.2 mt -122.41 134.4 65.73 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.249 0 N-CA-C 109.974 -0.38 . . . . 0.0 109.974 178.787 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' E' E ' 40' ' ' SER . . . . . . . . . . . . . 59.8 p -92.74 119.04 31.72 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.441 -0.345 . . . . 0.0 110.829 175.7 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' E' E ' 41' ' ' ILE . . . . . . . . . . . . . 72.3 mt -126.37 122.23 60.76 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.215 0 CA-C-N 116.553 -0.294 . . . . 0.0 110.32 178.652 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' E' E ' 42' ' ' LEU . . . . . . . . . . . . . 44.4 mt 52.11 34.25 13.8 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.251 -0.431 . . . . 0.0 111.853 177.675 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' E' E ' 43' ' ' GLY . . . . . . . . . . . . . . . 72.23 33.2 62.05 Favored Glycine 0 CA--C 1.529 0.935 0 C-N-CA 121.053 -0.594 . . . . 0.0 111.796 179.002 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' E' E ' 44' ' ' LYS . . . . . . . . . . . . . 44.2 tttp -138.35 128.76 26.13 Favored 'General case' 0 C--N 1.328 -0.33 0 N-CA-C 109.696 -0.483 . . . . 0.0 109.696 179.711 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' E' E ' 45' ' ' GLU . . . . . . . . . . . . . 83.7 tt0 -83.03 121.78 27.46 Favored 'General case' 0 C--N 1.328 -0.347 0 C-N-CA 120.786 -0.366 . . . . 0.0 111.127 -177.639 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' E' E ' 46' ' ' VAL . . . . . . . . . . . . . 7.5 p -119.94 125.88 74.73 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.194 0 N-CA-C 109.298 -0.63 . . . . 0.0 109.298 175.087 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' E' E ' 47' ' ' LYS . . . . . . . . . . . . . 96.5 mttt -100.87 129.78 46.78 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 115.964 -0.562 . . . . 0.0 111.437 179.442 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' E' E ' 48' ' ' PHE . . . . . . . . . . . . . 91.7 m-85 -112.73 131.81 55.5 Favored 'General case' 0 C--N 1.33 -0.253 0 N-CA-C 109.612 -0.514 . . . . 0.0 109.612 174.507 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' E' E ' 49' ' ' LYS . . . . . . . . . . . . . 68.5 tttt -107.87 137.42 45.91 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.643 -0.253 . . . . 0.0 110.715 179.817 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' E' E ' 50' ' ' VAL . . . . . . . . . . . . . 46.7 t -81.04 106.57 12.37 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.281 0 N-CA-C 109.175 -0.676 . . . . 0.0 109.175 175.148 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' E' E ' 51' ' ' VAL . . . . . . . . . . . . . 48.0 t -69.68 -53.99 21.64 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.324 0 N-CA-C 109.479 -0.563 . . . . 0.0 109.479 -176.302 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' E' E ' 52' ' ' GLN . . . . . . . . . . . . . 93.7 mt-30 -152.53 154.55 35.67 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.097 -0.501 . . . . 0.0 111.714 -179.226 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' E' E ' 53' ' ' ALA . . . . . 0.41 ' HB1' ' HB2' ' E' ' 58' ' ' LEU . . . -130.49 132.33 45.59 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 115.168 -0.924 . . . . 0.0 109.764 176.056 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' E' E ' 54' ' ' TYR . . . . . . . . . . . . . 57.9 t80 -129.1 108.82 18.04 Favored Pre-proline 0 CA--C 1.534 0.351 0 CA-C-O 118.312 -0.851 . . . . 0.0 110.368 -179.767 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' E' E ' 55' ' ' PRO . . . . . . . . . . . . . 73.8 Cg_endo -77.21 170.03 72.57 Favored 'Cis proline' 0 N--CA 1.499 1.813 0 CA-C-N 121.808 1.682 . . . . 0.0 112.583 -5.154 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' E' E ' 56' ' ' SER . . . . . . . . . . . . . 13.8 m -116.12 128.97 25.57 Favored Pre-proline 0 CA--C 1.539 0.53 0 CA-C-O 118.356 -0.83 . . . . 0.0 109.139 174.425 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' E' E ' 57' ' ' PRO . . . . . . . . . . . . . 54.3 Cg_endo -70.7 149.63 91.18 Favored 'Cis proline' 0 N--CA 1.497 1.684 0 CA-C-N 121.993 1.747 . . . . 0.0 111.733 0.454 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' E' E ' 58' ' ' LEU . . . . . 0.41 ' HB2' ' HB1' ' E' ' 53' ' ' ALA . 25.3 tp -108.39 136.53 47.86 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.572 -179.426 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' E' E ' 59' ' ' ARG . . . . . . . . . . . . . 72.8 ttt180 -104.55 125.96 51.19 Favored 'General case' 0 C--N 1.326 -0.438 0 N-CA-C 109.14 -0.689 . . . . 0.0 109.14 176.0 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' E' E ' 60' ' ' VAL . . . . . . . . . . . . . 45.8 t -80.44 118.07 27.48 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.213 0 C-N-CA 120.521 -0.471 . . . . 0.0 110.48 -174.765 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' E' E ' 61' ' ' GLU . . . . . . . . . . . . . 95.0 mt-10 -131.02 162.81 28.97 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 115.786 -0.643 . . . . 0.0 109.563 176.326 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' E' E ' 62' ' ' ASP . . . . . . . . . . . . . 21.1 p-10 -56.27 -33.12 65.17 Favored 'General case' 0 C--N 1.328 -0.328 0 N-CA-C 111.854 0.316 . . . . 0.0 111.854 -177.15 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' E' E ' 63' ' ' ARG . . . . . . . . . . . . . 27.1 mmm180 -73.31 -17.36 61.32 Favored 'General case' 0 CA--C 1.533 0.317 0 N-CA-C 113.178 0.807 . . . . 0.0 113.178 -177.08 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' E' E ' 64' ' ' THR . . . . . . . . . . . . . 25.7 m -70.07 139.25 52.56 Favored 'General case' 0 C--N 1.332 -0.156 0 CA-C-O 120.865 0.364 . . . . 0.0 110.987 -175.235 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' E' E ' 65' ' ' LYS . . . . . . . . . . . . . 64.4 mttm -86.06 133.94 33.86 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.041 -0.527 . . . . 0.0 109.922 178.167 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' E' E ' 66' ' ' ILE . . . . . . . . . . . . . 64.3 mt -114.31 125.59 71.65 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.29 0 N-CA-C 109.57 -0.53 . . . . 0.0 109.57 178.839 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' E' E ' 67' ' ' THR . . . . . . . . . . . . . 29.5 m -118.12 137.53 52.89 Favored 'General case' 0 C--N 1.331 -0.213 0 CA-C-N 116.06 -0.518 . . . . 0.0 110.555 -178.013 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' E' E ' 68' ' ' LEU . . . . . . . . . . . . . 19.6 tp -107.29 143.47 35.51 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 115.79 -0.641 . . . . 0.0 110.466 -179.222 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' E' E ' 69' ' ' VAL . . . . . . . . . . . . . 48.3 t -82.77 155.15 3.88 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.359 0 N-CA-C 109.027 -0.731 . . . . 0.0 109.027 175.322 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' E' E ' 70' ' ' THR . . . . . . . . . . . . . 73.8 p -76.05 153.47 36.39 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-O 121.347 0.594 . . . . 0.0 110.909 -169.892 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' E' E ' 71' ' ' HIS . . . . . . . . . . . . . 46.9 m-70 -96.49 172.24 5.33 Favored Pre-proline 0 C--N 1.329 -0.283 0 CA-C-N 115.09 -0.959 . . . . 0.0 111.159 -174.084 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' E' E ' 72' ' ' PRO . . . . . . . . . . . . . 22.7 Cg_exo -64.85 160.16 42.31 Favored 'Trans proline' 0 N--CA 1.493 1.498 0 C-N-CA 121.543 1.495 . . . . 0.0 111.226 174.399 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' E' E ' 73' ' ' VAL . . . . . . . . . . . . . 34.2 m -69.88 -179.74 0.31 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.331 0 CA-C-N 116.316 -0.402 . . . . 0.0 110.597 -174.565 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' E' E ' 74' ' ' ASP . . . . . . . . . . . . . 33.7 t0 -86.46 117.59 25.35 Favored 'General case' 0 C--N 1.33 -0.259 0 C-N-CA 120.933 -0.307 . . . . 0.0 110.187 -173.862 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' E' E ' 75' ' ' VAL . . . . . . . . . . . . . 46.4 t -117.28 120.78 65.99 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.235 0 CA-C-O 121.126 0.489 . . . . 0.0 110.191 -178.439 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' E' E ' 76' ' ' LEU . . . . . . . . . . . . . 15.7 mt -123.32 142.22 51.17 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 115.559 -0.746 . . . . 0.0 109.502 178.688 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' E' E ' 77' ' ' GLU . . . . . . . . . . . . . 97.1 mt-10 -135.4 129.58 33.53 Favored 'General case' 0 C--N 1.331 -0.227 0 CA-C-O 121.064 0.459 . . . . 0.0 111.058 -177.221 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' E' E ' 78' ' ' ALA . . . . . 0.606 ' HB2' HD21 ' E' ' 109' ' ' LEU . . . -116.25 126.54 53.73 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 115.649 -0.705 . . . . 0.0 109.586 177.24 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' E' E ' 79' ' ' LYS . . . . . 0.436 ' O ' HD13 ' E' ' 80' ' ' ILE . 48.0 pttt -76.72 119.18 20.16 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-O 121.284 0.564 . . . . 0.0 110.962 -177.386 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' E' E ' 80' ' ' ILE . . . . . 0.436 HD13 ' O ' ' E' ' 79' ' ' LYS . 26.8 mm -139.25 106.11 2.71 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.244 0 CA-C-N 115.563 -0.744 . . . . 0.0 109.09 -178.932 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' E' E ' 81' ' ' LYS . . . . . . . . . . . . . 53.1 mtmt -99.5 129.19 45.65 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-O 120.925 0.393 . . . . 0.0 110.865 -178.678 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' E' E ' 82' ' ' GLY . . . . . . . . . . . . . . . 89.16 42.18 5.65 Favored Glycine 0 CA--C 1.525 0.666 0 C-N-CA 120.915 -0.66 . . . . 0.0 111.701 175.423 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' E' E ' 83' ' ' ILE . . . . . . . . . . . . . 75.2 mt -67.95 138.16 23.16 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.302 0 N-CA-C 109.771 -0.455 . . . . 0.0 109.771 176.48 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' E' E ' 84' ' ' LYS . . . . . . . . . . . . . 58.6 tttp -95.06 -52.76 4.08 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.122 -0.49 . . . . 0.0 109.956 -179.702 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' E' E ' 85' ' ' ASP . . . . . . . . . . . . . 6.5 t70 -155.72 153.58 30.15 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 115.792 -0.64 . . . . 0.0 110.371 -179.458 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' E' E ' 86' ' ' VAL . . . . . . . . . . . . . 43.0 t -130.29 132.67 64.86 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.258 0 CA-C-O 120.991 0.424 . . . . 0.0 110.498 -179.628 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' E' E ' 87' ' ' ILE . . . . . . . . . . . . . 45.2 mm -116.95 125.72 74.0 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.252 0 CA-C-N 115.722 -0.672 . . . . 0.0 109.55 176.745 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' E' E ' 88' ' ' LEU . . . . . 0.499 HD21 ' NH1' ' D' ' 126' ' ' ARG . 16.8 tp -110.11 129.87 55.63 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-O 120.852 0.358 . . . . 0.0 110.946 -177.436 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' E' E ' 89' ' ' ASP . . . . . . . . . . . . . 13.9 t70 -125.47 155.7 40.08 Favored 'General case' 0 C--N 1.331 -0.221 0 CA-C-N 116.085 -0.507 . . . . 0.0 109.936 177.637 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' E' E ' 90' ' ' GLU . . . . . . . . . . . . . 45.3 tp10 -45.84 -38.84 7.75 Favored 'General case' 0 C--N 1.33 -0.282 0 N-CA-C 113.132 0.79 . . . . 0.0 113.132 -172.167 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' E' E ' 91' ' ' ASN . . . . . . . . . . . . . 20.9 t30 -132.04 22.37 4.52 Favored 'General case' 0 N--CA 1.468 0.462 0 N-CA-C 112.87 0.692 . . . . 0.0 112.87 -177.147 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' E' E ' 92' ' ' LEU . . . . . 0.413 HD12 ' O ' ' E' ' 127' ' ' ASN . 10.2 mt -149.48 147.14 27.87 Favored 'General case' 0 C--N 1.332 -0.167 0 N-CA-C 110.191 -0.3 . . . . 0.0 110.191 -177.025 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' E' E ' 93' ' ' ILE . . . . . . . . . . . . . 67.6 mt -124.34 119.57 56.88 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.203 0 N-CA-C 109.199 -0.667 . . . . 0.0 109.199 176.213 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' E' E ' 94' ' ' VAL . . . . . . . . . . . . . 45.7 t -118.84 127.44 75.74 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.252 0 N-CA-C 109.849 -0.426 . . . . 0.0 109.849 -179.482 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' E' E ' 95' ' ' VAL . . . . . . . . . . . . . 44.0 t -123.99 135.8 62.38 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.324 0 CA-C-N 116.135 -0.484 . . . . 0.0 110.177 -178.404 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' E' E ' 96' ' ' ILE . . . . . . . . . . . . . 57.7 mt -117.19 129.19 74.12 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.287 0 N-CA-C 109.269 -0.641 . . . . 0.0 109.269 178.117 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' E' E ' 97' ' ' THR . . . . . . . . . . . . . 78.5 p -103.63 158.16 16.56 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-O 121.185 0.517 . . . . 0.0 111.282 -177.431 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' E' E ' 98' ' ' GLU . . . . . . . . . . . . . 70.6 mm-40 -54.23 -25.62 24.12 Favored 'General case' 0 C--N 1.33 -0.247 0 N-CA-C 112.408 0.521 . . . . 0.0 112.408 -179.754 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' E' E ' 99' ' ' GLU . . . . . . . . . . . . . 47.2 mp0 -78.19 14.33 1.21 Allowed 'General case' 0 CA--C 1.535 0.402 0 N-CA-C 113.136 0.791 . . . . 0.0 113.136 -178.032 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' E' E ' 100' ' ' ASN . . . . . . . . . . . . . 3.6 m-20 62.21 37.33 14.32 Favored 'General case' 0 CA--C 1.53 0.201 0 CA-C-O 120.994 0.426 . . . . 0.0 110.997 178.741 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' E' E ' 101' ' ' GLU . . . . . . . . . . . . . 84.7 tt0 -113.99 144.14 43.58 Favored 'General case' 0 C--N 1.331 -0.198 0 CA-C-N 116.02 -0.536 . . . . 0.0 109.735 176.244 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' E' E ' 102' ' ' VAL . . . . . . . . . . . . . 44.3 t -114.98 126.0 72.45 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.299 0 CA-C-N 116.225 -0.443 . . . . 0.0 109.914 -178.803 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' E' E ' 103' ' ' LEU . . . . . . . . . . . . . 21.5 mt -118.29 132.08 56.31 Favored 'General case' 0 C--N 1.331 -0.217 0 CA-C-N 115.662 -0.699 . . . . 0.0 110.31 178.778 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' E' E ' 104' ' ' ILE . . . . . . . . . . . . . 69.7 mt -120.14 123.57 70.96 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.266 0 N-CA-C 110.063 -0.347 . . . . 0.0 110.063 178.601 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' E' E ' 105' ' ' PHE . . . . . . . . . . . . . 70.8 m-85 -124.88 162.43 24.41 Favored 'General case' 0 C--N 1.333 -0.15 0 O-C-N 123.848 0.718 . . . . 0.0 109.89 179.336 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' E' E ' 106' ' ' ASN . . . . . . . . . . . . . 46.0 p-10 -97.22 -170.46 2.03 Favored 'General case' 0 C--N 1.33 -0.266 0 N-CA-C 109.981 -0.377 . . . . 0.0 109.981 174.143 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' E' E ' 107' ' ' GLN . . . . . . . . . . . . . 55.6 tp60 -59.71 -30.07 68.55 Favored 'General case' 0 CA--C 1.531 0.214 0 N-CA-C 111.911 0.337 . . . . 0.0 111.911 179.911 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' E' E ' 108' ' ' ASN . . . . . . . . . . . . . 52.0 t30 -81.92 8.21 11.01 Favored 'General case' 0 CA--C 1.535 0.384 0 N-CA-C 113.109 0.781 . . . . 0.0 113.109 -177.601 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' E' E ' 109' ' ' LEU . . . . . 0.606 HD21 ' HB2' ' E' ' 78' ' ' ALA . 12.7 tp 58.39 38.79 25.75 Favored 'General case' 0 C--N 1.332 -0.183 0 CA-C-O 121.105 0.479 . . . . 0.0 110.901 179.339 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' E' E ' 110' ' ' GLU . . . . . . . . . . . . . 70.8 mm-40 -105.23 149.14 26.22 Favored 'General case' 0 C--N 1.332 -0.192 0 N-CA-C 109.925 -0.398 . . . . 0.0 109.925 176.798 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' E' E ' 111' ' ' GLU . . . . . . . . . . . . . 84.5 tt0 -78.39 121.83 25.01 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 116.419 -0.355 . . . . 0.0 110.616 -177.402 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' E' E ' 112' ' ' LEU . . . . . . . . . . . . . 18.4 mt -110.17 -46.11 3.49 Favored 'General case' 0 C--N 1.331 -0.21 0 CA-C-N 116.283 -0.417 . . . . 0.0 110.697 179.174 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' E' E ' 113' ' ' TYR . . . . . . . . . . . . . 64.3 t80 -138.89 136.27 35.35 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.262 -0.426 . . . . 0.0 111.045 -179.147 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' E' E ' 114' ' ' ARG . . . . . . . . . . . . . 70.1 ttp85 -138.53 120.37 15.37 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-N 116.025 -0.534 . . . . 0.0 110.277 176.695 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' E' E ' 115' ' ' GLY . . . . . . . . . . . . . . . -150.14 145.65 13.95 Favored Glycine 0 CA--C 1.524 0.641 0 N-CA-C 110.842 -0.903 . . . . 0.0 110.842 178.118 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' E' E ' 116' ' ' LYS . . . . . . . . . . . . . 28.4 ttmt -115.26 136.59 52.95 Favored 'General case' 0 C--N 1.331 -0.23 0 O-C-N 122.565 -0.374 . . . . 0.0 110.171 177.94 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' E' E ' 117' ' ' PHE . . . . . . . . . . . . . 58.5 m-85 -131.46 117.37 18.74 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 116.15 -0.477 . . . . 0.0 110.129 -177.018 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' E' E ' 118' ' ' GLU . . . . . . . . . . . . . 96.2 mt-10 -54.43 -41.64 69.6 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.507 -0.315 . . . . 0.0 111.486 -175.31 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' E' E ' 119' ' ' ASN . . . . . . . . . . . . . 19.0 m120 -104.05 31.1 4.73 Favored 'General case' 0 C--N 1.33 -0.249 0 N-CA-C 112.129 0.418 . . . . 0.0 112.129 -173.885 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' E' E ' 120' ' ' LEU . . . . . . . . . . . . . 21.3 tp -56.65 123.29 14.36 Favored 'General case' 0 C--N 1.332 -0.16 0 C-N-CA 121.118 -0.233 . . . . 0.0 110.412 178.555 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' E' E ' 121' ' ' ASN . . . . . . . . . . . . . 27.2 m120 -114.13 -44.28 3.15 Favored 'General case' 0 N--CA 1.462 0.165 0 CA-C-N 116.759 -0.201 . . . . 0.0 111.353 -176.829 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' E' E ' 122' ' ' LYS . . . . . . . . . . . . . 94.4 mttt -147.73 151.52 36.23 Favored 'General case' 0 C--N 1.332 -0.191 0 CA-C-O 121.03 0.443 . . . . 0.0 111.715 -176.963 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' E' E ' 123' ' ' VAL . . . . . . . . . . . . . 42.7 t -132.91 133.13 59.14 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.181 0 N-CA-C 109.633 -0.506 . . . . 0.0 109.633 175.249 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' E' E ' 124' ' ' LEU . . . . . . . . . . . . . 69.9 mt -130.09 137.72 50.33 Favored 'General case' 0 C--N 1.331 -0.197 0 CA-C-N 116.452 -0.34 . . . . 0.0 110.842 -178.772 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' E' E ' 125' ' ' VAL . . . . . . . . . . . . . 11.8 p -136.95 137.17 47.24 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.262 0 CA-C-N 116.385 -0.37 . . . . 0.0 110.651 179.669 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' E' E ' 126' ' ' ARG . . . . . . . . . . . . . 83.3 mtt180 -146.06 130.28 17.54 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.679 177.226 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' E' E ' 127' ' ' ASN . . . . . 0.413 ' O ' HD12 ' E' ' 92' ' ' LEU . 36.3 t30 50.64 -112.22 0.59 Allowed 'General case' 0 CA--C 1.545 0.761 0 CA-C-O 118.64 -0.695 . . . . 0.0 111.46 178.751 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' E' E ' 128' ' ' ASP . . . . . . . . . . . . . 17.3 p-10 -112.59 8.16 19.07 Favored 'General case' 0 N--CA 1.468 0.435 0 CA-C-N 120.157 1.344 . . . . 0.0 113.317 -177.317 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' E' E ' 129' ' ' LEU . . . . . . . . . . . . . 15.5 tp -116.38 137.49 52.11 Favored 'General case' 0 C--N 1.333 -0.139 0 N-CA-C 109.745 -0.465 . . . . 0.0 109.745 178.89 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' E' E ' 130' ' ' VAL . . . . . 0.532 HG13 ' HB ' ' E' ' 141' ' ' ILE . 12.7 p -132.62 143.39 39.86 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.198 0 CA-C-O 121.143 0.497 . . . . 0.0 110.563 -179.556 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' E' E ' 131' ' ' VAL . . . . . . . . . . . . . 39.3 t -135.53 140.72 44.08 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.246 0 CA-C-N 115.969 -0.559 . . . . 0.0 110.383 -178.941 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' E' E ' 132' ' ' ILE . . . . . . . . . . . . . 70.3 mt -115.93 132.86 64.17 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.316 0 CA-C-N 115.752 -0.658 . . . . 0.0 109.355 179.292 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' E' E ' 133' ' ' ILE . . . . . . . . . . . . . 41.9 mm -116.24 124.15 72.18 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.238 0 CA-C-O 120.896 0.379 . . . . 0.0 111.064 -175.061 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' E' E ' 134' ' ' ASP . . . . . . . . . . . . . 7.8 p-10 -135.35 149.76 49.79 Favored 'General case' 0 C--N 1.331 -0.205 0 CA-C-N 116.075 -0.511 . . . . 0.0 109.677 174.574 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' E' E ' 135' ' ' GLU . . . . . . . . . . . . . 40.2 tp10 -50.76 -28.38 9.09 Favored 'General case' 0 C--N 1.327 -0.377 0 N-CA-C 112.709 0.633 . . . . 0.0 112.709 -173.088 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' E' E ' 136' ' ' GLN . . . . . . . . . . . . . 98.3 mt-30 -84.55 -29.82 25.58 Favored 'General case' 0 C--O 1.233 0.229 0 N-CA-C 112.882 0.697 . . . . 0.0 112.882 -175.432 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' E' E ' 137' ' ' LYS . . . . . . . . . . . . . 58.9 pttt -168.86 175.35 5.98 Favored 'General case' 0 C--N 1.332 -0.171 0 CA-C-O 121.609 0.719 . . . . 0.0 112.449 -172.879 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' E' E ' 138' ' ' LEU . . . . . 0.457 ' C ' HD23 ' E' ' 138' ' ' LEU . 8.6 tt -121.62 129.42 52.81 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 114.997 -1.001 . . . . 0.0 109.958 178.475 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' E' E ' 139' ' ' THR . . . . . . . . . . . . . 43.7 m -109.1 128.22 54.82 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.188 179.316 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' E' E ' 140' ' ' LEU . . . . . 0.48 ' C ' HD23 ' E' ' 140' ' ' LEU . 7.2 tt -112.81 125.25 54.14 Favored 'General case' 0 C--N 1.328 -0.35 0 N-CA-C 109.174 -0.676 . . . . 0.0 109.174 -178.828 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' E' E ' 141' ' ' ILE . . . . . 0.532 ' HB ' HG13 ' E' ' 130' ' ' VAL . 19.4 mt -123.57 119.29 56.86 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.277 0 CA-C-O 121.132 0.492 . . . . 0.0 110.09 -176.469 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' E' E ' 142' ' ' ARG . . . . . . . . . . . . . 77.6 ttt-85 -106.39 130.0 54.28 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 115.001 -1.0 . . . . 0.0 110.226 -179.882 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' E' E ' 143' ' ' THR . . . . . . . . . . . . . 44.6 p . . . . . 0 C--O 1.219 -0.514 0 CA-C-O 117.959 -1.02 . . . . 0.0 110.547 179.112 . . . . . . . . 0 0 . 1 . 005 nuclear build full ' F' F ' -3' ' ' GLU . . . . . . . . . . . . . 45.8 tp10 . . . . . 0 N--CA 1.489 1.505 0 N-CA-C 109.332 -0.618 . . . . 0.0 109.332 . . . . . . . . . 0 0 . 1 . 005 nuclear build full ' F' F ' -2' ' ' GLY . . . . . . . . . . . . . . . -67.57 140.2 36.52 Favored Glycine 0 CA--C 1.524 0.63 0 N-CA-C 111.223 -0.751 . . . . 0.0 111.223 -178.651 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' F' F ' -1' ' ' VAL . . . . . . . . . . . . . 44.7 t -141.57 140.34 31.16 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.292 0 N-CA-C 110.079 -0.341 . . . . 0.0 110.079 179.603 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' F' F ' 0' ' ' ILE . . . . . . . . . . . . . 43.7 mm -110.64 136.11 47.68 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.295 0 CA-C-N 116.236 -0.438 . . . . 0.0 110.186 -179.742 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' F' F ' 1' ' ' MET . . . . . . . . . . . . . 26.2 ptt? -82.39 137.12 34.82 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.276 -0.42 . . . . 0.0 110.957 -179.212 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' F' F ' 2' ' ' SER . . . . . . . . . . . . . 14.3 p -130.8 135.33 47.65 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.083 -0.508 . . . . 0.0 110.082 178.419 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' F' F ' 3' ' ' GLU . . . . . . . . . . . . . 46.8 mp0 -139.45 141.15 37.45 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.146 -0.479 . . . . 0.0 111.321 -176.615 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' F' F ' 4' ' ' LEU . . . . . . . . . . . . . 57.6 mt -118.94 124.97 48.35 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 115.606 -0.725 . . . . 0.0 109.85 173.96 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' F' F ' 5' ' ' LYS . . . . . . . . . . . . . 98.3 mttt -102.36 119.81 39.44 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.459 -0.337 . . . . 0.0 110.144 177.646 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' F' F ' 6' ' ' LEU . . . . . . . . . . . . . 70.5 mt -119.45 144.32 47.03 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 115.416 -0.811 . . . . 0.0 110.421 -177.9 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' F' F ' 7' ' ' LYS . . . . . . . . . . . . . 47.4 tttm -134.64 142.78 43.86 Favored Pre-proline 0 CA--C 1.534 0.354 0 CA-C-O 119.2 -0.428 . . . . 0.0 110.142 177.331 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' F' F ' 8' ' ' PRO . . . . . . . . . . . . . 85.0 Cg_endo -92.16 143.35 2.63 Favored 'Trans proline' 0 N--CA 1.49 1.319 0 C-N-CA 121.749 1.633 . . . . 0.0 111.714 176.997 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' F' F ' 9' ' ' LEU . . . . . . . . . . . . . 62.0 mt -76.74 -47.02 3.04 Favored Pre-proline 0 CA--C 1.535 0.367 0 CA-C-O 118.691 -0.671 . . . . 0.0 112.041 179.735 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' F' F ' 10' ' ' PRO . . . . . . . . . . . . . 85.4 Cg_endo -81.71 150.2 16.5 Favored 'Trans proline' 0 N--CA 1.495 1.59 0 C-N-CA 121.185 1.257 . . . . 0.0 111.54 174.604 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' F' F ' 11' ' ' LYS . . . . . . . . . . . . . 54.0 pttt -86.95 113.12 22.45 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-O 121.552 0.692 . . . . 0.0 110.949 179.981 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' F' F ' 12' ' ' VAL . . . . . . . . . . . . . 13.3 p -151.09 148.34 14.99 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.194 0 CA-C-N 115.736 -0.666 . . . . 0.0 110.458 178.901 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' F' F ' 13' ' ' GLU . . . . . . . . . . . . . 45.3 mt-10 -88.0 124.19 33.48 Favored 'General case' 0 C--N 1.331 -0.224 0 CA-C-O 120.759 0.314 . . . . 0.0 110.595 177.836 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' F' F ' 14' ' ' LEU . . . . . . . . . . . . . 22.8 mt -99.77 154.61 37.16 Favored Pre-proline 0 CA--C 1.532 0.285 0 CA-C-N 116.276 -0.42 . . . . 0.0 111.012 -178.282 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' F' F ' 15' ' ' PRO . . . . . . . . . . . . . 27.7 Cg_exo -62.05 162.99 20.83 Favored 'Trans proline' 0 N--CA 1.498 1.736 0 C-N-CA 121.423 1.415 . . . . 0.0 111.963 176.07 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' F' F ' 16' ' ' PRO . . . . . . . . . . . . . 21.5 Cg_exo -64.61 -37.07 39.07 Favored 'Trans proline' 0 N--CA 1.497 1.705 0 C-N-CA 121.592 1.528 . . . . 0.0 112.724 -179.512 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' F' F ' 17' ' ' ASP . . . . . . . . . . . . . 12.7 p-10 -87.09 12.11 12.25 Favored 'General case' 0 CA--C 1.535 0.391 0 N-CA-C 113.142 0.793 . . . . 0.0 113.142 -177.149 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' F' F ' 18' ' ' PHE . . . . . . . . . . . . . 41.1 t80 -56.44 -41.85 77.15 Favored 'General case' 0 CA--C 1.526 0.047 0 O-C-N 121.939 -0.476 . . . . 0.0 110.375 -179.56 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' F' F ' 19' ' ' VAL . . . . . . . . . . . . . 44.3 t -55.98 -43.51 75.28 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.285 0 CA-C-N 116.399 -0.364 . . . . 0.0 110.579 -178.627 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' F' F ' 20' ' ' ASP . . . . . . . . . . . . . 29.8 t0 -59.88 -43.09 94.95 Favored 'General case' 0 C--N 1.33 -0.274 0 C-N-CA 120.915 -0.314 . . . . 0.0 110.784 -177.811 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' F' F ' 21' ' ' VAL . . . . . . . . . . . . . 45.4 t -63.33 -46.44 95.51 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.277 0 C-N-CA 120.63 -0.428 . . . . 0.0 110.437 -177.748 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' F' F ' 22' ' ' ILE . . . . . 0.437 HG22 ' CD1' ' F' ' 26' ' ' LEU . 51.4 mm -55.98 -47.11 80.54 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.275 0 C-N-CA 120.905 -0.318 . . . . 0.0 110.808 179.793 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' F' F ' 23' ' ' ARG . . . . . . . . . . . . . 55.4 ttp180 -55.02 -47.19 75.03 Favored 'General case' 0 C--N 1.331 -0.239 0 C-N-CA 120.932 -0.307 . . . . 0.0 111.303 -178.194 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' F' F ' 24' ' ' ILE . . . . . . . . . . . . . 75.5 mt -59.17 -42.58 87.23 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.268 0 C-N-CA 120.939 -0.304 . . . . 0.0 111.212 -177.672 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' F' F ' 25' ' ' LYS . . . . . . . . . . . . . 50.3 mttm -67.74 -39.57 84.23 Favored 'General case' 0 C--N 1.33 -0.266 0 N-CA-C 112.67 0.619 . . . . 0.0 112.67 -179.51 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' F' F ' 26' ' ' LEU . . . . . 0.437 ' CD1' HG22 ' F' ' 22' ' ' ILE . 95.8 mt -77.37 -39.85 45.96 Favored 'General case' 0 C--N 1.329 -0.307 0 N-CA-C 113.17 0.804 . . . . 0.0 113.17 -170.486 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' F' F ' 27' ' ' GLN . . . . . . . . . . . . . 15.5 pt20 -46.7 139.99 4.86 Favored 'General case' 0 N--CA 1.469 0.476 0 N-CA-C 112.785 0.661 . . . . 0.0 112.785 -174.501 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' F' F ' 28' ' ' GLY . . . . . . . . . . . . . . . 100.56 -29.29 12.67 Favored Glycine 0 CA--C 1.531 1.045 0 CA-C-N 115.592 -0.731 . . . . 0.0 112.016 -177.642 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' F' F ' 29' ' ' LYS . . . . . . . . . . . . . 72.8 mttt -97.92 155.08 17.25 Favored 'General case' 0 C--O 1.233 0.199 0 CA-C-N 117.203 0.501 . . . . 0.0 111.163 178.236 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' F' F ' 30' ' ' THR . . . . . . . . . . . . . 29.6 m -100.67 139.16 36.74 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 115.899 -0.591 . . . . 0.0 109.822 175.272 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' F' F ' 31' ' ' VAL . . . . . . . . . . . . . 35.0 m -122.08 149.55 25.45 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.259 0 CA-C-O 120.926 0.393 . . . . 0.0 110.823 -178.105 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' F' F ' 32' ' ' ARG . . . . . . . . . . . . . 39.1 ttp180 -132.95 147.86 52.28 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-N 115.669 -0.696 . . . . 0.0 110.314 177.582 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' F' F ' 33' ' ' THR . . . . . . . . . . . . . 27.4 m -53.61 137.34 37.16 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.418 -0.355 . . . . 0.0 111.281 -179.348 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' F' F ' 34' ' ' GLY . . . . . . . . . . . . . . . 101.76 -17.22 55.2 Favored Glycine 0 CA--C 1.532 1.108 0 CA-C-O 119.7 -0.5 . . . . 0.0 113.348 178.813 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' F' F ' 35' ' ' ASP . . . . . . . . . . . . . 78.8 m-20 -65.79 147.73 52.91 Favored 'General case' 0 N--CA 1.462 0.147 0 CA-C-N 118.015 0.907 . . . . 0.0 111.058 179.472 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' F' F ' 36' ' ' VAL . . . . . . . . . . . . . 44.3 t -122.97 129.62 74.99 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.267 0 CA-C-N 116.115 -0.493 . . . . 0.0 109.815 178.431 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' F' F ' 37' ' ' ILE . . . . . . . . . . . . . 68.0 mt -119.62 138.64 49.58 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.184 0 CA-C-N 116.123 -0.489 . . . . 0.0 109.846 -179.972 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' F' F ' 38' ' ' GLY . . . . . . . . . . . . . . . -110.58 128.65 8.9 Favored Glycine 0 CA--C 1.525 0.683 0 N-CA-C 111.19 -0.764 . . . . 0.0 111.19 -179.653 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' F' F ' 39' ' ' ILE . . . . . . . . . . . . . 72.5 mt -127.13 128.07 70.09 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.233 0 N-CA-C 109.922 -0.399 . . . . 0.0 109.922 178.537 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' F' F ' 40' ' ' SER . . . . . . . . . . . . . 30.8 t -92.42 121.19 33.65 Favored 'General case' 0 C--N 1.329 -0.305 0 C-N-CA 120.823 -0.351 . . . . 0.0 110.677 175.967 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' F' F ' 41' ' ' ILE . . . . . . . . . . . . . 71.1 mt -127.45 123.99 62.81 Favored 'Isoleucine or valine' 0 N--CA 1.462 0.159 0 CA-C-O 120.935 0.398 . . . . 0.0 110.582 -179.226 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' F' F ' 42' ' ' LEU . . . . . . . . . . . . . 7.0 tp 52.58 37.65 23.78 Favored 'General case' 0 C--N 1.331 -0.219 0 CA-C-N 116.062 -0.517 . . . . 0.0 111.671 175.661 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' F' F ' 43' ' ' GLY . . . . . . . . . . . . . . . 73.18 28.16 66.84 Favored Glycine 0 CA--C 1.53 1.025 0 C-N-CA 121.073 -0.584 . . . . 0.0 112.567 176.569 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' F' F ' 44' ' ' LYS . . . . . . . . . . . . . 62.8 tttm -140.59 126.38 19.28 Favored 'General case' 0 C--N 1.33 -0.272 0 N-CA-C 109.474 -0.565 . . . . 0.0 109.474 177.234 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' F' F ' 45' ' ' GLU . . . . . . . . . . . . . 34.7 tp10 -82.82 124.31 30.18 Favored 'General case' 0 C--N 1.328 -0.331 0 C-N-CA 120.718 -0.393 . . . . 0.0 110.836 -176.876 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' F' F ' 46' ' ' VAL . . . . . . . . . . . . . 7.6 p -120.8 129.45 75.64 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.204 0 N-CA-C 109.561 -0.533 . . . . 0.0 109.561 177.285 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' F' F ' 47' ' ' LYS . . . . . . . . . . . . . 61.3 mmtt -100.23 130.09 46.32 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 115.935 -0.575 . . . . 0.0 111.104 178.572 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' F' F ' 48' ' ' PHE . . . . . . . . . . . . . 94.2 m-85 -112.61 131.86 55.42 Favored 'General case' 0 C--N 1.331 -0.233 0 N-CA-C 109.638 -0.504 . . . . 0.0 109.638 175.795 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' F' F ' 49' ' ' LYS . . . . . . . . . . . . . 48.9 tttp -108.7 136.71 47.83 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.314 -0.403 . . . . 0.0 110.612 179.936 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' F' F ' 50' ' ' VAL . . . . . . . . . . . . . 46.8 t -78.92 106.46 9.92 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.333 0 N-CA-C 108.91 -0.774 . . . . 0.0 108.91 175.155 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' F' F ' 51' ' ' VAL . . . . . . . . . . . . . 47.3 t -74.81 -47.43 37.8 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.327 0 CA-C-N 116.075 -0.511 . . . . 0.0 110.139 -172.957 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' F' F ' 52' ' ' GLN . . . . . . . . . . . . . 57.5 tt0 -160.72 137.84 9.1 Favored 'General case' 0 C--N 1.33 -0.281 0 C-N-CA 120.465 -0.494 . . . . 0.0 111.351 -177.466 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' F' F ' 53' ' ' ALA . . . . . . . . . . . . . . . -114.75 131.79 56.66 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 115.964 -0.562 . . . . 0.0 109.983 174.494 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' F' F ' 54' ' ' TYR . . . . . . . . . . . . . 33.7 t80 -129.01 109.16 18.2 Favored Pre-proline 0 C--N 1.328 -0.334 0 CA-C-O 118.302 -0.856 . . . . 0.0 110.492 179.271 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' F' F ' 55' ' ' PRO . . . . . . . . . . . . . 74.0 Cg_endo -77.14 168.51 76.76 Favored 'Cis proline' 0 N--CA 1.499 1.841 0 CA-C-N 121.951 1.733 . . . . 0.0 112.292 -5.819 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' F' F ' 56' ' ' SER . . . . . . . . . . . . . 69.2 m -117.5 134.78 23.12 Favored Pre-proline 0 CA--C 1.539 0.524 0 CA-C-O 118.466 -0.778 . . . . 0.0 109.704 175.126 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' F' F ' 57' ' ' PRO . . . . . . . . . . . . . 57.6 Cg_endo -73.14 162.82 90.92 Favored 'Cis proline' 0 N--CA 1.496 1.619 0 CA-C-N 121.806 1.681 . . . . 0.0 111.375 -3.501 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' F' F ' 58' ' ' LEU . . . . . . . . . . . . . 33.6 tp -130.0 137.84 50.5 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-O 120.851 0.357 . . . . 0.0 110.793 -178.658 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' F' F ' 59' ' ' ARG . . . . . . . . . . . . . 32.2 ttp180 -99.65 127.52 45.76 Favored 'General case' 0 C--N 1.327 -0.374 0 N-CA-C 109.335 -0.617 . . . . 0.0 109.335 175.459 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' F' F ' 60' ' ' VAL . . . . . . . . . . . . . 41.2 t -80.96 123.15 37.27 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.266 0 C-N-CA 120.598 -0.441 . . . . 0.0 110.506 -175.073 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' F' F ' 61' ' ' GLU . . . . . . . . . . . . . 42.9 mt-10 -131.13 171.38 13.34 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 115.608 -0.724 . . . . 0.0 109.674 176.483 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' F' F ' 62' ' ' ASP . . . . . . . . . . . . . 83.8 m-20 -54.27 -32.59 56.58 Favored 'General case' 0 C--N 1.329 -0.308 0 C-N-CA 120.968 -0.293 . . . . 0.0 111.752 -179.279 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' F' F ' 63' ' ' ARG . . . . . . . . . . . . . 25.0 ptt180 -83.9 2.25 39.46 Favored 'General case' 0 CA--C 1.537 0.455 0 N-CA-C 113.727 1.01 . . . . 0.0 113.727 -175.263 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' F' F ' 64' ' ' THR . . . . . . . . . . . . . 28.4 m -78.44 136.8 37.71 Favored 'General case' 0 C--N 1.333 -0.133 0 CA-C-N 118.119 0.418 . . . . 0.0 110.705 -177.621 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' F' F ' 65' ' ' LYS . . . . . . . . . . . . . 24.6 mtpp -90.35 127.04 36.07 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.037 -0.529 . . . . 0.0 110.218 179.275 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' F' F ' 66' ' ' ILE . . . . . . . . . . . . . 4.3 mp -113.87 131.47 65.65 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.262 0 N-CA-C 110.012 -0.366 . . . . 0.0 110.012 179.628 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' F' F ' 67' ' ' THR . . . . . . . . . . . . . 20.9 m -122.19 132.62 54.54 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-O 121.069 0.462 . . . . 0.0 110.331 178.525 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' F' F ' 68' ' ' LEU . . . . . 0.435 HD23 ' C ' ' F' ' 68' ' ' LEU . 6.2 tt -106.91 124.79 50.14 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 115.825 -0.625 . . . . 0.0 110.002 -179.982 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' F' F ' 69' ' ' VAL . . . . . . . . . . . . . 43.4 t -95.22 135.95 27.76 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.315 0 CA-C-O 121.061 0.458 . . . . 0.0 110.412 -178.008 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' F' F ' 70' ' ' THR . . . . . . . . . . . . . 9.0 t -130.91 175.14 9.31 Favored 'General case' 0 C--N 1.331 -0.219 0 CA-C-N 115.882 -0.599 . . . . 0.0 110.304 -178.999 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' F' F ' 71' ' ' HIS . . . . . . . . . . . . . 96.1 m-70 -64.95 149.68 96.25 Favored Pre-proline 0 C--N 1.329 -0.324 0 CA-C-N 116.269 -0.423 . . . . 0.0 110.396 -178.367 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' F' F ' 72' ' ' PRO . . . . . . . . . . . . . 71.8 Cg_endo -77.58 -24.38 8.98 Favored 'Trans proline' 0 N--CA 1.495 1.592 0 C-N-CA 121.375 1.383 . . . . 0.0 113.038 -177.238 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' F' F ' 73' ' ' VAL . . . . . . . . . . . . . 34.8 m -129.11 154.24 39.78 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.158 0 CA-C-O 121.109 0.481 . . . . 0.0 111.154 -178.201 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' F' F ' 74' ' ' ASP . . . . . . . . . . . . . 12.8 t70 -101.82 123.72 46.24 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 115.542 -0.754 . . . . 0.0 109.594 177.464 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' F' F ' 75' ' ' VAL . . . . . . . . . . . . . 45.1 t -111.86 123.92 68.1 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.253 0 CA-C-O 121.145 0.498 . . . . 0.0 110.527 -178.105 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' F' F ' 76' ' ' LEU . . . . . . . . . . . . . 29.1 mt -123.86 142.23 51.31 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 115.533 -0.758 . . . . 0.0 109.418 177.661 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' F' F ' 77' ' ' GLU . . . . . . . . . . . . . 97.8 mt-10 -133.92 137.98 45.24 Favored 'General case' 0 C--N 1.331 -0.227 0 CA-C-O 121.018 0.437 . . . . 0.0 111.312 -178.145 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' F' F ' 78' ' ' ALA . . . . . 0.688 ' HB2' HD21 ' F' ' 109' ' ' LEU . . . -128.11 136.36 51.06 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 115.718 -0.673 . . . . 0.0 109.722 176.35 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' F' F ' 79' ' ' LYS . . . . . 0.593 ' O ' HD13 ' F' ' 80' ' ' ILE . 19.8 pttp -79.46 123.76 27.83 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-O 121.187 0.518 . . . . 0.0 111.142 -177.893 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' F' F ' 80' ' ' ILE . . . . . 0.593 HD13 ' O ' ' F' ' 79' ' ' LYS . 40.6 mm -139.21 112.73 6.57 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.279 0 CA-C-N 115.725 -0.671 . . . . 0.0 109.278 -178.199 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' F' F ' 81' ' ' LYS . . . . . . . . . . . . . 47.0 tptt -102.1 123.43 45.96 Favored 'General case' 0 C--N 1.329 -0.287 0 C-N-CA 120.921 -0.312 . . . . 0.0 111.072 -177.474 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' F' F ' 82' ' ' GLY . . . . . . . . . . . . . . . 89.07 42.15 5.69 Favored Glycine 0 CA--C 1.525 0.657 0 C-N-CA 120.722 -0.752 . . . . 0.0 111.954 173.551 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' F' F ' 83' ' ' ILE . . . . . . . . . . . . . 72.4 mt -64.04 137.47 24.75 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.29 0 N-CA-C 109.915 -0.402 . . . . 0.0 109.915 178.139 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' F' F ' 84' ' ' LYS . . . . . . . . . . . . . 82.2 tttt -99.43 -53.8 3.12 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 115.999 -0.546 . . . . 0.0 110.42 -178.975 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' F' F ' 85' ' ' ASP . . . . . . . . . . . . . 8.6 t0 -154.96 153.01 30.39 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 115.748 -0.66 . . . . 0.0 109.972 -179.706 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' F' F ' 86' ' ' VAL . . . . . . . . . . . . . 43.2 t -128.85 131.59 68.22 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.24 0 CA-C-O 120.9 0.381 . . . . 0.0 110.767 -178.016 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' F' F ' 87' ' ' ILE . . . . . . . . . . . . . 42.4 mm -118.22 124.26 72.84 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.245 0 CA-C-N 115.782 -0.644 . . . . 0.0 109.503 175.164 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' F' F ' 88' ' ' LEU . . . . . . . . . . . . . 14.8 tp -112.96 131.9 55.56 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-O 120.938 0.399 . . . . 0.0 111.36 -176.185 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' F' F ' 89' ' ' ASP . . . . . . . . . . . . . 13.5 t70 -131.08 151.52 51.35 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 115.861 -0.609 . . . . 0.0 109.442 175.932 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' F' F ' 90' ' ' GLU . . . . . . . . . . . . . 46.6 tp10 -48.96 -35.05 14.19 Favored 'General case' 0 C--N 1.329 -0.32 0 N-CA-C 112.712 0.634 . . . . 0.0 112.712 -172.49 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' F' F ' 91' ' ' ASN . . . . . . . . . . . . . 12.7 p30 -123.36 14.58 9.64 Favored 'General case' 0 N--CA 1.47 0.534 0 N-CA-C 113.452 0.908 . . . . 0.0 113.452 -175.883 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' F' F ' 92' ' ' LEU . . . . . . . . . . . . . 8.1 mt -151.66 143.17 23.53 Favored 'General case' 0 C--N 1.332 -0.171 0 N-CA-C 109.797 -0.446 . . . . 0.0 109.797 -177.101 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' F' F ' 93' ' ' ILE . . . . . . . . . . . . . 71.0 mt -127.26 117.13 46.39 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.346 0 N-CA-C 108.892 -0.781 . . . . 0.0 108.892 176.186 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' F' F ' 94' ' ' VAL . . . . . 0.468 HG21 HG21 ' F' ' 125' ' ' VAL . 48.4 t -121.71 128.11 75.67 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.257 0 CA-C-O 121.147 0.498 . . . . 0.0 110.189 -178.174 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' F' F ' 95' ' ' VAL . . . . . . . . . . . . . 45.2 t -120.78 135.08 62.12 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.358 0 CA-C-N 115.524 -0.762 . . . . 0.0 109.644 -179.168 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' F' F ' 96' ' ' ILE . . . . . . . . . . . . . 62.0 mt -111.66 129.03 67.8 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.358 0 N-CA-C 108.789 -0.819 . . . . 0.0 108.789 178.137 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' F' F ' 97' ' ' THR . . . . . . . . . . . . . 58.1 p -103.93 157.08 17.34 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-O 121.335 0.588 . . . . 0.0 111.235 -176.77 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' F' F ' 98' ' ' GLU . . . . . . . . . . . . . 85.4 tt0 -53.93 -24.03 14.97 Favored 'General case' 0 CA--C 1.534 0.36 0 CA-C-N 115.866 -0.606 . . . . 0.0 112.314 179.581 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' F' F ' 99' ' ' GLU . . . . . . . . . . . . . 41.3 tt0 -79.74 16.69 1.06 Allowed 'General case' 0 CA--C 1.54 0.561 0 N-CA-C 112.401 0.519 . . . . 0.0 112.401 -178.354 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' F' F ' 100' ' ' ASN . . . . . . . . . . . . . 2.2 m-20 60.05 37.39 21.14 Favored 'General case' 0 CA--C 1.53 0.209 0 O-C-N 121.675 -0.64 . . . . 0.0 110.818 178.367 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' F' F ' 101' ' ' GLU . . . . . . . . . . . . . 85.1 tt0 -117.1 145.38 43.81 Favored 'General case' 0 C--N 1.332 -0.186 0 CA-C-N 116.018 -0.537 . . . . 0.0 109.876 178.075 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' F' F ' 102' ' ' VAL . . . . . . . . . . . . . 46.2 t -115.51 124.79 72.36 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.372 0 N-CA-C 109.776 -0.453 . . . . 0.0 109.776 -178.83 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' F' F ' 103' ' ' LEU . . . . . . . . . . . . . 56.3 mt -114.47 129.92 56.69 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 115.83 -0.623 . . . . 0.0 110.016 176.961 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' F' F ' 104' ' ' ILE . . . . . . . . . . . . . 68.9 mt -117.93 118.43 58.25 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.27 0 N-CA-C 109.909 -0.404 . . . . 0.0 109.909 -179.811 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' F' F ' 105' ' ' PHE . . . . . . . . . . . . . 36.0 m-85 -119.36 164.18 16.08 Favored 'General case' 0 C--N 1.332 -0.163 0 O-C-N 123.898 0.749 . . . . 0.0 109.647 179.715 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' F' F ' 106' ' ' ASN . . . . . 0.446 ' HB3' HD11 ' F' ' 112' ' ' LEU . 44.3 p-10 -100.03 -170.65 1.91 Allowed 'General case' 0 C--N 1.33 -0.259 0 N-CA-C 109.808 -0.441 . . . . 0.0 109.808 173.575 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' F' F ' 107' ' ' GLN . . . . . . . . . . . . . 27.9 tt0 -59.75 -29.88 68.47 Favored 'General case' 0 C--N 1.329 -0.29 0 N-CA-C 111.944 0.35 . . . . 0.0 111.944 179.201 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' F' F ' 108' ' ' ASN . . . . . . . . . . . . . 16.6 t-20 -81.88 6.92 14.28 Favored 'General case' 0 CA--C 1.537 0.445 0 N-CA-C 113.232 0.827 . . . . 0.0 113.232 -177.948 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' F' F ' 109' ' ' LEU . . . . . 0.688 HD21 ' HB2' ' F' ' 78' ' ' ALA . 11.1 tp 62.4 36.68 14.18 Favored 'General case' 0 C--O 1.233 0.186 0 O-C-N 122.054 -0.404 . . . . 0.0 111.436 177.248 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' F' F ' 110' ' ' GLU . . . . . . . . . . . . . 70.9 mm-40 -109.58 156.96 19.53 Favored 'General case' 0 C--N 1.331 -0.237 0 N-CA-C 110.107 -0.331 . . . . 0.0 110.107 177.127 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' F' F ' 111' ' ' GLU . . . . . . . . . . . . . 46.4 mp0 -83.69 122.03 28.07 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-O 120.941 0.401 . . . . 0.0 111.053 -178.501 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' F' F ' 112' ' ' LEU . . . . . 0.446 HD11 ' HB3' ' F' ' 106' ' ' ASN . 29.5 mt -104.87 -45.97 4.42 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 115.987 -0.552 . . . . 0.0 109.941 175.117 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' F' F ' 113' ' ' TYR . . . . . . . . . . . . . 64.5 t80 -138.6 137.42 36.93 Favored 'General case' 0 C--N 1.33 -0.239 0 CA-C-N 115.988 -0.551 . . . . 0.0 110.842 -179.7 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' F' F ' 114' ' ' ARG . . . . . . . . . . . . . 83.4 mtm180 -139.61 122.66 16.77 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.448 -0.342 . . . . 0.0 110.315 176.254 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' F' F ' 115' ' ' GLY . . . . . . . . . . . . . . . -150.05 163.0 29.36 Favored Glycine 0 CA--C 1.526 0.722 0 N-CA-C 111.211 -0.756 . . . . 0.0 111.211 -179.937 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' F' F ' 116' ' ' LYS . . . . . . . . . . . . . 8.0 ttpm? -127.47 139.76 52.6 Favored 'General case' 0 C--N 1.33 -0.248 0 N-CA-C 110.074 -0.343 . . . . 0.0 110.074 178.368 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' F' F ' 117' ' ' PHE . . . . . . . . . . . . . 51.8 m-85 -136.44 113.96 10.95 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 116.397 -0.365 . . . . 0.0 110.054 -178.679 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' F' F ' 118' ' ' GLU . . . . . . . . . . . . . 96.1 mt-10 -55.1 -42.9 73.5 Favored 'General case' 0 C--N 1.33 -0.268 0 C-N-CA 121.0 -0.28 . . . . 0.0 111.13 -176.35 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' F' F ' 119' ' ' ASN . . . . . . . . . . . . . 2.4 m120 -97.97 31.0 2.83 Favored 'General case' 0 C--N 1.33 -0.258 0 N-CA-C 112.096 0.406 . . . . 0.0 112.096 -175.107 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' F' F ' 120' ' ' LEU . . . . . . . . . . . . . 14.8 tp -57.6 119.99 7.54 Favored 'General case' 0 C--N 1.333 -0.139 0 N-CA-C 110.264 -0.273 . . . . 0.0 110.264 178.166 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' F' F ' 121' ' ' ASN . . . . . . . . . . . . . 26.5 m120 -114.0 -43.95 3.2 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-N 116.487 -0.324 . . . . 0.0 110.832 -178.376 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' F' F ' 122' ' ' LYS . . . . . . . . . . . . . 38.3 ttpt -144.76 141.5 29.27 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-O 120.87 0.367 . . . . 0.0 111.28 -176.773 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' F' F ' 123' ' ' VAL . . . . . . . . . . . . . 46.1 t -126.69 127.19 69.9 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.315 0 N-CA-C 109.21 -0.663 . . . . 0.0 109.21 173.255 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' F' F ' 124' ' ' LEU . . . . . . . . . . . . . 16.2 tp -129.08 137.67 51.4 Favored 'General case' 0 C--N 1.331 -0.225 0 CA-C-O 121.034 0.445 . . . . 0.0 111.013 -176.344 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' F' F ' 125' ' ' VAL . . . . . 0.468 HG21 HG21 ' F' ' 94' ' ' VAL . 42.3 t -125.14 131.26 72.67 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.259 0 CA-C-N 115.844 -0.616 . . . . 0.0 109.624 177.864 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' F' F ' 126' ' ' ARG . . . . . . . . . . . . . 57.9 ttt180 -147.45 126.79 13.08 Favored 'General case' 0 C--N 1.329 -0.284 0 N-CA-C 109.46 -0.571 . . . . 0.0 109.46 178.858 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' F' F ' 127' ' ' ASN . . . . . . . . . . . . . 79.7 m-20 56.49 -147.13 0.53 Allowed 'General case' 0 CA--C 1.541 0.61 0 N-CA-C 109.682 -0.488 . . . . 0.0 109.682 -178.033 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' F' F ' 128' ' ' ASP . . . . . . . . . . . . . 24.1 p-10 -87.91 18.15 4.38 Favored 'General case' 0 CA--C 1.537 0.46 0 CA-C-N 118.901 0.773 . . . . 0.0 112.605 178.639 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' F' F ' 129' ' ' LEU . . . . . . . . . . . . . 15.6 tp -113.63 137.35 51.71 Favored 'General case' 0 N--CA 1.461 0.116 0 CA-C-N 117.99 0.359 . . . . 0.0 110.315 178.65 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' F' F ' 130' ' ' VAL . . . . . . . . . . . . . 46.1 t -121.89 135.9 60.53 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.215 0 CA-C-N 116.086 -0.506 . . . . 0.0 109.732 -179.963 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' F' F ' 131' ' ' VAL . . . . . . . . . . . . . 41.4 t -134.8 136.35 52.28 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.264 0 CA-C-O 121.104 0.478 . . . . 0.0 110.697 -179.454 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' F' F ' 132' ' ' ILE . . . . . . . . . . . . . 72.2 mt -116.62 132.93 64.84 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.234 0 CA-C-N 115.667 -0.697 . . . . 0.0 109.49 178.598 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' F' F ' 133' ' ' ILE . . . . . . . . . . . . . 42.7 mm -116.83 122.01 69.02 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.242 0 CA-C-O 120.764 0.316 . . . . 0.0 110.802 -176.629 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' F' F ' 134' ' ' ASP . . . . . . . . . . . . . 7.8 p-10 -133.42 146.23 51.0 Favored 'General case' 0 C--N 1.329 -0.29 0 N-CA-C 109.297 -0.631 . . . . 0.0 109.297 174.338 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' F' F ' 135' ' ' GLU . . . . . . . . . . . . . 84.6 tt0 -50.07 -27.79 6.15 Favored 'General case' 0 C--N 1.328 -0.333 0 N-CA-C 112.645 0.609 . . . . 0.0 112.645 -174.212 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' F' F ' 136' ' ' GLN . . . . . . . . . . . . . 95.7 mt-30 -79.09 -34.65 43.39 Favored 'General case' 0 C--O 1.232 0.174 0 N-CA-C 112.35 0.5 . . . . 0.0 112.35 -176.847 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' F' F ' 137' ' ' LYS . . . . . . . . . . . . . 49.8 pttt -170.06 176.2 4.75 Favored 'General case' 0 C--N 1.331 -0.227 0 CA-C-O 121.489 0.661 . . . . 0.0 112.577 -173.143 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' F' F ' 138' ' ' LEU . . . . . . . . . . . . . 6.7 tt -119.36 130.99 55.63 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 115.107 -0.951 . . . . 0.0 110.111 179.875 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' F' F ' 139' ' ' THR . . . . . . . . . . . . . 39.7 m -111.42 129.67 55.95 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.198 -0.455 . . . . 0.0 110.359 179.412 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' F' F ' 140' ' ' LEU . . . . . 0.468 HD23 ' C ' ' F' ' 140' ' ' LEU . 8.5 tt -113.73 125.42 54.1 Favored 'General case' 0 C--N 1.328 -0.365 0 N-CA-C 109.515 -0.55 . . . . 0.0 109.515 -178.867 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' F' F ' 141' ' ' ILE . . . . . . . . . . . . . 19.0 mt -124.55 125.91 70.91 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.371 0 N-CA-C 109.873 -0.417 . . . . 0.0 109.873 -175.64 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' F' F ' 142' ' ' ARG . . . . . . . . . . . . . 23.4 tpt180 -120.37 135.42 55.03 Favored 'General case' 0 C--N 1.332 -0.193 0 CA-C-N 115.973 -0.558 . . . . 0.0 109.936 -178.458 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' F' F ' 143' ' ' THR . . . . . . . . . . . . . 23.9 p . . . . . 0 C--O 1.22 -0.49 0 CA-C-O 118.025 -0.988 . . . . 0.0 110.485 179.776 . . . . . . . . 0 0 . 1 . 006 nuclear build full ' A' A ' -3' ' ' GLU . . . . . . . . . . . . . 40.5 mp0 . . . . . 0 N--CA 1.491 1.609 0 N-CA-C 109.73 -0.471 . . . . 0.0 109.73 . . . . . . . . . 0 0 . 1 . 006 nuclear build full ' A' A ' -2' ' ' GLY . . . . . . . . . . . . . . . -109.24 123.54 6.93 Favored Glycine 0 CA--C 1.525 0.688 0 N-CA-C 111.318 -0.713 . . . . 0.0 111.318 -178.935 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' -1' ' ' VAL . . . . . . . . . . . . . 45.3 t -97.07 139.63 19.22 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.325 0 CA-C-O 120.789 0.328 . . . . 0.0 110.16 178.892 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 0' ' ' ILE . . . . . . . . . . . . . 69.5 mt -103.14 126.92 57.41 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.288 0 N-CA-C 109.558 -0.534 . . . . 0.0 109.558 178.111 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 26.7 ptm -78.05 157.38 29.59 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.247 -0.433 . . . . 0.0 110.763 -178.546 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 2.9 p -113.91 138.42 50.35 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 116.044 -0.526 . . . . 0.0 110.677 -179.407 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 85.4 tt0 -139.71 139.97 36.7 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.092 -0.503 . . . . 0.0 110.909 -179.333 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 4' ' ' LEU . . . . . . . . . . . . . 22.1 tp -121.74 125.7 47.18 Favored 'General case' 0 C--N 1.332 -0.185 0 CA-C-N 115.781 -0.645 . . . . 0.0 110.065 178.256 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 5' ' ' LYS . . . . . . . . . . . . . 64.7 mttp -101.73 121.24 41.7 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.437 -0.347 . . . . 0.0 110.656 178.923 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 85.8 mt -116.34 145.96 42.8 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 115.622 -0.717 . . . . 0.0 110.574 -179.76 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 82.6 tttt -139.34 135.31 17.05 Favored Pre-proline 0 CA--C 1.533 0.326 0 CA-C-O 118.905 -0.569 . . . . 0.0 109.723 177.01 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 8' ' ' PRO . . . . . . . . . . . . . 96.1 Cg_endo -89.49 142.87 4.35 Favored 'Trans proline' 0 N--CA 1.491 1.333 0 C-N-CA 121.621 1.547 . . . . 0.0 111.728 177.954 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 46.3 mt -77.07 -46.44 2.77 Favored Pre-proline 0 C--N 1.329 -0.317 0 CA-C-O 118.889 -0.577 . . . . 0.0 111.644 -179.374 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 94.8 Cg_endo -82.67 144.87 12.71 Favored 'Trans proline' 0 N--CA 1.493 1.497 0 C-N-CA 121.174 1.249 . . . . 0.0 111.361 172.159 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 64.4 mttp -86.58 100.63 12.55 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-O 121.037 0.446 . . . . 0.0 110.596 178.967 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 11.6 p -137.52 145.36 29.42 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.26 0 CA-C-N 115.762 -0.654 . . . . 0.0 110.022 179.765 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 84.1 tt0 -82.13 116.42 21.69 Favored 'General case' 0 C--N 1.329 -0.299 0 N-CA-C 109.973 -0.38 . . . . 0.0 109.973 178.938 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 14' ' ' LEU . . . . . . . . . . . . . 17.9 mt -92.82 153.18 42.12 Favored Pre-proline 0 C--N 1.33 -0.25 0 CA-C-N 116.224 -0.443 . . . . 0.0 110.864 -176.387 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 15' ' ' PRO . . . . . . . . . . . . . 31.1 Cg_exo -60.22 156.58 39.46 Favored 'Trans proline' 0 N--CA 1.495 1.578 0 C-N-CA 121.314 1.343 . . . . 0.0 111.876 177.744 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 16' ' ' PRO . . . . . . . . . . . . . 38.0 Cg_exo -58.02 -38.07 93.38 Favored 'Trans proline' 0 N--CA 1.497 1.714 0 C-N-CA 121.441 1.427 . . . . 0.0 112.777 -177.681 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 17' ' ' ASP . . . . . . . . . . . . . 18.7 p-10 -89.72 10.51 23.08 Favored 'General case' 0 CA--C 1.535 0.393 0 N-CA-C 113.313 0.857 . . . . 0.0 113.313 -176.482 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 18' ' ' PHE . . . . . . . . . . . . . 44.1 t80 -58.09 -44.58 87.68 Favored 'General case' 0 C--N 1.334 -0.068 0 O-C-N 122.047 -0.408 . . . . 0.0 110.121 -177.624 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 19' ' ' VAL . . . . . . . . . . . . . 47.2 t -57.96 -44.6 87.13 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.318 0 CA-C-N 116.251 -0.431 . . . . 0.0 110.4 -178.647 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 14.7 t70 -59.52 -40.23 86.46 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-O 120.829 0.347 . . . . 0.0 110.75 -177.462 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 47.2 t -64.53 -48.61 84.27 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.304 0 CA-C-N 116.382 -0.372 . . . . 0.0 110.251 -178.514 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 22' ' ' ILE . . . . . 0.541 HG22 HD12 ' A' ' 26' ' ' LEU . 51.5 mm -55.18 -42.26 64.69 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.242 0 CA-C-O 120.833 0.349 . . . . 0.0 110.605 179.441 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 23' ' ' ARG . . . . . . . . . . . . . 54.5 ttp180 -53.89 -53.58 50.6 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.464 -0.335 . . . . 0.0 111.49 179.577 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 24' ' ' ILE . . . . . . . . . . . . . 71.9 mt -61.24 -38.76 80.52 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.335 0 CA-C-N 116.56 -0.291 . . . . 0.0 111.508 -177.18 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 59.9 mmtt -65.88 -40.94 92.07 Favored 'General case' 0 C--N 1.329 -0.311 0 N-CA-C 112.104 0.409 . . . . 0.0 112.104 179.884 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 26' ' ' LEU . . . . . 0.541 HD12 HG22 ' A' ' 22' ' ' ILE . 75.7 mt -78.41 -38.18 42.15 Favored 'General case' 0 C--N 1.33 -0.266 0 N-CA-C 113.312 0.856 . . . . 0.0 113.312 -171.205 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 27' ' ' GLN . . . . . . . . . . . . . 10.0 pt20 -46.99 140.22 5.01 Favored 'General case' 0 N--CA 1.47 0.552 0 N-CA-C 112.732 0.641 . . . . 0.0 112.732 -175.541 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 98.22 -26.08 25.09 Favored Glycine 0 CA--C 1.533 1.18 0 CA-C-N 115.58 -0.737 . . . . 0.0 112.242 -176.194 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 58.6 mtpt -98.07 155.12 17.28 Favored 'General case' 0 C--O 1.232 0.177 0 CA-C-N 117.117 0.458 . . . . 0.0 110.764 179.358 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 30' ' ' THR . . . . . . . . . . . . . 25.9 m -103.3 138.35 40.2 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.293 -0.412 . . . . 0.0 110.021 176.63 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 34.3 m -129.19 150.9 35.06 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.215 0 CA-C-O 121.066 0.46 . . . . 0.0 111.145 -178.179 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 32' ' ' ARG . . . . . . . . . . . . . 83.7 mtt180 -132.64 152.85 51.55 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 115.589 -0.732 . . . . 0.0 110.168 177.492 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 33' ' ' THR . . . . . . . . . . . . . 20.9 m -53.35 137.23 35.73 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.3 -0.409 . . . . 0.0 111.359 -177.685 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 102.06 -16.94 55.21 Favored Glycine 0 CA--C 1.532 1.122 0 CA-C-O 119.655 -0.525 . . . . 0.0 113.386 177.619 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 72.3 m-20 -64.26 148.31 50.48 Favored 'General case' 0 N--CA 1.461 0.112 0 CA-C-N 118.125 0.963 . . . . 0.0 110.987 179.494 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 44.7 t -125.83 133.23 69.54 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.19 0 CA-C-N 116.017 -0.538 . . . . 0.0 110.001 179.52 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 37' ' ' ILE . . . . . . . . . . . . . 68.6 mt -122.43 140.18 47.07 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.255 0 CA-C-N 116.081 -0.509 . . . . 0.0 109.981 179.849 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . -113.17 128.91 8.61 Favored Glycine 0 CA--C 1.527 0.815 0 N-CA-C 110.978 -0.849 . . . . 0.0 110.978 179.485 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 39' ' ' ILE . . . . . . . . . . . . . 71.9 mt -122.97 130.14 74.65 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.2 0 N-CA-C 110.091 -0.337 . . . . 0.0 110.091 179.793 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 40' ' ' SER . . . . . . . . . . . . . 35.8 t -94.58 124.79 38.82 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.483 -0.326 . . . . 0.0 111.007 175.377 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 41' ' ' ILE . . . . . . . . . . . . . 71.9 mt -133.42 123.79 47.34 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.247 0 CA-C-O 120.907 0.384 . . . . 0.0 110.567 177.183 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 10.9 tp 52.51 35.93 19.06 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 115.994 -0.548 . . . . 0.0 111.695 177.319 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . 73.23 28.38 66.31 Favored Glycine 0 CA--C 1.53 1.007 0 C-N-CA 121.169 -0.539 . . . . 0.0 112.46 176.6 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 44' ' ' LYS . . . . . . . . . . . . . 94.5 mttt -134.9 129.98 35.19 Favored 'General case' 0 C--N 1.332 -0.189 0 CA-C-N 117.044 0.422 . . . . 0.0 110.01 177.268 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 68.0 tt0 -86.96 125.78 34.29 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 116.067 -0.515 . . . . 0.0 111.371 -175.8 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 46' ' ' VAL . . . . . . . . . . . . . 7.1 p -125.17 129.77 73.16 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.19 0 CA-C-O 120.926 0.393 . . . . 0.0 110.02 175.744 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 56.5 mmtt -100.53 130.91 46.66 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 115.865 -0.607 . . . . 0.0 111.768 177.896 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 48' ' ' PHE . . . . . . . . . . . . . 93.8 m-85 -113.86 131.89 56.1 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.071 -0.513 . . . . 0.0 109.929 175.022 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 83.1 tttt -106.62 137.76 44.03 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.382 -0.372 . . . . 0.0 110.492 179.357 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 50' ' ' VAL . . . . . . . . . . . . . 44.5 t -81.3 105.98 11.86 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.297 0 N-CA-C 108.991 -0.744 . . . . 0.0 108.991 174.735 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 51' ' ' VAL . . . . . . . . . . . . . 45.6 t -69.54 -48.13 67.95 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.349 0 CA-C-N 116.05 -0.523 . . . . 0.0 110.016 -173.075 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 52' ' ' GLN . . . . . . . . . . . . . 48.0 tt0 -167.89 139.9 3.04 Favored 'General case' 0 C--N 1.328 -0.348 0 C-N-CA 120.362 -0.535 . . . . 0.0 111.651 -177.816 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 53' ' ' ALA . . . . . 0.484 ' HB3' ' OG ' ' A' ' 56' ' ' SER . . . -110.47 131.93 54.62 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 115.839 -0.619 . . . . 0.0 109.882 174.776 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 54' ' ' TYR . . . . . . . . . . . . . 40.7 t80 -129.07 110.66 18.28 Favored Pre-proline 0 CA--C 1.535 0.381 0 CA-C-O 118.292 -0.861 . . . . 0.0 110.546 179.769 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 55' ' ' PRO . . . . . . . . . . . . . 71.7 Cg_endo -77.22 166.96 80.91 Favored 'Cis proline' 0 N--CA 1.5 1.866 0 CA-C-N 121.874 1.705 . . . . 0.0 111.978 -7.102 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 56' ' ' SER . . . . . 0.484 ' OG ' ' HB3' ' A' ' 53' ' ' ALA . 51.3 m -118.02 141.97 30.18 Favored Pre-proline 0 CA--C 1.538 0.519 0 CA-C-O 118.699 -0.667 . . . . 0.0 109.596 174.132 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 57' ' ' PRO . . . . . . . . . . . . . 43.9 Cg_endo -68.96 142.87 70.55 Favored 'Cis proline' 0 N--CA 1.499 1.807 0 CA-C-N 121.484 1.566 . . . . 0.0 111.205 -3.006 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 58' ' ' LEU . . . . . . . . . . . . . 29.7 tp -107.75 136.05 48.14 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-O 120.729 0.3 . . . . 0.0 110.877 -177.849 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 59' ' ' ARG . . . . . . . . . . . . . 66.5 ttt180 -101.79 122.2 43.51 Favored 'General case' 0 C--N 1.326 -0.426 0 N-CA-C 109.099 -0.704 . . . . 0.0 109.099 175.919 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 43.9 t -76.18 120.88 27.03 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.263 0 C-N-CA 120.68 -0.408 . . . . 0.0 110.639 -173.964 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 43.7 mt-10 -131.04 165.38 23.34 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 115.954 -0.566 . . . . 0.0 109.838 175.181 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 62' ' ' ASP . . . . . . . . . . . . . 9.5 p-10 -55.51 -32.55 62.97 Favored 'General case' 0 C--N 1.329 -0.311 0 N-CA-C 111.89 0.33 . . . . 0.0 111.89 -177.289 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 63' ' ' ARG . . . . . . . . . . . . . 24.3 ptt180 -79.76 -4.4 51.79 Favored 'General case' 0 CA--C 1.536 0.441 0 N-CA-C 113.753 1.02 . . . . 0.0 113.753 -174.945 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 24.6 m -75.08 136.07 41.18 Favored 'General case' 0 C--N 1.333 -0.118 0 CA-C-N 118.118 0.417 . . . . 0.0 110.453 -177.943 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 65' ' ' LYS . . . . . . . . . . . . . 3.0 mptp? -88.35 128.12 35.5 Favored 'General case' 0 C--N 1.328 -0.329 0 N-CA-C 109.689 -0.486 . . . . 0.0 109.689 -179.86 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 66' ' ' ILE . . . . . . . . . . . . . 59.2 mt -112.03 131.96 62.01 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.244 0 N-CA-C 109.807 -0.442 . . . . 0.0 109.807 -179.223 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 67' ' ' THR . . . . . . . . . . . . . 27.5 m -123.95 137.15 54.66 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.138 -0.483 . . . . 0.0 110.744 -179.142 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 68' ' ' LEU . . . . . . . . . . . . . 3.6 tt -103.89 120.28 40.68 Favored 'General case' 0 C--N 1.329 -0.302 0 N-CA-C 109.37 -0.604 . . . . 0.0 109.37 178.072 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 69' ' ' VAL . . . . . . . . . . . . . 41.0 t -100.13 130.83 48.71 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.273 0 CA-C-O 120.98 0.419 . . . . 0.0 111.021 -174.683 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 70' ' ' THR . . . . . . . . . . . . . 10.1 p -146.88 178.63 8.18 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 115.746 -0.661 . . . . 0.0 110.387 177.514 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 71' ' ' HIS . . . . . . . . . . . . . 91.7 m-70 -122.52 85.68 48.48 Favored Pre-proline 0 CA--C 1.532 0.274 0 CA-C-N 116.42 -0.355 . . . . 0.0 110.589 -179.741 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 72' ' ' PRO . . . . . . . . . . . . . 84.0 Cg_endo -87.35 160.09 8.23 Favored 'Trans proline' 0 N--CA 1.492 1.405 0 C-N-CA 121.762 1.642 . . . . 0.0 112.717 -179.366 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 73' ' ' VAL . . . . . . . . . . . . . 28.7 m -114.95 170.28 5.25 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.245 0 CA-C-N 116.095 -0.502 . . . . 0.0 110.101 177.469 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 74' ' ' ASP . . . . . . . . . . . . . 40.5 t0 -95.22 116.58 28.94 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 116.359 -0.382 . . . . 0.0 110.11 -178.192 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 44.8 t -112.52 121.64 65.24 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.211 0 CA-C-O 121.081 0.467 . . . . 0.0 110.259 179.961 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 76' ' ' LEU . . . . . . . . . . . . . 35.1 mt -125.42 140.59 52.66 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 115.571 -0.74 . . . . 0.0 109.539 179.381 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 77' ' ' GLU . . . . . . . . . . . . . 96.8 mt-10 -133.94 143.96 48.52 Favored 'General case' 0 C--N 1.332 -0.185 0 CA-C-O 121.153 0.501 . . . . 0.0 111.622 -177.166 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 78' ' ' ALA . . . . . . . . . . . . . . . -130.62 133.64 46.32 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 115.435 -0.802 . . . . 0.0 109.886 175.574 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 79' ' ' LYS . . . . . 0.564 ' O ' HD13 ' A' ' 80' ' ' ILE . 36.6 ttpt -82.26 117.83 22.66 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.358 -0.383 . . . . 0.0 110.634 -178.019 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 80' ' ' ILE . . . . . 0.564 HD13 ' O ' ' A' ' 79' ' ' LYS . 42.7 mm -139.06 113.07 7.1 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.285 0 N-CA-C 109.156 -0.683 . . . . 0.0 109.156 -178.142 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 81' ' ' LYS . . . . . . . . . . . . . 6.3 mtmp? -100.5 124.69 46.37 Favored 'General case' 0 C--N 1.327 -0.409 0 CA-C-O 120.913 0.387 . . . . 0.0 111.116 -176.637 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . 89.25 42.05 5.66 Favored Glycine 0 CA--C 1.525 0.691 0 C-N-CA 120.961 -0.638 . . . . 0.0 111.642 176.259 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 83' ' ' ILE . . . . . . . . . . . . . 74.9 mt -68.06 132.58 32.6 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.309 0 N-CA-C 109.575 -0.528 . . . . 0.0 109.575 176.694 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 84' ' ' LYS . . . . . . . . . . . . . 39.6 ttpt -95.05 -53.41 3.82 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-O 120.986 0.422 . . . . 0.0 110.365 -177.96 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 85' ' ' ASP . . . . . . . . . . . . . 7.9 t70 -149.69 151.87 34.39 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 115.944 -0.571 . . . . 0.0 110.696 -179.131 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 86' ' ' VAL . . . . . . . . . . . . . 44.1 t -130.67 131.65 64.66 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.267 0 CA-C-N 116.339 -0.392 . . . . 0.0 110.305 179.444 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 87' ' ' ILE . . . . . 0.499 HD12 ' N ' ' A' ' 87' ' ' ILE . 5.1 mp -118.47 126.1 74.86 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.273 0 N-CA-C 109.564 -0.532 . . . . 0.0 109.564 177.027 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 88' ' ' LEU . . . . . . . . . . . . . 15.7 tp -109.79 130.41 55.52 Favored 'General case' 0 C--N 1.332 -0.191 0 CA-C-N 116.34 -0.391 . . . . 0.0 110.687 -178.534 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 89' ' ' ASP . . . . . . . . . . . . . 9.8 t70 -125.88 156.94 38.86 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 116.107 -0.497 . . . . 0.0 109.964 179.091 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 84.8 tt0 -46.48 -38.24 8.94 Favored 'General case' 0 C--N 1.33 -0.248 0 N-CA-C 113.088 0.773 . . . . 0.0 113.088 -172.068 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 91' ' ' ASN . . . . . . . . . . . . . 2.7 t-20 -132.06 20.99 4.49 Favored 'General case' 0 N--CA 1.47 0.532 0 N-CA-C 112.925 0.713 . . . . 0.0 112.925 -177.518 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 92' ' ' LEU . . . . . . . . . . . . . 28.4 mt -149.55 147.71 28.5 Favored 'General case' 0 C--N 1.331 -0.225 0 CA-C-O 120.78 0.324 . . . . 0.0 110.617 -175.938 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 93' ' ' ILE . . . . . . . . . . . . . 70.1 mt -126.22 119.47 54.21 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.264 0 N-CA-C 109.197 -0.668 . . . . 0.0 109.197 176.538 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 94' ' ' VAL . . . . . . . . . . . . . 44.1 t -120.11 127.77 75.91 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.253 0 N-CA-C 109.957 -0.386 . . . . 0.0 109.957 -179.275 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 95' ' ' VAL . . . . . . . . . . . . . 45.9 t -123.32 134.58 65.86 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.208 0 CA-C-N 116.082 -0.508 . . . . 0.0 109.939 -179.433 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 96' ' ' ILE . . . . . . . . . . . . . 63.4 mt -116.86 128.03 74.34 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.284 0 N-CA-C 109.434 -0.58 . . . . 0.0 109.434 -179.726 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 97' ' ' THR . . . . . . . . . . . . . 75.3 p -100.36 155.57 17.73 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-O 121.214 0.531 . . . . 0.0 111.286 -177.501 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 98' ' ' GLU . . . . . . . . . . . . . 84.9 tt0 -53.94 -25.84 22.48 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-N 115.954 -0.566 . . . . 0.0 112.34 179.851 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 99' ' ' GLU . . . . . . . . . . . . . 34.4 tt0 -80.41 17.95 0.99 Allowed 'General case' 0 CA--C 1.54 0.594 0 N-CA-C 112.553 0.575 . . . . 0.0 112.553 -177.164 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 100' ' ' ASN . . . . . . . . . . . . . 3.5 m-20 63.11 36.44 12.2 Favored 'General case' 0 CA--C 1.53 0.174 0 O-C-N 121.931 -0.481 . . . . 0.0 111.221 176.077 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 101' ' ' GLU . . . . . . . . . . . . . 84.8 tt0 -116.72 142.88 46.33 Favored 'General case' 0 C--N 1.332 -0.189 0 CA-C-N 116.318 -0.401 . . . . 0.0 109.942 175.788 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 102' ' ' VAL . . . . . . . . . . . . . 45.0 t -117.11 126.55 74.53 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.262 0 CA-C-N 116.193 -0.458 . . . . 0.0 109.947 -178.06 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 103' ' ' LEU . . . . . 0.407 HD12 ' N ' ' A' ' 103' ' ' LEU . 6.3 mp -118.43 133.73 55.64 Favored 'General case' 0 C--N 1.331 -0.227 0 CA-C-N 116.045 -0.525 . . . . 0.0 110.283 176.759 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 104' ' ' ILE . . . . . . . . . . . . . 70.4 mt -121.27 122.6 67.82 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.235 0 CA-C-N 116.542 -0.299 . . . . 0.0 110.21 -179.045 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 105' ' ' PHE . . . . . . . . . . . . . 39.0 m-85 -123.41 164.52 18.72 Favored 'General case' 0 C--N 1.332 -0.173 0 O-C-N 123.839 0.712 . . . . 0.0 109.809 179.754 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 106' ' ' ASN . . . . . . . . . . . . . 41.7 p-10 -97.55 -169.9 1.92 Allowed 'General case' 0 C--N 1.33 -0.254 0 N-CA-C 109.989 -0.374 . . . . 0.0 109.989 174.315 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 107' ' ' GLN . . . . . . . . . . . . . 27.5 tt0 -60.2 -27.29 67.04 Favored 'General case' 0 CA--C 1.533 0.308 0 N-CA-C 112.002 0.371 . . . . 0.0 112.002 177.925 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 108' ' ' ASN . . . . . . . . . . . . . 10.2 t-20 -81.87 4.21 23.23 Favored 'General case' 0 CA--C 1.536 0.419 0 N-CA-C 113.232 0.827 . . . . 0.0 113.232 -178.95 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 109' ' ' LEU . . . . . . . . . . . . . 12.5 tp 61.03 38.26 17.38 Favored 'General case' 0 C--O 1.234 0.26 0 CA-C-O 120.973 0.415 . . . . 0.0 111.072 179.109 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 110' ' ' GLU . . . . . . . . . . . . . 95.2 mt-10 -111.16 149.89 30.26 Favored 'General case' 0 C--N 1.332 -0.189 0 CA-C-N 116.539 -0.3 . . . . 0.0 110.332 177.086 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 111' ' ' GLU . . . . . . . . . . . . . 98.4 mt-10 -73.12 125.04 26.78 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-O 120.977 0.418 . . . . 0.0 111.48 -178.823 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 112' ' ' LEU . . . . . . . . . . . . . 21.7 mt -109.95 -45.95 3.55 Favored 'General case' 0 C--N 1.331 -0.221 0 CA-C-N 115.819 -0.628 . . . . 0.0 109.917 174.669 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 113' ' ' TYR . . . . . . . . . . . . . 63.7 t80 -141.55 142.55 33.52 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 115.877 -0.601 . . . . 0.0 110.608 178.782 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 114' ' ' ARG . . . . . . . . . . . . . 33.8 ptt-85 -149.14 124.07 9.99 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-O 121.059 0.457 . . . . 0.0 110.789 177.325 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 115' ' ' GLY . . . . . . . . . . . . . . . -150.11 163.03 29.38 Favored Glycine 0 CA--C 1.524 0.636 0 N-CA-C 110.964 -0.854 . . . . 0.0 110.964 -179.12 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 116' ' ' LYS . . . . . . . . . . . . . 34.5 ttmt -130.07 134.98 47.74 Favored 'General case' 0 C--N 1.33 -0.244 0 N-CA-C 110.088 -0.338 . . . . 0.0 110.088 177.928 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 117' ' ' PHE . . . . . 0.425 ' HE2' HD13 ' A' ' 132' ' ' ILE . 33.4 m-85 -130.93 117.39 19.17 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.403 -0.362 . . . . 0.0 110.297 -175.711 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 118' ' ' GLU . . . . . . . . . . . . . 48.9 mp0 -56.08 -43.37 77.95 Favored 'General case' 0 C--N 1.328 -0.352 0 C-N-CA 120.759 -0.376 . . . . 0.0 111.104 -175.025 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 119' ' ' ASN . . . . . . . . . . . . . 71.1 m-80 -100.26 31.08 3.52 Favored 'General case' 0 C--N 1.329 -0.299 0 N-CA-C 112.259 0.466 . . . . 0.0 112.259 -172.737 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 120' ' ' LEU . . . . . . . . . . . . . 11.1 tp -55.82 120.76 7.86 Favored 'General case' 0 C--O 1.232 0.138 0 C-N-CA 121.078 -0.249 . . . . 0.0 110.491 177.199 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 121' ' ' ASN . . . . . . . . . . . . . 33.1 m120 -114.02 -44.06 3.19 Favored 'General case' 0 N--CA 1.463 0.205 0 CA-C-N 116.654 -0.248 . . . . 0.0 111.035 -176.793 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 122' ' ' LYS . . . . . . . . . . . . . 89.0 mttt -143.58 144.89 32.12 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-O 120.942 0.401 . . . . 0.0 111.352 -177.628 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 123' ' ' VAL . . . . . . . . . . . . . 45.7 t -130.53 131.17 65.18 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.27 0 N-CA-C 109.387 -0.597 . . . . 0.0 109.387 175.27 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 124' ' ' LEU . . . . . . . . . . . . . 10.1 tp -131.43 136.27 47.84 Favored 'General case' 0 C--N 1.331 -0.199 0 CA-C-O 120.824 0.345 . . . . 0.0 111.151 -176.857 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 125' ' ' VAL . . . . . . . . . . . . . 45.0 t -127.58 129.96 70.38 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.232 0 CA-C-N 116.059 -0.519 . . . . 0.0 109.751 177.061 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 126' ' ' ARG . . . . . . . . . . . . . 63.0 ttm-85 -141.63 124.73 16.32 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-O 120.944 0.402 . . . . 0.0 110.603 179.851 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 127' ' ' ASN . . . . . . . . . . . . . 23.1 m120 50.58 -109.79 0.42 Allowed 'General case' 0 CA--C 1.545 0.754 0 CA-C-O 118.832 -0.604 . . . . 0.0 111.293 179.738 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 128' ' ' ASP . . . . . . . . . . . . . 9.9 p-10 -114.08 8.67 17.09 Favored 'General case' 0 N--CA 1.469 0.516 0 CA-C-N 119.875 1.216 . . . . 0.0 113.158 -179.124 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 129' ' ' LEU . . . . . . . . . . . . . 18.1 tp -107.75 134.99 49.92 Favored 'General case' 0 C--N 1.332 -0.166 0 CA-C-N 117.956 0.344 . . . . 0.0 110.123 179.643 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 130' ' ' VAL . . . . . . . . . . . . . 44.0 t -116.69 132.69 65.64 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.253 0 N-CA-C 109.583 -0.525 . . . . 0.0 109.583 179.617 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 131' ' ' VAL . . . . . . . . . . . . . 40.7 t -132.89 133.99 58.55 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.253 0 CA-C-O 121.034 0.445 . . . . 0.0 110.474 -179.258 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 132' ' ' ILE . . . . . 0.425 HD13 ' HE2' ' A' ' 117' ' ' PHE . 74.6 mt -118.45 130.66 72.99 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 CA-C-N 115.72 -0.673 . . . . 0.0 109.204 177.718 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 133' ' ' ILE . . . . . . . . . . . . . 40.0 mm -116.68 123.39 71.6 Favored 'Isoleucine or valine' 0 C--O 1.234 0.262 0 CA-C-O 120.933 0.397 . . . . 0.0 111.071 -174.228 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 134' ' ' ASP . . . . . . . . . . . . . 6.8 p-10 -136.45 146.33 46.23 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-N 116.006 -0.543 . . . . 0.0 109.557 175.227 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 135' ' ' GLU . . . . . . . . . . . . . 38.9 tp10 -50.32 -27.94 7.04 Favored 'General case' 0 C--N 1.328 -0.36 0 N-CA-C 112.598 0.592 . . . . 0.0 112.598 -173.592 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 136' ' ' GLN . . . . . . . . . . . . . 97.8 mt-30 -76.04 -37.23 58.59 Favored 'General case' 0 C--O 1.234 0.246 0 N-CA-C 112.34 0.496 . . . . 0.0 112.34 -177.903 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 137' ' ' LYS . . . . . . . . . . . . . 47.5 pttt -168.02 175.0 6.93 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-O 121.607 0.718 . . . . 0.0 112.19 -171.593 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 138' ' ' LEU . . . . . 0.412 ' C ' HD23 ' A' ' 138' ' ' LEU . 6.3 tt -118.94 128.57 54.54 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 115.13 -0.941 . . . . 0.0 110.039 179.247 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 139' ' ' THR . . . . . 0.403 ' N ' HD23 ' A' ' 138' ' ' LEU . 31.5 m -108.03 126.02 52.24 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.285 -0.416 . . . . 0.0 110.291 179.885 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 140' ' ' LEU . . . . . . . . . . . . . 36.5 tp -113.04 122.95 49.13 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 115.722 -0.672 . . . . 0.0 109.305 -179.364 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 141' ' ' ILE . . . . . . . . . . . . . 19.0 mt -121.84 119.82 59.81 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 CA-C-O 120.955 0.407 . . . . 0.0 110.052 -174.411 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 142' ' ' ARG . . . . . . . . . . . . . 54.8 mtp180 -105.09 123.22 47.44 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 115.583 -0.735 . . . . 0.0 110.165 178.856 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 143' ' ' THR . . . . . . . . . . . . . 31.8 p . . . . . 0 C--O 1.221 -0.446 0 CA-C-O 117.98 -1.01 . . . . 0.0 110.515 -179.672 . . . . . . . . 0 0 . 1 . 006 nuclear build full ' B' B ' -3' ' ' GLU . . . . . . . . . . . . . 70.5 mm-40 . . . . . 0 N--CA 1.49 1.526 0 N-CA-C 109.428 -0.582 . . . . 0.0 109.428 . . . . . . . . . 0 0 . 1 . 006 nuclear build full ' B' B ' -2' ' ' GLY . . . . . . . . . . . . . . . -72.27 146.26 38.98 Favored Glycine 0 CA--C 1.526 0.774 0 N-CA-C 110.912 -0.875 . . . . 0.0 110.912 179.825 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' -1' ' ' VAL . . . . . . . . . . . . . 43.3 t -141.41 137.15 32.8 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.299 0 N-CA-C 110.095 -0.335 . . . . 0.0 110.095 179.381 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 0' ' ' ILE . . . . . . . . . . . . . 44.7 mm -113.92 136.25 50.99 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.273 0 CA-C-N 116.258 -0.428 . . . . 0.0 110.088 179.376 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 1' ' ' MET . . . . . . . . . . . . . 23.7 ptm -81.14 133.04 35.39 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.065 -0.516 . . . . 0.0 110.916 -178.46 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 2' ' ' SER . . . . . . . . . . . . . 13.5 p -118.97 136.26 54.19 Favored 'General case' 0 C--O 1.233 0.197 0 CA-C-N 116.308 -0.405 . . . . 0.0 110.9 -179.668 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 3' ' ' GLU . . . . . . . . . . . . . 46.9 mp0 -140.65 147.37 39.21 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.181 -0.463 . . . . 0.0 111.33 -178.746 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 4' ' ' LEU . . . . . . . . . . . . . 17.8 tp -127.02 127.71 45.19 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 115.702 -0.681 . . . . 0.0 109.947 174.718 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 5' ' ' LYS . . . . . . . . . . . . . 92.5 mttt -109.51 121.23 44.72 Favored 'General case' 0 C--O 1.234 0.27 0 CA-C-O 120.815 0.34 . . . . 0.0 110.855 178.919 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 6' ' ' LEU . . . . . . . . . . . . . 58.1 mt -115.08 147.24 40.44 Favored 'General case' 0 C--N 1.331 -0.211 0 CA-C-N 115.375 -0.83 . . . . 0.0 110.716 -179.097 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 7' ' ' LYS . . . . . . . . . . . . . 69.5 tttt -134.89 138.02 28.63 Favored Pre-proline 0 CA--C 1.534 0.355 0 CA-C-O 118.955 -0.545 . . . . 0.0 109.989 175.78 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 8' ' ' PRO . . . . . . . . . . . . . 75.1 Cg_endo -90.06 139.67 3.16 Favored 'Trans proline' 0 N--CA 1.489 1.249 0 C-N-CA 121.7 1.6 . . . . 0.0 111.574 178.213 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 9' ' ' LEU . . . . . . . . . . . . . 26.8 mt -77.27 -51.91 1.91 Allowed Pre-proline 0 CA--C 1.531 0.239 0 CA-C-O 119.138 -0.458 . . . . 0.0 111.313 -177.488 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 10' ' ' PRO . . . . . . . . . . . . . 71.7 Cg_endo -76.56 149.86 31.03 Favored 'Trans proline' 0 N--CA 1.497 1.682 0 C-N-CA 121.156 1.238 . . . . 0.0 111.399 170.671 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 11' ' ' LYS . . . . . . . . . . . . . 25.1 pttm -84.91 117.02 23.66 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-O 121.45 0.643 . . . . 0.0 110.61 178.254 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 12' ' ' VAL . . . . . . . . . . . . . 12.8 p -151.06 148.04 15.2 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 CA-C-N 115.653 -0.703 . . . . 0.0 110.493 -179.44 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 13' ' ' GLU . . . . . . . . . . . . . 84.7 tt0 -91.03 125.5 35.84 Favored 'General case' 0 C--N 1.329 -0.321 0 N-CA-C 110.034 -0.358 . . . . 0.0 110.034 177.827 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 14' ' ' LEU . . . . . . . . . . . . . 28.2 mt -97.87 149.86 36.17 Favored Pre-proline 0 CA--C 1.533 0.291 0 CA-C-N 116.357 -0.383 . . . . 0.0 110.718 -176.583 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 15' ' ' PRO . . . . . . . . . . . . . 24.0 Cg_exo -63.69 161.28 32.75 Favored 'Trans proline' 0 N--CA 1.497 1.689 0 C-N-CA 121.402 1.401 . . . . 0.0 111.866 175.648 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 16' ' ' PRO . . . . . . . . . . . . . 27.4 Cg_exo -60.35 -35.64 90.42 Favored 'Trans proline' 0 N--CA 1.498 1.745 0 C-N-CA 121.451 1.434 . . . . 0.0 112.789 -178.535 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 17' ' ' ASP . . . . . . . . . . . . . 9.4 p-10 -89.13 8.07 31.85 Favored 'General case' 0 CA--C 1.536 0.426 0 N-CA-C 113.245 0.831 . . . . 0.0 113.245 -177.428 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 18' ' ' PHE . . . . . . . . . . . . . 47.5 t80 -58.27 -44.97 88.67 Favored 'General case' 0 C--N 1.334 -0.108 0 O-C-N 122.041 -0.412 . . . . 0.0 110.031 -178.017 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 19' ' ' VAL . . . . . 0.407 HG13 ' N ' ' B' ' 20' ' ' ASP . 13.8 p -55.66 -41.27 64.19 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.36 0 CA-C-N 116.283 -0.417 . . . . 0.0 111.058 -178.984 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' B' B ' 20' ' ' ASP . . . . . 0.407 ' N ' HG13 ' B' ' 19' ' ' VAL . 75.6 m-20 -60.9 -43.49 98.44 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-O 120.951 0.405 . . . . 0.0 110.888 -178.154 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' B' B ' 21' ' ' VAL . . . . . . . . . . . . . 47.4 t -65.07 -46.39 91.46 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.281 0 CA-C-N 116.331 -0.395 . . . . 0.0 110.555 -177.556 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 22' ' ' ILE . . . . . 0.626 HG22 HD12 ' B' ' 26' ' ' LEU . 50.9 mm -55.15 -46.52 77.68 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.259 0 CA-C-O 120.817 0.341 . . . . 0.0 110.645 179.483 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' B' B ' 23' ' ' ARG . . . . . . . . . . . . . 26.8 ttm-85 -53.65 -54.08 42.87 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-O 121.16 0.505 . . . . 0.0 111.385 -179.727 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 24' ' ' ILE . . . . . . . . . . . . . 77.3 mt -60.66 -36.72 72.47 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.373 0 CA-C-N 115.61 -0.723 . . . . 0.0 111.581 -173.675 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 25' ' ' LYS . . . . . . . . . . . . . 57.5 mttm -70.71 -42.86 70.07 Favored 'General case' 0 C--N 1.33 -0.281 0 N-CA-C 112.551 0.574 . . . . 0.0 112.551 179.781 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 26' ' ' LEU . . . . . 0.626 HD12 HG22 ' B' ' 22' ' ' ILE . 34.3 mt -77.75 -35.84 51.34 Favored 'General case' 0 C--N 1.331 -0.23 0 N-CA-C 113.15 0.796 . . . . 0.0 113.15 -170.748 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' B' B ' 27' ' ' GLN . . . . . . . . . . . . . 18.4 pt20 -46.97 140.91 4.44 Favored 'General case' 0 N--CA 1.468 0.462 0 N-CA-C 112.747 0.647 . . . . 0.0 112.747 -175.808 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 28' ' ' GLY . . . . . . . . . . . . . . . 99.96 -24.79 30.76 Favored Glycine 0 CA--C 1.534 1.223 0 CA-C-N 115.624 -0.716 . . . . 0.0 112.261 -176.733 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 29' ' ' LYS . . . . . . . . . . . . . 47.2 mtmt -98.24 155.15 17.32 Favored 'General case' 0 C--N 1.332 -0.187 0 CA-C-N 117.339 0.57 . . . . 0.0 111.269 179.64 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 30' ' ' THR . . . . . . . . . . . . . 38.9 m -107.19 138.48 43.3 Favored 'General case' 0 C--N 1.331 -0.209 0 CA-C-N 115.914 -0.585 . . . . 0.0 109.901 176.62 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 31' ' ' VAL . . . . . . . . . . . . . 34.1 m -131.72 155.89 42.09 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.206 0 CA-C-O 120.99 0.424 . . . . 0.0 111.551 -176.866 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 32' ' ' ARG . . . . . . . . . . . . . 36.3 mtp180 -129.28 152.69 48.57 Favored 'General case' 0 C--O 1.233 0.236 0 CA-C-N 115.667 -0.697 . . . . 0.0 110.688 176.802 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 33' ' ' THR . . . . . . . . . . . . . 24.6 m -53.57 139.71 30.77 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.203 -0.453 . . . . 0.0 111.253 -179.075 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 34' ' ' GLY . . . . . . . . . . . . . . . 99.43 -17.13 58.18 Favored Glycine 0 CA--C 1.532 1.109 0 CA-C-O 119.486 -0.619 . . . . 0.0 113.304 177.69 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 35' ' ' ASP . . . . . . . . . . . . . 76.1 m-20 -65.09 148.25 52.0 Favored 'General case' 0 C--O 1.232 0.178 0 CA-C-N 118.116 0.958 . . . . 0.0 110.97 179.346 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 36' ' ' VAL . . . . . . . . . . . . . 45.7 t -122.52 131.52 73.05 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.241 0 CA-C-N 115.969 -0.559 . . . . 0.0 109.85 178.58 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 37' ' ' ILE . . . . . . . . . . . . . 66.7 mt -118.68 138.52 49.12 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 CA-C-N 116.128 -0.487 . . . . 0.0 109.89 -179.462 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 38' ' ' GLY . . . . . . . . . . . . . . . -109.83 128.69 9.02 Favored Glycine 0 CA--C 1.526 0.757 0 N-CA-C 110.871 -0.892 . . . . 0.0 110.871 179.5 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 39' ' ' ILE . . . . . . . . . . . . . 71.7 mt -124.62 131.46 72.67 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.246 0 N-CA-C 110.047 -0.353 . . . . 0.0 110.047 179.437 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 40' ' ' SER . . . . . . . . . . . . . 31.5 t -92.86 119.99 32.75 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.332 -0.395 . . . . 0.0 110.675 175.819 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 41' ' ' ILE . . . . . . . . . . . . . 70.4 mt -131.54 119.99 44.23 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.202 0 N-CA-C 110.223 -0.288 . . . . 0.0 110.223 178.418 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 42' ' ' LEU . . . . . . . . . . . . . 30.1 mt 56.87 33.83 23.8 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.227 -0.442 . . . . 0.0 111.84 178.729 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 43' ' ' GLY . . . . . . . . . . . . . . . 81.05 -10.13 49.78 Favored Glycine 0 CA--C 1.535 1.302 0 C-N-CA 121.24 -0.505 . . . . 0.0 113.584 176.482 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 44' ' ' LYS . . . . . . . . . . . . . 93.4 mttt -100.03 134.43 42.96 Favored 'General case' 0 C--N 1.333 -0.126 0 CA-C-N 117.821 0.81 . . . . 0.0 110.188 177.563 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 45' ' ' GLU . . . . . . . . . . . . . 85.0 tt0 -85.71 130.5 34.55 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 116.213 -0.449 . . . . 0.0 111.217 -179.815 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 46' ' ' VAL . . . . . . . . . . . . . 7.3 p -124.46 129.85 73.73 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.211 0 N-CA-C 109.605 -0.517 . . . . 0.0 109.605 175.714 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 47' ' ' LYS . . . . . . . . . . . . . 79.9 mttt -101.08 130.75 47.16 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.006 -0.543 . . . . 0.0 111.171 177.674 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 48' ' ' PHE . . . . . . . . . . . . . 93.5 m-85 -112.46 132.0 55.28 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 116.478 -0.328 . . . . 0.0 110.131 176.102 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 49' ' ' LYS . . . . . . . . . . . . . 68.5 tttt -106.04 135.54 47.3 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.352 -0.386 . . . . 0.0 110.398 179.123 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 50' ' ' VAL . . . . . . . . . . . . . 43.4 t -81.96 110.18 16.92 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.243 0 N-CA-C 109.435 -0.58 . . . . 0.0 109.435 177.001 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 51' ' ' VAL . . . . . . . . . . . . . 47.5 t -75.53 -47.04 35.63 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.295 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.092 -173.964 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 52' ' ' GLN . . . . . . . . . . . . . 62.8 tt0 -160.83 137.26 8.57 Favored 'General case' 0 C--N 1.332 -0.186 0 C-N-CA 120.165 -0.614 . . . . 0.0 112.193 -177.917 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 53' ' ' ALA . . . . . . . . . . . . . . . -112.51 130.35 56.03 Favored 'General case' 0 C--N 1.331 -0.211 0 CA-C-N 115.741 -0.663 . . . . 0.0 109.312 172.295 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 54' ' ' TYR . . . . . . . . . . . . . 47.4 t80 -129.05 110.22 18.26 Favored Pre-proline 0 C--N 1.328 -0.341 0 CA-C-O 118.22 -0.895 . . . . 0.0 110.689 -178.342 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 55' ' ' PRO . . . . . . . . . . . . . 72.8 Cg_endo -77.31 170.11 72.23 Favored 'Cis proline' 0 N--CA 1.5 1.909 0 CA-C-N 121.949 1.732 . . . . 0.0 112.22 -6.177 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 56' ' ' SER . . . . . . . . . . . . . 13.7 m -116.24 135.88 22.91 Favored Pre-proline 0 CA--C 1.539 0.536 0 CA-C-O 118.491 -0.766 . . . . 0.0 109.329 175.143 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 57' ' ' PRO . . . . . . . . . . . . . 53.1 Cg_endo -70.34 145.57 81.06 Favored 'Cis proline' 0 N--CA 1.498 1.755 0 CA-C-N 121.795 1.677 . . . . 0.0 111.452 -1.546 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 58' ' ' LEU . . . . . . . . . . . . . 29.2 tp -108.34 138.3 44.85 Favored 'General case' 0 C--N 1.331 -0.225 0 CA-C-N 116.271 -0.422 . . . . 0.0 110.866 -177.865 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 59' ' ' ARG . . . . . . . . . . . . . 55.7 ttt180 -103.52 127.05 50.99 Favored 'General case' 0 C--N 1.328 -0.333 0 N-CA-C 109.341 -0.614 . . . . 0.0 109.341 174.543 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 60' ' ' VAL . . . . . . . . . . . . . 42.2 t -82.2 117.27 27.88 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.285 0 C-N-CA 120.74 -0.384 . . . . 0.0 110.327 -176.486 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 61' ' ' GLU . . . . . . . . . . . . . 77.5 tt0 -131.2 156.83 44.68 Favored 'General case' 0 C--N 1.329 -0.302 0 N-CA-C 109.12 -0.696 . . . . 0.0 109.12 176.158 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 62' ' ' ASP . . . . . . . . . . . . . 5.6 t70 -50.11 -30.99 12.24 Favored 'General case' 0 C--N 1.328 -0.363 0 N-CA-C 112.223 0.453 . . . . 0.0 112.223 -178.987 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 63' ' ' ARG . . . . . . . . . . . . . 20.5 mtp-105 -72.12 -22.08 61.38 Favored 'General case' 0 CA--C 1.533 0.311 0 N-CA-C 113.063 0.764 . . . . 0.0 113.063 -176.398 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 64' ' ' THR . . . . . . . . . . . . . 27.1 m -69.55 144.05 53.21 Favored 'General case' 0 C--N 1.331 -0.209 0 CA-C-O 120.92 0.39 . . . . 0.0 111.122 -174.989 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 65' ' ' LYS . . . . . . . . . . . . . 85.1 mttt -89.18 130.08 35.66 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.062 -0.517 . . . . 0.0 110.126 178.739 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 66' ' ' ILE . . . . . . . . . . . . . 67.6 mt -115.53 131.94 66.4 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.223 0 N-CA-C 109.886 -0.413 . . . . 0.0 109.886 -179.762 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 67' ' ' THR . . . . . . . . . . . . . 32.7 m -127.54 140.44 52.13 Favored 'General case' 0 C--N 1.331 -0.225 0 CA-C-O 121.232 0.539 . . . . 0.0 110.999 -178.235 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 68' ' ' LEU . . . . . . . . . . . . . 41.5 mt -101.51 130.25 47.74 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 115.768 -0.651 . . . . 0.0 109.978 177.349 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 69' ' ' VAL . . . . . . . . . . . . . 43.5 t -99.42 130.54 48.26 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.319 0 CA-C-N 116.359 -0.382 . . . . 0.0 110.1 -179.829 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 70' ' ' THR . . . . . . . . . . . . . 7.1 m -134.82 118.03 16.56 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.429 178.84 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 71' ' ' HIS . . . . . . . . . . . . . 39.9 m80 -148.72 151.51 35.66 Favored Pre-proline 0 C--N 1.329 -0.3 0 CA-C-N 116.052 -0.522 . . . . 0.0 109.957 178.848 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 72' ' ' PRO . . . . . . . . . . . . . 90.0 Cg_endo -81.26 -30.03 1.73 Allowed 'Trans proline' 0 N--CA 1.493 1.492 0 C-N-CA 121.254 1.303 . . . . 0.0 112.465 -179.198 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 73' ' ' VAL . . . . . . . . . . . . . 27.7 m -151.43 161.94 3.15 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.282 0 CA-C-O 120.874 0.368 . . . . 0.0 110.488 177.923 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 74' ' ' ASP . . . . . . . . . . . . . 31.9 t0 -102.88 116.96 33.57 Favored 'General case' 0 C--N 1.33 -0.27 0 N-CA-C 109.467 -0.568 . . . . 0.0 109.467 176.867 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 75' ' ' VAL . . . . . 0.492 ' C ' HD12 ' B' ' 76' ' ' LEU . 42.1 t -114.04 124.41 70.67 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.26 0 CA-C-O 121.057 0.456 . . . . 0.0 110.704 -176.148 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' B' B ' 76' ' ' LEU . . . . . 0.492 HD12 ' C ' ' B' ' 75' ' ' VAL . 7.3 mp -122.39 144.25 49.15 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 115.71 -0.677 . . . . 0.0 109.841 175.864 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' B' B ' 77' ' ' GLU . . . . . . . . . . . . . 97.7 mt-10 -134.6 130.28 36.24 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-O 121.07 0.462 . . . . 0.0 110.837 -178.887 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 78' ' ' ALA . . . . . 0.646 ' HB2' HD21 ' B' ' 109' ' ' LEU . . . -117.68 128.24 54.72 Favored 'General case' 0 C--N 1.331 -0.221 0 CA-C-N 115.8 -0.636 . . . . 0.0 109.938 177.966 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' B' B ' 79' ' ' LYS . . . . . 0.648 ' O ' HD13 ' B' ' 80' ' ' ILE . 49.0 tptt -75.65 118.75 18.81 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.306 -0.406 . . . . 0.0 110.62 -177.37 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' B' B ' 80' ' ' ILE . . . . . 0.648 HD13 ' O ' ' B' ' 79' ' ' LYS . 38.1 mm -139.11 106.24 2.84 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.325 0 N-CA-C 109.278 -0.638 . . . . 0.0 109.278 -177.588 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' B' B ' 81' ' ' LYS . . . . . . . . . . . . . 86.1 mttt -93.56 126.85 38.94 Favored 'General case' 0 C--N 1.328 -0.368 0 C-N-CA 120.709 -0.397 . . . . 0.0 111.086 -178.636 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 82' ' ' GLY . . . . . . . . . . . . . . . 89.04 42.14 5.7 Favored Glycine 0 CA--C 1.525 0.71 0 C-N-CA 120.811 -0.709 . . . . 0.0 111.839 174.092 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 83' ' ' ILE . . . . . . . . . . . . . 71.6 mt -70.28 131.46 34.22 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.312 0 N-CA-C 109.339 -0.615 . . . . 0.0 109.339 176.128 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 84' ' ' LYS . . . . . . . . . . . . . 38.5 ttpt -99.05 -43.99 6.47 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.568 -0.287 . . . . 0.0 110.389 -178.272 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 85' ' ' ASP . . . . . . . . . . . . . 9.7 t70 -155.48 154.26 31.56 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.356 -0.384 . . . . 0.0 110.792 179.348 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 86' ' ' VAL . . . . . . . . . . . . . 44.5 t -132.93 134.36 58.2 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.183 0 CA-C-O 120.959 0.409 . . . . 0.0 110.502 -179.476 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 87' ' ' ILE . . . . . . . . . . . . . 44.3 mm -121.03 128.47 76.07 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.274 0 CA-C-N 115.798 -0.637 . . . . 0.0 109.593 178.7 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 88' ' ' LEU . . . . . . . . . . . . . 17.4 tp -115.17 133.19 56.26 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-O 120.985 0.421 . . . . 0.0 111.116 -178.04 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 89' ' ' ASP . . . . . . . . . . . . . 7.0 t70 -127.42 159.9 33.08 Favored 'General case' 0 C--N 1.332 -0.17 0 CA-C-N 115.898 -0.592 . . . . 0.0 109.574 176.822 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 90' ' ' GLU . . . . . . . . . . . . . 96.3 mt-10 -47.15 -38.07 11.04 Favored 'General case' 0 C--N 1.33 -0.272 0 N-CA-C 113.2 0.815 . . . . 0.0 113.2 -171.009 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 91' ' ' ASN . . . . . . . . . . . . . 13.6 p-10 -132.04 20.69 4.5 Favored 'General case' 0 N--CA 1.468 0.442 0 N-CA-C 113.038 0.755 . . . . 0.0 113.038 -176.736 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 92' ' ' LEU . . . . . . . . . . . . . 57.5 mt -149.01 146.93 28.0 Favored 'General case' 0 C--N 1.331 -0.204 0 CA-C-O 120.767 0.318 . . . . 0.0 110.64 -177.038 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 93' ' ' ILE . . . . . . . . . . . . . 67.1 mt -123.89 119.86 58.08 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.291 0 N-CA-C 109.236 -0.653 . . . . 0.0 109.236 178.231 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 94' ' ' VAL . . . . . . . . . . . . . 44.7 t -118.76 128.28 75.64 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.257 0 N-CA-C 109.829 -0.434 . . . . 0.0 109.829 -179.076 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 95' ' ' VAL . . . . . . . . . . . . . 42.6 t -121.73 134.1 66.08 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.304 0 CA-C-N 116.138 -0.483 . . . . 0.0 109.829 -179.882 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 96' ' ' ILE . . . . . . . . . . . . . 63.7 mt -115.13 127.1 72.82 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.21 0 N-CA-C 109.411 -0.589 . . . . 0.0 109.411 179.95 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 97' ' ' THR . . . . . . . . . . . . . 66.4 p -102.6 157.71 16.75 Favored 'General case' 0 C--N 1.331 -0.222 0 CA-C-O 121.394 0.616 . . . . 0.0 111.376 -176.74 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 98' ' ' GLU . . . . . . . . . . . . . 84.0 tt0 -53.9 -25.54 20.61 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 115.867 -0.606 . . . . 0.0 112.317 179.834 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 99' ' ' GLU . . . . . . . . . . . . . 45.8 mp0 -77.69 14.37 1.06 Allowed 'General case' 0 CA--C 1.535 0.403 0 N-CA-C 113.161 0.8 . . . . 0.0 113.161 -177.206 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 100' ' ' ASN . . . . . . . . . . . . . 3.2 m-20 62.32 38.04 13.45 Favored 'General case' 0 CA--C 1.529 0.169 0 CA-C-O 121.05 0.453 . . . . 0.0 110.747 178.699 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 101' ' ' GLU . . . . . . . . . . . . . 84.7 tt0 -120.61 141.76 50.03 Favored 'General case' 0 C--N 1.332 -0.163 0 CA-C-N 116.098 -0.501 . . . . 0.0 109.75 177.214 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 102' ' ' VAL . . . . . . . . . . . . . 44.9 t -114.97 127.63 72.45 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.297 0 CA-C-N 116.331 -0.395 . . . . 0.0 109.972 -178.297 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 103' ' ' LEU . . . . . . . . . . . . . 6.7 mp -117.25 132.83 56.54 Favored 'General case' 0 C--N 1.331 -0.227 0 CA-C-N 115.763 -0.653 . . . . 0.0 110.273 176.988 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 104' ' ' ILE . . . . . 0.556 HD13 HG21 ' B' ' 130' ' ' VAL . 67.3 mt -118.24 121.69 67.79 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.24 0 CA-C-N 116.037 -0.529 . . . . 0.0 110.031 179.662 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' B' B ' 105' ' ' PHE . . . . . . . . . . . . . 56.7 m-85 -120.37 161.72 20.71 Favored 'General case' 0 C--N 1.331 -0.219 0 O-C-N 123.98 0.8 . . . . 0.0 109.651 178.64 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 106' ' ' ASN . . . . . . . . . . . . . 44.2 p-10 -93.97 -169.95 2.2 Favored 'General case' 0 C--N 1.33 -0.249 0 N-CA-C 110.053 -0.351 . . . . 0.0 110.053 175.019 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 107' ' ' GLN . . . . . . . . . . . . . 61.4 tt0 -58.91 -30.03 67.51 Favored 'General case' 0 C--N 1.33 -0.258 0 N-CA-C 111.876 0.324 . . . . 0.0 111.876 179.333 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 108' ' ' ASN . . . . . . . . . . . . . 3.0 t-20 -83.66 7.94 15.96 Favored 'General case' 0 CA--C 1.536 0.406 0 N-CA-C 113.193 0.812 . . . . 0.0 113.193 -177.274 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 109' ' ' LEU . . . . . 0.646 HD21 ' HB2' ' B' ' 78' ' ' ALA . 12.0 tp 60.78 37.66 18.64 Favored 'General case' 0 C--O 1.232 0.181 0 CA-C-O 120.962 0.41 . . . . 0.0 111.211 179.074 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' B' B ' 110' ' ' GLU . . . . . . . . . . . . . 95.4 mt-10 -107.34 151.24 25.76 Favored 'General case' 0 C--N 1.331 -0.238 0 N-CA-C 109.925 -0.398 . . . . 0.0 109.925 176.174 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 111' ' ' GLU . . . . . . . . . . . . . 84.8 tt0 -82.01 123.24 28.73 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-O 120.939 0.399 . . . . 0.0 111.175 -175.626 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 112' ' ' LEU . . . . . . . . . . . . . 33.7 mt -108.36 -46.0 3.79 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 115.933 -0.576 . . . . 0.0 110.481 177.443 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 113' ' ' TYR . . . . . . . . . . . . . 60.5 t80 -140.61 137.68 33.84 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.163 -0.471 . . . . 0.0 110.921 -179.053 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 114' ' ' ARG . . . . . . . . . . . . . 56.9 ttp180 -147.0 124.98 12.0 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-O 120.991 0.424 . . . . 0.0 110.386 175.866 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 115' ' ' GLY . . . . . . . . . . . . . . . -150.15 156.53 26.78 Favored Glycine 0 CA--C 1.526 0.737 0 N-CA-C 110.95 -0.86 . . . . 0.0 110.95 179.164 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 116' ' ' LYS . . . . . . . . . . . . . 35.0 ttpt -118.69 138.45 52.62 Favored 'General case' 0 C--O 1.233 0.189 0 CA-C-O 120.73 0.3 . . . . 0.0 110.288 179.18 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 117' ' ' PHE . . . . . . . . . . . . . 24.0 m-85 -135.78 114.07 11.53 Favored 'General case' 0 C--N 1.329 -0.299 0 N-CA-C 109.733 -0.469 . . . . 0.0 109.733 -178.973 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 118' ' ' GLU . . . . . . . . . . . . . 96.3 mt-10 -54.97 -42.22 72.12 Favored 'General case' 0 C--N 1.329 -0.29 0 C-N-CA 120.874 -0.33 . . . . 0.0 111.223 -176.234 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 119' ' ' ASN . . . . . . . . . . . . . 2.5 m120 -97.32 31.13 2.58 Favored 'General case' 0 C--N 1.33 -0.257 0 N-CA-C 112.148 0.425 . . . . 0.0 112.148 -174.97 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 120' ' ' LEU . . . . . . . . . . . . . 18.7 tp -57.13 121.85 11.03 Favored 'General case' 0 C--N 1.332 -0.174 0 N-CA-C 110.278 -0.268 . . . . 0.0 110.278 177.253 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 121' ' ' ASN . . . . . . . . . . . . . 57.9 m-20 -113.98 -44.17 3.18 Favored 'General case' 0 C--N 1.332 -0.186 0 CA-C-N 116.667 -0.242 . . . . 0.0 111.309 -176.766 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 122' ' ' LYS . . . . . . . . . . . . . 98.3 mttt -146.67 149.76 34.09 Favored 'General case' 0 C--O 1.232 0.171 0 C-N-CA 120.442 -0.503 . . . . 0.0 112.008 -177.951 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 123' ' ' VAL . . . . . . . . . . . . . 48.8 t -119.41 127.78 75.85 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.218 0 CA-C-N 115.697 -0.683 . . . . 0.0 109.163 174.326 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 124' ' ' LEU . . . . . . . . . . . . . 31.6 mt -120.89 136.01 55.04 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 116.531 -0.304 . . . . 0.0 110.633 -176.255 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 125' ' ' VAL . . . . . . . . . . . . . 42.6 t -131.1 131.45 63.84 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.264 0 CA-C-N 116.306 -0.406 . . . . 0.0 110.266 179.121 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 126' ' ' ARG . . . . . . . . . . . . . 27.7 mtp180 -151.55 129.73 11.93 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.113 -0.494 . . . . 0.0 109.842 176.619 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 127' ' ' ASN . . . . . . . . . . . . . 32.5 t30 56.2 -152.45 0.38 Allowed 'General case' 0 CA--C 1.54 0.565 0 N-CA-C 109.7 -0.481 . . . . 0.0 109.7 -179.119 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 128' ' ' ASP . . . . . . . . . . . . . 15.9 p-10 -83.6 18.04 2.03 Favored 'General case' 0 CA--C 1.537 0.45 0 CA-C-N 118.526 0.603 . . . . 0.0 112.562 177.558 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 129' ' ' LEU . . . . . . . . . . . . . 41.1 mt -115.24 144.92 42.99 Favored 'General case' 0 C--O 1.232 0.179 0 CA-C-N 117.956 0.344 . . . . 0.0 110.24 179.69 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 130' ' ' VAL . . . . . 0.556 HG21 HD13 ' B' ' 104' ' ' ILE . 32.3 m -129.31 143.21 41.89 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.232 0 CA-C-O 120.93 0.395 . . . . 0.0 110.6 -178.512 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' B' B ' 131' ' ' VAL . . . . . 0.587 HG22 HD12 ' B' ' 140' ' ' LEU . 38.0 t -136.1 141.34 41.87 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.254 0 CA-C-O 121.079 0.466 . . . . 0.0 110.551 -178.844 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' B' B ' 132' ' ' ILE . . . . . . . . . . . . . 74.1 mt -118.39 131.38 71.34 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.262 0 CA-C-N 115.805 -0.634 . . . . 0.0 109.396 178.726 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 133' ' ' ILE . . . . . . . . . . . . . 41.8 mm -117.11 125.12 73.75 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.235 0 CA-C-O 120.785 0.326 . . . . 0.0 111.158 -174.035 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 134' ' ' ASP . . . . . . . . . . . . . 9.7 p-10 -136.09 148.01 48.09 Favored 'General case' 0 C--N 1.332 -0.167 0 N-CA-C 109.514 -0.55 . . . . 0.0 109.514 172.89 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 135' ' ' GLU . . . . . . . . . . . . . 44.3 tp10 -49.92 -27.26 5.02 Favored 'General case' 0 C--N 1.326 -0.45 0 N-CA-C 112.873 0.694 . . . . 0.0 112.873 -172.668 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 136' ' ' GLN . . . . . . . . . . . . . 53.8 mt-30 -85.23 -30.46 23.82 Favored 'General case' 0 C--N 1.33 -0.24 0 N-CA-C 112.694 0.627 . . . . 0.0 112.694 -175.113 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 137' ' ' LYS . . . . . . . . . . . . . 22.9 pttm -167.62 171.18 10.44 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-O 121.518 0.675 . . . . 0.0 112.483 -173.024 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 138' ' ' LEU . . . . . 0.406 HD23 ' N ' ' B' ' 139' ' ' THR . 6.4 tt -121.11 130.02 53.56 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 115.059 -0.973 . . . . 0.0 110.164 -178.521 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' B' B ' 139' ' ' THR . . . . . 0.406 ' N ' HD23 ' B' ' 138' ' ' LEU . 29.2 m -109.57 125.38 52.47 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-N 116.26 -0.427 . . . . 0.0 110.291 178.593 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' B' B ' 140' ' ' LEU . . . . . 0.587 HD12 HG22 ' B' ' 131' ' ' VAL . 15.0 tp -114.24 119.24 36.35 Favored 'General case' 0 C--N 1.328 -0.328 0 N-CA-C 109.412 -0.588 . . . . 0.0 109.412 -178.015 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' B' B ' 141' ' ' ILE . . . . . 0.518 ' HB ' HG23 ' B' ' 130' ' ' VAL . 22.1 mt -120.08 121.18 65.2 Favored 'Isoleucine or valine' 0 C--O 1.234 0.248 0 CA-C-O 121.067 0.461 . . . . 0.0 110.217 -175.731 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' B' B ' 142' ' ' ARG . . . . . . . . . . . . . 85.3 mtm180 -107.13 127.23 53.31 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 115.219 -0.9 . . . . 0.0 110.435 -178.748 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 143' ' ' THR . . . . . . . . . . . . . 76.5 p . . . . . 0 C--O 1.22 -0.472 0 CA-C-O 117.976 -1.011 . . . . 0.0 110.537 179.778 . . . . . . . . 0 0 . 1 . 006 nuclear build full ' C' C ' -3' ' ' GLU . . . . . . . . . . . . . 70.5 mm-40 . . . . . 0 N--CA 1.49 1.537 0 N-CA-C 109.408 -0.59 . . . . 0.0 109.408 . . . . . . . . . 0 0 . 1 . 006 nuclear build full ' C' C ' -2' ' ' GLY . . . . . . . . . . . . . . . -67.31 147.61 49.12 Favored Glycine 0 CA--C 1.524 0.654 0 N-CA-C 110.875 -0.89 . . . . 0.0 110.875 179.984 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' C' C ' -1' ' ' VAL . . . . . . . . . . . . . 44.8 t -96.43 131.85 42.2 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.248 0 CA-C-O 120.868 0.366 . . . . 0.0 110.093 -179.925 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' C' C ' 0' ' ' ILE . . . . . . . . . . . . . 70.8 mt -119.02 127.88 75.82 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.265 0 CA-C-N 116.123 -0.49 . . . . 0.0 109.892 179.379 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' C' C ' 1' ' ' MET . . . . . . . . . . . . . 26.6 ptt? -93.36 133.61 36.44 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.241 -0.436 . . . . 0.0 110.325 179.156 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' C' C ' 2' ' ' SER . . . . . . . . . . . . . 5.7 p -110.41 132.32 54.28 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-O 121.071 0.463 . . . . 0.0 110.818 -178.297 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' C' C ' 3' ' ' GLU . . . . . . . . . . . . . 85.1 tt0 -142.12 140.44 32.48 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 115.801 -0.636 . . . . 0.0 111.001 -179.832 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' C' C ' 4' ' ' LEU . . . . . 0.438 HD21 HD21 ' C' ' 6' ' ' LEU . 15.9 tp -121.89 126.53 48.9 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 115.887 -0.597 . . . . 0.0 110.093 177.171 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' C' C ' 5' ' ' LYS . . . . . . . . . . . . . 99.0 mttt -104.64 121.0 42.65 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.414 -0.357 . . . . 0.0 110.572 178.577 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' C' C ' 6' ' ' LEU . . . . . 0.438 HD21 HD21 ' C' ' 4' ' ' LEU . 75.7 mt -116.63 148.71 40.71 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 115.43 -0.804 . . . . 0.0 110.284 -178.959 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' C' C ' 7' ' ' LYS . . . . . . . . . . . . . 64.2 tttm -133.18 136.04 26.68 Favored Pre-proline 0 CA--C 1.534 0.365 0 CA-C-O 118.929 -0.558 . . . . 0.0 109.91 177.084 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' C' C ' 8' ' ' PRO . . . . . . . . . . . . . 84.7 Cg_endo -90.61 140.64 3.07 Favored 'Trans proline' 0 N--CA 1.491 1.365 0 C-N-CA 121.716 1.611 . . . . 0.0 111.571 178.063 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' C' C ' 9' ' ' LEU . . . . . . . . . . . . . 68.6 mt -75.13 -47.53 4.55 Favored Pre-proline 0 CA--C 1.534 0.345 0 CA-C-O 118.712 -0.661 . . . . 0.0 112.311 -178.689 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' C' C ' 10' ' ' PRO . . . . . . . . . . . . . 91.4 Cg_endo -81.49 152.57 17.76 Favored 'Trans proline' 0 N--CA 1.497 1.715 0 C-N-CA 121.312 1.341 . . . . 0.0 111.987 176.038 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' C' C ' 11' ' ' LYS . . . . . . . . . . . . . 50.0 tttm -89.23 102.2 14.86 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.426 -0.352 . . . . 0.0 110.373 178.282 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' C' C ' 12' ' ' VAL . . . . . . . . . . . . . 12.8 p -147.36 145.7 18.89 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.359 0 CA-C-N 116.313 -0.403 . . . . 0.0 110.802 -179.461 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' C' C ' 13' ' ' GLU . . . . . . . . . . . . . 39.6 mt-10 -83.72 122.15 28.25 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.324 -0.398 . . . . 0.0 109.99 175.613 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' C' C ' 14' ' ' LEU . . . . . . . . . . . . . 27.4 mt -94.68 153.92 40.08 Favored Pre-proline 0 C--N 1.329 -0.288 0 CA-C-N 116.456 -0.338 . . . . 0.0 110.83 -177.699 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' C' C ' 15' ' ' PRO . . . . . . . . . . . . . 36.0 Cg_exo -58.35 154.96 37.84 Favored 'Trans proline' 0 N--CA 1.495 1.588 0 C-N-CA 121.268 1.312 . . . . 0.0 111.724 178.576 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' C' C ' 16' ' ' PRO . . . . . . . . . . . . . 34.2 Cg_exo -57.85 -33.61 97.21 Favored 'Trans proline' 0 N--CA 1.497 1.701 0 C-N-CA 121.483 1.455 . . . . 0.0 112.817 -179.098 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' C' C ' 17' ' ' ASP . . . . . . . . . . . . . 20.8 p-10 -90.1 8.79 30.98 Favored 'General case' 0 CA--C 1.536 0.41 0 N-CA-C 113.45 0.907 . . . . 0.0 113.45 -176.671 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' C' C ' 18' ' ' PHE . . . . . . . . . . . . . 35.4 t80 -58.4 -45.8 87.65 Favored 'General case' 0 N--CA 1.457 -0.094 0 O-C-N 121.972 -0.455 . . . . 0.0 110.122 -177.212 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' C' C ' 19' ' ' VAL . . . . . 0.408 HG13 ' N ' ' C' ' 20' ' ' ASP . 14.2 p -56.51 -41.33 72.47 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.411 0 CA-C-N 116.269 -0.423 . . . . 0.0 110.889 -178.916 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' C' C ' 20' ' ' ASP . . . . . 0.408 ' N ' HG13 ' C' ' 19' ' ' VAL . 68.8 m-20 -60.73 -42.83 98.09 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-O 120.83 0.348 . . . . 0.0 111.076 -178.191 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' C' C ' 21' ' ' VAL . . . . . . . . . . . . . 48.7 t -64.44 -48.52 84.78 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.32 0 CA-C-N 116.311 -0.404 . . . . 0.0 110.403 -177.566 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' C' C ' 22' ' ' ILE . . . . . 0.438 HG22 HD12 ' C' ' 26' ' ' LEU . 48.8 mm -55.73 -46.37 79.64 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.221 0 CA-C-O 120.869 0.366 . . . . 0.0 110.738 -179.742 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' C' C ' 23' ' ' ARG . . . . . . . . . . . . . 59.9 ttp180 -53.48 -51.7 61.91 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-O 120.777 0.323 . . . . 0.0 111.566 -178.719 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' C' C ' 24' ' ' ILE . . . . . . . . . . . . . 74.9 mt -60.12 -41.42 86.49 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.269 0 CA-C-N 116.6 -0.273 . . . . 0.0 111.214 -176.631 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' C' C ' 25' ' ' LYS . . . . . . . . . . . . . 53.6 mmtt -63.78 -39.97 95.54 Favored 'General case' 0 C--N 1.328 -0.33 0 N-CA-C 112.107 0.41 . . . . 0.0 112.107 -179.948 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' C' C ' 26' ' ' LEU . . . . . 0.438 HD12 HG22 ' C' ' 22' ' ' ILE . 87.7 mt -78.48 -41.12 33.47 Favored 'General case' 0 C--N 1.33 -0.252 0 N-CA-C 113.539 0.94 . . . . 0.0 113.539 -170.715 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' C' C ' 27' ' ' GLN . . . . . . . . . . . . . 17.4 pt20 -47.24 139.85 5.85 Favored 'General case' 0 N--CA 1.469 0.509 0 N-CA-C 112.75 0.648 . . . . 0.0 112.75 -174.237 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' C' C ' 28' ' ' GLY . . . . . . . . . . . . . . . 99.33 -26.75 23.12 Favored Glycine 0 CA--C 1.532 1.127 0 CA-C-N 115.633 -0.712 . . . . 0.0 112.217 -177.723 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' C' C ' 29' ' ' LYS . . . . . . . . . . . . . 98.9 mttt -98.51 155.06 17.45 Favored 'General case' 0 C--O 1.232 0.181 0 CA-C-N 117.273 0.536 . . . . 0.0 111.254 179.662 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' C' C ' 30' ' ' THR . . . . . . . . . . . . . 23.5 m -103.88 137.3 42.08 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-N 115.957 -0.565 . . . . 0.0 110.092 176.392 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' C' C ' 31' ' ' VAL . . . . . . . . . . . . . 34.8 m -130.51 154.07 40.01 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.245 0 CA-C-O 120.947 0.403 . . . . 0.0 110.971 -178.523 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' C' C ' 32' ' ' ARG . . . . . . . . . . . . . 95.6 mtt180 -130.11 151.58 50.49 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 116.013 -0.539 . . . . 0.0 110.466 178.502 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' C' C ' 33' ' ' THR . . . . . . . . . . . . . 29.3 m -53.4 139.25 31.07 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-O 120.851 0.358 . . . . 0.0 111.225 -178.314 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' C' C ' 34' ' ' GLY . . . . . . . . . . . . . . . 100.63 -17.05 57.14 Favored Glycine 0 CA--C 1.532 1.136 0 CA-C-O 119.671 -0.516 . . . . 0.0 113.244 179.732 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' C' C ' 35' ' ' ASP . . . . . . . . . . . . . 64.4 m-20 -65.65 150.81 47.85 Favored 'General case' 0 C--O 1.231 0.089 0 CA-C-N 118.028 0.914 . . . . 0.0 110.891 178.461 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' C' C ' 36' ' ' VAL . . . . . . . . . . . . . 43.7 t -124.38 133.61 68.89 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.188 0 CA-C-N 116.044 -0.526 . . . . 0.0 110.027 179.056 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' C' C ' 37' ' ' ILE . . . . . . . . . . . . . 69.9 mt -119.98 139.73 46.35 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.25 0 CA-C-N 116.087 -0.506 . . . . 0.0 109.842 179.882 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' C' C ' 38' ' ' GLY . . . . . . . . . . . . . . . -114.22 128.73 8.37 Favored Glycine 0 CA--C 1.526 0.727 0 N-CA-C 111.214 -0.754 . . . . 0.0 111.214 -179.82 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' C' C ' 39' ' ' ILE . . . . . . . . . . . . . 70.8 mt -125.34 130.84 72.84 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.267 0 N-CA-C 109.791 -0.448 . . . . 0.0 109.791 178.371 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' C' C ' 40' ' ' SER . . . . . . . . . . . . . 31.3 t -93.18 113.95 26.32 Favored 'General case' 0 C--N 1.33 -0.24 0 C-N-CA 120.747 -0.381 . . . . 0.0 110.817 176.185 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' C' C ' 41' ' ' ILE . . . . . . . . . . . . . 43.9 mm -123.82 121.79 63.12 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.204 0 CA-C-N 116.484 -0.326 . . . . 0.0 110.237 -179.413 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' C' C ' 42' ' ' LEU . . . . . . . . . . . . . 72.4 mt 57.68 35.33 25.51 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-N 116.349 -0.387 . . . . 0.0 111.8 177.118 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' C' C ' 43' ' ' GLY . . . . . . . . . . . . . . . 78.3 -10.18 30.01 Favored Glycine 0 CA--C 1.533 1.169 0 C-N-CA 121.178 -0.534 . . . . 0.0 113.449 177.248 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' C' C ' 44' ' ' LYS . . . . . . . . . . . . . 68.7 mttm -100.24 131.71 46.02 Favored 'General case' 0 C--N 1.333 -0.125 0 CA-C-N 118.016 0.908 . . . . 0.0 110.078 176.51 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' C' C ' 45' ' ' GLU . . . . . . . . . . . . . 31.5 tp10 -84.37 127.02 33.75 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.396 -0.366 . . . . 0.0 110.459 -179.905 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' C' C ' 46' ' ' VAL . . . . . . . . . . . . . 7.6 p -121.09 128.15 76.0 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.243 0 CA-C-O 121.116 0.484 . . . . 0.0 109.807 178.36 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' C' C ' 47' ' ' LYS . . . . . . . . . . . . . 62.8 mttp -100.57 130.66 46.66 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 115.903 -0.59 . . . . 0.0 111.459 178.058 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' C' C ' 48' ' ' PHE . . . . . . . . . . . . . 94.9 m-85 -113.95 131.95 56.13 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 115.915 -0.584 . . . . 0.0 109.873 176.023 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' C' C ' 49' ' ' LYS . . . . . . . . . . . . . 84.4 tttt -106.53 136.53 46.14 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.471 -0.331 . . . . 0.0 110.518 179.975 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' C' C ' 50' ' ' VAL . . . . . . . . . . . . . 43.6 t -80.99 109.3 15.21 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.302 0 N-CA-C 109.311 -0.626 . . . . 0.0 109.311 177.252 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' C' C ' 51' ' ' VAL . . . . . . . . . . . . . 47.9 t -73.96 -47.55 42.24 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.39 0 CA-C-N 116.148 -0.478 . . . . 0.0 110.11 -173.781 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' C' C ' 52' ' ' GLN . . . . . . . . . . . . . 61.9 tt0 -163.86 139.43 6.31 Favored 'General case' 0 C--N 1.331 -0.222 0 C-N-CA 120.218 -0.593 . . . . 0.0 111.912 -177.724 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' C' C ' 53' ' ' ALA . . . . . 0.421 ' HB1' ' HB2' ' C' ' 58' ' ' LEU . . . -112.94 133.67 54.8 Favored 'General case' 0 C--N 1.332 -0.195 0 CA-C-N 115.66 -0.7 . . . . 0.0 109.853 175.445 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' C' C ' 54' ' ' TYR . . . . . . . . . . . . . 48.9 t80 -129.08 111.14 18.33 Favored Pre-proline 0 CA--C 1.536 0.415 0 CA-C-O 118.172 -0.918 . . . . 0.0 110.456 179.263 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' C' C ' 55' ' ' PRO . . . . . . . . . . . . . 72.5 Cg_endo -77.17 168.09 77.89 Favored 'Cis proline' 0 N--CA 1.497 1.726 0 CA-C-N 121.883 1.708 . . . . 0.0 112.213 -6.24 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' C' C ' 56' ' ' SER . . . . . . . . . . . . . 48.1 m -117.32 136.5 23.48 Favored Pre-proline 0 CA--C 1.539 0.525 0 CA-C-O 118.518 -0.754 . . . . 0.0 109.683 174.652 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' C' C ' 57' ' ' PRO . . . . . . . . . . . . . 36.8 Cg_endo -66.95 145.99 73.87 Favored 'Cis proline' 0 N--CA 1.499 1.795 0 CA-C-N 121.822 1.687 . . . . 0.0 111.383 -3.473 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' C' C ' 58' ' ' LEU . . . . . 0.421 ' HB2' ' HB1' ' C' ' 53' ' ' ALA . 20.6 tp -107.76 136.17 47.95 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.505 -0.316 . . . . 0.0 110.699 -177.796 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' C' C ' 59' ' ' ARG . . . . . . . . . . . . . 71.3 ttt180 -104.58 124.42 49.29 Favored 'General case' 0 C--N 1.328 -0.355 0 N-CA-C 109.247 -0.649 . . . . 0.0 109.247 175.462 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' C' C ' 60' ' ' VAL . . . . . . . . . . . . . 42.3 t -79.73 126.23 39.14 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.251 0 C-N-CA 120.663 -0.415 . . . . 0.0 110.492 -174.459 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' C' C ' 61' ' ' GLU . . . . . . . . . . . . . 96.4 mt-10 -131.05 160.97 33.07 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 115.712 -0.676 . . . . 0.0 109.967 178.507 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' C' C ' 62' ' ' ASP . . . . . . . . . . . . . 11.7 t70 -53.76 -32.49 52.49 Favored 'General case' 0 C--N 1.328 -0.363 0 N-CA-C 111.822 0.304 . . . . 0.0 111.822 -179.154 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' C' C ' 63' ' ' ARG . . . . . . . . . . . . . 38.0 ptt180 -88.38 6.19 38.55 Favored 'General case' 0 CA--C 1.537 0.447 0 N-CA-C 113.688 0.996 . . . . 0.0 113.688 -175.616 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' C' C ' 64' ' ' THR . . . . . . . . . . . . . 38.2 m -81.12 142.51 33.22 Favored 'General case' 0 C--N 1.331 -0.2 0 CA-C-N 118.03 0.377 . . . . 0.0 110.549 -179.404 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' C' C ' 65' ' ' LYS . . . . . . . . . . . . . 68.4 mttm -89.26 129.9 35.75 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.237 179.543 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' C' C ' 66' ' ' ILE . . . . . . . . . . . . . 64.7 mt -116.93 130.1 72.4 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.217 0 N-CA-C 109.758 -0.46 . . . . 0.0 109.758 178.86 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' C' C ' 67' ' ' THR . . . . . . . . . . . . . 36.0 m -126.47 140.23 52.63 Favored 'General case' 0 C--N 1.331 -0.22 0 CA-C-O 121.069 0.461 . . . . 0.0 111.065 -177.119 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' C' C ' 68' ' ' LEU . . . . . 0.551 ' CD2' HG23 ' C' ' 70' ' ' THR . 6.4 tt -101.72 123.03 45.02 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 115.763 -0.653 . . . . 0.0 109.446 176.562 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' C' C ' 69' ' ' VAL . . . . . . . . . . . . . 40.4 t -96.22 106.05 17.85 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.309 0 CA-C-O 121.009 0.433 . . . . 0.0 110.944 -175.365 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' C' C ' 70' ' ' THR . . . . . 0.551 HG23 ' CD2' ' C' ' 68' ' ' LEU . 5.9 p -141.55 169.61 17.29 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 115.559 -0.746 . . . . 0.0 109.63 175.806 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' C' C ' 71' ' ' HIS . . . . . . . . . . . . . 21.6 m80 -127.45 64.19 61.78 Favored Pre-proline 0 CA--C 1.537 0.472 0 CA-C-O 120.653 0.263 . . . . 0.0 111.241 179.016 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' C' C ' 72' ' ' PRO . . . . . . . . . . . . . 63.6 Cg_endo -92.74 153.97 2.82 Favored 'Trans proline' 0 N--CA 1.49 1.305 0 C-N-CA 121.875 1.716 . . . . 0.0 111.289 172.447 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' C' C ' 73' ' ' VAL . . . . . . . . . . . . . 18.7 m -92.79 132.51 36.86 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.26 0 CA-C-O 121.201 0.524 . . . . 0.0 110.541 177.706 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' C' C ' 74' ' ' ASP . . . . . . . . . . . . . 13.7 t0 -97.52 123.72 41.49 Favored 'General case' 0 C--N 1.326 -0.417 0 CA-C-N 115.508 -0.769 . . . . 0.0 109.34 178.262 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' C' C ' 75' ' ' VAL . . . . . 0.478 ' C ' HD12 ' C' ' 76' ' ' LEU . 42.1 t -112.65 121.23 64.56 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.257 0 CA-C-O 121.187 0.518 . . . . 0.0 110.621 -176.221 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' C' C ' 76' ' ' LEU . . . . . 0.478 HD12 ' C ' ' C' ' 75' ' ' VAL . 7.6 mp -119.09 141.32 48.87 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 115.58 -0.737 . . . . 0.0 109.496 175.673 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' C' C ' 77' ' ' GLU . . . . . . . . . . . . . 46.3 mt-10 -132.23 137.0 47.38 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-O 121.059 0.457 . . . . 0.0 110.994 -178.515 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' C' C ' 78' ' ' ALA . . . . . 0.584 ' HB2' HD21 ' C' ' 109' ' ' LEU . . . -127.39 135.68 50.81 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 115.727 -0.67 . . . . 0.0 109.889 177.152 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' C' C ' 79' ' ' LYS . . . . . 0.6 ' O ' HD13 ' C' ' 80' ' ' ILE . 54.9 pttt -83.85 120.87 26.58 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-O 121.31 0.576 . . . . 0.0 110.932 -178.516 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' C' C ' 80' ' ' ILE . . . . . 0.6 HD13 ' O ' ' C' ' 79' ' ' LYS . 39.6 mm -139.18 115.92 10.34 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.274 0 CA-C-N 115.738 -0.665 . . . . 0.0 109.359 -177.769 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' C' C ' 81' ' ' LYS . . . . . . . . . . . . . 99.3 mttt -101.09 125.48 47.71 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-O 120.828 0.347 . . . . 0.0 111.156 -178.172 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' C' C ' 82' ' ' GLY . . . . . . . . . . . . . . . 89.13 42.2 5.66 Favored Glycine 0 CA--C 1.524 0.624 0 C-N-CA 120.714 -0.755 . . . . 0.0 111.772 173.117 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' C' C ' 83' ' ' ILE . . . . . . . . . . . . . 74.8 mt -65.61 134.91 29.18 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.374 0 N-CA-C 109.606 -0.516 . . . . 0.0 109.606 176.841 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' C' C ' 84' ' ' LYS . . . . . . . . . . . . . 51.0 tttp -99.09 -53.96 3.11 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-O 121.061 0.458 . . . . 0.0 110.375 -179.148 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' C' C ' 85' ' ' ASP . . . . . . . . . . . . . 10.1 t70 -148.78 146.37 28.0 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 115.786 -0.643 . . . . 0.0 110.284 -179.082 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' C' C ' 86' ' ' VAL . . . . . . . . . . . . . 43.7 t -127.14 127.61 69.63 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.196 0 CA-C-O 120.783 0.325 . . . . 0.0 110.414 -179.558 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' C' C ' 87' ' ' ILE . . . . . . . . . . . . . 44.6 mm -120.53 126.71 75.55 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.27 0 CA-C-N 115.996 -0.547 . . . . 0.0 109.766 177.935 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' C' C ' 88' ' ' LEU . . . . . . . . . . . . . 74.6 mt -107.25 139.61 41.44 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-O 121.006 0.432 . . . . 0.0 111.037 -179.314 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' C' C ' 89' ' ' ASP . . . . . . . . . . . . . 6.0 t70 -130.3 154.06 48.01 Favored 'General case' 0 C--N 1.328 -0.328 0 N-CA-C 109.302 -0.629 . . . . 0.0 109.302 176.253 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' C' C ' 90' ' ' GLU . . . . . . . . . . . . . 84.9 tt0 -47.91 -34.79 9.53 Favored 'General case' 0 C--N 1.33 -0.253 0 N-CA-C 112.972 0.73 . . . . 0.0 112.972 -172.07 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' C' C ' 91' ' ' ASN . . . . . . . . . . . . . 86.9 m-20 -132.03 19.51 4.53 Favored 'General case' 0 N--CA 1.468 0.464 0 N-CA-C 113.124 0.787 . . . . 0.0 113.124 -178.437 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' C' C ' 92' ' ' LEU . . . . . . . . . . . . . 48.5 mt -148.66 148.55 30.21 Favored 'General case' 0 C--N 1.331 -0.218 0 CA-C-O 120.644 0.259 . . . . 0.0 110.35 -177.702 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' C' C ' 93' ' ' ILE . . . . . . . . . . . . . 70.5 mt -126.94 118.39 50.33 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.345 0 N-CA-C 109.148 -0.686 . . . . 0.0 109.148 176.42 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' C' C ' 94' ' ' VAL . . . . . . . . . . . . . 46.3 t -118.89 126.29 75.19 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.281 0 CA-C-O 121.028 0.442 . . . . 0.0 110.022 -179.035 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' C' C ' 95' ' ' VAL . . . . . . . . . . . . . 44.7 t -119.91 133.1 67.77 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.382 0 CA-C-N 115.788 -0.642 . . . . 0.0 109.648 179.386 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' C' C ' 96' ' ' ILE . . . . . . . . . . . . . 63.9 mt -111.77 127.74 68.76 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.349 0 N-CA-C 109.089 -0.708 . . . . 0.0 109.089 178.016 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' C' C ' 97' ' ' THR . . . . . . . . . . . . . 80.9 p -97.83 157.91 15.82 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-O 121.159 0.504 . . . . 0.0 110.979 -178.071 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' C' C ' 98' ' ' GLU . . . . . . . . . . . . . 82.1 tt0 -53.73 -25.53 19.02 Favored 'General case' 0 CA--C 1.533 0.323 0 CA-C-N 116.105 -0.498 . . . . 0.0 112.145 179.509 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' C' C ' 99' ' ' GLU . . . . . . . . . . . . . 95.4 mt-10 -80.12 15.34 1.54 Allowed 'General case' 0 CA--C 1.535 0.398 0 N-CA-C 113.191 0.811 . . . . 0.0 113.191 -176.714 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' C' C ' 100' ' ' ASN . . . . . . . . . . . . . 3.3 m-20 61.96 37.89 14.71 Favored 'General case' 0 N--CA 1.463 0.198 0 CA-C-O 121.105 0.479 . . . . 0.0 110.939 179.001 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' C' C ' 101' ' ' GLU . . . . . . . . . . . . . 84.5 tt0 -117.99 144.43 45.54 Favored 'General case' 0 C--N 1.332 -0.172 0 CA-C-N 116.074 -0.512 . . . . 0.0 109.755 176.764 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' C' C ' 102' ' ' VAL . . . . . . . . . . . . . 44.7 t -115.14 126.26 72.67 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.253 0 CA-C-N 116.284 -0.416 . . . . 0.0 110.14 -176.75 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' C' C ' 103' ' ' LEU . . . . . . . . . . . . . 29.5 mt -115.25 127.14 55.29 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-N 115.686 -0.688 . . . . 0.0 109.932 175.905 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' C' C ' 104' ' ' ILE . . . . . . . . . . . . . 66.7 mt -116.33 120.32 64.57 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.225 0 N-CA-C 110.15 -0.315 . . . . 0.0 110.15 179.737 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' C' C ' 105' ' ' PHE . . . . . . . . . . . . . 47.8 m-85 -119.8 166.41 13.3 Favored 'General case' 0 C--N 1.332 -0.178 0 CA-C-N 115.415 -0.812 . . . . 0.0 109.535 178.364 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' C' C ' 106' ' ' ASN . . . . . . . . . . . . . 43.0 p-10 -99.5 -170.07 1.85 Allowed 'General case' 0 C--N 1.33 -0.261 0 N-CA-C 109.993 -0.373 . . . . 0.0 109.993 174.988 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' C' C ' 107' ' ' GLN . . . . . . . . . . . . . 29.7 tt0 -58.51 -30.07 66.77 Favored 'General case' 0 C--N 1.329 -0.313 0 N-CA-C 111.984 0.365 . . . . 0.0 111.984 179.287 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' C' C ' 108' ' ' ASN . . . . . . . . . . . . . 13.5 t-20 -84.05 7.57 18.16 Favored 'General case' 0 CA--C 1.536 0.439 0 N-CA-C 113.204 0.816 . . . . 0.0 113.204 -176.903 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' C' C ' 109' ' ' LEU . . . . . 0.584 HD21 ' HB2' ' C' ' 78' ' ' ALA . 10.6 tp 61.39 38.39 16.15 Favored 'General case' 0 C--N 1.332 -0.189 0 CA-C-O 121.131 0.491 . . . . 0.0 111.19 179.192 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' C' C ' 110' ' ' GLU . . . . . . . . . . . . . 96.8 mt-10 -105.38 153.29 21.86 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.219 -0.446 . . . . 0.0 109.928 176.85 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' C' C ' 111' ' ' GLU . . . . . . . . . . . . . 83.2 tt0 -85.67 121.9 29.01 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-O 120.768 0.318 . . . . 0.0 110.587 -178.508 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' C' C ' 112' ' ' LEU . . . . . . . . . . . . . 61.6 mt -111.61 -46.14 3.29 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.258 -0.428 . . . . 0.0 110.741 179.623 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' C' C ' 113' ' ' TYR . . . . . . . . . . . . . 55.8 t80 -137.17 134.72 36.64 Favored 'General case' 0 C--N 1.331 -0.223 0 CA-C-N 116.434 -0.348 . . . . 0.0 110.966 -179.094 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' C' C ' 114' ' ' ARG . . . . . . . . . . . . . 31.6 ttp180 -135.62 124.03 23.39 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.34 -0.391 . . . . 0.0 110.164 176.604 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' C' C ' 115' ' ' GLY . . . . . . . . . . . . . . . -150.05 162.68 29.26 Favored Glycine 0 CA--C 1.523 0.567 0 N-CA-C 111.038 -0.825 . . . . 0.0 111.038 179.334 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' C' C ' 116' ' ' LYS . . . . . . . . . . . . . 30.0 ttpt -131.28 137.85 49.02 Favored 'General case' 0 C--N 1.33 -0.248 0 N-CA-C 109.941 -0.392 . . . . 0.0 109.941 178.42 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' C' C ' 117' ' ' PHE . . . . . . . . . . . . . 39.2 m-85 -135.11 113.93 11.89 Favored 'General case' 0 C--N 1.331 -0.23 0 N-CA-C 109.919 -0.4 . . . . 0.0 109.919 -178.55 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' C' C ' 118' ' ' GLU . . . . . . . . . . . . . 44.1 mt-10 -57.07 -42.12 80.07 Favored 'General case' 0 C--N 1.328 -0.34 0 C-N-CA 120.774 -0.37 . . . . 0.0 110.886 -176.324 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' C' C ' 119' ' ' ASN . . . . . . . . . . . . . 3.9 p30 -100.51 31.19 3.56 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.232 -0.44 . . . . 0.0 111.964 -175.674 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' C' C ' 120' ' ' LEU . . . . . . . . . . . . . 14.2 tp -54.03 125.9 20.6 Favored 'General case' 0 N--CA 1.463 0.195 0 CA-C-O 120.487 0.184 . . . . 0.0 110.776 177.996 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' C' C ' 121' ' ' ASN . . . . . . . . . . . . . 16.6 m120 -112.72 -44.14 3.36 Favored 'General case' 0 C--O 1.231 0.12 0 C-N-CA 121.125 -0.23 . . . . 0.0 111.415 -176.422 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' C' C ' 122' ' ' LYS . . . . . . . . . . . . . 97.7 mttt -148.3 149.38 31.75 Favored 'General case' 0 C--N 1.332 -0.189 0 C-N-CA 120.557 -0.457 . . . . 0.0 111.879 -177.593 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' C' C ' 123' ' ' VAL . . . . . . . . . . . . . 44.3 t -130.18 126.92 62.47 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.325 0 N-CA-C 109.117 -0.697 . . . . 0.0 109.117 172.908 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' C' C ' 124' ' ' LEU . . . . . . . . . . . . . 12.1 tp -127.97 138.38 52.6 Favored 'General case' 0 N--CA 1.463 0.208 0 CA-C-O 120.859 0.362 . . . . 0.0 111.371 -175.661 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' C' C ' 125' ' ' VAL . . . . . 0.489 HG12 HG23 ' C' ' 130' ' ' VAL . 35.6 m -126.19 133.02 69.82 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.241 0 CA-C-N 115.942 -0.572 . . . . 0.0 110.436 177.715 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' C' C ' 126' ' ' ARG . . . . . . . . . . . . . 24.4 mmt180 -139.38 116.48 11.05 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.312 -0.404 . . . . 0.0 110.537 178.367 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' C' C ' 127' ' ' ASN . . . . . . . . . . . . . 17.8 m-80 52.1 -105.03 0.2 Allowed 'General case' 0 CA--C 1.543 0.68 0 CA-C-O 119.173 -0.441 . . . . 0.0 111.255 178.578 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' C' C ' 128' ' ' ASP . . . . . . . . . . . . . 21.2 p-10 -113.95 1.19 14.63 Favored 'General case' 0 N--CA 1.469 0.487 0 CA-C-N 119.501 1.046 . . . . 0.0 113.423 -176.916 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' C' C ' 129' ' ' LEU . . . . . . . . . . . . . 12.1 tp -108.13 137.77 45.54 Favored 'General case' 0 C--N 1.332 -0.166 0 N-CA-C 109.728 -0.471 . . . . 0.0 109.728 179.155 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' C' C ' 130' ' ' VAL . . . . . 0.507 HG13 ' HB ' ' C' ' 141' ' ' ILE . 13.0 p -126.74 137.97 56.21 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.235 0 CA-C-O 121.035 0.445 . . . . 0.0 110.131 179.906 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' C' C ' 131' ' ' VAL . . . . . . . . . . . . . 42.3 t -135.73 141.14 42.9 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.274 0 CA-C-O 121.16 0.505 . . . . 0.0 110.495 -177.358 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' C' C ' 132' ' ' ILE . . . . . . . . . . . . . 73.6 mt -115.92 132.1 66.4 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.345 0 CA-C-N 115.477 -0.783 . . . . 0.0 109.051 177.838 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' C' C ' 133' ' ' ILE . . . . . . . . . . . . . 43.3 mm -113.36 122.21 67.04 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.242 0 CA-C-O 120.9 0.381 . . . . 0.0 110.494 -175.715 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' C' C ' 134' ' ' ASP . . . . . . . . . . . . . 7.4 p-10 -135.17 146.98 49.26 Favored 'General case' 0 C--N 1.331 -0.209 0 CA-C-N 116.045 -0.525 . . . . 0.0 109.892 178.063 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' C' C ' 135' ' ' GLU . . . . . . . . . . . . . 85.2 tt0 -50.01 -27.9 6.16 Favored 'General case' 0 C--N 1.326 -0.417 0 N-CA-C 112.738 0.644 . . . . 0.0 112.738 -174.536 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' C' C ' 136' ' ' GLN . . . . . . . . . . . . . 97.3 mt-30 -79.81 -34.23 39.71 Favored 'General case' 0 C--O 1.233 0.232 0 N-CA-C 112.456 0.539 . . . . 0.0 112.456 -176.818 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' C' C ' 137' ' ' LYS . . . . . . . . . . . . . 53.1 pttt -169.99 177.06 4.46 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-O 121.551 0.691 . . . . 0.0 112.31 -172.289 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' C' C ' 138' ' ' LEU . . . . . 0.418 HD23 ' N ' ' C' ' 139' ' ' THR . 5.7 tt -116.32 126.38 53.44 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 115.126 -0.943 . . . . 0.0 109.634 176.547 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' C' C ' 139' ' ' THR . . . . . 0.418 ' N ' HD23 ' C' ' 138' ' ' LEU . 28.4 m -106.65 123.24 47.82 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.305 -0.407 . . . . 0.0 110.158 -179.638 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' C' C ' 140' ' ' LEU . . . . . 0.457 ' C ' HD23 ' C' ' 140' ' ' LEU . 5.7 tt -108.78 120.77 43.46 Favored 'General case' 0 C--N 1.329 -0.321 0 N-CA-C 109.114 -0.699 . . . . 0.0 109.114 -178.311 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' C' C ' 141' ' ' ILE . . . . . 0.507 ' HB ' HG13 ' C' ' 130' ' ' VAL . 21.1 mt -123.38 118.91 55.98 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.286 0 CA-C-O 121.211 0.529 . . . . 0.0 109.833 -177.153 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' C' C ' 142' ' ' ARG . . . . . . . . . . . . . 47.0 ttt180 -101.27 120.15 39.82 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 115.207 -0.906 . . . . 0.0 110.002 179.838 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' C' C ' 143' ' ' THR . . . . . . . . . . . . . 76.5 p . . . . . 0 C--O 1.22 -0.476 0 CA-C-O 117.988 -1.006 . . . . 0.0 110.474 -179.104 . . . . . . . . 0 0 . 1 . 006 nuclear build full ' D' D ' -3' ' ' GLU . . . . . . . . . . . . . 84.6 tt0 . . . . . 0 N--CA 1.49 1.543 0 N-CA-C 109.427 -0.582 . . . . 0.0 109.427 . . . . . . . . . 0 0 . 1 . 006 nuclear build full ' D' D ' -2' ' ' GLY . . . . . . . . . . . . . . . -67.88 143.56 41.92 Favored Glycine 0 CA--C 1.524 0.638 0 N-CA-C 110.963 -0.855 . . . . 0.0 110.963 179.882 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' D' D ' -1' ' ' VAL . . . . . . . . . . . . . 43.7 t -96.27 136.73 26.19 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.326 0 N-CA-C 110.067 -0.346 . . . . 0.0 110.067 -179.583 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' D' D ' 0' ' ' ILE . . . . . . . . . . . . . 69.6 mt -107.29 134.97 47.43 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.318 0 CA-C-N 116.157 -0.474 . . . . 0.0 109.982 -179.401 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' D' D ' 1' ' ' MET . . . . . . . . . . . . . 25.4 ptp -86.48 147.05 26.15 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.156 -0.475 . . . . 0.0 110.63 -179.874 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' D' D ' 2' ' ' SER . . . . . . . . . . . . . 3.2 p -114.73 134.13 55.34 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-N 116.096 -0.502 . . . . 0.0 110.219 178.848 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' D' D ' 3' ' ' GLU . . . . . . . . . . . . . 95.6 mt-10 -141.02 139.67 34.17 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-O 120.971 0.415 . . . . 0.0 111.074 -178.985 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' D' D ' 4' ' ' LEU . . . . . . . . . . . . . 20.1 tp -123.55 125.21 44.46 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 115.889 -0.596 . . . . 0.0 110.108 176.402 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' D' D ' 5' ' ' LYS . . . . . . . . . . . . . 54.2 mtmt -104.22 118.06 35.72 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.156 -0.474 . . . . 0.0 110.725 179.493 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' D' D ' 6' ' ' LEU . . . . . 0.404 HD23 ' HA ' ' D' ' 50' ' ' VAL . 26.3 mt -115.15 146.0 41.81 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 115.632 -0.713 . . . . 0.0 110.087 179.877 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' D' D ' 7' ' ' LYS . . . . . . . . . . . . . 74.2 tttt -131.93 139.56 35.44 Favored Pre-proline 0 CA--C 1.534 0.347 0 CA-C-O 119.164 -0.446 . . . . 0.0 109.841 176.763 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' D' D ' 8' ' ' PRO . . . . . . . . . . . . . 84.4 Cg_endo -91.96 139.23 2.1 Favored 'Trans proline' 0 N--CA 1.49 1.306 0 C-N-CA 121.776 1.651 . . . . 0.0 111.802 177.782 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' D' D ' 9' ' ' LEU . . . . . . . . . . . . . 59.0 mt -76.14 -46.93 3.65 Favored Pre-proline 0 CA--C 1.533 0.313 0 CA-C-O 118.818 -0.611 . . . . 0.0 112.146 -179.59 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' D' D ' 10' ' ' PRO . . . . . . . . . . . . . 89.1 Cg_endo -81.88 147.06 14.98 Favored 'Trans proline' 0 N--CA 1.495 1.582 0 C-N-CA 121.269 1.313 . . . . 0.0 111.614 174.175 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' D' D ' 11' ' ' LYS . . . . . . . . . . . . . 83.9 tttt -85.07 99.81 11.28 Favored 'General case' 0 C--N 1.33 -0.263 0 C-N-CA 120.801 -0.36 . . . . 0.0 110.136 178.84 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' D' D ' 12' ' ' VAL . . . . . . . . . . . . . 12.2 p -140.84 144.38 27.03 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.257 0 CA-C-N 116.219 -0.446 . . . . 0.0 110.65 -177.788 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' D' D ' 13' ' ' GLU . . . . . . . . . . . . . 43.4 mt-10 -77.69 130.32 36.65 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.253 -0.43 . . . . 0.0 110.02 176.687 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' D' D ' 14' ' ' LEU . . . . . . . . . . . . . 27.3 mt -97.88 146.1 30.89 Favored Pre-proline 0 C--N 1.329 -0.286 0 CA-C-O 119.096 -0.478 . . . . 0.0 109.996 -179.717 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' D' D ' 15' ' ' PRO . . . . . . . . . . . . . 26.9 Cg_exo -61.83 158.69 36.73 Favored 'Trans proline' 0 N--CA 1.498 1.741 0 C-N-CA 121.261 1.307 . . . . 0.0 111.693 177.144 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' D' D ' 16' ' ' PRO . . . . . . . . . . . . . 38.7 Cg_exo -58.79 -34.06 98.79 Favored 'Trans proline' 0 N--CA 1.497 1.711 0 C-N-CA 121.516 1.477 . . . . 0.0 112.898 -178.196 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' D' D ' 17' ' ' ASP . . . . . . . . . . . . . 17.3 p-10 -92.45 9.65 33.43 Favored 'General case' 0 CA--C 1.535 0.389 0 N-CA-C 113.322 0.86 . . . . 0.0 113.322 -177.348 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' D' D ' 18' ' ' PHE . . . . . . . . . . . . . 50.7 t80 -58.15 -45.71 86.93 Favored 'General case' 0 N--CA 1.457 -0.115 0 CA-C-O 121.04 0.448 . . . . 0.0 110.219 -177.709 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' D' D ' 19' ' ' VAL . . . . . . . . . . . . . 47.3 t -56.24 -44.01 78.17 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.337 0 CA-C-N 116.085 -0.507 . . . . 0.0 110.557 -177.493 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' D' D ' 20' ' ' ASP . . . . . . . . . . . . . 44.4 t0 -59.86 -43.41 94.7 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-O 120.729 0.3 . . . . 0.0 110.95 -177.338 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' D' D ' 21' ' ' VAL . . . . . . . . . . . . . 47.5 t -63.93 -46.65 93.49 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.305 0 C-N-CA 120.702 -0.399 . . . . 0.0 110.506 -177.086 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' D' D ' 22' ' ' ILE . . . . . 0.503 HG22 HD12 ' D' ' 26' ' ' LEU . 51.4 mm -55.87 -47.95 79.01 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.275 0 C-N-CA 120.946 -0.301 . . . . 0.0 110.774 179.937 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' D' D ' 23' ' ' ARG . . . . . . . . . . . . . 60.8 ttp180 -54.93 -48.76 72.7 Favored 'General case' 0 C--N 1.331 -0.233 0 C-N-CA 121.06 -0.256 . . . . 0.0 111.347 -178.143 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' D' D ' 24' ' ' ILE . . . . . . . . . . . . . 77.0 mt -59.33 -41.96 85.85 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.357 0 C-N-CA 121.027 -0.269 . . . . 0.0 111.21 -177.126 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' D' D ' 25' ' ' LYS . . . . . . . . . . . . . 73.5 mmtt -65.49 -43.58 89.75 Favored 'General case' 0 C--N 1.329 -0.312 0 N-CA-C 112.445 0.535 . . . . 0.0 112.445 -179.54 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' D' D ' 26' ' ' LEU . . . . . 0.503 HD12 HG22 ' D' ' 22' ' ' ILE . 83.8 mt -78.26 -36.15 47.19 Favored 'General case' 0 C--N 1.329 -0.308 0 N-CA-C 113.287 0.847 . . . . 0.0 113.287 -170.181 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' D' D ' 27' ' ' GLN . . . . . . . . . . . . . 4.6 pt20 -46.3 137.08 6.61 Favored 'General case' 0 N--CA 1.467 0.391 0 N-CA-C 112.871 0.693 . . . . 0.0 112.871 -174.709 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' D' D ' 28' ' ' GLY . . . . . . . . . . . . . . . 99.43 -25.37 28.52 Favored Glycine 0 CA--C 1.533 1.186 0 CA-C-N 115.883 -0.598 . . . . 0.0 112.374 -178.383 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' D' D ' 29' ' ' LYS . . . . . . . . . . . . . 54.7 mtmt -97.88 155.2 17.18 Favored 'General case' 0 C--N 1.332 -0.187 0 CA-C-N 117.341 0.57 . . . . 0.0 111.253 179.76 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' D' D ' 30' ' ' THR . . . . . . . . . . . . . 25.0 m -106.46 138.39 42.72 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 115.908 -0.587 . . . . 0.0 109.992 176.654 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' D' D ' 31' ' ' VAL . . . . . . . . . . . . . 35.8 m -128.85 155.96 41.12 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.239 0 CA-C-N 116.303 -0.408 . . . . 0.0 110.876 -178.486 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' D' D ' 32' ' ' ARG . . . . . . . . . . . . . 77.5 mtt85 -129.46 148.09 51.34 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-N 116.06 -0.518 . . . . 0.0 110.697 178.811 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' D' D ' 33' ' ' THR . . . . . . . . . . . . . 26.7 m -53.87 140.15 31.38 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.34 -0.391 . . . . 0.0 111.27 -179.703 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' D' D ' 34' ' ' GLY . . . . . . . . . . . . . . . 100.71 -17.1 56.99 Favored Glycine 0 CA--C 1.532 1.118 0 CA-C-O 119.618 -0.545 . . . . 0.0 113.306 179.541 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' D' D ' 35' ' ' ASP . . . . . . . . . . . . . 78.7 m-20 -66.51 147.87 52.68 Favored 'General case' 0 C--O 1.232 0.167 0 CA-C-N 118.017 0.909 . . . . 0.0 111.179 178.881 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' D' D ' 36' ' ' VAL . . . . . . . . . . . . . 45.1 t -121.63 129.81 75.18 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.206 0 CA-C-N 116.003 -0.544 . . . . 0.0 109.728 177.317 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' D' D ' 37' ' ' ILE . . . . . . . . . . . . . 68.0 mt -122.64 140.14 47.35 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.264 0 CA-C-N 116.293 -0.412 . . . . 0.0 110.109 -178.332 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' D' D ' 38' ' ' GLY . . . . . . . . . . . . . . . -108.96 128.74 9.18 Favored Glycine 0 CA--C 1.526 0.719 0 N-CA-C 111.086 -0.806 . . . . 0.0 111.086 179.166 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' D' D ' 39' ' ' ILE . . . . . . . . . . . . . 74.6 mt -125.54 140.81 47.29 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.258 0 N-CA-C 110.104 -0.332 . . . . 0.0 110.104 179.445 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' D' D ' 40' ' ' SER . . . . . 0.531 ' O ' HD13 ' D' ' 41' ' ' ILE . 36.3 t -92.13 117.57 29.98 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.41 -0.359 . . . . 0.0 110.828 175.998 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' D' D ' 41' ' ' ILE . . . . . 0.531 HD13 ' O ' ' D' ' 40' ' ' SER . 48.1 mm -130.03 123.35 56.13 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.243 0 N-CA-C 110.174 -0.306 . . . . 0.0 110.174 178.852 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' D' D ' 42' ' ' LEU . . . . . . . . . . . . . 9.0 tp 58.09 33.45 23.18 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.241 -0.436 . . . . 0.0 111.68 178.674 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' D' D ' 43' ' ' GLY . . . . . . . . . . . . . . . 77.02 -10.04 21.96 Favored Glycine 0 CA--C 1.534 1.262 0 C-N-CA 121.258 -0.496 . . . . 0.0 113.517 178.152 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' D' D ' 44' ' ' LYS . . . . . . . . . . . . . 99.2 mttt -103.06 146.26 28.64 Favored 'General case' 0 C--N 1.334 -0.081 0 CA-C-N 117.884 0.842 . . . . 0.0 110.081 178.443 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' D' D ' 45' ' ' GLU . . . . . . . . . . . . . 81.8 tt0 -83.85 127.42 33.82 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.377 -0.374 . . . . 0.0 110.797 -179.51 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' D' D ' 46' ' ' VAL . . . . . . . . . . . . . 7.4 p -122.11 128.8 75.66 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.183 0 N-CA-C 109.521 -0.548 . . . . 0.0 109.521 176.393 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' D' D ' 47' ' ' LYS . . . . . . . . . . . . . 89.8 mttt -100.1 130.0 46.2 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 115.993 -0.549 . . . . 0.0 111.28 178.969 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' D' D ' 48' ' ' PHE . . . . . . . . . . . . . 92.0 m-85 -113.43 131.77 55.89 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.01 176.541 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' D' D ' 49' ' ' LYS . . . . . . . . . . . . . 80.7 tttt -108.34 137.6 46.04 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 116.309 -0.405 . . . . 0.0 110.337 178.797 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' D' D ' 50' ' ' VAL . . . . . 0.404 ' HA ' HD23 ' D' ' 6' ' ' LEU . 44.1 t -82.39 109.71 16.7 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.288 0 N-CA-C 109.521 -0.548 . . . . 0.0 109.521 176.81 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' D' D ' 51' ' ' VAL . . . . . . . . . . . . . 47.8 t -72.82 -48.79 43.91 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.326 0 CA-C-N 115.794 -0.639 . . . . 0.0 110.043 -175.228 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' D' D ' 52' ' ' GLN . . . . . . . . . . . . . 49.7 tt0 -162.96 142.09 8.7 Favored 'General case' 0 C--N 1.332 -0.168 0 C-N-CA 120.037 -0.665 . . . . 0.0 111.941 -178.663 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' D' D ' 53' ' ' ALA . . . . . 0.414 ' HB1' ' HB2' ' D' ' 58' ' ' LEU . . . -116.83 132.63 56.65 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 115.766 -0.652 . . . . 0.0 109.998 175.577 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' D' D ' 54' ' ' TYR . . . . . . . . . . . . . 67.1 t80 -129.01 111.97 18.51 Favored Pre-proline 0 CA--C 1.535 0.379 0 CA-C-O 118.204 -0.903 . . . . 0.0 110.487 179.384 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' D' D ' 55' ' ' PRO . . . . . . . . . . . . . 74.4 Cg_endo -77.2 169.32 74.5 Favored 'Cis proline' 0 N--CA 1.499 1.848 0 CA-C-N 122.027 1.76 . . . . 0.0 112.198 -5.979 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' D' D ' 56' ' ' SER . . . . . . . . . . . . . 13.6 m -115.24 128.96 25.49 Favored Pre-proline 0 CA--C 1.539 0.525 0 CA-C-O 118.388 -0.815 . . . . 0.0 109.424 176.521 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' D' D ' 57' ' ' PRO . . . . . . . . . . . . . 56.7 Cg_endo -71.77 148.13 89.82 Favored 'Cis proline' 0 N--CA 1.497 1.688 0 CA-C-N 121.958 1.735 . . . . 0.0 111.62 0.19 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' D' D ' 58' ' ' LEU . . . . . 0.414 ' HB2' ' HB1' ' D' ' 53' ' ' ALA . 14.2 tp -107.69 135.73 48.63 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 116.296 -0.411 . . . . 0.0 110.559 -178.567 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' D' D ' 59' ' ' ARG . . . . . . . . . . . . . 43.6 ttp180 -106.19 124.47 49.64 Favored 'General case' 0 C--N 1.327 -0.41 0 N-CA-C 109.324 -0.621 . . . . 0.0 109.324 175.891 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' D' D ' 60' ' ' VAL . . . . . . . . . . . . . 41.4 t -79.98 120.99 32.47 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.299 0 C-N-CA 120.741 -0.384 . . . . 0.0 110.352 -175.46 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' D' D ' 61' ' ' GLU . . . . . . . . . . . . . 42.6 mt-10 -130.97 170.22 14.77 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.066 -0.515 . . . . 0.0 110.129 178.425 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' D' D ' 62' ' ' ASP . . . . . . . . . . . . . 45.1 m-20 -54.31 -32.54 56.79 Favored 'General case' 0 C--N 1.327 -0.379 0 N-CA-C 111.847 0.314 . . . . 0.0 111.847 -178.151 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' D' D ' 63' ' ' ARG . . . . . . . . . . . . . 30.7 ptt180 -88.47 4.41 46.64 Favored 'General case' 0 CA--C 1.537 0.446 0 N-CA-C 113.751 1.019 . . . . 0.0 113.751 -175.011 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' D' D ' 64' ' ' THR . . . . . . . . . . . . . 32.3 m -85.4 136.97 33.23 Favored 'General case' 0 C--N 1.332 -0.163 0 CA-C-O 120.934 0.397 . . . . 0.0 110.628 -178.609 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' D' D ' 65' ' ' LYS . . . . . . . . . . . . . 90.5 mttt -89.61 129.79 36.01 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.096 -0.502 . . . . 0.0 110.223 179.306 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' D' D ' 66' ' ' ILE . . . . . . . . . . . . . 62.5 mt -113.55 128.6 70.33 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.26 0 N-CA-C 109.575 -0.528 . . . . 0.0 109.575 178.684 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' D' D ' 67' ' ' THR . . . . . . . . . . . . . 27.0 m -122.3 138.73 54.41 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-O 120.991 0.424 . . . . 0.0 111.118 -176.31 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' D' D ' 68' ' ' LEU . . . . . . . . . . . . . 7.3 mp -100.56 111.18 23.4 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 115.863 -0.608 . . . . 0.0 110.282 177.706 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' D' D ' 69' ' ' VAL . . . . . . . . . . . . . 43.3 t -103.06 140.2 21.94 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.364 0 CA-C-N 115.867 -0.606 . . . . 0.0 110.081 -179.145 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' D' D ' 70' ' ' THR . . . . . . . . . . . . . 23.6 m -146.11 -60.05 0.32 Allowed 'General case' 0 C--N 1.328 -0.345 0 CA-C-O 120.844 0.354 . . . . 0.0 110.363 177.287 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' D' D ' 71' ' ' HIS . . . . . . . . . . . . . 2.5 t60 -150.06 80.99 7.04 Favored Pre-proline 0 C--N 1.329 -0.302 0 CA-C-N 116.021 -0.536 . . . . 0.0 110.121 177.865 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' D' D ' 72' ' ' PRO . . . . . . . . . . . . . 59.4 Cg_endo -73.27 -30.18 10.67 Favored 'Trans proline' 0 N--CA 1.496 1.619 0 C-N-CA 121.152 1.235 . . . . 0.0 112.515 -175.96 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' D' D ' 73' ' ' VAL . . . . . . . . . . . . . 15.6 m -155.16 151.51 10.35 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.299 0 CA-C-O 120.993 0.425 . . . . 0.0 110.667 178.435 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' D' D ' 74' ' ' ASP . . . . . . . . . . . . . 5.0 t70 -108.77 118.87 37.92 Favored 'General case' 0 C--N 1.328 -0.362 0 N-CA-C 109.288 -0.634 . . . . 0.0 109.288 174.541 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' D' D ' 75' ' ' VAL . . . . . 0.407 ' C ' HD12 ' D' ' 76' ' ' LEU . 41.9 t -113.74 125.68 71.06 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.214 0 CA-C-O 121.059 0.457 . . . . 0.0 110.898 -175.854 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' D' D ' 76' ' ' LEU . . . . . 0.407 HD12 ' C ' ' D' ' 75' ' ' VAL . 5.6 mp -125.56 146.42 49.69 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 115.581 -0.736 . . . . 0.0 109.538 174.953 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' D' D ' 77' ' ' GLU . . . . . . . . . . . . . 99.2 mt-10 -134.23 131.23 38.27 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-O 121.134 0.492 . . . . 0.0 111.291 -176.95 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' D' D ' 78' ' ' ALA . . . . . . . . . . . . . . . -118.38 121.72 41.06 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 115.69 -0.686 . . . . 0.0 109.558 176.647 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' D' D ' 79' ' ' LYS . . . . . 0.644 ' O ' HD13 ' D' ' 80' ' ' ILE . 19.2 pttp -71.77 122.65 21.04 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-O 121.134 0.492 . . . . 0.0 110.96 -178.091 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' D' D ' 80' ' ' ILE . . . . . 0.644 HD13 ' O ' ' D' ' 79' ' ' LYS . 37.4 mm -139.19 108.87 3.94 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.355 0 N-CA-C 109.023 -0.732 . . . . 0.0 109.023 -178.122 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' D' D ' 81' ' ' LYS . . . . . . . . . . . . . 50.7 pttt -97.59 123.7 41.58 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-O 120.941 0.401 . . . . 0.0 111.152 -177.617 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' D' D ' 82' ' ' GLY . . . . . . . . . . . . . . . 88.97 42.26 5.69 Favored Glycine 0 CA--C 1.525 0.699 0 C-N-CA 120.718 -0.753 . . . . 0.0 111.533 174.649 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' D' D ' 83' ' ' ILE . . . . . . . . . . . . . 75.3 mt -65.91 137.17 25.41 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.332 0 N-CA-C 109.809 -0.441 . . . . 0.0 109.809 178.106 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' D' D ' 84' ' ' LYS . . . . . . . . . . . . . 50.9 tttp -98.59 -54.18 3.1 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.246 -0.434 . . . . 0.0 110.283 -179.469 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' D' D ' 85' ' ' ASP . . . . . . . . . . . . . 13.4 t70 -151.77 150.89 30.67 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 115.902 -0.59 . . . . 0.0 110.456 -179.474 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' D' D ' 86' ' ' VAL . . . . . . . . . . . . . 42.5 t -129.86 129.79 66.18 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.248 0 CA-C-O 120.974 0.416 . . . . 0.0 110.598 -179.058 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' D' D ' 87' ' ' ILE . . . . . . . . . . . . . 45.2 mm -118.83 125.79 74.75 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.286 0 CA-C-N 115.826 -0.625 . . . . 0.0 109.373 175.31 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' D' D ' 88' ' ' LEU . . . . . . . . . . . . . 30.8 mt -118.65 138.84 52.33 Favored 'General case' 0 C--N 1.332 -0.188 0 CA-C-O 121.316 0.579 . . . . 0.0 111.941 -175.427 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' D' D ' 89' ' ' ASP . . . . . . . . . . . . . 12.2 t0 -136.09 151.72 50.11 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 115.171 -0.922 . . . . 0.0 108.764 174.725 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' D' D ' 90' ' ' GLU . . . . . . . . . . . . . 83.5 tt0 -49.0 -31.8 8.13 Favored 'General case' 0 C--N 1.329 -0.32 0 N-CA-C 112.876 0.695 . . . . 0.0 112.876 -172.829 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' D' D ' 91' ' ' ASN . . . . . . . . . . . . . 12.4 p30 -117.24 3.07 12.62 Favored 'General case' 0 N--CA 1.469 0.513 0 N-CA-C 113.815 1.043 . . . . 0.0 113.815 -174.867 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' D' D ' 92' ' ' LEU . . . . . . . . . . . . . 17.7 mt -148.47 148.45 30.29 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 118.241 0.473 . . . . 0.0 110.647 -175.421 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' D' D ' 93' ' ' ILE . . . . . . . . . . . . . 75.9 mt -129.65 118.36 44.84 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.285 0 N-CA-C 109.233 -0.654 . . . . 0.0 109.233 176.949 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' D' D ' 94' ' ' VAL . . . . . . . . . . . . . 44.7 t -118.29 125.12 74.05 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.288 0 N-CA-C 109.884 -0.413 . . . . 0.0 109.884 -178.786 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' D' D ' 95' ' ' VAL . . . . . . . . . . . . . 43.5 t -120.91 134.09 65.45 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.343 0 CA-C-N 116.133 -0.485 . . . . 0.0 109.841 -179.703 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' D' D ' 96' ' ' ILE . . . . . . . . . . . . . 68.6 mt -114.42 126.71 72.01 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.339 0 N-CA-C 109.042 -0.725 . . . . 0.0 109.042 178.439 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' D' D ' 97' ' ' THR . . . . . . . . . . . . . 79.7 p -98.82 158.15 15.82 Favored 'General case' 0 C--N 1.331 -0.239 0 CA-C-O 121.176 0.512 . . . . 0.0 111.124 -176.965 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' D' D ' 98' ' ' GLU . . . . . . . . . . . . . 83.1 tt0 -53.98 -27.3 30.61 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-N 116.093 -0.503 . . . . 0.0 112.065 179.843 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' D' D ' 99' ' ' GLU . . . . . . . . . . . . . 96.6 mt-10 -78.07 13.48 1.43 Allowed 'General case' 0 CA--C 1.536 0.421 0 N-CA-C 113.294 0.85 . . . . 0.0 113.294 -176.852 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' D' D ' 100' ' ' ASN . . . . . . . . . . . . . 3.2 m-20 62.49 32.93 16.4 Favored 'General case' 0 N--CA 1.464 0.266 0 CA-C-O 120.898 0.38 . . . . 0.0 111.637 179.155 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' D' D ' 101' ' ' GLU . . . . . . . . . . . . . 84.6 tt0 -109.59 144.4 37.95 Favored 'General case' 0 C--N 1.334 -0.105 0 N-CA-C 109.709 -0.478 . . . . 0.0 109.709 173.247 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' D' D ' 102' ' ' VAL . . . . . . . . . . . . . 45.9 t -114.94 125.88 72.37 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.331 0 CA-C-N 116.113 -0.494 . . . . 0.0 109.858 -178.181 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' D' D ' 103' ' ' LEU . . . . . . . . . . . . . 53.1 mt -117.71 129.77 55.92 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 115.998 -0.546 . . . . 0.0 110.331 177.553 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' D' D ' 104' ' ' ILE . . . . . . . . . . . . . 70.3 mt -118.15 119.58 61.83 Favored 'Isoleucine or valine' 0 C--O 1.234 0.256 0 CA-C-N 116.393 -0.367 . . . . 0.0 110.173 -179.692 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' D' D ' 105' ' ' PHE . . . . . . . . . . . . . 46.6 m-85 -121.55 168.15 12.07 Favored 'General case' 0 C--N 1.332 -0.194 0 O-C-N 123.879 0.737 . . . . 0.0 109.738 179.794 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' D' D ' 106' ' ' ASN . . . . . . . . . . . . . 44.0 p-10 -99.42 -170.2 1.87 Allowed 'General case' 0 C--N 1.331 -0.217 0 N-CA-C 109.734 -0.469 . . . . 0.0 109.734 172.036 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' D' D ' 107' ' ' GLN . . . . . . . . . . . . . 59.3 tt0 -59.37 -30.03 68.12 Favored 'General case' 0 C--N 1.329 -0.31 0 N-CA-C 111.824 0.305 . . . . 0.0 111.824 -179.724 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' D' D ' 108' ' ' ASN . . . . . . . . . . . . . 11.8 t-20 -86.56 13.53 8.34 Favored 'General case' 0 CA--C 1.535 0.399 0 N-CA-C 112.904 0.705 . . . . 0.0 112.904 -177.152 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' D' D ' 109' ' ' LEU . . . . . . . . . . . . . 21.7 mt 58.51 34.03 23.58 Favored 'General case' 0 C--O 1.233 0.198 0 CA-C-O 120.73 0.3 . . . . 0.0 111.747 177.563 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' D' D ' 110' ' ' GLU . . . . . . . . . . . . . 96.1 mt-10 -99.73 138.8 36.31 Favored 'General case' 0 C--N 1.33 -0.28 0 N-CA-C 109.455 -0.572 . . . . 0.0 109.455 175.222 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' D' D ' 111' ' ' GLU . . . . . . . . . . . . . 48.3 tt0 -79.67 121.86 25.83 Favored 'General case' 0 C--N 1.327 -0.373 0 C-N-CA 120.759 -0.376 . . . . 0.0 110.293 -176.402 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' D' D ' 112' ' ' LEU . . . . . . . . . . . . . 26.6 mt -105.79 -46.01 4.24 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.019 -0.537 . . . . 0.0 110.432 179.656 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' D' D ' 113' ' ' TYR . . . . . . . . . . . . . 61.3 t80 -135.91 138.85 42.83 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.089 -0.505 . . . . 0.0 110.838 -179.041 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' D' D ' 114' ' ' ARG . . . . . . . . . . . . . 39.6 ptt180 -141.6 126.38 18.07 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-O 120.941 0.401 . . . . 0.0 110.681 176.913 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' D' D ' 115' ' ' GLY . . . . . . . . . . . . . . . -150.06 163.08 29.38 Favored Glycine 0 CA--C 1.522 0.515 0 N-CA-C 110.604 -0.999 . . . . 0.0 110.604 -179.723 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' D' D ' 116' ' ' LYS . . . . . . . . . . . . . 72.4 tttt -134.35 134.07 41.35 Favored 'General case' 0 C--N 1.33 -0.257 0 N-CA-C 110.093 -0.336 . . . . 0.0 110.093 179.192 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' D' D ' 117' ' ' PHE . . . . . . . . . . . . . 39.2 m-85 -134.03 114.01 12.74 Favored 'General case' 0 C--N 1.331 -0.209 0 CA-C-N 116.328 -0.396 . . . . 0.0 110.124 -175.18 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' D' D ' 118' ' ' GLU . . . . . . . . . . . . . 45.0 tp10 -53.49 -43.82 68.54 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.467 -0.333 . . . . 0.0 111.526 -175.665 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' D' D ' 119' ' ' ASN . . . . . . . . . . . . . 80.4 m-20 -99.69 31.04 3.36 Favored 'General case' 0 C--N 1.332 -0.175 0 N-CA-C 112.319 0.489 . . . . 0.0 112.319 -173.875 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' D' D ' 120' ' ' LEU . . . . . . . . . . . . . 15.0 tp -57.44 122.72 13.31 Favored 'General case' 0 C--N 1.331 -0.213 0 N-CA-C 110.162 -0.31 . . . . 0.0 110.162 177.386 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' D' D ' 121' ' ' ASN . . . . . . . . . . . . . 73.8 m-20 -114.02 -44.15 3.18 Favored 'General case' 0 C--O 1.232 0.153 0 CA-C-N 116.689 -0.232 . . . . 0.0 111.378 -176.883 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' D' D ' 122' ' ' LYS . . . . . . . . . . . . . 98.0 mttt -143.83 147.02 33.5 Favored 'General case' 0 C--N 1.333 -0.15 0 CA-C-O 121.072 0.463 . . . . 0.0 111.657 -178.36 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' D' D ' 123' ' ' VAL . . . . . 0.44 ' C ' HD12 ' D' ' 124' ' ' LEU . 45.4 t -127.21 124.33 63.96 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.256 0 N-CA-C 109.302 -0.629 . . . . 0.0 109.302 174.158 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' D' D ' 124' ' ' LEU . . . . . 0.485 ' N ' HD12 ' D' ' 124' ' ' LEU . 7.2 mp -115.39 131.49 56.91 Favored 'General case' 0 C--N 1.331 -0.229 0 CA-C-N 116.306 -0.406 . . . . 0.0 110.617 -177.898 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' D' D ' 125' ' ' VAL . . . . . . . . . . . . . 45.9 t -126.72 126.83 69.39 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.243 0 CA-C-N 116.128 -0.487 . . . . 0.0 109.999 179.49 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' D' D ' 126' ' ' ARG . . . . . . . . . . . . . 69.6 ttt180 -155.22 141.13 18.22 Favored 'General case' 0 C--N 1.328 -0.356 0 N-CA-C 109.527 -0.545 . . . . 0.0 109.527 177.542 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' D' D ' 127' ' ' ASN . . . . . . . . . . . . . 9.7 p30 48.73 -151.84 0.13 Allowed 'General case' 0 CA--C 1.54 0.593 0 CA-C-O 119.299 -0.381 . . . . 0.0 110.897 178.989 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' D' D ' 128' ' ' ASP . . . . . . . . . . . . . 12.7 p-10 -84.49 22.71 1.23 Allowed 'General case' 0 CA--C 1.535 0.385 0 CA-C-N 118.61 0.641 . . . . 0.0 112.264 177.705 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' D' D ' 129' ' ' LEU . . . . . . . . . . . . . 13.4 tp -120.72 137.02 54.7 Favored 'General case' 0 C--O 1.233 0.216 0 CA-C-O 121.061 0.458 . . . . 0.0 110.508 -179.605 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' D' D ' 130' ' ' VAL . . . . . . . . . . . . . 45.0 t -123.24 136.01 61.32 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.218 0 CA-C-N 115.949 -0.569 . . . . 0.0 109.61 178.26 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' D' D ' 131' ' ' VAL . . . . . . . . . . . . . 42.2 t -134.9 136.82 51.63 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.238 0 CA-C-O 121.186 0.517 . . . . 0.0 110.516 179.957 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' D' D ' 132' ' ' ILE . . . . . . . . . . . . . 72.1 mt -117.55 133.89 62.87 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.295 0 CA-C-N 115.639 -0.71 . . . . 0.0 109.63 -179.579 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' D' D ' 133' ' ' ILE . . . . . . . . . . . . . 43.1 mm -118.55 122.21 68.92 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.19 0 CA-C-O 120.961 0.41 . . . . 0.0 110.947 -176.221 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' D' D ' 134' ' ' ASP . . . . . . . . . . . . . 8.0 p-10 -135.11 148.04 49.69 Favored 'General case' 0 C--N 1.329 -0.299 0 N-CA-C 109.3 -0.63 . . . . 0.0 109.3 173.029 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' D' D ' 135' ' ' GLU . . . . . . . . . . . . . 43.5 tp10 -49.83 -24.74 2.59 Favored 'General case' 0 C--N 1.327 -0.386 0 N-CA-C 112.768 0.655 . . . . 0.0 112.768 -171.671 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' D' D ' 136' ' ' GLN . . . . . . . . . . . . . 46.5 tt0 -102.83 -24.65 13.69 Favored 'General case' 0 CA--C 1.533 0.298 0 N-CA-C 112.96 0.726 . . . . 0.0 112.96 -173.995 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' D' D ' 137' ' ' LYS . . . . . . . . . . . . . 97.3 mttt -143.65 152.77 41.77 Favored 'General case' 0 C--N 1.331 -0.201 0 CA-C-O 121.168 0.508 . . . . 0.0 111.821 -172.574 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' D' D ' 138' ' ' LEU . . . . . . . . . . . . . 4.4 tt -120.41 121.8 39.32 Favored 'General case' 0 C--N 1.33 -0.262 0 N-CA-C 109.079 -0.712 . . . . 0.0 109.079 172.434 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' D' D ' 139' ' ' THR . . . . . . . . . . . . . 34.3 m -111.23 130.4 55.66 Favored 'General case' 0 C--N 1.332 -0.193 0 CA-C-O 120.734 0.302 . . . . 0.0 111.036 -175.683 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' D' D ' 140' ' ' LEU . . . . . 0.462 ' C ' HD23 ' D' ' 140' ' ' LEU . 5.6 tt -116.98 122.54 44.53 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 115.618 -0.719 . . . . 0.0 109.238 -179.683 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' D' D ' 141' ' ' ILE . . . . . 0.455 ' N ' HD23 ' D' ' 140' ' ' LEU . 18.8 mt -121.6 122.74 67.83 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.248 0 CA-C-O 120.888 0.375 . . . . 0.0 110.085 -175.663 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' D' D ' 142' ' ' ARG . . . . . . . . . . . . . 73.4 mtp180 -110.9 125.95 54.2 Favored 'General case' 0 C--N 1.331 -0.22 0 CA-C-N 115.682 -0.69 . . . . 0.0 110.16 -179.534 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' D' D ' 143' ' ' THR . . . . . . . . . . . . . 66.6 p . . . . . 0 C--O 1.219 -0.503 0 CA-C-O 118.074 -0.965 . . . . 0.0 110.492 -179.796 . . . . . . . . 0 0 . 1 . 006 nuclear build full ' E' E ' -3' ' ' GLU . . . . . . . . . . . . . 95.9 mt-10 . . . . . 0 N--CA 1.49 1.559 0 N-CA-C 109.404 -0.591 . . . . 0.0 109.404 . . . . . . . . . 0 0 . 1 . 006 nuclear build full ' E' E ' -2' ' ' GLY . . . . . . . . . . . . . . . -74.65 145.73 34.53 Favored Glycine 0 CA--C 1.524 0.638 0 N-CA-C 111.261 -0.735 . . . . 0.0 111.261 -179.325 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' E' E ' -1' ' ' VAL . . . . . . . . . . . . . 44.9 t -141.05 134.38 31.43 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.278 0 N-CA-C 109.748 -0.464 . . . . 0.0 109.748 178.719 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' E' E ' 0' ' ' ILE . . . . . . . . . . . . . 74.2 mt -116.01 138.59 45.97 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.255 0 CA-C-O 120.899 0.381 . . . . 0.0 110.148 -178.677 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' E' E ' 1' ' ' MET . . . . . . . . . . . . . 22.6 ptm -91.71 140.04 30.1 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.014 -0.539 . . . . 0.0 110.876 -178.306 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' E' E ' 2' ' ' SER . . . . . . . . . . . . . 6.4 p -122.88 132.97 54.42 Favored 'General case' 0 C--N 1.331 -0.22 0 CA-C-O 121.033 0.444 . . . . 0.0 110.994 -178.973 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' E' E ' 3' ' ' GLU . . . . . . . . . . . . . 95.1 mt-10 -140.91 141.95 34.49 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 115.876 -0.602 . . . . 0.0 110.961 -179.238 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' E' E ' 4' ' ' LEU . . . . . . . . . . . . . 15.0 tp -126.77 126.16 42.95 Favored 'General case' 0 C--N 1.331 -0.206 0 CA-C-N 116.091 -0.504 . . . . 0.0 109.97 176.516 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' E' E ' 5' ' ' LYS . . . . . . . . . . . . . 68.6 mttm -106.11 122.2 45.7 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-O 120.844 0.355 . . . . 0.0 110.826 178.426 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' E' E ' 6' ' ' LEU . . . . . . . . . . . . . 74.6 mt -118.59 146.56 44.52 Favored 'General case' 0 C--N 1.331 -0.209 0 CA-C-N 115.535 -0.757 . . . . 0.0 110.311 179.765 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' E' E ' 7' ' ' LYS . . . . . . . . . . . . . 80.0 tttt -135.66 140.24 33.26 Favored Pre-proline 0 CA--C 1.534 0.335 0 CA-C-O 119.093 -0.479 . . . . 0.0 110.254 176.985 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' E' E ' 8' ' ' PRO . . . . . . . . . . . . . 88.8 Cg_endo -91.98 143.39 2.74 Favored 'Trans proline' 0 N--CA 1.49 1.311 0 C-N-CA 121.827 1.685 . . . . 0.0 111.934 177.773 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' E' E ' 9' ' ' LEU . . . . . . . . . . . . . 60.8 mt -77.37 -47.51 2.52 Favored Pre-proline 0 CA--C 1.533 0.317 0 CA-C-O 118.688 -0.673 . . . . 0.0 112.226 179.533 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' E' E ' 10' ' ' PRO . . . . . . . . . . . . . 94.8 Cg_endo -80.26 142.82 15.31 Favored 'Trans proline' 0 N--CA 1.495 1.582 0 C-N-CA 121.133 1.222 . . . . 0.0 111.518 175.905 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' E' E ' 11' ' ' LYS . . . . . . . . . . . . . 46.0 pttt -83.76 113.38 20.86 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-O 121.496 0.665 . . . . 0.0 110.879 -179.74 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' E' E ' 12' ' ' VAL . . . . . . . . . . . . . 12.2 p -151.18 148.54 14.8 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.284 0 CA-C-N 115.649 -0.705 . . . . 0.0 110.377 179.873 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' E' E ' 13' ' ' GLU . . . . . . . . . . . . . 43.0 mt-10 -83.78 116.03 22.51 Favored 'General case' 0 C--N 1.329 -0.313 0 N-CA-C 110.144 -0.317 . . . . 0.0 110.144 177.658 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' E' E ' 14' ' ' LEU . . . . . . . . . . . . . 31.1 mt -99.33 143.53 26.59 Favored Pre-proline 0 CA--C 1.533 0.309 0 CA-C-O 119.09 -0.481 . . . . 0.0 110.279 -179.439 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' E' E ' 15' ' ' PRO . . . . . . . . . . . . . 25.7 Cg_exo -62.55 157.34 47.11 Favored 'Trans proline' 0 N--CA 1.498 1.774 0 C-N-CA 121.342 1.361 . . . . 0.0 112.013 177.682 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' E' E ' 16' ' ' PRO . . . . . . . . . . . . . 31.4 Cg_exo -59.76 -34.43 95.93 Favored 'Trans proline' 0 N--CA 1.498 1.752 0 C-N-CA 121.452 1.435 . . . . 0.0 112.782 179.969 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' E' E ' 17' ' ' ASP . . . . . . . . . . . . . 9.1 p-10 -83.32 4.43 27.24 Favored 'General case' 0 CA--C 1.537 0.465 0 N-CA-C 113.26 0.837 . . . . 0.0 113.26 -177.462 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' E' E ' 18' ' ' PHE . . . . . . . . . . . . . 33.8 t80 -58.06 -44.69 87.63 Favored 'General case' 0 C--N 1.334 -0.07 0 O-C-N 121.884 -0.51 . . . . 0.0 109.898 -178.574 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' E' E ' 19' ' ' VAL . . . . . . . . . . . . . 48.5 t -58.3 -40.33 77.45 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.361 0 CA-C-N 116.037 -0.529 . . . . 0.0 110.525 -178.725 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' E' E ' 20' ' ' ASP . . . . . . . . . . . . . 11.8 t70 -58.85 -43.74 90.86 Favored 'General case' 0 C--O 1.234 0.268 0 CA-C-O 120.947 0.403 . . . . 0.0 110.772 -177.223 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' E' E ' 21' ' ' VAL . . . . . . . . . . . . . 48.4 t -65.8 -51.98 55.24 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.291 0 C-N-CA 120.662 -0.415 . . . . 0.0 110.517 -179.011 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' E' E ' 22' ' ' ILE . . . . . 0.473 HG22 HD12 ' E' ' 26' ' ' LEU . 50.4 mm -55.24 -54.09 28.29 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.295 0 C-N-CA 120.901 -0.32 . . . . 0.0 111.168 -176.665 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' E' E ' 23' ' ' ARG . . . . . . . . . . . . . 13.8 ptm180 -58.52 -44.45 89.52 Favored 'General case' 0 C--N 1.33 -0.249 0 C-N-CA 120.773 -0.371 . . . . 0.0 111.721 -172.973 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' E' E ' 24' ' ' ILE . . . . . . . . . . . . . 86.9 mt -64.18 -34.97 72.29 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.303 0 C-N-CA 120.767 -0.373 . . . . 0.0 111.355 -177.714 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' E' E ' 25' ' ' LYS . . . . . . . . . . . . . 34.4 mmtp -67.87 -44.07 77.93 Favored 'General case' 0 C--N 1.33 -0.27 0 N-CA-C 112.09 0.404 . . . . 0.0 112.09 177.365 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' E' E ' 26' ' ' LEU . . . . . 0.473 HD12 HG22 ' E' ' 22' ' ' ILE . 75.8 mt -85.49 -23.79 27.63 Favored 'General case' 0 C--N 1.329 -0.294 0 N-CA-C 114.065 1.135 . . . . 0.0 114.065 -170.266 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' E' E ' 27' ' ' GLN . . . . . . . . . . . . . 12.5 pt20 -47.63 145.66 2.58 Favored 'General case' 0 N--CA 1.47 0.535 0 N-CA-C 112.553 0.575 . . . . 0.0 112.553 -176.152 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' E' E ' 28' ' ' GLY . . . . . . . . . . . . . . . 99.77 -23.82 34.58 Favored Glycine 0 CA--C 1.532 1.121 0 CA-C-N 115.512 -0.767 . . . . 0.0 112.2 -175.28 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' E' E ' 29' ' ' LYS . . . . . . . . . . . . . 79.9 mttt -94.54 155.06 17.09 Favored 'General case' 0 C--O 1.233 0.212 0 CA-C-N 117.577 0.689 . . . . 0.0 110.518 177.153 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' E' E ' 30' ' ' THR . . . . . . . . . . . . . 26.9 m -107.48 138.5 43.57 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 116.116 -0.493 . . . . 0.0 110.128 178.056 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' E' E ' 31' ' ' VAL . . . . . . . . . . . . . 34.7 m -127.24 151.66 34.36 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.199 0 CA-C-O 121.005 0.431 . . . . 0.0 110.893 -179.161 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' E' E ' 32' ' ' ARG . . . . . . . . . . . . . 55.0 ttt180 -128.32 150.09 50.23 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 115.893 -0.594 . . . . 0.0 110.073 179.389 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' E' E ' 33' ' ' THR . . . . . . . . . . . . . 23.2 m -52.59 137.62 30.08 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-O 120.733 0.302 . . . . 0.0 111.528 -177.357 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' E' E ' 34' ' ' GLY . . . . . . . . . . . . . . . 100.03 -17.04 57.73 Favored Glycine 0 CA--C 1.533 1.183 0 CA-C-O 119.671 -0.516 . . . . 0.0 113.313 178.763 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' E' E ' 35' ' ' ASP . . . . . . . . . . . . . 76.7 m-20 -67.22 149.88 49.83 Favored 'General case' 0 N--CA 1.462 0.144 0 CA-C-N 117.983 0.891 . . . . 0.0 111.266 179.043 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' E' E ' 36' ' ' VAL . . . . . . . . . . . . . 44.8 t -121.23 130.5 74.59 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.186 0 CA-C-N 115.966 -0.561 . . . . 0.0 109.956 178.464 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' E' E ' 37' ' ' ILE . . . . . . . . . . . . . 69.9 mt -121.27 139.09 49.52 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.279 0 CA-C-N 116.139 -0.482 . . . . 0.0 109.85 179.839 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' E' E ' 38' ' ' GLY . . . . . . . . . . . . . . . -114.33 129.38 8.68 Favored Glycine 0 CA--C 1.527 0.784 0 N-CA-C 111.53 -0.628 . . . . 0.0 111.53 -177.791 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' E' E ' 39' ' ' ILE . . . . . . . . . . . . . 69.9 mt -121.85 136.76 57.71 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.189 0 N-CA-C 109.829 -0.434 . . . . 0.0 109.829 177.765 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' E' E ' 40' ' ' SER . . . . . . . . . . . . . 39.7 t -92.88 113.98 26.41 Favored 'General case' 0 C--N 1.33 -0.264 0 C-N-CA 120.935 -0.306 . . . . 0.0 110.895 176.167 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' E' E ' 41' ' ' ILE . . . . . . . . . . . . . 47.9 mm -120.87 113.2 39.01 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.167 0 N-CA-C 110.157 -0.312 . . . . 0.0 110.157 179.196 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' E' E ' 42' ' ' LEU . . . . . . . . . . . . . 7.0 mp 57.01 36.17 27.41 Favored 'General case' 0 CA--C 1.533 0.298 0 CA-C-O 120.84 0.352 . . . . 0.0 111.232 179.681 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' E' E ' 43' ' ' GLY . . . . . . . . . . . . . . . 77.74 -10.17 26.21 Favored Glycine 0 CA--C 1.535 1.29 0 C-N-CA 121.245 -0.502 . . . . 0.0 113.566 177.708 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' E' E ' 44' ' ' LYS . . . . . . . . . . . . . 49.4 tptt -94.95 132.91 39.27 Favored 'General case' 0 C--N 1.332 -0.19 0 CA-C-N 117.763 0.781 . . . . 0.0 109.695 176.821 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' E' E ' 45' ' ' GLU . . . . . . . . . . . . . 84.5 tt0 -83.49 125.82 32.14 Favored 'General case' 0 C--N 1.328 -0.359 0 C-N-CA 120.838 -0.345 . . . . 0.0 111.003 -178.796 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' E' E ' 46' ' ' VAL . . . . . . . . . . . . . 7.2 p -119.44 124.68 73.42 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.231 0 N-CA-C 109.311 -0.626 . . . . 0.0 109.311 175.268 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' E' E ' 47' ' ' LYS . . . . . . . . . . . . . 60.6 mttp -99.36 128.34 45.47 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 115.976 -0.557 . . . . 0.0 111.11 178.486 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' E' E ' 48' ' ' PHE . . . . . . . . . . . . . 95.7 m-85 -110.2 131.87 54.67 Favored 'General case' 0 C--N 1.329 -0.321 0 N-CA-C 109.687 -0.486 . . . . 0.0 109.687 175.44 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' E' E ' 49' ' ' LYS . . . . . . . . . . . . . 61.9 tttm -106.99 136.6 46.58 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.485 -0.325 . . . . 0.0 110.283 178.984 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' E' E ' 50' ' ' VAL . . . . . . . . . . . . . 45.7 t -75.4 107.29 5.98 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.34 0 N-CA-C 109.023 -0.732 . . . . 0.0 109.023 175.715 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' E' E ' 51' ' ' VAL . . . . . . . . . . . . . 47.0 t -71.34 -48.07 55.98 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.261 0 O-C-N 123.511 0.507 . . . . 0.0 109.856 -174.063 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' E' E ' 52' ' ' GLN . . . . . . . . . . . . . 48.2 tt0 -168.11 135.65 2.19 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 116.051 -0.522 . . . . 0.0 111.445 -179.142 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' E' E ' 53' ' ' ALA . . . . . . . . . . . . . . . -110.34 131.44 55.05 Favored 'General case' 0 C--N 1.331 -0.23 0 CA-C-N 115.943 -0.571 . . . . 0.0 109.865 176.114 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' E' E ' 54' ' ' TYR . . . . . . . . . . . . . 34.0 t80 -129.07 108.0 18.01 Favored Pre-proline 0 CA--C 1.535 0.389 0 CA-C-O 118.28 -0.867 . . . . 0.0 110.379 -179.735 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' E' E ' 55' ' ' PRO . . . . . . . . . . . . . 73.9 Cg_endo -77.09 170.02 72.74 Favored 'Cis proline' 0 N--CA 1.499 1.833 0 CA-C-N 121.85 1.697 . . . . 0.0 112.369 -5.351 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' E' E ' 56' ' ' SER . . . . . . . . . . . . . 48.9 m -115.9 137.12 23.1 Favored Pre-proline 0 CA--C 1.538 0.518 0 CA-C-O 118.51 -0.757 . . . . 0.0 109.565 175.547 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' E' E ' 57' ' ' PRO . . . . . . . . . . . . . 59.7 Cg_endo -73.76 146.79 87.89 Favored 'Cis proline' 0 N--CA 1.497 1.712 0 CA-C-N 121.705 1.644 . . . . 0.0 111.553 -2.481 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' E' E ' 58' ' ' LEU . . . . . . . . . . . . . 31.1 tp -108.38 138.3 44.91 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.375 -0.375 . . . . 0.0 110.762 -177.509 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' E' E ' 59' ' ' ARG . . . . . . . . . . . . . 55.8 ttp180 -102.04 128.71 48.37 Favored 'General case' 0 C--N 1.327 -0.387 0 N-CA-C 109.266 -0.642 . . . . 0.0 109.266 175.837 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' E' E ' 60' ' ' VAL . . . . . . . . . . . . . 42.3 t -84.88 116.36 28.31 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.233 0 C-N-CA 120.743 -0.383 . . . . 0.0 110.815 -173.235 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' E' E ' 61' ' ' GLU . . . . . . . . . . . . . 95.8 mt-10 -131.25 159.47 37.72 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 115.909 -0.587 . . . . 0.0 110.139 175.095 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' E' E ' 62' ' ' ASP . . . . . . . . . . . . . 81.4 m-20 -54.43 -30.79 53.75 Favored 'General case' 0 C--N 1.329 -0.319 0 N-CA-C 111.893 0.331 . . . . 0.0 111.893 179.507 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' E' E ' 63' ' ' ARG . . . . . . . . . . . . . 39.0 ptt180 -78.4 -1.18 32.2 Favored 'General case' 0 CA--C 1.538 0.487 0 N-CA-C 113.72 1.007 . . . . 0.0 113.72 -175.8 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' E' E ' 64' ' ' THR . . . . . . . . . . . . . 31.6 m -93.4 148.25 22.23 Favored 'General case' 0 C--N 1.331 -0.199 0 CA-C-N 118.168 0.44 . . . . 0.0 110.305 -179.134 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' E' E ' 65' ' ' LYS . . . . . . . . . . . . . 43.7 mtmt -86.31 122.44 30.29 Favored 'General case' 0 C--N 1.329 -0.287 0 C-N-CA 120.654 -0.419 . . . . 0.0 110.213 179.413 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' E' E ' 66' ' ' ILE . . . . . . . . . . . . . 61.0 mt -112.26 125.71 69.57 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.246 0 N-CA-C 109.393 -0.595 . . . . 0.0 109.393 179.91 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' E' E ' 67' ' ' THR . . . . . . . . . . . . . 27.8 m -119.33 138.12 53.25 Favored 'General case' 0 C--N 1.331 -0.202 0 CA-C-N 116.235 -0.439 . . . . 0.0 110.891 -175.749 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' E' E ' 68' ' ' LEU . . . . . . . . . . . . . 4.4 tt -106.21 124.39 49.52 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 115.788 -0.642 . . . . 0.0 109.725 178.191 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' E' E ' 69' ' ' VAL . . . . . . . . . . . . . 41.8 t -95.32 139.17 19.35 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.281 0 CA-C-O 120.963 0.411 . . . . 0.0 110.59 -177.002 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' E' E ' 70' ' ' THR . . . . . . . . . . . . . 23.7 p -132.16 -37.95 1.1 Allowed 'General case' 0 C--N 1.332 -0.162 0 CA-C-N 115.865 -0.607 . . . . 0.0 111.037 179.799 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' E' E ' 71' ' ' HIS . . . . . . . . . . . . . 18.2 m80 -71.11 113.45 19.19 Favored Pre-proline 0 CA--C 1.536 0.416 0 CA-C-O 118.631 -0.699 . . . . 0.0 110.574 -178.887 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' E' E ' 72' ' ' PRO . . . . . . . . . . . . . 95.6 Cg_endo -82.33 -24.35 3.78 Favored 'Trans proline' 0 N--CA 1.496 1.645 0 C-N-CA 121.407 1.405 . . . . 0.0 112.989 178.966 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' E' E ' 73' ' ' VAL . . . . . . . . . . . . . 35.9 m -126.15 166.45 22.32 Favored 'Isoleucine or valine' 0 C--O 1.233 0.187 0 CA-C-O 120.8 0.333 . . . . 0.0 110.667 -179.046 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' E' E ' 74' ' ' ASP . . . . . . . . . . . . . 6.0 t70 -103.04 122.3 44.35 Favored 'General case' 0 C--N 1.329 -0.296 0 N-CA-C 109.614 -0.513 . . . . 0.0 109.614 -178.937 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' E' E ' 75' ' ' VAL . . . . . . . . . . . . . 40.5 t -119.37 125.73 74.68 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.241 0 CA-C-O 121.095 0.474 . . . . 0.0 110.808 -176.699 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' E' E ' 76' ' ' LEU . . . . . . . . . . . . . 6.0 mp -120.51 143.37 48.59 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 115.659 -0.7 . . . . 0.0 109.586 174.701 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' E' E ' 77' ' ' GLU . . . . . . . . . . . . . 47.1 mt-10 -134.99 129.05 33.57 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-O 121.022 0.439 . . . . 0.0 110.768 -178.563 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' E' E ' 78' ' ' ALA . . . . . 0.538 ' HB2' HD21 ' E' ' 109' ' ' LEU . . . -114.47 133.6 55.63 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 115.802 -0.635 . . . . 0.0 109.865 177.854 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' E' E ' 79' ' ' LYS . . . . . 0.58 ' O ' HD13 ' E' ' 80' ' ' ILE . 83.3 tttt -78.8 114.87 18.09 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.332 -0.395 . . . . 0.0 109.981 -179.792 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' E' E ' 80' ' ' ILE . . . . . 0.58 HD13 ' O ' ' E' ' 79' ' ' LYS . 41.9 mm -138.14 121.16 19.77 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.255 0 N-CA-C 109.864 -0.421 . . . . 0.0 109.864 -175.551 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' E' E ' 81' ' ' LYS . . . . . . . . . . . . . 9.6 mtmp? -110.92 126.9 55.22 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-O 120.962 0.41 . . . . 0.0 111.02 -178.426 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' E' E ' 82' ' ' GLY . . . . . . . . . . . . . . . 89.06 42.12 5.7 Favored Glycine 0 CA--C 1.525 0.679 0 C-N-CA 121.003 -0.618 . . . . 0.0 112.025 174.403 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' E' E ' 83' ' ' ILE . . . . . . . . . . . . . 74.7 mt -67.78 133.26 31.88 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.246 0 N-CA-C 109.719 -0.474 . . . . 0.0 109.719 177.329 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' E' E ' 84' ' ' LYS . . . . . . . . . . . . . 83.0 tttt -97.21 -54.15 3.25 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 115.999 -0.546 . . . . 0.0 110.465 -176.979 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' E' E ' 85' ' ' ASP . . . . . . . . . . . . . 13.8 t70 -152.15 149.87 29.24 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 115.604 -0.726 . . . . 0.0 110.163 -179.226 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' E' E ' 86' ' ' VAL . . . . . . . . . . . . . 44.0 t -133.5 131.08 57.31 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.297 0 CA-C-O 120.97 0.414 . . . . 0.0 110.523 -179.66 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' E' E ' 87' ' ' ILE . . . . . . . . . . . . . 46.9 mm -120.07 126.53 75.38 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.254 0 CA-C-N 115.846 -0.616 . . . . 0.0 109.585 176.241 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' E' E ' 88' ' ' LEU . . . . . . . . . . . . . 53.6 mt -110.96 135.75 51.0 Favored 'General case' 0 C--N 1.331 -0.218 0 CA-C-O 121.153 0.501 . . . . 0.0 111.375 -176.243 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' E' E ' 89' ' ' ASP . . . . . . . . . . . . . 7.8 t0 -128.84 150.52 50.3 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 115.596 -0.729 . . . . 0.0 109.034 175.045 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' E' E ' 90' ' ' GLU . . . . . . . . . . . . . 44.1 mt-10 -49.12 -32.82 10.65 Favored 'General case' 0 C--N 1.329 -0.31 0 N-CA-C 112.864 0.69 . . . . 0.0 112.864 -172.339 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' E' E ' 91' ' ' ASN . . . . . . . . . . . . . 65.7 m-80 -131.86 28.68 4.51 Favored 'General case' 0 N--CA 1.467 0.388 0 N-CA-C 112.412 0.523 . . . . 0.0 112.412 -176.208 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' E' E ' 92' ' ' LEU . . . . . . . . . . . . . 9.0 tp -166.2 145.7 6.02 Favored 'General case' 0 C--N 1.33 -0.258 0 N-CA-C 110.207 -0.294 . . . . 0.0 110.207 179.623 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' E' E ' 93' ' ' ILE . . . . . 0.409 HD11 HD11 ' D' ' 140' ' ' LEU . 69.2 mt -127.72 125.17 64.72 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.202 0 N-CA-C 109.795 -0.446 . . . . 0.0 109.795 179.857 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' E' E ' 94' ' ' VAL . . . . . . . . . . . . . 45.8 t -120.88 125.91 74.6 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.22 0 N-CA-C 109.688 -0.486 . . . . 0.0 109.688 179.255 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' E' E ' 95' ' ' VAL . . . . . . . . . . . . . 43.3 t -122.52 135.18 63.44 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.236 0 CA-C-N 116.205 -0.452 . . . . 0.0 109.979 -178.471 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' E' E ' 96' ' ' ILE . . . . . . . . . . . . . 57.1 mt -116.27 130.11 71.57 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 N-CA-C 109.372 -0.603 . . . . 0.0 109.372 179.224 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' E' E ' 97' ' ' THR . . . . . . . . . . . . . 72.9 p -102.23 154.85 18.64 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-O 121.184 0.516 . . . . 0.0 111.056 -178.778 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' E' E ' 98' ' ' GLU . . . . . . . . . . . . . 96.8 mt-10 -54.23 -23.26 14.07 Favored 'General case' 0 CA--C 1.533 0.318 0 N-CA-C 112.366 0.506 . . . . 0.0 112.366 178.932 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' E' E ' 99' ' ' GLU . . . . . . . . . . . . . 32.5 tt0 -79.09 14.69 1.35 Allowed 'General case' 0 CA--C 1.539 0.523 0 N-CA-C 112.688 0.625 . . . . 0.0 112.688 -177.97 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' E' E ' 100' ' ' ASN . . . . . . . . . . . . . 4.4 m-20 62.35 38.06 13.35 Favored 'General case' 0 C--O 1.231 0.117 0 O-C-N 121.801 -0.562 . . . . 0.0 111.002 178.817 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' E' E ' 101' ' ' GLU . . . . . . . . . . . . . 84.9 tt0 -118.01 142.64 47.16 Favored 'General case' 0 C--N 1.331 -0.212 0 CA-C-N 115.996 -0.547 . . . . 0.0 109.845 176.263 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' E' E ' 102' ' ' VAL . . . . . . . . . . . . . 45.5 t -114.97 128.51 72.09 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.306 0 N-CA-C 109.811 -0.44 . . . . 0.0 109.811 -178.688 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' E' E ' 103' ' ' LEU . . . . . . . . . . . . . 51.0 mt -120.29 134.85 55.18 Favored 'General case' 0 C--N 1.331 -0.219 0 CA-C-N 115.865 -0.607 . . . . 0.0 110.382 178.222 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' E' E ' 104' ' ' ILE . . . . . . . . . . . . . 67.8 mt -118.78 124.36 73.03 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.304 0 N-CA-C 110.077 -0.342 . . . . 0.0 110.077 -179.745 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' E' E ' 105' ' ' PHE . . . . . . . . . . . . . 92.2 m-85 -124.07 162.77 22.84 Favored 'General case' 0 C--N 1.332 -0.194 0 O-C-N 123.912 0.758 . . . . 0.0 109.984 -179.981 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' E' E ' 106' ' ' ASN . . . . . . . . . . . . . 47.7 p-10 -98.59 -170.5 1.95 Allowed 'General case' 0 C--N 1.33 -0.279 0 N-CA-C 109.871 -0.418 . . . . 0.0 109.871 174.551 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' E' E ' 107' ' ' GLN . . . . . . . . . . . . . 46.0 tt0 -60.18 -30.07 69.1 Favored 'General case' 0 C--N 1.329 -0.297 0 N-CA-C 111.987 0.366 . . . . 0.0 111.987 -178.827 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' E' E ' 108' ' ' ASN . . . . . . . . . . . . . 59.9 t30 -84.86 10.16 12.34 Favored 'General case' 0 CA--C 1.536 0.439 0 N-CA-C 113.154 0.798 . . . . 0.0 113.154 -177.632 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' E' E ' 109' ' ' LEU . . . . . 0.538 HD21 ' HB2' ' E' ' 78' ' ' ALA . 8.4 tp 58.6 37.18 25.4 Favored 'General case' 0 C--N 1.331 -0.198 0 CA-C-O 121.065 0.459 . . . . 0.0 111.232 179.476 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' E' E ' 110' ' ' GLU . . . . . . . . . . . . . 70.5 mm-40 -103.4 142.16 34.71 Favored 'General case' 0 C--N 1.329 -0.303 0 N-CA-C 109.358 -0.608 . . . . 0.0 109.358 174.908 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' E' E ' 111' ' ' GLU . . . . . . . . . . . . . 71.6 tt0 -78.36 121.77 24.9 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-O 120.94 0.4 . . . . 0.0 110.387 -175.199 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' E' E ' 112' ' ' LEU . . . . . . . . . . . . . 15.3 mt -106.21 -46.02 4.16 Favored 'General case' 0 C--N 1.331 -0.196 0 CA-C-N 116.08 -0.509 . . . . 0.0 110.778 -178.913 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' E' E ' 113' ' ' TYR . . . . . . . . . . . . . 59.0 t80 -137.31 144.38 42.58 Favored 'General case' 0 C--N 1.331 -0.223 0 CA-C-N 116.204 -0.453 . . . . 0.0 111.012 -178.4 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' E' E ' 114' ' ' ARG . . . . . . . . . . . . . 48.1 ptt85 -147.12 125.75 12.53 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.271 -0.422 . . . . 0.0 111.003 179.073 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' E' E ' 115' ' ' GLY . . . . . . . . . . . . . . . -149.98 153.95 25.4 Favored Glycine 0 CA--C 1.525 0.678 0 N-CA-C 111.231 -0.748 . . . . 0.0 111.231 178.206 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' E' E ' 116' ' ' LYS . . . . . . . . . . . . . 25.9 ttpp -124.83 132.49 53.33 Favored 'General case' 0 C--N 1.331 -0.212 0 N-CA-C 109.942 -0.392 . . . . 0.0 109.942 178.352 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' E' E ' 117' ' ' PHE . . . . . . . . . . . . . 48.5 m-85 -130.68 115.9 17.32 Favored 'General case' 0 C--N 1.331 -0.206 0 CA-C-O 120.928 0.394 . . . . 0.0 110.373 -175.568 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' E' E ' 118' ' ' GLU . . . . . . . . . . . . . 46.1 tp10 -52.84 -51.11 62.2 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.36 -0.382 . . . . 0.0 111.784 -174.734 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' E' E ' 119' ' ' ASN . . . . . . . . . . . . . 3.2 p30 -98.45 31.31 2.88 Favored 'General case' 0 C--N 1.33 -0.274 0 N-CA-C 112.197 0.443 . . . . 0.0 112.197 -174.418 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' E' E ' 120' ' ' LEU . . . . . . . . . . . . . 14.5 tp -51.71 124.81 13.24 Favored 'General case' 0 N--CA 1.464 0.237 0 CA-C-O 120.535 0.207 . . . . 0.0 111.057 178.025 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' E' E ' 121' ' ' ASN . . . . . . . . . . . . . 15.6 m120 -113.55 -44.06 3.25 Favored 'General case' 0 C--O 1.232 0.183 0 CA-C-N 116.727 -0.215 . . . . 0.0 111.285 -176.495 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' E' E ' 122' ' ' LYS . . . . . . . . . . . . . 98.8 mttt -145.36 148.53 33.48 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-O 121.049 0.452 . . . . 0.0 111.826 -176.737 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' E' E ' 123' ' ' VAL . . . . . . . . . . . . . 45.6 t -129.41 130.93 67.6 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.293 0 N-CA-C 109.396 -0.594 . . . . 0.0 109.396 175.462 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' E' E ' 124' ' ' LEU . . . . . . . . . . . . . 19.7 tp -130.26 133.97 46.9 Favored 'General case' 0 C--N 1.332 -0.163 0 CA-C-O 120.791 0.329 . . . . 0.0 110.748 -177.179 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' E' E ' 125' ' ' VAL . . . . . . . . . . . . . 11.1 p -133.67 135.49 55.49 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.25 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.303 179.776 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' E' E ' 126' ' ' ARG . . . . . . . . . . . . . 20.8 ttm180 -144.39 121.86 11.71 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.307 -0.406 . . . . 0.0 110.626 178.331 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' E' E ' 127' ' ' ASN . . . . . . . . . . . . . 4.3 m120 49.41 -106.39 0.2 Allowed 'General case' 0 CA--C 1.545 0.77 0 CA-C-O 118.957 -0.544 . . . . 0.0 111.639 178.994 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' E' E ' 128' ' ' ASP . . . . . . . . . . . . . 11.6 p-10 -114.09 4.0 15.47 Favored 'General case' 0 N--CA 1.468 0.468 0 CA-C-N 119.693 1.133 . . . . 0.0 113.408 -177.21 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' E' E ' 129' ' ' LEU . . . . . . . . . . . . . 15.5 tp -107.13 132.67 52.75 Favored 'General case' 0 C--N 1.333 -0.147 0 N-CA-C 109.561 -0.533 . . . . 0.0 109.561 178.617 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' E' E ' 130' ' ' VAL . . . . . . . . . . . . . 41.5 t -122.92 136.55 59.35 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.243 0 CA-C-O 120.668 0.271 . . . . 0.0 110.349 -177.309 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' E' E ' 131' ' ' VAL . . . . . 0.521 HG12 HD12 ' E' ' 140' ' ' LEU . 27.1 m -136.07 140.81 43.23 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.236 0 CA-C-O 121.166 0.508 . . . . 0.0 111.274 177.579 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' E' E ' 132' ' ' ILE . . . . . . . . . . . . . 75.5 mt -121.22 132.4 70.67 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.384 0 CA-C-N 115.39 -0.823 . . . . 0.0 109.171 178.125 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' E' E ' 133' ' ' ILE . . . . . . . . . . . . . 33.2 mm -115.37 121.17 66.65 Favored 'Isoleucine or valine' 0 C--O 1.234 0.251 0 CA-C-O 120.898 0.38 . . . . 0.0 111.237 -173.464 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' E' E ' 134' ' ' ASP . . . . . . . . . . . . . 7.3 p-10 -133.59 146.53 51.05 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 115.904 -0.589 . . . . 0.0 109.584 175.724 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' E' E ' 135' ' ' GLU . . . . . . . . . . . . . 39.2 tp10 -49.93 -26.8 4.49 Favored 'General case' 0 C--N 1.326 -0.422 0 N-CA-C 112.815 0.672 . . . . 0.0 112.815 -173.407 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' E' E ' 136' ' ' GLN . . . . . . . . . . . . . 49.7 tt0 -81.91 -32.99 30.66 Favored 'General case' 0 C--O 1.234 0.274 0 N-CA-C 112.328 0.492 . . . . 0.0 112.328 -175.968 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' E' E ' 137' ' ' LYS . . . . . . . . . . . . . 50.7 pttt -170.06 173.04 6.14 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-O 121.451 0.643 . . . . 0.0 112.27 -172.967 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' E' E ' 138' ' ' LEU . . . . . 0.405 ' C ' HD23 ' E' ' 138' ' ' LEU . 6.6 tt -118.33 129.13 55.26 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 115.212 -0.904 . . . . 0.0 110.055 179.521 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' E' E ' 139' ' ' THR . . . . . . . . . . . . . 24.4 m -106.87 130.25 54.58 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.439 -0.346 . . . . 0.0 110.516 -179.803 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' E' E ' 140' ' ' LEU . . . . . 0.521 HD12 HG12 ' E' ' 131' ' ' VAL . 51.2 tp -118.34 127.21 53.48 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 115.784 -0.644 . . . . 0.0 109.413 -177.766 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' E' E ' 141' ' ' ILE . . . . . . . . . . . . . 19.1 mt -123.49 122.38 64.92 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 CA-C-N 116.397 -0.365 . . . . 0.0 110.143 -174.996 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' E' E ' 142' ' ' ARG . . . . . . . . . . . . . 84.4 mtp180 -108.77 129.41 55.38 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-N 115.523 -0.762 . . . . 0.0 110.455 179.46 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' E' E ' 143' ' ' THR . . . . . . . . . . . . . 40.0 p . . . . . 0 C--O 1.221 -0.442 0 CA-C-O 117.961 -1.018 . . . . 0.0 110.605 179.145 . . . . . . . . 0 0 . 1 . 006 nuclear build full ' F' F ' -3' ' ' GLU . . . . . . . . . . . . . 95.7 mt-10 . . . . . 0 N--CA 1.49 1.56 0 N-CA-C 109.36 -0.607 . . . . 0.0 109.36 . . . . . . . . . 0 0 . 1 . 006 nuclear build full ' F' F ' -2' ' ' GLY . . . . . . . . . . . . . . . -69.48 136.37 27.99 Favored Glycine 0 CA--C 1.524 0.655 0 N-CA-C 110.918 -0.873 . . . . 0.0 110.918 179.699 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' F' F ' -1' ' ' VAL . . . . . . . . . . . . . 42.6 t -141.0 142.07 30.42 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.27 0 N-CA-C 109.907 -0.405 . . . . 0.0 109.907 179.306 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' F' F ' 0' ' ' ILE . . . . . . . . . . . . . 43.4 mm -102.3 135.05 41.16 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.285 0 CA-C-N 116.263 -0.426 . . . . 0.0 110.157 -179.355 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' F' F ' 1' ' ' MET . . . . . . . . . . . . . 24.2 ptp -90.63 144.48 25.71 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.228 -0.442 . . . . 0.0 110.728 -178.899 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' F' F ' 2' ' ' SER . . . . . . . . . . . . . 4.5 p -115.79 131.19 57.01 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.107 -0.497 . . . . 0.0 110.098 177.249 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' F' F ' 3' ' ' GLU . . . . . . . . . . . . . 84.8 tt0 -142.75 141.07 31.67 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.054 -0.521 . . . . 0.0 111.08 -178.304 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' F' F ' 4' ' ' LEU . . . . . . . . . . . . . 18.0 tp -127.41 132.52 50.1 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 115.883 -0.599 . . . . 0.0 110.216 178.097 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' F' F ' 5' ' ' LYS . . . . . . . . . . . . . 68.6 mttm -112.03 121.06 43.95 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-N 116.338 -0.392 . . . . 0.0 110.665 179.477 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' F' F ' 6' ' ' LEU . . . . . . . . . . . . . 68.4 mt -116.61 144.76 44.0 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 115.451 -0.795 . . . . 0.0 110.158 -178.394 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' F' F ' 7' ' ' LYS . . . . . . . . . . . . . 1.7 ttmp? -130.56 135.25 27.1 Favored Pre-proline 0 CA--C 1.534 0.351 0 CA-C-O 118.848 -0.596 . . . . 0.0 110.293 177.627 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' F' F ' 8' ' ' PRO . . . . . . . . . . . . . 62.9 Cg_endo -91.03 137.91 2.26 Favored 'Trans proline' 0 N--CA 1.49 1.265 0 C-N-CA 121.715 1.61 . . . . 0.0 111.348 175.75 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' F' F ' 9' ' ' LEU . . . . . . . . . . . . . 50.6 mt -77.01 -47.45 2.72 Favored Pre-proline 0 CA--C 1.532 0.274 0 CA-C-O 118.762 -0.637 . . . . 0.0 112.241 -176.693 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' F' F ' 10' ' ' PRO . . . . . . . . . . . . . 93.0 Cg_endo -82.03 151.21 16.17 Favored 'Trans proline' 0 N--CA 1.498 1.744 0 C-N-CA 121.178 1.252 . . . . 0.0 111.607 174.956 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' F' F ' 11' ' ' LYS . . . . . . . . . . . . . 19.5 pttp -84.6 114.02 21.68 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-O 121.623 0.725 . . . . 0.0 110.682 178.166 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' F' F ' 12' ' ' VAL . . . . . . . . . . . . . 11.5 p -151.05 148.79 14.69 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.241 0 CA-C-N 115.534 -0.757 . . . . 0.0 110.059 179.918 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' F' F ' 13' ' ' GLU . . . . . . . . . . . . . 84.8 tt0 -89.58 122.87 33.15 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-O 120.822 0.344 . . . . 0.0 110.246 178.458 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' F' F ' 14' ' ' LEU . . . . . . . . . . . . . 21.1 mt -97.61 151.48 37.64 Favored Pre-proline 0 C--N 1.33 -0.266 0 CA-C-N 116.293 -0.412 . . . . 0.0 110.431 -178.342 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' F' F ' 15' ' ' PRO . . . . . . . . . . . . . 27.0 Cg_exo -61.17 156.58 44.38 Favored 'Trans proline' 0 N--CA 1.496 1.676 0 C-N-CA 121.21 1.273 . . . . 0.0 111.577 177.381 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' F' F ' 16' ' ' PRO . . . . . . . . . . . . . 39.5 Cg_exo -58.78 -35.66 98.27 Favored 'Trans proline' 0 N--CA 1.496 1.621 0 C-N-CA 121.436 1.424 . . . . 0.0 112.708 -179.62 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' F' F ' 17' ' ' ASP . . . . . . . . . . . . . 12.4 p-10 -88.24 11.17 17.2 Favored 'General case' 0 CA--C 1.536 0.427 0 N-CA-C 113.12 0.785 . . . . 0.0 113.12 -178.211 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' F' F ' 18' ' ' PHE . . . . . . . . . . . . . 61.6 t80 -58.06 -43.52 86.95 Favored 'General case' 0 C--N 1.333 -0.111 0 O-C-N 121.994 -0.441 . . . . 0.0 110.131 -178.232 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' F' F ' 19' ' ' VAL . . . . . . . . . . . . . 48.5 t -57.01 -42.06 78.54 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.308 0 CA-C-N 116.256 -0.429 . . . . 0.0 110.416 -178.568 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' F' F ' 20' ' ' ASP . . . . . . . . . . . . . 17.0 t0 -59.95 -42.59 94.36 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-O 120.872 0.368 . . . . 0.0 110.882 -178.303 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' F' F ' 21' ' ' VAL . . . . . . . . . . . . . 48.0 t -64.55 -46.23 93.23 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.285 0 C-N-CA 120.84 -0.344 . . . . 0.0 110.518 -177.988 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' F' F ' 22' ' ' ILE . . . . . 0.603 HG22 HD12 ' F' ' 26' ' ' LEU . 48.5 mm -56.34 -45.04 81.35 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.177 0 C-N-CA 120.92 -0.312 . . . . 0.0 110.583 178.968 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' F' F ' 23' ' ' ARG . . . . . . . . . . . . . 56.6 ttp180 -54.39 -48.55 71.42 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-O 120.738 0.304 . . . . 0.0 111.305 -179.27 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' F' F ' 24' ' ' ILE . . . . . . . . . . . . . 72.4 mt -59.19 -44.3 91.54 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.21 0 CA-C-N 116.493 -0.321 . . . . 0.0 110.935 -178.047 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' F' F ' 25' ' ' LYS . . . . . . . . . . . . . 44.8 mtpt -63.91 -43.31 96.33 Favored 'General case' 0 C--N 1.328 -0.347 0 N-CA-C 112.357 0.502 . . . . 0.0 112.357 -177.997 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' F' F ' 26' ' ' LEU . . . . . 0.603 HD12 HG22 ' F' ' 22' ' ' ILE . 67.7 mt -79.18 -40.95 29.55 Favored 'General case' 0 C--N 1.33 -0.273 0 N-CA-C 113.428 0.899 . . . . 0.0 113.428 -170.551 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' F' F ' 27' ' ' GLN . . . . . . . . . . . . . 15.5 pt20 -46.67 137.66 6.73 Favored 'General case' 0 N--CA 1.468 0.449 0 N-CA-C 112.871 0.693 . . . . 0.0 112.871 -174.607 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' F' F ' 28' ' ' GLY . . . . . . . . . . . . . . . 100.47 -25.85 26.76 Favored Glycine 0 CA--C 1.533 1.181 0 CA-C-N 115.571 -0.741 . . . . 0.0 112.312 -177.589 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' F' F ' 29' ' ' LYS . . . . . . . . . . . . . 55.1 mmtt -97.4 155.17 17.03 Favored 'General case' 0 C--O 1.232 0.169 0 CA-C-N 117.272 0.536 . . . . 0.0 111.304 178.253 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' F' F ' 30' ' ' THR . . . . . . . . . . . . . 26.6 m -107.09 134.28 50.45 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 115.517 -0.765 . . . . 0.0 109.577 174.802 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' F' F ' 31' ' ' VAL . . . . . . . . . . . . . 35.0 m -130.1 158.94 42.54 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.226 0 CA-C-O 120.926 0.393 . . . . 0.0 110.918 -177.086 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' F' F ' 32' ' ' ARG . . . . . . . . . . . . . 34.9 mtp180 -131.46 152.82 50.36 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-O 121.458 0.647 . . . . 0.0 110.94 179.095 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' F' F ' 33' ' ' THR . . . . . 0.41 HG23 ' O ' ' F' ' 51' ' ' VAL . 16.8 m -53.53 139.67 30.64 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 115.786 -0.643 . . . . 0.0 111.22 -179.417 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' F' F ' 34' ' ' GLY . . . . . . . . . . . . . . . 101.81 -17.05 55.45 Favored Glycine 0 CA--C 1.533 1.181 0 CA-C-O 119.635 -0.536 . . . . 0.0 113.287 179.261 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' F' F ' 35' ' ' ASP . . . . . . . . . . . . . 72.0 m-20 -64.9 148.4 51.53 Favored 'General case' 0 N--CA 1.461 0.106 0 CA-C-N 118.073 0.936 . . . . 0.0 111.19 178.98 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' F' F ' 36' ' ' VAL . . . . . . . . . . . . . 44.3 t -124.01 131.82 72.32 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.179 0 CA-C-N 115.929 -0.578 . . . . 0.0 109.906 179.844 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' F' F ' 37' ' ' ILE . . . . . . . . . . . . . 68.4 mt -122.93 139.9 48.32 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.195 0 CA-C-N 116.076 -0.511 . . . . 0.0 109.777 179.702 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' F' F ' 38' ' ' GLY . . . . . . . . . . . . . . . -115.2 128.99 8.35 Favored Glycine 0 CA--C 1.526 0.742 0 N-CA-C 110.904 -0.878 . . . . 0.0 110.904 179.508 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' F' F ' 39' ' ' ILE . . . . . . . . . . . . . 72.6 mt -123.69 136.21 60.91 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.229 0 CA-C-O 120.722 0.296 . . . . 0.0 110.359 -179.18 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' F' F ' 40' ' ' SER . . . . . . . . . . . . . 48.0 t -93.77 120.3 33.86 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.326 -0.397 . . . . 0.0 110.654 173.833 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' F' F ' 41' ' ' ILE . . . . . . . . . . . . . 72.3 mt -125.84 121.07 58.91 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.243 0 CA-C-O 120.817 0.341 . . . . 0.0 110.343 178.337 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' F' F ' 42' ' ' LEU . . . . . . . . . . . . . 7.0 mp 50.94 35.09 11.72 Favored 'General case' 0 CA--C 1.532 0.256 0 CA-C-O 121.131 0.491 . . . . 0.0 111.636 178.326 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' F' F ' 43' ' ' GLY . . . . . . . . . . . . . . . 73.03 32.84 60.18 Favored Glycine 0 CA--C 1.527 0.839 0 C-N-CA 121.132 -0.556 . . . . 0.0 112.076 177.842 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' F' F ' 44' ' ' LYS . . . . . . . . . . . . . 44.7 tttp -137.54 130.01 29.65 Favored 'General case' 0 C--N 1.329 -0.288 0 N-CA-C 109.539 -0.541 . . . . 0.0 109.539 178.318 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' F' F ' 45' ' ' GLU . . . . . . . . . . . . . 77.5 tt0 -84.15 123.59 30.25 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.529 -0.305 . . . . 0.0 111.336 -175.462 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' F' F ' 46' ' ' VAL . . . . . . . . . . . . . 7.2 p -124.7 130.31 73.44 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.207 0 CA-C-O 120.918 0.389 . . . . 0.0 109.994 176.876 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' F' F ' 47' ' ' LYS . . . . . . . . . . . . . 33.8 mmtp -99.75 132.22 45.23 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 115.906 -0.588 . . . . 0.0 111.298 177.647 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' F' F ' 48' ' ' PHE . . . . . . . . . . . . . 95.4 m-85 -115.8 131.87 56.81 Favored 'General case' 0 C--N 1.331 -0.208 0 N-CA-C 109.603 -0.517 . . . . 0.0 109.603 174.449 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' F' F ' 49' ' ' LYS . . . . . . . . . . . . . 82.4 tttt -108.92 135.88 49.38 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.338 -0.392 . . . . 0.0 110.51 179.553 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' F' F ' 50' ' ' VAL . . . . . . . . . . . . . 47.1 t -79.03 105.82 8.98 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.253 0 N-CA-C 109.127 -0.694 . . . . 0.0 109.127 176.061 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' F' F ' 51' ' ' VAL . . . . . 0.41 ' O ' HG23 ' F' ' 33' ' ' THR . 46.3 t -70.54 -53.48 22.33 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.298 0 CA-C-N 115.887 -0.597 . . . . 0.0 109.579 -174.271 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' F' F ' 52' ' ' GLN . . . . . . . . . . . . . 90.9 mt-30 -153.75 152.05 30.3 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 115.974 -0.557 . . . . 0.0 111.742 -178.114 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' F' F ' 53' ' ' ALA . . . . . 0.463 ' HB1' ' HB2' ' F' ' 58' ' ' LEU . . . -128.42 132.92 48.47 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 115.317 -0.856 . . . . 0.0 109.765 174.547 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' F' F ' 54' ' ' TYR . . . . . . . . . . . . . 82.3 t80 -129.13 111.67 18.31 Favored Pre-proline 0 CA--C 1.535 0.368 0 CA-C-O 118.298 -0.858 . . . . 0.0 110.402 179.473 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' F' F ' 55' ' ' PRO . . . . . . . . . . . . . 73.6 Cg_endo -77.05 169.6 73.93 Favored 'Cis proline' 0 N--CA 1.5 1.854 0 CA-C-N 122.023 1.758 . . . . 0.0 112.226 -6.227 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' F' F ' 56' ' ' SER . . . . . . . . . . . . . 13.6 m -116.43 124.66 29.26 Favored Pre-proline 0 CA--C 1.539 0.554 0 CA-C-O 118.37 -0.824 . . . . 0.0 109.219 176.102 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' F' F ' 57' ' ' PRO . . . . . . . . . . . . . 53.9 Cg_endo -69.55 149.32 87.88 Favored 'Cis proline' 0 N--CA 1.498 1.754 0 CA-C-N 122.063 1.773 . . . . 0.0 112.086 2.128 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' F' F ' 58' ' ' LEU . . . . . 0.463 ' HB2' ' HB1' ' F' ' 53' ' ' ALA . 21.4 tp -108.63 136.3 48.45 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.111 -0.495 . . . . 0.0 110.619 -179.569 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' F' F ' 59' ' ' ARG . . . . . . . . . . . . . 40.9 ttm180 -103.75 123.4 46.98 Favored 'General case' 0 C--N 1.329 -0.291 0 N-CA-C 109.346 -0.613 . . . . 0.0 109.346 175.867 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' F' F ' 60' ' ' VAL . . . . . . . . . . . . . 42.1 t -81.91 124.09 38.73 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.269 0 C-N-CA 120.638 -0.425 . . . . 0.0 110.362 -175.581 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' F' F ' 61' ' ' GLU . . . . . . . . . . . . . 79.3 tt0 -131.09 157.47 43.0 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 115.74 -0.664 . . . . 0.0 109.27 179.367 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' F' F ' 62' ' ' ASP . . . . . . . . . . . . . 10.5 t0 -51.56 -32.48 28.39 Favored 'General case' 0 C--N 1.328 -0.368 0 N-CA-C 112.138 0.422 . . . . 0.0 112.138 -176.692 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' F' F ' 63' ' ' ARG . . . . . . . . . . . . . 16.7 ptp180 -89.4 10.05 23.98 Favored 'General case' 0 N--CA 1.466 0.36 0 N-CA-C 113.613 0.968 . . . . 0.0 113.613 -176.157 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' F' F ' 64' ' ' THR . . . . . . . . . . . . . 22.4 m -80.15 143.34 33.95 Favored 'General case' 0 C--N 1.331 -0.21 0 CA-C-N 118.001 0.364 . . . . 0.0 110.63 -178.508 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' F' F ' 65' ' ' LYS . . . . . . . . . . . . . 95.9 mttt -87.47 126.69 35.05 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.169 -0.468 . . . . 0.0 110.008 179.372 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' F' F ' 66' ' ' ILE . . . . . . . . . . . . . 66.6 mt -118.2 129.52 74.41 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.288 0 N-CA-C 109.903 -0.406 . . . . 0.0 109.903 -179.404 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' F' F ' 67' ' ' THR . . . . . . . . . . . . . 24.4 m -121.0 138.97 53.91 Favored 'General case' 0 C--N 1.331 -0.207 0 CA-C-N 116.248 -0.433 . . . . 0.0 110.856 -178.189 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' F' F ' 68' ' ' LEU . . . . . . . . . . . . . 15.2 tp -107.42 126.18 52.16 Favored 'General case' 0 C--N 1.332 -0.172 0 CA-C-N 115.929 -0.578 . . . . 0.0 110.347 179.155 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' F' F ' 69' ' ' VAL . . . . . . . . . . . . . 44.8 t -102.86 138.81 25.69 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.26 0 CA-C-N 116.068 -0.515 . . . . 0.0 110.17 178.873 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' F' F ' 70' ' ' THR . . . . . 0.428 HG23 ' N ' ' F' ' 71' ' ' HIS . 6.6 t -132.7 -39.46 0.99 Allowed 'General case' 0 C--N 1.332 -0.181 0 CA-C-N 116.138 -0.483 . . . . 0.0 110.726 179.549 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' F' F ' 71' ' ' HIS . . . . . 0.428 ' N ' HG23 ' F' ' 70' ' ' THR . 71.5 t60 -149.82 105.65 3.23 Favored Pre-proline 0 CA--C 1.535 0.366 0 CA-C-O 118.71 -0.662 . . . . 0.0 110.267 -179.649 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' F' F ' 72' ' ' PRO . . . . . . . . . . . . . 57.2 Cg_endo -70.3 160.04 50.92 Favored 'Trans proline' 0 N--CA 1.496 1.665 0 C-N-CA 121.274 1.316 . . . . 0.0 112.247 -177.984 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' F' F ' 73' ' ' VAL . . . . . . . . . . . . . 34.6 m -110.53 154.9 12.0 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.204 0 CA-C-N 116.18 -0.463 . . . . 0.0 110.193 178.541 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' F' F ' 74' ' ' ASP . . . . . . . . . . . . . 7.5 t0 -97.6 124.77 42.0 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.138 -0.483 . . . . 0.0 110.157 -177.769 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' F' F ' 75' ' ' VAL . . . . . . . . . . . . . 42.7 t -113.42 125.93 70.77 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.247 0 CA-C-O 121.078 0.466 . . . . 0.0 110.446 -178.745 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' F' F ' 76' ' ' LEU . . . . . . . . . . . . . 27.0 mt -128.78 149.54 50.68 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 115.671 -0.695 . . . . 0.0 109.727 178.737 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' F' F ' 77' ' ' GLU . . . . . . . . . . . . . 47.2 mt-10 -136.05 140.31 43.73 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-O 121.004 0.43 . . . . 0.0 111.44 -176.526 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' F' F ' 78' ' ' ALA . . . . . . . . . . . . . . . -124.03 126.62 46.58 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 115.663 -0.698 . . . . 0.0 109.56 175.906 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' F' F ' 79' ' ' LYS . . . . . 0.587 ' O ' HD13 ' F' ' 80' ' ' ILE . 53.7 pttt -80.06 123.93 28.29 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-O 121.133 0.492 . . . . 0.0 111.341 -176.714 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' F' F ' 80' ' ' ILE . . . . . 0.587 HD13 ' O ' ' F' ' 79' ' ' LYS . 39.5 mm -139.14 118.49 13.58 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.238 0 CA-C-N 115.901 -0.591 . . . . 0.0 109.692 -178.287 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' F' F ' 81' ' ' LYS . . . . . . . . . . . . . 40.2 mmtt -96.1 118.87 33.55 Favored 'General case' 0 C--N 1.327 -0.374 0 C-N-CA 120.905 -0.318 . . . . 0.0 111.205 179.667 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' F' F ' 82' ' ' GLY . . . . . . . . . . . . . . . 89.19 42.17 5.65 Favored Glycine 0 CA--C 1.526 0.747 0 C-N-CA 120.654 -0.784 . . . . 0.0 112.027 172.202 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' F' F ' 83' ' ' ILE . . . . . . . . . . . . . 73.1 mt -64.47 134.21 29.35 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.294 0 N-CA-C 109.505 -0.554 . . . . 0.0 109.505 175.835 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' F' F ' 84' ' ' LYS . . . . . . . . . . . . . 36.5 ttpt -97.73 -53.97 3.26 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-O 120.992 0.425 . . . . 0.0 110.14 -179.346 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' F' F ' 85' ' ' ASP . . . . . . . . . . . . . 9.1 t70 -149.35 151.56 34.33 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 115.745 -0.661 . . . . 0.0 110.503 -179.472 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' F' F ' 86' ' ' VAL . . . . . . . . . . . . . 44.6 t -126.67 130.58 71.63 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.218 0 CA-C-O 120.952 0.406 . . . . 0.0 110.321 -178.986 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' F' F ' 87' ' ' ILE . . . . . . . . . . . . . 43.4 mm -119.2 126.2 75.14 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.304 0 CA-C-N 115.84 -0.618 . . . . 0.0 109.388 177.961 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' F' F ' 88' ' ' LEU . . . . . . . . . . . . . 13.0 tp -116.94 135.32 53.8 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-O 120.976 0.417 . . . . 0.0 111.394 -175.943 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' F' F ' 89' ' ' ASP . . . . . . . . . . . . . 6.1 t70 -132.17 156.31 46.65 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 115.812 -0.631 . . . . 0.0 109.457 175.228 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' F' F ' 90' ' ' GLU . . . . . . . . . . . . . 96.6 mt-10 -48.03 -36.95 13.78 Favored 'General case' 0 C--N 1.33 -0.28 0 N-CA-C 113.176 0.806 . . . . 0.0 113.176 -171.123 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' F' F ' 91' ' ' ASN . . . . . . . . . . . . . 35.3 m120 -123.44 13.14 9.45 Favored 'General case' 0 N--CA 1.468 0.466 0 N-CA-C 113.555 0.946 . . . . 0.0 113.555 -174.763 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' F' F ' 92' ' ' LEU . . . . . . . . . . . . . 44.3 mt -149.73 147.98 28.69 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-N 117.925 0.33 . . . . 0.0 110.721 -176.577 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' F' F ' 93' ' ' ILE . . . . . . . . . . . . . 74.0 mt -122.71 118.3 54.62 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.268 0 N-CA-C 109.102 -0.703 . . . . 0.0 109.102 175.736 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' F' F ' 94' ' ' VAL . . . . . . . . . . . . . 45.5 t -117.42 127.28 74.91 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.249 0 N-CA-C 109.743 -0.466 . . . . 0.0 109.743 -179.054 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' F' F ' 95' ' ' VAL . . . . . . . . . . . . . 43.0 t -123.21 134.94 64.77 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.364 0 CA-C-N 116.1 -0.5 . . . . 0.0 109.964 -178.958 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' F' F ' 96' ' ' ILE . . . . . 0.406 HD11 ' HB ' ' F' ' 123' ' ' VAL . 65.8 mt -115.45 126.28 72.95 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.308 0 N-CA-C 109.259 -0.645 . . . . 0.0 109.259 178.718 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' F' F ' 97' ' ' THR . . . . . . . . . . . . . 69.4 p -99.75 155.93 17.37 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-O 121.228 0.537 . . . . 0.0 110.957 -177.341 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' F' F ' 98' ' ' GLU . . . . . . . . . . . . . 84.9 tt0 -53.87 -24.91 17.45 Favored 'General case' 0 CA--C 1.536 0.422 0 CA-C-N 116.057 -0.519 . . . . 0.0 112.267 179.658 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' F' F ' 99' ' ' GLU . . . . . . . . . . . . . 96.8 mt-10 -77.55 12.89 1.42 Allowed 'General case' 0 CA--C 1.537 0.45 0 N-CA-C 113.301 0.852 . . . . 0.0 113.301 -177.924 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' F' F ' 100' ' ' ASN . . . . . . . . . . . . . 2.2 m-20 61.84 33.62 17.55 Favored 'General case' 0 N--CA 1.464 0.262 0 CA-C-N 118.099 0.409 . . . . 0.0 111.315 -179.74 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' F' F ' 101' ' ' GLU . . . . . . . . . . . . . 54.4 tt0 -110.27 143.69 40.07 Favored 'General case' 0 C--N 1.333 -0.137 0 N-CA-C 109.571 -0.529 . . . . 0.0 109.571 174.189 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' F' F ' 102' ' ' VAL . . . . . . . . . . . . . 46.7 t -115.39 127.16 73.06 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.295 0 N-CA-C 109.84 -0.429 . . . . 0.0 109.84 -178.39 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' F' F ' 103' ' ' LEU . . . . . . . . . . . . . 19.7 mt -118.64 132.58 56.18 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 115.864 -0.607 . . . . 0.0 110.715 178.711 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' F' F ' 104' ' ' ILE . . . . . 0.575 HD13 HG11 ' F' ' 130' ' ' VAL . 63.8 mt -116.85 120.65 65.68 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.277 0 N-CA-C 109.81 -0.441 . . . . 0.0 109.81 177.921 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' F' F ' 105' ' ' PHE . . . . . . . . . . . . . 92.3 m-85 -120.43 162.78 18.95 Favored 'General case' 0 C--N 1.332 -0.157 0 O-C-N 123.859 0.724 . . . . 0.0 109.91 -179.906 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' F' F ' 106' ' ' ASN . . . . . . . . . . . . . 45.6 p-10 -97.62 -174.09 2.81 Favored 'General case' 0 C--N 1.33 -0.268 0 N-CA-C 109.593 -0.521 . . . . 0.0 109.593 172.214 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' F' F ' 107' ' ' GLN . . . . . . . . . . . . . 29.1 tt0 -62.21 -19.24 62.95 Favored 'General case' 0 CA--C 1.536 0.429 0 N-CA-C 112.586 0.588 . . . . 0.0 112.586 -178.725 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' F' F ' 108' ' ' ASN . . . . . . . . . . . . . 17.2 t30 -95.68 14.09 24.23 Favored 'General case' 0 CA--C 1.535 0.393 0 N-CA-C 113.124 0.787 . . . . 0.0 113.124 -178.259 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' F' F ' 109' ' ' LEU . . . . . . . . . . . . . 52.5 mt 58.98 38.92 24.1 Favored 'General case' 0 C--O 1.232 0.155 0 CA-C-O 121.139 0.495 . . . . 0.0 111.395 178.095 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' F' F ' 110' ' ' GLU . . . . . . . . . . . . . 96.5 mt-10 -106.14 156.9 17.97 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.15 -0.477 . . . . 0.0 109.95 176.055 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' F' F ' 111' ' ' GLU . . . . . . . . . . . . . 84.5 tt0 -86.98 121.91 30.1 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-O 120.884 0.374 . . . . 0.0 111.107 -177.258 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' F' F ' 112' ' ' LEU . . . . . . . . . . . . . 31.4 mt -108.43 -45.95 3.79 Favored 'General case' 0 C--N 1.332 -0.189 0 CA-C-N 116.054 -0.521 . . . . 0.0 110.448 176.735 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' F' F ' 113' ' ' TYR . . . . . 0.455 ' HB3' HD12 ' F' ' 104' ' ' ILE . 55.5 t80 -141.86 138.55 32.21 Favored 'General case' 0 C--N 1.331 -0.229 0 C-N-CA 120.614 -0.434 . . . . 0.0 111.319 179.947 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' F' F ' 114' ' ' ARG . . . . . . . . . . . . . 23.7 ttm180 -138.1 124.2 20.28 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.232 -0.44 . . . . 0.0 110.195 176.539 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' F' F ' 115' ' ' GLY . . . . . . . . . . . . . . . -150.17 159.64 28.2 Favored Glycine 0 CA--C 1.525 0.676 0 N-CA-C 110.798 -0.921 . . . . 0.0 110.798 178.283 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' F' F ' 116' ' ' LYS . . . . . . . . . . . . . 55.4 tttt -132.6 135.33 45.83 Favored 'General case' 0 C--N 1.329 -0.305 0 N-CA-C 110.098 -0.334 . . . . 0.0 110.098 178.714 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' F' F ' 117' ' ' PHE . . . . . . . . . . . . . 26.3 m-85 -137.72 116.31 12.11 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-O 120.799 0.333 . . . . 0.0 110.309 -174.611 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' F' F ' 118' ' ' GLU . . . . . . . . . . . . . 46.0 tp10 -53.96 -44.58 70.85 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.594 -0.276 . . . . 0.0 111.309 -177.621 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' F' F ' 119' ' ' ASN . . . . . . . . . . . . . 11.7 m120 -97.09 31.1 2.51 Favored 'General case' 0 C--N 1.329 -0.309 0 N-CA-C 112.202 0.445 . . . . 0.0 112.202 -174.497 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' F' F ' 120' ' ' LEU . . . . . . . . . . . . . 15.5 tp -57.76 122.53 13.06 Favored 'General case' 0 C--N 1.333 -0.126 0 N-CA-C 110.225 -0.287 . . . . 0.0 110.225 177.744 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' F' F ' 121' ' ' ASN . . . . . . . . . . . . . 88.6 m-20 -113.75 -43.95 3.23 Favored 'General case' 0 C--N 1.333 -0.124 0 CA-C-N 116.66 -0.246 . . . . 0.0 111.232 -176.729 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' F' F ' 122' ' ' LYS . . . . . . . . . . . . . 51.2 mttm -143.74 144.73 31.96 Favored 'General case' 0 C--N 1.33 -0.25 0 C-N-CA 120.629 -0.428 . . . . 0.0 111.669 -177.408 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' F' F ' 123' ' ' VAL . . . . . 0.406 ' HB ' HD11 ' F' ' 96' ' ' ILE . 43.9 t -127.18 127.84 69.77 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.249 0 N-CA-C 109.328 -0.619 . . . . 0.0 109.328 174.795 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' F' F ' 124' ' ' LEU . . . . . . . . . . . . . 56.5 mt -128.78 139.2 52.3 Favored 'General case' 0 C--N 1.331 -0.211 0 CA-C-O 120.792 0.33 . . . . 0.0 110.933 -176.653 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' F' F ' 125' ' ' VAL . . . . . . . . . . . . . 12.8 p -137.88 137.72 44.63 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.249 0 CA-C-N 116.344 -0.389 . . . . 0.0 110.569 178.487 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' F' F ' 126' ' ' ARG . . . . . . . . . . . . . 55.2 ttt180 -163.87 135.31 4.68 Favored 'General case' 0 C--N 1.33 -0.243 0 N-CA-C 109.803 -0.443 . . . . 0.0 109.803 177.775 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' F' F ' 127' ' ' ASN . . . . . . . . . . . . . 77.7 m-20 55.39 -153.34 0.33 Allowed 'General case' 0 CA--C 1.541 0.607 0 N-CA-C 109.974 -0.38 . . . . 0.0 109.974 -179.791 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' F' F ' 128' ' ' ASP . . . . . . . . . . . . . 10.4 p-10 -80.76 16.06 1.54 Allowed 'General case' 0 CA--C 1.535 0.386 0 N-CA-C 112.815 0.672 . . . . 0.0 112.815 179.439 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' F' F ' 129' ' ' LEU . . . . . . . . . . . . . 38.5 mt -117.51 138.32 51.97 Favored 'General case' 0 C--O 1.231 0.106 0 CA-C-N 118.131 0.423 . . . . 0.0 110.371 179.778 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' F' F ' 130' ' ' VAL . . . . . 0.575 HG11 HD13 ' F' ' 104' ' ' ILE . 12.9 p -132.07 141.0 46.59 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.217 0 N-CA-C 109.919 -0.4 . . . . 0.0 109.919 175.983 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' F' F ' 131' ' ' VAL . . . . . 0.417 HG22 HD12 ' F' ' 140' ' ' LEU . 39.4 t -134.58 140.77 45.03 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.218 0 CA-C-O 121.13 0.491 . . . . 0.0 110.636 -175.24 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' F' F ' 132' ' ' ILE . . . . . . . . . . . . . 71.4 mt -119.28 130.75 73.53 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.316 0 CA-C-N 115.526 -0.761 . . . . 0.0 109.133 177.451 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' F' F ' 133' ' ' ILE . . . . . . . . . . . . . 41.4 mm -117.87 123.49 71.75 Favored 'Isoleucine or valine' 0 C--O 1.233 0.221 0 CA-C-O 120.773 0.321 . . . . 0.0 111.041 -175.184 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' F' F ' 134' ' ' ASP . . . . . . . . . . . . . 8.5 p-10 -135.63 146.51 47.94 Favored 'General case' 0 C--N 1.33 -0.25 0 N-CA-C 109.57 -0.53 . . . . 0.0 109.57 173.268 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' F' F ' 135' ' ' GLU . . . . . . . . . . . . . 40.6 tp10 -49.87 -25.83 3.51 Favored 'General case' 0 C--N 1.327 -0.387 0 N-CA-C 112.725 0.639 . . . . 0.0 112.725 -173.259 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' F' F ' 136' ' ' GLN . . . . . . . . . . . . . 61.7 tt0 -82.39 -35.7 27.44 Favored 'General case' 0 C--O 1.233 0.236 0 N-CA-C 112.269 0.47 . . . . 0.0 112.269 -176.333 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' F' F ' 137' ' ' LYS . . . . . . . . . . . . . 45.6 pttt -165.12 167.98 17.68 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-O 121.486 0.66 . . . . 0.0 112.12 -172.315 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' F' F ' 138' ' ' LEU . . . . . 0.412 HD23 ' C ' ' F' ' 138' ' ' LEU . 7.3 tt -118.34 130.79 56.22 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 115.169 -0.923 . . . . 0.0 109.866 -179.526 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' F' F ' 139' ' ' THR . . . . . . . . . . . . . 38.0 m -113.1 126.22 55.23 Favored 'General case' 0 C--N 1.331 -0.21 0 CA-C-N 116.328 -0.396 . . . . 0.0 110.773 179.92 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' F' F ' 140' ' ' LEU . . . . . 0.417 HD12 HG22 ' F' ' 131' ' ' VAL . 18.7 tp -109.85 122.77 48.28 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 115.526 -0.761 . . . . 0.0 108.973 178.745 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' F' F ' 141' ' ' ILE . . . . . 0.535 ' HB ' HG13 ' F' ' 130' ' ' VAL . 19.6 mt -122.04 119.48 58.69 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.32 0 N-CA-C 109.594 -0.521 . . . . 0.0 109.594 -177.158 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' F' F ' 142' ' ' ARG . . . . . . . . . . . . . 66.4 ttp85 -110.92 128.85 55.96 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 115.488 -0.778 . . . . 0.0 110.57 -176.415 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' F' F ' 143' ' ' THR . . . . . . . . . . . . . 39.4 p . . . . . 0 C--O 1.222 -0.37 0 CA-C-O 117.952 -1.023 . . . . 0.0 110.558 -179.983 . . . . . . . . 0 0 . 1 . 007 nuclear build full ' A' A ' -3' ' ' GLU . . . . . . . . . . . . . 95.9 mt-10 . . . . . 0 N--CA 1.491 1.622 0 N-CA-C 109.46 -0.571 . . . . 0.0 109.46 . . . . . . . . . 0 0 . 1 . 007 nuclear build full ' A' A ' -2' ' ' GLY . . . . . . . . . . . . . . . -70.5 140.22 31.69 Favored Glycine 0 CA--C 1.525 0.697 0 N-CA-C 111.035 -0.826 . . . . 0.0 111.035 -179.377 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' -1' ' ' VAL . . . . . . . . . . . . . 42.9 t -141.51 144.37 26.12 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.358 0 N-CA-C 109.895 -0.409 . . . . 0.0 109.895 179.216 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 0' ' ' ILE . . . . . . . . . . . . . 44.1 mm -102.06 134.68 41.96 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.22 0 CA-C-N 116.221 -0.445 . . . . 0.0 110.381 -178.757 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 27.6 ptm -77.92 136.57 38.04 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.076 -0.511 . . . . 0.0 110.48 178.779 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 88.8 p -131.0 160.54 34.26 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.48 179.809 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 85.2 tt0 -140.5 142.53 35.25 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-N 116.149 -0.478 . . . . 0.0 111.057 -177.527 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 4' ' ' LEU . . . . . . . . . . . . . 19.0 tp -122.99 127.57 49.0 Favored 'General case' 0 C--N 1.331 -0.198 0 CA-C-N 115.964 -0.562 . . . . 0.0 110.148 177.046 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 5' ' ' LYS . . . . . . . . . . . . . 98.8 mttt -106.71 122.88 47.24 Favored 'General case' 0 C--O 1.234 0.244 0 CA-C-N 116.543 -0.299 . . . . 0.0 110.641 179.275 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 63.5 mt -116.08 144.65 43.85 Favored 'General case' 0 N--CA 1.464 0.235 0 CA-C-N 115.859 -0.609 . . . . 0.0 110.692 -179.241 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 85.0 tttt -125.81 131.22 23.94 Favored Pre-proline 0 CA--C 1.536 0.433 0 CA-C-O 118.583 -0.722 . . . . 0.0 109.523 175.758 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 8' ' ' PRO . . . . . . . . . . . . . 96.1 Cg_endo -83.56 137.79 8.12 Favored 'Trans proline' 0 N--CA 1.494 1.529 0 C-N-CA 121.295 1.33 . . . . 0.0 112.078 177.851 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 67.4 mt -77.95 -47.87 2.18 Favored Pre-proline 0 CA--C 1.534 0.352 0 CA-C-O 118.548 -0.739 . . . . 0.0 112.084 179.165 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 72.2 Cg_endo -77.8 151.34 27.99 Favored 'Trans proline' 0 N--CA 1.497 1.679 0 CA-C-N 120.28 1.136 . . . . 0.0 111.642 176.36 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 23.2 tptm -85.67 95.15 9.27 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.421 -0.354 . . . . 0.0 110.55 -179.336 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 12.1 p -143.7 144.33 23.29 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.319 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.552 -179.92 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 45.6 mp0 -90.4 127.23 36.14 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.334 -0.393 . . . . 0.0 109.963 177.58 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 14' ' ' LEU . . . . . . . . . . . . . 37.2 mt -97.87 146.89 32.24 Favored Pre-proline 0 CA--C 1.533 0.29 0 CA-C-O 119.19 -0.433 . . . . 0.0 110.371 -177.44 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 15' ' ' PRO . . . . . . . . . . . . . 26.2 Cg_exo -61.29 162.32 20.55 Favored 'Trans proline' 0 N--CA 1.498 1.759 0 C-N-CA 121.345 1.363 . . . . 0.0 111.939 178.148 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 16' ' ' PRO . . . . . . . . . . . . . 34.8 Cg_exo -59.34 -38.64 83.42 Favored 'Trans proline' 0 N--CA 1.496 1.629 0 C-N-CA 121.541 1.494 . . . . 0.0 112.907 -177.699 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 17' ' ' ASP . . . . . . . . . . . . . 18.9 p-10 -86.52 6.34 31.09 Favored 'General case' 0 CA--C 1.537 0.443 0 N-CA-C 113.303 0.853 . . . . 0.0 113.303 -178.161 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 18' ' ' PHE . . . . . . . . . . . . . 39.2 t80 -58.33 -43.09 88.07 Favored 'General case' 0 C--N 1.334 -0.108 0 O-C-N 121.982 -0.449 . . . . 0.0 110.103 -178.212 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 19' ' ' VAL . . . . . . . . . . . . . 47.5 t -56.69 -41.14 73.79 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.282 0 CA-C-N 116.243 -0.435 . . . . 0.0 110.468 -179.405 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 5.7 t70 -59.77 -42.0 92.33 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-O 120.873 0.368 . . . . 0.0 110.534 -179.002 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 47.9 t -63.86 -46.18 94.97 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.325 0 CA-C-N 116.242 -0.435 . . . . 0.0 110.301 -178.971 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 22' ' ' ILE . . . . . 0.558 HG22 HD12 ' A' ' 26' ' ' LEU . 51.6 mm -55.03 -47.93 76.41 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.282 0 CA-C-O 120.572 0.225 . . . . 0.0 110.819 179.241 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 23' ' ' ARG . . . . . . . . . . . . . 30.8 ttp180 -54.53 -51.5 64.97 Favored 'General case' 0 C--N 1.329 -0.307 0 C-N-CA 121.121 -0.232 . . . . 0.0 111.332 -177.813 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 24' ' ' ILE . . . . . . . . . . . . . 72.9 mt -59.53 -41.3 84.37 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.277 0 C-N-CA 121.031 -0.267 . . . . 0.0 111.232 -176.881 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 60.7 mtpt -68.67 -41.9 78.64 Favored 'General case' 0 C--N 1.328 -0.333 0 N-CA-C 112.45 0.537 . . . . 0.0 112.45 -177.324 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 26' ' ' LEU . . . . . 0.558 HD12 HG22 ' A' ' 22' ' ' ILE . 95.3 mt -79.57 -37.46 36.32 Favored 'General case' 0 C--N 1.33 -0.266 0 N-CA-C 113.152 0.797 . . . . 0.0 113.152 -171.365 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 27' ' ' GLN . . . . . . . . . . . . . 14.1 pt20 -46.33 140.48 4.09 Favored 'General case' 0 N--CA 1.47 0.544 0 N-CA-C 112.802 0.667 . . . . 0.0 112.802 -175.273 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 100.97 -25.44 28.33 Favored Glycine 0 CA--C 1.532 1.14 0 CA-C-N 115.575 -0.739 . . . . 0.0 112.229 -176.089 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 96.9 mttt -98.18 155.1 17.33 Favored 'General case' 0 C--O 1.233 0.185 0 CA-C-N 117.451 0.625 . . . . 0.0 111.192 179.267 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 30' ' ' THR . . . . . . . . . . . . . 41.5 m -100.96 138.73 37.62 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.138 -0.483 . . . . 0.0 110.273 177.154 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 34.7 m -131.3 148.52 32.81 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.247 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.79 -178.971 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 32' ' ' ARG . . . . . . . . . . . . . 23.0 ttm180 -130.06 146.69 51.74 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.163 -0.471 . . . . 0.0 110.26 178.166 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 33' ' ' THR . . . . . . . . . . . . . 29.6 m -52.39 139.18 25.36 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-O 120.777 0.323 . . . . 0.0 111.469 -178.285 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 98.91 -17.25 58.48 Favored Glycine 0 CA--C 1.534 1.23 0 CA-C-O 119.737 -0.479 . . . . 0.0 113.135 -179.907 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 78.1 m-20 -67.67 149.19 50.35 Favored 'General case' 0 C--N 1.334 -0.09 0 CA-C-N 117.948 0.874 . . . . 0.0 111.346 179.065 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 46.3 t -117.01 126.45 74.44 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.179 0 CA-C-N 115.652 -0.703 . . . . 0.0 109.441 176.513 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 37' ' ' ILE . . . . . . . . . . . . . 64.0 mt -118.36 137.15 53.25 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.297 0 N-CA-C 109.866 -0.42 . . . . 0.0 109.866 -179.118 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . -114.74 128.51 8.19 Favored Glycine 0 CA--C 1.524 0.656 0 N-CA-C 110.876 -0.889 . . . . 0.0 110.876 179.304 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 39' ' ' ILE . . . . . . . . . . . . . 70.4 mt -124.45 127.36 72.99 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.224 0 N-CA-C 110.08 -0.341 . . . . 0.0 110.08 179.223 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 40' ' ' SER . . . . . . . . . . . . . 27.5 t -92.84 119.04 31.76 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.312 -0.403 . . . . 0.0 110.931 176.727 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 41' ' ' ILE . . . . . . . . . . . . . 71.7 mt -134.02 129.13 53.92 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.211 0 CA-C-O 121.017 0.436 . . . . 0.0 110.462 178.491 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 8.3 tp 54.75 33.4 19.5 Favored 'General case' 0 CA--C 1.531 0.244 0 CA-C-N 115.958 -0.565 . . . . 0.0 111.737 177.523 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . 71.52 29.02 68.48 Favored Glycine 0 CA--C 1.53 0.996 0 C-N-CA 121.046 -0.597 . . . . 0.0 112.253 177.794 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 44' ' ' LYS . . . . . . . . . . . . . 81.3 tttt -139.1 127.4 22.75 Favored 'General case' 0 C--N 1.33 -0.255 0 N-CA-C 109.739 -0.467 . . . . 0.0 109.739 178.833 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 84.8 tt0 -85.24 125.78 33.15 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-N 116.375 -0.375 . . . . 0.0 111.423 -178.395 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 46' ' ' VAL . . . . . 0.405 ' O ' HG13 ' A' ' 46' ' ' VAL . 9.6 p -118.69 124.41 73.1 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.172 0 N-CA-C 109.434 -0.58 . . . . 0.0 109.434 173.587 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 61.9 mtpt -98.49 124.27 43.12 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 116.046 -0.525 . . . . 0.0 110.523 177.726 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 48' ' ' PHE . . . . . . . . . . . . . 38.9 m-85 -111.1 131.81 54.78 Favored 'General case' 0 C--N 1.328 -0.344 0 N-CA-C 109.555 -0.535 . . . . 0.0 109.555 177.573 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 43.0 tttp -106.42 131.92 53.06 Favored 'General case' 0 C--N 1.328 -0.345 0 N-CA-C 109.936 -0.394 . . . . 0.0 109.936 178.638 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 50' ' ' VAL . . . . . . . . . . . . . 46.0 t -75.38 106.58 5.27 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.332 0 N-CA-C 109.336 -0.616 . . . . 0.0 109.336 178.068 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 51' ' ' VAL . . . . . . . . . . . . . 44.6 t -71.17 -49.65 47.12 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.288 0 CA-C-N 116.165 -0.471 . . . . 0.0 109.79 -174.789 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 52' ' ' GLN . . . . . . . . . . . . . 43.3 tt0 -162.73 136.88 6.33 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 115.88 -0.6 . . . . 0.0 111.289 -178.102 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 53' ' ' ALA . . . . . 0.412 ' HB3' ' OG ' ' A' ' 56' ' ' SER . . . -115.9 132.84 56.53 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 115.968 -0.56 . . . . 0.0 109.999 176.119 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 54' ' ' TYR . . . . . . . . . . . . . 11.6 t80 -129.06 110.64 18.3 Favored Pre-proline 0 CA--C 1.534 0.346 0 CA-C-O 118.157 -0.925 . . . . 0.0 110.192 178.466 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 55' ' ' PRO . . . . . . . . . . . . . 72.7 Cg_endo -77.22 170.13 72.29 Favored 'Cis proline' 0 N--CA 1.501 1.931 0 CA-C-N 122.024 1.758 . . . . 0.0 112.49 -6.054 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 56' ' ' SER . . . . . 0.412 ' OG ' ' HB3' ' A' ' 53' ' ' ALA . 48.9 m -124.01 137.55 29.11 Favored Pre-proline 0 CA--C 1.538 0.514 0 CA-C-O 118.532 -0.747 . . . . 0.0 109.546 174.904 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 57' ' ' PRO . . . . . . . . . . . . . 37.8 Cg_endo -67.52 145.52 74.37 Favored 'Cis proline' 0 N--CA 1.498 1.778 0 CA-C-N 121.687 1.638 . . . . 0.0 111.487 -2.894 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 58' ' ' LEU . . . . . . . . . . . . . 20.7 tp -107.99 137.95 45.09 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.256 -0.429 . . . . 0.0 110.47 -178.768 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 59' ' ' ARG . . . . . . . . . . . . . 56.7 ttp180 -103.31 120.61 41.1 Favored 'General case' 0 C--N 1.328 -0.366 0 N-CA-C 109.133 -0.691 . . . . 0.0 109.133 174.917 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 42.2 t -72.95 118.53 18.29 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.276 0 C-N-CA 120.766 -0.374 . . . . 0.0 110.647 -173.8 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 70.6 mm-40 -131.02 159.12 38.45 Favored 'General case' 0 C--N 1.331 -0.216 0 CA-C-N 115.951 -0.568 . . . . 0.0 109.734 176.909 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 62' ' ' ASP . . . . . . . . . . . . . 11.0 p-10 -53.34 -31.43 44.3 Favored 'General case' 0 C--N 1.328 -0.343 0 N-CA-C 112.034 0.383 . . . . 0.0 112.034 -178.27 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 63' ' ' ARG . . . . . . . . . . . . . 86.2 mtt-85 -72.02 -21.94 61.48 Favored 'General case' 0 CA--C 1.533 0.324 0 N-CA-C 112.888 0.699 . . . . 0.0 112.888 -175.444 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 33.3 m -70.1 143.75 52.31 Favored 'General case' 0 C--N 1.332 -0.191 0 CA-C-O 120.988 0.423 . . . . 0.0 111.209 -174.479 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 65' ' ' LYS . . . . . . . . . . . . . 1.1 mptm? -89.54 134.8 33.95 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 115.839 -0.619 . . . . 0.0 110.013 177.827 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 66' ' ' ILE . . . . . . . . . . . . . 58.9 mt -114.82 130.36 69.39 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.27 0 N-CA-C 109.771 -0.455 . . . . 0.0 109.771 178.394 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 67' ' ' THR . . . . . . . . . . . . . 30.8 m -124.47 142.1 51.58 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-O 121.247 0.546 . . . . 0.0 111.136 -177.253 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 68' ' ' LEU . . . . . 0.543 HD23 ' N ' ' A' ' 69' ' ' VAL . 2.6 tt -100.88 134.49 43.79 Favored 'General case' 0 C--N 1.331 -0.224 0 CA-C-N 115.544 -0.753 . . . . 0.0 109.68 178.485 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 69' ' ' VAL . . . . . 0.543 ' N ' HD23 ' A' ' 68' ' ' LEU . 43.3 t -82.86 148.7 4.98 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.25 0 CA-C-O 120.919 0.39 . . . . 0.0 110.196 -179.25 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 70' ' ' THR . . . . . . . . . . . . . 6.9 m -82.6 149.19 27.58 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.087 -0.506 . . . . 0.0 110.673 -175.832 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 71' ' ' HIS . . . . . . . . . . . . . 1.3 m-70 -123.91 171.91 6.41 Favored Pre-proline 0 CA--C 1.535 0.393 0 CA-C-N 115.82 -0.627 . . . . 0.0 110.581 -175.073 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 72' ' ' PRO . . . . . . . . . . . . . 19.8 Cg_endo -64.82 160.35 41.27 Favored 'Trans proline' 0 N--CA 1.496 1.67 0 C-N-CA 121.43 1.42 . . . . 0.0 111.719 175.869 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 73' ' ' VAL . . . . . . . . . . . . . 35.1 m -69.62 -176.43 0.16 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.287 0 CA-C-N 116.255 -0.43 . . . . 0.0 110.438 -171.782 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 74' ' ' ASP . . . . . . . . . . . . . 13.0 t70 -81.99 114.98 20.93 Favored 'General case' 0 C--N 1.331 -0.199 0 C-N-CA 120.388 -0.525 . . . . 0.0 110.229 -168.937 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 45.7 t -117.37 117.92 56.82 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 CA-C-O 121.192 0.52 . . . . 0.0 109.919 -179.439 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 76' ' ' LEU . . . . . . . . . . . . . 14.9 mt -120.9 142.92 49.25 Favored 'General case' 0 C--N 1.327 -0.403 0 CA-C-N 115.453 -0.794 . . . . 0.0 109.3 178.552 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 77' ' ' GLU . . . . . . . . . . . . . 96.8 mt-10 -135.31 128.91 32.66 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-O 121.16 0.505 . . . . 0.0 110.527 -177.548 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 78' ' ' ALA . . . . . 0.746 ' HB2' HD21 ' A' ' 109' ' ' LEU . . . -113.0 130.71 56.04 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 115.582 -0.735 . . . . 0.0 109.478 177.353 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 79' ' ' LYS . . . . . 0.581 ' O ' HD13 ' A' ' 80' ' ' ILE . 84.2 tttt -76.07 112.7 12.79 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-O 120.963 0.411 . . . . 0.0 110.532 -177.193 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 80' ' ' ILE . . . . . 0.581 HD13 ' O ' ' A' ' 79' ' ' LYS . 42.4 mm -139.08 109.95 4.7 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.346 0 CA-C-N 115.768 -0.651 . . . . 0.0 109.316 -177.727 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 81' ' ' LYS . . . . . . . . . . . . . 48.5 mtmt -108.64 130.76 55.32 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-O 120.875 0.369 . . . . 0.0 110.728 -178.321 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . 89.06 42.18 5.68 Favored Glycine 0 CA--C 1.525 0.708 0 C-N-CA 120.794 -0.717 . . . . 0.0 111.434 176.806 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 83' ' ' ILE . . . . . . . . . . . . . 73.5 mt -68.49 136.16 26.99 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.297 0 N-CA-C 109.872 -0.418 . . . . 0.0 109.872 177.423 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 84' ' ' LYS . . . . . . . . . . . . . 50.0 tttp -93.05 -50.45 5.52 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.213 -0.448 . . . . 0.0 110.18 -179.341 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 85' ' ' ASP . . . . . . . . . . . . . 6.6 t0 -157.22 154.97 30.05 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 115.908 -0.587 . . . . 0.0 110.517 179.734 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 86' ' ' VAL . . . . . . . . . . . . . 42.7 t -129.81 132.34 65.91 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.201 0 CA-C-O 120.974 0.416 . . . . 0.0 110.552 -178.862 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 87' ' ' ILE . . . . . 0.494 HD12 ' N ' ' A' ' 87' ' ' ILE . 5.0 mp -121.84 128.83 75.79 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.193 0 CA-C-N 115.957 -0.565 . . . . 0.0 109.629 176.887 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 88' ' ' LEU . . . . . . . . . . . . . 75.2 mt -112.6 135.96 52.7 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-O 120.997 0.427 . . . . 0.0 111.268 -177.826 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 89' ' ' ASP . . . . . . . . . . . . . 13.6 t70 -133.02 152.4 51.97 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 115.754 -0.657 . . . . 0.0 109.532 175.613 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 97.4 mt-10 -48.56 -36.27 15.14 Favored 'General case' 0 C--N 1.329 -0.319 0 N-CA-C 113.036 0.754 . . . . 0.0 113.036 -172.678 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 91' ' ' ASN . . . . . . . . . . . . . 81.8 m-20 -121.96 12.19 10.42 Favored 'General case' 0 N--CA 1.468 0.473 0 N-CA-C 113.379 0.881 . . . . 0.0 113.379 -176.268 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 92' ' ' LEU . . . . . . . . . . . . . 11.8 mt -148.68 145.3 27.64 Favored 'General case' 0 C--N 1.332 -0.185 0 CA-C-N 118.101 0.41 . . . . 0.0 110.455 -175.701 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 93' ' ' ILE . . . . . . . . . . . . . 66.8 mt -120.95 117.81 54.21 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.294 0 N-CA-C 108.942 -0.762 . . . . 0.0 108.942 174.499 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 94' ' ' VAL . . . . . 0.456 HG11 HG11 ' A' ' 123' ' ' VAL . 46.2 t -118.83 128.2 75.69 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.24 0 CA-C-O 120.82 0.343 . . . . 0.0 110.224 -177.097 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 95' ' ' VAL . . . . . . . . . . . . . 44.2 t -125.63 137.25 58.28 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.334 0 CA-C-N 116.115 -0.493 . . . . 0.0 109.916 179.977 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 96' ' ' ILE . . . . . . . . . . . . . 57.0 mt -116.6 128.45 73.95 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.325 0 N-CA-C 109.098 -0.705 . . . . 0.0 109.098 178.575 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 97' ' ' THR . . . . . . . . . . . . . 81.7 p -102.59 159.96 14.99 Favored 'General case' 0 C--N 1.331 -0.223 0 CA-C-O 121.099 0.476 . . . . 0.0 111.471 -175.202 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 98' ' ' GLU . . . . . . . . . . . . . 84.8 tt0 -53.86 -27.5 30.37 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.168 -0.469 . . . . 0.0 112.037 179.443 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 99' ' ' GLU . . . . . . . . . . . . . 42.8 mt-10 -79.62 15.83 1.24 Allowed 'General case' 0 CA--C 1.535 0.398 0 N-CA-C 113.07 0.767 . . . . 0.0 113.07 -178.393 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 100' ' ' ASN . . . . . . . . . . . . . 3.3 m-20 62.37 30.97 17.46 Favored 'General case' 0 CA--C 1.532 0.279 0 N-CA-C 111.832 0.308 . . . . 0.0 111.832 177.663 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 101' ' ' GLU . . . . . . . . . . . . . 98.5 mt-10 -101.28 150.58 22.84 Favored 'General case' 0 C--N 1.333 -0.128 0 CA-C-O 120.78 0.324 . . . . 0.0 110.851 171.687 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 102' ' ' VAL . . . . . . . . . . . . . 47.3 t -117.83 124.44 73.08 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.379 0 CA-C-N 115.469 -0.787 . . . . 0.0 109.208 176.442 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 103' ' ' LEU . . . . . . . . . . . . . 40.2 mt -116.44 130.06 56.56 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 115.925 -0.58 . . . . 0.0 110.261 178.602 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 104' ' ' ILE . . . . . 0.434 HD12 ' HB3' ' A' ' 113' ' ' TYR . 68.0 mt -118.76 117.94 56.13 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.291 0 N-CA-C 109.948 -0.39 . . . . 0.0 109.948 179.194 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 105' ' ' PHE . . . . . . . . . . . . . 40.1 m-85 -118.5 163.96 16.0 Favored 'General case' 0 C--N 1.332 -0.19 0 O-C-N 124.086 0.866 . . . . 0.0 110.255 179.282 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 106' ' ' ASN . . . . . . . . . . . . . 43.6 p-10 -98.69 -169.91 1.86 Allowed 'General case' 0 C--N 1.33 -0.263 0 N-CA-C 109.898 -0.408 . . . . 0.0 109.898 173.506 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 107' ' ' GLN . . . . . . . . . . . . . 41.2 tt0 -58.67 -29.89 66.93 Favored 'General case' 0 C--N 1.329 -0.322 0 N-CA-C 112.01 0.374 . . . . 0.0 112.01 179.242 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 108' ' ' ASN . . . . . . . . . . . . . 8.3 t-20 -83.55 6.61 19.91 Favored 'General case' 0 CA--C 1.537 0.458 0 N-CA-C 113.298 0.851 . . . . 0.0 113.298 -177.509 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 109' ' ' LEU . . . . . 0.746 HD21 ' HB2' ' A' ' 78' ' ' ALA . 9.1 tp 61.98 36.24 15.72 Favored 'General case' 0 CA--C 1.53 0.2 0 CA-C-O 120.877 0.37 . . . . 0.0 111.536 178.595 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 110' ' ' GLU . . . . . . . . . . . . . 70.8 mm-40 -105.6 152.27 23.31 Favored 'General case' 0 C--N 1.332 -0.189 0 CA-C-N 116.516 -0.311 . . . . 0.0 110.196 177.443 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 111' ' ' GLU . . . . . . . . . . . . . 98.6 mt-10 -80.9 122.06 26.76 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-O 120.878 0.371 . . . . 0.0 111.193 -178.486 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 112' ' ' LEU . . . . . . . . . . . . . 19.2 mt -108.55 -46.01 3.76 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 115.969 -0.56 . . . . 0.0 110.054 176.165 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 113' ' ' TYR . . . . . 0.434 ' HB3' HD12 ' A' ' 104' ' ' ILE . 57.7 t80 -134.74 133.06 39.52 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 116.284 -0.416 . . . . 0.0 110.735 179.184 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 114' ' ' ARG . . . . . . . . . . . . . 55.1 ttp180 -138.11 123.44 19.42 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.262 -0.426 . . . . 0.0 110.006 178.089 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 115' ' ' GLY . . . . . . . . . . . . . . . -150.12 162.84 29.33 Favored Glycine 0 CA--C 1.523 0.553 0 N-CA-C 110.902 -0.879 . . . . 0.0 110.902 -178.522 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 116' ' ' LYS . . . . . . . . . . . . . 76.3 tttt -131.9 131.02 42.36 Favored 'General case' 0 C--N 1.33 -0.278 0 N-CA-C 110.082 -0.34 . . . . 0.0 110.082 178.184 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 117' ' ' PHE . . . . . . . . . . . . . 47.9 m-85 -130.03 117.34 19.88 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 116.238 -0.437 . . . . 0.0 110.25 -177.196 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 118' ' ' GLU . . . . . . . . . . . . . 97.5 mt-10 -53.81 -43.69 69.57 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 116.433 -0.349 . . . . 0.0 111.363 -176.803 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 119' ' ' ASN . . . . . . . . . . . . . 2.8 m-20 -101.98 31.09 4.06 Favored 'General case' 0 C--N 1.331 -0.214 0 N-CA-C 112.089 0.403 . . . . 0.0 112.089 -174.786 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 120' ' ' LEU . . . . . . . . . . . . . 13.8 tp -55.04 120.07 6.38 Favored 'General case' 0 N--CA 1.462 0.169 0 CA-C-O 120.62 0.248 . . . . 0.0 110.666 178.65 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 121' ' ' ASN . . . . . . . . . . . . . 32.7 t-20 -110.77 -44.11 3.7 Favored 'General case' 0 C--N 1.332 -0.189 0 CA-C-N 116.565 -0.288 . . . . 0.0 111.137 -176.543 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 122' ' ' LYS . . . . . . . . . . . . . 90.6 mttt -148.23 152.03 36.49 Favored 'General case' 0 C--N 1.331 -0.204 0 CA-C-O 121.129 0.49 . . . . 0.0 111.955 -177.996 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 123' ' ' VAL . . . . . 0.456 HG11 HG11 ' A' ' 94' ' ' VAL . 42.2 t -129.45 124.66 60.24 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.268 0 CA-C-N 115.685 -0.689 . . . . 0.0 109.158 172.407 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 124' ' ' LEU . . . . . 0.496 HD12 ' N ' ' A' ' 124' ' ' LEU . 6.2 mp -118.1 141.67 48.23 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-O 120.765 0.316 . . . . 0.0 111.004 -175.65 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 125' ' ' VAL . . . . . 0.412 ' CG2' HG21 ' A' ' 94' ' ' VAL . 41.2 t -129.17 135.66 61.39 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.209 0 CA-C-N 116.24 -0.436 . . . . 0.0 110.427 -179.901 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 126' ' ' ARG . . . . . . . . . . . . . 26.3 mmt85 -139.48 109.92 6.6 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.081 -0.509 . . . . 0.0 110.215 176.712 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 127' ' ' ASN . . . . . . . . . . . . . 79.1 m-20 51.96 -104.83 0.19 Allowed 'General case' 0 CA--C 1.543 0.691 0 CA-C-O 119.1 -0.476 . . . . 0.0 111.341 179.521 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 128' ' ' ASP . . . . . . . . . . . . . 18.7 p-10 -110.3 -2.13 16.88 Favored 'General case' 0 CA--C 1.536 0.439 0 CA-C-N 119.513 1.051 . . . . 0.0 113.459 -176.105 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 129' ' ' LEU . . . . . . . . . . . . . 27.5 mt -104.99 143.89 32.56 Favored 'General case' 0 C--N 1.332 -0.17 0 N-CA-C 109.721 -0.474 . . . . 0.0 109.721 178.557 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 130' ' ' VAL . . . . . 0.525 HG13 ' HB ' ' A' ' 141' ' ' ILE . 12.2 p -132.23 142.06 43.72 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.212 0 CA-C-O 121.147 0.499 . . . . 0.0 110.507 -178.92 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 131' ' ' VAL . . . . . 0.576 HG22 HD12 ' A' ' 140' ' ' LEU . 40.9 t -134.39 138.09 50.43 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.252 0 CA-C-N 115.917 -0.583 . . . . 0.0 110.315 -178.236 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 132' ' ' ILE . . . . . . . . . . . . . 70.7 mt -113.98 131.52 65.67 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.341 0 N-CA-C 109.137 -0.69 . . . . 0.0 109.137 178.308 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 133' ' ' ILE . . . . . . . . . . . . . 40.2 mm -115.65 121.02 66.43 Favored 'Isoleucine or valine' 0 C--O 1.234 0.257 0 CA-C-O 120.665 0.269 . . . . 0.0 110.993 -174.501 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 134' ' ' ASP . . . . . . . . . . . . . 9.7 p-10 -134.72 146.39 49.39 Favored 'General case' 0 C--N 1.331 -0.215 0 CA-C-N 115.984 -0.553 . . . . 0.0 109.66 174.509 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 135' ' ' GLU . . . . . . . . . . . . . 85.2 tt0 -49.89 -26.49 4.13 Favored 'General case' 0 C--N 1.328 -0.33 0 N-CA-C 112.792 0.664 . . . . 0.0 112.792 -173.946 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 136' ' ' GLN . . . . . . . . . . . . . 43.2 tt0 -80.03 -35.19 37.58 Favored 'General case' 0 C--O 1.233 0.205 0 N-CA-C 112.124 0.416 . . . . 0.0 112.124 -176.644 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 137' ' ' LYS . . . . . . . . . . . . . 50.3 pttt -167.61 171.47 10.21 Favored 'General case' 0 C--N 1.331 -0.208 0 CA-C-O 121.527 0.68 . . . . 0.0 112.244 -172.5 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 138' ' ' LEU . . . . . 0.466 HD23 ' N ' ' A' ' 139' ' ' THR . 4.3 tt -114.83 127.34 55.66 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 115.053 -0.976 . . . . 0.0 109.821 178.269 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 139' ' ' THR . . . . . 0.466 ' N ' HD23 ' A' ' 138' ' ' LEU . 22.8 m -107.08 125.41 51.01 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.323 -0.399 . . . . 0.0 110.458 179.609 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 140' ' ' LEU . . . . . 0.576 HD12 HG22 ' A' ' 131' ' ' VAL . 14.9 tp -113.49 119.64 38.25 Favored 'General case' 0 C--N 1.328 -0.365 0 N-CA-C 109.252 -0.647 . . . . 0.0 109.252 -178.371 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 141' ' ' ILE . . . . . 0.525 ' HB ' HG13 ' A' ' 130' ' ' VAL . 19.4 mt -119.65 120.91 64.86 Favored 'Isoleucine or valine' 0 C--O 1.234 0.269 0 CA-C-O 120.949 0.404 . . . . 0.0 110.046 -175.977 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 142' ' ' ARG . . . . . . . . . . . . . 73.3 mtm180 -107.32 129.48 54.89 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 115.38 -0.827 . . . . 0.0 110.258 179.575 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 143' ' ' THR . . . . . . . . . . . . . 32.1 p . . . . . 0 C--O 1.22 -0.448 0 CA-C-O 118.045 -0.979 . . . . 0.0 110.618 179.691 . . . . . . . . 0 0 . 1 . 007 nuclear build full ' B' B ' -3' ' ' GLU . . . . . . . . . . . . . 85.0 tt0 . . . . . 0 N--CA 1.49 1.563 0 N-CA-C 109.438 -0.579 . . . . 0.0 109.438 . . . . . . . . . 0 0 . 1 . 007 nuclear build full ' B' B ' -2' ' ' GLY . . . . . . . . . . . . . . . -65.9 138.45 37.38 Favored Glycine 0 CA--C 1.525 0.673 0 N-CA-C 110.981 -0.848 . . . . 0.0 110.981 -179.939 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' -1' ' ' VAL . . . . . . . . . . . . . 44.5 t -96.65 133.19 38.96 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.283 0 CA-C-O 120.775 0.321 . . . . 0.0 110.156 179.42 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 0' ' ' ILE . . . . . . . . . . . . . 71.8 mt -115.94 129.44 72.31 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.248 0 N-CA-C 109.725 -0.472 . . . . 0.0 109.725 179.124 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 1' ' ' MET . . . . . . . . . . . . . 23.6 ptm -144.55 139.96 28.51 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.125 -0.489 . . . . 0.0 110.781 -179.222 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 2' ' ' SER . . . . . . . . . . . . . 3.6 p -121.78 129.45 52.68 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 116.319 -0.401 . . . . 0.0 110.411 178.514 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 3' ' ' GLU . . . . . . . . . . . . . 95.1 mt-10 -140.62 140.63 35.1 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-N 116.094 -0.503 . . . . 0.0 110.882 -178.445 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 4' ' ' LEU . . . . . 0.475 HD21 HD21 ' B' ' 6' ' ' LEU . 16.5 tp -126.21 127.5 45.76 Favored 'General case' 0 C--N 1.331 -0.216 0 CA-C-N 115.971 -0.559 . . . . 0.0 110.36 177.441 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' B' B ' 5' ' ' LYS . . . . . . . . . . . . . 98.1 mttt -104.37 120.95 42.37 Favored 'General case' 0 C--O 1.234 0.237 0 CA-C-N 116.287 -0.415 . . . . 0.0 110.336 177.727 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 6' ' ' LEU . . . . . 0.475 HD21 HD21 ' B' ' 4' ' ' LEU . 54.3 mt -117.14 148.0 41.94 Favored 'General case' 0 C--N 1.331 -0.227 0 CA-C-N 115.499 -0.773 . . . . 0.0 110.613 -178.501 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' B' B ' 7' ' ' LYS . . . . . . . . . . . . . 79.4 tttt -138.84 141.04 29.14 Favored Pre-proline 0 CA--C 1.534 0.344 0 CA-C-O 119.135 -0.46 . . . . 0.0 110.163 175.505 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 8' ' ' PRO . . . . . . . . . . . . . 88.0 Cg_endo -92.04 142.11 2.53 Favored 'Trans proline' 0 N--CA 1.49 1.287 0 C-N-CA 121.792 1.661 . . . . 0.0 111.723 177.438 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 9' ' ' LEU . . . . . . . . . . . . . 57.8 mt -77.36 -46.78 2.6 Favored Pre-proline 0 CA--C 1.534 0.348 0 CA-C-O 118.671 -0.68 . . . . 0.0 112.175 -179.736 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 10' ' ' PRO . . . . . . . . . . . . . 86.5 Cg_endo -81.75 150.47 16.51 Favored 'Trans proline' 0 N--CA 1.495 1.612 0 C-N-CA 121.266 1.311 . . . . 0.0 111.79 175.232 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 11' ' ' LYS . . . . . . . . . . . . . 28.2 ttpp -88.87 99.72 12.61 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-O 120.778 0.323 . . . . 0.0 110.541 179.742 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 12' ' ' VAL . . . . . . . . . . . . . 12.6 p -143.68 148.02 19.39 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.29 0 CA-C-N 116.261 -0.427 . . . . 0.0 110.559 -179.398 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 13' ' ' GLU . . . . . . . . . . . . . 44.5 mp0 -84.51 126.09 32.98 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.315 -0.402 . . . . 0.0 110.298 178.676 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 14' ' ' LEU . . . . . . . . . . . . . 47.9 mt -98.63 148.27 34.32 Favored Pre-proline 0 CA--C 1.532 0.284 0 CA-C-O 119.168 -0.444 . . . . 0.0 110.498 -179.415 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 15' ' ' PRO . . . . . . . . . . . . . 24.7 Cg_exo -63.16 159.62 38.24 Favored 'Trans proline' 0 N--CA 1.497 1.73 0 C-N-CA 121.301 1.334 . . . . 0.0 111.831 176.518 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 16' ' ' PRO . . . . . . . . . . . . . 28.8 Cg_exo -60.18 -33.69 94.73 Favored 'Trans proline' 0 N--CA 1.497 1.722 0 C-N-CA 121.52 1.48 . . . . 0.0 112.677 -178.998 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 17' ' ' ASP . . . . . . . . . . . . . 10.6 p-10 -82.79 1.07 40.86 Favored 'General case' 0 CA--C 1.537 0.458 0 N-CA-C 113.281 0.845 . . . . 0.0 113.281 -177.617 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 18' ' ' PHE . . . . . . . . . . . . . 36.2 t80 -57.61 -45.04 85.84 Favored 'General case' 0 C--N 1.334 -0.106 0 O-C-N 121.962 -0.461 . . . . 0.0 110.23 -178.182 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 19' ' ' VAL . . . . . . . . . . . . . 46.9 t -57.08 -43.99 82.24 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.349 0 CA-C-N 116.263 -0.426 . . . . 0.0 110.492 -178.407 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 20' ' ' ASP . . . . . . . . . . . . . 40.8 m-20 -59.76 -42.54 93.5 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-O 120.742 0.306 . . . . 0.0 110.948 -177.467 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 21' ' ' VAL . . . . . . . . . . . . . 46.8 t -63.85 -48.31 86.86 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.241 0 C-N-CA 120.724 -0.391 . . . . 0.0 110.515 -177.792 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 22' ' ' ILE . . . . . 0.479 HG22 HD12 ' B' ' 26' ' ' LEU . 50.4 mm -55.57 -46.92 79.25 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.258 0 C-N-CA 120.997 -0.281 . . . . 0.0 110.798 179.639 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' B' B ' 23' ' ' ARG . . . . . . . . . . . . . 57.8 ttp180 -53.8 -50.39 66.23 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-O 120.594 0.235 . . . . 0.0 111.449 -178.152 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 24' ' ' ILE . . . . . . . . . . . . . 74.8 mt -60.13 -42.96 91.89 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.317 0 CA-C-N 116.57 -0.286 . . . . 0.0 111.304 -177.462 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 25' ' ' LYS . . . . . . . . . . . . . 70.7 mmtt -65.13 -38.44 90.65 Favored 'General case' 0 C--N 1.33 -0.265 0 N-CA-C 112.127 0.417 . . . . 0.0 112.127 -178.73 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 26' ' ' LEU . . . . . 0.479 HD12 HG22 ' B' ' 22' ' ' ILE . 83.4 mt -77.9 -44.77 26.02 Favored 'General case' 0 C--N 1.329 -0.307 0 N-CA-C 112.747 0.647 . . . . 0.0 112.747 -172.119 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' B' B ' 27' ' ' GLN . . . . . . . . . . . . . 15.3 pt20 -46.98 137.88 7.01 Favored 'General case' 0 N--CA 1.469 0.489 0 N-CA-C 112.751 0.648 . . . . 0.0 112.751 -176.168 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 28' ' ' GLY . . . . . . . . . . . . . . . 100.66 -28.82 14.15 Favored Glycine 0 CA--C 1.533 1.195 0 CA-C-N 115.619 -0.718 . . . . 0.0 111.978 -177.066 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 29' ' ' LYS . . . . . . . . . . . . . 93.3 mttt -98.84 155.19 17.5 Favored 'General case' 0 C--O 1.233 0.216 0 CA-C-O 121.053 0.454 . . . . 0.0 111.133 179.285 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 30' ' ' THR . . . . . . . . . . . . . 27.3 m -104.28 137.39 42.26 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.136 -0.484 . . . . 0.0 110.065 175.884 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 31' ' ' VAL . . . . . . . . . . . . . 34.9 m -130.56 155.84 42.07 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.308 0 CA-C-N 116.375 -0.375 . . . . 0.0 110.927 -178.133 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 32' ' ' ARG . . . . . . . . . . . . . 66.2 mtp180 -132.29 152.9 51.16 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-O 121.334 0.588 . . . . 0.0 110.835 179.084 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 33' ' ' THR . . . . . . . . . . . . . 23.9 m -53.27 140.06 27.77 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 115.985 -0.552 . . . . 0.0 111.378 -178.245 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 34' ' ' GLY . . . . . . . . . . . . . . . 99.28 -17.02 58.48 Favored Glycine 0 CA--C 1.532 1.121 0 CA-C-O 119.611 -0.549 . . . . 0.0 113.279 178.273 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 35' ' ' ASP . . . . . . . . . . . . . 77.0 m-20 -66.1 147.71 52.92 Favored 'General case' 0 C--O 1.231 0.109 0 CA-C-N 118.06 0.93 . . . . 0.0 110.888 178.6 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 36' ' ' VAL . . . . . . . . . . . . . 44.3 t -124.58 131.06 73.24 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.271 0 CA-C-N 116.07 -0.514 . . . . 0.0 109.927 178.853 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 37' ' ' ILE . . . . . . . . . . . . . 64.8 mt -120.47 138.97 49.22 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.277 0 CA-C-N 116.197 -0.456 . . . . 0.0 109.951 -179.69 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 38' ' ' GLY . . . . . . . . . . . . . . . -109.22 128.7 9.12 Favored Glycine 0 CA--C 1.526 0.729 0 N-CA-C 111.171 -0.772 . . . . 0.0 111.171 179.969 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 39' ' ' ILE . . . . . . . . . . . . . 72.1 mt -124.38 130.12 73.7 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.256 0 N-CA-C 109.779 -0.452 . . . . 0.0 109.779 178.422 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 40' ' ' SER . . . . . 0.535 ' O ' HD13 ' B' ' 41' ' ' ILE . 78.6 p -91.42 117.02 29.32 Favored 'General case' 0 C--N 1.329 -0.294 0 C-N-CA 120.973 -0.291 . . . . 0.0 111.02 178.512 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' B' B ' 41' ' ' ILE . . . . . 0.535 HD13 ' O ' ' B' ' 40' ' ' SER . 47.1 mm -130.32 125.07 58.94 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.23 0 CA-C-O 120.778 0.323 . . . . 0.0 110.191 179.512 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' B' B ' 42' ' ' LEU . . . . . . . . . . . . . 52.8 mt 57.8 34.23 24.16 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.246 -0.433 . . . . 0.0 111.782 177.802 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 43' ' ' GLY . . . . . . . . . . . . . . . 77.7 -10.08 26.42 Favored Glycine 0 CA--C 1.534 1.279 0 C-N-CA 121.265 -0.493 . . . . 0.0 113.456 177.525 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 44' ' ' LYS . . . . . . . . . . . . . 39.1 mtpt -104.83 133.93 48.81 Favored 'General case' 0 C--N 1.333 -0.121 0 CA-C-N 117.952 0.876 . . . . 0.0 109.855 177.086 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 45' ' ' GLU . . . . . . . . . . . . . 36.3 tp10 -84.6 129.25 34.87 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.425 -0.352 . . . . 0.0 110.864 -179.475 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 46' ' ' VAL . . . . . . . . . . . . . 7.5 p -116.79 129.62 73.0 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.224 0 N-CA-C 109.312 -0.625 . . . . 0.0 109.312 176.599 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 47' ' ' LYS . . . . . . . . . . . . . 58.9 mtpt -99.99 126.8 46.22 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 115.912 -0.585 . . . . 0.0 111.032 179.134 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 48' ' ' PHE . . . . . . . . . . . . . 92.4 m-85 -109.86 131.88 54.66 Favored 'General case' 0 C--N 1.331 -0.213 0 CA-C-N 116.318 -0.401 . . . . 0.0 110.047 176.454 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 49' ' ' LYS . . . . . . . . . . . . . 62.4 tttm -107.64 137.42 45.7 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 116.276 -0.42 . . . . 0.0 110.509 179.2 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 50' ' ' VAL . . . . . . . . . . . . . 45.5 t -80.29 107.42 12.65 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.286 0 N-CA-C 109.135 -0.691 . . . . 0.0 109.135 174.615 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 51' ' ' VAL . . . . . . . . . . . . . 47.8 t -73.5 -47.3 45.9 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.374 0 CA-C-N 116.35 -0.386 . . . . 0.0 110.024 -173.773 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 52' ' ' GLN . . . . . . . . . . . . . 43.3 tt0 -162.17 137.07 7.02 Favored 'General case' 0 C--N 1.33 -0.279 0 C-N-CA 120.418 -0.513 . . . . 0.0 111.606 -178.964 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 53' ' ' ALA . . . . . . . . . . . . . . . -113.47 133.01 55.44 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 115.782 -0.645 . . . . 0.0 109.987 175.35 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 54' ' ' TYR . . . . . . . . . . . . . 12.5 t80 -129.11 112.65 18.44 Favored Pre-proline 0 CA--C 1.534 0.358 0 CA-C-O 118.32 -0.848 . . . . 0.0 110.469 179.208 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 55' ' ' PRO . . . . . . . . . . . . . 73.9 Cg_endo -77.07 169.61 73.87 Favored 'Cis proline' 0 N--CA 1.499 1.8 0 CA-C-N 121.934 1.726 . . . . 0.0 112.195 -6.412 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 56' ' ' SER . . . . . . . . . . . . . 13.6 m -116.83 131.02 24.15 Favored Pre-proline 0 CA--C 1.54 0.559 0 CA-C-O 118.37 -0.824 . . . . 0.0 109.474 176.097 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 57' ' ' PRO . . . . . . . . . . . . . 48.4 Cg_endo -69.99 148.2 86.74 Favored 'Cis proline' 0 N--CA 1.497 1.683 0 CA-C-N 121.937 1.728 . . . . 0.0 111.573 -1.349 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 58' ' ' LEU . . . . . . . . . . . . . 25.8 tp -107.74 135.38 49.25 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.384 -0.371 . . . . 0.0 110.744 -178.399 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 59' ' ' ARG . . . . . . . . . . . . . 55.0 ttt180 -101.96 121.15 41.6 Favored 'General case' 0 C--N 1.327 -0.382 0 N-CA-C 109.297 -0.631 . . . . 0.0 109.297 176.14 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 60' ' ' VAL . . . . . . . . . . . . . 44.4 t -78.97 123.19 35.62 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.263 0 C-N-CA 120.694 -0.402 . . . . 0.0 110.36 -174.987 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 61' ' ' GLU . . . . . . . . . . . . . 95.7 mt-10 -131.03 165.57 22.93 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.062 -0.517 . . . . 0.0 110.057 178.269 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 62' ' ' ASP . . . . . . . . . . . . . 18.0 p-10 -54.61 -32.64 59.19 Favored 'General case' 0 C--N 1.328 -0.329 0 C-N-CA 120.975 -0.29 . . . . 0.0 111.675 179.872 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 63' ' ' ARG . . . . . . . . . . . . . 10.8 ptm180 -85.21 7.29 22.52 Favored 'General case' 0 CA--C 1.537 0.452 0 N-CA-C 113.523 0.934 . . . . 0.0 113.523 -176.273 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 64' ' ' THR . . . . . . . . . . . . . 33.0 m -83.84 138.48 33.19 Favored 'General case' 0 C--N 1.332 -0.17 0 CA-C-N 118.135 0.425 . . . . 0.0 110.76 -178.319 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 65' ' ' LYS . . . . . . . . . . . . . 69.2 mttm -89.99 129.27 36.34 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.106 -0.497 . . . . 0.0 110.281 178.541 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 66' ' ' ILE . . . . . . . . . . . . . 63.0 mt -116.84 130.37 71.83 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.292 0 N-CA-C 109.935 -0.395 . . . . 0.0 109.935 179.454 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 67' ' ' THR . . . . . . . . . . . . . 25.5 m -123.3 136.69 54.81 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.596 -179.513 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 68' ' ' LEU . . . . . . . . . . . . . 17.7 tp -107.86 126.06 52.21 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.039 -0.528 . . . . 0.0 110.551 179.515 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 69' ' ' VAL . . . . . . . . . . . . . 43.2 t -101.29 146.72 9.2 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.308 0 CA-C-N 116.243 -0.435 . . . . 0.0 110.059 179.256 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 70' ' ' THR . . . . . . . . . . . . . 4.8 m -130.49 -49.33 1.07 Allowed 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 116.261 -0.427 . . . . 0.0 110.59 -178.522 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 71' ' ' HIS . . . . . . . . . . . . . 82.6 m-70 -72.49 154.08 91.73 Favored Pre-proline 0 C--N 1.329 -0.321 0 CA-C-N 116.336 -0.393 . . . . 0.0 110.601 -179.464 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 72' ' ' PRO . . . . . . . . . . . . . 87.3 Cg_endo -86.08 24.54 0.74 Allowed 'Trans proline' 0 N--CA 1.492 1.384 0 C-N-CA 121.692 1.595 . . . . 0.0 113.131 -178.188 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 73' ' ' VAL . . . . . . . . . . . . . 31.0 m -130.94 163.13 37.7 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.17 0 CA-C-O 120.902 0.382 . . . . 0.0 110.668 179.148 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 74' ' ' ASP . . . . . . . . . . . . . 7.5 t70 -102.84 120.69 41.05 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.041 -0.527 . . . . 0.0 109.731 179.695 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 75' ' ' VAL . . . . . . . . . . . . . 42.5 t -113.74 122.21 67.42 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.219 0 CA-C-O 121.087 0.47 . . . . 0.0 110.531 -177.76 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 76' ' ' LEU . . . . . . . . . . . . . 32.6 mt -119.85 145.57 46.53 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 115.575 -0.739 . . . . 0.0 109.434 177.471 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 77' ' ' GLU . . . . . . . . . . . . . 98.0 mt-10 -136.46 134.24 37.46 Favored 'General case' 0 C--N 1.332 -0.187 0 CA-C-O 121.189 0.518 . . . . 0.0 111.18 -178.095 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 78' ' ' ALA . . . . . 0.662 ' HB2' HD21 ' B' ' 109' ' ' LEU . . . -122.22 123.76 42.22 Favored 'General case' 0 C--N 1.331 -0.224 0 CA-C-N 115.62 -0.718 . . . . 0.0 109.666 176.471 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' B' B ' 79' ' ' LYS . . . . . 0.566 ' O ' HD13 ' B' ' 80' ' ' ILE . 45.9 pttt -73.6 121.04 20.03 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-O 121.295 0.569 . . . . 0.0 110.811 -177.832 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' B' B ' 80' ' ' ILE . . . . . 0.566 HD13 ' O ' ' B' ' 79' ' ' LYS . 40.4 mm -139.33 112.49 6.22 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.267 0 CA-C-N 115.658 -0.701 . . . . 0.0 109.267 -177.799 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' B' B ' 81' ' ' LYS . . . . . . . . . . . . . 28.9 mtpt -99.46 122.31 42.38 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-O 120.845 0.355 . . . . 0.0 111.113 -177.789 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 82' ' ' GLY . . . . . . . . . . . . . . . 89.22 42.2 5.63 Favored Glycine 0 CA--C 1.525 0.694 0 C-N-CA 120.738 -0.744 . . . . 0.0 111.808 174.362 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 83' ' ' ILE . . . . . . . . . . . . . 68.5 mt -61.92 135.39 26.55 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.33 0 N-CA-C 109.727 -0.472 . . . . 0.0 109.727 176.938 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 84' ' ' LYS . . . . . . . . . . . . . 75.6 tttt -94.39 -51.6 4.71 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.129 -0.487 . . . . 0.0 109.988 -179.312 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 85' ' ' ASP . . . . . . . . . . . . . 11.6 t70 -157.86 152.14 24.57 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 115.666 -0.697 . . . . 0.0 110.347 178.979 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 86' ' ' VAL . . . . . . . . . . . . . 42.6 t -127.41 129.46 70.58 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.275 0 CA-C-O 120.897 0.38 . . . . 0.0 110.313 -179.541 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 87' ' ' ILE . . . . . . . . . . . . . 44.7 mm -119.55 128.95 75.88 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.312 0 CA-C-N 115.985 -0.552 . . . . 0.0 109.755 177.984 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 88' ' ' LEU . . . . . 0.447 HD12 HD22 ' A' ' 124' ' ' LEU . 47.7 mt -111.85 138.12 48.88 Favored 'General case' 0 C--N 1.332 -0.185 0 CA-C-O 121.057 0.456 . . . . 0.0 111.791 -176.645 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' B' B ' 89' ' ' ASP . . . . . . . . . . . . . 13.4 t70 -132.87 155.34 49.2 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 115.401 -0.818 . . . . 0.0 109.226 174.876 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 90' ' ' GLU . . . . . . . . . . . . . 35.0 tt0 -47.54 -37.21 11.72 Favored 'General case' 0 N--CA 1.465 0.301 0 N-CA-C 113.005 0.743 . . . . 0.0 113.005 -171.409 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 91' ' ' ASN . . . . . . . . . . . . . 0.3 OUTLIER -129.59 20.3 5.63 Favored 'General case' 0 N--CA 1.469 0.507 0 N-CA-C 112.823 0.675 . . . . 0.0 112.823 -177.005 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' B' B ' 92' ' ' LEU . . . . . . . . . . . . . 19.6 mt -148.73 143.25 26.29 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-O 120.822 0.344 . . . . 0.0 110.288 -177.427 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 93' ' ' ILE . . . . . . . . . . . . . 71.3 mt -121.54 117.0 51.2 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.331 0 N-CA-C 108.947 -0.76 . . . . 0.0 108.947 175.755 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 94' ' ' VAL . . . . . . . . . . . . . 46.8 t -114.37 123.51 70.12 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.292 0 N-CA-C 109.728 -0.471 . . . . 0.0 109.728 -179.102 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 95' ' ' VAL . . . . . . . . . . . . . 44.1 t -119.95 132.0 70.83 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.321 0 CA-C-N 116.032 -0.531 . . . . 0.0 109.767 -179.447 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 96' ' ' ILE . . . . . . . . . . . . . 66.1 mt -114.48 127.93 71.76 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.33 0 N-CA-C 109.073 -0.714 . . . . 0.0 109.073 178.471 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 97' ' ' THR . . . . . . . . . . . . . 61.3 p -102.31 154.9 18.61 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-O 121.061 0.457 . . . . 0.0 111.094 -177.644 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 98' ' ' GLU . . . . . . . . . . . . . 98.0 mt-10 -53.96 -22.2 9.77 Favored 'General case' 0 CA--C 1.533 0.302 0 N-CA-C 112.355 0.502 . . . . 0.0 112.355 178.177 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 99' ' ' GLU . . . . . . . . . . . . . 95.9 mt-10 -76.54 11.67 1.54 Allowed 'General case' 0 CA--C 1.537 0.468 0 N-CA-C 113.149 0.796 . . . . 0.0 113.149 -178.939 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 100' ' ' ASN . . . . . . . . . . . . . 2.4 m-20 61.96 37.94 14.66 Favored 'General case' 0 CA--C 1.529 0.172 0 CA-C-O 121.077 0.465 . . . . 0.0 110.836 179.785 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 101' ' ' GLU . . . . . . . . . . . . . 84.6 tt0 -120.39 142.02 49.57 Favored 'General case' 0 C--N 1.332 -0.193 0 N-CA-C 109.564 -0.532 . . . . 0.0 109.564 176.215 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 102' ' ' VAL . . . . . . . . . . . . . 45.9 t -114.92 127.57 72.41 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.238 0 N-CA-C 109.976 -0.379 . . . . 0.0 109.976 -178.362 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 103' ' ' LEU . . . . . . . . . . . . . 55.6 mt -116.77 131.89 56.84 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 115.641 -0.709 . . . . 0.0 110.335 177.771 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 104' ' ' ILE . . . . . 0.414 HD12 ' HB3' ' B' ' 113' ' ' TYR . 66.2 mt -115.97 119.35 61.63 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.256 0 CA-C-N 116.375 -0.375 . . . . 0.0 110.03 178.511 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' B' B ' 105' ' ' PHE . . . . . . . . . . . . . 34.7 m-85 -119.59 167.1 12.33 Favored 'General case' 0 C--N 1.333 -0.142 0 O-C-N 123.995 0.809 . . . . 0.0 109.994 178.657 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 106' ' ' ASN . . . . . . . . . . . . . 44.3 p-10 -104.02 -169.98 1.71 Allowed 'General case' 0 C--N 1.331 -0.232 0 N-CA-C 110.078 -0.341 . . . . 0.0 110.078 174.631 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 107' ' ' GLN . . . . . . . . . . . . . 16.0 tt0 -59.64 -29.9 68.35 Favored 'General case' 0 CA--C 1.531 0.244 0 N-CA-C 111.963 0.357 . . . . 0.0 111.963 179.612 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 108' ' ' ASN . . . . . . . . . . . . . 4.9 t-20 -82.87 6.77 17.34 Favored 'General case' 0 CA--C 1.537 0.45 0 N-CA-C 113.171 0.804 . . . . 0.0 113.171 -177.749 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 109' ' ' LEU . . . . . 0.662 HD21 ' HB2' ' B' ' 78' ' ' ALA . 12.0 tp 61.85 37.76 15.15 Favored 'General case' 0 CA--C 1.53 0.18 0 CA-C-O 120.948 0.404 . . . . 0.0 111.294 178.188 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' B' B ' 110' ' ' GLU . . . . . . . . . . . . . 96.0 mt-10 -107.66 165.59 11.32 Favored 'General case' 0 C--N 1.331 -0.218 0 CA-C-N 116.342 -0.39 . . . . 0.0 110.123 176.9 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 111' ' ' GLU . . . . . . . . . . . . . 45.4 tp10 -89.1 125.51 35.06 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-O 120.928 0.394 . . . . 0.0 111.0 -177.452 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 112' ' ' LEU . . . . . . . . . . . . . 17.4 mt -109.62 -46.05 3.58 Favored 'General case' 0 C--N 1.332 -0.19 0 CA-C-N 115.991 -0.55 . . . . 0.0 110.404 177.201 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 113' ' ' TYR . . . . . 0.414 ' HB3' HD12 ' B' ' 104' ' ' ILE . 64.4 t80 -145.42 140.31 27.53 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.226 -0.443 . . . . 0.0 111.382 -179.398 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' B' B ' 114' ' ' ARG . . . . . . . . . . . . . 21.3 ttm180 -132.39 127.8 36.21 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-N 116.006 -0.543 . . . . 0.0 109.842 175.627 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 115' ' ' GLY . . . . . . . . . . . . . . . -150.1 131.35 3.58 Favored Glycine 0 CA--C 1.523 0.573 0 N-CA-C 111.137 -0.785 . . . . 0.0 111.137 178.334 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 116' ' ' LYS . . . . . . . . . . . . . 28.4 ttpp -106.68 133.24 51.65 Favored 'General case' 0 C--N 1.331 -0.235 0 N-CA-C 109.664 -0.495 . . . . 0.0 109.664 176.85 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 117' ' ' PHE . . . . . . . . . . . . . 39.4 m-85 -136.01 113.92 11.23 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-O 120.903 0.382 . . . . 0.0 110.246 -175.591 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 118' ' ' GLU . . . . . . . . . . . . . 97.0 mt-10 -54.34 -44.01 71.73 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.485 -0.325 . . . . 0.0 111.279 -177.628 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 119' ' ' ASN . . . . . . . . . . . . . 83.9 m-20 -96.67 31.03 2.41 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 116.182 -0.463 . . . . 0.0 112.146 -174.661 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 120' ' ' LEU . . . . . . . . . . . . . 14.9 tp -57.04 120.25 7.68 Favored 'General case' 0 C--N 1.333 -0.137 0 CA-C-O 120.641 0.258 . . . . 0.0 110.33 177.447 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 121' ' ' ASN . . . . . . . . . . . . . 61.1 m-80 -113.6 -44.0 3.25 Favored 'General case' 0 C--N 1.332 -0.156 0 CA-C-N 116.627 -0.26 . . . . 0.0 111.084 -177.357 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 122' ' ' LYS . . . . . . . . . . . . . 88.6 mttt -147.4 149.8 33.43 Favored 'General case' 0 C--N 1.331 -0.197 0 CA-C-O 121.221 0.534 . . . . 0.0 111.744 -178.035 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 123' ' ' VAL . . . . . . . . . . . . . 44.6 t -128.19 129.2 69.29 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.263 0 CA-C-N 115.71 -0.677 . . . . 0.0 109.589 175.506 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 124' ' ' LEU . . . . . . . . . . . . . 83.8 mt -123.63 131.93 53.74 Favored 'General case' 0 C--N 1.331 -0.224 0 CA-C-N 116.396 -0.366 . . . . 0.0 110.573 -179.041 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 125' ' ' VAL . . . . . 0.452 ' O ' HG13 ' B' ' 125' ' ' VAL . 11.2 p -131.12 122.86 52.46 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.232 0 CA-C-N 116.163 -0.471 . . . . 0.0 109.835 177.161 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' B' B ' 126' ' ' ARG . . . . . . . . . . . . . 88.8 mtt180 -147.45 128.82 14.86 Favored 'General case' 0 C--N 1.33 -0.252 0 N-CA-C 109.62 -0.511 . . . . 0.0 109.62 -179.802 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 127' ' ' ASN . . . . . . . . . . . . . 32.0 m120 55.95 -151.94 0.39 Allowed 'General case' 0 CA--C 1.541 0.616 0 N-CA-C 109.784 -0.451 . . . . 0.0 109.784 -178.749 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 128' ' ' ASP . . . . . . . . . . . . . 19.4 p-10 -83.69 19.73 1.59 Allowed 'General case' 0 CA--C 1.536 0.412 0 CA-C-N 118.67 0.668 . . . . 0.0 112.49 177.337 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 129' ' ' LEU . . . . . . . . . . . . . 2.0 tt -116.41 131.81 56.85 Favored 'General case' 0 C--O 1.232 0.156 0 N-CA-C 109.96 -0.385 . . . . 0.0 109.96 -179.92 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 130' ' ' VAL . . . . . . . . . . . . . 44.7 t -124.19 138.26 54.38 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.228 0 CA-C-O 120.765 0.317 . . . . 0.0 110.146 -178.826 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 131' ' ' VAL . . . . . 0.434 HG22 HD12 ' B' ' 140' ' ' LEU . 41.2 t -136.1 137.75 48.14 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.261 0 CA-C-O 121.037 0.446 . . . . 0.0 110.444 179.851 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' B' B ' 132' ' ' ILE . . . . . . . . . . . . . 73.5 mt -119.84 133.39 66.76 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.254 0 N-CA-C 109.342 -0.614 . . . . 0.0 109.342 178.68 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 133' ' ' ILE . . . . . . . . . . . . . 40.1 mm -117.44 121.71 68.22 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.29 0 CA-C-O 120.824 0.345 . . . . 0.0 111.205 -174.498 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 134' ' ' ASP . . . . . . . . . . . . . 6.8 p-10 -132.07 147.25 52.43 Favored 'General case' 0 C--N 1.332 -0.178 0 CA-C-N 115.852 -0.613 . . . . 0.0 109.521 173.831 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 135' ' ' GLU . . . . . . . . . . . . . 43.7 tp10 -49.9 -26.72 4.37 Favored 'General case' 0 C--N 1.328 -0.33 0 N-CA-C 112.904 0.705 . . . . 0.0 112.904 -170.756 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 136' ' ' GLN . . . . . . . . . . . . . 96.9 mt-30 -92.88 -34.76 13.69 Favored 'General case' 0 C--N 1.331 -0.232 0 N-CA-C 112.381 0.511 . . . . 0.0 112.381 -175.475 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 137' ' ' LYS . . . . . . . . . . . . . 55.4 mtmt -145.49 154.98 42.81 Favored 'General case' 0 C--N 1.33 -0.239 0 CA-C-O 121.474 0.654 . . . . 0.0 111.856 -170.141 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 138' ' ' LEU . . . . . 0.454 HD23 ' N ' ' B' ' 139' ' ' THR . 4.2 tt -113.31 123.05 49.22 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 115.144 -0.935 . . . . 0.0 108.981 174.403 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' B' B ' 139' ' ' THR . . . . . 0.454 ' N ' HD23 ' B' ' 138' ' ' LEU . 33.1 m -107.61 128.48 54.58 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-O 120.848 0.356 . . . . 0.0 110.852 -177.218 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' B' B ' 140' ' ' LEU . . . . . 0.434 HD12 HG22 ' B' ' 131' ' ' VAL . 18.8 tp -114.08 121.53 44.09 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 115.45 -0.796 . . . . 0.0 109.355 -179.28 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' B' B ' 141' ' ' ILE . . . . . . . . . . . . . 19.5 mt -120.86 120.13 61.5 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.342 0 N-CA-C 109.855 -0.424 . . . . 0.0 109.855 -175.733 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 142' ' ' ARG . . . . . . . . . . . . . 73.5 mtm180 -111.01 129.23 55.96 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 115.55 -0.75 . . . . 0.0 110.547 -179.401 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 143' ' ' THR . . . . . . . . . . . . . 39.9 p . . . . . 0 C--O 1.222 -0.373 0 CA-C-O 117.959 -1.02 . . . . 0.0 110.56 179.939 . . . . . . . . 0 0 . 1 . 007 nuclear build full ' C' C ' -3' ' ' GLU . . . . . . . . . . . . . 84.9 tt0 . . . . . 0 N--CA 1.489 1.508 0 N-CA-C 109.345 -0.613 . . . . 0.0 109.345 . . . . . . . . . 0 0 . 1 . 007 nuclear build full ' C' C ' -2' ' ' GLY . . . . . . . . . . . . . . . -84.03 110.34 3.31 Favored Glycine 0 CA--C 1.525 0.706 0 N-CA-C 110.784 -0.927 . . . . 0.0 110.784 179.599 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' C' C ' -1' ' ' VAL . . . . . . . . . . . . . 46.2 t -84.99 123.93 39.57 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.321 0 N-CA-C 109.547 -0.538 . . . . 0.0 109.547 179.112 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' C' C ' 0' ' ' ILE . . . . . . . . . . . . . 71.3 mt -120.29 137.19 54.91 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.262 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.254 -177.506 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' C' C ' 1' ' ' MET . . . . . . . . . . . . . 26.4 ptm -90.15 131.96 35.72 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.017 -0.538 . . . . 0.0 110.489 178.511 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' C' C ' 2' ' ' SER . . . . . . . . . . . . . 25.9 p -117.71 150.13 39.6 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.312 179.179 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' C' C ' 3' ' ' GLU . . . . . . . . . . . . . 95.7 mt-10 -139.42 141.8 37.48 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.191 -0.459 . . . . 0.0 111.014 -178.021 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' C' C ' 4' ' ' LEU . . . . . 0.4 HD11 HG13 ' C' ' 50' ' ' VAL . 16.9 tp -125.11 125.83 44.37 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 115.724 -0.671 . . . . 0.0 110.197 177.165 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' C' C ' 5' ' ' LYS . . . . . . . . . . . . . 60.5 mttp -105.23 121.53 44.04 Favored 'General case' 0 C--O 1.234 0.25 0 CA-C-N 116.505 -0.316 . . . . 0.0 110.282 177.632 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' C' C ' 6' ' ' LEU . . . . . . . . . . . . . 53.2 mt -114.46 145.71 41.55 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-N 115.623 -0.717 . . . . 0.0 110.917 -178.058 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' C' C ' 7' ' ' LYS . . . . . . . . . . . . . 25.9 ttpt -132.7 134.53 24.77 Favored Pre-proline 0 CA--C 1.536 0.412 0 CA-C-O 118.884 -0.579 . . . . 0.0 109.64 176.449 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' C' C ' 8' ' ' PRO . . . . . . . . . . . . . 86.5 Cg_endo -90.67 133.3 1.75 Allowed 'Trans proline' 0 N--CA 1.489 1.228 0 C-N-CA 121.624 1.55 . . . . 0.0 111.343 174.095 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' C' C ' 9' ' ' LEU . . . . . . . . . . . . . 62.1 mt -69.13 -48.21 27.59 Favored Pre-proline 0 CA--C 1.533 0.325 0 CA-C-O 118.608 -0.711 . . . . 0.0 112.48 -177.085 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' C' C ' 10' ' ' PRO . . . . . . . . . . . . . 90.0 Cg_endo -78.81 146.83 21.17 Favored 'Trans proline' 0 N--CA 1.495 1.59 0 C-N-CA 121.109 1.206 . . . . 0.0 111.817 177.367 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' C' C ' 11' ' ' LYS . . . . . . . . . . . . . 62.0 tttm -78.55 91.39 4.57 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.436 -0.347 . . . . 0.0 110.424 179.185 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' C' C ' 12' ' ' VAL . . . . . . . . . . . . . 12.4 p -139.63 146.15 25.77 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.308 0 CA-C-N 116.297 -0.41 . . . . 0.0 110.485 -179.705 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' C' C ' 13' ' ' GLU . . . . . . . . . . . . . 44.7 tp10 -90.26 129.37 36.51 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.33 -0.396 . . . . 0.0 110.298 179.351 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' C' C ' 14' ' ' LEU . . . . . . . . . . . . . 27.3 mt -97.99 152.36 38.02 Favored Pre-proline 0 CA--C 1.531 0.246 0 CA-C-N 116.33 -0.395 . . . . 0.0 110.653 -178.323 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' C' C ' 15' ' ' PRO . . . . . . . . . . . . . 27.2 Cg_exo -61.31 159.01 32.77 Favored 'Trans proline' 0 N--CA 1.499 1.795 0 C-N-CA 121.307 1.338 . . . . 0.0 111.815 177.265 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' C' C ' 16' ' ' PRO . . . . . . . . . . . . . 39.8 Cg_exo -58.63 -39.37 83.27 Favored 'Trans proline' 0 N--CA 1.498 1.74 0 C-N-CA 121.483 1.455 . . . . 0.0 112.871 -178.481 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' C' C ' 17' ' ' ASP . . . . . . . . . . . . . 12.9 p-10 -85.81 8.51 19.73 Favored 'General case' 0 CA--C 1.536 0.44 0 N-CA-C 113.176 0.806 . . . . 0.0 113.176 -177.738 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' C' C ' 18' ' ' PHE . . . . . . . . . . . . . 55.0 t80 -58.1 -45.53 87.06 Favored 'General case' 0 C--N 1.333 -0.118 0 O-C-N 122.077 -0.389 . . . . 0.0 110.178 -177.925 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' C' C ' 19' ' ' VAL . . . . . 0.414 HG13 ' N ' ' C' ' 20' ' ' ASP . 13.8 p -55.88 -41.69 67.9 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.371 0 CA-C-N 116.336 -0.393 . . . . 0.0 111.006 -178.244 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' C' C ' 20' ' ' ASP . . . . . 0.414 ' N ' HG13 ' C' ' 19' ' ' VAL . 11.3 t70 -60.82 -42.03 96.91 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-O 120.977 0.418 . . . . 0.0 110.655 -178.831 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' C' C ' 21' ' ' VAL . . . . . . . . . . . . . 47.3 t -64.04 -45.47 96.58 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.248 0 CA-C-N 116.244 -0.434 . . . . 0.0 110.442 -178.138 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' C' C ' 22' ' ' ILE . . . . . 0.45 HG22 HD12 ' C' ' 26' ' ' LEU . 51.5 mm -55.4 -47.25 78.41 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.265 0 C-N-CA 121.056 -0.258 . . . . 0.0 110.661 179.037 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' C' C ' 23' ' ' ARG . . . . . . . . . . . . . 54.0 ttp180 -54.35 -49.83 68.86 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-O 120.671 0.272 . . . . 0.0 111.411 -179.068 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' C' C ' 24' ' ' ILE . . . . . . . . . . . . . 73.1 mt -59.34 -41.76 85.26 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.314 0 CA-C-N 116.566 -0.288 . . . . 0.0 111.422 -176.889 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' C' C ' 25' ' ' LYS . . . . . . . . . . . . . 49.6 mttm -67.28 -42.64 83.46 Favored 'General case' 0 C--N 1.329 -0.32 0 N-CA-C 112.351 0.5 . . . . 0.0 112.351 -178.791 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' C' C ' 26' ' ' LEU . . . . . 0.45 HD12 HG22 ' C' ' 22' ' ' ILE . 92.6 mt -78.34 -37.91 43.38 Favored 'General case' 0 C--N 1.33 -0.272 0 N-CA-C 113.116 0.784 . . . . 0.0 113.116 -170.651 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' C' C ' 27' ' ' GLN . . . . . . . . . . . . . 13.8 pt20 -46.87 139.12 5.72 Favored 'General case' 0 N--CA 1.47 0.531 0 N-CA-C 112.918 0.71 . . . . 0.0 112.918 -175.016 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' C' C ' 28' ' ' GLY . . . . . . . . . . . . . . . 100.01 -26.69 23.51 Favored Glycine 0 CA--C 1.533 1.17 0 CA-C-N 115.493 -0.776 . . . . 0.0 112.207 -177.505 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' C' C ' 29' ' ' LYS . . . . . . . . . . . . . 60.8 mttp -98.24 155.12 17.34 Favored 'General case' 0 C--O 1.232 0.169 0 CA-C-N 117.264 0.532 . . . . 0.0 111.071 179.555 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' C' C ' 30' ' ' THR . . . . . . . . . . . . . 32.8 m -110.0 133.52 53.1 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-N 116.048 -0.523 . . . . 0.0 110.186 176.823 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' C' C ' 31' ' ' VAL . . . . . . . . . . . . . 35.0 m -133.45 164.3 35.32 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.267 0 CA-C-N 116.265 -0.425 . . . . 0.0 110.364 -179.641 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' C' C ' 32' ' ' ARG . . . . . . . . . . . . . 29.9 ttp180 -132.53 153.59 50.8 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-O 121.294 0.569 . . . . 0.0 110.605 179.232 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' C' C ' 33' ' ' THR . . . . . . . . . . . . . 28.8 m -52.41 140.35 22.46 Favored 'General case' 0 C--N 1.331 -0.227 0 CA-C-N 116.127 -0.488 . . . . 0.0 111.561 -178.327 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' C' C ' 34' ' ' GLY . . . . . . . . . . . . . . . 100.02 -17.2 57.52 Favored Glycine 0 CA--C 1.533 1.181 0 CA-C-O 119.713 -0.493 . . . . 0.0 113.199 179.875 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' C' C ' 35' ' ' ASP . . . . . . . . . . . . . 60.7 m-20 -66.77 149.73 50.12 Favored 'General case' 0 C--O 1.232 0.164 0 CA-C-N 118.074 0.937 . . . . 0.0 111.2 178.918 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' C' C ' 36' ' ' VAL . . . . . . . . . . . . . 45.2 t -123.65 130.44 74.05 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.261 0 CA-C-N 115.897 -0.592 . . . . 0.0 109.825 178.905 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' C' C ' 37' ' ' ILE . . . . . . . . . . . . . 62.1 mt -122.15 139.2 49.84 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.265 0 CA-C-N 116.259 -0.428 . . . . 0.0 109.898 -178.84 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' C' C ' 38' ' ' GLY . . . . . . . . . . . . . . . -109.83 128.74 9.05 Favored Glycine 0 CA--C 1.525 0.696 0 N-CA-C 111.192 -0.763 . . . . 0.0 111.192 179.744 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' C' C ' 39' ' ' ILE . . . . . . . . . . . . . 68.8 mt -120.76 130.96 74.02 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.19 0 N-CA-C 109.944 -0.391 . . . . 0.0 109.944 178.406 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' C' C ' 40' ' ' SER . . . . . . . . . . . . . 32.8 t -93.12 122.58 35.65 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.423 -0.353 . . . . 0.0 111.099 177.324 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' C' C ' 41' ' ' ILE . . . . . . . . . . . . . 70.3 mt -129.75 120.24 49.66 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.206 0 CA-C-O 120.881 0.372 . . . . 0.0 110.325 177.405 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' C' C ' 42' ' ' LEU . . . . . . . . . . . . . 62.6 mt 52.84 36.13 20.67 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 116.02 -0.536 . . . . 0.0 111.677 177.163 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' C' C ' 43' ' ' GLY . . . . . . . . . . . . . . . 72.64 30.0 64.74 Favored Glycine 0 CA--C 1.529 0.967 0 C-N-CA 121.108 -0.567 . . . . 0.0 112.284 177.615 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' C' C ' 44' ' ' LYS . . . . . . . . . . . . . 62.3 mtpt -134.65 129.06 34.27 Favored 'General case' 0 C--N 1.331 -0.222 0 N-CA-C 109.645 -0.502 . . . . 0.0 109.645 177.809 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' C' C ' 45' ' ' GLU . . . . . . . . . . . . . 84.5 tt0 -84.23 122.2 28.55 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-O 120.871 0.367 . . . . 0.0 111.304 -178.255 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' C' C ' 46' ' ' VAL . . . . . . . . . . . . . 7.6 p -119.03 125.6 74.64 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.168 0 N-CA-C 109.06 -0.718 . . . . 0.0 109.06 173.643 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' C' C ' 47' ' ' LYS . . . . . . . . . . . . . 97.9 mttt -99.62 126.87 45.7 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.099 -0.5 . . . . 0.0 111.151 -179.843 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' C' C ' 48' ' ' PHE . . . . . . . . . . . . . 93.6 m-85 -110.39 131.78 54.75 Favored 'General case' 0 C--N 1.329 -0.289 0 N-CA-C 109.624 -0.51 . . . . 0.0 109.624 176.76 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' C' C ' 49' ' ' LYS . . . . . . . . . . . . . 71.4 tttt -108.79 136.83 47.71 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.388 -0.369 . . . . 0.0 110.459 179.075 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' C' C ' 50' ' ' VAL . . . . . 0.4 HG13 HD11 ' C' ' 4' ' ' LEU . 48.0 t -78.87 105.36 8.0 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.278 0 N-CA-C 109.087 -0.709 . . . . 0.0 109.087 175.899 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' C' C ' 51' ' ' VAL . . . . . . . . . . . . . 46.8 t -69.19 -48.96 65.75 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.291 0 CA-C-N 116.07 -0.514 . . . . 0.0 109.843 -173.922 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' C' C ' 52' ' ' GLN . . . . . . . . . . . . . 32.3 tt0 -162.43 143.23 10.12 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-N 115.949 -0.569 . . . . 0.0 111.522 -179.1 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' C' C ' 53' ' ' ALA . . . . . . . . . . . . . . . -122.58 133.85 54.54 Favored 'General case' 0 C--N 1.331 -0.212 0 CA-C-N 115.786 -0.643 . . . . 0.0 109.718 176.714 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' C' C ' 54' ' ' TYR . . . . . . . . . . . . . 14.9 t80 -129.08 113.08 18.52 Favored Pre-proline 0 CA--C 1.535 0.397 0 CA-C-O 118.041 -0.981 . . . . 0.0 110.345 179.265 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' C' C ' 55' ' ' PRO . . . . . . . . . . . . . 73.7 Cg_endo -77.08 169.15 75.09 Favored 'Cis proline' 0 N--CA 1.501 1.967 0 CA-C-N 122.017 1.756 . . . . 0.0 112.214 -6.95 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' C' C ' 56' ' ' SER . . . . . . . . . . . . . 13.5 m -117.74 135.95 23.51 Favored Pre-proline 0 CA--C 1.539 0.533 0 CA-C-O 118.549 -0.738 . . . . 0.0 109.825 175.681 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' C' C ' 57' ' ' PRO . . . . . . . . . . . . . 36.5 Cg_endo -67.22 164.68 70.47 Favored 'Cis proline' 0 N--CA 1.496 1.665 0 CA-C-N 121.743 1.658 . . . . 0.0 111.231 -4.318 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' C' C ' 58' ' ' LEU . . . . . . . . . . . . . 42.4 tp -130.71 138.4 49.99 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-O 121.126 0.489 . . . . 0.0 110.777 -178.737 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' C' C ' 59' ' ' ARG . . . . . . . . . . . . . 51.1 ttt180 -104.1 125.81 50.72 Favored 'General case' 0 C--N 1.327 -0.395 0 N-CA-C 108.939 -0.763 . . . . 0.0 108.939 173.297 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' C' C ' 60' ' ' VAL . . . . . . . . . . . . . 44.1 t -78.94 122.46 34.2 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.319 0 CA-C-O 120.937 0.398 . . . . 0.0 110.609 -174.135 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' C' C ' 61' ' ' GLU . . . . . . . . . . . . . 43.1 mt-10 -131.03 166.04 21.89 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 115.79 -0.641 . . . . 0.0 109.697 174.739 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' C' C ' 62' ' ' ASP . . . . . . . . . . . . . 81.0 m-20 -52.87 -31.85 41.69 Favored 'General case' 0 C--N 1.328 -0.369 0 N-CA-C 111.971 0.36 . . . . 0.0 111.971 -179.883 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' C' C ' 63' ' ' ARG . . . . . . . . . . . . . 21.0 mmm180 -71.17 -21.88 62.11 Favored 'General case' 0 CA--C 1.534 0.351 0 N-CA-C 112.76 0.652 . . . . 0.0 112.76 -176.128 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' C' C ' 64' ' ' THR . . . . . . . . . . . . . 25.3 m -72.12 136.3 46.49 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-O 120.933 0.397 . . . . 0.0 110.947 -175.829 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' C' C ' 65' ' ' LYS . . . . . . . . . . . . . 96.9 mttt -89.8 131.45 35.74 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.011 -0.54 . . . . 0.0 110.144 179.221 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' C' C ' 66' ' ' ILE . . . . . . . . . . . . . 64.0 mt -116.67 130.52 71.38 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.256 0 CA-C-O 120.89 0.376 . . . . 0.0 110.121 -179.892 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' C' C ' 67' ' ' THR . . . . . . . . . . . . . 21.7 m -129.19 142.5 50.85 Favored 'General case' 0 C--N 1.332 -0.185 0 CA-C-N 116.084 -0.507 . . . . 0.0 110.787 -178.846 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' C' C ' 68' ' ' LEU . . . . . 0.5 HD12 ' N ' ' C' ' 68' ' ' LEU . 7.1 mp -105.09 138.46 41.26 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 116.081 -0.509 . . . . 0.0 110.417 178.631 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' C' C ' 69' ' ' VAL . . . . . 0.478 HG11 ' HB3' ' C' ' 72' ' ' PRO . 38.6 t -82.9 138.62 19.04 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.265 0 N-CA-C 109.869 -0.419 . . . . 0.0 109.869 178.18 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' C' C ' 70' ' ' THR . . . . . . . . . . . . . 42.9 p -86.17 -60.04 2.12 Favored 'General case' 0 C--N 1.33 -0.258 0 N-CA-C 112.247 0.462 . . . . 0.0 112.247 -172.557 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' C' C ' 71' ' ' HIS . . . . . . . . . . . . . 91.3 m-70 -129.3 67.85 79.28 Favored Pre-proline 0 CA--C 1.536 0.442 0 CA-C-O 120.662 0.268 . . . . 0.0 111.262 -174.793 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' C' C ' 72' ' ' PRO . . . . . 0.478 ' HB3' HG11 ' C' ' 69' ' ' VAL . 72.7 Cg_endo -94.94 160.13 1.74 Allowed 'Trans proline' 0 N--CA 1.488 1.156 0 C-N-CA 122.034 1.823 . . . . 0.0 112.297 175.925 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' C' C ' 73' ' ' VAL . . . . . . . . . . . . . 26.8 m -103.59 161.63 4.32 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.299 0 N-CA-C 109.802 -0.444 . . . . 0.0 109.802 175.347 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' C' C ' 74' ' ' ASP . . . . . . . . . . . . . 14.0 t70 -91.35 115.24 27.87 Favored 'General case' 0 C--N 1.328 -0.33 0 N-CA-C 109.921 -0.4 . . . . 0.0 109.921 -178.351 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' C' C ' 75' ' ' VAL . . . . . . . . . . . . . 45.6 t -113.1 120.29 62.72 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.268 0 CA-C-O 121.094 0.473 . . . . 0.0 110.216 -178.446 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' C' C ' 76' ' ' LEU . . . . . . . . . . . . . 19.8 mt -123.18 144.94 49.02 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 115.605 -0.725 . . . . 0.0 109.585 179.452 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' C' C ' 77' ' ' GLU . . . . . . . . . . . . . 46.2 mt-10 -134.31 133.5 40.78 Favored 'General case' 0 C--N 1.332 -0.188 0 CA-C-O 121.042 0.449 . . . . 0.0 111.149 -178.804 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' C' C ' 78' ' ' ALA . . . . . . . . . . . . . . . -118.94 135.75 54.43 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 115.713 -0.676 . . . . 0.0 109.808 176.461 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' C' C ' 79' ' ' LYS . . . . . 0.664 ' O ' HD13 ' C' ' 80' ' ' ILE . 62.5 mtpt -80.7 115.3 20.13 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-O 120.813 0.34 . . . . 0.0 110.869 -177.627 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' C' C ' 80' ' ' ILE . . . . . 0.664 HD13 ' O ' ' C' ' 79' ' ' LYS . 37.2 mm -139.23 104.61 2.22 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.281 0 N-CA-C 109.284 -0.636 . . . . 0.0 109.284 -178.527 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' C' C ' 81' ' ' LYS . . . . . . . . . . . . . 93.1 mttt -97.65 128.48 44.38 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-O 120.782 0.325 . . . . 0.0 110.839 -178.766 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' C' C ' 82' ' ' GLY . . . . . . . . . . . . . . . 89.08 42.25 5.66 Favored Glycine 0 CA--C 1.524 0.655 0 N-CA-C 111.176 -0.77 . . . . 0.0 111.176 176.685 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' C' C ' 83' ' ' ILE . . . . . . . . . . . . . 73.6 mt -67.37 132.3 32.5 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.306 0 N-CA-C 109.771 -0.455 . . . . 0.0 109.771 177.689 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' C' C ' 84' ' ' LYS . . . . . . . . . . . . . 76.4 tttt -95.42 -54.06 3.53 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.22 -0.445 . . . . 0.0 110.311 -178.736 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' C' C ' 85' ' ' ASP . . . . . . . . . . . . . 7.4 t0 -149.81 146.3 27.07 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 115.806 -0.634 . . . . 0.0 110.39 -178.652 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' C' C ' 86' ' ' VAL . . . . . . . . . . . . . 42.6 t -124.31 129.5 73.96 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.216 0 CA-C-O 120.858 0.361 . . . . 0.0 110.291 -179.597 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' C' C ' 87' ' ' ILE . . . . . . . . . . . . . 45.1 mm -120.18 126.15 74.97 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.268 0 CA-C-N 115.957 -0.565 . . . . 0.0 109.738 177.637 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' C' C ' 88' ' ' LEU . . . . . . . . . . . . . 19.9 tp -115.15 134.72 54.91 Favored 'General case' 0 C--N 1.332 -0.171 0 CA-C-O 120.992 0.425 . . . . 0.0 111.222 -177.736 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' C' C ' 89' ' ' ASP . . . . . . . . . . . . . 5.6 t70 -131.53 162.23 30.77 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 115.861 -0.609 . . . . 0.0 109.562 176.43 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' C' C ' 90' ' ' GLU . . . . . . . . . . . . . 43.2 mt-10 -46.94 -41.9 16.83 Favored 'General case' 0 N--CA 1.464 0.26 0 N-CA-C 113.015 0.746 . . . . 0.0 113.015 -171.224 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' C' C ' 91' ' ' ASN . . . . . . . . . . . . . 11.3 p-10 -132.04 28.29 4.48 Favored 'General case' 0 N--CA 1.466 0.329 0 N-CA-C 112.301 0.482 . . . . 0.0 112.301 -177.773 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' C' C ' 92' ' ' LEU . . . . . . . . . . . . . 16.1 mt -148.62 142.33 25.57 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-O 120.689 0.281 . . . . 0.0 110.35 -177.38 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' C' C ' 93' ' ' ILE . . . . . . . . . . . . . 72.9 mt -125.25 116.58 47.27 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.286 0 N-CA-C 109.143 -0.688 . . . . 0.0 109.143 176.11 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' C' C ' 94' ' ' VAL . . . . . 0.588 HG21 HG11 ' C' ' 125' ' ' VAL . 45.2 t -118.54 127.73 75.53 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.29 0 CA-C-O 120.959 0.409 . . . . 0.0 109.939 -178.795 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' C' C ' 95' ' ' VAL . . . . . . . . . . . . . 44.0 t -122.59 132.78 70.53 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.373 0 CA-C-N 115.96 -0.564 . . . . 0.0 109.854 -179.524 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' C' C ' 96' ' ' ILE . . . . . . . . . . . . . 58.6 mt -113.12 125.58 70.4 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.327 0 N-CA-C 109.058 -0.719 . . . . 0.0 109.058 178.066 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' C' C ' 97' ' ' THR . . . . . . . . . . . . . 71.5 p -98.95 154.53 17.99 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-O 121.197 0.522 . . . . 0.0 111.108 -177.758 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' C' C ' 98' ' ' GLU . . . . . . . . . . . . . 85.1 tt0 -53.82 -25.48 19.62 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 115.959 -0.564 . . . . 0.0 112.341 179.771 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' C' C ' 99' ' ' GLU . . . . . . . . . . . . . 37.0 tt0 -81.07 17.96 1.14 Allowed 'General case' 0 CA--C 1.539 0.525 0 N-CA-C 112.625 0.602 . . . . 0.0 112.625 -177.436 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' C' C ' 100' ' ' ASN . . . . . . . . . . . . . 2.7 m-20 62.39 32.77 16.72 Favored 'General case' 0 N--CA 1.464 0.259 0 O-C-N 121.85 -0.531 . . . . 0.0 111.836 176.276 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' C' C ' 101' ' ' GLU . . . . . . . . . . . . . 84.8 tt0 -113.06 144.82 41.96 Favored 'General case' 0 C--N 1.332 -0.155 0 N-CA-C 109.812 -0.44 . . . . 0.0 109.812 174.14 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' C' C ' 102' ' ' VAL . . . . . . . . . . . . . 45.7 t -115.09 127.43 72.65 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.293 0 CA-C-N 116.244 -0.435 . . . . 0.0 109.926 -177.695 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' C' C ' 103' ' ' LEU . . . . . . . . . . . . . 50.6 mt -117.38 131.53 56.76 Favored 'General case' 0 C--N 1.331 -0.215 0 CA-C-N 115.881 -0.6 . . . . 0.0 110.132 178.531 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' C' C ' 104' ' ' ILE . . . . . . . . . . . . . 65.1 mt -122.56 122.65 66.61 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.227 0 CA-C-O 120.568 0.223 . . . . 0.0 110.46 -179.657 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' C' C ' 105' ' ' PHE . . . . . . . . . . . . . 47.7 m-85 -124.07 164.64 19.0 Favored 'General case' 0 C--N 1.331 -0.225 0 CA-C-N 115.596 -0.729 . . . . 0.0 109.843 178.432 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' C' C ' 106' ' ' ASN . . . . . . . . . . . . . 42.9 p-10 -96.29 -171.41 2.29 Favored 'General case' 0 C--N 1.331 -0.212 0 N-CA-C 109.992 -0.373 . . . . 0.0 109.992 174.929 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' C' C ' 107' ' ' GLN . . . . . . . . . . . . . 15.4 tt0 -60.23 -29.46 68.77 Favored 'General case' 0 C--N 1.329 -0.32 0 N-CA-C 111.96 0.355 . . . . 0.0 111.96 -179.659 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' C' C ' 108' ' ' ASN . . . . . . . . . . . . . 5.0 t-20 -83.95 6.16 22.83 Favored 'General case' 0 CA--C 1.536 0.441 0 N-CA-C 113.277 0.843 . . . . 0.0 113.277 -177.468 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' C' C ' 109' ' ' LEU . . . . . . . . . . . . . 12.0 tp 62.09 41.67 10.64 Favored 'General case' 0 C--N 1.332 -0.164 0 CA-C-O 121.383 0.611 . . . . 0.0 110.98 178.657 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' C' C ' 110' ' ' GLU . . . . . . . . . . . . . 96.2 mt-10 -108.55 155.97 20.04 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.139 -0.482 . . . . 0.0 110.014 176.094 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' C' C ' 111' ' ' GLU . . . . . . . . . . . . . 83.7 tt0 -79.97 121.93 26.09 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.394 -0.366 . . . . 0.0 110.683 -179.121 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' C' C ' 112' ' ' LEU . . . . . . . . . . . . . 17.9 mt -112.44 -46.03 3.2 Favored 'General case' 0 C--N 1.331 -0.212 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.306 177.026 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' C' C ' 113' ' ' TYR . . . . . . . . . . . . . 62.7 t80 -147.07 137.2 23.35 Favored 'General case' 0 C--N 1.33 -0.243 0 C-N-CA 120.606 -0.438 . . . . 0.0 111.462 179.991 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' C' C ' 114' ' ' ARG . . . . . . . . . . . . . 93.2 mtt180 -137.67 127.83 26.05 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.131 -0.486 . . . . 0.0 110.096 173.876 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' C' C ' 115' ' ' GLY . . . . . . . . . . . . . . . -149.99 162.89 29.31 Favored Glycine 0 CA--C 1.524 0.596 0 N-CA-C 110.682 -0.967 . . . . 0.0 110.682 179.337 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' C' C ' 116' ' ' LYS . . . . . . . . . . . . . 75.2 tttt -132.31 138.5 47.84 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-O 120.856 0.36 . . . . 0.0 110.143 179.287 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' C' C ' 117' ' ' PHE . . . . . . . . . . . . . 33.4 m-85 -136.28 116.72 13.71 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.158 -0.474 . . . . 0.0 109.812 -177.113 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' C' C ' 118' ' ' GLU . . . . . . . . . . . . . 45.7 mp0 -56.01 -40.62 73.65 Favored 'General case' 0 C--N 1.329 -0.304 0 C-N-CA 120.803 -0.359 . . . . 0.0 110.92 -175.758 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' C' C ' 119' ' ' ASN . . . . . . . . . . . . . 30.5 m120 -100.07 31.19 3.42 Favored 'General case' 0 CA--C 1.53 0.21 0 N-CA-C 112.103 0.408 . . . . 0.0 112.103 -174.912 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' C' C ' 120' ' ' LEU . . . . . . . . . . . . . 15.0 tp -57.34 119.9 7.25 Favored 'General case' 0 C--N 1.333 -0.148 0 C-N-CA 121.005 -0.278 . . . . 0.0 110.352 178.087 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' C' C ' 121' ' ' ASN . . . . . . . . . . . . . 46.8 m-80 -114.15 -44.1 3.17 Favored 'General case' 0 C--N 1.332 -0.195 0 CA-C-N 116.571 -0.286 . . . . 0.0 111.245 -177.705 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' C' C ' 122' ' ' LYS . . . . . . . . . . . . . 75.7 mttt -143.35 149.22 37.44 Favored 'General case' 0 C--N 1.331 -0.222 0 CA-C-O 121.066 0.46 . . . . 0.0 111.834 -176.312 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' C' C ' 123' ' ' VAL . . . . . . . . . . . . . 43.1 t -128.62 130.96 69.03 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.227 0 N-CA-C 109.266 -0.642 . . . . 0.0 109.266 174.847 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' C' C ' 124' ' ' LEU . . . . . . . . . . . . . 13.3 tp -130.27 138.3 50.43 Favored 'General case' 0 C--N 1.332 -0.184 0 CA-C-O 120.837 0.351 . . . . 0.0 110.916 -177.484 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' C' C ' 125' ' ' VAL . . . . . 0.588 HG11 HG21 ' C' ' 94' ' ' VAL . 34.9 m -129.74 138.82 53.19 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.229 0 CA-C-N 116.127 -0.488 . . . . 0.0 110.603 179.939 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' C' C ' 126' ' ' ARG . . . . . . . . . . . . . 77.9 mtp85 -147.17 121.88 9.87 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-O 120.868 0.366 . . . . 0.0 110.938 178.162 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' C' C ' 127' ' ' ASN . . . . . . . . . . . . . 9.5 m120 51.02 -105.11 0.19 Allowed 'General case' 0 CA--C 1.544 0.739 0 CA-C-N 116.113 -0.494 . . . . 0.0 111.437 178.684 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' C' C ' 128' ' ' ASP . . . . . . . . . . . . . 12.6 p-10 -114.13 -0.32 14.02 Favored 'General case' 0 CA--C 1.537 0.461 0 CA-C-N 119.504 1.047 . . . . 0.0 113.372 -177.37 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' C' C ' 129' ' ' LEU . . . . . . . . . . . . . 58.3 mt -105.01 143.65 32.89 Favored 'General case' 0 C--O 1.232 0.166 0 CA-C-N 118.135 0.425 . . . . 0.0 110.373 -179.465 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' C' C ' 130' ' ' VAL . . . . . . . . . . . . . 44.9 t -124.4 136.97 58.81 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.284 0 N-CA-C 109.642 -0.503 . . . . 0.0 109.642 -179.956 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' C' C ' 131' ' ' VAL . . . . . 0.496 HG22 HD12 ' C' ' 140' ' ' LEU . 41.3 t -134.55 137.62 51.0 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.248 0 CA-C-O 121.194 0.521 . . . . 0.0 110.376 179.974 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' C' C ' 132' ' ' ILE . . . . . . . . . . . . . 73.3 mt -118.85 133.71 64.82 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.29 0 CA-C-N 115.54 -0.755 . . . . 0.0 109.366 179.565 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' C' C ' 133' ' ' ILE . . . . . . . . . . . . . 37.7 mm -117.02 121.62 68.21 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.229 0 CA-C-N 116.462 -0.336 . . . . 0.0 110.889 -175.035 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' C' C ' 134' ' ' ASP . . . . . . . . . . . . . 7.9 p-10 -133.57 145.86 50.46 Favored 'General case' 0 C--N 1.332 -0.163 0 N-CA-C 109.652 -0.499 . . . . 0.0 109.652 174.067 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' C' C ' 135' ' ' GLU . . . . . . . . . . . . . 80.4 tt0 -49.75 -23.0 1.58 Allowed 'General case' 0 C--N 1.327 -0.403 0 N-CA-C 113.055 0.761 . . . . 0.0 113.055 -171.356 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' C' C ' 136' ' ' GLN . . . . . . . . . . . . . 44.6 tt0 -105.0 -22.56 13.1 Favored 'General case' 0 N--CA 1.465 0.294 0 N-CA-C 113.075 0.769 . . . . 0.0 113.075 -174.976 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' C' C ' 137' ' ' LYS . . . . . . . . . . . . . 78.4 mttt -145.37 153.09 40.85 Favored 'General case' 0 C--N 1.333 -0.143 0 CA-C-O 121.538 0.685 . . . . 0.0 112.22 -172.342 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' C' C ' 138' ' ' LEU . . . . . . . . . . . . . 14.6 tp -115.2 122.16 45.18 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 115.064 -0.971 . . . . 0.0 109.237 173.743 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' C' C ' 139' ' ' THR . . . . . . . . . . . . . 24.4 m -111.79 126.5 55.14 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-O 120.584 0.23 . . . . 0.0 111.011 -177.817 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' C' C ' 140' ' ' LEU . . . . . 0.496 HD12 HG22 ' C' ' 131' ' ' VAL . 15.0 tp -117.84 122.5 43.54 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 115.796 -0.638 . . . . 0.0 109.387 -178.976 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' C' C ' 141' ' ' ILE . . . . . . . . . . . . . 19.1 mt -121.7 123.05 68.51 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.252 0 CA-C-O 120.853 0.359 . . . . 0.0 110.127 -176.317 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' C' C ' 142' ' ' ARG . . . . . . . . . . . . . 84.2 mtp180 -109.62 129.61 55.58 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 115.521 -0.763 . . . . 0.0 110.536 -178.696 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' C' C ' 143' ' ' THR . . . . . . . . . . . . . 61.2 p . . . . . 0 C--O 1.219 -0.5 0 CA-C-O 117.963 -1.018 . . . . 0.0 110.497 179.78 . . . . . . . . 0 0 . 1 . 007 nuclear build full ' D' D ' -3' ' ' GLU . . . . . . . . . . . . . 70.4 mm-40 . . . . . 0 N--CA 1.49 1.537 0 N-CA-C 109.351 -0.611 . . . . 0.0 109.351 . . . . . . . . . 0 0 . 1 . 007 nuclear build full ' D' D ' -2' ' ' GLY . . . . . . . . . . . . . . . -76.36 141.61 27.04 Favored Glycine 0 CA--C 1.524 0.654 0 N-CA-C 110.76 -0.936 . . . . 0.0 110.76 178.977 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' D' D ' -1' ' ' VAL . . . . . . . . . . . . . 43.5 t -96.39 126.87 48.94 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.334 0 CA-C-O 120.813 0.339 . . . . 0.0 110.187 -179.872 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' D' D ' 0' ' ' ILE . . . . . . . . . . . . . 71.3 mt -124.72 140.48 47.81 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.196 0 CA-C-N 116.192 -0.458 . . . . 0.0 109.924 -179.865 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' D' D ' 1' ' ' MET . . . . . . . . . . . . . 25.6 ptp -78.52 143.58 36.44 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.224 -0.444 . . . . 0.0 111.044 -178.704 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' D' D ' 2' ' ' SER . . . . . . . . . . . . . 1.8 p -131.05 121.99 25.98 Favored 'General case' 0 C--N 1.331 -0.216 0 CA-C-N 116.097 -0.501 . . . . 0.0 110.178 177.706 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' D' D ' 3' ' ' GLU . . . . . . . . . . . . . 93.3 mt-10 -139.99 143.17 36.34 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-N 116.042 -0.526 . . . . 0.0 111.403 -175.819 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' D' D ' 4' ' ' LEU . . . . . . . . . . . . . 20.9 tp -126.53 129.52 48.77 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 115.776 -0.647 . . . . 0.0 109.751 175.49 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' D' D ' 5' ' ' LYS . . . . . . . . . . . . . 99.7 mttt -113.43 122.43 47.3 Favored 'General case' 0 C--O 1.235 0.336 0 CA-C-N 116.581 -0.281 . . . . 0.0 111.069 -178.624 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' D' D ' 6' ' ' LEU . . . . . . . . . . . . . 43.7 mt -114.0 143.34 44.91 Favored 'General case' 0 C--N 1.332 -0.19 0 CA-C-N 115.49 -0.777 . . . . 0.0 110.202 -179.958 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' D' D ' 7' ' ' LYS . . . . . . . . . . . . . 31.3 ttpt -125.88 138.57 32.32 Favored Pre-proline 0 CA--C 1.534 0.346 0 CA-C-O 118.917 -0.564 . . . . 0.0 109.637 175.601 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' D' D ' 8' ' ' PRO . . . . . . . . . . . . . 85.9 Cg_endo -91.14 135.22 1.8 Allowed 'Trans proline' 0 N--CA 1.489 1.23 0 C-N-CA 121.71 1.607 . . . . 0.0 112.049 179.537 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' D' D ' 9' ' ' LEU . . . . . . . . . . . . . 35.3 mt -73.81 -46.78 6.91 Favored Pre-proline 0 C--N 1.329 -0.313 0 CA-C-O 118.715 -0.66 . . . . 0.0 111.865 179.527 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' D' D ' 10' ' ' PRO . . . . . . . . . . . . . 89.4 Cg_endo -81.77 153.17 17.32 Favored 'Trans proline' 0 N--CA 1.495 1.588 0 C-N-CA 121.179 1.253 . . . . 0.0 111.574 174.71 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' D' D ' 11' ' ' LYS . . . . . . . . . . . . . 62.7 tttm -87.6 99.08 11.78 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-O 120.893 0.378 . . . . 0.0 110.443 178.863 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' D' D ' 12' ' ' VAL . . . . . . . . . . . . . 12.2 p -140.47 145.46 25.8 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.293 0 CA-C-N 116.108 -0.496 . . . . 0.0 110.352 179.971 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' D' D ' 13' ' ' GLU . . . . . . . . . . . . . 84.6 tt0 -90.1 125.45 35.43 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.317 -0.401 . . . . 0.0 110.029 178.588 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' D' D ' 14' ' ' LEU . . . . . 0.407 HD22 ' CD1' ' D' ' 18' ' ' PHE . 21.1 mt -96.77 151.17 37.7 Favored Pre-proline 0 C--N 1.329 -0.309 0 CA-C-N 116.404 -0.362 . . . . 0.0 110.692 -177.669 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' D' D ' 15' ' ' PRO . . . . . . . . . . . . . 26.7 Cg_exo -61.61 157.38 42.29 Favored 'Trans proline' 0 N--CA 1.497 1.697 0 C-N-CA 121.225 1.283 . . . . 0.0 111.669 176.812 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' D' D ' 16' ' ' PRO . . . . . . . . . . . . . 37.2 Cg_exo -57.59 -36.21 98.63 Favored 'Trans proline' 0 N--CA 1.496 1.66 0 C-N-CA 121.461 1.441 . . . . 0.0 112.981 -177.466 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' D' D ' 17' ' ' ASP . . . . . . . . . . . . . 22.4 p-10 -92.03 9.06 34.86 Favored 'General case' 0 CA--C 1.535 0.403 0 N-CA-C 113.418 0.896 . . . . 0.0 113.418 -175.988 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' D' D ' 18' ' ' PHE . . . . . 0.407 ' CD1' HD22 ' D' ' 14' ' ' LEU . 62.4 t80 -57.09 -47.61 80.63 Favored 'General case' 0 C--N 1.333 -0.145 0 O-C-N 121.837 -0.539 . . . . 0.0 110.483 -177.585 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' D' D ' 19' ' ' VAL . . . . . . . . . . . . . 44.3 t -55.57 -51.0 62.7 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.382 0 CA-C-N 116.281 -0.418 . . . . 0.0 111.235 -174.429 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' D' D ' 20' ' ' ASP . . . . . . . . . . . . . 2.3 p-10 -59.33 -37.27 77.39 Favored 'General case' 0 N--CA 1.464 0.228 0 C-N-CA 120.381 -0.527 . . . . 0.0 111.252 -176.32 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' D' D ' 21' ' ' VAL . . . . . . . . . . . . . 59.7 t -63.0 -45.15 99.61 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.266 0 C-N-CA 120.314 -0.555 . . . . 0.0 110.191 179.885 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' D' D ' 22' ' ' ILE . . . . . 0.534 HG22 HD12 ' D' ' 26' ' ' LEU . 46.1 mm -57.39 -39.46 68.45 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.317 0 C-N-CA 120.961 -0.296 . . . . 0.0 110.475 178.36 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' D' D ' 23' ' ' ARG . . . . . . . . . . . . . 55.5 ttp180 -57.26 -49.97 74.38 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-O 121.057 0.456 . . . . 0.0 110.437 176.751 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' D' D ' 24' ' ' ILE . . . . . . . . . . . . . 76.6 mt -60.0 -38.89 78.56 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.34 0 CA-C-N 116.028 -0.533 . . . . 0.0 111.858 -176.884 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' D' D ' 25' ' ' LYS . . . . . . . . . . . . . 25.9 pttt -76.64 -40.82 47.97 Favored 'General case' 0 CA--C 1.534 0.36 0 C-N-CA 120.343 -0.543 . . . . 0.0 112.112 -174.426 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' D' D ' 26' ' ' LEU . . . . . 0.534 HD12 HG22 ' D' ' 22' ' ' ILE . 14.7 mt -79.35 -28.39 42.0 Favored 'General case' 0 CA--C 1.53 0.211 0 N-CA-C 113.172 0.804 . . . . 0.0 113.172 -171.828 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' D' D ' 27' ' ' GLN . . . . . . . . . . . . . 17.3 pt20 -46.37 141.68 3.4 Favored 'General case' 0 N--CA 1.471 0.589 0 N-CA-C 112.931 0.715 . . . . 0.0 112.931 -175.518 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' D' D ' 28' ' ' GLY . . . . . . . . . . . . . . . 100.36 -25.85 26.74 Favored Glycine 0 CA--C 1.532 1.117 0 CA-C-N 115.58 -0.736 . . . . 0.0 112.189 -176.55 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' D' D ' 29' ' ' LYS . . . . . . . . . . . . . 53.2 mttm -97.65 155.13 17.13 Favored 'General case' 0 C--N 1.332 -0.162 0 CA-C-N 117.422 0.611 . . . . 0.0 110.854 178.45 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' D' D ' 30' ' ' THR . . . . . . . . . . . . . 33.4 m -106.19 140.64 38.83 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.235 -0.438 . . . . 0.0 110.24 176.946 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' D' D ' 31' ' ' VAL . . . . . . . . . . . . . 35.0 m -127.82 155.03 39.03 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.198 0 CA-C-O 120.819 0.342 . . . . 0.0 110.875 -178.581 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' D' D ' 32' ' ' ARG . . . . . . . . . . . . . 43.6 mtp180 -133.31 152.57 51.93 Favored 'General case' 0 C--N 1.331 -0.203 0 CA-C-N 115.854 -0.612 . . . . 0.0 110.675 177.719 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' D' D ' 33' ' ' THR . . . . . . . . . . . . . 18.8 m -53.46 139.14 31.72 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.034 -0.53 . . . . 0.0 111.387 -179.256 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' D' D ' 34' ' ' GLY . . . . . . . . . . . . . . . 99.84 -17.2 57.69 Favored Glycine 0 CA--C 1.533 1.202 0 C-N-CA 121.123 -0.56 . . . . 0.0 113.284 178.13 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' D' D ' 35' ' ' ASP . . . . . . . . . . . . . 77.3 m-20 -66.12 147.79 52.8 Favored 'General case' 0 C--O 1.231 0.112 0 CA-C-N 118.053 0.927 . . . . 0.0 111.064 179.444 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' D' D ' 36' ' ' VAL . . . . . . . . . . . . . 45.0 t -122.23 129.61 75.19 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.241 0 CA-C-N 115.933 -0.576 . . . . 0.0 109.751 177.775 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' D' D ' 37' ' ' ILE . . . . . . . . . . . . . 63.9 mt -120.14 137.91 52.44 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.254 0 CA-C-N 116.289 -0.414 . . . . 0.0 110.031 -179.381 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' D' D ' 38' ' ' GLY . . . . . . . . . . . . . . . -112.65 127.72 8.12 Favored Glycine 0 CA--C 1.526 0.746 0 N-CA-C 110.828 -0.909 . . . . 0.0 110.828 178.557 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' D' D ' 39' ' ' ILE . . . . . . . . . . . . . 70.8 mt -124.76 131.0 73.24 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.282 0 N-CA-C 110.113 -0.329 . . . . 0.0 110.113 179.58 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' D' D ' 40' ' ' SER . . . . . . . . . . . . . 53.1 p -91.94 123.05 35.02 Favored 'General case' 0 C--N 1.331 -0.2 0 CA-C-N 116.292 -0.413 . . . . 0.0 110.928 177.555 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' D' D ' 41' ' ' ILE . . . . . . . . . . . . . 72.9 mt -132.34 122.43 48.03 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.229 0 CA-C-N 116.469 -0.332 . . . . 0.0 110.344 177.756 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' D' D ' 42' ' ' LEU . . . . . . . . . . . . . 52.9 mt 53.87 35.9 22.84 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.161 -0.472 . . . . 0.0 111.742 176.821 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' D' D ' 43' ' ' GLY . . . . . . . . . . . . . . . 72.85 28.03 67.75 Favored Glycine 0 CA--C 1.53 1.031 0 C-N-CA 121.171 -0.537 . . . . 0.0 112.457 177.241 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' D' D ' 44' ' ' LYS . . . . . . . . . . . . . 48.7 mtmt -138.12 128.24 25.8 Favored 'General case' 0 C--N 1.331 -0.206 0 N-CA-C 109.778 -0.453 . . . . 0.0 109.778 177.77 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' D' D ' 45' ' ' GLU . . . . . . . . . . . . . 84.5 tt0 -84.62 125.92 32.89 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.515 -0.311 . . . . 0.0 111.444 -177.939 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' D' D ' 46' ' ' VAL . . . . . 0.417 HG13 ' O ' ' D' ' 46' ' ' VAL . 8.9 p -118.58 124.39 73.06 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.23 0 N-CA-C 109.22 -0.659 . . . . 0.0 109.22 173.553 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' D' D ' 47' ' ' LYS . . . . . . . . . . . . . 91.8 mttt -98.96 124.86 44.21 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 116.087 -0.506 . . . . 0.0 110.845 178.362 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' D' D ' 48' ' ' PHE . . . . . . . . . . . . . 31.7 m-85 -108.03 131.86 54.15 Favored 'General case' 0 C--N 1.329 -0.32 0 N-CA-C 109.626 -0.509 . . . . 0.0 109.626 176.812 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' D' D ' 49' ' ' LYS . . . . . . . . . . . . . 82.2 tttt -106.79 132.08 53.17 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.246 -0.434 . . . . 0.0 110.123 178.718 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' D' D ' 50' ' ' VAL . . . . . . . . . . . . . 45.7 t -75.65 105.02 4.24 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.323 0 N-CA-C 109.257 -0.645 . . . . 0.0 109.257 177.5 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' D' D ' 51' ' ' VAL . . . . . . . . . . . . . 47.7 t -71.61 -51.43 32.7 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.273 0 CA-C-N 116.04 -0.527 . . . . 0.0 109.774 -174.687 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' D' D ' 52' ' ' GLN . . . . . . . . . . . . . 55.0 mt-30 -155.35 147.48 23.62 Favored 'General case' 0 C--N 1.33 -0.256 0 C-N-CA 120.343 -0.543 . . . . 0.0 111.789 -177.862 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' D' D ' 53' ' ' ALA . . . . . . . . . . . . . . . -124.47 130.8 53.14 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 115.291 -0.868 . . . . 0.0 109.51 173.909 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' D' D ' 54' ' ' TYR . . . . . . . . . . . . . 16.0 t80 -128.97 108.19 18.19 Favored Pre-proline 0 CA--C 1.534 0.341 0 CA-C-O 118.272 -0.871 . . . . 0.0 110.458 -179.465 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' D' D ' 55' ' ' PRO . . . . . . . . . . . . . 74.2 Cg_endo -77.16 170.0 72.71 Favored 'Cis proline' 0 N--CA 1.499 1.845 0 CA-C-N 121.86 1.7 . . . . 0.0 112.422 -5.915 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' D' D ' 56' ' ' SER . . . . . . . . . . . . . 19.6 m -116.85 133.19 23.1 Favored Pre-proline 0 CA--C 1.539 0.533 0 CA-C-O 118.465 -0.778 . . . . 0.0 109.487 174.826 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' D' D ' 57' ' ' PRO . . . . . . . . . . . . . 49.0 Cg_endo -69.91 164.18 80.32 Favored 'Cis proline' 0 N--CA 1.497 1.726 0 CA-C-N 121.848 1.696 . . . . 0.0 111.485 -1.898 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' D' D ' 58' ' ' LEU . . . . . . . . . . . . . 37.4 tp -130.23 138.05 50.35 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-O 120.886 0.374 . . . . 0.0 110.589 -179.355 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' D' D ' 59' ' ' ARG . . . . . . . . . . . . . 30.1 ttm180 -99.66 132.51 44.96 Favored 'General case' 0 C--N 1.327 -0.396 0 CA-C-N 115.85 -0.614 . . . . 0.0 109.617 176.236 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' D' D ' 60' ' ' VAL . . . . . . . . . . . . . 42.9 t -82.34 114.79 23.78 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.259 0 C-N-CA 120.787 -0.365 . . . . 0.0 110.238 -178.092 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' D' D ' 61' ' ' GLU . . . . . . . . . . . . . 96.0 mt-10 -131.19 169.43 15.93 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.079 -0.51 . . . . 0.0 109.928 176.709 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' D' D ' 62' ' ' ASP . . . . . . . . . . . . . 10.1 p-10 -55.26 -32.58 62.45 Favored 'General case' 0 C--N 1.329 -0.3 0 C-N-CA 120.904 -0.319 . . . . 0.0 111.572 178.716 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' D' D ' 63' ' ' ARG . . . . . . . . . . . . . 16.8 ptp180 -82.51 7.66 13.82 Favored 'General case' 0 CA--C 1.536 0.407 0 N-CA-C 113.504 0.927 . . . . 0.0 113.504 -176.743 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' D' D ' 64' ' ' THR . . . . . . . . . . . . . 28.5 m -91.65 134.31 34.81 Favored 'General case' 0 C--N 1.333 -0.133 0 CA-C-N 118.167 0.439 . . . . 0.0 110.618 -179.385 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' D' D ' 65' ' ' LYS . . . . . . . . . . . . . 23.0 mtpp -89.86 127.6 36.03 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.034 -0.53 . . . . 0.0 110.268 179.589 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' D' D ' 66' ' ' ILE . . . . . . . . . . . . . 65.0 mt -117.35 132.84 65.97 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.25 0 CA-C-O 120.805 0.336 . . . . 0.0 110.291 -178.327 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' D' D ' 67' ' ' THR . . . . . . . . . . . . . 23.1 m -128.7 144.19 51.1 Favored 'General case' 0 N--CA 1.463 0.217 0 CA-C-N 116.094 -0.503 . . . . 0.0 110.941 -179.139 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' D' D ' 68' ' ' LEU . . . . . . . . . . . . . 15.8 tp -107.7 134.4 50.73 Favored 'General case' 0 C--N 1.331 -0.225 0 CA-C-N 115.916 -0.584 . . . . 0.0 110.622 179.348 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' D' D ' 69' ' ' VAL . . . . . . . . . . . . . 43.6 t -99.67 140.43 18.98 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.295 0 CA-C-N 116.057 -0.52 . . . . 0.0 110.043 178.358 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' D' D ' 70' ' ' THR . . . . . . . . . . . . . 3.1 m -136.24 40.62 2.65 Favored 'General case' 0 C--N 1.331 -0.213 0 CA-C-O 121.131 0.491 . . . . 0.0 110.975 -178.263 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' D' D ' 71' ' ' HIS . . . . . . . . . . . . . 5.9 t60 -130.8 75.99 77.88 Favored Pre-proline 0 CA--C 1.535 0.382 0 CA-C-N 116.36 -0.382 . . . . 0.0 110.523 179.569 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' D' D ' 72' ' ' PRO . . . . . . . . . . . . . 90.1 Cg_endo -91.62 160.07 3.53 Favored 'Trans proline' 0 N--CA 1.491 1.364 0 C-N-CA 121.936 1.757 . . . . 0.0 112.851 -178.448 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' D' D ' 73' ' ' VAL . . . . . . . . . . . . . 34.7 m -117.31 168.29 9.22 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.205 0 CA-C-N 116.076 -0.511 . . . . 0.0 109.801 176.576 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' D' D ' 74' ' ' ASP . . . . . . . . . . . . . 13.7 t70 -97.75 116.88 30.83 Favored 'General case' 0 C--N 1.33 -0.259 0 C-N-CA 120.86 -0.336 . . . . 0.0 110.149 -177.257 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' D' D ' 75' ' ' VAL . . . . . . . . . . . . . 45.3 t -112.76 122.09 66.27 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.212 0 CA-C-O 121.086 0.469 . . . . 0.0 110.218 -178.617 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' D' D ' 76' ' ' LEU . . . . . . . . . . . . . 29.7 mt -126.78 143.2 51.32 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 115.623 -0.717 . . . . 0.0 109.433 179.28 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' D' D ' 77' ' ' GLU . . . . . . . . . . . . . 39.4 tt0 -138.44 138.97 38.67 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-O 121.052 0.453 . . . . 0.0 111.228 -177.156 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' D' D ' 78' ' ' ALA . . . . . . . . . . . . . . . -122.94 142.01 51.29 Favored 'General case' 0 C--N 1.331 -0.239 0 CA-C-N 115.881 -0.6 . . . . 0.0 110.063 177.613 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' D' D ' 79' ' ' LYS . . . . . 0.639 ' O ' HD13 ' D' ' 80' ' ' ILE . 84.4 tttt -84.7 119.2 24.98 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-O 120.743 0.306 . . . . 0.0 110.741 -178.263 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' D' D ' 80' ' ' ILE . . . . . 0.639 HD13 ' O ' ' D' ' 79' ' ' LYS . 38.2 mm -139.13 113.33 7.27 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.283 0 N-CA-C 109.763 -0.458 . . . . 0.0 109.763 -178.302 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' D' D ' 81' ' ' LYS . . . . . . . . . . . . . 39.2 tptt -105.12 125.56 51.11 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-O 120.734 0.302 . . . . 0.0 110.814 -178.275 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' D' D ' 82' ' ' GLY . . . . . . . . . . . . . . . 89.16 42.16 5.66 Favored Glycine 0 CA--C 1.526 0.726 0 C-N-CA 120.83 -0.7 . . . . 0.0 111.473 174.986 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' D' D ' 83' ' ' ILE . . . . . . . . . . . . . 71.5 mt -67.92 137.02 25.41 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.286 0 N-CA-C 109.897 -0.408 . . . . 0.0 109.897 177.78 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' D' D ' 84' ' ' LYS . . . . . . . . . . . . . 42.8 tttp -95.11 -52.31 4.26 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 116.139 -0.482 . . . . 0.0 110.075 -179.63 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' D' D ' 85' ' ' ASP . . . . . . . . . . . . . 10.9 t70 -158.48 154.32 26.6 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 115.694 -0.685 . . . . 0.0 110.252 178.632 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' D' D ' 86' ' ' VAL . . . . . . . . . . . . . 43.3 t -130.11 132.86 65.05 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.223 0 CA-C-O 120.935 0.398 . . . . 0.0 110.563 -178.939 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' D' D ' 87' ' ' ILE . . . . . 0.492 HD12 ' N ' ' D' ' 87' ' ' ILE . 5.0 mp -120.48 128.37 76.0 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.272 0 CA-C-N 115.851 -0.613 . . . . 0.0 109.516 176.752 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' D' D ' 88' ' ' LEU . . . . . . . . . . . . . 16.6 tp -114.17 134.46 54.89 Favored 'General case' 0 C--N 1.331 -0.218 0 CA-C-O 121.066 0.46 . . . . 0.0 110.949 -177.652 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' D' D ' 89' ' ' ASP . . . . . . . . . . . . . 7.6 t70 -130.49 160.93 32.62 Favored 'General case' 0 C--N 1.332 -0.187 0 CA-C-N 115.849 -0.614 . . . . 0.0 109.734 177.046 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' D' D ' 90' ' ' GLU . . . . . . . . . . . . . 71.0 mm-40 -46.63 -40.11 12.45 Favored 'General case' 0 C--N 1.329 -0.289 0 N-CA-C 113.117 0.784 . . . . 0.0 113.117 -171.517 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' D' D ' 91' ' ' ASN . . . . . . . . . . . . . 82.4 m-20 -132.04 25.44 4.59 Favored 'General case' 0 N--CA 1.467 0.403 0 N-CA-C 112.665 0.617 . . . . 0.0 112.665 -177.015 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' D' D ' 92' ' ' LEU . . . . . . . . . . . . . 18.1 mt -149.76 143.36 25.36 Favored 'General case' 0 C--N 1.331 -0.223 0 CA-C-O 120.622 0.249 . . . . 0.0 110.382 -177.361 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' D' D ' 93' ' ' ILE . . . . . . . . . . . . . 73.4 mt -126.19 115.1 41.39 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.345 0 N-CA-C 109.19 -0.67 . . . . 0.0 109.19 176.022 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' D' D ' 94' ' ' VAL . . . . . 0.623 HG21 HG11 ' D' ' 125' ' ' VAL . 45.1 t -117.82 126.4 74.79 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.267 0 CA-C-O 120.878 0.371 . . . . 0.0 110.049 -177.857 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' D' D ' 95' ' ' VAL . . . . . . . . . . . . . 43.4 t -120.63 134.01 65.46 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 CA-C-N 115.918 -0.583 . . . . 0.0 109.824 179.978 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' D' D ' 96' ' ' ILE . . . . . 0.459 HD11 ' HB ' ' D' ' 123' ' ' VAL . 63.3 mt -112.58 126.88 70.03 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 N-CA-C 108.951 -0.759 . . . . 0.0 108.951 178.466 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' D' D ' 97' ' ' THR . . . . . . . . . . . . . 81.7 p -99.34 156.95 16.73 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-O 121.21 0.529 . . . . 0.0 111.154 -177.036 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' D' D ' 98' ' ' GLU . . . . . . . . . . . . . 45.9 tp10 -53.85 -27.61 30.9 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.193 -0.458 . . . . 0.0 112.182 -179.529 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' D' D ' 99' ' ' GLU . . . . . . . . . . . . . 40.8 tt0 -79.78 16.31 1.17 Allowed 'General case' 0 CA--C 1.538 0.517 0 N-CA-C 112.666 0.617 . . . . 0.0 112.666 -176.808 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' D' D ' 100' ' ' ASN . . . . . . . . . . . . . 4.2 m-20 61.24 34.37 18.74 Favored 'General case' 0 CA--C 1.531 0.245 0 O-C-N 121.749 -0.595 . . . . 0.0 111.399 177.828 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' D' D ' 101' ' ' GLU . . . . . . . . . . . . . 84.9 tt0 -111.79 145.65 39.02 Favored 'General case' 0 C--N 1.331 -0.2 0 N-CA-C 109.594 -0.521 . . . . 0.0 109.594 173.604 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' D' D ' 102' ' ' VAL . . . . . . . . . . . . . 45.5 t -114.93 125.98 72.39 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.356 0 CA-C-N 116.275 -0.421 . . . . 0.0 110.125 -177.502 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' D' D ' 103' ' ' LEU . . . . . . . . . . . . . 29.8 mt -117.55 128.28 54.81 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 115.794 -0.639 . . . . 0.0 110.232 177.441 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' D' D ' 104' ' ' ILE . . . . . . . . . . . . . 67.3 mt -119.45 122.18 68.3 Favored 'Isoleucine or valine' 0 C--O 1.235 0.299 0 N-CA-C 110.403 -0.221 . . . . 0.0 110.403 -179.612 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' D' D ' 105' ' ' PHE . . . . . . . . . . . . . 62.4 m-85 -120.78 165.16 15.53 Favored 'General case' 0 C--O 1.232 0.147 0 O-C-N 123.95 0.781 . . . . 0.0 109.804 179.126 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' D' D ' 106' ' ' ASN . . . . . . . . . . . . . 43.3 p-10 -99.56 -170.1 1.85 Allowed 'General case' 0 C--N 1.33 -0.249 0 N-CA-C 109.78 -0.452 . . . . 0.0 109.78 172.708 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' D' D ' 107' ' ' GLN . . . . . . . . . . . . . 50.9 tt0 -57.65 -29.79 64.88 Favored 'General case' 0 C--N 1.328 -0.337 0 N-CA-C 112.033 0.383 . . . . 0.0 112.033 179.707 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' D' D ' 108' ' ' ASN . . . . . . . . . . . . . 15.1 t-20 -88.07 13.43 11.18 Favored 'General case' 0 CA--C 1.535 0.386 0 N-CA-C 112.917 0.71 . . . . 0.0 112.917 -176.215 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' D' D ' 109' ' ' LEU . . . . . . . . . . . . . 29.4 mt 57.64 34.81 24.97 Favored 'General case' 0 CA--C 1.53 0.182 0 O-C-N 122.108 -0.37 . . . . 0.0 111.661 177.98 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' D' D ' 110' ' ' GLU . . . . . . . . . . . . . 43.3 mt-10 -101.3 153.99 19.17 Favored 'General case' 0 C--N 1.331 -0.235 0 N-CA-C 109.984 -0.376 . . . . 0.0 109.984 176.991 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' D' D ' 111' ' ' GLU . . . . . . . . . . . . . 80.6 tt0 -82.7 121.96 27.54 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.383 -0.371 . . . . 0.0 110.589 -178.246 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' D' D ' 112' ' ' LEU . . . . . . . . . . . . . 25.5 mt -110.92 -46.05 3.39 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 116.293 -0.412 . . . . 0.0 110.444 178.354 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' D' D ' 113' ' ' TYR . . . . . . . . . . . . . 46.8 t80 -137.93 136.3 36.89 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-O 120.839 0.352 . . . . 0.0 111.061 -179.679 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' D' D ' 114' ' ' ARG . . . . . . . . . . . . . 60.1 ttt180 -138.01 121.45 17.17 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 115.931 -0.577 . . . . 0.0 110.257 177.034 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' D' D ' 115' ' ' GLY . . . . . . . . . . . . . . . -150.07 162.44 29.19 Favored Glycine 0 CA--C 1.525 0.677 0 N-CA-C 110.977 -0.849 . . . . 0.0 110.977 179.506 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' D' D ' 116' ' ' LYS . . . . . . . . . . . . . 70.3 tttt -136.72 137.5 40.0 Favored 'General case' 0 C--N 1.328 -0.36 0 N-CA-C 110.124 -0.324 . . . . 0.0 110.124 178.762 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' D' D ' 117' ' ' PHE . . . . . . . . . . . . . 26.3 m-85 -135.61 117.59 15.29 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 116.403 -0.362 . . . . 0.0 110.198 -176.135 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' D' D ' 118' ' ' GLU . . . . . . . . . . . . . 96.0 mt-10 -54.17 -44.96 71.94 Favored 'General case' 0 C--N 1.33 -0.27 0 C-N-CA 120.937 -0.305 . . . . 0.0 111.392 -176.316 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' D' D ' 119' ' ' ASN . . . . . . . . . . . . . 3.2 m-20 -97.78 31.04 2.75 Favored 'General case' 0 C--N 1.329 -0.317 0 N-CA-C 112.143 0.423 . . . . 0.0 112.143 -174.838 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' D' D ' 120' ' ' LEU . . . . . . . . . . . . . 20.3 tp -56.48 122.61 12.35 Favored 'General case' 0 C--O 1.233 0.197 0 CA-C-O 120.587 0.232 . . . . 0.0 110.407 178.01 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' D' D ' 121' ' ' ASN . . . . . . . . . . . . . 53.4 m-20 -114.11 -44.13 3.17 Favored 'General case' 0 C--N 1.332 -0.18 0 CA-C-N 116.707 -0.224 . . . . 0.0 111.394 -176.325 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' D' D ' 122' ' ' LYS . . . . . . . . . . . . . 26.1 ttmt -149.97 147.52 27.97 Favored 'General case' 0 C--N 1.332 -0.177 0 C-N-CA 120.417 -0.513 . . . . 0.0 111.563 -176.312 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' D' D ' 123' ' ' VAL . . . . . 0.459 ' HB ' HD11 ' D' ' 96' ' ' ILE . 43.9 t -126.73 134.35 66.45 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.181 0 CA-C-N 116.038 -0.528 . . . . 0.0 109.731 177.742 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' D' D ' 124' ' ' LEU . . . . . . . . . . . . . 65.7 mt -130.08 142.7 50.58 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-O 120.809 0.338 . . . . 0.0 110.986 -178.275 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' D' D ' 125' ' ' VAL . . . . . 0.623 HG11 HG21 ' D' ' 94' ' ' VAL . 35.1 m -132.79 140.25 47.84 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.243 0 CA-C-N 116.26 -0.427 . . . . 0.0 110.569 178.416 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' D' D ' 126' ' ' ARG . . . . . . . . . . . . . 95.3 mtt-85 -144.26 119.09 9.89 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.443 -0.344 . . . . 0.0 110.617 178.74 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' D' D ' 127' ' ' ASN . . . . . . . . . . . . . 84.9 m-20 51.36 -104.98 0.19 Allowed 'General case' 0 CA--C 1.543 0.697 0 CA-C-O 119.095 -0.479 . . . . 0.0 111.334 179.707 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' D' D ' 128' ' ' ASP . . . . . . . . . . . . . 18.9 p-10 -114.19 1.35 14.51 Favored 'General case' 0 N--CA 1.468 0.442 0 CA-C-N 119.548 1.067 . . . . 0.0 113.371 -177.794 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' D' D ' 129' ' ' LEU . . . . . . . . . . . . . 58.8 mt -104.96 144.84 31.24 Favored 'General case' 0 C--N 1.334 -0.108 0 O-C-N 121.961 -0.462 . . . . 0.0 110.246 179.881 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' D' D ' 130' ' ' VAL . . . . . . . . . . . . . 42.4 t -124.48 139.56 50.38 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.214 0 CA-C-N 116.375 -0.375 . . . . 0.0 110.009 -178.107 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' D' D ' 131' ' ' VAL . . . . . 0.516 HG22 HD12 ' D' ' 140' ' ' LEU . 42.6 t -134.55 135.37 53.8 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.24 0 CA-C-O 121.065 0.459 . . . . 0.0 110.271 179.275 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' D' D ' 132' ' ' ILE . . . . . . . . . . . . . 73.2 mt -118.47 130.82 72.77 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.282 0 CA-C-N 115.657 -0.701 . . . . 0.0 109.354 179.068 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' D' D ' 133' ' ' ILE . . . . . 0.412 HG21 HG21 ' E' ' 86' ' ' VAL . 43.1 mm -115.83 121.95 68.45 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.249 0 CA-C-O 120.975 0.417 . . . . 0.0 110.912 -175.992 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' D' D ' 134' ' ' ASP . . . . . . . . . . . . . 7.2 p-10 -133.43 146.08 50.86 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 115.826 -0.625 . . . . 0.0 109.507 174.615 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' D' D ' 135' ' ' GLU . . . . . . . . . . . . . 85.9 tt0 -49.8 -23.02 1.64 Allowed 'General case' 0 C--N 1.328 -0.36 0 N-CA-C 113.022 0.749 . . . . 0.0 113.022 -171.573 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' D' D ' 136' ' ' GLN . . . . . . . . . . . . . 50.2 tt0 -100.18 -31.57 11.33 Favored 'General case' 0 N--CA 1.462 0.175 0 N-CA-C 112.342 0.497 . . . . 0.0 112.342 -176.07 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' D' D ' 137' ' ' LYS . . . . . . . . . . . . . 88.4 mttt -140.45 153.11 46.16 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-O 121.288 0.566 . . . . 0.0 111.644 -171.057 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' D' D ' 138' ' ' LEU . . . . . 0.418 ' C ' HD23 ' D' ' 138' ' ' LEU . 5.5 tt -116.87 120.52 38.72 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 115.488 -0.778 . . . . 0.0 109.017 171.733 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' D' D ' 139' ' ' THR . . . . . . . . . . . . . 30.5 m -108.38 128.11 54.48 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 116.322 -0.399 . . . . 0.0 110.744 -176.451 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' D' D ' 140' ' ' LEU . . . . . 0.516 HD12 HG22 ' D' ' 131' ' ' VAL . 14.0 tp -117.54 122.6 44.1 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 115.619 -0.719 . . . . 0.0 109.354 -178.811 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' D' D ' 141' ' ' ILE . . . . . . . . . . . . . 19.1 mt -120.92 119.64 60.02 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.274 0 N-CA-C 109.964 -0.384 . . . . 0.0 109.964 -175.404 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' D' D ' 142' ' ' ARG . . . . . . . . . . . . . 74.3 mtm180 -106.93 131.31 54.15 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 115.782 -0.645 . . . . 0.0 110.481 -178.318 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' D' D ' 143' ' ' THR . . . . . . . . . . . . . 44.6 p . . . . . 0 C--O 1.22 -0.466 0 CA-C-O 117.984 -1.008 . . . . 0.0 110.591 179.798 . . . . . . . . 0 0 . 1 . 007 nuclear build full ' E' E ' -3' ' ' GLU . . . . . . . . . . . . . 96.0 mt-10 . . . . . 0 N--CA 1.49 1.529 0 N-CA-C 109.464 -0.569 . . . . 0.0 109.464 . . . . . . . . . 0 0 . 1 . 007 nuclear build full ' E' E ' -2' ' ' GLY . . . . . . . . . . . . . . . -69.58 102.29 0.94 Allowed Glycine 0 CA--C 1.524 0.649 0 N-CA-C 111.182 -0.767 . . . . 0.0 111.182 -179.337 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' E' E ' -1' ' ' VAL . . . . . . . . . . . . . 44.1 t -141.91 142.35 28.22 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.262 0 N-CA-C 109.908 -0.404 . . . . 0.0 109.908 179.198 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' E' E ' 0' ' ' ILE . . . . . . . . . . . . . 70.4 mt -88.39 142.54 12.77 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.236 0 CA-C-N 116.31 -0.405 . . . . 0.0 110.265 -178.572 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' E' E ' 1' ' ' MET . . . . . . . . . . . . . 24.8 ptp -82.4 153.27 25.8 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.077 -0.511 . . . . 0.0 110.639 179.89 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' E' E ' 2' ' ' SER . . . . . . . . . . . . . 98.5 p -124.57 152.56 43.36 Favored 'General case' 0 C--O 1.232 0.155 0 CA-C-N 116.227 -0.442 . . . . 0.0 110.664 -179.516 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' E' E ' 3' ' ' GLU . . . . . . . . . . . . . 85.0 tt0 -140.33 144.73 36.48 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.107 -0.497 . . . . 0.0 111.109 -178.025 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' E' E ' 4' ' ' LEU . . . . . . . . . . . . . 16.3 tp -127.56 134.59 49.72 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 115.852 -0.613 . . . . 0.0 110.131 177.426 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' E' E ' 5' ' ' LYS . . . . . . . . . . . . . 68.9 mttm -115.23 122.67 46.7 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.635 -0.257 . . . . 0.0 110.997 -178.808 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' E' E ' 6' ' ' LEU . . . . . 0.429 HD23 ' HA ' ' E' ' 50' ' ' VAL . 58.5 mt -114.34 142.52 46.21 Favored 'General case' 0 N--CA 1.462 0.163 0 CA-C-N 115.564 -0.744 . . . . 0.0 110.095 178.601 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' E' E ' 7' ' ' LYS . . . . . . . . . . . . . 79.3 tttt -122.49 136.19 26.33 Favored Pre-proline 0 CA--C 1.534 0.348 0 CA-C-O 118.775 -0.631 . . . . 0.0 109.781 176.634 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' E' E ' 8' ' ' PRO . . . . . . . . . . . . . 89.4 Cg_endo -91.36 131.49 1.38 Allowed 'Trans proline' 0 N--CA 1.49 1.279 0 C-N-CA 121.741 1.627 . . . . 0.0 111.705 178.089 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' E' E ' 9' ' ' LEU . . . . . 0.406 HD12 ' HB2' ' E' ' 47' ' ' LYS . 59.4 mt -72.01 -47.86 11.11 Favored Pre-proline 0 CA--C 1.534 0.335 0 CA-C-O 118.563 -0.732 . . . . 0.0 112.286 -178.642 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' E' E ' 10' ' ' PRO . . . . . . . . . . . . . 95.1 Cg_endo -79.61 152.37 22.81 Favored 'Trans proline' 0 N--CA 1.497 1.713 0 C-N-CA 121.166 1.244 . . . . 0.0 111.916 177.145 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' E' E ' 11' ' ' LYS . . . . . . . . . . . . . 97.7 mttt -83.86 91.92 7.67 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.366 -0.379 . . . . 0.0 110.262 178.34 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' E' E ' 12' ' ' VAL . . . . . . . . . . . . . 12.2 p -139.0 145.15 28.05 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.257 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.476 -178.931 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' E' E ' 13' ' ' GLU . . . . . . . . . . . . . 44.6 mp0 -91.6 125.93 36.51 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.235 -0.439 . . . . 0.0 110.179 178.671 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' E' E ' 14' ' ' LEU . . . . . . . . . . . . . 20.8 mt -97.93 149.99 36.29 Favored Pre-proline 0 CA--C 1.532 0.287 0 CA-C-O 119.331 -0.366 . . . . 0.0 110.562 -178.843 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' E' E ' 15' ' ' PRO . . . . . . . . . . . . . 27.4 Cg_exo -61.02 158.74 32.76 Favored 'Trans proline' 0 N--CA 1.496 1.675 0 C-N-CA 121.317 1.345 . . . . 0.0 111.943 177.979 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' E' E ' 16' ' ' PRO . . . . . . . . . . . . . 29.8 Cg_exo -59.68 -34.85 96.15 Favored 'Trans proline' 0 N--CA 1.496 1.675 0 C-N-CA 121.403 1.402 . . . . 0.0 112.76 -178.938 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' E' E ' 17' ' ' ASP . . . . . . . . . . . . . 8.3 p-10 -85.03 4.73 32.49 Favored 'General case' 0 C--N 1.327 -0.401 0 N-CA-C 113.322 0.86 . . . . 0.0 113.322 -177.497 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' E' E ' 18' ' ' PHE . . . . . . . . . . . . . 44.0 t80 -57.95 -44.85 87.24 Favored 'General case' 0 N--CA 1.457 -0.091 0 O-C-N 121.836 -0.54 . . . . 0.0 110.187 -178.315 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' E' E ' 19' ' ' VAL . . . . . . . . . . . . . 46.6 t -56.78 -44.99 82.88 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 CA-C-N 116.152 -0.476 . . . . 0.0 110.544 -178.304 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' E' E ' 20' ' ' ASP . . . . . . . . . . . . . 80.1 m-20 -59.54 -41.9 91.12 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-O 120.772 0.32 . . . . 0.0 110.808 -177.233 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' E' E ' 21' ' ' VAL . . . . . . . . . . . . . 46.9 t -64.55 -46.79 91.6 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.284 0 C-N-CA 120.809 -0.356 . . . . 0.0 110.621 -177.801 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' E' E ' 22' ' ' ILE . . . . . 0.662 HG22 HD12 ' E' ' 26' ' ' LEU . 51.4 mm -57.26 -39.98 70.97 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.217 0 C-N-CA 120.902 -0.319 . . . . 0.0 110.774 -179.562 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' E' E ' 23' ' ' ARG . . . . . . . . . . . . . 34.2 ttp180 -56.91 -50.28 73.02 Favored 'General case' 0 N--CA 1.464 0.255 0 CA-C-O 121.08 0.466 . . . . 0.0 110.443 177.326 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' E' E ' 24' ' ' ILE . . . . . . . . . . . . . 70.6 mt -61.16 -38.65 80.17 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.327 0 CA-C-N 115.807 -0.633 . . . . 0.0 112.072 -176.739 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' E' E ' 25' ' ' LYS . . . . . . . . . . . . . 14.7 pttp -78.34 -36.42 46.29 Favored 'General case' 0 CA--C 1.534 0.348 0 C-N-CA 120.606 -0.437 . . . . 0.0 112.007 -174.049 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' E' E ' 26' ' ' LEU . . . . . 0.662 HD12 HG22 ' E' ' 22' ' ' ILE . 47.6 mt -79.74 -35.06 39.38 Favored 'General case' 0 C--N 1.33 -0.266 0 N-CA-C 113.046 0.758 . . . . 0.0 113.046 -173.022 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' E' E ' 27' ' ' GLN . . . . . . . . . . . . . 15.9 pt20 -46.82 139.75 5.18 Favored 'General case' 0 N--CA 1.468 0.465 0 N-CA-C 112.906 0.706 . . . . 0.0 112.906 -175.49 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' E' E ' 28' ' ' GLY . . . . . . . . . . . . . . . 100.54 -25.94 26.44 Favored Glycine 0 CA--C 1.533 1.166 0 CA-C-N 115.511 -0.768 . . . . 0.0 112.304 -177.991 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' E' E ' 29' ' ' LYS . . . . . . . . . . . . . 98.9 mttt -98.3 155.12 17.36 Favored 'General case' 0 C--N 1.332 -0.167 0 CA-C-N 117.423 0.611 . . . . 0.0 111.175 179.439 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' E' E ' 30' ' ' THR . . . . . . . . . . . . . 31.2 m -102.72 137.14 41.33 Favored 'General case' 0 C--N 1.331 -0.199 0 CA-C-N 116.105 -0.498 . . . . 0.0 110.204 177.069 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' E' E ' 31' ' ' VAL . . . . . . . . . . . . . 34.9 m -128.98 154.27 39.74 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.26 0 CA-C-N 116.444 -0.344 . . . . 0.0 110.816 -179.226 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' E' E ' 32' ' ' ARG . . . . . . . . . . . . . 94.8 mtt180 -131.67 149.08 52.61 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-O 121.179 0.514 . . . . 0.0 110.611 178.332 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' E' E ' 33' ' ' THR . . . . . . . . . . . . . 22.3 m -53.44 139.74 29.84 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.22 -0.446 . . . . 0.0 111.357 -179.382 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' E' E ' 34' ' ' GLY . . . . . . . . . . . . . . . 99.69 -17.12 57.94 Favored Glycine 0 CA--C 1.532 1.126 0 CA-C-O 119.62 -0.545 . . . . 0.0 113.263 179.36 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' E' E ' 35' ' ' ASP . . . . . . . . . . . . . 78.3 m-20 -66.67 148.5 51.82 Favored 'General case' 0 C--N 1.333 -0.152 0 CA-C-N 118.041 0.921 . . . . 0.0 111.078 178.934 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' E' E ' 36' ' ' VAL . . . . . . . . . . . . . 44.3 t -120.97 129.91 75.21 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.262 0 CA-C-N 115.933 -0.576 . . . . 0.0 109.785 178.236 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' E' E ' 37' ' ' ILE . . . . . . . . . . . . . 63.8 mt -119.79 136.96 55.23 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.257 0 N-CA-C 109.751 -0.463 . . . . 0.0 109.751 -179.636 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' E' E ' 38' ' ' GLY . . . . . . . . . . . . . . . -114.97 128.72 8.25 Favored Glycine 0 CA--C 1.524 0.644 0 N-CA-C 111.006 -0.838 . . . . 0.0 111.006 -179.77 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' E' E ' 39' ' ' ILE . . . . . . . . . . . . . 72.5 mt -126.47 127.67 70.63 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.232 0 N-CA-C 110.143 -0.317 . . . . 0.0 110.143 179.142 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' E' E ' 40' ' ' SER . . . . . . . . . . . . . 7.4 m -92.7 119.35 32.01 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.295 -0.411 . . . . 0.0 110.595 175.423 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' E' E ' 41' ' ' ILE . . . . . . . . . . . . . 69.3 mt -129.73 126.57 62.98 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.175 0 CA-C-O 120.951 0.405 . . . . 0.0 110.49 179.769 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' E' E ' 42' ' ' LEU . . . . . . . . . . . . . 30.7 mt 54.1 33.8 18.57 Favored 'General case' 0 C--N 1.331 -0.223 0 CA-C-N 116.033 -0.53 . . . . 0.0 111.781 177.395 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' E' E ' 43' ' ' GLY . . . . . . . . . . . . . . . 72.36 29.54 66.04 Favored Glycine 0 CA--C 1.529 0.936 0 C-N-CA 121.127 -0.559 . . . . 0.0 112.296 177.811 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' E' E ' 44' ' ' LYS . . . . . . . . . . . . . 83.6 tttt -139.43 126.92 21.61 Favored 'General case' 0 C--N 1.331 -0.225 0 N-CA-C 109.637 -0.505 . . . . 0.0 109.637 178.217 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' E' E ' 45' ' ' GLU . . . . . . . . . . . . . 47.1 tt0 -85.65 126.59 34.05 Favored 'General case' 0 C--N 1.327 -0.397 0 CA-C-N 116.229 -0.441 . . . . 0.0 111.539 -175.483 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' E' E ' 46' ' ' VAL . . . . . . . . . . . . . 9.9 p -123.21 126.08 72.9 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.198 0 N-CA-C 109.966 -0.383 . . . . 0.0 109.966 174.457 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' E' E ' 47' ' ' LYS . . . . . 0.406 ' HB2' HD12 ' E' ' 9' ' ' LEU . 33.8 mmtp -99.48 127.44 45.54 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 115.967 -0.561 . . . . 0.0 110.877 176.223 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' E' E ' 48' ' ' PHE . . . . . . . . . . . . . 34.6 m-85 -109.78 131.7 54.82 Favored 'General case' 0 C--N 1.329 -0.289 0 N-CA-C 109.444 -0.576 . . . . 0.0 109.444 175.506 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' E' E ' 49' ' ' LYS . . . . . . . . . . . . . 46.2 tttp -107.67 132.12 53.67 Favored 'General case' 0 C--N 1.327 -0.38 0 N-CA-C 110.08 -0.341 . . . . 0.0 110.08 178.081 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' E' E ' 50' ' ' VAL . . . . . 0.429 ' HA ' HD23 ' E' ' 6' ' ' LEU . 46.7 t -76.58 104.42 4.61 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.268 0 N-CA-C 109.188 -0.671 . . . . 0.0 109.188 177.022 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' E' E ' 51' ' ' VAL . . . . . . . . . . . . . 48.3 t -69.74 -52.94 27.02 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.363 0 N-CA-C 109.609 -0.515 . . . . 0.0 109.609 -174.959 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' E' E ' 52' ' ' GLN . . . . . . . . . . . . . 91.1 mt-30 -153.64 153.69 32.79 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-O 121.253 0.549 . . . . 0.0 111.783 -178.08 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' E' E ' 53' ' ' ALA . . . . . 0.444 ' HB3' ' OG ' ' E' ' 56' ' ' SER . . . -130.57 132.69 45.68 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 115.02 -0.991 . . . . 0.0 109.621 174.978 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' E' E ' 54' ' ' TYR . . . . . . . . . . . . . 40.4 t80 -129.0 107.65 18.1 Favored Pre-proline 0 CA--C 1.535 0.397 0 CA-C-O 118.138 -0.934 . . . . 0.0 110.36 179.893 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' E' E ' 55' ' ' PRO . . . . . . . . . . . . . 72.8 Cg_endo -77.17 168.07 77.94 Favored 'Cis proline' 0 N--CA 1.5 1.891 0 CA-C-N 121.783 1.672 . . . . 0.0 112.713 -5.278 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' E' E ' 56' ' ' SER . . . . . 0.444 ' OG ' ' HB3' ' E' ' 53' ' ' ALA . 68.4 m -118.2 132.89 23.54 Favored Pre-proline 0 CA--C 1.539 0.553 0 CA-C-O 118.377 -0.821 . . . . 0.0 109.463 173.77 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' E' E ' 57' ' ' PRO . . . . . . . . . . . . . 34.4 Cg_endo -66.19 163.97 66.91 Favored 'Cis proline' 0 N--CA 1.496 1.675 0 CA-C-N 121.95 1.732 . . . . 0.0 111.66 -1.788 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' E' E ' 58' ' ' LEU . . . . . . . . . . . . . 33.5 tp -130.07 136.83 49.79 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.104 -0.498 . . . . 0.0 110.281 -179.537 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' E' E ' 59' ' ' ARG . . . . . . . . . . . . . 41.8 ttm180 -102.72 123.58 46.67 Favored 'General case' 0 C--N 1.327 -0.403 0 CA-C-N 115.791 -0.64 . . . . 0.0 109.31 176.349 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' E' E ' 60' ' ' VAL . . . . . . . . . . . . . 45.8 t -71.99 116.97 14.7 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.294 0 C-N-CA 120.803 -0.359 . . . . 0.0 110.331 -174.584 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' E' E ' 61' ' ' GLU . . . . . . . . . . . . . 95.7 mt-10 -131.05 159.5 37.36 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 115.816 -0.629 . . . . 0.0 109.761 176.475 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' E' E ' 62' ' ' ASP . . . . . . . . . . . . . 13.8 t70 -52.48 -31.94 37.57 Favored 'General case' 0 C--N 1.328 -0.357 0 N-CA-C 111.953 0.353 . . . . 0.0 111.953 -179.209 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' E' E ' 63' ' ' ARG . . . . . . . . . . . . . 37.3 mtp180 -72.22 -21.89 61.34 Favored 'General case' 0 C--N 1.33 -0.281 0 N-CA-C 112.954 0.724 . . . . 0.0 112.954 -175.935 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' E' E ' 64' ' ' THR . . . . . . . . . . . . . 28.4 m -69.33 136.77 52.25 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-O 120.93 0.395 . . . . 0.0 110.865 -175.988 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' E' E ' 65' ' ' LYS . . . . . . . . . . . . . 92.1 mttt -89.31 127.91 35.83 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-N 115.97 -0.559 . . . . 0.0 109.917 177.987 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' E' E ' 66' ' ' ILE . . . . . . . . . . . . . 64.4 mt -114.49 129.33 70.73 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 N-CA-C 110.008 -0.368 . . . . 0.0 110.008 -179.705 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' E' E ' 67' ' ' THR . . . . . . . . . . . . . 30.2 m -122.74 142.27 50.89 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-O 121.16 0.505 . . . . 0.0 111.11 -177.644 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' E' E ' 68' ' ' LEU . . . . . . . . . . . . . 17.6 tp -101.56 125.84 48.28 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 115.563 -0.744 . . . . 0.0 109.898 177.491 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' E' E ' 69' ' ' VAL . . . . . . . . . . . . . 43.3 t -101.38 127.98 54.16 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.298 0 CA-C-N 116.333 -0.394 . . . . 0.0 110.174 -179.445 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' E' E ' 70' ' ' THR . . . . . . . . . . . . . 21.6 p -101.7 -52.26 3.24 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.137 -0.483 . . . . 0.0 110.602 179.689 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' E' E ' 71' ' ' HIS . . . . . . . . . . . . . 66.2 m80 -91.09 164.93 23.27 Favored Pre-proline 0 C--N 1.33 -0.257 0 CA-C-N 116.25 -0.432 . . . . 0.0 110.712 -179.471 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' E' E ' 72' ' ' PRO . . . . . . . . . . . . . 16.9 Cg_exo -64.91 -21.81 63.65 Favored 'Trans proline' 0 N--CA 1.497 1.696 0 C-N-CA 121.521 1.481 . . . . 0.0 113.081 -179.012 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' E' E ' 73' ' ' VAL . . . . . . . . . . . . . 27.0 m -99.89 163.63 2.82 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.222 0 CA-C-O 120.893 0.378 . . . . 0.0 110.752 -179.162 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' E' E ' 74' ' ' ASP . . . . . . . . . . . . . 28.2 t0 -98.77 119.6 37.78 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.028 -0.533 . . . . 0.0 110.023 -178.762 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' E' E ' 75' ' ' VAL . . . . . . . . . . . . . 42.7 t -112.64 123.43 68.32 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.256 0 CA-C-O 120.987 0.422 . . . . 0.0 110.427 -178.263 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' E' E ' 76' ' ' LEU . . . . . . . . . . . . . 27.0 mt -125.02 142.64 51.36 Favored 'General case' 0 C--N 1.331 -0.239 0 CA-C-N 115.842 -0.617 . . . . 0.0 109.772 177.492 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' E' E ' 77' ' ' GLU . . . . . . . . . . . . . 97.6 mt-10 -135.22 131.24 36.42 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-O 121.005 0.431 . . . . 0.0 111.123 -177.747 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' E' E ' 78' ' ' ALA . . . . . . . . . . . . . . . -118.06 135.86 53.92 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 115.814 -0.63 . . . . 0.0 109.67 176.588 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' E' E ' 79' ' ' LYS . . . . . 0.594 ' O ' HD13 ' E' ' 80' ' ' ILE . 90.0 mttt -79.65 118.46 21.5 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-O 121.003 0.43 . . . . 0.0 110.677 -178.864 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' E' E ' 80' ' ' ILE . . . . . 0.594 HD13 ' O ' ' E' ' 79' ' ' LYS . 41.1 mm -139.12 114.09 8.15 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.376 0 N-CA-C 108.944 -0.761 . . . . 0.0 108.944 -178.502 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' E' E ' 81' ' ' LYS . . . . . . . . . . . . . 56.2 pttt -111.06 129.46 55.91 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-O 121.009 0.433 . . . . 0.0 111.628 -174.253 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' E' E ' 82' ' ' GLY . . . . . . . . . . . . . . . 89.13 42.04 5.7 Favored Glycine 0 CA--C 1.526 0.728 0 N-CA-C 111.524 -0.63 . . . . 0.0 111.524 175.974 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' E' E ' 83' ' ' ILE . . . . . . . . . . . . . 69.1 mt -74.23 138.62 20.76 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.342 0 N-CA-C 109.833 -0.432 . . . . 0.0 109.833 178.145 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' E' E ' 84' ' ' LYS . . . . . . . . . . . . . 39.4 ttpt -102.49 -47.4 4.47 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.302 -0.408 . . . . 0.0 110.163 -179.756 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' E' E ' 85' ' ' ASP . . . . . . . . . . . . . 45.5 t0 -148.91 147.06 28.21 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 115.987 -0.551 . . . . 0.0 110.608 179.876 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' E' E ' 86' ' ' VAL . . . . . 0.412 HG21 HG21 ' D' ' 133' ' ' ILE . 42.4 t -127.84 131.46 69.73 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.266 0 CA-C-O 120.902 0.382 . . . . 0.0 110.404 -179.208 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' E' E ' 87' ' ' ILE . . . . . . . . . . . . . 46.7 mm -121.4 125.12 73.26 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.271 0 CA-C-N 115.955 -0.566 . . . . 0.0 109.686 176.772 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' E' E ' 88' ' ' LEU . . . . . . . . . . . . . 18.3 tp -114.26 130.49 56.65 Favored 'General case' 0 C--N 1.332 -0.163 0 CA-C-O 120.924 0.392 . . . . 0.0 111.074 -177.445 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' E' E ' 89' ' ' ASP . . . . . . . . . . . . . 13.0 t70 -127.33 154.79 44.52 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 115.957 -0.565 . . . . 0.0 109.896 177.16 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' E' E ' 90' ' ' GLU . . . . . . . . . . . . . 96.8 mt-10 -48.1 -36.93 14.15 Favored 'General case' 0 C--N 1.329 -0.313 0 N-CA-C 112.923 0.712 . . . . 0.0 112.923 -172.722 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' E' E ' 91' ' ' ASN . . . . . . . . . . . . . 87.6 m-20 -132.0 33.76 3.89 Favored 'General case' 0 N--CA 1.465 0.31 0 N-CA-C 111.939 0.348 . . . . 0.0 111.939 -175.942 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' E' E ' 92' ' ' LEU . . . . . . . . . . . . . 17.3 tp -166.12 141.66 4.77 Favored 'General case' 0 C--N 1.329 -0.308 0 C-N-CA 121.027 -0.269 . . . . 0.0 110.719 179.46 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' E' E ' 93' ' ' ILE . . . . . . . . . . . . . 72.8 mt -121.86 120.42 61.48 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.27 0 N-CA-C 109.138 -0.69 . . . . 0.0 109.138 178.017 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' E' E ' 94' ' ' VAL . . . . . . . . . . . . . 47.1 t -121.4 125.74 74.03 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.261 0 CA-C-O 121.052 0.453 . . . . 0.0 109.986 -177.763 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' E' E ' 95' ' ' VAL . . . . . . . . . . . . . 43.0 t -121.27 132.81 69.7 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.245 0 CA-C-N 115.873 -0.603 . . . . 0.0 109.847 -179.257 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' E' E ' 96' ' ' ILE . . . . . . . . . . . . . 66.7 mt -115.48 124.19 71.72 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.273 0 N-CA-C 109.147 -0.686 . . . . 0.0 109.147 178.395 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' E' E ' 97' ' ' THR . . . . . . . . . . . . . 77.1 p -99.9 155.02 17.9 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-O 121.523 0.678 . . . . 0.0 111.595 -174.657 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' E' E ' 98' ' ' GLU . . . . . . . . . . . . . 84.7 tt0 -54.03 -26.72 27.87 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 115.548 -0.751 . . . . 0.0 112.141 179.726 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' E' E ' 99' ' ' GLU . . . . . . . . . . . . . 96.3 mt-10 -79.76 16.72 1.06 Allowed 'General case' 0 CA--C 1.537 0.454 0 N-CA-C 113.126 0.788 . . . . 0.0 113.126 -177.369 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' E' E ' 100' ' ' ASN . . . . . . . . . . . . . 4.2 m-20 62.81 37.38 12.39 Favored 'General case' 0 CA--C 1.53 0.198 0 CA-C-O 121.073 0.463 . . . . 0.0 111.048 178.168 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' E' E ' 101' ' ' GLU . . . . . . . . . . . . . 84.7 tt0 -116.46 143.98 44.89 Favored 'General case' 0 C--N 1.333 -0.139 0 CA-C-N 116.159 -0.473 . . . . 0.0 109.909 176.939 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' E' E ' 102' ' ' VAL . . . . . . . . . . . . . 46.4 t -115.0 125.68 72.38 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.27 0 N-CA-C 109.803 -0.443 . . . . 0.0 109.803 -179.468 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' E' E ' 103' ' ' LEU . . . . . . . . . . . . . 27.7 mt -118.94 128.69 54.65 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-N 115.732 -0.667 . . . . 0.0 110.251 177.783 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' E' E ' 104' ' ' ILE . . . . . 0.61 HD13 HG21 ' E' ' 130' ' ' VAL . 66.4 mt -117.66 122.67 70.36 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.2 0 N-CA-C 110.028 -0.36 . . . . 0.0 110.028 179.787 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' E' E ' 105' ' ' PHE . . . . . . . . . . . . . 91.6 m-85 -122.75 166.08 15.53 Favored 'General case' 0 N--CA 1.462 0.129 0 O-C-N 123.999 0.812 . . . . 0.0 110.131 -179.464 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' E' E ' 106' ' ' ASN . . . . . . . . . . . . . 48.7 p-10 -102.94 -172.59 2.14 Favored 'General case' 0 C--N 1.331 -0.196 0 N-CA-C 109.888 -0.412 . . . . 0.0 109.888 172.378 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' E' E ' 107' ' ' GLN . . . . . . . . . . . . . 53.3 tp60 -59.16 -27.9 66.1 Favored 'General case' 0 C--N 1.329 -0.294 0 N-CA-C 112.239 0.459 . . . . 0.0 112.239 -178.586 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' E' E ' 108' ' ' ASN . . . . . . . . . . . . . 8.4 t-20 -88.24 14.06 10.17 Favored 'General case' 0 CA--C 1.533 0.306 0 N-CA-C 112.92 0.711 . . . . 0.0 112.92 -176.918 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' E' E ' 109' ' ' LEU . . . . . . . . . . . . . 41.4 mt 57.99 34.53 24.36 Favored 'General case' 0 CA--C 1.531 0.224 0 CA-C-O 120.718 0.294 . . . . 0.0 111.643 178.514 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' E' E ' 110' ' ' GLU . . . . . . . . . . . . . 43.5 mt-10 -101.49 154.51 18.76 Favored 'General case' 0 C--N 1.33 -0.272 0 N-CA-C 109.28 -0.637 . . . . 0.0 109.28 174.968 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' E' E ' 111' ' ' GLU . . . . . . . . . . . . . 41.6 tt0 -90.96 121.83 33.12 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-O 121.048 0.451 . . . . 0.0 110.987 -175.444 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' E' E ' 112' ' ' LEU . . . . . . . . . . . . . 90.4 mt -101.23 -46.15 5.13 Favored 'General case' 0 C--N 1.332 -0.195 0 CA-C-N 115.803 -0.635 . . . . 0.0 110.388 178.675 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' E' E ' 113' ' ' TYR . . . . . 0.402 ' HB3' HD12 ' E' ' 104' ' ' ILE . 59.8 t80 -139.17 136.56 35.2 Favored 'General case' 0 C--N 1.331 -0.211 0 CA-C-N 116.174 -0.467 . . . . 0.0 111.355 -177.475 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' E' E ' 114' ' ' ARG . . . . . . . . . . . . . 57.3 ttp180 -135.05 120.15 18.75 Favored 'General case' 0 C--N 1.331 -0.22 0 CA-C-N 115.943 -0.572 . . . . 0.0 110.107 177.239 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' E' E ' 115' ' ' GLY . . . . . . . . . . . . . . . -150.07 149.39 21.29 Favored Glycine 0 CA--C 1.524 0.617 0 N-CA-C 111.073 -0.811 . . . . 0.0 111.073 178.281 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' E' E ' 116' ' ' LYS . . . . . . . . . . . . . 34.3 ttmt -125.8 136.45 53.13 Favored 'General case' 0 C--N 1.33 -0.266 0 N-CA-C 109.977 -0.379 . . . . 0.0 109.977 176.042 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' E' E ' 117' ' ' PHE . . . . . . . . . . . . . 40.1 m-85 -129.65 115.97 18.14 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.167 -0.47 . . . . 0.0 110.136 -176.584 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' E' E ' 118' ' ' GLU . . . . . . . . . . . . . 85.4 tt0 -53.7 -46.18 70.63 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.493 -0.322 . . . . 0.0 111.451 -177.133 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' E' E ' 119' ' ' ASN . . . . . . . . . . . . . 86.7 m-20 -96.99 31.07 2.49 Favored 'General case' 0 C--N 1.331 -0.2 0 N-CA-C 112.11 0.411 . . . . 0.0 112.11 -175.8 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' E' E ' 120' ' ' LEU . . . . . . . . . . . . . 10.4 tp -56.12 121.06 8.55 Favored 'General case' 0 C--N 1.332 -0.161 0 O-C-N 122.313 -0.242 . . . . 0.0 110.449 178.343 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' E' E ' 121' ' ' ASN . . . . . . . . . . . . . 31.1 m120 -113.82 -44.07 3.21 Favored 'General case' 0 C--N 1.331 -0.217 0 CA-C-N 116.734 -0.212 . . . . 0.0 111.245 -175.765 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' E' E ' 122' ' ' LYS . . . . . . . . . . . . . 97.9 mttt -146.5 147.3 31.04 Favored 'General case' 0 C--N 1.332 -0.194 0 C-N-CA 120.488 -0.485 . . . . 0.0 111.389 -177.705 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' E' E ' 123' ' ' VAL . . . . . 0.512 ' C ' HD12 ' E' ' 124' ' ' LEU . 44.6 t -130.61 129.11 64.11 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.252 0 CA-C-N 115.982 -0.554 . . . . 0.0 109.678 176.759 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' E' E ' 124' ' ' LEU . . . . . 0.512 HD12 ' C ' ' E' ' 123' ' ' VAL . 6.5 mp -126.49 131.06 51.71 Favored 'General case' 0 C--N 1.331 -0.205 0 N-CA-C 109.999 -0.371 . . . . 0.0 109.999 -179.513 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' E' E ' 125' ' ' VAL . . . . . . . . . . . . . 33.7 m -139.7 137.02 39.8 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.342 0 CA-C-O 120.766 0.317 . . . . 0.0 110.792 -179.071 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' E' E ' 126' ' ' ARG . . . . . . . . . . . . . 74.5 ttt-85 -143.91 127.73 17.28 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.708 -179.683 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' E' E ' 127' ' ' ASN . . . . . . . . . . . . . 4.6 m120 51.24 -106.62 0.26 Allowed 'General case' 0 CA--C 1.544 0.713 0 CA-C-O 118.982 -0.532 . . . . 0.0 111.594 179.064 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' E' E ' 128' ' ' ASP . . . . . . . . . . . . . 23.7 p-10 -114.16 1.86 14.69 Favored 'General case' 0 CA--C 1.536 0.406 0 CA-C-N 119.675 1.125 . . . . 0.0 113.582 -175.854 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' E' E ' 129' ' ' LEU . . . . . . . . . . . . . 13.5 tp -112.79 136.43 52.41 Favored 'General case' 0 C--N 1.333 -0.135 0 N-CA-C 109.771 -0.455 . . . . 0.0 109.771 179.605 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' E' E ' 130' ' ' VAL . . . . . 0.61 HG21 HD13 ' E' ' 104' ' ' ILE . 32.4 m -132.74 142.89 41.22 Favored 'Isoleucine or valine' 0 C--O 1.233 0.198 0 CA-C-O 121.115 0.484 . . . . 0.0 110.976 -179.18 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' E' E ' 131' ' ' VAL . . . . . . . . . . . . . 41.4 t -136.12 138.63 46.98 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.338 0 CA-C-N 115.986 -0.552 . . . . 0.0 109.981 178.37 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' E' E ' 132' ' ' ILE . . . . . . . . . . . . . 74.1 mt -113.57 133.75 58.52 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.312 0 CA-C-N 115.665 -0.698 . . . . 0.0 109.508 -179.568 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' E' E ' 133' ' ' ILE . . . . . . . . . . . . . 42.6 mm -116.04 122.62 69.99 Favored 'Isoleucine or valine' 0 C--O 1.233 0.225 0 CA-C-O 120.991 0.424 . . . . 0.0 110.928 -176.18 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' E' E ' 134' ' ' ASP . . . . . . . . . . . . . 10.5 p-10 -134.86 147.59 49.92 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 115.84 -0.618 . . . . 0.0 109.537 174.625 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' E' E ' 135' ' ' GLU . . . . . . . . . . . . . 84.6 tt0 -49.76 -26.64 4.04 Favored 'General case' 0 C--N 1.325 -0.463 0 N-CA-C 112.811 0.671 . . . . 0.0 112.811 -171.627 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' E' E ' 136' ' ' GLN . . . . . . . . . . . . . 96.8 mt-30 -83.6 -37.88 22.34 Favored 'General case' 0 C--O 1.234 0.243 0 N-CA-C 112.332 0.493 . . . . 0.0 112.332 -176.243 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' E' E ' 137' ' ' LYS . . . . . . . . . . . . . 19.5 pttp -159.91 174.09 14.93 Favored 'General case' 0 C--N 1.331 -0.209 0 CA-C-O 121.51 0.671 . . . . 0.0 112.296 -171.834 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' E' E ' 138' ' ' LEU . . . . . 0.424 ' C ' HD23 ' E' ' 138' ' ' LEU . 8.1 tt -121.91 130.5 53.39 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 114.926 -1.034 . . . . 0.0 109.732 177.599 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' E' E ' 139' ' ' THR . . . . . . . . . . . . . 40.8 m -113.07 125.51 54.46 Favored 'General case' 0 C--N 1.331 -0.23 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.716 -178.558 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' E' E ' 140' ' ' LEU . . . . . 0.484 ' C ' HD23 ' E' ' 140' ' ' LEU . 8.7 tt -107.65 122.57 46.98 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 115.636 -0.711 . . . . 0.0 109.288 -179.502 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' E' E ' 141' ' ' ILE . . . . . 0.509 ' HB ' HG23 ' E' ' 130' ' ' VAL . 19.2 mt -125.07 118.87 54.25 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.288 0 CA-C-O 121.066 0.46 . . . . 0.0 109.886 -177.692 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' E' E ' 142' ' ' ARG . . . . . . . . . . . . . 77.4 ttt-85 -110.94 119.3 38.62 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 115.474 -0.785 . . . . 0.0 109.822 -179.428 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' E' E ' 143' ' ' THR . . . . . . . . . . . . . 71.4 p . . . . . 0 C--O 1.221 -0.442 0 CA-C-O 117.951 -1.023 . . . . 0.0 110.623 -178.14 . . . . . . . . 0 0 . 1 . 007 nuclear build full ' F' F ' -3' ' ' GLU . . . . . . . . . . . . . 70.5 mm-40 . . . . . 0 N--CA 1.49 1.531 0 N-CA-C 109.388 -0.597 . . . . 0.0 109.388 . . . . . . . . . 0 0 . 1 . 007 nuclear build full ' F' F ' -2' ' ' GLY . . . . . . . . . . . . . . . -77.62 130.85 10.58 Favored Glycine 0 CA--C 1.525 0.71 0 N-CA-C 110.875 -0.89 . . . . 0.0 110.875 179.448 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' F' F ' -1' ' ' VAL . . . . . . . . . . . . . 43.0 t -96.61 129.45 46.65 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.34 0 CA-C-O 120.789 0.328 . . . . 0.0 110.335 -179.786 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' F' F ' 0' ' ' ILE . . . . . . . . . . . . . 71.3 mt -124.57 143.01 39.53 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.164 0 CA-C-N 116.302 -0.408 . . . . 0.0 109.931 -179.888 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' F' F ' 1' ' ' MET . . . . . . . . . . . . . 25.3 ptp -91.02 146.28 23.99 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.312 -0.404 . . . . 0.0 110.691 179.826 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' F' F ' 2' ' ' SER . . . . . . . . . . . . . 2.2 p -122.52 125.24 45.35 Favored 'General case' 0 C--N 1.331 -0.227 0 CA-C-O 121.096 0.474 . . . . 0.0 110.564 178.426 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' F' F ' 3' ' ' GLU . . . . . . . . . . . . . 85.1 tt0 -144.49 144.56 31.41 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-N 115.942 -0.572 . . . . 0.0 111.184 -178.973 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' F' F ' 4' ' ' LEU . . . . . 0.444 HD21 HD21 ' F' ' 6' ' ' LEU . 12.1 tp -126.11 135.32 51.57 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 115.782 -0.645 . . . . 0.0 110.292 178.092 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' F' F ' 5' ' ' LYS . . . . . . . . . . . . . 98.9 mttt -111.37 121.57 45.59 Favored 'General case' 0 C--O 1.235 0.316 0 CA-C-N 116.345 -0.389 . . . . 0.0 110.505 179.764 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' F' F ' 6' ' ' LEU . . . . . 0.444 HD21 HD21 ' F' ' 4' ' ' LEU . 78.7 mt -116.93 147.24 42.4 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 115.735 -0.666 . . . . 0.0 110.538 -178.981 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' F' F ' 7' ' ' LYS . . . . . . . . . . . . . 55.0 tttt -137.45 140.38 30.27 Favored Pre-proline 0 CA--C 1.534 0.328 0 CA-C-O 119.201 -0.428 . . . . 0.0 110.1 177.035 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' F' F ' 8' ' ' PRO . . . . . . . . . . . . . 93.5 Cg_endo -91.55 143.2 2.95 Favored 'Trans proline' 0 N--CA 1.49 1.303 0 C-N-CA 121.764 1.643 . . . . 0.0 111.717 177.781 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' F' F ' 9' ' ' LEU . . . . . . . . . . . . . 41.6 mt -79.81 -47.41 1.45 Allowed Pre-proline 0 CA--C 1.535 0.373 0 CA-C-O 118.686 -0.673 . . . . 0.0 112.42 -178.594 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' F' F ' 10' ' ' PRO . . . . . . . . . . . . . 86.1 Cg_endo -80.67 155.98 21.11 Favored 'Trans proline' 0 N--CA 1.496 1.638 0 C-N-CA 121.243 1.296 . . . . 0.0 111.951 176.252 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' F' F ' 11' ' ' LYS . . . . . . . . . . . . . 53.9 tptt -88.01 99.32 12.07 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.393 -0.367 . . . . 0.0 110.39 179.094 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' F' F ' 12' ' ' VAL . . . . . . . . . . . . . 11.9 p -145.94 143.21 21.51 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.305 0 CA-C-N 116.118 -0.492 . . . . 0.0 110.378 179.03 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' F' F ' 13' ' ' GLU . . . . . . . . . . . . . 43.8 mt-10 -85.91 124.27 32.19 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.373 -0.376 . . . . 0.0 110.219 177.677 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' F' F ' 14' ' ' LEU . . . . . . . . . . . . . 18.7 mt -94.76 152.19 39.59 Favored Pre-proline 0 C--N 1.329 -0.298 0 CA-C-N 116.315 -0.402 . . . . 0.0 110.544 -178.695 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' F' F ' 15' ' ' PRO . . . . . . . . . . . . . 39.7 Cg_exo -58.43 157.31 27.19 Favored 'Trans proline' 0 N--CA 1.498 1.752 0 C-N-CA 121.235 1.29 . . . . 0.0 111.796 179.586 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' F' F ' 16' ' ' PRO . . . . . . . . . . . . . 32.1 Cg_exo -59.5 -37.92 86.21 Favored 'Trans proline' 0 N--CA 1.497 1.729 0 C-N-CA 121.42 1.414 . . . . 0.0 112.672 -178.182 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' F' F ' 17' ' ' ASP . . . . . . . . . . . . . 15.2 p-10 -87.59 11.25 15.48 Favored 'General case' 0 CA--C 1.535 0.387 0 N-CA-C 113.074 0.768 . . . . 0.0 113.074 -178.149 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' F' F ' 18' ' ' PHE . . . . . . . . . . . . . 45.2 t80 -58.28 -43.33 87.92 Favored 'General case' 0 CA--C 1.522 -0.114 0 O-C-N 121.863 -0.523 . . . . 0.0 110.089 -178.524 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' F' F ' 19' ' ' VAL . . . . . . . . . . . . . 46.8 t -55.54 -42.77 69.81 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.323 0 CA-C-N 116.354 -0.384 . . . . 0.0 110.675 -178.583 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' F' F ' 20' ' ' ASP . . . . . . . . . . . . . 81.2 m-20 -60.2 -44.94 94.71 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-O 120.859 0.362 . . . . 0.0 110.857 -177.97 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' F' F ' 21' ' ' VAL . . . . . . . . . . . . . 48.7 t -64.13 -46.71 92.83 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.309 0 C-N-CA 120.788 -0.365 . . . . 0.0 110.547 -177.52 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' F' F ' 22' ' ' ILE . . . . . 0.461 HG22 HD12 ' F' ' 26' ' ' LEU . 49.4 mm -55.88 -46.63 80.25 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.257 0 CA-C-O 120.633 0.254 . . . . 0.0 110.597 179.375 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' F' F ' 23' ' ' ARG . . . . . . . . . . . . . 53.9 ttp180 -54.11 -47.91 71.32 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-O 120.607 0.242 . . . . 0.0 111.349 -178.502 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' F' F ' 24' ' ' ILE . . . . . . . . . . . . . 72.2 mt -59.12 -44.51 91.76 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.285 0 CA-C-N 116.677 -0.238 . . . . 0.0 111.098 -178.405 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' F' F ' 25' ' ' LYS . . . . . . . . . . . . . 67.6 mttm -65.05 -39.75 93.75 Favored 'General case' 0 C--N 1.328 -0.339 0 N-CA-C 112.429 0.529 . . . . 0.0 112.429 -177.977 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' F' F ' 26' ' ' LEU . . . . . 0.461 HD12 HG22 ' F' ' 22' ' ' ILE . 63.6 mt -78.62 -43.27 26.71 Favored 'General case' 0 C--N 1.331 -0.229 0 N-CA-C 112.882 0.697 . . . . 0.0 112.882 -171.824 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' F' F ' 27' ' ' GLN . . . . . . . . . . . . . 15.6 pt20 -46.73 139.4 5.33 Favored 'General case' 0 N--CA 1.467 0.41 0 N-CA-C 112.883 0.697 . . . . 0.0 112.883 -174.641 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' F' F ' 28' ' ' GLY . . . . . . . . . . . . . . . 99.82 -25.57 27.76 Favored Glycine 0 CA--C 1.533 1.199 0 CA-C-N 115.472 -0.786 . . . . 0.0 112.197 -176.154 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' F' F ' 29' ' ' LYS . . . . . . . . . . . . . 91.4 mttt -98.0 155.22 17.21 Favored 'General case' 0 C--O 1.233 0.197 0 CA-C-N 117.242 0.521 . . . . 0.0 110.929 178.091 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' F' F ' 30' ' ' THR . . . . . . . . . . . . . 26.0 m -107.28 134.57 50.16 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 115.894 -0.594 . . . . 0.0 109.565 173.9 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' F' F ' 31' ' ' VAL . . . . . . . . . . . . . 34.9 m -125.98 153.5 34.18 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.214 0 CA-C-O 120.924 0.393 . . . . 0.0 110.938 -176.978 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' F' F ' 32' ' ' ARG . . . . . . . . . . . . . 47.8 ttp180 -126.46 147.07 49.86 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 116.044 -0.525 . . . . 0.0 110.334 179.421 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' F' F ' 33' ' ' THR . . . . . . . . . . . . . 15.8 m -52.84 138.74 28.86 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.323 -0.399 . . . . 0.0 111.46 -177.514 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' F' F ' 34' ' ' GLY . . . . . . . . . . . . . . . 101.17 -17.22 56.23 Favored Glycine 0 CA--C 1.535 1.287 0 CA-C-O 119.662 -0.521 . . . . 0.0 113.253 179.248 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' F' F ' 35' ' ' ASP . . . . . . . . . . . . . 78.5 m-20 -66.06 149.06 50.85 Favored 'General case' 0 N--CA 1.461 0.11 0 CA-C-N 117.947 0.873 . . . . 0.0 110.938 178.645 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' F' F ' 36' ' ' VAL . . . . . . . . . . . . . 44.1 t -122.25 131.99 72.01 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.219 0 CA-C-N 116.034 -0.53 . . . . 0.0 109.967 179.178 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' F' F ' 37' ' ' ILE . . . . . . . . . . . . . 66.0 mt -120.76 139.3 48.43 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.247 0 CA-C-N 115.973 -0.558 . . . . 0.0 109.667 179.7 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' F' F ' 38' ' ' GLY . . . . . . . . . . . . . . . -114.49 128.9 8.41 Favored Glycine 0 CA--C 1.525 0.686 0 N-CA-C 111.371 -0.692 . . . . 0.0 111.371 -178.536 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' F' F ' 39' ' ' ILE . . . . . . . . . . . . . 72.1 mt -125.19 129.41 73.2 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.188 0 N-CA-C 109.896 -0.409 . . . . 0.0 109.896 178.014 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' F' F ' 40' ' ' SER . . . . . . . . . . . . . 28.8 t -92.47 121.82 34.31 Favored 'General case' 0 C--N 1.329 -0.301 0 C-N-CA 120.997 -0.281 . . . . 0.0 110.834 176.935 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' F' F ' 41' ' ' ILE . . . . . . . . . . . . . 72.9 mt -133.98 124.96 47.84 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.224 0 CA-C-O 120.774 0.321 . . . . 0.0 110.253 179.304 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' F' F ' 42' ' ' LEU . . . . . . . . . . . . . 60.6 mt 58.29 33.65 23.33 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-N 116.145 -0.48 . . . . 0.0 111.798 178.082 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' F' F ' 43' ' ' GLY . . . . . . . . . . . . . . . 77.66 -10.23 25.37 Favored Glycine 0 CA--C 1.536 1.361 0 C-N-CA 121.268 -0.492 . . . . 0.0 113.456 178.203 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' F' F ' 44' ' ' LYS . . . . . . . . . . . . . 27.1 mtpp -100.52 130.58 46.61 Favored 'General case' 0 C--N 1.332 -0.171 0 CA-C-N 117.852 0.826 . . . . 0.0 109.891 176.937 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' F' F ' 45' ' ' GLU . . . . . . . . . . . . . 38.2 tp10 -84.53 128.46 34.61 Favored 'General case' 0 C--N 1.33 -0.271 0 C-N-CA 120.884 -0.326 . . . . 0.0 110.808 179.877 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' F' F ' 46' ' ' VAL . . . . . . . . . . . . . 7.6 p -119.89 128.57 75.93 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.242 0 N-CA-C 109.702 -0.481 . . . . 0.0 109.702 177.543 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' F' F ' 47' ' ' LYS . . . . . . . . . . . . . 64.9 mttp -100.25 130.17 46.34 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 115.948 -0.569 . . . . 0.0 111.214 178.975 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' F' F ' 48' ' ' PHE . . . . . . . . . . . . . 92.2 m-85 -113.46 131.87 55.87 Favored 'General case' 0 C--N 1.33 -0.267 0 N-CA-C 109.721 -0.474 . . . . 0.0 109.721 176.024 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' F' F ' 49' ' ' LYS . . . . . . . . . . . . . 54.1 tttm -107.83 137.79 45.22 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.545 -0.298 . . . . 0.0 110.622 179.197 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' F' F ' 50' ' ' VAL . . . . . . . . . . . . . 44.5 t -79.17 107.23 11.39 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.282 0 N-CA-C 109.179 -0.674 . . . . 0.0 109.179 175.22 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' F' F ' 51' ' ' VAL . . . . . . . . . . . . . 46.0 t -70.52 -52.78 26.24 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.339 0 CA-C-N 115.934 -0.576 . . . . 0.0 109.585 -174.664 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' F' F ' 52' ' ' GLN . . . . . . . . . . . . . 46.9 mt-30 -155.73 153.6 30.18 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.058 -0.519 . . . . 0.0 111.669 -177.527 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' F' F ' 53' ' ' ALA . . . . . 0.446 ' HB1' ' HB2' ' F' ' 58' ' ' LEU . . . -128.97 132.44 47.57 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 115.292 -0.867 . . . . 0.0 109.889 175.546 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' F' F ' 54' ' ' TYR . . . . . . . . . . . . . 27.1 t80 -129.01 107.71 18.08 Favored Pre-proline 0 CA--C 1.535 0.378 0 CA-C-O 118.238 -0.887 . . . . 0.0 110.43 -179.849 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' F' F ' 55' ' ' PRO . . . . . . . . . . . . . 73.7 Cg_endo -77.1 170.1 72.53 Favored 'Cis proline' 0 N--CA 1.5 1.862 0 CA-C-N 121.787 1.674 . . . . 0.0 112.364 -5.812 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' F' F ' 56' ' ' SER . . . . . . . . . . . . . 45.5 m -115.61 131.44 23.65 Favored Pre-proline 0 CA--C 1.538 0.507 0 CA-C-O 118.499 -0.763 . . . . 0.0 109.448 175.74 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' F' F ' 57' ' ' PRO . . . . . . . . . . . . . 53.7 Cg_endo -70.88 149.04 90.61 Favored 'Cis proline' 0 N--CA 1.496 1.675 0 CA-C-N 121.955 1.734 . . . . 0.0 111.577 -1.899 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' F' F ' 58' ' ' LEU . . . . . 0.446 ' HB2' ' HB1' ' F' ' 53' ' ' ALA . 23.8 tp -108.29 136.43 47.95 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.219 -0.446 . . . . 0.0 110.725 -177.449 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' F' F ' 59' ' ' ARG . . . . . . . . . . . . . 70.7 ttt180 -103.02 126.12 50.06 Favored 'General case' 0 C--N 1.327 -0.384 0 N-CA-C 109.117 -0.697 . . . . 0.0 109.117 175.744 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' F' F ' 60' ' ' VAL . . . . . . . . . . . . . 41.2 t -91.07 123.21 43.12 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.303 0 C-N-CA 120.663 -0.415 . . . . 0.0 111.014 -174.059 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' F' F ' 61' ' ' GLU . . . . . . . . . . . . . 96.1 mt-10 -131.13 172.06 12.55 Favored 'General case' 0 C--N 1.329 -0.317 0 N-CA-C 109.407 -0.59 . . . . 0.0 109.407 173.055 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' F' F ' 62' ' ' ASP . . . . . . . . . . . . . 73.3 m-20 -54.22 -32.67 56.47 Favored 'General case' 0 C--N 1.328 -0.334 0 C-N-CA 121.029 -0.268 . . . . 0.0 111.583 179.299 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' F' F ' 63' ' ' ARG . . . . . . . . . . . . . 13.5 ptm180 -74.56 -11.91 60.33 Favored 'General case' 0 CA--C 1.535 0.394 0 N-CA-C 113.409 0.892 . . . . 0.0 113.409 -177.298 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' F' F ' 64' ' ' THR . . . . . . . . . . . . . 37.6 m -74.67 138.72 43.04 Favored 'General case' 0 C--O 1.233 0.193 0 O-C-N 122.096 -0.377 . . . . 0.0 110.75 -176.09 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' F' F ' 65' ' ' LYS . . . . . . . . . . . . . 55.5 mtmt -89.24 129.12 35.86 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.149 -0.478 . . . . 0.0 110.141 177.863 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' F' F ' 66' ' ' ILE . . . . . . . . . . . . . 65.3 mt -114.75 129.84 70.19 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.295 0 N-CA-C 109.899 -0.408 . . . . 0.0 109.899 -179.835 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' F' F ' 67' ' ' THR . . . . . . . . . . . . . 24.8 m -118.82 135.51 54.5 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-N 116.076 -0.511 . . . . 0.0 110.464 179.862 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' F' F ' 68' ' ' LEU . . . . . 0.479 HD23 ' C ' ' F' ' 68' ' ' LEU . 6.5 tt -106.75 122.97 47.44 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 115.912 -0.586 . . . . 0.0 110.01 179.062 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' F' F ' 69' ' ' VAL . . . . . . . . . . . . . 43.4 t -99.58 129.98 49.32 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.291 0 CA-C-N 116.31 -0.404 . . . . 0.0 110.043 179.83 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' F' F ' 70' ' ' THR . . . . . . . . . . . . . 74.7 p -101.31 162.48 12.86 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.246 -0.434 . . . . 0.0 110.585 -179.681 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' F' F ' 71' ' ' HIS . . . . . . . . . . . . . 20.3 m-70 -82.93 119.07 73.64 Favored Pre-proline 0 CA--C 1.535 0.372 0 CA-C-O 118.74 -0.648 . . . . 0.0 110.842 -177.328 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' F' F ' 72' ' ' PRO . . . . . . . . . . . . . 7.3 Cg_exo -70.74 -27.43 21.8 Favored 'Trans proline' 0 N--CA 1.498 1.776 0 C-N-CA 121.274 1.316 . . . . 0.0 112.18 174.448 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' F' F ' 73' ' ' VAL . . . . . . . . . . . . . 34.4 m -124.84 178.91 3.36 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.228 0 N-CA-C 110.118 -0.327 . . . . 0.0 110.118 -179.44 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' F' F ' 74' ' ' ASP . . . . . . . . . . . . . 24.1 t0 -96.37 121.9 38.67 Favored 'General case' 0 C--N 1.33 -0.263 0 C-N-CA 120.941 -0.304 . . . . 0.0 110.186 -177.302 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' F' F ' 75' ' ' VAL . . . . . 0.49 ' C ' HD12 ' F' ' 76' ' ' LEU . 41.0 t -121.29 124.68 72.52 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.214 0 CA-C-O 121.039 0.447 . . . . 0.0 110.913 -177.781 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' F' F ' 76' ' ' LEU . . . . . 0.49 HD12 ' C ' ' F' ' 75' ' ' VAL . 7.5 mp -121.57 143.73 49.13 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 115.61 -0.723 . . . . 0.0 109.512 176.473 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' F' F ' 77' ' ' GLU . . . . . . . . . . . . . 98.3 mt-10 -134.78 140.83 46.2 Favored 'General case' 0 N--CA 1.463 0.186 0 CA-C-O 121.091 0.472 . . . . 0.0 111.617 -178.16 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' F' F ' 78' ' ' ALA . . . . . 0.608 ' HB2' HD21 ' F' ' 109' ' ' LEU . . . -133.95 141.2 47.21 Favored 'General case' 0 C--N 1.331 -0.223 0 CA-C-N 115.706 -0.679 . . . . 0.0 110.229 176.248 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' F' F ' 79' ' ' LYS . . . . . 0.571 ' O ' HD13 ' F' ' 80' ' ' ILE . 10.0 mtpm? -82.19 119.96 24.74 Favored 'General case' 0 C--N 1.331 -0.225 0 CA-C-O 120.934 0.397 . . . . 0.0 110.801 -178.868 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' F' F ' 80' ' ' ILE . . . . . 0.571 HD13 ' O ' ' F' ' 79' ' ' LYS . 42.2 mm -139.23 102.09 1.65 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 N-CA-C 109.165 -0.679 . . . . 0.0 109.165 -178.705 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' F' F ' 81' ' ' LYS . . . . . . . . . . . . . 54.6 mtpt -97.21 127.71 43.42 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-O 120.957 0.408 . . . . 0.0 111.133 -176.92 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' F' F ' 82' ' ' GLY . . . . . . . . . . . . . . . 89.16 42.12 5.67 Favored Glycine 0 CA--C 1.525 0.695 0 C-N-CA 120.937 -0.649 . . . . 0.0 111.522 175.793 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' F' F ' 83' ' ' ILE . . . . . . . . . . . . . 71.9 mt -67.49 138.03 23.55 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.297 0 N-CA-C 109.89 -0.411 . . . . 0.0 109.89 178.407 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' F' F ' 84' ' ' LYS . . . . . . . . . . . . . 56.3 tttp -99.63 -51.91 3.62 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.02 -0.536 . . . . 0.0 110.173 -179.726 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' F' F ' 85' ' ' ASP . . . . . . . . . . . . . 7.9 t70 -156.85 153.31 28.02 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 115.811 -0.632 . . . . 0.0 110.293 -179.914 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' F' F ' 86' ' ' VAL . . . . . . . . . . . . . 41.9 t -133.36 134.75 56.96 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.246 0 CA-C-O 121.083 0.468 . . . . 0.0 110.548 -179.128 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' F' F ' 87' ' ' ILE . . . . . . . . . . . . . 45.1 mm -119.36 128.16 75.85 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.25 0 CA-C-N 115.666 -0.697 . . . . 0.0 109.733 176.892 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' F' F ' 88' ' ' LEU . . . . . . . . . . . . . 63.9 mt -114.54 133.62 55.65 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-O 121.078 0.466 . . . . 0.0 111.173 -178.754 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' F' F ' 89' ' ' ASP . . . . . . . . . . . . . 8.8 t70 -131.89 154.62 49.03 Favored 'General case' 0 C--N 1.327 -0.385 0 CA-C-N 115.667 -0.697 . . . . 0.0 109.425 177.094 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' F' F ' 90' ' ' GLU . . . . . . . . . . . . . 83.9 tt0 -47.49 -32.98 5.73 Favored 'General case' 0 C--N 1.328 -0.33 0 N-CA-C 113.031 0.752 . . . . 0.0 113.031 -172.483 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' F' F ' 91' ' ' ASN . . . . . . . . . . . . . 35.0 m120 -124.47 7.82 8.34 Favored 'General case' 0 N--CA 1.469 0.489 0 N-CA-C 113.613 0.968 . . . . 0.0 113.613 -175.128 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' F' F ' 92' ' ' LEU . . . . . . . . . . . . . 27.5 mt -147.15 148.57 31.69 Favored 'General case' 0 C--N 1.333 -0.14 0 CA-C-N 118.247 0.476 . . . . 0.0 110.965 -175.464 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' F' F ' 93' ' ' ILE . . . . . . . . . . . . . 74.0 mt -126.52 116.45 45.26 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.286 0 N-CA-C 109.105 -0.702 . . . . 0.0 109.105 175.846 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' F' F ' 94' ' ' VAL . . . . . 0.402 HG21 HG21 ' F' ' 125' ' ' VAL . 46.1 t -118.79 128.59 75.64 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.193 0 CA-C-O 120.827 0.346 . . . . 0.0 110.101 -177.967 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' F' F ' 95' ' ' VAL . . . . . . . . . . . . . 42.1 t -123.27 134.98 64.68 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.317 0 CA-C-N 116.079 -0.509 . . . . 0.0 109.871 -179.853 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' F' F ' 96' ' ' ILE . . . . . . . . . . . . . 59.8 mt -115.25 129.22 71.85 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.282 0 N-CA-C 109.324 -0.621 . . . . 0.0 109.324 178.822 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' F' F ' 97' ' ' THR . . . . . . . . . . . . . 82.5 p -100.72 158.83 15.66 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-O 121.298 0.571 . . . . 0.0 111.157 -177.95 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' F' F ' 98' ' ' GLU . . . . . . . . . . . . . 46.4 tp10 -53.74 -27.2 27.02 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.011 -0.541 . . . . 0.0 112.259 -179.436 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' F' F ' 99' ' ' GLU . . . . . . . . . . . . . 39.4 tt0 -80.25 17.87 0.97 Allowed 'General case' 0 CA--C 1.539 0.555 0 N-CA-C 112.679 0.622 . . . . 0.0 112.679 -176.822 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' F' F ' 100' ' ' ASN . . . . . . . . . . . . . 4.1 m-20 61.05 38.0 17.52 Favored 'General case' 0 N--CA 1.462 0.166 0 O-C-N 121.857 -0.527 . . . . 0.0 111.017 176.792 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' F' F ' 101' ' ' GLU . . . . . . . . . . . . . 84.8 tt0 -117.66 143.08 46.51 Favored 'General case' 0 C--N 1.331 -0.226 0 N-CA-C 109.574 -0.528 . . . . 0.0 109.574 175.838 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' F' F ' 102' ' ' VAL . . . . . . . . . . . . . 44.9 t -116.73 126.59 74.25 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.353 0 CA-C-N 116.319 -0.4 . . . . 0.0 110.107 -176.986 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' F' F ' 103' ' ' LEU . . . . . . . . . . . . . 6.8 mp -118.42 135.31 54.42 Favored 'General case' 0 C--N 1.331 -0.215 0 CA-C-N 115.752 -0.658 . . . . 0.0 110.01 176.446 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' F' F ' 104' ' ' ILE . . . . . . . . . . . . . 72.4 mt -123.67 122.24 64.39 Favored 'Isoleucine or valine' 0 C--O 1.234 0.246 0 CA-C-N 116.503 -0.317 . . . . 0.0 110.29 -178.525 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' F' F ' 105' ' ' PHE . . . . . . . . . . . . . 47.5 m-85 -121.16 166.5 13.85 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 115.314 -0.857 . . . . 0.0 109.92 179.778 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' F' F ' 106' ' ' ASN . . . . . . . . . . . . . 42.3 p-10 -99.7 -169.89 1.81 Allowed 'General case' 0 C--N 1.33 -0.25 0 N-CA-C 109.821 -0.437 . . . . 0.0 109.821 172.992 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' F' F ' 107' ' ' GLN . . . . . . . . . . . . . 36.2 tt0 -60.44 -30.07 69.42 Favored 'General case' 0 C--N 1.329 -0.317 0 N-CA-C 111.734 0.272 . . . . 0.0 111.734 178.857 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' F' F ' 108' ' ' ASN . . . . . . . . . . . . . 10.1 t-20 -81.96 4.93 20.79 Favored 'General case' 0 CA--C 1.537 0.458 0 N-CA-C 113.305 0.854 . . . . 0.0 113.305 -178.833 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' F' F ' 109' ' ' LEU . . . . . 0.608 HD21 ' HB2' ' F' ' 78' ' ' ALA . 6.0 tp 63.4 38.51 10.02 Favored 'General case' 0 C--O 1.232 0.167 0 CA-C-O 121.107 0.479 . . . . 0.0 111.377 177.158 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' F' F ' 110' ' ' GLU . . . . . . . . . . . . . 70.7 mm-40 -107.76 152.44 24.36 Favored 'General case' 0 C--N 1.331 -0.23 0 CA-C-N 116.256 -0.429 . . . . 0.0 110.12 176.03 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' F' F ' 111' ' ' GLU . . . . . . . . . . . . . 98.6 mt-10 -78.58 125.83 29.91 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-O 120.944 0.402 . . . . 0.0 111.188 -178.542 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' F' F ' 112' ' ' LEU . . . . . . . . . . . . . 8.4 mt -111.97 -46.04 3.26 Favored 'General case' 0 C--N 1.332 -0.159 0 CA-C-N 116.012 -0.54 . . . . 0.0 109.905 176.336 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' F' F ' 113' ' ' TYR . . . . . . . . . . . . . 49.5 t80 -139.69 140.94 36.97 Favored 'General case' 0 C--N 1.332 -0.19 0 CA-C-N 116.128 -0.487 . . . . 0.0 110.773 -179.637 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' F' F ' 114' ' ' ARG . . . . . . . . . . . . . 42.4 ptt85 -150.96 118.75 6.16 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-O 121.043 0.449 . . . . 0.0 110.959 179.731 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' F' F ' 115' ' ' GLY . . . . . . . . . . . . . . . -150.28 162.98 29.41 Favored Glycine 0 CA--C 1.527 0.786 0 N-CA-C 111.177 -0.769 . . . . 0.0 111.177 -178.846 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' F' F ' 116' ' ' LYS . . . . . . . . . . . . . 26.6 ttpp -122.41 144.84 48.79 Favored 'General case' 0 C--N 1.33 -0.245 0 O-C-N 122.644 -0.327 . . . . 0.0 110.172 176.457 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' F' F ' 117' ' ' PHE . . . . . . . . . . . . . 45.4 m-85 -138.22 113.9 9.76 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-O 121.035 0.445 . . . . 0.0 110.278 179.771 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' F' F ' 118' ' ' GLU . . . . . . . . . . . . . 84.7 tt0 -52.53 -50.17 63.39 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-N 116.385 -0.371 . . . . 0.0 111.702 -176.016 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' F' F ' 119' ' ' ASN . . . . . . . . . . . . . 72.2 m-80 -95.78 30.98 2.18 Favored 'General case' 0 C--N 1.329 -0.285 0 N-CA-C 112.246 0.462 . . . . 0.0 112.246 -174.458 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' F' F ' 120' ' ' LEU . . . . . . . . . . . . . 17.3 tp -55.29 120.75 7.54 Favored 'General case' 0 C--N 1.332 -0.163 0 CA-C-O 120.703 0.287 . . . . 0.0 110.77 178.392 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' F' F ' 121' ' ' ASN . . . . . . . . . . . . . 37.2 t30 -114.16 -44.05 3.17 Favored 'General case' 0 C--N 1.333 -0.125 0 CA-C-N 116.6 -0.273 . . . . 0.0 111.039 -177.995 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' F' F ' 122' ' ' LYS . . . . . . . . . . . . . 61.2 mtpt -140.6 148.54 41.1 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-O 121.045 0.45 . . . . 0.0 111.584 -175.461 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' F' F ' 123' ' ' VAL . . . . . . . . . . . . . 45.0 t -132.6 133.19 59.76 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.274 0 N-CA-C 109.374 -0.602 . . . . 0.0 109.374 174.761 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' F' F ' 124' ' ' LEU . . . . . . . . . . . . . 66.8 mt -131.74 136.05 47.3 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-O 120.988 0.423 . . . . 0.0 111.201 -176.415 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' F' F ' 125' ' ' VAL . . . . . 0.402 HG21 HG21 ' F' ' 94' ' ' VAL . 38.7 t -129.2 135.19 62.48 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.207 0 CA-C-N 115.73 -0.668 . . . . 0.0 110.067 -179.582 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' F' F ' 126' ' ' ARG . . . . . . . . . . . . . 17.1 ptp180 -165.18 142.78 6.02 Favored 'General case' 0 C--N 1.331 -0.202 0 CA-C-O 121.004 0.431 . . . . 0.0 110.414 176.31 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' F' F ' 127' ' ' ASN . . . . . . . . . . . . . 1.3 t-20 54.74 -155.13 0.26 Allowed 'General case' 0 CA--C 1.538 0.517 0 N-CA-C 110.104 -0.332 . . . . 0.0 110.104 -179.656 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' F' F ' 128' ' ' ASP . . . . . . . . . . . . . 23.1 p-10 -84.12 20.71 1.51 Allowed 'General case' 0 CA--C 1.534 0.35 0 CA-C-N 118.325 0.511 . . . . 0.0 112.347 176.481 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' F' F ' 129' ' ' LEU . . . . . . . . . . . . . 46.2 mt -121.09 144.47 48.54 Favored 'General case' 0 C--O 1.234 0.246 0 O-C-N 122.053 -0.405 . . . . 0.0 110.438 -179.376 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' F' F ' 130' ' ' VAL . . . . . 0.532 HG13 ' HB ' ' F' ' 141' ' ' ILE . 11.1 p -134.19 139.76 47.51 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.268 0 CA-C-N 116.286 -0.415 . . . . 0.0 110.016 178.832 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' F' F ' 131' ' ' VAL . . . . . 0.554 HG12 HD12 ' F' ' 140' ' ' LEU . 34.6 m -136.06 146.49 29.23 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.254 0 CA-C-O 121.268 0.556 . . . . 0.0 111.286 -178.265 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' F' F ' 132' ' ' ILE . . . . . . . . . . . . . 68.2 mt -121.91 133.97 66.64 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.299 0 CA-C-N 115.389 -0.823 . . . . 0.0 109.497 179.645 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' F' F ' 133' ' ' ILE . . . . . . . . . . . . . 37.3 mm -115.57 117.52 55.85 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.267 0 CA-C-N 116.463 -0.335 . . . . 0.0 110.828 -175.984 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' F' F ' 134' ' ' ASP . . . . . . . . . . . . . 8.0 p-10 -129.92 146.65 51.63 Favored 'General case' 0 C--N 1.33 -0.245 0 N-CA-C 109.649 -0.501 . . . . 0.0 109.649 175.526 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' F' F ' 135' ' ' GLU . . . . . . . . . . . . . 41.5 tp10 -49.93 -23.04 1.75 Allowed 'General case' 0 C--N 1.327 -0.371 0 N-CA-C 112.799 0.666 . . . . 0.0 112.799 -172.207 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' F' F ' 136' ' ' GLN . . . . . . . . . . . . . 48.1 tt0 -101.38 -28.73 12.43 Favored 'General case' 0 CA--C 1.531 0.215 0 N-CA-C 112.481 0.549 . . . . 0.0 112.481 -174.801 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' F' F ' 137' ' ' LYS . . . . . . . . . . . . . 76.6 mttt -141.95 151.74 42.85 Favored 'General case' 0 C--O 1.233 0.22 0 CA-C-O 121.363 0.601 . . . . 0.0 112.378 -170.714 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' F' F ' 138' ' ' LEU . . . . . . . . . . . . . 24.3 tp -109.14 119.14 38.63 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 115.011 -0.995 . . . . 0.0 108.941 170.251 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' F' F ' 139' ' ' THR . . . . . . . . . . . . . 33.0 m -108.19 123.73 49.2 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-O 120.751 0.31 . . . . 0.0 110.914 -177.263 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' F' F ' 140' ' ' LEU . . . . . 0.554 HD12 HG12 ' F' ' 131' ' ' VAL . 12.4 tp -115.82 120.61 39.81 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 115.601 -0.727 . . . . 0.0 109.503 -179.219 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' F' F ' 141' ' ' ILE . . . . . 0.532 ' HB ' HG13 ' F' ' 130' ' ' VAL . 19.7 mt -118.97 121.18 66.19 Favored 'Isoleucine or valine' 0 C--O 1.235 0.302 0 N-CA-C 109.801 -0.444 . . . . 0.0 109.801 -176.676 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' F' F ' 142' ' ' ARG . . . . . . . . . . . . . 73.8 mtm180 -111.56 126.82 55.4 Favored 'General case' 0 C--N 1.332 -0.175 0 CA-C-N 115.798 -0.637 . . . . 0.0 110.125 -178.348 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' F' F ' 143' ' ' THR . . . . . . . . . . . . . 25.8 p . . . . . 0 C--O 1.221 -0.443 0 CA-C-O 118.235 -0.888 . . . . 0.0 110.998 -179.368 . . . . . . . . 0 0 . 1 . 008 nuclear build full ' A' A ' -3' ' ' GLU . . . . . . . . . . . . . 85.1 tt0 . . . . . 0 N--CA 1.49 1.556 0 N-CA-C 109.432 -0.581 . . . . 0.0 109.432 . . . . . . . . . 0 0 . 1 . 008 nuclear build full ' A' A ' -2' ' ' GLY . . . . . . . . . . . . . . . -75.5 99.67 1.23 Allowed Glycine 0 CA--C 1.525 0.702 0 N-CA-C 111.066 -0.813 . . . . 0.0 111.066 179.866 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' -1' ' ' VAL . . . . . . . . . . . . . 45.3 t -141.46 139.54 32.17 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.311 0 N-CA-C 109.989 -0.374 . . . . 0.0 109.989 179.488 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 0' ' ' ILE . . . . . . . . . . . . . 44.3 mm -109.0 128.49 64.83 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.243 0 CA-C-N 116.23 -0.441 . . . . 0.0 110.138 179.925 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 25.8 ptt? -81.03 145.09 31.32 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.131 -0.486 . . . . 0.0 110.783 -179.537 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 5.0 p -119.65 137.49 53.86 Favored 'General case' 0 C--N 1.332 -0.181 0 CA-C-N 116.211 -0.45 . . . . 0.0 110.781 179.989 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 41.2 mt-10 -140.4 140.74 35.53 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 115.985 -0.552 . . . . 0.0 111.029 -179.332 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 4' ' ' LEU . . . . . 0.425 HD12 HD23 ' A' ' 58' ' ' LEU . 3.0 tt -124.2 126.3 45.89 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 115.918 -0.583 . . . . 0.0 109.707 177.338 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 5' ' ' LYS . . . . . . . . . . . . . 63.9 mttp -106.91 120.24 41.51 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-O 120.69 0.281 . . . . 0.0 110.807 -179.791 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 37.2 mt -114.66 145.64 41.79 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 115.502 -0.772 . . . . 0.0 110.742 -178.573 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 53.6 tttm -137.78 140.56 30.05 Favored Pre-proline 0 CA--C 1.534 0.35 0 CA-C-O 119.104 -0.474 . . . . 0.0 109.791 174.36 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 8' ' ' PRO . . . . . . . . . . . . . 88.4 Cg_endo -91.81 144.71 3.01 Favored 'Trans proline' 0 N--CA 1.489 1.23 0 C-N-CA 121.775 1.65 . . . . 0.0 111.83 177.931 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 62.7 mt -78.64 -46.51 1.91 Allowed Pre-proline 0 CA--C 1.532 0.277 0 CA-C-O 118.859 -0.591 . . . . 0.0 111.906 179.663 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 75.5 Cg_endo -83.93 144.98 11.11 Favored 'Trans proline' 0 N--CA 1.494 1.543 0 C-N-CA 121.219 1.28 . . . . 0.0 111.516 173.362 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 22.3 pttm -74.53 116.44 15.22 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-O 121.319 0.58 . . . . 0.0 110.437 177.639 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 12.3 p -150.41 147.32 16.04 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.359 0 CA-C-N 115.682 -0.69 . . . . 0.0 110.56 -177.966 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 84.6 tt0 -95.73 121.98 38.02 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.394 -0.366 . . . . 0.0 110.099 177.881 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 14' ' ' LEU . . . . . . . . . . . . . 21.9 mt -99.14 144.03 27.48 Favored Pre-proline 0 CA--C 1.533 0.324 0 CA-C-O 119.093 -0.48 . . . . 0.0 110.521 -176.718 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 15' ' ' PRO . . . . . . . . . . . . . 23.6 Cg_exo -64.76 161.66 35.08 Favored 'Trans proline' 0 N--CA 1.498 1.754 0 C-N-CA 121.292 1.328 . . . . 0.0 111.933 175.209 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 16' ' ' PRO . . . . . . . . . . . . . 27.1 Cg_exo -60.67 -31.97 92.67 Favored 'Trans proline' 0 N--CA 1.496 1.643 0 C-N-CA 121.538 1.492 . . . . 0.0 112.79 -178.96 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 17' ' ' ASP . . . . . . . . . . . . . 10.0 p-10 -83.16 -2.41 55.42 Favored 'General case' 0 CA--C 1.535 0.386 0 N-CA-C 113.351 0.871 . . . . 0.0 113.351 -176.556 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 18' ' ' PHE . . . . . . . . . . . . . 45.5 t80 -57.45 -43.76 84.2 Favored 'General case' 0 C--O 1.23 0.035 0 O-C-N 121.913 -0.492 . . . . 0.0 110.236 -178.478 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 19' ' ' VAL . . . . . . . . . . . . . 48.5 t -57.02 -44.1 82.18 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.314 0 CA-C-N 116.269 -0.423 . . . . 0.0 110.485 -178.497 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 18.2 t70 -59.69 -41.81 91.55 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-O 120.757 0.313 . . . . 0.0 110.902 -177.651 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 43.8 t -64.32 -47.28 90.32 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.274 0 C-N-CA 120.692 -0.403 . . . . 0.0 110.459 -177.948 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 22' ' ' ILE . . . . . 0.581 HG22 HD12 ' A' ' 26' ' ' LEU . 50.2 mm -57.3 -42.05 79.48 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.244 0 C-N-CA 120.801 -0.359 . . . . 0.0 110.591 179.942 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 23' ' ' ARG . . . . . . . . . . . . . 56.5 ttp180 -55.8 -50.31 70.85 Favored 'General case' 0 C--N 1.331 -0.211 0 CA-C-O 120.928 0.394 . . . . 0.0 110.899 179.73 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 24' ' ' ILE . . . . . . . . . . . . . 77.5 mt -60.44 -41.02 86.01 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.251 0 CA-C-N 116.09 -0.505 . . . . 0.0 111.67 -176.961 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 25' ' ' LYS . . . . . 0.574 ' HE3' HD13 ' A' ' 22' ' ' ILE . 16.5 ptpt -72.49 -37.57 68.41 Favored 'General case' 0 CA--C 1.535 0.376 0 C-N-CA 120.622 -0.431 . . . . 0.0 112.115 -175.15 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 26' ' ' LEU . . . . . 0.581 HD12 HG22 ' A' ' 22' ' ' ILE . 43.9 mt -79.84 -39.5 30.52 Favored 'General case' 0 C--N 1.331 -0.209 0 N-CA-C 113.383 0.883 . . . . 0.0 113.383 -173.406 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 27' ' ' GLN . . . . . . . . . . . . . 17.5 pt20 -46.49 141.24 3.76 Favored 'General case' 0 N--CA 1.469 0.503 0 N-CA-C 112.958 0.725 . . . . 0.0 112.958 -173.492 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 97.26 -25.97 24.82 Favored Glycine 0 CA--C 1.534 1.262 0 CA-C-N 115.553 -0.749 . . . . 0.0 112.164 -177.304 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 84.0 mttt -97.94 155.14 17.22 Favored 'General case' 0 C--O 1.233 0.21 0 CA-C-N 117.232 0.516 . . . . 0.0 110.943 179.812 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 30' ' ' THR . . . . . . . . . . . . . 29.1 m -106.86 137.62 44.57 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.142 -0.481 . . . . 0.0 110.101 177.168 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 34.8 m -130.2 159.45 42.21 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.202 0 CA-C-N 116.321 -0.4 . . . . 0.0 110.84 -178.8 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 32' ' ' ARG . . . . . . . . . . . . . 82.2 mtm180 -132.82 150.93 52.11 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-O 121.31 0.576 . . . . 0.0 110.682 178.357 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 33' ' ' THR . . . . . . . . . . . . . 22.0 m -53.4 139.82 29.34 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.074 -0.512 . . . . 0.0 111.312 -178.764 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 100.11 -17.15 57.49 Favored Glycine 0 CA--C 1.532 1.119 0 CA-C-O 119.591 -0.561 . . . . 0.0 113.226 178.881 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 76.6 m-20 -66.08 147.98 52.52 Favored 'General case' 0 C--O 1.233 0.187 0 CA-C-N 118.078 0.939 . . . . 0.0 111.155 178.857 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 44.0 t -122.79 131.53 73.08 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.224 0 CA-C-N 115.937 -0.574 . . . . 0.0 109.906 178.871 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 37' ' ' ILE . . . . . . . . . . . . . 69.0 mt -120.95 139.01 49.5 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.253 0 CA-C-N 116.167 -0.469 . . . . 0.0 110.008 -179.683 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . -109.43 128.85 9.16 Favored Glycine 0 CA--C 1.527 0.785 0 N-CA-C 110.975 -0.85 . . . . 0.0 110.975 179.663 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 39' ' ' ILE . . . . . . . . . . . . . 77.6 mt -126.06 135.9 62.46 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.229 0 CA-C-O 120.765 0.317 . . . . 0.0 110.181 179.612 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 40' ' ' SER . . . . . . . . . . . . . 36.6 t -93.87 122.28 36.19 Favored 'General case' 0 C--N 1.331 -0.239 0 CA-C-N 116.309 -0.405 . . . . 0.0 110.902 175.149 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 41' ' ' ILE . . . . . . . . . . . . . 70.6 mt -133.36 127.43 53.89 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.202 0 CA-C-O 120.841 0.353 . . . . 0.0 110.376 178.662 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 83.4 mt 53.66 33.04 15.71 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 116.203 -0.453 . . . . 0.0 111.959 177.788 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . 72.39 29.37 66.22 Favored Glycine 0 CA--C 1.529 0.952 0 C-N-CA 121.112 -0.566 . . . . 0.0 112.313 177.839 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 44' ' ' LYS . . . . . . . . . . . . . 60.3 mttm -137.36 136.5 37.98 Favored 'General case' 0 C--N 1.331 -0.215 0 N-CA-C 109.862 -0.422 . . . . 0.0 109.862 178.723 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 84.4 tt0 -83.81 122.02 28.11 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.459 -0.337 . . . . 0.0 110.899 -179.688 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 46' ' ' VAL . . . . . . . . . . . . . 7.3 p -122.07 130.06 74.87 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.212 0 N-CA-C 109.547 -0.538 . . . . 0.0 109.547 176.221 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 64.3 mttp -100.66 128.4 46.72 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.011 -0.541 . . . . 0.0 110.994 178.935 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 48' ' ' PHE . . . . . . . . . . . . . 91.0 m-85 -111.12 131.89 54.72 Favored 'General case' 0 C--N 1.33 -0.272 0 N-CA-C 109.698 -0.482 . . . . 0.0 109.698 176.035 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 84.5 tttt -109.12 136.89 47.87 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.356 -0.383 . . . . 0.0 110.729 -179.558 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 50' ' ' VAL . . . . . . . . . . . . . 44.0 t -80.49 106.22 11.33 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.317 0 N-CA-C 109.178 -0.675 . . . . 0.0 109.178 175.159 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 51' ' ' VAL . . . . . . . . . . . . . 47.0 t -70.55 -53.21 23.47 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.354 0 N-CA-C 109.493 -0.558 . . . . 0.0 109.493 -175.035 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 52' ' ' GLN . . . . . . . . . . . . . 90.5 mt-30 -153.85 153.55 32.31 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-O 121.258 0.552 . . . . 0.0 111.796 -178.575 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -129.06 132.11 47.4 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 115.072 -0.967 . . . . 0.0 109.552 175.041 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 54' ' ' TYR . . . . . . . . . . . . . 25.1 t80 -129.03 110.1 18.28 Favored Pre-proline 0 CA--C 1.536 0.41 0 CA-C-O 118.197 -0.906 . . . . 0.0 110.048 179.391 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 55' ' ' PRO . . . . . . . . . . . . . 74.2 Cg_endo -77.17 170.01 72.67 Favored 'Cis proline' 0 N--CA 1.499 1.851 0 CA-C-N 121.877 1.706 . . . . 0.0 112.542 -4.103 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 56' ' ' SER . . . . . . . . . . . . . 13.6 m -115.55 127.61 26.65 Favored Pre-proline 0 CA--C 1.538 0.485 0 CA-C-O 118.344 -0.836 . . . . 0.0 109.506 176.214 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 57' ' ' PRO . . . . . . . . . . . . . 38.0 Cg_endo -66.6 168.5 50.82 Favored 'Cis proline' 0 N--CA 1.498 1.739 0 CA-C-N 122.081 1.779 . . . . 0.0 111.41 -0.657 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 58' ' ' LEU . . . . . 0.425 HD23 HD12 ' A' ' 4' ' ' LEU . 32.7 tp -130.55 136.15 48.63 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-O 120.926 0.393 . . . . 0.0 110.622 -178.997 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 59' ' ' ARG . . . . . . . . . . . . . 49.3 ttp180 -103.69 127.65 51.12 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 115.974 -0.557 . . . . 0.0 109.554 177.303 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 41.7 t -79.67 120.89 31.89 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.181 0 C-N-CA 120.57 -0.452 . . . . 0.0 110.143 -176.247 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 90.7 mt-10 -131.05 161.16 32.63 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 115.86 -0.609 . . . . 0.0 109.88 179.956 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 62' ' ' ASP . . . . . . . . . . . . . 12.7 t70 -54.34 -32.26 56.37 Favored 'General case' 0 C--N 1.328 -0.345 0 C-N-CA 120.926 -0.309 . . . . 0.0 111.714 177.728 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 63' ' ' ARG . . . . . . . . . . . . . 8.1 ptp180 -87.79 9.86 20.35 Favored 'General case' 0 CA--C 1.535 0.391 0 N-CA-C 113.568 0.951 . . . . 0.0 113.568 -175.405 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 39.5 m -92.2 141.0 29.06 Favored 'General case' 0 C--N 1.334 -0.085 0 CA-C-N 118.199 0.454 . . . . 0.0 110.437 -179.426 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 65' ' ' LYS . . . . . . . . . . . . . 67.0 mttm -88.82 127.16 35.61 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.151 -0.477 . . . . 0.0 110.258 179.915 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 66' ' ' ILE . . . . . . . . . . . . . 67.2 mt -115.18 129.13 71.93 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.236 0 N-CA-C 109.87 -0.419 . . . . 0.0 109.87 179.741 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 67' ' ' THR . . . . . . . . . . . . . 31.0 m -126.7 139.4 53.18 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-O 121.076 0.465 . . . . 0.0 111.107 -177.404 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 68' ' ' LEU . . . . . . . . . . . . . 33.8 mt -102.32 131.67 48.77 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 115.825 -0.625 . . . . 0.0 110.229 176.481 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 69' ' ' VAL . . . . . . . . . . . . . 42.5 t -97.31 133.18 39.97 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.369 0 CA-C-N 116.137 -0.483 . . . . 0.0 109.855 179.322 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 70' ' ' THR . . . . . . . . . . . . . 19.8 p -131.81 -38.1 1.14 Allowed 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.187 -0.46 . . . . 0.0 110.974 -178.906 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 71' ' ' HIS . . . . . . . . . . . . . 48.7 m80 -65.11 128.65 93.98 Favored Pre-proline 0 CA--C 1.535 0.367 0 CA-C-O 118.824 -0.608 . . . . 0.0 109.939 -179.617 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 72' ' ' PRO . . . . . . . . . . . . . 96.5 Cg_endo -90.71 -22.46 0.66 Allowed 'Trans proline' 0 N--CA 1.493 1.471 0 C-N-CA 121.628 1.552 . . . . 0.0 113.286 179.338 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 73' ' ' VAL . . . . . . . . . . . . . 34.5 m -127.01 162.3 32.15 Favored 'Isoleucine or valine' 0 C--N 1.333 -0.151 0 CA-C-O 120.939 0.4 . . . . 0.0 110.72 -177.459 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 74' ' ' ASP . . . . . . . . . . . . . 12.1 t70 -99.14 120.25 39.18 Favored 'General case' 0 C--N 1.331 -0.225 0 CA-C-N 116.088 -0.506 . . . . 0.0 109.713 179.399 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 42.4 t -110.98 121.06 62.99 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.263 0 CA-C-O 121.17 0.509 . . . . 0.0 110.534 -177.671 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 76' ' ' LEU . . . . . . . . . . . . . 29.7 mt -123.9 137.48 54.63 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 115.483 -0.781 . . . . 0.0 109.083 177.149 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 77' ' ' GLU . . . . . . . . . . . . . 33.5 tt0 -136.7 135.84 38.53 Favored 'General case' 0 C--N 1.33 -0.257 0 C-N-CA 120.745 -0.382 . . . . 0.0 111.111 -175.727 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 78' ' ' ALA . . . . . 0.592 ' HB2' HD21 ' A' ' 109' ' ' LEU . . . -124.72 140.77 52.63 Favored 'General case' 0 N--CA 1.463 0.211 0 CA-C-N 116.059 -0.518 . . . . 0.0 110.281 179.064 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 79' ' ' LYS . . . . . 0.589 ' O ' HD13 ' A' ' 80' ' ' ILE . 63.6 mttp -83.25 123.66 29.81 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.358 -0.383 . . . . 0.0 110.546 -179.501 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 80' ' ' ILE . . . . . 0.589 HD13 ' O ' ' A' ' 79' ' ' LYS . 23.3 mm -139.23 114.1 7.96 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.247 0 N-CA-C 108.967 -0.753 . . . . 0.0 108.967 -178.822 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 81' ' ' LYS . . . . . . . . . . . . . 84.2 tttt -103.16 123.92 47.62 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-O 120.92 0.39 . . . . 0.0 111.35 -175.696 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . 89.1 42.17 5.68 Favored Glycine 0 CA--C 1.525 0.707 0 C-N-CA 120.95 -0.643 . . . . 0.0 111.933 173.185 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 83' ' ' ILE . . . . . . . . . . . . . 71.2 mt -68.33 136.9 25.54 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.287 0 N-CA-C 109.847 -0.427 . . . . 0.0 109.847 177.925 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 84' ' ' LYS . . . . . . . . . . . . . 28.6 ttpp -99.66 -48.29 4.78 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.086 -0.506 . . . . 0.0 109.999 179.858 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 85' ' ' ASP . . . . . . . . . . . . . 8.9 t70 -153.36 149.09 27.48 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 115.842 -0.617 . . . . 0.0 110.542 179.303 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 86' ' ' VAL . . . . . . . . . . . . . 45.0 t -128.16 130.51 69.6 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.218 0 CA-C-O 120.917 0.389 . . . . 0.0 110.245 179.558 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 87' ' ' ILE . . . . . 0.492 HD12 ' N ' ' A' ' 87' ' ' ILE . 5.1 mp -122.1 126.18 74.03 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.23 0 CA-C-N 116.007 -0.542 . . . . 0.0 109.58 177.721 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 88' ' ' LEU . . . . . . . . . . . . . 39.0 mt -113.21 137.99 50.64 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-O 121.207 0.527 . . . . 0.0 111.294 -178.104 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 89' ' ' ASP . . . . . . . . . . . . . 13.0 t70 -128.8 157.75 40.59 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 115.376 -0.829 . . . . 0.0 109.008 175.781 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 85.0 tt0 -46.79 -37.9 9.32 Favored 'General case' 0 C--N 1.33 -0.271 0 N-CA-C 112.97 0.73 . . . . 0.0 112.97 -172.07 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 91' ' ' ASN . . . . . . . . . . . . . 28.7 p30 -132.06 23.91 4.56 Favored 'General case' 0 N--CA 1.465 0.306 0 N-CA-C 112.863 0.69 . . . . 0.0 112.863 -177.89 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 92' ' ' LEU . . . . . . . . . . . . . 9.8 mt -149.24 144.45 26.54 Favored 'General case' 0 C--N 1.331 -0.206 0 N-CA-C 110.131 -0.322 . . . . 0.0 110.131 -177.547 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 93' ' ' ILE . . . . . . . . . . . . . 75.8 mt -127.69 119.0 50.63 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.247 0 N-CA-C 109.428 -0.582 . . . . 0.0 109.428 177.757 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 94' ' ' VAL . . . . . 0.427 HG21 HG21 ' A' ' 125' ' ' VAL . 45.5 t -121.39 128.3 75.87 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.261 0 CA-C-O 120.925 0.393 . . . . 0.0 110.133 179.984 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 95' ' ' VAL . . . . . . . . . . . . . 47.2 t -122.63 134.1 66.82 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.298 0 CA-C-N 115.863 -0.608 . . . . 0.0 109.754 -179.307 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 96' ' ' ILE . . . . . . . . . . . . . 60.0 mt -115.21 130.02 70.45 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.294 0 N-CA-C 109.273 -0.64 . . . . 0.0 109.273 179.127 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 97' ' ' THR . . . . . . . . . . . . . 73.1 p -103.81 156.28 17.94 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-O 121.253 0.549 . . . . 0.0 111.243 -178.107 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 98' ' ' GLU . . . . . . . . . . . . . 96.2 mt-10 -54.95 -26.89 39.45 Favored 'General case' 0 CA--C 1.532 0.276 0 CA-C-N 116.091 -0.504 . . . . 0.0 112.325 -179.041 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 99' ' ' GLU . . . . . . . . . . . . . 12.7 pt-20 -78.9 16.67 0.85 Allowed 'General case' 0 CA--C 1.535 0.382 0 N-CA-C 113.261 0.838 . . . . 0.0 113.261 -177.638 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 100' ' ' ASN . . . . . . . . . . . . . 3.1 m-20 63.53 37.59 10.35 Favored 'General case' 0 C--O 1.232 0.147 0 CA-C-O 121.072 0.463 . . . . 0.0 111.106 176.992 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 101' ' ' GLU . . . . . . . . . . . . . 85.0 tt0 -116.36 142.63 46.59 Favored 'General case' 0 C--N 1.331 -0.238 0 N-CA-C 109.709 -0.478 . . . . 0.0 109.709 175.819 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 102' ' ' VAL . . . . . . . . . . . . . 46.6 t -117.4 125.79 74.23 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.29 0 CA-C-N 116.179 -0.464 . . . . 0.0 109.908 -178.057 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 103' ' ' LEU . . . . . 0.483 HD12 ' N ' ' A' ' 103' ' ' LEU . 6.3 mp -116.5 134.57 54.7 Favored 'General case' 0 N--CA 1.463 0.185 0 CA-C-N 115.813 -0.631 . . . . 0.0 110.287 177.311 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 104' ' ' ILE . . . . . 0.43 HD12 ' HB3' ' A' ' 113' ' ' TYR . 66.0 mt -121.39 120.94 63.37 Favored 'Isoleucine or valine' 0 C--O 1.234 0.261 0 N-CA-C 110.051 -0.352 . . . . 0.0 110.051 -179.065 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 105' ' ' PHE . . . . . . . . . . . . . 66.3 m-85 -120.89 164.7 16.28 Favored 'General case' 0 C--N 1.331 -0.234 0 O-C-N 124.012 0.82 . . . . 0.0 109.688 179.593 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 106' ' ' ASN . . . . . . . . . . . . . 44.2 p-10 -100.88 -171.13 1.95 Allowed 'General case' 0 C--N 1.33 -0.276 0 N-CA-C 109.737 -0.468 . . . . 0.0 109.737 172.842 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 107' ' ' GLN . . . . . . . . . . . . . 32.6 tt0 -60.83 -27.59 68.19 Favored 'General case' 0 CA--C 1.533 0.31 0 N-CA-C 111.96 0.355 . . . . 0.0 111.96 178.785 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 108' ' ' ASN . . . . . 0.428 ' ND2' ' O ' ' A' ' 108' ' ' ASN . 0.9 OUTLIER -81.97 6.0 17.4 Favored 'General case' 0 CA--C 1.538 0.501 0 N-CA-C 113.06 0.763 . . . . 0.0 113.06 -178.693 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 109' ' ' LEU . . . . . 0.592 HD21 ' HB2' ' A' ' 78' ' ' ALA . 11.2 tp 61.58 37.52 16.17 Favored 'General case' 0 C--O 1.233 0.204 0 CA-C-O 120.952 0.406 . . . . 0.0 111.3 178.319 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 110' ' ' GLU . . . . . . . . . . . . . 43.2 mt-10 -109.02 153.97 22.87 Favored 'General case' 0 C--N 1.33 -0.245 0 N-CA-C 110.091 -0.337 . . . . 0.0 110.091 177.375 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 111' ' ' GLU . . . . . . . . . . . . . 98.3 mt-10 -81.7 121.94 27.02 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-O 120.974 0.416 . . . . 0.0 111.098 -179.814 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 112' ' ' LEU . . . . . . . . . . . . . 21.3 mt -107.45 -45.47 4.07 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 115.887 -0.597 . . . . 0.0 109.963 175.835 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 113' ' ' TYR . . . . . 0.43 ' HB3' HD12 ' A' ' 104' ' ' ILE . 50.4 t80 -139.37 140.51 37.48 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 115.944 -0.571 . . . . 0.0 110.502 179.678 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 114' ' ' ARG . . . . . . . . . . . . . 32.0 ptt180 -150.92 120.74 7.06 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-O 120.917 0.389 . . . . 0.0 110.818 178.476 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 115' ' ' GLY . . . . . . . . . . . . . . . -150.24 163.04 29.42 Favored Glycine 0 CA--C 1.525 0.7 0 N-CA-C 111.314 -0.714 . . . . 0.0 111.314 -179.309 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 116' ' ' LYS . . . . . . . . . . . . . 36.2 ttpt -122.87 136.63 54.93 Favored 'General case' 0 C--N 1.33 -0.261 0 N-CA-C 109.671 -0.492 . . . . 0.0 109.671 175.988 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 117' ' ' PHE . . . . . . . . . . . . . 43.9 m-85 -134.21 115.55 14.3 Favored 'General case' 0 C--N 1.331 -0.22 0 CA-C-O 121.006 0.431 . . . . 0.0 110.343 -176.791 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 118' ' ' GLU . . . . . . . . . . . . . 84.2 tt0 -52.31 -49.16 64.75 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.271 -0.422 . . . . 0.0 111.785 -175.574 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 119' ' ' ASN . . . . . . . . . . . . . 86.2 m-20 -97.57 31.02 2.69 Favored 'General case' 0 C--N 1.33 -0.273 0 N-CA-C 112.284 0.475 . . . . 0.0 112.284 -173.791 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 120' ' ' LEU . . . . . . . . . . . . . 14.7 tp -58.24 121.8 11.63 Favored 'General case' 0 C--N 1.332 -0.177 0 N-CA-C 110.039 -0.356 . . . . 0.0 110.039 177.354 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 121' ' ' ASN . . . . . . . . . . . . . 72.7 m-20 -113.47 -44.05 3.26 Favored 'General case' 0 C--N 1.331 -0.203 0 CA-C-N 116.537 -0.301 . . . . 0.0 111.044 -177.176 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 122' ' ' LYS . . . . . . . . . . . . . 98.9 mttt -144.62 149.07 35.12 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-O 121.068 0.461 . . . . 0.0 111.689 -177.409 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 123' ' ' VAL . . . . . . . . . . . . . 40.3 t -128.81 129.63 68.4 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.305 0 N-CA-C 109.124 -0.695 . . . . 0.0 109.124 173.723 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 124' ' ' LEU . . . . . . . . . . . . . 66.2 mt -124.6 133.68 53.19 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-O 120.892 0.377 . . . . 0.0 111.017 -176.162 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 125' ' ' VAL . . . . . 0.427 HG21 HG21 ' A' ' 94' ' ' VAL . 42.0 t -124.92 125.07 69.08 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.239 0 CA-C-N 115.866 -0.606 . . . . 0.0 109.619 177.257 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 126' ' ' ARG . . . . . . . . . . . . . 84.7 mtt180 -149.08 130.35 14.62 Favored 'General case' 0 C--N 1.328 -0.35 0 N-CA-C 110.034 -0.358 . . . . 0.0 110.034 179.058 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 127' ' ' ASN . . . . . . . . . . . . . 3.4 t-20 55.75 -151.72 0.39 Allowed 'General case' 0 CA--C 1.54 0.57 0 N-CA-C 109.841 -0.429 . . . . 0.0 109.841 -179.514 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 128' ' ' ASP . . . . . . . . . . . . . 18.8 p-10 -83.64 17.27 2.31 Favored 'General case' 0 CA--C 1.535 0.37 0 N-CA-C 112.695 0.628 . . . . 0.0 112.695 178.44 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 129' ' ' LEU . . . . . . . . . . . . . 47.4 mt -116.96 138.87 51.27 Favored 'General case' 0 C--O 1.232 0.133 0 CA-C-N 118.1 0.409 . . . . 0.0 110.697 179.563 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 130' ' ' VAL . . . . . . . . . . . . . 45.6 t -124.66 138.64 53.39 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.215 0 CA-C-N 116.127 -0.488 . . . . 0.0 109.814 179.419 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 131' ' ' VAL . . . . . 0.489 HG12 HD12 ' A' ' 140' ' ' LEU . 35.3 m -136.0 144.36 33.56 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.24 0 CA-C-O 121.236 0.541 . . . . 0.0 111.359 -179.738 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 132' ' ' ILE . . . . . . . . . . . . . 73.9 mt -117.36 133.64 63.49 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.297 0 CA-C-N 115.326 -0.852 . . . . 0.0 109.269 179.202 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 133' ' ' ILE . . . . . . . . . . . . . 40.9 mm -116.03 119.09 60.87 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.255 0 CA-C-O 120.806 0.336 . . . . 0.0 111.159 -175.204 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 134' ' ' ASP . . . . . . . . . . . . . 8.0 p-10 -133.85 145.59 49.83 Favored 'General case' 0 C--N 1.331 -0.212 0 N-CA-C 109.365 -0.605 . . . . 0.0 109.365 174.181 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 135' ' ' GLU . . . . . . . . . . . . . 43.3 tp10 -50.03 -28.01 6.38 Favored 'General case' 0 C--N 1.327 -0.375 0 N-CA-C 112.616 0.598 . . . . 0.0 112.616 -172.755 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 136' ' ' GLN . . . . . . . . . . . . . 97.4 mt-30 -78.11 -37.19 46.88 Favored 'General case' 0 C--N 1.331 -0.221 0 N-CA-C 112.35 0.5 . . . . 0.0 112.35 -177.188 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 137' ' ' LYS . . . . . . . . . . . . . 53.4 pttt -165.85 172.87 11.17 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-O 121.683 0.754 . . . . 0.0 112.271 -171.964 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 138' ' ' LEU . . . . . . . . . . . . . 6.5 tt -118.14 130.93 56.4 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 114.902 -1.045 . . . . 0.0 109.787 178.359 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 139' ' ' THR . . . . . . . . . . . . . 37.2 m -108.16 129.93 55.15 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.353 179.727 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 140' ' ' LEU . . . . . 0.489 HD12 HG12 ' A' ' 131' ' ' VAL . 36.7 tp -113.46 121.83 45.47 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 115.478 -0.783 . . . . 0.0 109.254 -178.298 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 141' ' ' ILE . . . . . . . . . . . . . 19.8 mt -119.65 116.26 50.11 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.292 0 N-CA-C 109.797 -0.446 . . . . 0.0 109.797 -176.42 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 142' ' ' ARG . . . . . . . . . . . . . 84.3 mtp180 -104.88 124.17 49.0 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 115.329 -0.851 . . . . 0.0 110.537 -178.832 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 143' ' ' THR . . . . . . . . . . . . . 37.0 p . . . . . 0 C--O 1.221 -0.412 0 CA-C-O 117.972 -1.013 . . . . 0.0 110.595 -179.912 . . . . . . . . 0 0 . 1 . 008 nuclear build full ' B' B ' -3' ' ' GLU . . . . . . . . . . . . . 95.8 mt-10 . . . . . 0 N--CA 1.491 1.591 0 N-CA-C 109.354 -0.61 . . . . 0.0 109.354 . . . . . . . . . 0 0 . 1 . 008 nuclear build full ' B' B ' -2' ' ' GLY . . . . . . . . . . . . . . . -61.45 149.98 45.17 Favored Glycine 0 CA--C 1.526 0.728 0 N-CA-C 110.775 -0.93 . . . . 0.0 110.775 179.804 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' -1' ' ' VAL . . . . . . . . . . . . . 45.2 t -95.77 134.21 34.11 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.332 0 N-CA-C 110.021 -0.363 . . . . 0.0 110.021 -179.796 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 0' ' ' ILE . . . . . . . . . . . . . 43.2 mm -114.51 128.96 71.35 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.236 0 CA-C-N 116.104 -0.498 . . . . 0.0 109.953 179.935 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 1' ' ' MET . . . . . . . . . . . . . 25.4 ptp -81.64 144.37 31.26 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.168 -0.469 . . . . 0.0 110.406 179.534 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 2' ' ' SER . . . . . . . . . . . . . 6.1 p -108.1 132.41 53.61 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-O 121.026 0.441 . . . . 0.0 110.481 -179.879 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 3' ' ' GLU . . . . . . . . . . . . . 84.6 tt0 -141.24 139.35 33.74 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 115.901 -0.591 . . . . 0.0 111.188 -179.108 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 4' ' ' LEU . . . . . . . . . . . . . 48.4 mt -119.75 129.77 54.65 Favored 'General case' 0 C--N 1.331 -0.212 0 CA-C-N 115.791 -0.64 . . . . 0.0 110.37 176.814 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 5' ' ' LYS . . . . . . . . . . . . . 59.9 mttp -104.75 119.22 38.48 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.167 -0.47 . . . . 0.0 110.257 177.187 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 6' ' ' LEU . . . . . . . . . . . . . 62.4 mt -117.46 144.16 45.3 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 115.516 -0.766 . . . . 0.0 110.075 -178.395 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 7' ' ' LYS . . . . . . . . . . . . . 33.7 ttpt -132.71 140.26 37.2 Favored Pre-proline 0 CA--C 1.532 0.279 0 CA-C-O 119.176 -0.44 . . . . 0.0 110.231 176.549 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 8' ' ' PRO . . . . . . . . . . . . . 91.5 Cg_endo -91.98 134.74 1.47 Allowed 'Trans proline' 0 N--CA 1.488 1.191 0 C-N-CA 121.795 1.663 . . . . 0.0 111.543 176.864 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 9' ' ' LEU . . . . . 0.436 HD12 ' HB2' ' B' ' 47' ' ' LYS . 26.8 mt -70.19 -46.99 21.33 Favored Pre-proline 0 CA--C 1.533 0.308 0 CA-C-O 118.683 -0.675 . . . . 0.0 112.026 -178.855 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' B' B ' 10' ' ' PRO . . . . . . . . . . . . . 94.6 Cg_endo -81.89 155.26 17.66 Favored 'Trans proline' 0 N--CA 1.496 1.631 0 C-N-CA 121.29 1.327 . . . . 0.0 111.883 175.372 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 11' ' ' LYS . . . . . . . . . . . . . 38.6 mmtm -88.18 102.6 14.96 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-O 120.793 0.33 . . . . 0.0 110.65 178.105 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 12' ' ' VAL . . . . . . . . . . . . . 12.2 p -146.45 146.47 18.89 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.26 0 CA-C-N 116.207 -0.451 . . . . 0.0 110.267 178.946 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 13' ' ' GLU . . . . . . . . . . . . . 80.6 tt0 -86.54 131.32 34.2 Favored 'General case' 0 C--N 1.33 -0.269 0 N-CA-C 109.941 -0.392 . . . . 0.0 109.941 178.312 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 14' ' ' LEU . . . . . . . . . . . . . 29.5 mt -96.57 151.67 38.11 Favored Pre-proline 0 CA--C 1.533 0.32 0 CA-C-N 116.402 -0.363 . . . . 0.0 110.814 -176.703 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 15' ' ' PRO . . . . . . . . . . . . . 25.8 Cg_exo -62.03 158.64 37.93 Favored 'Trans proline' 0 N--CA 1.497 1.735 0 C-N-CA 121.273 1.315 . . . . 0.0 111.93 176.793 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 16' ' ' PRO . . . . . . . . . . . . . 37.9 Cg_exo -58.71 -38.99 86.29 Favored 'Trans proline' 0 N--CA 1.498 1.741 0 C-N-CA 121.388 1.392 . . . . 0.0 112.835 -178.899 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 17' ' ' ASP . . . . . . . . . . . . . 10.7 p-10 -87.67 10.26 18.71 Favored 'General case' 0 CA--C 1.535 0.371 0 N-CA-C 113.279 0.844 . . . . 0.0 113.279 -176.951 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 18' ' ' PHE . . . . . . . . . . . . . 42.7 t80 -58.0 -44.95 87.5 Favored 'General case' 0 N--CA 1.457 -0.087 0 O-C-N 121.973 -0.454 . . . . 0.0 110.26 -177.489 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 19' ' ' VAL . . . . . 0.41 HG13 ' N ' ' B' ' 20' ' ' ASP . 13.6 p -56.15 -41.68 70.27 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.327 0 CA-C-N 116.62 -0.263 . . . . 0.0 110.958 -178.589 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' B' B ' 20' ' ' ASP . . . . . 0.41 ' N ' HG13 ' B' ' 19' ' ' VAL . 82.5 m-20 -60.83 -43.53 98.14 Favored 'General case' 0 C--N 1.331 -0.21 0 CA-C-O 120.799 0.333 . . . . 0.0 110.82 -178.278 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' B' B ' 21' ' ' VAL . . . . . . . . . . . . . 49.1 t -63.94 -48.46 86.05 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.285 0 C-N-CA 120.744 -0.383 . . . . 0.0 110.509 -177.347 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 22' ' ' ILE . . . . . 0.496 HG22 HD12 ' B' ' 26' ' ' LEU . 49.8 mm -55.61 -47.06 79.35 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.274 0 C-N-CA 120.978 -0.289 . . . . 0.0 110.892 -179.34 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' B' B ' 23' ' ' ARG . . . . . . . . . . . . . 45.7 ttp180 -55.69 -48.94 74.25 Favored 'General case' 0 C--N 1.33 -0.255 0 C-N-CA 120.83 -0.348 . . . . 0.0 111.234 -177.841 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 24' ' ' ILE . . . . . . . . . . . . . 76.3 mt -59.85 -41.63 86.39 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.215 0 C-N-CA 121.081 -0.248 . . . . 0.0 111.203 -177.407 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 25' ' ' LYS . . . . . . . . . . . . . 40.3 mmtm -64.08 -43.03 96.67 Favored 'General case' 0 C--N 1.329 -0.3 0 N-CA-C 112.216 0.451 . . . . 0.0 112.216 -179.593 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 26' ' ' LEU . . . . . 0.496 HD12 HG22 ' B' ' 22' ' ' ILE . 71.4 mt -78.69 -38.51 39.05 Favored 'General case' 0 C--N 1.328 -0.327 0 N-CA-C 113.502 0.927 . . . . 0.0 113.502 -169.888 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' B' B ' 27' ' ' GLN . . . . . . . . . . . . . 15.7 pt20 -47.52 140.13 6.21 Favored 'General case' 0 N--CA 1.469 0.51 0 N-CA-C 112.704 0.631 . . . . 0.0 112.704 -174.788 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 28' ' ' GLY . . . . . . . . . . . . . . . 98.73 -27.46 19.64 Favored Glycine 0 CA--C 1.532 1.137 0 CA-C-N 115.53 -0.759 . . . . 0.0 112.179 -178.438 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 29' ' ' LYS . . . . . . . . . . . . . 61.3 mtpt -98.25 155.03 17.38 Favored 'General case' 0 C--N 1.332 -0.181 0 CA-C-N 117.314 0.557 . . . . 0.0 111.06 179.602 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 30' ' ' THR . . . . . . . . . . . . . 30.1 m -94.54 136.73 34.51 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.032 -0.531 . . . . 0.0 110.003 176.321 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 31' ' ' VAL . . . . . . . . . . . . . 35.1 m -124.87 148.4 29.28 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.228 0 CA-C-N 116.308 -0.406 . . . . 0.0 110.549 -179.798 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 32' ' ' ARG . . . . . . . . . . . . . 33.6 ttm180 -136.02 146.52 47.24 Favored 'General case' 0 C--N 1.331 -0.219 0 CA-C-O 121.267 0.555 . . . . 0.0 110.583 178.501 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 33' ' ' THR . . . . . . . . . . . . . 22.8 m -53.04 139.93 26.72 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.206 -0.452 . . . . 0.0 111.317 -178.56 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 34' ' ' GLY . . . . . . . . . . . . . . . 101.23 -17.18 56.19 Favored Glycine 0 CA--C 1.534 1.254 0 CA-C-O 119.669 -0.517 . . . . 0.0 113.172 -179.989 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 35' ' ' ASP . . . . . . . . . . . . . 80.2 m-20 -66.57 146.99 53.9 Favored 'General case' 0 N--CA 1.461 0.108 0 CA-C-N 118.024 0.912 . . . . 0.0 111.086 178.421 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 36' ' ' VAL . . . . . . . . . . . . . 43.6 t -123.1 130.99 74.06 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.258 0 CA-C-N 116.009 -0.541 . . . . 0.0 109.781 177.898 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 37' ' ' ILE . . . . . . . . . . . . . 66.7 mt -122.17 138.84 51.02 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.289 0 CA-C-N 116.285 -0.416 . . . . 0.0 110.093 -179.401 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 38' ' ' GLY . . . . . . . . . . . . . . . -108.76 128.63 9.15 Favored Glycine 0 CA--C 1.526 0.746 0 N-CA-C 110.995 -0.842 . . . . 0.0 110.995 178.878 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 39' ' ' ILE . . . . . . . . . . . . . 74.6 mt -125.77 136.84 59.61 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.21 0 N-CA-C 110.16 -0.311 . . . . 0.0 110.16 179.766 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 40' ' ' SER . . . . . . . . . . . . . 38.0 t -92.59 115.33 28.0 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.363 -0.38 . . . . 0.0 110.832 175.822 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 41' ' ' ILE . . . . . . . . . . . . . 44.3 mm -121.48 119.1 58.03 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.198 0 CA-C-N 116.509 -0.314 . . . . 0.0 110.412 -179.905 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 42' ' ' LEU . . . . . . . . . . . . . 9.6 tp 53.27 36.88 23.86 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.194 -0.457 . . . . 0.0 111.576 176.964 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 43' ' ' GLY . . . . . . . . . . . . . . . 72.99 27.26 69.06 Favored Glycine 0 CA--C 1.53 0.993 0 C-N-CA 121.145 -0.55 . . . . 0.0 112.591 177.02 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 44' ' ' LYS . . . . . . . . . . . . . 97.8 mttt -136.67 134.91 37.76 Favored 'General case' 0 C--N 1.331 -0.212 0 N-CA-C 109.58 -0.526 . . . . 0.0 109.58 177.47 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 45' ' ' GLU . . . . . . . . . . . . . 84.3 tt0 -82.82 122.55 28.36 Favored 'General case' 0 C--N 1.329 -0.321 0 C-N-CA 120.701 -0.4 . . . . 0.0 111.066 -177.726 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 46' ' ' VAL . . . . . . . . . . . . . 7.1 p -121.04 128.53 76.08 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.206 0 N-CA-C 109.391 -0.596 . . . . 0.0 109.391 175.768 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 47' ' ' LYS . . . . . 0.436 ' HB2' HD12 ' B' ' 9' ' ' LEU . 68.5 mttm -100.31 126.87 46.69 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 115.979 -0.555 . . . . 0.0 110.971 178.335 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' B' B ' 48' ' ' PHE . . . . . . . . . . . . . 90.3 m-85 -109.14 131.95 54.58 Favored 'General case' 0 C--N 1.331 -0.228 0 N-CA-C 109.697 -0.483 . . . . 0.0 109.697 176.661 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 49' ' ' LYS . . . . . . . . . . . . . 83.1 tttt -108.54 135.5 49.7 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.282 -0.417 . . . . 0.0 110.371 179.037 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 50' ' ' VAL . . . . . . . . . . . . . 47.4 t -79.8 106.84 11.49 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.273 0 N-CA-C 109.164 -0.68 . . . . 0.0 109.164 175.906 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 51' ' ' VAL . . . . . . . . . . . . . 47.9 t -72.65 -48.62 45.55 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.273 0 CA-C-N 115.961 -0.563 . . . . 0.0 110.098 -173.547 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 52' ' ' GLN . . . . . . . . . . . . . 62.5 tt0 -161.83 145.58 12.4 Favored 'General case' 0 C--N 1.33 -0.246 0 C-N-CA 120.207 -0.597 . . . . 0.0 111.597 -177.341 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 53' ' ' ALA . . . . . . . . . . . . . . . -122.71 134.73 54.45 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 115.877 -0.602 . . . . 0.0 109.852 175.852 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 54' ' ' TYR . . . . . . . . . . . . . 31.2 t80 -129.07 111.71 18.4 Favored Pre-proline 0 CA--C 1.534 0.361 0 CA-C-O 118.331 -0.842 . . . . 0.0 110.506 -179.716 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 55' ' ' PRO . . . . . . . . . . . . . 74.3 Cg_endo -77.18 168.28 77.37 Favored 'Cis proline' 0 N--CA 1.5 1.882 0 CA-C-N 121.832 1.69 . . . . 0.0 112.005 -8.089 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 56' ' ' SER . . . . . . . . . . . . . 49.8 m -117.03 136.38 23.3 Favored Pre-proline 0 CA--C 1.537 0.468 0 CA-C-O 118.525 -0.75 . . . . 0.0 109.796 175.952 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 57' ' ' PRO . . . . . . . . . . . . . 43.1 Cg_endo -69.61 163.52 81.22 Favored 'Cis proline' 0 N--CA 1.497 1.714 0 CA-C-N 121.794 1.677 . . . . 0.0 111.259 -4.277 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 58' ' ' LEU . . . . . . . . . . . . . 20.8 tp -130.4 138.95 50.61 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-O 120.811 0.338 . . . . 0.0 110.829 -178.583 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 59' ' ' ARG . . . . . . . . . . . . . 55.9 ttp180 -99.18 124.17 44.02 Favored 'General case' 0 C--N 1.328 -0.352 0 N-CA-C 109.2 -0.667 . . . . 0.0 109.2 174.035 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 60' ' ' VAL . . . . . . . . . . . . . 40.7 t -73.77 125.35 32.77 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.289 0 C-N-CA 120.595 -0.442 . . . . 0.0 110.341 -175.113 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 61' ' ' GLU . . . . . . . . . . . . . 95.9 mt-10 -130.26 160.9 32.48 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 115.837 -0.619 . . . . 0.0 110.092 179.699 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 62' ' ' ASP . . . . . . . . . . . . . 7.3 p-10 -56.08 -32.9 64.56 Favored 'General case' 0 C--N 1.328 -0.349 0 C-N-CA 120.852 -0.339 . . . . 0.0 111.435 178.69 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 63' ' ' ARG . . . . . . . . . . . . . 15.5 ptm180 -82.59 6.7 16.82 Favored 'General case' 0 CA--C 1.537 0.473 0 N-CA-C 113.52 0.933 . . . . 0.0 113.52 -177.361 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 64' ' ' THR . . . . . . . . . . . . . 21.3 m -87.2 139.39 30.61 Favored 'General case' 0 C--N 1.333 -0.13 0 CA-C-N 118.119 0.418 . . . . 0.0 110.611 -178.262 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 65' ' ' LYS . . . . . . . . . . . . . 48.7 mtmt -88.89 128.71 35.68 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.082 -0.508 . . . . 0.0 110.373 179.291 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 66' ' ' ILE . . . . . . . . . . . . . 66.9 mt -117.73 128.31 74.94 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.261 0 N-CA-C 109.783 -0.451 . . . . 0.0 109.783 179.928 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 67' ' ' THR . . . . . . . . . . . . . 25.2 m -122.2 135.88 54.83 Favored 'General case' 0 C--N 1.332 -0.172 0 CA-C-O 121.074 0.464 . . . . 0.0 110.727 -179.096 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 68' ' ' LEU . . . . . 0.478 HD12 ' N ' ' B' ' 68' ' ' LEU . 8.0 mp -106.48 126.98 52.94 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 115.815 -0.63 . . . . 0.0 110.344 178.781 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' B' B ' 69' ' ' VAL . . . . . . . . . . . . . 44.1 t -98.17 130.91 46.25 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.247 0 CA-C-N 116.037 -0.529 . . . . 0.0 109.717 178.487 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 70' ' ' THR . . . . . . . . . . . . . 36.7 p -139.35 -54.63 0.57 Allowed 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.295 -0.411 . . . . 0.0 110.723 -178.389 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 71' ' ' HIS . . . . . . . . . . . . . 77.7 m80 -121.03 155.27 58.03 Favored Pre-proline 0 C--N 1.33 -0.261 0 CA-C-N 116.335 -0.393 . . . . 0.0 110.591 -179.504 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 72' ' ' PRO . . . . . . . . . . . . . 42.3 Cg_endo -67.94 -29.23 34.74 Favored 'Trans proline' 0 N--CA 1.496 1.622 0 C-N-CA 121.331 1.354 . . . . 0.0 112.481 178.931 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 73' ' ' VAL . . . . . . . . . . . . . 34.9 m -73.08 142.86 14.49 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.236 0 CA-C-O 121.052 0.453 . . . . 0.0 110.828 -179.19 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 74' ' ' ASP . . . . . . . . . . . . . 12.8 t70 -94.07 121.33 35.45 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 115.679 -0.691 . . . . 0.0 109.686 178.067 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 75' ' ' VAL . . . . . . . . . . . . . 45.8 t -110.29 122.57 65.06 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.236 0 CA-C-O 121.246 0.545 . . . . 0.0 110.42 -178.378 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 76' ' ' LEU . . . . . . . . . . . . . 26.7 mt -126.93 146.56 50.27 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 115.39 -0.823 . . . . 0.0 109.422 178.687 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 77' ' ' GLU . . . . . . . . . . . . . 97.6 mt-10 -134.35 138.8 45.18 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-O 121.089 0.471 . . . . 0.0 111.193 -177.346 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 78' ' ' ALA . . . . . 0.533 ' HB2' HD21 ' B' ' 109' ' ' LEU . . . -125.29 130.54 52.22 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 115.636 -0.711 . . . . 0.0 109.607 176.203 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' B' B ' 79' ' ' LYS . . . . . 0.66 ' O ' HD13 ' B' ' 80' ' ' ILE . 79.4 tttt -78.45 119.48 21.81 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-O 120.906 0.384 . . . . 0.0 110.636 -176.508 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' B' B ' 80' ' ' ILE . . . . . 0.66 HD13 ' O ' ' B' ' 79' ' ' LYS . 37.6 mm -139.24 105.02 2.32 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.325 0 N-CA-C 108.926 -0.768 . . . . 0.0 108.926 -178.807 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' B' B ' 81' ' ' LYS . . . . . . . . . . . . . 56.1 pttt -98.54 127.98 44.68 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-O 120.936 0.398 . . . . 0.0 111.557 -176.71 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 82' ' ' GLY . . . . . . . . . . . . . . . 89.14 42.12 5.67 Favored Glycine 0 CA--C 1.526 0.766 0 C-N-CA 121.036 -0.602 . . . . 0.0 111.975 175.148 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 83' ' ' ILE . . . . . . . . . . . . . 74.2 mt -71.81 138.88 20.72 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 N-CA-C 109.646 -0.502 . . . . 0.0 109.646 176.478 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 84' ' ' LYS . . . . . . . . . . . . . 33.1 ttpt -99.88 -52.94 3.3 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-O 120.938 0.399 . . . . 0.0 110.177 -179.802 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 85' ' ' ASP . . . . . . . . . . . . . 11.1 t70 -145.88 147.43 31.77 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 115.915 -0.584 . . . . 0.0 110.518 -178.813 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 86' ' ' VAL . . . . . . . . . . . . . 44.9 t -128.06 131.88 69.04 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.254 0 CA-C-O 120.81 0.338 . . . . 0.0 110.496 -179.105 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 87' ' ' ILE . . . . . 0.496 ' N ' HD12 ' B' ' 87' ' ' ILE . 5.1 mp -122.26 127.15 75.1 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.168 0 N-CA-C 109.692 -0.485 . . . . 0.0 109.692 177.434 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' B' B ' 88' ' ' LEU . . . . . . . . . . . . . 17.4 tp -111.22 131.63 54.97 Favored 'General case' 0 C--N 1.331 -0.201 0 CA-C-O 120.954 0.407 . . . . 0.0 110.934 -178.471 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 89' ' ' ASP . . . . . . . . . . . . . 5.9 t70 -126.09 155.33 41.77 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.014 -0.539 . . . . 0.0 109.73 178.039 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 90' ' ' GLU . . . . . . . . . . . . . 84.2 tt0 -47.12 -38.52 11.68 Favored 'General case' 0 CA--C 1.531 0.248 0 N-CA-C 112.888 0.699 . . . . 0.0 112.888 -172.181 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 91' ' ' ASN . . . . . . . . . . . . . 14.7 m120 -128.09 17.42 6.66 Favored 'General case' 0 N--CA 1.469 0.482 0 N-CA-C 113.007 0.743 . . . . 0.0 113.007 -177.085 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 92' ' ' LEU . . . . . . . . . . . . . 35.6 mt -147.91 144.46 28.09 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-O 120.801 0.334 . . . . 0.0 110.433 -176.171 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 93' ' ' ILE . . . . . . . . . . . . . 70.5 mt -122.84 115.32 45.49 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.373 0 N-CA-C 109.056 -0.72 . . . . 0.0 109.056 177.376 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 94' ' ' VAL . . . . . . . . . . . . . 42.6 t -117.32 126.84 74.81 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.283 0 CA-C-O 120.901 0.381 . . . . 0.0 110.178 -177.111 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 95' ' ' VAL . . . . . . . . . . . . . 46.5 t -122.39 133.18 69.41 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.337 0 CA-C-N 115.933 -0.576 . . . . 0.0 109.773 179.874 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 96' ' ' ILE . . . . . 0.51 HD11 ' HB ' ' B' ' 123' ' ' VAL . 66.0 mt -115.21 125.22 72.43 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.329 0 N-CA-C 109.315 -0.624 . . . . 0.0 109.315 179.097 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' B' B ' 97' ' ' THR . . . . . . . . . . . . . 80.4 p -99.75 158.0 16.09 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-O 121.202 0.525 . . . . 0.0 111.191 -176.127 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 98' ' ' GLU . . . . . . . . . . . . . 44.9 mt-10 -53.95 -26.12 24.03 Favored 'General case' 0 C--N 1.329 -0.319 0 N-CA-C 112.308 0.485 . . . . 0.0 112.308 -179.268 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 99' ' ' GLU . . . . . . . . . . . . . 70.0 mm-40 -78.84 15.73 1.02 Allowed 'General case' 0 CA--C 1.535 0.371 0 N-CA-C 113.203 0.816 . . . . 0.0 113.203 -176.829 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 100' ' ' ASN . . . . . . . . . . . . . 2.4 m-20 62.24 38.01 13.74 Favored 'General case' 0 N--CA 1.463 0.2 0 CA-C-O 121.118 0.485 . . . . 0.0 110.996 178.647 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 101' ' ' GLU . . . . . . . . . . . . . 84.6 tt0 -116.77 142.79 46.46 Favored 'General case' 0 C--N 1.331 -0.224 0 CA-C-N 116.021 -0.536 . . . . 0.0 109.917 176.486 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 102' ' ' VAL . . . . . . . . . . . . . 43.2 t -114.96 125.0 72.17 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.327 0 N-CA-C 109.738 -0.467 . . . . 0.0 109.738 -178.957 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 103' ' ' LEU . . . . . . . . . . . . . 57.5 mt -115.23 131.52 56.9 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 115.637 -0.71 . . . . 0.0 109.906 177.819 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 104' ' ' ILE . . . . . 0.419 HD12 ' HB3' ' B' ' 113' ' ' TYR . 67.4 mt -118.82 118.39 57.61 Favored 'Isoleucine or valine' 0 C--O 1.234 0.271 0 N-CA-C 110.096 -0.335 . . . . 0.0 110.096 -178.831 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' B' B ' 105' ' ' PHE . . . . . . . . . . . . . 68.8 m-85 -115.07 162.95 16.31 Favored 'General case' 0 C--N 1.332 -0.191 0 O-C-N 124.196 0.935 . . . . 0.0 109.893 179.265 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 106' ' ' ASN . . . . . . . . . . . . . 45.0 p-10 -102.62 -170.11 1.76 Allowed 'General case' 0 C--N 1.329 -0.3 0 N-CA-C 109.801 -0.444 . . . . 0.0 109.801 174.392 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 107' ' ' GLN . . . . . . . . . . . . . 60.3 tt0 -58.52 -28.27 65.28 Favored 'General case' 0 C--N 1.33 -0.248 0 N-CA-C 111.968 0.359 . . . . 0.0 111.968 177.682 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 108' ' ' ASN . . . . . . . . . . . . . 10.6 t-20 -84.11 7.09 19.9 Favored 'General case' 0 CA--C 1.536 0.439 0 N-CA-C 113.235 0.828 . . . . 0.0 113.235 -177.625 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 109' ' ' LEU . . . . . 0.533 HD21 ' HB2' ' B' ' 78' ' ' ALA . 6.5 tp 60.52 36.61 19.97 Favored 'General case' 0 C--O 1.233 0.197 0 CA-C-O 120.891 0.377 . . . . 0.0 111.414 178.745 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' B' B ' 110' ' ' GLU . . . . . . . . . . . . . 70.8 mm-40 -115.45 150.64 36.14 Favored 'General case' 0 C--N 1.331 -0.215 0 CA-C-O 120.723 0.297 . . . . 0.0 110.321 177.117 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 111' ' ' GLU . . . . . . . . . . . . . 24.7 mm-40 -78.14 122.69 25.97 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-O 121.188 0.518 . . . . 0.0 111.762 -177.752 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 112' ' ' LEU . . . . . . . . . . . . . 57.7 mt -102.94 -42.63 5.76 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 115.449 -0.796 . . . . 0.0 110.137 173.622 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 113' ' ' TYR . . . . . 0.419 ' HB3' HD12 ' B' ' 104' ' ' ILE . 56.3 t80 -139.12 140.81 38.05 Favored 'General case' 0 N--CA 1.463 0.205 0 CA-C-O 120.978 0.418 . . . . 0.0 111.329 -179.677 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' B' B ' 114' ' ' ARG . . . . . . . . . . . . . 66.4 mtm180 -139.85 125.27 19.06 Favored 'General case' 0 C--N 1.331 -0.22 0 CA-C-N 115.794 -0.639 . . . . 0.0 110.247 177.515 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 115' ' ' GLY . . . . . . . . . . . . . . . -150.03 153.12 24.9 Favored Glycine 0 CA--C 1.524 0.604 0 C-N-CA 120.697 -0.763 . . . . 0.0 111.581 179.46 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 116' ' ' LYS . . . . . . . . . . . . . 39.8 ttpt -122.16 135.15 54.75 Favored 'General case' 0 C--N 1.33 -0.258 0 N-CA-C 109.602 -0.518 . . . . 0.0 109.602 176.104 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 117' ' ' PHE . . . . . . . . . . . . . 47.1 m-85 -134.92 113.96 12.06 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-O 121.037 0.446 . . . . 0.0 110.335 -176.611 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 118' ' ' GLU . . . . . . . . . . . . . 84.8 tt0 -53.41 -49.87 66.38 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.384 -0.371 . . . . 0.0 111.485 -176.771 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 119' ' ' ASN . . . . . . . . . . . . . 13.3 m120 -94.21 30.99 1.77 Allowed 'General case' 0 C--N 1.329 -0.284 0 N-CA-C 112.111 0.412 . . . . 0.0 112.111 -174.591 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 120' ' ' LEU . . . . . . . . . . . . . 14.9 tp -57.42 122.88 13.65 Favored 'General case' 0 C--N 1.332 -0.188 0 N-CA-C 110.28 -0.267 . . . . 0.0 110.28 178.289 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 121' ' ' ASN . . . . . . . . . . . . . 80.9 m-20 -114.01 -44.07 3.19 Favored 'General case' 0 C--N 1.331 -0.204 0 CA-C-N 116.628 -0.26 . . . . 0.0 111.215 -176.617 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 122' ' ' LYS . . . . . . . . . . . . . 54.0 mttm -143.34 145.71 32.92 Favored 'General case' 0 C--N 1.331 -0.199 0 C-N-CA 120.593 -0.443 . . . . 0.0 111.478 -177.406 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 123' ' ' VAL . . . . . 0.51 ' HB ' HD11 ' B' ' 96' ' ' ILE . 46.3 t -126.31 128.54 71.59 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.259 0 N-CA-C 109.38 -0.6 . . . . 0.0 109.38 175.522 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' B' B ' 124' ' ' LEU . . . . . . . . . . . . . 40.4 mt -126.84 136.45 52.37 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-O 120.812 0.339 . . . . 0.0 110.773 -177.292 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 125' ' ' VAL . . . . . . . . . . . . . 11.4 p -136.23 130.39 47.83 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.298 0 CA-C-N 116.338 -0.392 . . . . 0.0 110.134 177.244 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 126' ' ' ARG . . . . . . . . . . . . . 29.5 mmm180 -138.17 119.91 15.2 Favored 'General case' 0 C--N 1.331 -0.201 0 CA-C-N 116.281 -0.418 . . . . 0.0 110.417 -178.977 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 127' ' ' ASN . . . . . . . . . . . . . 33.7 m120 50.14 -104.85 0.16 Allowed 'General case' 0 CA--C 1.544 0.713 0 CA-C-O 119.176 -0.44 . . . . 0.0 111.794 176.622 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 128' ' ' ASP . . . . . . . . . . . . . 18.1 p-10 -110.54 -0.43 17.34 Favored 'General case' 0 CA--C 1.536 0.415 0 N-CA-C 113.752 1.019 . . . . 0.0 113.752 -174.759 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 129' ' ' LEU . . . . . . . . . . . . . 83.7 mt -111.01 144.22 40.47 Favored 'General case' 0 C--N 1.332 -0.175 0 O-C-N 121.972 -0.455 . . . . 0.0 110.273 179.349 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 130' ' ' VAL . . . . . 0.566 HG13 ' HB ' ' B' ' 141' ' ' ILE . 13.6 p -130.81 138.58 53.25 Favored 'Isoleucine or valine' 0 C--O 1.233 0.214 0 CA-C-O 121.188 0.518 . . . . 0.0 110.423 178.706 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' B' B ' 131' ' ' VAL . . . . . . . . . . . . . 37.5 t -135.11 138.95 48.06 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.263 0 CA-C-N 115.858 -0.61 . . . . 0.0 110.47 -175.773 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 132' ' ' ILE . . . . . . . . . . . . . 70.1 mt -117.22 129.77 73.21 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.283 0 CA-C-N 115.866 -0.606 . . . . 0.0 109.409 178.869 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 133' ' ' ILE . . . . . . . . . . . . . 43.5 mm -114.0 119.46 61.22 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.244 0 CA-C-O 120.815 0.34 . . . . 0.0 110.652 -176.183 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 134' ' ' ASP . . . . . . . . . . . . . 9.0 p-10 -134.43 143.04 47.33 Favored 'General case' 0 C--N 1.33 -0.27 0 N-CA-C 109.586 -0.524 . . . . 0.0 109.586 177.05 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 135' ' ' GLU . . . . . . . . . . . . . 85.7 tt0 -49.93 -25.84 3.63 Favored 'General case' 0 C--N 1.328 -0.347 0 N-CA-C 112.594 0.59 . . . . 0.0 112.594 -174.316 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 136' ' ' GLN . . . . . . . . . . . . . 53.2 mt-30 -78.95 -38.28 37.48 Favored 'General case' 0 CA--C 1.531 0.216 0 N-CA-C 112.138 0.422 . . . . 0.0 112.138 -178.016 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 137' ' ' LYS . . . . . . . . . . . . . 19.6 ptpt -162.77 174.46 12.44 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-O 121.49 0.662 . . . . 0.0 111.958 -173.458 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 138' ' ' LEU . . . . . . . . . . . . . 6.1 tt -117.88 126.77 53.0 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 115.098 -0.956 . . . . 0.0 109.568 177.007 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 139' ' ' THR . . . . . . . . . . . . . 28.6 m -108.78 124.86 51.26 Favored 'General case' 0 C--N 1.331 -0.204 0 CA-C-N 116.372 -0.376 . . . . 0.0 110.619 -178.882 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 140' ' ' LEU . . . . . . . . . . . . . 17.9 tp -112.17 119.02 36.95 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 115.579 -0.737 . . . . 0.0 109.124 -179.449 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 141' ' ' ILE . . . . . 0.566 ' HB ' HG13 ' B' ' 130' ' ' VAL . 19.9 mt -119.29 121.11 65.74 Favored 'Isoleucine or valine' 0 C--O 1.235 0.309 0 CA-C-O 121.236 0.541 . . . . 0.0 110.375 -176.209 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' B' B ' 142' ' ' ARG . . . . . . . . . . . . . 7.8 mmm180 -94.75 117.34 29.97 Favored 'General case' 0 C--N 1.331 -0.224 0 CA-C-N 114.861 -1.063 . . . . 0.0 109.718 177.86 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 143' ' ' THR . . . . . . . . . . . . . 6.0 p . . . . . 0 C--O 1.221 -0.444 0 CA-C-O 117.929 -1.034 . . . . 0.0 110.523 -177.914 . . . . . . . . 0 0 . 1 . 008 nuclear build full ' C' C ' -3' ' ' GLU . . . . . . . . . . . . . 95.9 mt-10 . . . . . 0 N--CA 1.49 1.541 0 N-CA-C 109.442 -0.577 . . . . 0.0 109.442 . . . . . . . . . 0 0 . 1 . 008 nuclear build full ' C' C ' -2' ' ' GLY . . . . . . . . . . . . . . . -76.62 150.02 37.55 Favored Glycine 0 CA--C 1.525 0.68 0 N-CA-C 110.945 -0.862 . . . . 0.0 110.945 179.665 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' C' C ' -1' ' ' VAL . . . . . . . . . . . . . 47.5 t -88.9 133.85 29.97 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.325 0 CA-C-O 120.892 0.377 . . . . 0.0 110.007 179.792 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' C' C ' 0' ' ' ILE . . . . . . . . . . . . . 73.6 mt -112.27 133.92 56.45 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.242 0 CA-C-N 116.142 -0.481 . . . . 0.0 109.943 -179.606 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' C' C ' 1' ' ' MET . . . . . . . . . . . . . 26.0 ptm -79.67 132.18 36.16 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.224 -0.443 . . . . 0.0 110.246 178.181 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' C' C ' 2' ' ' SER . . . . . . . . . . . . . 3.1 p -130.58 125.96 35.5 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-O 121.041 0.448 . . . . 0.0 110.41 -179.63 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' C' C ' 3' ' ' GLU . . . . . . . . . . . . . 96.0 mt-10 -140.35 141.1 35.68 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 115.72 -0.673 . . . . 0.0 110.951 -177.886 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' C' C ' 4' ' ' LEU . . . . . . . . . . . . . 18.3 tp -123.19 127.06 48.12 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 115.771 -0.65 . . . . 0.0 109.799 175.795 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' C' C ' 5' ' ' LYS . . . . . . . . . . . . . 98.8 mttt -110.41 119.77 40.28 Favored 'General case' 0 C--O 1.234 0.26 0 CA-C-N 116.427 -0.352 . . . . 0.0 110.789 -179.257 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' C' C ' 6' ' ' LEU . . . . . . . . . . . . . 70.9 mt -114.8 143.98 44.23 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 115.302 -0.863 . . . . 0.0 110.277 -179.187 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' C' C ' 7' ' ' LYS . . . . . . . . . . . . . 51.3 tttm -128.26 133.29 24.99 Favored Pre-proline 0 CA--C 1.535 0.39 0 CA-C-O 118.777 -0.63 . . . . 0.0 110.102 177.442 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' C' C ' 8' ' ' PRO . . . . . . . . . . . . . 73.4 Cg_endo -89.01 136.32 2.95 Favored 'Trans proline' 0 N--CA 1.491 1.378 0 C-N-CA 121.61 1.54 . . . . 0.0 111.501 176.699 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' C' C ' 9' ' ' LEU . . . . . . . . . . . . . 75.8 mt -75.29 -52.08 3.16 Favored Pre-proline 0 CA--C 1.533 0.32 0 CA-C-O 118.712 -0.661 . . . . 0.0 112.02 -177.312 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' C' C ' 10' ' ' PRO . . . . . . . . . . . . . 60.4 Cg_endo -72.95 150.23 48.54 Favored 'Trans proline' 0 N--CA 1.5 1.866 0 C-N-CA 121.085 1.19 . . . . 0.0 111.948 174.375 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' C' C ' 11' ' ' LYS . . . . . . . . . . . . . 41.0 mtpt -89.13 100.78 13.49 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.502 -0.317 . . . . 0.0 110.825 179.391 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' C' C ' 12' ' ' VAL . . . . . . . . . . . . . 12.4 p -146.24 143.39 21.09 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.336 0 CA-C-N 116.265 -0.425 . . . . 0.0 110.579 179.223 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' C' C ' 13' ' ' GLU . . . . . . . . . . . . . 95.0 mt-10 -81.09 123.99 28.85 Favored 'General case' 0 C--N 1.33 -0.274 0 N-CA-C 109.98 -0.378 . . . . 0.0 109.98 177.916 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' C' C ' 14' ' ' LEU . . . . . . . . . . . . . 28.2 mt -98.27 152.31 37.92 Favored Pre-proline 0 CA--C 1.532 0.287 0 CA-C-N 116.425 -0.352 . . . . 0.0 110.601 -179.046 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' C' C ' 15' ' ' PRO . . . . . . . . . . . . . 34.3 Cg_exo -58.41 156.07 32.74 Favored 'Trans proline' 0 N--CA 1.497 1.693 0 C-N-CA 121.323 1.348 . . . . 0.0 111.854 178.088 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' C' C ' 16' ' ' PRO . . . . . . . . . . . . . 39.3 Cg_exo -58.85 -34.36 99.01 Favored 'Trans proline' 0 N--CA 1.496 1.64 0 C-N-CA 121.475 1.45 . . . . 0.0 112.677 -179.821 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' C' C ' 17' ' ' ASP . . . . . . . . . . . . . 19.4 p-10 -85.3 9.78 14.37 Favored 'General case' 0 CA--C 1.535 0.375 0 N-CA-C 113.081 0.771 . . . . 0.0 113.081 -177.545 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' C' C ' 18' ' ' PHE . . . . . . . . . . . . . 34.7 t80 -56.79 -42.15 78.96 Favored 'General case' 0 C--N 1.333 -0.118 0 O-C-N 121.939 -0.476 . . . . 0.0 110.365 -179.378 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' C' C ' 19' ' ' VAL . . . . . . . . . . . . . 53.1 t -56.43 -44.47 80.34 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 CA-C-N 116.361 -0.381 . . . . 0.0 110.469 -179.335 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' C' C ' 20' ' ' ASP . . . . . . . . . . . . . 82.8 m-20 -59.8 -42.5 93.55 Favored 'General case' 0 C--N 1.329 -0.308 0 C-N-CA 120.817 -0.353 . . . . 0.0 110.785 -178.271 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' C' C ' 21' ' ' VAL . . . . . . . . . . . . . 56.2 t -63.37 -47.75 90.45 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.303 0 C-N-CA 120.736 -0.385 . . . . 0.0 110.464 -177.294 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' C' C ' 22' ' ' ILE . . . . . 0.569 HG22 HD12 ' C' ' 26' ' ' LEU . 51.3 mm -55.42 -48.75 76.64 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.326 0 C-N-CA 121.077 -0.249 . . . . 0.0 110.8 -179.976 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' C' C ' 23' ' ' ARG . . . . . . . . . . . . . 55.4 ttp180 -55.66 -47.8 76.09 Favored 'General case' 0 C--N 1.33 -0.276 0 C-N-CA 120.806 -0.358 . . . . 0.0 111.415 -177.314 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' C' C ' 24' ' ' ILE . . . . . . . . . . . . . 75.8 mt -59.29 -42.01 85.87 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.311 0 C-N-CA 121.089 -0.244 . . . . 0.0 111.315 -177.284 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' C' C ' 25' ' ' LYS . . . . . . . . . . . . . 93.3 mttt -67.82 -43.79 78.78 Favored 'General case' 0 C--N 1.331 -0.219 0 N-CA-C 112.6 0.592 . . . . 0.0 112.6 -178.903 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' C' C ' 26' ' ' LEU . . . . . 0.569 HD12 HG22 ' C' ' 22' ' ' ILE . 70.6 mt -78.31 -33.96 48.98 Favored 'General case' 0 C--N 1.329 -0.313 0 N-CA-C 113.548 0.944 . . . . 0.0 113.548 -169.967 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' C' C ' 27' ' ' GLN . . . . . . . . . . . . . 20.9 pt20 -46.76 138.79 5.86 Favored 'General case' 0 N--CA 1.467 0.385 0 N-CA-C 112.971 0.73 . . . . 0.0 112.971 -173.925 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' C' C ' 28' ' ' GLY . . . . . . . . . . . . . . . 100.05 -27.18 21.51 Favored Glycine 0 CA--C 1.532 1.116 0 CA-C-N 115.614 -0.721 . . . . 0.0 112.214 -178.906 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' C' C ' 29' ' ' LYS . . . . . . . . . . . . . 61.8 mttp -97.96 155.21 17.2 Favored 'General case' 0 C--O 1.232 0.159 0 CA-C-N 117.341 0.571 . . . . 0.0 111.301 179.475 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' C' C ' 30' ' ' THR . . . . . . . . . . . . . 37.3 m -104.92 139.95 38.89 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-N 115.954 -0.566 . . . . 0.0 109.898 175.817 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' C' C ' 31' ' ' VAL . . . . . . . . . . . . . 34.7 m -127.31 152.26 35.13 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.218 0 CA-C-O 120.947 0.403 . . . . 0.0 111.077 -178.048 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' C' C ' 32' ' ' ARG . . . . . . . . . . . . . 97.1 mtt180 -126.35 149.47 49.17 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 115.834 -0.621 . . . . 0.0 110.622 177.912 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' C' C ' 33' ' ' THR . . . . . 0.401 HG23 ' O ' ' C' ' 51' ' ' VAL . 17.6 m -53.65 138.81 33.93 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-N 116.118 -0.492 . . . . 0.0 111.308 -178.658 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' C' C ' 34' ' ' GLY . . . . . . . . . . . . . . . 100.2 -17.15 57.4 Favored Glycine 0 CA--C 1.533 1.194 0 CA-C-O 119.672 -0.515 . . . . 0.0 113.333 178.967 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' C' C ' 35' ' ' ASP . . . . . . . . . . . . . 77.5 m-20 -65.53 148.35 51.88 Favored 'General case' 0 N--CA 1.462 0.142 0 CA-C-N 117.965 0.883 . . . . 0.0 110.922 178.869 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' C' C ' 36' ' ' VAL . . . . . . . . . . . . . 41.4 t -120.53 131.52 72.49 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.258 0 CA-C-N 116.007 -0.542 . . . . 0.0 109.858 178.943 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' C' C ' 37' ' ' ILE . . . . . . . . . . . . . 67.1 mt -118.68 138.11 50.46 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.225 0 CA-C-N 116.082 -0.508 . . . . 0.0 109.682 179.276 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' C' C ' 38' ' ' GLY . . . . . . . . . . . . . . . -114.85 128.75 8.28 Favored Glycine 0 CA--C 1.525 0.67 0 N-CA-C 111.006 -0.838 . . . . 0.0 111.006 -179.878 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' C' C ' 39' ' ' ILE . . . . . . . . . . . . . 73.0 mt -123.21 137.35 56.89 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.186 0 N-CA-C 110.252 -0.277 . . . . 0.0 110.252 179.585 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' C' C ' 40' ' ' SER . . . . . . . . . . . . . 99.5 p -91.69 117.71 30.0 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.329 -0.396 . . . . 0.0 110.713 175.767 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' C' C ' 41' ' ' ILE . . . . . 0.426 HD12 HG11 ' C' ' 46' ' ' VAL . 72.0 mt -127.79 121.48 56.64 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.202 0 CA-C-O 120.902 0.382 . . . . 0.0 110.397 178.82 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' C' C ' 42' ' ' LEU . . . . . . . . . . . . . 10.8 tp 52.3 35.61 17.5 Favored 'General case' 0 CA--C 1.531 0.23 0 CA-C-N 116.036 -0.529 . . . . 0.0 111.614 177.087 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' C' C ' 43' ' ' GLY . . . . . . . . . . . . . . . 72.07 31.88 63.73 Favored Glycine 0 CA--C 1.529 0.92 0 C-N-CA 121.183 -0.532 . . . . 0.0 111.972 178.047 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' C' C ' 44' ' ' LYS . . . . . . . . . . . . . 40.7 ttpt -138.79 129.75 26.58 Favored 'General case' 0 C--N 1.329 -0.313 0 N-CA-C 109.609 -0.515 . . . . 0.0 109.609 178.743 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' C' C ' 45' ' ' GLU . . . . . . . . . . . . . 84.6 tt0 -82.6 118.23 23.14 Favored 'General case' 0 C--N 1.328 -0.335 0 C-N-CA 120.753 -0.379 . . . . 0.0 110.673 -178.768 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' C' C ' 46' ' ' VAL . . . . . 0.426 HG11 HD12 ' C' ' 41' ' ' ILE . 7.5 p -114.94 127.36 72.52 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.153 0 N-CA-C 109.285 -0.635 . . . . 0.0 109.285 176.795 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' C' C ' 47' ' ' LYS . . . . . . . . . . . . . 64.2 mttp -100.45 128.15 46.59 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 115.817 -0.629 . . . . 0.0 111.306 179.724 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' C' C ' 48' ' ' PHE . . . . . . . . . . . . . 94.9 m-85 -111.83 131.86 55.07 Favored 'General case' 0 C--N 1.329 -0.283 0 N-CA-C 109.652 -0.499 . . . . 0.0 109.652 174.956 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' C' C ' 49' ' ' LYS . . . . . . . . . . . . . 41.8 tttp -107.57 136.57 47.12 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.619 -0.264 . . . . 0.0 110.427 179.287 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' C' C ' 50' ' ' VAL . . . . . . . . . . . . . 46.4 t -79.87 108.75 13.69 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.305 0 N-CA-C 109.164 -0.68 . . . . 0.0 109.164 176.273 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' C' C ' 51' ' ' VAL . . . . . 0.401 ' O ' HG23 ' C' ' 33' ' ' THR . 46.8 t -73.24 -51.63 25.13 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.293 0 CA-C-N 116.153 -0.476 . . . . 0.0 109.737 -175.336 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' C' C ' 52' ' ' GLN . . . . . . . . . . . . . 86.2 mt-30 -154.03 149.17 26.91 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-O 121.334 0.587 . . . . 0.0 112.077 -178.007 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' C' C ' 53' ' ' ALA . . . . . 0.531 ' HB3' ' OG ' ' C' ' 56' ' ' SER . . . -124.25 130.31 52.3 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 115.091 -0.958 . . . . 0.0 109.5 172.885 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' C' C ' 54' ' ' TYR . . . . . . . . . . . . . 45.5 t80 -128.97 107.08 18.1 Favored Pre-proline 0 CA--C 1.535 0.386 0 CA-C-O 118.24 -0.886 . . . . 0.0 110.593 -179.383 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' C' C ' 55' ' ' PRO . . . . . . . . . . . . . 73.3 Cg_endo -77.1 168.68 76.34 Favored 'Cis proline' 0 N--CA 1.499 1.827 0 CA-C-N 121.821 1.686 . . . . 0.0 112.243 -5.413 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' C' C ' 56' ' ' SER . . . . . 0.531 ' OG ' ' HB3' ' C' ' 53' ' ' ALA . 71.1 m -116.57 133.26 23.03 Favored Pre-proline 0 CA--C 1.537 0.472 0 CA-C-O 118.544 -0.741 . . . . 0.0 109.342 174.989 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' C' C ' 57' ' ' PRO . . . . . . . . . . . . . 55.3 Cg_endo -70.79 146.27 83.94 Favored 'Cis proline' 0 N--CA 1.498 1.745 0 CA-C-N 121.844 1.694 . . . . 0.0 111.688 -0.561 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' C' C ' 58' ' ' LEU . . . . . . . . . . . . . 31.4 tp -108.03 137.63 45.7 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.085 -0.507 . . . . 0.0 110.605 -178.7 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' C' C ' 59' ' ' ARG . . . . . . . . . . . . . 37.1 ttm180 -98.91 133.56 43.02 Favored 'General case' 0 C--N 1.328 -0.355 0 N-CA-C 109.453 -0.573 . . . . 0.0 109.453 175.273 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' C' C ' 60' ' ' VAL . . . . . . . . . . . . . 40.1 t -87.01 113.8 25.16 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.236 0 C-N-CA 120.616 -0.434 . . . . 0.0 110.386 -178.112 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' C' C ' 61' ' ' GLU . . . . . . . . . . . . . 15.7 mm-40 -131.1 163.66 27.17 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 115.944 -0.571 . . . . 0.0 109.769 174.246 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' C' C ' 62' ' ' ASP . . . . . . . . . . . . . 81.8 m-20 -52.32 -32.21 36.79 Favored 'General case' 0 C--N 1.329 -0.309 0 N-CA-C 111.802 0.297 . . . . 0.0 111.802 177.743 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' C' C ' 63' ' ' ARG . . . . . . . . . . . . . 41.4 mtp180 -72.07 -22.07 61.42 Favored 'General case' 0 CA--C 1.533 0.299 0 N-CA-C 112.884 0.698 . . . . 0.0 112.884 -176.484 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' C' C ' 64' ' ' THR . . . . . . . . . . . . . 40.5 m -72.27 138.12 47.22 Favored 'General case' 0 C--N 1.332 -0.186 0 CA-C-O 120.918 0.39 . . . . 0.0 110.657 -176.467 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' C' C ' 65' ' ' LYS . . . . . . . . . . . . . 38.8 ttpt -88.63 127.11 35.56 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 115.989 -0.551 . . . . 0.0 110.239 179.549 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' C' C ' 66' ' ' ILE . . . . . . . . . . . . . 72.5 mt -112.96 132.09 62.72 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.28 0 CA-C-O 120.892 0.377 . . . . 0.0 110.064 -178.053 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' C' C ' 67' ' ' THR . . . . . . . . . . . . . 23.4 m -125.29 137.26 54.07 Favored 'General case' 0 C--N 1.331 -0.212 0 CA-C-N 116.091 -0.504 . . . . 0.0 110.655 -179.239 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' C' C ' 68' ' ' LEU . . . . . . . . . . . . . 13.8 tp -104.74 124.82 50.06 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 115.887 -0.597 . . . . 0.0 110.527 179.841 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' C' C ' 69' ' ' VAL . . . . . . . . . . . . . 44.5 t -102.09 129.52 53.33 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.284 0 CA-C-N 116.02 -0.536 . . . . 0.0 109.695 178.589 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' C' C ' 70' ' ' THR . . . . . . . . . . . . . 40.5 p -144.71 -44.74 0.24 Allowed 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.299 -0.41 . . . . 0.0 110.574 -178.997 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' C' C ' 71' ' ' HIS . . . . . . . . . . . . . 31.7 m80 -124.52 166.43 19.84 Favored Pre-proline 0 C--N 1.329 -0.295 0 CA-C-N 115.909 -0.587 . . . . 0.0 110.297 -179.661 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' C' C ' 72' ' ' PRO . . . . . . . . . . . . . 17.3 Cg_exo -64.82 -23.16 62.81 Favored 'Trans proline' 0 N--CA 1.497 1.703 0 C-N-CA 121.356 1.371 . . . . 0.0 112.838 179.924 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' C' C ' 73' ' ' VAL . . . . . . . . . . . . . 34.6 m -126.3 157.57 36.64 Favored 'Isoleucine or valine' 0 N--CA 1.462 0.159 0 CA-C-O 120.752 0.31 . . . . 0.0 110.369 179.134 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' C' C ' 74' ' ' ASP . . . . . . . . . . . . . 42.3 t0 -104.55 121.52 43.66 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-N 116.332 -0.394 . . . . 0.0 110.183 -177.966 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' C' C ' 75' ' ' VAL . . . . . 0.44 ' C ' HD12 ' C' ' 76' ' ' LEU . 40.6 t -118.24 125.91 74.62 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.326 0 CA-C-O 121.107 0.479 . . . . 0.0 111.005 -176.462 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' C' C ' 76' ' ' LEU . . . . . 0.44 HD12 ' C ' ' C' ' 75' ' ' VAL . 6.8 mp -121.53 143.99 48.96 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 115.601 -0.727 . . . . 0.0 109.732 174.681 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' C' C ' 77' ' ' GLU . . . . . . . . . . . . . 97.0 mt-10 -134.47 130.67 37.06 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-O 120.988 0.423 . . . . 0.0 111.016 -177.995 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' C' C ' 78' ' ' ALA . . . . . . . . . . . . . . . -117.98 134.09 55.29 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 115.663 -0.699 . . . . 0.0 109.766 176.933 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' C' C ' 79' ' ' LYS . . . . . 0.58 ' O ' HD13 ' C' ' 80' ' ' ILE . 49.2 mtmt -77.47 120.71 22.85 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-O 120.967 0.413 . . . . 0.0 110.967 -177.956 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' C' C ' 80' ' ' ILE . . . . . 0.58 HD13 ' O ' ' C' ' 79' ' ' LYS . 42.1 mm -139.09 108.54 3.87 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.322 0 N-CA-C 108.933 -0.765 . . . . 0.0 108.933 -179.009 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' C' C ' 81' ' ' LYS . . . . . . . . . . . . . 44.0 mtmt -101.44 123.34 45.34 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-O 120.723 0.297 . . . . 0.0 111.257 -176.382 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' C' C ' 82' ' ' GLY . . . . . . . . . . . . . . . 89.07 42.43 5.62 Favored Glycine 0 CA--C 1.526 0.738 0 C-N-CA 120.652 -0.785 . . . . 0.0 111.794 174.674 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' C' C ' 83' ' ' ILE . . . . . . . . . . . . . 68.0 mt -65.29 137.03 25.73 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 CA-C-O 121.001 0.429 . . . . 0.0 109.862 177.733 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' C' C ' 84' ' ' LYS . . . . . . . . . . . . . 46.3 tttp -92.94 -52.52 4.55 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 115.942 -0.572 . . . . 0.0 109.94 179.891 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' C' C ' 85' ' ' ASP . . . . . . . . . . . . . 7.0 t70 -154.33 151.98 29.71 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 115.478 -0.783 . . . . 0.0 110.321 -179.225 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' C' C ' 86' ' ' VAL . . . . . . . . . . . . . 43.4 t -130.46 129.76 64.8 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.287 0 CA-C-N 116.47 -0.332 . . . . 0.0 110.495 -179.485 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' C' C ' 87' ' ' ILE . . . . . 0.501 ' N ' HD12 ' C' ' 87' ' ' ILE . 5.1 mp -119.37 128.78 75.85 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.285 0 N-CA-C 109.405 -0.591 . . . . 0.0 109.405 176.184 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' C' C ' 88' ' ' LEU . . . . . . . . . . . . . 23.7 tp -117.58 135.96 53.61 Favored 'General case' 0 C--N 1.331 -0.216 0 CA-C-O 121.014 0.435 . . . . 0.0 111.556 -176.126 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' C' C ' 89' ' ' ASP . . . . . . . . . . . . . 10.9 t70 -130.01 154.31 47.53 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 115.665 -0.698 . . . . 0.0 109.19 174.537 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' C' C ' 90' ' ' GLU . . . . . . . . . . . . . 96.6 mt-10 -49.81 -35.0 21.26 Favored 'General case' 0 C--N 1.33 -0.261 0 N-CA-C 112.718 0.636 . . . . 0.0 112.718 -172.277 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' C' C ' 91' ' ' ASN . . . . . . . . . . . . . 86.2 m-20 -130.29 32.61 4.44 Favored 'General case' 0 N--CA 1.465 0.294 0 N-CA-C 111.99 0.367 . . . . 0.0 111.99 -175.902 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' C' C ' 92' ' ' LEU . . . . . . . . . . . . . 8.7 tp -166.1 145.75 6.15 Favored 'General case' 0 C--N 1.331 -0.228 0 C-N-CA 120.933 -0.307 . . . . 0.0 110.782 178.67 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' C' C ' 93' ' ' ILE . . . . . . . . . . . . . 68.0 mt -125.93 124.08 65.47 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.181 0 N-CA-C 109.586 -0.524 . . . . 0.0 109.586 179.391 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' C' C ' 94' ' ' VAL . . . . . . . . . . . . . 43.3 t -122.64 125.21 72.21 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.223 0 N-CA-C 109.937 -0.394 . . . . 0.0 109.937 179.344 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' C' C ' 95' ' ' VAL . . . . . . . . . . . . . 43.8 t -124.08 134.67 65.94 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.299 0 CA-C-N 116.305 -0.407 . . . . 0.0 110.168 -179.461 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' C' C ' 96' ' ' ILE . . . . . . . . . . . . . 61.1 mt -118.99 130.52 73.7 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.238 0 N-CA-C 109.457 -0.571 . . . . 0.0 109.457 179.54 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' C' C ' 97' ' ' THR . . . . . . . . . . . . . 81.1 p -103.46 158.44 16.35 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-O 121.088 0.47 . . . . 0.0 111.44 -177.295 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' C' C ' 98' ' ' GLU . . . . . . . . . . . . . 98.1 mt-10 -53.97 -26.5 26.09 Favored 'General case' 0 CA--C 1.532 0.257 0 N-CA-C 112.392 0.516 . . . . 0.0 112.392 179.998 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' C' C ' 99' ' ' GLU . . . . . . . . . . . . . 95.8 mt-10 -77.78 14.05 1.18 Allowed 'General case' 0 CA--C 1.535 0.391 0 N-CA-C 113.302 0.853 . . . . 0.0 113.302 -177.23 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' C' C ' 100' ' ' ASN . . . . . . . . . . . . . 4.6 m-20 63.01 37.95 11.35 Favored 'General case' 0 C--O 1.232 0.142 0 CA-C-O 121.08 0.467 . . . . 0.0 111.033 178.489 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' C' C ' 101' ' ' GLU . . . . . . . . . . . . . 84.9 tt0 -117.65 140.11 50.1 Favored 'General case' 0 C--N 1.333 -0.151 0 CA-C-N 116.083 -0.508 . . . . 0.0 109.646 175.697 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' C' C ' 102' ' ' VAL . . . . . . . . . . . . . 45.7 t -115.16 128.83 72.18 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.263 0 CA-C-N 116.311 -0.404 . . . . 0.0 110.063 -178.667 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' C' C ' 103' ' ' LEU . . . . . 0.514 HD12 ' N ' ' C' ' 103' ' ' LEU . 6.1 mp -118.4 132.94 56.24 Favored 'General case' 0 C--N 1.331 -0.201 0 CA-C-N 115.695 -0.684 . . . . 0.0 110.131 176.904 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' C' C ' 104' ' ' ILE . . . . . . . . . . . . . 67.9 mt -117.92 122.48 69.82 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.228 0 CA-C-N 116.328 -0.397 . . . . 0.0 109.972 -179.766 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' C' C ' 105' ' ' PHE . . . . . . . . . . . . . 67.1 m-85 -123.16 164.67 18.24 Favored 'General case' 0 C--N 1.333 -0.132 0 O-C-N 123.916 0.76 . . . . 0.0 109.777 -179.972 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' C' C ' 106' ' ' ASN . . . . . . . . . . . . . 47.3 p-10 -102.42 -172.08 2.07 Favored 'General case' 0 C--N 1.33 -0.246 0 N-CA-C 110.151 -0.315 . . . . 0.0 110.151 174.688 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' C' C ' 107' ' ' GLN . . . . . . . . . . . . . 29.9 tt0 -58.81 -28.07 65.67 Favored 'General case' 0 C--N 1.329 -0.311 0 N-CA-C 112.086 0.402 . . . . 0.0 112.086 179.166 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' C' C ' 108' ' ' ASN . . . . . . . . . . . . . 7.9 t-20 -84.75 12.12 7.85 Favored 'General case' 0 CA--C 1.537 0.453 0 N-CA-C 112.89 0.7 . . . . 0.0 112.89 -177.956 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' C' C ' 109' ' ' LEU . . . . . . . . . . . . . 10.7 tp 53.8 37.22 25.89 Favored 'General case' 0 C--N 1.333 -0.148 0 CA-C-O 121.089 0.471 . . . . 0.0 111.315 179.409 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' C' C ' 110' ' ' GLU . . . . . . . . . . . . . 96.0 mt-10 -105.98 141.88 36.64 Favored 'General case' 0 C--N 1.33 -0.272 0 N-CA-C 109.325 -0.62 . . . . 0.0 109.325 174.528 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' C' C ' 111' ' ' GLU . . . . . . . . . . . . . 51.4 tt0 -79.61 121.92 25.87 Favored 'General case' 0 C--N 1.328 -0.332 0 C-N-CA 120.693 -0.403 . . . . 0.0 110.286 -176.478 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' C' C ' 112' ' ' LEU . . . . . . . . . . . . . 34.3 mt -102.85 -46.11 4.79 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.034 -0.53 . . . . 0.0 110.72 -179.668 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' C' C ' 113' ' ' TYR . . . . . . . . . . . . . 59.1 t80 -137.45 140.8 41.46 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.034 -0.53 . . . . 0.0 110.927 -177.824 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' C' C ' 114' ' ' ARG . . . . . . . . . . . . . 28.5 ptt180 -144.83 126.08 14.75 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-O 120.93 0.395 . . . . 0.0 110.664 176.56 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' C' C ' 115' ' ' GLY . . . . . . . . . . . . . . . -150.01 151.8 23.82 Favored Glycine 0 CA--C 1.524 0.61 0 N-CA-C 111.131 -0.788 . . . . 0.0 111.131 179.297 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' C' C ' 116' ' ' LYS . . . . . . . . . . . . . 39.7 ttpt -119.53 132.55 55.78 Favored 'General case' 0 C--N 1.329 -0.296 0 N-CA-C 110.006 -0.368 . . . . 0.0 110.006 178.185 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' C' C ' 117' ' ' PHE . . . . . . . . . . . . . 37.5 m-85 -128.93 113.8 15.66 Favored 'General case' 0 C--N 1.329 -0.286 0 N-CA-C 109.878 -0.416 . . . . 0.0 109.878 -178.257 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' C' C ' 118' ' ' GLU . . . . . . . . . . . . . 85.1 tt0 -55.54 -38.49 69.35 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-N 116.398 -0.364 . . . . 0.0 111.339 -175.308 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' C' C ' 119' ' ' ASN . . . . . . . . . . . . . 10.5 p-10 -108.73 31.14 5.87 Favored 'General case' 0 N--CA 1.463 0.196 0 N-CA-C 112.237 0.458 . . . . 0.0 112.237 -173.106 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' C' C ' 120' ' ' LEU . . . . . . . . . . . . . 15.0 tp -54.36 126.81 24.71 Favored 'General case' 0 N--CA 1.463 0.21 0 O-C-N 122.358 -0.213 . . . . 0.0 110.683 177.024 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' C' C ' 121' ' ' ASN . . . . . . . . . . . . . 27.1 m120 -110.56 -44.22 3.72 Favored 'General case' 0 C--N 1.332 -0.187 0 C-N-CA 121.169 -0.212 . . . . 0.0 111.173 -177.06 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' C' C ' 122' ' ' LYS . . . . . . . . . . . . . 95.2 mttt -148.36 148.15 30.05 Favored 'General case' 0 C--N 1.331 -0.229 0 CA-C-O 121.028 0.442 . . . . 0.0 111.44 -178.266 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' C' C ' 123' ' ' VAL . . . . . . . . . . . . . 47.0 t -127.42 128.33 69.83 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.223 0 N-CA-C 109.569 -0.53 . . . . 0.0 109.569 174.769 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' C' C ' 124' ' ' LEU . . . . . . . . . . . . . 67.9 mt -126.45 135.22 51.1 Favored 'General case' 0 C--N 1.331 -0.217 0 CA-C-N 116.494 -0.321 . . . . 0.0 110.626 -178.785 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' C' C ' 125' ' ' VAL . . . . . 0.515 HG23 HG22 ' C' ' 130' ' ' VAL . 12.4 p -138.05 137.45 44.5 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.284 0 CA-C-N 116.442 -0.345 . . . . 0.0 110.524 179.141 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' C' C ' 126' ' ' ARG . . . . . . . . . . . . . 90.6 mtt180 -143.96 123.32 13.08 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.565 178.676 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' C' C ' 127' ' ' ASN . . . . . . . . . . . . . 1.9 m-80 51.67 -105.02 0.19 Allowed 'General case' 0 CA--C 1.544 0.723 0 CA-C-O 119.134 -0.46 . . . . 0.0 111.279 -179.814 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' C' C ' 128' ' ' ASP . . . . . . . . . . . . . 8.9 p-10 -114.11 1.99 14.77 Favored 'General case' 0 CA--C 1.536 0.406 0 CA-C-N 119.538 1.063 . . . . 0.0 113.49 -176.53 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' C' C ' 129' ' ' LEU . . . . . . . . . . . . . 54.4 mt -104.97 135.49 46.21 Favored 'General case' 0 C--N 1.332 -0.185 0 CA-C-N 118.193 0.451 . . . . 0.0 110.401 179.618 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' C' C ' 130' ' ' VAL . . . . . 0.515 HG22 HG23 ' C' ' 125' ' ' VAL . 47.2 t -123.35 135.16 64.15 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.22 0 N-CA-C 109.913 -0.403 . . . . 0.0 109.913 179.991 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' C' C ' 131' ' ' VAL . . . . . 0.48 HG22 HD12 ' C' ' 140' ' ' LEU . 42.0 t -134.32 135.37 54.29 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.344 0 CA-C-O 121.125 0.488 . . . . 0.0 110.103 178.257 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' C' C ' 132' ' ' ILE . . . . . . . . . . . . . 72.5 mt -115.35 130.2 70.31 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.361 0 CA-C-N 115.498 -0.774 . . . . 0.0 109.179 -179.682 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' C' C ' 133' ' ' ILE . . . . . . . . . . . . . 44.6 mm -114.06 120.03 62.78 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.248 0 CA-C-O 120.981 0.419 . . . . 0.0 110.631 -176.226 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' C' C ' 134' ' ' ASP . . . . . . . . . . . . . 6.7 p-10 -129.58 149.51 51.31 Favored 'General case' 0 C--N 1.331 -0.23 0 CA-C-N 115.97 -0.559 . . . . 0.0 109.539 176.117 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' C' C ' 135' ' ' GLU . . . . . . . . . . . . . 41.4 tp10 -49.96 -27.05 4.81 Favored 'General case' 0 C--N 1.327 -0.378 0 N-CA-C 112.806 0.669 . . . . 0.0 112.806 -169.927 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' C' C ' 136' ' ' GLN . . . . . . . . . . . . . 30.7 tt0 -103.67 -22.82 13.51 Favored 'General case' 0 N--CA 1.465 0.282 0 N-CA-C 113.093 0.775 . . . . 0.0 113.093 -173.402 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' C' C ' 137' ' ' LYS . . . . . . . . . . . . . 54.0 mtmt -148.77 157.16 43.24 Favored 'General case' 0 C--N 1.332 -0.153 0 CA-C-O 121.212 0.529 . . . . 0.0 112.008 -170.649 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' C' C ' 138' ' ' LEU . . . . . 0.415 HD23 ' C ' ' C' ' 138' ' ' LEU . 5.5 tt -120.18 125.48 48.29 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 115.568 -0.742 . . . . 0.0 109.444 175.312 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' C' C ' 139' ' ' THR . . . . . . . . . . . . . 37.6 m -111.57 131.57 55.15 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-O 120.762 0.315 . . . . 0.0 111.126 -176.463 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' C' C ' 140' ' ' LEU . . . . . 0.48 HD12 HG22 ' C' ' 131' ' ' VAL . 14.3 tp -116.35 122.5 45.06 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 115.527 -0.761 . . . . 0.0 109.428 -179.67 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' C' C ' 141' ' ' ILE . . . . . . . . . . . . . 19.5 mt -120.77 119.45 59.59 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.29 0 N-CA-C 109.687 -0.486 . . . . 0.0 109.687 -177.258 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' C' C ' 142' ' ' ARG . . . . . . . . . . . . . 53.2 ttt180 -108.96 125.28 51.87 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 115.301 -0.863 . . . . 0.0 110.501 -176.341 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' C' C ' 143' ' ' THR . . . . . 0.43 HG22 HG12 ' D' ' 73' ' ' VAL . 81.0 p . . . . . 0 C--O 1.219 -0.503 0 CA-C-O 117.945 -1.026 . . . . 0.0 110.522 179.33 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' D' D ' -3' ' ' GLU . . . . . . . . . . . . . 84.6 tt0 . . . . . 0 N--CA 1.491 1.61 0 N-CA-C 109.505 -0.554 . . . . 0.0 109.505 . . . . . . . . . 0 0 . 1 . 008 nuclear build full ' D' D ' -2' ' ' GLY . . . . . . . . . . . . . . . -60.69 146.28 47.07 Favored Glycine 0 CA--C 1.525 0.683 0 N-CA-C 110.501 -1.04 . . . . 0.0 110.501 178.607 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' D' D ' -1' ' ' VAL . . . . . . . . . . . . . 43.0 t -95.08 129.8 44.73 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.28 0 CA-C-O 120.818 0.342 . . . . 0.0 110.143 -178.933 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' D' D ' 0' ' ' ILE . . . . . . . . . . . . . 70.8 mt -118.56 143.43 29.54 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.28 0 CA-C-N 116.066 -0.515 . . . . 0.0 109.78 -179.975 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' D' D ' 1' ' ' MET . . . . . . . . . . . . . 22.2 ptm -142.91 125.53 15.86 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.043 -0.526 . . . . 0.0 110.382 -179.62 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' D' D ' 2' ' ' SER . . . . . . . . . . . . . 4.2 p -107.28 127.81 53.87 Favored 'General case' 0 C--N 1.331 -0.206 0 CA-C-O 121.167 0.508 . . . . 0.0 110.698 -179.343 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' D' D ' 3' ' ' GLU . . . . . . . . . . . . . 84.8 tt0 -141.28 141.97 33.92 Favored 'General case' 0 C--N 1.326 -0.423 0 CA-C-N 115.578 -0.737 . . . . 0.0 111.121 -178.25 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' D' D ' 4' ' ' LEU . . . . . . . . . . . . . 65.2 mt -119.9 128.98 54.14 Favored 'General case' 0 C--N 1.331 -0.224 0 CA-C-N 115.739 -0.664 . . . . 0.0 110.436 176.303 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' D' D ' 5' ' ' LYS . . . . . . . . . . . . . 61.1 mttp -106.02 119.55 39.49 Favored 'General case' 0 C--O 1.235 0.322 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.303 176.62 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' D' D ' 6' ' ' LEU . . . . . . . . . . . . . 73.2 mt -118.18 152.08 36.36 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-N 115.457 -0.792 . . . . 0.0 110.726 -177.72 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' D' D ' 7' ' ' LYS . . . . . . . . . . . . . 29.2 ttpt -143.27 140.92 18.28 Favored Pre-proline 0 CA--C 1.534 0.354 0 CA-C-O 119.19 -0.434 . . . . 0.0 110.067 174.33 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' D' D ' 8' ' ' PRO . . . . . . . . . . . . . 93.9 Cg_endo -89.27 138.23 3.25 Favored 'Trans proline' 0 N--CA 1.489 1.23 0 C-N-CA 121.752 1.635 . . . . 0.0 111.555 177.875 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' D' D ' 9' ' ' LEU . . . . . . . . . . . . . 84.9 mt -70.85 -48.81 14.59 Favored Pre-proline 0 C--N 1.329 -0.306 0 CA-C-O 119.143 -0.456 . . . . 0.0 111.045 -178.824 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' D' D ' 10' ' ' PRO . . . . . . . . . . . . . 95.6 Cg_endo -79.75 138.44 13.36 Favored 'Trans proline' 0 N--CA 1.495 1.57 0 C-N-CA 121.098 1.198 . . . . 0.0 111.228 169.398 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' D' D ' 11' ' ' LYS . . . . . . . . . . . . . 82.3 tttt -87.88 102.86 15.11 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-O 120.886 0.375 . . . . 0.0 110.472 -178.923 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' D' D ' 12' ' ' VAL . . . . . . . . . . . . . 12.1 p -140.77 147.86 22.43 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.248 0 CA-C-N 116.127 -0.488 . . . . 0.0 110.518 -179.391 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' D' D ' 13' ' ' GLU . . . . . . . . . . . . . 95.2 mt-10 -78.93 123.36 27.19 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 116.3 -0.409 . . . . 0.0 110.041 178.392 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' D' D ' 14' ' ' LEU . . . . . . . . . . . . . 21.8 mt -98.55 153.88 37.76 Favored Pre-proline 0 C--N 1.33 -0.24 0 CA-C-N 116.427 -0.351 . . . . 0.0 111.103 -178.072 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' D' D ' 15' ' ' PRO . . . . . . . . . . . . . 37.9 Cg_exo -59.72 158.8 26.85 Favored 'Trans proline' 0 N--CA 1.497 1.717 0 C-N-CA 121.359 1.373 . . . . 0.0 111.83 178.295 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' D' D ' 16' ' ' PRO . . . . . . . . . . . . . 26.4 Cg_exo -60.47 -37.96 77.21 Favored 'Trans proline' 0 N--CA 1.498 1.787 0 C-N-CA 121.424 1.416 . . . . 0.0 112.911 -177.347 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' D' D ' 17' ' ' ASP . . . . . . . . . . . . . 22.6 p-10 -89.93 11.01 21.71 Favored 'General case' 0 CA--C 1.537 0.464 0 N-CA-C 113.303 0.853 . . . . 0.0 113.303 -176.47 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' D' D ' 18' ' ' PHE . . . . . . . . . . . . . 51.2 t80 -57.97 -42.81 85.83 Favored 'General case' 0 C--O 1.227 -0.081 0 O-C-N 121.996 -0.44 . . . . 0.0 110.113 -178.933 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' D' D ' 19' ' ' VAL . . . . . . . . . . . . . 48.2 t -57.34 -41.22 77.93 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.306 0 CA-C-N 116.234 -0.439 . . . . 0.0 110.391 -178.624 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' D' D ' 20' ' ' ASP . . . . . . . . . . . . . 79.7 m-20 -59.9 -43.53 94.77 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-O 120.798 0.333 . . . . 0.0 110.876 -177.916 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' D' D ' 21' ' ' VAL . . . . . . . . . . . . . 45.4 t -64.63 -46.46 92.37 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.312 0 C-N-CA 120.719 -0.392 . . . . 0.0 110.527 -177.801 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' D' D ' 22' ' ' ILE . . . . . 0.646 HG22 HD12 ' D' ' 26' ' ' LEU . 50.3 mm -56.44 -45.6 81.86 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.276 0 CA-C-O 120.727 0.299 . . . . 0.0 110.571 179.215 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' D' D ' 23' ' ' ARG . . . . . . . . . . . . . 59.4 ttp180 -53.34 -49.7 66.56 Favored 'General case' 0 C--N 1.331 -0.224 0 CA-C-O 120.835 0.35 . . . . 0.0 111.412 -178.704 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' D' D ' 24' ' ' ILE . . . . . . . . . . . . . 72.9 mt -59.61 -45.76 93.83 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.262 0 CA-C-N 116.281 -0.418 . . . . 0.0 111.136 -177.32 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' D' D ' 25' ' ' LYS . . . . . . . . . . . . . 59.4 mtpt -65.32 -37.35 86.83 Favored 'General case' 0 C--N 1.33 -0.263 0 N-CA-C 112.354 0.502 . . . . 0.0 112.354 -177.121 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' D' D ' 26' ' ' LEU . . . . . 0.646 HD12 HG22 ' D' ' 22' ' ' ILE . 25.9 mt -78.25 -45.68 22.26 Favored 'General case' 0 C--N 1.329 -0.296 0 N-CA-C 112.979 0.733 . . . . 0.0 112.979 -172.781 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' D' D ' 27' ' ' GLN . . . . . . . . . . . . . 16.2 pt20 -46.89 138.52 6.29 Favored 'General case' 0 N--CA 1.468 0.452 0 N-CA-C 112.728 0.64 . . . . 0.0 112.728 -175.68 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' D' D ' 28' ' ' GLY . . . . . . . . . . . . . . . 100.89 -26.6 24.04 Favored Glycine 0 CA--C 1.534 1.223 0 CA-C-N 115.542 -0.754 . . . . 0.0 112.274 -176.596 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' D' D ' 29' ' ' LYS . . . . . . . . . . . . . 65.8 mttm -98.74 155.12 17.51 Favored 'General case' 0 C--N 1.332 -0.154 0 CA-C-N 117.261 0.53 . . . . 0.0 111.217 179.259 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' D' D ' 30' ' ' THR . . . . . . . . . . . . . 17.7 m -102.73 137.13 41.35 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.185 -0.461 . . . . 0.0 110.084 176.128 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' D' D ' 31' ' ' VAL . . . . . . . . . . . . . 33.8 m -130.87 156.88 43.04 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.263 0 CA-C-O 120.816 0.341 . . . . 0.0 110.857 -179.158 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' D' D ' 32' ' ' ARG . . . . . . . . . . . . . 60.9 ttt180 -134.62 150.0 50.63 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 115.992 -0.549 . . . . 0.0 110.218 178.283 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' D' D ' 33' ' ' THR . . . . . . . . . . . . . 31.7 m -52.38 140.17 22.79 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-O 120.826 0.346 . . . . 0.0 111.421 -177.737 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' D' D ' 34' ' ' GLY . . . . . . . . . . . . . . . 99.68 -17.1 57.99 Favored Glycine 0 CA--C 1.531 1.053 0 C-N-CA 121.199 -0.524 . . . . 0.0 113.286 179.105 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' D' D ' 35' ' ' ASP . . . . . . . . . . . . . 72.5 m-20 -65.16 149.1 50.49 Favored 'General case' 0 C--O 1.231 0.101 0 CA-C-N 118.086 0.943 . . . . 0.0 111.141 179.427 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' D' D ' 36' ' ' VAL . . . . . . . . . . . . . 46.1 t -123.1 131.13 73.81 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.223 0 CA-C-N 115.683 -0.69 . . . . 0.0 109.798 178.409 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' D' D ' 37' ' ' ILE . . . . . . . . . . . . . 71.5 mt -119.59 139.79 45.75 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.251 0 CA-C-N 116.166 -0.47 . . . . 0.0 109.958 -179.709 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' D' D ' 38' ' ' GLY . . . . . . . . . . . . . . . -113.01 128.74 8.55 Favored Glycine 0 CA--C 1.526 0.721 0 N-CA-C 111.051 -0.82 . . . . 0.0 111.051 179.492 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' D' D ' 39' ' ' ILE . . . . . . . . . . . . . 68.3 mt -123.28 133.65 68.53 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.185 0 N-CA-C 110.103 -0.332 . . . . 0.0 110.103 179.241 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' D' D ' 40' ' ' SER . . . . . . . . . . . . . 93.4 p -92.69 122.67 35.32 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.394 -0.366 . . . . 0.0 110.729 175.859 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' D' D ' 41' ' ' ILE . . . . . . . . . . . . . 68.2 mt -129.04 119.64 49.76 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.219 0 CA-C-O 120.754 0.312 . . . . 0.0 110.482 178.218 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' D' D ' 42' ' ' LEU . . . . . . . . . . . . . 10.4 tp 51.94 37.21 20.4 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.143 -0.48 . . . . 0.0 111.594 176.907 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' D' D ' 43' ' ' GLY . . . . . . . . . . . . . . . 72.96 30.13 63.84 Favored Glycine 0 CA--C 1.528 0.886 0 C-N-CA 121.007 -0.616 . . . . 0.0 112.34 177.512 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' D' D ' 44' ' ' LYS . . . . . . . . . . . . . 81.9 mttt -136.57 129.39 30.78 Favored 'General case' 0 C--N 1.329 -0.313 0 N-CA-C 109.667 -0.494 . . . . 0.0 109.667 177.925 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' D' D ' 45' ' ' GLU . . . . . . . . . . . . . 85.2 tt0 -83.56 123.42 29.74 Favored 'General case' 0 C--N 1.329 -0.3 0 C-N-CA 120.812 -0.355 . . . . 0.0 111.141 -177.854 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' D' D ' 46' ' ' VAL . . . . . . . . . . . . . 7.7 p -120.97 128.3 76.06 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.231 0 N-CA-C 109.481 -0.563 . . . . 0.0 109.481 175.972 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' D' D ' 47' ' ' LYS . . . . . . . . . . . . . 35.3 mtmm -102.11 129.72 48.52 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 115.809 -0.632 . . . . 0.0 111.645 -179.892 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' D' D ' 48' ' ' PHE . . . . . . . . . . . . . 88.3 m-85 -112.8 131.97 55.46 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.368 -0.378 . . . . 0.0 110.37 177.224 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' D' D ' 49' ' ' LYS . . . . . . . . . . . . . 60.5 tttt -106.01 137.39 44.0 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.517 -0.31 . . . . 0.0 110.576 178.796 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' D' D ' 50' ' ' VAL . . . . . . . . . . . . . 45.5 t -84.82 107.84 16.24 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.241 0 N-CA-C 109.198 -0.667 . . . . 0.0 109.198 174.735 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' D' D ' 51' ' ' VAL . . . . . . . . . . . . . 47.2 t -73.07 -47.61 47.1 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.302 0 CA-C-N 116.153 -0.476 . . . . 0.0 110.159 -173.099 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' D' D ' 52' ' ' GLN . . . . . . . . . . . . . 62.8 tt0 -161.4 139.18 9.16 Favored 'General case' 0 C--N 1.331 -0.226 0 C-N-CA 120.231 -0.588 . . . . 0.0 111.884 -177.321 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' D' D ' 53' ' ' ALA . . . . . . . . . . . . . . . -115.96 133.61 55.85 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 115.655 -0.702 . . . . 0.0 109.609 174.144 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' D' D ' 54' ' ' TYR . . . . . . . . . . . . . 44.3 t80 -128.94 110.77 18.49 Favored Pre-proline 0 CA--C 1.537 0.449 0 CA-C-O 118.112 -0.947 . . . . 0.0 110.489 -179.531 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' D' D ' 55' ' ' PRO . . . . . . . . . . . . . 73.6 Cg_endo -77.13 169.9 73.03 Favored 'Cis proline' 0 N--CA 1.5 1.869 0 CA-C-N 121.853 1.698 . . . . 0.0 112.155 -6.987 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' D' D ' 56' ' ' SER . . . . . . . . . . . . . 49.1 m -117.79 135.01 23.19 Favored Pre-proline 0 CA--C 1.54 0.574 0 CA-C-O 118.42 -0.8 . . . . 0.0 109.949 175.901 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' D' D ' 57' ' ' PRO . . . . . . . . . . . . . 38.3 Cg_endo -68.45 163.73 77.04 Favored 'Cis proline' 0 N--CA 1.498 1.773 0 CA-C-N 121.875 1.705 . . . . 0.0 111.361 -3.754 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' D' D ' 58' ' ' LEU . . . . . . . . . . . . . 37.4 tp -129.78 137.94 50.79 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-O 120.877 0.37 . . . . 0.0 110.595 -179.866 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' D' D ' 59' ' ' ARG . . . . . . . . . . . . . 62.0 ttm-85 -100.62 121.28 41.35 Favored 'General case' 0 C--N 1.326 -0.414 0 N-CA-C 109.142 -0.688 . . . . 0.0 109.142 174.593 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' D' D ' 60' ' ' VAL . . . . . . . . . . . . . 42.3 t -74.54 124.81 32.92 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 C-N-CA 120.778 -0.369 . . . . 0.0 110.391 -173.786 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' D' D ' 61' ' ' GLU . . . . . . . . . . . . . 70.5 mm-40 -131.01 163.39 27.68 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 115.913 -0.585 . . . . 0.0 109.868 177.569 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' D' D ' 62' ' ' ASP . . . . . . . . . . . . . 14.9 p-10 -55.67 -31.64 62.56 Favored 'General case' 0 C--N 1.328 -0.346 0 N-CA-C 111.749 0.278 . . . . 0.0 111.749 -178.898 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' D' D ' 63' ' ' ARG . . . . . . . . . . . . . 10.0 ptm180 -83.68 6.75 19.81 Favored 'General case' 0 CA--C 1.536 0.438 0 N-CA-C 113.553 0.946 . . . . 0.0 113.553 -176.121 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' D' D ' 64' ' ' THR . . . . . . . . . . . . . 29.3 m -85.64 139.68 31.2 Favored 'General case' 0 C--N 1.332 -0.184 0 CA-C-N 118.192 0.451 . . . . 0.0 110.651 -179.074 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' D' D ' 65' ' ' LYS . . . . . . . . . . . . . 38.1 mtmt -89.07 132.6 34.7 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.273 -0.421 . . . . 0.0 110.419 179.657 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' D' D ' 66' ' ' ILE . . . . . . . . . . . . . 61.6 mt -120.38 128.16 75.97 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.221 0 CA-C-N 116.366 -0.379 . . . . 0.0 110.046 -177.244 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' D' D ' 67' ' ' THR . . . . . . . . . . . . . 27.8 m -130.21 142.65 50.55 Favored 'General case' 0 C--N 1.332 -0.177 0 CA-C-O 120.978 0.418 . . . . 0.0 111.234 -178.638 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' D' D ' 68' ' ' LEU . . . . . 0.456 ' N ' HD12 ' D' ' 68' ' ' LEU . 7.2 mp -107.09 140.53 39.77 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.049 -0.523 . . . . 0.0 110.65 177.827 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' D' D ' 69' ' ' VAL . . . . . . . . . . . . . 43.2 t -100.18 126.53 53.68 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.263 0 CA-C-N 116.209 -0.451 . . . . 0.0 109.976 177.129 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' D' D ' 70' ' ' THR . . . . . . . . . . . . . 81.8 p -148.41 169.17 20.78 Favored 'General case' 0 C--N 1.332 -0.195 0 CA-C-O 120.91 0.386 . . . . 0.0 111.192 -179.585 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' D' D ' 71' ' ' HIS . . . . . . . . . . . . . 6.1 m-70 -136.77 157.13 75.52 Favored Pre-proline 0 C--N 1.329 -0.301 0 CA-C-N 115.882 -0.599 . . . . 0.0 109.952 177.591 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' D' D ' 72' ' ' PRO . . . . . 0.523 ' O ' HG13 ' D' ' 73' ' ' VAL . 56.0 Cg_endo -71.07 -30.24 16.62 Favored 'Trans proline' 0 N--CA 1.497 1.688 0 C-N-CA 121.128 1.219 . . . . 0.0 112.397 -179.38 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' D' D ' 73' ' ' VAL . . . . . 0.523 HG13 ' O ' ' D' ' 72' ' ' PRO . 2.5 m -158.97 132.83 1.32 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.214 0 CA-C-N 116.224 -0.444 . . . . 0.0 110.262 176.242 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' D' D ' 74' ' ' ASP . . . . . . . . . . . . . 15.3 t0 -99.06 118.81 36.67 Favored 'General case' 0 C--N 1.325 -0.497 0 N-CA-C 108.829 -0.804 . . . . 0.0 108.829 173.894 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' D' D ' 75' ' ' VAL . . . . . . . . . . . . . 47.8 t -110.19 122.04 64.07 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.218 0 CA-C-O 121.132 0.491 . . . . 0.0 110.671 -176.325 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' D' D ' 76' ' ' LEU . . . . . . . . . . . . . 5.1 mp -124.08 138.66 54.41 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 115.657 -0.701 . . . . 0.0 109.28 174.5 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' D' D ' 77' ' ' GLU . . . . . . . . . . . . . 69.3 tt0 -134.37 136.9 43.71 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-O 120.955 0.407 . . . . 0.0 110.803 -177.801 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' D' D ' 78' ' ' ALA . . . . . . . . . . . . . . . -121.52 138.59 54.23 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 115.959 -0.564 . . . . 0.0 110.434 178.774 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' D' D ' 79' ' ' LYS . . . . . 0.581 ' O ' HD13 ' D' ' 80' ' ' ILE . 7.6 ttpm? -77.75 115.38 17.46 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 116.438 -0.346 . . . . 0.0 110.419 179.582 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' D' D ' 80' ' ' ILE . . . . . 0.581 HD13 ' O ' ' D' ' 79' ' ' LYS . 42.1 mm -139.06 108.09 3.68 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.273 0 N-CA-C 109.328 -0.619 . . . . 0.0 109.328 -178.369 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' D' D ' 81' ' ' LYS . . . . . . . . . . . . . 55.1 pttt -106.76 129.82 54.57 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-O 120.921 0.391 . . . . 0.0 111.518 -176.33 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' D' D ' 82' ' ' GLY . . . . . . . . . . . . . . . 88.95 42.19 5.72 Favored Glycine 0 CA--C 1.526 0.778 0 N-CA-C 111.529 -0.628 . . . . 0.0 111.529 176.752 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' D' D ' 83' ' ' ILE . . . . . . . . . . . . . 73.3 mt -71.92 138.76 20.95 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.32 0 N-CA-C 109.718 -0.475 . . . . 0.0 109.718 178.064 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' D' D ' 84' ' ' LYS . . . . . . . . . . . . . 50.4 tttp -95.7 -53.87 3.56 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 116.023 -0.535 . . . . 0.0 110.207 -178.136 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' D' D ' 85' ' ' ASP . . . . . . . . . . . . . 8.3 t70 -152.55 152.26 31.66 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 115.795 -0.639 . . . . 0.0 110.14 -179.594 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' D' D ' 86' ' ' VAL . . . . . . . . . . . . . 46.6 t -127.74 129.07 70.01 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.224 0 CA-C-O 120.883 0.373 . . . . 0.0 110.44 -179.041 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' D' D ' 87' ' ' ILE . . . . . . . . . . . . . 44.5 mm -117.97 127.5 75.2 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.217 0 CA-C-N 115.941 -0.572 . . . . 0.0 109.461 176.682 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' D' D ' 88' ' ' LEU . . . . . . . . . . . . . 12.5 tp -113.98 131.63 56.26 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-O 120.998 0.427 . . . . 0.0 111.154 -176.861 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' D' D ' 89' ' ' ASP . . . . . . . . . . . . . 13.8 t70 -123.88 152.08 42.76 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 115.78 -0.646 . . . . 0.0 109.432 176.837 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' D' D ' 90' ' ' GLU . . . . . . . . . . . . . 46.2 tp10 -47.84 -36.85 12.65 Favored 'General case' 0 CA--C 1.531 0.242 0 N-CA-C 112.735 0.643 . . . . 0.0 112.735 -172.967 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' D' D ' 91' ' ' ASN . . . . . . . . . . . . . 28.7 m120 -132.02 32.39 4.04 Favored 'General case' 0 N--CA 1.466 0.338 0 C-N-CA 120.846 -0.342 . . . . 0.0 111.916 -176.508 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' D' D ' 92' ' ' LEU . . . . . . . . . . . . . 9.7 tp -166.11 148.14 6.97 Favored 'General case' 0 C--N 1.329 -0.291 0 C-N-CA 121.008 -0.277 . . . . 0.0 110.591 -179.839 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' D' D ' 93' ' ' ILE . . . . . . . . . . . . . 64.1 mt -127.06 124.54 64.68 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.284 0 N-CA-C 109.58 -0.526 . . . . 0.0 109.58 -179.356 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' D' D ' 94' ' ' VAL . . . . . 0.624 HG21 HG11 ' D' ' 125' ' ' VAL . 46.7 t -124.08 127.74 73.64 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.234 0 CA-C-O 121.004 0.431 . . . . 0.0 110.181 179.99 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' D' D ' 95' ' ' VAL . . . . . . . . . . . . . 44.6 t -121.88 135.47 61.9 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.261 0 CA-C-N 116.054 -0.521 . . . . 0.0 109.931 179.984 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' D' D ' 96' ' ' ILE . . . . . . . . . . . . . 66.2 mt -116.3 129.49 72.64 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 N-CA-C 109.356 -0.609 . . . . 0.0 109.356 178.82 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' D' D ' 97' ' ' THR . . . . . . . . . . . . . 79.6 p -100.0 158.48 15.8 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-O 121.02 0.438 . . . . 0.0 111.105 -177.334 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' D' D ' 98' ' ' GLU . . . . . . . . . . . . . 97.1 mt-10 -54.06 -26.36 26.43 Favored 'General case' 0 C--N 1.329 -0.288 0 N-CA-C 112.219 0.451 . . . . 0.0 112.219 -179.795 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' D' D ' 99' ' ' GLU . . . . . . . . . . . . . 41.0 mt-10 -80.04 16.85 1.1 Allowed 'General case' 0 CA--C 1.536 0.412 0 N-CA-C 112.99 0.737 . . . . 0.0 112.99 -177.759 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' D' D ' 100' ' ' ASN . . . . . . . . . . . . . 3.3 m-20 63.16 37.94 10.99 Favored 'General case' 0 N--CA 1.463 0.197 0 CA-C-O 121.05 0.452 . . . . 0.0 111.085 177.453 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' D' D ' 101' ' ' GLU . . . . . . . . . . . . . 98.2 mt-10 -112.18 146.0 38.87 Favored 'General case' 0 C--N 1.332 -0.162 0 CA-C-N 116.2 -0.455 . . . . 0.0 110.419 174.981 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' D' D ' 102' ' ' VAL . . . . . 0.449 ' C ' HD12 ' D' ' 103' ' ' LEU . 45.3 t -117.01 127.18 74.69 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.363 0 CA-C-N 115.762 -0.654 . . . . 0.0 109.606 179.134 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' D' D ' 103' ' ' LEU . . . . . 0.449 HD12 ' C ' ' D' ' 102' ' ' VAL . 7.4 mp -119.45 129.76 54.92 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 115.883 -0.599 . . . . 0.0 110.207 175.716 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' D' D ' 104' ' ' ILE . . . . . . . . . . . . . 73.8 mt -114.13 122.22 67.81 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.335 0 CA-C-N 116.024 -0.534 . . . . 0.0 109.885 -179.341 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' D' D ' 105' ' ' PHE . . . . . . . . . . . . . 85.8 m-85 -119.23 160.03 22.94 Favored 'General case' 0 C--N 1.331 -0.229 0 O-C-N 124.17 0.919 . . . . 0.0 109.894 179.96 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' D' D ' 106' ' ' ASN . . . . . . . . . . . . . 42.8 p-10 -95.04 -170.22 2.15 Favored 'General case' 0 C--N 1.329 -0.321 0 N-CA-C 109.557 -0.534 . . . . 0.0 109.557 172.799 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' D' D ' 107' ' ' GLN . . . . . . . . . . . . . 58.2 tt0 -61.07 -25.57 67.03 Favored 'General case' 0 C--N 1.329 -0.314 0 N-CA-C 112.123 0.416 . . . . 0.0 112.123 178.54 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' D' D ' 108' ' ' ASN . . . . . . . . . . . . . 5.7 t-20 -83.66 3.2 33.93 Favored 'General case' 0 CA--C 1.538 0.518 0 N-CA-C 113.133 0.79 . . . . 0.0 113.133 -178.703 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' D' D ' 109' ' ' LEU . . . . . . . . . . . . . 9.1 tp 62.86 37.23 12.35 Favored 'General case' 0 C--O 1.232 0.151 0 CA-C-O 120.945 0.402 . . . . 0.0 111.36 179.39 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' D' D ' 110' ' ' GLU . . . . . . . . . . . . . 96.3 mt-10 -106.82 149.95 26.86 Favored 'General case' 0 C--N 1.331 -0.216 0 N-CA-C 110.025 -0.361 . . . . 0.0 110.025 176.458 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' D' D ' 111' ' ' GLU . . . . . . . . . . . . . 43.0 tp10 -79.67 121.98 25.98 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-O 121.114 0.483 . . . . 0.0 110.803 -176.889 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' D' D ' 112' ' ' LEU . . . . . . . . . . . . . 28.4 mt -103.93 -46.08 4.58 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 115.747 -0.661 . . . . 0.0 110.119 176.541 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' D' D ' 113' ' ' TYR . . . . . . . . . . . . . 65.2 t80 -142.53 135.5 28.37 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.226 -0.443 . . . . 0.0 111.33 -179.614 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' D' D ' 114' ' ' ARG . . . . . . . . . . . . . 79.0 ttt-85 -139.98 121.94 15.62 Favored 'General case' 0 C--N 1.331 -0.229 0 CA-C-N 116.321 -0.399 . . . . 0.0 110.121 177.17 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' D' D ' 115' ' ' GLY . . . . . . . . . . . . . . . -150.15 161.98 29.07 Favored Glycine 0 CA--C 1.525 0.656 0 N-CA-C 110.982 -0.847 . . . . 0.0 110.982 -178.761 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' D' D ' 116' ' ' LYS . . . . . . . . . . . . . 39.0 ttpt -120.08 137.32 54.2 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-O 120.741 0.305 . . . . 0.0 110.307 178.622 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' D' D ' 117' ' ' PHE . . . . . . . . . . . . . 31.6 m-85 -133.39 113.95 13.13 Favored 'General case' 0 C--N 1.33 -0.244 0 N-CA-C 109.859 -0.423 . . . . 0.0 109.859 179.224 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' D' D ' 118' ' ' GLU . . . . . . . . . . . . . 95.9 mt-10 -55.72 -44.8 77.83 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.33 -0.396 . . . . 0.0 111.228 -174.898 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' D' D ' 119' ' ' ASN . . . . . . . . . . . . . 20.2 m120 -95.89 30.93 2.23 Favored 'General case' 0 C--N 1.33 -0.275 0 N-CA-C 112.132 0.419 . . . . 0.0 112.132 -174.11 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' D' D ' 120' ' ' LEU . . . . . . . . . . . . . 13.3 tp -57.35 119.74 6.99 Favored 'General case' 0 C--N 1.334 -0.083 0 C-N-CA 120.984 -0.287 . . . . 0.0 110.259 178.078 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' D' D ' 121' ' ' ASN . . . . . . . . . . . . . 73.4 m-20 -114.12 -44.06 3.17 Favored 'General case' 0 C--N 1.332 -0.156 0 CA-C-N 116.409 -0.359 . . . . 0.0 111.118 -178.405 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' D' D ' 122' ' ' LYS . . . . . . . . . . . . . 63.1 mtpt -141.96 148.73 39.09 Favored 'General case' 0 C--N 1.331 -0.219 0 CA-C-O 121.079 0.466 . . . . 0.0 111.607 -176.611 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' D' D ' 123' ' ' VAL . . . . . . . . . . . . . 43.9 t -131.53 125.9 57.1 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.252 0 CA-C-N 115.854 -0.612 . . . . 0.0 109.512 174.565 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' D' D ' 124' ' ' LEU . . . . . . . . . . . . . 49.7 mt -122.79 137.46 54.92 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-O 120.74 0.305 . . . . 0.0 110.697 -178.157 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' D' D ' 125' ' ' VAL . . . . . 0.624 HG11 HG21 ' D' ' 94' ' ' VAL . 34.8 m -129.69 130.1 66.69 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.25 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.789 179.735 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' D' D ' 126' ' ' ARG . . . . . . . . . . . . . 83.0 mtt180 -144.94 118.96 9.37 Favored 'General case' 0 C--N 1.328 -0.348 0 N-CA-C 109.56 -0.533 . . . . 0.0 109.56 177.164 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' D' D ' 127' ' ' ASN . . . . . . . . . . . . . 30.8 m120 56.73 -149.05 0.47 Allowed 'General case' 0 CA--C 1.54 0.596 0 N-CA-C 109.648 -0.501 . . . . 0.0 109.648 -178.229 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' D' D ' 128' ' ' ASP . . . . . . . . . . . . . 23.3 p-10 -82.41 12.96 3.92 Favored 'General case' 0 CA--C 1.536 0.429 0 CA-C-N 118.773 0.715 . . . . 0.0 112.88 178.364 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' D' D ' 129' ' ' LEU . . . . . . . . . . . . . 16.1 tp -108.64 134.98 50.64 Favored 'General case' 0 C--O 1.233 0.196 0 CA-C-N 118.261 0.482 . . . . 0.0 110.088 178.637 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' D' D ' 130' ' ' VAL . . . . . . . . . . . . . 44.0 t -126.26 141.36 46.05 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.303 0 CA-C-O 120.929 0.395 . . . . 0.0 110.623 -177.539 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' D' D ' 131' ' ' VAL . . . . . . . . . . . . . 42.6 t -133.63 133.99 56.8 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.305 0 CA-C-N 116.049 -0.523 . . . . 0.0 110.126 177.994 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' D' D ' 132' ' ' ILE . . . . . . . . . . . . . 65.8 mt -118.41 134.0 63.42 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.343 0 N-CA-C 109.364 -0.606 . . . . 0.0 109.364 178.834 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' D' D ' 133' ' ' ILE . . . . . . . . . . . . . 37.6 mm -117.14 123.56 71.96 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.254 0 CA-C-O 120.619 0.247 . . . . 0.0 111.122 -174.367 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' D' D ' 134' ' ' ASP . . . . . . . . . . . . . 9.8 p-10 -135.82 147.62 48.36 Favored 'General case' 0 C--N 1.331 -0.202 0 N-CA-C 109.537 -0.542 . . . . 0.0 109.537 173.295 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' D' D ' 135' ' ' GLU . . . . . . . . . . . . . 85.2 tt0 -49.9 -27.7 5.58 Favored 'General case' 0 C--N 1.328 -0.356 0 N-CA-C 112.89 0.7 . . . . 0.0 112.89 -170.184 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' D' D ' 136' ' ' GLN . . . . . . . . . . . . . 98.0 mt-30 -82.21 -40.03 22.26 Favored 'General case' 0 C--O 1.235 0.297 0 N-CA-C 112.185 0.439 . . . . 0.0 112.185 -176.92 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' D' D ' 137' ' ' LYS . . . . . . . . . . . . . 56.6 pttt -156.73 167.04 31.66 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-O 121.523 0.678 . . . . 0.0 112.294 -169.745 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' D' D ' 138' ' ' LEU . . . . . . . . . . . . . 6.0 tt -116.24 127.74 55.01 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 115.06 -0.973 . . . . 0.0 109.664 178.156 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' D' D ' 139' ' ' THR . . . . . . . . . . . . . 29.0 m -106.71 126.62 52.52 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-N 116.281 -0.418 . . . . 0.0 110.712 -178.313 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' D' D ' 140' ' ' LEU . . . . . . . . . . . . . 21.1 tp -111.51 122.83 48.86 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 115.664 -0.698 . . . . 0.0 109.191 179.553 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' D' D ' 141' ' ' ILE . . . . . . . . . . . . . 19.5 mt -121.16 118.89 57.61 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.279 0 N-CA-C 109.87 -0.419 . . . . 0.0 109.87 -174.664 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' D' D ' 142' ' ' ARG . . . . . . . . . . . . . 48.5 mtm180 -109.0 127.97 54.55 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 115.481 -0.781 . . . . 0.0 110.098 -178.527 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' D' D ' 143' ' ' THR . . . . . . . . . . . . . 6.9 p . . . . . 0 C--O 1.22 -0.497 0 CA-C-O 117.989 -1.005 . . . . 0.0 110.61 -179.472 . . . . . . . . 0 0 . 1 . 008 nuclear build full ' E' E ' -3' ' ' GLU . . . . . . . . . . . . . 95.9 mt-10 . . . . . 0 N--CA 1.489 1.523 0 N-CA-C 109.432 -0.581 . . . . 0.0 109.432 . . . . . . . . . 0 0 . 1 . 008 nuclear build full ' E' E ' -2' ' ' GLY . . . . . . . . . . . . . . . -69.71 130.89 23.34 Favored Glycine 0 CA--C 1.526 0.737 0 N-CA-C 111.065 -0.814 . . . . 0.0 111.065 -179.444 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' E' E ' -1' ' ' VAL . . . . . . . . . . . . . 45.4 t -141.4 140.85 31.19 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.285 0 N-CA-C 109.806 -0.442 . . . . 0.0 109.806 179.271 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' E' E ' 0' ' ' ILE . . . . . . . . . . . . . 71.6 mt -107.72 135.95 44.67 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.288 0 CA-C-O 120.89 0.376 . . . . 0.0 110.078 -178.748 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' E' E ' 1' ' ' MET . . . . . . . . . . . . . 26.1 ptm -78.67 138.41 38.28 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 116.011 -0.541 . . . . 0.0 110.549 179.397 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' E' E ' 2' ' ' SER . . . . . . . . . . . . . 2.9 p -128.59 130.56 47.52 Favored 'General case' 0 C--N 1.331 -0.201 0 CA-C-N 116.24 -0.436 . . . . 0.0 110.449 179.101 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' E' E ' 3' ' ' GLU . . . . . . . . . . . . . 84.7 tt0 -141.99 141.59 32.88 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.089 -0.505 . . . . 0.0 111.06 -179.302 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' E' E ' 4' ' ' LEU . . . . . . . . . . . . . 17.0 tp -126.12 126.86 44.85 Favored 'General case' 0 C--N 1.332 -0.195 0 CA-C-N 116.136 -0.483 . . . . 0.0 110.257 177.664 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' E' E ' 5' ' ' LYS . . . . . . . . . . . . . 61.6 mttp -107.06 121.39 44.39 Favored 'General case' 0 C--O 1.235 0.319 0 CA-C-N 116.251 -0.431 . . . . 0.0 110.7 178.5 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' E' E ' 6' ' ' LEU . . . . . . . . . . . . . 72.6 mt -116.84 146.25 43.02 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 115.326 -0.852 . . . . 0.0 110.46 -178.784 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' E' E ' 7' ' ' LYS . . . . . . . . . . . . . 55.6 tttm -135.24 139.75 32.55 Favored Pre-proline 0 CA--C 1.534 0.351 0 CA-C-O 119.135 -0.459 . . . . 0.0 110.361 176.927 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' E' E ' 8' ' ' PRO . . . . . . . . . . . . . 84.7 Cg_endo -91.85 139.46 2.19 Favored 'Trans proline' 0 N--CA 1.489 1.262 0 C-N-CA 121.694 1.596 . . . . 0.0 111.632 176.602 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' E' E ' 9' ' ' LEU . . . . . . . . . . . . . 38.7 mt -76.03 -48.4 3.52 Favored Pre-proline 0 CA--C 1.534 0.363 0 CA-C-O 118.631 -0.7 . . . . 0.0 112.569 -178.036 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' E' E ' 10' ' ' PRO . . . . . . . . . . . . . 91.3 Cg_endo -80.06 157.13 23.49 Favored 'Trans proline' 0 N--CA 1.497 1.723 0 C-N-CA 121.315 1.343 . . . . 0.0 111.912 178.126 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' E' E ' 11' ' ' LYS . . . . . . . . . . . . . 17.4 pttp -83.17 112.54 19.93 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-O 121.55 0.691 . . . . 0.0 110.428 176.84 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' E' E ' 12' ' ' VAL . . . . . . . . . . . . . 12.5 p -151.13 151.19 12.65 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.248 0 CA-C-N 115.629 -0.714 . . . . 0.0 110.58 -178.769 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' E' E ' 13' ' ' GLU . . . . . . . . . . . . . 96.5 mt-10 -97.71 121.68 39.9 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.3 -0.409 . . . . 0.0 110.351 177.679 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' E' E ' 14' ' ' LEU . . . . . . . . . . . . . 39.4 mt -98.45 137.65 20.72 Favored Pre-proline 0 CA--C 1.534 0.351 0 CA-C-O 118.808 -0.615 . . . . 0.0 110.213 -179.377 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' E' E ' 15' ' ' PRO . . . . . . . . . . . . . 25.3 Cg_exo -62.59 162.24 25.25 Favored 'Trans proline' 0 N--CA 1.498 1.765 0 C-N-CA 121.299 1.333 . . . . 0.0 112.013 176.942 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' E' E ' 16' ' ' PRO . . . . . . . . . . . . . 28.1 Cg_exo -59.95 -32.71 95.48 Favored 'Trans proline' 0 N--CA 1.497 1.691 0 C-N-CA 121.568 1.512 . . . . 0.0 112.931 -178.219 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' E' E ' 17' ' ' ASP . . . . . . . . . . . . . 10.1 p-10 -81.52 -3.93 54.54 Favored 'General case' 0 CA--C 1.535 0.383 0 N-CA-C 113.357 0.873 . . . . 0.0 113.357 -177.451 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' E' E ' 18' ' ' PHE . . . . . . . . . . . . . 30.0 t80 -56.62 -44.49 81.24 Favored 'General case' 0 C--N 1.334 -0.09 0 O-C-N 121.885 -0.509 . . . . 0.0 110.242 -179.182 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' E' E ' 19' ' ' VAL . . . . . . . . . . . . . 14.4 p -57.38 -40.67 75.66 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.329 0 CA-C-N 116.346 -0.388 . . . . 0.0 110.698 -179.707 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' E' E ' 20' ' ' ASP . . . . . . . . . . . . . 8.2 t70 -60.33 -42.74 96.29 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-O 120.921 0.391 . . . . 0.0 110.781 -177.827 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' E' E ' 21' ' ' VAL . . . . . . . . . . . . . 46.4 t -64.46 -47.33 89.78 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.297 0 CA-C-N 116.331 -0.395 . . . . 0.0 110.476 -177.751 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' E' E ' 22' ' ' ILE . . . . . 0.448 HG22 HD12 ' E' ' 26' ' ' LEU . 49.1 mm -57.5 -42.04 80.11 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.362 0 C-N-CA 120.934 -0.306 . . . . 0.0 110.673 -179.633 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' E' E ' 23' ' ' ARG . . . . . . . . . . . . . 61.9 ttp180 -54.8 -51.09 66.87 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-O 120.981 0.42 . . . . 0.0 110.9 178.935 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' E' E ' 24' ' ' ILE . . . . . . . . . . . . . 73.0 mt -60.85 -41.64 89.47 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.355 0 CA-C-N 115.92 -0.582 . . . . 0.0 111.764 -176.564 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' E' E ' 25' ' ' LYS . . . . . . . . . . . . . 15.1 ptpt -70.39 -39.64 74.4 Favored 'General case' 0 CA--C 1.535 0.373 0 N-CA-C 112.174 0.435 . . . . 0.0 112.174 -174.804 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' E' E ' 26' ' ' LEU . . . . . 0.448 HD12 HG22 ' E' ' 22' ' ' ILE . 15.4 mt -78.87 -39.27 35.61 Favored 'General case' 0 C--N 1.33 -0.278 0 N-CA-C 113.268 0.84 . . . . 0.0 113.268 -171.291 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' E' E ' 27' ' ' GLN . . . . . . . . . . . . . 16.1 pt20 -47.0 135.69 9.21 Favored 'General case' 0 N--CA 1.469 0.499 0 N-CA-C 112.763 0.653 . . . . 0.0 112.763 -175.13 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' E' E ' 28' ' ' GLY . . . . . . . . . . . . . . . 101.05 -24.02 33.44 Favored Glycine 0 CA--C 1.534 1.259 0 CA-C-N 115.606 -0.725 . . . . 0.0 112.378 -176.784 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' E' E ' 29' ' ' LYS . . . . . . . . . . . . . 91.8 mttt -98.82 155.17 17.51 Favored 'General case' 0 C--O 1.233 0.208 0 CA-C-N 117.443 0.622 . . . . 0.0 111.311 179.534 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' E' E ' 30' ' ' THR . . . . . . . . . . . . . 28.8 m -109.39 138.57 45.55 Favored 'General case' 0 C--N 1.331 -0.209 0 CA-C-N 116.27 -0.423 . . . . 0.0 110.005 175.841 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' E' E ' 31' ' ' VAL . . . . . . . . . . . . . 34.5 m -132.13 160.92 42.16 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.22 0 CA-C-N 116.392 -0.367 . . . . 0.0 110.857 -178.95 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' E' E ' 32' ' ' ARG . . . . . . . . . . . . . 63.5 mtt85 -130.44 149.04 52.3 Favored 'General case' 0 C--N 1.332 -0.19 0 CA-C-O 121.199 0.523 . . . . 0.0 110.667 177.303 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' E' E ' 33' ' ' THR . . . . . . . . . . . . . 31.5 m -53.59 141.38 25.91 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.129 -0.487 . . . . 0.0 111.259 -179.581 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' E' E ' 34' ' ' GLY . . . . . . . . . . . . . . . 99.28 -17.16 58.27 Favored Glycine 0 CA--C 1.533 1.2 0 CA-C-O 119.643 -0.532 . . . . 0.0 113.156 179.874 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' E' E ' 35' ' ' ASP . . . . . . . . . . . . . 78.8 m-20 -66.5 147.72 52.9 Favored 'General case' 0 C--O 1.232 0.145 0 CA-C-N 118.026 0.913 . . . . 0.0 110.999 178.163 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' E' E ' 36' ' ' VAL . . . . . . . . . . . . . 46.9 t -119.85 129.78 74.99 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.212 0 CA-C-N 115.829 -0.623 . . . . 0.0 109.829 178.611 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' E' E ' 37' ' ' ILE . . . . . . . . . . . . . 66.7 mt -120.13 138.18 51.55 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.269 0 N-CA-C 109.748 -0.464 . . . . 0.0 109.748 179.833 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' E' E ' 38' ' ' GLY . . . . . . . . . . . . . . . -113.77 128.78 8.46 Favored Glycine 0 CA--C 1.524 0.624 0 N-CA-C 111.389 -0.684 . . . . 0.0 111.389 -179.024 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' E' E ' 39' ' ' ILE . . . . . . . . . . . . . 71.2 mt -122.51 126.74 74.52 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.24 0 N-CA-C 109.747 -0.464 . . . . 0.0 109.747 177.336 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' E' E ' 40' ' ' SER . . . . . . . . . . . . . 43.1 t -92.16 119.51 31.88 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.442 -0.344 . . . . 0.0 110.786 177.162 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' E' E ' 41' ' ' ILE . . . . . . . . . . . . . 71.8 mt -131.47 123.9 53.55 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.225 0 N-CA-C 110.052 -0.351 . . . . 0.0 110.052 178.594 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' E' E ' 42' ' ' LEU . . . . . . . . . . . . . 82.6 mt 57.8 33.74 23.58 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.2 -0.455 . . . . 0.0 111.87 178.485 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' E' E ' 43' ' ' GLY . . . . . . . . . . . . . . . 77.87 -10.15 27.25 Favored Glycine 0 CA--C 1.535 1.306 0 C-N-CA 121.274 -0.489 . . . . 0.0 113.431 177.79 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' E' E ' 44' ' ' LYS . . . . . . . . . . . . . 62.8 tttm -98.78 127.24 44.65 Favored 'General case' 0 C--O 1.232 0.138 0 CA-C-N 117.808 0.804 . . . . 0.0 109.696 176.723 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' E' E ' 45' ' ' GLU . . . . . . . . . . . . . 39.2 tp10 -84.76 126.84 33.77 Favored 'General case' 0 C--N 1.328 -0.336 0 C-N-CA 120.811 -0.356 . . . . 0.0 110.662 -179.935 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' E' E ' 46' ' ' VAL . . . . . . . . . . . . . 7.6 p -117.09 128.71 74.41 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.199 0 N-CA-C 109.368 -0.604 . . . . 0.0 109.368 176.585 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' E' E ' 47' ' ' LYS . . . . . . . . . . . . . 64.6 mttp -100.32 129.35 46.29 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 115.884 -0.598 . . . . 0.0 111.142 179.052 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' E' E ' 48' ' ' PHE . . . . . . . . . . . . . 93.5 m-85 -112.19 131.86 55.23 Favored 'General case' 0 C--N 1.33 -0.27 0 N-CA-C 109.604 -0.517 . . . . 0.0 109.604 175.889 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' E' E ' 49' ' ' LYS . . . . . . . . . . . . . 52.5 tttp -108.05 135.46 49.37 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 116.434 -0.348 . . . . 0.0 110.332 179.244 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' E' E ' 50' ' ' VAL . . . . . . . . . . . . . 46.2 t -78.43 106.53 9.29 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.281 0 N-CA-C 108.954 -0.758 . . . . 0.0 108.954 175.317 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' E' E ' 51' ' ' VAL . . . . . . . . . . . . . 51.5 t -71.74 -47.05 58.89 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.319 0 CA-C-N 116.18 -0.464 . . . . 0.0 110.106 -172.98 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' E' E ' 52' ' ' GLN . . . . . . . . . . . . . 46.9 tt0 -163.5 136.86 5.6 Favored 'General case' 0 C--N 1.329 -0.297 0 C-N-CA 120.175 -0.61 . . . . 0.0 111.834 -178.281 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' E' E ' 53' ' ' ALA . . . . . . . . . . . . . . . -113.01 134.36 54.55 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 115.721 -0.672 . . . . 0.0 109.699 174.566 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' E' E ' 54' ' ' TYR . . . . . . . . . . . . . 24.8 t80 -129.03 111.28 18.4 Favored Pre-proline 0 CA--C 1.536 0.419 0 CA-C-O 118.17 -0.919 . . . . 0.0 110.555 -179.889 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' E' E ' 55' ' ' PRO . . . . . . . . . . . . . 73.6 Cg_endo -77.08 168.8 76.03 Favored 'Cis proline' 0 N--CA 1.501 1.946 0 CA-C-N 121.899 1.714 . . . . 0.0 112.068 -7.245 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' E' E ' 56' ' ' SER . . . . . . . . . . . . . 27.0 m -115.04 131.27 23.61 Favored Pre-proline 0 CA--C 1.539 0.525 0 CA-C-O 118.456 -0.783 . . . . 0.0 109.533 176.24 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' E' E ' 57' ' ' PRO . . . . . . . . . . . . . 36.5 Cg_endo -66.6 164.17 68.67 Favored 'Cis proline' 0 N--CA 1.496 1.671 0 CA-C-N 121.957 1.734 . . . . 0.0 111.503 -1.501 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' E' E ' 58' ' ' LEU . . . . . . . . . . . . . 28.7 tp -129.45 135.47 48.7 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.436 -0.347 . . . . 0.0 110.623 -179.693 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' E' E ' 59' ' ' ARG . . . . . . . . . . . . . 73.5 ttt-85 -103.21 127.2 50.59 Favored 'General case' 0 C--N 1.327 -0.4 0 N-CA-C 109.028 -0.73 . . . . 0.0 109.028 175.504 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' E' E ' 60' ' ' VAL . . . . . . . . . . . . . 40.1 t -87.41 124.39 40.75 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.305 0 C-N-CA 120.767 -0.373 . . . . 0.0 110.878 -173.071 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' E' E ' 61' ' ' GLU . . . . . . . . . . . . . 40.6 mt-10 -131.01 166.52 20.82 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.01 -0.541 . . . . 0.0 109.703 176.002 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' E' E ' 62' ' ' ASP . . . . . . . . . . . . . 5.5 t70 -53.57 -32.92 52.87 Favored 'General case' 0 C--N 1.329 -0.318 0 N-CA-C 111.746 0.276 . . . . 0.0 111.746 -179.166 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' E' E ' 63' ' ' ARG . . . . . . . . . . . . . 35.2 mmt180 -73.51 -19.07 61.02 Favored 'General case' 0 N--CA 1.465 0.318 0 N-CA-C 113.023 0.749 . . . . 0.0 113.023 -176.863 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' E' E ' 64' ' ' THR . . . . . . . . . . . . . 25.0 m -66.23 141.9 57.89 Favored 'General case' 0 C--N 1.331 -0.2 0 CA-C-O 120.862 0.363 . . . . 0.0 110.876 -174.935 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' E' E ' 65' ' ' LYS . . . . . . . . . . . . . 92.1 mttt -87.83 128.71 35.34 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 115.995 -0.548 . . . . 0.0 109.893 178.285 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' E' E ' 66' ' ' ILE . . . . . . . . . . . . . 51.7 mt -116.18 131.24 69.27 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 N-CA-C 110.036 -0.357 . . . . 0.0 110.036 179.82 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' E' E ' 67' ' ' THR . . . . . . . . . . . . . 22.5 m -127.26 135.82 51.13 Favored 'General case' 0 C--N 1.332 -0.157 0 CA-C-O 121.036 0.446 . . . . 0.0 110.948 -179.89 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' E' E ' 68' ' ' LEU . . . . . . . . . . . . . 32.8 mt -107.93 133.33 52.43 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 115.938 -0.574 . . . . 0.0 110.337 176.918 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' E' E ' 69' ' ' VAL . . . . . . . . . . . . . 43.2 t -97.31 138.66 21.63 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.307 0 CA-C-N 116.356 -0.384 . . . . 0.0 110.328 179.579 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' E' E ' 70' ' ' THR . . . . . . . . . . . . . 7.9 t -146.02 -33.42 0.33 Allowed 'General case' 0 C--N 1.331 -0.224 0 N-CA-C 111.913 0.338 . . . . 0.0 111.913 -178.067 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' E' E ' 71' ' ' HIS . . . . . . . . . . . . . 15.4 m80 -117.92 90.4 36.68 Favored Pre-proline 0 CA--C 1.534 0.359 0 CA-C-O 119.5 -0.286 . . . . 0.0 110.952 -176.484 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' E' E ' 72' ' ' PRO . . . . . . . . . . . . . 58.4 Cg_endo -71.32 -15.22 31.46 Favored 'Trans proline' 0 N--CA 1.498 1.744 0 C-N-CA 121.402 1.401 . . . . 0.0 113.737 -178.433 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' E' E ' 73' ' ' VAL . . . . . . . . . . . . . 33.5 m -114.59 163.69 11.61 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.281 0 CA-C-O 121.019 0.438 . . . . 0.0 110.784 -178.174 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' E' E ' 74' ' ' ASP . . . . . . . . . . . . . 5.0 t70 -100.13 120.12 39.38 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 115.859 -0.609 . . . . 0.0 109.795 -178.613 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' E' E ' 75' ' ' VAL . . . . . . . . . . . . . 44.0 t -119.75 126.4 75.27 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.246 0 CA-C-O 121.014 0.435 . . . . 0.0 110.749 -176.262 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' E' E ' 76' ' ' LEU . . . . . . . . . . . . . 5.9 mp -124.03 149.65 45.83 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 115.671 -0.695 . . . . 0.0 109.683 175.503 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' E' E ' 77' ' ' GLU . . . . . . . . . . . . . 96.2 mt-10 -136.01 131.54 35.14 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-O 121.022 0.439 . . . . 0.0 110.989 -178.646 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' E' E ' 78' ' ' ALA . . . . . . . . . . . . . . . -115.12 140.8 48.77 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 115.71 -0.677 . . . . 0.0 109.822 177.367 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' E' E ' 79' ' ' LYS . . . . . 0.58 ' O ' HD13 ' E' ' 80' ' ' ILE . 69.4 mttm -87.99 116.73 26.36 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-O 120.846 0.355 . . . . 0.0 111.223 -176.442 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' E' E ' 80' ' ' ILE . . . . . 0.58 HD13 ' O ' ' E' ' 79' ' ' LYS . 40.1 mm -139.19 102.32 1.69 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.312 0 N-CA-C 109.074 -0.713 . . . . 0.0 109.074 179.438 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' E' E ' 81' ' ' LYS . . . . . . . . . . . . . 41.0 tttp -91.3 126.15 36.29 Favored 'General case' 0 C--N 1.328 -0.351 0 C-N-CA 120.695 -0.402 . . . . 0.0 110.892 -177.171 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' E' E ' 82' ' ' GLY . . . . . . . . . . . . . . . 89.12 42.08 5.69 Favored Glycine 0 CA--C 1.524 0.629 0 C-N-CA 120.885 -0.674 . . . . 0.0 111.721 176.038 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' E' E ' 83' ' ' ILE . . . . . . . . . . . . . 72.6 mt -69.61 137.95 23.12 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.37 0 N-CA-C 109.711 -0.478 . . . . 0.0 109.711 177.027 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' E' E ' 84' ' ' LYS . . . . . . . . . . . . . 38.9 ttpt -100.87 -49.27 4.19 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-O 120.752 0.31 . . . . 0.0 110.234 -179.378 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' E' E ' 85' ' ' ASP . . . . . . . . . . . . . 9.0 t70 -151.85 154.06 35.42 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.243 -0.435 . . . . 0.0 110.7 -178.771 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' E' E ' 86' ' ' VAL . . . . . . . . . . . . . 44.6 t -132.57 136.36 56.14 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.22 0 CA-C-O 121.003 0.43 . . . . 0.0 110.392 -179.812 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' E' E ' 87' ' ' ILE . . . . . . . . . . . . . 47.4 mm -122.74 128.14 75.15 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.289 0 CA-C-N 115.71 -0.677 . . . . 0.0 109.674 178.919 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' E' E ' 88' ' ' LEU . . . . . . . . . . . . . 70.3 mt -111.99 136.52 51.22 Favored 'General case' 0 C--N 1.332 -0.185 0 CA-C-O 121.094 0.473 . . . . 0.0 111.396 -177.759 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' E' E ' 89' ' ' ASP . . . . . . . . . . . . . 9.5 t70 -127.2 154.87 44.28 Favored 'General case' 0 C--N 1.33 -0.274 0 N-CA-C 109.067 -0.716 . . . . 0.0 109.067 175.576 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' E' E ' 90' ' ' GLU . . . . . . . . . . . . . 82.9 tt0 -48.04 -34.32 9.34 Favored 'General case' 0 C--N 1.331 -0.235 0 N-CA-C 112.933 0.716 . . . . 0.0 112.933 -171.74 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' E' E ' 91' ' ' ASN . . . . . . . . . . . . . 13.6 p30 -131.99 18.25 4.59 Favored 'General case' 0 N--CA 1.468 0.454 0 N-CA-C 113.207 0.818 . . . . 0.0 113.207 -177.717 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' E' E ' 92' ' ' LEU . . . . . . . . . . . . . 25.3 mt -146.98 151.08 36.39 Favored 'General case' 0 C--N 1.332 -0.175 0 CA-C-N 117.861 0.301 . . . . 0.0 110.404 -177.069 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' E' E ' 93' ' ' ILE . . . . . . . . . . . . . 67.1 mt -127.1 121.73 58.49 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.213 0 N-CA-C 109.43 -0.582 . . . . 0.0 109.43 178.189 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' E' E ' 94' ' ' VAL . . . . . . . . . . . . . 45.9 t -120.62 129.91 75.1 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.291 0 CA-C-O 120.889 0.376 . . . . 0.0 110.013 -179.816 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' E' E ' 95' ' ' VAL . . . . . . . . . . . . . 44.3 t -122.7 136.0 60.94 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 CA-C-N 116.015 -0.539 . . . . 0.0 109.867 -179.562 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' E' E ' 96' ' ' ILE . . . . . . . . . . . . . 63.1 mt -118.26 127.18 75.41 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.232 0 N-CA-C 109.402 -0.592 . . . . 0.0 109.402 178.896 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' E' E ' 97' ' ' THR . . . . . . . . . . . . . 77.8 p -100.75 158.52 15.9 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-O 121.083 0.468 . . . . 0.0 111.106 -177.464 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' E' E ' 98' ' ' GLU . . . . . . . . . . . . . 47.1 tp10 -53.85 -26.32 23.93 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.279 -0.419 . . . . 0.0 112.105 -179.861 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' E' E ' 99' ' ' GLU . . . . . . . . . . . . . 96.0 mt-10 -76.1 11.61 1.42 Allowed 'General case' 0 CA--C 1.535 0.381 0 N-CA-C 113.404 0.89 . . . . 0.0 113.404 -177.204 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' E' E ' 100' ' ' ASN . . . . . . . . . . . . . 4.0 m-20 63.42 37.67 10.55 Favored 'General case' 0 CA--C 1.529 0.156 0 CA-C-O 121.143 0.497 . . . . 0.0 111.023 179.792 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' E' E ' 101' ' ' GLU . . . . . . . . . . . . . 85.0 tt0 -114.97 140.07 49.32 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.025 -0.534 . . . . 0.0 109.6 175.559 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' E' E ' 102' ' ' VAL . . . . . . . . . . . . . 47.5 t -114.88 126.1 72.37 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.243 0 N-CA-C 109.795 -0.446 . . . . 0.0 109.795 -178.508 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' E' E ' 103' ' ' LEU . . . . . . . . . . . . . 45.7 mt -119.15 133.15 55.95 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 115.768 -0.651 . . . . 0.0 110.483 178.233 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' E' E ' 104' ' ' ILE . . . . . . . . . . . . . 69.4 mt -119.0 122.42 69.28 Favored 'Isoleucine or valine' 0 C--O 1.235 0.296 0 CA-C-N 116.399 -0.364 . . . . 0.0 110.41 -179.618 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' E' E ' 105' ' ' PHE . . . . . . . . . . . . . 61.9 m-85 -121.72 167.1 13.34 Favored 'General case' 0 C--N 1.333 -0.142 0 O-C-N 124.013 0.821 . . . . 0.0 109.498 178.208 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' E' E ' 106' ' ' ASN . . . . . . . . . . . . . 46.3 p-10 -101.05 -170.36 1.83 Allowed 'General case' 0 C--N 1.33 -0.261 0 N-CA-C 109.95 -0.389 . . . . 0.0 109.95 172.99 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' E' E ' 107' ' ' GLN . . . . . . . . . . . . . 58.6 tt0 -58.99 -29.82 67.5 Favored 'General case' 0 C--N 1.328 -0.327 0 N-CA-C 111.902 0.334 . . . . 0.0 111.902 -179.998 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' E' E ' 108' ' ' ASN . . . . . . . . . . . . . 51.3 t30 -84.77 11.32 9.35 Favored 'General case' 0 CA--C 1.535 0.4 0 N-CA-C 112.838 0.681 . . . . 0.0 112.838 -177.307 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' E' E ' 109' ' ' LEU . . . . . . . . . . . . . 17.8 mt 57.58 36.46 26.82 Favored 'General case' 0 CA--C 1.53 0.185 0 CA-C-O 120.898 0.38 . . . . 0.0 111.342 178.63 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' E' E ' 110' ' ' GLU . . . . . . . . . . . . . 70.4 mm-40 -101.87 138.18 39.18 Favored 'General case' 0 C--N 1.33 -0.281 0 N-CA-C 109.172 -0.677 . . . . 0.0 109.172 174.909 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' E' E ' 111' ' ' GLU . . . . . . . . . . . . . 73.1 tt0 -82.55 121.81 27.27 Favored 'General case' 0 C--N 1.33 -0.28 0 C-N-CA 120.665 -0.414 . . . . 0.0 110.029 -176.655 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' E' E ' 112' ' ' LEU . . . . . . . . . . . . . 22.5 mt -108.95 -44.76 3.92 Favored 'General case' 0 C--N 1.332 -0.195 0 CA-C-N 116.129 -0.487 . . . . 0.0 110.789 -177.655 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' E' E ' 113' ' ' TYR . . . . . . . . . . . . . 50.9 t80 -132.91 137.07 46.51 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.365 -0.38 . . . . 0.0 110.911 -177.739 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' E' E ' 114' ' ' ARG . . . . . . . . . . . . . 16.3 ptm180 -143.31 126.95 17.0 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-O 121.034 0.445 . . . . 0.0 110.664 176.57 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' E' E ' 115' ' ' GLY . . . . . . . . . . . . . . . -150.11 140.27 7.9 Favored Glycine 0 CA--C 1.524 0.64 0 N-CA-C 111.147 -0.781 . . . . 0.0 111.147 178.599 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' E' E ' 116' ' ' LYS . . . . . . . . . . . . . 39.6 ttpt -104.89 128.98 53.33 Favored 'General case' 0 C--N 1.33 -0.269 0 N-CA-C 109.721 -0.474 . . . . 0.0 109.721 175.67 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' E' E ' 117' ' ' PHE . . . . . . . . . . . . . 69.8 m-85 -125.68 114.96 19.36 Favored 'General case' 0 C--N 1.331 -0.22 0 CA-C-O 121.019 0.438 . . . . 0.0 110.129 -177.268 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' E' E ' 118' ' ' GLU . . . . . . . . . . . . . 96.0 mt-10 -54.55 -41.35 69.68 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.462 -0.336 . . . . 0.0 111.265 -175.825 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' E' E ' 119' ' ' ASN . . . . . . . . . . . . . 69.9 m-80 -104.07 31.07 4.76 Favored 'General case' 0 C--O 1.234 0.246 0 CA-C-N 116.229 -0.441 . . . . 0.0 112.111 -173.92 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' E' E ' 120' ' ' LEU . . . . . . . . . . . . . 11.7 tp -56.24 120.05 6.95 Favored 'General case' 0 N--CA 1.462 0.147 0 CA-C-O 120.715 0.293 . . . . 0.0 110.311 178.884 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' E' E ' 121' ' ' ASN . . . . . . . . . . . . . 45.7 m-80 -114.34 -44.03 3.15 Favored 'General case' 0 C--O 1.232 0.153 0 CA-C-N 116.385 -0.37 . . . . 0.0 111.169 -176.655 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' E' E ' 122' ' ' LYS . . . . . . . . . . . . . 97.8 mttt -142.59 147.62 36.16 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-O 121.021 0.439 . . . . 0.0 111.596 -175.915 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' E' E ' 123' ' ' VAL . . . . . . . . . . . . . 44.1 t -127.09 129.16 71.07 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.275 0 N-CA-C 109.278 -0.638 . . . . 0.0 109.278 174.126 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' E' E ' 124' ' ' LEU . . . . . . . . . . . . . 38.1 mt -129.52 137.06 50.58 Favored 'General case' 0 C--N 1.331 -0.202 0 CA-C-O 120.838 0.352 . . . . 0.0 110.948 -178.394 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' E' E ' 125' ' ' VAL . . . . . . . . . . . . . 12.8 p -137.55 138.22 44.88 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.255 0 CA-C-N 116.282 -0.417 . . . . 0.0 110.329 177.908 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' E' E ' 126' ' ' ARG . . . . . . . . . . . . . 37.8 mtp180 -146.2 127.67 15.01 Favored 'General case' 0 C--N 1.331 -0.229 0 CA-C-O 120.954 0.406 . . . . 0.0 110.839 179.159 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' E' E ' 127' ' ' ASN . . . . . . . . . . . . . 62.1 t30 49.55 -104.93 0.15 Allowed 'General case' 0 CA--C 1.543 0.684 0 CA-C-O 118.953 -0.546 . . . . 0.0 111.826 179.157 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' E' E ' 128' ' ' ASP . . . . . . . . . . . . . 12.0 p-10 -114.19 0.61 14.28 Favored 'General case' 0 CA--C 1.537 0.445 0 CA-C-N 119.612 1.096 . . . . 0.0 113.591 -175.148 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' E' E ' 129' ' ' LEU . . . . . . . . . . . . . 84.3 mt -112.32 145.16 40.52 Favored 'General case' 0 C--N 1.333 -0.133 0 CA-C-N 118.203 0.456 . . . . 0.0 110.03 179.839 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' E' E ' 130' ' ' VAL . . . . . 0.507 HG13 ' HB ' ' E' ' 141' ' ' ILE . 12.0 p -131.95 141.93 44.26 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.175 0 CA-C-O 121.059 0.457 . . . . 0.0 110.25 179.954 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' E' E ' 131' ' ' VAL . . . . . 0.673 HG22 HD12 ' E' ' 140' ' ' LEU . 27.0 t -135.42 139.32 46.92 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.315 0 CA-C-N 115.961 -0.563 . . . . 0.0 110.397 -177.348 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' E' E ' 132' ' ' ILE . . . . . . . . . . . . . 74.6 mt -115.97 130.45 70.65 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.332 0 N-CA-C 109.215 -0.661 . . . . 0.0 109.215 178.582 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' E' E ' 133' ' ' ILE . . . . . . . . . . . . . 39.5 mm -116.47 123.08 71.14 Favored 'Isoleucine or valine' 0 N--CA 1.462 0.159 0 CA-C-O 120.727 0.299 . . . . 0.0 110.923 -174.662 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' E' E ' 134' ' ' ASP . . . . . . . . . . . . . 12.1 p-10 -136.47 151.71 49.76 Favored 'General case' 0 C--N 1.332 -0.173 0 N-CA-C 109.883 -0.414 . . . . 0.0 109.883 174.422 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' E' E ' 135' ' ' GLU . . . . . . . . . . . . . 41.2 tp10 -50.05 -26.42 4.35 Favored 'General case' 0 C--N 1.328 -0.343 0 N-CA-C 113.025 0.75 . . . . 0.0 113.025 -171.781 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' E' E ' 136' ' ' GLN . . . . . . . . . . . . . 47.1 tt0 -91.47 -25.11 19.46 Favored 'General case' 0 C--O 1.234 0.264 0 N-CA-C 112.977 0.732 . . . . 0.0 112.977 -173.121 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' E' E ' 137' ' ' LYS . . . . . . . . . . . . . 22.6 pttm -170.06 171.36 7.02 Favored 'General case' 0 C--O 1.232 0.148 0 CA-C-O 121.501 0.667 . . . . 0.0 112.659 -172.522 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' E' E ' 138' ' ' LEU . . . . . 0.439 HD23 ' N ' ' E' ' 139' ' ' THR . 5.1 tt -122.28 129.01 51.78 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 115.009 -0.996 . . . . 0.0 109.817 179.727 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' E' E ' 139' ' ' THR . . . . . 0.439 ' N ' HD23 ' E' ' 138' ' ' LEU . 43.5 m -111.46 127.61 55.74 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.528 -0.306 . . . . 0.0 110.354 179.288 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' E' E ' 140' ' ' LEU . . . . . 0.673 HD12 HG22 ' E' ' 131' ' ' VAL . 11.9 tp -114.27 123.34 49.3 Favored 'General case' 0 C--N 1.33 -0.268 0 N-CA-C 109.554 -0.535 . . . . 0.0 109.554 -178.976 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' E' E ' 141' ' ' ILE . . . . . 0.507 ' HB ' HG13 ' E' ' 130' ' ' VAL . 19.6 mt -121.5 124.79 72.54 Favored 'Isoleucine or valine' 0 C--O 1.234 0.253 0 CA-C-O 120.943 0.401 . . . . 0.0 110.261 -174.648 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' E' E ' 142' ' ' ARG . . . . . . . . . . . . . 82.2 mtp180 -108.68 128.13 54.59 Favored 'General case' 0 C--N 1.331 -0.222 0 CA-C-N 115.229 -0.896 . . . . 0.0 110.181 -178.654 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' E' E ' 143' ' ' THR . . . . . . . . . . . . . 24.9 p . . . . . 0 C--O 1.221 -0.412 0 CA-C-O 117.964 -1.017 . . . . 0.0 110.52 -179.754 . . . . . . . . 0 0 . 1 . 008 nuclear build full ' F' F ' -3' ' ' GLU . . . . . . . . . . . . . 45.3 tp10 . . . . . 0 N--CA 1.49 1.553 0 N-CA-C 109.215 -0.661 . . . . 0.0 109.215 . . . . . . . . . 0 0 . 1 . 008 nuclear build full ' F' F ' -2' ' ' GLY . . . . . . . . . . . . . . . -62.26 150.04 47.23 Favored Glycine 0 CA--C 1.525 0.714 0 N-CA-C 110.925 -0.87 . . . . 0.0 110.925 -179.434 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' F' F ' -1' ' ' VAL . . . . . . . . . . . . . 43.5 t -95.47 137.06 24.59 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.316 0 N-CA-C 109.944 -0.391 . . . . 0.0 109.944 -179.86 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' F' F ' 0' ' ' ILE . . . . . . . . . . . . . 42.9 mm -112.77 141.04 29.64 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.263 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.321 -177.662 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' F' F ' 1' ' ' MET . . . . . . . . . . . . . 25.2 ptp -81.59 137.63 35.48 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.061 -0.518 . . . . 0.0 110.789 179.929 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' F' F ' 2' ' ' SER . . . . . . . . . . . . . 2.5 p -131.03 125.44 33.28 Favored 'General case' 0 C--N 1.331 -0.224 0 CA-C-N 116.461 -0.336 . . . . 0.0 110.358 178.738 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' F' F ' 3' ' ' GLU . . . . . . . . . . . . . 93.9 mt-10 -139.47 139.66 37.07 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 116.144 -0.48 . . . . 0.0 111.056 -176.439 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' F' F ' 4' ' ' LEU . . . . . . . . . . . . . 20.6 tp -123.24 127.66 48.9 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 115.805 -0.634 . . . . 0.0 109.91 175.387 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' F' F ' 5' ' ' LYS . . . . . . . . . . . . . 90.9 mttt -109.76 122.25 47.07 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 116.466 -0.334 . . . . 0.0 110.829 179.891 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' F' F ' 6' ' ' LEU . . . . . . . . . . . . . 71.7 mt -116.69 147.2 42.2 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 115.551 -0.75 . . . . 0.0 110.094 179.274 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' F' F ' 7' ' ' LYS . . . . . . . . . . . . . 39.4 ttmt -137.44 142.29 36.8 Favored Pre-proline 0 CA--C 1.533 0.319 0 CA-C-O 119.298 -0.382 . . . . 0.0 110.043 175.845 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' F' F ' 8' ' ' PRO . . . . . . . . . . . . . 87.7 Cg_endo -90.51 143.89 3.75 Favored 'Trans proline' 0 N--CA 1.489 1.244 0 C-N-CA 121.761 1.641 . . . . 0.0 111.846 178.376 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' F' F ' 9' ' ' LEU . . . . . . . . . . . . . 50.4 mt -76.84 -47.97 2.81 Favored Pre-proline 0 CA--C 1.534 0.347 0 CA-C-O 118.709 -0.663 . . . . 0.0 112.27 -179.652 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' F' F ' 10' ' ' PRO . . . . . . . . . . . . . 84.5 Cg_endo -80.41 157.76 22.48 Favored 'Trans proline' 0 N--CA 1.497 1.702 0 C-N-CA 121.237 1.291 . . . . 0.0 111.967 176.561 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' F' F ' 11' ' ' LYS . . . . . . . . . . . . . 53.3 mttm -87.48 100.54 12.84 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-O 120.817 0.341 . . . . 0.0 110.539 178.049 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' F' F ' 12' ' ' VAL . . . . . . . . . . . . . 11.4 p -139.97 144.2 28.62 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.275 0 CA-C-N 116.05 -0.523 . . . . 0.0 110.071 179.281 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' F' F ' 13' ' ' GLU . . . . . . . . . . . . . 41.6 tp10 -91.01 116.67 28.97 Favored 'General case' 0 C--N 1.329 -0.325 0 N-CA-C 109.989 -0.374 . . . . 0.0 109.989 178.611 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' F' F ' 14' ' ' LEU . . . . . . . . . . . . . 23.0 mt -98.24 153.67 37.98 Favored Pre-proline 0 C--N 1.33 -0.269 0 CA-C-N 116.251 -0.431 . . . . 0.0 111.177 -176.124 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' F' F ' 15' ' ' PRO . . . . . . . . . . . . . 37.4 Cg_exo -59.7 156.88 35.11 Favored 'Trans proline' 0 N--CA 1.497 1.733 0 C-N-CA 121.332 1.355 . . . . 0.0 112.132 179.065 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' F' F ' 16' ' ' PRO . . . . . . . . . . . . . 28.1 Cg_exo -60.68 -34.34 92.17 Favored 'Trans proline' 0 N--CA 1.497 1.701 0 C-N-CA 121.404 1.403 . . . . 0.0 112.187 178.043 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' F' F ' 17' ' ' ASP . . . . . . . . . . . . . 15.1 p-10 -85.11 12.29 8.07 Favored 'General case' 0 CA--C 1.536 0.427 0 N-CA-C 113.113 0.783 . . . . 0.0 113.113 -177.939 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' F' F ' 18' ' ' PHE . . . . . . . . . . . . . 33.4 t80 -57.83 -42.36 84.2 Favored 'General case' 0 C--N 1.333 -0.115 0 O-C-N 121.988 -0.445 . . . . 0.0 110.142 -179.678 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' F' F ' 19' ' ' VAL . . . . . . . . . . . . . 49.8 t -55.89 -52.98 43.18 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.316 0 CA-C-N 116.352 -0.385 . . . . 0.0 111.102 -176.675 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' F' F ' 20' ' ' ASP . . . . . . . . . . . . . 2.5 p-10 -59.82 -36.25 76.38 Favored 'General case' 0 N--CA 1.464 0.268 0 C-N-CA 120.582 -0.447 . . . . 0.0 111.342 -176.452 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' F' F ' 21' ' ' VAL . . . . . . . . . . . . . 51.7 t -63.93 -47.13 91.96 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.239 0 C-N-CA 120.575 -0.45 . . . . 0.0 110.34 -179.853 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' F' F ' 22' ' ' ILE . . . . . 0.446 HG22 HD12 ' F' ' 26' ' ' LEU . 49.2 mm -55.54 -48.35 77.48 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.219 0 CA-C-O 120.736 0.303 . . . . 0.0 110.505 178.129 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' F' F ' 23' ' ' ARG . . . . . . . . . . . . . 53.2 ttp180 -54.41 -49.54 69.7 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.521 -0.309 . . . . 0.0 111.572 -177.109 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' F' F ' 24' ' ' ILE . . . . . . . . . . . . . 78.0 mt -59.16 -46.15 92.24 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.316 0 C-N-CA 120.971 -0.291 . . . . 0.0 111.166 -176.7 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' F' F ' 25' ' ' LYS . . . . . . . . . . . . . 90.8 mttt -64.76 -44.05 91.34 Favored 'General case' 0 C--N 1.33 -0.275 0 N-CA-C 112.54 0.57 . . . . 0.0 112.54 -177.25 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' F' F ' 26' ' ' LEU . . . . . 0.446 HD12 HG22 ' F' ' 22' ' ' ILE . 61.4 mt -83.67 -24.16 31.44 Favored 'General case' 0 C--N 1.329 -0.302 0 N-CA-C 113.467 0.914 . . . . 0.0 113.467 -171.508 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' F' F ' 27' ' ' GLN . . . . . . . . . . . . . 6.4 pt20 -46.15 136.58 6.76 Favored 'General case' 0 CA--C 1.534 0.351 0 N-CA-C 112.813 0.671 . . . . 0.0 112.813 -174.633 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' F' F ' 28' ' ' GLY . . . . . . . . . . . . . . . 100.53 -21.56 43.58 Favored Glycine 0 CA--C 1.533 1.214 0 CA-C-N 115.701 -0.681 . . . . 0.0 112.786 -178.623 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' F' F ' 29' ' ' LYS . . . . . . . . . . . . . 63.2 mttp -97.79 155.08 17.2 Favored 'General case' 0 C--N 1.331 -0.199 0 CA-C-N 117.604 0.702 . . . . 0.0 111.144 179.125 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' F' F ' 30' ' ' THR . . . . . . . . . . . . . 24.2 m -104.7 139.23 39.82 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.196 177.366 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' F' F ' 31' ' ' VAL . . . . . . . . . . . . . 34.3 m -129.33 157.45 42.1 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.19 0 CA-C-O 120.856 0.36 . . . . 0.0 110.915 -178.741 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' F' F ' 32' ' ' ARG . . . . . . . . . . . . . 93.4 mtt180 -133.74 152.33 51.85 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 115.959 -0.564 . . . . 0.0 110.779 177.934 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' F' F ' 33' ' ' THR . . . . . . . . . . . . . 28.5 m -53.31 139.97 28.33 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.133 -0.485 . . . . 0.0 111.399 -178.852 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' F' F ' 34' ' ' GLY . . . . . . . . . . . . . . . 99.21 -17.17 58.33 Favored Glycine 0 CA--C 1.532 1.118 0 C-N-CA 121.16 -0.543 . . . . 0.0 113.222 178.81 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' F' F ' 35' ' ' ASP . . . . . . . . . . . . . 76.0 m-20 -65.83 148.66 51.42 Favored 'General case' 0 C--O 1.232 0.176 0 CA-C-N 118.065 0.933 . . . . 0.0 111.188 179.092 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' F' F ' 36' ' ' VAL . . . . . . . . . . . . . 45.0 t -122.3 129.76 75.06 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.243 0 CA-C-N 115.981 -0.554 . . . . 0.0 109.874 178.468 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' F' F ' 37' ' ' ILE . . . . . . . . . . . . . 66.1 mt -119.77 138.79 49.24 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.201 0 CA-C-N 116.21 -0.45 . . . . 0.0 109.933 -179.776 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' F' F ' 38' ' ' GLY . . . . . . . . . . . . . . . -110.76 128.78 8.93 Favored Glycine 0 CA--C 1.525 0.691 0 N-CA-C 111.193 -0.763 . . . . 0.0 111.193 -179.331 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' F' F ' 39' ' ' ILE . . . . . . . . . . . . . 72.9 mt -123.85 132.69 70.96 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.216 0 N-CA-C 110.137 -0.32 . . . . 0.0 110.137 178.89 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' F' F ' 40' ' ' SER . . . . . . . . . . . . . 23.0 t -92.7 118.86 31.51 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.332 -0.394 . . . . 0.0 110.685 175.34 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' F' F ' 41' ' ' ILE . . . . . . . . . . . . . 70.5 mt -130.69 125.33 58.47 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.229 0 CA-C-O 120.884 0.374 . . . . 0.0 110.469 179.219 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' F' F ' 42' ' ' LEU . . . . . . . . . . . . . 48.3 mt 51.94 34.46 13.69 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 115.994 -0.548 . . . . 0.0 111.913 176.833 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' F' F ' 43' ' ' GLY . . . . . . . . . . . . . . . 72.92 31.36 62.18 Favored Glycine 0 CA--C 1.53 0.993 0 C-N-CA 121.076 -0.583 . . . . 0.0 112.187 177.089 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' F' F ' 44' ' ' LYS . . . . . . . . . . . . . 40.6 ttpt -138.31 130.89 29.23 Favored 'General case' 0 C--N 1.329 -0.314 0 N-CA-C 109.613 -0.514 . . . . 0.0 109.613 178.081 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' F' F ' 45' ' ' GLU . . . . . . . . . . . . . 84.6 tt0 -83.06 118.91 23.86 Favored 'General case' 0 C--N 1.328 -0.351 0 C-N-CA 120.815 -0.354 . . . . 0.0 110.847 -179.66 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' F' F ' 46' ' ' VAL . . . . . . . . . . . . . 7.6 p -119.13 126.74 75.62 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.27 0 N-CA-C 109.375 -0.602 . . . . 0.0 109.375 176.623 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' F' F ' 47' ' ' LYS . . . . . . . . . . . . . 61.0 mttm -100.12 130.61 46.28 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.033 -0.53 . . . . 0.0 111.342 177.813 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' F' F ' 48' ' ' PHE . . . . . . . . . . . . . 90.0 m-85 -111.03 131.91 54.67 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 115.969 -0.559 . . . . 0.0 109.777 175.589 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' F' F ' 49' ' ' LYS . . . . . . . . . . . . . 83.6 tttt -106.81 134.68 49.6 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 116.213 -0.448 . . . . 0.0 110.379 -179.559 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' F' F ' 50' ' ' VAL . . . . . . . . . . . . . 46.8 t -77.07 106.98 7.68 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.283 0 N-CA-C 109.142 -0.688 . . . . 0.0 109.142 176.368 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' F' F ' 51' ' ' VAL . . . . . . . . . . . . . 47.9 t -69.57 -47.95 68.76 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.325 0 CA-C-N 115.932 -0.577 . . . . 0.0 109.979 -173.278 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' F' F ' 52' ' ' GLN . . . . . . . . . . . . . 61.1 tt0 -168.22 148.39 4.8 Favored 'General case' 0 C--N 1.331 -0.22 0 C-N-CA 120.228 -0.589 . . . . 0.0 111.678 -178.838 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' F' F ' 53' ' ' ALA . . . . . . . . . . . . . . . -123.25 132.07 53.9 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 115.651 -0.704 . . . . 0.0 109.86 176.492 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' F' F ' 54' ' ' TYR . . . . . . . . . . . . . 54.3 t80 -129.04 110.11 18.27 Favored Pre-proline 0 CA--C 1.535 0.385 0 CA-C-O 118.317 -0.849 . . . . 0.0 110.166 179.92 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' F' F ' 55' ' ' PRO . . . . . . . . . . . . . 73.9 Cg_endo -77.07 170.03 72.74 Favored 'Cis proline' 0 N--CA 1.497 1.713 0 CA-C-N 121.861 1.7 . . . . 0.0 112.27 -4.661 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' F' F ' 56' ' ' SER . . . . . . . . . . . . . 13.5 m -113.93 131.91 22.91 Favored Pre-proline 0 CA--C 1.538 0.484 0 CA-C-O 118.513 -0.756 . . . . 0.0 109.326 175.652 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' F' F ' 57' ' ' PRO . . . . . . . . . . . . . 55.6 Cg_endo -71.33 166.88 76.79 Favored 'Cis proline' 0 N--CA 1.498 1.757 0 CA-C-N 121.923 1.722 . . . . 0.0 111.643 -0.321 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' F' F ' 58' ' ' LEU . . . . . . . . . . . . . 35.3 tp -129.54 137.34 50.72 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.271 -0.422 . . . . 0.0 110.152 179.491 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' F' F ' 59' ' ' ARG . . . . . . . . . . . . . 38.5 ttm180 -103.71 133.89 47.95 Favored 'General case' 0 C--N 1.327 -0.381 0 N-CA-C 109.706 -0.479 . . . . 0.0 109.706 177.836 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' F' F ' 60' ' ' VAL . . . . . . . . . . . . . 44.1 t -85.28 111.38 20.65 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.264 0 C-N-CA 120.761 -0.376 . . . . 0.0 110.36 -176.428 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' F' F ' 61' ' ' GLU . . . . . . . . . . . . . 95.5 mt-10 -131.06 165.26 23.63 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 115.835 -0.621 . . . . 0.0 109.677 176.043 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' F' F ' 62' ' ' ASP . . . . . . . . . . . . . 19.9 p-10 -53.7 -32.47 51.98 Favored 'General case' 0 C--N 1.328 -0.365 0 N-CA-C 111.85 0.315 . . . . 0.0 111.85 -179.42 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' F' F ' 63' ' ' ARG . . . . . . . . . . . . . 81.3 mtp180 -72.97 -21.93 60.78 Favored 'General case' 0 CA--C 1.533 0.299 0 N-CA-C 113.041 0.756 . . . . 0.0 113.041 -176.313 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' F' F ' 64' ' ' THR . . . . . . . . . . . . . 17.8 m -71.17 142.01 50.7 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-O 120.952 0.406 . . . . 0.0 111.09 -174.568 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' F' F ' 65' ' ' LYS . . . . . . . . . . . . . 39.7 mtpt -89.48 125.46 35.19 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 115.883 -0.599 . . . . 0.0 109.925 178.784 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' F' F ' 66' ' ' ILE . . . . . . . . . . . . . 68.1 mt -119.07 131.64 71.25 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.339 0 CA-C-O 120.874 0.368 . . . . 0.0 110.277 -178.15 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' F' F ' 67' ' ' THR . . . . . . . . . . . . . 26.1 m -123.98 136.89 54.6 Favored 'General case' 0 C--N 1.331 -0.215 0 CA-C-N 116.015 -0.539 . . . . 0.0 110.742 -179.048 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' F' F ' 68' ' ' LEU . . . . . 0.472 HD23 ' C ' ' F' ' 68' ' ' LEU . 5.7 tt -108.39 119.15 38.67 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 115.968 -0.56 . . . . 0.0 110.515 179.485 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' F' F ' 69' ' ' VAL . . . . . . . . . . . . . 44.7 t -104.36 137.01 35.16 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.238 0 CA-C-N 116.139 -0.482 . . . . 0.0 110.069 179.138 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' F' F ' 70' ' ' THR . . . . . 0.425 HG23 ' N ' ' F' ' 71' ' ' HIS . 7.2 t -132.21 -39.58 1.05 Allowed 'General case' 0 C--N 1.331 -0.203 0 CA-C-O 120.75 0.31 . . . . 0.0 110.789 179.156 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' F' F ' 71' ' ' HIS . . . . . 0.425 ' N ' HG23 ' F' ' 70' ' ' THR . 39.1 m80 -128.32 154.95 79.1 Favored Pre-proline 0 CA--C 1.531 0.234 0 CA-C-N 116.503 -0.317 . . . . 0.0 110.452 179.944 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' F' F ' 72' ' ' PRO . . . . . . . . . . . . . 59.6 Cg_endo -73.95 -30.16 9.42 Favored 'Trans proline' 0 N--CA 1.494 1.554 0 C-N-CA 121.335 1.357 . . . . 0.0 112.462 -179.31 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' F' F ' 73' ' ' VAL . . . . . . . . . . . . . 35.9 m -137.34 163.41 31.6 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.262 0 CA-C-O 120.837 0.351 . . . . 0.0 110.686 179.005 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' F' F ' 74' ' ' ASP . . . . . . . . . . . . . 19.5 t0 -107.05 123.04 47.64 Favored 'General case' 0 C--N 1.328 -0.329 0 N-CA-C 109.584 -0.525 . . . . 0.0 109.584 179.156 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' F' F ' 75' ' ' VAL . . . . . 0.429 ' C ' HD12 ' F' ' 76' ' ' LEU . 46.2 t -117.34 126.26 74.48 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.233 0 CA-C-O 121.173 0.511 . . . . 0.0 110.771 -177.43 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' F' F ' 76' ' ' LEU . . . . . 0.429 HD12 ' C ' ' F' ' 75' ' ' VAL . 6.5 mp -122.82 143.66 49.7 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 115.463 -0.79 . . . . 0.0 109.128 174.546 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' F' F ' 77' ' ' GLU . . . . . . . . . . . . . 30.1 tt0 -135.85 140.76 44.42 Favored 'General case' 0 C--N 1.331 -0.225 0 C-N-CA 120.734 -0.386 . . . . 0.0 111.273 -174.73 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' F' F ' 78' ' ' ALA . . . . . . . . . . . . . . . -130.16 134.96 47.68 Favored 'General case' 0 C--N 1.331 -0.239 0 CA-C-N 115.933 -0.576 . . . . 0.0 110.013 176.762 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' F' F ' 79' ' ' LYS . . . . . 0.403 ' O ' HD13 ' F' ' 80' ' ' ILE . 31.1 ttmt -82.4 125.71 31.36 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-O 120.74 0.305 . . . . 0.0 110.822 -178.607 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' F' F ' 80' ' ' ILE . . . . . 0.403 HD13 ' O ' ' F' ' 79' ' ' LYS . 28.0 mm -139.12 114.81 8.98 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.265 0 N-CA-C 109.062 -0.718 . . . . 0.0 109.062 -177.8 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' F' F ' 81' ' ' LYS . . . . . . . . . . . . . 70.1 tttt -103.69 122.11 44.36 Favored 'General case' 0 C--N 1.328 -0.334 0 C-N-CA 121.027 -0.269 . . . . 0.0 111.116 -175.884 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' F' F ' 82' ' ' GLY . . . . . . . . . . . . . . . 89.09 42.18 5.68 Favored Glycine 0 CA--C 1.525 0.66 0 C-N-CA 120.715 -0.755 . . . . 0.0 111.892 174.789 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' F' F ' 83' ' ' ILE . . . . . . . . . . . . . 69.0 mt -65.27 136.49 26.6 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.243 0 N-CA-C 109.91 -0.404 . . . . 0.0 109.91 178.044 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' F' F ' 84' ' ' LYS . . . . . . . . . . . . . 29.0 ttmt -94.32 -51.78 4.64 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.088 -0.506 . . . . 0.0 109.93 179.482 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' F' F ' 85' ' ' ASP . . . . . . . . . . . . . 4.3 t70 -157.29 153.59 27.7 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 115.621 -0.718 . . . . 0.0 110.504 -179.659 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' F' F ' 86' ' ' VAL . . . . . . . . . . . . . 43.8 t -131.52 133.41 61.85 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.232 0 CA-C-O 120.98 0.419 . . . . 0.0 110.356 -179.181 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' F' F ' 87' ' ' ILE . . . . . 0.497 HD12 ' N ' ' F' ' 87' ' ' ILE . 5.0 mp -120.37 126.29 75.1 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.241 0 CA-C-N 115.943 -0.572 . . . . 0.0 109.528 177.765 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' F' F ' 88' ' ' LEU . . . . . . . . . . . . . 10.7 tp -109.5 128.2 55.0 Favored 'General case' 0 C--N 1.331 -0.226 0 CA-C-O 120.902 0.382 . . . . 0.0 110.895 -177.929 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' F' F ' 89' ' ' ASP . . . . . . . . . . . . . 4.2 t0 -120.69 158.14 28.1 Favored 'General case' 0 C--N 1.329 -0.286 0 N-CA-C 109.497 -0.557 . . . . 0.0 109.497 177.441 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' F' F ' 90' ' ' GLU . . . . . . . . . . . . . 84.0 tt0 -45.12 -46.19 11.68 Favored 'General case' 0 N--CA 1.465 0.291 0 N-CA-C 112.985 0.735 . . . . 0.0 112.985 -172.484 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' F' F ' 91' ' ' ASN . . . . . . . . . . . . . 79.4 m-20 -132.05 30.84 4.22 Favored 'General case' 0 N--CA 1.465 0.29 0 N-CA-C 112.189 0.44 . . . . 0.0 112.189 -179.608 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' F' F ' 92' ' ' LEU . . . . . . . . . . . . . 7.2 mt -150.35 140.94 22.56 Favored 'General case' 0 C--N 1.331 -0.204 0 N-CA-C 109.564 -0.532 . . . . 0.0 109.564 -178.088 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' F' F ' 93' ' ' ILE . . . . . . . . . . . . . 73.5 mt -124.01 119.45 56.87 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.289 0 N-CA-C 109.338 -0.616 . . . . 0.0 109.338 178.997 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' F' F ' 94' ' ' VAL . . . . . . . . . . . . . 44.0 t -119.55 126.59 75.46 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.198 0 CA-C-O 120.892 0.377 . . . . 0.0 109.998 -179.648 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' F' F ' 95' ' ' VAL . . . . . . . . . . . . . 44.1 t -121.58 133.14 69.01 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.298 0 CA-C-N 116.101 -0.5 . . . . 0.0 109.738 179.623 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' F' F ' 96' ' ' ILE . . . . . . . . . . . . . 64.3 mt -114.26 126.15 71.71 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.326 0 N-CA-C 109.234 -0.654 . . . . 0.0 109.234 178.88 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' F' F ' 97' ' ' THR . . . . . . . . . . . . . 64.6 p -98.62 154.8 17.67 Favored 'General case' 0 C--N 1.327 -0.385 0 CA-C-O 121.109 0.48 . . . . 0.0 110.952 -178.311 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' F' F ' 98' ' ' GLU . . . . . . . . . . . . . 83.4 tt0 -53.89 -23.5 12.91 Favored 'General case' 0 CA--C 1.535 0.371 0 N-CA-C 112.419 0.525 . . . . 0.0 112.419 179.966 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' F' F ' 99' ' ' GLU . . . . . . . . . . . . . 13.8 mm-40 -77.54 13.92 1.14 Allowed 'General case' 0 CA--C 1.536 0.431 0 N-CA-C 113.272 0.841 . . . . 0.0 113.272 -178.444 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' F' F ' 100' ' ' ASN . . . . . . . . . . . . . 2.2 m-20 63.65 37.73 9.95 Favored 'General case' 0 N--CA 1.463 0.212 0 CA-C-O 121.111 0.481 . . . . 0.0 110.948 178.322 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' F' F ' 101' ' ' GLU . . . . . . . . . . . . . 84.9 tt0 -120.09 140.93 50.3 Favored 'General case' 0 C--N 1.333 -0.151 0 CA-C-N 116.203 -0.453 . . . . 0.0 109.853 176.68 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' F' F ' 102' ' ' VAL . . . . . . . . . . . . . 43.2 t -115.03 126.74 72.7 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 CA-C-N 116.197 -0.456 . . . . 0.0 109.881 -178.32 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' F' F ' 103' ' ' LEU . . . . . 0.516 HD12 ' N ' ' F' ' 103' ' ' LEU . 6.2 mp -117.29 134.89 54.27 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 115.994 -0.548 . . . . 0.0 110.294 177.784 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' F' F ' 104' ' ' ILE . . . . . . . . . . . . . 66.3 mt -119.0 122.22 68.78 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.218 0 CA-C-N 116.422 -0.354 . . . . 0.0 110.217 -179.147 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' F' F ' 105' ' ' PHE . . . . . . . . . . . . . 79.3 m-85 -120.54 161.46 21.27 Favored 'General case' 0 C--N 1.331 -0.235 0 O-C-N 124.046 0.841 . . . . 0.0 109.987 179.614 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' F' F ' 106' ' ' ASN . . . . . . . . . . . . . 46.8 p-10 -97.4 -169.85 1.92 Allowed 'General case' 0 CA--C 1.531 0.228 0 N-CA-C 110.19 -0.3 . . . . 0.0 110.19 175.559 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' F' F ' 107' ' ' GLN . . . . . . . . . . . . . 63.0 tt0 -59.0 -30.09 67.72 Favored 'General case' 0 C--N 1.33 -0.271 0 N-CA-C 111.954 0.353 . . . . 0.0 111.954 179.618 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' F' F ' 108' ' ' ASN . . . . . . . . . . . . . 8.5 t-20 -83.98 11.76 7.32 Favored 'General case' 0 CA--C 1.536 0.428 0 N-CA-C 112.877 0.695 . . . . 0.0 112.877 -178.124 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' F' F ' 109' ' ' LEU . . . . . . . . . . . . . 10.5 tp 54.96 35.41 24.49 Favored 'General case' 0 C--N 1.331 -0.201 0 CA-C-O 120.902 0.382 . . . . 0.0 111.431 -179.602 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' F' F ' 110' ' ' GLU . . . . . . . . . . . . . 94.9 mt-10 -104.46 147.06 28.0 Favored 'General case' 0 C--N 1.331 -0.233 0 N-CA-C 109.335 -0.617 . . . . 0.0 109.335 175.38 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' F' F ' 111' ' ' GLU . . . . . . . . . . . . . 64.8 tt0 -81.47 121.95 26.92 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-O 120.913 0.387 . . . . 0.0 110.639 -174.97 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' F' F ' 112' ' ' LEU . . . . . . . . . . . . . 16.9 mt -104.7 -46.04 4.44 Favored 'General case' 0 C--N 1.331 -0.227 0 CA-C-N 116.04 -0.527 . . . . 0.0 110.623 179.513 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' F' F ' 113' ' ' TYR . . . . . . . . . . . . . 49.5 t80 -137.25 146.04 44.28 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.166 -0.47 . . . . 0.0 111.026 -177.919 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' F' F ' 114' ' ' ARG . . . . . . . . . . . . . 37.6 ptt180 -148.58 126.58 12.0 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.141 -0.481 . . . . 0.0 110.779 178.505 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' F' F ' 115' ' ' GLY . . . . . . . . . . . . . . . -150.16 142.78 9.98 Favored Glycine 0 CA--C 1.524 0.641 0 N-CA-C 111.062 -0.815 . . . . 0.0 111.062 179.159 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' F' F ' 116' ' ' LYS . . . . . . . . . . . . . 39.1 ttpt -112.37 134.09 54.09 Favored 'General case' 0 C--N 1.331 -0.236 0 N-CA-C 109.694 -0.484 . . . . 0.0 109.694 176.908 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' F' F ' 117' ' ' PHE . . . . . . . . . . . . . 28.1 m-85 -136.54 114.38 11.25 Favored 'General case' 0 C--N 1.329 -0.313 0 N-CA-C 110.055 -0.35 . . . . 0.0 110.055 -175.351 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' F' F ' 118' ' ' GLU . . . . . . . . . . . . . 43.7 mt-10 -54.94 -44.1 74.0 Favored 'General case' 0 C--N 1.33 -0.274 0 C-N-CA 120.883 -0.327 . . . . 0.0 111.348 -176.618 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' F' F ' 119' ' ' ASN . . . . . . . . . . . . . 30.6 m120 -94.87 30.49 2.07 Favored 'General case' 0 C--N 1.33 -0.263 0 N-CA-C 112.161 0.43 . . . . 0.0 112.161 -174.659 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' F' F ' 120' ' ' LEU . . . . . . . . . . . . . 22.0 tp -57.5 120.08 7.65 Favored 'General case' 0 C--N 1.331 -0.211 0 C-N-CA 120.925 -0.31 . . . . 0.0 110.293 177.577 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' F' F ' 121' ' ' ASN . . . . . . . . . . . . . 76.2 m-20 -111.63 -44.1 3.55 Favored 'General case' 0 C--N 1.331 -0.221 0 CA-C-N 116.425 -0.352 . . . . 0.0 110.711 -179.273 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' F' F ' 122' ' ' LYS . . . . . . . . . . . . . 97.0 mttt -146.93 145.08 29.67 Favored 'General case' 0 C--N 1.331 -0.216 0 C-N-CA 120.536 -0.466 . . . . 0.0 111.899 -179.316 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' F' F ' 123' ' ' VAL . . . . . . . . . . . . . 45.1 t -122.95 125.86 72.89 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.234 0 N-CA-C 108.998 -0.742 . . . . 0.0 108.998 171.531 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' F' F ' 124' ' ' LEU . . . . . 0.462 HD23 ' N ' ' F' ' 125' ' ' VAL . 3.3 tt -125.26 131.86 53.03 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.461 -0.336 . . . . 0.0 110.482 -175.28 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' F' F ' 125' ' ' VAL . . . . . 0.462 ' N ' HD23 ' F' ' 124' ' ' LEU . 11.7 p -131.14 135.95 58.78 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.224 0 CA-C-N 116.377 -0.374 . . . . 0.0 110.502 178.961 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' F' F ' 126' ' ' ARG . . . . . . . . . . . . . 96.6 mtt180 -149.43 128.37 12.63 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 116.109 -0.496 . . . . 0.0 110.873 177.333 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' F' F ' 127' ' ' ASN . . . . . . . . . . . . . 36.1 t30 50.46 -106.77 0.24 Allowed 'General case' 0 CA--C 1.543 0.677 0 CA-C-O 118.975 -0.536 . . . . 0.0 111.543 178.85 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' F' F ' 128' ' ' ASP . . . . . . . . . . . . . 18.7 p-10 -114.14 5.17 15.85 Favored 'General case' 0 N--CA 1.469 0.476 0 CA-C-N 119.667 1.121 . . . . 0.0 113.531 -176.332 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' F' F ' 129' ' ' LEU . . . . . . . . . . . . . 61.9 mt -109.39 137.52 47.12 Favored 'General case' 0 C--O 1.232 0.159 0 CA-C-N 118.155 0.434 . . . . 0.0 110.702 -179.428 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' F' F ' 130' ' ' VAL . . . . . . . . . . . . . 44.4 t -124.02 132.0 72.05 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.194 0 N-CA-C 109.609 -0.515 . . . . 0.0 109.609 177.596 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' F' F ' 131' ' ' VAL . . . . . 0.464 HG22 HD12 ' F' ' 140' ' ' LEU . 41.4 t -135.56 137.08 50.06 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.208 0 CA-C-O 121.091 0.472 . . . . 0.0 110.511 -179.452 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' F' F ' 132' ' ' ILE . . . . . . . . . . . . . 71.0 mt -118.26 132.82 66.99 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.239 0 CA-C-N 115.815 -0.629 . . . . 0.0 109.542 178.717 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' F' F ' 133' ' ' ILE . . . . . . . . . . . . . 43.1 mm -118.31 124.6 73.37 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.238 0 CA-C-N 116.519 -0.31 . . . . 0.0 111.205 -174.758 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' F' F ' 134' ' ' ASP . . . . . . . . . . . . . 13.9 p-10 -140.52 151.42 44.76 Favored 'General case' 0 C--N 1.332 -0.19 0 N-CA-C 109.737 -0.468 . . . . 0.0 109.737 172.655 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' F' F ' 135' ' ' GLU . . . . . . . . . . . . . 42.5 tp10 -50.89 -27.44 7.5 Favored 'General case' 0 C--N 1.328 -0.357 0 N-CA-C 112.971 0.73 . . . . 0.0 112.971 -171.028 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' F' F ' 136' ' ' GLN . . . . . . . . . . . . . 99.3 mm-40 -86.28 -29.62 22.93 Favored 'General case' 0 C--O 1.233 0.23 0 N-CA-C 112.705 0.631 . . . . 0.0 112.705 -174.332 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' F' F ' 137' ' ' LYS . . . . . . . . . . . . . 55.7 pttt -164.95 169.11 16.84 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-O 121.524 0.678 . . . . 0.0 112.545 -170.605 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' F' F ' 138' ' ' LEU . . . . . 0.417 HD23 ' N ' ' F' ' 139' ' ' THR . 5.3 tt -122.26 127.52 50.01 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 114.986 -1.006 . . . . 0.0 109.598 178.565 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' F' F ' 139' ' ' THR . . . . . 0.417 ' N ' HD23 ' F' ' 138' ' ' LEU . 35.0 m -108.07 124.59 50.43 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.423 -0.353 . . . . 0.0 110.333 -179.299 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' F' F ' 140' ' ' LEU . . . . . 0.464 HD12 HG22 ' F' ' 131' ' ' VAL . 14.5 tp -113.0 120.2 40.56 Favored 'General case' 0 C--N 1.329 -0.284 0 N-CA-C 109.337 -0.616 . . . . 0.0 109.337 -179.069 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' F' F ' 141' ' ' ILE . . . . . . . . . . . . . 18.9 mt -120.94 121.96 66.48 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.28 0 CA-C-O 120.961 0.41 . . . . 0.0 110.052 -175.364 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' F' F ' 142' ' ' ARG . . . . . . . . . . . . . 75.3 mtp180 -105.84 117.18 33.37 Favored 'General case' 0 C--O 1.232 0.163 0 CA-C-N 115.548 -0.751 . . . . 0.0 109.945 179.113 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' F' F ' 143' ' ' THR . . . . . . . . . . . . . 18.8 p . . . . . 0 C--O 1.219 -0.505 0 CA-C-O 118.029 -0.986 . . . . 0.0 110.663 -179.015 . . . . . . . . 0 0 . 1 . 009 nuclear build full ' A' A ' -3' ' ' GLU . . . . . . . . . . . . . 70.8 mm-40 . . . . . 0 N--CA 1.49 1.557 0 N-CA-C 109.343 -0.614 . . . . 0.0 109.343 . . . . . . . . . 0 0 . 1 . 009 nuclear build full ' A' A ' -2' ' ' GLY . . . . . . . . . . . . . . . -69.81 145.28 41.49 Favored Glycine 0 CA--C 1.525 0.702 0 N-CA-C 111.049 -0.82 . . . . 0.0 111.049 -179.55 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' -1' ' ' VAL . . . . . . . . . . . . . 44.7 t -141.86 135.67 29.77 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.34 0 N-CA-C 109.938 -0.393 . . . . 0.0 109.938 179.361 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 0' ' ' ILE . . . . . . . . . . . . . 71.2 mt -107.13 133.0 53.08 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.322 0 N-CA-C 109.779 -0.452 . . . . 0.0 109.779 179.574 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 25.7 ptm -77.69 140.55 39.57 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.198 -0.455 . . . . 0.0 111.17 -177.264 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 5.3 p -115.97 132.99 56.49 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 115.967 -0.56 . . . . 0.0 110.013 177.29 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 84.9 tt0 -146.14 143.85 29.59 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.27 -0.423 . . . . 0.0 111.371 -178.232 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 4' ' ' LEU . . . . . . . . . . . . . 16.8 tp -127.54 132.84 49.84 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 115.937 -0.574 . . . . 0.0 110.079 176.934 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 5' ' ' LYS . . . . . . . . . . . . . 91.6 mttt -112.05 120.64 42.55 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.589 -179.555 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 6' ' ' LEU . . . . . 0.465 HD23 ' HA ' ' A' ' 50' ' ' VAL . 71.5 mt -115.95 142.67 46.47 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 115.471 -0.786 . . . . 0.0 110.305 -178.685 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 39.4 ttmt -122.71 138.42 29.42 Favored Pre-proline 0 CA--C 1.532 0.286 0 CA-C-O 118.991 -0.528 . . . . 0.0 109.807 176.013 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 8' ' ' PRO . . . . . . . . . . . . . 91.3 Cg_endo -91.44 131.76 1.37 Allowed 'Trans proline' 0 N--CA 1.489 1.229 0 C-N-CA 121.702 1.602 . . . . 0.0 111.803 178.688 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 41.2 mt -71.91 -46.98 11.88 Favored Pre-proline 0 C--N 1.327 -0.376 0 CA-C-O 118.648 -0.691 . . . . 0.0 112.004 -179.388 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 83.6 Cg_endo -81.05 150.42 17.93 Favored 'Trans proline' 0 N--CA 1.495 1.581 0 C-N-CA 121.213 1.276 . . . . 0.0 111.878 175.412 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 68.8 mttm -88.85 99.33 12.3 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.401 -0.363 . . . . 0.0 110.496 178.932 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 12.4 p -144.52 149.16 17.52 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.282 0 CA-C-N 116.239 -0.437 . . . . 0.0 110.522 -179.494 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 44.2 mp0 -90.48 120.61 31.72 Favored 'General case' 0 C--N 1.331 -0.208 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.436 179.064 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 14' ' ' LEU . . . . . . . . . . . . . 24.2 mt -98.24 154.23 37.74 Favored Pre-proline 0 C--N 1.329 -0.291 0 CA-C-N 116.351 -0.386 . . . . 0.0 110.867 -179.744 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 15' ' ' PRO . . . . . . . . . . . . . 37.5 Cg_exo -59.63 155.93 39.84 Favored 'Trans proline' 0 N--CA 1.497 1.729 0 C-N-CA 121.272 1.315 . . . . 0.0 111.615 177.742 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 16' ' ' PRO . . . . . . . . . . . . . 35.8 Cg_exo -58.18 -38.29 91.84 Favored 'Trans proline' 0 N--CA 1.496 1.643 0 C-N-CA 121.491 1.461 . . . . 0.0 112.697 -179.514 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 17' ' ' ASP . . . . . . . . . . . . . 15.9 p-10 -85.18 10.69 11.59 Favored 'General case' 0 CA--C 1.534 0.363 0 N-CA-C 113.215 0.82 . . . . 0.0 113.215 -177.816 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 18' ' ' PHE . . . . . . . . . . . . . 42.1 t80 -58.2 -42.3 85.86 Favored 'General case' 0 N--CA 1.458 -0.046 0 O-C-N 121.95 -0.469 . . . . 0.0 110.116 -179.158 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 19' ' ' VAL . . . . . 0.403 HG13 ' N ' ' A' ' 20' ' ' ASP . 12.6 p -55.9 -40.51 62.74 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.287 0 CA-C-N 116.436 -0.347 . . . . 0.0 110.709 179.65 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 20' ' ' ASP . . . . . 0.403 ' N ' HG13 ' A' ' 19' ' ' VAL . 53.9 m-20 -60.59 -44.0 96.74 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-O 120.83 0.348 . . . . 0.0 110.722 -179.394 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 47.0 t -63.64 -47.13 92.67 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.324 0 CA-C-N 116.358 -0.383 . . . . 0.0 110.587 -177.643 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 22' ' ' ILE . . . . . 0.581 HG22 HD12 ' A' ' 26' ' ' LEU . 50.7 mm -54.97 -49.51 70.52 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.204 0 O-C-N 122.227 -0.296 . . . . 0.0 110.835 179.3 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 23' ' ' ARG . . . . . . . . . . . . . 34.8 ttp180 -54.04 -49.32 69.21 Favored 'General case' 0 C--N 1.33 -0.247 0 C-N-CA 121.043 -0.263 . . . . 0.0 111.53 -178.339 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 24' ' ' ILE . . . . . . . . . . . . . 79.1 mt -58.85 -42.0 84.45 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.281 0 C-N-CA 121.181 -0.208 . . . . 0.0 111.428 -177.147 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 45.2 mttm -67.97 -42.13 81.33 Favored 'General case' 0 C--N 1.328 -0.347 0 N-CA-C 112.212 0.449 . . . . 0.0 112.212 -178.442 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 26' ' ' LEU . . . . . 0.581 HD12 HG22 ' A' ' 22' ' ' ILE . 81.6 mt -80.19 -34.72 37.22 Favored 'General case' 0 C--N 1.328 -0.34 0 N-CA-C 113.501 0.926 . . . . 0.0 113.501 -169.64 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 27' ' ' GLN . . . . . . . . . . . . . 15.8 pt20 -46.64 141.52 3.75 Favored 'General case' 0 N--CA 1.467 0.412 0 N-CA-C 112.876 0.695 . . . . 0.0 112.876 -174.84 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 100.25 -26.89 22.83 Favored Glycine 0 CA--C 1.534 1.225 0 CA-C-N 115.644 -0.707 . . . . 0.0 112.166 -177.485 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 49.2 mtpt -97.52 155.04 17.13 Favored 'General case' 0 C--O 1.233 0.205 0 CA-C-N 117.322 0.561 . . . . 0.0 110.976 178.802 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 30' ' ' THR . . . . . . . . . . . . . 25.6 m -106.21 137.71 43.67 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.189 -0.459 . . . . 0.0 110.007 176.436 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 34.9 m -129.14 159.21 41.43 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.275 0 CA-C-N 116.409 -0.359 . . . . 0.0 110.866 -178.286 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 32' ' ' ARG . . . . . . . . . . . . . 76.7 mtm180 -133.46 150.82 51.73 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-O 121.209 0.528 . . . . 0.0 110.564 178.391 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 33' ' ' THR . . . . . . . . . . . . . 13.6 m -52.69 140.23 24.12 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.203 -0.453 . . . . 0.0 111.416 -178.148 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 100.53 -17.16 57.08 Favored Glycine 0 CA--C 1.532 1.111 0 CA-C-O 119.805 -0.442 . . . . 0.0 113.315 179.673 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 74.1 m-20 -66.82 149.31 50.76 Favored 'General case' 0 N--CA 1.461 0.098 0 CA-C-N 118.021 0.91 . . . . 0.0 111.205 178.931 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 45.3 t -119.42 129.87 74.74 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.2 0 CA-C-N 115.915 -0.584 . . . . 0.0 109.737 178.007 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 37' ' ' ILE . . . . . . . . . . . . . 64.1 mt -120.48 138.71 50.1 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.238 0 CA-C-N 116.091 -0.504 . . . . 0.0 109.854 -179.332 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . -116.52 128.8 8.11 Favored Glycine 0 CA--C 1.525 0.701 0 N-CA-C 111.052 -0.819 . . . . 0.0 111.052 179.953 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 39' ' ' ILE . . . . . . . . . . . . . 71.1 mt -126.72 134.24 66.71 Favored 'Isoleucine or valine' 0 C--N 1.333 -0.138 0 CA-C-O 120.822 0.344 . . . . 0.0 110.219 178.988 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 40' ' ' SER . . . . . . . . . . . . . 8.6 t -92.79 114.52 27.1 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.224 -0.444 . . . . 0.0 110.938 175.139 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 41' ' ' ILE . . . . . . . . . . . . . 44.3 mm -121.79 119.37 58.57 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.232 0 CA-C-O 120.87 0.367 . . . . 0.0 110.353 179.912 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 9.4 tp 55.45 36.63 27.52 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.182 -0.463 . . . . 0.0 111.483 177.254 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . 72.43 24.9 75.53 Favored Glycine 0 CA--C 1.532 1.111 0 C-N-CA 121.14 -0.553 . . . . 0.0 112.659 177.929 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 44' ' ' LYS . . . . . . . . . . . . . 43.4 mmtm -132.02 130.9 41.98 Favored 'General case' 0 C--N 1.332 -0.174 0 CA-C-N 117.28 0.54 . . . . 0.0 109.748 178.609 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 84.0 tt0 -83.32 121.22 26.84 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.479 -0.328 . . . . 0.0 111.154 -178.286 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 46' ' ' VAL . . . . . 0.429 HG13 ' O ' ' A' ' 46' ' ' VAL . 11.2 p -119.73 121.41 66.09 Favored 'Isoleucine or valine' 0 C--O 1.232 0.166 0 N-CA-C 109.6 -0.518 . . . . 0.0 109.6 173.935 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 51.9 mtmt -98.72 126.48 44.35 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 115.968 -0.56 . . . . 0.0 110.657 178.243 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 48' ' ' PHE . . . . . . . . . . . . . 46.2 m-85 -110.99 131.85 54.7 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.201 -0.454 . . . . 0.0 109.816 178.631 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 80.9 tttt -106.43 130.89 54.16 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.362 -0.381 . . . . 0.0 110.044 178.329 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 50' ' ' VAL . . . . . 0.465 ' HA ' HD23 ' A' ' 6' ' ' LEU . 43.3 t -75.04 105.54 4.1 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.322 0 N-CA-C 109.414 -0.587 . . . . 0.0 109.414 177.785 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 51' ' ' VAL . . . . . . . . . . . . . 45.8 t -71.24 -51.95 30.54 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.363 0 CA-C-N 116.053 -0.521 . . . . 0.0 109.713 -175.015 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 52' ' ' GLN . . . . . . . . . . . . . 87.1 mt-30 -153.74 151.91 30.16 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-O 121.146 0.498 . . . . 0.0 111.44 -178.313 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -128.08 133.69 49.08 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 115.253 -0.885 . . . . 0.0 109.828 175.819 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 54' ' ' TYR . . . . . . . . . . . . . 58.1 t80 -129.03 108.81 18.15 Favored Pre-proline 0 CA--C 1.535 0.373 0 CA-C-O 118.363 -0.827 . . . . 0.0 110.324 -179.421 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 55' ' ' PRO . . . . . . . . . . . . . 73.5 Cg_endo -77.14 170.13 72.39 Favored 'Cis proline' 0 N--CA 1.499 1.845 0 CA-C-N 121.766 1.666 . . . . 0.0 112.372 -5.47 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 56' ' ' SER . . . . . . . . . . . . . 32.3 m -115.54 127.2 26.99 Favored Pre-proline 0 CA--C 1.538 0.494 0 CA-C-O 118.384 -0.817 . . . . 0.0 109.322 175.495 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 57' ' ' PRO . . . . . . . . . . . . . 36.9 Cg_endo -66.28 167.43 53.59 Favored 'Cis proline' 0 N--CA 1.497 1.682 0 CA-C-N 121.977 1.742 . . . . 0.0 111.708 0.063 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 58' ' ' LEU . . . . . . . . . . . . . 28.5 tp -130.98 137.26 49.16 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.136 -0.484 . . . . 0.0 110.447 -179.912 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 59' ' ' ARG . . . . . . . . . . . . . 70.8 ttt180 -102.44 130.94 49.38 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 116.149 -0.478 . . . . 0.0 109.791 177.163 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 40.8 t -80.43 112.39 18.39 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 CA-C-O 120.878 0.37 . . . . 0.0 110.397 -177.101 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 83.0 tt0 -131.0 155.41 46.87 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 115.84 -0.618 . . . . 0.0 109.461 177.433 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 62' ' ' ASP . . . . . . . . . . . . . 76.3 m-20 -50.5 -30.38 12.72 Favored 'General case' 0 C--N 1.328 -0.356 0 N-CA-C 112.208 0.447 . . . . 0.0 112.208 179.733 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 63' ' ' ARG . . . . . . . . . . . . . 77.2 mtp180 -71.99 -21.6 61.55 Favored 'General case' 0 CA--C 1.534 0.352 0 N-CA-C 112.843 0.682 . . . . 0.0 112.843 -176.768 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 27.5 m -71.59 139.3 49.33 Favored 'General case' 0 C--N 1.332 -0.159 0 CA-C-O 120.971 0.415 . . . . 0.0 111.0 -176.687 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 65' ' ' LYS . . . . . . . . . . . . . 55.0 mtmt -89.09 134.51 33.97 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-N 115.902 -0.59 . . . . 0.0 109.896 176.714 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 66' ' ' ILE . . . . . . . . . . . . . 63.3 mt -115.55 129.83 71.18 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.259 0 N-CA-C 109.925 -0.398 . . . . 0.0 109.925 -178.643 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 67' ' ' THR . . . . . . . . . . . . . 24.5 m -120.02 135.78 54.8 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.851 -179.148 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 68' ' ' LEU . . . . . 0.478 HD23 ' C ' ' A' ' 68' ' ' LEU . 6.6 tt -106.16 123.54 48.18 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 115.701 -0.681 . . . . 0.0 110.039 178.168 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 69' ' ' VAL . . . . . . . . . . . . . 42.3 t -98.46 127.19 51.23 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.293 0 CA-C-N 116.185 -0.461 . . . . 0.0 110.191 -179.259 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 70' ' ' THR . . . . . . . . . . . . . 9.1 m -93.19 -59.97 1.9 Allowed 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.747 -179.69 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 71' ' ' HIS . . . . . . . . . . . . . 46.1 m80 -79.27 161.09 69.07 Favored Pre-proline 0 C--N 1.33 -0.264 0 CA-C-N 116.299 -0.409 . . . . 0.0 110.618 -178.927 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 72' ' ' PRO . . . . . . . . . . . . . 15.6 Cg_endo -84.19 -25.45 2.19 Favored 'Trans proline' 0 N--CA 1.49 1.32 0 C-N-CA 121.605 1.537 . . . . 0.0 112.94 -179.103 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 73' ' ' VAL . . . . . . . . . . . . . 35.6 m -89.52 172.9 0.93 Allowed 'Isoleucine or valine' 0 C--N 1.332 -0.183 0 CA-C-O 120.984 0.421 . . . . 0.0 110.895 -178.544 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 74' ' ' ASP . . . . . . . . . . . . . 9.0 t0 -102.86 124.82 49.1 Favored 'General case' 0 C--N 1.331 -0.22 0 CA-C-N 115.979 -0.555 . . . . 0.0 109.904 -179.285 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 41.0 t -114.26 121.98 67.46 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.255 0 CA-C-O 121.213 0.53 . . . . 0.0 110.521 -178.321 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 76' ' ' LEU . . . . . . . . . . . . . 29.9 mt -117.74 141.29 48.57 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 115.446 -0.797 . . . . 0.0 109.165 176.28 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 77' ' ' GLU . . . . . . . . . . . . . 16.8 tt0 -137.31 133.53 35.05 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-O 120.851 0.358 . . . . 0.0 111.135 -176.11 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 78' ' ' ALA . . . . . . . . . . . . . . . -125.99 141.06 52.13 Favored 'General case' 0 C--N 1.331 -0.202 0 CA-C-N 116.058 -0.519 . . . . 0.0 110.457 178.913 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 79' ' ' LYS . . . . . 0.638 ' O ' HD13 ' A' ' 80' ' ' ILE . 45.0 mmtt -79.63 121.89 25.85 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.382 -0.372 . . . . 0.0 110.38 177.992 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 80' ' ' ILE . . . . . 0.638 HD13 ' O ' ' A' ' 79' ' ' LYS . 38.5 mm -138.9 107.41 3.5 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.343 0 N-CA-C 109.386 -0.598 . . . . 0.0 109.386 -179.413 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 81' ' ' LYS . . . . . . . . . . . . . 28.7 ttpp -103.25 125.22 49.8 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-O 120.811 0.339 . . . . 0.0 111.64 -175.321 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . 89.19 42.05 5.68 Favored Glycine 0 CA--C 1.524 0.646 0 C-N-CA 121.102 -0.57 . . . . 0.0 112.012 172.48 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 83' ' ' ILE . . . . . . . . . . . . . 71.3 mt -72.85 136.75 24.87 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 N-CA-C 109.851 -0.426 . . . . 0.0 109.851 176.965 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 84' ' ' LYS . . . . . . . . . . . . . 39.6 ttpt -100.54 -48.14 4.64 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-O 120.966 0.412 . . . . 0.0 110.105 -179.438 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 85' ' ' ASP . . . . . . . . . . . . . 6.3 t70 -151.41 152.51 33.17 Favored 'General case' 0 C--N 1.331 -0.23 0 CA-C-N 115.891 -0.595 . . . . 0.0 110.548 179.1 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 86' ' ' VAL . . . . . . . . . . . . . 41.5 t -131.16 133.64 62.3 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.266 0 CA-C-O 121.034 0.445 . . . . 0.0 110.664 -178.461 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 87' ' ' ILE . . . . . . . . . . . . . 44.2 mm -119.75 125.48 74.36 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.247 0 CA-C-N 115.757 -0.656 . . . . 0.0 109.434 175.924 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 88' ' ' LEU . . . . . . . . . . . . . 14.5 tp -110.74 134.2 52.68 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-O 121.018 0.437 . . . . 0.0 111.309 -176.069 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 89' ' ' ASP . . . . . . . . . . . . . 12.9 t70 -127.5 155.1 44.28 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 115.875 -0.602 . . . . 0.0 109.829 177.497 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 43.1 tp10 -45.61 -44.09 12.78 Favored 'General case' 0 N--CA 1.465 0.308 0 N-CA-C 113.105 0.78 . . . . 0.0 113.105 -172.432 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 91' ' ' ASN . . . . . . . . . . . . . 66.0 m-80 -128.3 24.42 5.9 Favored 'General case' 0 N--CA 1.467 0.42 0 N-CA-C 112.547 0.573 . . . . 0.0 112.547 -178.421 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 92' ' ' LEU . . . . . . . . . . . . . 13.8 mt -149.78 145.68 26.76 Favored 'General case' 0 C--N 1.332 -0.169 0 N-CA-C 109.689 -0.486 . . . . 0.0 109.689 -176.832 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 93' ' ' ILE . . . . . . . . . . . . . 68.2 mt -128.47 118.54 48.0 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.306 0 N-CA-C 109.491 -0.559 . . . . 0.0 109.491 179.003 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 94' ' ' VAL . . . . . 0.451 HG21 HG11 ' A' ' 125' ' ' VAL . 46.4 t -118.53 126.14 74.91 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.252 0 N-CA-C 109.92 -0.4 . . . . 0.0 109.92 -179.6 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 95' ' ' VAL . . . . . . . . . . . . . 42.1 t -122.21 135.15 63.25 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.317 0 CA-C-N 116.054 -0.521 . . . . 0.0 109.988 -179.336 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 96' ' ' ILE . . . . . 0.423 HD11 ' HB ' ' A' ' 123' ' ' VAL . 67.1 mt -114.07 127.1 71.64 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.291 0 N-CA-C 109.366 -0.605 . . . . 0.0 109.366 179.075 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 97' ' ' THR . . . . . . . . . . . . . 68.0 p -100.08 156.73 17.02 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-O 121.397 0.617 . . . . 0.0 111.442 -176.879 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 98' ' ' GLU . . . . . . . . . . . . . 97.5 mt-10 -53.93 -25.79 22.13 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 115.822 -0.626 . . . . 0.0 112.312 -179.983 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 99' ' ' GLU . . . . . . . . . . . . . 41.5 mt-10 -80.4 18.11 0.96 Allowed 'General case' 0 CA--C 1.534 0.353 0 N-CA-C 113.003 0.742 . . . . 0.0 113.003 -177.148 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 100' ' ' ASN . . . . . . . . . . . . . 1.8 m120 63.87 35.48 10.95 Favored 'General case' 0 CA--C 1.531 0.222 0 CA-C-O 120.93 0.395 . . . . 0.0 111.145 176.634 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 101' ' ' GLU . . . . . . . . . . . . . 85.0 tt0 -118.47 142.33 47.68 Favored 'General case' 0 C--N 1.333 -0.14 0 N-CA-C 110.018 -0.364 . . . . 0.0 110.018 178.369 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 102' ' ' VAL . . . . . . . . . . . . . 45.6 t -116.39 126.67 73.97 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.297 0 N-CA-C 109.851 -0.425 . . . . 0.0 109.851 -178.686 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 103' ' ' LEU . . . . . . . . . . . . . 6.1 mp -118.37 133.48 55.84 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-N 115.807 -0.633 . . . . 0.0 110.458 177.95 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 104' ' ' ILE . . . . . . . . . . . . . 64.5 mt -117.88 119.54 61.85 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.22 0 CA-C-N 116.441 -0.345 . . . . 0.0 110.216 -179.761 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 105' ' ' PHE . . . . . . . . . . . . . 85.3 m-85 -114.87 165.26 13.04 Favored 'General case' 0 C--N 1.333 -0.146 0 O-C-N 124.042 0.839 . . . . 0.0 109.873 178.194 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 106' ' ' ASN . . . . . . . . . . . . . 49.3 p-10 -100.93 -170.27 1.82 Allowed 'General case' 0 C--N 1.331 -0.236 0 N-CA-C 109.636 -0.505 . . . . 0.0 109.636 171.727 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 107' ' ' GLN . . . . . . . . . . . . . 30.2 tt0 -58.06 -28.63 64.71 Favored 'General case' 0 C--N 1.328 -0.347 0 N-CA-C 112.261 0.467 . . . . 0.0 112.261 -179.201 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 108' ' ' ASN . . . . . . . . . . . . . 12.1 t-20 -90.88 14.19 14.4 Favored 'General case' 0 CA--C 1.533 0.314 0 N-CA-C 112.942 0.719 . . . . 0.0 112.942 -176.059 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 109' ' ' LEU . . . . . . . . . . . . . 63.4 mt 57.68 33.76 23.63 Favored 'General case' 0 CA--C 1.53 0.176 0 O-C-N 122.211 -0.306 . . . . 0.0 111.738 179.193 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 110' ' ' GLU . . . . . . . . . . . . . 70.6 mm-40 -99.66 140.83 33.29 Favored 'General case' 0 C--N 1.331 -0.225 0 N-CA-C 109.334 -0.617 . . . . 0.0 109.334 174.527 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 111' ' ' GLU . . . . . . . . . . . . . 47.5 tt0 -81.06 121.89 26.63 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-O 120.889 0.376 . . . . 0.0 110.714 -176.04 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 112' ' ' LEU . . . . . . . . . . . . . 30.9 mt -104.72 -46.02 4.44 Favored 'General case' 0 C--N 1.331 -0.219 0 CA-C-N 115.992 -0.549 . . . . 0.0 110.588 -179.857 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 113' ' ' TYR . . . . . . . . . . . . . 59.4 t80 -135.31 141.12 45.58 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.235 -0.439 . . . . 0.0 110.813 -178.682 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 114' ' ' ARG . . . . . . . . . . . . . 44.5 ptt85 -146.54 121.18 9.8 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.396 -0.366 . . . . 0.0 110.7 178.962 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 115' ' ' GLY . . . . . . . . . . . . . . . -150.15 160.4 28.52 Favored Glycine 0 CA--C 1.525 0.665 0 N-CA-C 111.008 -0.837 . . . . 0.0 111.008 179.296 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 116' ' ' LYS . . . . . . . . . . . . . 27.8 ttmt -125.59 137.41 53.9 Favored 'General case' 0 C--N 1.33 -0.248 0 N-CA-C 109.883 -0.414 . . . . 0.0 109.883 176.966 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 117' ' ' PHE . . . . . . . . . . . . . 44.1 m-85 -134.34 114.93 13.48 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.265 -0.425 . . . . 0.0 110.351 -175.513 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 118' ' ' GLU . . . . . . . . . . . . . 84.1 tt0 -50.62 -53.07 33.73 Favored 'General case' 0 C--N 1.329 -0.305 0 N-CA-C 111.98 0.363 . . . . 0.0 111.98 -176.019 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 119' ' ' ASN . . . . . . . . . . . . . 73.5 m-20 -94.94 31.01 1.94 Allowed 'General case' 0 C--N 1.33 -0.246 0 N-CA-C 112.308 0.484 . . . . 0.0 112.308 -173.505 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 120' ' ' LEU . . . . . . . . . . . . . 16.9 tp -56.4 123.07 13.42 Favored 'General case' 0 C--N 1.332 -0.178 0 C-N-CA 120.87 -0.332 . . . . 0.0 110.528 177.281 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 121' ' ' ASN . . . . . . . . . . . . . 9.9 m120 -114.09 -44.12 3.17 Favored 'General case' 0 C--N 1.331 -0.212 0 CA-C-N 116.55 -0.296 . . . . 0.0 110.985 -177.494 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 122' ' ' LYS . . . . . . . . . . . . . 91.4 mttt -145.15 148.78 33.97 Favored 'General case' 0 C--N 1.331 -0.209 0 CA-C-O 121.028 0.442 . . . . 0.0 111.728 -177.362 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 123' ' ' VAL . . . . . 0.423 ' HB ' HD11 ' A' ' 96' ' ' ILE . 44.6 t -128.63 125.73 64.0 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 N-CA-C 109.071 -0.714 . . . . 0.0 109.071 173.403 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 124' ' ' LEU . . . . . . . . . . . . . 5.8 mp -122.65 142.83 50.24 Favored 'General case' 0 C--N 1.332 -0.188 0 CA-C-O 120.836 0.351 . . . . 0.0 111.014 -175.68 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 125' ' ' VAL . . . . . 0.451 HG11 HG21 ' A' ' 94' ' ' VAL . 35.5 m -137.37 140.58 41.7 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.265 0 CA-C-N 115.999 -0.546 . . . . 0.0 110.581 179.053 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 126' ' ' ARG . . . . . . . . . . . . . 7.2 ptm85 -153.18 131.1 11.73 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-O 120.906 0.384 . . . . 0.0 110.577 176.068 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 127' ' ' ASN . . . . . . . . . . . . . 30.5 m120 50.6 -110.54 0.47 Allowed 'General case' 0 CA--C 1.545 0.763 0 CA-C-O 118.86 -0.591 . . . . 0.0 111.229 -179.691 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 128' ' ' ASP . . . . . . . . . . . . . 8.9 p-10 -114.11 7.79 16.8 Favored 'General case' 0 N--CA 1.468 0.428 0 CA-C-N 119.878 1.217 . . . . 0.0 113.314 -178.081 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 129' ' ' LEU . . . . . . . . . . . . . 11.8 tp -108.92 138.5 45.16 Favored 'General case' 0 C--N 1.332 -0.167 0 CA-C-N 118.153 0.433 . . . . 0.0 110.423 -178.825 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 130' ' ' VAL . . . . . . . . . . . . . 44.5 t -121.56 136.29 58.96 Favored 'Isoleucine or valine' 0 N--CA 1.462 0.169 0 N-CA-C 109.691 -0.485 . . . . 0.0 109.691 179.843 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 131' ' ' VAL . . . . . 0.512 HG22 HD12 ' A' ' 140' ' ' LEU . 39.0 t -134.46 136.31 52.95 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.235 0 CA-C-O 120.974 0.416 . . . . 0.0 110.504 -178.84 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 132' ' ' ILE . . . . . . . . . . . . . 71.0 mt -116.77 131.39 69.56 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 CA-C-N 115.746 -0.661 . . . . 0.0 109.267 178.722 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 133' ' ' ILE . . . . . . . . . . . . . 42.7 mm -119.36 122.3 68.69 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.223 0 CA-C-O 120.746 0.308 . . . . 0.0 110.987 -174.793 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 134' ' ' ASP . . . . . . . . . . . . . 16.6 p-10 -138.82 146.86 41.8 Favored 'General case' 0 C--N 1.332 -0.163 0 CA-C-N 116.272 -0.422 . . . . 0.0 109.872 173.744 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 135' ' ' GLU . . . . . . . . . . . . . 77.8 tt0 -49.9 -23.05 1.73 Allowed 'General case' 0 C--N 1.329 -0.305 0 N-CA-C 113.606 0.965 . . . . 0.0 113.606 -168.013 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 136' ' ' GLN . . . . . . . . . . . . . 22.3 pt20 -96.69 -27.21 14.88 Favored 'General case' 0 C--O 1.235 0.293 0 N-CA-C 112.551 0.574 . . . . 0.0 112.551 -174.011 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 137' ' ' LYS . . . . . . . . . . . . . 53.7 pttt -156.01 165.32 36.8 Favored 'General case' 0 C--O 1.233 0.205 0 CA-C-O 121.599 0.714 . . . . 0.0 112.125 -176.95 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 138' ' ' LEU . . . . . 0.408 ' C ' HD23 ' A' ' 138' ' ' LEU . 6.0 tt -119.58 127.04 52.6 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 115.02 -0.991 . . . . 0.0 109.416 176.375 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 139' ' ' THR . . . . . 0.407 ' N ' HD23 ' A' ' 138' ' ' LEU . 34.1 m -111.78 131.08 55.57 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.368 -0.378 . . . . 0.0 110.572 -178.458 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 140' ' ' LEU . . . . . 0.512 HD12 HG22 ' A' ' 131' ' ' VAL . 12.7 tp -117.31 123.81 47.44 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 115.657 -0.701 . . . . 0.0 109.273 -178.328 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 141' ' ' ILE . . . . . . . . . . . . . 19.5 mt -120.28 118.76 57.84 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.332 0 CA-C-O 120.983 0.42 . . . . 0.0 109.88 -174.859 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 142' ' ' ARG . . . . . . . . . . . . . 29.6 tpt85 -105.3 122.08 45.2 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 115.302 -0.863 . . . . 0.0 109.932 -178.251 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 143' ' ' THR . . . . . . . . . . . . . 57.2 p . . . . . 0 C--O 1.221 -0.445 0 CA-C-O 117.949 -1.024 . . . . 0.0 110.632 -178.721 . . . . . . . . 0 0 . 1 . 009 nuclear build full ' B' B ' -3' ' ' GLU . . . . . . . . . . . . . 84.6 tt0 . . . . . 0 N--CA 1.49 1.569 0 N-CA-C 109.445 -0.576 . . . . 0.0 109.445 . . . . . . . . . 0 0 . 1 . 009 nuclear build full ' B' B ' -2' ' ' GLY . . . . . . . . . . . . . . . -82.31 150.01 28.24 Favored Glycine 0 CA--C 1.525 0.675 0 N-CA-C 111.191 -0.764 . . . . 0.0 111.191 -179.716 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' -1' ' ' VAL . . . . . . . . . . . . . 45.0 t -95.57 135.06 30.85 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.284 0 N-CA-C 109.998 -0.371 . . . . 0.0 109.998 179.257 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 0' ' ' ILE . . . . . . . . . . . . . 71.5 mt -117.07 136.88 52.8 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.241 0 CA-C-N 116.346 -0.388 . . . . 0.0 110.202 -179.247 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 1' ' ' MET . . . . . . . . . . . . . 23.9 ptp -86.97 148.76 25.19 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 116.128 -0.487 . . . . 0.0 110.608 179.553 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 2' ' ' SER . . . . . . . . . . . . . 2.9 p -120.88 131.09 54.19 Favored 'General case' 0 C--N 1.332 -0.192 0 CA-C-N 116.302 -0.408 . . . . 0.0 110.913 -178.236 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 3' ' ' GLU . . . . . . . . . . . . . 84.9 tt0 -144.21 143.15 30.92 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.14 -0.482 . . . . 0.0 111.206 179.998 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 4' ' ' LEU . . . . . . . . . . . . . 15.5 tp -127.04 132.88 50.61 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 115.892 -0.595 . . . . 0.0 110.187 177.264 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 5' ' ' LYS . . . . . . . . . . . . . 95.8 mttt -112.61 122.25 47.13 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.326 -0.397 . . . . 0.0 110.799 -179.279 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 6' ' ' LEU . . . . . . . . . . . . . 38.7 mt -114.05 141.0 47.99 Favored 'General case' 0 C--N 1.332 -0.19 0 CA-C-N 115.506 -0.77 . . . . 0.0 110.266 -179.452 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 7' ' ' LYS . . . . . . . . . . . . . 74.6 tttt -121.97 136.26 26.08 Favored Pre-proline 0 CA--C 1.535 0.385 0 CA-C-O 118.839 -0.601 . . . . 0.0 109.697 176.304 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 8' ' ' PRO . . . . . . . . . . . . . 84.4 Cg_endo -90.47 135.31 2.1 Favored 'Trans proline' 0 N--CA 1.491 1.349 0 C-N-CA 121.656 1.57 . . . . 0.0 112.011 178.357 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 9' ' ' LEU . . . . . . . . . . . . . 53.9 mt -74.2 -47.93 5.96 Favored Pre-proline 0 CA--C 1.535 0.366 0 CA-C-O 118.628 -0.701 . . . . 0.0 112.336 -179.738 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 10' ' ' PRO . . . . . . . . . . . . . 97.4 Cg_endo -79.11 151.98 24.01 Favored 'Trans proline' 0 N--CA 1.497 1.677 0 C-N-CA 121.092 1.195 . . . . 0.0 111.882 177.563 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 11' ' ' LYS . . . . . . . . . . . . . 62.1 tttm -81.27 95.7 7.05 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.333 -0.394 . . . . 0.0 110.167 178.341 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 12' ' ' VAL . . . . . . . . . . . . . 12.3 p -141.69 146.43 23.09 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.321 0 CA-C-N 116.273 -0.421 . . . . 0.0 110.752 -177.629 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 13' ' ' GLU . . . . . . . . . . . . . 85.2 tt0 -99.5 114.61 27.69 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.067 -0.515 . . . . 0.0 109.895 176.581 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 14' ' ' LEU . . . . . . . . . . . . . 32.2 mt -92.46 160.6 34.48 Favored Pre-proline 0 C--N 1.328 -0.33 0 CA-C-N 116.328 -0.396 . . . . 0.0 111.115 -176.341 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 15' ' ' PRO . . . . . . . . . . . . . 35.3 Cg_exo -57.64 155.26 32.51 Favored 'Trans proline' 0 N--CA 1.496 1.62 0 C-N-CA 121.341 1.361 . . . . 0.0 111.874 -179.464 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 16' ' ' PRO . . . . . . . . . . . . . 33.7 Cg_exo -57.19 -40.91 79.22 Favored 'Trans proline' 0 N--CA 1.498 1.74 0 C-N-CA 121.347 1.364 . . . . 0.0 112.734 -178.262 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 17' ' ' ASP . . . . . . . . . . . . . 16.9 p-10 -89.46 15.69 8.85 Favored 'General case' 0 CA--C 1.534 0.362 0 N-CA-C 112.929 0.714 . . . . 0.0 112.929 -177.239 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 18' ' ' PHE . . . . . 0.447 ' CE2' HD11 ' B' ' 22' ' ' ILE . 27.3 t80 -57.14 -39.9 76.11 Favored 'General case' 0 C--O 1.227 -0.089 0 O-C-N 122.052 -0.405 . . . . 0.0 110.438 -179.07 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' B' B ' 19' ' ' VAL . . . . . . . . . . . . . 46.0 t -54.91 -44.59 73.57 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.201 0 CA-C-O 120.762 0.315 . . . . 0.0 110.584 -179.96 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 20' ' ' ASP . . . . . . . . . . . . . 74.8 m-20 -59.92 -40.99 90.76 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.482 -0.326 . . . . 0.0 110.631 -179.738 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 21' ' ' VAL . . . . . . . . . . . . . 47.5 t -62.69 -45.08 99.7 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.305 0 CA-C-N 116.448 -0.342 . . . . 0.0 110.265 -178.526 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 22' ' ' ILE . . . . . 0.714 HG22 HD12 ' B' ' 26' ' ' LEU . 51.0 mm -55.14 -49.74 69.52 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.332 0 C-N-CA 121.136 -0.226 . . . . 0.0 110.649 178.224 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' B' B ' 23' ' ' ARG . . . . . 0.46 ' HB2' HD12 ' B' ' 66' ' ' ILE . 58.7 ttp180 -53.83 -47.05 71.29 Favored 'General case' 0 C--N 1.33 -0.281 0 C-N-CA 121.079 -0.248 . . . . 0.0 111.538 -179.019 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' B' B ' 24' ' ' ILE . . . . . . . . . . . . . 70.9 mt -57.88 -45.42 87.53 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.322 0 C-N-CA 121.065 -0.254 . . . . 0.0 111.067 -177.224 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 25' ' ' LYS . . . . . . . . . . . . . 46.1 mtmt -70.21 -34.19 72.61 Favored 'General case' 0 C--N 1.328 -0.34 0 N-CA-C 112.378 0.51 . . . . 0.0 112.378 -177.607 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 26' ' ' LEU . . . . . 0.714 HD12 HG22 ' B' ' 22' ' ' ILE . 31.2 mt -80.87 -38.17 28.59 Favored 'General case' 0 C--N 1.331 -0.232 0 N-CA-C 113.579 0.955 . . . . 0.0 113.579 -171.514 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' B' B ' 27' ' ' GLN . . . . . . . . . . . . . 18.1 pt20 -45.39 139.42 3.64 Favored 'General case' 0 N--CA 1.47 0.557 0 N-CA-C 113.071 0.767 . . . . 0.0 113.071 -173.2 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 28' ' ' GLY . . . . . . . . . . . . . . . 98.27 -27.17 20.58 Favored Glycine 0 CA--C 1.532 1.124 0 CA-C-N 115.53 -0.759 . . . . 0.0 112.257 -178.003 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 29' ' ' LYS . . . . . . . . . . . . . 99.1 mttt -97.46 155.18 17.05 Favored 'General case' 0 C--O 1.233 0.22 0 CA-C-N 117.257 0.529 . . . . 0.0 111.066 179.159 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 30' ' ' THR . . . . . . . . . . . . . 34.7 m -105.26 138.57 41.25 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 115.879 -0.601 . . . . 0.0 110.035 176.108 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 31' ' ' VAL . . . . . . . . . . . . . 34.6 m -127.52 151.38 34.29 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.225 0 CA-C-O 120.925 0.393 . . . . 0.0 110.855 -178.634 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 32' ' ' ARG . . . . . . . . . . . . . 58.3 ttp180 -127.18 148.8 50.18 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.042 -0.526 . . . . 0.0 110.551 179.43 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 33' ' ' THR . . . . . . . . . . . . . 25.4 m -52.93 137.43 32.56 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.339 -0.391 . . . . 0.0 111.289 179.985 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 34' ' ' GLY . . . . . . . . . . . . . . . 100.96 -17.17 56.64 Favored Glycine 0 CA--C 1.533 1.175 0 C-N-CA 121.191 -0.528 . . . . 0.0 113.202 179.764 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 35' ' ' ASP . . . . . . . . . . . . . 57.3 m-20 -65.75 151.26 47.0 Favored 'General case' 0 C--O 1.232 0.168 0 CA-C-N 118.007 0.903 . . . . 0.0 111.089 179.86 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 36' ' ' VAL . . . . . . . . . . . . . 45.1 t -123.93 130.36 73.91 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.245 0 CA-C-N 116.048 -0.524 . . . . 0.0 109.868 178.717 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 37' ' ' ILE . . . . . . . . . . . . . 62.1 mt -120.09 137.63 53.29 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.206 0 CA-C-N 116.136 -0.484 . . . . 0.0 109.919 -179.969 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 38' ' ' GLY . . . . . . . . . . . . . . . -118.72 128.78 7.84 Favored Glycine 0 CA--C 1.525 0.712 0 N-CA-C 111.028 -0.829 . . . . 0.0 111.028 179.597 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 39' ' ' ILE . . . . . . . . . . . . . 70.8 mt -126.7 131.85 70.74 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.245 0 CA-C-O 120.825 0.345 . . . . 0.0 110.158 178.87 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 40' ' ' SER . . . . . . . . . . . . . 33.6 t -91.66 120.9 32.84 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.28 -0.418 . . . . 0.0 110.797 177.039 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 41' ' ' ILE . . . . . . . . . . . . . 72.7 mt -133.84 126.49 50.83 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.18 0 CA-C-O 120.884 0.373 . . . . 0.0 110.539 178.772 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 42' ' ' LEU . . . . . . . . . . . . . 42.7 mt 54.79 34.64 22.31 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-N 116.018 -0.537 . . . . 0.0 111.79 176.15 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 43' ' ' GLY . . . . . . . . . . . . . . . 71.89 29.36 67.28 Favored Glycine 0 CA--C 1.531 1.053 0 C-N-CA 121.027 -0.606 . . . . 0.0 112.311 177.683 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 44' ' ' LYS . . . . . . . . . . . . . 53.6 tttm -141.53 127.11 18.95 Favored 'General case' 0 C--N 1.33 -0.259 0 N-CA-C 109.754 -0.461 . . . . 0.0 109.754 178.144 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 45' ' ' GLU . . . . . . . . . . . . . 80.4 tt0 -84.07 123.36 29.95 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 116.441 -0.345 . . . . 0.0 111.133 -178.386 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 46' ' ' VAL . . . . . 0.43 ' O ' HG13 ' B' ' 46' ' ' VAL . 10.6 p -115.59 120.83 65.86 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.195 0 N-CA-C 109.473 -0.566 . . . . 0.0 109.473 175.034 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' B' B ' 47' ' ' LYS . . . . . . . . . . . . . 52.2 mtpt -99.2 126.98 45.11 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.047 -0.524 . . . . 0.0 110.968 178.248 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 48' ' ' PHE . . . . . . . . . . . . . 37.7 m-85 -110.12 132.0 54.55 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.049 -0.523 . . . . 0.0 109.746 176.7 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 49' ' ' LYS . . . . . . . . . . . . . 85.6 tttt -106.21 132.05 52.73 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.319 -0.401 . . . . 0.0 110.002 178.407 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 50' ' ' VAL . . . . . . . . . . . . . 44.4 t -76.19 105.46 5.12 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.392 0 N-CA-C 109.471 -0.566 . . . . 0.0 109.471 178.252 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 51' ' ' VAL . . . . . . . . . . . . . 50.6 t -73.41 -46.42 49.27 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.261 0 CA-C-N 116.042 -0.526 . . . . 0.0 110.089 -174.05 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 52' ' ' GLN . . . . . . . . . . . . . 30.6 tt0 -157.87 144.4 17.72 Favored 'General case' 0 C--N 1.332 -0.166 0 C-N-CA 120.09 -0.644 . . . . 0.0 111.894 -178.085 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 53' ' ' ALA . . . . . . . . . . . . . . . -123.5 130.91 53.38 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 115.442 -0.799 . . . . 0.0 109.775 176.364 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 54' ' ' TYR . . . . . . . . . . . . . 64.8 t80 -128.95 109.84 18.37 Favored Pre-proline 0 CA--C 1.535 0.377 0 CA-C-O 118.15 -0.928 . . . . 0.0 110.449 179.99 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 55' ' ' PRO . . . . . . . . . . . . . 74.1 Cg_endo -77.05 169.94 73.01 Favored 'Cis proline' 0 N--CA 1.499 1.841 0 CA-C-N 121.993 1.748 . . . . 0.0 112.436 -5.299 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 56' ' ' SER . . . . . . . . . . . . . 13.6 m -114.95 126.14 28.19 Favored Pre-proline 0 CA--C 1.537 0.463 0 CA-C-O 118.416 -0.802 . . . . 0.0 109.241 175.824 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 57' ' ' PRO . . . . . . . . . . . . . 61.3 Cg_endo -74.18 152.65 98.5 Favored 'Cis proline' 0 N--CA 1.495 1.61 0 CA-C-N 121.976 1.741 . . . . 0.0 111.873 1.36 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 58' ' ' LEU . . . . . . . . . . . . . 17.8 tp -109.44 136.09 49.41 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.165 -0.471 . . . . 0.0 110.819 -178.292 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 59' ' ' ARG . . . . . . . . . . . . . 57.4 ttp180 -105.2 126.2 51.82 Favored 'General case' 0 C--N 1.329 -0.319 0 N-CA-C 109.509 -0.552 . . . . 0.0 109.509 176.076 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 60' ' ' VAL . . . . . . . . . . . . . 40.4 t -83.23 121.03 35.58 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.315 0 C-N-CA 120.694 -0.402 . . . . 0.0 111.046 -174.498 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 61' ' ' GLU . . . . . . . . . . . . . 95.4 mt-10 -131.01 165.68 22.65 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 115.674 -0.694 . . . . 0.0 109.424 175.243 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 62' ' ' ASP . . . . . . . . . . . . . 79.8 m-20 -52.47 -33.45 44.6 Favored 'General case' 0 C--N 1.329 -0.324 0 N-CA-C 112.056 0.391 . . . . 0.0 112.056 -175.64 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 63' ' ' ARG . . . . . . . . . . . . . 65.8 mtp180 -76.58 -21.97 54.89 Favored 'General case' 0 C--N 1.329 -0.297 0 N-CA-C 113.088 0.773 . . . . 0.0 113.088 -175.512 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 64' ' ' THR . . . . . . . . . . . . . 29.8 m -61.1 138.28 58.21 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-O 120.915 0.388 . . . . 0.0 111.164 -175.137 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 65' ' ' LYS . . . . . . . . . . . . . 55.6 mttm -89.99 133.32 34.87 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 115.913 -0.585 . . . . 0.0 110.38 179.129 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 66' ' ' ILE . . . . . 0.46 HD12 ' HB2' ' B' ' 23' ' ' ARG . 66.8 mt -120.05 129.84 74.98 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.202 0 N-CA-C 109.93 -0.396 . . . . 0.0 109.93 178.0 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' B' B ' 67' ' ' THR . . . . . . . . . . . . . 31.4 m -121.33 140.13 52.5 Favored 'General case' 0 C--N 1.331 -0.213 0 CA-C-N 116.062 -0.517 . . . . 0.0 111.002 -178.352 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 68' ' ' LEU . . . . . 0.476 ' C ' HD23 ' B' ' 68' ' ' LEU . 6.1 tt -104.05 123.6 47.53 Favored 'General case' 0 C--N 1.331 -0.225 0 CA-C-N 115.863 -0.608 . . . . 0.0 110.238 178.882 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' B' B ' 69' ' ' VAL . . . . . 0.424 ' N ' HD23 ' B' ' 68' ' ' LEU . 45.0 t -101.44 136.84 31.39 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.327 0 CA-C-N 116.069 -0.514 . . . . 0.0 109.888 179.704 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' B' B ' 70' ' ' THR . . . . . . . . . . . . . 5.6 t -85.44 161.7 19.3 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.329 -0.396 . . . . 0.0 110.924 -178.643 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 71' ' ' HIS . . . . . . . . . . . . . 4.0 t60 -73.58 112.52 16.49 Favored Pre-proline 0 CA--C 1.534 0.357 0 CA-C-O 118.845 -0.598 . . . . 0.0 110.754 -178.788 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 72' ' ' PRO . . . . . . . . . . . . . 97.7 Cg_endo -94.19 156.96 2.13 Favored 'Trans proline' 0 N--CA 1.491 1.347 0 C-N-CA 121.758 1.639 . . . . 0.0 112.255 179.054 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 73' ' ' VAL . . . . . . . . . . . . . 35.5 m -70.1 178.01 0.44 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.325 0 CA-C-N 116.283 -0.417 . . . . 0.0 109.882 177.288 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 74' ' ' ASP . . . . . . . . . . . . . 27.6 t0 -99.86 116.46 31.98 Favored 'General case' 0 C--N 1.331 -0.217 0 C-N-CA 120.794 -0.363 . . . . 0.0 110.041 -178.804 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 75' ' ' VAL . . . . . . . . . . . . . 44.4 t -114.97 123.13 70.36 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.217 0 CA-C-O 120.96 0.41 . . . . 0.0 110.401 -177.658 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 76' ' ' LEU . . . . . . . . . . . . . 26.0 mt -125.31 146.95 49.33 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 115.775 -0.648 . . . . 0.0 109.65 178.806 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 77' ' ' GLU . . . . . . . . . . . . . 96.8 mt-10 -138.48 141.95 39.42 Favored 'General case' 0 C--N 1.332 -0.188 0 CA-C-O 121.016 0.436 . . . . 0.0 111.57 -177.656 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 78' ' ' ALA . . . . . 0.58 ' HB2' HD21 ' B' ' 109' ' ' LEU . . . -129.81 139.41 51.24 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 115.801 -0.636 . . . . 0.0 110.003 175.827 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' B' B ' 79' ' ' LYS . . . . . 0.45 ' O ' HD13 ' B' ' 80' ' ' ILE . 98.2 mttt -79.4 119.54 22.56 Favored 'General case' 0 C--N 1.331 -0.198 0 CA-C-O 120.78 0.324 . . . . 0.0 110.937 -178.128 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' B' B ' 80' ' ' ILE . . . . . 0.45 HD13 ' O ' ' B' ' 79' ' ' LYS . 25.9 mm -139.19 113.08 6.91 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 N-CA-C 109.171 -0.678 . . . . 0.0 109.171 -178.673 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' B' B ' 81' ' ' LYS . . . . . . . . . . . . . 62.4 mttm -108.99 127.27 53.93 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-O 121.04 0.448 . . . . 0.0 111.376 -177.173 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 82' ' ' GLY . . . . . . . . . . . . . . . 89.15 41.99 5.71 Favored Glycine 0 CA--C 1.526 0.747 0 CA-C-N 115.833 -0.621 . . . . 0.0 111.823 174.199 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 83' ' ' ILE . . . . . . . . . . . . . 71.0 mt -72.95 140.44 17.88 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.318 0 N-CA-C 110.099 -0.334 . . . . 0.0 110.099 178.329 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 84' ' ' LYS . . . . . . . . . . . . . 28.5 ttmt -97.53 -53.22 3.51 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.174 -0.466 . . . . 0.0 109.94 179.175 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 85' ' ' ASP . . . . . . . . . . . . . 7.0 t70 -152.38 151.51 30.92 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 115.76 -0.655 . . . . 0.0 110.556 -179.535 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 86' ' ' VAL . . . . . . . . . . . . . 42.8 t -128.82 130.11 68.52 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.24 0 CA-C-O 120.912 0.387 . . . . 0.0 110.289 -179.238 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 87' ' ' ILE . . . . . 0.498 ' N ' HD12 ' B' ' 87' ' ' ILE . 5.1 mp -119.44 128.26 75.86 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.178 0 N-CA-C 109.531 -0.544 . . . . 0.0 109.531 177.134 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' B' B ' 88' ' ' LEU . . . . . . . . . . . . . 57.0 mt -114.34 140.89 48.26 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-O 121.204 0.526 . . . . 0.0 111.263 -177.764 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 89' ' ' ASP . . . . . . . . . . . . . 5.0 t70 -132.27 158.94 40.53 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 115.376 -0.829 . . . . 0.0 109.457 176.517 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 90' ' ' GLU . . . . . . . . . . . . . 83.0 tt0 -46.33 -41.68 13.7 Favored 'General case' 0 C--N 1.331 -0.238 0 N-CA-C 112.975 0.731 . . . . 0.0 112.975 -173.19 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 91' ' ' ASN . . . . . . . . . . . . . 9.5 p-10 -132.19 38.01 3.52 Favored 'General case' 0 N--CA 1.464 0.231 0 CA-C-O 120.704 0.288 . . . . 0.0 111.391 -177.696 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 92' ' ' LEU . . . . . . . . . . . . . 11.6 tp -163.45 142.23 8.11 Favored 'General case' 0 C--N 1.331 -0.226 0 C-N-CA 120.865 -0.334 . . . . 0.0 110.89 -177.978 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 93' ' ' ILE . . . . . . . . . . . . . 76.9 mt -127.65 119.08 50.92 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 N-CA-C 109.284 -0.635 . . . . 0.0 109.284 177.715 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 94' ' ' VAL . . . . . 0.749 HG21 HG11 ' B' ' 125' ' ' VAL . 47.3 t -123.44 127.11 74.07 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.234 0 CA-C-O 120.978 0.418 . . . . 0.0 110.123 -179.8 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' B' B ' 95' ' ' VAL . . . . . . . . . . . . . 41.9 t -121.97 137.18 56.43 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.337 0 CA-C-N 115.741 -0.663 . . . . 0.0 109.91 -178.377 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 96' ' ' ILE . . . . . 0.522 HD11 ' HB ' ' B' ' 123' ' ' VAL . 58.0 mt -114.75 127.8 72.12 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.263 0 N-CA-C 109.362 -0.607 . . . . 0.0 109.362 179.126 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' B' B ' 97' ' ' THR . . . . . . . . . . . . . 67.6 p -102.5 154.34 19.19 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-O 121.199 0.524 . . . . 0.0 111.383 -177.626 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 98' ' ' GLU . . . . . . . . . . . . . 46.5 tp10 -53.95 -25.56 21.24 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 115.984 -0.553 . . . . 0.0 112.207 179.751 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 99' ' ' GLU . . . . . . . . . . . . . 32.6 tt0 -78.82 16.74 0.82 Allowed 'General case' 0 CA--C 1.537 0.469 0 N-CA-C 112.812 0.671 . . . . 0.0 112.812 -177.82 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 100' ' ' ASN . . . . . . . . . . . . . 4.1 m-20 61.67 37.94 15.59 Favored 'General case' 0 CA--C 1.53 0.181 0 O-C-N 121.894 -0.503 . . . . 0.0 110.855 178.066 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 101' ' ' GLU . . . . . . . . . . . . . 84.5 tt0 -116.54 143.35 45.71 Favored 'General case' 0 C--N 1.333 -0.149 0 CA-C-N 115.935 -0.575 . . . . 0.0 109.724 177.603 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 102' ' ' VAL . . . . . . . . . . . . . 44.7 t -114.98 125.05 72.2 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.331 0 CA-C-N 116.206 -0.452 . . . . 0.0 109.857 -178.822 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 103' ' ' LEU . . . . . . . . . . . . . 24.2 mt -116.84 128.26 55.09 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 115.807 -0.633 . . . . 0.0 110.348 177.84 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 104' ' ' ILE . . . . . . . . . . . . . 68.1 mt -120.39 121.04 64.57 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.26 0 CA-C-N 116.64 -0.254 . . . . 0.0 110.428 179.688 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 105' ' ' PHE . . . . . . . . . . . . . 52.5 m-85 -121.85 166.77 13.88 Favored 'General case' 0 C--N 1.333 -0.139 0 CA-C-N 115.674 -0.693 . . . . 0.0 109.678 178.611 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 106' ' ' ASN . . . . . . . . . . . . . 45.1 p-10 -99.57 -171.02 1.99 Allowed 'General case' 0 C--N 1.329 -0.285 0 N-CA-C 109.876 -0.416 . . . . 0.0 109.876 173.318 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 107' ' ' GLN . . . . . . . . . . . . . 45.4 tt0 -60.23 -29.63 68.87 Favored 'General case' 0 C--N 1.329 -0.293 0 N-CA-C 112.001 0.371 . . . . 0.0 112.001 179.979 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 108' ' ' ASN . . . . . . . . . . . . . 4.5 t-20 -82.49 7.34 14.64 Favored 'General case' 0 CA--C 1.536 0.431 0 N-CA-C 113.163 0.801 . . . . 0.0 113.163 -177.633 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 109' ' ' LEU . . . . . 0.58 HD21 ' HB2' ' B' ' 78' ' ' ALA . 12.5 tp 61.63 38.18 15.53 Favored 'General case' 0 C--N 1.333 -0.139 0 CA-C-O 121.165 0.507 . . . . 0.0 111.205 179.073 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' B' B ' 110' ' ' GLU . . . . . . . . . . . . . 95.7 mt-10 -108.07 148.13 30.21 Favored 'General case' 0 C--N 1.33 -0.281 0 N-CA-C 109.539 -0.541 . . . . 0.0 109.539 174.871 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 111' ' ' GLU . . . . . . . . . . . . . 49.3 tt0 -83.21 122.03 27.87 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-O 120.896 0.379 . . . . 0.0 111.023 -175.624 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 112' ' ' LEU . . . . . . . . . . . . . 84.8 mt -104.83 -46.03 4.41 Favored 'General case' 0 C--N 1.331 -0.203 0 CA-C-N 116.025 -0.534 . . . . 0.0 110.591 178.844 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 113' ' ' TYR . . . . . . . . . . . . . 42.3 t80 -137.15 136.71 38.48 Favored 'General case' 0 C--N 1.331 -0.223 0 CA-C-N 116.357 -0.383 . . . . 0.0 111.363 -177.823 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 114' ' ' ARG . . . . . . . . . . . . . 46.2 ttp180 -137.17 125.64 23.51 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 115.913 -0.585 . . . . 0.0 110.039 176.474 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 115' ' ' GLY . . . . . . . . . . . . . . . -150.03 154.71 25.85 Favored Glycine 0 CA--C 1.525 0.667 0 C-N-CA 120.756 -0.735 . . . . 0.0 111.271 178.932 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 116' ' ' LYS . . . . . . . . . . . . . 30.8 ttpt -128.62 130.67 47.62 Favored 'General case' 0 C--N 1.329 -0.304 0 N-CA-C 109.797 -0.446 . . . . 0.0 109.797 177.778 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 117' ' ' PHE . . . . . . . . . . . . . 46.1 m-85 -128.79 116.21 19.13 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-O 120.926 0.393 . . . . 0.0 110.464 -175.987 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 118' ' ' GLU . . . . . . . . . . . . . 95.9 mt-10 -52.65 -46.76 67.29 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.361 -0.381 . . . . 0.0 111.573 -176.942 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 119' ' ' ASN . . . . . . . . . . . . . 9.8 m120 -99.57 30.97 3.35 Favored 'General case' 0 C--N 1.33 -0.272 0 N-CA-C 112.22 0.452 . . . . 0.0 112.22 -174.35 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 120' ' ' LEU . . . . . . . . . . . . . 15.8 tp -54.21 125.78 20.47 Favored 'General case' 0 N--CA 1.462 0.17 0 CA-C-O 120.718 0.294 . . . . 0.0 110.984 179.22 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 121' ' ' ASN . . . . . . . . . . . . . 31.3 m120 -107.92 -44.1 4.28 Favored 'General case' 0 C--N 1.331 -0.212 0 CA-C-N 116.367 -0.379 . . . . 0.0 110.806 -177.98 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 122' ' ' LYS . . . . . . . . . . . . . 1.2 ptpm? -160.29 157.35 27.9 Favored 'General case' 0 C--N 1.332 -0.19 0 CA-C-O 121.231 0.538 . . . . 0.0 112.056 -179.348 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 123' ' ' VAL . . . . . 0.522 ' HB ' HD11 ' B' ' 96' ' ' ILE . 46.8 t -127.23 131.51 70.53 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.224 0 CA-C-N 115.587 -0.733 . . . . 0.0 109.526 176.707 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' B' B ' 124' ' ' LEU . . . . . . . . . . . . . 14.4 tp -126.8 138.81 53.41 Favored 'General case' 0 N--CA 1.463 0.19 0 CA-C-N 116.496 -0.32 . . . . 0.0 110.541 -177.988 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 125' ' ' VAL . . . . . 0.749 HG11 HG21 ' B' ' 94' ' ' VAL . 34.7 m -132.68 141.99 43.6 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.182 0 CA-C-O 120.835 0.35 . . . . 0.0 111.328 -177.654 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' B' B ' 126' ' ' ARG . . . . . . . . . . . . . 88.9 mtt180 -146.57 118.07 7.97 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.658 175.128 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 127' ' ' ASN . . . . . . . . . . . . . 75.2 m-80 52.0 -106.43 0.27 Allowed 'General case' 0 CA--C 1.544 0.715 0 CA-C-O 118.97 -0.538 . . . . 0.0 111.256 178.996 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 128' ' ' ASP . . . . . . . . . . . . . 15.5 p-10 -114.07 3.16 15.18 Favored 'General case' 0 N--CA 1.469 0.484 0 CA-C-N 119.649 1.113 . . . . 0.0 113.295 -177.893 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 129' ' ' LEU . . . . . . . . . . . . . 15.6 tp -105.34 135.48 46.65 Favored 'General case' 0 C--N 1.332 -0.184 0 N-CA-C 109.553 -0.536 . . . . 0.0 109.553 178.084 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 130' ' ' VAL . . . . . . . . . . . . . 41.1 t -124.63 140.46 47.79 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.235 0 N-CA-C 110.136 -0.32 . . . . 0.0 110.136 -177.751 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 131' ' ' VAL . . . . . 0.403 HG22 HD12 ' B' ' 140' ' ' LEU . 41.5 t -133.51 135.07 56.39 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 CA-C-O 120.963 0.411 . . . . 0.0 110.145 178.788 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' B' B ' 132' ' ' ILE . . . . . . . . . . . . . 70.1 mt -116.92 131.41 69.68 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.314 0 N-CA-C 109.197 -0.668 . . . . 0.0 109.197 178.297 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 133' ' ' ILE . . . . . . . . . . . . . 43.3 mm -115.94 120.94 66.3 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.316 0 CA-C-N 116.406 -0.361 . . . . 0.0 110.819 -174.901 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 134' ' ' ASP . . . . . . . . . . . . . 8.6 p-10 -134.37 147.48 50.52 Favored 'General case' 0 C--N 1.331 -0.2 0 N-CA-C 109.545 -0.539 . . . . 0.0 109.545 174.346 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 135' ' ' GLU . . . . . . . . . . . . . 84.9 tt0 -49.84 -24.36 2.39 Favored 'General case' 0 C--N 1.328 -0.357 0 N-CA-C 112.894 0.702 . . . . 0.0 112.894 -172.537 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 136' ' ' GLN . . . . . . . . . . . . . 96.1 mt-30 -99.81 -27.93 13.39 Favored 'General case' 0 N--CA 1.463 0.182 0 N-CA-C 112.727 0.64 . . . . 0.0 112.727 -174.672 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 137' ' ' LYS . . . . . . . . . . . . . 94.4 mttt -141.94 150.66 41.73 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-O 121.467 0.651 . . . . 0.0 112.296 -169.531 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 138' ' ' LEU . . . . . . . . . . . . . 11.3 tp -112.06 118.48 35.53 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 114.988 -1.005 . . . . 0.0 108.987 170.945 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 139' ' ' THR . . . . . . . . . . . . . 25.6 m -110.38 125.22 52.98 Favored 'General case' 0 C--N 1.331 -0.216 0 CA-C-O 120.644 0.259 . . . . 0.0 111.127 -177.014 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 140' ' ' LEU . . . . . 0.403 HD12 HG22 ' B' ' 131' ' ' VAL . 23.3 tp -114.56 122.8 47.65 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 115.652 -0.704 . . . . 0.0 109.354 179.586 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' B' B ' 141' ' ' ILE . . . . . . . . . . . . . 19.3 mt -121.87 125.16 72.86 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.247 0 CA-C-O 120.856 0.36 . . . . 0.0 110.199 -174.094 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 142' ' ' ARG . . . . . . . . . . . . . 79.0 mtp180 -114.53 129.38 56.66 Favored 'General case' 0 C--N 1.331 -0.212 0 CA-C-N 115.67 -0.695 . . . . 0.0 110.351 -179.34 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 143' ' ' THR . . . . . . . . . . . . . 26.0 p . . . . . 0 C--O 1.221 -0.424 0 CA-C-O 118.015 -0.993 . . . . 0.0 110.525 179.749 . . . . . . . . 0 0 . 1 . 009 nuclear build full ' C' C ' -3' ' ' GLU . . . . . . . . . . . . . 95.8 mt-10 . . . . . 0 N--CA 1.49 1.557 0 N-CA-C 109.368 -0.604 . . . . 0.0 109.368 . . . . . . . . . 0 0 . 1 . 009 nuclear build full ' C' C ' -2' ' ' GLY . . . . . . . . . . . . . . . -88.18 135.44 13.09 Favored Glycine 0 CA--C 1.525 0.689 0 N-CA-C 110.916 -0.873 . . . . 0.0 110.916 179.751 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' C' C ' -1' ' ' VAL . . . . . . . . . . . . . 43.3 t -142.21 139.55 29.83 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.284 0 CA-C-O 120.773 0.321 . . . . 0.0 110.144 -179.996 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' C' C ' 0' ' ' ILE . . . . . . . . . . . . . 72.1 mt -109.78 136.52 45.45 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.257 0 CA-C-N 116.141 -0.481 . . . . 0.0 109.772 179.357 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' C' C ' 1' ' ' MET . . . . . . . . . . . . . 25.6 ptp -77.92 157.61 29.7 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.104 -0.498 . . . . 0.0 110.935 -178.541 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' C' C ' 2' ' ' SER . . . . . . . . . . . . . 2.3 p -126.99 123.93 38.26 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.095 -0.502 . . . . 0.0 110.36 178.287 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' C' C ' 3' ' ' GLU . . . . . . . . . . . . . 85.3 tt0 -140.12 141.6 36.09 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 115.795 -0.639 . . . . 0.0 111.088 -177.001 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' C' C ' 4' ' ' LEU . . . . . 0.422 HD21 HD21 ' C' ' 6' ' ' LEU . 13.2 tp -124.11 130.39 52.46 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 115.765 -0.652 . . . . 0.0 110.116 177.497 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' C' C ' 5' ' ' LYS . . . . . . . . . . . . . 53.5 mttp -108.65 120.35 42.21 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.185 -0.462 . . . . 0.0 110.541 179.817 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' C' C ' 6' ' ' LEU . . . . . 0.422 HD21 HD21 ' C' ' 4' ' ' LEU . 55.4 mt -114.48 147.93 38.6 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 115.427 -0.806 . . . . 0.0 110.45 -178.827 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' C' C ' 7' ' ' LYS . . . . . . . . . . . . . 78.7 tttt -139.85 138.87 20.4 Favored Pre-proline 0 CA--C 1.534 0.328 0 CA-C-O 119.081 -0.485 . . . . 0.0 110.162 176.249 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' C' C ' 8' ' ' PRO . . . . . . . . . . . . . 98.2 Cg_endo -92.08 144.43 2.81 Favored 'Trans proline' 0 N--CA 1.49 1.267 0 C-N-CA 121.69 1.593 . . . . 0.0 111.812 177.482 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' C' C ' 9' ' ' LEU . . . . . . . . . . . . . 53.0 mt -74.94 -47.1 4.88 Favored Pre-proline 0 CA--C 1.534 0.353 0 CA-C-O 118.699 -0.667 . . . . 0.0 112.051 -179.524 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' C' C ' 10' ' ' PRO . . . . . . . . . . . . . 96.5 Cg_endo -82.28 156.56 17.04 Favored 'Trans proline' 0 N--CA 1.496 1.64 0 C-N-CA 121.221 1.281 . . . . 0.0 111.808 175.27 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' C' C ' 11' ' ' LYS . . . . . . . . . . . . . 59.3 tttm -88.7 106.57 18.42 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.428 -0.351 . . . . 0.0 110.24 178.32 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' C' C ' 12' ' ' VAL . . . . . . . . . . . . . 12.4 p -140.46 148.47 22.19 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.243 0 CA-C-N 116.248 -0.433 . . . . 0.0 110.632 -178.659 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' C' C ' 13' ' ' GLU . . . . . . . . . . . . . 83.2 tt0 -90.91 122.0 33.23 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 116.131 -0.486 . . . . 0.0 110.21 178.522 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' C' C ' 14' ' ' LEU . . . . . . . . . . . . . 35.5 mt -98.55 151.84 37.64 Favored Pre-proline 0 CA--C 1.532 0.282 0 CA-C-N 116.383 -0.371 . . . . 0.0 110.948 -176.706 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' C' C ' 15' ' ' PRO . . . . . . . . . . . . . 24.2 Cg_exo -63.96 158.01 49.75 Favored 'Trans proline' 0 N--CA 1.497 1.722 0 C-N-CA 121.266 1.311 . . . . 0.0 111.721 174.871 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' C' C ' 16' ' ' PRO . . . . . . . . . . . . . 39.4 Cg_exo -58.72 -38.87 86.86 Favored 'Trans proline' 0 N--CA 1.496 1.665 0 C-N-CA 121.409 1.406 . . . . 0.0 112.776 -178.965 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' C' C ' 17' ' ' ASP . . . . . . . . . . . . . 12.7 p-10 -87.95 11.94 14.54 Favored 'General case' 0 CA--C 1.536 0.424 0 N-CA-C 113.148 0.796 . . . . 0.0 113.148 -177.402 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' C' C ' 18' ' ' PHE . . . . . . . . . . . . . 44.9 t80 -57.95 -44.74 87.17 Favored 'General case' 0 C--N 1.335 -0.065 0 O-C-N 122.007 -0.433 . . . . 0.0 110.113 -178.826 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' C' C ' 19' ' ' VAL . . . . . 0.413 HG13 ' N ' ' C' ' 20' ' ' ASP . 12.7 p -56.94 -41.61 77.15 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.357 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.726 -179.145 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' C' C ' 20' ' ' ASP . . . . . 0.413 ' N ' HG13 ' C' ' 19' ' ' VAL . 79.6 m-20 -60.65 -42.93 97.97 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-O 120.843 0.354 . . . . 0.0 111.015 -177.709 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' C' C ' 21' ' ' VAL . . . . . . . . . . . . . 47.1 t -63.94 -47.98 88.18 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.338 0 C-N-CA 120.782 -0.367 . . . . 0.0 110.383 -178.076 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' C' C ' 22' ' ' ILE . . . . . 0.485 HG22 HD12 ' C' ' 26' ' ' LEU . 46.4 mm -58.11 -38.49 67.96 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.298 0 CA-C-O 120.841 0.353 . . . . 0.0 110.56 179.407 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' C' C ' 23' ' ' ARG . . . . . . . . . . . . . 56.3 ttp180 -55.53 -48.24 75.01 Favored 'General case' 0 C--N 1.33 -0.253 0 O-C-N 122.094 -0.379 . . . . 0.0 110.845 177.429 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' C' C ' 24' ' ' ILE . . . . . . . . . . . . . 67.2 mt -60.24 -41.9 88.54 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.358 0 CA-C-N 116.148 -0.478 . . . . 0.0 111.75 -177.776 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' C' C ' 25' ' ' LYS . . . . . . . . . . . . . 16.1 ptmt -72.33 -36.08 68.76 Favored 'General case' 0 CA--C 1.534 0.328 0 C-N-CA 120.561 -0.455 . . . . 0.0 112.077 -176.044 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' C' C ' 26' ' ' LEU . . . . . 0.485 HD12 HG22 ' C' ' 22' ' ' ILE . 78.3 mt -78.54 -41.78 31.19 Favored 'General case' 0 C--N 1.33 -0.247 0 N-CA-C 112.887 0.699 . . . . 0.0 112.887 -172.952 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' C' C ' 27' ' ' GLN . . . . . . . . . . . . . 14.4 pt20 -46.38 138.53 5.56 Favored 'General case' 0 N--CA 1.468 0.466 0 N-CA-C 112.812 0.671 . . . . 0.0 112.812 -175.338 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' C' C ' 28' ' ' GLY . . . . . . . . . . . . . . . 100.62 -26.65 23.82 Favored Glycine 0 CA--C 1.532 1.119 0 CA-C-N 115.55 -0.75 . . . . 0.0 112.135 -177.891 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' C' C ' 29' ' ' LYS . . . . . . . . . . . . . 59.7 mmtt -97.82 155.23 17.14 Favored 'General case' 0 C--O 1.233 0.217 0 CA-C-N 117.445 0.623 . . . . 0.0 111.019 178.699 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' C' C ' 30' ' ' THR . . . . . . . . . . . . . 40.5 m -100.08 135.79 40.97 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 115.883 -0.599 . . . . 0.0 109.688 174.24 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' C' C ' 31' ' ' VAL . . . . . . . . . . . . . 34.9 m -125.91 154.8 35.23 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.211 0 CA-C-N 116.5 -0.318 . . . . 0.0 110.602 -178.367 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' C' C ' 32' ' ' ARG . . . . . . . . . . . . . 46.3 ttt180 -135.71 149.13 49.13 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-O 121.225 0.536 . . . . 0.0 110.667 179.624 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' C' C ' 33' ' ' THR . . . . . . . . . . . . . 18.2 m -52.48 140.51 22.35 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.286 -0.415 . . . . 0.0 111.426 -178.339 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' C' C ' 34' ' ' GLY . . . . . . . . . . . . . . . 99.71 -17.04 58.03 Favored Glycine 0 CA--C 1.532 1.11 0 CA-C-O 119.656 -0.524 . . . . 0.0 113.224 179.073 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' C' C ' 35' ' ' ASP . . . . . . . . . . . . . 72.6 m-20 -64.59 149.19 49.33 Favored 'General case' 0 C--O 1.231 0.1 0 CA-C-N 118.13 0.965 . . . . 0.0 111.081 179.426 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' C' C ' 36' ' ' VAL . . . . . . . . . . . . . 45.6 t -126.01 130.69 72.24 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.249 0 CA-C-N 115.995 -0.548 . . . . 0.0 109.838 178.477 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' C' C ' 37' ' ' ILE . . . . . . . . . . . . . 66.6 mt -121.93 139.69 48.2 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.299 0 CA-C-N 116.292 -0.413 . . . . 0.0 110.194 -178.953 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' C' C ' 38' ' ' GLY . . . . . . . . . . . . . . . -108.7 128.85 9.25 Favored Glycine 0 CA--C 1.526 0.748 0 N-CA-C 110.96 -0.856 . . . . 0.0 110.96 179.285 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' C' C ' 39' ' ' ILE . . . . . . . . . . . . . 72.6 mt -125.78 132.22 71.02 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.181 0 N-CA-C 110.191 -0.3 . . . . 0.0 110.191 179.829 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' C' C ' 40' ' ' SER . . . . . . . . . . . . . 27.6 t -92.78 122.16 34.9 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.418 -0.356 . . . . 0.0 110.886 175.581 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' C' C ' 41' ' ' ILE . . . . . . . . . . . . . 72.3 mt -131.01 116.89 35.43 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.223 0 CA-C-O 121.031 0.443 . . . . 0.0 110.55 178.699 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' C' C ' 42' ' ' LEU . . . . . 0.532 ' O ' HD23 ' C' ' 42' ' ' LEU . 1.3 tt 51.46 47.4 24.89 Favored 'General case' 0 CA--C 1.531 0.217 0 CA-C-N 115.768 -0.651 . . . . 0.0 111.208 175.996 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' C' C ' 43' ' ' GLY . . . . . . . . . . . . . . . 70.17 21.38 77.09 Favored Glycine 0 CA--C 1.531 1.075 0 C-N-CA 121.081 -0.58 . . . . 0.0 112.79 175.016 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' C' C ' 44' ' ' LYS . . . . . . . . . . . . . 59.4 mtpt -131.65 128.35 38.88 Favored 'General case' 0 C--N 1.331 -0.212 0 CA-C-N 117.692 0.746 . . . . 0.0 110.098 179.068 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' C' C ' 45' ' ' GLU . . . . . . . . . . . . . 83.2 tt0 -83.8 123.14 29.58 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 116.441 -0.345 . . . . 0.0 110.997 -179.68 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' C' C ' 46' ' ' VAL . . . . . . . . . . . . . 7.2 p -123.15 128.26 74.92 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.204 0 N-CA-C 109.722 -0.473 . . . . 0.0 109.722 176.669 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' C' C ' 47' ' ' LYS . . . . . . . . . . . . . 63.2 mttp -100.19 128.65 46.23 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.085 -0.507 . . . . 0.0 111.089 177.664 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' C' C ' 48' ' ' PHE . . . . . . . . . . . . . 91.1 m-85 -110.5 131.83 54.71 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.206 -0.452 . . . . 0.0 109.863 176.346 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' C' C ' 49' ' ' LYS . . . . . . . . . . . . . 79.2 tttt -108.61 137.99 45.66 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.377 -0.374 . . . . 0.0 110.424 178.978 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' C' C ' 50' ' ' VAL . . . . . . . . . . . . . 44.9 t -79.73 106.28 10.55 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.335 0 N-CA-C 109.335 -0.617 . . . . 0.0 109.335 175.828 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' C' C ' 51' ' ' VAL . . . . . . . . . . . . . 48.2 t -69.81 -47.67 68.69 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.284 0 CA-C-N 116.052 -0.522 . . . . 0.0 109.863 -173.486 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' C' C ' 52' ' ' GLN . . . . . . . . . . . . . 21.4 pt20 -167.85 158.88 11.11 Favored 'General case' 0 C--N 1.332 -0.192 0 C-N-CA 120.165 -0.614 . . . . 0.0 111.643 179.482 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' C' C ' 53' ' ' ALA . . . . . . . . . . . . . . . -135.56 138.68 43.24 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 115.564 -0.743 . . . . 0.0 110.229 178.94 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' C' C ' 54' ' ' TYR . . . . . . . . . . . . . 63.6 t80 -128.9 110.31 18.52 Favored Pre-proline 0 CA--C 1.534 0.36 0 CA-C-O 118.156 -0.926 . . . . 0.0 110.259 179.772 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' C' C ' 55' ' ' PRO . . . . . . . . . . . . . 73.4 Cg_endo -77.17 170.06 72.55 Favored 'Cis proline' 0 N--CA 1.501 1.926 0 CA-C-N 121.908 1.717 . . . . 0.0 112.236 -7.91 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' C' C ' 56' ' ' SER . . . . . . . . . . . . . 51.1 m -121.24 134.6 24.49 Favored Pre-proline 0 CA--C 1.537 0.457 0 CA-C-O 118.582 -0.723 . . . . 0.0 109.619 175.09 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' C' C ' 57' ' ' PRO . . . . . . . . . . . . . 36.3 Cg_endo -66.41 164.68 66.05 Favored 'Cis proline' 0 N--CA 1.499 1.799 0 CA-C-N 121.841 1.693 . . . . 0.0 111.521 -2.944 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' C' C ' 58' ' ' LEU . . . . . . . . . . . . . 32.8 tp -130.77 139.68 50.25 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-O 120.947 0.403 . . . . 0.0 110.663 -178.338 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' C' C ' 59' ' ' ARG . . . . . . . . . . . . . 55.2 ttm-85 -96.1 129.5 43.37 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-N 115.762 -0.654 . . . . 0.0 109.338 174.367 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' C' C ' 60' ' ' VAL . . . . . . . . . . . . . 40.9 t -86.14 121.11 37.02 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.268 0 C-N-CA 120.624 -0.431 . . . . 0.0 110.4 -177.917 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' C' C ' 61' ' ' GLU . . . . . . . . . . . . . 71.6 tt0 -130.57 157.66 42.1 Favored 'General case' 0 C--N 1.329 -0.31 0 N-CA-C 109.113 -0.699 . . . . 0.0 109.113 177.523 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' C' C ' 62' ' ' ASP . . . . . . . . . . . . . 12.8 t70 -51.22 -32.28 23.45 Favored 'General case' 0 C--N 1.327 -0.404 0 N-CA-C 112.07 0.396 . . . . 0.0 112.07 -178.282 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' C' C ' 63' ' ' ARG . . . . . . . . . . . . . 98.2 mtt180 -77.18 -21.94 53.21 Favored 'General case' 0 CA--C 1.533 0.29 0 N-CA-C 112.857 0.688 . . . . 0.0 112.857 -177.812 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' C' C ' 64' ' ' THR . . . . . . . . . . . . . 20.0 m -57.46 141.8 46.27 Favored 'General case' 0 C--N 1.331 -0.207 0 CA-C-O 120.842 0.353 . . . . 0.0 110.642 -176.478 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' C' C ' 65' ' ' LYS . . . . . . . . . . . . . 40.2 ttpt -89.13 121.44 31.45 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.1 -0.5 . . . . 0.0 110.279 -179.63 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' C' C ' 66' ' ' ILE . . . . . . . . . . . . . 63.1 mt -113.5 129.15 69.82 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.241 0 N-CA-C 109.87 -0.418 . . . . 0.0 109.87 -179.718 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' C' C ' 67' ' ' THR . . . . . . . . . . . . . 18.8 m -129.08 143.86 51.0 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-O 121.142 0.496 . . . . 0.0 111.236 -177.433 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' C' C ' 68' ' ' LEU . . . . . . . . . . . . . 17.1 tp -101.39 132.28 47.04 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 115.827 -0.624 . . . . 0.0 110.092 177.58 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' C' C ' 69' ' ' VAL . . . . . . . . . . . . . 41.1 t -92.5 136.05 25.82 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.346 0 CA-C-N 116.281 -0.418 . . . . 0.0 110.529 -177.7 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' C' C ' 70' ' ' THR . . . . . . . . . . . . . 40.2 p -91.12 -172.45 3.32 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 115.955 -0.566 . . . . 0.0 110.265 178.616 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' C' C ' 71' ' ' HIS . . . . . . . . . . . . . 66.1 t-80 -121.31 76.19 32.93 Favored Pre-proline 0 CA--C 1.533 0.31 0 CA-C-N 116.758 -0.201 . . . . 0.0 111.12 -178.561 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' C' C ' 72' ' ' PRO . . . . . . . . . . . . . 92.0 Cg_endo -93.48 160.08 2.43 Favored 'Trans proline' 0 N--CA 1.489 1.24 0 C-N-CA 122.079 1.853 . . . . 0.0 111.932 175.493 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' C' C ' 73' ' ' VAL . . . . . . . . . . . . . 35.5 m -69.92 178.88 0.39 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.286 0 N-CA-C 109.598 -0.519 . . . . 0.0 109.598 177.508 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' C' C ' 74' ' ' ASP . . . . . . . . . . . . . 27.6 t0 -98.71 119.81 38.08 Favored 'General case' 0 C--N 1.331 -0.203 0 C-N-CA 120.805 -0.358 . . . . 0.0 110.193 -176.185 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' C' C ' 75' ' ' VAL . . . . . 0.402 ' C ' HD12 ' C' ' 76' ' ' LEU . 40.6 t -119.13 121.9 67.87 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.237 0 CA-C-O 121.094 0.473 . . . . 0.0 110.63 -178.009 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' C' C ' 76' ' ' LEU . . . . . 0.402 HD12 ' C ' ' C' ' 75' ' ' VAL . 7.1 mp -117.25 139.78 50.37 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 115.669 -0.696 . . . . 0.0 109.402 175.437 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' C' C ' 77' ' ' GLU . . . . . . . . . . . . . 98.0 mt-10 -135.47 129.08 32.6 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-O 121.072 0.463 . . . . 0.0 111.007 -178.401 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' C' C ' 78' ' ' ALA . . . . . 0.481 ' HB2' HD21 ' C' ' 109' ' ' LEU . . . -117.66 136.69 53.15 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 115.638 -0.71 . . . . 0.0 109.957 177.778 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' C' C ' 79' ' ' LYS . . . . . 0.612 ' O ' HD13 ' C' ' 80' ' ' ILE . 68.4 mmtt -73.37 116.01 13.42 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.512 -0.313 . . . . 0.0 110.16 -179.107 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' C' C ' 80' ' ' ILE . . . . . 0.612 HD13 ' O ' ' C' ' 79' ' ' LYS . 39.7 mm -139.09 110.63 5.13 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.303 0 N-CA-C 109.56 -0.533 . . . . 0.0 109.56 -177.433 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' C' C ' 81' ' ' LYS . . . . . . . . . . . . . 99.5 mttt -112.56 128.73 56.44 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-O 120.95 0.405 . . . . 0.0 110.775 -178.852 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' C' C ' 82' ' ' GLY . . . . . . . . . . . . . . . 89.08 42.16 5.68 Favored Glycine 0 CA--C 1.525 0.679 0 C-N-CA 121.024 -0.608 . . . . 0.0 111.649 176.835 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' C' C ' 83' ' ' ILE . . . . . . . . . . . . . 72.0 mt -69.51 136.17 26.78 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.22 0 N-CA-C 109.718 -0.475 . . . . 0.0 109.718 177.23 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' C' C ' 84' ' ' LYS . . . . . . . . . . . . . 60.2 tttp -97.81 -53.56 3.37 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.054 -0.521 . . . . 0.0 110.195 -178.187 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' C' C ' 85' ' ' ASP . . . . . . . . . . . . . 13.1 t70 -151.17 148.67 28.54 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 115.746 -0.661 . . . . 0.0 110.232 -179.342 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' C' C ' 86' ' ' VAL . . . . . . . . . . . . . 41.4 t -129.2 129.62 67.63 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.264 0 CA-C-O 120.944 0.402 . . . . 0.0 110.397 -179.294 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' C' C ' 87' ' ' ILE . . . . . . . . . . . . . 44.6 mm -119.14 126.0 74.97 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.263 0 CA-C-N 115.923 -0.58 . . . . 0.0 109.657 177.097 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' C' C ' 88' ' ' LEU . . . . . . . . . . . . . 19.4 tp -109.82 123.4 49.49 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-O 121.005 0.431 . . . . 0.0 110.826 -178.333 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' C' C ' 89' ' ' ASP . . . . . . . . . . . . . 13.6 t70 -113.61 156.86 22.92 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 115.81 -0.632 . . . . 0.0 109.336 176.325 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' C' C ' 90' ' ' GLU . . . . . . . . . . . . . 81.8 tt0 -45.14 -42.28 8.82 Favored 'General case' 0 N--CA 1.465 0.282 0 N-CA-C 113.266 0.839 . . . . 0.0 113.266 -171.694 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' C' C ' 91' ' ' ASN . . . . . . . . . . . . . 73.1 m-20 -132.02 25.19 4.6 Favored 'General case' 0 N--CA 1.467 0.377 0 N-CA-C 112.652 0.612 . . . . 0.0 112.652 -178.539 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' C' C ' 92' ' ' LEU . . . . . . . . . . . . . 38.1 mt -148.17 142.02 25.74 Favored 'General case' 0 C--N 1.332 -0.19 0 N-CA-C 110.171 -0.307 . . . . 0.0 110.171 -177.635 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' C' C ' 93' ' ' ILE . . . . . . . . . . . . . 62.7 mt -118.62 116.9 52.72 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.266 0 N-CA-C 109.425 -0.583 . . . . 0.0 109.425 179.986 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' C' C ' 94' ' ' VAL . . . . . 0.506 HG21 HG11 ' C' ' 125' ' ' VAL . 44.2 t -119.39 124.13 72.45 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.2 0 CA-C-O 121.026 0.441 . . . . 0.0 110.075 -179.671 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' C' C ' 95' ' ' VAL . . . . . . . . . . . . . 42.7 t -121.23 135.35 61.68 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.297 0 CA-C-N 115.803 -0.635 . . . . 0.0 109.96 -179.258 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' C' C ' 96' ' ' ILE . . . . . . . . . . . . . 60.4 mt -115.9 128.86 73.04 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.288 0 N-CA-C 109.411 -0.588 . . . . 0.0 109.411 178.264 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' C' C ' 97' ' ' THR . . . . . . . . . . . . . 80.5 p -98.67 160.08 14.51 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-O 121.08 0.467 . . . . 0.0 110.828 -179.184 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' C' C ' 98' ' ' GLU . . . . . . . . . . . . . 97.6 mt-10 -53.82 -25.73 20.86 Favored 'General case' 0 CA--C 1.532 0.265 0 N-CA-C 112.257 0.465 . . . . 0.0 112.257 -179.927 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' C' C ' 99' ' ' GLU . . . . . . . . . . . . . 43.2 mt-10 -79.86 16.37 1.18 Allowed 'General case' 0 CA--C 1.535 0.375 0 N-CA-C 113.071 0.767 . . . . 0.0 113.071 -177.732 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' C' C ' 100' ' ' ASN . . . . . . . . . . . . . 3.9 m-20 61.83 38.07 15.0 Favored 'General case' 0 CA--C 1.529 0.155 0 CA-C-O 121.12 0.486 . . . . 0.0 110.91 178.27 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' C' C ' 101' ' ' GLU . . . . . . . . . . . . . 84.7 tt0 -113.18 141.42 46.96 Favored 'General case' 0 C--N 1.331 -0.199 0 CA-C-N 116.159 -0.473 . . . . 0.0 109.854 176.55 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' C' C ' 102' ' ' VAL . . . . . . . . . . . . . 46.1 t -114.86 125.08 72.09 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.272 0 CA-C-N 116.221 -0.445 . . . . 0.0 109.917 -178.55 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' C' C ' 103' ' ' LEU . . . . . . . . . . . . . 16.8 mt -116.65 129.83 56.38 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 115.616 -0.72 . . . . 0.0 110.182 177.763 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' C' C ' 104' ' ' ILE . . . . . . . . . . . . . 61.5 mt -117.7 120.71 65.53 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.286 0 N-CA-C 110.296 -0.261 . . . . 0.0 110.296 179.028 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' C' C ' 105' ' ' PHE . . . . . . . . . . . . . 46.0 m-85 -120.75 163.28 18.35 Favored 'General case' 0 C--N 1.332 -0.171 0 O-C-N 123.97 0.794 . . . . 0.0 109.654 177.86 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' C' C ' 106' ' ' ASN . . . . . . . . . . . . . 45.8 p-10 -97.42 -171.02 2.11 Favored 'General case' 0 C--N 1.331 -0.219 0 N-CA-C 109.783 -0.451 . . . . 0.0 109.783 173.719 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' C' C ' 107' ' ' GLN . . . . . . . . . . . . . 51.1 tt0 -59.67 -28.69 67.49 Favored 'General case' 0 C--N 1.329 -0.309 0 N-CA-C 112.043 0.386 . . . . 0.0 112.043 179.687 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' C' C ' 108' ' ' ASN . . . . . . . . . . . . . 6.3 t-20 -84.88 11.94 8.37 Favored 'General case' 0 CA--C 1.537 0.447 0 N-CA-C 112.955 0.724 . . . . 0.0 112.955 -178.012 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' C' C ' 109' ' ' LEU . . . . . 0.481 HD21 ' HB2' ' C' ' 78' ' ' ALA . 11.6 tp 55.76 38.19 29.79 Favored 'General case' 0 C--O 1.232 0.154 0 CA-C-O 121.099 0.476 . . . . 0.0 111.338 178.722 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' C' C ' 110' ' ' GLU . . . . . . . . . . . . . 70.7 mm-40 -101.97 148.91 24.78 Favored 'General case' 0 C--N 1.328 -0.336 0 N-CA-C 109.636 -0.505 . . . . 0.0 109.636 175.707 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' C' C ' 111' ' ' GLU . . . . . . . . . . . . . 82.8 tt0 -81.85 121.91 27.05 Favored 'General case' 0 C--N 1.326 -0.415 0 CA-C-O 120.834 0.349 . . . . 0.0 110.357 -179.45 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' C' C ' 112' ' ' LEU . . . . . . . . . . . . . 34.1 mt -111.56 -46.04 3.31 Favored 'General case' 0 C--N 1.331 -0.203 0 CA-C-N 116.107 -0.497 . . . . 0.0 110.595 -179.689 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' C' C ' 113' ' ' TYR . . . . . . . . . . . . . 56.9 t80 -138.58 135.29 34.83 Favored 'General case' 0 C--N 1.33 -0.259 0 C-N-CA 120.772 -0.371 . . . . 0.0 111.332 -179.154 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' C' C ' 114' ' ' ARG . . . . . . . . . . . . . 63.8 ttp85 -137.88 122.08 18.07 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 115.949 -0.569 . . . . 0.0 110.026 178.956 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' C' C ' 115' ' ' GLY . . . . . . . . . . . . . . . -150.12 142.81 10.02 Favored Glycine 0 CA--C 1.525 0.671 0 C-N-CA 120.79 -0.719 . . . . 0.0 111.336 178.826 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' C' C ' 116' ' ' LYS . . . . . . . . . . . . . 38.8 ttpt -111.49 132.94 54.13 Favored 'General case' 0 C--N 1.33 -0.25 0 N-CA-C 109.782 -0.451 . . . . 0.0 109.782 176.379 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' C' C ' 117' ' ' PHE . . . . . . . . . . . . . 57.8 m-85 -130.69 113.97 14.82 Favored 'General case' 0 C--N 1.332 -0.193 0 CA-C-O 120.983 0.421 . . . . 0.0 110.385 -176.631 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' C' C ' 118' ' ' GLU . . . . . . . . . . . . . 71.0 mm-40 -54.28 -47.52 72.27 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.284 -0.416 . . . . 0.0 111.283 -177.276 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' C' C ' 119' ' ' ASN . . . . . . . . . . . . . 33.3 m120 -94.63 30.99 1.87 Allowed 'General case' 0 C--N 1.33 -0.251 0 N-CA-C 112.194 0.442 . . . . 0.0 112.194 -175.043 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' C' C ' 120' ' ' LEU . . . . . . . . . . . . . 13.7 tp -57.64 121.21 9.82 Favored 'General case' 0 C--N 1.332 -0.165 0 N-CA-C 110.204 -0.295 . . . . 0.0 110.204 177.163 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' C' C ' 121' ' ' ASN . . . . . . . . . . . . . 94.2 m-20 -114.01 -43.91 3.2 Favored 'General case' 0 C--O 1.232 0.171 0 CA-C-N 116.484 -0.326 . . . . 0.0 111.338 -176.113 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' C' C ' 122' ' ' LYS . . . . . . . . . . . . . 39.5 ttpt -150.97 148.88 28.93 Favored 'General case' 0 C--N 1.331 -0.227 0 CA-C-O 121.04 0.448 . . . . 0.0 111.637 -176.617 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' C' C ' 123' ' ' VAL . . . . . . . . . . . . . 44.9 t -128.65 133.87 65.62 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.227 0 CA-C-N 116.007 -0.542 . . . . 0.0 109.737 177.417 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' C' C ' 124' ' ' LEU . . . . . . . . . . . . . 79.5 mt -128.93 139.35 52.16 Favored 'General case' 0 C--N 1.331 -0.201 0 CA-C-O 120.759 0.314 . . . . 0.0 110.942 -178.595 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' C' C ' 125' ' ' VAL . . . . . 0.506 HG11 HG21 ' C' ' 94' ' ' VAL . 35.6 m -133.17 128.93 56.58 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.206 0 CA-C-N 116.254 -0.43 . . . . 0.0 110.53 178.242 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' C' C ' 126' ' ' ARG . . . . . . . . . . . . . 91.0 mtt180 -150.78 128.33 11.48 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.419 -0.355 . . . . 0.0 110.177 178.199 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' C' C ' 127' ' ' ASN . . . . . . . . . . . . . 77.5 m-20 54.52 -151.58 0.36 Allowed 'General case' 0 CA--C 1.541 0.6 0 CA-C-O 119.449 -0.31 . . . . 0.0 110.228 178.017 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' C' C ' 128' ' ' ASP . . . . . . . . . . . . . 23.5 p-10 -81.03 18.14 1.09 Allowed 'General case' 0 CA--C 1.536 0.405 0 N-CA-C 112.881 0.697 . . . . 0.0 112.881 -179.62 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' C' C ' 129' ' ' LEU . . . . . . . . . . . . . 15.9 tp -123.92 137.02 54.69 Favored 'General case' 0 C--O 1.232 0.165 0 CA-C-N 117.983 0.356 . . . . 0.0 110.185 178.715 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' C' C ' 130' ' ' VAL . . . . . 0.496 HG23 ' HB ' ' C' ' 141' ' ' ILE . 32.1 m -131.78 145.81 34.4 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.197 0 CA-C-O 120.905 0.383 . . . . 0.0 110.327 178.575 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' C' C ' 131' ' ' VAL . . . . . 0.515 HG22 HD12 ' C' ' 140' ' ' LEU . 40.7 t -136.1 140.49 43.8 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.325 0 CA-C-O 121.058 0.456 . . . . 0.0 110.553 -177.704 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' C' C ' 132' ' ' ILE . . . . . . . . . . . . . 73.9 mt -116.8 129.68 72.92 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 CA-C-N 115.585 -0.734 . . . . 0.0 109.032 177.45 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' C' C ' 133' ' ' ILE . . . . . . . . . . . . . 40.3 mm -114.06 121.84 66.99 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.275 0 CA-C-O 120.698 0.285 . . . . 0.0 110.942 -174.428 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' C' C ' 134' ' ' ASP . . . . . . . . . . . . . 9.0 p-10 -135.23 146.54 48.72 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.116 -0.493 . . . . 0.0 109.786 175.501 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' C' C ' 135' ' ' GLU . . . . . . . . . . . . . 81.2 tt0 -49.92 -25.41 3.21 Favored 'General case' 0 CA--C 1.533 0.325 0 N-CA-C 112.77 0.656 . . . . 0.0 112.77 -175.465 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' C' C ' 136' ' ' GLN . . . . . . . . . . . . . 8.4 tp-100 -80.88 -34.28 33.7 Favored 'General case' 0 C--O 1.233 0.2 0 N-CA-C 112.036 0.384 . . . . 0.0 112.036 -176.032 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' C' C ' 137' ' ' LYS . . . . . . . . . . . . . 40.3 pttt -169.57 175.49 5.38 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-O 121.522 0.677 . . . . 0.0 112.085 -173.597 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' C' C ' 138' ' ' LEU . . . . . 0.479 HD23 ' N ' ' C' ' 139' ' ' THR . 4.8 tt -117.74 125.34 50.47 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 115.05 -0.977 . . . . 0.0 109.81 177.931 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' C' C ' 139' ' ' THR . . . . . 0.479 ' N ' HD23 ' C' ' 138' ' ' LEU . 28.6 m -105.18 124.01 48.81 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.312 -0.404 . . . . 0.0 110.497 179.701 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' C' C ' 140' ' ' LEU . . . . . 0.515 HD12 HG22 ' C' ' 131' ' ' VAL . 19.6 tp -110.68 117.89 34.71 Favored 'General case' 0 C--N 1.329 -0.302 0 N-CA-C 109.046 -0.724 . . . . 0.0 109.046 -179.496 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' C' C ' 141' ' ' ILE . . . . . 0.496 ' HB ' HG23 ' C' ' 130' ' ' VAL . 19.9 mt -118.63 121.29 66.63 Favored 'Isoleucine or valine' 0 C--O 1.234 0.25 0 CA-C-O 121.24 0.543 . . . . 0.0 109.877 -175.496 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' C' C ' 142' ' ' ARG . . . . . . . . . . . . . 70.5 mtt180 -104.11 113.31 26.77 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 115.042 -0.981 . . . . 0.0 110.112 -177.952 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' C' C ' 143' ' ' THR . . . . . . . . . . . . . 80.3 p . . . . . 0 C--O 1.219 -0.514 0 CA-C-O 117.921 -1.037 . . . . 0.0 110.636 -179.406 . . . . . . . . 0 0 . 1 . 009 nuclear build full ' D' D ' -3' ' ' GLU . . . . . . . . . . . . . 84.1 tt0 . . . . . 0 N--CA 1.489 1.508 0 N-CA-C 109.315 -0.624 . . . . 0.0 109.315 . . . . . . . . . 0 0 . 1 . 009 nuclear build full ' D' D ' -2' ' ' GLY . . . . . . . . . . . . . . . -62.2 145.52 49.38 Favored Glycine 0 CA--C 1.525 0.685 0 N-CA-C 111.24 -0.744 . . . . 0.0 111.24 -178.325 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' D' D ' -1' ' ' VAL . . . . . . . . . . . . . 44.8 t -95.92 129.61 45.77 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.262 0 N-CA-C 109.93 -0.396 . . . . 0.0 109.93 179.216 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' D' D ' 0' ' ' ILE . . . . . . . . . . . . . 73.6 mt -121.28 143.49 33.46 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.242 0 CA-C-N 116.293 -0.412 . . . . 0.0 110.181 -178.573 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' D' D ' 1' ' ' MET . . . . . . . . . . . . . 23.2 ptp -144.07 148.33 35.01 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 115.954 -0.566 . . . . 0.0 110.568 -179.63 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' D' D ' 2' ' ' SER . . . . . . . . . . . . . 12.7 p -117.44 133.32 56.1 Favored 'General case' 0 C--N 1.331 -0.227 0 CA-C-O 121.164 0.507 . . . . 0.0 110.677 -179.868 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' D' D ' 3' ' ' GLU . . . . . . . . . . . . . 84.9 tt0 -143.99 140.87 29.85 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 115.748 -0.66 . . . . 0.0 111.161 -178.709 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' D' D ' 4' ' ' LEU . . . . . . . . . . . . . 19.2 tp -124.56 131.74 53.47 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.014 -0.539 . . . . 0.0 110.06 177.093 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' D' D ' 5' ' ' LYS . . . . . . . . . . . . . 77.9 mttt -111.93 120.91 43.51 Favored 'General case' 0 C--O 1.234 0.259 0 CA-C-N 116.365 -0.379 . . . . 0.0 110.767 -179.406 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' D' D ' 6' ' ' LEU . . . . . . . . . . . . . 54.5 mt -114.57 142.47 46.39 Favored 'General case' 0 C--N 1.332 -0.174 0 CA-C-N 115.553 -0.749 . . . . 0.0 110.163 -179.563 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' D' D ' 7' ' ' LYS . . . . . . . . . . . . . 31.0 ttpt -122.3 136.87 26.86 Favored Pre-proline 0 CA--C 1.534 0.351 0 CA-C-O 118.84 -0.6 . . . . 0.0 109.602 175.794 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' D' D ' 8' ' ' PRO . . . . . . . . . . . . . 98.8 Cg_endo -91.22 131.78 1.44 Allowed 'Trans proline' 0 N--CA 1.489 1.255 0 C-N-CA 121.687 1.591 . . . . 0.0 111.799 178.215 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' D' D ' 9' ' ' LEU . . . . . . . . . . . . . 36.1 mt -72.8 -47.48 8.83 Favored Pre-proline 0 CA--C 1.535 0.38 0 CA-C-O 118.49 -0.767 . . . . 0.0 112.128 -178.593 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' D' D ' 10' ' ' PRO . . . . . . . . . . . . . 75.8 Cg_endo -78.62 149.1 23.53 Favored 'Trans proline' 0 N--CA 1.496 1.623 0 CA-C-N 120.347 1.159 . . . . 0.0 111.794 176.397 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' D' D ' 11' ' ' LYS . . . . . . . . . . . . . 53.7 mttp -85.51 95.85 9.43 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.481 -0.327 . . . . 0.0 110.693 -179.721 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' D' D ' 12' ' ' VAL . . . . . . . . . . . . . 12.1 p -144.35 145.19 21.79 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.278 0 CA-C-N 116.285 -0.416 . . . . 0.0 110.43 179.361 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' D' D ' 13' ' ' GLU . . . . . . . . . . . . . 95.7 mt-10 -90.11 122.09 32.76 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.254 -0.43 . . . . 0.0 110.271 178.681 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' D' D ' 14' ' ' LEU . . . . . . . . . . . . . 23.1 mt -98.07 154.34 37.77 Favored Pre-proline 0 CA--C 1.532 0.265 0 CA-C-N 116.283 -0.417 . . . . 0.0 111.174 -177.874 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' D' D ' 15' ' ' PRO . . . . . . . . . . . . . 36.6 Cg_exo -59.35 162.29 14.88 Favored 'Trans proline' 0 N--CA 1.496 1.669 0 C-N-CA 121.4 1.4 . . . . 0.0 112.079 178.581 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' D' D ' 16' ' ' PRO . . . . . . . . . . . . . 23.7 Cg_exo -63.01 -41.42 28.83 Favored 'Trans proline' 0 N--CA 1.497 1.703 0 C-N-CA 121.493 1.462 . . . . 0.0 112.815 -179.175 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' D' D ' 17' ' ' ASP . . . . . . . . . . . . . 22.8 p-10 -82.91 9.53 9.81 Favored 'General case' 0 CA--C 1.537 0.47 0 N-CA-C 113.241 0.83 . . . . 0.0 113.241 -176.859 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' D' D ' 18' ' ' PHE . . . . . . . . . . . . . 29.3 t80 -56.98 -41.81 79.09 Favored 'General case' 0 C--N 1.334 -0.09 0 O-C-N 121.986 -0.446 . . . . 0.0 110.369 -179.562 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' D' D ' 19' ' ' VAL . . . . . . . . . . . . . 46.5 t -56.23 -44.44 79.35 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.252 0 CA-C-N 116.327 -0.397 . . . . 0.0 110.599 -179.379 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' D' D ' 20' ' ' ASP . . . . . . . . . . . . . 41.6 m-20 -59.81 -41.26 90.87 Favored 'General case' 0 C--N 1.33 -0.247 0 C-N-CA 120.84 -0.344 . . . . 0.0 110.943 -178.091 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' D' D ' 21' ' ' VAL . . . . . . . . . . . . . 47.2 t -63.66 -47.54 90.78 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 C-N-CA 120.759 -0.377 . . . . 0.0 110.494 -178.357 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' D' D ' 22' ' ' ILE . . . . . 0.667 HG22 HD12 ' D' ' 26' ' ' LEU . 49.8 mm -54.78 -47.28 74.55 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.273 0 C-N-CA 120.97 -0.292 . . . . 0.0 110.798 178.907 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' D' D ' 23' ' ' ARG . . . . . . . . . . . . . 53.2 ttp180 -53.74 -52.0 61.55 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-O 120.609 0.242 . . . . 0.0 111.533 -178.953 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' D' D ' 24' ' ' ILE . . . . . . . . . . . . . 76.7 mt -58.61 -41.26 81.6 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.377 0 CA-C-N 116.749 -0.205 . . . . 0.0 111.367 -176.339 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' D' D ' 25' ' ' LYS . . . . . . . . . . . . . 73.0 mmtt -68.4 -42.29 79.23 Favored 'General case' 0 C--N 1.329 -0.292 0 N-CA-C 112.277 0.473 . . . . 0.0 112.277 -178.338 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' D' D ' 26' ' ' LEU . . . . . 0.667 HD12 HG22 ' D' ' 22' ' ' ILE . 33.1 mt -80.47 -34.31 35.99 Favored 'General case' 0 C--N 1.33 -0.258 0 N-CA-C 113.661 0.986 . . . . 0.0 113.661 -169.41 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' D' D ' 27' ' ' GLN . . . . . . . . . . . . . 13.9 pt20 -46.1 139.71 4.34 Favored 'General case' 0 N--CA 1.469 0.489 0 N-CA-C 112.853 0.686 . . . . 0.0 112.853 -175.17 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' D' D ' 28' ' ' GLY . . . . . . . . . . . . . . . 101.05 -27.01 22.54 Favored Glycine 0 CA--C 1.532 1.144 0 CA-C-N 115.657 -0.701 . . . . 0.0 112.163 -175.99 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' D' D ' 29' ' ' LYS . . . . . . . . . . . . . 64.9 mttp -97.65 155.09 17.15 Favored 'General case' 0 C--O 1.233 0.226 0 CA-C-N 117.336 0.568 . . . . 0.0 110.986 178.751 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' D' D ' 30' ' ' THR . . . . . . . . . . . . . 40.1 m -106.77 140.63 39.32 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.232 -0.44 . . . . 0.0 110.151 177.251 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' D' D ' 31' ' ' VAL . . . . . . . . . . . . . 34.9 m -128.22 156.12 40.21 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.19 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.851 -179.125 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' D' D ' 32' ' ' ARG . . . . . . . . . . . . . 67.3 ttt180 -131.65 147.0 52.48 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 115.974 -0.557 . . . . 0.0 110.314 178.285 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' D' D ' 33' ' ' THR . . . . . . . . . . . . . 22.8 m -52.52 139.22 25.94 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-O 120.762 0.315 . . . . 0.0 111.502 -178.329 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' D' D ' 34' ' ' GLY . . . . . . . . . . . . . . . 99.67 -17.05 58.07 Favored Glycine 0 CA--C 1.533 1.159 0 CA-C-O 119.762 -0.466 . . . . 0.0 113.32 179.26 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' D' D ' 35' ' ' ASP . . . . . . . . . . . . . 76.7 m-20 -66.44 149.24 50.72 Favored 'General case' 0 N--CA 1.46 0.074 0 CA-C-N 117.992 0.896 . . . . 0.0 111.17 179.787 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' D' D ' 36' ' ' VAL . . . . . . . . . . . . . 45.6 t -120.18 128.9 76.0 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.202 0 CA-C-N 115.749 -0.66 . . . . 0.0 109.687 177.439 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' D' D ' 37' ' ' ILE . . . . . . . . . . . . . 64.1 mt -121.37 138.85 50.38 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.229 0 CA-C-N 116.194 -0.457 . . . . 0.0 109.889 -179.145 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' D' D ' 38' ' ' GLY . . . . . . . . . . . . . . . -117.97 128.87 7.97 Favored Glycine 0 CA--C 1.526 0.749 0 N-CA-C 110.97 -0.852 . . . . 0.0 110.97 -179.943 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' D' D ' 39' ' ' ILE . . . . . . . . . . . . . 71.5 mt -128.05 129.83 69.64 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.198 0 N-CA-C 110.036 -0.357 . . . . 0.0 110.036 178.815 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' D' D ' 40' ' ' SER . . . . . . . . . . . . . 87.2 p -92.16 123.73 35.72 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.267 -0.424 . . . . 0.0 110.861 176.804 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' D' D ' 41' ' ' ILE . . . . . . . . . . . . . 71.9 mt -134.14 121.04 36.83 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.263 0 CA-C-O 120.993 0.425 . . . . 0.0 110.278 177.82 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' D' D ' 42' ' ' LEU . . . . . 0.546 HD23 ' O ' ' D' ' 42' ' ' LEU . 1.3 tt 57.81 44.78 19.66 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-O 121.42 0.629 . . . . 0.0 110.187 178.46 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' D' D ' 43' ' ' GLY . . . . . . . . . . . . . . . 72.36 -5.75 13.89 Favored Glycine 0 CA--C 1.534 1.276 0 C-N-CA 121.146 -0.549 . . . . 0.0 113.644 175.897 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' D' D ' 44' ' ' LYS . . . . . . . . . . . . . 22.9 tptm -109.27 126.05 52.93 Favored 'General case' 0 N--CA 1.462 0.129 0 CA-C-N 118.141 0.971 . . . . 0.0 110.183 -178.908 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' D' D ' 45' ' ' GLU . . . . . . . . . . . . . 43.6 tp10 -84.69 130.31 34.72 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-O 120.816 0.341 . . . . 0.0 111.124 -179.482 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' D' D ' 46' ' ' VAL . . . . . . . . . . . . . 10.3 p -120.3 126.99 75.86 Favored 'Isoleucine or valine' 0 N--CA 1.462 0.167 0 N-CA-C 109.818 -0.438 . . . . 0.0 109.818 175.25 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' D' D ' 47' ' ' LYS . . . . . . . . . . . . . 86.4 mttt -99.09 126.16 44.77 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 115.912 -0.585 . . . . 0.0 110.931 178.248 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' D' D ' 48' ' ' PHE . . . . . . . . . . . . . 34.2 m-85 -111.43 131.97 54.8 Favored 'General case' 0 C--N 1.331 -0.207 0 N-CA-C 109.812 -0.44 . . . . 0.0 109.812 177.665 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' D' D ' 49' ' ' LYS . . . . . . . . . . . . . 38.4 tttp -107.71 132.15 53.66 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.362 -0.381 . . . . 0.0 110.274 177.655 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' D' D ' 50' ' ' VAL . . . . . . . . . . . . . 45.5 t -76.56 104.11 4.38 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.332 0 N-CA-C 109.361 -0.607 . . . . 0.0 109.361 177.06 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' D' D ' 51' ' ' VAL . . . . . . . . . . . . . 47.5 t -69.48 -53.2 26.11 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.341 0 N-CA-C 109.554 -0.536 . . . . 0.0 109.554 -175.692 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' D' D ' 52' ' ' GLN . . . . . . . . . . . . . 81.8 mt-30 -154.86 152.45 29.79 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.053 -0.522 . . . . 0.0 111.677 -178.381 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' D' D ' 53' ' ' ALA . . . . . 0.44 ' HB3' ' OG ' ' D' ' 56' ' ' SER . . . -129.29 133.29 47.4 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 115.361 -0.836 . . . . 0.0 109.703 175.539 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' D' D ' 54' ' ' TYR . . . . . . . . . . . . . 45.8 t80 -129.0 109.69 18.28 Favored Pre-proline 0 CA--C 1.535 0.397 0 CA-C-O 118.162 -0.923 . . . . 0.0 110.463 179.217 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' D' D ' 55' ' ' PRO . . . . . . . . . . . . . 73.7 Cg_endo -77.17 167.47 79.58 Favored 'Cis proline' 0 N--CA 1.5 1.871 0 CA-C-N 121.808 1.681 . . . . 0.0 112.103 -6.676 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' D' D ' 56' ' ' SER . . . . . 0.44 ' OG ' ' HB3' ' D' ' 53' ' ' ALA . 62.7 m -117.41 133.04 23.27 Favored Pre-proline 0 CA--C 1.54 0.567 0 CA-C-O 118.437 -0.792 . . . . 0.0 109.458 174.803 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' D' D ' 57' ' ' PRO . . . . . . . . . . . . . 38.4 Cg_endo -67.7 164.5 72.51 Favored 'Cis proline' 0 N--CA 1.498 1.774 0 CA-C-N 121.881 1.707 . . . . 0.0 111.433 -1.407 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' D' D ' 58' ' ' LEU . . . . . . . . . . . . . 24.0 tp -130.73 138.05 49.8 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 116.321 -0.399 . . . . 0.0 110.612 -179.478 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' D' D ' 59' ' ' ARG . . . . . . . . . . . . . 56.7 ttp180 -103.24 127.96 50.4 Favored 'General case' 0 C--N 1.328 -0.342 0 N-CA-C 109.362 -0.607 . . . . 0.0 109.362 174.882 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' D' D ' 60' ' ' VAL . . . . . . . . . . . . . 43.5 t -78.48 119.47 27.57 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.28 0 C-N-CA 120.75 -0.38 . . . . 0.0 110.836 -174.591 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' D' D ' 61' ' ' GLU . . . . . . . . . . . . . 15.6 mm-40 -131.09 161.33 32.31 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 115.729 -0.669 . . . . 0.0 109.666 175.378 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' D' D ' 62' ' ' ASP . . . . . . . . . . . . . 54.0 m-20 -52.6 -31.65 37.51 Favored 'General case' 0 C--N 1.328 -0.343 0 N-CA-C 112.085 0.402 . . . . 0.0 112.085 -178.252 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' D' D ' 63' ' ' ARG . . . . . . . . . . . . . 79.7 mtp180 -73.2 -21.91 60.57 Favored 'General case' 0 CA--C 1.532 0.256 0 N-CA-C 112.949 0.722 . . . . 0.0 112.949 -175.41 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' D' D ' 64' ' ' THR . . . . . . . . . . . . . 25.7 m -69.31 139.96 54.33 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-O 120.951 0.405 . . . . 0.0 110.965 -175.752 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' D' D ' 65' ' ' LYS . . . . . . . . . . . . . 67.5 mttm -89.34 132.14 35.09 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 115.945 -0.57 . . . . 0.0 110.134 178.341 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' D' D ' 66' ' ' ILE . . . . . . . . . . . . . 62.7 mt -117.51 129.52 73.85 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.261 0 N-CA-C 109.893 -0.41 . . . . 0.0 109.893 179.446 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' D' D ' 67' ' ' THR . . . . . . . . . . . . . 25.5 m -122.86 137.47 54.93 Favored 'General case' 0 C--N 1.332 -0.181 0 CA-C-N 116.128 -0.487 . . . . 0.0 110.769 -178.872 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' D' D ' 68' ' ' LEU . . . . . . . . . . . . . 14.9 tp -107.33 129.36 54.91 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 115.964 -0.562 . . . . 0.0 110.348 178.805 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' D' D ' 69' ' ' VAL . . . . . . . . . . . . . 43.3 t -92.72 134.12 31.74 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.352 0 CA-C-N 116.033 -0.531 . . . . 0.0 110.005 178.495 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' D' D ' 70' ' ' THR . . . . . . . . . . . . . 21.5 p -84.85 -54.36 4.73 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.36 -0.382 . . . . 0.0 110.422 -179.455 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' D' D ' 71' ' ' HIS . . . . . . . . . . . . . 96.7 m-70 -149.98 151.61 32.49 Favored Pre-proline 0 C--N 1.329 -0.296 0 CA-C-N 116.314 -0.403 . . . . 0.0 110.561 178.671 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' D' D ' 72' ' ' PRO . . . . . . . . . . . . . 86.5 Cg_endo -89.88 158.25 5.01 Favored 'Trans proline' 0 N--CA 1.49 1.266 0 C-N-CA 121.762 1.641 . . . . 0.0 111.988 178.859 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' D' D ' 73' ' ' VAL . . . . . . . . . . . . . 30.3 m -77.97 143.51 12.66 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.238 0 CA-C-O 120.936 0.398 . . . . 0.0 110.404 178.906 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' D' D ' 74' ' ' ASP . . . . . . . . . . . . . 15.2 t0 -97.04 124.46 41.04 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 115.997 -0.547 . . . . 0.0 109.59 178.905 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' D' D ' 75' ' ' VAL . . . . . . . . . . . . . 41.9 t -116.75 125.29 73.62 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.211 0 CA-C-O 121.091 0.472 . . . . 0.0 110.891 -175.29 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' D' D ' 76' ' ' LEU . . . . . . . . . . . . . 5.7 mp -125.73 144.71 50.5 Favored 'General case' 0 C--N 1.331 -0.205 0 CA-C-N 115.704 -0.68 . . . . 0.0 109.55 173.896 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' D' D ' 77' ' ' GLU . . . . . . . . . . . . . 98.0 mt-10 -133.52 131.03 39.31 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-O 120.961 0.41 . . . . 0.0 111.007 -177.666 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' D' D ' 78' ' ' ALA . . . . . . . . . . . . . . . -116.13 130.95 57.04 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 115.833 -0.621 . . . . 0.0 109.697 177.516 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' D' D ' 79' ' ' LYS . . . . . 0.614 ' O ' HD13 ' D' ' 80' ' ' ILE . 88.1 mttt -77.34 123.85 27.07 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-O 120.854 0.359 . . . . 0.0 110.906 -177.059 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' D' D ' 80' ' ' ILE . . . . . 0.614 HD13 ' O ' ' D' ' 79' ' ' LYS . 39.5 mm -139.1 114.4 8.56 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.277 0 N-CA-C 109.309 -0.626 . . . . 0.0 109.309 -177.858 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' D' D ' 81' ' ' LYS . . . . . . . . . . . . . 69.3 mttm -100.48 118.93 37.68 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-O 120.793 0.33 . . . . 0.0 111.245 -177.234 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' D' D ' 82' ' ' GLY . . . . . . . . . . . . . . . 89.17 42.22 5.64 Favored Glycine 0 CA--C 1.526 0.738 0 C-N-CA 120.668 -0.777 . . . . 0.0 111.989 172.888 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' D' D ' 83' ' ' ILE . . . . . . . . . . . . . 72.3 mt -61.99 135.92 25.97 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.341 0 N-CA-C 109.835 -0.431 . . . . 0.0 109.835 176.434 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' D' D ' 84' ' ' LYS . . . . . . . . . . . . . 15.5 ttmm -95.21 -51.45 4.61 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-O 121.118 0.485 . . . . 0.0 109.744 179.115 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' D' D ' 85' ' ' ASP . . . . . . . . . . . . . 7.5 t70 -158.38 154.9 27.73 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 115.548 -0.751 . . . . 0.0 110.145 179.105 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' D' D ' 86' ' ' VAL . . . . . . . . . . . . . 44.4 t -130.56 133.98 62.81 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.176 0 CA-C-O 121.055 0.455 . . . . 0.0 110.459 -179.436 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' D' D ' 87' ' ' ILE . . . . . . . . . . . . . 44.3 mm -119.25 125.72 74.7 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.253 0 CA-C-N 115.653 -0.703 . . . . 0.0 109.664 177.657 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' D' D ' 88' ' ' LEU . . . . . . . . . . . . . 14.2 tp -108.14 127.17 53.58 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.299 -0.409 . . . . 0.0 110.848 -178.331 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' D' D ' 89' ' ' ASP . . . . . . . . . . . . . 13.6 t70 -121.22 154.41 36.32 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.002 -0.545 . . . . 0.0 109.843 178.23 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' D' D ' 90' ' ' GLU . . . . . . . . . . . . . 82.3 tt0 -46.32 -37.58 7.61 Favored 'General case' 0 C--N 1.33 -0.271 0 N-CA-C 113.079 0.77 . . . . 0.0 113.079 -172.754 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' D' D ' 91' ' ' ASN . . . . . . . . . . . . . 13.4 t-20 -132.0 22.02 4.53 Favored 'General case' 0 N--CA 1.469 0.477 0 N-CA-C 112.779 0.659 . . . . 0.0 112.779 -177.446 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' D' D ' 92' ' ' LEU . . . . . . . . . . . . . 19.9 mt -150.49 144.15 25.19 Favored 'General case' 0 C--N 1.331 -0.204 0 CA-C-O 120.773 0.321 . . . . 0.0 110.269 -176.59 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' D' D ' 93' ' ' ILE . . . . . . . . . . . . . 74.6 mt -121.78 115.08 45.33 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.276 0 N-CA-C 109.168 -0.678 . . . . 0.0 109.168 176.944 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' D' D ' 94' ' ' VAL . . . . . . . . . . . . . 46.8 t -118.06 127.04 75.32 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.217 0 CA-C-O 121.071 0.462 . . . . 0.0 110.111 -177.883 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' D' D ' 95' ' ' VAL . . . . . . . . . . . . . 41.1 t -121.42 134.55 64.41 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.277 0 CA-C-N 115.769 -0.651 . . . . 0.0 109.772 -179.678 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' D' D ' 96' ' ' ILE . . . . . . . . . . . . . 63.4 mt -113.57 127.58 70.84 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.287 0 N-CA-C 109.209 -0.663 . . . . 0.0 109.209 178.381 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' D' D ' 97' ' ' THR . . . . . . . . . . . . . 59.9 p -101.44 156.15 17.63 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-O 121.289 0.566 . . . . 0.0 111.379 -177.106 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' D' D ' 98' ' ' GLU . . . . . . . . . . . . . 45.5 tp10 -53.81 -26.65 25.1 Favored 'General case' 0 CA--C 1.533 0.32 0 CA-C-N 116.009 -0.542 . . . . 0.0 112.075 179.309 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' D' D ' 99' ' ' GLU . . . . . . . . . . . . . 96.7 mt-10 -79.97 17.49 0.96 Allowed 'General case' 0 CA--C 1.534 0.357 0 N-CA-C 113.084 0.772 . . . . 0.0 113.084 -177.217 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' D' D ' 100' ' ' ASN . . . . . . . . . . . . . 2.7 m-20 62.41 37.65 13.45 Favored 'General case' 0 C--O 1.233 0.19 0 CA-C-O 121.004 0.43 . . . . 0.0 110.959 177.456 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' D' D ' 101' ' ' GLU . . . . . . . . . . . . . 84.5 tt0 -116.27 143.64 45.26 Favored 'General case' 0 C--N 1.332 -0.173 0 CA-C-N 116.22 -0.445 . . . . 0.0 109.864 177.356 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' D' D ' 102' ' ' VAL . . . . . . . . . . . . . 45.3 t -114.93 124.37 71.52 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.267 0 CA-C-N 116.103 -0.499 . . . . 0.0 109.842 -179.122 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' D' D ' 103' ' ' LEU . . . . . . . . . . . . . 30.9 mt -115.88 131.31 56.98 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-N 115.815 -0.63 . . . . 0.0 110.464 178.075 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' D' D ' 104' ' ' ILE . . . . . 0.51 HD13 HG11 ' D' ' 130' ' ' VAL . 68.9 mt -120.77 120.1 61.49 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.302 0 N-CA-C 110.268 -0.271 . . . . 0.0 110.268 179.425 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' D' D ' 105' ' ' PHE . . . . . . . . . . . . . 59.1 m-85 -121.64 166.95 13.49 Favored 'General case' 0 C--N 1.333 -0.149 0 O-C-N 123.886 0.741 . . . . 0.0 110.043 178.494 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' D' D ' 106' ' ' ASN . . . . . . . . . . . . . 45.2 p-10 -104.1 -170.63 1.8 Allowed 'General case' 0 CA--C 1.531 0.227 0 N-CA-C 110.088 -0.338 . . . . 0.0 110.088 173.187 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' D' D ' 107' ' ' GLN . . . . . . . . . . . . . 63.3 tt0 -57.56 -29.77 64.69 Favored 'General case' 0 C--N 1.33 -0.255 0 N-CA-C 112.071 0.396 . . . . 0.0 112.071 179.338 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' D' D ' 108' ' ' ASN . . . . . . . . . . . . . 4.0 t-20 -87.3 12.62 11.46 Favored 'General case' 0 CA--C 1.536 0.415 0 N-CA-C 113.045 0.757 . . . . 0.0 113.045 -176.295 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' D' D ' 109' ' ' LEU . . . . . . . . . . . . . 24.9 mt 55.1 36.75 27.66 Favored 'General case' 0 CA--C 1.528 0.132 0 CA-C-O 120.943 0.401 . . . . 0.0 111.43 178.665 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' D' D ' 110' ' ' GLU . . . . . . . . . . . . . 95.8 mt-10 -102.28 148.86 24.93 Favored 'General case' 0 C--N 1.33 -0.251 0 N-CA-C 109.689 -0.485 . . . . 0.0 109.689 175.917 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' D' D ' 111' ' ' GLU . . . . . . . . . . . . . 79.9 tt0 -79.34 122.0 25.82 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.339 -0.392 . . . . 0.0 110.565 -178.027 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' D' D ' 112' ' ' LEU . . . . . . . . . . . . . 43.4 mt -109.05 -46.01 3.67 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-N 116.128 -0.487 . . . . 0.0 110.245 178.677 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' D' D ' 113' ' ' TYR . . . . . . . . . . . . . 60.3 t80 -140.94 137.49 33.14 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.32 -0.4 . . . . 0.0 111.147 -179.959 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' D' D ' 114' ' ' ARG . . . . . . . . . . . . . 68.5 ttp85 -140.72 119.25 12.3 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 115.881 -0.6 . . . . 0.0 109.98 177.377 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' D' D ' 115' ' ' GLY . . . . . . . . . . . . . . . -150.08 151.13 23.24 Favored Glycine 0 CA--C 1.523 0.588 0 N-CA-C 110.919 -0.872 . . . . 0.0 110.919 179.554 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' D' D ' 116' ' ' LYS . . . . . . . . . . . . . 35.2 ttmt -124.29 140.0 53.38 Favored 'General case' 0 C--N 1.329 -0.298 0 N-CA-C 109.968 -0.382 . . . . 0.0 109.968 177.449 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' D' D ' 117' ' ' PHE . . . . . . . . . . . . . 28.9 m-85 -136.16 118.89 16.08 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.04 -176.232 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' D' D ' 118' ' ' GLU . . . . . . . . . . . . . 96.1 mt-10 -53.45 -46.55 69.91 Favored 'General case' 0 C--N 1.33 -0.278 0 C-N-CA 121.041 -0.264 . . . . 0.0 111.307 -177.88 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' D' D ' 119' ' ' ASN . . . . . . . . . . . . . 24.3 m120 -95.87 31.04 2.19 Favored 'General case' 0 C--N 1.331 -0.216 0 CA-C-N 116.149 -0.478 . . . . 0.0 112.198 -175.891 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' D' D ' 120' ' ' LEU . . . . . . . . . . . . . 19.4 tp -57.59 122.04 11.78 Favored 'General case' 0 C--O 1.231 0.123 0 N-CA-C 110.077 -0.342 . . . . 0.0 110.077 177.271 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' D' D ' 121' ' ' ASN . . . . . . . . . . . . . 29.2 t-20 -113.56 -44.0 3.26 Favored 'General case' 0 C--O 1.233 0.199 0 CA-C-N 116.683 -0.235 . . . . 0.0 111.329 -175.37 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' D' D ' 122' ' ' LYS . . . . . . . . . . . . . 34.7 ttmt -150.98 141.81 22.85 Favored 'General case' 0 C--N 1.331 -0.201 0 C-N-CA 120.513 -0.475 . . . . 0.0 111.703 -177.457 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' D' D ' 123' ' ' VAL . . . . . . . . . . . . . 46.5 t -119.57 127.87 75.87 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.231 0 N-CA-C 108.972 -0.751 . . . . 0.0 108.972 173.539 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' D' D ' 124' ' ' LEU . . . . . . . . . . . . . 17.7 tp -127.16 140.72 52.05 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-O 120.867 0.365 . . . . 0.0 110.924 -175.506 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' D' D ' 125' ' ' VAL . . . . . 0.585 HG12 HG23 ' D' ' 130' ' ' VAL . 35.6 m -126.82 140.91 47.65 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.276 0 CA-C-N 116.065 -0.516 . . . . 0.0 110.629 179.787 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' D' D ' 126' ' ' ARG . . . . . . . . . . . . . 47.7 ttt180 -159.34 134.08 7.98 Favored 'General case' 0 C--N 1.329 -0.318 0 N-CA-C 109.53 -0.544 . . . . 0.0 109.53 178.287 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' D' D ' 127' ' ' ASN . . . . . . . . . . . . . 1.6 t-20 56.68 -154.0 0.35 Allowed 'General case' 0 CA--C 1.537 0.47 0 N-CA-C 109.588 -0.523 . . . . 0.0 109.588 -178.333 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' D' D ' 128' ' ' ASP . . . . . . . . . . . . . 13.7 p-10 -84.99 20.7 1.79 Allowed 'General case' 0 CA--C 1.535 0.381 0 CA-C-N 118.433 0.561 . . . . 0.0 112.346 177.178 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' D' D ' 129' ' ' LEU . . . . . . . . . . . . . 59.1 mt -122.87 150.3 43.07 Favored 'General case' 0 C--O 1.233 0.228 0 O-C-N 122.119 -0.363 . . . . 0.0 110.307 -179.699 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' D' D ' 130' ' ' VAL . . . . . 0.585 HG23 HG12 ' D' ' 125' ' ' VAL . 12.9 p -134.46 147.15 30.07 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.205 0 CA-C-O 120.891 0.377 . . . . 0.0 110.412 -179.16 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' D' D ' 131' ' ' VAL . . . . . . . . . . . . . 14.9 p -136.23 142.84 37.48 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.211 0 CA-C-O 121.121 0.486 . . . . 0.0 110.904 -179.528 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' D' D ' 132' ' ' ILE . . . . . . . . . . . . . 72.4 mt -115.63 131.41 68.09 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.231 0 CA-C-N 115.689 -0.687 . . . . 0.0 109.374 178.333 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' D' D ' 133' ' ' ILE . . . . . . . . . . . . . 42.5 mm -115.61 124.23 71.85 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.307 0 CA-C-O 120.878 0.371 . . . . 0.0 110.911 -175.597 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' D' D ' 134' ' ' ASP . . . . . . . . . . . . . 10.3 p-10 -137.46 146.33 44.17 Favored 'General case' 0 C--N 1.331 -0.201 0 CA-C-N 116.103 -0.499 . . . . 0.0 109.762 174.294 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' D' D ' 135' ' ' GLU . . . . . . . . . . . . . 84.9 tt0 -49.87 -25.95 3.63 Favored 'General case' 0 C--N 1.329 -0.309 0 N-CA-C 112.776 0.658 . . . . 0.0 112.776 -173.798 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' D' D ' 136' ' ' GLN . . . . . . . . . . . . . 48.0 tt0 -81.91 -34.04 30.12 Favored 'General case' 0 C--N 1.331 -0.231 0 N-CA-C 111.939 0.348 . . . . 0.0 111.939 -175.828 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' D' D ' 137' ' ' LYS . . . . . . . . . . . . . 53.7 pttt -167.78 175.3 6.99 Favored 'General case' 0 C--N 1.331 -0.223 0 CA-C-O 121.561 0.696 . . . . 0.0 112.079 -173.396 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' D' D ' 138' ' ' LEU . . . . . 0.454 HD23 ' N ' ' D' ' 139' ' ' THR . 5.5 tt -119.2 129.6 55.05 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 115.095 -0.957 . . . . 0.0 109.853 179.07 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' D' D ' 139' ' ' THR . . . . . 0.454 ' N ' HD23 ' D' ' 138' ' ' LEU . 39.1 m -112.49 124.22 52.02 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.289 -0.414 . . . . 0.0 110.353 178.829 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' D' D ' 140' ' ' LEU . . . . . . . . . . . . . 31.7 tp -112.07 124.97 53.57 Favored 'General case' 0 C--N 1.327 -0.378 0 N-CA-C 109.186 -0.672 . . . . 0.0 109.186 -178.663 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' D' D ' 141' ' ' ILE . . . . . 0.416 ' HB ' HG13 ' D' ' 130' ' ' VAL . 19.7 mt -121.99 117.16 51.44 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.292 0 CA-C-O 120.954 0.406 . . . . 0.0 109.983 -173.071 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' D' D ' 142' ' ' ARG . . . . . . . . . . . . . 78.6 mtp180 -107.11 125.26 50.83 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-N 115.382 -0.826 . . . . 0.0 110.445 -177.35 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' D' D ' 143' ' ' THR . . . . . . . . . . . . . 25.4 p . . . . . 0 C--O 1.219 -0.544 0 CA-C-O 118.004 -0.998 . . . . 0.0 110.61 -179.748 . . . . . . . . 0 0 . 1 . 009 nuclear build full ' E' E ' -3' ' ' GLU . . . . . . . . . . . . . 45.1 tp10 . . . . . 0 N--CA 1.49 1.558 0 N-CA-C 109.378 -0.601 . . . . 0.0 109.378 . . . . . . . . . 0 0 . 1 . 009 nuclear build full ' E' E ' -2' ' ' GLY . . . . . . . . . . . . . . . -77.88 138.34 21.32 Favored Glycine 0 CA--C 1.524 0.646 0 N-CA-C 110.893 -0.883 . . . . 0.0 110.893 179.647 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' E' E ' -1' ' ' VAL . . . . . . . . . . . . . 43.9 t -96.04 130.07 45.24 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.289 0 N-CA-C 110.065 -0.346 . . . . 0.0 110.065 179.733 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' E' E ' 0' ' ' ILE . . . . . . . . . . . . . 44.0 mm -117.67 140.09 42.16 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.222 0 CA-C-O 120.901 0.382 . . . . 0.0 110.46 -178.649 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' E' E ' 1' ' ' MET . . . . . . . . . . . . . 20.1 ptt? -144.4 140.47 29.05 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 115.924 -0.58 . . . . 0.0 110.503 -179.832 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' E' E ' 2' ' ' SER . . . . . . . . . . . . . 2.0 p -128.3 122.27 31.22 Favored 'General case' 0 C--O 1.233 0.207 0 CA-C-O 121.014 0.435 . . . . 0.0 110.67 -178.6 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' E' E ' 3' ' ' GLU . . . . . . . . . . . . . 66.3 tt0 -144.87 142.52 29.98 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-N 115.794 -0.639 . . . . 0.0 111.251 -175.29 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' E' E ' 4' ' ' LEU . . . . . . . . . . . . . 15.9 tp -123.37 135.0 53.94 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 115.918 -0.583 . . . . 0.0 110.001 175.583 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' E' E ' 5' ' ' LYS . . . . . . . . . . . . . 89.9 mttt -115.42 121.98 44.41 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.581 -0.281 . . . . 0.0 110.89 -179.125 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' E' E ' 6' ' ' LEU . . . . . . . . . . . . . 69.4 mt -114.48 145.93 41.3 Favored 'General case' 0 C--N 1.331 -0.225 0 CA-C-N 115.808 -0.633 . . . . 0.0 110.19 178.227 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' E' E ' 7' ' ' LYS . . . . . . . . . . . . . 26.3 ttpp -127.76 142.58 44.69 Favored Pre-proline 0 CA--C 1.533 0.323 0 CA-C-O 119.129 -0.462 . . . . 0.0 109.826 175.928 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' E' E ' 8' ' ' PRO . . . . . . . . . . . . . 87.2 Cg_endo -91.04 132.49 1.54 Allowed 'Trans proline' 0 N--CA 1.489 1.234 0 C-N-CA 121.652 1.568 . . . . 0.0 111.843 178.769 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' E' E ' 9' ' ' LEU . . . . . . . . . . . . . 71.6 mt -71.0 -47.17 14.73 Favored Pre-proline 0 CA--C 1.534 0.331 0 CA-C-O 118.663 -0.684 . . . . 0.0 112.111 -179.696 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' E' E ' 10' ' ' PRO . . . . . . . . . . . . . 98.3 Cg_endo -79.96 155.95 23.37 Favored 'Trans proline' 0 N--CA 1.495 1.614 0 C-N-CA 121.106 1.204 . . . . 0.0 111.878 175.573 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' E' E ' 11' ' ' LYS . . . . . . . . . . . . . 62.4 mttp -88.14 96.03 10.38 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-O 120.774 0.321 . . . . 0.0 110.695 179.696 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' E' E ' 12' ' ' VAL . . . . . . . . . . . . . 12.5 p -143.35 147.01 20.74 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.248 0 CA-C-N 116.231 -0.44 . . . . 0.0 110.37 179.228 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' E' E ' 13' ' ' GLU . . . . . . . . . . . . . 84.8 tt0 -92.06 123.59 35.53 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.321 -0.399 . . . . 0.0 110.276 179.175 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' E' E ' 14' ' ' LEU . . . . . . . . . . . . . 41.7 mt -97.9 149.01 35.28 Favored Pre-proline 0 CA--C 1.533 0.307 0 CA-C-O 119.352 -0.356 . . . . 0.0 110.6 -178.099 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' E' E ' 15' ' ' PRO . . . . . . . . . . . . . 26.1 Cg_exo -62.08 157.57 43.58 Favored 'Trans proline' 0 N--CA 1.498 1.751 0 C-N-CA 121.349 1.366 . . . . 0.0 111.906 177.412 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' E' E ' 16' ' ' PRO . . . . . . . . . . . . . 34.0 Cg_exo -59.36 -37.85 87.89 Favored 'Trans proline' 0 N--CA 1.498 1.758 0 C-N-CA 121.49 1.46 . . . . 0.0 112.875 -179.228 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' E' E ' 17' ' ' ASP . . . . . . . . . . . . . 18.2 p-10 -79.43 1.86 23.95 Favored 'General case' 0 CA--C 1.538 0.499 0 N-CA-C 113.327 0.862 . . . . 0.0 113.327 -177.34 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' E' E ' 18' ' ' PHE . . . . . . . . . . . . . 46.9 t80 -57.61 -47.18 82.88 Favored 'General case' 0 N--CA 1.458 -0.074 0 O-C-N 121.97 -0.456 . . . . 0.0 110.142 -178.605 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' E' E ' 19' ' ' VAL . . . . . 0.41 HG13 ' N ' ' E' ' 20' ' ' ASP . 13.8 p -55.34 -41.49 62.11 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.319 0 CA-C-N 116.26 -0.427 . . . . 0.0 111.095 -178.553 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' E' E ' 20' ' ' ASP . . . . . 0.41 ' N ' HG13 ' E' ' 19' ' ' VAL . 9.5 t0 -60.44 -43.16 97.11 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-O 120.925 0.393 . . . . 0.0 110.899 -177.977 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' E' E ' 21' ' ' VAL . . . . . . . . . . . . . 47.2 t -64.34 -45.98 94.45 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.287 0 CA-C-N 116.272 -0.422 . . . . 0.0 110.496 -178.177 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' E' E ' 22' ' ' ILE . . . . . 0.62 HG22 HD12 ' E' ' 26' ' ' LEU . 50.2 mm -54.63 -47.09 73.05 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.287 0 CA-C-O 120.676 0.275 . . . . 0.0 110.753 178.809 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' E' E ' 23' ' ' ARG . . . . . . . . . . . . . 25.1 ttm-85 -53.3 -54.17 40.28 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-O 121.258 0.551 . . . . 0.0 111.677 179.963 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' E' E ' 24' ' ' ILE . . . . . . . . . . . . . 76.4 mt -61.0 -36.52 72.94 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.38 0 CA-C-N 115.67 -0.696 . . . . 0.0 111.59 -172.857 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' E' E ' 25' ' ' LYS . . . . . . . . . . . . . 64.1 mttm -75.22 -40.66 58.91 Favored 'General case' 0 C--N 1.33 -0.267 0 N-CA-C 112.349 0.5 . . . . 0.0 112.349 -178.855 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' E' E ' 26' ' ' LEU . . . . . 0.62 HD12 HG22 ' E' ' 22' ' ' ILE . 75.9 mt -80.22 -25.64 39.52 Favored 'General case' 0 C--N 1.331 -0.201 0 N-CA-C 113.195 0.813 . . . . 0.0 113.195 -171.112 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' E' E ' 27' ' ' GLN . . . . . . . . . . . . . 18.4 pt20 -46.38 136.67 7.1 Favored 'General case' 0 N--CA 1.469 0.495 0 N-CA-C 112.594 0.59 . . . . 0.0 112.594 -177.368 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' E' E ' 28' ' ' GLY . . . . . . . . . . . . . . . 99.8 -21.06 46.67 Favored Glycine 0 CA--C 1.535 1.305 0 CA-C-N 115.824 -0.626 . . . . 0.0 112.661 -177.162 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' E' E ' 29' ' ' LYS . . . . . . . . . . . . . 61.1 mttp -97.02 155.14 16.91 Favored 'General case' 0 C--O 1.233 0.218 0 CA-C-N 117.471 0.636 . . . . 0.0 110.935 179.492 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' E' E ' 30' ' ' THR . . . . . . . . . . . . . 28.5 m -108.65 137.45 46.57 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.042 -0.526 . . . . 0.0 110.031 176.748 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' E' E ' 31' ' ' VAL . . . . . . . . . . . . . 35.3 m -130.35 152.77 37.98 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.223 0 CA-C-O 120.919 0.39 . . . . 0.0 110.778 -178.751 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' E' E ' 32' ' ' ARG . . . . . . . . . . . . . 37.9 ttm180 -133.23 148.23 51.99 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-O 121.246 0.546 . . . . 0.0 110.398 179.568 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' E' E ' 33' ' ' THR . . . . . . . . . . . . . 16.4 m -52.11 139.33 23.49 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.244 -0.434 . . . . 0.0 111.624 -177.145 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' E' E ' 34' ' ' GLY . . . . . . . . . . . . . . . 101.03 -17.24 56.45 Favored Glycine 0 CA--C 1.534 1.235 0 CA-C-O 119.667 -0.519 . . . . 0.0 113.201 179.051 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' E' E ' 35' ' ' ASP . . . . . . . . . . . . . 79.2 m-20 -66.78 147.3 53.43 Favored 'General case' 0 N--CA 1.462 0.163 0 CA-C-N 118.026 0.913 . . . . 0.0 111.229 179.25 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' E' E ' 36' ' ' VAL . . . . . . . . . . . . . 45.8 t -122.51 129.1 75.49 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.204 0 CA-C-N 115.779 -0.646 . . . . 0.0 109.737 177.802 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' E' E ' 37' ' ' ILE . . . . . . . . . . . . . 63.2 mt -123.16 139.23 50.53 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.256 0 CA-C-N 116.286 -0.416 . . . . 0.0 109.953 -179.011 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' E' E ' 38' ' ' GLY . . . . . . . . . . . . . . . -115.46 128.65 8.16 Favored Glycine 0 CA--C 1.524 0.605 0 N-CA-C 110.982 -0.847 . . . . 0.0 110.982 178.661 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' E' E ' 39' ' ' ILE . . . . . . . . . . . . . 68.7 mt -126.98 125.71 67.05 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.271 0 N-CA-C 110.019 -0.363 . . . . 0.0 110.019 179.501 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' E' E ' 40' ' ' SER . . . . . . . . . . . . . 24.0 t -91.99 118.66 30.99 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.388 -0.369 . . . . 0.0 110.794 176.545 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' E' E ' 41' ' ' ILE . . . . . . . . . . . . . 70.9 mt -130.35 131.05 65.63 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.227 0 CA-C-O 120.927 0.394 . . . . 0.0 110.299 179.283 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' E' E ' 42' ' ' LEU . . . . . . . . . . . . . 47.3 mt 54.94 33.47 20.15 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-N 116.039 -0.528 . . . . 0.0 111.817 177.954 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' E' E ' 43' ' ' GLY . . . . . . . . . . . . . . . 71.77 28.99 68.03 Favored Glycine 0 CA--C 1.53 0.983 0 C-N-CA 121.075 -0.583 . . . . 0.0 112.299 178.094 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' E' E ' 44' ' ' LYS . . . . . . . . . . . . . 20.0 tptm -142.43 125.92 16.75 Favored 'General case' 0 C--N 1.331 -0.205 0 N-CA-C 109.748 -0.464 . . . . 0.0 109.748 178.46 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' E' E ' 45' ' ' GLU . . . . . . . . . . . . . 41.0 tp10 -85.21 128.6 34.74 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-O 120.843 0.354 . . . . 0.0 111.589 -177.413 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' E' E ' 46' ' ' VAL . . . . . . . . . . . . . 8.9 p -120.15 127.74 75.92 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.188 0 N-CA-C 109.525 -0.546 . . . . 0.0 109.525 174.261 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' E' E ' 47' ' ' LYS . . . . . . . . . . . . . 52.7 mtpt -98.55 124.41 43.28 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.035 -0.529 . . . . 0.0 110.792 178.01 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' E' E ' 48' ' ' PHE . . . . . . . . . . . . . 37.6 m-85 -109.27 131.82 54.7 Favored 'General case' 0 C--N 1.33 -0.265 0 N-CA-C 109.782 -0.451 . . . . 0.0 109.782 178.069 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' E' E ' 49' ' ' LYS . . . . . . . . . . . . . 76.8 tttt -108.63 132.58 53.75 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.417 -0.356 . . . . 0.0 110.344 178.009 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' E' E ' 50' ' ' VAL . . . . . . . . . . . . . 45.6 t -76.29 105.07 4.83 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.367 0 N-CA-C 109.249 -0.649 . . . . 0.0 109.249 176.087 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' E' E ' 51' ' ' VAL . . . . . . . . . . . . . 47.0 t -68.64 -53.92 24.32 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.351 0 N-CA-C 109.401 -0.592 . . . . 0.0 109.401 -175.64 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' E' E ' 52' ' ' GLN . . . . . . . . . . . . . 80.8 mt-30 -155.7 154.61 31.78 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 115.967 -0.561 . . . . 0.0 111.584 -178.163 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' E' E ' 53' ' ' ALA . . . . . . . . . . . . . . . -130.9 132.17 44.97 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 115.371 -0.831 . . . . 0.0 109.667 174.91 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' E' E ' 54' ' ' TYR . . . . . . . . . . . . . 39.7 t80 -129.07 108.92 18.1 Favored Pre-proline 0 CA--C 1.534 0.353 0 CA-C-O 118.273 -0.87 . . . . 0.0 110.421 179.892 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' E' E ' 55' ' ' PRO . . . . . . . . . . . . . 73.2 Cg_endo -77.21 169.89 72.94 Favored 'Cis proline' 0 N--CA 1.5 1.866 0 CA-C-N 121.84 1.693 . . . . 0.0 112.32 -6.428 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' E' E ' 56' ' ' SER . . . . . . . . . . . . . 13.6 m -117.22 134.71 23.03 Favored Pre-proline 0 CA--C 1.539 0.528 0 CA-C-O 118.401 -0.809 . . . . 0.0 109.45 174.031 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' E' E ' 57' ' ' PRO . . . . . . . . . . . . . 50.8 Cg_endo -70.07 146.79 83.81 Favored 'Cis proline' 0 N--CA 1.496 1.672 0 CA-C-N 121.85 1.696 . . . . 0.0 111.519 -1.379 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' E' E ' 58' ' ' LEU . . . . . . . . . . . . . 33.6 tp -107.89 138.76 43.57 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-O 120.87 0.367 . . . . 0.0 110.689 -177.838 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' E' E ' 59' ' ' ARG . . . . . . . . . . . . . 72.7 ttt180 -102.66 131.59 49.34 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 115.813 -0.63 . . . . 0.0 109.679 176.952 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' E' E ' 60' ' ' VAL . . . . . . . . . . . . . 41.7 t -86.29 118.65 33.08 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.213 0 C-N-CA 120.775 -0.37 . . . . 0.0 110.602 -177.167 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' E' E ' 61' ' ' GLU . . . . . . . . . . . . . 96.6 mt-10 -131.11 158.17 41.13 Favored 'General case' 0 C--N 1.331 -0.229 0 CA-C-N 115.874 -0.603 . . . . 0.0 109.748 177.302 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' E' E ' 62' ' ' ASP . . . . . . . . . . . . . 48.5 m-20 -52.44 -32.94 41.92 Favored 'General case' 0 C--N 1.329 -0.324 0 N-CA-C 111.816 0.302 . . . . 0.0 111.816 -178.663 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' E' E ' 63' ' ' ARG . . . . . . . . . . . . . 75.5 mtp180 -78.91 -19.96 50.53 Favored 'General case' 0 CA--C 1.533 0.301 0 N-CA-C 113.153 0.797 . . . . 0.0 113.153 -176.258 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' E' E ' 64' ' ' THR . . . . . . . . . . . . . 24.9 m -66.34 149.2 50.74 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-O 120.993 0.425 . . . . 0.0 111.117 -174.739 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' E' E ' 65' ' ' LYS . . . . . . . . . . . . . 24.6 mtpp -89.67 127.26 35.9 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 115.964 -0.562 . . . . 0.0 110.651 179.997 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' E' E ' 66' ' ' ILE . . . . . . . . . . . . . 64.1 mt -117.64 128.52 74.84 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.272 0 N-CA-C 109.842 -0.429 . . . . 0.0 109.842 177.476 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' E' E ' 67' ' ' THR . . . . . . . . . . . . . 28.8 m -120.56 137.76 54.23 Favored 'General case' 0 C--N 1.331 -0.229 0 CA-C-O 121.123 0.487 . . . . 0.0 110.928 -178.587 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' E' E ' 68' ' ' LEU . . . . . . . . . . . . . 13.3 tp -106.03 122.37 46.01 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 115.706 -0.679 . . . . 0.0 110.254 178.44 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' E' E ' 69' ' ' VAL . . . . . . . . . . . . . 43.4 t -99.6 123.84 52.6 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.271 0 CA-C-N 116.219 -0.446 . . . . 0.0 109.922 179.881 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' E' E ' 70' ' ' THR . . . . . 0.413 HG23 ' N ' ' E' ' 71' ' ' HIS . 8.8 t -96.11 -42.28 8.31 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.185 -0.461 . . . . 0.0 110.764 -179.552 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' E' E ' 71' ' ' HIS . . . . . 0.413 ' N ' HG23 ' E' ' 70' ' ' THR . 92.4 m-70 -149.96 156.78 38.15 Favored Pre-proline 0 C--N 1.328 -0.336 0 CA-C-O 119.519 -0.276 . . . . 0.0 110.653 178.936 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' E' E ' 72' ' ' PRO . . . . . . . . . . . . . 16.6 Cg_exo -65.02 -26.24 58.53 Favored 'Trans proline' 0 N--CA 1.497 1.679 0 C-N-CA 121.258 1.306 . . . . 0.0 112.447 176.264 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' E' E ' 73' ' ' VAL . . . . . . . . . . . . . 35.2 m -123.15 170.62 13.21 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.198 0 CA-C-O 120.709 0.29 . . . . 0.0 110.466 -178.664 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' E' E ' 74' ' ' ASP . . . . . . . . . . . . . 10.8 t70 -98.04 118.04 33.74 Favored 'General case' 0 C--N 1.33 -0.274 0 N-CA-C 109.935 -0.394 . . . . 0.0 109.935 -178.471 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' E' E ' 75' ' ' VAL . . . . . . . . . . . . . 42.0 t -112.32 122.65 66.97 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.2 0 CA-C-O 121.09 0.471 . . . . 0.0 110.369 -178.31 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' E' E ' 76' ' ' LEU . . . . . . . . . . . . . 29.9 mt -122.79 137.62 54.87 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 115.63 -0.713 . . . . 0.0 109.432 178.398 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' E' E ' 77' ' ' GLU . . . . . . . . . . . . . 96.4 mt-10 -133.27 140.3 47.39 Favored 'General case' 0 C--N 1.331 -0.217 0 CA-C-O 121.035 0.445 . . . . 0.0 111.301 -177.29 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' E' E ' 78' ' ' ALA . . . . . 0.577 ' HB2' HD21 ' E' ' 109' ' ' LEU . . . -130.12 129.62 43.76 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 115.678 -0.692 . . . . 0.0 109.957 176.377 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' E' E ' 79' ' ' LYS . . . . . 0.583 ' O ' HD13 ' E' ' 80' ' ' ILE . 32.7 mmtp -75.24 119.09 18.9 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-O 120.949 0.404 . . . . 0.0 110.58 -179.428 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' E' E ' 80' ' ' ILE . . . . . 0.583 HD13 ' O ' ' E' ' 79' ' ' LYS . 22.7 mm -139.25 112.53 6.36 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.269 0 N-CA-C 108.947 -0.76 . . . . 0.0 108.947 -178.578 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' E' E ' 81' ' ' LYS . . . . . . . . . . . . . 40.6 mttp -99.72 126.75 45.82 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-O 120.875 0.369 . . . . 0.0 111.293 -176.07 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' E' E ' 82' ' ' GLY . . . . . . . . . . . . . . . 89.11 42.21 5.66 Favored Glycine 0 CA--C 1.526 0.744 0 C-N-CA 120.989 -0.624 . . . . 0.0 111.892 174.119 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' E' E ' 83' ' ' ILE . . . . . . . . . . . . . 69.8 mt -67.93 137.99 23.5 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.34 0 N-CA-C 109.793 -0.447 . . . . 0.0 109.793 177.099 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' E' E ' 84' ' ' LYS . . . . . . . . . . . . . 70.4 tttt -100.24 -53.63 3.08 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.165 -0.471 . . . . 0.0 110.226 -178.58 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' E' E ' 85' ' ' ASP . . . . . . . . . . . . . 8.5 t70 -151.23 148.45 28.23 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 115.837 -0.619 . . . . 0.0 110.387 -178.985 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' E' E ' 86' ' ' VAL . . . . . . . . . . . . . 43.7 t -129.47 129.42 66.93 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.269 0 CA-C-O 120.928 0.394 . . . . 0.0 110.377 -179.648 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' E' E ' 87' ' ' ILE . . . . . . . . . . . . . 4.6 mp -122.19 134.28 65.93 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.255 0 CA-C-N 115.972 -0.558 . . . . 0.0 109.709 178.593 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' E' E ' 88' ' ' LEU . . . . . . . . . . . . . 10.2 tp -111.59 134.89 52.85 Favored 'General case' 0 C--N 1.331 -0.205 0 CA-C-O 121.105 0.479 . . . . 0.0 111.059 -178.206 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' E' E ' 89' ' ' ASP . . . . . . . . . . . . . 4.7 t70 -121.53 159.12 27.01 Favored 'General case' 0 C--N 1.331 -0.205 0 CA-C-N 115.651 -0.704 . . . . 0.0 109.634 177.515 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' E' E ' 90' ' ' GLU . . . . . . . . . . . . . 84.3 tt0 -44.97 -44.37 9.8 Favored 'General case' 0 N--CA 1.465 0.301 0 N-CA-C 113.094 0.775 . . . . 0.0 113.094 -172.224 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' E' E ' 91' ' ' ASN . . . . . . . . . . . . . 23.8 m120 -132.02 26.34 4.59 Favored 'General case' 0 N--CA 1.467 0.419 0 N-CA-C 112.401 0.519 . . . . 0.0 112.401 -179.427 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' E' E ' 92' ' ' LEU . . . . . . . . . . . . . 12.8 mt -149.24 151.88 35.02 Favored 'General case' 0 C--N 1.333 -0.143 0 N-CA-C 110.105 -0.332 . . . . 0.0 110.105 -176.159 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' E' E ' 93' ' ' ILE . . . . . . . . . . . . . 72.2 mt -127.71 121.98 57.93 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.28 0 N-CA-C 109.349 -0.612 . . . . 0.0 109.349 177.812 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' E' E ' 94' ' ' VAL . . . . . 0.46 HG21 HG11 ' E' ' 125' ' ' VAL . 44.6 t -118.07 128.1 75.19 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.294 0 CA-C-O 120.813 0.34 . . . . 0.0 110.119 -178.343 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' E' E ' 95' ' ' VAL . . . . . . . . . . . . . 43.6 t -122.19 135.11 63.37 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.381 0 CA-C-N 115.986 -0.552 . . . . 0.0 109.996 -179.238 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' E' E ' 96' ' ' ILE . . . . . . . . . . . . . 62.2 mt -115.3 128.04 72.65 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.346 0 N-CA-C 109.241 -0.652 . . . . 0.0 109.241 178.392 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' E' E ' 97' ' ' THR . . . . . . . . . . . . . 66.5 p -101.32 155.74 17.86 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-O 121.056 0.455 . . . . 0.0 111.04 -177.521 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' E' E ' 98' ' ' GLU . . . . . . . . . . . . . 97.1 mt-10 -53.91 -26.22 24.08 Favored 'General case' 0 CA--C 1.532 0.265 0 N-CA-C 112.194 0.442 . . . . 0.0 112.194 179.874 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' E' E ' 99' ' ' GLU . . . . . . . . . . . . . 97.0 mt-10 -78.86 15.53 1.06 Allowed 'General case' 0 CA--C 1.535 0.37 0 N-CA-C 113.167 0.803 . . . . 0.0 113.167 -177.383 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' E' E ' 100' ' ' ASN . . . . . . . . . . . . . 3.6 m-20 61.54 37.41 16.4 Favored 'General case' 0 CA--C 1.529 0.17 0 CA-C-O 120.974 0.416 . . . . 0.0 111.124 178.728 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' E' E ' 101' ' ' GLU . . . . . . . . . . . . . 80.9 tt0 -115.23 145.45 42.41 Favored 'General case' 0 C--N 1.332 -0.173 0 CA-C-N 115.951 -0.568 . . . . 0.0 109.616 175.803 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' E' E ' 102' ' ' VAL . . . . . . . . . . . . . 43.4 t -115.59 125.98 72.97 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.335 0 CA-C-N 116.318 -0.401 . . . . 0.0 110.143 -177.043 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' E' E ' 103' ' ' LEU . . . . . . . . . . . . . 23.4 mt -117.92 130.5 56.26 Favored 'General case' 0 C--N 1.331 -0.226 0 CA-C-N 115.888 -0.596 . . . . 0.0 110.15 177.747 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' E' E ' 104' ' ' ILE . . . . . 0.556 HD13 HG21 ' E' ' 130' ' ' VAL . 68.8 mt -119.9 120.85 64.45 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.189 0 CA-C-O 120.646 0.26 . . . . 0.0 110.308 179.02 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' E' E ' 105' ' ' PHE . . . . . . . . . . . . . 55.6 m-85 -119.86 166.5 13.21 Favored 'General case' 0 C--N 1.332 -0.18 0 CA-C-N 115.352 -0.84 . . . . 0.0 109.796 178.618 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' E' E ' 106' ' ' ASN . . . . . . . . . . . . . 47.1 p-10 -97.87 -169.94 1.91 Allowed 'General case' 0 C--N 1.331 -0.231 0 N-CA-C 109.708 -0.478 . . . . 0.0 109.708 172.972 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' E' E ' 107' ' ' GLN . . . . . . . . . . . . . 5.6 tp-100 -60.89 -28.17 68.69 Favored 'General case' 0 CA--C 1.533 0.295 0 N-CA-C 112.012 0.375 . . . . 0.0 112.012 179.564 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' E' E ' 108' ' ' ASN . . . . . . . . . . . . . 15.6 t-20 -82.94 9.43 10.07 Favored 'General case' 0 CA--C 1.536 0.42 0 N-CA-C 112.94 0.718 . . . . 0.0 112.94 -179.125 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' E' E ' 109' ' ' LEU . . . . . 0.577 HD21 ' HB2' ' E' ' 78' ' ' ALA . 9.4 tp 57.78 36.92 26.94 Favored 'General case' 0 C--O 1.232 0.164 0 CA-C-O 120.877 0.37 . . . . 0.0 111.278 179.973 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' E' E ' 110' ' ' GLU . . . . . . . . . . . . . 96.6 mt-10 -102.14 150.07 23.64 Favored 'General case' 0 C--N 1.331 -0.23 0 N-CA-C 109.788 -0.449 . . . . 0.0 109.788 176.364 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' E' E ' 111' ' ' GLU . . . . . . . . . . . . . 68.0 tt0 -83.24 121.93 27.75 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 116.47 -0.332 . . . . 0.0 110.846 -176.509 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' E' E ' 112' ' ' LEU . . . . . . . . . . . . . 13.4 mt -110.47 -45.99 3.46 Favored 'General case' 0 C--N 1.332 -0.182 0 CA-C-N 116.228 -0.442 . . . . 0.0 110.553 179.685 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' E' E ' 113' ' ' TYR . . . . . . . . . . . . . 57.3 t80 -135.77 133.74 38.26 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.341 -0.391 . . . . 0.0 110.936 -178.346 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' E' E ' 114' ' ' ARG . . . . . . . . . . . . . 76.7 ttt180 -134.57 120.18 19.32 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.14 -0.482 . . . . 0.0 110.054 176.938 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' E' E ' 115' ' ' GLY . . . . . . . . . . . . . . . -148.32 162.46 28.82 Favored Glycine 0 CA--C 1.524 0.635 0 N-CA-C 110.694 -0.962 . . . . 0.0 110.694 -179.773 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' E' E ' 116' ' ' LYS . . . . . . . . . . . . . 33.6 ttmt -136.81 139.09 41.5 Favored 'General case' 0 C--N 1.327 -0.371 0 N-CA-C 110.224 -0.287 . . . . 0.0 110.224 -179.623 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' E' E ' 117' ' ' PHE . . . . . . . . . . . . . 32.9 m-85 -137.51 113.94 10.21 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-O 121.047 0.451 . . . . 0.0 110.272 -176.487 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' E' E ' 118' ' ' GLU . . . . . . . . . . . . . 96.5 mt-10 -53.59 -45.6 70.07 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.142 -0.481 . . . . 0.0 111.514 -176.425 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' E' E ' 119' ' ' ASN . . . . . . . . . . . . . 32.7 m120 -96.55 30.93 2.41 Favored 'General case' 0 C--N 1.329 -0.299 0 N-CA-C 112.306 0.484 . . . . 0.0 112.306 -174.316 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' E' E ' 120' ' ' LEU . . . . . . . . . . . . . 12.9 tp -56.24 122.94 12.94 Favored 'General case' 0 C--N 1.332 -0.191 0 C-N-CA 121.139 -0.224 . . . . 0.0 110.559 177.645 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' E' E ' 121' ' ' ASN . . . . . . . . . . . . . 44.7 t30 -114.07 -44.01 3.19 Favored 'General case' 0 C--N 1.333 -0.131 0 CA-C-N 116.684 -0.235 . . . . 0.0 111.559 -176.641 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' E' E ' 122' ' ' LYS . . . . . 0.424 ' HE3' HD11 ' E' ' 124' ' ' LEU . 33.6 ttpt -149.1 149.16 30.61 Favored 'General case' 0 C--N 1.332 -0.158 0 CA-C-O 121.077 0.465 . . . . 0.0 111.431 -174.647 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' E' E ' 123' ' ' VAL . . . . . . . . . . . . . 45.7 t -126.52 136.49 60.67 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.265 0 CA-C-N 116.11 -0.495 . . . . 0.0 109.935 179.126 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' E' E ' 124' ' ' LEU . . . . . 0.424 HD11 ' HE3' ' E' ' 122' ' ' LYS . 57.3 mt -129.86 138.32 50.91 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-O 120.714 0.292 . . . . 0.0 110.655 -178.926 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' E' E ' 125' ' ' VAL . . . . . 0.46 HG11 HG21 ' E' ' 94' ' ' VAL . 35.7 m -135.9 143.67 35.58 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.269 0 CA-C-N 116.341 -0.391 . . . . 0.0 110.644 178.509 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' E' E ' 126' ' ' ARG . . . . . . . . . . . . . 67.6 ttt180 -162.02 122.09 2.51 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 116.128 -0.487 . . . . 0.0 110.103 177.921 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' E' E ' 127' ' ' ASN . . . . . . . . . . . . . 3.7 t-20 56.02 -149.58 0.45 Allowed 'General case' 0 CA--C 1.54 0.591 0 N-CA-C 109.973 -0.38 . . . . 0.0 109.973 179.822 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' E' E ' 128' ' ' ASP . . . . . . . . . . . . . 14.2 p-10 -80.01 13.54 2.21 Favored 'General case' 0 CA--C 1.536 0.441 0 N-CA-C 112.879 0.696 . . . . 0.0 112.879 -179.792 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' E' E ' 129' ' ' LEU . . . . . . . . . . . . . 39.6 mt -110.82 138.58 47.03 Favored 'General case' 0 C--O 1.231 0.129 0 CA-C-N 118.143 0.429 . . . . 0.0 109.981 178.053 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' E' E ' 130' ' ' VAL . . . . . 0.556 HG21 HD13 ' E' ' 104' ' ' ILE . 30.6 m -132.63 140.76 46.78 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.185 0 CA-C-O 120.957 0.408 . . . . 0.0 110.377 178.478 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' E' E ' 131' ' ' VAL . . . . . 0.537 HG22 HD12 ' E' ' 140' ' ' LEU . 39.7 t -136.06 139.31 46.02 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.256 0 CA-C-O 121.166 0.507 . . . . 0.0 110.392 -178.419 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' E' E ' 132' ' ' ILE . . . . . . . . . . . . . 68.1 mt -116.63 130.95 70.62 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.325 0 CA-C-N 115.552 -0.749 . . . . 0.0 109.379 179.932 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' E' E ' 133' ' ' ILE . . . . . . . . . . . . . 41.8 mm -114.47 119.12 60.59 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.214 0 CA-C-O 121.026 0.441 . . . . 0.0 110.797 -176.07 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' E' E ' 134' ' ' ASP . . . . . . . . . . . . . 7.0 p-10 -128.18 147.44 50.57 Favored 'General case' 0 C--N 1.33 -0.259 0 N-CA-C 109.649 -0.5 . . . . 0.0 109.649 175.684 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' E' E ' 135' ' ' GLU . . . . . . . . . . . . . 85.6 tt0 -49.81 -24.21 2.28 Favored 'General case' 0 C--N 1.327 -0.371 0 N-CA-C 112.971 0.73 . . . . 0.0 112.971 -171.084 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' E' E ' 136' ' ' GLN . . . . . . . . . . . . . 63.0 tt0 -100.03 -31.16 11.58 Favored 'General case' 0 CA--C 1.529 0.165 0 N-CA-C 112.145 0.424 . . . . 0.0 112.145 -175.318 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' E' E ' 137' ' ' LYS . . . . . . . . . . . . . 74.5 mttt -142.23 155.52 45.26 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-O 121.384 0.612 . . . . 0.0 111.818 -169.66 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' E' E ' 138' ' ' LEU . . . . . 0.407 ' C ' HD23 ' E' ' 138' ' ' LEU . 4.4 tt -116.47 120.98 40.51 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 115.323 -0.853 . . . . 0.0 109.054 171.772 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' E' E ' 139' ' ' THR . . . . . . . . . . . . . 26.3 m -108.39 126.39 52.82 Favored 'General case' 0 C--N 1.331 -0.204 0 CA-C-N 116.381 -0.372 . . . . 0.0 110.974 -176.764 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' E' E ' 140' ' ' LEU . . . . . 0.537 HD12 HG22 ' E' ' 131' ' ' VAL . 15.4 tp -112.34 122.43 47.71 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 115.486 -0.779 . . . . 0.0 109.418 -179.618 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' E' E ' 141' ' ' ILE . . . . . 0.523 ' HB ' HG23 ' E' ' 130' ' ' VAL . 19.2 mt -123.14 121.36 62.83 Favored 'Isoleucine or valine' 0 C--O 1.234 0.259 0 N-CA-C 109.778 -0.452 . . . . 0.0 109.778 -177.339 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' E' E ' 142' ' ' ARG . . . . . . . . . . . . . 29.2 ttp180 -118.68 127.06 53.22 Favored 'General case' 0 C--N 1.331 -0.22 0 CA-C-N 115.437 -0.801 . . . . 0.0 110.276 -177.7 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' E' E ' 143' ' ' THR . . . . . . . . . . . . . 72.9 p . . . . . 0 C--O 1.221 -0.432 0 CA-C-O 118.108 -0.948 . . . . 0.0 110.677 -179.265 . . . . . . . . 0 0 . 1 . 009 nuclear build full ' F' F ' -3' ' ' GLU . . . . . . . . . . . . . 95.8 mt-10 . . . . . 0 N--CA 1.49 1.567 0 N-CA-C 109.291 -0.633 . . . . 0.0 109.291 . . . . . . . . . 0 0 . 1 . 009 nuclear build full ' F' F ' -2' ' ' GLY . . . . . . . . . . . . . . . -66.72 149.09 51.13 Favored Glycine 0 CA--C 1.525 0.705 0 N-CA-C 111.221 -0.751 . . . . 0.0 111.221 -179.096 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' F' F ' -1' ' ' VAL . . . . . . . . . . . . . 44.5 t -96.3 134.79 32.58 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.367 0 N-CA-C 110.123 -0.325 . . . . 0.0 110.123 179.616 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' F' F ' 0' ' ' ILE . . . . . . . . . . . . . 69.1 mt -116.59 137.96 48.72 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.251 0 CA-C-N 116.29 -0.413 . . . . 0.0 110.095 -179.576 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' F' F ' 1' ' ' MET . . . . . . . . . . . . . 26.2 ptt? -89.35 134.06 34.23 Favored 'General case' 0 C--N 1.331 -0.211 0 CA-C-N 116.151 -0.477 . . . . 0.0 110.7 179.768 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' F' F ' 2' ' ' SER . . . . . 0.566 ' HB2' HD11 ' F' ' 58' ' ' LEU . 9.1 p -126.83 147.62 50.01 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-N 116.261 -0.427 . . . . 0.0 110.684 179.985 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' F' F ' 3' ' ' GLU . . . . . . . . . . . . . 81.9 tt0 -140.78 140.13 34.71 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.068 -0.515 . . . . 0.0 111.132 -178.424 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' F' F ' 4' ' ' LEU . . . . . . . . . . . . . 18.1 tp -122.1 131.11 53.8 Favored 'General case' 0 C--N 1.332 -0.185 0 CA-C-N 115.971 -0.559 . . . . 0.0 109.907 176.418 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' F' F ' 5' ' ' LYS . . . . . . . . . . . . . 64.1 mttp -109.72 121.14 44.54 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.238 -0.437 . . . . 0.0 110.576 -179.041 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' F' F ' 6' ' ' LEU . . . . . . . . . . . . . 63.0 mt -114.0 149.33 35.51 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 115.467 -0.788 . . . . 0.0 110.811 -177.878 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' F' F ' 7' ' ' LYS . . . . . . . . . . . . . 29.6 ttpt -135.0 134.87 22.07 Favored Pre-proline 0 CA--C 1.534 0.357 0 CA-C-O 118.929 -0.558 . . . . 0.0 109.728 176.72 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' F' F ' 8' ' ' PRO . . . . . . . . . . . . . 97.1 Cg_endo -91.05 131.2 1.46 Allowed 'Trans proline' 0 N--CA 1.49 1.265 0 C-N-CA 121.73 1.62 . . . . 0.0 111.396 175.331 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' F' F ' 9' ' ' LEU . . . . . . . . . . . . . 27.9 mt -68.63 -46.84 35.11 Favored Pre-proline 0 CA--C 1.532 0.28 0 CA-C-O 118.791 -0.623 . . . . 0.0 111.509 -177.067 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' F' F ' 10' ' ' PRO . . . . . . . . . . . . . 98.4 Cg_endo -80.71 140.96 13.37 Favored 'Trans proline' 0 N--CA 1.496 1.643 0 C-N-CA 121.012 1.141 . . . . 0.0 111.25 171.542 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' F' F ' 11' ' ' LYS . . . . . . . . . . . . . 54.0 tttp -84.82 106.47 16.38 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-O 120.86 0.362 . . . . 0.0 110.586 -179.433 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' F' F ' 12' ' ' VAL . . . . . . . . . . . . . 12.2 p -142.98 148.72 19.23 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.344 0 CA-C-N 116.101 -0.5 . . . . 0.0 110.497 -179.758 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' F' F ' 13' ' ' GLU . . . . . . . . . . . . . 43.8 tp10 -82.18 117.07 22.04 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.211 -0.449 . . . . 0.0 109.984 177.74 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' F' F ' 14' ' ' LEU . . . . . . . . . . . . . 32.3 mt -89.61 149.79 43.0 Favored Pre-proline 0 C--N 1.33 -0.263 0 CA-C-O 119.326 -0.369 . . . . 0.0 110.618 -177.62 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' F' F ' 15' ' ' PRO . . . . . . . . . . . . . 26.0 Cg_exo -61.67 159.12 33.94 Favored 'Trans proline' 0 N--CA 1.496 1.631 0 C-N-CA 121.186 1.257 . . . . 0.0 111.627 176.756 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' F' F ' 16' ' ' PRO . . . . . . . . . . . . . 38.5 Cg_exo -58.52 -36.17 97.73 Favored 'Trans proline' 0 N--CA 1.497 1.712 0 C-N-CA 121.386 1.391 . . . . 0.0 112.931 -177.499 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' F' F ' 17' ' ' ASP . . . . . . . . . . . . . 7.2 p-10 -90.77 8.42 34.76 Favored 'General case' 0 CA--C 1.535 0.372 0 N-CA-C 113.393 0.886 . . . . 0.0 113.393 -176.867 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' F' F ' 18' ' ' PHE . . . . . . . . . . . . . 34.9 t80 -58.42 -45.45 88.42 Favored 'General case' 0 C--O 1.231 0.102 0 O-C-N 121.983 -0.448 . . . . 0.0 110.018 -178.187 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' F' F ' 19' ' ' VAL . . . . . 0.4 HG13 ' N ' ' F' ' 20' ' ' ASP . 13.2 p -57.22 -40.66 75.04 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.372 0 CA-C-N 116.156 -0.475 . . . . 0.0 110.571 179.939 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' F' F ' 20' ' ' ASP . . . . . 0.4 ' N ' HG13 ' F' ' 19' ' ' VAL . 65.8 m-20 -60.02 -43.12 95.48 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-O 120.798 0.333 . . . . 0.0 110.84 -178.013 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' F' F ' 21' ' ' VAL . . . . . . . . . . . . . 46.6 t -64.06 -47.33 90.76 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.284 0 CA-C-N 116.398 -0.365 . . . . 0.0 110.377 -178.183 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' F' F ' 22' ' ' ILE . . . . . 0.446 HG22 HD12 ' F' ' 26' ' ' LEU . 49.9 mm -57.73 -39.24 69.43 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.353 0 CA-C-O 120.793 0.33 . . . . 0.0 110.896 -179.941 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' F' F ' 23' ' ' ARG . . . . . . . . . . . . . 54.6 ttp180 -57.13 -50.55 72.45 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-O 120.904 0.383 . . . . 0.0 110.562 177.243 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' F' F ' 24' ' ' ILE . . . . . . . . . . . . . 72.8 mt -61.0 -40.1 84.44 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.287 0 CA-C-N 115.986 -0.552 . . . . 0.0 111.968 -176.979 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' F' F ' 25' ' ' LYS . . . . . . . . . . . . . 13.8 pttp -75.48 -35.18 60.9 Favored 'General case' 0 CA--C 1.534 0.348 0 C-N-CA 120.671 -0.412 . . . . 0.0 112.046 -174.03 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' F' F ' 26' ' ' LEU . . . . . 0.446 HD12 HG22 ' F' ' 22' ' ' ILE . 34.3 mt -80.32 -41.42 24.89 Favored 'General case' 0 C--N 1.33 -0.256 0 N-CA-C 112.841 0.682 . . . . 0.0 112.841 -174.762 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' F' F ' 27' ' ' GLN . . . . . . . . . . . . . 18.9 pt20 -46.3 139.63 4.63 Favored 'General case' 0 N--CA 1.467 0.392 0 N-CA-C 113.006 0.743 . . . . 0.0 113.006 -174.551 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' F' F ' 28' ' ' GLY . . . . . . . . . . . . . . . 99.61 -25.85 26.66 Favored Glycine 0 CA--C 1.534 1.243 0 CA-C-N 115.539 -0.755 . . . . 0.0 112.199 -175.362 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' F' F ' 29' ' ' LYS . . . . . . . . . . . . . 25.7 mtpp -98.43 155.18 17.37 Favored 'General case' 0 C--N 1.333 -0.146 0 CA-C-N 117.18 0.49 . . . . 0.0 111.167 179.648 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' F' F ' 30' ' ' THR . . . . . . . . . . . . . 29.8 m -101.17 137.73 39.14 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.036 -0.529 . . . . 0.0 109.96 175.657 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' F' F ' 31' ' ' VAL . . . . . . . . . . . . . 35.3 m -129.26 154.24 39.82 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.254 0 CA-C-O 120.94 0.4 . . . . 0.0 110.742 -179.754 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' F' F ' 32' ' ' ARG . . . . . . . . . . . . . 80.8 mtm180 -132.53 148.29 52.38 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 115.849 -0.614 . . . . 0.0 110.335 178.395 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' F' F ' 33' ' ' THR . . . . . . . . . . . . . 25.3 m -52.79 138.01 30.33 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.344 -0.389 . . . . 0.0 111.418 -178.688 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' F' F ' 34' ' ' GLY . . . . . . . . . . . . . . . 101.64 -17.14 55.56 Favored Glycine 0 CA--C 1.532 1.155 0 CA-C-O 119.697 -0.501 . . . . 0.0 113.28 179.369 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' F' F ' 35' ' ' ASP . . . . . . . . . . . . . 73.3 m-20 -65.84 149.17 50.61 Favored 'General case' 0 C--O 1.232 0.136 0 CA-C-N 117.981 0.89 . . . . 0.0 110.952 179.23 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' F' F ' 36' ' ' VAL . . . . . . . . . . . . . 45.8 t -126.0 131.61 71.54 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.289 0 CA-C-N 116.049 -0.523 . . . . 0.0 109.854 178.302 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' F' F ' 37' ' ' ILE . . . . . . . . . . . . . 65.2 mt -121.06 139.15 49.18 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.233 0 CA-C-N 116.162 -0.472 . . . . 0.0 109.891 -178.995 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' F' F ' 38' ' ' GLY . . . . . . . . . . . . . . . -110.36 128.8 9.0 Favored Glycine 0 CA--C 1.525 0.662 0 N-CA-C 111.059 -0.816 . . . . 0.0 111.059 179.916 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' F' F ' 39' ' ' ILE . . . . . . . . . . . . . 73.7 mt -123.9 133.68 68.59 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.185 0 N-CA-C 110.049 -0.352 . . . . 0.0 110.049 179.347 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' F' F ' 40' ' ' SER . . . . . . . . . . . . . 99.8 p -93.23 123.66 36.66 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.398 -0.364 . . . . 0.0 111.0 176.298 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' F' F ' 41' ' ' ILE . . . . . . . . . . . . . 70.9 mt -131.21 120.69 47.28 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.209 0 CA-C-O 120.918 0.39 . . . . 0.0 110.345 177.869 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' F' F ' 42' ' ' LEU . . . . . . . . . . . . . 48.9 mt 52.76 35.45 18.64 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.011 -0.54 . . . . 0.0 111.699 177.166 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' F' F ' 43' ' ' GLY . . . . . . . . . . . . . . . 72.31 31.48 63.55 Favored Glycine 0 CA--C 1.53 1.027 0 C-N-CA 121.139 -0.553 . . . . 0.0 112.142 178.064 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' F' F ' 44' ' ' LYS . . . . . . . . . . . . . 58.8 mtpt -135.91 131.49 35.28 Favored 'General case' 0 C--N 1.33 -0.278 0 N-CA-C 109.714 -0.476 . . . . 0.0 109.714 177.783 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' F' F ' 45' ' ' GLU . . . . . . . . . . . . . 83.8 tt0 -83.6 119.39 24.68 Favored 'General case' 0 C--N 1.328 -0.343 0 C-N-CA 120.844 -0.342 . . . . 0.0 111.219 -178.631 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' F' F ' 46' ' ' VAL . . . . . . . . . . . . . 7.7 p -118.66 122.75 70.21 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.198 0 N-CA-C 109.195 -0.669 . . . . 0.0 109.195 174.824 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' F' F ' 47' ' ' LYS . . . . . . . . . . . . . 55.5 mtmt -100.22 128.64 46.25 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 115.999 -0.546 . . . . 0.0 111.303 -179.815 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' F' F ' 48' ' ' PHE . . . . . . . . . . . . . 93.6 m-85 -110.55 131.92 54.64 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-N 116.099 -0.501 . . . . 0.0 109.872 177.529 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' F' F ' 49' ' ' LYS . . . . . . . . . . . . . 84.3 tttt -107.77 137.09 46.4 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.281 -0.418 . . . . 0.0 110.683 179.339 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' F' F ' 50' ' ' VAL . . . . . . . . . . . . . 43.5 t -82.32 106.29 13.07 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.24 0 N-CA-C 109.279 -0.637 . . . . 0.0 109.279 175.389 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' F' F ' 51' ' ' VAL . . . . . . . . . . . . . 47.7 t -71.06 -52.58 26.32 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.373 0 N-CA-C 109.707 -0.479 . . . . 0.0 109.707 -174.475 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' F' F ' 52' ' ' GLN . . . . . . . . . . . . . 88.5 mt-30 -154.81 153.67 31.56 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-O 121.206 0.527 . . . . 0.0 111.748 -176.64 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' F' F ' 53' ' ' ALA . . . . . . . . . . . . . . . -132.17 133.01 43.72 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 115.333 -0.849 . . . . 0.0 109.526 174.42 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' F' F ' 54' ' ' TYR . . . . . . . . . . . . . 17.2 t80 -129.13 111.47 18.29 Favored Pre-proline 0 CA--C 1.535 0.385 0 CA-C-O 118.16 -0.924 . . . . 0.0 110.204 179.088 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' F' F ' 55' ' ' PRO . . . . . . . . . . . . . 73.9 Cg_endo -77.14 168.88 75.76 Favored 'Cis proline' 0 N--CA 1.5 1.876 0 CA-C-N 121.872 1.704 . . . . 0.0 112.321 -6.644 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' F' F ' 56' ' ' SER . . . . . . . . . . . . . 13.4 m -117.32 135.04 23.05 Favored Pre-proline 0 CA--C 1.539 0.531 0 CA-C-O 118.477 -0.773 . . . . 0.0 109.627 175.243 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' F' F ' 57' ' ' PRO . . . . . . . . . . . . . 35.4 Cg_endo -66.38 164.68 65.91 Favored 'Cis proline' 0 N--CA 1.498 1.774 0 CA-C-N 121.809 1.682 . . . . 0.0 111.338 -3.225 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' F' F ' 58' ' ' LEU . . . . . 0.566 HD11 ' HB2' ' F' ' 2' ' ' SER . 16.4 tp -130.77 139.08 50.21 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-O 120.996 0.427 . . . . 0.0 110.38 179.738 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' F' F ' 59' ' ' ARG . . . . . . . . . . . . . 60.3 ttm-85 -104.48 127.93 52.29 Favored 'General case' 0 C--N 1.327 -0.397 0 N-CA-C 109.152 -0.685 . . . . 0.0 109.152 174.986 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' F' F ' 60' ' ' VAL . . . . . . . . . . . . . 41.6 t -81.0 119.38 30.55 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.271 0 C-N-CA 120.732 -0.387 . . . . 0.0 110.604 -174.941 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' F' F ' 61' ' ' GLU . . . . . . . . . . . . . 95.5 mt-10 -131.05 163.07 28.43 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 115.853 -0.612 . . . . 0.0 109.689 175.301 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' F' F ' 62' ' ' ASP . . . . . . . . . . . . . 41.2 m-20 -52.51 -31.64 36.35 Favored 'General case' 0 C--N 1.328 -0.354 0 N-CA-C 112.045 0.387 . . . . 0.0 112.045 -178.942 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' F' F ' 63' ' ' ARG . . . . . . . . . . . . . 79.3 mtt85 -72.94 -22.03 60.79 Favored 'General case' 0 CA--C 1.533 0.324 0 N-CA-C 112.896 0.702 . . . . 0.0 112.896 -176.205 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' F' F ' 64' ' ' THR . . . . . . . . . . . . . 20.3 m -72.54 141.48 48.47 Favored 'General case' 0 C--N 1.331 -0.206 0 CA-C-O 120.833 0.349 . . . . 0.0 110.999 -175.755 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' F' F ' 65' ' ' LYS . . . . . . . . . . . . . 67.1 mttm -90.01 137.09 32.63 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.009 -0.541 . . . . 0.0 110.49 179.578 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' F' F ' 66' ' ' ILE . . . . . . . . . . . . . 60.4 mt -119.33 130.03 74.5 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.268 0 N-CA-C 109.68 -0.489 . . . . 0.0 109.68 177.856 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' F' F ' 67' ' ' THR . . . . . . . . . . . . . 31.9 m -125.97 145.33 50.33 Favored 'General case' 0 C--N 1.331 -0.21 0 CA-C-O 121.089 0.471 . . . . 0.0 111.37 -176.81 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' F' F ' 68' ' ' LEU . . . . . 0.462 HD23 ' N ' ' F' ' 69' ' ' VAL . 4.8 tt -100.56 124.7 46.48 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 115.721 -0.672 . . . . 0.0 109.786 176.553 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' F' F ' 69' ' ' VAL . . . . . 0.462 ' N ' HD23 ' F' ' 68' ' ' LEU . 41.2 t -96.68 142.43 14.0 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.298 0 CA-C-O 120.929 0.395 . . . . 0.0 111.0 -175.804 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' F' F ' 70' ' ' THR . . . . . . . . . . . . . 27.7 m -85.2 146.05 27.28 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 115.976 -0.556 . . . . 0.0 109.792 176.985 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' F' F ' 71' ' ' HIS . . . . . . . . . . . . . 6.4 m80 -149.91 175.86 2.58 Favored Pre-proline 0 C--N 1.328 -0.337 0 C-N-CA 120.846 -0.342 . . . . 0.0 111.233 -174.046 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' F' F ' 72' ' ' PRO . . . . . . . . . . . . . 24.2 Cg_exo -64.93 160.28 42.02 Favored 'Trans proline' 0 N--CA 1.495 1.61 0 C-N-CA 121.695 1.597 . . . . 0.0 111.474 176.56 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' F' F ' 73' ' ' VAL . . . . . . . . . . . . . 34.9 m -69.6 -178.31 0.23 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.276 0 CA-C-N 116.368 -0.378 . . . . 0.0 110.305 -172.054 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' F' F ' 74' ' ' ASP . . . . . . . . . . . . . 47.4 t0 -84.98 114.92 22.51 Favored 'General case' 0 C--N 1.33 -0.264 0 C-N-CA 120.524 -0.47 . . . . 0.0 110.381 -171.112 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' F' F ' 75' ' ' VAL . . . . . . . . . . . . . 46.5 t -118.16 117.89 56.28 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.27 0 CA-C-O 121.178 0.513 . . . . 0.0 109.74 178.643 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' F' F ' 76' ' ' LEU . . . . . . . . . . . . . 13.9 mt -120.86 142.44 49.66 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 115.453 -0.794 . . . . 0.0 109.216 179.385 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' F' F ' 77' ' ' GLU . . . . . . . . . . . . . 97.7 mt-10 -135.49 130.05 34.08 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-O 121.225 0.536 . . . . 0.0 111.343 -176.713 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' F' F ' 78' ' ' ALA . . . . . . . . . . . . . . . -118.7 134.46 55.11 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-N 115.47 -0.786 . . . . 0.0 109.649 176.373 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' F' F ' 79' ' ' LYS . . . . . 0.512 ' O ' HD13 ' F' ' 80' ' ' ILE . 39.7 mtmt -83.81 115.44 22.24 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-O 120.958 0.408 . . . . 0.0 110.751 -178.784 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' F' F ' 80' ' ' ILE . . . . . 0.512 HD13 ' O ' ' F' ' 79' ' ' LYS . 24.0 mm -139.19 114.73 8.74 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.323 0 CA-C-N 115.722 -0.672 . . . . 0.0 109.266 -177.93 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' F' F ' 81' ' ' LYS . . . . . . . . . . . . . 75.6 mttt -101.65 126.49 48.5 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-O 120.802 0.334 . . . . 0.0 111.029 -178.086 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' F' F ' 82' ' ' GLY . . . . . . . . . . . . . . . 89.04 42.14 5.7 Favored Glycine 0 CA--C 1.525 0.718 0 C-N-CA 120.905 -0.665 . . . . 0.0 111.933 175.423 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' F' F ' 83' ' ' ILE . . . . . . . . . . . . . 74.1 mt -66.69 138.41 22.98 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 N-CA-C 109.634 -0.506 . . . . 0.0 109.634 176.461 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' F' F ' 84' ' ' LYS . . . . . . . . . . . . . 53.8 tttp -99.34 -51.85 3.68 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.597 -176.729 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' F' F ' 85' ' ' ASP . . . . . . . . . . . . . 7.3 t70 -154.7 154.81 33.49 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.024 -0.534 . . . . 0.0 110.633 -179.807 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' F' F ' 86' ' ' VAL . . . . . . . . . . . . . 41.4 t -130.68 132.6 64.2 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.258 0 CA-C-O 121.032 0.444 . . . . 0.0 110.535 -179.516 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' F' F ' 87' ' ' ILE . . . . . . . . . . . . . 45.1 mm -120.76 128.37 76.04 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.229 0 CA-C-N 115.72 -0.673 . . . . 0.0 109.582 177.738 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' F' F ' 88' ' ' LEU . . . . . . . . . . . . . 37.4 mt -109.39 138.72 45.33 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-O 121.159 0.504 . . . . 0.0 111.312 -178.389 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' F' F ' 89' ' ' ASP . . . . . . . . . . . . . 11.7 t70 -130.07 154.89 47.0 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 115.485 -0.78 . . . . 0.0 109.197 175.319 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' F' F ' 90' ' ' GLU . . . . . . . . . . . . . 84.8 tt0 -46.12 -39.1 8.98 Favored 'General case' 0 N--CA 1.465 0.276 0 N-CA-C 113.175 0.806 . . . . 0.0 113.175 -172.315 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' F' F ' 91' ' ' ASN . . . . . . . . . . . . . 14.5 p30 -132.09 25.03 4.58 Favored 'General case' 0 N--CA 1.467 0.393 0 N-CA-C 112.71 0.633 . . . . 0.0 112.71 -178.391 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' F' F ' 92' ' ' LEU . . . . . . . . . . . . . 13.6 mt -150.38 147.22 27.32 Favored 'General case' 0 C--N 1.331 -0.218 0 N-CA-C 109.963 -0.384 . . . . 0.0 109.963 -177.398 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' F' F ' 93' ' ' ILE . . . . . . . . . . . . . 71.3 mt -126.98 117.79 48.66 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.269 0 N-CA-C 109.294 -0.632 . . . . 0.0 109.294 178.705 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' F' F ' 94' ' ' VAL . . . . . . . . . . . . . 44.3 t -118.09 127.98 75.22 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.217 0 N-CA-C 109.955 -0.387 . . . . 0.0 109.955 -178.584 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' F' F ' 95' ' ' VAL . . . . . . . . . . . . . 42.7 t -124.31 134.35 66.9 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.293 0 CA-C-N 116.18 -0.463 . . . . 0.0 109.992 -179.409 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' F' F ' 96' ' ' ILE . . . . . . . . . . . . . 57.5 mt -113.27 129.9 68.18 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.284 0 N-CA-C 109.423 -0.584 . . . . 0.0 109.423 178.722 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' F' F ' 97' ' ' THR . . . . . . . . . . . . . 59.7 p -102.1 156.92 17.24 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-O 120.946 0.403 . . . . 0.0 110.782 179.958 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' F' F ' 98' ' ' GLU . . . . . . . . . . . . . 97.8 mt-10 -53.95 -24.42 16.45 Favored 'General case' 0 CA--C 1.533 0.304 0 N-CA-C 112.344 0.498 . . . . 0.0 112.344 179.854 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' F' F ' 99' ' ' GLU . . . . . . . . . . . . . 97.1 mt-10 -75.49 9.07 2.38 Favored 'General case' 0 CA--C 1.536 0.435 0 N-CA-C 113.402 0.889 . . . . 0.0 113.402 -178.22 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' F' F ' 100' ' ' ASN . . . . . . . . . . . . . 4.2 m-20 63.07 33.94 14.2 Favored 'General case' 0 CA--C 1.532 0.263 0 CA-C-N 118.131 0.423 . . . . 0.0 111.332 -178.512 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' F' F ' 101' ' ' GLU . . . . . . . . . . . . . 84.0 tt0 -110.1 142.29 41.77 Favored 'General case' 0 C--N 1.333 -0.146 0 N-CA-C 109.475 -0.565 . . . . 0.0 109.475 172.39 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' F' F ' 102' ' ' VAL . . . . . . . . . . . . . 45.6 t -114.9 124.57 71.68 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.319 0 CA-C-N 116.226 -0.443 . . . . 0.0 109.814 -179.242 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' F' F ' 103' ' ' LEU . . . . . . . . . . . . . 26.1 mt -112.27 132.55 54.89 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 115.508 -0.769 . . . . 0.0 109.798 177.245 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' F' F ' 104' ' ' ILE . . . . . . . . . . . . . 69.9 mt -123.02 117.8 52.84 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.286 0 N-CA-C 109.983 -0.377 . . . . 0.0 109.983 -178.84 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' F' F ' 105' ' ' PHE . . . . . . . . . . . . . 20.8 m-85 -120.3 165.68 14.53 Favored 'General case' 0 C--N 1.331 -0.221 0 CA-C-N 115.568 -0.742 . . . . 0.0 109.892 179.838 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' F' F ' 106' ' ' ASN . . . . . . . . . . . . . 45.8 p-10 -98.67 -169.96 1.87 Allowed 'General case' 0 C--N 1.329 -0.288 0 N-CA-C 109.702 -0.481 . . . . 0.0 109.702 173.993 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' F' F ' 107' ' ' GLN . . . . . . . . . . . . . 45.4 tt0 -58.85 -28.09 65.75 Favored 'General case' 0 C--N 1.327 -0.379 0 N-CA-C 112.168 0.433 . . . . 0.0 112.168 179.272 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' F' F ' 108' ' ' ASN . . . . . . . . . . . . . 5.1 t-20 -86.22 10.24 15.23 Favored 'General case' 0 CA--C 1.535 0.377 0 N-CA-C 113.136 0.791 . . . . 0.0 113.136 -177.72 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' F' F ' 109' ' ' LEU . . . . . . . . . . . . . 9.9 tp 59.7 35.89 22.34 Favored 'General case' 0 C--O 1.233 0.187 0 O-C-N 122.106 -0.371 . . . . 0.0 111.426 178.612 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' F' F ' 110' ' ' GLU . . . . . . . . . . . . . 70.9 mm-40 -106.79 149.9 26.88 Favored 'General case' 0 C--N 1.33 -0.275 0 N-CA-C 110.207 -0.294 . . . . 0.0 110.207 177.168 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' F' F ' 111' ' ' GLU . . . . . . . . . . . . . 98.5 mt-10 -77.85 122.11 25.01 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.264 -0.426 . . . . 0.0 111.389 -176.944 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' F' F ' 112' ' ' LEU . . . . . . . . . . . . . 17.8 mt -107.45 -44.71 4.24 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 115.928 -0.578 . . . . 0.0 109.954 176.21 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' F' F ' 113' ' ' TYR . . . . . . . . . . . . . 42.1 t80 -141.59 137.44 31.91 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.054 -0.521 . . . . 0.0 110.987 -179.3 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' F' F ' 114' ' ' ARG . . . . . . . . . . . . . 23.9 ttm180 -138.13 125.76 22.19 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.109 -0.496 . . . . 0.0 109.869 175.823 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' F' F ' 115' ' ' GLY . . . . . . . . . . . . . . . -150.12 142.07 9.36 Favored Glycine 0 CA--C 1.524 0.597 0 N-CA-C 110.756 -0.938 . . . . 0.0 110.756 178.454 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' F' F ' 116' ' ' LYS . . . . . . . . . . . . . 84.8 tttt -118.76 128.06 54.13 Favored 'General case' 0 C--N 1.33 -0.25 0 N-CA-C 109.693 -0.484 . . . . 0.0 109.693 177.754 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' F' F ' 117' ' ' PHE . . . . . . . . . . . . . 22.7 m-85 -129.57 117.48 20.49 Favored 'General case' 0 C--N 1.332 -0.166 0 CA-C-O 120.921 0.391 . . . . 0.0 110.32 -172.954 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' F' F ' 118' ' ' GLU . . . . . . . . . . . . . 43.4 mt-10 -52.35 -49.27 64.66 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.349 -0.387 . . . . 0.0 111.765 -176.242 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' F' F ' 119' ' ' ASN . . . . . . . . . . . . . 90.3 m-20 -97.32 31.06 2.6 Favored 'General case' 0 C--N 1.33 -0.24 0 N-CA-C 112.164 0.431 . . . . 0.0 112.164 -174.293 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' F' F ' 120' ' ' LEU . . . . . . . . . . . . . 12.5 tp -56.33 124.32 17.64 Favored 'General case' 0 C--N 1.331 -0.21 0 CA-C-O 120.588 0.233 . . . . 0.0 110.604 178.273 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' F' F ' 121' ' ' ASN . . . . . . . . . . . . . 31.4 m120 -114.08 -44.04 3.18 Favored 'General case' 0 C--N 1.331 -0.198 0 CA-C-N 116.524 -0.307 . . . . 0.0 111.149 -177.327 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' F' F ' 122' ' ' LYS . . . . . . . . . . . . . 98.6 mttt -144.35 148.79 35.18 Favored 'General case' 0 C--N 1.332 -0.194 0 CA-C-O 121.198 0.523 . . . . 0.0 112.028 -175.921 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' F' F ' 123' ' ' VAL . . . . . . . . . . . . . 45.6 t -127.42 124.5 63.92 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.239 0 CA-C-N 115.624 -0.716 . . . . 0.0 109.078 172.711 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' F' F ' 124' ' ' LEU . . . . . . . . . . . . . 57.9 mt -118.93 138.8 52.53 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-O 120.837 0.351 . . . . 0.0 111.078 -175.567 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' F' F ' 125' ' ' VAL . . . . . . . . . . . . . 34.3 m -130.34 129.58 64.99 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.273 0 CA-C-N 115.961 -0.563 . . . . 0.0 110.284 177.888 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' F' F ' 126' ' ' ARG . . . . . . . . . . . . . 31.1 mmt180 -135.9 108.11 7.26 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.224 -0.444 . . . . 0.0 110.29 179.074 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' F' F ' 127' ' ' ASN . . . . . . . . . . . . . 42.1 m-80 54.26 -104.81 0.23 Allowed 'General case' 0 CA--C 1.541 0.628 0 CA-C-O 119.163 -0.446 . . . . 0.0 110.934 179.403 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' F' F ' 128' ' ' ASP . . . . . . . . . . . . . 7.5 p-10 -111.41 1.6 17.1 Favored 'General case' 0 N--CA 1.468 0.437 0 CA-C-N 119.45 1.023 . . . . 0.0 113.447 -176.053 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' F' F ' 129' ' ' LEU . . . . . . . . . . . . . 38.2 mt -104.97 141.82 35.88 Favored 'General case' 0 C--O 1.231 0.131 0 CA-C-N 118.195 0.452 . . . . 0.0 110.257 178.915 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' F' F ' 130' ' ' VAL . . . . . . . . . . . . . 44.0 t -123.37 137.08 57.9 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.224 0 CA-C-N 116.268 -0.424 . . . . 0.0 109.916 -179.275 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' F' F ' 131' ' ' VAL . . . . . . . . . . . . . 42.7 t -135.69 136.44 50.35 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.29 0 CA-C-O 121.041 0.448 . . . . 0.0 110.408 179.326 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' F' F ' 132' ' ' ILE . . . . . . . . . . . . . 67.7 mt -117.71 130.2 72.96 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.232 0 CA-C-N 115.74 -0.664 . . . . 0.0 109.286 179.567 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' F' F ' 133' ' ' ILE . . . . . . . . . . . . . 41.9 mm -118.06 120.02 63.22 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.227 0 CA-C-O 120.831 0.348 . . . . 0.0 111.221 -174.329 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' F' F ' 134' ' ' ASP . . . . . . . . . . . . . 7.1 p-10 -131.58 145.59 51.78 Favored 'General case' 0 C--N 1.332 -0.173 0 N-CA-C 109.422 -0.584 . . . . 0.0 109.422 173.403 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' F' F ' 135' ' ' GLU . . . . . . . . . . . . . 73.6 tt0 -49.92 -22.97 1.71 Allowed 'General case' 0 C--N 1.329 -0.322 0 N-CA-C 113.286 0.847 . . . . 0.0 113.286 -170.615 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' F' F ' 136' ' ' GLN . . . . . . . . . . . . . 57.1 tp60 -99.04 -34.08 10.55 Favored 'General case' 0 C--N 1.331 -0.225 0 N-CA-C 111.94 0.348 . . . . 0.0 111.94 -176.135 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' F' F ' 137' ' ' LYS . . . . . . . . . . . . . 57.5 mtpt -138.77 151.84 47.43 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-O 121.13 0.491 . . . . 0.0 111.128 -169.612 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' F' F ' 138' ' ' LEU . . . . . 0.441 HD23 ' C ' ' F' ' 138' ' ' LEU . 5.2 tt -119.29 122.76 42.63 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 115.809 -0.632 . . . . 0.0 109.437 174.445 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' F' F ' 139' ' ' THR . . . . . 0.413 ' N ' HD23 ' F' ' 138' ' ' LEU . 19.8 m -110.36 130.39 55.56 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-N 116.323 -0.399 . . . . 0.0 110.838 -177.27 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' F' F ' 140' ' ' LEU . . . . . 0.476 HD23 ' C ' ' F' ' 140' ' ' LEU . 8.9 tt -118.75 123.58 45.2 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 115.821 -0.627 . . . . 0.0 109.404 -179.232 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' F' F ' 141' ' ' ILE . . . . . . . . . . . . . 19.8 mt -120.47 120.72 63.56 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.309 0 CA-C-O 121.039 0.447 . . . . 0.0 109.887 -175.698 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' F' F ' 142' ' ' ARG . . . . . . . . . . . . . 68.9 ttt180 -110.69 130.77 55.48 Favored 'General case' 0 C--N 1.331 -0.22 0 CA-C-N 115.2 -0.909 . . . . 0.0 110.717 -175.494 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' F' F ' 143' ' ' THR . . . . . . . . . . . . . 41.2 p . . . . . 0 C--O 1.22 -0.475 0 CA-C-O 118.158 -0.925 . . . . 0.0 110.958 179.469 . . . . . . . . 0 0 . 1 . 010 nuclear build full ' A' A ' -3' ' ' GLU . . . . . . . . . . . . . 95.6 mt-10 . . . . . 0 N--CA 1.491 1.588 0 N-CA-C 109.371 -0.603 . . . . 0.0 109.371 . . . . . . . . . 0 0 . 1 . 010 nuclear build full ' A' A ' -2' ' ' GLY . . . . . . . . . . . . . . . -62.75 141.78 47.11 Favored Glycine 0 CA--C 1.524 0.654 0 N-CA-C 110.944 -0.862 . . . . 0.0 110.944 179.767 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' -1' ' ' VAL . . . . . . . . . . . . . 47.6 t -96.06 138.92 20.22 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.297 0 CA-C-O 120.853 0.358 . . . . 0.0 110.109 179.723 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 0' ' ' ILE . . . . . . . . . . . . . 66.8 mt -110.43 133.76 54.82 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.267 0 CA-C-N 116.146 -0.479 . . . . 0.0 110.056 179.941 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 24.8 ptp -85.35 143.29 28.74 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.29 -0.414 . . . . 0.0 110.538 179.662 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 10.5 p -121.96 135.28 54.85 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.196 -0.457 . . . . 0.0 110.588 179.265 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 95.7 mt-10 -141.06 136.8 32.37 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.111 -0.495 . . . . 0.0 110.746 179.836 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 4' ' ' LEU . . . . . 0.477 HD21 HD21 ' A' ' 6' ' ' LEU . 14.5 tp -125.42 132.05 52.81 Favored 'General case' 0 C--N 1.332 -0.176 0 CA-C-N 116.114 -0.494 . . . . 0.0 110.218 177.616 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 5' ' ' LYS . . . . . . . . . . . . . 97.9 mttt -110.26 120.88 43.87 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.145 -0.479 . . . . 0.0 110.403 179.342 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 6' ' ' LEU . . . . . 0.477 HD21 HD21 ' A' ' 4' ' ' LEU . 66.3 mt -117.44 145.81 43.89 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 115.535 -0.757 . . . . 0.0 110.157 -178.864 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 25.8 ttpp -135.69 139.78 31.86 Favored Pre-proline 0 CA--C 1.534 0.334 0 CA-C-O 119.087 -0.483 . . . . 0.0 110.156 176.929 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 8' ' ' PRO . . . . . . . . . . . . . 92.7 Cg_endo -91.84 141.12 2.49 Favored 'Trans proline' 0 N--CA 1.489 1.227 0 C-N-CA 121.806 1.67 . . . . 0.0 111.766 177.157 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 58.8 mt -75.8 -49.65 3.46 Favored Pre-proline 0 CA--C 1.533 0.324 0 CA-C-O 118.507 -0.759 . . . . 0.0 112.588 -178.588 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 74.2 Cg_endo -76.33 155.56 36.94 Favored 'Trans proline' 0 N--CA 1.498 1.751 0 C-N-CA 121.062 1.175 . . . . 0.0 112.171 -179.436 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 27.0 tptp -87.74 92.47 9.12 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.117 -0.492 . . . . 0.0 110.468 179.42 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 12.6 p -143.63 148.75 18.66 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.32 0 CA-C-O 120.889 0.376 . . . . 0.0 110.837 -179.181 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 42.4 mp0 -87.68 129.6 35.09 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.1 -0.5 . . . . 0.0 110.332 178.47 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 14' ' ' LEU . . . . . . . . . . . . . 34.5 mt -99.24 151.66 37.49 Favored Pre-proline 0 C--N 1.33 -0.281 0 CA-C-N 116.41 -0.359 . . . . 0.0 110.813 -179.38 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 15' ' ' PRO . . . . . . . . . . . . . 27.4 Cg_exo -61.24 155.67 50.13 Favored 'Trans proline' 0 N--CA 1.497 1.717 0 C-N-CA 121.348 1.365 . . . . 0.0 111.624 177.051 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 16' ' ' PRO . . . . . . . . . . . . . 39.4 Cg_exo -58.58 -38.0 91.71 Favored 'Trans proline' 0 N--CA 1.498 1.74 0 C-N-CA 121.347 1.365 . . . . 0.0 112.798 -178.398 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 17' ' ' ASP . . . . . . . . . . . . . 12.3 p-10 -87.12 10.56 16.33 Favored 'General case' 0 CA--C 1.535 0.402 0 N-CA-C 113.231 0.826 . . . . 0.0 113.231 -177.476 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 18' ' ' PHE . . . . . . . . . . . . . 44.1 t80 -57.76 -43.14 85.26 Favored 'General case' 0 C--N 1.334 -0.085 0 O-C-N 121.942 -0.474 . . . . 0.0 110.229 -178.327 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 19' ' ' VAL . . . . . . . . . . . . . 48.1 t -56.32 -43.97 78.5 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.325 0 CA-C-N 116.291 -0.413 . . . . 0.0 110.64 -178.399 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 66.4 m-20 -59.57 -42.99 93.72 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-O 121.059 0.457 . . . . 0.0 110.815 -177.681 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 46.0 t -64.21 -48.79 84.09 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.253 0 CA-C-N 116.349 -0.387 . . . . 0.0 110.669 -177.856 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 22' ' ' ILE . . . . . 0.55 HG22 HD12 ' A' ' 26' ' ' LEU . 50.1 mm -55.65 -43.66 73.99 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.211 0 C-N-CA 120.911 -0.316 . . . . 0.0 110.689 179.861 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 23' ' ' ARG . . . . . . . . . . . . . 53.8 ttp180 -52.92 -51.92 59.62 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-O 120.55 0.214 . . . . 0.0 111.554 -179.367 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 24' ' ' ILE . . . . . . . . . . . . . 73.1 mt -60.01 -41.47 86.32 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.37 0 C-N-CA 121.095 -0.242 . . . . 0.0 111.295 -178.218 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 69.6 mmtt -64.19 -40.76 96.78 Favored 'General case' 0 C--N 1.328 -0.345 0 N-CA-C 112.187 0.44 . . . . 0.0 112.187 -178.516 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 26' ' ' LEU . . . . . 0.55 HD12 HG22 ' A' ' 22' ' ' ILE . 36.1 mt -79.61 -42.45 24.89 Favored 'General case' 0 C--N 1.329 -0.307 0 N-CA-C 113.025 0.75 . . . . 0.0 113.025 -171.289 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 27' ' ' GLN . . . . . . . . . . . . . 14.8 pt20 -46.4 140.08 4.45 Favored 'General case' 0 N--CA 1.469 0.492 0 N-CA-C 112.808 0.67 . . . . 0.0 112.808 -175.447 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 101.19 -27.93 18.35 Favored Glycine 0 CA--C 1.531 1.05 0 CA-C-N 115.591 -0.731 . . . . 0.0 112.214 -177.67 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 99.2 mttt -98.57 155.06 17.48 Favored 'General case' 0 C--O 1.232 0.18 0 CA-C-N 117.338 0.569 . . . . 0.0 111.228 179.095 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 30' ' ' THR . . . . . . . . . . . . . 49.3 m -105.29 135.54 46.48 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.117 -0.492 . . . . 0.0 109.709 174.994 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 34.4 m -129.26 159.99 40.67 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.206 0 CA-C-O 120.803 0.335 . . . . 0.0 110.996 -177.768 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 32' ' ' ARG . . . . . . . . . . . . . 38.2 ttm180 -130.66 147.88 52.39 Favored 'General case' 0 C--N 1.331 -0.217 0 CA-C-N 116.008 -0.542 . . . . 0.0 110.357 179.17 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 33' ' ' THR . . . . . . . . . . . . . 30.6 m -52.2 140.73 20.51 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-O 120.849 0.357 . . . . 0.0 111.386 -179.099 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 99.65 -17.13 57.96 Favored Glycine 0 CA--C 1.533 1.207 0 C-N-CA 121.156 -0.545 . . . . 0.0 113.202 -179.455 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 60.7 m-20 -64.92 150.1 48.47 Favored 'General case' 0 C--O 1.231 0.129 0 CA-C-N 118.059 0.93 . . . . 0.0 111.205 179.686 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 45.8 t -124.44 130.88 73.43 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.221 0 CA-C-N 115.762 -0.654 . . . . 0.0 109.838 178.963 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 37' ' ' ILE . . . . . . . . . . . . . 66.9 mt -122.89 139.86 48.4 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.221 0 CA-C-N 116.181 -0.463 . . . . 0.0 109.929 -179.647 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . -108.93 128.87 9.24 Favored Glycine 0 CA--C 1.525 0.668 0 N-CA-C 111.034 -0.826 . . . . 0.0 111.034 179.456 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 39' ' ' ILE . . . . . . . . . . . . . 70.3 mt -124.93 137.67 56.79 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.282 0 N-CA-C 110.008 -0.367 . . . . 0.0 110.008 179.59 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 40' ' ' SER . . . . . . . . . . . . . 53.6 p -91.37 114.28 26.76 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.443 -0.344 . . . . 0.0 110.789 176.697 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 41' ' ' ILE . . . . . . . . . . . . . 43.3 mm -121.69 113.44 39.17 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.185 0 N-CA-C 109.939 -0.393 . . . . 0.0 109.939 179.075 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 85.6 mt 58.83 35.46 24.26 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.36 -0.382 . . . . 0.0 111.475 178.61 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . 77.57 -10.14 25.24 Favored Glycine 0 CA--C 1.534 1.264 0 C-N-CA 121.283 -0.484 . . . . 0.0 113.434 178.419 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 44' ' ' LYS . . . . . . . . . . . . . 18.7 tptm -97.13 135.17 39.48 Favored 'General case' 0 C--N 1.333 -0.149 0 CA-C-N 117.941 0.87 . . . . 0.0 109.767 176.918 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 85.9 tt0 -82.38 123.96 29.58 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-O 120.802 0.334 . . . . 0.0 110.959 -178.977 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 46' ' ' VAL . . . . . . . . . . . . . 7.4 p -118.64 127.44 75.62 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.217 0 N-CA-C 109.465 -0.568 . . . . 0.0 109.465 176.765 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 62.3 mtpt -99.57 127.73 45.66 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.027 -0.533 . . . . 0.0 110.981 179.318 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 48' ' ' PHE . . . . . . . . . . . . . 86.8 m-85 -110.65 131.85 54.7 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.41 -0.359 . . . . 0.0 110.132 177.425 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 77.7 tttt -108.93 136.59 48.23 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.115 -0.493 . . . . 0.0 110.464 179.117 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 50' ' ' VAL . . . . . . . . . . . . . 44.6 t -81.0 106.19 11.86 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.288 0 N-CA-C 109.357 -0.609 . . . . 0.0 109.357 175.612 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 51' ' ' VAL . . . . . . . . . . . . . 55.3 t -69.38 -48.29 68.15 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.255 0 CA-C-N 116.065 -0.516 . . . . 0.0 109.89 -173.896 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 52' ' ' GLN . . . . . . . . . . . . . 21.5 pt20 -164.34 158.21 18.44 Favored 'General case' 0 C--N 1.331 -0.215 0 C-N-CA 120.198 -0.601 . . . . 0.0 111.786 179.549 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -135.87 136.4 40.53 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-N 115.292 -0.867 . . . . 0.0 110.062 179.126 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 54' ' ' TYR . . . . . . . . . . . . . 41.5 t80 -129.15 113.23 18.45 Favored Pre-proline 0 CA--C 1.535 0.368 0 CA-C-O 118.164 -0.922 . . . . 0.0 110.126 177.5 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 55' ' ' PRO . . . . . . . . . . . . . 74.3 Cg_endo -77.11 167.82 78.7 Favored 'Cis proline' 0 N--CA 1.499 1.804 0 CA-C-N 122.01 1.754 . . . . 0.0 112.343 -6.878 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 56' ' ' SER . . . . . . . . . . . . . 13.7 m -117.6 131.53 24.04 Favored Pre-proline 0 CA--C 1.539 0.531 0 CA-C-O 118.389 -0.815 . . . . 0.0 109.609 175.526 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 57' ' ' PRO . . . . . . . . . . . . . 36.6 Cg_endo -66.73 167.28 56.98 Favored 'Cis proline' 0 N--CA 1.498 1.756 0 CA-C-N 121.937 1.727 . . . . 0.0 111.253 -2.472 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 58' ' ' LEU . . . . . . . . . . . . . 34.5 tp -130.47 136.48 49.04 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.348 -0.387 . . . . 0.0 110.525 -179.831 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 59' ' ' ARG . . . . . . . . . . . . . 58.2 ttp180 -101.67 121.0 41.22 Favored 'General case' 0 C--N 1.326 -0.422 0 N-CA-C 109.164 -0.68 . . . . 0.0 109.164 175.721 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 43.7 t -76.28 120.29 26.05 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.308 0 C-N-CA 120.723 -0.391 . . . . 0.0 110.637 -173.049 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 95.0 mt-10 -131.02 163.21 28.09 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 115.78 -0.646 . . . . 0.0 109.726 176.891 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 62' ' ' ASP . . . . . . . . . . . . . 77.8 m-20 -53.99 -32.27 53.57 Favored 'General case' 0 C--N 1.329 -0.318 0 C-N-CA 120.981 -0.288 . . . . 0.0 111.695 -179.793 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 63' ' ' ARG . . . . . . . . . . . . . 39.7 ptt180 -78.47 2.35 19.25 Favored 'General case' 0 CA--C 1.537 0.465 0 N-CA-C 113.682 0.993 . . . . 0.0 113.682 -175.738 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 29.0 m -89.55 139.49 30.48 Favored 'General case' 0 C--N 1.333 -0.121 0 CA-C-N 118.131 0.423 . . . . 0.0 110.91 -178.446 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 65' ' ' LYS . . . . . . . . . . . . . 98.2 mttt -88.83 129.71 35.53 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.076 -0.511 . . . . 0.0 110.2 178.579 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 66' ' ' ILE . . . . . . . . . . . . . 60.6 mt -115.27 129.75 70.99 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.275 0 N-CA-C 109.903 -0.406 . . . . 0.0 109.903 179.296 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 67' ' ' THR . . . . . . . . . . . . . 25.7 m -120.25 136.97 54.48 Favored 'General case' 0 C--N 1.331 -0.224 0 CA-C-N 116.061 -0.518 . . . . 0.0 110.674 -179.587 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 68' ' ' LEU . . . . . 0.468 HD23 ' C ' ' A' ' 68' ' ' LEU . 6.6 tt -103.92 124.28 48.68 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 115.863 -0.608 . . . . 0.0 110.158 178.778 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 69' ' ' VAL . . . . . . . . . . . . . 46.3 t -96.58 127.74 48.44 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 CA-C-N 116.218 -0.446 . . . . 0.0 110.162 -179.379 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 70' ' ' THR . . . . . . . . . . . . . 67.6 p -106.88 -176.04 2.97 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.049 -0.523 . . . . 0.0 110.26 179.028 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 71' ' ' HIS . . . . . . . . . . . . . 1.8 t-80 -65.13 145.66 99.06 Favored Pre-proline 0 CA--C 1.534 0.353 0 N-CA-C 109.665 -0.494 . . . . 0.0 109.665 179.907 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 72' ' ' PRO . . . . . . . . . . . . . 71.5 Cg_endo -80.0 -23.63 6.45 Favored 'Trans proline' 0 N--CA 1.493 1.469 0 C-N-CA 121.395 1.397 . . . . 0.0 113.161 -176.905 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 73' ' ' VAL . . . . . . . . . . . . . 35.5 m -129.03 160.55 39.77 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.196 0 CA-C-O 121.144 0.497 . . . . 0.0 111.198 -178.988 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 74' ' ' ASP . . . . . . . . . . . . . 30.7 t0 -104.9 122.42 45.77 Favored 'General case' 0 C--N 1.327 -0.385 0 CA-C-N 115.308 -0.86 . . . . 0.0 109.617 177.327 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 39.4 t -112.71 122.76 67.51 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.207 0 CA-C-O 120.953 0.406 . . . . 0.0 110.481 -177.897 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 76' ' ' LEU . . . . . . . . . . . . . 25.0 mt -125.64 149.27 48.57 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 115.844 -0.616 . . . . 0.0 109.829 178.195 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 77' ' ' GLU . . . . . . . . . . . . . 96.8 mt-10 -137.03 138.04 40.04 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-O 121.015 0.436 . . . . 0.0 111.213 -177.986 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 78' ' ' ALA . . . . . . . . . . . . . . . -123.1 136.61 54.87 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 115.642 -0.708 . . . . 0.0 109.813 177.076 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 79' ' ' LYS . . . . . 0.62 ' O ' HD13 ' A' ' 80' ' ' ILE . 24.9 pttm -79.3 119.82 22.9 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-O 121.262 0.553 . . . . 0.0 111.018 -177.479 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 80' ' ' ILE . . . . . 0.62 HD13 ' O ' ' A' ' 79' ' ' LYS . 35.7 mm -139.28 104.67 2.21 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.252 0 CA-C-N 115.75 -0.659 . . . . 0.0 109.33 179.822 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 81' ' ' LYS . . . . . . . . . . . . . 99.3 mttt -102.21 127.03 49.33 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-O 120.958 0.409 . . . . 0.0 111.211 -176.726 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . 89.29 42.03 5.65 Favored Glycine 0 CA--C 1.525 0.673 0 N-CA-C 111.504 -0.638 . . . . 0.0 111.504 175.883 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 83' ' ' ILE . . . . . . . . . . . . . 71.0 mt -69.66 137.49 24.04 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.298 0 N-CA-C 109.77 -0.455 . . . . 0.0 109.77 176.749 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 84' ' ' LYS . . . . . . . . . . . . . 6.9 ttpm? -101.96 -48.56 4.21 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.102 179.362 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 85' ' ' ASP . . . . . . . . . . . . . 11.1 t70 -150.44 151.39 32.69 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 115.85 -0.614 . . . . 0.0 110.38 -179.721 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 86' ' ' VAL . . . . . 0.402 HG21 HG21 ' F' ' 133' ' ' ILE . 45.1 t -131.33 132.88 62.78 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.283 0 CA-C-O 120.958 0.409 . . . . 0.0 110.447 -179.134 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 87' ' ' ILE . . . . . 0.494 HD12 ' N ' ' A' ' 87' ' ' ILE . 5.1 mp -119.31 123.64 71.62 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.206 0 N-CA-C 109.169 -0.678 . . . . 0.0 109.169 175.891 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 88' ' ' LEU . . . . . 0.709 HD13 HG21 ' F' ' 131' ' ' VAL . 23.2 mt -114.0 129.71 56.59 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.164 -0.471 . . . . 0.0 111.148 -176.089 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 89' ' ' ASP . . . . . . . . . . . . . 13.6 t70 -124.02 154.6 39.64 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 115.83 -0.623 . . . . 0.0 109.677 176.709 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 41.6 mp0 -50.69 -37.33 40.66 Favored 'General case' 0 C--N 1.329 -0.316 0 N-CA-C 112.396 0.517 . . . . 0.0 112.396 -171.789 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 91' ' ' ASN . . . . . . . . . . . . . 20.2 p-10 -132.23 35.64 3.68 Favored 'General case' 0 N--CA 1.464 0.268 0 CA-C-O 120.679 0.276 . . . . 0.0 111.727 -177.112 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 92' ' ' LEU . . . . . . . . . . . . . 7.1 tp -166.12 139.76 4.24 Favored 'General case' 0 C--N 1.33 -0.282 0 N-CA-C 110.08 -0.341 . . . . 0.0 110.08 179.792 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 93' ' ' ILE . . . . . . . . . . . . . 66.7 mt -124.93 122.96 64.63 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.178 0 N-CA-C 109.749 -0.463 . . . . 0.0 109.749 -178.758 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 94' ' ' VAL . . . . . 0.486 HG11 HG11 ' A' ' 123' ' ' VAL . 41.8 t -125.6 127.84 71.9 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.181 0 CA-C-O 120.958 0.408 . . . . 0.0 110.142 179.44 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 95' ' ' VAL . . . . . . . . . . . . . 47.7 t -120.58 135.41 60.9 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.343 0 CA-C-N 115.909 -0.587 . . . . 0.0 109.875 -179.951 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 96' ' ' ILE . . . . . . . . . . . . . 65.7 mt -114.08 127.04 71.68 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.279 0 N-CA-C 109.341 -0.615 . . . . 0.0 109.341 178.388 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 97' ' ' THR . . . . . . . . . . . . . 67.8 p -97.72 162.8 13.1 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-O 121.331 0.586 . . . . 0.0 111.316 -176.918 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 98' ' ' GLU . . . . . . . . . . . . . 79.7 tt0 -53.84 -29.05 39.36 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 115.86 -0.609 . . . . 0.0 112.1 -178.993 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 99' ' ' GLU . . . . . . . . . . . . . 95.6 mt-10 -79.2 13.38 1.88 Allowed 'General case' 0 CA--C 1.534 0.365 0 N-CA-C 113.224 0.824 . . . . 0.0 113.224 -176.936 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 100' ' ' ASN . . . . . . . . . . . . . 4.0 m-20 61.18 34.41 18.88 Favored 'General case' 0 CA--C 1.53 0.179 0 CA-C-N 118.058 0.39 . . . . 0.0 111.414 -179.388 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 101' ' ' GLU . . . . . . . . . . . . . 84.0 tt0 -107.74 143.99 35.5 Favored 'General case' 0 C--N 1.333 -0.138 0 N-CA-C 109.537 -0.542 . . . . 0.0 109.537 172.993 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 102' ' ' VAL . . . . . . . . . . . . . 42.6 t -115.52 125.98 72.91 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.302 0 CA-C-N 116.273 -0.421 . . . . 0.0 110.007 -177.195 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 103' ' ' LEU . . . . . . . . . . . . . 66.2 mt -116.72 130.77 56.93 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 115.767 -0.651 . . . . 0.0 110.189 176.749 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 104' ' ' ILE . . . . . . . . . . . . . 68.6 mt -118.63 123.33 71.38 Favored 'Isoleucine or valine' 0 C--O 1.234 0.247 0 N-CA-C 110.26 -0.274 . . . . 0.0 110.26 -178.854 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 105' ' ' PHE . . . . . . . . . . . . . 67.6 m-85 -122.99 163.7 19.94 Favored 'General case' 0 C--O 1.232 0.148 0 O-C-N 124.003 0.815 . . . . 0.0 110.136 -178.176 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 106' ' ' ASN . . . . . . . . . . . . . 43.5 p-10 -97.77 -169.9 1.9 Allowed 'General case' 0 C--N 1.329 -0.283 0 N-CA-C 109.566 -0.531 . . . . 0.0 109.566 171.93 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 107' ' ' GLN . . . . . . . . . . . . . 23.5 tt0 -57.38 -29.68 64.26 Favored 'General case' 0 C--N 1.328 -0.348 0 N-CA-C 111.988 0.366 . . . . 0.0 111.988 178.983 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 108' ' ' ASN . . . . . . . . . . . . . 6.1 t-20 -86.98 11.57 13.29 Favored 'General case' 0 CA--C 1.536 0.421 0 N-CA-C 113.09 0.774 . . . . 0.0 113.09 -175.792 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 109' ' ' LEU . . . . . . . . . . . . . 41.6 mt 57.69 37.03 27.21 Favored 'General case' 0 C--N 1.332 -0.181 0 CA-C-O 120.88 0.372 . . . . 0.0 111.475 177.303 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 110' ' ' GLU . . . . . . . . . . . . . 43.5 mt-10 -104.73 146.72 28.56 Favored 'General case' 0 C--N 1.331 -0.228 0 N-CA-C 110.108 -0.33 . . . . 0.0 110.108 176.475 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 111' ' ' GLU . . . . . . . . . . . . . 99.3 mt-10 -76.89 121.98 24.19 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-O 120.92 0.39 . . . . 0.0 110.928 -178.57 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 112' ' ' LEU . . . . . . . . . . . . . 49.0 mt -110.12 -45.69 3.56 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 115.941 -0.572 . . . . 0.0 110.158 177.575 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 113' ' ' TYR . . . . . . . . . . . . . 64.8 t80 -134.15 135.86 43.4 Favored 'General case' 0 C--N 1.332 -0.187 0 CA-C-N 116.119 -0.491 . . . . 0.0 110.99 179.845 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 114' ' ' ARG . . . . . . . . . . . . . 83.3 mtp180 -135.17 123.25 22.81 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 116.043 -0.526 . . . . 0.0 110.248 177.937 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 115' ' ' GLY . . . . . . . . . . . . . . . -150.08 158.8 27.83 Favored Glycine 0 CA--C 1.524 0.625 0 N-CA-C 110.854 -0.898 . . . . 0.0 110.854 178.761 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 116' ' ' LYS . . . . . . . . . . . . . 79.8 tttt -134.18 131.76 38.99 Favored 'General case' 0 C--N 1.329 -0.32 0 N-CA-C 110.016 -0.365 . . . . 0.0 110.016 178.199 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 117' ' ' PHE . . . . . . . . . . . . . 20.0 m-85 -136.36 114.07 11.1 Favored 'General case' 0 C--N 1.331 -0.216 0 CA-C-N 116.362 -0.381 . . . . 0.0 110.066 -174.65 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 118' ' ' GLU . . . . . . . . . . . . . 96.1 mt-10 -54.5 -38.57 66.63 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.557 -0.292 . . . . 0.0 111.283 -177.945 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 119' ' ' ASN . . . . . . . . . . . . . 7.9 m-80 -100.44 30.53 3.85 Favored 'General case' 0 C--N 1.331 -0.232 0 N-CA-C 112.142 0.423 . . . . 0.0 112.142 -175.24 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 120' ' ' LEU . . . . . . . . . . . . . 16.3 tp -58.33 122.27 12.83 Favored 'General case' 0 C--N 1.331 -0.196 0 N-CA-C 110.084 -0.339 . . . . 0.0 110.084 177.322 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 121' ' ' ASN . . . . . . . . . . . . . 60.8 t30 -114.13 -44.09 3.17 Favored 'General case' 0 N--CA 1.462 0.169 0 CA-C-N 116.712 -0.222 . . . . 0.0 111.426 -176.986 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 122' ' ' LYS . . . . . . . . . . . . . 98.5 mttt -147.02 150.69 35.6 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-O 121.016 0.436 . . . . 0.0 111.665 -176.39 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 123' ' ' VAL . . . . . 0.486 HG11 HG11 ' A' ' 94' ' ' VAL . 40.9 t -128.79 129.16 68.31 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.319 0 CA-C-N 115.89 -0.596 . . . . 0.0 109.414 174.691 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 124' ' ' LEU . . . . . . . . . . . . . 52.6 mt -117.2 132.94 56.53 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-O 120.723 0.297 . . . . 0.0 110.372 -178.787 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 125' ' ' VAL . . . . . 0.473 HG12 HG23 ' A' ' 130' ' ' VAL . 34.9 m -134.32 133.75 55.19 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.252 0 CA-C-N 116.152 -0.477 . . . . 0.0 111.045 -178.092 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 126' ' ' ARG . . . . . . . . . . . . . 14.9 ptm180 -163.4 137.19 5.82 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.185 -0.461 . . . . 0.0 109.85 175.291 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 127' ' ' ASN . . . . . . . . . . . . . 69.4 m-20 55.56 -154.82 0.29 Allowed 'General case' 0 CA--C 1.539 0.531 0 N-CA-C 109.818 -0.438 . . . . 0.0 109.818 -178.77 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 128' ' ' ASP . . . . . . . . . . . . . 23.8 p-10 -84.65 22.25 1.36 Allowed 'General case' 0 CA--C 1.534 0.334 0 CA-C-N 118.383 0.538 . . . . 0.0 112.339 177.419 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 129' ' ' LEU . . . . . . . . . . . . . 16.5 tp -118.58 138.92 52.23 Favored 'General case' 0 C--O 1.234 0.249 0 O-C-N 122.112 -0.367 . . . . 0.0 110.178 178.764 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 130' ' ' VAL . . . . . 0.515 HG13 ' HB ' ' A' ' 141' ' ' ILE . 12.3 p -135.37 140.35 44.99 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.2 0 CA-C-O 120.96 0.41 . . . . 0.0 110.396 -178.773 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 131' ' ' VAL . . . . . 0.461 HG23 ' O ' ' A' ' 139' ' ' THR . 14.6 p -136.17 141.12 42.42 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.233 0 CA-C-O 120.981 0.42 . . . . 0.0 110.891 179.29 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 132' ' ' ILE . . . . . . . . . . . . . 73.4 mt -112.96 134.02 56.93 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.292 0 CA-C-N 115.859 -0.61 . . . . 0.0 109.637 179.756 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 133' ' ' ILE . . . . . . . . . . . . . 41.7 mm -117.66 124.35 72.94 Favored 'Isoleucine or valine' 0 C--O 1.233 0.198 0 CA-C-O 120.806 0.336 . . . . 0.0 110.976 -176.192 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 134' ' ' ASP . . . . . . . . . . . . . 7.1 p-10 -136.61 148.46 47.49 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.253 -0.43 . . . . 0.0 109.85 175.747 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 135' ' ' GLU . . . . . . . . . . . . . 83.0 tt0 -50.02 -26.9 4.76 Favored 'General case' 0 C--N 1.328 -0.341 0 N-CA-C 112.67 0.619 . . . . 0.0 112.67 -174.66 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 136' ' ' GLN . . . . . . . . . . . . . 94.3 mt-30 -82.67 -32.44 28.14 Favored 'General case' 0 C--N 1.33 -0.251 0 N-CA-C 112.344 0.498 . . . . 0.0 112.344 -175.596 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 137' ' ' LYS . . . . . . . . . . . . . 56.5 pttt -170.01 176.63 4.62 Favored 'General case' 0 C--N 1.333 -0.133 0 CA-C-O 121.592 0.71 . . . . 0.0 112.29 -172.795 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 138' ' ' LEU . . . . . 0.427 ' C ' HD23 ' A' ' 138' ' ' LEU . 7.5 tt -122.18 130.17 52.96 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-N 115.006 -0.997 . . . . 0.0 110.045 179.201 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 139' ' ' THR . . . . . 0.461 ' O ' HG23 ' A' ' 131' ' ' VAL . 85.2 m -115.42 124.54 51.43 Favored 'General case' 0 C--N 1.331 -0.224 0 CA-C-N 116.253 -0.431 . . . . 0.0 110.212 179.206 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 140' ' ' LEU . . . . . . . . . . . . . 21.0 tp -111.86 125.93 54.55 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.005 -0.543 . . . . 0.0 109.606 -178.979 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 141' ' ' ILE . . . . . 0.515 ' HB ' HG13 ' A' ' 130' ' ' VAL . 19.6 mt -123.31 124.56 70.14 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.252 0 CA-C-O 120.996 0.427 . . . . 0.0 110.234 -172.814 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 142' ' ' ARG . . . . . . . . . . . . . 81.1 mtp180 -111.84 125.78 54.38 Favored 'General case' 0 C--O 1.233 0.22 0 CA-C-N 115.429 -0.805 . . . . 0.0 109.843 -178.895 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 143' ' ' THR . . . . . . . . . . . . . 40.0 p . . . . . 0 C--O 1.22 -0.452 0 CA-C-O 118.014 -0.994 . . . . 0.0 110.555 -179.226 . . . . . . . . 0 0 . 1 . 010 nuclear build full ' B' B ' -3' ' ' GLU . . . . . . . . . . . . . 95.7 mt-10 . . . . . 0 N--CA 1.488 1.463 0 N-CA-C 109.326 -0.62 . . . . 0.0 109.326 . . . . . . . . . 0 0 . 1 . 010 nuclear build full ' B' B ' -2' ' ' GLY . . . . . . . . . . . . . . . -70.5 129.49 19.7 Favored Glycine 0 CA--C 1.525 0.663 0 N-CA-C 110.956 -0.858 . . . . 0.0 110.956 179.537 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' -1' ' ' VAL . . . . . . . . . . . . . 43.4 t -96.46 138.43 21.73 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.305 0 N-CA-C 110.098 -0.334 . . . . 0.0 110.098 179.76 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 0' ' ' ILE . . . . . . . . . . . . . 72.0 mt -88.33 129.58 39.28 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.222 0 CA-C-N 116.346 -0.388 . . . . 0.0 110.275 -178.695 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 1' ' ' MET . . . . . . . . . . . . . 26.2 ptt? -78.3 131.58 37.11 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.044 -0.526 . . . . 0.0 110.764 179.743 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 2' ' ' SER . . . . . . . . . . . . . 4.9 p -113.05 135.14 54.11 Favored 'General case' 0 C--N 1.331 -0.201 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.585 -179.687 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 3' ' ' GLU . . . . . . . . . . . . . 40.7 mt-10 -141.08 141.44 34.25 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.243 -0.435 . . . . 0.0 111.09 -178.962 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 4' ' ' LEU . . . . . . . . . . . . . 16.4 tp -125.9 129.82 50.09 Favored 'General case' 0 C--N 1.333 -0.143 0 CA-C-N 116.011 -0.541 . . . . 0.0 109.912 176.047 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 5' ' ' LYS . . . . . . . . . . . . . 57.1 mttp -108.79 123.24 48.71 Favored 'General case' 0 C--O 1.236 0.359 0 CA-C-N 116.625 -0.262 . . . . 0.0 110.891 -179.394 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 6' ' ' LEU . . . . . . . . . . . . . 66.6 mt -114.62 145.88 41.48 Favored 'General case' 0 C--N 1.331 -0.223 0 CA-C-N 115.71 -0.677 . . . . 0.0 110.557 179.646 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 7' ' ' LYS . . . . . . . . . . . . . 83.7 tttt -128.12 142.0 43.08 Favored Pre-proline 0 CA--C 1.533 0.303 0 CA-C-O 119.057 -0.497 . . . . 0.0 109.787 175.569 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 8' ' ' PRO . . . . . . . . . . . . . 93.7 Cg_endo -90.37 136.06 2.26 Favored 'Trans proline' 0 N--CA 1.49 1.318 0 C-N-CA 121.717 1.611 . . . . 0.0 111.832 179.131 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 9' ' ' LEU . . . . . . . . . . . . . 28.0 mt -82.96 -47.2 0.84 Allowed Pre-proline 0 CA--C 1.535 0.401 0 CA-C-O 118.631 -0.699 . . . . 0.0 112.061 -179.358 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 10' ' ' PRO . . . . . . . . . . . . . 83.8 Cg_endo -82.53 157.03 16.52 Favored 'Trans proline' 0 N--CA 1.495 1.592 0 C-N-CA 121.29 1.326 . . . . 0.0 111.802 175.688 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 11' ' ' LYS . . . . . . . . . . . . . 18.2 pttp -86.03 110.38 19.46 Favored 'General case' 0 C--N 1.331 -0.216 0 CA-C-O 121.523 0.677 . . . . 0.0 110.329 177.42 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 12' ' ' VAL . . . . . . . . . . . . . 12.0 p -151.07 149.53 14.09 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.359 0 CA-C-N 115.72 -0.673 . . . . 0.0 110.329 -179.978 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 13' ' ' GLU . . . . . . . . . . . . . 42.0 tp10 -95.73 120.6 36.28 Favored 'General case' 0 C--N 1.329 -0.293 0 C-N-CA 120.853 -0.339 . . . . 0.0 110.217 177.714 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 14' ' ' LEU . . . . . . . . . . . . . 37.2 mt -97.94 149.05 35.32 Favored Pre-proline 0 CA--C 1.533 0.316 0 CA-C-O 119.318 -0.372 . . . . 0.0 110.592 -177.736 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 15' ' ' PRO . . . . . . . . . . . . . 26.7 Cg_exo -61.8 157.11 44.55 Favored 'Trans proline' 0 N--CA 1.499 1.83 0 C-N-CA 121.286 1.324 . . . . 0.0 111.663 176.998 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 16' ' ' PRO . . . . . . . . . . . . . 39.1 Cg_exo -58.97 -33.95 98.94 Favored 'Trans proline' 0 N--CA 1.497 1.685 0 C-N-CA 121.416 1.411 . . . . 0.0 112.498 179.584 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 17' ' ' ASP . . . . . . . . . . . . . 18.7 p-10 -88.02 9.69 21.54 Favored 'General case' 0 CA--C 1.536 0.413 0 N-CA-C 113.234 0.828 . . . . 0.0 113.234 -177.791 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 18' ' ' PHE . . . . . . . . . . . . . 43.5 t80 -58.32 -46.49 86.08 Favored 'General case' 0 CA--C 1.523 -0.06 0 O-C-N 121.965 -0.459 . . . . 0.0 109.996 -177.983 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 19' ' ' VAL . . . . . 0.417 HG13 ' N ' ' B' ' 20' ' ' ASP . 12.9 p -53.91 -41.4 48.95 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.328 0 CA-C-N 116.501 -0.318 . . . . 0.0 111.188 -178.422 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' B' B ' 20' ' ' ASP . . . . . 0.417 ' N ' HG13 ' B' ' 19' ' ' VAL . 81.2 m-20 -60.82 -45.15 95.57 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-O 120.935 0.398 . . . . 0.0 110.83 -178.841 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' B' B ' 21' ' ' VAL . . . . . . . . . . . . . 40.7 t -64.16 -44.32 97.54 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.287 0 CA-C-N 116.272 -0.422 . . . . 0.0 110.654 -177.614 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 22' ' ' ILE . . . . . 0.553 HG22 HD12 ' B' ' 26' ' ' LEU . 50.3 mm -59.68 -40.01 81.16 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.199 0 C-N-CA 120.816 -0.354 . . . . 0.0 110.829 -179.65 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' B' B ' 23' ' ' ARG . . . . . . . . . . . . . 57.7 ttp180 -55.16 -49.14 72.6 Favored 'General case' 0 N--CA 1.463 0.219 0 CA-C-O 121.103 0.478 . . . . 0.0 110.692 177.736 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 24' ' ' ILE . . . . . . . . . . . . . 72.4 mt -60.39 -42.85 92.43 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 CA-C-N 115.729 -0.668 . . . . 0.0 111.845 -177.047 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 25' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -72.01 -37.43 69.79 Favored 'General case' 0 CA--C 1.535 0.37 0 N-CA-C 112.103 0.409 . . . . 0.0 112.103 -175.157 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' B' B ' 26' ' ' LEU . . . . . 0.553 HD12 HG22 ' B' ' 22' ' ' ILE . 40.4 mt -79.54 -39.7 31.25 Favored 'General case' 0 C--N 1.331 -0.231 0 N-CA-C 112.91 0.707 . . . . 0.0 112.91 -172.569 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' B' B ' 27' ' ' GLN . . . . . . . . . . . . . 14.3 pt20 -45.78 139.03 4.36 Favored 'General case' 0 N--CA 1.469 0.523 0 N-CA-C 112.84 0.682 . . . . 0.0 112.84 -175.095 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 28' ' ' GLY . . . . . . . . . . . . . . . 102.01 -26.65 23.57 Favored Glycine 0 CA--C 1.531 1.066 0 CA-C-N 115.367 -0.833 . . . . 0.0 112.191 -176.737 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 29' ' ' LYS . . . . . . . . . . . . . 54.8 mtpt -98.59 155.18 17.42 Favored 'General case' 0 C--O 1.233 0.198 0 CA-C-N 117.523 0.661 . . . . 0.0 111.237 179.058 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 30' ' ' THR . . . . . . . . . . . . . 53.7 m -101.03 139.43 36.73 Favored 'General case' 0 C--N 1.331 -0.216 0 CA-C-N 116.045 -0.525 . . . . 0.0 110.1 176.03 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 31' ' ' VAL . . . . . . . . . . . . . 34.5 m -130.47 155.4 41.7 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.305 0 CA-C-N 116.142 -0.481 . . . . 0.0 110.413 179.394 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 32' ' ' ARG . . . . . . . . . . . . . 71.5 ttt-85 -135.41 150.25 49.84 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-O 121.048 0.451 . . . . 0.0 110.24 178.211 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 33' ' ' THR . . . . . . . . . . . . . 19.8 m -52.28 137.67 28.2 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-O 120.894 0.378 . . . . 0.0 111.634 -177.068 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 34' ' ' GLY . . . . . . . . . . . . . . . 101.97 -17.2 54.86 Favored Glycine 0 CA--C 1.533 1.179 0 CA-C-O 119.622 -0.543 . . . . 0.0 113.21 179.087 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 35' ' ' ASP . . . . . . . . . . . . . 76.3 m-20 -67.28 148.58 51.51 Favored 'General case' 0 N--CA 1.462 0.128 0 CA-C-N 118.087 0.943 . . . . 0.0 111.299 179.514 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 36' ' ' VAL . . . . . . . . . . . . . 46.3 t -121.44 131.15 73.74 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.198 0 CA-C-N 115.935 -0.575 . . . . 0.0 109.873 177.737 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 37' ' ' ILE . . . . . . . . . . . . . 63.8 mt -121.27 138.57 51.21 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.299 0 CA-C-N 116.26 -0.427 . . . . 0.0 109.957 -179.921 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 38' ' ' GLY . . . . . . . . . . . . . . . -114.42 127.52 7.78 Favored Glycine 0 CA--C 1.524 0.636 0 N-CA-C 111.01 -0.836 . . . . 0.0 111.01 179.126 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 39' ' ' ILE . . . . . . . . . . . . . 70.8 mt -128.94 130.92 68.57 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.213 0 N-CA-C 110.003 -0.369 . . . . 0.0 110.003 178.685 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 40' ' ' SER . . . . . 0.428 ' O ' HD13 ' B' ' 41' ' ' ILE . 59.7 p -90.93 118.19 30.12 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.422 -0.354 . . . . 0.0 110.693 176.959 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' B' B ' 41' ' ' ILE . . . . . 0.428 HD13 ' O ' ' B' ' 40' ' ' SER . 48.2 mm -125.08 116.95 48.58 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.19 0 CA-C-O 120.974 0.416 . . . . 0.0 110.237 179.686 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' B' B ' 42' ' ' LEU . . . . . 0.542 ' O ' HD23 ' B' ' 42' ' ' LEU . 1.3 tt 56.65 45.58 21.8 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-O 121.414 0.626 . . . . 0.0 110.366 178.217 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' B' B ' 43' ' ' GLY . . . . . . . . . . . . . . . 75.16 -9.65 12.21 Favored Glycine 0 CA--C 1.534 1.238 0 CA-C-N 116.062 -0.517 . . . . 0.0 113.726 175.378 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 44' ' ' LYS . . . . . . . . . . . . . 46.8 tttp -107.29 126.9 53.03 Favored 'General case' 0 C--N 1.333 -0.121 0 CA-C-N 118.064 0.932 . . . . 0.0 110.189 -179.216 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 45' ' ' GLU . . . . . . . . . . . . . 42.6 tp10 -83.51 128.84 34.83 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-O 120.829 0.347 . . . . 0.0 111.222 -178.781 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 46' ' ' VAL . . . . . . . . . . . . . 8.7 p -120.18 127.08 75.88 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.198 0 N-CA-C 109.574 -0.528 . . . . 0.0 109.574 176.004 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 47' ' ' LYS . . . . . . . . . . . . . 87.0 mttt -98.94 124.82 44.16 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.03 -0.532 . . . . 0.0 110.603 177.092 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 48' ' ' PHE . . . . . . . . . . . . . 40.5 m-85 -108.96 131.8 54.71 Favored 'General case' 0 C--N 1.327 -0.379 0 N-CA-C 109.698 -0.482 . . . . 0.0 109.698 177.145 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 49' ' ' LYS . . . . . . . . . . . . . 84.3 tttt -107.89 134.71 50.44 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.452 -0.34 . . . . 0.0 110.406 178.21 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 50' ' ' VAL . . . . . . . . . . . . . 43.4 t -76.34 104.86 4.72 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.303 0 N-CA-C 109.25 -0.648 . . . . 0.0 109.25 176.729 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 51' ' ' VAL . . . . . . . . . . . . . 47.0 t -69.6 -49.79 55.87 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.275 0 CA-C-N 116.088 -0.505 . . . . 0.0 109.799 -174.428 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 52' ' ' GLN . . . . . . . . . . . . . 34.2 tt0 -161.91 145.05 11.99 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 115.928 -0.578 . . . . 0.0 111.569 -178.458 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 53' ' ' ALA . . . . . . . . . . . . . . . -120.71 133.57 55.34 Favored 'General case' 0 C--N 1.331 -0.219 0 CA-C-N 115.792 -0.64 . . . . 0.0 110.051 176.963 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 54' ' ' TYR . . . . . . . . . . . . . 45.9 t80 -129.06 109.63 18.19 Favored Pre-proline 0 CA--C 1.534 0.362 0 CA-C-O 118.27 -0.871 . . . . 0.0 110.243 178.276 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 55' ' ' PRO . . . . . . . . . . . . . 73.6 Cg_endo -77.11 168.24 77.54 Favored 'Cis proline' 0 N--CA 1.5 1.862 0 CA-C-N 121.818 1.685 . . . . 0.0 112.518 -5.921 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 56' ' ' SER . . . . . . . . . . . . . 50.5 m -117.3 134.02 23.13 Favored Pre-proline 0 CA--C 1.539 0.532 0 CA-C-O 118.418 -0.801 . . . . 0.0 109.557 174.851 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 57' ' ' PRO . . . . . . . . . . . . . 35.2 Cg_endo -66.27 164.37 66.14 Favored 'Cis proline' 0 N--CA 1.497 1.713 0 CA-C-N 121.838 1.692 . . . . 0.0 111.341 -2.547 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 58' ' ' LEU . . . . . . . . . . . . . 20.7 tp -129.78 136.05 49.16 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-O 120.966 0.413 . . . . 0.0 110.321 -179.061 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 59' ' ' ARG . . . . . . . . . . . . . 36.4 ttm180 -104.47 126.89 51.98 Favored 'General case' 0 C--N 1.326 -0.455 0 N-CA-C 109.169 -0.678 . . . . 0.0 109.169 175.69 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 60' ' ' VAL . . . . . . . . . . . . . 49.3 t -77.3 117.51 22.43 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.243 0 C-N-CA 120.638 -0.425 . . . . 0.0 109.933 -176.159 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 61' ' ' GLU . . . . . . . . . . . . . 94.9 mt-10 -130.99 167.9 18.27 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.088 -0.505 . . . . 0.0 110.247 -179.789 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 62' ' ' ASP . . . . . . . . . . . . . 24.6 t0 -54.26 -32.5 56.28 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-N 116.506 -0.315 . . . . 0.0 111.799 -178.816 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 63' ' ' ARG . . . . . . . . . . . . . 5.0 ptp180 -88.9 10.14 22.35 Favored 'General case' 0 CA--C 1.534 0.353 0 N-CA-C 113.499 0.926 . . . . 0.0 113.499 -175.147 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 64' ' ' THR . . . . . . . . . . . . . 27.2 m -94.02 134.4 36.46 Favored 'General case' 0 C--N 1.333 -0.122 0 CA-C-N 118.199 0.454 . . . . 0.0 110.507 -179.557 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 65' ' ' LYS . . . . . . . . . . . . . 67.2 mttm -90.7 133.31 35.24 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.011 -0.54 . . . . 0.0 110.616 179.706 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 66' ' ' ILE . . . . . . . . . . . . . 61.5 mt -110.75 129.6 65.64 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.21 0 N-CA-C 109.737 -0.468 . . . . 0.0 109.737 178.959 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 67' ' ' THR . . . . . . . . . . . . . 27.5 m -123.47 145.52 48.76 Favored 'General case' 0 C--N 1.331 -0.23 0 CA-C-N 116.055 -0.52 . . . . 0.0 110.644 -178.277 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 68' ' ' LEU . . . . . . . . . . . . . 52.9 mt -107.84 147.22 31.2 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-N 115.931 -0.577 . . . . 0.0 111.135 -178.442 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 69' ' ' VAL . . . . . . . . . . . . . 48.5 t -82.81 155.28 3.87 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.293 0 CA-C-N 115.664 -0.698 . . . . 0.0 109.122 175.602 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 70' ' ' THR . . . . . . . . . . . . . 9.9 t -73.69 166.49 23.18 Favored 'General case' 0 C--N 1.331 -0.208 0 CA-C-O 121.257 0.551 . . . . 0.0 110.996 -169.921 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 71' ' ' HIS . . . . . . . . . . . . . 64.6 m-70 -64.99 156.38 80.56 Favored Pre-proline 0 CA--C 1.533 0.32 0 CA-C-N 115.399 -0.819 . . . . 0.0 112.341 -170.562 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 72' ' ' PRO . . . . . . . . . . . . . 38.8 Cg_endo -67.5 160.28 48.65 Favored 'Trans proline' 0 N--CA 1.497 1.678 0 C-N-CA 121.729 1.62 . . . . 0.0 111.856 175.706 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 73' ' ' VAL . . . . . . . . . . . . . 34.5 m -69.68 -174.27 0.11 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.235 0 N-CA-C 109.629 -0.508 . . . . 0.0 109.629 -179.163 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 74' ' ' ASP . . . . . . . . . . . . . 28.9 t0 -84.85 115.35 22.7 Favored 'General case' 0 C--N 1.329 -0.323 0 C-N-CA 120.474 -0.49 . . . . 0.0 110.242 -170.972 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 75' ' ' VAL . . . . . . . . . . . . . 40.8 t -120.26 122.19 67.66 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.211 0 CA-C-O 121.099 0.476 . . . . 0.0 110.55 -177.842 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 76' ' ' LEU . . . . . . . . . . . . . 5.9 mp -119.25 137.64 53.53 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 115.609 -0.723 . . . . 0.0 109.288 174.627 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 77' ' ' GLU . . . . . . . . . . . . . 96.8 mt-10 -129.6 138.11 51.08 Favored 'General case' 0 C--N 1.331 -0.208 0 CA-C-O 121.159 0.504 . . . . 0.0 111.106 -176.405 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 78' ' ' ALA . . . . . . . . . . . . . . . -127.35 129.19 47.17 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 115.591 -0.731 . . . . 0.0 109.681 176.785 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 79' ' ' LYS . . . . . 0.611 ' O ' HD13 ' B' ' 80' ' ' ILE . 79.9 tttt -76.35 119.34 20.09 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.413 -0.358 . . . . 0.0 110.304 -178.294 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' B' B ' 80' ' ' ILE . . . . . 0.611 HD13 ' O ' ' B' ' 79' ' ' LYS . 40.6 mm -139.2 113.86 7.75 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.306 0 N-CA-C 109.469 -0.567 . . . . 0.0 109.469 -175.027 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' B' B ' 81' ' ' LYS . . . . . . . . . . . . . 86.9 tttt -99.33 122.89 43.1 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-O 120.82 0.343 . . . . 0.0 111.214 -177.219 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 82' ' ' GLY . . . . . . . . . . . . . . . 89.15 42.18 5.66 Favored Glycine 0 CA--C 1.526 0.752 0 C-N-CA 120.683 -0.77 . . . . 0.0 112.413 171.715 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 83' ' ' ILE . . . . . . . . . . . . . 71.3 mt -63.83 137.93 23.9 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.283 0 N-CA-C 109.484 -0.562 . . . . 0.0 109.484 174.818 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 84' ' ' LYS . . . . . . . . . . . . . 36.7 ttpt -106.58 -51.22 2.98 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-O 120.878 0.37 . . . . 0.0 110.352 -178.152 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 85' ' ' ASP . . . . . . . . . . . . . 13.1 t70 -145.25 146.16 31.58 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 115.969 -0.559 . . . . 0.0 110.54 -178.108 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 86' ' ' VAL . . . . . . . . . . . . . 46.2 t -129.97 131.89 65.89 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.263 0 CA-C-O 120.996 0.427 . . . . 0.0 110.448 -179.098 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 87' ' ' ILE . . . . . 0.489 ' N ' HD12 ' B' ' 87' ' ' ILE . 5.0 mp -120.47 127.29 75.9 Favored 'Isoleucine or valine' 0 C--O 1.233 0.22 0 CA-C-N 115.86 -0.609 . . . . 0.0 109.494 176.846 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' B' B ' 88' ' ' LEU . . . . . . . . . . . . . 13.7 tp -113.68 132.93 55.61 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-O 120.963 0.411 . . . . 0.0 111.284 -177.036 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 89' ' ' ASP . . . . . . . . . . . . . 11.4 t70 -130.38 155.25 46.69 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 115.745 -0.661 . . . . 0.0 109.675 176.602 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 90' ' ' GLU . . . . . . . . . . . . . 84.4 tt0 -45.74 -48.56 15.27 Favored 'General case' 0 N--CA 1.466 0.34 0 N-CA-C 112.798 0.666 . . . . 0.0 112.798 -173.194 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 91' ' ' ASN . . . . . . . . . . . . . 2.6 p30 -126.04 39.33 3.97 Favored 'General case' 0 N--CA 1.465 0.294 0 CA-C-O 120.958 0.409 . . . . 0.0 110.966 -177.904 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 92' ' ' LEU . . . . . . . . . . . . . 10.8 tp -165.5 140.17 4.87 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.312 -0.404 . . . . 0.0 110.383 -179.376 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 93' ' ' ILE . . . . . . . . . . . . . 69.6 mt -128.77 122.56 57.3 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.289 0 N-CA-C 109.294 -0.632 . . . . 0.0 109.294 179.55 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 94' ' ' VAL . . . . . . . . . . . . . 46.4 t -122.54 128.62 75.42 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.229 0 CA-C-O 120.947 0.403 . . . . 0.0 110.147 -178.838 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 95' ' ' VAL . . . . . . . . . . . . . 42.1 t -123.16 134.28 66.67 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.283 0 CA-C-N 116.017 -0.538 . . . . 0.0 109.834 -179.785 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 96' ' ' ILE . . . . . . . . . . . . . 62.1 mt -117.8 129.92 73.47 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.237 0 N-CA-C 109.464 -0.569 . . . . 0.0 109.464 179.845 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 97' ' ' THR . . . . . . . . . . . . . 70.8 p -103.38 161.2 14.04 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-O 121.23 0.538 . . . . 0.0 111.547 -176.522 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 98' ' ' GLU . . . . . . . . . . . . . 71.0 mm-40 -53.79 -27.42 29.06 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 115.97 -0.559 . . . . 0.0 112.149 178.679 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 99' ' ' GLU . . . . . . . . . . . . . 95.5 mt-10 -76.6 11.8 1.51 Allowed 'General case' 0 CA--C 1.536 0.433 0 N-CA-C 113.235 0.828 . . . . 0.0 113.235 -178.113 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 100' ' ' ASN . . . . . . . . . . . . . 6.2 m-20 61.24 37.61 17.19 Favored 'General case' 0 CA--C 1.528 0.116 0 CA-C-O 120.912 0.387 . . . . 0.0 110.984 179.524 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 101' ' ' GLU . . . . . . . . . . . . . 85.0 tt0 -113.44 142.89 45.36 Favored 'General case' 0 C--N 1.331 -0.197 0 N-CA-C 109.606 -0.516 . . . . 0.0 109.606 174.321 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 102' ' ' VAL . . . . . . . . . . . . . 40.3 t -115.69 125.67 72.95 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.312 0 CA-C-N 116.158 -0.474 . . . . 0.0 109.968 -178.173 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 103' ' ' LEU . . . . . . . . . . . . . 23.5 mt -115.87 126.97 54.64 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 115.736 -0.665 . . . . 0.0 109.959 176.296 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 104' ' ' ILE . . . . . . . . . . . . . 66.2 mt -117.38 120.26 64.32 Favored 'Isoleucine or valine' 0 C--O 1.235 0.29 0 CA-C-N 116.612 -0.267 . . . . 0.0 110.355 -179.429 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 105' ' ' PHE . . . . . . . . . . . . . 17.7 m-85 -122.97 168.4 12.37 Favored 'General case' 0 C--N 1.332 -0.188 0 O-C-N 123.797 0.686 . . . . 0.0 109.949 178.686 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 106' ' ' ASN . . . . . . . . . . . . . 41.7 p-10 -96.93 -169.86 1.94 Allowed 'General case' 0 C--N 1.329 -0.316 0 N-CA-C 109.627 -0.508 . . . . 0.0 109.627 173.485 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 107' ' ' GLN . . . . . . . . . . . . . 60.4 tt0 -59.5 -30.04 68.28 Favored 'General case' 0 CA--C 1.532 0.274 0 C-N-CA 120.968 -0.293 . . . . 0.0 111.775 178.438 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 108' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -82.0 5.76 18.22 Favored 'General case' 0 CA--C 1.537 0.47 0 N-CA-C 113.167 0.803 . . . . 0.0 113.167 -178.053 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' B' B ' 109' ' ' LEU . . . . . . . . . . . . . 10.2 tp 61.97 37.8 14.73 Favored 'General case' 0 C--N 1.332 -0.166 0 O-C-N 122.047 -0.408 . . . . 0.0 111.377 178.106 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 110' ' ' GLU . . . . . . . . . . . . . 70.9 mm-40 -103.17 159.41 15.56 Favored 'General case' 0 C--N 1.33 -0.277 0 N-CA-C 109.749 -0.463 . . . . 0.0 109.749 175.688 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 111' ' ' GLU . . . . . . . . . . . . . 84.0 tt0 -85.17 123.31 30.53 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-O 120.974 0.416 . . . . 0.0 111.053 -177.397 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 112' ' ' LEU . . . . . . . . . . . . . 12.7 mt -110.04 -45.96 3.53 Favored 'General case' 0 C--N 1.331 -0.216 0 CA-C-N 115.884 -0.598 . . . . 0.0 110.144 176.776 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 113' ' ' TYR . . . . . . . . . . . . . 63.8 t80 -141.46 138.23 32.71 Favored 'General case' 0 C--N 1.331 -0.217 0 CA-C-N 116.212 -0.449 . . . . 0.0 111.152 179.977 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 114' ' ' ARG . . . . . . . . . . . . . 67.0 ttt180 -138.62 119.58 14.37 Favored 'General case' 0 C--N 1.332 -0.191 0 CA-C-N 116.015 -0.539 . . . . 0.0 110.132 178.41 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 115' ' ' GLY . . . . . . . . . . . . . . . -150.15 158.04 27.49 Favored Glycine 0 CA--C 1.525 0.696 0 C-N-CA 120.666 -0.778 . . . . 0.0 111.367 179.342 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 116' ' ' LYS . . . . . . . . . . . . . 29.8 ttmt -130.81 139.31 50.17 Favored 'General case' 0 C--N 1.331 -0.231 0 N-CA-C 109.898 -0.408 . . . . 0.0 109.898 176.643 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 117' ' ' PHE . . . . . . . . . . . . . 30.7 m-85 -135.84 114.5 11.9 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.329 -0.396 . . . . 0.0 110.372 -176.047 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 118' ' ' GLU . . . . . . . . . . . . . 96.0 mt-10 -52.82 -47.63 67.52 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.351 -0.386 . . . . 0.0 111.579 -176.473 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 119' ' ' ASN . . . . . . . . . . . . . 32.4 m120 -94.91 31.03 1.93 Allowed 'General case' 0 C--N 1.331 -0.238 0 N-CA-C 112.199 0.444 . . . . 0.0 112.199 -174.553 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 120' ' ' LEU . . . . . . . . . . . . . 11.8 tp -56.48 120.46 7.75 Favored 'General case' 0 C--N 1.332 -0.156 0 CA-C-O 120.728 0.299 . . . . 0.0 110.504 177.68 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 121' ' ' ASN . . . . . . . . . . . . . 64.3 t30 -112.53 -44.09 3.4 Favored 'General case' 0 C--N 1.331 -0.23 0 CA-C-N 116.317 -0.401 . . . . 0.0 110.874 -176.502 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 122' ' ' LYS . . . . . . . . . . . . . 34.2 mtmm -147.45 145.97 29.37 Favored 'General case' 0 C--N 1.331 -0.217 0 CA-C-O 121.08 0.467 . . . . 0.0 111.445 -178.191 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 123' ' ' VAL . . . . . . . . . . . . . 46.6 t -125.92 129.64 72.39 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.24 0 CA-C-N 115.831 -0.622 . . . . 0.0 109.409 176.395 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 124' ' ' LEU . . . . . . . . . . . . . 44.9 mt -118.88 128.33 54.34 Favored 'General case' 0 C--N 1.331 -0.239 0 CA-C-N 116.308 -0.405 . . . . 0.0 110.431 -179.204 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 125' ' ' VAL . . . . . . . . . . . . . 47.7 t -130.61 124.35 56.78 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.324 0 CA-C-N 116.141 -0.481 . . . . 0.0 109.824 179.105 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 126' ' ' ARG . . . . . . . . . . . . . 37.0 mtm105 -145.0 119.72 9.83 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-O 120.973 0.416 . . . . 0.0 110.195 178.248 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 127' ' ' ASN . . . . . . . . . . . . . 89.8 m-20 55.44 -130.17 1.99 Allowed 'General case' 0 CA--C 1.545 0.759 0 CA-C-O 118.516 -0.754 . . . . 0.0 110.196 -179.398 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 128' ' ' ASP . . . . . . . . . . . . . 11.5 p-10 -97.23 10.05 40.55 Favored 'General case' 0 CA--C 1.536 0.417 0 CA-C-N 120.04 1.291 . . . . 0.0 113.237 -178.1 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 129' ' ' LEU . . . . . . . . . . . . . 6.2 tt -109.05 133.57 52.82 Favored 'General case' 0 C--O 1.232 0.178 0 CA-C-N 118.28 0.491 . . . . 0.0 110.065 -179.923 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 130' ' ' VAL . . . . . . . . . . . . . 46.4 t -125.89 137.35 57.99 Favored 'Isoleucine or valine' 0 N--CA 1.462 0.175 0 CA-C-O 120.953 0.406 . . . . 0.0 110.453 -176.947 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 131' ' ' VAL . . . . . 0.538 HG22 HD12 ' B' ' 140' ' ' LEU . 46.9 t -136.1 135.4 50.15 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.277 0 CA-C-N 116.137 -0.483 . . . . 0.0 110.187 178.414 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' B' B ' 132' ' ' ILE . . . . . . . . . . . . . 74.1 mt -120.28 131.65 71.99 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.271 0 N-CA-C 109.708 -0.479 . . . . 0.0 109.708 -179.833 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 133' ' ' ILE . . . . . . . . . . . . . 39.0 mm -117.83 121.47 67.46 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.271 0 CA-C-N 116.493 -0.321 . . . . 0.0 110.868 -176.989 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 134' ' ' ASP . . . . . . . . . . . . . 8.8 p-10 -132.69 149.43 52.29 Favored 'General case' 0 CA--C 1.528 0.128 0 N-CA-C 109.898 -0.408 . . . . 0.0 109.898 173.837 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 135' ' ' GLU . . . . . . . . . . . . . 85.4 tt0 -49.89 -25.5 3.25 Favored 'General case' 0 C--N 1.328 -0.357 0 N-CA-C 113.083 0.771 . . . . 0.0 113.083 -170.315 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 136' ' ' GLN . . . . . . . . . . . . . 97.5 mt-30 -92.86 -29.95 15.68 Favored 'General case' 0 C--N 1.33 -0.269 0 N-CA-C 112.581 0.585 . . . . 0.0 112.581 -173.932 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 137' ' ' LYS . . . . . . . . . . . . . 43.8 pttt -161.11 165.69 29.22 Favored 'General case' 0 C--O 1.233 0.212 0 CA-C-O 121.475 0.655 . . . . 0.0 112.19 -173.221 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 138' ' ' LEU . . . . . . . . . . . . . 7.0 tt -117.44 129.92 56.14 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 115.103 -0.953 . . . . 0.0 110.01 178.798 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 139' ' ' THR . . . . . . . . . . . . . 31.0 m -112.57 128.18 56.29 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.157 -0.474 . . . . 0.0 110.51 -179.888 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 140' ' ' LEU . . . . . 0.538 HD12 HG22 ' B' ' 131' ' ' VAL . 11.5 tp -117.1 120.82 39.51 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 115.814 -0.63 . . . . 0.0 109.352 -178.761 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' B' B ' 141' ' ' ILE . . . . . . . . . . . . . 19.9 mt -116.96 119.69 62.78 Favored 'Isoleucine or valine' 0 C--O 1.233 0.193 0 CA-C-O 121.037 0.446 . . . . 0.0 110.417 -173.657 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 142' ' ' ARG . . . . . . . . . . . . . 84.2 mtp180 -108.06 133.77 51.89 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 115.009 -0.996 . . . . 0.0 110.507 -177.565 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 143' ' ' THR . . . . . . . . . . . . . 15.1 p . . . . . 0 C--O 1.219 -0.503 0 CA-C-O 117.907 -1.044 . . . . 0.0 110.984 179.886 . . . . . . . . 0 0 . 1 . 010 nuclear build full ' C' C ' -3' ' ' GLU . . . . . . . . . . . . . 70.8 mm-40 . . . . . 0 N--CA 1.49 1.529 0 N-CA-C 109.394 -0.595 . . . . 0.0 109.394 . . . . . . . . . 0 0 . 1 . 010 nuclear build full ' C' C ' -2' ' ' GLY . . . . . . . . . . . . . . . -82.09 140.82 21.06 Favored Glycine 0 CA--C 1.524 0.654 0 N-CA-C 110.85 -0.9 . . . . 0.0 110.85 179.398 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' C' C ' -1' ' ' VAL . . . . . . . . . . . . . 46.1 t -95.58 140.61 16.66 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.302 0 CA-C-O 120.785 0.326 . . . . 0.0 110.192 -179.732 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' C' C ' 0' ' ' ILE . . . . . . . . . . . . . 71.1 mt -95.23 131.01 43.19 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.332 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.248 -179.879 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' C' C ' 1' ' ' MET . . . . . . . . . . . . . 25.1 ptp -79.2 148.83 32.12 Favored 'General case' 0 C--N 1.327 -0.395 0 CA-C-N 116.023 -0.535 . . . . 0.0 110.471 178.247 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' C' C ' 2' ' ' SER . . . . . . . . . . . . . 3.3 p -113.73 129.97 56.5 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.315 -0.402 . . . . 0.0 110.487 -179.988 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' C' C ' 3' ' ' GLU . . . . . . . . . . . . . 95.3 mt-10 -140.29 139.34 35.47 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.057 -0.52 . . . . 0.0 110.953 -178.34 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' C' C ' 4' ' ' LEU . . . . . . . . . . . . . 20.2 tp -127.05 128.48 46.35 Favored 'General case' 0 C--N 1.331 -0.221 0 CA-C-N 115.891 -0.595 . . . . 0.0 109.838 176.067 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' C' C ' 5' ' ' LYS . . . . . . . . . . . . . 96.3 mttt -112.48 122.8 48.73 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-O 120.769 0.318 . . . . 0.0 110.872 -178.581 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' C' C ' 6' ' ' LEU . . . . . . . . . . . . . 47.8 mt -114.24 142.61 46.05 Favored 'General case' 0 N--CA 1.462 0.143 0 CA-C-N 115.404 -0.817 . . . . 0.0 110.271 -179.451 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' C' C ' 7' ' ' LYS . . . . . . . . . . . . . 40.1 ttmt -123.45 137.16 28.05 Favored Pre-proline 0 CA--C 1.533 0.305 0 CA-C-O 119.001 -0.523 . . . . 0.0 109.622 175.545 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' C' C ' 8' ' ' PRO . . . . . . . . . . . . . 85.4 Cg_endo -91.83 136.01 1.69 Allowed 'Trans proline' 0 N--CA 1.489 1.231 0 C-N-CA 121.692 1.595 . . . . 0.0 111.895 179.314 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' C' C ' 9' ' ' LEU . . . . . . . . . . . . . 71.1 mt -74.62 -47.65 5.3 Favored Pre-proline 0 CA--C 1.534 0.35 0 CA-C-O 118.578 -0.725 . . . . 0.0 112.283 -179.744 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' C' C ' 10' ' ' PRO . . . . . . . . . . . . . 85.4 Cg_endo -80.15 151.49 20.81 Favored 'Trans proline' 0 N--CA 1.496 1.623 0 C-N-CA 121.162 1.241 . . . . 0.0 111.898 176.82 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' C' C ' 11' ' ' LYS . . . . . . . . . . . . . 50.5 tttp -87.21 98.25 11.22 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-O 120.752 0.311 . . . . 0.0 110.444 178.813 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' C' C ' 12' ' ' VAL . . . . . . . . . . . . . 11.9 p -144.55 144.88 21.86 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.289 0 CA-C-N 116.198 -0.455 . . . . 0.0 110.433 179.954 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' C' C ' 13' ' ' GLU . . . . . . . . . . . . . 95.2 mt-10 -82.05 126.76 32.37 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-N 116.352 -0.385 . . . . 0.0 110.041 177.846 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' C' C ' 14' ' ' LEU . . . . . . . . . . . . . 46.3 mt -95.48 148.48 34.68 Favored Pre-proline 0 C--N 1.329 -0.29 0 CA-C-O 119.235 -0.412 . . . . 0.0 110.4 -179.11 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' C' C ' 15' ' ' PRO . . . . . . . . . . . . . 38.8 Cg_exo -58.65 156.86 30.03 Favored 'Trans proline' 0 N--CA 1.496 1.651 0 C-N-CA 121.187 1.258 . . . . 0.0 111.772 178.97 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' C' C ' 16' ' ' PRO . . . . . . . . . . . . . 35.5 Cg_exo -58.49 -42.84 50.97 Favored 'Trans proline' 0 N--CA 1.498 1.762 0 C-N-CA 121.315 1.344 . . . . 0.0 112.703 -177.206 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' C' C ' 17' ' ' ASP . . . . . . . . . . . . . 12.8 p-10 -86.86 13.21 9.35 Favored 'General case' 0 C--N 1.327 -0.402 0 N-CA-C 112.999 0.741 . . . . 0.0 112.999 -177.961 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' C' C ' 18' ' ' PHE . . . . . . . . . . . . . 44.2 t80 -57.63 -50.52 72.87 Favored 'General case' 0 N--CA 1.456 -0.166 0 O-C-N 121.991 -0.443 . . . . 0.0 110.459 -176.958 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' C' C ' 19' ' ' VAL . . . . . . . . . . . . . 13.9 p -54.25 -40.46 47.62 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.285 0 CA-C-N 116.493 -0.321 . . . . 0.0 111.209 -177.911 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' C' C ' 20' ' ' ASP . . . . . . . . . . . . . 82.5 m-20 -60.53 -44.75 95.75 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-O 120.969 0.414 . . . . 0.0 110.86 -178.566 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' C' C ' 21' ' ' VAL . . . . . . . . . . . . . 46.4 t -64.16 -44.48 97.56 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.319 0 CA-C-N 116.291 -0.413 . . . . 0.0 110.396 -178.141 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' C' C ' 22' ' ' ILE . . . . . 0.669 HG22 HD12 ' C' ' 26' ' ' LEU . 50.6 mm -55.9 -44.71 78.8 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.248 0 C-N-CA 121.026 -0.269 . . . . 0.0 110.712 179.019 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' C' C ' 23' ' ' ARG . . . . . . . . . . . . . 55.5 ttp180 -53.8 -50.61 65.74 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-O 120.674 0.274 . . . . 0.0 111.439 179.727 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' C' C ' 24' ' ' ILE . . . . . . . . . . . . . 66.9 mt -58.34 -42.18 83.24 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.274 0 CA-C-N 116.558 -0.292 . . . . 0.0 110.884 -178.183 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' C' C ' 25' ' ' LYS . . . . . . . . . . . . . 53.1 mtpt -66.71 -43.82 83.29 Favored 'General case' 0 C--N 1.328 -0.367 0 N-CA-C 112.531 0.567 . . . . 0.0 112.531 -177.481 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' C' C ' 26' ' ' LEU . . . . . 0.669 HD12 HG22 ' C' ' 22' ' ' ILE . 62.9 mt -80.47 -36.23 33.74 Favored 'General case' 0 C--N 1.33 -0.256 0 N-CA-C 113.542 0.941 . . . . 0.0 113.542 -169.117 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' C' C ' 27' ' ' GLN . . . . . . . . . . . . . 16.9 pt20 -46.81 141.01 4.21 Favored 'General case' 0 N--CA 1.47 0.573 0 N-CA-C 112.674 0.62 . . . . 0.0 112.674 -176.006 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' C' C ' 28' ' ' GLY . . . . . . . . . . . . . . . 101.23 -25.77 27.02 Favored Glycine 0 CA--C 1.532 1.107 0 CA-C-N 115.752 -0.658 . . . . 0.0 112.235 -175.959 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' C' C ' 29' ' ' LYS . . . . . . . . . . . . . 73.3 mmtt -97.24 155.11 17.0 Favored 'General case' 0 C--O 1.234 0.247 0 CA-C-N 117.462 0.631 . . . . 0.0 111.191 178.46 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' C' C ' 30' ' ' THR . . . . . . . . . . . . . 23.7 m -104.8 136.01 45.11 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 115.807 -0.633 . . . . 0.0 109.785 174.841 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' C' C ' 31' ' ' VAL . . . . . . . . . . . . . 34.3 m -128.34 154.79 39.53 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.254 0 CA-C-O 120.918 0.39 . . . . 0.0 111.022 -176.916 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' C' C ' 32' ' ' ARG . . . . . . . . . . . . . 94.3 mtm-85 -133.32 150.37 51.87 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-O 121.249 0.547 . . . . 0.0 110.625 178.351 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' C' C ' 33' ' ' THR . . . . . . . . . . . . . 25.9 m -52.45 139.89 23.8 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 116.188 -0.46 . . . . 0.0 111.513 -178.327 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' C' C ' 34' ' ' GLY . . . . . . . . . . . . . . . 99.29 -17.06 58.4 Favored Glycine 0 CA--C 1.532 1.143 0 CA-C-O 119.533 -0.593 . . . . 0.0 113.214 179.228 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' C' C ' 35' ' ' ASP . . . . . . . . . . . . . 59.6 m-20 -63.15 149.76 44.48 Favored 'General case' 0 C--O 1.231 0.126 0 CA-C-N 118.138 0.969 . . . . 0.0 110.911 179.205 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' C' C ' 36' ' ' VAL . . . . . . . . . . . . . 42.0 t -122.45 129.33 75.34 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.251 0 CA-C-N 115.897 -0.592 . . . . 0.0 109.766 179.068 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' C' C ' 37' ' ' ILE . . . . . . . . . . . . . 66.2 mt -122.93 138.65 52.28 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.226 0 CA-C-N 116.265 -0.425 . . . . 0.0 109.968 179.815 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' C' C ' 38' ' ' GLY . . . . . . . . . . . . . . . -118.93 129.0 7.91 Favored Glycine 0 CA--C 1.525 0.683 0 N-CA-C 110.891 -0.884 . . . . 0.0 110.891 178.978 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' C' C ' 39' ' ' ILE . . . . . . . . . . . . . 70.2 mt -125.07 134.53 66.66 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.241 0 CA-C-O 120.764 0.316 . . . . 0.0 110.297 179.269 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' C' C ' 40' ' ' SER . . . . . . . . . . . . . 36.3 t -91.3 117.87 30.02 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.078 -0.51 . . . . 0.0 110.723 176.196 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' C' C ' 41' ' ' ILE . . . . . . . . . . . . . 65.7 mt -126.5 122.25 60.63 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.164 0 CA-C-O 120.816 0.341 . . . . 0.0 110.209 179.506 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' C' C ' 42' ' ' LEU . . . . . . . . . . . . . 5.5 mp 52.9 35.88 20.25 Favored 'General case' 0 CA--C 1.532 0.279 0 CA-C-N 116.186 -0.461 . . . . 0.0 111.399 178.099 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' C' C ' 43' ' ' GLY . . . . . . . . . . . . . . . 73.87 27.99 65.73 Favored Glycine 0 CA--C 1.531 1.087 0 C-N-CA 121.15 -0.548 . . . . 0.0 112.542 176.528 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' C' C ' 44' ' ' LYS . . . . . . . . . . . . . 95.7 mttt -139.52 128.71 23.9 Favored 'General case' 0 C--N 1.33 -0.282 0 N-CA-C 109.744 -0.465 . . . . 0.0 109.744 176.971 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' C' C ' 45' ' ' GLU . . . . . . . . . . . . . 85.2 tt0 -84.08 127.75 34.11 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-O 120.882 0.372 . . . . 0.0 111.533 -177.473 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' C' C ' 46' ' ' VAL . . . . . . . . . . . . . 9.3 p -118.41 126.76 75.34 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.21 0 N-CA-C 109.569 -0.53 . . . . 0.0 109.569 174.342 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' C' C ' 47' ' ' LYS . . . . . . . . . . . . . 75.9 mttt -98.28 123.89 42.61 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.044 -0.526 . . . . 0.0 110.808 178.315 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' C' C ' 48' ' ' PHE . . . . . . . . . . . . . 34.5 m-85 -109.18 131.77 54.75 Favored 'General case' 0 C--N 1.329 -0.299 0 N-CA-C 109.691 -0.485 . . . . 0.0 109.691 176.75 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' C' C ' 49' ' ' LYS . . . . . . . . . . . . . 49.1 tttp -107.37 132.54 53.04 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.432 -0.349 . . . . 0.0 110.164 177.638 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' C' C ' 50' ' ' VAL . . . . . . . . . . . . . 44.5 t -75.6 107.25 6.19 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.327 0 N-CA-C 109.594 -0.521 . . . . 0.0 109.594 178.314 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' C' C ' 51' ' ' VAL . . . . . . . . . . . . . 47.1 t -68.94 -49.12 66.12 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.305 0 CA-C-N 116.116 -0.493 . . . . 0.0 109.721 -175.594 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' C' C ' 52' ' ' GLN . . . . . . . . . . . . . 49.1 tt0 -162.84 143.03 9.38 Favored 'General case' 0 C--N 1.329 -0.291 0 C-N-CA 120.211 -0.596 . . . . 0.0 111.773 -178.836 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' C' C ' 53' ' ' ALA . . . . . . . . . . . . . . . -114.86 130.92 56.97 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 115.32 -0.855 . . . . 0.0 109.456 174.096 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' C' C ' 54' ' ' TYR . . . . . . . . . . . . . 22.2 t80 -128.62 110.27 19.0 Favored Pre-proline 0 CA--C 1.534 0.363 0 CA-C-O 118.34 -0.838 . . . . 0.0 110.306 -178.891 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' C' C ' 55' ' ' PRO . . . . . . . . . . . . . 74.5 Cg_endo -77.23 170.06 72.46 Favored 'Cis proline' 0 N--CA 1.499 1.831 0 CA-C-N 121.827 1.688 . . . . 0.0 112.367 -5.623 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' C' C ' 56' ' ' SER . . . . . . . . . . . . . 13.8 m -114.73 129.13 25.25 Favored Pre-proline 0 CA--C 1.538 0.496 0 CA-C-O 118.451 -0.785 . . . . 0.0 109.451 175.855 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' C' C ' 57' ' ' PRO . . . . . . . . . . . . . 59.6 Cg_endo -73.61 148.95 93.29 Favored 'Cis proline' 0 N--CA 1.497 1.689 0 CA-C-N 121.99 1.747 . . . . 0.0 111.759 -0.352 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' C' C ' 58' ' ' LEU . . . . . . . . . . . . . 23.8 tp -108.3 136.6 47.68 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.376 -0.374 . . . . 0.0 110.836 -178.174 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' C' C ' 59' ' ' ARG . . . . . . . . . . . . . 60.1 ttm-85 -103.13 123.21 46.25 Favored 'General case' 0 C--N 1.329 -0.323 0 N-CA-C 109.242 -0.651 . . . . 0.0 109.242 174.779 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' C' C ' 60' ' ' VAL . . . . . . . . . . . . . 44.1 t -80.56 121.6 34.28 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.264 0 C-N-CA 120.712 -0.395 . . . . 0.0 110.246 -176.94 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' C' C ' 61' ' ' GLU . . . . . . . . . . . . . 40.3 mt-10 -130.72 172.37 12.05 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 115.958 -0.565 . . . . 0.0 109.863 178.821 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' C' C ' 62' ' ' ASP . . . . . . . . . . . . . 60.1 m-20 -54.92 -32.52 61.28 Favored 'General case' 0 C--N 1.328 -0.365 0 N-CA-C 111.773 0.286 . . . . 0.0 111.773 -178.978 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' C' C ' 63' ' ' ARG . . . . . . . . . . . . . 17.5 ptm180 -88.92 6.31 39.94 Favored 'General case' 0 CA--C 1.536 0.437 0 N-CA-C 113.507 0.929 . . . . 0.0 113.507 -176.226 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' C' C ' 64' ' ' THR . . . . . . . . . . . . . 32.8 m -82.39 131.53 35.22 Favored 'General case' 0 C--N 1.331 -0.203 0 CA-C-N 118.143 0.429 . . . . 0.0 110.559 -178.874 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' C' C ' 65' ' ' LYS . . . . . . . . . . . . . 96.6 mttt -88.77 129.34 35.58 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.155 -0.475 . . . . 0.0 110.104 179.744 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' C' C ' 66' ' ' ILE . . . . . . . . . . . . . 64.2 mt -114.17 130.36 68.52 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.252 0 N-CA-C 109.82 -0.437 . . . . 0.0 109.82 179.305 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' C' C ' 67' ' ' THR . . . . . . . . . . . . . 22.4 m -121.53 140.09 52.66 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-N 116.118 -0.492 . . . . 0.0 111.0 -177.732 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' C' C ' 68' ' ' LEU . . . . . . . . . . . . . 44.1 mt -103.71 132.31 50.08 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 115.832 -0.622 . . . . 0.0 110.415 178.173 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' C' C ' 69' ' ' VAL . . . . . . . . . . . . . 42.0 t -96.95 144.44 10.59 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.367 0 CA-C-N 116.164 -0.471 . . . . 0.0 109.891 178.461 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' C' C ' 70' ' ' THR . . . . . . . . . . . . . 68.6 p -130.54 45.34 2.83 Favored 'General case' 0 C--N 1.331 -0.203 0 CA-C-O 121.408 0.623 . . . . 0.0 110.866 -176.675 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' C' C ' 71' ' ' HIS . . . . . . . . . . . . . 58.5 t-80 -131.07 66.23 78.54 Favored Pre-proline 0 CA--C 1.536 0.421 0 CA-C-N 116.097 -0.502 . . . . 0.0 110.277 178.196 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' C' C ' 72' ' ' PRO . . . . . . . . . . . . . 97.7 Cg_endo -91.97 160.04 3.31 Favored 'Trans proline' 0 N--CA 1.49 1.277 0 C-N-CA 121.999 1.799 . . . . 0.0 112.412 179.263 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' C' C ' 73' ' ' VAL . . . . . . . . . . . . . 27.6 m -103.0 165.07 3.15 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.232 0 CA-C-N 116.314 -0.403 . . . . 0.0 110.191 177.326 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' C' C ' 74' ' ' ASP . . . . . 0.436 ' OD1' HD11 ' C' ' 76' ' ' LEU . 3.1 t70 -105.53 121.68 44.44 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.273 -0.421 . . . . 0.0 109.964 -178.563 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' C' C ' 75' ' ' VAL . . . . . 0.42 ' C ' HD12 ' C' ' 76' ' ' LEU . 40.4 t -117.47 123.77 72.19 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.229 0 CA-C-O 121.095 0.474 . . . . 0.0 110.566 -177.41 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' C' C ' 76' ' ' LEU . . . . . 0.455 ' N ' HD12 ' C' ' 76' ' ' LEU . 7.0 mp -117.86 142.0 47.8 Favored 'General case' 0 C--N 1.332 -0.189 0 CA-C-N 115.683 -0.689 . . . . 0.0 109.468 176.147 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' C' C ' 77' ' ' GLU . . . . . . . . . . . . . 96.5 mt-10 -133.02 136.94 46.3 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-O 121.022 0.439 . . . . 0.0 111.259 -178.261 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' C' C ' 78' ' ' ALA . . . . . . . . . . . . . . . -126.84 135.44 51.0 Favored 'General case' 0 C--N 1.331 -0.225 0 CA-C-N 115.8 -0.636 . . . . 0.0 109.877 176.428 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' C' C ' 79' ' ' LYS . . . . . 0.477 ' O ' HD13 ' C' ' 80' ' ' ILE . 90.6 mttt -74.72 122.82 23.85 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-O 120.802 0.334 . . . . 0.0 110.553 -179.678 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' C' C ' 80' ' ' ILE . . . . . 0.477 HD13 ' O ' ' C' ' 79' ' ' LYS . 26.0 mm -139.16 113.36 7.27 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.306 0 N-CA-C 109.059 -0.719 . . . . 0.0 109.059 -178.47 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' C' C ' 81' ' ' LYS . . . . . . . . . . . . . 19.5 pttp -105.88 124.69 49.97 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-O 121.02 0.438 . . . . 0.0 111.363 -176.225 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' C' C ' 82' ' ' GLY . . . . . . . . . . . . . . . 88.99 42.09 5.73 Favored Glycine 0 CA--C 1.525 0.702 0 C-N-CA 120.73 -0.748 . . . . 0.0 111.75 173.152 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' C' C ' 83' ' ' ILE . . . . . . . . . . . . . 72.9 mt -65.75 136.14 27.2 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.311 0 CA-C-O 121.001 0.429 . . . . 0.0 110.081 178.668 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' C' C ' 84' ' ' LYS . . . . . . . . . . . . . 33.8 tttp -97.42 -53.54 3.43 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 115.824 -0.625 . . . . 0.0 110.128 -178.988 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' C' C ' 85' ' ' ASP . . . . . . . . . . . . . 12.7 t70 -153.99 153.16 31.48 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 115.596 -0.729 . . . . 0.0 110.251 179.569 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' C' C ' 86' ' ' VAL . . . . . . . . . . . . . 47.2 t -129.75 131.32 66.69 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.258 0 CA-C-O 121.003 0.43 . . . . 0.0 110.552 -179.312 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' C' C ' 87' ' ' ILE . . . . . . . . . . . . . 4.8 mp -119.92 127.28 75.88 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.236 0 CA-C-N 115.738 -0.664 . . . . 0.0 109.509 175.529 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' C' C ' 88' ' ' LEU . . . . . . . . . . . . . 11.0 tp -112.66 130.19 56.13 Favored 'General case' 0 C--N 1.331 -0.198 0 CA-C-O 120.994 0.425 . . . . 0.0 111.083 -177.144 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' C' C ' 89' ' ' ASP . . . . . . . . . . . . . 6.3 t70 -128.64 154.25 46.45 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 115.884 -0.598 . . . . 0.0 109.749 177.087 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' C' C ' 90' ' ' GLU . . . . . . . . . . . . . 81.4 tt0 -47.52 -41.41 20.95 Favored 'General case' 0 N--CA 1.464 0.229 0 N-CA-C 112.915 0.709 . . . . 0.0 112.915 -172.952 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' C' C ' 91' ' ' ASN . . . . . . . . . . . . . 19.7 m120 -121.54 16.79 11.25 Favored 'General case' 0 N--CA 1.467 0.401 0 N-CA-C 113.255 0.835 . . . . 0.0 113.255 -175.938 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' C' C ' 92' ' ' LEU . . . . . . . . . . . . . 55.2 mt -150.97 142.78 23.8 Favored 'General case' 0 C--N 1.332 -0.193 0 CA-C-O 120.818 0.342 . . . . 0.0 110.33 -177.096 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' C' C ' 93' ' ' ILE . . . . . . . . . . . . . 69.1 mt -123.28 115.41 45.45 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.32 0 N-CA-C 108.904 -0.776 . . . . 0.0 108.904 175.767 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' C' C ' 94' ' ' VAL . . . . . . . . . . . . . 45.2 t -116.58 123.9 72.11 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.308 0 CA-C-O 120.886 0.374 . . . . 0.0 110.085 -176.765 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' C' C ' 95' ' ' VAL . . . . . . . . . . . . . 42.2 t -121.04 131.92 71.79 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 CA-C-N 116.001 -0.545 . . . . 0.0 109.788 -179.815 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' C' C ' 96' ' ' ILE . . . . . 0.508 HD11 ' HB ' ' C' ' 123' ' ' VAL . 62.9 mt -112.94 127.16 70.33 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.284 0 N-CA-C 109.366 -0.605 . . . . 0.0 109.366 179.439 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' C' C ' 97' ' ' THR . . . . . . . . . . . . . 81.0 p -96.89 154.36 17.34 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-O 120.896 0.379 . . . . 0.0 110.733 -178.965 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' C' C ' 98' ' ' GLU . . . . . . . . . . . . . 97.3 mt-10 -53.91 -25.85 22.27 Favored 'General case' 0 C--N 1.328 -0.329 0 N-CA-C 112.335 0.495 . . . . 0.0 112.335 -179.722 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' C' C ' 99' ' ' GLU . . . . . . . . . . . . . 94.3 mt-10 -77.11 12.27 1.5 Allowed 'General case' 0 CA--C 1.537 0.466 0 N-CA-C 113.218 0.822 . . . . 0.0 113.218 -178.147 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' C' C ' 100' ' ' ASN . . . . . . . . . . . . . 4.0 m-20 65.08 32.81 10.03 Favored 'General case' 0 CA--C 1.531 0.248 0 CA-C-N 117.998 0.363 . . . . 0.0 111.68 178.242 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' C' C ' 101' ' ' GLU . . . . . . . . . . . . . 84.6 tt0 -112.26 143.48 43.27 Favored 'General case' 0 C--O 1.232 0.162 0 N-CA-C 109.457 -0.572 . . . . 0.0 109.457 173.149 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' C' C ' 102' ' ' VAL . . . . . . . . . . . . . 45.3 t -115.52 127.76 72.99 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.336 0 CA-C-O 120.886 0.374 . . . . 0.0 110.165 -177.591 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' C' C ' 103' ' ' LEU . . . . . . . . . . . . . 42.0 mt -114.8 127.42 55.72 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 115.489 -0.778 . . . . 0.0 109.874 176.518 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' C' C ' 104' ' ' ILE . . . . . 0.464 HD12 ' HB3' ' C' ' 113' ' ' TYR . 66.7 mt -116.48 118.52 59.05 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.292 0 N-CA-C 110.054 -0.351 . . . . 0.0 110.054 179.955 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' C' C ' 105' ' ' PHE . . . . . . . . . . . . . 63.8 m-85 -118.37 164.85 14.63 Favored 'General case' 0 C--N 1.333 -0.146 0 O-C-N 123.952 0.782 . . . . 0.0 110.523 179.613 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' C' C ' 106' ' ' ASN . . . . . . . . . . . . . 45.8 p-10 -97.96 -169.97 1.91 Allowed 'General case' 0 C--N 1.33 -0.28 0 N-CA-C 109.699 -0.482 . . . . 0.0 109.699 171.868 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' C' C ' 107' ' ' GLN . . . . . . . . . . . . . 58.7 tt0 -57.66 -29.11 64.35 Favored 'General case' 0 C--N 1.329 -0.291 0 N-CA-C 112.044 0.387 . . . . 0.0 112.044 -179.682 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' C' C ' 108' ' ' ASN . . . . . . . . . . . . . 50.8 t30 -90.4 14.08 13.85 Favored 'General case' 0 CA--C 1.534 0.329 0 N-CA-C 113.103 0.779 . . . . 0.0 113.103 -175.661 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' C' C ' 109' ' ' LEU . . . . . . . . . . . . . 59.9 mt 58.43 35.69 24.89 Favored 'General case' 0 CA--C 1.529 0.165 0 CA-C-O 120.775 0.321 . . . . 0.0 111.651 176.783 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' C' C ' 110' ' ' GLU . . . . . . . . . . . . . 95.4 mt-10 -101.78 152.85 20.38 Favored 'General case' 0 C--N 1.33 -0.254 0 N-CA-C 109.566 -0.531 . . . . 0.0 109.566 175.313 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' C' C ' 111' ' ' GLU . . . . . . . . . . . . . 44.0 tp10 -82.21 121.93 27.25 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-O 120.903 0.382 . . . . 0.0 110.954 -177.673 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' C' C ' 112' ' ' LEU . . . . . . . . . . . . . 17.6 mt -106.53 -45.94 4.12 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.006 -0.543 . . . . 0.0 110.147 177.319 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' C' C ' 113' ' ' TYR . . . . . 0.464 ' HB3' HD12 ' C' ' 104' ' ' ILE . 59.6 t80 -137.88 135.56 36.26 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.079 -0.51 . . . . 0.0 110.929 179.153 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' C' C ' 114' ' ' ARG . . . . . . . . . . . . . 41.1 ttm180 -135.7 119.82 17.67 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.027 -0.533 . . . . 0.0 110.038 177.474 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' C' C ' 115' ' ' GLY . . . . . . . . . . . . . . . -150.03 159.14 27.98 Favored Glycine 0 CA--C 1.525 0.664 0 N-CA-C 111.016 -0.834 . . . . 0.0 111.016 179.168 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' C' C ' 116' ' ' LYS . . . . . . . . . . . . . 69.4 tttt -131.15 130.32 42.91 Favored 'General case' 0 C--N 1.329 -0.316 0 N-CA-C 109.963 -0.384 . . . . 0.0 109.963 178.122 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' C' C ' 117' ' ' PHE . . . . . 0.422 ' CE2' HG21 ' C' ' 132' ' ' ILE . 41.7 m-85 -125.83 117.3 23.09 Favored 'General case' 0 C--N 1.331 -0.215 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.228 -175.271 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' C' C ' 118' ' ' GLU . . . . . . . . . . . . . 81.9 tt0 -51.94 -46.68 64.82 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.428 -0.351 . . . . 0.0 111.702 -176.422 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' C' C ' 119' ' ' ASN . . . . . . . . . . . . . 83.6 m-20 -101.47 31.26 3.82 Favored 'General case' 0 C--N 1.33 -0.239 0 N-CA-C 112.174 0.435 . . . . 0.0 112.174 -173.971 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' C' C ' 120' ' ' LEU . . . . . . . . . . . . . 13.8 tp -53.53 122.97 10.83 Favored 'General case' 0 N--CA 1.464 0.254 0 CA-C-O 120.832 0.349 . . . . 0.0 111.078 179.506 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' C' C ' 121' ' ' ASN . . . . . . . . . . . . . 9.9 t-20 -112.86 -44.07 3.35 Favored 'General case' 0 C--N 1.331 -0.199 0 CA-C-N 116.257 -0.429 . . . . 0.0 110.746 -177.507 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' C' C ' 122' ' ' LYS . . . . . . . . . . . . . 98.4 mttt -147.98 148.53 30.84 Favored 'General case' 0 C--N 1.332 -0.181 0 CA-C-O 121.061 0.458 . . . . 0.0 111.855 -178.593 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' C' C ' 123' ' ' VAL . . . . . 0.508 ' HB ' HD11 ' C' ' 96' ' ' ILE . 45.1 t -129.41 124.58 60.17 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.316 0 N-CA-C 109.175 -0.676 . . . . 0.0 109.175 173.278 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' C' C ' 124' ' ' LEU . . . . . . . . . . . . . 48.0 mt -129.55 143.79 50.98 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-O 120.946 0.403 . . . . 0.0 110.988 -176.175 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' C' C ' 125' ' ' VAL . . . . . . . . . . . . . 11.4 p -135.95 138.64 47.23 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.249 0 CA-C-N 115.881 -0.599 . . . . 0.0 110.235 178.752 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' C' C ' 126' ' ' ARG . . . . . . . . . . . . . 26.8 ttm180 -144.46 127.64 16.66 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-N 116.209 -0.45 . . . . 0.0 110.224 178.557 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' C' C ' 127' ' ' ASN . . . . . . . . . . . . . 80.7 m-20 53.16 -110.4 0.53 Allowed 'General case' 0 CA--C 1.545 0.772 0 CA-C-O 118.843 -0.599 . . . . 0.0 110.927 -179.402 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' C' C ' 128' ' ' ASP . . . . . . . . . . . . . 19.0 p-10 -114.2 5.64 15.96 Favored 'General case' 0 CA--C 1.536 0.416 0 CA-C-N 119.893 1.224 . . . . 0.0 113.384 -177.819 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' C' C ' 129' ' ' LEU . . . . . . . . . . . . . 58.4 mt -108.6 141.11 41.01 Favored 'General case' 0 C--N 1.334 -0.093 0 CA-C-N 118.133 0.424 . . . . 0.0 110.351 -179.185 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' C' C ' 130' ' ' VAL . . . . . 0.403 HG11 HD13 ' C' ' 104' ' ' ILE . 42.5 t -122.69 136.73 58.54 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.246 0 N-CA-C 109.884 -0.413 . . . . 0.0 109.884 -179.806 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' C' C ' 131' ' ' VAL . . . . . 0.447 HG22 HD12 ' C' ' 140' ' ' LEU . 44.3 t -134.63 135.14 53.88 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.214 0 CA-C-O 121.066 0.46 . . . . 0.0 110.342 -179.591 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' C' C ' 132' ' ' ILE . . . . . 0.422 HG21 ' CE2' ' C' ' 117' ' ' PHE . 68.9 mt -118.43 131.21 71.86 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.264 0 CA-C-N 115.753 -0.658 . . . . 0.0 109.371 178.854 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' C' C ' 133' ' ' ILE . . . . . . . . . . . . . 40.4 mm -116.07 122.77 70.33 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.237 0 CA-C-N 116.515 -0.311 . . . . 0.0 110.913 -175.301 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' C' C ' 134' ' ' ASP . . . . . . . . . . . . . 7.1 p-10 -133.62 148.74 51.58 Favored 'General case' 0 C--N 1.331 -0.224 0 N-CA-C 110.043 -0.354 . . . . 0.0 110.043 174.934 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' C' C ' 135' ' ' GLU . . . . . . . . . . . . . 81.3 tt0 -49.72 -25.11 2.69 Favored 'General case' 0 C--N 1.327 -0.384 0 N-CA-C 112.99 0.737 . . . . 0.0 112.99 -172.206 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' C' C ' 136' ' ' GLN . . . . . . . . . . . . . 63.1 tt0 -88.51 -37.52 15.69 Favored 'General case' 0 C--O 1.234 0.24 0 N-CA-C 112.111 0.411 . . . . 0.0 112.111 -175.656 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' C' C ' 137' ' ' LYS . . . . . . . . . . . . . 45.0 pttt -159.44 169.08 24.7 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-O 121.568 0.699 . . . . 0.0 112.252 -171.34 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' C' C ' 138' ' ' LEU . . . . . 0.449 HD23 ' C ' ' C' ' 138' ' ' LEU . 6.4 tt -116.33 126.43 53.51 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 114.942 -1.027 . . . . 0.0 109.829 178.362 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' C' C ' 139' ' ' THR . . . . . 0.411 ' N ' HD23 ' C' ' 138' ' ' LEU . 49.8 m -107.73 128.4 54.54 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.178 -0.464 . . . . 0.0 110.357 179.928 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' C' C ' 140' ' ' LEU . . . . . 0.447 HD12 HG22 ' C' ' 131' ' ' VAL . 9.5 tp -114.36 122.65 47.34 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 115.736 -0.665 . . . . 0.0 109.368 -178.748 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' C' C ' 141' ' ' ILE . . . . . . . . . . . . . 19.6 mt -120.18 124.57 72.9 Favored 'Isoleucine or valine' 0 C--O 1.234 0.238 0 CA-C-O 120.912 0.387 . . . . 0.0 110.034 -173.402 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' C' C ' 142' ' ' ARG . . . . . . . . . . . . . 64.9 mtt180 -114.05 130.43 56.56 Favored 'General case' 0 C--O 1.233 0.19 0 CA-C-N 115.574 -0.739 . . . . 0.0 110.05 -175.77 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' C' C ' 143' ' ' THR . . . . . . . . . . . . . 22.5 p . . . . . 0 C--O 1.219 -0.507 0 CA-C-O 118.014 -0.993 . . . . 0.0 110.542 -179.634 . . . . . . . . 0 0 . 1 . 010 nuclear build full ' D' D ' -3' ' ' GLU . . . . . . . . . . . . . 85.6 tt0 . . . . . 0 N--CA 1.49 1.547 0 N-CA-C 109.303 -0.629 . . . . 0.0 109.303 . . . . . . . . . 0 0 . 1 . 010 nuclear build full ' D' D ' -2' ' ' GLY . . . . . . . . . . . . . . . -72.12 137.0 24.58 Favored Glycine 0 CA--C 1.524 0.62 0 N-CA-C 111.256 -0.738 . . . . 0.0 111.256 -178.644 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' D' D ' -1' ' ' VAL . . . . . . . . . . . . . 41.7 t -96.45 135.35 30.86 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.337 0 N-CA-C 110.179 -0.304 . . . . 0.0 110.179 179.424 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' D' D ' 0' ' ' ILE . . . . . . . . . . . . . 45.9 mm -115.36 138.01 47.09 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.201 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.115 179.761 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' D' D ' 1' ' ' MET . . . . . . . . . . . . . 24.5 ptp -143.89 163.23 34.02 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.313 -0.403 . . . . 0.0 110.789 -179.435 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' D' D ' 2' ' ' SER . . . . . . . . . . . . . 99.1 p -114.71 157.06 23.67 Favored 'General case' 0 N--CA 1.462 0.149 0 CA-C-N 116.247 -0.433 . . . . 0.0 110.761 -178.357 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' D' D ' 3' ' ' GLU . . . . . . . . . . . . . 95.7 mt-10 -141.65 145.28 34.77 Favored 'General case' 0 C--N 1.331 -0.223 0 CA-C-N 116.031 -0.531 . . . . 0.0 111.246 -177.56 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' D' D ' 4' ' ' LEU . . . . . . . . . . . . . 15.4 tp -125.58 129.45 49.71 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-N 116.047 -0.524 . . . . 0.0 109.936 174.828 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' D' D ' 5' ' ' LYS . . . . . . . . . . . . . 52.4 mttm -110.63 123.63 50.37 Favored 'General case' 0 C--O 1.233 0.235 0 CA-C-O 120.71 0.291 . . . . 0.0 110.857 -179.248 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' D' D ' 6' ' ' LEU . . . . . . . . . . . . . 68.9 mt -116.63 144.57 44.24 Favored 'General case' 0 C--N 1.333 -0.148 0 CA-C-N 115.739 -0.664 . . . . 0.0 110.554 179.838 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' D' D ' 7' ' ' LYS . . . . . . . . . . . . . 55.3 tttm -126.93 141.84 41.79 Favored Pre-proline 0 CA--C 1.533 0.305 0 N-CA-C 109.704 -0.48 . . . . 0.0 109.704 175.293 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' D' D ' 8' ' ' PRO . . . . . . . . . . . . . 87.5 Cg_endo -91.4 144.15 3.17 Favored 'Trans proline' 0 N--CA 1.49 1.308 0 C-N-CA 121.645 1.563 . . . . 0.0 112.271 179.577 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' D' D ' 9' ' ' LEU . . . . . . . . . . . . . 49.6 mt -85.46 -47.17 0.61 Allowed Pre-proline 0 C--N 1.328 -0.334 0 CA-C-O 118.645 -0.693 . . . . 0.0 112.024 178.131 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' D' D ' 10' ' ' PRO . . . . . . . . . . . . . 86.4 Cg_endo -81.03 154.88 19.62 Favored 'Trans proline' 0 N--CA 1.495 1.605 0 C-N-CA 121.244 1.296 . . . . 0.0 111.8 175.956 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' D' D ' 11' ' ' LYS . . . . . . . . . . . . . 60.3 mttp -87.79 95.16 9.98 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-O 120.846 0.355 . . . . 0.0 110.654 178.824 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' D' D ' 12' ' ' VAL . . . . . . . . . . . . . 11.3 p -142.08 139.07 30.51 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.268 0 CA-C-N 116.133 -0.485 . . . . 0.0 110.303 178.691 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' D' D ' 13' ' ' GLU . . . . . . . . . . . . . 42.2 mp0 -82.5 127.15 33.04 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.311 -0.404 . . . . 0.0 110.06 178.313 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' D' D ' 14' ' ' LEU . . . . . . . . . . . . . 47.0 mt -93.68 149.69 37.53 Favored Pre-proline 0 C--N 1.329 -0.288 0 CA-C-O 119.207 -0.425 . . . . 0.0 110.27 -178.917 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' D' D ' 15' ' ' PRO . . . . . . . . . . . . . 25.6 Cg_exo -61.74 159.41 33.05 Favored 'Trans proline' 0 N--CA 1.497 1.7 0 C-N-CA 121.158 1.238 . . . . 0.0 111.381 177.007 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' D' D ' 16' ' ' PRO . . . . . . . . . . . . . 26.5 Cg_exo -60.78 -31.98 92.42 Favored 'Trans proline' 0 N--CA 1.497 1.731 0 C-N-CA 121.368 1.378 . . . . 0.0 112.362 -179.343 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' D' D ' 17' ' ' ASP . . . . . . . . . . . . . 10.2 p-10 -90.38 9.19 29.94 Favored 'General case' 0 CA--C 1.536 0.423 0 N-CA-C 113.166 0.802 . . . . 0.0 113.166 -178.506 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' D' D ' 18' ' ' PHE . . . . . . . . . . . . . 41.2 t80 -57.86 -46.73 84.38 Favored 'General case' 0 CA--C 1.522 -0.108 0 O-C-N 122.006 -0.434 . . . . 0.0 110.298 -176.915 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' D' D ' 19' ' ' VAL . . . . . . . . . . . . . 45.9 t -55.33 -44.25 74.67 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.259 0 CA-C-N 116.379 -0.373 . . . . 0.0 110.8 -177.555 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' D' D ' 20' ' ' ASP . . . . . . . . . . . . . 75.6 m-20 -59.87 -43.63 94.61 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-O 120.86 0.362 . . . . 0.0 110.965 -176.918 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' D' D ' 21' ' ' VAL . . . . . . . . . . . . . 48.9 t -64.62 -47.68 87.93 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.251 0 C-N-CA 120.817 -0.353 . . . . 0.0 110.54 -177.861 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' D' D ' 22' ' ' ILE . . . . . 0.544 HG22 HD12 ' D' ' 26' ' ' LEU . 47.1 mm -56.05 -44.4 78.47 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.282 0 CA-C-O 120.796 0.332 . . . . 0.0 110.557 179.3 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' D' D ' 23' ' ' ARG . . . . . . . . . . . . . 54.6 ttp180 -53.22 -52.29 59.4 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-O 120.848 0.356 . . . . 0.0 111.378 -179.662 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' D' D ' 24' ' ' ILE . . . . . . . . . . . . . 71.8 mt -59.08 -40.94 82.02 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.268 0 CA-C-N 116.232 -0.44 . . . . 0.0 111.404 -176.561 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' D' D ' 25' ' ' LYS . . . . . . . . . . . . . 55.8 mmtt -67.89 -39.88 83.57 Favored 'General case' 0 C--N 1.33 -0.279 0 N-CA-C 112.462 0.541 . . . . 0.0 112.462 -178.796 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' D' D ' 26' ' ' LEU . . . . . 0.544 HD12 HG22 ' D' ' 22' ' ' ILE . 76.2 mt -78.29 -39.29 40.31 Favored 'General case' 0 C--N 1.329 -0.284 0 N-CA-C 113.255 0.835 . . . . 0.0 113.255 -169.825 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' D' D ' 27' ' ' GLN . . . . . . . . . . . . . 16.8 pt20 -46.6 138.67 5.74 Favored 'General case' 0 N--CA 1.47 0.559 0 N-CA-C 112.742 0.645 . . . . 0.0 112.742 -175.81 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' D' D ' 28' ' ' GLY . . . . . . . . . . . . . . . 102.34 -26.3 24.71 Favored Glycine 0 CA--C 1.533 1.174 0 CA-C-N 115.638 -0.71 . . . . 0.0 112.297 -176.767 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' D' D ' 29' ' ' LYS . . . . . . . . . . . . . 61.5 mttm -98.45 155.19 17.37 Favored 'General case' 0 CA--C 1.528 0.105 0 CA-C-N 117.364 0.582 . . . . 0.0 111.045 178.191 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' D' D ' 30' ' ' THR . . . . . . . . . . . . . 55.5 m -107.2 138.72 42.87 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-N 116.155 -0.475 . . . . 0.0 109.906 175.937 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' D' D ' 31' ' ' VAL . . . . . . . . . . . . . 34.7 m -130.43 159.07 42.78 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.232 0 CA-C-O 120.817 0.341 . . . . 0.0 111.019 -178.016 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' D' D ' 32' ' ' ARG . . . . . . . . . . . . . 96.8 mtt180 -132.58 149.07 52.37 Favored 'General case' 0 C--N 1.332 -0.176 0 CA-C-N 115.934 -0.576 . . . . 0.0 110.662 178.65 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' D' D ' 33' ' ' THR . . . . . . . . . . . . . 18.7 m -52.96 140.4 24.93 Favored 'General case' 0 C--N 1.331 -0.23 0 CA-C-N 116.33 -0.396 . . . . 0.0 111.412 -179.387 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' D' D ' 34' ' ' GLY . . . . . . . . . . . . . . . 99.17 -17.1 58.48 Favored Glycine 0 CA--C 1.532 1.13 0 CA-C-O 119.62 -0.545 . . . . 0.0 113.274 179.335 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' D' D ' 35' ' ' ASP . . . . . . . . . . . . . 77.9 m-20 -66.61 148.9 51.26 Favored 'General case' 0 C--O 1.231 0.112 0 CA-C-N 118.037 0.919 . . . . 0.0 111.131 179.076 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' D' D ' 36' ' ' VAL . . . . . . . . . . . . . 45.5 t -119.56 128.7 75.88 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.213 0 CA-C-N 115.931 -0.577 . . . . 0.0 109.734 177.962 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' D' D ' 37' ' ' ILE . . . . . . . . . . . . . 63.3 mt -120.1 138.25 51.29 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.271 0 CA-C-N 116.158 -0.474 . . . . 0.0 109.83 -179.179 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' D' D ' 38' ' ' GLY . . . . . . . . . . . . . . . -118.38 128.86 7.91 Favored Glycine 0 CA--C 1.524 0.638 0 N-CA-C 111.058 -0.817 . . . . 0.0 111.058 -179.859 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' D' D ' 39' ' ' ILE . . . . . . . . . . . . . 68.0 mt -123.88 129.78 74.2 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.196 0 N-CA-C 110.026 -0.361 . . . . 0.0 110.026 178.808 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' D' D ' 40' ' ' SER . . . . . . . . . . . . . 20.3 t -92.09 117.42 29.82 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.142 -0.481 . . . . 0.0 110.734 176.453 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' D' D ' 41' ' ' ILE . . . . . . . . . . . . . 72.6 mt -131.95 122.56 49.43 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.232 0 CA-C-O 120.813 0.34 . . . . 0.0 110.095 178.376 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' D' D ' 42' ' ' LEU . . . . . . . . . . . . . 76.3 mt 58.3 34.9 24.48 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.023 -0.535 . . . . 0.0 111.506 179.012 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' D' D ' 43' ' ' GLY . . . . . . . . . . . . . . . 77.23 -10.15 22.8 Favored Glycine 0 CA--C 1.535 1.342 0 CA-C-O 119.785 -0.453 . . . . 0.0 113.427 178.123 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' D' D ' 44' ' ' LYS . . . . . . . . . . . . . 21.4 tptm -99.86 128.21 45.97 Favored 'General case' 0 C--N 1.332 -0.175 0 CA-C-N 117.915 0.858 . . . . 0.0 110.064 178.452 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' D' D ' 45' ' ' GLU . . . . . . . . . . . . . 85.0 tt0 -85.25 129.65 34.76 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.393 -0.367 . . . . 0.0 111.239 179.911 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' D' D ' 46' ' ' VAL . . . . . 0.423 HG13 ' O ' ' D' ' 46' ' ' VAL . 10.3 p -119.14 124.19 72.69 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.16 0 N-CA-C 109.654 -0.499 . . . . 0.0 109.654 174.82 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' D' D ' 47' ' ' LYS . . . . . . . . . . . . . 63.6 mttp -98.19 125.07 43.08 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.072 -0.513 . . . . 0.0 110.614 177.24 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' D' D ' 48' ' ' PHE . . . . . . . . . . . . . 40.0 m-85 -111.4 131.83 54.9 Favored 'General case' 0 C--N 1.329 -0.29 0 N-CA-C 109.481 -0.562 . . . . 0.0 109.481 176.985 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' D' D ' 49' ' ' LYS . . . . . . . . . . . . . 42.2 tttp -107.36 132.1 53.52 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.29 -0.413 . . . . 0.0 110.206 179.08 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' D' D ' 50' ' ' VAL . . . . . . . . . . . . . 41.9 t -74.86 105.03 3.59 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.289 0 N-CA-C 109.34 -0.615 . . . . 0.0 109.34 177.495 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' D' D ' 51' ' ' VAL . . . . . . . . . . . . . 51.4 t -72.3 -48.6 47.55 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.331 0 CA-C-N 116.182 -0.463 . . . . 0.0 109.996 -174.038 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' D' D ' 52' ' ' GLN . . . . . . . . . . . . . 60.2 tt0 -162.21 148.21 13.13 Favored 'General case' 0 C--N 1.329 -0.29 0 C-N-CA 120.242 -0.583 . . . . 0.0 111.757 -179.21 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' D' D ' 53' ' ' ALA . . . . . . . . . . . . . . . -126.33 134.47 51.09 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 115.597 -0.729 . . . . 0.0 110.117 177.892 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' D' D ' 54' ' ' TYR . . . . . . . . . . . . . 59.9 t80 -129.09 111.06 18.3 Favored Pre-proline 0 CA--C 1.535 0.376 0 CA-C-O 118.198 -0.906 . . . . 0.0 110.086 177.879 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' D' D ' 55' ' ' PRO . . . . . . . . . . . . . 72.5 Cg_endo -77.19 169.93 72.86 Favored 'Cis proline' 0 N--CA 1.5 1.887 0 CA-C-N 121.932 1.726 . . . . 0.0 112.643 -4.822 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' D' D ' 56' ' ' SER . . . . . . . . . . . . . 13.6 m -118.49 130.82 24.55 Favored Pre-proline 0 CA--C 1.539 0.545 0 CA-C-O 118.431 -0.795 . . . . 0.0 109.743 174.737 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' D' D ' 57' ' ' PRO . . . . . . . . . . . . . 32.9 Cg_endo -65.16 167.65 46.12 Favored 'Cis proline' 0 N--CA 1.498 1.753 0 CA-C-N 121.953 1.733 . . . . 0.0 111.147 -2.952 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' D' D ' 58' ' ' LEU . . . . . . . . . . . . . 14.9 tp -128.38 134.79 48.9 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-O 121.069 0.461 . . . . 0.0 110.255 -179.812 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' D' D ' 59' ' ' ARG . . . . . . . . . . . . . 58.6 ttt-85 -103.05 119.58 39.11 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 115.406 -0.815 . . . . 0.0 109.133 176.817 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' D' D ' 60' ' ' VAL . . . . . . . . . . . . . 40.6 t -74.17 117.07 17.57 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.315 0 C-N-CA 120.867 -0.333 . . . . 0.0 110.731 -172.939 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' D' D ' 61' ' ' GLU . . . . . . . . . . . . . 40.5 mt-10 -131.08 161.18 32.62 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 115.982 -0.554 . . . . 0.0 109.952 175.977 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' D' D ' 62' ' ' ASP . . . . . . . . . . . . . 61.6 m-20 -52.09 -31.43 30.44 Favored 'General case' 0 C--N 1.328 -0.33 0 N-CA-C 112.157 0.428 . . . . 0.0 112.157 -177.664 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' D' D ' 63' ' ' ARG . . . . . . . . . . . . . 78.3 mtp180 -72.58 -22.04 61.05 Favored 'General case' 0 CA--C 1.532 0.268 0 N-CA-C 113.091 0.775 . . . . 0.0 113.091 -174.607 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' D' D ' 64' ' ' THR . . . . . . . . . . . . . 34.5 m -71.2 140.39 50.45 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-O 120.888 0.375 . . . . 0.0 111.244 -175.118 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' D' D ' 65' ' ' LYS . . . . . . . . . . . . . 3.9 mptp? -90.06 138.76 31.24 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 115.85 -0.614 . . . . 0.0 110.261 178.196 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' D' D ' 66' ' ' ILE . . . . . . . . . . . . . 60.6 mt -114.1 128.25 71.15 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.231 0 N-CA-C 109.658 -0.497 . . . . 0.0 109.658 178.754 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' D' D ' 67' ' ' THR . . . . . . . . . . . . . 15.5 m -122.35 146.71 47.07 Favored 'General case' 0 C--N 1.332 -0.159 0 CA-C-O 121.233 0.54 . . . . 0.0 111.133 -176.253 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' D' D ' 68' ' ' LEU . . . . . . . . . . . . . 15.1 tp -102.38 140.46 36.63 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 115.647 -0.706 . . . . 0.0 110.765 -179.467 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' D' D ' 69' ' ' VAL . . . . . 0.4 HG12 ' N ' ' D' ' 70' ' ' THR . 46.6 t -82.93 155.3 3.85 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 CA-C-N 116.078 -0.51 . . . . 0.0 109.848 177.851 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' D' D ' 70' ' ' THR . . . . . 0.412 HG22 ' N ' ' D' ' 71' ' ' HIS . 7.6 m -79.62 158.82 26.99 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-O 121.116 0.484 . . . . 0.0 110.942 -174.01 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' D' D ' 71' ' ' HIS . . . . . 0.412 ' N ' HG22 ' D' ' 70' ' ' THR . 79.9 m80 -65.14 156.96 79.25 Favored Pre-proline 0 CA--C 1.534 0.352 0 CA-C-N 115.563 -0.744 . . . . 0.0 112.055 -173.578 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' D' D ' 72' ' ' PRO . . . . . . . . . . . . . 57.2 Cg_endo -71.97 160.17 48.35 Favored 'Trans proline' 0 N--CA 1.496 1.647 0 C-N-CA 121.704 1.603 . . . . 0.0 112.673 178.175 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' D' D ' 73' ' ' VAL . . . . . . . . . . . . . 33.5 m -69.82 -171.59 0.08 OUTLIER 'Isoleucine or valine' 0 C--N 1.33 -0.27 0 CA-C-N 116.122 -0.49 . . . . 0.0 110.124 179.898 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' D' D ' 74' ' ' ASP . . . . . . . . . . . . . 22.4 t0 -84.56 118.36 24.29 Favored 'General case' 0 C--N 1.33 -0.258 0 C-N-CA 120.601 -0.44 . . . . 0.0 110.295 -172.538 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' D' D ' 75' ' ' VAL . . . . . . . . . . . . . 39.4 t -122.22 121.93 65.15 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.271 0 CA-C-O 120.961 0.41 . . . . 0.0 110.659 -176.948 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' D' D ' 76' ' ' LEU . . . . . . . . . . . . . 5.8 mp -122.03 149.13 43.94 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 115.735 -0.666 . . . . 0.0 109.39 174.861 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' D' D ' 77' ' ' GLU . . . . . . . . . . . . . 96.5 mt-10 -136.68 137.12 39.67 Favored 'General case' 0 C--N 1.332 -0.189 0 CA-C-O 121.16 0.505 . . . . 0.0 111.516 -176.644 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' D' D ' 78' ' ' ALA . . . . . . . . . . . . . . . -123.58 135.37 53.94 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 115.587 -0.733 . . . . 0.0 109.414 175.156 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' D' D ' 79' ' ' LYS . . . . . 0.597 ' O ' HD13 ' D' ' 80' ' ' ILE . 59.4 mtpt -82.73 120.63 25.84 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-O 120.907 0.384 . . . . 0.0 111.129 -176.42 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' D' D ' 80' ' ' ILE . . . . . 0.597 HD13 ' O ' ' D' ' 79' ' ' LYS . 40.2 mm -139.19 105.8 2.63 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.305 0 N-CA-C 109.103 -0.703 . . . . 0.0 109.103 -178.769 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' D' D ' 81' ' ' LYS . . . . . . . . . . . . . 19.2 pttp -98.14 128.69 44.77 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-O 120.869 0.366 . . . . 0.0 111.225 -176.544 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' D' D ' 82' ' ' GLY . . . . . . . . . . . . . . . 89.21 41.99 5.69 Favored Glycine 0 CA--C 1.524 0.651 0 C-N-CA 120.685 -0.769 . . . . 0.0 111.52 176.2 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' D' D ' 83' ' ' ILE . . . . . . . . . . . . . 71.7 mt -65.3 139.25 21.67 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.328 0 CA-C-O 121.009 0.433 . . . . 0.0 110.046 178.86 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' D' D ' 84' ' ' LYS . . . . . . . . . . . . . 59.5 tttm -99.17 -53.93 3.11 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 115.89 -0.595 . . . . 0.0 109.906 -179.609 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' D' D ' 85' ' ' ASP . . . . . . . . . . . . . 13.4 t70 -156.7 150.11 24.37 Favored 'General case' 0 C--N 1.326 -0.42 0 CA-C-N 115.646 -0.706 . . . . 0.0 110.187 -179.991 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' D' D ' 86' ' ' VAL . . . . . . . . . . . . . 42.8 t -128.41 128.74 68.6 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.279 0 CA-C-O 120.93 0.395 . . . . 0.0 110.41 -179.227 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' D' D ' 87' ' ' ILE . . . . . . . . . . . . . 44.1 mm -118.08 127.63 75.26 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.284 0 CA-C-N 115.824 -0.626 . . . . 0.0 109.488 176.679 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' D' D ' 88' ' ' LEU . . . . . . . . . . . . . 18.7 tp -112.74 133.65 54.65 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-O 121.137 0.494 . . . . 0.0 111.123 -177.64 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' D' D ' 89' ' ' ASP . . . . . . . . . . . . . 10.7 t70 -125.35 158.51 34.07 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 115.587 -0.733 . . . . 0.0 109.431 176.256 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' D' D ' 90' ' ' GLU . . . . . . . . . . . . . 96.0 mt-10 -46.74 -37.74 8.96 Favored 'General case' 0 C--N 1.331 -0.237 0 N-CA-C 113.17 0.804 . . . . 0.0 113.17 -172.138 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' D' D ' 91' ' ' ASN . . . . . . . . . . . . . 4.7 p-10 -132.04 23.35 4.54 Favored 'General case' 0 N--CA 1.467 0.413 0 N-CA-C 112.815 0.672 . . . . 0.0 112.815 -177.747 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' D' D ' 92' ' ' LEU . . . . . . . . . . . . . 16.5 mt -148.97 144.45 26.79 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-O 120.858 0.361 . . . . 0.0 110.56 -176.522 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' D' D ' 93' ' ' ILE . . . . . . . . . . . . . 71.4 mt -122.6 115.31 45.61 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.316 0 N-CA-C 109.224 -0.658 . . . . 0.0 109.224 176.728 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' D' D ' 94' ' ' VAL . . . . . . . . . . . . . 44.9 t -117.06 123.0 71.31 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.267 0 N-CA-C 109.867 -0.42 . . . . 0.0 109.867 -178.932 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' D' D ' 95' ' ' VAL . . . . . . . . . . . . . 42.0 t -120.18 133.75 65.89 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.236 0 CA-C-N 116.021 -0.536 . . . . 0.0 110.025 -178.039 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' D' D ' 96' ' ' ILE . . . . . . . . . . . . . 56.1 mt -113.88 130.76 67.46 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 N-CA-C 109.124 -0.695 . . . . 0.0 109.124 177.145 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' D' D ' 97' ' ' THR . . . . . . . . . . . . . 68.6 p -103.48 157.18 17.21 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-O 120.872 0.368 . . . . 0.0 110.988 -178.638 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' D' D ' 98' ' ' GLU . . . . . . . . . . . . . 97.4 mt-10 -53.89 -22.89 10.96 Favored 'General case' 0 CA--C 1.535 0.375 0 N-CA-C 112.307 0.484 . . . . 0.0 112.307 179.121 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' D' D ' 99' ' ' GLU . . . . . . . . . . . . . 95.6 mt-10 -77.49 12.55 1.54 Allowed 'General case' 0 CA--C 1.536 0.441 0 N-CA-C 113.208 0.818 . . . . 0.0 113.208 -178.714 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' D' D ' 100' ' ' ASN . . . . . . . . . . . . . 3.0 m-20 61.85 37.46 15.36 Favored 'General case' 0 CA--C 1.531 0.217 0 CA-C-O 121.023 0.439 . . . . 0.0 110.979 179.833 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' D' D ' 101' ' ' GLU . . . . . . . . . . . . . 85.4 tt0 -116.84 145.63 43.43 Favored 'General case' 0 C--N 1.333 -0.137 0 CA-C-N 116.086 -0.506 . . . . 0.0 109.886 176.239 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' D' D ' 102' ' ' VAL . . . . . . . . . . . . . 42.9 t -117.64 127.1 75.07 Favored 'Isoleucine or valine' 0 C--O 1.233 0.224 0 CA-C-N 116.277 -0.42 . . . . 0.0 109.929 -178.284 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' D' D ' 103' ' ' LEU . . . . . . . . . . . . . 63.0 mt -119.57 134.61 55.15 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 115.991 -0.549 . . . . 0.0 110.511 178.058 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' D' D ' 104' ' ' ILE . . . . . . . . . . . . . 66.1 mt -120.99 120.18 61.52 Favored 'Isoleucine or valine' 0 C--O 1.234 0.252 0 CA-C-N 116.567 -0.288 . . . . 0.0 110.513 -179.09 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' D' D ' 105' ' ' PHE . . . . . . . . . . . . . 54.2 m-85 -120.53 167.71 12.11 Favored 'General case' 0 N--CA 1.462 0.146 0 O-C-N 124.066 0.854 . . . . 0.0 109.829 177.707 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' D' D ' 106' ' ' ASN . . . . . . . . . . . . . 47.5 p-10 -104.04 -170.39 1.77 Allowed 'General case' 0 CA--C 1.532 0.264 0 N-CA-C 110.221 -0.288 . . . . 0.0 110.221 173.091 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' D' D ' 107' ' ' GLN . . . . . . . . . . . . . 61.7 tt0 -57.75 -29.85 65.12 Favored 'General case' 0 CA--C 1.532 0.286 0 N-CA-C 111.97 0.359 . . . . 0.0 111.97 178.987 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' D' D ' 108' ' ' ASN . . . . . . . . . . . . . 10.2 t-20 -86.52 12.7 9.81 Favored 'General case' 0 CA--C 1.535 0.367 0 N-CA-C 112.922 0.712 . . . . 0.0 112.922 -176.681 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' D' D ' 109' ' ' LEU . . . . . . . . . . . . . 26.4 mt 56.76 32.34 21.06 Favored 'General case' 0 CA--C 1.53 0.211 0 N-CA-C 111.75 0.278 . . . . 0.0 111.75 179.356 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' D' D ' 110' ' ' GLU . . . . . . . . . . . . . 69.3 mm-40 -98.27 143.38 28.81 Favored 'General case' 0 C--N 1.33 -0.28 0 N-CA-C 109.258 -0.645 . . . . 0.0 109.258 175.372 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' D' D ' 111' ' ' GLU . . . . . . . . . . . . . 58.9 tt0 -83.33 121.88 27.72 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-O 121.082 0.467 . . . . 0.0 110.344 -177.162 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' D' D ' 112' ' ' LEU . . . . . . . . . . . . . 23.7 mt -104.31 -45.83 4.57 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 115.816 -0.629 . . . . 0.0 110.413 -178.759 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' D' D ' 113' ' ' TYR . . . . . . . . . . . . . 61.1 t80 -140.39 140.75 35.56 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.096 -0.502 . . . . 0.0 111.008 -178.361 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' D' D ' 114' ' ' ARG . . . . . . . . . . . . . 35.6 ptt-85 -142.21 125.41 16.41 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.305 -0.407 . . . . 0.0 110.489 176.427 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' D' D ' 115' ' ' GLY . . . . . . . . . . . . . . . -150.14 159.79 28.26 Favored Glycine 0 CA--C 1.522 0.522 0 N-CA-C 110.691 -0.964 . . . . 0.0 110.691 179.203 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' D' D ' 116' ' ' LYS . . . . . . . . . . . . . 2.1 ttmp? -127.84 138.95 52.88 Favored 'General case' 0 C--N 1.329 -0.312 0 N-CA-C 110.027 -0.361 . . . . 0.0 110.027 177.566 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' D' D ' 117' ' ' PHE . . . . . . . . . . . . . 43.8 m-85 -135.68 113.89 11.43 Favored 'General case' 0 C--N 1.331 -0.23 0 CA-C-N 116.207 -0.451 . . . . 0.0 109.895 -177.032 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' D' D ' 118' ' ' GLU . . . . . . . . . . . . . 70.8 mm-40 -54.69 -42.66 71.68 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.448 -0.342 . . . . 0.0 111.294 -176.3 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' D' D ' 119' ' ' ASN . . . . . . . . . . . . . 19.9 m120 -100.94 31.03 3.75 Favored 'General case' 0 C--N 1.331 -0.227 0 N-CA-C 112.188 0.44 . . . . 0.0 112.188 -174.287 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' D' D ' 120' ' ' LEU . . . . . . . . . . . . . 16.3 tp -56.96 121.1 9.14 Favored 'General case' 0 N--CA 1.462 0.167 0 C-N-CA 121.009 -0.276 . . . . 0.0 110.345 177.727 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' D' D ' 121' ' ' ASN . . . . . . . . . . . . . 60.5 m-20 -114.2 -44.06 3.16 Favored 'General case' 0 C--N 1.332 -0.154 0 CA-C-N 116.678 -0.237 . . . . 0.0 111.26 -176.898 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' D' D ' 122' ' ' LYS . . . . . 0.446 ' HE3' HD11 ' D' ' 124' ' ' LEU . 39.0 ttpt -144.82 143.12 30.47 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-O 120.953 0.406 . . . . 0.0 111.343 -175.976 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' D' D ' 123' ' ' VAL . . . . . . . . . . . . . 43.6 t -128.77 134.23 64.8 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.219 0 CA-C-N 116.172 -0.467 . . . . 0.0 109.762 177.18 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' D' D ' 124' ' ' LEU . . . . . 0.446 HD11 ' HE3' ' D' ' 122' ' ' LYS . 59.0 mt -129.51 135.27 48.41 Favored 'General case' 0 C--N 1.331 -0.196 0 CA-C-O 120.815 0.341 . . . . 0.0 110.949 -179.048 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' D' D ' 125' ' ' VAL . . . . . . . . . . . . . 10.6 p -132.33 131.12 60.67 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.274 0 CA-C-N 116.11 -0.496 . . . . 0.0 109.958 177.526 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' D' D ' 126' ' ' ARG . . . . . . . . . . . . . 53.8 ttm-85 -143.08 116.04 8.83 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.462 -0.335 . . . . 0.0 110.815 -178.72 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' D' D ' 127' ' ' ASN . . . . . . . . . . . . . 3.1 m120 51.97 -105.0 0.2 Allowed 'General case' 0 CA--C 1.544 0.721 0 CA-C-O 119.172 -0.442 . . . . 0.0 111.323 178.214 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' D' D ' 128' ' ' ASP . . . . . . . . . . . . . 19.1 p-10 -113.9 3.95 15.62 Favored 'General case' 0 CA--C 1.538 0.496 0 CA-C-N 119.42 1.009 . . . . 0.0 113.426 -176.208 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' D' D ' 129' ' ' LEU . . . . . . . . . . . . . 21.6 tp -110.43 137.01 48.71 Favored 'General case' 0 C--N 1.331 -0.222 0 CA-C-N 118.047 0.385 . . . . 0.0 110.05 178.857 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' D' D ' 130' ' ' VAL . . . . . . . . . . . . . 54.6 t -124.99 137.25 58.2 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.284 0 CA-C-O 120.833 0.349 . . . . 0.0 110.15 -179.475 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' D' D ' 131' ' ' VAL . . . . . . . . . . . . . 42.9 t -135.98 136.27 49.84 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.274 0 CA-C-N 116.271 -0.422 . . . . 0.0 110.363 179.698 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' D' D ' 132' ' ' ILE . . . . . . . . . . . . . 74.1 mt -119.33 133.37 66.35 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.298 0 N-CA-C 109.52 -0.548 . . . . 0.0 109.52 178.784 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' D' D ' 133' ' ' ILE . . . . . . . . . . . . . 40.4 mm -119.12 124.3 72.88 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.223 0 CA-C-O 120.829 0.347 . . . . 0.0 111.315 -174.831 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' D' D ' 134' ' ' ASP . . . . . . . . . . . . . 9.7 p-10 -137.68 150.1 47.07 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-N 116.307 -0.406 . . . . 0.0 109.932 173.637 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' D' D ' 135' ' ' GLU . . . . . . . . . . . . . 86.0 tt0 -49.77 -22.93 1.57 Allowed 'General case' 0 C--N 1.328 -0.359 0 N-CA-C 113.067 0.765 . . . . 0.0 113.067 -174.21 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' D' D ' 136' ' ' GLN . . . . . . . . . . . . . 63.1 tt0 -93.16 -28.76 16.11 Favored 'General case' 0 C--O 1.234 0.265 0 N-CA-C 112.384 0.512 . . . . 0.0 112.384 -174.004 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' D' D ' 137' ' ' LYS . . . . . . . . . . . . . 47.7 pttt -166.04 170.58 13.4 Favored 'General case' 0 C--N 1.332 -0.185 0 CA-C-O 121.55 0.69 . . . . 0.0 112.317 -172.849 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' D' D ' 138' ' ' LEU . . . . . 0.406 HD23 ' N ' ' D' ' 139' ' ' THR . 5.6 tt -121.96 128.61 51.7 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 114.882 -1.053 . . . . 0.0 109.836 178.797 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' D' D ' 139' ' ' THR . . . . . 0.406 ' N ' HD23 ' D' ' 138' ' ' LEU . 26.4 m -109.69 132.65 53.95 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-N 116.198 -0.455 . . . . 0.0 110.629 -179.254 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' D' D ' 140' ' ' LEU . . . . . 0.464 HD21 ' O ' ' E' ' 107' ' ' GLN . 12.1 tp -118.58 124.14 46.74 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 115.583 -0.735 . . . . 0.0 109.381 -178.425 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' D' D ' 141' ' ' ILE . . . . . . . . . . . . . 19.6 mt -120.48 119.62 60.32 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.344 0 N-CA-C 109.87 -0.418 . . . . 0.0 109.87 -175.795 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' D' D ' 142' ' ' ARG . . . . . . . . . . . . . 7.8 mmm180 -109.03 126.13 52.81 Favored 'General case' 0 C--N 1.331 -0.227 0 CA-C-N 115.496 -0.775 . . . . 0.0 110.508 -177.857 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' D' D ' 143' ' ' THR . . . . . . . . . . . . . 49.5 p . . . . . 0 C--O 1.219 -0.501 0 CA-C-O 117.998 -1.001 . . . . 0.0 110.627 -179.864 . . . . . . . . 0 0 . 1 . 010 nuclear build full ' E' E ' -3' ' ' GLU . . . . . . . . . . . . . 95.7 mt-10 . . . . . 0 N--CA 1.491 1.578 0 N-CA-C 109.289 -0.634 . . . . 0.0 109.289 . . . . . . . . . 0 0 . 1 . 010 nuclear build full ' E' E ' -2' ' ' GLY . . . . . . . . . . . . . . . -73.35 120.82 7.24 Favored Glycine 0 CA--C 1.524 0.654 0 N-CA-C 110.894 -0.882 . . . . 0.0 110.894 179.463 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' E' E ' -1' ' ' VAL . . . . . . . . . . . . . 40.8 t -96.41 136.15 28.19 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.273 0 N-CA-C 110.17 -0.307 . . . . 0.0 110.17 179.849 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' E' E ' 0' ' ' ILE . . . . . . . . . . . . . 70.5 mt -104.35 135.87 40.22 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.321 0 N-CA-C 109.936 -0.394 . . . . 0.0 109.936 -179.588 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' E' E ' 1' ' ' MET . . . . . . . . . . . . . 24.3 ptp -143.46 154.0 43.21 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.044 -0.526 . . . . 0.0 110.66 -178.342 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' E' E ' 2' ' ' SER . . . . . . . . . . . . . 94.5 p -116.97 152.12 35.25 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-O 121.106 0.479 . . . . 0.0 110.637 -179.771 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' E' E ' 3' ' ' GLU . . . . . . . . . . . . . 82.4 tt0 -140.63 143.99 35.49 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 115.935 -0.575 . . . . 0.0 110.851 -177.842 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' E' E ' 4' ' ' LEU . . . . . . . . . . . . . 20.6 tp -124.86 130.87 53.24 Favored 'General case' 0 C--N 1.331 -0.216 0 CA-C-N 116.016 -0.538 . . . . 0.0 110.176 177.673 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' E' E ' 5' ' ' LYS . . . . . . . . . . . . . 61.3 mttp -108.44 121.84 45.78 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-O 120.876 0.37 . . . . 0.0 110.616 178.856 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' E' E ' 6' ' ' LEU . . . . . . . . . . . . . 67.2 mt -114.05 150.21 34.31 Favored 'General case' 0 C--N 1.331 -0.217 0 CA-C-N 115.548 -0.751 . . . . 0.0 110.702 -179.982 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' E' E ' 7' ' ' LYS . . . . . . . . . . . . . 84.6 tttt -140.46 140.11 22.06 Favored Pre-proline 0 CA--C 1.534 0.354 0 CA-C-O 119.09 -0.481 . . . . 0.0 110.02 175.189 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' E' E ' 8' ' ' PRO . . . . . . . . . . . . . 95.2 Cg_endo -92.01 143.7 2.76 Favored 'Trans proline' 0 N--CA 1.49 1.315 0 C-N-CA 121.765 1.643 . . . . 0.0 111.73 177.593 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' E' E ' 9' ' ' LEU . . . . . . . . . . . . . 60.7 mt -78.36 -47.51 1.99 Allowed Pre-proline 0 CA--C 1.533 0.298 0 CA-C-O 118.715 -0.66 . . . . 0.0 112.242 -179.257 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' E' E ' 10' ' ' PRO . . . . . . . . . . . . . 92.9 Cg_endo -80.36 153.84 21.26 Favored 'Trans proline' 0 N--CA 1.496 1.63 0 C-N-CA 121.067 1.178 . . . . 0.0 111.904 176.129 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' E' E ' 11' ' ' LYS . . . . . . . . . . . . . 55.7 mtmt -88.35 98.95 11.89 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.376 -0.374 . . . . 0.0 110.604 179.312 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' E' E ' 12' ' ' VAL . . . . . . . . . . . . . 11.2 p -145.06 144.04 21.91 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.294 0 CA-C-N 116.111 -0.495 . . . . 0.0 110.357 -179.718 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' E' E ' 13' ' ' GLU . . . . . . . . . . . . . 95.4 mt-10 -85.02 121.51 27.9 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.176 -0.465 . . . . 0.0 109.972 177.774 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' E' E ' 14' ' ' LEU . . . . . . . . . . . . . 20.0 mt -93.62 156.5 39.58 Favored Pre-proline 0 C--N 1.329 -0.323 0 CA-C-N 116.349 -0.387 . . . . 0.0 110.784 -177.188 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' E' E ' 15' ' ' PRO . . . . . . . . . . . . . 27.0 Cg_exo -60.73 155.07 50.8 Favored 'Trans proline' 0 N--CA 1.496 1.625 0 C-N-CA 121.354 1.369 . . . . 0.0 111.764 179.614 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' E' E ' 16' ' ' PRO . . . . . . . . . . . . . 32.3 Cg_exo -57.63 -36.48 98.51 Favored 'Trans proline' 0 N--CA 1.497 1.689 0 C-N-CA 121.328 1.352 . . . . 0.0 112.572 179.598 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' E' E ' 17' ' ' ASP . . . . . . . . . . . . . 8.8 p-10 -88.74 13.78 11.65 Favored 'General case' 0 CA--C 1.535 0.389 0 N-CA-C 113.027 0.751 . . . . 0.0 113.027 -177.74 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' E' E ' 18' ' ' PHE . . . . . . . . . . . . . 40.8 t80 -58.43 -44.37 89.08 Favored 'General case' 0 C--N 1.333 -0.134 0 O-C-N 121.968 -0.457 . . . . 0.0 110.198 -178.599 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' E' E ' 19' ' ' VAL . . . . . 0.44 HG13 ' N ' ' E' ' 20' ' ' ASP . 14.4 p -58.42 -46.42 89.46 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.354 0 CA-C-N 116.459 -0.337 . . . . 0.0 111.807 -174.83 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' E' E ' 20' ' ' ASP . . . . . 0.44 ' N ' HG13 ' E' ' 19' ' ' VAL . 2.7 p-10 -64.75 -36.17 83.44 Favored 'General case' 0 N--CA 1.463 0.224 0 C-N-CA 120.655 -0.418 . . . . 0.0 111.169 -177.383 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' E' E ' 21' ' ' VAL . . . . . . . . . . . . . 48.2 t -63.95 -48.19 87.2 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.217 0 C-N-CA 120.632 -0.427 . . . . 0.0 110.193 179.374 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' E' E ' 22' ' ' ILE . . . . . 0.483 HG22 HD12 ' E' ' 26' ' ' LEU . 51.0 mm -56.17 -43.09 75.15 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.216 0 C-N-CA 121.019 -0.272 . . . . 0.0 110.416 177.321 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' E' E ' 23' ' ' ARG . . . . . . . . . . . . . 43.2 ttp180 -52.1 -51.11 59.84 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-O 120.723 0.297 . . . . 0.0 111.498 -179.457 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' E' E ' 24' ' ' ILE . . . . . . . . . . . . . 70.3 mt -59.78 -41.69 86.4 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.256 0 CA-C-N 116.471 -0.331 . . . . 0.0 110.963 -179.047 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' E' E ' 25' ' ' LYS . . . . . . . . . . . . . 60.6 mtpt -62.98 -41.85 99.68 Favored 'General case' 0 C--N 1.327 -0.388 0 N-CA-C 112.076 0.399 . . . . 0.0 112.076 -178.598 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' E' E ' 26' ' ' LEU . . . . . 0.483 HD12 HG22 ' E' ' 22' ' ' ILE . 72.4 mt -80.42 -39.65 27.88 Favored 'General case' 0 C--N 1.33 -0.256 0 N-CA-C 113.27 0.841 . . . . 0.0 113.27 -170.916 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' E' E ' 27' ' ' GLN . . . . . . . . . . . . . 11.5 pt20 -46.59 135.08 8.93 Favored 'General case' 0 N--CA 1.468 0.462 0 N-CA-C 113.003 0.742 . . . . 0.0 113.003 -174.768 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' E' E ' 28' ' ' GLY . . . . . . . . . . . . . . . 100.44 -21.79 42.68 Favored Glycine 0 CA--C 1.534 1.251 0 CA-C-N 115.523 -0.762 . . . . 0.0 112.719 -178.416 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' E' E ' 29' ' ' LYS . . . . . . . . . . . . . 65.6 mttm -98.79 155.12 17.52 Favored 'General case' 0 C--O 1.232 0.177 0 CA-C-N 117.512 0.656 . . . . 0.0 111.29 -179.767 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' E' E ' 30' ' ' THR . . . . . . . . . . . . . 38.1 m -104.07 133.64 48.66 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 115.901 -0.591 . . . . 0.0 109.73 175.223 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' E' E ' 31' ' ' VAL . . . . . . . . . . . . . 33.6 m -131.72 154.91 41.14 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.211 0 CA-C-O 121.03 0.443 . . . . 0.0 111.343 -176.984 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' E' E ' 32' ' ' ARG . . . . . . . . . . . . . 55.7 mtp180 -132.25 152.33 51.4 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 115.771 -0.65 . . . . 0.0 110.436 177.553 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' E' E ' 33' ' ' THR . . . . . . . . . . . . . 20.5 m -53.18 139.68 28.36 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.271 -0.422 . . . . 0.0 111.322 -179.121 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' E' E ' 34' ' ' GLY . . . . . . . . . . . . . . . 100.82 -17.28 56.61 Favored Glycine 0 CA--C 1.532 1.126 0 CA-C-O 119.608 -0.551 . . . . 0.0 113.279 179.709 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' E' E ' 35' ' ' ASP . . . . . . . . . . . . . 66.7 m-20 -65.93 149.58 49.99 Favored 'General case' 0 C--O 1.231 0.131 0 CA-C-N 118.036 0.918 . . . . 0.0 110.998 179.059 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' E' E ' 36' ' ' VAL . . . . . . . . . . . . . 46.4 t -122.1 131.75 72.48 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.196 0 CA-C-N 115.911 -0.586 . . . . 0.0 110.134 179.825 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' E' E ' 37' ' ' ILE . . . . . . . . . . . . . 67.7 mt -119.92 139.02 48.62 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.245 0 CA-C-N 116.086 -0.506 . . . . 0.0 109.797 178.637 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' E' E ' 38' ' ' GLY . . . . . . . . . . . . . . . -113.48 128.99 8.6 Favored Glycine 0 CA--C 1.526 0.741 0 N-CA-C 111.139 -0.784 . . . . 0.0 111.139 -179.614 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' E' E ' 39' ' ' ILE . . . . . . . . . . . . . 72.1 mt -123.43 135.78 62.15 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.186 0 N-CA-C 110.015 -0.365 . . . . 0.0 110.015 178.656 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' E' E ' 40' ' ' SER . . . . . . . . . . . . . 30.0 t -92.67 123.02 35.65 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.225 -0.443 . . . . 0.0 110.835 175.8 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' E' E ' 41' ' ' ILE . . . . . . . . . . . . . 71.4 mt -131.34 114.57 26.36 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.214 0 N-CA-C 110.08 -0.341 . . . . 0.0 110.08 177.69 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' E' E ' 42' ' ' LEU . . . . . . . . . . . . . 84.4 mt 58.11 33.28 23.01 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.038 -0.528 . . . . 0.0 111.797 178.893 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' E' E ' 43' ' ' GLY . . . . . . . . . . . . . . . 83.24 -10.18 59.18 Favored Glycine 0 CA--C 1.535 1.283 0 C-N-CA 121.156 -0.545 . . . . 0.0 113.497 177.018 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' E' E ' 44' ' ' LYS . . . . . . . . . . . . . 64.6 mttp -98.46 136.18 38.96 Favored 'General case' 0 C--N 1.333 -0.115 0 CA-C-N 117.892 0.846 . . . . 0.0 110.271 177.785 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' E' E ' 45' ' ' GLU . . . . . . . . . . . . . 84.3 tt0 -85.26 128.87 34.85 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-N 116.464 -0.334 . . . . 0.0 111.373 179.946 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' E' E ' 46' ' ' VAL . . . . . . . . . . . . . 7.4 p -121.8 126.33 74.47 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.18 0 N-CA-C 109.457 -0.571 . . . . 0.0 109.457 174.697 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' E' E ' 47' ' ' LYS . . . . . . . . . . . . . 61.6 mttm -100.06 129.18 46.08 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-N 116.052 -0.522 . . . . 0.0 111.162 179.004 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' E' E ' 48' ' ' PHE . . . . . . . . . . . . . 92.6 m-85 -111.43 131.93 54.83 Favored 'General case' 0 C--N 1.332 -0.182 0 CA-C-N 116.28 -0.418 . . . . 0.0 109.954 176.28 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' E' E ' 49' ' ' LYS . . . . . . . . . . . . . 54.8 tttp -107.68 137.17 46.17 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.464 -0.335 . . . . 0.0 110.564 179.368 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' E' E ' 50' ' ' VAL . . . . . . . . . . . . . 45.6 t -79.92 108.25 13.2 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.25 0 N-CA-C 109.258 -0.645 . . . . 0.0 109.258 174.894 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' E' E ' 51' ' ' VAL . . . . . . . . . . . . . 48.7 t -71.46 -47.62 57.74 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.326 0 CA-C-N 116.223 -0.444 . . . . 0.0 110.004 -173.795 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' E' E ' 52' ' ' GLN . . . . . . . . . . . . . 62.3 tt0 -166.13 143.83 5.45 Favored 'General case' 0 C--N 1.329 -0.307 0 C-N-CA 120.441 -0.504 . . . . 0.0 111.847 -178.952 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' E' E ' 53' ' ' ALA . . . . . . . . . . . . . . . -119.66 134.11 55.36 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 115.915 -0.584 . . . . 0.0 109.774 175.599 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' E' E ' 54' ' ' TYR . . . . . . . . . . . . . 10.9 t80 -129.1 112.33 18.42 Favored Pre-proline 0 CA--C 1.534 0.348 0 CA-C-O 118.191 -0.909 . . . . 0.0 110.028 177.917 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' E' E ' 55' ' ' PRO . . . . . . . . . . . . . 71.7 Cg_endo -77.2 170.17 72.2 Favored 'Cis proline' 0 N--CA 1.5 1.911 0 CA-C-N 122.002 1.751 . . . . 0.0 112.527 -5.94 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' E' E ' 56' ' ' SER . . . . . . . . . . . . . 15.8 m -123.47 139.02 31.12 Favored Pre-proline 0 CA--C 1.539 0.545 0 CA-C-O 118.553 -0.737 . . . . 0.0 109.443 174.06 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' E' E ' 57' ' ' PRO . . . . . . . . . . . . . 37.6 Cg_endo -67.45 145.2 73.48 Favored 'Cis proline' 0 N--CA 1.498 1.773 0 CA-C-N 121.616 1.613 . . . . 0.0 111.53 -3.128 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' E' E ' 58' ' ' LEU . . . . . . . . . . . . . 16.2 tp -107.99 139.05 43.19 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-O 120.999 0.428 . . . . 0.0 110.837 -177.331 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' E' E ' 59' ' ' ARG . . . . . . . . . . . . . 21.3 ttm180 -102.45 122.54 44.52 Favored 'General case' 0 C--N 1.327 -0.389 0 N-CA-C 108.985 -0.746 . . . . 0.0 108.985 173.393 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' E' E ' 60' ' ' VAL . . . . . . . . . . . . . 45.6 t -81.55 119.17 30.62 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.35 0 C-N-CA 120.689 -0.404 . . . . 0.0 110.634 -174.281 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' E' E ' 61' ' ' GLU . . . . . . . . . . . . . 95.5 mt-10 -131.19 160.96 33.3 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 115.765 -0.652 . . . . 0.0 109.71 175.422 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' E' E ' 62' ' ' ASP . . . . . . . . . . . . . 10.9 p-10 -52.77 -29.93 30.08 Favored 'General case' 0 C--N 1.328 -0.363 0 N-CA-C 112.067 0.395 . . . . 0.0 112.067 -179.302 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' E' E ' 63' ' ' ARG . . . . . . . . . . . . . 60.0 mtp180 -72.35 -22.06 61.22 Favored 'General case' 0 CA--C 1.533 0.295 0 N-CA-C 113.002 0.742 . . . . 0.0 113.002 -175.616 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' E' E ' 64' ' ' THR . . . . . . . . . . . . . 36.8 m -66.7 142.27 57.48 Favored 'General case' 0 C--N 1.331 -0.225 0 CA-C-O 120.983 0.421 . . . . 0.0 110.913 -176.444 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' E' E ' 65' ' ' LYS . . . . . . . . . . . . . 46.6 mtmt -88.4 129.52 35.4 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 115.938 -0.574 . . . . 0.0 109.912 177.684 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' E' E ' 66' ' ' ILE . . . . . . . . . . . . . 60.7 mt -113.54 126.65 71.03 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.347 0 N-CA-C 109.976 -0.379 . . . . 0.0 109.976 -178.089 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' E' E ' 67' ' ' THR . . . . . . . . . . . . . 25.8 m -127.14 149.73 49.82 Favored 'General case' 0 C--N 1.331 -0.226 0 CA-C-O 121.147 0.498 . . . . 0.0 111.112 -176.896 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' E' E ' 68' ' ' LEU . . . . . . . . . . . . . 72.3 mt -106.46 147.15 29.67 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 115.909 -0.587 . . . . 0.0 110.791 179.543 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' E' E ' 69' ' ' VAL . . . . . . . . . . . . . 45.9 t -82.83 155.23 3.87 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.281 0 CA-C-N 115.906 -0.588 . . . . 0.0 109.731 177.208 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' E' E ' 70' ' ' THR . . . . . . . . . . . . . 69.8 p -79.49 162.85 25.16 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-O 121.108 0.48 . . . . 0.0 111.033 -172.959 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' E' E ' 71' ' ' HIS . . . . . . . . . . . . . 48.4 m80 -75.84 168.47 27.48 Favored Pre-proline 0 CA--C 1.533 0.311 0 CA-C-N 115.544 -0.753 . . . . 0.0 111.676 -174.982 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' E' E ' 72' ' ' PRO . . . . . . . . . . . . . 18.6 Cg_exo -65.04 160.16 43.02 Favored 'Trans proline' 0 N--CA 1.495 1.594 0 C-N-CA 121.7 1.6 . . . . 0.0 112.132 177.513 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' E' E ' 73' ' ' VAL . . . . . . . . . . . . . 32.6 m -69.77 165.12 2.67 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.279 0 CA-C-N 116.124 -0.489 . . . . 0.0 110.634 -176.894 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' E' E ' 74' ' ' ASP . . . . . . . . . . . . . 42.1 t0 -93.3 122.54 35.8 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-N 116.348 -0.387 . . . . 0.0 110.264 -175.607 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' E' E ' 75' ' ' VAL . . . . . . . . . . . . . 41.3 t -116.97 123.34 71.71 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.237 0 CA-C-O 121.051 0.453 . . . . 0.0 110.345 -178.845 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' E' E ' 76' ' ' LEU . . . . . . . . . . . . . 20.4 mt -123.82 148.73 46.47 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 115.659 -0.701 . . . . 0.0 109.64 178.518 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' E' E ' 77' ' ' GLU . . . . . . . . . . . . . 46.0 mt-10 -139.1 136.39 35.14 Favored 'General case' 0 C--N 1.331 -0.208 0 CA-C-O 121.052 0.453 . . . . 0.0 111.334 -177.946 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' E' E ' 78' ' ' ALA . . . . . 0.599 ' HB2' HD21 ' E' ' 109' ' ' LEU . . . -123.42 134.82 53.91 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 115.707 -0.678 . . . . 0.0 109.724 176.28 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' E' E ' 79' ' ' LYS . . . . . 0.642 ' O ' HD13 ' E' ' 80' ' ' ILE . 77.8 mttt -77.98 121.51 24.3 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-O 120.791 0.329 . . . . 0.0 110.837 -177.065 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' E' E ' 80' ' ' ILE . . . . . 0.642 HD13 ' O ' ' E' ' 79' ' ' LYS . 38.2 mm -139.21 109.95 4.57 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.327 0 N-CA-C 109.538 -0.541 . . . . 0.0 109.538 -178.571 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' E' E ' 81' ' ' LYS . . . . . . . . . . . . . 15.4 ptpt -103.85 126.84 51.26 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-O 121.114 0.483 . . . . 0.0 111.102 -177.808 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' E' E ' 82' ' ' GLY . . . . . . . . . . . . . . . 89.13 42.11 5.68 Favored Glycine 0 CA--C 1.524 0.624 0 N-CA-C 111.512 -0.635 . . . . 0.0 111.512 175.047 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' E' E ' 83' ' ' ILE . . . . . . . . . . . . . 72.0 mt -67.63 140.24 19.57 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.293 0 CA-C-O 120.889 0.376 . . . . 0.0 110.132 179.252 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' E' E ' 84' ' ' LYS . . . . . . . . . . . . . 82.6 tttt -100.82 -53.85 2.96 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 115.895 -0.593 . . . . 0.0 110.089 -179.403 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' E' E ' 85' ' ' ASP . . . . . . . . . . . . . 5.8 t70 -157.57 155.66 30.58 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 115.731 -0.668 . . . . 0.0 110.477 -178.577 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' E' E ' 86' ' ' VAL . . . . . . . . . . . . . 42.9 t -133.27 132.67 58.26 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.258 0 CA-C-O 121.02 0.438 . . . . 0.0 110.533 -178.662 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' E' E ' 87' ' ' ILE . . . . . 0.401 HG21 ' CG1' ' E' ' 125' ' ' VAL . 43.3 mm -117.63 130.5 72.42 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.259 0 CA-C-N 115.813 -0.631 . . . . 0.0 109.503 174.714 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' E' E ' 88' ' ' LEU . . . . . . . . . . . . . 18.6 tp -114.7 134.61 54.95 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-O 121.127 0.489 . . . . 0.0 111.493 -175.995 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' E' E ' 89' ' ' ASP . . . . . . . . . . . . . 7.0 t70 -127.39 155.37 43.74 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 115.605 -0.725 . . . . 0.0 109.426 174.931 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' E' E ' 90' ' ' GLU . . . . . . . . . . . . . 96.0 mt-10 -47.49 -42.07 22.16 Favored 'General case' 0 N--CA 1.463 0.217 0 N-CA-C 112.781 0.659 . . . . 0.0 112.781 -172.862 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' E' E ' 91' ' ' ASN . . . . . . . . . . . . . 87.2 m-20 -132.02 39.9 3.39 Favored 'General case' 0 C--O 1.233 0.227 0 CA-C-O 120.871 0.367 . . . . 0.0 111.161 -178.279 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' E' E ' 92' ' ' LEU . . . . . . . . . . . . . 10.5 tp -166.11 141.77 4.82 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.517 -0.311 . . . . 0.0 110.521 -179.579 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' E' E ' 93' ' ' ILE . . . . . . . . . . . . . 65.1 mt -126.98 124.34 64.4 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.283 0 N-CA-C 109.695 -0.483 . . . . 0.0 109.695 -178.965 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' E' E ' 94' ' ' VAL . . . . . . . . . . . . . 41.9 t -121.64 124.7 72.2 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.28 0 N-CA-C 109.794 -0.447 . . . . 0.0 109.794 179.71 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' E' E ' 95' ' ' VAL . . . . . . . . . . . . . 45.6 t -122.53 135.5 62.43 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.237 0 CA-C-N 116.443 -0.344 . . . . 0.0 110.147 -178.952 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' E' E ' 96' ' ' ILE . . . . . . . . . . . . . 60.0 mt -117.54 130.99 71.56 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.294 0 CA-C-N 115.954 -0.566 . . . . 0.0 109.476 179.155 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' E' E ' 97' ' ' THR . . . . . . . . . . . . . 40.7 p -101.01 157.37 16.8 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-O 121.095 0.474 . . . . 0.0 111.127 -179.403 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' E' E ' 98' ' ' GLU . . . . . . . . . . . . . 46.0 mt-10 -54.85 -29.49 55.4 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.231 -0.44 . . . . 0.0 112.138 -179.216 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' E' E ' 99' ' ' GLU . . . . . . . . . . . . . 71.2 mm-40 -78.64 14.18 1.39 Allowed 'General case' 0 CA--C 1.536 0.409 0 N-CA-C 113.124 0.787 . . . . 0.0 113.124 -177.361 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' E' E ' 100' ' ' ASN . . . . . . . . . . . . . 38.1 m-20 63.46 36.23 11.46 Favored 'General case' 0 N--CA 1.462 0.141 0 CA-C-O 120.947 0.403 . . . . 0.0 111.585 178.728 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' E' E ' 101' ' ' GLU . . . . . . . . . . . . . 84.8 tt0 -107.38 140.21 40.67 Favored 'General case' 0 C--N 1.331 -0.201 0 N-CA-C 109.372 -0.603 . . . . 0.0 109.372 170.989 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' E' E ' 102' ' ' VAL . . . . . . . . . . . . . 47.9 t -115.1 128.53 72.24 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.269 0 CA-C-N 116.256 -0.429 . . . . 0.0 109.9 -178.187 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' E' E ' 103' ' ' LEU . . . . . . . . . . . . . 31.0 mt -120.42 131.31 54.73 Favored 'General case' 0 C--N 1.331 -0.215 0 CA-C-N 115.757 -0.656 . . . . 0.0 110.368 177.43 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' E' E ' 104' ' ' ILE . . . . . . . . . . . . . 65.8 mt -117.64 121.61 67.87 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.241 0 CA-C-N 116.346 -0.388 . . . . 0.0 110.007 179.038 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' E' E ' 105' ' ' PHE . . . . . . . . . . . . . 75.6 m-85 -121.87 165.24 16.21 Favored 'General case' 0 C--N 1.332 -0.158 0 O-C-N 123.885 0.741 . . . . 0.0 109.823 179.819 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' E' E ' 106' ' ' ASN . . . . . . . . . . . . . 46.6 p-10 -100.21 -169.99 1.81 Allowed 'General case' 0 C--N 1.329 -0.291 0 N-CA-C 109.716 -0.476 . . . . 0.0 109.716 173.437 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' E' E ' 107' ' ' GLN . . . . . 0.464 ' O ' HD21 ' D' ' 140' ' ' LEU . 46.7 tt0 -59.27 -30.06 68.02 Favored 'General case' 0 C--N 1.329 -0.301 0 N-CA-C 111.89 0.33 . . . . 0.0 111.89 179.2 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' E' E ' 108' ' ' ASN . . . . . . . . . . . . . 58.6 t30 -82.19 6.94 15.01 Favored 'General case' 0 CA--C 1.536 0.429 0 N-CA-C 113.161 0.8 . . . . 0.0 113.161 -177.536 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' E' E ' 109' ' ' LEU . . . . . 0.599 HD21 ' HB2' ' E' ' 78' ' ' ALA . 7.4 tp 59.69 34.79 22.21 Favored 'General case' 0 C--O 1.232 0.167 0 O-C-N 122.07 -0.394 . . . . 0.0 111.602 179.42 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' E' E ' 110' ' ' GLU . . . . . . . . . . . . . 42.7 mt-10 -101.9 148.67 25.05 Favored 'General case' 0 C--N 1.33 -0.282 0 N-CA-C 109.52 -0.548 . . . . 0.0 109.52 175.118 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' E' E ' 111' ' ' GLU . . . . . . . . . . . . . 53.0 tt0 -81.98 121.97 27.2 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-O 120.849 0.357 . . . . 0.0 110.759 -176.288 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' E' E ' 112' ' ' LEU . . . . . . . . . . . . . 14.5 mt -106.91 -45.89 4.07 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.071 -0.513 . . . . 0.0 110.594 -179.958 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' E' E ' 113' ' ' TYR . . . . . . . . . . . . . 49.4 t80 -134.88 134.85 41.13 Favored 'General case' 0 C--N 1.331 -0.209 0 CA-C-N 116.28 -0.418 . . . . 0.0 111.026 -178.489 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' E' E ' 114' ' ' ARG . . . . . . . . . . . . . 78.7 ttt-85 -134.06 121.74 21.97 Favored 'General case' 0 C--N 1.331 -0.2 0 CA-C-N 116.04 -0.527 . . . . 0.0 110.262 179.655 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' E' E ' 115' ' ' GLY . . . . . . . . . . . . . . . -150.11 146.67 16.06 Favored Glycine 0 CA--C 1.523 0.553 0 N-CA-C 111.114 -0.794 . . . . 0.0 111.114 179.007 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' E' E ' 116' ' ' LYS . . . . . . . . . . . . . 61.8 tttm -128.04 126.88 42.13 Favored 'General case' 0 C--N 1.33 -0.267 0 N-CA-C 109.734 -0.469 . . . . 0.0 109.734 177.087 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' E' E ' 117' ' ' PHE . . . . . . . . . . . . . 33.6 m-85 -125.22 117.28 23.5 Favored 'General case' 0 N--CA 1.463 0.203 0 CA-C-O 121.037 0.446 . . . . 0.0 110.455 -174.47 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' E' E ' 118' ' ' GLU . . . . . . . . . . . . . 84.0 tt0 -52.08 -50.76 60.93 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.367 -0.379 . . . . 0.0 111.537 -177.891 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' E' E ' 119' ' ' ASN . . . . . . . . . . . . . 23.9 m120 -94.53 31.17 1.82 Allowed 'General case' 0 C--N 1.33 -0.243 0 N-CA-C 112.2 0.444 . . . . 0.0 112.2 -174.735 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' E' E ' 120' ' ' LEU . . . . . . . . . . . . . 20.5 tp -56.4 124.51 18.34 Favored 'General case' 0 N--CA 1.462 0.136 0 C-N-CA 120.992 -0.283 . . . . 0.0 110.448 177.789 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' E' E ' 121' ' ' ASN . . . . . . . . . . . . . 33.6 m120 -113.58 -43.97 3.26 Favored 'General case' 0 C--N 1.331 -0.217 0 CA-C-N 116.588 -0.278 . . . . 0.0 111.137 -175.948 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' E' E ' 122' ' ' LYS . . . . . . . . . . . . . 39.6 ttpt -148.59 147.29 28.83 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-O 121.016 0.436 . . . . 0.0 111.419 -176.888 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' E' E ' 123' ' ' VAL . . . . . . . . . . . . . 46.2 t -132.41 135.71 57.41 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.281 0 CA-C-N 116.021 -0.536 . . . . 0.0 109.644 176.06 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' E' E ' 124' ' ' LEU . . . . . . . . . . . . . 37.8 mt -132.8 141.63 48.58 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-O 120.791 0.329 . . . . 0.0 110.973 -178.567 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' E' E ' 125' ' ' VAL . . . . . 0.653 HG23 HG22 ' E' ' 130' ' ' VAL . 10.6 p -139.26 141.54 35.55 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.23 0 CA-C-N 116.258 -0.428 . . . . 0.0 110.309 177.964 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' E' E ' 126' ' ' ARG . . . . . . . . . . . . . 35.0 ptt-85 -150.88 126.77 10.36 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.09 -0.505 . . . . 0.0 110.579 178.486 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' E' E ' 127' ' ' ASN . . . . . . . . . . . . . 39.2 m-20 49.17 -107.37 0.23 Allowed 'General case' 0 CA--C 1.546 0.807 0 CA-C-O 119.033 -0.508 . . . . 0.0 111.792 178.715 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' E' E ' 128' ' ' ASP . . . . . . . . . . . . . 11.2 p-10 -114.06 11.88 17.78 Favored 'General case' 0 N--CA 1.467 0.408 0 CA-C-N 119.627 1.103 . . . . 0.0 113.416 -175.33 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' E' E ' 129' ' ' LEU . . . . . . . . . . . . . 81.9 mt -120.04 140.74 50.53 Favored 'General case' 0 C--N 1.333 -0.143 0 CA-C-N 118.058 0.39 . . . . 0.0 110.274 178.978 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' E' E ' 130' ' ' VAL . . . . . 0.653 HG22 HG23 ' E' ' 125' ' ' VAL . 46.2 t -128.25 138.91 53.35 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.212 0 N-CA-C 109.741 -0.466 . . . . 0.0 109.741 -179.988 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' E' E ' 131' ' ' VAL . . . . . . . . . . . . . 41.6 t -134.53 138.03 50.34 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.321 0 CA-C-N 116.287 -0.415 . . . . 0.0 110.242 -179.725 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' E' E ' 132' ' ' ILE . . . . . . . . . . . . . 72.9 mt -119.55 132.61 68.85 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.306 0 N-CA-C 109.374 -0.602 . . . . 0.0 109.374 179.942 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' E' E ' 133' ' ' ILE . . . . . . . . . . . . . 39.7 mm -117.64 119.23 61.02 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.253 0 CA-C-N 116.307 -0.406 . . . . 0.0 110.883 -175.991 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' E' E ' 134' ' ' ASP . . . . . . . . . . . . . 8.1 p-10 -131.68 146.46 52.19 Favored 'General case' 0 C--N 1.331 -0.217 0 N-CA-C 109.536 -0.542 . . . . 0.0 109.536 174.504 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' E' E ' 135' ' ' GLU . . . . . . . . . . . . . 43.5 tp10 -49.88 -23.66 2.05 Favored 'General case' 0 C--N 1.328 -0.344 0 N-CA-C 112.941 0.719 . . . . 0.0 112.941 -172.061 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' E' E ' 136' ' ' GLN . . . . . . . . . . . . . 55.6 tp60 -100.97 -27.91 13.03 Favored 'General case' 0 C--O 1.233 0.237 0 N-CA-C 112.46 0.541 . . . . 0.0 112.46 -174.838 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' E' E ' 137' ' ' LYS . . . . . . . . . . . . . 86.6 mttt -142.39 151.35 41.76 Favored 'General case' 0 C--N 1.332 -0.193 0 CA-C-O 121.464 0.649 . . . . 0.0 112.188 -170.396 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' E' E ' 138' ' ' LEU . . . . . . . . . . . . . 14.3 tp -112.49 122.21 47.05 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 115.11 -0.95 . . . . 0.0 108.925 171.977 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' E' E ' 139' ' ' THR . . . . . . . . . . . . . 24.0 m -114.61 124.08 50.95 Favored 'General case' 0 C--N 1.331 -0.212 0 CA-C-O 120.82 0.343 . . . . 0.0 110.868 -177.92 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' E' E ' 140' ' ' LEU . . . . . . . . . . . . . 13.2 tp -111.48 118.48 35.88 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 115.5 -0.773 . . . . 0.0 108.926 178.73 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' E' E ' 141' ' ' ILE . . . . . . . . . . . . . 19.6 mt -119.77 114.31 43.8 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.193 0 N-CA-C 109.726 -0.472 . . . . 0.0 109.726 -176.009 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' E' E ' 142' ' ' ARG . . . . . . . . . . . . . 79.5 mtm180 -90.98 113.67 25.98 Favored 'General case' 0 C--N 1.326 -0.43 0 CA-C-N 115.882 -0.599 . . . . 0.0 110.621 178.039 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' E' E ' 143' ' ' THR . . . . . . . . . . . . . 2.4 p . . . . . 0 C--O 1.221 -0.447 0 CA-C-O 117.951 -1.023 . . . . 0.0 110.559 -179.229 . . . . . . . . 0 0 . 1 . 010 nuclear build full ' F' F ' -3' ' ' GLU . . . . . . . . . . . . . 84.9 tt0 . . . . . 0 N--CA 1.49 1.545 0 N-CA-C 109.298 -0.63 . . . . 0.0 109.298 . . . . . . . . . 0 0 . 1 . 010 nuclear build full ' F' F ' -2' ' ' GLY . . . . . . . . . . . . . . . -73.79 149.95 42.21 Favored Glycine 0 CA--C 1.526 0.739 0 N-CA-C 110.804 -0.918 . . . . 0.0 110.804 179.193 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' F' F ' -1' ' ' VAL . . . . . . . . . . . . . 42.3 t -93.84 134.87 30.03 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 CA-C-O 120.874 0.369 . . . . 0.0 110.068 -179.894 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' F' F ' 0' ' ' ILE . . . . . . . . . . . . . 70.9 mt -111.76 133.63 56.8 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.185 0 CA-C-N 116.16 -0.473 . . . . 0.0 109.877 179.685 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' F' F ' 1' ' ' MET . . . . . . . . . . . . . 25.1 ptt? -82.86 139.28 33.55 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.18 -0.463 . . . . 0.0 110.772 -179.347 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' F' F ' 2' ' ' SER . . . . . . . . . . . . . 6.3 p -116.12 132.9 56.53 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 116.255 -0.429 . . . . 0.0 110.142 178.42 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' F' F ' 3' ' ' GLU . . . . . . . . . . . . . 95.7 mt-10 -140.8 138.04 33.78 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.095 -0.502 . . . . 0.0 110.829 -178.351 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' F' F ' 4' ' ' LEU . . . . . 0.485 HD21 HD21 ' F' ' 6' ' ' LEU . 23.4 tp -123.92 125.31 44.4 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 115.994 -0.548 . . . . 0.0 109.971 175.956 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' F' F ' 5' ' ' LYS . . . . . . . . . . . . . 62.2 mttp -103.78 119.14 38.31 Favored 'General case' 0 C--O 1.234 0.281 0 CA-C-N 116.32 -0.4 . . . . 0.0 110.457 178.395 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' F' F ' 6' ' ' LEU . . . . . 0.485 HD21 HD21 ' F' ' 4' ' ' LEU . 58.1 mt -115.08 141.6 47.79 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 115.398 -0.819 . . . . 0.0 110.223 -178.488 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' F' F ' 7' ' ' LYS . . . . . . . . . . . . . 35.3 ttpt -121.45 136.24 25.73 Favored Pre-proline 0 CA--C 1.534 0.359 0 CA-C-O 118.784 -0.627 . . . . 0.0 109.896 176.627 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' F' F ' 8' ' ' PRO . . . . . . . . . . . . . 95.8 Cg_endo -91.92 133.23 1.32 Allowed 'Trans proline' 0 N--CA 1.489 1.25 0 C-N-CA 121.698 1.599 . . . . 0.0 111.901 178.048 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' F' F ' 9' ' ' LEU . . . . . . . . . . . . . 57.6 mt -73.31 -47.2 7.74 Favored Pre-proline 0 CA--C 1.534 0.336 0 CA-C-O 118.616 -0.707 . . . . 0.0 112.13 -179.117 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' F' F ' 10' ' ' PRO . . . . . . . . . . . . . 97.2 Cg_endo -81.54 147.6 15.78 Favored 'Trans proline' 0 N--CA 1.496 1.622 0 C-N-CA 121.226 1.284 . . . . 0.0 111.504 175.817 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' F' F ' 11' ' ' LYS . . . . . . . . . . . . . 32.3 ttmt -86.51 90.7 8.31 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-O 120.941 0.401 . . . . 0.0 110.498 179.469 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' F' F ' 12' ' ' VAL . . . . . . . . . . . . . 12.6 p -136.11 147.57 28.04 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.252 0 CA-C-N 116.064 -0.517 . . . . 0.0 110.29 179.562 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' F' F ' 13' ' ' GLU . . . . . . . . . . . . . 84.9 tt0 -85.55 130.08 34.66 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.391 -0.368 . . . . 0.0 110.464 179.685 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' F' F ' 14' ' ' LEU . . . . . . . . . . . . . 22.9 mt -97.72 150.7 37.05 Favored Pre-proline 0 C--N 1.33 -0.252 0 CA-C-N 116.207 -0.451 . . . . 0.0 110.354 -179.506 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' F' F ' 15' ' ' PRO . . . . . . . . . . . . . 29.9 Cg_exo -60.36 158.56 30.71 Favored 'Trans proline' 0 N--CA 1.496 1.653 0 C-N-CA 121.199 1.266 . . . . 0.0 111.9 178.096 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' F' F ' 16' ' ' PRO . . . . . . . . . . . . . 39.0 Cg_exo -58.54 -44.37 37.77 Favored 'Trans proline' 0 N--CA 1.497 1.713 0 C-N-CA 121.445 1.43 . . . . 0.0 112.662 -178.373 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' F' F ' 17' ' ' ASP . . . . . . . . . . . . . 12.3 p-10 -83.29 12.89 4.74 Favored 'General case' 0 CA--C 1.536 0.426 0 N-CA-C 112.973 0.731 . . . . 0.0 112.973 -178.718 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' F' F ' 18' ' ' PHE . . . . . 0.505 ' CZ ' HD11 ' F' ' 22' ' ' ILE . 51.4 t80 -56.98 -41.18 77.93 Favored 'General case' 0 C--O 1.227 -0.108 0 O-C-N 122.016 -0.427 . . . . 0.0 110.477 -178.537 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' F' F ' 19' ' ' VAL . . . . . . . . . . . . . 47.0 t -55.78 -44.95 79.17 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.244 0 CA-C-N 116.57 -0.287 . . . . 0.0 110.649 -178.726 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' F' F ' 20' ' ' ASP . . . . . . . . . . . . . 83.1 m-20 -59.95 -41.91 92.92 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-O 120.847 0.356 . . . . 0.0 110.723 -178.851 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' F' F ' 21' ' ' VAL . . . . . . . . . . . . . 57.6 t -63.86 -46.91 92.94 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.303 0 CA-C-N 116.377 -0.374 . . . . 0.0 110.727 -177.809 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' F' F ' 22' ' ' ILE . . . . . 0.616 HG22 HD12 ' F' ' 26' ' ' LEU . 51.6 mm -55.59 -46.37 79.15 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.206 0 CA-C-O 120.694 0.283 . . . . 0.0 110.566 178.628 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' F' F ' 23' ' ' ARG . . . . . . . . . . . . . 41.6 ttp180 -54.39 -51.62 64.27 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.71 -0.223 . . . . 0.0 111.489 -179.502 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' F' F ' 24' ' ' ILE . . . . . . . . . . . . . 75.9 mt -58.65 -44.36 89.52 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.323 0 CA-C-N 116.652 -0.249 . . . . 0.0 111.433 -175.861 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' F' F ' 25' ' ' LYS . . . . . . . . . . . . . 95.3 mttt -68.14 -42.7 79.74 Favored 'General case' 0 C--N 1.328 -0.337 0 N-CA-C 112.331 0.493 . . . . 0.0 112.331 -176.928 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' F' F ' 26' ' ' LEU . . . . . 0.616 HD12 HG22 ' F' ' 22' ' ' ILE . 80.0 mt -78.81 -38.19 38.86 Favored 'General case' 0 C--N 1.329 -0.326 0 N-CA-C 112.984 0.735 . . . . 0.0 112.984 -170.636 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' F' F ' 27' ' ' GLN . . . . . . . . . . . . . 14.8 pt20 -46.97 139.42 5.62 Favored 'General case' 0 N--CA 1.47 0.547 0 N-CA-C 112.633 0.605 . . . . 0.0 112.633 -176.431 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' F' F ' 28' ' ' GLY . . . . . . . . . . . . . . . 101.05 -25.36 28.62 Favored Glycine 0 CA--C 1.533 1.202 0 CA-C-N 115.437 -0.801 . . . . 0.0 112.197 -176.058 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' F' F ' 29' ' ' LYS . . . . . . . . . . . . . 95.1 mttt -97.98 155.2 17.21 Favored 'General case' 0 C--O 1.233 0.192 0 CA-C-N 117.427 0.614 . . . . 0.0 111.01 178.5 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' F' F ' 30' ' ' THR . . . . . . . . . . . . . 21.7 m -107.13 135.93 47.83 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 115.882 -0.599 . . . . 0.0 109.913 175.41 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' F' F ' 31' ' ' VAL . . . . . . . . . . . . . 34.5 m -132.12 156.73 42.76 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.207 0 CA-C-O 120.876 0.369 . . . . 0.0 111.159 -177.107 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' F' F ' 32' ' ' ARG . . . . . . . . . . . . . 82.8 mtt180 -132.18 152.53 51.24 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-O 121.333 0.587 . . . . 0.0 110.673 179.214 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' F' F ' 33' ' ' THR . . . . . . . . . . . . . 18.3 m -52.87 139.95 25.72 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.096 -0.502 . . . . 0.0 111.311 -178.758 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' F' F ' 34' ' ' GLY . . . . . . . . . . . . . . . 100.18 -17.3 57.21 Favored Glycine 0 CA--C 1.533 1.172 0 CA-C-O 119.619 -0.545 . . . . 0.0 113.242 179.274 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' F' F ' 35' ' ' ASP . . . . . . . . . . . . . 74.3 m-20 -67.15 150.03 49.69 Favored 'General case' 0 N--CA 1.46 0.07 0 CA-C-N 118.086 0.943 . . . . 0.0 110.991 178.774 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' F' F ' 36' ' ' VAL . . . . . . . . . . . . . 44.3 t -122.47 130.3 74.62 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.205 0 CA-C-N 116.055 -0.52 . . . . 0.0 109.909 178.44 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' F' F ' 37' ' ' ILE . . . . . . . . . . . . . 69.6 mt -122.34 140.87 44.88 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.218 0 CA-C-N 116.105 -0.498 . . . . 0.0 110.017 -178.527 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' F' F ' 38' ' ' GLY . . . . . . . . . . . . . . . -115.82 128.85 8.21 Favored Glycine 0 CA--C 1.526 0.744 0 N-CA-C 111.179 -0.768 . . . . 0.0 111.179 179.736 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' F' F ' 39' ' ' ILE . . . . . . . . . . . . . 76.3 mt -127.63 140.23 49.7 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.228 0 CA-C-O 120.746 0.308 . . . . 0.0 110.218 179.247 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' F' F ' 40' ' ' SER . . . . . . . . . . . . . 52.8 p -93.32 115.85 28.42 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 116.298 -0.41 . . . . 0.0 111.19 176.229 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' F' F ' 41' ' ' ILE . . . . . . . . . . . . . 44.8 mm -122.58 118.99 56.91 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.214 0 N-CA-C 110.19 -0.3 . . . . 0.0 110.19 178.72 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' F' F ' 42' ' ' LEU . . . . . . . . . . . . . 69.2 mt 55.89 35.64 25.82 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.191 -0.458 . . . . 0.0 111.63 177.412 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' F' F ' 43' ' ' GLY . . . . . . . . . . . . . . . 73.22 23.75 76.88 Favored Glycine 0 CA--C 1.532 1.144 0 C-N-CA 121.151 -0.547 . . . . 0.0 112.795 177.818 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' F' F ' 44' ' ' LYS . . . . . . . . . . . . . 34.7 mmtp -131.5 133.81 45.49 Favored 'General case' 0 C--N 1.331 -0.206 0 CA-C-N 117.264 0.532 . . . . 0.0 109.572 177.538 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' F' F ' 45' ' ' GLU . . . . . . . . . . . . . 85.9 tt0 -82.7 120.21 25.3 Favored 'General case' 0 C--N 1.329 -0.322 0 C-N-CA 120.745 -0.382 . . . . 0.0 110.89 -179.331 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' F' F ' 46' ' ' VAL . . . . . . . . . . . . . 11.2 p -116.83 124.28 72.71 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.154 0 N-CA-C 109.647 -0.501 . . . . 0.0 109.647 175.724 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' F' F ' 47' ' ' LYS . . . . . . . . . . . . . 55.3 mttp -98.58 126.5 44.18 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-N 116.101 -0.5 . . . . 0.0 110.955 179.208 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' F' F ' 48' ' ' PHE . . . . . . . . . . . . . 29.1 m-85 -109.3 131.82 54.71 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.168 -0.469 . . . . 0.0 109.971 177.056 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' F' F ' 49' ' ' LYS . . . . . . . . . . . . . 37.5 tttp -107.66 132.31 53.46 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-N 116.24 -0.436 . . . . 0.0 110.091 177.751 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' F' F ' 50' ' ' VAL . . . . . 0.44 HG13 HD11 ' F' ' 4' ' ' LEU . 42.4 t -75.53 107.05 5.86 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.345 0 N-CA-C 109.453 -0.573 . . . . 0.0 109.453 178.151 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' F' F ' 51' ' ' VAL . . . . . . . . . . . . . 47.4 t -74.5 -48.75 34.09 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.309 0 N-CA-C 109.759 -0.46 . . . . 0.0 109.759 -175.661 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' F' F ' 52' ' ' GLN . . . . . . . . . . . . . 49.4 tt0 -160.11 137.15 9.3 Favored 'General case' 0 C--N 1.33 -0.28 0 C-N-CA 120.316 -0.553 . . . . 0.0 111.568 -179.262 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' F' F ' 53' ' ' ALA . . . . . 0.484 ' HB1' ' HB2' ' F' ' 58' ' ' LEU . . . -113.46 133.06 55.41 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 115.708 -0.678 . . . . 0.0 109.81 175.94 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' F' F ' 54' ' ' TYR . . . . . . . . . . . . . 65.3 t80 -129.18 112.63 18.35 Favored Pre-proline 0 CA--C 1.535 0.386 0 CA-C-O 118.292 -0.861 . . . . 0.0 110.294 178.219 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' F' F ' 55' ' ' PRO . . . . . . . . . . . . . 73.2 Cg_endo -77.18 168.08 77.89 Favored 'Cis proline' 0 N--CA 1.499 1.822 0 CA-C-N 121.935 1.727 . . . . 0.0 112.238 -5.903 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' F' F ' 56' ' ' SER . . . . . . . . . . . . . 13.9 m -116.66 130.51 24.49 Favored Pre-proline 0 CA--C 1.538 0.484 0 CA-C-O 118.536 -0.745 . . . . 0.0 109.413 174.906 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' F' F ' 57' ' ' PRO . . . . . . . . . . . . . 39.3 Cg_endo -67.46 146.74 76.93 Favored 'Cis proline' 0 N--CA 1.498 1.76 0 CA-C-N 121.898 1.713 . . . . 0.0 111.434 -0.786 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' F' F ' 58' ' ' LEU . . . . . 0.484 ' HB2' ' HB1' ' F' ' 53' ' ' ALA . 20.6 tp -106.12 135.82 46.91 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.409 -0.359 . . . . 0.0 110.492 -178.634 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' F' F ' 59' ' ' ARG . . . . . . . . . . . . . 39.3 ttm180 -105.76 126.55 52.29 Favored 'General case' 0 C--N 1.326 -0.438 0 N-CA-C 109.211 -0.663 . . . . 0.0 109.211 175.889 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' F' F ' 60' ' ' VAL . . . . . . . . . . . . . 46.6 t -83.58 119.6 33.15 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.27 0 C-N-CA 120.665 -0.414 . . . . 0.0 110.514 -175.624 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' F' F ' 61' ' ' GLU . . . . . . . . . . . . . 91.6 mt-10 -130.98 165.72 22.55 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 115.926 -0.579 . . . . 0.0 109.775 177.507 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' F' F ' 62' ' ' ASP . . . . . . . . . . . . . 59.7 m-20 -53.34 -32.46 49.25 Favored 'General case' 0 C--N 1.329 -0.303 0 N-CA-C 111.858 0.318 . . . . 0.0 111.858 -178.563 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' F' F ' 63' ' ' ARG . . . . . . . . . . . . . 92.7 mtt180 -74.72 -22.06 59.03 Favored 'General case' 0 C--N 1.33 -0.25 0 N-CA-C 113.02 0.748 . . . . 0.0 113.02 -176.796 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' F' F ' 64' ' ' THR . . . . . . . . . . . . . 39.5 m -65.89 136.52 56.24 Favored 'General case' 0 C--N 1.331 -0.197 0 CA-C-O 120.894 0.378 . . . . 0.0 110.95 -174.547 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' F' F ' 65' ' ' LYS . . . . . . . . . . . . . 96.8 mttt -89.75 133.01 34.92 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 115.912 -0.586 . . . . 0.0 110.153 177.512 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' F' F ' 66' ' ' ILE . . . . . 0.486 HD12 ' N ' ' F' ' 66' ' ' ILE . 4.7 mp -113.29 125.54 70.57 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.284 0 N-CA-C 109.596 -0.52 . . . . 0.0 109.596 178.65 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' F' F ' 67' ' ' THR . . . . . . . . . . . . . 25.6 m -120.59 141.89 49.89 Favored 'General case' 0 C--N 1.331 -0.204 0 CA-C-N 116.111 -0.495 . . . . 0.0 110.997 -176.235 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' F' F ' 68' ' ' LEU . . . . . . . . . . . . . 25.4 tp -100.76 135.26 42.49 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 115.823 -0.626 . . . . 0.0 110.344 179.021 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' F' F ' 69' ' ' VAL . . . . . . . . . . . . . 39.2 t -82.86 130.36 35.86 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.315 0 CA-C-N 116.175 -0.466 . . . . 0.0 109.97 179.285 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' F' F ' 70' ' ' THR . . . . . . . . . . . . . 71.3 p -103.57 -175.31 2.76 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 115.962 -0.563 . . . . 0.0 109.741 -177.801 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' F' F ' 71' ' ' HIS . . . . . . . . . . . . . 5.8 m-70 -64.95 173.12 1.83 Allowed Pre-proline 0 C--N 1.329 -0.324 0 N-CA-C 109.576 -0.527 . . . . 0.0 109.576 177.876 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' F' F ' 72' ' ' PRO . . . . . 0.417 ' O ' HG13 ' F' ' 73' ' ' VAL . 20.2 Cg_exo -64.81 -29.28 59.06 Favored 'Trans proline' 0 N--CA 1.497 1.731 0 C-N-CA 121.15 1.233 . . . . 0.0 111.974 -179.905 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' F' F ' 73' ' ' VAL . . . . . 0.417 HG13 ' O ' ' F' ' 72' ' ' PRO . 3.1 m -150.82 102.64 0.28 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.227 0 CA-C-O 121.227 0.537 . . . . 0.0 111.25 174.143 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' F' F ' 74' ' ' ASP . . . . . . . . . . . . . 13.2 t0 -96.42 115.81 28.03 Favored 'General case' 0 C--N 1.325 -0.469 0 N-CA-C 108.271 -1.011 . . . . 0.0 108.271 171.175 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' F' F ' 75' ' ' VAL . . . . . . . . . . . . . 42.9 t -107.39 124.77 63.53 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.268 0 CA-C-O 121.156 0.503 . . . . 0.0 111.064 -171.235 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' F' F ' 76' ' ' LEU . . . . . . . . . . . . . 24.3 mt -125.24 133.59 52.65 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 115.399 -0.819 . . . . 0.0 109.442 176.452 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' F' F ' 77' ' ' GLU . . . . . . . . . . . . . 98.3 mt-10 -129.35 136.41 49.96 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-O 121.046 0.451 . . . . 0.0 111.126 -178.147 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' F' F ' 78' ' ' ALA . . . . . . . . . . . . . . . -128.2 138.14 52.34 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 115.748 -0.66 . . . . 0.0 109.868 177.124 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' F' F ' 79' ' ' LYS . . . . . 0.603 ' O ' HD13 ' F' ' 80' ' ' ILE . 19.9 pttp -76.07 121.9 23.47 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-O 121.193 0.52 . . . . 0.0 110.599 -179.025 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' F' F ' 80' ' ' ILE . . . . . 0.603 HD13 ' O ' ' F' ' 79' ' ' LYS . 39.1 mm -139.22 116.58 11.18 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.282 0 N-CA-C 109.25 -0.648 . . . . 0.0 109.25 -178.242 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' F' F ' 81' ' ' LYS . . . . . . . . . . . . . 83.7 tttt -112.56 126.39 55.29 Favored 'General case' 0 C--N 1.331 -0.215 0 CA-C-O 120.958 0.408 . . . . 0.0 111.206 -176.139 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' F' F ' 82' ' ' GLY . . . . . . . . . . . . . . . 89.0 42.24 5.69 Favored Glycine 0 CA--C 1.525 0.714 0 C-N-CA 120.86 -0.686 . . . . 0.0 111.569 174.652 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' F' F ' 83' ' ' ILE . . . . . . . . . . . . . 72.8 mt -69.15 141.81 16.89 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.342 0 CA-C-O 120.975 0.417 . . . . 0.0 110.001 178.446 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' F' F ' 84' ' ' LYS . . . . . . . . . . . . . 57.0 tttp -103.59 -52.57 2.96 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 115.884 -0.598 . . . . 0.0 110.356 -178.663 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' F' F ' 85' ' ' ASP . . . . . . . . . . . . . 11.1 t70 -153.55 155.56 36.4 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 115.988 -0.551 . . . . 0.0 110.587 -178.904 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' F' F ' 86' ' ' VAL . . . . . 0.45 ' O ' HD13 ' F' ' 87' ' ' ILE . 45.1 t -130.72 133.39 63.41 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.236 0 CA-C-O 120.976 0.417 . . . . 0.0 110.682 -177.765 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' F' F ' 87' ' ' ILE . . . . . 0.45 HD13 ' O ' ' F' ' 86' ' ' VAL . 46.1 mm -124.76 126.61 71.77 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.221 0 CA-C-N 115.883 -0.599 . . . . 0.0 109.748 176.432 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' F' F ' 88' ' ' LEU . . . . . . . . . . . . . 36.4 mt -116.22 136.54 52.92 Favored 'General case' 0 N--CA 1.464 0.239 0 CA-C-O 121.129 0.49 . . . . 0.0 111.504 -177.02 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' F' F ' 89' ' ' ASP . . . . . . . . . . . . . 10.6 t70 -130.01 159.33 37.04 Favored 'General case' 0 C--N 1.331 -0.221 0 CA-C-N 115.566 -0.743 . . . . 0.0 109.605 175.439 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' F' F ' 90' ' ' GLU . . . . . . . . . . . . . 95.4 mt-10 -46.7 -39.34 11.32 Favored 'General case' 0 CA--C 1.531 0.237 0 N-CA-C 113.118 0.784 . . . . 0.0 113.118 -171.68 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' F' F ' 91' ' ' ASN . . . . . . . . . . . . . 23.9 p30 -131.73 23.55 4.66 Favored 'General case' 0 N--CA 1.466 0.35 0 N-CA-C 112.725 0.639 . . . . 0.0 112.725 -177.383 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' F' F ' 92' ' ' LEU . . . . . . . . . . . . . 16.3 mt -148.7 141.13 24.24 Favored 'General case' 0 C--N 1.33 -0.243 0 N-CA-C 110.137 -0.32 . . . . 0.0 110.137 -176.691 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' F' F ' 93' ' ' ILE . . . . . . . . . . . . . 69.6 mt -124.93 117.39 50.02 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.362 0 N-CA-C 109.604 -0.517 . . . . 0.0 109.604 179.029 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' F' F ' 94' ' ' VAL . . . . . 0.428 HG21 HG21 ' F' ' 125' ' ' VAL . 46.7 t -117.13 127.07 74.78 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.242 0 CA-C-O 120.959 0.409 . . . . 0.0 110.106 179.844 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' F' F ' 95' ' ' VAL . . . . . . . . . . . . . 47.7 t -121.59 132.51 70.58 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.322 0 CA-C-N 115.844 -0.616 . . . . 0.0 109.626 178.799 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' F' F ' 96' ' ' ILE . . . . . . . . . . . . . 63.0 mt -113.71 129.09 70.18 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.269 0 N-CA-C 109.351 -0.611 . . . . 0.0 109.351 179.476 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' F' F ' 97' ' ' THR . . . . . . . . . . . . . 72.8 p -101.21 158.34 16.11 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-O 121.136 0.493 . . . . 0.0 111.121 -178.299 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' F' F ' 98' ' ' GLU . . . . . . . . . . . . . 96.9 mt-10 -54.0 -25.79 22.8 Favored 'General case' 0 CA--C 1.532 0.274 0 N-CA-C 112.316 0.487 . . . . 0.0 112.316 -179.037 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' F' F ' 99' ' ' GLU . . . . . . . . . . . . . 71.4 mm-40 -80.7 16.68 1.32 Allowed 'General case' 0 CA--C 1.535 0.385 0 N-CA-C 113.031 0.752 . . . . 0.0 113.031 -177.298 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' F' F ' 100' ' ' ASN . . . . . . . . . . . . . 3.8 m-20 62.11 37.57 14.48 Favored 'General case' 0 C--N 1.332 -0.156 0 CA-C-O 121.076 0.465 . . . . 0.0 111.088 177.847 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' F' F ' 101' ' ' GLU . . . . . . . . . . . . . 84.0 tt0 -114.79 143.12 45.59 Favored 'General case' 0 C--N 1.333 -0.111 0 N-CA-C 109.704 -0.48 . . . . 0.0 109.704 175.922 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' F' F ' 102' ' ' VAL . . . . . . . . . . . . . 43.0 t -115.22 125.02 72.37 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 CA-C-N 116.146 -0.479 . . . . 0.0 110.055 -178.184 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' F' F ' 103' ' ' LEU . . . . . . . . . . . . . 20.2 mt -114.1 128.64 56.47 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 115.695 -0.684 . . . . 0.0 109.973 176.251 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' F' F ' 104' ' ' ILE . . . . . . . . . . . . . 71.2 mt -117.49 118.97 60.31 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.253 0 N-CA-C 110.371 -0.233 . . . . 0.0 110.371 179.999 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' F' F ' 105' ' ' PHE . . . . . . . . . . . . . 66.0 m-85 -117.54 166.3 12.53 Favored 'General case' 0 C--N 1.333 -0.152 0 CA-C-N 115.455 -0.793 . . . . 0.0 109.898 178.401 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' F' F ' 106' ' ' ASN . . . . . . . . . . . . . 44.4 p-10 -100.4 -169.98 1.8 Allowed 'General case' 0 C--N 1.33 -0.275 0 N-CA-C 109.91 -0.404 . . . . 0.0 109.91 173.988 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' F' F ' 107' ' ' GLN . . . . . . . . . . . . . 30.1 tt0 -59.38 -29.99 68.1 Favored 'General case' 0 C--N 1.329 -0.298 0 N-CA-C 111.855 0.317 . . . . 0.0 111.855 178.221 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' F' F ' 108' ' ' ASN . . . . . . . . . . . . . 14.1 t-20 -81.98 5.17 20.05 Favored 'General case' 0 CA--C 1.537 0.448 0 N-CA-C 113.276 0.843 . . . . 0.0 113.276 -177.796 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' F' F ' 109' ' ' LEU . . . . . . . . . . . . . 9.9 tp 62.61 36.28 13.77 Favored 'General case' 0 CA--C 1.53 0.2 0 O-C-N 122.073 -0.392 . . . . 0.0 111.476 178.119 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' F' F ' 110' ' ' GLU . . . . . . . . . . . . . 96.0 mt-10 -108.1 156.24 19.5 Favored 'General case' 0 C--N 1.332 -0.193 0 N-CA-C 109.894 -0.41 . . . . 0.0 109.894 176.304 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' F' F ' 111' ' ' GLU . . . . . . . . . . . . . 46.2 tp10 -82.91 123.05 29.03 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-O 121.02 0.438 . . . . 0.0 110.852 -177.479 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' F' F ' 112' ' ' LEU . . . . . . . . . . . . . 12.5 mt -108.3 -46.01 3.8 Favored 'General case' 0 C--N 1.332 -0.184 0 CA-C-N 115.93 -0.577 . . . . 0.0 110.136 177.577 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' F' F ' 113' ' ' TYR . . . . . . . . . . . . . 62.3 t80 -140.67 136.54 32.75 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.443 -0.344 . . . . 0.0 110.981 179.863 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' F' F ' 114' ' ' ARG . . . . . . . . . . . . . 59.6 ttp180 -137.97 125.25 21.74 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.28 -0.418 . . . . 0.0 110.169 177.536 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' F' F ' 115' ' ' GLY . . . . . . . . . . . . . . . -150.2 161.87 29.05 Favored Glycine 0 CA--C 1.524 0.613 0 N-CA-C 111.167 -0.773 . . . . 0.0 111.167 179.94 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' F' F ' 116' ' ' LYS . . . . . . . . . . . . . 36.3 ttpt -128.27 134.55 48.97 Favored 'General case' 0 C--N 1.33 -0.273 0 N-CA-C 109.855 -0.424 . . . . 0.0 109.855 178.09 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' F' F ' 117' ' ' PHE . . . . . . . . . . . . . 39.9 m-85 -133.33 113.84 13.04 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-O 120.968 0.414 . . . . 0.0 110.404 -176.412 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' F' F ' 118' ' ' GLU . . . . . . . . . . . . . 44.0 mp0 -57.55 -44.1 84.93 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.088 -0.505 . . . . 0.0 110.71 -175.011 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' F' F ' 119' ' ' ASN . . . . . . . . . . . . . 14.8 m120 -99.12 30.99 3.2 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.201 -0.454 . . . . 0.0 112.192 -173.722 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' F' F ' 120' ' ' LEU . . . . . . . . . . . . . 14.2 tp -55.49 121.6 9.38 Favored 'General case' 0 C--O 1.232 0.16 0 O-C-N 122.235 -0.29 . . . . 0.0 110.671 177.78 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' F' F ' 121' ' ' ASN . . . . . . . . . . . . . 38.6 m-80 -113.9 -44.14 3.2 Favored 'General case' 0 C--N 1.332 -0.183 0 CA-C-N 116.544 -0.298 . . . . 0.0 111.301 -177.756 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' F' F ' 122' ' ' LYS . . . . . . . . . . . . . 33.6 ttpt -145.27 143.5 30.26 Favored 'General case' 0 C--N 1.331 -0.21 0 C-N-CA 120.66 -0.416 . . . . 0.0 111.639 -176.514 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' F' F ' 123' ' ' VAL . . . . . . . . . . . . . 42.1 t -124.86 131.65 72.34 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.237 0 N-CA-C 109.385 -0.598 . . . . 0.0 109.385 175.15 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' F' F ' 124' ' ' LEU . . . . . 0.569 HD13 HD12 ' A' ' 88' ' ' LEU . 9.6 tt -133.9 130.75 38.22 Favored 'General case' 0 C--N 1.332 -0.194 0 CA-C-O 121.073 0.464 . . . . 0.0 111.105 -178.402 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' F' F ' 125' ' ' VAL . . . . . 0.428 HG21 HG21 ' F' ' 94' ' ' VAL . 43.3 t -121.16 133.54 67.44 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.233 0 CA-C-N 115.783 -0.644 . . . . 0.0 109.543 176.867 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' F' F ' 126' ' ' ARG . . . . . . . . . . . . . 36.6 ptt-85 -142.83 125.03 15.4 Favored 'General case' 0 C--N 1.331 -0.226 0 CA-C-O 121.021 0.438 . . . . 0.0 111.087 179.759 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' F' F ' 127' ' ' ASN . . . . . . . . . . . . . 58.8 m-80 49.21 -105.06 0.15 Allowed 'General case' 0 CA--C 1.544 0.738 0 CA-C-N 116.126 -0.488 . . . . 0.0 111.748 177.42 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' F' F ' 128' ' ' ASP . . . . . . . . . . . . . 8.8 p-10 -114.15 1.79 14.67 Favored 'General case' 0 CA--C 1.534 0.359 0 CA-C-N 119.524 1.057 . . . . 0.0 113.57 -176.366 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' F' F ' 129' ' ' LEU . . . . . . . . . . . . . 82.9 mt -113.7 145.7 40.94 Favored 'General case' 0 C--N 1.333 -0.131 0 O-C-N 121.92 -0.488 . . . . 0.0 110.5 -178.805 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' F' F ' 130' ' ' VAL . . . . . . . . . . . . . 45.7 t -125.41 135.78 62.91 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.22 0 CA-C-N 116.123 -0.49 . . . . 0.0 109.769 179.955 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' F' F ' 131' ' ' VAL . . . . . 0.709 HG21 HD13 ' A' ' 88' ' ' LEU . 27.5 m -136.03 143.1 37.01 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.251 0 CA-C-O 121.356 0.598 . . . . 0.0 111.126 178.774 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' F' F ' 132' ' ' ILE . . . . . . . . . . . . . 70.7 mt -123.6 133.95 67.74 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.288 0 CA-C-N 115.219 -0.9 . . . . 0.0 109.502 -179.336 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' F' F ' 133' ' ' ILE . . . . . 0.402 HG21 HG21 ' A' ' 86' ' ' VAL . 39.6 mm -115.57 122.01 68.48 Favored 'Isoleucine or valine' 0 C--O 1.233 0.225 0 CA-C-O 120.735 0.302 . . . . 0.0 110.89 -176.165 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' F' F ' 134' ' ' ASP . . . . . . . . . . . . . 6.7 p-10 -131.98 146.39 52.06 Favored 'General case' 0 C--N 1.331 -0.216 0 N-CA-C 109.457 -0.571 . . . . 0.0 109.457 174.098 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' F' F ' 135' ' ' GLU . . . . . . . . . . . . . 42.7 tp10 -49.82 -23.9 2.12 Favored 'General case' 0 C--N 1.328 -0.348 0 N-CA-C 112.883 0.697 . . . . 0.0 112.883 -171.406 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' F' F ' 136' ' ' GLN . . . . . . . . . . . . . 94.3 mt-30 -92.73 -37.21 12.49 Favored 'General case' 0 C--N 1.332 -0.185 0 N-CA-C 112.115 0.413 . . . . 0.0 112.115 -176.284 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' F' F ' 137' ' ' LYS . . . . . . . . . . . . . 45.9 mtmt -148.48 159.17 44.31 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-O 121.512 0.672 . . . . 0.0 111.819 -168.968 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' F' F ' 138' ' ' LEU . . . . . . . . . . . . . 5.0 tt -115.43 124.74 51.93 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 115.173 -0.921 . . . . 0.0 109.365 175.737 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' F' F ' 139' ' ' THR . . . . . . . . . . . . . 27.5 m -108.27 129.52 55.21 Favored 'General case' 0 C--N 1.331 -0.22 0 CA-C-N 116.437 -0.347 . . . . 0.0 110.878 -177.523 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' F' F ' 140' ' ' LEU . . . . . 0.455 HD23 ' C ' ' F' ' 140' ' ' LEU . 5.9 tt -117.31 122.56 44.25 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 115.607 -0.724 . . . . 0.0 109.109 -178.427 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' F' F ' 141' ' ' ILE . . . . . 0.444 ' N ' HD23 ' F' ' 140' ' ' LEU . 19.3 mt -120.06 116.97 52.02 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.345 0 N-CA-C 109.815 -0.439 . . . . 0.0 109.815 -175.969 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' F' F ' 142' ' ' ARG . . . . . . . . . . . . . 56.4 ttp180 -104.67 129.04 52.9 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 115.445 -0.798 . . . . 0.0 110.638 -178.829 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' F' F ' 143' ' ' THR . . . . . . . . . . . . . 55.8 p . . . . . 0 C--O 1.221 -0.427 0 CA-C-O 117.962 -1.018 . . . . 0.0 110.467 178.603 . . . . . . . . 0 0 . 1 . 011 nuclear build full ' A' A ' -3' ' ' GLU . . . . . . . . . . . . . 95.6 mt-10 . . . . . 0 N--CA 1.49 1.53 0 N-CA-C 109.346 -0.613 . . . . 0.0 109.346 . . . . . . . . . 0 0 . 1 . 011 nuclear build full ' A' A ' -2' ' ' GLY . . . . . . . . . . . . . . . -67.31 141.83 39.9 Favored Glycine 0 CA--C 1.525 0.663 0 N-CA-C 111.057 -0.817 . . . . 0.0 111.057 -179.609 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' -1' ' ' VAL . . . . . . . . . . . . . 42.9 t -141.12 144.29 26.78 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.308 0 N-CA-C 110.023 -0.362 . . . . 0.0 110.023 179.804 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 0' ' ' ILE . . . . . . . . . . . . . 72.4 mt -99.9 137.16 28.26 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.343 0 CA-C-O 120.931 0.396 . . . . 0.0 110.162 -179.407 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 25.4 ptp -91.46 153.55 19.75 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 115.966 -0.561 . . . . 0.0 110.563 -179.827 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 2.8 p -126.49 129.92 49.6 Favored 'General case' 0 C--N 1.331 -0.223 0 CA-C-N 116.296 -0.411 . . . . 0.0 110.609 179.537 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 84.9 tt0 -141.74 138.14 32.15 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.097 -0.501 . . . . 0.0 110.856 179.501 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 4' ' ' LEU . . . . . 0.445 HD21 HD21 ' A' ' 6' ' ' LEU . 12.7 tp -123.27 133.19 54.2 Favored 'General case' 0 C--N 1.332 -0.155 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.166 177.157 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 5' ' ' LYS . . . . . . . . . . . . . 95.6 mttt -108.48 120.62 42.94 Favored 'General case' 0 C--O 1.234 0.271 0 CA-C-N 116.421 -0.354 . . . . 0.0 110.417 179.737 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 6' ' ' LEU . . . . . 0.445 HD21 HD21 ' A' ' 4' ' ' LEU . 56.2 mt -115.89 148.23 40.22 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 115.457 -0.792 . . . . 0.0 110.715 -177.755 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 31.9 ttpt -138.57 140.59 28.29 Favored Pre-proline 0 CA--C 1.534 0.357 0 CA-C-O 119.164 -0.446 . . . . 0.0 110.075 175.421 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 8' ' ' PRO . . . . . . . . . . . . . 85.5 Cg_endo -92.02 141.96 2.52 Favored 'Trans proline' 0 N--CA 1.491 1.332 0 C-N-CA 121.734 1.622 . . . . 0.0 111.802 177.794 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 51.2 mt -77.4 -48.19 2.42 Favored Pre-proline 0 CA--C 1.534 0.338 0 CA-C-O 118.649 -0.691 . . . . 0.0 112.435 -179.459 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 90.1 Cg_endo -79.82 156.66 24.1 Favored 'Trans proline' 0 N--CA 1.496 1.636 0 C-N-CA 121.15 1.233 . . . . 0.0 111.812 177.292 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 61.6 tttm -87.97 95.66 10.21 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.378 -0.374 . . . . 0.0 110.281 178.292 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 12.4 p -140.14 144.57 27.68 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.263 0 CA-C-N 116.145 -0.479 . . . . 0.0 110.532 -179.43 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 95.6 mt-10 -82.18 127.13 32.85 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.234 -0.439 . . . . 0.0 110.07 177.392 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 14' ' ' LEU . . . . . . . . . . . . . 23.9 mt -97.94 139.42 21.28 Favored Pre-proline 0 CA--C 1.533 0.318 0 CA-C-O 118.796 -0.621 . . . . 0.0 109.767 179.871 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 15' ' ' PRO . . . . . . . . . . . . . 26.6 Cg_exo -60.99 160.57 25.27 Favored 'Trans proline' 0 N--CA 1.498 1.758 0 C-N-CA 121.161 1.241 . . . . 0.0 111.713 178.348 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 16' ' ' PRO . . . . . . . . . . . . . 30.7 Cg_exo -59.66 -32.71 96.29 Favored 'Trans proline' 0 N--CA 1.499 1.794 0 C-N-CA 121.396 1.397 . . . . 0.0 112.863 -177.618 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 17' ' ' ASP . . . . . . . . . . . . . 9.6 p-10 -91.56 6.1 47.0 Favored 'General case' 0 CA--C 1.538 0.498 0 N-CA-C 113.254 0.835 . . . . 0.0 113.254 -177.275 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 18' ' ' PHE . . . . . . . . . . . . . 47.1 t80 -58.54 -46.08 87.55 Favored 'General case' 0 C--N 1.333 -0.122 0 CA-C-O 120.985 0.421 . . . . 0.0 109.975 -178.356 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 19' ' ' VAL . . . . . . . . . . . . . 48.5 t -57.37 -40.9 76.95 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.328 0 CA-C-N 116.074 -0.512 . . . . 0.0 110.41 -178.784 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 9.2 t70 -60.07 -44.11 94.98 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-O 120.743 0.306 . . . . 0.0 111.099 -177.613 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 49.0 t -64.66 -46.71 91.53 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.248 0 C-N-CA 120.694 -0.402 . . . . 0.0 110.512 -177.893 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 22' ' ' ILE . . . . . 0.504 HG22 HD12 ' A' ' 26' ' ' LEU . 50.7 mm -56.19 -45.19 80.85 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.246 0 C-N-CA 120.915 -0.314 . . . . 0.0 110.626 178.912 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 23' ' ' ARG . . . . . . . . . . . . . 55.7 ttp180 -54.76 -49.82 69.92 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-O 120.658 0.266 . . . . 0.0 111.296 -178.626 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 24' ' ' ILE . . . . . . . . . . . . . 75.9 mt -59.72 -42.22 87.92 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.249 0 CA-C-N 116.574 -0.285 . . . . 0.0 111.178 -177.522 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 99.4 mttt -67.6 -38.16 83.6 Favored 'General case' 0 C--N 1.328 -0.362 0 N-CA-C 112.604 0.594 . . . . 0.0 112.604 -178.686 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 26' ' ' LEU . . . . . 0.504 HD12 HG22 ' A' ' 22' ' ' ILE . 83.1 mt -78.13 -41.27 35.55 Favored 'General case' 0 C--N 1.33 -0.261 0 N-CA-C 113.144 0.794 . . . . 0.0 113.144 -172.168 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 27' ' ' GLN . . . . . . . . . . . . . 14.8 pt20 -46.98 138.06 6.85 Favored 'General case' 0 N--CA 1.47 0.551 0 N-CA-C 112.704 0.631 . . . . 0.0 112.704 -175.675 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 101.63 -26.43 24.48 Favored Glycine 0 CA--C 1.532 1.115 0 CA-C-N 115.571 -0.74 . . . . 0.0 112.306 -177.331 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 71.6 mmtt -98.17 155.14 17.3 Favored 'General case' 0 C--N 1.331 -0.209 0 CA-C-N 117.51 0.655 . . . . 0.0 111.097 177.802 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 30' ' ' THR . . . . . . . . . . . . . 41.4 m -105.33 137.52 43.01 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 115.895 -0.593 . . . . 0.0 109.862 176.068 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 34.8 m -129.51 157.38 42.24 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.245 0 CA-C-N 116.354 -0.385 . . . . 0.0 110.798 -178.468 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 32' ' ' ARG . . . . . . . . . . . . . 73.5 mtt85 -131.37 153.13 49.97 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-O 121.282 0.563 . . . . 0.0 110.701 177.899 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 33' ' ' THR . . . . . . . . . . . . . 22.7 m -53.02 139.66 27.32 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.051 -0.522 . . . . 0.0 111.397 -177.84 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 99.13 -16.99 58.66 Favored Glycine 0 CA--C 1.533 1.17 0 CA-C-O 119.593 -0.56 . . . . 0.0 113.327 178.345 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 61.3 m-20 -62.81 148.82 45.81 Favored 'General case' 0 C--O 1.231 0.11 0 CA-C-N 118.044 0.922 . . . . 0.0 111.084 179.696 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 45.1 t -123.66 130.69 73.93 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.257 0 CA-C-N 115.585 -0.734 . . . . 0.0 109.853 179.343 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 37' ' ' ILE . . . . . . . . . . . . . 69.6 mt -122.71 139.19 50.32 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.237 0 CA-C-N 116.248 -0.433 . . . . 0.0 110.04 -179.773 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . -110.72 128.78 8.94 Favored Glycine 0 CA--C 1.525 0.665 0 N-CA-C 111.037 -0.825 . . . . 0.0 111.037 179.556 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 39' ' ' ILE . . . . . . . . . . . . . 72.1 mt -123.06 135.62 62.51 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.257 0 N-CA-C 110.109 -0.33 . . . . 0.0 110.109 179.33 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 40' ' ' SER . . . . . . . . . . . . . 41.5 t -93.6 116.91 29.44 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.394 -0.366 . . . . 0.0 111.039 176.01 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 41' ' ' ILE . . . . . . . . . . . . . 44.2 mm -121.53 115.26 45.99 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.241 0 CA-C-N 116.476 -0.329 . . . . 0.0 110.333 179.34 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 78.5 mt 54.38 37.07 26.89 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-O 120.93 0.395 . . . . 0.0 111.548 176.942 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . 74.13 24.46 73.54 Favored Glycine 0 CA--C 1.532 1.123 0 C-N-CA 121.061 -0.59 . . . . 0.0 112.797 177.622 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 44' ' ' LYS . . . . . . . . . . . . . 70.0 mmtt -130.36 132.54 45.85 Favored 'General case' 0 C--N 1.331 -0.223 0 N-CA-C 109.57 -0.529 . . . . 0.0 109.57 177.74 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 81.3 tt0 -84.02 122.5 28.87 Favored 'General case' 0 C--N 1.329 -0.308 0 C-N-CA 120.74 -0.384 . . . . 0.0 111.099 -178.142 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 46' ' ' VAL . . . . . . . . . . . . . 7.1 p -120.86 128.15 76.03 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.194 0 N-CA-C 109.356 -0.609 . . . . 0.0 109.356 175.241 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 60.3 mttp -100.48 127.78 46.73 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 115.988 -0.551 . . . . 0.0 111.015 179.277 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 48' ' ' PHE . . . . . . . . . . . . . 92.2 m-85 -110.48 131.83 54.71 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.368 -0.378 . . . . 0.0 110.099 176.44 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 45.5 tttp -108.46 136.96 47.21 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.246 -0.433 . . . . 0.0 110.598 179.158 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 50' ' ' VAL . . . . . . . . . . . . . 47.0 t -82.33 107.35 14.18 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.33 0 N-CA-C 109.161 -0.681 . . . . 0.0 109.161 175.416 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 51' ' ' VAL . . . . . . . . . . . . . 47.8 t -71.68 -52.26 26.96 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.364 0 CA-C-N 115.952 -0.567 . . . . 0.0 109.668 -174.295 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 52' ' ' GLN . . . . . . . . . . . . . 90.8 mt-30 -152.94 151.09 29.93 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-O 121.182 0.515 . . . . 0.0 111.572 -177.755 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -126.46 131.88 51.57 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 115.214 -0.903 . . . . 0.0 109.639 175.087 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 54' ' ' TYR . . . . . . . . . . . . . 51.7 t80 -128.93 108.43 18.29 Favored Pre-proline 0 CA--C 1.533 0.323 0 CA-C-O 118.294 -0.86 . . . . 0.0 110.421 -179.826 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 55' ' ' PRO . . . . . . . . . . . . . 73.4 Cg_endo -77.12 170.0 72.77 Favored 'Cis proline' 0 N--CA 1.499 1.837 0 CA-C-N 121.809 1.682 . . . . 0.0 112.501 -5.54 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 56' ' ' SER . . . . . . . . . . . . . 15.2 m -115.27 129.05 25.41 Favored Pre-proline 0 CA--C 1.539 0.554 0 CA-C-O 118.448 -0.787 . . . . 0.0 109.462 174.994 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 57' ' ' PRO . . . . . . . . . . . . . 38.4 Cg_endo -67.48 165.73 67.61 Favored 'Cis proline' 0 N--CA 1.498 1.741 0 CA-C-N 121.979 1.742 . . . . 0.0 111.517 -0.601 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 58' ' ' LEU . . . . . . . . . . . . . 27.9 tp -129.28 135.89 49.35 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.268 179.646 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 59' ' ' ARG . . . . . . . . . . . . . 74.0 ttt180 -104.72 128.69 52.89 Favored 'General case' 0 C--N 1.326 -0.421 0 N-CA-C 109.188 -0.671 . . . . 0.0 109.188 176.562 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 46.2 t -79.92 122.4 35.06 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.212 0 C-N-CA 120.566 -0.453 . . . . 0.0 109.982 -175.945 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 78.9 tt0 -130.75 157.82 41.78 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 115.713 -0.676 . . . . 0.0 109.264 -179.511 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 62' ' ' ASP . . . . . . . . . . . . . 79.9 m-20 -51.58 -32.21 27.62 Favored 'General case' 0 C--N 1.328 -0.339 0 N-CA-C 112.125 0.417 . . . . 0.0 112.125 -177.642 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 63' ' ' ARG . . . . . . . . . . . . . 46.8 ptt85 -88.97 5.11 45.69 Favored 'General case' 0 CA--C 1.538 0.518 0 N-CA-C 113.767 1.025 . . . . 0.0 113.767 -175.598 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 30.4 m -80.14 141.03 36.12 Favored 'General case' 0 C--N 1.331 -0.206 0 CA-C-N 117.981 0.355 . . . . 0.0 110.742 -178.483 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 65' ' ' LYS . . . . . . . . . . . . . 97.0 mttt -88.67 131.36 35.03 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.237 -0.438 . . . . 0.0 110.262 178.895 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 66' ' ' ILE . . . . . . . . . . . . . 59.1 mt -115.26 126.45 72.83 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.297 0 N-CA-C 109.502 -0.555 . . . . 0.0 109.502 179.061 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 67' ' ' THR . . . . . . . . . . . . . 26.4 m -117.56 136.61 53.15 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-O 121.05 0.452 . . . . 0.0 110.731 -177.756 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 68' ' ' LEU . . . . . 0.462 HD23 ' C ' ' A' ' 68' ' ' LEU . 6.3 tt -104.71 123.96 48.53 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 115.782 -0.645 . . . . 0.0 109.69 178.277 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 69' ' ' VAL . . . . . . . . . . . . . 45.6 t -92.55 131.27 40.08 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.269 0 CA-C-O 120.974 0.416 . . . . 0.0 110.131 -178.474 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 70' ' ' THR . . . . . . . . . . . . . 6.5 m -90.03 145.67 24.91 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 115.924 -0.58 . . . . 0.0 110.566 -179.216 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 71' ' ' HIS . . . . . . . . . . . . . 65.3 m80 -64.87 160.3 56.12 Favored Pre-proline 0 C--N 1.329 -0.318 0 CA-C-N 116.254 -0.43 . . . . 0.0 110.458 -179.976 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 72' ' ' PRO . . . . . . . . . . . . . 47.7 Cg_endo -85.67 155.74 10.38 Favored 'Trans proline' 0 N--CA 1.49 1.314 0 C-N-CA 121.697 1.598 . . . . 0.0 112.384 -178.697 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 73' ' ' VAL . . . . . . . . . . . . . 35.4 m -80.63 167.1 2.24 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.246 0 CA-C-N 116.168 -0.469 . . . . 0.0 110.622 -179.709 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 74' ' ' ASP . . . . . . . . . . . . . 30.2 t0 -101.45 121.42 41.92 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.227 -0.442 . . . . 0.0 109.845 -179.623 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 43.5 t -115.7 124.27 71.95 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.215 0 CA-C-O 121.071 0.462 . . . . 0.0 110.467 -178.62 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 76' ' ' LEU . . . . . . . . . . . . . 6.3 mp -118.35 138.52 52.36 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 115.692 -0.685 . . . . 0.0 109.501 175.569 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 77' ' ' GLU . . . . . . . . . . . . . 96.8 mt-10 -134.15 136.3 43.71 Favored 'General case' 0 C--N 1.331 -0.204 0 CA-C-O 121.079 0.466 . . . . 0.0 111.017 -179.222 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 78' ' ' ALA . . . . . . . . . . . . . . . -124.81 141.68 51.95 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 115.632 -0.713 . . . . 0.0 110.077 177.704 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 79' ' ' LYS . . . . . 0.596 ' O ' HD13 ' A' ' 80' ' ' ILE . 11.4 mptt -81.52 109.83 16.35 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-O 120.858 0.361 . . . . 0.0 110.379 -179.922 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 80' ' ' ILE . . . . . 0.596 HD13 ' O ' ' A' ' 79' ' ' LYS . 41.5 mm -139.09 103.77 2.04 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.356 0 N-CA-C 109.2 -0.667 . . . . 0.0 109.2 -178.122 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 81' ' ' LYS . . . . . . . . . . . . . 19.7 pttp -112.38 140.39 47.15 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-O 121.002 0.429 . . . . 0.0 111.335 -176.857 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . 89.2 42.07 5.67 Favored Glycine 0 CA--C 1.526 0.724 0 N-CA-C 110.865 -0.894 . . . . 0.0 110.865 178.599 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 83' ' ' ILE . . . . . . . . . . . . . 70.7 mt -75.79 140.94 16.5 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.333 0 CA-C-O 120.88 0.372 . . . . 0.0 110.205 -179.139 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 84' ' ' LYS . . . . . . . . . . . . . 58.0 tttp -95.13 -53.4 3.82 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 115.904 -0.589 . . . . 0.0 109.991 179.597 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 85' ' ' ASP . . . . . . . . . . . . . 10.2 t70 -155.04 154.16 32.06 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 115.629 -0.714 . . . . 0.0 110.349 -179.627 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 86' ' ' VAL . . . . . . . . . . . . . 41.6 t -126.01 131.09 72.12 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.205 0 CA-C-O 120.925 0.393 . . . . 0.0 110.422 -179.197 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 87' ' ' ILE . . . . . . . . . . . . . 46.0 mm -120.33 124.75 73.19 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.285 0 CA-C-N 115.849 -0.614 . . . . 0.0 109.39 177.423 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 88' ' ' LEU . . . . . 0.458 HD13 HG21 ' F' ' 131' ' ' VAL . 30.1 mt -118.66 136.1 54.1 Favored 'General case' 0 C--N 1.331 -0.22 0 CA-C-O 121.209 0.528 . . . . 0.0 111.29 -176.147 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 89' ' ' ASP . . . . . . . . . . . . . 6.6 t0 -131.13 157.91 41.87 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 115.448 -0.796 . . . . 0.0 109.533 177.759 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 14.2 pt-20 -46.4 -36.93 6.96 Favored 'General case' 0 C--N 1.33 -0.272 0 N-CA-C 113.218 0.822 . . . . 0.0 113.218 -172.326 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 91' ' ' ASN . . . . . . . . . . . . . 11.9 t-20 -131.99 20.81 4.52 Favored 'General case' 0 N--CA 1.468 0.467 0 N-CA-C 112.93 0.715 . . . . 0.0 112.93 -177.083 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 92' ' ' LEU . . . . . . . . . . . . . 35.2 mt -147.52 142.61 27.09 Favored 'General case' 0 C--N 1.33 -0.267 0 N-CA-C 110.323 -0.251 . . . . 0.0 110.323 -177.625 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 93' ' ' ILE . . . . . . . . . . . . . 71.5 mt -125.34 116.02 45.48 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.336 0 N-CA-C 109.416 -0.587 . . . . 0.0 109.416 179.09 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 94' ' ' VAL . . . . . 0.437 HG21 HG11 ' A' ' 125' ' ' VAL . 46.7 t -119.13 126.79 75.67 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.295 0 CA-C-O 121.001 0.429 . . . . 0.0 110.114 -178.814 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 95' ' ' VAL . . . . . . . . . . . . . 47.3 t -118.66 131.16 72.26 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.376 0 CA-C-N 115.704 -0.68 . . . . 0.0 109.455 178.982 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 96' ' ' ILE . . . . . . . . . . . . . 65.6 mt -112.04 125.82 69.37 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.299 0 N-CA-C 109.127 -0.694 . . . . 0.0 109.127 178.699 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 97' ' ' THR . . . . . . . . . . . . . 71.2 p -98.25 157.1 16.37 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-O 121.216 0.532 . . . . 0.0 111.06 -177.22 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 98' ' ' GLU . . . . . . . . . . . . . 97.1 mt-10 -54.34 -24.25 18.61 Favored 'General case' 0 C--N 1.329 -0.322 0 N-CA-C 112.434 0.531 . . . . 0.0 112.434 -179.571 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 99' ' ' GLU . . . . . . . . . . . . . 35.3 tt0 -80.78 16.74 1.33 Allowed 'General case' 0 CA--C 1.538 0.51 0 N-CA-C 112.642 0.608 . . . . 0.0 112.642 -177.551 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 100' ' ' ASN . . . . . . . . . . . . . 3.4 m-20 61.83 37.91 15.1 Favored 'General case' 0 C--O 1.232 0.153 0 O-C-N 121.91 -0.494 . . . . 0.0 111.151 178.129 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 101' ' ' GLU . . . . . . . . . . . . . 84.7 tt0 -116.31 144.55 44.1 Favored 'General case' 0 C--N 1.331 -0.214 0 CA-C-N 116.165 -0.471 . . . . 0.0 109.858 176.501 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 102' ' ' VAL . . . . . . . . . . . . . 41.3 t -115.8 125.54 72.99 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.26 0 CA-C-N 116.207 -0.451 . . . . 0.0 110.177 -178.299 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 103' ' ' LEU . . . . . . . . . . . . . 22.6 mt -116.25 127.86 55.1 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 115.782 -0.645 . . . . 0.0 109.867 175.811 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 104' ' ' ILE . . . . . . . . . . . . . 62.4 mt -118.15 122.55 69.91 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.295 0 N-CA-C 110.342 -0.244 . . . . 0.0 110.342 179.639 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 105' ' ' PHE . . . . . . . . . . . . . 62.4 m-85 -120.18 163.58 17.52 Favored 'General case' 0 C--N 1.332 -0.182 0 O-C-N 124.136 0.897 . . . . 0.0 109.679 178.689 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 106' ' ' ASN . . . . . . . . . . . . . 46.8 p-10 -95.24 -170.69 2.23 Favored 'General case' 0 C--N 1.331 -0.232 0 N-CA-C 109.752 -0.462 . . . . 0.0 109.752 173.23 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 107' ' ' GLN . . . . . . . . . . . . . 12.3 tt0 -59.32 -30.1 68.12 Favored 'General case' 0 C--N 1.33 -0.278 0 N-CA-C 111.879 0.326 . . . . 0.0 111.879 179.144 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 108' ' ' ASN . . . . . . . . . . . . . 6.8 t-20 -82.23 9.68 8.31 Favored 'General case' 0 CA--C 1.536 0.438 0 N-CA-C 113.052 0.76 . . . . 0.0 113.052 -177.809 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 109' ' ' LEU . . . . . . . . . . . . . 11.1 tp 58.03 35.71 25.43 Favored 'General case' 0 CA--C 1.531 0.215 0 CA-C-O 120.965 0.412 . . . . 0.0 111.409 179.203 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 110' ' ' GLU . . . . . . . . . . . . . 70.7 mm-40 -104.98 143.53 33.05 Favored 'General case' 0 C--N 1.331 -0.222 0 N-CA-C 109.264 -0.643 . . . . 0.0 109.264 174.812 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 111' ' ' GLU . . . . . . . . . . . . . 62.6 tt0 -81.64 121.97 27.02 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-O 121.058 0.456 . . . . 0.0 110.678 -175.144 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 112' ' ' LEU . . . . . . . . . . . . . 29.5 mt -104.58 -45.62 4.57 Favored 'General case' 0 C--N 1.331 -0.211 0 CA-C-N 115.935 -0.575 . . . . 0.0 110.736 179.716 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 113' ' ' TYR . . . . . . . . . . . . . 63.6 t80 -133.02 135.69 45.57 Favored 'General case' 0 C--N 1.331 -0.218 0 CA-C-N 116.376 -0.375 . . . . 0.0 111.277 -177.604 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 114' ' ' ARG . . . . . . . . . . . . . 55.6 ttp180 -133.98 121.22 21.31 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 115.868 -0.605 . . . . 0.0 110.109 177.333 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 115' ' ' GLY . . . . . . . . . . . . . . . -150.12 160.8 28.68 Favored Glycine 0 CA--C 1.524 0.642 0 N-CA-C 111.013 -0.835 . . . . 0.0 111.013 -179.987 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 116' ' ' LYS . . . . . . . . . . . . . 33.4 ttmt -135.97 139.43 43.2 Favored 'General case' 0 C--N 1.328 -0.368 0 N-CA-C 109.971 -0.381 . . . . 0.0 109.971 177.312 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 117' ' ' PHE . . . . . . . . . . . . . 39.9 m-85 -136.88 114.68 11.28 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-O 121.053 0.454 . . . . 0.0 110.312 -175.127 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 118' ' ' GLU . . . . . . . . . . . . . 96.6 mt-10 -53.38 -45.06 69.1 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 116.287 -0.415 . . . . 0.0 111.664 -175.413 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 119' ' ' ASN . . . . . . . . . . . . . 69.5 m-80 -98.66 31.08 3.02 Favored 'General case' 0 C--N 1.33 -0.271 0 N-CA-C 112.255 0.465 . . . . 0.0 112.255 -173.035 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 120' ' ' LEU . . . . . . . . . . . . . 26.8 tp -56.44 122.53 12.15 Favored 'General case' 0 C--N 1.332 -0.171 0 C-N-CA 121.059 -0.256 . . . . 0.0 110.494 177.638 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 121' ' ' ASN . . . . . . . . . . . . . 34.9 m120 -114.0 -44.15 3.18 Favored 'General case' 0 C--O 1.232 0.149 0 CA-C-N 116.687 -0.233 . . . . 0.0 111.181 -178.373 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 122' ' ' LYS . . . . . . . . . . . . . 97.3 mttt -148.31 152.92 37.92 Favored 'General case' 0 C--N 1.332 -0.156 0 CA-C-O 121.126 0.489 . . . . 0.0 111.468 -177.896 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 123' ' ' VAL . . . . . . . . . . . . . 45.0 t -127.19 132.41 69.72 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.217 0 CA-C-N 115.897 -0.592 . . . . 0.0 109.679 176.931 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 124' ' ' LEU . . . . . . . . . . . . . 75.8 mt -126.67 131.04 51.5 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.455 -0.339 . . . . 0.0 110.307 -179.993 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 125' ' ' VAL . . . . . 0.437 HG11 HG21 ' A' ' 94' ' ' VAL . 35.3 m -136.59 138.85 46.02 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.258 0 CA-C-O 120.844 0.354 . . . . 0.0 110.829 -179.748 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 126' ' ' ARG . . . . . . . . . . . . . 14.5 ptm180 -165.96 143.55 5.53 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.066 -0.515 . . . . 0.0 110.081 177.216 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 127' ' ' ASN . . . . . . . . . . . . . 4.3 t30 55.24 -153.82 0.31 Allowed 'General case' 0 CA--C 1.539 0.539 0 N-CA-C 110.017 -0.364 . . . . 0.0 110.017 -179.844 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 128' ' ' ASP . . . . . . . . . . . . . 8.2 p-10 -83.66 18.53 1.89 Allowed 'General case' 0 CA--C 1.535 0.37 0 N-CA-C 112.679 0.622 . . . . 0.0 112.679 179.269 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 129' ' ' LEU . . . . . . . . . . . . . 15.5 tp -122.94 138.25 54.72 Favored 'General case' 0 C--O 1.232 0.157 0 O-C-N 121.983 -0.448 . . . . 0.0 110.503 -179.608 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 130' ' ' VAL . . . . . 0.478 HG23 ' HB ' ' A' ' 141' ' ' ILE . 32.7 m -131.23 141.75 45.19 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.184 0 CA-C-O 120.805 0.336 . . . . 0.0 110.449 177.578 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 131' ' ' VAL . . . . . . . . . . . . . 47.9 t -136.14 138.61 46.99 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.285 0 CA-C-O 121.274 0.559 . . . . 0.0 110.682 -179.526 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 132' ' ' ILE . . . . . . . . . . . . . 72.1 mt -111.74 133.27 57.92 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.329 0 CA-C-N 115.41 -0.814 . . . . 0.0 109.135 178.089 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 133' ' ' ILE . . . . . . . . . . . . . 43.4 mm -114.82 120.04 63.35 Favored 'Isoleucine or valine' 0 C--O 1.233 0.229 0 CA-C-O 120.884 0.373 . . . . 0.0 110.964 -175.294 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 134' ' ' ASP . . . . . . . . . . . . . 6.2 p-10 -130.46 144.83 51.65 Favored 'General case' 0 C--N 1.331 -0.227 0 N-CA-C 109.366 -0.605 . . . . 0.0 109.366 173.83 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 135' ' ' GLU . . . . . . . . . . . . . 43.4 tp10 -49.78 -24.97 2.65 Favored 'General case' 0 C--N 1.328 -0.334 0 N-CA-C 112.793 0.664 . . . . 0.0 112.793 -170.799 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 136' ' ' GLN . . . . . . . . . . . . . 96.0 mt-30 -91.53 -40.08 11.57 Favored 'General case' 0 C--N 1.331 -0.231 0 N-CA-C 112.305 0.483 . . . . 0.0 112.305 -177.389 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 137' ' ' LYS . . . . . . . . . . . . . 61.2 mtpt -141.96 155.81 45.47 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-O 121.34 0.59 . . . . 0.0 111.718 -167.989 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 138' ' ' LEU . . . . . 0.426 ' C ' HD23 ' A' ' 138' ' ' LEU . 5.9 tt -116.0 124.69 51.13 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 115.519 -0.764 . . . . 0.0 109.177 173.832 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 139' ' ' THR . . . . . . . . . . . . . 31.1 m -111.12 124.38 52.08 Favored 'General case' 0 C--N 1.331 -0.196 0 CA-C-N 116.438 -0.346 . . . . 0.0 110.794 -176.993 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 140' ' ' LEU . . . . . 0.479 HD23 ' C ' ' A' ' 140' ' ' LEU . 9.9 tt -112.07 126.85 55.62 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 115.762 -0.653 . . . . 0.0 109.591 -178.468 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 141' ' ' ILE . . . . . 0.478 ' HB ' HG23 ' A' ' 130' ' ' VAL . 19.5 mt -125.21 123.88 66.15 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.302 0 CA-C-O 121.008 0.432 . . . . 0.0 109.873 -176.543 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 142' ' ' ARG . . . . . . . . . . . . . 61.5 ttt180 -110.06 124.88 52.27 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 115.119 -0.946 . . . . 0.0 110.459 -177.794 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 143' ' ' THR . . . . . . . . . . . . . 9.3 p . . . . . 0 C--O 1.22 -0.49 0 CA-C-O 117.979 -1.01 . . . . 0.0 110.592 179.959 . . . . . . . . 0 0 . 1 . 011 nuclear build full ' B' B ' -3' ' ' GLU . . . . . . . . . . . . . 95.2 mt-10 . . . . . 0 N--CA 1.49 1.553 0 N-CA-C 109.319 -0.623 . . . . 0.0 109.319 . . . . . . . . . 0 0 . 1 . 011 nuclear build full ' B' B ' -2' ' ' GLY . . . . . . . . . . . . . . . -72.55 135.2 21.78 Favored Glycine 0 CA--C 1.524 0.652 0 N-CA-C 111.059 -0.816 . . . . 0.0 111.059 -179.668 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' B' B ' -1' ' ' VAL . . . . . . . . . . . . . 46.4 t -96.52 136.08 28.52 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.284 0 N-CA-C 109.871 -0.418 . . . . 0.0 109.871 179.072 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' B' B ' 0' ' ' ILE . . . . . . . . . . . . . 71.9 mt -109.66 132.01 59.02 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.234 0 CA-C-N 116.27 -0.423 . . . . 0.0 110.053 -179.058 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' B' B ' 1' ' ' MET . . . . . . . . . . . . . 25.0 ptp -88.04 134.08 33.82 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.05 -0.523 . . . . 0.0 110.429 178.938 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' B' B ' 2' ' ' SER . . . . . . . . . . . . . 11.6 p -112.89 134.45 54.4 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-O 120.953 0.406 . . . . 0.0 110.549 179.976 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' B' B ' 3' ' ' GLU . . . . . . . . . . . . . 95.0 mt-10 -140.91 140.48 34.5 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 115.941 -0.572 . . . . 0.0 111.0 -178.762 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' B' B ' 4' ' ' LEU . . . . . . . . . . . . . 18.2 tp -125.23 130.73 52.68 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 115.915 -0.584 . . . . 0.0 110.119 176.558 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' B' B ' 5' ' ' LYS . . . . . . . . . . . . . 93.6 mttt -112.19 121.43 44.9 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-O 120.843 0.354 . . . . 0.0 110.569 179.588 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' B' B ' 6' ' ' LEU . . . . . . . . . . . . . 62.7 mt -114.1 147.16 39.22 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 115.388 -0.823 . . . . 0.0 111.157 -177.869 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' B' B ' 7' ' ' LYS . . . . . . . . . . . . . 79.4 tttt -137.0 140.26 31.0 Favored Pre-proline 0 CA--C 1.534 0.333 0 CA-C-N 116.07 -0.514 . . . . 0.0 109.724 175.715 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' B' B ' 8' ' ' PRO . . . . . . . . . . . . . 89.4 Cg_endo -91.58 146.45 3.31 Favored 'Trans proline' 0 N--CA 1.491 1.333 0 C-N-CA 121.735 1.624 . . . . 0.0 111.972 178.968 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' B' B ' 9' ' ' LEU . . . . . . . . . . . . . 41.4 mt -82.57 -46.84 0.91 Allowed Pre-proline 0 CA--C 1.534 0.353 0 CA-C-O 118.78 -0.628 . . . . 0.0 111.909 179.317 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' B' B ' 10' ' ' PRO . . . . . . . . . . . . . 94.3 Cg_endo -82.05 155.84 17.42 Favored 'Trans proline' 0 N--CA 1.495 1.56 0 C-N-CA 121.253 1.302 . . . . 0.0 111.767 174.433 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' B' B ' 11' ' ' LYS . . . . . . . . . . . . . 92.2 mttt -88.53 98.43 11.64 Favored 'General case' 0 C--N 1.329 -0.316 0 C-N-CA 120.883 -0.327 . . . . 0.0 110.513 178.725 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' B' B ' 12' ' ' VAL . . . . . . . . . . . . . 12.2 p -140.34 147.4 23.34 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.302 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.433 -179.976 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' B' B ' 13' ' ' GLU . . . . . . . . . . . . . 43.0 tp10 -89.21 129.93 35.7 Favored 'General case' 0 C--N 1.329 -0.298 0 N-CA-C 109.862 -0.421 . . . . 0.0 109.862 178.298 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' B' B ' 14' ' ' LEU . . . . . . . . . . . . . 53.8 mt -97.33 147.58 33.16 Favored Pre-proline 0 CA--C 1.532 0.286 0 CA-C-O 119.196 -0.43 . . . . 0.0 110.727 -176.94 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' B' B ' 15' ' ' PRO . . . . . . . . . . . . . 24.4 Cg_exo -63.31 161.11 32.03 Favored 'Trans proline' 0 N--CA 1.498 1.738 0 C-N-CA 121.248 1.299 . . . . 0.0 111.762 175.881 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' B' B ' 16' ' ' PRO . . . . . . . . . . . . . 31.2 Cg_exo -59.24 -38.15 87.22 Favored 'Trans proline' 0 N--CA 1.497 1.721 0 C-N-CA 121.471 1.447 . . . . 0.0 112.78 -177.706 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' B' B ' 17' ' ' ASP . . . . . . . . . . . . . 18.2 p-10 -88.79 9.44 24.58 Favored 'General case' 0 CA--C 1.536 0.419 0 N-CA-C 113.243 0.831 . . . . 0.0 113.243 -177.735 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' B' B ' 18' ' ' PHE . . . . . . . . . . . . . 34.2 t80 -58.25 -43.74 88.01 Favored 'General case' 0 C--N 1.334 -0.081 0 O-C-N 122.023 -0.423 . . . . 0.0 109.9 -178.446 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' B' B ' 19' ' ' VAL . . . . . . . . . . . . . 53.9 t -56.92 -42.91 79.54 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.369 0 CA-C-N 116.18 -0.464 . . . . 0.0 110.494 -179.479 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' B' B ' 20' ' ' ASP . . . . . . . . . . . . . 10.4 t0 -60.04 -42.6 94.77 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-O 120.847 0.356 . . . . 0.0 111.049 -177.796 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' B' B ' 21' ' ' VAL . . . . . . . . . . . . . 51.3 t -64.25 -47.01 91.67 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.335 0 CA-C-N 116.448 -0.342 . . . . 0.0 110.515 -177.685 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' B' B ' 22' ' ' ILE . . . . . 0.507 HG22 HD12 ' B' ' 26' ' ' LEU . 49.7 mm -56.48 -45.42 81.97 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.252 0 C-N-CA 120.982 -0.287 . . . . 0.0 110.572 178.819 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' B' B ' 23' ' ' ARG . . . . . . . . . . . . . 24.8 ttp180 -53.8 -50.16 66.75 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-O 120.58 0.229 . . . . 0.0 111.48 -178.446 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' B' B ' 24' ' ' ILE . . . . . . . . . . . . . 73.9 mt -59.86 -45.15 95.27 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.316 0 CA-C-N 116.574 -0.284 . . . . 0.0 111.281 -176.536 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' B' B ' 25' ' ' LYS . . . . . . . . . . . . . 50.2 mttm -65.44 -39.28 91.86 Favored 'General case' 0 C--N 1.329 -0.289 0 N-CA-C 112.607 0.595 . . . . 0.0 112.607 -177.629 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' B' B ' 26' ' ' LEU . . . . . 0.507 HD12 HG22 ' B' ' 22' ' ' ILE . 26.8 mt -77.55 -43.19 32.69 Favored 'General case' 0 C--N 1.33 -0.272 0 N-CA-C 112.763 0.653 . . . . 0.0 112.763 -172.838 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' B' B ' 27' ' ' GLN . . . . . . . . . . . . . 13.3 pt20 -47.0 137.49 7.42 Favored 'General case' 0 N--CA 1.469 0.51 0 N-CA-C 112.629 0.603 . . . . 0.0 112.629 -177.071 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' B' B ' 28' ' ' GLY . . . . . . . . . . . . . . . 100.72 -26.84 23.13 Favored Glycine 0 CA--C 1.533 1.183 0 CA-C-N 115.565 -0.743 . . . . 0.0 112.209 -176.477 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' B' B ' 29' ' ' LYS . . . . . . . . . . . . . 94.8 mttt -98.38 155.13 17.38 Favored 'General case' 0 C--O 1.232 0.166 0 CA-C-N 117.219 0.509 . . . . 0.0 110.842 178.555 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' B' B ' 30' ' ' THR . . . . . . . . . . . . . 28.5 m -103.04 136.45 42.82 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.279 -0.419 . . . . 0.0 109.962 175.269 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' B' B ' 31' ' ' VAL . . . . . . . . . . . . . 35.5 m -128.99 153.39 38.52 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.216 0 CA-C-O 121.047 0.451 . . . . 0.0 111.019 -177.856 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' B' B ' 32' ' ' ARG . . . . . . . . . . . . . 90.0 mtm-85 -128.81 148.98 50.92 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 115.905 -0.589 . . . . 0.0 110.457 178.877 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' B' B ' 33' ' ' THR . . . . . . . . . . . . . 18.7 m -53.42 138.6 32.86 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.326 -0.397 . . . . 0.0 111.279 -177.978 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' B' B ' 34' ' ' GLY . . . . . . . . . . . . . . . 101.06 -17.1 56.62 Favored Glycine 0 CA--C 1.533 1.167 0 CA-C-O 119.609 -0.55 . . . . 0.0 113.284 179.574 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' B' B ' 35' ' ' ASP . . . . . . . . . . . . . 69.0 m-20 -64.26 148.88 49.18 Favored 'General case' 0 C--N 1.334 -0.106 0 CA-C-N 118.07 0.935 . . . . 0.0 111.029 179.537 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' B' B ' 36' ' ' VAL . . . . . . . . . . . . . 45.6 t -123.8 131.58 72.77 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.215 0 CA-C-N 115.774 -0.648 . . . . 0.0 109.8 178.899 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' B' B ' 37' ' ' ILE . . . . . . . . . . . . . 65.6 mt -121.2 139.23 49.04 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.217 0 CA-C-N 116.197 -0.456 . . . . 0.0 109.973 -179.925 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' B' B ' 38' ' ' GLY . . . . . . . . . . . . . . . -112.31 128.78 8.68 Favored Glycine 0 CA--C 1.526 0.767 0 N-CA-C 111.033 -0.827 . . . . 0.0 111.033 179.799 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' B' B ' 39' ' ' ILE . . . . . . . . . . . . . 71.6 mt -124.12 134.81 65.56 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.21 0 N-CA-C 110.091 -0.337 . . . . 0.0 110.091 179.199 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' B' B ' 40' ' ' SER . . . . . . . . . . . . . 95.0 p -93.64 124.49 37.66 Favored 'General case' 0 C--N 1.331 -0.225 0 CA-C-N 116.338 -0.392 . . . . 0.0 111.096 176.24 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' B' B ' 41' ' ' ILE . . . . . . . . . . . . . 75.0 mt -130.63 122.5 52.87 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.254 0 CA-C-N 116.488 -0.324 . . . . 0.0 110.331 176.749 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' B' B ' 42' ' ' LEU . . . . . . . . . . . . . 6.6 tp 52.16 36.03 18.11 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 116.279 -0.419 . . . . 0.0 111.652 176.823 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' B' B ' 43' ' ' GLY . . . . . . . . . . . . . . . 71.84 32.56 63.7 Favored Glycine 0 CA--C 1.529 0.964 0 C-N-CA 121.085 -0.578 . . . . 0.0 112.033 178.543 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' B' B ' 44' ' ' LYS . . . . . . . . . . . . . 84.8 tttt -137.19 127.18 25.87 Favored 'General case' 0 C--N 1.328 -0.356 0 N-CA-C 109.74 -0.467 . . . . 0.0 109.74 178.915 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' B' B ' 45' ' ' GLU . . . . . . . . . . . . . 84.7 tt0 -83.01 122.84 28.83 Favored 'General case' 0 C--N 1.327 -0.409 0 CA-C-O 120.802 0.334 . . . . 0.0 110.923 -178.874 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' B' B ' 46' ' ' VAL . . . . . . . . . . . . . 7.6 p -120.16 127.74 75.92 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.229 0 N-CA-C 109.35 -0.611 . . . . 0.0 109.35 175.35 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' B' B ' 47' ' ' LYS . . . . . . . . . . . . . 58.2 mtpt -101.26 128.14 47.53 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 115.798 -0.637 . . . . 0.0 111.148 -179.658 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' B' B ' 48' ' ' PHE . . . . . . . . . . . . . 95.6 m-85 -112.44 131.94 55.3 Favored 'General case' 0 C--N 1.331 -0.223 0 CA-C-N 116.335 -0.393 . . . . 0.0 110.196 176.946 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' B' B ' 49' ' ' LYS . . . . . . . . . . . . . 74.4 tttt -108.39 137.45 46.33 Favored 'General case' 0 C--N 1.331 -0.229 0 CA-C-N 116.449 -0.342 . . . . 0.0 110.664 179.022 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' B' B ' 50' ' ' VAL . . . . . . . . . . . . . 47.1 t -82.88 110.59 18.1 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.254 0 N-CA-C 109.434 -0.58 . . . . 0.0 109.434 176.265 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' B' B ' 51' ' ' VAL . . . . . . . . . . . . . 47.5 t -73.78 -51.53 24.27 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.231 0 CA-C-N 116.108 -0.496 . . . . 0.0 109.754 -174.774 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' B' B ' 52' ' ' GLN . . . . . . . . . . . . . 92.6 mt-30 -153.26 152.82 31.61 Favored 'General case' 0 C--N 1.331 -0.211 0 CA-C-O 121.176 0.513 . . . . 0.0 111.82 -177.739 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' B' B ' 53' ' ' ALA . . . . . . . . . . . . . . . -132.27 133.59 44.28 Favored 'General case' 0 C--N 1.327 -0.404 0 CA-C-N 115.113 -0.949 . . . . 0.0 109.677 174.9 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' B' B ' 54' ' ' TYR . . . . . . . . . . . . . 63.1 t80 -129.2 113.6 18.43 Favored Pre-proline 0 CA--C 1.536 0.411 0 CA-C-O 118.077 -0.963 . . . . 0.0 110.569 179.07 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' B' B ' 55' ' ' PRO . . . . . . . . . . . . . 71.8 Cg_endo -77.25 164.11 87.57 Favored 'Cis proline' 0 N--CA 1.5 1.879 0 CA-C-N 121.993 1.748 . . . . 0.0 112.123 -8.831 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' B' B ' 56' ' ' SER . . . . . . . . . . . . . 13.7 m -114.03 132.82 22.51 Favored Pre-proline 0 CA--C 1.539 0.52 0 CA-C-O 118.495 -0.764 . . . . 0.0 109.388 175.173 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' B' B ' 57' ' ' PRO . . . . . . . . . . . . . 43.5 Cg_endo -69.02 143.81 73.45 Favored 'Cis proline' 0 N--CA 1.498 1.763 0 CA-C-N 121.865 1.702 . . . . 0.0 111.439 -0.713 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' B' B ' 58' ' ' LEU . . . . . . . . . . . . . 24.2 tp -105.68 135.51 46.96 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.382 -0.372 . . . . 0.0 110.667 -178.282 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' B' B ' 59' ' ' ARG . . . . . . . . . . . . . 41.7 ttm180 -99.98 121.54 41.51 Favored 'General case' 0 C--N 1.326 -0.438 0 N-CA-C 108.983 -0.747 . . . . 0.0 108.983 174.133 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' B' B ' 60' ' ' VAL . . . . . . . . . . . . . 39.9 t -79.53 122.57 35.02 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.225 0 C-N-CA 120.587 -0.445 . . . . 0.0 110.205 -174.107 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' B' B ' 61' ' ' GLU . . . . . . . . . . . . . 34.9 tp10 -130.89 156.7 44.61 Favored 'General case' 0 C--N 1.329 -0.32 0 N-CA-C 109.071 -0.715 . . . . 0.0 109.071 179.131 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' B' B ' 62' ' ' ASP . . . . . . . . . . . . . 5.5 t70 -51.42 -32.53 26.83 Favored 'General case' 0 C--N 1.326 -0.454 0 N-CA-C 111.946 0.35 . . . . 0.0 111.946 -178.945 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' B' B ' 63' ' ' ARG . . . . . . . . . . . . . 48.0 mmm-85 -73.91 -19.17 60.78 Favored 'General case' 0 CA--C 1.536 0.431 0 N-CA-C 113.095 0.776 . . . . 0.0 113.095 -176.928 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' B' B ' 64' ' ' THR . . . . . . . . . . . . . 32.0 m -67.9 141.69 56.3 Favored 'General case' 0 C--N 1.331 -0.209 0 CA-C-O 120.978 0.418 . . . . 0.0 111.114 -175.307 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' B' B ' 65' ' ' LYS . . . . . . . . . . . . . 68.4 mttm -90.23 132.88 35.26 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 115.833 -0.621 . . . . 0.0 110.322 179.639 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' B' B ' 66' ' ' ILE . . . . . . . . . . . . . 66.4 mt -112.56 131.2 64.75 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.239 0 N-CA-C 109.865 -0.42 . . . . 0.0 109.865 179.574 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' B' B ' 67' ' ' THR . . . . . . . . . . . . . 22.6 m -126.05 142.84 51.35 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-N 115.989 -0.551 . . . . 0.0 110.917 -177.723 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' B' B ' 68' ' ' LEU . . . . . . . . . . . . . 16.5 tp -98.69 141.21 31.8 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 115.845 -0.616 . . . . 0.0 109.829 177.282 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' B' B ' 69' ' ' VAL . . . . . . . . . . . . . 42.5 t -82.9 136.93 21.86 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.292 0 CA-C-O 121.3 0.572 . . . . 0.0 110.231 -178.231 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' B' B ' 70' ' ' THR . . . . . . . . . . . . . 12.2 t -89.61 -169.89 2.63 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 115.34 -0.845 . . . . 0.0 111.058 -176.328 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' B' B ' 71' ' ' HIS . . . . . . . . . . . . . 2.0 m-70 -64.82 172.94 1.87 Allowed Pre-proline 0 CA--C 1.533 0.305 0 CA-C-N 116.284 -0.416 . . . . 0.0 110.028 -177.975 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' B' B ' 72' ' ' PRO . . . . . . . . . . . . . 23.6 Cg_exo -64.74 1.06 1.99 Allowed 'Trans proline' 0 N--CA 1.498 1.784 0 C-N-CA 121.309 1.339 . . . . 0.0 113.985 -174.469 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' B' B ' 73' ' ' VAL . . . . . . . . . . . . . 27.6 m -104.64 145.17 13.53 Favored 'Isoleucine or valine' 0 C--O 1.232 0.164 0 N-CA-C 109.422 -0.584 . . . . 0.0 109.422 170.841 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' B' B ' 74' ' ' ASP . . . . . . . . . . . . . 36.2 t0 -92.62 123.71 36.12 Favored 'General case' 0 C--N 1.327 -0.397 0 CA-C-N 116.252 -0.431 . . . . 0.0 110.195 -176.764 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' B' B ' 75' ' ' VAL . . . . . . . . . . . . . 43.0 t -118.23 123.64 71.92 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.267 0 CA-C-O 121.16 0.505 . . . . 0.0 110.455 -178.592 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' B' B ' 76' ' ' LEU . . . . . . . . . . . . . 5.7 mp -123.48 146.04 48.36 Favored 'General case' 0 C--N 1.331 -0.22 0 CA-C-N 115.572 -0.74 . . . . 0.0 109.554 175.812 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' B' B ' 77' ' ' GLU . . . . . . . . . . . . . 96.9 mt-10 -134.5 132.29 39.05 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-O 121.085 0.469 . . . . 0.0 111.106 -178.267 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' B' B ' 78' ' ' ALA . . . . . . . . . . . . . . . -117.18 136.81 52.77 Favored 'General case' 0 C--N 1.331 -0.229 0 CA-C-N 115.657 -0.701 . . . . 0.0 109.91 176.898 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' B' B ' 79' ' ' LYS . . . . . 0.61 ' O ' HD13 ' B' ' 80' ' ' ILE . 55.6 mtmt -85.37 112.8 21.16 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.501 -0.318 . . . . 0.0 110.721 -178.359 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' B' B ' 80' ' ' ILE . . . . . 0.61 HD13 ' O ' ' B' ' 79' ' ' LYS . 41.0 mm -139.04 104.2 2.18 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.302 0 N-CA-C 109.33 -0.619 . . . . 0.0 109.33 -178.164 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' B' B ' 81' ' ' LYS . . . . . . . . . . . . . 52.9 pttt -98.99 130.87 45.36 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-O 120.923 0.392 . . . . 0.0 111.123 -178.497 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' B' B ' 82' ' ' GLY . . . . . . . . . . . . . . . 89.22 42.1 5.66 Favored Glycine 0 CA--C 1.524 0.649 0 N-CA-C 111.191 -0.764 . . . . 0.0 111.191 178.087 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' B' B ' 83' ' ' ILE . . . . . . . . . . . . . 66.6 mt -70.23 135.55 27.94 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.342 0 N-CA-C 109.539 -0.541 . . . . 0.0 109.539 177.676 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' B' B ' 84' ' ' LYS . . . . . . . . . . . . . 16.4 ttmm -89.37 -52.24 5.14 Favored 'General case' 0 C--N 1.328 -0.36 0 N-CA-C 109.734 -0.469 . . . . 0.0 109.734 179.687 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' B' B ' 85' ' ' ASP . . . . . . . . . . . . . 8.5 t70 -160.46 154.39 22.84 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 115.615 -0.72 . . . . 0.0 110.476 178.845 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' B' B ' 86' ' ' VAL . . . . . . . . . . . . . 40.5 t -128.34 131.47 69.03 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.259 0 CA-C-O 120.89 0.376 . . . . 0.0 110.194 179.985 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' B' B ' 87' ' ' ILE . . . . . 0.491 ' N ' HD12 ' B' ' 87' ' ' ILE . 5.0 mp -120.54 127.12 75.89 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.238 0 CA-C-N 116.021 -0.536 . . . . 0.0 109.755 177.855 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' B' B ' 88' ' ' LEU . . . . . . . . . . . . . 42.4 mt -104.75 139.78 39.04 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 116.248 -0.433 . . . . 0.0 111.0 -179.842 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' B' B ' 89' ' ' ASP . . . . . . . . . . . . . 9.5 t70 -132.98 158.4 42.77 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 115.922 -0.581 . . . . 0.0 109.672 176.917 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' B' B ' 90' ' ' GLU . . . . . . . . . . . . . 43.0 mt-10 -46.83 -39.69 12.43 Favored 'General case' 0 C--N 1.329 -0.306 0 N-CA-C 113.139 0.792 . . . . 0.0 113.139 -170.469 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' B' B ' 91' ' ' ASN . . . . . . . . . . . . . 29.2 m-80 -131.99 21.33 4.52 Favored 'General case' 0 N--CA 1.468 0.444 0 N-CA-C 113.044 0.757 . . . . 0.0 113.044 -177.591 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' B' B ' 92' ' ' LEU . . . . . . . . . . . . . 34.1 mt -150.37 150.34 31.28 Favored 'General case' 0 C--N 1.331 -0.222 0 CA-C-O 120.766 0.317 . . . . 0.0 110.451 -176.923 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' B' B ' 93' ' ' ILE . . . . . . . . . . . . . 73.3 mt -127.07 121.48 57.97 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.251 0 N-CA-C 109.133 -0.691 . . . . 0.0 109.133 175.361 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' B' B ' 94' ' ' VAL . . . . . . . . . . . . . 46.9 t -118.64 126.25 75.05 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.215 0 N-CA-C 109.814 -0.439 . . . . 0.0 109.814 -179.192 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' B' B ' 95' ' ' VAL . . . . . . . . . . . . . 46.5 t -118.91 133.19 66.56 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.316 0 CA-C-N 115.901 -0.591 . . . . 0.0 109.643 -179.951 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' B' B ' 96' ' ' ILE . . . . . . . . . . . . . 64.4 mt -111.91 126.22 69.28 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.317 0 N-CA-C 109.081 -0.711 . . . . 0.0 109.081 178.982 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' B' B ' 97' ' ' THR . . . . . . . . . . . . . 74.3 p -99.34 154.12 18.44 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-O 121.192 0.52 . . . . 0.0 111.117 -176.877 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' B' B ' 98' ' ' GLU . . . . . . . . . . . . . 84.9 tt0 -53.88 -25.51 20.34 Favored 'General case' 0 CA--C 1.535 0.372 0 CA-C-N 116.069 -0.514 . . . . 0.0 112.231 -179.513 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' B' B ' 99' ' ' GLU . . . . . . . . . . . . . 45.5 mp0 -80.91 18.08 1.08 Allowed 'General case' 0 CA--C 1.535 0.386 0 N-CA-C 112.989 0.737 . . . . 0.0 112.989 -176.619 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' B' B ' 100' ' ' ASN . . . . . . . . . . . . . 3.1 m-20 62.4 37.97 13.24 Favored 'General case' 0 C--O 1.232 0.171 0 CA-C-O 121.193 0.52 . . . . 0.0 110.997 178.121 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' B' B ' 101' ' ' GLU . . . . . . . . . . . . . 84.8 tt0 -118.77 144.77 46.08 Favored 'General case' 0 C--N 1.332 -0.175 0 CA-C-N 116.211 -0.449 . . . . 0.0 109.954 177.136 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' B' B ' 102' ' ' VAL . . . . . . . . . . . . . 44.1 t -115.09 125.34 72.37 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.29 0 N-CA-C 109.797 -0.445 . . . . 0.0 109.797 -178.034 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' B' B ' 103' ' ' LEU . . . . . . . . . . . . . 34.6 mt -117.07 130.23 56.52 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-N 115.814 -0.63 . . . . 0.0 110.006 177.874 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' B' B ' 104' ' ' ILE . . . . . . . . . . . . . 69.7 mt -118.05 122.73 70.37 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.249 0 N-CA-C 110.222 -0.288 . . . . 0.0 110.222 -179.115 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' B' B ' 105' ' ' PHE . . . . . . . . . . . . . 90.9 m-85 -122.77 164.31 18.59 Favored 'General case' 0 C--N 1.332 -0.168 0 O-C-N 123.783 0.677 . . . . 0.0 110.236 -178.496 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' B' B ' 106' ' ' ASN . . . . . . . . . . . . . 49.6 p-10 -98.14 -170.74 2.02 Favored 'General case' 0 C--N 1.33 -0.28 0 N-CA-C 109.866 -0.42 . . . . 0.0 109.866 174.933 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' B' B ' 107' ' ' GLN . . . . . . . . . . . . . 58.9 tt0 -58.24 -30.01 66.2 Favored 'General case' 0 C--N 1.328 -0.332 0 N-CA-C 112.038 0.384 . . . . 0.0 112.038 -178.407 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' B' B ' 108' ' ' ASN . . . . . . . . . . . . . 10.6 t-20 -89.88 14.02 13.11 Favored 'General case' 0 CA--C 1.534 0.348 0 N-CA-C 113.098 0.777 . . . . 0.0 113.098 -176.033 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' B' B ' 109' ' ' LEU . . . . . . . . . . . . . 14.5 mt 58.61 35.38 24.49 Favored 'General case' 0 C--N 1.331 -0.201 0 CA-C-O 120.924 0.392 . . . . 0.0 111.502 179.628 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' B' B ' 110' ' ' GLU . . . . . . . . . . . . . 96.5 mt-10 -101.92 143.3 31.97 Favored 'General case' 0 C--N 1.328 -0.34 0 N-CA-C 109.189 -0.671 . . . . 0.0 109.189 174.392 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' B' B ' 111' ' ' GLU . . . . . . . . . . . . . 51.1 tt0 -81.23 121.83 26.65 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-O 120.97 0.414 . . . . 0.0 110.653 -175.299 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' B' B ' 112' ' ' LEU . . . . . . . . . . . . . 23.2 mt -103.67 -46.09 4.63 Favored 'General case' 0 C--N 1.331 -0.212 0 CA-C-N 115.88 -0.6 . . . . 0.0 110.691 179.668 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' B' B ' 113' ' ' TYR . . . . . . . . . . . . . 58.7 t80 -137.67 146.73 44.19 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.961 -178.929 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' B' B ' 114' ' ' ARG . . . . . . . . . . . . . 30.4 ptt180 -149.69 124.58 9.92 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-N 116.158 -0.473 . . . . 0.0 111.051 -178.527 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' B' B ' 115' ' ' GLY . . . . . . . . . . . . . . . -150.16 162.42 29.21 Favored Glycine 0 CA--C 1.525 0.692 0 N-CA-C 110.928 -0.869 . . . . 0.0 110.928 178.806 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' B' B ' 116' ' ' LYS . . . . . . . . . . . . . 38.3 ttpt -131.95 138.67 48.42 Favored 'General case' 0 C--N 1.33 -0.259 0 N-CA-C 109.979 -0.378 . . . . 0.0 109.979 177.13 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' B' B ' 117' ' ' PHE . . . . . . . . . . . . . 41.8 m-85 -136.37 117.31 14.23 Favored 'General case' 0 C--N 1.331 -0.227 0 C-N-CA 120.874 -0.331 . . . . 0.0 110.362 -175.716 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' B' B ' 118' ' ' GLU . . . . . . . . . . . . . 70.6 mm-40 -54.11 -45.23 71.82 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.616 -0.265 . . . . 0.0 111.246 -177.515 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' B' B ' 119' ' ' ASN . . . . . . . . . . . . . 84.1 m-20 -98.87 31.06 3.09 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.181 -0.463 . . . . 0.0 112.171 -174.479 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' B' B ' 120' ' ' LEU . . . . . . . . . . . . . 23.0 tp -56.23 120.78 8.13 Favored 'General case' 0 C--N 1.332 -0.17 0 CA-C-O 120.626 0.25 . . . . 0.0 110.393 178.512 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' B' B ' 121' ' ' ASN . . . . . . . . . . . . . 34.3 m120 -109.66 -44.21 3.9 Favored 'General case' 0 N--CA 1.462 0.152 0 CA-C-N 116.649 -0.251 . . . . 0.0 111.211 -176.118 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' B' B ' 122' ' ' LYS . . . . . . . . . . . . . 94.3 mttt -147.94 148.14 30.47 Favored 'General case' 0 C--N 1.333 -0.139 0 C-N-CA 120.392 -0.523 . . . . 0.0 111.966 -177.918 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' B' B ' 123' ' ' VAL . . . . . . . . . . . . . 48.0 t -124.09 128.17 73.88 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.255 0 N-CA-C 109.251 -0.648 . . . . 0.0 109.251 173.792 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' B' B ' 124' ' ' LEU . . . . . . . . . . . . . 12.9 tp -129.07 132.42 47.43 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-O 120.651 0.262 . . . . 0.0 110.729 -177.092 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' B' B ' 125' ' ' VAL . . . . . . . . . . . . . 12.3 p -135.45 136.08 51.17 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.23 0 CA-C-O 120.735 0.302 . . . . 0.0 110.393 179.095 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' B' B ' 126' ' ' ARG . . . . . . . . . . . . . 96.4 mtt180 -148.72 134.16 18.58 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-O 120.977 0.418 . . . . 0.0 111.052 179.583 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' B' B ' 127' ' ' ASN . . . . . . . . . . . . . 86.3 m-20 50.32 -111.52 0.52 Allowed 'General case' 0 CA--C 1.545 0.778 0 CA-C-O 118.786 -0.626 . . . . 0.0 111.398 178.827 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' B' B ' 128' ' ' ASP . . . . . . . . . . . . . 8.2 p-10 -114.12 8.62 17.01 Favored 'General case' 0 CA--C 1.536 0.423 0 CA-C-N 119.908 1.231 . . . . 0.0 113.322 -176.934 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' B' B ' 129' ' ' LEU . . . . . . . . . . . . . 42.3 mt -117.72 144.75 44.99 Favored 'General case' 0 C--O 1.232 0.134 0 CA-C-N 118.028 0.376 . . . . 0.0 110.197 179.73 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' B' B ' 130' ' ' VAL . . . . . 0.506 HG13 ' HB ' ' B' ' 141' ' ' ILE . 12.1 p -132.97 140.31 47.58 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.212 0 CA-C-O 120.967 0.413 . . . . 0.0 110.366 -179.572 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' B' B ' 131' ' ' VAL . . . . . 0.565 HG22 HD12 ' B' ' 140' ' ' LEU . 44.1 t -136.01 139.95 44.9 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.287 0 CA-C-N 116.046 -0.524 . . . . 0.0 110.337 -178.531 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' B' B ' 132' ' ' ILE . . . . . . . . . . . . . 74.4 mt -115.92 131.43 68.39 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.364 0 CA-C-N 115.548 -0.751 . . . . 0.0 109.05 177.735 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' B' B ' 133' ' ' ILE . . . . . . . . . . . . . 42.9 mm -114.86 121.07 66.2 Favored 'Isoleucine or valine' 0 C--O 1.234 0.252 0 CA-C-O 120.867 0.365 . . . . 0.0 111.027 -174.744 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' B' B ' 134' ' ' ASP . . . . . . . . . . . . . 6.3 p-10 -129.74 146.41 51.5 Favored 'General case' 0 C--N 1.332 -0.191 0 CA-C-N 115.834 -0.621 . . . . 0.0 109.485 174.605 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' B' B ' 135' ' ' GLU . . . . . . . . . . . . . 41.7 tp10 -49.9 -24.25 2.4 Favored 'General case' 0 C--N 1.328 -0.369 0 N-CA-C 112.976 0.732 . . . . 0.0 112.976 -169.808 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' B' B ' 136' ' ' GLN . . . . . . . . . . . . . 21.3 pt20 -102.4 -30.45 11.02 Favored 'General case' 0 CA--C 1.532 0.255 0 N-CA-C 112.709 0.633 . . . . 0.0 112.709 -174.603 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' B' B ' 137' ' ' LYS . . . . . . . . . . . . . 27.4 mtpp -141.48 153.86 45.2 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-O 121.278 0.561 . . . . 0.0 111.519 -172.044 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' B' B ' 138' ' ' LEU . . . . . . . . . . . . . 5.0 tt -114.94 124.43 51.66 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 115.615 -0.72 . . . . 0.0 109.382 174.72 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' B' B ' 139' ' ' THR . . . . . . . . . . . . . 44.0 m -108.04 122.97 47.96 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.471 -0.331 . . . . 0.0 110.727 -177.994 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' B' B ' 140' ' ' LEU . . . . . 0.565 HD12 HG22 ' B' ' 131' ' ' VAL . 38.8 tp -112.97 121.56 45.0 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 115.665 -0.698 . . . . 0.0 109.322 -179.294 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' B' B ' 141' ' ' ILE . . . . . 0.506 ' HB ' HG13 ' B' ' 130' ' ' VAL . 19.2 mt -123.91 125.84 71.63 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.268 0 CA-C-O 121.012 0.434 . . . . 0.0 109.937 -176.991 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' B' B ' 142' ' ' ARG . . . . . . . . . . . . . 72.7 mtp180 -108.53 124.01 49.8 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 115.304 -0.862 . . . . 0.0 110.344 179.716 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' B' B ' 143' ' ' THR . . . . . . . . . . . . . 77.2 p . . . . . 0 C--O 1.219 -0.501 0 CA-C-O 118.016 -0.992 . . . . 0.0 110.522 -179.316 . . . . . . . . 0 0 . 1 . 011 nuclear build full ' C' C ' -3' ' ' GLU . . . . . . . . . . . . . 70.5 mm-40 . . . . . 0 N--CA 1.489 1.513 0 N-CA-C 109.278 -0.638 . . . . 0.0 109.278 . . . . . . . . . 0 0 . 1 . 011 nuclear build full ' C' C ' -2' ' ' GLY . . . . . . . . . . . . . . . -62.31 127.86 40.67 Favored Glycine 0 CA--C 1.526 0.743 0 N-CA-C 110.676 -0.97 . . . . 0.0 110.676 179.548 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' C' C ' -1' ' ' VAL . . . . . . . . . . . . . 46.2 t -96.58 135.85 29.33 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.321 0 CA-C-O 120.848 0.356 . . . . 0.0 110.069 -179.215 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' C' C ' 0' ' ' ILE . . . . . . . . . . . . . 71.2 mt -107.91 127.14 64.26 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.256 0 CA-C-N 116.154 -0.476 . . . . 0.0 109.845 178.675 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' C' C ' 1' ' ' MET . . . . . . . . . . . . . 25.8 ptt? -82.54 149.23 27.62 Favored 'General case' 0 C--N 1.326 -0.429 0 CA-C-N 115.935 -0.575 . . . . 0.0 110.487 179.747 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' C' C ' 2' ' ' SER . . . . . . . . . . . . . 5.5 p -107.75 132.06 53.78 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.361 -0.381 . . . . 0.0 110.128 177.143 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' C' C ' 3' ' ' GLU . . . . . . . . . . . . . 94.7 mt-10 -141.28 136.6 31.78 Favored 'General case' 0 C--N 1.327 -0.407 0 CA-C-N 116.129 -0.487 . . . . 0.0 111.066 -178.681 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' C' C ' 4' ' ' LEU . . . . . . . . . . . . . 15.2 tp -123.04 126.38 46.99 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 115.983 -0.553 . . . . 0.0 109.806 175.554 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' C' C ' 5' ' ' LYS . . . . . . . . . . . . . 69.2 mttm -113.49 121.49 44.41 Favored 'General case' 0 C--N 1.331 -0.221 0 CA-C-N 116.371 -0.377 . . . . 0.0 110.669 -179.267 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' C' C ' 6' ' ' LEU . . . . . . . . . . . . . 58.2 mt -115.83 143.57 45.22 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 115.415 -0.812 . . . . 0.0 110.264 -178.726 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' C' C ' 7' ' ' LYS . . . . . . . . . . . . . 82.8 tttt -124.19 135.17 26.09 Favored Pre-proline 0 CA--C 1.534 0.359 0 CA-C-O 118.792 -0.623 . . . . 0.0 109.575 175.098 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' C' C ' 8' ' ' PRO . . . . . . . . . . . . . 88.3 Cg_endo -91.27 137.99 2.18 Favored 'Trans proline' 0 N--CA 1.49 1.317 0 C-N-CA 121.665 1.577 . . . . 0.0 111.901 179.357 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' C' C ' 9' ' ' LEU . . . . . . . . . . . . . 65.1 mt -71.8 -47.44 12.02 Favored Pre-proline 0 CA--C 1.533 0.312 0 CA-C-O 118.725 -0.655 . . . . 0.0 112.071 179.628 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' C' C ' 10' ' ' PRO . . . . . . . . . . . . . 98.7 Cg_endo -79.53 151.95 22.78 Favored 'Trans proline' 0 N--CA 1.495 1.57 0 C-N-CA 121.156 1.237 . . . . 0.0 111.779 175.696 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' C' C ' 11' ' ' LYS . . . . . . . . . . . . . 64.3 mttp -88.32 91.83 8.93 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-O 120.783 0.325 . . . . 0.0 110.69 179.807 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' C' C ' 12' ' ' VAL . . . . . . . . . . . . . 12.6 p -140.47 145.93 25.13 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.325 0 CA-C-N 116.16 -0.473 . . . . 0.0 110.34 178.684 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' C' C ' 13' ' ' GLU . . . . . . . . . . . . . 13.9 pt-20 -86.81 134.07 33.59 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.784 179.828 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' C' C ' 14' ' ' LEU . . . . . . . . . . . . . 50.0 mt -97.65 149.33 35.6 Favored Pre-proline 0 CA--C 1.532 0.28 0 CA-C-O 119.244 -0.407 . . . . 0.0 110.27 179.492 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' C' C ' 15' ' ' PRO . . . . . . . . . . . . . 26.8 Cg_exo -60.7 160.23 25.49 Favored 'Trans proline' 0 N--CA 1.498 1.786 0 C-N-CA 121.321 1.347 . . . . 0.0 111.834 178.584 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' C' C ' 16' ' ' PRO . . . . . . . . . . . . . 33.7 Cg_exo -59.17 -41.99 54.81 Favored 'Trans proline' 0 N--CA 1.497 1.705 0 C-N-CA 121.5 1.467 . . . . 0.0 112.587 -178.16 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' C' C ' 17' ' ' ASP . . . . . . . . . . . . . 8.7 p-10 -85.27 11.07 10.78 Favored 'General case' 0 CA--C 1.537 0.456 0 N-CA-C 113.065 0.765 . . . . 0.0 113.065 -178.816 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' C' C ' 18' ' ' PHE . . . . . . . . . . . . . 51.3 t80 -58.21 -42.96 87.36 Favored 'General case' 0 C--N 1.333 -0.109 0 O-C-N 122.06 -0.4 . . . . 0.0 110.082 -177.54 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' C' C ' 19' ' ' VAL . . . . . . . . . . . . . 48.3 t -57.54 -42.09 80.34 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.319 0 CA-C-N 116.385 -0.37 . . . . 0.0 110.522 -177.919 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' C' C ' 20' ' ' ASP . . . . . . . . . . . . . 83.4 m-20 -59.86 -43.52 94.65 Favored 'General case' 0 C--O 1.234 0.261 0 CA-C-O 120.96 0.409 . . . . 0.0 110.848 -178.493 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' C' C ' 21' ' ' VAL . . . . . . . . . . . . . 49.1 t -64.39 -48.54 84.81 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.251 0 CA-C-N 116.376 -0.374 . . . . 0.0 110.433 -178.097 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' C' C ' 22' ' ' ILE . . . . . . . . . . . . . 51.7 mm -56.68 -43.05 78.31 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.254 0 C-N-CA 121.079 -0.248 . . . . 0.0 110.574 179.175 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' C' C ' 23' ' ' ARG . . . . . . . . . . . . . 47.3 ttp180 -55.06 -46.64 75.38 Favored 'General case' 0 C--N 1.33 -0.255 0 C-N-CA 121.065 -0.254 . . . . 0.0 111.212 -178.495 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' C' C ' 24' ' ' ILE . . . . . . . . . . . . . 72.4 mt -59.57 -42.95 89.8 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.229 0 C-N-CA 120.869 -0.333 . . . . 0.0 110.758 179.571 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' C' C ' 25' ' ' LYS . . . . . . . . . . . . . 45.9 mmtt -62.0 -43.35 99.03 Favored 'General case' 0 C--N 1.328 -0.36 0 N-CA-C 112.037 0.384 . . . . 0.0 112.037 -179.425 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' C' C ' 26' ' ' LEU . . . . . . . . . . . . . 92.8 mt -79.67 -39.28 31.73 Favored 'General case' 0 C--N 1.329 -0.288 0 N-CA-C 113.646 0.98 . . . . 0.0 113.646 -169.899 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' C' C ' 27' ' ' GLN . . . . . . . . . . . . . 14.1 pt20 -46.77 137.51 7.02 Favored 'General case' 0 N--CA 1.469 0.502 0 N-CA-C 112.925 0.713 . . . . 0.0 112.925 -173.627 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' C' C ' 28' ' ' GLY . . . . . . . . . . . . . . . 99.47 -25.53 27.9 Favored Glycine 0 CA--C 1.533 1.179 0 CA-C-N 115.45 -0.796 . . . . 0.0 112.367 -176.934 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' C' C ' 29' ' ' LYS . . . . . . . . . . . . . 68.5 mttm -98.38 155.16 17.36 Favored 'General case' 0 C--O 1.233 0.187 0 CA-C-N 117.256 0.528 . . . . 0.0 111.061 179.537 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' C' C ' 30' ' ' THR . . . . . . . . . . . . . 25.9 m -108.59 139.92 42.69 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.149 176.267 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' C' C ' 31' ' ' VAL . . . . . . . . . . . . . 34.6 m -130.06 153.92 39.63 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.277 0 CA-C-N 116.292 -0.413 . . . . 0.0 110.9 -178.738 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' C' C ' 32' ' ' ARG . . . . . . . . . . . . . 84.3 mtm180 -128.82 147.55 50.81 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-O 121.325 0.583 . . . . 0.0 110.702 179.436 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' C' C ' 33' ' ' THR . . . . . . . . . . . . . 19.0 m -53.58 139.8 30.57 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.133 -0.485 . . . . 0.0 111.329 -178.902 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' C' C ' 34' ' ' GLY . . . . . . . . . . . . . . . 98.45 -17.13 58.92 Favored Glycine 0 CA--C 1.533 1.207 0 CA-C-O 119.706 -0.496 . . . . 0.0 113.266 178.969 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' C' C ' 35' ' ' ASP . . . . . . . . . . . . . 81.9 m-20 -66.75 149.34 50.69 Favored 'General case' 0 N--CA 1.461 0.109 0 CA-C-N 118.017 0.908 . . . . 0.0 111.044 178.978 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' C' C ' 36' ' ' VAL . . . . . . . . . . . . . 43.6 t -118.71 128.27 75.6 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.211 0 CA-C-N 116.154 -0.475 . . . . 0.0 109.725 176.832 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' C' C ' 37' ' ' ILE . . . . . . . . . . . . . 61.6 mt -119.46 137.47 53.27 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.251 0 CA-C-N 116.105 -0.498 . . . . 0.0 109.867 -179.515 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' C' C ' 38' ' ' GLY . . . . . . . . . . . . . . . -115.45 127.9 7.82 Favored Glycine 0 CA--C 1.525 0.668 0 N-CA-C 110.95 -0.86 . . . . 0.0 110.95 178.971 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' C' C ' 39' ' ' ILE . . . . . . . . . . . . . 70.5 mt -126.72 127.78 70.41 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.232 0 N-CA-C 109.905 -0.405 . . . . 0.0 109.905 178.493 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' C' C ' 40' ' ' SER . . . . . . . . . . . . . 60.4 p -91.97 119.63 31.88 Favored 'General case' 0 C--N 1.33 -0.264 0 C-N-CA 120.968 -0.293 . . . . 0.0 110.667 176.463 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' C' C ' 41' ' ' ILE . . . . . . . . . . . . . 73.3 mt -131.45 130.33 62.62 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.215 0 CA-C-O 120.868 0.366 . . . . 0.0 110.367 179.708 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' C' C ' 42' ' ' LEU . . . . . . . . . . . . . 72.8 mt 57.38 33.06 22.76 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 116.105 -0.498 . . . . 0.0 111.895 177.589 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' C' C ' 43' ' ' GLY . . . . . . . . . . . . . . . 72.55 23.06 78.57 Favored Glycine 0 CA--C 1.532 1.138 0 C-N-CA 121.132 -0.556 . . . . 0.0 112.727 177.882 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' C' C ' 44' ' ' LYS . . . . . . . . . . . . . 33.4 ttmt -139.09 129.56 25.73 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 117.315 0.557 . . . . 0.0 109.746 178.379 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' C' C ' 45' ' ' GLU . . . . . . . . . . . . . 45.9 tp10 -84.14 129.66 34.89 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-O 120.836 0.35 . . . . 0.0 111.279 -177.172 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' C' C ' 46' ' ' VAL . . . . . . . . . . . . . 9.1 p -122.75 126.12 73.43 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.246 0 N-CA-C 109.409 -0.589 . . . . 0.0 109.409 174.578 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' C' C ' 47' ' ' LYS . . . . . . . . . . . . . 64.3 mttm -100.03 128.76 46.07 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.03 -0.532 . . . . 0.0 111.339 179.068 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' C' C ' 48' ' ' PHE . . . . . . . . . . . . . 28.4 m-85 -112.51 131.97 55.32 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 116.015 -0.539 . . . . 0.0 109.795 177.549 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' C' C ' 49' ' ' LYS . . . . . . . . . . . . . 46.2 tttp -105.45 132.21 51.91 Favored 'General case' 0 C--N 1.329 -0.315 0 N-CA-C 109.812 -0.44 . . . . 0.0 109.812 177.741 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' C' C ' 50' ' ' VAL . . . . . . . . . . . . . 46.2 t -72.86 106.03 2.74 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.324 0 N-CA-C 109.454 -0.573 . . . . 0.0 109.454 178.454 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' C' C ' 51' ' ' VAL . . . . . . . . . . . . . 49.0 t -68.5 -50.61 54.8 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.279 0 N-CA-C 109.5 -0.556 . . . . 0.0 109.5 -176.357 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' C' C ' 52' ' ' GLN . . . . . . . . . . . . . 21.5 pt20 -162.67 157.81 22.31 Favored 'General case' 0 C--N 1.331 -0.201 0 CA-C-N 115.908 -0.587 . . . . 0.0 111.649 179.239 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' C' C ' 53' ' ' ALA . . . . . . . . . . . . . . . -130.97 132.61 45.16 Favored 'General case' 0 C--N 1.326 -0.422 0 CA-C-N 115.176 -0.92 . . . . 0.0 109.817 178.165 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' C' C ' 54' ' ' TYR . . . . . . . . . . . . . 29.3 t80 -128.98 108.37 18.19 Favored Pre-proline 0 CA--C 1.534 0.358 0 CA-C-O 118.204 -0.903 . . . . 0.0 110.413 -179.008 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' C' C ' 55' ' ' PRO . . . . . . . . . . . . . 73.1 Cg_endo -77.16 170.03 72.63 Favored 'Cis proline' 0 N--CA 1.501 1.916 0 CA-C-N 121.833 1.69 . . . . 0.0 112.451 -5.776 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' C' C ' 56' ' ' SER . . . . . . . . . . . . . 14.5 m -114.23 128.34 25.91 Favored Pre-proline 0 CA--C 1.54 0.568 0 CA-C-O 118.368 -0.825 . . . . 0.0 109.348 175.356 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' C' C ' 57' ' ' PRO . . . . . . . . . . . . . 57.0 Cg_endo -71.97 149.5 92.95 Favored 'Cis proline' 0 N--CA 1.497 1.689 0 CA-C-N 121.98 1.743 . . . . 0.0 111.857 -0.556 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' C' C ' 58' ' ' LEU . . . . . . . . . . . . . 24.9 tp -108.64 137.03 47.26 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.294 -0.412 . . . . 0.0 110.643 -178.622 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' C' C ' 59' ' ' ARG . . . . . . . . . . . . . 57.0 ttm-85 -107.11 127.53 53.57 Favored 'General case' 0 C--N 1.329 -0.321 0 N-CA-C 109.322 -0.621 . . . . 0.0 109.322 175.95 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' C' C ' 60' ' ' VAL . . . . . . . . . . . . . 40.9 t -81.71 120.69 33.75 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.231 0 CA-C-O 121.074 0.464 . . . . 0.0 110.968 -173.733 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' C' C ' 61' ' ' GLU . . . . . . . . . . . . . 80.4 tt0 -131.15 158.21 41.08 Favored 'General case' 0 C--N 1.33 -0.275 0 N-CA-C 108.73 -0.841 . . . . 0.0 108.73 174.729 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' C' C ' 62' ' ' ASP . . . . . . . . . . . . . 52.8 m-20 -49.82 -32.2 13.56 Favored 'General case' 0 C--N 1.329 -0.294 0 N-CA-C 112.352 0.501 . . . . 0.0 112.352 -178.146 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' C' C ' 63' ' ' ARG . . . . . . . . . . . . . 26.7 mmm180 -71.25 -20.79 62.19 Favored 'General case' 0 CA--C 1.536 0.415 0 N-CA-C 112.999 0.741 . . . . 0.0 112.999 -176.357 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' C' C ' 64' ' ' THR . . . . . . . . . . . . . 36.8 m -67.87 141.76 56.31 Favored 'General case' 0 C--N 1.331 -0.239 0 CA-C-O 121.051 0.453 . . . . 0.0 111.222 -175.592 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' C' C ' 65' ' ' LYS . . . . . . . . . . . . . 63.6 mttm -89.65 132.94 34.89 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 115.749 -0.66 . . . . 0.0 109.86 177.35 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' C' C ' 66' ' ' ILE . . . . . . . . . . . . . 63.1 mt -118.59 132.04 69.61 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.22 0 N-CA-C 110.055 -0.35 . . . . 0.0 110.055 -179.276 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' C' C ' 67' ' ' THR . . . . . . . . . . . . . 25.9 m -129.24 139.08 51.97 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-O 121.048 0.451 . . . . 0.0 111.26 -178.348 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' C' C ' 68' ' ' LEU . . . . . . . . . . . . . 39.3 mt -102.38 122.9 45.19 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 115.891 -0.595 . . . . 0.0 110.165 176.066 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' C' C ' 69' ' ' VAL . . . . . . . . . . . . . 43.3 t -102.99 136.02 37.59 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.338 0 CA-C-N 116.088 -0.505 . . . . 0.0 110.31 -178.922 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' C' C ' 70' ' ' THR . . . . . . . . . . . . . 17.2 p -136.55 97.61 3.6 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.266 -0.425 . . . . 0.0 110.4 178.454 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' C' C ' 71' ' ' HIS . . . . . . . . . . . . . 83.7 m-70 -142.5 154.25 63.19 Favored Pre-proline 0 C--N 1.33 -0.241 0 CA-C-N 116.131 -0.486 . . . . 0.0 110.468 179.692 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' C' C ' 72' ' ' PRO . . . . . . . . . . . . . 70.3 Cg_endo -76.1 -28.04 7.77 Favored 'Trans proline' 0 N--CA 1.495 1.561 0 C-N-CA 121.304 1.336 . . . . 0.0 112.562 178.266 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' C' C ' 73' ' ' VAL . . . . . . . . . . . . . 32.9 m -77.99 156.57 5.15 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.203 0 CA-C-O 120.888 0.375 . . . . 0.0 110.782 -179.175 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' C' C ' 74' ' ' ASP . . . . . . . . . . . . . 10.8 t70 -97.04 122.29 39.87 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.109 -0.496 . . . . 0.0 109.734 179.222 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' C' C ' 75' ' ' VAL . . . . . . . . . . . . . 46.0 t -116.98 125.54 73.93 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.196 0 CA-C-O 120.879 0.371 . . . . 0.0 110.698 -175.27 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' C' C ' 76' ' ' LEU . . . . . . . . . . . . . 19.4 mt -131.51 145.57 51.82 Favored 'General case' 0 C--N 1.333 -0.148 0 CA-C-N 116.012 -0.54 . . . . 0.0 110.488 179.559 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' C' C ' 77' ' ' GLU . . . . . . . . . . . . . 33.1 mp0 -135.48 141.92 45.42 Favored 'General case' 0 C--N 1.331 -0.225 0 CA-C-O 121.136 0.493 . . . . 0.0 111.046 178.345 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' C' C ' 78' ' ' ALA . . . . . 0.697 ' HB2' HD21 ' C' ' 109' ' ' LEU . . . -126.57 135.03 50.73 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 115.677 -0.692 . . . . 0.0 109.86 176.184 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' C' C ' 79' ' ' LYS . . . . . 0.58 ' O ' HD13 ' C' ' 80' ' ' ILE . 76.5 tttt -81.73 111.19 17.76 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.315 -0.402 . . . . 0.0 110.57 -177.57 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' C' C ' 80' ' ' ILE . . . . . 0.58 HD13 ' O ' ' C' ' 79' ' ' LYS . 42.8 mm -139.14 105.92 2.7 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.341 0 N-CA-C 109.15 -0.685 . . . . 0.0 109.15 -177.45 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' C' C ' 81' ' ' LYS . . . . . . . . . . . . . 32.1 ttpt -102.24 132.29 48.27 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-O 120.921 0.391 . . . . 0.0 110.845 -176.213 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' C' C ' 82' ' ' GLY . . . . . . . . . . . . . . . 89.19 42.09 5.67 Favored Glycine 0 CA--C 1.526 0.78 0 N-CA-C 111.563 -0.615 . . . . 0.0 111.563 177.623 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' C' C ' 83' ' ' ILE . . . . . 0.403 HD11 ' HB ' ' C' ' 80' ' ' ILE . 69.1 mt -79.26 141.87 14.78 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.284 0 N-CA-C 109.717 -0.475 . . . . 0.0 109.717 177.562 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' C' C ' 84' ' ' LYS . . . . . . . . . . . . . 38.8 ttpt -101.08 -54.02 2.89 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.309 -0.405 . . . . 0.0 110.464 -178.454 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' C' C ' 85' ' ' ASP . . . . . . . . . . . . . 7.2 t0 -146.46 150.61 35.94 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.097 -0.501 . . . . 0.0 110.781 -176.949 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' C' C ' 86' ' ' VAL . . . . . . . . . . . . . 44.1 t -128.12 131.2 69.58 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.259 0 CA-C-N 116.34 -0.391 . . . . 0.0 110.275 -179.065 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' C' C ' 87' ' ' ILE . . . . . . . . . . . . . 44.9 mm -118.61 126.84 75.5 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.254 0 N-CA-C 109.696 -0.483 . . . . 0.0 109.696 176.827 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' C' C ' 88' ' ' LEU . . . . . . . . . . . . . 13.7 tp -115.61 130.21 56.78 Favored 'General case' 0 C--N 1.331 -0.227 0 CA-C-O 120.964 0.411 . . . . 0.0 111.067 -177.014 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' C' C ' 89' ' ' ASP . . . . . . . . . . . . . 6.1 t0 -126.1 152.57 45.71 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 115.836 -0.62 . . . . 0.0 109.449 176.829 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' C' C ' 90' ' ' GLU . . . . . . . . . . . . . 84.8 tt0 -48.23 -35.72 12.5 Favored 'General case' 0 C--N 1.329 -0.312 0 N-CA-C 112.751 0.648 . . . . 0.0 112.751 -173.219 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' C' C ' 91' ' ' ASN . . . . . . . . . . . . . 85.1 m-20 -131.97 33.59 3.92 Favored 'General case' 0 N--CA 1.465 0.314 0 N-CA-C 111.877 0.325 . . . . 0.0 111.877 -176.804 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' C' C ' 92' ' ' LEU . . . . . . . . . . . . . 8.2 tp -166.07 142.6 5.11 Favored 'General case' 0 C--N 1.331 -0.215 0 C-N-CA 121.014 -0.274 . . . . 0.0 110.566 -179.002 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' C' C ' 93' ' ' ILE . . . . . . . . . . . . . 74.0 mt -127.14 125.17 65.8 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.26 0 N-CA-C 109.493 -0.558 . . . . 0.0 109.493 178.227 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' C' C ' 94' ' ' VAL . . . . . 0.578 HG21 HG11 ' C' ' 125' ' ' VAL . 45.2 t -127.1 129.83 71.11 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.259 0 CA-C-O 120.968 0.414 . . . . 0.0 110.197 179.914 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' C' C ' 95' ' ' VAL . . . . . . . . . . . . . 42.3 t -121.35 134.4 64.84 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.339 0 CA-C-N 115.936 -0.574 . . . . 0.0 109.76 179.324 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' C' C ' 96' ' ' ILE . . . . . . . . . . . . . 64.1 mt -116.15 128.71 73.37 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 N-CA-C 109.371 -0.604 . . . . 0.0 109.371 179.64 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' C' C ' 97' ' ' THR . . . . . . . . . . . . . 73.3 p -101.82 160.56 14.37 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-O 121.185 0.517 . . . . 0.0 111.13 -177.577 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' C' C ' 98' ' ' GLU . . . . . . . . . . . . . 12.5 pt-20 -54.04 -25.94 24.0 Favored 'General case' 0 C--N 1.328 -0.337 0 N-CA-C 112.39 0.515 . . . . 0.0 112.39 -178.108 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' C' C ' 99' ' ' GLU . . . . . . . . . . . . . 95.5 mt-10 -79.87 15.44 1.43 Allowed 'General case' 0 CA--C 1.536 0.404 0 N-CA-C 113.131 0.789 . . . . 0.0 113.131 -176.164 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' C' C ' 100' ' ' ASN . . . . . . . . . . . . . 3.5 m-20 61.82 37.35 15.54 Favored 'General case' 0 CA--C 1.531 0.245 0 CA-C-O 121.047 0.451 . . . . 0.0 110.995 179.499 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' C' C ' 101' ' ' GLU . . . . . . . . . . . . . 84.9 tt0 -114.82 141.27 48.12 Favored 'General case' 0 C--N 1.332 -0.159 0 CA-C-N 116.071 -0.513 . . . . 0.0 109.62 175.98 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' C' C ' 102' ' ' VAL . . . . . . . . . . . . . 43.7 t -116.46 127.01 74.19 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.341 0 CA-C-N 116.298 -0.41 . . . . 0.0 110.047 -178.122 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' C' C ' 103' ' ' LEU . . . . . . . . . . . . . 40.6 mt -114.85 130.14 56.83 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 115.719 -0.673 . . . . 0.0 110.071 176.496 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' C' C ' 104' ' ' ILE . . . . . . . . . . . . . 66.4 mt -114.95 122.22 68.62 Favored 'Isoleucine or valine' 0 C--O 1.234 0.254 0 N-CA-C 110.161 -0.311 . . . . 0.0 110.161 -178.693 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' C' C ' 105' ' ' PHE . . . . . . . . . . . . . 81.2 m-85 -123.24 163.57 20.41 Favored 'General case' 0 C--O 1.231 0.121 0 O-C-N 124.02 0.825 . . . . 0.0 109.591 -179.17 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' C' C ' 106' ' ' ASN . . . . . . . . . . . . . 47.4 p-10 -98.32 -170.61 1.99 Allowed 'General case' 0 C--N 1.33 -0.265 0 N-CA-C 109.828 -0.434 . . . . 0.0 109.828 173.525 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' C' C ' 107' ' ' GLN . . . . . . . . . . . . . 49.0 tt0 -59.44 -30.1 68.25 Favored 'General case' 0 C--N 1.33 -0.273 0 N-CA-C 112.128 0.418 . . . . 0.0 112.128 -179.252 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' C' C ' 108' ' ' ASN . . . . . . . . . . . . . 30.7 t30 -84.75 9.2 14.67 Favored 'General case' 0 CA--C 1.536 0.419 0 N-CA-C 113.181 0.808 . . . . 0.0 113.181 -177.009 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' C' C ' 109' ' ' LEU . . . . . 0.697 HD21 ' HB2' ' C' ' 78' ' ' ALA . 12.4 tp 61.56 37.51 16.24 Favored 'General case' 0 CA--C 1.53 0.188 0 CA-C-O 120.993 0.425 . . . . 0.0 111.249 178.573 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' C' C ' 110' ' ' GLU . . . . . . . . . . . . . 95.3 mt-10 -105.12 149.55 25.78 Favored 'General case' 0 C--N 1.33 -0.254 0 N-CA-C 109.687 -0.486 . . . . 0.0 109.687 175.584 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' C' C ' 111' ' ' GLU . . . . . . . . . . . . . 74.1 tt0 -87.45 121.92 30.52 Favored 'General case' 0 C--N 1.33 -0.272 0 C-N-CA 120.77 -0.372 . . . . 0.0 110.583 -175.31 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' C' C ' 112' ' ' LEU . . . . . . . . . . . . . 17.8 mt -108.01 -45.98 3.86 Favored 'General case' 0 C--N 1.332 -0.176 0 CA-C-N 115.992 -0.549 . . . . 0.0 110.78 -179.856 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' C' C ' 113' ' ' TYR . . . . . . . . . . . . . 46.8 t80 -135.55 141.89 45.27 Favored 'General case' 0 C--N 1.331 -0.23 0 CA-C-N 116.361 -0.381 . . . . 0.0 111.213 -178.179 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' C' C ' 114' ' ' ARG . . . . . . . . . . . . . 38.8 ptt180 -142.48 125.26 15.99 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.254 -0.43 . . . . 0.0 110.475 176.757 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' C' C ' 115' ' ' GLY . . . . . . . . . . . . . . . -150.09 162.25 29.14 Favored Glycine 0 CA--C 1.524 0.628 0 C-N-CA 120.693 -0.765 . . . . 0.0 111.55 -179.92 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' C' C ' 116' ' ' LYS . . . . . . . . . . . . . 39.1 ttpt -125.83 135.52 52.07 Favored 'General case' 0 C--N 1.332 -0.185 0 N-CA-C 109.866 -0.42 . . . . 0.0 109.866 176.994 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' C' C ' 117' ' ' PHE . . . . . . . . . . . . . 64.3 m-85 -130.65 113.81 14.64 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-O 120.856 0.36 . . . . 0.0 110.365 -178.256 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' C' C ' 118' ' ' GLU . . . . . . . . . . . . . 14.3 mm-40 -55.76 -48.19 75.71 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 116.397 -0.365 . . . . 0.0 111.056 -175.916 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' C' C ' 119' ' ' ASN . . . . . . . . . . . . . 68.1 m-80 -97.19 31.11 2.54 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.005 -0.543 . . . . 0.0 112.12 -174.185 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' C' C ' 120' ' ' LEU . . . . . . . . . . . . . 13.8 tp -52.63 119.88 5.04 Favored 'General case' 0 N--CA 1.466 0.325 0 O-C-N 122.238 -0.289 . . . . 0.0 111.029 178.999 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' C' C ' 121' ' ' ASN . . . . . . . . . . . . . 90.9 m-20 -113.93 -44.05 3.2 Favored 'General case' 0 C--N 1.331 -0.226 0 CA-C-N 116.317 -0.401 . . . . 0.0 111.242 -177.959 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' C' C ' 122' ' ' LYS . . . . . . . . . . . . . 38.4 ttpt -143.9 143.44 31.28 Favored 'General case' 0 C--N 1.333 -0.113 0 C-N-CA 120.507 -0.477 . . . . 0.0 111.577 -177.163 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' C' C ' 123' ' ' VAL . . . . . . . . . . . . . 43.9 t -126.41 127.44 70.5 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.285 0 N-CA-C 109.148 -0.686 . . . . 0.0 109.148 173.773 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' C' C ' 124' ' ' LEU . . . . . 0.652 HD13 HD12 ' D' ' 88' ' ' LEU . 8.7 tt -131.39 133.03 44.84 Favored 'General case' 0 N--CA 1.463 0.219 0 CA-C-O 120.961 0.41 . . . . 0.0 111.142 -176.377 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' C' C ' 125' ' ' VAL . . . . . 0.729 HG12 HG23 ' C' ' 130' ' ' VAL . 35.8 m -126.68 144.96 35.11 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.238 0 CA-C-N 115.798 -0.637 . . . . 0.0 110.441 179.607 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' C' C ' 126' ' ' ARG . . . . . . . . . . . . . 34.8 ttm180 -150.0 117.04 5.95 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-O 120.996 0.427 . . . . 0.0 110.412 177.819 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' C' C ' 127' ' ' ASN . . . . . . . . . . . . . 96.2 m-20 53.77 -107.6 0.37 Allowed 'General case' 0 CA--C 1.542 0.651 0 CA-C-N 116.0 -0.546 . . . . 0.0 110.859 -178.268 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' C' C ' 128' ' ' ASP . . . . . . . . . . . . . 8.4 p-10 -114.13 1.9 14.73 Favored 'General case' 0 CA--C 1.537 0.447 0 CA-C-N 119.742 1.156 . . . . 0.0 113.271 -177.994 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' C' C ' 129' ' ' LEU . . . . . . . . . . . . . 12.7 tp -105.15 139.59 39.58 Favored 'General case' 0 C--O 1.232 0.156 0 N-CA-C 109.429 -0.582 . . . . 0.0 109.429 178.789 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' C' C ' 130' ' ' VAL . . . . . 0.729 HG23 HG12 ' C' ' 125' ' ' VAL . 12.2 p -135.81 140.29 44.54 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.21 0 CA-C-O 121.295 0.569 . . . . 0.0 110.869 -177.564 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' C' C ' 131' ' ' VAL . . . . . . . . . . . . . 35.6 m -136.11 146.43 29.26 Favored 'Isoleucine or valine' 0 C--O 1.234 0.251 0 CA-C-N 115.793 -0.64 . . . . 0.0 110.935 178.782 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' C' C ' 132' ' ' ILE . . . . . . . . . . . . . 68.1 mt -122.88 134.0 67.32 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.293 0 CA-C-N 115.596 -0.729 . . . . 0.0 109.521 179.69 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' C' C ' 133' ' ' ILE . . . . . . . . . . . . . 42.7 mm -116.26 120.43 64.89 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.212 0 CA-C-N 116.548 -0.297 . . . . 0.0 110.733 -176.996 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' C' C ' 134' ' ' ASP . . . . . . . . . . . . . 6.1 p-10 -131.83 146.56 52.21 Favored 'General case' 0 C--N 1.331 -0.214 0 CA-C-N 116.21 -0.45 . . . . 0.0 109.806 176.379 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' C' C ' 135' ' ' GLU . . . . . . . . . . . . . 84.2 tt0 -50.0 -26.31 4.17 Favored 'General case' 0 C--N 1.328 -0.359 0 N-CA-C 112.937 0.718 . . . . 0.0 112.937 -170.779 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' C' C ' 136' ' ' GLN . . . . . . . . . . . . . 97.4 mt-30 -92.6 -35.47 13.53 Favored 'General case' 0 C--N 1.331 -0.196 0 N-CA-C 112.461 0.541 . . . . 0.0 112.461 -176.819 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' C' C ' 137' ' ' LYS . . . . . . . . . . . . . 54.4 mtmt -147.14 157.97 43.79 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-O 121.501 0.667 . . . . 0.0 112.048 -169.543 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' C' C ' 138' ' ' LEU . . . . . 0.444 HD23 ' C ' ' C' ' 138' ' ' LEU . 6.9 tt -116.08 126.26 53.5 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 115.203 -0.908 . . . . 0.0 109.317 174.621 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' C' C ' 139' ' ' THR . . . . . . . . . . . . . 33.8 m -111.47 127.98 55.86 Favored 'General case' 0 C--N 1.331 -0.212 0 CA-C-N 116.401 -0.363 . . . . 0.0 110.713 -177.831 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' C' C ' 140' ' ' LEU . . . . . 0.481 ' C ' HD23 ' C' ' 140' ' ' LEU . 9.0 tt -115.39 122.84 47.06 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 115.48 -0.782 . . . . 0.0 109.203 -179.781 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' C' C ' 141' ' ' ILE . . . . . 0.529 ' HB ' HG13 ' C' ' 130' ' ' VAL . 20.2 mt -120.5 117.72 54.24 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.27 0 CA-C-O 120.973 0.416 . . . . 0.0 110.046 -176.309 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' C' C ' 142' ' ' ARG . . . . . . . . . . . . . 62.6 ttp85 -106.64 130.83 54.32 Favored 'General case' 0 C--N 1.331 -0.205 0 CA-C-N 115.096 -0.956 . . . . 0.0 110.621 -177.72 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' C' C ' 143' ' ' THR . . . . . . . . . . . . . 63.6 p . . . . . 0 C--O 1.22 -0.473 0 CA-C-O 118.047 -0.978 . . . . 0.0 110.527 179.162 . . . . . . . . 0 0 . 1 . 011 nuclear build full ' D' D ' -3' ' ' GLU . . . . . . . . . . . . . 45.2 tp10 . . . . . 0 N--CA 1.488 1.46 0 N-CA-C 109.408 -0.59 . . . . 0.0 109.408 . . . . . . . . . 0 0 . 1 . 011 nuclear build full ' D' D ' -2' ' ' GLY . . . . . . . . . . . . . . . -64.67 141.97 44.72 Favored Glycine 0 CA--C 1.525 0.705 0 N-CA-C 110.938 -0.865 . . . . 0.0 110.938 -179.541 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' D' D ' -1' ' ' VAL . . . . . . . . . . . . . 45.5 t -141.08 134.18 31.02 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.282 0 CA-C-O 120.817 0.342 . . . . 0.0 110.109 -179.981 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' D' D ' 0' ' ' ILE . . . . . . . . . . . . . 71.2 mt -118.94 137.12 53.93 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.234 0 CA-C-N 116.059 -0.519 . . . . 0.0 109.943 179.529 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' D' D ' 1' ' ' MET . . . . . . . . . . . . . 24.9 ptp -143.24 150.15 38.91 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.252 -0.431 . . . . 0.0 110.691 -179.862 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' D' D ' 2' ' ' SER . . . . . . . . . . . . . 5.8 p -111.74 133.37 54.01 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.236 -0.438 . . . . 0.0 110.354 178.779 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' D' D ' 3' ' ' GLU . . . . . . . . . . . . . 94.2 mt-10 -141.28 137.92 32.82 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-N 116.072 -0.513 . . . . 0.0 111.014 -178.376 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' D' D ' 4' ' ' LEU . . . . . 0.407 HD21 HD21 ' D' ' 6' ' ' LEU . 15.5 tp -122.49 128.69 51.15 Favored 'General case' 0 C--N 1.33 -0.282 0 N-CA-C 109.86 -0.422 . . . . 0.0 109.86 175.695 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' D' D ' 5' ' ' LYS . . . . . . . . . . . . . 55.7 mttp -107.93 119.13 38.6 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.432 -0.349 . . . . 0.0 110.48 179.699 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' D' D ' 6' ' ' LEU . . . . . 0.407 HD21 HD21 ' D' ' 4' ' ' LEU . 71.3 mt -114.8 145.7 41.84 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 115.464 -0.789 . . . . 0.0 110.386 -177.698 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' D' D ' 7' ' ' LYS . . . . . . . . . . . . . 52.3 tttm -135.0 137.66 27.64 Favored Pre-proline 0 CA--C 1.534 0.329 0 CA-C-O 118.966 -0.54 . . . . 0.0 109.818 176.757 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' D' D ' 8' ' ' PRO . . . . . . . . . . . . . 94.0 Cg_endo -91.48 143.92 3.09 Favored 'Trans proline' 0 N--CA 1.49 1.322 0 C-N-CA 121.652 1.568 . . . . 0.0 111.877 178.495 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' D' D ' 9' ' ' LEU . . . . . . . . . . . . . 69.5 mt -80.31 -48.46 1.26 Allowed Pre-proline 0 C--N 1.328 -0.331 0 CA-C-O 118.467 -0.778 . . . . 0.0 112.372 -179.488 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' D' D ' 10' ' ' PRO . . . . . . . . . . . . . 77.7 Cg_endo -77.64 151.73 28.85 Favored 'Trans proline' 0 N--CA 1.496 1.635 0 C-N-CA 121.09 1.193 . . . . 0.0 112.009 177.618 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' D' D ' 11' ' ' LYS . . . . . . . . . . . . . 24.8 mtmt -88.29 92.32 9.12 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.311 -0.404 . . . . 0.0 110.616 179.965 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' D' D ' 12' ' ' VAL . . . . . . . . . . . . . 12.4 p -139.61 148.67 23.02 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.242 0 CA-C-N 116.073 -0.512 . . . . 0.0 110.454 -179.972 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' D' D ' 13' ' ' GLU . . . . . . . . . . . . . 84.6 tt0 -88.38 125.34 34.66 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.251 -0.431 . . . . 0.0 109.962 177.321 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' D' D ' 14' ' ' LEU . . . . . . . . . . . . . 38.2 mt -97.94 150.79 37.12 Favored Pre-proline 0 CA--C 1.531 0.249 0 CA-C-N 116.297 -0.41 . . . . 0.0 110.719 -176.328 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' D' D ' 15' ' ' PRO . . . . . . . . . . . . . 25.3 Cg_exo -62.66 155.61 57.88 Favored 'Trans proline' 0 N--CA 1.497 1.722 0 C-N-CA 121.347 1.365 . . . . 0.0 111.939 176.732 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' D' D ' 16' ' ' PRO . . . . . . . . . . . . . 35.4 Cg_exo -59.8 -30.65 92.47 Favored 'Trans proline' 0 N--CA 1.498 1.736 0 C-N-CA 121.345 1.363 . . . . 0.0 112.57 179.331 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' D' D ' 17' ' ' ASP . . . . . . . . . . . . . 7.9 p-10 -84.09 3.26 35.51 Favored 'General case' 0 C--N 1.327 -0.384 0 N-CA-C 113.329 0.862 . . . . 0.0 113.329 -177.448 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' D' D ' 18' ' ' PHE . . . . . . . . . . . . . 10.8 t80 -57.99 -45.98 85.93 Favored 'General case' 0 C--O 1.227 -0.118 0 O-C-N 121.871 -0.518 . . . . 0.0 110.058 -177.819 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' D' D ' 19' ' ' VAL . . . . . . . . . . . . . 48.6 t -56.23 -42.82 74.71 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.273 0 CA-C-N 116.168 -0.469 . . . . 0.0 110.61 -178.075 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' D' D ' 20' ' ' ASP . . . . . . . . . . . . . 83.3 m-20 -60.05 -44.05 94.94 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-O 120.782 0.325 . . . . 0.0 111.231 -177.338 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' D' D ' 21' ' ' VAL . . . . . . . . . . . . . 46.7 t -64.8 -45.6 94.55 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 C-N-CA 120.72 -0.392 . . . . 0.0 110.528 -177.532 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' D' D ' 22' ' ' ILE . . . . . 0.631 HG22 HD12 ' D' ' 26' ' ' LEU . 51.3 mm -56.63 -45.83 82.62 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.168 0 C-N-CA 120.87 -0.332 . . . . 0.0 110.547 179.386 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' D' D ' 23' ' ' ARG . . . . . . . . . . . . . 54.8 ttp180 -54.2 -49.52 69.18 Favored 'General case' 0 C--N 1.33 -0.258 0 C-N-CA 121.09 -0.244 . . . . 0.0 111.315 -178.165 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' D' D ' 24' ' ' ILE . . . . . . . . . . . . . 71.8 mt -60.32 -43.1 92.92 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.216 0 C-N-CA 121.059 -0.256 . . . . 0.0 111.32 -178.478 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' D' D ' 25' ' ' LYS . . . . . . . . . . . . . 62.4 mtpt -65.13 -40.99 95.22 Favored 'General case' 0 C--N 1.329 -0.323 0 N-CA-C 112.32 0.489 . . . . 0.0 112.32 -177.499 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' D' D ' 26' ' ' LEU . . . . . 0.631 HD12 HG22 ' D' ' 22' ' ' ILE . 45.2 mt -79.15 -41.61 28.09 Favored 'General case' 0 C--N 1.329 -0.324 0 N-CA-C 113.354 0.872 . . . . 0.0 113.354 -171.202 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' D' D ' 27' ' ' GLN . . . . . . . . . . . . . 15.2 pt20 -46.43 137.52 6.47 Favored 'General case' 0 N--CA 1.469 0.512 0 N-CA-C 112.823 0.675 . . . . 0.0 112.823 -174.882 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' D' D ' 28' ' ' GLY . . . . . . . . . . . . . . . 100.17 -27.27 21.12 Favored Glycine 0 CA--C 1.532 1.146 0 CA-C-N 115.591 -0.731 . . . . 0.0 112.249 -177.765 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' D' D ' 29' ' ' LYS . . . . . . . . . . . . . 97.2 mttt -98.21 155.24 17.27 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 117.142 0.471 . . . . 0.0 111.123 179.218 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' D' D ' 30' ' ' THR . . . . . . . . . . . . . 28.2 m -101.0 138.52 37.94 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 115.953 -0.567 . . . . 0.0 110.172 176.044 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' D' D ' 31' ' ' VAL . . . . . . . . . . . . . 34.9 m -131.07 152.57 37.76 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.255 0 CA-C-N 116.32 -0.4 . . . . 0.0 110.759 -179.586 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' D' D ' 32' ' ' ARG . . . . . . . . . . . . . 58.5 ttp180 -129.28 148.98 51.26 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-O 121.202 0.525 . . . . 0.0 110.673 179.676 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' D' D ' 33' ' ' THR . . . . . . . . . . . . . 27.4 m -53.52 138.96 32.65 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 116.276 -0.42 . . . . 0.0 111.24 179.964 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' D' D ' 34' ' ' GLY . . . . . . . . . . . . . . . 100.51 -17.11 57.17 Favored Glycine 0 CA--C 1.531 1.077 0 C-N-CA 121.272 -0.489 . . . . 0.0 113.225 -179.871 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' D' D ' 35' ' ' ASP . . . . . . . . . . . . . 69.3 m-20 -65.67 149.76 49.58 Favored 'General case' 0 C--O 1.232 0.147 0 CA-C-N 118.014 0.907 . . . . 0.0 111.314 179.564 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' D' D ' 36' ' ' VAL . . . . . . . . . . . . . 45.6 t -121.72 129.58 75.36 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.23 0 CA-C-N 115.774 -0.648 . . . . 0.0 109.771 177.511 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' D' D ' 37' ' ' ILE . . . . . . . . . . . . . 69.2 mt -121.41 138.98 49.97 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.282 0 CA-C-N 116.3 -0.409 . . . . 0.0 109.956 -179.504 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' D' D ' 38' ' ' GLY . . . . . . . . . . . . . . . -109.08 128.79 9.18 Favored Glycine 0 CA--C 1.526 0.762 0 N-CA-C 111.073 -0.811 . . . . 0.0 111.073 179.914 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' D' D ' 39' ' ' ILE . . . . . . . . . . . . . 71.7 mt -123.83 136.08 61.39 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.234 0 CA-C-O 120.842 0.353 . . . . 0.0 110.091 179.728 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' D' D ' 40' ' ' SER . . . . . . . . . . . . . 59.9 p -92.88 114.23 26.73 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.245 -0.434 . . . . 0.0 110.641 174.335 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' D' D ' 41' ' ' ILE . . . . . . . . . . . . . 47.0 mm -122.91 112.85 35.65 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.211 0 CA-C-O 120.724 0.297 . . . . 0.0 110.379 179.473 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' D' D ' 42' ' ' LEU . . . . . 0.529 HD23 ' O ' ' D' ' 42' ' ' LEU . 1.3 tt 55.23 45.79 25.05 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-O 121.443 0.639 . . . . 0.0 110.521 178.111 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' D' D ' 43' ' ' GLY . . . . . . . . . . . . . . . 74.99 -9.67 11.15 Favored Glycine 0 CA--C 1.535 1.324 0 C-N-CA 121.342 -0.456 . . . . 0.0 113.712 175.687 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' D' D ' 44' ' ' LYS . . . . . . . . . . . . . 22.0 tptp -100.37 134.19 43.68 Favored 'General case' 0 C--N 1.331 -0.206 0 CA-C-N 117.927 0.863 . . . . 0.0 110.153 -178.998 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' D' D ' 45' ' ' GLU . . . . . . . . . . . . . 84.8 tt0 -83.29 123.03 29.21 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 116.458 -0.337 . . . . 0.0 110.732 -179.869 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' D' D ' 46' ' ' VAL . . . . . . . . . . . . . 7.1 p -123.49 127.64 74.26 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.182 0 N-CA-C 109.715 -0.476 . . . . 0.0 109.715 177.643 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' D' D ' 47' ' ' LYS . . . . . . . . . . . . . 63.7 mttp -100.23 129.98 46.3 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 115.954 -0.566 . . . . 0.0 111.172 178.59 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' D' D ' 48' ' ' PHE . . . . . . . . . . . . . 90.7 m-85 -113.19 131.89 55.7 Favored 'General case' 0 C--N 1.331 -0.213 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.09 177.054 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' D' D ' 49' ' ' LYS . . . . . . . . . . . . . 82.5 tttt -107.92 137.14 46.44 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.489 179.262 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' D' D ' 50' ' ' VAL . . . . . . . . . . . . . 46.4 t -83.04 108.79 16.13 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.312 0 N-CA-C 109.311 -0.625 . . . . 0.0 109.311 176.219 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' D' D ' 51' ' ' VAL . . . . . . . . . . . . . 46.1 t -73.4 -50.76 28.78 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.328 0 CA-C-N 116.142 -0.481 . . . . 0.0 109.907 -174.573 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' D' D ' 52' ' ' GLN . . . . . . . . . . . . . 92.4 mt-30 -152.72 154.22 34.81 Favored 'General case' 0 C--N 1.332 -0.18 0 CA-C-O 121.285 0.564 . . . . 0.0 111.552 -178.167 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' D' D ' 53' ' ' ALA . . . . . . . . . . . . . . . -132.56 132.59 42.74 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 115.212 -0.904 . . . . 0.0 109.788 175.832 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' D' D ' 54' ' ' TYR . . . . . . . . . . . . . 41.7 t80 -129.08 109.23 18.11 Favored Pre-proline 0 CA--C 1.534 0.364 0 CA-C-O 118.251 -0.88 . . . . 0.0 110.355 179.509 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' D' D ' 55' ' ' PRO . . . . . . . . . . . . . 73.2 Cg_endo -77.18 168.91 75.62 Favored 'Cis proline' 0 N--CA 1.5 1.873 0 CA-C-N 121.839 1.692 . . . . 0.0 112.43 -6.826 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' D' D ' 56' ' ' SER . . . . . . . . . . . . . 13.6 m -116.98 129.49 25.28 Favored Pre-proline 0 CA--C 1.538 0.49 0 CA-C-O 118.459 -0.781 . . . . 0.0 109.262 173.911 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' D' D ' 57' ' ' PRO . . . . . . . . . . . . . 56.1 Cg_endo -71.65 149.4 92.36 Favored 'Cis proline' 0 N--CA 1.498 1.768 0 CA-C-N 122.002 1.751 . . . . 0.0 111.691 0.37 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' D' D ' 58' ' ' LEU . . . . . . . . . . . . . 23.7 tp -108.98 137.99 46.03 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.176 -0.466 . . . . 0.0 110.843 -177.723 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' D' D ' 59' ' ' ARG . . . . . . . . . . . . . 31.7 ttp180 -102.23 122.87 45.03 Favored 'General case' 0 C--N 1.329 -0.315 0 N-CA-C 109.158 -0.682 . . . . 0.0 109.158 175.111 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' D' D ' 60' ' ' VAL . . . . . . . . . . . . . 43.3 t -79.84 122.37 34.93 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.262 0 C-N-CA 120.703 -0.399 . . . . 0.0 110.802 -173.36 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' D' D ' 61' ' ' GLU . . . . . . . . . . . . . 84.1 mt-10 -131.1 161.18 32.66 Favored 'General case' 0 C--N 1.332 -0.184 0 CA-C-N 115.91 -0.586 . . . . 0.0 109.562 177.214 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' D' D ' 62' ' ' ASP . . . . . . . . . . . . . 79.0 m-20 -53.3 -33.16 52.15 Favored 'General case' 0 C--N 1.329 -0.291 0 N-CA-C 111.782 0.29 . . . . 0.0 111.782 178.319 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' D' D ' 63' ' ' ARG . . . . . . . . . . . . . 92.8 mtt-85 -72.97 -21.97 60.77 Favored 'General case' 0 CA--C 1.533 0.324 0 N-CA-C 113.004 0.742 . . . . 0.0 113.004 -176.004 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' D' D ' 64' ' ' THR . . . . . . . . . . . . . 30.8 m -65.2 141.72 58.56 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-O 120.974 0.416 . . . . 0.0 111.085 -174.509 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' D' D ' 65' ' ' LYS . . . . . . . . . . . . . 68.9 mttm -87.7 131.31 34.51 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 115.787 -0.642 . . . . 0.0 109.915 178.17 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' D' D ' 66' ' ' ILE . . . . . . . . . . . . . 60.0 mt -116.27 124.93 73.05 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.272 0 N-CA-C 109.552 -0.536 . . . . 0.0 109.552 179.375 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' D' D ' 67' ' ' THR . . . . . . . . . . . . . 22.7 m -121.28 144.0 48.86 Favored 'General case' 0 C--O 1.233 0.218 0 CA-C-O 121.035 0.445 . . . . 0.0 111.242 -175.307 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' D' D ' 68' ' ' LEU . . . . . . . . . . . . . 14.2 tp -101.91 121.02 41.32 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 115.834 -0.621 . . . . 0.0 110.465 179.486 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' D' D ' 69' ' ' VAL . . . . . . . . . . . . . 44.0 t -103.84 133.39 47.95 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.361 0 CA-C-N 116.137 -0.483 . . . . 0.0 110.001 178.088 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' D' D ' 70' ' ' THR . . . . . . . . . . . . . 18.0 m -138.11 113.95 9.87 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.437 -0.347 . . . . 0.0 110.234 177.757 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' D' D ' 71' ' ' HIS . . . . . . . . . . . . . 41.8 m80 -102.1 152.04 38.16 Favored Pre-proline 0 C--N 1.331 -0.233 0 CA-C-N 116.28 -0.418 . . . . 0.0 110.294 179.612 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' D' D ' 72' ' ' PRO . . . . . . . . . . . . . 96.7 Cg_endo -84.84 -28.44 0.96 Allowed 'Trans proline' 0 N--CA 1.492 1.4 0 C-N-CA 121.552 1.501 . . . . 0.0 112.778 -178.737 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' D' D ' 73' ' ' VAL . . . . . . . . . . . . . 33.5 m -81.16 157.71 4.19 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.341 0 CA-C-O 120.978 0.418 . . . . 0.0 111.003 -178.087 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' D' D ' 74' ' ' ASP . . . . . . . . . . . . . 27.4 t0 -95.56 120.91 36.63 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 115.834 -0.621 . . . . 0.0 109.838 179.872 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' D' D ' 75' ' ' VAL . . . . . . . . . . . . . 42.9 t -112.02 122.76 66.92 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.234 0 CA-C-O 121.245 0.545 . . . . 0.0 110.337 -178.454 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' D' D ' 76' ' ' LEU . . . . . . . . . . . . . 33.7 mt -120.79 142.36 49.66 Favored 'General case' 0 C--N 1.331 -0.225 0 CA-C-N 115.555 -0.748 . . . . 0.0 109.617 177.814 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' D' D ' 77' ' ' GLU . . . . . . . . . . . . . 97.5 mt-10 -135.23 136.98 42.15 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-O 121.091 0.472 . . . . 0.0 111.382 -178.091 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' D' D ' 78' ' ' ALA . . . . . 0.534 ' HB2' HD21 ' D' ' 109' ' ' LEU . . . -124.83 138.37 54.27 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 115.706 -0.679 . . . . 0.0 109.816 176.804 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' D' D ' 79' ' ' LYS . . . . . 0.58 ' O ' HD13 ' D' ' 80' ' ' ILE . 62.0 mttp -81.54 118.07 22.45 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-O 120.871 0.367 . . . . 0.0 110.666 -178.568 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' D' D ' 80' ' ' ILE . . . . . 0.58 HD13 ' O ' ' D' ' 79' ' ' LYS . 42.3 mm -139.07 107.27 3.28 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.306 0 N-CA-C 109.264 -0.643 . . . . 0.0 109.264 -178.408 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' D' D ' 81' ' ' LYS . . . . . . . . . . . . . 38.0 ttpt -102.13 128.12 48.76 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-O 120.817 0.341 . . . . 0.0 110.932 -178.054 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' D' D ' 82' ' ' GLY . . . . . . . . . . . . . . . 89.05 42.17 5.69 Favored Glycine 0 CA--C 1.524 0.615 0 C-N-CA 120.725 -0.75 . . . . 0.0 111.444 174.817 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' D' D ' 83' ' ' ILE . . . . . . . . . . . . . 72.4 mt -68.25 134.88 29.5 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.264 0 N-CA-C 109.838 -0.43 . . . . 0.0 109.838 178.319 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' D' D ' 84' ' ' LYS . . . . . . . . . . . . . 30.8 tttp -94.15 -52.71 4.26 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 115.886 -0.597 . . . . 0.0 110.046 -178.22 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' D' D ' 85' ' ' ASP . . . . . . . . . . . . . 6.4 t70 -156.98 154.84 30.28 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 115.767 -0.651 . . . . 0.0 110.167 179.021 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' D' D ' 86' ' ' VAL . . . . . . . . . . . . . 44.5 t -128.72 133.61 66.05 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.219 0 CA-C-O 121.046 0.451 . . . . 0.0 110.791 179.964 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' D' D ' 87' ' ' ILE . . . . . . . . . . . . . 44.2 mm -114.62 122.39 68.64 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.249 0 CA-C-N 115.619 -0.718 . . . . 0.0 109.216 175.304 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' D' D ' 88' ' ' LEU . . . . . 0.652 HD12 HD13 ' C' ' 124' ' ' LEU . 34.8 mt -110.92 134.07 52.86 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-O 121.085 0.469 . . . . 0.0 111.34 -176.013 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' D' D ' 89' ' ' ASP . . . . . . . . . . . . . 9.8 t70 -131.92 154.94 48.74 Favored 'General case' 0 C--N 1.331 -0.211 0 CA-C-N 115.793 -0.639 . . . . 0.0 109.508 175.686 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' D' D ' 90' ' ' GLU . . . . . . . . . . . . . 84.7 tt0 -48.33 -38.13 18.31 Favored 'General case' 0 C--N 1.329 -0.284 0 N-CA-C 112.802 0.668 . . . . 0.0 112.802 -171.902 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' D' D ' 91' ' ' ASN . . . . . . . . . . . . . 35.0 m120 -132.0 36.74 3.64 Favored 'General case' 0 N--CA 1.466 0.328 0 N-CA-C 111.782 0.29 . . . . 0.0 111.782 -177.167 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' D' D ' 92' ' ' LEU . . . . . . . . . . . . . 12.9 tp -166.0 145.31 6.11 Favored 'General case' 0 C--N 1.332 -0.195 0 C-N-CA 120.827 -0.349 . . . . 0.0 110.91 -179.393 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' D' D ' 93' ' ' ILE . . . . . . . . . . . . . 68.1 mt -130.26 120.48 49.08 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.189 0 N-CA-C 109.579 -0.526 . . . . 0.0 109.579 -179.684 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' D' D ' 94' ' ' VAL . . . . . . . . . . . . . 46.9 t -121.66 126.13 74.31 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.253 0 N-CA-C 109.723 -0.473 . . . . 0.0 109.723 179.038 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' D' D ' 95' ' ' VAL . . . . . . . . . . . . . 44.1 t -121.16 134.79 63.4 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.236 0 CA-C-N 116.354 -0.385 . . . . 0.0 110.125 -178.902 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' D' D ' 96' ' ' ILE . . . . . . . . . . . . . 63.8 mt -113.68 128.63 70.47 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.316 0 N-CA-C 109.257 -0.646 . . . . 0.0 109.257 178.841 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' D' D ' 97' ' ' THR . . . . . . . . . . . . . 65.8 p -95.35 159.17 15.13 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-O 120.865 0.364 . . . . 0.0 110.443 179.746 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' D' D ' 98' ' ' GLU . . . . . . . . . . . . . 97.4 mt-10 -53.98 -27.5 31.91 Favored 'General case' 0 C--N 1.328 -0.36 0 N-CA-C 112.215 0.45 . . . . 0.0 112.215 -179.372 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' D' D ' 99' ' ' GLU . . . . . . . . . . . . . 45.8 mp0 -76.59 7.92 4.07 Favored 'General case' 0 CA--C 1.536 0.41 0 N-CA-C 113.502 0.927 . . . . 0.0 113.502 -176.733 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' D' D ' 100' ' ' ASN . . . . . . . . . . . . . 4.1 m-20 65.7 35.95 6.62 Favored 'General case' 0 N--CA 1.464 0.238 0 CA-C-N 118.133 0.424 . . . . 0.0 111.335 -178.064 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' D' D ' 101' ' ' GLU . . . . . . . . . . . . . 85.2 tt0 -109.93 142.68 40.94 Favored 'General case' 0 C--N 1.332 -0.179 0 N-CA-C 109.361 -0.607 . . . . 0.0 109.361 172.187 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' D' D ' 102' ' ' VAL . . . . . . . . . . . . . 44.5 t -115.02 126.86 72.72 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.312 0 CA-C-N 116.39 -0.368 . . . . 0.0 110.229 -175.84 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' D' D ' 103' ' ' LEU . . . . . . . . . . . . . 39.3 mt -116.62 129.91 56.43 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 115.678 -0.692 . . . . 0.0 109.897 175.629 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' D' D ' 104' ' ' ILE . . . . . . . . . . . . . 66.6 mt -117.7 124.41 73.02 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.259 0 N-CA-C 110.079 -0.341 . . . . 0.0 110.079 -179.996 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' D' D ' 105' ' ' PHE . . . . . . . . . . . . . 52.9 m-85 -123.72 163.54 20.91 Favored 'General case' 0 C--N 1.333 -0.142 0 O-C-N 123.963 0.79 . . . . 0.0 109.72 -179.376 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' D' D ' 106' ' ' ASN . . . . . . . . . . . . . 45.1 p-10 -97.86 -170.41 1.98 Allowed 'General case' 0 C--N 1.33 -0.281 0 N-CA-C 109.859 -0.422 . . . . 0.0 109.859 175.073 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' D' D ' 107' ' ' GLN . . . . . . . . . . . . . 62.4 tt0 -58.37 -30.04 66.46 Favored 'General case' 0 C--N 1.329 -0.297 0 N-CA-C 111.771 0.286 . . . . 0.0 111.771 179.097 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' D' D ' 108' ' ' ASN . . . . . . . . . . . . . 18.0 t30 -83.8 6.86 19.78 Favored 'General case' 0 CA--C 1.537 0.442 0 N-CA-C 113.389 0.885 . . . . 0.0 113.389 -176.53 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' D' D ' 109' ' ' LEU . . . . . 0.534 HD21 ' HB2' ' D' ' 78' ' ' ALA . 11.0 tp 62.37 37.54 13.68 Favored 'General case' 0 C--O 1.232 0.152 0 CA-C-O 120.957 0.408 . . . . 0.0 111.29 177.972 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' D' D ' 110' ' ' GLU . . . . . . . . . . . . . 95.5 mt-10 -106.44 153.99 21.47 Favored 'General case' 0 C--N 1.331 -0.198 0 CA-C-N 116.518 -0.31 . . . . 0.0 110.198 176.487 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' D' D ' 111' ' ' GLU . . . . . . . . . . . . . 85.0 tt0 -82.31 121.89 27.26 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.366 -0.379 . . . . 0.0 110.761 -177.721 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' D' D ' 112' ' ' LEU . . . . . . . . . . . . . 16.1 mt -110.44 -46.13 3.45 Favored 'General case' 0 C--N 1.331 -0.214 0 CA-C-N 116.198 -0.456 . . . . 0.0 110.723 179.367 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' D' D ' 113' ' ' TYR . . . . . . . . . . . . . 49.2 t80 -136.4 138.25 41.36 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-N 116.361 -0.381 . . . . 0.0 111.106 -179.104 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' D' D ' 114' ' ' ARG . . . . . . . . . . . . . 60.2 ttp180 -137.25 121.72 18.33 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 115.995 -0.548 . . . . 0.0 110.205 176.438 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' D' D ' 115' ' ' GLY . . . . . . . . . . . . . . . -150.05 162.2 29.12 Favored Glycine 0 CA--C 1.523 0.548 0 N-CA-C 110.481 -1.048 . . . . 0.0 110.481 178.903 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' D' D ' 116' ' ' LYS . . . . . . . . . . . . . 54.6 tttm -137.61 133.81 34.81 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.917 0.359 . . . . 0.0 110.219 -179.824 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' D' D ' 117' ' ' PHE . . . . . . . . . . . . . 38.5 m-85 -129.27 115.43 17.6 Favored 'General case' 0 C--N 1.331 -0.2 0 CA-C-O 120.901 0.381 . . . . 0.0 110.393 -175.689 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' D' D ' 118' ' ' GLU . . . . . . . . . . . . . 46.0 tp10 -52.86 -49.86 64.94 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.462 -0.336 . . . . 0.0 111.492 -176.792 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' D' D ' 119' ' ' ASN . . . . . . . . . . . . . 31.3 m120 -94.75 31.07 1.89 Allowed 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.257 -0.429 . . . . 0.0 112.138 -174.099 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' D' D ' 120' ' ' LEU . . . . . . . . . . . . . 17.9 tp -54.87 121.67 9.15 Favored 'General case' 0 C--N 1.332 -0.166 0 CA-C-O 120.698 0.285 . . . . 0.0 110.809 179.078 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' D' D ' 121' ' ' ASN . . . . . . . . . . . . . 15.0 m120 -114.03 -44.07 3.19 Favored 'General case' 0 C--N 1.331 -0.217 0 CA-C-N 116.356 -0.384 . . . . 0.0 110.909 -178.3 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' D' D ' 122' ' ' LYS . . . . . . . . . . . . . 59.9 mtpt -142.91 148.77 37.49 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-O 121.066 0.46 . . . . 0.0 111.74 -176.98 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' D' D ' 123' ' ' VAL . . . . . . . . . . . . . 44.5 t -131.33 128.2 61.11 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.246 0 CA-C-N 115.857 -0.611 . . . . 0.0 109.428 173.765 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' D' D ' 124' ' ' LEU . . . . . . . . . . . . . 60.8 mt -121.52 134.89 55.05 Favored 'General case' 0 C--N 1.331 -0.203 0 CA-C-N 116.357 -0.383 . . . . 0.0 110.558 -178.417 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' D' D ' 125' ' ' VAL . . . . . . . . . . . . . 40.8 t -130.19 131.8 65.54 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.266 0 CA-C-N 116.315 -0.402 . . . . 0.0 110.129 -179.785 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' D' D ' 126' ' ' ARG . . . . . . . . . . . . . 96.2 mtt-85 -140.08 117.69 11.55 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.333 -0.394 . . . . 0.0 110.627 178.487 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' D' D ' 127' ' ' ASN . . . . . . . . . . . . . 82.8 m-20 51.27 -104.96 0.18 Allowed 'General case' 0 CA--C 1.544 0.746 0 CA-C-O 119.032 -0.509 . . . . 0.0 111.408 178.718 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' D' D ' 128' ' ' ASP . . . . . . . . . . . . . 22.8 p-10 -114.03 1.1 14.54 Favored 'General case' 0 N--CA 1.468 0.473 0 CA-C-N 119.518 1.054 . . . . 0.0 113.489 -177.467 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' D' D ' 129' ' ' LEU . . . . . . . . . . . . . 44.7 mt -105.01 141.03 37.32 Favored 'General case' 0 C--O 1.231 0.129 0 CA-C-N 118.105 0.411 . . . . 0.0 110.078 179.245 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' D' D ' 130' ' ' VAL . . . . . . . . . . . . . 44.3 t -126.15 137.63 57.14 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.247 0 CA-C-N 116.388 -0.369 . . . . 0.0 110.153 -178.203 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' D' D ' 131' ' ' VAL . . . . . 0.463 HG21 ' CD1' ' E' ' 88' ' ' LEU . 44.2 t -134.13 134.17 55.48 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.324 0 CA-C-O 121.005 0.431 . . . . 0.0 110.011 177.629 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' D' D ' 132' ' ' ILE . . . . . . . . . . . . . 68.0 mt -117.28 133.61 63.48 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.297 0 CA-C-N 115.919 -0.582 . . . . 0.0 109.49 179.927 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' D' D ' 133' ' ' ILE . . . . . . . . . . . . . 37.1 mm -117.05 120.89 66.43 Favored 'Isoleucine or valine' 0 C--O 1.233 0.206 0 CA-C-O 120.682 0.277 . . . . 0.0 111.093 -175.218 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' D' D ' 134' ' ' ASP . . . . . . . . . . . . . 8.1 p-10 -132.91 147.06 52.29 Favored 'General case' 0 C--N 1.331 -0.234 0 N-CA-C 109.276 -0.638 . . . . 0.0 109.276 174.403 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' D' D ' 135' ' ' GLU . . . . . . . . . . . . . 84.4 tt0 -49.91 -26.42 4.11 Favored 'General case' 0 C--N 1.329 -0.316 0 N-CA-C 112.9 0.704 . . . . 0.0 112.9 -172.222 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' D' D ' 136' ' ' GLN . . . . . . . . . . . . . 31.4 tt0 -83.61 -34.29 25.15 Favored 'General case' 0 C--N 1.331 -0.224 0 N-CA-C 112.399 0.518 . . . . 0.0 112.399 -175.559 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' D' D ' 137' ' ' LYS . . . . . . . . . . . . . 20.5 pttp -168.35 172.37 8.47 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-O 121.544 0.688 . . . . 0.0 112.221 -172.076 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' D' D ' 138' ' ' LEU . . . . . 0.403 ' C ' HD23 ' D' ' 138' ' ' LEU . 7.7 tt -120.03 131.16 55.03 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 115.093 -0.958 . . . . 0.0 110.258 -178.46 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' D' D ' 139' ' ' THR . . . . . . . . . . . . . 33.8 m -109.04 130.08 55.47 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 116.133 -0.485 . . . . 0.0 110.675 -179.497 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' D' D ' 140' ' ' LEU . . . . . 0.428 HD12 HG22 ' D' ' 131' ' ' VAL . 27.1 tp -114.9 121.15 42.32 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 115.765 -0.652 . . . . 0.0 109.315 -179.201 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' D' D ' 141' ' ' ILE . . . . . . . . . . . . . 19.5 mt -119.85 121.96 67.41 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.222 0 N-CA-C 109.858 -0.423 . . . . 0.0 109.858 -175.158 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' D' D ' 142' ' ' ARG . . . . . . . . . . . . . 81.5 mtm180 -116.61 131.59 56.91 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 115.496 -0.775 . . . . 0.0 110.299 -176.823 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' D' D ' 143' ' ' THR . . . . . . . . . . . . . 59.5 p . . . . . 0 C--O 1.221 -0.421 0 CA-C-O 118.044 -0.979 . . . . 0.0 110.62 -179.819 . . . . . . . . 0 0 . 1 . 011 nuclear build full ' E' E ' -3' ' ' GLU . . . . . . . . . . . . . 95.6 mt-10 . . . . . 0 N--CA 1.489 1.503 0 N-CA-C 109.359 -0.608 . . . . 0.0 109.359 . . . . . . . . . 0 0 . 1 . 011 nuclear build full ' E' E ' -2' ' ' GLY . . . . . . . . . . . . . . . -71.13 147.31 42.58 Favored Glycine 0 CA--C 1.525 0.688 0 N-CA-C 111.024 -0.83 . . . . 0.0 111.024 -179.733 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' E' E ' -1' ' ' VAL . . . . . . . . . . . . . 44.8 t -96.22 137.63 23.66 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.294 0 N-CA-C 109.918 -0.401 . . . . 0.0 109.918 179.58 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' E' E ' 0' ' ' ILE . . . . . . . . . . . . . 68.3 mt -104.38 133.09 49.42 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.263 0 CA-C-N 116.333 -0.394 . . . . 0.0 110.059 -179.479 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' E' E ' 1' ' ' MET . . . . . . . . . . . . . 25.2 ptp -86.17 150.15 24.6 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-N 116.0 -0.546 . . . . 0.0 110.788 -179.328 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' E' E ' 2' ' ' SER . . . . . . . . . . . . . 2.1 p -123.66 124.53 42.97 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.227 -0.442 . . . . 0.0 109.944 177.872 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' E' E ' 3' ' ' GLU . . . . . . . . . . . . . 80.4 tt0 -143.48 142.3 31.11 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 116.149 -0.478 . . . . 0.0 111.246 -175.384 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' E' E ' 4' ' ' LEU . . . . . . . . . . . . . 16.8 tp -122.26 132.24 54.33 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-N 116.079 -0.509 . . . . 0.0 110.163 176.172 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' E' E ' 5' ' ' LYS . . . . . . . . . . . . . 52.0 mttp -107.25 119.61 39.85 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.469 -0.332 . . . . 0.0 110.51 178.597 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' E' E ' 6' ' ' LEU . . . . . . . . . . . . . 37.6 mt -114.19 147.33 39.09 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 115.354 -0.839 . . . . 0.0 110.669 -178.571 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' E' E ' 7' ' ' LYS . . . . . . . . . . . . . 47.6 tttp -138.47 141.3 30.85 Favored Pre-proline 0 CA--C 1.534 0.343 0 CA-C-O 119.128 -0.463 . . . . 0.0 110.075 174.811 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' E' E ' 8' ' ' PRO . . . . . . . . . . . . . 73.7 Cg_endo -91.51 141.36 2.7 Favored 'Trans proline' 0 N--CA 1.49 1.298 0 C-N-CA 121.664 1.576 . . . . 0.0 111.561 176.047 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' E' E ' 9' ' ' LEU . . . . . . . . . . . . . 67.7 mt -77.2 -47.68 2.59 Favored Pre-proline 0 CA--C 1.533 0.322 0 CA-C-O 118.645 -0.693 . . . . 0.0 112.428 -179.288 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' E' E ' 10' ' ' PRO . . . . . . . . . . . . . 90.6 Cg_endo -79.98 155.36 23.09 Favored 'Trans proline' 0 N--CA 1.496 1.642 0 C-N-CA 121.282 1.321 . . . . 0.0 111.892 176.733 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' E' E ' 11' ' ' LYS . . . . . . . . . . . . . 28.2 ttpt -88.29 92.33 9.12 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-O 120.833 0.349 . . . . 0.0 110.532 178.876 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' E' E ' 12' ' ' VAL . . . . . . . . . . . . . 12.5 p -141.39 143.88 27.02 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.283 0 CA-C-N 116.241 -0.436 . . . . 0.0 110.343 178.68 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' E' E ' 13' ' ' GLU . . . . . . . . . . . . . 15.2 pt-20 -87.13 131.13 34.25 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.362 -0.381 . . . . 0.0 110.704 179.345 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' E' E ' 14' ' ' LEU . . . . . . . . . . . . . 17.5 mt -98.41 155.08 37.25 Favored Pre-proline 0 C--N 1.33 -0.266 0 CA-C-N 116.246 -0.433 . . . . 0.0 110.686 -179.967 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' E' E ' 15' ' ' PRO . . . . . . . . . . . . . 26.5 Cg_exo -61.57 160.07 29.62 Favored 'Trans proline' 0 N--CA 1.496 1.647 0 C-N-CA 121.363 1.375 . . . . 0.0 111.667 176.233 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' E' E ' 16' ' ' PRO . . . . . . . . . . . . . 34.7 Cg_exo -58.87 -40.76 68.97 Favored 'Trans proline' 0 N--CA 1.496 1.667 0 C-N-CA 121.4 1.4 . . . . 0.0 112.963 -177.304 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' E' E ' 17' ' ' ASP . . . . . . . . . . . . . 23.5 p-10 -89.01 11.33 18.58 Favored 'General case' 0 C--N 1.326 -0.417 0 N-CA-C 113.156 0.799 . . . . 0.0 113.156 -177.175 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' E' E ' 18' ' ' PHE . . . . . . . . . . . . . 47.1 t80 -58.04 -43.75 87.0 Favored 'General case' 0 C--N 1.334 -0.1 0 O-C-N 121.944 -0.473 . . . . 0.0 109.972 -179.619 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' E' E ' 19' ' ' VAL . . . . . . . . . . . . . 47.8 t -57.54 -39.3 68.51 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.309 0 CA-C-N 116.028 -0.533 . . . . 0.0 110.406 179.206 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' E' E ' 20' ' ' ASP . . . . . . . . . . . . . 28.3 t0 -58.94 -43.61 91.26 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-O 120.691 0.281 . . . . 0.0 110.579 -178.507 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' E' E ' 21' ' ' VAL . . . . . . . . . . . . . 52.4 t -64.22 -45.14 97.13 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.326 0 C-N-CA 120.689 -0.404 . . . . 0.0 110.354 -178.642 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' E' E ' 22' ' ' ILE . . . . . 0.687 HG22 HD12 ' E' ' 26' ' ' LEU . 49.3 mm -58.93 -41.59 83.48 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.327 0 C-N-CA 120.969 -0.292 . . . . 0.0 110.908 -179.929 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' E' E ' 23' ' ' ARG . . . . . . . . . . . . . 42.6 ttp180 -57.07 -47.02 82.01 Favored 'General case' 0 C--N 1.331 -0.209 0 C-N-CA 120.7 -0.4 . . . . 0.0 110.522 178.899 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' E' E ' 24' ' ' ILE . . . . . . . . . . . . . 79.6 mt -61.63 -44.95 99.5 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.302 0 CA-C-N 116.153 -0.476 . . . . 0.0 111.88 -178.559 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' E' E ' 25' ' ' LYS . . . . . . . . . . . . . 13.6 pttp -70.1 -36.21 74.71 Favored 'General case' 0 CA--C 1.533 0.307 0 C-N-CA 120.487 -0.485 . . . . 0.0 111.61 -173.729 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' E' E ' 26' ' ' LEU . . . . . 0.687 HD12 HG22 ' E' ' 22' ' ' ILE . 20.7 mt -79.05 -40.52 31.11 Favored 'General case' 0 C--N 1.33 -0.254 0 N-CA-C 112.86 0.689 . . . . 0.0 112.86 -174.482 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' E' E ' 27' ' ' GLN . . . . . . . . . . . . . 8.4 pt20 -47.32 139.47 6.36 Favored 'General case' 0 N--CA 1.467 0.4 0 N-CA-C 112.795 0.665 . . . . 0.0 112.795 -174.644 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' E' E ' 28' ' ' GLY . . . . . . . . . . . . . . . 98.77 -26.63 23.29 Favored Glycine 0 CA--C 1.534 1.239 0 CA-C-N 115.582 -0.736 . . . . 0.0 112.184 -176.021 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' E' E ' 29' ' ' LYS . . . . . . . . . . . . . 98.8 mttt -98.07 155.2 17.24 Favored 'General case' 0 C--O 1.233 0.202 0 CA-C-N 117.116 0.458 . . . . 0.0 111.154 179.21 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' E' E ' 30' ' ' THR . . . . . . . . . . . . . 24.6 m -104.82 137.11 43.1 Favored 'General case' 0 C--N 1.332 -0.186 0 CA-C-N 115.851 -0.613 . . . . 0.0 109.79 174.643 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' E' E ' 31' ' ' VAL . . . . . . . . . . . . . 34.9 m -127.94 159.37 39.01 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.19 0 CA-C-N 116.416 -0.356 . . . . 0.0 110.747 -178.185 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' E' E ' 32' ' ' ARG . . . . . . . . . . . . . 73.9 mtt85 -133.79 149.42 51.42 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-O 121.394 0.616 . . . . 0.0 110.773 179.241 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' E' E ' 33' ' ' THR . . . . . . . . . . . . . 18.4 m -53.54 140.09 29.47 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.143 -0.48 . . . . 0.0 111.18 -179.327 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' E' E ' 34' ' ' GLY . . . . . . . . . . . . . . . 100.69 -17.23 56.82 Favored Glycine 0 CA--C 1.533 1.164 0 CA-C-O 119.622 -0.544 . . . . 0.0 113.151 179.517 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' E' E ' 35' ' ' ASP . . . . . . . . . . . . . 77.1 m-20 -65.78 147.51 53.27 Favored 'General case' 0 C--N 1.333 -0.121 0 CA-C-N 118.058 0.929 . . . . 0.0 111.067 178.764 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' E' E ' 36' ' ' VAL . . . . . . . . . . . . . 45.3 t -125.02 131.71 72.21 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.245 0 CA-C-N 115.843 -0.617 . . . . 0.0 109.874 178.455 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' E' E ' 37' ' ' ILE . . . . . . . . . . . . . 68.1 mt -122.46 139.18 50.17 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.26 0 CA-C-N 116.331 -0.395 . . . . 0.0 109.948 -179.79 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' E' E ' 38' ' ' GLY . . . . . . . . . . . . . . . -111.79 128.63 8.7 Favored Glycine 0 CA--C 1.525 0.714 0 N-CA-C 111.243 -0.743 . . . . 0.0 111.243 179.928 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' E' E ' 39' ' ' ILE . . . . . . . . . . . . . 73.1 mt -127.74 129.94 70.14 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.229 0 N-CA-C 109.984 -0.376 . . . . 0.0 109.984 178.512 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' E' E ' 40' ' ' SER . . . . . . . . . . . . . 43.4 t -92.25 113.91 26.31 Favored 'General case' 0 C--N 1.329 -0.303 0 C-N-CA 120.997 -0.281 . . . . 0.0 110.92 177.501 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' E' E ' 41' ' ' ILE . . . . . . . . . . . . . 45.2 mm -123.06 124.45 70.24 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.207 0 N-CA-C 109.864 -0.421 . . . . 0.0 109.864 179.853 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' E' E ' 42' ' ' LEU . . . . . . . . . . . . . 55.6 mt 57.48 34.47 24.66 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.35 -0.387 . . . . 0.0 111.681 178.755 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' E' E ' 43' ' ' GLY . . . . . . . . . . . . . . . 77.6 -10.1 25.67 Favored Glycine 0 CA--C 1.535 1.314 0 C-N-CA 121.297 -0.478 . . . . 0.0 113.396 177.601 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' E' E ' 44' ' ' LYS . . . . . . . . . . . . . 60.2 tttm -101.65 130.29 47.97 Favored 'General case' 0 C--N 1.332 -0.172 0 CA-C-N 117.976 0.888 . . . . 0.0 109.814 177.396 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' E' E ' 45' ' ' GLU . . . . . . . . . . . . . 39.6 tp10 -83.8 128.72 34.74 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.389 -0.369 . . . . 0.0 110.813 -178.57 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' E' E ' 46' ' ' VAL . . . . . . . . . . . . . 7.3 p -120.64 132.24 70.72 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.277 0 N-CA-C 109.659 -0.497 . . . . 0.0 109.659 177.509 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' E' E ' 47' ' ' LYS . . . . . . . . . . . . . 62.5 mttp -100.72 127.95 46.95 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 115.929 -0.578 . . . . 0.0 111.088 177.245 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' E' E ' 48' ' ' PHE . . . . . . . . . . . . . 92.4 m-85 -109.61 131.73 54.79 Favored 'General case' 0 C--N 1.329 -0.298 0 N-CA-C 109.57 -0.53 . . . . 0.0 109.57 175.304 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' E' E ' 49' ' ' LYS . . . . . . . . . . . . . 47.5 tttp -111.57 139.12 47.28 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.661 -0.245 . . . . 0.0 110.656 -179.953 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' E' E ' 50' ' ' VAL . . . . . . . . . . . . . 45.1 t -83.49 108.42 16.03 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.307 0 N-CA-C 109.34 -0.615 . . . . 0.0 109.34 175.731 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' E' E ' 51' ' ' VAL . . . . . . . . . . . . . 46.7 t -74.2 -50.84 25.83 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.305 0 CA-C-N 116.117 -0.492 . . . . 0.0 109.955 -174.461 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' E' E ' 52' ' ' GLN . . . . . . . . . . . . . 92.2 mt-30 -152.69 152.7 32.03 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-O 121.18 0.514 . . . . 0.0 111.766 -178.54 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' E' E ' 53' ' ' ALA . . . . . . . . . . . . . . . -130.69 131.89 45.08 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 115.213 -0.903 . . . . 0.0 109.762 175.644 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' E' E ' 54' ' ' TYR . . . . . . . . . . . . . 39.5 t80 -129.07 108.96 18.09 Favored Pre-proline 0 CA--C 1.535 0.398 0 CA-C-O 118.306 -0.854 . . . . 0.0 110.277 179.348 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' E' E ' 55' ' ' PRO . . . . . . . . . . . . . 73.7 Cg_endo -77.27 169.28 74.53 Favored 'Cis proline' 0 N--CA 1.499 1.825 0 CA-C-N 121.829 1.689 . . . . 0.0 112.384 -4.473 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' E' E ' 56' ' ' SER . . . . . . . . . . . . . 14.5 m -113.88 122.62 34.44 Favored Pre-proline 0 CA--C 1.539 0.535 0 CA-C-O 118.309 -0.853 . . . . 0.0 109.372 175.275 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' E' E ' 57' ' ' PRO . . . . . . . . . . . . . 42.0 Cg_endo -67.72 167.96 59.48 Favored 'Cis proline' 0 N--CA 1.498 1.787 0 CA-C-N 122.104 1.787 . . . . 0.0 112.076 2.004 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' E' E ' 58' ' ' LEU . . . . . . . . . . . . . 25.6 tp -130.05 137.96 50.5 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-N 115.915 -0.584 . . . . 0.0 110.317 179.875 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' E' E ' 59' ' ' ARG . . . . . . . . . . . . . 66.6 ttt180 -102.36 134.34 45.82 Favored 'General case' 0 C--N 1.329 -0.298 0 N-CA-C 109.671 -0.492 . . . . 0.0 109.671 176.267 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' E' E ' 60' ' ' VAL . . . . . . . . . . . . . 41.1 t -90.34 122.53 41.81 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.192 0 C-N-CA 120.586 -0.446 . . . . 0.0 110.614 -177.851 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' E' E ' 61' ' ' GLU . . . . . . . . . . . . . 77.5 tt0 -131.06 158.14 41.17 Favored 'General case' 0 C--N 1.33 -0.269 0 N-CA-C 109.069 -0.715 . . . . 0.0 109.069 176.696 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' E' E ' 62' ' ' ASP . . . . . . . . . . . . . 64.2 m-20 -52.98 -34.3 55.46 Favored 'General case' 0 C--N 1.328 -0.355 0 N-CA-C 111.686 0.254 . . . . 0.0 111.686 -179.03 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' E' E ' 63' ' ' ARG . . . . . . . . . . . . . 22.6 mmt85 -78.67 -13.02 60.03 Favored 'General case' 0 CA--C 1.535 0.37 0 N-CA-C 113.384 0.883 . . . . 0.0 113.384 -178.549 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' E' E ' 64' ' ' THR . . . . . . . . . . . . . 18.2 m -64.58 146.71 54.23 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-O 120.977 0.417 . . . . 0.0 111.022 -175.654 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' E' E ' 65' ' ' LYS . . . . . . . . . . . . . 22.6 mtpp -86.32 127.2 34.76 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 115.736 -0.665 . . . . 0.0 110.32 -179.883 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' E' E ' 66' ' ' ILE . . . . . . . . . . . . . 60.4 mt -118.2 128.09 75.28 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.307 0 N-CA-C 109.774 -0.454 . . . . 0.0 109.774 178.458 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' E' E ' 67' ' ' THR . . . . . . . . . . . . . 30.7 m -125.88 144.16 50.78 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-O 121.052 0.453 . . . . 0.0 111.168 -176.989 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' E' E ' 68' ' ' LEU . . . . . . . . . . . . . 13.4 tp -104.86 135.66 45.81 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 115.754 -0.657 . . . . 0.0 110.192 179.098 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' E' E ' 69' ' ' VAL . . . . . . . . . . . . . 37.5 t -83.07 146.29 7.22 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.323 0 CA-C-O 121.009 0.433 . . . . 0.0 110.759 -178.607 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' E' E ' 70' ' ' THR . . . . . . . . . . . . . 68.0 p -85.76 174.59 9.24 Favored 'General case' 0 C--N 1.331 -0.2 0 CA-C-N 115.817 -0.629 . . . . 0.0 110.873 -178.978 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' E' E ' 71' ' ' HIS . . . . . . . . . . . . . 73.6 m-70 -67.65 153.4 95.09 Favored Pre-proline 0 CA--C 1.533 0.292 0 CA-C-N 115.955 -0.566 . . . . 0.0 111.207 -177.807 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' E' E ' 72' ' ' PRO . . . . . . . . . . . . . 72.2 Cg_endo -93.25 160.0 2.54 Favored 'Trans proline' 0 N--CA 1.49 1.267 0 C-N-CA 122.045 1.83 . . . . 0.0 112.564 178.189 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' E' E ' 73' ' ' VAL . . . . . . . . . . . . . 35.3 m -70.84 -173.78 0.11 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.228 0 CA-C-N 116.202 -0.454 . . . . 0.0 110.315 176.95 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' E' E ' 74' ' ' ASP . . . . . . . . . . . . . 22.0 t0 -104.04 125.04 50.09 Favored 'General case' 0 C--N 1.332 -0.191 0 C-N-CA 121.02 -0.272 . . . . 0.0 110.27 -178.885 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' E' E ' 75' ' ' VAL . . . . . . . . . . . . . 46.3 t -121.48 124.12 71.09 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.258 0 CA-C-O 121.049 0.452 . . . . 0.0 110.691 -178.86 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' E' E ' 76' ' ' LEU . . . . . 0.438 ' N ' HD12 ' E' ' 76' ' ' LEU . 6.4 mp -121.39 149.21 43.31 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-N 115.764 -0.653 . . . . 0.0 109.787 176.027 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' E' E ' 77' ' ' GLU . . . . . . . . . . . . . 97.1 mt-10 -138.38 134.45 34.18 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-O 121.028 0.442 . . . . 0.0 111.214 -179.604 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' E' E ' 78' ' ' ALA . . . . . 0.656 ' HB2' HD21 ' E' ' 109' ' ' LEU . . . -121.33 136.18 55.0 Favored 'General case' 0 C--N 1.331 -0.21 0 CA-C-N 115.763 -0.653 . . . . 0.0 109.773 176.709 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' E' E ' 79' ' ' LYS . . . . . 0.635 ' O ' HD13 ' E' ' 80' ' ' ILE . 40.7 mttm -81.4 117.3 21.74 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-O 120.828 0.347 . . . . 0.0 110.949 -177.478 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' E' E ' 80' ' ' ILE . . . . . 0.635 HD13 ' O ' ' E' ' 79' ' ' LYS . 38.4 mm -139.28 106.07 2.68 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.27 0 N-CA-C 109.164 -0.68 . . . . 0.0 109.164 -179.475 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' E' E ' 81' ' ' LYS . . . . . . . . . . . . . 42.4 mtmt -99.61 126.74 45.66 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-O 121.041 0.448 . . . . 0.0 111.056 -177.992 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' E' E ' 82' ' ' GLY . . . . . . . . . . . . . . . 89.1 42.23 5.66 Favored Glycine 0 CA--C 1.525 0.695 0 C-N-CA 120.881 -0.676 . . . . 0.0 111.615 176.34 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' E' E ' 83' ' ' ILE . . . . . . . . . . . . . 75.3 mt -68.93 137.09 25.03 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.271 0 N-CA-C 109.734 -0.469 . . . . 0.0 109.734 177.149 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' E' E ' 84' ' ' LYS . . . . . . . . . . . . . 29.8 ttmt -92.49 -51.65 5.03 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-O 121.091 0.472 . . . . 0.0 109.8 -179.958 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' E' E ' 85' ' ' ASP . . . . . . . . . . . . . 5.8 t70 -156.19 152.26 27.63 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 115.492 -0.776 . . . . 0.0 110.234 -179.93 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' E' E ' 86' ' ' VAL . . . . . . . . . . . . . 44.1 t -128.07 130.62 69.75 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.27 0 CA-C-O 120.866 0.365 . . . . 0.0 110.258 179.718 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' E' E ' 87' ' ' ILE . . . . . . . . . . . . . 45.4 mm -117.3 124.19 72.73 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.291 0 CA-C-N 115.907 -0.588 . . . . 0.0 109.5 176.771 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' E' E ' 88' ' ' LEU . . . . . 0.463 ' CD1' HG21 ' D' ' 131' ' ' VAL . 13.4 tp -113.64 131.92 55.96 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-O 121.144 0.497 . . . . 0.0 111.218 -175.75 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' E' E ' 89' ' ' ASP . . . . . . . . . . . . . 9.5 t70 -125.94 153.92 43.58 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 115.63 -0.714 . . . . 0.0 109.312 174.679 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' E' E ' 90' ' ' GLU . . . . . . . . . . . . . 96.2 mt-10 -49.05 -34.55 13.77 Favored 'General case' 0 C--N 1.328 -0.367 0 N-CA-C 112.804 0.668 . . . . 0.0 112.804 -172.402 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' E' E ' 91' ' ' ASN . . . . . . . . . . . . . 85.1 m-20 -132.08 33.03 3.95 Favored 'General case' 0 N--CA 1.465 0.3 0 N-CA-C 112.099 0.407 . . . . 0.0 112.099 -176.285 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' E' E ' 92' ' ' LEU . . . . . . . . . . . . . 14.2 tp -166.05 143.8 5.53 Favored 'General case' 0 C--N 1.331 -0.231 0 C-N-CA 120.994 -0.282 . . . . 0.0 110.819 179.767 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' E' E ' 93' ' ' ILE . . . . . . . . . . . . . 69.9 mt -124.45 118.6 54.05 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.244 0 N-CA-C 109.577 -0.527 . . . . 0.0 109.577 179.863 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' E' E ' 94' ' ' VAL . . . . . 0.489 HG21 HG21 ' E' ' 125' ' ' VAL . 46.4 t -118.75 125.77 74.7 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.213 0 N-CA-C 109.73 -0.47 . . . . 0.0 109.73 179.333 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' E' E ' 95' ' ' VAL . . . . . . . . . . . . . 41.8 t -122.97 133.71 68.25 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.356 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.03 -179.08 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' E' E ' 96' ' ' ILE . . . . . . . . . . . . . 60.9 mt -115.42 127.79 72.87 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.324 0 N-CA-C 109.217 -0.66 . . . . 0.0 109.217 178.658 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' E' E ' 97' ' ' THR . . . . . . . . . . . . . 68.2 p -99.56 155.42 17.59 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-O 120.98 0.419 . . . . 0.0 110.678 -178.876 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' E' E ' 98' ' ' GLU . . . . . . . . . . . . . 45.2 mt-10 -55.64 -23.58 28.72 Favored 'General case' 0 CA--C 1.533 0.325 0 N-CA-C 112.366 0.506 . . . . 0.0 112.366 -179.717 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' E' E ' 99' ' ' GLU . . . . . . . . . . . . . 96.4 mt-10 -76.95 13.06 1.14 Allowed 'General case' 0 CA--C 1.536 0.431 0 N-CA-C 113.192 0.812 . . . . 0.0 113.192 -179.273 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' E' E ' 100' ' ' ASN . . . . . . . . . . . . . 4.0 m-20 63.69 38.07 9.63 Favored 'General case' 0 CA--C 1.529 0.149 0 CA-C-O 121.065 0.459 . . . . 0.0 111.076 178.129 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' E' E ' 101' ' ' GLU . . . . . . . . . . . . . 85.3 tt0 -118.58 144.15 46.3 Favored 'General case' 0 C--N 1.333 -0.134 0 CA-C-N 115.922 -0.581 . . . . 0.0 109.731 176.064 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' E' E ' 102' ' ' VAL . . . . . . . . . . . . . 47.2 t -116.13 127.58 73.69 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.238 0 CA-C-N 116.307 -0.406 . . . . 0.0 110.221 -177.244 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' E' E ' 103' ' ' LEU . . . . . . . . . . . . . 27.9 mt -117.73 132.99 56.39 Favored 'General case' 0 C--N 1.331 -0.213 0 CA-C-N 115.632 -0.713 . . . . 0.0 110.196 176.768 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' E' E ' 104' ' ' ILE . . . . . . . . . . . . . 67.6 mt -120.99 123.35 69.92 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.238 0 N-CA-C 110.198 -0.297 . . . . 0.0 110.198 179.378 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' E' E ' 105' ' ' PHE . . . . . . . . . . . . . 55.8 m-85 -124.91 165.69 17.64 Favored 'General case' 0 C--N 1.332 -0.164 0 O-C-N 123.896 0.748 . . . . 0.0 109.813 179.278 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' E' E ' 106' ' ' ASN . . . . . . . . . . . . . 47.3 p-10 -101.84 -170.96 1.9 Allowed 'General case' 0 C--N 1.331 -0.237 0 N-CA-C 109.966 -0.383 . . . . 0.0 109.966 173.568 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' E' E ' 107' ' ' GLN . . . . . . . . . . . . . 50.3 tt0 -58.57 -30.2 66.98 Favored 'General case' 0 C--N 1.329 -0.299 0 N-CA-C 111.998 0.37 . . . . 0.0 111.998 179.638 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' E' E ' 108' ' ' ASN . . . . . . . . . . . . . 58.1 t30 -83.11 10.79 7.39 Favored 'General case' 0 CA--C 1.537 0.463 0 N-CA-C 112.987 0.736 . . . . 0.0 112.987 -177.422 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' E' E ' 109' ' ' LEU . . . . . 0.656 HD21 ' HB2' ' E' ' 78' ' ' ALA . 8.6 tp 55.09 37.61 29.18 Favored 'General case' 0 C--N 1.332 -0.186 0 CA-C-O 121.039 0.447 . . . . 0.0 111.277 179.006 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' E' E ' 110' ' ' GLU . . . . . . . . . . . . . 70.6 mm-40 -102.9 154.94 18.71 Favored 'General case' 0 C--N 1.331 -0.235 0 N-CA-C 109.771 -0.455 . . . . 0.0 109.771 176.319 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' E' E ' 111' ' ' GLU . . . . . . . . . . . . . 85.0 tt0 -82.84 121.94 27.59 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-O 120.908 0.385 . . . . 0.0 110.598 -177.924 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' E' E ' 112' ' ' LEU . . . . . . . . . . . . . 18.8 mt -108.6 -45.92 3.76 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 115.964 -0.562 . . . . 0.0 110.38 178.34 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' E' E ' 113' ' ' TYR . . . . . . . . . . . . . 64.2 t80 -142.03 139.96 32.48 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.37 -0.377 . . . . 0.0 111.573 -179.9 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' E' E ' 114' ' ' ARG . . . . . . . . . . . . . 59.3 ttp180 -140.71 121.93 14.83 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.031 -0.531 . . . . 0.0 110.104 176.835 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' E' E ' 115' ' ' GLY . . . . . . . . . . . . . . . -150.06 161.35 28.87 Favored Glycine 0 CA--C 1.525 0.698 0 N-CA-C 111.296 -0.721 . . . . 0.0 111.296 178.563 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' E' E ' 116' ' ' LYS . . . . . . . . . . . . . 40.0 ttpt -130.9 140.7 50.23 Favored 'General case' 0 C--N 1.331 -0.215 0 N-CA-C 110.253 -0.277 . . . . 0.0 110.253 179.002 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' E' E ' 117' ' ' PHE . . . . . . . . . . . . . 30.3 m-85 -139.11 114.01 9.33 Favored 'General case' 0 C--N 1.331 -0.214 0 C-N-CA 120.839 -0.344 . . . . 0.0 110.188 -178.517 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' E' E ' 118' ' ' GLU . . . . . . . . . . . . . 95.9 mt-10 -54.83 -41.44 70.7 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 116.47 -0.332 . . . . 0.0 111.216 -176.401 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' E' E ' 119' ' ' ASN . . . . . . . . . . . . . 28.4 m120 -100.36 30.96 3.6 Favored 'General case' 0 C--N 1.33 -0.249 0 N-CA-C 112.176 0.435 . . . . 0.0 112.176 -174.016 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' E' E ' 120' ' ' LEU . . . . . . . . . . . . . 24.8 tp -57.57 119.98 7.51 Favored 'General case' 0 C--N 1.332 -0.155 0 C-N-CA 120.903 -0.319 . . . . 0.0 110.179 177.546 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' E' E ' 121' ' ' ASN . . . . . . . . . . . . . 21.1 m120 -114.19 -44.02 3.17 Favored 'General case' 0 N--CA 1.462 0.149 0 CA-C-N 116.553 -0.294 . . . . 0.0 111.319 -176.708 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' E' E ' 122' ' ' LYS . . . . . . . . . . . . . 35.8 mtmm -140.17 146.29 38.57 Favored 'General case' 0 C--N 1.331 -0.224 0 CA-C-O 121.032 0.444 . . . . 0.0 111.618 -175.825 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' E' E ' 123' ' ' VAL . . . . . . . . . . . . . 44.3 t -128.58 130.81 69.05 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.269 0 CA-C-N 115.998 -0.547 . . . . 0.0 109.796 177.038 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' E' E ' 124' ' ' LEU . . . . . . . . . . . . . 45.9 mt -123.39 129.7 51.66 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-N 116.49 -0.323 . . . . 0.0 110.597 179.645 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' E' E ' 125' ' ' VAL . . . . . 0.489 HG21 HG21 ' E' ' 94' ' ' VAL . 42.2 t -132.71 126.72 54.94 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.248 0 CA-C-N 116.231 -0.44 . . . . 0.0 109.982 178.68 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' E' E ' 126' ' ' ARG . . . . . . . . . . . . . 51.8 mmm-85 -140.05 125.14 18.63 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-O 120.918 0.389 . . . . 0.0 110.329 177.996 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' E' E ' 127' ' ' ASN . . . . . . . . . . . . . 67.3 m-80 51.25 -111.61 0.56 Allowed 'General case' 0 CA--C 1.546 0.794 0 CA-C-O 118.598 -0.715 . . . . 0.0 111.172 179.817 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' E' E ' 128' ' ' ASP . . . . . . . . . . . . . 11.6 p-10 -114.14 9.97 17.28 Favored 'General case' 0 CA--C 1.535 0.384 0 CA-C-N 120.089 1.313 . . . . 0.0 113.26 -178.357 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' E' E ' 129' ' ' LEU . . . . . . . . . . . . . 17.2 tp -109.52 138.33 46.05 Favored 'General case' 0 C--O 1.233 0.216 0 O-C-N 121.987 -0.445 . . . . 0.0 110.053 179.199 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' E' E ' 130' ' ' VAL . . . . . . . . . . . . . 41.2 t -125.02 137.19 58.43 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.226 0 CA-C-O 120.958 0.409 . . . . 0.0 110.494 -176.802 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' E' E ' 131' ' ' VAL . . . . . 0.517 HG22 HD12 ' E' ' 140' ' ' LEU . 41.8 t -135.82 136.68 49.9 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.259 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.242 177.39 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' E' E ' 132' ' ' ILE . . . . . . . . . . . . . 71.6 mt -118.3 132.98 66.58 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.337 0 CA-C-N 115.886 -0.597 . . . . 0.0 109.446 -179.031 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' E' E ' 133' ' ' ILE . . . . . . . . . . . . . 40.3 mm -117.16 123.77 72.22 Favored 'Isoleucine or valine' 0 C--O 1.233 0.214 0 CA-C-O 121.001 0.429 . . . . 0.0 111.053 -174.914 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' E' E ' 134' ' ' ASP . . . . . . . . . . . . . 6.7 p-10 -131.07 152.75 50.04 Favored 'General case' 0 C--N 1.332 -0.157 0 CA-C-N 116.048 -0.524 . . . . 0.0 109.786 174.723 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' E' E ' 135' ' ' GLU . . . . . . . . . . . . . 46.4 tp10 -49.93 -28.33 6.58 Favored 'General case' 0 C--N 1.328 -0.356 0 N-CA-C 112.91 0.707 . . . . 0.0 112.91 -169.263 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' E' E ' 136' ' ' GLN . . . . . . . . . . . . . 52.7 mt-30 -105.03 -24.96 12.73 Favored 'General case' 0 N--CA 1.464 0.275 0 N-CA-C 112.982 0.734 . . . . 0.0 112.982 -173.767 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' E' E ' 137' ' ' LYS . . . . . . . . . . . . . 59.6 mtpt -143.11 154.14 43.62 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-O 121.229 0.538 . . . . 0.0 111.891 -169.589 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' E' E ' 138' ' ' LEU . . . . . 0.423 ' C ' HD23 ' E' ' 138' ' ' LEU . 5.7 tt -119.09 124.18 46.27 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 115.546 -0.752 . . . . 0.0 109.378 174.587 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' E' E ' 139' ' ' THR . . . . . . . . . . . . . 30.6 m -110.39 130.54 55.53 Favored 'General case' 0 C--N 1.331 -0.229 0 CA-C-O 120.795 0.331 . . . . 0.0 110.774 -177.173 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' E' E ' 140' ' ' LEU . . . . . 0.517 HD12 HG22 ' E' ' 131' ' ' VAL . 12.6 tp -116.52 125.29 51.7 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 115.664 -0.698 . . . . 0.0 109.429 -178.093 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' E' E ' 141' ' ' ILE . . . . . . . . . . . . . 19.3 mt -122.56 117.75 52.99 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.308 0 N-CA-C 109.736 -0.468 . . . . 0.0 109.736 -177.205 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' E' E ' 142' ' ' ARG . . . . . . . . . . . . . 81.2 mtp180 -108.1 128.45 54.69 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 115.39 -0.823 . . . . 0.0 110.398 -176.473 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' E' E ' 143' ' ' THR . . . . . . . . . . . . . 77.8 p . . . . . 0 C--O 1.22 -0.459 0 CA-C-O 118.058 -0.972 . . . . 0.0 110.48 -179.994 . . . . . . . . 0 0 . 1 . 011 nuclear build full ' F' F ' -3' ' ' GLU . . . . . . . . . . . . . 95.8 mt-10 . . . . . 0 N--CA 1.491 1.602 0 N-CA-C 109.38 -0.6 . . . . 0.0 109.38 . . . . . . . . . 0 0 . 1 . 011 nuclear build full ' F' F ' -2' ' ' GLY . . . . . . . . . . . . . . . -70.25 130.94 22.06 Favored Glycine 0 CA--C 1.525 0.709 0 N-CA-C 110.679 -0.968 . . . . 0.0 110.679 178.454 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' F' F ' -1' ' ' VAL . . . . . . . . . . . . . 45.1 t -96.03 138.29 21.82 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.343 0 CA-C-O 120.876 0.37 . . . . 0.0 110.168 -179.327 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' F' F ' 0' ' ' ILE . . . . . . . . . . . . . 69.3 mt -105.83 125.04 61.3 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.241 0 N-CA-C 109.718 -0.475 . . . . 0.0 109.718 179.455 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' F' F ' 1' ' ' MET . . . . . . . . . . . . . 27.4 ptm -79.96 138.56 37.11 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.262 -0.426 . . . . 0.0 110.756 -179.598 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' F' F ' 2' ' ' SER . . . . . . . . . . . . . 7.4 p -118.99 133.92 55.52 Favored 'General case' 0 C--N 1.331 -0.21 0 CA-C-O 121.157 0.503 . . . . 0.0 110.356 177.9 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' F' F ' 3' ' ' GLU . . . . . . . . . . . . . 84.7 tt0 -145.19 142.32 29.46 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 115.878 -0.601 . . . . 0.0 110.965 179.951 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' F' F ' 4' ' ' LEU . . . . . . . . . . . . . 17.5 tp -121.34 128.21 52.05 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 115.84 -0.618 . . . . 0.0 109.998 176.597 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' F' F ' 5' ' ' LYS . . . . . . . . . . . . . 62.4 mttp -108.3 121.0 44.0 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.415 -0.357 . . . . 0.0 110.745 179.407 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' F' F ' 6' ' ' LEU . . . . . 0.461 HD23 ' HA ' ' F' ' 50' ' ' VAL . 23.8 mt -114.23 148.47 37.33 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 115.331 -0.85 . . . . 0.0 110.46 -179.461 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' F' F ' 7' ' ' LYS . . . . . . . . . . . . . 77.1 tttt -128.5 138.27 32.7 Favored Pre-proline 0 CA--C 1.533 0.302 0 CA-C-O 118.85 -0.595 . . . . 0.0 109.681 173.518 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' F' F ' 8' ' ' PRO . . . . . . . . . . . . . 95.7 Cg_endo -91.48 135.38 1.72 Allowed 'Trans proline' 0 N--CA 1.49 1.288 0 C-N-CA 121.727 1.618 . . . . 0.0 111.953 178.373 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' F' F ' 9' ' ' LEU . . . . . . . . . . . . . 55.6 mt -75.94 -46.98 3.85 Favored Pre-proline 0 CA--C 1.534 0.338 0 CA-C-O 118.777 -0.63 . . . . 0.0 111.725 179.639 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' F' F ' 10' ' ' PRO . . . . . . . . . . . . . 78.9 Cg_endo -82.86 149.04 13.9 Favored 'Trans proline' 0 N--CA 1.495 1.579 0 C-N-CA 121.246 1.297 . . . . 0.0 111.531 174.098 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' F' F ' 11' ' ' LYS . . . . . . . . . . . . . 53.8 pttt -86.59 112.17 21.32 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-O 121.588 0.709 . . . . 0.0 110.592 178.035 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' F' F ' 12' ' ' VAL . . . . . . . . . . . . . 12.2 p -151.15 149.22 14.32 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.253 0 CA-C-N 115.621 -0.718 . . . . 0.0 110.545 -179.673 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' F' F ' 13' ' ' GLU . . . . . . . . . . . . . 95.7 mt-10 -87.74 125.74 34.59 Favored 'General case' 0 C--N 1.329 -0.283 0 N-CA-C 109.85 -0.426 . . . . 0.0 109.85 176.224 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' F' F ' 14' ' ' LEU . . . . . . . . . . . . . 31.4 mt -97.86 150.71 37.04 Favored Pre-proline 0 C--N 1.33 -0.254 0 CA-C-O 119.407 -0.33 . . . . 0.0 110.679 -178.378 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' F' F ' 15' ' ' PRO . . . . . . . . . . . . . 28.1 Cg_exo -60.69 159.56 27.98 Favored 'Trans proline' 0 N--CA 1.497 1.702 0 C-N-CA 121.297 1.331 . . . . 0.0 112.007 177.826 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' F' F ' 16' ' ' PRO . . . . . . . . . . . . . 31.6 Cg_exo -59.76 -44.27 32.26 Favored 'Trans proline' 0 N--CA 1.497 1.689 0 C-N-CA 121.495 1.463 . . . . 0.0 112.688 -178.594 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' F' F ' 17' ' ' ASP . . . . . . . . . . . . . 9.1 p-10 -83.8 12.55 5.86 Favored 'General case' 0 CA--C 1.534 0.345 0 N-CA-C 113.156 0.799 . . . . 0.0 113.156 -177.709 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' F' F ' 18' ' ' PHE . . . . . . . . . . . . . 52.6 t80 -57.46 -43.77 84.28 Favored 'General case' 0 N--CA 1.458 -0.07 0 O-C-N 121.986 -0.447 . . . . 0.0 110.332 -178.39 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' F' F ' 19' ' ' VAL . . . . . . . . . . . . . 47.7 t -56.48 -44.06 79.5 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.302 0 CA-C-N 116.332 -0.394 . . . . 0.0 110.54 -178.11 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' F' F ' 20' ' ' ASP . . . . . . . . . . . . . 64.0 m-20 -60.01 -42.52 94.48 Favored 'General case' 0 C--N 1.329 -0.288 0 C-N-CA 120.905 -0.318 . . . . 0.0 110.951 -178.115 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' F' F ' 21' ' ' VAL . . . . . . . . . . . . . 50.6 t -64.5 -46.75 91.81 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.246 0 C-N-CA 120.745 -0.382 . . . . 0.0 110.691 -177.556 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' F' F ' 22' ' ' ILE . . . . . 0.514 HG22 HD12 ' F' ' 26' ' ' LEU . 51.4 mm -55.49 -46.79 78.95 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.224 0 C-N-CA 120.957 -0.297 . . . . 0.0 110.625 179.623 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' F' F ' 23' ' ' ARG . . . . . . . . . . . . . 55.9 ttp180 -54.8 -50.8 67.63 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-O 120.645 0.26 . . . . 0.0 111.314 -178.707 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' F' F ' 24' ' ' ILE . . . . . . . . . . . . . 75.6 mt -59.48 -41.86 86.0 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.268 0 CA-C-N 116.536 -0.302 . . . . 0.0 111.499 -176.266 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' F' F ' 25' ' ' LYS . . . . . . . . . . . . . 40.5 mmtt -66.41 -43.93 84.41 Favored 'General case' 0 C--N 1.329 -0.291 0 N-CA-C 112.468 0.544 . . . . 0.0 112.468 -178.655 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' F' F ' 26' ' ' LEU . . . . . 0.514 HD12 HG22 ' F' ' 22' ' ' ILE . 58.0 mt -78.77 -35.1 45.03 Favored 'General case' 0 C--N 1.33 -0.271 0 N-CA-C 113.77 1.026 . . . . 0.0 113.77 -169.837 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' F' F ' 27' ' ' GLN . . . . . . . . . . . . . 15.6 pt20 -47.39 139.41 6.58 Favored 'General case' 0 N--CA 1.469 0.524 0 N-CA-C 112.758 0.651 . . . . 0.0 112.758 -175.653 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' F' F ' 28' ' ' GLY . . . . . . . . . . . . . . . 101.22 -24.46 31.74 Favored Glycine 0 CA--C 1.534 1.274 0 CA-C-N 115.536 -0.756 . . . . 0.0 112.308 -176.242 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' F' F ' 29' ' ' LYS . . . . . . . . . . . . . 55.2 mttp -97.35 155.1 17.04 Favored 'General case' 0 C--O 1.231 0.129 0 CA-C-N 117.535 0.667 . . . . 0.0 111.253 178.589 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' F' F ' 30' ' ' THR . . . . . . . . . . . . . 41.2 m -106.17 137.49 44.02 Favored 'General case' 0 C--N 1.331 -0.23 0 CA-C-N 116.02 -0.536 . . . . 0.0 109.854 175.828 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' F' F ' 31' ' ' VAL . . . . . . . . . . . . . 34.6 m -130.21 153.08 38.42 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.243 0 CA-C-O 121.055 0.455 . . . . 0.0 111.192 -177.49 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' F' F ' 32' ' ' ARG . . . . . . . . . . . . . 55.5 mtp180 -128.92 152.53 48.46 Favored 'General case' 0 C--N 1.332 -0.187 0 CA-C-N 115.749 -0.66 . . . . 0.0 110.668 177.885 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' F' F ' 33' ' ' THR . . . . . . . . . . . . . 14.0 m -54.09 137.83 39.18 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 115.98 -0.554 . . . . 0.0 111.26 -179.206 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' F' F ' 34' ' ' GLY . . . . . . . . . . . . . . . 101.68 -17.17 55.44 Favored Glycine 0 CA--C 1.533 1.159 0 CA-C-O 119.59 -0.561 . . . . 0.0 113.354 178.804 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' F' F ' 35' ' ' ASP . . . . . . . . . . . . . 75.2 m-20 -65.88 148.03 52.43 Favored 'General case' 0 N--CA 1.461 0.091 0 CA-C-N 118.09 0.945 . . . . 0.0 111.192 179.469 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' F' F ' 36' ' ' VAL . . . . . . . . . . . . . 47.2 t -120.48 129.07 75.98 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.196 0 CA-C-N 115.872 -0.604 . . . . 0.0 109.829 178.789 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' F' F ' 37' ' ' ILE . . . . . . . . . . . . . 63.3 mt -122.29 138.85 51.08 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.226 0 CA-C-N 116.19 -0.459 . . . . 0.0 109.963 -178.958 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' F' F ' 38' ' ' GLY . . . . . . . . . . . . . . . -115.03 128.74 8.25 Favored Glycine 0 CA--C 1.526 0.72 0 N-CA-C 111.143 -0.783 . . . . 0.0 111.143 179.411 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' F' F ' 39' ' ' ILE . . . . . . . . . . . . . 76.6 mt -125.91 138.32 54.91 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.212 0 CA-C-O 120.808 0.337 . . . . 0.0 110.421 179.659 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' F' F ' 40' ' ' SER . . . . . . . . . . . . . 23.0 t -92.71 114.69 27.32 Favored 'General case' 0 C--N 1.332 -0.192 0 CA-C-N 116.335 -0.393 . . . . 0.0 111.059 176.131 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' F' F ' 41' ' ' ILE . . . . . . . . . . . . . 44.6 mm -121.43 122.75 68.05 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.215 0 CA-C-O 120.846 0.355 . . . . 0.0 110.303 179.274 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' F' F ' 42' ' ' LEU . . . . . . . . . . . . . 9.1 tp 52.84 35.38 18.73 Favored 'General case' 0 CA--C 1.532 0.252 0 CA-C-N 116.254 -0.43 . . . . 0.0 111.643 177.128 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' F' F ' 43' ' ' GLY . . . . . . . . . . . . . . . 72.15 30.41 65.26 Favored Glycine 0 CA--C 1.529 0.966 0 C-N-CA 121.058 -0.591 . . . . 0.0 112.165 178.066 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' F' F ' 44' ' ' LYS . . . . . . . . . . . . . 85.9 tttt -139.71 130.66 26.24 Favored 'General case' 0 C--N 1.33 -0.259 0 N-CA-C 109.564 -0.532 . . . . 0.0 109.564 178.886 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' F' F ' 45' ' ' GLU . . . . . . . . . . . . . 85.1 tt0 -82.5 121.66 27.05 Favored 'General case' 0 C--N 1.326 -0.425 0 CA-C-O 120.9 0.381 . . . . 0.0 110.985 -177.496 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' F' F ' 46' ' ' VAL . . . . . . . . . . . . . 9.7 p -118.2 125.74 74.48 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.171 0 N-CA-C 109.385 -0.598 . . . . 0.0 109.385 175.434 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' F' F ' 47' ' ' LYS . . . . . . . . . . . . . 98.8 mttt -98.84 125.56 44.26 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 115.948 -0.569 . . . . 0.0 110.705 179.1 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' F' F ' 48' ' ' PHE . . . . . . . . . . . . . 31.5 m-85 -110.56 131.89 54.66 Favored 'General case' 0 C--N 1.33 -0.267 0 N-CA-C 109.8 -0.444 . . . . 0.0 109.8 178.062 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' F' F ' 49' ' ' LYS . . . . . . . . . . . . . 46.1 tttp -107.05 132.75 52.61 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.26 -0.427 . . . . 0.0 110.081 178.337 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' F' F ' 50' ' ' VAL . . . . . 0.461 ' HA ' HD23 ' F' ' 6' ' ' LEU . 46.5 t -76.47 104.22 4.38 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.295 0 N-CA-C 109.263 -0.644 . . . . 0.0 109.263 177.215 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' F' F ' 51' ' ' VAL . . . . . . . . . . . . . 49.0 t -72.45 -52.41 23.86 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.298 0 N-CA-C 109.538 -0.541 . . . . 0.0 109.538 -175.239 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' F' F ' 52' ' ' GLN . . . . . . . . . . . . . 86.6 mt-30 -151.77 140.73 21.09 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-O 121.245 0.545 . . . . 0.0 111.675 -178.99 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' F' F ' 53' ' ' ALA . . . . . 0.424 ' HB1' ' HB2' ' F' ' 58' ' ' LEU . . . -116.22 127.58 54.88 Favored 'General case' 0 C--N 1.325 -0.46 0 CA-C-N 114.918 -1.037 . . . . 0.0 109.491 174.712 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' F' F ' 54' ' ' TYR . . . . . . . . . . . . . 27.4 t80 -125.92 109.06 25.02 Favored Pre-proline 0 CA--C 1.534 0.359 0 CA-C-O 118.21 -0.9 . . . . 0.0 110.511 -179.342 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' F' F ' 55' ' ' PRO . . . . . . . . . . . . . 73.3 Cg_endo -77.24 170.09 72.39 Favored 'Cis proline' 0 N--CA 1.501 1.914 0 CA-C-N 121.852 1.697 . . . . 0.0 112.658 -4.617 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' F' F ' 56' ' ' SER . . . . . . . . . . . . . 13.5 m -113.51 126.88 27.49 Favored Pre-proline 0 CA--C 1.54 0.585 0 CA-C-O 118.32 -0.848 . . . . 0.0 109.271 174.511 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' F' F ' 57' ' ' PRO . . . . . . . . . . . . . 57.3 Cg_endo -72.47 150.4 95.01 Favored 'Cis proline' 0 N--CA 1.496 1.66 0 CA-C-N 122.053 1.769 . . . . 0.0 111.692 0.043 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' F' F ' 58' ' ' LEU . . . . . 0.424 ' HB2' ' HB1' ' F' ' 53' ' ' ALA . 29.6 tp -107.9 137.36 46.03 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.221 -0.445 . . . . 0.0 110.659 -178.143 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' F' F ' 59' ' ' ARG . . . . . . . . . . . . . 73.6 ttt-85 -101.67 123.86 46.36 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 115.845 -0.616 . . . . 0.0 109.498 176.034 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' F' F ' 60' ' ' VAL . . . . . . . . . . . . . 44.6 t -76.51 114.9 17.38 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.239 0 C-N-CA 120.658 -0.417 . . . . 0.0 110.109 -177.426 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' F' F ' 61' ' ' GLU . . . . . . . . . . . . . 84.6 tt0 -131.11 154.21 48.54 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 115.759 -0.655 . . . . 0.0 109.503 179.532 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' F' F ' 62' ' ' ASP . . . . . . . . . . . . . 9.7 t0 -51.54 -32.59 28.6 Favored 'General case' 0 C--N 1.327 -0.376 0 N-CA-C 112.0 0.37 . . . . 0.0 112.0 -177.924 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' F' F ' 63' ' ' ARG . . . . . . . . . . . . . 27.2 mmm180 -72.4 -22.03 61.18 Favored 'General case' 0 N--CA 1.466 0.353 0 N-CA-C 112.934 0.716 . . . . 0.0 112.934 -177.627 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' F' F ' 64' ' ' THR . . . . . . . . . . . . . 21.6 m -67.84 137.87 55.65 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-O 120.825 0.345 . . . . 0.0 110.979 -175.461 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' F' F ' 65' ' ' LYS . . . . . . . . . . . . . 55.9 mtmt -88.95 140.21 29.67 Favored 'General case' 0 C--N 1.331 -0.224 0 CA-C-N 116.224 -0.444 . . . . 0.0 110.573 178.351 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' F' F ' 66' ' ' ILE . . . . . . . . . . . . . 4.3 mp -116.13 127.4 73.74 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.244 0 N-CA-C 109.755 -0.461 . . . . 0.0 109.755 -179.184 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' F' F ' 67' ' ' THR . . . . . . . . . . . . . 21.4 m -124.82 136.95 54.28 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-O 121.002 0.429 . . . . 0.0 110.873 -177.431 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' F' F ' 68' ' ' LEU . . . . . . . . . . . . . 15.9 tp -108.68 133.83 52.23 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.099 -0.501 . . . . 0.0 110.561 178.241 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' F' F ' 69' ' ' VAL . . . . . . . . . . . . . 48.1 t -84.94 135.47 24.77 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.314 0 CA-C-N 116.278 -0.419 . . . . 0.0 109.915 177.814 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' F' F ' 70' ' ' THR . . . . . . . . . . . . . 66.5 p -106.22 174.83 5.71 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.962 -178.308 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' F' F ' 71' ' ' HIS . . . . . . . . . . . . . 80.4 m80 -64.97 156.66 79.56 Favored Pre-proline 0 C--N 1.329 -0.284 0 CA-C-N 116.065 -0.516 . . . . 0.0 110.933 -178.345 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' F' F ' 72' ' ' PRO . . . . . . . . . . . . . 72.1 Cg_endo -80.75 159.99 21.62 Favored 'Trans proline' 0 N--CA 1.493 1.467 0 C-N-CA 121.71 1.607 . . . . 0.0 112.549 -178.512 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' F' F ' 73' ' ' VAL . . . . . . . . . . . . . 31.1 m -107.28 167.29 3.63 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.283 0 CA-C-N 115.989 -0.55 . . . . 0.0 110.165 179.005 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' F' F ' 74' ' ' ASP . . . . . . . . . . . . . 13.5 t70 -95.49 118.72 32.71 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.296 -0.411 . . . . 0.0 110.24 -177.575 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' F' F ' 75' ' ' VAL . . . . . . . . . . . . . 40.3 t -114.82 124.59 71.63 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.241 0 CA-C-O 121.043 0.449 . . . . 0.0 110.297 -178.746 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' F' F ' 76' ' ' LEU . . . . . . . . . . . . . 15.0 mt -128.78 146.15 50.99 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 115.661 -0.7 . . . . 0.0 109.723 178.88 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' F' F ' 77' ' ' GLU . . . . . . . . . . . . . 97.6 mt-10 -135.38 135.94 41.07 Favored 'General case' 0 C--N 1.331 -0.198 0 CA-C-O 121.075 0.464 . . . . 0.0 111.32 -178.502 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' F' F ' 78' ' ' ALA . . . . . . . . . . . . . . . -121.51 140.97 51.51 Favored 'General case' 0 C--N 1.332 -0.184 0 CA-C-N 115.775 -0.648 . . . . 0.0 109.735 176.09 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' F' F ' 79' ' ' LYS . . . . . 0.628 ' O ' HD13 ' F' ' 80' ' ' ILE . 96.1 mttt -85.26 115.1 22.84 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-O 120.909 0.385 . . . . 0.0 110.865 -178.3 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' F' F ' 80' ' ' ILE . . . . . 0.628 HD13 ' O ' ' F' ' 79' ' ' LYS . 39.7 mm -139.09 108.39 3.8 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.325 0 N-CA-C 109.239 -0.652 . . . . 0.0 109.239 -178.197 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' F' F ' 81' ' ' LYS . . . . . . . . . . . . . 39.2 ttpt -106.66 134.91 49.07 Favored 'General case' 0 C--N 1.331 -0.226 0 CA-C-O 120.939 0.4 . . . . 0.0 111.178 -177.242 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' F' F ' 82' ' ' GLY . . . . . . . . . . . . . . . 89.09 41.92 5.74 Favored Glycine 0 CA--C 1.523 0.556 0 N-CA-C 111.114 -0.795 . . . . 0.0 111.114 176.404 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' F' F ' 83' ' ' ILE . . . . . . . . . . . . . 68.0 mt -78.13 130.69 35.88 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.363 0 N-CA-C 109.525 -0.546 . . . . 0.0 109.525 178.398 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' F' F ' 84' ' ' LYS . . . . . . . . . . . . . 38.2 ttpt -95.73 -46.35 6.63 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-O 120.863 0.363 . . . . 0.0 110.147 -178.783 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' F' F ' 85' ' ' ASP . . . . . . . . . . . . . 7.2 t70 -152.08 149.15 28.51 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.111 -0.495 . . . . 0.0 110.629 178.581 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' F' F ' 86' ' ' VAL . . . . . . . . . . . . . 42.1 t -126.84 132.7 69.77 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.26 0 CA-C-O 120.859 0.361 . . . . 0.0 110.448 -179.524 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' F' F ' 87' ' ' ILE . . . . . . . . . . . . . 45.5 mm -119.27 124.59 73.33 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.223 0 N-CA-C 109.412 -0.588 . . . . 0.0 109.412 176.439 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' F' F ' 88' ' ' LEU . . . . . . . . . . . . . 16.8 tp -112.36 130.51 55.94 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-O 121.116 0.484 . . . . 0.0 111.19 -176.912 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' F' F ' 89' ' ' ASP . . . . . . . . . . . . . 9.1 t70 -123.64 155.15 38.27 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-N 115.754 -0.657 . . . . 0.0 109.388 175.443 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' F' F ' 90' ' ' GLU . . . . . . . . . . . . . 84.5 tt0 -47.59 -40.55 19.57 Favored 'General case' 0 C--N 1.329 -0.287 0 N-CA-C 112.818 0.673 . . . . 0.0 112.818 -172.07 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' F' F ' 91' ' ' ASN . . . . . . . . . . . . . 33.6 m120 -132.16 38.96 3.45 Favored 'General case' 0 CA--C 1.53 0.187 0 CA-C-O 120.856 0.36 . . . . 0.0 111.496 -178.208 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' F' F ' 92' ' ' LEU . . . . . . . . . . . . . 12.5 tp -166.0 139.63 4.3 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.593 -0.276 . . . . 0.0 110.325 -178.613 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' F' F ' 93' ' ' ILE . . . . . . . . . . . . . 68.2 mt -125.65 122.76 63.08 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.18 0 N-CA-C 109.588 -0.523 . . . . 0.0 109.588 179.851 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' F' F ' 94' ' ' VAL . . . . . 0.486 HG21 HG21 ' F' ' 125' ' ' VAL . 45.1 t -122.2 128.41 75.51 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.206 0 CA-C-O 120.977 0.417 . . . . 0.0 109.957 179.703 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' F' F ' 95' ' ' VAL . . . . . . . . . . . . . 41.3 t -119.91 132.93 68.26 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.323 0 CA-C-N 115.899 -0.591 . . . . 0.0 109.744 179.951 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' F' F ' 96' ' ' ILE . . . . . . . . . . . . . 69.5 mt -112.85 124.03 69.1 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 N-CA-C 108.96 -0.756 . . . . 0.0 108.96 177.912 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' F' F ' 97' ' ' THR . . . . . . . . . . . . . 43.6 p -98.51 155.89 17.05 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-O 121.544 0.688 . . . . 0.0 111.545 -175.424 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' F' F ' 98' ' ' GLU . . . . . . . . . . . . . 84.5 tt0 -54.11 -27.38 32.72 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 115.54 -0.755 . . . . 0.0 112.151 -179.864 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' F' F ' 99' ' ' GLU . . . . . . . . . . . . . 95.4 mt-10 -80.32 14.98 1.73 Allowed 'General case' 0 CA--C 1.535 0.381 0 N-CA-C 113.173 0.805 . . . . 0.0 113.173 -176.538 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' F' F ' 100' ' ' ASN . . . . . . . . . . . . . 3.6 m-20 63.0 35.38 13.22 Favored 'General case' 0 C--O 1.233 0.236 0 CA-C-N 118.126 0.421 . . . . 0.0 111.392 179.229 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' F' F ' 101' ' ' GLU . . . . . . . . . . . . . 85.0 tt0 -113.64 145.03 41.92 Favored 'General case' 0 C--N 1.331 -0.238 0 N-CA-C 109.633 -0.506 . . . . 0.0 109.633 174.393 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' F' F ' 102' ' ' VAL . . . . . . . . . . . . . 45.4 t -115.1 125.75 72.49 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.281 0 CA-C-N 116.22 -0.445 . . . . 0.0 109.929 -178.202 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' F' F ' 103' ' ' LEU . . . . . . . . . . . . . 61.2 mt -117.46 129.12 55.63 Favored 'General case' 0 C--N 1.332 -0.191 0 CA-C-N 115.743 -0.662 . . . . 0.0 110.325 177.445 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' F' F ' 104' ' ' ILE . . . . . . . . . . . . . 67.1 mt -119.04 124.49 73.25 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.181 0 N-CA-C 110.11 -0.33 . . . . 0.0 110.11 179.494 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' F' F ' 105' ' ' PHE . . . . . . . . . . . . . 88.9 m-85 -123.41 163.39 20.92 Favored 'General case' 0 C--O 1.232 0.168 0 O-C-N 123.954 0.784 . . . . 0.0 109.937 -179.497 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' F' F ' 106' ' ' ASN . . . . . . . . . . . . . 46.3 p-10 -97.66 -173.09 2.54 Favored 'General case' 0 C--N 1.33 -0.252 0 N-CA-C 109.821 -0.437 . . . . 0.0 109.821 171.821 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' F' F ' 107' ' ' GLN . . . . . . . . . . . . . 55.4 tt0 -60.12 -26.4 66.22 Favored 'General case' 0 C--N 1.328 -0.332 0 N-CA-C 112.19 0.441 . . . . 0.0 112.19 -178.823 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' F' F ' 108' ' ' ASN . . . . . . . . . . . . . 11.9 t-20 -88.68 13.99 11.08 Favored 'General case' 0 CA--C 1.535 0.389 0 N-CA-C 112.865 0.691 . . . . 0.0 112.865 -177.824 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' F' F ' 109' ' ' LEU . . . . . . . . . . . . . 43.2 mt 58.25 34.17 23.84 Favored 'General case' 0 CA--C 1.53 0.202 0 O-C-N 122.138 -0.351 . . . . 0.0 111.84 177.464 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' F' F ' 110' ' ' GLU . . . . . . . . . . . . . 70.5 mm-40 -103.14 142.95 33.27 Favored 'General case' 0 C--N 1.329 -0.31 0 N-CA-C 109.006 -0.738 . . . . 0.0 109.006 173.315 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' F' F ' 111' ' ' GLU . . . . . . . . . . . . . 51.1 tt0 -85.28 121.78 28.51 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-O 121.017 0.437 . . . . 0.0 110.538 -175.41 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' F' F ' 112' ' ' LEU . . . . . . . . . . . . . 44.8 mt -100.95 -42.96 6.21 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 115.708 -0.678 . . . . 0.0 110.68 179.636 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' F' F ' 113' ' ' TYR . . . . . . . . . . . . . 57.5 t80 -133.09 136.54 45.92 Favored 'General case' 0 C--N 1.331 -0.2 0 CA-C-N 116.329 -0.396 . . . . 0.0 111.221 -177.85 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' F' F ' 114' ' ' ARG . . . . . . . . . . . . . 69.8 ttt180 -137.53 118.61 14.41 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 115.716 -0.675 . . . . 0.0 110.142 178.197 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' F' F ' 115' ' ' GLY . . . . . . . . . . . . . . . -149.99 162.3 29.13 Favored Glycine 0 CA--C 1.524 0.605 0 C-N-CA 120.693 -0.765 . . . . 0.0 111.405 179.746 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' F' F ' 116' ' ' LYS . . . . . . . . . . . . . 74.2 tttt -136.97 140.42 42.17 Favored 'General case' 0 C--N 1.328 -0.338 0 N-CA-C 110.085 -0.339 . . . . 0.0 110.085 178.401 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' F' F ' 117' ' ' PHE . . . . . . . . . . . . . 34.8 m-85 -136.6 113.88 10.76 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.309 -0.405 . . . . 0.0 110.214 -177.45 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' F' F ' 118' ' ' GLU . . . . . . . . . . . . . 84.9 tt0 -53.79 -48.93 69.32 Favored 'General case' 0 C--N 1.329 -0.307 0 C-N-CA 121.112 -0.235 . . . . 0.0 111.292 -177.39 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' F' F ' 119' ' ' ASN . . . . . . . . . . . . . 6.0 m120 -92.98 31.12 1.46 Allowed 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 116.273 -0.421 . . . . 0.0 111.999 -175.464 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' F' F ' 120' ' ' LEU . . . . . . . . . . . . . 25.2 tp -55.56 122.77 12.05 Favored 'General case' 0 N--CA 1.462 0.173 0 CA-C-O 120.698 0.285 . . . . 0.0 110.535 178.413 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' F' F ' 121' ' ' ASN . . . . . . . . . . . . . 3.8 m-20 -113.86 -44.03 3.21 Favored 'General case' 0 C--O 1.232 0.146 0 CA-C-N 116.426 -0.352 . . . . 0.0 111.162 -176.189 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' F' F ' 122' ' ' LYS . . . . . . . . . . . . . 39.2 ttpt -146.01 141.6 27.83 Favored 'General case' 0 C--N 1.33 -0.24 0 C-N-CA 120.689 -0.404 . . . . 0.0 111.531 -175.1 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' F' F ' 123' ' ' VAL . . . . . . . . . . . . . 43.9 t -129.28 131.45 67.56 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.267 0 N-CA-C 109.486 -0.561 . . . . 0.0 109.486 174.786 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' F' F ' 124' ' ' LEU . . . . . 0.41 HD22 HD12 ' A' ' 88' ' ' LEU . 14.6 tp -127.37 131.85 50.28 Favored 'General case' 0 N--CA 1.464 0.227 0 CA-C-O 120.859 0.362 . . . . 0.0 110.919 -178.718 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' F' F ' 125' ' ' VAL . . . . . 0.522 HG22 HG23 ' F' ' 130' ' ' VAL . 45.4 t -126.13 129.43 72.17 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.218 0 CA-C-N 115.992 -0.549 . . . . 0.0 110.059 179.362 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' F' F ' 126' ' ' ARG . . . . . . . . . . . . . 42.0 ttm180 -154.22 131.26 10.99 Favored 'General case' 0 C--N 1.33 -0.27 0 N-CA-C 109.808 -0.441 . . . . 0.0 109.808 177.306 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' F' F ' 127' ' ' ASN . . . . . . . . . . . . . 3.4 t-20 56.67 -155.02 0.32 Allowed 'General case' 0 CA--C 1.538 0.507 0 N-CA-C 109.595 -0.521 . . . . 0.0 109.595 -178.319 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' F' F ' 128' ' ' ASP . . . . . . . . . . . . . 22.1 p-10 -82.5 17.24 1.81 Allowed 'General case' 0 CA--C 1.539 0.52 0 N-CA-C 112.491 0.552 . . . . 0.0 112.491 176.879 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' F' F ' 129' ' ' LEU . . . . . . . . . . . . . 16.5 tp -116.37 137.36 52.22 Favored 'General case' 0 C--O 1.232 0.18 0 N-CA-C 109.934 -0.395 . . . . 0.0 109.934 179.148 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' F' F ' 130' ' ' VAL . . . . . 0.522 HG23 HG22 ' F' ' 125' ' ' VAL . 12.6 p -136.9 143.37 35.19 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.25 0 CA-C-O 121.033 0.444 . . . . 0.0 110.663 -179.951 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' F' F ' 131' ' ' VAL . . . . . 0.458 HG21 HD13 ' A' ' 88' ' ' LEU . 32.5 m -136.09 146.94 28.42 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.275 0 CA-C-O 121.238 0.542 . . . . 0.0 110.912 178.804 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' F' F ' 132' ' ' ILE . . . . . . . . . . . . . 73.2 mt -122.36 134.01 66.88 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.228 0 CA-C-N 115.505 -0.771 . . . . 0.0 109.581 -179.572 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' F' F ' 133' ' ' ILE . . . . . . . . . . . . . 40.1 mm -115.91 122.79 70.3 Favored 'Isoleucine or valine' 0 C--O 1.234 0.262 0 CA-C-N 116.353 -0.385 . . . . 0.0 110.86 -176.304 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' F' F ' 134' ' ' ASP . . . . . . . . . . . . . 7.3 p-10 -131.88 150.97 52.0 Favored 'General case' 0 C--N 1.331 -0.23 0 CA-C-N 116.128 -0.487 . . . . 0.0 109.744 174.441 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' F' F ' 135' ' ' GLU . . . . . . . . . . . . . 85.6 tt0 -49.92 -25.86 3.62 Favored 'General case' 0 C--N 1.327 -0.378 0 N-CA-C 112.896 0.702 . . . . 0.0 112.896 -170.738 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' F' F ' 136' ' ' GLN . . . . . . . . . . . . . 97.8 mt-30 -105.05 -25.22 12.62 Favored 'General case' 0 N--CA 1.464 0.266 0 N-CA-C 113.015 0.746 . . . . 0.0 113.015 -175.081 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' F' F ' 137' ' ' LYS . . . . . . . . . . . . . 66.2 mttm -140.27 150.21 43.77 Favored 'General case' 0 C--N 1.331 -0.217 0 CA-C-O 121.587 0.708 . . . . 0.0 112.529 -167.529 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' F' F ' 138' ' ' LEU . . . . . . . . . . . . . 13.0 tp -112.99 121.55 44.98 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 114.787 -1.097 . . . . 0.0 109.003 173.103 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' F' F ' 139' ' ' THR . . . . . . . . . . . . . 31.8 m -113.95 126.96 55.73 Favored 'General case' 0 C--N 1.331 -0.215 0 CA-C-O 120.837 0.351 . . . . 0.0 110.862 -178.761 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' F' F ' 140' ' ' LEU . . . . . 0.485 HD23 ' C ' ' F' ' 140' ' ' LEU . 8.8 tt -116.34 124.13 49.34 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 115.577 -0.738 . . . . 0.0 109.354 179.913 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' F' F ' 141' ' ' ILE . . . . . 0.509 ' HB ' HG13 ' F' ' 130' ' ' VAL . 19.3 mt -121.48 120.88 63.11 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.275 0 CA-C-O 120.923 0.392 . . . . 0.0 109.971 -175.199 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' F' F ' 142' ' ' ARG . . . . . . . . . . . . . 34.7 tpt85 -110.22 127.07 54.77 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-N 115.337 -0.847 . . . . 0.0 109.965 -178.136 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' F' F ' 143' ' ' THR . . . . . . . . . . . . . 34.4 p . . . . . 0 C--O 1.22 -0.458 0 CA-C-O 118.02 -0.991 . . . . 0.0 110.656 -179.748 . . . . . . . . 0 0 . 1 . 012 nuclear build full ' A' A ' -3' ' ' GLU . . . . . . . . . . . . . 96.0 mt-10 . . . . . 0 N--CA 1.489 1.483 0 N-CA-C 109.469 -0.567 . . . . 0.0 109.469 . . . . . . . . . 0 0 . 1 . 012 nuclear build full ' A' A ' -2' ' ' GLY . . . . . . . . . . . . . . . -72.93 112.92 4.12 Favored Glycine 0 CA--C 1.526 0.73 0 N-CA-C 111.077 -0.809 . . . . 0.0 111.077 -179.533 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' -1' ' ' VAL . . . . . . . . . . . . . 46.5 t -96.95 135.6 30.54 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.331 0 N-CA-C 110.019 -0.363 . . . . 0.0 110.019 179.006 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 0' ' ' ILE . . . . . . . . . . . . . 44.1 mm -112.47 130.49 66.13 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.215 0 CA-C-N 116.23 -0.441 . . . . 0.0 110.153 179.966 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 27.2 ptm -90.9 138.26 31.73 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.573 179.902 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 1.7 p -113.3 119.48 37.84 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-O 121.377 0.608 . . . . 0.0 110.336 177.931 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 85.1 tt0 -143.05 142.1 31.47 Favored 'General case' 0 C--N 1.327 -0.399 0 CA-C-N 115.451 -0.795 . . . . 0.0 111.114 -178.325 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 4' ' ' LEU . . . . . . . . . . . . . 18.9 tp -123.93 128.18 49.05 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 115.887 -0.597 . . . . 0.0 109.952 176.922 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 5' ' ' LYS . . . . . . . . . . . . . 95.2 mttt -107.24 122.56 46.79 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.572 -0.285 . . . . 0.0 110.71 -179.873 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 58.1 mt -115.54 147.65 40.45 Favored 'General case' 0 C--N 1.331 -0.215 0 CA-C-N 115.577 -0.738 . . . . 0.0 110.244 -179.123 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 26.5 ttpp -125.98 139.7 34.98 Favored Pre-proline 0 CA--C 1.532 0.284 0 CA-C-O 118.983 -0.532 . . . . 0.0 109.725 174.244 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 8' ' ' PRO . . . . . . . . . . . . . 83.7 Cg_endo -91.75 133.61 1.42 Allowed 'Trans proline' 0 N--CA 1.489 1.224 0 C-N-CA 121.786 1.657 . . . . 0.0 111.808 178.275 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 73.2 mt -75.64 -47.01 4.14 Favored Pre-proline 0 CA--C 1.534 0.339 0 CA-C-O 118.527 -0.749 . . . . 0.0 111.948 179.03 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 73.9 Cg_endo -77.88 145.66 22.71 Favored 'Trans proline' 0 N--CA 1.496 1.635 0 CA-C-N 120.427 1.188 . . . . 0.0 111.656 175.154 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 58.1 mttm -84.76 89.53 7.54 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-O 120.815 0.34 . . . . 0.0 110.701 -179.781 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 12.3 p -139.55 146.24 25.72 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.293 0 CA-C-N 116.096 -0.502 . . . . 0.0 110.289 178.989 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 45.4 tp10 -89.47 129.35 35.97 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.342 -0.39 . . . . 0.0 110.254 178.554 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 14' ' ' LEU . . . . . . . . . . . . . 35.2 mt -97.36 144.88 28.69 Favored Pre-proline 0 C--N 1.329 -0.3 0 CA-C-O 119.14 -0.457 . . . . 0.0 110.05 -179.01 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 15' ' ' PRO . . . . . . . . . . . . . 24.8 Cg_exo -61.83 163.03 20.03 Favored 'Trans proline' 0 N--CA 1.498 1.783 0 C-N-CA 121.268 1.312 . . . . 0.0 111.751 178.447 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 16' ' ' PRO . . . . . . . . . . . . . 31.7 Cg_exo -59.52 -36.07 94.1 Favored 'Trans proline' 0 N--CA 1.497 1.698 0 C-N-CA 121.562 1.508 . . . . 0.0 112.971 -177.502 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 17' ' ' ASP . . . . . . . . . . . . . 7.9 p-10 -84.64 0.16 51.24 Favored 'General case' 0 CA--C 1.537 0.459 0 N-CA-C 113.274 0.842 . . . . 0.0 113.274 -177.748 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 18' ' ' PHE . . . . . . . . . . . . . 35.3 t80 -58.64 -43.75 89.85 Favored 'General case' 0 C--N 1.333 -0.128 0 O-C-N 121.95 -0.469 . . . . 0.0 109.963 -177.75 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 19' ' ' VAL . . . . . . . . . . . . . 53.3 t -57.19 -42.51 80.0 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.253 0 CA-C-N 116.155 -0.475 . . . . 0.0 110.383 -179.366 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 19.1 t0 -60.02 -42.89 95.33 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-O 120.775 0.322 . . . . 0.0 111.057 -177.869 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 45.4 t -64.38 -46.49 92.86 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.269 0 C-N-CA 120.784 -0.367 . . . . 0.0 110.361 -177.693 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 22' ' ' ILE . . . . . 0.411 HG22 HD12 ' A' ' 26' ' ' LEU . 51.9 mm -56.27 -44.23 78.97 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.223 0 CA-C-O 120.73 0.3 . . . . 0.0 110.54 178.633 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 23' ' ' ARG . . . . . . . . . . . . . 57.3 ttp180 -54.53 -47.82 72.71 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-O 120.774 0.321 . . . . 0.0 111.305 -179.934 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 24' ' ' ILE . . . . . . . . . . . . . 79.9 mt -59.15 -41.41 83.62 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.295 0 CA-C-N 116.438 -0.346 . . . . 0.0 111.022 -178.574 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 58.3 mttm -67.48 -41.0 85.31 Favored 'General case' 0 C--N 1.328 -0.343 0 N-CA-C 112.571 0.582 . . . . 0.0 112.571 -179.006 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 26' ' ' LEU . . . . . 0.411 HD12 HG22 ' A' ' 22' ' ' ILE . 79.5 mt -77.92 -38.67 45.05 Favored 'General case' 0 C--N 1.331 -0.233 0 N-CA-C 113.512 0.93 . . . . 0.0 113.512 -170.227 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 27' ' ' GLN . . . . . . . . . . . . . 17.9 pt20 -46.94 138.62 6.26 Favored 'General case' 0 N--CA 1.468 0.429 0 N-CA-C 112.796 0.665 . . . . 0.0 112.796 -174.722 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 101.13 -25.69 27.36 Favored Glycine 0 CA--C 1.533 1.165 0 CA-C-N 115.609 -0.723 . . . . 0.0 112.341 -177.865 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 69.8 mmtt -98.31 155.18 17.33 Favored 'General case' 0 C--N 1.333 -0.128 0 CA-C-N 117.4 0.6 . . . . 0.0 111.31 178.443 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 30' ' ' THR . . . . . . . . . . . . . 40.2 m -108.88 139.87 43.13 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 115.804 -0.634 . . . . 0.0 109.792 175.244 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 33.6 m -130.69 155.77 42.08 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.222 0 CA-C-O 121.032 0.444 . . . . 0.0 111.144 -177.542 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 32' ' ' ARG . . . . . . . . . . . . . 61.5 mtt85 -129.02 150.58 50.37 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-N 115.862 -0.608 . . . . 0.0 110.733 178.36 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 33' ' ' THR . . . . . . . . . . . . . 23.3 m -53.26 138.91 31.09 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.054 -0.521 . . . . 0.0 111.39 -178.087 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 100.65 -17.2 56.91 Favored Glycine 0 CA--C 1.534 1.266 0 CA-C-O 119.607 -0.552 . . . . 0.0 113.232 178.526 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 79.5 m-20 -66.44 147.31 53.48 Favored 'General case' 0 N--CA 1.461 0.097 0 CA-C-N 118.008 0.904 . . . . 0.0 111.117 178.63 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 42.1 t -121.74 130.35 74.68 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.288 0 CA-C-N 116.083 -0.508 . . . . 0.0 109.865 178.403 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 37' ' ' ILE . . . . . . . . . . . . . 68.4 mt -120.4 138.55 50.56 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.279 0 CA-C-N 116.161 -0.472 . . . . 0.0 109.877 -179.813 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . -117.48 128.72 7.96 Favored Glycine 0 CA--C 1.526 0.735 0 N-CA-C 110.636 -0.986 . . . . 0.0 110.636 178.611 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 39' ' ' ILE . . . . . . . . . . . . . 69.9 mt -123.75 132.46 71.34 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.24 0 CA-C-O 120.735 0.302 . . . . 0.0 110.3 -179.986 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 40' ' ' SER . . . . . . . . . . . . . 30.1 t -92.37 118.35 30.83 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.14 -0.482 . . . . 0.0 110.605 175.698 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 41' ' ' ILE . . . . . . . . . . . . . 69.2 mt -130.71 122.5 52.67 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.234 0 CA-C-O 120.849 0.357 . . . . 0.0 110.499 178.612 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 45.8 mt 55.12 33.91 21.45 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.033 -0.53 . . . . 0.0 111.897 176.666 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . 72.81 28.4 67.09 Favored Glycine 0 CA--C 1.531 1.046 0 C-N-CA 121.016 -0.611 . . . . 0.0 112.375 178.026 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 44' ' ' LYS . . . . . . . . . . . . . 26.4 ttpp -137.24 127.61 26.5 Favored 'General case' 0 C--N 1.331 -0.228 0 N-CA-C 109.54 -0.541 . . . . 0.0 109.54 177.288 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 67.6 tt0 -86.05 126.68 34.35 Favored 'General case' 0 C--N 1.327 -0.392 0 CA-C-N 116.336 -0.393 . . . . 0.0 111.12 -176.851 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 46' ' ' VAL . . . . . . . . . . . . . 10.2 p -119.55 126.81 75.68 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.172 0 N-CA-C 109.909 -0.404 . . . . 0.0 109.909 175.436 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 72.7 mmtt -98.2 125.54 43.29 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 115.927 -0.579 . . . . 0.0 110.752 176.148 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 48' ' ' PHE . . . . . . . . . . . . . 32.8 m-85 -112.16 131.61 55.36 Favored 'General case' 0 C--N 1.329 -0.295 0 N-CA-C 109.185 -0.672 . . . . 0.0 109.185 174.651 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 42.2 tttp -108.4 132.92 53.27 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.484 -0.325 . . . . 0.0 110.208 178.931 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 50' ' ' VAL . . . . . . . . . . . . . 41.3 t -76.23 103.99 4.04 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.332 0 N-CA-C 109.21 -0.663 . . . . 0.0 109.21 177.427 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 51' ' ' VAL . . . . . . . . . . . . . 47.8 t -69.65 -50.19 52.21 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.347 0 CA-C-N 116.086 -0.506 . . . . 0.0 109.801 -174.722 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 52' ' ' GLN . . . . . . . . . . . . . 62.2 tt0 -160.3 140.15 11.25 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 115.875 -0.602 . . . . 0.0 111.724 -177.84 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 53' ' ' ALA . . . . . 0.411 ' HB1' ' HB2' ' A' ' 58' ' ' LEU . . . -112.76 130.67 55.99 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-N 115.735 -0.666 . . . . 0.0 109.709 175.017 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 54' ' ' TYR . . . . . . . . . . . . . 59.5 t80 -129.16 107.94 17.89 Favored Pre-proline 0 CA--C 1.535 0.394 0 CA-C-O 118.324 -0.846 . . . . 0.0 110.457 -179.661 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 55' ' ' PRO . . . . . . . . . . . . . 73.7 Cg_endo -77.1 170.09 72.56 Favored 'Cis proline' 0 N--CA 1.499 1.821 0 CA-C-N 121.829 1.689 . . . . 0.0 112.339 -5.624 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 56' ' ' SER . . . . . . . . . . . . . 20.1 m -114.5 130.71 23.8 Favored Pre-proline 0 CA--C 1.539 0.526 0 CA-C-O 118.412 -0.804 . . . . 0.0 109.506 175.441 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 57' ' ' PRO . . . . . . . . . . . . . 55.2 Cg_endo -71.44 146.99 86.78 Favored 'Cis proline' 0 N--CA 1.496 1.664 0 CA-C-N 121.947 1.731 . . . . 0.0 111.622 -0.914 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 58' ' ' LEU . . . . . 0.411 ' HB2' ' HB1' ' A' ' 53' ' ' ALA . 22.3 tp -106.53 135.28 48.31 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.28 -0.418 . . . . 0.0 110.22 -179.506 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 59' ' ' ARG . . . . . . . . . . . . . 56.7 ttt85 -105.55 127.12 52.85 Favored 'General case' 0 C--N 1.326 -0.426 0 N-CA-C 109.2 -0.667 . . . . 0.0 109.2 176.639 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 43.4 t -86.03 124.1 40.01 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.234 0 C-N-CA 120.588 -0.445 . . . . 0.0 110.61 -174.528 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 96.0 mt-10 -131.02 172.48 12.04 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 115.774 -0.648 . . . . 0.0 109.877 177.999 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 62' ' ' ASP . . . . . . . . . . . . . 7.5 p-10 -55.56 -32.75 63.25 Favored 'General case' 0 C--N 1.328 -0.339 0 C-N-CA 120.922 -0.311 . . . . 0.0 111.557 179.42 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 63' ' ' ARG . . . . . . . . . . . . . 25.8 ptt180 -86.33 3.74 42.18 Favored 'General case' 0 CA--C 1.537 0.477 0 N-CA-C 113.724 1.009 . . . . 0.0 113.724 -176.94 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 30.7 m -83.51 135.29 34.71 Favored 'General case' 0 C--N 1.333 -0.135 0 CA-C-N 118.04 0.382 . . . . 0.0 110.612 -177.427 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 65' ' ' LYS . . . . . . . . . . . . . 52.1 mtmt -89.72 129.28 36.15 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.064 -0.517 . . . . 0.0 110.503 179.556 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 66' ' ' ILE . . . . . . . . . . . . . 66.4 mt -114.45 129.08 71.1 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.309 0 N-CA-C 109.41 -0.589 . . . . 0.0 109.41 177.61 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 67' ' ' THR . . . . . . . . . . . . . 22.0 m -125.74 144.64 50.54 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.215 -0.448 . . . . 0.0 111.345 -175.66 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 68' ' ' LEU . . . . . 0.449 HD23 ' N ' ' A' ' 69' ' ' VAL . 5.6 tt -95.64 126.66 41.07 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 115.805 -0.634 . . . . 0.0 109.43 175.788 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 69' ' ' VAL . . . . . 0.449 ' N ' HD23 ' A' ' 68' ' ' LEU . 45.6 t -91.12 130.28 40.54 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.326 0 CA-C-O 121.221 0.534 . . . . 0.0 110.959 -175.551 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 70' ' ' THR . . . . . . . . . . . . . 14.4 p -139.0 42.3 2.1 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 115.374 -0.83 . . . . 0.0 109.92 176.422 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 71' ' ' HIS . . . . . . . . . . . . . 22.1 m-70 -95.8 173.3 4.4 Favored Pre-proline 0 CA--C 1.532 0.282 0 CA-C-N 115.932 -0.576 . . . . 0.0 111.245 -174.923 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 72' ' ' PRO . . . . . . . . . . . . . 22.4 Cg_exo -64.95 160.13 42.81 Favored 'Trans proline' 0 N--CA 1.496 1.667 0 C-N-CA 121.617 1.545 . . . . 0.0 111.603 176.395 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 73' ' ' VAL . . . . . . . . . . . . . 34.9 m -69.68 -177.42 0.2 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.275 0 CA-C-N 116.333 -0.394 . . . . 0.0 110.495 -174.364 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 74' ' ' ASP . . . . . . . . . . . . . 25.1 t0 -89.32 120.5 30.72 Favored 'General case' 0 C--N 1.329 -0.292 0 C-N-CA 120.724 -0.39 . . . . 0.0 110.507 -171.208 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 75' ' ' VAL . . . . . 0.45 ' C ' HD12 ' A' ' 76' ' ' LEU . 40.0 t -118.67 121.01 65.91 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.212 0 CA-C-O 120.955 0.407 . . . . 0.0 110.52 -178.561 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 76' ' ' LEU . . . . . 0.45 HD12 ' C ' ' A' ' 75' ' ' VAL . 7.5 mp -117.3 141.31 48.46 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 115.79 -0.641 . . . . 0.0 109.502 175.608 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 77' ' ' GLU . . . . . . . . . . . . . 97.0 mt-10 -132.56 136.13 46.39 Favored 'General case' 0 C--N 1.331 -0.197 0 CA-C-O 121.151 0.5 . . . . 0.0 111.465 -177.724 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 78' ' ' ALA . . . . . . . . . . . . . . . -124.24 131.45 53.53 Favored 'General case' 0 C--N 1.332 -0.185 0 CA-C-N 115.482 -0.781 . . . . 0.0 109.7 176.079 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 79' ' ' LYS . . . . . 0.645 ' O ' HD13 ' A' ' 80' ' ' ILE . 99.2 mttt -78.31 117.48 19.6 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-O 120.918 0.39 . . . . 0.0 110.714 -177.533 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 80' ' ' ILE . . . . . 0.645 HD13 ' O ' ' A' ' 79' ' ' LYS . 38.7 mm -139.24 111.47 5.55 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.311 0 N-CA-C 109.241 -0.652 . . . . 0.0 109.241 -177.448 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 81' ' ' LYS . . . . . . . . . . . . . 20.0 pttp -106.31 127.41 53.23 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-O 121.165 0.507 . . . . 0.0 111.608 -176.721 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . 89.01 42.16 5.71 Favored Glycine 0 CA--C 1.525 0.691 0 C-N-CA 120.883 -0.675 . . . . 0.0 111.832 174.267 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 83' ' ' ILE . . . . . . . . . . . . . 71.1 mt -71.49 138.0 22.58 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.231 0 N-CA-C 109.921 -0.4 . . . . 0.0 109.921 178.314 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 84' ' ' LYS . . . . . . . . . . . . . 31.0 ttmt -88.96 -53.09 4.75 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 115.943 -0.572 . . . . 0.0 109.788 -179.605 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 85' ' ' ASP . . . . . . . . . . . . . 7.2 t0 -157.39 151.91 25.19 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 115.51 -0.768 . . . . 0.0 110.136 179.637 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 86' ' ' VAL . . . . . . . . . . . . . 41.9 t -126.59 131.7 70.99 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.187 0 CA-C-O 120.956 0.408 . . . . 0.0 110.375 -179.138 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 87' ' ' ILE . . . . . 0.494 HD12 ' N ' ' A' ' 87' ' ' ILE . 5.0 mp -117.37 124.75 73.43 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.224 0 N-CA-C 109.351 -0.611 . . . . 0.0 109.351 175.998 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 88' ' ' LEU . . . . . . . . . . . . . 10.6 tp -111.88 129.54 56.13 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-O 120.991 0.424 . . . . 0.0 111.098 -176.15 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 89' ' ' ASP . . . . . . . . . . . . . 13.4 t70 -125.22 150.55 46.9 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-N 115.789 -0.641 . . . . 0.0 109.535 175.428 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 84.4 tt0 -48.67 -34.88 12.68 Favored 'General case' 0 C--N 1.328 -0.351 0 N-CA-C 112.772 0.656 . . . . 0.0 112.772 -172.946 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 91' ' ' ASN . . . . . . . . . . . . . 25.1 m120 -130.48 29.79 4.79 Favored 'General case' 0 N--CA 1.468 0.459 0 N-CA-C 112.184 0.439 . . . . 0.0 112.184 -176.559 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 92' ' ' LEU . . . . . . . . . . . . . 12.4 tp -166.09 141.99 4.9 Favored 'General case' 0 C--N 1.33 -0.275 0 C-N-CA 121.103 -0.239 . . . . 0.0 110.384 179.569 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 93' ' ' ILE . . . . . . . . . . . . . 74.2 mt -124.79 123.49 65.93 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.23 0 N-CA-C 109.609 -0.515 . . . . 0.0 109.609 179.191 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 94' ' ' VAL . . . . . . . . . . . . . 45.5 t -122.56 126.87 74.66 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.241 0 N-CA-C 109.876 -0.416 . . . . 0.0 109.876 179.856 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 95' ' ' VAL . . . . . . . . . . . . . 47.8 t -121.46 132.53 70.47 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.292 0 CA-C-N 116.028 -0.533 . . . . 0.0 109.862 -179.293 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 96' ' ' ILE . . . . . . . . . . . . . 57.3 mt -112.83 126.42 70.22 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.337 0 N-CA-C 109.021 -0.733 . . . . 0.0 109.021 178.62 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 97' ' ' THR . . . . . . . . . . . . . 72.9 p -101.73 154.27 19.05 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-O 121.265 0.555 . . . . 0.0 111.137 -176.426 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 98' ' ' GLU . . . . . . . . . . . . . 48.0 tp10 -54.14 -25.92 24.84 Favored 'General case' 0 CA--C 1.535 0.366 0 CA-C-N 116.111 -0.495 . . . . 0.0 112.107 -179.809 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 99' ' ' GLU . . . . . . . . . . . . . 40.0 tt0 -80.13 18.11 0.91 Allowed 'General case' 0 CA--C 1.539 0.522 0 N-CA-C 112.573 0.582 . . . . 0.0 112.573 -176.688 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 100' ' ' ASN . . . . . . . . . . . . . 2.9 m-20 62.97 37.12 12.09 Favored 'General case' 0 CA--C 1.529 0.163 0 O-C-N 121.738 -0.601 . . . . 0.0 111.141 176.378 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 101' ' ' GLU . . . . . . . . . . . . . 84.5 tt0 -118.71 143.09 47.09 Favored 'General case' 0 C--N 1.332 -0.182 0 CA-C-N 116.072 -0.513 . . . . 0.0 109.925 176.231 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 102' ' ' VAL . . . . . . . . . . . . . 47.0 t -114.97 125.57 72.33 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.278 0 N-CA-C 109.761 -0.459 . . . . 0.0 109.761 179.858 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 103' ' ' LEU . . . . . . . . . . . . . 54.4 mt -116.71 135.12 54.03 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 115.732 -0.667 . . . . 0.0 109.955 178.886 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 104' ' ' ILE . . . . . . . . . . . . . 72.9 mt -122.97 123.09 67.25 Favored 'Isoleucine or valine' 0 C--O 1.234 0.246 0 N-CA-C 110.349 -0.241 . . . . 0.0 110.349 -178.674 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 105' ' ' PHE . . . . . . . . . . . . . 85.5 m-85 -123.82 165.43 17.35 Favored 'General case' 0 C--O 1.232 0.184 0 O-C-N 123.996 0.81 . . . . 0.0 110.071 -178.618 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 106' ' ' ASN . . . . . . . . . . . . . 47.4 p-10 -101.3 -169.96 1.77 Allowed 'General case' 0 C--N 1.329 -0.317 0 N-CA-C 109.577 -0.527 . . . . 0.0 109.577 171.769 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 107' ' ' GLN . . . . . . . . . . . . . 16.2 tt0 -59.01 -29.97 67.65 Favored 'General case' 0 C--N 1.329 -0.312 0 N-CA-C 112.006 0.373 . . . . 0.0 112.006 -178.975 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 108' ' ' ASN . . . . . . . . . . . . . 6.7 t-20 -87.07 12.31 11.73 Favored 'General case' 0 CA--C 1.533 0.321 0 N-CA-C 113.015 0.746 . . . . 0.0 113.015 -176.653 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 109' ' ' LEU . . . . . . . . . . . . . 24.9 mt 58.56 37.03 25.5 Favored 'General case' 0 C--O 1.233 0.191 0 CA-C-O 120.828 0.346 . . . . 0.0 111.497 177.245 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 110' ' ' GLU . . . . . . . . . . . . . 95.4 mt-10 -104.66 146.87 28.32 Favored 'General case' 0 C--N 1.329 -0.293 0 N-CA-C 110.013 -0.365 . . . . 0.0 110.013 176.513 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 111' ' ' GLU . . . . . . . . . . . . . 98.8 mt-10 -76.16 121.94 23.59 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-O 120.989 0.423 . . . . 0.0 111.204 -178.304 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 112' ' ' LEU . . . . . . . . . . . . . 50.3 mt -107.47 -45.81 3.99 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 115.767 -0.651 . . . . 0.0 110.033 175.985 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 113' ' ' TYR . . . . . . . . . . . . . 63.2 t80 -140.64 138.71 34.55 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.012 -0.54 . . . . 0.0 110.859 179.973 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 114' ' ' ARG . . . . . . . . . . . . . 36.5 mtm105 -144.03 124.15 13.67 Favored 'General case' 0 C--N 1.331 -0.221 0 CA-C-N 116.388 -0.369 . . . . 0.0 110.494 176.309 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 115' ' ' GLY . . . . . . . . . . . . . . . -150.15 143.66 10.98 Favored Glycine 0 CA--C 1.524 0.614 0 N-CA-C 110.939 -0.864 . . . . 0.0 110.939 179.345 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 116' ' ' LYS . . . . . . . . . . . . . 35.3 ttmt -114.15 140.43 48.53 Favored 'General case' 0 C--N 1.331 -0.201 0 CA-C-O 120.861 0.362 . . . . 0.0 110.054 177.032 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 117' ' ' PHE . . . . . . . . . . . . . 32.5 m-85 -137.63 115.04 11.09 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.19 -0.459 . . . . 0.0 109.889 -176.487 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 118' ' ' GLU . . . . . . . . . . . . . 96.0 mt-10 -54.64 -44.12 72.91 Favored 'General case' 0 C--N 1.328 -0.335 0 C-N-CA 120.965 -0.294 . . . . 0.0 111.321 -175.698 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 119' ' ' ASN . . . . . . . . . . . . . 25.1 m120 -96.44 30.58 2.5 Favored 'General case' 0 C--N 1.33 -0.248 0 N-CA-C 112.29 0.478 . . . . 0.0 112.29 -174.878 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 120' ' ' LEU . . . . . . . . . . . . . 28.7 tp -60.6 126.74 28.55 Favored 'General case' 0 C--N 1.332 -0.189 0 N-CA-C 109.83 -0.433 . . . . 0.0 109.83 177.287 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 121' ' ' ASN . . . . . . . . . . . . . 18.2 m120 -110.88 -44.09 3.68 Favored 'General case' 0 C--N 1.331 -0.225 0 CA-C-N 116.361 -0.381 . . . . 0.0 111.128 -176.863 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 122' ' ' LYS . . . . . . . . . . . . . 56.2 pttt -161.44 159.21 27.82 Favored 'General case' 0 C--N 1.332 -0.167 0 C-N-CA 120.428 -0.509 . . . . 0.0 111.84 -179.266 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 123' ' ' VAL . . . . . . . . . . . . . 38.0 t -131.18 135.86 58.89 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.221 0 CA-C-N 116.094 -0.503 . . . . 0.0 110.321 -179.481 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 124' ' ' LEU . . . . . . . . . . . . . 46.0 mt -119.85 130.53 54.92 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.068 -0.514 . . . . 0.0 109.788 177.773 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 125' ' ' VAL . . . . . 0.409 ' CG1' HG21 ' A' ' 87' ' ' ILE . 13.6 p -138.29 137.49 43.91 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.2 0 CA-C-O 121.073 0.464 . . . . 0.0 111.166 -179.026 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 126' ' ' ARG . . . . . . . . . . . . . 14.0 ptm180 -163.28 135.97 5.41 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 115.804 -0.634 . . . . 0.0 109.776 175.673 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 127' ' ' ASN . . . . . . . . . . . . . 78.6 m-20 55.34 -154.55 0.3 Allowed 'General case' 0 CA--C 1.539 0.544 0 N-CA-C 110.074 -0.343 . . . . 0.0 110.074 179.875 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 128' ' ' ASP . . . . . . . . . . . . . 20.0 p-10 -80.15 15.49 1.51 Allowed 'General case' 0 CA--C 1.536 0.411 0 N-CA-C 112.938 0.718 . . . . 0.0 112.938 179.394 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 129' ' ' LEU . . . . . . . . . . . . . 13.9 tp -119.68 132.42 55.67 Favored 'General case' 0 C--O 1.232 0.142 0 CA-C-N 118.154 0.434 . . . . 0.0 110.223 179.575 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 130' ' ' VAL . . . . . 0.402 HG13 ' HB ' ' A' ' 141' ' ' ILE . 14.1 p -138.87 145.36 27.88 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.292 0 CA-C-O 120.979 0.418 . . . . 0.0 110.604 178.912 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 131' ' ' VAL . . . . . . . . . . . . . 43.1 t -135.04 138.68 48.57 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.252 0 CA-C-N 116.18 -0.464 . . . . 0.0 110.223 179.3 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 132' ' ' ILE . . . . . . . . . . . . . 67.6 mt -112.52 131.68 63.36 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.331 0 N-CA-C 109.349 -0.611 . . . . 0.0 109.349 179.849 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 133' ' ' ILE . . . . . . . . . . . . . 43.8 mm -115.02 123.21 70.48 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.254 0 CA-C-O 120.667 0.27 . . . . 0.0 111.083 -174.945 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 134' ' ' ASP . . . . . . . . . . . . . 7.2 p-10 -135.93 147.64 48.2 Favored 'General case' 0 C--N 1.332 -0.186 0 N-CA-C 109.584 -0.524 . . . . 0.0 109.584 172.896 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 135' ' ' GLU . . . . . . . . . . . . . 84.6 tt0 -49.81 -27.65 5.3 Favored 'General case' 0 C--N 1.327 -0.409 0 N-CA-C 112.767 0.654 . . . . 0.0 112.767 -172.749 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 136' ' ' GLN . . . . . . . . . . . . . 48.2 tt0 -83.57 -32.76 25.63 Favored 'General case' 0 C--O 1.235 0.323 0 N-CA-C 112.34 0.496 . . . . 0.0 112.34 -174.967 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 137' ' ' LYS . . . . . . . . . . . . . 52.0 pttt -167.04 169.88 12.49 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-O 121.497 0.665 . . . . 0.0 112.098 -172.365 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 138' ' ' LEU . . . . . 0.466 ' C ' HD23 ' A' ' 138' ' ' LEU . 8.8 tt -119.87 129.25 54.3 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 115.273 -0.876 . . . . 0.0 110.065 179.439 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 139' ' ' THR . . . . . . . . . . . . . 44.4 m -110.03 127.01 54.57 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.084 -0.507 . . . . 0.0 110.294 179.657 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 140' ' ' LEU . . . . . 0.475 HD23 ' C ' ' A' ' 140' ' ' LEU . 8.7 tt -110.8 123.33 49.87 Favored 'General case' 0 C--N 1.328 -0.329 0 N-CA-C 109.421 -0.585 . . . . 0.0 109.421 179.782 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 141' ' ' ILE . . . . . 0.402 ' HB ' HG13 ' A' ' 130' ' ' VAL . 18.9 mt -124.64 123.59 66.33 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.259 0 CA-C-O 120.964 0.412 . . . . 0.0 109.933 -175.336 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 142' ' ' ARG . . . . . . . . . . . . . 69.4 ttt180 -111.59 119.73 39.69 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 115.75 -0.659 . . . . 0.0 109.587 178.598 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 143' ' ' THR . . . . . . . . . . . . . 71.0 p . . . . . 0 C--O 1.22 -0.46 0 CA-C-O 117.981 -1.009 . . . . 0.0 110.606 -178.451 . . . . . . . . 0 0 . 1 . 012 nuclear build full ' B' B ' -3' ' ' GLU . . . . . . . . . . . . . 95.2 mt-10 . . . . . 0 N--CA 1.489 1.525 0 N-CA-C 109.245 -0.65 . . . . 0.0 109.245 . . . . . . . . . 0 0 . 1 . 012 nuclear build full ' B' B ' -2' ' ' GLY . . . . . . . . . . . . . . . -68.59 150.06 50.31 Favored Glycine 0 CA--C 1.524 0.616 0 N-CA-C 110.904 -0.878 . . . . 0.0 110.904 179.623 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' B' B ' -1' ' ' VAL . . . . . . . . . . . . . 44.0 t -96.14 132.92 39.18 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.282 0 CA-C-O 120.873 0.368 . . . . 0.0 110.032 -179.641 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' B' B ' 0' ' ' ILE . . . . . . . . . . . . . 70.4 mt -116.67 134.04 61.4 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.239 0 CA-C-N 116.202 -0.454 . . . . 0.0 109.95 -179.779 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' B' B ' 1' ' ' MET . . . . . . . . . . . . . 25.6 ptp -81.51 151.34 27.83 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.146 -0.479 . . . . 0.0 110.509 179.395 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' B' B ' 2' ' ' SER . . . . . . . . . . . . . 9.6 p -107.78 135.25 49.52 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.16 -0.473 . . . . 0.0 110.558 179.554 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' B' B ' 3' ' ' GLU . . . . . . . . . . . . . 95.0 mt-10 -139.84 142.39 36.6 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.021 -0.536 . . . . 0.0 110.954 -178.532 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' B' B ' 4' ' ' LEU . . . . . 0.404 HD23 ' N ' ' B' ' 5' ' ' LYS . 4.3 tt -126.14 124.73 41.19 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 115.829 -0.623 . . . . 0.0 109.559 176.899 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' B' B ' 5' ' ' LYS . . . . . 0.404 ' N ' HD23 ' B' ' 4' ' ' LEU . 96.1 mttt -108.12 120.87 43.58 Favored 'General case' 0 C--O 1.234 0.265 0 CA-C-O 120.755 0.312 . . . . 0.0 110.913 -178.2 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' B' B ' 6' ' ' LEU . . . . . 0.412 HD23 ' HA ' ' B' ' 50' ' ' VAL . 54.4 mt -114.82 148.96 37.79 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 115.439 -0.8 . . . . 0.0 110.656 -178.992 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' B' B ' 7' ' ' LYS . . . . . . . . . . . . . 26.3 ttpp -136.53 140.78 33.33 Favored Pre-proline 0 CA--C 1.532 0.267 0 CA-C-O 119.166 -0.445 . . . . 0.0 109.991 174.701 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' B' B ' 8' ' ' PRO . . . . . . . . . . . . . 87.9 Cg_endo -91.88 138.98 2.09 Favored 'Trans proline' 0 N--CA 1.49 1.274 0 C-N-CA 121.756 1.638 . . . . 0.0 111.638 177.645 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' B' B ' 9' ' ' LEU . . . . . . . . . . . . . 69.0 mt -73.65 -46.99 7.2 Favored Pre-proline 0 CA--C 1.534 0.357 0 CA-C-O 118.682 -0.675 . . . . 0.0 111.961 -179.991 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' B' B ' 10' ' ' PRO . . . . . . . . . . . . . 83.1 Cg_endo -81.36 150.81 17.43 Favored 'Trans proline' 0 N--CA 1.497 1.7 0 C-N-CA 121.166 1.244 . . . . 0.0 111.824 174.738 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' B' B ' 11' ' ' LYS . . . . . . . . . . . . . 39.4 ttpt -87.6 94.26 9.67 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.442 -0.345 . . . . 0.0 110.325 178.648 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' B' B ' 12' ' ' VAL . . . . . . . . . . . . . 12.0 p -140.07 142.19 32.29 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.297 0 CA-C-N 116.211 -0.449 . . . . 0.0 110.394 179.252 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' B' B ' 13' ' ' GLU . . . . . . . . . . . . . 41.9 mt-10 -75.69 132.24 40.41 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-O 120.802 0.335 . . . . 0.0 110.251 178.623 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' B' B ' 14' ' ' LEU . . . . . . . . . . . . . 30.5 mt -98.32 153.16 38.16 Favored Pre-proline 0 C--N 1.33 -0.253 0 CA-C-N 116.346 -0.388 . . . . 0.0 110.666 -179.224 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' B' B ' 15' ' ' PRO . . . . . . . . . . . . . 27.7 Cg_exo -61.12 154.12 59.66 Favored 'Trans proline' 0 N--CA 1.496 1.667 0 C-N-CA 121.276 1.317 . . . . 0.0 111.599 177.626 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' B' B ' 16' ' ' PRO . . . . . . . . . . . . . 33.9 Cg_exo -57.74 -36.44 98.39 Favored 'Trans proline' 0 N--CA 1.498 1.751 0 C-N-CA 121.389 1.393 . . . . 0.0 112.793 -178.896 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' B' B ' 17' ' ' ASP . . . . . . . . . . . . . 18.0 p-10 -92.43 15.04 14.89 Favored 'General case' 0 C--N 1.327 -0.383 0 N-CA-C 113.02 0.748 . . . . 0.0 113.02 -177.489 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' B' B ' 18' ' ' PHE . . . . . . . . . . . . . 44.4 t80 -58.38 -44.69 89.0 Favored 'General case' 0 C--O 1.228 -0.078 0 O-C-N 122.008 -0.432 . . . . 0.0 110.057 -177.722 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' B' B ' 19' ' ' VAL . . . . . . . . . . . . . 48.4 t -56.91 -42.97 79.59 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.305 0 CA-C-N 116.055 -0.521 . . . . 0.0 110.53 -178.346 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' B' B ' 20' ' ' ASP . . . . . . . . . . . . . 32.9 t0 -59.59 -43.49 93.67 Favored 'General case' 0 C--N 1.329 -0.315 0 C-N-CA 120.887 -0.325 . . . . 0.0 111.026 -177.22 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' B' B ' 21' ' ' VAL . . . . . . . . . . . . . 45.1 t -64.88 -46.52 91.58 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.248 0 C-N-CA 120.716 -0.393 . . . . 0.0 110.43 -178.116 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' B' B ' 22' ' ' ILE . . . . . 0.632 HG22 HD12 ' B' ' 26' ' ' LEU . 50.9 mm -57.8 -38.87 67.98 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.324 0 CA-C-O 120.668 0.271 . . . . 0.0 110.407 179.272 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' B' B ' 23' ' ' ARG . . . . . . . . . . . . . 57.1 ttp180 -55.84 -49.87 72.11 Favored 'General case' 0 C--N 1.331 -0.216 0 CA-C-O 120.976 0.417 . . . . 0.0 110.558 177.861 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' B' B ' 24' ' ' ILE . . . . . . . . . . . . . 74.0 mt -60.85 -43.85 96.45 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.334 0 CA-C-N 115.834 -0.621 . . . . 0.0 111.73 -177.398 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' B' B ' 25' ' ' LYS . . . . . . . . . . . . . 14.8 pttp -72.97 -36.62 67.14 Favored 'General case' 0 CA--C 1.533 0.298 0 C-N-CA 120.526 -0.47 . . . . 0.0 111.901 -172.933 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' B' B ' 26' ' ' LEU . . . . . 0.632 HD12 HG22 ' B' ' 22' ' ' ILE . 42.0 mt -80.21 -41.78 24.53 Favored 'General case' 0 C--N 1.331 -0.22 0 N-CA-C 113.185 0.809 . . . . 0.0 113.185 -173.796 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' B' B ' 27' ' ' GLN . . . . . . . . . . . . . 19.2 pt20 -47.18 139.28 6.19 Favored 'General case' 0 N--CA 1.469 0.484 0 N-CA-C 112.73 0.641 . . . . 0.0 112.73 -174.539 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' B' B ' 28' ' ' GLY . . . . . . . . . . . . . . . 99.48 -26.0 26.08 Favored Glycine 0 CA--C 1.533 1.179 0 CA-C-N 115.687 -0.688 . . . . 0.0 112.255 -176.877 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' B' B ' 29' ' ' LYS . . . . . . . . . . . . . 56.4 mtmt -98.9 155.16 17.54 Favored 'General case' 0 C--O 1.232 0.164 0 CA-C-N 117.247 0.523 . . . . 0.0 111.103 179.425 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' B' B ' 30' ' ' THR . . . . . . . . . . . . . 31.4 m -105.38 137.73 42.72 Favored 'General case' 0 C--N 1.332 -0.195 0 CA-C-N 116.101 -0.499 . . . . 0.0 110.094 176.949 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' B' B ' 31' ' ' VAL . . . . . . . . . . . . . 34.3 m -130.71 160.41 41.93 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.236 0 CA-C-O 120.911 0.386 . . . . 0.0 110.971 -178.372 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' B' B ' 32' ' ' ARG . . . . . . . . . . . . . 80.3 mtm180 -134.24 149.26 50.95 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 115.907 -0.588 . . . . 0.0 110.477 177.844 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' B' B ' 33' ' ' THR . . . . . . . . . . . . . 24.7 m -53.41 141.63 24.11 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.443 -0.344 . . . . 0.0 111.39 -178.363 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' B' B ' 34' ' ' GLY . . . . . . . . . . . . . . . 99.49 -17.13 58.12 Favored Glycine 0 CA--C 1.533 1.194 0 CA-C-O 119.687 -0.507 . . . . 0.0 113.23 179.762 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' B' B ' 35' ' ' ASP . . . . . . . . . . . . . 76.1 m-20 -65.33 147.99 52.47 Favored 'General case' 0 C--O 1.231 0.123 0 CA-C-N 118.037 0.919 . . . . 0.0 111.041 178.739 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' B' B ' 36' ' ' VAL . . . . . . . . . . . . . 46.7 t -120.58 129.96 75.03 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.204 0 CA-C-N 115.829 -0.623 . . . . 0.0 109.887 179.099 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' B' B ' 37' ' ' ILE . . . . . . . . . . . . . 69.9 mt -120.31 139.18 48.42 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.219 0 N-CA-C 109.841 -0.429 . . . . 0.0 109.841 179.848 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' B' B ' 38' ' ' GLY . . . . . . . . . . . . . . . -114.04 128.74 8.4 Favored Glycine 0 CA--C 1.525 0.691 0 N-CA-C 111.256 -0.738 . . . . 0.0 111.256 -179.683 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' B' B ' 39' ' ' ILE . . . . . . . . . . . . . 69.4 mt -122.9 127.97 75.01 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.218 0 N-CA-C 109.64 -0.504 . . . . 0.0 109.64 177.418 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' B' B ' 40' ' ' SER . . . . . . . . . . . . . 56.3 p -91.95 118.12 30.45 Favored 'General case' 0 C--N 1.33 -0.257 0 C-N-CA 120.908 -0.317 . . . . 0.0 110.75 177.527 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' B' B ' 41' ' ' ILE . . . . . . . . . . . . . 73.8 mt -134.63 128.25 50.68 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.234 0 CA-C-O 120.732 0.301 . . . . 0.0 110.266 178.786 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' B' B ' 42' ' ' LEU . . . . . . . . . . . . . 49.3 mt 57.76 33.08 22.8 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.24 -0.436 . . . . 0.0 111.858 178.543 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' B' B ' 43' ' ' GLY . . . . . . . . . . . . . . . 77.29 -10.05 23.77 Favored Glycine 0 CA--C 1.535 1.334 0 C-N-CA 121.276 -0.487 . . . . 0.0 113.472 178.03 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' B' B ' 44' ' ' LYS . . . . . . . . . . . . . 65.3 tttm -102.22 129.91 48.75 Favored 'General case' 0 C--O 1.233 0.195 0 CA-C-N 117.948 0.874 . . . . 0.0 109.964 177.224 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' B' B ' 45' ' ' GLU . . . . . . . . . . . . . 44.7 tp10 -84.7 125.66 32.71 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.43 -0.35 . . . . 0.0 110.55 178.998 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' B' B ' 46' ' ' VAL . . . . . . . . . . . . . 7.5 p -113.74 128.77 70.48 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.258 0 N-CA-C 109.336 -0.616 . . . . 0.0 109.336 177.108 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' B' B ' 47' ' ' LYS . . . . . . . . . . . . . 93.5 mttt -100.05 126.58 46.27 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 115.849 -0.614 . . . . 0.0 111.12 178.725 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' B' B ' 48' ' ' PHE . . . . . . . . . . . . . 95.3 m-85 -109.48 131.9 54.64 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.079 -0.51 . . . . 0.0 109.679 176.358 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' B' B ' 49' ' ' LYS . . . . . . . . . . . . . 86.4 tttt -107.12 134.73 49.8 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.18 -0.463 . . . . 0.0 110.366 179.25 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' B' B ' 50' ' ' VAL . . . . . 0.412 ' HA ' HD23 ' B' ' 6' ' ' LEU . 46.2 t -79.0 106.42 9.97 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.336 0 N-CA-C 109.167 -0.679 . . . . 0.0 109.167 175.695 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' B' B ' 51' ' ' VAL . . . . . . . . . . . . . 52.5 t -69.9 -52.81 27.73 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.354 0 N-CA-C 109.613 -0.514 . . . . 0.0 109.613 -174.844 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' B' B ' 52' ' ' GLN . . . . . . . . . . . . . 90.7 mt-30 -153.75 151.64 29.82 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-O 121.274 0.559 . . . . 0.0 111.86 -178.114 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' B' B ' 53' ' ' ALA . . . . . . . . . . . . . . . -127.29 132.55 50.29 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 115.065 -0.971 . . . . 0.0 109.323 174.561 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' B' B ' 54' ' ' TYR . . . . . . . . . . . . . 39.7 t80 -129.06 109.78 18.2 Favored Pre-proline 0 CA--C 1.533 0.318 0 CA-C-O 118.183 -0.913 . . . . 0.0 110.381 -179.697 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' B' B ' 55' ' ' PRO . . . . . . . . . . . . . 73.6 Cg_endo -77.1 170.1 72.53 Favored 'Cis proline' 0 N--CA 1.502 2.006 0 CA-C-N 121.907 1.717 . . . . 0.0 112.594 -5.443 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' B' B ' 56' ' ' SER . . . . . . . . . . . . . 15.5 m -116.56 128.05 26.29 Favored Pre-proline 0 CA--C 1.539 0.537 0 CA-C-O 118.409 -0.805 . . . . 0.0 109.37 175.276 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' B' B ' 57' ' ' PRO . . . . . . . . . . . . . 36.6 Cg_endo -66.2 166.04 59.15 Favored 'Cis proline' 0 N--CA 1.499 1.799 0 CA-C-N 121.986 1.745 . . . . 0.0 111.662 -0.113 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' B' B ' 58' ' ' LEU . . . . . . . . . . . . . 29.7 tp -130.21 135.92 48.66 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.318 -0.401 . . . . 0.0 110.734 -179.716 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' B' B ' 59' ' ' ARG . . . . . . . . . . . . . 58.2 ttp180 -101.82 126.75 48.76 Favored 'General case' 0 C--N 1.328 -0.366 0 N-CA-C 109.237 -0.653 . . . . 0.0 109.237 175.815 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' B' B ' 60' ' ' VAL . . . . . . . . . . . . . 46.9 t -78.56 117.98 24.96 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.192 0 C-N-CA 120.546 -0.462 . . . . 0.0 109.915 -177.352 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' B' B ' 61' ' ' GLU . . . . . . . . . . . . . 74.4 tt0 -131.12 159.6 37.16 Favored 'General case' 0 C--N 1.328 -0.337 0 N-CA-C 109.422 -0.584 . . . . 0.0 109.422 -179.504 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' B' B ' 62' ' ' ASP . . . . . . . . . . . . . 52.2 m-20 -51.51 -32.17 26.62 Favored 'General case' 0 C--N 1.328 -0.355 0 N-CA-C 112.074 0.398 . . . . 0.0 112.074 -179.367 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' B' B ' 63' ' ' ARG . . . . . . . . . . . . . 14.5 ptm180 -85.15 5.4 30.06 Favored 'General case' 0 CA--C 1.535 0.403 0 N-CA-C 113.733 1.012 . . . . 0.0 113.733 -175.739 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' B' B ' 64' ' ' THR . . . . . . . . . . . . . 24.4 m -89.72 136.4 33.06 Favored 'General case' 0 C--N 1.332 -0.18 0 CA-C-N 118.151 0.432 . . . . 0.0 110.401 -178.647 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' B' B ' 65' ' ' LYS . . . . . . . . . . . . . 55.1 mtmt -89.1 128.38 35.76 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.299 -0.41 . . . . 0.0 110.31 -179.994 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' B' B ' 66' ' ' ILE . . . . . . . . . . . . . 66.1 mt -113.68 127.18 71.16 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.294 0 N-CA-C 109.638 -0.504 . . . . 0.0 109.638 179.998 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' B' B ' 67' ' ' THR . . . . . . . . . . . . . 23.4 m -126.97 144.09 51.11 Favored 'General case' 0 C--N 1.332 -0.185 0 CA-C-N 116.122 -0.49 . . . . 0.0 111.069 -175.903 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' B' B ' 68' ' ' LEU . . . . . . . . . . . . . 42.8 mt -104.07 135.18 46.05 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 115.942 -0.572 . . . . 0.0 110.61 177.887 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' B' B ' 69' ' ' VAL . . . . . . . . . . . . . 43.1 t -100.42 140.76 18.67 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.339 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.004 178.969 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' B' B ' 70' ' ' THR . . . . . . . . . . . . . 6.7 p -131.13 -45.25 1.02 Allowed 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.088 -0.505 . . . . 0.0 110.531 -178.58 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' B' B ' 71' ' ' HIS . . . . . . . . . . . . . 89.2 m-70 -106.18 154.4 39.68 Favored Pre-proline 0 C--N 1.33 -0.277 0 CA-C-N 116.267 -0.424 . . . . 0.0 110.521 -179.792 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' B' B ' 72' ' ' PRO . . . . . . . . . . . . . 93.9 Cg_endo -83.19 -7.76 10.94 Favored 'Trans proline' 0 N--CA 1.496 1.654 0 C-N-CA 121.532 1.488 . . . . 0.0 113.809 179.401 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' B' B ' 73' ' ' VAL . . . . . . . . . . . . . 33.8 m -125.68 171.13 14.81 Favored 'Isoleucine or valine' 0 C--N 1.334 -0.092 0 CA-C-O 120.66 0.267 . . . . 0.0 110.376 -179.289 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' B' B ' 74' ' ' ASP . . . . . . . . . . . . . 38.8 t0 -95.66 119.28 33.89 Favored 'General case' 0 C--N 1.329 -0.287 0 N-CA-C 110.121 -0.326 . . . . 0.0 110.121 -177.644 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' B' B ' 75' ' ' VAL . . . . . . . . . . . . . 40.6 t -122.52 125.2 72.31 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.295 0 CA-C-O 121.142 0.496 . . . . 0.0 110.818 -177.652 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' B' B ' 76' ' ' LEU . . . . . . . . . . . . . 5.9 mp -121.99 145.29 48.27 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 115.67 -0.695 . . . . 0.0 109.619 175.361 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' B' B ' 77' ' ' GLU . . . . . . . . . . . . . 97.3 mt-10 -134.38 132.06 38.97 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-O 121.061 0.458 . . . . 0.0 111.133 -178.634 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' B' B ' 78' ' ' ALA . . . . . . . . . . . . . . . -120.84 134.28 55.29 Favored 'General case' 0 C--N 1.33 -0.239 0 CA-C-N 115.761 -0.654 . . . . 0.0 109.84 177.028 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' B' B ' 79' ' ' LYS . . . . . 0.438 ' O ' HD13 ' B' ' 80' ' ' ILE . 94.4 mttt -79.1 120.79 24.14 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-O 120.809 0.337 . . . . 0.0 110.566 -178.575 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' B' B ' 80' ' ' ILE . . . . . 0.438 HD13 ' O ' ' B' ' 79' ' ' LYS . 26.8 mm -139.09 110.06 4.76 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.28 0 N-CA-C 109.148 -0.686 . . . . 0.0 109.148 -177.465 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' B' B ' 81' ' ' LYS . . . . . . . . . . . . . 49.0 pttt -99.42 123.39 43.66 Favored 'General case' 0 C--N 1.33 -0.283 0 CA-C-O 121.104 0.478 . . . . 0.0 111.419 -176.778 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' B' B ' 82' ' ' GLY . . . . . . . . . . . . . . . 88.85 42.18 5.76 Favored Glycine 0 CA--C 1.524 0.617 0 C-N-CA 120.769 -0.729 . . . . 0.0 111.664 173.404 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' B' B ' 83' ' ' ILE . . . . . . . . . . . . . 76.8 mt -64.38 135.13 28.45 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.285 0 N-CA-C 109.861 -0.422 . . . . 0.0 109.861 178.669 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' B' B ' 84' ' ' LYS . . . . . . . . . . . . . 84.7 tttt -92.63 -53.85 4.02 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 115.903 -0.589 . . . . 0.0 110.348 -177.326 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' B' B ' 85' ' ' ASP . . . . . . . . . . . . . 3.7 t70 -158.29 158.01 33.58 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 115.678 -0.692 . . . . 0.0 110.147 -178.783 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' B' B ' 86' ' ' VAL . . . . . . . . . . . . . 40.3 t -135.56 134.08 51.87 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.248 0 CA-C-O 121.023 0.44 . . . . 0.0 110.746 -177.69 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' B' B ' 87' ' ' ILE . . . . . . . . . . . . . 44.2 mm -117.48 127.68 74.88 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.226 0 CA-C-N 115.751 -0.659 . . . . 0.0 109.389 174.386 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' B' B ' 88' ' ' LEU . . . . . . . . . . . . . 17.3 tp -112.55 133.06 54.81 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-O 121.01 0.434 . . . . 0.0 111.19 -176.673 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' B' B ' 89' ' ' ASP . . . . . . . . . . . . . 9.0 t0 -128.22 150.51 50.0 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 115.743 -0.662 . . . . 0.0 109.43 176.591 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' B' B ' 90' ' ' GLU . . . . . . . . . . . . . 84.3 tt0 -48.03 -37.63 15.32 Favored 'General case' 0 CA--C 1.531 0.25 0 N-CA-C 112.612 0.597 . . . . 0.0 112.612 -173.336 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' B' B ' 91' ' ' ASN . . . . . . . . . . . . . 84.9 m-20 -131.6 35.07 3.85 Favored 'General case' 0 N--CA 1.465 0.285 0 CA-C-O 120.816 0.341 . . . . 0.0 111.639 -177.301 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' B' B ' 92' ' ' LEU . . . . . . . . . . . . . 11.6 tp -166.07 142.41 5.05 Favored 'General case' 0 C--N 1.331 -0.22 0 CA-C-O 120.673 0.273 . . . . 0.0 110.339 179.723 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' B' B ' 93' ' ' ILE . . . . . . . . . . . . . 70.1 mt -125.47 124.36 66.77 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.343 0 N-CA-C 109.622 -0.51 . . . . 0.0 109.622 -179.896 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' B' B ' 94' ' ' VAL . . . . . . . . . . . . . 41.0 t -124.79 127.33 72.58 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.252 0 N-CA-C 110.008 -0.368 . . . . 0.0 110.008 179.39 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' B' B ' 95' ' ' VAL . . . . . . . . . . . . . 40.1 t -123.37 137.67 55.88 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.293 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.036 -179.48 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' B' B ' 96' ' ' ILE . . . . . . . . . . . . . 65.1 mt -116.46 130.43 71.29 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.256 0 N-CA-C 109.158 -0.682 . . . . 0.0 109.158 178.254 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' B' B ' 97' ' ' THR . . . . . . . . . . . . . 65.4 p -103.96 155.78 18.38 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-O 121.029 0.443 . . . . 0.0 111.255 -177.324 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' B' B ' 98' ' ' GLU . . . . . . . . . . . . . 85.1 tt0 -54.04 -24.54 17.49 Favored 'General case' 0 CA--C 1.534 0.332 0 N-CA-C 112.068 0.396 . . . . 0.0 112.068 178.922 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' B' B ' 99' ' ' GLU . . . . . . . . . . . . . 70.9 mm-40 -76.4 13.49 0.94 Allowed 'General case' 0 CA--C 1.535 0.4 0 N-CA-C 113.2 0.815 . . . . 0.0 113.2 -179.333 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' B' B ' 100' ' ' ASN . . . . . . . . . . . . . 2.3 m-20 64.62 38.1 7.37 Favored 'General case' 0 C--O 1.232 0.15 0 CA-C-O 120.988 0.423 . . . . 0.0 110.788 177.813 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' B' B ' 101' ' ' GLU . . . . . . . . . . . . . 46.2 mt-10 -115.84 143.94 44.72 Favored 'General case' 0 C--N 1.332 -0.16 0 CA-C-N 116.074 -0.512 . . . . 0.0 110.399 177.078 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' B' B ' 102' ' ' VAL . . . . . 0.435 ' C ' HD12 ' B' ' 103' ' ' LEU . 47.2 t -115.11 126.46 72.7 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.357 0 N-CA-C 109.245 -0.65 . . . . 0.0 109.245 176.864 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' B' B ' 103' ' ' LEU . . . . . 0.435 HD12 ' C ' ' B' ' 102' ' ' VAL . 6.4 mp -121.9 132.88 54.8 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-N 116.008 -0.542 . . . . 0.0 110.386 177.796 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' B' B ' 104' ' ' ILE . . . . . . . . . . . . . 71.6 mt -117.62 124.77 73.5 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.315 0 CA-C-N 115.834 -0.621 . . . . 0.0 109.914 -179.092 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' B' B ' 105' ' ' PHE . . . . . . . . . . . . . 75.9 m-85 -123.46 162.23 23.25 Favored 'General case' 0 C--N 1.331 -0.222 0 O-C-N 123.985 0.803 . . . . 0.0 109.823 179.786 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' B' B ' 106' ' ' ASN . . . . . . . . . . . . . 47.9 p-10 -97.22 -170.41 2.02 Favored 'General case' 0 C--N 1.329 -0.31 0 N-CA-C 109.919 -0.4 . . . . 0.0 109.919 173.939 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' B' B ' 107' ' ' GLN . . . . . . . . . . . . . 47.5 tt0 -59.0 -30.05 67.69 Favored 'General case' 0 C--N 1.329 -0.287 0 N-CA-C 111.888 0.329 . . . . 0.0 111.888 179.607 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' B' B ' 108' ' ' ASN . . . . . . . . . . . . . 56.4 t30 -83.96 7.76 17.32 Favored 'General case' 0 CA--C 1.536 0.412 0 N-CA-C 113.259 0.837 . . . . 0.0 113.259 -177.022 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' B' B ' 109' ' ' LEU . . . . . . . . . . . . . 9.8 tp 60.52 36.35 20.0 Favored 'General case' 0 CA--C 1.529 0.165 0 CA-C-O 120.965 0.412 . . . . 0.0 111.413 178.613 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' B' B ' 110' ' ' GLU . . . . . . . . . . . . . 70.6 mm-40 -101.35 147.5 26.25 Favored 'General case' 0 C--N 1.329 -0.322 0 N-CA-C 109.685 -0.487 . . . . 0.0 109.685 175.837 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' B' B ' 111' ' ' GLU . . . . . . . . . . . . . 85.2 tt0 -79.51 121.95 25.85 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-O 120.94 0.4 . . . . 0.0 110.483 -177.508 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' B' B ' 112' ' ' LEU . . . . . . . . . . . . . 20.5 mt -108.26 -46.04 3.8 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 115.911 -0.586 . . . . 0.0 110.548 179.379 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' B' B ' 113' ' ' TYR . . . . . . . . . . . . . 64.4 t80 -140.27 135.17 32.01 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.145 -0.48 . . . . 0.0 111.364 -178.667 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' B' B ' 114' ' ' ARG . . . . . . . . . . . . . 71.6 ttt180 -142.16 125.16 16.2 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.306 -0.406 . . . . 0.0 110.158 176.141 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' B' B ' 115' ' ' GLY . . . . . . . . . . . . . . . -150.04 149.14 21.0 Favored Glycine 0 CA--C 1.523 0.582 0 N-CA-C 111.175 -0.77 . . . . 0.0 111.175 179.115 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' B' B ' 116' ' ' LYS . . . . . . . . . . . . . 35.3 ttpt -114.22 131.75 56.36 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-O 120.732 0.301 . . . . 0.0 110.422 178.283 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' B' B ' 117' ' ' PHE . . . . . 0.426 ' HE2' HD13 ' B' ' 132' ' ' ILE . 43.1 m-85 -129.46 113.94 15.52 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.279 -0.419 . . . . 0.0 109.938 -179.244 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' B' B ' 118' ' ' GLU . . . . . . . . . . . . . 84.6 tt0 -54.91 -48.5 73.0 Favored 'General case' 0 C--N 1.329 -0.318 0 C-N-CA 120.901 -0.319 . . . . 0.0 111.419 -175.601 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' B' B ' 119' ' ' ASN . . . . . . . . . . . . . 91.0 m-20 -94.44 31.2 1.79 Allowed 'General case' 0 C--N 1.33 -0.279 0 N-CA-C 112.187 0.44 . . . . 0.0 112.187 -174.199 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' B' B ' 120' ' ' LEU . . . . . . . . . . . . . 21.9 tp -53.28 123.67 12.51 Favored 'General case' 0 N--CA 1.464 0.254 0 CA-C-O 120.713 0.292 . . . . 0.0 110.953 178.221 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' B' B ' 121' ' ' ASN . . . . . . . . . . . . . 43.2 m-20 -106.37 -44.16 4.59 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-N 116.337 -0.392 . . . . 0.0 110.909 -177.533 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' B' B ' 122' ' ' LYS . . . . . . . . . . . . . 50.7 pttt -161.14 157.73 26.41 Favored 'General case' 0 C--N 1.331 -0.225 0 C-N-CA 120.454 -0.498 . . . . 0.0 112.204 -179.462 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' B' B ' 123' ' ' VAL . . . . . . . . . . . . . 44.0 t -125.6 131.16 72.4 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.246 0 CA-C-N 115.805 -0.634 . . . . 0.0 109.845 177.522 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' B' B ' 124' ' ' LEU . . . . . . . . . . . . . 76.8 mt -116.73 133.3 56.17 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.301 -0.408 . . . . 0.0 110.392 179.979 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' B' B ' 125' ' ' VAL . . . . . . . . . . . . . 47.3 t -131.74 129.51 61.27 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.215 0 CA-C-N 116.284 -0.417 . . . . 0.0 110.228 -179.057 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' B' B ' 126' ' ' ARG . . . . . . . . . . . . . 77.0 mtt180 -141.3 119.79 12.36 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-O 121.076 0.465 . . . . 0.0 110.458 176.538 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' B' B ' 127' ' ' ASN . . . . . . . . . . . . . 42.4 t-20 50.63 -106.47 0.24 Allowed 'General case' 0 CA--C 1.543 0.711 0 CA-C-O 119.003 -0.523 . . . . 0.0 111.37 -179.106 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' B' B ' 128' ' ' ASP . . . . . . . . . . . . . 11.7 p-10 -114.12 2.51 14.92 Favored 'General case' 0 N--CA 1.467 0.407 0 CA-C-N 119.642 1.11 . . . . 0.0 113.466 -177.334 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' B' B ' 129' ' ' LEU . . . . . . . . . . . . . 11.6 tp -104.96 136.85 43.68 Favored 'General case' 0 C--O 1.232 0.134 0 CA-C-N 118.267 0.485 . . . . 0.0 109.849 -179.916 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' B' B ' 130' ' ' VAL . . . . . . . . . . . . . 43.0 t -125.14 138.08 55.51 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.268 0 CA-C-O 121.061 0.457 . . . . 0.0 110.406 -176.885 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' B' B ' 131' ' ' VAL . . . . . 0.461 HG22 HD12 ' B' ' 140' ' ' LEU . 44.2 t -134.52 135.24 54.01 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.34 0 CA-C-N 115.895 -0.593 . . . . 0.0 110.008 177.915 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' B' B ' 132' ' ' ILE . . . . . 0.426 HD13 ' HE2' ' B' ' 117' ' ' PHE . 73.7 mt -115.79 132.28 65.69 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.281 0 N-CA-C 109.501 -0.555 . . . . 0.0 109.501 179.752 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' B' B ' 133' ' ' ILE . . . . . . . . . . . . . 42.7 mm -116.33 125.14 73.24 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.226 0 CA-C-N 116.569 -0.287 . . . . 0.0 111.074 -174.624 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' B' B ' 134' ' ' ASP . . . . . . . . . . . . . 10.1 p-10 -137.45 150.07 47.34 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 116.19 -0.459 . . . . 0.0 109.846 173.378 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' B' B ' 135' ' ' GLU . . . . . . . . . . . . . 40.1 tp10 -49.91 -27.2 4.91 Favored 'General case' 0 C--N 1.327 -0.371 0 N-CA-C 112.791 0.663 . . . . 0.0 112.791 -172.066 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' B' B ' 136' ' ' GLN . . . . . . . . . . . . . 63.2 tt0 -87.14 -33.72 19.32 Favored 'General case' 0 C--N 1.331 -0.221 0 N-CA-C 112.497 0.554 . . . . 0.0 112.497 -174.747 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' B' B ' 137' ' ' LYS . . . . . . . . . . . . . 48.3 pttt -162.1 171.22 17.84 Favored 'General case' 0 C--N 1.332 -0.181 0 CA-C-O 121.537 0.684 . . . . 0.0 112.525 -171.445 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' B' B ' 138' ' ' LEU . . . . . 0.427 ' C ' HD23 ' B' ' 138' ' ' LEU . 7.2 tt -121.45 128.74 52.45 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 114.918 -1.037 . . . . 0.0 109.896 178.531 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' B' B ' 139' ' ' THR . . . . . . . . . . . . . 39.4 m -108.18 127.13 53.55 Favored 'General case' 0 C--N 1.331 -0.221 0 CA-C-N 116.292 -0.413 . . . . 0.0 110.425 -179.929 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' B' B ' 140' ' ' LEU . . . . . 0.461 HD12 HG22 ' B' ' 131' ' ' VAL . 29.6 tp -112.2 120.9 43.35 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 115.788 -0.642 . . . . 0.0 109.531 -179.09 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' B' B ' 141' ' ' ILE . . . . . . . . . . . . . 19.1 mt -121.72 119.63 59.35 Favored 'Isoleucine or valine' 0 C--O 1.233 0.198 0 CA-C-O 121.09 0.471 . . . . 0.0 110.282 -175.249 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' B' B ' 142' ' ' ARG . . . . . . . . . . . . . 83.1 mtp180 -108.03 125.87 52.06 Favored 'General case' 0 C--N 1.331 -0.217 0 CA-C-N 115.206 -0.906 . . . . 0.0 110.091 179.044 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' B' B ' 143' ' ' THR . . . . . . . . . . . . . 15.2 p . . . . . 0 C--O 1.219 -0.501 0 CA-C-O 118.046 -0.978 . . . . 0.0 110.495 179.831 . . . . . . . . 0 0 . 1 . 012 nuclear build full ' C' C ' -3' ' ' GLU . . . . . . . . . . . . . 96.1 mt-10 . . . . . 0 N--CA 1.489 1.499 0 N-CA-C 109.427 -0.583 . . . . 0.0 109.427 . . . . . . . . . 0 0 . 1 . 012 nuclear build full ' C' C ' -2' ' ' GLY . . . . . . . . . . . . . . . -67.78 131.45 28.68 Favored Glycine 0 CA--C 1.524 0.641 0 N-CA-C 111.094 -0.802 . . . . 0.0 111.094 -179.348 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' C' C ' -1' ' ' VAL . . . . . . . . . . . . . 45.1 t -96.54 126.39 49.23 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 N-CA-C 109.689 -0.486 . . . . 0.0 109.689 178.98 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' C' C ' 0' ' ' ILE . . . . . . . . . . . . . 71.6 mt -120.31 139.29 48.07 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.222 0 CA-C-N 116.251 -0.431 . . . . 0.0 110.35 -177.599 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' C' C ' 1' ' ' MET . . . . . . . . . . . . . 25.2 ptp -143.51 149.09 36.98 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 115.947 -0.57 . . . . 0.0 110.411 178.253 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' C' C ' 2' ' ' SER . . . . . . . . . . . . . 4.1 p -118.89 132.49 56.1 Favored 'General case' 0 C--N 1.332 -0.184 0 CA-C-O 120.85 0.357 . . . . 0.0 110.826 -179.264 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' C' C ' 3' ' ' GLU . . . . . . . . . . . . . 57.0 mp0 -140.49 140.35 35.3 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.074 -0.512 . . . . 0.0 110.867 179.267 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' C' C ' 4' ' ' LEU . . . . . . . . . . . . . 14.8 tp -125.17 127.94 47.6 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.046 -0.525 . . . . 0.0 110.111 176.46 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' C' C ' 5' ' ' LYS . . . . . . . . . . . . . 87.9 mttt -109.3 122.93 48.41 Favored 'General case' 0 C--O 1.235 0.294 0 CA-C-O 120.66 0.267 . . . . 0.0 110.888 178.929 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' C' C ' 6' ' ' LEU . . . . . . . . . . . . . 67.2 mt -114.72 145.07 42.49 Favored 'General case' 0 N--CA 1.463 0.216 0 CA-C-N 115.676 -0.693 . . . . 0.0 110.362 179.491 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' C' C ' 7' ' ' LYS . . . . . . . . . . . . . 73.6 tttt -125.25 137.02 28.99 Favored Pre-proline 0 CA--C 1.534 0.335 0 CA-C-O 118.866 -0.588 . . . . 0.0 109.703 174.635 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' C' C ' 8' ' ' PRO . . . . . . . . . . . . . 83.5 Cg_endo -92.04 132.68 1.24 Allowed 'Trans proline' 0 N--CA 1.489 1.249 0 C-N-CA 121.663 1.575 . . . . 0.0 111.759 178.528 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' C' C ' 9' ' ' LEU . . . . . . . . . . . . . 55.7 mt -69.63 -46.74 25.76 Favored Pre-proline 0 CA--C 1.532 0.272 0 CA-C-O 118.742 -0.647 . . . . 0.0 112.079 -179.557 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' C' C ' 10' ' ' PRO . . . . . . . . . . . . . 88.4 Cg_endo -80.79 155.65 20.61 Favored 'Trans proline' 0 N--CA 1.495 1.611 0 C-N-CA 121.184 1.256 . . . . 0.0 111.78 174.769 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' C' C ' 11' ' ' LYS . . . . . . . . . . . . . 79.1 mttt -87.7 101.37 13.6 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.415 -0.357 . . . . 0.0 110.503 178.978 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' C' C ' 12' ' ' VAL . . . . . . . . . . . . . 12.2 p -145.33 144.36 21.45 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.299 0 CA-C-N 116.299 -0.41 . . . . 0.0 110.836 -179.251 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' C' C ' 13' ' ' GLU . . . . . . . . . . . . . 43.5 mt-10 -92.36 126.23 37.35 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.252 -0.431 . . . . 0.0 109.879 176.25 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' C' C ' 14' ' ' LEU . . . . . . . . . . . . . 17.3 mt -97.22 152.81 38.49 Favored Pre-proline 0 C--N 1.33 -0.267 0 CA-C-N 116.501 -0.318 . . . . 0.0 110.742 -177.649 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' C' C ' 15' ' ' PRO . . . . . . . . . . . . . 33.6 Cg_exo -59.77 159.23 25.44 Favored 'Trans proline' 0 N--CA 1.496 1.67 0 C-N-CA 121.311 1.341 . . . . 0.0 111.884 178.348 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' C' C ' 16' ' ' PRO . . . . . . . . . . . . . 29.6 Cg_exo -59.9 -34.84 95.15 Favored 'Trans proline' 0 N--CA 1.497 1.725 0 C-N-CA 121.383 1.389 . . . . 0.0 112.811 -177.675 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' C' C ' 17' ' ' ASP . . . . . . . . . . . . . 10.7 p-10 -90.18 8.74 31.46 Favored 'General case' 0 CA--C 1.536 0.423 0 N-CA-C 113.284 0.846 . . . . 0.0 113.284 -176.896 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' C' C ' 18' ' ' PHE . . . . . . . . . . . . . 53.6 t80 -57.8 -45.55 85.91 Favored 'General case' 0 C--N 1.334 -0.101 0 O-C-N 122.057 -0.402 . . . . 0.0 110.33 -178.516 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' C' C ' 19' ' ' VAL . . . . . . . . . . . . . 48.7 t -56.75 -42.11 76.62 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.289 0 CA-C-N 116.523 -0.308 . . . . 0.0 110.414 -178.633 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' C' C ' 20' ' ' ASP . . . . . . . . . . . . . 14.9 t0 -59.7 -44.0 93.87 Favored 'General case' 0 C--N 1.328 -0.352 0 C-N-CA 120.841 -0.343 . . . . 0.0 110.762 -177.939 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' C' C ' 21' ' ' VAL . . . . . . . . . . . . . 45.3 t -64.8 -46.28 92.51 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.279 0 C-N-CA 120.753 -0.379 . . . . 0.0 110.498 -177.636 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' C' C ' 22' ' ' ILE . . . . . 0.597 HG22 HD12 ' C' ' 26' ' ' LEU . 50.3 mm -56.9 -39.98 68.76 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.333 0 C-N-CA 120.983 -0.287 . . . . 0.0 110.637 179.957 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' C' C ' 23' ' ' ARG . . . . . . . . . . . . . 45.1 ttp180 -57.26 -50.38 73.09 Favored 'General case' 0 C--N 1.331 -0.21 0 C-N-CA 120.673 -0.411 . . . . 0.0 110.386 177.194 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' C' C ' 24' ' ' ILE . . . . . . . . . . . . . 71.8 mt -60.44 -39.84 82.35 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.335 0 CA-C-N 115.995 -0.548 . . . . 0.0 111.827 -176.824 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' C' C ' 25' ' ' LYS . . . . . . . . . . . . . 14.9 pttp -77.11 -37.28 54.56 Favored 'General case' 0 CA--C 1.534 0.33 0 C-N-CA 120.592 -0.443 . . . . 0.0 111.938 -173.597 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' C' C ' 26' ' ' LEU . . . . . 0.597 HD12 HG22 ' C' ' 22' ' ' ILE . 49.0 mt -79.43 -32.42 42.82 Favored 'General case' 0 C--N 1.333 -0.146 0 N-CA-C 113.479 0.918 . . . . 0.0 113.479 -173.083 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' C' C ' 27' ' ' GLN . . . . . . . . . . . . . 17.7 pt20 -46.32 139.54 4.72 Favored 'General case' 0 N--CA 1.47 0.538 0 N-CA-C 112.922 0.712 . . . . 0.0 112.922 -174.839 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' C' C ' 28' ' ' GLY . . . . . . . . . . . . . . . 99.86 -26.66 23.58 Favored Glycine 0 CA--C 1.531 1.084 0 CA-C-N 115.697 -0.683 . . . . 0.0 112.255 -177.528 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' C' C ' 29' ' ' LYS . . . . . . . . . . . . . 94.0 mttt -97.09 155.09 16.96 Favored 'General case' 0 C--N 1.332 -0.193 0 CA-C-N 117.351 0.575 . . . . 0.0 110.854 178.237 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' C' C ' 30' ' ' THR . . . . . . . . . . . . . 28.5 m -107.27 138.13 44.02 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 116.104 -0.498 . . . . 0.0 110.104 177.072 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' C' C ' 31' ' ' VAL . . . . . . . . . . . . . 34.4 m -127.51 151.97 34.99 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.244 0 CA-C-N 116.242 -0.435 . . . . 0.0 110.571 -179.393 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' C' C ' 32' ' ' ARG . . . . . . . . . . . . . 67.0 ttt180 -132.74 149.83 52.23 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-O 121.179 0.514 . . . . 0.0 110.267 179.809 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' C' C ' 33' ' ' THR . . . . . . . . . . . . . 26.1 m -52.82 138.4 29.56 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.368 -0.378 . . . . 0.0 111.499 -177.394 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' C' C ' 34' ' ' GLY . . . . . . . . . . . . . . . 101.42 -17.21 55.81 Favored Glycine 0 CA--C 1.534 1.278 0 CA-C-O 119.651 -0.527 . . . . 0.0 113.17 179.444 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' C' C ' 35' ' ' ASP . . . . . . . . . . . . . 75.2 m-20 -66.56 148.34 52.03 Favored 'General case' 0 N--CA 1.461 0.111 0 CA-C-N 118.072 0.936 . . . . 0.0 111.224 178.869 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' C' C ' 36' ' ' VAL . . . . . . . . . . . . . 42.5 t -121.5 129.0 75.97 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.247 0 CA-C-N 115.88 -0.6 . . . . 0.0 109.809 177.638 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' C' C ' 37' ' ' ILE . . . . . . . . . . . . . 64.5 mt -120.92 138.15 52.32 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.244 0 CA-C-N 116.237 -0.438 . . . . 0.0 109.948 -179.811 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' C' C ' 38' ' ' GLY . . . . . . . . . . . . . . . -116.47 126.93 7.25 Favored Glycine 0 CA--C 1.524 0.645 0 N-CA-C 110.828 -0.909 . . . . 0.0 110.828 178.402 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' C' C ' 39' ' ' ILE . . . . . . . . . . . . . 72.1 mt -123.71 131.18 73.45 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.247 0 N-CA-C 110.136 -0.32 . . . . 0.0 110.136 179.395 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' C' C ' 40' ' ' SER . . . . . . . . . . . . . 54.4 p -91.33 117.51 29.72 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.43 -0.35 . . . . 0.0 110.823 177.615 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' C' C ' 41' ' ' ILE . . . . . . . . . . . . . 72.6 mt -134.4 127.51 50.47 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.197 0 N-CA-C 110.067 -0.346 . . . . 0.0 110.067 177.857 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' C' C ' 42' ' ' LEU . . . . . . . . . . . . . 9.5 tp 57.73 34.72 24.8 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.163 -0.471 . . . . 0.0 111.562 178.258 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' C' C ' 43' ' ' GLY . . . . . . . . . . . . . . . 77.42 -10.08 24.52 Favored Glycine 0 CA--C 1.534 1.261 0 C-N-CA 121.334 -0.46 . . . . 0.0 113.467 177.32 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' C' C ' 44' ' ' LYS . . . . . . . . . . . . . 95.0 mttt -104.65 134.26 48.12 Favored 'General case' 0 C--N 1.333 -0.11 0 CA-C-N 117.993 0.897 . . . . 0.0 110.361 178.357 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' C' C ' 45' ' ' GLU . . . . . . . . . . . . . 84.8 tt0 -85.85 128.68 34.88 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.337 -0.392 . . . . 0.0 110.866 178.275 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' C' C ' 46' ' ' VAL . . . . . 0.403 ' O ' HG13 ' C' ' 46' ' ' VAL . 9.7 p -115.38 124.57 72.05 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.167 0 N-CA-C 109.417 -0.586 . . . . 0.0 109.417 175.219 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' C' C ' 47' ' ' LYS . . . . . . . . . . . . . 98.5 mttt -98.96 122.91 42.84 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.021 -0.536 . . . . 0.0 110.673 178.562 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' C' C ' 48' ' ' PHE . . . . . . . . . . . . . 40.2 m-85 -109.78 131.86 54.68 Favored 'General case' 0 C--N 1.329 -0.283 0 N-CA-C 109.607 -0.516 . . . . 0.0 109.607 177.5 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' C' C ' 49' ' ' LYS . . . . . . . . . . . . . 48.5 tttp -108.12 133.64 52.11 Favored 'General case' 0 C--N 1.329 -0.285 0 N-CA-C 109.96 -0.385 . . . . 0.0 109.96 178.201 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' C' C ' 50' ' ' VAL . . . . . . . . . . . . . 44.5 t -74.91 107.04 5.1 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.322 0 N-CA-C 109.261 -0.644 . . . . 0.0 109.261 177.854 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' C' C ' 51' ' ' VAL . . . . . . . . . . . . . 46.4 t -71.14 -48.91 52.29 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.252 0 CA-C-N 116.155 -0.475 . . . . 0.0 109.731 -174.735 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' C' C ' 52' ' ' GLN . . . . . . . . . . . . . 50.3 tt0 -163.73 139.49 6.49 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 115.823 -0.626 . . . . 0.0 111.442 -178.859 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' C' C ' 53' ' ' ALA . . . . . . . . . . . . . . . -116.13 132.88 56.53 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-N 115.78 -0.646 . . . . 0.0 109.728 174.863 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' C' C ' 54' ' ' TYR . . . . . . . . . . . . . 46.8 t80 -129.02 111.88 18.48 Favored Pre-proline 0 CA--C 1.535 0.397 0 CA-C-O 118.22 -0.895 . . . . 0.0 110.395 179.455 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' C' C ' 55' ' ' PRO . . . . . . . . . . . . . 73.2 Cg_endo -77.27 169.04 75.18 Favored 'Cis proline' 0 N--CA 1.501 1.912 0 CA-C-N 121.897 1.713 . . . . 0.0 112.22 -6.949 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' C' C ' 56' ' ' SER . . . . . . . . . . . . . 15.4 m -116.84 137.21 23.57 Favored Pre-proline 0 CA--C 1.538 0.495 0 CA-C-O 118.552 -0.737 . . . . 0.0 109.667 175.477 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' C' C ' 57' ' ' PRO . . . . . . . . . . . . . 48.6 Cg_endo -70.38 145.67 81.44 Favored 'Cis proline' 0 N--CA 1.497 1.701 0 CA-C-N 121.683 1.637 . . . . 0.0 111.334 -3.955 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' C' C ' 58' ' ' LEU . . . . . . . . . . . . . 19.3 tp -106.89 135.91 47.64 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.469 -0.332 . . . . 0.0 110.659 -177.402 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' C' C ' 59' ' ' ARG . . . . . . . . . . . . . 28.6 ttm180 -100.97 126.77 47.65 Favored 'General case' 0 C--N 1.327 -0.409 0 N-CA-C 109.51 -0.552 . . . . 0.0 109.51 176.134 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' C' C ' 60' ' ' VAL . . . . . . . . . . . . . 43.3 t -76.01 116.4 18.96 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.249 0 C-N-CA 120.729 -0.388 . . . . 0.0 110.047 -177.202 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' C' C ' 61' ' ' GLU . . . . . . . . . . . . . 95.8 mt-10 -131.02 167.32 19.24 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 115.84 -0.618 . . . . 0.0 110.104 178.994 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' C' C ' 62' ' ' ASP . . . . . . . . . . . . . 12.1 p-10 -55.65 -32.47 63.22 Favored 'General case' 0 C--N 1.328 -0.351 0 N-CA-C 111.837 0.31 . . . . 0.0 111.837 -178.46 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' C' C ' 63' ' ' ARG . . . . . . . . . . . . . 40.4 ptt180 -82.52 0.52 42.17 Favored 'General case' 0 CA--C 1.537 0.463 0 N-CA-C 113.749 1.018 . . . . 0.0 113.749 -175.068 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' C' C ' 64' ' ' THR . . . . . . . . . . . . . 33.2 m -82.55 134.33 35.19 Favored 'General case' 0 C--N 1.333 -0.151 0 CA-C-N 118.159 0.436 . . . . 0.0 110.903 -176.258 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' C' C ' 65' ' ' LYS . . . . . . . . . . . . . 53.6 mtmt -89.26 127.35 35.76 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 115.935 -0.575 . . . . 0.0 109.879 177.017 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' C' C ' 66' ' ' ILE . . . . . . . . . . . . . 64.5 mt -111.82 126.6 69.23 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.314 0 N-CA-C 109.656 -0.498 . . . . 0.0 109.656 -179.115 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' C' C ' 67' ' ' THR . . . . . . . . . . . . . 23.5 m -124.49 144.69 49.96 Favored 'General case' 0 C--N 1.331 -0.229 0 CA-C-O 121.281 0.562 . . . . 0.0 111.227 -175.453 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' C' C ' 68' ' ' LEU . . . . . . . . . . . . . 20.6 tp -100.33 135.72 41.33 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 115.573 -0.74 . . . . 0.0 110.243 177.731 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' C' C ' 69' ' ' VAL . . . . . . . . . . . . . 46.0 t -82.94 134.31 27.19 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 N-CA-C 109.839 -0.43 . . . . 0.0 109.839 178.931 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' C' C ' 70' ' ' THR . . . . . . . . . . . . . 33.6 p -107.25 -175.96 2.94 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 116.11 -0.495 . . . . 0.0 110.964 -177.049 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' C' C ' 71' ' ' HIS . . . . . . . . . . . . . 84.7 m-70 -64.94 158.41 70.69 Favored Pre-proline 0 C--N 1.329 -0.296 0 CA-C-N 115.848 -0.615 . . . . 0.0 110.207 179.895 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' C' C ' 72' ' ' PRO . . . . . . . . . . . . . 32.1 Cg_endo -64.85 -20.14 64.45 Favored 'Trans proline' 0 N--CA 1.498 1.74 0 C-N-CA 121.241 1.294 . . . . 0.0 112.993 -178.622 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' C' C ' 73' ' ' VAL . . . . . . . . . . . . . 31.5 m -127.19 146.56 32.84 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.184 0 CA-C-O 121.077 0.465 . . . . 0.0 110.844 178.456 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' C' C ' 74' ' ' ASP . . . . . . . . . . . . . 26.0 t0 -98.47 122.07 41.2 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-N 115.571 -0.741 . . . . 0.0 109.411 177.19 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' C' C ' 75' ' ' VAL . . . . . 0.403 ' C ' HD12 ' C' ' 76' ' ' LEU . 44.3 t -114.09 123.78 70.09 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.226 0 CA-C-O 121.095 0.474 . . . . 0.0 110.742 -176.38 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' C' C ' 76' ' ' LEU . . . . . 0.403 HD12 ' C ' ' C' ' 75' ' ' VAL . 5.9 mp -124.93 144.8 50.16 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 115.669 -0.696 . . . . 0.0 109.696 175.288 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' C' C ' 77' ' ' GLU . . . . . . . . . . . . . 97.3 mt-10 -134.12 134.92 42.78 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-O 120.98 0.419 . . . . 0.0 111.141 -178.219 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' C' C ' 78' ' ' ALA . . . . . . . . . . . . . . . -120.19 135.44 54.98 Favored 'General case' 0 C--N 1.331 -0.219 0 CA-C-N 115.825 -0.625 . . . . 0.0 109.953 177.166 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' C' C ' 79' ' ' LYS . . . . . 0.606 ' O ' HD13 ' C' ' 80' ' ' ILE . 28.9 mtpp -84.0 117.1 23.17 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-O 120.81 0.338 . . . . 0.0 110.79 -177.91 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' C' C ' 80' ' ' ILE . . . . . 0.606 HD13 ' O ' ' C' ' 79' ' ' LYS . 41.6 mm -139.15 112.15 6.2 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.28 0 N-CA-C 109.355 -0.609 . . . . 0.0 109.355 -177.877 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' C' C ' 81' ' ' LYS . . . . . . . . . . . . . 49.6 pttt -98.72 125.96 44.19 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-O 120.969 0.414 . . . . 0.0 111.402 -177.922 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' C' C ' 82' ' ' GLY . . . . . . . . . . . . . . . 89.05 42.18 5.69 Favored Glycine 0 CA--C 1.526 0.73 0 C-N-CA 121.003 -0.618 . . . . 0.0 112.013 174.25 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' C' C ' 83' ' ' ILE . . . . . . . . . . . . . 72.7 mt -71.23 135.57 27.71 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.281 0 N-CA-C 109.326 -0.62 . . . . 0.0 109.326 176.038 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' C' C ' 84' ' ' LYS . . . . . . . . . . . . . 28.4 ttpp -102.68 -51.27 3.35 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-O 120.913 0.387 . . . . 0.0 110.597 -177.289 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' C' C ' 85' ' ' ASP . . . . . . . . . . . . . 8.5 t0 -143.69 144.07 31.7 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.008 -0.542 . . . . 0.0 110.545 -178.651 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' C' C ' 86' ' ' VAL . . . . . . . . . . . . . 42.9 t -125.91 131.19 72.1 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 CA-C-O 120.897 0.38 . . . . 0.0 110.24 179.742 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' C' C ' 87' ' ' ILE . . . . . 0.49 ' N ' HD12 ' C' ' 87' ' ' ILE . 5.1 mp -119.23 125.39 74.41 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.261 0 N-CA-C 109.573 -0.528 . . . . 0.0 109.573 176.808 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' C' C ' 88' ' ' LEU . . . . . . . . . . . . . 11.6 tp -115.91 131.35 56.96 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-O 120.992 0.425 . . . . 0.0 110.992 -177.159 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' C' C ' 89' ' ' ASP . . . . . . . . . . . . . 9.5 t70 -128.19 158.86 36.93 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-N 115.906 -0.588 . . . . 0.0 109.495 176.625 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' C' C ' 90' ' ' GLU . . . . . . . . . . . . . 83.7 tt0 -46.92 -38.81 11.12 Favored 'General case' 0 CA--C 1.531 0.217 0 N-CA-C 113.029 0.752 . . . . 0.0 113.029 -171.905 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' C' C ' 91' ' ' ASN . . . . . . . . . . . . . 30.5 t30 -132.09 26.36 4.56 Favored 'General case' 0 N--CA 1.467 0.416 0 N-CA-C 112.552 0.575 . . . . 0.0 112.552 -177.553 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' C' C ' 92' ' ' LEU . . . . . . . . . . . . . 9.2 mt -149.32 142.38 24.91 Favored 'General case' 0 C--N 1.331 -0.238 0 N-CA-C 109.98 -0.378 . . . . 0.0 109.98 -177.843 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' C' C ' 93' ' ' ILE . . . . . . . . . . . . . 75.3 mt -127.43 117.71 47.66 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.283 0 N-CA-C 109.38 -0.6 . . . . 0.0 109.38 177.256 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' C' C ' 94' ' ' VAL . . . . . 0.53 HG21 HG11 ' C' ' 125' ' ' VAL . 44.1 t -122.9 127.55 74.84 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.225 0 CA-C-O 120.959 0.409 . . . . 0.0 110.066 -179.229 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' C' C ' 95' ' ' VAL . . . . . . . . . . . . . 44.8 t -120.34 132.62 69.47 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.355 0 CA-C-N 115.886 -0.597 . . . . 0.0 109.688 -179.982 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' C' C ' 96' ' ' ILE . . . . . . . . . . . . . 66.3 mt -115.58 128.5 72.79 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.243 0 N-CA-C 109.218 -0.66 . . . . 0.0 109.218 178.789 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' C' C ' 97' ' ' THR . . . . . . . . . . . . . 67.6 p -101.53 160.46 14.42 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-O 121.144 0.497 . . . . 0.0 111.131 -176.949 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' C' C ' 98' ' ' GLU . . . . . . . . . . . . . 96.8 mt-10 -54.01 -26.6 27.14 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.117 -0.492 . . . . 0.0 112.284 -179.318 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' C' C ' 99' ' ' GLU . . . . . . . . . . . . . 71.0 mm-40 -79.18 15.65 1.13 Allowed 'General case' 0 CA--C 1.534 0.342 0 N-CA-C 113.183 0.808 . . . . 0.0 113.183 -177.549 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' C' C ' 100' ' ' ASN . . . . . . . . . . . . . 3.2 m-20 61.6 38.08 15.7 Favored 'General case' 0 N--CA 1.463 0.191 0 CA-C-O 121.14 0.495 . . . . 0.0 110.978 178.476 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' C' C ' 101' ' ' GLU . . . . . . . . . . . . . 84.6 tt0 -114.44 141.14 48.05 Favored 'General case' 0 C--N 1.332 -0.169 0 CA-C-N 116.108 -0.496 . . . . 0.0 109.762 176.306 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' C' C ' 102' ' ' VAL . . . . . . . . . . . . . 43.0 t -115.13 125.79 72.52 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.324 0 CA-C-N 116.17 -0.468 . . . . 0.0 109.894 -178.234 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' C' C ' 103' ' ' LEU . . . . . . . . . . . . . 34.9 mt -115.41 129.0 56.44 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 115.732 -0.667 . . . . 0.0 109.9 175.821 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' C' C ' 104' ' ' ILE . . . . . 0.609 HD13 HG11 ' C' ' 130' ' ' VAL . 65.1 mt -117.19 120.56 65.37 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.193 0 N-CA-C 110.261 -0.274 . . . . 0.0 110.261 -178.273 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' C' C ' 105' ' ' PHE . . . . . . . . . . . . . 56.9 m-85 -122.12 166.27 14.82 Favored 'General case' 0 C--N 1.333 -0.119 0 O-C-N 124.009 0.818 . . . . 0.0 109.722 178.931 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' C' C ' 106' ' ' ASN . . . . . . . . . . . . . 46.3 p-10 -101.07 -171.15 1.95 Allowed 'General case' 0 C--N 1.331 -0.203 0 N-CA-C 110.062 -0.347 . . . . 0.0 110.062 173.714 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' C' C ' 107' ' ' GLN . . . . . . . . . . . . . 46.2 tt0 -60.34 -26.97 66.98 Favored 'General case' 0 CA--C 1.533 0.31 0 N-CA-C 112.142 0.423 . . . . 0.0 112.142 179.494 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' C' C ' 108' ' ' ASN . . . . . . . . . . . . . 53.3 t30 -84.2 6.96 20.62 Favored 'General case' 0 CA--C 1.537 0.459 0 N-CA-C 113.159 0.8 . . . . 0.0 113.159 -178.343 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' C' C ' 109' ' ' LEU . . . . . . . . . . . . . 11.9 tp 61.64 36.86 16.42 Favored 'General case' 0 C--O 1.232 0.177 0 CA-C-O 120.932 0.396 . . . . 0.0 111.405 179.013 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' C' C ' 110' ' ' GLU . . . . . . . . . . . . . 95.7 mt-10 -108.01 153.46 23.06 Favored 'General case' 0 C--N 1.33 -0.262 0 N-CA-C 109.6 -0.519 . . . . 0.0 109.6 175.059 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' C' C ' 111' ' ' GLU . . . . . . . . . . . . . 55.8 tt0 -90.73 124.14 34.87 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-O 121.017 0.437 . . . . 0.0 111.146 -174.694 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' C' C ' 112' ' ' LEU . . . . . . . . . . . . . 25.6 mt -106.84 -46.07 4.04 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 115.87 -0.604 . . . . 0.0 110.914 179.787 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' C' C ' 113' ' ' TYR . . . . . 0.504 ' HB3' HD12 ' C' ' 104' ' ' ILE . 49.0 t80 -137.63 141.44 41.21 Favored 'General case' 0 C--N 1.331 -0.209 0 CA-C-N 116.319 -0.401 . . . . 0.0 110.802 -177.367 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' C' C ' 114' ' ' ARG . . . . . . . . . . . . . 36.7 ptt-85 -145.39 125.03 13.25 Favored 'General case' 0 C--N 1.331 -0.235 0 C-N-CA 120.94 -0.304 . . . . 0.0 110.825 178.002 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' C' C ' 115' ' ' GLY . . . . . . . . . . . . . . . -150.19 160.78 28.69 Favored Glycine 0 CA--C 1.525 0.666 0 C-N-CA 120.699 -0.762 . . . . 0.0 111.408 179.791 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' C' C ' 116' ' ' LYS . . . . . . . . . . . . . 36.7 ttpt -125.75 130.15 50.91 Favored 'General case' 0 C--N 1.331 -0.219 0 N-CA-C 109.412 -0.588 . . . . 0.0 109.412 174.344 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' C' C ' 117' ' ' PHE . . . . . . . . . . . . . 49.9 m-85 -130.56 114.64 15.72 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-O 120.958 0.409 . . . . 0.0 110.598 -174.215 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' C' C ' 118' ' ' GLU . . . . . . . . . . . . . 46.2 tp10 -52.88 -51.28 61.72 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.301 -0.409 . . . . 0.0 111.622 -176.086 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' C' C ' 119' ' ' ASN . . . . . . . . . . . . . 28.9 m120 -95.41 31.01 2.07 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.259 -0.428 . . . . 0.0 112.075 -174.103 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' C' C ' 120' ' ' LEU . . . . . . . . . . . . . 19.3 tp -54.94 122.54 11.09 Favored 'General case' 0 C--O 1.232 0.157 0 CA-C-O 120.729 0.299 . . . . 0.0 110.813 179.228 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' C' C ' 121' ' ' ASN . . . . . . . . . . . . . 17.3 m120 -103.26 -44.07 5.28 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.399 -0.364 . . . . 0.0 110.681 -177.316 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' C' C ' 122' ' ' LYS . . . . . . . . . . . . . 24.2 pttm -166.96 155.11 9.71 Favored 'General case' 0 C--N 1.331 -0.219 0 C-N-CA 120.572 -0.451 . . . . 0.0 111.843 -179.732 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' C' C ' 123' ' ' VAL . . . . . . . . . . . . . 43.0 t -123.33 135.26 63.82 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.284 0 CA-C-N 116.021 -0.536 . . . . 0.0 109.626 176.82 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' C' C ' 124' ' ' LEU . . . . . . . . . . . . . 31.5 mt -128.19 142.19 51.25 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-O 120.954 0.407 . . . . 0.0 110.977 -177.604 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' C' C ' 125' ' ' VAL . . . . . 0.53 HG11 HG21 ' C' ' 94' ' ' VAL . 35.9 m -133.48 141.18 45.07 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.293 0 CA-C-N 115.994 -0.548 . . . . 0.0 110.55 178.16 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' C' C ' 126' ' ' ARG . . . . . . . . . . . . . 19.6 ttm180 -162.86 127.61 3.1 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.122 -0.49 . . . . 0.0 109.72 178.196 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' C' C ' 127' ' ' ASN . . . . . . . . . . . . . 36.0 m120 56.4 -150.78 0.43 Allowed 'General case' 0 CA--C 1.541 0.627 0 N-CA-C 109.519 -0.548 . . . . 0.0 109.519 -176.494 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' C' C ' 128' ' ' ASP . . . . . . . . . . . . . 12.7 p-10 -82.35 16.32 2.1 Favored 'General case' 0 CA--C 1.535 0.393 0 CA-C-N 118.875 0.761 . . . . 0.0 112.762 178.725 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' C' C ' 129' ' ' LEU . . . . . . . . . . . . . 17.9 tp -107.22 133.31 51.98 Favored 'General case' 0 C--O 1.232 0.141 0 CA-C-N 118.084 0.402 . . . . 0.0 110.51 179.845 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' C' C ' 130' ' ' VAL . . . . . 0.609 HG11 HD13 ' C' ' 104' ' ' ILE . 45.2 t -121.71 133.25 68.72 Favored 'Isoleucine or valine' 0 C--N 1.333 -0.144 0 N-CA-C 109.374 -0.602 . . . . 0.0 109.374 177.787 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' C' C ' 131' ' ' VAL . . . . . 0.548 HG22 HD12 ' C' ' 140' ' ' LEU . 43.9 t -135.28 136.61 51.09 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.208 0 CA-C-O 121.084 0.468 . . . . 0.0 110.919 -177.904 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' C' C ' 132' ' ' ILE . . . . . . . . . . . . . 69.8 mt -116.69 128.91 73.94 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.292 0 CA-C-N 115.658 -0.701 . . . . 0.0 109.231 178.302 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' C' C ' 133' ' ' ILE . . . . . . . . . . . . . 42.1 mm -114.49 123.58 70.3 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.213 0 CA-C-O 120.741 0.305 . . . . 0.0 110.947 -175.239 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' C' C ' 134' ' ' ASP . . . . . . . . . . . . . 8.9 p-10 -135.31 146.65 48.68 Favored 'General case' 0 C--N 1.331 -0.2 0 N-CA-C 109.553 -0.536 . . . . 0.0 109.553 173.396 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' C' C ' 135' ' ' GLU . . . . . . . . . . . . . 85.4 tt0 -50.09 -26.17 4.18 Favored 'General case' 0 C--N 1.327 -0.405 0 N-CA-C 112.878 0.695 . . . . 0.0 112.878 -172.696 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' C' C ' 136' ' ' GLN . . . . . . . . . . . . . 96.1 mt-30 -85.18 -30.63 23.77 Favored 'General case' 0 C--O 1.234 0.278 0 N-CA-C 112.581 0.585 . . . . 0.0 112.581 -175.384 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' C' C ' 137' ' ' LYS . . . . . . . . . . . . . 19.8 pttp -168.19 170.14 10.41 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-O 121.513 0.673 . . . . 0.0 112.242 -173.29 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' C' C ' 138' ' ' LEU . . . . . 0.453 HD23 ' C ' ' C' ' 138' ' ' LEU . 7.4 tt -118.89 128.16 54.17 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 115.126 -0.943 . . . . 0.0 109.933 -179.9 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' C' C ' 139' ' ' THR . . . . . . . . . . . . . 39.1 m -109.03 126.11 52.78 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-N 116.246 -0.434 . . . . 0.0 110.09 178.63 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' C' C ' 140' ' ' LEU . . . . . 0.548 HD12 HG22 ' C' ' 131' ' ' VAL . 9.0 tp -112.77 123.4 50.22 Favored 'General case' 0 C--N 1.329 -0.303 0 N-CA-C 109.292 -0.633 . . . . 0.0 109.292 -178.588 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' C' C ' 141' ' ' ILE . . . . . . . . . . . . . 19.0 mt -121.9 125.53 73.33 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.29 0 CA-C-O 121.085 0.469 . . . . 0.0 110.303 -173.887 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' C' C ' 142' ' ' ARG . . . . . . . . . . . . . 23.2 mmm180 -109.44 129.33 55.55 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 115.459 -0.791 . . . . 0.0 109.93 179.13 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' C' C ' 143' ' ' THR . . . . . . . . . . . . . 26.9 p . . . . . 0 C--O 1.22 -0.493 0 CA-C-O 117.997 -1.002 . . . . 0.0 110.628 -179.465 . . . . . . . . 0 0 . 1 . 012 nuclear build full ' D' D ' -3' ' ' GLU . . . . . . . . . . . . . 95.7 mt-10 . . . . . 0 N--CA 1.489 1.514 0 N-CA-C 109.362 -0.607 . . . . 0.0 109.362 . . . . . . . . . 0 0 . 1 . 012 nuclear build full ' D' D ' -2' ' ' GLY . . . . . . . . . . . . . . . -82.71 144.77 23.29 Favored Glycine 0 CA--C 1.525 0.678 0 N-CA-C 111.041 -0.823 . . . . 0.0 111.041 179.872 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' D' D ' -1' ' ' VAL . . . . . . . . . . . . . 47.3 t -142.1 143.61 26.32 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.249 0 N-CA-C 110.039 -0.356 . . . . 0.0 110.039 179.731 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' D' D ' 0' ' ' ILE . . . . . . . . . . . . . 69.6 mt -99.83 130.61 48.67 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.258 0 N-CA-C 109.869 -0.419 . . . . 0.0 109.869 179.569 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' D' D ' 1' ' ' MET . . . . . . . . . . . . . 25.4 ptt? -80.32 136.52 36.43 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.319 -0.401 . . . . 0.0 110.659 -179.197 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' D' D ' 2' ' ' SER . . . . . . . . . . . . . 4.4 p -106.01 128.78 54.06 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-O 121.009 0.433 . . . . 0.0 110.374 178.704 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' D' D ' 3' ' ' GLU . . . . . . . . . . . . . 85.0 tt0 -141.12 139.65 34.0 Favored 'General case' 0 C--N 1.326 -0.424 0 CA-C-N 115.873 -0.603 . . . . 0.0 111.147 -177.957 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' D' D ' 4' ' ' LEU . . . . . . . . . . . . . 18.0 tp -123.68 125.61 45.09 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 115.936 -0.575 . . . . 0.0 110.084 176.956 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' D' D ' 5' ' ' LYS . . . . . . . . . . . . . 67.1 mttm -104.22 119.91 40.0 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.218 -0.446 . . . . 0.0 110.401 178.768 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' D' D ' 6' ' ' LEU . . . . . . . . . . . . . 59.1 mt -116.32 147.31 41.69 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 115.393 -0.821 . . . . 0.0 110.324 -178.241 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' D' D ' 7' ' ' LYS . . . . . . . . . . . . . 83.7 tttt -134.67 136.23 25.03 Favored Pre-proline 0 CA--C 1.535 0.372 0 CA-C-O 118.931 -0.557 . . . . 0.0 109.844 176.254 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' D' D ' 8' ' ' PRO . . . . . . . . . . . . . 90.2 Cg_endo -91.6 140.59 2.52 Favored 'Trans proline' 0 N--CA 1.488 1.195 0 C-N-CA 121.751 1.634 . . . . 0.0 111.506 177.323 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' D' D ' 9' ' ' LEU . . . . . . . . . . . . . 62.3 mt -75.55 -47.9 4.07 Favored Pre-proline 0 CA--C 1.534 0.355 0 CA-C-O 118.586 -0.721 . . . . 0.0 112.336 -178.525 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' D' D ' 10' ' ' PRO . . . . . . . . . . . . . 88.1 Cg_endo -80.01 154.92 22.81 Favored 'Trans proline' 0 N--CA 1.497 1.689 0 C-N-CA 121.224 1.282 . . . . 0.0 112.187 177.166 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' D' D ' 11' ' ' LYS . . . . . . . . . . . . . 55.0 tptt -85.97 100.0 11.83 Favored 'General case' 0 C--N 1.328 -0.329 0 N-CA-C 109.914 -0.402 . . . . 0.0 109.914 176.767 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' D' D ' 12' ' ' VAL . . . . . . . . . . . . . 12.2 p -141.17 146.14 24.04 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.346 0 CA-C-O 120.956 0.408 . . . . 0.0 110.819 -178.386 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' D' D ' 13' ' ' GLU . . . . . . . . . . . . . 95.6 mt-10 -93.57 114.86 27.31 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 115.99 -0.55 . . . . 0.0 109.76 176.324 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' D' D ' 14' ' ' LEU . . . . . . . . . . . . . 38.8 mt -87.75 151.96 50.8 Favored Pre-proline 0 C--N 1.329 -0.304 0 CA-C-N 116.442 -0.344 . . . . 0.0 110.718 -177.164 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' D' D ' 15' ' ' PRO . . . . . . . . . . . . . 33.7 Cg_exo -57.34 158.66 18.07 Favored 'Trans proline' 0 N--CA 1.496 1.62 0 C-N-CA 121.26 1.306 . . . . 0.0 111.809 179.511 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' D' D ' 16' ' ' PRO . . . . . . . . . . . . . 30.7 Cg_exo -59.31 -36.64 94.15 Favored 'Trans proline' 0 N--CA 1.497 1.701 0 C-N-CA 121.432 1.421 . . . . 0.0 112.845 -177.776 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' D' D ' 17' ' ' ASP . . . . . . . . . . . . . 22.0 p-10 -89.96 11.29 20.94 Favored 'General case' 0 CA--C 1.537 0.46 0 N-CA-C 113.139 0.792 . . . . 0.0 113.139 -177.939 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' D' D ' 18' ' ' PHE . . . . . . . . . . . . . 47.7 t80 -58.0 -42.97 86.34 Favored 'General case' 0 N--CA 1.457 -0.108 0 O-C-N 121.983 -0.448 . . . . 0.0 110.16 -178.451 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' D' D ' 19' ' ' VAL . . . . . . . . . . . . . 48.1 t -57.51 -42.48 81.06 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.326 0 CA-C-N 116.244 -0.435 . . . . 0.0 110.376 -179.067 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' D' D ' 20' ' ' ASP . . . . . . . . . . . . . 11.7 t70 -59.62 -42.8 93.48 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-O 120.756 0.313 . . . . 0.0 110.857 -177.802 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' D' D ' 21' ' ' VAL . . . . . . . . . . . . . 46.5 t -64.42 -47.6 88.74 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.303 0 C-N-CA 120.74 -0.384 . . . . 0.0 110.507 -177.999 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' D' D ' 22' ' ' ILE . . . . . 0.72 HG22 HD12 ' D' ' 26' ' ' LEU . 49.9 mm -58.53 -38.46 70.72 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.283 0 C-N-CA 120.904 -0.319 . . . . 0.0 110.734 -179.644 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' D' D ' 23' ' ' ARG . . . . . . . . . . . . . 55.1 ttp180 -56.62 -49.23 75.56 Favored 'General case' 0 C--N 1.331 -0.22 0 CA-C-O 120.837 0.351 . . . . 0.0 110.533 178.066 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' D' D ' 24' ' ' ILE . . . . . . . . . . . . . 74.5 mt -61.26 -43.45 96.53 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.272 0 CA-C-N 116.04 -0.527 . . . . 0.0 111.968 -177.883 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' D' D ' 25' ' ' LYS . . . . . . . . . . . . . 15.1 pttp -71.65 -36.59 70.75 Favored 'General case' 0 CA--C 1.533 0.315 0 C-N-CA 120.364 -0.534 . . . . 0.0 111.702 -173.621 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' D' D ' 26' ' ' LEU . . . . . 0.72 HD12 HG22 ' D' ' 22' ' ' ILE . 18.9 mt -78.16 -43.38 28.86 Favored 'General case' 0 C--N 1.332 -0.177 0 N-CA-C 112.735 0.643 . . . . 0.0 112.735 -173.558 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' D' D ' 27' ' ' GLN . . . . . . . . . . . . . 15.5 pt20 -47.58 137.86 8.62 Favored 'General case' 0 N--CA 1.468 0.472 0 N-CA-C 112.647 0.61 . . . . 0.0 112.647 -175.946 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' D' D ' 28' ' ' GLY . . . . . . . . . . . . . . . 100.17 -27.38 20.6 Favored Glycine 0 CA--C 1.534 1.231 0 CA-C-N 115.631 -0.713 . . . . 0.0 112.013 -176.35 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' D' D ' 29' ' ' LYS . . . . . . . . . . . . . 56.1 mttm -98.52 155.16 17.41 Favored 'General case' 0 C--O 1.233 0.215 0 CA-C-N 117.144 0.472 . . . . 0.0 110.979 179.267 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' D' D ' 30' ' ' THR . . . . . . . . . . . . . 39.5 m -106.38 139.46 40.83 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 116.13 -0.486 . . . . 0.0 110.03 175.668 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' D' D ' 31' ' ' VAL . . . . . . . . . . . . . 34.5 m -128.66 158.67 40.97 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.289 0 CA-C-N 116.305 -0.407 . . . . 0.0 110.847 -178.304 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' D' D ' 32' ' ' ARG . . . . . . . . . . . . . 59.7 mtm180 -135.5 149.48 49.52 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.048 -0.523 . . . . 0.0 110.587 178.415 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' D' D ' 33' ' ' THR . . . . . . . . . . . . . 25.6 m -53.67 139.88 30.94 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.346 -0.388 . . . . 0.0 111.323 -178.186 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' D' D ' 34' ' ' GLY . . . . . . . . . . . . . . . 100.47 -17.13 57.18 Favored Glycine 0 CA--C 1.533 1.185 0 CA-C-O 119.702 -0.499 . . . . 0.0 113.304 178.672 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' D' D ' 35' ' ' ASP . . . . . . . . . . . . . 79.9 m-20 -66.2 147.88 52.66 Favored 'General case' 0 C--O 1.232 0.143 0 CA-C-N 118.053 0.926 . . . . 0.0 111.14 178.931 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' D' D ' 36' ' ' VAL . . . . . . . . . . . . . 45.1 t -123.42 131.13 73.68 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.224 0 CA-C-N 116.007 -0.542 . . . . 0.0 109.908 178.111 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' D' D ' 37' ' ' ILE . . . . . . . . . . . . . 66.4 mt -122.36 139.69 48.52 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.268 0 CA-C-N 116.28 -0.418 . . . . 0.0 110.042 -178.454 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' D' D ' 38' ' ' GLY . . . . . . . . . . . . . . . -111.81 128.77 8.76 Favored Glycine 0 CA--C 1.526 0.759 0 N-CA-C 111.08 -0.808 . . . . 0.0 111.08 179.472 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' D' D ' 39' ' ' ILE . . . . . . . . . . . . . 71.2 mt -122.54 134.18 66.5 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.187 0 N-CA-C 110.077 -0.342 . . . . 0.0 110.077 179.071 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' D' D ' 40' ' ' SER . . . . . . . . . . . . . 35.0 t -93.58 124.32 37.49 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.412 -0.358 . . . . 0.0 111.009 176.6 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' D' D ' 41' ' ' ILE . . . . . . . . . . . . . 71.3 mt -129.22 118.41 46.13 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.171 0 CA-C-O 120.826 0.346 . . . . 0.0 110.371 177.954 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' D' D ' 42' ' ' LEU . . . . . . . . . . . . . 56.2 mt 51.94 35.96 17.2 Favored 'General case' 0 C--O 1.233 0.201 0 CA-C-N 116.182 -0.463 . . . . 0.0 111.882 176.107 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' D' D ' 43' ' ' GLY . . . . . . . . . . . . . . . 73.98 31.65 59.65 Favored Glycine 0 CA--C 1.53 0.988 0 C-N-CA 121.115 -0.564 . . . . 0.0 112.123 178.162 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' D' D ' 44' ' ' LYS . . . . . . . . . . . . . 53.4 tttm -137.21 128.28 27.66 Favored 'General case' 0 C--N 1.329 -0.316 0 N-CA-C 109.536 -0.542 . . . . 0.0 109.536 177.94 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' D' D ' 45' ' ' GLU . . . . . . . . . . . . . 84.4 tt0 -83.83 123.14 29.6 Favored 'General case' 0 C--N 1.329 -0.318 0 C-N-CA 120.748 -0.381 . . . . 0.0 111.244 -177.766 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' D' D ' 46' ' ' VAL . . . . . . . . . . . . . 7.5 p -121.06 127.2 75.88 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.226 0 N-CA-C 109.342 -0.614 . . . . 0.0 109.342 175.497 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' D' D ' 47' ' ' LYS . . . . . . . . . . . . . 97.9 mttt -100.83 130.28 46.82 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.121 -0.491 . . . . 0.0 111.486 179.702 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' D' D ' 48' ' ' PHE . . . . . . . . . . . . . 93.6 m-85 -114.13 131.84 56.28 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.11 -0.495 . . . . 0.0 109.72 176.1 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' D' D ' 49' ' ' LYS . . . . . . . . . . . . . 71.5 tttt -108.66 138.66 44.62 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.628 -0.26 . . . . 0.0 110.494 179.148 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' D' D ' 50' ' ' VAL . . . . . . . . . . . . . 45.4 t -81.55 109.87 16.27 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.259 0 N-CA-C 109.443 -0.577 . . . . 0.0 109.443 177.047 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' D' D ' 51' ' ' VAL . . . . . . . . . . . . . 47.6 t -73.92 -47.63 42.11 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.304 0 CA-C-N 116.131 -0.486 . . . . 0.0 110.11 -174.322 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' D' D ' 52' ' ' GLN . . . . . . . . . . . . . 49.5 tt0 -162.65 139.09 7.54 Favored 'General case' 0 C--N 1.331 -0.219 0 C-N-CA 120.21 -0.596 . . . . 0.0 111.731 -178.126 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' D' D ' 53' ' ' ALA . . . . . . . . . . . . . . . -110.09 130.77 55.48 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 115.573 -0.739 . . . . 0.0 109.49 173.764 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' D' D ' 54' ' ' TYR . . . . . . . . . . . . . 24.9 t80 -126.76 108.09 22.67 Favored Pre-proline 0 CA--C 1.534 0.353 0 CA-C-O 118.379 -0.819 . . . . 0.0 110.553 -177.669 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' D' D ' 55' ' ' PRO . . . . . . . . . . . . . 73.3 Cg_endo -77.17 170.02 72.66 Favored 'Cis proline' 0 N--CA 1.5 1.896 0 CA-C-N 121.747 1.66 . . . . 0.0 112.139 -6.248 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' D' D ' 56' ' ' SER . . . . . . . . . . . . . 20.3 m -110.56 128.35 25.49 Favored Pre-proline 0 CA--C 1.538 0.511 0 CA-C-O 118.435 -0.793 . . . . 0.0 109.674 176.441 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' D' D ' 57' ' ' PRO . . . . . . . . . . . . . 46.6 Cg_endo -70.21 165.44 77.92 Favored 'Cis proline' 0 N--CA 1.496 1.676 0 CA-C-N 121.932 1.726 . . . . 0.0 111.677 -0.455 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' D' D ' 58' ' ' LEU . . . . . . . . . . . . . 25.0 tp -129.92 135.99 48.97 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.441 -0.345 . . . . 0.0 110.538 -179.234 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' D' D ' 59' ' ' ARG . . . . . . . . . . . . . 76.3 ttt180 -105.31 134.37 48.53 Favored 'General case' 0 C--N 1.327 -0.388 0 N-CA-C 109.419 -0.586 . . . . 0.0 109.419 175.725 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' D' D ' 60' ' ' VAL . . . . . . . . . . . . . 43.9 t -88.58 123.07 40.75 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.275 0 C-N-CA 120.644 -0.423 . . . . 0.0 110.359 -177.062 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' D' D ' 61' ' ' GLU . . . . . . . . . . . . . 94.7 mt-10 -131.09 173.42 11.03 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.077 -0.51 . . . . 0.0 109.962 177.242 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' D' D ' 62' ' ' ASP . . . . . . . . . . . . . 75.9 m-20 -54.39 -32.81 57.95 Favored 'General case' 0 C--N 1.327 -0.376 0 C-N-CA 120.964 -0.294 . . . . 0.0 111.635 179.786 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' D' D ' 63' ' ' ARG . . . . . . . . . . . . . 26.4 ptt180 -87.41 5.25 39.74 Favored 'General case' 0 CA--C 1.537 0.476 0 N-CA-C 113.652 0.982 . . . . 0.0 113.652 -176.32 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' D' D ' 64' ' ' THR . . . . . . . . . . . . . 28.5 m -82.3 133.74 35.25 Favored 'General case' 0 C--N 1.331 -0.211 0 CA-C-N 118.027 0.376 . . . . 0.0 110.602 -178.724 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' D' D ' 65' ' ' LYS . . . . . . . . . . . . . 87.1 mttt -89.71 124.62 34.77 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 116.106 -0.497 . . . . 0.0 110.02 178.75 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' D' D ' 66' ' ' ILE . . . . . . . . . . . . . 58.8 mt -113.6 129.4 69.49 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.305 0 N-CA-C 109.68 -0.489 . . . . 0.0 109.68 179.329 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' D' D ' 67' ' ' THR . . . . . . . . . . . . . 24.4 m -127.82 138.55 52.75 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-O 121.063 0.458 . . . . 0.0 111.124 -177.672 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' D' D ' 68' ' ' LEU . . . . . 0.509 ' N ' HD12 ' D' ' 68' ' ' LEU . 7.0 mp -100.65 124.15 45.84 Favored 'General case' 0 C--N 1.331 -0.206 0 CA-C-N 115.927 -0.579 . . . . 0.0 109.908 176.217 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' D' D ' 69' ' ' VAL . . . . . . . . . . . . . 41.9 t -102.24 137.0 31.75 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.29 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.495 -176.729 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' D' D ' 70' ' ' THR . . . . . 0.432 HG23 ' N ' ' D' ' 71' ' ' HIS . 7.3 t -150.0 -40.57 0.14 Allowed 'General case' 0 C--N 1.331 -0.205 0 CA-C-N 116.148 -0.478 . . . . 0.0 110.966 178.847 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' D' D ' 71' ' ' HIS . . . . . 0.432 ' N ' HG23 ' D' ' 70' ' ' THR . 58.0 m-70 -148.66 86.44 5.82 Favored Pre-proline 0 CA--C 1.534 0.33 0 CA-C-N 116.478 -0.328 . . . . 0.0 110.605 -178.215 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' D' D ' 72' ' ' PRO . . . . . . . . . . . . . 91.1 Cg_endo -84.55 132.46 4.99 Favored 'Trans proline' 0 N--CA 1.495 1.565 0 C-N-CA 121.537 1.491 . . . . 0.0 113.382 -176.544 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' D' D ' 73' ' ' VAL . . . . . . . . . . . . . 26.9 m -138.99 170.8 15.68 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.265 0 CA-C-N 115.76 -0.655 . . . . 0.0 109.815 174.001 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' D' D ' 74' ' ' ASP . . . . . . . . . . . . . 30.3 t0 -104.21 117.22 33.7 Favored 'General case' 0 C--N 1.33 -0.274 0 N-CA-C 109.884 -0.413 . . . . 0.0 109.884 179.466 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' D' D ' 75' ' ' VAL . . . . . . . . . . . . . 46.7 t -119.63 126.15 75.04 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.281 0 CA-C-O 121.066 0.46 . . . . 0.0 110.817 -176.91 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' D' D ' 76' ' ' LEU . . . . . . . . . . . . . 5.5 mp -125.23 143.97 50.69 Favored 'General case' 0 C--N 1.332 -0.178 0 CA-C-N 115.71 -0.677 . . . . 0.0 109.787 175.388 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' D' D ' 77' ' ' GLU . . . . . . . . . . . . . 97.1 mt-10 -133.63 136.42 44.8 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-O 120.986 0.422 . . . . 0.0 111.074 -178.31 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' D' D ' 78' ' ' ALA . . . . . . . . . . . . . . . -124.31 132.85 53.58 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 115.883 -0.598 . . . . 0.0 109.919 176.953 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' D' D ' 79' ' ' LYS . . . . . 0.578 ' O ' HD13 ' D' ' 80' ' ' ILE . 59.5 mtpt -79.26 117.09 19.94 Favored 'General case' 0 C--N 1.331 -0.225 0 CA-C-N 116.312 -0.404 . . . . 0.0 110.644 -178.027 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' D' D ' 80' ' ' ILE . . . . . 0.578 HD13 ' O ' ' D' ' 79' ' ' LYS . 43.3 mm -139.16 112.16 6.2 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.322 0 N-CA-C 109.079 -0.711 . . . . 0.0 109.079 -177.426 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' D' D ' 81' ' ' LYS . . . . . . . . . . . . . 55.4 pttt -104.6 129.44 52.71 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-O 120.995 0.426 . . . . 0.0 111.65 -175.909 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' D' D ' 82' ' ' GLY . . . . . . . . . . . . . . . 89.12 42.11 5.68 Favored Glycine 0 CA--C 1.524 0.653 0 CA-C-N 115.835 -0.621 . . . . 0.0 111.701 174.478 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' D' D ' 83' ' ' ILE . . . . . . . . . . . . . 69.2 mt -73.21 136.87 24.55 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.27 0 N-CA-C 109.526 -0.546 . . . . 0.0 109.526 177.207 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' D' D ' 84' ' ' LYS . . . . . . . . . . . . . 39.7 ttpt -102.25 -48.42 4.2 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-O 120.849 0.357 . . . . 0.0 110.517 -178.348 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' D' D ' 85' ' ' ASP . . . . . . . . . . . . . 12.8 t70 -146.8 145.2 29.83 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.7 -179.33 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' D' D ' 86' ' ' VAL . . . . . . . . . . . . . 43.7 t -126.38 129.56 71.9 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.223 0 CA-C-N 116.325 -0.398 . . . . 0.0 110.204 179.855 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' D' D ' 87' ' ' ILE . . . . . 0.498 HD12 ' N ' ' D' ' 87' ' ' ILE . 5.0 mp -122.27 128.16 75.4 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.227 0 N-CA-C 109.865 -0.42 . . . . 0.0 109.865 177.689 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' D' D ' 88' ' ' LEU . . . . . . . . . . . . . 68.4 mt -112.01 136.18 51.68 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-O 121.011 0.434 . . . . 0.0 111.211 -178.814 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' D' D ' 89' ' ' ASP . . . . . . . . . . . . . 9.1 t70 -130.12 154.28 47.65 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 115.812 -0.631 . . . . 0.0 109.55 175.334 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' D' D ' 90' ' ' GLU . . . . . . . . . . . . . 96.2 mt-10 -48.92 -37.4 19.76 Favored 'General case' 0 C--N 1.329 -0.325 0 N-CA-C 112.773 0.657 . . . . 0.0 112.773 -172.207 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' D' D ' 91' ' ' ASN . . . . . . . . . . . . . 86.5 m-20 -132.03 33.39 3.92 Favored 'General case' 0 N--CA 1.465 0.297 0 N-CA-C 111.914 0.338 . . . . 0.0 111.914 -176.966 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' D' D ' 92' ' ' LEU . . . . . . . . . . . . . 7.4 tp -166.06 142.37 5.04 Favored 'General case' 0 C--N 1.332 -0.17 0 C-N-CA 120.952 -0.299 . . . . 0.0 110.635 -179.344 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' D' D ' 93' ' ' ILE . . . . . . . . . . . . . 73.8 mt -124.05 124.81 69.72 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.261 0 N-CA-C 109.479 -0.563 . . . . 0.0 109.479 178.605 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' D' D ' 94' ' ' VAL . . . . . . . . . . . . . 43.8 t -123.34 125.89 72.45 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.188 0 CA-C-O 120.972 0.415 . . . . 0.0 109.96 -179.798 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' D' D ' 95' ' ' VAL . . . . . . . . . . . . . 44.6 t -120.78 131.46 72.8 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.261 0 CA-C-N 115.964 -0.562 . . . . 0.0 109.643 179.31 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' D' D ' 96' ' ' ILE . . . . . . . . . . . . . 63.2 mt -115.72 128.04 73.11 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.256 0 N-CA-C 109.446 -0.575 . . . . 0.0 109.446 -179.282 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' D' D ' 97' ' ' THR . . . . . . . . . . . . . 70.7 p -100.9 159.15 15.44 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-O 121.152 0.501 . . . . 0.0 111.111 -177.307 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' D' D ' 98' ' ' GLU . . . . . . . . . . . . . 46.5 tp10 -53.9 -26.53 25.55 Favored 'General case' 0 C--N 1.327 -0.392 0 CA-C-N 116.079 -0.509 . . . . 0.0 112.098 179.751 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' D' D ' 99' ' ' GLU . . . . . . . . . . . . . 19.9 tp10 -79.72 16.76 1.04 Allowed 'General case' 0 CA--C 1.539 0.524 0 N-CA-C 112.777 0.658 . . . . 0.0 112.777 -175.998 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' D' D ' 100' ' ' ASN . . . . . . . . . . . . . 3.7 m-20 60.88 30.87 19.91 Favored 'General case' 0 CA--C 1.532 0.285 0 O-C-N 121.958 -0.464 . . . . 0.0 111.682 178.424 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' D' D ' 101' ' ' GLU . . . . . . . . . . . . . 84.7 tt0 -112.53 144.21 42.39 Favored 'General case' 0 C--N 1.332 -0.157 0 N-CA-C 109.548 -0.538 . . . . 0.0 109.548 175.045 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' D' D ' 102' ' ' VAL . . . . . . . . . . . . . 44.3 t -118.71 130.12 73.99 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.252 0 CA-C-O 120.954 0.407 . . . . 0.0 110.16 -176.587 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' D' D ' 103' ' ' LEU . . . . . . . . . . . . . 21.2 mt -113.01 129.65 56.42 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 115.435 -0.802 . . . . 0.0 109.989 176.359 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' D' D ' 104' ' ' ILE . . . . . . . . . . . . . 66.3 mt -115.46 120.14 63.85 Favored 'Isoleucine or valine' 0 C--O 1.234 0.248 0 N-CA-C 110.169 -0.308 . . . . 0.0 110.169 -179.604 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' D' D ' 105' ' ' PHE . . . . . . . . . . . . . 73.5 m-85 -123.83 167.08 14.55 Favored 'General case' 0 C--N 1.333 -0.117 0 O-C-N 123.876 0.735 . . . . 0.0 109.976 -179.736 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' D' D ' 106' ' ' ASN . . . . . . . . . . . . . 48.8 p-10 -102.97 -170.81 1.85 Allowed 'General case' 0 C--N 1.33 -0.256 0 N-CA-C 109.903 -0.406 . . . . 0.0 109.903 172.762 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' D' D ' 107' ' ' GLN . . . . . . . . . . . . . 42.9 tt0 -61.23 -29.25 69.72 Favored 'General case' 0 N--CA 1.464 0.249 0 N-CA-C 111.902 0.334 . . . . 0.0 111.902 -179.893 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' D' D ' 108' ' ' ASN . . . . . . . . . . . . . 4.2 t-20 -81.9 11.7 4.77 Favored 'General case' 0 CA--C 1.538 0.511 0 N-CA-C 112.771 0.656 . . . . 0.0 112.771 -179.498 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' D' D ' 109' ' ' LEU . . . . . . . . . . . . . 10.9 tp 54.58 36.72 26.56 Favored 'General case' 0 C--O 1.233 0.202 0 CA-C-O 120.982 0.42 . . . . 0.0 111.4 178.554 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' D' D ' 110' ' ' GLU . . . . . . . . . . . . . 95.3 mt-10 -103.02 143.22 32.86 Favored 'General case' 0 C--N 1.328 -0.328 0 N-CA-C 109.369 -0.604 . . . . 0.0 109.369 175.091 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' D' D ' 111' ' ' GLU . . . . . . . . . . . . . 73.7 tt0 -82.67 121.87 27.41 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-O 121.017 0.437 . . . . 0.0 110.296 -176.479 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' D' D ' 112' ' ' LEU . . . . . . . . . . . . . 45.9 mt -107.0 -45.96 4.03 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-N 115.86 -0.609 . . . . 0.0 110.65 -179.137 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' D' D ' 113' ' ' TYR . . . . . . . . . . . . . 55.3 t80 -135.23 138.53 43.65 Favored 'General case' 0 C--N 1.332 -0.188 0 CA-C-O 120.845 0.355 . . . . 0.0 111.278 -178.567 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' D' D ' 114' ' ' ARG . . . . . . . . . . . . . 70.1 ttt180 -136.13 123.81 22.41 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 115.914 -0.584 . . . . 0.0 110.077 177.67 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' D' D ' 115' ' ' GLY . . . . . . . . . . . . . . . -149.96 157.46 27.23 Favored Glycine 0 CA--C 1.523 0.591 0 N-CA-C 111.136 -0.786 . . . . 0.0 111.136 -179.91 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' D' D ' 116' ' ' LYS . . . . . . . . . . . . . 67.3 tttt -131.77 129.79 41.02 Favored 'General case' 0 C--N 1.328 -0.352 0 N-CA-C 109.734 -0.469 . . . . 0.0 109.734 178.846 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' D' D ' 117' ' ' PHE . . . . . . . . . . . . . 49.0 m-85 -125.17 114.23 18.72 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.289 -0.414 . . . . 0.0 110.184 -174.837 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' D' D ' 118' ' ' GLU . . . . . . . . . . . . . 48.7 mp0 -56.9 -46.14 82.12 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.344 -0.389 . . . . 0.0 110.851 -175.297 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' D' D ' 119' ' ' ASN . . . . . . . . . . . . . 23.9 m120 -97.36 31.1 2.6 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.099 -0.5 . . . . 0.0 112.109 -174.678 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' D' D ' 120' ' ' LEU . . . . . 0.473 ' C ' HD23 ' D' ' 120' ' ' LEU . 7.2 tt -54.91 120.1 6.37 Favored 'General case' 0 N--CA 1.462 0.148 0 CA-C-O 120.817 0.341 . . . . 0.0 110.598 178.337 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' D' D ' 121' ' ' ASN . . . . . . . . . . . . . 43.3 m-20 -105.11 -44.03 4.88 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 116.303 -0.408 . . . . 0.0 110.874 -176.731 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' D' D ' 122' ' ' LYS . . . . . . . . . . . . . 55.8 pttt -162.41 153.89 18.14 Favored 'General case' 0 C--N 1.331 -0.204 0 C-N-CA 120.427 -0.509 . . . . 0.0 112.028 -179.118 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' D' D ' 123' ' ' VAL . . . . . . . . . . . . . 42.0 t -125.81 136.49 60.67 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.248 0 CA-C-N 115.806 -0.633 . . . . 0.0 109.948 179.663 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' D' D ' 124' ' ' LEU . . . . . . . . . . . . . 48.4 mt -125.72 131.13 52.61 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.278 -0.419 . . . . 0.0 110.133 178.782 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' D' D ' 125' ' ' VAL . . . . . . . . . . . . . 13.5 p -134.88 134.06 53.7 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.259 0 CA-C-O 121.113 0.482 . . . . 0.0 110.809 179.616 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' D' D ' 126' ' ' ARG . . . . . . . . . . . . . 79.0 mtp180 -147.6 122.69 10.13 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 115.513 -0.767 . . . . 0.0 109.301 177.969 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' D' D ' 127' ' ' ASN . . . . . . . . . . . . . 1.5 t-20 57.03 -148.65 0.49 Allowed 'General case' 0 CA--C 1.542 0.643 0 N-CA-C 109.579 -0.526 . . . . 0.0 109.579 -178.371 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' D' D ' 128' ' ' ASP . . . . . . . . . . . . . 19.7 p-10 -81.44 12.99 3.23 Favored 'General case' 0 CA--C 1.538 0.488 0 N-CA-C 113.044 0.757 . . . . 0.0 113.044 178.507 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' D' D ' 129' ' ' LEU . . . . . . . . . . . . . 32.9 mt -107.41 133.0 52.57 Favored 'General case' 0 C--O 1.231 0.128 0 N-CA-C 109.542 -0.54 . . . . 0.0 109.542 178.545 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' D' D ' 130' ' ' VAL . . . . . 0.531 HG13 ' HB ' ' D' ' 141' ' ' ILE . 14.7 p -138.32 139.69 41.31 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.204 0 CA-C-O 121.273 0.559 . . . . 0.0 111.314 -179.758 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' D' D ' 131' ' ' VAL . . . . . . . . . . . . . 46.4 t -136.08 140.16 44.43 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.237 0 CA-C-N 115.784 -0.644 . . . . 0.0 110.271 179.446 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' D' D ' 132' ' ' ILE . . . . . . . . . . . . . 72.4 mt -116.78 133.99 61.73 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.263 0 CA-C-N 115.966 -0.561 . . . . 0.0 109.754 -179.717 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' D' D ' 133' ' ' ILE . . . . . . . . . . . . . 42.8 mm -114.25 123.64 70.11 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.222 0 CA-C-N 116.603 -0.271 . . . . 0.0 110.926 -176.434 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' D' D ' 134' ' ' ASP . . . . . . . . . . . . . 7.0 p-10 -135.21 147.95 49.49 Favored 'General case' 0 C--N 1.332 -0.16 0 N-CA-C 109.637 -0.505 . . . . 0.0 109.637 174.459 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' D' D ' 135' ' ' GLU . . . . . . . . . . . . . 84.9 tt0 -50.06 -28.2 6.74 Favored 'General case' 0 C--N 1.328 -0.355 0 N-CA-C 112.923 0.712 . . . . 0.0 112.923 -171.287 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' D' D ' 136' ' ' GLN . . . . . . . . . . . . . 97.2 mt-30 -83.26 -35.11 25.59 Favored 'General case' 0 C--O 1.234 0.253 0 N-CA-C 112.538 0.569 . . . . 0.0 112.538 -175.829 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' D' D ' 137' ' ' LYS . . . . . . . . . . . . . 24.8 pttm -163.36 172.07 15.14 Favored 'General case' 0 C--N 1.331 -0.217 0 CA-C-O 121.525 0.678 . . . . 0.0 112.413 -171.455 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' D' D ' 138' ' ' LEU . . . . . 0.407 ' C ' HD23 ' D' ' 138' ' ' LEU . 5.9 tt -117.36 127.6 54.21 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 114.938 -1.028 . . . . 0.0 109.748 178.512 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' D' D ' 139' ' ' THR . . . . . . . . . . . . . 36.9 m -107.64 125.76 51.74 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.207 -0.451 . . . . 0.0 110.187 -179.414 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' D' D ' 140' ' ' LEU . . . . . 0.541 HD21 ' NE ' ' D' ' 142' ' ' ARG . 6.1 tt -113.06 119.34 37.52 Favored 'General case' 0 C--N 1.327 -0.392 0 CA-C-N 115.824 -0.626 . . . . 0.0 109.651 -176.951 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' D' D ' 141' ' ' ILE . . . . . 0.531 ' HB ' HG13 ' D' ' 130' ' ' VAL . 22.2 mt -123.05 125.48 72.21 Favored 'Isoleucine or valine' 0 C--O 1.234 0.244 0 CA-C-O 121.033 0.444 . . . . 0.0 110.396 -175.03 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' D' D ' 142' ' ' ARG . . . . . 0.541 ' NE ' HD21 ' D' ' 140' ' ' LEU . 61.4 mmt-85 -121.96 129.33 52.41 Favored 'General case' 0 C--N 1.331 -0.203 0 CA-C-N 115.548 -0.751 . . . . 0.0 110.466 -178.62 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' D' D ' 143' ' ' THR . . . . . . . . . . . . . 41.1 p . . . . . 0 C--O 1.219 -0.55 0 CA-C-O 118.046 -0.978 . . . . 0.0 110.6 -179.874 . . . . . . . . 0 0 . 1 . 012 nuclear build full ' E' E ' -3' ' ' GLU . . . . . . . . . . . . . 12.8 pt-20 . . . . . 0 N--CA 1.49 1.574 0 N-CA-C 109.947 -0.39 . . . . 0.0 109.947 . . . . . . . . . 0 0 . 1 . 012 nuclear build full ' E' E ' -2' ' ' GLY . . . . . . . . . . . . . . . -82.59 127.53 8.01 Favored Glycine 0 CA--C 1.523 0.563 0 N-CA-C 110.856 -0.898 . . . . 0.0 110.856 178.787 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' E' E ' -1' ' ' VAL . . . . . . . . . . . . . 43.0 t -96.79 133.41 38.33 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.329 0 CA-C-O 120.818 0.342 . . . . 0.0 110.08 -179.942 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' E' E ' 0' ' ' ILE . . . . . . . . . . . . . 42.9 mm -111.35 132.41 59.97 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.204 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.087 -179.811 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' E' E ' 1' ' ' MET . . . . . . . . . . . . . 25.5 ptp -91.39 155.19 18.66 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.322 -0.399 . . . . 0.0 110.684 -179.637 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' E' E ' 2' ' ' SER . . . . . . . . . . . . . 2.4 p -122.48 128.95 51.49 Favored 'General case' 0 C--N 1.332 -0.178 0 CA-C-N 116.168 -0.469 . . . . 0.0 110.395 178.87 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' E' E ' 3' ' ' GLU . . . . . . . . . . . . . 84.8 tt0 -142.6 142.84 32.2 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.083 -0.508 . . . . 0.0 111.045 179.238 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' E' E ' 4' ' ' LEU . . . . . . . . . . . . . 21.4 tp -122.01 128.19 51.14 Favored 'General case' 0 C--N 1.331 -0.21 0 CA-C-N 115.875 -0.602 . . . . 0.0 110.183 177.918 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' E' E ' 5' ' ' LYS . . . . . . . . . . . . . 89.2 mttt -105.43 121.11 43.24 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.3 -0.409 . . . . 0.0 110.485 178.298 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' E' E ' 6' ' ' LEU . . . . . . . . . . . . . 29.6 mt -116.79 150.29 38.56 Favored 'General case' 0 C--N 1.332 -0.187 0 CA-C-N 115.289 -0.869 . . . . 0.0 110.735 -178.097 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' E' E ' 7' ' ' LYS . . . . . . . . . . . . . 23.7 ttmt -138.35 135.32 18.16 Favored Pre-proline 0 CA--C 1.535 0.392 0 CA-C-O 118.846 -0.597 . . . . 0.0 109.933 174.984 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' E' E ' 8' ' ' PRO . . . . . . . . . . . . . 93.1 Cg_endo -90.72 143.11 3.45 Favored 'Trans proline' 0 N--CA 1.492 1.43 0 C-N-CA 121.602 1.535 . . . . 0.0 111.837 178.394 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' E' E ' 9' ' ' LEU . . . . . . . . . . . . . 35.3 mt -78.14 -47.67 2.09 Favored Pre-proline 0 CA--C 1.533 0.307 0 CA-C-O 118.759 -0.638 . . . . 0.0 112.099 -179.179 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' E' E ' 10' ' ' PRO . . . . . . . . . . . . . 76.8 Cg_endo -82.31 145.38 13.48 Favored 'Trans proline' 0 N--CA 1.495 1.593 0 C-N-CA 121.235 1.29 . . . . 0.0 111.681 175.689 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' E' E ' 11' ' ' LYS . . . . . . . . . . . . . 53.3 pttt -85.27 114.72 22.57 Favored 'General case' 0 C--N 1.331 -0.214 0 CA-C-O 121.453 0.644 . . . . 0.0 110.326 177.426 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' E' E ' 12' ' ' VAL . . . . . . . . . . . . . 12.1 p -151.11 150.93 12.92 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.299 0 CA-C-N 115.732 -0.667 . . . . 0.0 110.83 -177.538 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' E' E ' 13' ' ' GLU . . . . . . . . . . . . . 14.6 mm-40 -86.93 122.38 30.72 Favored 'General case' 0 C--N 1.331 -0.239 0 N-CA-C 110.019 -0.363 . . . . 0.0 110.019 175.901 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' E' E ' 14' ' ' LEU . . . . . . . . . . . . . 46.3 mt -98.7 149.54 35.84 Favored Pre-proline 0 CA--C 1.533 0.308 0 CA-C-O 119.318 -0.372 . . . . 0.0 110.632 -178.533 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' E' E ' 15' ' ' PRO . . . . . . . . . . . . . 24.6 Cg_exo -62.94 161.7 28.46 Favored 'Trans proline' 0 N--CA 1.499 1.818 0 C-N-CA 121.297 1.331 . . . . 0.0 111.876 176.81 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' E' E ' 16' ' ' PRO . . . . . . . . . . . . . 25.8 Cg_exo -61.28 -37.46 73.09 Favored 'Trans proline' 0 N--CA 1.499 1.807 0 C-N-CA 121.546 1.498 . . . . 0.0 112.967 -177.719 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' E' E ' 17' ' ' ASP . . . . . . . . . . . . . 13.0 p-10 -89.34 8.2 31.81 Favored 'General case' 0 CA--C 1.536 0.406 0 N-CA-C 113.351 0.871 . . . . 0.0 113.351 -176.786 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' E' E ' 18' ' ' PHE . . . . . . . . . . . . . 42.7 t80 -58.18 -42.78 86.82 Favored 'General case' 0 C--N 1.334 -0.086 0 O-C-N 121.925 -0.485 . . . . 0.0 110.099 -178.267 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' E' E ' 19' ' ' VAL . . . . . . . . . . . . . 54.9 t -57.12 -43.09 80.8 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.352 0 CA-C-N 116.225 -0.443 . . . . 0.0 110.306 -179.678 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' E' E ' 20' ' ' ASP . . . . . . . . . . . . . 75.2 m-20 -59.83 -41.74 91.99 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-O 120.782 0.325 . . . . 0.0 110.928 -177.846 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' E' E ' 21' ' ' VAL . . . . . . . . . . . . . 44.7 t -63.81 -46.36 94.61 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 C-N-CA 120.79 -0.364 . . . . 0.0 110.328 -177.76 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' E' E ' 22' ' ' ILE . . . . . 0.62 HG22 HD12 ' E' ' 26' ' ' LEU . 49.7 mm -55.95 -47.0 80.6 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.275 0 C-N-CA 120.971 -0.292 . . . . 0.0 110.827 178.932 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' E' E ' 23' ' ' ARG . . . . . . . . . . . . . 55.5 ttp180 -54.8 -48.73 72.38 Favored 'General case' 0 C--N 1.33 -0.275 0 C-N-CA 120.982 -0.287 . . . . 0.0 111.461 -178.323 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' E' E ' 24' ' ' ILE . . . . . . . . . . . . . 81.2 mt -59.0 -44.68 91.72 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.332 0 C-N-CA 121.102 -0.239 . . . . 0.0 111.179 -177.035 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' E' E ' 25' ' ' LYS . . . . . . . . . . . . . 57.3 mttm -64.5 -40.07 94.97 Favored 'General case' 0 C--N 1.327 -0.406 0 N-CA-C 112.356 0.502 . . . . 0.0 112.356 -178.48 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' E' E ' 26' ' ' LEU . . . . . 0.62 HD12 HG22 ' E' ' 22' ' ' ILE . 47.2 mt -79.27 -40.65 29.98 Favored 'General case' 0 C--N 1.33 -0.271 0 N-CA-C 113.573 0.953 . . . . 0.0 113.573 -171.367 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' E' E ' 27' ' ' GLN . . . . . . . . . . . . . 14.3 pt20 -46.7 137.04 7.33 Favored 'General case' 0 N--CA 1.47 0.544 0 N-CA-C 112.75 0.648 . . . . 0.0 112.75 -174.591 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' E' E ' 28' ' ' GLY . . . . . . . . . . . . . . . 100.52 -25.86 26.73 Favored Glycine 0 CA--C 1.534 1.222 0 CA-C-N 115.531 -0.759 . . . . 0.0 112.252 -176.082 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' E' E ' 29' ' ' LYS . . . . . . . . . . . . . 62.2 mttp -97.94 155.22 17.19 Favored 'General case' 0 C--N 1.332 -0.175 0 CA-C-N 117.265 0.532 . . . . 0.0 111.148 179.073 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' E' E ' 30' ' ' THR . . . . . . . . . . . . . 34.4 m -105.2 140.79 37.82 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 115.78 -0.645 . . . . 0.0 110.075 176.184 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' E' E ' 31' ' ' VAL . . . . . . . . . . . . . 35.0 m -126.44 151.16 32.67 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.234 0 CA-C-O 121.004 0.43 . . . . 0.0 111.229 -177.791 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' E' E ' 32' ' ' ARG . . . . . . . . . . . . . 67.0 mtp85 -128.12 151.04 49.69 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 115.68 -0.691 . . . . 0.0 110.846 177.362 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' E' E ' 33' ' ' THR . . . . . . . . . . . . . 15.2 m -54.29 139.34 36.67 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 115.987 -0.552 . . . . 0.0 111.186 -178.817 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' E' E ' 34' ' ' GLY . . . . . . . . . . . . . . . 98.77 -17.16 58.68 Favored Glycine 0 CA--C 1.533 1.162 0 C-N-CA 121.019 -0.61 . . . . 0.0 113.306 178.27 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' E' E ' 35' ' ' ASP . . . . . . . . . . . . . 73.3 m-20 -63.88 149.86 46.16 Favored 'General case' 0 C--O 1.231 0.09 0 CA-C-N 118.081 0.941 . . . . 0.0 111.016 179.685 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' E' E ' 36' ' ' VAL . . . . . . . . . . . . . 44.6 t -124.08 130.16 73.89 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.217 0 CA-C-N 116.05 -0.523 . . . . 0.0 109.923 178.971 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' E' E ' 37' ' ' ILE . . . . . . . . . . . . . 62.6 mt -122.03 140.41 46.04 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.244 0 CA-C-N 116.378 -0.374 . . . . 0.0 110.069 -179.465 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' E' E ' 38' ' ' GLY . . . . . . . . . . . . . . . -114.06 128.84 8.44 Favored Glycine 0 CA--C 1.524 0.638 0 N-CA-C 111.086 -0.806 . . . . 0.0 111.086 178.766 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' E' E ' 39' ' ' ILE . . . . . . . . . . . . . 71.7 mt -122.59 135.87 61.25 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.217 0 N-CA-C 110.075 -0.343 . . . . 0.0 110.075 178.935 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' E' E ' 40' ' ' SER . . . . . . . . . . . . . 53.0 p -93.4 117.37 29.99 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.519 -0.31 . . . . 0.0 111.202 176.015 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' E' E ' 41' ' ' ILE . . . . . . . . . . . . . 44.4 mm -121.71 121.61 64.83 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.181 0 CA-C-N 116.469 -0.332 . . . . 0.0 110.118 178.176 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' E' E ' 42' ' ' LEU . . . . . . . . . . . . . 83.8 mt 52.53 33.66 13.87 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.43 -0.35 . . . . 0.0 111.853 177.41 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' E' E ' 43' ' ' GLY . . . . . . . . . . . . . . . 73.22 32.09 60.68 Favored Glycine 0 CA--C 1.529 0.915 0 C-N-CA 121.049 -0.596 . . . . 0.0 112.125 178.797 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' E' E ' 44' ' ' LYS . . . . . . . . . . . . . 80.2 tttt -138.72 130.37 27.61 Favored 'General case' 0 C--N 1.33 -0.257 0 N-CA-C 109.482 -0.562 . . . . 0.0 109.482 179.064 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' E' E ' 45' ' ' GLU . . . . . . . . . . . . . 82.0 tt0 -83.1 124.83 30.85 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-O 120.799 0.333 . . . . 0.0 111.248 -176.144 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' E' E ' 46' ' ' VAL . . . . . . . . . . . . . 7.3 p -122.09 128.11 75.48 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.175 0 N-CA-C 109.493 -0.558 . . . . 0.0 109.493 174.909 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' E' E ' 47' ' ' LYS . . . . . . . . . . . . . 94.6 mttt -100.27 129.56 46.29 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.035 -0.53 . . . . 0.0 111.38 179.099 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' E' E ' 48' ' ' PHE . . . . . . . . . . . . . 95.3 m-85 -113.27 132.01 55.7 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.088 -0.505 . . . . 0.0 109.826 175.383 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' E' E ' 49' ' ' LYS . . . . . . . . . . . . . 80.6 tttt -105.51 137.74 42.84 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.41 -0.359 . . . . 0.0 110.21 179.278 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' E' E ' 50' ' ' VAL . . . . . . . . . . . . . 42.1 t -78.06 107.3 9.8 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.332 0 N-CA-C 109.533 -0.543 . . . . 0.0 109.533 177.427 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' E' E ' 51' ' ' VAL . . . . . . . . . . . . . 52.1 t -71.54 -48.76 50.96 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.288 0 CA-C-N 116.082 -0.508 . . . . 0.0 109.882 -174.557 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' E' E ' 52' ' ' GLN . . . . . . . . . . . . . 62.5 tt0 -167.46 138.68 3.05 Favored 'General case' 0 C--N 1.331 -0.211 0 C-N-CA 120.323 -0.551 . . . . 0.0 111.682 -179.271 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' E' E ' 53' ' ' ALA . . . . . 0.52 ' HB1' ' HB2' ' E' ' 58' ' ' LEU . . . -107.19 130.82 54.67 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 115.669 -0.696 . . . . 0.0 109.642 175.098 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' E' E ' 54' ' ' TYR . . . . . . . . . . . . . 30.1 t80 -127.65 106.9 20.76 Favored Pre-proline 0 CA--C 1.534 0.348 0 CA-C-O 118.39 -0.814 . . . . 0.0 110.598 -177.975 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' E' E ' 55' ' ' PRO . . . . . . . . . . . . . 73.1 Cg_endo -77.19 170.07 72.49 Favored 'Cis proline' 0 N--CA 1.5 1.867 0 CA-C-N 121.725 1.652 . . . . 0.0 112.323 -5.726 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' E' E ' 56' ' ' SER . . . . . . . . . . . . . 16.3 m -111.39 129.99 23.52 Favored Pre-proline 0 CA--C 1.538 0.502 0 CA-C-O 118.414 -0.803 . . . . 0.0 109.48 175.272 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' E' E ' 57' ' ' PRO . . . . . . . . . . . . . 56.9 Cg_endo -72.36 147.7 89.56 Favored 'Cis proline' 0 N--CA 1.497 1.702 0 CA-C-N 121.956 1.734 . . . . 0.0 111.792 -0.918 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' E' E ' 58' ' ' LEU . . . . . 0.52 ' HB2' ' HB1' ' E' ' 53' ' ' ALA . 18.1 tp -108.08 136.6 47.49 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.32 -0.4 . . . . 0.0 110.534 -179.203 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' E' E ' 59' ' ' ARG . . . . . . . . . . . . . 32.2 ttm180 -106.1 130.02 54.08 Favored 'General case' 0 C--N 1.328 -0.329 0 N-CA-C 109.565 -0.532 . . . . 0.0 109.565 176.35 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' E' E ' 60' ' ' VAL . . . . . . . . . . . . . 40.4 t -86.71 123.0 39.47 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.219 0 C-N-CA 120.544 -0.463 . . . . 0.0 110.487 -176.904 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' E' E ' 61' ' ' GLU . . . . . . . . . . . . . 95.0 mt-10 -131.01 170.79 14.01 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 115.895 -0.593 . . . . 0.0 109.909 177.727 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' E' E ' 62' ' ' ASP . . . . . . . . . . . . . 60.3 m-20 -55.0 -33.63 62.73 Favored 'General case' 0 C--N 1.328 -0.361 0 N-CA-C 111.827 0.306 . . . . 0.0 111.827 -177.627 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' E' E ' 63' ' ' ARG . . . . . . . . . . . . . 40.0 ptt180 -89.55 5.28 46.25 Favored 'General case' 0 CA--C 1.536 0.438 0 N-CA-C 113.818 1.044 . . . . 0.0 113.818 -175.496 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' E' E ' 64' ' ' THR . . . . . . . . . . . . . 31.4 m -76.27 139.85 41.3 Favored 'General case' 0 C--N 1.332 -0.184 0 CA-C-O 120.851 0.358 . . . . 0.0 110.859 -177.874 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' E' E ' 65' ' ' LYS . . . . . . . . . . . . . 99.6 mttt -88.32 129.4 35.4 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.05 -0.523 . . . . 0.0 110.192 178.601 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' E' E ' 66' ' ' ILE . . . . . . . . . . . . . 57.7 mt -114.04 127.34 71.49 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.312 0 N-CA-C 109.728 -0.471 . . . . 0.0 109.728 -179.705 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' E' E ' 67' ' ' THR . . . . . . . . . . . . . 26.9 m -128.26 139.11 52.61 Favored 'General case' 0 C--N 1.331 -0.221 0 CA-C-O 121.063 0.459 . . . . 0.0 111.001 -177.426 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' E' E ' 68' ' ' LEU . . . . . 0.475 HD12 ' N ' ' E' ' 68' ' ' LEU . 7.7 mp -106.0 136.71 45.18 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 115.922 -0.581 . . . . 0.0 110.28 176.778 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' E' E ' 69' ' ' VAL . . . . . . . . . . . . . 39.2 t -90.41 131.76 36.79 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.371 0 N-CA-C 109.932 -0.396 . . . . 0.0 109.932 178.731 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' E' E ' 70' ' ' THR . . . . . . . . . . . . . 80.4 p -105.98 178.06 4.67 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.163 -0.471 . . . . 0.0 110.532 -179.01 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' E' E ' 71' ' ' HIS . . . . . . . . . . . . . 34.9 t60 -64.99 130.9 95.05 Favored Pre-proline 0 CA--C 1.535 0.396 0 CA-C-O 118.827 -0.606 . . . . 0.0 109.978 -178.53 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' E' E ' 72' ' ' PRO . . . . . . . . . . . . . 96.3 Cg_endo -91.04 159.03 3.91 Favored 'Trans proline' 0 N--CA 1.49 1.284 0 C-N-CA 121.69 1.593 . . . . 0.0 112.26 -179.434 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' E' E ' 73' ' ' VAL . . . . . . . . . . . . . 32.8 m -70.02 168.6 1.58 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.318 0 CA-C-N 116.136 -0.484 . . . . 0.0 110.421 178.862 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' E' E ' 74' ' ' ASP . . . . . . . . . . . . . 46.8 t0 -92.29 118.82 31.28 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.161 -0.472 . . . . 0.0 109.925 -179.615 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' E' E ' 75' ' ' VAL . . . . . . . . . . . . . 38.9 t -119.35 121.22 65.94 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.208 0 CA-C-O 120.988 0.423 . . . . 0.0 110.373 -179.756 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' E' E ' 76' ' ' LEU . . . . . . . . . . . . . 5.1 mp -122.26 146.41 47.31 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 115.851 -0.613 . . . . 0.0 109.752 176.527 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' E' E ' 77' ' ' GLU . . . . . . . . . . . . . 97.9 mt-10 -135.8 133.39 37.83 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-O 121.021 0.439 . . . . 0.0 111.125 -179.208 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' E' E ' 78' ' ' ALA . . . . . 0.632 ' HB2' HD21 ' E' ' 109' ' ' LEU . . . -121.81 133.28 54.9 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 115.729 -0.669 . . . . 0.0 109.727 176.364 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' E' E ' 79' ' ' LYS . . . . . 0.607 ' O ' HD13 ' E' ' 80' ' ' ILE . 49.1 tptt -80.01 118.04 21.39 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-O 120.899 0.38 . . . . 0.0 110.477 -177.3 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' E' E ' 80' ' ' ILE . . . . . 0.607 HD13 ' O ' ' E' ' 79' ' ' LYS . 41.2 mm -139.17 109.25 4.18 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.288 0 N-CA-C 109.235 -0.654 . . . . 0.0 109.235 -177.369 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' E' E ' 81' ' ' LYS . . . . . . . . . . . . . 57.5 pttt -102.23 127.31 49.24 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-O 120.938 0.399 . . . . 0.0 111.493 -177.283 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' E' E ' 82' ' ' GLY . . . . . . . . . . . . . . . 89.09 42.09 5.7 Favored Glycine 0 CA--C 1.526 0.735 0 C-N-CA 120.637 -0.792 . . . . 0.0 111.78 173.852 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' E' E ' 83' ' ' ILE . . . . . . . . . . . . . 74.0 mt -68.28 138.61 22.19 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.28 0 N-CA-C 109.932 -0.396 . . . . 0.0 109.932 178.203 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' E' E ' 84' ' ' LYS . . . . . . . . . . . . . 23.5 ttmt -95.92 -53.58 3.63 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.09 -0.505 . . . . 0.0 110.306 -179.721 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' E' E ' 85' ' ' ASP . . . . . . . . . . . . . 12.4 t70 -154.49 157.67 38.73 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 115.724 -0.671 . . . . 0.0 110.33 -178.401 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' E' E ' 86' ' ' VAL . . . . . . . . . . . . . 42.0 t -137.02 136.13 47.63 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.307 0 CA-C-O 120.939 0.4 . . . . 0.0 110.67 -178.172 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' E' E ' 87' ' ' ILE . . . . . 0.487 ' N ' HD12 ' E' ' 87' ' ' ILE . 5.1 mp -119.78 127.58 75.88 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 CA-C-N 115.774 -0.648 . . . . 0.0 109.42 176.608 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' E' E ' 88' ' ' LEU . . . . . . . . . . . . . 18.8 tp -115.69 136.41 53.09 Favored 'General case' 0 C--N 1.332 -0.192 0 CA-C-O 121.02 0.438 . . . . 0.0 111.406 -177.0 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' E' E ' 89' ' ' ASP . . . . . . . . . . . . . 42.0 t0 -134.87 160.75 37.26 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 115.777 -0.647 . . . . 0.0 109.729 176.532 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' E' E ' 90' ' ' GLU . . . . . . . . . . . . . 96.3 mt-10 -47.65 -37.6 13.15 Favored 'General case' 0 N--CA 1.463 0.179 0 N-CA-C 113.064 0.764 . . . . 0.0 113.064 -171.82 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' E' E ' 91' ' ' ASN . . . . . . . . . . . . . 5.2 p30 -132.06 23.89 4.56 Favored 'General case' 0 N--CA 1.469 0.483 0 N-CA-C 112.79 0.663 . . . . 0.0 112.79 -176.833 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' E' E ' 92' ' ' LEU . . . . . . . . . . . . . 44.5 mt -148.39 141.2 24.66 Favored 'General case' 0 C--N 1.331 -0.225 0 CA-C-O 120.823 0.344 . . . . 0.0 110.589 -178.556 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' E' E ' 93' ' ' ILE . . . . . . . . . . . . . 72.1 mt -123.7 114.27 40.79 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.362 0 N-CA-C 109.098 -0.705 . . . . 0.0 109.098 176.288 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' E' E ' 94' ' ' VAL . . . . . . . . . . . . . 43.7 t -116.55 127.02 74.28 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.236 0 N-CA-C 109.823 -0.436 . . . . 0.0 109.823 -178.741 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' E' E ' 95' ' ' VAL . . . . . . . . . . . . . 43.9 t -123.21 135.02 64.55 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 CA-C-N 116.217 -0.447 . . . . 0.0 109.934 -179.059 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' E' E ' 96' ' ' ILE . . . . . . . . . . . . . 65.2 mt -115.31 127.4 72.9 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.351 0 N-CA-C 109.391 -0.596 . . . . 0.0 109.391 178.506 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' E' E ' 97' ' ' THR . . . . . . . . . . . . . 66.7 p -101.8 157.29 16.95 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-O 121.05 0.452 . . . . 0.0 111.077 -177.852 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' E' E ' 98' ' ' GLU . . . . . . . . . . . . . 12.8 pt-20 -55.63 -21.7 19.1 Favored 'General case' 0 CA--C 1.533 0.314 0 N-CA-C 112.669 0.618 . . . . 0.0 112.669 -179.42 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' E' E ' 99' ' ' GLU . . . . . . . . . . . . . 48.4 mp0 -78.74 14.29 1.38 Allowed 'General case' 0 CA--C 1.537 0.463 0 N-CA-C 113.04 0.755 . . . . 0.0 113.04 -179.68 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' E' E ' 100' ' ' ASN . . . . . . . . . . . . . 3.0 m-20 62.76 37.88 12.2 Favored 'General case' 0 C--O 1.233 0.201 0 CA-C-O 121.068 0.461 . . . . 0.0 110.949 178.24 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' E' E ' 101' ' ' GLU . . . . . . . . . . . . . 84.9 tt0 -118.99 141.69 48.45 Favored 'General case' 0 C--N 1.332 -0.164 0 CA-C-N 116.014 -0.539 . . . . 0.0 109.895 177.223 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' E' E ' 102' ' ' VAL . . . . . . . . . . . . . 46.5 t -114.93 127.47 72.46 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.293 0 CA-C-N 116.324 -0.398 . . . . 0.0 110.041 -178.68 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' E' E ' 103' ' ' LEU . . . . . . . . . . . . . 25.7 mt -117.08 132.54 56.66 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 115.561 -0.745 . . . . 0.0 110.503 177.82 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' E' E ' 104' ' ' ILE . . . . . 0.434 HD13 HG11 ' E' ' 130' ' ' VAL . 65.9 mt -119.53 122.16 68.17 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.237 0 N-CA-C 110.22 -0.289 . . . . 0.0 110.22 178.782 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' E' E ' 105' ' ' PHE . . . . . . . . . . . . . 47.2 m-85 -122.26 162.3 21.71 Favored 'General case' 0 C--N 1.333 -0.146 0 O-C-N 124.005 0.815 . . . . 0.0 109.981 177.748 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' E' E ' 106' ' ' ASN . . . . . . . . . . . . . 41.4 p-10 -97.03 -169.93 1.95 Allowed 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.606 -0.27 . . . . 0.0 110.499 175.554 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' E' E ' 107' ' ' GLN . . . . . . . . . . . . . 46.4 tt0 -56.15 -30.2 61.83 Favored 'General case' 0 CA--C 1.531 0.247 0 N-CA-C 112.05 0.389 . . . . 0.0 112.05 -179.516 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' E' E ' 108' ' ' ASN . . . . . . . . . . . . . 30.6 t30 -90.79 12.9 17.82 Favored 'General case' 0 CA--C 1.535 0.373 0 N-CA-C 113.41 0.893 . . . . 0.0 113.41 -175.356 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' E' E ' 109' ' ' LEU . . . . . 0.632 HD21 ' HB2' ' E' ' 78' ' ' ALA . 11.3 tp 58.8 38.92 24.61 Favored 'General case' 0 C--N 1.331 -0.212 0 CA-C-O 121.168 0.508 . . . . 0.0 111.103 178.552 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' E' E ' 110' ' ' GLU . . . . . . . . . . . . . 96.0 mt-10 -102.64 151.93 21.78 Favored 'General case' 0 C--N 1.329 -0.292 0 N-CA-C 109.788 -0.449 . . . . 0.0 109.788 175.419 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' E' E ' 111' ' ' GLU . . . . . . . . . . . . . 85.1 tt0 -81.68 121.98 27.05 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-O 120.922 0.391 . . . . 0.0 110.507 -178.872 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' E' E ' 112' ' ' LEU . . . . . . . . . . . . . 17.5 mt -110.04 -45.98 3.53 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 115.962 -0.563 . . . . 0.0 110.518 179.185 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' E' E ' 113' ' ' TYR . . . . . . . . . . . . . 58.7 t80 -140.72 136.87 33.02 Favored 'General case' 0 C--N 1.331 -0.227 0 C-N-CA 120.771 -0.372 . . . . 0.0 111.398 -179.06 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' E' E ' 114' ' ' ARG . . . . . . . . . . . . . 22.0 ttm180 -135.69 124.77 24.36 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 115.958 -0.564 . . . . 0.0 109.721 174.979 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' E' E ' 115' ' ' GLY . . . . . . . . . . . . . . . -149.38 148.79 20.48 Favored Glycine 0 CA--C 1.525 0.701 0 N-CA-C 111.12 -0.792 . . . . 0.0 111.12 178.758 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' E' E ' 116' ' ' LYS . . . . . . . . . . . . . 40.3 ttpt -119.86 136.85 54.33 Favored 'General case' 0 C--N 1.33 -0.266 0 N-CA-C 110.096 -0.335 . . . . 0.0 110.096 179.172 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' E' E ' 117' ' ' PHE . . . . . . . . . . . . . 46.1 m-85 -134.49 116.11 14.72 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-N 116.302 -0.408 . . . . 0.0 110.229 -177.148 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' E' E ' 118' ' ' GLU . . . . . . . . . . . . . 84.8 tt0 -53.64 -45.07 70.07 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 116.597 -0.274 . . . . 0.0 111.515 -177.252 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' E' E ' 119' ' ' ASN . . . . . . . . . . . . . 4.2 m-80 -99.27 31.12 3.2 Favored 'General case' 0 C--N 1.33 -0.263 0 N-CA-C 112.156 0.428 . . . . 0.0 112.156 -175.225 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' E' E ' 120' ' ' LEU . . . . . . . . . . . . . 15.0 tp -55.22 120.69 7.42 Favored 'General case' 0 C--N 1.333 -0.151 0 O-C-N 122.308 -0.245 . . . . 0.0 110.694 178.465 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' E' E ' 121' ' ' ASN . . . . . . . . . . . . . 72.1 m-20 -108.82 -44.05 4.1 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.478 -0.328 . . . . 0.0 111.084 -176.728 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' E' E ' 122' ' ' LYS . . . . . . . . . . . . . 57.2 pttt -162.4 160.21 26.14 Favored 'General case' 0 CA--C 1.529 0.143 0 C-N-CA 120.43 -0.508 . . . . 0.0 112.064 -178.59 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' E' E ' 123' ' ' VAL . . . . . . . . . . . . . 42.1 t -129.08 137.87 55.99 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.201 0 CA-C-N 115.947 -0.57 . . . . 0.0 109.86 179.011 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' E' E ' 124' ' ' LEU . . . . . . . . . . . . . 80.9 mt -124.94 140.35 53.0 Favored 'General case' 0 C--N 1.332 -0.189 0 CA-C-O 120.87 0.367 . . . . 0.0 110.794 -179.007 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' E' E ' 125' ' ' VAL . . . . . . . . . . . . . 46.5 t -127.55 133.95 66.66 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.234 0 CA-C-N 116.105 -0.498 . . . . 0.0 109.822 178.118 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' E' E ' 126' ' ' ARG . . . . . . . . . . . . . 49.3 ttt85 -138.57 113.76 9.43 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-O 120.884 0.374 . . . . 0.0 110.28 -179.647 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' E' E ' 127' ' ' ASN . . . . . . . . . . . . . 12.1 m120 53.04 -104.82 0.21 Allowed 'General case' 0 CA--C 1.543 0.68 0 CA-C-O 119.2 -0.429 . . . . 0.0 111.196 179.513 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' E' E ' 128' ' ' ASP . . . . . . . . . . . . . 13.5 p-10 -113.57 0.78 14.76 Favored 'General case' 0 N--CA 1.467 0.422 0 CA-C-N 119.447 1.021 . . . . 0.0 113.549 -176.108 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' E' E ' 129' ' ' LEU . . . . . . . . . . . . . 71.4 mt -108.18 147.36 31.43 Favored 'General case' 0 C--N 1.332 -0.174 0 O-C-N 121.952 -0.467 . . . . 0.0 110.061 179.454 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' E' E ' 130' ' ' VAL . . . . . 0.469 HG13 ' HB ' ' E' ' 141' ' ' ILE . 12.4 p -129.42 140.05 50.15 Favored 'Isoleucine or valine' 0 C--O 1.233 0.22 0 CA-C-O 120.981 0.42 . . . . 0.0 110.595 -178.831 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' E' E ' 131' ' ' VAL . . . . . 0.589 HG22 HD12 ' E' ' 140' ' ' LEU . 40.7 t -135.94 139.28 46.25 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.25 0 CA-C-N 115.953 -0.567 . . . . 0.0 110.425 -178.506 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' E' E ' 132' ' ' ILE . . . . . . . . . . . . . 73.2 mt -114.09 133.51 59.88 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 N-CA-C 109.406 -0.59 . . . . 0.0 109.406 178.838 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' E' E ' 133' ' ' ILE . . . . . . . . . . . . . 43.3 mm -115.34 123.3 70.75 Favored 'Isoleucine or valine' 0 C--O 1.234 0.251 0 CA-C-O 120.936 0.398 . . . . 0.0 111.113 -174.36 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' E' E ' 134' ' ' ASP . . . . . . . . . . . . . 9.5 p-10 -136.18 147.41 47.66 Favored 'General case' 0 C--N 1.331 -0.224 0 N-CA-C 109.337 -0.616 . . . . 0.0 109.337 173.666 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' E' E ' 135' ' ' GLU . . . . . . . . . . . . . 43.3 tp10 -51.33 -28.06 11.28 Favored 'General case' 0 C--N 1.327 -0.408 0 N-CA-C 112.641 0.608 . . . . 0.0 112.641 -172.893 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' E' E ' 136' ' ' GLN . . . . . . . . . . . . . 97.6 mt-30 -80.48 -31.62 37.28 Favored 'General case' 0 C--N 1.33 -0.239 0 N-CA-C 112.629 0.603 . . . . 0.0 112.629 -176.63 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' E' E ' 137' ' ' LYS . . . . . . . . . . . . . 17.6 ptpt -170.08 175.26 5.1 Favored 'General case' 0 C--N 1.331 -0.227 0 CA-C-O 121.526 0.679 . . . . 0.0 112.374 -171.669 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' E' E ' 138' ' ' LEU . . . . . 0.417 ' C ' HD23 ' E' ' 138' ' ' LEU . 7.8 tt -123.16 130.16 52.39 Favored 'General case' 0 C--N 1.331 -0.199 0 CA-C-N 115.145 -0.934 . . . . 0.0 110.23 -179.524 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' E' E ' 139' ' ' THR . . . . . . . . . . . . . 35.1 m -107.26 125.88 51.71 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.245 -0.434 . . . . 0.0 110.442 179.518 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' E' E ' 140' ' ' LEU . . . . . 0.589 HD12 HG22 ' E' ' 131' ' ' VAL . 19.0 tp -113.84 121.37 43.81 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 115.788 -0.642 . . . . 0.0 109.555 -177.594 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' E' E ' 141' ' ' ILE . . . . . 0.469 ' HB ' HG13 ' E' ' 130' ' ' VAL . 19.3 mt -122.01 119.9 59.89 Favored 'Isoleucine or valine' 0 C--O 1.235 0.296 0 CA-C-O 120.974 0.416 . . . . 0.0 110.081 -177.229 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' E' E ' 142' ' ' ARG . . . . . . . . . . . . . 78.0 mtp180 -103.9 123.85 47.88 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 115.264 -0.88 . . . . 0.0 110.382 179.644 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' E' E ' 143' ' ' THR . . . . . . . . . . . . . 37.3 p . . . . . 0 C--O 1.22 -0.456 0 CA-C-O 118.028 -0.987 . . . . 0.0 110.648 -179.989 . . . . . . . . 0 0 . 1 . 012 nuclear build full ' F' F ' -3' ' ' GLU . . . . . . . . . . . . . 69.2 mm-40 . . . . . 0 N--CA 1.49 1.566 0 N-CA-C 109.258 -0.645 . . . . 0.0 109.258 . . . . . . . . . 0 0 . 1 . 012 nuclear build full ' F' F ' -2' ' ' GLY . . . . . . . . . . . . . . . -69.31 143.8 39.79 Favored Glycine 0 CA--C 1.525 0.676 0 N-CA-C 110.959 -0.856 . . . . 0.0 110.959 179.956 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' F' F ' -1' ' ' VAL . . . . . . . . . . . . . 46.9 t -141.38 138.0 32.92 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.258 0 N-CA-C 109.984 -0.376 . . . . 0.0 109.984 179.85 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' F' F ' 0' ' ' ILE . . . . . . . . . . . . . 72.5 mt -111.48 134.03 55.2 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.195 0 CA-C-N 116.206 -0.452 . . . . 0.0 109.959 179.802 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' F' F ' 1' ' ' MET . . . . . . . . . . . . . 25.6 ptp -94.98 163.97 13.09 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.085 -0.507 . . . . 0.0 111.006 -178.966 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' F' F ' 2' ' ' SER . . . . . . . . . . . . . 11.8 p -111.89 135.46 52.48 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.135 -0.484 . . . . 0.0 110.403 178.676 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' F' F ' 3' ' ' GLU . . . . . . . . . . . . . 95.5 mt-10 -140.81 141.87 34.7 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.117 -0.492 . . . . 0.0 110.982 -177.817 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' F' F ' 4' ' ' LEU . . . . . . . . . . . . . 28.6 tp -128.42 128.62 44.8 Favored 'General case' 0 C--N 1.331 -0.22 0 CA-C-N 115.928 -0.578 . . . . 0.0 110.22 176.869 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' F' F ' 5' ' ' LYS . . . . . . . . . . . . . 99.0 mttt -108.16 121.61 45.21 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-O 120.954 0.407 . . . . 0.0 110.538 178.376 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' F' F ' 6' ' ' LEU . . . . . . . . . . . . . 70.3 mt -116.41 148.49 40.63 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 115.364 -0.835 . . . . 0.0 110.483 -179.122 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' F' F ' 7' ' ' LYS . . . . . . . . . . . . . 78.0 tttt -139.57 139.02 21.11 Favored Pre-proline 0 CA--C 1.533 0.305 0 CA-C-O 119.086 -0.483 . . . . 0.0 109.924 175.894 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' F' F ' 8' ' ' PRO . . . . . . . . . . . . . 93.5 Cg_endo -91.41 145.11 3.3 Favored 'Trans proline' 0 N--CA 1.491 1.34 0 C-N-CA 121.724 1.616 . . . . 0.0 111.944 178.414 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' F' F ' 9' ' ' LEU . . . . . . . . . . . . . 64.4 mt -80.89 -47.67 1.15 Allowed Pre-proline 0 CA--C 1.534 0.331 0 CA-C-O 118.671 -0.68 . . . . 0.0 112.078 179.805 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' F' F ' 10' ' ' PRO . . . . . . . . . . . . . 88.5 Cg_endo -80.81 145.24 15.84 Favored 'Trans proline' 0 N--CA 1.497 1.686 0 C-N-CA 121.104 1.203 . . . . 0.0 111.555 175.995 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' F' F ' 11' ' ' LYS . . . . . . . . . . . . . 39.0 pttt -78.56 111.33 14.51 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-O 121.563 0.697 . . . . 0.0 110.382 177.873 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' F' F ' 12' ' ' VAL . . . . . . . . . . . . . 11.7 p -151.02 144.83 16.76 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.351 0 CA-C-N 115.629 -0.714 . . . . 0.0 110.512 -178.292 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' F' F ' 13' ' ' GLU . . . . . . . . . . . . . 40.1 mt-10 -86.25 124.55 32.75 Favored 'General case' 0 C--N 1.33 -0.26 0 N-CA-C 109.965 -0.383 . . . . 0.0 109.965 177.015 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' F' F ' 14' ' ' LEU . . . . . . . . . . . . . 19.3 mt -96.76 148.05 33.85 Favored Pre-proline 0 C--N 1.33 -0.273 0 CA-C-O 119.184 -0.436 . . . . 0.0 110.072 -179.263 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' F' F ' 15' ' ' PRO . . . . . . . . . . . . . 28.3 Cg_exo -60.54 159.13 28.99 Favored 'Trans proline' 0 N--CA 1.497 1.705 0 C-N-CA 121.28 1.32 . . . . 0.0 111.439 177.318 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' F' F ' 16' ' ' PRO . . . . . . . . . . . . . 38.7 Cg_exo -58.49 -35.95 98.04 Favored 'Trans proline' 0 N--CA 1.496 1.668 0 C-N-CA 121.418 1.412 . . . . 0.0 112.639 -178.617 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' F' F ' 17' ' ' ASP . . . . . . . . . . . . . 7.3 p-10 -91.66 11.55 24.06 Favored 'General case' 0 CA--C 1.535 0.396 0 N-CA-C 113.152 0.797 . . . . 0.0 113.152 -177.637 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' F' F ' 18' ' ' PHE . . . . . . . . . . . . . 52.2 t80 -58.29 -45.47 87.89 Favored 'General case' 0 C--N 1.333 -0.112 0 O-C-N 122.02 -0.425 . . . . 0.0 110.075 -177.67 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' F' F ' 19' ' ' VAL . . . . . 0.411 HG13 ' N ' ' F' ' 20' ' ' ASP . 13.7 p -55.89 -40.99 65.21 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 CA-C-N 116.114 -0.494 . . . . 0.0 110.904 -179.125 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' F' F ' 20' ' ' ASP . . . . . 0.411 ' N ' HG13 ' F' ' 19' ' ' VAL . 80.7 m-20 -61.22 -42.84 99.29 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-O 120.818 0.342 . . . . 0.0 110.975 -178.558 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' F' F ' 21' ' ' VAL . . . . . . . . . . . . . 48.1 t -63.84 -46.07 95.32 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.291 0 C-N-CA 120.759 -0.376 . . . . 0.0 110.318 -178.03 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' F' F ' 22' ' ' ILE . . . . . 0.621 HG22 HD12 ' F' ' 26' ' ' LEU . 49.2 mm -56.58 -46.02 82.47 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.258 0 C-N-CA 120.948 -0.301 . . . . 0.0 110.622 178.917 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' F' F ' 23' ' ' ARG . . . . . . . . . . . . . 25.8 ttp180 -54.33 -49.43 69.75 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-O 120.594 0.235 . . . . 0.0 111.418 -178.843 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' F' F ' 24' ' ' ILE . . . . . . . . . . . . . 77.1 mt -59.71 -44.07 92.87 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.368 0 CA-C-N 116.629 -0.259 . . . . 0.0 111.291 -177.194 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' F' F ' 25' ' ' LYS . . . . . . . . . . . . . 62.8 mttm -66.18 -38.18 87.41 Favored 'General case' 0 C--N 1.327 -0.371 0 N-CA-C 112.28 0.474 . . . . 0.0 112.28 -178.455 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' F' F ' 26' ' ' LEU . . . . . 0.621 HD12 HG22 ' F' ' 22' ' ' ILE . 58.2 mt -79.13 -40.52 30.8 Favored 'General case' 0 C--N 1.33 -0.241 0 N-CA-C 113.349 0.87 . . . . 0.0 113.349 -172.446 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' F' F ' 27' ' ' GLN . . . . . . . . . . . . . 8.3 pt20 -47.1 141.49 4.28 Favored 'General case' 0 N--CA 1.47 0.534 0 N-CA-C 112.726 0.639 . . . . 0.0 112.726 -174.359 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' F' F ' 28' ' ' GLY . . . . . . . . . . . . . . . 96.91 -25.76 25.39 Favored Glycine 0 CA--C 1.534 1.227 0 CA-C-N 115.626 -0.715 . . . . 0.0 112.1 -176.638 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' F' F ' 29' ' ' LYS . . . . . . . . . . . . . 59.1 mtpt -98.33 155.1 17.37 Favored 'General case' 0 C--O 1.233 0.217 0 CA-C-N 117.275 0.538 . . . . 0.0 111.002 179.284 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' F' F ' 30' ' ' THR . . . . . . . . . . . . . 31.4 m -111.45 139.27 47.0 Favored 'General case' 0 C--N 1.331 -0.217 0 CA-C-N 116.093 -0.503 . . . . 0.0 110.217 175.743 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' F' F ' 31' ' ' VAL . . . . . . . . . . . . . 35.2 m -134.37 164.43 34.26 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.225 0 CA-C-O 120.796 0.331 . . . . 0.0 110.981 -179.22 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' F' F ' 32' ' ' ARG . . . . . . . . . . . . . 77.9 mtp180 -131.3 153.97 49.01 Favored 'General case' 0 C--N 1.331 -0.223 0 CA-C-O 121.227 0.537 . . . . 0.0 110.735 177.908 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' F' F ' 33' ' ' THR . . . . . . . . . . . . . 32.3 m -53.78 140.94 28.41 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.221 -0.445 . . . . 0.0 111.222 -179.603 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' F' F ' 34' ' ' GLY . . . . . . . . . . . . . . . 99.9 -17.13 57.72 Favored Glycine 0 CA--C 1.531 1.068 0 C-N-CA 121.211 -0.519 . . . . 0.0 113.26 179.371 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' F' F ' 35' ' ' ASP . . . . . . . . . . . . . 65.6 m-20 -65.23 149.34 50.1 Favored 'General case' 0 C--O 1.231 0.121 0 CA-C-N 118.089 0.945 . . . . 0.0 111.188 179.044 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' F' F ' 36' ' ' VAL . . . . . . . . . . . . . 46.4 t -122.71 130.16 74.69 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.256 0 CA-C-N 115.78 -0.645 . . . . 0.0 109.867 178.909 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' F' F ' 37' ' ' ILE . . . . . . . . . . . . . 69.7 mt -122.07 139.47 48.95 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.234 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.044 -179.524 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' F' F ' 38' ' ' GLY . . . . . . . . . . . . . . . -113.86 129.17 8.64 Favored Glycine 0 CA--C 1.525 0.703 0 N-CA-C 111.115 -0.794 . . . . 0.0 111.115 -179.933 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' F' F ' 39' ' ' ILE . . . . . . . . . . . . . 67.7 mt -120.0 133.73 65.79 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.216 0 N-CA-C 110.084 -0.339 . . . . 0.0 110.084 178.964 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' F' F ' 40' ' ' SER . . . . . . . . . . . . . 53.6 p -93.4 120.04 33.21 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.343 -0.389 . . . . 0.0 110.844 175.399 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' F' F ' 41' ' ' ILE . . . . . . . . . . . . . 68.9 mt -129.81 122.55 54.94 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.179 0 CA-C-O 120.787 0.327 . . . . 0.0 110.462 177.903 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' F' F ' 42' ' ' LEU . . . . . . . . . . . . . 8.9 tp 52.23 35.11 16.0 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-N 116.131 -0.486 . . . . 0.0 111.628 177.308 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' F' F ' 43' ' ' GLY . . . . . . . . . . . . . . . 72.07 32.32 63.32 Favored Glycine 0 CA--C 1.529 0.952 0 C-N-CA 121.05 -0.595 . . . . 0.0 111.907 178.253 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' F' F ' 44' ' ' LYS . . . . . . . . . . . . . 54.4 tttp -137.94 128.79 27.02 Favored 'General case' 0 C--N 1.329 -0.296 0 N-CA-C 109.668 -0.493 . . . . 0.0 109.668 179.259 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' F' F ' 45' ' ' GLU . . . . . . . . . . . . . 84.6 tt0 -84.23 124.68 31.46 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-O 120.878 0.37 . . . . 0.0 111.298 -178.215 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' F' F ' 46' ' ' VAL . . . . . . . . . . . . . 7.1 p -121.0 127.74 75.99 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.209 0 N-CA-C 109.299 -0.63 . . . . 0.0 109.299 174.261 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' F' F ' 47' ' ' LYS . . . . . . . . . . . . . 93.1 mttt -99.98 127.24 46.21 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.062 -0.517 . . . . 0.0 111.006 179.583 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' F' F ' 48' ' ' PHE . . . . . . . . . . . . . 94.0 m-85 -111.07 131.96 54.65 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.305 -0.407 . . . . 0.0 109.951 175.961 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' F' F ' 49' ' ' LYS . . . . . . . . . . . . . 84.0 tttt -107.24 135.5 48.65 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.281 -0.418 . . . . 0.0 110.218 179.457 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' F' F ' 50' ' ' VAL . . . . . . . . . . . . . 46.4 t -79.38 108.02 12.47 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.295 0 N-CA-C 109.22 -0.659 . . . . 0.0 109.22 176.541 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' F' F ' 51' ' ' VAL . . . . . . . . . . . . . 47.8 t -70.9 -48.11 58.54 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.267 0 CA-C-N 115.991 -0.549 . . . . 0.0 109.974 -173.768 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' F' F ' 52' ' ' GLN . . . . . . . . . . . . . 63.2 tt0 -163.67 140.08 6.83 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.05 -0.523 . . . . 0.0 111.553 -178.233 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' F' F ' 53' ' ' ALA . . . . . 0.49 ' HB1' ' HB2' ' F' ' 58' ' ' LEU . . . -111.9 130.49 55.81 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-N 115.565 -0.743 . . . . 0.0 109.54 174.137 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' F' F ' 54' ' ' TYR . . . . . . . . . . . . . 41.8 t80 -129.06 110.16 18.24 Favored Pre-proline 0 C--N 1.327 -0.38 0 CA-C-O 118.358 -0.829 . . . . 0.0 110.484 -179.3 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' F' F ' 55' ' ' PRO . . . . . . . . . . . . . 73.8 Cg_endo -76.99 169.69 73.74 Favored 'Cis proline' 0 N--CA 1.498 1.783 0 CA-C-N 121.906 1.716 . . . . 0.0 112.296 -4.343 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' F' F ' 56' ' ' SER . . . . . . . . . . . . . 13.7 m -113.45 128.03 26.16 Favored Pre-proline 0 CA--C 1.539 0.553 0 CA-C-O 118.448 -0.787 . . . . 0.0 109.383 176.706 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' F' F ' 57' ' ' PRO . . . . . . . . . . . . . 38.5 Cg_endo -66.96 165.35 67.11 Favored 'Cis proline' 0 N--CA 1.497 1.693 0 CA-C-N 121.924 1.723 . . . . 0.0 111.463 0.388 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' F' F ' 58' ' ' LEU . . . . . 0.49 ' HB2' ' HB1' ' F' ' 53' ' ' ALA . 27.7 tp -129.26 135.76 49.2 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-O 120.934 0.397 . . . . 0.0 110.612 -179.31 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' F' F ' 59' ' ' ARG . . . . . . . . . . . . . 40.6 ttm180 -106.56 137.21 44.98 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-N 115.897 -0.592 . . . . 0.0 109.569 176.309 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' F' F ' 60' ' ' VAL . . . . . . . . . . . . . 44.2 t -91.0 122.7 42.66 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 C-N-CA 120.601 -0.44 . . . . 0.0 110.272 -178.178 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' F' F ' 61' ' ' GLU . . . . . . . . . . . . . 70.6 mm-40 -131.09 167.76 18.57 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 115.938 -0.574 . . . . 0.0 110.006 177.208 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' F' F ' 62' ' ' ASP . . . . . . . . . . . . . 75.1 m-20 -54.68 -32.95 60.16 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-N 116.58 -0.282 . . . . 0.0 111.748 -178.715 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' F' F ' 63' ' ' ARG . . . . . . . . . . . . . 7.0 ptp180 -89.45 8.55 30.36 Favored 'General case' 0 CA--C 1.536 0.413 0 N-CA-C 113.527 0.936 . . . . 0.0 113.527 -175.499 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' F' F ' 64' ' ' THR . . . . . . . . . . . . . 30.3 m -85.2 137.77 32.79 Favored 'General case' 0 C--O 1.232 0.155 0 CA-C-N 118.115 0.416 . . . . 0.0 110.343 -178.644 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' F' F ' 65' ' ' LYS . . . . . . . . . . . . . 97.3 mttt -88.58 125.94 35.03 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-N 116.27 -0.423 . . . . 0.0 110.041 -179.899 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' F' F ' 66' ' ' ILE . . . . . . . . . . . . . 64.9 mt -115.24 128.77 72.3 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.279 0 N-CA-C 109.812 -0.44 . . . . 0.0 109.812 -179.825 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' F' F ' 67' ' ' THR . . . . . . . . . . . . . 18.6 m -124.65 138.7 54.29 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.74 -177.726 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' F' F ' 68' ' ' LEU . . . . . 0.504 HD12 ' N ' ' F' ' 68' ' ' LEU . 7.1 mp -103.98 128.87 51.54 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 115.895 -0.593 . . . . 0.0 110.226 177.218 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' F' F ' 69' ' ' VAL . . . . . . . . . . . . . 43.9 t -101.29 133.51 44.42 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.303 0 CA-C-N 116.287 -0.415 . . . . 0.0 109.967 179.658 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' F' F ' 70' ' ' THR . . . . . . . . . . . . . 9.5 m -136.99 95.56 3.14 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.344 -0.389 . . . . 0.0 110.806 -179.573 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' F' F ' 71' ' ' HIS . . . . . . . . . . . . . 40.6 t-80 -148.26 64.87 8.36 Favored Pre-proline 0 CA--C 1.536 0.436 0 CA-C-N 116.089 -0.505 . . . . 0.0 110.199 176.015 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' F' F ' 72' ' ' PRO . . . . . . . . . . . . . 68.9 Cg_endo -94.96 37.39 0.16 Allowed 'Trans proline' 0 N--CA 1.488 1.172 0 C-N-CA 121.955 1.77 . . . . 0.0 112.75 -177.827 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' F' F ' 73' ' ' VAL . . . . . . . . . . . . . 27.5 m -104.08 141.11 20.37 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.235 0 CA-C-O 121.248 0.547 . . . . 0.0 111.079 -178.937 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' F' F ' 74' ' ' ASP . . . . . . . . . . . . . 33.5 t0 -96.61 119.83 35.81 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 115.477 -0.783 . . . . 0.0 109.236 176.583 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' F' F ' 75' ' ' VAL . . . . . . . . . . . . . 42.0 t -109.6 123.15 65.25 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.247 0 CA-C-O 121.178 0.514 . . . . 0.0 110.521 -176.73 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' F' F ' 76' ' ' LEU . . . . . . . . . . . . . 23.8 mt -128.9 141.27 51.33 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 115.485 -0.78 . . . . 0.0 109.281 177.508 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' F' F ' 77' ' ' GLU . . . . . . . . . . . . . 45.7 tt0 -136.76 133.07 35.62 Favored 'General case' 0 C--N 1.331 -0.225 0 C-N-CA 120.736 -0.386 . . . . 0.0 110.978 -176.354 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' F' F ' 78' ' ' ALA . . . . . . . . . . . . . . . -120.6 135.55 55.07 Favored 'General case' 0 C--N 1.332 -0.177 0 CA-C-N 116.259 -0.428 . . . . 0.0 110.281 179.796 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' F' F ' 79' ' ' LYS . . . . . 0.655 ' O ' HD13 ' F' ' 80' ' ' ILE . 87.1 mttt -79.49 120.87 24.48 Favored 'General case' 0 C--N 1.331 -0.209 0 CA-C-O 120.853 0.359 . . . . 0.0 110.787 -179.242 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' F' F ' 80' ' ' ILE . . . . . 0.655 HD13 ' O ' ' F' ' 79' ' ' LYS . 37.2 mm -139.14 108.16 3.65 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.314 0 N-CA-C 108.869 -0.789 . . . . 0.0 108.869 -177.78 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' F' F ' 81' ' ' LYS . . . . . . . . . . . . . 79.5 tttt -99.96 125.79 46.02 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-O 120.837 0.351 . . . . 0.0 111.43 -174.834 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' F' F ' 82' ' ' GLY . . . . . . . . . . . . . . . 89.05 42.14 5.7 Favored Glycine 0 CA--C 1.525 0.683 0 C-N-CA 120.956 -0.64 . . . . 0.0 111.617 174.417 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' F' F ' 83' ' ' ILE . . . . . . . . . . . . . 68.5 mt -68.83 138.23 22.78 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.29 0 CA-C-O 120.921 0.391 . . . . 0.0 110.019 179.695 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' F' F ' 84' ' ' LYS . . . . . . . . . . . . . 38.2 tttp -99.91 -53.12 3.25 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 115.924 -0.58 . . . . 0.0 110.158 -179.475 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' F' F ' 85' ' ' ASP . . . . . . . . . . . . . 11.1 t0 -151.85 148.31 27.66 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 115.748 -0.66 . . . . 0.0 110.241 179.72 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' F' F ' 86' ' ' VAL . . . . . . . . . . . . . 45.3 t -125.94 130.24 72.33 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.191 0 CA-C-O 120.898 0.38 . . . . 0.0 110.308 -179.309 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' F' F ' 87' ' ' ILE . . . . . . . . . . . . . 46.2 mm -121.75 130.21 74.8 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.246 0 CA-C-N 115.926 -0.579 . . . . 0.0 109.948 177.365 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' F' F ' 88' ' ' LEU . . . . . . . . . . . . . 58.5 mt -108.17 137.25 46.47 Favored 'General case' 0 C--N 1.332 -0.194 0 CA-C-O 121.04 0.448 . . . . 0.0 111.361 -177.966 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' F' F ' 89' ' ' ASP . . . . . . . . . . . . . 13.8 t70 -126.58 153.14 45.67 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 115.653 -0.703 . . . . 0.0 109.489 176.695 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' F' F ' 90' ' ' GLU . . . . . . . . . . . . . 84.8 tt0 -47.54 -36.12 10.0 Favored 'General case' 0 C--N 1.329 -0.288 0 N-CA-C 112.851 0.686 . . . . 0.0 112.851 -172.259 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' F' F ' 91' ' ' ASN . . . . . . . . . . . . . 16.9 t30 -131.96 19.99 4.55 Favored 'General case' 0 N--CA 1.468 0.435 0 N-CA-C 112.995 0.739 . . . . 0.0 112.995 -178.411 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' F' F ' 92' ' ' LEU . . . . . . . . . . . . . 35.7 mt -150.28 152.83 35.12 Favored 'General case' 0 C--N 1.331 -0.209 0 CA-C-O 120.824 0.345 . . . . 0.0 110.513 -177.114 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' F' F ' 93' ' ' ILE . . . . . . . . . . . . . 71.9 mt -126.77 121.27 57.99 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.379 0 N-CA-C 109.319 -0.623 . . . . 0.0 109.319 177.206 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' F' F ' 94' ' ' VAL . . . . . . . . . . . . . 45.4 t -117.47 125.83 74.27 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.268 0 N-CA-C 109.829 -0.434 . . . . 0.0 109.829 -178.907 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' F' F ' 95' ' ' VAL . . . . . . . . . . . . . 46.1 t -122.16 133.03 69.72 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.291 0 CA-C-N 116.071 -0.513 . . . . 0.0 109.919 -179.468 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' F' F ' 96' ' ' ILE . . . . . . . . . . . . . 57.4 mt -114.77 127.77 72.15 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.323 0 N-CA-C 109.141 -0.689 . . . . 0.0 109.141 178.473 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' F' F ' 97' ' ' THR . . . . . . . . . . . . . 74.0 p -99.33 159.34 15.08 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-O 121.139 0.495 . . . . 0.0 111.423 -177.303 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' F' F ' 98' ' ' GLU . . . . . . . . . . . . . 12.6 pt-20 -54.69 -28.02 44.62 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.091 -0.504 . . . . 0.0 112.263 -179.135 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' F' F ' 99' ' ' GLU . . . . . . . . . . . . . 70.9 mm-40 -80.28 14.39 1.97 Allowed 'General case' 0 CA--C 1.535 0.397 0 N-CA-C 113.084 0.772 . . . . 0.0 113.084 -177.684 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' F' F ' 100' ' ' ASN . . . . . . . . . . . . . 5.3 m-20 62.09 35.25 15.91 Favored 'General case' 0 C--N 1.332 -0.164 0 CA-C-O 120.96 0.41 . . . . 0.0 111.354 179.56 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' F' F ' 101' ' ' GLU . . . . . . . . . . . . . 84.5 tt0 -106.61 143.0 35.35 Favored 'General case' 0 C--N 1.333 -0.145 0 N-CA-C 109.513 -0.551 . . . . 0.0 109.513 172.008 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' F' F ' 102' ' ' VAL . . . . . . . . . . . . . 43.2 t -115.02 125.45 72.34 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.311 0 N-CA-C 109.823 -0.436 . . . . 0.0 109.823 -177.867 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' F' F ' 103' ' ' LEU . . . . . . . . . . . . . 42.5 mt -116.81 129.13 55.9 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 115.762 -0.654 . . . . 0.0 110.17 177.508 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' F' F ' 104' ' ' ILE . . . . . . . . . . . . . 70.3 mt -118.36 119.43 61.24 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.261 0 N-CA-C 110.118 -0.327 . . . . 0.0 110.118 179.187 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' F' F ' 105' ' ' PHE . . . . . . . . . . . . . 65.8 m-85 -119.81 166.32 13.42 Favored 'General case' 0 C--N 1.331 -0.202 0 O-C-N 124.169 0.918 . . . . 0.0 109.591 178.858 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' F' F ' 106' ' ' ASN . . . . . . . . . . . . . 43.6 p-10 -99.3 -170.91 1.98 Allowed 'General case' 0 C--N 1.329 -0.284 0 N-CA-C 109.756 -0.461 . . . . 0.0 109.756 171.834 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' F' F ' 107' ' ' GLN . . . . . . . . . . . . . 5.8 tp-100 -57.82 -27.91 63.58 Favored 'General case' 0 CA--C 1.533 0.323 0 N-CA-C 112.005 0.372 . . . . 0.0 112.005 -179.815 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' F' F ' 108' ' ' ASN . . . . . . . . . . . . . 23.5 t30 -90.47 13.85 14.6 Favored 'General case' 0 CA--C 1.534 0.336 0 N-CA-C 113.067 0.766 . . . . 0.0 113.067 -175.997 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' F' F ' 109' ' ' LEU . . . . . . . . . . . . . 47.5 mt 57.95 38.0 26.85 Favored 'General case' 0 C--O 1.232 0.144 0 CA-C-O 120.975 0.416 . . . . 0.0 111.468 177.292 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' F' F ' 110' ' ' GLU . . . . . . . . . . . . . 95.7 mt-10 -102.07 155.12 18.39 Favored 'General case' 0 C--N 1.329 -0.319 0 N-CA-C 109.939 -0.393 . . . . 0.0 109.939 176.076 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' F' F ' 111' ' ' GLU . . . . . . . . . . . . . 84.9 tt0 -85.85 121.91 29.17 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-O 120.914 0.388 . . . . 0.0 110.698 -178.067 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' F' F ' 112' ' ' LEU . . . . . . . . . . . . . 32.5 mt -111.8 -45.97 3.29 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.043 -0.526 . . . . 0.0 110.414 178.297 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' F' F ' 113' ' ' TYR . . . . . . . . . . . . . 63.3 t80 -138.79 135.79 35.0 Favored 'General case' 0 C--N 1.331 -0.213 0 CA-C-N 116.43 -0.35 . . . . 0.0 111.117 179.351 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' F' F ' 114' ' ' ARG . . . . . . . . . . . . . 59.6 ttp180 -137.69 122.3 18.55 Favored 'General case' 0 C--N 1.331 -0.227 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.308 177.65 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' F' F ' 115' ' ' GLY . . . . . . . . . . . . . . . -150.08 161.1 28.79 Favored Glycine 0 CA--C 1.525 0.668 0 N-CA-C 111.053 -0.819 . . . . 0.0 111.053 177.943 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' F' F ' 116' ' ' LYS . . . . . . . . . . . . . 83.4 tttt -134.9 128.97 33.59 Favored 'General case' 0 C--N 1.33 -0.274 0 N-CA-C 109.972 -0.381 . . . . 0.0 109.972 177.703 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' F' F ' 117' ' ' PHE . . . . . . . . . . . . . 30.8 m-85 -129.03 118.85 23.23 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 116.402 -0.363 . . . . 0.0 110.047 -174.778 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' F' F ' 118' ' ' GLU . . . . . . . . . . . . . 95.9 mt-10 -55.59 -40.25 71.77 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.469 -0.332 . . . . 0.0 110.987 -177.264 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' F' F ' 119' ' ' ASN . . . . . . . . . . . . . 19.1 m120 -101.28 30.99 3.88 Favored 'General case' 0 C--N 1.33 -0.257 0 N-CA-C 112.047 0.388 . . . . 0.0 112.047 -175.022 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' F' F ' 120' ' ' LEU . . . . . . . . . . . . . 17.5 tp -58.08 124.48 19.5 Favored 'General case' 0 C--N 1.333 -0.15 0 CA-C-O 120.752 0.311 . . . . 0.0 110.221 178.781 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' F' F ' 121' ' ' ASN . . . . . . . . . . . . . 17.6 m120 -109.23 -44.19 3.99 Favored 'General case' 0 C--N 1.331 -0.222 0 CA-C-N 116.328 -0.396 . . . . 0.0 111.116 -176.962 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' F' F ' 122' ' ' LYS . . . . . . . . . . . . . 19.5 ptpt -163.65 163.15 24.42 Favored 'General case' 0 C--N 1.331 -0.199 0 CA-C-O 121.099 0.476 . . . . 0.0 111.726 -179.043 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' F' F ' 123' ' ' VAL . . . . . . . . . . . . . 42.2 t -132.95 137.15 54.38 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.251 0 CA-C-N 116.023 -0.535 . . . . 0.0 110.006 178.613 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' F' F ' 124' ' ' LEU . . . . . . . . . . . . . 80.0 mt -120.77 138.52 53.97 Favored 'General case' 0 C--N 1.331 -0.224 0 CA-C-N 116.293 -0.412 . . . . 0.0 110.535 -179.418 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' F' F ' 125' ' ' VAL . . . . . 0.53 HG23 HG12 ' F' ' 130' ' ' VAL . 12.0 p -133.63 130.28 56.25 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.246 0 CA-C-O 120.938 0.399 . . . . 0.0 110.785 179.641 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' F' F ' 126' ' ' ARG . . . . . . . . . . . . . 79.4 mtt85 -151.32 125.12 9.1 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 115.851 -0.613 . . . . 0.0 109.948 175.469 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' F' F ' 127' ' ' ASN . . . . . . . . . . . . . 17.3 m120 55.99 -149.32 0.46 Allowed 'General case' 0 CA--C 1.54 0.579 0 N-CA-C 109.897 -0.408 . . . . 0.0 109.897 178.99 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' F' F ' 128' ' ' ASP . . . . . . . . . . . . . 24.3 p-10 -82.17 13.08 3.67 Favored 'General case' 0 CA--C 1.537 0.446 0 N-CA-C 112.995 0.739 . . . . 0.0 112.995 -179.96 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' F' F ' 129' ' ' LEU . . . . . . . . . . . . . 19.9 tp -112.5 133.45 54.56 Favored 'General case' 0 C--O 1.232 0.182 0 CA-C-N 118.171 0.441 . . . . 0.0 110.104 179.196 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' F' F ' 130' ' ' VAL . . . . . 0.53 HG12 HG23 ' F' ' 125' ' ' VAL . 33.7 m -131.55 141.56 45.46 Favored 'Isoleucine or valine' 0 C--O 1.232 0.136 0 CA-C-O 120.782 0.325 . . . . 0.0 110.506 -179.651 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' F' F ' 131' ' ' VAL . . . . . 0.428 ' CG1' HD21 ' F' ' 138' ' ' LEU . 40.0 t -136.09 140.29 44.17 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.305 0 CA-C-O 120.986 0.422 . . . . 0.0 110.525 -179.104 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' F' F ' 132' ' ' ILE . . . . . . . . . . . . . 69.4 mt -115.16 133.8 60.28 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.249 0 N-CA-C 109.255 -0.646 . . . . 0.0 109.255 178.035 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' F' F ' 133' ' ' ILE . . . . . . . . . . . . . 42.7 mm -115.11 124.4 71.7 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.229 0 CA-C-N 116.568 -0.287 . . . . 0.0 110.859 -175.051 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' F' F ' 134' ' ' ASP . . . . . . . . . . . . . 7.2 p-10 -134.6 147.5 50.23 Favored 'General case' 0 C--N 1.332 -0.195 0 N-CA-C 109.605 -0.517 . . . . 0.0 109.605 174.089 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' F' F ' 135' ' ' GLU . . . . . . . . . . . . . 85.2 tt0 -50.7 -27.55 7.3 Favored 'General case' 0 C--N 1.328 -0.335 0 N-CA-C 112.822 0.675 . . . . 0.0 112.822 -173.129 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' F' F ' 136' ' ' GLN . . . . . . . . . . . . . 97.5 mt-30 -81.55 -32.47 32.2 Favored 'General case' 0 C--N 1.331 -0.239 0 N-CA-C 112.663 0.616 . . . . 0.0 112.663 -176.784 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' F' F ' 137' ' ' LYS . . . . . . . . . . . . . 53.3 pttt -169.02 173.54 6.83 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-O 121.562 0.696 . . . . 0.0 112.576 -172.458 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' F' F ' 138' ' ' LEU . . . . . 0.463 HD23 ' N ' ' F' ' 139' ' ' THR . 4.6 tt -117.07 129.74 56.19 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 115.113 -0.949 . . . . 0.0 109.923 179.622 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' F' F ' 139' ' ' THR . . . . . 0.463 ' N ' HD23 ' F' ' 138' ' ' LEU . 33.2 m -112.22 124.68 52.97 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.421 -0.354 . . . . 0.0 110.199 178.917 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' F' F ' 140' ' ' LEU . . . . . 0.482 HD23 ' C ' ' F' ' 140' ' ' LEU . 7.8 tt -113.86 125.19 53.79 Favored 'General case' 0 C--N 1.33 -0.281 0 N-CA-C 109.326 -0.62 . . . . 0.0 109.326 -178.724 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' F' F ' 141' ' ' ILE . . . . . 0.509 ' HB ' HG23 ' F' ' 130' ' ' VAL . 20.1 mt -121.98 125.32 72.97 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.272 0 CA-C-O 121.03 0.443 . . . . 0.0 110.022 -175.39 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' F' F ' 142' ' ' ARG . . . . . . . . . . . . . 39.1 tpt85 -113.8 128.04 56.25 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 115.132 -0.94 . . . . 0.0 109.944 -177.403 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' F' F ' 143' ' ' THR . . . . . . . . . . . . . 23.5 p . . . . . 0 C--O 1.22 -0.49 0 CA-C-O 117.953 -1.023 . . . . 0.0 110.516 -179.328 . . . . . . . . 0 0 . 1 . 013 nuclear build full ' A' A ' -3' ' ' GLU . . . . . . . . . . . . . 95.8 mt-10 . . . . . 0 N--CA 1.489 1.52 0 N-CA-C 109.401 -0.592 . . . . 0.0 109.401 . . . . . . . . . 0 0 . 1 . 013 nuclear build full ' A' A ' -2' ' ' GLY . . . . . . . . . . . . . . . -69.92 137.86 29.0 Favored Glycine 0 CA--C 1.523 0.559 0 N-CA-C 110.786 -0.926 . . . . 0.0 110.786 179.152 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' -1' ' ' VAL . . . . . . . . . . . . . 43.1 t -96.18 134.38 33.97 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.321 0 CA-C-O 120.821 0.343 . . . . 0.0 110.108 -179.875 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 0' ' ' ILE . . . . . . . . . . . . . 70.2 mt -109.78 121.08 62.13 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.272 0 N-CA-C 109.704 -0.48 . . . . 0.0 109.704 179.258 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 25.6 ptp -82.62 142.25 31.88 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.102 -0.499 . . . . 0.0 110.662 -179.219 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 2.6 p -114.34 130.96 56.7 Favored 'General case' 0 C--N 1.331 -0.224 0 CA-C-N 115.977 -0.556 . . . . 0.0 110.711 -178.971 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 82.8 tt0 -145.87 144.03 29.96 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.169 -0.469 . . . . 0.0 111.011 179.58 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 4' ' ' LEU . . . . . . . . . . . . . 14.8 tp -125.9 132.43 52.14 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.069 -0.514 . . . . 0.0 110.109 177.227 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 5' ' ' LYS . . . . . . . . . . . . . 68.3 mttm -109.75 122.74 48.18 Favored 'General case' 0 C--O 1.233 0.195 0 CA-C-N 116.345 -0.389 . . . . 0.0 110.823 179.941 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 31.2 mt -113.84 150.0 34.21 Favored 'General case' 0 C--N 1.331 -0.217 0 CA-C-N 115.349 -0.841 . . . . 0.0 110.196 -179.781 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 81.9 tttt -133.0 138.8 32.65 Favored Pre-proline 0 CA--C 1.534 0.332 0 CA-C-O 118.949 -0.548 . . . . 0.0 109.525 174.077 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 8' ' ' PRO . . . . . . . . . . . . . 88.5 Cg_endo -91.66 141.3 2.61 Favored 'Trans proline' 0 N--CA 1.489 1.253 0 C-N-CA 121.747 1.631 . . . . 0.0 112.16 179.741 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 62.5 mt -77.41 -47.4 2.51 Favored Pre-proline 0 CA--C 1.535 0.393 0 CA-C-O 118.69 -0.672 . . . . 0.0 112.074 178.729 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 97.8 Cg_endo -81.77 152.98 17.26 Favored 'Trans proline' 0 N--CA 1.495 1.604 0 C-N-CA 121.293 1.329 . . . . 0.0 111.995 176.088 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 46.3 tttp -88.68 98.08 11.49 Favored 'General case' 0 C--N 1.331 -0.237 0 C-N-CA 120.89 -0.324 . . . . 0.0 110.189 177.682 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 12.3 p -141.47 147.94 21.6 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.308 0 CA-C-N 116.283 -0.417 . . . . 0.0 110.673 -178.48 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 93.6 mt-10 -88.94 124.35 34.15 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.259 -0.428 . . . . 0.0 109.993 177.904 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 14' ' ' LEU . . . . . . . . . . . . . 26.2 mt -98.15 149.81 36.1 Favored Pre-proline 0 CA--C 1.534 0.335 0 CA-C-O 119.266 -0.397 . . . . 0.0 110.508 -179.25 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 15' ' ' PRO . . . . . . . . . . . . . 26.9 Cg_exo -62.06 158.55 38.52 Favored 'Trans proline' 0 N--CA 1.498 1.744 0 C-N-CA 121.282 1.322 . . . . 0.0 112.015 177.416 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 16' ' ' PRO . . . . . . . . . . . . . 32.9 Cg_exo -59.78 -35.66 93.64 Favored 'Trans proline' 0 N--CA 1.498 1.765 0 C-N-CA 121.384 1.389 . . . . 0.0 112.676 -179.739 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 17' ' ' ASP . . . . . . . . . . . . . 18.7 p-10 -86.91 8.81 21.5 Favored 'General case' 0 C--N 1.327 -0.376 0 N-CA-C 113.276 0.843 . . . . 0.0 113.276 -177.644 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 18' ' ' PHE . . . . . . . . . . . . . 37.9 t80 -58.12 -47.86 81.99 Favored 'General case' 0 N--CA 1.457 -0.081 0 O-C-N 121.963 -0.46 . . . . 0.0 110.194 -177.158 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 19' ' ' VAL . . . . . 0.408 HG13 ' N ' ' A' ' 20' ' ' ASP . 14.8 p -55.92 -41.3 66.79 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.339 0 CA-C-N 116.359 -0.382 . . . . 0.0 111.141 -177.614 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 20' ' ' ASP . . . . . 0.408 ' N ' HG13 ' A' ' 19' ' ' VAL . 49.8 m-20 -60.26 -44.74 95.04 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-O 120.805 0.336 . . . . 0.0 111.045 -177.387 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 47.0 t -64.78 -48.44 84.47 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.283 0 C-N-CA 120.726 -0.39 . . . . 0.0 110.495 -177.648 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 22' ' ' ILE . . . . . 0.542 HG22 HD12 ' A' ' 26' ' ' LEU . 44.5 mm -56.92 -43.86 81.3 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.247 0 CA-C-O 120.777 0.322 . . . . 0.0 110.489 179.957 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 23' ' ' ARG . . . . . . . . . . . . . 32.1 ttp180 -54.58 -49.76 69.62 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.65 -0.25 . . . . 0.0 111.283 -178.637 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 24' ' ' ILE . . . . . . . . . . . . . 75.9 mt -59.41 -41.39 84.3 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.238 0 C-N-CA 120.971 -0.291 . . . . 0.0 111.148 -177.622 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 91.9 mttt -64.97 -43.47 92.56 Favored 'General case' 0 C--N 1.329 -0.295 0 N-CA-C 112.439 0.533 . . . . 0.0 112.439 -179.437 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 26' ' ' LEU . . . . . 0.542 HD12 HG22 ' A' ' 22' ' ' ILE . 88.7 mt -79.75 -36.81 36.74 Favored 'General case' 0 C--N 1.331 -0.217 0 N-CA-C 113.589 0.959 . . . . 0.0 113.589 -170.541 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 27' ' ' GLN . . . . . . . . . . . . . 13.2 pt20 -47.13 142.17 3.9 Favored 'General case' 0 N--CA 1.469 0.508 0 N-CA-C 112.699 0.629 . . . . 0.0 112.699 -175.04 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 99.15 -24.99 30.02 Favored Glycine 0 CA--C 1.534 1.237 0 CA-C-N 115.591 -0.732 . . . . 0.0 112.251 -176.155 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 68.3 mttm -97.52 155.15 17.08 Favored 'General case' 0 C--O 1.232 0.177 0 CA-C-N 117.399 0.599 . . . . 0.0 111.028 178.635 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 30' ' ' THR . . . . . . . . . . . . . 30.2 m -103.25 137.68 41.06 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 115.887 -0.597 . . . . 0.0 109.933 176.13 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 35.2 m -126.33 153.52 34.89 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.248 0 CA-C-N 116.404 -0.362 . . . . 0.0 110.468 -179.4 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 32' ' ' ARG . . . . . . . . . . . . . 60.3 ttp180 -131.23 148.58 52.71 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.048 -0.524 . . . . 0.0 110.458 179.293 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 33' ' ' THR . . . . . . . . . . . . . 17.2 m -53.12 138.7 30.61 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.266 -0.425 . . . . 0.0 111.365 -177.936 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 99.91 -17.2 57.62 Favored Glycine 0 CA--C 1.532 1.155 0 CA-C-O 119.718 -0.49 . . . . 0.0 113.228 179.873 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 72.9 m-20 -66.2 151.73 46.35 Favored 'General case' 0 C--N 1.334 -0.107 0 CA-C-N 118.039 0.92 . . . . 0.0 111.288 179.404 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 45.2 t -122.73 130.46 74.47 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.198 0 CA-C-N 115.756 -0.656 . . . . 0.0 109.884 177.784 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 37' ' ' ILE . . . . . . . . . . . . . 65.3 mt -120.66 138.06 52.37 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.231 0 CA-C-N 116.18 -0.464 . . . . 0.0 109.834 -179.921 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . -116.04 128.55 8.05 Favored Glycine 0 CA--C 1.525 0.665 0 N-CA-C 110.991 -0.844 . . . . 0.0 110.991 179.582 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 39' ' ' ILE . . . . . . . . . . . . . 75.1 mt -126.82 134.28 66.59 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.226 0 CA-C-O 120.695 0.283 . . . . 0.0 110.285 179.445 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 40' ' ' SER . . . . . . . . . . . . . 53.2 p -92.39 114.61 27.2 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-N 116.225 -0.443 . . . . 0.0 110.758 175.949 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 41' ' ' ILE . . . . . . . . . . . . . 43.1 mm -120.47 117.42 53.26 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.26 0 CA-C-O 120.937 0.398 . . . . 0.0 110.601 179.545 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 42' ' ' LEU . . . . . 0.546 ' O ' HD23 ' A' ' 42' ' ' LEU . 1.3 tt 51.66 45.96 27.29 Favored 'General case' 0 CA--C 1.531 0.248 0 CA-C-O 121.404 0.621 . . . . 0.0 111.004 176.701 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . 70.76 21.68 78.01 Favored Glycine 0 CA--C 1.532 1.138 0 C-N-CA 121.175 -0.536 . . . . 0.0 112.851 175.523 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 44' ' ' LYS . . . . . . . . . . . . . 56.5 mttm -133.14 129.31 37.71 Favored 'General case' 0 C--N 1.332 -0.178 0 CA-C-N 117.55 0.675 . . . . 0.0 110.09 179.195 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 84.5 tt0 -83.95 123.81 30.36 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 116.552 -0.294 . . . . 0.0 111.067 -178.568 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 46' ' ' VAL . . . . . 0.415 HG13 ' O ' ' A' ' 46' ' ' VAL . 10.4 p -121.21 124.17 71.49 Favored 'Isoleucine or valine' 0 C--O 1.233 0.194 0 N-CA-C 109.687 -0.486 . . . . 0.0 109.687 174.674 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 93.8 mttt -99.6 127.18 45.69 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.095 -0.502 . . . . 0.0 110.783 177.702 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 48' ' ' PHE . . . . . . . . . . . . . 35.8 m-85 -110.81 131.95 54.61 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 115.855 -0.612 . . . . 0.0 109.666 177.593 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 84.2 tttt -106.52 135.78 47.44 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.246 -0.434 . . . . 0.0 110.215 179.058 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 50' ' ' VAL . . . . . . . . . . . . . 45.1 t -79.21 105.33 8.38 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.317 0 N-CA-C 109.549 -0.537 . . . . 0.0 109.549 177.622 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 51' ' ' VAL . . . . . . . . . . . . . 50.5 t -70.14 -54.32 19.33 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.366 0 N-CA-C 109.36 -0.607 . . . . 0.0 109.36 -176.347 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 52' ' ' GLN . . . . . . . . . . . . . 91.7 mt-30 -153.52 154.35 34.16 Favored 'General case' 0 C--N 1.331 -0.22 0 CA-C-N 115.913 -0.585 . . . . 0.0 111.595 -178.864 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -129.35 134.34 47.85 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 115.148 -0.933 . . . . 0.0 109.779 175.984 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 54' ' ' TYR . . . . . . . . . . . . . 57.3 t80 -128.75 107.24 18.54 Favored Pre-proline 0 CA--C 1.534 0.345 0 CA-C-O 118.281 -0.866 . . . . 0.0 110.449 -178.891 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 55' ' ' PRO . . . . . . . . . . . . . 73.5 Cg_endo -77.16 170.07 72.52 Favored 'Cis proline' 0 N--CA 1.5 1.854 0 CA-C-N 121.688 1.639 . . . . 0.0 112.405 -5.77 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 56' ' ' SER . . . . . . . . . . . . . 32.6 m -113.93 126.94 27.38 Favored Pre-proline 0 CA--C 1.54 0.57 0 CA-C-O 118.31 -0.852 . . . . 0.0 109.51 175.486 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 57' ' ' PRO . . . . . . . . . . . . . 52.7 Cg_endo -71.06 167.21 75.33 Favored 'Cis proline' 0 N--CA 1.497 1.677 0 CA-C-N 122.084 1.78 . . . . 0.0 111.89 -0.387 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 58' ' ' LEU . . . . . . . . . . . . . 18.9 tp -130.57 138.27 50.09 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.232 -0.44 . . . . 0.0 110.542 -179.426 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 59' ' ' ARG . . . . . . . . . . . . . 55.2 ttp180 -105.38 128.17 53.36 Favored 'General case' 0 C--N 1.329 -0.317 0 N-CA-C 109.118 -0.697 . . . . 0.0 109.118 175.031 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 40.2 t -82.84 123.12 38.22 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.196 0 C-N-CA 120.581 -0.448 . . . . 0.0 110.638 -173.835 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 95.1 mt-10 -131.07 168.76 16.87 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 115.78 -0.646 . . . . 0.0 109.998 177.958 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 62' ' ' ASP . . . . . . . . . . . . . 51.7 m-20 -54.36 -32.4 56.83 Favored 'General case' 0 C--N 1.329 -0.283 0 N-CA-C 111.747 0.277 . . . . 0.0 111.747 -179.712 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 63' ' ' ARG . . . . . . . . . . . . . 41.0 ptt180 -87.45 5.65 37.87 Favored 'General case' 0 CA--C 1.537 0.473 0 N-CA-C 113.712 1.004 . . . . 0.0 113.712 -174.999 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 28.8 m -87.4 139.14 30.85 Favored 'General case' 0 C--N 1.332 -0.179 0 CA-C-N 117.994 0.361 . . . . 0.0 110.537 -179.867 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 65' ' ' LYS . . . . . . . . . . . . . 61.8 mttm -87.63 130.44 34.77 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.096 -0.502 . . . . 0.0 110.281 179.154 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 66' ' ' ILE . . . . . . . . . . . . . 57.7 mt -115.47 124.93 72.47 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.316 0 N-CA-C 109.436 -0.579 . . . . 0.0 109.436 178.231 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 67' ' ' THR . . . . . . . . . . . . . 24.9 m -129.42 148.3 51.32 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-O 121.189 0.518 . . . . 0.0 111.531 -175.608 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 68' ' ' LEU . . . . . 0.408 HD23 ' N ' ' A' ' 69' ' ' VAL . 4.0 tt -102.3 129.33 48.7 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 115.764 -0.653 . . . . 0.0 109.589 176.52 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 69' ' ' VAL . . . . . 0.408 ' N ' HD23 ' A' ' 68' ' ' LEU . 41.7 t -96.34 138.62 21.14 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.241 0 CA-C-O 120.962 0.41 . . . . 0.0 110.826 -175.562 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 70' ' ' THR . . . . . . . . . . . . . 10.2 t -88.35 -175.42 5.0 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-N 115.754 -0.657 . . . . 0.0 110.29 179.393 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 71' ' ' HIS . . . . . . . . . . . . . 82.2 t60 -117.6 81.69 14.88 Favored Pre-proline 0 CA--C 1.533 0.296 0 CA-C-N 116.746 -0.206 . . . . 0.0 111.096 -177.295 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 72' ' ' PRO . . . . . . . . . . . . . 94.4 Cg_endo -93.0 154.46 2.67 Favored 'Trans proline' 0 N--CA 1.489 1.225 0 C-N-CA 122.022 1.814 . . . . 0.0 111.916 176.698 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 73' ' ' VAL . . . . . . . . . . . . . 33.7 m -71.5 151.16 8.82 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.184 0 CA-C-O 121.029 0.442 . . . . 0.0 110.933 179.875 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 74' ' ' ASP . . . . . . . . . . . . . 5.3 t0 -98.87 123.41 43.12 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 115.724 -0.671 . . . . 0.0 109.655 177.628 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 42.4 t -115.09 122.36 69.0 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.178 0 CA-C-O 121.038 0.446 . . . . 0.0 110.572 -177.783 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 76' ' ' LEU . . . . . . . . . . . . . 5.2 mp -121.09 142.87 49.44 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 115.623 -0.717 . . . . 0.0 109.739 176.386 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 77' ' ' GLU . . . . . . . . . . . . . 45.9 mt-10 -134.65 137.54 43.71 Favored 'General case' 0 C--N 1.331 -0.196 0 CA-C-O 120.955 0.407 . . . . 0.0 111.158 -179.355 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 78' ' ' ALA . . . . . 0.603 ' HB2' HD21 ' A' ' 109' ' ' LEU . . . -126.68 144.32 50.96 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 115.934 -0.576 . . . . 0.0 110.299 177.92 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 79' ' ' LYS . . . . . 0.624 ' O ' HD13 ' A' ' 80' ' ' ILE . 40.8 mmtm -82.99 116.04 22.09 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.392 -0.367 . . . . 0.0 110.688 -179.541 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 80' ' ' ILE . . . . . 0.624 HD13 ' O ' ' A' ' 79' ' ' LYS . 39.5 mm -139.09 110.69 5.16 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.286 0 N-CA-C 109.42 -0.585 . . . . 0.0 109.42 -179.288 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 81' ' ' LYS . . . . . . . . . . . . . 63.8 tttt -111.26 132.59 54.24 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-O 120.877 0.37 . . . . 0.0 111.064 -178.05 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . 89.04 42.11 5.71 Favored Glycine 0 CA--C 1.524 0.654 0 N-CA-C 111.432 -0.667 . . . . 0.0 111.432 175.46 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 83' ' ' ILE . . . . . . . . . . . . . 72.4 mt -76.54 137.68 22.12 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.326 0 N-CA-C 109.673 -0.491 . . . . 0.0 109.673 178.364 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 84' ' ' LYS . . . . . . . . . . . . . 39.3 ttpt -98.27 -48.14 5.18 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-N 116.241 -0.436 . . . . 0.0 110.036 -179.07 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 85' ' ' ASP . . . . . . . . . . . . . 5.5 t70 -155.12 155.77 34.58 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.089 -0.505 . . . . 0.0 110.814 179.357 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 86' ' ' VAL . . . . . . . . . . . . . 41.6 t -132.24 135.79 57.51 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.222 0 CA-C-O 120.962 0.411 . . . . 0.0 110.803 -178.423 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 87' ' ' ILE . . . . . . . . . . . . . 47.9 mm -119.22 123.59 71.6 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.308 0 CA-C-N 115.883 -0.599 . . . . 0.0 109.632 175.027 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 88' ' ' LEU . . . . . . . . . . . . . 14.2 tp -111.46 130.58 55.67 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-O 120.816 0.341 . . . . 0.0 110.89 -177.798 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 89' ' ' ASP . . . . . . . . . . . . . 6.9 t0 -130.89 156.02 45.76 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.048 -0.523 . . . . 0.0 109.704 178.328 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 79.5 tt0 -47.86 -39.61 19.12 Favored 'General case' 0 C--N 1.33 -0.27 0 N-CA-C 112.845 0.683 . . . . 0.0 112.845 -171.675 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 91' ' ' ASN . . . . . . . . . . . . . 16.4 m120 -123.58 14.98 9.52 Favored 'General case' 0 N--CA 1.467 0.406 0 N-CA-C 113.312 0.856 . . . . 0.0 113.312 -175.884 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 92' ' ' LEU . . . . . . . . . . . . . 33.4 mt -149.82 146.03 26.92 Favored 'General case' 0 C--N 1.331 -0.225 0 CA-C-N 117.93 0.332 . . . . 0.0 110.52 -176.214 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 93' ' ' ILE . . . . . . . . . . . . . 73.6 mt -127.62 116.92 45.12 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.331 0 N-CA-C 109.113 -0.699 . . . . 0.0 109.113 175.913 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 94' ' ' VAL . . . . . . . . . . . . . 45.0 t -116.7 126.87 74.36 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.278 0 N-CA-C 109.889 -0.412 . . . . 0.0 109.889 -177.941 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 95' ' ' VAL . . . . . . . . . . . . . 43.0 t -121.06 133.93 66.11 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.293 0 CA-C-N 116.177 -0.465 . . . . 0.0 109.807 179.465 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 96' ' ' ILE . . . . . 0.402 HD11 ' HB ' ' A' ' 123' ' ' VAL . 66.3 mt -113.52 126.1 70.9 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.365 0 N-CA-C 109.071 -0.714 . . . . 0.0 109.071 178.818 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 97' ' ' THR . . . . . . . . . . . . . 72.5 p -101.75 158.24 16.26 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-O 121.519 0.676 . . . . 0.0 111.593 -175.701 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 98' ' ' GLU . . . . . . . . . . . . . 82.4 tt0 -53.83 -27.3 28.73 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 115.549 -0.75 . . . . 0.0 112.295 179.991 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 99' ' ' GLU . . . . . . . . . . . . . 95.3 mt-10 -78.83 14.42 1.36 Allowed 'General case' 0 CA--C 1.535 0.369 0 N-CA-C 113.282 0.845 . . . . 0.0 113.282 -176.866 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 100' ' ' ASN . . . . . . . . . . . . . 3.2 m-20 61.03 37.5 17.92 Favored 'General case' 0 CA--C 1.53 0.211 0 CA-C-O 121.08 0.467 . . . . 0.0 110.891 -179.782 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 101' ' ' GLU . . . . . . . . . . . . . 84.3 tt0 -115.78 145.78 42.51 Favored 'General case' 0 C--O 1.232 0.16 0 CA-C-N 116.142 -0.481 . . . . 0.0 109.732 176.473 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 102' ' ' VAL . . . . . . . . . . . . . 45.7 t -114.95 125.3 72.24 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.298 0 N-CA-C 109.805 -0.442 . . . . 0.0 109.805 -177.332 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 103' ' ' LEU . . . . . . . . . . . . . 39.0 mt -116.3 126.48 53.6 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 115.634 -0.712 . . . . 0.0 110.185 177.263 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 104' ' ' ILE . . . . . 0.402 HD13 HG11 ' A' ' 130' ' ' VAL . 64.3 mt -117.59 120.11 63.75 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.214 0 N-CA-C 110.142 -0.318 . . . . 0.0 110.142 -179.993 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 105' ' ' PHE . . . . . . . . . . . . . 68.6 m-85 -119.95 165.57 14.47 Favored 'General case' 0 C--N 1.332 -0.19 0 O-C-N 123.818 0.698 . . . . 0.0 109.526 178.94 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 106' ' ' ASN . . . . . . . . . . . . . 36.7 p-10 -99.59 -170.33 1.88 Allowed 'General case' 0 C--N 1.331 -0.218 0 N-CA-C 109.952 -0.388 . . . . 0.0 109.952 174.926 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 107' ' ' GLN . . . . . . . . . . . . . 48.6 tp60 -59.47 -30.15 68.32 Favored 'General case' 0 C--N 1.328 -0.328 0 N-CA-C 111.94 0.348 . . . . 0.0 111.94 179.474 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 108' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -84.35 9.19 13.78 Favored 'General case' 0 CA--C 1.537 0.477 0 N-CA-C 113.204 0.816 . . . . 0.0 113.204 -177.326 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 109' ' ' LEU . . . . . 0.603 HD21 ' HB2' ' A' ' 78' ' ' ALA . 9.8 tp 61.67 35.04 17.23 Favored 'General case' 0 CA--C 1.531 0.222 0 CA-C-O 120.868 0.366 . . . . 0.0 111.545 178.64 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 110' ' ' GLU . . . . . . . . . . . . . 70.6 mm-40 -104.86 142.92 33.89 Favored 'General case' 0 C--N 1.33 -0.276 0 N-CA-C 109.373 -0.603 . . . . 0.0 109.373 174.719 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 111' ' ' GLU . . . . . . . . . . . . . 48.7 tt0 -83.63 121.85 27.81 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-O 120.892 0.377 . . . . 0.0 110.201 -176.725 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 112' ' ' LEU . . . . . . . . . . . . . 52.2 mt -105.1 -42.25 5.35 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 115.86 -0.609 . . . . 0.0 110.619 -179.526 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 113' ' ' TYR . . . . . . . . . . . . . 51.7 t80 -133.05 131.61 40.84 Favored 'General case' 0 C--N 1.331 -0.204 0 CA-C-O 121.01 0.433 . . . . 0.0 111.042 -179.095 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 114' ' ' ARG . . . . . . . . . . . . . 57.1 ttt180 -132.48 119.01 20.02 Favored 'General case' 0 C--N 1.331 -0.226 0 CA-C-N 115.745 -0.661 . . . . 0.0 109.812 177.242 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 115' ' ' GLY . . . . . . . . . . . . . . . -150.14 159.28 28.04 Favored Glycine 0 CA--C 1.522 0.522 0 N-CA-C 110.766 -0.934 . . . . 0.0 110.766 179.136 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 116' ' ' LYS . . . . . . . . . . . . . 34.3 ttmt -130.24 139.61 50.78 Favored 'General case' 0 C--N 1.329 -0.296 0 N-CA-C 110.03 -0.359 . . . . 0.0 110.03 177.646 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 117' ' ' PHE . . . . . . . . . . . . . 49.1 m-85 -134.87 113.96 12.09 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.288 -0.415 . . . . 0.0 110.012 -176.832 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 118' ' ' GLU . . . . . . . . . . . . . 79.6 tt0 -53.72 -43.28 68.91 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.64 -0.254 . . . . 0.0 111.263 -176.47 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 119' ' ' ASN . . . . . . . . . . . . . 32.5 m120 -99.31 30.99 3.26 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.091 -0.504 . . . . 0.0 112.119 -174.781 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 120' ' ' LEU . . . . . . . . . . . . . 15.4 tp -55.24 122.83 11.96 Favored 'General case' 0 N--CA 1.462 0.171 0 CA-C-O 120.751 0.31 . . . . 0.0 110.66 179.22 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 121' ' ' ASN . . . . . . . . . . . . . 64.9 t30 -113.33 -44.15 3.27 Favored 'General case' 0 C--N 1.331 -0.197 0 CA-C-N 116.362 -0.381 . . . . 0.0 111.046 -176.871 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 122' ' ' LYS . . . . . . . . . . . . . 93.4 mttt -144.26 148.1 34.43 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-O 121.057 0.456 . . . . 0.0 112.014 -177.869 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 123' ' ' VAL . . . . . 0.402 ' HB ' HD11 ' A' ' 96' ' ' ILE . 45.6 t -126.66 123.59 63.33 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.288 0 N-CA-C 109.066 -0.716 . . . . 0.0 109.066 172.567 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 124' ' ' LEU . . . . . . . . . . . . . 62.1 mt -125.74 136.93 53.72 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-O 120.855 0.36 . . . . 0.0 111.047 -176.954 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 125' ' ' VAL . . . . . . . . . . . . . 11.4 p -134.75 130.31 52.69 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.308 0 CA-C-N 115.967 -0.56 . . . . 0.0 110.148 178.196 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 126' ' ' ARG . . . . . . . . . . . . . 35.7 mmt180 -140.46 127.2 20.42 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.186 179.14 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 127' ' ' ASN . . . . . . . . . . . . . 12.5 t-20 52.04 -111.58 0.59 Allowed 'General case' 0 CA--C 1.544 0.742 0 CA-C-O 118.696 -0.668 . . . . 0.0 110.933 -179.969 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 128' ' ' ASP . . . . . . . . . . . . . 13.3 p-10 -114.06 8.6 17.09 Favored 'General case' 0 CA--C 1.537 0.45 0 CA-C-N 120.073 1.306 . . . . 0.0 113.23 179.918 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 129' ' ' LEU . . . . . . . . . . . . . 14.3 tp -106.41 135.61 47.61 Favored 'General case' 0 C--O 1.231 0.115 0 CA-C-N 118.037 0.38 . . . . 0.0 110.144 -179.993 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 130' ' ' VAL . . . . . 0.402 HG11 HD13 ' A' ' 104' ' ' ILE . 43.1 t -119.82 135.86 58.79 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.202 0 N-CA-C 109.831 -0.433 . . . . 0.0 109.831 -179.475 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 131' ' ' VAL . . . . . 0.498 HG12 HD12 ' A' ' 140' ' ' LEU . 21.0 m -136.04 138.8 46.88 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.239 0 CA-C-O 121.314 0.578 . . . . 0.0 110.94 177.928 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 132' ' ' ILE . . . . . . . . . . . . . 72.2 mt -118.86 131.12 72.58 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.319 0 CA-C-N 115.353 -0.84 . . . . 0.0 109.001 178.871 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 133' ' ' ILE . . . . . . . . . . . . . 39.3 mm -115.86 123.96 71.73 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.271 0 CA-C-N 116.596 -0.275 . . . . 0.0 110.747 -174.211 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 134' ' ' ASP . . . . . . . . . . . . . 13.4 p-10 -136.02 154.57 51.02 Favored 'General case' 0 C--N 1.332 -0.181 0 CA-C-N 116.295 -0.412 . . . . 0.0 110.086 176.409 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 135' ' ' GLU . . . . . . . . . . . . . 75.9 tt0 -50.02 -29.27 8.38 Favored 'General case' 0 C--N 1.328 -0.346 0 N-CA-C 113.4 0.889 . . . . 0.0 113.4 -168.815 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 136' ' ' GLN . . . . . . . . . . . . . 14.5 pt20 -99.83 -17.01 17.86 Favored 'General case' 0 C--O 1.235 0.34 0 N-CA-C 113.596 0.962 . . . . 0.0 113.596 -171.233 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 137' ' ' LYS . . . . . . . . . . . . . 19.2 pttp -168.04 172.2 9.01 Favored 'General case' 0 C--O 1.232 0.152 0 CA-C-O 121.692 0.758 . . . . 0.0 112.661 -175.41 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 138' ' ' LEU . . . . . . . . . . . . . 7.0 tt -123.26 129.55 51.52 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 114.71 -1.132 . . . . 0.0 110.01 178.985 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 139' ' ' THR . . . . . . . . . . . . . 30.4 m -108.3 127.99 54.35 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-N 116.247 -0.433 . . . . 0.0 110.579 179.69 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 140' ' ' LEU . . . . . 0.498 HD12 HG12 ' A' ' 131' ' ' VAL . 29.1 tp -111.93 123.33 50.02 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 115.61 -0.723 . . . . 0.0 109.159 -179.074 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 141' ' ' ILE . . . . . . . . . . . . . 19.6 mt -122.13 121.57 64.34 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.354 0 CA-C-O 120.911 0.386 . . . . 0.0 110.07 -174.662 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 142' ' ' ARG . . . . . . . . . . . . . 77.6 mtp180 -105.04 118.51 36.71 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 115.588 -0.733 . . . . 0.0 109.836 179.413 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 143' ' ' THR . . . . . . . . . . . . . 73.0 p . . . . . 0 C--O 1.221 -0.428 0 CA-C-O 117.976 -1.011 . . . . 0.0 110.592 -178.69 . . . . . . . . 0 0 . 1 . 013 nuclear build full ' B' B ' -3' ' ' GLU . . . . . . . . . . . . . 95.5 mt-10 . . . . . 0 N--CA 1.492 1.634 0 N-CA-C 109.299 -0.63 . . . . 0.0 109.299 . . . . . . . . . 0 0 . 1 . 013 nuclear build full ' B' B ' -2' ' ' GLY . . . . . . . . . . . . . . . -91.98 143.91 16.83 Favored Glycine 0 CA--C 1.525 0.669 0 N-CA-C 111.049 -0.821 . . . . 0.0 111.049 179.645 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' B' B ' -1' ' ' VAL . . . . . . . . . . . . . 44.6 t -96.82 136.94 25.95 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.323 0 CA-C-O 120.821 0.343 . . . . 0.0 110.082 179.855 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' B' B ' 0' ' ' ILE . . . . . . . . . . . . . 71.2 mt -108.17 131.46 58.55 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 N-CA-C 109.537 -0.542 . . . . 0.0 109.537 178.92 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' B' B ' 1' ' ' MET . . . . . . . . . . . . . 22.7 ptt? -78.99 128.04 32.76 Favored 'General case' 0 C--N 1.331 -0.21 0 C-N-CA 120.743 -0.383 . . . . 0.0 110.87 -177.905 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' B' B ' 2' ' ' SER . . . . . . . . . . . . . 3.1 p -123.1 131.02 53.52 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.096 -0.502 . . . . 0.0 110.077 177.445 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' B' B ' 3' ' ' GLU . . . . . . . . . . . . . 78.2 tt0 -140.64 137.57 33.7 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.622 -179.4 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' B' B ' 4' ' ' LEU . . . . . . . . . . . . . 12.6 tp -121.77 127.67 50.89 Favored 'General case' 0 C--N 1.331 -0.2 0 CA-C-N 116.096 -0.502 . . . . 0.0 110.143 177.501 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' B' B ' 5' ' ' LYS . . . . . . . . . . . . . 94.9 mttt -102.44 121.27 42.01 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.34 -0.391 . . . . 0.0 110.422 178.2 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' B' B ' 6' ' ' LEU . . . . . . . . . . . . . 59.5 mt -116.34 148.43 40.6 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-N 115.538 -0.756 . . . . 0.0 110.507 -178.98 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' B' B ' 7' ' ' LYS . . . . . . . . . . . . . 47.8 tttp -137.67 138.3 23.91 Favored Pre-proline 0 CA--C 1.534 0.341 0 CA-C-O 118.935 -0.555 . . . . 0.0 110.14 175.502 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' B' B ' 8' ' ' PRO . . . . . . . . . . . . . 98.9 Cg_endo -91.98 138.31 1.95 Allowed 'Trans proline' 0 N--CA 1.491 1.326 0 C-N-CA 121.803 1.669 . . . . 0.0 111.544 176.51 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' B' B ' 9' ' ' LEU . . . . . . . . . . . . . 65.7 mt -73.27 -47.33 7.77 Favored Pre-proline 0 CA--C 1.533 0.326 0 CA-C-O 118.751 -0.642 . . . . 0.0 112.238 -178.583 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' B' B ' 10' ' ' PRO . . . . . . . . . . . . . 87.8 Cg_endo -81.16 152.58 18.51 Favored 'Trans proline' 0 N--CA 1.496 1.672 0 C-N-CA 121.234 1.29 . . . . 0.0 111.894 175.807 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' B' B ' 11' ' ' LYS . . . . . . . . . . . . . 68.1 mttm -85.54 102.91 13.92 Favored 'General case' 0 C--N 1.33 -0.24 0 N-CA-C 110.106 -0.331 . . . . 0.0 110.106 177.459 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' B' B ' 12' ' ' VAL . . . . . . . . . . . . . 12.2 p -139.79 145.31 26.84 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.281 0 CA-C-N 116.335 -0.393 . . . . 0.0 110.722 -178.242 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' B' B ' 13' ' ' GLU . . . . . . . . . . . . . 95.5 mt-10 -87.83 121.32 30.11 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.094 -0.503 . . . . 0.0 109.887 177.13 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' B' B ' 14' ' ' LEU . . . . . . . . . . . . . 16.3 mt -97.71 153.0 38.43 Favored Pre-proline 0 C--N 1.329 -0.321 0 CA-C-N 116.498 -0.319 . . . . 0.0 110.678 -176.931 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' B' B ' 15' ' ' PRO . . . . . . . . . . . . . 26.0 Cg_exo -62.24 155.67 55.34 Favored 'Trans proline' 0 N--CA 1.497 1.713 0 C-N-CA 121.288 1.325 . . . . 0.0 111.581 176.076 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' B' B ' 16' ' ' PRO . . . . . . . . . . . . . 35.0 Cg_exo -58.0 -35.75 98.54 Favored 'Trans proline' 0 N--CA 1.498 1.742 0 C-N-CA 121.418 1.412 . . . . 0.0 112.704 -179.619 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' B' B ' 17' ' ' ASP . . . . . . . . . . . . . 17.8 p-10 -89.15 11.53 18.36 Favored 'General case' 0 C--N 1.327 -0.39 0 N-CA-C 113.202 0.816 . . . . 0.0 113.202 -177.462 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' B' B ' 18' ' ' PHE . . . . . . . . . . . . . 47.3 t80 -58.1 -42.64 86.13 Favored 'General case' 0 C--N 1.334 -0.088 0 O-C-N 121.905 -0.497 . . . . 0.0 110.023 -178.174 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' B' B ' 19' ' ' VAL . . . . . . . . . . . . . 49.1 t -58.0 -42.89 83.8 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.319 0 CA-C-N 116.438 -0.346 . . . . 0.0 110.283 -178.42 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' B' B ' 20' ' ' ASP . . . . . . . . . . . . . 81.2 m-20 -59.66 -42.16 92.19 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-O 120.796 0.331 . . . . 0.0 110.91 -177.955 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' B' B ' 21' ' ' VAL . . . . . . . . . . . . . 47.0 t -64.35 -49.31 81.53 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.321 0 CA-C-N 116.361 -0.381 . . . . 0.0 110.412 -178.215 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' B' B ' 22' ' ' ILE . . . . . 0.456 HG22 HD12 ' B' ' 26' ' ' LEU . 49.5 mm -56.89 -43.29 80.06 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.271 0 C-N-CA 120.993 -0.283 . . . . 0.0 110.542 179.592 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' B' B ' 23' ' ' ARG . . . . . . . . . . . . . 38.3 ttp180 -54.17 -49.63 68.86 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-O 120.732 0.301 . . . . 0.0 111.303 -178.73 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' B' B ' 24' ' ' ILE . . . . . . . . . . . . . 69.6 mt -60.44 -41.92 89.22 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.265 0 CA-C-N 116.416 -0.357 . . . . 0.0 110.899 -178.573 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' B' B ' 25' ' ' LYS . . . . . . . . . . . . . 88.4 mttt -64.91 -40.17 94.66 Favored 'General case' 0 C--N 1.328 -0.344 0 N-CA-C 112.469 0.544 . . . . 0.0 112.469 -179.096 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' B' B ' 26' ' ' LEU . . . . . 0.456 HD12 HG22 ' B' ' 22' ' ' ILE . 57.8 mt -77.81 -41.81 35.95 Favored 'General case' 0 C--N 1.33 -0.276 0 N-CA-C 113.141 0.793 . . . . 0.0 113.141 -171.408 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' B' B ' 27' ' ' GLN . . . . . . . . . . . . . 14.3 pt20 -46.86 135.62 9.0 Favored 'General case' 0 N--CA 1.469 0.516 0 N-CA-C 112.717 0.636 . . . . 0.0 112.717 -175.929 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' B' B ' 28' ' ' GLY . . . . . . . . . . . . . . . 101.06 -25.38 28.51 Favored Glycine 0 CA--C 1.533 1.161 0 CA-C-N 115.671 -0.695 . . . . 0.0 112.483 -177.792 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' B' B ' 29' ' ' LYS . . . . . . . . . . . . . 97.5 mttt -98.63 155.09 17.48 Favored 'General case' 0 C--N 1.331 -0.207 0 CA-C-N 117.398 0.599 . . . . 0.0 111.163 178.78 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' B' B ' 30' ' ' THR . . . . . . . . . . . . . 25.7 m -104.65 137.71 42.06 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.076 -0.511 . . . . 0.0 109.921 175.186 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' B' B ' 31' ' ' VAL . . . . . . . . . . . . . 34.5 m -128.26 155.64 40.02 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.254 0 CA-C-O 120.824 0.345 . . . . 0.0 110.894 -178.798 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' B' B ' 32' ' ' ARG . . . . . . . . . . . . . 97.1 mtt180 -133.51 149.93 51.7 Favored 'General case' 0 C--N 1.331 -0.225 0 CA-C-O 121.193 0.521 . . . . 0.0 110.654 177.823 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' B' B ' 33' ' ' THR . . . . . . . . . . . . . 23.6 m -53.21 139.64 28.65 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.237 -0.438 . . . . 0.0 111.419 -178.2 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' B' B ' 34' ' ' GLY . . . . . . . . . . . . . . . 99.4 -17.12 58.22 Favored Glycine 0 CA--C 1.531 1.092 0 C-N-CA 121.18 -0.533 . . . . 0.0 113.28 178.891 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' B' B ' 35' ' ' ASP . . . . . . . . . . . . . 75.6 m-20 -65.79 148.95 50.95 Favored 'General case' 0 C--O 1.232 0.145 0 CA-C-N 118.109 0.954 . . . . 0.0 111.152 179.631 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' B' B ' 36' ' ' VAL . . . . . . . . . . . . . 42.5 t -122.71 130.59 74.39 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.207 0 CA-C-N 115.938 -0.574 . . . . 0.0 109.966 177.7 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' B' B ' 37' ' ' ILE . . . . . . . . . . . . . 66.4 mt -121.63 139.23 49.36 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.305 0 N-CA-C 109.772 -0.455 . . . . 0.0 109.772 -179.721 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' B' B ' 38' ' ' GLY . . . . . . . . . . . . . . . -113.37 128.8 8.53 Favored Glycine 0 CA--C 1.526 0.77 0 N-CA-C 111.384 -0.686 . . . . 0.0 111.384 -178.673 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' B' B ' 39' ' ' ILE . . . . . . . . . . . . . 68.5 mt -123.89 127.91 73.95 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.204 0 N-CA-C 109.771 -0.455 . . . . 0.0 109.771 178.084 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' B' B ' 40' ' ' SER . . . . . . . . . . . . . 30.6 t -93.81 123.15 36.96 Favored 'General case' 0 C--N 1.329 -0.294 0 C-N-CA 120.923 -0.311 . . . . 0.0 111.005 176.589 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' B' B ' 41' ' ' ILE . . . . . . . . . . . . . 70.4 mt -131.73 125.67 56.09 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.233 0 CA-C-O 120.877 0.37 . . . . 0.0 110.588 178.834 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' B' B ' 42' ' ' LEU . . . . . . . . . . . . . 9.9 tp 54.62 35.45 23.69 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.067 -0.515 . . . . 0.0 111.623 176.88 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' B' B ' 43' ' ' GLY . . . . . . . . . . . . . . . 71.96 27.29 70.75 Favored Glycine 0 CA--C 1.531 1.087 0 C-N-CA 121.078 -0.582 . . . . 0.0 112.392 177.34 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' B' B ' 44' ' ' LYS . . . . . . . . . . . . . 91.4 mttt -138.05 126.84 23.82 Favored 'General case' 0 C--N 1.331 -0.211 0 N-CA-C 109.434 -0.58 . . . . 0.0 109.434 178.292 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' B' B ' 45' ' ' GLU . . . . . . . . . . . . . 29.1 tp10 -85.25 129.22 34.85 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-O 120.801 0.334 . . . . 0.0 111.233 -175.887 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' B' B ' 46' ' ' VAL . . . . . . . . . . . . . 7.4 p -122.36 129.48 75.26 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.2 0 N-CA-C 109.435 -0.58 . . . . 0.0 109.435 174.865 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' B' B ' 47' ' ' LYS . . . . . . . . . . . . . 69.0 mmtt -100.42 128.26 46.53 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.023 -0.535 . . . . 0.0 111.336 177.545 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' B' B ' 48' ' ' PHE . . . . . . . . . . . . . 91.7 m-85 -109.93 131.84 54.69 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 115.954 -0.566 . . . . 0.0 109.58 175.096 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' B' B ' 49' ' ' LYS . . . . . . . . . . . . . 41.5 tttp -108.62 137.63 46.25 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.422 -0.353 . . . . 0.0 110.365 179.638 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' B' B ' 50' ' ' VAL . . . . . . . . . . . . . 44.8 t -78.98 107.1 11.05 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.213 0 N-CA-C 109.326 -0.62 . . . . 0.0 109.326 176.352 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' B' B ' 51' ' ' VAL . . . . . . . . . . . . . 46.4 t -69.0 -48.97 67.06 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.329 0 CA-C-N 115.935 -0.575 . . . . 0.0 109.8 -174.097 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' B' B ' 52' ' ' GLN . . . . . . . . . . . . . 60.1 tt0 -170.1 147.93 3.28 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 115.838 -0.619 . . . . 0.0 111.274 -178.863 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' B' B ' 53' ' ' ALA . . . . . . . . . . . . . . . -122.77 136.78 54.98 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.085 -0.507 . . . . 0.0 110.34 178.843 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' B' B ' 54' ' ' TYR . . . . . . . . . . . . . 47.0 t80 -129.16 111.84 18.29 Favored Pre-proline 0 CA--C 1.535 0.387 0 CA-C-O 118.265 -0.874 . . . . 0.0 110.212 177.995 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' B' B ' 55' ' ' PRO . . . . . . . . . . . . . 73.4 Cg_endo -77.17 167.88 78.46 Favored 'Cis proline' 0 N--CA 1.5 1.901 0 CA-C-N 121.932 1.726 . . . . 0.0 112.127 -6.991 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' B' B ' 56' ' ' SER . . . . . . . . . . . . . 24.0 m -117.22 133.12 23.21 Favored Pre-proline 0 CA--C 1.537 0.476 0 CA-C-O 118.492 -0.766 . . . . 0.0 109.576 175.102 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' B' B ' 57' ' ' PRO . . . . . . . . . . . . . 36.4 Cg_endo -66.34 164.0 67.66 Favored 'Cis proline' 0 N--CA 1.499 1.809 0 CA-C-N 121.953 1.733 . . . . 0.0 111.375 -2.504 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' B' B ' 58' ' ' LEU . . . . . . . . . . . . . 23.0 tp -129.27 135.72 49.15 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.328 -0.396 . . . . 0.0 110.513 -179.217 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' B' B ' 59' ' ' ARG . . . . . . . . . . . . . 74.7 ttt180 -102.45 126.86 49.62 Favored 'General case' 0 C--N 1.327 -0.376 0 N-CA-C 109.241 -0.652 . . . . 0.0 109.241 175.362 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' B' B ' 60' ' ' VAL . . . . . . . . . . . . . 40.7 t -81.35 121.81 35.39 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.322 0 C-N-CA 120.634 -0.426 . . . . 0.0 110.402 -175.045 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' B' B ' 61' ' ' GLU . . . . . . . . . . . . . 95.1 mt-10 -131.11 165.38 23.4 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 115.803 -0.635 . . . . 0.0 109.634 176.698 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' B' B ' 62' ' ' ASP . . . . . . . . . . . . . 80.0 m-20 -53.82 -32.62 53.41 Favored 'General case' 0 C--N 1.328 -0.364 0 N-CA-C 111.787 0.291 . . . . 0.0 111.787 -179.852 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' B' B ' 63' ' ' ARG . . . . . . . . . . . . . 24.7 mmm180 -72.82 -18.96 61.41 Favored 'General case' 0 CA--C 1.535 0.379 0 N-CA-C 113.092 0.775 . . . . 0.0 113.092 -177.085 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' B' B ' 64' ' ' THR . . . . . . . . . . . . . 25.8 m -72.44 138.98 47.47 Favored 'General case' 0 C--N 1.331 -0.204 0 CA-C-O 120.962 0.411 . . . . 0.0 111.24 -174.642 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' B' B ' 65' ' ' LYS . . . . . . . . . . . . . 98.4 mttt -90.81 136.45 33.06 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 115.887 -0.597 . . . . 0.0 110.429 178.615 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' B' B ' 66' ' ' ILE . . . . . . . . . . . . . 60.6 mt -117.1 129.33 73.82 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.233 0 N-CA-C 109.662 -0.496 . . . . 0.0 109.662 179.147 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' B' B ' 67' ' ' THR . . . . . . . . . . . . . 28.0 m -125.74 144.85 50.45 Favored 'General case' 0 N--CA 1.463 0.205 0 CA-C-O 121.133 0.492 . . . . 0.0 111.581 -175.581 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' B' B ' 68' ' ' LEU . . . . . 0.492 HD23 ' N ' ' B' ' 69' ' ' VAL . 4.4 tt -96.45 127.27 42.29 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 115.614 -0.721 . . . . 0.0 109.559 177.026 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' B' B ' 69' ' ' VAL . . . . . 0.492 ' N ' HD23 ' B' ' 68' ' ' LEU . 40.7 t -83.87 134.43 26.97 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.361 0 CA-C-O 121.155 0.502 . . . . 0.0 111.14 -176.121 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' B' B ' 70' ' ' THR . . . . . . . . . . . . . 15.4 p -134.73 -170.04 2.47 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 115.419 -0.809 . . . . 0.0 109.442 177.227 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' B' B ' 71' ' ' HIS . . . . . . . . . . . . . 50.4 t60 -120.38 59.98 7.22 Favored Pre-proline 0 CA--C 1.54 0.569 0 CA-C-O 120.774 0.321 . . . . 0.0 111.775 179.584 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' B' B ' 72' ' ' PRO . . . . . . . . . . . . . 45.3 Cg_endo -91.34 160.08 3.71 Favored 'Trans proline' 0 N--CA 1.492 1.433 0 C-N-CA 121.965 1.777 . . . . 0.0 112.015 170.784 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' B' B ' 73' ' ' VAL . . . . . . . . . . . . . 33.8 m -69.98 165.62 2.52 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.229 0 N-CA-C 109.616 -0.512 . . . . 0.0 109.616 175.168 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' B' B ' 74' ' ' ASP . . . . . . . . . . . . . 12.6 t70 -96.62 121.2 38.19 Favored 'General case' 0 C--N 1.33 -0.264 0 C-N-CA 120.779 -0.369 . . . . 0.0 110.346 -176.082 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' B' B ' 75' ' ' VAL . . . . . . . . . . . . . 41.3 t -115.87 126.04 73.23 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.184 0 CA-C-O 121.057 0.456 . . . . 0.0 110.66 -178.263 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' B' B ' 76' ' ' LEU . . . . . . . . . . . . . 15.6 mt -127.59 148.16 50.36 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 115.587 -0.733 . . . . 0.0 109.367 176.929 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' B' B ' 77' ' ' GLU . . . . . . . . . . . . . 98.0 mt-10 -136.87 141.44 42.78 Favored 'General case' 0 C--N 1.333 -0.125 0 CA-C-O 121.173 0.511 . . . . 0.0 111.532 -176.423 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' B' B ' 78' ' ' ALA . . . . . . . . . . . . . . . -127.01 133.5 50.52 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 115.529 -0.76 . . . . 0.0 109.794 176.394 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' B' B ' 79' ' ' LYS . . . . . 0.637 ' O ' HD13 ' B' ' 80' ' ' ILE . 85.8 tttt -78.12 116.68 18.76 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-O 120.891 0.377 . . . . 0.0 110.728 -177.608 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' B' B ' 80' ' ' ILE . . . . . 0.637 HD13 ' O ' ' B' ' 79' ' ' LYS . 37.9 mm -139.15 108.43 3.77 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.302 0 N-CA-C 109.432 -0.581 . . . . 0.0 109.432 -176.447 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' B' B ' 81' ' ' LYS . . . . . . . . . . . . . 38.6 ttpt -104.36 127.7 52.07 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-O 120.839 0.352 . . . . 0.0 110.939 -177.629 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' B' B ' 82' ' ' GLY . . . . . . . . . . . . . . . 89.05 42.13 5.7 Favored Glycine 0 CA--C 1.525 0.675 0 C-N-CA 120.847 -0.692 . . . . 0.0 111.687 175.522 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' B' B ' 83' ' ' ILE . . . . . . . . . . . . . 72.2 mt -70.12 136.05 26.9 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.339 0 N-CA-C 109.669 -0.493 . . . . 0.0 109.669 177.515 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' B' B ' 84' ' ' LYS . . . . . . . . . . . . . 81.1 tttt -94.19 -52.12 4.51 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 115.996 -0.547 . . . . 0.0 110.307 -179.025 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' B' B ' 85' ' ' ASP . . . . . . . . . . . . . 9.5 t70 -156.33 155.79 32.85 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 115.838 -0.619 . . . . 0.0 110.439 179.936 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' B' B ' 86' ' ' VAL . . . . . . . . . . . . . 42.5 t -126.35 133.67 68.21 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.18 0 CA-C-O 121.048 0.451 . . . . 0.0 110.67 -178.338 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' B' B ' 87' ' ' ILE . . . . . . . . . . . . . 44.7 mm -118.42 121.15 66.4 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.282 0 CA-C-N 115.644 -0.707 . . . . 0.0 109.245 175.264 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' B' B ' 88' ' ' LEU . . . . . 0.405 HD22 ' CG2' ' A' ' 131' ' ' VAL . 17.7 tp -109.98 132.51 54.09 Favored 'General case' 0 C--N 1.332 -0.194 0 CA-C-O 120.907 0.384 . . . . 0.0 111.428 -175.055 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' B' B ' 89' ' ' ASP . . . . . . . . . . . . . 9.8 t70 -129.49 153.33 48.09 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 115.91 -0.586 . . . . 0.0 109.56 175.869 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' B' B ' 90' ' ' GLU . . . . . . . . . . . . . 83.5 tt0 -48.21 -36.33 13.54 Favored 'General case' 0 C--N 1.329 -0.294 0 N-CA-C 112.738 0.644 . . . . 0.0 112.738 -172.641 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' B' B ' 91' ' ' ASN . . . . . . . . . . . . . 7.1 p30 -132.09 29.37 4.37 Favored 'General case' 0 N--CA 1.466 0.341 0 N-CA-C 112.301 0.482 . . . . 0.0 112.301 -177.378 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' B' B ' 92' ' ' LEU . . . . . . . . . . . . . 5.0 mt -154.78 143.16 20.48 Favored 'General case' 0 C--N 1.331 -0.213 0 N-CA-C 109.809 -0.441 . . . . 0.0 109.809 -178.474 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' B' B ' 93' ' ' ILE . . . . . . . . . . . . . 70.6 mt -123.38 112.26 32.75 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.213 0 N-CA-C 108.926 -0.768 . . . . 0.0 108.926 176.752 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' B' B ' 94' ' ' VAL . . . . . . . . . . . . . 46.3 t -116.05 125.56 73.2 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.258 0 N-CA-C 109.589 -0.523 . . . . 0.0 109.589 -179.599 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' B' B ' 95' ' ' VAL . . . . . . . . . . . . . 43.2 t -122.93 135.81 61.79 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.349 0 CA-C-N 116.127 -0.488 . . . . 0.0 109.976 -178.141 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' B' B ' 96' ' ' ILE . . . . . . . . . . . . . 63.8 mt -111.6 127.58 68.67 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.355 0 N-CA-C 109.075 -0.713 . . . . 0.0 109.075 178.145 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' B' B ' 97' ' ' THR . . . . . . . . . . . . . 78.4 p -101.18 156.79 17.22 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-O 120.967 0.413 . . . . 0.0 111.136 -177.479 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' B' B ' 98' ' ' GLU . . . . . . . . . . . . . 13.5 pt-20 -53.87 -23.62 13.16 Favored 'General case' 0 CA--C 1.533 0.319 0 N-CA-C 112.434 0.531 . . . . 0.0 112.434 -179.97 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' B' B ' 99' ' ' GLU . . . . . . . . . . . . . 95.6 mt-10 -79.24 14.5 1.48 Allowed 'General case' 0 CA--C 1.536 0.433 0 N-CA-C 112.969 0.729 . . . . 0.0 112.969 -178.212 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' B' B ' 100' ' ' ASN . . . . . . . . . . . . . 2.4 m-20 61.71 37.95 15.47 Favored 'General case' 0 CA--C 1.529 0.169 0 CA-C-O 121.081 0.467 . . . . 0.0 110.893 178.9 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' B' B ' 101' ' ' GLU . . . . . . . . . . . . . 83.5 tt0 -116.53 144.74 43.98 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-N 116.039 -0.528 . . . . 0.0 109.728 176.561 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' B' B ' 102' ' ' VAL . . . . . . . . . . . . . 46.1 t -114.94 123.6 70.78 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.314 0 N-CA-C 109.592 -0.521 . . . . 0.0 109.592 -179.942 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' B' B ' 103' ' ' LEU . . . . . . . . . . . . . 70.9 mt -114.34 131.78 56.43 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 115.806 -0.634 . . . . 0.0 110.255 178.411 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' B' B ' 104' ' ' ILE . . . . . 0.612 HD12 ' HB3' ' B' ' 113' ' ' TYR . 66.7 mt -117.9 117.54 55.26 Favored 'Isoleucine or valine' 0 C--O 1.234 0.252 0 CA-C-N 116.441 -0.345 . . . . 0.0 110.247 -178.756 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' B' B ' 105' ' ' PHE . . . . . . . . . . . . . 82.7 m-85 -117.43 163.29 16.6 Favored 'General case' 0 C--N 1.332 -0.157 0 O-C-N 124.241 0.963 . . . . 0.0 109.846 -179.906 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' B' B ' 106' ' ' ASN . . . . . . . . . . . . . 52.9 p-10 -102.41 -172.26 2.1 Favored 'General case' 0 C--N 1.331 -0.211 0 N-CA-C 109.757 -0.46 . . . . 0.0 109.757 171.256 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' B' B ' 107' ' ' GLN . . . . . . . . . . . . . 48.9 tt0 -58.45 -29.73 66.4 Favored 'General case' 0 C--N 1.328 -0.329 0 N-CA-C 112.227 0.454 . . . . 0.0 112.227 -178.066 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' B' B ' 108' ' ' ASN . . . . . . . . . . . . . 11.7 t-20 -88.74 14.16 10.8 Favored 'General case' 0 CA--C 1.535 0.385 0 N-CA-C 112.862 0.69 . . . . 0.0 112.862 -176.22 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' B' B ' 109' ' ' LEU . . . . . . . . . . . . . 71.6 mt 58.61 35.53 24.56 Favored 'General case' 0 C--O 1.234 0.238 0 CA-C-O 120.822 0.344 . . . . 0.0 111.547 178.771 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' B' B ' 110' ' ' GLU . . . . . . . . . . . . . 43.3 mt-10 -105.27 141.32 37.0 Favored 'General case' 0 C--N 1.329 -0.299 0 N-CA-C 109.771 -0.455 . . . . 0.0 109.771 176.35 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' B' B ' 111' ' ' GLU . . . . . . . . . . . . . 97.7 mt-10 -77.29 125.51 29.44 Favored 'General case' 0 C--N 1.327 -0.399 0 CA-C-N 116.331 -0.395 . . . . 0.0 111.257 -176.77 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' B' B ' 112' ' ' LEU . . . . . . . . . . . . . 11.6 mt -106.71 -45.99 4.08 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.041 -0.527 . . . . 0.0 110.176 176.889 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' B' B ' 113' ' ' TYR . . . . . 0.612 ' HB3' HD12 ' B' ' 104' ' ' ILE . 55.9 t80 -140.45 140.69 35.43 Favored 'General case' 0 C--N 1.33 -0.243 0 C-N-CA 120.74 -0.384 . . . . 0.0 110.956 -178.84 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' B' B ' 114' ' ' ARG . . . . . . . . . . . . . 21.0 mtp-105 -139.36 126.22 20.88 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.244 -0.435 . . . . 0.0 110.209 176.04 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' B' B ' 115' ' ' GLY . . . . . . . . . . . . . . . -150.07 142.81 10.03 Favored Glycine 0 CA--C 1.523 0.532 0 N-CA-C 111.229 -0.748 . . . . 0.0 111.229 179.826 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' B' B ' 116' ' ' LYS . . . . . . . . . . . . . 39.1 ttpt -112.02 132.82 54.57 Favored 'General case' 0 C--N 1.33 -0.245 0 N-CA-C 109.774 -0.454 . . . . 0.0 109.774 177.955 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' B' B ' 117' ' ' PHE . . . . . . . . . . . . . 40.9 m-85 -134.27 113.87 12.42 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-O 120.942 0.401 . . . . 0.0 110.198 -176.532 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' B' B ' 118' ' ' GLU . . . . . . . . . . . . . 95.8 mt-10 -56.34 -41.93 76.9 Favored 'General case' 0 C--N 1.326 -0.426 0 CA-C-N 116.13 -0.487 . . . . 0.0 111.196 -174.594 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' B' B ' 119' ' ' ASN . . . . . . . . . . . . . 88.5 m-20 -100.6 31.12 3.61 Favored 'General case' 0 C--N 1.329 -0.295 0 N-CA-C 112.213 0.449 . . . . 0.0 112.213 -173.853 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' B' B ' 120' ' ' LEU . . . . . . . . . . . . . 9.7 tp -55.25 122.03 10.18 Favored 'General case' 0 N--CA 1.462 0.158 0 C-N-CA 121.044 -0.262 . . . . 0.0 110.674 178.062 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' B' B ' 121' ' ' ASN . . . . . . . . . . . . . 3.5 m-20 -114.09 -44.14 3.17 Favored 'General case' 0 C--N 1.332 -0.153 0 CA-C-N 116.63 -0.259 . . . . 0.0 111.18 -176.242 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' B' B ' 122' ' ' LYS . . . . . . . . . . . . . 16.1 ttmm -151.79 142.65 22.97 Favored 'General case' 0 C--N 1.331 -0.206 0 C-N-CA 120.363 -0.535 . . . . 0.0 111.712 -176.828 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' B' B ' 123' ' ' VAL . . . . . . . . . . . . . 46.2 t -120.72 130.79 74.18 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.256 0 CA-C-N 115.825 -0.625 . . . . 0.0 109.628 177.139 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' B' B ' 124' ' ' LEU . . . . . . . . . . . . . 75.4 mt -127.83 138.48 52.72 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-O 120.831 0.348 . . . . 0.0 110.692 -178.424 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' B' B ' 125' ' ' VAL . . . . . . . . . . . . . 35.0 m -130.7 143.15 41.78 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.245 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.909 -179.567 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' B' B ' 126' ' ' ARG . . . . . . . . . . . . . 94.3 mtt-85 -148.34 117.72 6.94 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 115.832 -0.622 . . . . 0.0 109.397 176.205 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' B' B ' 127' ' ' ASN . . . . . . . . . . . . . 79.8 m-20 56.61 -143.35 0.71 Allowed 'General case' 0 CA--C 1.541 0.615 0 CA-C-O 119.138 -0.458 . . . . 0.0 109.773 -179.39 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' B' B ' 128' ' ' ASP . . . . . . . . . . . . . 12.0 p-10 -85.76 10.28 14.06 Favored 'General case' 0 CA--C 1.535 0.396 0 CA-C-N 119.248 0.931 . . . . 0.0 113.229 179.953 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' B' B ' 129' ' ' LEU . . . . . 0.47 HD13 HH21 ' B' ' 142' ' ' ARG . 28.2 mt -111.22 145.15 39.22 Favored 'General case' 0 N--CA 1.463 0.189 0 O-C-N 121.841 -0.537 . . . . 0.0 109.762 179.112 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' B' B ' 130' ' ' VAL . . . . . 0.475 HG23 ' HB ' ' B' ' 141' ' ' ILE . 32.6 m -137.13 148.09 26.53 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.262 0 CA-C-O 121.315 0.578 . . . . 0.0 111.923 -175.943 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' B' B ' 131' ' ' VAL . . . . . 0.461 HG22 HD12 ' B' ' 140' ' ' LEU . 43.9 t -136.14 137.7 48.14 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.225 0 CA-C-N 115.535 -0.757 . . . . 0.0 110.087 177.504 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' B' B ' 132' ' ' ILE . . . . . . . . . . . . . 75.3 mt -118.77 132.02 69.87 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.287 0 CA-C-N 116.028 -0.533 . . . . 0.0 109.669 -179.757 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' B' B ' 133' ' ' ILE . . . . . . . . . . . . . 41.0 mm -115.62 122.83 70.23 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.251 0 CA-C-N 116.414 -0.357 . . . . 0.0 110.883 -175.339 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' B' B ' 134' ' ' ASP . . . . . . . . . . . . . 9.3 p-10 -136.91 144.24 43.37 Favored 'General case' 0 C--N 1.331 -0.222 0 N-CA-C 109.691 -0.485 . . . . 0.0 109.691 173.282 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' B' B ' 135' ' ' GLU . . . . . . . . . . . . . 33.0 tp10 -49.91 -24.38 2.48 Favored 'General case' 0 C--N 1.326 -0.431 0 N-CA-C 112.806 0.669 . . . . 0.0 112.806 -172.394 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' B' B ' 136' ' ' GLN . . . . . . . . . . . . . 48.1 tt0 -82.51 -38.57 23.65 Favored 'General case' 0 C--N 1.332 -0.168 0 N-CA-C 112.082 0.401 . . . . 0.0 112.082 -176.934 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' B' B ' 137' ' ' LYS . . . . . . . . . . . . . 58.7 pttt -160.01 168.55 25.37 Favored 'General case' 0 C--O 1.234 0.256 0 CA-C-O 121.495 0.664 . . . . 0.0 112.119 -173.1 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' B' B ' 138' ' ' LEU . . . . . 0.445 HD23 ' N ' ' B' ' 139' ' ' THR . 5.1 tt -116.39 127.45 54.65 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 115.155 -0.93 . . . . 0.0 109.781 178.38 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' B' B ' 139' ' ' THR . . . . . 0.445 ' N ' HD23 ' B' ' 138' ' ' LEU . 31.8 m -109.79 124.83 51.96 Favored 'General case' 0 C--N 1.331 -0.217 0 CA-C-O 120.738 0.304 . . . . 0.0 110.381 179.926 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' B' B ' 140' ' ' LEU . . . . . 0.461 HD12 HG22 ' B' ' 131' ' ' VAL . 11.2 tp -114.86 117.27 30.23 Favored 'General case' 0 C--N 1.328 -0.367 0 N-CA-C 108.897 -0.779 . . . . 0.0 108.897 -179.183 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' B' B ' 141' ' ' ILE . . . . . 0.475 ' HB ' HG23 ' B' ' 130' ' ' VAL . 18.9 mt -117.22 117.01 53.85 Favored 'Isoleucine or valine' 0 C--O 1.236 0.361 0 CA-C-O 121.129 0.49 . . . . 0.0 110.069 -174.373 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' B' B ' 142' ' ' ARG . . . . . 0.47 HH21 HD13 ' B' ' 129' ' ' LEU . 2.0 mtp85 -103.72 135.01 46.09 Favored 'General case' 0 C--N 1.331 -0.201 0 CA-C-N 115.033 -0.985 . . . . 0.0 109.824 -177.353 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' B' B ' 143' ' ' THR . . . . . . . . . . . . . 72.7 p . . . . . 0 C--O 1.22 -0.478 0 CA-C-O 118.241 -0.885 . . . . 0.0 110.763 -179.722 . . . . . . . . 0 0 . 1 . 013 nuclear build full ' C' C ' -3' ' ' GLU . . . . . . . . . . . . . 84.8 tt0 . . . . . 0 N--CA 1.491 1.609 0 N-CA-C 109.256 -0.646 . . . . 0.0 109.256 . . . . . . . . . 0 0 . 1 . 013 nuclear build full ' C' C ' -2' ' ' GLY . . . . . . . . . . . . . . . -71.31 145.16 38.72 Favored Glycine 0 CA--C 1.524 0.617 0 N-CA-C 110.686 -0.966 . . . . 0.0 110.686 178.718 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' C' C ' -1' ' ' VAL . . . . . . . . . . . . . 47.4 t -93.88 133.78 33.78 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.275 0 N-CA-C 109.902 -0.407 . . . . 0.0 109.902 179.868 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' C' C ' 0' ' ' ILE . . . . . . . . . . . . . 71.6 mt -110.41 129.94 64.58 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.217 0 CA-C-N 116.127 -0.488 . . . . 0.0 109.875 -179.082 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' C' C ' 1' ' ' MET . . . . . . . . . . . . . 24.9 ptp -80.98 133.3 35.48 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.062 -0.517 . . . . 0.0 110.938 -178.626 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' C' C ' 2' ' ' SER . . . . . . . . . . . . . 2.4 p -127.24 124.95 40.08 Favored 'General case' 0 C--N 1.332 -0.191 0 CA-C-N 116.084 -0.507 . . . . 0.0 110.274 177.919 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' C' C ' 3' ' ' GLU . . . . . . . . . . . . . 84.2 tt0 -139.77 140.1 36.62 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 115.918 -0.583 . . . . 0.0 111.045 -177.244 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' C' C ' 4' ' ' LEU . . . . . . . . . . . . . 18.0 tp -126.7 130.16 49.83 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.028 -0.533 . . . . 0.0 110.203 177.752 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' C' C ' 5' ' ' LYS . . . . . . . . . . . . . 61.4 mttp -109.06 119.8 40.63 Favored 'General case' 0 C--O 1.233 0.22 0 CA-C-O 120.9 0.381 . . . . 0.0 110.693 179.054 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' C' C ' 6' ' ' LEU . . . . . 0.473 HD23 ' HA ' ' C' ' 50' ' ' VAL . 36.6 mt -115.04 148.82 38.38 Favored 'General case' 0 C--N 1.331 -0.211 0 CA-C-N 115.359 -0.837 . . . . 0.0 110.554 179.495 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' C' C ' 7' ' ' LYS . . . . . . . . . . . . . 25.9 ttpp -135.25 135.29 22.36 Favored Pre-proline 0 CA--C 1.535 0.392 0 CA-C-O 118.773 -0.632 . . . . 0.0 109.966 176.418 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' C' C ' 8' ' ' PRO . . . . . . . . . . . . . 89.7 Cg_endo -88.82 136.6 3.12 Favored 'Trans proline' 0 N--CA 1.492 1.383 0 C-N-CA 121.534 1.489 . . . . 0.0 111.515 176.344 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' C' C ' 9' ' ' LEU . . . . . . . . . . . . . 51.1 mt -73.32 -47.62 7.57 Favored Pre-proline 0 CA--C 1.534 0.335 0 CA-C-O 118.616 -0.707 . . . . 0.0 112.17 -178.237 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' C' C ' 10' ' ' PRO . . . . . . . . . . . . . 97.8 Cg_endo -79.8 145.57 18.06 Favored 'Trans proline' 0 N--CA 1.495 1.598 0 C-N-CA 121.104 1.202 . . . . 0.0 111.639 175.381 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' C' C ' 11' ' ' LYS . . . . . . . . . . . . . 52.9 pttt -78.43 111.88 14.9 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-O 121.601 0.715 . . . . 0.0 110.561 179.026 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' C' C ' 12' ' ' VAL . . . . . . . . . . . . . 12.4 p -151.11 148.32 14.99 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.295 0 CA-C-N 115.609 -0.723 . . . . 0.0 110.612 -179.437 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' C' C ' 13' ' ' GLU . . . . . . . . . . . . . 49.1 mp0 -91.65 120.78 32.72 Favored 'General case' 0 C--N 1.331 -0.236 0 N-CA-C 109.752 -0.462 . . . . 0.0 109.752 174.997 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' C' C ' 14' ' ' LEU . . . . . . . . . . . . . 14.7 mt -89.01 152.11 47.88 Favored Pre-proline 0 C--N 1.329 -0.287 0 CA-C-N 116.501 -0.318 . . . . 0.0 110.768 -176.984 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' C' C ' 15' ' ' PRO . . . . . . . . . . . . . 37.0 Cg_exo -59.8 162.33 16.11 Favored 'Trans proline' 0 N--CA 1.498 1.768 0 C-N-CA 121.329 1.353 . . . . 0.0 111.835 176.771 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' C' C ' 16' ' ' PRO . . . . . . . . . . . . . 37.9 Cg_exo -58.46 -44.02 41.13 Favored 'Trans proline' 0 N--CA 1.497 1.731 0 C-N-CA 121.444 1.429 . . . . 0.0 112.861 -177.242 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' C' C ' 17' ' ' ASP . . . . . . . . . . . . . 23.3 p-10 -92.44 17.05 10.53 Favored 'General case' 0 CA--C 1.536 0.433 0 N-CA-C 112.924 0.712 . . . . 0.0 112.924 -176.964 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' C' C ' 18' ' ' PHE . . . . . . . . . . . . . 52.8 t80 -57.24 -41.8 80.25 Favored 'General case' 0 C--N 1.333 -0.128 0 O-C-N 122.106 -0.371 . . . . 0.0 110.227 -179.193 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' C' C ' 19' ' ' VAL . . . . . . . . . . . . . 48.7 t -56.93 -43.41 80.51 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.303 0 CA-C-N 116.434 -0.348 . . . . 0.0 110.317 -179.468 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' C' C ' 20' ' ' ASP . . . . . . . . . . . . . 16.4 m-20 -60.1 -42.57 94.97 Favored 'General case' 0 C--N 1.33 -0.272 0 C-N-CA 120.98 -0.288 . . . . 0.0 111.173 -178.821 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' C' C ' 21' ' ' VAL . . . . . . . . . . . . . 48.3 t -63.96 -46.62 93.52 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.278 0 C-N-CA 120.794 -0.362 . . . . 0.0 110.37 -177.491 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' C' C ' 22' ' ' ILE . . . . . 0.562 HG22 HD12 ' C' ' 26' ' ' LEU . 51.4 mm -56.42 -45.82 81.88 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.208 0 CA-C-O 120.747 0.308 . . . . 0.0 110.423 178.221 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' C' C ' 23' ' ' ARG . . . . . . . . . . . . . 50.6 ttp180 -54.6 -47.83 72.9 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.589 -0.278 . . . . 0.0 111.488 -178.501 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' C' C ' 24' ' ' ILE . . . . . . . . . . . . . 76.5 mt -59.85 -44.09 93.38 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.362 0 CA-C-O 120.606 0.241 . . . . 0.0 111.045 -178.376 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' C' C ' 25' ' ' LYS . . . . . . . . . . . . . 54.7 mtmt -64.62 -41.44 96.19 Favored 'General case' 0 C--N 1.327 -0.377 0 N-CA-C 112.367 0.506 . . . . 0.0 112.367 -178.332 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' C' C ' 26' ' ' LEU . . . . . 0.562 HD12 HG22 ' C' ' 22' ' ' ILE . 79.6 mt -79.2 -40.35 31.0 Favored 'General case' 0 C--N 1.33 -0.266 0 N-CA-C 113.416 0.895 . . . . 0.0 113.416 -171.397 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' C' C ' 27' ' ' GLN . . . . . . . . . . . . . 14.3 pt20 -46.78 139.5 5.32 Favored 'General case' 0 N--CA 1.47 0.526 0 N-CA-C 112.703 0.631 . . . . 0.0 112.703 -175.041 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' C' C ' 28' ' ' GLY . . . . . . . . . . . . . . . 100.72 -26.19 25.54 Favored Glycine 0 CA--C 1.534 1.271 0 CA-C-N 115.467 -0.788 . . . . 0.0 112.179 -176.586 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' C' C ' 29' ' ' LYS . . . . . . . . . . . . . 99.1 mttt -98.6 155.12 17.46 Favored 'General case' 0 C--N 1.331 -0.198 0 CA-C-N 117.411 0.605 . . . . 0.0 111.365 179.277 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' C' C ' 30' ' ' THR . . . . . . . . . . . . . 38.1 m -103.28 135.91 44.03 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 115.886 -0.597 . . . . 0.0 109.979 175.758 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' C' C ' 31' ' ' VAL . . . . . . . . . . . . . 34.7 m -130.01 152.95 38.17 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.229 0 CA-C-O 120.934 0.397 . . . . 0.0 110.867 -178.597 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' C' C ' 32' ' ' ARG . . . . . . . . . . . . . 34.5 ttp180 -130.59 149.84 52.07 Favored 'General case' 0 C--N 1.331 -0.221 0 CA-C-N 116.027 -0.533 . . . . 0.0 110.452 179.519 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' C' C ' 33' ' ' THR . . . . . . . . . . . . . 19.1 m -52.65 139.17 26.77 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.241 -0.436 . . . . 0.0 111.498 -177.111 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' C' C ' 34' ' ' GLY . . . . . . . . . . . . . . . 100.21 -17.19 57.34 Favored Glycine 0 CA--C 1.533 1.165 0 CA-C-O 119.644 -0.531 . . . . 0.0 113.179 179.321 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' C' C ' 35' ' ' ASP . . . . . . . . . . . . . 70.9 m-20 -65.41 149.24 50.35 Favored 'General case' 0 C--O 1.231 0.083 0 CA-C-N 118.087 0.944 . . . . 0.0 111.276 179.303 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' C' C ' 36' ' ' VAL . . . . . . . . . . . . . 45.2 t -123.3 130.71 74.12 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.215 0 CA-C-N 115.735 -0.666 . . . . 0.0 109.658 178.065 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' C' C ' 37' ' ' ILE . . . . . . . . . . . . . 67.8 mt -121.06 138.57 51.04 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.24 0 CA-C-N 116.306 -0.406 . . . . 0.0 110.05 -179.609 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' C' C ' 38' ' ' GLY . . . . . . . . . . . . . . . -110.47 128.77 8.97 Favored Glycine 0 CA--C 1.525 0.703 0 N-CA-C 110.859 -0.896 . . . . 0.0 110.859 179.263 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' C' C ' 39' ' ' ILE . . . . . . . . . . . . . 73.2 mt -122.68 129.56 75.11 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.226 0 N-CA-C 110.069 -0.345 . . . . 0.0 110.069 179.812 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' C' C ' 40' ' ' SER . . . . . . . . . . . . . 87.3 p -93.15 120.34 33.34 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.425 -0.352 . . . . 0.0 110.991 176.744 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' C' C ' 41' ' ' ILE . . . . . . . . . . . . . 70.2 mt -133.3 127.49 54.17 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.258 0 CA-C-O 120.886 0.374 . . . . 0.0 110.446 177.955 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' C' C ' 42' ' ' LEU . . . . . . . . . . . . . 11.2 tp 53.23 34.53 17.85 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.035 -0.53 . . . . 0.0 111.593 177.1 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' C' C ' 43' ' ' GLY . . . . . . . . . . . . . . . 71.2 31.07 66.62 Favored Glycine 0 CA--C 1.531 1.061 0 C-N-CA 121.094 -0.574 . . . . 0.0 111.941 177.907 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' C' C ' 44' ' ' LYS . . . . . . . . . . . . . 80.5 tttt -138.43 126.83 23.14 Favored 'General case' 0 C--N 1.329 -0.296 0 N-CA-C 109.751 -0.463 . . . . 0.0 109.751 179.834 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' C' C ' 45' ' ' GLU . . . . . . . . . . . . . 81.9 tt0 -84.37 122.83 29.49 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-N 116.45 -0.341 . . . . 0.0 111.003 -178.398 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' C' C ' 46' ' ' VAL . . . . . . . . . . . . . 7.2 p -119.88 130.29 74.38 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.302 0 N-CA-C 109.449 -0.574 . . . . 0.0 109.449 175.877 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' C' C ' 47' ' ' LYS . . . . . . . . . . . . . 64.9 mttp -100.27 127.86 46.47 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 115.979 -0.555 . . . . 0.0 111.356 178.768 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' C' C ' 48' ' ' PHE . . . . . . . . . . . . . 94.6 m-85 -111.33 131.88 54.83 Favored 'General case' 0 C--N 1.33 -0.273 0 N-CA-C 109.674 -0.491 . . . . 0.0 109.674 175.495 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' C' C ' 49' ' ' LYS . . . . . . . . . . . . . 83.3 tttt -108.48 137.06 47.06 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.401 -0.363 . . . . 0.0 110.654 179.869 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' C' C ' 50' ' ' VAL . . . . . 0.473 ' HA ' HD23 ' C' ' 6' ' ' LEU . 41.0 t -83.21 107.57 15.01 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.243 0 N-CA-C 109.421 -0.585 . . . . 0.0 109.421 176.465 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' C' C ' 51' ' ' VAL . . . . . . . . . . . . . 48.9 t -72.46 -53.48 19.23 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.275 0 N-CA-C 109.581 -0.525 . . . . 0.0 109.581 -175.455 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' C' C ' 52' ' ' GLN . . . . . . . . . . . . . 90.9 mt-30 -154.07 151.6 29.5 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.02 -0.536 . . . . 0.0 111.832 -177.647 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' C' C ' 53' ' ' ALA . . . . . . . . . . . . . . . -130.12 133.78 46.88 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 115.318 -0.855 . . . . 0.0 109.827 174.463 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' C' C ' 54' ' ' TYR . . . . . . . . . . . . . 53.7 t80 -129.16 111.27 18.22 Favored Pre-proline 0 CA--C 1.535 0.377 0 CA-C-O 118.267 -0.873 . . . . 0.0 110.395 178.662 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' C' C ' 55' ' ' PRO . . . . . . . . . . . . . 73.3 Cg_endo -77.1 166.33 82.64 Favored 'Cis proline' 0 N--CA 1.499 1.84 0 CA-C-N 121.919 1.721 . . . . 0.0 112.348 -6.855 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' C' C ' 56' ' ' SER . . . . . . . . . . . . . 20.3 m -116.74 135.94 23.09 Favored Pre-proline 0 CA--C 1.538 0.519 0 CA-C-O 118.423 -0.798 . . . . 0.0 109.363 173.775 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' C' C ' 57' ' ' PRO . . . . . . . . . . . . . 49.4 Cg_endo -70.0 146.03 81.58 Favored 'Cis proline' 0 N--CA 1.497 1.733 0 CA-C-N 121.832 1.69 . . . . 0.0 111.473 -1.837 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' C' C ' 58' ' ' LEU . . . . . . . . . . . . . 31.9 tp -108.16 137.65 45.77 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.331 -0.395 . . . . 0.0 110.696 -177.704 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' C' C ' 59' ' ' ARG . . . . . . . . . . . . . 55.6 ttp180 -102.89 125.23 49.56 Favored 'General case' 0 C--N 1.327 -0.377 0 N-CA-C 109.227 -0.657 . . . . 0.0 109.227 174.653 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' C' C ' 60' ' ' VAL . . . . . . . . . . . . . 45.8 t -79.66 120.78 31.66 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.293 0 C-N-CA 120.689 -0.404 . . . . 0.0 110.65 -174.717 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' C' C ' 61' ' ' GLU . . . . . . . . . . . . . 43.3 mt-10 -131.03 163.05 28.44 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 115.747 -0.661 . . . . 0.0 109.675 176.542 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' C' C ' 62' ' ' ASP . . . . . . . . . . . . . 9.3 p-10 -53.36 -32.58 49.93 Favored 'General case' 0 C--N 1.328 -0.342 0 N-CA-C 111.894 0.331 . . . . 0.0 111.894 -178.634 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' C' C ' 63' ' ' ARG . . . . . . . . . . . . . 47.8 mtp180 -73.52 -21.5 60.37 Favored 'General case' 0 CA--C 1.534 0.335 0 N-CA-C 113.033 0.753 . . . . 0.0 113.033 -176.216 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' C' C ' 64' ' ' THR . . . . . . . . . . . . . 30.2 m -61.53 138.53 58.29 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-O 120.973 0.416 . . . . 0.0 111.341 -174.02 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' C' C ' 65' ' ' LYS . . . . . . . . . . . . . 40.5 ttpt -89.34 120.37 30.62 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 115.821 -0.627 . . . . 0.0 109.946 177.631 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' C' C ' 66' ' ' ILE . . . . . . . . . . . . . 64.0 mt -113.19 130.26 67.42 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.201 0 CA-C-O 120.894 0.378 . . . . 0.0 109.989 -178.434 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' C' C ' 67' ' ' THR . . . . . . . . . . . . . 25.5 m -129.41 147.36 51.22 Favored 'General case' 0 C--N 1.332 -0.186 0 CA-C-N 116.106 -0.497 . . . . 0.0 111.173 -177.815 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' C' C ' 68' ' ' LEU . . . . . . . . . . . . . 62.8 mt -100.38 136.67 39.91 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 115.851 -0.613 . . . . 0.0 110.381 177.038 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' C' C ' 69' ' ' VAL . . . . . . . . . . . . . 43.3 t -96.99 135.47 30.99 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.361 0 CA-C-N 116.136 -0.484 . . . . 0.0 109.995 179.266 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' C' C ' 70' ' ' THR . . . . . . . . . . . . . 47.9 p -131.33 174.83 9.67 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 116.209 -0.451 . . . . 0.0 110.886 -178.076 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' C' C ' 71' ' ' HIS . . . . . . . . . . . . . 19.6 m-70 -64.9 159.47 63.28 Favored Pre-proline 0 C--N 1.329 -0.315 0 CA-C-N 115.842 -0.617 . . . . 0.0 110.478 179.832 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' C' C ' 72' ' ' PRO . . . . . . . . . . . . . 30.9 Cg_endo -64.97 -28.4 57.96 Favored 'Trans proline' 0 N--CA 1.497 1.704 0 C-N-CA 121.114 1.209 . . . . 0.0 112.179 177.816 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' C' C ' 73' ' ' VAL . . . . . . . . . . . . . 33.2 m -132.21 151.91 35.73 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.19 0 CA-C-O 120.978 0.418 . . . . 0.0 110.718 177.827 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' C' C ' 74' ' ' ASP . . . . . . . . . . . . . 27.7 t0 -102.16 121.62 42.58 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 115.698 -0.683 . . . . 0.0 109.405 176.745 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' C' C ' 75' ' ' VAL . . . . . . . . . . . . . 43.1 t -110.82 121.32 63.33 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.249 0 CA-C-O 121.056 0.455 . . . . 0.0 110.825 -175.543 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' C' C ' 76' ' ' LEU . . . . . . . . . . . . . 21.9 mt -117.86 141.9 47.91 Favored 'General case' 0 C--N 1.331 -0.206 0 CA-C-N 115.598 -0.728 . . . . 0.0 109.693 176.114 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' C' C ' 77' ' ' GLU . . . . . . . . . . . . . 97.9 mt-10 -136.2 135.53 39.2 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-O 120.98 0.419 . . . . 0.0 111.307 -178.168 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' C' C ' 78' ' ' ALA . . . . . 0.595 ' HB2' HD21 ' C' ' 109' ' ' LEU . . . -124.61 134.56 52.88 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 115.627 -0.715 . . . . 0.0 109.882 176.801 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' C' C ' 79' ' ' LYS . . . . . 0.582 ' O ' HD13 ' C' ' 80' ' ' ILE . 66.3 mmtt -78.54 121.25 24.36 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-O 120.976 0.417 . . . . 0.0 110.597 179.851 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' C' C ' 80' ' ' ILE . . . . . 0.582 HD13 ' O ' ' C' ' 79' ' ' LYS . 42.2 mm -139.06 115.06 9.41 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.305 0 N-CA-C 109.291 -0.633 . . . . 0.0 109.291 -178.422 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' C' C ' 81' ' ' LYS . . . . . . . . . . . . . 46.7 pttt -104.11 123.37 47.13 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-O 121.085 0.469 . . . . 0.0 111.096 -178.437 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' C' C ' 82' ' ' GLY . . . . . . . . . . . . . . . 89.07 42.13 5.69 Favored Glycine 0 CA--C 1.525 0.697 0 C-N-CA 120.701 -0.761 . . . . 0.0 111.838 174.358 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' C' C ' 83' ' ' ILE . . . . . . . . . . . . . 70.6 mt -64.22 138.45 23.04 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.272 0 N-CA-C 109.73 -0.471 . . . . 0.0 109.73 177.691 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' C' C ' 84' ' ' LYS . . . . . . . . . . . . . 77.4 tttt -100.14 -51.15 3.75 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 115.995 -0.548 . . . . 0.0 110.465 -177.325 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' C' C ' 85' ' ' ASP . . . . . . . . . . . . . 5.1 t0 -156.51 152.26 27.13 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.014 -0.539 . . . . 0.0 110.319 -179.707 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' C' C ' 86' ' ' VAL . . . . . 0.42 ' O ' HD13 ' C' ' 87' ' ' ILE . 44.0 t -130.16 132.73 65.04 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.229 0 CA-C-O 121.021 0.438 . . . . 0.0 110.622 -179.461 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' C' C ' 87' ' ' ILE . . . . . 0.42 HD13 ' O ' ' C' ' 86' ' ' VAL . 43.5 mm -122.04 125.19 72.75 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.29 0 CA-C-N 115.948 -0.569 . . . . 0.0 109.604 176.098 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' C' C ' 88' ' ' LEU . . . . . . . . . . . . . 14.8 tp -111.03 129.27 55.96 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-O 120.84 0.352 . . . . 0.0 111.139 -177.145 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' C' C ' 89' ' ' ASP . . . . . . . . . . . . . 12.6 t70 -121.38 151.25 40.36 Favored 'General case' 0 C--N 1.33 -0.258 0 N-CA-C 109.555 -0.535 . . . . 0.0 109.555 176.67 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' C' C ' 90' ' ' GLU . . . . . . . . . . . . . 83.5 tt0 -48.86 -33.24 10.24 Favored 'General case' 0 C--N 1.328 -0.342 0 N-CA-C 112.64 0.607 . . . . 0.0 112.64 -173.082 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' C' C ' 91' ' ' ASN . . . . . . . . . . . . . 79.2 m-20 -131.99 28.14 4.5 Favored 'General case' 0 N--CA 1.466 0.333 0 N-CA-C 112.411 0.523 . . . . 0.0 112.411 -175.764 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' C' C ' 92' ' ' LEU . . . . . . . . . . . . . 11.7 tp -166.2 150.94 8.05 Favored 'General case' 0 C--N 1.33 -0.245 0 C-N-CA 120.835 -0.346 . . . . 0.0 110.851 -179.281 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' C' C ' 93' ' ' ILE . . . . . . . . . . . . . 69.0 mt -126.87 125.72 67.21 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.173 0 N-CA-C 109.757 -0.46 . . . . 0.0 109.757 179.629 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' C' C ' 94' ' ' VAL . . . . . . . . . . . . . 43.2 t -123.14 128.67 75.1 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.238 0 N-CA-C 110.077 -0.342 . . . . 0.0 110.077 178.957 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' C' C ' 95' ' ' VAL . . . . . . . . . . . . . 40.9 t -124.23 136.86 59.08 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.235 0 CA-C-O 120.933 0.397 . . . . 0.0 110.072 -179.406 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' C' C ' 96' ' ' ILE . . . . . . . . . . . . . 59.7 mt -114.31 130.11 69.16 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.335 0 N-CA-C 109.266 -0.642 . . . . 0.0 109.266 179.035 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' C' C ' 97' ' ' THR . . . . . . . . . . . . . 68.1 p -102.93 154.36 19.29 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-O 121.253 0.549 . . . . 0.0 111.192 -177.704 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' C' C ' 98' ' ' GLU . . . . . . . . . . . . . 84.0 tt0 -53.86 -24.61 16.41 Favored 'General case' 0 CA--C 1.533 0.322 0 N-CA-C 112.299 0.481 . . . . 0.0 112.299 179.625 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' C' C ' 99' ' ' GLU . . . . . . . . . . . . . 13.8 mm-40 -77.67 14.71 0.97 Allowed 'General case' 0 CA--C 1.535 0.391 0 N-CA-C 113.266 0.839 . . . . 0.0 113.266 -177.471 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' C' C ' 100' ' ' ASN . . . . . . . . . . . . . 2.9 m-20 62.89 38.05 11.64 Favored 'General case' 0 N--CA 1.464 0.245 0 CA-C-O 121.116 0.484 . . . . 0.0 110.757 178.686 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' C' C ' 101' ' ' GLU . . . . . . . . . . . . . 83.6 tt0 -122.36 145.97 47.77 Favored 'General case' 0 C--N 1.331 -0.217 0 CA-C-N 116.182 -0.463 . . . . 0.0 109.924 177.773 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' C' C ' 102' ' ' VAL . . . . . . . . . . . . . 44.1 t -114.95 129.26 71.44 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.232 0 CA-C-N 116.302 -0.408 . . . . 0.0 110.047 -177.396 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' C' C ' 103' ' ' LEU . . . . . . . . . . . . . 27.6 mt -119.63 131.55 55.49 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 115.59 -0.732 . . . . 0.0 110.131 177.06 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' C' C ' 104' ' ' ILE . . . . . . . . . . . . . 72.3 mt -117.15 125.07 73.73 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.276 0 N-CA-C 109.816 -0.438 . . . . 0.0 109.816 178.872 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' C' C ' 105' ' ' PHE . . . . . . . . . . . . . 93.8 m-85 -122.49 163.44 19.89 Favored 'General case' 0 C--O 1.232 0.144 0 O-C-N 123.904 0.752 . . . . 0.0 109.945 -177.909 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' C' C ' 106' ' ' ASN . . . . . . . . . . . . . 44.9 p-10 -101.08 -171.25 1.96 Allowed 'General case' 0 C--N 1.332 -0.19 0 CA-C-N 116.549 -0.296 . . . . 0.0 110.249 174.755 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' C' C ' 107' ' ' GLN . . . . . . . . . . . . . 14.0 tt0 -58.32 -29.51 65.97 Favored 'General case' 0 CA--C 1.533 0.297 0 N-CA-C 112.027 0.38 . . . . 0.0 112.027 -179.972 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' C' C ' 108' ' ' ASN . . . . . 0.42 ' O ' ' ND2' ' C' ' 108' ' ' ASN . 0.7 OUTLIER -85.27 7.9 20.51 Favored 'General case' 0 CA--C 1.538 0.506 0 N-CA-C 113.279 0.844 . . . . 0.0 113.279 -176.559 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' C' C ' 109' ' ' LEU . . . . . 0.595 HD21 ' HB2' ' C' ' 78' ' ' ALA . 10.7 tp 60.07 36.97 21.3 Favored 'General case' 0 CA--C 1.531 0.225 0 CA-C-O 120.98 0.419 . . . . 0.0 111.28 179.513 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' C' C ' 110' ' ' GLU . . . . . . . . . . . . . 70.6 mm-40 -108.83 147.96 31.3 Favored 'General case' 0 C--N 1.33 -0.269 0 N-CA-C 109.653 -0.499 . . . . 0.0 109.653 175.199 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' C' C ' 111' ' ' GLU . . . . . . . . . . . . . 55.4 tt0 -82.57 121.92 27.42 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-O 120.958 0.409 . . . . 0.0 111.022 -174.122 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' C' C ' 112' ' ' LEU . . . . . . . . . . . . . 11.8 mt -103.28 -46.2 4.67 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 115.936 -0.574 . . . . 0.0 110.888 179.47 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' C' C ' 113' ' ' TYR . . . . . . . . . . . . . 64.2 t80 -133.34 136.6 45.48 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 116.464 -0.335 . . . . 0.0 111.397 -177.444 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' C' C ' 114' ' ' ARG . . . . . . . . . . . . . 35.8 ttp180 -135.44 121.0 19.36 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 115.918 -0.583 . . . . 0.0 110.316 177.841 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' C' C ' 115' ' ' GLY . . . . . . . . . . . . . . . -150.01 145.44 13.54 Favored Glycine 0 CA--C 1.524 0.638 0 N-CA-C 111.062 -0.815 . . . . 0.0 111.062 178.122 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' C' C ' 116' ' ' LYS . . . . . . . . . . . . . 34.6 ttpt -117.16 138.34 51.73 Favored 'General case' 0 C--N 1.33 -0.249 0 N-CA-C 109.9 -0.407 . . . . 0.0 109.9 177.974 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' C' C ' 117' ' ' PHE . . . . . 0.403 ' HE2' HD13 ' C' ' 132' ' ' ILE . 46.1 m-85 -135.47 113.97 11.66 Favored 'General case' 0 C--N 1.33 -0.264 0 N-CA-C 109.941 -0.392 . . . . 0.0 109.941 -178.573 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' C' C ' 118' ' ' GLU . . . . . . . . . . . . . 45.8 tp10 -55.05 -42.66 72.98 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.391 -0.368 . . . . 0.0 111.211 -176.304 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' C' C ' 119' ' ' ASN . . . . . . . . . . . . . 4.7 m120 -99.81 31.11 3.37 Favored 'General case' 0 C--N 1.33 -0.247 0 N-CA-C 112.255 0.465 . . . . 0.0 112.255 -173.852 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' C' C ' 120' ' ' LEU . . . . . . . . . . . . . 15.9 tp -56.02 119.99 6.75 Favored 'General case' 0 N--CA 1.461 0.118 0 CA-C-O 120.783 0.325 . . . . 0.0 110.377 177.603 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' C' C ' 121' ' ' ASN . . . . . . . . . . . . . 7.8 t-20 -113.84 -44.1 3.21 Favored 'General case' 0 C--N 1.332 -0.157 0 CA-C-N 116.457 -0.338 . . . . 0.0 110.944 -176.208 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' C' C ' 122' ' ' LYS . . . . . . . . . . . . . 61.8 mtpt -140.23 146.17 38.32 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-O 121.079 0.466 . . . . 0.0 111.518 -177.682 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' C' C ' 123' ' ' VAL . . . . . . . . . . . . . 47.7 t -124.16 126.88 72.93 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.319 0 CA-C-N 115.816 -0.629 . . . . 0.0 109.582 175.557 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' C' C ' 124' ' ' LEU . . . . . . . . . . . . . 50.9 mt -114.5 127.75 55.97 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.141 -0.481 . . . . 0.0 110.126 -179.331 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' C' C ' 125' ' ' VAL . . . . . . . . . . . . . 41.4 t -135.6 121.93 32.3 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.33 0 CA-C-O 120.765 0.317 . . . . 0.0 110.259 179.478 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' C' C ' 126' ' ' ARG . . . . . . . . . . . . . 79.0 mtt85 -151.39 136.15 17.19 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 116.094 -0.503 . . . . 0.0 109.696 175.831 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' C' C ' 127' ' ' ASN . . . . . . . . . . . . . 75.6 m-20 56.13 -152.1 0.38 Allowed 'General case' 0 CA--C 1.539 0.532 0 N-CA-C 109.702 -0.481 . . . . 0.0 109.702 -178.202 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' C' C ' 128' ' ' ASP . . . . . . . . . . . . . 20.2 p-10 -88.08 21.54 2.72 Favored 'General case' 0 CA--C 1.534 0.346 0 CA-C-N 118.596 0.635 . . . . 0.0 112.377 176.806 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' C' C ' 129' ' ' LEU . . . . . . . . . . . . . 1.4 tt -115.43 134.67 54.87 Favored 'General case' 0 C--O 1.235 0.312 0 O-C-N 122.039 -0.413 . . . . 0.0 109.963 -179.338 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' C' C ' 130' ' ' VAL . . . . . . . . . . . . . 41.6 t -123.06 139.88 48.45 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.313 0 CA-C-O 121.017 0.437 . . . . 0.0 110.579 -175.788 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' C' C ' 131' ' ' VAL . . . . . 0.465 HG22 HD12 ' C' ' 140' ' ' LEU . 41.4 t -135.99 135.8 50.14 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.278 0 CA-C-N 116.097 -0.501 . . . . 0.0 110.266 178.209 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' C' C ' 132' ' ' ILE . . . . . 0.403 HD13 ' HE2' ' C' ' 117' ' ' PHE . 71.8 mt -117.44 131.53 69.88 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.314 0 N-CA-C 109.502 -0.555 . . . . 0.0 109.502 179.297 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' C' C ' 133' ' ' ILE . . . . . . . . . . . . . 35.7 mm -115.6 119.62 62.36 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.25 0 CA-C-O 120.803 0.335 . . . . 0.0 110.86 -176.387 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' C' C ' 134' ' ' ASP . . . . . . . . . . . . . 5.9 p-10 -129.71 148.81 51.63 Favored 'General case' 0 C--N 1.332 -0.193 0 CA-C-N 116.016 -0.538 . . . . 0.0 109.734 176.502 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' C' C ' 135' ' ' GLU . . . . . . . . . . . . . 75.2 tt0 -50.29 -27.55 6.31 Favored 'General case' 0 C--N 1.328 -0.333 0 N-CA-C 113.096 0.776 . . . . 0.0 113.096 -170.884 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' C' C ' 136' ' ' GLN . . . . . . . . . . . . . 13.9 pt20 -101.94 -14.65 17.11 Favored 'General case' 0 CA--C 1.535 0.378 0 N-CA-C 113.514 0.931 . . . . 0.0 113.514 -172.237 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' C' C ' 137' ' ' LYS . . . . . . . . . . . . . 13.3 ptpt -168.52 168.2 11.17 Favored 'General case' 0 N--CA 1.462 0.175 0 CA-C-O 121.622 0.725 . . . . 0.0 112.228 178.743 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' C' C ' 138' ' ' LEU . . . . . . . . . . . . . 5.8 tt -119.39 129.57 54.87 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 114.957 -1.019 . . . . 0.0 109.737 179.395 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' C' C ' 139' ' ' THR . . . . . . . . . . . . . 38.6 m -110.29 130.04 55.62 Favored 'General case' 0 C--N 1.331 -0.214 0 CA-C-N 116.449 -0.341 . . . . 0.0 110.488 -179.218 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' C' C ' 140' ' ' LEU . . . . . 0.465 HD12 HG22 ' C' ' 131' ' ' VAL . 15.2 tp -115.71 125.29 52.62 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 115.688 -0.687 . . . . 0.0 109.41 -178.661 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' C' C ' 141' ' ' ILE . . . . . . . . . . . . . 19.2 mt -122.73 117.4 51.77 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.24 0 CA-C-O 120.861 0.362 . . . . 0.0 110.032 -175.33 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' C' C ' 142' ' ' ARG . . . . . . . . . . . . . 81.3 mtm180 -108.26 125.32 51.53 Favored 'General case' 0 C--N 1.331 -0.196 0 CA-C-N 115.499 -0.773 . . . . 0.0 109.939 179.917 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' C' C ' 143' ' ' THR . . . . . . . . . . . . . 43.7 p . . . . . 0 C--O 1.221 -0.417 0 CA-C-O 117.991 -1.004 . . . . 0.0 110.648 -178.532 . . . . . . . . 0 0 . 1 . 013 nuclear build full ' D' D ' -3' ' ' GLU . . . . . . . . . . . . . 21.3 pt-20 . . . . . 0 N--CA 1.491 1.581 0 N-CA-C 109.443 -0.577 . . . . 0.0 109.443 . . . . . . . . . 0 0 . 1 . 013 nuclear build full ' D' D ' -2' ' ' GLY . . . . . . . . . . . . . . . -94.85 139.8 14.7 Favored Glycine 0 CA--C 1.525 0.68 0 N-CA-C 111.037 -0.825 . . . . 0.0 111.037 179.993 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' D' D ' -1' ' ' VAL . . . . . . . . . . . . . 44.4 t -96.48 136.6 26.79 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.361 0 N-CA-C 110.008 -0.367 . . . . 0.0 110.008 179.494 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' D' D ' 0' ' ' ILE . . . . . . . . . . . . . 70.9 mt -114.99 137.79 47.35 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.191 0 CA-C-N 116.249 -0.432 . . . . 0.0 110.204 -179.355 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' D' D ' 1' ' ' MET . . . . . . . . . . . . . 25.7 ptm -79.76 140.2 37.0 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 115.999 -0.546 . . . . 0.0 110.728 -179.893 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' D' D ' 2' ' ' SER . . . . . . . . . . . . . 2.5 p -128.0 124.98 38.52 Favored 'General case' 0 C--N 1.331 -0.218 0 CA-C-N 116.254 -0.43 . . . . 0.0 110.36 177.792 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' D' D ' 3' ' ' GLU . . . . . . . . . . . . . 83.7 tt0 -141.54 142.26 33.54 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-N 115.931 -0.577 . . . . 0.0 111.056 -177.123 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' D' D ' 4' ' ' LEU . . . . . . . . . . . . . 21.6 tp -124.81 129.77 51.08 Favored 'General case' 0 C--N 1.331 -0.213 0 CA-C-N 116.109 -0.496 . . . . 0.0 110.192 175.803 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' D' D ' 5' ' ' LYS . . . . . . . . . . . . . 68.7 mttm -104.7 120.08 40.51 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-N 116.25 -0.432 . . . . 0.0 110.542 178.635 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' D' D ' 6' ' ' LEU . . . . . . . . . . . . . 45.5 mt -115.22 146.76 41.12 Favored 'General case' 0 C--N 1.331 -0.223 0 CA-C-N 115.389 -0.823 . . . . 0.0 110.236 -179.872 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' D' D ' 7' ' ' LYS . . . . . . . . . . . . . 85.5 tttt -132.71 131.76 22.26 Favored Pre-proline 0 CA--C 1.537 0.453 0 CA-C-O 118.67 -0.681 . . . . 0.0 110.2 176.465 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' D' D ' 8' ' ' PRO . . . . . . . . . . . . . 95.1 Cg_endo -87.37 140.78 5.55 Favored 'Trans proline' 0 N--CA 1.491 1.362 0 C-N-CA 121.508 1.472 . . . . 0.0 111.632 175.776 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' D' D ' 9' ' ' LEU . . . . . . . . . . . . . 37.2 mt -79.98 -49.21 1.3 Allowed Pre-proline 0 CA--C 1.535 0.376 0 CA-C-O 118.566 -0.731 . . . . 0.0 112.494 -177.927 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' D' D ' 10' ' ' PRO . . . . . . . . . . . . . 85.6 Cg_endo -77.5 154.32 31.29 Favored 'Trans proline' 0 N--CA 1.498 1.752 0 C-N-CA 121.183 1.255 . . . . 0.0 112.27 179.808 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' D' D ' 11' ' ' LYS . . . . . . . . . . . . . 80.8 tttt -88.1 100.18 12.75 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 116.236 -0.438 . . . . 0.0 110.382 178.438 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' D' D ' 12' ' ' VAL . . . . . . . . . . . . . 12.3 p -143.94 147.89 19.31 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.273 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.667 -178.985 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' D' D ' 13' ' ' GLU . . . . . . . . . . . . . 70.7 mm-40 -81.55 123.14 28.4 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.229 -0.441 . . . . 0.0 109.999 177.13 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' D' D ' 14' ' ' LEU . . . . . . . . . . . . . 18.2 mt -98.12 147.02 32.51 Favored Pre-proline 0 CA--C 1.532 0.285 0 CA-C-O 119.158 -0.448 . . . . 0.0 110.444 -179.203 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' D' D ' 15' ' ' PRO . . . . . . . . . . . . . 27.1 Cg_exo -61.8 156.0 51.02 Favored 'Trans proline' 0 N--CA 1.499 1.807 0 C-N-CA 121.316 1.344 . . . . 0.0 112.004 177.489 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' D' D ' 16' ' ' PRO . . . . . . . . . . . . . 32.1 Cg_exo -59.85 -37.2 87.77 Favored 'Trans proline' 0 N--CA 1.497 1.689 0 C-N-CA 121.398 1.399 . . . . 0.0 112.55 178.962 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' D' D ' 17' ' ' ASP . . . . . . . . . . . . . 8.8 p-10 -87.53 15.77 6.29 Favored 'General case' 0 CA--C 1.536 0.419 0 N-CA-C 112.869 0.692 . . . . 0.0 112.869 -177.529 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' D' D ' 18' ' ' PHE . . . . . . . . . . . . . 35.7 t80 -56.38 -47.34 79.13 Favored 'General case' 0 C--N 1.334 -0.089 0 O-C-N 122.031 -0.418 . . . . 0.0 110.536 -178.283 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' D' D ' 19' ' ' VAL . . . . . . . . . . . . . 48.5 t -55.05 -40.89 56.28 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.259 0 C-N-CA 121.139 -0.224 . . . . 0.0 110.915 -177.337 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' D' D ' 20' ' ' ASP . . . . . . . . . . . . . 70.0 m-20 -60.06 -45.01 94.29 Favored 'General case' 0 C--N 1.331 -0.233 0 C-N-CA 120.864 -0.335 . . . . 0.0 110.959 -178.143 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' D' D ' 21' ' ' VAL . . . . . . . . . . . . . 47.5 t -65.52 -46.27 90.26 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.336 0 C-N-CA 120.631 -0.428 . . . . 0.0 110.585 -178.316 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' D' D ' 22' ' ' ILE . . . . . 0.497 HG22 HD12 ' D' ' 26' ' ' LEU . 49.4 mm -55.61 -58.67 4.01 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.295 0 C-N-CA 121.074 -0.25 . . . . 0.0 111.038 -178.101 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' D' D ' 23' ' ' ARG . . . . . . . . . . . . . 12.2 ptm180 -55.83 -42.78 76.25 Favored 'General case' 0 C--N 1.332 -0.183 0 C-N-CA 120.71 -0.396 . . . . 0.0 111.747 -174.662 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' D' D ' 24' ' ' ILE . . . . . . . . . . . . . 74.4 mt -59.78 -42.66 89.59 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.321 0 C-N-CA 120.871 -0.331 . . . . 0.0 111.314 -177.502 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' D' D ' 25' ' ' LYS . . . . . . . . . . . . . 97.5 mttt -69.08 -42.02 76.76 Favored 'General case' 0 C--N 1.329 -0.298 0 N-CA-C 112.457 0.54 . . . . 0.0 112.457 -179.808 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' D' D ' 26' ' ' LEU . . . . . 0.497 HD12 HG22 ' D' ' 22' ' ' ILE . 86.9 mt -78.87 -30.9 45.32 Favored 'General case' 0 C--N 1.329 -0.3 0 N-CA-C 113.708 1.003 . . . . 0.0 113.708 -169.851 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' D' D ' 27' ' ' GLN . . . . . . . . . . . . . 17.3 pt20 -47.45 141.4 4.98 Favored 'General case' 0 N--CA 1.469 0.497 0 N-CA-C 112.679 0.622 . . . . 0.0 112.679 -175.223 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' D' D ' 28' ' ' GLY . . . . . . . . . . . . . . . 100.07 -22.38 40.43 Favored Glycine 0 CA--C 1.533 1.158 0 CA-C-N 115.709 -0.678 . . . . 0.0 112.495 -177.109 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' D' D ' 29' ' ' LYS . . . . . . . . . . . . . 74.2 mmtt -96.59 155.02 16.95 Favored 'General case' 0 C--O 1.232 0.137 0 CA-C-N 117.588 0.694 . . . . 0.0 110.721 177.901 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' D' D ' 30' ' ' THR . . . . . . . . . . . . . 32.3 m -106.6 136.76 45.83 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.154 -0.475 . . . . 0.0 109.885 176.225 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' D' D ' 31' ' ' VAL . . . . . . . . . . . . . 34.8 m -129.47 156.27 41.8 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.203 0 CA-C-O 120.907 0.384 . . . . 0.0 110.864 -178.289 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' D' D ' 32' ' ' ARG . . . . . . . . . . . . . 54.0 ttp180 -133.99 150.82 51.28 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 115.857 -0.611 . . . . 0.0 110.384 178.652 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' D' D ' 33' ' ' THR . . . . . . . . . . . . . 27.4 m -53.06 139.99 26.66 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.419 -0.355 . . . . 0.0 111.339 -179.37 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' D' D ' 34' ' ' GLY . . . . . . . . . . . . . . . 99.74 -17.18 57.81 Favored Glycine 0 CA--C 1.533 1.181 0 CA-C-O 119.762 -0.466 . . . . 0.0 113.218 179.909 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' D' D ' 35' ' ' ASP . . . . . . . . . . . . . 73.4 m-20 -66.89 149.21 50.92 Favored 'General case' 0 C--O 1.231 0.122 0 CA-C-N 118.019 0.909 . . . . 0.0 111.3 178.609 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' D' D ' 36' ' ' VAL . . . . . . . . . . . . . 45.9 t -122.24 129.46 75.31 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.286 0 CA-C-N 115.815 -0.63 . . . . 0.0 109.692 177.463 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' D' D ' 37' ' ' ILE . . . . . . . . . . . . . 66.6 mt -119.9 138.08 51.65 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.264 0 CA-C-N 116.367 -0.379 . . . . 0.0 110.042 -178.942 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' D' D ' 38' ' ' GLY . . . . . . . . . . . . . . . -112.3 128.79 8.69 Favored Glycine 0 CA--C 1.524 0.653 0 N-CA-C 111.009 -0.836 . . . . 0.0 111.009 179.487 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' D' D ' 39' ' ' ILE . . . . . . . . . . . . . 72.1 mt -122.91 132.58 71.1 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.184 0 N-CA-C 110.039 -0.356 . . . . 0.0 110.039 179.319 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' D' D ' 40' ' ' SER . . . . . . . . . . . . . 13.6 t -92.51 119.41 31.97 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.474 -0.33 . . . . 0.0 110.647 176.153 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' D' D ' 41' ' ' ILE . . . . . . . . . . . . . 73.0 mt -131.1 115.99 31.74 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.208 0 CA-C-O 120.987 0.422 . . . . 0.0 110.691 179.51 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' D' D ' 42' ' ' LEU . . . . . 0.519 HD23 ' O ' ' D' ' 42' ' ' LEU . 1.4 tt 52.58 48.17 23.12 Favored 'General case' 0 CA--C 1.532 0.288 0 CA-C-N 115.738 -0.665 . . . . 0.0 110.989 175.9 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' D' D ' 43' ' ' GLY . . . . . . . . . . . . . . . 70.19 16.44 73.13 Favored Glycine 0 CA--C 1.534 1.266 0 C-N-CA 121.064 -0.589 . . . . 0.0 113.089 174.75 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' D' D ' 44' ' ' LYS . . . . . . . . . . . . . 53.3 mtmt -128.38 130.01 47.07 Favored 'General case' 0 C--N 1.333 -0.133 0 CA-C-N 117.788 0.794 . . . . 0.0 110.304 179.629 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' D' D ' 45' ' ' GLU . . . . . . . . . . . . . 81.4 tt0 -84.84 124.51 31.67 Favored 'General case' 0 C--N 1.327 -0.406 0 CA-C-N 116.451 -0.341 . . . . 0.0 110.737 -179.858 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' D' D ' 46' ' ' VAL . . . . . . . . . . . . . 7.3 p -122.26 127.06 75.07 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.235 0 N-CA-C 109.651 -0.5 . . . . 0.0 109.651 176.498 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' D' D ' 47' ' ' LYS . . . . . . . . . . . . . 99.3 mttt -101.03 130.66 47.07 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.008 -0.542 . . . . 0.0 111.481 178.171 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' D' D ' 48' ' ' PHE . . . . . . . . . . . . . 92.1 m-85 -113.86 131.95 56.08 Favored 'General case' 0 C--N 1.329 -0.303 0 N-CA-C 109.559 -0.534 . . . . 0.0 109.559 174.592 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' D' D ' 49' ' ' LYS . . . . . . . . . . . . . 80.6 tttt -107.99 137.44 45.98 Favored 'General case' 0 C--N 1.329 -0.309 0 N-CA-C 110.284 -0.265 . . . . 0.0 110.284 178.8 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' D' D ' 50' ' ' VAL . . . . . . . . . . . . . 45.6 t -81.69 109.2 15.61 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.252 0 N-CA-C 109.236 -0.653 . . . . 0.0 109.236 176.889 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' D' D ' 51' ' ' VAL . . . . . . . . . . . . . 48.8 t -74.35 -47.07 41.96 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.278 0 CA-C-N 115.902 -0.59 . . . . 0.0 110.213 -173.809 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' D' D ' 52' ' ' GLN . . . . . . . . . . . . . 31.2 tt0 -163.88 142.49 7.63 Favored 'General case' 0 C--N 1.332 -0.19 0 C-N-CA 120.26 -0.576 . . . . 0.0 111.789 -178.432 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' D' D ' 53' ' ' ALA . . . . . . . . . . . . . . . -118.55 132.33 56.21 Favored 'General case' 0 C--N 1.332 -0.184 0 CA-C-N 115.812 -0.631 . . . . 0.0 110.194 177.207 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' D' D ' 54' ' ' TYR . . . . . . . . . . . . . 55.0 t80 -128.98 107.92 18.14 Favored Pre-proline 0 CA--C 1.534 0.362 0 CA-C-O 118.252 -0.88 . . . . 0.0 110.557 -179.849 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' D' D ' 55' ' ' PRO . . . . . . . . . . . . . 73.8 Cg_endo -77.27 170.08 72.37 Favored 'Cis proline' 0 N--CA 1.501 1.914 0 CA-C-N 121.89 1.711 . . . . 0.0 112.274 -5.67 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' D' D ' 56' ' ' SER . . . . . . . . . . . . . 32.8 m -116.46 133.57 22.97 Favored Pre-proline 0 CA--C 1.539 0.547 0 CA-C-O 118.418 -0.801 . . . . 0.0 109.408 174.447 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' D' D ' 57' ' ' PRO . . . . . . . . . . . . . 41.9 Cg_endo -67.8 166.33 66.7 Favored 'Cis proline' 0 N--CA 1.499 1.8 0 CA-C-N 121.874 1.705 . . . . 0.0 111.524 -1.446 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' D' D ' 58' ' ' LEU . . . . . . . . . . . . . 38.5 tp -129.27 138.03 51.41 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.239 -0.437 . . . . 0.0 110.173 179.657 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' D' D ' 59' ' ' ARG . . . . . . . . . . . . . 72.7 ttt-85 -101.95 129.32 48.19 Favored 'General case' 0 C--N 1.329 -0.306 0 N-CA-C 109.405 -0.591 . . . . 0.0 109.405 178.013 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' D' D ' 60' ' ' VAL . . . . . . . . . . . . . 41.5 t -78.5 113.77 18.23 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.299 0 C-N-CA 120.782 -0.367 . . . . 0.0 110.255 -176.165 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' D' D ' 61' ' ' GLU . . . . . . . . . . . . . 82.8 tt0 -131.24 151.57 51.35 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 115.913 -0.585 . . . . 0.0 109.66 175.998 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' D' D ' 62' ' ' ASP . . . . . . . . . . . . . 50.6 m-20 -49.58 -32.08 11.92 Favored 'General case' 0 C--N 1.327 -0.396 0 N-CA-C 112.129 0.418 . . . . 0.0 112.129 179.394 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' D' D ' 63' ' ' ARG . . . . . . . . . . . . . 35.0 mtp180 -75.0 -21.75 58.95 Favored 'General case' 0 CA--C 1.533 0.32 0 N-CA-C 113.1 0.778 . . . . 0.0 113.1 -174.859 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' D' D ' 64' ' ' THR . . . . . . . . . . . . . 23.1 m -70.23 146.72 50.48 Favored 'General case' 0 C--N 1.331 -0.222 0 CA-C-O 120.726 0.298 . . . . 0.0 110.995 -175.536 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' D' D ' 65' ' ' LYS . . . . . . . . . . . . . 40.2 ttpt -88.28 121.64 30.9 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-O 121.068 0.461 . . . . 0.0 110.306 179.64 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' D' D ' 66' ' ' ILE . . . . . . . . . . . . . 69.1 mt -113.75 125.22 70.99 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.271 0 N-CA-C 109.556 -0.535 . . . . 0.0 109.556 -178.24 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' D' D ' 67' ' ' THR . . . . . . . . . . . . . 10.8 m -123.92 141.73 51.78 Favored 'General case' 0 C--N 1.331 -0.216 0 CA-C-O 121.062 0.458 . . . . 0.0 111.295 -174.57 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' D' D ' 68' ' ' LEU . . . . . 0.409 ' C ' HD23 ' D' ' 68' ' ' LEU . 5.7 tt -100.21 125.48 46.37 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 115.746 -0.661 . . . . 0.0 109.735 177.132 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' D' D ' 69' ' ' VAL . . . . . . . . . . . . . 45.2 t -99.71 130.59 48.54 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 CA-C-O 121.048 0.452 . . . . 0.0 110.5 -176.697 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' D' D ' 70' ' ' THR . . . . . . . . . . . . . 7.8 t -150.04 24.9 0.83 Allowed 'General case' 0 CA--C 1.535 0.375 0 CA-C-N 115.875 -0.602 . . . . 0.0 112.175 177.645 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' D' D ' 71' ' ' HIS . . . . . . . . . . . . . 10.9 m80 -149.97 86.45 5.28 Favored Pre-proline 0 CA--C 1.534 0.328 0 N-CA-C 110.192 -0.299 . . . . 0.0 110.192 -179.705 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' D' D ' 72' ' ' PRO . . . . . . . . . . . . . 74.5 Cg_endo -80.58 -26.7 3.74 Favored 'Trans proline' 0 N--CA 1.494 1.516 0 C-N-CA 121.473 1.448 . . . . 0.0 113.195 -175.728 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' D' D ' 73' ' ' VAL . . . . . . . . . . . . . 34.5 m -72.91 179.95 0.39 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.299 0 C-N-CA 121.035 -0.266 . . . . 0.0 110.534 -179.218 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' D' D ' 74' ' ' ASP . . . . . . . . . . . . . 15.6 t0 -100.85 116.48 32.82 Favored 'General case' 0 C--N 1.332 -0.162 0 N-CA-C 109.965 -0.383 . . . . 0.0 109.965 -178.795 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' D' D ' 75' ' ' VAL . . . . . . . . . . . . . 45.2 t -113.77 124.08 70.07 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.196 0 CA-C-O 121.057 0.456 . . . . 0.0 110.304 -177.992 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' D' D ' 76' ' ' LEU . . . . . . . . . . . . . 19.2 mt -127.85 145.51 50.91 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 115.726 -0.67 . . . . 0.0 109.872 179.014 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' D' D ' 77' ' ' GLU . . . . . . . . . . . . . 97.0 mt-10 -134.03 138.62 45.48 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-O 121.092 0.472 . . . . 0.0 111.359 -178.526 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' D' D ' 78' ' ' ALA . . . . . . . . . . . . . . . -125.2 138.83 54.13 Favored 'General case' 0 C--N 1.331 -0.226 0 CA-C-N 115.743 -0.662 . . . . 0.0 109.708 176.301 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' D' D ' 79' ' ' LYS . . . . . 0.516 ' O ' HD13 ' D' ' 80' ' ' ILE . 69.2 mttm -75.12 122.8 24.15 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-O 120.913 0.387 . . . . 0.0 110.797 -177.865 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' D' D ' 80' ' ' ILE . . . . . 0.516 HD13 ' O ' ' D' ' 79' ' ' LYS . 24.5 mm -139.11 114.42 8.54 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.263 0 N-CA-C 109.29 -0.633 . . . . 0.0 109.29 -177.09 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' D' D ' 81' ' ' LYS . . . . . . . . . . . . . 61.7 mttp -113.42 123.24 49.61 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-O 120.866 0.365 . . . . 0.0 111.493 -175.722 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' D' D ' 82' ' ' GLY . . . . . . . . . . . . . . . 89.04 42.08 5.72 Favored Glycine 0 CA--C 1.525 0.715 0 C-N-CA 121.004 -0.617 . . . . 0.0 112.006 174.201 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' D' D ' 83' ' ' ILE . . . . . . . . . . . . . 68.9 mt -68.74 137.39 24.48 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.269 0 N-CA-C 109.992 -0.373 . . . . 0.0 109.992 178.668 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' D' D ' 84' ' ' LYS . . . . . . . . . . . . . 25.6 ttpt -105.94 -47.27 3.9 Favored 'General case' 0 C--N 1.331 -0.217 0 CA-C-N 116.455 -0.339 . . . . 0.0 110.165 177.91 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' D' D ' 85' ' ' ASP . . . . . . . . . . . . . 12.0 t70 -150.34 151.04 32.27 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.043 -0.526 . . . . 0.0 110.441 -179.272 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' D' D ' 86' ' ' VAL . . . . . . . . . . . . . 40.5 t -138.13 137.01 44.7 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.235 0 CA-C-O 121.029 0.443 . . . . 0.0 110.764 -179.266 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' D' D ' 87' ' ' ILE . . . . . . . . . . . . . 46.2 mm -122.16 130.65 74.38 Favored 'Isoleucine or valine' 0 C--O 1.233 0.192 0 CA-C-N 115.781 -0.645 . . . . 0.0 109.793 177.159 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' D' D ' 88' ' ' LEU . . . . . . . . . . . . . 18.8 tp -116.85 132.16 56.77 Favored 'General case' 0 C--N 1.331 -0.201 0 CA-C-O 121.021 0.439 . . . . 0.0 111.161 -177.623 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' D' D ' 89' ' ' ASP . . . . . . . . . . . . . 5.5 t70 -130.66 156.29 45.15 Favored 'General case' 0 C--N 1.331 -0.204 0 CA-C-N 115.835 -0.621 . . . . 0.0 109.668 175.483 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' D' D ' 90' ' ' GLU . . . . . . . . . . . . . 83.9 tt0 -47.04 -39.49 12.9 Favored 'General case' 0 C--N 1.331 -0.201 0 N-CA-C 112.97 0.73 . . . . 0.0 112.97 -172.359 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' D' D ' 91' ' ' ASN . . . . . . . . . . . . . 21.6 p-10 -131.99 36.03 3.7 Favored 'General case' 0 C--O 1.233 0.22 0 N-CA-C 111.767 0.284 . . . . 0.0 111.767 -176.215 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' D' D ' 92' ' ' LEU . . . . . . . . . . . . . 16.0 tp -165.86 138.73 4.17 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-O 120.754 0.312 . . . . 0.0 110.605 -179.821 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' D' D ' 93' ' ' ILE . . . . . . . . . . . . . 73.2 mt -124.27 123.11 65.74 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.204 0 N-CA-C 109.431 -0.581 . . . . 0.0 109.431 179.55 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' D' D ' 94' ' ' VAL . . . . . . . . . . . . . 46.0 t -124.03 128.2 73.94 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.299 0 N-CA-C 109.897 -0.409 . . . . 0.0 109.897 -178.783 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' D' D ' 95' ' ' VAL . . . . . . . . . . . . . 40.7 t -123.78 135.28 63.99 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.346 0 CA-C-N 116.133 -0.485 . . . . 0.0 109.965 -178.611 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' D' D ' 96' ' ' ILE . . . . . . . . . . . . . 66.2 mt -117.13 128.47 74.49 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.237 0 N-CA-C 109.394 -0.595 . . . . 0.0 109.394 178.661 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' D' D ' 97' ' ' THR . . . . . . . . . . . . . 71.2 p -104.35 157.06 17.41 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-O 121.388 0.613 . . . . 0.0 111.502 -176.56 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' D' D ' 98' ' ' GLU . . . . . . . . . . . . . 12.8 pt-20 -54.85 -24.49 23.33 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 115.73 -0.668 . . . . 0.0 112.492 -179.444 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' D' D ' 99' ' ' GLU . . . . . . . . . . . . . 14.8 mm-40 -80.2 16.8 1.16 Allowed 'General case' 0 CA--C 1.536 0.441 0 N-CA-C 112.959 0.725 . . . . 0.0 112.959 -178.578 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' D' D ' 100' ' ' ASN . . . . . . . . . . . . . 4.2 m-20 62.47 37.84 13.13 Favored 'General case' 0 C--O 1.233 0.198 0 CA-C-O 121.019 0.437 . . . . 0.0 110.976 178.344 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' D' D ' 101' ' ' GLU . . . . . . . . . . . . . 84.4 tt0 -114.99 140.84 48.71 Favored 'General case' 0 C--N 1.331 -0.213 0 CA-C-N 116.127 -0.488 . . . . 0.0 109.912 177.364 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' D' D ' 102' ' ' VAL . . . . . . . . . . . . . 44.7 t -114.83 124.77 71.81 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.287 0 N-CA-C 109.656 -0.498 . . . . 0.0 109.656 179.282 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' D' D ' 103' ' ' LEU . . . . . . . . . . . . . 22.0 mt -116.6 133.6 55.82 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 115.805 -0.634 . . . . 0.0 110.155 179.055 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' D' D ' 104' ' ' ILE . . . . . . . . . . . . . 69.1 mt -121.73 121.92 65.59 Favored 'Isoleucine or valine' 0 C--O 1.234 0.239 0 CA-C-N 116.577 -0.283 . . . . 0.0 110.323 -178.35 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' D' D ' 105' ' ' PHE . . . . . . . . . . . . . 74.1 m-85 -123.81 165.81 16.68 Favored 'General case' 0 C--N 1.333 -0.141 0 O-C-N 123.994 0.808 . . . . 0.0 109.937 179.933 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' D' D ' 106' ' ' ASN . . . . . . . . . . . . . 49.8 p-10 -100.54 -174.03 2.55 Favored 'General case' 0 C--N 1.331 -0.209 0 N-CA-C 109.816 -0.438 . . . . 0.0 109.816 171.422 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' D' D ' 107' ' ' GLN . . . . . . . . . . . . . 5.0 tp-100 -59.21 -25.37 63.92 Favored 'General case' 0 CA--C 1.533 0.313 0 N-CA-C 112.331 0.493 . . . . 0.0 112.331 -178.016 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' D' D ' 108' ' ' ASN . . . . . . . . . . . . . 9.7 t30 -91.45 14.17 15.52 Favored 'General case' 0 CA--C 1.534 0.365 0 N-CA-C 112.9 0.704 . . . . 0.0 112.9 -176.553 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' D' D ' 109' ' ' LEU . . . . . . . . . . . . . 76.8 mt 58.77 33.57 23.15 Favored 'General case' 0 CA--C 1.529 0.172 0 CA-C-O 120.789 0.328 . . . . 0.0 111.864 179.162 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' D' D ' 110' ' ' GLU . . . . . . . . . . . . . 70.5 mm-40 -100.21 134.82 42.58 Favored 'General case' 0 C--N 1.329 -0.284 0 N-CA-C 108.932 -0.766 . . . . 0.0 108.932 173.85 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' D' D ' 111' ' ' GLU . . . . . . . . . . . . . 45.2 tt0 -82.18 121.79 27.06 Favored 'General case' 0 C--N 1.328 -0.355 0 C-N-CA 120.643 -0.423 . . . . 0.0 110.519 -174.566 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' D' D ' 112' ' ' LEU . . . . . . . . . . . . . 34.2 mt -97.85 -45.99 6.11 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 115.851 -0.613 . . . . 0.0 110.552 179.282 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' D' D ' 113' ' ' TYR . . . . . . . . . . . . . 58.6 t80 -140.84 144.7 35.49 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.072 -0.513 . . . . 0.0 111.1 -177.854 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' D' D ' 114' ' ' ARG . . . . . . . . . . . . . 33.4 ptt180 -145.89 125.11 12.95 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 115.825 -0.625 . . . . 0.0 110.21 173.617 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' D' D ' 115' ' ' GLY . . . . . . . . . . . . . . . -149.98 143.14 10.38 Favored Glycine 0 CA--C 1.523 0.536 0 N-CA-C 110.82 -0.912 . . . . 0.0 110.82 -179.706 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' D' D ' 116' ' ' LYS . . . . . . . . . . . . . 31.4 ttmt -115.86 132.53 56.62 Favored 'General case' 0 C--N 1.329 -0.318 0 N-CA-C 109.974 -0.38 . . . . 0.0 109.974 179.184 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' D' D ' 117' ' ' PHE . . . . . . . . . . . . . 52.0 m-85 -123.52 116.27 22.91 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.123 -0.49 . . . . 0.0 110.087 -177.085 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' D' D ' 118' ' ' GLU . . . . . . . . . . . . . 84.1 tt0 -53.69 -48.47 69.48 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.576 -0.284 . . . . 0.0 111.355 -176.63 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' D' D ' 119' ' ' ASN . . . . . . . . . . . . . 87.0 m-20 -95.25 31.05 2.02 Favored 'General case' 0 C--N 1.33 -0.27 0 N-CA-C 112.203 0.446 . . . . 0.0 112.203 -174.964 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' D' D ' 120' ' ' LEU . . . . . . . . . . . . . 14.6 tp -55.34 120.32 6.92 Favored 'General case' 0 C--N 1.331 -0.202 0 CA-C-O 120.714 0.292 . . . . 0.0 110.525 178.298 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' D' D ' 121' ' ' ASN . . . . . . . . . . . . . 60.3 m-80 -113.99 -44.1 3.19 Favored 'General case' 0 C--O 1.231 0.109 0 CA-C-N 116.522 -0.308 . . . . 0.0 111.332 -176.795 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' D' D ' 122' ' ' LYS . . . . . . . . . . . . . 53.3 mttm -140.86 145.7 36.54 Favored 'General case' 0 C--N 1.331 -0.219 0 CA-C-O 120.965 0.412 . . . . 0.0 111.665 -177.647 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' D' D ' 123' ' ' VAL . . . . . . . . . . . . . 45.5 t -131.58 127.51 59.48 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.258 0 CA-C-N 116.014 -0.539 . . . . 0.0 109.696 175.319 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' D' D ' 124' ' ' LEU . . . . . . . . . . . . . 14.2 tp -131.29 133.47 45.41 Favored 'General case' 0 C--N 1.33 -0.251 0 N-CA-C 110.108 -0.33 . . . . 0.0 110.108 179.13 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' D' D ' 125' ' ' VAL . . . . . 0.559 HG12 HG13 ' D' ' 130' ' ' VAL . 32.8 m -141.24 138.5 33.39 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 CA-C-O 120.883 0.373 . . . . 0.0 111.074 -178.89 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' D' D ' 126' ' ' ARG . . . . . . . . . . . . . 98.5 mtt180 -144.04 131.05 20.5 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 115.933 -0.576 . . . . 0.0 110.249 178.64 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' D' D ' 127' ' ' ASN . . . . . . . . . . . . . 56.5 t30 52.84 -113.46 0.77 Allowed 'General case' 0 CA--C 1.546 0.813 0 CA-C-O 118.626 -0.702 . . . . 0.0 110.849 179.366 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' D' D ' 128' ' ' ASP . . . . . . . . . . . . . 12.9 p-10 -114.03 12.65 18.01 Favored 'General case' 0 CA--C 1.536 0.416 0 CA-C-N 120.126 1.33 . . . . 0.0 113.144 179.929 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' D' D ' 129' ' ' LEU . . . . . . . . . . . . . 15.8 tp -107.0 131.92 53.52 Favored 'General case' 0 C--O 1.232 0.171 0 N-CA-C 110.002 -0.37 . . . . 0.0 110.002 179.095 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' D' D ' 130' ' ' VAL . . . . . 0.559 HG13 HG12 ' D' ' 125' ' ' VAL . 46.5 t -122.7 133.76 67.88 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.246 0 CA-C-O 120.773 0.321 . . . . 0.0 110.353 -177.0 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' D' D ' 131' ' ' VAL . . . . . 0.535 HG22 HD12 ' D' ' 140' ' ' LEU . 42.8 t -135.52 133.55 52.03 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.191 0 CA-C-O 121.093 0.473 . . . . 0.0 110.204 176.441 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' D' D ' 132' ' ' ILE . . . . . . . . . . . . . 72.5 mt -122.15 134.0 66.73 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.25 0 CA-C-N 115.743 -0.662 . . . . 0.0 109.606 -178.728 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' D' D ' 133' ' ' ILE . . . . . . . . . . . . . 40.3 mm -114.98 124.39 71.6 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.251 0 CA-C-O 120.693 0.282 . . . . 0.0 110.92 -175.298 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' D' D ' 134' ' ' ASP . . . . . . . . . . . . . 9.6 p-10 -134.63 147.83 50.27 Favored 'General case' 0 C--N 1.332 -0.179 0 N-CA-C 109.721 -0.474 . . . . 0.0 109.721 174.804 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' D' D ' 135' ' ' GLU . . . . . . . . . . . . . 43.2 tp10 -50.49 -29.48 10.56 Favored 'General case' 0 C--N 1.329 -0.296 0 N-CA-C 112.845 0.683 . . . . 0.0 112.845 -171.43 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' D' D ' 136' ' ' GLN . . . . . . . . . . . . . 98.7 mt-30 -81.17 -32.71 33.48 Favored 'General case' 0 C--N 1.331 -0.197 0 N-CA-C 112.63 0.604 . . . . 0.0 112.63 -176.016 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' D' D ' 137' ' ' LYS . . . . . . . . . . . . . 37.7 pttt -167.67 172.87 8.93 Favored 'General case' 0 C--N 1.331 -0.223 0 CA-C-O 121.625 0.726 . . . . 0.0 112.261 -172.234 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' D' D ' 138' ' ' LEU . . . . . . . . . . . . . 5.5 tt -115.06 127.64 55.75 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 115.029 -0.987 . . . . 0.0 109.828 179.158 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' D' D ' 139' ' ' THR . . . . . . . . . . . . . 28.1 m -106.2 124.86 50.24 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.143 -0.481 . . . . 0.0 110.145 -179.675 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' D' D ' 140' ' ' LEU . . . . . 0.535 HD12 HG22 ' D' ' 131' ' ' VAL . 11.6 tp -115.67 121.65 43.17 Favored 'General case' 0 C--N 1.327 -0.376 0 N-CA-C 109.311 -0.626 . . . . 0.0 109.311 -178.54 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' D' D ' 141' ' ' ILE . . . . . . . . . . . . . 19.5 mt -119.13 116.75 51.95 Favored 'Isoleucine or valine' 0 C--O 1.234 0.274 0 CA-C-O 120.924 0.392 . . . . 0.0 109.966 -174.847 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' D' D ' 142' ' ' ARG . . . . . . . . . . . . . 81.7 mtp180 -106.87 131.23 54.2 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-N 115.27 -0.877 . . . . 0.0 110.626 -177.751 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' D' D ' 143' ' ' THR . . . . . . . . . . . . . 33.6 p . . . . . 0 C--O 1.221 -0.441 0 CA-C-O 117.907 -1.045 . . . . 0.0 110.893 179.624 . . . . . . . . 0 0 . 1 . 013 nuclear build full ' E' E ' -3' ' ' GLU . . . . . . . . . . . . . 45.5 mp0 . . . . . 0 N--CA 1.489 1.484 0 N-CA-C 109.336 -0.616 . . . . 0.0 109.336 . . . . . . . . . 0 0 . 1 . 013 nuclear build full ' E' E ' -2' ' ' GLY . . . . . . . . . . . . . . . -61.87 128.84 43.36 Favored Glycine 0 CA--C 1.525 0.68 0 N-CA-C 110.546 -1.021 . . . . 0.0 110.546 178.788 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' E' E ' -1' ' ' VAL . . . . . . . . . . . . . 46.1 t -93.8 138.1 21.22 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.332 0 N-CA-C 110.014 -0.365 . . . . 0.0 110.014 -179.235 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' E' E ' 0' ' ' ILE . . . . . . . . . . . . . 68.6 mt -103.58 142.25 17.71 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.276 0 CA-C-N 116.071 -0.513 . . . . 0.0 110.041 -177.983 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' E' E ' 1' ' ' MET . . . . . . . . . . . . . 25.2 ptm -77.61 132.82 38.44 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.043 -0.526 . . . . 0.0 110.693 -179.077 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' E' E ' 2' ' ' SER . . . . . . . . . . . . . 11.1 p -123.24 138.31 54.67 Favored 'General case' 0 C--N 1.331 -0.217 0 CA-C-N 116.187 -0.46 . . . . 0.0 110.646 179.851 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' E' E ' 3' ' ' GLU . . . . . . . . . . . . . 77.6 tt0 -141.0 140.7 34.37 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.773 179.787 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' E' E ' 4' ' ' LEU . . . . . . . . . . . . . 5.2 tt -125.82 128.28 47.42 Favored 'General case' 0 C--N 1.331 -0.215 0 CA-C-N 116.087 -0.506 . . . . 0.0 110.124 177.79 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' E' E ' 5' ' ' LYS . . . . . . . . . . . . . 68.9 mttm -105.04 122.59 46.19 Favored 'General case' 0 C--O 1.235 0.291 0 CA-C-N 116.428 -0.351 . . . . 0.0 110.868 -179.307 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' E' E ' 6' ' ' LEU . . . . . . . . . . . . . 64.6 mt -114.61 148.99 37.3 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-N 115.633 -0.712 . . . . 0.0 110.899 -179.153 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' E' E ' 7' ' ' LYS . . . . . . . . . . . . . 79.6 tttt -138.61 134.38 17.29 Favored Pre-proline 0 CA--C 1.535 0.387 0 CA-C-O 118.893 -0.575 . . . . 0.0 109.909 174.676 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' E' E ' 8' ' ' PRO . . . . . . . . . . . . . 88.8 Cg_endo -88.63 142.29 4.9 Favored 'Trans proline' 0 N--CA 1.492 1.42 0 C-N-CA 121.536 1.49 . . . . 0.0 111.624 177.497 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' E' E ' 9' ' ' LEU . . . . . . . . . . . . . 73.7 mt -76.03 -47.27 3.71 Favored Pre-proline 0 CA--C 1.534 0.341 0 CA-C-O 118.792 -0.623 . . . . 0.0 112.058 -178.432 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' E' E ' 10' ' ' PRO . . . . . . . . . . . . . 97.7 Cg_endo -82.34 149.1 14.91 Favored 'Trans proline' 0 N--CA 1.495 1.603 0 C-N-CA 121.276 1.318 . . . . 0.0 111.712 174.463 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' E' E ' 11' ' ' LYS . . . . . . . . . . . . . 59.8 mttp -88.47 97.6 11.16 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-O 120.886 0.374 . . . . 0.0 110.558 178.648 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' E' E ' 12' ' ' VAL . . . . . . . . . . . . . 11.9 p -139.54 148.28 23.45 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.274 0 CA-C-N 115.946 -0.57 . . . . 0.0 110.216 179.79 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' E' E ' 13' ' ' GLU . . . . . . . . . . . . . 81.1 tt0 -81.95 121.72 26.86 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.35 -0.386 . . . . 0.0 109.974 179.085 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' E' E ' 14' ' ' LEU . . . . . . . . . . . . . 31.2 mt -95.89 150.48 37.38 Favored Pre-proline 0 CA--C 1.532 0.271 0 CA-C-N 116.355 -0.384 . . . . 0.0 110.466 -178.581 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' E' E ' 15' ' ' PRO . . . . . . . . . . . . . 33.1 Cg_exo -60.09 158.91 27.98 Favored 'Trans proline' 0 N--CA 1.497 1.728 0 C-N-CA 121.182 1.254 . . . . 0.0 112.024 178.9 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' E' E ' 16' ' ' PRO . . . . . . . . . . . . . 26.8 Cg_exo -60.69 -44.05 28.59 Favored 'Trans proline' 0 N--CA 1.497 1.708 0 C-N-CA 121.453 1.435 . . . . 0.0 112.962 -178.106 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' E' E ' 17' ' ' ASP . . . . . . . . . . . . . 14.3 p-10 -82.69 9.83 8.81 Favored 'General case' 0 C--N 1.327 -0.388 0 N-CA-C 113.259 0.837 . . . . 0.0 113.259 -176.772 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' E' E ' 18' ' ' PHE . . . . . . . . . . . . . 48.0 t80 -57.45 -42.95 83.49 Favored 'General case' 0 N--CA 1.457 -0.089 0 O-C-N 121.896 -0.502 . . . . 0.0 110.243 -178.539 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' E' E ' 19' ' ' VAL . . . . . . . . . . . . . 47.7 t -56.88 -44.63 82.56 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.362 0 CA-C-N 116.384 -0.371 . . . . 0.0 110.473 -177.945 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' E' E ' 20' ' ' ASP . . . . . . . . . . . . . 72.3 m-20 -59.61 -41.31 90.07 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-O 120.773 0.32 . . . . 0.0 110.78 -177.824 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' E' E ' 21' ' ' VAL . . . . . . . . . . . . . 46.4 t -64.24 -46.36 93.6 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.323 0 C-N-CA 120.725 -0.39 . . . . 0.0 110.476 -178.239 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' E' E ' 22' ' ' ILE . . . . . 0.594 HG22 HD12 ' E' ' 26' ' ' LEU . 48.6 mm -61.6 -35.58 68.03 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.266 0 C-N-CA 121.034 -0.267 . . . . 0.0 111.058 -179.852 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' E' E ' 23' ' ' ARG . . . . . . . . . . . . . 58.1 ttp180 -57.38 -47.79 80.74 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-O 120.965 0.412 . . . . 0.0 110.355 176.971 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' E' E ' 24' ' ' ILE . . . . . . . . . . . . . 76.0 mt -61.83 -46.67 96.0 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.238 0 CA-C-N 115.928 -0.578 . . . . 0.0 112.02 -178.037 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' E' E ' 25' ' ' LYS . . . . . . . . . . . . . 12.6 ptmm? -68.45 -35.17 77.21 Favored 'General case' 0 CA--C 1.532 0.283 0 C-N-CA 120.632 -0.427 . . . . 0.0 111.824 -174.05 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' E' E ' 26' ' ' LEU . . . . . 0.594 HD12 HG22 ' E' ' 22' ' ' ILE . 63.3 mt -79.19 -46.45 17.88 Favored 'General case' 0 C--N 1.331 -0.219 0 N-CA-C 112.963 0.727 . . . . 0.0 112.963 -174.918 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' E' E ' 27' ' ' GLN . . . . . . . . . . . . . 15.2 pt20 -46.52 140.84 4.05 Favored 'General case' 0 N--CA 1.468 0.466 0 N-CA-C 112.937 0.717 . . . . 0.0 112.937 -173.786 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' E' E ' 28' ' ' GLY . . . . . . . . . . . . . . . 100.72 -29.93 11.37 Favored Glycine 0 CA--C 1.53 1.01 0 CA-C-N 115.382 -0.827 . . . . 0.0 112.0 -176.776 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' E' E ' 29' ' ' LYS . . . . . . . . . . . . . 98.4 mttt -99.52 155.3 17.64 Favored 'General case' 0 C--O 1.234 0.273 0 CA-C-N 117.137 0.469 . . . . 0.0 111.58 179.435 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' E' E ' 30' ' ' THR . . . . . . . . . . . . . 32.2 m -97.12 140.03 32.23 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 115.93 -0.577 . . . . 0.0 110.266 176.203 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' E' E ' 31' ' ' VAL . . . . . . . . . . . . . 35.1 m -131.13 153.7 39.52 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.238 0 CA-C-N 116.234 -0.439 . . . . 0.0 110.711 -179.616 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' E' E ' 32' ' ' ARG . . . . . . . . . . . . . 75.9 mtt180 -132.7 150.1 52.2 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.04 -0.527 . . . . 0.0 110.489 178.476 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' E' E ' 33' ' ' THR . . . . . . . . . . . . . 26.6 m -53.17 140.56 25.71 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 116.241 -0.436 . . . . 0.0 111.416 -178.016 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' E' E ' 34' ' ' GLY . . . . . . . . . . . . . . . 99.62 -17.22 57.86 Favored Glycine 0 CA--C 1.531 1.082 0 C-N-CA 121.208 -0.52 . . . . 0.0 113.259 179.447 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' E' E ' 35' ' ' ASP . . . . . . . . . . . . . 75.9 m-20 -66.11 148.89 51.14 Favored 'General case' 0 C--N 1.334 -0.098 0 CA-C-N 118.092 0.946 . . . . 0.0 110.908 178.272 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' E' E ' 36' ' ' VAL . . . . . . . . . . . . . 44.1 t -123.76 132.52 71.24 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.214 0 CA-C-N 116.096 -0.502 . . . . 0.0 109.918 178.166 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' E' E ' 37' ' ' ILE . . . . . . . . . . . . . 66.8 mt -118.43 138.79 47.99 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.317 0 CA-C-N 116.12 -0.491 . . . . 0.0 109.766 -179.648 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' E' E ' 38' ' ' GLY . . . . . . . . . . . . . . . -110.87 128.77 8.91 Favored Glycine 0 CA--C 1.526 0.751 0 N-CA-C 111.171 -0.771 . . . . 0.0 111.171 -179.337 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' E' E ' 39' ' ' ILE . . . . . . . . . . . . . 77.0 mt -123.84 136.05 61.5 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.199 0 CA-C-O 120.791 0.329 . . . . 0.0 110.123 179.018 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' E' E ' 40' ' ' SER . . . . . . . . . . . . . 78.0 p -93.64 124.07 37.38 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.705 174.8 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' E' E ' 41' ' ' ILE . . . . . . . . . . . . . 70.7 mt -127.82 118.62 49.4 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.2 0 CA-C-O 120.919 0.39 . . . . 0.0 110.373 177.785 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' E' E ' 42' ' ' LEU . . . . . . . . . . . . . 44.4 mt 51.37 34.32 11.64 Favored 'General case' 0 CA--C 1.531 0.213 0 CA-C-N 116.202 -0.454 . . . . 0.0 111.952 177.621 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' E' E ' 43' ' ' GLY . . . . . . . . . . . . . . . 74.65 32.4 57.41 Favored Glycine 0 CA--C 1.528 0.898 0 C-N-CA 121.138 -0.553 . . . . 0.0 112.095 178.303 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' E' E ' 44' ' ' LYS . . . . . . . . . . . . . 47.8 tptt -137.14 131.32 32.43 Favored 'General case' 0 C--N 1.33 -0.253 0 N-CA-C 109.549 -0.537 . . . . 0.0 109.549 177.776 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' E' E ' 45' ' ' GLU . . . . . . . . . . . . . 69.0 tt0 -85.13 123.3 30.49 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 116.538 -0.301 . . . . 0.0 111.415 -174.666 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' E' E ' 46' ' ' VAL . . . . . . . . . . . . . 7.1 p -124.99 128.7 73.27 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.21 0 CA-C-O 120.904 0.383 . . . . 0.0 110.056 176.412 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' E' E ' 47' ' ' LYS . . . . . . . . . . . . . 34.9 mmtp -101.77 132.81 47.3 Favored 'General case' 0 C--N 1.331 -0.21 0 CA-C-N 115.934 -0.575 . . . . 0.0 111.653 177.604 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' E' E ' 48' ' ' PHE . . . . . . . . . . . . . 89.6 m-85 -114.73 131.9 56.62 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-N 115.922 -0.581 . . . . 0.0 109.734 174.258 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' E' E ' 49' ' ' LYS . . . . . . . . . . . . . 57.6 tttm -106.67 139.8 40.54 Favored 'General case' 0 C--O 1.233 0.23 0 CA-C-N 116.69 -0.232 . . . . 0.0 110.586 179.426 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' E' E ' 50' ' ' VAL . . . . . . . . . . . . . 47.2 t -80.88 108.14 13.92 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.282 0 N-CA-C 109.155 -0.683 . . . . 0.0 109.155 176.026 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' E' E ' 51' ' ' VAL . . . . . . . . . . . . . 47.8 t -71.31 -47.88 57.27 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.309 0 CA-C-N 116.158 -0.474 . . . . 0.0 110.125 -174.266 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' E' E ' 52' ' ' GLN . . . . . . . . . . . . . 48.3 tt0 -164.86 141.58 5.95 Favored 'General case' 0 C--N 1.332 -0.169 0 C-N-CA 120.128 -0.629 . . . . 0.0 111.693 -178.338 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' E' E ' 53' ' ' ALA . . . . . 0.418 ' HB3' ' OG ' ' E' ' 56' ' ' SER . . . -115.0 133.11 56.32 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 115.764 -0.653 . . . . 0.0 110.001 176.5 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' E' E ' 54' ' ' TYR . . . . . . . . . . . . . 13.7 t80 -129.19 110.89 18.14 Favored Pre-proline 0 CA--C 1.534 0.364 0 CA-C-O 118.198 -0.906 . . . . 0.0 110.358 178.556 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' E' E ' 55' ' ' PRO . . . . . . . . . . . . . 72.3 Cg_endo -77.28 170.13 72.23 Favored 'Cis proline' 0 N--CA 1.5 1.862 0 CA-C-N 122.062 1.772 . . . . 0.0 112.075 -6.444 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' E' E ' 56' ' ' SER . . . . . 0.418 ' OG ' ' HB3' ' E' ' 53' ' ' ALA . 48.8 m -123.18 139.09 30.97 Favored Pre-proline 0 CA--C 1.538 0.485 0 CA-C-O 118.501 -0.761 . . . . 0.0 109.505 174.758 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' E' E ' 57' ' ' PRO . . . . . . . . . . . . . 36.7 Cg_endo -67.07 144.29 69.51 Favored 'Cis proline' 0 N--CA 1.499 1.849 0 CA-C-N 121.764 1.666 . . . . 0.0 111.489 -3.54 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' E' E ' 58' ' ' LEU . . . . . . . . . . . . . 19.6 tp -108.37 136.33 48.18 Favored 'General case' 0 C--N 1.331 -0.239 0 CA-C-N 116.313 -0.403 . . . . 0.0 111.024 -176.905 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' E' E ' 59' ' ' ARG . . . . . . . . . . . . . 74.5 ttt180 -103.63 123.78 47.62 Favored 'General case' 0 C--N 1.329 -0.32 0 N-CA-C 108.823 -0.806 . . . . 0.0 108.823 173.04 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' E' E ' 60' ' ' VAL . . . . . . . . . . . . . 43.9 t -81.67 123.02 37.51 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.258 0 C-N-CA 120.475 -0.49 . . . . 0.0 110.58 -173.367 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' E' E ' 61' ' ' GLU . . . . . . . . . . . . . 70.6 mm-40 -131.09 165.06 24.09 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 115.824 -0.625 . . . . 0.0 109.727 176.471 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' E' E ' 62' ' ' ASP . . . . . . . . . . . . . 11.7 t0 -52.62 -30.83 33.49 Favored 'General case' 0 C--N 1.328 -0.338 0 N-CA-C 111.983 0.364 . . . . 0.0 111.983 -179.822 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' E' E ' 63' ' ' ARG . . . . . . . . . . . . . 90.8 mtt-85 -71.78 -22.01 61.64 Favored 'General case' 0 CA--C 1.533 0.302 0 N-CA-C 112.829 0.677 . . . . 0.0 112.829 -176.309 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' E' E ' 64' ' ' THR . . . . . . . . . . . . . 27.3 m -73.03 136.82 45.08 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-O 120.844 0.354 . . . . 0.0 111.203 -174.246 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' E' E ' 65' ' ' LYS . . . . . . . . . . . . . 57.2 mtmt -90.08 132.61 35.32 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 115.956 -0.566 . . . . 0.0 110.454 177.946 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' E' E ' 66' ' ' ILE . . . . . . . . . . . . . 66.4 mt -112.62 128.2 69.43 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.283 0 N-CA-C 109.571 -0.529 . . . . 0.0 109.571 178.837 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' E' E ' 67' ' ' THR . . . . . . . . . . . . . 21.9 m -122.85 144.67 49.05 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-O 121.219 0.533 . . . . 0.0 111.317 -175.425 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' E' E ' 68' ' ' LEU . . . . . 0.452 ' C ' HD23 ' E' ' 68' ' ' LEU . 6.2 tt -98.6 125.29 43.8 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 115.601 -0.727 . . . . 0.0 109.96 178.698 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' E' E ' 69' ' ' VAL . . . . . 0.413 ' N ' HD23 ' E' ' 68' ' ' LEU . 43.0 t -87.95 128.55 40.27 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.284 0 CA-C-O 120.964 0.411 . . . . 0.0 110.258 -178.315 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' E' E ' 70' ' ' THR . . . . . . . . . . . . . 81.5 p -105.72 177.19 4.93 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.033 -0.53 . . . . 0.0 110.95 -177.368 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' E' E ' 71' ' ' HIS . . . . . . . . . . . . . 54.1 m-70 -64.91 168.22 7.7 Favored Pre-proline 0 C--N 1.329 -0.3 0 CA-C-N 115.672 -0.694 . . . . 0.0 110.519 -179.345 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' E' E ' 72' ' ' PRO . . . . . . . . . . . . . 18.7 Cg_exo -64.86 -5.55 10.83 Favored 'Trans proline' 0 N--CA 1.498 1.776 0 C-N-CA 121.322 1.348 . . . . 0.0 113.763 -177.82 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' E' E ' 73' ' ' VAL . . . . . . . . . . . . . 27.0 m -124.4 154.61 31.76 Favored 'Isoleucine or valine' 0 N--CA 1.461 0.112 0 CA-C-O 121.078 0.466 . . . . 0.0 110.564 177.632 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' E' E ' 74' ' ' ASP . . . . . . . . . . . . . 19.2 t0 -98.88 117.77 34.14 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 115.729 -0.669 . . . . 0.0 109.514 178.306 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' E' E ' 75' ' ' VAL . . . . . . . . . . . . . 43.3 t -109.0 119.34 58.38 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.251 0 CA-C-O 121.034 0.445 . . . . 0.0 110.279 -178.235 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' E' E ' 76' ' ' LEU . . . . . . . . . . . . . 28.7 mt -119.77 143.24 47.93 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 115.653 -0.703 . . . . 0.0 109.731 178.254 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' E' E ' 77' ' ' GLU . . . . . . . . . . . . . 97.2 mt-10 -134.86 129.38 34.35 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-O 121.071 0.463 . . . . 0.0 111.011 -178.294 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' E' E ' 78' ' ' ALA . . . . . . . . . . . . . . . -115.1 127.11 55.39 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 115.707 -0.679 . . . . 0.0 109.531 177.121 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' E' E ' 79' ' ' LYS . . . . . 0.545 ' O ' HD13 ' E' ' 80' ' ' ILE . 95.4 mttt -75.18 117.7 17.3 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-O 121.014 0.435 . . . . 0.0 110.747 -177.793 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' E' E ' 80' ' ' ILE . . . . . 0.545 HD13 ' O ' ' E' ' 79' ' ' LYS . 25.2 mm -139.27 111.23 5.33 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.378 0 N-CA-C 108.918 -0.771 . . . . 0.0 108.918 -178.601 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' E' E ' 81' ' ' LYS . . . . . . . . . . . . . 20.4 pttp -101.55 128.48 47.79 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-O 121.179 0.514 . . . . 0.0 111.402 -176.883 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' E' E ' 82' ' ' GLY . . . . . . . . . . . . . . . 89.19 42.14 5.66 Favored Glycine 0 CA--C 1.527 0.789 0 CA-C-N 115.697 -0.683 . . . . 0.0 111.858 175.6 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' E' E ' 83' ' ' ILE . . . . . . . . . . . . . 68.6 mt -69.37 137.37 24.36 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.337 0 N-CA-C 109.675 -0.491 . . . . 0.0 109.675 176.737 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' E' E ' 84' ' ' LYS . . . . . . . . . . . . . 23.4 ttpp -104.72 -51.73 3.01 Favored 'General case' 0 C--N 1.331 -0.212 0 CA-C-O 120.935 0.398 . . . . 0.0 110.252 179.968 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' E' E ' 85' ' ' ASP . . . . . . . . . . . . . 11.3 t70 -147.88 148.73 31.16 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 115.988 -0.551 . . . . 0.0 110.525 -178.865 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' E' E ' 86' ' ' VAL . . . . . . . . . . . . . 43.3 t -130.37 133.58 63.67 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.212 0 CA-C-O 120.984 0.421 . . . . 0.0 110.621 -179.498 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' E' E ' 87' ' ' ILE . . . . . . . . . . . . . 43.3 mm -119.31 122.87 70.16 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 CA-C-N 115.769 -0.651 . . . . 0.0 109.374 176.532 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' E' E ' 88' ' ' LEU . . . . . . . . . . . . . 60.4 mt -113.4 133.06 55.37 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-O 120.962 0.41 . . . . 0.0 111.312 -176.86 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' E' E ' 89' ' ' ASP . . . . . . . . . . . . . 6.5 t0 -134.2 157.56 45.93 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 115.821 -0.627 . . . . 0.0 109.72 176.627 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' E' E ' 90' ' ' GLU . . . . . . . . . . . . . 82.6 tt0 -46.41 -39.08 9.9 Favored 'General case' 0 C--N 1.329 -0.287 0 N-CA-C 113.295 0.85 . . . . 0.0 113.295 -170.588 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' E' E ' 91' ' ' ASN . . . . . . . . . . . . . 44.2 t30 -124.54 11.64 8.6 Favored 'General case' 0 N--CA 1.469 0.499 0 N-CA-C 113.528 0.936 . . . . 0.0 113.528 -174.231 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' E' E ' 92' ' ' LEU . . . . . . . . . . . . . 18.5 mt -148.22 143.48 27.04 Favored 'General case' 0 C--N 1.333 -0.141 0 CA-C-N 117.941 0.337 . . . . 0.0 110.36 -176.322 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' E' E ' 93' ' ' ILE . . . . . . . . . . . . . 70.1 mt -123.98 117.37 50.73 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.294 0 N-CA-C 109.222 -0.658 . . . . 0.0 109.222 176.724 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' E' E ' 94' ' ' VAL . . . . . . . . . . . . . 44.5 t -116.59 125.99 73.83 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.281 0 N-CA-C 109.791 -0.448 . . . . 0.0 109.791 -179.44 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' E' E ' 95' ' ' VAL . . . . . . . . . . . . . 43.4 t -118.81 133.45 65.61 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.34 0 CA-C-N 115.987 -0.552 . . . . 0.0 109.83 -179.601 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' E' E ' 96' ' ' ILE . . . . . 0.434 HD11 ' HB ' ' E' ' 123' ' ' VAL . 68.7 mt -114.17 127.11 71.74 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.305 0 N-CA-C 109.255 -0.646 . . . . 0.0 109.255 178.085 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' E' E ' 97' ' ' THR . . . . . . . . . . . . . 76.4 p -99.59 158.94 15.4 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-O 121.207 0.527 . . . . 0.0 111.117 -177.242 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' E' E ' 98' ' ' GLU . . . . . . . . . . . . . 96.8 mt-10 -53.82 -25.69 20.65 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.079 -0.509 . . . . 0.0 112.181 179.296 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' E' E ' 99' ' ' GLU . . . . . . . . . . . . . 34.7 tt0 -79.34 15.29 1.27 Allowed 'General case' 0 CA--C 1.539 0.533 0 N-CA-C 112.623 0.601 . . . . 0.0 112.623 -177.277 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' E' E ' 100' ' ' ASN . . . . . . . . . . . . . 2.8 m-20 61.16 37.94 17.21 Favored 'General case' 0 CA--C 1.53 0.186 0 O-C-N 121.815 -0.553 . . . . 0.0 110.936 178.752 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' E' E ' 101' ' ' GLU . . . . . . . . . . . . . 84.0 tt0 -115.27 145.11 42.78 Favored 'General case' 0 C--N 1.332 -0.182 0 CA-C-N 116.023 -0.535 . . . . 0.0 109.8 176.89 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' E' E ' 102' ' ' VAL . . . . . . . . . . . . . 45.5 t -115.02 124.22 71.46 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.331 0 CA-C-N 116.121 -0.491 . . . . 0.0 109.867 -178.251 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' E' E ' 103' ' ' LEU . . . . . . . . . . . . . 22.3 mt -118.48 128.16 54.32 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 115.8 -0.636 . . . . 0.0 110.144 176.667 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' E' E ' 104' ' ' ILE . . . . . . . . . . . . . 71.5 mt -118.42 122.28 69.14 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.257 0 N-CA-C 110.284 -0.265 . . . . 0.0 110.284 -179.652 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' E' E ' 105' ' ' PHE . . . . . . . . . . . . . 71.3 m-85 -120.79 165.84 14.58 Favored 'General case' 0 C--N 1.332 -0.161 0 O-C-N 124.035 0.835 . . . . 0.0 110.265 -179.985 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' E' E ' 106' ' ' ASN . . . . . . . . . . . . . 53.4 p-10 -99.35 -169.98 1.84 Allowed 'General case' 0 C--N 1.331 -0.236 0 N-CA-C 109.826 -0.435 . . . . 0.0 109.826 172.731 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' E' E ' 107' ' ' GLN . . . . . . . . . . . . . 5.4 tp-100 -57.45 -27.77 62.75 Favored 'General case' 0 CA--C 1.534 0.334 0 N-CA-C 112.193 0.442 . . . . 0.0 112.193 -177.889 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' E' E ' 108' ' ' ASN . . . . . . . . . . . . . 9.1 t-20 -93.68 14.34 19.38 Favored 'General case' 0 CA--C 1.534 0.351 0 N-CA-C 113.136 0.791 . . . . 0.0 113.136 -175.453 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' E' E ' 109' ' ' LEU . . . . . . . . . . . . . 72.5 mt 58.72 35.81 24.57 Favored 'General case' 0 CA--C 1.53 0.176 0 CA-C-O 120.881 0.372 . . . . 0.0 111.55 179.494 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' E' E ' 110' ' ' GLU . . . . . . . . . . . . . 95.9 mt-10 -99.26 148.19 24.39 Favored 'General case' 0 C--N 1.33 -0.282 0 N-CA-C 109.774 -0.454 . . . . 0.0 109.774 175.894 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' E' E ' 111' ' ' GLU . . . . . . . . . . . . . 57.1 tt0 -79.9 122.86 27.2 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.399 -0.364 . . . . 0.0 111.016 -176.273 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' E' E ' 112' ' ' LEU . . . . . . . . . . . . . 17.0 mt -109.89 -45.98 3.55 Favored 'General case' 0 C--N 1.331 -0.202 0 CA-C-N 116.207 -0.451 . . . . 0.0 110.616 177.584 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' E' E ' 113' ' ' TYR . . . . . . . . . . . . . 53.2 t80 -138.47 135.5 35.23 Favored 'General case' 0 C--N 1.331 -0.238 0 C-N-CA 120.837 -0.345 . . . . 0.0 111.079 -179.318 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' E' E ' 114' ' ' ARG . . . . . . . . . . . . . 61.3 ttp180 -136.19 123.45 21.83 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-N 116.228 -0.442 . . . . 0.0 110.373 178.047 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' E' E ' 115' ' ' GLY . . . . . . . . . . . . . . . -150.14 158.91 27.88 Favored Glycine 0 CA--C 1.526 0.726 0 N-CA-C 111.181 -0.768 . . . . 0.0 111.181 177.956 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' E' E ' 116' ' ' LYS . . . . . . . . . . . . . 39.5 ttpt -127.75 137.46 52.44 Favored 'General case' 0 C--N 1.331 -0.238 0 N-CA-C 109.497 -0.557 . . . . 0.0 109.497 175.105 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' E' E ' 117' ' ' PHE . . . . . . . . . . . . . 37.1 m-85 -139.75 113.89 8.95 Favored 'General case' 0 C--N 1.331 -0.209 0 C-N-CA 120.697 -0.401 . . . . 0.0 110.214 -177.094 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' E' E ' 118' ' ' GLU . . . . . . . . . . . . . 96.1 mt-10 -56.86 -43.92 81.66 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.398 -0.364 . . . . 0.0 110.891 -176.67 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' E' E ' 119' ' ' ASN . . . . . . . . . . . . . 79.0 m-20 -93.87 28.66 2.32 Favored 'General case' 0 C--N 1.329 -0.299 0 N-CA-C 112.312 0.486 . . . . 0.0 112.312 -174.943 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' E' E ' 120' ' ' LEU . . . . . . . . . . . . . 18.6 tp -59.3 123.46 16.79 Favored 'General case' 0 C--N 1.333 -0.122 0 N-CA-C 109.945 -0.391 . . . . 0.0 109.945 177.645 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' E' E ' 121' ' ' ASN . . . . . . . . . . . . . 33.7 m120 -114.13 -43.92 3.19 Favored 'General case' 0 C--N 1.332 -0.19 0 CA-C-N 116.509 -0.314 . . . . 0.0 110.953 -177.526 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' E' E ' 122' ' ' LYS . . . . . . . . . . . . . 98.6 mttt -144.03 148.05 34.69 Favored 'General case' 0 C--N 1.332 -0.195 0 CA-C-O 121.089 0.471 . . . . 0.0 111.714 -177.109 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' E' E ' 123' ' ' VAL . . . . . 0.434 ' HB ' HD11 ' E' ' 96' ' ' ILE . 45.8 t -127.95 129.97 69.82 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.341 0 N-CA-C 109.183 -0.673 . . . . 0.0 109.183 173.528 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' E' E ' 124' ' ' LEU . . . . . . . . . . . . . 28.2 mt -129.31 137.74 51.19 Favored 'General case' 0 N--CA 1.463 0.206 0 CA-C-O 121.047 0.451 . . . . 0.0 111.036 -176.147 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' E' E ' 125' ' ' VAL . . . . . . . . . . . . . 41.4 t -124.71 129.46 73.63 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.225 0 CA-C-N 115.77 -0.65 . . . . 0.0 109.922 179.725 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' E' E ' 126' ' ' ARG . . . . . . . . . . . . . 43.4 mmm-85 -140.61 115.32 9.56 Favored 'General case' 0 C--N 1.329 -0.298 0 N-CA-C 109.416 -0.587 . . . . 0.0 109.416 177.869 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' E' E ' 127' ' ' ASN . . . . . . . . . . . . . 78.5 m-20 56.02 -149.84 0.45 Allowed 'General case' 0 CA--C 1.541 0.629 0 N-CA-C 109.838 -0.43 . . . . 0.0 109.838 -179.93 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' E' E ' 128' ' ' ASP . . . . . . . . . . . . . 38.4 p30 -80.01 14.19 1.93 Allowed 'General case' 0 CA--C 1.535 0.39 0 N-CA-C 112.932 0.716 . . . . 0.0 112.932 179.136 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' E' E ' 129' ' ' LEU . . . . . . . . . . . . . 14.3 tp -111.93 136.46 51.22 Favored 'General case' 0 C--O 1.232 0.141 0 N-CA-C 109.688 -0.486 . . . . 0.0 109.688 177.289 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' E' E ' 130' ' ' VAL . . . . . 0.52 HG13 ' HB ' ' E' ' 141' ' ' ILE . 11.3 p -129.09 140.75 48.4 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.254 0 CA-C-O 120.934 0.397 . . . . 0.0 110.341 -177.924 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' E' E ' 131' ' ' VAL . . . . . . . . . . . . . 35.1 m -136.05 145.1 31.56 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.252 0 CA-C-O 121.237 0.541 . . . . 0.0 111.292 -179.096 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' E' E ' 132' ' ' ILE . . . . . . . . . . . . . 72.5 mt -118.94 133.69 64.98 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.32 0 CA-C-N 115.269 -0.878 . . . . 0.0 109.243 179.986 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' E' E ' 133' ' ' ILE . . . . . . . . . . . . . 39.5 mm -115.37 119.84 62.96 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.274 0 CA-C-O 120.722 0.296 . . . . 0.0 110.885 -175.399 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' E' E ' 134' ' ' ASP . . . . . . . . . . . . . 9.5 p-10 -131.79 148.26 52.55 Favored 'General case' 0 C--N 1.332 -0.173 0 N-CA-C 109.542 -0.54 . . . . 0.0 109.542 175.221 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' E' E ' 135' ' ' GLU . . . . . . . . . . . . . 84.8 tt0 -49.87 -27.61 5.4 Favored 'General case' 0 C--N 1.326 -0.422 0 N-CA-C 112.796 0.665 . . . . 0.0 112.796 -172.567 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' E' E ' 136' ' ' GLN . . . . . . . . . . . . . 98.4 mt-30 -81.85 -34.45 30.11 Favored 'General case' 0 C--N 1.33 -0.249 0 N-CA-C 112.746 0.647 . . . . 0.0 112.746 -176.192 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' E' E ' 137' ' ' LYS . . . . . . . . . . . . . 54.1 pttt -167.93 171.53 9.71 Favored 'General case' 0 C--N 1.332 -0.196 0 CA-C-O 121.66 0.743 . . . . 0.0 112.573 -171.131 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' E' E ' 138' ' ' LEU . . . . . 0.582 HD23 ' N ' ' E' ' 139' ' ' THR . 3.4 tt -114.05 127.91 56.15 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 114.73 -1.123 . . . . 0.0 109.679 -179.958 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' E' E ' 139' ' ' THR . . . . . 0.582 ' N ' HD23 ' E' ' 138' ' ' LEU . 30.5 m -108.86 128.02 54.55 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-O 120.715 0.293 . . . . 0.0 110.401 179.219 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' E' E ' 140' ' ' LEU . . . . . 0.48 ' C ' HD23 ' E' ' 140' ' ' LEU . 8.0 tt -117.57 124.34 48.44 Favored 'General case' 0 C--N 1.329 -0.285 0 N-CA-C 109.359 -0.608 . . . . 0.0 109.359 -178.594 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' E' E ' 141' ' ' ILE . . . . . 0.52 ' HB ' HG13 ' E' ' 130' ' ' VAL . 19.5 mt -120.94 121.73 65.87 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.305 0 N-CA-C 109.714 -0.476 . . . . 0.0 109.714 -175.431 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' E' E ' 142' ' ' ARG . . . . . . . . . . . . . 73.7 ttt180 -112.7 130.21 56.13 Favored 'General case' 0 C--N 1.331 -0.208 0 CA-C-N 115.709 -0.678 . . . . 0.0 110.407 -176.89 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' E' E ' 143' ' ' THR . . . . . . . . . . . . . 50.8 p . . . . . 0 C--O 1.22 -0.475 0 CA-C-O 117.997 -1.001 . . . . 0.0 110.603 -179.81 . . . . . . . . 0 0 . 1 . 013 nuclear build full ' F' F ' -3' ' ' GLU . . . . . . . . . . . . . 95.8 mt-10 . . . . . 0 N--CA 1.491 1.594 0 N-CA-C 109.368 -0.604 . . . . 0.0 109.368 . . . . . . . . . 0 0 . 1 . 013 nuclear build full ' F' F ' -2' ' ' GLY . . . . . . . . . . . . . . . -60.69 150.0 42.9 Favored Glycine 0 CA--C 1.525 0.662 0 N-CA-C 110.706 -0.958 . . . . 0.0 110.706 178.807 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' F' F ' -1' ' ' VAL . . . . . . . . . . . . . 44.0 t -94.85 127.48 46.79 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.358 0 CA-C-O 120.917 0.389 . . . . 0.0 110.17 -179.096 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' F' F ' 0' ' ' ILE . . . . . . . . . . . . . 71.8 mt -120.88 124.16 71.74 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.269 0 CA-C-N 116.05 -0.523 . . . . 0.0 109.676 178.833 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' F' F ' 1' ' ' MET . . . . . . . . . . . . . 25.6 ptp -84.68 140.82 31.03 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.26 -0.427 . . . . 0.0 110.615 -178.712 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' F' F ' 2' ' ' SER . . . . . . . . . . . . . 3.0 p -110.51 127.54 55.22 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-O 121.134 0.492 . . . . 0.0 110.449 178.916 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' F' F ' 3' ' ' GLU . . . . . . . . . . . . . 84.2 tt0 -140.17 139.14 35.66 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 115.69 -0.687 . . . . 0.0 110.771 -178.827 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' F' F ' 4' ' ' LEU . . . . . . . . . . . . . 19.1 tp -122.13 124.75 44.62 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 115.985 -0.552 . . . . 0.0 110.376 178.497 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' F' F ' 5' ' ' LYS . . . . . . . . . . . . . 97.9 mttt -101.92 118.84 37.75 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.146 -0.479 . . . . 0.0 110.28 177.261 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' F' F ' 6' ' ' LEU . . . . . . . . . . . . . 31.0 mt -114.99 148.28 38.99 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 115.486 -0.779 . . . . 0.0 110.242 -179.07 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' F' F ' 7' ' ' LYS . . . . . . . . . . . . . 52.3 tttp -137.2 140.71 31.84 Favored Pre-proline 0 CA--C 1.534 0.34 0 CA-C-O 119.124 -0.465 . . . . 0.0 110.047 175.433 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' F' F ' 8' ' ' PRO . . . . . . . . . . . . . 89.3 Cg_endo -91.85 139.37 2.17 Favored 'Trans proline' 0 N--CA 1.49 1.293 0 C-N-CA 121.736 1.624 . . . . 0.0 111.745 177.898 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' F' F ' 9' ' ' LEU . . . . . . . . . . . . . 46.1 mt -77.68 -47.66 2.34 Favored Pre-proline 0 CA--C 1.534 0.35 0 CA-C-O 118.682 -0.675 . . . . 0.0 112.237 -179.663 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' F' F ' 10' ' ' PRO . . . . . . . . . . . . . 86.2 Cg_endo -80.6 152.93 20.18 Favored 'Trans proline' 0 N--CA 1.495 1.616 0 C-N-CA 121.185 1.257 . . . . 0.0 111.89 176.064 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' F' F ' 11' ' ' LYS . . . . . . . . . . . . . 60.7 tttm -88.8 93.66 9.66 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-O 120.818 0.342 . . . . 0.0 110.456 179.038 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' F' F ' 12' ' ' VAL . . . . . . . . . . . . . 13.0 p -141.38 143.34 27.86 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.231 0 CA-C-N 116.318 -0.401 . . . . 0.0 110.701 -179.525 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' F' F ' 13' ' ' GLU . . . . . . . . . . . . . 45.9 mp0 -77.67 132.83 38.38 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.29 -0.414 . . . . 0.0 110.255 178.065 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' F' F ' 14' ' ' LEU . . . . . . . . . . . . . 31.0 mt -98.37 147.74 33.55 Favored Pre-proline 0 CA--C 1.533 0.307 0 CA-C-O 119.185 -0.436 . . . . 0.0 110.233 -179.738 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' F' F ' 15' ' ' PRO . . . . . . . . . . . . . 25.8 Cg_exo -62.17 158.95 36.94 Favored 'Trans proline' 0 N--CA 1.498 1.741 0 C-N-CA 121.335 1.356 . . . . 0.0 111.876 176.793 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' F' F ' 16' ' ' PRO . . . . . . . . . . . . . 38.7 Cg_exo -58.56 -41.17 67.31 Favored 'Trans proline' 0 N--CA 1.498 1.785 0 C-N-CA 121.497 1.465 . . . . 0.0 112.808 -177.72 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' F' F ' 17' ' ' ASP . . . . . . . . . . . . . 19.2 p-10 -85.71 9.02 17.55 Favored 'General case' 0 C--N 1.326 -0.414 0 N-CA-C 113.23 0.826 . . . . 0.0 113.23 -177.609 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' F' F ' 18' ' ' PHE . . . . . . . . . . . . . 36.7 t80 -58.34 -45.43 88.14 Favored 'General case' 0 C--N 1.333 -0.114 0 O-C-N 121.998 -0.439 . . . . 0.0 110.152 -177.594 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' F' F ' 19' ' ' VAL . . . . . 0.413 HG13 ' N ' ' F' ' 20' ' ' ASP . 13.6 p -56.69 -41.51 74.63 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.329 0 CA-C-N 116.25 -0.432 . . . . 0.0 110.954 -178.738 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' F' F ' 20' ' ' ASP . . . . . 0.413 ' N ' HG13 ' F' ' 19' ' ' VAL . 30.0 m-20 -60.53 -43.5 97.07 Favored 'General case' 0 C--N 1.331 -0.198 0 C-N-CA 120.937 -0.305 . . . . 0.0 111.12 -178.087 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' F' F ' 21' ' ' VAL . . . . . . . . . . . . . 47.0 t -64.58 -46.11 93.52 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.255 0 C-N-CA 120.834 -0.346 . . . . 0.0 110.519 -177.498 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' F' F ' 22' ' ' ILE . . . . . 0.53 HG22 HD12 ' F' ' 26' ' ' LEU . 51.5 mm -57.46 -41.05 77.93 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.288 0 C-N-CA 121.089 -0.244 . . . . 0.0 110.628 179.418 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' F' F ' 23' ' ' ARG . . . . . . . . . . . . . 32.0 ttp180 -56.14 -48.29 76.55 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-O 120.945 0.402 . . . . 0.0 110.718 178.04 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' F' F ' 24' ' ' ILE . . . . . . . . . . . . . 73.0 mt -61.66 -42.48 94.38 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.306 0 CA-C-N 116.014 -0.539 . . . . 0.0 111.941 -177.969 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' F' F ' 25' ' ' LYS . . . . . . . . . . . . . 16.4 pttp -73.58 -35.07 65.4 Favored 'General case' 0 CA--C 1.533 0.314 0 C-N-CA 120.537 -0.465 . . . . 0.0 111.801 -173.326 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' F' F ' 26' ' ' LEU . . . . . 0.53 HD12 HG22 ' F' ' 22' ' ' ILE . 64.5 mt -79.07 -43.06 24.94 Favored 'General case' 0 C--N 1.33 -0.258 0 N-CA-C 112.971 0.73 . . . . 0.0 112.971 -174.528 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' F' F ' 27' ' ' GLN . . . . . . . . . . . . . 15.1 pt20 -46.73 139.67 5.12 Favored 'General case' 0 N--CA 1.469 0.505 0 N-CA-C 112.884 0.698 . . . . 0.0 112.884 -174.54 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' F' F ' 28' ' ' GLY . . . . . . . . . . . . . . . 100.31 -29.99 11.1 Favored Glycine 0 CA--C 1.529 0.948 0 CA-C-N 115.471 -0.786 . . . . 0.0 111.971 -177.915 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' F' F ' 29' ' ' LYS . . . . . . . . . . . . . 98.1 mttt -98.09 155.2 17.25 Favored 'General case' 0 C--O 1.233 0.19 0 CA-C-O 121.061 0.458 . . . . 0.0 111.035 177.988 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' F' F ' 30' ' ' THR . . . . . . . . . . . . . 23.9 m -103.91 139.43 39.09 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.019 -0.537 . . . . 0.0 109.994 175.816 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' F' F ' 31' ' ' VAL . . . . . . . . . . . . . 34.9 m -127.34 157.61 38.93 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.288 0 CA-C-N 116.254 -0.43 . . . . 0.0 110.514 -179.125 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' F' F ' 32' ' ' ARG . . . . . . . . . . . . . 56.3 ttp180 -133.77 151.92 51.73 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-O 121.178 0.514 . . . . 0.0 110.612 179.569 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' F' F ' 33' ' ' THR . . . . . . . . . . . . . 20.7 m -53.09 138.43 31.06 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 116.221 -0.445 . . . . 0.0 111.406 -178.489 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' F' F ' 34' ' ' GLY . . . . . . . . . . . . . . . 100.84 -17.08 56.9 Favored Glycine 0 CA--C 1.534 1.223 0 CA-C-O 119.584 -0.565 . . . . 0.0 113.262 179.16 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' F' F ' 35' ' ' ASP . . . . . . . . . . . . . 63.2 m-20 -65.13 149.45 49.88 Favored 'General case' 0 N--CA 1.461 0.096 0 CA-C-N 118.006 0.903 . . . . 0.0 111.308 179.602 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' F' F ' 36' ' ' VAL . . . . . . . . . . . . . 45.8 t -125.15 129.63 73.2 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.196 0 CA-C-N 115.686 -0.688 . . . . 0.0 109.71 178.399 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' F' F ' 37' ' ' ILE . . . . . . . . . . . . . 68.4 mt -122.29 138.92 50.85 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.265 0 N-CA-C 109.839 -0.43 . . . . 0.0 109.839 -179.948 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' F' F ' 38' ' ' GLY . . . . . . . . . . . . . . . -111.07 128.87 8.93 Favored Glycine 0 CA--C 1.524 0.654 0 N-CA-C 111.191 -0.764 . . . . 0.0 111.191 -179.372 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' F' F ' 39' ' ' ILE . . . . . . . . . . . . . 72.4 mt -122.57 136.47 59.28 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.215 0 N-CA-C 109.902 -0.407 . . . . 0.0 109.902 179.014 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' F' F ' 40' ' ' SER . . . . . 0.518 ' O ' HD13 ' F' ' 41' ' ' ILE . 21.8 t -92.74 118.32 30.95 Favored 'General case' 0 C--N 1.33 -0.25 0 C-N-CA 120.956 -0.298 . . . . 0.0 110.802 176.26 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' F' F ' 41' ' ' ILE . . . . . 0.518 HD13 ' O ' ' F' ' 40' ' ' SER . 47.8 mm -128.77 115.77 38.38 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.207 0 CA-C-O 120.811 0.339 . . . . 0.0 110.273 178.331 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' F' F ' 42' ' ' LEU . . . . . . . . . . . . . 11.4 tp 57.14 37.16 28.34 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 116.137 -0.483 . . . . 0.0 111.386 178.428 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' F' F ' 43' ' ' GLY . . . . . . . . . . . . . . . 77.67 -10.09 26.21 Favored Glycine 0 CA--C 1.534 1.268 0 C-N-CA 121.316 -0.469 . . . . 0.0 113.5 177.074 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' F' F ' 44' ' ' LYS . . . . . . . . . . . . . 38.7 mmtm -97.52 135.5 39.27 Favored 'General case' 0 C--N 1.332 -0.193 0 CA-C-N 117.966 0.883 . . . . 0.0 110.17 177.277 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' F' F ' 45' ' ' GLU . . . . . . . . . . . . . 82.7 tt0 -84.65 125.99 32.96 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.358 -0.383 . . . . 0.0 110.819 179.873 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' F' F ' 46' ' ' VAL . . . . . . . . . . . . . 7.3 p -119.34 126.44 75.34 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.159 0 N-CA-C 109.437 -0.579 . . . . 0.0 109.437 176.135 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' F' F ' 47' ' ' LYS . . . . . . . . . . . . . 60.4 mttp -100.1 127.46 46.33 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 115.865 -0.607 . . . . 0.0 111.007 178.806 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' F' F ' 48' ' ' PHE . . . . . . . . . . . . . 93.9 m-85 -109.89 131.91 54.64 Favored 'General case' 0 C--N 1.33 -0.262 0 N-CA-C 109.817 -0.438 . . . . 0.0 109.817 175.925 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' F' F ' 49' ' ' LYS . . . . . . . . . . . . . 53.7 tttp -108.44 138.83 44.09 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.406 -0.361 . . . . 0.0 110.349 179.128 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' F' F ' 50' ' ' VAL . . . . . . . . . . . . . 45.2 t -81.77 108.69 15.13 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.257 0 N-CA-C 109.384 -0.598 . . . . 0.0 109.384 176.226 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' F' F ' 51' ' ' VAL . . . . . . . . . . . . . 48.5 t -74.89 -48.06 34.66 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.276 0 CA-C-N 115.988 -0.551 . . . . 0.0 110.068 -174.015 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' F' F ' 52' ' ' GLN . . . . . . . . . . . . . 62.6 tt0 -158.7 133.94 8.52 Favored 'General case' 0 C--N 1.331 -0.23 0 C-N-CA 120.241 -0.584 . . . . 0.0 111.811 -177.518 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' F' F ' 53' ' ' ALA . . . . . 0.481 ' HB1' ' HB2' ' F' ' 58' ' ' LEU . . . -108.22 127.29 53.71 Favored 'General case' 0 C--N 1.332 -0.185 0 CA-C-N 115.667 -0.697 . . . . 0.0 109.644 174.395 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' F' F ' 54' ' ' TYR . . . . . . . . . . . . . 56.5 t80 -123.38 107.45 32.24 Favored Pre-proline 0 CA--C 1.534 0.346 0 CA-C-O 118.304 -0.855 . . . . 0.0 110.643 -178.606 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' F' F ' 55' ' ' PRO . . . . . . . . . . . . . 74.0 Cg_endo -76.96 169.86 73.28 Favored 'Cis proline' 0 N--CA 1.5 1.887 0 CA-C-N 121.725 1.652 . . . . 0.0 112.434 -5.681 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' F' F ' 56' ' ' SER . . . . . . . . . . . . . 25.1 m -108.52 124.55 34.1 Favored Pre-proline 0 CA--C 1.538 0.51 0 CA-C-O 118.372 -0.823 . . . . 0.0 109.561 175.819 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' F' F ' 57' ' ' PRO . . . . . . . . . . . . . 48.1 Cg_endo -70.19 166.66 74.6 Favored 'Cis proline' 0 N--CA 1.498 1.771 0 CA-C-N 122.106 1.788 . . . . 0.0 111.824 0.391 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' F' F ' 58' ' ' LEU . . . . . 0.481 ' HB2' ' HB1' ' F' ' 53' ' ' ALA . 24.2 tp -129.09 135.37 48.81 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.137 -0.483 . . . . 0.0 110.296 -179.926 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' F' F ' 59' ' ' ARG . . . . . . . . . . . . . 52.1 ttp180 -104.56 131.87 51.46 Favored 'General case' 0 C--N 1.327 -0.4 0 N-CA-C 109.68 -0.489 . . . . 0.0 109.68 178.749 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' F' F ' 60' ' ' VAL . . . . . . . . . . . . . 45.3 t -86.2 123.22 39.45 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.214 0 C-N-CA 120.671 -0.411 . . . . 0.0 110.404 -175.469 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' F' F ' 61' ' ' GLU . . . . . . . . . . . . . 95.3 mt-10 -131.06 166.26 21.43 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 115.942 -0.572 . . . . 0.0 110.14 177.806 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' F' F ' 62' ' ' ASP . . . . . . . . . . . . . 64.0 m-20 -54.92 -32.75 61.5 Favored 'General case' 0 C--N 1.327 -0.382 0 C-N-CA 121.096 -0.242 . . . . 0.0 111.604 179.536 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' F' F ' 63' ' ' ARG . . . . . . . . . . . . . 10.3 ptm180 -87.78 6.91 32.88 Favored 'General case' 0 CA--C 1.537 0.446 0 N-CA-C 113.59 0.959 . . . . 0.0 113.59 -176.73 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' F' F ' 64' ' ' THR . . . . . . . . . . . . . 11.8 m -82.41 139.98 33.72 Favored 'General case' 0 C--N 1.333 -0.137 0 CA-C-N 118.051 0.387 . . . . 0.0 110.655 -177.967 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' F' F ' 65' ' ' LYS . . . . . . . . . . . . . 97.9 mttt -89.15 125.05 34.89 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.085 179.21 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' F' F ' 66' ' ' ILE . . . . . . . . . . . . . 59.4 mt -116.36 127.93 73.83 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.262 0 N-CA-C 109.679 -0.489 . . . . 0.0 109.679 179.0 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' F' F ' 67' ' ' THR . . . . . . . . . . . . . 25.1 m -129.13 145.63 51.25 Favored 'General case' 0 C--N 1.331 -0.214 0 CA-C-O 121.112 0.482 . . . . 0.0 111.42 -176.658 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' F' F ' 68' ' ' LEU . . . . . . . . . . . . . 15.5 tp -95.09 120.58 35.55 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 115.79 -0.641 . . . . 0.0 109.527 175.899 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' F' F ' 69' ' ' VAL . . . . . . . . . . . . . 40.1 t -103.85 139.68 24.13 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 CA-C-O 121.046 0.451 . . . . 0.0 111.181 -173.847 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' F' F ' 70' ' ' THR . . . . . . . . . . . . . 47.2 m -102.59 134.95 45.11 Favored 'General case' 0 C--N 1.328 -0.341 0 N-CA-C 109.068 -0.715 . . . . 0.0 109.068 172.542 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' F' F ' 71' ' ' HIS . . . . . . . . . . . . . 65.1 m-70 -126.48 165.2 29.54 Favored Pre-proline 0 N--CA 1.464 0.264 0 N-CA-C 111.845 0.313 . . . . 0.0 111.845 -174.499 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' F' F ' 72' ' ' PRO . . . . . . . . . . . . . 8.1 Cg_exo -68.34 160.19 50.09 Favored 'Trans proline' 0 N--CA 1.495 1.607 0 C-N-CA 121.782 1.655 . . . . 0.0 112.07 177.915 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' F' F ' 73' ' ' VAL . . . . . . . . . . . . . 35.8 m -69.9 -174.1 0.11 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.312 0 N-CA-C 109.694 -0.484 . . . . 0.0 109.694 178.928 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' F' F ' 74' ' ' ASP . . . . . . . . . . . . . 7.2 t70 -90.64 115.17 27.54 Favored 'General case' 0 C--N 1.331 -0.226 0 C-N-CA 120.645 -0.422 . . . . 0.0 110.31 -173.593 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' F' F ' 75' ' ' VAL . . . . . . . . . . . . . 44.5 t -114.89 120.45 64.55 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.228 0 CA-C-O 121.038 0.447 . . . . 0.0 110.085 -179.272 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' F' F ' 76' ' ' LEU . . . . . . . . . . . . . 20.6 mt -124.47 144.29 50.17 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 115.662 -0.699 . . . . 0.0 109.717 179.34 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' F' F ' 77' ' ' GLU . . . . . . . . . . . . . 46.6 mt-10 -134.11 135.86 43.48 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-O 121.073 0.463 . . . . 0.0 111.286 -177.761 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' F' F ' 78' ' ' ALA . . . . . . . . . . . . . . . -122.64 127.71 49.7 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 115.483 -0.78 . . . . 0.0 109.457 175.712 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' F' F ' 79' ' ' LYS . . . . . 0.651 ' O ' HD13 ' F' ' 80' ' ' ILE . 37.7 tttp -79.79 120.29 23.86 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-O 120.993 0.425 . . . . 0.0 110.828 -175.785 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' F' F ' 80' ' ' ILE . . . . . 0.651 HD13 ' O ' ' F' ' 79' ' ' LYS . 37.5 mm -139.3 108.85 3.84 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.291 0 N-CA-C 108.983 -0.747 . . . . 0.0 108.983 -179.289 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' F' F ' 81' ' ' LYS . . . . . . . . . . . . . 39.7 ttpt -99.26 123.69 43.74 Favored 'General case' 0 C--N 1.329 -0.298 0 C-N-CA 120.862 -0.335 . . . . 0.0 110.97 -176.236 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' F' F ' 82' ' ' GLY . . . . . . . . . . . . . . . 89.21 42.18 5.64 Favored Glycine 0 CA--C 1.525 0.708 0 C-N-CA 120.7 -0.762 . . . . 0.0 111.677 176.368 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' F' F ' 83' ' ' ILE . . . . . . . . . . . . . 75.3 mt -67.2 140.31 19.57 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.338 0 N-CA-C 109.875 -0.417 . . . . 0.0 109.875 177.603 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' F' F ' 84' ' ' LYS . . . . . . . . . . . . . 47.0 tttp -100.82 -53.94 2.94 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.029 -0.532 . . . . 0.0 110.654 -178.644 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' F' F ' 85' ' ' ASP . . . . . . . . . . . . . 13.5 t70 -146.22 149.43 33.9 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 115.916 -0.584 . . . . 0.0 110.705 -178.095 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' F' F ' 86' ' ' VAL . . . . . . . . . . . . . 41.3 t -128.51 127.56 67.09 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.221 0 CA-C-O 120.815 0.341 . . . . 0.0 110.364 -179.782 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' F' F ' 87' ' ' ILE . . . . . . . . . . . . . 44.4 mm -120.84 130.39 74.67 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.223 0 CA-C-N 116.071 -0.513 . . . . 0.0 109.923 178.674 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' F' F ' 88' ' ' LEU . . . . . . . . . . . . . 27.1 mt -115.47 137.4 52.09 Favored 'General case' 0 C--N 1.332 -0.182 0 CA-C-O 120.951 0.405 . . . . 0.0 111.069 -178.946 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' F' F ' 89' ' ' ASP . . . . . . . . . . . . . 7.4 t70 -135.31 162.19 33.28 Favored 'General case' 0 C--N 1.331 -0.239 0 CA-C-N 115.999 -0.546 . . . . 0.0 110.084 177.335 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' F' F ' 90' ' ' GLU . . . . . . . . . . . . . 96.4 mt-10 -45.15 -48.14 12.27 Favored 'General case' 0 N--CA 1.465 0.307 0 N-CA-C 113.149 0.796 . . . . 0.0 113.149 -171.263 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' F' F ' 91' ' ' ASN . . . . . . . . . . . . . 21.0 t-20 -132.04 39.91 3.39 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-O 120.974 0.416 . . . . 0.0 110.861 -177.606 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' F' F ' 92' ' ' LEU . . . . . . . . . . . . . 10.7 tp -163.45 138.01 6.14 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.355 -0.384 . . . . 0.0 110.89 -177.539 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' F' F ' 93' ' ' ILE . . . . . . . . . . . . . 69.0 mt -122.3 124.81 71.79 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.311 0 N-CA-C 109.226 -0.657 . . . . 0.0 109.226 177.29 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' F' F ' 94' ' ' VAL . . . . . . . . . . . . . 45.8 t -123.54 128.62 74.68 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.258 0 CA-C-O 120.983 0.42 . . . . 0.0 110.069 -178.931 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' F' F ' 95' ' ' VAL . . . . . . . . . . . . . 44.4 t -121.58 134.76 63.89 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.314 0 CA-C-N 115.921 -0.581 . . . . 0.0 109.724 178.958 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' F' F ' 96' ' ' ILE . . . . . . . . . . . . . 61.6 mt -114.47 127.71 71.83 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.354 0 N-CA-C 109.146 -0.687 . . . . 0.0 109.146 178.493 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' F' F ' 97' ' ' THR . . . . . . . . . . . . . 58.3 p -98.5 159.5 14.91 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-O 121.102 0.477 . . . . 0.0 111.177 -177.498 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' F' F ' 98' ' ' GLU . . . . . . . . . . . . . 80.4 tt0 -53.88 -28.16 34.55 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.171 -0.468 . . . . 0.0 112.092 -179.622 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' F' F ' 99' ' ' GLU . . . . . . . . . . . . . 95.6 mt-10 -79.96 16.5 1.17 Allowed 'General case' 0 CA--C 1.535 0.392 0 N-CA-C 113.043 0.757 . . . . 0.0 113.043 -177.263 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' F' F ' 100' ' ' ASN . . . . . . . . . . . . . 4.2 m-20 62.48 38.04 12.95 Favored 'General case' 0 CA--C 1.53 0.198 0 CA-C-O 121.009 0.433 . . . . 0.0 111.072 177.757 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' F' F ' 101' ' ' GLU . . . . . . . . . . . . . 83.6 tt0 -111.8 144.05 41.74 Favored 'General case' 0 C--N 1.332 -0.186 0 CA-C-N 116.004 -0.544 . . . . 0.0 109.775 175.891 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' F' F ' 102' ' ' VAL . . . . . . . . . . . . . 42.7 t -115.02 125.09 72.24 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.293 0 N-CA-C 109.798 -0.445 . . . . 0.0 109.798 -178.67 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' F' F ' 103' ' ' LEU . . . . . . . . . . . . . 44.1 mt -118.3 131.63 56.33 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 115.725 -0.67 . . . . 0.0 110.046 178.395 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' F' F ' 104' ' ' ILE . . . . . 0.614 HD13 HG11 ' F' ' 130' ' ' VAL . 67.3 mt -121.09 123.09 69.25 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.245 0 CA-C-O 120.66 0.266 . . . . 0.0 110.374 -179.787 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' F' F ' 105' ' ' PHE . . . . . . . . . . . . . 48.7 m-85 -123.95 167.42 14.17 Favored 'General case' 0 C--N 1.333 -0.122 0 CA-C-N 115.358 -0.837 . . . . 0.0 109.885 178.931 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' F' F ' 106' ' ' ASN . . . . . . . . . . . . . 36.8 p-10 -98.74 -169.97 1.86 Allowed 'General case' 0 C--N 1.331 -0.207 0 N-CA-C 109.866 -0.42 . . . . 0.0 109.866 172.919 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' F' F ' 107' ' ' GLN . . . . . . . . . . . . . 12.1 tt0 -58.6 -30.08 66.94 Favored 'General case' 0 C--N 1.329 -0.31 0 N-CA-C 112.048 0.388 . . . . 0.0 112.048 -179.339 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' F' F ' 108' ' ' ASN . . . . . . . . . . . . . 5.7 t30 -91.33 14.01 15.77 Favored 'General case' 0 CA--C 1.535 0.394 0 N-CA-C 113.153 0.797 . . . . 0.0 113.153 -176.631 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' F' F ' 109' ' ' LEU . . . . . . . . . . . . . 30.7 mt 59.25 34.61 23.12 Favored 'General case' 0 C--N 1.332 -0.167 0 N-CA-C 111.992 0.367 . . . . 0.0 111.992 177.019 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' F' F ' 110' ' ' GLU . . . . . . . . . . . . . 95.9 mt-10 -98.64 136.37 38.81 Favored 'General case' 0 C--N 1.328 -0.338 0 N-CA-C 109.049 -0.723 . . . . 0.0 109.049 173.187 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' F' F ' 111' ' ' GLU . . . . . . . . . . . . . 56.1 tt0 -78.64 121.9 25.27 Favored 'General case' 0 C--N 1.327 -0.401 0 CA-C-O 120.898 0.38 . . . . 0.0 110.743 -173.727 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' F' F ' 112' ' ' LEU . . . . . . . . . . . . . 15.3 mt -103.73 -45.97 4.65 Favored 'General case' 0 C--N 1.331 -0.204 0 CA-C-N 115.868 -0.606 . . . . 0.0 110.703 179.574 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' F' F ' 113' ' ' TYR . . . . . . . . . . . . . 44.5 t80 -136.26 141.88 43.93 Favored 'General case' 0 C--N 1.331 -0.239 0 CA-C-N 116.193 -0.458 . . . . 0.0 111.181 -177.174 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' F' F ' 114' ' ' ARG . . . . . . . . . . . . . 32.3 ptt180 -147.06 123.25 10.86 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.107 -0.497 . . . . 0.0 110.826 176.893 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' F' F ' 115' ' ' GLY . . . . . . . . . . . . . . . -150.09 163.02 29.37 Favored Glycine 0 CA--C 1.523 0.554 0 N-CA-C 110.789 -0.924 . . . . 0.0 110.789 179.472 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' F' F ' 116' ' ' LYS . . . . . . . . . . . . . 38.3 ttpt -130.17 135.77 48.54 Favored 'General case' 0 C--N 1.329 -0.295 0 O-C-N 122.627 -0.337 . . . . 0.0 110.123 179.066 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' F' F ' 117' ' ' PHE . . . . . . . . . . . . . 48.6 m-85 -133.58 114.85 14.01 Favored 'General case' 0 C--N 1.331 -0.206 0 CA-C-O 120.967 0.413 . . . . 0.0 110.176 -176.95 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' F' F ' 118' ' ' GLU . . . . . . . . . . . . . 70.6 mm-40 -54.54 -41.1 69.34 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 116.412 -0.358 . . . . 0.0 111.371 -176.319 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' F' F ' 119' ' ' ASN . . . . . . . . . . . . . 85.6 m-20 -100.73 31.04 3.68 Favored 'General case' 0 C--N 1.33 -0.276 0 N-CA-C 112.176 0.435 . . . . 0.0 112.176 -173.919 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' F' F ' 120' ' ' LEU . . . . . . . . . . . . . 15.0 tp -56.59 119.92 6.91 Favored 'General case' 0 C--N 1.332 -0.19 0 CA-C-O 120.707 0.289 . . . . 0.0 110.379 178.254 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' F' F ' 121' ' ' ASN . . . . . . . . . . . . . 72.9 m-20 -114.15 -44.13 3.16 Favored 'General case' 0 C--N 1.333 -0.141 0 CA-C-N 116.368 -0.378 . . . . 0.0 111.282 -177.647 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' F' F ' 122' ' ' LYS . . . . . . . . . . . . . 53.4 mtmt -145.3 151.27 38.08 Favored 'General case' 0 C--N 1.331 -0.239 0 CA-C-O 121.042 0.449 . . . . 0.0 111.749 -176.234 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' F' F ' 123' ' ' VAL . . . . . . . . . . . . . 46.7 t -130.8 127.97 62.3 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.235 0 CA-C-N 116.01 -0.541 . . . . 0.0 109.545 174.697 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' F' F ' 124' ' ' LEU . . . . . . . . . . . . . 41.2 mt -115.99 136.99 52.52 Favored 'General case' 0 C--N 1.331 -0.196 0 CA-C-N 116.307 -0.406 . . . . 0.0 110.709 -178.736 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' F' F ' 125' ' ' VAL . . . . . . . . . . . . . 35.1 m -128.43 138.16 55.4 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.209 0 CA-C-N 116.265 -0.425 . . . . 0.0 110.817 -179.359 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' F' F ' 126' ' ' ARG . . . . . . . . . . . . . 96.3 mtt-85 -143.9 111.44 5.98 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.102 -0.499 . . . . 0.0 110.38 177.155 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' F' F ' 127' ' ' ASN . . . . . . . . . . . . . 79.1 m-20 53.13 -104.95 0.22 Allowed 'General case' 0 CA--C 1.544 0.722 0 CA-C-O 119.122 -0.466 . . . . 0.0 111.057 -179.847 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' F' F ' 128' ' ' ASP . . . . . . . . . . . . . 12.3 p-10 -113.98 0.17 14.28 Favored 'General case' 0 CA--C 1.536 0.434 0 CA-C-N 119.509 1.049 . . . . 0.0 113.386 -177.531 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' F' F ' 129' ' ' LEU . . . . . 0.458 HD12 ' N ' ' F' ' 129' ' ' LEU . 9.9 mp -105.0 147.84 27.38 Favored 'General case' 0 CA--C 1.523 -0.096 0 N-CA-C 109.669 -0.493 . . . . 0.0 109.669 177.842 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' F' F ' 130' ' ' VAL . . . . . 0.614 HG11 HD13 ' F' ' 104' ' ' ILE . 13.1 p -137.37 145.19 29.88 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.245 0 CA-C-O 121.23 0.538 . . . . 0.0 110.87 -176.757 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' F' F ' 131' ' ' VAL . . . . . . . . . . . . . 44.1 t -134.61 136.97 51.97 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.294 0 CA-C-N 115.722 -0.672 . . . . 0.0 109.869 178.079 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' F' F ' 132' ' ' ILE . . . . . . . . . . . . . 71.1 mt -114.18 132.2 63.92 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.335 0 N-CA-C 109.452 -0.573 . . . . 0.0 109.452 -178.825 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' F' F ' 133' ' ' ILE . . . . . . . . . . . . . 43.0 mm -117.77 121.8 68.28 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.27 0 CA-C-O 120.791 0.329 . . . . 0.0 110.621 -176.041 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' F' F ' 134' ' ' ASP . . . . . . . . . . . . . 7.1 p-10 -132.38 148.56 52.42 Favored 'General case' 0 C--N 1.33 -0.249 0 N-CA-C 109.578 -0.527 . . . . 0.0 109.578 174.934 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' F' F ' 135' ' ' GLU . . . . . . . . . . . . . 32.3 tp10 -49.9 -24.4 2.48 Favored 'General case' 0 C--N 1.328 -0.328 0 N-CA-C 112.943 0.72 . . . . 0.0 112.943 -169.775 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' F' F ' 136' ' ' GLN . . . . . . . . . . . . . 60.7 tt0 -105.02 -26.42 12.15 Favored 'General case' 0 N--CA 1.466 0.327 0 N-CA-C 112.748 0.647 . . . . 0.0 112.748 -174.637 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' F' F ' 137' ' ' LYS . . . . . . . . . . . . . 77.3 mttt -141.7 154.0 45.02 Favored 'General case' 0 C--N 1.331 -0.198 0 CA-C-O 121.252 0.549 . . . . 0.0 111.798 -171.731 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' F' F ' 138' ' ' LEU . . . . . 0.41 HD23 ' C ' ' F' ' 138' ' ' LEU . 6.1 tt -120.29 124.97 46.9 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 115.616 -0.72 . . . . 0.0 109.299 173.765 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' F' F ' 139' ' ' THR . . . . . . . . . . . . . 31.1 m -114.21 129.83 56.63 Favored 'General case' 0 C--N 1.332 -0.191 0 CA-C-N 116.385 -0.37 . . . . 0.0 110.757 -177.362 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' F' F ' 140' ' ' LEU . . . . . 0.475 HD23 ' C ' ' F' ' 140' ' ' LEU . 7.4 tt -116.87 121.53 41.75 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 115.686 -0.688 . . . . 0.0 109.387 -179.119 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' F' F ' 141' ' ' ILE . . . . . 0.424 ' HB ' HG13 ' F' ' 130' ' ' VAL . 19.0 mt -121.37 118.5 56.2 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.253 0 N-CA-C 109.778 -0.453 . . . . 0.0 109.778 -176.764 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' F' F ' 142' ' ' ARG . . . . . . . . . . . . . 61.7 ttt180 -110.87 127.77 55.55 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 115.5 -0.773 . . . . 0.0 110.403 -176.86 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' F' F ' 143' ' ' THR . . . . . . . . . . . . . 42.3 p . . . . . 0 C--O 1.22 -0.458 0 CA-C-O 117.989 -1.005 . . . . 0.0 110.66 -179.706 . . . . . . . . 0 0 . 1 . 014 nuclear build full ' A' A ' -3' ' ' GLU . . . . . . . . . . . . . 95.8 mt-10 . . . . . 0 N--CA 1.491 1.606 0 N-CA-C 109.269 -0.641 . . . . 0.0 109.269 . . . . . . . . . 0 0 . 1 . 014 nuclear build full ' A' A ' -2' ' ' GLY . . . . . . . . . . . . . . . -65.78 141.06 41.39 Favored Glycine 0 CA--C 1.526 0.723 0 N-CA-C 110.777 -0.929 . . . . 0.0 110.777 179.359 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' -1' ' ' VAL . . . . . . . . . . . . . 46.3 t -96.24 137.68 23.55 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.305 0 N-CA-C 109.83 -0.433 . . . . 0.0 109.83 179.742 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 0' ' ' ILE . . . . . . . . . . . . . 70.3 mt -104.17 132.23 51.17 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.288 0 CA-C-N 116.151 -0.477 . . . . 0.0 110.204 -177.649 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 25.8 ptt? -81.7 170.49 15.71 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.003 -0.544 . . . . 0.0 110.526 179.343 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 41.1 p -118.8 148.57 42.7 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-N 116.252 -0.431 . . . . 0.0 110.485 -179.369 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 95.2 mt-10 -140.54 142.71 35.16 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.174 -0.466 . . . . 0.0 111.243 -178.162 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 4' ' ' LEU . . . . . 0.648 HD21 HD23 ' A' ' 58' ' ' LEU . 56.0 mt -119.73 130.1 54.83 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 115.819 -0.628 . . . . 0.0 110.317 175.319 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 5' ' ' LYS . . . . . . . . . . . . . 67.1 mttm -107.38 120.57 42.52 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.306 -0.406 . . . . 0.0 110.436 177.242 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 73.9 mt -116.82 150.81 37.74 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 115.532 -0.758 . . . . 0.0 110.378 -179.238 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 74.8 tttt -140.69 139.11 19.33 Favored Pre-proline 0 CA--C 1.534 0.335 0 CA-C-O 119.167 -0.444 . . . . 0.0 110.092 175.594 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 8' ' ' PRO . . . . . . . . . . . . . 86.4 Cg_endo -91.76 140.99 2.52 Favored 'Trans proline' 0 N--CA 1.49 1.267 0 C-N-CA 121.733 1.622 . . . . 0.0 111.672 176.971 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 68.8 mt -74.05 -47.93 6.22 Favored Pre-proline 0 C--N 1.328 -0.348 0 CA-C-O 118.622 -0.704 . . . . 0.0 112.243 -178.473 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 89.0 Cg_endo -80.76 146.36 16.58 Favored 'Trans proline' 0 N--CA 1.495 1.614 0 C-N-CA 121.211 1.274 . . . . 0.0 111.931 176.419 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 63.3 mttm -85.8 95.82 9.55 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-O 120.943 0.401 . . . . 0.0 110.416 178.234 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 11.7 p -139.87 149.23 22.34 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.277 0 CA-C-N 115.894 -0.594 . . . . 0.0 110.348 -179.465 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 45.5 tp10 -87.25 122.21 30.73 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 116.337 -0.392 . . . . 0.0 110.322 178.966 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 14' ' ' LEU . . . . . . . . . . . . . 44.7 mt -97.91 157.65 34.23 Favored Pre-proline 0 C--N 1.329 -0.296 0 CA-C-N 116.163 -0.471 . . . . 0.0 110.861 -179.188 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 15' ' ' PRO . . . . . . . . . . . . . 36.9 Cg_exo -59.56 158.31 28.26 Favored 'Trans proline' 0 N--CA 1.496 1.663 0 C-N-CA 121.413 1.408 . . . . 0.0 111.875 178.719 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 16' ' ' PRO . . . . . . . . . . . . . 33.4 Cg_exo -59.2 -42.65 48.27 Favored 'Trans proline' 0 N--CA 1.496 1.649 0 C-N-CA 121.516 1.478 . . . . 0.0 112.84 -177.606 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 17' ' ' ASP . . . . . . . . . . . . . 7.9 p-10 -87.43 13.42 10.01 Favored 'General case' 0 CA--C 1.536 0.414 0 N-CA-C 113.072 0.767 . . . . 0.0 113.072 -177.06 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 18' ' ' PHE . . . . . . . . . . . . . 42.0 t80 -57.16 -45.45 83.61 Favored 'General case' 0 C--N 1.334 -0.088 0 O-C-N 122.041 -0.412 . . . . 0.0 110.238 -178.994 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 19' ' ' VAL . . . . . . . . . . . . . 47.0 t -57.43 -43.37 82.53 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.262 0 CA-C-N 116.154 -0.475 . . . . 0.0 110.378 -178.451 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 32.0 m-20 -59.1 -41.96 89.37 Favored 'General case' 0 C--N 1.331 -0.224 0 C-N-CA 120.916 -0.314 . . . . 0.0 111.082 -177.634 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 46.9 t -64.55 -44.46 96.83 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.264 0 C-N-CA 120.709 -0.396 . . . . 0.0 110.427 -178.372 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 22' ' ' ILE . . . . . 0.582 HG22 HD12 ' A' ' 26' ' ' LEU . 50.9 mm -56.94 -40.14 70.11 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 C-N-CA 120.987 -0.285 . . . . 0.0 110.567 178.709 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 23' ' ' ARG . . . . . . . . . . . . . 53.4 ttp180 -57.13 -48.88 77.58 Favored 'General case' 0 C--N 1.331 -0.214 0 CA-C-O 121.018 0.437 . . . . 0.0 110.468 177.136 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 24' ' ' ILE . . . . . . . . . . . . . 72.7 mt -61.15 -39.5 82.63 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.324 0 CA-C-N 115.839 -0.619 . . . . 0.0 111.944 -177.089 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 16.6 pttp -77.35 -36.07 54.1 Favored 'General case' 0 CA--C 1.535 0.389 0 C-N-CA 120.537 -0.465 . . . . 0.0 111.806 -174.218 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 26' ' ' LEU . . . . . 0.582 HD12 HG22 ' A' ' 22' ' ' ILE . 83.4 mt -77.89 -38.55 45.57 Favored 'General case' 0 C--N 1.33 -0.275 0 N-CA-C 112.979 0.733 . . . . 0.0 112.979 -173.304 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 27' ' ' GLN . . . . . . . . . . . . . 15.5 pt20 -46.92 139.84 5.23 Favored 'General case' 0 N--CA 1.469 0.48 0 N-CA-C 112.867 0.691 . . . . 0.0 112.867 -175.265 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 100.77 -27.76 19.06 Favored Glycine 0 CA--C 1.532 1.122 0 CA-C-N 115.573 -0.739 . . . . 0.0 112.166 -177.544 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 38.0 mmtm -97.84 155.12 17.2 Favored 'General case' 0 C--O 1.232 0.169 0 CA-C-N 117.202 0.501 . . . . 0.0 111.095 178.159 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 30' ' ' THR . . . . . . . . . . . . . 32.3 m -98.92 137.0 38.11 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.107 -0.497 . . . . 0.0 109.884 175.55 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 34.7 m -126.44 151.73 33.27 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.222 0 CA-C-O 120.826 0.346 . . . . 0.0 110.655 -179.296 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 32' ' ' ARG . . . . . . . . . . . . . 76.2 ttt-85 -136.09 149.12 48.58 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.089 -0.505 . . . . 0.0 110.448 178.59 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 33' ' ' THR . . . . . . . . . . . . . 32.1 m -52.92 139.81 26.4 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.386 -0.37 . . . . 0.0 111.301 -178.448 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 100.87 -17.17 56.74 Favored Glycine 0 CA--C 1.533 1.172 0 CA-C-O 119.744 -0.476 . . . . 0.0 113.218 179.644 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 76.7 m-20 -66.69 147.94 52.59 Favored 'General case' 0 N--CA 1.461 0.099 0 CA-C-N 118.028 0.914 . . . . 0.0 111.149 178.728 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 44.6 t -124.25 130.15 73.78 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.197 0 CA-C-N 115.882 -0.599 . . . . 0.0 109.8 178.02 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 37' ' ' ILE . . . . . . . . . . . . . 66.7 mt -122.37 139.65 48.66 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.234 0 CA-C-N 116.266 -0.425 . . . . 0.0 110.126 -179.019 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . -110.18 128.78 9.02 Favored Glycine 0 CA--C 1.526 0.74 0 N-CA-C 111.053 -0.819 . . . . 0.0 111.053 179.586 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 39' ' ' ILE . . . . . . . . . . . . . 73.7 mt -123.87 135.09 64.65 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.171 0 N-CA-C 110.247 -0.279 . . . . 0.0 110.247 179.585 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 40' ' ' SER . . . . . 0.511 ' O ' HD13 ' A' ' 41' ' ' ILE . 96.6 p -92.97 120.94 33.81 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.398 -0.365 . . . . 0.0 110.984 176.07 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 41' ' ' ILE . . . . . 0.511 HD13 ' O ' ' A' ' 40' ' ' SER . 48.1 mm -128.62 115.06 35.92 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.187 0 CA-C-O 120.834 0.35 . . . . 0.0 110.371 177.698 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 42' ' ' LEU . . . . . 0.549 ' O ' HD23 ' A' ' 42' ' ' LEU . 1.3 tt 54.52 44.47 28.71 Favored 'General case' 0 CA--C 1.532 0.251 0 CA-C-O 121.392 0.615 . . . . 0.0 110.546 177.636 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . 70.64 16.28 73.96 Favored Glycine 0 CA--C 1.534 1.278 0 C-N-CA 121.093 -0.575 . . . . 0.0 113.12 175.469 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 44' ' ' LYS . . . . . . . . . . . . . 58.5 mtpt -124.05 132.61 53.7 Favored 'General case' 0 C--N 1.332 -0.17 0 CA-C-N 117.765 0.783 . . . . 0.0 109.902 179.413 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 84.8 tt0 -84.46 123.28 30.07 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 116.444 -0.344 . . . . 0.0 111.115 -179.156 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 46' ' ' VAL . . . . . . . . . . . . . 7.3 p -121.64 128.49 75.8 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.244 0 N-CA-C 109.333 -0.617 . . . . 0.0 109.333 175.731 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 66.6 mttm -100.77 128.58 46.76 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.099 -0.5 . . . . 0.0 111.259 178.602 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 48' ' ' PHE . . . . . . . . . . . . . 93.1 m-85 -110.81 131.79 54.75 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-N 116.129 -0.487 . . . . 0.0 109.811 175.603 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 78.5 tttt -108.61 137.41 46.6 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 116.314 -0.403 . . . . 0.0 110.382 179.342 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 50' ' ' VAL . . . . . . . . . . . . . 45.8 t -79.95 109.72 14.79 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.366 0 N-CA-C 109.275 -0.639 . . . . 0.0 109.275 176.326 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 51' ' ' VAL . . . . . . . . . . . . . 55.9 t -71.47 -47.31 59.39 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.324 0 CA-C-N 116.055 -0.521 . . . . 0.0 109.895 -173.795 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 52' ' ' GLN . . . . . . . . . . . . . 61.6 tt0 -171.14 142.14 1.74 Allowed 'General case' 0 C--N 1.33 -0.244 0 C-N-CA 120.145 -0.622 . . . . 0.0 111.557 -178.657 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -114.38 136.08 53.38 Favored 'General case' 0 C--N 1.331 -0.239 0 CA-C-N 115.711 -0.677 . . . . 0.0 109.99 176.135 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 54' ' ' TYR . . . . . . . . . . . . . 30.5 t80 -129.07 108.33 18.04 Favored Pre-proline 0 CA--C 1.536 0.433 0 CA-C-O 118.21 -0.9 . . . . 0.0 110.393 179.616 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 55' ' ' PRO . . . . . . . . . . . . . 73.8 Cg_endo -77.17 169.99 72.71 Favored 'Cis proline' 0 N--CA 1.5 1.873 0 CA-C-N 121.824 1.687 . . . . 0.0 112.318 -5.371 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 56' ' ' SER . . . . . . . . . . . . . 66.6 m -117.45 136.51 23.55 Favored Pre-proline 0 CA--C 1.538 0.514 0 CA-C-O 118.482 -0.771 . . . . 0.0 109.885 175.688 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 57' ' ' PRO . . . . . . . . . . . . . 50.5 Cg_endo -71.24 163.09 86.6 Favored 'Cis proline' 0 N--CA 1.497 1.706 0 CA-C-N 121.791 1.675 . . . . 0.0 111.291 -5.867 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 58' ' ' LEU . . . . . 0.648 HD23 HD21 ' A' ' 4' ' ' LEU . 39.4 tp -129.69 138.69 51.3 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-O 121.042 0.449 . . . . 0.0 110.67 -179.205 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 59' ' ' ARG . . . . . . . . . . . . . 41.6 ttm180 -95.58 125.5 40.22 Favored 'General case' 0 C--N 1.326 -0.449 0 CA-C-N 115.717 -0.674 . . . . 0.0 109.219 174.177 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 39.9 t -77.18 116.57 20.73 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.241 0 C-N-CA 120.678 -0.409 . . . . 0.0 110.332 -175.082 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 70.6 mm-40 -131.22 161.77 31.48 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.018 -0.537 . . . . 0.0 109.756 175.977 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 62' ' ' ASP . . . . . . . . . . . . . 81.4 m-20 -52.32 -28.0 17.53 Favored 'General case' 0 C--N 1.328 -0.335 0 N-CA-C 112.034 0.383 . . . . 0.0 112.034 177.816 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 63' ' ' ARG . . . . . . . . . . . . . 77.6 mtp85 -70.77 -22.01 62.44 Favored 'General case' 0 CA--C 1.534 0.331 0 N-CA-C 112.879 0.696 . . . . 0.0 112.879 -176.444 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 29.6 m -80.63 142.05 34.38 Favored 'General case' 0 C--N 1.331 -0.227 0 CA-C-O 121.041 0.448 . . . . 0.0 111.119 -175.239 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 65' ' ' LYS . . . . . . . . . . . . . 96.8 mttt -90.11 138.18 31.73 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 115.902 -0.59 . . . . 0.0 110.066 179.176 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 66' ' ' ILE . . . . . . . . . . . . . 63.9 mt -117.55 129.75 73.52 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.212 0 N-CA-C 110.03 -0.359 . . . . 0.0 110.03 179.329 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 67' ' ' THR . . . . . . . . . . . . . 33.4 m -127.19 142.34 51.51 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-O 121.091 0.472 . . . . 0.0 110.861 -178.855 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 68' ' ' LEU . . . . . . . . . . . . . 15.4 tp -101.76 123.3 45.49 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.081 -0.509 . . . . 0.0 110.187 178.057 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 69' ' ' VAL . . . . . . . . . . . . . 45.8 t -102.7 118.46 49.63 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.275 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.07 -179.631 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 70' ' ' THR . . . . . 0.449 HG23 ' N ' ' A' ' 71' ' ' HIS . 5.0 t -150.01 -46.01 0.13 Allowed 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.365 177.689 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 71' ' ' HIS . . . . . 0.449 ' N ' HG23 ' A' ' 70' ' ' THR . 78.8 m80 -150.03 153.91 36.17 Favored Pre-proline 0 C--N 1.329 -0.32 0 CA-C-N 116.253 -0.431 . . . . 0.0 110.637 179.066 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 72' ' ' PRO . . . . . . . . . . . . . 60.8 Cg_endo -73.92 -19.62 20.5 Favored 'Trans proline' 0 N--CA 1.496 1.649 0 C-N-CA 121.364 1.376 . . . . 0.0 113.158 178.212 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 73' ' ' VAL . . . . . . . . . . . . . 34.8 m -125.66 169.5 16.98 Favored 'Isoleucine or valine' 0 C--O 1.232 0.132 0 CA-C-O 120.772 0.32 . . . . 0.0 110.602 -178.49 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 74' ' ' ASP . . . . . . . . . . . . . 10.5 t0 -91.96 118.29 30.62 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.272 -0.422 . . . . 0.0 109.903 -178.336 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 43.9 t -111.63 120.67 62.62 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.254 0 CA-C-O 121.249 0.547 . . . . 0.0 110.329 -178.635 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 76' ' ' LEU . . . . . . . . . . . . . 18.3 mt -121.38 139.44 53.44 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 115.463 -0.79 . . . . 0.0 109.035 176.787 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 77' ' ' GLU . . . . . . . . . . . . . 26.0 tt0 -135.71 141.62 44.94 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-O 120.986 0.422 . . . . 0.0 111.361 -174.476 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 78' ' ' ALA . . . . . 0.58 ' HB2' HD21 ' A' ' 109' ' ' LEU . . . -132.14 135.26 46.26 Favored 'General case' 0 C--N 1.331 -0.201 0 CA-C-N 115.821 -0.627 . . . . 0.0 110.073 176.572 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 79' ' ' LYS . . . . . 0.651 ' O ' HD13 ' A' ' 80' ' ' ILE . 62.3 mtpt -77.95 123.28 26.6 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-O 120.868 0.366 . . . . 0.0 110.43 -179.616 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 80' ' ' ILE . . . . . 0.651 HD13 ' O ' ' A' ' 79' ' ' LYS . 38.1 mm -139.19 108.81 3.92 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.257 0 N-CA-C 109.018 -0.734 . . . . 0.0 109.018 -176.87 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 81' ' ' LYS . . . . . . . . . . . . . 95.0 mttt -102.48 125.63 49.27 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-O 120.897 0.379 . . . . 0.0 111.148 -176.12 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . 89.06 42.05 5.72 Favored Glycine 0 CA--C 1.524 0.618 0 C-N-CA 120.818 -0.706 . . . . 0.0 111.547 174.644 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 83' ' ' ILE . . . . . . . . . . . . . 73.5 mt -68.12 135.7 27.95 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.339 0 N-CA-C 109.674 -0.491 . . . . 0.0 109.674 177.939 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 84' ' ' LYS . . . . . . . . . . . . . 82.9 tttt -96.84 -53.51 3.51 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.025 -0.534 . . . . 0.0 110.18 -179.136 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 85' ' ' ASP . . . . . . . . . . . . . 8.7 t70 -154.52 151.74 29.26 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 115.627 -0.715 . . . . 0.0 110.327 -179.916 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 86' ' ' VAL . . . . . . . . . . . . . 44.1 t -130.15 132.22 65.37 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.298 0 CA-C-O 121.049 0.452 . . . . 0.0 110.383 179.774 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 87' ' ' ILE . . . . . 0.496 HD12 ' N ' ' A' ' 87' ' ' ILE . 5.1 mp -117.78 124.09 72.59 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.242 0 N-CA-C 108.975 -0.75 . . . . 0.0 108.975 176.255 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 88' ' ' LEU . . . . . . . . . . . . . 14.4 tp -112.39 128.45 56.31 Favored 'General case' 0 C--N 1.331 -0.226 0 CA-C-O 121.073 0.463 . . . . 0.0 111.309 -175.497 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 89' ' ' ASP . . . . . . . . . . . . . 5.9 t70 -120.65 155.47 33.75 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 115.831 -0.622 . . . . 0.0 109.415 175.833 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 44.4 mp0 -51.02 -36.35 39.07 Favored 'General case' 0 C--N 1.328 -0.33 0 N-CA-C 112.464 0.542 . . . . 0.0 112.464 -171.448 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 91' ' ' ASN . . . . . . . . . . . . . 84.8 m-20 -132.05 33.07 3.95 Favored 'General case' 0 N--CA 1.465 0.309 0 N-CA-C 111.963 0.357 . . . . 0.0 111.963 -176.729 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 92' ' ' LEU . . . . . . . . . . . . . 10.4 tp -166.09 146.63 6.48 Favored 'General case' 0 C--N 1.331 -0.217 0 C-N-CA 120.997 -0.281 . . . . 0.0 110.593 179.525 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 93' ' ' ILE . . . . . . . . . . . . . 63.8 mt -127.09 125.81 67.03 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.238 0 N-CA-C 109.724 -0.473 . . . . 0.0 109.724 -179.611 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 94' ' ' VAL . . . . . . . . . . . . . 45.1 t -122.21 126.04 73.76 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.197 0 N-CA-C 109.742 -0.466 . . . . 0.0 109.742 177.874 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 95' ' ' VAL . . . . . . . . . . . . . 43.5 t -122.61 134.95 64.27 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.235 0 N-CA-C 110.055 -0.35 . . . . 0.0 110.055 -179.047 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 96' ' ' ILE . . . . . . . . . . . . . 61.6 mt -114.43 129.86 69.76 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.322 0 N-CA-C 109.341 -0.614 . . . . 0.0 109.341 178.632 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 97' ' ' THR . . . . . . . . . . . . . 63.4 p -100.26 156.74 17.05 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-O 121.01 0.434 . . . . 0.0 110.814 -179.706 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 98' ' ' GLU . . . . . . . . . . . . . 45.6 tp10 -54.01 -28.1 36.02 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.304 -0.407 . . . . 0.0 112.071 -178.233 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 99' ' ' GLU . . . . . . . . . . . . . 96.0 mt-10 -79.78 16.89 1.02 Allowed 'General case' 0 CA--C 1.534 0.363 0 N-CA-C 113.218 0.821 . . . . 0.0 113.218 -175.465 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 100' ' ' ASN . . . . . . . . . . . . . 3.7 m-20 62.93 37.91 11.61 Favored 'General case' 0 N--CA 1.464 0.232 0 CA-C-O 121.159 0.504 . . . . 0.0 111.021 177.973 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 101' ' ' GLU . . . . . . . . . . . . . 84.5 tt0 -116.8 144.03 44.97 Favored 'General case' 0 C--N 1.332 -0.169 0 N-CA-C 109.583 -0.525 . . . . 0.0 109.583 175.262 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 102' ' ' VAL . . . . . . . . . . . . . 41.1 t -116.4 128.55 73.7 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.283 0 CA-C-O 120.923 0.392 . . . . 0.0 110.187 -176.035 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 103' ' ' LEU . . . . . . . . . . . . . 27.0 mt -118.21 130.29 55.99 Favored 'General case' 0 C--N 1.331 -0.239 0 CA-C-N 115.643 -0.708 . . . . 0.0 110.053 176.215 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 104' ' ' ILE . . . . . 0.424 HD12 ' HB3' ' A' ' 113' ' ' TYR . 70.3 mt -117.85 122.67 70.3 Favored 'Isoleucine or valine' 0 C--O 1.234 0.259 0 N-CA-C 110.136 -0.32 . . . . 0.0 110.136 179.822 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 105' ' ' PHE . . . . . . . . . . . . . 80.7 m-85 -122.11 164.19 18.17 Favored 'General case' 0 C--N 1.331 -0.208 0 O-C-N 124.037 0.836 . . . . 0.0 110.143 -178.353 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 106' ' ' ASN . . . . . 0.415 ' HB3' HD11 ' A' ' 112' ' ' LEU . 44.3 p-10 -100.54 -170.05 1.81 Allowed 'General case' 0 C--N 1.331 -0.198 0 N-CA-C 109.884 -0.413 . . . . 0.0 109.884 172.35 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 107' ' ' GLN . . . . . . . . . . . . . 30.2 tt0 -59.16 -29.99 67.84 Favored 'General case' 0 C--N 1.328 -0.329 0 N-CA-C 112.008 0.374 . . . . 0.0 112.008 -179.508 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 108' ' ' ASN . . . . . . . . . . . . . 3.0 t-20 -84.67 8.31 17.38 Favored 'General case' 0 CA--C 1.536 0.413 0 N-CA-C 113.271 0.841 . . . . 0.0 113.271 -176.751 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 109' ' ' LEU . . . . . 0.58 HD21 ' HB2' ' A' ' 78' ' ' ALA . 11.3 tp 61.6 36.51 16.74 Favored 'General case' 0 C--O 1.233 0.185 0 CA-C-O 120.89 0.376 . . . . 0.0 111.309 178.823 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 110' ' ' GLU . . . . . . . . . . . . . 16.1 mm-40 -103.35 155.46 18.46 Favored 'General case' 0 C--N 1.33 -0.282 0 N-CA-C 109.847 -0.427 . . . . 0.0 109.847 176.056 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 111' ' ' GLU . . . . . . . . . . . . . 44.6 tp10 -84.83 121.96 28.47 Favored 'General case' 0 C--N 1.331 -0.231 0 C-N-CA 120.807 -0.357 . . . . 0.0 110.791 -178.092 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 112' ' ' LEU . . . . . 0.415 HD11 ' HB3' ' A' ' 106' ' ' ASN . 49.7 mt -107.0 -46.05 4.01 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.091 -0.504 . . . . 0.0 110.397 177.735 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 113' ' ' TYR . . . . . 0.424 ' HB3' HD12 ' A' ' 104' ' ' ILE . 60.0 t80 -136.35 135.45 38.85 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.22 -0.446 . . . . 0.0 110.863 179.68 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 114' ' ' ARG . . . . . . . . . . . . . 61.5 ttp85 -135.66 119.09 16.84 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 116.086 -0.506 . . . . 0.0 110.028 178.624 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 115' ' ' GLY . . . . . . . . . . . . . . . -150.04 159.56 28.15 Favored Glycine 0 CA--C 1.523 0.586 0 C-N-CA 120.693 -0.765 . . . . 0.0 111.441 179.855 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 116' ' ' LYS . . . . . . . . . . . . . 39.3 ttpt -130.04 138.26 50.67 Favored 'General case' 0 C--N 1.33 -0.282 0 N-CA-C 109.858 -0.423 . . . . 0.0 109.858 176.47 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 117' ' ' PHE . . . . . . . . . . . . . 38.6 m-85 -137.38 114.04 10.38 Favored 'General case' 0 C--N 1.329 -0.319 0 N-CA-C 110.121 -0.325 . . . . 0.0 110.121 -176.453 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 118' ' ' GLU . . . . . . . . . . . . . 21.7 pt-20 -55.54 -39.71 70.92 Favored 'General case' 0 C--N 1.33 -0.276 0 C-N-CA 120.942 -0.303 . . . . 0.0 111.08 -176.615 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 119' ' ' ASN . . . . . . . . . . . . . 92.8 m-20 -100.01 29.98 3.97 Favored 'General case' 0 C--N 1.33 -0.251 0 N-CA-C 112.252 0.464 . . . . 0.0 112.252 -175.182 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 120' ' ' LEU . . . . . . . . . . . . . 13.8 tp -59.72 120.36 9.35 Favored 'General case' 0 C--N 1.331 -0.209 0 N-CA-C 109.775 -0.454 . . . . 0.0 109.775 177.751 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 121' ' ' ASN . . . . . . . . . . . . . 83.3 m-20 -113.31 -43.99 3.29 Favored 'General case' 0 C--N 1.332 -0.188 0 CA-C-N 116.578 -0.283 . . . . 0.0 111.027 -176.819 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 122' ' ' LYS . . . . . . . . . . . . . 93.4 mttt -144.2 146.93 33.01 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-O 121.054 0.454 . . . . 0.0 111.672 -178.354 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 123' ' ' VAL . . . . . 0.429 ' C ' HD12 ' A' ' 124' ' ' LEU . 44.2 t -123.22 123.45 67.77 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.334 0 N-CA-C 109.375 -0.602 . . . . 0.0 109.375 174.474 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 124' ' ' LEU . . . . . 0.483 HD12 ' N ' ' A' ' 124' ' ' LEU . 7.3 mp -114.03 127.23 55.85 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.308 -0.405 . . . . 0.0 110.209 -179.064 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 125' ' ' VAL . . . . . . . . . . . . . 11.4 p -135.31 134.08 52.56 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.328 0 CA-C-N 116.504 -0.316 . . . . 0.0 110.326 -179.602 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 126' ' ' ARG . . . . . . . . . . . . . 44.8 ttt180 -146.4 119.67 8.94 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.471 178.903 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 127' ' ' ASN . . . . . . . . . . . . . 33.3 t30 51.26 -104.88 0.18 Allowed 'General case' 0 CA--C 1.544 0.72 0 CA-C-O 119.121 -0.466 . . . . 0.0 111.42 179.309 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 128' ' ' ASP . . . . . . . . . . . . . 20.1 p-10 -112.12 0.35 15.87 Favored 'General case' 0 N--CA 1.468 0.45 0 CA-C-N 119.448 1.022 . . . . 0.0 113.653 -174.444 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 129' ' ' LEU . . . . . . . . . . . . . 76.3 mt -107.63 138.85 43.1 Favored 'General case' 0 C--O 1.231 0.117 0 CA-C-N 118.33 0.514 . . . . 0.0 110.358 179.676 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 130' ' ' VAL . . . . . . . . . . . . . 44.0 t -127.7 135.63 62.6 Favored 'Isoleucine or valine' 0 N--CA 1.462 0.156 0 CA-C-O 120.925 0.393 . . . . 0.0 110.248 -178.932 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 131' ' ' VAL . . . . . 0.516 ' CG1' HD21 ' A' ' 138' ' ' LEU . 40.9 t -134.01 134.16 55.78 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.283 0 CA-C-N 116.083 -0.508 . . . . 0.0 110.006 178.144 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 132' ' ' ILE . . . . . . . . . . . . . 72.2 mt -111.25 129.78 65.95 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.317 0 N-CA-C 109.363 -0.606 . . . . 0.0 109.363 179.653 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 133' ' ' ILE . . . . . . . . . . . . . 41.9 mm -113.67 118.8 59.26 Favored 'Isoleucine or valine' 0 C--O 1.234 0.265 0 CA-C-O 120.92 0.39 . . . . 0.0 110.865 -175.426 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 134' ' ' ASP . . . . . . . . . . . . . 8.6 p-10 -131.03 147.03 52.58 Favored 'General case' 0 C--N 1.331 -0.218 0 N-CA-C 109.303 -0.629 . . . . 0.0 109.303 174.823 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 135' ' ' GLU . . . . . . . . . . . . . 39.0 tp10 -49.89 -28.15 6.2 Favored 'General case' 0 C--N 1.326 -0.417 0 N-CA-C 112.662 0.616 . . . . 0.0 112.662 -172.564 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 136' ' ' GLN . . . . . . . . . . . . . 97.8 mt-30 -82.59 -33.71 27.92 Favored 'General case' 0 C--N 1.331 -0.226 0 N-CA-C 112.806 0.669 . . . . 0.0 112.806 -176.073 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 137' ' ' LYS . . . . . . . . . . . . . 53.7 pttt -166.33 172.98 10.48 Favored 'General case' 0 C--O 1.232 0.165 0 CA-C-O 121.72 0.772 . . . . 0.0 112.746 -172.458 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 138' ' ' LEU . . . . . 0.516 HD21 ' CG1' ' A' ' 131' ' ' VAL . 4.2 tt -117.83 128.88 55.28 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-N 114.767 -1.106 . . . . 0.0 109.798 179.479 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 139' ' ' THR . . . . . 0.485 ' N ' HD23 ' A' ' 138' ' ' LEU . 29.2 m -108.9 127.27 53.9 Favored 'General case' 0 C--N 1.331 -0.23 0 CA-C-N 116.422 -0.354 . . . . 0.0 110.241 178.611 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 140' ' ' LEU . . . . . 0.482 HD23 ' C ' ' A' ' 140' ' ' LEU . 7.4 tt -111.48 121.77 46.08 Favored 'General case' 0 C--N 1.327 -0.382 0 N-CA-C 109.347 -0.612 . . . . 0.0 109.347 -178.594 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 141' ' ' ILE . . . . . . . . . . . . . 19.3 mt -121.08 120.62 62.73 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 CA-C-O 120.955 0.407 . . . . 0.0 110.181 -175.275 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 142' ' ' ARG . . . . . . . . . . . . . 76.4 mtp180 -106.87 122.11 45.75 Favored 'General case' 0 C--N 1.33 -0.239 0 CA-C-N 115.258 -0.883 . . . . 0.0 109.758 179.527 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 143' ' ' THR . . . . . . . . . . . . . 27.6 p . . . . . 0 C--O 1.22 -0.468 0 CA-C-O 117.996 -1.002 . . . . 0.0 110.523 179.907 . . . . . . . . 0 0 . 1 . 014 nuclear build full ' B' B ' -3' ' ' GLU . . . . . . . . . . . . . 96.1 mt-10 . . . . . 0 N--CA 1.489 1.509 0 N-CA-C 109.473 -0.565 . . . . 0.0 109.473 . . . . . . . . . 0 0 . 1 . 014 nuclear build full ' B' B ' -2' ' ' GLY . . . . . . . . . . . . . . . -61.47 143.35 48.62 Favored Glycine 0 CA--C 1.524 0.628 0 N-CA-C 110.903 -0.879 . . . . 0.0 110.903 179.938 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' B' B ' -1' ' ' VAL . . . . . . . . . . . . . 44.0 t -96.17 135.89 28.82 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.382 0 N-CA-C 110.066 -0.346 . . . . 0.0 110.066 -179.906 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' B' B ' 0' ' ' ILE . . . . . . . . . . . . . 68.3 mt -107.45 131.14 58.37 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.275 0 CA-C-N 116.391 -0.368 . . . . 0.0 110.011 -179.111 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' B' B ' 1' ' ' MET . . . . . . . . . . . . . 26.1 ptt? -84.31 143.87 29.23 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.516 179.642 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' B' B ' 2' ' ' SER . . . . . . . . . . . . . 2.8 p -106.6 135.59 47.85 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.425 179.511 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' B' B ' 3' ' ' GLU . . . . . . . . . . . . . 84.5 tt0 -139.95 139.1 36.04 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-O 120.996 0.426 . . . . 0.0 111.114 -179.248 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' B' B ' 4' ' ' LEU . . . . . . . . . . . . . 4.7 tt -123.24 125.32 44.86 Favored 'General case' 0 C--N 1.331 -0.22 0 CA-C-N 115.689 -0.687 . . . . 0.0 109.752 177.868 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' B' B ' 5' ' ' LYS . . . . . . . . . . . . . 62.7 mttp -106.07 122.57 46.45 Favored 'General case' 0 C--O 1.234 0.269 0 CA-C-O 120.841 0.353 . . . . 0.0 110.877 -179.551 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' B' B ' 6' ' ' LEU . . . . . . . . . . . . . 79.2 mt -114.08 154.43 27.75 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 115.367 -0.833 . . . . 0.0 110.787 -179.179 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' B' B ' 7' ' ' LYS . . . . . . . . . . . . . 62.9 tttm -143.23 140.54 17.89 Favored Pre-proline 0 CA--C 1.533 0.326 0 CA-C-O 119.152 -0.452 . . . . 0.0 110.057 174.007 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' B' B ' 8' ' ' PRO . . . . . . . . . . . . . 71.8 Cg_endo -90.27 139.56 3.01 Favored 'Trans proline' 0 N--CA 1.49 1.282 0 C-N-CA 121.723 1.615 . . . . 0.0 111.407 176.959 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' B' B ' 9' ' ' LEU . . . . . . . . . . . . . 53.6 mt -77.68 -46.69 2.43 Favored Pre-proline 0 C--N 1.329 -0.308 0 CA-C-O 118.811 -0.614 . . . . 0.0 112.102 -177.486 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' B' B ' 10' ' ' PRO . . . . . . . . . . . . . 76.8 Cg_endo -84.08 157.72 13.3 Favored 'Trans proline' 0 N--CA 1.495 1.609 0 C-N-CA 121.353 1.369 . . . . 0.0 111.686 173.771 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' B' B ' 11' ' ' LYS . . . . . . . . . . . . . 24.5 pttm -86.91 114.64 23.71 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-O 121.527 0.68 . . . . 0.0 110.544 177.417 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' B' B ' 12' ' ' VAL . . . . . . . . . . . . . 12.4 p -151.01 148.67 14.79 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.289 0 CA-C-N 115.659 -0.7 . . . . 0.0 110.447 -179.886 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' B' B ' 13' ' ' GLU . . . . . . . . . . . . . 84.5 tt0 -89.06 119.58 29.7 Favored 'General case' 0 C--N 1.329 -0.326 0 N-CA-C 109.877 -0.416 . . . . 0.0 109.877 176.494 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' B' B ' 14' ' ' LEU . . . . . . . . . . . . . 21.4 mt -93.92 147.54 33.68 Favored Pre-proline 0 C--N 1.329 -0.317 0 CA-C-O 119.102 -0.475 . . . . 0.0 110.479 -176.91 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' B' B ' 15' ' ' PRO . . . . . . . . . . . . . 25.3 Cg_exo -62.65 160.41 32.58 Favored 'Trans proline' 0 N--CA 1.497 1.733 0 C-N-CA 121.284 1.322 . . . . 0.0 112.001 177.714 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' B' B ' 16' ' ' PRO . . . . . . . . . . . . . 39.0 Cg_exo -58.88 -44.13 38.07 Favored 'Trans proline' 0 N--CA 1.498 1.781 0 C-N-CA 121.365 1.377 . . . . 0.0 112.892 -178.716 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' B' B ' 17' ' ' ASP . . . . . . . . . . . . . 11.1 p-10 -83.77 10.33 9.74 Favored 'General case' 0 C--N 1.327 -0.404 0 N-CA-C 113.169 0.803 . . . . 0.0 113.169 -177.03 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' B' B ' 18' ' ' PHE . . . . . . . . . . . . . 36.1 t80 -57.91 -43.03 85.91 Favored 'General case' 0 C--N 1.334 -0.084 0 O-C-N 121.975 -0.453 . . . . 0.0 110.088 -178.746 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' B' B ' 19' ' ' VAL . . . . . . . . . . . . . 48.3 t -57.4 -43.39 82.47 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.352 0 CA-C-N 116.247 -0.433 . . . . 0.0 110.403 -179.514 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' B' B ' 20' ' ' ASP . . . . . . . . . . . . . 53.6 m-20 -59.97 -42.57 94.44 Favored 'General case' 0 C--N 1.331 -0.204 0 C-N-CA 120.979 -0.288 . . . . 0.0 110.996 -177.299 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' B' B ' 21' ' ' VAL . . . . . . . . . . . . . 48.3 t -64.53 -45.53 95.34 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.319 0 C-N-CA 120.728 -0.389 . . . . 0.0 110.433 -178.089 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' B' B ' 22' ' ' ILE . . . . . 0.556 HG22 HD12 ' B' ' 26' ' ' LEU . 50.0 mm -58.73 -40.63 80.14 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.318 0 C-N-CA 121.081 -0.247 . . . . 0.0 110.681 179.227 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' B' B ' 23' ' ' ARG . . . . . . . . . . . . . 46.2 ttp180 -56.15 -48.29 76.56 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-O 120.984 0.421 . . . . 0.0 110.585 178.503 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' B' B ' 24' ' ' ILE . . . . . . . . . . . . . 72.5 mt -61.5 -45.19 99.15 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.274 0 CA-C-N 115.94 -0.573 . . . . 0.0 111.769 -177.966 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' B' B ' 25' ' ' LYS . . . . . . . . . . . . . 15.6 pttp -71.22 -37.35 72.05 Favored 'General case' 0 CA--C 1.534 0.36 0 C-N-CA 120.615 -0.434 . . . . 0.0 111.838 -172.545 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' B' B ' 26' ' ' LEU . . . . . 0.556 HD12 HG22 ' B' ' 22' ' ' ILE . 23.7 mt -80.5 -42.23 22.86 Favored 'General case' 0 C--N 1.33 -0.245 0 N-CA-C 113.096 0.776 . . . . 0.0 113.096 -174.674 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' B' B ' 27' ' ' GLN . . . . . . . . . . . . . 14.9 pt20 -47.0 139.98 5.21 Favored 'General case' 0 N--CA 1.469 0.487 0 N-CA-C 112.751 0.649 . . . . 0.0 112.751 -174.875 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' B' B ' 28' ' ' GLY . . . . . . . . . . . . . . . 99.92 -24.51 31.85 Favored Glycine 0 CA--C 1.533 1.187 0 CA-C-N 115.525 -0.762 . . . . 0.0 112.274 -175.539 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' B' B ' 29' ' ' LYS . . . . . . . . . . . . . 65.2 mttm -98.79 155.09 17.53 Favored 'General case' 0 C--O 1.233 0.187 0 CA-C-N 117.288 0.544 . . . . 0.0 111.009 179.525 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' B' B ' 30' ' ' THR . . . . . . . . . . . . . 31.8 m -100.21 135.26 41.92 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.196 -0.457 . . . . 0.0 109.885 175.436 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' B' B ' 31' ' ' VAL . . . . . . . . . . . . . 35.0 m -127.84 154.46 38.4 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.245 0 CA-C-O 120.897 0.379 . . . . 0.0 110.967 -178.379 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' B' B ' 32' ' ' ARG . . . . . . . . . . . . . 85.6 mtm180 -133.32 151.03 51.85 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 115.823 -0.626 . . . . 0.0 110.396 178.259 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' B' B ' 33' ' ' THR . . . . . . . . . . . . . 23.7 m -53.29 138.51 32.23 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.338 -0.392 . . . . 0.0 111.362 -178.336 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' B' B ' 34' ' ' GLY . . . . . . . . . . . . . . . 101.11 -17.05 56.62 Favored Glycine 0 CA--C 1.531 1.084 0 CA-C-O 119.658 -0.523 . . . . 0.0 113.269 178.978 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' B' B ' 35' ' ' ASP . . . . . . . . . . . . . 69.2 m-20 -64.55 148.93 49.75 Favored 'General case' 0 N--CA 1.461 0.107 0 CA-C-N 118.123 0.962 . . . . 0.0 111.018 179.098 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' B' B ' 36' ' ' VAL . . . . . . . . . . . . . 45.3 t -125.47 132.02 71.49 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.217 0 CA-C-N 115.825 -0.625 . . . . 0.0 109.869 179.157 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' B' B ' 37' ' ' ILE . . . . . . . . . . . . . 68.5 mt -120.22 138.07 51.97 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.234 0 CA-C-N 116.141 -0.482 . . . . 0.0 109.853 179.624 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' B' B ' 38' ' ' GLY . . . . . . . . . . . . . . . -108.05 128.74 9.27 Favored Glycine 0 CA--C 1.524 0.61 0 N-CA-C 110.872 -0.891 . . . . 0.0 110.872 179.848 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' B' B ' 39' ' ' ILE . . . . . . . . . . . . . 75.5 mt -125.63 137.12 58.69 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.259 0 N-CA-C 110.186 -0.302 . . . . 0.0 110.186 179.994 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' B' B ' 40' ' ' SER . . . . . 0.528 ' O ' HD13 ' B' ' 41' ' ' ILE . 42.2 p -92.8 119.17 31.88 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.378 -0.374 . . . . 0.0 110.924 176.227 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' B' B ' 41' ' ' ILE . . . . . 0.528 HD13 ' O ' ' B' ' 40' ' ' SER . 47.6 mm -129.59 117.91 43.66 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.189 0 CA-C-O 120.716 0.293 . . . . 0.0 110.325 178.69 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' B' B ' 42' ' ' LEU . . . . . . . . . . . . . 51.0 mt 57.88 34.32 24.21 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.317 -0.401 . . . . 0.0 111.819 177.7 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' B' B ' 43' ' ' GLY . . . . . . . . . . . . . . . 78.74 -10.1 33.45 Favored Glycine 0 CA--C 1.534 1.236 0 C-N-CA 121.215 -0.517 . . . . 0.0 113.438 177.539 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' B' B ' 44' ' ' LYS . . . . . . . . . . . . . 72.9 mmtt -97.82 138.63 34.88 Favored 'General case' 0 C--N 1.333 -0.132 0 CA-C-N 117.854 0.827 . . . . 0.0 109.946 176.912 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' B' B ' 45' ' ' GLU . . . . . . . . . . . . . 84.8 tt0 -84.07 125.16 31.85 Favored 'General case' 0 C--N 1.328 -0.35 0 C-N-CA 120.874 -0.33 . . . . 0.0 110.76 179.447 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' B' B ' 46' ' ' VAL . . . . . . . . . . . . . 7.4 p -121.77 127.8 75.57 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.182 0 N-CA-C 109.627 -0.509 . . . . 0.0 109.627 177.603 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' B' B ' 47' ' ' LYS . . . . . . . . . . . . . 64.0 mttp -100.45 130.43 46.53 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 115.91 -0.586 . . . . 0.0 111.16 178.911 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' B' B ' 48' ' ' PHE . . . . . . . . . . . . . 93.6 m-85 -112.73 131.84 55.49 Favored 'General case' 0 C--N 1.33 -0.258 0 N-CA-C 109.889 -0.411 . . . . 0.0 109.889 175.748 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' B' B ' 49' ' ' LYS . . . . . . . . . . . . . 85.6 tttt -108.82 139.73 43.24 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.279 -0.418 . . . . 0.0 110.846 -178.499 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' B' B ' 50' ' ' VAL . . . . . . . . . . . . . 46.2 t -83.13 108.0 15.39 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.346 0 N-CA-C 109.301 -0.629 . . . . 0.0 109.301 174.852 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' B' B ' 51' ' ' VAL . . . . . . . . . . . . . 47.7 t -72.7 -48.11 47.43 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.306 0 CA-C-N 116.118 -0.492 . . . . 0.0 110.001 -173.06 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' B' B ' 52' ' ' GLN . . . . . . . . . . . . . 60.4 tt0 -165.25 146.97 7.63 Favored 'General case' 0 C--N 1.33 -0.246 0 C-N-CA 120.266 -0.574 . . . . 0.0 111.863 -177.972 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' B' B ' 53' ' ' ALA . . . . . . . . . . . . . . . -123.23 134.54 54.11 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 115.677 -0.692 . . . . 0.0 109.929 176.48 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' B' B ' 54' ' ' TYR . . . . . . . . . . . . . 33.4 t80 -129.14 112.16 18.35 Favored Pre-proline 0 CA--C 1.535 0.403 0 CA-C-O 118.184 -0.912 . . . . 0.0 110.289 178.726 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' B' B ' 55' ' ' PRO . . . . . . . . . . . . . 73.5 Cg_endo -77.11 169.22 74.86 Favored 'Cis proline' 0 N--CA 1.5 1.904 0 CA-C-N 121.99 1.747 . . . . 0.0 112.212 -6.698 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' B' B ' 56' ' ' SER . . . . . . . . . . . . . 13.8 m -117.25 137.19 23.76 Favored Pre-proline 0 CA--C 1.537 0.467 0 CA-C-O 118.537 -0.744 . . . . 0.0 109.802 175.296 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' B' B ' 57' ' ' PRO . . . . . . . . . . . . . 32.4 Cg_endo -65.71 162.94 67.82 Favored 'Cis proline' 0 N--CA 1.498 1.757 0 CA-C-N 121.761 1.665 . . . . 0.0 111.309 -4.724 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' B' B ' 58' ' ' LEU . . . . . . . . . . . . . 31.7 tp -129.18 137.52 51.2 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-O 120.945 0.402 . . . . 0.0 110.511 -178.651 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' B' B ' 59' ' ' ARG . . . . . . . . . . . . . 27.0 ttm180 -101.49 127.43 48.18 Favored 'General case' 0 C--N 1.327 -0.392 0 N-CA-C 109.301 -0.629 . . . . 0.0 109.301 176.151 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' B' B ' 60' ' ' VAL . . . . . . . . . . . . . 46.9 t -79.57 117.73 25.82 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.33 0 C-N-CA 120.677 -0.409 . . . . 0.0 110.095 -175.967 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' B' B ' 61' ' ' GLU . . . . . . . . . . . . . 70.8 mm-40 -131.06 161.83 31.17 Favored 'General case' 0 C--N 1.331 -0.208 0 CA-C-N 116.047 -0.524 . . . . 0.0 110.284 178.846 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' B' B ' 62' ' ' ASP . . . . . . . . . . . . . 67.4 m-20 -54.53 -32.45 58.22 Favored 'General case' 0 C--N 1.327 -0.396 0 CA-C-N 116.463 -0.335 . . . . 0.0 111.748 -179.901 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' B' B ' 63' ' ' ARG . . . . . . . . . . . . . 13.8 ptp180 -84.24 10.09 11.29 Favored 'General case' 0 CA--C 1.535 0.398 0 N-CA-C 113.471 0.915 . . . . 0.0 113.471 -175.854 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' B' B ' 64' ' ' THR . . . . . . . . . . . . . 32.3 m -94.92 143.0 26.82 Favored 'General case' 0 C--O 1.231 0.128 0 CA-C-N 118.02 0.373 . . . . 0.0 110.632 -179.73 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' B' B ' 65' ' ' LYS . . . . . . . . . . . . . 92.3 mttt -88.52 129.0 35.56 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.155 -0.475 . . . . 0.0 110.267 179.633 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' B' B ' 66' ' ' ILE . . . . . . . . . . . . . 59.5 mt -115.08 130.21 69.99 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.196 0 N-CA-C 109.707 -0.479 . . . . 0.0 109.707 179.479 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' B' B ' 67' ' ' THR . . . . . . . . . . . . . 28.0 m -132.49 144.68 50.61 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-O 121.111 0.482 . . . . 0.0 111.3 -177.923 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' B' B ' 68' ' ' LEU . . . . . 0.464 HD12 ' N ' ' B' ' 68' ' ' LEU . 7.3 mp -100.61 132.49 45.98 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 115.96 -0.564 . . . . 0.0 109.94 174.79 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' B' B ' 69' ' ' VAL . . . . . . . . . . . . . 42.6 t -94.25 105.97 17.53 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.268 0 CA-C-N 116.392 -0.367 . . . . 0.0 110.281 -178.9 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' B' B ' 70' ' ' THR . . . . . . . . . . . . . 7.6 t -150.01 32.62 0.68 Allowed 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 116.219 -0.446 . . . . 0.0 111.511 178.877 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' B' B ' 71' ' ' HIS . . . . . . . . . . . . . 18.9 t-80 -133.42 75.87 68.9 Favored Pre-proline 0 CA--C 1.534 0.36 0 N-CA-C 110.403 -0.221 . . . . 0.0 110.403 -179.824 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' B' B ' 72' ' ' PRO . . . . . . . . . . . . . 89.5 Cg_endo -83.59 -18.29 5.79 Favored 'Trans proline' 0 N--CA 1.494 1.538 0 C-N-CA 121.639 1.559 . . . . 0.0 113.471 -179.14 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' B' B ' 73' ' ' VAL . . . . . . . . . . . . . 34.6 m -125.96 165.92 22.97 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.162 0 CA-C-O 120.793 0.33 . . . . 0.0 110.603 -178.198 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' B' B ' 74' ' ' ASP . . . . . . . . . . . . . 36.1 t0 -94.66 117.57 30.34 Favored 'General case' 0 C--N 1.329 -0.309 0 N-CA-C 109.669 -0.493 . . . . 0.0 109.669 -179.443 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' B' B ' 75' ' ' VAL . . . . . . . . . . . . . 44.0 t -117.9 124.66 73.4 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.287 0 CA-C-O 121.123 0.487 . . . . 0.0 110.771 -176.382 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' B' B ' 76' ' ' LEU . . . . . . . . . . . . . 5.3 mp -122.55 148.45 45.18 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 115.539 -0.755 . . . . 0.0 109.47 174.964 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' B' B ' 77' ' ' GLU . . . . . . . . . . . . . 45.8 mt-10 -135.05 139.52 44.85 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-O 120.999 0.428 . . . . 0.0 111.471 -177.645 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' B' B ' 78' ' ' ALA . . . . . 0.618 ' HB2' HD21 ' B' ' 109' ' ' LEU . . . -128.39 132.29 48.52 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 115.701 -0.681 . . . . 0.0 109.642 175.585 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' B' B ' 79' ' ' LYS . . . . . 0.565 ' O ' HD13 ' B' ' 80' ' ' ILE . 84.5 mttt -76.72 121.45 23.31 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-O 121.077 0.465 . . . . 0.0 110.851 -178.072 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' B' B ' 80' ' ' ILE . . . . . 0.565 HD13 ' O ' ' B' ' 79' ' ' LYS . 43.5 mm -139.19 109.36 4.23 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.27 0 N-CA-C 108.963 -0.754 . . . . 0.0 108.963 -177.854 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' B' B ' 81' ' ' LYS . . . . . . . . . . . . . 93.5 mttt -101.98 124.38 47.5 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-O 120.916 0.388 . . . . 0.0 111.346 -176.244 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' B' B ' 82' ' ' GLY . . . . . . . . . . . . . . . 89.07 42.16 5.69 Favored Glycine 0 CA--C 1.526 0.72 0 C-N-CA 120.956 -0.64 . . . . 0.0 111.841 174.666 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' B' B ' 83' ' ' ILE . . . . . . . . . . . . . 69.0 mt -67.39 136.86 25.85 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.28 0 N-CA-C 109.632 -0.507 . . . . 0.0 109.632 177.116 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' B' B ' 84' ' ' LYS . . . . . . . . . . . . . 38.6 ttpt -101.56 -52.4 3.23 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-O 121.022 0.439 . . . . 0.0 110.422 -178.673 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' B' B ' 85' ' ' ASP . . . . . . . . . . . . . 10.7 t70 -145.46 147.77 32.55 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 115.943 -0.571 . . . . 0.0 110.458 -178.644 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' B' B ' 86' ' ' VAL . . . . . . . . . . . . . 42.2 t -129.68 130.85 67.0 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.26 0 CA-C-O 120.905 0.383 . . . . 0.0 110.373 -179.617 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' B' B ' 87' ' ' ILE . . . . . 0.488 ' N ' HD12 ' B' ' 87' ' ' ILE . 5.0 mp -119.74 123.74 71.54 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.214 0 N-CA-C 109.313 -0.625 . . . . 0.0 109.313 176.105 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' B' B ' 88' ' ' LEU . . . . . . . . . . . . . 17.9 tp -111.01 127.77 55.64 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-O 121.038 0.447 . . . . 0.0 110.972 -177.774 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' B' B ' 89' ' ' ASP . . . . . . . . . . . . . 8.2 t70 -121.61 152.12 39.64 Favored 'General case' 0 C--N 1.331 -0.201 0 CA-C-N 115.797 -0.638 . . . . 0.0 109.6 177.005 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' B' B ' 90' ' ' GLU . . . . . . . . . . . . . 96.4 mt-10 -48.84 -36.24 16.43 Favored 'General case' 0 C--N 1.328 -0.337 0 N-CA-C 112.642 0.608 . . . . 0.0 112.642 -173.04 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' B' B ' 91' ' ' ASN . . . . . . . . . . . . . 30.5 m120 -132.21 32.87 3.93 Favored 'General case' 0 N--CA 1.466 0.336 0 N-CA-C 111.909 0.337 . . . . 0.0 111.909 -177.001 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' B' B ' 92' ' ' LEU . . . . . . . . . . . . . 15.5 tp -166.13 144.42 5.66 Favored 'General case' 0 C--N 1.331 -0.206 0 C-N-CA 121.028 -0.269 . . . . 0.0 110.574 179.722 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' B' B ' 93' ' ' ILE . . . . . . . . . . . . . 70.1 mt -123.36 122.38 65.09 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.279 0 N-CA-C 109.594 -0.521 . . . . 0.0 109.594 178.741 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' B' B ' 94' ' ' VAL . . . . . . . . . . . . . 47.3 t -120.65 125.03 73.63 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 N-CA-C 109.776 -0.453 . . . . 0.0 109.776 179.281 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' B' B ' 95' ' ' VAL . . . . . . . . . . . . . 43.5 t -124.04 134.6 66.11 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.325 0 CA-C-N 116.286 -0.415 . . . . 0.0 109.976 -178.726 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' B' B ' 96' ' ' ILE . . . . . . . . . . . . . 58.3 mt -117.6 126.96 75.04 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.255 0 N-CA-C 109.367 -0.605 . . . . 0.0 109.367 179.343 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' B' B ' 97' ' ' THR . . . . . . . . . . . . . 77.1 p -98.32 157.72 16.01 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-O 121.188 0.518 . . . . 0.0 111.137 -178.086 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' B' B ' 98' ' ' GLU . . . . . . . . . . . . . 80.2 tt0 -53.92 -29.23 41.26 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 116.1 -0.5 . . . . 0.0 112.059 -178.675 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' B' B ' 99' ' ' GLU . . . . . . . . . . . . . 39.3 tt0 -80.01 15.89 1.35 Allowed 'General case' 0 CA--C 1.541 0.61 0 N-CA-C 112.599 0.592 . . . . 0.0 112.599 -176.074 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' B' B ' 100' ' ' ASN . . . . . . . . . . . . . 4.8 m-20 63.8 33.18 12.98 Favored 'General case' 0 CA--C 1.532 0.271 0 O-C-N 121.873 -0.517 . . . . 0.0 111.703 177.859 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' B' B ' 101' ' ' GLU . . . . . . . . . . . . . 84.7 tt0 -106.47 141.94 36.95 Favored 'General case' 0 C--N 1.331 -0.215 0 N-CA-C 109.506 -0.553 . . . . 0.0 109.506 172.179 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' B' B ' 102' ' ' VAL . . . . . . . . . . . . . 45.2 t -116.89 128.18 74.35 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.299 0 N-CA-C 109.805 -0.443 . . . . 0.0 109.805 -177.813 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' B' B ' 103' ' ' LEU . . . . . . . . . . . . . 26.8 mt -118.8 131.2 56.09 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 115.839 -0.619 . . . . 0.0 110.611 178.185 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' B' B ' 104' ' ' ILE . . . . . 0.432 HD12 ' HB3' ' B' ' 113' ' ' TYR . 69.7 mt -116.17 120.12 63.93 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.245 0 N-CA-C 109.72 -0.474 . . . . 0.0 109.72 178.076 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' B' B ' 105' ' ' PHE . . . . . . . . . . . . . 70.7 m-85 -123.13 163.87 19.74 Favored 'General case' 0 C--N 1.331 -0.207 0 O-C-N 123.81 0.694 . . . . 0.0 109.722 179.867 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' B' B ' 106' ' ' ASN . . . . . . . . . . . . . 48.1 p-10 -98.87 -170.75 1.98 Allowed 'General case' 0 C--N 1.329 -0.298 0 N-CA-C 109.754 -0.461 . . . . 0.0 109.754 172.742 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' B' B ' 107' ' ' GLN . . . . . . . . . . . . . 44.7 tt0 -61.04 -30.05 70.08 Favored 'General case' 0 C--N 1.328 -0.369 0 N-CA-C 111.851 0.315 . . . . 0.0 111.851 -179.159 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' B' B ' 108' ' ' ASN . . . . . . . . . . . . . 13.7 t-20 -82.77 6.4 18.27 Favored 'General case' 0 CA--C 1.537 0.469 0 N-CA-C 113.215 0.821 . . . . 0.0 113.215 -178.421 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' B' B ' 109' ' ' LEU . . . . . 0.618 HD21 ' HB2' ' B' ' 78' ' ' ALA . 10.7 tp 61.95 39.34 13.59 Favored 'General case' 0 C--O 1.233 0.209 0 CA-C-O 121.246 0.546 . . . . 0.0 111.197 178.267 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' B' B ' 110' ' ' GLU . . . . . . . . . . . . . 70.8 mm-40 -105.77 157.83 17.17 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.105 176.419 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' B' B ' 111' ' ' GLU . . . . . . . . . . . . . 84.6 tt0 -83.17 121.99 27.8 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-O 120.901 0.381 . . . . 0.0 111.064 -176.613 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' B' B ' 112' ' ' LEU . . . . . . . . . . . . . 34.0 mt -108.29 -46.09 3.79 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-N 115.959 -0.564 . . . . 0.0 110.133 176.462 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' B' B ' 113' ' ' TYR . . . . . 0.432 ' HB3' HD12 ' B' ' 104' ' ' ILE . 63.0 t80 -143.39 135.94 27.32 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.091 -0.504 . . . . 0.0 111.182 179.141 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' B' B ' 114' ' ' ARG . . . . . . . . . . . . . 26.3 ttm180 -133.16 122.7 24.41 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.235 -0.439 . . . . 0.0 109.88 175.669 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' B' B ' 115' ' ' GLY . . . . . . . . . . . . . . . -150.08 152.34 24.27 Favored Glycine 0 CA--C 1.523 0.556 0 N-CA-C 110.69 -0.964 . . . . 0.0 110.69 179.293 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' B' B ' 116' ' ' LYS . . . . . . . . . . . . . 60.8 tttm -129.2 127.46 41.36 Favored 'General case' 0 C--N 1.328 -0.343 0 N-CA-C 109.697 -0.482 . . . . 0.0 109.697 178.351 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' B' B ' 117' ' ' PHE . . . . . 0.442 ' HE2' HD13 ' B' ' 132' ' ' ILE . 49.8 m-85 -123.27 114.06 19.72 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.258 -0.428 . . . . 0.0 110.257 -174.917 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' B' B ' 118' ' ' GLU . . . . . . . . . . . . . 84.7 tt0 -53.99 -43.29 69.86 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 116.363 -0.381 . . . . 0.0 111.357 -176.716 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' B' B ' 119' ' ' ASN . . . . . . . . . . . . . 17.7 m-80 -99.26 31.01 3.23 Favored 'General case' 0 C--N 1.33 -0.257 0 N-CA-C 112.275 0.472 . . . . 0.0 112.275 -174.203 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' B' B ' 120' ' ' LEU . . . . . . . . . . . . . 21.3 tp -56.4 120.26 7.37 Favored 'General case' 0 C--O 1.232 0.148 0 C-N-CA 121.014 -0.274 . . . . 0.0 110.445 177.877 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' B' B ' 121' ' ' ASN . . . . . . . . . . . . . 72.2 m-20 -114.16 -43.99 3.17 Favored 'General case' 0 C--O 1.232 0.181 0 CA-C-N 116.574 -0.284 . . . . 0.0 111.162 -177.283 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' B' B ' 122' ' ' LYS . . . . . . . . . . . . . 95.1 mttt -145.55 150.43 36.4 Favored 'General case' 0 C--N 1.329 -0.283 0 C-N-CA 120.69 -0.404 . . . . 0.0 111.489 -177.17 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' B' B ' 123' ' ' VAL . . . . . . . . . . . . . 43.8 t -132.77 133.26 59.36 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.235 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.107 177.896 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' B' B ' 124' ' ' LEU . . . . . . . . . . . . . 77.8 mt -120.76 130.53 54.07 Favored 'General case' 0 C--O 1.233 0.202 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.596 178.745 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' B' B ' 125' ' ' VAL . . . . . . . . . . . . . 44.8 t -128.21 128.04 68.16 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.281 0 N-CA-C 109.861 -0.422 . . . . 0.0 109.861 179.054 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' B' B ' 126' ' ' ARG . . . . . . . . . . . . . 73.3 mtp85 -140.4 115.06 9.49 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-O 120.812 0.339 . . . . 0.0 110.792 179.468 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' B' B ' 127' ' ' ASN . . . . . . . . . . . . . 21.0 t-20 51.39 -104.91 0.18 Allowed 'General case' 0 CA--C 1.544 0.718 0 CA-C-O 119.131 -0.461 . . . . 0.0 111.382 178.367 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' B' B ' 128' ' ' ASP . . . . . . . . . . . . . 18.3 p-10 -114.0 2.51 15.01 Favored 'General case' 0 N--CA 1.468 0.436 0 CA-C-N 119.562 1.074 . . . . 0.0 113.432 -177.14 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' B' B ' 129' ' ' LEU . . . . . . . . . . . . . 13.3 tp -106.45 136.89 45.41 Favored 'General case' 0 C--N 1.331 -0.218 0 CA-C-N 118.146 0.43 . . . . 0.0 109.909 178.835 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' B' B ' 130' ' ' VAL . . . . . . . . . . . . . 42.5 t -124.7 136.18 61.52 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.242 0 CA-C-O 120.881 0.372 . . . . 0.0 110.314 -177.358 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' B' B ' 131' ' ' VAL . . . . . 0.46 HG22 HD12 ' B' ' 140' ' ' LEU . 46.4 t -134.81 133.83 53.94 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.214 0 CA-C-N 116.264 -0.425 . . . . 0.0 110.187 177.984 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' B' B ' 132' ' ' ILE . . . . . 0.442 HD13 ' HE2' ' B' ' 117' ' ' PHE . 75.7 mt -117.59 133.73 63.43 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.343 0 N-CA-C 109.64 -0.504 . . . . 0.0 109.64 -179.688 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' B' B ' 133' ' ' ILE . . . . . . . . . . . . . 35.6 mm -115.76 123.25 70.93 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.242 0 CA-C-O 120.748 0.309 . . . . 0.0 111.064 -175.448 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' B' B ' 134' ' ' ASP . . . . . . . . . . . . . 9.8 p-10 -134.09 149.77 51.13 Favored 'General case' 0 C--N 1.331 -0.22 0 N-CA-C 109.621 -0.511 . . . . 0.0 109.621 174.755 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' B' B ' 135' ' ' GLU . . . . . . . . . . . . . 40.8 tp10 -50.05 -30.05 10.04 Favored 'General case' 0 C--N 1.328 -0.338 0 N-CA-C 112.651 0.612 . . . . 0.0 112.651 -170.896 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' B' B ' 136' ' ' GLN . . . . . . . . . . . . . 98.2 mt-30 -81.41 -36.4 29.54 Favored 'General case' 0 C--N 1.329 -0.3 0 N-CA-C 112.687 0.625 . . . . 0.0 112.687 -175.981 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' B' B ' 137' ' ' LYS . . . . . . . . . . . . . 20.4 pttm -163.07 172.52 14.82 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-O 121.626 0.727 . . . . 0.0 112.391 -169.706 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' B' B ' 138' ' ' LEU . . . . . . . . . . . . . 6.7 tt -118.53 129.16 55.19 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 114.94 -1.027 . . . . 0.0 109.842 178.27 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' B' B ' 139' ' ' THR . . . . . . . . . . . . . 31.5 m -108.23 128.16 54.47 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.207 -0.452 . . . . 0.0 110.328 -179.857 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' B' B ' 140' ' ' LEU . . . . . 0.46 HD12 HG22 ' B' ' 131' ' ' VAL . 9.4 tp -114.02 122.56 47.28 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 115.763 -0.653 . . . . 0.0 109.567 -178.058 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' B' B ' 141' ' ' ILE . . . . . . . . . . . . . 19.6 mt -121.37 119.71 59.85 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.34 0 N-CA-C 109.949 -0.389 . . . . 0.0 109.949 -175.322 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' B' B ' 142' ' ' ARG . . . . . . . . . . . . . 45.2 ttp180 -114.05 127.9 56.15 Favored 'General case' 0 C--N 1.331 -0.229 0 CA-C-N 115.517 -0.765 . . . . 0.0 110.314 -177.216 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' B' B ' 143' ' ' THR . . . . . . . . . . . . . 20.3 p . . . . . 0 C--O 1.22 -0.489 0 CA-C-O 118.09 -0.957 . . . . 0.0 110.625 -179.661 . . . . . . . . 0 0 . 1 . 014 nuclear build full ' C' C ' -3' ' ' GLU . . . . . . . . . . . . . 95.6 mt-10 . . . . . 0 N--CA 1.49 1.562 0 N-CA-C 109.284 -0.636 . . . . 0.0 109.284 . . . . . . . . . 0 0 . 1 . 014 nuclear build full ' C' C ' -2' ' ' GLY . . . . . . . . . . . . . . . -76.91 142.24 27.33 Favored Glycine 0 CA--C 1.525 0.678 0 N-CA-C 111.009 -0.836 . . . . 0.0 111.009 179.998 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' C' C ' -1' ' ' VAL . . . . . . . . . . . . . 42.0 t -96.8 136.51 27.36 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.378 0 N-CA-C 110.026 -0.361 . . . . 0.0 110.026 179.788 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' C' C ' 0' ' ' ILE . . . . . . . . . . . . . 72.5 mt -104.21 127.09 58.75 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.264 0 N-CA-C 109.84 -0.429 . . . . 0.0 109.84 178.844 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' C' C ' 1' ' ' MET . . . . . . . . . . . . . 24.2 ptm -144.84 144.87 31.35 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.849 -178.341 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' C' C ' 2' ' ' SER . . . . . . . . . . . . . 5.5 p -130.95 130.5 43.51 Favored 'General case' 0 C--N 1.331 -0.202 0 CA-C-O 121.119 0.485 . . . . 0.0 110.954 179.129 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' C' C ' 3' ' ' GLU . . . . . . . . . . . . . 45.9 mp0 -139.45 142.19 37.41 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 115.785 -0.643 . . . . 0.0 110.707 179.232 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' C' C ' 4' ' ' LEU . . . . . 0.457 HD21 HD21 ' C' ' 6' ' ' LEU . 14.3 tp -124.52 127.42 47.4 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 116.085 -0.507 . . . . 0.0 110.214 176.593 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' C' C ' 5' ' ' LYS . . . . . . . . . . . . . 60.7 mttp -104.41 121.1 42.71 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.404 -0.362 . . . . 0.0 110.538 177.926 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' C' C ' 6' ' ' LEU . . . . . 0.457 HD21 HD21 ' C' ' 4' ' ' LEU . 54.8 mt -116.8 149.94 39.14 Favored 'General case' 0 C--N 1.331 -0.225 0 CA-C-N 115.603 -0.726 . . . . 0.0 110.927 -178.155 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' C' C ' 7' ' ' LYS . . . . . . . . . . . . . 59.7 tttm -138.07 142.91 37.39 Favored Pre-proline 0 CA--C 1.534 0.341 0 CA-C-N 116.28 -0.418 . . . . 0.0 109.958 175.448 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' C' C ' 8' ' ' PRO . . . . . . . . . . . . . 96.7 Cg_endo -91.46 143.39 3.02 Favored 'Trans proline' 0 N--CA 1.49 1.317 0 C-N-CA 121.763 1.642 . . . . 0.0 112.01 179.04 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' C' C ' 9' ' ' LEU . . . . . . . . . . . . . 50.5 mt -85.57 -48.19 0.58 Allowed Pre-proline 0 CA--C 1.534 0.363 0 CA-C-O 118.661 -0.685 . . . . 0.0 112.393 -179.544 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' C' C ' 10' ' ' PRO . . . . . . . . . . . . . 90.8 Cg_endo -79.97 157.97 23.93 Favored 'Trans proline' 0 N--CA 1.497 1.677 0 C-N-CA 121.17 1.247 . . . . 0.0 111.99 176.976 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' C' C ' 11' ' ' LYS . . . . . . . . . . . . . 1.9 ttmp? -88.35 95.35 10.16 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 116.333 -0.394 . . . . 0.0 110.548 179.358 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' C' C ' 12' ' ' VAL . . . . . . . . . . . . . 12.7 p -144.78 147.34 19.18 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.284 0 CA-C-N 116.296 -0.411 . . . . 0.0 110.669 -179.596 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' C' C ' 13' ' ' GLU . . . . . . . . . . . . . 84.7 tt0 -94.09 129.54 40.59 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.348 -0.387 . . . . 0.0 110.145 177.685 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' C' C ' 14' ' ' LEU . . . . . . . . . . . . . 18.3 mt -97.47 153.05 38.5 Favored Pre-proline 0 C--N 1.329 -0.304 0 CA-C-N 116.458 -0.337 . . . . 0.0 110.9 -176.575 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' C' C ' 15' ' ' PRO . . . . . . . . . . . . . 25.6 Cg_exo -62.48 162.19 25.08 Favored 'Trans proline' 0 N--CA 1.498 1.753 0 C-N-CA 121.242 1.295 . . . . 0.0 111.939 176.905 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' C' C ' 16' ' ' PRO . . . . . . . . . . . . . 25.6 Cg_exo -61.32 -36.58 78.32 Favored 'Trans proline' 0 N--CA 1.499 1.811 0 C-N-CA 121.423 1.415 . . . . 0.0 112.611 -178.488 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' C' C ' 17' ' ' ASP . . . . . . . . . . . . . 19.4 p-10 -89.5 9.72 25.51 Favored 'General case' 0 CA--C 1.535 0.4 0 N-CA-C 113.35 0.87 . . . . 0.0 113.35 -176.882 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' C' C ' 18' ' ' PHE . . . . . . . . . . . . . 47.3 t80 -58.07 -43.24 86.86 Favored 'General case' 0 C--O 1.227 -0.101 0 O-C-N 122.051 -0.406 . . . . 0.0 110.078 -178.281 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' C' C ' 19' ' ' VAL . . . . . . . . . . . . . 54.6 t -57.04 -42.17 78.85 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.321 0 CA-C-N 116.415 -0.357 . . . . 0.0 110.458 -178.751 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' C' C ' 20' ' ' ASP . . . . . . . . . . . . . 38.7 t0 -59.59 -43.52 93.66 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-O 120.874 0.369 . . . . 0.0 110.814 -178.153 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' C' C ' 21' ' ' VAL . . . . . . . . . . . . . 48.2 t -64.81 -46.01 93.3 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.326 0 CA-C-N 116.34 -0.391 . . . . 0.0 110.511 -178.23 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' C' C ' 22' ' ' ILE . . . . . 0.52 HG22 HD12 ' C' ' 26' ' ' LEU . 50.5 mm -59.77 -37.84 73.21 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.311 0 C-N-CA 120.946 -0.302 . . . . 0.0 110.779 -179.353 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' C' C ' 23' ' ' ARG . . . . . . . . . . . . . 36.7 ttp180 -57.75 -49.15 77.53 Favored 'General case' 0 C--N 1.33 -0.263 0 C-N-CA 120.689 -0.404 . . . . 0.0 110.457 178.187 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' C' C ' 24' ' ' ILE . . . . . . . . . . . . . 74.1 mt -61.45 -44.55 98.74 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.295 0 CA-C-N 116.1 -0.5 . . . . 0.0 111.952 -177.225 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' C' C ' 25' ' ' LYS . . . . . 0.472 ' HE3' HD13 ' C' ' 22' ' ' ILE . 0.7 OUTLIER -70.06 -34.52 73.31 Favored 'General case' 0 CA--C 1.534 0.361 0 C-N-CA 120.834 -0.346 . . . . 0.0 111.815 -174.676 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' C' C ' 26' ' ' LEU . . . . . 0.52 HD12 HG22 ' C' ' 22' ' ' ILE . 89.4 mt -78.78 -45.03 21.89 Favored 'General case' 0 C--N 1.331 -0.22 0 N-CA-C 113.085 0.772 . . . . 0.0 113.085 -174.18 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' C' C ' 27' ' ' GLN . . . . . . . . . . . . . 16.6 pt20 -47.29 139.78 6.03 Favored 'General case' 0 N--CA 1.469 0.517 0 N-CA-C 112.674 0.62 . . . . 0.0 112.674 -174.542 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' C' C ' 28' ' ' GLY . . . . . . . . . . . . . . . 99.75 -25.42 28.33 Favored Glycine 0 CA--C 1.535 1.286 0 CA-C-N 115.497 -0.774 . . . . 0.0 112.235 -176.535 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' C' C ' 29' ' ' LYS . . . . . . . . . . . . . 90.2 mttt -97.95 155.17 17.21 Favored 'General case' 0 C--O 1.232 0.169 0 CA-C-N 117.285 0.543 . . . . 0.0 110.963 178.755 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' C' C ' 30' ' ' THR . . . . . . . . . . . . . 24.8 m -106.65 136.63 46.13 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.034 -0.53 . . . . 0.0 109.977 175.515 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' C' C ' 31' ' ' VAL . . . . . . . . . . . . . 34.8 m -132.11 158.05 43.22 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.219 0 CA-C-O 120.889 0.375 . . . . 0.0 111.211 -177.378 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' C' C ' 32' ' ' ARG . . . . . . . . . . . . . 75.2 mtp180 -134.24 153.22 51.98 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-O 121.299 0.571 . . . . 0.0 110.809 178.656 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' C' C ' 33' ' ' THR . . . . . . . . . . . . . 28.0 m -53.52 139.74 30.39 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 116.066 -0.515 . . . . 0.0 111.317 -179.047 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' C' C ' 34' ' ' GLY . . . . . . . . . . . . . . . 99.78 -17.23 57.69 Favored Glycine 0 CA--C 1.533 1.173 0 CA-C-O 119.67 -0.517 . . . . 0.0 113.289 178.21 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' C' C ' 35' ' ' ASP . . . . . . . . . . . . . 79.2 m-20 -66.6 147.9 52.64 Favored 'General case' 0 C--O 1.232 0.172 0 CA-C-N 118.072 0.936 . . . . 0.0 111.166 178.901 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' C' C ' 36' ' ' VAL . . . . . . . . . . . . . 43.1 t -121.79 129.8 75.15 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.239 0 CA-C-N 116.039 -0.528 . . . . 0.0 109.696 177.282 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' C' C ' 37' ' ' ILE . . . . . . . . . . . . . 68.0 mt -120.84 139.57 47.69 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.322 0 CA-C-N 116.343 -0.39 . . . . 0.0 110.052 -178.726 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' C' C ' 38' ' ' GLY . . . . . . . . . . . . . . . -110.62 128.76 8.94 Favored Glycine 0 CA--C 1.526 0.728 0 N-CA-C 111.208 -0.757 . . . . 0.0 111.208 -179.953 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' C' C ' 39' ' ' ILE . . . . . . . . . . . . . 72.8 mt -123.52 137.94 55.04 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.255 0 N-CA-C 109.965 -0.383 . . . . 0.0 109.965 178.999 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' C' C ' 40' ' ' SER . . . . . . . . . . . . . 46.7 t -92.2 113.93 26.33 Favored 'General case' 0 C--N 1.329 -0.296 0 C-N-CA 120.896 -0.321 . . . . 0.0 110.742 176.479 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' C' C ' 41' ' ' ILE . . . . . . . . . . . . . 45.2 mm -122.54 114.91 44.33 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.214 0 N-CA-C 110.026 -0.361 . . . . 0.0 110.026 179.093 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' C' C ' 42' ' ' LEU . . . . . . . . . . . . . 79.5 mt 57.33 35.11 25.66 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.456 -0.338 . . . . 0.0 111.686 178.806 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' C' C ' 43' ' ' GLY . . . . . . . . . . . . . . . 77.98 -10.14 28.05 Favored Glycine 0 CA--C 1.534 1.249 0 C-N-CA 121.311 -0.471 . . . . 0.0 113.575 177.903 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' C' C ' 44' ' ' LYS . . . . . . . . . . . . . 61.9 tttm -96.1 134.2 39.44 Favored 'General case' 0 C--N 1.333 -0.111 0 CA-C-N 117.742 0.771 . . . . 0.0 109.762 176.445 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' C' C ' 45' ' ' GLU . . . . . . . . . . . . . 84.5 tt0 -83.04 123.63 29.66 Favored 'General case' 0 C--N 1.328 -0.335 0 C-N-CA 120.789 -0.365 . . . . 0.0 110.629 -179.73 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' C' C ' 46' ' ' VAL . . . . . . . . . . . . . 7.3 p -117.71 127.26 75.08 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.257 0 N-CA-C 109.448 -0.575 . . . . 0.0 109.448 177.235 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' C' C ' 47' ' ' LYS . . . . . . . . . . . . . 54.8 mtpt -99.51 127.99 45.6 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 115.848 -0.614 . . . . 0.0 110.89 178.858 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' C' C ' 48' ' ' PHE . . . . . . . . . . . . . 92.2 m-85 -110.98 131.97 54.6 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.272 -0.422 . . . . 0.0 110.017 176.153 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' C' C ' 49' ' ' LYS . . . . . . . . . . . . . 78.7 tttt -107.64 135.66 48.7 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.409 -0.36 . . . . 0.0 110.207 179.479 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' C' C ' 50' ' ' VAL . . . . . . . . . . . . . 43.9 t -81.16 109.57 15.64 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.272 0 N-CA-C 109.408 -0.59 . . . . 0.0 109.408 176.833 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' C' C ' 51' ' ' VAL . . . . . . . . . . . . . 48.8 t -70.12 -47.91 65.1 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.292 0 N-CA-C 109.785 -0.45 . . . . 0.0 109.785 -174.923 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' C' C ' 52' ' ' GLN . . . . . . . . . . . . . 46.1 tt0 -168.11 139.95 2.92 Favored 'General case' 0 C--N 1.33 -0.267 0 C-N-CA 120.278 -0.569 . . . . 0.0 111.638 -179.217 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' C' C ' 53' ' ' ALA . . . . . 0.44 ' HB1' ' HB2' ' C' ' 58' ' ' LEU . . . -110.59 133.45 53.3 Favored 'General case' 0 C--N 1.33 -0.239 0 CA-C-N 115.673 -0.694 . . . . 0.0 109.904 176.059 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' C' C ' 54' ' ' TYR . . . . . . . . . . . . . 30.3 t80 -129.08 112.12 18.42 Favored Pre-proline 0 CA--C 1.536 0.44 0 CA-C-O 118.247 -0.882 . . . . 0.0 110.551 179.396 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' C' C ' 55' ' ' PRO . . . . . . . . . . . . . 72.6 Cg_endo -77.07 165.79 84.0 Favored 'Cis proline' 0 N--CA 1.499 1.826 0 CA-C-N 121.953 1.733 . . . . 0.0 112.205 -7.299 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' C' C ' 56' ' ' SER . . . . . . . . . . . . . 41.8 m -113.82 130.8 23.49 Favored Pre-proline 0 CA--C 1.538 0.492 0 CA-C-O 118.529 -0.748 . . . . 0.0 109.337 175.072 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' C' C ' 57' ' ' PRO . . . . . . . . . . . . . 50.0 Cg_endo -69.55 145.47 79.04 Favored 'Cis proline' 0 N--CA 1.498 1.738 0 CA-C-N 121.885 1.709 . . . . 0.0 111.626 0.711 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' C' C ' 58' ' ' LEU . . . . . 0.44 ' HB2' ' HB1' ' C' ' 53' ' ' ALA . 21.8 tp -108.16 134.53 50.89 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.291 -0.413 . . . . 0.0 110.761 -178.784 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' C' C ' 59' ' ' ARG . . . . . . . . . . . . . 31.5 ttm180 -100.78 128.55 46.78 Favored 'General case' 0 C--N 1.328 -0.361 0 N-CA-C 109.325 -0.62 . . . . 0.0 109.325 175.227 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' C' C ' 60' ' ' VAL . . . . . . . . . . . . . 44.2 t -84.35 116.94 28.93 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.266 0 C-N-CA 120.613 -0.435 . . . . 0.0 110.411 -177.522 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' C' C ' 61' ' ' GLU . . . . . . . . . . . . . 65.2 mm-40 -126.14 163.68 22.59 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-N 115.744 -0.662 . . . . 0.0 109.774 176.862 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' C' C ' 62' ' ' ASP . . . . . . . . . . . . . 62.7 m-20 -52.72 -32.38 42.62 Favored 'General case' 0 C--N 1.329 -0.32 0 N-CA-C 111.794 0.294 . . . . 0.0 111.794 178.921 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' C' C ' 63' ' ' ARG . . . . . . . . . . . . . 92.6 mtt-85 -73.69 -22.08 60.04 Favored 'General case' 0 CA--C 1.533 0.312 0 N-CA-C 112.922 0.712 . . . . 0.0 112.922 -177.163 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' C' C ' 64' ' ' THR . . . . . . . . . . . . . 35.7 m -67.82 136.83 54.74 Favored 'General case' 0 C--N 1.332 -0.187 0 CA-C-O 120.982 0.42 . . . . 0.0 110.999 -173.631 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' C' C ' 65' ' ' LYS . . . . . . . . . . . . . 55.2 mtmt -90.56 132.11 35.9 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 115.807 -0.633 . . . . 0.0 110.578 178.484 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' C' C ' 66' ' ' ILE . . . . . . . . . . . . . 64.8 mt -113.65 128.55 70.48 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.258 0 N-CA-C 109.645 -0.502 . . . . 0.0 109.645 178.909 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' C' C ' 67' ' ' THR . . . . . . . . . . . . . 18.0 m -127.27 142.67 51.41 Favored 'General case' 0 C--O 1.233 0.218 0 CA-C-O 121.047 0.451 . . . . 0.0 111.11 -177.147 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' C' C ' 68' ' ' LEU . . . . . . . . . . . . . 13.7 tp -100.43 133.81 44.31 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 115.912 -0.586 . . . . 0.0 109.832 176.975 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' C' C ' 69' ' ' VAL . . . . . . . . . . . . . 42.9 t -82.88 117.58 29.06 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.305 0 C-N-CA 120.745 -0.382 . . . . 0.0 110.274 -178.408 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' C' C ' 70' ' ' THR . . . . . . . . . . . . . 69.7 p -145.48 172.92 12.51 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.016 -0.538 . . . . 0.0 110.675 -179.817 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' C' C ' 71' ' ' HIS . . . . . . . . . . . . . 5.6 t60 -127.04 89.6 51.56 Favored Pre-proline 0 CA--C 1.534 0.335 0 CA-C-N 116.286 -0.415 . . . . 0.0 110.794 -178.76 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' C' C ' 72' ' ' PRO . . . . . . . . . . . . . 73.7 Cg_endo -78.72 158.83 28.2 Favored 'Trans proline' 0 N--CA 1.495 1.591 0 C-N-CA 121.512 1.475 . . . . 0.0 112.886 -178.907 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' C' C ' 73' ' ' VAL . . . . . . . . . . . . . 35.9 m -127.0 174.38 10.89 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.157 0 CA-C-N 115.952 -0.567 . . . . 0.0 110.043 177.46 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' C' C ' 74' ' ' ASP . . . . . . . . . . . . . 21.4 t0 -99.06 122.9 42.9 Favored 'General case' 0 C--N 1.329 -0.291 0 C-N-CA 120.896 -0.322 . . . . 0.0 110.24 -177.552 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' C' C ' 75' ' ' VAL . . . . . . . . . . . . . 41.5 t -119.96 123.33 70.6 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.2 0 CA-C-O 121.044 0.449 . . . . 0.0 110.527 -179.225 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' C' C ' 76' ' ' LEU . . . . . . . . . . . . . 5.3 mp -119.49 147.63 44.2 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 115.671 -0.695 . . . . 0.0 109.788 176.285 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' C' C ' 77' ' ' GLU . . . . . . . . . . . . . 97.8 mt-10 -136.06 134.37 38.36 Favored 'General case' 0 C--N 1.331 -0.211 0 CA-C-O 121.074 0.464 . . . . 0.0 111.327 -179.303 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' C' C ' 78' ' ' ALA . . . . . 0.743 ' HB2' HD21 ' C' ' 109' ' ' LEU . . . -124.22 133.45 53.52 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 115.696 -0.684 . . . . 0.0 109.603 176.083 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' C' C ' 79' ' ' LYS . . . . . 0.563 ' O ' HD13 ' C' ' 80' ' ' ILE . 50.0 mtpt -81.52 119.07 23.29 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-O 120.975 0.417 . . . . 0.0 110.697 -178.273 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' C' C ' 80' ' ' ILE . . . . . 0.563 HD13 ' O ' ' C' ' 79' ' ' LYS . 44.1 mm -139.18 103.09 1.83 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.338 0 N-CA-C 109.009 -0.737 . . . . 0.0 109.009 -177.1 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' C' C ' 81' ' ' LYS . . . . . . . . . . . . . 73.2 mttt -92.2 127.9 37.85 Favored 'General case' 0 C--N 1.328 -0.359 0 C-N-CA 120.644 -0.422 . . . . 0.0 111.037 -176.776 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' C' C ' 82' ' ' GLY . . . . . . . . . . . . . . . 88.98 42.18 5.71 Favored Glycine 0 CA--C 1.523 0.591 0 C-N-CA 120.889 -0.672 . . . . 0.0 112.204 173.978 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' C' C ' 83' ' ' ILE . . . . . . . . . . . . . 67.9 mt -71.26 131.89 33.96 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.217 0 N-CA-C 109.306 -0.627 . . . . 0.0 109.306 176.206 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' C' C ' 84' ' ' LYS . . . . . . . . . . . . . 28.0 ttpp -101.47 -45.73 5.21 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-O 120.724 0.297 . . . . 0.0 110.741 -176.375 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' C' C ' 85' ' ' ASP . . . . . . . . . . . . . 9.1 t70 -148.25 147.08 28.97 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.324 -0.398 . . . . 0.0 110.674 179.897 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' C' C ' 86' ' ' VAL . . . . . . . . . . . . . 44.2 t -131.74 132.41 61.96 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.229 0 CA-C-O 120.967 0.413 . . . . 0.0 110.683 -178.827 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' C' C ' 87' ' ' ILE . . . . . 0.497 ' N ' HD12 ' C' ' 87' ' ' ILE . 5.1 mp -122.9 130.42 74.48 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.256 0 CA-C-N 115.79 -0.641 . . . . 0.0 109.439 175.814 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' C' C ' 88' ' ' LEU . . . . . . . . . . . . . 23.9 tp -115.49 132.53 56.59 Favored 'General case' 0 N--CA 1.463 0.22 0 CA-C-O 120.991 0.424 . . . . 0.0 111.484 -177.086 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' C' C ' 89' ' ' ASP . . . . . . . . . . . . . 13.8 t70 -120.63 156.62 31.29 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 115.709 -0.678 . . . . 0.0 109.477 175.747 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' C' C ' 90' ' ' GLU . . . . . . . . . . . . . 70.9 mm-40 -48.05 -42.32 28.17 Favored 'General case' 0 N--CA 1.465 0.29 0 N-CA-C 112.723 0.638 . . . . 0.0 112.723 -171.629 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' C' C ' 91' ' ' ASN . . . . . . . . . . . . . 6.3 p30 -132.07 38.49 3.5 Favored 'General case' 0 C--O 1.233 0.223 0 CA-C-O 120.692 0.282 . . . . 0.0 111.488 -178.316 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' C' C ' 92' ' ' LEU . . . . . . . . . . . . . 9.9 tp -165.7 145.19 6.4 Favored 'General case' 0 C--N 1.332 -0.191 0 C-N-CA 120.754 -0.378 . . . . 0.0 110.6 -178.966 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' C' C ' 93' ' ' ILE . . . . . . . . . . . . . 55.9 mt -123.53 125.76 71.99 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.226 0 N-CA-C 109.814 -0.439 . . . . 0.0 109.814 -177.715 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' C' C ' 94' ' ' VAL . . . . . . . . . . . . . 45.8 t -124.01 126.41 72.4 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.221 0 N-CA-C 109.872 -0.418 . . . . 0.0 109.872 178.781 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' C' C ' 95' ' ' VAL . . . . . . . . . . . . . 42.4 t -126.63 137.76 56.82 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.229 0 CA-C-N 116.285 -0.416 . . . . 0.0 110.374 -178.203 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' C' C ' 96' ' ' ILE . . . . . . . . . . . . . 54.8 mt -116.65 129.44 73.14 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.28 0 N-CA-C 109.276 -0.638 . . . . 0.0 109.276 178.505 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' C' C ' 97' ' ' THR . . . . . . . . . . . . . 64.6 p -106.08 157.73 17.33 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-O 121.334 0.588 . . . . 0.0 111.628 -175.955 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' C' C ' 98' ' ' GLU . . . . . . . . . . . . . 12.8 pt-20 -53.87 -23.7 13.46 Favored 'General case' 0 CA--C 1.535 0.375 0 CA-C-N 115.818 -0.628 . . . . 0.0 112.491 179.013 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' C' C ' 99' ' ' GLU . . . . . . . . . . . . . 96.5 mt-10 -77.76 13.31 1.37 Allowed 'General case' 0 CA--C 1.536 0.433 0 N-CA-C 113.074 0.768 . . . . 0.0 113.074 -178.321 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' C' C ' 100' ' ' ASN . . . . . . . . . . . . . 1.9 m-20 61.78 37.53 15.54 Favored 'General case' 0 N--CA 1.463 0.18 0 CA-C-O 120.995 0.426 . . . . 0.0 110.759 179.599 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' C' C ' 101' ' ' GLU . . . . . . . . . . . . . 84.4 tt0 -118.92 145.21 45.94 Favored 'General case' 0 C--O 1.232 0.184 0 CA-C-N 116.058 -0.519 . . . . 0.0 109.919 179.221 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' C' C ' 102' ' ' VAL . . . . . . . . . . . . . 46.8 t -114.98 125.32 72.27 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 N-CA-C 109.646 -0.501 . . . . 0.0 109.646 -179.096 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' C' C ' 103' ' ' LEU . . . . . . . . . . . . . 37.5 mt -116.14 131.77 56.85 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-N 115.707 -0.678 . . . . 0.0 110.423 178.567 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' C' C ' 104' ' ' ILE . . . . . 0.4 HD12 ' HB3' ' C' ' 113' ' ' TYR . 66.3 mt -118.46 121.34 66.83 Favored 'Isoleucine or valine' 0 C--O 1.234 0.277 0 CA-C-N 116.332 -0.395 . . . . 0.0 110.003 177.892 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' C' C ' 105' ' ' PHE . . . . . . . . . . . . . 80.0 m-85 -120.65 162.76 19.13 Favored 'General case' 0 C--N 1.331 -0.219 0 O-C-N 123.994 0.809 . . . . 0.0 109.905 -179.749 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' C' C ' 106' ' ' ASN . . . . . . . . . . . . . 46.4 p-10 -101.09 -170.59 1.86 Allowed 'General case' 0 C--N 1.329 -0.296 0 N-CA-C 110.013 -0.366 . . . . 0.0 110.013 173.76 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' C' C ' 107' ' ' GLN . . . . . . . . . . . . . 46.2 tt0 -58.67 -29.87 66.92 Favored 'General case' 0 C--N 1.329 -0.293 0 N-CA-C 111.942 0.349 . . . . 0.0 111.942 -179.999 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' C' C ' 108' ' ' ASN . . . . . . . . . . . . . 3.7 t-20 -85.12 9.98 13.39 Favored 'General case' 0 CA--C 1.535 0.381 0 N-CA-C 113.137 0.791 . . . . 0.0 113.137 -177.177 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' C' C ' 109' ' ' LEU . . . . . 0.743 HD21 ' HB2' ' C' ' 78' ' ' ALA . 8.7 tp 59.18 36.25 23.83 Favored 'General case' 0 C--O 1.232 0.159 0 O-C-N 122.159 -0.338 . . . . 0.0 111.406 178.441 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' C' C ' 110' ' ' GLU . . . . . . . . . . . . . 95.6 mt-10 -105.17 159.81 15.57 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-O 120.758 0.313 . . . . 0.0 110.35 177.766 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' C' C ' 111' ' ' GLU . . . . . . . . . . . . . 84.6 tt0 -84.67 121.98 28.42 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.309 -0.405 . . . . 0.0 110.851 -178.402 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' C' C ' 112' ' ' LEU . . . . . . . . . . . . . 14.7 mt -109.93 -46.07 3.53 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-N 116.081 -0.509 . . . . 0.0 110.158 177.211 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' C' C ' 113' ' ' TYR . . . . . 0.4 ' HB3' HD12 ' C' ' 104' ' ' ILE . 53.2 t80 -139.33 136.94 35.34 Favored 'General case' 0 C--N 1.331 -0.224 0 CA-C-N 116.254 -0.43 . . . . 0.0 111.082 179.854 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' C' C ' 114' ' ' ARG . . . . . . . . . . . . . 71.3 ttp85 -139.09 121.11 15.63 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.054 -0.521 . . . . 0.0 110.18 177.785 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' C' C ' 115' ' ' GLY . . . . . . . . . . . . . . . -150.06 159.85 28.28 Favored Glycine 0 CA--C 1.524 0.634 0 N-CA-C 110.908 -0.877 . . . . 0.0 110.908 178.316 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' C' C ' 116' ' ' LYS . . . . . . . . . . . . . 1.4 ttmp? -131.73 142.64 49.85 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-O 120.822 0.344 . . . . 0.0 110.288 178.491 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' C' C ' 117' ' ' PHE . . . . . . . . . . . . . 31.0 m-85 -138.92 115.46 10.56 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.182 -0.463 . . . . 0.0 109.948 -177.183 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' C' C ' 118' ' ' GLU . . . . . . . . . . . . . 82.9 tt0 -52.9 -48.81 66.93 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.528 -0.305 . . . . 0.0 111.662 -176.005 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' C' C ' 119' ' ' ASN . . . . . . . . . . . . . 4.0 p30 -97.25 31.13 2.55 Favored 'General case' 0 C--N 1.33 -0.259 0 N-CA-C 112.101 0.408 . . . . 0.0 112.101 -175.349 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' C' C ' 120' ' ' LEU . . . . . . . . . . . . . 15.1 tp -52.96 126.55 20.82 Favored 'General case' 0 N--CA 1.463 0.212 0 CA-C-O 120.45 0.167 . . . . 0.0 110.862 177.813 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' C' C ' 121' ' ' ASN . . . . . . . . . . . . . 51.3 t30 -113.76 -44.2 3.21 Favored 'General case' 0 C--N 1.33 -0.258 0 C-N-CA 121.165 -0.214 . . . . 0.0 111.258 -176.133 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' C' C ' 122' ' ' LYS . . . . . . . . . . . . . 88.2 mttt -148.08 151.91 36.46 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-O 121.016 0.436 . . . . 0.0 111.81 -177.267 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' C' C ' 123' ' ' VAL . . . . . . . . . . . . . 42.9 t -131.12 128.92 62.67 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 CA-C-N 115.949 -0.569 . . . . 0.0 109.503 173.865 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' C' C ' 124' ' ' LEU . . . . . . . . . . . . . 62.0 mt -122.35 136.79 54.96 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.43 -0.35 . . . . 0.0 110.308 -178.814 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' C' C ' 125' ' ' VAL . . . . . 0.436 HG23 HG22 ' C' ' 130' ' ' VAL . 12.9 p -133.16 134.59 57.52 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.219 0 CA-C-O 120.997 0.427 . . . . 0.0 110.768 -179.463 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' C' C ' 126' ' ' ARG . . . . . . . . . . . . . 88.8 mtt180 -151.67 135.24 16.2 Favored 'General case' 0 C--N 1.327 -0.37 0 N-CA-C 109.094 -0.706 . . . . 0.0 109.094 176.123 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' C' C ' 127' ' ' ASN . . . . . . . . . . . . . 9.7 p30 48.88 -150.37 0.17 Allowed 'General case' 0 CA--C 1.541 0.62 0 CA-C-O 119.431 -0.318 . . . . 0.0 110.932 179.078 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' C' C ' 128' ' ' ASP . . . . . . . . . . . . . 10.2 p-10 -81.83 18.05 1.38 Allowed 'General case' 0 CA--C 1.535 0.4 0 N-CA-C 112.723 0.638 . . . . 0.0 112.723 179.393 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' C' C ' 129' ' ' LEU . . . . . . . . . . . . . 73.0 mt -117.6 137.66 52.46 Favored 'General case' 0 C--O 1.233 0.184 0 O-C-N 122.083 -0.386 . . . . 0.0 110.416 179.477 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' C' C ' 130' ' ' VAL . . . . . 0.436 HG22 HG23 ' C' ' 125' ' ' VAL . 43.8 t -128.72 140.45 49.21 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.212 0 CA-C-N 116.254 -0.43 . . . . 0.0 110.091 -179.151 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' C' C ' 131' ' ' VAL . . . . . 0.438 ' CG1' HD21 ' C' ' 138' ' ' LEU . 41.4 t -135.46 135.27 51.83 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.226 0 CA-C-O 121.033 0.445 . . . . 0.0 110.273 178.504 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' C' C ' 132' ' ' ILE . . . . . . . . . . . . . 70.6 mt -114.51 133.31 61.0 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.352 0 CA-C-N 115.741 -0.663 . . . . 0.0 109.399 179.263 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' C' C ' 133' ' ' ILE . . . . . . . . . . . . . 39.5 mm -114.8 122.77 69.59 Favored 'Isoleucine or valine' 0 C--O 1.234 0.237 0 CA-C-O 120.714 0.292 . . . . 0.0 110.817 -175.389 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' C' C ' 134' ' ' ASP . . . . . . . . . . . . . 8.2 p-10 -131.92 150.61 52.1 Favored 'General case' 0 C--N 1.331 -0.2 0 N-CA-C 109.855 -0.424 . . . . 0.0 109.855 176.091 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' C' C ' 135' ' ' GLU . . . . . . . . . . . . . 84.7 tt0 -49.89 -26.97 4.58 Favored 'General case' 0 C--N 1.327 -0.39 0 N-CA-C 112.902 0.704 . . . . 0.0 112.902 -172.117 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' C' C ' 136' ' ' GLN . . . . . . . . . . . . . 94.0 mt-30 -93.35 -24.71 18.01 Favored 'General case' 0 C--N 1.33 -0.281 0 N-CA-C 113.088 0.774 . . . . 0.0 113.088 -172.626 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' C' C ' 137' ' ' LYS . . . . . . . . . . . . . 55.6 pttt -170.0 173.72 5.87 Favored 'General case' 0 C--O 1.232 0.163 0 CA-C-O 121.583 0.706 . . . . 0.0 112.553 -173.432 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' C' C ' 138' ' ' LEU . . . . . 0.49 HD23 ' N ' ' C' ' 139' ' ' THR . 4.4 tt -118.51 129.75 55.54 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 114.967 -1.015 . . . . 0.0 109.937 179.592 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' C' C ' 139' ' ' THR . . . . . 0.49 ' N ' HD23 ' C' ' 138' ' ' LEU . 25.9 m -109.83 124.75 51.87 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.406 -0.361 . . . . 0.0 110.319 178.834 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' C' C ' 140' ' ' LEU . . . . . 0.484 ' C ' HD23 ' C' ' 140' ' ' LEU . 7.9 tt -111.52 125.18 53.63 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 115.705 -0.679 . . . . 0.0 109.381 -178.665 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' C' C ' 141' ' ' ILE . . . . . . . . . . . . . 19.3 mt -125.08 120.16 57.66 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.251 0 CA-C-O 120.993 0.425 . . . . 0.0 110.058 -176.011 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' C' C ' 142' ' ' ARG . . . . . . . . . . . . . 59.3 ttp180 -110.8 126.96 55.17 Favored 'General case' 0 C--N 1.331 -0.21 0 CA-C-N 115.574 -0.739 . . . . 0.0 110.19 179.352 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' C' C ' 143' ' ' THR . . . . . . . . . . . . . 24.3 p . . . . . 0 C--O 1.22 -0.464 0 CA-C-O 118.078 -0.963 . . . . 0.0 110.524 179.58 . . . . . . . . 0 0 . 1 . 014 nuclear build full ' D' D ' -3' ' ' GLU . . . . . . . . . . . . . 12.1 pt-20 . . . . . 0 N--CA 1.49 1.544 0 N-CA-C 109.483 -0.562 . . . . 0.0 109.483 . . . . . . . . . 0 0 . 1 . 014 nuclear build full ' D' D ' -2' ' ' GLY . . . . . . . . . . . . . . . -79.04 149.94 33.32 Favored Glycine 0 CA--C 1.525 0.67 0 N-CA-C 110.999 -0.84 . . . . 0.0 110.999 -179.95 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' D' D ' -1' ' ' VAL . . . . . . . . . . . . . 45.1 t -96.25 134.15 34.9 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.32 0 CA-C-O 120.85 0.357 . . . . 0.0 110.083 179.688 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' D' D ' 0' ' ' ILE . . . . . . . . . . . . . 73.4 mt -116.55 131.4 69.25 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.196 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.115 -178.98 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' D' D ' 1' ' ' MET . . . . . . . . . . . . . 25.3 ptp -144.21 179.02 7.49 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.789 179.618 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' D' D ' 2' ' ' SER . . . . . . . . . . . . . 2.8 p -108.06 132.87 53.11 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.202 -0.454 . . . . 0.0 110.521 179.541 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' D' D ' 3' ' ' GLU . . . . . . . . . . . . . 95.8 mt-10 -141.3 140.51 33.85 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.168 -0.469 . . . . 0.0 111.166 -179.217 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' D' D ' 4' ' ' LEU . . . . . 0.4 HD21 HD21 ' D' ' 6' ' ' LEU . 17.8 tp -125.34 131.57 52.98 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 115.928 -0.578 . . . . 0.0 110.062 176.139 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' D' D ' 5' ' ' LYS . . . . . . . . . . . . . 95.2 mttt -109.8 119.93 40.88 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.424 -0.353 . . . . 0.0 110.577 179.514 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' D' D ' 6' ' ' LEU . . . . . 0.4 HD21 HD21 ' D' ' 4' ' ' LEU . 51.5 mt -115.07 145.77 41.98 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 115.365 -0.834 . . . . 0.0 110.555 -177.821 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' D' D ' 7' ' ' LYS . . . . . . . . . . . . . 61.8 tttp -132.65 134.36 24.6 Favored Pre-proline 0 CA--C 1.537 0.458 0 CA-C-O 118.7 -0.667 . . . . 0.0 109.966 177.153 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' D' D ' 8' ' ' PRO . . . . . . . . . . . . . 90.5 Cg_endo -89.54 139.39 3.39 Favored 'Trans proline' 0 N--CA 1.491 1.336 0 C-N-CA 121.437 1.425 . . . . 0.0 111.634 176.531 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' D' D ' 9' ' ' LEU . . . . . . . . . . . . . 55.0 mt -78.02 -47.8 2.15 Favored Pre-proline 0 CA--C 1.533 0.301 0 CA-C-O 118.65 -0.69 . . . . 0.0 112.417 -178.356 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' D' D ' 10' ' ' PRO . . . . . . . . . . . . . 84.2 Cg_endo -80.33 152.53 20.79 Favored 'Trans proline' 0 N--CA 1.497 1.711 0 C-N-CA 121.232 1.288 . . . . 0.0 111.83 176.725 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' D' D ' 11' ' ' LYS . . . . . . . . . . . . . 53.5 tttp -87.97 98.37 11.47 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-O 120.924 0.392 . . . . 0.0 110.373 178.767 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' D' D ' 12' ' ' VAL . . . . . . . . . . . . . 11.9 p -141.12 147.07 22.83 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.262 0 CA-C-N 116.037 -0.529 . . . . 0.0 110.432 -179.538 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' D' D ' 13' ' ' GLU . . . . . . . . . . . . . 96.1 mt-10 -84.87 124.01 31.13 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.347 -0.388 . . . . 0.0 110.371 179.06 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' D' D ' 14' ' ' LEU . . . . . . . . . . . . . 39.8 mt -98.88 144.82 28.87 Favored Pre-proline 0 CA--C 1.534 0.356 0 CA-C-O 119.005 -0.522 . . . . 0.0 110.186 -179.511 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' D' D ' 15' ' ' PRO . . . . . . . . . . . . . 25.2 Cg_exo -62.38 159.32 36.26 Favored 'Trans proline' 0 N--CA 1.497 1.728 0 C-N-CA 121.247 1.298 . . . . 0.0 111.964 177.091 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' D' D ' 16' ' ' PRO . . . . . . . . . . . . . 38.2 Cg_exo -58.32 -41.25 68.13 Favored 'Trans proline' 0 N--CA 1.498 1.758 0 C-N-CA 121.463 1.442 . . . . 0.0 112.948 -178.467 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' D' D ' 17' ' ' ASP . . . . . . . . . . . . . 14.5 p-10 -81.9 5.99 17.22 Favored 'General case' 0 C--N 1.326 -0.432 0 N-CA-C 113.208 0.818 . . . . 0.0 113.208 -177.599 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' D' D ' 18' ' ' PHE . . . . . . . . . . . . . 55.1 t80 -57.59 -42.33 82.97 Favored 'General case' 0 N--CA 1.457 -0.075 0 O-C-N 121.937 -0.477 . . . . 0.0 110.228 -179.514 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' D' D ' 19' ' ' VAL . . . . . . . . . . . . . 47.7 t -56.63 -43.26 78.45 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.263 0 CA-C-N 116.301 -0.409 . . . . 0.0 110.371 -179.358 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' D' D ' 20' ' ' ASP . . . . . . . . . . . . . 81.4 m-20 -60.48 -41.95 95.26 Favored 'General case' 0 C--N 1.33 -0.26 0 C-N-CA 120.981 -0.288 . . . . 0.0 110.895 -178.085 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' D' D ' 21' ' ' VAL . . . . . . . . . . . . . 47.2 t -64.18 -47.93 87.87 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.27 0 C-N-CA 120.742 -0.383 . . . . 0.0 110.35 -177.821 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' D' D ' 22' ' ' ILE . . . . . 0.5 HG22 HD12 ' D' ' 26' ' ' LEU . 50.7 mm -56.11 -46.36 80.96 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.25 0 CA-C-O 120.762 0.315 . . . . 0.0 110.604 179.205 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' D' D ' 23' ' ' ARG . . . . . . . . . . . . . 52.8 ttp180 -54.9 -50.53 68.53 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 116.535 -0.302 . . . . 0.0 111.518 -178.064 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' D' D ' 24' ' ' ILE . . . . . . . . . . . . . 74.9 mt -60.16 -42.17 89.23 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 C-N-CA 121.056 -0.258 . . . . 0.0 111.351 -176.397 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' D' D ' 25' ' ' LYS . . . . . . . . . . . . . 43.6 mtmt -66.85 -39.81 87.7 Favored 'General case' 0 C--N 1.329 -0.316 0 N-CA-C 112.386 0.513 . . . . 0.0 112.386 -178.72 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' D' D ' 26' ' ' LEU . . . . . 0.5 HD12 HG22 ' D' ' 22' ' ' ILE . 92.2 mt -78.48 -40.92 34.04 Favored 'General case' 0 C--N 1.331 -0.23 0 N-CA-C 112.881 0.697 . . . . 0.0 112.881 -173.096 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' D' D ' 27' ' ' GLN . . . . . . . . . . . . . 12.3 pt20 -46.61 140.39 4.46 Favored 'General case' 0 N--CA 1.469 0.496 0 N-CA-C 112.691 0.626 . . . . 0.0 112.691 -176.082 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' D' D ' 28' ' ' GLY . . . . . . . . . . . . . . . 99.51 -26.51 24.08 Favored Glycine 0 CA--C 1.532 1.126 0 CA-C-N 115.511 -0.768 . . . . 0.0 112.144 -176.394 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' D' D ' 29' ' ' LYS . . . . . . . . . . . . . 98.7 mttt -97.86 155.2 17.17 Favored 'General case' 0 C--O 1.234 0.269 0 CA-C-N 117.267 0.534 . . . . 0.0 111.134 178.59 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' D' D ' 30' ' ' THR . . . . . . . . . . . . . 18.5 m -105.8 135.58 46.96 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.002 -0.544 . . . . 0.0 109.695 174.922 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' D' D ' 31' ' ' VAL . . . . . . . . . . . . . 35.1 m -128.35 159.68 39.43 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.245 0 CA-C-N 116.382 -0.372 . . . . 0.0 110.681 -177.916 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' D' D ' 32' ' ' ARG . . . . . . . . . . . . . 57.8 ttp180 -132.75 149.8 52.24 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-O 121.22 0.533 . . . . 0.0 110.507 179.561 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' D' D ' 33' ' ' THR . . . . . . . . . . . . . 22.4 m -53.1 139.58 28.07 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 116.333 -0.394 . . . . 0.0 111.326 -178.412 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' D' D ' 34' ' ' GLY . . . . . . . . . . . . . . . 101.26 -17.05 56.36 Favored Glycine 0 CA--C 1.532 1.155 0 CA-C-O 119.645 -0.53 . . . . 0.0 113.251 179.703 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' D' D ' 35' ' ' ASP . . . . . . . . . . . . . 62.8 m-20 -64.09 148.59 49.49 Favored 'General case' 0 C--O 1.231 0.1 0 CA-C-N 118.037 0.918 . . . . 0.0 111.222 179.102 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' D' D ' 36' ' ' VAL . . . . . . . . . . . . . 45.7 t -124.71 128.82 73.62 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.234 0 CA-C-N 115.577 -0.738 . . . . 0.0 109.541 178.185 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' D' D ' 37' ' ' ILE . . . . . . . . . . . . . 66.0 mt -121.21 138.32 52.0 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.256 0 CA-C-N 116.273 -0.421 . . . . 0.0 110.02 -179.293 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' D' D ' 38' ' ' GLY . . . . . . . . . . . . . . . -108.38 128.53 9.14 Favored Glycine 0 CA--C 1.524 0.646 0 N-CA-C 110.754 -0.938 . . . . 0.0 110.754 178.408 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' D' D ' 39' ' ' ILE . . . . . . . . . . . . . 71.9 mt -123.23 138.16 54.13 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.265 0 N-CA-C 109.934 -0.395 . . . . 0.0 109.934 179.803 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' D' D ' 40' ' ' SER . . . . . 0.513 ' O ' HD13 ' D' ' 41' ' ' ILE . 79.2 p -90.32 118.47 29.84 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.316 -0.402 . . . . 0.0 110.55 176.654 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' D' D ' 41' ' ' ILE . . . . . 0.513 HD13 ' O ' ' D' ' 40' ' ' SER . 48.5 mm -129.5 116.11 37.6 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.266 0 CA-C-N 116.453 -0.339 . . . . 0.0 110.177 179.269 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' D' D ' 42' ' ' LEU . . . . . . . . . . . . . 78.1 mt 57.46 35.77 26.27 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.217 -0.447 . . . . 0.0 111.568 177.991 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' D' D ' 43' ' ' GLY . . . . . . . . . . . . . . . 77.79 -10.1 26.99 Favored Glycine 0 CA--C 1.534 1.237 0 C-N-CA 121.303 -0.475 . . . . 0.0 113.537 177.141 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' D' D ' 44' ' ' LYS . . . . . . . . . . . . . 48.5 tttp -101.52 139.8 36.68 Favored 'General case' 0 C--N 1.333 -0.128 0 CA-C-N 117.838 0.819 . . . . 0.0 109.831 177.123 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' D' D ' 45' ' ' GLU . . . . . . . . . . . . . 84.5 tt0 -83.54 127.81 34.02 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-O 120.957 0.408 . . . . 0.0 110.931 -179.201 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' D' D ' 46' ' ' VAL . . . . . . . . . . . . . 7.4 p -121.15 126.9 75.66 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.169 0 N-CA-C 109.339 -0.615 . . . . 0.0 109.339 176.294 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' D' D ' 47' ' ' LYS . . . . . . . . . . . . . 66.3 mttm -100.31 130.12 46.38 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.166 -0.47 . . . . 0.0 111.415 179.063 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' D' D ' 48' ' ' PHE . . . . . . . . . . . . . 95.4 m-85 -112.96 131.99 55.53 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 115.97 -0.559 . . . . 0.0 109.769 176.192 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' D' D ' 49' ' ' LYS . . . . . . . . . . . . . 81.6 tttt -108.31 137.81 45.65 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.297 -0.41 . . . . 0.0 110.497 179.644 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' D' D ' 50' ' ' VAL . . . . . . . . . . . . . 46.2 t -82.41 107.05 13.94 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.287 0 N-CA-C 109.169 -0.678 . . . . 0.0 109.169 175.785 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' D' D ' 51' ' ' VAL . . . . . . . . . . . . . 46.2 t -72.15 -52.38 24.85 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.318 0 CA-C-N 116.041 -0.527 . . . . 0.0 109.683 -174.442 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' D' D ' 52' ' ' GLN . . . . . . . . . . . . . 91.6 mt-30 -152.43 151.57 30.94 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-O 121.291 0.567 . . . . 0.0 111.595 -178.011 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' D' D ' 53' ' ' ALA . . . . . . . . . . . . . . . -127.01 130.66 50.45 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 115.012 -0.995 . . . . 0.0 109.871 176.658 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' D' D ' 54' ' ' TYR . . . . . . . . . . . . . 68.2 t80 -128.66 106.78 18.74 Favored Pre-proline 0 C--N 1.327 -0.384 0 CA-C-O 118.355 -0.831 . . . . 0.0 110.248 -179.776 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' D' D ' 55' ' ' PRO . . . . . . . . . . . . . 73.3 Cg_endo -77.13 170.07 72.56 Favored 'Cis proline' 0 N--CA 1.501 1.919 0 CA-C-N 121.786 1.674 . . . . 0.0 112.631 -3.156 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' D' D ' 56' ' ' SER . . . . . . . . . . . . . 13.6 m -112.15 121.35 39.55 Favored Pre-proline 0 CA--C 1.539 0.522 0 CA-C-O 118.258 -0.877 . . . . 0.0 109.447 175.584 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' D' D ' 57' ' ' PRO . . . . . . . . . . . . . 54.3 Cg_endo -70.6 170.99 59.53 Favored 'Cis proline' 0 N--CA 1.497 1.704 0 CA-C-N 122.11 1.789 . . . . 0.0 112.109 1.35 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' D' D ' 58' ' ' LEU . . . . . . . . . . . . . 19.3 tp -130.15 137.6 50.21 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 115.885 -0.598 . . . . 0.0 110.246 -179.285 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' D' D ' 59' ' ' ARG . . . . . . . . . . . . . 32.6 ttp180 -106.77 126.74 52.69 Favored 'General case' 0 C--N 1.328 -0.338 0 N-CA-C 109.367 -0.605 . . . . 0.0 109.367 176.169 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' D' D ' 60' ' ' VAL . . . . . . . . . . . . . 47.8 t -83.35 122.4 37.51 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.239 0 C-N-CA 120.667 -0.413 . . . . 0.0 110.384 -174.544 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' D' D ' 61' ' ' GLU . . . . . . . . . . . . . 93.8 mt-10 -131.09 166.94 19.97 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-N 115.794 -0.639 . . . . 0.0 110.081 179.656 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' D' D ' 62' ' ' ASP . . . . . . . . . . . . . 81.9 m-20 -55.41 -32.91 63.05 Favored 'General case' 0 C--N 1.328 -0.363 0 C-N-CA 120.951 -0.3 . . . . 0.0 111.49 179.085 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' D' D ' 63' ' ' ARG . . . . . . . . . . . . . 7.4 ptp180 -89.49 10.13 23.92 Favored 'General case' 0 CA--C 1.535 0.389 0 N-CA-C 113.408 0.892 . . . . 0.0 113.408 -176.225 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' D' D ' 64' ' ' THR . . . . . . . . . . . . . 28.6 m -90.91 137.36 32.42 Favored 'General case' 0 C--O 1.232 0.147 0 CA-C-N 118.126 0.421 . . . . 0.0 110.24 -179.732 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' D' D ' 65' ' ' LYS . . . . . . . . . . . . . 2.2 mptp? -88.52 129.25 35.51 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 116.228 -0.442 . . . . 0.0 110.303 -178.317 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' D' D ' 66' ' ' ILE . . . . . . . . . . . . . 63.6 mt -114.68 129.93 69.95 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.298 0 N-CA-C 109.713 -0.477 . . . . 0.0 109.713 178.594 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' D' D ' 67' ' ' THR . . . . . . . . . . . . . 26.7 m -121.73 136.68 54.94 Favored 'General case' 0 C--N 1.33 -0.239 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.536 -179.22 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' D' D ' 68' ' ' LEU . . . . . . . . . . . . . 19.1 tp -105.2 124.75 50.06 Favored 'General case' 0 C--N 1.33 -0.283 0 CA-C-N 115.936 -0.574 . . . . 0.0 110.218 178.819 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' D' D ' 69' ' ' VAL . . . . . . . . . . . . . 46.8 t -100.88 112.18 32.91 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.323 0 N-CA-C 109.757 -0.46 . . . . 0.0 109.757 179.44 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' D' D ' 70' ' ' THR . . . . . . . . . . . . . 7.1 m -150.16 -35.91 0.16 Allowed 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.067 -0.515 . . . . 0.0 111.369 -179.236 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' D' D ' 71' ' ' HIS . . . . . . . . . . . . . 50.6 t-80 -110.12 89.79 8.77 Favored Pre-proline 0 C--N 1.331 -0.203 0 CA-C-N 116.689 -0.232 . . . . 0.0 111.333 -175.593 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' D' D ' 72' ' ' PRO . . . . . . . . . . . . . 71.8 Cg_endo -80.66 -30.19 1.96 Allowed 'Trans proline' 0 N--CA 1.495 1.596 0 C-N-CA 121.364 1.376 . . . . 0.0 111.997 172.555 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' D' D ' 73' ' ' VAL . . . . . . . . . . . . . 30.2 m -145.45 171.41 5.27 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.308 0 N-CA-C 109.566 -0.531 . . . . 0.0 109.566 175.787 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' D' D ' 74' ' ' ASP . . . . . . . . . . . . . 33.2 t0 -96.06 115.04 26.83 Favored 'General case' 0 C--N 1.329 -0.314 0 N-CA-C 109.82 -0.437 . . . . 0.0 109.82 179.384 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' D' D ' 75' ' ' VAL . . . . . . . . . . . . . 40.0 t -113.42 123.76 69.39 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.206 0 CA-C-O 121.069 0.461 . . . . 0.0 110.24 -178.721 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' D' D ' 76' ' ' LEU . . . . . . . . . . . . . 22.0 mt -126.26 140.42 52.54 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 115.706 -0.679 . . . . 0.0 109.782 179.05 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' D' D ' 77' ' ' GLU . . . . . . . . . . . . . 97.2 mt-10 -133.21 134.39 44.0 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-O 121.018 0.437 . . . . 0.0 111.242 -178.635 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' D' D ' 78' ' ' ALA . . . . . 0.502 ' HB2' HD21 ' D' ' 109' ' ' LEU . . . -124.63 132.82 53.4 Favored 'General case' 0 C--N 1.331 -0.202 0 CA-C-N 115.766 -0.652 . . . . 0.0 109.936 177.026 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' D' D ' 79' ' ' LYS . . . . . 0.597 ' O ' HD13 ' D' ' 80' ' ' ILE . 98.3 mttt -77.85 119.01 20.73 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-O 120.948 0.404 . . . . 0.0 110.924 -177.673 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' D' D ' 80' ' ' ILE . . . . . 0.597 HD13 ' O ' ' D' ' 79' ' ' LYS . 41.3 mm -139.17 110.56 4.99 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.271 0 N-CA-C 109.034 -0.728 . . . . 0.0 109.034 -177.839 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' D' D ' 81' ' ' LYS . . . . . . . . . . . . . 84.3 mttt -104.16 127.0 51.73 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-O 120.765 0.316 . . . . 0.0 111.213 -177.023 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' D' D ' 82' ' ' GLY . . . . . . . . . . . . . . . 88.21 42.2 5.98 Favored Glycine 0 CA--C 1.525 0.667 0 C-N-CA 120.621 -0.8 . . . . 0.0 111.857 173.807 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' D' D ' 83' ' ' ILE . . . . . . . . . . . . . 73.1 mt -71.01 134.27 30.31 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.323 0 N-CA-C 109.858 -0.423 . . . . 0.0 109.858 178.093 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' D' D ' 84' ' ' LYS . . . . . . . . . . . . . 53.3 tttp -89.18 -53.43 4.57 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.09 -0.505 . . . . 0.0 110.063 -179.504 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' D' D ' 85' ' ' ASP . . . . . . . . . . . . . 13.2 t70 -151.52 149.52 29.31 Favored 'General case' 0 C--N 1.327 -0.396 0 CA-C-N 115.671 -0.695 . . . . 0.0 110.529 -179.033 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' D' D ' 86' ' ' VAL . . . . . . . . . . . . . 41.0 t -127.48 128.32 69.72 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.242 0 CA-C-O 120.848 0.356 . . . . 0.0 110.069 178.971 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' D' D ' 87' ' ' ILE . . . . . . . . . . . . . 44.5 mm -116.73 126.38 74.15 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.253 0 N-CA-C 109.582 -0.525 . . . . 0.0 109.582 177.452 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' D' D ' 88' ' ' LEU . . . . . . . . . . . . . 13.0 tp -111.89 133.27 54.19 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-O 121.099 0.476 . . . . 0.0 111.108 -176.864 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' D' D ' 89' ' ' ASP . . . . . . . . . . . . . 12.3 t70 -127.34 158.15 38.03 Favored 'General case' 0 C--N 1.331 -0.23 0 CA-C-N 115.705 -0.679 . . . . 0.0 109.424 176.021 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' D' D ' 90' ' ' GLU . . . . . . . . . . . . . 96.4 mt-10 -46.94 -39.46 12.38 Favored 'General case' 0 C--N 1.33 -0.261 0 N-CA-C 113.066 0.765 . . . . 0.0 113.066 -171.342 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' D' D ' 91' ' ' ASN . . . . . . . . . . . . . 87.1 m-20 -132.04 26.05 4.58 Favored 'General case' 0 N--CA 1.467 0.424 0 N-CA-C 112.631 0.604 . . . . 0.0 112.631 -177.742 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' D' D ' 92' ' ' LEU . . . . . . . . . . . . . 10.2 mt -151.37 144.26 24.49 Favored 'General case' 0 C--N 1.329 -0.285 0 N-CA-C 109.962 -0.384 . . . . 0.0 109.962 -177.706 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' D' D ' 93' ' ' ILE . . . . . . . . . . . . . 70.9 mt -126.92 117.72 48.53 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 N-CA-C 109.241 -0.652 . . . . 0.0 109.241 178.133 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' D' D ' 94' ' ' VAL . . . . . . . . . . . . . 44.3 t -118.99 125.71 74.73 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.271 0 N-CA-C 109.77 -0.455 . . . . 0.0 109.77 -178.832 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' D' D ' 95' ' ' VAL . . . . . . . . . . . . . 45.3 t -121.04 132.8 69.59 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.294 0 CA-C-N 115.949 -0.568 . . . . 0.0 109.79 -179.411 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' D' D ' 96' ' ' ILE . . . . . 0.464 HD11 ' HB ' ' D' ' 123' ' ' VAL . 63.2 mt -113.35 125.12 70.57 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.325 0 N-CA-C 109.114 -0.698 . . . . 0.0 109.114 178.72 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' D' D ' 97' ' ' THR . . . . . . . . . . . . . 69.2 p -99.49 157.34 16.5 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-O 121.315 0.579 . . . . 0.0 111.312 -176.471 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' D' D ' 98' ' ' GLU . . . . . . . . . . . . . 78.2 tt0 -53.89 -24.37 15.82 Favored 'General case' 0 CA--C 1.534 0.364 0 CA-C-N 115.953 -0.567 . . . . 0.0 112.245 178.846 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' D' D ' 99' ' ' GLU . . . . . . . . . . . . . 36.1 tt0 -78.4 13.7 1.47 Allowed 'General case' 0 CA--C 1.54 0.586 0 N-CA-C 112.684 0.624 . . . . 0.0 112.684 -177.438 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' D' D ' 100' ' ' ASN . . . . . . . . . . . . . 3.2 m-20 61.32 38.02 16.65 Favored 'General case' 0 CA--C 1.53 0.175 0 O-C-N 121.871 -0.518 . . . . 0.0 110.974 179.651 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' D' D ' 101' ' ' GLU . . . . . . . . . . . . . 84.4 tt0 -118.79 143.94 46.61 Favored 'General case' 0 C--N 1.331 -0.2 0 CA-C-N 115.947 -0.57 . . . . 0.0 109.72 176.932 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' D' D ' 102' ' ' VAL . . . . . . . . . . . . . 47.4 t -115.0 124.65 71.87 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.323 0 CA-C-N 116.251 -0.432 . . . . 0.0 109.863 -178.537 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' D' D ' 103' ' ' LEU . . . . . . . . . . . . . 69.5 mt -114.13 129.89 56.61 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 115.842 -0.617 . . . . 0.0 109.971 176.823 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' D' D ' 104' ' ' ILE . . . . . 0.587 HD13 HG11 ' D' ' 130' ' ' VAL . 66.7 mt -120.0 119.47 60.25 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.225 0 N-CA-C 110.087 -0.338 . . . . 0.0 110.087 -178.028 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' D' D ' 105' ' ' PHE . . . . . . . . . . . . . 54.2 m-85 -121.42 162.77 19.85 Favored 'General case' 0 C--N 1.331 -0.219 0 O-C-N 123.998 0.811 . . . . 0.0 109.661 179.959 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' D' D ' 106' ' ' ASN . . . . . . . . . . . . . 41.1 p-10 -95.52 -169.99 2.07 Favored 'General case' 0 C--N 1.33 -0.272 0 N-CA-C 109.782 -0.451 . . . . 0.0 109.782 173.2 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' D' D ' 107' ' ' GLN . . . . . . . . . . . . . 13.5 tt0 -58.64 -30.04 66.99 Favored 'General case' 0 C--N 1.329 -0.313 0 N-CA-C 111.847 0.314 . . . . 0.0 111.847 178.951 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' D' D ' 108' ' ' ASN . . . . . . . . . . . . . 21.1 t-20 -84.17 6.61 21.85 Favored 'General case' 0 CA--C 1.536 0.425 0 N-CA-C 113.339 0.866 . . . . 0.0 113.339 -176.68 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' D' D ' 109' ' ' LEU . . . . . 0.502 HD21 ' HB2' ' D' ' 78' ' ' ALA . 11.6 tp 62.23 37.71 13.98 Favored 'General case' 0 CA--C 1.531 0.219 0 CA-C-O 121.013 0.435 . . . . 0.0 111.196 178.456 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' D' D ' 110' ' ' GLU . . . . . . . . . . . . . 42.9 mt-10 -107.26 151.49 25.39 Favored 'General case' 0 C--N 1.33 -0.273 0 N-CA-C 109.859 -0.423 . . . . 0.0 109.859 176.016 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' D' D ' 111' ' ' GLU . . . . . . . . . . . . . 97.7 mt-10 -79.02 121.94 25.56 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-O 121.008 0.432 . . . . 0.0 111.136 -178.575 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' D' D ' 112' ' ' LEU . . . . . . . . . . . . . 29.9 mt -106.92 -45.9 4.06 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 115.888 -0.596 . . . . 0.0 109.811 175.468 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' D' D ' 113' ' ' TYR . . . . . 0.412 ' HB3' HD12 ' D' ' 104' ' ' ILE . 53.4 t80 -141.23 142.92 33.92 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 115.858 -0.61 . . . . 0.0 110.381 179.485 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' D' D ' 114' ' ' ARG . . . . . . . . . . . . . 35.6 ptt-85 -150.58 124.06 9.01 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-O 121.128 0.49 . . . . 0.0 110.841 177.316 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' D' D ' 115' ' ' GLY . . . . . . . . . . . . . . . -150.19 163.0 29.39 Favored Glycine 0 CA--C 1.525 0.673 0 N-CA-C 111.076 -0.81 . . . . 0.0 111.076 -179.417 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' D' D ' 116' ' ' LYS . . . . . . . . . . . . . 34.0 ttpt -131.03 134.55 46.78 Favored 'General case' 0 C--N 1.33 -0.265 0 N-CA-C 109.846 -0.428 . . . . 0.0 109.846 177.717 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' D' D ' 117' ' ' PHE . . . . . . . . . . . . . 26.3 m-85 -133.07 120.44 21.31 Favored 'General case' 0 C--N 1.331 -0.218 0 CA-C-O 120.894 0.378 . . . . 0.0 110.232 -174.915 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' D' D ' 118' ' ' GLU . . . . . . . . . . . . . 46.4 tp10 -51.52 -52.08 49.84 Favored 'General case' 0 C--N 1.328 -0.351 0 N-CA-C 112.01 0.374 . . . . 0.0 112.01 -174.757 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' D' D ' 119' ' ' ASN . . . . . . . . . . . . . 3.3 p30 -100.06 31.28 3.38 Favored 'General case' 0 C--N 1.33 -0.265 0 N-CA-C 112.173 0.434 . . . . 0.0 112.173 -173.735 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' D' D ' 120' ' ' LEU . . . . . . . . . . . . . 14.1 tp -52.92 125.95 18.76 Favored 'General case' 0 N--CA 1.464 0.229 0 O-C-N 122.343 -0.223 . . . . 0.0 110.985 178.263 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' D' D ' 121' ' ' ASN . . . . . . . . . . . . . 4.3 t-20 -113.96 -44.15 3.19 Favored 'General case' 0 C--N 1.331 -0.229 0 C-N-CA 121.129 -0.229 . . . . 0.0 111.218 -176.839 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' D' D ' 122' ' ' LYS . . . . . . . . . . . . . 49.3 mttm -141.98 146.91 36.14 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-O 120.983 0.42 . . . . 0.0 111.908 -177.309 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' D' D ' 123' ' ' VAL . . . . . 0.464 ' HB ' HD11 ' D' ' 96' ' ' ILE . 43.7 t -130.44 123.28 55.01 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.261 0 N-CA-C 109.22 -0.659 . . . . 0.0 109.22 173.106 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' D' D ' 124' ' ' LEU . . . . . 0.409 HD12 ' C ' ' D' ' 123' ' ' VAL . 6.2 mp -122.97 139.31 54.21 Favored 'General case' 0 C--N 1.332 -0.173 0 CA-C-O 120.93 0.395 . . . . 0.0 111.222 -175.763 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' D' D ' 125' ' ' VAL . . . . . . . . . . . . . 11.0 p -133.15 131.99 58.52 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.194 0 CA-C-N 115.921 -0.581 . . . . 0.0 110.239 178.182 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' D' D ' 126' ' ' ARG . . . . . . . . . . . . . 55.9 mtp180 -144.49 120.91 10.98 Favored 'General case' 0 C--N 1.331 -0.23 0 CA-C-N 116.482 -0.326 . . . . 0.0 110.947 179.012 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' D' D ' 127' ' ' ASN . . . . . . . . . . . . . 75.8 m-20 49.96 -105.97 0.2 Allowed 'General case' 0 CA--C 1.543 0.696 0 CA-C-O 119.043 -0.503 . . . . 0.0 111.546 178.537 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' D' D ' 128' ' ' ASP . . . . . . . . . . . . . 12.0 p-10 -114.06 4.76 15.79 Favored 'General case' 0 N--CA 1.468 0.456 0 CA-C-N 119.684 1.129 . . . . 0.0 113.372 -178.455 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' D' D ' 129' ' ' LEU . . . . . . . . . . . . . 11.4 tp -106.01 131.27 53.5 Favored 'General case' 0 C--N 1.332 -0.19 0 N-CA-C 109.867 -0.42 . . . . 0.0 109.867 178.845 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' D' D ' 130' ' ' VAL . . . . . 0.587 HG11 HD13 ' D' ' 104' ' ' ILE . 44.1 t -119.23 134.06 64.06 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.283 0 N-CA-C 109.603 -0.517 . . . . 0.0 109.603 178.77 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' D' D ' 131' ' ' VAL . . . . . . . . . . . . . 40.4 t -136.06 135.22 50.38 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.246 0 CA-C-O 121.054 0.454 . . . . 0.0 110.504 -178.948 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' D' D ' 132' ' ' ILE . . . . . . . . . . . . . 68.4 mt -115.69 133.39 62.22 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.271 0 CA-C-N 115.75 -0.659 . . . . 0.0 109.24 177.317 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' D' D ' 133' ' ' ILE . . . . . . . . . . . . . 36.9 mm -116.67 120.69 65.76 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.308 0 CA-C-N 116.356 -0.384 . . . . 0.0 110.743 -174.093 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' D' D ' 134' ' ' ASP . . . . . . . . . . . . . 18.9 p-10 -138.93 150.87 46.4 Favored 'General case' 0 C--N 1.331 -0.202 0 N-CA-C 109.821 -0.437 . . . . 0.0 109.821 173.682 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' D' D ' 135' ' ' GLU . . . . . . . . . . . . . 39.8 tp10 -50.07 -25.92 3.91 Favored 'General case' 0 C--N 1.328 -0.356 0 N-CA-C 113.389 0.885 . . . . 0.0 113.389 -168.375 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' D' D ' 136' ' ' GLN . . . . . . . . . . . . . 20.5 pt20 -99.02 -18.15 17.91 Favored 'General case' 0 N--CA 1.464 0.262 0 N-CA-C 113.566 0.95 . . . . 0.0 113.566 -172.356 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' D' D ' 137' ' ' LYS . . . . . . . . . . . . . 54.6 pttt -161.61 166.73 26.44 Favored 'General case' 0 C--O 1.233 0.193 0 CA-C-O 121.999 0.904 . . . . 0.0 113.344 -175.146 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' D' D ' 138' ' ' LEU . . . . . . . . . . . . . 12.2 tp -117.1 125.73 51.73 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 114.143 -1.389 . . . . 0.0 109.345 176.043 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' D' D ' 139' ' ' THR . . . . . . . . . . . . . 19.4 m -108.41 123.19 48.47 Favored 'General case' 0 C--N 1.331 -0.209 0 CA-C-O 120.705 0.288 . . . . 0.0 110.485 179.289 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' D' D ' 140' ' ' LEU . . . . . 0.477 ' C ' HD23 ' D' ' 140' ' ' LEU . 7.6 tt -112.81 120.74 42.51 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 115.568 -0.742 . . . . 0.0 109.136 -179.09 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' D' D ' 141' ' ' ILE . . . . . . . . . . . . . 19.3 mt -120.91 120.24 61.76 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.367 0 CA-C-O 121.007 0.432 . . . . 0.0 109.953 -176.152 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' D' D ' 142' ' ' ARG . . . . . . . . . . . . . 71.5 ttt180 -106.89 120.28 41.61 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 115.332 -0.849 . . . . 0.0 110.188 -179.778 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' D' D ' 143' ' ' THR . . . . . . . . . . . . . 73.2 p . . . . . 0 C--O 1.22 -0.469 0 CA-C-O 118.011 -0.995 . . . . 0.0 110.63 -179.295 . . . . . . . . 0 0 . 1 . 014 nuclear build full ' E' E ' -3' ' ' GLU . . . . . . . . . . . . . 45.8 tp10 . . . . . 0 N--CA 1.491 1.593 0 N-CA-C 109.361 -0.607 . . . . 0.0 109.361 . . . . . . . . . 0 0 . 1 . 014 nuclear build full ' E' E ' -2' ' ' GLY . . . . . . . . . . . . . . . -64.38 148.39 51.08 Favored Glycine 0 CA--C 1.525 0.692 0 N-CA-C 110.803 -0.919 . . . . 0.0 110.803 179.94 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' E' E ' -1' ' ' VAL . . . . . . . . . . . . . 43.2 t -96.38 138.24 22.18 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.309 0 N-CA-C 110.158 -0.312 . . . . 0.0 110.158 -179.197 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' E' E ' 0' ' ' ILE . . . . . . . . . . . . . 70.1 mt -106.16 125.56 61.78 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 N-CA-C 109.664 -0.495 . . . . 0.0 109.664 178.605 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' E' E ' 1' ' ' MET . . . . . . . . . . . . . 24.4 ptp -91.68 131.09 37.32 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.064 -0.516 . . . . 0.0 110.557 -179.491 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' E' E ' 2' ' ' SER . . . . . . . . . . . . . 6.4 p -122.9 136.65 54.94 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-O 121.038 0.447 . . . . 0.0 110.961 -178.378 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' E' E ' 3' ' ' GLU . . . . . . . . . . . . . 83.5 tt0 -141.27 142.18 33.91 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 115.804 -0.634 . . . . 0.0 110.893 179.946 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' E' E ' 4' ' ' LEU . . . . . 0.518 HD23 ' N ' ' E' ' 5' ' ' LYS . 3.6 tt -123.44 123.32 40.4 Favored 'General case' 0 C--N 1.33 -0.251 0 N-CA-C 109.702 -0.481 . . . . 0.0 109.702 177.978 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' E' E ' 5' ' ' LYS . . . . . 0.518 ' N ' HD23 ' E' ' 4' ' ' LEU . 49.1 mtmt -103.31 119.62 39.21 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.205 -0.452 . . . . 0.0 111.035 -179.263 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' E' E ' 6' ' ' LEU . . . . . . . . . . . . . 15.1 mt -116.01 153.36 31.8 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 115.731 -0.668 . . . . 0.0 110.585 178.768 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' E' E ' 7' ' ' LYS . . . . . . . . . . . . . 59.5 tttp -135.02 136.89 25.86 Favored Pre-proline 0 CA--C 1.534 0.35 0 CA-C-O 119.047 -0.502 . . . . 0.0 109.987 174.609 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' E' E ' 8' ' ' PRO . . . . . . . . . . . . . 88.5 Cg_endo -91.4 137.58 2.07 Favored 'Trans proline' 0 N--CA 1.49 1.287 0 C-N-CA 121.76 1.64 . . . . 0.0 111.366 178.119 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' E' E ' 9' ' ' LEU . . . . . . . . . . . . . 27.0 mt -83.03 -47.66 0.81 Allowed Pre-proline 0 CA--C 1.533 0.309 0 CA-C-O 118.743 -0.646 . . . . 0.0 112.429 -177.133 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' E' E ' 10' ' ' PRO . . . . . . . . . . . . . 62.8 Cg_endo -83.75 156.22 13.73 Favored 'Trans proline' 0 N--CA 1.495 1.609 0 C-N-CA 121.39 1.393 . . . . 0.0 112.151 177.115 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' E' E ' 11' ' ' LYS . . . . . . . . . . . . . 20.2 pttp -78.93 116.59 19.34 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-O 121.286 0.565 . . . . 0.0 110.286 175.523 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' E' E ' 12' ' ' VAL . . . . . . . . . . . . . 12.6 p -150.65 151.99 11.95 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.28 0 CA-C-N 115.779 -0.646 . . . . 0.0 110.756 -177.192 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' E' E ' 13' ' ' GLU . . . . . . . . . . . . . 13.0 pt-20 -91.88 130.95 37.54 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.555 178.394 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' E' E ' 14' ' ' LEU . . . . . . . . . . . . . 31.4 mt -99.87 130.69 25.89 Favored Pre-proline 0 CA--C 1.536 0.437 0 CA-C-O 118.715 -0.66 . . . . 0.0 110.621 -178.341 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' E' E ' 15' ' ' PRO . . . . . . . . . . . . . 23.0 Cg_exo -65.1 161.16 38.35 Favored 'Trans proline' 0 N--CA 1.499 1.842 0 C-N-CA 121.301 1.334 . . . . 0.0 111.893 175.826 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' E' E ' 16' ' ' PRO . . . . . . . . . . . . . 30.4 Cg_exo -59.96 -32.94 95.79 Favored 'Trans proline' 0 N--CA 1.496 1.627 0 C-N-CA 121.442 1.428 . . . . 0.0 112.635 -179.096 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' E' E ' 17' ' ' ASP . . . . . . . . . . . . . 11.3 p-10 -91.13 14.44 14.16 Favored 'General case' 0 CA--C 1.535 0.38 0 N-CA-C 112.989 0.737 . . . . 0.0 112.989 -178.412 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' E' E ' 18' ' ' PHE . . . . . . . . . . . . . 47.8 t80 -55.82 -49.13 74.11 Favored 'General case' 0 C--N 1.334 -0.076 0 O-C-N 121.977 -0.452 . . . . 0.0 110.7 -177.839 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' E' E ' 19' ' ' VAL . . . . . . . . . . . . . 47.5 t -55.77 -42.33 69.6 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.304 0 CA-C-N 116.578 -0.283 . . . . 0.0 110.723 -176.703 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' E' E ' 20' ' ' ASP . . . . . . . . . . . . . 60.5 m-20 -60.12 -43.03 95.95 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-O 120.849 0.357 . . . . 0.0 110.922 -177.85 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' E' E ' 21' ' ' VAL . . . . . . . . . . . . . 44.9 t -64.98 -47.54 87.69 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.306 0 C-N-CA 120.718 -0.393 . . . . 0.0 110.415 -178.036 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' E' E ' 22' ' ' ILE . . . . . 0.565 HG22 HD12 ' E' ' 26' ' ' LEU . 50.2 mm -55.71 -58.72 3.92 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.263 0 C-N-CA 120.92 -0.312 . . . . 0.0 111.108 -178.3 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' E' E ' 23' ' ' ARG . . . . . . . . . . . . . 7.5 ptm180 -56.48 -43.44 79.63 Favored 'General case' 0 C--N 1.332 -0.177 0 C-N-CA 120.618 -0.433 . . . . 0.0 111.859 -173.783 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' E' E ' 24' ' ' ILE . . . . . . . . . . . . . 78.0 mt -60.79 -43.68 95.88 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.293 0 C-N-CA 120.996 -0.281 . . . . 0.0 111.588 -176.682 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' E' E ' 25' ' ' LYS . . . . . . . . . . . . . 98.3 mttt -71.07 -40.73 71.42 Favored 'General case' 0 C--N 1.329 -0.299 0 N-CA-C 112.421 0.526 . . . . 0.0 112.421 -178.365 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' E' E ' 26' ' ' LEU . . . . . 0.565 HD12 HG22 ' E' ' 22' ' ' ILE . 77.1 mt -80.31 -32.59 37.98 Favored 'General case' 0 C--N 1.329 -0.289 0 N-CA-C 113.708 1.003 . . . . 0.0 113.708 -170.859 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' E' E ' 27' ' ' GLN . . . . . . . . . . . . . 14.0 pt20 -47.41 142.13 4.38 Favored 'General case' 0 N--CA 1.469 0.516 0 N-CA-C 112.602 0.593 . . . . 0.0 112.602 -175.61 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' E' E ' 28' ' ' GLY . . . . . . . . . . . . . . . 99.02 -22.17 42.27 Favored Glycine 0 CA--C 1.532 1.149 0 CA-C-N 115.63 -0.714 . . . . 0.0 112.561 -177.494 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' E' E ' 29' ' ' LYS . . . . . . . . . . . . . 28.5 mmtp -96.5 154.97 16.97 Favored 'General case' 0 C--O 1.231 0.122 0 CA-C-N 117.734 0.767 . . . . 0.0 110.846 178.424 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' E' E ' 30' ' ' THR . . . . . . . . . . . . . 41.2 m -110.13 138.64 46.22 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-N 115.803 -0.635 . . . . 0.0 110.307 178.446 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' E' E ' 31' ' ' VAL . . . . . . . . . . . . . 34.7 m -133.4 159.33 42.9 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.247 0 CA-C-N 116.233 -0.44 . . . . 0.0 111.026 -179.159 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' E' E ' 32' ' ' ARG . . . . . . . . . . . . . 77.8 mtp180 -131.98 153.34 50.43 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 115.874 -0.603 . . . . 0.0 110.424 176.408 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' E' E ' 33' ' ' THR . . . . . . . . . . . . . 30.6 m -53.1 139.68 27.8 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.37 -0.377 . . . . 0.0 111.395 -177.915 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' E' E ' 34' ' ' GLY . . . . . . . . . . . . . . . 99.39 -17.14 58.2 Favored Glycine 0 CA--C 1.532 1.153 0 CA-C-O 119.601 -0.555 . . . . 0.0 113.274 178.157 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' E' E ' 35' ' ' ASP . . . . . . . . . . . . . 74.2 m-20 -65.37 148.08 52.33 Favored 'General case' 0 N--CA 1.461 0.112 0 CA-C-N 118.043 0.921 . . . . 0.0 111.211 179.318 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' E' E ' 36' ' ' VAL . . . . . . . . . . . . . 44.4 t -119.61 129.59 75.15 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 CA-C-N 115.649 -0.705 . . . . 0.0 109.705 178.875 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' E' E ' 37' ' ' ILE . . . . . . . . . . . . . 68.9 mt -121.17 139.03 49.62 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.29 0 CA-C-N 116.272 -0.422 . . . . 0.0 109.971 -179.374 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' E' E ' 38' ' ' GLY . . . . . . . . . . . . . . . -112.19 128.7 8.67 Favored Glycine 0 CA--C 1.525 0.701 0 N-CA-C 110.502 -1.039 . . . . 0.0 110.502 177.698 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' E' E ' 39' ' ' ILE . . . . . . . . . . . . . 72.1 mt -123.1 133.42 69.14 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.279 0 N-CA-C 109.944 -0.391 . . . . 0.0 109.944 -179.522 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' E' E ' 40' ' ' SER . . . . . . . . . . . . . 43.2 t -93.44 120.62 33.93 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.444 -0.344 . . . . 0.0 110.949 176.281 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' E' E ' 41' ' ' ILE . . . . . . . . . . . . . 73.6 mt -122.47 114.79 43.89 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.195 0 CA-C-O 120.955 0.407 . . . . 0.0 110.104 177.856 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' E' E ' 42' ' ' LEU . . . . . 0.542 ' O ' HD23 ' E' ' 42' ' ' LEU . 1.3 tt 51.01 44.18 28.68 Favored 'General case' 0 CA--C 1.532 0.274 0 CA-C-O 121.479 0.656 . . . . 0.0 110.829 177.866 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' E' E ' 43' ' ' GLY . . . . . . . . . . . . . . . 71.26 27.8 71.07 Favored Glycine 0 CA--C 1.531 1.084 0 C-N-CA 121.113 -0.565 . . . . 0.0 112.392 176.095 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' E' E ' 44' ' ' LYS . . . . . . . . . . . . . 61.2 tttm -133.9 129.88 36.99 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-N 117.188 0.494 . . . . 0.0 109.952 178.8 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' E' E ' 45' ' ' GLU . . . . . . . . . . . . . 82.6 tt0 -83.35 122.92 29.11 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-O 120.873 0.368 . . . . 0.0 111.274 -177.008 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' E' E ' 46' ' ' VAL . . . . . . . . . . . . . 7.4 p -122.53 128.41 75.36 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.228 0 N-CA-C 109.441 -0.577 . . . . 0.0 109.441 175.213 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' E' E ' 47' ' ' LYS . . . . . . . . . . . . . 62.5 mtpt -100.56 133.14 45.43 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 115.992 -0.549 . . . . 0.0 111.262 179.943 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' E' E ' 48' ' ' PHE . . . . . . . . . . . . . 96.0 m-85 -120.47 132.06 55.04 Favored 'General case' 0 C--N 1.331 -0.219 0 CA-C-N 116.102 -0.499 . . . . 0.0 110.075 176.897 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' E' E ' 49' ' ' LYS . . . . . . . . . . . . . 60.6 tttm -106.32 137.73 43.76 Favored 'General case' 0 C--O 1.233 0.202 0 CA-C-N 116.504 -0.316 . . . . 0.0 110.418 178.076 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' E' E ' 50' ' ' VAL . . . . . . . . . . . . . 44.0 t -80.45 105.22 9.9 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.279 0 N-CA-C 109.133 -0.692 . . . . 0.0 109.133 175.101 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' E' E ' 51' ' ' VAL . . . . . . . . . . . . . 48.0 t -70.18 -49.32 55.87 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.35 0 CA-C-N 115.956 -0.566 . . . . 0.0 109.968 -174.057 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' E' E ' 52' ' ' GLN . . . . . . . . . . . . . 60.0 tt0 -163.31 140.09 7.25 Favored 'General case' 0 C--N 1.332 -0.183 0 C-N-CA 120.179 -0.608 . . . . 0.0 111.681 -179.185 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' E' E ' 53' ' ' ALA . . . . . . . . . . . . . . . -113.64 130.96 56.31 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 115.821 -0.627 . . . . 0.0 109.907 176.238 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' E' E ' 54' ' ' TYR . . . . . . . . . . . . . 65.1 t80 -129.08 109.98 18.19 Favored Pre-proline 0 CA--C 1.535 0.385 0 CA-C-O 118.274 -0.869 . . . . 0.0 110.207 179.588 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' E' E ' 55' ' ' PRO . . . . . . . . . . . . . 73.4 Cg_endo -77.18 170.1 72.43 Favored 'Cis proline' 0 N--CA 1.499 1.838 0 CA-C-N 121.948 1.731 . . . . 0.0 112.541 -3.918 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' E' E ' 56' ' ' SER . . . . . . . . . . . . . 13.4 m -115.12 128.97 25.46 Favored Pre-proline 0 CA--C 1.539 0.546 0 CA-C-O 118.356 -0.83 . . . . 0.0 109.315 175.412 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' E' E ' 57' ' ' PRO . . . . . . . . . . . . . 44.3 Cg_endo -68.27 166.56 68.16 Favored 'Cis proline' 0 N--CA 1.497 1.722 0 CA-C-N 122.037 1.763 . . . . 0.0 111.576 0.407 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' E' E ' 58' ' ' LEU . . . . . 0.485 HD23 HD12 ' E' ' 4' ' ' LEU . 23.3 tp -129.84 138.57 51.06 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-O 121.022 0.439 . . . . 0.0 110.417 -179.148 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' E' E ' 59' ' ' ARG . . . . . . . . . . . . . 55.3 ttp180 -107.1 130.16 54.72 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 115.632 -0.713 . . . . 0.0 109.51 176.969 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' E' E ' 60' ' ' VAL . . . . . . . . . . . . . 43.7 t -77.74 119.9 27.35 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.252 0 C-N-CA 120.74 -0.384 . . . . 0.0 110.266 -177.079 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' E' E ' 61' ' ' GLU . . . . . . . . . . . . . 43.0 mt-10 -130.95 155.06 47.43 Favored 'General case' 0 C--N 1.331 -0.213 0 CA-C-N 115.944 -0.571 . . . . 0.0 110.528 179.148 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' E' E ' 62' ' ' ASP . . . . . . . . . . . . . 28.6 m-20 -54.61 -32.99 59.73 Favored 'General case' 0 C--N 1.326 -0.429 0 CA-C-N 116.491 -0.322 . . . . 0.0 111.777 179.683 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' E' E ' 63' ' ' ARG . . . . . . . . . . . . . 9.3 ptm180 -88.96 7.66 33.5 Favored 'General case' 0 CA--C 1.536 0.441 0 N-CA-C 113.652 0.982 . . . . 0.0 113.652 -175.082 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' E' E ' 64' ' ' THR . . . . . . . . . . . . . 23.3 m -89.51 146.15 24.81 Favored 'General case' 0 C--N 1.331 -0.196 0 CA-C-N 118.066 0.394 . . . . 0.0 110.319 179.648 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' E' E ' 65' ' ' LYS . . . . . . . . . . . . . 94.7 mttt -84.74 121.82 28.22 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-O 120.841 0.353 . . . . 0.0 110.211 179.914 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' E' E ' 66' ' ' ILE . . . . . . . . . . . . . 58.1 mt -112.52 122.53 66.91 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.263 0 N-CA-C 109.237 -0.653 . . . . 0.0 109.237 179.648 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' E' E ' 67' ' ' THR . . . . . . . . . . . . . 9.6 m -129.95 143.41 50.78 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-O 121.127 0.489 . . . . 0.0 111.679 -172.911 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' E' E ' 68' ' ' LEU . . . . . 0.479 HD12 ' N ' ' E' ' 68' ' ' LEU . 7.9 mp -94.57 133.18 38.48 Favored 'General case' 0 C--N 1.331 -0.239 0 CA-C-N 115.799 -0.637 . . . . 0.0 109.631 173.859 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' E' E ' 69' ' ' VAL . . . . . . . . . . . . . 41.8 t -90.59 119.18 37.28 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.342 0 CA-C-O 121.034 0.445 . . . . 0.0 110.764 -176.864 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' E' E ' 70' ' ' THR . . . . . . . . . . . . . 28.5 m -150.04 111.36 4.43 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 115.782 -0.645 . . . . 0.0 109.931 175.793 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' E' E ' 71' ' ' HIS . . . . . . . . . . . . . 97.5 m-70 -150.03 160.48 33.45 Favored Pre-proline 0 C--N 1.33 -0.264 0 C-N-CA 120.758 -0.377 . . . . 0.0 111.187 -177.844 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' E' E ' 72' ' ' PRO . . . . . . . . . . . . . 76.1 Cg_endo -87.37 158.19 8.12 Favored 'Trans proline' 0 N--CA 1.491 1.354 0 C-N-CA 121.747 1.631 . . . . 0.0 112.183 178.312 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' E' E ' 73' ' ' VAL . . . . . . . . . . . . . 32.9 m -70.14 156.28 7.22 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.336 0 CA-C-N 116.253 -0.43 . . . . 0.0 111.226 -179.371 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' E' E ' 74' ' ' ASP . . . . . . . . . . . . . 10.6 t0 -101.07 124.11 46.28 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 115.777 -0.647 . . . . 0.0 109.882 178.366 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' E' E ' 75' ' ' VAL . . . . . . . . . . . . . 41.7 t -111.53 125.02 68.82 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.224 0 CA-C-O 121.133 0.492 . . . . 0.0 110.622 -178.111 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' E' E ' 76' ' ' LEU . . . . . . . . . . . . . 42.5 mt -121.28 143.45 49.16 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 115.593 -0.731 . . . . 0.0 109.6 177.22 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' E' E ' 77' ' ' GLU . . . . . . . . . . . . . 97.9 mt-10 -136.47 134.66 37.88 Favored 'General case' 0 C--N 1.331 -0.201 0 CA-C-O 120.996 0.427 . . . . 0.0 111.462 -178.662 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' E' E ' 78' ' ' ALA . . . . . 0.408 ' HB2' HD21 ' E' ' 109' ' ' LEU . . . -121.86 137.11 54.91 Favored 'General case' 0 C--N 1.331 -0.206 0 CA-C-N 115.728 -0.669 . . . . 0.0 109.751 175.738 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' E' E ' 79' ' ' LYS . . . . . 0.582 ' O ' HD13 ' E' ' 80' ' ' ILE . 61.5 mtpt -84.49 120.73 26.66 Favored 'General case' 0 C--N 1.331 -0.219 0 CA-C-O 120.884 0.373 . . . . 0.0 110.831 -178.166 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' E' E ' 80' ' ' ILE . . . . . 0.582 HD13 ' O ' ' E' ' 79' ' ' LYS . 22.6 mm -139.16 124.84 22.38 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.231 0 CA-C-N 115.937 -0.574 . . . . 0.0 109.688 -177.235 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' E' E ' 81' ' ' LYS . . . . . . . . . . . . . 64.8 mmtt -110.22 123.85 50.54 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-O 120.837 0.351 . . . . 0.0 111.419 -179.169 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' E' E ' 82' ' ' GLY . . . . . . . . . . . . . . . 89.06 42.15 5.69 Favored Glycine 0 CA--C 1.524 0.638 0 C-N-CA 120.698 -0.763 . . . . 0.0 112.044 171.664 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' E' E ' 83' ' ' ILE . . . . . . . . . . . . . 71.9 mt -61.66 135.92 25.73 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.335 0 CA-C-O 120.958 0.408 . . . . 0.0 109.957 178.691 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' E' E ' 84' ' ' LYS . . . . . . . . . . . . . 72.7 tttt -96.54 -50.8 4.58 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 115.739 -0.664 . . . . 0.0 110.021 -179.001 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' E' E ' 85' ' ' ASP . . . . . . . . . . . . . 6.1 t0 -156.12 150.11 25.25 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 115.54 -0.755 . . . . 0.0 110.075 179.261 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' E' E ' 86' ' ' VAL . . . . . . . . . . . . . 45.7 t -129.1 129.29 67.77 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.268 0 CA-C-O 120.92 0.391 . . . . 0.0 110.315 -179.26 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' E' E ' 87' ' ' ILE . . . . . 0.473 HG21 HG21 ' E' ' 125' ' ' VAL . 43.1 mm -118.39 125.18 74.13 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.285 0 CA-C-N 115.99 -0.55 . . . . 0.0 109.767 176.489 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' E' E ' 88' ' ' LEU . . . . . . . . . . . . . 52.1 mt -111.04 136.03 50.67 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-O 121.078 0.466 . . . . 0.0 111.437 -178.14 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' E' E ' 89' ' ' ASP . . . . . . . . . . . . . 13.8 t70 -131.42 153.56 49.58 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 115.537 -0.756 . . . . 0.0 109.319 175.384 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' E' E ' 90' ' ' GLU . . . . . . . . . . . . . 46.2 tp10 -47.28 -39.2 14.03 Favored 'General case' 0 N--CA 1.464 0.264 0 N-CA-C 112.817 0.673 . . . . 0.0 112.817 -172.872 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' E' E ' 91' ' ' ASN . . . . . . . . . . . . . 30.2 m120 -132.11 35.51 3.71 Favored 'General case' 0 N--CA 1.464 0.258 0 C-N-CA 120.974 -0.29 . . . . 0.0 111.743 -177.336 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' E' E ' 92' ' ' LEU . . . . . . . . . . . . . 11.3 tp -166.1 145.82 6.19 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-O 120.781 0.324 . . . . 0.0 110.775 -179.835 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' E' E ' 93' ' ' ILE . . . . . . . . . . . . . 72.1 mt -130.63 125.64 59.16 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.24 0 N-CA-C 109.716 -0.475 . . . . 0.0 109.716 -179.736 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' E' E ' 94' ' ' VAL . . . . . 0.462 HG21 HG11 ' E' ' 125' ' ' VAL . 44.3 t -122.89 126.39 73.73 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.292 0 N-CA-C 109.722 -0.473 . . . . 0.0 109.722 178.986 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' E' E ' 95' ' ' VAL . . . . . . . . . . . . . 45.5 t -123.71 132.73 70.89 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.207 0 N-CA-C 109.915 -0.402 . . . . 0.0 109.915 -178.863 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' E' E ' 96' ' ' ILE . . . . . . . . . . . . . 56.0 mt -118.1 134.64 61.08 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.308 0 N-CA-C 109.125 -0.694 . . . . 0.0 109.125 179.51 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' E' E ' 97' ' ' THR . . . . . . . . . . . . . 58.0 p -109.86 157.29 19.36 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-O 121.357 0.599 . . . . 0.0 111.452 -177.174 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' E' E ' 98' ' ' GLU . . . . . . . . . . . . . 96.4 mt-10 -55.13 -22.1 15.56 Favored 'General case' 0 C--N 1.329 -0.306 0 N-CA-C 112.531 0.567 . . . . 0.0 112.531 179.204 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' E' E ' 99' ' ' GLU . . . . . . . . . . . . . 38.4 tt0 -78.75 14.93 1.16 Allowed 'General case' 0 CA--C 1.54 0.57 0 N-CA-C 112.52 0.563 . . . . 0.0 112.52 -178.614 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' E' E ' 100' ' ' ASN . . . . . . . . . . . . . 2.8 m-20 61.96 37.88 14.7 Favored 'General case' 0 CA--C 1.529 0.167 0 O-C-N 121.763 -0.585 . . . . 0.0 110.857 178.537 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' E' E ' 101' ' ' GLU . . . . . . . . . . . . . 84.5 tt0 -120.57 143.57 48.55 Favored 'General case' 0 C--N 1.333 -0.134 0 CA-C-N 116.051 -0.522 . . . . 0.0 109.73 177.821 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' E' E ' 102' ' ' VAL . . . . . . . . . . . . . 41.1 t -120.94 130.85 74.22 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.267 0 CA-C-N 116.313 -0.403 . . . . 0.0 110.049 -178.247 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' E' E ' 103' ' ' LEU . . . . . . . . . . . . . 5.2 mp -121.33 136.8 54.92 Favored 'General case' 0 C--N 1.331 -0.203 0 CA-C-N 115.938 -0.574 . . . . 0.0 110.486 176.456 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' E' E ' 104' ' ' ILE . . . . . . . . . . . . . 68.2 mt -117.56 122.46 69.89 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.297 0 CA-C-N 115.639 -0.71 . . . . 0.0 109.688 -179.551 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' E' E ' 105' ' ' PHE . . . . . . . . . . . . . 55.5 m-85 -123.26 165.76 16.4 Favored 'General case' 0 C--N 1.331 -0.207 0 O-C-N 123.961 0.788 . . . . 0.0 109.455 179.421 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' E' E ' 106' ' ' ASN . . . . . . . . . . . . . 44.0 p-10 -101.65 -171.84 2.05 Favored 'General case' 0 C--N 1.331 -0.225 0 N-CA-C 109.891 -0.411 . . . . 0.0 109.891 173.746 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' E' E ' 107' ' ' GLN . . . . . . . . . . . . . 43.2 tt0 -60.27 -29.88 69.09 Favored 'General case' 0 C--N 1.328 -0.347 0 N-CA-C 111.912 0.338 . . . . 0.0 111.912 179.886 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' E' E ' 108' ' ' ASN . . . . . . . . . . . . . 60.5 t30 -81.9 6.51 15.61 Favored 'General case' 0 CA--C 1.536 0.405 0 N-CA-C 113.278 0.844 . . . . 0.0 113.278 -177.944 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' E' E ' 109' ' ' LEU . . . . . 0.408 HD21 ' HB2' ' E' ' 78' ' ' ALA . 8.8 tp 62.1 36.45 15.23 Favored 'General case' 0 C--O 1.232 0.163 0 CA-C-O 120.966 0.412 . . . . 0.0 111.533 177.905 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' E' E ' 110' ' ' GLU . . . . . . . . . . . . . 70.9 mm-40 -104.26 148.63 26.12 Favored 'General case' 0 C--N 1.329 -0.315 0 N-CA-C 109.807 -0.442 . . . . 0.0 109.807 175.796 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' E' E ' 111' ' ' GLU . . . . . . . . . . . . . 77.3 tt0 -80.22 122.03 26.35 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.429 -0.351 . . . . 0.0 110.971 -176.528 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' E' E ' 112' ' ' LEU . . . . . . . . . . . . . 26.7 mt -105.02 -46.18 4.34 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 116.29 -0.414 . . . . 0.0 110.725 178.596 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' E' E ' 113' ' ' TYR . . . . . . . . . . . . . 64.5 t80 -143.75 139.8 29.61 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.353 -0.385 . . . . 0.0 111.376 -178.875 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' E' E ' 114' ' ' ARG . . . . . . . . . . . . . 60.8 ttp180 -141.07 120.89 13.49 Favored 'General case' 0 C--N 1.33 -0.239 0 CA-C-N 116.274 -0.421 . . . . 0.0 110.165 176.008 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' E' E ' 115' ' ' GLY . . . . . . . . . . . . . . . -150.01 161.7 28.96 Favored Glycine 0 CA--C 1.524 0.652 0 N-CA-C 110.898 -0.881 . . . . 0.0 110.898 178.557 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' E' E ' 116' ' ' LYS . . . . . . . . . . . . . 32.8 ttmt -128.72 139.56 52.16 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-O 120.777 0.322 . . . . 0.0 110.411 179.462 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' E' E ' 117' ' ' PHE . . . . . . . . . . . . . 43.5 m-85 -131.6 115.48 16.14 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.233 -0.44 . . . . 0.0 110.187 -176.949 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' E' E ' 118' ' ' GLU . . . . . . . . . . . . . 96.3 mt-10 -54.64 -46.5 73.95 Favored 'General case' 0 C--N 1.329 -0.299 0 C-N-CA 121.003 -0.279 . . . . 0.0 111.408 -176.004 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' E' E ' 119' ' ' ASN . . . . . . . . . . . . . 28.6 m120 -97.4 31.04 2.63 Favored 'General case' 0 C--N 1.33 -0.269 0 N-CA-C 112.318 0.488 . . . . 0.0 112.318 -174.22 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' E' E ' 120' ' ' LEU . . . . . . . . . . . . . 19.0 tp -55.43 120.82 7.73 Favored 'General case' 0 C--O 1.232 0.175 0 C-N-CA 121.197 -0.201 . . . . 0.0 110.688 178.125 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' E' E ' 121' ' ' ASN . . . . . . . . . . . . . 31.4 m120 -114.04 -44.15 3.18 Favored 'General case' 0 C--N 1.332 -0.195 0 CA-C-N 116.689 -0.232 . . . . 0.0 111.361 -177.321 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' E' E ' 122' ' ' LYS . . . . . . . . . . . . . 93.5 mttt -146.95 154.09 40.85 Favored 'General case' 0 C--N 1.331 -0.222 0 CA-C-O 121.064 0.459 . . . . 0.0 111.895 -176.313 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' E' E ' 123' ' ' VAL . . . . . . . . . . . . . 43.3 t -132.69 133.8 59.07 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.27 0 CA-C-N 115.971 -0.559 . . . . 0.0 110.089 177.142 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' E' E ' 124' ' ' LEU . . . . . . . . . . . . . 54.4 mt -124.17 134.97 53.18 Favored 'General case' 0 C--N 1.33 -0.239 0 CA-C-N 116.591 -0.277 . . . . 0.0 110.545 179.846 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' E' E ' 125' ' ' VAL . . . . . 0.473 HG21 HG21 ' E' ' 87' ' ' ILE . 35.4 m -134.75 135.67 53.07 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.255 0 CA-C-N 116.454 -0.339 . . . . 0.0 110.836 -179.685 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' E' E ' 126' ' ' ARG . . . . . . . . . . . . . 29.9 mtp180 -148.87 124.79 10.61 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-O 121.01 0.433 . . . . 0.0 110.974 175.925 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' E' E ' 127' ' ' ASN . . . . . . . . . . . . . 23.0 t-20 49.92 -106.52 0.22 Allowed 'General case' 0 CA--C 1.543 0.708 0 CA-C-N 116.094 -0.503 . . . . 0.0 111.544 179.066 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' E' E ' 128' ' ' ASP . . . . . . . . . . . . . 23.7 p-10 -114.01 3.26 15.26 Favored 'General case' 0 N--CA 1.467 0.413 0 CA-C-N 119.63 1.105 . . . . 0.0 113.469 -177.014 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' E' E ' 129' ' ' LEU . . . . . . . . . . . . . 15.1 tp -105.23 134.94 47.51 Favored 'General case' 0 C--N 1.334 -0.106 0 N-CA-C 109.876 -0.416 . . . . 0.0 109.876 179.182 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' E' E ' 130' ' ' VAL . . . . . . . . . . . . . 44.6 t -124.29 135.58 63.26 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.246 0 N-CA-C 109.925 -0.398 . . . . 0.0 109.925 -179.532 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' E' E ' 131' ' ' VAL . . . . . 0.446 HG22 HD12 ' E' ' 140' ' ' LEU . 43.4 t -134.01 133.94 55.88 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.262 0 CA-C-O 121.037 0.446 . . . . 0.0 110.094 179.004 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' E' E ' 132' ' ' ILE . . . . . . . . . . . . . 71.0 mt -114.71 132.36 64.12 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.322 0 CA-C-N 115.808 -0.633 . . . . 0.0 109.306 179.36 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' E' E ' 133' ' ' ILE . . . . . . . . . . . . . 39.3 mm -114.93 120.0 63.32 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.231 0 CA-C-O 120.892 0.377 . . . . 0.0 110.954 -174.909 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' E' E ' 134' ' ' ASP . . . . . . . . . . . . . 9.2 p-10 -132.91 145.3 50.8 Favored 'General case' 0 C--N 1.33 -0.25 0 N-CA-C 109.35 -0.611 . . . . 0.0 109.35 174.516 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' E' E ' 135' ' ' GLU . . . . . . . . . . . . . 76.9 tt0 -49.92 -25.72 3.5 Favored 'General case' 0 C--N 1.327 -0.397 0 N-CA-C 112.859 0.688 . . . . 0.0 112.859 -171.304 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' E' E ' 136' ' ' GLN . . . . . . . . . . . . . 44.2 tt0 -82.69 -38.1 23.86 Favored 'General case' 0 C--O 1.233 0.226 0 N-CA-C 112.136 0.421 . . . . 0.0 112.136 -176.172 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' E' E ' 137' ' ' LYS . . . . . . . . . . . . . 18.2 pttp -160.74 169.25 23.14 Favored 'General case' 0 C--O 1.233 0.207 0 CA-C-O 121.451 0.643 . . . . 0.0 112.126 -173.351 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' E' E ' 138' ' ' LEU . . . . . . . . . . . . . 5.9 tt -114.6 127.4 55.76 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 115.221 -0.899 . . . . 0.0 109.63 177.446 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' E' E ' 139' ' ' THR . . . . . . . . . . . . . 23.4 m -105.21 124.03 48.84 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.275 -179.37 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' E' E ' 140' ' ' LEU . . . . . 0.446 HD12 HG22 ' E' ' 131' ' ' VAL . 35.4 tp -110.79 119.94 40.76 Favored 'General case' 0 C--N 1.327 -0.384 0 N-CA-C 109.287 -0.635 . . . . 0.0 109.287 -179.153 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' E' E ' 141' ' ' ILE . . . . . . . . . . . . . 19.3 mt -121.26 117.11 51.73 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.353 0 CA-C-O 121.002 0.43 . . . . 0.0 109.863 -176.211 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' E' E ' 142' ' ' ARG . . . . . . . . . . . . . 73.9 mtp180 -103.76 129.08 51.11 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 115.433 -0.803 . . . . 0.0 110.417 179.653 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' E' E ' 143' ' ' THR . . . . . . . . . . . . . 11.9 p . . . . . 0 C--O 1.219 -0.506 0 CA-C-O 117.997 -1.001 . . . . 0.0 110.531 179.999 . . . . . . . . 0 0 . 1 . 014 nuclear build full ' F' F ' -3' ' ' GLU . . . . . . . . . . . . . 84.2 tt0 . . . . . 0 N--CA 1.49 1.557 0 N-CA-C 109.243 -0.651 . . . . 0.0 109.243 . . . . . . . . . 0 0 . 1 . 014 nuclear build full ' F' F ' -2' ' ' GLY . . . . . . . . . . . . . . . -95.05 149.96 19.53 Favored Glycine 0 CA--C 1.526 0.732 0 N-CA-C 111.488 -0.645 . . . . 0.0 111.488 -177.476 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' F' F ' -1' ' ' VAL . . . . . . . . . . . . . 45.0 t -141.65 139.31 31.76 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.274 0 N-CA-C 109.736 -0.468 . . . . 0.0 109.736 178.684 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' F' F ' 0' ' ' ILE . . . . . . . . . . . . . 71.0 mt -104.4 120.88 55.42 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.253 0 CA-C-O 120.877 0.37 . . . . 0.0 110.048 -179.446 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' F' F ' 1' ' ' MET . . . . . . . . . . . . . 22.4 ptm -145.07 142.39 29.67 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.099 -0.5 . . . . 0.0 110.81 -179.486 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' F' F ' 2' ' ' SER . . . . . . . . . . . . . 3.5 p -121.95 129.07 52.2 Favored 'General case' 0 C--N 1.331 -0.217 0 CA-C-O 120.904 0.383 . . . . 0.0 110.624 178.75 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' F' F ' 3' ' ' GLU . . . . . . . . . . . . . 95.0 mt-10 -140.16 141.43 36.03 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.025 -0.534 . . . . 0.0 111.141 -177.573 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' F' F ' 4' ' ' LEU . . . . . . . . . . . . . 15.5 tp -125.49 126.99 45.76 Favored 'General case' 0 C--N 1.331 -0.225 0 CA-C-N 115.832 -0.622 . . . . 0.0 110.198 176.828 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' F' F ' 5' ' ' LYS . . . . . . . . . . . . . 95.4 mttt -105.35 120.97 42.92 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.412 -0.358 . . . . 0.0 110.812 178.886 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' F' F ' 6' ' ' LEU . . . . . . . . . . . . . 77.6 mt -116.09 150.27 37.61 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-N 115.495 -0.775 . . . . 0.0 110.371 -179.885 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' F' F ' 7' ' ' LYS . . . . . . . . . . . . . 58.3 tttp -140.96 137.87 17.47 Favored Pre-proline 0 CA--C 1.535 0.369 0 CA-C-O 119.025 -0.512 . . . . 0.0 110.26 176.52 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' F' F ' 8' ' ' PRO . . . . . . . . . . . . . 80.9 Cg_endo -91.73 143.76 2.93 Favored 'Trans proline' 0 N--CA 1.491 1.333 0 C-N-CA 121.69 1.593 . . . . 0.0 111.65 177.065 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' F' F ' 9' ' ' LEU . . . . . . . . . . . . . 64.7 mt -76.69 -48.67 2.86 Favored Pre-proline 0 CA--C 1.534 0.33 0 CA-C-O 118.606 -0.712 . . . . 0.0 112.529 -177.796 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' F' F ' 10' ' ' PRO . . . . . . . . . . . . . 83.7 Cg_endo -79.62 147.71 19.92 Favored 'Trans proline' 0 N--CA 1.497 1.729 0 C-N-CA 121.166 1.244 . . . . 0.0 111.627 178.033 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' F' F ' 11' ' ' LYS . . . . . . . . . . . . . 53.5 pttt -79.36 108.85 13.19 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-O 121.778 0.799 . . . . 0.0 110.315 177.563 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' F' F ' 12' ' ' VAL . . . . . . . . . . . . . 11.7 p -148.37 145.25 18.53 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.291 0 CA-C-N 115.425 -0.807 . . . . 0.0 110.12 -179.134 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' F' F ' 13' ' ' GLU . . . . . . . . . . . . . 41.0 tp10 -87.78 123.18 32.31 Favored 'General case' 0 C--N 1.329 -0.312 0 N-CA-C 109.884 -0.413 . . . . 0.0 109.884 179.165 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' F' F ' 14' ' ' LEU . . . . . . . . . . . . . 33.5 mt -98.09 149.08 35.36 Favored Pre-proline 0 CA--C 1.532 0.288 0 CA-C-N 116.404 -0.362 . . . . 0.0 110.644 -177.258 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' F' F ' 15' ' ' PRO . . . . . . . . . . . . . 25.4 Cg_exo -62.62 159.54 36.36 Favored 'Trans proline' 0 N--CA 1.498 1.791 0 C-N-CA 121.25 1.3 . . . . 0.0 111.978 176.86 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' F' F ' 16' ' ' PRO . . . . . . . . . . . . . 27.9 Cg_exo -60.47 -34.83 92.51 Favored 'Trans proline' 0 N--CA 1.496 1.639 0 C-N-CA 121.414 1.409 . . . . 0.0 112.494 -179.659 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' F' F ' 17' ' ' ASP . . . . . . . . . . . . . 22.2 p-10 -88.04 10.79 17.89 Favored 'General case' 0 CA--C 1.535 0.393 0 N-CA-C 113.024 0.75 . . . . 0.0 113.024 -178.431 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' F' F ' 18' ' ' PHE . . . . . . . . . . . . . 30.1 t80 -58.01 -42.01 84.32 Favored 'General case' 0 N--CA 1.457 -0.115 0 O-C-N 121.932 -0.48 . . . . 0.0 110.158 -178.507 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' F' F ' 19' ' ' VAL . . . . . . . . . . . . . 49.1 t -56.35 -42.86 75.61 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.282 0 CA-C-N 116.469 -0.332 . . . . 0.0 110.41 -179.676 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' F' F ' 20' ' ' ASP . . . . . . . . . . . . . 81.7 m-20 -60.15 -43.0 96.08 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.428 -0.351 . . . . 0.0 110.884 -178.049 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' F' F ' 21' ' ' VAL . . . . . . . . . . . . . 48.7 t -64.18 -48.11 87.08 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.309 0 C-N-CA 120.832 -0.347 . . . . 0.0 110.548 -177.39 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' F' F ' 22' ' ' ILE . . . . . 0.572 HG22 HD12 ' F' ' 26' ' ' LEU . 50.1 mm -55.9 -47.44 79.83 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.312 0 C-N-CA 121.036 -0.266 . . . . 0.0 110.74 -179.978 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' F' F ' 23' ' ' ARG . . . . . . . . . . . . . 54.6 ttp180 -55.38 -48.8 73.76 Favored 'General case' 0 C--N 1.33 -0.276 0 C-N-CA 121.038 -0.265 . . . . 0.0 111.337 -178.291 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' F' F ' 24' ' ' ILE . . . . . . . . . . . . . 73.9 mt -58.48 -41.98 83.18 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.281 0 CA-C-O 120.706 0.288 . . . . 0.0 110.799 -177.378 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' F' F ' 25' ' ' LYS . . . . . . . . . . . . . 51.7 mtpt -65.55 -43.66 89.21 Favored 'General case' 0 C--N 1.327 -0.382 0 N-CA-C 112.319 0.489 . . . . 0.0 112.319 -178.697 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' F' F ' 26' ' ' LEU . . . . . 0.572 HD12 HG22 ' F' ' 22' ' ' ILE . 79.5 mt -79.74 -33.2 40.97 Favored 'General case' 0 C--N 1.331 -0.201 0 N-CA-C 113.874 1.064 . . . . 0.0 113.874 -169.549 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' F' F ' 27' ' ' GLN . . . . . . . . . . . . . 17.0 pt20 -46.76 139.42 5.35 Favored 'General case' 0 N--CA 1.469 0.507 0 N-CA-C 113.027 0.751 . . . . 0.0 113.027 -173.497 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' F' F ' 28' ' ' GLY . . . . . . . . . . . . . . . 99.35 -23.61 35.58 Favored Glycine 0 CA--C 1.535 1.292 0 CA-C-N 115.442 -0.799 . . . . 0.0 112.451 -178.962 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' F' F ' 29' ' ' LYS . . . . . . . . . . . . . 61.1 mttp -97.89 155.15 17.2 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 117.527 0.664 . . . . 0.0 111.136 179.682 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' F' F ' 30' ' ' THR . . . . . . . . . . . . . 36.3 m -104.61 137.01 43.09 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 115.931 -0.577 . . . . 0.0 109.852 175.586 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' F' F ' 31' ' ' VAL . . . . . . . . . . . . . 34.9 m -129.64 153.54 38.94 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.21 0 CA-C-O 121.003 0.43 . . . . 0.0 110.953 -178.379 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' F' F ' 32' ' ' ARG . . . . . . . . . . . . . 38.9 ttm180 -133.66 149.41 51.55 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 115.991 -0.549 . . . . 0.0 110.454 -179.991 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' F' F ' 33' ' ' THR . . . . . . . . . . . . . 21.4 m -52.17 138.7 25.27 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.307 -0.406 . . . . 0.0 111.563 -176.17 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' F' F ' 34' ' ' GLY . . . . . . . . . . . . . . . 100.48 -17.1 57.21 Favored Glycine 0 CA--C 1.533 1.209 0 CA-C-O 119.64 -0.533 . . . . 0.0 113.326 178.536 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' F' F ' 35' ' ' ASP . . . . . . . . . . . . . 80.2 m-20 -66.2 147.37 53.42 Favored 'General case' 0 C--N 1.332 -0.155 0 CA-C-N 118.014 0.907 . . . . 0.0 110.953 178.856 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' F' F ' 36' ' ' VAL . . . . . . . . . . . . . 46.3 t -122.32 129.99 74.88 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.197 0 CA-C-N 115.965 -0.561 . . . . 0.0 109.849 178.225 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' F' F ' 37' ' ' ILE . . . . . . . . . . . . . 69.3 mt -121.83 139.93 47.38 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.247 0 CA-C-N 116.194 -0.457 . . . . 0.0 109.955 -179.138 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' F' F ' 38' ' ' GLY . . . . . . . . . . . . . . . -113.64 128.74 8.46 Favored Glycine 0 CA--C 1.526 0.743 0 N-CA-C 111.282 -0.727 . . . . 0.0 111.282 -179.928 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' F' F ' 39' ' ' ILE . . . . . . . . . . . . . 70.0 mt -121.03 134.94 62.8 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.171 0 N-CA-C 109.959 -0.386 . . . . 0.0 109.959 178.269 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' F' F ' 40' ' ' SER . . . . . . . . . . . . . 87.4 p -92.16 120.68 32.97 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 116.422 -0.353 . . . . 0.0 110.62 175.537 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' F' F ' 41' ' ' ILE . . . . . . . . . . . . . 72.2 mt -132.36 117.56 32.45 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.207 0 CA-C-O 120.757 0.313 . . . . 0.0 110.157 178.554 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' F' F ' 42' ' ' LEU . . . . . . . . . . . . . 8.4 tp 57.95 35.85 25.67 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.176 -0.466 . . . . 0.0 111.363 178.515 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' F' F ' 43' ' ' GLY . . . . . . . . . . . . . . . 77.41 -10.08 24.43 Favored Glycine 0 CA--C 1.535 1.326 0 C-N-CA 121.26 -0.495 . . . . 0.0 113.381 177.431 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' F' F ' 44' ' ' LYS . . . . . . . . . . . . . 59.2 tttm -98.28 134.29 41.51 Favored 'General case' 0 C--N 1.333 -0.126 0 CA-C-N 117.996 0.898 . . . . 0.0 109.897 177.905 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' F' F ' 45' ' ' GLU . . . . . . . . . . . . . 82.3 tt0 -84.53 128.14 34.43 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.325 -0.398 . . . . 0.0 110.903 -179.423 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' F' F ' 46' ' ' VAL . . . . . . . . . . . . . 7.3 p -121.87 126.84 75.1 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.211 0 N-CA-C 109.632 -0.507 . . . . 0.0 109.632 175.936 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' F' F ' 47' ' ' LYS . . . . . . . . . . . . . 59.5 mtpt -100.58 128.85 46.5 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 115.895 -0.593 . . . . 0.0 111.24 179.573 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' F' F ' 48' ' ' PHE . . . . . . . . . . . . . 95.8 m-85 -113.28 131.88 55.76 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.279 -0.419 . . . . 0.0 110.064 176.361 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' F' F ' 49' ' ' LYS . . . . . . . . . . . . . 57.0 tttm -108.66 139.69 43.09 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.47 -0.332 . . . . 0.0 110.471 178.326 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' F' F ' 50' ' ' VAL . . . . . . . . . . . . . 45.2 t -82.22 109.18 15.96 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.308 0 N-CA-C 109.137 -0.69 . . . . 0.0 109.137 175.66 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' F' F ' 51' ' ' VAL . . . . . . . . . . . . . 47.0 t -73.5 -48.4 41.48 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.294 0 CA-C-N 116.015 -0.539 . . . . 0.0 110.032 -173.81 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' F' F ' 52' ' ' GLN . . . . . . . . . . . . . 61.4 tt0 -163.82 139.48 6.38 Favored 'General case' 0 C--N 1.33 -0.239 0 C-N-CA 120.264 -0.574 . . . . 0.0 111.817 -177.604 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' F' F ' 53' ' ' ALA . . . . . . . . . . . . . . . -116.63 131.45 56.95 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 115.832 -0.622 . . . . 0.0 110.108 175.839 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' F' F ' 54' ' ' TYR . . . . . . . . . . . . . 69.0 t80 -129.12 110.63 18.22 Favored Pre-proline 0 CA--C 1.534 0.352 0 CA-C-O 118.343 -0.837 . . . . 0.0 110.393 178.959 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' F' F ' 55' ' ' PRO . . . . . . . . . . . . . 73.9 Cg_endo -77.1 170.1 72.53 Favored 'Cis proline' 0 N--CA 1.499 1.831 0 CA-C-N 121.977 1.742 . . . . 0.0 112.292 -5.93 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' F' F ' 56' ' ' SER . . . . . . . . . . . . . 14.3 m -116.16 135.55 22.83 Favored Pre-proline 0 CA--C 1.54 0.571 0 CA-C-O 118.425 -0.798 . . . . 0.0 109.678 176.155 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' F' F ' 57' ' ' PRO . . . . . . . . . . . . . 56.8 Cg_endo -72.47 148.94 92.67 Favored 'Cis proline' 0 N--CA 1.496 1.651 0 CA-C-N 121.694 1.641 . . . . 0.0 111.339 -3.024 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' F' F ' 58' ' ' LEU . . . . . . . . . . . . . 37.7 tp -107.43 137.78 44.85 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-O 120.929 0.395 . . . . 0.0 110.688 -177.096 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' F' F ' 59' ' ' ARG . . . . . . . . . . . . . 61.0 ttt180 -98.92 125.81 44.44 Favored 'General case' 0 C--N 1.325 -0.457 0 CA-C-N 115.783 -0.644 . . . . 0.0 109.292 176.527 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' F' F ' 60' ' ' VAL . . . . . . . . . . . . . 42.0 t -84.34 114.87 25.45 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.246 0 C-N-CA 120.642 -0.423 . . . . 0.0 110.352 -174.975 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' F' F ' 61' ' ' GLU . . . . . . . . . . . . . 41.0 mt-10 -131.16 160.94 33.29 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 115.931 -0.577 . . . . 0.0 109.827 177.329 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' F' F ' 62' ' ' ASP . . . . . . . . . . . . . 74.4 m-20 -53.24 -32.49 48.58 Favored 'General case' 0 C--N 1.329 -0.283 0 N-CA-C 111.858 0.318 . . . . 0.0 111.858 -179.789 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' F' F ' 63' ' ' ARG . . . . . . . . . . . . . 83.1 mtp180 -72.87 -22.03 60.84 Favored 'General case' 0 CA--C 1.533 0.306 0 N-CA-C 112.913 0.708 . . . . 0.0 112.913 -177.048 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' F' F ' 64' ' ' THR . . . . . . . . . . . . . 32.5 m -69.55 142.67 53.57 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-O 120.82 0.343 . . . . 0.0 110.815 -175.455 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' F' F ' 65' ' ' LYS . . . . . . . . . . . . . 97.7 mttt -88.73 123.22 32.95 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.066 -0.515 . . . . 0.0 110.065 179.698 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' F' F ' 66' ' ' ILE . . . . . . . . . . . . . 63.0 mt -113.58 129.35 69.54 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.295 0 N-CA-C 109.702 -0.481 . . . . 0.0 109.702 -179.916 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' F' F ' 67' ' ' THR . . . . . . . . . . . . . 28.1 m -128.26 142.65 51.09 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.144 -0.48 . . . . 0.0 111.082 -177.473 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' F' F ' 68' ' ' LEU . . . . . . . . . . . . . 4.8 tt -103.48 127.16 50.92 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 115.876 -0.602 . . . . 0.0 109.484 177.135 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' F' F ' 69' ' ' VAL . . . . . . . . . . . . . 42.8 t -84.09 129.39 37.68 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.343 0 CA-C-O 121.047 0.451 . . . . 0.0 110.915 -175.225 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' F' F ' 70' ' ' THR . . . . . . . . . . . . . 74.9 p -145.78 -178.29 6.03 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 115.794 -0.639 . . . . 0.0 110.405 178.438 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' F' F ' 71' ' ' HIS . . . . . . . . . . . . . 73.9 m80 -64.92 162.32 38.92 Favored Pre-proline 0 C--N 1.33 -0.279 0 CA-C-N 116.405 -0.361 . . . . 0.0 110.177 178.626 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' F' F ' 72' ' ' PRO . . . . . . . . . . . . . 11.1 Cg_endo -81.07 -30.16 1.76 Allowed 'Trans proline' 0 N--CA 1.491 1.341 0 C-N-CA 121.501 1.467 . . . . 0.0 112.81 -175.051 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' F' F ' 73' ' ' VAL . . . . . . . . . . . . . 29.6 m -150.14 154.26 9.27 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.225 0 CA-C-O 121.203 0.525 . . . . 0.0 111.471 178.618 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' F' F ' 74' ' ' ASP . . . . . . . . . . . . . 10.0 t70 -102.96 119.32 38.64 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 115.441 -0.8 . . . . 0.0 109.503 175.898 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' F' F ' 75' ' ' VAL . . . . . . . . . . . . . 44.9 t -111.13 123.89 67.43 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.217 0 CA-C-O 121.15 0.5 . . . . 0.0 110.556 -177.347 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' F' F ' 76' ' ' LEU . . . . . . . . . . . . . 25.9 mt -125.93 147.37 49.51 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 115.561 -0.745 . . . . 0.0 109.615 178.546 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' F' F ' 77' ' ' GLU . . . . . . . . . . . . . 98.4 mt-10 -136.24 135.6 39.18 Favored 'General case' 0 C--N 1.331 -0.204 0 CA-C-O 121.134 0.493 . . . . 0.0 111.457 -177.318 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' F' F ' 78' ' ' ALA . . . . . 0.658 ' HB2' HD21 ' F' ' 109' ' ' LEU . . . -123.34 129.2 50.98 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 115.493 -0.776 . . . . 0.0 109.699 176.14 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' F' F ' 79' ' ' LYS . . . . . 0.566 ' O ' HD13 ' F' ' 80' ' ' ILE . 96.8 mttt -76.88 119.23 20.36 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-O 120.915 0.388 . . . . 0.0 110.836 -178.585 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' F' F ' 80' ' ' ILE . . . . . 0.566 HD13 ' O ' ' F' ' 79' ' ' LYS . 42.6 mm -139.09 116.68 11.64 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.326 0 N-CA-C 108.781 -0.822 . . . . 0.0 108.781 -178.186 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' F' F ' 81' ' ' LYS . . . . . . . . . . . . . 17.6 ptpt -105.96 127.72 53.34 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-O 121.303 0.573 . . . . 0.0 111.323 -175.696 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' F' F ' 82' ' ' GLY . . . . . . . . . . . . . . . 88.75 42.17 5.8 Favored Glycine 0 CA--C 1.525 0.684 0 CA-C-N 115.725 -0.67 . . . . 0.0 111.838 173.795 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' F' F ' 83' ' ' ILE . . . . . . . . . . . . . 74.6 mt -69.88 140.91 17.86 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.292 0 CA-C-O 121.043 0.449 . . . . 0.0 110.053 179.021 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' F' F ' 84' ' ' LYS . . . . . . . . . . . . . 67.5 tttt -99.75 -53.98 3.04 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 115.868 -0.605 . . . . 0.0 110.204 -178.869 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' F' F ' 85' ' ' ASP . . . . . . . . . . . . . 5.6 t70 -155.38 155.78 34.23 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 115.817 -0.629 . . . . 0.0 110.134 -179.021 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' F' F ' 86' ' ' VAL . . . . . . . . . . . . . 44.3 t -135.6 135.66 51.18 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.238 0 CA-C-O 121.038 0.447 . . . . 0.0 110.806 -178.135 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' F' F ' 87' ' ' ILE . . . . . . . . . . . . . 44.2 mm -119.38 128.5 75.85 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.199 0 CA-C-N 115.708 -0.678 . . . . 0.0 109.466 176.139 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' F' F ' 88' ' ' LEU . . . . . 0.406 HD13 HG21 ' E' ' 131' ' ' VAL . 24.0 tp -111.98 131.51 55.35 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-O 120.89 0.376 . . . . 0.0 110.996 -177.803 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' F' F ' 89' ' ' ASP . . . . . . . . . . . . . 10.0 t70 -126.09 154.05 43.63 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 116.036 -0.529 . . . . 0.0 109.597 176.39 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' F' F ' 90' ' ' GLU . . . . . . . . . . . . . 46.5 tp10 -47.29 -38.36 12.43 Favored 'General case' 0 C--N 1.33 -0.253 0 N-CA-C 112.794 0.665 . . . . 0.0 112.794 -172.394 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' F' F ' 91' ' ' ASN . . . . . . . . . . . . . 15.0 t-20 -132.06 33.34 3.92 Favored 'General case' 0 N--CA 1.466 0.353 0 C-N-CA 120.883 -0.327 . . . . 0.0 111.855 -175.889 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' F' F ' 92' ' ' LEU . . . . . . . . . . . . . 10.1 tp -166.12 148.31 7.01 Favored 'General case' 0 C--N 1.332 -0.169 0 C-N-CA 120.705 -0.398 . . . . 0.0 111.043 179.205 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' F' F ' 93' ' ' ILE . . . . . . . . . . . . . 67.4 mt -125.55 124.49 66.9 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.211 0 N-CA-C 109.588 -0.523 . . . . 0.0 109.588 -179.883 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' F' F ' 94' ' ' VAL . . . . . . . . . . . . . 43.7 t -122.27 126.57 74.45 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.186 0 N-CA-C 109.91 -0.404 . . . . 0.0 109.91 179.466 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' F' F ' 95' ' ' VAL . . . . . . . . . . . . . 46.3 t -123.59 135.0 64.81 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.175 0 CA-C-N 116.338 -0.392 . . . . 0.0 110.103 -179.175 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' F' F ' 96' ' ' ILE . . . . . . . . . . . . . 65.1 mt -116.48 130.64 70.95 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.265 0 N-CA-C 109.38 -0.6 . . . . 0.0 109.38 178.606 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' F' F ' 97' ' ' THR . . . . . . . . . . . . . 81.5 p -101.3 159.86 14.9 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-O 121.039 0.447 . . . . 0.0 111.19 -179.154 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' F' F ' 98' ' ' GLU . . . . . . . . . . . . . 45.1 mt-10 -54.35 -26.32 29.31 Favored 'General case' 0 C--N 1.328 -0.359 0 N-CA-C 112.257 0.465 . . . . 0.0 112.257 -179.497 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' F' F ' 99' ' ' GLU . . . . . . . . . . . . . 14.3 mm-40 -78.53 14.86 1.14 Allowed 'General case' 0 CA--C 1.535 0.366 0 N-CA-C 113.183 0.808 . . . . 0.0 113.183 -178.012 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' F' F ' 100' ' ' ASN . . . . . . . . . . . . . 7.6 m-20 60.13 37.46 20.85 Favored 'General case' 0 CA--C 1.529 0.138 0 CA-C-O 121.019 0.437 . . . . 0.0 111.091 -179.845 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' F' F ' 101' ' ' GLU . . . . . . . . . . . . . 84.7 tt0 -112.04 141.03 46.22 Favored 'General case' 0 C--N 1.331 -0.223 0 CA-C-N 116.023 -0.535 . . . . 0.0 109.659 174.09 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' F' F ' 102' ' ' VAL . . . . . . . . . . . . . 42.8 t -114.98 127.8 72.39 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.293 0 N-CA-C 109.9 -0.408 . . . . 0.0 109.9 -178.848 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' F' F ' 103' ' ' LEU . . . . . 0.488 HD12 ' N ' ' F' ' 103' ' ' LEU . 6.4 mp -117.6 134.48 54.83 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 115.668 -0.696 . . . . 0.0 110.164 176.739 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' F' F ' 104' ' ' ILE . . . . . . . . . . . . . 66.2 mt -117.37 123.87 72.32 Favored 'Isoleucine or valine' 0 C--O 1.233 0.211 0 CA-C-N 116.267 -0.424 . . . . 0.0 109.957 -179.601 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' F' F ' 105' ' ' PHE . . . . . . . . . . . . . 92.3 m-85 -123.25 161.36 24.72 Favored 'General case' 0 C--N 1.332 -0.184 0 O-C-N 123.992 0.808 . . . . 0.0 109.97 -179.548 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' F' F ' 106' ' ' ASN . . . . . . . . . . . . . 44.3 p-10 -99.42 -171.74 2.13 Favored 'General case' 0 C--N 1.33 -0.277 0 N-CA-C 110.209 -0.293 . . . . 0.0 110.209 175.266 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' F' F ' 107' ' ' GLN . . . . . . . . . . . . . 50.7 tt0 -58.87 -28.21 65.92 Favored 'General case' 0 C--N 1.329 -0.316 0 N-CA-C 112.176 0.436 . . . . 0.0 112.176 179.7 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' F' F ' 108' ' ' ASN . . . . . . . . . . . . . 2.7 t-20 -85.63 7.75 22.11 Favored 'General case' 0 CA--C 1.538 0.486 0 N-CA-C 113.252 0.834 . . . . 0.0 113.252 -176.857 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' F' F ' 109' ' ' LEU . . . . . 0.658 HD21 ' HB2' ' F' ' 78' ' ' ALA . 11.7 tp 59.94 38.13 21.15 Favored 'General case' 0 CA--C 1.53 0.181 0 CA-C-O 121.086 0.47 . . . . 0.0 111.166 178.984 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' F' F ' 110' ' ' GLU . . . . . . . . . . . . . 95.7 mt-10 -108.22 148.76 29.5 Favored 'General case' 0 C--N 1.33 -0.267 0 N-CA-C 109.73 -0.47 . . . . 0.0 109.73 175.274 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' F' F ' 111' ' ' GLU . . . . . . . . . . . . . 60.0 tt0 -83.51 121.88 27.8 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-O 120.774 0.321 . . . . 0.0 110.725 -175.763 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' F' F ' 112' ' ' LEU . . . . . . . . . . . . . 27.7 mt -106.92 -46.05 4.03 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.1 -0.5 . . . . 0.0 110.814 179.673 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' F' F ' 113' ' ' TYR . . . . . . . . . . . . . 60.1 t80 -134.86 141.88 46.47 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 116.437 -0.347 . . . . 0.0 111.229 -178.227 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' F' F ' 114' ' ' ARG . . . . . . . . . . . . . 36.9 ptt180 -146.61 121.05 9.66 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.738 178.12 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' F' F ' 115' ' ' GLY . . . . . . . . . . . . . . . -150.12 149.75 21.69 Favored Glycine 0 CA--C 1.526 0.744 0 N-CA-C 111.203 -0.759 . . . . 0.0 111.203 178.332 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' F' F ' 116' ' ' LYS . . . . . . . . . . . . . 35.1 ttmt -115.35 136.77 52.75 Favored 'General case' 0 C--N 1.331 -0.233 0 N-CA-C 110.133 -0.321 . . . . 0.0 110.133 176.678 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' F' F ' 117' ' ' PHE . . . . . . . . . . . . . 44.1 m-85 -132.35 114.52 14.48 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-O 120.974 0.416 . . . . 0.0 110.137 -177.344 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' F' F ' 118' ' ' GLU . . . . . . . . . . . . . 96.2 mt-10 -53.97 -46.94 71.8 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.336 -0.393 . . . . 0.0 111.427 -175.775 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' F' F ' 119' ' ' ASN . . . . . . . . . . . . . 28.6 m120 -94.43 31.06 1.81 Allowed 'General case' 0 C--N 1.328 -0.342 0 N-CA-C 112.165 0.432 . . . . 0.0 112.165 -174.334 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' F' F ' 120' ' ' LEU . . . . . . . . . . . . . 16.0 tp -57.35 119.98 7.39 Favored 'General case' 0 C--N 1.332 -0.169 0 N-CA-C 110.175 -0.305 . . . . 0.0 110.175 177.657 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' F' F ' 121' ' ' ASN . . . . . . . . . . . . . 81.2 m-20 -114.1 -44.08 3.17 Favored 'General case' 0 C--O 1.233 0.223 0 CA-C-N 116.365 -0.379 . . . . 0.0 111.026 -178.419 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' F' F ' 122' ' ' LYS . . . . . . . . . . . . . 98.4 mttt -145.77 149.55 34.57 Favored 'General case' 0 C--N 1.333 -0.128 0 CA-C-O 121.092 0.472 . . . . 0.0 111.856 -178.319 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' F' F ' 123' ' ' VAL . . . . . . . . . . . . . 46.8 t -124.92 126.66 71.64 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.211 0 CA-C-N 115.694 -0.684 . . . . 0.0 109.497 175.043 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' F' F ' 124' ' ' LEU . . . . . 0.42 HD12 ' N ' ' F' ' 124' ' ' LEU . 6.2 mp -117.88 133.94 55.43 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.473 -0.331 . . . . 0.0 110.434 -179.314 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' F' F ' 125' ' ' VAL . . . . . . . . . . . . . 12.0 p -133.77 135.91 54.74 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.285 0 CA-C-N 116.233 -0.44 . . . . 0.0 110.522 -179.875 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' F' F ' 126' ' ' ARG . . . . . . . . . . . . . 95.9 mtt-85 -143.31 116.88 9.17 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.115 -0.493 . . . . 0.0 110.267 177.716 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' F' F ' 127' ' ' ASN . . . . . . . . . . . . . 64.3 t30 52.56 -104.98 0.21 Allowed 'General case' 0 CA--C 1.544 0.744 0 CA-C-O 118.986 -0.53 . . . . 0.0 111.357 179.74 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' F' F ' 128' ' ' ASP . . . . . . . . . . . . . 8.6 p-10 -114.08 4.43 15.64 Favored 'General case' 0 CA--C 1.537 0.463 0 CA-C-N 119.526 1.057 . . . . 0.0 113.547 -176.623 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' F' F ' 129' ' ' LEU . . . . . . . . . . . . . 14.6 tp -107.37 139.0 42.53 Favored 'General case' 0 C--N 1.332 -0.173 0 CA-C-N 118.207 0.458 . . . . 0.0 110.292 179.693 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' F' F ' 130' ' ' VAL . . . . . . . . . . . . . 41.3 t -126.71 137.14 58.73 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.233 0 CA-C-O 120.942 0.401 . . . . 0.0 110.424 -178.339 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' F' F ' 131' ' ' VAL . . . . . . . . . . . . . 43.0 t -136.02 136.46 49.63 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.271 0 CA-C-N 116.239 -0.437 . . . . 0.0 110.198 176.916 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' F' F ' 132' ' ' ILE . . . . . . . . . . . . . 77.5 mt -116.57 133.16 64.07 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.257 0 CA-C-N 115.908 -0.587 . . . . 0.0 109.605 -179.071 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' F' F ' 133' ' ' ILE . . . . . . . . . . . . . 41.2 mm -116.53 125.26 73.44 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.249 0 CA-C-N 116.377 -0.374 . . . . 0.0 111.112 -174.66 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' F' F ' 134' ' ' ASP . . . . . . . . . . . . . 11.7 p-10 -139.02 151.6 46.94 Favored 'General case' 0 C--N 1.333 -0.135 0 CA-C-N 116.198 -0.455 . . . . 0.0 109.912 174.037 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' F' F ' 135' ' ' GLU . . . . . . . . . . . . . 84.8 tt0 -50.82 -27.94 8.39 Favored 'General case' 0 C--N 1.33 -0.267 0 N-CA-C 112.862 0.69 . . . . 0.0 112.862 -172.513 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' F' F ' 136' ' ' GLN . . . . . . . . . . . . . 96.9 mt-30 -84.9 -30.02 24.73 Favored 'General case' 0 C--N 1.329 -0.291 0 N-CA-C 112.63 0.604 . . . . 0.0 112.63 -174.663 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' F' F ' 137' ' ' LYS . . . . . . . . . . . . . 56.7 pttt -169.08 173.16 7.01 Favored 'General case' 0 C--O 1.233 0.212 0 CA-C-O 121.683 0.754 . . . . 0.0 112.672 -170.267 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' F' F ' 138' ' ' LEU . . . . . 0.46 HD23 ' N ' ' F' ' 139' ' ' THR . 4.7 tt -121.73 128.9 52.29 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 114.77 -1.105 . . . . 0.0 109.673 178.862 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' F' F ' 139' ' ' THR . . . . . 0.46 ' N ' HD23 ' F' ' 138' ' ' LEU . 42.1 m -111.71 126.09 54.67 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.443 -0.344 . . . . 0.0 110.146 179.402 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' F' F ' 140' ' ' LEU . . . . . 0.471 HD23 ' C ' ' F' ' 140' ' ' LEU . 6.3 tt -113.0 124.14 51.94 Favored 'General case' 0 C--N 1.329 -0.291 0 N-CA-C 109.579 -0.526 . . . . 0.0 109.579 -178.625 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' F' F ' 141' ' ' ILE . . . . . 0.433 ' N ' HD23 ' F' ' 140' ' ' LEU . 19.4 mt -122.55 120.42 60.91 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.309 0 CA-C-O 121.014 0.435 . . . . 0.0 110.049 -175.128 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' F' F ' 142' ' ' ARG . . . . . . . . . . . . . 67.7 ttt180 -111.4 126.97 55.5 Favored 'General case' 0 C--N 1.332 -0.17 0 CA-C-N 115.376 -0.829 . . . . 0.0 110.492 -177.114 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' F' F ' 143' ' ' THR . . . . . . . . . . . . . 56.0 p . . . . . 0 C--O 1.219 -0.52 0 CA-C-O 118.12 -0.943 . . . . 0.0 110.623 179.921 . . . . . . . . 0 0 . 1 . 015 nuclear build full ' A' A ' -3' ' ' GLU . . . . . . . . . . . . . 96.2 mt-10 . . . . . 0 N--CA 1.489 1.519 0 N-CA-C 109.52 -0.548 . . . . 0.0 109.52 . . . . . . . . . 0 0 . 1 . 015 nuclear build full ' A' A ' -2' ' ' GLY . . . . . . . . . . . . . . . -71.97 150.03 45.37 Favored Glycine 0 CA--C 1.524 0.614 0 N-CA-C 110.733 -0.947 . . . . 0.0 110.733 178.581 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' -1' ' ' VAL . . . . . . . . . . . . . 44.3 t -89.86 129.19 41.17 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.318 0 CA-C-O 120.921 0.391 . . . . 0.0 110.036 -179.085 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 0' ' ' ILE . . . . . . . . . . . . . 74.2 mt -119.5 131.3 72.49 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.25 0 CA-C-N 116.023 -0.535 . . . . 0.0 109.804 179.79 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 25.5 ptp -83.01 140.87 32.47 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.319 -0.4 . . . . 0.0 110.661 -179.704 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 40.9 p -115.56 141.17 48.42 Favored 'General case' 0 C--N 1.331 -0.218 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.384 179.466 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 95.2 mt-10 -141.32 140.56 33.83 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.194 -0.457 . . . . 0.0 111.355 -177.861 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 4' ' ' LEU . . . . . . . . . . . . . 75.9 mt -121.82 128.38 51.6 Favored 'General case' 0 C--O 1.233 0.226 0 CA-C-N 115.951 -0.568 . . . . 0.0 110.17 174.884 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 5' ' ' LYS . . . . . . . . . . . . . 68.5 mttm -107.55 122.15 46.09 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.451 -0.341 . . . . 0.0 110.259 177.769 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 6' ' ' LEU . . . . . 0.422 HD23 ' HA ' ' A' ' 50' ' ' VAL . 70.5 mt -118.14 144.29 45.8 Favored 'General case' 0 C--N 1.331 -0.224 0 CA-C-N 115.769 -0.65 . . . . 0.0 110.287 -179.105 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 59.3 tttm -121.64 135.13 24.89 Favored Pre-proline 0 CA--C 1.534 0.363 0 CA-C-O 118.675 -0.679 . . . . 0.0 109.603 175.475 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 8' ' ' PRO . . . . . . . . . . . . . 84.9 Cg_endo -90.04 131.79 1.86 Allowed 'Trans proline' 0 N--CA 1.488 1.176 0 C-N-CA 121.605 1.537 . . . . 0.0 111.735 178.054 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 28.2 mt -73.65 -47.4 7.06 Favored Pre-proline 0 CA--C 1.535 0.384 0 CA-C-O 118.604 -0.712 . . . . 0.0 111.972 -179.072 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 95.5 Cg_endo -79.76 151.04 21.66 Favored 'Trans proline' 0 N--CA 1.497 1.697 0 C-N-CA 121.056 1.171 . . . . 0.0 111.873 176.049 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 19.2 ttpp -85.65 107.06 17.37 Favored 'General case' 0 C--N 1.33 -0.27 0 C-N-CA 120.885 -0.326 . . . . 0.0 110.31 178.895 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 12.0 p -149.22 147.68 16.34 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.323 0 CA-C-N 116.352 -0.385 . . . . 0.0 110.805 -179.153 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 94.7 mt-10 -95.75 110.05 22.26 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.087 -0.506 . . . . 0.0 109.668 175.843 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 14' ' ' LEU . . . . . . . . . . . . . 51.2 mt -86.54 148.78 47.39 Favored Pre-proline 0 CA--C 1.533 0.307 0 CA-C-O 119.303 -0.379 . . . . 0.0 110.481 -176.793 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 15' ' ' PRO . . . . . . . . . . . . . 28.6 Cg_exo -61.03 159.57 29.28 Favored 'Trans proline' 0 N--CA 1.497 1.685 0 C-N-CA 121.269 1.313 . . . . 0.0 111.738 177.263 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 16' ' ' PRO . . . . . . . . . . . . . 32.7 Cg_exo -59.75 -35.89 93.14 Favored 'Trans proline' 0 N--CA 1.498 1.74 0 C-N-CA 121.374 1.383 . . . . 0.0 112.692 -178.736 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 17' ' ' ASP . . . . . . . . . . . . . 8.5 p-10 -84.03 4.85 28.14 Favored 'General case' 0 CA--C 1.536 0.423 0 N-CA-C 113.26 0.837 . . . . 0.0 113.26 -177.959 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 18' ' ' PHE . . . . . . . . . . . . . 40.2 t80 -58.47 -46.03 87.43 Favored 'General case' 0 N--CA 1.456 -0.145 0 O-C-N 121.912 -0.493 . . . . 0.0 109.978 -178.699 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 19' ' ' VAL . . . . . . . . . . . . . 47.9 t -57.12 -41.22 77.3 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.368 0 CA-C-N 116.236 -0.438 . . . . 0.0 110.479 -177.743 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 74.9 m-20 -60.34 -45.16 94.43 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-O 120.756 0.313 . . . . 0.0 111.043 -177.356 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 46.5 t -64.98 -46.46 91.52 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.276 0 C-N-CA 120.692 -0.403 . . . . 0.0 110.436 -177.761 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 22' ' ' ILE . . . . . . . . . . . . . 51.6 mm -57.32 -42.36 80.16 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.218 0 CA-C-O 120.899 0.38 . . . . 0.0 110.362 178.389 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 23' ' ' ARG . . . . . . . . . . . . . 59.7 ttp180 -53.71 -49.17 68.67 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-O 120.794 0.33 . . . . 0.0 111.278 -179.223 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 24' ' ' ILE . . . . . . . . . . . . . 70.2 mt -60.67 -41.48 88.33 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.255 0 CA-C-N 116.497 -0.32 . . . . 0.0 110.935 -179.488 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 52.9 mmtt -63.15 -37.4 87.07 Favored 'General case' 0 C--N 1.329 -0.314 0 N-CA-C 112.073 0.397 . . . . 0.0 112.073 179.239 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 58.9 mt -79.06 -42.4 26.51 Favored 'General case' 0 C--N 1.329 -0.297 0 N-CA-C 113.347 0.869 . . . . 0.0 113.347 -172.125 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 27' ' ' GLN . . . . . . . . . . . . . 10.3 pt20 -47.37 140.68 5.42 Favored 'General case' 0 N--CA 1.47 0.545 0 N-CA-C 112.716 0.636 . . . . 0.0 112.716 -174.735 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 98.09 -25.21 28.55 Favored Glycine 0 CA--C 1.532 1.147 0 CA-C-N 115.541 -0.754 . . . . 0.0 112.398 -178.627 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 69.1 mttm -97.73 155.11 17.17 Favored 'General case' 0 C--N 1.332 -0.181 0 CA-C-N 117.397 0.598 . . . . 0.0 110.81 179.375 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 30' ' ' THR . . . . . . . . . . . . . 33.1 m -102.96 137.53 41.03 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.242 -0.435 . . . . 0.0 110.076 177.297 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 35.0 m -126.67 151.4 33.28 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.251 0 CA-C-N 116.325 -0.398 . . . . 0.0 110.97 -178.998 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 32' ' ' ARG . . . . . . . . . . . . . 62.0 mtt85 -133.26 148.71 51.97 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 115.665 -0.698 . . . . 0.0 110.202 176.645 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 33' ' ' THR . . . . . . . . . . . . . 21.5 m -53.4 138.24 33.59 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-O 120.86 0.362 . . . . 0.0 111.372 -177.644 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 101.0 -17.05 56.79 Favored Glycine 0 CA--C 1.533 1.165 0 CA-C-O 119.656 -0.525 . . . . 0.0 113.359 178.587 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 80.3 m-20 -66.5 150.03 49.57 Favored 'General case' 0 N--CA 1.463 0.202 0 CA-C-N 118.043 0.922 . . . . 0.0 111.359 179.592 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 46.2 t -122.58 129.59 75.11 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.236 0 CA-C-N 116.029 -0.532 . . . . 0.0 109.852 177.524 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 37' ' ' ILE . . . . . . . . . . . . . 62.1 mt -122.08 139.83 47.87 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.235 0 CA-C-N 116.228 -0.442 . . . . 0.0 109.962 -178.495 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . -117.01 128.3 7.82 Favored Glycine 0 CA--C 1.524 0.605 0 N-CA-C 110.89 -0.884 . . . . 0.0 110.89 178.284 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 39' ' ' ILE . . . . . . . . . . . . . 75.6 mt -127.25 132.46 69.58 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.29 0 CA-C-O 120.765 0.317 . . . . 0.0 110.199 179.754 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 40' ' ' SER . . . . . . . . . . . . . 13.0 t -93.04 122.18 35.14 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.304 -0.407 . . . . 0.0 110.923 176.419 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 41' ' ' ILE . . . . . 0.492 HD12 ' N ' ' A' ' 41' ' ' ILE . 5.1 mp -128.72 120.83 53.37 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.232 0 N-CA-C 109.902 -0.407 . . . . 0.0 109.902 176.728 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 6.8 mp 56.62 35.42 26.07 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-O 121.088 0.47 . . . . 0.0 111.203 -179.704 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . 80.14 -10.14 43.27 Favored Glycine 0 CA--C 1.533 1.198 0 C-N-CA 121.255 -0.498 . . . . 0.0 113.538 176.169 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 44' ' ' LYS . . . . . . . . . . . . . 61.7 mttp -99.68 131.25 45.79 Favored 'General case' 0 C--O 1.23 0.049 0 CA-C-N 117.891 0.846 . . . . 0.0 110.207 178.419 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 83.0 tt0 -85.57 131.06 34.43 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.371 -0.377 . . . . 0.0 111.301 -178.989 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 46' ' ' VAL . . . . . 0.405 ' O ' HG13 ' A' ' 46' ' ' VAL . 10.0 p -123.09 125.06 71.51 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.167 0 N-CA-C 109.565 -0.531 . . . . 0.0 109.565 173.786 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 66.6 mttm -99.28 127.07 45.23 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.133 -0.485 . . . . 0.0 111.042 177.856 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 48' ' ' PHE . . . . . . . . . . . . . 39.4 m-85 -112.68 131.81 55.47 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 115.918 -0.583 . . . . 0.0 110.004 178.656 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 77.8 tttt -106.4 132.36 52.52 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.471 -0.331 . . . . 0.0 110.231 178.204 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 50' ' ' VAL . . . . . 0.422 ' HA ' HD23 ' A' ' 6' ' ' LEU . 45.3 t -75.63 105.16 4.34 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.244 0 N-CA-C 109.401 -0.592 . . . . 0.0 109.401 178.002 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 51' ' ' VAL . . . . . . . . . . . . . 48.5 t -69.73 -49.64 56.29 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 N-CA-C 109.751 -0.463 . . . . 0.0 109.751 -175.035 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 52' ' ' GLN . . . . . . . . . . . . . 62.7 tt0 -167.01 147.42 5.61 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 115.971 -0.559 . . . . 0.0 111.498 -178.718 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -123.11 134.99 54.19 Favored 'General case' 0 C--N 1.332 -0.19 0 CA-C-N 116.035 -0.53 . . . . 0.0 109.972 176.884 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 54' ' ' TYR . . . . . . . . . . . . . 64.0 t80 -129.11 113.88 18.58 Favored Pre-proline 0 CA--C 1.535 0.375 0 CA-C-O 118.103 -0.951 . . . . 0.0 110.246 178.443 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 55' ' ' PRO . . . . . . . . . . . . . 72.8 Cg_endo -77.16 170.15 72.31 Favored 'Cis proline' 0 N--CA 1.501 1.956 0 CA-C-N 122.154 1.805 . . . . 0.0 111.842 -8.476 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 56' ' ' SER . . . . . . . . . . . . . 14.7 m -123.67 141.91 37.8 Favored Pre-proline 0 CA--C 1.538 0.51 0 CA-C-O 118.755 -0.641 . . . . 0.0 109.81 175.483 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 57' ' ' PRO . . . . . . . . . . . . . 37.1 Cg_endo -67.27 158.39 82.78 Favored 'Cis proline' 0 N--CA 1.5 1.892 0 CA-C-N 121.466 1.559 . . . . 0.0 111.179 -5.023 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 58' ' ' LEU . . . . . . . . . . . . . 27.9 tp -128.44 137.19 51.71 Favored 'General case' 0 C--N 1.331 -0.223 0 CA-C-O 120.833 0.349 . . . . 0.0 110.808 -178.201 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 59' ' ' ARG . . . . . . . . . . . . . 57.2 ttp180 -100.34 122.92 43.88 Favored 'General case' 0 C--N 1.328 -0.357 0 N-CA-C 108.919 -0.771 . . . . 0.0 108.919 173.613 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 40.1 t -70.25 124.62 26.74 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.327 0 C-N-CA 120.718 -0.393 . . . . 0.0 110.396 -174.21 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 42.9 mt-10 -131.04 160.69 33.88 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 115.851 -0.613 . . . . 0.0 109.907 176.798 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 62' ' ' ASP . . . . . . . . . . . . . 70.6 m-20 -52.36 -31.72 35.0 Favored 'General case' 0 CA--C 1.533 0.314 0 N-CA-C 111.957 0.355 . . . . 0.0 111.957 179.137 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 63' ' ' ARG . . . . . . . . . . . . . 79.3 mtp180 -71.41 -21.74 61.95 Favored 'General case' 0 CA--C 1.532 0.281 0 N-CA-C 113.026 0.75 . . . . 0.0 113.026 -175.5 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 19.4 m -70.81 140.56 51.25 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-O 120.948 0.404 . . . . 0.0 111.288 -173.786 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 65' ' ' LYS . . . . . . . . . . . . . 97.8 mttt -89.24 136.7 32.88 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-N 115.936 -0.575 . . . . 0.0 109.972 177.407 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 66' ' ' ILE . . . . . . . . . . . . . 65.4 mt -123.02 128.8 75.27 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.264 0 N-CA-C 110.009 -0.367 . . . . 0.0 110.009 -178.575 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 67' ' ' THR . . . . . . . . . . . . . 9.3 m -124.04 144.24 49.96 Favored 'General case' 0 N--CA 1.463 0.213 0 CA-C-O 120.951 0.405 . . . . 0.0 111.421 -176.224 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 68' ' ' LEU . . . . . 0.458 HD23 ' C ' ' A' ' 68' ' ' LEU . 5.9 tt -104.56 123.95 48.44 Favored 'General case' 0 C--N 1.332 -0.158 0 CA-C-N 116.041 -0.527 . . . . 0.0 110.283 178.83 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 69' ' ' VAL . . . . . 0.425 ' N ' HD23 ' A' ' 68' ' ' LEU . 41.9 t -104.47 142.23 18.33 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.277 0 CA-C-O 121.021 0.439 . . . . 0.0 111.163 -177.549 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 70' ' ' THR . . . . . . . . . . . . . 7.4 p -130.1 173.6 10.59 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-N 115.814 -0.63 . . . . 0.0 109.505 174.926 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 71' ' ' HIS . . . . . . . . . . . . . 61.2 t-80 -120.17 61.06 7.6 Favored Pre-proline 0 CA--C 1.538 0.483 0 N-CA-C 112.247 0.462 . . . . 0.0 112.247 -176.608 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 72' ' ' PRO . . . . . . . . . . . . . 62.0 Cg_endo -91.9 156.89 3.37 Favored 'Trans proline' 0 N--CA 1.491 1.381 0 C-N-CA 121.762 1.641 . . . . 0.0 111.102 168.137 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 73' ' ' VAL . . . . . . . . . . . . . 35.4 m -71.88 141.91 16.03 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.175 0 C-N-CA 120.562 -0.455 . . . . 0.0 110.332 177.946 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 74' ' ' ASP . . . . . . . . . . . . . 17.9 t0 -97.68 124.89 42.17 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 115.867 -0.606 . . . . 0.0 109.744 179.712 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 75' ' ' VAL . . . . . 0.408 ' C ' HD12 ' A' ' 76' ' ' LEU . 40.6 t -115.75 124.48 72.21 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.311 0 CA-C-O 121.061 0.458 . . . . 0.0 110.682 -176.163 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 76' ' ' LEU . . . . . 0.408 HD12 ' C ' ' A' ' 75' ' ' VAL . 6.4 mp -122.43 142.72 50.25 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-N 115.848 -0.615 . . . . 0.0 110.007 176.358 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 77' ' ' GLU . . . . . . . . . . . . . 96.8 mt-10 -134.38 143.12 47.44 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-O 121.097 0.475 . . . . 0.0 111.242 179.739 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 78' ' ' ALA . . . . . . . . . . . . . . . -129.83 145.17 51.59 Favored 'General case' 0 C--N 1.332 -0.185 0 CA-C-N 115.712 -0.676 . . . . 0.0 109.997 176.492 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 79' ' ' LYS . . . . . 0.676 ' O ' HD13 ' A' ' 80' ' ' ILE . 33.8 mmtm -77.39 116.7 18.2 Favored 'General case' 0 C--N 1.331 -0.219 0 CA-C-N 116.374 -0.375 . . . . 0.0 110.405 179.538 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 80' ' ' ILE . . . . . 0.676 HD13 ' O ' ' A' ' 79' ' ' LYS . 35.3 mm -139.11 106.78 3.04 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.251 0 N-CA-C 109.26 -0.644 . . . . 0.0 109.26 -178.243 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 81' ' ' LYS . . . . . . . . . . . . . 38.7 tttp -109.77 130.93 55.47 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-O 120.971 0.415 . . . . 0.0 111.104 -177.135 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . 88.99 42.07 5.73 Favored Glycine 0 CA--C 1.525 0.689 0 C-N-CA 121.03 -0.605 . . . . 0.0 111.66 175.336 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 83' ' ' ILE . . . . . . . . . . . . . 67.9 mt -74.02 137.1 23.9 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.265 0 N-CA-C 110.007 -0.368 . . . . 0.0 110.007 179.307 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 84' ' ' LYS . . . . . . . . . . . . . 58.0 tttp -96.26 -52.88 3.82 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-N 116.007 -0.542 . . . . 0.0 109.875 179.035 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 85' ' ' ASP . . . . . . . . . . . . . 4.0 t70 -155.67 157.26 36.37 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 115.871 -0.604 . . . . 0.0 110.593 -179.101 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 86' ' ' VAL . . . . . . . . . . . . . 45.2 t -132.37 135.89 57.16 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.204 0 CA-C-O 120.994 0.426 . . . . 0.0 110.408 179.856 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 87' ' ' ILE . . . . . . . . . . . . . 42.3 mm -116.16 123.14 71.03 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.356 0 N-CA-C 109.161 -0.681 . . . . 0.0 109.161 176.968 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 88' ' ' LEU . . . . . . . . . . . . . 14.0 tp -109.61 130.47 55.51 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-O 121.075 0.464 . . . . 0.0 110.956 -176.597 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 89' ' ' ASP . . . . . . . . . . . . . 10.9 t70 -128.95 154.86 46.16 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-N 115.87 -0.604 . . . . 0.0 109.489 177.162 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 76.2 tt0 -48.22 -35.58 12.17 Favored 'General case' 0 C--N 1.329 -0.307 0 N-CA-C 112.808 0.669 . . . . 0.0 112.808 -172.444 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 91' ' ' ASN . . . . . . . . . . . . . 94.5 m-20 -128.43 18.3 6.4 Favored 'General case' 0 N--CA 1.469 0.487 0 N-CA-C 113.127 0.788 . . . . 0.0 113.127 -176.519 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 92' ' ' LEU . . . . . . . . . . . . . 28.5 mt -149.66 147.48 28.15 Favored 'General case' 0 C--N 1.331 -0.226 0 CA-C-O 121.0 0.429 . . . . 0.0 110.752 -177.637 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 93' ' ' ILE . . . . . . . . . . . . . 65.7 mt -127.0 113.48 32.86 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.315 0 N-CA-C 108.892 -0.781 . . . . 0.0 108.892 177.284 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 94' ' ' VAL . . . . . . . . . . . . . 45.4 t -116.08 129.42 72.5 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.241 0 N-CA-C 110.044 -0.354 . . . . 0.0 110.044 -177.93 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 95' ' ' VAL . . . . . . . . . . . . . 41.4 t -122.74 135.17 63.69 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.388 0 CA-C-N 116.111 -0.495 . . . . 0.0 110.078 -178.338 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 96' ' ' ILE . . . . . . . . . . . . . 66.0 mt -115.62 128.61 72.8 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.271 0 N-CA-C 109.364 -0.606 . . . . 0.0 109.364 178.278 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 97' ' ' THR . . . . . . . . . . . . . 79.0 p -102.43 159.51 15.36 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-O 121.132 0.492 . . . . 0.0 111.386 -177.675 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 98' ' ' GLU . . . . . . . . . . . . . 45.6 mt-10 -54.06 -25.88 23.86 Favored 'General case' 0 CA--C 1.532 0.264 0 N-CA-C 112.335 0.494 . . . . 0.0 112.335 179.736 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 99' ' ' GLU . . . . . . . . . . . . . 95.8 mt-10 -77.84 13.48 1.35 Allowed 'General case' 0 CA--C 1.535 0.37 0 N-CA-C 113.167 0.803 . . . . 0.0 113.167 -178.048 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 100' ' ' ASN . . . . . . . . . . . . . 3.3 m-20 60.87 36.59 18.93 Favored 'General case' 0 CA--C 1.529 0.173 0 CA-C-O 120.956 0.408 . . . . 0.0 110.998 -179.833 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 101' ' ' GLU . . . . . . . . . . . . . 82.9 tt0 -113.59 143.22 44.92 Favored 'General case' 0 C--N 1.332 -0.178 0 N-CA-C 109.381 -0.6 . . . . 0.0 109.381 176.348 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 102' ' ' VAL . . . . . . . . . . . . . 43.1 t -115.29 125.74 72.64 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.356 0 CA-C-O 120.909 0.385 . . . . 0.0 109.996 -177.625 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 103' ' ' LEU . . . . . . . . . . . . . 23.4 mt -114.15 130.92 56.59 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 115.518 -0.764 . . . . 0.0 109.966 176.667 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 104' ' ' ILE . . . . . 0.521 HD12 ' HB3' ' A' ' 113' ' ' TYR . 67.8 mt -119.37 118.84 58.77 Favored 'Isoleucine or valine' 0 C--O 1.234 0.27 0 N-CA-C 110.118 -0.327 . . . . 0.0 110.118 -179.846 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 105' ' ' PHE . . . . . . . . . . . . . 79.7 m-85 -117.98 164.07 15.64 Favored 'General case' 0 C--N 1.332 -0.182 0 O-C-N 123.979 0.799 . . . . 0.0 109.604 178.04 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 106' ' ' ASN . . . . . . . . . . . . . 44.2 p-10 -101.11 -170.49 1.85 Allowed 'General case' 0 C--N 1.331 -0.22 0 N-CA-C 109.992 -0.373 . . . . 0.0 109.992 173.652 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 107' ' ' GLN . . . . . . . . . . . . . 57.9 tt0 -57.43 -29.99 64.61 Favored 'General case' 0 CA--C 1.534 0.36 0 N-CA-C 111.839 0.311 . . . . 0.0 111.839 178.673 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 108' ' ' ASN . . . . . . . . . . . . . 60.3 t30 -83.94 7.42 18.37 Favored 'General case' 0 CA--C 1.536 0.434 0 N-CA-C 113.373 0.879 . . . . 0.0 113.373 -176.515 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 109' ' ' LEU . . . . . . . . . . . . . 11.2 tp 60.32 37.38 20.3 Favored 'General case' 0 CA--C 1.53 0.194 0 CA-C-O 120.955 0.407 . . . . 0.0 111.208 179.434 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 110' ' ' GLU . . . . . . . . . . . . . 70.8 mm-40 -106.88 160.95 15.13 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 116.466 -0.334 . . . . 0.0 110.169 177.85 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 111' ' ' GLU . . . . . . . . . . . . . 83.0 tt0 -85.31 122.75 29.92 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.312 -0.404 . . . . 0.0 110.801 -178.15 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 112' ' ' LEU . . . . . . . . . . . . . 17.0 mt -111.19 -46.11 3.35 Favored 'General case' 0 C--N 1.332 -0.189 0 CA-C-N 116.223 -0.444 . . . . 0.0 110.566 177.176 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 113' ' ' TYR . . . . . 0.521 ' HB3' HD12 ' A' ' 104' ' ' ILE . 46.8 t80 -141.67 139.71 33.05 Favored 'General case' 0 C--N 1.332 -0.195 0 CA-C-N 116.371 -0.377 . . . . 0.0 110.97 179.895 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 114' ' ' ARG . . . . . . . . . . . . . 58.7 ttp180 -143.09 116.02 8.81 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.068 -0.515 . . . . 0.0 110.125 178.921 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 115' ' ' GLY . . . . . . . . . . . . . . . -150.26 163.05 29.43 Favored Glycine 0 CA--C 1.525 0.678 0 N-CA-C 111.0 -0.84 . . . . 0.0 111.0 -179.506 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 116' ' ' LYS . . . . . . . . . . . . . 34.5 ttmt -128.38 137.54 51.94 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-O 120.723 0.297 . . . . 0.0 110.27 177.229 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 117' ' ' PHE . . . . . . . . . . . . . 54.4 m-85 -131.47 114.95 15.54 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.324 -0.398 . . . . 0.0 110.286 -177.007 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 118' ' ' GLU . . . . . . . . . . . . . 46.4 tp10 -53.76 -47.81 70.35 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.554 -0.294 . . . . 0.0 111.491 -176.067 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 119' ' ' ASN . . . . . . . . . . . . . 6.4 m120 -97.14 31.02 2.55 Favored 'General case' 0 C--N 1.329 -0.302 0 N-CA-C 112.088 0.403 . . . . 0.0 112.088 -174.126 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 120' ' ' LEU . . . . . 0.411 HD11 HG23 ' A' ' 132' ' ' ILE . 12.3 tp -56.63 122.22 11.55 Favored 'General case' 0 C--N 1.331 -0.224 0 C-N-CA 121.026 -0.27 . . . . 0.0 110.496 179.08 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 121' ' ' ASN . . . . . . . . . . . . . 29.2 m120 -112.78 -44.01 3.37 Favored 'General case' 0 C--O 1.232 0.157 0 CA-C-N 116.564 -0.289 . . . . 0.0 111.115 -177.299 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 122' ' ' LYS . . . . . . . . . . . . . 96.1 mttt -146.42 149.17 33.2 Favored 'General case' 0 C--N 1.331 -0.218 0 CA-C-O 120.996 0.427 . . . . 0.0 111.725 -179.544 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 123' ' ' VAL . . . . . . . . . . . . . 44.5 t -126.87 123.48 62.77 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.327 0 N-CA-C 108.971 -0.752 . . . . 0.0 108.971 171.628 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 124' ' ' LEU . . . . . . . . . . . . . 13.6 tp -120.54 137.31 54.45 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.395 -0.366 . . . . 0.0 110.537 -175.703 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 125' ' ' VAL . . . . . . . . . . . . . 43.9 t -125.36 132.76 70.67 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.243 0 CA-C-N 116.101 -0.499 . . . . 0.0 110.27 -179.412 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 126' ' ' ARG . . . . . . . . . . . . . 40.3 mmt180 -131.77 108.06 9.19 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 115.96 -0.563 . . . . 0.0 109.933 176.686 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 127' ' ' ASN . . . . . . . . . . . . . 7.8 m120 54.12 -104.83 0.23 Allowed 'General case' 0 CA--C 1.543 0.688 0 CA-C-O 119.037 -0.506 . . . . 0.0 110.935 179.85 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 128' ' ' ASP . . . . . . . . . . . . . 7.5 p-10 -113.31 4.17 16.28 Favored 'General case' 0 N--CA 1.468 0.458 0 CA-C-N 119.575 1.08 . . . . 0.0 113.387 -176.886 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 129' ' ' LEU . . . . . . . . . . . . . 76.3 mt -104.97 139.51 39.57 Favored 'General case' 0 C--N 1.332 -0.162 0 CA-C-N 118.17 0.441 . . . . 0.0 110.051 177.412 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 130' ' ' VAL . . . . . . . . . . . . . 44.8 t -120.5 135.45 60.68 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.223 0 CA-C-N 116.271 -0.422 . . . . 0.0 110.004 -177.485 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 131' ' ' VAL . . . . . 0.428 HG22 HD12 ' A' ' 140' ' ' LEU . 42.7 t -132.6 132.53 59.94 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.29 0 CA-C-O 120.985 0.421 . . . . 0.0 109.993 177.562 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 132' ' ' ILE . . . . . 0.411 HG23 HD11 ' A' ' 120' ' ' LEU . 70.8 mt -115.3 130.76 69.31 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 N-CA-C 109.251 -0.648 . . . . 0.0 109.251 178.903 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 133' ' ' ILE . . . . . . . . . . . . . 43.1 mm -115.97 121.11 66.72 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.287 0 CA-C-N 116.305 -0.407 . . . . 0.0 110.531 -175.651 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 134' ' ' ASP . . . . . . . . . . . . . 7.1 p-10 -133.0 149.98 52.19 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.045 -0.525 . . . . 0.0 109.626 175.8 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 135' ' ' GLU . . . . . . . . . . . . . 78.7 tt0 -49.79 -25.99 3.54 Favored 'General case' 0 C--N 1.327 -0.391 0 N-CA-C 113.005 0.743 . . . . 0.0 113.005 -169.244 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 136' ' ' GLN . . . . . . . . . . . . . 87.7 mt-30 -103.95 -27.43 12.17 Favored 'General case' 0 N--CA 1.465 0.32 0 N-CA-C 112.955 0.724 . . . . 0.0 112.955 -174.745 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 137' ' ' LYS . . . . . . . . . . . . . 60.5 mtpt -140.48 152.54 45.7 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-O 121.333 0.587 . . . . 0.0 111.775 -170.227 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 138' ' ' LEU . . . . . 0.4 ' C ' HD23 ' A' ' 138' ' ' LEU . 5.1 tt -117.7 121.69 41.53 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 115.504 -0.771 . . . . 0.0 109.145 172.684 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 139' ' ' THR . . . . . . . . . . . . . 26.5 m -108.5 126.63 53.13 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.425 -0.352 . . . . 0.0 110.604 -177.242 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 140' ' ' LEU . . . . . 0.428 HD12 HG22 ' A' ' 131' ' ' VAL . 12.9 tp -113.63 119.07 36.19 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 115.651 -0.704 . . . . 0.0 109.156 -179.73 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 141' ' ' ILE . . . . . . . . . . . . . 19.4 mt -119.02 120.73 64.88 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.328 0 N-CA-C 109.851 -0.426 . . . . 0.0 109.851 -174.734 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 142' ' ' ARG . . . . . . . . . . . . . 81.1 mtm180 -110.7 125.46 53.5 Favored 'General case' 0 C--N 1.331 -0.218 0 CA-C-N 115.677 -0.692 . . . . 0.0 110.203 -178.493 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 143' ' ' THR . . . . . . . . . . . . . 82.3 p . . . . . 0 C--O 1.22 -0.483 0 CA-C-O 118.04 -0.981 . . . . 0.0 110.589 -179.199 . . . . . . . . 0 0 . 1 . 015 nuclear build full ' B' B ' -3' ' ' GLU . . . . . . . . . . . . . 73.7 tt0 . . . . . 0 N--CA 1.49 1.543 0 N-CA-C 109.112 -0.699 . . . . 0.0 109.112 . . . . . . . . . 0 0 . 1 . 015 nuclear build full ' B' B ' -2' ' ' GLY . . . . . . . . . . . . . . . -82.95 149.75 27.01 Favored Glycine 0 CA--C 1.524 0.617 0 N-CA-C 110.721 -0.951 . . . . 0.0 110.721 178.58 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' B' B ' -1' ' ' VAL . . . . . . . . . . . . . 46.0 t -86.95 133.06 30.88 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.295 0 N-CA-C 109.793 -0.447 . . . . 0.0 109.793 179.826 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' B' B ' 0' ' ' ILE . . . . . . . . . . . . . 43.7 mm -96.2 126.9 48.71 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.346 0 CA-C-N 116.248 -0.433 . . . . 0.0 110.011 -178.699 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' B' B ' 1' ' ' MET . . . . . . . . . . . . . 23.5 ptm -81.21 133.72 35.5 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.191 -0.458 . . . . 0.0 111.005 -177.715 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' B' B ' 2' ' ' SER . . . . . . . . . . . . . 7.0 p -124.47 134.91 52.9 Favored 'General case' 0 C--N 1.331 -0.199 0 CA-C-N 116.124 -0.489 . . . . 0.0 110.59 179.831 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' B' B ' 3' ' ' GLU . . . . . . . . . . . . . 92.4 mt-10 -141.74 142.02 33.26 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 115.977 -0.556 . . . . 0.0 110.821 -179.299 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' B' B ' 4' ' ' LEU . . . . . . . . . . . . . 18.6 tp -127.41 130.95 50.26 Favored 'General case' 0 C--N 1.331 -0.23 0 CA-C-N 116.37 -0.377 . . . . 0.0 110.219 176.179 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' B' B ' 5' ' ' LYS . . . . . . . . . . . . . 68.5 mttm -110.64 120.46 42.49 Favored 'General case' 0 C--N 1.331 -0.215 0 CA-C-N 116.347 -0.388 . . . . 0.0 110.581 179.393 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' B' B ' 6' ' ' LEU . . . . . . . . . . . . . 65.5 mt -114.82 147.94 39.15 Favored 'General case' 0 C--N 1.331 -0.225 0 CA-C-N 115.303 -0.862 . . . . 0.0 110.687 -178.492 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' B' B ' 7' ' ' LYS . . . . . . . . . . . . . 74.7 tttt -133.55 135.06 24.42 Favored Pre-proline 0 CA--C 1.535 0.366 0 CA-C-O 118.848 -0.596 . . . . 0.0 109.933 176.174 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' B' B ' 8' ' ' PRO . . . . . . . . . . . . . 93.9 Cg_endo -90.79 142.26 3.25 Favored 'Trans proline' 0 N--CA 1.489 1.263 0 C-N-CA 121.666 1.577 . . . . 0.0 111.721 177.579 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' B' B ' 9' ' ' LEU . . . . . . . . . . . . . 47.0 mt -81.13 -47.22 1.13 Allowed Pre-proline 0 CA--C 1.533 0.323 0 CA-C-O 118.714 -0.66 . . . . 0.0 112.258 -178.544 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' B' B ' 10' ' ' PRO . . . . . . . . . . . . . 86.5 Cg_endo -80.69 150.46 18.85 Favored 'Trans proline' 0 N--CA 1.497 1.722 0 C-N-CA 121.179 1.253 . . . . 0.0 111.879 175.17 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' B' B ' 11' ' ' LYS . . . . . . . . . . . . . 33.9 ttmt -85.65 100.04 11.7 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-O 120.879 0.371 . . . . 0.0 110.57 178.463 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' B' B ' 12' ' ' VAL . . . . . . . . . . . . . 12.1 p -143.66 138.82 25.7 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.273 0 CA-C-N 116.125 -0.489 . . . . 0.0 110.493 179.22 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' B' B ' 13' ' ' GLU . . . . . . . . . . . . . 15.0 mm-40 -74.93 129.49 37.74 Favored 'General case' 0 C--N 1.329 -0.316 0 N-CA-C 109.955 -0.387 . . . . 0.0 109.955 177.098 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' B' B ' 14' ' ' LEU . . . . . . . . . . . . . 33.2 mt -97.86 146.32 31.26 Favored Pre-proline 0 CA--C 1.533 0.304 0 CA-C-O 119.142 -0.456 . . . . 0.0 110.265 -179.379 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' B' B ' 15' ' ' PRO . . . . . . . . . . . . . 26.2 Cg_exo -61.96 160.04 31.36 Favored 'Trans proline' 0 N--CA 1.498 1.768 0 C-N-CA 121.251 1.3 . . . . 0.0 112.001 177.818 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' B' B ' 16' ' ' PRO . . . . . . . . . . . . . 27.5 Cg_exo -60.37 -35.04 92.69 Favored 'Trans proline' 0 N--CA 1.496 1.634 0 C-N-CA 121.452 1.435 . . . . 0.0 112.659 -179.446 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' B' B ' 17' ' ' ASP . . . . . . . . . . . . . 10.3 p-10 -87.61 9.49 21.07 Favored 'General case' 0 CA--C 1.535 0.399 0 N-CA-C 113.168 0.803 . . . . 0.0 113.168 -178.073 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' B' B ' 18' ' ' PHE . . . . . . . . . . . . . 28.8 t80 -57.25 -41.38 79.51 Favored 'General case' 0 CA--C 1.527 0.073 0 O-C-N 121.939 -0.476 . . . . 0.0 110.296 -178.971 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' B' B ' 19' ' ' VAL . . . . . . . . . . . . . 50.0 t -56.94 -42.73 79.28 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 CA-C-N 116.399 -0.364 . . . . 0.0 110.396 -179.983 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' B' B ' 20' ' ' ASP . . . . . 0.557 ' OD1' HD11 ' B' ' 24' ' ' ILE . 4.9 t70 -60.28 -39.68 87.76 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-O 120.849 0.357 . . . . 0.0 110.747 -178.603 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' B' B ' 21' ' ' VAL . . . . . . . . . . . . . 46.2 t -64.28 -47.99 87.37 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.314 0 C-N-CA 120.755 -0.378 . . . . 0.0 110.24 -179.316 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' B' B ' 22' ' ' ILE . . . . . 0.404 HG22 HD12 ' B' ' 26' ' ' LEU . 51.7 mm -55.59 -58.04 5.93 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.237 0 C-N-CA 120.954 -0.298 . . . . 0.0 111.171 -178.38 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' B' B ' 23' ' ' ARG . . . . . . . . . . . . . 12.0 ptm180 -55.85 -42.97 76.59 Favored 'General case' 0 CA--C 1.531 0.223 0 C-N-CA 120.527 -0.469 . . . . 0.0 111.792 -173.797 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' B' B ' 24' ' ' ILE . . . . . 0.557 HD11 ' OD1' ' B' ' 20' ' ' ASP . 75.5 mt -60.81 -44.17 96.98 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.264 0 C-N-CA 120.815 -0.354 . . . . 0.0 111.421 -177.958 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' B' B ' 25' ' ' LYS . . . . . . . . . . . . . 68.6 mttm -67.71 -42.66 81.64 Favored 'General case' 0 C--N 1.329 -0.311 0 N-CA-C 112.558 0.577 . . . . 0.0 112.558 -178.306 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' B' B ' 26' ' ' LEU . . . . . 0.404 HD12 HG22 ' B' ' 22' ' ' ILE . 29.3 mt -79.45 -35.83 39.77 Favored 'General case' 0 C--N 1.33 -0.265 0 N-CA-C 113.522 0.934 . . . . 0.0 113.522 -170.782 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' B' B ' 27' ' ' GLN . . . . . . . . . . . . . 13.9 pt20 -47.13 138.62 6.69 Favored 'General case' 0 N--CA 1.47 0.556 0 N-CA-C 112.742 0.645 . . . . 0.0 112.742 -175.502 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' B' B ' 28' ' ' GLY . . . . . . . . . . . . . . . 98.4 -23.19 37.24 Favored Glycine 0 CA--C 1.534 1.279 0 CA-C-N 115.636 -0.711 . . . . 0.0 112.386 -177.298 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' B' B ' 29' ' ' LYS . . . . . . . . . . . . . 64.6 mttp -97.64 155.1 17.14 Favored 'General case' 0 C--O 1.233 0.229 0 CA-C-N 117.382 0.591 . . . . 0.0 111.084 179.297 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' B' B ' 30' ' ' THR . . . . . . . . . . . . . 27.4 m -102.95 135.87 43.82 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.119 -0.491 . . . . 0.0 109.87 175.565 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' B' B ' 31' ' ' VAL . . . . . . . . . . . . . 34.9 m -128.48 153.85 38.51 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.212 0 CA-C-O 120.928 0.394 . . . . 0.0 110.706 -178.161 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' B' B ' 32' ' ' ARG . . . . . . . . . . . . . 91.8 mtm-85 -132.68 147.71 52.33 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-O 121.283 0.563 . . . . 0.0 110.883 179.868 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' B' B ' 33' ' ' THR . . . . . . . . . . . . . 26.4 m -53.23 140.18 27.19 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.127 -0.488 . . . . 0.0 111.344 -177.971 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' B' B ' 34' ' ' GLY . . . . . . . . . . . . . . . 100.15 -17.09 57.55 Favored Glycine 0 CA--C 1.533 1.166 0 CA-C-O 119.608 -0.551 . . . . 0.0 113.22 179.574 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' B' B ' 35' ' ' ASP . . . . . . . . . . . . . 76.9 m-20 -65.19 148.92 50.82 Favored 'General case' 0 C--N 1.333 -0.109 0 CA-C-N 118.037 0.918 . . . . 0.0 111.08 178.924 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' B' B ' 36' ' ' VAL . . . . . . . . . . . . . 46.8 t -120.53 129.95 75.02 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.275 0 CA-C-N 115.83 -0.623 . . . . 0.0 109.625 177.337 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' B' B ' 37' ' ' ILE . . . . . . . . . . . . . 70.0 mt -118.8 138.93 47.91 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.274 0 CA-C-N 116.137 -0.483 . . . . 0.0 109.867 -178.242 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' B' B ' 38' ' ' GLY . . . . . . . . . . . . . . . -115.36 128.88 8.28 Favored Glycine 0 CA--C 1.525 0.707 0 N-CA-C 110.915 -0.874 . . . . 0.0 110.915 179.596 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' B' B ' 39' ' ' ILE . . . . . . . . . . . . . 76.2 mt -125.09 137.0 59.07 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.28 0 N-CA-C 110.195 -0.298 . . . . 0.0 110.195 -179.839 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' B' B ' 40' ' ' SER . . . . . . . . . . . . . 32.0 t -93.12 122.94 36.02 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.346 -0.388 . . . . 0.0 110.726 175.181 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' B' B ' 41' ' ' ILE . . . . . . . . . . . . . 71.4 mt -129.19 118.33 45.98 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.226 0 CA-C-O 120.929 0.395 . . . . 0.0 110.344 178.367 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' B' B ' 42' ' ' LEU . . . . . 0.541 ' O ' HD23 ' B' ' 42' ' ' LEU . 1.3 tt 50.68 45.27 27.16 Favored 'General case' 0 N--CA 1.465 0.288 0 CA-C-O 121.421 0.629 . . . . 0.0 111.047 176.621 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' B' B ' 43' ' ' GLY . . . . . . . . . . . . . . . 70.43 24.7 76.56 Favored Glycine 0 CA--C 1.531 1.064 0 C-N-CA 121.093 -0.575 . . . . 0.0 112.585 175.433 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' B' B ' 44' ' ' LYS . . . . . . . . . . . . . 35.5 ttpt -136.57 133.43 36.38 Favored 'General case' 0 C--N 1.333 -0.145 0 CA-C-N 117.438 0.619 . . . . 0.0 110.213 179.672 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' B' B ' 45' ' ' GLU . . . . . . . . . . . . . 68.0 tt0 -84.08 127.8 34.14 Favored 'General case' 0 C--N 1.326 -0.419 0 CA-C-N 116.437 -0.347 . . . . 0.0 111.203 -177.096 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' B' B ' 46' ' ' VAL . . . . . . . . . . . . . 7.5 p -125.51 128.38 72.42 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.2 0 CA-C-O 121.138 0.494 . . . . 0.0 109.837 175.88 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' B' B ' 47' ' ' LYS . . . . . . . . . . . . . 34.0 mmtp -100.29 131.78 46.03 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 115.789 -0.641 . . . . 0.0 111.457 178.417 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' B' B ' 48' ' ' PHE . . . . . . . . . . . . . 96.3 m-85 -118.04 131.98 56.41 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 115.976 -0.556 . . . . 0.0 109.812 175.313 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' B' B ' 49' ' ' LYS . . . . . . . . . . . . . 83.4 tttt -106.95 138.68 42.66 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.757 -0.202 . . . . 0.0 110.468 178.984 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' B' B ' 50' ' ' VAL . . . . . . . . . . . . . 43.4 t -84.14 108.57 16.57 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.298 0 N-CA-C 109.423 -0.584 . . . . 0.0 109.423 176.768 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' B' B ' 51' ' ' VAL . . . . . . . . . . . . . 47.1 t -73.51 -51.79 23.9 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.277 0 CA-C-N 116.022 -0.536 . . . . 0.0 109.842 -174.603 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' B' B ' 52' ' ' GLN . . . . . . . . . . . . . 88.0 mt-30 -153.89 151.45 29.48 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-N 116.06 -0.518 . . . . 0.0 111.769 -177.912 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' B' B ' 53' ' ' ALA . . . . . . . . . . . . . . . -130.85 134.61 46.96 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 115.371 -0.832 . . . . 0.0 109.651 174.468 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' B' B ' 54' ' ' TYR . . . . . . . . . . . . . 35.8 t80 -129.09 114.2 18.65 Favored Pre-proline 0 CA--C 1.535 0.366 0 CA-C-O 118.062 -0.97 . . . . 0.0 110.407 178.669 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' B' B ' 55' ' ' PRO . . . . . . . . . . . . . 74.1 Cg_endo -77.2 166.19 82.81 Favored 'Cis proline' 0 N--CA 1.5 1.875 0 CA-C-N 122.181 1.815 . . . . 0.0 112.081 -7.468 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' B' B ' 56' ' ' SER . . . . . . . . . . . . . 13.7 m -115.79 127.38 26.83 Favored Pre-proline 0 CA--C 1.538 0.502 0 CA-C-O 118.436 -0.793 . . . . 0.0 109.048 175.297 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' B' B ' 57' ' ' PRO . . . . . . . . . . . . . 44.3 Cg_endo -68.09 146.95 79.3 Favored 'Cis proline' 0 N--CA 1.498 1.75 0 CA-C-N 121.981 1.743 . . . . 0.0 111.855 2.007 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' B' B ' 58' ' ' LEU . . . . . . . . . . . . . 22.7 tp -108.31 137.1 46.85 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.158 -0.473 . . . . 0.0 110.556 -179.381 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' B' B ' 59' ' ' ARG . . . . . . . . . . . . . 23.6 ttm180 -100.91 124.85 47.22 Favored 'General case' 0 C--N 1.326 -0.434 0 N-CA-C 109.341 -0.614 . . . . 0.0 109.341 176.281 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' B' B ' 60' ' ' VAL . . . . . . . . . . . . . 40.9 t -82.68 120.16 33.56 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.281 0 C-N-CA 120.739 -0.385 . . . . 0.0 110.684 -174.374 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' B' B ' 61' ' ' GLU . . . . . . . . . . . . . 71.0 mm-40 -131.17 155.98 46.1 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 115.926 -0.579 . . . . 0.0 109.845 175.138 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' B' B ' 62' ' ' ASP . . . . . . . . . . . . . 21.6 m-20 -52.25 -33.86 43.45 Favored 'General case' 0 C--N 1.328 -0.33 0 N-CA-C 111.842 0.312 . . . . 0.0 111.842 -179.998 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' B' B ' 63' ' ' ARG . . . . . . . . . . . . . 94.6 mtt180 -73.17 -21.89 60.6 Favored 'General case' 0 CA--C 1.532 0.273 0 N-CA-C 113.05 0.759 . . . . 0.0 113.05 -176.559 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' B' B ' 64' ' ' THR . . . . . . . . . . . . . 27.1 m -62.61 143.42 57.31 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-O 120.731 0.3 . . . . 0.0 110.514 -176.983 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' B' B ' 65' ' ' LYS . . . . . . . . . . . . . 54.6 mttm -85.18 124.17 31.53 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.283 -0.417 . . . . 0.0 110.097 179.38 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' B' B ' 66' ' ' ILE . . . . . . . . . . . . . 58.2 mt -115.22 124.06 71.44 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.307 0 N-CA-C 109.646 -0.502 . . . . 0.0 109.646 -179.42 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' B' B ' 67' ' ' THR . . . . . . . . . . . . . 14.4 m -127.64 144.58 51.06 Favored 'General case' 0 C--N 1.333 -0.151 0 CA-C-O 121.01 0.433 . . . . 0.0 111.118 -176.617 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' B' B ' 68' ' ' LEU . . . . . 0.451 HD12 ' N ' ' B' ' 68' ' ' LEU . 6.5 mp -107.06 140.63 39.57 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.132 -0.485 . . . . 0.0 110.901 178.538 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' B' B ' 69' ' ' VAL . . . . . . . . . . . . . 42.7 t -95.27 147.46 5.83 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 CA-C-N 115.883 -0.598 . . . . 0.0 110.23 179.728 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' B' B ' 70' ' ' THR . . . . . . . . . . . . . 69.5 p -84.69 166.08 17.35 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-O 120.973 0.416 . . . . 0.0 110.957 -178.32 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' B' B ' 71' ' ' HIS . . . . . . . . . . . . . 65.8 m80 -75.01 161.95 75.39 Favored Pre-proline 0 CA--C 1.532 0.277 0 CA-C-N 115.999 -0.546 . . . . 0.0 111.221 -177.784 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' B' B ' 72' ' ' PRO . . . . . . . . . . . . . 72.6 Cg_endo -87.93 159.98 7.41 Favored 'Trans proline' 0 N--CA 1.489 1.263 0 C-N-CA 121.878 1.718 . . . . 0.0 112.773 -179.232 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' B' B ' 73' ' ' VAL . . . . . . . . . . . . . 34.7 m -70.04 179.58 0.35 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.295 0 CA-C-N 116.094 -0.503 . . . . 0.0 110.83 -179.956 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' B' B ' 74' ' ' ASP . . . . . . . . . . . . . 19.3 t0 -104.62 123.61 47.87 Favored 'General case' 0 C--N 1.331 -0.225 0 CA-C-N 116.389 -0.368 . . . . 0.0 110.087 -179.699 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' B' B ' 75' ' ' VAL . . . . . . . . . . . . . 42.6 t -117.44 121.72 68.24 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.221 0 CA-C-O 120.993 0.425 . . . . 0.0 110.538 -178.381 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' B' B ' 76' ' ' LEU . . . . . . . . . . . . . 5.7 mp -120.99 142.09 50.11 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 115.846 -0.615 . . . . 0.0 109.904 176.012 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' B' B ' 77' ' ' GLU . . . . . . . . . . . . . 97.5 mt-10 -133.59 134.89 43.85 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-O 121.01 0.433 . . . . 0.0 110.962 -178.991 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' B' B ' 78' ' ' ALA . . . . . 0.552 ' HB2' HD21 ' B' ' 109' ' ' LEU . . . -122.82 140.88 52.45 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 115.896 -0.593 . . . . 0.0 109.977 177.26 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' B' B ' 79' ' ' LYS . . . . . 0.687 ' O ' HD13 ' B' ' 80' ' ' ILE . 70.4 mmtt -75.0 115.86 15.09 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-O 120.972 0.415 . . . . 0.0 110.442 179.905 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' B' B ' 80' ' ' ILE . . . . . 0.687 HD13 ' O ' ' B' ' 79' ' ' LYS . 35.2 mm -139.04 105.87 2.74 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.328 0 N-CA-C 109.022 -0.733 . . . . 0.0 109.022 -178.302 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' B' B ' 81' ' ' LYS . . . . . . . . . . . . . 54.6 pttt -115.44 132.29 56.67 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-O 121.1 0.476 . . . . 0.0 111.195 -177.313 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' B' B ' 82' ' ' GLY . . . . . . . . . . . . . . . 89.07 42.09 5.71 Favored Glycine 0 CA--C 1.526 0.731 0 N-CA-C 111.135 -0.786 . . . . 0.0 111.135 179.239 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' B' B ' 83' ' ' ILE . . . . . . . . . . . . . 72.6 mt -71.55 139.27 20.1 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.293 0 CA-C-O 120.827 0.346 . . . . 0.0 110.162 -179.813 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' B' B ' 84' ' ' LYS . . . . . . . . . . . . . 15.2 ttmm -96.55 -54.07 3.37 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-O 121.179 0.514 . . . . 0.0 109.939 178.2 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' B' B ' 85' ' ' ASP . . . . . . . . . . . . . 8.9 t70 -155.44 146.41 22.45 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 115.508 -0.769 . . . . 0.0 110.125 -179.425 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' B' B ' 86' ' ' VAL . . . . . . . . . . . . . 43.6 t -124.2 129.2 74.16 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.256 0 CA-C-O 120.93 0.395 . . . . 0.0 110.249 179.888 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' B' B ' 87' ' ' ILE . . . . . . . . . . . . . 44.2 mm -118.34 124.76 73.61 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.262 0 CA-C-N 115.887 -0.597 . . . . 0.0 109.496 177.297 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' B' B ' 88' ' ' LEU . . . . . . . . . . . . . 15.3 tp -114.26 124.36 51.84 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-O 121.088 0.471 . . . . 0.0 111.238 -176.898 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' B' B ' 89' ' ' ASP . . . . . . . . . . . . . 5.7 t70 -112.44 159.61 18.58 Favored 'General case' 0 C--N 1.33 -0.24 0 N-CA-C 108.99 -0.744 . . . . 0.0 108.99 175.419 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' B' B ' 90' ' ' GLU . . . . . . . . . . . . . 94.5 mt-10 -48.28 -42.61 31.3 Favored 'General case' 0 N--CA 1.465 0.291 0 N-CA-C 112.689 0.626 . . . . 0.0 112.689 -171.479 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' B' B ' 91' ' ' ASN . . . . . . . . . . . . . 33.8 p-10 -132.2 37.06 3.58 Favored 'General case' 0 N--CA 1.464 0.251 0 N-CA-C 111.753 0.279 . . . . 0.0 111.753 -178.691 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' B' B ' 92' ' ' LEU . . . . . . . . . . . . . 15.9 tp -160.6 140.1 10.82 Favored 'General case' 0 C--N 1.331 -0.237 0 C-N-CA 120.826 -0.35 . . . . 0.0 110.667 -177.877 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' B' B ' 93' ' ' ILE . . . . . . . . . . . . . 68.2 mt -122.7 123.12 67.61 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.198 0 N-CA-C 109.679 -0.489 . . . . 0.0 109.679 -178.663 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' B' B ' 94' ' ' VAL . . . . . . . . . . . . . 46.8 t -124.46 125.77 70.8 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.243 0 N-CA-C 109.718 -0.475 . . . . 0.0 109.718 177.629 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' B' B ' 95' ' ' VAL . . . . . . . . . . . . . 44.4 t -122.3 133.44 68.56 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.341 0 CA-C-N 116.022 -0.536 . . . . 0.0 109.789 -179.178 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' B' B ' 96' ' ' ILE . . . . . 0.405 HD11 ' HB ' ' B' ' 123' ' ' VAL . 51.7 mt -114.07 127.33 71.53 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.329 0 N-CA-C 108.782 -0.822 . . . . 0.0 108.782 178.301 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' B' B ' 97' ' ' THR . . . . . . . . . . . . . 82.7 p -99.0 153.76 18.61 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-O 121.292 0.568 . . . . 0.0 111.279 -176.85 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' B' B ' 98' ' ' GLU . . . . . . . . . . . . . 73.0 tt0 -53.97 -24.02 15.21 Favored 'General case' 0 C--N 1.325 -0.471 0 CA-C-N 115.811 -0.631 . . . . 0.0 112.166 179.322 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' B' B ' 99' ' ' GLU . . . . . . . . . . . . . 91.1 mt-10 -82.07 16.09 2.07 Favored 'General case' 0 CA--C 1.535 0.389 0 N-CA-C 113.082 0.771 . . . . 0.0 113.082 -176.981 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' B' B ' 100' ' ' ASN . . . . . . . . . . . . . 2.7 m-20 64.78 36.97 7.66 Favored 'General case' 0 CA--C 1.53 0.201 0 CA-C-O 121.001 0.429 . . . . 0.0 111.343 177.218 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' B' B ' 101' ' ' GLU . . . . . . . . . . . . . 82.7 tt0 -118.1 145.05 45.15 Favored 'General case' 0 C--N 1.331 -0.199 0 CA-C-N 116.147 -0.479 . . . . 0.0 110.031 175.294 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' B' B ' 102' ' ' VAL . . . . . . . . . . . . . 44.4 t -118.13 128.5 75.18 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.295 0 N-CA-C 110.137 -0.32 . . . . 0.0 110.137 -179.286 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' B' B ' 103' ' ' LEU . . . . . . . . . . . . . 6.1 mp -120.95 135.37 55.22 Favored 'General case' 0 C--N 1.331 -0.224 0 CA-C-N 115.94 -0.573 . . . . 0.0 110.489 177.642 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' B' B ' 104' ' ' ILE . . . . . . . . . . . . . 70.0 mt -121.82 124.74 72.11 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.276 0 CA-C-N 116.509 -0.314 . . . . 0.0 110.454 -179.848 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' B' B ' 105' ' ' PHE . . . . . . . . . . . . . 62.8 m-85 -123.23 166.0 15.98 Favored 'General case' 0 C--O 1.232 0.134 0 O-C-N 124.033 0.833 . . . . 0.0 109.873 -179.534 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' B' B ' 106' ' ' ASN . . . . . . . . . . . . . 43.7 p-10 -102.52 -170.66 1.84 Allowed 'General case' 0 CA--C 1.53 0.197 0 N-CA-C 110.164 -0.309 . . . . 0.0 110.164 173.894 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' B' B ' 107' ' ' GLN . . . . . . . . . . . . . 40.4 tt0 -59.05 -30.09 67.79 Favored 'General case' 0 C--N 1.33 -0.267 0 N-CA-C 112.085 0.402 . . . . 0.0 112.085 -179.265 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' B' B ' 108' ' ' ASN . . . . . . . . . . . . . 5.3 t30 -85.53 11.03 11.42 Favored 'General case' 0 CA--C 1.536 0.412 0 N-CA-C 113.052 0.76 . . . . 0.0 113.052 -176.915 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' B' B ' 109' ' ' LEU . . . . . 0.552 HD21 ' HB2' ' B' ' 78' ' ' ALA . 9.0 tp 60.59 34.81 20.15 Favored 'General case' 0 C--N 1.331 -0.215 0 CA-C-O 120.758 0.313 . . . . 0.0 111.558 178.905 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' B' B ' 110' ' ' GLU . . . . . . . . . . . . . 95.7 mt-10 -103.01 147.02 27.47 Favored 'General case' 0 C--N 1.33 -0.258 0 N-CA-C 109.68 -0.489 . . . . 0.0 109.68 176.205 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' B' B ' 111' ' ' GLU . . . . . . . . . . . . . 55.5 tt0 -85.49 121.88 28.83 Favored 'General case' 0 C--N 1.328 -0.362 0 C-N-CA 120.831 -0.348 . . . . 0.0 110.68 -177.273 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' B' B ' 112' ' ' LEU . . . . . . . . . . . . . 37.3 mt -104.39 -46.03 4.5 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.122 -0.49 . . . . 0.0 110.88 179.151 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' B' B ' 113' ' ' TYR . . . . . 0.418 ' CE1' HG21 ' C' ' 75' ' ' VAL . 66.3 t80 -136.5 144.9 44.55 Favored 'General case' 0 N--CA 1.464 0.23 0 CA-C-O 120.969 0.414 . . . . 0.0 111.132 -179.053 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' B' B ' 114' ' ' ARG . . . . . . . . . . . . . 14.3 ptt180 -146.55 124.39 11.94 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 115.621 -0.718 . . . . 0.0 110.365 178.765 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' B' B ' 115' ' ' GLY . . . . . . . . . . . . . . . -150.16 155.26 26.14 Favored Glycine 0 CA--C 1.523 0.539 0 N-CA-C 110.908 -0.877 . . . . 0.0 110.908 -179.948 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' B' B ' 116' ' ' LYS . . . . . . . . . . . . . 19.8 ttmt -126.66 140.46 52.4 Favored 'General case' 0 C--N 1.331 -0.228 0 N-CA-C 109.638 -0.504 . . . . 0.0 109.638 178.667 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' B' B ' 117' ' ' PHE . . . . . . . . . . . . . 32.2 m-85 -138.51 114.02 9.68 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-O 120.935 0.398 . . . . 0.0 110.258 -176.35 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' B' B ' 118' ' ' GLU . . . . . . . . . . . . . 75.1 tt0 -53.42 -49.73 66.7 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 116.528 -0.306 . . . . 0.0 111.432 -176.638 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' B' B ' 119' ' ' ASN . . . . . . . . . . . . . 33.7 m120 -91.45 30.47 1.3 Allowed 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.081 -0.508 . . . . 0.0 112.213 -174.324 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' B' B ' 120' ' ' LEU . . . . . . . . . . . . . 14.2 tp -56.73 122.14 11.42 Favored 'General case' 0 C--N 1.332 -0.154 0 CA-C-O 120.666 0.27 . . . . 0.0 110.459 178.579 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' B' B ' 121' ' ' ASN . . . . . . . . . . . . . 44.8 m-20 -114.01 -44.08 3.19 Favored 'General case' 0 C--N 1.332 -0.174 0 CA-C-N 116.485 -0.325 . . . . 0.0 110.956 -176.844 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' B' B ' 122' ' ' LYS . . . . . . . . . . . . . 99.1 mttt -143.76 148.64 35.91 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-O 121.027 0.441 . . . . 0.0 111.448 -177.765 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' B' B ' 123' ' ' VAL . . . . . 0.405 ' HB ' HD11 ' B' ' 96' ' ' ILE . 45.2 t -125.0 125.85 70.21 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.292 0 CA-C-N 115.885 -0.598 . . . . 0.0 109.572 175.605 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' B' B ' 124' ' ' LEU . . . . . . . . . . . . . 28.2 mt -112.08 125.44 54.1 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 116.239 -0.437 . . . . 0.0 110.333 -179.448 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' B' B ' 125' ' ' VAL . . . . . . . . . . . . . 44.2 t -133.54 126.4 51.71 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.276 0 CA-C-N 116.495 -0.32 . . . . 0.0 110.365 -179.124 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' B' B ' 126' ' ' ARG . . . . . . . . . . . . . 69.2 ttt-85 -162.61 141.67 9.0 Favored 'General case' 0 C--N 1.329 -0.32 0 N-CA-C 109.611 -0.515 . . . . 0.0 109.611 175.094 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' B' B ' 127' ' ' ASN . . . . . . . . . . . . . 10.1 p30 48.88 -151.99 0.13 Allowed 'General case' 0 CA--C 1.54 0.563 0 CA-C-O 119.373 -0.346 . . . . 0.0 111.001 178.988 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' B' B ' 128' ' ' ASP . . . . . . . . . . . . . 13.7 p-10 -83.55 21.54 1.19 Allowed 'General case' 0 CA--C 1.533 0.307 0 CA-C-N 118.512 0.596 . . . . 0.0 112.517 179.271 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' B' B ' 129' ' ' LEU . . . . . . . . . . . . . 17.1 tp -119.66 135.23 54.9 Favored 'General case' 0 C--O 1.233 0.235 0 CA-C-O 120.969 0.414 . . . . 0.0 110.327 179.541 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' B' B ' 130' ' ' VAL . . . . . . . . . . . . . 44.6 t -128.58 135.65 61.88 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.233 0 CA-C-N 115.961 -0.563 . . . . 0.0 109.802 179.322 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' B' B ' 131' ' ' VAL . . . . . 0.44 HG22 HD12 ' B' ' 140' ' ' LEU . 43.1 t -133.82 135.59 55.05 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.285 0 CA-C-O 120.924 0.392 . . . . 0.0 110.16 179.705 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' B' B ' 132' ' ' ILE . . . . . . . . . . . . . 72.8 mt -116.22 129.76 72.1 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.327 0 N-CA-C 109.341 -0.614 . . . . 0.0 109.341 -179.958 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' B' B ' 133' ' ' ILE . . . . . . . . . . . . . 41.9 mm -116.72 120.51 65.22 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.21 0 CA-C-O 120.807 0.337 . . . . 0.0 110.859 -175.779 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' B' B ' 134' ' ' ASP . . . . . . . . . . . . . 7.7 p-10 -134.22 145.59 49.31 Favored 'General case' 0 C--N 1.33 -0.265 0 N-CA-C 109.601 -0.518 . . . . 0.0 109.601 175.11 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' B' B ' 135' ' ' GLU . . . . . . . . . . . . . 73.9 tt0 -49.96 -25.45 3.3 Favored 'General case' 0 C--N 1.329 -0.309 0 N-CA-C 112.975 0.731 . . . . 0.0 112.975 -170.578 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' B' B ' 136' ' ' GLN . . . . . . . . . . . . . 97.1 mt-30 -96.81 -31.83 12.42 Favored 'General case' 0 C--O 1.234 0.276 0 N-CA-C 112.256 0.465 . . . . 0.0 112.256 -176.291 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' B' B ' 137' ' ' LYS . . . . . . . . . . . . . 92.5 mttt -139.53 152.87 47.27 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-O 121.172 0.511 . . . . 0.0 111.48 -170.408 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' B' B ' 138' ' ' LEU . . . . . 0.469 ' C ' HD23 ' B' ' 138' ' ' LEU . 6.2 tt -119.34 119.55 34.33 Favored 'General case' 0 C--N 1.327 -0.4 0 N-CA-C 108.977 -0.749 . . . . 0.0 108.977 172.682 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' B' B ' 139' ' ' THR . . . . . . . . . . . . . 28.3 m -111.16 130.32 55.67 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-O 120.655 0.264 . . . . 0.0 110.803 -175.899 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' B' B ' 140' ' ' LEU . . . . . 0.44 HD12 HG22 ' B' ' 131' ' ' VAL . 10.6 tp -115.28 120.62 40.28 Favored 'General case' 0 C--N 1.328 -0.353 0 N-CA-C 109.299 -0.63 . . . . 0.0 109.299 -179.526 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' B' B ' 141' ' ' ILE . . . . . . . . . . . . . 19.5 mt -119.88 124.92 73.69 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.242 0 CA-C-O 121.077 0.465 . . . . 0.0 110.158 -175.044 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' B' B ' 142' ' ' ARG . . . . . . . . . . . . . 82.1 mtp180 -108.35 121.66 45.38 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 115.404 -0.816 . . . . 0.0 110.004 179.472 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' B' B ' 143' ' ' THR . . . . . . . . . . . . . 81.2 p . . . . . 0 C--O 1.219 -0.516 0 CA-C-O 117.932 -1.032 . . . . 0.0 110.747 -178.885 . . . . . . . . 0 0 . 1 . 015 nuclear build full ' C' C ' -3' ' ' GLU . . . . . . . . . . . . . 21.9 pt-20 . . . . . 0 N--CA 1.491 1.62 0 N-CA-C 110.215 -0.291 . . . . 0.0 110.215 . . . . . . . . . 0 0 . 1 . 015 nuclear build full ' C' C ' -2' ' ' GLY . . . . . . . . . . . . . . . -100.09 132.94 11.11 Favored Glycine 0 CA--C 1.524 0.609 0 N-CA-C 111.066 -0.814 . . . . 0.0 111.066 -179.945 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' C' C ' -1' ' ' VAL . . . . . . . . . . . . . 45.1 t -140.59 138.33 35.78 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.255 0 N-CA-C 109.829 -0.434 . . . . 0.0 109.829 179.0 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' C' C ' 0' ' ' ILE . . . . . . . . . . . . . 69.3 mt -106.08 129.78 58.74 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.34 0 CA-C-N 116.243 -0.435 . . . . 0.0 109.83 -179.48 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' C' C ' 1' ' ' MET . . . . . . . . . . . . . 25.3 ptt? -77.89 137.52 38.41 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.363 -0.38 . . . . 0.0 110.393 179.696 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' C' C ' 2' ' ' SER . . . . . . . . . . . . . 8.0 p -124.61 149.47 47.03 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-O 121.094 0.473 . . . . 0.0 111.146 -178.184 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' C' C ' 3' ' ' GLU . . . . . . . . . . . . . 47.7 mp0 -137.72 140.44 40.71 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 115.81 -0.632 . . . . 0.0 110.578 179.789 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' C' C ' 4' ' ' LEU . . . . . . . . . . . . . 13.4 tp -123.19 128.66 50.34 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 115.813 -0.63 . . . . 0.0 109.923 178.259 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' C' C ' 5' ' ' LYS . . . . . . . . . . . . . 61.3 mttp -108.89 119.61 40.07 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.538 -0.301 . . . . 0.0 110.922 -179.801 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' C' C ' 6' ' ' LEU . . . . . . . . . . . . . 38.8 mt -114.04 147.68 38.28 Favored 'General case' 0 C--N 1.331 -0.227 0 CA-C-N 115.279 -0.873 . . . . 0.0 110.232 179.286 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' C' C ' 7' ' ' LYS . . . . . . . . . . . . . 75.1 tttt -136.87 137.15 22.48 Favored Pre-proline 0 CA--C 1.534 0.33 0 CA-C-O 118.999 -0.524 . . . . 0.0 110.113 176.763 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' C' C ' 8' ' ' PRO . . . . . . . . . . . . . 98.5 Cg_endo -90.86 139.67 2.7 Favored 'Trans proline' 0 N--CA 1.491 1.328 0 C-N-CA 121.646 1.564 . . . . 0.0 111.813 177.839 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' C' C ' 9' ' ' LEU . . . . . . . . . . . . . 37.9 mt -76.3 -48.09 3.31 Favored Pre-proline 0 CA--C 1.533 0.307 0 CA-C-O 118.649 -0.691 . . . . 0.0 112.288 -179.242 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' C' C ' 10' ' ' PRO . . . . . . . . . . . . . 81.4 Cg_endo -78.26 147.36 23.11 Favored 'Trans proline' 0 N--CA 1.496 1.666 0 C-N-CA 121.003 1.135 . . . . 0.0 111.648 176.714 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' C' C ' 11' ' ' LYS . . . . . . . . . . . . . 7.3 ttpm? -86.56 87.69 7.5 Favored 'General case' 0 C--N 1.33 -0.273 0 C-N-CA 120.846 -0.342 . . . . 0.0 110.428 -179.652 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' C' C ' 12' ' ' VAL . . . . . . . . . . . . . 11.6 p -136.32 143.45 35.68 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.271 0 CA-C-N 116.03 -0.532 . . . . 0.0 110.324 179.776 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' C' C ' 13' ' ' GLU . . . . . . . . . . . . . 94.8 mt-10 -79.03 131.03 36.14 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.349 -0.387 . . . . 0.0 110.581 -179.664 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' C' C ' 14' ' ' LEU . . . . . . . . . . . . . 21.2 mt -99.42 152.52 37.83 Favored Pre-proline 0 CA--C 1.532 0.276 0 CA-C-N 116.275 -0.421 . . . . 0.0 110.787 179.236 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' C' C ' 15' ' ' PRO . . . . . . . . . . . . . 26.6 Cg_exo -61.91 157.28 44.26 Favored 'Trans proline' 0 N--CA 1.498 1.738 0 C-N-CA 121.312 1.341 . . . . 0.0 111.793 175.961 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' C' C ' 16' ' ' PRO . . . . . . . . . . . . . 33.1 Cg_exo -57.47 -41.62 70.01 Favored 'Trans proline' 0 N--CA 1.497 1.694 0 C-N-CA 121.418 1.412 . . . . 0.0 112.901 -178.478 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' C' C ' 17' ' ' ASP . . . . . . . . . . . . . 19.8 p-10 -86.35 11.93 11.21 Favored 'General case' 0 CA--C 1.536 0.433 0 N-CA-C 113.105 0.78 . . . . 0.0 113.105 -177.64 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' C' C ' 18' ' ' PHE . . . . . . . . . . . . . 51.7 t80 -57.59 -43.33 84.53 Favored 'General case' 0 C--N 1.334 -0.08 0 O-C-N 121.986 -0.446 . . . . 0.0 110.171 -178.431 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' C' C ' 19' ' ' VAL . . . . . 0.402 HG13 ' N ' ' C' ' 20' ' ' ASP . 14.9 p -56.59 -41.94 74.89 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.243 0 CA-C-N 116.29 -0.414 . . . . 0.0 110.919 -178.732 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' C' C ' 20' ' ' ASP . . . . . 0.402 ' N ' HG13 ' C' ' 19' ' ' VAL . 34.7 m-20 -60.44 -41.59 94.36 Favored 'General case' 0 C--N 1.331 -0.222 0 CA-C-O 120.831 0.348 . . . . 0.0 110.9 -178.758 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' C' C ' 21' ' ' VAL . . . . . . . . . . . . . 48.6 t -63.69 -46.96 93.23 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.287 0 CA-C-N 116.343 -0.389 . . . . 0.0 110.261 -178.828 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' C' C ' 22' ' ' ILE . . . . . 0.402 HG22 HD12 ' C' ' 26' ' ' LEU . 50.3 mm -56.68 -45.31 82.64 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.243 0 CA-C-O 120.822 0.344 . . . . 0.0 110.577 178.851 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' C' C ' 23' ' ' ARG . . . . . . . . . . . . . 49.1 ttp180 -54.22 -49.0 70.45 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.649 -0.25 . . . . 0.0 111.374 -178.018 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' C' C ' 24' ' ' ILE . . . . . . . . . . . . . 73.2 mt -59.49 -43.8 91.48 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.321 0 CA-C-O 120.864 0.364 . . . . 0.0 110.842 -178.751 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' C' C ' 25' ' ' LYS . . . . . . . . . . . . . 60.6 mtpt -62.61 -40.52 97.19 Favored 'General case' 0 C--N 1.327 -0.409 0 N-CA-C 112.113 0.412 . . . . 0.0 112.113 -178.298 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' C' C ' 26' ' ' LEU . . . . . 0.402 HD12 HG22 ' C' ' 22' ' ' ILE . 89.8 mt -79.86 -43.43 22.32 Favored 'General case' 0 C--N 1.33 -0.246 0 N-CA-C 113.352 0.871 . . . . 0.0 113.352 -171.759 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' C' C ' 27' ' ' GLN . . . . . . . . . . . . . 15.4 pt20 -46.78 138.62 6.05 Favored 'General case' 0 N--CA 1.468 0.468 0 N-CA-C 112.822 0.675 . . . . 0.0 112.822 -173.813 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' C' C ' 28' ' ' GLY . . . . . . . . . . . . . . . 100.22 -25.87 26.66 Favored Glycine 0 CA--C 1.533 1.174 0 CA-C-N 115.402 -0.817 . . . . 0.0 112.359 -177.338 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' C' C ' 29' ' ' LYS . . . . . . . . . . . . . 63.0 mttp -98.71 155.09 17.51 Favored 'General case' 0 C--N 1.332 -0.194 0 CA-C-N 117.396 0.598 . . . . 0.0 111.367 179.779 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' C' C ' 30' ' ' THR . . . . . . . . . . . . . 28.6 m -96.87 136.4 37.48 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 115.985 -0.552 . . . . 0.0 110.012 175.445 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' C' C ' 31' ' ' VAL . . . . . . . . . . . . . 34.9 m -128.94 148.76 33.26 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.316 0 CA-C-N 116.282 -0.417 . . . . 0.0 110.654 -179.368 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' C' C ' 32' ' ' ARG . . . . . . . . . . . . . 53.9 ttp180 -131.34 147.78 52.61 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-O 121.191 0.52 . . . . 0.0 110.332 178.661 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' C' C ' 33' ' ' THR . . . . . . . . . . . . . 17.5 m -52.99 138.82 29.47 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.383 -0.371 . . . . 0.0 111.46 -177.4 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' C' C ' 34' ' ' GLY . . . . . . . . . . . . . . . 101.51 -17.2 55.68 Favored Glycine 0 CA--C 1.533 1.214 0 CA-C-O 119.66 -0.522 . . . . 0.0 113.135 -179.782 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' C' C ' 35' ' ' ASP . . . . . . . . . . . . . 67.2 m-20 -65.14 149.84 49.2 Favored 'General case' 0 C--O 1.231 0.127 0 CA-C-N 118.046 0.923 . . . . 0.0 111.249 179.127 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' C' C ' 36' ' ' VAL . . . . . . . . . . . . . 46.0 t -123.3 131.46 73.13 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.239 0 CA-C-N 115.788 -0.642 . . . . 0.0 109.835 177.784 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' C' C ' 37' ' ' ILE . . . . . . . . . . . . . 69.7 mt -120.57 139.36 48.08 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.234 0 CA-C-N 116.254 -0.43 . . . . 0.0 109.984 -179.115 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' C' C ' 38' ' ' GLY . . . . . . . . . . . . . . . -113.83 128.84 8.48 Favored Glycine 0 CA--C 1.526 0.721 0 N-CA-C 111.095 -0.802 . . . . 0.0 111.095 -179.972 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' C' C ' 39' ' ' ILE . . . . . . . . . . . . . 72.8 mt -123.18 133.44 69.09 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.265 0 N-CA-C 110.026 -0.361 . . . . 0.0 110.026 179.116 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' C' C ' 40' ' ' SER . . . . . . . . . . . . . 85.8 p -92.11 122.64 34.8 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.454 -0.339 . . . . 0.0 110.684 176.222 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' C' C ' 41' ' ' ILE . . . . . . . . . . . . . 73.3 mt -135.39 118.13 22.65 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.176 0 CA-C-O 120.95 0.405 . . . . 0.0 110.467 178.738 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' C' C ' 42' ' ' LEU . . . . . 0.533 ' O ' HD23 ' C' ' 42' ' ' LEU . 1.4 tt 55.17 45.48 25.87 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-O 121.496 0.665 . . . . 0.0 110.424 177.79 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' C' C ' 43' ' ' GLY . . . . . . . . . . . . . . . 74.99 -10.01 10.4 Favored Glycine 0 CA--C 1.535 1.31 0 C-N-CA 121.239 -0.505 . . . . 0.0 113.761 174.679 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' C' C ' 44' ' ' LYS . . . . . . . . . . . . . 93.1 mttt -104.79 137.61 42.32 Favored 'General case' 0 C--N 1.334 -0.103 0 CA-C-N 118.116 0.958 . . . . 0.0 110.6 -179.464 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' C' C ' 45' ' ' GLU . . . . . . . . . . . . . 79.5 tt0 -85.58 130.0 34.68 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.247 -0.433 . . . . 0.0 111.002 179.453 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' C' C ' 46' ' ' VAL . . . . . . . . . . . . . 7.4 p -123.24 127.96 74.69 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.247 0 N-CA-C 109.587 -0.523 . . . . 0.0 109.587 175.369 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' C' C ' 47' ' ' LYS . . . . . . . . . . . . . 57.3 mtmt -101.47 129.71 47.58 Favored 'General case' 0 C--N 1.331 -0.201 0 CA-C-N 115.888 -0.596 . . . . 0.0 111.626 179.824 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' C' C ' 48' ' ' PHE . . . . . . . . . . . . . 93.1 m-85 -113.85 132.07 56.03 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.079 -0.509 . . . . 0.0 110.154 176.861 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' C' C ' 49' ' ' LYS . . . . . . . . . . . . . 77.8 tttt -106.18 139.56 40.5 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.558 -0.292 . . . . 0.0 110.635 178.978 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' C' C ' 50' ' ' VAL . . . . . . . . . . . . . 44.9 t -83.64 105.61 13.38 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.252 0 N-CA-C 109.194 -0.669 . . . . 0.0 109.194 174.64 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' C' C ' 51' ' ' VAL . . . . . . . . . . . . . 48.7 t -69.65 -54.89 17.13 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.39 0 CA-C-N 115.791 -0.64 . . . . 0.0 109.513 -175.041 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' C' C ' 52' ' ' GLN . . . . . . . . . . . . . 88.5 mt-30 -155.26 154.36 32.04 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 115.882 -0.599 . . . . 0.0 111.906 -177.561 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' C' C ' 53' ' ' ALA . . . . . 0.639 ' HB3' ' OG ' ' C' ' 56' ' ' SER . . . -131.6 132.49 44.11 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 115.334 -0.848 . . . . 0.0 109.782 174.1 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' C' C ' 54' ' ' TYR . . . . . . . . . . . . . 19.8 t80 -129.11 110.45 18.21 Favored Pre-proline 0 CA--C 1.533 0.32 0 CA-C-O 118.142 -0.932 . . . . 0.0 110.092 177.224 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' C' C ' 55' ' ' PRO . . . . . . . . . . . . . 72.7 Cg_endo -77.1 170.1 72.51 Favored 'Cis proline' 0 N--CA 1.5 1.869 0 CA-C-N 121.983 1.744 . . . . 0.0 112.326 -4.973 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' C' C ' 56' ' ' SER . . . . . 0.639 ' OG ' ' HB3' ' C' ' 53' ' ' ALA . 67.2 m -128.19 138.9 33.98 Favored Pre-proline 0 CA--C 1.536 0.429 0 CA-C-O 118.585 -0.721 . . . . 0.0 109.32 174.039 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' C' C ' 57' ' ' PRO . . . . . . . . . . . . . 40.4 Cg_endo -68.53 143.12 70.03 Favored 'Cis proline' 0 N--CA 1.498 1.789 0 CA-C-N 121.662 1.629 . . . . 0.0 111.678 -1.093 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' C' C ' 58' ' ' LEU . . . . . . . . . . . . . 27.8 tp -107.58 138.03 44.54 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.055 -0.52 . . . . 0.0 110.764 -176.085 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' C' C ' 59' ' ' ARG . . . . . . . . . . . . . 43.1 ttp180 -101.44 119.31 38.57 Favored 'General case' 0 C--N 1.328 -0.354 0 N-CA-C 108.894 -0.78 . . . . 0.0 108.894 173.698 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' C' C ' 60' ' ' VAL . . . . . . . . . . . . . 45.0 t -72.25 120.04 19.97 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.258 0 C-N-CA 120.644 -0.423 . . . . 0.0 110.3 -173.677 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' C' C ' 61' ' ' GLU . . . . . . . . . . . . . 42.8 mt-10 -131.04 162.61 29.42 Favored 'General case' 0 C--N 1.331 -0.23 0 CA-C-N 116.03 -0.532 . . . . 0.0 110.284 178.411 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' C' C ' 62' ' ' ASP . . . . . . . . . . . . . 7.7 p-10 -56.19 -32.54 64.46 Favored 'General case' 0 C--N 1.329 -0.304 0 N-CA-C 111.922 0.342 . . . . 0.0 111.922 -178.412 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' C' C ' 63' ' ' ARG . . . . . . . . . . . . . 40.4 ptt180 -81.4 3.83 23.05 Favored 'General case' 0 CA--C 1.537 0.452 0 N-CA-C 113.746 1.017 . . . . 0.0 113.746 -175.582 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' C' C ' 64' ' ' THR . . . . . . . . . . . . . 26.4 m -87.99 138.75 31.17 Favored 'General case' 0 C--N 1.332 -0.166 0 CA-C-N 118.103 0.41 . . . . 0.0 110.48 -179.061 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' C' C ' 65' ' ' LYS . . . . . . . . . . . . . 95.4 mttt -87.93 128.31 35.37 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.373 -0.376 . . . . 0.0 110.127 -179.755 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' C' C ' 66' ' ' ILE . . . . . . . . . . . . . 59.1 mt -115.64 131.62 67.48 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.215 0 N-CA-C 109.936 -0.394 . . . . 0.0 109.936 -179.329 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' C' C ' 67' ' ' THR . . . . . . . . . . . . . 26.3 m -124.69 138.21 54.31 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-N 116.151 -0.477 . . . . 0.0 110.723 -179.689 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' C' C ' 68' ' ' LEU . . . . . . . . . . . . . 48.2 mt -103.06 122.82 45.44 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 115.902 -0.59 . . . . 0.0 110.297 177.367 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' C' C ' 69' ' ' VAL . . . . . . . . . . . . . 43.3 t -102.44 144.89 12.87 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.351 0 CA-C-N 115.926 -0.579 . . . . 0.0 110.042 -179.809 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' C' C ' 70' ' ' THR . . . . . . . . . . . . . 8.5 m -128.43 -41.86 1.52 Allowed 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.097 -0.501 . . . . 0.0 110.011 178.809 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' C' C ' 71' ' ' HIS . . . . . . . . . . . . . 28.7 m80 -105.54 152.69 40.06 Favored Pre-proline 0 C--N 1.331 -0.229 0 N-CA-C 109.812 -0.44 . . . . 0.0 109.812 175.647 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' C' C ' 72' ' ' PRO . . . . . . . . . . . . . 33.3 Cg_endo -65.01 -22.71 62.13 Favored 'Trans proline' 0 N--CA 1.496 1.667 0 C-N-CA 121.219 1.279 . . . . 0.0 112.867 179.159 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' C' C ' 73' ' ' VAL . . . . . . . . . . . . . 30.4 m -105.44 164.3 4.15 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.211 0 N-CA-C 110.138 -0.319 . . . . 0.0 110.138 179.289 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' C' C ' 74' ' ' ASP . . . . . 0.407 ' OD1' HD11 ' C' ' 76' ' ' LEU . 13.6 t0 -96.38 119.04 34.15 Favored 'General case' 0 C--N 1.33 -0.253 0 N-CA-C 109.919 -0.401 . . . . 0.0 109.919 -177.498 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' C' C ' 75' ' ' VAL . . . . . 0.418 HG21 ' CE1' ' B' ' 113' ' ' TYR . 43.2 t -119.44 122.95 70.25 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.208 0 CA-C-O 121.125 0.488 . . . . 0.0 110.811 -176.954 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' C' C ' 76' ' ' LEU . . . . . 0.48 ' N ' HD12 ' C' ' 76' ' ' LEU . 5.8 mp -121.05 141.48 50.72 Favored 'General case' 0 C--N 1.331 -0.205 0 CA-C-N 115.647 -0.706 . . . . 0.0 109.12 174.112 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' C' C ' 77' ' ' GLU . . . . . . . . . . . . . 31.3 tt0 -132.08 132.13 43.02 Favored 'General case' 0 C--N 1.331 -0.209 0 CA-C-O 120.841 0.353 . . . . 0.0 110.902 -176.161 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' C' C ' 78' ' ' ALA . . . . . . . . . . . . . . . -119.1 142.44 47.9 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 116.002 -0.545 . . . . 0.0 109.869 177.454 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' C' C ' 79' ' ' LYS . . . . . 0.565 ' O ' HD13 ' C' ' 80' ' ' ILE . 81.3 tttt -84.45 119.73 25.47 Favored 'General case' 0 C--N 1.328 -0.332 0 C-N-CA 120.934 -0.307 . . . . 0.0 110.58 -178.69 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' C' C ' 80' ' ' ILE . . . . . 0.565 HD13 ' O ' ' C' ' 79' ' ' LYS . 44.8 mm -138.26 117.94 14.96 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.27 0 N-CA-C 109.533 -0.543 . . . . 0.0 109.533 -177.486 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' C' C ' 81' ' ' LYS . . . . . . . . . . . . . 59.4 mtmt -112.83 125.69 54.62 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.407 -0.361 . . . . 0.0 111.37 -176.298 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' C' C ' 82' ' ' GLY . . . . . . . . . . . . . . . 89.13 42.11 5.68 Favored Glycine 0 CA--C 1.524 0.595 0 C-N-CA 120.865 -0.683 . . . . 0.0 111.458 175.485 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' C' C ' 83' ' ' ILE . . . . . . . . . . . . . 70.1 mt -67.59 132.77 32.34 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.291 0 N-CA-C 109.835 -0.431 . . . . 0.0 109.835 178.909 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' C' C ' 84' ' ' LYS . . . . . . . . . . . . . 59.4 tttp -93.5 -49.25 6.0 Favored 'General case' 0 C--N 1.327 -0.407 0 CA-C-N 116.011 -0.54 . . . . 0.0 109.837 179.967 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' C' C ' 85' ' ' ASP . . . . . . . . . . . . . 5.1 t0 -159.84 153.14 22.15 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 115.71 -0.677 . . . . 0.0 110.28 179.031 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' C' C ' 86' ' ' VAL . . . . . . . . . . . . . 42.6 t -125.92 131.75 71.46 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.274 0 CA-C-O 120.868 0.366 . . . . 0.0 110.199 -179.939 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' C' C ' 87' ' ' ILE . . . . . . . . . . . . . 44.2 mm -120.13 129.27 75.68 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.264 0 CA-C-N 116.027 -0.533 . . . . 0.0 109.632 178.981 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' C' C ' 88' ' ' LEU . . . . . . . . . . . . . 12.4 tp -112.31 130.77 55.84 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-O 120.985 0.421 . . . . 0.0 111.296 -175.857 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' C' C ' 89' ' ' ASP . . . . . . . . . . . . . 13.1 t70 -125.27 152.01 45.2 Favored 'General case' 0 C--N 1.33 -0.249 0 N-CA-C 109.272 -0.64 . . . . 0.0 109.272 175.016 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' C' C ' 90' ' ' GLU . . . . . . . . . . . . . 95.4 mt-10 -48.92 -37.8 20.93 Favored 'General case' 0 C--N 1.329 -0.324 0 N-CA-C 112.754 0.649 . . . . 0.0 112.754 -171.804 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' C' C ' 91' ' ' ASN . . . . . . . . . . . . . 14.7 m-80 -125.49 16.7 8.23 Favored 'General case' 0 N--CA 1.468 0.474 0 N-CA-C 113.21 0.819 . . . . 0.0 113.21 -177.352 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' C' C ' 92' ' ' LEU . . . . . . . . . . . . . 12.5 mt -148.86 143.26 26.15 Favored 'General case' 0 C--N 1.333 -0.114 0 N-CA-C 110.112 -0.329 . . . . 0.0 110.112 -176.605 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' C' C ' 93' ' ' ILE . . . . . . . . . . . . . 73.7 mt -121.23 119.27 58.7 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.353 0 N-CA-C 109.157 -0.683 . . . . 0.0 109.157 177.55 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' C' C ' 94' ' ' VAL . . . . . . . . . . . . . 45.3 t -118.73 127.16 75.68 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.201 0 CA-C-O 121.023 0.439 . . . . 0.0 110.061 -178.314 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' C' C ' 95' ' ' VAL . . . . . . . . . . . . . 44.9 t -118.97 132.91 67.5 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.357 0 CA-C-N 115.784 -0.644 . . . . 0.0 109.519 178.681 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' C' C ' 96' ' ' ILE . . . . . . . . . . . . . 68.3 mt -112.67 126.06 70.01 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.346 0 N-CA-C 109.214 -0.662 . . . . 0.0 109.214 178.775 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' C' C ' 97' ' ' THR . . . . . . . . . . . . . 60.6 p -99.76 158.27 15.91 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-O 121.313 0.578 . . . . 0.0 111.386 -176.904 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' C' C ' 98' ' ' GLU . . . . . . . . . . . . . 83.8 tt0 -53.88 -26.71 26.17 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.049 -0.523 . . . . 0.0 112.23 179.73 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' C' C ' 99' ' ' GLU . . . . . . . . . . . . . 71.0 mm-40 -78.87 15.35 1.1 Allowed 'General case' 0 CA--C 1.534 0.353 0 N-CA-C 113.185 0.809 . . . . 0.0 113.185 -177.691 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' C' C ' 100' ' ' ASN . . . . . . . . . . . . . 4.1 m-20 60.88 38.16 17.97 Favored 'General case' 0 C--O 1.232 0.146 0 CA-C-O 121.101 0.477 . . . . 0.0 110.823 179.833 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' C' C ' 101' ' ' GLU . . . . . . . . . . . . . 83.7 tt0 -114.83 144.36 43.65 Favored 'General case' 0 C--N 1.332 -0.16 0 CA-C-N 116.001 -0.545 . . . . 0.0 109.64 177.016 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' C' C ' 102' ' ' VAL . . . . . . . . . . . . . 44.4 t -114.93 124.84 71.98 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.306 0 N-CA-C 109.919 -0.401 . . . . 0.0 109.919 -178.156 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' C' C ' 103' ' ' LEU . . . . . . . . . . . . . 28.7 mt -113.64 131.28 56.2 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 115.717 -0.674 . . . . 0.0 110.198 176.6 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' C' C ' 104' ' ' ILE . . . . . . . . . . . . . 73.5 mt -120.36 119.06 58.76 Favored 'Isoleucine or valine' 0 C--O 1.235 0.325 0 N-CA-C 110.295 -0.261 . . . . 0.0 110.295 -179.79 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' C' C ' 105' ' ' PHE . . . . . . . . . . . . . 79.7 m-85 -120.19 167.37 12.32 Favored 'General case' 0 C--N 1.331 -0.217 0 O-C-N 124.205 0.941 . . . . 0.0 109.766 178.956 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' C' C ' 106' ' ' ASN . . . . . . . . . . . . . 39.7 p-10 -103.77 -169.91 1.7 Allowed 'General case' 0 CA--C 1.53 0.181 0 N-CA-C 109.703 -0.48 . . . . 0.0 109.703 171.394 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' C' C ' 107' ' ' GLN . . . . . . . . . . . . . 50.0 tt0 -58.69 -30.12 67.15 Favored 'General case' 0 C--N 1.329 -0.302 0 N-CA-C 111.862 0.319 . . . . 0.0 111.862 179.361 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' C' C ' 108' ' ' ASN . . . . . . . . . . . . . 45.7 t30 -89.21 12.88 14.66 Favored 'General case' 0 CA--C 1.535 0.393 0 N-CA-C 113.048 0.759 . . . . 0.0 113.048 -176.855 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' C' C ' 109' ' ' LEU . . . . . . . . . . . . . 63.3 mt 58.28 35.72 25.12 Favored 'General case' 0 C--N 1.332 -0.182 0 CA-C-O 120.755 0.312 . . . . 0.0 111.767 175.934 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' C' C ' 110' ' ' GLU . . . . . . . . . . . . . 70.3 mm-40 -103.91 135.28 45.74 Favored 'General case' 0 C--N 1.33 -0.264 0 N-CA-C 110.014 -0.365 . . . . 0.0 110.014 175.238 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' C' C ' 111' ' ' GLU . . . . . . . . . . . . . 98.1 mt-10 -67.14 123.62 20.78 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-O 121.044 0.45 . . . . 0.0 111.071 -178.39 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' C' C ' 112' ' ' LEU . . . . . . . . . . . . . 13.9 mt -105.99 -43.88 4.74 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-N 115.793 -0.64 . . . . 0.0 109.946 175.78 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' C' C ' 113' ' ' TYR . . . . . . . . . . . . . 65.0 t80 -143.86 140.76 29.96 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.236 -0.438 . . . . 0.0 111.637 -179.315 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' C' C ' 114' ' ' ARG . . . . . . . . . . . . . 37.2 ttm180 -136.31 128.1 29.16 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 115.797 -0.638 . . . . 0.0 109.96 174.026 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' C' C ' 115' ' ' GLY . . . . . . . . . . . . . . . -150.04 159.41 28.09 Favored Glycine 0 CA--C 1.526 0.774 0 N-CA-C 111.169 -0.772 . . . . 0.0 111.169 177.441 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' C' C ' 116' ' ' LYS . . . . . . . . . . . . . 33.7 ttpt -130.81 136.6 48.85 Favored 'General case' 0 C--N 1.33 -0.244 0 N-CA-C 109.974 -0.38 . . . . 0.0 109.974 177.555 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' C' C ' 117' ' ' PHE . . . . . . . . . . . . . 40.8 m-85 -135.14 117.14 15.3 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-O 120.703 0.287 . . . . 0.0 110.39 -176.672 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' C' C ' 118' ' ' GLU . . . . . . . . . . . . . 70.6 mm-40 -54.65 -46.32 73.96 Favored 'General case' 0 C--N 1.329 -0.29 0 C-N-CA 120.996 -0.282 . . . . 0.0 111.38 -177.014 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' C' C ' 119' ' ' ASN . . . . . . . . . . . . . 6.0 m120 -95.99 30.99 2.24 Favored 'General case' 0 C--N 1.329 -0.322 0 N-CA-C 112.046 0.387 . . . . 0.0 112.046 -175.457 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' C' C ' 120' ' ' LEU . . . . . . . . . . . . . 14.0 tp -57.82 120.93 9.3 Favored 'General case' 0 C--O 1.232 0.154 0 CA-C-O 120.679 0.276 . . . . 0.0 110.39 179.008 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' C' C ' 121' ' ' ASN . . . . . . . . . . . . . 93.9 m-20 -114.16 -43.96 3.18 Favored 'General case' 0 C--N 1.331 -0.217 0 CA-C-N 116.38 -0.373 . . . . 0.0 111.311 -178.304 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' C' C ' 122' ' ' LYS . . . . . . . . . . . . . 97.2 mttt -144.28 151.11 38.93 Favored 'General case' 0 C--N 1.331 -0.215 0 C-N-CA 120.647 -0.421 . . . . 0.0 111.848 -175.993 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' C' C ' 123' ' ' VAL . . . . . . . . . . . . . 46.1 t -132.08 128.59 59.4 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.311 0 N-CA-C 109.259 -0.645 . . . . 0.0 109.259 172.159 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' C' C ' 124' ' ' LEU . . . . . . . . . . . . . 8.7 tp -128.31 143.27 51.0 Favored 'General case' 0 N--CA 1.464 0.245 0 CA-C-O 120.726 0.298 . . . . 0.0 110.91 -175.845 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' C' C ' 125' ' ' VAL . . . . . 0.474 HG12 HG23 ' C' ' 130' ' ' VAL . 35.0 m -130.19 143.84 39.78 Favored 'Isoleucine or valine' 0 C--O 1.232 0.177 0 CA-C-N 116.35 -0.386 . . . . 0.0 111.254 -178.637 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' C' C ' 126' ' ' ARG . . . . . . . . . . . . . 96.0 mtt-85 -149.73 124.9 10.08 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 116.246 -0.434 . . . . 0.0 110.781 175.634 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' C' C ' 127' ' ' ASN . . . . . . . . . . . . . 24.8 m120 49.63 -109.18 0.35 Allowed 'General case' 0 CA--C 1.545 0.764 0 CA-C-O 118.828 -0.606 . . . . 0.0 111.649 178.938 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' C' C ' 128' ' ' ASP . . . . . . . . . . . . . 19.5 p-10 -114.09 7.3 16.68 Favored 'General case' 0 N--CA 1.469 0.482 0 CA-C-N 119.891 1.223 . . . . 0.0 113.371 -177.442 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' C' C ' 129' ' ' LEU . . . . . . . . . . . . . 42.1 mt -113.7 147.88 37.4 Favored 'General case' 0 C--O 1.232 0.14 0 N-CA-C 109.795 -0.446 . . . . 0.0 109.795 178.723 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' C' C ' 130' ' ' VAL . . . . . 0.49 HG13 ' HB ' ' C' ' 141' ' ' ILE . 12.9 p -133.62 143.18 39.55 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.222 0 CA-C-O 121.166 0.508 . . . . 0.0 110.511 -179.758 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' C' C ' 131' ' ' VAL . . . . . 0.476 HG22 HD12 ' C' ' 140' ' ' LEU . 41.1 t -132.92 138.4 51.82 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.248 0 CA-C-N 115.848 -0.614 . . . . 0.0 110.234 -178.068 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' C' C ' 132' ' ' ILE . . . . . . . . . . . . . 72.2 mt -116.8 133.86 62.15 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.331 0 N-CA-C 109.308 -0.627 . . . . 0.0 109.308 179.471 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' C' C ' 133' ' ' ILE . . . . . . . . . . . . . 40.1 mm -117.02 122.89 71.08 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.245 0 CA-C-N 116.673 -0.239 . . . . 0.0 110.81 -174.756 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' C' C ' 134' ' ' ASP . . . . . . . . . . . . . 7.2 p-10 -135.59 150.28 49.63 Favored 'General case' 0 C--N 1.331 -0.225 0 N-CA-C 110.003 -0.369 . . . . 0.0 110.003 175.55 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' C' C ' 135' ' ' GLU . . . . . . . . . . . . . 44.8 tp10 -50.67 -28.08 8.26 Favored 'General case' 0 C--N 1.328 -0.361 0 N-CA-C 112.756 0.65 . . . . 0.0 112.756 -173.218 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' C' C ' 136' ' ' GLN . . . . . . . . . . . . . 96.9 mt-30 -86.17 -29.22 23.41 Favored 'General case' 0 C--N 1.33 -0.253 0 N-CA-C 112.805 0.669 . . . . 0.0 112.805 -174.98 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' C' C ' 137' ' ' LYS . . . . . . . . . . . . . 43.1 pttt -170.14 173.67 5.77 Favored 'General case' 0 C--N 1.332 -0.189 0 CA-C-O 121.53 0.681 . . . . 0.0 112.503 -172.544 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' C' C ' 138' ' ' LEU . . . . . 0.42 HD23 ' N ' ' C' ' 139' ' ' THR . 5.5 tt -118.55 128.62 54.74 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 114.967 -1.015 . . . . 0.0 109.766 179.168 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' C' C ' 139' ' ' THR . . . . . 0.42 ' N ' HD23 ' C' ' 138' ' ' LEU . 31.9 m -107.09 128.16 54.13 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.43 -0.35 . . . . 0.0 110.281 179.798 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' C' C ' 140' ' ' LEU . . . . . 0.476 HD12 HG22 ' C' ' 131' ' ' VAL . 11.0 tp -114.6 121.42 43.38 Favored 'General case' 0 C--N 1.328 -0.339 0 N-CA-C 109.23 -0.655 . . . . 0.0 109.23 -178.718 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' C' C ' 141' ' ' ILE . . . . . 0.49 ' HB ' HG13 ' C' ' 130' ' ' VAL . 20.1 mt -119.28 121.6 66.97 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 CA-C-O 121.032 0.444 . . . . 0.0 110.04 -175.803 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' C' C ' 142' ' ' ARG . . . . . . . . . . . . . 69.5 mtt180 -109.35 128.83 55.41 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 114.989 -1.005 . . . . 0.0 109.849 -175.263 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' C' C ' 143' ' ' THR . . . . . . . . . . . . . 36.3 p . . . . . 0 C--O 1.219 -0.513 0 CA-C-O 118.098 -0.954 . . . . 0.0 110.608 -179.3 . . . . . . . . 0 0 . 1 . 015 nuclear build full ' D' D ' -3' ' ' GLU . . . . . . . . . . . . . 96.0 mt-10 . . . . . 0 N--CA 1.49 1.537 0 N-CA-C 109.504 -0.554 . . . . 0.0 109.504 . . . . . . . . . 0 0 . 1 . 015 nuclear build full ' D' D ' -2' ' ' GLY . . . . . . . . . . . . . . . -77.71 150.04 35.71 Favored Glycine 0 CA--C 1.524 0.653 0 N-CA-C 111.043 -0.823 . . . . 0.0 111.043 179.947 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' D' D ' -1' ' ' VAL . . . . . . . . . . . . . 44.7 t -94.28 130.48 43.11 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.302 0 CA-C-O 120.89 0.376 . . . . 0.0 110.0 179.932 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' D' D ' 0' ' ' ILE . . . . . . . . . . . . . 72.9 mt -120.68 134.58 63.66 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.192 0 CA-C-N 116.131 -0.486 . . . . 0.0 109.874 -179.513 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' D' D ' 1' ' ' MET . . . . . . . . . . . . . 25.6 ptp -83.3 136.39 34.39 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.316 -0.402 . . . . 0.0 110.728 -179.905 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' D' D ' 2' ' ' SER . . . . . . . . . . . . . 25.2 p -122.56 138.96 54.41 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.211 -0.45 . . . . 0.0 110.574 179.517 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' D' D ' 3' ' ' GLU . . . . . . . . . . . . . 95.3 mt-10 -141.13 138.78 33.72 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.1 -0.5 . . . . 0.0 111.489 -177.498 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' D' D ' 4' ' ' LEU . . . . . . . . . . . . . 70.1 mt -118.96 127.74 53.75 Favored 'General case' 0 C--N 1.331 -0.214 0 CA-C-N 115.953 -0.567 . . . . 0.0 110.079 174.392 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' D' D ' 5' ' ' LYS . . . . . . . . . . . . . 98.7 mttt -109.67 122.4 47.38 Favored 'General case' 0 C--O 1.235 0.311 0 CA-C-O 120.673 0.273 . . . . 0.0 110.659 177.225 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' D' D ' 6' ' ' LEU . . . . . . . . . . . . . 46.8 mt -113.94 146.55 39.93 Favored 'General case' 0 C--N 1.331 -0.219 0 CA-C-N 115.435 -0.802 . . . . 0.0 109.919 179.786 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' D' D ' 7' ' ' LYS . . . . . . . . . . . . . 76.4 tttt -131.28 137.63 31.01 Favored Pre-proline 0 CA--C 1.533 0.318 0 CA-C-O 118.935 -0.555 . . . . 0.0 109.732 175.74 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' D' D ' 8' ' ' PRO . . . . . . . . . . . . . 85.9 Cg_endo -90.96 135.18 1.86 Allowed 'Trans proline' 0 N--CA 1.489 1.225 0 C-N-CA 121.705 1.603 . . . . 0.0 111.825 179.316 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' D' D ' 9' ' ' LEU . . . . . . . . . . . . . 38.0 mt -73.3 -45.13 7.86 Favored Pre-proline 0 CA--C 1.533 0.311 0 CA-C-O 119.019 -0.515 . . . . 0.0 111.036 179.79 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' D' D ' 10' ' ' PRO . . . . . . . . . . . . . 64.5 Cg_endo -86.11 152.82 9.6 Favored 'Trans proline' 0 N--CA 1.492 1.425 0 C-N-CA 121.241 1.294 . . . . 0.0 111.066 169.041 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' D' D ' 11' ' ' LYS . . . . . . . . . . . . . 25.5 pttm -86.1 119.86 26.86 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-O 121.291 0.567 . . . . 0.0 110.461 177.084 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' D' D ' 12' ' ' VAL . . . . . . . . . . . . . 13.1 p -150.47 143.29 17.22 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.327 0 CA-C-N 115.928 -0.578 . . . . 0.0 110.523 -179.966 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' D' D ' 13' ' ' GLU . . . . . . . . . . . . . 43.3 mt-10 -90.36 110.47 21.55 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.296 -0.411 . . . . 0.0 110.04 177.808 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' D' D ' 14' ' ' LEU . . . . . . . . . . . . . 15.8 mt -88.08 153.05 51.47 Favored Pre-proline 0 C--N 1.33 -0.281 0 CA-C-N 116.345 -0.389 . . . . 0.0 110.646 -178.154 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' D' D ' 15' ' ' PRO . . . . . . . . . . . . . 25.4 Cg_exo -62.58 155.16 60.19 Favored 'Trans proline' 0 N--CA 1.497 1.679 0 C-N-CA 121.267 1.311 . . . . 0.0 111.35 175.17 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' D' D ' 16' ' ' PRO . . . . . . . . . . . . . 36.5 Cg_exo -58.02 -35.64 98.61 Favored 'Trans proline' 0 N--CA 1.497 1.723 0 C-N-CA 121.318 1.345 . . . . 0.0 112.923 -178.68 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' D' D ' 17' ' ' ASP . . . . . . . . . . . . . 10.8 p-10 -85.48 5.96 28.99 Favored 'General case' 0 CA--C 1.536 0.411 0 N-CA-C 113.336 0.865 . . . . 0.0 113.336 -176.508 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' D' D ' 18' ' ' PHE . . . . . . . . . . . . . 42.3 t80 -58.37 -44.49 88.9 Favored 'General case' 0 C--N 1.334 -0.101 0 O-C-N 121.939 -0.475 . . . . 0.0 109.892 -179.251 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' D' D ' 19' ' ' VAL . . . . . . . . . . . . . 47.6 t -56.76 -42.6 77.79 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.284 0 CA-C-N 116.243 -0.435 . . . . 0.0 110.316 -179.423 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' D' D ' 20' ' ' ASP . . . . . . . . . . . . . 9.6 t70 -59.47 -42.59 92.39 Favored 'General case' 0 C--N 1.33 -0.278 0 C-N-CA 120.853 -0.339 . . . . 0.0 110.72 -177.522 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' D' D ' 21' ' ' VAL . . . . . . . . . . . . . 47.3 t -64.42 -46.37 93.12 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 C-N-CA 120.754 -0.378 . . . . 0.0 110.646 -177.611 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' D' D ' 22' ' ' ILE . . . . . 0.551 HG22 HD12 ' D' ' 26' ' ' LEU . 45.4 mm -58.57 -40.27 78.38 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.267 0 C-N-CA 121.05 -0.26 . . . . 0.0 110.758 -179.449 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' D' D ' 23' ' ' ARG . . . . . . . . . . . . . 35.4 ttp180 -57.73 -49.64 75.88 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-O 121.148 0.499 . . . . 0.0 110.32 177.285 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' D' D ' 24' ' ' ILE . . . . . . . . . . . . . 66.0 mt -60.96 -38.41 79.32 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.304 0 CA-C-N 115.737 -0.665 . . . . 0.0 111.841 -176.781 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' D' D ' 25' ' ' LYS . . . . . . . . . . . . . 35.5 pttt -77.21 -37.57 53.14 Favored 'General case' 0 CA--C 1.534 0.341 0 C-N-CA 120.396 -0.521 . . . . 0.0 111.864 -174.952 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' D' D ' 26' ' ' LEU . . . . . 0.551 HD12 HG22 ' D' ' 22' ' ' ILE . 72.0 mt -77.7 -32.42 52.99 Favored 'General case' 0 C--N 1.331 -0.238 0 N-CA-C 113.237 0.828 . . . . 0.0 113.237 -172.354 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' D' D ' 27' ' ' GLN . . . . . . . . . . . . . 20.4 pt20 -45.71 135.71 6.58 Favored 'General case' 0 N--CA 1.469 0.517 0 N-CA-C 112.951 0.723 . . . . 0.0 112.951 -175.49 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' D' D ' 28' ' ' GLY . . . . . . . . . . . . . . . 99.37 -24.76 30.93 Favored Glycine 0 CA--C 1.534 1.223 0 CA-C-N 115.62 -0.718 . . . . 0.0 112.441 -177.713 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' D' D ' 29' ' ' LYS . . . . . . . . . . . . . 69.0 mttm -98.05 155.17 17.25 Favored 'General case' 0 C--N 1.333 -0.12 0 CA-C-N 117.29 0.545 . . . . 0.0 111.002 179.599 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' D' D ' 30' ' ' THR . . . . . . . . . . . . . 21.6 m -101.1 140.19 35.74 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.36 -0.382 . . . . 0.0 110.465 178.206 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' D' D ' 31' ' ' VAL . . . . . . . . . . . . . 34.9 m -130.14 150.4 34.58 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.232 0 CA-C-N 116.232 -0.44 . . . . 0.0 110.992 -179.418 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' D' D ' 32' ' ' ARG . . . . . . . . . . . . . 82.0 mtm180 -135.42 151.09 50.1 Favored 'General case' 0 C--N 1.331 -0.23 0 CA-C-O 121.258 0.551 . . . . 0.0 110.672 178.275 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' D' D ' 33' ' ' THR . . . . . . . . . . . . . 29.3 m -53.65 139.93 30.6 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.273 -0.421 . . . . 0.0 111.193 -179.49 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' D' D ' 34' ' ' GLY . . . . . . . . . . . . . . . 101.01 -17.02 56.82 Favored Glycine 0 CA--C 1.532 1.131 0 CA-C-O 119.703 -0.498 . . . . 0.0 113.244 179.609 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' D' D ' 35' ' ' ASP . . . . . . . . . . . . . 67.5 m-20 -65.15 148.63 51.33 Favored 'General case' 0 C--O 1.232 0.133 0 CA-C-N 118.103 0.951 . . . . 0.0 110.999 178.739 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' D' D ' 36' ' ' VAL . . . . . . . . . . . . . 45.4 t -126.75 131.76 70.79 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.232 0 CA-C-N 116.044 -0.525 . . . . 0.0 109.935 179.444 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' D' D ' 37' ' ' ILE . . . . . . . . . . . . . 63.0 mt -124.89 139.78 50.01 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.215 0 CA-C-N 116.226 -0.443 . . . . 0.0 110.173 -179.09 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' D' D ' 38' ' ' GLY . . . . . . . . . . . . . . . -113.83 128.41 8.28 Favored Glycine 0 CA--C 1.526 0.724 0 N-CA-C 110.741 -0.944 . . . . 0.0 110.741 177.73 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' D' D ' 39' ' ' ILE . . . . . . . . . . . . . 70.6 mt -126.92 137.72 57.0 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.282 0 CA-C-O 120.654 0.264 . . . . 0.0 110.297 -179.758 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' D' D ' 40' ' ' SER . . . . . . . . . . . . . 42.9 t -92.11 120.8 33.06 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.307 -0.406 . . . . 0.0 110.755 176.058 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' D' D ' 41' ' ' ILE . . . . . . . . . . . . . 67.7 mt -126.57 117.51 48.4 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.193 0 CA-C-O 120.707 0.289 . . . . 0.0 110.268 178.672 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' D' D ' 42' ' ' LEU . . . . . . . . . . . . . 8.2 mp 50.94 39.13 22.05 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-O 121.094 0.474 . . . . 0.0 111.729 177.262 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' D' D ' 43' ' ' GLY . . . . . . . . . . . . . . . 75.36 26.57 65.55 Favored Glycine 0 CA--C 1.531 1.077 0 C-N-CA 121.218 -0.515 . . . . 0.0 112.669 175.742 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' D' D ' 44' ' ' LYS . . . . . . . . . . . . . 98.8 mttt -136.56 129.35 30.76 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 117.142 0.471 . . . . 0.0 109.798 176.606 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' D' D ' 45' ' ' GLU . . . . . . . . . . . . . 73.0 tt0 -84.16 123.38 30.02 Favored 'General case' 0 C--N 1.329 -0.314 0 C-N-CA 120.788 -0.365 . . . . 0.0 110.8 -178.102 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' D' D ' 46' ' ' VAL . . . . . . . . . . . . . 11.3 p -117.22 127.29 74.79 Favored 'Isoleucine or valine' 0 C--O 1.233 0.196 0 N-CA-C 109.832 -0.433 . . . . 0.0 109.832 176.368 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' D' D ' 47' ' ' LYS . . . . . . . . . . . . . 34.3 mmtp -98.23 122.91 41.96 Favored 'General case' 0 C--N 1.327 -0.404 0 CA-C-N 115.927 -0.578 . . . . 0.0 110.659 177.165 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' D' D ' 48' ' ' PHE . . . . . . . . . . . . . 30.6 m-85 -108.32 131.79 54.37 Favored 'General case' 0 C--N 1.33 -0.276 0 N-CA-C 109.668 -0.493 . . . . 0.0 109.668 175.693 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' D' D ' 49' ' ' LYS . . . . . . . . . . . . . 60.1 tttm -108.82 136.12 48.9 Favored 'General case' 0 C--N 1.329 -0.316 0 N-CA-C 110.04 -0.355 . . . . 0.0 110.04 175.858 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' D' D ' 50' ' ' VAL . . . . . . . . . . . . . 45.3 t -77.63 107.05 8.71 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.343 0 N-CA-C 109.176 -0.675 . . . . 0.0 109.176 176.487 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' D' D ' 51' ' ' VAL . . . . . . . . . . . . . 45.0 t -70.96 -48.75 54.27 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.315 0 CA-C-N 116.132 -0.486 . . . . 0.0 109.781 -174.221 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' D' D ' 52' ' ' GLN . . . . . . . . . . . . . 62.2 tt0 -164.66 139.8 5.55 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 115.983 -0.553 . . . . 0.0 111.187 -176.614 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' D' D ' 53' ' ' ALA . . . . . . . . . . . . . . . -120.37 135.87 54.89 Favored 'General case' 0 C--N 1.332 -0.191 0 CA-C-N 116.009 -0.541 . . . . 0.0 109.868 174.342 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' D' D ' 54' ' ' TYR . . . . . . . . . . . . . 43.7 t80 -129.11 116.58 18.9 Favored Pre-proline 0 CA--C 1.536 0.413 0 CA-C-O 118.091 -0.957 . . . . 0.0 110.338 178.226 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' D' D ' 55' ' ' PRO . . . . . . . . . . . . . 73.8 Cg_endo -77.13 170.07 72.57 Favored 'Cis proline' 0 N--CA 1.501 1.94 0 CA-C-N 122.015 1.756 . . . . 0.0 111.56 -9.836 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' D' D ' 56' ' ' SER . . . . . . . . . . . . . 13.7 m -128.03 141.72 42.15 Favored Pre-proline 0 CA--C 1.536 0.41 0 CA-C-O 118.625 -0.702 . . . . 0.0 109.575 174.777 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' D' D ' 57' ' ' PRO . . . . . . . . . . . . . 49.8 Cg_endo -69.94 141.71 67.49 Favored 'Cis proline' 0 N--CA 1.5 1.859 0 CA-C-N 121.489 1.567 . . . . 0.0 111.689 -1.082 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' D' D ' 58' ' ' LEU . . . . . . . . . . . . . 28.1 tp -108.53 138.74 44.34 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-N 116.381 -0.372 . . . . 0.0 110.881 -177.989 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' D' D ' 59' ' ' ARG . . . . . . . . . . . . . 66.9 ttp85 -99.67 124.14 44.61 Favored 'General case' 0 C--N 1.328 -0.332 0 N-CA-C 109.099 -0.704 . . . . 0.0 109.099 173.323 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' D' D ' 60' ' ' VAL . . . . . . . . . . . . . 41.1 t -72.78 120.28 21.12 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.254 0 CA-C-O 120.964 0.411 . . . . 0.0 110.51 -175.066 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' D' D ' 61' ' ' GLU . . . . . . . . . . . . . 74.7 tt0 -131.09 156.79 44.62 Favored 'General case' 0 C--N 1.328 -0.331 0 N-CA-C 108.874 -0.787 . . . . 0.0 108.874 175.991 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' D' D ' 62' ' ' ASP . . . . . . . . . . . . . 53.1 m-20 -49.6 -30.37 8.67 Favored 'General case' 0 CA--C 1.534 0.336 0 N-CA-C 112.378 0.51 . . . . 0.0 112.378 -179.169 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' D' D ' 63' ' ' ARG . . . . . . . . . . . . . 94.2 mtt180 -72.5 -21.96 61.12 Favored 'General case' 0 CA--C 1.533 0.3 0 N-CA-C 113.118 0.784 . . . . 0.0 113.118 -175.217 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' D' D ' 64' ' ' THR . . . . . . . . . . . . . 34.2 m -66.57 139.78 57.93 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-O 120.871 0.367 . . . . 0.0 110.913 -176.257 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' D' D ' 65' ' ' LYS . . . . . . . . . . . . . 99.4 mttt -89.09 130.69 35.49 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.093 -0.503 . . . . 0.0 109.906 176.971 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' D' D ' 66' ' ' ILE . . . . . . . . . . . . . 4.0 mp -112.39 124.14 68.79 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.229 0 N-CA-C 109.518 -0.549 . . . . 0.0 109.518 178.517 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' D' D ' 67' ' ' THR . . . . . . . . . . . . . 24.4 m -119.94 137.34 54.11 Favored 'General case' 0 C--N 1.331 -0.208 0 CA-C-O 121.102 0.477 . . . . 0.0 110.877 -176.985 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' D' D ' 68' ' ' LEU . . . . . . . . . . . . . 17.3 tp -103.16 122.17 44.16 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 115.831 -0.622 . . . . 0.0 109.99 178.084 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' D' D ' 69' ' ' VAL . . . . . . . . . . . . . 44.7 t -102.17 127.24 55.91 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.366 0 CA-C-N 116.285 -0.416 . . . . 0.0 110.061 -179.47 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' D' D ' 70' ' ' THR . . . . . . . . . . . . . 18.1 m -85.29 -52.89 5.58 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.227 -0.442 . . . . 0.0 110.475 179.891 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' D' D ' 71' ' ' HIS . . . . . . . . . . . . . 53.5 m-70 -149.87 152.95 35.37 Favored Pre-proline 0 CA--C 1.531 0.244 0 CA-C-N 116.251 -0.431 . . . . 0.0 110.654 179.551 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' D' D ' 72' ' ' PRO . . . . . . . . . . . . . 90.7 Cg_endo -88.98 -24.17 0.79 Allowed 'Trans proline' 0 N--CA 1.491 1.331 0 C-N-CA 121.729 1.619 . . . . 0.0 112.94 176.492 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' D' D ' 73' ' ' VAL . . . . . . . . . . . . . 35.2 m -125.52 175.82 7.19 Favored 'Isoleucine or valine' 0 C--N 1.333 -0.152 0 CA-C-O 120.684 0.278 . . . . 0.0 110.254 -178.931 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' D' D ' 74' ' ' ASP . . . . . . . . . . . . . 17.9 t0 -99.85 123.73 44.4 Favored 'General case' 0 C--N 1.331 -0.233 0 N-CA-C 110.04 -0.356 . . . . 0.0 110.04 -178.242 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' D' D ' 75' ' ' VAL . . . . . 0.55 ' C ' HD12 ' D' ' 76' ' ' LEU . 43.3 t -117.96 122.82 70.62 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.197 0 CA-C-O 120.922 0.391 . . . . 0.0 110.494 -177.862 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' D' D ' 76' ' ' LEU . . . . . 0.55 HD12 ' C ' ' D' ' 75' ' ' VAL . 8.0 mp -124.42 149.33 46.87 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 115.848 -0.615 . . . . 0.0 109.737 176.25 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' D' D ' 77' ' ' GLU . . . . . . . . . . . . . 97.2 mt-10 -136.3 136.6 39.9 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-O 121.049 0.452 . . . . 0.0 111.138 -178.476 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' D' D ' 78' ' ' ALA . . . . . . . . . . . . . . . -119.23 128.75 54.49 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 115.707 -0.679 . . . . 0.0 109.803 176.511 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' D' D ' 79' ' ' LYS . . . . . 0.652 ' O ' HD13 ' D' ' 80' ' ' ILE . 32.9 ttmt -79.46 118.05 20.98 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-O 120.963 0.411 . . . . 0.0 110.986 -176.348 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' D' D ' 80' ' ' ILE . . . . . 0.652 HD13 ' O ' ' D' ' 79' ' ' LYS . 37.1 mm -139.2 104.37 2.16 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.272 0 N-CA-C 109.067 -0.716 . . . . 0.0 109.067 -178.848 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' D' D ' 81' ' ' LYS . . . . . . . . . . . . . 84.5 tttt -95.0 125.56 39.75 Favored 'General case' 0 C--N 1.329 -0.287 0 C-N-CA 120.758 -0.377 . . . . 0.0 110.944 -177.277 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' D' D ' 82' ' ' GLY . . . . . . . . . . . . . . . 89.03 42.2 5.69 Favored Glycine 0 CA--C 1.524 0.594 0 N-CA-C 111.237 -0.745 . . . . 0.0 111.237 176.401 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' D' D ' 83' ' ' ILE . . . . . . . . . . . . . 71.1 mt -65.4 131.51 31.18 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.273 0 N-CA-C 109.68 -0.489 . . . . 0.0 109.68 177.521 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' D' D ' 84' ' ' LYS . . . . . . . . . . . . . 48.6 tttp -89.97 -50.54 5.96 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.025 -0.534 . . . . 0.0 109.947 -179.117 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' D' D ' 85' ' ' ASP . . . . . . . . . . . . . 10.0 t70 -159.85 153.12 22.1 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 115.653 -0.703 . . . . 0.0 110.173 178.366 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' D' D ' 86' ' ' VAL . . . . . . . . . . . . . 41.3 t -127.4 132.63 69.23 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.244 0 CA-C-O 120.965 0.412 . . . . 0.0 110.48 -179.328 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' D' D ' 87' ' ' ILE . . . . . 0.492 HD12 ' N ' ' D' ' 87' ' ' ILE . 5.0 mp -119.95 122.83 69.55 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.238 0 N-CA-C 109.329 -0.619 . . . . 0.0 109.329 176.471 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' D' D ' 88' ' ' LEU . . . . . . . . . . . . . 86.1 mt -109.49 137.18 47.72 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-O 121.157 0.503 . . . . 0.0 111.307 -177.73 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' D' D ' 89' ' ' ASP . . . . . . . . . . . . . 8.6 t70 -131.48 156.47 45.6 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 115.598 -0.728 . . . . 0.0 109.29 176.499 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' D' D ' 90' ' ' GLU . . . . . . . . . . . . . 48.1 mp0 -50.85 -29.07 10.85 Favored 'General case' 0 C--N 1.327 -0.387 0 N-CA-C 112.544 0.572 . . . . 0.0 112.544 -171.177 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' D' D ' 91' ' ' ASN . . . . . . . . . . . . . 54.0 t30 -131.61 13.74 4.94 Favored 'General case' 0 N--CA 1.468 0.464 0 N-CA-C 113.307 0.854 . . . . 0.0 113.307 -176.228 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' D' D ' 92' ' ' LEU . . . . . . . . . . . . . 41.8 mt -147.82 148.72 31.2 Favored 'General case' 0 C--N 1.331 -0.204 0 CA-C-N 118.04 0.382 . . . . 0.0 110.55 -176.85 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' D' D ' 93' ' ' ILE . . . . . . . . . . . . . 72.3 mt -126.09 114.08 37.03 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.357 0 N-CA-C 109.063 -0.717 . . . . 0.0 109.063 175.845 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' D' D ' 94' ' ' VAL . . . . . . . . . . . . . 42.3 t -115.29 125.49 72.56 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.24 0 N-CA-C 109.816 -0.438 . . . . 0.0 109.816 -178.945 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' D' D ' 95' ' ' VAL . . . . . . . . . . . . . 44.6 t -119.29 133.24 66.77 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.283 0 CA-C-N 116.056 -0.52 . . . . 0.0 109.813 -179.83 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' D' D ' 96' ' ' ILE . . . . . . . . . . . . . 64.2 mt -111.7 126.0 69.05 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.358 0 N-CA-C 108.804 -0.813 . . . . 0.0 108.804 177.239 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' D' D ' 97' ' ' THR . . . . . . . . . . . . . 60.3 p -99.82 159.89 14.72 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-O 121.215 0.531 . . . . 0.0 111.388 -176.315 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' D' D ' 98' ' ' GLU . . . . . . . . . . . . . 81.0 tt0 -53.89 -26.28 24.23 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.043 -0.526 . . . . 0.0 112.12 179.254 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' D' D ' 99' ' ' GLU . . . . . . . . . . . . . 95.6 mt-10 -78.01 13.07 1.53 Allowed 'General case' 0 CA--C 1.536 0.432 0 N-CA-C 113.146 0.795 . . . . 0.0 113.146 -177.794 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' D' D ' 100' ' ' ASN . . . . . . . . . . . . . 3.0 m-20 60.47 37.74 19.61 Favored 'General case' 0 CA--C 1.529 0.167 0 CA-C-O 121.126 0.489 . . . . 0.0 110.961 -179.443 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' D' D ' 101' ' ' GLU . . . . . . . . . . . . . 83.4 tt0 -113.74 145.5 41.28 Favored 'General case' 0 C--N 1.332 -0.169 0 N-CA-C 109.45 -0.574 . . . . 0.0 109.45 176.097 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' D' D ' 102' ' ' VAL . . . . . . . . . . . . . 46.3 t -114.82 121.44 66.91 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.319 0 N-CA-C 109.615 -0.513 . . . . 0.0 109.615 -178.817 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' D' D ' 103' ' ' LEU . . . . . . . . . . . . . 39.0 mt -115.31 127.59 55.54 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 115.705 -0.68 . . . . 0.0 109.925 177.593 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' D' D ' 104' ' ' ILE . . . . . 0.417 HD13 HG11 ' D' ' 130' ' ' VAL . 68.4 mt -118.87 120.5 64.24 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.271 0 N-CA-C 110.164 -0.31 . . . . 0.0 110.164 -178.627 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' D' D ' 105' ' ' PHE . . . . . . . . . . . . . 54.8 m-85 -119.72 165.91 13.9 Favored 'General case' 0 C--N 1.331 -0.202 0 O-C-N 123.978 0.798 . . . . 0.0 109.542 179.268 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' D' D ' 106' ' ' ASN . . . . . . . . . . . . . 39.2 p-10 -97.32 -173.0 2.54 Favored 'General case' 0 C--N 1.329 -0.294 0 N-CA-C 109.683 -0.488 . . . . 0.0 109.683 172.597 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' D' D ' 107' ' ' GLN . . . . . . . . . . . . . 43.3 tp60 -58.77 -27.68 65.2 Favored 'General case' 0 CA--C 1.534 0.355 0 N-CA-C 111.78 0.289 . . . . 0.0 111.78 178.382 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' D' D ' 108' ' ' ASN . . . . . . . . . . . . . 9.2 t30 -84.54 9.6 13.15 Favored 'General case' 0 CA--C 1.536 0.415 0 N-CA-C 113.147 0.795 . . . . 0.0 113.147 -177.17 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' D' D ' 109' ' ' LEU . . . . . . . . . . . . . 18.8 mt 58.89 34.34 23.6 Favored 'General case' 0 CA--C 1.53 0.21 0 CA-C-O 120.942 0.401 . . . . 0.0 111.804 178.777 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' D' D ' 110' ' ' GLU . . . . . . . . . . . . . 70.7 mm-40 -107.25 141.52 38.44 Favored 'General case' 0 C--N 1.33 -0.275 0 N-CA-C 108.998 -0.742 . . . . 0.0 108.998 173.14 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' D' D ' 111' ' ' GLU . . . . . . . . . . . . . 52.1 tt0 -85.04 123.38 30.51 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-O 121.186 0.517 . . . . 0.0 111.07 -173.369 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' D' D ' 112' ' ' LEU . . . . . . . . . . . . . 30.4 mt -101.35 -43.23 6.02 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 115.625 -0.716 . . . . 0.0 110.89 178.852 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' D' D ' 113' ' ' TYR . . . . . . . . . . . . . 43.9 t80 -133.01 135.98 45.76 Favored 'General case' 0 C--N 1.332 -0.164 0 CA-C-O 120.784 0.326 . . . . 0.0 111.548 -176.367 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' D' D ' 114' ' ' ARG . . . . . . . . . . . . . 32.3 ttm180 -134.19 120.26 19.84 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-N 115.892 -0.594 . . . . 0.0 110.067 176.664 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' D' D ' 115' ' ' GLY . . . . . . . . . . . . . . . -150.01 159.73 28.22 Favored Glycine 0 CA--C 1.523 0.555 0 N-CA-C 110.825 -0.91 . . . . 0.0 110.825 178.659 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' D' D ' 116' ' ' LYS . . . . . . . . . . . . . 32.9 ttmt -136.05 139.7 43.27 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-O 120.817 0.341 . . . . 0.0 110.288 178.067 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' D' D ' 117' ' ' PHE . . . . . . . . . . . . . 20.4 m-85 -138.19 119.97 15.25 Favored 'General case' 0 C--N 1.331 -0.236 0 N-CA-C 109.911 -0.404 . . . . 0.0 109.911 -177.427 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' D' D ' 118' ' ' GLU . . . . . . . . . . . . . 96.1 mt-10 -55.51 -40.17 71.42 Favored 'General case' 0 C--N 1.329 -0.326 0 C-N-CA 120.916 -0.313 . . . . 0.0 110.915 -178.224 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' D' D ' 119' ' ' ASN . . . . . . . . . . . . . 78.3 m-20 -97.23 28.94 3.38 Favored 'General case' 0 C--N 1.331 -0.218 0 N-CA-C 112.35 0.5 . . . . 0.0 112.35 -174.795 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' D' D ' 120' ' ' LEU . . . . . . . . . . . . . 16.7 tp -58.18 119.97 7.81 Favored 'General case' 0 C--N 1.333 -0.131 0 N-CA-C 110.125 -0.324 . . . . 0.0 110.125 178.237 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' D' D ' 121' ' ' ASN . . . . . . . . . . . . . 66.2 t30 -114.01 -44.22 3.17 Favored 'General case' 0 C--N 1.331 -0.227 0 CA-C-N 116.511 -0.313 . . . . 0.0 111.273 -177.053 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' D' D ' 122' ' ' LYS . . . . . . . . . . . . . 59.8 mttm -146.7 154.5 41.5 Favored 'General case' 0 C--N 1.33 -0.241 0 C-N-CA 120.653 -0.419 . . . . 0.0 111.739 -176.434 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' D' D ' 123' ' ' VAL . . . . . . . . . . . . . 43.8 t -131.71 129.95 61.66 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.243 0 CA-C-N 115.971 -0.559 . . . . 0.0 109.731 175.221 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' D' D ' 124' ' ' LEU . . . . . . . . . . . . . 30.3 mt -118.92 133.7 55.66 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-N 116.31 -0.405 . . . . 0.0 110.623 -179.164 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' D' D ' 125' ' ' VAL . . . . . 0.426 HG22 HG23 ' D' ' 130' ' ' VAL . 45.3 t -129.01 124.41 60.81 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 N-CA-C 109.895 -0.409 . . . . 0.0 109.895 178.153 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' D' D ' 126' ' ' ARG . . . . . . . . . . . . . 44.1 mtp180 -148.87 130.92 15.33 Favored 'General case' 0 C--N 1.329 -0.296 0 N-CA-C 109.69 -0.485 . . . . 0.0 109.69 179.189 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' D' D ' 127' ' ' ASN . . . . . . . . . . . . . 37.2 t30 56.32 -152.54 0.38 Allowed 'General case' 0 CA--C 1.539 0.527 0 N-CA-C 109.742 -0.466 . . . . 0.0 109.742 -179.943 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' D' D ' 128' ' ' ASP . . . . . . . . . . . . . 12.3 p-10 -84.05 18.67 2.01 Favored 'General case' 0 CA--C 1.536 0.428 0 CA-C-N 118.506 0.594 . . . . 0.0 112.602 177.936 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' D' D ' 129' ' ' LEU . . . . . . . . . . . . . 15.3 tp -117.82 138.83 51.82 Favored 'General case' 0 C--O 1.232 0.181 0 O-C-N 122.172 -0.33 . . . . 0.0 110.164 179.632 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' D' D ' 130' ' ' VAL . . . . . 0.487 HG13 ' HB ' ' D' ' 141' ' ' ILE . 12.5 p -129.11 141.18 47.27 Favored 'Isoleucine or valine' 0 N--CA 1.462 0.171 0 CA-C-O 121.133 0.492 . . . . 0.0 110.248 179.891 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' D' D ' 131' ' ' VAL . . . . . . . . . . . . . 58.8 t -136.06 137.56 48.47 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.276 0 CA-C-N 115.85 -0.614 . . . . 0.0 110.555 -177.197 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' D' D ' 132' ' ' ILE . . . . . . . . . . . . . 74.4 mt -114.14 133.94 58.59 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.243 0 CA-C-N 115.881 -0.599 . . . . 0.0 109.441 179.296 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' D' D ' 133' ' ' ILE . . . . . . . . . . . . . 42.9 mm -116.29 122.23 69.27 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.243 0 CA-C-O 120.822 0.344 . . . . 0.0 110.8 -175.323 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' D' D ' 134' ' ' ASP . . . . . . . . . . . . . 7.2 p-10 -136.03 146.04 46.69 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.148 -0.478 . . . . 0.0 109.838 175.248 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' D' D ' 135' ' ' GLU . . . . . . . . . . . . . 80.6 tt0 -49.85 -22.97 1.65 Allowed 'General case' 0 C--N 1.328 -0.344 0 N-CA-C 113.076 0.769 . . . . 0.0 113.076 -171.464 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' D' D ' 136' ' ' GLN . . . . . . . . . . . . . 13.3 pt20 -100.9 -30.44 11.66 Favored 'General case' 0 N--CA 1.464 0.249 0 N-CA-C 112.674 0.62 . . . . 0.0 112.674 -175.587 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' D' D ' 137' ' ' LYS . . . . . . . . . . . . . 87.3 mttt -142.6 158.05 44.07 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-O 121.407 0.622 . . . . 0.0 112.129 -173.019 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' D' D ' 138' ' ' LEU . . . . . . . . . . . . . 4.6 tt -118.48 122.13 41.96 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-N 115.174 -0.921 . . . . 0.0 108.883 171.459 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' D' D ' 139' ' ' THR . . . . . . . . . . . . . 28.0 m -111.16 125.06 53.39 Favored 'General case' 0 C--N 1.332 -0.162 0 CA-C-O 120.644 0.259 . . . . 0.0 110.899 -176.71 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' D' D ' 140' ' ' LEU . . . . . 0.479 ' C ' HD23 ' D' ' 140' ' ' LEU . 7.7 tt -114.03 125.68 54.27 Favored 'General case' 0 C--N 1.327 -0.388 0 N-CA-C 109.294 -0.632 . . . . 0.0 109.294 -179.265 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' D' D ' 141' ' ' ILE . . . . . 0.487 ' HB ' HG13 ' D' ' 130' ' ' VAL . 19.7 mt -123.28 120.37 60.08 Favored 'Isoleucine or valine' 0 C--O 1.235 0.311 0 N-CA-C 109.715 -0.476 . . . . 0.0 109.715 -176.146 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' D' D ' 142' ' ' ARG . . . . . . . . . . . . . 61.2 ttt180 -114.51 127.24 55.7 Favored 'General case' 0 C--N 1.332 -0.177 0 CA-C-N 115.448 -0.796 . . . . 0.0 110.327 -176.347 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' D' D ' 143' ' ' THR . . . . . . . . . . . . . 28.7 p . . . . . 0 C--O 1.219 -0.516 0 CA-C-O 118.018 -0.992 . . . . 0.0 110.597 -179.68 . . . . . . . . 0 0 . 1 . 015 nuclear build full ' E' E ' -3' ' ' GLU . . . . . . . . . . . . . 96.0 mt-10 . . . . . 0 N--CA 1.49 1.554 0 N-CA-C 109.382 -0.599 . . . . 0.0 109.382 . . . . . . . . . 0 0 . 1 . 015 nuclear build full ' E' E ' -2' ' ' GLY . . . . . . . . . . . . . . . -73.08 143.57 33.45 Favored Glycine 0 CA--C 1.523 0.592 0 N-CA-C 110.706 -0.958 . . . . 0.0 110.706 178.918 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' E' E ' -1' ' ' VAL . . . . . . . . . . . . . 45.6 t -95.85 123.14 47.93 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.297 0 N-CA-C 109.851 -0.426 . . . . 0.0 109.851 179.934 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' E' E ' 0' ' ' ILE . . . . . . . . . . . . . 71.7 mt -127.36 140.07 50.14 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.242 0 CA-C-N 116.144 -0.48 . . . . 0.0 109.992 -178.343 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' E' E ' 1' ' ' MET . . . . . . . . . . . . . 25.8 ptm -93.54 134.48 35.77 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.063 -0.517 . . . . 0.0 110.629 179.437 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' E' E ' 2' ' ' SER . . . . . . . . . . . . . 4.9 p -126.67 130.28 50.11 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-O 121.103 0.478 . . . . 0.0 110.67 179.226 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' E' E ' 3' ' ' GLU . . . . . . . . . . . . . 79.8 tt0 -145.83 143.06 29.4 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 115.884 -0.598 . . . . 0.0 111.021 -178.003 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' E' E ' 4' ' ' LEU . . . . . 0.509 HD21 HD21 ' E' ' 6' ' ' LEU . 15.1 tp -123.59 135.37 53.93 Favored 'General case' 0 C--N 1.331 -0.217 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.281 177.359 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' E' E ' 5' ' ' LYS . . . . . . . . . . . . . 90.3 mttt -109.09 120.04 41.34 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.23 -0.441 . . . . 0.0 110.38 178.87 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' E' E ' 6' ' ' LEU . . . . . 0.509 HD21 HD21 ' E' ' 4' ' ' LEU . 59.4 mt -116.58 142.89 46.3 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 115.63 -0.713 . . . . 0.0 111.096 -177.815 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' E' E ' 7' ' ' LYS . . . . . . . . . . . . . 60.3 tttm -133.89 140.6 36.92 Favored Pre-proline 0 CA--C 1.534 0.338 0 CA-C-O 119.015 -0.517 . . . . 0.0 110.033 176.522 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' E' E ' 8' ' ' PRO . . . . . . . . . . . . . 98.1 Cg_endo -90.78 143.73 3.5 Favored 'Trans proline' 0 N--CA 1.49 1.314 0 C-N-CA 121.804 1.669 . . . . 0.0 111.866 178.247 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' E' E ' 9' ' ' LEU . . . . . . . . . . . . . 43.6 mt -84.08 -48.26 0.7 Allowed Pre-proline 0 CA--C 1.534 0.342 0 CA-C-O 118.683 -0.675 . . . . 0.0 112.389 -179.205 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' E' E ' 10' ' ' PRO . . . . . . . . . . . . . 88.1 Cg_endo -79.91 158.02 24.13 Favored 'Trans proline' 0 N--CA 1.496 1.642 0 C-N-CA 121.258 1.305 . . . . 0.0 111.845 177.408 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' E' E ' 11' ' ' LYS . . . . . . . . . . . . . 39.3 ttpt -88.0 94.84 9.91 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-O 120.863 0.363 . . . . 0.0 110.422 179.47 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' E' E ' 12' ' ' VAL . . . . . . . . . . . . . 12.4 p -143.15 143.47 24.86 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.286 0 CA-C-N 116.23 -0.441 . . . . 0.0 110.583 179.099 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' E' E ' 13' ' ' GLU . . . . . . . . . . . . . 70.6 mm-40 -84.4 132.62 34.56 Favored 'General case' 0 C--N 1.33 -0.254 0 N-CA-C 109.951 -0.388 . . . . 0.0 109.951 177.263 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' E' E ' 14' ' ' LEU . . . . . . . . . . . . . 48.8 mt -97.97 147.7 33.43 Favored Pre-proline 0 CA--C 1.532 0.278 0 CA-C-O 119.309 -0.376 . . . . 0.0 110.381 -178.151 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' E' E ' 15' ' ' PRO . . . . . . . . . . . . . 24.9 Cg_exo -62.69 161.72 27.49 Favored 'Trans proline' 0 N--CA 1.498 1.749 0 C-N-CA 121.25 1.3 . . . . 0.0 111.825 175.98 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' E' E ' 16' ' ' PRO . . . . . . . . . . . . . 31.2 Cg_exo -59.38 -39.51 76.21 Favored 'Trans proline' 0 N--CA 1.497 1.691 0 C-N-CA 121.422 1.414 . . . . 0.0 112.661 -178.219 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' E' E ' 17' ' ' ASP . . . . . . . . . . . . . 22.8 p-10 -88.71 11.28 18.03 Favored 'General case' 0 CA--C 1.535 0.387 0 N-CA-C 113.172 0.805 . . . . 0.0 113.172 -177.646 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' E' E ' 18' ' ' PHE . . . . . . . . . . . . . 43.5 t80 -57.82 -44.53 86.46 Favored 'General case' 0 C--N 1.335 -0.056 0 O-C-N 122.014 -0.429 . . . . 0.0 110.121 -178.059 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' E' E ' 19' ' ' VAL . . . . . . . . . . . . . 47.6 t -58.16 -41.52 80.99 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.336 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.309 -179.069 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' E' E ' 20' ' ' ASP . . . . . . . . . . . . . 76.2 m-20 -59.72 -42.35 92.89 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-O 120.851 0.358 . . . . 0.0 110.805 -177.655 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' E' E ' 21' ' ' VAL . . . . . . . . . . . . . 47.0 t -64.6 -47.87 87.2 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.294 0 CA-C-N 116.36 -0.382 . . . . 0.0 110.42 -178.194 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' E' E ' 22' ' ' ILE . . . . . 0.581 HG22 HD12 ' E' ' 26' ' ' LEU . 49.6 mm -56.05 -45.03 80.32 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.256 0 CA-C-O 120.727 0.299 . . . . 0.0 110.662 179.102 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' E' E ' 23' ' ' ARG . . . . . . . . . . . . . 59.4 ttp180 -54.09 -49.94 67.94 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-O 120.694 0.283 . . . . 0.0 111.388 -178.313 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' E' E ' 24' ' ' ILE . . . . . . . . . . . . . 71.2 mt -60.06 -44.59 95.25 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.271 0 CA-C-N 116.626 -0.261 . . . . 0.0 111.105 -178.044 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' E' E ' 25' ' ' LYS . . . . . . . . . . . . . 83.4 mttt -64.84 -37.91 89.21 Favored 'General case' 0 C--N 1.329 -0.308 0 N-CA-C 112.394 0.516 . . . . 0.0 112.394 -177.694 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' E' E ' 26' ' ' LEU . . . . . 0.581 HD12 HG22 ' E' ' 22' ' ' ILE . 50.0 mt -79.27 -42.19 26.42 Favored 'General case' 0 C--N 1.331 -0.221 0 N-CA-C 113.53 0.937 . . . . 0.0 113.53 -172.046 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' E' E ' 27' ' ' GLN . . . . . . . . . . . . . 11.1 pt20 -46.83 141.88 3.71 Favored 'General case' 0 N--CA 1.469 0.491 0 N-CA-C 112.905 0.705 . . . . 0.0 112.905 -173.772 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' E' E ' 28' ' ' GLY . . . . . . . . . . . . . . . 97.75 -26.26 23.96 Favored Glycine 0 CA--C 1.531 1.086 0 CA-C-N 115.418 -0.81 . . . . 0.0 112.184 -177.818 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' E' E ' 29' ' ' LYS . . . . . . . . . . . . . 69.5 mttm -97.77 155.12 17.18 Favored 'General case' 0 C--N 1.331 -0.222 0 CA-C-N 117.365 0.583 . . . . 0.0 110.976 178.249 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' E' E ' 30' ' ' THR . . . . . . . . . . . . . 19.2 m -106.79 137.12 45.42 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 115.931 -0.577 . . . . 0.0 109.727 175.149 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' E' E ' 31' ' ' VAL . . . . . . . . . . . . . 35.0 m -128.17 154.97 39.5 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.253 0 CA-C-O 120.973 0.416 . . . . 0.0 110.862 -177.691 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' E' E ' 32' ' ' ARG . . . . . . . . . . . . . 59.1 ttm-85 -127.24 146.1 50.54 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.04 -0.527 . . . . 0.0 110.327 -179.972 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' E' E ' 33' ' ' THR . . . . . . . . . . . . . 18.6 m -53.08 139.26 28.91 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.469 -0.332 . . . . 0.0 111.355 -177.861 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' E' E ' 34' ' ' GLY . . . . . . . . . . . . . . . 101.13 -17.13 56.44 Favored Glycine 0 CA--C 1.532 1.156 0 CA-C-O 119.674 -0.514 . . . . 0.0 113.243 -179.826 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' E' E ' 35' ' ' ASP . . . . . . . . . . . . . 78.8 m-20 -66.51 149.03 51.05 Favored 'General case' 0 C--O 1.23 0.071 0 CA-C-N 118.018 0.909 . . . . 0.0 111.198 178.542 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' E' E ' 36' ' ' VAL . . . . . . . . . . . . . 44.0 t -123.38 131.95 72.25 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.18 0 CA-C-N 115.865 -0.607 . . . . 0.0 109.786 177.985 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' E' E ' 37' ' ' ILE . . . . . . . . . . . . . 67.8 mt -121.91 140.65 45.21 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.21 0 CA-C-N 116.256 -0.429 . . . . 0.0 109.952 -178.936 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' E' E ' 38' ' ' GLY . . . . . . . . . . . . . . . -110.71 128.81 8.95 Favored Glycine 0 CA--C 1.527 0.802 0 N-CA-C 111.348 -0.701 . . . . 0.0 111.348 -179.528 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' E' E ' 39' ' ' ILE . . . . . . . . . . . . . 72.8 mt -123.83 134.25 67.0 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.207 0 N-CA-C 110.135 -0.32 . . . . 0.0 110.135 179.134 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' E' E ' 40' ' ' SER . . . . . . . . . . . . . 19.5 p -93.57 114.19 26.47 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.508 -0.314 . . . . 0.0 110.993 176.214 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' E' E ' 41' ' ' ILE . . . . . . . . . . . . . 44.7 mm -121.58 124.46 71.75 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.269 0 CA-C-O 120.789 0.328 . . . . 0.0 110.334 179.074 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' E' E ' 42' ' ' LEU . . . . . . . . . . . . . 57.7 mt 52.0 33.06 11.11 Favored 'General case' 0 C--N 1.331 -0.23 0 CA-C-N 116.254 -0.43 . . . . 0.0 111.933 177.359 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' E' E ' 43' ' ' GLY . . . . . . . . . . . . . . . 72.4 33.65 61.22 Favored Glycine 0 CA--C 1.529 0.932 0 C-N-CA 121.091 -0.576 . . . . 0.0 111.749 178.747 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' E' E ' 44' ' ' LYS . . . . . . . . . . . . . 21.1 tptm -138.86 131.23 28.54 Favored 'General case' 0 C--N 1.329 -0.3 0 N-CA-C 109.463 -0.569 . . . . 0.0 109.463 179.539 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' E' E ' 45' ' ' GLU . . . . . . . . . . . . . 80.9 tt0 -82.52 119.25 23.99 Favored 'General case' 0 C--N 1.328 -0.359 0 C-N-CA 120.795 -0.362 . . . . 0.0 110.941 -177.267 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' E' E ' 46' ' ' VAL . . . . . . . . . . . . . 7.4 p -119.97 126.44 75.29 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.18 0 N-CA-C 109.451 -0.574 . . . . 0.0 109.451 176.26 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' E' E ' 47' ' ' LYS . . . . . . . . . . . . . 63.2 mttp -99.97 129.53 46.05 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 115.898 -0.592 . . . . 0.0 111.206 178.916 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' E' E ' 48' ' ' PHE . . . . . . . . . . . . . 87.4 m-85 -112.01 131.8 55.18 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.062 -0.517 . . . . 0.0 110.191 177.162 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' E' E ' 49' ' ' LYS . . . . . . . . . . . . . 79.0 tttt -107.71 135.71 48.68 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.343 -0.39 . . . . 0.0 110.63 -179.666 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' E' E ' 50' ' ' VAL . . . . . . . . . . . . . 45.9 t -81.41 107.55 13.72 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.242 0 N-CA-C 109.123 -0.695 . . . . 0.0 109.123 175.406 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' E' E ' 51' ' ' VAL . . . . . . . . . . . . . 42.9 t -73.14 -50.85 29.01 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.346 0 CA-C-N 115.994 -0.548 . . . . 0.0 109.791 -174.399 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' E' E ' 52' ' ' GLN . . . . . . . . . . . . . 70.2 mt-30 -154.92 155.1 33.69 Favored 'General case' 0 C--N 1.331 -0.218 0 CA-C-O 121.135 0.493 . . . . 0.0 111.699 -179.332 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' E' E ' 53' ' ' ALA . . . . . 0.501 ' HB1' ' HB2' ' E' ' 58' ' ' LEU . . . -131.68 133.78 45.24 Favored 'General case' 0 C--N 1.33 -0.283 0 CA-C-N 115.364 -0.835 . . . . 0.0 109.886 175.629 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' E' E ' 54' ' ' TYR . . . . . . . . . . . . . 57.7 t80 -129.13 109.08 18.03 Favored Pre-proline 0 CA--C 1.534 0.344 0 CA-C-O 118.284 -0.865 . . . . 0.0 110.439 179.399 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' E' E ' 55' ' ' PRO . . . . . . . . . . . . . 72.8 Cg_endo -77.1 169.8 73.32 Favored 'Cis proline' 0 N--CA 1.498 1.746 0 CA-C-N 121.911 1.718 . . . . 0.0 112.356 -5.457 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' E' E ' 56' ' ' SER . . . . . . . . . . . . . 30.7 m -116.6 129.03 25.57 Favored Pre-proline 0 CA--C 1.538 0.516 0 CA-C-O 118.368 -0.825 . . . . 0.0 109.404 175.244 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' E' E ' 57' ' ' PRO . . . . . . . . . . . . . 42.6 Cg_endo -68.97 148.93 85.87 Favored 'Cis proline' 0 N--CA 1.498 1.771 0 CA-C-N 122.052 1.768 . . . . 0.0 111.815 -0.586 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' E' E ' 58' ' ' LEU . . . . . 0.501 ' HB2' ' HB1' ' E' ' 53' ' ' ALA . 23.5 tp -108.2 138.53 44.32 Favored 'General case' 0 C--N 1.331 -0.222 0 CA-C-N 116.101 -0.499 . . . . 0.0 110.667 -178.304 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' E' E ' 59' ' ' ARG . . . . . . . . . . . . . 60.6 ttt180 -103.44 131.33 50.63 Favored 'General case' 0 C--N 1.328 -0.346 0 N-CA-C 109.404 -0.591 . . . . 0.0 109.404 175.872 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' E' E ' 60' ' ' VAL . . . . . . . . . . . . . 42.1 t -89.71 119.0 36.1 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.287 0 C-N-CA 120.669 -0.412 . . . . 0.0 110.516 -176.483 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' E' E ' 61' ' ' GLU . . . . . . . . . . . . . 95.1 mt-10 -131.18 167.46 19.12 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.104 -0.498 . . . . 0.0 110.002 176.525 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' E' E ' 62' ' ' ASP . . . . . . . . . . . . . 80.5 m-20 -54.4 -32.71 57.77 Favored 'General case' 0 C--N 1.328 -0.365 0 N-CA-C 111.678 0.251 . . . . 0.0 111.678 -179.712 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' E' E ' 63' ' ' ARG . . . . . . . . . . . . . 11.1 ptm180 -85.7 6.41 27.81 Favored 'General case' 0 CA--C 1.536 0.423 0 N-CA-C 113.551 0.945 . . . . 0.0 113.551 -175.505 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' E' E ' 64' ' ' THR . . . . . . . . . . . . . 23.8 m -85.66 138.68 31.98 Favored 'General case' 0 C--N 1.332 -0.155 0 CA-C-N 118.237 0.472 . . . . 0.0 110.591 -179.09 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' E' E ' 65' ' ' LYS . . . . . . . . . . . . . 48.7 mtmt -87.68 129.78 35.02 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-O 120.949 0.404 . . . . 0.0 110.322 178.565 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' E' E ' 66' ' ' ILE . . . . . . . . . . . . . 58.8 mt -113.11 124.87 70.18 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.316 0 N-CA-C 109.504 -0.554 . . . . 0.0 109.504 179.73 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' E' E ' 67' ' ' THR . . . . . . . . . . . . . 17.8 m -115.48 137.78 51.7 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-O 121.077 0.465 . . . . 0.0 110.663 -177.582 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' E' E ' 68' ' ' LEU . . . . . . . . . . . . . 15.8 tp -104.34 136.13 44.5 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 115.817 -0.628 . . . . 0.0 110.772 -178.333 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' E' E ' 69' ' ' VAL . . . . . . . . . . . . . 46.7 t -82.81 155.14 3.87 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 N-CA-C 109.48 -0.563 . . . . 0.0 109.48 175.923 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' E' E ' 70' ' ' THR . . . . . . . . . . . . . 60.9 p -78.36 161.96 26.8 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-O 121.198 0.523 . . . . 0.0 111.139 -172.514 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' E' E ' 71' ' ' HIS . . . . . . . . . . . . . 23.6 m80 -108.55 170.91 4.97 Favored Pre-proline 0 CA--C 1.532 0.266 0 CA-C-N 115.357 -0.838 . . . . 0.0 110.324 -174.703 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' E' E ' 72' ' ' PRO . . . . . . . . . . . . . 23.9 Cg_exo -64.87 160.1 42.66 Favored 'Trans proline' 0 N--CA 1.495 1.58 0 C-N-CA 121.514 1.476 . . . . 0.0 111.507 175.883 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' E' E ' 73' ' ' VAL . . . . . . . . . . . . . 30.1 m -69.69 166.8 2.03 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.279 0 CA-C-O 120.905 0.383 . . . . 0.0 111.143 -172.999 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' E' E ' 74' ' ' ASP . . . . . . . . . . . . . 12.3 t70 -91.28 122.78 34.19 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 115.882 -0.599 . . . . 0.0 110.48 -174.048 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' E' E ' 75' ' ' VAL . . . . . . . . . . . . . 44.3 t -116.99 120.71 65.92 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.248 0 CA-C-O 121.14 0.495 . . . . 0.0 110.134 178.98 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' E' E ' 76' ' ' LEU . . . . . . . . . . . . . 16.5 mt -122.31 143.23 49.75 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 115.603 -0.726 . . . . 0.0 109.75 178.098 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' E' E ' 77' ' ' GLU . . . . . . . . . . . . . 96.0 mt-10 -136.89 135.51 37.88 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-O 121.048 0.451 . . . . 0.0 111.112 -177.804 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' E' E ' 78' ' ' ALA . . . . . . . . . . . . . . . -119.93 139.69 52.05 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 115.643 -0.708 . . . . 0.0 109.795 176.678 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' E' E ' 79' ' ' LYS . . . . . 0.707 ' O ' HD13 ' E' ' 80' ' ' ILE . 54.7 mttp -87.94 114.5 24.62 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.412 -0.358 . . . . 0.0 110.774 -177.058 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' E' E ' 80' ' ' ILE . . . . . 0.707 HD13 ' O ' ' E' ' 79' ' ' LYS . 33.4 mm -139.05 103.7 2.04 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.325 0 N-CA-C 109.252 -0.647 . . . . 0.0 109.252 -178.703 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' E' E ' 81' ' ' LYS . . . . . . . . . . . . . 37.9 ttpt -98.12 130.51 44.89 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-O 120.93 0.395 . . . . 0.0 110.547 -178.5 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' E' E ' 82' ' ' GLY . . . . . . . . . . . . . . . 89.15 42.13 5.67 Favored Glycine 0 CA--C 1.523 0.563 0 N-CA-C 111.142 -0.783 . . . . 0.0 111.142 178.053 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' E' E ' 83' ' ' ILE . . . . . . . . . . . . . 71.8 mt -72.43 135.38 27.91 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.291 0 N-CA-C 109.323 -0.621 . . . . 0.0 109.323 176.459 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' E' E ' 84' ' ' LYS . . . . . . . . . . . . . 31.4 ttpt -100.0 -50.67 3.92 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-O 120.888 0.375 . . . . 0.0 110.528 -177.062 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' E' E ' 85' ' ' ASP . . . . . . . . . . . . . 8.1 t70 -147.24 150.17 34.32 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.109 -0.496 . . . . 0.0 110.655 -178.783 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' E' E ' 86' ' ' VAL . . . . . . . . . . . . . 42.5 t -131.28 130.71 63.33 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.202 0 CA-C-O 120.993 0.425 . . . . 0.0 110.527 -179.333 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' E' E ' 87' ' ' ILE . . . . . . . . . . . . . 43.6 mm -118.59 125.59 74.5 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.189 0 N-CA-C 109.444 -0.576 . . . . 0.0 109.444 175.843 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' E' E ' 88' ' ' LEU . . . . . . . . . . . . . 17.2 tp -112.98 128.83 56.6 Favored 'General case' 0 C--N 1.331 -0.201 0 CA-C-O 120.924 0.392 . . . . 0.0 111.135 -176.949 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' E' E ' 89' ' ' ASP . . . . . . . . . . . . . 6.7 t70 -125.95 156.28 40.03 Favored 'General case' 0 C--N 1.331 -0.22 0 CA-C-N 115.988 -0.551 . . . . 0.0 109.927 177.172 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' E' E ' 90' ' ' GLU . . . . . . . . . . . . . 64.0 tt0 -45.73 -46.19 14.88 Favored 'General case' 0 N--CA 1.464 0.238 0 N-CA-C 112.988 0.736 . . . . 0.0 112.988 -172.166 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' E' E ' 91' ' ' ASN . . . . . . . . . . . . . 41.0 t30 -132.17 39.98 3.37 Favored 'General case' 0 C--N 1.332 -0.173 0 CA-C-O 121.124 0.488 . . . . 0.0 110.882 -177.647 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' E' E ' 92' ' ' LEU . . . . . . . . . . . . . 11.9 tp -165.39 138.14 4.36 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.243 -0.435 . . . . 0.0 110.168 -178.453 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' E' E ' 93' ' ' ILE . . . . . . . . . . . . . 70.8 mt -126.08 125.17 67.47 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.29 0 N-CA-C 109.905 -0.406 . . . . 0.0 109.905 -178.531 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' E' E ' 94' ' ' VAL . . . . . 0.631 HG21 HG21 ' E' ' 125' ' ' VAL . 43.7 t -122.87 126.61 74.06 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.187 0 N-CA-C 109.938 -0.393 . . . . 0.0 109.938 179.369 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' E' E ' 95' ' ' VAL . . . . . . . . . . . . . 43.7 t -121.43 133.79 66.83 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.317 0 CA-C-N 116.1 -0.5 . . . . 0.0 109.699 179.555 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' E' E ' 96' ' ' ILE . . . . . . . . . . . . . 68.4 mt -117.36 129.63 73.54 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.283 0 N-CA-C 109.348 -0.612 . . . . 0.0 109.348 -179.778 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' E' E ' 97' ' ' THR . . . . . . . . . . . . . 61.6 p -105.31 162.42 13.44 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-O 121.549 0.69 . . . . 0.0 111.896 -174.53 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' E' E ' 98' ' ' GLU . . . . . . . . . . . . . 13.1 mm-40 -53.8 -28.91 38.0 Favored 'General case' 0 CA--C 1.531 0.241 0 CA-C-N 115.727 -0.669 . . . . 0.0 112.121 179.254 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' E' E ' 99' ' ' GLU . . . . . . . . . . . . . 95.2 mt-10 -79.53 16.92 0.95 Allowed 'General case' 0 CA--C 1.535 0.402 0 N-CA-C 113.164 0.801 . . . . 0.0 113.164 -175.032 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' E' E ' 100' ' ' ASN . . . . . . . . . . . . . 4.0 m-20 62.11 38.12 14.07 Favored 'General case' 0 N--CA 1.463 0.208 0 CA-C-O 121.094 0.473 . . . . 0.0 110.84 177.935 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' E' E ' 101' ' ' GLU . . . . . . . . . . . . . 83.3 tt0 -120.41 143.04 48.67 Favored 'General case' 0 C--N 1.331 -0.203 0 CA-C-N 116.184 -0.462 . . . . 0.0 109.979 178.242 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' E' E ' 102' ' ' VAL . . . . . . . . . . . . . 43.1 t -115.03 127.71 72.48 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.282 0 CA-C-N 116.262 -0.426 . . . . 0.0 109.938 179.135 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' E' E ' 103' ' ' LEU . . . . . 0.507 HD12 ' N ' ' E' ' 103' ' ' LEU . 6.3 mp -116.34 131.53 56.92 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-N 115.676 -0.693 . . . . 0.0 109.786 175.954 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' E' E ' 104' ' ' ILE . . . . . . . . . . . . . 69.7 mt -118.74 123.69 71.94 Favored 'Isoleucine or valine' 0 C--O 1.234 0.269 0 N-CA-C 110.118 -0.327 . . . . 0.0 110.118 -179.004 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' E' E ' 105' ' ' PHE . . . . . . . . . . . . . 57.5 m-85 -124.6 164.28 20.17 Favored 'General case' 0 C--N 1.332 -0.191 0 O-C-N 124.07 0.856 . . . . 0.0 109.774 -179.725 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' E' E ' 106' ' ' ASN . . . . . . . . . . . . . 44.1 p-10 -96.71 -169.87 1.96 Allowed 'General case' 0 C--N 1.331 -0.199 0 N-CA-C 110.114 -0.328 . . . . 0.0 110.114 173.749 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' E' E ' 107' ' ' GLN . . . . . . . . . . . . . 46.5 tt0 -58.2 -30.04 66.15 Favored 'General case' 0 C--N 1.33 -0.279 0 N-CA-C 111.927 0.344 . . . . 0.0 111.927 -179.897 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' E' E ' 108' ' ' ASN . . . . . . . . . . . . . 11.9 t-20 -88.58 13.29 12.43 Favored 'General case' 0 CA--C 1.535 0.389 0 N-CA-C 113.037 0.754 . . . . 0.0 113.037 -176.578 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' E' E ' 109' ' ' LEU . . . . . . . . . . . . . 21.2 mt 57.06 33.81 23.92 Favored 'General case' 0 CA--C 1.53 0.196 0 N-CA-C 111.812 0.301 . . . . 0.0 111.812 179.01 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' E' E ' 110' ' ' GLU . . . . . . . . . . . . . 96.0 mt-10 -100.19 132.7 45.41 Favored 'General case' 0 C--N 1.329 -0.311 0 N-CA-C 109.171 -0.677 . . . . 0.0 109.171 174.688 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' E' E ' 111' ' ' GLU . . . . . . . . . . . . . 52.6 tt0 -74.79 121.84 22.39 Favored 'General case' 0 C--N 1.327 -0.385 0 CA-C-O 121.017 0.437 . . . . 0.0 110.875 -173.606 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' E' E ' 112' ' ' LEU . . . . . . . . . . . . . 73.4 mt -100.64 -46.12 5.28 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 115.872 -0.603 . . . . 0.0 110.61 179.519 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' E' E ' 113' ' ' TYR . . . . . . . . . . . . . 64.2 t80 -140.89 143.66 34.8 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.121 -0.491 . . . . 0.0 111.277 -177.237 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' E' E ' 114' ' ' ARG . . . . . . . . . . . . . 47.0 ptt85 -144.25 126.14 15.32 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.09 -0.504 . . . . 0.0 110.603 176.417 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' E' E ' 115' ' ' GLY . . . . . . . . . . . . . . . -150.03 147.52 17.83 Favored Glycine 0 CA--C 1.524 0.646 0 N-CA-C 111.11 -0.796 . . . . 0.0 111.11 179.203 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' E' E ' 116' ' ' LYS . . . . . . . . . . . . . 37.1 ttpt -118.72 135.53 54.44 Favored 'General case' 0 C--N 1.33 -0.264 0 N-CA-C 109.92 -0.4 . . . . 0.0 109.92 177.64 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' E' E ' 117' ' ' PHE . . . . . . . . . . . . . 43.0 m-85 -127.25 115.42 19.03 Favored 'General case' 0 C--N 1.331 -0.211 0 CA-C-N 116.215 -0.448 . . . . 0.0 109.914 -177.2 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' E' E ' 118' ' ' GLU . . . . . . . . . . . . . 96.1 mt-10 -53.99 -48.26 70.58 Favored 'General case' 0 C--N 1.33 -0.282 0 C-N-CA 121.005 -0.278 . . . . 0.0 111.344 -176.364 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' E' E ' 119' ' ' ASN . . . . . . . . . . . . . 65.7 m-80 -95.69 31.13 2.12 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 115.964 -0.562 . . . . 0.0 112.074 -174.828 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' E' E ' 120' ' ' LEU . . . . . . . . . . . . . 17.5 tp -53.23 119.92 5.34 Favored 'General case' 0 N--CA 1.463 0.215 0 CA-C-O 120.795 0.331 . . . . 0.0 110.909 179.421 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' E' E ' 121' ' ' ASN . . . . . . . . . . . . . 43.2 m-80 -114.13 -44.13 3.17 Favored 'General case' 0 C--N 1.333 -0.15 0 CA-C-N 116.273 -0.421 . . . . 0.0 111.102 -177.581 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' E' E ' 122' ' ' LYS . . . . . . . . . . . . . 18.7 mtpp -139.79 142.5 36.7 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.33 -0.395 . . . . 0.0 111.706 -174.876 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' E' E ' 123' ' ' VAL . . . . . . . . . . . . . 46.4 t -132.81 126.16 53.7 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.377 0 N-CA-C 109.339 -0.615 . . . . 0.0 109.339 172.953 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' E' E ' 124' ' ' LEU . . . . . . . . . . . . . 7.4 tp -129.09 130.94 47.13 Favored 'General case' 0 C--O 1.232 0.179 0 CA-C-O 120.939 0.4 . . . . 0.0 110.538 -178.114 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' E' E ' 125' ' ' VAL . . . . . 0.631 HG21 HG21 ' E' ' 94' ' ' VAL . 41.5 t -124.75 133.17 70.12 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.218 0 CA-C-N 116.014 -0.539 . . . . 0.0 109.884 179.345 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' E' E ' 126' ' ' ARG . . . . . . . . . . . . . 34.7 ttm180 -155.68 124.04 5.88 Favored 'General case' 0 C--N 1.328 -0.327 0 N-CA-C 109.619 -0.512 . . . . 0.0 109.619 179.06 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' E' E ' 127' ' ' ASN . . . . . . . . . . . . . 32.1 t30 57.97 -154.44 0.36 Allowed 'General case' 0 CA--C 1.538 0.487 0 N-CA-C 109.296 -0.631 . . . . 0.0 109.296 -175.936 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' E' E ' 128' ' ' ASP . . . . . . . . . . . . . 9.0 p-10 -80.94 16.5 1.45 Allowed 'General case' 0 CA--C 1.536 0.424 0 N-CA-C 112.51 0.559 . . . . 0.0 112.51 176.635 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' E' E ' 129' ' ' LEU . . . . . . . . . . . . . 26.3 tp -107.7 131.28 54.59 Favored 'General case' 0 C--O 1.232 0.155 0 O-C-N 122.019 -0.426 . . . . 0.0 110.014 177.865 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' E' E ' 130' ' ' VAL . . . . . . . . . . . . . 44.6 t -125.3 134.93 65.58 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.27 0 N-CA-C 109.843 -0.428 . . . . 0.0 109.843 -179.352 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' E' E ' 131' ' ' VAL . . . . . 0.437 HG22 HD12 ' E' ' 140' ' ' LEU . 43.4 t -134.05 133.42 56.01 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.252 0 CA-C-O 121.137 0.494 . . . . 0.0 110.252 178.388 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' E' E ' 132' ' ' ILE . . . . . . . . . . . . . 73.1 mt -119.63 132.96 67.95 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.252 0 CA-C-N 115.601 -0.727 . . . . 0.0 109.411 179.648 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' E' E ' 133' ' ' ILE . . . . . . . . . . . . . 42.8 mm -118.03 123.27 71.41 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.277 0 CA-C-O 120.886 0.374 . . . . 0.0 111.2 -174.029 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' E' E ' 134' ' ' ASP . . . . . . . . . . . . . 5.3 p-10 -127.38 151.6 48.58 Favored 'General case' 0 C--N 1.331 -0.227 0 CA-C-N 115.843 -0.617 . . . . 0.0 109.6 173.397 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' E' E ' 135' ' ' GLU . . . . . . . . . . . . . 43.2 tp10 -49.73 -26.38 3.76 Favored 'General case' 0 C--N 1.329 -0.314 0 N-CA-C 112.86 0.689 . . . . 0.0 112.86 -169.859 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' E' E ' 136' ' ' GLN . . . . . . . . . . . . . 97.3 mt-30 -102.9 -31.12 10.41 Favored 'General case' 0 N--CA 1.464 0.228 0 N-CA-C 112.851 0.686 . . . . 0.0 112.851 -174.345 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' E' E ' 137' ' ' LYS . . . . . . . . . . . . . 27.7 ttpp -144.17 153.91 42.59 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-O 121.223 0.535 . . . . 0.0 111.673 -166.689 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' E' E ' 138' ' ' LEU . . . . . 0.41 ' C ' HD23 ' E' ' 138' ' ' LEU . 6.8 tt -118.73 126.31 51.61 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 115.616 -0.72 . . . . 0.0 110.056 178.388 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' E' E ' 139' ' ' THR . . . . . . . . . . . . . 33.4 m -107.45 125.44 51.25 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.095 -179.901 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' E' E ' 140' ' ' LEU . . . . . 0.437 HD12 HG22 ' E' ' 131' ' ' VAL . 7.5 tp -113.91 120.25 40.06 Favored 'General case' 0 C--N 1.329 -0.299 0 N-CA-C 109.065 -0.717 . . . . 0.0 109.065 -179.948 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' E' E ' 141' ' ' ILE . . . . . . . . . . . . . 18.3 mt -120.99 126.09 74.8 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.268 0 CA-C-O 120.894 0.378 . . . . 0.0 110.459 -172.779 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' E' E ' 142' ' ' ARG . . . . . . . . . . . . . 77.9 mtp180 -109.12 130.65 55.48 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 115.651 -0.704 . . . . 0.0 109.977 176.571 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' E' E ' 143' ' ' THR . . . . . . . . . . . . . 58.9 p . . . . . 0 C--O 1.22 -0.453 0 CA-C-O 118.025 -0.988 . . . . 0.0 110.452 -179.937 . . . . . . . . 0 0 . 1 . 015 nuclear build full ' F' F ' -3' ' ' GLU . . . . . . . . . . . . . 46.2 mp0 . . . . . 0 N--CA 1.491 1.617 0 N-CA-C 109.323 -0.621 . . . . 0.0 109.323 . . . . . . . . . 0 0 . 1 . 015 nuclear build full ' F' F ' -2' ' ' GLY . . . . . . . . . . . . . . . -92.7 110.93 3.99 Favored Glycine 0 CA--C 1.524 0.622 0 N-CA-C 110.661 -0.976 . . . . 0.0 110.661 178.728 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' F' F ' -1' ' ' VAL . . . . . . . . . . . . . 45.9 t -88.01 138.77 18.49 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.341 0 N-CA-C 109.863 -0.421 . . . . 0.0 109.863 -179.668 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' F' F ' 0' ' ' ILE . . . . . . . . . . . . . 41.2 mm -94.18 124.98 46.86 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.328 0 CA-C-N 116.227 -0.442 . . . . 0.0 109.926 179.944 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' F' F ' 1' ' ' MET . . . . . . . . . . . . . 26.1 ptt? -81.57 128.45 33.93 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.126 -0.488 . . . . 0.0 111.126 -177.701 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' F' F ' 2' ' ' SER . . . . . . . . . . . . . 7.6 p -111.57 139.94 46.6 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.028 -0.533 . . . . 0.0 110.31 178.26 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' F' F ' 3' ' ' GLU . . . . . . . . . . . . . 81.1 tt0 -143.79 143.89 31.55 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.333 -0.394 . . . . 0.0 111.356 -176.836 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' F' F ' 4' ' ' LEU . . . . . . . . . . . . . 24.1 tp -124.52 129.87 51.42 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 115.872 -0.604 . . . . 0.0 109.87 175.305 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' F' F ' 5' ' ' LYS . . . . . . . . . . . . . 99.3 mttt -110.58 122.08 46.88 Favored 'General case' 0 C--O 1.234 0.26 0 CA-C-N 116.395 -0.366 . . . . 0.0 110.901 -179.513 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' F' F ' 6' ' ' LEU . . . . . . . . . . . . . 32.8 mt -114.52 146.69 40.42 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 115.342 -0.845 . . . . 0.0 110.263 -179.264 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' F' F ' 7' ' ' LYS . . . . . . . . . . . . . 36.7 ttmt -132.92 137.76 30.35 Favored Pre-proline 0 CA--C 1.534 0.338 0 CA-C-O 118.974 -0.536 . . . . 0.0 109.805 174.758 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' F' F ' 8' ' ' PRO . . . . . . . . . . . . . 83.6 Cg_endo -91.52 141.65 2.74 Favored 'Trans proline' 0 N--CA 1.49 1.305 0 C-N-CA 121.773 1.649 . . . . 0.0 112.014 179.359 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' F' F ' 9' ' ' LEU . . . . . . . . . . . . . 37.6 mt -78.44 -46.59 2.01 Favored Pre-proline 0 CA--C 1.534 0.328 0 CA-C-O 118.765 -0.636 . . . . 0.0 111.735 179.056 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' F' F ' 10' ' ' PRO . . . . . . . . . . . . . 91.1 Cg_endo -83.08 145.96 12.54 Favored 'Trans proline' 0 N--CA 1.494 1.54 0 C-N-CA 121.218 1.279 . . . . 0.0 111.52 173.452 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' F' F ' 11' ' ' LYS . . . . . . . . . . . . . 19.8 pttp -84.01 116.78 23.0 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-O 121.324 0.583 . . . . 0.0 110.545 177.988 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' F' F ' 12' ' ' VAL . . . . . . . . . . . . . 11.9 p -151.06 143.88 16.71 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.306 0 CA-C-N 115.662 -0.699 . . . . 0.0 110.274 -179.662 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' F' F ' 13' ' ' GLU . . . . . . . . . . . . . 43.3 mt-10 -83.13 117.16 22.69 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.517 -0.311 . . . . 0.0 110.26 178.53 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' F' F ' 14' ' ' LEU . . . . . . . . . . . . . 34.7 mt -98.41 142.31 24.38 Favored Pre-proline 0 CA--C 1.534 0.358 0 CA-C-O 118.997 -0.525 . . . . 0.0 109.853 -179.695 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' F' F ' 15' ' ' PRO . . . . . . . . . . . . . 26.4 Cg_exo -61.22 160.93 24.79 Favored 'Trans proline' 0 N--CA 1.497 1.724 0 C-N-CA 121.202 1.268 . . . . 0.0 111.828 178.282 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' F' F ' 16' ' ' PRO . . . . . . . . . . . . . 32.7 Cg_exo -59.55 -37.52 88.23 Favored 'Trans proline' 0 N--CA 1.497 1.684 0 C-N-CA 121.508 1.472 . . . . 0.0 112.633 -178.303 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' F' F ' 17' ' ' ASP . . . . . . . . . . . . . 13.6 p-10 -86.44 7.94 23.83 Favored 'General case' 0 CA--C 1.536 0.423 0 N-CA-C 113.132 0.79 . . . . 0.0 113.132 -177.989 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' F' F ' 18' ' ' PHE . . . . . . . . . . . . . 52.0 t80 -58.26 -43.8 88.05 Favored 'General case' 0 N--CA 1.457 -0.102 0 O-C-N 121.985 -0.447 . . . . 0.0 109.991 -179.55 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' F' F ' 19' ' ' VAL . . . . . . . . . . . . . 47.1 t -57.33 -40.86 76.65 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.324 0 CA-C-N 116.112 -0.494 . . . . 0.0 110.322 -179.626 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' F' F ' 20' ' ' ASP . . . . . . . . . . . . . 36.6 t0 -60.37 -43.56 96.46 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-O 120.769 0.319 . . . . 0.0 110.974 -178.258 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' F' F ' 21' ' ' VAL . . . . . . . . . . . . . 47.3 t -64.35 -45.94 94.53 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.279 0 C-N-CA 120.821 -0.352 . . . . 0.0 110.361 -178.382 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' F' F ' 22' ' ' ILE . . . . . 0.669 HG22 HD12 ' F' ' 26' ' ' LEU . 50.9 mm -56.21 -43.36 76.15 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.271 0 CA-C-O 120.768 0.318 . . . . 0.0 110.49 177.957 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' F' F ' 23' ' ' ARG . . . . . . . . . . . . . 58.8 ttp180 -55.26 -49.09 72.94 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-O 120.723 0.296 . . . . 0.0 111.182 179.693 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' F' F ' 24' ' ' ILE . . . . . . . . . . . . . 73.7 mt -59.32 -41.34 83.88 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.293 0 CA-C-N 116.447 -0.342 . . . . 0.0 111.042 -177.608 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' F' F ' 25' ' ' LYS . . . . . . . . . . . . . 48.0 mttm -69.04 -42.53 76.2 Favored 'General case' 0 C--N 1.328 -0.344 0 N-CA-C 112.696 0.628 . . . . 0.0 112.696 -178.056 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' F' F ' 26' ' ' LEU . . . . . 0.669 HD12 HG22 ' F' ' 22' ' ' ILE . 53.6 mt -79.47 -34.58 41.34 Favored 'General case' 0 C--N 1.331 -0.225 0 N-CA-C 113.72 1.007 . . . . 0.0 113.72 -170.451 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' F' F ' 27' ' ' GLN . . . . . . . . . . . . . 19.4 pt20 -46.67 138.37 6.1 Favored 'General case' 0 N--CA 1.469 0.486 0 N-CA-C 112.998 0.74 . . . . 0.0 112.998 -174.18 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' F' F ' 28' ' ' GLY . . . . . . . . . . . . . . . 100.23 -24.58 31.55 Favored Glycine 0 CA--C 1.533 1.163 0 CA-C-N 115.528 -0.76 . . . . 0.0 112.525 -177.963 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' F' F ' 29' ' ' LYS . . . . . . . . . . . . . 68.7 mttm -98.04 155.08 17.28 Favored 'General case' 0 C--O 1.232 0.177 0 CA-C-N 117.387 0.594 . . . . 0.0 111.337 179.637 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' F' F ' 30' ' ' THR . . . . . . . . . . . . . 29.5 m -105.92 139.43 40.49 Favored 'General case' 0 C--N 1.331 -0.218 0 CA-C-N 115.928 -0.578 . . . . 0.0 110.345 177.989 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' F' F ' 31' ' ' VAL . . . . . . . . . . . . . 34.4 m -129.9 156.71 42.33 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.271 0 CA-C-N 116.357 -0.383 . . . . 0.0 110.616 179.918 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' F' F ' 32' ' ' ARG . . . . . . . . . . . . . 68.1 mtm180 -131.68 152.41 50.89 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-O 121.099 0.476 . . . . 0.0 110.853 177.55 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' F' F ' 33' ' ' THR . . . . . . . . . . . . . 19.8 m -53.39 138.69 32.46 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.304 -0.407 . . . . 0.0 111.175 -179.534 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' F' F ' 34' ' ' GLY . . . . . . . . . . . . . . . 99.59 -17.21 57.91 Favored Glycine 0 CA--C 1.532 1.151 0 C-N-CA 121.211 -0.519 . . . . 0.0 113.268 178.869 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' F' F ' 35' ' ' ASP . . . . . . . . . . . . . 74.3 m-20 -66.83 149.87 49.95 Favored 'General case' 0 N--CA 1.462 0.145 0 CA-C-N 118.076 0.938 . . . . 0.0 111.191 178.98 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' F' F ' 36' ' ' VAL . . . . . . . . . . . . . 43.9 t -121.83 130.0 74.97 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.209 0 N-CA-C 109.607 -0.516 . . . . 0.0 109.607 177.018 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' F' F ' 37' ' ' ILE . . . . . . . . . . . . . 66.2 mt -121.29 138.48 51.52 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.245 0 CA-C-N 116.186 -0.461 . . . . 0.0 109.978 -178.627 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' F' F ' 38' ' ' GLY . . . . . . . . . . . . . . . -113.61 128.02 8.12 Favored Glycine 0 CA--C 1.524 0.652 0 N-CA-C 110.936 -0.866 . . . . 0.0 110.936 179.219 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' F' F ' 39' ' ' ILE . . . . . . . . . . . . . 78.4 mt -127.9 140.49 49.02 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.186 0 CA-C-O 120.789 0.328 . . . . 0.0 110.265 179.2 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' F' F ' 40' ' ' SER . . . . . . . . . . . . . 42.7 t -91.26 115.5 28.07 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.226 -0.443 . . . . 0.0 110.649 176.392 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' F' F ' 41' ' ' ILE . . . . . . . . . . . . . 44.8 mm -119.62 113.22 40.24 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.231 0 N-CA-C 109.961 -0.385 . . . . 0.0 109.961 178.439 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' F' F ' 42' ' ' LEU . . . . . . . . . . . . . 69.1 mt 57.62 36.1 26.39 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.415 -0.357 . . . . 0.0 111.498 179.5 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' F' F ' 43' ' ' GLY . . . . . . . . . . . . . . . 80.34 -10.2 44.35 Favored Glycine 0 CA--C 1.533 1.197 0 C-N-CA 121.289 -0.482 . . . . 0.0 113.517 177.306 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' F' F ' 44' ' ' LYS . . . . . . . . . . . . . 42.8 tttp -99.6 134.68 42.14 Favored 'General case' 0 C--N 1.333 -0.132 0 CA-C-N 117.831 0.816 . . . . 0.0 110.007 177.339 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' F' F ' 45' ' ' GLU . . . . . . . . . . . . . 83.8 tt0 -82.61 127.99 33.89 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-O 120.797 0.332 . . . . 0.0 110.838 -179.014 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' F' F ' 46' ' ' VAL . . . . . . . . . . . . . 10.7 p -121.63 126.11 74.32 Favored 'Isoleucine or valine' 0 C--N 1.333 -0.15 0 N-CA-C 109.639 -0.504 . . . . 0.0 109.639 175.759 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' F' F ' 47' ' ' LYS . . . . . . . . . . . . . 97.7 mttt -99.23 124.82 44.6 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.044 -0.525 . . . . 0.0 110.807 178.235 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' F' F ' 48' ' ' PHE . . . . . . . . . . . . . 32.6 m-85 -108.84 131.89 54.54 Favored 'General case' 0 C--N 1.33 -0.277 0 N-CA-C 109.798 -0.445 . . . . 0.0 109.798 176.548 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' F' F ' 49' ' ' LYS . . . . . . . . . . . . . 34.6 tttp -106.86 135.51 48.29 Favored 'General case' 0 C--N 1.328 -0.355 0 N-CA-C 109.849 -0.426 . . . . 0.0 109.849 177.518 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' F' F ' 50' ' ' VAL . . . . . . . . . . . . . 45.2 t -76.99 106.82 7.37 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.308 0 N-CA-C 109.438 -0.579 . . . . 0.0 109.438 178.027 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' F' F ' 51' ' ' VAL . . . . . . . . . . . . . 47.0 t -73.91 -47.87 41.19 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.324 0 CA-C-N 116.22 -0.446 . . . . 0.0 109.982 -175.009 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' F' F ' 52' ' ' GLN . . . . . . . . . . . . . 63.0 tt0 -159.75 143.85 14.7 Favored 'General case' 0 C--N 1.33 -0.275 0 C-N-CA 120.422 -0.511 . . . . 0.0 111.447 -177.874 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' F' F ' 53' ' ' ALA . . . . . . . . . . . . . . . -123.64 132.9 53.97 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 115.747 -0.66 . . . . 0.0 109.778 175.004 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' F' F ' 54' ' ' TYR . . . . . . . . . . . . . 25.9 t80 -129.2 111.59 18.21 Favored Pre-proline 0 CA--C 1.536 0.416 0 CA-C-O 118.13 -0.938 . . . . 0.0 110.386 178.931 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' F' F ' 55' ' ' PRO . . . . . . . . . . . . . 73.6 Cg_endo -77.26 161.25 93.12 Favored 'Cis proline' 0 N--CA 1.499 1.821 0 CA-C-N 121.943 1.729 . . . . 0.0 112.407 -6.835 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' F' F ' 56' ' ' SER . . . . . . . . . . . . . 60.8 m -108.76 130.78 22.32 Favored Pre-proline 0 CA--C 1.539 0.557 0 CA-C-O 118.434 -0.793 . . . . 0.0 109.487 175.304 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' F' F ' 57' ' ' PRO . . . . . . . . . . . . . 36.5 Cg_endo -66.31 163.13 70.1 Favored 'Cis proline' 0 N--CA 1.498 1.78 0 CA-C-N 121.972 1.74 . . . . 0.0 111.601 -1.3 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' F' F ' 58' ' ' LEU . . . . . . . . . . . . . 15.7 tp -129.37 138.98 51.84 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-O 121.026 0.441 . . . . 0.0 110.405 -178.131 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' F' F ' 59' ' ' ARG . . . . . . . . . . . . . 74.2 ttt180 -104.68 136.31 44.44 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 115.836 -0.62 . . . . 0.0 109.683 176.244 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' F' F ' 60' ' ' VAL . . . . . . . . . . . . . 43.3 t -85.35 116.72 29.14 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.262 0 C-N-CA 120.662 -0.415 . . . . 0.0 110.234 -178.345 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' F' F ' 61' ' ' GLU . . . . . . . . . . . . . 39.1 tp10 -131.06 155.54 46.72 Favored 'General case' 0 C--N 1.328 -0.362 0 N-CA-C 109.005 -0.739 . . . . 0.0 109.005 176.856 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' F' F ' 62' ' ' ASP . . . . . . . . . . . . . 13.9 t70 -51.04 -32.37 21.55 Favored 'General case' 0 C--N 1.327 -0.391 0 N-CA-C 112.011 0.374 . . . . 0.0 112.011 -178.868 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' F' F ' 63' ' ' ARG . . . . . . . . . . . . . 87.6 mtt180 -73.21 -22.06 60.52 Favored 'General case' 0 CA--C 1.534 0.335 0 N-CA-C 112.908 0.707 . . . . 0.0 112.908 -176.801 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' F' F ' 64' ' ' THR . . . . . . . . . . . . . 18.9 m -71.8 143.02 49.65 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-O 120.929 0.395 . . . . 0.0 110.88 -175.3 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' F' F ' 65' ' ' LYS . . . . . . . . . . . . . 91.4 mttt -87.71 129.91 34.99 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 115.973 -0.558 . . . . 0.0 110.049 178.809 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' F' F ' 66' ' ' ILE . . . . . . . . . . . . . 58.2 mt -115.9 125.57 73.08 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.226 0 N-CA-C 109.579 -0.526 . . . . 0.0 109.579 178.32 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' F' F ' 67' ' ' THR . . . . . . . . . . . . . 24.6 m -121.79 142.3 50.35 Favored 'General case' 0 C--N 1.331 -0.227 0 CA-C-O 121.008 0.432 . . . . 0.0 111.215 -176.246 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' F' F ' 68' ' ' LEU . . . . . . . . . . . . . 4.9 tt -106.59 125.06 50.52 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 115.743 -0.662 . . . . 0.0 109.85 178.173 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' F' F ' 69' ' ' VAL . . . . . . . . . . . . . 42.6 t -90.37 130.83 38.97 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.316 0 CA-C-O 120.837 0.351 . . . . 0.0 110.296 -178.675 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' F' F ' 70' ' ' THR . . . . . . . . . . . . . 68.2 p -85.55 -29.65 24.01 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.091 -0.504 . . . . 0.0 111.957 -179.235 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' F' F ' 71' ' ' HIS . . . . . . . . . . . . . 70.9 m-70 -65.04 151.66 93.03 Favored Pre-proline 0 C--O 1.234 0.244 0 C-N-CA 121.045 -0.262 . . . . 0.0 110.582 -178.411 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' F' F ' 72' ' ' PRO . . . . . . . . . . . . . 73.5 Cg_endo -83.74 -28.6 1.27 Allowed 'Trans proline' 0 N--CA 1.491 1.325 0 C-N-CA 121.627 1.551 . . . . 0.0 112.77 -179.598 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' F' F ' 73' ' ' VAL . . . . . . . . . . . . . 35.6 m -128.83 163.48 33.54 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.199 0 CA-C-O 120.902 0.382 . . . . 0.0 110.702 -179.372 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' F' F ' 74' ' ' ASP . . . . . . . . . . . . . 14.4 t0 -104.47 118.42 36.57 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.017 -0.538 . . . . 0.0 109.784 179.341 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' F' F ' 75' ' ' VAL . . . . . 0.568 ' C ' HD12 ' F' ' 76' ' ' LEU . 42.9 t -115.55 124.17 71.76 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.301 0 CA-C-O 120.965 0.412 . . . . 0.0 110.658 -177.466 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' F' F ' 76' ' ' LEU . . . . . 0.568 HD12 ' C ' ' F' ' 75' ' ' VAL . 8.7 mp -122.61 150.73 42.25 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-N 115.74 -0.664 . . . . 0.0 109.687 175.945 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' F' F ' 77' ' ' GLU . . . . . . . . . . . . . 98.9 mt-10 -135.59 141.47 45.14 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-O 121.183 0.516 . . . . 0.0 111.816 -175.984 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' F' F ' 78' ' ' ALA . . . . . . . . . . . . . . . -127.81 143.83 51.11 Favored 'General case' 0 C--N 1.331 -0.204 0 CA-C-N 115.518 -0.764 . . . . 0.0 109.82 175.868 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' F' F ' 79' ' ' LYS . . . . . 0.625 ' O ' HD13 ' F' ' 80' ' ' ILE . 37.8 mtmt -95.26 112.33 24.05 Favored 'General case' 0 C--N 1.33 -0.239 0 CA-C-O 120.738 0.304 . . . . 0.0 111.074 -176.89 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' F' F ' 80' ' ' ILE . . . . . 0.625 HD13 ' O ' ' F' ' 79' ' ' LYS . 39.3 mm -139.23 112.67 6.5 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.238 0 N-CA-C 109.404 -0.591 . . . . 0.0 109.404 -179.265 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' F' F ' 81' ' ' LYS . . . . . . . . . . . . . 56.3 pttt -106.67 131.48 53.76 Favored 'General case' 0 N--CA 1.464 0.242 0 CA-C-O 120.961 0.41 . . . . 0.0 111.389 -178.223 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' F' F ' 82' ' ' GLY . . . . . . . . . . . . . . . 89.13 41.95 5.72 Favored Glycine 0 CA--C 1.527 0.804 0 C-N-CA 121.018 -0.61 . . . . 0.0 111.813 176.154 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' F' F ' 83' ' ' ILE . . . . . . . . . . . . . 74.5 mt -77.13 137.9 21.55 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 N-CA-C 109.351 -0.611 . . . . 0.0 109.351 176.329 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' F' F ' 84' ' ' LYS . . . . . . . . . . . . . 19.3 ttpt -101.47 -46.85 4.86 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.431 -0.35 . . . . 0.0 110.527 -176.897 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' F' F ' 85' ' ' ASP . . . . . . . . . . . . . 13.7 t70 -143.72 146.6 33.29 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.448 -0.342 . . . . 0.0 110.479 -179.176 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' F' F ' 86' ' ' VAL . . . . . . . . . . . . . 44.7 t -128.96 128.86 67.81 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.215 0 CA-C-O 120.91 0.386 . . . . 0.0 110.405 -178.847 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' F' F ' 87' ' ' ILE . . . . . . . . . . . . . 44.7 mm -121.35 128.36 75.91 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.235 0 N-CA-C 109.359 -0.608 . . . . 0.0 109.359 177.903 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' F' F ' 88' ' ' LEU . . . . . . . . . . . . . 62.1 mt -120.21 139.26 52.92 Favored 'General case' 0 C--N 1.332 -0.194 0 CA-C-O 121.207 0.527 . . . . 0.0 111.882 -175.277 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' F' F ' 89' ' ' ASP . . . . . . . . . . . . . 13.4 t70 -133.61 154.92 50.52 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 115.423 -0.808 . . . . 0.0 109.436 175.394 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' F' F ' 90' ' ' GLU . . . . . . . . . . . . . 44.2 mt-10 -49.46 -36.78 23.7 Favored 'General case' 0 C--N 1.329 -0.294 0 N-CA-C 112.832 0.678 . . . . 0.0 112.832 -171.805 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' F' F ' 91' ' ' ASN . . . . . . . . . . . . . 9.1 m120 -127.1 22.11 6.69 Favored 'General case' 0 N--CA 1.468 0.449 0 N-CA-C 112.869 0.692 . . . . 0.0 112.869 -176.651 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' F' F ' 92' ' ' LEU . . . . . . . . . . . . . 5.8 mt -153.49 144.4 22.79 Favored 'General case' 0 C--N 1.331 -0.199 0 N-CA-C 109.573 -0.528 . . . . 0.0 109.573 -177.894 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' F' F ' 93' ' ' ILE . . . . . . . . . . . . . 71.2 mt -127.28 122.25 59.34 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.288 0 N-CA-C 109.407 -0.59 . . . . 0.0 109.407 178.41 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' F' F ' 94' ' ' VAL . . . . . . . . . . . . . 43.5 t -121.95 126.97 75.22 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.242 0 CA-C-O 120.911 0.386 . . . . 0.0 110.014 -179.821 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' F' F ' 95' ' ' VAL . . . . . . . . . . . . . 44.0 t -120.47 133.25 67.78 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.384 0 CA-C-N 115.963 -0.562 . . . . 0.0 109.662 179.671 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' F' F ' 96' ' ' ILE . . . . . . . . . . . . . 66.9 mt -114.99 124.54 71.75 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.231 0 N-CA-C 109.121 -0.696 . . . . 0.0 109.121 178.726 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' F' F ' 97' ' ' THR . . . . . . . . . . . . . 45.3 p -98.28 156.75 16.56 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-O 121.114 0.483 . . . . 0.0 111.474 -176.139 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' F' F ' 98' ' ' GLU . . . . . . . . . . . . . 96.7 mt-10 -54.09 -26.35 26.68 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 116.037 -0.529 . . . . 0.0 112.027 178.307 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' F' F ' 99' ' ' GLU . . . . . . . . . . . . . 34.6 tt0 -79.33 17.03 0.88 Allowed 'General case' 0 CA--C 1.538 0.51 0 N-CA-C 112.582 0.586 . . . . 0.0 112.582 -176.83 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' F' F ' 100' ' ' ASN . . . . . . . . . . . . . 2.0 m120 64.18 36.2 9.68 Favored 'General case' 0 CA--C 1.531 0.224 0 O-C-N 121.84 -0.538 . . . . 0.0 110.984 176.002 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' F' F ' 101' ' ' GLU . . . . . . . . . . . . . 79.1 tt0 -117.15 142.88 46.46 Favored 'General case' 0 C--O 1.231 0.099 0 N-CA-C 109.917 -0.401 . . . . 0.0 109.917 178.248 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' F' F ' 102' ' ' VAL . . . . . . . . . . . . . 43.4 t -115.56 125.16 72.66 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.312 0 N-CA-C 109.728 -0.471 . . . . 0.0 109.728 -179.848 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' F' F ' 103' ' ' LEU . . . . . . . . . . . . . 40.0 mt -117.08 131.06 57.01 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 115.972 -0.558 . . . . 0.0 110.606 178.256 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' F' F ' 104' ' ' ILE . . . . . 0.468 HD12 ' HB3' ' F' ' 113' ' ' TYR . 67.0 mt -117.19 120.08 63.87 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.221 0 CA-C-N 116.405 -0.361 . . . . 0.0 110.314 -179.477 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' F' F ' 105' ' ' PHE . . . . . . . . . . . . . 76.1 m-85 -121.58 167.4 12.93 Favored 'General case' 0 C--O 1.231 0.128 0 O-C-N 124.092 0.87 . . . . 0.0 109.688 178.238 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' F' F ' 106' ' ' ASN . . . . . . . . . . . . . 43.0 p-10 -104.09 -170.99 1.85 Allowed 'General case' 0 C--N 1.332 -0.172 0 N-CA-C 109.657 -0.497 . . . . 0.0 109.657 170.653 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' F' F ' 107' ' ' GLN . . . . . . . . . . . . . 50.3 tt0 -58.41 -29.98 66.51 Favored 'General case' 0 C--N 1.328 -0.338 0 N-CA-C 111.925 0.343 . . . . 0.0 111.925 179.735 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' F' F ' 108' ' ' ASN . . . . . . . . . . . . . 47.1 t30 -88.22 13.7 10.89 Favored 'General case' 0 CA--C 1.534 0.359 0 N-CA-C 112.91 0.707 . . . . 0.0 112.91 -176.484 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' F' F ' 109' ' ' LEU . . . . . . . . . . . . . 82.1 mt 57.2 33.6 23.55 Favored 'General case' 0 CA--C 1.529 0.173 0 N-CA-C 111.823 0.305 . . . . 0.0 111.823 176.875 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' F' F ' 110' ' ' GLU . . . . . . . . . . . . . 95.8 mt-10 -100.0 138.61 36.84 Favored 'General case' 0 C--N 1.331 -0.239 0 N-CA-C 109.339 -0.615 . . . . 0.0 109.339 175.616 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' F' F ' 111' ' ' GLU . . . . . . . . . . . . . 56.7 tt0 -75.49 121.9 23.05 Favored 'General case' 0 C--N 1.328 -0.338 0 C-N-CA 120.64 -0.424 . . . . 0.0 110.532 -175.727 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' F' F ' 112' ' ' LEU . . . . . . . . . . . . . 32.4 mt -104.36 -46.02 4.51 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.065 -0.516 . . . . 0.0 110.657 179.715 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' F' F ' 113' ' ' TYR . . . . . 0.468 ' HB3' HD12 ' F' ' 104' ' ' ILE . 58.8 t80 -143.16 141.06 31.06 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 116.247 -0.433 . . . . 0.0 111.295 -179.35 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' F' F ' 114' ' ' ARG . . . . . . . . . . . . . 39.0 ptt180 -137.81 123.76 20.16 Favored 'General case' 0 C--N 1.331 -0.203 0 CA-C-N 115.837 -0.619 . . . . 0.0 110.252 178.124 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' F' F ' 115' ' ' GLY . . . . . . . . . . . . . . . -150.08 160.94 28.74 Favored Glycine 0 CA--C 1.523 0.582 0 C-N-CA 120.565 -0.826 . . . . 0.0 111.472 -179.289 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' F' F ' 116' ' ' LYS . . . . . . . . . . . . . 32.5 ttpt -127.18 141.4 51.75 Favored 'General case' 0 C--N 1.33 -0.249 0 N-CA-C 109.838 -0.431 . . . . 0.0 109.838 176.487 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' F' F ' 117' ' ' PHE . . . . . . . . . . . . . 43.0 m-85 -141.17 113.82 8.28 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.408 -0.36 . . . . 0.0 110.061 -179.545 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' F' F ' 118' ' ' GLU . . . . . . . . . . . . . 95.9 mt-10 -55.6 -44.13 76.7 Favored 'General case' 0 C--N 1.329 -0.321 0 C-N-CA 120.867 -0.333 . . . . 0.0 111.093 -176.252 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' F' F ' 119' ' ' ASN . . . . . . . . . . . . . 3.5 m120 -98.72 31.11 3.03 Favored 'General case' 0 C--N 1.33 -0.246 0 N-CA-C 112.216 0.45 . . . . 0.0 112.216 -174.387 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' F' F ' 120' ' ' LEU . . . . . . . . . . . . . 17.5 tp -57.04 121.03 9.04 Favored 'General case' 0 N--CA 1.463 0.206 0 N-CA-C 110.092 -0.336 . . . . 0.0 110.092 177.475 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' F' F ' 121' ' ' ASN . . . . . . . . . . . . . 5.3 t30 -114.08 -44.11 3.18 Favored 'General case' 0 C--N 1.332 -0.182 0 C-N-CA 121.208 -0.197 . . . . 0.0 111.25 -176.75 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' F' F ' 122' ' ' LYS . . . . . . . . . . . . . 86.3 mttt -142.97 147.87 35.9 Favored 'General case' 0 C--N 1.332 -0.19 0 CA-C-O 121.164 0.507 . . . . 0.0 111.788 -178.986 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' F' F ' 123' ' ' VAL . . . . . . . . . . . . . 42.9 t -128.74 129.56 68.49 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.186 0 CA-C-N 115.729 -0.668 . . . . 0.0 109.553 174.823 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' F' F ' 124' ' ' LEU . . . . . . . . . . . . . 21.7 mt -123.81 135.32 53.71 Favored 'General case' 0 C--N 1.331 -0.212 0 CA-C-O 120.81 0.338 . . . . 0.0 110.679 -178.841 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' F' F ' 125' ' ' VAL . . . . . 0.439 ' O ' HG13 ' F' ' 125' ' ' VAL . 11.7 p -136.86 123.95 30.91 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.273 0 CA-C-N 116.233 -0.44 . . . . 0.0 110.214 178.0 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' F' F ' 126' ' ' ARG . . . . . . . . . . . . . 89.6 mtt180 -152.94 132.92 13.33 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.053 -0.521 . . . . 0.0 109.873 178.938 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' F' F ' 127' ' ' ASN . . . . . . . . . . . . . 3.9 m120 55.58 -151.76 0.38 Allowed 'General case' 0 CA--C 1.541 0.602 0 N-CA-C 109.898 -0.408 . . . . 0.0 109.898 179.38 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' F' F ' 128' ' ' ASP . . . . . . . . . . . . . 19.7 p-10 -81.35 15.3 2.05 Favored 'General case' 0 CA--C 1.536 0.417 0 CA-C-N 118.643 0.656 . . . . 0.0 112.764 178.675 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' F' F ' 129' ' ' LEU . . . . . . . . . . . . . 31.7 mt -111.05 131.14 55.31 Favored 'General case' 0 C--O 1.233 0.213 0 O-C-N 121.936 -0.477 . . . . 0.0 110.651 179.588 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' F' F ' 130' ' ' VAL . . . . . . . . . . . . . 41.2 t -122.15 133.64 67.85 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.223 0 N-CA-C 109.115 -0.698 . . . . 0.0 109.115 176.839 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' F' F ' 131' ' ' VAL . . . . . 0.417 HG22 HD12 ' F' ' 140' ' ' LEU . 42.6 t -135.73 137.4 49.3 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.213 0 CA-C-O 121.049 0.452 . . . . 0.0 110.694 -176.852 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' F' F ' 132' ' ' ILE . . . . . . . . . . . . . 67.7 mt -120.55 133.42 67.29 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.242 0 CA-C-N 115.748 -0.66 . . . . 0.0 109.604 179.732 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' F' F ' 133' ' ' ILE . . . . . . . . . . . . . 40.5 mm -119.8 120.6 63.79 Favored 'Isoleucine or valine' 0 C--O 1.234 0.269 0 CA-C-O 120.876 0.37 . . . . 0.0 110.949 -177.294 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' F' F ' 134' ' ' ASP . . . . . . . . . . . . . 7.2 p-10 -134.16 146.9 50.62 Favored 'General case' 0 C--N 1.329 -0.285 0 N-CA-C 109.497 -0.556 . . . . 0.0 109.497 174.562 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' F' F ' 135' ' ' GLU . . . . . . . . . . . . . 52.6 tt0 -49.86 -25.96 3.62 Favored 'General case' 0 C--N 1.328 -0.358 0 N-CA-C 112.948 0.722 . . . . 0.0 112.948 -170.145 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' F' F ' 136' ' ' GLN . . . . . . . . . . . . . 60.8 tp60 -99.2 -31.2 11.85 Favored 'General case' 0 C--N 1.332 -0.183 0 N-CA-C 112.384 0.512 . . . . 0.0 112.384 -174.767 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' F' F ' 137' ' ' LYS . . . . . . . . . . . . . 89.4 mttt -139.85 153.9 47.16 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-O 121.214 0.53 . . . . 0.0 111.532 -170.515 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' F' F ' 138' ' ' LEU . . . . . . . . . . . . . 4.3 tt -121.37 126.85 50.43 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 115.625 -0.716 . . . . 0.0 109.32 174.171 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' F' F ' 139' ' ' THR . . . . . . . . . . . . . 31.8 m -116.67 134.21 55.09 Favored 'General case' 0 N--CA 1.462 0.144 0 CA-C-O 120.891 0.377 . . . . 0.0 111.385 -176.338 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' F' F ' 140' ' ' LEU . . . . . 0.417 HD12 HG22 ' F' ' 131' ' ' VAL . 24.0 tp -120.99 122.65 40.6 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 115.387 -0.824 . . . . 0.0 109.167 179.721 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' F' F ' 141' ' ' ILE . . . . . . . . . . . . . 19.2 mt -119.87 125.24 74.09 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.323 0 CA-C-O 120.974 0.416 . . . . 0.0 110.278 -175.638 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' F' F ' 142' ' ' ARG . . . . . . . . . . . . . 43.1 mtm180 -107.59 124.67 50.29 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 115.205 -0.907 . . . . 0.0 110.134 178.948 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' F' F ' 143' ' ' THR . . . . . . . . . . . . . 21.5 p . . . . . 0 C--O 1.221 -0.443 0 CA-C-O 117.991 -1.004 . . . . 0.0 110.584 179.852 . . . . . . . . 0 0 . 1 . 016 nuclear build full ' A' A ' -3' ' ' GLU . . . . . . . . . . . . . 44.6 tp10 . . . . . 0 N--CA 1.491 1.597 0 N-CA-C 109.307 -0.627 . . . . 0.0 109.307 . . . . . . . . . 0 0 . 1 . 016 nuclear build full ' A' A ' -2' ' ' GLY . . . . . . . . . . . . . . . -82.98 149.96 27.19 Favored Glycine 0 CA--C 1.525 0.687 0 N-CA-C 111.043 -0.823 . . . . 0.0 111.043 179.678 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' -1' ' ' VAL . . . . . . . . . . . . . 45.0 t -92.81 133.3 34.52 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.288 0 N-CA-C 109.932 -0.395 . . . . 0.0 109.932 179.531 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 0' ' ' ILE . . . . . . . . . . . . . 67.1 mt -115.4 135.27 55.95 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.261 0 CA-C-N 116.298 -0.41 . . . . 0.0 110.124 -178.57 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 25.9 ptt? -82.2 146.72 29.37 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.085 -0.507 . . . . 0.0 110.606 179.18 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 5.0 p -107.82 131.01 54.93 Favored 'General case' 0 C--N 1.331 -0.226 0 CA-C-O 120.932 0.396 . . . . 0.0 110.362 178.455 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 95.5 mt-10 -141.85 142.42 33.12 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.115 -0.493 . . . . 0.0 111.242 -178.061 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 4' ' ' LEU . . . . . . . . . . . . . 18.1 tp -124.32 124.45 42.41 Favored 'General case' 0 C--N 1.331 -0.218 0 CA-C-N 115.757 -0.656 . . . . 0.0 109.848 175.718 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 5' ' ' LYS . . . . . 0.401 ' HB3' HG21 ' A' ' 69' ' ' VAL . 98.0 mttt -105.09 120.55 41.79 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.65 -179.7 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 37.8 mt -115.37 148.81 38.86 Favored 'General case' 0 C--N 1.332 -0.183 0 CA-C-N 115.624 -0.716 . . . . 0.0 110.237 -178.414 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 21.3 ttpt -129.83 135.53 27.64 Favored Pre-proline 0 CA--C 1.534 0.339 0 CA-C-O 118.851 -0.595 . . . . 0.0 109.443 174.276 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 8' ' ' PRO . . . . . . . . . . . . . 76.8 Cg_endo -91.54 135.54 1.72 Allowed 'Trans proline' 0 N--CA 1.489 1.239 0 C-N-CA 121.694 1.596 . . . . 0.0 111.683 177.52 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 48.6 mt -72.15 -47.24 10.99 Favored Pre-proline 0 CA--C 1.533 0.309 0 CA-C-O 118.594 -0.717 . . . . 0.0 112.171 -178.988 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 83.4 Cg_endo -80.8 148.65 17.75 Favored 'Trans proline' 0 N--CA 1.496 1.666 0 C-N-CA 121.217 1.278 . . . . 0.0 111.753 175.905 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 51.2 tptt -85.2 96.05 9.36 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.466 -0.334 . . . . 0.0 110.275 179.234 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 12.5 p -142.52 149.65 18.98 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.243 0 CA-C-N 116.25 -0.432 . . . . 0.0 110.692 -178.326 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 83.1 tt0 -89.92 129.48 36.27 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-N 116.163 -0.471 . . . . 0.0 110.551 179.378 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 14' ' ' LEU . . . . . . . . . . . . . 48.3 mt -98.44 153.06 38.16 Favored Pre-proline 0 CA--C 1.532 0.282 0 CA-C-N 116.425 -0.352 . . . . 0.0 110.888 -178.872 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 15' ' ' PRO . . . . . . . . . . . . . 30.1 Cg_exo -61.19 159.88 28.78 Favored 'Trans proline' 0 N--CA 1.497 1.705 0 C-N-CA 121.356 1.371 . . . . 0.0 111.963 176.627 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 16' ' ' PRO . . . . . . . . . . . . . 31.6 Cg_exo -59.72 -42.17 48.8 Favored 'Trans proline' 0 N--CA 1.495 1.613 0 C-N-CA 121.475 1.45 . . . . 0.0 112.648 -179.068 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 17' ' ' ASP . . . . . . . . . . . . . 13.1 p-10 -84.13 11.65 7.72 Favored 'General case' 0 CA--C 1.535 0.383 0 N-CA-C 113.129 0.789 . . . . 0.0 113.129 -177.676 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 18' ' ' PHE . . . . . 0.466 ' HE1' HD13 ' A' ' 41' ' ' ILE . 31.2 t80 -57.12 -45.04 83.81 Favored 'General case' 0 N--CA 1.458 -0.074 0 O-C-N 121.917 -0.489 . . . . 0.0 110.433 -178.408 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 19' ' ' VAL . . . . . . . . . . . . . 48.0 t -57.06 -41.06 76.85 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.245 0 CA-C-N 116.371 -0.377 . . . . 0.0 110.534 -178.711 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 68.8 m-20 -59.79 -43.38 94.43 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-O 120.899 0.381 . . . . 0.0 110.703 -178.342 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 45.4 t -64.34 -46.56 92.77 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.321 0 CA-C-N 116.281 -0.418 . . . . 0.0 110.56 -178.231 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 22' ' ' ILE . . . . . 0.63 HG22 HD12 ' A' ' 26' ' ' LEU . 50.6 mm -55.11 -47.07 77.63 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.222 0 C-N-CA 120.99 -0.284 . . . . 0.0 110.828 179.272 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 23' ' ' ARG . . . . . . . . . . . . . 56.5 ttp180 -54.12 -50.03 67.82 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-O 120.697 0.284 . . . . 0.0 111.329 -179.021 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 24' ' ' ILE . . . . . . . . . . . . . 74.0 mt -58.91 -42.31 85.52 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.239 0 CA-C-N 116.432 -0.349 . . . . 0.0 111.25 -178.157 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 61.9 mtpt -67.76 -41.77 82.8 Favored 'General case' 0 C--N 1.328 -0.354 0 N-CA-C 112.404 0.52 . . . . 0.0 112.404 -177.405 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 26' ' ' LEU . . . . . 0.63 HD12 HG22 ' A' ' 22' ' ' ILE . 49.2 mt -79.43 -37.38 37.21 Favored 'General case' 0 C--N 1.33 -0.28 0 N-CA-C 113.368 0.877 . . . . 0.0 113.368 -169.495 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 27' ' ' GLN . . . . . . . . . . . . . 15.9 pt20 -46.84 136.19 8.39 Favored 'General case' 0 N--CA 1.47 0.553 0 N-CA-C 112.728 0.64 . . . . 0.0 112.728 -176.09 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 99.72 -23.99 33.94 Favored Glycine 0 CA--C 1.534 1.252 0 CA-C-N 115.624 -0.716 . . . . 0.0 112.448 -176.633 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 28.8 mtpp -97.91 155.17 17.2 Favored 'General case' 0 C--O 1.233 0.209 0 CA-C-N 117.344 0.572 . . . . 0.0 111.005 179.983 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 30' ' ' THR . . . . . . . . . . . . . 33.8 m -105.53 138.03 42.39 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.143 -0.481 . . . . 0.0 110.118 176.848 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 35.2 m -129.95 149.48 33.65 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.271 0 CA-C-O 121.018 0.437 . . . . 0.0 110.933 -179.27 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 32' ' ' ARG . . . . . . . . . . . . . 29.5 ttm105 -130.05 148.01 51.86 Favored 'General case' 0 C--N 1.331 -0.239 0 CA-C-N 115.905 -0.589 . . . . 0.0 110.233 178.9 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 33' ' ' THR . . . . . . . . . . . . . 25.4 m -52.24 138.07 27.08 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.397 -0.365 . . . . 0.0 111.496 -177.58 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 100.28 -17.1 57.41 Favored Glycine 0 CA--C 1.533 1.161 0 CA-C-O 119.649 -0.528 . . . . 0.0 113.288 178.862 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 72.6 m-20 -65.85 149.85 49.52 Favored 'General case' 0 C--O 1.231 0.128 0 CA-C-N 118.053 0.927 . . . . 0.0 111.199 -179.965 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 45.6 t -119.8 129.3 75.57 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.275 0 CA-C-N 115.904 -0.589 . . . . 0.0 109.701 177.548 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 37' ' ' ILE . . . . . . . . . . . . . 63.8 mt -120.0 137.24 54.49 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.266 0 CA-C-N 116.162 -0.472 . . . . 0.0 109.797 -179.647 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . -116.45 128.86 8.14 Favored Glycine 0 CA--C 1.525 0.672 0 N-CA-C 110.848 -0.901 . . . . 0.0 110.848 179.948 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 39' ' ' ILE . . . . . . . . . . . . . 68.3 mt -126.66 129.94 71.62 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.169 0 N-CA-C 110.056 -0.349 . . . . 0.0 110.056 179.238 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 40' ' ' SER . . . . . . . . . . . . . 16.8 p -91.31 119.0 30.98 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.1 -0.5 . . . . 0.0 110.4 175.49 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 41' ' ' ILE . . . . . 0.466 HD13 ' HE1' ' A' ' 18' ' ' PHE . 70.2 mt -127.26 113.74 33.5 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.197 0 N-CA-C 110.113 -0.329 . . . . 0.0 110.113 -179.546 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 7.8 mp 56.62 39.25 29.89 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-O 121.247 0.546 . . . . 0.0 110.913 179.184 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . 79.38 -10.23 37.33 Favored Glycine 0 CA--C 1.533 1.172 0 C-N-CA 121.252 -0.499 . . . . 0.0 113.653 175.952 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 44' ' ' LYS . . . . . . . . . . . . . 78.7 tttt -98.27 126.49 43.78 Favored 'General case' 0 C--N 1.333 -0.11 0 CA-C-N 117.913 0.856 . . . . 0.0 110.094 177.882 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 77.3 tt0 -84.9 127.45 34.16 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.372 -0.376 . . . . 0.0 111.081 -179.427 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 46' ' ' VAL . . . . . . . . . . . . . 10.9 p -123.07 125.18 71.73 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.187 0 N-CA-C 110.085 -0.339 . . . . 0.0 110.085 175.874 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 99.1 mttt -99.34 127.88 45.41 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.057 -0.52 . . . . 0.0 111.024 177.248 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 48' ' ' PHE . . . . . . . . . . . . . 34.2 m-85 -112.49 131.91 55.34 Favored 'General case' 0 C--N 1.33 -0.279 0 N-CA-C 109.605 -0.517 . . . . 0.0 109.605 176.913 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 85.9 tttt -105.07 134.36 48.29 Favored 'General case' 0 C--N 1.328 -0.363 0 N-CA-C 110.084 -0.339 . . . . 0.0 110.084 177.562 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 50' ' ' VAL . . . . . . . . . . . . . 43.2 t -77.84 105.09 6.41 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.371 0 N-CA-C 109.491 -0.559 . . . . 0.0 109.491 177.908 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 51' ' ' VAL . . . . . . . . . . . . . 46.9 t -72.88 -47.99 46.81 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.335 0 CA-C-N 116.018 -0.537 . . . . 0.0 110.075 -174.145 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 52' ' ' GLN . . . . . . . . . . . . . 44.4 tt0 -158.44 135.53 9.91 Favored 'General case' 0 C--N 1.33 -0.27 0 C-N-CA 120.274 -0.571 . . . . 0.0 111.796 -177.954 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 53' ' ' ALA . . . . . 0.613 ' HB3' ' OG ' ' A' ' 56' ' ' SER . . . -110.23 129.44 55.72 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 115.839 -0.619 . . . . 0.0 109.649 175.032 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 54' ' ' TYR . . . . . . . . . . . . . 60.2 t80 -129.03 106.64 18.02 Favored Pre-proline 0 CA--C 1.535 0.378 0 CA-C-O 118.373 -0.823 . . . . 0.0 110.546 -178.437 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 55' ' ' PRO . . . . . . . . . . . . . 73.0 Cg_endo -77.13 168.94 75.59 Favored 'Cis proline' 0 N--CA 1.499 1.81 0 CA-C-N 121.67 1.632 . . . . 0.0 112.458 -5.766 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 56' ' ' SER . . . . . 0.613 ' OG ' ' HB3' ' A' ' 53' ' ' ALA . 74.3 m -118.01 134.42 23.31 Favored Pre-proline 0 CA--C 1.539 0.556 0 CA-C-O 118.486 -0.769 . . . . 0.0 109.473 174.494 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 57' ' ' PRO . . . . . . . . . . . . . 51.7 Cg_endo -70.78 146.98 85.78 Favored 'Cis proline' 0 N--CA 1.497 1.699 0 CA-C-N 121.88 1.707 . . . . 0.0 111.347 -1.911 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 58' ' ' LEU . . . . . . . . . . . . . 20.6 tp -108.0 136.3 47.93 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 116.39 -0.368 . . . . 0.0 110.86 -177.944 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 59' ' ' ARG . . . . . . . . . . . . . 55.8 ttp180 -104.31 117.94 35.42 Favored 'General case' 0 C--N 1.327 -0.389 0 N-CA-C 109.052 -0.721 . . . . 0.0 109.052 174.018 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 42.4 t -71.55 122.13 23.08 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.353 0 CA-C-N 116.353 -0.385 . . . . 0.0 110.698 -173.114 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 95.4 mt-10 -131.07 165.32 23.51 Favored 'General case' 0 C--N 1.331 -0.225 0 CA-C-N 115.795 -0.639 . . . . 0.0 110.033 177.28 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 62' ' ' ASP . . . . . . . . . . . . . 14.9 m-20 -55.19 -32.68 62.39 Favored 'General case' 0 C--N 1.329 -0.315 0 N-CA-C 111.758 0.281 . . . . 0.0 111.758 -179.252 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 63' ' ' ARG . . . . . . . . . . . . . 17.6 ptm180 -81.35 6.56 13.99 Favored 'General case' 0 CA--C 1.535 0.399 0 N-CA-C 113.524 0.935 . . . . 0.0 113.524 -176.512 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 34.4 m -91.41 136.16 33.31 Favored 'General case' 0 C--O 1.232 0.147 0 CA-C-N 118.26 0.482 . . . . 0.0 110.751 -179.754 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 65' ' ' LYS . . . . . . . . . . . . . 68.7 mttm -89.51 135.42 33.61 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.005 -0.543 . . . . 0.0 110.319 179.473 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 66' ' ' ILE . . . . . 0.475 HD12 ' N ' ' A' ' 66' ' ' ILE . 4.3 mp -116.45 127.42 74.06 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.282 0 N-CA-C 109.552 -0.536 . . . . 0.0 109.552 178.76 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 67' ' ' THR . . . . . . . . . . . . . 25.0 m -131.38 148.66 52.68 Favored 'General case' 0 N--CA 1.464 0.237 0 CA-C-O 121.137 0.494 . . . . 0.0 111.944 -175.376 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 68' ' ' LEU . . . . . 0.425 ' N ' HD12 ' A' ' 68' ' ' LEU . 8.5 mp -95.19 129.28 42.36 Favored 'General case' 0 C--N 1.331 -0.219 0 CA-C-N 115.629 -0.714 . . . . 0.0 109.909 175.356 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 69' ' ' VAL . . . . . 0.401 HG21 ' HB3' ' A' ' 5' ' ' LYS . 43.1 t -103.18 143.38 15.42 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.272 0 CA-C-O 120.873 0.368 . . . . 0.0 110.957 -176.935 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 70' ' ' THR . . . . . . . . . . . . . 12.0 m -84.85 130.94 34.58 Favored 'General case' 0 C--N 1.33 -0.27 0 N-CA-C 108.9 -0.778 . . . . 0.0 108.9 172.645 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 71' ' ' HIS . . . . . . . . . . . . . 1.8 m80 -135.44 174.94 4.0 Favored Pre-proline 0 CA--C 1.537 0.457 0 C-N-CA 121.049 -0.261 . . . . 0.0 111.367 -171.515 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 72' ' ' PRO . . . . . . . . . . . . . 22.5 Cg_exo -64.84 160.24 41.87 Favored 'Trans proline' 0 N--CA 1.496 1.632 0 C-N-CA 121.974 1.783 . . . . 0.0 112.671 -179.667 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 73' ' ' VAL . . . . . . . . . . . . . 33.0 m -69.72 -170.61 0.07 OUTLIER 'Isoleucine or valine' 0 C--N 1.33 -0.272 0 CA-C-N 115.767 -0.651 . . . . 0.0 110.481 -174.93 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 74' ' ' ASP . . . . . . . . . . . . . 13.3 t70 -77.17 118.77 20.02 Favored 'General case' 0 C--N 1.329 -0.316 0 C-N-CA 121.01 -0.276 . . . . 0.0 110.432 -170.146 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 75' ' ' VAL . . . . . 0.417 ' C ' HD12 ' A' ' 76' ' ' LEU . 41.4 t -124.91 124.11 67.08 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.206 0 CA-C-O 121.141 0.496 . . . . 0.0 110.691 -176.481 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 76' ' ' LEU . . . . . 0.417 HD12 ' C ' ' A' ' 75' ' ' VAL . 6.4 mp -122.1 150.14 42.58 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 115.586 -0.734 . . . . 0.0 109.22 173.841 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 77' ' ' GLU . . . . . . . . . . . . . 97.0 mt-10 -137.86 137.07 37.74 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-O 121.126 0.489 . . . . 0.0 111.237 -178.073 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 78' ' ' ALA . . . . . 0.485 ' HB2' HD21 ' A' ' 109' ' ' LEU . . . -125.06 129.61 50.6 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 115.708 -0.678 . . . . 0.0 109.532 175.803 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 79' ' ' LYS . . . . . 0.695 ' O ' HD13 ' A' ' 80' ' ' ILE . 39.2 ttpt -73.69 120.15 18.89 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-O 120.795 0.331 . . . . 0.0 110.575 -177.848 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 80' ' ' ILE . . . . . 0.695 HD13 ' O ' ' A' ' 79' ' ' LYS . 25.9 mm -139.34 98.48 1.15 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.326 0 N-CA-C 109.268 -0.642 . . . . 0.0 109.268 -178.238 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 81' ' ' LYS . . . . . . . . . . . . . 56.2 mtmt -95.75 127.22 41.59 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-O 120.982 0.42 . . . . 0.0 110.97 -177.896 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . 89.18 42.08 5.67 Favored Glycine 0 CA--C 1.525 0.675 0 N-CA-C 111.566 -0.614 . . . . 0.0 111.566 176.43 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 83' ' ' ILE . . . . . . . . . . . . . 69.0 mt -67.26 137.86 23.94 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.289 0 N-CA-C 109.657 -0.497 . . . . 0.0 109.657 176.871 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 84' ' ' LYS . . . . . . . . . . . . . 54.5 tttp -95.46 -49.91 5.22 Favored 'General case' 0 C--N 1.327 -0.395 0 CA-C-N 116.15 -0.477 . . . . 0.0 109.868 -179.031 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 85' ' ' ASP . . . . . . . . . . . . . 10.4 t70 -159.16 149.95 19.77 Favored 'General case' 0 C--N 1.327 -0.401 0 CA-C-N 115.589 -0.732 . . . . 0.0 110.239 178.605 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 86' ' ' VAL . . . . . . . . . . . . . 42.1 t -130.12 131.32 65.94 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.275 0 CA-C-O 120.898 0.38 . . . . 0.0 110.237 179.241 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 87' ' ' ILE . . . . . 0.49 HD12 ' N ' ' A' ' 87' ' ' ILE . 5.1 mp -119.07 129.01 75.77 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.281 0 CA-C-N 115.89 -0.596 . . . . 0.0 109.395 178.383 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 88' ' ' LEU . . . . . . . . . . . . . 13.3 tp -118.58 133.24 56.01 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-O 121.069 0.461 . . . . 0.0 111.302 -176.078 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 89' ' ' ASP . . . . . . . . . . . . . 12.8 t70 -130.92 159.03 38.63 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 115.637 -0.71 . . . . 0.0 109.38 175.109 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 95.8 mt-10 -47.41 -37.69 11.92 Favored 'General case' 0 C--N 1.33 -0.241 0 N-CA-C 113.029 0.751 . . . . 0.0 113.029 -172.362 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 91' ' ' ASN . . . . . . . . . . . . . 69.7 m-80 -132.11 36.38 3.65 Favored 'General case' 0 N--CA 1.464 0.235 0 N-CA-C 111.877 0.325 . . . . 0.0 111.877 -175.443 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 92' ' ' LEU . . . . . . . . . . . . . 19.3 tp -166.07 139.68 4.26 Favored 'General case' 0 C--N 1.332 -0.181 0 C-N-CA 120.836 -0.346 . . . . 0.0 110.99 -179.288 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 93' ' ' ILE . . . . . . . . . . . . . 68.9 mt -126.27 118.03 50.22 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.164 0 N-CA-C 109.089 -0.708 . . . . 0.0 109.089 177.625 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 94' ' ' VAL . . . . . . . . . . . . . 42.9 t -120.25 127.0 75.87 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.289 0 N-CA-C 109.903 -0.406 . . . . 0.0 109.903 -179.004 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 95' ' ' VAL . . . . . . . . . . . . . 42.7 t -120.89 134.04 65.6 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.311 0 CA-C-N 116.131 -0.486 . . . . 0.0 109.983 -179.435 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 96' ' ' ILE . . . . . . . . . . . . . 57.5 mt -115.42 127.62 72.92 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.324 0 N-CA-C 109.155 -0.683 . . . . 0.0 109.155 178.105 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 97' ' ' THR . . . . . . . . . . . . . 59.4 p -101.95 153.31 19.98 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-O 121.015 0.436 . . . . 0.0 110.955 -177.752 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 98' ' ' GLU . . . . . . . . . . . . . 96.4 mt-10 -53.9 -23.4 12.62 Favored 'General case' 0 CA--C 1.534 0.36 0 N-CA-C 112.297 0.481 . . . . 0.0 112.297 179.426 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 99' ' ' GLU . . . . . . . . . . . . . 95.0 mt-10 -78.79 15.27 1.1 Allowed 'General case' 0 CA--C 1.536 0.419 0 N-CA-C 113.121 0.785 . . . . 0.0 113.121 -177.536 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 100' ' ' ASN . . . . . . . . . . . . . 3.6 m-20 64.01 38.07 8.86 Favored 'General case' 0 N--CA 1.463 0.188 0 CA-C-O 120.972 0.415 . . . . 0.0 110.965 177.435 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 101' ' ' GLU . . . . . . . . . . . . . 83.4 tt0 -119.22 142.82 47.68 Favored 'General case' 0 C--N 1.332 -0.165 0 CA-C-N 116.177 -0.465 . . . . 0.0 109.876 176.551 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 102' ' ' VAL . . . . . . . . . . . . . 45.5 t -115.77 126.46 73.31 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.283 0 CA-C-N 116.117 -0.492 . . . . 0.0 109.759 -178.845 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 103' ' ' LEU . . . . . . . . . . . . . 46.6 mt -120.48 132.41 55.19 Favored 'General case' 0 C--N 1.331 -0.202 0 CA-C-N 115.992 -0.549 . . . . 0.0 110.517 178.313 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 104' ' ' ILE . . . . . . . . . . . . . 67.7 mt -118.95 122.43 69.33 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.256 0 CA-C-N 116.332 -0.395 . . . . 0.0 110.324 -178.48 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 105' ' ' PHE . . . . . . . . . . . . . 85.8 m-85 -123.99 165.06 18.1 Favored 'General case' 0 C--O 1.232 0.17 0 O-C-N 123.895 0.747 . . . . 0.0 109.892 -179.527 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 106' ' ' ASN . . . . . . . . . . . . . 46.8 p-10 -100.63 -171.36 2.0 Favored 'General case' 0 C--N 1.331 -0.21 0 N-CA-C 109.742 -0.466 . . . . 0.0 109.742 172.665 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 107' ' ' GLN . . . . . . . . . . . . . 29.4 tt0 -61.09 -29.85 70.0 Favored 'General case' 0 C--N 1.329 -0.285 0 N-CA-C 111.974 0.361 . . . . 0.0 111.974 -178.642 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 108' ' ' ASN . . . . . . . . . . . . . 3.8 t-20 -83.54 10.69 8.44 Favored 'General case' 0 CA--C 1.537 0.457 0 N-CA-C 113.014 0.746 . . . . 0.0 113.014 -178.303 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 109' ' ' LEU . . . . . 0.485 HD21 ' HB2' ' A' ' 78' ' ' ALA . 7.6 tp 57.72 37.72 27.32 Favored 'General case' 0 CA--C 1.529 0.172 0 CA-C-O 121.206 0.527 . . . . 0.0 111.341 179.277 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 110' ' ' GLU . . . . . . . . . . . . . 70.8 mm-40 -103.93 142.7 33.97 Favored 'General case' 0 C--N 1.33 -0.266 0 N-CA-C 109.33 -0.619 . . . . 0.0 109.33 174.071 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 111' ' ' GLU . . . . . . . . . . . . . 48.6 tt0 -79.14 121.94 25.63 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-N 116.454 -0.339 . . . . 0.0 110.893 -176.062 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 112' ' ' LEU . . . . . . . . . . . . . 44.1 mt -102.93 -46.12 4.76 Favored 'General case' 0 C--N 1.33 -0.239 0 CA-C-N 116.128 -0.487 . . . . 0.0 110.515 179.589 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 113' ' ' TYR . . . . . . . . . . . . . 63.9 t80 -140.59 145.02 36.17 Favored 'General case' 0 C--N 1.332 -0.182 0 CA-C-N 116.397 -0.365 . . . . 0.0 111.061 -179.682 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 114' ' ' ARG . . . . . . . . . . . . . 39.0 ptt180 -144.59 126.7 15.58 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.085 -0.507 . . . . 0.0 110.462 178.807 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 115' ' ' GLY . . . . . . . . . . . . . . . -150.05 150.75 22.85 Favored Glycine 0 CA--C 1.524 0.602 0 C-N-CA 120.682 -0.77 . . . . 0.0 111.192 179.654 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 116' ' ' LYS . . . . . . . . . . . . . 27.5 ttpp -123.45 135.77 54.26 Favored 'General case' 0 C--N 1.33 -0.274 0 N-CA-C 109.687 -0.486 . . . . 0.0 109.687 177.27 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 117' ' ' PHE . . . . . . . . . . . . . 36.2 m-85 -134.07 113.92 12.62 Favored 'General case' 0 C--N 1.33 -0.262 0 N-CA-C 110.037 -0.357 . . . . 0.0 110.037 -177.291 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 118' ' ' GLU . . . . . . . . . . . . . 83.5 tt0 -55.09 -44.72 75.16 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.383 -0.371 . . . . 0.0 111.185 -177.123 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 119' ' ' ASN . . . . . . . . . . . . . 85.2 m-20 -95.48 30.99 2.1 Favored 'General case' 0 C--N 1.33 -0.264 0 N-CA-C 112.214 0.45 . . . . 0.0 112.214 -175.649 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 120' ' ' LEU . . . . . . . . . . . . . 24.8 tp -57.63 122.16 12.08 Favored 'General case' 0 C--N 1.333 -0.132 0 N-CA-C 110.141 -0.318 . . . . 0.0 110.141 176.656 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 121' ' ' ASN . . . . . . . . . . . . . 61.5 m-20 -114.05 -43.99 3.19 Favored 'General case' 0 C--N 1.332 -0.187 0 CA-C-N 116.647 -0.251 . . . . 0.0 110.998 -176.773 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 122' ' ' LYS . . . . . . . . . . . . . 98.1 mttt -145.91 150.87 36.91 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-O 121.061 0.457 . . . . 0.0 111.505 -177.596 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 123' ' ' VAL . . . . . . . . . . . . . 43.5 t -128.75 131.16 68.72 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.253 0 CA-C-N 115.955 -0.566 . . . . 0.0 109.695 176.516 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 124' ' ' LEU . . . . . . . . . . . . . 34.0 mt -121.76 128.75 52.1 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.277 -0.419 . . . . 0.0 110.16 -179.547 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 125' ' ' VAL . . . . . 0.459 ' CG2' HG21 ' A' ' 87' ' ' ILE . 35.6 m -140.07 141.45 33.71 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 CA-C-O 120.862 0.363 . . . . 0.0 110.81 179.688 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 126' ' ' ARG . . . . . . . . . . . . . 51.0 ttp180 -161.29 129.66 4.4 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.07 -0.514 . . . . 0.0 110.622 177.502 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 127' ' ' ASN . . . . . . . . . . . . . 6.1 m120 52.77 -111.24 0.58 Allowed 'General case' 0 CA--C 1.544 0.741 0 CA-C-O 118.871 -0.585 . . . . 0.0 111.024 179.347 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 128' ' ' ASP . . . . . . . . . . . . . 11.9 p-10 -114.04 12.21 17.89 Favored 'General case' 0 N--CA 1.466 0.337 0 CA-C-N 119.892 1.224 . . . . 0.0 113.244 -177.747 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 129' ' ' LEU . . . . . . . . . . . . . 30.5 mt -107.7 134.11 51.15 Favored 'General case' 0 C--N 1.333 -0.147 0 O-C-N 121.968 -0.457 . . . . 0.0 110.136 178.013 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 130' ' ' VAL . . . . . . . . . . . . . 45.5 t -125.08 131.02 73.03 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.229 0 N-CA-C 109.58 -0.526 . . . . 0.0 109.58 178.759 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 131' ' ' VAL . . . . . 0.523 HG22 HD12 ' A' ' 140' ' ' LEU . 42.2 t -135.61 133.81 51.75 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.307 0 CA-C-O 120.999 0.428 . . . . 0.0 110.192 178.514 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 132' ' ' ILE . . . . . . . . . . . . . 74.6 mt -114.48 130.63 68.47 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.378 0 CA-C-N 115.81 -0.632 . . . . 0.0 109.308 179.44 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 133' ' ' ILE . . . . . . . . . . . . . 42.9 mm -114.56 119.24 60.96 Favored 'Isoleucine or valine' 0 C--O 1.234 0.263 0 CA-C-O 120.874 0.368 . . . . 0.0 110.748 -175.353 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 134' ' ' ASP . . . . . . . . . . . . . 9.6 p-10 -133.94 147.95 51.12 Favored 'General case' 0 C--N 1.331 -0.225 0 N-CA-C 109.678 -0.489 . . . . 0.0 109.678 176.282 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 135' ' ' GLU . . . . . . . . . . . . . 78.8 tt0 -49.9 -27.84 5.81 Favored 'General case' 0 C--N 1.328 -0.368 0 N-CA-C 112.833 0.679 . . . . 0.0 112.833 -173.698 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 136' ' ' GLN . . . . . . . . . . . . . 48.2 tt0 -79.05 -37.39 39.11 Favored 'General case' 0 C--O 1.233 0.229 0 N-CA-C 111.973 0.361 . . . . 0.0 111.973 -176.064 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 137' ' ' LYS . . . . . . . . . . . . . 51.8 pttt -166.32 175.46 8.22 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-O 121.689 0.756 . . . . 0.0 112.197 -171.129 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 138' ' ' LEU . . . . . 0.41 HD23 ' N ' ' A' ' 139' ' ' THR . 4.8 tt -119.46 128.45 54.02 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 114.877 -1.056 . . . . 0.0 109.757 178.7 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 139' ' ' THR . . . . . 0.41 ' N ' HD23 ' A' ' 138' ' ' LEU . 19.5 m -109.12 124.08 50.23 Favored 'General case' 0 C--N 1.331 -0.205 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.598 -179.496 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 140' ' ' LEU . . . . . 0.523 HD12 HG22 ' A' ' 131' ' ' VAL . 48.0 tp -112.09 120.43 41.82 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 115.982 -0.554 . . . . 0.0 109.574 -179.166 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 141' ' ' ILE . . . . . . . . . . . . . 19.1 mt -122.95 120.65 61.18 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.278 0 CA-C-O 120.993 0.425 . . . . 0.0 110.088 -176.198 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 142' ' ' ARG . . . . . . . . . . . . . 22.3 mtp-105 -97.59 121.23 39.25 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 115.463 -0.79 . . . . 0.0 109.976 176.49 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 143' ' ' THR . . . . . . . . . . . . . 48.2 p . . . . . 0 C--O 1.22 -0.459 0 CA-C-O 118.051 -0.976 . . . . 0.0 110.423 179.339 . . . . . . . . 0 0 . 1 . 016 nuclear build full ' B' B ' -3' ' ' GLU . . . . . . . . . . . . . 96.0 mt-10 . . . . . 0 N--CA 1.49 1.542 0 N-CA-C 109.416 -0.587 . . . . 0.0 109.416 . . . . . . . . . 0 0 . 1 . 016 nuclear build full ' B' B ' -2' ' ' GLY . . . . . . . . . . . . . . . -77.77 149.97 35.52 Favored Glycine 0 CA--C 1.525 0.701 0 N-CA-C 110.895 -0.882 . . . . 0.0 110.895 179.411 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' B' B ' -1' ' ' VAL . . . . . . . . . . . . . 44.9 t -88.08 131.05 36.66 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.277 0 CA-C-O 120.887 0.375 . . . . 0.0 110.252 -179.695 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' B' B ' 0' ' ' ILE . . . . . . . . . . . . . 72.6 mt -119.78 136.67 56.15 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.252 0 CA-C-N 116.003 -0.544 . . . . 0.0 109.79 179.532 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' B' B ' 1' ' ' MET . . . . . . . . . . . . . 25.4 ptp -78.13 134.65 37.65 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-O 121.012 0.434 . . . . 0.0 111.236 -177.614 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' B' B ' 2' ' ' SER . . . . . . . . . . . . . 2.3 p -131.02 125.18 32.61 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-N 115.918 -0.583 . . . . 0.0 110.017 177.271 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' B' B ' 3' ' ' GLU . . . . . . . . . . . . . 81.3 tt0 -140.94 142.46 34.36 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-N 116.172 -0.467 . . . . 0.0 111.158 -176.266 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' B' B ' 4' ' ' LEU . . . . . . . . . . . . . 11.4 tp -123.6 130.95 53.43 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 115.946 -0.57 . . . . 0.0 109.744 176.298 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' B' B ' 5' ' ' LYS . . . . . . . . . . . . . 91.5 mttt -110.87 121.43 45.33 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 116.31 -0.405 . . . . 0.0 110.729 -178.307 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' B' B ' 6' ' ' LEU . . . . . . . . . . . . . 55.9 mt -116.54 151.27 36.51 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 115.569 -0.741 . . . . 0.0 110.653 -178.856 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' B' B ' 7' ' ' LYS . . . . . . . . . . . . . 59.1 tttt -139.04 135.42 17.46 Favored Pre-proline 0 CA--C 1.535 0.396 0 CA-C-O 118.966 -0.54 . . . . 0.0 110.152 175.936 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' B' B ' 8' ' ' PRO . . . . . . . . . . . . . 94.7 Cg_endo -92.04 144.79 2.89 Favored 'Trans proline' 0 N--CA 1.49 1.274 0 C-N-CA 121.814 1.676 . . . . 0.0 111.632 177.359 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' B' B ' 9' ' ' LEU . . . . . . . . . . . . . 47.3 mt -86.54 -47.91 0.52 Allowed Pre-proline 0 CA--C 1.534 0.345 0 CA-C-O 118.701 -0.666 . . . . 0.0 112.646 -177.981 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' B' B ' 10' ' ' PRO . . . . . . . . . . . . . 97.3 Cg_endo -81.91 160.77 18.54 Favored 'Trans proline' 0 N--CA 1.495 1.616 0 C-N-CA 121.421 1.414 . . . . 0.0 112.063 177.802 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' B' B ' 11' ' ' LYS . . . . . . . . . . . . . 52.5 pttt -85.67 121.67 28.67 Favored 'General case' 0 C--N 1.331 -0.196 0 CA-C-O 120.953 0.406 . . . . 0.0 110.377 178.145 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' B' B ' 12' ' ' VAL . . . . . . . . . . . . . 12.5 p -151.09 144.81 16.7 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.251 0 CA-C-N 116.226 -0.443 . . . . 0.0 110.705 -179.971 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' B' B ' 13' ' ' GLU . . . . . . . . . . . . . 81.4 tt0 -91.88 108.98 20.32 Favored 'General case' 0 C--N 1.329 -0.325 0 N-CA-C 109.718 -0.475 . . . . 0.0 109.718 176.263 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' B' B ' 14' ' ' LEU . . . . . . . . . . . . . 81.2 mt -84.44 143.41 41.56 Favored Pre-proline 0 CA--C 1.534 0.343 0 CA-C-O 119.168 -0.444 . . . . 0.0 110.666 -175.923 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' B' B ' 15' ' ' PRO . . . . . . . . . . . . . 24.8 Cg_exo -63.06 163.33 22.97 Favored 'Trans proline' 0 N--CA 1.497 1.703 0 C-N-CA 121.301 1.334 . . . . 0.0 111.879 175.608 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' B' B ' 16' ' ' PRO . . . . . . . . . . . . . 29.6 Cg_exo -60.17 -39.17 71.28 Favored 'Trans proline' 0 N--CA 1.496 1.671 0 C-N-CA 121.478 1.452 . . . . 0.0 112.846 -178.105 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' B' B ' 17' ' ' ASP . . . . . . . . . . . . . 20.1 p-10 -90.74 12.5 18.96 Favored 'General case' 0 CA--C 1.536 0.423 0 N-CA-C 113.161 0.8 . . . . 0.0 113.161 -176.814 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' B' B ' 18' ' ' PHE . . . . . . . . . . . . . 33.9 t80 -56.21 -46.0 79.66 Favored 'General case' 0 C--N 1.334 -0.104 0 O-C-N 121.937 -0.477 . . . . 0.0 110.671 -178.364 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' B' B ' 19' ' ' VAL . . . . . . . . . . . . . 46.6 t -55.48 -43.54 72.64 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.277 0 CA-C-N 116.61 -0.268 . . . . 0.0 110.858 -177.931 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' B' B ' 20' ' ' ASP . . . . . . . . . . . . . 50.7 m-20 -60.01 -43.79 94.99 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-O 120.988 0.423 . . . . 0.0 111.017 -177.682 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' B' B ' 21' ' ' VAL . . . . . . . . . . . . . 45.1 t -64.38 -46.6 92.54 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.259 0 CA-C-N 116.401 -0.363 . . . . 0.0 110.573 -177.554 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' B' B ' 22' ' ' ILE . . . . . 0.45 HG22 HD12 ' B' ' 26' ' ' LEU . 50.7 mm -56.27 -44.5 79.7 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.206 0 C-N-CA 120.926 -0.31 . . . . 0.0 110.564 178.678 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' B' B ' 23' ' ' ARG . . . . . . . . . . . . . 55.7 ttp180 -53.36 -48.08 68.85 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-O 120.722 0.296 . . . . 0.0 111.396 -179.76 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' B' B ' 24' ' ' ILE . . . . . . . . . . . . . 71.4 mt -58.97 -44.53 91.27 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.251 0 CA-C-N 116.496 -0.32 . . . . 0.0 110.938 -179.228 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' B' B ' 25' ' ' LYS . . . . . . . . . . . . . 53.0 mttm -65.59 -35.27 80.33 Favored 'General case' 0 C--N 1.327 -0.404 0 N-CA-C 112.3 0.482 . . . . 0.0 112.3 -178.051 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' B' B ' 26' ' ' LEU . . . . . 0.45 HD12 HG22 ' B' ' 22' ' ' ILE . 56.1 mt -80.01 -46.02 17.36 Favored 'General case' 0 C--N 1.329 -0.31 0 N-CA-C 112.943 0.72 . . . . 0.0 112.943 -172.896 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' B' B ' 27' ' ' GLN . . . . . . . . . . . . . 15.5 pt20 -46.56 138.74 5.63 Favored 'General case' 0 N--CA 1.468 0.464 0 N-CA-C 112.677 0.621 . . . . 0.0 112.677 -174.909 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' B' B ' 28' ' ' GLY . . . . . . . . . . . . . . . 100.09 -24.92 30.24 Favored Glycine 0 CA--C 1.533 1.195 0 CA-C-N 115.599 -0.728 . . . . 0.0 112.412 -177.869 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' B' B ' 29' ' ' LYS . . . . . . . . . . . . . 67.9 mttm -97.72 155.08 17.18 Favored 'General case' 0 C--N 1.331 -0.198 0 CA-C-N 117.402 0.601 . . . . 0.0 111.145 179.656 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' B' B ' 30' ' ' THR . . . . . . . . . . . . . 28.9 m -106.04 133.34 50.9 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 115.861 -0.609 . . . . 0.0 109.778 175.008 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' B' B ' 31' ' ' VAL . . . . . . . . . . . . . 35.2 m -128.63 156.1 40.86 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.214 0 CA-C-N 116.437 -0.347 . . . . 0.0 110.693 -178.619 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' B' B ' 32' ' ' ARG . . . . . . . . . . . . . 72.2 ttt180 -132.73 148.03 52.33 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.036 -0.529 . . . . 0.0 110.351 178.929 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' B' B ' 33' ' ' THR . . . . . . . . . . . . . 19.6 m -52.64 138.09 29.27 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-O 120.858 0.361 . . . . 0.0 111.396 -178.25 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' B' B ' 34' ' ' GLY . . . . . . . . . . . . . . . 102.13 -17.24 54.51 Favored Glycine 0 CA--C 1.534 1.23 0 CA-C-N 116.074 -0.512 . . . . 0.0 113.235 179.286 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' B' B ' 35' ' ' ASP . . . . . . . . . . . . . 78.6 m-20 -66.91 151.17 48.09 Favored 'General case' 0 N--CA 1.462 0.158 0 CA-C-N 117.972 0.886 . . . . 0.0 111.052 178.715 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' B' B ' 36' ' ' VAL . . . . . . . . . . . . . 44.4 t -124.25 132.73 70.91 Favored 'Isoleucine or valine' 0 C--N 1.333 -0.145 0 CA-C-N 115.959 -0.564 . . . . 0.0 109.902 178.234 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' B' B ' 37' ' ' ILE . . . . . . . . . . . . . 68.5 mt -119.66 140.16 44.58 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.189 0 CA-C-N 116.063 -0.517 . . . . 0.0 109.96 -179.258 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' B' B ' 38' ' ' GLY . . . . . . . . . . . . . . . -116.95 128.84 8.07 Favored Glycine 0 CA--C 1.525 0.714 0 N-CA-C 111.043 -0.823 . . . . 0.0 111.043 179.598 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' B' B ' 39' ' ' ILE . . . . . . . . . . . . . 76.9 mt -128.89 139.68 51.26 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.248 0 N-CA-C 110.147 -0.316 . . . . 0.0 110.147 179.245 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' B' B ' 40' ' ' SER . . . . . . . . . . . . . 53.7 p -93.22 126.01 38.12 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.263 -0.426 . . . . 0.0 110.863 175.26 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' B' B ' 41' ' ' ILE . . . . . . . . . . . . . 68.6 mt -134.99 113.94 16.62 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.247 0 CA-C-O 120.826 0.346 . . . . 0.0 110.534 177.702 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' B' B ' 42' ' ' LEU . . . . . 0.516 ' O ' HD23 ' B' ' 42' ' ' LEU . 1.5 tt 56.33 47.84 18.3 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-O 121.52 0.676 . . . . 0.0 110.358 177.604 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' B' B ' 43' ' ' GLY . . . . . . . . . . . . . . . 72.2 -5.49 14.05 Favored Glycine 0 CA--C 1.536 1.351 0 C-N-CA 121.162 -0.542 . . . . 0.0 113.724 175.118 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' B' B ' 44' ' ' LYS . . . . . . . . . . . . . 80.6 tttt -108.85 135.04 50.71 Favored 'General case' 0 C--N 1.332 -0.181 0 CA-C-N 118.049 0.924 . . . . 0.0 110.19 -179.212 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' B' B ' 45' ' ' GLU . . . . . . . . . . . . . 84.1 tt0 -83.73 130.65 34.95 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-N 116.458 -0.337 . . . . 0.0 111.079 -179.075 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' B' B ' 46' ' ' VAL . . . . . . . . . . . . . 7.3 p -124.04 125.06 70.25 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.189 0 CA-C-O 121.002 0.43 . . . . 0.0 109.875 175.616 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' B' B ' 47' ' ' LYS . . . . . . . . . . . . . 91.9 mttt -100.08 131.46 46.02 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 115.951 -0.568 . . . . 0.0 111.031 176.529 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' B' B ' 48' ' ' PHE . . . . . . . . . . . . . 94.6 m-85 -113.08 131.88 55.64 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.057 -0.52 . . . . 0.0 109.644 175.341 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' B' B ' 49' ' ' LYS . . . . . . . . . . . . . 76.1 tttt -107.22 135.46 48.71 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.605 -0.27 . . . . 0.0 110.302 178.094 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' B' B ' 50' ' ' VAL . . . . . . . . . . . . . 43.9 t -81.16 107.48 13.48 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.315 0 N-CA-C 109.219 -0.66 . . . . 0.0 109.219 176.268 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' B' B ' 51' ' ' VAL . . . . . . . . . . . . . 40.4 t -74.88 -49.65 28.29 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.337 0 CA-C-N 115.982 -0.554 . . . . 0.0 110.14 -172.716 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' B' B ' 52' ' ' GLN . . . . . . . . . . . . . 85.8 mt-30 -154.34 152.98 30.87 Favored 'General case' 0 C--N 1.331 -0.199 0 C-N-CA 120.449 -0.5 . . . . 0.0 111.797 -177.304 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' B' B ' 53' ' ' ALA . . . . . 0.413 ' HB3' ' OG ' ' B' ' 56' ' ' SER . . . -130.35 130.5 44.51 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 115.339 -0.846 . . . . 0.0 109.643 175.016 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' B' B ' 54' ' ' TYR . . . . . . . . . . . . . 19.1 t80 -129.13 105.91 17.95 Favored Pre-proline 0 CA--C 1.534 0.357 0 CA-C-O 118.357 -0.83 . . . . 0.0 110.464 -179.572 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' B' B ' 55' ' ' PRO . . . . . . . . . . . . . 73.8 Cg_endo -77.2 170.06 72.49 Favored 'Cis proline' 0 N--CA 1.5 1.912 0 CA-C-N 121.673 1.633 . . . . 0.0 112.474 -5.98 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' B' B ' 56' ' ' SER . . . . . 0.413 ' OG ' ' HB3' ' B' ' 53' ' ' ALA . 36.0 m -116.42 134.16 22.89 Favored Pre-proline 0 CA--C 1.539 0.524 0 CA-C-O 118.461 -0.781 . . . . 0.0 109.606 175.17 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' B' B ' 57' ' ' PRO . . . . . . . . . . . . . 36.2 Cg_endo -67.07 166.53 62.35 Favored 'Cis proline' 0 N--CA 1.497 1.732 0 CA-C-N 121.856 1.698 . . . . 0.0 111.349 -3.727 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' B' B ' 58' ' ' LEU . . . . . . . . . . . . . 31.4 tp -130.77 138.04 49.75 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.239 -0.437 . . . . 0.0 110.512 -179.324 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' B' B ' 59' ' ' ARG . . . . . . . . . . . . . 59.8 ttm-85 -105.47 127.34 52.95 Favored 'General case' 0 C--N 1.327 -0.37 0 N-CA-C 109.148 -0.686 . . . . 0.0 109.148 175.0 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' B' B ' 60' ' ' VAL . . . . . . . . . . . . . 40.1 t -81.2 123.99 38.33 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.338 0 C-N-CA 120.651 -0.42 . . . . 0.0 110.872 -173.788 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' B' B ' 61' ' ' GLU . . . . . . . . . . . . . 95.7 mt-10 -131.0 162.55 29.52 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 115.691 -0.686 . . . . 0.0 109.666 176.251 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' B' B ' 62' ' ' ASP . . . . . . . . . . . . . 78.7 m-20 -54.85 -33.96 62.35 Favored 'General case' 0 C--N 1.328 -0.329 0 C-N-CA 121.015 -0.274 . . . . 0.0 111.646 -178.86 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' B' B ' 63' ' ' ARG . . . . . . . . . . . . . 7.3 mmm180 -76.18 -10.3 59.3 Favored 'General case' 0 CA--C 1.537 0.446 0 N-CA-C 113.186 0.81 . . . . 0.0 113.186 -176.74 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' B' B ' 64' ' ' THR . . . . . . . . . . . . . 30.0 m -72.27 145.32 47.98 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-O 121.004 0.43 . . . . 0.0 111.246 -175.915 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' B' B ' 65' ' ' LYS . . . . . . . . . . . . . 23.9 mtpp -89.58 127.52 35.9 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 115.878 -0.601 . . . . 0.0 110.265 178.491 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' B' B ' 66' ' ' ILE . . . . . . . . . . . . . 55.7 mt -114.77 129.93 70.07 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.245 0 N-CA-C 109.779 -0.452 . . . . 0.0 109.779 179.59 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' B' B ' 67' ' ' THR . . . . . . . . . . . . . 25.9 m -127.76 143.63 51.12 Favored 'General case' 0 C--N 1.332 -0.176 0 CA-C-O 121.171 0.51 . . . . 0.0 111.586 -176.842 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' B' B ' 68' ' ' LEU . . . . . . . . . . . . . 16.0 tp -100.95 125.47 47.53 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 115.59 -0.732 . . . . 0.0 109.622 175.666 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' B' B ' 69' ' ' VAL . . . . . . . . . . . . . 40.2 t -95.47 138.32 21.43 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.309 0 CA-C-O 120.895 0.379 . . . . 0.0 110.64 -176.264 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' B' B ' 70' ' ' THR . . . . . . . . . . . . . 25.7 m -108.09 150.46 27.15 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-N 115.881 -0.6 . . . . 0.0 110.794 -179.327 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' B' B ' 71' ' ' HIS . . . . . . . . . . . . . 47.8 m-70 -137.4 156.71 74.96 Favored Pre-proline 0 CA--C 1.532 0.269 0 CA-C-N 116.249 -0.432 . . . . 0.0 110.393 179.203 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' B' B ' 72' ' ' PRO . . . . . . . . . . . . . 57.9 Cg_endo -73.69 -30.0 10.06 Favored 'Trans proline' 0 N--CA 1.495 1.56 0 C-N-CA 121.274 1.316 . . . . 0.0 112.775 -176.424 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' B' B ' 73' ' ' VAL . . . . . . . . . . . . . 35.4 m -135.46 159.66 40.3 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.22 0 CA-C-O 120.854 0.359 . . . . 0.0 110.697 179.806 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' B' B ' 74' ' ' ASP . . . . . . . . . . . . . 18.6 t0 -104.09 115.43 30.42 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.001 -0.545 . . . . 0.0 109.893 179.245 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' B' B ' 75' ' ' VAL . . . . . . . . . . . . . 40.8 t -116.69 123.58 71.82 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.291 0 CA-C-O 121.086 0.47 . . . . 0.0 110.738 -176.271 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' B' B ' 76' ' ' LEU . . . . . . . . . . . . . 4.9 mp -125.19 146.63 49.42 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 115.635 -0.712 . . . . 0.0 109.516 176.273 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' B' B ' 77' ' ' GLU . . . . . . . . . . . . . 46.4 mt-10 -134.22 141.11 46.91 Favored 'General case' 0 C--N 1.331 -0.227 0 CA-C-O 120.944 0.402 . . . . 0.0 111.119 -178.513 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' B' B ' 78' ' ' ALA . . . . . 0.788 ' HB2' HD21 ' B' ' 109' ' ' LEU . . . -129.81 135.34 48.3 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 115.879 -0.601 . . . . 0.0 109.925 176.289 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' B' B ' 79' ' ' LYS . . . . . 0.553 ' O ' HD13 ' B' ' 80' ' ' ILE . 43.3 pttt -80.36 121.59 25.88 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-O 121.123 0.487 . . . . 0.0 111.18 -176.951 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' B' B ' 80' ' ' ILE . . . . . 0.553 HD13 ' O ' ' B' ' 79' ' ' LYS . 23.7 mm -139.45 112.26 5.87 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.327 0 N-CA-C 109.119 -0.697 . . . . 0.0 109.119 -179.018 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' B' B ' 81' ' ' LYS . . . . . . . . . . . . . 36.2 ttpt -100.45 123.08 44.2 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-O 120.911 0.386 . . . . 0.0 111.148 -178.363 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' B' B ' 82' ' ' GLY . . . . . . . . . . . . . . . 89.17 42.07 5.68 Favored Glycine 0 CA--C 1.527 0.792 0 C-N-CA 120.859 -0.686 . . . . 0.0 112.225 173.732 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' B' B ' 83' ' ' ILE . . . . . . . . . . . . . 69.2 mt -67.46 136.1 27.26 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.321 0 N-CA-C 109.689 -0.486 . . . . 0.0 109.689 175.993 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' B' B ' 84' ' ' LYS . . . . . . . . . . . . . 38.6 ttpt -104.48 -48.21 3.88 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-O 120.873 0.368 . . . . 0.0 110.584 -178.266 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' B' B ' 85' ' ' ASP . . . . . . . . . . . . . 13.8 t70 -143.37 146.64 33.68 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.06 -0.518 . . . . 0.0 110.631 -178.594 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' B' B ' 86' ' ' VAL . . . . . . . . . . . . . 44.7 t -131.08 132.69 63.42 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.268 0 CA-C-O 120.863 0.363 . . . . 0.0 110.389 -179.285 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' B' B ' 87' ' ' ILE . . . . . 0.496 ' N ' HD12 ' B' ' 87' ' ' ILE . 5.2 mp -123.97 128.09 73.95 Favored 'Isoleucine or valine' 0 C--O 1.233 0.187 0 CA-C-N 115.945 -0.571 . . . . 0.0 109.762 177.527 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' B' B ' 88' ' ' LEU . . . . . . . . . . . . . 18.8 tp -113.62 133.14 55.46 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.284 -0.416 . . . . 0.0 110.953 -177.901 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' B' B ' 89' ' ' ASP . . . . . . . . . . . . . 6.4 t0 -132.33 160.5 36.1 Favored 'General case' 0 C--N 1.331 -0.199 0 CA-C-N 116.171 -0.468 . . . . 0.0 109.848 177.955 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' B' B ' 90' ' ' GLU . . . . . . . . . . . . . 95.7 mt-10 -44.95 -47.29 11.38 Favored 'General case' 0 N--CA 1.465 0.28 0 N-CA-C 113.328 0.862 . . . . 0.0 113.328 -171.785 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' B' B ' 91' ' ' ASN . . . . . . . . . . . . . 77.7 m-20 -124.26 21.48 8.76 Favored 'General case' 0 N--CA 1.468 0.428 0 N-CA-C 112.809 0.67 . . . . 0.0 112.809 -176.237 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' B' B ' 92' ' ' LEU . . . . . . . . . . . . . 26.6 mt -148.23 145.96 28.46 Favored 'General case' 0 C--N 1.331 -0.208 0 CA-C-O 120.757 0.313 . . . . 0.0 110.872 -174.861 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' B' B ' 93' ' ' ILE . . . . . . . . . . . . . 71.7 mt -125.58 115.93 44.86 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.319 0 N-CA-C 108.898 -0.779 . . . . 0.0 108.898 176.683 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' B' B ' 94' ' ' VAL . . . . . . . . . . . . . 43.6 t -116.45 127.06 74.16 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.322 0 N-CA-C 109.95 -0.389 . . . . 0.0 109.95 -177.283 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' B' B ' 95' ' ' VAL . . . . . . . . . . . . . 43.7 t -122.56 134.4 65.86 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.265 0 CA-C-N 116.099 -0.5 . . . . 0.0 109.91 -179.318 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' B' B ' 96' ' ' ILE . . . . . . . . . . . . . 68.8 mt -118.07 126.75 75.15 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.287 0 N-CA-C 109.349 -0.611 . . . . 0.0 109.349 178.981 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' B' B ' 97' ' ' THR . . . . . . . . . . . . . 69.6 p -99.39 157.08 16.66 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-O 121.274 0.559 . . . . 0.0 111.495 -176.029 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' B' B ' 98' ' ' GLU . . . . . . . . . . . . . 12.1 pt-20 -53.82 -25.23 18.45 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 115.966 -0.561 . . . . 0.0 112.489 -179.275 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' B' B ' 99' ' ' GLU . . . . . . . . . . . . . 95.6 mt-10 -81.97 17.85 1.47 Allowed 'General case' 0 CA--C 1.535 0.366 0 N-CA-C 113.021 0.748 . . . . 0.0 113.021 -177.529 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' B' B ' 100' ' ' ASN . . . . . . . . . . . . . 3.2 m-20 61.75 37.96 15.34 Favored 'General case' 0 C--O 1.232 0.175 0 CA-C-O 120.955 0.407 . . . . 0.0 110.98 177.86 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' B' B ' 101' ' ' GLU . . . . . . . . . . . . . 83.9 tt0 -115.2 142.97 45.94 Favored 'General case' 0 C--N 1.331 -0.208 0 N-CA-C 109.709 -0.478 . . . . 0.0 109.709 176.35 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' B' B ' 102' ' ' VAL . . . . . . . . . . . . . 44.4 t -116.04 127.06 73.75 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.34 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.037 -177.247 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' B' B ' 103' ' ' LEU . . . . . . . . . . . . . 45.3 mt -120.44 131.12 54.63 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 115.828 -0.624 . . . . 0.0 110.243 177.081 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' B' B ' 104' ' ' ILE . . . . . 0.663 HD13 HG21 ' B' ' 130' ' ' VAL . 67.5 mt -119.68 121.47 66.3 Favored 'Isoleucine or valine' 0 C--O 1.234 0.285 0 CA-C-N 116.471 -0.331 . . . . 0.0 110.182 -178.791 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' B' B ' 105' ' ' PHE . . . . . . . . . . . . . 51.2 m-85 -123.38 163.95 19.81 Favored 'General case' 0 C--N 1.334 -0.089 0 O-C-N 123.838 0.711 . . . . 0.0 109.769 178.7 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' B' B ' 106' ' ' ASN . . . . . . . . . . . . . 43.3 p-10 -97.06 -169.95 1.95 Allowed 'General case' 0 C--N 1.331 -0.221 0 N-CA-C 110.096 -0.335 . . . . 0.0 110.096 174.845 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' B' B ' 107' ' ' GLN . . . . . . . . . . . . . 50.7 tt0 -59.55 -30.0 68.31 Favored 'General case' 0 C--N 1.328 -0.327 0 N-CA-C 111.886 0.328 . . . . 0.0 111.886 179.029 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' B' B ' 108' ' ' ASN . . . . . . . . . . . . . 65.9 t30 -82.56 7.09 15.52 Favored 'General case' 0 CA--C 1.536 0.421 0 N-CA-C 113.283 0.846 . . . . 0.0 113.283 -177.864 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' B' B ' 109' ' ' LEU . . . . . 0.788 HD21 ' HB2' ' B' ' 78' ' ' ALA . 11.9 tp 60.21 37.49 20.57 Favored 'General case' 0 C--N 1.331 -0.2 0 CA-C-O 121.112 0.482 . . . . 0.0 111.218 179.464 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' B' B ' 110' ' ' GLU . . . . . . . . . . . . . 70.9 mm-40 -103.61 148.43 26.01 Favored 'General case' 0 C--N 1.33 -0.264 0 N-CA-C 109.639 -0.504 . . . . 0.0 109.639 175.199 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' B' B ' 111' ' ' GLU . . . . . . . . . . . . . 62.6 tt0 -84.97 122.04 28.64 Favored 'General case' 0 C--N 1.327 -0.396 0 CA-C-O 120.893 0.377 . . . . 0.0 110.586 -176.75 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' B' B ' 112' ' ' LEU . . . . . . . . . . . . . 45.5 mt -109.57 -45.99 3.6 Favored 'General case' 0 C--N 1.332 -0.171 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.722 179.963 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' B' B ' 113' ' ' TYR . . . . . . . . . . . . . 55.5 t80 -133.33 139.12 46.68 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.328 -0.396 . . . . 0.0 110.872 -178.861 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' B' B ' 114' ' ' ARG . . . . . . . . . . . . . 34.7 ptt-85 -145.12 121.01 10.63 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.235 -0.438 . . . . 0.0 110.726 179.624 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' B' B ' 115' ' ' GLY . . . . . . . . . . . . . . . -150.24 159.2 28.01 Favored Glycine 0 CA--C 1.524 0.646 0 C-N-CA 120.871 -0.681 . . . . 0.0 111.439 178.88 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' B' B ' 116' ' ' LYS . . . . . . . . . . . . . 38.6 ttpt -125.59 130.71 52.2 Favored 'General case' 0 C--N 1.33 -0.251 0 N-CA-C 109.525 -0.546 . . . . 0.0 109.525 175.524 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' B' B ' 117' ' ' PHE . . . . . . . . . . . . . 44.5 m-85 -132.43 116.31 16.64 Favored 'General case' 0 C--N 1.331 -0.224 0 CA-C-O 120.934 0.397 . . . . 0.0 110.481 -174.535 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' B' B ' 118' ' ' GLU . . . . . . . . . . . . . 95.8 mt-10 -53.46 -45.03 69.37 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.374 -0.376 . . . . 0.0 111.503 -177.228 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' B' B ' 119' ' ' ASN . . . . . . . . . . . . . 4.6 m120 -97.12 29.72 3.03 Favored 'General case' 0 C--N 1.33 -0.249 0 N-CA-C 112.403 0.52 . . . . 0.0 112.403 -173.958 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' B' B ' 120' ' ' LEU . . . . . . . . . . . . . 17.8 tp -59.07 119.89 8.13 Favored 'General case' 0 C--N 1.331 -0.205 0 N-CA-C 110.067 -0.346 . . . . 0.0 110.067 177.647 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' B' B ' 121' ' ' ASN . . . . . . . . . . . . . 72.8 m-20 -114.07 -44.03 3.18 Favored 'General case' 0 C--N 1.332 -0.167 0 CA-C-N 116.493 -0.321 . . . . 0.0 111.162 -177.521 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' B' B ' 122' ' ' LYS . . . . . . . . . . . . . 97.8 mttt -143.77 151.37 39.9 Favored 'General case' 0 C--N 1.332 -0.162 0 CA-C-O 121.184 0.516 . . . . 0.0 111.748 -176.353 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' B' B ' 123' ' ' VAL . . . . . . . . . . . . . 45.1 t -128.38 126.71 66.19 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.22 0 CA-C-N 115.83 -0.623 . . . . 0.0 109.515 175.225 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' B' B ' 124' ' ' LEU . . . . . 0.425 ' N ' HD12 ' B' ' 124' ' ' LEU . 7.0 mp -114.36 131.61 56.49 Favored 'General case' 0 C--N 1.332 -0.186 0 CA-C-N 116.373 -0.376 . . . . 0.0 110.772 -178.179 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' B' B ' 125' ' ' VAL . . . . . . . . . . . . . 9.2 p -131.94 131.33 61.68 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.215 0 CA-C-N 116.151 -0.477 . . . . 0.0 109.855 178.024 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' B' B ' 126' ' ' ARG . . . . . . . . . . . . . 48.2 ttt180 -151.44 128.77 11.28 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-O 120.951 0.405 . . . . 0.0 110.772 178.74 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' B' B ' 127' ' ' ASN . . . . . . . . . . . . . 6.9 m120 52.1 -112.73 0.69 Allowed 'General case' 0 CA--C 1.545 0.756 0 CA-C-O 118.837 -0.601 . . . . 0.0 111.029 179.242 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' B' B ' 128' ' ' ASP . . . . . . . . . . . . . 10.9 p-10 -114.17 10.16 17.27 Favored 'General case' 0 N--CA 1.468 0.447 0 CA-C-N 119.934 1.243 . . . . 0.0 113.216 -177.288 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' B' B ' 129' ' ' LEU . . . . . . . . . . . . . 77.9 mt -118.43 149.81 40.62 Favored 'General case' 0 C--O 1.233 0.235 0 CA-C-N 118.212 0.46 . . . . 0.0 110.445 -178.605 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' B' B ' 130' ' ' VAL . . . . . 0.663 HG21 HD13 ' B' ' 104' ' ' ILE . 32.9 m -135.43 144.6 33.57 Favored 'Isoleucine or valine' 0 C--O 1.232 0.182 0 CA-C-O 121.326 0.584 . . . . 0.0 111.042 -179.876 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' B' B ' 131' ' ' VAL . . . . . 0.557 HG22 HD12 ' B' ' 140' ' ' LEU . 45.7 t -136.03 137.88 48.11 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.324 0 CA-C-N 115.595 -0.73 . . . . 0.0 109.901 179.013 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' B' B ' 132' ' ' ILE . . . . . . . . . . . . . 71.6 mt -112.32 130.35 66.19 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.337 0 N-CA-C 109.317 -0.623 . . . . 0.0 109.317 179.452 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' B' B ' 133' ' ' ILE . . . . . . . . . . . . . 38.9 mm -114.48 120.09 63.22 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.255 0 CA-C-O 120.752 0.31 . . . . 0.0 111.007 -174.513 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' B' B ' 134' ' ' ASP . . . . . . . . . . . . . 6.9 p-10 -130.93 146.3 52.3 Favored 'General case' 0 C--N 1.332 -0.194 0 N-CA-C 109.465 -0.568 . . . . 0.0 109.465 175.048 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' B' B ' 135' ' ' GLU . . . . . . . . . . . . . 33.6 tt0 -49.95 -27.49 5.41 Favored 'General case' 0 C--N 1.329 -0.323 0 N-CA-C 112.731 0.641 . . . . 0.0 112.731 -173.262 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' B' B ' 136' ' ' GLN . . . . . . . . . . . . . 98.7 mt-30 -79.4 -36.2 39.51 Favored 'General case' 0 C--N 1.331 -0.202 0 N-CA-C 112.175 0.435 . . . . 0.0 112.175 -176.86 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' B' B ' 137' ' ' LYS . . . . . . . . . . . . . 45.6 pttt -169.45 175.39 5.51 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-O 121.448 0.642 . . . . 0.0 112.148 -172.137 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' B' B ' 138' ' ' LEU . . . . . 0.429 ' C ' HD23 ' B' ' 138' ' ' LEU . 7.7 tt -118.18 129.5 55.55 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 115.266 -0.879 . . . . 0.0 110.355 -179.459 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' B' B ' 139' ' ' THR . . . . . . . . . . . . . 32.7 m -107.35 126.45 52.48 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 115.923 -0.58 . . . . 0.0 110.238 178.191 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' B' B ' 140' ' ' LEU . . . . . 0.557 HD12 HG22 ' B' ' 131' ' ' VAL . 12.3 tp -111.63 119.11 37.59 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 115.904 -0.589 . . . . 0.0 109.652 -176.602 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' B' B ' 141' ' ' ILE . . . . . 0.529 ' HB ' HG23 ' B' ' 130' ' ' VAL . 27.2 mt -121.71 121.47 64.47 Favored 'Isoleucine or valine' 0 C--O 1.234 0.245 0 CA-C-O 121.351 0.596 . . . . 0.0 110.525 -173.969 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' B' B ' 142' ' ' ARG . . . . . . . . . . . . . 0.5 OUTLIER -108.25 123.99 49.62 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 114.903 -1.044 . . . . 0.0 110.068 -179.794 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' B' B ' 143' ' ' THR . . . . . . . . . . . . . 40.3 p . . . . . 0 C--O 1.219 -0.516 0 CA-C-O 118.002 -0.999 . . . . 0.0 110.574 179.443 . . . . . . . . 0 0 . 1 . 016 nuclear build full ' C' C ' -3' ' ' GLU . . . . . . . . . . . . . 96.0 mt-10 . . . . . 0 N--CA 1.489 1.524 0 N-CA-C 109.387 -0.598 . . . . 0.0 109.387 . . . . . . . . . 0 0 . 1 . 016 nuclear build full ' C' C ' -2' ' ' GLY . . . . . . . . . . . . . . . -65.36 148.62 51.4 Favored Glycine 0 CA--C 1.524 0.602 0 N-CA-C 111.114 -0.795 . . . . 0.0 111.114 -179.435 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' C' C ' -1' ' ' VAL . . . . . . . . . . . . . 45.3 t -141.62 128.56 20.41 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.304 0 N-CA-C 109.934 -0.395 . . . . 0.0 109.934 179.452 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' C' C ' 0' ' ' ILE . . . . . . . . . . . . . 71.4 mt -120.43 128.96 76.05 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.27 0 CA-C-N 116.051 -0.522 . . . . 0.0 109.686 179.485 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' C' C ' 1' ' ' MET . . . . . . . . . . . . . 24.6 ptt? -82.56 127.43 33.33 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-O 120.919 0.39 . . . . 0.0 110.715 -179.14 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' C' C ' 2' ' ' SER . . . . . . . . . . . . . 2.9 p -107.97 144.91 34.6 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 116.035 -0.529 . . . . 0.0 110.691 -179.952 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' C' C ' 3' ' ' GLU . . . . . . . . . . . . . 45.0 mt-10 -140.12 143.1 36.05 Favored 'General case' 0 C--N 1.331 -0.227 0 CA-C-N 116.027 -0.533 . . . . 0.0 110.981 -179.656 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' C' C ' 4' ' ' LEU . . . . . 0.595 HD12 HD23 ' C' ' 58' ' ' LEU . 2.4 tt -124.57 124.35 42.05 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 115.65 -0.705 . . . . 0.0 109.535 177.075 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' C' C ' 5' ' ' LYS . . . . . . . . . . . . . 78.6 mttt -103.87 118.77 37.48 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.721 -178.564 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' C' C ' 6' ' ' LEU . . . . . . . . . . . . . 27.3 mt -116.79 147.96 41.61 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 115.566 -0.743 . . . . 0.0 110.317 -179.172 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' C' C ' 7' ' ' LYS . . . . . . . . . . . . . 81.2 tttt -134.87 139.87 33.49 Favored Pre-proline 0 CA--C 1.533 0.308 0 CA-C-O 119.124 -0.465 . . . . 0.0 109.957 175.643 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' C' C ' 8' ' ' PRO . . . . . . . . . . . . . 88.4 Cg_endo -91.34 137.74 2.12 Favored 'Trans proline' 0 N--CA 1.489 1.236 0 C-N-CA 121.722 1.615 . . . . 0.0 111.555 177.813 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' C' C ' 9' ' ' LEU . . . . . . . . . . . . . 68.0 mt -77.73 -47.79 2.3 Favored Pre-proline 0 CA--C 1.535 0.396 0 CA-C-O 118.634 -0.698 . . . . 0.0 112.444 -178.25 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' C' C ' 10' ' ' PRO . . . . . . . . . . . . . 88.9 Cg_endo -80.28 152.84 21.08 Favored 'Trans proline' 0 N--CA 1.497 1.678 0 C-N-CA 121.135 1.223 . . . . 0.0 112.03 177.006 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' C' C ' 11' ' ' LYS . . . . . . . . . . . . . 33.9 mmtp -85.65 97.57 10.19 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.354 -0.384 . . . . 0.0 110.396 177.851 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' C' C ' 12' ' ' VAL . . . . . . . . . . . . . 11.8 p -140.03 145.17 26.76 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.288 0 CA-C-N 116.107 -0.497 . . . . 0.0 110.308 179.778 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' C' C ' 13' ' ' GLU . . . . . . . . . . . . . 70.5 tt0 -84.27 116.16 22.83 Favored 'General case' 0 C--N 1.328 -0.333 0 N-CA-C 109.756 -0.461 . . . . 0.0 109.756 178.179 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' C' C ' 14' ' ' LEU . . . . . . . . . . . . . 19.0 mt -87.21 152.24 52.55 Favored Pre-proline 0 C--N 1.328 -0.33 0 CA-C-N 116.421 -0.354 . . . . 0.0 111.079 -175.131 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' C' C ' 15' ' ' PRO . . . . . . . . . . . . . 26.8 Cg_exo -61.95 161.61 25.2 Favored 'Trans proline' 0 N--CA 1.496 1.65 0 C-N-CA 121.443 1.428 . . . . 0.0 111.698 176.451 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' C' C ' 16' ' ' PRO . . . . . . . . . . . . . 24.0 Cg_exo -62.81 -38.14 50.74 Favored 'Trans proline' 0 N--CA 1.497 1.729 0 C-N-CA 121.485 1.457 . . . . 0.0 112.75 -179.248 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' C' C ' 17' ' ' ASP . . . . . . . . . . . . . 9.4 p-10 -93.88 15.84 15.7 Favored 'General case' 0 C--N 1.327 -0.388 0 N-CA-C 113.154 0.798 . . . . 0.0 113.154 -175.688 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' C' C ' 18' ' ' PHE . . . . . . . . . . . . . 38.2 t80 -57.06 -47.03 81.97 Favored 'General case' 0 C--N 1.334 -0.076 0 O-C-N 122.06 -0.4 . . . . 0.0 110.595 -176.998 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' C' C ' 19' ' ' VAL . . . . . . . . . . . . . 46.3 t -56.33 -46.28 81.69 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.323 0 CA-C-N 116.464 -0.335 . . . . 0.0 110.852 -176.261 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' C' C ' 20' ' ' ASP . . . . . . . . . . . . . 77.2 m-20 -60.08 -41.55 92.7 Favored 'General case' 0 C--N 1.329 -0.298 0 C-N-CA 120.939 -0.304 . . . . 0.0 111.159 -177.066 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' C' C ' 21' ' ' VAL . . . . . . . . . . . . . 44.5 t -64.04 -46.75 92.95 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.29 0 C-N-CA 120.759 -0.376 . . . . 0.0 110.383 -177.968 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' C' C ' 22' ' ' ILE . . . . . 0.597 HG22 HD12 ' C' ' 26' ' ' LEU . 51.5 mm -56.36 -46.32 81.8 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.218 0 C-N-CA 120.951 -0.3 . . . . 0.0 110.567 178.352 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' C' C ' 23' ' ' ARG . . . . . . . . . . . . . 56.4 ttp180 -52.88 -49.05 66.64 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-O 120.652 0.263 . . . . 0.0 111.558 -178.798 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' C' C ' 24' ' ' ILE . . . . . . . . . . . . . 71.3 mt -58.32 -47.75 86.84 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.341 0 CA-C-N 116.661 -0.245 . . . . 0.0 110.802 -178.187 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' C' C ' 25' ' ' LYS . . . . . . . . . . . . . 40.4 mmtt -60.76 -43.96 97.34 Favored 'General case' 0 C--N 1.329 -0.315 0 N-CA-C 112.129 0.418 . . . . 0.0 112.129 -177.959 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' C' C ' 26' ' ' LEU . . . . . 0.597 HD12 HG22 ' C' ' 22' ' ' ILE . 81.8 mt -80.88 -29.21 35.75 Favored 'General case' 0 C--N 1.33 -0.273 0 N-CA-C 113.392 0.886 . . . . 0.0 113.392 -170.721 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' C' C ' 27' ' ' GLN . . . . . . . . . . . . . 4.4 pt20 -45.87 134.53 7.78 Favored 'General case' 0 N--CA 1.467 0.423 0 N-CA-C 112.856 0.687 . . . . 0.0 112.856 -174.931 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' C' C ' 28' ' ' GLY . . . . . . . . . . . . . . . 101.11 -20.21 48.45 Favored Glycine 0 CA--C 1.533 1.191 0 CA-C-N 115.948 -0.569 . . . . 0.0 112.863 -179.038 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' C' C ' 29' ' ' LYS . . . . . . . . . . . . . 59.9 mtpt -97.53 155.08 17.11 Favored 'General case' 0 C--N 1.332 -0.17 0 CA-C-N 117.78 0.79 . . . . 0.0 111.153 179.84 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' C' C ' 30' ' ' THR . . . . . . . . . . . . . 42.6 m -107.38 138.41 43.63 Favored 'General case' 0 C--N 1.332 -0.164 0 CA-C-N 116.157 -0.474 . . . . 0.0 110.038 176.262 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' C' C ' 31' ' ' VAL . . . . . . . . . . . . . 35.0 m -131.33 160.61 42.19 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.252 0 CA-C-N 116.38 -0.373 . . . . 0.0 110.771 -178.928 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' C' C ' 32' ' ' ARG . . . . . . . . . . . . . 21.1 mtp-105 -132.99 153.3 51.6 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-O 121.37 0.605 . . . . 0.0 110.552 178.236 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' C' C ' 33' ' ' THR . . . . . . . . . . . . . 17.9 m -52.98 139.72 26.97 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.022 -0.536 . . . . 0.0 111.457 -177.817 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' C' C ' 34' ' ' GLY . . . . . . . . . . . . . . . 99.85 -17.06 57.87 Favored Glycine 0 CA--C 1.532 1.108 0 CA-C-O 119.623 -0.543 . . . . 0.0 113.447 177.678 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' C' C ' 35' ' ' ASP . . . . . . . . . . . . . 70.9 m-20 -64.23 148.85 49.19 Favored 'General case' 0 C--O 1.232 0.167 0 CA-C-N 118.004 0.902 . . . . 0.0 111.17 -179.833 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' C' C ' 36' ' ' VAL . . . . . . . . . . . . . 45.9 t -122.63 129.69 75.03 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.241 0 CA-C-N 115.794 -0.639 . . . . 0.0 109.629 178.117 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' C' C ' 37' ' ' ILE . . . . . . . . . . . . . 67.7 mt -121.82 140.23 46.44 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.278 0 CA-C-N 116.396 -0.365 . . . . 0.0 110.129 -178.146 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' C' C ' 38' ' ' GLY . . . . . . . . . . . . . . . -113.2 128.96 8.62 Favored Glycine 0 CA--C 1.526 0.745 0 N-CA-C 111.082 -0.807 . . . . 0.0 111.082 -179.845 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' C' C ' 39' ' ' ILE . . . . . . . . . . . . . 76.2 mt -124.24 142.64 40.35 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.205 0 N-CA-C 110.025 -0.361 . . . . 0.0 110.025 179.564 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' C' C ' 40' ' ' SER . . . . . 0.536 ' O ' HD13 ' C' ' 41' ' ' ILE . 89.7 p -91.3 120.47 32.22 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.361 -0.381 . . . . 0.0 111.067 177.888 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' C' C ' 41' ' ' ILE . . . . . 0.536 HD13 ' O ' ' C' ' 40' ' ' SER . 46.3 mm -130.16 114.96 30.9 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.242 0 CA-C-N 116.435 -0.348 . . . . 0.0 110.098 177.904 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' C' C ' 42' ' ' LEU . . . . . . . . . . . . . 49.0 mt 58.03 35.16 24.97 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.391 -0.368 . . . . 0.0 111.566 178.248 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' C' C ' 43' ' ' GLY . . . . . . . . . . . . . . . 77.89 -10.08 27.74 Favored Glycine 0 CA--C 1.533 1.203 0 C-N-CA 121.316 -0.469 . . . . 0.0 113.499 177.81 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' C' C ' 44' ' ' LYS . . . . . . . . . . . . . 68.4 mmtt -98.04 139.47 33.81 Favored 'General case' 0 C--N 1.333 -0.11 0 CA-C-N 117.96 0.88 . . . . 0.0 109.869 176.057 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' C' C ' 45' ' ' GLU . . . . . . . . . . . . . 82.2 tt0 -83.3 123.81 29.99 Favored 'General case' 0 C--N 1.329 -0.315 0 C-N-CA 120.936 -0.306 . . . . 0.0 110.713 179.536 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' C' C ' 46' ' ' VAL . . . . . . . . . . . . . 7.7 p -115.5 128.37 72.74 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.167 0 N-CA-C 109.511 -0.552 . . . . 0.0 109.511 177.441 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' C' C ' 47' ' ' LYS . . . . . . . . . . . . . 67.4 mttm -100.24 130.74 46.4 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 115.97 -0.559 . . . . 0.0 111.56 -179.927 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' C' C ' 48' ' ' PHE . . . . . . . . . . . . . 91.1 m-85 -115.31 131.91 56.78 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.079 -0.509 . . . . 0.0 109.714 175.813 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' C' C ' 49' ' ' LYS . . . . . . . . . . . . . 82.8 tttt -107.92 137.18 46.37 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.498 -0.319 . . . . 0.0 110.716 -179.478 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' C' C ' 50' ' ' VAL . . . . . . . . . . . . . 44.3 t -82.29 105.64 12.36 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.262 0 N-CA-C 109.543 -0.54 . . . . 0.0 109.543 176.288 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' C' C ' 51' ' ' VAL . . . . . . . . . . . . . 46.4 t -71.0 -52.89 24.08 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.333 0 CA-C-N 115.926 -0.579 . . . . 0.0 109.75 -174.914 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' C' C ' 52' ' ' GLN . . . . . . . . . . . . . 81.9 mt-30 -154.57 149.92 27.19 Favored 'General case' 0 C--N 1.331 -0.198 0 C-N-CA 120.41 -0.516 . . . . 0.0 111.58 -177.418 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' C' C ' 53' ' ' ALA . . . . . . . . . . . . . . . -122.89 130.69 53.17 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 115.41 -0.813 . . . . 0.0 109.43 174.833 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' C' C ' 54' ' ' TYR . . . . . . . . . . . . . 67.9 t80 -129.0 107.41 18.08 Favored Pre-proline 0 CA--C 1.533 0.318 0 CA-C-O 118.215 -0.898 . . . . 0.0 110.493 -179.416 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' C' C ' 55' ' ' PRO . . . . . . . . . . . . . 73.1 Cg_endo -77.09 170.05 72.67 Favored 'Cis proline' 0 N--CA 1.5 1.907 0 CA-C-N 121.726 1.652 . . . . 0.0 112.583 -5.07 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' C' C ' 56' ' ' SER . . . . . . . . . . . . . 32.5 m -115.71 132.12 23.33 Favored Pre-proline 0 CA--C 1.538 0.516 0 CA-C-O 118.429 -0.796 . . . . 0.0 109.515 175.428 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' C' C ' 57' ' ' PRO . . . . . . . . . . . . . 33.5 Cg_endo -65.76 166.26 55.41 Favored 'Cis proline' 0 N--CA 1.498 1.785 0 CA-C-N 121.971 1.74 . . . . 0.0 111.378 -2.583 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' C' C ' 58' ' ' LEU . . . . . 0.595 HD23 HD12 ' C' ' 4' ' ' LEU . 19.4 tp -130.5 138.58 50.31 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-O 121.018 0.437 . . . . 0.0 110.662 -179.919 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' C' C ' 59' ' ' ARG . . . . . . . . . . . . . 78.6 ttt-85 -103.61 128.4 50.9 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 115.579 -0.737 . . . . 0.0 109.47 175.767 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' C' C ' 60' ' ' VAL . . . . . . . . . . . . . 43.2 t -78.86 112.93 17.48 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.344 0 CA-C-O 120.817 0.342 . . . . 0.0 110.378 -177.114 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' C' C ' 61' ' ' GLU . . . . . . . . . . . . . 72.9 tt0 -130.95 157.01 44.11 Favored 'General case' 0 C--N 1.329 -0.314 0 N-CA-C 109.359 -0.608 . . . . 0.0 109.359 177.936 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' C' C ' 62' ' ' ASP . . . . . . . . . . . . . 9.5 t0 -51.7 -30.79 23.51 Favored 'General case' 0 C--N 1.326 -0.414 0 N-CA-C 112.213 0.449 . . . . 0.0 112.213 -177.479 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' C' C ' 63' ' ' ARG . . . . . . . . . . . . . 73.8 mtp180 -72.66 -22.06 60.99 Favored 'General case' 0 CA--C 1.532 0.288 0 N-CA-C 112.966 0.728 . . . . 0.0 112.966 -175.38 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' C' C ' 64' ' ' THR . . . . . . . . . . . . . 32.3 m -73.69 140.58 46.14 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-O 120.895 0.379 . . . . 0.0 110.829 -176.226 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' C' C ' 65' ' ' LYS . . . . . . . . . . . . . 42.1 mtmt -89.22 127.79 35.78 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.099 -0.501 . . . . 0.0 110.12 177.868 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' C' C ' 66' ' ' ILE . . . . . . . . . . . . . 64.8 mt -109.48 125.73 66.62 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.32 0 N-CA-C 109.427 -0.583 . . . . 0.0 109.427 179.152 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' C' C ' 67' ' ' THR . . . . . . . . . . . . . 23.1 m -124.81 142.29 51.53 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-O 121.277 0.56 . . . . 0.0 111.358 -174.9 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' C' C ' 68' ' ' LEU . . . . . . . . . . . . . 43.8 mt -95.25 127.73 41.54 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 115.59 -0.732 . . . . 0.0 109.894 176.123 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' C' C ' 69' ' ' VAL . . . . . . . . . . . . . 43.1 t -97.73 135.86 30.68 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.412 0 CA-C-N 116.233 -0.44 . . . . 0.0 110.157 -178.973 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' C' C ' 70' ' ' THR . . . . . . . . . . . . . 41.4 p -131.09 30.05 4.6 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.263 -0.426 . . . . 0.0 111.752 -179.579 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' C' C ' 71' ' ' HIS . . . . . . . . . . . . . 59.7 m80 -116.42 147.87 40.54 Favored Pre-proline 0 CA--C 1.531 0.225 0 N-CA-C 109.595 -0.52 . . . . 0.0 109.595 176.574 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' C' C ' 72' ' ' PRO . . . . . . . . . . . . . 98.3 Cg_endo -86.32 -28.85 0.58 Allowed 'Trans proline' 0 N--CA 1.491 1.361 0 C-N-CA 121.589 1.526 . . . . 0.0 112.793 -177.164 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' C' C ' 73' ' ' VAL . . . . . . . . . . . . . 34.8 m -130.92 155.57 42.04 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.272 0 CA-C-O 120.717 0.294 . . . . 0.0 110.799 -178.341 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' C' C ' 74' ' ' ASP . . . . . . . . . . . . . 35.6 t0 -102.83 118.06 36.0 Favored 'General case' 0 C--N 1.331 -0.199 0 N-CA-C 109.455 -0.572 . . . . 0.0 109.455 177.835 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' C' C ' 75' ' ' VAL . . . . . . . . . . . . . 39.9 t -118.63 123.88 72.25 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.245 0 CA-C-O 121.141 0.496 . . . . 0.0 110.795 -176.634 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' C' C ' 76' ' ' LEU . . . . . . . . . . . . . 6.7 mp -117.62 150.39 39.11 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 115.503 -0.771 . . . . 0.0 109.613 176.184 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' C' C ' 77' ' ' GLU . . . . . . . . . . . . . 47.2 mt-10 -134.62 132.32 38.85 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-O 120.963 0.411 . . . . 0.0 111.019 179.916 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' C' C ' 78' ' ' ALA . . . . . 0.776 ' HB2' HD21 ' C' ' 109' ' ' LEU . . . -124.66 127.76 47.8 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 115.838 -0.619 . . . . 0.0 109.919 177.05 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' C' C ' 79' ' ' LYS . . . . . 0.559 ' O ' HD13 ' C' ' 80' ' ' ILE . 14.4 ptpt -72.81 119.29 16.85 Favored 'General case' 0 C--N 1.331 -0.239 0 CA-C-O 121.239 0.543 . . . . 0.0 110.589 -178.772 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' C' C ' 80' ' ' ILE . . . . . 0.559 HD13 ' O ' ' C' ' 79' ' ' LYS . 24.1 mm -139.44 105.59 2.43 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.285 0 N-CA-C 109.213 -0.662 . . . . 0.0 109.213 -177.781 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' C' C ' 81' ' ' LYS . . . . . . . . . . . . . 55.9 pttt -98.91 126.83 44.68 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-O 121.032 0.444 . . . . 0.0 111.26 -177.205 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' C' C ' 82' ' ' GLY . . . . . . . . . . . . . . . 89.16 42.03 5.69 Favored Glycine 0 CA--C 1.526 0.754 0 CA-C-N 115.838 -0.619 . . . . 0.0 111.834 175.05 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' C' C ' 83' ' ' ILE . . . . . . . . . . . . . 67.3 mt -71.99 139.35 19.88 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.391 0 N-CA-C 109.551 -0.537 . . . . 0.0 109.551 176.57 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' C' C ' 84' ' ' LYS . . . . . . . . . . . . . 20.2 ttpp -102.28 -50.21 3.68 Favored 'General case' 0 C--N 1.331 -0.215 0 CA-C-O 120.895 0.378 . . . . 0.0 110.317 -178.857 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' C' C ' 85' ' ' ASP . . . . . . . . . . . . . 11.1 t70 -150.95 150.0 30.29 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.034 -0.53 . . . . 0.0 110.641 -179.184 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' C' C ' 86' ' ' VAL . . . . . . . . . . . . . 44.7 t -132.93 131.12 59.06 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.275 0 CA-C-O 120.89 0.376 . . . . 0.0 110.3 179.779 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' C' C ' 87' ' ' ILE . . . . . . . . . . . . . 40.3 mm -119.5 127.08 75.86 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.233 0 N-CA-C 109.359 -0.608 . . . . 0.0 109.359 177.457 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' C' C ' 88' ' ' LEU . . . . . . . . . . . . . 20.4 tp -113.03 132.15 55.5 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-O 120.973 0.416 . . . . 0.0 111.119 -177.209 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' C' C ' 89' ' ' ASP . . . . . . . . . . . . . 8.6 t70 -125.1 156.5 38.19 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 115.77 -0.65 . . . . 0.0 109.587 176.272 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' C' C ' 90' ' ' GLU . . . . . . . . . . . . . 95.4 mt-10 -47.02 -39.28 12.34 Favored 'General case' 0 C--N 1.329 -0.301 0 N-CA-C 113.007 0.743 . . . . 0.0 113.007 -172.167 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' C' C ' 91' ' ' ASN . . . . . . . . . . . . . 3.7 t-20 -132.09 34.8 3.77 Favored 'General case' 0 N--CA 1.464 0.251 0 N-CA-C 111.832 0.308 . . . . 0.0 111.832 -175.862 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' C' C ' 92' ' ' LEU . . . . . . . . . . . . . 11.4 tp -166.09 146.03 6.27 Favored 'General case' 0 C--N 1.332 -0.187 0 C-N-CA 120.755 -0.378 . . . . 0.0 111.058 -179.335 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' C' C ' 93' ' ' ILE . . . . . . . . . . . . . 64.4 mt -125.3 123.42 65.05 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.18 0 N-CA-C 109.575 -0.528 . . . . 0.0 109.575 178.622 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' C' C ' 94' ' ' VAL . . . . . 0.452 HG21 HG11 ' C' ' 125' ' ' VAL . 47.0 t -122.64 125.02 71.92 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.218 0 N-CA-C 109.887 -0.412 . . . . 0.0 109.887 178.806 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' C' C ' 95' ' ' VAL . . . . . . . . . . . . . 44.3 t -121.61 135.8 60.6 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.273 0 CA-C-N 116.068 -0.515 . . . . 0.0 110.049 -178.38 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' C' C ' 96' ' ' ILE . . . . . . . . . . . . . 64.9 mt -117.87 127.31 75.17 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.307 0 N-CA-C 109.647 -0.501 . . . . 0.0 109.647 -179.949 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' C' C ' 97' ' ' THR . . . . . . . . . . . . . 81.2 p -98.94 156.41 16.91 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-O 121.021 0.439 . . . . 0.0 110.984 -178.965 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' C' C ' 98' ' ' GLU . . . . . . . . . . . . . 14.2 pt-20 -55.58 -22.18 20.83 Favored 'General case' 0 CA--C 1.534 0.343 0 N-CA-C 112.603 0.594 . . . . 0.0 112.603 -178.736 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' C' C ' 99' ' ' GLU . . . . . . . . . . . . . 51.0 mp0 -81.22 15.49 1.92 Allowed 'General case' 0 CA--C 1.535 0.399 0 N-CA-C 112.95 0.722 . . . . 0.0 112.95 -178.881 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' C' C ' 100' ' ' ASN . . . . . . . . . . . . . 22.3 m-20 59.66 37.37 22.42 Favored 'General case' 0 C--N 1.332 -0.153 0 CA-C-O 121.026 0.441 . . . . 0.0 111.159 -179.428 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' C' C ' 101' ' ' GLU . . . . . . . . . . . . . 84.4 tt0 -111.91 142.35 44.41 Favored 'General case' 0 C--N 1.333 -0.132 0 N-CA-C 109.575 -0.528 . . . . 0.0 109.575 173.198 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' C' C ' 102' ' ' VAL . . . . . . . . . . . . . 44.3 t -114.95 127.93 72.31 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.249 0 CA-C-N 116.27 -0.423 . . . . 0.0 109.998 -177.025 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' C' C ' 103' ' ' LEU . . . . . . . . . . . . . 39.8 mt -117.01 131.56 56.92 Favored 'General case' 0 C--N 1.331 -0.216 0 CA-C-N 115.604 -0.726 . . . . 0.0 110.224 177.087 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' C' C ' 104' ' ' ILE . . . . . 0.5 HD12 ' HB3' ' C' ' 113' ' ' TYR . 66.8 mt -118.44 122.9 70.66 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.255 0 CA-C-N 116.491 -0.322 . . . . 0.0 110.155 -179.865 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' C' C ' 105' ' ' PHE . . . . . . . . . . . . . 89.7 m-85 -124.85 162.66 23.88 Favored 'General case' 0 N--CA 1.462 0.135 0 O-C-N 123.983 0.802 . . . . 0.0 110.3 -178.3 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' C' C ' 106' ' ' ASN . . . . . . . . . . . . . 41.3 p-10 -100.27 -169.95 1.8 Allowed 'General case' 0 C--N 1.331 -0.21 0 CA-C-N 116.309 -0.405 . . . . 0.0 109.934 174.018 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' C' C ' 107' ' ' GLN . . . . . . . . . . . . . 32.3 tt0 -58.49 -30.01 66.68 Favored 'General case' 0 CA--C 1.532 0.252 0 N-CA-C 111.998 0.37 . . . . 0.0 111.998 179.553 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' C' C ' 108' ' ' ASN . . . . . . . . . . . . . 10.7 t-20 -84.24 9.62 12.46 Favored 'General case' 0 CA--C 1.536 0.407 0 N-CA-C 113.114 0.783 . . . . 0.0 113.114 -176.787 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' C' C ' 109' ' ' LEU . . . . . 0.776 HD21 ' HB2' ' C' ' 78' ' ' ALA . 11.1 tp 56.13 35.85 26.39 Favored 'General case' 0 CA--C 1.531 0.225 0 CA-C-O 120.898 0.38 . . . . 0.0 111.266 -179.97 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' C' C ' 110' ' ' GLU . . . . . . . . . . . . . 42.8 mt-10 -103.17 147.62 26.79 Favored 'General case' 0 C--N 1.331 -0.22 0 N-CA-C 109.522 -0.547 . . . . 0.0 109.522 175.613 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' C' C ' 111' ' ' GLU . . . . . . . . . . . . . 50.9 tt0 -79.68 121.9 25.88 Favored 'General case' 0 C--N 1.327 -0.396 0 CA-C-O 120.822 0.344 . . . . 0.0 110.877 -175.838 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' C' C ' 112' ' ' LEU . . . . . . . . . . . . . 22.9 mt -106.03 -45.89 4.23 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-N 116.029 -0.532 . . . . 0.0 110.42 178.805 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' C' C ' 113' ' ' TYR . . . . . 0.5 ' HB3' HD12 ' C' ' 104' ' ' ILE . 53.4 t80 -136.26 138.79 42.17 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-O 120.905 0.383 . . . . 0.0 111.294 -178.849 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' C' C ' 114' ' ' ARG . . . . . . . . . . . . . 58.8 ttp180 -137.08 121.62 18.37 Favored 'General case' 0 C--N 1.331 -0.197 0 CA-C-N 115.775 -0.648 . . . . 0.0 110.221 178.164 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' C' C ' 115' ' ' GLY . . . . . . . . . . . . . . . -150.0 151.13 23.25 Favored Glycine 0 CA--C 1.523 0.584 0 N-CA-C 111.094 -0.802 . . . . 0.0 111.094 178.033 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' C' C ' 116' ' ' LYS . . . . . . . . . . . . . 72.6 tttt -130.01 133.19 46.6 Favored 'General case' 0 C--N 1.33 -0.261 0 N-CA-C 109.793 -0.447 . . . . 0.0 109.793 178.013 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' C' C ' 117' ' ' PHE . . . . . . . . . . . . . 23.1 m-85 -133.5 113.94 13.04 Favored 'General case' 0 C--N 1.331 -0.226 0 CA-C-O 120.884 0.373 . . . . 0.0 110.339 -174.136 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' C' C ' 118' ' ' GLU . . . . . . . . . . . . . 95.7 mt-10 -54.15 -50.43 66.98 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.396 -0.365 . . . . 0.0 111.179 -177.736 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' C' C ' 119' ' ' ASN . . . . . . . . . . . . . 35.6 m120 -89.67 29.64 1.13 Allowed 'General case' 0 C--N 1.33 -0.278 0 N-CA-C 112.261 0.467 . . . . 0.0 112.261 -174.922 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' C' C ' 120' ' ' LEU . . . . . . . . . . . . . 30.6 tp -57.95 121.22 10.05 Favored 'General case' 0 C--N 1.332 -0.162 0 N-CA-C 110.161 -0.311 . . . . 0.0 110.161 177.313 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' C' C ' 121' ' ' ASN . . . . . . . . . . . . . 32.1 m120 -114.11 -43.41 3.24 Favored 'General case' 0 C--N 1.331 -0.209 0 CA-C-N 116.326 -0.397 . . . . 0.0 111.017 -177.155 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' C' C ' 122' ' ' LYS . . . . . . . . . . . . . 67.9 mttm -138.68 144.34 39.57 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-O 121.152 0.501 . . . . 0.0 111.614 -175.909 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' C' C ' 123' ' ' VAL . . . . . . . . . . . . . 45.7 t -124.55 126.23 71.41 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.21 0 CA-C-N 115.715 -0.675 . . . . 0.0 109.448 176.146 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' C' C ' 124' ' ' LEU . . . . . . . . . . . . . 27.3 mt -123.18 131.0 53.52 Favored 'General case' 0 C--N 1.332 -0.166 0 CA-C-O 120.642 0.258 . . . . 0.0 110.683 -178.212 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' C' C ' 125' ' ' VAL . . . . . 0.452 HG11 HG21 ' C' ' 94' ' ' VAL . 35.1 m -136.31 134.41 49.84 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.288 0 CA-C-N 116.321 -0.4 . . . . 0.0 110.752 179.896 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' C' C ' 126' ' ' ARG . . . . . . . . . . . . . 95.7 mtt-85 -146.28 118.17 8.19 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.325 -0.398 . . . . 0.0 110.671 178.053 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' C' C ' 127' ' ' ASN . . . . . . . . . . . . . 34.8 m120 49.84 -104.97 0.16 Allowed 'General case' 0 CA--C 1.544 0.718 0 CA-C-O 119.202 -0.428 . . . . 0.0 111.78 177.599 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' C' C ' 128' ' ' ASP . . . . . . . . . . . . . 13.0 p-10 -114.23 13.5 17.94 Favored 'General case' 0 N--CA 1.467 0.408 0 CA-C-N 119.406 1.003 . . . . 0.0 113.263 -175.112 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' C' C ' 129' ' ' LEU . . . . . . . . . . . . . 24.4 tp -118.32 136.83 53.48 Favored 'General case' 0 C--N 1.332 -0.161 0 O-C-N 122.029 -0.42 . . . . 0.0 110.046 177.592 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' C' C ' 130' ' ' VAL . . . . . . . . . . . . . 42.4 t -125.09 136.56 60.47 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.196 0 CA-C-O 120.926 0.393 . . . . 0.0 110.025 -179.347 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' C' C ' 131' ' ' VAL . . . . . 0.485 HG22 HD12 ' C' ' 140' ' ' LEU . 41.8 t -136.02 135.26 50.46 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.291 0 CA-C-O 121.131 0.491 . . . . 0.0 110.167 178.022 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' C' C ' 132' ' ' ILE . . . . . . . . . . . . . 73.1 mt -117.08 129.85 72.95 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.323 0 CA-C-N 115.717 -0.674 . . . . 0.0 109.388 -179.295 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' C' C ' 133' ' ' ILE . . . . . . . . . . . . . 37.6 mm -115.46 120.3 64.31 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.301 0 CA-C-O 120.608 0.242 . . . . 0.0 111.047 -174.494 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' C' C ' 134' ' ' ASP . . . . . . . . . . . . . 7.5 p-10 -130.42 149.87 51.9 Favored 'General case' 0 C--N 1.333 -0.138 0 N-CA-C 109.944 -0.391 . . . . 0.0 109.944 174.655 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' C' C ' 135' ' ' GLU . . . . . . . . . . . . . 58.0 tt0 -49.92 -25.93 3.69 Favored 'General case' 0 C--N 1.327 -0.375 0 N-CA-C 113.088 0.773 . . . . 0.0 113.088 -170.889 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' C' C ' 136' ' ' GLN . . . . . . . . . . . . . 30.1 tt0 -95.38 -26.87 15.71 Favored 'General case' 0 CA--C 1.531 0.221 0 N-CA-C 112.765 0.654 . . . . 0.0 112.765 -172.472 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' C' C ' 137' ' ' LYS . . . . . . . . . . . . . 58.3 pttt -163.86 167.46 20.72 Favored 'General case' 0 C--O 1.233 0.193 0 CA-C-O 121.576 0.703 . . . . 0.0 112.162 -175.114 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' C' C ' 138' ' ' LEU . . . . . 0.413 HD23 ' C ' ' C' ' 138' ' ' LEU . 6.3 tt -117.12 128.43 55.12 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 115.029 -0.987 . . . . 0.0 109.928 179.712 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' C' C ' 139' ' ' THR . . . . . . . . . . . . . 27.7 m -108.24 124.83 50.9 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.156 -0.474 . . . . 0.0 110.402 179.236 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' C' C ' 140' ' ' LEU . . . . . 0.485 HD12 HG22 ' C' ' 131' ' ' VAL . 10.5 tp -111.21 120.47 42.38 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 115.853 -0.612 . . . . 0.0 109.355 -178.977 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' C' C ' 141' ' ' ILE . . . . . . . . . . . . . 18.9 mt -123.21 118.28 54.18 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.269 0 CA-C-O 121.118 0.485 . . . . 0.0 110.081 -174.862 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' C' C ' 142' ' ' ARG . . . . . . . . . . . . . 72.1 mtp180 -94.55 107.74 19.71 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 115.435 -0.802 . . . . 0.0 110.176 176.736 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' C' C ' 143' ' ' THR . . . . . . . . . . . . . 13.6 p . . . . . 0 C--O 1.22 -0.457 0 CA-C-O 117.967 -1.016 . . . . 0.0 110.507 -179.866 . . . . . . . . 0 0 . 1 . 016 nuclear build full ' D' D ' -3' ' ' GLU . . . . . . . . . . . . . 95.8 mt-10 . . . . . 0 N--CA 1.488 1.473 0 N-CA-C 109.489 -0.56 . . . . 0.0 109.489 . . . . . . . . . 0 0 . 1 . 016 nuclear build full ' D' D ' -2' ' ' GLY . . . . . . . . . . . . . . . -68.93 146.17 44.42 Favored Glycine 0 CA--C 1.526 0.722 0 N-CA-C 111.111 -0.796 . . . . 0.0 111.111 -179.558 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' D' D ' -1' ' ' VAL . . . . . . . . . . . . . 42.8 t -96.62 137.76 23.59 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.33 0 CA-C-O 120.8 0.333 . . . . 0.0 110.288 -179.937 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' D' D ' 0' ' ' ILE . . . . . . . . . . . . . 69.0 mt -113.01 132.63 61.28 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.24 0 CA-C-N 116.185 -0.461 . . . . 0.0 109.863 178.617 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' D' D ' 1' ' ' MET . . . . . . . . . . . . . 25.1 ptp -94.65 146.71 23.95 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.269 -0.423 . . . . 0.0 110.692 -179.546 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' D' D ' 2' ' ' SER . . . . . . . . . . . . . 3.9 p -118.16 129.96 55.83 Favored 'General case' 0 C--N 1.331 -0.216 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.613 179.076 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' D' D ' 3' ' ' GLU . . . . . . . . . . . . . 80.7 tt0 -146.6 142.93 28.45 Favored 'General case' 0 C--N 1.327 -0.396 0 CA-C-N 115.987 -0.551 . . . . 0.0 111.019 -178.658 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' D' D ' 4' ' ' LEU . . . . . . . . . . . . . 17.2 tp -124.3 132.27 53.56 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.01 -0.541 . . . . 0.0 110.056 177.171 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' D' D ' 5' ' ' LYS . . . . . . . . . . . . . 66.4 mttm -111.13 121.76 46.14 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 116.331 -0.395 . . . . 0.0 110.513 -179.176 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' D' D ' 6' ' ' LEU . . . . . . . . . . . . . 71.1 mt -117.2 151.43 36.9 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 115.668 -0.696 . . . . 0.0 110.94 -177.384 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' D' D ' 7' ' ' LYS . . . . . . . . . . . . . 74.9 tttt -142.5 141.72 21.47 Favored Pre-proline 0 CA--C 1.532 0.278 0 CA-C-N 116.18 -0.464 . . . . 0.0 109.952 174.005 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' D' D ' 8' ' ' PRO . . . . . . . . . . . . . 84.1 Cg_endo -90.76 144.8 3.7 Favored 'Trans proline' 0 N--CA 1.491 1.325 0 C-N-CA 121.74 1.627 . . . . 0.0 112.081 179.039 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' D' D ' 9' ' ' LEU . . . . . . . . . . . . . 40.9 mt -81.07 -47.18 1.14 Allowed Pre-proline 0 CA--C 1.533 0.292 0 CA-C-O 118.71 -0.662 . . . . 0.0 112.048 179.784 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' D' D ' 10' ' ' PRO . . . . . . . . . . . . . 88.1 Cg_endo -81.34 154.3 18.68 Favored 'Trans proline' 0 N--CA 1.497 1.711 0 C-N-CA 121.149 1.233 . . . . 0.0 111.643 175.223 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' D' D ' 11' ' ' LYS . . . . . . . . . . . . . 61.6 tttm -88.71 100.41 13.1 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.473 -0.331 . . . . 0.0 110.513 179.392 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' D' D ' 12' ' ' VAL . . . . . . . . . . . . . 12.3 p -144.92 146.44 19.98 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.233 0 CA-C-N 116.22 -0.446 . . . . 0.0 110.679 -179.516 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' D' D ' 13' ' ' GLU . . . . . . . . . . . . . 95.1 mt-10 -82.57 130.56 35.14 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 116.28 -0.418 . . . . 0.0 109.97 176.782 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' D' D ' 14' ' ' LEU . . . . . . . . . . . . . 16.8 mt -97.52 146.93 32.25 Favored Pre-proline 0 CA--C 1.533 0.303 0 CA-C-O 119.223 -0.418 . . . . 0.0 110.238 -178.476 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' D' D ' 15' ' ' PRO . . . . . . . . . . . . . 30.5 Cg_exo -60.43 159.36 27.68 Favored 'Trans proline' 0 N--CA 1.497 1.721 0 C-N-CA 121.328 1.352 . . . . 0.0 111.783 177.176 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' D' D ' 16' ' ' PRO . . . . . . . . . . . . . 39.4 Cg_exo -58.4 -41.04 69.67 Favored 'Trans proline' 0 N--CA 1.497 1.683 0 C-N-CA 121.472 1.448 . . . . 0.0 112.676 -178.261 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' D' D ' 17' ' ' ASP . . . . . . . . . . . . . 12.6 p-10 -87.82 13.01 11.55 Favored 'General case' 0 CA--C 1.535 0.404 0 N-CA-C 113.086 0.772 . . . . 0.0 113.086 -178.084 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' D' D ' 18' ' ' PHE . . . . . . . . . . . . . 46.6 t80 -58.26 -45.01 88.61 Favored 'General case' 0 C--N 1.334 -0.079 0 CA-C-O 120.935 0.398 . . . . 0.0 110.078 -178.542 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' D' D ' 19' ' ' VAL . . . . . . . . . . . . . 47.7 t -56.87 -41.2 75.64 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.249 0 CA-C-N 116.142 -0.481 . . . . 0.0 110.438 -178.805 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' D' D ' 20' ' ' ASP . . . . . . . . . . . . . 71.1 m-20 -60.39 -44.0 96.1 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-O 120.811 0.339 . . . . 0.0 111.071 -178.074 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' D' D ' 21' ' ' VAL . . . . . . . . . . . . . 46.1 t -64.22 -48.6 84.89 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 CA-C-N 116.353 -0.385 . . . . 0.0 110.484 -177.844 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' D' D ' 22' ' ' ILE . . . . . 0.666 HG22 HD12 ' D' ' 26' ' ' LEU . 50.6 mm -55.09 -47.92 76.62 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.241 0 CA-C-O 120.687 0.279 . . . . 0.0 110.829 179.356 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' D' D ' 23' ' ' ARG . . . . . . . . . . . . . 3.7 tmm_? -53.5 -53.38 52.33 Favored 'General case' 0 C--N 1.329 -0.313 0 N-CA-C 111.605 0.224 . . . . 0.0 111.605 -177.719 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' D' D ' 24' ' ' ILE . . . . . . . . . . . . . 72.2 mt -60.31 -41.86 88.64 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.28 0 N-CA-C 111.659 0.244 . . . . 0.0 111.659 -175.711 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' D' D ' 25' ' ' LYS . . . . . . . . . . . . . 53.0 mttm -67.79 -36.95 81.37 Favored 'General case' 0 C--N 1.328 -0.334 0 N-CA-C 112.147 0.425 . . . . 0.0 112.147 -177.707 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' D' D ' 26' ' ' LEU . . . . . 0.666 HD12 HG22 ' D' ' 22' ' ' ILE . 26.5 mt -79.46 -41.94 26.41 Favored 'General case' 0 C--N 1.33 -0.275 0 N-CA-C 112.798 0.666 . . . . 0.0 112.798 -173.617 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' D' D ' 27' ' ' GLN . . . . . . . . . . . . . 10.8 pt20 -46.0 138.57 4.99 Favored 'General case' 0 N--CA 1.47 0.554 0 N-CA-C 112.686 0.625 . . . . 0.0 112.686 -175.669 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' D' D ' 28' ' ' GLY . . . . . . . . . . . . . . . 100.79 -27.86 18.59 Favored Glycine 0 CA--C 1.53 1.02 0 CA-C-N 115.334 -0.848 . . . . 0.0 112.073 -176.086 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' D' D ' 29' ' ' LYS . . . . . . . . . . . . . 94.4 mttt -97.91 155.14 17.22 Favored 'General case' 0 C--O 1.232 0.164 0 CA-C-N 117.186 0.493 . . . . 0.0 111.01 178.796 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' D' D ' 30' ' ' THR . . . . . . . . . . . . . 25.2 m -103.96 139.39 39.18 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.167 -0.47 . . . . 0.0 110.33 176.935 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' D' D ' 31' ' ' VAL . . . . . . . . . . . . . 35.1 m -128.76 151.05 35.0 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.278 0 CA-C-O 121.047 0.451 . . . . 0.0 110.91 -178.922 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' D' D ' 32' ' ' ARG . . . . . . . . . . . . . 26.3 ttm180 -129.05 146.25 51.06 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 115.971 -0.559 . . . . 0.0 110.212 178.895 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' D' D ' 33' ' ' THR . . . . . . . . . . . . . 16.9 m -52.5 139.07 26.2 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.455 -0.339 . . . . 0.0 111.488 -177.301 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' D' D ' 34' ' ' GLY . . . . . . . . . . . . . . . 101.1 -17.21 56.38 Favored Glycine 0 CA--C 1.532 1.151 0 CA-C-O 119.702 -0.499 . . . . 0.0 113.242 179.962 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' D' D ' 35' ' ' ASP . . . . . . . . . . . . . 74.3 m-20 -66.08 149.65 49.94 Favored 'General case' 0 N--CA 1.461 0.095 0 CA-C-N 118.033 0.916 . . . . 0.0 111.15 179.176 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' D' D ' 36' ' ' VAL . . . . . . . . . . . . . 45.9 t -122.12 130.74 74.31 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.193 0 CA-C-N 115.838 -0.619 . . . . 0.0 109.776 177.947 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' D' D ' 37' ' ' ILE . . . . . . . . . . . . . 71.9 mt -121.13 140.13 46.2 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.218 0 CA-C-N 116.299 -0.409 . . . . 0.0 109.994 -179.149 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' D' D ' 38' ' ' GLY . . . . . . . . . . . . . . . -114.26 128.91 8.44 Favored Glycine 0 CA--C 1.526 0.767 0 N-CA-C 111.297 -0.721 . . . . 0.0 111.297 -178.685 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' D' D ' 39' ' ' ILE . . . . . . . . . . . . . 72.2 mt -123.51 135.63 62.69 Favored 'Isoleucine or valine' 0 C--N 1.333 -0.135 0 N-CA-C 109.963 -0.384 . . . . 0.0 109.963 178.268 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' D' D ' 40' ' ' SER . . . . . . . . . . . . . 23.1 t -92.71 123.12 35.76 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-N 116.521 -0.309 . . . . 0.0 111.018 176.786 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' D' D ' 41' ' ' ILE . . . . . . . . . . . . . 73.2 mt -132.21 112.9 20.49 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.167 0 CA-C-O 120.844 0.355 . . . . 0.0 110.315 177.511 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' D' D ' 42' ' ' LEU . . . . . 0.527 HD23 ' O ' ' D' ' 42' ' ' LEU . 1.4 tt 54.5 47.35 22.97 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-O 121.53 0.681 . . . . 0.0 110.647 178.237 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' D' D ' 43' ' ' GLY . . . . . . . . . . . . . . . 75.23 -10.1 11.51 Favored Glycine 0 CA--C 1.535 1.289 0 CA-C-O 119.692 -0.504 . . . . 0.0 113.796 175.274 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' D' D ' 44' ' ' LYS . . . . . . . . . . . . . 35.8 mmtm -99.79 132.65 45.01 Favored 'General case' 0 C--N 1.332 -0.165 0 CA-C-N 118.066 0.933 . . . . 0.0 110.378 -179.981 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' D' D ' 45' ' ' GLU . . . . . . . . . . . . . 80.3 tt0 -84.45 122.83 29.52 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.22 -0.446 . . . . 0.0 110.806 178.635 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' D' D ' 46' ' ' VAL . . . . . . . . . . . . . 7.7 p -117.19 124.27 72.81 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.199 0 N-CA-C 109.542 -0.54 . . . . 0.0 109.542 176.09 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' D' D ' 47' ' ' LYS . . . . . . . . . . . . . 57.7 mtmt -99.94 129.58 46.03 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 115.812 -0.631 . . . . 0.0 111.18 179.515 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' D' D ' 48' ' ' PHE . . . . . . . . . . . . . 91.3 m-85 -112.34 132.36 55.03 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-N 116.166 -0.47 . . . . 0.0 109.982 177.277 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' D' D ' 49' ' ' LYS . . . . . . . . . . . . . 76.1 tttt -105.84 135.54 47.09 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.348 -0.387 . . . . 0.0 110.41 179.581 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' D' D ' 50' ' ' VAL . . . . . . . . . . . . . 44.1 t -79.47 107.2 11.64 Favored 'Isoleucine or valine' 0 C--O 1.232 0.177 0 N-CA-C 109.324 -0.621 . . . . 0.0 109.324 175.717 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' D' D ' 51' ' ' VAL . . . . . . . . . . . . . 48.2 t -71.21 -51.69 32.54 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.344 0 CA-C-N 115.998 -0.547 . . . . 0.0 109.787 -174.376 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' D' D ' 52' ' ' GLN . . . . . . . . . . . . . 45.1 mt-30 -155.53 150.73 26.83 Favored 'General case' 0 C--N 1.331 -0.221 0 CA-C-O 121.18 0.514 . . . . 0.0 111.74 -177.467 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' D' D ' 53' ' ' ALA . . . . . . . . . . . . . . . -125.19 127.27 46.53 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 115.216 -0.902 . . . . 0.0 109.604 175.907 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' D' D ' 54' ' ' TYR . . . . . . . . . . . . . 62.6 t80 -126.37 107.32 24.02 Favored Pre-proline 0 CA--C 1.535 0.392 0 CA-C-O 118.321 -0.847 . . . . 0.0 110.689 -178.242 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' D' D ' 55' ' ' PRO . . . . . . . . . . . . . 74.1 Cg_endo -77.12 170.02 72.71 Favored 'Cis proline' 0 N--CA 1.499 1.836 0 CA-C-N 121.697 1.642 . . . . 0.0 112.355 -6.022 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' D' D ' 56' ' ' SER . . . . . . . . . . . . . 14.5 m -110.59 128.69 24.93 Favored Pre-proline 0 CA--C 1.539 0.526 0 CA-C-O 118.407 -0.806 . . . . 0.0 109.384 175.739 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' D' D ' 57' ' ' PRO . . . . . . . . . . . . . 61.2 Cg_endo -74.84 149.09 93.3 Favored 'Cis proline' 0 N--CA 1.496 1.639 0 CA-C-N 121.96 1.736 . . . . 0.0 111.716 -0.714 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' D' D ' 58' ' ' LEU . . . . . . . . . . . . . 27.9 tp -108.19 137.52 46.02 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.227 -0.442 . . . . 0.0 110.454 -179.04 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' D' D ' 59' ' ' ARG . . . . . . . . . . . . . 25.5 ttm180 -103.82 126.59 51.06 Favored 'General case' 0 C--N 1.327 -0.383 0 N-CA-C 109.394 -0.595 . . . . 0.0 109.394 176.029 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' D' D ' 60' ' ' VAL . . . . . . . . . . . . . 45.6 t -78.8 116.63 22.96 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.231 0 C-N-CA 120.684 -0.407 . . . . 0.0 110.409 -174.833 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' D' D ' 61' ' ' GLU . . . . . . . . . . . . . 94.7 mt-10 -131.06 163.1 28.36 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 116.0 -0.545 . . . . 0.0 109.849 177.795 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' D' D ' 62' ' ' ASP . . . . . . . . . . . . . 14.2 t0 -52.81 -32.99 47.06 Favored 'General case' 0 C--N 1.329 -0.296 0 N-CA-C 111.864 0.32 . . . . 0.0 111.864 -178.67 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' D' D ' 63' ' ' ARG . . . . . . . . . . . . . 77.2 mtt85 -73.64 -21.97 60.13 Favored 'General case' 0 C--N 1.33 -0.258 0 N-CA-C 113.076 0.769 . . . . 0.0 113.076 -176.061 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' D' D ' 64' ' ' THR . . . . . . . . . . . . . 31.4 m -66.14 138.39 57.69 Favored 'General case' 0 C--N 1.331 -0.211 0 CA-C-O 120.955 0.407 . . . . 0.0 111.14 -175.14 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' D' D ' 65' ' ' LYS . . . . . . . . . . . . . 93.2 mttt -89.01 136.62 32.92 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 115.763 -0.653 . . . . 0.0 109.827 176.969 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' D' D ' 66' ' ' ILE . . . . . . . . . . . . . 58.1 mt -115.8 127.21 73.46 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.294 0 N-CA-C 109.852 -0.425 . . . . 0.0 109.852 -179.181 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' D' D ' 67' ' ' THR . . . . . . . . . . . . . 26.5 m -126.45 147.57 49.78 Favored 'General case' 0 N--CA 1.463 0.215 0 CA-C-O 121.148 0.499 . . . . 0.0 111.362 -175.928 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' D' D ' 68' ' ' LEU . . . . . 0.473 ' N ' HD12 ' D' ' 68' ' ' LEU . 8.9 mp -102.43 137.83 40.15 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 115.869 -0.605 . . . . 0.0 110.454 177.389 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' D' D ' 69' ' ' VAL . . . . . . . . . . . . . 44.5 t -83.08 136.0 23.69 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 CA-C-N 116.409 -0.359 . . . . 0.0 110.364 179.414 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' D' D ' 70' ' ' THR . . . . . . . . . . . . . 10.4 t -107.69 -170.36 1.68 Allowed 'General case' 0 C--N 1.331 -0.233 0 CA-C-N 116.051 -0.522 . . . . 0.0 110.686 -178.444 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' D' D ' 71' ' ' HIS . . . . . . . . . . . . . 22.1 m-70 -64.96 168.34 7.51 Favored Pre-proline 0 CA--C 1.53 0.209 0 CA-C-N 116.364 -0.38 . . . . 0.0 110.333 179.396 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' D' D ' 72' ' ' PRO . . . . . 0.456 ' O ' HG13 ' D' ' 73' ' ' VAL . 18.6 Cg_exo -64.75 -30.18 59.34 Favored 'Trans proline' 0 N--CA 1.496 1.676 0 C-N-CA 121.23 1.287 . . . . 0.0 112.201 -179.152 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' D' D ' 73' ' ' VAL . . . . . 0.456 HG13 ' O ' ' D' ' 72' ' ' PRO . 3.5 m -153.77 100.7 0.15 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 CA-C-O 121.138 0.494 . . . . 0.0 110.992 175.1 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' D' D ' 74' ' ' ASP . . . . . . . . . . . . . 6.0 t70 -93.1 118.77 31.59 Favored 'General case' 0 C--N 1.327 -0.409 0 N-CA-C 108.691 -0.855 . . . . 0.0 108.691 173.136 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' D' D ' 75' ' ' VAL . . . . . 0.427 ' C ' HD12 ' D' ' 76' ' ' LEU . 36.6 t -111.44 126.8 68.86 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.313 0 CA-C-O 121.241 0.543 . . . . 0.0 111.312 -171.754 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' D' D ' 76' ' ' LEU . . . . . 0.427 HD12 ' C ' ' D' ' 75' ' ' VAL . 5.9 mp -125.97 145.53 50.25 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 115.363 -0.835 . . . . 0.0 109.531 174.672 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' D' D ' 77' ' ' GLU . . . . . . . . . . . . . 97.7 mt-10 -135.26 137.81 42.91 Favored 'General case' 0 N--CA 1.463 0.202 0 CA-C-O 120.982 0.42 . . . . 0.0 111.183 -179.468 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' D' D ' 78' ' ' ALA . . . . . 0.528 ' HB2' HD21 ' D' ' 109' ' ' LEU . . . -131.41 142.12 49.97 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 115.885 -0.598 . . . . 0.0 110.199 177.492 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' D' D ' 79' ' ' LYS . . . . . 0.558 ' O ' HD13 ' D' ' 80' ' ' ILE . 71.2 mmtt -82.05 122.2 27.52 Favored 'General case' 0 C--N 1.331 -0.239 0 CA-C-O 121.058 0.456 . . . . 0.0 111.276 -178.031 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' D' D ' 80' ' ' ILE . . . . . 0.558 HD13 ' O ' ' D' ' 79' ' ' LYS . 41.6 mm -139.17 118.94 13.97 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.304 0 N-CA-C 108.926 -0.768 . . . . 0.0 108.926 179.889 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' D' D ' 81' ' ' LYS . . . . . . . . . . . . . 47.5 pttt -112.28 125.56 54.29 Favored 'General case' 0 N--CA 1.464 0.269 0 CA-C-O 121.051 0.453 . . . . 0.0 111.381 -177.051 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' D' D ' 82' ' ' GLY . . . . . . . . . . . . . . . 88.52 42.22 5.86 Favored Glycine 0 CA--C 1.525 0.677 0 C-N-CA 120.825 -0.702 . . . . 0.0 111.689 173.659 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' D' D ' 83' ' ' ILE . . . . . . . . . . . . . 70.1 mt -63.55 138.64 22.63 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.33 0 CA-C-O 121.017 0.437 . . . . 0.0 110.206 179.343 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' D' D ' 84' ' ' LYS . . . . . . . . . . . . . 83.7 tttt -96.96 -50.3 4.68 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 115.792 -0.64 . . . . 0.0 109.718 179.306 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' D' D ' 85' ' ' ASP . . . . . . . . . . . . . 9.8 t70 -158.63 152.52 23.57 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 115.636 -0.711 . . . . 0.0 110.182 179.214 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' D' D ' 86' ' ' VAL . . . . . . . . . . . . . 43.4 t -130.48 130.13 64.93 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.297 0 CA-C-O 120.863 0.364 . . . . 0.0 110.429 -178.991 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' D' D ' 87' ' ' ILE . . . . . 0.493 HD12 ' N ' ' D' ' 87' ' ' ILE . 5.0 mp -119.6 126.13 75.02 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.261 0 N-CA-C 109.43 -0.582 . . . . 0.0 109.43 176.696 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' D' D ' 88' ' ' LEU . . . . . 0.452 ' CD1' HG21 ' C' ' 131' ' ' VAL . 12.9 tp -113.45 126.19 55.06 Favored 'General case' 0 C--N 1.331 -0.23 0 CA-C-O 120.987 0.422 . . . . 0.0 111.29 -176.636 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' D' D ' 89' ' ' ASP . . . . . . . . . . . . . 9.3 t0 -118.52 151.42 37.88 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 115.871 -0.604 . . . . 0.0 109.524 175.77 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' D' D ' 90' ' ' GLU . . . . . . . . . . . . . 95.4 mt-10 -48.63 -36.85 16.72 Favored 'General case' 0 C--N 1.33 -0.263 0 N-CA-C 112.782 0.66 . . . . 0.0 112.782 -173.054 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' D' D ' 91' ' ' ASN . . . . . . . . . . . . . 36.2 m120 -130.95 31.58 4.45 Favored 'General case' 0 N--CA 1.465 0.307 0 N-CA-C 112.022 0.378 . . . . 0.0 112.022 -176.711 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' D' D ' 92' ' ' LEU . . . . . . . . . . . . . 13.1 tp -166.14 139.38 4.12 Favored 'General case' 0 C--N 1.33 -0.274 0 N-CA-C 110.06 -0.348 . . . . 0.0 110.06 -179.818 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' D' D ' 93' ' ' ILE . . . . . . . . . . . . . 66.2 mt -125.01 124.15 67.02 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.255 0 N-CA-C 109.698 -0.482 . . . . 0.0 109.698 -178.435 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' D' D ' 94' ' ' VAL . . . . . 0.422 HG21 HG11 ' D' ' 125' ' ' VAL . 43.0 t -125.72 127.15 71.2 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.256 0 CA-C-O 121.023 0.44 . . . . 0.0 110.169 -179.367 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' D' D ' 95' ' ' VAL . . . . . . . . . . . . . 43.7 t -122.17 135.4 62.39 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.262 0 CA-C-N 115.893 -0.594 . . . . 0.0 109.856 179.845 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' D' D ' 96' ' ' ILE . . . . . . . . . . . . . 58.5 mt -115.43 129.29 71.95 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.323 0 N-CA-C 109.24 -0.652 . . . . 0.0 109.24 179.631 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' D' D ' 97' ' ' THR . . . . . . . . . . . . . 69.7 p -103.92 157.71 16.91 Favored 'General case' 0 C--N 1.331 -0.211 0 CA-C-O 121.381 0.61 . . . . 0.0 111.631 -176.522 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' D' D ' 98' ' ' GLU . . . . . . . . . . . . . 44.6 tp10 -53.77 -29.05 38.31 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 115.832 -0.622 . . . . 0.0 112.16 -178.871 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' D' D ' 99' ' ' GLU . . . . . . . . . . . . . 12.9 pt-20 -80.1 18.07 0.91 Allowed 'General case' 0 CA--C 1.534 0.359 0 N-CA-C 113.12 0.785 . . . . 0.0 113.12 -176.419 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' D' D ' 100' ' ' ASN . . . . . . . . . . . . . 4.6 m-20 62.91 38.13 11.53 Favored 'General case' 0 CA--C 1.529 0.151 0 CA-C-O 121.039 0.447 . . . . 0.0 110.897 177.773 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' D' D ' 101' ' ' GLU . . . . . . . . . . . . . 82.8 tt0 -114.71 142.07 46.99 Favored 'General case' 0 C--N 1.332 -0.173 0 CA-C-N 116.111 -0.495 . . . . 0.0 109.743 176.707 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' D' D ' 102' ' ' VAL . . . . . . . . . . . . . 44.8 t -115.84 125.97 73.18 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.312 0 N-CA-C 109.754 -0.462 . . . . 0.0 109.754 -179.49 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' D' D ' 103' ' ' LEU . . . . . . . . . . . . . 47.7 mt -117.15 130.31 56.53 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 115.746 -0.661 . . . . 0.0 110.295 177.777 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' D' D ' 104' ' ' ILE . . . . . 0.4 HD13 HG21 ' D' ' 130' ' ' VAL . 68.9 mt -120.06 121.35 65.64 Favored 'Isoleucine or valine' 0 C--O 1.235 0.316 0 N-CA-C 110.095 -0.335 . . . . 0.0 110.095 -179.139 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' D' D ' 105' ' ' PHE . . . . . . . . . . . . . 62.5 m-85 -122.69 162.65 21.57 Favored 'General case' 0 C--N 1.332 -0.159 0 O-C-N 123.924 0.765 . . . . 0.0 110.099 -178.902 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' D' D ' 106' ' ' ASN . . . . . 0.401 ' HB3' HD11 ' D' ' 112' ' ' LEU . 43.5 p30 -96.03 -171.63 2.37 Favored 'General case' 0 C--N 1.328 -0.348 0 N-CA-C 109.368 -0.604 . . . . 0.0 109.368 172.174 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' D' D ' 107' ' ' GLN . . . . . . . . . . . . . 45.8 tt0 -60.97 -29.9 69.94 Favored 'General case' 0 C--N 1.329 -0.325 0 N-CA-C 112.027 0.38 . . . . 0.0 112.027 -178.634 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' D' D ' 108' ' ' ASN . . . . . . . . . . . . . 6.7 t-20 -82.58 8.59 11.42 Favored 'General case' 0 CA--C 1.537 0.463 0 N-CA-C 113.15 0.796 . . . . 0.0 113.15 -178.069 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' D' D ' 109' ' ' LEU . . . . . 0.528 HD21 ' HB2' ' D' ' 78' ' ' ALA . 11.7 tp 61.67 37.92 15.61 Favored 'General case' 0 CA--C 1.53 0.182 0 CA-C-O 121.089 0.471 . . . . 0.0 111.324 178.122 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' D' D ' 110' ' ' GLU . . . . . . . . . . . . . 70.7 mm-40 -105.72 154.5 20.38 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.272 -0.422 . . . . 0.0 110.058 175.98 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' D' D ' 111' ' ' GLU . . . . . . . . . . . . . 44.4 mt-10 -83.61 122.19 28.25 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-O 120.852 0.358 . . . . 0.0 111.336 -177.88 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' D' D ' 112' ' ' LEU . . . . . 0.401 HD11 ' HB3' ' D' ' 106' ' ' ASN . 95.0 mt -106.25 -45.92 4.18 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.054 -0.521 . . . . 0.0 109.903 175.516 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' D' D ' 113' ' ' TYR . . . . . . . . . . . . . 59.9 t80 -140.0 139.95 36.14 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-N 116.26 -0.427 . . . . 0.0 110.808 179.602 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' D' D ' 114' ' ' ARG . . . . . . . . . . . . . 34.2 ptt180 -145.31 123.01 11.84 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.222 -0.445 . . . . 0.0 110.536 178.579 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' D' D ' 115' ' ' GLY . . . . . . . . . . . . . . . -150.12 156.91 26.97 Favored Glycine 0 CA--C 1.525 0.717 0 C-N-CA 120.694 -0.765 . . . . 0.0 111.641 179.516 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' D' D ' 116' ' ' LYS . . . . . . . . . . . . . 27.1 ttpp -128.44 133.13 48.48 Favored 'General case' 0 C--N 1.33 -0.259 0 N-CA-C 109.826 -0.435 . . . . 0.0 109.826 176.849 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' D' D ' 117' ' ' PHE . . . . . 0.439 ' HE2' HD13 ' D' ' 132' ' ' ILE . 31.4 m-85 -130.41 113.94 14.95 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-O 120.85 0.357 . . . . 0.0 110.237 -175.896 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' D' D ' 118' ' ' GLU . . . . . . . . . . . . . 95.9 mt-10 -52.97 -47.88 67.84 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.477 -0.328 . . . . 0.0 111.491 -176.981 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' D' D ' 119' ' ' ASN . . . . . . . . . . . . . 3.6 m-20 -94.96 31.01 1.95 Allowed 'General case' 0 C--N 1.329 -0.326 0 N-CA-C 112.338 0.496 . . . . 0.0 112.338 -174.131 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' D' D ' 120' ' ' LEU . . . . . . . . . . . . . 18.6 tp -55.96 124.5 17.91 Favored 'General case' 0 C--N 1.333 -0.146 0 CA-C-O 120.565 0.222 . . . . 0.0 110.507 176.86 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' D' D ' 121' ' ' ASN . . . . . . . . . . . . . 35.1 m120 -111.94 -44.0 3.51 Favored 'General case' 0 C--N 1.331 -0.222 0 CA-C-N 116.596 -0.275 . . . . 0.0 110.959 -177.605 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' D' D ' 122' ' ' LYS . . . . . . . . . . . . . 97.9 mttt -144.73 146.1 32.02 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-O 121.001 0.429 . . . . 0.0 111.621 -178.112 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' D' D ' 123' ' ' VAL . . . . . . . . . . . . . 45.6 t -125.69 125.28 68.25 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.26 0 N-CA-C 109.446 -0.575 . . . . 0.0 109.446 175.162 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' D' D ' 124' ' ' LEU . . . . . . . . . . . . . 49.3 mt -124.07 131.05 53.51 Favored 'General case' 0 C--N 1.331 -0.227 0 CA-C-O 120.676 0.274 . . . . 0.0 110.737 -178.169 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' D' D ' 125' ' ' VAL . . . . . 0.449 ' CG2' HG21 ' D' ' 87' ' ' ILE . 34.8 m -132.09 131.48 61.26 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.294 0 CA-C-N 116.274 -0.421 . . . . 0.0 110.389 179.285 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' D' D ' 126' ' ' ARG . . . . . . . . . . . . . 94.3 mtt180 -144.13 125.44 14.71 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-O 121.068 0.461 . . . . 0.0 111.12 -179.555 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' D' D ' 127' ' ' ASN . . . . . . . . . . . . . 6.7 m120 49.98 -109.53 0.38 Allowed 'General case' 0 CA--C 1.545 0.772 0 CA-C-O 118.972 -0.537 . . . . 0.0 111.685 177.334 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' D' D ' 128' ' ' ASP . . . . . . . . . . . . . 11.3 p-10 -114.15 8.72 17.01 Favored 'General case' 0 N--CA 1.469 0.479 0 CA-C-N 119.71 1.141 . . . . 0.0 113.224 -176.194 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' D' D ' 129' ' ' LEU . . . . . . . . . . . . . 58.4 mt -121.98 143.63 49.36 Favored 'General case' 0 C--N 1.333 -0.145 0 N-CA-C 109.483 -0.562 . . . . 0.0 109.483 177.357 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' D' D ' 130' ' ' VAL . . . . . 0.4 HG21 HD13 ' D' ' 104' ' ' ILE . 34.9 m -134.8 146.04 31.38 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.288 0 CA-C-O 121.229 0.537 . . . . 0.0 110.644 179.848 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' D' D ' 131' ' ' VAL . . . . . . . . . . . . . 43.1 t -136.03 139.84 45.09 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.396 0 CA-C-N 115.758 -0.655 . . . . 0.0 110.112 -179.789 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' D' D ' 132' ' ' ILE . . . . . 0.439 HD13 ' HE2' ' D' ' 117' ' ' PHE . 71.6 mt -114.59 130.95 68.08 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.322 0 N-CA-C 109.209 -0.663 . . . . 0.0 109.209 178.89 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' D' D ' 133' ' ' ILE . . . . . . . . . . . . . 40.3 mm -112.45 118.94 59.09 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.263 0 CA-C-N 116.438 -0.346 . . . . 0.0 110.763 -174.767 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' D' D ' 134' ' ' ASP . . . . . . . . . . . . . 6.6 p-10 -129.0 145.27 51.29 Favored 'General case' 0 C--N 1.331 -0.214 0 N-CA-C 109.396 -0.594 . . . . 0.0 109.396 175.984 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' D' D ' 135' ' ' GLU . . . . . . . . . . . . . 39.7 tp10 -49.95 -27.32 5.19 Favored 'General case' 0 C--O 1.235 0.315 0 N-CA-C 112.63 0.604 . . . . 0.0 112.63 -174.155 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' D' D ' 136' ' ' GLN . . . . . . . . . . . . . 95.4 mt-30 -76.88 -39.5 50.81 Favored 'General case' 0 C--O 1.235 0.319 0 CA-C-O 120.814 0.34 . . . . 0.0 111.893 -177.884 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' D' D ' 137' ' ' LYS . . . . . . . . . . . . . 55.0 pttt -170.01 176.91 4.51 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-O 121.475 0.655 . . . . 0.0 112.328 -171.825 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' D' D ' 138' ' ' LEU . . . . . 0.411 ' C ' HD23 ' D' ' 138' ' ' LEU . 6.8 tt -117.23 129.3 55.84 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 115.065 -0.97 . . . . 0.0 110.317 -178.515 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' D' D ' 139' ' ' THR . . . . . . . . . . . . . 35.6 m -109.08 124.88 51.47 Favored 'General case' 0 C--N 1.331 -0.219 0 CA-C-N 116.024 -0.535 . . . . 0.0 110.179 178.577 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' D' D ' 140' ' ' LEU . . . . . 0.457 ' C ' HD23 ' D' ' 140' ' ' LEU . 5.8 tt -111.29 122.14 47.08 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 115.781 -0.645 . . . . 0.0 109.308 -178.145 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' D' D ' 141' ' ' ILE . . . . . 0.43 ' N ' HD23 ' D' ' 140' ' ' LEU . 19.6 mt -122.79 118.55 55.37 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.221 0 CA-C-O 121.177 0.513 . . . . 0.0 110.201 -175.993 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' D' D ' 142' ' ' ARG . . . . . . . . . . . . . 92.6 mtt180 -92.77 120.45 33.16 Favored 'General case' 0 C--O 1.234 0.24 0 CA-C-N 115.223 -0.899 . . . . 0.0 109.823 176.865 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' D' D ' 143' ' ' THR . . . . . . . . . . . . . 67.1 p . . . . . 0 C--O 1.221 -0.428 0 CA-C-O 118.006 -0.997 . . . . 0.0 110.464 179.724 . . . . . . . . 0 0 . 1 . 016 nuclear build full ' E' E ' -3' ' ' GLU . . . . . . . . . . . . . 43.1 mp0 . . . . . 0 N--CA 1.49 1.543 0 N-CA-C 109.243 -0.651 . . . . 0.0 109.243 . . . . . . . . . 0 0 . 1 . 016 nuclear build full ' E' E ' -2' ' ' GLY . . . . . . . . . . . . . . . -89.41 126.86 8.43 Favored Glycine 0 CA--C 1.525 0.702 0 N-CA-C 110.895 -0.882 . . . . 0.0 110.895 179.304 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' E' E ' -1' ' ' VAL . . . . . . . . . . . . . 42.9 t -142.31 144.45 24.92 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.357 0 CA-C-O 120.885 0.374 . . . . 0.0 110.125 -179.414 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' E' E ' 0' ' ' ILE . . . . . . . . . . . . . 43.4 mm -113.39 145.02 19.84 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.226 0 CA-C-N 116.116 -0.493 . . . . 0.0 110.109 -179.985 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' E' E ' 1' ' ' MET . . . . . . . . . . . . . 25.2 ptp -143.05 163.61 32.35 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 116.312 -0.404 . . . . 0.0 110.754 -179.859 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' E' E ' 2' ' ' SER . . . . . . . . . . . . . 13.1 p -114.1 137.27 51.96 Favored 'General case' 0 C--N 1.331 -0.202 0 CA-C-O 121.087 0.47 . . . . 0.0 110.809 -177.98 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' E' E ' 3' ' ' GLU . . . . . . . . . . . . . 46.8 tt0 -152.46 145.63 24.65 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 116.059 -0.519 . . . . 0.0 111.152 -177.227 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' E' E ' 4' ' ' LEU . . . . . . . . . . . . . 18.4 tp -124.04 129.4 50.84 Favored 'General case' 0 C--N 1.331 -0.198 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.281 177.397 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' E' E ' 5' ' ' LYS . . . . . . . . . . . . . 67.6 mttm -108.24 123.1 48.26 Favored 'General case' 0 C--N 1.331 -0.215 0 CA-C-N 116.339 -0.391 . . . . 0.0 110.888 179.047 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' E' E ' 6' ' ' LEU . . . . . . . . . . . . . 33.7 mt -115.83 146.3 42.1 Favored 'General case' 0 N--CA 1.464 0.227 0 CA-C-N 115.641 -0.709 . . . . 0.0 110.155 179.132 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' E' E ' 7' ' ' LYS . . . . . . . . . . . . . 31.2 ttmt -128.32 136.76 29.57 Favored Pre-proline 0 CA--C 1.534 0.329 0 CA-C-O 118.88 -0.581 . . . . 0.0 109.585 174.912 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' E' E ' 8' ' ' PRO . . . . . . . . . . . . . 83.1 Cg_endo -92.0 141.51 2.47 Favored 'Trans proline' 0 N--CA 1.49 1.271 0 C-N-CA 121.719 1.613 . . . . 0.0 112.126 178.53 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' E' E ' 9' ' ' LEU . . . . . . . . . . . . . 20.3 mt -78.95 -46.91 1.72 Allowed Pre-proline 0 CA--C 1.534 0.359 0 CA-C-O 118.628 -0.701 . . . . 0.0 111.712 178.419 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' E' E ' 10' ' ' PRO . . . . . . . . . . . . . 91.5 Cg_endo -81.79 150.79 16.54 Favored 'Trans proline' 0 N--CA 1.495 1.615 0 C-N-CA 121.156 1.237 . . . . 0.0 111.539 174.645 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' E' E ' 11' ' ' LYS . . . . . . . . . . . . . 25.1 pttm -86.91 115.84 24.58 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-O 121.389 0.614 . . . . 0.0 110.742 179.423 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' E' E ' 12' ' ' VAL . . . . . . . . . . . . . 12.4 p -151.16 144.77 16.64 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.295 0 CA-C-N 115.822 -0.627 . . . . 0.0 110.341 177.496 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' E' E ' 13' ' ' GLU . . . . . . . . . . . . . 81.5 tt0 -92.83 114.18 26.67 Favored 'General case' 0 C--N 1.329 -0.32 0 N-CA-C 109.749 -0.463 . . . . 0.0 109.749 176.13 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' E' E ' 14' ' ' LEU . . . . . . . . . . . . . 27.9 mt -86.29 144.22 37.96 Favored Pre-proline 0 CA--C 1.533 0.301 0 CA-C-O 119.075 -0.488 . . . . 0.0 110.238 -176.508 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' E' E ' 15' ' ' PRO . . . . . . . . . . . . . 29.4 Cg_exo -60.34 162.62 16.83 Favored 'Trans proline' 0 N--CA 1.498 1.758 0 C-N-CA 121.271 1.314 . . . . 0.0 111.667 178.221 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' E' E ' 16' ' ' PRO . . . . . . . . . . . . . 33.0 Cg_exo -59.09 -38.86 84.7 Favored 'Trans proline' 0 N--CA 1.497 1.711 0 C-N-CA 121.511 1.474 . . . . 0.0 112.904 -176.892 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' E' E ' 17' ' ' ASP . . . . . . . . . . . . . 14.8 p-10 -83.94 1.67 42.41 Favored 'General case' 0 C--N 1.327 -0.383 0 N-CA-C 113.326 0.861 . . . . 0.0 113.326 -177.376 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' E' E ' 18' ' ' PHE . . . . . 0.405 ' CZ ' HD11 ' E' ' 22' ' ' ILE . 61.5 t80 -58.15 -46.4 85.73 Favored 'General case' 0 N--CA 1.457 -0.088 0 O-C-N 121.899 -0.5 . . . . 0.0 110.255 -178.048 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' E' E ' 19' ' ' VAL . . . . . . . . . . . . . 46.6 t -55.45 -43.02 70.39 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.264 0 CA-C-N 116.269 -0.423 . . . . 0.0 110.639 -178.082 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' E' E ' 20' ' ' ASP . . . . . . . . . . . . . 9.5 t0 -60.31 -43.15 96.61 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-O 120.803 0.335 . . . . 0.0 110.844 -178.588 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' E' E ' 21' ' ' VAL . . . . . . . . . . . . . 47.5 t -64.19 -45.88 95.06 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.299 0 C-N-CA 120.882 -0.327 . . . . 0.0 110.603 -177.851 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' E' E ' 22' ' ' ILE . . . . . 0.608 HG22 HD12 ' E' ' 26' ' ' LEU . 51.5 mm -55.53 -46.27 78.89 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.251 0 CA-C-O 120.822 0.344 . . . . 0.0 110.521 178.372 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' E' E ' 23' ' ' ARG . . . . . . . . . . . . . 60.0 ttp180 -53.31 -50.88 64.01 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.65 -0.25 . . . . 0.0 111.509 179.744 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' E' E ' 24' ' ' ILE . . . . . . . . . . . . . 73.7 mt -58.81 -42.9 86.87 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.27 0 CA-C-N 116.546 -0.297 . . . . 0.0 111.332 -176.737 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' E' E ' 25' ' ' LYS . . . . . . . . . . . . . 93.1 mttt -68.88 -38.59 79.79 Favored 'General case' 0 C--N 1.328 -0.332 0 N-CA-C 112.379 0.511 . . . . 0.0 112.379 -177.639 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' E' E ' 26' ' ' LEU . . . . . 0.608 HD12 HG22 ' E' ' 22' ' ' ILE . 78.3 mt -79.85 -38.81 31.96 Favored 'General case' 0 C--N 1.331 -0.236 0 N-CA-C 113.311 0.856 . . . . 0.0 113.311 -170.947 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' E' E ' 27' ' ' GLN . . . . . . . . . . . . . 17.0 pt20 -46.79 140.03 4.93 Favored 'General case' 0 N--CA 1.47 0.559 0 N-CA-C 112.643 0.609 . . . . 0.0 112.643 -175.376 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' E' E ' 28' ' ' GLY . . . . . . . . . . . . . . . 101.4 -26.02 26.06 Favored Glycine 0 CA--C 1.533 1.201 0 CA-C-N 115.57 -0.741 . . . . 0.0 112.174 -175.811 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' E' E ' 29' ' ' LYS . . . . . . . . . . . . . 88.0 mttt -97.51 155.06 17.11 Favored 'General case' 0 C--O 1.232 0.178 0 CA-C-N 117.374 0.587 . . . . 0.0 111.147 178.713 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' E' E ' 30' ' ' THR . . . . . . . . . . . . . 20.8 m -102.57 140.72 36.48 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 115.947 -0.57 . . . . 0.0 110.28 176.735 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' E' E ' 31' ' ' VAL . . . . . . . . . . . . . 34.9 m -128.4 147.48 32.94 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.25 0 CA-C-O 120.901 0.381 . . . . 0.0 110.64 -179.566 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' E' E ' 32' ' ' ARG . . . . . . . . . . . . . 68.8 ttt-85 -130.12 147.16 51.82 Favored 'General case' 0 C--N 1.331 -0.21 0 CA-C-N 116.07 -0.514 . . . . 0.0 110.415 179.541 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' E' E ' 33' ' ' THR . . . . . . . . . . . . . 22.9 m -52.46 139.36 25.28 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 116.458 -0.337 . . . . 0.0 111.594 -177.958 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' E' E ' 34' ' ' GLY . . . . . . . . . . . . . . . 97.48 -17.13 59.52 Favored Glycine 0 CA--C 1.533 1.179 0 C-N-CA 121.176 -0.535 . . . . 0.0 113.322 178.837 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' E' E ' 35' ' ' ASP . . . . . . . . . . . . . 77.1 m-20 -66.16 151.17 47.53 Favored 'General case' 0 C--O 1.231 0.087 0 CA-C-N 118.032 0.916 . . . . 0.0 111.057 179.838 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' E' E ' 36' ' ' VAL . . . . . . . . . . . . . 44.1 t -123.95 128.05 73.95 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.236 0 N-CA-C 109.678 -0.49 . . . . 0.0 109.678 177.038 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' E' E ' 37' ' ' ILE . . . . . . . . . . . . . 60.7 mt -120.78 137.5 54.31 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.26 0 CA-C-N 116.023 -0.535 . . . . 0.0 109.87 -179.473 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' E' E ' 38' ' ' GLY . . . . . . . . . . . . . . . -113.91 127.35 7.77 Favored Glycine 0 CA--C 1.526 0.748 0 N-CA-C 110.854 -0.898 . . . . 0.0 110.854 178.867 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' E' E ' 39' ' ' ILE . . . . . . . . . . . . . 72.7 mt -126.23 126.53 69.57 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.237 0 N-CA-C 110.005 -0.368 . . . . 0.0 110.005 179.451 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' E' E ' 40' ' ' SER . . . . . . . . . . . . . 80.2 p -93.33 123.1 36.38 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.398 -0.364 . . . . 0.0 111.052 176.423 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' E' E ' 41' ' ' ILE . . . . . . . . . . . . . 71.4 mt -137.3 127.97 39.38 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.215 0 CA-C-O 120.943 0.401 . . . . 0.0 110.21 177.11 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' E' E ' 42' ' ' LEU . . . . . . . . . . . . . 8.7 tp 58.47 35.15 24.5 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.045 -0.525 . . . . 0.0 111.522 179.257 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' E' E ' 43' ' ' GLY . . . . . . . . . . . . . . . 72.48 14.61 77.37 Favored Glycine 0 CA--C 1.535 1.285 0 C-N-CA 121.246 -0.502 . . . . 0.0 113.222 176.933 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' E' E ' 44' ' ' LYS . . . . . . . . . . . . . 72.0 mmtt -124.45 130.28 52.18 Favored 'General case' 0 N--CA 1.462 0.172 0 CA-C-N 117.89 0.845 . . . . 0.0 110.203 178.129 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' E' E ' 45' ' ' GLU . . . . . . . . . . . . . 79.1 tt0 -85.34 122.78 30.0 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 115.954 -0.567 . . . . 0.0 111.11 -179.812 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' E' E ' 46' ' ' VAL . . . . . 0.406 ' O ' HG13 ' E' ' 46' ' ' VAL . 10.9 p -118.82 123.0 70.79 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.197 0 N-CA-C 109.555 -0.535 . . . . 0.0 109.555 174.376 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' E' E ' 47' ' ' LYS . . . . . . . . . . . . . 68.1 mttm -99.33 126.93 45.28 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 115.984 -0.553 . . . . 0.0 111.014 179.114 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' E' E ' 48' ' ' PHE . . . . . . . . . . . . . 29.1 m-85 -111.09 131.82 54.77 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.116 -0.493 . . . . 0.0 109.944 177.446 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' E' E ' 49' ' ' LYS . . . . . . . . . . . . . 80.9 tttt -107.11 137.19 45.64 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.374 -0.376 . . . . 0.0 110.284 177.557 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' E' E ' 50' ' ' VAL . . . . . . . . . . . . . 42.9 t -74.15 106.72 4.19 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.345 0 N-CA-C 109.812 -0.44 . . . . 0.0 109.812 178.682 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' E' E ' 51' ' ' VAL . . . . . . . . . . . . . 46.1 t -70.75 -50.34 44.73 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.277 0 O-C-N 123.65 0.594 . . . . 0.0 109.704 -176.104 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' E' E ' 52' ' ' GLN . . . . . . . . . . . . . 56.3 tt0 -168.02 138.19 2.66 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 115.908 -0.587 . . . . 0.0 111.145 -179.19 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' E' E ' 53' ' ' ALA . . . . . . . . . . . . . . . -112.15 132.4 54.9 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 115.873 -0.603 . . . . 0.0 110.135 177.04 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' E' E ' 54' ' ' TYR . . . . . . . . . . . . . 22.9 t80 -127.97 107.22 20.1 Favored Pre-proline 0 CA--C 1.534 0.345 0 CA-C-O 118.285 -0.864 . . . . 0.0 110.364 179.778 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' E' E ' 55' ' ' PRO . . . . . . . . . . . . . 73.3 Cg_endo -77.06 170.05 72.7 Favored 'Cis proline' 0 N--CA 1.5 1.888 0 CA-C-N 121.682 1.637 . . . . 0.0 112.488 -5.286 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' E' E ' 56' ' ' SER . . . . . . . . . . . . . 70.5 m -115.54 129.93 24.73 Favored Pre-proline 0 CA--C 1.539 0.538 0 CA-C-O 118.427 -0.796 . . . . 0.0 109.35 175.391 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' E' E ' 57' ' ' PRO . . . . . . . . . . . . . 60.8 Cg_endo -74.34 150.61 95.81 Favored 'Cis proline' 0 N--CA 1.497 1.684 0 CA-C-N 121.952 1.733 . . . . 0.0 111.722 -0.31 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' E' E ' 58' ' ' LEU . . . . . . . . . . . . . 21.4 tp -109.02 138.11 45.88 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 116.299 -0.409 . . . . 0.0 110.85 -177.84 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' E' E ' 59' ' ' ARG . . . . . . . . . . . . . 78.0 ttt180 -101.75 125.88 48.5 Favored 'General case' 0 C--N 1.328 -0.339 0 N-CA-C 109.244 -0.65 . . . . 0.0 109.244 173.537 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' E' E ' 60' ' ' VAL . . . . . . . . . . . . . 46.8 t -77.81 114.64 18.6 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.308 0 C-N-CA 120.72 -0.392 . . . . 0.0 110.378 -176.88 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' E' E ' 61' ' ' GLU . . . . . . . . . . . . . 44.2 mt-10 -131.01 161.19 32.51 Favored 'General case' 0 C--N 1.332 -0.167 0 CA-C-N 115.933 -0.576 . . . . 0.0 110.012 177.663 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' E' E ' 62' ' ' ASP . . . . . . . . . . . . . 77.9 m-20 -54.4 -33.71 59.86 Favored 'General case' 0 C--N 1.328 -0.352 0 N-CA-C 112.088 0.403 . . . . 0.0 112.088 -175.798 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' E' E ' 63' ' ' ARG . . . . . . . . . . . . . 25.0 mmm180 -74.87 -17.21 60.62 Favored 'General case' 0 CA--C 1.535 0.391 0 N-CA-C 113.125 0.787 . . . . 0.0 113.125 -175.427 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' E' E ' 64' ' ' THR . . . . . . . . . . . . . 11.4 m -75.77 142.93 42.24 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-O 120.852 0.358 . . . . 0.0 110.865 -176.131 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' E' E ' 65' ' ' LYS . . . . . . . . . . . . . 95.6 mttt -89.63 139.76 30.23 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.111 -0.495 . . . . 0.0 110.531 179.938 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' E' E ' 66' ' ' ILE . . . . . . . . . . . . . 55.3 mt -113.81 133.37 59.99 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.287 0 N-CA-C 109.837 -0.431 . . . . 0.0 109.837 178.256 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' E' E ' 67' ' ' THR . . . . . . . . . . . . . 25.3 m -128.34 139.14 52.56 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-O 121.056 0.455 . . . . 0.0 111.166 -178.191 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' E' E ' 68' ' ' LEU . . . . . 0.489 HD12 ' N ' ' E' ' 68' ' ' LEU . 7.2 mp -100.31 124.46 45.8 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 115.826 -0.625 . . . . 0.0 109.853 176.411 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' E' E ' 69' ' ' VAL . . . . . . . . . . . . . 43.8 t -100.7 139.52 21.85 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.372 0 CA-C-N 116.118 -0.492 . . . . 0.0 110.409 -176.685 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' E' E ' 70' ' ' THR . . . . . . . . . . . . . 3.3 m -131.64 117.87 19.27 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.02 -0.536 . . . . 0.0 110.099 178.087 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' E' E ' 71' ' ' HIS . . . . . . . . . . . . . 2.1 m80 -96.5 160.01 30.54 Favored Pre-proline 0 C--N 1.327 -0.372 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.264 -179.21 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' E' E ' 72' ' ' PRO . . . . . . . . . . . . . 51.5 Cg_endo -69.73 -23.54 30.84 Favored 'Trans proline' 0 N--CA 1.497 1.691 0 C-N-CA 121.313 1.342 . . . . 0.0 112.822 -179.93 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' E' E ' 73' ' ' VAL . . . . . . . . . . . . . 34.7 m -118.28 147.44 21.75 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.172 0 CA-C-O 120.98 0.419 . . . . 0.0 110.616 -179.853 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' E' E ' 74' ' ' ASP . . . . . . . . . . . . . 9.7 t0 -104.33 120.39 41.09 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.025 -0.534 . . . . 0.0 109.822 179.104 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' E' E ' 75' ' ' VAL . . . . . . . . . . . . . 40.5 t -114.39 123.05 69.68 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.18 0 CA-C-O 121.055 0.455 . . . . 0.0 110.955 -175.4 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' E' E ' 76' ' ' LEU . . . . . . . . . . . . . 6.0 mp -123.34 146.71 47.72 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 115.657 -0.701 . . . . 0.0 109.591 175.632 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' E' E ' 77' ' ' GLU . . . . . . . . . . . . . 97.1 mt-10 -134.03 140.84 46.95 Favored 'General case' 0 N--CA 1.463 0.207 0 CA-C-O 121.167 0.508 . . . . 0.0 111.383 -178.418 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' E' E ' 78' ' ' ALA . . . . . . . . . . . . . . . -130.51 129.51 42.98 Favored 'General case' 0 C--N 1.332 -0.193 0 CA-C-N 115.684 -0.689 . . . . 0.0 109.751 175.849 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' E' E ' 79' ' ' LYS . . . . . 0.714 ' O ' HD13 ' E' ' 80' ' ' ILE . 37.3 mmtm -71.74 119.54 16.04 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-O 120.886 0.374 . . . . 0.0 110.981 -178.234 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' E' E ' 80' ' ' ILE . . . . . 0.714 HD13 ' O ' ' E' ' 79' ' ' LYS . 32.1 mm -139.31 99.91 1.32 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.259 0 N-CA-C 109.089 -0.708 . . . . 0.0 109.089 -178.213 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' E' E ' 81' ' ' LYS . . . . . . . . . . . . . 53.0 pttt -101.51 128.13 47.89 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-O 121.103 0.478 . . . . 0.0 111.31 -176.639 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' E' E ' 82' ' ' GLY . . . . . . . . . . . . . . . 89.21 41.95 5.7 Favored Glycine 0 CA--C 1.526 0.777 0 CA-C-N 115.799 -0.637 . . . . 0.0 111.66 177.2 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' E' E ' 83' ' ' ILE . . . . . . . . . . . . . 73.7 mt -68.94 144.66 13.95 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 CA-C-O 121.034 0.445 . . . . 0.0 110.234 179.078 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' E' E ' 84' ' ' LYS . . . . . . . . . . . . . 87.6 tttt -100.99 -51.77 3.46 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 115.792 -0.64 . . . . 0.0 109.993 -179.905 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' E' E ' 85' ' ' ASP . . . . . . . . . . . . . 7.9 t70 -160.44 154.69 23.33 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 115.597 -0.729 . . . . 0.0 110.057 179.459 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' E' E ' 86' ' ' VAL . . . . . . . . . . . . . 40.6 t -132.95 131.61 59.04 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.212 0 CA-C-O 121.06 0.457 . . . . 0.0 110.576 -178.588 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' E' E ' 87' ' ' ILE . . . . . . . . . . . . . 44.9 mm -119.45 128.23 75.86 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.208 0 CA-C-N 115.804 -0.634 . . . . 0.0 109.556 176.515 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' E' E ' 88' ' ' LEU . . . . . . . . . . . . . 84.2 mt -110.29 137.82 47.5 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-O 121.111 0.481 . . . . 0.0 111.499 -177.363 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' E' E ' 89' ' ' ASP . . . . . . . . . . . . . 10.9 t70 -127.07 153.23 46.24 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 115.502 -0.772 . . . . 0.0 109.074 174.436 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' E' E ' 90' ' ' GLU . . . . . . . . . . . . . 95.8 mt-10 -48.06 -36.91 13.9 Favored 'General case' 0 C--N 1.33 -0.244 0 N-CA-C 112.903 0.705 . . . . 0.0 112.903 -172.605 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' E' E ' 91' ' ' ASN . . . . . . . . . . . . . 27.6 m120 -132.06 32.03 4.08 Favored 'General case' 0 N--CA 1.465 0.277 0 N-CA-C 112.102 0.408 . . . . 0.0 112.102 -176.848 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' E' E ' 92' ' ' LEU . . . . . . . . . . . . . 8.1 tp -166.09 152.94 9.59 Favored 'General case' 0 C--N 1.33 -0.247 0 C-N-CA 120.897 -0.321 . . . . 0.0 110.81 -179.44 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' E' E ' 93' ' ' ILE . . . . . . . . . . . . . 73.0 mt -130.37 129.91 65.08 Favored 'Isoleucine or valine' 0 N--CA 1.462 0.166 0 N-CA-C 109.971 -0.381 . . . . 0.0 109.971 179.171 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' E' E ' 94' ' ' VAL . . . . . . . . . . . . . 44.7 t -122.56 125.0 71.97 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.246 0 N-CA-C 109.597 -0.52 . . . . 0.0 109.597 176.942 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' E' E ' 95' ' ' VAL . . . . . . . . . . . . . 43.5 t -120.66 134.52 63.82 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.295 0 CA-C-N 116.285 -0.416 . . . . 0.0 110.145 -177.929 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' E' E ' 96' ' ' ILE . . . . . . . . . . . . . 66.9 mt -115.83 129.4 72.25 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 N-CA-C 109.361 -0.607 . . . . 0.0 109.361 178.985 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' E' E ' 97' ' ' THR . . . . . . . . . . . . . 77.8 p -101.28 155.89 17.76 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-O 121.033 0.444 . . . . 0.0 111.111 -178.028 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' E' E ' 98' ' ' GLU . . . . . . . . . . . . . 12.8 pt-20 -54.05 -22.14 10.07 Favored 'General case' 0 CA--C 1.535 0.393 0 N-CA-C 112.613 0.598 . . . . 0.0 112.613 -179.256 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' E' E ' 99' ' ' GLU . . . . . . . . . . . . . 31.2 tt0 -83.38 18.15 1.9 Allowed 'General case' 0 CA--C 1.536 0.417 0 N-CA-C 112.79 0.663 . . . . 0.0 112.79 -177.333 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' E' E ' 100' ' ' ASN . . . . . . . . . . . . . 2.6 m-20 62.16 37.98 14.03 Favored 'General case' 0 CA--C 1.53 0.198 0 CA-C-O 121.011 0.434 . . . . 0.0 110.828 177.961 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' E' E ' 101' ' ' GLU . . . . . . . . . . . . . 81.4 tt0 -119.75 141.55 49.35 Favored 'General case' 0 C--N 1.332 -0.195 0 N-CA-C 109.765 -0.457 . . . . 0.0 109.765 177.684 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' E' E ' 102' ' ' VAL . . . . . . . . . . . . . 41.0 t -115.12 128.69 72.2 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.271 0 N-CA-C 110.216 -0.29 . . . . 0.0 110.216 -178.238 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' E' E ' 103' ' ' LEU . . . . . . . . . . . . . 7.0 mp -116.5 136.69 52.77 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 115.559 -0.746 . . . . 0.0 109.93 176.864 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' E' E ' 104' ' ' ILE . . . . . 0.498 HD12 ' HB3' ' E' ' 113' ' ' TYR . 68.2 mt -116.02 121.82 68.26 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.259 0 N-CA-C 109.766 -0.457 . . . . 0.0 109.766 179.742 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' E' E ' 105' ' ' PHE . . . . . . . . . . . . . 93.0 m-85 -123.33 165.76 16.44 Favored 'General case' 0 C--N 1.332 -0.163 0 O-C-N 124.281 0.988 . . . . 0.0 109.997 -177.713 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' E' E ' 106' ' ' ASN . . . . . . . . . . . . . 46.0 p-10 -104.0 -171.61 1.96 Allowed 'General case' 0 C--N 1.331 -0.197 0 N-CA-C 109.61 -0.515 . . . . 0.0 109.61 171.205 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' E' E ' 107' ' ' GLN . . . . . . . . . . . . . 25.4 tt0 -60.55 -24.37 65.35 Favored 'General case' 0 CA--C 1.534 0.35 0 N-CA-C 112.221 0.452 . . . . 0.0 112.221 179.831 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' E' E ' 108' ' ' ASN . . . . . . . . . . . . . 26.1 t30 -90.19 13.66 14.57 Favored 'General case' 0 CA--C 1.534 0.356 0 N-CA-C 112.978 0.733 . . . . 0.0 112.978 -178.609 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' E' E ' 109' ' ' LEU . . . . . . . . . . . . . 46.0 mt 56.73 35.24 25.91 Favored 'General case' 0 CA--C 1.53 0.206 0 CA-C-N 117.866 0.303 . . . . 0.0 111.557 177.511 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' E' E ' 110' ' ' GLU . . . . . . . . . . . . . 71.0 mm-40 -102.38 146.8 27.53 Favored 'General case' 0 C--N 1.33 -0.269 0 N-CA-C 109.906 -0.405 . . . . 0.0 109.906 176.926 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' E' E ' 111' ' ' GLU . . . . . . . . . . . . . 79.6 tt0 -82.29 124.73 30.23 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-O 120.953 0.406 . . . . 0.0 111.254 -175.993 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' E' E ' 112' ' ' LEU . . . . . . . . . . . . . 15.4 mt -108.38 -46.05 3.78 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 115.915 -0.584 . . . . 0.0 110.061 176.569 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' E' E ' 113' ' ' TYR . . . . . 0.498 ' HB3' HD12 ' E' ' 104' ' ' ILE . 48.3 t80 -142.55 145.06 33.22 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.169 -0.469 . . . . 0.0 111.317 -178.915 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' E' E ' 114' ' ' ARG . . . . . . . . . . . . . 55.1 ttp180 -151.02 125.26 9.38 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-O 121.065 0.459 . . . . 0.0 110.448 174.798 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' E' E ' 115' ' ' GLY . . . . . . . . . . . . . . . -150.13 155.65 26.34 Favored Glycine 0 CA--C 1.524 0.64 0 N-CA-C 110.67 -0.972 . . . . 0.0 110.67 178.374 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' E' E ' 116' ' ' LYS . . . . . . . . . . . . . 38.8 ttpt -114.9 140.29 49.1 Favored 'General case' 0 C--N 1.331 -0.197 0 O-C-N 122.593 -0.357 . . . . 0.0 110.338 179.14 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' E' E ' 117' ' ' PHE . . . . . . . . . . . . . 41.4 m-85 -133.95 114.59 13.43 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.2 -0.455 . . . . 0.0 110.17 -177.778 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' E' E ' 118' ' ' GLU . . . . . . . . . . . . . 70.8 mm-40 -51.28 -53.16 38.34 Favored 'General case' 0 C--N 1.33 -0.27 0 N-CA-C 111.837 0.31 . . . . 0.0 111.837 -175.925 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' E' E ' 119' ' ' ASN . . . . . . . . . . . . . 25.2 m120 -94.22 31.07 1.76 Allowed 'General case' 0 C--N 1.328 -0.334 0 N-CA-C 112.176 0.436 . . . . 0.0 112.176 -174.128 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' E' E ' 120' ' ' LEU . . . . . . . . . . . . . 12.9 tp -54.33 119.82 5.7 Favored 'General case' 0 N--CA 1.464 0.257 0 CA-C-O 120.749 0.309 . . . . 0.0 110.854 179.156 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' E' E ' 121' ' ' ASN . . . . . . . . . . . . . 88.8 m-20 -114.1 -44.03 3.18 Favored 'General case' 0 C--N 1.332 -0.176 0 CA-C-N 116.356 -0.384 . . . . 0.0 111.141 -178.036 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' E' E ' 122' ' ' LYS . . . . . . . . . . . . . 63.2 mtpt -140.63 148.61 41.14 Favored 'General case' 0 C--N 1.331 -0.211 0 CA-C-O 121.137 0.494 . . . . 0.0 111.682 -175.754 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' E' E ' 123' ' ' VAL . . . . . . . . . . . . . 43.5 t -131.27 126.45 58.81 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.261 0 CA-C-N 115.79 -0.641 . . . . 0.0 109.359 174.052 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' E' E ' 124' ' ' LEU . . . . . . . . . . . . . 41.1 mt -121.61 135.61 54.98 Favored 'General case' 0 C--N 1.331 -0.22 0 CA-C-N 116.496 -0.32 . . . . 0.0 110.565 -177.898 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' E' E ' 125' ' ' VAL . . . . . . . . . . . . . 11.6 p -134.0 129.26 54.11 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.277 0 CA-C-N 116.257 -0.429 . . . . 0.0 110.249 179.151 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' E' E ' 126' ' ' ARG . . . . . . . . . . . . . 52.1 mmm-85 -137.33 116.16 12.27 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.348 179.32 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' E' E ' 127' ' ' ASN . . . . . . . . . . . . . 7.1 m-80 52.65 -104.85 0.21 Allowed 'General case' 0 CA--C 1.543 0.689 0 CA-C-O 119.205 -0.426 . . . . 0.0 111.273 178.956 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' E' E ' 128' ' ' ASP . . . . . . . . . . . . . 10.9 p-10 -114.1 2.25 14.86 Favored 'General case' 0 N--CA 1.468 0.468 0 CA-C-N 119.48 1.036 . . . . 0.0 113.464 -176.458 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' E' E ' 129' ' ' LEU . . . . . . . . . . . . . 14.5 tp -105.36 135.1 47.36 Favored 'General case' 0 C--N 1.333 -0.146 0 CA-C-N 118.233 0.469 . . . . 0.0 110.012 179.018 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' E' E ' 130' ' ' VAL . . . . . . . . . . . . . 43.1 t -121.32 135.58 61.03 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.192 0 CA-C-O 120.897 0.379 . . . . 0.0 110.003 -178.288 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' E' E ' 131' ' ' VAL . . . . . . . . . . . . . 43.5 t -135.64 134.14 51.65 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.202 0 CA-C-O 120.991 0.424 . . . . 0.0 110.176 178.541 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' E' E ' 132' ' ' ILE . . . . . . . . . . . . . 71.5 mt -116.86 132.32 66.94 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.352 0 CA-C-N 115.713 -0.676 . . . . 0.0 109.357 179.748 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' E' E ' 133' ' ' ILE . . . . . . . . . . . . . 39.9 mm -116.0 119.26 61.37 Favored 'Isoleucine or valine' 0 C--O 1.234 0.25 0 CA-C-O 120.79 0.329 . . . . 0.0 111.029 -173.862 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' E' E ' 134' ' ' ASP . . . . . . . . . . . . . 10.4 p-10 -131.11 144.98 51.81 Favored 'General case' 0 C--N 1.332 -0.18 0 N-CA-C 109.454 -0.573 . . . . 0.0 109.454 174.584 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' E' E ' 135' ' ' GLU . . . . . . . . . . . . . 80.0 tt0 -49.8 -26.07 3.62 Favored 'General case' 0 C--N 1.328 -0.334 0 N-CA-C 112.95 0.722 . . . . 0.0 112.95 -171.656 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' E' E ' 136' ' ' GLN . . . . . . . . . . . . . 35.0 tt0 -80.9 -38.33 28.15 Favored 'General case' 0 C--O 1.234 0.256 0 N-CA-C 111.887 0.328 . . . . 0.0 111.887 -176.417 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' E' E ' 137' ' ' LYS . . . . . . . . . . . . . 15.3 pttp -162.02 171.56 17.37 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-O 121.602 0.715 . . . . 0.0 112.119 -172.423 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' E' E ' 138' ' ' LEU . . . . . 0.484 HD23 ' N ' ' E' ' 139' ' ' THR . 3.6 tt -114.07 126.51 55.19 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 114.864 -1.062 . . . . 0.0 109.744 179.171 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' E' E ' 139' ' ' THR . . . . . 0.484 ' N ' HD23 ' E' ' 138' ' ' LEU . 26.2 m -105.32 123.39 47.78 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.338 -0.392 . . . . 0.0 110.529 -179.858 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' E' E ' 140' ' ' LEU . . . . . 0.472 ' C ' HD23 ' E' ' 140' ' ' LEU . 7.6 tt -110.67 122.28 47.41 Favored 'General case' 0 C--N 1.327 -0.401 0 N-CA-C 109.251 -0.648 . . . . 0.0 109.251 -179.35 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' E' E ' 141' ' ' ILE . . . . . . . . . . . . . 19.7 mt -122.46 113.89 40.28 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.264 0 N-CA-C 109.786 -0.45 . . . . 0.0 109.786 -176.45 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' E' E ' 142' ' ' ARG . . . . . . . . . . . . . 67.8 ttp85 -103.05 129.7 49.94 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 115.416 -0.811 . . . . 0.0 110.831 -177.934 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' E' E ' 143' ' ' THR . . . . . . . . . . . . . 81.3 p . . . . . 0 C--O 1.22 -0.47 0 CA-C-O 117.873 -1.06 . . . . 0.0 110.834 179.463 . . . . . . . . 0 0 . 1 . 016 nuclear build full ' F' F ' -3' ' ' GLU . . . . . . . . . . . . . 95.6 mt-10 . . . . . 0 N--CA 1.491 1.587 0 N-CA-C 109.307 -0.627 . . . . 0.0 109.307 . . . . . . . . . 0 0 . 1 . 016 nuclear build full ' F' F ' -2' ' ' GLY . . . . . . . . . . . . . . . -62.71 131.29 43.52 Favored Glycine 0 CA--C 1.525 0.669 0 N-CA-C 111.222 -0.751 . . . . 0.0 111.222 -178.994 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' F' F ' -1' ' ' VAL . . . . . . . . . . . . . 44.7 t -96.54 140.75 16.7 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.27 0 N-CA-C 110.068 -0.345 . . . . 0.0 110.068 179.11 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' F' F ' 0' ' ' ILE . . . . . . . . . . . . . 67.3 mt -104.18 132.05 51.6 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.307 0 CA-C-N 116.261 -0.427 . . . . 0.0 109.982 -179.802 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' F' F ' 1' ' ' MET . . . . . . . . . . . . . 23.5 ptp -85.48 143.6 28.45 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.14 -0.482 . . . . 0.0 110.685 179.763 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' F' F ' 2' ' ' SER . . . . . . . . . . . . . 6.8 p -114.45 132.55 56.22 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.252 -0.431 . . . . 0.0 110.723 -179.566 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' F' F ' 3' ' ' GLU . . . . . . . . . . . . . 81.8 tt0 -141.35 141.06 33.87 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 115.963 -0.562 . . . . 0.0 111.032 -179.07 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' F' F ' 4' ' ' LEU . . . . . . . . . . . . . 15.2 tp -125.58 132.02 52.61 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.049 -0.523 . . . . 0.0 110.01 176.618 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' F' F ' 5' ' ' LYS . . . . . . . . . . . . . 65.1 mttm -111.61 120.18 41.21 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.249 -0.432 . . . . 0.0 110.606 -179.673 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' F' F ' 6' ' ' LEU . . . . . . . . . . . . . 67.1 mt -114.35 150.34 34.72 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 115.477 -0.783 . . . . 0.0 110.279 -178.609 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' F' F ' 7' ' ' LYS . . . . . . . . . . . . . 40.9 tttp -137.65 139.72 27.8 Favored Pre-proline 0 CA--C 1.534 0.353 0 CA-C-O 119.048 -0.501 . . . . 0.0 110.145 176.758 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' F' F ' 8' ' ' PRO . . . . . . . . . . . . . 94.0 Cg_endo -90.21 139.92 3.13 Favored 'Trans proline' 0 N--CA 1.489 1.263 0 C-N-CA 121.746 1.63 . . . . 0.0 111.662 177.575 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' F' F ' 9' ' ' LEU . . . . . . . . . . . . . 46.8 mt -78.7 -47.64 1.81 Allowed Pre-proline 0 CA--C 1.533 0.3 0 CA-C-O 118.652 -0.689 . . . . 0.0 112.181 -178.963 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' F' F ' 10' ' ' PRO . . . . . . . . . . . . . 92.1 Cg_endo -79.47 150.18 21.9 Favored 'Trans proline' 0 N--CA 1.496 1.647 0 C-N-CA 121.139 1.226 . . . . 0.0 111.766 175.95 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' F' F ' 11' ' ' LYS . . . . . . . . . . . . . 82.9 tttt -86.31 101.43 13.07 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.295 -0.411 . . . . 0.0 110.371 179.256 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' F' F ' 12' ' ' VAL . . . . . . . . . . . . . 12.5 p -146.64 149.84 15.55 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.255 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.76 -178.526 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' F' F ' 13' ' ' GLU . . . . . . . . . . . . . 70.7 mm-40 -79.87 126.64 31.25 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.152 -0.477 . . . . 0.0 110.098 177.112 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' F' F ' 14' ' ' LEU . . . . . . . . . . . . . 37.8 mt -97.53 144.48 28.03 Favored Pre-proline 0 CA--C 1.533 0.291 0 CA-C-O 119.012 -0.518 . . . . 0.0 110.038 179.464 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' F' F ' 15' ' ' PRO . . . . . . . . . . . . . 25.7 Cg_exo -62.01 153.97 65.23 Favored 'Trans proline' 0 N--CA 1.497 1.72 0 C-N-CA 121.204 1.27 . . . . 0.0 111.442 177.133 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' F' F ' 16' ' ' PRO . . . . . . . . . . . . . 31.2 Cg_exo -57.2 -38.84 94.14 Favored 'Trans proline' 0 N--CA 1.497 1.715 0 C-N-CA 121.412 1.408 . . . . 0.0 112.856 -179.244 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' F' F ' 17' ' ' ASP . . . . . . . . . . . . . 21.7 p-10 -85.98 9.63 16.45 Favored 'General case' 0 CA--C 1.537 0.444 0 N-CA-C 113.319 0.859 . . . . 0.0 113.319 -177.138 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' F' F ' 18' ' ' PHE . . . . . . . . . . . . . 43.3 t80 -58.47 -48.51 80.51 Favored 'General case' 0 N--CA 1.457 -0.109 0 O-C-N 121.971 -0.455 . . . . 0.0 110.153 -177.239 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' F' F ' 19' ' ' VAL . . . . . . . . . . . . . 14.0 p -54.46 -41.36 53.58 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.256 0 CA-C-N 116.378 -0.374 . . . . 0.0 111.284 -177.611 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' F' F ' 20' ' ' ASP . . . . . . . . . . . . . 73.3 m-20 -60.87 -45.95 92.52 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-O 120.823 0.344 . . . . 0.0 111.039 -177.806 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' F' F ' 21' ' ' VAL . . . . . . . . . . . . . 46.4 t -64.34 -46.92 91.71 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 C-N-CA 120.76 -0.376 . . . . 0.0 110.573 -177.103 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' F' F ' 22' ' ' ILE . . . . . 0.488 HG22 HD12 ' F' ' 26' ' ' LEU . 49.1 mm -56.21 -46.72 81.39 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.221 0 C-N-CA 120.917 -0.313 . . . . 0.0 110.647 179.347 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' F' F ' 23' ' ' ARG . . . . . . . . . . . . . 50.9 ttp180 -53.51 -48.42 69.02 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-O 120.639 0.257 . . . . 0.0 111.468 -178.477 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' F' F ' 24' ' ' ILE . . . . . . . . . . . . . 73.1 mt -59.58 -43.38 90.84 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.337 0 C-N-CA 121.072 -0.251 . . . . 0.0 111.05 -178.984 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' F' F ' 25' ' ' LYS . . . . . . . . . . . . . 53.5 mtmt -64.61 -39.1 93.11 Favored 'General case' 0 C--N 1.329 -0.307 0 N-CA-C 112.255 0.465 . . . . 0.0 112.255 -178.409 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' F' F ' 26' ' ' LEU . . . . . 0.488 HD12 HG22 ' F' ' 22' ' ' ILE . 63.3 mt -79.8 -40.59 28.27 Favored 'General case' 0 C--N 1.329 -0.298 0 N-CA-C 113.501 0.926 . . . . 0.0 113.501 -170.591 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' F' F ' 27' ' ' GLN . . . . . . . . . . . . . 18.2 pt20 -46.38 138.4 5.66 Favored 'General case' 0 N--CA 1.469 0.506 0 N-CA-C 112.995 0.739 . . . . 0.0 112.995 -173.821 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' F' F ' 28' ' ' GLY . . . . . . . . . . . . . . . 100.92 -26.88 23.05 Favored Glycine 0 CA--C 1.533 1.201 0 CA-C-N 115.611 -0.722 . . . . 0.0 112.185 -177.379 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' F' F ' 29' ' ' LYS . . . . . . . . . . . . . 83.1 mttt -97.98 155.12 17.25 Favored 'General case' 0 C--O 1.233 0.187 0 CA-C-N 117.329 0.564 . . . . 0.0 111.227 179.6 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' F' F ' 30' ' ' THR . . . . . . . . . . . . . 40.9 m -101.19 140.54 35.34 Favored 'General case' 0 C--N 1.33 -0.239 0 CA-C-N 116.01 -0.541 . . . . 0.0 110.375 177.755 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' F' F ' 31' ' ' VAL . . . . . . . . . . . . . 35.4 m -129.79 152.97 38.14 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.164 0 CA-C-N 116.313 -0.403 . . . . 0.0 110.327 178.673 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' F' F ' 32' ' ' ARG . . . . . . . . . . . . . 50.1 ttt180 -132.04 149.08 52.51 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-O 121.185 0.517 . . . . 0.0 110.277 178.529 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' F' F ' 33' ' ' THR . . . . . . . . . . . . . 19.5 m -52.46 137.63 29.34 Favored 'General case' 0 C--N 1.331 -0.212 0 CA-C-N 116.369 -0.378 . . . . 0.0 111.44 -178.218 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' F' F ' 34' ' ' GLY . . . . . . . . . . . . . . . 100.51 -17.15 57.11 Favored Glycine 0 CA--C 1.534 1.238 0 C-N-CA 121.172 -0.537 . . . . 0.0 113.188 179.532 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' F' F ' 35' ' ' ASP . . . . . . . . . . . . . 52.2 m-20 -64.54 151.04 45.59 Favored 'General case' 0 C--N 1.333 -0.115 0 CA-C-N 118.034 0.917 . . . . 0.0 111.19 -179.817 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' F' F ' 36' ' ' VAL . . . . . . . . . . . . . 44.7 t -127.85 130.92 70.12 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.199 0 CA-C-N 115.815 -0.629 . . . . 0.0 109.858 178.685 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' F' F ' 37' ' ' ILE . . . . . . . . . . . . . 66.0 mt -124.37 142.76 40.1 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.231 0 CA-C-N 116.282 -0.417 . . . . 0.0 110.033 -178.73 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' F' F ' 38' ' ' GLY . . . . . . . . . . . . . . . -111.98 128.84 8.77 Favored Glycine 0 CA--C 1.526 0.75 0 N-CA-C 111.036 -0.826 . . . . 0.0 111.036 179.133 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' F' F ' 39' ' ' ILE . . . . . . . . . . . . . 76.2 mt -125.14 135.68 63.26 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.224 0 N-CA-C 110.107 -0.331 . . . . 0.0 110.107 179.469 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' F' F ' 40' ' ' SER . . . . . . . . . . . . . 60.0 p -92.86 116.41 29.01 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.307 -0.406 . . . . 0.0 111.046 176.431 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' F' F ' 41' ' ' ILE . . . . . . . . . . . . . 44.5 mm -121.54 121.52 64.76 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.205 0 CA-C-O 120.86 0.362 . . . . 0.0 110.235 178.865 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' F' F ' 42' ' ' LEU . . . . . . . . . . . . . 60.3 mt 52.28 34.69 15.24 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.166 -0.47 . . . . 0.0 111.819 176.961 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' F' F ' 43' ' ' GLY . . . . . . . . . . . . . . . 72.98 32.56 60.61 Favored Glycine 0 CA--C 1.529 0.939 0 C-N-CA 121.047 -0.597 . . . . 0.0 112.064 177.869 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' F' F ' 44' ' ' LYS . . . . . . . . . . . . . 28.0 ttpp -139.92 132.96 29.51 Favored 'General case' 0 C--N 1.329 -0.322 0 N-CA-C 109.635 -0.506 . . . . 0.0 109.635 177.657 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' F' F ' 45' ' ' GLU . . . . . . . . . . . . . 79.5 tt0 -82.25 121.11 26.23 Favored 'General case' 0 C--N 1.328 -0.326 0 C-N-CA 120.928 -0.309 . . . . 0.0 111.134 -177.025 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' F' F ' 46' ' ' VAL . . . . . . . . . . . . . 7.5 p -120.88 127.03 75.89 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.254 0 N-CA-C 109.454 -0.572 . . . . 0.0 109.454 175.384 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' F' F ' 47' ' ' LYS . . . . . . . . . . . . . 69.0 mttm -100.02 129.93 46.13 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 115.96 -0.564 . . . . 0.0 111.159 179.338 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' F' F ' 48' ' ' PHE . . . . . . . . . . . . . 92.0 m-85 -113.18 131.81 55.73 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.233 -0.439 . . . . 0.0 110.002 177.489 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' F' F ' 49' ' ' LYS . . . . . . . . . . . . . 76.5 tttt -109.52 139.33 44.64 Favored 'General case' 0 C--N 1.331 -0.205 0 CA-C-N 116.409 -0.359 . . . . 0.0 110.581 178.839 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' F' F ' 50' ' ' VAL . . . . . . . . . . . . . 43.6 t -82.59 108.85 15.87 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.212 0 N-CA-C 109.528 -0.545 . . . . 0.0 109.528 176.251 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' F' F ' 51' ' ' VAL . . . . . . . . . . . . . 46.9 t -71.64 -53.68 19.74 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.338 0 CA-C-N 115.91 -0.586 . . . . 0.0 109.536 -175.316 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' F' F ' 52' ' ' GLN . . . . . . . . . . . . . 85.2 mt-30 -154.63 152.55 30.12 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-O 121.114 0.483 . . . . 0.0 111.481 -177.31 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' F' F ' 53' ' ' ALA . . . . . . . . . . . . . . . -129.79 133.3 46.89 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 115.496 -0.774 . . . . 0.0 109.858 175.156 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' F' F ' 54' ' ' TYR . . . . . . . . . . . . . 29.7 t80 -129.08 107.91 18.0 Favored Pre-proline 0 C--N 1.328 -0.331 0 CA-C-O 118.27 -0.871 . . . . 0.0 110.211 179.218 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' F' F ' 55' ' ' PRO . . . . . . . . . . . . . 73.9 Cg_endo -77.2 170.07 72.48 Favored 'Cis proline' 0 N--CA 1.501 1.916 0 CA-C-N 121.881 1.707 . . . . 0.0 112.549 -4.245 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' F' F ' 56' ' ' SER . . . . . . . . . . . . . 60.6 m -117.2 130.74 24.42 Favored Pre-proline 0 CA--C 1.538 0.495 0 CA-C-O 118.413 -0.803 . . . . 0.0 109.602 175.494 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' F' F ' 57' ' ' PRO . . . . . . . . . . . . . 31.3 Cg_endo -65.06 167.32 46.71 Favored 'Cis proline' 0 N--CA 1.498 1.749 0 CA-C-N 121.953 1.733 . . . . 0.0 111.542 -2.848 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' F' F ' 58' ' ' LEU . . . . . . . . . . . . . 18.2 tp -130.77 139.06 50.21 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.081 -0.509 . . . . 0.0 110.203 -179.81 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' F' F ' 59' ' ' ARG . . . . . . . . . . . . . 41.4 ttm180 -101.77 134.35 45.08 Favored 'General case' 0 C--N 1.326 -0.445 0 N-CA-C 109.276 -0.638 . . . . 0.0 109.276 174.523 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' F' F ' 60' ' ' VAL . . . . . . . . . . . . . 42.2 t -84.53 119.29 33.21 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.299 0 C-N-CA 120.569 -0.452 . . . . 0.0 110.161 -178.631 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' F' F ' 61' ' ' GLU . . . . . . . . . . . . . 70.5 tt0 -131.14 155.57 46.77 Favored 'General case' 0 C--N 1.327 -0.373 0 N-CA-C 109.094 -0.706 . . . . 0.0 109.094 176.276 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' F' F ' 62' ' ' ASP . . . . . . . . . . . . . 10.4 p-10 -52.49 -29.78 26.68 Favored 'General case' 0 C--N 1.326 -0.438 0 N-CA-C 112.064 0.394 . . . . 0.0 112.064 -177.72 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' F' F ' 63' ' ' ARG . . . . . . . . . . . . . 84.5 mtt-85 -75.5 -21.97 57.57 Favored 'General case' 0 CA--C 1.532 0.26 0 N-CA-C 113.092 0.775 . . . . 0.0 113.092 -175.902 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' F' F ' 64' ' ' THR . . . . . . . . . . . . . 31.5 m -67.07 146.47 54.28 Favored 'General case' 0 C--N 1.331 -0.227 0 CA-C-O 120.903 0.382 . . . . 0.0 111.195 -174.148 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' F' F ' 65' ' ' LYS . . . . . . . . . . . . . 68.3 mttm -88.63 127.65 35.57 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 115.954 -0.566 . . . . 0.0 110.036 177.691 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' F' F ' 66' ' ' ILE . . . . . . . . . . . . . 60.6 mt -115.02 127.43 72.58 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.322 0 N-CA-C 109.637 -0.505 . . . . 0.0 109.637 179.343 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' F' F ' 67' ' ' THR . . . . . . . . . . . . . 26.0 m -124.73 143.54 50.71 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-O 121.166 0.508 . . . . 0.0 111.357 -176.435 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' F' F ' 68' ' ' LEU . . . . . 0.474 HD23 ' C ' ' F' ' 68' ' ' LEU . 6.3 tt -96.45 121.72 38.57 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 115.557 -0.747 . . . . 0.0 109.525 175.473 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' F' F ' 69' ' ' VAL . . . . . . . . . . . . . 42.2 t -99.14 133.96 39.92 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.291 0 CA-C-O 120.89 0.376 . . . . 0.0 110.177 -177.668 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' F' F ' 70' ' ' THR . . . . . . . . . . . . . 24.2 m -131.52 134.4 46.08 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.01 -0.541 . . . . 0.0 110.474 -179.618 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' F' F ' 71' ' ' HIS . . . . . . . . . . . . . 10.5 m80 -131.31 164.12 44.62 Favored Pre-proline 0 C--N 1.33 -0.259 0 CA-C-N 116.006 -0.543 . . . . 0.0 109.864 179.794 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' F' F ' 72' ' ' PRO . . . . . . . . . . . . . 29.9 Cg_endo -65.05 -28.46 57.28 Favored 'Trans proline' 0 N--CA 1.495 1.582 0 C-N-CA 121.177 1.251 . . . . 0.0 112.257 179.212 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' F' F ' 73' ' ' VAL . . . . . . . . . . . . . 33.5 m -135.51 158.3 40.01 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.234 0 CA-C-O 121.044 0.449 . . . . 0.0 110.929 178.624 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' F' F ' 74' ' ' ASP . . . . . . . . . . . . . 12.9 t70 -98.75 118.35 35.29 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 115.697 -0.683 . . . . 0.0 109.463 176.505 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' F' F ' 75' ' ' VAL . . . . . . . . . . . . . 38.5 t -111.5 125.44 68.81 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.298 0 CA-C-O 121.083 0.468 . . . . 0.0 110.619 -176.351 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' F' F ' 76' ' ' LEU . . . . . . . . . . . . . 21.1 mt -129.5 147.98 51.36 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 115.575 -0.739 . . . . 0.0 109.765 178.793 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' F' F ' 77' ' ' GLU . . . . . . . . . . . . . 43.9 mp0 -135.57 136.49 41.16 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-O 120.981 0.419 . . . . 0.0 111.01 -179.301 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' F' F ' 78' ' ' ALA . . . . . 0.722 ' HB2' HD21 ' F' ' 109' ' ' LEU . . . -123.12 135.25 54.28 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 115.701 -0.681 . . . . 0.0 109.935 176.903 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' F' F ' 79' ' ' LYS . . . . . 0.724 ' O ' HD13 ' F' ' 80' ' ' ILE . 99.0 mttt -74.93 120.25 20.22 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-O 120.85 0.357 . . . . 0.0 110.801 -177.565 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' F' F ' 80' ' ' ILE . . . . . 0.724 HD13 ' O ' ' F' ' 79' ' ' LYS . 31.6 mm -139.19 104.6 2.23 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.241 0 N-CA-C 108.956 -0.757 . . . . 0.0 108.956 -178.635 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' F' F ' 81' ' ' LYS . . . . . . . . . . . . . 60.4 tttm -99.11 121.55 41.15 Favored 'General case' 0 C--N 1.327 -0.403 0 CA-C-O 120.881 0.372 . . . . 0.0 111.318 -175.47 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' F' F ' 82' ' ' GLY . . . . . . . . . . . . . . . 89.17 42.17 5.65 Favored Glycine 0 CA--C 1.525 0.681 0 C-N-CA 121.026 -0.607 . . . . 0.0 111.99 174.705 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' F' F ' 83' ' ' ILE . . . . . . . . . . . . . 71.7 mt -66.3 137.38 24.99 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.314 0 N-CA-C 109.65 -0.5 . . . . 0.0 109.65 175.909 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' F' F ' 84' ' ' LYS . . . . . . . . . . . . . 24.1 ttpp -102.38 -50.6 3.56 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-O 120.863 0.363 . . . . 0.0 110.464 -179.758 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' F' F ' 85' ' ' ASP . . . . . . . . . . . . . 8.6 t70 -149.41 151.33 33.86 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 115.976 -0.556 . . . . 0.0 110.648 -179.59 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' F' F ' 86' ' ' VAL . . . . . . . . . . . . . 44.0 t -131.34 132.84 62.76 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.248 0 CA-C-O 120.895 0.379 . . . . 0.0 110.547 -178.645 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' F' F ' 87' ' ' ILE . . . . . 0.497 HD12 ' N ' ' F' ' 87' ' ' ILE . 5.1 mp -121.94 129.93 75.01 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.289 0 N-CA-C 109.364 -0.606 . . . . 0.0 109.364 176.315 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' F' F ' 88' ' ' LEU . . . . . . . . . . . . . 13.9 tp -115.29 134.58 55.0 Favored 'General case' 0 C--N 1.332 -0.182 0 CA-C-O 121.182 0.515 . . . . 0.0 111.693 -175.366 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' F' F ' 89' ' ' ASP . . . . . . . . . . . . . 7.4 t0 -126.53 148.9 49.66 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 115.465 -0.788 . . . . 0.0 109.0 174.067 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' F' F ' 90' ' ' GLU . . . . . . . . . . . . . 93.5 mt-10 -49.38 -34.08 15.28 Favored 'General case' 0 C--N 1.329 -0.286 0 N-CA-C 112.625 0.602 . . . . 0.0 112.625 -173.769 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' F' F ' 91' ' ' ASN . . . . . . . . . . . . . 21.9 m120 -128.05 30.32 5.26 Favored 'General case' 0 N--CA 1.465 0.323 0 N-CA-C 112.187 0.44 . . . . 0.0 112.187 -176.974 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' F' F ' 92' ' ' LEU . . . . . . . . . . . . . 13.4 tp -166.19 147.57 6.68 Favored 'General case' 0 C--N 1.332 -0.179 0 CA-C-O 120.609 0.242 . . . . 0.0 110.52 -179.993 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' F' F ' 93' ' ' ILE . . . . . . . . . . . . . 70.4 mt -128.83 123.39 59.02 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.254 0 N-CA-C 109.541 -0.54 . . . . 0.0 109.541 179.416 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' F' F ' 94' ' ' VAL . . . . . 0.541 HG21 HG11 ' F' ' 125' ' ' VAL . 44.0 t -122.05 129.21 75.57 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.253 0 CA-C-O 120.884 0.373 . . . . 0.0 110.137 -179.424 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' F' F ' 95' ' ' VAL . . . . . . . . . . . . . 43.9 t -124.63 136.1 61.76 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.275 0 CA-C-N 116.04 -0.527 . . . . 0.0 110.054 -179.452 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' F' F ' 96' ' ' ILE . . . . . . . . . . . . . 59.6 mt -116.05 128.48 73.33 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.274 0 N-CA-C 109.255 -0.646 . . . . 0.0 109.255 178.783 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' F' F ' 97' ' ' THR . . . . . . . . . . . . . 82.6 p -102.89 156.63 17.53 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-O 121.156 0.503 . . . . 0.0 111.559 -175.845 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' F' F ' 98' ' ' GLU . . . . . . . . . . . . . 45.0 mt-10 -53.93 -26.04 23.39 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 116.099 -0.5 . . . . 0.0 112.179 179.395 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' F' F ' 99' ' ' GLU . . . . . . . . . . . . . 71.2 mm-40 -79.36 16.32 1.04 Allowed 'General case' 0 CA--C 1.535 0.377 0 N-CA-C 113.158 0.799 . . . . 0.0 113.158 -176.973 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' F' F ' 100' ' ' ASN . . . . . . . . . . . . . 2.1 m-20 62.11 32.78 17.35 Favored 'General case' 0 CA--C 1.531 0.232 0 CA-C-N 117.996 0.362 . . . . 0.0 111.555 178.412 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' F' F ' 101' ' ' GLU . . . . . . . . . . . . . 84.1 tt0 -112.56 144.71 41.59 Favored 'General case' 0 C--O 1.232 0.164 0 N-CA-C 109.735 -0.469 . . . . 0.0 109.735 175.412 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' F' F ' 102' ' ' VAL . . . . . . . . . . . . . 46.5 t -117.21 127.19 74.8 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.367 0 N-CA-C 109.67 -0.493 . . . . 0.0 109.67 -179.087 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' F' F ' 103' ' ' LEU . . . . . . . . . . . . . 27.9 mt -118.99 133.69 55.66 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 115.919 -0.582 . . . . 0.0 110.275 179.561 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' F' F ' 104' ' ' ILE . . . . . . . . . . . . . 70.5 mt -120.2 121.94 67.04 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.205 0 CA-C-N 116.469 -0.332 . . . . 0.0 110.295 -179.791 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' F' F ' 105' ' ' PHE . . . . . . . . . . . . . 81.4 m-85 -120.17 164.03 16.84 Favored 'General case' 0 C--N 1.332 -0.194 0 O-C-N 124.043 0.84 . . . . 0.0 109.681 179.504 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' F' F ' 106' ' ' ASN . . . . . . . . . . . . . 38.8 p-10 -97.41 -171.75 2.27 Favored 'General case' 0 C--N 1.331 -0.216 0 N-CA-C 109.957 -0.386 . . . . 0.0 109.957 174.091 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' F' F ' 107' ' ' GLN . . . . . . . . . . . . . 29.5 tt0 -60.01 -30.07 68.9 Favored 'General case' 0 C--N 1.33 -0.263 0 N-CA-C 111.986 0.365 . . . . 0.0 111.986 179.73 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' F' F ' 108' ' ' ASN . . . . . . . . . . . . . 44.6 t30 -82.71 6.04 19.3 Favored 'General case' 0 CA--C 1.536 0.433 0 N-CA-C 113.246 0.832 . . . . 0.0 113.246 -177.354 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' F' F ' 109' ' ' LEU . . . . . 0.722 HD21 ' HB2' ' F' ' 78' ' ' ALA . 12.6 tp 63.13 40.84 8.61 Favored 'General case' 0 C--O 1.233 0.189 0 CA-C-O 121.229 0.537 . . . . 0.0 111.091 178.107 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' F' F ' 110' ' ' GLU . . . . . . . . . . . . . 43.8 mt-10 -111.67 150.68 29.82 Favored 'General case' 0 C--N 1.33 -0.271 0 N-CA-C 109.814 -0.439 . . . . 0.0 109.814 174.639 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' F' F ' 111' ' ' GLU . . . . . . . . . . . . . 62.8 tt0 -84.75 121.98 28.46 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.389 -0.369 . . . . 0.0 110.956 -176.292 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' F' F ' 112' ' ' LEU . . . . . . . . . . . . . 57.7 mt -109.83 -46.02 3.55 Favored 'General case' 0 C--N 1.333 -0.144 0 CA-C-N 116.277 -0.419 . . . . 0.0 110.796 179.771 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' F' F ' 113' ' ' TYR . . . . . 0.415 ' HE2' HG21 ' A' ' 75' ' ' VAL . 61.0 t80 -132.99 140.56 47.83 Favored 'General case' 0 N--CA 1.464 0.271 0 CA-C-O 120.852 0.358 . . . . 0.0 110.745 -179.551 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' F' F ' 114' ' ' ARG . . . . . . . . . . . . . 36.0 ptt180 -143.99 123.46 13.17 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 115.848 -0.615 . . . . 0.0 110.347 178.384 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' F' F ' 115' ' ' GLY . . . . . . . . . . . . . . . -150.13 160.82 28.69 Favored Glycine 0 CA--C 1.525 0.661 0 N-CA-C 111.196 -0.762 . . . . 0.0 111.196 179.58 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' F' F ' 116' ' ' LYS . . . . . . . . . . . . . 76.8 tttt -130.5 140.6 50.51 Favored 'General case' 0 C--N 1.329 -0.287 0 N-CA-C 109.846 -0.428 . . . . 0.0 109.846 177.597 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' F' F ' 117' ' ' PHE . . . . . . . . . . . . . 30.8 m-85 -139.28 114.02 9.26 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.11 -0.495 . . . . 0.0 109.975 -177.222 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' F' F ' 118' ' ' GLU . . . . . . . . . . . . . 44.9 tp10 -52.05 -45.81 64.86 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.534 -0.303 . . . . 0.0 111.565 -176.927 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' F' F ' 119' ' ' ASN . . . . . . . . . . . . . 86.4 m-20 -98.52 31.14 2.96 Favored 'General case' 0 C--N 1.329 -0.299 0 N-CA-C 112.185 0.439 . . . . 0.0 112.185 -174.608 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' F' F ' 120' ' ' LEU . . . . . . . . . . . . . 17.5 tp -55.33 120.12 6.61 Favored 'General case' 0 N--CA 1.462 0.146 0 O-C-N 122.266 -0.271 . . . . 0.0 110.608 178.067 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' F' F ' 121' ' ' ASN . . . . . . . . . . . . . 89.1 m-20 -112.49 -44.09 3.41 Favored 'General case' 0 C--O 1.232 0.167 0 CA-C-N 116.579 -0.282 . . . . 0.0 111.219 -176.491 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' F' F ' 122' ' ' LYS . . . . . . . . . . . . . 92.4 mttt -146.68 150.24 35.02 Favored 'General case' 0 C--N 1.333 -0.138 0 C-N-CA 120.389 -0.524 . . . . 0.0 111.978 -177.862 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' F' F ' 123' ' ' VAL . . . . . . . . . . . . . 46.1 t -125.62 126.05 69.63 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.224 0 CA-C-N 115.726 -0.67 . . . . 0.0 109.53 175.471 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' F' F ' 124' ' ' LEU . . . . . . . . . . . . . 48.3 mt -115.97 132.99 56.49 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.399 -0.364 . . . . 0.0 110.363 -178.685 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' F' F ' 125' ' ' VAL . . . . . 0.541 HG11 HG21 ' F' ' 94' ' ' VAL . 34.9 m -131.73 137.1 55.83 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.211 0 CA-C-O 120.868 0.366 . . . . 0.0 111.074 -177.902 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' F' F ' 126' ' ' ARG . . . . . . . . . . . . . 96.7 mtt-85 -145.43 111.37 5.55 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.151 -0.477 . . . . 0.0 110.575 176.179 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' F' F ' 127' ' ' ASN . . . . . . . . . . . . . 6.2 m120 53.29 -104.91 0.22 Allowed 'General case' 0 CA--C 1.542 0.651 0 CA-C-O 119.07 -0.49 . . . . 0.0 111.193 178.869 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' F' F ' 128' ' ' ASP . . . . . . . . . . . . . 13.3 p-10 -113.66 3.22 15.53 Favored 'General case' 0 N--CA 1.469 0.495 0 CA-C-N 119.454 1.025 . . . . 0.0 113.378 -176.239 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' F' F ' 129' ' ' LEU . . . . . . . . . . . . . 17.2 tp -106.82 139.66 40.89 Favored 'General case' 0 C--N 1.334 -0.104 0 N-CA-C 109.787 -0.449 . . . . 0.0 109.787 177.853 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' F' F ' 130' ' ' VAL . . . . . . . . . . . . . 41.8 t -129.36 139.79 50.85 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.231 0 CA-C-O 121.064 0.459 . . . . 0.0 110.339 -177.565 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' F' F ' 131' ' ' VAL . . . . . . . . . . . . . 44.6 t -136.1 135.61 50.01 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.319 0 CA-C-N 116.015 -0.539 . . . . 0.0 109.838 176.915 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' F' F ' 132' ' ' ILE . . . . . . . . . . . . . 71.3 mt -117.57 134.05 62.4 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.292 0 CA-C-N 116.141 -0.481 . . . . 0.0 109.709 -178.681 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' F' F ' 133' ' ' ILE . . . . . . . . . . . . . 43.0 mm -115.3 123.24 70.67 Favored 'Isoleucine or valine' 0 C--O 1.233 0.217 0 CA-C-N 116.277 -0.42 . . . . 0.0 111.003 -175.054 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' F' F ' 134' ' ' ASP . . . . . . . . . . . . . 8.1 p-10 -134.87 145.48 48.32 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 115.892 -0.595 . . . . 0.0 109.505 173.952 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' F' F ' 135' ' ' GLU . . . . . . . . . . . . . 40.1 tp10 -49.9 -24.83 2.72 Favored 'General case' 0 CA--C 1.534 0.346 0 N-CA-C 112.737 0.643 . . . . 0.0 112.737 -173.901 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' F' F ' 136' ' ' GLN . . . . . . . . . . . . . 60.1 tt0 -81.91 -36.76 27.74 Favored 'General case' 0 C--O 1.234 0.243 0 N-CA-C 111.859 0.318 . . . . 0.0 111.859 -176.533 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' F' F ' 137' ' ' LYS . . . . . . . . . . . . . 20.0 pttp -168.18 175.36 6.59 Favored 'General case' 0 C--N 1.331 -0.201 0 CA-C-O 121.503 0.668 . . . . 0.0 111.984 -173.0 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' F' F ' 138' ' ' LEU . . . . . 0.418 HD23 ' C ' ' F' ' 138' ' ' LEU . 7.3 tt -118.94 129.79 55.36 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 115.107 -0.951 . . . . 0.0 110.15 179.563 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' F' F ' 139' ' ' THR . . . . . . . . . . . . . 37.7 m -110.39 130.02 55.64 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.104 -0.498 . . . . 0.0 110.508 -179.984 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' F' F ' 140' ' ' LEU . . . . . 0.446 HD23 ' N ' ' F' ' 141' ' ' ILE . 5.2 tt -115.38 123.98 50.04 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 115.855 -0.611 . . . . 0.0 109.755 -178.091 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' F' F ' 141' ' ' ILE . . . . . 0.446 ' N ' HD23 ' F' ' 140' ' ' LEU . 18.8 mt -123.4 124.69 70.32 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.184 0 N-CA-C 110.015 -0.365 . . . . 0.0 110.015 -174.379 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' F' F ' 142' ' ' ARG . . . . . . . . . . . . . 77.1 ttt180 -120.91 134.57 55.3 Favored 'General case' 0 C--O 1.234 0.259 0 CA-C-N 116.106 -0.497 . . . . 0.0 110.297 -178.823 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' F' F ' 143' ' ' THR . . . . . . . . . . . . . 21.5 p . . . . . 0 C--O 1.219 -0.533 0 CA-C-O 117.99 -1.005 . . . . 0.0 110.567 -179.607 . . . . . . . . 0 0 . 1 . 017 nuclear build full ' A' A ' -3' ' ' GLU . . . . . . . . . . . . . 78.6 tt0 . . . . . 0 N--CA 1.489 1.491 0 N-CA-C 109.232 -0.655 . . . . 0.0 109.232 . . . . . . . . . 0 0 . 1 . 017 nuclear build full ' A' A ' -2' ' ' GLY . . . . . . . . . . . . . . . -74.55 150.04 41.08 Favored Glycine 0 CA--C 1.525 0.691 0 N-CA-C 110.899 -0.88 . . . . 0.0 110.899 179.775 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' -1' ' ' VAL . . . . . . . . . . . . . 42.3 t -94.33 130.89 42.58 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.243 0 CA-C-O 120.906 0.384 . . . . 0.0 110.061 -179.536 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 0' ' ' ILE . . . . . . . . . . . . . 68.7 mt -119.35 131.91 70.67 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.214 0 CA-C-N 116.12 -0.491 . . . . 0.0 110.007 -179.709 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 26.5 ptm -94.34 134.04 37.26 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.238 -0.437 . . . . 0.0 110.344 178.179 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 7.1 p -117.95 131.61 56.49 Favored 'General case' 0 C--N 1.332 -0.172 0 CA-C-O 121.084 0.469 . . . . 0.0 110.598 179.307 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 95.6 mt-10 -141.23 141.41 34.03 Favored 'General case' 0 C--N 1.327 -0.406 0 CA-C-N 115.861 -0.609 . . . . 0.0 110.876 -179.096 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 4' ' ' LEU . . . . . 0.488 HD23 ' N ' ' A' ' 5' ' ' LYS . 3.7 tt -128.19 124.95 38.04 Favored 'General case' 0 C--N 1.33 -0.268 0 N-CA-C 109.679 -0.489 . . . . 0.0 109.679 176.887 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 5' ' ' LYS . . . . . 0.488 ' N ' HD23 ' A' ' 4' ' ' LEU . 63.0 mttp -107.7 122.61 47.08 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-O 120.625 0.25 . . . . 0.0 111.087 -179.189 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 25.2 mt -114.0 144.51 42.97 Favored 'General case' 0 C--O 1.232 0.145 0 CA-C-N 115.542 -0.754 . . . . 0.0 110.525 179.419 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 24.8 ttmt -126.52 139.38 34.56 Favored Pre-proline 0 CA--C 1.531 0.247 0 N-CA-C 109.537 -0.542 . . . . 0.0 109.537 173.224 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 8' ' ' PRO . . . . . . . . . . . . . 98.3 Cg_endo -91.5 141.76 2.76 Favored 'Trans proline' 0 N--CA 1.491 1.335 0 C-N-CA 121.715 1.61 . . . . 0.0 112.156 -179.674 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 56.3 mt -80.07 -47.22 1.39 Allowed Pre-proline 0 CA--C 1.534 0.364 0 CA-C-O 118.64 -0.695 . . . . 0.0 112.222 178.799 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 89.8 Cg_endo -80.98 153.79 19.36 Favored 'Trans proline' 0 N--CA 1.496 1.644 0 C-N-CA 121.168 1.245 . . . . 0.0 111.749 176.142 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 19.4 tptp -88.23 99.09 11.95 Favored 'General case' 0 C--N 1.33 -0.274 0 N-CA-C 110.005 -0.369 . . . . 0.0 110.005 179.303 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 12.7 p -142.34 148.54 20.09 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.258 0 CA-C-N 116.326 -0.397 . . . . 0.0 110.928 -177.766 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 84.2 tt0 -93.69 121.1 34.78 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.05 -0.523 . . . . 0.0 110.04 176.628 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 14' ' ' LEU . . . . . . . . . . . . . 46.6 mt -98.58 152.3 37.84 Favored Pre-proline 0 CA--C 1.533 0.29 0 CA-C-N 116.468 -0.333 . . . . 0.0 110.843 -178.309 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 15' ' ' PRO . . . . . . . . . . . . . 28.6 Cg_exo -61.03 158.65 33.24 Favored 'Trans proline' 0 N--CA 1.498 1.74 0 C-N-CA 121.3 1.333 . . . . 0.0 112.013 177.706 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 16' ' ' PRO . . . . . . . . . . . . . 29.5 Cg_exo -59.99 -36.08 91.04 Favored 'Trans proline' 0 N--CA 1.497 1.677 0 C-N-CA 121.443 1.429 . . . . 0.0 112.689 -179.919 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 17' ' ' ASP . . . . . . . . . . . . . 21.7 p-10 -85.84 8.72 19.02 Favored 'General case' 0 CA--C 1.536 0.406 0 N-CA-C 113.295 0.85 . . . . 0.0 113.295 -177.172 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 18' ' ' PHE . . . . . . . . . . . . . 41.9 t80 -58.09 -44.01 87.36 Favored 'General case' 0 N--CA 1.457 -0.087 0 O-C-N 122.03 -0.419 . . . . 0.0 110.102 -178.713 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 19' ' ' VAL . . . . . . . . . . . . . 48.5 t -56.15 -42.66 73.64 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.291 0 CA-C-N 116.275 -0.42 . . . . 0.0 110.457 -178.81 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 73.0 m-20 -59.89 -43.68 94.67 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-O 120.791 0.329 . . . . 0.0 110.885 -177.907 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 45.8 t -64.35 -45.57 95.61 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.292 0 C-N-CA 120.715 -0.394 . . . . 0.0 110.574 -177.466 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 22' ' ' ILE . . . . . 0.687 HG22 HD12 ' A' ' 26' ' ' LEU . 51.1 mm -55.36 -47.61 77.83 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.254 0 C-N-CA 120.921 -0.312 . . . . 0.0 110.73 179.26 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 23' ' ' ARG . . . . . . . . . . . . . 55.6 ttp180 -55.44 -49.1 73.34 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-O 120.704 0.288 . . . . 0.0 111.207 -178.48 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 24' ' ' ILE . . . . . . . . . . . . . 71.6 mt -58.99 -41.72 84.06 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.258 0 CA-C-N 116.529 -0.305 . . . . 0.0 111.351 -176.419 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 83.6 mttt -71.75 -41.1 68.86 Favored 'General case' 0 C--N 1.328 -0.346 0 N-CA-C 112.714 0.635 . . . . 0.0 112.714 -178.02 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 26' ' ' LEU . . . . . 0.687 HD12 HG22 ' A' ' 22' ' ' ILE . 34.2 mt -78.53 -32.58 48.03 Favored 'General case' 0 C--N 1.328 -0.343 0 N-CA-C 113.697 0.999 . . . . 0.0 113.697 -170.332 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 27' ' ' GLN . . . . . . . . . . . . . 16.5 pt20 -47.11 140.76 4.81 Favored 'General case' 0 N--CA 1.468 0.463 0 N-CA-C 112.771 0.656 . . . . 0.0 112.771 -175.873 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 99.62 -24.11 33.49 Favored Glycine 0 CA--C 1.534 1.222 0 CA-C-N 115.696 -0.684 . . . . 0.0 112.399 -178.047 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 57.2 mtpt -97.62 155.06 17.15 Favored 'General case' 0 C--N 1.333 -0.13 0 CA-C-N 117.531 0.666 . . . . 0.0 111.125 179.312 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 30' ' ' THR . . . . . . . . . . . . . 41.0 m -105.18 137.32 43.14 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 115.89 -0.595 . . . . 0.0 110.036 176.273 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 31' ' ' VAL . . . . . 0.429 HG21 HD11 ' A' ' 4' ' ' LEU . 34.7 m -129.08 152.27 36.96 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.213 0 CA-C-O 120.932 0.396 . . . . 0.0 110.932 -178.402 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 32' ' ' ARG . . . . . . . . . . . . . 68.3 ttp85 -130.28 148.51 52.12 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 115.94 -0.573 . . . . 0.0 110.477 179.924 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 33' ' ' THR . . . . . . . . . . . . . 25.0 m -52.99 139.3 28.17 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.308 -0.405 . . . . 0.0 111.435 -178.024 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 100.16 -17.12 57.49 Favored Glycine 0 CA--C 1.532 1.137 0 CA-C-O 119.698 -0.501 . . . . 0.0 113.342 179.437 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 77.8 m-20 -66.43 149.58 50.2 Favored 'General case' 0 C--N 1.334 -0.102 0 CA-C-N 118.055 0.927 . . . . 0.0 111.228 179.122 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 47.4 t -122.35 130.55 74.44 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.199 0 CA-C-N 115.881 -0.6 . . . . 0.0 109.729 177.922 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 37' ' ' ILE . . . . . . . . . . . . . 65.4 mt -122.56 140.24 46.98 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.282 0 CA-C-N 116.063 -0.517 . . . . 0.0 109.998 -178.196 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . -113.89 128.45 8.28 Favored Glycine 0 CA--C 1.525 0.71 0 N-CA-C 110.983 -0.847 . . . . 0.0 110.983 178.343 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 39' ' ' ILE . . . . . . . . . . . . . 73.9 mt -127.95 136.63 59.77 Favored 'Isoleucine or valine' 0 N--CA 1.462 0.175 0 N-CA-C 110.069 -0.345 . . . . 0.0 110.069 178.928 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 40' ' ' SER . . . . . . . . . . . . . 88.3 p -92.69 118.99 31.64 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.481 -0.327 . . . . 0.0 111.15 177.014 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 41' ' ' ILE . . . . . . . . . . . . . 45.2 mm -121.66 121.99 65.84 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.214 0 CA-C-N 116.438 -0.346 . . . . 0.0 110.232 178.327 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 38.1 mt 53.25 34.25 17.27 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.265 -0.425 . . . . 0.0 111.918 176.602 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . 75.72 27.51 62.81 Favored Glycine 0 CA--C 1.53 1.016 0 C-N-CA 121.077 -0.583 . . . . 0.0 112.594 176.646 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 44' ' ' LYS . . . . . . . . . . . . . 24.7 ttpp -140.33 133.44 29.51 Favored 'General case' 0 C--N 1.33 -0.25 0 N-CA-C 109.427 -0.583 . . . . 0.0 109.427 176.582 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 84.3 tt0 -82.85 126.12 32.09 Favored 'General case' 0 C--N 1.329 -0.318 0 C-N-CA 120.796 -0.361 . . . . 0.0 111.327 -176.325 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 46' ' ' VAL . . . . . . . . . . . . . 9.2 p -120.29 125.67 74.44 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.199 0 N-CA-C 109.166 -0.679 . . . . 0.0 109.166 173.975 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 95.5 mttt -99.2 127.67 45.21 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.085 -0.507 . . . . 0.0 110.807 179.076 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 48' ' ' PHE . . . . . . . . . . . . . 37.7 m-85 -111.39 131.89 54.85 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.075 -0.511 . . . . 0.0 109.998 178.486 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 80.4 tttt -106.61 134.86 49.09 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.45 -0.341 . . . . 0.0 110.164 177.469 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 50' ' ' VAL . . . . . . . . . . . . . 44.4 t -78.16 106.14 8.29 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.285 0 N-CA-C 109.559 -0.534 . . . . 0.0 109.559 177.949 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 51' ' ' VAL . . . . . . . . . . . . . 48.7 t -71.25 -49.96 44.61 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.303 0 CA-C-N 115.946 -0.57 . . . . 0.0 109.83 -175.457 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 52' ' ' GLN . . . . . . . . . . . . . 62.0 tt0 -158.55 139.63 13.09 Favored 'General case' 0 C--N 1.33 -0.28 0 C-N-CA 120.278 -0.569 . . . . 0.0 111.764 -177.82 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -115.5 131.52 56.91 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 115.569 -0.741 . . . . 0.0 109.739 174.976 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 54' ' ' TYR . . . . . . . . . . . . . 43.6 t80 -129.03 110.21 18.29 Favored Pre-proline 0 CA--C 1.535 0.397 0 CA-C-O 118.208 -0.901 . . . . 0.0 110.52 -179.334 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 55' ' ' PRO . . . . . . . . . . . . . 72.9 Cg_endo -77.1 169.95 72.9 Favored 'Cis proline' 0 N--CA 1.498 1.781 0 CA-C-N 121.913 1.719 . . . . 0.0 112.228 -5.067 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 56' ' ' SER . . . . . . . . . . . . . 15.0 m -113.64 127.88 26.34 Favored Pre-proline 0 CA--C 1.539 0.529 0 CA-C-O 118.446 -0.788 . . . . 0.0 109.633 176.616 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 57' ' ' PRO . . . . . . . . . . . . . 60.4 Cg_endo -74.11 149.55 94.17 Favored 'Cis proline' 0 N--CA 1.498 1.739 0 CA-C-N 122.002 1.751 . . . . 0.0 111.685 0.063 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 58' ' ' LEU . . . . . . . . . . . . . 32.0 tp -108.16 137.09 46.74 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.229 -0.441 . . . . 0.0 110.606 -178.253 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 59' ' ' ARG . . . . . . . . . . . . . 52.8 ttp180 -104.4 127.94 52.17 Favored 'General case' 0 C--N 1.328 -0.338 0 N-CA-C 109.24 -0.652 . . . . 0.0 109.24 175.345 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 42.2 t -83.5 121.26 36.01 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.259 0 C-N-CA 120.731 -0.388 . . . . 0.0 110.771 -173.758 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 95.8 mt-10 -131.12 165.02 24.18 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 115.667 -0.697 . . . . 0.0 109.627 175.749 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 62' ' ' ASP . . . . . . . . . . . . . 19.0 p-10 -53.78 -32.49 52.69 Favored 'General case' 0 C--N 1.329 -0.322 0 C-N-CA 121.035 -0.266 . . . . 0.0 111.663 179.428 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 63' ' ' ARG . . . . . . . . . . . . . 67.7 mtp180 -72.52 -22.08 61.09 Favored 'General case' 0 CA--C 1.532 0.282 0 N-CA-C 112.963 0.727 . . . . 0.0 112.963 -176.814 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 25.8 m -69.18 138.97 54.54 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-O 120.981 0.42 . . . . 0.0 110.876 -174.982 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 65' ' ' LYS . . . . . . . . . . . . . 90.8 mttt -88.56 127.78 35.55 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 115.964 -0.562 . . . . 0.0 109.854 178.673 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 66' ' ' ILE . . . . . . . . . . . . . 63.4 mt -112.47 129.01 68.79 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.189 0 N-CA-C 109.62 -0.511 . . . . 0.0 109.62 178.718 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 67' ' ' THR . . . . . . . . . . . . . 19.4 m -121.03 136.29 55.02 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.09 -0.504 . . . . 0.0 110.689 -177.311 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 68' ' ' LEU . . . . . . . . . . . . . 17.7 tp -106.06 124.94 50.38 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 115.938 -0.574 . . . . 0.0 110.342 178.753 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 69' ' ' VAL . . . . . . . . . . . . . 45.7 t -98.22 130.07 47.55 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.361 0 N-CA-C 109.639 -0.504 . . . . 0.0 109.639 177.621 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 70' ' ' THR . . . . . . . . . . . . . 4.7 m -107.16 109.26 21.05 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.308 -0.405 . . . . 0.0 110.809 -177.759 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 71' ' ' HIS . . . . . . . . . . . . . 30.4 m80 -149.93 158.39 37.06 Favored Pre-proline 0 C--N 1.33 -0.281 0 CA-C-N 116.048 -0.524 . . . . 0.0 110.439 177.096 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 72' ' ' PRO . . . . . . . . . . . . . 52.1 Cg_endo -84.11 -23.77 2.88 Favored 'Trans proline' 0 N--CA 1.49 1.315 0 C-N-CA 121.558 1.505 . . . . 0.0 113.044 179.269 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 73' ' ' VAL . . . . . . . . . . . . . 35.3 m -132.44 167.38 26.65 Favored 'Isoleucine or valine' 0 C--O 1.232 0.145 0 CA-C-O 121.006 0.431 . . . . 0.0 110.955 -179.028 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 74' ' ' ASP . . . . . . . . . . . . . 7.2 t70 -101.2 122.62 43.96 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 115.777 -0.647 . . . . 0.0 109.71 179.333 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 42.7 t -119.19 128.84 75.81 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.322 0 CA-C-O 121.188 0.518 . . . . 0.0 110.899 -176.342 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 76' ' ' LEU . . . . . . . . . . . . . 5.0 mp -124.56 145.63 49.48 Favored 'General case' 0 C--N 1.332 -0.161 0 CA-C-N 115.643 -0.708 . . . . 0.0 109.818 174.679 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 77' ' ' GLU . . . . . . . . . . . . . 97.5 mt-10 -136.15 133.04 36.78 Favored 'General case' 0 C--N 1.331 -0.226 0 CA-C-O 120.927 0.394 . . . . 0.0 111.3 -179.935 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 78' ' ' ALA . . . . . . . . . . . . . . . -121.53 139.62 53.26 Favored 'General case' 0 C--N 1.331 -0.197 0 CA-C-N 115.82 -0.627 . . . . 0.0 109.698 176.105 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 79' ' ' LYS . . . . . 0.622 ' O ' HD13 ' A' ' 80' ' ' ILE . 32.8 ttpt -76.96 119.85 21.27 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-O 120.889 0.376 . . . . 0.0 110.247 -179.919 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 80' ' ' ILE . . . . . 0.622 HD13 ' O ' ' A' ' 79' ' ' LYS . 22.9 mm -139.24 111.86 5.86 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.327 0 N-CA-C 109.007 -0.738 . . . . 0.0 109.007 -178.544 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 81' ' ' LYS . . . . . . . . . . . . . 79.0 tttt -115.77 129.09 56.31 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-O 120.902 0.382 . . . . 0.0 110.657 -177.138 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . 89.11 41.98 5.72 Favored Glycine 0 CA--C 1.525 0.704 0 N-CA-C 111.342 -0.703 . . . . 0.0 111.342 178.085 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 83' ' ' ILE . . . . . . . . . . . . . 75.9 mt -67.33 140.21 19.7 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.309 0 CA-C-O 120.902 0.382 . . . . 0.0 109.993 178.593 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 84' ' ' LYS . . . . . . . . . . . . . 71.6 tttt -99.71 -52.03 3.57 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.043 -0.526 . . . . 0.0 110.074 -179.901 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 85' ' ' ASP . . . . . . . . . . . . . 5.0 t70 -159.86 156.73 27.86 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 115.758 -0.656 . . . . 0.0 110.365 179.809 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 86' ' ' VAL . . . . . . . . . . . . . 40.7 t -131.13 132.87 63.22 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.228 0 CA-C-O 120.983 0.42 . . . . 0.0 110.744 -178.94 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 87' ' ' ILE . . . . . . . . . . . . . 43.9 mm -120.07 126.82 75.68 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.268 0 CA-C-N 115.771 -0.649 . . . . 0.0 109.361 177.08 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 88' ' ' LEU . . . . . . . . . . . . . 19.1 tp -114.84 134.33 55.22 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-O 120.944 0.402 . . . . 0.0 111.423 -176.8 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 89' ' ' ASP . . . . . . . . . . . . . 13.5 t70 -129.38 157.17 42.67 Favored 'General case' 0 C--N 1.331 -0.226 0 CA-C-N 115.787 -0.642 . . . . 0.0 109.606 176.719 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 60.2 mp0 -48.51 -35.96 14.24 Favored 'General case' 0 C--N 1.332 -0.192 0 N-CA-C 113.06 0.763 . . . . 0.0 113.06 -171.154 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 91' ' ' ASN . . . . . . . . . . . . . 27.6 t30 -130.65 18.35 5.21 Favored 'General case' 0 N--CA 1.47 0.534 0 N-CA-C 113.15 0.796 . . . . 0.0 113.15 -177.238 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 92' ' ' LEU . . . . . . . . . . . . . 22.6 mt -146.99 142.52 27.59 Favored 'General case' 0 C--N 1.331 -0.216 0 N-CA-C 110.221 -0.288 . . . . 0.0 110.221 -177.595 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 93' ' ' ILE . . . . . . . . . . . . . 71.9 mt -123.21 117.86 52.89 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.354 0 N-CA-C 109.312 -0.625 . . . . 0.0 109.312 177.695 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 94' ' ' VAL . . . . . . . . . . . . . 41.9 t -120.24 128.75 76.0 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.25 0 CA-C-O 120.959 0.409 . . . . 0.0 110.102 -178.987 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 95' ' ' VAL . . . . . . . . . . . . . 42.5 t -123.24 135.56 62.79 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.367 0 CA-C-N 115.933 -0.576 . . . . 0.0 109.77 179.616 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 96' ' ' ILE . . . . . . . . . . . . . 66.9 mt -114.17 130.94 67.53 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.36 0 N-CA-C 109.425 -0.583 . . . . 0.0 109.425 179.259 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 97' ' ' THR . . . . . . . . . . . . . 60.4 p -104.65 158.09 16.73 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-O 121.04 0.447 . . . . 0.0 111.267 -177.825 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 98' ' ' GLU . . . . . . . . . . . . . 97.3 mt-10 -53.98 -26.03 23.89 Favored 'General case' 0 C--N 1.328 -0.355 0 N-CA-C 112.371 0.508 . . . . 0.0 112.371 -179.763 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 99' ' ' GLU . . . . . . . . . . . . . 95.6 mt-10 -78.56 14.62 1.22 Allowed 'General case' 0 CA--C 1.536 0.417 0 N-CA-C 113.171 0.804 . . . . 0.0 113.171 -177.343 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 100' ' ' ASN . . . . . . . . . . . . . 3.6 m-20 62.17 37.94 14.02 Favored 'General case' 0 N--CA 1.462 0.172 0 CA-C-O 121.125 0.488 . . . . 0.0 110.894 178.818 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 101' ' ' GLU . . . . . . . . . . . . . 84.6 tt0 -115.36 144.24 44.07 Favored 'General case' 0 C--O 1.233 0.2 0 CA-C-N 116.047 -0.524 . . . . 0.0 109.807 176.584 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 102' ' ' VAL . . . . . . . . . . . . . 45.1 t -115.03 124.69 71.93 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.338 0 CA-C-N 116.067 -0.515 . . . . 0.0 109.94 -178.339 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 103' ' ' LEU . . . . . . . . . . . . . 23.2 mt -115.13 126.82 55.09 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 115.753 -0.658 . . . . 0.0 110.168 176.449 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 104' ' ' ILE . . . . . . . . . . . . . 72.6 mt -118.21 120.42 64.37 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.232 0 N-CA-C 109.983 -0.377 . . . . 0.0 109.983 179.438 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 105' ' ' PHE . . . . . . . . . . . . . 53.5 m-85 -120.32 162.33 19.63 Favored 'General case' 0 C--N 1.332 -0.178 0 CA-C-N 115.5 -0.773 . . . . 0.0 110.052 179.955 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 106' ' ' ASN . . . . . . . . . . . . . 43.1 p-10 -93.8 -169.83 2.19 Favored 'General case' 0 C--N 1.329 -0.311 0 N-CA-C 109.785 -0.45 . . . . 0.0 109.785 173.375 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 107' ' ' GLN . . . . . . . . . . . . . 48.6 tt0 -57.64 -30.03 65.06 Favored 'General case' 0 CA--C 1.532 0.268 0 N-CA-C 112.061 0.393 . . . . 0.0 112.061 179.37 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 108' ' ' ASN . . . . . . . . . . . . . 49.4 t30 -84.72 9.48 13.87 Favored 'General case' 0 CA--C 1.536 0.412 0 N-CA-C 113.251 0.834 . . . . 0.0 113.251 -177.131 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 109' ' ' LEU . . . . . . . . . . . . . 10.9 tp 58.28 37.03 26.03 Favored 'General case' 0 C--N 1.331 -0.23 0 CA-C-O 120.983 0.421 . . . . 0.0 111.28 179.167 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 110' ' ' GLU . . . . . . . . . . . . . 95.7 mt-10 -106.64 159.48 16.16 Favored 'General case' 0 C--N 1.332 -0.174 0 CA-C-O 120.811 0.338 . . . . 0.0 110.166 176.846 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 111' ' ' GLU . . . . . . . . . . . . . 80.4 tt0 -81.58 121.92 26.93 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.282 -0.417 . . . . 0.0 111.213 -175.646 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 112' ' ' LEU . . . . . . . . . . . . . 15.3 mt -110.29 -46.08 3.48 Favored 'General case' 0 C--N 1.331 -0.227 0 CA-C-N 116.064 -0.516 . . . . 0.0 109.829 175.238 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 113' ' ' TYR . . . . . 0.423 ' CE2' HG21 ' B' ' 75' ' ' VAL . 58.7 t80 -139.24 136.6 35.13 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.145 -0.48 . . . . 0.0 110.931 178.849 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 114' ' ' ARG . . . . . . . . . . . . . 63.3 ttt180 -140.3 122.06 15.4 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 116.095 -0.502 . . . . 0.0 110.187 178.117 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 115' ' ' GLY . . . . . . . . . . . . . . . -150.08 161.66 28.96 Favored Glycine 0 CA--C 1.525 0.703 0 C-N-CA 120.732 -0.747 . . . . 0.0 111.391 179.676 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 116' ' ' LYS . . . . . . . . . . . . . 39.8 ttpt -128.88 136.17 50.07 Favored 'General case' 0 C--N 1.33 -0.27 0 N-CA-C 109.869 -0.419 . . . . 0.0 109.869 177.179 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 117' ' ' PHE . . . . . . . . . . . . . 39.3 m-85 -134.55 113.88 12.23 Favored 'General case' 0 C--N 1.329 -0.285 0 N-CA-C 109.878 -0.416 . . . . 0.0 109.878 -178.012 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 118' ' ' GLU . . . . . . . . . . . . . 12.9 pt-20 -57.06 -39.29 74.64 Favored 'General case' 0 C--N 1.329 -0.313 0 C-N-CA 120.726 -0.39 . . . . 0.0 111.084 -176.415 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 119' ' ' ASN . . . . . . . . . . . . . 32.7 m120 -94.81 26.0 3.79 Favored 'General case' 0 C--N 1.331 -0.207 0 N-CA-C 112.644 0.609 . . . . 0.0 112.644 -174.558 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 120' ' ' LEU . . . . . . . . . . . . . 17.5 tp -58.55 125.01 21.58 Favored 'General case' 0 C--N 1.333 -0.139 0 CA-C-O 120.816 0.341 . . . . 0.0 110.227 178.973 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 121' ' ' ASN . . . . . . . . . . . . . 2.7 m-80 -113.96 -44.16 3.19 Favored 'General case' 0 C--N 1.332 -0.186 0 CA-C-N 116.262 -0.426 . . . . 0.0 110.581 -179.141 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 122' ' ' LYS . . . . . . . . . . . . . 56.6 pttt -159.71 157.93 30.41 Favored 'General case' 0 C--N 1.332 -0.186 0 C-N-CA 120.525 -0.47 . . . . 0.0 111.671 -179.624 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 123' ' ' VAL . . . . . . . . . . . . . 43.7 t -129.99 136.78 58.11 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.229 0 CA-C-N 116.022 -0.535 . . . . 0.0 110.09 179.956 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 124' ' ' LEU . . . . . . . . . . . . . 78.4 mt -119.82 133.96 55.41 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.152 -0.476 . . . . 0.0 110.81 -178.93 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 125' ' ' VAL . . . . . . . . . . . . . 48.3 t -126.91 127.25 69.67 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.218 0 N-CA-C 109.482 -0.562 . . . . 0.0 109.482 176.671 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 126' ' ' ARG . . . . . . . . . . . . . 41.7 ttt180 -144.01 124.4 13.89 Favored 'General case' 0 C--N 1.33 -0.242 0 C-N-CA 120.763 -0.375 . . . . 0.0 110.834 -179.192 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 127' ' ' ASN . . . . . . . . . . . . . 3.5 m120 51.2 -106.63 0.26 Allowed 'General case' 0 CA--C 1.544 0.726 0 CA-C-O 118.934 -0.555 . . . . 0.0 111.311 179.916 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 128' ' ' ASP . . . . . . . . . . . . . 10.9 p-10 -114.09 0.4 14.28 Favored 'General case' 0 N--CA 1.467 0.407 0 CA-C-N 119.754 1.161 . . . . 0.0 113.463 -177.883 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 129' ' ' LEU . . . . . . . . . . . . . 30.6 mt -104.91 141.73 36.02 Favored 'General case' 0 C--O 1.232 0.161 0 CA-C-N 118.249 0.477 . . . . 0.0 110.668 -178.429 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 130' ' ' VAL . . . . . . . . . . . . . 46.2 t -123.42 133.59 68.73 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.274 0 CA-C-N 115.973 -0.558 . . . . 0.0 109.574 178.422 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 131' ' ' VAL . . . . . 0.445 HG22 HD12 ' A' ' 140' ' ' LEU . 44.4 t -133.86 135.8 54.69 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.27 0 CA-C-O 121.119 0.485 . . . . 0.0 110.162 179.451 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 132' ' ' ILE . . . . . . . . . . . . . 73.8 mt -113.41 130.94 66.5 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.289 0 CA-C-N 115.668 -0.696 . . . . 0.0 109.249 179.423 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 133' ' ' ILE . . . . . . . . . . . . . 42.1 mm -114.2 120.33 63.66 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.277 0 CA-C-O 120.888 0.375 . . . . 0.0 110.727 -176.356 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 134' ' ' ASP . . . . . . . . . . . . . 7.1 p-10 -132.36 145.96 51.62 Favored 'General case' 0 C--N 1.33 -0.255 0 N-CA-C 109.104 -0.702 . . . . 0.0 109.104 174.003 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 135' ' ' GLU . . . . . . . . . . . . . 41.8 tp10 -49.69 -24.66 2.39 Favored 'General case' 0 C--N 1.328 -0.34 0 N-CA-C 112.881 0.697 . . . . 0.0 112.881 -170.961 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 136' ' ' GLN . . . . . . . . . . . . . 54.1 tp60 -96.53 -34.08 11.59 Favored 'General case' 0 CA--C 1.53 0.18 0 N-CA-C 112.223 0.453 . . . . 0.0 112.223 -175.871 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 137' ' ' LYS . . . . . . . . . . . . . 65.3 mttt -141.22 156.57 45.89 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-O 121.31 0.576 . . . . 0.0 111.905 -169.551 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 138' ' ' LEU . . . . . 0.497 HD23 ' N ' ' A' ' 139' ' ' THR . 5.1 tt -119.41 122.9 42.81 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 115.392 -0.822 . . . . 0.0 109.042 172.028 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 139' ' ' THR . . . . . 0.497 ' N ' HD23 ' A' ' 138' ' ' LEU . 24.8 m -107.06 128.11 54.08 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.552 -0.295 . . . . 0.0 110.548 -178.107 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 140' ' ' LEU . . . . . 0.445 HD12 HG22 ' A' ' 131' ' ' VAL . 44.4 tp -113.32 119.73 38.69 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 115.74 -0.664 . . . . 0.0 109.417 -179.08 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 141' ' ' ILE . . . . . . . . . . . . . 19.3 mt -119.89 118.11 55.96 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.264 0 CA-C-O 121.006 0.431 . . . . 0.0 109.88 -176.713 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 142' ' ' ARG . . . . . . . . . . . . . 78.1 mtm180 -104.47 129.7 52.45 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 115.285 -0.871 . . . . 0.0 110.549 -178.693 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 143' ' ' THR . . . . . . . . . . . . . 77.1 p . . . . . 0 C--O 1.22 -0.466 0 CA-C-O 117.944 -1.027 . . . . 0.0 110.482 179.501 . . . . . . . . 0 0 . 1 . 017 nuclear build full ' B' B ' -3' ' ' GLU . . . . . . . . . . . . . 95.6 mt-10 . . . . . 0 N--CA 1.49 1.543 0 N-CA-C 109.308 -0.627 . . . . 0.0 109.308 . . . . . . . . . 0 0 . 1 . 017 nuclear build full ' B' B ' -2' ' ' GLY . . . . . . . . . . . . . . . -76.86 139.05 23.04 Favored Glycine 0 CA--C 1.524 0.595 0 N-CA-C 110.92 -0.872 . . . . 0.0 110.92 179.273 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' B' B ' -1' ' ' VAL . . . . . . . . . . . . . 45.3 t -141.42 132.03 26.41 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.258 0 N-CA-C 110.04 -0.356 . . . . 0.0 110.04 -179.899 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' B' B ' 0' ' ' ILE . . . . . . . . . . . . . 72.0 mt -119.77 128.09 75.9 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.2 0 CA-C-N 116.198 -0.455 . . . . 0.0 109.818 178.403 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' B' B ' 1' ' ' MET . . . . . . . . . . . . . 24.8 ptt? -81.79 124.59 29.79 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 116.256 -0.429 . . . . 0.0 110.539 179.625 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' B' B ' 2' ' ' SER . . . . . . . . . . . . . 12.5 p -123.97 132.64 53.74 Favored 'General case' 0 C--N 1.331 -0.207 0 CA-C-N 116.235 -0.439 . . . . 0.0 110.37 179.216 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' B' B ' 3' ' ' GLU . . . . . . . . . . . . . 43.6 mt-10 -140.52 145.02 36.28 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-N 115.751 -0.658 . . . . 0.0 110.999 -176.989 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' B' B ' 4' ' ' LEU . . . . . . . . . . . . . 23.1 tp -124.28 128.25 48.87 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.063 -0.517 . . . . 0.0 110.131 174.747 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' B' B ' 5' ' ' LYS . . . . . . . . . . . . . 63.8 mmtt -105.45 113.8 27.58 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 115.988 -0.551 . . . . 0.0 111.121 -179.202 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' B' B ' 6' ' ' LEU . . . . . . . . . . . . . 28.7 mt -113.71 137.48 51.55 Favored 'General case' 0 C--N 1.333 -0.147 0 O-C-N 124.034 0.834 . . . . 0.0 109.659 178.214 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' B' B ' 7' ' ' LYS . . . . . . . . . . . . . 57.7 tttp -123.2 137.95 29.14 Favored Pre-proline 0 CA--C 1.533 0.32 0 CA-C-O 118.853 -0.594 . . . . 0.0 109.862 177.333 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' B' B ' 8' ' ' PRO . . . . . . . . . . . . . 85.0 Cg_endo -90.41 137.2 2.44 Favored 'Trans proline' 0 N--CA 1.491 1.377 0 C-N-CA 121.625 1.55 . . . . 0.0 111.872 179.062 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' B' B ' 9' ' ' LEU . . . . . . . . . . . . . 39.5 mt -80.43 -48.57 1.23 Allowed Pre-proline 0 CA--C 1.535 0.374 0 CA-C-O 118.555 -0.736 . . . . 0.0 112.441 -179.69 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' B' B ' 10' ' ' PRO . . . . . . . . . . . . . 90.0 Cg_endo -78.88 156.21 27.0 Favored 'Trans proline' 0 N--CA 1.497 1.694 0 C-N-CA 121.183 1.256 . . . . 0.0 112.051 178.727 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' B' B ' 11' ' ' LYS . . . . . . . . . . . . . 60.6 mttp -82.71 93.13 7.32 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.353 -0.385 . . . . 0.0 110.333 178.476 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' B' B ' 12' ' ' VAL . . . . . . . . . . . . . 12.7 p -140.16 146.91 24.05 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.303 0 CA-C-N 116.296 -0.411 . . . . 0.0 110.718 -179.262 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' B' B ' 13' ' ' GLU . . . . . . . . . . . . . 84.7 tt0 -97.66 129.04 44.77 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.345 -0.389 . . . . 0.0 110.057 177.823 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' B' B ' 14' ' ' LEU . . . . . . . . . . . . . 27.3 mt -98.37 149.91 36.2 Favored Pre-proline 0 CA--C 1.532 0.282 0 CA-C-O 119.298 -0.382 . . . . 0.0 110.65 -177.12 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' B' B ' 15' ' ' PRO . . . . . . . . . . . . . 24.2 Cg_exo -63.68 160.57 35.87 Favored 'Trans proline' 0 N--CA 1.498 1.737 0 C-N-CA 121.366 1.377 . . . . 0.0 111.733 175.36 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' B' B ' 16' ' ' PRO . . . . . . . . . . . . . 30.4 Cg_exo -59.84 -35.81 92.86 Favored 'Trans proline' 0 N--CA 1.498 1.737 0 C-N-CA 121.47 1.447 . . . . 0.0 112.688 -178.589 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' B' B ' 17' ' ' ASP . . . . . . . . . . . . . 38.1 p30 -90.2 9.6 27.87 Favored 'General case' 0 CA--C 1.535 0.391 0 N-CA-C 113.367 0.877 . . . . 0.0 113.367 -177.553 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' B' B ' 18' ' ' PHE . . . . . . . . . . . . . 37.4 t80 -58.43 -46.38 86.61 Favored 'General case' 0 N--CA 1.458 -0.059 0 O-C-N 121.965 -0.459 . . . . 0.0 110.017 -177.598 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' B' B ' 19' ' ' VAL . . . . . . . . . . . . . 48.5 t -56.86 -41.72 76.63 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.399 0 CA-C-N 116.228 -0.442 . . . . 0.0 110.392 -178.176 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' B' B ' 20' ' ' ASP . . . . . . . . . . . . . 78.3 m-20 -60.14 -44.0 95.29 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-O 120.784 0.326 . . . . 0.0 111.0 -177.399 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' B' B ' 21' ' ' VAL . . . . . . . . . . . . . 48.0 t -64.5 -46.13 93.65 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.294 0 C-N-CA 120.765 -0.374 . . . . 0.0 110.468 -177.648 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' B' B ' 22' ' ' ILE . . . . . 0.536 HG22 HD12 ' B' ' 26' ' ' LEU . 50.1 mm -56.31 -44.73 80.48 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.25 0 C-N-CA 120.857 -0.337 . . . . 0.0 110.582 179.083 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' B' B ' 23' ' ' ARG . . . . . . . . . . . . . 59.6 ttp180 -54.49 -48.81 71.4 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-O 120.763 0.316 . . . . 0.0 111.17 -179.549 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' B' B ' 24' ' ' ILE . . . . . . . . . . . . . 74.2 mt -59.52 -41.1 83.69 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.247 0 CA-C-N 116.336 -0.393 . . . . 0.0 111.424 -176.66 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' B' B ' 25' ' ' LYS . . . . . . . . . . . . . 97.7 mttt -70.07 -43.33 71.38 Favored 'General case' 0 C--N 1.33 -0.273 0 N-CA-C 112.719 0.637 . . . . 0.0 112.719 -178.625 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' B' B ' 26' ' ' LEU . . . . . 0.536 HD12 HG22 ' B' ' 22' ' ' ILE . 92.2 mt -78.11 -34.23 50.12 Favored 'General case' 0 C--N 1.33 -0.26 0 N-CA-C 113.444 0.905 . . . . 0.0 113.444 -170.336 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' B' B ' 27' ' ' GLN . . . . . . . . . . . . . 20.2 pt20 -46.98 139.38 5.66 Favored 'General case' 0 N--CA 1.468 0.47 0 N-CA-C 112.755 0.65 . . . . 0.0 112.755 -175.95 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' B' B ' 28' ' ' GLY . . . . . . . . . . . . . . . 100.8 -23.95 33.79 Favored Glycine 0 CA--C 1.535 1.283 0 CA-C-N 115.671 -0.695 . . . . 0.0 112.384 -176.232 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' B' B ' 29' ' ' LYS . . . . . . . . . . . . . 45.4 mtmt -97.99 155.16 17.23 Favored 'General case' 0 C--O 1.231 0.1 0 CA-C-N 117.396 0.598 . . . . 0.0 111.037 178.804 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' B' B ' 30' ' ' THR . . . . . . . . . . . . . 32.0 m -105.05 137.7 42.39 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 116.043 -0.526 . . . . 0.0 110.236 177.978 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' B' B ' 31' ' ' VAL . . . . . . . . . . . . . 35.2 m -131.35 158.26 43.29 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.22 0 CA-C-O 120.865 0.364 . . . . 0.0 110.898 -179.153 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' B' B ' 32' ' ' ARG . . . . . . . . . . . . . 98.1 mtt180 -135.63 153.15 51.74 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-O 121.284 0.564 . . . . 0.0 110.77 178.245 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' B' B ' 33' ' ' THR . . . . . . . . . . . . . 19.8 m -53.6 140.67 28.05 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.153 -0.476 . . . . 0.0 111.441 -178.478 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' B' B ' 34' ' ' GLY . . . . . . . . . . . . . . . 99.29 -17.11 58.34 Favored Glycine 0 CA--C 1.532 1.109 0 CA-C-N 116.09 -0.505 . . . . 0.0 113.309 178.996 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' B' B ' 35' ' ' ASP . . . . . . . . . . . . . 78.2 m-20 -67.02 149.14 51.03 Favored 'General case' 0 N--CA 1.462 0.13 0 CA-C-N 118.036 0.918 . . . . 0.0 111.194 178.946 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' B' B ' 36' ' ' VAL . . . . . . . . . . . . . 45.7 t -119.48 129.84 74.8 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.197 0 CA-C-N 115.895 -0.593 . . . . 0.0 109.668 176.768 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' B' B ' 37' ' ' ILE . . . . . . . . . . . . . 65.1 mt -119.08 137.71 52.17 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.275 0 CA-C-N 116.125 -0.489 . . . . 0.0 109.968 -178.93 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' B' B ' 38' ' ' GLY . . . . . . . . . . . . . . . -113.34 127.77 8.04 Favored Glycine 0 CA--C 1.526 0.725 0 N-CA-C 110.873 -0.891 . . . . 0.0 110.873 179.43 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' B' B ' 39' ' ' ILE . . . . . . . . . . . . . 72.2 mt -125.6 131.55 71.94 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.27 0 N-CA-C 110.127 -0.323 . . . . 0.0 110.127 179.254 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' B' B ' 40' ' ' SER . . . . . . . . . . . . . 26.7 p -92.15 114.68 27.28 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.418 -0.356 . . . . 0.0 110.997 176.875 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' B' B ' 41' ' ' ILE . . . . . 0.443 HG22 HD13 ' B' ' 42' ' ' LEU . 44.1 mm -121.44 123.43 69.62 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.236 0 CA-C-N 116.483 -0.326 . . . . 0.0 110.33 179.714 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' B' B ' 42' ' ' LEU . . . . . 0.443 HD13 HG22 ' B' ' 41' ' ' ILE . 6.7 mp 52.94 34.53 17.02 Favored 'General case' 0 CA--C 1.533 0.29 0 CA-C-N 116.292 -0.413 . . . . 0.0 111.505 177.92 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' B' B ' 43' ' ' GLY . . . . . . . . . . . . . . . 72.67 30.48 63.96 Favored Glycine 0 CA--C 1.53 0.999 0 C-N-CA 121.199 -0.524 . . . . 0.0 112.211 177.888 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' B' B ' 44' ' ' LYS . . . . . . . . . . . . . 61.5 tttm -138.21 128.94 26.69 Favored 'General case' 0 C--N 1.329 -0.288 0 N-CA-C 109.585 -0.524 . . . . 0.0 109.585 178.132 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' B' B ' 45' ' ' GLU . . . . . . . . . . . . . 84.7 tt0 -83.28 122.0 27.85 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-O 120.817 0.342 . . . . 0.0 111.019 -177.153 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' B' B ' 46' ' ' VAL . . . . . . . . . . . . . 10.6 p -119.98 125.03 73.85 Favored 'Isoleucine or valine' 0 C--O 1.232 0.147 0 N-CA-C 109.444 -0.576 . . . . 0.0 109.444 174.651 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' B' B ' 47' ' ' LYS . . . . . . . . . . . . . 99.3 mttt -99.91 128.31 46.01 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.145 -0.479 . . . . 0.0 111.025 179.094 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' B' B ' 48' ' ' PHE . . . . . . . . . . . . . 26.7 m-85 -110.74 131.84 54.7 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 115.946 -0.57 . . . . 0.0 109.588 175.489 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' B' B ' 49' ' ' LYS . . . . . . . . . . . . . 60.8 tttm -105.62 135.42 47.05 Favored 'General case' 0 C--N 1.327 -0.37 0 N-CA-C 109.867 -0.42 . . . . 0.0 109.867 177.047 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' B' B ' 50' ' ' VAL . . . . . . . . . . . . . 47.3 t -79.99 104.99 8.93 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.326 0 N-CA-C 109.563 -0.532 . . . . 0.0 109.563 178.509 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' B' B ' 51' ' ' VAL . . . . . . . . . . . . . 46.4 t -69.88 -51.86 36.49 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.335 0 CA-C-N 115.945 -0.57 . . . . 0.0 109.8 -176.721 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' B' B ' 52' ' ' GLN . . . . . . . . . . . . . 92.4 mt-30 -151.88 151.36 31.18 Favored 'General case' 0 C--N 1.334 -0.105 0 C-N-CA 120.244 -0.582 . . . . 0.0 111.957 -179.456 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' B' B ' 53' ' ' ALA . . . . . . . . . . . . . . . -126.8 131.11 51.34 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 115.092 -0.958 . . . . 0.0 109.555 174.402 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' B' B ' 54' ' ' TYR . . . . . . . . . . . . . 30.2 t80 -129.12 109.67 18.1 Favored Pre-proline 0 C--N 1.328 -0.351 0 CA-C-O 118.201 -0.904 . . . . 0.0 110.31 178.902 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' B' B ' 55' ' ' PRO . . . . . . . . . . . . . 73.7 Cg_endo -77.28 168.3 77.18 Favored 'Cis proline' 0 N--CA 1.5 1.911 0 CA-C-N 121.985 1.745 . . . . 0.0 112.634 -3.558 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' B' B ' 56' ' ' SER . . . . . . . . . . . . . 13.5 m -114.63 125.84 28.64 Favored Pre-proline 0 CA--C 1.538 0.516 0 CA-C-O 118.368 -0.825 . . . . 0.0 109.241 174.907 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' B' B ' 57' ' ' PRO . . . . . . . . . . . . . 44.8 Cg_endo -68.67 168.38 63.03 Favored 'Cis proline' 0 N--CA 1.496 1.66 0 CA-C-N 122.041 1.764 . . . . 0.0 111.573 1.325 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' B' B ' 58' ' ' LEU . . . . . . . . . . . . . 26.9 tp -129.23 135.64 49.07 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.137 179.28 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' B' B ' 59' ' ' ARG . . . . . . . . . . . . . 69.8 ttt180 -104.16 124.27 48.8 Favored 'General case' 0 C--N 1.327 -0.388 0 N-CA-C 109.277 -0.638 . . . . 0.0 109.277 177.413 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' B' B ' 60' ' ' VAL . . . . . . . . . . . . . 46.5 t -73.2 115.45 14.1 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.234 0 C-N-CA 120.61 -0.436 . . . . 0.0 110.078 -175.488 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' B' B ' 61' ' ' GLU . . . . . . . . . . . . . 75.0 tt0 -131.02 155.08 47.46 Favored 'General case' 0 C--N 1.329 -0.314 0 N-CA-C 109.152 -0.685 . . . . 0.0 109.152 177.897 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' B' B ' 62' ' ' ASP . . . . . . . . . . . . . 13.6 t70 -52.0 -32.79 35.37 Favored 'General case' 0 C--N 1.327 -0.405 0 N-CA-C 111.946 0.351 . . . . 0.0 111.946 -177.732 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' B' B ' 63' ' ' ARG . . . . . . . . . . . . . 98.6 mtt180 -74.16 -22.14 59.56 Favored 'General case' 0 C--N 1.33 -0.272 0 N-CA-C 113.04 0.756 . . . . 0.0 113.04 -177.185 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' B' B ' 64' ' ' THR . . . . . . . . . . . . . 31.0 m -64.84 136.85 57.34 Favored 'General case' 0 C--N 1.331 -0.226 0 CA-C-O 120.725 0.298 . . . . 0.0 110.57 -176.843 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' B' B ' 65' ' ' LYS . . . . . . . . . . . . . 40.3 ttpt -88.66 124.6 34.24 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-O 121.079 0.466 . . . . 0.0 110.176 -179.976 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' B' B ' 66' ' ' ILE . . . . . . . . . . . . . 69.9 mt -108.09 126.59 64.66 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.298 0 N-CA-C 109.815 -0.439 . . . . 0.0 109.815 -177.906 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' B' B ' 67' ' ' THR . . . . . . . . . . . . . 42.1 m -120.69 139.93 52.34 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.039 -0.528 . . . . 0.0 110.769 -176.422 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' B' B ' 68' ' ' LEU . . . . . . . . . . . . . 19.8 tp -105.0 131.94 51.88 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 115.796 -0.638 . . . . 0.0 110.463 179.749 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' B' B ' 69' ' ' VAL . . . . . . . . . . . . . 43.1 t -92.81 129.89 42.7 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.315 0 CA-C-N 116.146 -0.479 . . . . 0.0 109.76 178.69 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' B' B ' 70' ' ' THR . . . . . 0.434 HG22 ' H ' ' B' ' 71' ' ' HIS . 2.3 m -107.96 166.71 10.51 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.835 -177.843 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' B' B ' 71' ' ' HIS . . . . . 0.434 ' H ' HG22 ' B' ' 70' ' ' THR . 17.2 m-70 -65.01 167.3 9.89 Favored Pre-proline 0 C--N 1.329 -0.295 0 CA-C-N 115.998 -0.546 . . . . 0.0 109.967 178.521 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' B' B ' 72' ' ' PRO . . . . . . . . . . . . . 18.5 Cg_exo -64.82 -30.09 58.63 Favored 'Trans proline' 0 N--CA 1.497 1.72 0 C-N-CA 121.167 1.244 . . . . 0.0 111.99 179.238 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' B' B ' 73' ' ' VAL . . . . . . . . . . . . . 17.2 m -149.51 138.39 15.16 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.263 0 CA-C-O 121.171 0.51 . . . . 0.0 110.78 174.747 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' B' B ' 74' ' ' ASP . . . . . . . . . . . . . 18.1 t0 -103.43 121.42 42.76 Favored 'General case' 0 C--N 1.328 -0.36 0 N-CA-C 108.955 -0.757 . . . . 0.0 108.955 175.441 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' B' B ' 75' ' ' VAL . . . . . 0.423 HG21 ' CE2' ' A' ' 113' ' ' TYR . 41.8 t -114.86 124.99 72.05 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.225 0 CA-C-O 121.135 0.493 . . . . 0.0 110.954 -175.017 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' B' B ' 76' ' ' LEU . . . . . . . . . . . . . 5.6 mp -125.13 147.37 49.05 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 115.394 -0.821 . . . . 0.0 109.492 175.069 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' B' B ' 77' ' ' GLU . . . . . . . . . . . . . 97.6 mt-10 -133.35 131.23 39.85 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-O 121.053 0.454 . . . . 0.0 111.165 -178.444 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' B' B ' 78' ' ' ALA . . . . . . . . . . . . . . . -117.67 139.08 51.5 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 115.67 -0.696 . . . . 0.0 109.662 176.822 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' B' B ' 79' ' ' LYS . . . . . 0.515 ' O ' HD13 ' B' ' 80' ' ' ILE . 9.4 mtpm? -87.34 117.88 26.41 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-O 120.948 0.404 . . . . 0.0 110.707 -178.501 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' B' B ' 80' ' ' ILE . . . . . 0.515 HD13 ' O ' ' B' ' 79' ' ' LYS . 25.2 mm -139.08 114.29 8.45 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.268 0 N-CA-C 108.979 -0.749 . . . . 0.0 108.979 -177.958 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' B' B ' 81' ' ' LYS . . . . . . . . . . . . . 53.8 tttp -103.92 127.3 51.45 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-O 120.812 0.339 . . . . 0.0 111.402 -175.718 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' B' B ' 82' ' ' GLY . . . . . . . . . . . . . . . 89.19 41.98 5.7 Favored Glycine 0 CA--C 1.527 0.843 0 C-N-CA 120.839 -0.696 . . . . 0.0 112.258 173.271 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' B' B ' 83' ' ' ILE . . . . . . . . . . . . . 69.7 mt -73.57 138.91 20.31 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.347 0 N-CA-C 109.571 -0.529 . . . . 0.0 109.571 176.961 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' B' B ' 84' ' ' LYS . . . . . . . . . . . . . 38.5 ttpt -103.52 -49.08 3.78 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-N 116.294 -0.412 . . . . 0.0 110.606 -177.828 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' B' B ' 85' ' ' ASP . . . . . . . . . . . . . 12.2 t70 -144.49 148.51 34.62 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.091 -0.504 . . . . 0.0 110.603 -178.532 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' B' B ' 86' ' ' VAL . . . . . . . . . . . . . 46.4 t -130.38 133.12 64.33 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.247 0 CA-C-O 120.87 0.367 . . . . 0.0 110.428 -179.189 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' B' B ' 87' ' ' ILE . . . . . 0.489 ' N ' HD12 ' B' ' 87' ' ' ILE . 5.0 mp -122.64 124.38 70.52 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.195 0 CA-C-N 115.935 -0.575 . . . . 0.0 109.522 176.617 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' B' B ' 88' ' ' LEU . . . . . . . . . . . . . 16.0 tp -109.74 129.61 55.6 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-O 120.866 0.365 . . . . 0.0 110.709 -178.629 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' B' B ' 89' ' ' ASP . . . . . . . . . . . . . 13.4 t70 -128.23 155.68 44.16 Favored 'General case' 0 C--N 1.331 -0.215 0 CA-C-N 116.12 -0.491 . . . . 0.0 110.031 178.122 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' B' B ' 90' ' ' GLU . . . . . . . . . . . . . 96.2 mt-10 -47.5 -36.84 10.84 Favored 'General case' 0 C--N 1.328 -0.357 0 N-CA-C 113.055 0.761 . . . . 0.0 113.055 -171.457 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' B' B ' 91' ' ' ASN . . . . . . . . . . . . . 66.0 m-80 -129.01 16.54 6.22 Favored 'General case' 0 N--CA 1.469 0.502 0 N-CA-C 113.285 0.846 . . . . 0.0 113.285 -176.435 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' B' B ' 92' ' ' LEU . . . . . . . . . . . . . 11.4 mt -148.73 144.89 27.37 Favored 'General case' 0 C--N 1.331 -0.198 0 CA-C-O 120.818 0.342 . . . . 0.0 110.248 -176.265 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' B' B ' 93' ' ' ILE . . . . . . . . . . . . . 72.3 mt -121.59 116.43 49.48 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.224 0 N-CA-C 108.838 -0.801 . . . . 0.0 108.838 174.946 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' B' B ' 94' ' ' VAL . . . . . . . . . . . . . 43.9 t -115.7 125.8 73.0 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.294 0 N-CA-C 109.68 -0.489 . . . . 0.0 109.68 -178.084 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' B' B ' 95' ' ' VAL . . . . . . . . . . . . . 41.9 t -120.8 132.74 69.55 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.315 0 CA-C-N 116.065 -0.516 . . . . 0.0 109.681 -179.636 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' B' B ' 96' ' ' ILE . . . . . . . . . . . . . 70.7 mt -114.31 125.27 71.57 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.353 0 N-CA-C 109.228 -0.656 . . . . 0.0 109.228 178.577 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' B' B ' 97' ' ' THR . . . . . . . . . . . . . 54.6 p -96.2 155.29 16.82 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-O 121.164 0.506 . . . . 0.0 111.115 -177.583 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' B' B ' 98' ' ' GLU . . . . . . . . . . . . . 12.6 pt-20 -55.4 -20.67 12.82 Favored 'General case' 0 C--N 1.328 -0.338 0 N-CA-C 112.707 0.632 . . . . 0.0 112.707 -179.396 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' B' B ' 99' ' ' GLU . . . . . . . . . . . . . 12.8 pt-20 -84.56 17.61 2.62 Favored 'General case' 0 CA--C 1.535 0.377 0 N-CA-C 113.117 0.784 . . . . 0.0 113.117 -178.7 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' B' B ' 100' ' ' ASN . . . . . . . . . . . . . 3.1 m-20 62.86 37.95 11.8 Favored 'General case' 0 N--CA 1.462 0.171 0 CA-C-O 121.084 0.468 . . . . 0.0 111.129 177.29 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' B' B ' 101' ' ' GLU . . . . . . . . . . . . . 84.6 tt0 -117.72 141.01 48.88 Favored 'General case' 0 C--N 1.332 -0.158 0 N-CA-C 109.77 -0.456 . . . . 0.0 109.77 175.358 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' B' B ' 102' ' ' VAL . . . . . . . . . . . . . 45.2 t -114.96 127.67 72.42 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.329 0 N-CA-C 109.991 -0.374 . . . . 0.0 109.991 -178.134 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' B' B ' 103' ' ' LEU . . . . . . . . . . . . . 29.4 mt -119.27 133.99 55.45 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 115.762 -0.653 . . . . 0.0 110.19 177.599 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' B' B ' 104' ' ' ILE . . . . . 0.409 ' CD1' HG11 ' B' ' 130' ' ' VAL . 69.8 mt -118.73 121.48 67.05 Favored 'Isoleucine or valine' 0 C--O 1.233 0.215 0 CA-C-N 116.52 -0.309 . . . . 0.0 110.272 -179.449 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' B' B ' 105' ' ' PHE . . . . . . . . . . . . . 90.1 m-85 -118.57 163.31 16.98 Favored 'General case' 0 C--O 1.232 0.143 0 O-C-N 124.116 0.885 . . . . 0.0 109.692 178.442 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' B' B ' 106' ' ' ASN . . . . . . . . . . . . . 44.6 p-10 -101.21 -170.64 1.87 Allowed 'General case' 0 C--N 1.33 -0.276 0 N-CA-C 110.185 -0.302 . . . . 0.0 110.185 174.1 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' B' B ' 107' ' ' GLN . . . . . . . . . . . . . 16.5 tt0 -57.49 -26.89 61.98 Favored 'General case' 0 C--N 1.328 -0.331 0 N-CA-C 112.325 0.491 . . . . 0.0 112.325 179.526 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' B' B ' 108' ' ' ASN . . . . . . . . . . . . . 21.4 t-20 -92.41 13.53 19.26 Favored 'General case' 0 CA--C 1.535 0.396 0 N-CA-C 113.144 0.794 . . . . 0.0 113.144 -176.43 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' B' B ' 109' ' ' LEU . . . . . 0.4 HD11 ' HB3' ' A' ' 140' ' ' LEU . 38.9 mt 57.26 32.92 22.54 Favored 'General case' 0 C--O 1.233 0.22 0 N-CA-C 112.013 0.375 . . . . 0.0 112.013 178.332 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' B' B ' 110' ' ' GLU . . . . . . . . . . . . . 70.7 mm-40 -103.21 140.19 37.69 Favored 'General case' 0 C--N 1.329 -0.303 0 N-CA-C 109.497 -0.557 . . . . 0.0 109.497 175.203 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' B' B ' 111' ' ' GLU . . . . . . . . . . . . . 52.7 tt0 -76.95 121.72 23.87 Favored 'General case' 0 C--N 1.326 -0.418 0 CA-C-N 116.426 -0.352 . . . . 0.0 110.512 -175.698 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' B' B ' 112' ' ' LEU . . . . . . . . . . . . . 85.6 mt -103.09 -45.77 4.83 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.13 -0.487 . . . . 0.0 110.522 178.841 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' B' B ' 113' ' ' TYR . . . . . . . . . . . . . 65.0 t80 -137.87 144.06 41.21 Favored 'General case' 0 C--N 1.331 -0.2 0 CA-C-N 116.188 -0.46 . . . . 0.0 111.29 -178.105 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' B' B ' 114' ' ' ARG . . . . . . . . . . . . . 37.3 ptt180 -145.59 125.47 13.52 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 115.994 -0.548 . . . . 0.0 110.513 177.429 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' B' B ' 115' ' ' GLY . . . . . . . . . . . . . . . -150.22 149.22 21.07 Favored Glycine 0 CA--C 1.525 0.668 0 N-CA-C 111.12 -0.792 . . . . 0.0 111.12 179.467 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' B' B ' 116' ' ' LYS . . . . . . . . . . . . . 7.4 ttpm? -114.49 137.6 51.65 Favored 'General case' 0 C--N 1.33 -0.265 0 N-CA-C 109.661 -0.496 . . . . 0.0 109.661 176.288 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' B' B ' 117' ' ' PHE . . . . . . . . . . . . . 39.0 m-85 -137.02 113.79 10.37 Favored 'General case' 0 C--N 1.329 -0.305 0 N-CA-C 109.962 -0.384 . . . . 0.0 109.962 -179.036 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' B' B ' 118' ' ' GLU . . . . . . . . . . . . . 96.3 mt-10 -57.91 -42.42 84.69 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.332 -0.395 . . . . 0.0 110.742 -176.371 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' B' B ' 119' ' ' ASN . . . . . . . . . . . . . 69.1 m-80 -97.22 31.1 2.55 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.207 -0.451 . . . . 0.0 112.094 -174.707 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' B' B ' 120' ' ' LEU . . . . . . . . . . . . . 24.2 tp -57.1 121.23 9.54 Favored 'General case' 0 C--N 1.333 -0.136 0 C-N-CA 120.944 -0.302 . . . . 0.0 110.429 177.969 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' B' B ' 121' ' ' ASN . . . . . . . . . . . . . 27.2 m-80 -103.43 -43.56 5.38 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.356 -0.384 . . . . 0.0 110.287 -179.556 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' B' B ' 122' ' ' LYS . . . . . . . . . . . . . 53.6 pttt -165.95 152.98 9.87 Favored 'General case' 0 C--N 1.331 -0.222 0 CA-C-O 121.186 0.517 . . . . 0.0 111.892 179.047 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' B' B ' 123' ' ' VAL . . . . . . . . . . . . . 45.1 t -119.71 132.46 69.39 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.261 0 CA-C-N 115.852 -0.613 . . . . 0.0 109.538 177.911 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' B' B ' 124' ' ' LEU . . . . . . . . . . . . . 6.5 mp -119.36 136.42 54.28 Favored 'General case' 0 C--N 1.332 -0.193 0 CA-C-N 116.156 -0.474 . . . . 0.0 110.673 -177.757 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' B' B ' 125' ' ' VAL . . . . . . . . . . . . . 46.0 t -119.2 131.89 70.62 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.273 0 CA-C-N 116.002 -0.545 . . . . 0.0 109.833 178.36 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' B' B ' 126' ' ' ARG . . . . . . . . . . . . . 40.7 mmt180 -133.27 99.14 4.44 Favored 'General case' 0 C--N 1.331 -0.21 0 CA-C-N 116.25 -0.432 . . . . 0.0 110.278 179.12 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' B' B ' 127' ' ' ASN . . . . . . . . . . . . . 34.3 t-20 53.42 -104.89 0.22 Allowed 'General case' 0 CA--C 1.542 0.65 0 CA-C-O 119.02 -0.514 . . . . 0.0 111.157 178.793 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' B' B ' 128' ' ' ASP . . . . . . . . . . . . . 19.5 p-10 -105.86 -3.09 22.3 Favored 'General case' 0 CA--C 1.537 0.468 0 CA-C-N 119.562 1.074 . . . . 0.0 113.684 -175.971 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' B' B ' 129' ' ' LEU . . . . . . . . . . . . . 60.2 mt -105.09 142.84 34.16 Favored 'General case' 0 C--N 1.332 -0.157 0 O-C-N 122.102 -0.374 . . . . 0.0 110.116 178.571 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' B' B ' 130' ' ' VAL . . . . . 0.409 HG11 ' CD1' ' B' ' 104' ' ' ILE . 42.9 t -121.27 135.88 60.02 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.213 0 N-CA-C 110.016 -0.365 . . . . 0.0 110.016 -178.582 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' B' B ' 131' ' ' VAL . . . . . . . . . . . . . 39.6 t -133.13 133.34 58.47 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.278 0 CA-C-O 120.932 0.396 . . . . 0.0 110.275 179.479 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' B' B ' 132' ' ' ILE . . . . . . . . . . . . . 73.1 mt -114.06 130.17 68.73 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.363 0 N-CA-C 109.263 -0.643 . . . . 0.0 109.263 178.604 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' B' B ' 133' ' ' ILE . . . . . . . . . . . . . 42.3 mm -111.98 119.61 60.46 Favored 'Isoleucine or valine' 0 C--O 1.234 0.247 0 CA-C-O 120.877 0.37 . . . . 0.0 110.878 -176.095 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' B' B ' 134' ' ' ASP . . . . . . . . . . . . . 7.4 p-10 -132.88 143.56 49.59 Favored 'General case' 0 C--N 1.33 -0.246 0 N-CA-C 109.312 -0.625 . . . . 0.0 109.312 175.449 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' B' B ' 135' ' ' GLU . . . . . . . . . . . . . 77.7 tt0 -49.99 -25.77 3.64 Favored 'General case' 0 C--N 1.327 -0.389 0 N-CA-C 112.697 0.629 . . . . 0.0 112.697 -174.599 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' B' B ' 136' ' ' GLN . . . . . . . . . . . . . 47.7 tt0 -85.54 -31.42 22.71 Favored 'General case' 0 C--O 1.233 0.192 0 N-CA-C 112.386 0.513 . . . . 0.0 112.386 -175.388 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' B' B ' 137' ' ' LYS . . . . . . . . . . . . . 18.2 ptpt -164.7 174.06 11.17 Favored 'General case' 0 C--O 1.233 0.205 0 CA-C-O 121.64 0.733 . . . . 0.0 112.193 -175.359 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' B' B ' 138' ' ' LEU . . . . . 0.409 HD23 ' N ' ' B' ' 139' ' ' THR . 6.5 tt -119.5 128.87 54.37 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 114.938 -1.028 . . . . 0.0 109.504 176.418 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' B' B ' 139' ' ' THR . . . . . 0.409 ' N ' HD23 ' B' ' 138' ' ' LEU . 25.4 m -108.1 126.0 52.24 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.315 -0.402 . . . . 0.0 110.467 -179.933 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' B' B ' 140' ' ' LEU . . . . . . . . . . . . . 17.2 tp -112.95 119.9 39.55 Favored 'General case' 0 C--N 1.331 -0.209 0 CA-C-N 115.791 -0.64 . . . . 0.0 109.304 -178.926 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' B' B ' 141' ' ' ILE . . . . . . . . . . . . . 19.2 mt -119.16 123.19 70.93 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.289 0 CA-C-O 120.884 0.373 . . . . 0.0 110.118 -173.845 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' B' B ' 142' ' ' ARG . . . . . . . . . . . . . 72.7 mtt180 -108.79 127.58 54.14 Favored 'General case' 0 C--N 1.331 -0.239 0 CA-C-N 115.439 -0.801 . . . . 0.0 110.027 -176.301 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' B' B ' 143' ' ' THR . . . . . . . . . . . . . 52.9 p . . . . . 0 C--O 1.221 -0.442 0 CA-C-O 117.992 -1.004 . . . . 0.0 110.576 179.804 . . . . . . . . 0 0 . 1 . 017 nuclear build full ' C' C ' -3' ' ' GLU . . . . . . . . . . . . . 95.6 mt-10 . . . . . 0 N--CA 1.49 1.537 0 N-CA-C 109.344 -0.613 . . . . 0.0 109.344 . . . . . . . . . 0 0 . 1 . 017 nuclear build full ' C' C ' -2' ' ' GLY . . . . . . . . . . . . . . . -67.29 105.67 1.43 Allowed Glycine 0 CA--C 1.524 0.647 0 N-CA-C 111.067 -0.813 . . . . 0.0 111.067 -179.559 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' C' C ' -1' ' ' VAL . . . . . . . . . . . . . 43.5 t -140.95 138.81 34.39 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.336 0 N-CA-C 109.991 -0.374 . . . . 0.0 109.991 179.093 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' C' C ' 0' ' ' ILE . . . . . . . . . . . . . 72.6 mt -107.26 130.24 59.73 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.289 0 CA-C-N 116.283 -0.417 . . . . 0.0 109.943 -179.505 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' C' C ' 1' ' ' MET . . . . . . . . . . . . . 25.8 ptm -84.04 131.49 34.81 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.106 -0.497 . . . . 0.0 110.468 178.937 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' C' C ' 2' ' ' SER . . . . . . . . . . . . . 55.2 p -117.04 146.0 43.36 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-N 116.291 -0.413 . . . . 0.0 110.554 -179.95 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' C' C ' 3' ' ' GLU . . . . . . . . . . . . . 42.7 mt-10 -140.37 141.07 35.64 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.039 -0.528 . . . . 0.0 111.013 -178.458 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' C' C ' 4' ' ' LEU . . . . . . . . . . . . . 19.0 tp -124.27 128.28 48.92 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 115.808 -0.633 . . . . 0.0 109.976 176.19 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' C' C ' 5' ' ' LYS . . . . . . . . . . . . . 99.1 mttt -110.36 123.43 49.83 Favored 'General case' 0 C--O 1.234 0.254 0 CA-C-O 120.672 0.272 . . . . 0.0 110.929 179.877 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' C' C ' 6' ' ' LEU . . . . . . . . . . . . . 52.4 mt -114.61 145.62 41.77 Favored 'General case' 0 C--N 1.332 -0.185 0 CA-C-N 115.559 -0.746 . . . . 0.0 110.146 178.586 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' C' C ' 7' ' ' LYS . . . . . . . . . . . . . 35.7 ttpt -127.36 141.41 40.78 Favored Pre-proline 0 CA--C 1.533 0.319 0 CA-C-O 119.071 -0.49 . . . . 0.0 109.711 175.286 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' C' C ' 8' ' ' PRO . . . . . . . . . . . . . 91.7 Cg_endo -91.69 138.56 2.1 Favored 'Trans proline' 0 N--CA 1.489 1.211 0 C-N-CA 121.718 1.612 . . . . 0.0 112.129 179.255 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' C' C ' 9' ' ' LEU . . . . . . . . . . . . . 67.8 mt -78.19 -47.16 2.12 Favored Pre-proline 0 C--N 1.329 -0.312 0 CA-C-O 118.714 -0.66 . . . . 0.0 111.826 178.189 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' C' C ' 10' ' ' PRO . . . . . . . . . . . . . 85.5 Cg_endo -81.14 151.61 18.19 Favored 'Trans proline' 0 N--CA 1.495 1.613 0 C-N-CA 121.14 1.226 . . . . 0.0 111.536 174.58 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' C' C ' 11' ' ' LYS . . . . . . . . . . . . . 66.7 tttt -88.33 98.85 11.82 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-O 120.836 0.351 . . . . 0.0 110.194 178.712 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' C' C ' 12' ' ' VAL . . . . . . . . . . . . . 13.2 p -140.03 147.14 23.93 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.285 0 CA-C-N 116.29 -0.414 . . . . 0.0 110.727 -178.463 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' C' C ' 13' ' ' GLU . . . . . . . . . . . . . 84.1 tt0 -88.96 123.82 33.66 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.21 -0.45 . . . . 0.0 109.908 176.978 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' C' C ' 14' ' ' LEU . . . . . . . . . . . . . 22.2 mt -98.14 152.29 37.94 Favored Pre-proline 0 C--N 1.329 -0.299 0 CA-C-N 116.402 -0.363 . . . . 0.0 110.84 -177.189 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' C' C ' 15' ' ' PRO . . . . . . . . . . . . . 25.6 Cg_exo -62.31 157.02 47.6 Favored 'Trans proline' 0 N--CA 1.498 1.761 0 C-N-CA 121.261 1.308 . . . . 0.0 111.713 176.116 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' C' C ' 16' ' ' PRO . . . . . . . . . . . . . 39.5 Cg_exo -58.72 -36.47 97.08 Favored 'Trans proline' 0 N--CA 1.498 1.776 0 C-N-CA 121.389 1.393 . . . . 0.0 112.65 -179.533 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' C' C ' 17' ' ' ASP . . . . . . . . . . . . . 16.6 p-10 -85.66 7.94 21.46 Favored 'General case' 0 CA--C 1.535 0.393 0 N-CA-C 113.23 0.826 . . . . 0.0 113.23 -177.641 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' C' C ' 18' ' ' PHE . . . . . . . . . . . . . 43.9 t80 -58.09 -46.8 84.89 Favored 'General case' 0 N--CA 1.456 -0.126 0 O-C-N 121.983 -0.448 . . . . 0.0 110.285 -176.876 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' C' C ' 19' ' ' VAL . . . . . 0.4 HG13 ' N ' ' C' ' 20' ' ' ASP . 14.7 p -55.48 -41.76 64.72 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.288 0 CA-C-N 116.523 -0.308 . . . . 0.0 111.029 -178.019 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' C' C ' 20' ' ' ASP . . . . . 0.4 ' N ' HG13 ' C' ' 19' ' ' VAL . 78.3 m-20 -61.4 -44.44 97.14 Favored 'General case' 0 C--N 1.329 -0.286 0 C-N-CA 120.935 -0.306 . . . . 0.0 111.231 -178.198 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' C' C ' 21' ' ' VAL . . . . . . . . . . . . . 47.6 t -64.11 -45.22 97.12 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.287 0 C-N-CA 120.715 -0.394 . . . . 0.0 110.447 -176.953 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' C' C ' 22' ' ' ILE . . . . . 0.41 HG22 HD12 ' C' ' 26' ' ' LEU . 51.0 mm -56.5 -46.25 82.27 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.227 0 C-N-CA 120.872 -0.331 . . . . 0.0 110.55 178.614 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' C' C ' 23' ' ' ARG . . . . . . . . . . . . . 56.1 ttp180 -54.89 -46.75 74.84 Favored 'General case' 0 C--N 1.329 -0.302 0 C-N-CA 121.057 -0.257 . . . . 0.0 111.384 -179.269 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' C' C ' 24' ' ' ILE . . . . . . . . . . . . . 79.7 mt -59.58 -43.87 91.97 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.303 0 C-N-CA 121.075 -0.25 . . . . 0.0 111.246 -177.987 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' C' C ' 25' ' ' LYS . . . . . . . . . . . . . 97.4 mttt -66.01 -42.1 90.12 Favored 'General case' 0 C--N 1.328 -0.361 0 N-CA-C 112.504 0.557 . . . . 0.0 112.504 -178.878 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' C' C ' 26' ' ' LEU . . . . . 0.41 HD12 HG22 ' C' ' 22' ' ' ILE . 93.0 mt -77.91 -38.79 44.88 Favored 'General case' 0 C--N 1.33 -0.254 0 N-CA-C 113.216 0.821 . . . . 0.0 113.216 -170.833 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' C' C ' 27' ' ' GLN . . . . . . . . . . . . . 14.0 pt20 -47.19 139.94 5.66 Favored 'General case' 0 N--CA 1.469 0.521 0 N-CA-C 112.709 0.633 . . . . 0.0 112.709 -176.137 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' C' C ' 28' ' ' GLY . . . . . . . . . . . . . . . 100.61 -26.15 25.69 Favored Glycine 0 CA--C 1.534 1.269 0 CA-C-N 115.598 -0.728 . . . . 0.0 112.14 -176.3 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' C' C ' 29' ' ' LYS . . . . . . . . . . . . . 37.9 mtmm -98.79 155.02 17.57 Favored 'General case' 0 C--N 1.332 -0.181 0 CA-C-N 117.295 0.547 . . . . 0.0 111.292 179.115 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' C' C ' 30' ' ' THR . . . . . . . . . . . . . 50.1 m -107.84 136.45 47.55 Favored 'General case' 0 C--N 1.332 -0.19 0 CA-C-N 116.147 -0.479 . . . . 0.0 109.991 176.349 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' C' C ' 31' ' ' VAL . . . . . . . . . . . . . 34.9 m -132.2 162.16 40.16 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.247 0 CA-C-N 116.302 -0.408 . . . . 0.0 111.036 -178.347 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' C' C ' 32' ' ' ARG . . . . . . . . . . . . . 81.6 mtt180 -132.29 152.43 51.38 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 115.989 -0.551 . . . . 0.0 110.591 178.654 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' C' C ' 33' ' ' THR . . . . . . . . . . . . . 28.8 m -53.61 140.18 29.63 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.299 -0.41 . . . . 0.0 111.237 -179.313 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' C' C ' 34' ' ' GLY . . . . . . . . . . . . . . . 100.49 -17.16 57.12 Favored Glycine 0 CA--C 1.532 1.139 0 CA-C-O 119.589 -0.562 . . . . 0.0 113.17 179.755 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' C' C ' 35' ' ' ASP . . . . . . . . . . . . . 72.1 m-20 -65.98 149.69 49.83 Favored 'General case' 0 N--CA 1.461 0.123 0 CA-C-N 118.127 0.963 . . . . 0.0 111.151 178.79 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' C' C ' 36' ' ' VAL . . . . . . . . . . . . . 43.5 t -122.6 130.82 74.23 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.213 0 CA-C-N 115.968 -0.56 . . . . 0.0 109.934 178.9 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' C' C ' 37' ' ' ILE . . . . . . . . . . . . . 69.3 mt -122.53 140.55 45.99 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.205 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.093 -178.928 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' C' C ' 38' ' ' GLY . . . . . . . . . . . . . . . -115.7 128.73 8.17 Favored Glycine 0 CA--C 1.525 0.708 0 N-CA-C 111.177 -0.769 . . . . 0.0 111.177 179.42 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' C' C ' 39' ' ' ILE . . . . . . . . . . . . . 72.9 mt -125.9 135.69 63.12 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.306 0 N-CA-C 110.136 -0.32 . . . . 0.0 110.136 179.245 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' C' C ' 40' ' ' SER . . . . . . . . . . . . . 9.7 t -93.32 114.08 26.43 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.343 -0.389 . . . . 0.0 111.132 177.268 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' C' C ' 41' ' ' ILE . . . . . . . . . . . . . 45.8 mm -122.58 119.55 58.46 Favored 'Isoleucine or valine' 0 CA--C 1.529 0.153 0 N-CA-C 110.07 -0.344 . . . . 0.0 110.07 178.758 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' C' C ' 42' ' ' LEU . . . . . . . . . . . . . 41.3 mt 57.39 34.06 24.15 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.394 -0.366 . . . . 0.0 111.916 177.479 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' C' C ' 43' ' ' GLY . . . . . . . . . . . . . . . 79.32 -10.13 37.37 Favored Glycine 0 CA--C 1.535 1.325 0 C-N-CA 121.271 -0.49 . . . . 0.0 113.485 177.312 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' C' C ' 44' ' ' LYS . . . . . . . . . . . . . 64.0 mmtt -100.46 134.72 42.99 Favored 'General case' 0 C--N 1.332 -0.156 0 CA-C-N 117.887 0.844 . . . . 0.0 110.079 175.878 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' C' C ' 45' ' ' GLU . . . . . . . . . . . . . 84.0 tt0 -85.18 131.57 34.41 Favored 'General case' 0 C--N 1.326 -0.425 0 CA-C-N 116.455 -0.339 . . . . 0.0 111.159 -179.279 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' C' C ' 46' ' ' VAL . . . . . . . . . . . . . 9.5 p -120.97 125.77 74.41 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.189 0 N-CA-C 109.585 -0.524 . . . . 0.0 109.585 174.428 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' C' C ' 47' ' ' LYS . . . . . . . . . . . . . 82.8 mttt -98.8 125.96 44.31 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 115.993 -0.549 . . . . 0.0 110.524 177.83 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' C' C ' 48' ' ' PHE . . . . . . . . . . . . . 31.0 m-85 -110.53 131.91 54.64 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.359 -0.382 . . . . 0.0 110.175 178.293 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' C' C ' 49' ' ' LYS . . . . . . . . . . . . . 58.5 tttt -105.92 132.42 52.05 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.251 -0.431 . . . . 0.0 109.97 177.677 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' C' C ' 50' ' ' VAL . . . . . . . . . . . . . 46.0 t -75.74 104.98 4.29 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.247 0 N-CA-C 109.14 -0.689 . . . . 0.0 109.14 176.552 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' C' C ' 51' ' ' VAL . . . . . . . . . . . . . 47.3 t -69.17 -48.51 68.43 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.324 0 CA-C-N 116.085 -0.507 . . . . 0.0 109.925 -173.418 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' C' C ' 52' ' ' GLN . . . . . . . . . . . . . 46.9 tt0 -168.33 146.83 4.34 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 115.95 -0.568 . . . . 0.0 111.381 -178.706 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' C' C ' 53' ' ' ALA . . . . . . . . . . . . . . . -122.61 136.54 54.91 Favored 'General case' 0 C--N 1.331 -0.209 0 CA-C-N 115.842 -0.617 . . . . 0.0 110.109 177.032 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' C' C ' 54' ' ' TYR . . . . . . . . . . . . . 58.3 t80 -129.12 112.11 18.37 Favored Pre-proline 0 CA--C 1.534 0.329 0 CA-C-O 118.081 -0.961 . . . . 0.0 110.202 177.55 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' C' C ' 55' ' ' PRO . . . . . . . . . . . . . 72.8 Cg_endo -77.31 170.14 72.16 Favored 'Cis proline' 0 N--CA 1.499 1.829 0 CA-C-N 122.015 1.755 . . . . 0.0 112.337 -6.283 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' C' C ' 56' ' ' SER . . . . . . . . . . . . . 25.5 m -122.25 135.65 25.67 Favored Pre-proline 0 CA--C 1.538 0.491 0 CA-C-O 118.513 -0.756 . . . . 0.0 109.537 175.049 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' C' C ' 57' ' ' PRO . . . . . . . . . . . . . 34.9 Cg_endo -66.29 160.85 75.13 Favored 'Cis proline' 0 N--CA 1.499 1.799 0 CA-C-N 121.864 1.701 . . . . 0.0 111.525 -2.839 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' C' C ' 58' ' ' LEU . . . . . . . . . . . . . 30.3 tp -127.57 136.4 51.64 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-O 121.118 0.485 . . . . 0.0 110.713 -178.101 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' C' C ' 59' ' ' ARG . . . . . . . . . . . . . 20.7 ttm180 -103.01 122.52 44.78 Favored 'General case' 0 C--N 1.327 -0.411 0 N-CA-C 108.919 -0.771 . . . . 0.0 108.919 173.936 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' C' C ' 60' ' ' VAL . . . . . . . . . . . . . 39.9 t -77.72 120.81 29.09 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.323 0 C-N-CA 120.561 -0.456 . . . . 0.0 110.349 -173.647 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' C' C ' 61' ' ' GLU . . . . . . . . . . . . . 96.3 mt-10 -131.13 165.5 23.15 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 115.679 -0.691 . . . . 0.0 109.567 176.807 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' C' C ' 62' ' ' ASP . . . . . . . . . . . . . 7.8 p-10 -53.09 -31.25 40.9 Favored 'General case' 0 C--N 1.329 -0.325 0 N-CA-C 111.912 0.338 . . . . 0.0 111.912 179.816 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' C' C ' 63' ' ' ARG . . . . . . . . . . . . . 87.6 mtt180 -71.77 -22.1 61.64 Favored 'General case' 0 CA--C 1.533 0.293 0 N-CA-C 112.962 0.727 . . . . 0.0 112.962 -176.307 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' C' C ' 64' ' ' THR . . . . . . . . . . . . . 32.9 m -74.48 136.6 42.26 Favored 'General case' 0 C--N 1.332 -0.192 0 CA-C-O 120.918 0.389 . . . . 0.0 110.832 -175.956 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' C' C ' 65' ' ' LYS . . . . . . . . . . . . . 96.0 mttt -89.36 133.88 34.31 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.023 -0.535 . . . . 0.0 109.977 179.013 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' C' C ' 66' ' ' ILE . . . . . . . . . . . . . 65.3 mt -115.48 130.56 69.87 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.266 0 N-CA-C 109.976 -0.379 . . . . 0.0 109.976 179.739 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' C' C ' 67' ' ' THR . . . . . . . . . . . . . 23.8 m -122.54 138.42 54.58 Favored 'General case' 0 C--N 1.331 -0.214 0 CA-C-N 115.929 -0.578 . . . . 0.0 110.516 -179.071 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' C' C ' 68' ' ' LEU . . . . . 0.437 HD23 ' C ' ' C' ' 68' ' ' LEU . 5.8 tt -106.24 124.34 49.44 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 115.959 -0.564 . . . . 0.0 110.173 178.795 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' C' C ' 69' ' ' VAL . . . . . 0.401 ' N ' HD23 ' C' ' 68' ' ' LEU . 46.6 t -98.1 128.82 49.14 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.283 0 N-CA-C 109.598 -0.519 . . . . 0.0 109.598 179.016 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' C' C ' 70' ' ' THR . . . . . . . . . . . . . 24.0 m -107.35 92.47 4.09 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.209 -0.45 . . . . 0.0 110.735 -177.976 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' C' C ' 71' ' ' HIS . . . . . . . . . . . . . 51.4 m80 -150.05 146.92 20.98 Favored Pre-proline 0 C--N 1.329 -0.319 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.195 177.377 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' C' C ' 72' ' ' PRO . . . . . . . . . . . . . 86.8 Cg_endo -91.1 -7.27 3.72 Favored 'Trans proline' 0 N--CA 1.492 1.44 0 C-N-CA 121.786 1.657 . . . . 0.0 113.831 178.215 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' C' C ' 73' ' ' VAL . . . . . . . . . . . . . 34.0 m -130.59 170.91 18.57 Favored 'Isoleucine or valine' 0 C--O 1.231 0.094 0 CA-C-O 120.894 0.378 . . . . 0.0 110.871 -176.762 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' C' C ' 74' ' ' ASP . . . . . . . . . . . . . 8.0 t70 -103.84 126.03 50.68 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.105 -0.498 . . . . 0.0 109.737 179.993 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' C' C ' 75' ' ' VAL . . . . . . . . . . . . . 40.5 t -121.13 127.95 75.95 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.345 0 CA-C-O 121.169 0.509 . . . . 0.0 110.957 -176.633 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' C' C ' 76' ' ' LEU . . . . . . . . . . . . . 5.2 mp -121.47 144.67 48.56 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 115.488 -0.778 . . . . 0.0 109.523 174.244 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' C' C ' 77' ' ' GLU . . . . . . . . . . . . . 47.1 mt-10 -133.92 137.84 45.15 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-O 121.033 0.444 . . . . 0.0 111.127 -177.629 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' C' C ' 78' ' ' ALA . . . . . 0.643 ' HB2' HD21 ' C' ' 109' ' ' LEU . . . -125.79 128.61 47.96 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 115.78 -0.646 . . . . 0.0 109.707 176.477 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' C' C ' 79' ' ' LYS . . . . . 0.622 ' O ' HD13 ' C' ' 80' ' ' ILE . 54.1 mtmt -77.45 122.72 25.59 Favored 'General case' 0 C--N 1.331 -0.214 0 CA-C-O 121.044 0.449 . . . . 0.0 110.667 -178.327 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' C' C ' 80' ' ' ILE . . . . . 0.622 HD13 ' O ' ' C' ' 79' ' ' LYS . 39.4 mm -139.05 114.16 8.36 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.356 0 N-CA-C 109.178 -0.675 . . . . 0.0 109.178 -177.779 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' C' C ' 81' ' ' LYS . . . . . . . . . . . . . 31.8 ttpt -101.4 121.99 42.92 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-O 120.821 0.343 . . . . 0.0 111.002 -177.461 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' C' C ' 82' ' ' GLY . . . . . . . . . . . . . . . 89.12 42.23 5.65 Favored Glycine 0 CA--C 1.527 0.786 0 C-N-CA 120.683 -0.77 . . . . 0.0 111.91 174.246 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' C' C ' 83' ' ' ILE . . . . . . . . . . . . . 73.4 mt -67.74 131.91 32.87 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.341 0 N-CA-C 109.468 -0.567 . . . . 0.0 109.468 175.944 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' C' C ' 84' ' ' LYS . . . . . . . . . . . . . 72.8 tttt -88.84 -53.26 4.69 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-O 121.046 0.451 . . . . 0.0 110.181 -178.22 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' C' C ' 85' ' ' ASP . . . . . . . . . . . . . 11.5 t70 -155.85 152.96 29.0 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 115.626 -0.715 . . . . 0.0 110.146 179.201 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' C' C ' 86' ' ' VAL . . . . . . . . . . . . . 46.6 t -128.65 130.59 68.9 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.252 0 CA-C-O 120.961 0.41 . . . . 0.0 110.564 -178.475 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' C' C ' 87' ' ' ILE . . . . . . . . . . . . . 45.0 mm -119.58 126.54 75.42 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.303 0 CA-C-N 115.781 -0.645 . . . . 0.0 109.612 177.453 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' C' C ' 88' ' ' LEU . . . . . . . . . . . . . 86.5 mt -111.15 139.34 46.61 Favored 'General case' 0 C--N 1.331 -0.214 0 CA-C-O 121.152 0.501 . . . . 0.0 111.286 -178.151 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' C' C ' 89' ' ' ASP . . . . . . . . . . . . . 46.8 t0 -130.57 162.94 28.18 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 115.462 -0.79 . . . . 0.0 109.457 176.864 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' C' C ' 90' ' ' GLU . . . . . . . . . . . . . 45.5 tp10 -44.99 -44.51 9.96 Favored 'General case' 0 N--CA 1.465 0.293 0 N-CA-C 113.222 0.823 . . . . 0.0 113.222 -170.874 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' C' C ' 91' ' ' ASN . . . . . . . . . . . . . 31.0 m120 -132.12 26.41 4.55 Favored 'General case' 0 N--CA 1.467 0.381 0 N-CA-C 112.473 0.546 . . . . 0.0 112.473 -178.478 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' C' C ' 92' ' ' LEU . . . . . . . . . . . . . 36.5 mt -146.58 144.87 29.86 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-O 120.736 0.303 . . . . 0.0 110.51 -176.931 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' C' C ' 93' ' ' ILE . . . . . . . . . . . . . 65.3 mt -124.18 115.07 43.75 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.311 0 N-CA-C 109.104 -0.702 . . . . 0.0 109.104 177.505 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' C' C ' 94' ' ' VAL . . . . . 0.516 HG11 HG11 ' C' ' 123' ' ' VAL . 46.6 t -115.89 126.4 73.39 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.218 0 N-CA-C 109.763 -0.458 . . . . 0.0 109.763 -179.382 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' C' C ' 95' ' ' VAL . . . . . . . . . . . . . 43.2 t -121.18 133.72 66.86 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.372 0 CA-C-N 116.047 -0.524 . . . . 0.0 109.935 -178.893 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' C' C ' 96' ' ' ILE . . . . . . . . . . . . . 67.8 mt -110.14 124.52 66.95 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.317 0 N-CA-C 108.939 -0.763 . . . . 0.0 108.939 177.637 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' C' C ' 97' ' ' THR . . . . . . . . . . . . . 82.7 p -97.8 155.01 17.23 Favored 'General case' 0 C--N 1.327 -0.395 0 CA-C-O 121.059 0.457 . . . . 0.0 111.025 -177.176 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' C' C ' 98' ' ' GLU . . . . . . . . . . . . . 84.2 tt0 -53.79 -23.22 11.36 Favored 'General case' 0 C--N 1.327 -0.399 0 N-CA-C 112.379 0.511 . . . . 0.0 112.379 -179.835 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' C' C ' 99' ' ' GLU . . . . . . . . . . . . . 68.9 mm-40 -82.26 15.05 2.58 Favored 'General case' 0 CA--C 1.536 0.412 0 N-CA-C 113.2 0.815 . . . . 0.0 113.2 -176.569 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' C' C ' 100' ' ' ASN . . . . . . . . . . . . . 3.0 m-20 62.83 33.5 15.18 Favored 'General case' 0 N--CA 1.465 0.276 0 CA-C-O 120.914 0.387 . . . . 0.0 111.535 179.336 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' C' C ' 101' ' ' GLU . . . . . . . . . . . . . 84.9 tt0 -113.12 145.88 40.17 Favored 'General case' 0 C--N 1.331 -0.225 0 N-CA-C 109.639 -0.504 . . . . 0.0 109.639 174.144 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' C' C ' 102' ' ' VAL . . . . . . . . . . . . . 44.9 t -114.87 123.56 70.68 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.316 0 N-CA-C 109.717 -0.475 . . . . 0.0 109.717 -178.484 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' C' C ' 103' ' ' LEU . . . . . . . . . . . . . 35.5 mt -115.29 132.74 56.52 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 115.804 -0.634 . . . . 0.0 109.82 178.888 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' C' C ' 104' ' ' ILE . . . . . . . . . . . . . 64.6 mt -123.86 121.56 62.54 Favored 'Isoleucine or valine' 0 C--O 1.234 0.248 0 N-CA-C 110.432 -0.21 . . . . 0.0 110.432 -179.241 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' C' C ' 105' ' ' PHE . . . . . . . . . . . . . 61.8 m-85 -118.91 165.29 14.25 Favored 'General case' 0 C--N 1.33 -0.254 0 O-C-N 124.104 0.878 . . . . 0.0 109.617 178.561 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' C' C ' 106' ' ' ASN . . . . . . . . . . . . . 40.9 p-10 -101.21 -169.9 1.76 Allowed 'General case' 0 C--N 1.33 -0.25 0 N-CA-C 109.857 -0.423 . . . . 0.0 109.857 173.627 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' C' C ' 107' ' ' GLN . . . . . . . . . . . . . 49.2 tt0 -56.42 -29.69 61.89 Favored 'General case' 0 CA--C 1.534 0.332 0 N-CA-C 111.823 0.305 . . . . 0.0 111.823 176.744 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' C' C ' 108' ' ' ASN . . . . . . . . . . . . . 8.0 t-20 -84.35 9.57 12.81 Favored 'General case' 0 CA--C 1.536 0.43 0 N-CA-C 113.205 0.816 . . . . 0.0 113.205 -176.684 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' C' C ' 109' ' ' LEU . . . . . 0.643 HD21 ' HB2' ' C' ' 78' ' ' ALA . 8.0 tp 56.05 36.55 27.59 Favored 'General case' 0 C--N 1.332 -0.167 0 CA-C-O 120.923 0.392 . . . . 0.0 111.339 179.442 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' C' C ' 110' ' ' GLU . . . . . . . . . . . . . 70.5 mm-40 -107.79 150.29 27.17 Favored 'General case' 0 C--N 1.333 -0.141 0 N-CA-C 110.07 -0.344 . . . . 0.0 110.07 176.876 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' C' C ' 111' ' ' GLU . . . . . . . . . . . . . 98.0 mt-10 -77.16 122.29 24.8 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-O 120.876 0.37 . . . . 0.0 111.051 -178.296 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' C' C ' 112' ' ' LEU . . . . . . . . . . . . . 17.9 mt -108.62 -46.0 3.75 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 115.988 -0.551 . . . . 0.0 110.388 177.08 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' C' C ' 113' ' ' TYR . . . . . . . . . . . . . 59.6 t80 -136.75 137.68 40.13 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.359 -0.382 . . . . 0.0 111.048 179.943 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' C' C ' 114' ' ' ARG . . . . . . . . . . . . . 72.4 mtm180 -141.44 122.08 14.25 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 115.998 -0.546 . . . . 0.0 110.482 178.111 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' C' C ' 115' ' ' GLY . . . . . . . . . . . . . . . -150.11 160.91 28.73 Favored Glycine 0 CA--C 1.525 0.708 0 N-CA-C 111.03 -0.828 . . . . 0.0 111.03 178.572 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' C' C ' 116' ' ' LYS . . . . . . . . . . . . . 72.5 tttt -134.27 133.43 40.79 Favored 'General case' 0 C--N 1.33 -0.266 0 N-CA-C 110.021 -0.363 . . . . 0.0 110.021 179.27 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' C' C ' 117' ' ' PHE . . . . . . . . . . . . . 31.2 m-85 -133.06 123.15 25.25 Favored 'General case' 0 C--N 1.331 -0.202 0 CA-C-O 120.932 0.396 . . . . 0.0 110.363 -174.457 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' C' C ' 118' ' ' GLU . . . . . . . . . . . . . 43.4 mt-10 -53.77 -48.54 69.65 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.459 -0.337 . . . . 0.0 111.4 -176.49 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' C' C ' 119' ' ' ASN . . . . . . . . . . . . . 67.5 m-80 -98.57 31.03 3.01 Favored 'General case' 0 C--N 1.329 -0.321 0 N-CA-C 112.255 0.465 . . . . 0.0 112.255 -174.098 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' C' C ' 120' ' ' LEU . . . . . . . . . . . . . 18.4 tp -56.6 120.27 7.49 Favored 'General case' 0 N--CA 1.462 0.15 0 C-N-CA 121.04 -0.264 . . . . 0.0 110.325 177.888 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' C' C ' 121' ' ' ASN . . . . . . . . . . . . . 9.8 t-20 -109.42 -44.03 3.98 Favored 'General case' 0 C--N 1.331 -0.219 0 CA-C-N 116.58 -0.282 . . . . 0.0 111.192 -175.646 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' C' C ' 122' ' ' LYS . . . . . . . . . . . . . 15.9 ptpt -154.77 153.54 31.39 Favored 'General case' 0 C--N 1.332 -0.187 0 CA-C-O 121.286 0.565 . . . . 0.0 112.019 -178.291 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' C' C ' 123' ' ' VAL . . . . . 0.516 HG11 HG11 ' C' ' 94' ' ' VAL . 45.6 t -121.68 130.89 74.2 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.224 0 CA-C-N 115.698 -0.683 . . . . 0.0 109.474 176.223 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' C' C ' 124' ' ' LEU . . . . . 0.429 HD12 ' N ' ' C' ' 124' ' ' LEU . 6.2 mp -121.4 140.02 52.69 Favored 'General case' 0 C--N 1.331 -0.215 0 CA-C-N 116.319 -0.401 . . . . 0.0 110.635 -178.05 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' C' C ' 125' ' ' VAL . . . . . 0.436 HG11 HG21 ' C' ' 94' ' ' VAL . 35.2 m -134.78 140.12 46.16 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.258 0 CA-C-N 116.334 -0.394 . . . . 0.0 110.453 178.237 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' C' C ' 126' ' ' ARG . . . . . . . . . . . . . 52.5 ttt85 -149.13 118.69 6.95 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-O 120.907 0.384 . . . . 0.0 110.615 178.322 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' C' C ' 127' ' ' ASN . . . . . . . . . . . . . 35.7 t30 50.83 -104.95 0.18 Allowed 'General case' 0 CA--C 1.542 0.668 0 CA-C-N 116.144 -0.48 . . . . 0.0 111.572 179.862 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' C' C ' 128' ' ' ASP . . . . . . . . . . . . . 11.8 p-10 -110.61 -0.17 17.34 Favored 'General case' 0 CA--C 1.536 0.413 0 CA-C-N 119.501 1.046 . . . . 0.0 113.658 -175.043 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' C' C ' 129' ' ' LEU . . . . . . . . . . . . . 88.0 mt -106.35 142.73 35.54 Favored 'General case' 0 C--O 1.232 0.138 0 CA-C-N 118.186 0.448 . . . . 0.0 110.838 -179.451 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' C' C ' 130' ' ' VAL . . . . . . . . . . . . . 47.0 t -122.04 135.91 60.63 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.302 0 N-CA-C 109.619 -0.511 . . . . 0.0 109.619 178.625 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' C' C ' 131' ' ' VAL . . . . . . . . . . . . . 42.9 t -133.48 137.1 53.64 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.269 0 CA-C-O 121.018 0.437 . . . . 0.0 110.624 -178.726 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' C' C ' 132' ' ' ILE . . . . . . . . . . . . . 74.3 mt -115.61 130.46 70.21 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.304 0 CA-C-N 115.642 -0.708 . . . . 0.0 109.262 178.762 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' C' C ' 133' ' ' ILE . . . . . . . . . . . . . 43.7 mm -116.62 121.32 67.4 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.215 0 CA-C-O 120.774 0.321 . . . . 0.0 111.04 -175.447 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' C' C ' 134' ' ' ASP . . . . . . . . . . . . . 8.2 p-10 -136.11 144.3 45.03 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 115.878 -0.601 . . . . 0.0 109.443 173.756 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' C' C ' 135' ' ' GLU . . . . . . . . . . . . . 42.2 tp10 -49.81 -23.85 2.08 Favored 'General case' 0 C--N 1.327 -0.395 0 N-CA-C 112.724 0.639 . . . . 0.0 112.724 -172.226 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' C' C ' 136' ' ' GLN . . . . . . . . . . . . . 50.5 tt0 -93.13 -36.77 12.48 Favored 'General case' 0 C--O 1.233 0.2 0 N-CA-C 112.082 0.401 . . . . 0.0 112.082 -176.468 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' C' C ' 137' ' ' LYS . . . . . . . . . . . . . 89.9 mttt -140.12 155.06 47.15 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-O 121.251 0.548 . . . . 0.0 111.648 -171.185 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' C' C ' 138' ' ' LEU . . . . . . . . . . . . . 5.2 tt -117.8 123.54 46.22 Favored 'General case' 0 C--N 1.329 -0.321 0 N-CA-C 108.881 -0.785 . . . . 0.0 108.881 171.544 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' C' C ' 139' ' ' THR . . . . . . . . . . . . . 31.2 m -113.35 131.11 56.09 Favored 'General case' 0 C--N 1.331 -0.215 0 CA-C-O 120.875 0.369 . . . . 0.0 111.05 -176.353 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' C' C ' 140' ' ' LEU . . . . . 0.476 ' C ' HD23 ' C' ' 140' ' ' LEU . 6.8 tt -116.61 122.67 45.3 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 115.333 -0.849 . . . . 0.0 108.914 -179.407 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' C' C ' 141' ' ' ILE . . . . . . . . . . . . . 19.5 mt -119.81 120.41 63.21 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.276 0 CA-C-O 120.929 0.395 . . . . 0.0 110.02 -176.239 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' C' C ' 142' ' ' ARG . . . . . . . . . . . . . 57.6 mtp180 -105.05 124.38 49.43 Favored 'General case' 0 C--N 1.331 -0.212 0 CA-C-N 115.431 -0.804 . . . . 0.0 110.014 179.319 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' C' C ' 143' ' ' THR . . . . . . . . . . . . . 21.3 p . . . . . 0 C--O 1.221 -0.44 0 CA-C-O 117.98 -1.009 . . . . 0.0 110.572 -179.248 . . . . . . . . 0 0 . 1 . 017 nuclear build full ' D' D ' -3' ' ' GLU . . . . . . . . . . . . . 84.6 tt0 . . . . . 0 N--CA 1.489 1.504 0 N-CA-C 109.356 -0.609 . . . . 0.0 109.356 . . . . . . . . . 0 0 . 1 . 017 nuclear build full ' D' D ' -2' ' ' GLY . . . . . . . . . . . . . . . -59.87 148.42 42.49 Favored Glycine 0 CA--C 1.524 0.601 0 N-CA-C 111.006 -0.838 . . . . 0.0 111.006 -179.31 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' D' D ' -1' ' ' VAL . . . . . . . . . . . . . 40.7 t -95.77 136.15 27.64 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.284 0 N-CA-C 109.897 -0.409 . . . . 0.0 109.897 179.851 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' D' D ' 0' ' ' ILE . . . . . . . . . . . . . 71.5 mt -111.22 140.22 31.53 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.241 0 CA-C-N 116.097 -0.501 . . . . 0.0 109.941 -179.085 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' D' D ' 1' ' ' MET . . . . . . . . . . . . . 25.1 ptp -141.82 145.59 34.89 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.109 -0.496 . . . . 0.0 110.495 -179.407 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' D' D ' 2' ' ' SER . . . . . . . . . . . . . 2.9 p -114.94 141.55 47.81 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.616 -179.437 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' D' D ' 3' ' ' GLU . . . . . . . . . . . . . 94.3 mt-10 -141.19 139.82 33.91 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.12 -0.491 . . . . 0.0 111.158 -178.798 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' D' D ' 4' ' ' LEU . . . . . . . . . . . . . 21.7 tp -123.27 128.96 50.69 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 115.869 -0.605 . . . . 0.0 109.763 174.799 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' D' D ' 5' ' ' LYS . . . . . . . . . . . . . 94.8 mttt -112.75 121.6 45.2 Favored 'General case' 0 C--O 1.235 0.302 0 CA-C-O 120.897 0.38 . . . . 0.0 111.014 -177.95 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' D' D ' 6' ' ' LEU . . . . . 0.454 HD23 ' HA ' ' D' ' 50' ' ' VAL . 61.9 mt -114.94 142.17 46.97 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-N 115.225 -0.898 . . . . 0.0 110.274 -179.185 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' D' D ' 7' ' ' LYS . . . . . . . . . . . . . 44.7 tttm -122.35 140.48 32.72 Favored Pre-proline 0 CA--C 1.533 0.291 0 CA-C-O 119.017 -0.516 . . . . 0.0 109.993 176.056 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' D' D ' 8' ' ' PRO . . . . . . . . . . . . . 96.9 Cg_endo -91.72 137.76 1.97 Allowed 'Trans proline' 0 N--CA 1.49 1.316 0 C-N-CA 121.83 1.687 . . . . 0.0 111.964 179.45 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' D' D ' 9' ' ' LEU . . . . . . . . . . . . . 26.3 mt -77.54 -48.28 2.34 Favored Pre-proline 0 CA--C 1.535 0.371 0 CA-C-O 118.675 -0.678 . . . . 0.0 112.341 -179.991 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' D' D ' 10' ' ' PRO . . . . . . . . . . . . . 87.0 Cg_endo -80.23 159.35 23.29 Favored 'Trans proline' 0 N--CA 1.497 1.685 0 C-N-CA 121.308 1.339 . . . . 0.0 112.219 177.961 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' D' D ' 11' ' ' LYS . . . . . . . . . . . . . 82.5 mttt -86.54 95.69 9.82 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.51 -0.314 . . . . 0.0 110.318 177.543 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' D' D ' 12' ' ' VAL . . . . . . . . . . . . . 12.4 p -142.2 147.55 21.26 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.324 0 CA-C-N 116.238 -0.437 . . . . 0.0 110.443 179.928 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' D' D ' 13' ' ' GLU . . . . . . . . . . . . . 45.5 tp10 -92.09 121.83 34.01 Favored 'General case' 0 C--N 1.328 -0.336 0 N-CA-C 109.985 -0.376 . . . . 0.0 109.985 177.797 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' D' D ' 14' ' ' LEU . . . . . . . . . . . . . 41.0 mt -93.02 138.15 23.41 Favored Pre-proline 0 C--N 1.329 -0.305 0 CA-C-O 118.88 -0.581 . . . . 0.0 110.073 -178.666 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' D' D ' 15' ' ' PRO . . . . . . . . . . . . . 28.7 Cg_exo -60.47 158.55 31.25 Favored 'Trans proline' 0 N--CA 1.498 1.782 0 C-N-CA 121.268 1.312 . . . . 0.0 111.953 178.995 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' D' D ' 16' ' ' PRO . . . . . . . . . . . . . 39.3 Cg_exo -58.91 -35.52 98.47 Favored 'Trans proline' 0 N--CA 1.498 1.766 0 C-N-CA 121.527 1.485 . . . . 0.0 112.894 -179.469 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' D' D ' 17' ' ' ASP . . . . . . . . . . . . . 15.8 p-10 -82.18 2.65 30.62 Favored 'General case' 0 CA--C 1.537 0.454 0 N-CA-C 113.296 0.85 . . . . 0.0 113.296 -177.682 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' D' D ' 18' ' ' PHE . . . . . . . . . . . . . 36.7 t80 -58.15 -47.08 84.45 Favored 'General case' 0 C--N 1.333 -0.115 0 O-C-N 121.933 -0.48 . . . . 0.0 110.019 -178.242 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' D' D ' 19' ' ' VAL . . . . . 0.425 HG13 ' N ' ' D' ' 20' ' ' ASP . 12.7 p -55.19 -41.73 62.03 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 CA-C-N 116.353 -0.385 . . . . 0.0 111.197 -178.094 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' D' D ' 20' ' ' ASP . . . . . 0.425 ' N ' HG13 ' D' ' 19' ' ' VAL . 7.7 t0 -60.91 -44.31 97.36 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-O 120.9 0.381 . . . . 0.0 110.827 -177.811 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' D' D ' 21' ' ' VAL . . . . . . . . . . . . . 45.5 t -64.62 -45.71 94.61 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.324 0 CA-C-N 116.326 -0.397 . . . . 0.0 110.41 -177.486 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' D' D ' 22' ' ' ILE . . . . . 0.671 HG22 HD12 ' D' ' 26' ' ' LEU . 49.5 mm -55.55 -47.73 78.31 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.264 0 C-N-CA 121.096 -0.242 . . . . 0.0 110.672 179.533 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' D' D ' 23' ' ' ARG . . . . . . . . . . . . . 47.0 ttp180 -55.15 -49.05 72.8 Favored 'General case' 0 C--N 1.331 -0.219 0 C-N-CA 121.042 -0.263 . . . . 0.0 111.155 -178.33 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' D' D ' 24' ' ' ILE . . . . . . . . . . . . . 71.4 mt -58.93 -43.97 89.85 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.281 0 C-N-CA 121.05 -0.26 . . . . 0.0 111.251 -176.308 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' D' D ' 25' ' ' LYS . . . . . . . . . . . . . 49.2 mttm -68.18 -41.05 82.05 Favored 'General case' 0 C--N 1.328 -0.332 0 N-CA-C 112.582 0.586 . . . . 0.0 112.582 -177.86 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' D' D ' 26' ' ' LEU . . . . . 0.671 HD12 HG22 ' D' ' 22' ' ' ILE . 36.1 mt -79.46 -33.49 42.32 Favored 'General case' 0 C--N 1.329 -0.311 0 N-CA-C 113.837 1.051 . . . . 0.0 113.837 -170.421 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' D' D ' 27' ' ' GLN . . . . . . . . . . . . . 18.3 pt20 -46.84 140.76 4.43 Favored 'General case' 0 N--CA 1.469 0.514 0 N-CA-C 112.956 0.725 . . . . 0.0 112.956 -174.247 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' D' D ' 28' ' ' GLY . . . . . . . . . . . . . . . 98.14 -24.15 33.05 Favored Glycine 0 CA--C 1.532 1.141 0 CA-C-N 115.571 -0.74 . . . . 0.0 112.427 -178.355 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' D' D ' 29' ' ' LYS . . . . . . . . . . . . . 48.9 mtpt -97.45 155.11 17.07 Favored 'General case' 0 C--N 1.333 -0.126 0 CA-C-N 117.425 0.612 . . . . 0.0 110.783 179.101 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' D' D ' 30' ' ' THR . . . . . . . . . . . . . 23.5 m -104.51 139.84 38.83 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.196 -0.456 . . . . 0.0 110.338 178.876 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' D' D ' 31' ' ' VAL . . . . . . . . . . . . . 34.4 m -130.98 150.28 34.44 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.303 0 CA-C-N 116.101 -0.5 . . . . 0.0 110.783 -179.176 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' D' D ' 32' ' ' ARG . . . . . . . . . . . . . 83.0 mtm180 -128.67 150.34 50.29 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 115.913 -0.585 . . . . 0.0 110.475 178.324 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' D' D ' 33' ' ' THR . . . . . . . . . . . . . 15.0 m -53.64 138.53 34.51 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.305 -0.407 . . . . 0.0 111.385 -178.036 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' D' D ' 34' ' ' GLY . . . . . . . . . . . . . . . 100.43 -17.23 57.07 Favored Glycine 0 CA--C 1.532 1.145 0 CA-C-O 119.67 -0.517 . . . . 0.0 113.192 179.589 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' D' D ' 35' ' ' ASP . . . . . . . . . . . . . 75.1 m-20 -66.35 149.8 49.84 Favored 'General case' 0 N--CA 1.461 0.085 0 CA-C-N 118.015 0.907 . . . . 0.0 111.087 178.838 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' D' D ' 36' ' ' VAL . . . . . . . . . . . . . 44.2 t -118.77 130.75 73.17 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.244 0 CA-C-N 115.908 -0.587 . . . . 0.0 109.839 178.08 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' D' D ' 37' ' ' ILE . . . . . . . . . . . . . 64.7 mt -119.72 138.12 51.38 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.233 0 N-CA-C 109.854 -0.425 . . . . 0.0 109.854 -179.723 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' D' D ' 38' ' ' GLY . . . . . . . . . . . . . . . -113.54 127.89 8.07 Favored Glycine 0 CA--C 1.525 0.661 0 N-CA-C 110.782 -0.927 . . . . 0.0 110.782 179.064 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' D' D ' 39' ' ' ILE . . . . . . . . . . . . . 78.0 mt -128.25 137.46 57.39 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.237 0 CA-C-O 120.814 0.34 . . . . 0.0 110.313 179.626 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' D' D ' 40' ' ' SER . . . . . . . . . . . . . 32.4 t -91.54 116.53 28.94 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.248 -0.433 . . . . 0.0 110.598 175.285 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' D' D ' 41' ' ' ILE . . . . . . . . . . . . . 44.0 mm -119.83 114.34 43.86 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.216 0 CA-C-O 120.886 0.374 . . . . 0.0 110.177 178.823 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' D' D ' 42' ' ' LEU . . . . . 0.545 HD23 ' O ' ' D' ' 42' ' ' LEU . 1.3 tt 52.27 46.23 27.02 Favored 'General case' 0 CA--C 1.532 0.262 0 CA-C-O 121.399 0.618 . . . . 0.0 111.036 177.527 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' D' D ' 43' ' ' GLY . . . . . . . . . . . . . . . 70.9 25.79 75.14 Favored Glycine 0 CA--C 1.532 1.109 0 C-N-CA 121.1 -0.571 . . . . 0.0 112.532 175.398 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' D' D ' 44' ' ' LYS . . . . . . . . . . . . . 85.9 tttt -136.01 129.65 32.35 Favored 'General case' 0 C--N 1.331 -0.221 0 CA-C-N 117.274 0.537 . . . . 0.0 109.975 179.323 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' D' D ' 45' ' ' GLU . . . . . . . . . . . . . 84.7 tt0 -82.47 119.33 24.07 Favored 'General case' 0 C--N 1.328 -0.355 0 C-N-CA 120.816 -0.354 . . . . 0.0 110.842 -179.275 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' D' D ' 46' ' ' VAL . . . . . . . . . . . . . 10.0 p -118.57 125.17 74.16 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.179 0 N-CA-C 109.425 -0.583 . . . . 0.0 109.425 175.391 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' D' D ' 47' ' ' LYS . . . . . . . . . . . . . 39.6 mtmt -98.73 126.77 44.45 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 115.953 -0.567 . . . . 0.0 110.729 177.809 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' D' D ' 48' ' ' PHE . . . . . . . . . . . . . 45.9 m-85 -111.2 131.95 54.71 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 115.747 -0.66 . . . . 0.0 109.928 178.532 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' D' D ' 49' ' ' LYS . . . . . . . . . . . . . 38.2 tttp -104.48 131.78 51.46 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.334 -0.394 . . . . 0.0 110.09 178.531 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' D' D ' 50' ' ' VAL . . . . . 0.454 ' HA ' HD23 ' D' ' 6' ' ' LEU . 45.7 t -77.04 105.33 5.79 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.33 0 N-CA-C 109.204 -0.665 . . . . 0.0 109.204 177.623 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' D' D ' 51' ' ' VAL . . . . . . . . . . . . . 48.8 t -71.27 -52.5 26.37 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.317 0 CA-C-N 116.064 -0.516 . . . . 0.0 109.683 -174.93 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' D' D ' 52' ' ' GLN . . . . . . . . . . . . . 89.4 mt-30 -153.7 151.17 29.33 Favored 'General case' 0 C--N 1.331 -0.239 0 CA-C-N 115.995 -0.548 . . . . 0.0 111.845 -178.308 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' D' D ' 53' ' ' ALA . . . . . . . . . . . . . . . -129.74 133.24 46.91 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 115.145 -0.934 . . . . 0.0 109.561 174.057 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' D' D ' 54' ' ' TYR . . . . . . . . . . . . . 44.0 t80 -129.08 112.04 18.42 Favored Pre-proline 0 CA--C 1.536 0.419 0 CA-C-O 118.107 -0.949 . . . . 0.0 110.124 178.122 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' D' D ' 55' ' ' PRO . . . . . . . . . . . . . 73.3 Cg_endo -77.19 167.56 79.31 Favored 'Cis proline' 0 N--CA 1.5 1.857 0 CA-C-N 121.907 1.717 . . . . 0.0 112.585 -5.875 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' D' D ' 56' ' ' SER . . . . . . . . . . . . . 13.6 m -117.34 134.09 23.14 Favored Pre-proline 0 CA--C 1.539 0.549 0 CA-C-O 118.483 -0.77 . . . . 0.0 109.292 174.204 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' D' D ' 57' ' ' PRO . . . . . . . . . . . . . 56.0 Cg_endo -70.68 147.7 87.16 Favored 'Cis proline' 0 N--CA 1.498 1.785 0 CA-C-N 121.844 1.694 . . . . 0.0 111.415 -1.608 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' D' D ' 58' ' ' LEU . . . . . . . . . . . . . 24.2 tp -107.84 138.14 44.62 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-O 120.896 0.379 . . . . 0.0 110.495 -179.139 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' D' D ' 59' ' ' ARG . . . . . . . . . . . . . 61.2 ttt180 -103.04 120.25 40.32 Favored 'General case' 0 C--N 1.327 -0.397 0 N-CA-C 108.981 -0.748 . . . . 0.0 108.981 174.812 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' D' D ' 60' ' ' VAL . . . . . . . . . . . . . 42.4 t -71.93 119.7 18.93 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.277 0 C-N-CA 120.615 -0.434 . . . . 0.0 110.198 -174.276 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' D' D ' 61' ' ' GLU . . . . . . . . . . . . . 81.3 tt0 -131.14 152.15 50.72 Favored 'General case' 0 C--N 1.328 -0.33 0 N-CA-C 109.268 -0.641 . . . . 0.0 109.268 178.166 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' D' D ' 62' ' ' ASP . . . . . . . . . . . . . 19.3 p-10 -54.48 -31.97 56.89 Favored 'General case' 0 N--CA 1.465 0.301 0 C-N-CA 120.751 -0.38 . . . . 0.0 111.835 -176.405 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' D' D ' 63' ' ' ARG . . . . . . . . . . . . . 77.6 mtp180 -72.32 -21.24 61.36 Favored 'General case' 0 CA--C 1.535 0.38 0 N-CA-C 112.816 0.673 . . . . 0.0 112.816 -177.514 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' D' D ' 64' ' ' THR . . . . . . . . . . . . . 33.1 m -72.26 146.91 46.92 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-O 120.926 0.393 . . . . 0.0 110.905 -176.238 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' D' D ' 65' ' ' LYS . . . . . . . . . . . . . 68.8 mttm -90.14 131.67 35.86 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.018 -0.537 . . . . 0.0 110.819 -179.229 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' D' D ' 66' ' ' ILE . . . . . . . . . . . . . 68.3 mt -118.2 130.52 72.94 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.24 0 N-CA-C 109.655 -0.498 . . . . 0.0 109.655 178.391 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' D' D ' 67' ' ' THR . . . . . . . . . . . . . 29.5 m -126.48 139.65 53.07 Favored 'General case' 0 C--N 1.332 -0.194 0 CA-C-O 121.169 0.509 . . . . 0.0 111.253 -177.537 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' D' D ' 68' ' ' LEU . . . . . . . . . . . . . 51.0 mt -103.83 132.77 49.77 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 115.733 -0.667 . . . . 0.0 110.121 176.62 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' D' D ' 69' ' ' VAL . . . . . . . . . . . . . 41.8 t -102.06 141.25 18.66 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.239 0 CA-C-N 116.358 -0.383 . . . . 0.0 110.562 -178.314 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' D' D ' 70' ' ' THR . . . . . . . . . . . . . 9.5 t -88.76 -179.81 6.07 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 115.959 -0.564 . . . . 0.0 110.628 179.989 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' D' D ' 71' ' ' HIS . . . . . . . . . . . . . 37.7 t-80 -103.08 103.51 34.69 Favored Pre-proline 0 CA--C 1.534 0.343 0 CA-C-O 119.049 -0.501 . . . . 0.0 110.926 -177.757 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' D' D ' 72' ' ' PRO . . . . . . . . . . . . . 74.3 Cg_endo -85.96 156.47 10.02 Favored 'Trans proline' 0 N--CA 1.492 1.39 0 C-N-CA 121.588 1.525 . . . . 0.0 112.436 178.483 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' D' D ' 73' ' ' VAL . . . . . . . . . . . . . 34.8 m -70.9 166.65 2.28 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.241 0 CA-C-N 116.295 -0.411 . . . . 0.0 110.716 179.985 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' D' D ' 74' ' ' ASP . . . . . . . . . . . . . 39.7 t0 -101.77 119.03 38.14 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.309 -0.405 . . . . 0.0 110.126 -179.836 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' D' D ' 75' ' ' VAL . . . . . . . . . . . . . 44.3 t -114.0 123.04 69.27 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.25 0 CA-C-O 121.131 0.491 . . . . 0.0 110.268 -179.451 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' D' D ' 76' ' ' LEU . . . . . . . . . . . . . 33.9 mt -123.4 141.58 51.85 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 115.616 -0.72 . . . . 0.0 109.511 178.535 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' D' D ' 77' ' ' GLU . . . . . . . . . . . . . 96.7 mt-10 -134.75 138.6 44.47 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-O 121.211 0.529 . . . . 0.0 111.375 -177.849 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' D' D ' 78' ' ' ALA . . . . . . . . . . . . . . . -125.11 137.31 54.18 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 115.556 -0.747 . . . . 0.0 109.581 175.809 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' D' D ' 79' ' ' LYS . . . . . 0.616 ' O ' HD13 ' D' ' 80' ' ' ILE . 65.0 mttp -80.17 117.91 21.39 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-O 120.864 0.364 . . . . 0.0 110.65 -179.017 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' D' D ' 80' ' ' ILE . . . . . 0.616 HD13 ' O ' ' D' ' 79' ' ' LYS . 40.7 mm -138.96 102.82 1.84 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.32 0 N-CA-C 109.135 -0.691 . . . . 0.0 109.135 -178.052 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' D' D ' 81' ' ' LYS . . . . . . . . . . . . . 78.1 tttt -99.49 128.37 45.6 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-O 120.889 0.376 . . . . 0.0 110.92 -176.195 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' D' D ' 82' ' ' GLY . . . . . . . . . . . . . . . 89.07 42.21 5.67 Favored Glycine 0 CA--C 1.526 0.743 0 C-N-CA 120.987 -0.625 . . . . 0.0 111.862 175.791 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' D' D ' 83' ' ' ILE . . . . . . . . . . . . . 70.1 mt -70.17 137.77 23.36 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.311 0 N-CA-C 109.358 -0.608 . . . . 0.0 109.358 175.874 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' D' D ' 84' ' ' LYS . . . . . . . . . . . . . 38.5 ttpt -99.57 -46.59 5.4 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.343 -0.39 . . . . 0.0 110.243 -178.541 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' D' D ' 85' ' ' ASP . . . . . . . . . . . . . 8.0 t70 -155.11 152.66 29.76 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.072 -0.513 . . . . 0.0 110.663 179.21 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' D' D ' 86' ' ' VAL . . . . . . . . . . . . . 44.0 t -128.57 134.82 63.87 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.19 0 CA-C-O 120.91 0.386 . . . . 0.0 110.347 179.843 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' D' D ' 87' ' ' ILE . . . . . . . . . . . . . 43.7 mm -119.73 125.34 74.23 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.228 0 CA-C-N 115.909 -0.587 . . . . 0.0 109.719 178.152 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' D' D ' 88' ' ' LEU . . . . . . . . . . . . . 14.7 tp -111.05 131.46 55.04 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-O 120.835 0.35 . . . . 0.0 110.96 -177.622 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' D' D ' 89' ' ' ASP . . . . . . . . . . . . . 13.6 t70 -133.1 157.44 45.28 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 116.151 -0.477 . . . . 0.0 110.039 177.737 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' D' D ' 90' ' ' GLU . . . . . . . . . . . . . 82.6 tt0 -46.18 -39.11 9.19 Favored 'General case' 0 C--N 1.331 -0.23 0 N-CA-C 113.127 0.788 . . . . 0.0 113.127 -172.146 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' D' D ' 91' ' ' ASN . . . . . . . . . . . . . 82.8 m-20 -130.75 22.76 5.01 Favored 'General case' 0 N--CA 1.469 0.488 0 N-CA-C 112.762 0.653 . . . . 0.0 112.762 -176.785 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' D' D ' 92' ' ' LEU . . . . . . . . . . . . . 37.6 mt -149.05 141.22 23.97 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-O 120.826 0.346 . . . . 0.0 110.581 -176.931 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' D' D ' 93' ' ' ILE . . . . . . . . . . . . . 69.5 mt -122.08 113.11 37.52 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.255 0 N-CA-C 108.638 -0.875 . . . . 0.0 108.638 174.895 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' D' D ' 94' ' ' VAL . . . . . 0.453 HG21 HG11 ' D' ' 125' ' ' VAL . 41.4 t -116.57 128.93 73.79 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.291 0 CA-C-O 120.949 0.404 . . . . 0.0 110.013 -176.955 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' D' D ' 95' ' ' VAL . . . . . . . . . . . . . 46.1 t -121.65 132.58 70.46 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.282 0 CA-C-N 116.021 -0.536 . . . . 0.0 109.808 -179.826 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' D' D ' 96' ' ' ILE . . . . . . . . . . . . . 62.8 mt -113.29 126.41 70.71 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.322 0 N-CA-C 109.074 -0.713 . . . . 0.0 109.074 178.482 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' D' D ' 97' ' ' THR . . . . . . . . . . . . . 81.0 p -101.79 156.91 17.22 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-O 121.085 0.469 . . . . 0.0 111.44 -175.262 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' D' D ' 98' ' ' GLU . . . . . . . . . . . . . 46.1 mt-10 -55.62 -25.35 38.29 Favored 'General case' 0 CA--C 1.533 0.298 0 N-CA-C 112.324 0.49 . . . . 0.0 112.324 178.783 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' D' D ' 99' ' ' GLU . . . . . . . . . . . . . 14.1 mm-40 -76.12 11.92 1.33 Allowed 'General case' 0 CA--C 1.537 0.467 0 N-CA-C 113.161 0.8 . . . . 0.0 113.161 -179.708 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' D' D ' 100' ' ' ASN . . . . . . . . . . . . . 3.2 m-20 62.72 38.0 12.22 Favored 'General case' 0 CA--C 1.529 0.147 0 CA-C-O 121.039 0.447 . . . . 0.0 110.949 179.113 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' D' D ' 101' ' ' GLU . . . . . . . . . . . . . 84.8 tt0 -117.69 145.29 44.51 Favored 'General case' 0 C--N 1.332 -0.155 0 N-CA-C 109.505 -0.554 . . . . 0.0 109.505 176.658 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' D' D ' 102' ' ' VAL . . . . . . . . . . . . . 42.2 t -115.8 124.45 72.22 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.337 0 CA-C-N 116.272 -0.422 . . . . 0.0 109.98 -178.406 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' D' D ' 103' ' ' LEU . . . . . . . . . . . . . 19.3 mt -115.17 127.85 55.8 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 115.69 -0.686 . . . . 0.0 110.129 176.87 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' D' D ' 104' ' ' ILE . . . . . 0.433 HD12 ' HB3' ' D' ' 113' ' ' TYR . 65.6 mt -119.95 120.32 62.83 Favored 'Isoleucine or valine' 0 C--O 1.233 0.223 0 N-CA-C 110.136 -0.32 . . . . 0.0 110.136 -179.496 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' D' D ' 105' ' ' PHE . . . . . . . . . . . . . 46.3 m-85 -120.44 164.2 16.75 Favored 'General case' 0 C--N 1.334 -0.109 0 O-C-N 123.885 0.741 . . . . 0.0 109.977 179.61 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' D' D ' 106' ' ' ASN . . . . . . . . . . . . . 43.4 p-10 -99.24 -169.79 1.81 Allowed 'General case' 0 C--N 1.332 -0.192 0 N-CA-C 110.1 -0.333 . . . . 0.0 110.1 174.883 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' D' D ' 107' ' ' GLN . . . . . . . . . . . . . 62.3 tt0 -57.37 -30.16 64.64 Favored 'General case' 0 C--N 1.33 -0.243 0 N-CA-C 112.121 0.415 . . . . 0.0 112.121 -179.581 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' D' D ' 108' ' ' ASN . . . . . . . . . . . . . 5.4 t30 -88.43 11.24 17.48 Favored 'General case' 0 CA--C 1.536 0.424 0 N-CA-C 113.304 0.853 . . . . 0.0 113.304 -176.405 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' D' D ' 109' ' ' LEU . . . . . . . . . . . . . 9.5 tp 60.63 36.07 19.76 Favored 'General case' 0 CA--C 1.531 0.213 0 O-C-N 122.141 -0.349 . . . . 0.0 111.446 178.452 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' D' D ' 110' ' ' GLU . . . . . . . . . . . . . 95.5 mt-10 -107.84 152.22 24.69 Favored 'General case' 0 C--N 1.331 -0.237 0 N-CA-C 109.836 -0.431 . . . . 0.0 109.836 176.495 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' D' D ' 111' ' ' GLU . . . . . . . . . . . . . 97.3 mt-10 -78.48 126.87 31.36 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-O 121.102 0.477 . . . . 0.0 111.661 -176.359 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' D' D ' 112' ' ' LEU . . . . . . . . . . . . . 30.9 mt -108.93 -46.03 3.69 Favored 'General case' 0 C--N 1.332 -0.181 0 CA-C-N 115.573 -0.74 . . . . 0.0 109.952 174.736 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' D' D ' 113' ' ' TYR . . . . . 0.433 ' HB3' HD12 ' D' ' 104' ' ' ILE . 50.8 t80 -140.45 137.45 33.92 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.095 -0.502 . . . . 0.0 110.91 -179.813 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' D' D ' 114' ' ' ARG . . . . . . . . . . . . . 60.2 ttp180 -142.15 119.09 11.24 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.262 -0.426 . . . . 0.0 110.416 178.701 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' D' D ' 115' ' ' GLY . . . . . . . . . . . . . . . -150.19 162.59 29.27 Favored Glycine 0 CA--C 1.525 0.687 0 N-CA-C 111.021 -0.832 . . . . 0.0 111.021 179.3 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' D' D ' 116' ' ' LYS . . . . . . . . . . . . . 35.0 ttmt -131.66 135.44 46.9 Favored 'General case' 0 C--N 1.33 -0.251 0 N-CA-C 110.024 -0.362 . . . . 0.0 110.024 177.221 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' D' D ' 117' ' ' PHE . . . . . . . . . . . . . 39.8 m-85 -132.2 120.78 22.69 Favored 'General case' 0 C--N 1.331 -0.211 0 CA-C-O 120.86 0.362 . . . . 0.0 110.46 -174.532 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' D' D ' 118' ' ' GLU . . . . . . . . . . . . . 95.9 mt-10 -53.97 -48.53 70.25 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.413 -0.358 . . . . 0.0 111.571 -175.438 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' D' D ' 119' ' ' ASN . . . . . . . . . . . . . 9.4 m120 -99.28 31.11 3.2 Favored 'General case' 0 C--N 1.329 -0.288 0 N-CA-C 112.201 0.445 . . . . 0.0 112.201 -173.771 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' D' D ' 120' ' ' LEU . . . . . . . . . . . . . 23.7 tp -54.88 127.7 29.83 Favored 'General case' 0 C--N 1.332 -0.169 0 CA-C-O 120.805 0.336 . . . . 0.0 110.8 179.544 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' D' D ' 121' ' ' ASN . . . . . . . . . . . . . 95.1 m-20 -111.11 -44.05 3.65 Favored 'General case' 0 C--O 1.233 0.211 0 CA-C-N 116.287 -0.415 . . . . 0.0 111.109 -177.496 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' D' D ' 122' ' ' LYS . . . . . . . . . . . . . 19.0 ptpt -164.34 166.99 20.28 Favored 'General case' 0 N--CA 1.463 0.176 0 CA-C-O 121.277 0.56 . . . . 0.0 112.149 -178.285 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' D' D ' 123' ' ' VAL . . . . . . . . . . . . . 45.5 t -131.49 139.36 50.89 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.207 0 CA-C-N 115.584 -0.735 . . . . 0.0 110.121 179.749 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' D' D ' 124' ' ' LEU . . . . . . . . . . . . . 37.2 mt -121.55 138.9 54.11 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-N 116.313 -0.403 . . . . 0.0 110.737 -179.151 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' D' D ' 125' ' ' VAL . . . . . 0.453 HG11 HG21 ' D' ' 94' ' ' VAL . 35.6 m -135.06 134.12 53.23 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.211 0 CA-C-N 116.585 -0.28 . . . . 0.0 110.939 178.922 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' D' D ' 126' ' ' ARG . . . . . . . . . . . . . 22.3 mtp-105 -148.87 118.31 6.92 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 116.523 -0.308 . . . . 0.0 111.048 177.0 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' D' D ' 127' ' ' ASN . . . . . . . . . . . . . 34.6 m120 48.97 -104.89 0.14 Allowed 'General case' 0 CA--C 1.545 0.76 0 CA-C-O 119.193 -0.432 . . . . 0.0 111.976 175.604 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' D' D ' 128' ' ' ASP . . . . . . . . . . . . . 19.2 p-10 -114.05 14.61 18.38 Favored 'General case' 0 N--CA 1.468 0.463 0 CA-C-N 119.407 1.003 . . . . 0.0 113.28 -174.968 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' D' D ' 129' ' ' LEU . . . . . . . . . . . . . 19.1 tp -123.62 139.22 54.22 Favored 'General case' 0 C--N 1.331 -0.233 0 N-CA-C 109.736 -0.468 . . . . 0.0 109.736 177.458 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' D' D ' 130' ' ' VAL . . . . . 0.549 HG13 ' HB ' ' D' ' 141' ' ' ILE . 13.4 p -131.91 140.54 47.78 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.202 0 CA-C-O 121.173 0.511 . . . . 0.0 110.317 179.523 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' D' D ' 131' ' ' VAL . . . . . . . . . . . . . 40.7 t -135.99 140.46 43.98 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.241 0 CA-C-N 115.864 -0.607 . . . . 0.0 110.493 -177.013 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' D' D ' 132' ' ' ILE . . . . . . . . . . . . . 73.4 mt -115.8 131.33 68.52 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.283 0 N-CA-C 109.188 -0.671 . . . . 0.0 109.188 177.501 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' D' D ' 133' ' ' ILE . . . . . . . . . . . . . 43.6 mm -115.12 119.63 62.32 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.191 0 CA-C-O 120.716 0.293 . . . . 0.0 110.752 -175.904 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' D' D ' 134' ' ' ASP . . . . . . . . . . . . . 8.0 p-10 -133.01 144.25 49.96 Favored 'General case' 0 C--N 1.331 -0.233 0 N-CA-C 109.425 -0.583 . . . . 0.0 109.425 175.896 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' D' D ' 135' ' ' GLU . . . . . . . . . . . . . 83.4 tt0 -49.93 -26.86 4.55 Favored 'General case' 0 C--N 1.327 -0.391 0 N-CA-C 112.779 0.659 . . . . 0.0 112.779 -173.63 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' D' D ' 136' ' ' GLN . . . . . . . . . . . . . 97.3 mt-30 -79.01 -36.89 40.44 Favored 'General case' 0 C--O 1.233 0.225 0 N-CA-C 112.448 0.536 . . . . 0.0 112.448 -178.122 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' D' D ' 137' ' ' LYS . . . . . . . . . . . . . 1.2 ptpm? -164.39 174.11 11.41 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-O 121.671 0.748 . . . . 0.0 112.223 -173.206 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' D' D ' 138' ' ' LEU . . . . . 0.413 HD23 ' N ' ' D' ' 139' ' ' THR . 5.7 tt -117.89 127.3 53.72 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 114.905 -1.043 . . . . 0.0 109.553 177.637 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' D' D ' 139' ' ' THR . . . . . 0.413 ' N ' HD23 ' D' ' 138' ' ' LEU . 42.4 m -106.42 123.61 48.34 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.354 -0.385 . . . . 0.0 110.152 179.301 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' D' D ' 140' ' ' LEU . . . . . . . . . . . . . 14.1 tp -110.61 118.41 36.13 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-N 115.723 -0.672 . . . . 0.0 109.33 -177.901 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' D' D ' 141' ' ' ILE . . . . . 0.549 ' HB ' HG13 ' D' ' 130' ' ' VAL . 19.4 mt -120.11 118.25 56.27 Favored 'Isoleucine or valine' 0 C--O 1.234 0.279 0 CA-C-O 121.045 0.45 . . . . 0.0 110.042 -176.632 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' D' D ' 142' ' ' ARG . . . . . . . . . . . . . 81.3 mtp180 -92.03 128.98 38.08 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 115.433 -0.803 . . . . 0.0 110.009 177.459 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' D' D ' 143' ' ' THR . . . . . 0.58 HG22 HG12 ' E' ' 73' ' ' VAL . 63.6 p . . . . . 0 C--O 1.221 -0.431 0 CA-C-O 117.965 -1.017 . . . . 0.0 110.424 -179.701 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' E' E ' -3' ' ' GLU . . . . . . . . . . . . . 95.9 mt-10 . . . . . 0 N--CA 1.491 1.606 0 N-CA-C 109.344 -0.613 . . . . 0.0 109.344 . . . . . . . . . 0 0 . 1 . 017 nuclear build full ' E' E ' -2' ' ' GLY . . . . . . . . . . . . . . . -80.19 145.63 27.05 Favored Glycine 0 CA--C 1.525 0.666 0 N-CA-C 111.142 -0.783 . . . . 0.0 111.142 -179.799 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' E' E ' -1' ' ' VAL . . . . . . . . . . . . . 45.1 t -96.42 137.37 24.48 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.303 0 N-CA-C 109.872 -0.418 . . . . 0.0 109.872 179.144 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' E' E ' 0' ' ' ILE . . . . . . . . . . . . . 43.0 mm -108.47 134.36 50.61 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.265 0 CA-C-N 116.357 -0.383 . . . . 0.0 110.419 -178.698 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' E' E ' 1' ' ' MET . . . . . . . . . . . . . 25.2 ptp -87.2 142.43 27.91 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.079 -0.509 . . . . 0.0 110.318 178.816 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' E' E ' 2' ' ' SER . . . . . . . . . . . . . 2.7 p -123.53 126.45 46.72 Favored 'General case' 0 C--N 1.331 -0.215 0 CA-C-O 121.138 0.494 . . . . 0.0 110.856 -179.995 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' E' E ' 3' ' ' GLU . . . . . . . . . . . . . 84.2 tt0 -141.53 138.23 32.58 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 115.699 -0.682 . . . . 0.0 110.882 -179.911 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' E' E ' 4' ' ' LEU . . . . . . . . . . . . . 13.6 tp -123.47 127.13 47.95 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.113 -0.494 . . . . 0.0 109.983 176.78 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' E' E ' 5' ' ' LYS . . . . . . . . . . . . . 91.5 mttt -107.2 121.24 44.14 Favored 'General case' 0 C--N 1.331 -0.23 0 CA-C-N 116.442 -0.345 . . . . 0.0 110.627 178.844 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' E' E ' 6' ' ' LEU . . . . . . . . . . . . . 30.6 mt -115.97 147.05 41.59 Favored 'General case' 0 C--N 1.331 -0.222 0 CA-C-N 115.529 -0.76 . . . . 0.0 110.385 -179.147 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' E' E ' 7' ' ' LYS . . . . . . . . . . . . . 36.9 ttmt -133.18 137.93 30.48 Favored Pre-proline 0 CA--C 1.535 0.384 0 CA-C-O 119.028 -0.51 . . . . 0.0 109.928 176.246 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' E' E ' 8' ' ' PRO . . . . . . . . . . . . . 85.9 Cg_endo -90.63 143.97 3.67 Favored 'Trans proline' 0 N--CA 1.49 1.314 0 C-N-CA 121.798 1.665 . . . . 0.0 111.84 178.805 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' E' E ' 9' ' ' LEU . . . . . . . . . . . . . 57.8 mt -81.15 -48.47 1.07 Allowed Pre-proline 0 CA--C 1.534 0.335 0 CA-C-O 118.669 -0.682 . . . . 0.0 112.385 -178.915 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' E' E ' 10' ' ' PRO . . . . . . . . . . . . . 86.0 Cg_endo -80.41 154.24 21.27 Favored 'Trans proline' 0 N--CA 1.496 1.637 0 C-N-CA 121.281 1.321 . . . . 0.0 111.934 177.169 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' E' E ' 11' ' ' LYS . . . . . . . . . . . . . 46.8 pttt -85.06 111.01 19.35 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-O 121.543 0.687 . . . . 0.0 110.426 177.415 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' E' E ' 12' ' ' VAL . . . . . . . . . . . . . 12.7 p -151.09 151.0 12.86 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.276 0 CA-C-N 115.769 -0.65 . . . . 0.0 110.858 -179.196 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' E' E ' 13' ' ' GLU . . . . . . . . . . . . . 95.2 mt-10 -94.26 120.93 35.22 Favored 'General case' 0 C--N 1.329 -0.32 0 N-CA-C 109.827 -0.434 . . . . 0.0 109.827 175.842 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' E' E ' 14' ' ' LEU . . . . . . . . . . . . . 27.4 mt -97.35 150.96 37.37 Favored Pre-proline 0 CA--C 1.532 0.265 0 CA-C-O 119.333 -0.365 . . . . 0.0 110.735 -177.916 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' E' E ' 15' ' ' PRO . . . . . . . . . . . . . 28.0 Cg_exo -60.86 159.5 28.9 Favored 'Trans proline' 0 N--CA 1.497 1.735 0 C-N-CA 121.339 1.359 . . . . 0.0 111.977 178.055 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' E' E ' 16' ' ' PRO . . . . . . . . . . . . . 27.5 Cg_exo -60.14 -37.22 85.2 Favored 'Trans proline' 0 N--CA 1.496 1.661 0 C-N-CA 121.464 1.443 . . . . 0.0 112.497 -179.006 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' E' E ' 17' ' ' ASP . . . . . . . . . . . . . 19.6 p-10 -86.84 10.26 16.61 Favored 'General case' 0 CA--C 1.537 0.455 0 N-CA-C 113.144 0.794 . . . . 0.0 113.144 -177.89 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' E' E ' 18' ' ' PHE . . . . . . . . . . . . . 59.7 t80 -57.56 -45.66 84.89 Favored 'General case' 0 N--CA 1.458 -0.059 0 O-C-N 122.059 -0.401 . . . . 0.0 110.275 -178.075 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' E' E ' 19' ' ' VAL . . . . . . . . . . . . . 14.4 p -56.35 -41.46 71.4 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.307 0 CA-C-N 116.499 -0.318 . . . . 0.0 110.858 -178.832 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' E' E ' 20' ' ' ASP . . . . . . . . . . . . . 67.0 m-20 -60.78 -41.17 94.99 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-O 120.762 0.315 . . . . 0.0 110.7 -179.54 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' E' E ' 21' ' ' VAL . . . . . . . . . . . . . 50.0 t -64.02 -43.91 97.69 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.323 0 CA-C-N 116.346 -0.388 . . . . 0.0 110.148 -178.359 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' E' E ' 22' ' ' ILE . . . . . 0.641 HG22 HD12 ' E' ' 26' ' ' LEU . 46.2 mm -55.8 -49.15 76.45 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.227 0 C-N-CA 120.889 -0.324 . . . . 0.0 110.705 178.373 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' E' E ' 23' ' ' ARG . . . . . . . . . . . . . 30.7 ttp180 -54.86 -50.28 69.04 Favored 'General case' 0 C--N 1.33 -0.261 0 C-N-CA 121.013 -0.275 . . . . 0.0 111.466 -178.452 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' E' E ' 24' ' ' ILE . . . . . 0.428 ' O ' ' NE2' ' E' ' 27' ' ' GLN . 75.0 mt -58.77 -46.43 90.79 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.293 0 C-N-CA 120.988 -0.285 . . . . 0.0 111.132 -176.308 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' E' E ' 25' ' ' LYS . . . . . . . . . . . . . 8.5 mtpm? -67.17 -42.31 84.5 Favored 'General case' 0 C--N 1.328 -0.366 0 N-CA-C 112.283 0.475 . . . . 0.0 112.283 -176.607 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' E' E ' 26' ' ' LEU . . . . . 0.641 HD12 HG22 ' E' ' 22' ' ' ILE . 42.3 mt -80.11 -29.72 39.0 Favored 'General case' 0 C--N 1.33 -0.252 0 N-CA-C 113.326 0.861 . . . . 0.0 113.326 -171.957 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' E' E ' 27' ' ' GLN . . . . . 0.428 ' NE2' ' O ' ' E' ' 24' ' ' ILE . 18.8 pt20 -45.99 134.49 8.06 Favored 'General case' 0 N--CA 1.467 0.406 0 N-CA-C 112.78 0.659 . . . . 0.0 112.78 -174.38 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' E' E ' 28' ' ' GLY . . . . . . . . . . . . . . . 99.78 -21.94 42.67 Favored Glycine 0 CA--C 1.535 1.325 0 CA-C-N 115.815 -0.629 . . . . 0.0 112.477 -177.428 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' E' E ' 29' ' ' LYS . . . . . . . . . . . . . 9.1 mtpm? -97.39 155.16 17.03 Favored 'General case' 0 C--N 1.331 -0.2 0 CA-C-N 117.542 0.671 . . . . 0.0 110.875 179.63 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' E' E ' 30' ' ' THR . . . . . . . . . . . . . 37.8 m -102.42 139.03 38.57 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 115.929 -0.578 . . . . 0.0 110.424 177.997 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' E' E ' 31' ' ' VAL . . . . . . . . . . . . . 35.4 m -126.26 150.3 31.76 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.266 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.127 179.028 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' E' E ' 32' ' ' ARG . . . . . . . . . . . . . 66.9 ttt-85 -136.04 148.4 48.34 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-O 121.06 0.457 . . . . 0.0 110.332 179.377 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' E' E ' 33' ' ' THR . . . . . . . . . . . . . 28.0 m -52.84 138.27 29.95 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.35 -0.386 . . . . 0.0 111.515 -177.195 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' E' E ' 34' ' ' GLY . . . . . . . . . . . . . . . 98.44 -17.04 59.06 Favored Glycine 0 CA--C 1.533 1.189 0 CA-C-N 116.141 -0.482 . . . . 0.0 113.316 178.536 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' E' E ' 35' ' ' ASP . . . . . . . . . . . . . 81.2 m-20 -66.66 149.31 50.7 Favored 'General case' 0 C--O 1.231 0.131 0 CA-C-N 117.976 0.888 . . . . 0.0 111.312 179.85 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' E' E ' 36' ' ' VAL . . . . . . . . . . . . . 47.0 t -118.79 129.41 75.04 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.233 0 CA-C-N 115.745 -0.661 . . . . 0.0 109.674 176.679 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' E' E ' 37' ' ' ILE . . . . . . . . . . . . . 70.3 mt -120.17 138.46 50.64 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.26 0 N-CA-C 109.82 -0.437 . . . . 0.0 109.82 179.909 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' E' E ' 38' ' ' GLY . . . . . . . . . . . . . . . -111.9 128.57 8.65 Favored Glycine 0 CA--C 1.525 0.689 0 N-CA-C 111.055 -0.818 . . . . 0.0 111.055 179.384 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' E' E ' 39' ' ' ILE . . . . . . . . . . . . . 73.8 mt -127.59 135.98 61.72 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.189 0 CA-C-O 120.731 0.3 . . . . 0.0 110.267 179.186 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' E' E ' 40' ' ' SER . . . . . . . . . . . . . 91.0 p -92.99 116.24 28.87 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.278 -0.419 . . . . 0.0 110.733 174.429 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' E' E ' 41' ' ' ILE . . . . . . . . . . . . . 44.0 mm -121.1 123.17 69.43 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.216 0 CA-C-N 116.552 -0.294 . . . . 0.0 110.431 179.588 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' E' E ' 42' ' ' LEU . . . . . . . . . . . . . 47.0 mt 52.27 33.27 12.29 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.303 -0.408 . . . . 0.0 111.951 176.919 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' E' E ' 43' ' ' GLY . . . . . . . . . . . . . . . 74.15 31.69 59.27 Favored Glycine 0 CA--C 1.528 0.88 0 C-N-CA 121.135 -0.555 . . . . 0.0 112.159 177.711 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' E' E ' 44' ' ' LYS . . . . . . . . . . . . . 67.6 tttt -139.58 135.54 33.48 Favored 'General case' 0 C--N 1.329 -0.308 0 N-CA-C 109.674 -0.491 . . . . 0.0 109.674 177.747 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' E' E ' 45' ' ' GLU . . . . . . . . . . . . . 83.6 tt0 -82.16 120.92 25.95 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-O 120.861 0.362 . . . . 0.0 110.971 -177.098 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' E' E ' 46' ' ' VAL . . . . . . . . . . . . . 7.6 p -124.58 125.04 69.46 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.179 0 N-CA-C 109.41 -0.589 . . . . 0.0 109.41 176.277 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' E' E ' 47' ' ' LYS . . . . . . . . . . . . . 96.1 mttt -101.08 134.5 43.99 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.019 -0.537 . . . . 0.0 111.31 177.768 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' E' E ' 48' ' ' PHE . . . . . . . . . . . . . 88.5 m-85 -115.19 132.89 56.46 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 115.88 -0.6 . . . . 0.0 109.965 176.553 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' E' E ' 49' ' ' LYS . . . . . . . . . . . . . 83.3 tttt -105.33 136.91 43.99 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 116.347 -0.388 . . . . 0.0 109.987 177.303 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' E' E ' 50' ' ' VAL . . . . . . . . . . . . . 43.1 t -80.42 109.92 15.42 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.277 0 N-CA-C 109.353 -0.61 . . . . 0.0 109.353 176.821 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' E' E ' 51' ' ' VAL . . . . . . . . . . . . . 53.4 t -68.91 -47.33 76.46 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.24 0 CA-C-N 115.898 -0.592 . . . . 0.0 109.889 -174.777 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' E' E ' 52' ' ' GLN . . . . . . . . . . . . . 48.7 tt0 -167.85 141.77 3.46 Favored 'General case' 0 C--N 1.331 -0.219 0 C-N-CA 120.342 -0.543 . . . . 0.0 111.672 -179.688 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' E' E ' 53' ' ' ALA . . . . . . . . . . . . . . . -111.58 131.49 55.22 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 115.55 -0.75 . . . . 0.0 109.675 175.742 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' E' E ' 54' ' ' TYR . . . . . . . . . . . . . 50.6 t80 -127.67 106.48 20.8 Favored Pre-proline 0 CA--C 1.536 0.418 0 CA-C-O 118.319 -0.848 . . . . 0.0 110.438 -179.61 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' E' E ' 55' ' ' PRO . . . . . . . . . . . . . 73.4 Cg_endo -77.02 170.02 72.83 Favored 'Cis proline' 0 N--CA 1.499 1.836 0 CA-C-N 121.696 1.641 . . . . 0.0 112.607 -2.91 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' E' E ' 56' ' ' SER . . . . . . . . . . . . . 13.6 m -109.49 121.19 43.1 Favored Pre-proline 0 CA--C 1.539 0.537 0 CA-C-O 118.381 -0.819 . . . . 0.0 109.563 177.22 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' E' E ' 57' ' ' PRO . . . . . . . . . . . . . 61.1 Cg_endo -74.36 169.3 74.38 Favored 'Cis proline' 0 N--CA 1.497 1.686 0 CA-C-N 122.049 1.767 . . . . 0.0 112.073 0.97 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' E' E ' 58' ' ' LEU . . . . . . . . . . . . . 26.3 tp -128.13 136.16 50.78 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 115.999 -0.546 . . . . 0.0 110.014 179.755 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' E' E ' 59' ' ' ARG . . . . . . . . . . . . . 39.4 ttm180 -101.2 124.99 47.77 Favored 'General case' 0 C--N 1.326 -0.425 0 CA-C-N 115.89 -0.595 . . . . 0.0 109.467 178.512 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' E' E ' 60' ' ' VAL . . . . . . . . . . . . . 42.9 t -80.04 116.56 24.36 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.207 0 C-N-CA 120.57 -0.452 . . . . 0.0 110.353 -175.691 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' E' E ' 61' ' ' GLU . . . . . . . . . . . . . 95.6 mt-10 -131.04 166.07 21.85 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 115.792 -0.64 . . . . 0.0 110.045 178.765 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' E' E ' 62' ' ' ASP . . . . . . . . . . . . . 81.1 m-20 -54.94 -32.6 61.46 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.505 -0.316 . . . . 0.0 111.763 -179.991 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' E' E ' 63' ' ' ARG . . . . . . . . . . . . . 16.8 ptp180 -85.5 7.71 21.88 Favored 'General case' 0 CA--C 1.535 0.402 0 N-CA-C 113.536 0.939 . . . . 0.0 113.536 -175.751 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' E' E ' 64' ' ' THR . . . . . . . . . . . . . 34.0 m -94.35 141.79 28.16 Favored 'General case' 0 C--N 1.332 -0.166 0 CA-C-N 118.156 0.435 . . . . 0.0 110.587 -177.969 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' E' E ' 65' ' ' LYS . . . . . . . . . . . . . 98.3 mttt -88.87 126.8 35.54 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.09 -0.504 . . . . 0.0 110.195 179.234 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' E' E ' 66' ' ' ILE . . . . . . . . . . . . . 59.4 mt -114.23 126.45 71.75 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.292 0 N-CA-C 109.542 -0.54 . . . . 0.0 109.542 178.23 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' E' E ' 67' ' ' THR . . . . . . . . . . . . . 20.6 m -119.46 134.83 55.03 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-O 120.944 0.402 . . . . 0.0 110.481 -178.497 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' E' E ' 68' ' ' LEU . . . . . 0.481 ' C ' HD23 ' E' ' 68' ' ' LEU . 6.4 tt -103.95 119.01 38.03 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 115.886 -0.597 . . . . 0.0 110.113 179.247 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' E' E ' 69' ' ' VAL . . . . . . . . . . . . . 47.2 t -102.32 141.53 18.3 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.371 0 CA-C-N 115.988 -0.551 . . . . 0.0 109.711 179.248 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' E' E ' 70' ' ' THR . . . . . . . . . . . . . 7.8 t -130.25 129.8 43.77 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-O 121.025 0.441 . . . . 0.0 110.437 -179.872 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' E' E ' 71' ' ' HIS . . . . . . . . . . . . . 33.3 m80 -132.25 154.87 81.77 Favored Pre-proline 0 C--N 1.33 -0.272 0 CA-C-N 115.822 -0.626 . . . . 0.0 110.011 179.205 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' E' E ' 72' ' ' PRO . . . . . . . . . . . . . 86.6 Cg_endo -87.13 21.37 1.07 Allowed 'Trans proline' 0 N--CA 1.492 1.39 0 C-N-CA 121.534 1.489 . . . . 0.0 113.075 179.369 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' E' E ' 73' ' ' VAL . . . . . 0.58 HG12 HG22 ' D' ' 143' ' ' THR . 26.7 m -130.5 149.28 33.4 Favored 'Isoleucine or valine' 0 C--O 1.232 0.136 0 CA-C-O 121.06 0.457 . . . . 0.0 110.968 -179.985 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' E' E ' 74' ' ' ASP . . . . . . . . . . . . . 19.6 t0 -112.33 119.13 37.23 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 115.738 -0.665 . . . . 0.0 109.521 177.646 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' E' E ' 75' ' ' VAL . . . . . . . . . . . . . 43.8 t -110.63 126.53 67.96 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.258 0 CA-C-O 121.141 0.496 . . . . 0.0 111.0 -174.983 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' E' E ' 76' ' ' LEU . . . . . . . . . . . . . 23.0 mt -128.76 144.52 51.19 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 115.456 -0.793 . . . . 0.0 109.475 176.379 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' E' E ' 77' ' ' GLU . . . . . . . . . . . . . 98.0 mt-10 -131.72 139.33 48.97 Favored 'General case' 0 C--N 1.332 -0.163 0 CA-C-O 121.117 0.484 . . . . 0.0 111.622 -177.07 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' E' E ' 78' ' ' ALA . . . . . . . . . . . . . . . -126.68 129.41 48.39 Favored 'General case' 0 C--N 1.331 -0.196 0 CA-C-N 115.573 -0.74 . . . . 0.0 109.685 175.693 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' E' E ' 79' ' ' LYS . . . . . 0.602 ' O ' HD13 ' E' ' 80' ' ' ILE . 51.8 pttt -75.85 121.09 22.11 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-O 121.471 0.653 . . . . 0.0 110.997 -177.996 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' E' E ' 80' ' ' ILE . . . . . 0.602 HD13 ' O ' ' E' ' 79' ' ' LYS . 41.2 mm -139.28 107.52 3.26 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.224 0 CA-C-N 115.531 -0.759 . . . . 0.0 109.111 -177.131 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' E' E ' 81' ' ' LYS . . . . . . . . . . . . . 31.7 ttpt -103.61 126.94 51.06 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-O 120.838 0.351 . . . . 0.0 111.111 -177.199 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' E' E ' 82' ' ' GLY . . . . . . . . . . . . . . . 89.03 42.01 5.74 Favored Glycine 0 CA--C 1.526 0.722 0 C-N-CA 120.8 -0.714 . . . . 0.0 111.716 174.977 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' E' E ' 83' ' ' ILE . . . . . . . . . . . . . 70.8 mt -65.48 138.97 22.11 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.356 0 CA-C-O 120.931 0.396 . . . . 0.0 110.033 179.194 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' E' E ' 84' ' ' LYS . . . . . . . . . . . . . 57.0 tttp -98.72 -50.27 4.3 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 115.964 -0.562 . . . . 0.0 109.893 179.043 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' E' E ' 85' ' ' ASP . . . . . . . . . . . . . 5.3 t70 -157.92 153.4 26.16 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 115.647 -0.706 . . . . 0.0 110.228 178.696 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' E' E ' 86' ' ' VAL . . . . . . . . . . . . . 44.6 t -128.39 131.77 68.7 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.208 0 CA-C-O 121.014 0.435 . . . . 0.0 110.559 -178.838 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' E' E ' 87' ' ' ILE . . . . . . . . . . . . . 4.9 mp -117.99 123.3 71.46 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.253 0 CA-C-N 115.743 -0.662 . . . . 0.0 109.245 175.149 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' E' E ' 88' ' ' LEU . . . . . . . . . . . . . 13.0 tp -111.08 130.98 55.44 Favored 'General case' 0 C--N 1.331 -0.198 0 CA-C-O 120.99 0.424 . . . . 0.0 111.032 -177.328 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' E' E ' 89' ' ' ASP . . . . . . . . . . . . . 13.2 t70 -126.65 153.12 45.81 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 115.867 -0.606 . . . . 0.0 109.451 176.51 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' E' E ' 90' ' ' GLU . . . . . . . . . . . . . 80.4 tt0 -47.81 -33.42 7.25 Favored 'General case' 0 C--N 1.331 -0.23 0 N-CA-C 112.866 0.691 . . . . 0.0 112.866 -172.271 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' E' E ' 91' ' ' ASN . . . . . . . . . . . . . 3.8 p30 -129.14 14.55 6.22 Favored 'General case' 0 N--CA 1.469 0.509 0 N-CA-C 113.349 0.87 . . . . 0.0 113.349 -175.905 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' E' E ' 92' ' ' LEU . . . . . . . . . . . . . 34.9 mt -149.42 147.17 27.95 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-O 120.796 0.331 . . . . 0.0 110.508 -176.355 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' E' E ' 93' ' ' ILE . . . . . . . . . . . . . 71.7 mt -125.07 117.17 49.25 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.274 0 N-CA-C 109.319 -0.623 . . . . 0.0 109.319 177.696 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' E' E ' 94' ' ' VAL . . . . . . . . . . . . . 46.6 t -116.39 125.85 73.6 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.273 0 N-CA-C 109.753 -0.462 . . . . 0.0 109.753 -179.897 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' E' E ' 95' ' ' VAL . . . . . . . . . . . . . 38.7 t -122.74 132.93 70.32 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.293 0 CA-C-N 116.113 -0.494 . . . . 0.0 109.838 -179.097 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' E' E ' 96' ' ' ILE . . . . . . . . . . . . . 59.4 mt -114.53 129.57 70.37 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.327 0 N-CA-C 109.224 -0.658 . . . . 0.0 109.224 178.451 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' E' E ' 97' ' ' THR . . . . . . . . . . . . . 68.1 p -101.51 157.79 16.56 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-O 121.001 0.429 . . . . 0.0 110.968 -177.762 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' E' E ' 98' ' ' GLU . . . . . . . . . . . . . 44.6 mt-10 -53.81 -25.01 17.34 Favored 'General case' 0 C--N 1.329 -0.298 0 N-CA-C 112.489 0.551 . . . . 0.0 112.489 179.982 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' E' E ' 99' ' ' GLU . . . . . . . . . . . . . 96.4 mt-10 -78.1 14.69 1.08 Allowed 'General case' 0 CA--C 1.536 0.42 0 N-CA-C 113.331 0.863 . . . . 0.0 113.331 -177.052 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' E' E ' 100' ' ' ASN . . . . . . . . . . . . . 2.2 m-20 63.06 34.43 13.82 Favored 'General case' 0 N--CA 1.464 0.264 0 CA-C-N 117.909 0.322 . . . . 0.0 111.352 178.032 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' E' E ' 101' ' ' GLU . . . . . . . . . . . . . 81.4 tt0 -116.49 144.23 44.59 Favored 'General case' 0 C--N 1.332 -0.189 0 N-CA-C 109.582 -0.525 . . . . 0.0 109.582 175.195 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' E' E ' 102' ' ' VAL . . . . . . . . . . . . . 46.2 t -118.94 127.47 75.79 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.257 0 N-CA-C 109.864 -0.421 . . . . 0.0 109.864 -178.269 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' E' E ' 103' ' ' LEU . . . . . 0.506 HD12 ' N ' ' E' ' 103' ' ' LEU . 6.1 mp -118.39 135.8 54.12 Favored 'General case' 0 C--N 1.332 -0.188 0 CA-C-N 115.829 -0.623 . . . . 0.0 110.112 177.26 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' E' E ' 104' ' ' ILE . . . . . 0.408 HD13 HG21 ' E' ' 130' ' ' VAL . 66.2 mt -119.46 122.0 67.84 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.265 0 N-CA-C 110.147 -0.316 . . . . 0.0 110.147 -179.723 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' E' E ' 105' ' ' PHE . . . . . . . . . . . . . 73.7 m-85 -118.84 163.67 16.55 Favored 'General case' 0 C--N 1.33 -0.245 0 O-C-N 123.991 0.807 . . . . 0.0 109.405 179.353 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' E' E ' 106' ' ' ASN . . . . . . . . . . . . . 47.6 p-10 -96.64 -170.93 2.15 Favored 'General case' 0 C--N 1.331 -0.201 0 N-CA-C 109.803 -0.443 . . . . 0.0 109.803 172.714 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' E' E ' 107' ' ' GLN . . . . . . . . . . . . . 42.1 tt0 -59.73 -27.62 66.64 Favored 'General case' 0 C--N 1.327 -0.373 0 N-CA-C 112.104 0.409 . . . . 0.0 112.104 -179.963 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' E' E ' 108' ' ' ASN . . . . . . . . . . . . . 6.9 t-20 -88.14 13.9 10.33 Favored 'General case' 0 CA--C 1.536 0.418 0 N-CA-C 112.874 0.694 . . . . 0.0 112.874 -178.161 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' E' E ' 109' ' ' LEU . . . . . . . . . . . . . 42.0 mt 57.25 32.3 21.51 Favored 'General case' 0 CA--C 1.529 0.172 0 N-CA-C 112.013 0.375 . . . . 0.0 112.013 178.697 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' E' E ' 110' ' ' GLU . . . . . . . . . . . . . 95.1 mt-10 -101.18 140.02 36.05 Favored 'General case' 0 C--N 1.33 -0.261 0 N-CA-C 109.125 -0.694 . . . . 0.0 109.125 174.269 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' E' E ' 111' ' ' GLU . . . . . . . . . . . . . 44.7 tt0 -82.43 121.91 27.34 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-O 120.948 0.404 . . . . 0.0 110.69 -174.605 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' E' E ' 112' ' ' LEU . . . . . . . . . . . . . 14.0 mt -102.12 -45.18 5.23 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 115.909 -0.587 . . . . 0.0 110.547 179.338 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' E' E ' 113' ' ' TYR . . . . . . . . . . . . . 57.4 t80 -134.8 143.51 47.12 Favored 'General case' 0 C--N 1.331 -0.218 0 CA-C-N 116.387 -0.37 . . . . 0.0 111.078 -177.536 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' E' E ' 114' ' ' ARG . . . . . . . . . . . . . 35.1 ptt180 -147.06 125.49 12.36 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.18 -0.463 . . . . 0.0 110.727 177.863 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' E' E ' 115' ' ' GLY . . . . . . . . . . . . . . . -150.15 162.97 29.38 Favored Glycine 0 CA--C 1.523 0.572 0 N-CA-C 110.834 -0.907 . . . . 0.0 110.834 -179.927 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' E' E ' 116' ' ' LYS . . . . . . . . . . . . . 30.7 ttmt -132.06 138.97 48.37 Favored 'General case' 0 C--N 1.329 -0.305 0 O-C-N 122.59 -0.359 . . . . 0.0 110.051 177.922 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' E' E ' 117' ' ' PHE . . . . . . . . . . . . . 28.0 m-85 -137.09 114.78 11.22 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-O 120.875 0.369 . . . . 0.0 110.038 -175.938 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' E' E ' 118' ' ' GLU . . . . . . . . . . . . . 96.8 mt-10 -54.27 -43.03 70.64 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.458 -0.337 . . . . 0.0 111.333 -176.679 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' E' E ' 119' ' ' ASN . . . . . . . . . . . . . 59.2 m-80 -98.9 31.06 3.1 Favored 'General case' 0 C--N 1.331 -0.215 0 CA-C-N 116.222 -0.444 . . . . 0.0 112.159 -174.257 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' E' E ' 120' ' ' LEU . . . . . . . . . . . . . 25.1 tp -57.03 119.82 6.96 Favored 'General case' 0 C--N 1.333 -0.127 0 C-N-CA 121.028 -0.269 . . . . 0.0 110.322 177.937 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' E' E ' 121' ' ' ASN . . . . . . . . . . . . . 9.9 t-20 -114.14 -44.14 3.16 Favored 'General case' 0 C--N 1.332 -0.182 0 CA-C-N 116.545 -0.298 . . . . 0.0 111.192 -177.28 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' E' E ' 122' ' ' LYS . . . . . . . . . . . . . 61.8 mtpt -144.29 152.59 41.0 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-O 121.048 0.451 . . . . 0.0 111.561 -176.814 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' E' E ' 123' ' ' VAL . . . . . . . . . . . . . 43.5 t -132.32 131.89 60.64 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.238 0 CA-C-N 116.01 -0.541 . . . . 0.0 109.808 175.983 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' E' E ' 124' ' ' LEU . . . . . . . . . . . . . 52.6 mt -120.15 133.12 55.58 Favored 'General case' 0 C--N 1.331 -0.213 0 CA-C-N 116.275 -0.421 . . . . 0.0 110.624 -179.339 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' E' E ' 125' ' ' VAL . . . . . . . . . . . . . 43.3 t -127.83 120.34 53.8 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.188 0 N-CA-C 109.788 -0.449 . . . . 0.0 109.788 177.818 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' E' E ' 126' ' ' ARG . . . . . . . . . . . . . 51.2 mtp180 -148.87 138.86 22.16 Favored 'General case' 0 C--N 1.329 -0.323 0 N-CA-C 109.661 -0.496 . . . . 0.0 109.661 179.615 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' E' E ' 127' ' ' ASN . . . . . . . . . . . . . 4.9 p-10 48.67 -151.13 0.14 Allowed 'General case' 0 CA--C 1.54 0.585 0 CA-C-O 119.434 -0.317 . . . . 0.0 111.024 177.353 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' E' E ' 128' ' ' ASP . . . . . . . . . . . . . 13.3 p-10 -84.14 22.84 1.14 Allowed 'General case' 0 CA--C 1.534 0.332 0 CA-C-N 118.541 0.61 . . . . 0.0 112.416 178.653 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' E' E ' 129' ' ' LEU . . . . . . . . . . . . . 15.0 tp -127.08 140.4 52.31 Favored 'General case' 0 C--O 1.233 0.2 0 O-C-N 122.072 -0.393 . . . . 0.0 110.354 -179.398 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' E' E ' 130' ' ' VAL . . . . . 0.495 HG23 ' HB ' ' E' ' 141' ' ' ILE . 30.9 m -129.5 142.81 42.98 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.218 0 CA-C-O 121.001 0.429 . . . . 0.0 110.468 179.297 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' E' E ' 131' ' ' VAL . . . . . 0.525 HG22 HD12 ' E' ' 140' ' ' LEU . 39.8 t -136.1 138.92 46.65 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.234 0 CA-C-N 116.118 -0.492 . . . . 0.0 110.545 -177.77 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' E' E ' 132' ' ' ILE . . . . . . . . . . . . . 73.8 mt -117.18 132.22 67.61 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.289 0 N-CA-C 109.347 -0.612 . . . . 0.0 109.347 177.761 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' E' E ' 133' ' ' ILE . . . . . . . . . . . . . 35.2 mm -115.65 122.39 69.32 Favored 'Isoleucine or valine' 0 C--O 1.234 0.278 0 CA-C-O 120.656 0.265 . . . . 0.0 111.06 -174.766 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' E' E ' 134' ' ' ASP . . . . . . . . . . . . . 7.5 p-10 -135.15 146.44 48.78 Favored 'General case' 0 C--N 1.329 -0.31 0 N-CA-C 109.374 -0.602 . . . . 0.0 109.374 174.812 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' E' E ' 135' ' ' GLU . . . . . . . . . . . . . 84.4 tt0 -49.91 -26.37 4.06 Favored 'General case' 0 CA--C 1.532 0.285 0 N-CA-C 112.721 0.637 . . . . 0.0 112.721 -174.242 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' E' E ' 136' ' ' GLN . . . . . . . . . . . . . 24.9 tt0 -77.64 -38.56 47.63 Favored 'General case' 0 C--O 1.234 0.28 0 CA-C-O 120.896 0.379 . . . . 0.0 111.933 -177.01 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' E' E ' 137' ' ' LYS . . . . . . . . . . . . . 17.4 ptpt -166.83 176.47 7.05 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-O 121.496 0.665 . . . . 0.0 111.621 -173.364 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' E' E ' 138' ' ' LEU . . . . . 0.425 ' C ' HD23 ' E' ' 138' ' ' LEU . 7.4 tt -119.62 128.07 53.53 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 115.243 -0.89 . . . . 0.0 109.954 177.83 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' E' E ' 139' ' ' THR . . . . . . . . . . . . . 36.9 m -105.94 125.85 51.49 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.245 -0.434 . . . . 0.0 110.372 179.869 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' E' E ' 140' ' ' LEU . . . . . 0.525 HD12 HG22 ' E' ' 131' ' ' VAL . 21.3 tp -113.08 119.52 38.12 Favored 'General case' 0 C--N 1.329 -0.306 0 N-CA-C 109.018 -0.734 . . . . 0.0 109.018 -179.137 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' E' E ' 141' ' ' ILE . . . . . 0.495 ' HB ' HG23 ' E' ' 130' ' ' VAL . 19.5 mt -119.17 121.64 67.18 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.309 0 CA-C-O 121.042 0.449 . . . . 0.0 110.012 -175.944 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' E' E ' 142' ' ' ARG . . . . . . . . . . . . . 78.9 mtp180 -109.97 115.76 30.38 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 115.126 -0.943 . . . . 0.0 109.901 -177.748 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' E' E ' 143' ' ' THR . . . . . . . . . . . . . 34.9 p . . . . . 0 C--O 1.219 -0.51 0 CA-C-O 118.037 -0.983 . . . . 0.0 110.649 -178.24 . . . . . . . . 0 0 . 1 . 017 nuclear build full ' F' F ' -3' ' ' GLU . . . . . . . . . . . . . 70.4 mm-40 . . . . . 0 N--CA 1.49 1.573 0 N-CA-C 109.484 -0.562 . . . . 0.0 109.484 . . . . . . . . . 0 0 . 1 . 017 nuclear build full ' F' F ' -2' ' ' GLY . . . . . . . . . . . . . . . -70.32 150.01 47.95 Favored Glycine 0 CA--C 1.525 0.67 0 N-CA-C 110.91 -0.876 . . . . 0.0 110.91 179.111 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' F' F ' -1' ' ' VAL . . . . . . . . . . . . . 45.8 t -94.03 129.89 43.72 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.328 0 N-CA-C 109.851 -0.426 . . . . 0.0 109.851 179.878 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' F' F ' 0' ' ' ILE . . . . . . . . . . . . . 43.6 mm -116.91 133.88 62.21 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.259 0 CA-C-N 116.249 -0.432 . . . . 0.0 110.283 -178.986 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' F' F ' 1' ' ' MET . . . . . . . . . . . . . 24.6 ptp -80.85 138.27 36.19 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.018 -0.537 . . . . 0.0 110.683 -179.947 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' F' F ' 2' ' ' SER . . . . . . . . . . . . . 50.6 p -123.7 141.06 52.37 Favored 'General case' 0 C--N 1.332 -0.184 0 CA-C-O 120.986 0.422 . . . . 0.0 110.534 178.968 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' F' F ' 3' ' ' GLU . . . . . . . . . . . . . 84.7 tt0 -142.01 140.45 32.67 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.041 -0.527 . . . . 0.0 111.376 -178.777 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' F' F ' 4' ' ' LEU . . . . . . . . . . . . . 67.9 mt -120.16 134.0 55.36 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.042 -0.526 . . . . 0.0 110.2 176.253 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' F' F ' 5' ' ' LYS . . . . . . . . . . . . . 68.1 mttm -109.97 119.85 40.6 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.303 -0.408 . . . . 0.0 110.275 178.194 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' F' F ' 6' ' ' LEU . . . . . . . . . . . . . 57.1 mt -114.51 147.51 39.28 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 115.382 -0.826 . . . . 0.0 110.472 -178.109 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' F' F ' 7' ' ' LYS . . . . . . . . . . . . . 56.4 tttm -136.84 137.14 22.52 Favored Pre-proline 0 CA--C 1.534 0.34 0 CA-C-O 118.901 -0.571 . . . . 0.0 109.962 176.78 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' F' F ' 8' ' ' PRO . . . . . . . . . . . . . 97.3 Cg_endo -91.97 141.98 2.55 Favored 'Trans proline' 0 N--CA 1.488 1.2 0 C-N-CA 121.688 1.592 . . . . 0.0 111.776 177.397 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' F' F ' 9' ' ' LEU . . . . . . . . . . . . . 21.9 mt -79.79 -47.3 1.46 Allowed Pre-proline 0 CA--C 1.532 0.274 0 CA-C-O 118.697 -0.668 . . . . 0.0 111.92 -178.94 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' F' F ' 10' ' ' PRO . . . . . . . . . . . . . 96.0 Cg_endo -81.66 140.61 11.83 Favored 'Trans proline' 0 N--CA 1.494 1.55 0 C-N-CA 121.188 1.258 . . . . 0.0 111.509 175.254 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' F' F ' 11' ' ' LYS . . . . . . . . . . . . . 46.3 tptt -79.94 98.09 7.01 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-O 120.863 0.363 . . . . 0.0 110.184 179.726 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' F' F ' 12' ' ' VAL . . . . . . . . . . . . . 12.7 p -138.16 145.81 27.98 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.245 0 CA-C-N 116.132 -0.485 . . . . 0.0 110.542 -179.357 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' F' F ' 13' ' ' GLU . . . . . . . . . . . . . 84.6 tt0 -83.56 126.13 32.49 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.353 -0.385 . . . . 0.0 110.403 179.515 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' F' F ' 14' ' ' LEU . . . . . . . . . . . . . 15.5 mt -98.13 149.86 36.15 Favored Pre-proline 0 CA--C 1.532 0.284 0 CA-C-N 116.338 -0.392 . . . . 0.0 110.352 -178.593 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' F' F ' 15' ' ' PRO . . . . . . . . . . . . . 25.8 Cg_exo -62.51 164.11 19.03 Favored 'Trans proline' 0 N--CA 1.496 1.628 0 C-N-CA 121.277 1.318 . . . . 0.0 111.916 176.001 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' F' F ' 16' ' ' PRO . . . . . . . . . . . . . 27.6 Cg_exo -60.32 -41.84 46.86 Favored 'Trans proline' 0 N--CA 1.498 1.748 0 C-N-CA 121.439 1.426 . . . . 0.0 112.842 -177.974 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' F' F ' 17' ' ' ASP . . . . . . . . . . . . . 7.9 p-10 -88.67 11.09 18.45 Favored 'General case' 0 C--N 1.327 -0.376 0 N-CA-C 113.249 0.833 . . . . 0.0 113.249 -176.679 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' F' F ' 18' ' ' PHE . . . . . . . . . . . . . 49.2 t80 -57.18 -42.72 81.69 Favored 'General case' 0 C--N 1.334 -0.07 0 O-C-N 121.922 -0.486 . . . . 0.0 110.25 -178.816 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' F' F ' 19' ' ' VAL . . . . . . . . . . . . . 47.7 t -57.52 -43.05 82.3 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.321 0 CA-C-N 116.144 -0.48 . . . . 0.0 110.36 -179.092 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' F' F ' 20' ' ' ASP . . . . . . . . . . . . . 8.6 t70 -59.85 -41.13 90.74 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-O 120.873 0.368 . . . . 0.0 110.726 -178.217 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' F' F ' 21' ' ' VAL . . . . . . . . . . . . . 51.1 t -64.36 -47.2 90.58 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.332 0 CA-C-N 116.323 -0.398 . . . . 0.0 110.392 -178.2 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' F' F ' 22' ' ' ILE . . . . . 0.446 HG22 HD12 ' F' ' 26' ' ' LEU . 50.5 mm -55.93 -45.37 80.0 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.202 0 C-N-CA 120.928 -0.309 . . . . 0.0 110.662 179.201 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' F' F ' 23' ' ' ARG . . . . . . . . . . . . . 36.1 ttp180 -53.83 -50.7 65.62 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-O 120.675 0.274 . . . . 0.0 111.428 -178.999 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' F' F ' 24' ' ' ILE . . . . . . . . . . . . . 71.5 mt -60.31 -41.36 86.83 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.264 0 CA-C-N 116.514 -0.312 . . . . 0.0 111.314 -177.18 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' F' F ' 25' ' ' LYS . . . . . . . . . . . . . 82.3 mttt -66.39 -39.02 88.81 Favored 'General case' 0 C--N 1.33 -0.265 0 N-CA-C 112.354 0.502 . . . . 0.0 112.354 -178.674 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' F' F ' 26' ' ' LEU . . . . . 0.446 HD12 HG22 ' F' ' 22' ' ' ILE . 75.7 mt -78.42 -41.9 31.64 Favored 'General case' 0 C--N 1.33 -0.278 0 N-CA-C 113.005 0.742 . . . . 0.0 113.005 -173.39 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' F' F ' 27' ' ' GLN . . . . . . . . . . . . . 10.8 pt20 -46.91 142.1 3.66 Favored 'General case' 0 N--CA 1.47 0.538 0 N-CA-C 112.694 0.627 . . . . 0.0 112.694 -175.377 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' F' F ' 28' ' ' GLY . . . . . . . . . . . . . . . 98.94 -29.77 11.09 Favored Glycine 0 CA--C 1.531 1.087 0 CA-C-N 115.514 -0.766 . . . . 0.0 111.96 -177.477 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' F' F ' 29' ' ' LYS . . . . . . . . . . . . . 8.7 mtpm? -98.66 155.14 17.47 Favored 'General case' 0 C--O 1.232 0.167 0 CA-C-O 121.013 0.435 . . . . 0.0 110.955 179.264 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' F' F ' 30' ' ' THR . . . . . . . . . . . . . 29.7 m -97.28 138.4 34.82 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.151 -0.477 . . . . 0.0 109.947 175.682 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' F' F ' 31' ' ' VAL . . . . . . . . . . . . . 35.3 m -124.94 151.45 30.56 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.257 0 CA-C-N 116.289 -0.414 . . . . 0.0 110.82 -178.47 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' F' F ' 32' ' ' ARG . . . . . . . . . . . . . 61.5 mtp180 -135.3 152.19 51.26 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-O 121.398 0.618 . . . . 0.0 110.717 176.82 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' F' F ' 33' ' ' THR . . . . . . . . . . . . . 8.4 m -54.0 138.3 37.48 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 115.973 -0.558 . . . . 0.0 111.18 -179.085 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' F' F ' 34' ' ' GLY . . . . . . . . . . . . . . . 101.57 -17.08 55.79 Favored Glycine 0 CA--C 1.532 1.139 0 CA-C-O 119.539 -0.59 . . . . 0.0 113.293 178.768 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' F' F ' 35' ' ' ASP . . . . . . . . . . . . . 74.2 m-20 -65.27 148.81 51.04 Favored 'General case' 0 N--CA 1.461 0.113 0 CA-C-N 118.134 0.967 . . . . 0.0 111.25 179.869 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' F' F ' 36' ' ' VAL . . . . . . . . . . . . . 44.8 t -122.48 129.84 74.96 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.16 0 CA-C-N 115.741 -0.663 . . . . 0.0 109.793 178.308 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' F' F ' 37' ' ' ILE . . . . . . . . . . . . . 70.4 mt -122.71 140.18 47.28 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.185 0 CA-C-N 116.233 -0.439 . . . . 0.0 109.96 -179.813 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' F' F ' 38' ' ' GLY . . . . . . . . . . . . . . . -114.0 128.78 8.42 Favored Glycine 0 CA--C 1.525 0.679 0 N-CA-C 111.211 -0.756 . . . . 0.0 111.211 -179.973 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' F' F ' 39' ' ' ILE . . . . . . . . . . . . . 72.4 mt -126.25 130.27 72.03 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.214 0 N-CA-C 109.746 -0.465 . . . . 0.0 109.746 178.539 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' F' F ' 40' ' ' SER . . . . . 0.558 ' O ' HD13 ' F' ' 41' ' ' ILE . 83.7 p -93.45 121.62 35.04 Favored 'General case' 0 C--N 1.331 -0.227 0 C-N-CA 120.945 -0.302 . . . . 0.0 111.456 178.826 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' F' F ' 41' ' ' ILE . . . . . 0.558 HD13 ' O ' ' F' ' 40' ' ' SER . 44.5 mm -133.4 129.13 55.99 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.181 0 CA-C-N 116.427 -0.351 . . . . 0.0 110.163 177.813 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' F' F ' 42' ' ' LEU . . . . . 0.481 ' HG ' HG22 ' F' ' 41' ' ' ILE . 70.3 mt 57.6 32.99 22.67 Favored 'General case' 0 C--N 1.33 -0.249 0 N-CA-C 112.023 0.379 . . . . 0.0 112.023 176.93 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' F' F ' 43' ' ' GLY . . . . . . . . . . . . . . . 77.46 -10.12 24.6 Favored Glycine 0 CA--C 1.533 1.205 0 C-N-CA 121.108 -0.568 . . . . 0.0 113.553 177.502 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' F' F ' 44' ' ' LYS . . . . . . . . . . . . . 37.6 mmtm -103.25 136.31 43.26 Favored 'General case' 0 C--O 1.232 0.173 0 CA-C-N 117.988 0.894 . . . . 0.0 110.051 176.638 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' F' F ' 45' ' ' GLU . . . . . . . . . . . . . 35.1 tp10 -84.58 127.56 34.13 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.344 -0.389 . . . . 0.0 110.628 -179.805 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' F' F ' 46' ' ' VAL . . . . . . . . . . . . . 5.8 p -115.22 126.67 72.85 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.223 0 N-CA-C 109.212 -0.662 . . . . 0.0 109.212 176.23 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' F' F ' 47' ' ' LYS . . . . . . . . . . . . . 63.4 mttm -100.14 128.99 46.12 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 115.791 -0.641 . . . . 0.0 110.924 -179.482 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' F' F ' 48' ' ' PHE . . . . . . . . . . . . . 95.6 m-85 -113.73 131.83 56.04 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.358 -0.383 . . . . 0.0 110.324 177.884 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' F' F ' 49' ' ' LYS . . . . . . . . . . . . . 80.0 tttt -108.06 139.01 43.34 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.357 -0.383 . . . . 0.0 110.633 178.214 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' F' F ' 50' ' ' VAL . . . . . . . . . . . . . 45.0 t -82.11 107.33 14.0 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.343 0 N-CA-C 109.224 -0.658 . . . . 0.0 109.224 175.011 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' F' F ' 51' ' ' VAL . . . . . . . . . . . . . 50.3 t -72.25 -51.87 27.42 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.258 0 CA-C-N 116.103 -0.499 . . . . 0.0 109.757 -174.753 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' F' F ' 52' ' ' GLN . . . . . . . . . . . . . 90.7 mt-30 -153.84 153.23 31.73 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-O 121.296 0.57 . . . . 0.0 111.722 -178.564 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' F' F ' 53' ' ' ALA . . . . . . . . . . . . . . . -129.98 132.64 46.37 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 115.252 -0.885 . . . . 0.0 109.635 173.825 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' F' F ' 54' ' ' TYR . . . . . . . . . . . . . 41.1 t80 -129.09 110.58 18.24 Favored Pre-proline 0 CA--C 1.536 0.406 0 CA-C-O 118.231 -0.89 . . . . 0.0 110.555 179.974 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' F' F ' 55' ' ' PRO . . . . . . . . . . . . . 74.4 Cg_endo -77.21 169.37 74.35 Favored 'Cis proline' 0 N--CA 1.5 1.869 0 CA-C-N 121.823 1.687 . . . . 0.0 112.165 -7.971 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' F' F ' 56' ' ' SER . . . . . . . . . . . . . 13.6 m -117.84 135.03 23.22 Favored Pre-proline 0 CA--C 1.538 0.487 0 CA-C-O 118.515 -0.755 . . . . 0.0 109.599 174.809 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' F' F ' 57' ' ' PRO . . . . . . . . . . . . . 58.8 Cg_endo -73.18 162.01 92.69 Favored 'Cis proline' 0 N--CA 1.498 1.736 0 CA-C-N 121.898 1.714 . . . . 0.0 111.412 -2.656 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' F' F ' 58' ' ' LEU . . . . . . . . . . . . . 23.9 tp -130.88 139.64 50.13 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-O 121.003 0.43 . . . . 0.0 110.936 -179.673 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' F' F ' 59' ' ' ARG . . . . . . . . . . . . . 35.7 ttm180 -97.84 125.22 42.59 Favored 'General case' 0 C--N 1.327 -0.399 0 N-CA-C 109.087 -0.708 . . . . 0.0 109.087 173.052 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' F' F ' 60' ' ' VAL . . . . . . . . . . . . . 43.4 t -79.44 119.86 29.59 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.262 0 C-N-CA 120.599 -0.44 . . . . 0.0 110.426 -175.144 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' F' F ' 61' ' ' GLU . . . . . . . . . . . . . 95.2 mt-10 -131.08 169.93 15.21 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 115.792 -0.64 . . . . 0.0 109.742 176.592 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' F' F ' 62' ' ' ASP . . . . . . . . . . . . . 80.1 m-20 -52.8 -32.37 43.66 Favored 'General case' 0 C--N 1.329 -0.305 0 N-CA-C 111.948 0.351 . . . . 0.0 111.948 -178.417 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' F' F ' 63' ' ' ARG . . . . . . . . . . . . . 85.4 mtt180 -72.29 -22.06 61.26 Favored 'General case' 0 CA--C 1.533 0.308 0 N-CA-C 113.019 0.748 . . . . 0.0 113.019 -175.661 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' F' F ' 64' ' ' THR . . . . . . . . . . . . . 33.1 m -68.72 135.43 51.29 Favored 'General case' 0 C--N 1.331 -0.229 0 CA-C-O 120.995 0.426 . . . . 0.0 111.049 -175.099 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' F' F ' 65' ' ' LYS . . . . . . . . . . . . . 63.3 mttm -89.95 136.47 33.02 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 115.912 -0.585 . . . . 0.0 110.064 177.922 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' F' F ' 66' ' ' ILE . . . . . . . . . . . . . 60.1 mt -118.29 129.95 73.86 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.185 0 N-CA-C 109.851 -0.426 . . . . 0.0 109.851 179.06 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' F' F ' 67' ' ' THR . . . . . . . . . . . . . 24.2 m -124.88 142.26 51.57 Favored 'General case' 0 C--N 1.332 -0.186 0 CA-C-O 121.103 0.477 . . . . 0.0 110.9 -178.878 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' F' F ' 68' ' ' LEU . . . . . 0.478 HD23 ' C ' ' F' ' 68' ' ' LEU . 7.1 tt -98.78 123.0 42.73 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 115.944 -0.571 . . . . 0.0 109.822 177.396 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' F' F ' 69' ' ' VAL . . . . . . . . . . . . . 41.3 t -103.18 123.44 56.64 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.304 0 CA-C-N 116.354 -0.385 . . . . 0.0 110.817 -176.774 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' F' F ' 70' ' ' THR . . . . . . . . . . . . . 18.2 m -109.46 109.64 20.53 Favored 'General case' 0 C--N 1.33 -0.247 0 N-CA-C 109.298 -0.63 . . . . 0.0 109.298 172.979 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' F' F ' 71' ' ' HIS . . . . . . . . . . . . . 2.0 m-70 -146.15 174.47 3.4 Favored Pre-proline 0 CA--C 1.536 0.409 0 C-N-CA 120.807 -0.357 . . . . 0.0 110.775 -175.617 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' F' F ' 72' ' ' PRO . . . . . . . . . . . . . 18.9 Cg_exo -64.87 160.09 42.73 Favored 'Trans proline' 0 N--CA 1.494 1.516 0 C-N-CA 121.594 1.529 . . . . 0.0 111.745 177.712 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' F' F ' 73' ' ' VAL . . . . . . . . . . . . . 33.1 m -69.78 175.6 0.58 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.284 0 CA-C-N 116.291 -0.413 . . . . 0.0 110.112 -178.061 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' F' F ' 74' ' ' ASP . . . . . . . . . . . . . 14.4 t0 -92.85 117.49 30.08 Favored 'General case' 0 C--N 1.331 -0.227 0 C-N-CA 120.735 -0.386 . . . . 0.0 110.3 -173.729 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' F' F ' 75' ' ' VAL . . . . . . . . . . . . . 41.8 t -113.72 120.43 63.56 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.287 0 CA-C-O 121.101 0.477 . . . . 0.0 110.075 -179.785 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' F' F ' 76' ' ' LEU . . . . . . . . . . . . . 15.4 mt -125.17 144.17 50.58 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 115.728 -0.669 . . . . 0.0 109.686 178.129 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' F' F ' 77' ' ' GLU . . . . . . . . . . . . . 97.4 mt-10 -134.6 132.69 39.35 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-O 121.151 0.501 . . . . 0.0 110.981 -176.855 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' F' F ' 78' ' ' ALA . . . . . . . . . . . . . . . -116.33 127.29 54.56 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 115.658 -0.701 . . . . 0.0 109.719 177.309 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' F' F ' 79' ' ' LYS . . . . . 0.623 ' O ' HD13 ' F' ' 80' ' ' ILE . 52.5 mtmt -78.39 116.31 18.71 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-O 120.85 0.357 . . . . 0.0 110.691 -177.586 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' F' F ' 80' ' ' ILE . . . . . 0.623 HD13 ' O ' ' F' ' 79' ' ' LYS . 40.1 mm -139.14 106.25 2.83 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.295 0 N-CA-C 109.003 -0.74 . . . . 0.0 109.003 -177.313 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' F' F ' 81' ' ' LYS . . . . . . . . . . . . . 44.3 tptt -98.05 124.17 42.42 Favored 'General case' 0 C--N 1.328 -0.355 0 C-N-CA 120.788 -0.365 . . . . 0.0 110.806 -175.95 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' F' F ' 82' ' ' GLY . . . . . . . . . . . . . . . 89.09 42.24 5.66 Favored Glycine 0 CA--C 1.524 0.648 0 C-N-CA 120.756 -0.735 . . . . 0.0 111.798 175.423 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' F' F ' 83' ' ' ILE . . . . . . . . . . . . . 75.7 mt -66.45 141.09 18.45 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.286 0 N-CA-C 109.815 -0.439 . . . . 0.0 109.815 177.122 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' F' F ' 84' ' ' LYS . . . . . . . . . . . . . 41.6 tttp -95.4 -53.42 3.77 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 115.93 -0.577 . . . . 0.0 110.361 -178.775 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' F' F ' 85' ' ' ASP . . . . . . . . . . . . . 12.9 t70 -153.21 151.98 30.69 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 115.714 -0.675 . . . . 0.0 110.419 -179.711 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' F' F ' 86' ' ' VAL . . . . . . . . . . . . . 44.6 t -127.22 130.68 71.01 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.266 0 CA-C-O 120.951 0.405 . . . . 0.0 110.406 -179.113 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' F' F ' 87' ' ' ILE . . . . . 0.498 HD12 ' N ' ' F' ' 87' ' ' ILE . 5.0 mp -122.03 129.02 75.74 Favored 'Isoleucine or valine' 0 C--O 1.233 0.206 0 CA-C-N 115.932 -0.576 . . . . 0.0 109.604 176.954 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' F' F ' 88' ' ' LEU . . . . . . . . . . . . . 18.5 tp -112.32 128.36 56.26 Favored 'General case' 0 C--N 1.332 -0.183 0 CA-C-O 121.03 0.443 . . . . 0.0 110.983 -179.0 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' F' F ' 89' ' ' ASP . . . . . . . . . . . . . 6.5 t0 -117.28 152.1 35.56 Favored 'General case' 0 C--N 1.329 -0.3 0 N-CA-C 109.093 -0.706 . . . . 0.0 109.093 175.63 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' F' F ' 90' ' ' GLU . . . . . . . . . . . . . 84.3 tt0 -48.86 -30.57 5.96 Favored 'General case' 0 C--N 1.329 -0.299 0 N-CA-C 112.83 0.678 . . . . 0.0 112.83 -172.534 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' F' F ' 91' ' ' ASN . . . . . . . . . . . . . 7.3 m120 -130.55 15.78 5.43 Favored 'General case' 0 N--CA 1.468 0.468 0 N-CA-C 113.308 0.855 . . . . 0.0 113.308 -177.051 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' F' F ' 92' ' ' LEU . . . . . . . . . . . . . 55.7 mt -149.96 149.59 30.62 Favored 'General case' 0 C--N 1.332 -0.195 0 CA-C-N 117.964 0.347 . . . . 0.0 110.764 -176.396 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' F' F ' 93' ' ' ILE . . . . . . . . . . . . . 68.2 mt -122.16 119.63 59.01 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.244 0 N-CA-C 108.985 -0.746 . . . . 0.0 108.985 176.631 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' F' F ' 94' ' ' VAL . . . . . 0.452 HG21 HG21 ' F' ' 125' ' ' VAL . 47.6 t -120.67 127.31 75.91 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.254 0 CA-C-O 121.008 0.432 . . . . 0.0 110.016 -178.785 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' F' F ' 95' ' ' VAL . . . . . . . . . . . . . 40.4 t -122.87 134.84 64.84 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.342 0 CA-C-N 115.809 -0.632 . . . . 0.0 109.876 -179.754 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' F' F ' 96' ' ' ILE . . . . . 0.528 HD11 ' HB ' ' F' ' 123' ' ' VAL . 59.1 mt -114.48 125.65 71.83 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.379 0 N-CA-C 108.947 -0.76 . . . . 0.0 108.947 178.266 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' F' F ' 97' ' ' THR . . . . . . . . . . . . . 73.9 p -98.91 155.23 17.51 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-O 121.221 0.534 . . . . 0.0 111.438 -175.585 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' F' F ' 98' ' ' GLU . . . . . . . . . . . . . 22.1 pt-20 -54.26 -21.76 10.01 Favored 'General case' 0 CA--C 1.534 0.353 0 N-CA-C 112.568 0.581 . . . . 0.0 112.568 179.339 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' F' F ' 99' ' ' GLU . . . . . . . . . . . . . 34.7 tt0 -83.74 18.11 2.07 Favored 'General case' 0 CA--C 1.539 0.542 0 N-CA-C 112.394 0.516 . . . . 0.0 112.394 -177.548 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' F' F ' 100' ' ' ASN . . . . . . . . . . . . . 3.6 m-20 62.04 37.98 14.37 Favored 'General case' 0 C--O 1.232 0.183 0 CA-C-O 121.161 0.505 . . . . 0.0 111.029 177.247 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' F' F ' 101' ' ' GLU . . . . . . . . . . . . . 84.2 tt0 -118.13 143.36 46.55 Favored 'General case' 0 C--N 1.331 -0.219 0 CA-C-N 116.147 -0.479 . . . . 0.0 109.998 176.836 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' F' F ' 102' ' ' VAL . . . . . . . . . . . . . 44.8 t -114.9 125.54 72.25 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.345 0 N-CA-C 109.822 -0.436 . . . . 0.0 109.822 -179.268 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' F' F ' 103' ' ' LEU . . . . . . . . . . . . . 21.2 mt -118.79 129.45 55.25 Favored 'General case' 0 C--N 1.331 -0.223 0 CA-C-N 115.791 -0.64 . . . . 0.0 110.28 178.116 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' F' F ' 104' ' ' ILE . . . . . . . . . . . . . 67.4 mt -118.63 121.56 67.3 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.251 0 N-CA-C 109.974 -0.38 . . . . 0.0 109.974 178.575 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' F' F ' 105' ' ' PHE . . . . . . . . . . . . . 52.7 m-85 -120.74 163.59 17.88 Favored 'General case' 0 C--N 1.332 -0.176 0 O-C-N 123.978 0.799 . . . . 0.0 109.623 179.647 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' F' F ' 106' ' ' ASN . . . . . . . . . . . . . 48.7 p-10 -97.67 -173.45 2.63 Favored 'General case' 0 C--N 1.328 -0.34 0 N-CA-C 109.618 -0.512 . . . . 0.0 109.618 171.887 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' F' F ' 107' ' ' GLN . . . . . . . . . . . . . 47.2 tt0 -58.57 -26.56 63.72 Favored 'General case' 0 C--N 1.329 -0.317 0 N-CA-C 112.349 0.5 . . . . 0.0 112.349 -178.543 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' F' F ' 108' ' ' ASN . . . . . . . . . . . . . 8.3 t-20 -89.63 14.07 12.55 Favored 'General case' 0 CA--C 1.535 0.379 0 N-CA-C 112.96 0.726 . . . . 0.0 112.96 -176.725 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' F' F ' 109' ' ' LEU . . . . . . . . . . . . . 48.9 mt 57.56 38.98 28.08 Favored 'General case' 0 C--N 1.332 -0.154 0 CA-C-O 121.163 0.506 . . . . 0.0 111.504 178.01 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' F' F ' 110' ' ' GLU . . . . . . . . . . . . . 95.9 mt-10 -104.05 161.03 14.34 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.076 -0.511 . . . . 0.0 109.958 176.466 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' F' F ' 111' ' ' GLU . . . . . . . . . . . . . 84.6 tt0 -89.64 122.33 32.67 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-O 120.905 0.383 . . . . 0.0 110.922 -177.869 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' F' F ' 112' ' ' LEU . . . . . . . . . . . . . 14.0 mt -112.1 -46.04 3.24 Favored 'General case' 0 C--N 1.332 -0.195 0 CA-C-N 116.071 -0.513 . . . . 0.0 110.419 178.029 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' F' F ' 113' ' ' TYR . . . . . . . . . . . . . 54.3 t80 -140.84 134.61 30.37 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.286 -0.416 . . . . 0.0 110.921 179.85 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' F' F ' 114' ' ' ARG . . . . . . . . . . . . . 43.4 ttp180 -141.71 122.49 14.37 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.489 -0.323 . . . . 0.0 110.479 177.782 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' F' F ' 115' ' ' GLY . . . . . . . . . . . . . . . -150.16 146.94 16.6 Favored Glycine 0 CA--C 1.526 0.72 0 N-CA-C 111.193 -0.763 . . . . 0.0 111.193 178.998 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' F' F ' 116' ' ' LYS . . . . . . . . . . . . . 33.2 ttpt -115.2 133.76 55.75 Favored 'General case' 0 C--N 1.33 -0.24 0 N-CA-C 109.776 -0.453 . . . . 0.0 109.776 176.228 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' F' F ' 117' ' ' PHE . . . . . . . . . . . . . 52.3 m-85 -131.77 114.59 14.92 Favored 'General case' 0 C--N 1.332 -0.184 0 CA-C-O 120.924 0.392 . . . . 0.0 110.279 -176.298 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' F' F ' 118' ' ' GLU . . . . . . . . . . . . . 84.4 tt0 -54.26 -45.39 72.4 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.443 -0.344 . . . . 0.0 111.539 -176.015 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' F' F ' 119' ' ' ASN . . . . . . . . . . . . . 9.2 m120 -97.54 30.94 2.7 Favored 'General case' 0 C--N 1.33 -0.281 0 N-CA-C 112.178 0.436 . . . . 0.0 112.178 -174.934 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' F' F ' 120' ' ' LEU . . . . . . . . . . . . . 23.9 tp -58.01 126.95 29.68 Favored 'General case' 0 C--N 1.333 -0.148 0 CA-C-O 120.76 0.314 . . . . 0.0 110.304 178.411 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' F' F ' 121' ' ' ASN . . . . . . . . . . . . . 20.8 t-20 -109.77 -44.0 3.92 Favored 'General case' 0 C--N 1.332 -0.181 0 CA-C-N 116.376 -0.374 . . . . 0.0 110.946 -177.987 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' F' F ' 122' ' ' LYS . . . . . . . . . . . . . 18.8 ptpt -161.29 159.72 28.91 Favored 'General case' 0 C--N 1.333 -0.136 0 CA-C-O 121.141 0.496 . . . . 0.0 111.82 -179.33 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' F' F ' 123' ' ' VAL . . . . . 0.528 ' HB ' HD11 ' F' ' 96' ' ' ILE . 45.8 t -127.27 135.59 63.02 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.199 0 CA-C-N 115.867 -0.606 . . . . 0.0 109.749 177.15 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' F' F ' 124' ' ' LEU . . . . . . . . . . . . . 6.5 mp -118.53 130.41 55.9 Favored 'General case' 0 C--N 1.331 -0.22 0 CA-C-N 116.37 -0.377 . . . . 0.0 110.636 -179.22 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' F' F ' 125' ' ' VAL . . . . . 0.568 HG22 HG23 ' F' ' 130' ' ' VAL . 44.6 t -131.69 127.71 59.4 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.236 0 CA-C-N 116.331 -0.395 . . . . 0.0 110.17 179.371 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' F' F ' 126' ' ' ARG . . . . . . . . . . . . . 78.7 mtt180 -149.98 133.63 16.72 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-O 120.95 0.405 . . . . 0.0 110.889 177.154 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' F' F ' 127' ' ' ASN . . . . . . . . . . . . . 9.4 m120 52.48 -118.28 1.29 Allowed 'General case' 0 CA--C 1.545 0.77 0 CA-C-O 118.657 -0.687 . . . . 0.0 110.798 178.826 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' F' F ' 128' ' ' ASP . . . . . . . . . . . . . 8.2 p-10 -113.26 13.55 19.17 Favored 'General case' 0 N--CA 1.469 0.477 0 CA-C-N 120.107 1.321 . . . . 0.0 112.838 -179.624 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' F' F ' 129' ' ' LEU . . . . . . . . . . . . . 13.5 tp -116.26 139.2 50.62 Favored 'General case' 0 C--O 1.233 0.187 0 N-CA-C 109.832 -0.433 . . . . 0.0 109.832 179.121 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' F' F ' 130' ' ' VAL . . . . . 0.568 HG23 HG22 ' F' ' 125' ' ' VAL . 13.0 p -134.06 141.22 44.44 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.196 0 CA-C-O 121.1 0.476 . . . . 0.0 110.554 -179.326 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' F' F ' 131' ' ' VAL . . . . . . . . . . . . . 35.3 m -136.06 147.45 28.16 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.362 0 CA-C-N 115.963 -0.562 . . . . 0.0 110.801 179.212 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' F' F ' 132' ' ' ILE . . . . . . . . . . . . . 71.0 mt -118.43 131.05 72.33 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.373 0 CA-C-N 115.736 -0.665 . . . . 0.0 109.285 -179.873 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' F' F ' 133' ' ' ILE . . . . . . . . . . . . . 43.4 mm -115.6 121.81 68.08 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.241 0 CA-C-O 120.753 0.311 . . . . 0.0 110.708 -175.979 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' F' F ' 134' ' ' ASP . . . . . . . . . . . . . 7.6 p-10 -133.88 149.15 51.32 Favored 'General case' 0 C--N 1.331 -0.212 0 N-CA-C 109.586 -0.524 . . . . 0.0 109.586 174.562 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' F' F ' 135' ' ' GLU . . . . . . . . . . . . . 84.9 tt0 -49.84 -24.33 2.38 Favored 'General case' 0 C--N 1.326 -0.423 0 N-CA-C 112.949 0.722 . . . . 0.0 112.949 -170.869 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' F' F ' 136' ' ' GLN . . . . . . . . . . . . . 48.5 tt0 -104.68 -25.57 12.65 Favored 'General case' 0 N--CA 1.465 0.297 0 N-CA-C 112.846 0.684 . . . . 0.0 112.846 -174.484 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' F' F ' 137' ' ' LYS . . . . . . . . . . . . . 88.5 mttt -141.62 151.72 43.36 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-O 121.169 0.509 . . . . 0.0 111.777 -171.23 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' F' F ' 138' ' ' LEU . . . . . . . . . . . . . 5.0 tt -120.04 120.27 35.81 Favored 'General case' 0 C--N 1.329 -0.29 0 N-CA-C 109.151 -0.685 . . . . 0.0 109.151 172.502 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' F' F ' 139' ' ' THR . . . . . . . . . . . . . 40.6 m -110.92 131.15 55.29 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.416 -0.356 . . . . 0.0 110.792 -176.956 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' F' F ' 140' ' ' LEU . . . . . 0.485 HD23 ' C ' ' F' ' 140' ' ' LEU . 8.0 tt -116.26 123.77 48.53 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 115.769 -0.651 . . . . 0.0 109.309 -179.671 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' F' F ' 141' ' ' ILE . . . . . 0.566 ' HB ' HG13 ' F' ' 130' ' ' VAL . 19.2 mt -122.54 121.1 62.77 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.295 0 CA-C-O 121.08 0.467 . . . . 0.0 110.072 -175.811 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' F' F ' 142' ' ' ARG . . . . . . . . . . . . . 65.8 ttt180 -109.98 129.23 55.7 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 115.318 -0.855 . . . . 0.0 110.364 -178.992 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' F' F ' 143' ' ' THR . . . . . . . . . . . . . 81.3 p . . . . . 0 C--O 1.219 -0.505 0 CA-C-O 117.915 -1.04 . . . . 0.0 110.484 178.927 . . . . . . . . 0 0 . 1 . 018 nuclear build full ' A' A ' -3' ' ' GLU . . . . . . . . . . . . . 83.7 tt0 . . . . . 0 N--CA 1.489 1.508 0 N-CA-C 109.367 -0.605 . . . . 0.0 109.367 . . . . . . . . . 0 0 . 1 . 018 nuclear build full ' A' A ' -2' ' ' GLY . . . . . . . . . . . . . . . -67.64 150.05 51.13 Favored Glycine 0 CA--C 1.526 0.759 0 N-CA-C 110.956 -0.858 . . . . 0.0 110.956 179.358 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' -1' ' ' VAL . . . . . . . . . . . . . 46.9 t -95.55 131.43 42.36 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.292 0 CA-C-O 120.891 0.377 . . . . 0.0 109.997 179.864 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 0' ' ' ILE . . . . . . . . . . . . . 70.0 mt -119.01 138.1 50.83 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.208 0 CA-C-N 116.156 -0.474 . . . . 0.0 110.184 -179.397 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 25.1 ptt? -143.48 145.37 32.53 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.02 -0.536 . . . . 0.0 110.443 178.867 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 2' ' ' SER . . . . . 0.415 ' HB2' HD11 ' A' ' 58' ' ' LEU . 79.0 p -123.8 150.6 44.28 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 116.265 -0.425 . . . . 0.0 110.625 -179.102 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 44.5 mp0 -138.2 141.26 40.01 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.098 -0.501 . . . . 0.0 110.882 -178.523 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 4' ' ' LEU . . . . . . . . . . . . . 15.1 tp -126.77 131.05 51.38 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 115.939 -0.573 . . . . 0.0 110.077 177.274 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 5' ' ' LYS . . . . . . . . . . . . . 68.9 mttm -114.04 121.52 44.12 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-O 120.901 0.381 . . . . 0.0 110.923 -179.164 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 6' ' ' LEU . . . . . 0.433 HD23 ' HA ' ' A' ' 50' ' ' VAL . 63.7 mt -115.45 141.05 48.57 Favored 'General case' 0 C--N 1.331 -0.227 0 CA-C-N 115.237 -0.892 . . . . 0.0 110.046 179.686 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 86.3 tttt -121.0 136.87 25.95 Favored Pre-proline 0 CA--C 1.533 0.308 0 CA-C-O 118.867 -0.587 . . . . 0.0 109.751 177.032 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 8' ' ' PRO . . . . . . . . . . . . . 93.0 Cg_endo -89.03 131.91 2.25 Favored 'Trans proline' 0 N--CA 1.491 1.327 0 C-N-CA 121.699 1.599 . . . . 0.0 111.921 179.088 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 57.1 mt -70.95 -47.91 14.57 Favored Pre-proline 0 CA--C 1.533 0.321 0 CA-C-O 118.575 -0.726 . . . . 0.0 112.211 -179.985 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 71.5 Cg_endo -77.77 153.13 29.5 Favored 'Trans proline' 0 N--CA 1.496 1.626 0 C-N-CA 121.14 1.227 . . . . 0.0 111.913 176.528 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 58.7 tttm -87.18 89.71 8.09 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-O 120.842 0.353 . . . . 0.0 110.266 179.634 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 12.1 p -139.34 148.01 23.93 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.245 0 CA-C-N 116.231 -0.441 . . . . 0.0 110.707 -178.072 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 95.6 mt-10 -90.89 128.53 36.79 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.141 -0.481 . . . . 0.0 110.026 177.248 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 14' ' ' LEU . . . . . . . . . . . . . 24.0 mt -98.0 152.55 38.11 Favored Pre-proline 0 CA--C 1.532 0.267 0 CA-C-O 119.512 -0.28 . . . . 0.0 110.801 -178.586 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 15' ' ' PRO . . . . . . . . . . . . . 25.5 Cg_exo -62.09 159.06 36.07 Favored 'Trans proline' 0 N--CA 1.497 1.727 0 C-N-CA 121.281 1.321 . . . . 0.0 112.165 177.513 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 16' ' ' PRO . . . . . . . . . . . . . 37.5 Cg_exo -58.35 -45.02 33.37 Favored 'Trans proline' 0 N--CA 1.498 1.792 0 C-N-CA 121.437 1.425 . . . . 0.0 112.866 -178.863 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 17' ' ' ASP . . . . . . . . . . . . . 19.8 p-10 -85.32 12.9 7.28 Favored 'General case' 0 C--N 1.326 -0.435 0 N-CA-C 113.14 0.793 . . . . 0.0 113.14 -177.016 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 18' ' ' PHE . . . . . . . . . . . . . 42.6 t80 -58.36 -46.79 85.61 Favored 'General case' 0 CA--C 1.523 -0.078 0 O-C-N 122.096 -0.378 . . . . 0.0 110.162 -177.963 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 19' ' ' VAL . . . . . . . . . . . . . 14.0 p -55.92 -40.23 61.43 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.347 0 CA-C-N 116.227 -0.442 . . . . 0.0 111.104 -178.345 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 78.3 m-20 -61.15 -45.18 95.69 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-O 120.783 0.325 . . . . 0.0 111.093 -177.977 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 60.7 t -64.66 -47.02 90.6 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 C-N-CA 120.781 -0.368 . . . . 0.0 110.591 -177.919 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 22' ' ' ILE . . . . . 0.53 HG22 HD12 ' A' ' 26' ' ' LEU . 50.5 mm -56.89 -43.35 80.18 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.189 0 C-N-CA 120.829 -0.348 . . . . 0.0 110.483 179.142 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 23' ' ' ARG . . . . . . . . . . . . . 43.2 ttp180 -54.71 -49.38 70.86 Favored 'General case' 0 C--N 1.33 -0.257 0 C-N-CA 121.143 -0.223 . . . . 0.0 111.309 -178.727 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 24' ' ' ILE . . . . . . . . . . . . . 73.2 mt -59.25 -39.84 79.78 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.244 0 C-N-CA 120.869 -0.332 . . . . 0.0 110.751 -178.699 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 8.3 mtpm? -66.05 -41.82 90.33 Favored 'General case' 0 C--N 1.327 -0.385 0 N-CA-C 112.276 0.473 . . . . 0.0 112.276 -179.253 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 26' ' ' LEU . . . . . 0.53 HD12 HG22 ' A' ' 22' ' ' ILE . 67.0 mt -80.75 -36.07 32.46 Favored 'General case' 0 C--N 1.331 -0.228 0 N-CA-C 113.881 1.067 . . . . 0.0 113.881 -171.134 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 27' ' ' GLN . . . . . . . . . . . . . 11.5 pt20 -46.85 141.49 3.97 Favored 'General case' 0 N--CA 1.47 0.527 0 N-CA-C 112.81 0.67 . . . . 0.0 112.81 -175.17 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 98.64 -24.21 33.07 Favored Glycine 0 CA--C 1.533 1.201 0 CA-C-N 115.673 -0.694 . . . . 0.0 112.354 -176.886 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 60.5 mttp -98.07 155.22 17.23 Favored 'General case' 0 C--O 1.232 0.16 0 CA-C-N 117.45 0.625 . . . . 0.0 110.901 179.167 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 30' ' ' THR . . . . . . . . . . . . . 30.9 m -104.51 136.71 43.56 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.161 -0.472 . . . . 0.0 109.88 176.25 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 33.9 m -129.27 152.51 37.35 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.194 0 CA-C-O 120.987 0.423 . . . . 0.0 110.975 -178.683 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 32' ' ' ARG . . . . . . . . . . . . . 94.2 mtt180 -129.34 152.3 49.05 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-O 121.32 0.581 . . . . 0.0 110.614 179.943 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 33' ' ' THR . . . . . . . . . . . . . 21.4 m -53.63 139.75 31.01 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-N 116.162 -0.472 . . . . 0.0 111.202 -179.297 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 98.62 -17.09 58.88 Favored Glycine 0 CA--C 1.534 1.263 0 C-N-CA 121.106 -0.569 . . . . 0.0 113.269 178.844 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 58.7 m-20 -64.14 149.7 47.18 Favored 'General case' 0 C--O 1.231 0.11 0 CA-C-N 117.997 0.898 . . . . 0.0 111.369 -179.609 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 45.6 t -119.46 126.55 75.44 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.288 0 CA-C-N 115.458 -0.792 . . . . 0.0 109.538 177.896 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 37' ' ' ILE . . . . . . . . . . . . . 69.4 mt -120.71 138.34 51.52 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.226 0 CA-C-N 116.397 -0.365 . . . . 0.0 110.05 -179.072 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . -118.67 128.77 7.84 Favored Glycine 0 CA--C 1.525 0.66 0 N-CA-C 110.98 -0.848 . . . . 0.0 110.98 179.467 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 39' ' ' ILE . . . . . . . . . . . . . 70.8 mt -123.21 134.58 65.8 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.184 0 N-CA-C 109.938 -0.393 . . . . 0.0 109.938 178.228 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 40' ' ' SER . . . . . . . . . . . . . 23.2 t -91.49 120.54 32.4 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 116.272 -0.422 . . . . 0.0 111.04 178.72 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 41' ' ' ILE . . . . . . . . . . . . . 71.4 mt -127.5 116.38 43.39 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.234 0 CA-C-N 116.41 -0.359 . . . . 0.0 110.16 177.392 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 42' ' ' LEU . . . . . 0.532 ' O ' HD23 ' A' ' 42' ' ' LEU . 1.3 tt 49.58 47.65 22.41 Favored 'General case' 0 CA--C 1.533 0.311 0 CA-C-O 121.468 0.652 . . . . 0.0 111.43 177.166 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . 71.24 21.73 78.51 Favored Glycine 0 CA--C 1.532 1.094 0 C-N-CA 121.102 -0.571 . . . . 0.0 112.862 174.632 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 44' ' ' LYS . . . . . . . . . . . . . 85.3 tttt -135.14 126.43 28.3 Favored 'General case' 0 C--N 1.331 -0.222 0 CA-C-N 117.636 0.718 . . . . 0.0 109.881 178.959 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 84.9 tt0 -84.72 125.82 32.86 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.485 -0.325 . . . . 0.0 111.176 -178.682 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 46' ' ' VAL . . . . . 0.425 HG13 ' O ' ' A' ' 46' ' ' VAL . 10.3 p -113.34 123.25 68.8 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.252 0 N-CA-C 109.144 -0.687 . . . . 0.0 109.144 174.072 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 88.6 mttt -98.98 122.94 42.9 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 115.92 -0.582 . . . . 0.0 110.857 179.726 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 48' ' ' PHE . . . . . . . . . . . . . 31.0 m-85 -108.76 131.87 54.53 Favored 'General case' 0 C--N 1.329 -0.3 0 N-CA-C 109.71 -0.478 . . . . 0.0 109.71 176.924 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 76.6 tttt -106.57 130.62 54.3 Favored 'General case' 0 C--N 1.328 -0.33 0 N-CA-C 109.964 -0.384 . . . . 0.0 109.964 178.239 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 50' ' ' VAL . . . . . 0.433 ' HA ' HD23 ' A' ' 6' ' ' LEU . 45.5 t -74.82 105.29 3.75 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.305 0 N-CA-C 109.366 -0.605 . . . . 0.0 109.366 178.433 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 51' ' ' VAL . . . . . . . . . . . . . 48.2 t -70.35 -54.01 20.42 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.303 0 N-CA-C 109.475 -0.565 . . . . 0.0 109.475 -175.916 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 52' ' ' GLN . . . . . . . . . . . . . 89.9 mt-30 -153.73 150.15 28.23 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 115.856 -0.611 . . . . 0.0 111.79 -178.129 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -127.21 131.57 50.61 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 115.041 -0.981 . . . . 0.0 109.524 173.5 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 54' ' ' TYR . . . . . . . . . . . . . 14.5 t80 -129.06 110.24 18.25 Favored Pre-proline 0 C--N 1.329 -0.304 0 CA-C-O 118.198 -0.906 . . . . 0.0 110.234 177.453 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 55' ' ' PRO . . . . . . . . . . . . . 75.4 Cg_endo -77.31 170.22 71.94 Favored 'Cis proline' 0 N--CA 1.5 1.861 0 CA-C-N 121.958 1.735 . . . . 0.0 112.492 -5.927 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 56' ' ' SER . . . . . . . . . . . . . 14.1 m -123.91 138.9 31.34 Favored Pre-proline 0 CA--C 1.537 0.462 0 CA-C-O 118.499 -0.762 . . . . 0.0 109.401 173.532 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 57' ' ' PRO . . . . . . . . . . . . . 39.3 Cg_endo -67.67 144.28 71.07 Favored 'Cis proline' 0 N--CA 1.499 1.797 0 CA-C-N 121.695 1.641 . . . . 0.0 111.61 -2.627 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 58' ' ' LEU . . . . . 0.415 HD11 ' HB2' ' A' ' 2' ' ' SER . 15.7 tp -107.16 136.92 46.17 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-O 120.934 0.397 . . . . 0.0 110.629 -176.841 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 59' ' ' ARG . . . . . . . . . . . . . 56.5 ttp180 -103.73 124.9 49.73 Favored 'General case' 0 C--N 1.327 -0.378 0 N-CA-C 109.272 -0.64 . . . . 0.0 109.272 176.229 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 43.9 t -77.87 116.42 21.39 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 C-N-CA 120.73 -0.388 . . . . 0.0 110.745 -173.306 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 95.2 mt-10 -131.02 161.1 32.72 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 115.699 -0.682 . . . . 0.0 109.531 175.028 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 62' ' ' ASP . . . . . . . . . . . . . 70.0 m-20 -52.36 -31.67 34.77 Favored 'General case' 0 C--N 1.328 -0.349 0 N-CA-C 112.179 0.437 . . . . 0.0 112.179 -178.001 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 63' ' ' ARG . . . . . . . . . . . . . 87.5 mtt180 -70.92 -22.07 62.29 Favored 'General case' 0 CA--C 1.533 0.301 0 N-CA-C 113.038 0.755 . . . . 0.0 113.038 -174.942 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 27.8 m -68.43 137.16 54.28 Favored 'General case' 0 C--N 1.332 -0.188 0 CA-C-O 120.925 0.393 . . . . 0.0 111.061 -175.482 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 65' ' ' LYS . . . . . . . . . . . . . 90.5 mttt -88.92 127.62 35.66 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 115.984 -0.553 . . . . 0.0 109.772 177.832 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 66' ' ' ILE . . . . . . . . . . . . . 65.4 mt -118.06 130.24 73.22 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.278 0 CA-C-O 120.773 0.32 . . . . 0.0 110.236 -177.502 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 67' ' ' THR . . . . . . . . . . . . . 31.4 m -125.55 139.82 53.27 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-O 121.064 0.459 . . . . 0.0 110.967 -178.844 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 68' ' ' LEU . . . . . 0.499 ' N ' HD12 ' A' ' 68' ' ' LEU . 7.1 mp -105.82 133.57 50.35 Favored 'General case' 0 C--N 1.331 -0.211 0 CA-C-N 115.941 -0.572 . . . . 0.0 110.442 177.264 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 69' ' ' VAL . . . . . . . . . . . . . 43.1 t -97.81 140.22 18.38 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.37 0 CA-C-N 115.947 -0.57 . . . . 0.0 110.318 -179.29 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 70' ' ' THR . . . . . . . . . . . . . 18.1 p -130.51 -51.19 1.08 Allowed 'General case' 0 C--N 1.331 -0.228 0 CA-C-N 116.269 -0.423 . . . . 0.0 110.597 -179.256 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 71' ' ' HIS . . . . . . . . . . . . . 75.3 m80 -77.76 139.31 62.31 Favored Pre-proline 0 CA--C 1.533 0.323 0 CA-C-O 118.667 -0.683 . . . . 0.0 109.964 179.912 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 72' ' ' PRO . . . . . . . . . . . . . 11.4 Cg_exo -65.85 -30.11 49.55 Favored 'Trans proline' 0 N--CA 1.498 1.762 0 C-N-CA 120.998 1.132 . . . . 0.0 112.313 177.841 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 73' ' ' VAL . . . . . . . . . . . . . 35.4 m -147.93 169.91 3.45 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.243 0 CA-C-N 116.511 -0.313 . . . . 0.0 110.659 -179.292 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 74' ' ' ASP . . . . . . . . . . . . . 31.6 t0 -100.2 118.87 37.41 Favored 'General case' 0 C--N 1.33 -0.264 0 N-CA-C 109.717 -0.475 . . . . 0.0 109.717 177.908 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 40.9 t -114.74 123.87 70.84 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.249 0 CA-C-O 121.083 0.468 . . . . 0.0 110.776 -177.253 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 76' ' ' LEU . . . . . . . . . . . . . 5.5 mp -120.96 144.35 48.53 Favored 'General case' 0 C--N 1.331 -0.226 0 CA-C-N 115.667 -0.697 . . . . 0.0 109.59 175.185 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 77' ' ' GLU . . . . . . . . . . . . . 97.8 mt-10 -133.96 138.01 45.19 Favored 'General case' 0 C--N 1.331 -0.213 0 CA-C-O 121.112 0.482 . . . . 0.0 111.445 -178.95 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 78' ' ' ALA . . . . . . . . . . . . . . . -127.12 142.05 51.61 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 115.579 -0.737 . . . . 0.0 109.745 177.314 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 79' ' ' LYS . . . . . 0.645 ' O ' HD13 ' A' ' 80' ' ' ILE . 47.3 pttt -85.79 120.78 27.58 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-O 121.23 0.538 . . . . 0.0 110.967 -178.218 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 80' ' ' ILE . . . . . 0.645 HD13 ' O ' ' A' ' 79' ' ' LYS . 37.0 mm -139.2 114.9 8.9 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.312 0 CA-C-N 115.768 -0.651 . . . . 0.0 109.411 -179.159 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 81' ' ' LYS . . . . . . . . . . . . . 97.7 mttt -107.4 126.96 53.14 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-O 120.804 0.335 . . . . 0.0 111.011 -179.178 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . 89.05 42.17 5.69 Favored Glycine 0 CA--C 1.525 0.683 0 C-N-CA 120.845 -0.693 . . . . 0.0 111.65 175.526 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 83' ' ' ILE . . . . . . . . . . . . . 69.7 mt -69.91 138.2 22.56 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.309 0 CA-C-O 120.901 0.381 . . . . 0.0 110.042 178.514 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 84' ' ' LYS . . . . . . . . . . . . . 63.4 tttm -94.5 -54.05 3.67 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-N 115.945 -0.57 . . . . 0.0 110.07 -179.104 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 85' ' ' ASP . . . . . . . . . . . . . 7.2 t70 -158.01 154.95 28.52 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 115.652 -0.704 . . . . 0.0 110.412 -179.969 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 86' ' ' VAL . . . . . . . . . . . . . 40.0 t -131.94 132.32 61.5 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.259 0 CA-C-O 120.914 0.388 . . . . 0.0 110.576 179.473 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 87' ' ' ILE . . . . . 0.493 HD12 ' N ' ' A' ' 87' ' ' ILE . 5.1 mp -118.9 128.37 75.73 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.281 0 CA-C-N 115.816 -0.629 . . . . 0.0 109.414 176.044 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 88' ' ' LEU . . . . . . . . . . . . . 16.9 tp -110.95 134.6 52.45 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-O 121.138 0.494 . . . . 0.0 111.414 -176.234 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 89' ' ' ASP . . . . . . . . . . . . . 12.9 t70 -127.14 149.75 49.81 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 115.602 -0.727 . . . . 0.0 109.36 175.129 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 83.6 tt0 -48.89 -32.57 9.15 Favored 'General case' 0 C--N 1.33 -0.264 0 N-CA-C 112.606 0.595 . . . . 0.0 112.606 -173.357 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 91' ' ' ASN . . . . . . . . . . . . . 79.2 m-20 -131.18 29.67 4.62 Favored 'General case' 0 N--CA 1.465 0.316 0 N-CA-C 112.216 0.45 . . . . 0.0 112.216 -176.368 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 92' ' ' LEU . . . . . . . . . . . . . 8.1 tp -166.21 148.83 7.07 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-O 120.784 0.326 . . . . 0.0 110.602 179.299 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 93' ' ' ILE . . . . . . . . . . . . . 69.9 mt -126.74 122.99 61.92 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.277 0 N-CA-C 109.487 -0.56 . . . . 0.0 109.487 178.931 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 94' ' ' VAL . . . . . . . . . . . . . 42.8 t -121.27 127.6 75.81 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.265 0 N-CA-C 110.084 -0.339 . . . . 0.0 110.084 -179.442 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 95' ' ' VAL . . . . . . . . . . . . . 43.4 t -125.66 136.0 62.19 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.239 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.228 -179.294 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 96' ' ' ILE . . . . . . . . . . . . . 51.6 mt -115.86 129.42 72.25 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 N-CA-C 109.112 -0.699 . . . . 0.0 109.112 178.495 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 97' ' ' THR . . . . . . . . . . . . . 81.7 p -101.21 159.06 15.57 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-O 121.105 0.479 . . . . 0.0 111.16 -178.024 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 98' ' ' GLU . . . . . . . . . . . . . 84.8 tt0 -53.85 -28.37 35.47 Favored 'General case' 0 CA--C 1.533 0.312 0 CA-C-N 116.208 -0.451 . . . . 0.0 112.152 -178.797 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 99' ' ' GLU . . . . . . . . . . . . . 96.0 mt-10 -79.04 14.61 1.35 Allowed 'General case' 0 CA--C 1.535 0.375 0 N-CA-C 113.22 0.822 . . . . 0.0 113.22 -176.316 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 100' ' ' ASN . . . . . . . . . . . . . 3.3 m-20 61.54 33.23 18.51 Favored 'General case' 0 N--CA 1.464 0.24 0 CA-C-N 118.067 0.394 . . . . 0.0 111.639 -179.833 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 101' ' ' GLU . . . . . . . . . . . . . 84.9 tt0 -107.61 144.2 34.99 Favored 'General case' 0 C--O 1.232 0.143 0 N-CA-C 109.607 -0.516 . . . . 0.0 109.607 173.08 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 102' ' ' VAL . . . . . . . . . . . . . 42.7 t -114.93 126.07 72.41 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.304 0 CA-C-N 116.294 -0.412 . . . . 0.0 110.009 -177.627 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 103' ' ' LEU . . . . . . . . . . . . . 21.2 mt -115.72 129.7 56.57 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 115.79 -0.641 . . . . 0.0 109.889 177.324 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 104' ' ' ILE . . . . . 0.612 HD13 HG11 ' A' ' 130' ' ' VAL . 68.3 mt -118.49 121.51 67.24 Favored 'Isoleucine or valine' 0 C--O 1.235 0.297 0 N-CA-C 110.13 -0.322 . . . . 0.0 110.13 179.274 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 105' ' ' PHE . . . . . . . . . . . . . 78.3 m-85 -118.92 164.47 15.4 Favored 'General case' 0 C--N 1.333 -0.126 0 O-C-N 124.129 0.893 . . . . 0.0 109.757 -179.499 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 106' ' ' ASN . . . . . . . . . . . . . 42.3 p-10 -101.66 -170.83 1.88 Allowed 'General case' 0 C--N 1.331 -0.221 0 N-CA-C 110.039 -0.356 . . . . 0.0 110.039 173.54 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 107' ' ' GLN . . . . . . . . . . . . . 59.4 tt0 -57.67 -28.69 64.0 Favored 'General case' 0 CA--C 1.534 0.341 0 N-CA-C 111.894 0.331 . . . . 0.0 111.894 177.243 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 108' ' ' ASN . . . . . . . . . . . . . 50.1 t30 -82.94 3.28 30.61 Favored 'General case' 0 CA--C 1.536 0.415 0 N-CA-C 113.353 0.872 . . . . 0.0 113.353 -176.447 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 109' ' ' LEU . . . . . . . . . . . . . 11.5 tp 62.66 39.6 11.09 Favored 'General case' 0 CA--C 1.529 0.172 0 CA-C-O 121.115 0.483 . . . . 0.0 111.051 178.378 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 110' ' ' GLU . . . . . . . . . . . . . 95.5 mt-10 -114.28 150.32 34.61 Favored 'General case' 0 C--N 1.331 -0.198 0 CA-C-N 116.366 -0.379 . . . . 0.0 110.278 176.31 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 111' ' ' GLU . . . . . . . . . . . . . 45.6 mt-10 -76.07 123.62 26.08 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 116.359 -0.382 . . . . 0.0 110.894 -179.739 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 112' ' ' LEU . . . . . . . . . . . . . 16.3 mt -110.04 -46.05 3.52 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.142 -0.481 . . . . 0.0 110.178 176.665 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 113' ' ' TYR . . . . . . . . . . . . . 41.0 t80 -134.79 136.73 42.77 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.235 -0.439 . . . . 0.0 110.659 -179.682 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 114' ' ' ARG . . . . . . . . . . . . . 65.8 ttp85 -141.37 123.25 15.36 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.406 -0.361 . . . . 0.0 110.569 178.014 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 115' ' ' GLY . . . . . . . . . . . . . . . -150.14 163.04 29.39 Favored Glycine 0 CA--C 1.523 0.556 0 N-CA-C 111.054 -0.819 . . . . 0.0 111.054 -179.192 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 116' ' ' LYS . . . . . . . . . . . . . 57.1 tttm -131.56 136.63 47.98 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-O 120.781 0.324 . . . . 0.0 110.188 178.656 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 117' ' ' PHE . . . . . . . . . . . . . 36.2 m-85 -136.34 115.58 12.55 Favored 'General case' 0 C--N 1.331 -0.209 0 CA-C-N 116.245 -0.434 . . . . 0.0 110.283 -176.062 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 118' ' ' GLU . . . . . . . . . . . . . 45.4 mp0 -56.48 -44.46 80.64 Favored 'General case' 0 C--N 1.327 -0.381 0 C-N-CA 120.781 -0.368 . . . . 0.0 111.098 -175.194 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 119' ' ' ASN . . . . . . . . . . . . . 11.4 m120 -98.01 30.97 2.85 Favored 'General case' 0 C--N 1.33 -0.259 0 N-CA-C 112.194 0.442 . . . . 0.0 112.194 -174.011 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 120' ' ' LEU . . . . . . . . . . . . . 21.9 tp -57.64 123.29 15.11 Favored 'General case' 0 C--N 1.332 -0.163 0 C-N-CA 120.854 -0.338 . . . . 0.0 110.379 177.941 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 121' ' ' ASN . . . . . . . . . . . . . 34.6 m120 -114.09 -44.08 3.18 Favored 'General case' 0 C--O 1.233 0.191 0 CA-C-N 116.548 -0.296 . . . . 0.0 111.002 -177.561 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 122' ' ' LYS . . . . . . . . . . . . . 98.3 mttt -144.49 149.16 35.49 Favored 'General case' 0 C--N 1.331 -0.198 0 CA-C-O 121.152 0.501 . . . . 0.0 111.621 -176.365 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 123' ' ' VAL . . . . . . . . . . . . . 47.3 t -129.67 128.55 65.77 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.276 0 CA-C-N 115.733 -0.667 . . . . 0.0 109.538 175.952 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 124' ' ' LEU . . . . . . . . . . . . . 75.0 mt -119.72 134.83 55.08 Favored 'General case' 0 C--N 1.331 -0.219 0 CA-C-N 116.48 -0.327 . . . . 0.0 110.443 -178.213 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 125' ' ' VAL . . . . . . . . . . . . . 12.4 p -140.13 130.93 30.6 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.223 0 CA-C-O 120.878 0.37 . . . . 0.0 110.97 -179.76 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 126' ' ' ARG . . . . . . . . . . . . . 72.8 mtt180 -152.55 134.1 14.53 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 115.822 -0.626 . . . . 0.0 109.674 175.848 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 127' ' ' ASN . . . . . . . . . . . . . 31.5 m120 55.74 -147.77 0.51 Allowed 'General case' 0 CA--C 1.542 0.647 0 N-CA-C 109.729 -0.471 . . . . 0.0 109.729 -178.855 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 128' ' ' ASP . . . . . . . . . . . . . 9.3 p-10 -87.23 14.62 7.45 Favored 'General case' 0 CA--C 1.536 0.409 0 CA-C-N 118.809 0.732 . . . . 0.0 112.934 178.641 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 129' ' ' LEU . . . . . . . . . . . . . 80.5 mt -110.89 138.21 47.57 Favored 'General case' 0 C--O 1.233 0.216 0 O-C-N 121.974 -0.454 . . . . 0.0 110.273 179.575 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 130' ' ' VAL . . . . . 0.612 HG11 HD13 ' A' ' 104' ' ' ILE . 14.4 p -134.03 142.14 41.97 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.176 0 CA-C-O 121.177 0.513 . . . . 0.0 110.847 -178.937 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 131' ' ' VAL . . . . . 0.558 HG22 HD12 ' A' ' 140' ' ' LEU . 44.5 t -135.76 138.51 47.7 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.228 0 CA-C-N 115.876 -0.602 . . . . 0.0 110.243 -178.923 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 132' ' ' ILE . . . . . . . . . . . . . 72.6 mt -115.87 132.39 65.48 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.298 0 CA-C-N 115.948 -0.569 . . . . 0.0 109.488 -179.856 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 133' ' ' ILE . . . . . . . . . . . . . 39.0 mm -116.9 117.37 55.18 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.21 0 CA-C-N 116.5 -0.318 . . . . 0.0 110.624 -176.333 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 134' ' ' ASP . . . . . . . . . . . . . 7.2 p-10 -128.63 151.43 49.5 Favored 'General case' 0 C--N 1.331 -0.204 0 N-CA-C 109.629 -0.508 . . . . 0.0 109.629 175.252 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 135' ' ' GLU . . . . . . . . . . . . . 45.8 tp10 -49.92 -28.16 6.31 Favored 'General case' 0 C--N 1.327 -0.398 0 N-CA-C 112.748 0.647 . . . . 0.0 112.748 -171.056 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 136' ' ' GLN . . . . . . . . . . . . . 76.9 mt-30 -103.45 -22.95 13.58 Favored 'General case' 0 N--CA 1.464 0.254 0 N-CA-C 113.144 0.794 . . . . 0.0 113.144 -173.874 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 137' ' ' LYS . . . . . . . . . . . . . 94.9 mttt -141.93 147.19 36.65 Favored 'General case' 0 C--N 1.331 -0.224 0 CA-C-O 121.376 0.608 . . . . 0.0 112.007 -168.695 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 138' ' ' LEU . . . . . . . . . . . . . 10.5 tp -111.66 118.3 35.29 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 115.193 -0.912 . . . . 0.0 108.863 172.326 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 139' ' ' THR . . . . . . . . . . . . . 24.9 m -111.98 125.61 54.25 Favored 'General case' 0 N--CA 1.463 0.21 0 CA-C-O 120.695 0.283 . . . . 0.0 110.882 -176.819 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 140' ' ' LEU . . . . . 0.558 HD12 HG22 ' A' ' 131' ' ' VAL . 11.6 tp -114.03 122.96 48.51 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 115.664 -0.698 . . . . 0.0 109.23 179.534 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 141' ' ' ILE . . . . . 0.515 ' HB ' HG13 ' A' ' 130' ' ' VAL . 20.3 mt -123.15 122.66 66.01 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.243 0 CA-C-O 120.997 0.427 . . . . 0.0 110.3 -175.778 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 142' ' ' ARG . . . . . . . . . . . . . 84.2 mtp180 -106.91 123.22 47.86 Favored 'General case' 0 C--N 1.331 -0.22 0 CA-C-N 115.264 -0.88 . . . . 0.0 110.068 179.252 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 143' ' ' THR . . . . . . . . . . . . . 26.6 p . . . . . 0 C--O 1.221 -0.428 0 CA-C-O 117.939 -1.029 . . . . 0.0 110.58 179.742 . . . . . . . . 0 0 . 1 . 018 nuclear build full ' B' B ' -3' ' ' GLU . . . . . . . . . . . . . 95.6 mt-10 . . . . . 0 N--CA 1.49 1.543 0 N-CA-C 109.423 -0.584 . . . . 0.0 109.423 . . . . . . . . . 0 0 . 1 . 018 nuclear build full ' B' B ' -2' ' ' GLY . . . . . . . . . . . . . . . -73.27 140.25 28.14 Favored Glycine 0 CA--C 1.526 0.768 0 N-CA-C 111.095 -0.802 . . . . 0.0 111.095 -179.778 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' B' B ' -1' ' ' VAL . . . . . . . . . . . . . 43.2 t -141.83 137.34 31.16 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.349 0 N-CA-C 109.998 -0.371 . . . . 0.0 109.998 179.36 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' B' B ' 0' ' ' ILE . . . . . . . . . . . . . 70.8 mt -114.04 133.83 58.83 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.246 0 CA-C-O 120.896 0.379 . . . . 0.0 110.069 -179.557 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' B' B ' 1' ' ' MET . . . . . . . . . . . . . 25.8 ptt? -143.76 177.95 8.16 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.002 -0.545 . . . . 0.0 110.557 -179.322 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' B' B ' 2' ' ' SER . . . . . . . . . . . . . 2.8 p -124.88 127.59 47.36 Favored 'General case' 0 C--N 1.332 -0.178 0 CA-C-O 120.901 0.382 . . . . 0.0 110.606 -179.042 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' B' B ' 3' ' ' GLU . . . . . . . . . . . . . 84.6 tt0 -142.64 142.55 32.1 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 115.981 -0.554 . . . . 0.0 111.193 -178.297 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' B' B ' 4' ' ' LEU . . . . . . . . . . . . . 13.4 tp -123.05 131.01 53.52 Favored 'General case' 0 C--N 1.331 -0.209 0 CA-C-N 115.757 -0.656 . . . . 0.0 110.143 177.109 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' B' B ' 5' ' ' LYS . . . . . . . . . . . . . 94.6 mttt -107.72 121.8 45.44 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.232 -0.44 . . . . 0.0 110.433 178.727 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' B' B ' 6' ' ' LEU . . . . . . . . . . . . . 44.4 mt -115.88 148.18 40.25 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 115.554 -0.748 . . . . 0.0 110.195 -179.283 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' B' B ' 7' ' ' LYS . . . . . . . . . . . . . 83.4 tttt -135.35 140.31 34.02 Favored Pre-proline 0 CA--C 1.535 0.388 0 CA-C-O 119.092 -0.48 . . . . 0.0 110.118 176.335 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' B' B ' 8' ' ' PRO . . . . . . . . . . . . . 88.8 Cg_endo -92.04 143.71 2.74 Favored 'Trans proline' 0 N--CA 1.491 1.345 0 C-N-CA 121.718 1.612 . . . . 0.0 111.653 177.689 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' B' B ' 9' ' ' LEU . . . . . . . . . . . . . 75.3 mt -81.8 -47.67 1.0 Allowed Pre-proline 0 CA--C 1.535 0.384 0 CA-C-O 118.611 -0.709 . . . . 0.0 112.303 -179.321 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' B' B ' 10' ' ' PRO . . . . . . . . . . . . . 95.1 Cg_endo -79.61 154.48 23.84 Favored 'Trans proline' 0 N--CA 1.496 1.662 0 C-N-CA 121.125 1.217 . . . . 0.0 111.869 176.412 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' B' B ' 11' ' ' LYS . . . . . . . . . . . . . 62.2 tttm -88.46 102.79 15.25 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-N 116.378 -0.374 . . . . 0.0 110.439 179.058 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' B' B ' 12' ' ' VAL . . . . . . . . . . . . . 12.8 p -149.67 144.29 17.82 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.319 0 CA-C-N 116.294 -0.412 . . . . 0.0 110.875 179.945 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' B' B ' 13' ' ' GLU . . . . . . . . . . . . . 95.8 mt-10 -79.62 131.99 36.14 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.14 -0.482 . . . . 0.0 110.062 177.468 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' B' B ' 14' ' ' LEU . . . . . . . . . . . . . 26.6 mt -98.67 147.97 33.91 Favored Pre-proline 0 CA--C 1.534 0.337 0 CA-C-O 119.252 -0.404 . . . . 0.0 110.623 -177.955 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' B' B ' 15' ' ' PRO . . . . . . . . . . . . . 24.7 Cg_exo -62.88 158.26 43.88 Favored 'Trans proline' 0 N--CA 1.498 1.772 0 C-N-CA 121.328 1.352 . . . . 0.0 111.779 176.828 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' B' B ' 16' ' ' PRO . . . . . . . . . . . . . 33.6 Cg_exo -59.2 -39.31 79.87 Favored 'Trans proline' 0 N--CA 1.498 1.748 0 C-N-CA 121.508 1.472 . . . . 0.0 112.714 -177.581 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' B' B ' 17' ' ' ASP . . . . . . . . . . . . . 24.1 p-10 -89.12 11.9 17.25 Favored 'General case' 0 C--N 1.328 -0.358 0 N-CA-C 113.154 0.798 . . . . 0.0 113.154 -177.411 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' B' B ' 18' ' ' PHE . . . . . . . . . . . . . 44.2 t80 -58.09 -45.82 86.53 Favored 'General case' 0 C--N 1.335 -0.056 0 O-C-N 121.993 -0.442 . . . . 0.0 110.081 -178.458 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' B' B ' 19' ' ' VAL . . . . . . . . . . . . . 13.7 p -56.57 -40.52 69.23 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.297 0 CA-C-N 116.15 -0.477 . . . . 0.0 110.878 -179.219 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' B' B ' 20' ' ' ASP . . . . . . . . . . . . . 9.8 t70 -60.53 -44.78 95.71 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-O 120.768 0.318 . . . . 0.0 111.032 -177.766 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' B' B ' 21' ' ' VAL . . . . . . . . . . . . . 46.9 t -64.3 -47.83 88.04 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.282 0 C-N-CA 120.676 -0.41 . . . . 0.0 110.377 -177.891 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' B' B ' 22' ' ' ILE . . . . . 0.468 HG22 HD12 ' B' ' 26' ' ' LEU . 51.1 mm -55.92 -46.16 80.23 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.261 0 CA-C-O 120.672 0.273 . . . . 0.0 110.589 179.813 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' B' B ' 23' ' ' ARG . . . . . . . . . . . . . 60.4 ttp180 -54.38 -50.88 66.48 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.779 -0.191 . . . . 0.0 111.39 -178.281 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' B' B ' 24' ' ' ILE . . . . . . . . . . . . . 75.6 mt -59.8 -42.47 89.05 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.298 0 C-N-CA 121.036 -0.266 . . . . 0.0 110.939 -177.686 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' B' B ' 25' ' ' LYS . . . . . . . . . . . . . 60.3 mtpt -64.6 -39.38 93.62 Favored 'General case' 0 C--N 1.328 -0.333 0 N-CA-C 112.232 0.456 . . . . 0.0 112.232 -177.898 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' B' B ' 26' ' ' LEU . . . . . 0.468 HD12 HG22 ' B' ' 22' ' ' ILE . 55.7 mt -79.0 -43.5 24.23 Favored 'General case' 0 C--N 1.33 -0.268 0 N-CA-C 113.089 0.774 . . . . 0.0 113.089 -172.454 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' B' B ' 27' ' ' GLN . . . . . . . . . . . . . 14.2 pt20 -46.55 139.31 5.17 Favored 'General case' 0 N--CA 1.469 0.475 0 N-CA-C 112.841 0.682 . . . . 0.0 112.841 -174.084 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' B' B ' 28' ' ' GLY . . . . . . . . . . . . . . . 100.23 -28.06 17.47 Favored Glycine 0 CA--C 1.533 1.192 0 CA-C-N 115.43 -0.805 . . . . 0.0 112.083 -176.215 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' B' B ' 29' ' ' LYS . . . . . . . . . . . . . 55.5 mtmt -98.88 155.16 17.53 Favored 'General case' 0 C--O 1.233 0.226 0 CA-C-N 117.085 0.442 . . . . 0.0 111.248 178.494 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' B' B ' 30' ' ' THR . . . . . . . . . . . . . 35.2 m -104.35 140.39 37.96 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.13 -0.486 . . . . 0.0 110.115 176.305 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' B' B ' 31' ' ' VAL . . . . . . . . . . . . . 35.2 m -129.08 156.61 41.78 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.274 0 CA-C-N 116.321 -0.399 . . . . 0.0 110.627 -179.575 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' B' B ' 32' ' ' ARG . . . . . . . . . . . . . 62.7 ttt180 -133.37 148.64 51.85 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.066 -0.516 . . . . 0.0 110.143 179.076 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' B' B ' 33' ' ' THR . . . . . . . . . . . . . 18.0 m -53.05 139.11 29.14 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.43 -0.35 . . . . 0.0 111.414 -177.248 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' B' B ' 34' ' ' GLY . . . . . . . . . . . . . . . 100.94 -17.19 56.64 Favored Glycine 0 CA--C 1.532 1.142 0 CA-C-O 119.571 -0.572 . . . . 0.0 113.281 179.085 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' B' B ' 35' ' ' ASP . . . . . . . . . . . . . 79.4 m-20 -66.28 149.3 50.56 Favored 'General case' 0 C--N 1.334 -0.09 0 CA-C-N 118.119 0.959 . . . . 0.0 111.077 179.04 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' B' B ' 36' ' ' VAL . . . . . . . . . . . . . 44.3 t -121.71 129.88 75.1 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.204 0 CA-C-N 115.92 -0.582 . . . . 0.0 109.826 178.523 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' B' B ' 37' ' ' ILE . . . . . . . . . . . . . 65.8 mt -120.8 138.69 50.43 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.254 0 N-CA-C 109.982 -0.377 . . . . 0.0 109.982 -179.534 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' B' B ' 38' ' ' GLY . . . . . . . . . . . . . . . -111.61 128.87 8.84 Favored Glycine 0 CA--C 1.526 0.723 0 N-CA-C 111.07 -0.812 . . . . 0.0 111.07 -179.94 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' B' B ' 39' ' ' ILE . . . . . . . . . . . . . 72.3 mt -123.11 138.52 52.82 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.188 0 N-CA-C 110.165 -0.309 . . . . 0.0 110.165 179.161 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' B' B ' 40' ' ' SER . . . . . 0.465 ' O ' HD13 ' B' ' 41' ' ' ILE . 32.9 t -93.22 117.13 29.71 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.481 -0.327 . . . . 0.0 110.981 175.636 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' B' B ' 41' ' ' ILE . . . . . 0.465 HD13 ' O ' ' B' ' 40' ' ' SER . 47.7 mm -125.68 122.96 63.49 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.262 0 CA-C-O 120.844 0.354 . . . . 0.0 110.586 178.694 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' B' B ' 42' ' ' LEU . . . . . . . . . . . . . 65.3 mt 52.61 33.63 14.06 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.185 -0.462 . . . . 0.0 111.881 177.368 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' B' B ' 43' ' ' GLY . . . . . . . . . . . . . . . 73.19 31.19 61.79 Favored Glycine 0 CA--C 1.529 0.963 0 C-N-CA 121.09 -0.576 . . . . 0.0 112.194 177.951 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' B' B ' 44' ' ' LYS . . . . . . . . . . . . . 40.3 ttpt -138.57 133.72 32.91 Favored 'General case' 0 C--N 1.329 -0.303 0 N-CA-C 109.663 -0.495 . . . . 0.0 109.663 178.098 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' B' B ' 45' ' ' GLU . . . . . . . . . . . . . 78.0 tt0 -83.2 118.55 23.68 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-O 120.918 0.39 . . . . 0.0 110.814 -177.598 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' B' B ' 46' ' ' VAL . . . . . . . . . . . . . 7.4 p -117.18 128.08 74.6 Favored 'Isoleucine or valine' 0 N--CA 1.462 0.159 0 N-CA-C 109.611 -0.514 . . . . 0.0 109.611 177.917 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' B' B ' 47' ' ' LYS . . . . . . . . . . . . . 32.3 mmtp -98.93 129.5 45.26 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 115.96 -0.564 . . . . 0.0 111.357 178.721 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' B' B ' 48' ' ' PHE . . . . . . . . . . . . . 90.5 m-85 -114.08 131.83 56.25 Favored 'General case' 0 C--N 1.329 -0.296 0 N-CA-C 109.378 -0.601 . . . . 0.0 109.378 173.966 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' B' B ' 49' ' ' LYS . . . . . . . . . . . . . 59.5 tttm -108.28 138.54 44.39 Favored 'General case' 0 C--N 1.329 -0.308 0 N-CA-C 110.315 -0.254 . . . . 0.0 110.315 179.359 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' B' B ' 50' ' ' VAL . . . . . . . . . . . . . 44.8 t -78.99 107.88 11.96 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.299 0 N-CA-C 109.226 -0.657 . . . . 0.0 109.226 176.529 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' B' B ' 51' ' ' VAL . . . . . . . . . . . . . 52.9 t -73.04 -48.17 45.14 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.271 0 CA-C-N 115.938 -0.574 . . . . 0.0 110.225 -173.573 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' B' B ' 52' ' ' GLN . . . . . . . . . . . . . 45.3 tt0 -162.62 145.17 10.87 Favored 'General case' 0 C--N 1.332 -0.192 0 C-N-CA 120.303 -0.559 . . . . 0.0 111.554 -177.711 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' B' B ' 53' ' ' ALA . . . . . . . . . . . . . . . -121.1 133.89 55.23 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 115.821 -0.627 . . . . 0.0 110.044 176.76 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' B' B ' 54' ' ' TYR . . . . . . . . . . . . . 33.9 t80 -129.01 106.97 18.02 Favored Pre-proline 0 CA--C 1.534 0.342 0 CA-C-O 118.303 -0.856 . . . . 0.0 110.355 179.435 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' B' B ' 55' ' ' PRO . . . . . . . . . . . . . 73.8 Cg_endo -77.13 169.27 74.69 Favored 'Cis proline' 0 N--CA 1.5 1.858 0 CA-C-N 121.812 1.683 . . . . 0.0 112.503 -4.478 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' B' B ' 56' ' ' SER . . . . . . . . . . . . . 67.4 m -115.3 128.07 26.26 Favored Pre-proline 0 CA--C 1.539 0.543 0 CA-C-O 118.454 -0.784 . . . . 0.0 109.466 175.891 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' B' B ' 57' ' ' PRO . . . . . . . . . . . . . 40.0 Cg_endo -67.84 167.38 62.69 Favored 'Cis proline' 0 N--CA 1.496 1.666 0 CA-C-N 121.984 1.744 . . . . 0.0 111.648 -0.845 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' B' B ' 58' ' ' LEU . . . . . . . . . . . . . 31.4 tp -129.85 136.71 49.87 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.187 -0.46 . . . . 0.0 110.334 179.674 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' B' B ' 59' ' ' ARG . . . . . . . . . . . . . 53.6 ttp180 -103.06 128.3 49.98 Favored 'General case' 0 C--N 1.326 -0.417 0 N-CA-C 109.16 -0.682 . . . . 0.0 109.16 176.898 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' B' B ' 60' ' ' VAL . . . . . . . . . . . . . 42.1 t -84.05 127.64 39.6 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.185 0 C-N-CA 120.533 -0.467 . . . . 0.0 110.622 -174.139 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' B' B ' 61' ' ' GLU . . . . . . . . . . . . . 96.0 mt-10 -129.9 159.13 37.55 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 115.558 -0.747 . . . . 0.0 109.611 176.969 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' B' B ' 62' ' ' ASP . . . . . . . . . . . . . 6.8 t0 -53.5 -32.47 50.49 Favored 'General case' 0 C--N 1.328 -0.363 0 N-CA-C 111.88 0.326 . . . . 0.0 111.88 -178.58 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' B' B ' 63' ' ' ARG . . . . . . . . . . . . . 28.7 ptt180 -90.04 6.23 43.24 Favored 'General case' 0 CA--C 1.537 0.476 0 N-CA-C 113.878 1.066 . . . . 0.0 113.878 -175.633 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' B' B ' 64' ' ' THR . . . . . . . . . . . . . 25.7 m -75.11 147.23 40.74 Favored 'General case' 0 C--N 1.331 -0.206 0 CA-C-O 121.006 0.432 . . . . 0.0 111.069 -177.854 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' B' B ' 65' ' ' LYS . . . . . . . . . . . . . 25.2 mtpp -84.94 126.71 33.74 Favored 'General case' 0 C--N 1.331 -0.227 0 CA-C-N 115.893 -0.594 . . . . 0.0 110.208 179.453 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' B' B ' 66' ' ' ILE . . . . . . . . . . . . . 60.4 mt -121.94 132.17 71.51 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.235 0 N-CA-C 110.151 -0.314 . . . . 0.0 110.151 -179.426 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' B' B ' 67' ' ' THR . . . . . . . . . . . . . 29.6 m -130.11 141.55 50.68 Favored 'General case' 0 C--N 1.332 -0.154 0 CA-C-O 121.02 0.438 . . . . 0.0 111.184 -179.458 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' B' B ' 68' ' ' LEU . . . . . 0.488 HD12 ' N ' ' B' ' 68' ' ' LEU . 7.0 mp -103.02 124.26 48.19 Favored 'General case' 0 C--N 1.332 -0.195 0 CA-C-N 115.942 -0.572 . . . . 0.0 110.427 177.013 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' B' B ' 69' ' ' VAL . . . . . . . . . . . . . 46.2 t -103.08 128.45 56.02 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.284 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.169 179.606 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' B' B ' 70' ' ' THR . . . . . . . . . . . . . 30.9 p -138.43 153.83 48.86 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.389 -0.369 . . . . 0.0 110.813 178.188 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' B' B ' 71' ' ' HIS . . . . . . . . . . . . . 77.0 m-70 -149.98 82.06 6.68 Favored Pre-proline 0 C--N 1.328 -0.327 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.349 177.992 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' B' B ' 72' ' ' PRO . . . . . . . . . . . . . 92.2 Cg_endo -86.98 160.05 8.76 Favored 'Trans proline' 0 N--CA 1.49 1.32 0 C-N-CA 121.676 1.584 . . . . 0.0 112.599 -178.225 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' B' B ' 73' ' ' VAL . . . . . . . . . . . . . 27.1 m -99.84 159.32 3.65 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.251 0 CA-C-N 116.096 -0.502 . . . . 0.0 110.365 178.764 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' B' B ' 74' ' ' ASP . . . . . . . . . . . . . 36.3 t0 -97.78 116.26 29.65 Favored 'General case' 0 C--N 1.329 -0.289 0 N-CA-C 109.732 -0.47 . . . . 0.0 109.732 -179.28 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' B' B ' 75' ' ' VAL . . . . . . . . . . . . . 42.0 t -112.38 122.15 66.07 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.171 0 CA-C-O 121.112 0.482 . . . . 0.0 110.388 -177.97 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' B' B ' 76' ' ' LEU . . . . . . . . . . . . . 14.7 mt -124.82 133.7 53.02 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 115.537 -0.756 . . . . 0.0 109.2 177.422 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' B' B ' 77' ' ' GLU . . . . . . . . . . . . . 35.9 tt0 -131.91 136.89 47.73 Favored 'General case' 0 C--N 1.331 -0.222 0 CA-C-O 121.013 0.435 . . . . 0.0 110.98 -176.25 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' B' B ' 78' ' ' ALA . . . . . . . . . . . . . . . -123.87 139.81 53.6 Favored 'General case' 0 C--N 1.331 -0.219 0 CA-C-N 115.947 -0.57 . . . . 0.0 110.214 178.08 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' B' B ' 79' ' ' LYS . . . . . 0.626 ' O ' HD13 ' B' ' 80' ' ' ILE . 50.0 pttt -73.37 118.15 15.98 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-O 121.292 0.567 . . . . 0.0 110.453 179.402 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' B' B ' 80' ' ' ILE . . . . . 0.626 HD13 ' O ' ' B' ' 79' ' ' LYS . 38.0 mm -139.22 109.68 4.4 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.346 0 CA-C-N 115.906 -0.588 . . . . 0.0 109.718 -177.734 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' B' B ' 81' ' ' LYS . . . . . . . . . . . . . 67.6 mttm -110.76 130.6 55.53 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-O 120.948 0.404 . . . . 0.0 110.927 -179.67 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' B' B ' 82' ' ' GLY . . . . . . . . . . . . . . . 89.05 42.22 5.68 Favored Glycine 0 CA--C 1.525 0.698 0 C-N-CA 120.971 -0.633 . . . . 0.0 111.655 175.527 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' B' B ' 83' ' ' ILE . . . . . . . . . . . . . 71.9 mt -66.91 132.35 32.27 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.317 0 N-CA-C 109.672 -0.492 . . . . 0.0 109.672 177.688 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' B' B ' 84' ' ' LYS . . . . . . . . . . . . . 44.9 tttp -96.37 -52.72 3.87 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-O 121.091 0.472 . . . . 0.0 110.227 -178.742 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' B' B ' 85' ' ' ASP . . . . . . . . . . . . . 7.3 t70 -150.98 149.41 29.56 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 115.647 -0.706 . . . . 0.0 110.118 179.422 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' B' B ' 86' ' ' VAL . . . . . . . . . . . . . 43.2 t -128.6 128.77 68.31 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.292 0 CA-C-O 120.887 0.375 . . . . 0.0 110.529 -178.307 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' B' B ' 87' ' ' ILE . . . . . . . . . . . . . 43.7 mm -120.3 125.2 73.93 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.224 0 CA-C-N 116.002 -0.545 . . . . 0.0 109.968 176.251 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' B' B ' 88' ' ' LEU . . . . . . . . . . . . . 19.2 tp -109.64 130.04 55.54 Favored 'General case' 0 C--N 1.331 -0.225 0 CA-C-O 120.967 0.413 . . . . 0.0 111.141 -178.086 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' B' B ' 89' ' ' ASP . . . . . . . . . . . . . 12.7 t70 -123.12 151.6 41.91 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 115.827 -0.624 . . . . 0.0 109.583 176.0 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' B' B ' 90' ' ' GLU . . . . . . . . . . . . . 96.8 mt-10 -47.08 -36.56 8.32 Favored 'General case' 0 C--N 1.33 -0.253 0 N-CA-C 112.993 0.738 . . . . 0.0 112.993 -173.061 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' B' B ' 91' ' ' ASN . . . . . . . . . . . . . 8.6 p30 -130.47 19.69 5.23 Favored 'General case' 0 N--CA 1.467 0.421 0 N-CA-C 113.051 0.76 . . . . 0.0 113.051 -177.668 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' B' B ' 92' ' ' LEU . . . . . . . . . . . . . 16.5 mt -148.89 143.16 26.05 Favored 'General case' 0 C--N 1.332 -0.169 0 N-CA-C 109.982 -0.377 . . . . 0.0 109.982 -177.336 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' B' B ' 93' ' ' ILE . . . . . . . . . . . . . 70.7 mt -120.09 118.03 55.55 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.328 0 N-CA-C 109.314 -0.624 . . . . 0.0 109.314 178.003 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' B' B ' 94' ' ' VAL . . . . . . . . . . . . . 48.4 t -119.22 123.5 71.44 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.207 0 N-CA-C 109.901 -0.407 . . . . 0.0 109.901 -179.304 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' B' B ' 95' ' ' VAL . . . . . . . . . . . . . 44.3 t -122.4 132.83 70.32 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.397 0 CA-C-N 115.916 -0.584 . . . . 0.0 109.876 -179.439 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' B' B ' 96' ' ' ILE . . . . . . . . . . . . . 67.0 mt -112.78 126.77 70.22 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.287 0 N-CA-C 109.12 -0.696 . . . . 0.0 109.12 178.265 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' B' B ' 97' ' ' THR . . . . . . . . . . . . . 68.2 p -99.6 152.72 19.72 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-O 120.877 0.37 . . . . 0.0 110.929 -178.543 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' B' B ' 98' ' ' GLU . . . . . . . . . . . . . 45.0 mt-10 -53.87 -24.23 15.19 Favored 'General case' 0 CA--C 1.533 0.324 0 N-CA-C 112.346 0.498 . . . . 0.0 112.346 179.927 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' B' B ' 99' ' ' GLU . . . . . . . . . . . . . 31.1 tt0 -79.27 15.54 1.19 Allowed 'General case' 0 CA--C 1.539 0.549 0 N-CA-C 112.697 0.629 . . . . 0.0 112.697 -177.306 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' B' B ' 100' ' ' ASN . . . . . . . . . . . . . 3.8 m-20 63.56 38.0 9.99 Favored 'General case' 0 CA--C 1.531 0.213 0 CA-C-O 121.006 0.432 . . . . 0.0 111.107 177.366 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' B' B ' 101' ' ' GLU . . . . . . . . . . . . . 85.0 tt0 -118.95 143.26 47.13 Favored 'General case' 0 C--N 1.331 -0.202 0 CA-C-N 116.042 -0.526 . . . . 0.0 109.909 176.014 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' B' B ' 102' ' ' VAL . . . . . . . . . . . . . 45.0 t -114.99 126.29 72.53 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.273 0 CA-C-N 116.262 -0.427 . . . . 0.0 109.946 -177.534 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' B' B ' 103' ' ' LEU . . . . . . . . . . . . . 21.2 mt -116.0 129.38 56.35 Favored 'General case' 0 C--N 1.331 -0.201 0 CA-C-N 115.848 -0.614 . . . . 0.0 110.555 178.263 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' B' B ' 104' ' ' ILE . . . . . . . . . . . . . 66.9 mt -118.82 119.55 61.37 Favored 'Isoleucine or valine' 0 C--O 1.233 0.215 0 CA-C-N 116.443 -0.344 . . . . 0.0 110.109 179.216 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' B' B ' 105' ' ' PHE . . . . . . . . . . . . . 66.8 m-85 -120.72 164.69 16.17 Favored 'General case' 0 C--N 1.331 -0.212 0 O-C-N 123.972 0.795 . . . . 0.0 109.878 178.741 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' B' B ' 106' ' ' ASN . . . . . . . . . . . . . 46.0 p-10 -101.08 -171.49 2.01 Favored 'General case' 0 N--CA 1.463 0.215 0 N-CA-C 110.267 -0.272 . . . . 0.0 110.267 174.605 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' B' B ' 107' ' ' GLN . . . . . . . . . . . . . 60.3 tt0 -59.47 -29.37 67.77 Favored 'General case' 0 CA--C 1.531 0.225 0 N-CA-C 112.021 0.378 . . . . 0.0 112.021 -179.347 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' B' B ' 108' ' ' ASN . . . . . . . . . . . . . 17.9 t30 -86.59 10.01 16.78 Favored 'General case' 0 CA--C 1.536 0.426 0 N-CA-C 113.189 0.811 . . . . 0.0 113.189 -177.115 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' B' B ' 109' ' ' LEU . . . . . . . . . . . . . 12.9 tp 59.68 41.65 18.24 Favored 'General case' 0 C--N 1.331 -0.198 0 CA-C-O 121.25 0.548 . . . . 0.0 110.897 178.318 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' B' B ' 110' ' ' GLU . . . . . . . . . . . . . 70.9 mm-40 -108.07 156.79 18.88 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.138 -0.483 . . . . 0.0 109.866 176.133 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' B' B ' 111' ' ' GLU . . . . . . . . . . . . . 84.9 tt0 -84.39 121.96 28.28 Favored 'General case' 0 C--N 1.329 -0.298 0 C-N-CA 120.845 -0.342 . . . . 0.0 110.79 -178.566 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' B' B ' 112' ' ' LEU . . . . . . . . . . . . . 28.4 mt -110.58 -46.18 3.42 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 116.16 -0.473 . . . . 0.0 110.547 178.169 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' B' B ' 113' ' ' TYR . . . . . . . . . . . . . 54.0 t80 -142.17 134.24 27.44 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.357 -0.383 . . . . 0.0 111.249 -179.941 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' B' B ' 114' ' ' ARG . . . . . . . . . . . . . 29.9 ttm180 -135.28 124.27 24.21 Favored 'General case' 0 C--N 1.329 -0.292 0 N-CA-C 109.839 -0.43 . . . . 0.0 109.839 175.44 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' B' B ' 115' ' ' GLY . . . . . . . . . . . . . . . -150.03 151.64 23.67 Favored Glycine 0 CA--C 1.523 0.569 0 C-N-CA 120.754 -0.736 . . . . 0.0 111.325 179.213 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' B' B ' 116' ' ' LYS . . . . . . . . . . . . . 39.1 ttpt -121.94 136.43 54.92 Favored 'General case' 0 C--N 1.328 -0.333 0 N-CA-C 109.662 -0.495 . . . . 0.0 109.662 177.744 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' B' B ' 117' ' ' PHE . . . . . . . . . . . . . 40.6 m-85 -135.2 113.76 11.66 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-O 121.082 0.468 . . . . 0.0 110.074 -176.861 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' B' B ' 118' ' ' GLU . . . . . . . . . . . . . 97.0 mt-10 -53.86 -43.78 69.82 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.073 -0.512 . . . . 0.0 111.662 -174.256 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' B' B ' 119' ' ' ASN . . . . . . . . . . . . . 5.6 p30 -104.63 31.13 4.91 Favored 'General case' 0 C--N 1.33 -0.257 0 N-CA-C 112.244 0.461 . . . . 0.0 112.244 -173.942 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' B' B ' 120' ' ' LEU . . . . . . . . . . . . . 13.7 tp -53.48 126.05 20.14 Favored 'General case' 0 N--CA 1.464 0.238 0 CA-C-O 120.469 0.176 . . . . 0.0 110.8 177.72 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' B' B ' 121' ' ' ASN . . . . . . . . . . . . . 77.3 m-20 -114.1 -44.12 3.17 Favored 'General case' 0 N--CA 1.462 0.173 0 C-N-CA 121.195 -0.202 . . . . 0.0 111.283 -176.843 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' B' B ' 122' ' ' LYS . . . . . . . . . . . . . 62.2 mtpt -142.1 145.69 34.57 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-O 121.121 0.486 . . . . 0.0 111.727 -176.775 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' B' B ' 123' ' ' VAL . . . . . . . . . . . . . 44.0 t -127.24 127.52 69.35 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.264 0 N-CA-C 109.21 -0.663 . . . . 0.0 109.21 174.909 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' B' B ' 124' ' ' LEU . . . . . . . . . . . . . 51.1 mt -128.03 136.38 51.18 Favored 'General case' 0 C--N 1.331 -0.196 0 CA-C-O 120.853 0.358 . . . . 0.0 111.097 -177.216 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' B' B ' 125' ' ' VAL . . . . . . . . . . . . . 11.1 p -133.97 133.65 56.11 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.249 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.027 177.304 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' B' B ' 126' ' ' ARG . . . . . . . . . . . . . 77.0 mtp85 -146.64 126.47 13.52 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-O 120.86 0.362 . . . . 0.0 111.073 -179.275 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' B' B ' 127' ' ' ASN . . . . . . . . . . . . . 7.6 m-80 49.23 -105.21 0.15 Allowed 'General case' 0 CA--C 1.545 0.76 0 CA-C-O 119.036 -0.507 . . . . 0.0 111.784 178.162 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' B' B ' 128' ' ' ASP . . . . . . . . . . . . . 15.9 p-10 -114.09 3.02 15.11 Favored 'General case' 0 CA--C 1.535 0.396 0 CA-C-N 119.552 1.069 . . . . 0.0 113.546 -176.36 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' B' B ' 129' ' ' LEU . . . . . . . . . . . . . 52.8 mt -111.48 140.85 45.73 Favored 'General case' 0 C--N 1.333 -0.114 0 O-C-N 121.972 -0.455 . . . . 0.0 110.522 -179.078 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' B' B ' 130' ' ' VAL . . . . . . . . . . . . . 46.5 t -122.98 134.85 64.9 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.326 0 N-CA-C 109.401 -0.592 . . . . 0.0 109.401 177.839 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' B' B ' 131' ' ' VAL . . . . . . . . . . . . . 39.3 t -134.36 138.06 50.53 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.223 0 CA-C-O 121.187 0.518 . . . . 0.0 110.45 -179.002 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' B' B ' 132' ' ' ILE . . . . . . . . . . . . . 70.7 mt -116.76 130.19 72.04 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.339 0 CA-C-N 115.556 -0.747 . . . . 0.0 109.388 179.508 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' B' B ' 133' ' ' ILE . . . . . . . . . . . . . 40.4 mm -112.2 119.25 59.72 Favored 'Isoleucine or valine' 0 C--O 1.233 0.221 0 CA-C-O 120.855 0.36 . . . . 0.0 110.67 -177.241 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' B' B ' 134' ' ' ASP . . . . . . . . . . . . . 7.2 p-10 -134.13 148.78 51.01 Favored 'General case' 0 C--N 1.331 -0.206 0 CA-C-N 116.103 -0.499 . . . . 0.0 109.76 177.156 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' B' B ' 135' ' ' GLU . . . . . . . . . . . . . 42.8 tp10 -49.9 -30.0 9.33 Favored 'General case' 0 C--N 1.328 -0.36 0 N-CA-C 112.576 0.584 . . . . 0.0 112.576 -173.523 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' B' B ' 136' ' ' GLN . . . . . . . . . . . . . 43.2 tp60 -80.18 -34.91 37.13 Favored 'General case' 0 C--N 1.33 -0.251 0 N-CA-C 112.282 0.475 . . . . 0.0 112.282 -175.046 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' B' B ' 137' ' ' LYS . . . . . . . . . . . . . 40.0 pttt -170.0 174.2 5.64 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-O 121.452 0.644 . . . . 0.0 112.179 -170.512 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' B' B ' 138' ' ' LEU . . . . . . . . . . . . . 6.1 tt -118.0 128.21 54.56 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 115.186 -0.915 . . . . 0.0 109.9 178.969 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' B' B ' 139' ' ' THR . . . . . . . . . . . . . 34.0 m -106.27 127.76 53.48 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.261 -0.427 . . . . 0.0 110.396 -179.87 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' B' B ' 140' ' ' LEU . . . . . 0.461 ' C ' HD23 ' B' ' 140' ' ' LEU . 5.5 tt -113.88 121.02 42.71 Favored 'General case' 0 C--N 1.328 -0.351 0 N-CA-C 109.149 -0.686 . . . . 0.0 109.149 -178.922 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' B' B ' 141' ' ' ILE . . . . . 0.416 ' N ' HD23 ' B' ' 140' ' ' LEU . 19.1 mt -119.88 116.81 51.65 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.303 0 N-CA-C 109.814 -0.439 . . . . 0.0 109.814 -176.604 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' B' B ' 142' ' ' ARG . . . . . . . . . . . . . 68.5 ttt180 -108.18 131.97 54.11 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 115.417 -0.81 . . . . 0.0 110.463 -177.092 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' B' B ' 143' ' ' THR . . . . . . . . . . . . . 35.2 p . . . . . 0 C--O 1.22 -0.45 0 CA-C-O 117.936 -1.03 . . . . 0.0 110.522 179.092 . . . . . . . . 0 0 . 1 . 018 nuclear build full ' C' C ' -3' ' ' GLU . . . . . . . . . . . . . 85.4 tt0 . . . . . 0 N--CA 1.49 1.564 0 N-CA-C 109.393 -0.595 . . . . 0.0 109.393 . . . . . . . . . 0 0 . 1 . 018 nuclear build full ' C' C ' -2' ' ' GLY . . . . . . . . . . . . . . . -79.46 135.98 16.38 Favored Glycine 0 CA--C 1.526 0.726 0 N-CA-C 111.035 -0.826 . . . . 0.0 111.035 179.411 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' C' C ' -1' ' ' VAL . . . . . . . . . . . . . 42.9 t -141.48 143.08 28.07 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.237 0 N-CA-C 110.067 -0.346 . . . . 0.0 110.067 179.559 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' C' C ' 0' ' ' ILE . . . . . . . . . . . . . 44.8 mm -106.88 138.19 33.92 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.194 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.422 -179.165 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' C' C ' 1' ' ' MET . . . . . . . . . . . . . 25.2 ptp -88.58 162.81 16.16 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 116.049 -0.523 . . . . 0.0 110.635 179.927 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' C' C ' 2' ' ' SER . . . . . . . . . . . . . 12.6 p -119.87 143.2 48.05 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-O 121.024 0.44 . . . . 0.0 110.906 -179.646 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' C' C ' 3' ' ' GLU . . . . . . . . . . . . . 95.8 mt-10 -141.0 142.44 34.26 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 115.863 -0.608 . . . . 0.0 110.961 -178.356 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' C' C ' 4' ' ' LEU . . . . . . . . . . . . . 16.2 tp -122.73 127.05 48.7 Favored 'General case' 0 C--N 1.331 -0.207 0 CA-C-N 116.103 -0.499 . . . . 0.0 109.719 175.402 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' C' C ' 5' ' ' LYS . . . . . . . . . . . . . 52.5 mttp -108.07 122.12 46.23 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-O 120.763 0.315 . . . . 0.0 110.995 -179.109 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' C' C ' 6' ' ' LEU . . . . . . . . . . . . . 27.6 mt -116.21 151.81 34.98 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 115.543 -0.753 . . . . 0.0 110.522 179.863 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' C' C ' 7' ' ' LYS . . . . . . . . . . . . . 74.2 tttt -144.02 139.56 16.11 Favored Pre-proline 0 CA--C 1.534 0.331 0 CA-C-O 119.124 -0.465 . . . . 0.0 109.949 173.569 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' C' C ' 8' ' ' PRO . . . . . . . . . . . . . 80.3 Cg_endo -90.65 141.54 3.23 Favored 'Trans proline' 0 N--CA 1.491 1.364 0 C-N-CA 121.66 1.573 . . . . 0.0 111.72 176.764 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' C' C ' 9' ' ' LEU . . . . . . . . . . . . . 54.6 mt -73.78 -47.97 6.66 Favored Pre-proline 0 CA--C 1.535 0.392 0 CA-C-O 118.665 -0.683 . . . . 0.0 112.472 -178.519 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' C' C ' 10' ' ' PRO . . . . . . . . . . . . . 88.1 Cg_endo -80.66 152.3 19.73 Favored 'Trans proline' 0 N--CA 1.497 1.677 0 C-N-CA 121.313 1.342 . . . . 0.0 111.99 177.422 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' C' C ' 11' ' ' LYS . . . . . . . . . . . . . 73.8 mmtt -82.49 102.0 11.06 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-O 120.929 0.395 . . . . 0.0 110.222 177.524 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' C' C ' 12' ' ' VAL . . . . . . . . . . . . . 12.9 p -141.31 146.4 23.53 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 CA-C-N 116.136 -0.483 . . . . 0.0 110.466 -179.225 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' C' C ' 13' ' ' GLU . . . . . . . . . . . . . 85.0 tt0 -85.19 124.44 31.84 Favored 'General case' 0 C--N 1.329 -0.306 0 N-CA-C 109.93 -0.396 . . . . 0.0 109.93 177.429 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' C' C ' 14' ' ' LEU . . . . . . . . . . . . . 48.8 mt -93.12 142.8 25.81 Favored Pre-proline 0 CA--C 1.533 0.314 0 CA-C-O 119.072 -0.49 . . . . 0.0 110.379 -177.453 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' C' C ' 15' ' ' PRO . . . . . . . . . . . . . 35.6 Cg_exo -60.22 162.1 17.94 Favored 'Trans proline' 0 N--CA 1.496 1.665 0 C-N-CA 121.353 1.369 . . . . 0.0 112.034 176.887 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' C' C ' 16' ' ' PRO . . . . . . . . . . . . . 38.3 Cg_exo -58.2 -42.33 57.87 Favored 'Trans proline' 0 N--CA 1.496 1.632 0 C-N-CA 121.507 1.472 . . . . 0.0 112.897 -176.399 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' C' C ' 17' ' ' ASP . . . . . . . . . . . . . 15.2 p-10 -92.87 13.03 21.68 Favored 'General case' 0 C--N 1.327 -0.383 0 N-CA-C 113.239 0.829 . . . . 0.0 113.239 -175.966 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' C' C ' 18' ' ' PHE . . . . . . . . . . . . . 41.8 t80 -57.71 -43.98 85.59 Favored 'General case' 0 C--O 1.231 0.1 0 CA-C-O 121.073 0.463 . . . . 0.0 110.08 -178.188 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' C' C ' 19' ' ' VAL . . . . . . . . . . . . . 44.9 t -59.47 -42.39 87.66 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.346 0 CA-C-N 116.122 -0.49 . . . . 0.0 110.21 -179.259 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' C' C ' 20' ' ' ASP . . . . . . . . . . . . . 78.5 m-20 -59.69 -42.66 93.46 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-O 120.732 0.301 . . . . 0.0 110.951 -177.361 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' C' C ' 21' ' ' VAL . . . . . . . . . . . . . 43.7 t -64.58 -46.8 91.46 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.318 0 C-N-CA 120.79 -0.364 . . . . 0.0 110.315 -177.755 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' C' C ' 22' ' ' ILE . . . . . 0.488 HG22 HD12 ' C' ' 26' ' ' LEU . 24.5 mm -59.32 -40.1 80.58 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.276 0 C-N-CA 120.869 -0.332 . . . . 0.0 110.362 -179.017 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' C' C ' 23' ' ' ARG . . . . . . . . . . . . . 55.8 ttp180 -55.36 -50.04 70.72 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-O 121.038 0.447 . . . . 0.0 110.736 178.335 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' C' C ' 24' ' ' ILE . . . . . . . . . . . . . 78.0 mt -60.21 -46.06 95.2 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.327 0 CA-C-N 116.005 -0.543 . . . . 0.0 111.595 -177.379 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' C' C ' 25' ' ' LYS . . . . . . . . . . . . . 17.7 ptpt -67.47 -39.15 85.28 Favored 'General case' 0 CA--C 1.534 0.358 0 C-N-CA 120.584 -0.446 . . . . 0.0 111.94 -173.71 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' C' C ' 26' ' ' LEU . . . . . 0.488 HD12 HG22 ' C' ' 22' ' ' ILE . 21.8 mt -79.49 -31.66 42.33 Favored 'General case' 0 C--N 1.33 -0.255 0 N-CA-C 113.045 0.757 . . . . 0.0 113.045 -174.765 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' C' C ' 27' ' ' GLN . . . . . . . . . . . . . 4.5 pt20 -45.9 135.48 7.14 Favored 'General case' 0 CA--C 1.536 0.436 0 N-CA-C 112.78 0.659 . . . . 0.0 112.78 -175.083 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' C' C ' 28' ' ' GLY . . . . . . . . . . . . . . . 97.06 -21.14 47.83 Favored Glycine 0 CA--C 1.534 1.264 0 CA-C-N 115.985 -0.552 . . . . 0.0 112.683 -177.822 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' C' C ' 29' ' ' LYS . . . . . . . . . . . . . 61.7 mttp -97.53 155.14 17.08 Favored 'General case' 0 C--N 1.331 -0.213 0 CA-C-N 117.522 0.661 . . . . 0.0 110.963 -178.984 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' C' C ' 30' ' ' THR . . . . . . . . . . . . . 13.9 m -104.02 139.72 38.74 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.337 177.989 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' C' C ' 31' ' ' VAL . . . . . . . . . . . . . 34.0 m -131.61 157.35 43.15 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.206 0 CA-C-N 116.234 -0.439 . . . . 0.0 110.856 -179.151 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' C' C ' 32' ' ' ARG . . . . . . . . . . . . . 81.7 mtt85 -133.65 150.7 51.57 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-N 115.957 -0.565 . . . . 0.0 110.744 176.828 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' C' C ' 33' ' ' THR . . . . . . . . . . . . . 33.5 m -53.41 139.98 28.95 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.206 -0.452 . . . . 0.0 111.282 -178.944 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' C' C ' 34' ' ' GLY . . . . . . . . . . . . . . . 98.65 -16.98 59.02 Favored Glycine 0 CA--C 1.532 1.125 0 CA-C-O 119.638 -0.535 . . . . 0.0 113.329 178.332 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' C' C ' 35' ' ' ASP . . . . . . . . . . . . . 76.9 m-20 -64.3 149.08 48.86 Favored 'General case' 0 C--O 1.231 0.125 0 CA-C-N 118.054 0.927 . . . . 0.0 111.225 -179.865 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' C' C ' 36' ' ' VAL . . . . . . . . . . . . . 46.2 t -121.07 129.66 75.46 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.211 0 CA-C-N 115.777 -0.647 . . . . 0.0 109.816 178.644 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' C' C ' 37' ' ' ILE . . . . . . . . . . . . . 72.1 mt -123.23 139.98 48.27 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.276 0 CA-C-N 116.182 -0.463 . . . . 0.0 109.994 -179.77 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' C' C ' 38' ' ' GLY . . . . . . . . . . . . . . . -108.91 128.67 9.15 Favored Glycine 0 CA--C 1.526 0.736 0 N-CA-C 111.317 -0.713 . . . . 0.0 111.317 -179.302 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' C' C ' 39' ' ' ILE . . . . . . . . . . . . . 77.7 mt -128.34 135.36 62.82 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.187 0 CA-C-O 120.757 0.313 . . . . 0.0 110.185 178.535 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' C' C ' 40' ' ' SER . . . . . . . . . . . . . 32.6 p -92.78 117.03 29.57 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.324 -0.398 . . . . 0.0 110.822 175.377 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' C' C ' 41' ' ' ILE . . . . . . . . . . . . . 45.7 mm -121.12 112.91 37.66 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.21 0 CA-C-O 120.794 0.331 . . . . 0.0 110.186 178.686 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' C' C ' 42' ' ' LEU . . . . . 0.424 ' O ' HD23 ' C' ' 42' ' ' LEU . 2.0 tt 55.58 48.56 18.4 Favored 'General case' 0 CA--C 1.533 0.307 0 CA-C-O 121.538 0.685 . . . . 0.0 110.098 178.643 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' C' C ' 43' ' ' GLY . . . . . . . . . . . . . . . 71.77 -5.48 11.92 Favored Glycine 0 CA--C 1.536 1.359 0 C-N-CA 121.125 -0.559 . . . . 0.0 113.766 175.642 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' C' C ' 44' ' ' LYS . . . . . . . . . . . . . 25.6 tptp -103.34 132.97 49.17 Favored 'General case' 0 C--O 1.231 0.126 0 CA-C-N 117.975 0.888 . . . . 0.0 110.031 -178.716 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' C' C ' 45' ' ' GLU . . . . . . . . . . . . . 82.5 tt0 -82.34 119.7 24.48 Favored 'General case' 0 C--N 1.329 -0.32 0 C-N-CA 120.808 -0.357 . . . . 0.0 110.78 -178.476 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' C' C ' 46' ' ' VAL . . . . . . . . . . . . . 7.2 p -122.8 124.52 70.65 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.21 0 N-CA-C 109.42 -0.585 . . . . 0.0 109.42 177.283 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' C' C ' 47' ' ' LYS . . . . . . . . . . . . . 53.7 mtmt -100.88 132.0 46.49 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.073 -0.512 . . . . 0.0 111.124 177.201 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' C' C ' 48' ' ' PHE . . . . . . . . . . . . . 84.3 m-85 -109.42 134.17 52.17 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 115.87 -0.605 . . . . 0.0 110.417 179.741 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' C' C ' 49' ' ' LYS . . . . . . . . . . . . . 87.5 tttt -105.3 134.36 48.54 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 115.844 -0.616 . . . . 0.0 110.05 178.589 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' C' C ' 50' ' ' VAL . . . . . . . . . . . . . 44.6 t -77.87 106.69 8.62 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.243 0 N-CA-C 109.147 -0.686 . . . . 0.0 109.147 174.873 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' C' C ' 51' ' ' VAL . . . . . . . . . . . . . 45.8 t -68.71 -46.63 79.37 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.308 0 CA-C-N 116.107 -0.497 . . . . 0.0 110.018 -172.59 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' C' C ' 52' ' ' GLN . . . . . . . . . . . . . 45.0 tt0 -171.39 145.25 2.09 Favored 'General case' 0 C--N 1.331 -0.207 0 C-N-CA 120.229 -0.588 . . . . 0.0 111.662 -179.361 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' C' C ' 53' ' ' ALA . . . . . . . . . . . . . . . -116.63 132.1 56.77 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 115.766 -0.652 . . . . 0.0 110.013 176.459 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' C' C ' 54' ' ' TYR . . . . . . . . . . . . . 48.2 t80 -129.11 108.87 18.03 Favored Pre-proline 0 CA--C 1.535 0.39 0 CA-C-O 118.264 -0.874 . . . . 0.0 110.242 177.983 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' C' C ' 55' ' ' PRO . . . . . . . . . . . . . 72.4 Cg_endo -77.11 168.5 76.83 Favored 'Cis proline' 0 N--CA 1.498 1.774 0 CA-C-N 121.865 1.702 . . . . 0.0 112.504 -3.823 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' C' C ' 56' ' ' SER . . . . . . . . . . . . . 50.2 m -115.71 130.49 24.31 Favored Pre-proline 0 CA--C 1.538 0.501 0 CA-C-O 118.456 -0.783 . . . . 0.0 109.373 174.446 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' C' C ' 57' ' ' PRO . . . . . . . . . . . . . 54.8 Cg_endo -70.0 165.3 77.7 Favored 'Cis proline' 0 N--CA 1.497 1.732 0 CA-C-N 121.918 1.721 . . . . 0.0 111.432 0.606 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' C' C ' 58' ' ' LEU . . . . . . . . . . . . . 29.3 tp -129.73 137.51 50.61 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-O 120.908 0.385 . . . . 0.0 110.419 -179.957 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' C' C ' 59' ' ' ARG . . . . . . . . . . . . . 64.7 ttp85 -106.98 125.72 51.38 Favored 'General case' 0 C--N 1.328 -0.332 0 N-CA-C 109.328 -0.619 . . . . 0.0 109.328 176.917 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' C' C ' 60' ' ' VAL . . . . . . . . . . . . . 45.0 t -75.48 115.97 17.66 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.288 0 CA-C-O 120.878 0.37 . . . . 0.0 110.656 -173.884 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' C' C ' 61' ' ' GLU . . . . . . . . . . . . . 39.1 tp10 -131.05 154.76 47.89 Favored 'General case' 0 C--N 1.33 -0.263 0 N-CA-C 109.062 -0.718 . . . . 0.0 109.062 176.77 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' C' C ' 62' ' ' ASP . . . . . . . . . . . . . 83.4 m-20 -50.86 -32.33 20.01 Favored 'General case' 0 C--N 1.326 -0.444 0 N-CA-C 112.162 0.43 . . . . 0.0 112.162 -176.612 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' C' C ' 63' ' ' ARG . . . . . . . . . . . . . 75.4 mtt85 -72.37 -22.19 61.18 Favored 'General case' 0 C--N 1.33 -0.261 0 N-CA-C 113.154 0.798 . . . . 0.0 113.154 -175.627 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' C' C ' 64' ' ' THR . . . . . . . . . . . . . 33.3 m -68.81 140.36 55.26 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-O 120.86 0.362 . . . . 0.0 110.697 -176.778 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' C' C ' 65' ' ' LYS . . . . . . . . . . . . . 97.2 mttt -88.08 134.64 33.71 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.045 -0.525 . . . . 0.0 109.989 179.159 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' C' C ' 66' ' ' ILE . . . . . . . . . . . . . 53.7 mt -111.09 129.84 65.64 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.238 0 N-CA-C 109.607 -0.516 . . . . 0.0 109.607 -178.248 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' C' C ' 67' ' ' THR . . . . . . . . . . . . . 34.6 m -123.69 140.24 53.19 Favored 'General case' 0 C--N 1.331 -0.223 0 CA-C-O 121.079 0.466 . . . . 0.0 111.295 -175.724 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' C' C ' 68' ' ' LEU . . . . . 0.465 HD12 ' N ' ' C' ' 68' ' ' LEU . 8.2 mp -101.4 122.88 44.55 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 115.667 -0.697 . . . . 0.0 110.1 176.077 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' C' C ' 69' ' ' VAL . . . . . . . . . . . . . 46.2 t -101.67 134.4 42.19 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.325 0 N-CA-C 109.878 -0.416 . . . . 0.0 109.878 179.592 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' C' C ' 70' ' ' THR . . . . . . . . . . . . . 15.9 p -132.79 120.41 21.57 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 116.243 -0.435 . . . . 0.0 110.646 179.433 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' C' C ' 71' ' ' HIS . . . . . . . . . . . . . 40.7 m80 -121.3 154.68 59.02 Favored Pre-proline 0 C--N 1.33 -0.282 0 CA-C-N 116.005 -0.543 . . . . 0.0 109.656 177.49 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' C' C ' 72' ' ' PRO . . . . . . . . . . . . . 58.3 Cg_endo -72.74 -30.14 11.96 Favored 'Trans proline' 0 N--CA 1.495 1.579 0 C-N-CA 121.152 1.234 . . . . 0.0 112.538 -177.002 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' C' C ' 73' ' ' VAL . . . . . . . . . . . . . 21.1 m -153.61 160.3 2.94 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.27 0 CA-C-O 121.137 0.494 . . . . 0.0 111.038 179.198 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' C' C ' 74' ' ' ASP . . . . . . . . . . . . . 7.0 t0 -107.95 122.92 47.81 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 115.572 -0.74 . . . . 0.0 109.371 175.251 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' C' C ' 75' ' ' VAL . . . . . . . . . . . . . 40.1 t -112.52 121.32 64.63 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.231 0 CA-C-O 121.128 0.49 . . . . 0.0 110.676 -177.69 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' C' C ' 76' ' ' LEU . . . . . 0.469 ' N ' HD12 ' C' ' 76' ' ' LEU . 6.4 mp -119.57 148.48 43.26 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 115.573 -0.74 . . . . 0.0 109.621 176.309 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' C' C ' 77' ' ' GLU . . . . . . . . . . . . . 98.0 mt-10 -137.84 133.58 34.1 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-O 121.108 0.48 . . . . 0.0 111.129 -177.988 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' C' C ' 78' ' ' ALA . . . . . 0.663 ' HB2' HD21 ' C' ' 109' ' ' LEU . . . -118.74 128.0 54.08 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 115.674 -0.693 . . . . 0.0 109.672 176.724 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' C' C ' 79' ' ' LYS . . . . . 0.563 ' O ' HD13 ' C' ' 80' ' ' ILE . 61.7 mttp -83.87 114.94 22.01 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-O 121.05 0.452 . . . . 0.0 110.897 -176.072 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' C' C ' 80' ' ' ILE . . . . . 0.563 HD13 ' O ' ' C' ' 79' ' ' LYS . 43.7 mm -139.26 107.33 3.19 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.28 0 N-CA-C 109.025 -0.731 . . . . 0.0 109.025 -178.023 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' C' C ' 81' ' ' LYS . . . . . . . . . . . . . 77.4 tttt -95.34 127.41 41.37 Favored 'General case' 0 C--N 1.328 -0.369 0 C-N-CA 120.676 -0.409 . . . . 0.0 110.687 -177.837 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' C' C ' 82' ' ' GLY . . . . . . . . . . . . . . . 89.29 42.03 5.65 Favored Glycine 0 CA--C 1.524 0.645 0 C-N-CA 120.749 -0.738 . . . . 0.0 111.744 176.426 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' C' C ' 83' ' ' ILE . . . . . . . . . . . . . 67.9 mt -68.39 139.28 20.92 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.324 0 N-CA-C 109.47 -0.567 . . . . 0.0 109.47 176.586 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' C' C ' 84' ' ' LYS . . . . . . . . . . . . . 68.5 tttt -98.42 -54.14 3.13 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.112 -0.495 . . . . 0.0 110.704 -176.009 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' C' C ' 85' ' ' ASP . . . . . . . . . . . . . 6.9 t70 -152.14 155.31 37.6 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 115.885 -0.598 . . . . 0.0 110.353 -177.883 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' C' C ' 86' ' ' VAL . . . . . . . . . . . . . 40.3 t -133.17 132.23 58.48 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.254 0 CA-C-O 121.017 0.437 . . . . 0.0 110.729 -178.485 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' C' C ' 87' ' ' ILE . . . . . . . . . . . . . 45.1 mm -117.63 122.28 69.47 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.276 0 CA-C-N 115.776 -0.647 . . . . 0.0 109.325 174.431 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' C' C ' 88' ' ' LEU . . . . . . . . . . . . . 13.4 tp -113.04 130.75 56.04 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-O 120.992 0.425 . . . . 0.0 110.998 -176.219 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' C' C ' 89' ' ' ASP . . . . . . . . . . . . . 11.7 t70 -128.65 160.24 33.06 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 115.888 -0.597 . . . . 0.0 109.863 178.38 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' C' C ' 90' ' ' GLU . . . . . . . . . . . . . 83.3 tt0 -46.23 -41.13 12.45 Favored 'General case' 0 CA--C 1.532 0.282 0 N-CA-C 113.073 0.768 . . . . 0.0 113.073 -172.041 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' C' C ' 91' ' ' ASN . . . . . . . . . . . . . 25.6 m120 -132.05 27.55 4.53 Favored 'General case' 0 N--CA 1.467 0.409 0 N-CA-C 112.44 0.533 . . . . 0.0 112.44 -177.451 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' C' C ' 92' ' ' LEU . . . . . . . . . . . . . 12.2 mt -149.98 141.17 23.11 Favored 'General case' 0 C--N 1.33 -0.265 0 N-CA-C 110.221 -0.288 . . . . 0.0 110.221 -177.43 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' C' C ' 93' ' ' ILE . . . . . . . . . . . . . 73.0 mt -124.5 113.63 37.22 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.284 0 N-CA-C 109.075 -0.713 . . . . 0.0 109.075 176.887 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' C' C ' 94' ' ' VAL . . . . . . . . . . . . . 45.0 t -116.6 126.49 74.08 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.247 0 N-CA-C 109.806 -0.442 . . . . 0.0 109.806 -179.388 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' C' C ' 95' ' ' VAL . . . . . . . . . . . . . 40.2 t -124.38 136.63 59.89 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.325 0 CA-C-N 116.28 -0.418 . . . . 0.0 110.056 -178.687 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' C' C ' 96' ' ' ILE . . . . . . . . . . . . . 61.4 mt -116.55 130.55 71.19 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.361 0 N-CA-C 109.221 -0.659 . . . . 0.0 109.221 179.112 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' C' C ' 97' ' ' THR . . . . . . . . . . . . . 71.4 p -98.37 159.99 14.58 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-O 120.908 0.385 . . . . 0.0 110.619 -178.346 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' C' C ' 98' ' ' GLU . . . . . . . . . . . . . 12.8 pt-20 -53.99 -19.27 4.45 Favored 'General case' 0 CA--C 1.535 0.367 0 N-CA-C 112.801 0.667 . . . . 0.0 112.801 -179.266 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' C' C ' 99' ' ' GLU . . . . . . . . . . . . . 37.1 tt0 -85.67 16.34 4.02 Favored 'General case' 0 CA--C 1.539 0.545 0 N-CA-C 112.567 0.58 . . . . 0.0 112.567 -177.259 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' C' C ' 100' ' ' ASN . . . . . . . . . . . . . 3.4 m-20 61.14 38.06 17.18 Favored 'General case' 0 CA--C 1.529 0.17 0 O-C-N 121.818 -0.551 . . . . 0.0 110.971 178.564 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' C' C ' 101' ' ' GLU . . . . . . . . . . . . . 82.0 tt0 -116.12 143.24 45.74 Favored 'General case' 0 C--N 1.331 -0.207 0 N-CA-C 109.444 -0.576 . . . . 0.0 109.444 175.831 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' C' C ' 102' ' ' VAL . . . . . . . . . . . . . 44.4 t -117.66 128.41 74.87 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.263 0 CA-C-O 120.972 0.415 . . . . 0.0 110.098 -177.609 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' C' C ' 103' ' ' LEU . . . . . . . . . . . . . 25.0 mt -118.38 136.35 53.8 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 115.564 -0.743 . . . . 0.0 109.752 176.164 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' C' C ' 104' ' ' ILE . . . . . . . . . . . . . 69.2 mt -118.19 121.34 66.99 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.244 0 N-CA-C 109.844 -0.428 . . . . 0.0 109.844 179.725 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' C' C ' 105' ' ' PHE . . . . . . . . . . . . . 53.9 m-85 -118.11 161.31 20.06 Favored 'General case' 0 C--N 1.333 -0.139 0 O-C-N 124.183 0.927 . . . . 0.0 109.836 -179.328 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' C' C ' 106' ' ' ASN . . . . . . . . . . . . . 44.7 p-10 -98.82 -171.04 2.03 Favored 'General case' 0 C--N 1.33 -0.246 0 N-CA-C 110.049 -0.352 . . . . 0.0 110.049 175.427 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' C' C ' 107' ' ' GLN . . . . . . . . . . . . . 41.0 tt0 -58.29 -30.13 66.39 Favored 'General case' 0 C--N 1.329 -0.284 0 N-CA-C 111.968 0.358 . . . . 0.0 111.968 -179.459 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' C' C ' 108' ' ' ASN . . . . . . . . . . . . . 12.9 t30 -86.17 8.78 19.68 Favored 'General case' 0 CA--C 1.535 0.398 0 N-CA-C 113.475 0.917 . . . . 0.0 113.475 -175.954 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' C' C ' 109' ' ' LEU . . . . . 0.663 HD21 ' HB2' ' C' ' 78' ' ' ALA . 11.9 tp 62.96 38.55 11.06 Favored 'General case' 0 CA--C 1.53 0.185 0 CA-C-O 121.073 0.464 . . . . 0.0 111.301 177.752 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' C' C ' 110' ' ' GLU . . . . . . . . . . . . . 70.7 mm-40 -109.16 157.43 18.78 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 116.37 -0.377 . . . . 0.0 110.114 176.211 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' C' C ' 111' ' ' GLU . . . . . . . . . . . . . 98.5 mt-10 -86.35 124.24 32.48 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-O 120.806 0.336 . . . . 0.0 111.263 -178.401 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' C' C ' 112' ' ' LEU . . . . . . . . . . . . . 13.5 mt -111.14 -45.99 3.37 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 115.982 -0.554 . . . . 0.0 110.711 178.479 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' C' C ' 113' ' ' TYR . . . . . . . . . . . . . 61.6 t80 -135.85 142.45 44.79 Favored 'General case' 0 N--CA 1.464 0.256 0 C-N-CA 120.749 -0.381 . . . . 0.0 111.532 -178.224 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' C' C ' 114' ' ' ARG . . . . . . . . . . . . . 51.3 mtt85 -135.75 125.88 26.2 Favored 'General case' 0 C--N 1.331 -0.21 0 CA-C-N 115.996 -0.547 . . . . 0.0 109.937 179.684 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' C' C ' 115' ' ' GLY . . . . . . . . . . . . . . . -150.13 155.06 26.04 Favored Glycine 0 CA--C 1.524 0.65 0 C-N-CA 120.643 -0.789 . . . . 0.0 111.296 177.886 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' C' C ' 116' ' ' LYS . . . . . . . . . . . . . 36.1 ttpt -129.98 136.07 49.02 Favored 'General case' 0 C--N 1.331 -0.224 0 N-CA-C 109.64 -0.504 . . . . 0.0 109.64 175.875 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' C' C ' 117' ' ' PHE . . . . . . . . . . . . . 40.0 m-85 -137.7 113.92 10.08 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-O 120.927 0.394 . . . . 0.0 110.313 -176.033 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' C' C ' 118' ' ' GLU . . . . . . . . . . . . . 95.7 mt-10 -56.0 -46.4 78.74 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.388 -0.369 . . . . 0.0 110.976 -176.321 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' C' C ' 119' ' ' ASN . . . . . . . . . . . . . 71.0 m-80 -95.86 31.03 2.19 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.102 -0.499 . . . . 0.0 112.002 -174.99 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' C' C ' 120' ' ' LEU . . . . . . . . . . . . . 12.2 tp -56.7 119.96 7.02 Favored 'General case' 0 C--N 1.333 -0.144 0 C-N-CA 120.993 -0.283 . . . . 0.0 110.278 178.284 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' C' C ' 121' ' ' ASN . . . . . . . . . . . . . 56.3 m-20 -114.08 -44.2 3.17 Favored 'General case' 0 C--N 1.331 -0.226 0 CA-C-N 116.491 -0.322 . . . . 0.0 110.983 -176.883 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' C' C ' 122' ' ' LYS . . . . . . . . . . . . . 92.5 mttt -143.26 145.21 32.54 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-O 121.126 0.489 . . . . 0.0 111.688 -178.133 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' C' C ' 123' ' ' VAL . . . . . . . . . . . . . 43.8 t -124.75 126.2 71.11 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.262 0 CA-C-N 115.735 -0.666 . . . . 0.0 109.325 174.997 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' C' C ' 124' ' ' LEU . . . . . . . . . . . . . 74.4 mt -115.13 129.45 56.67 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.507 -0.315 . . . . 0.0 110.379 -177.122 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' C' C ' 125' ' ' VAL . . . . . . . . . . . . . 43.6 t -127.9 122.6 58.99 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.225 0 CA-C-N 116.282 -0.417 . . . . 0.0 109.898 178.851 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' C' C ' 126' ' ' ARG . . . . . . . . . . . . . 80.9 mtt85 -151.99 135.6 16.18 Favored 'General case' 0 C--N 1.33 -0.255 0 N-CA-C 109.748 -0.464 . . . . 0.0 109.748 178.267 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' C' C ' 127' ' ' ASN . . . . . . . . . . . . . 3.1 m120 55.99 -154.99 0.3 Allowed 'General case' 0 CA--C 1.539 0.549 0 N-CA-C 109.644 -0.502 . . . . 0.0 109.644 -179.282 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' C' C ' 128' ' ' ASP . . . . . . . . . . . . . 9.3 p-10 -84.88 21.47 1.58 Allowed 'General case' 0 CA--C 1.535 0.384 0 CA-C-N 118.432 0.56 . . . . 0.0 112.199 175.831 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' C' C ' 129' ' ' LEU . . . . . . . . . . . . . 12.8 tp -116.42 137.76 51.9 Favored 'General case' 0 C--O 1.234 0.254 0 CA-C-O 120.91 0.386 . . . . 0.0 110.381 -179.676 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' C' C ' 130' ' ' VAL . . . . . . . . . . . . . 42.8 t -124.33 136.8 59.32 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.204 0 CA-C-N 116.079 -0.509 . . . . 0.0 110.049 -178.864 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' C' C ' 131' ' ' VAL . . . . . . . . . . . . . 44.6 t -136.02 137.79 48.24 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.292 0 CA-C-O 120.946 0.403 . . . . 0.0 110.329 179.181 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' C' C ' 132' ' ' ILE . . . . . . . . . . . . . 72.4 mt -121.26 134.09 65.74 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.247 0 CA-C-N 116.064 -0.516 . . . . 0.0 109.795 -179.027 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' C' C ' 133' ' ' ILE . . . . . . . . . . . . . 42.9 mm -117.2 121.56 67.97 Favored 'Isoleucine or valine' 0 C--O 1.233 0.228 0 CA-C-O 120.834 0.349 . . . . 0.0 111.156 -176.275 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' C' C ' 134' ' ' ASP . . . . . . . . . . . . . 6.9 p-10 -133.47 147.12 51.65 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 115.78 -0.645 . . . . 0.0 109.52 174.003 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' C' C ' 135' ' ' GLU . . . . . . . . . . . . . 83.3 tt0 -50.05 -25.05 3.05 Favored 'General case' 0 C--N 1.327 -0.373 0 N-CA-C 112.96 0.726 . . . . 0.0 112.96 -171.247 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' C' C ' 136' ' ' GLN . . . . . . . . . . . . . 95.6 mm-40 -93.46 -35.03 13.17 Favored 'General case' 0 C--N 1.33 -0.267 0 N-CA-C 112.633 0.605 . . . . 0.0 112.633 -176.379 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' C' C ' 137' ' ' LYS . . . . . . . . . . . . . 50.0 mtmt -146.2 154.74 42.1 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-O 121.303 0.573 . . . . 0.0 112.056 -169.13 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' C' C ' 138' ' ' LEU . . . . . 0.423 HD23 ' C ' ' C' ' 138' ' ' LEU . 5.5 tt -116.81 123.45 47.15 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 115.349 -0.841 . . . . 0.0 109.16 175.151 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' C' C ' 139' ' ' THR . . . . . . . . . . . . . 30.7 m -111.57 129.71 55.98 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 116.483 -0.326 . . . . 0.0 110.97 -175.939 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' C' C ' 140' ' ' LEU . . . . . 0.473 ' C ' HD23 ' C' ' 140' ' ' LEU . 7.4 tt -117.77 124.36 48.24 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 115.747 -0.66 . . . . 0.0 109.449 -179.624 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' C' C ' 141' ' ' ILE . . . . . . . . . . . . . 19.0 mt -122.43 120.54 61.35 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.277 0 N-CA-C 109.909 -0.404 . . . . 0.0 109.909 -175.972 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' C' C ' 142' ' ' ARG . . . . . . . . . . . . . 78.3 ttt-85 -111.24 131.2 55.32 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 115.84 -0.618 . . . . 0.0 110.099 -178.086 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' C' C ' 143' ' ' THR . . . . . . . . . . . . . 41.4 p . . . . . 0 C--O 1.219 -0.518 0 CA-C-O 117.96 -1.019 . . . . 0.0 110.618 -179.365 . . . . . . . . 0 0 . 1 . 018 nuclear build full ' D' D ' -3' ' ' GLU . . . . . . . . . . . . . 22.2 pt-20 . . . . . 0 N--CA 1.493 1.679 0 N-CA-C 110.155 -0.313 . . . . 0.0 110.155 . . . . . . . . . 0 0 . 1 . 018 nuclear build full ' D' D ' -2' ' ' GLY . . . . . . . . . . . . . . . -66.39 140.41 39.15 Favored Glycine 0 CA--C 1.526 0.744 0 N-CA-C 110.887 -0.885 . . . . 0.0 110.887 179.896 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' D' D ' -1' ' ' VAL . . . . . . . . . . . . . 43.7 t -141.32 133.91 29.67 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.305 0 N-CA-C 110.023 -0.362 . . . . 0.0 110.023 -179.853 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' D' D ' 0' ' ' ILE . . . . . . . . . . . . . 44.3 mm -117.41 133.35 64.44 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.238 0 CA-C-N 116.326 -0.397 . . . . 0.0 110.33 179.791 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' D' D ' 1' ' ' MET . . . . . . . . . . . . . 26.0 ptt? -84.23 133.64 34.57 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.135 -0.484 . . . . 0.0 110.635 -179.782 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' D' D ' 2' ' ' SER . . . . . . . . . . . . . 79.5 p -124.57 145.2 49.73 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.312 -0.404 . . . . 0.0 110.522 179.571 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' D' D ' 3' ' ' GLU . . . . . . . . . . . . . 84.9 tt0 -140.22 138.4 35.06 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.063 -0.517 . . . . 0.0 110.987 -178.647 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' D' D ' 4' ' ' LEU . . . . . 0.491 HD21 HG13 ' D' ' 50' ' ' VAL . 4.9 tt -124.25 130.23 52.15 Favored 'General case' 0 C--N 1.332 -0.187 0 CA-C-N 115.96 -0.564 . . . . 0.0 110.137 178.309 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' D' D ' 5' ' ' LYS . . . . . 0.415 ' N ' HD23 ' D' ' 4' ' ' LEU . 67.6 mttm -109.65 122.58 47.78 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.455 -0.339 . . . . 0.0 111.017 -178.739 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' D' D ' 6' ' ' LEU . . . . . 0.453 HD23 ' HA ' ' D' ' 50' ' ' VAL . 79.6 mt -115.38 149.78 37.41 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 115.369 -0.832 . . . . 0.0 110.331 179.793 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' D' D ' 7' ' ' LYS . . . . . . . . . . . . . 64.1 tttm -137.45 137.07 21.29 Favored Pre-proline 0 CA--C 1.534 0.338 0 CA-C-O 119.014 -0.517 . . . . 0.0 110.087 176.587 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' D' D ' 8' ' ' PRO . . . . . . . . . . . . . 93.1 Cg_endo -92.01 141.73 2.49 Favored 'Trans proline' 0 N--CA 1.49 1.3 0 C-N-CA 121.823 1.682 . . . . 0.0 111.491 176.701 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' D' D ' 9' ' ' LEU . . . . . . . . . . . . . 66.7 mt -75.86 -47.48 3.84 Favored Pre-proline 0 CA--C 1.533 0.292 0 CA-C-O 118.74 -0.648 . . . . 0.0 112.219 -178.439 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' D' D ' 10' ' ' PRO . . . . . . . . . . . . . 98.6 Cg_endo -81.74 149.04 16.04 Favored 'Trans proline' 0 N--CA 1.495 1.612 0 C-N-CA 121.184 1.256 . . . . 0.0 111.852 175.542 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' D' D ' 11' ' ' LYS . . . . . . . . . . . . . 24.3 tptp -88.86 100.53 13.24 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-O 120.764 0.316 . . . . 0.0 110.399 179.539 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' D' D ' 12' ' ' VAL . . . . . . . . . . . . . 11.4 p -139.62 142.23 33.19 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.233 0 CA-C-N 116.358 -0.383 . . . . 0.0 110.548 -179.206 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' D' D ' 13' ' ' GLU . . . . . . . . . . . . . 43.1 mp0 -78.17 122.44 25.65 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 116.3 -0.409 . . . . 0.0 110.165 178.041 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' D' D ' 14' ' ' LEU . . . . . . . . . . . . . 35.8 mt -98.4 153.44 38.02 Favored Pre-proline 0 CA--C 1.532 0.285 0 CA-C-N 116.462 -0.336 . . . . 0.0 110.51 -179.283 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' D' D ' 15' ' ' PRO . . . . . . . . . . . . . 33.5 Cg_exo -60.56 157.41 36.92 Favored 'Trans proline' 0 N--CA 1.496 1.653 0 C-N-CA 121.256 1.304 . . . . 0.0 111.792 176.801 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' D' D ' 16' ' ' PRO . . . . . . . . . . . . . 36.2 Cg_exo -58.83 -37.39 94.05 Favored 'Trans proline' 0 N--CA 1.498 1.737 0 C-N-CA 121.376 1.384 . . . . 0.0 112.654 -178.177 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' D' D ' 17' ' ' ASP . . . . . . . . . . . . . 7.1 p-10 -88.46 9.94 21.9 Favored 'General case' 0 CA--C 1.534 0.355 0 N-CA-C 113.284 0.846 . . . . 0.0 113.284 -176.832 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' D' D ' 18' ' ' PHE . . . . . . . . . . . . . 19.8 t80 -57.72 -45.06 86.25 Favored 'General case' 0 C--N 1.334 -0.091 0 O-C-N 121.916 -0.49 . . . . 0.0 110.041 -177.653 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' D' D ' 19' ' ' VAL . . . . . . . . . . . . . 48.0 t -57.61 -43.15 82.82 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.286 0 CA-C-N 116.273 -0.421 . . . . 0.0 110.548 -178.521 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' D' D ' 20' ' ' ASP . . . . . . . . . . . . . 82.5 m-20 -60.15 -42.56 95.15 Favored 'General case' 0 C--N 1.33 -0.258 0 C-N-CA 120.837 -0.345 . . . . 0.0 111.112 -176.789 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' D' D ' 21' ' ' VAL . . . . . . . . . . . . . 45.6 t -64.73 -46.28 92.67 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.33 0 C-N-CA 120.807 -0.357 . . . . 0.0 110.347 -177.863 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' D' D ' 22' ' ' ILE . . . . . . . . . . . . . 50.5 mm -56.91 -42.98 79.61 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.229 0 C-N-CA 120.815 -0.354 . . . . 0.0 110.441 178.379 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' D' D ' 23' ' ' ARG . . . . . . . . . . . . . 54.7 ttp180 -53.5 -47.39 69.9 Favored 'General case' 0 C--N 1.33 -0.266 0 O-C-N 122.32 -0.237 . . . . 0.0 111.339 -179.208 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' D' D ' 24' ' ' ILE . . . . . . . . . . . . . 71.7 mt -60.02 -43.41 92.52 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.342 0 C-N-CA 120.933 -0.307 . . . . 0.0 110.698 179.541 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' D' D ' 25' ' ' LYS . . . . . . . . . . . . . 89.0 mttt -61.73 -38.09 86.62 Favored 'General case' 0 C--N 1.328 -0.343 0 N-CA-C 112.379 0.511 . . . . 0.0 112.379 -179.564 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' D' D ' 26' ' ' LEU . . . . . . . . . . . . . 86.3 mt -77.99 -46.63 20.52 Favored 'General case' 0 C--N 1.329 -0.32 0 N-CA-C 112.702 0.63 . . . . 0.0 112.702 -171.719 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' D' D ' 27' ' ' GLN . . . . . . . . . . . . . 15.2 pt20 -47.03 137.76 7.25 Favored 'General case' 0 N--CA 1.47 0.556 0 N-CA-C 112.75 0.648 . . . . 0.0 112.75 -175.839 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' D' D ' 28' ' ' GLY . . . . . . . . . . . . . . . 101.14 -26.86 23.1 Favored Glycine 0 CA--C 1.531 1.092 0 CA-C-N 115.591 -0.731 . . . . 0.0 112.312 -178.454 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' D' D ' 29' ' ' LYS . . . . . . . . . . . . . 87.4 mttt -99.67 155.14 17.77 Favored 'General case' 0 C--N 1.332 -0.182 0 CA-C-N 117.398 0.599 . . . . 0.0 111.385 179.707 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' D' D ' 30' ' ' THR . . . . . . . . . . . . . 22.2 m -101.07 135.38 42.63 Favored 'General case' 0 C--N 1.33 -0.239 0 CA-C-N 116.099 -0.501 . . . . 0.0 109.662 174.119 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' D' D ' 31' ' ' VAL . . . . . . . . . . . . . 34.3 m -127.48 156.33 39.12 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.226 0 CA-C-O 120.866 0.365 . . . . 0.0 111.14 -177.644 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' D' D ' 32' ' ' ARG . . . . . . . . . . . . . 72.8 mtt85 -132.93 149.35 52.25 Favored 'General case' 0 C--O 1.233 0.186 0 CA-C-N 115.724 -0.671 . . . . 0.0 110.838 178.864 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' D' D ' 33' ' ' THR . . . . . 0.432 HG23 ' HA ' ' D' ' 52' ' ' GLN . 23.7 m -53.8 140.46 29.97 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.07 -0.514 . . . . 0.0 111.146 -179.784 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' D' D ' 34' ' ' GLY . . . . . . . . . . . . . . . 99.7 -17.08 57.99 Favored Glycine 0 CA--C 1.531 1.047 0 C-N-CA 121.105 -0.569 . . . . 0.0 113.31 178.753 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' D' D ' 35' ' ' ASP . . . . . . . . . . . . . 75.8 m-20 -62.15 147.63 47.03 Favored 'General case' 0 N--CA 1.461 0.125 0 CA-C-N 118.054 0.927 . . . . 0.0 111.156 179.683 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' D' D ' 36' ' ' VAL . . . . . . . . . . . . . 46.5 t -124.63 129.12 73.79 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.234 0 CA-C-N 115.659 -0.7 . . . . 0.0 109.721 178.883 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' D' D ' 37' ' ' ILE . . . . . . . . . . . . . 68.0 mt -120.74 137.6 53.95 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.229 0 N-CA-C 109.857 -0.423 . . . . 0.0 109.857 -179.706 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' D' D ' 38' ' ' GLY . . . . . . . . . . . . . . . -111.5 128.74 8.8 Favored Glycine 0 CA--C 1.525 0.666 0 N-CA-C 111.018 -0.833 . . . . 0.0 111.018 179.606 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' D' D ' 39' ' ' ILE . . . . . . . . . . . . . 69.6 mt -125.44 126.64 70.89 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.228 0 N-CA-C 109.849 -0.426 . . . . 0.0 109.849 178.782 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' D' D ' 40' ' ' SER . . . . . . . . . . . . . 46.6 t -93.4 120.45 33.69 Favored 'General case' 0 C--N 1.33 -0.262 0 C-N-CA 120.825 -0.35 . . . . 0.0 110.88 176.158 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' D' D ' 41' ' ' ILE . . . . . . . . . . . . . 71.1 mt -132.88 125.47 52.32 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.186 0 CA-C-O 120.749 0.309 . . . . 0.0 110.316 178.589 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' D' D ' 42' ' ' LEU . . . . . . . . . . . . . 61.4 mt 57.5 34.39 24.54 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.098 -0.501 . . . . 0.0 111.891 177.296 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' D' D ' 43' ' ' GLY . . . . . . . . . . . . . . . 78.52 -10.11 31.88 Favored Glycine 0 CA--C 1.535 1.295 0 C-N-CA 121.192 -0.528 . . . . 0.0 113.463 176.975 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' D' D ' 44' ' ' LYS . . . . . . . . . . . . . 52.7 mtmt -101.76 130.25 48.13 Favored 'General case' 0 C--N 1.333 -0.14 0 CA-C-N 117.884 0.842 . . . . 0.0 110.066 176.65 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' D' D ' 45' ' ' GLU . . . . . . . . . . . . . 38.9 tp10 -85.53 130.33 34.6 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.4 -0.364 . . . . 0.0 110.777 -179.924 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' D' D ' 46' ' ' VAL . . . . . . . . . . . . . 7.2 p -121.61 129.46 75.5 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.235 0 N-CA-C 109.631 -0.507 . . . . 0.0 109.631 176.298 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' D' D ' 47' ' ' LYS . . . . . . . . . . . . . 98.5 mttt -101.03 130.44 47.03 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 115.892 -0.595 . . . . 0.0 111.119 178.387 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' D' D ' 48' ' ' PHE . . . . . . . . . . . . . 95.3 m-85 -113.41 131.83 55.85 Favored 'General case' 0 C--N 1.33 -0.244 0 N-CA-C 109.831 -0.433 . . . . 0.0 109.831 176.211 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' D' D ' 49' ' ' LYS . . . . . . . . . . . . . 81.8 tttt -110.5 139.11 46.05 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.402 -0.363 . . . . 0.0 110.63 179.454 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' D' D ' 50' ' ' VAL . . . . . 0.491 HG13 HD21 ' D' ' 4' ' ' LEU . 42.5 t -83.53 108.13 15.76 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.276 0 N-CA-C 109.4 -0.593 . . . . 0.0 109.4 175.59 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' D' D ' 51' ' ' VAL . . . . . . . . . . . . . 48.8 t -70.37 -48.26 61.36 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.314 0 CA-C-N 116.039 -0.528 . . . . 0.0 109.851 -173.816 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' D' D ' 52' ' ' GLN . . . . . 0.432 ' HA ' HG23 ' D' ' 33' ' ' THR . 14.0 pt20 -167.79 157.6 10.24 Favored 'General case' 0 C--N 1.331 -0.201 0 C-N-CA 120.115 -0.634 . . . . 0.0 112.017 -179.864 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' D' D ' 53' ' ' ALA . . . . . 0.656 ' HB3' ' OG ' ' D' ' 56' ' ' SER . . . -133.85 135.28 43.62 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 115.314 -0.857 . . . . 0.0 109.97 177.317 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' D' D ' 54' ' ' TYR . . . . . . . . . . . . . 13.8 t80 -129.01 111.69 18.47 Favored Pre-proline 0 CA--C 1.535 0.39 0 CA-C-O 118.24 -0.886 . . . . 0.0 110.133 179.163 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' D' D ' 55' ' ' PRO . . . . . . . . . . . . . 73.4 Cg_endo -77.12 170.21 72.21 Favored 'Cis proline' 0 N--CA 1.501 1.93 0 CA-C-N 121.899 1.714 . . . . 0.0 112.127 -7.587 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' D' D ' 56' ' ' SER . . . . . 0.656 ' OG ' ' HB3' ' D' ' 53' ' ' ALA . 66.0 m -129.71 140.64 39.23 Favored Pre-proline 0 CA--C 1.538 0.499 0 CA-C-O 118.71 -0.662 . . . . 0.0 109.489 174.52 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' D' D ' 57' ' ' PRO . . . . . . . . . . . . . 38.3 Cg_endo -68.05 156.31 87.46 Favored 'Cis proline' 0 N--CA 1.499 1.836 0 CA-C-N 121.559 1.592 . . . . 0.0 111.723 -2.018 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' D' D ' 58' ' ' LEU . . . . . . . . . . . . . 32.4 tp -128.75 138.86 52.34 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.252 -0.431 . . . . 0.0 110.778 -176.664 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' D' D ' 59' ' ' ARG . . . . . . . . . . . . . 60.1 ttt180 -100.48 120.36 39.88 Favored 'General case' 0 C--N 1.327 -0.4 0 N-CA-C 108.904 -0.776 . . . . 0.0 108.904 173.413 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' D' D ' 60' ' ' VAL . . . . . . . . . . . . . 43.3 t -72.63 126.38 33.12 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.252 0 C-N-CA 120.67 -0.412 . . . . 0.0 110.279 -174.084 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' D' D ' 61' ' ' GLU . . . . . . . . . . . . . 95.5 mt-10 -130.39 162.88 28.12 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 115.85 -0.613 . . . . 0.0 109.687 178.567 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' D' D ' 62' ' ' ASP . . . . . . . . . . . . . 5.2 t70 -53.34 -32.08 47.44 Favored 'General case' 0 C--N 1.328 -0.353 0 N-CA-C 111.782 0.29 . . . . 0.0 111.782 -179.638 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' D' D ' 63' ' ' ARG . . . . . . . . . . . . . 34.4 ptt180 -84.07 4.26 30.98 Favored 'General case' 0 CA--C 1.537 0.456 0 N-CA-C 113.779 1.029 . . . . 0.0 113.779 -174.926 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' D' D ' 64' ' ' THR . . . . . . . . . . . . . 35.4 m -86.93 139.61 30.45 Favored 'General case' 0 C--N 1.332 -0.186 0 CA-C-N 118.211 0.46 . . . . 0.0 110.713 -178.659 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' D' D ' 65' ' ' LYS . . . . . . . . . . . . . 67.5 mttm -90.14 134.05 34.51 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.252 -0.431 . . . . 0.0 110.581 -179.443 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' D' D ' 66' ' ' ILE . . . . . . . . . . . . . 58.8 mt -116.35 134.32 60.15 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.201 0 CA-C-O 120.897 0.379 . . . . 0.0 110.002 -179.719 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' D' D ' 67' ' ' THR . . . . . . . . . . . . . 34.6 m -125.31 141.46 52.07 Favored 'General case' 0 C--N 1.332 -0.17 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.92 -178.344 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' D' D ' 68' ' ' LEU . . . . . 0.426 ' C ' HD23 ' D' ' 68' ' ' LEU . 5.3 tt -105.93 124.03 48.92 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.002 -0.544 . . . . 0.0 110.128 178.468 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' D' D ' 69' ' ' VAL . . . . . 0.415 ' N ' HD23 ' D' ' 68' ' ' LEU . 44.4 t -102.82 140.3 21.49 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.24 0 CA-C-N 116.352 -0.385 . . . . 0.0 110.578 -177.237 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' D' D ' 70' ' ' THR . . . . . . . . . . . . . 11.2 p -140.83 -45.24 0.39 Allowed 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 116.265 -0.425 . . . . 0.0 110.964 178.846 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' D' D ' 71' ' ' HIS . . . . . . . . . . . . . 62.7 m80 -99.5 101.21 12.53 Favored Pre-proline 0 CA--C 1.534 0.348 0 CA-C-O 118.955 -0.545 . . . . 0.0 110.415 -177.977 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' D' D ' 72' ' ' PRO . . . . . . . . . . . . . 33.1 Cg_endo -64.82 -29.91 58.68 Favored 'Trans proline' 0 N--CA 1.5 1.87 0 C-N-CA 121.275 1.317 . . . . 0.0 112.407 -178.423 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' D' D ' 73' ' ' VAL . . . . . . . . . . . . . 27.7 m -75.21 -177.63 0.3 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.316 0 C-N-CA 120.948 -0.301 . . . . 0.0 110.468 178.651 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' D' D ' 74' ' ' ASP . . . . . . . . . . . . . 10.3 t0 -103.68 117.98 35.66 Favored 'General case' 0 C--N 1.33 -0.242 0 N-CA-C 109.796 -0.446 . . . . 0.0 109.796 179.821 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' D' D ' 75' ' ' VAL . . . . . . . . . . . . . 45.4 t -113.52 122.86 68.46 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.227 0 CA-C-O 121.173 0.511 . . . . 0.0 110.474 -178.756 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' D' D ' 76' ' ' LEU . . . . . . . . . . . . . 24.5 mt -122.71 138.04 54.73 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 115.398 -0.819 . . . . 0.0 109.035 176.451 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' D' D ' 77' ' ' GLU . . . . . . . . . . . . . 58.6 tt0 -136.84 135.34 37.83 Favored 'General case' 0 C--N 1.331 -0.197 0 CA-C-O 121.027 0.441 . . . . 0.0 110.995 -177.133 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' D' D ' 78' ' ' ALA . . . . . 0.576 ' HB2' HD21 ' D' ' 109' ' ' LEU . . . -122.47 137.67 54.8 Favored 'General case' 0 C--N 1.331 -0.203 0 CA-C-N 115.862 -0.608 . . . . 0.0 109.926 178.517 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' D' D ' 79' ' ' LYS . . . . . 0.59 ' O ' HD13 ' D' ' 80' ' ' ILE . 54.2 mtmt -81.97 120.41 25.21 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-O 120.884 0.374 . . . . 0.0 110.483 179.831 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' D' D ' 80' ' ' ILE . . . . . 0.59 HD13 ' O ' ' D' ' 79' ' ' LYS . 42.6 mm -138.99 112.55 6.76 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.344 0 N-CA-C 109.254 -0.647 . . . . 0.0 109.254 -177.423 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' D' D ' 81' ' ' LYS . . . . . . . . . . . . . 9.3 mtmp? -103.33 126.88 50.72 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-O 120.91 0.386 . . . . 0.0 111.259 -177.158 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' D' D ' 82' ' ' GLY . . . . . . . . . . . . . . . 89.18 42.06 5.68 Favored Glycine 0 CA--C 1.525 0.712 0 C-N-CA 120.989 -0.624 . . . . 0.0 111.645 174.795 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' D' D ' 83' ' ' ILE . . . . . . . . . . . . . 72.5 mt -69.92 134.71 29.65 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.331 0 N-CA-C 109.501 -0.555 . . . . 0.0 109.501 176.347 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' D' D ' 84' ' ' LYS . . . . . . . . . . . . . 35.7 ttpt -98.65 -54.11 3.12 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-O 121.057 0.456 . . . . 0.0 110.423 -178.811 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' D' D ' 85' ' ' ASP . . . . . . . . . . . . . 10.6 t70 -148.53 149.94 32.5 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 115.758 -0.656 . . . . 0.0 110.387 -178.168 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' D' D ' 86' ' ' VAL . . . . . . . . . . . . . 40.7 t -127.41 129.51 70.58 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.252 0 CA-C-O 120.813 0.339 . . . . 0.0 110.474 -178.906 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' D' D ' 87' ' ' ILE . . . . . . . . . . . . . 43.7 mm -119.49 130.87 73.48 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.255 0 CA-C-N 115.98 -0.554 . . . . 0.0 109.61 177.305 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' D' D ' 88' ' ' LEU . . . . . . . . . . . . . 19.3 tp -115.42 135.79 53.75 Favored 'General case' 0 C--N 1.331 -0.205 0 CA-C-O 120.952 0.406 . . . . 0.0 111.544 -175.797 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' D' D ' 89' ' ' ASP . . . . . . . . . . . . . 13.3 t70 -128.67 156.97 42.6 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-N 115.755 -0.657 . . . . 0.0 109.537 176.091 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' D' D ' 90' ' ' GLU . . . . . . . . . . . . . 70.8 mm-40 -46.96 -38.53 10.79 Favored 'General case' 0 N--CA 1.465 0.305 0 N-CA-C 113.035 0.754 . . . . 0.0 113.035 -171.102 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' D' D ' 91' ' ' ASN . . . . . . . . . . . . . 59.7 m-80 -131.97 20.0 4.54 Favored 'General case' 0 N--CA 1.467 0.413 0 N-CA-C 112.968 0.729 . . . . 0.0 112.968 -177.421 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' D' D ' 92' ' ' LEU . . . . . 0.408 HD21 HG21 ' D' ' 143' ' ' THR . 15.8 mt -147.04 143.93 28.73 Favored 'General case' 0 C--N 1.331 -0.213 0 N-CA-C 110.141 -0.318 . . . . 0.0 110.141 -176.654 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' D' D ' 93' ' ' ILE . . . . . . . . . . . . . 75.2 mt -123.55 119.5 57.44 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.285 0 N-CA-C 109.294 -0.632 . . . . 0.0 109.294 179.035 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' D' D ' 94' ' ' VAL . . . . . 0.475 HG21 HG11 ' D' ' 125' ' ' VAL . 46.5 t -118.35 125.09 74.04 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.208 0 CA-C-O 120.988 0.423 . . . . 0.0 109.912 -178.57 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' D' D ' 95' ' ' VAL . . . . . . . . . . . . . 47.0 t -118.72 131.98 69.91 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.344 0 CA-C-N 115.862 -0.608 . . . . 0.0 109.643 -179.564 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' D' D ' 96' ' ' ILE . . . . . . . . . . . . . 68.7 mt -112.61 126.79 70.04 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.328 0 N-CA-C 109.184 -0.672 . . . . 0.0 109.184 178.354 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' D' D ' 97' ' ' THR . . . . . . . . . . . . . 78.4 p -97.63 159.64 14.8 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-O 121.28 0.562 . . . . 0.0 111.214 -176.678 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' D' D ' 98' ' ' GLU . . . . . . . . . . . . . 85.4 tt0 -53.96 -27.48 31.5 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 115.906 -0.588 . . . . 0.0 112.202 -179.061 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' D' D ' 99' ' ' GLU . . . . . . . . . . . . . 95.2 mt-10 -82.32 15.4 2.47 Favored 'General case' 0 CA--C 1.535 0.403 0 N-CA-C 113.14 0.793 . . . . 0.0 113.14 -176.581 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' D' D ' 100' ' ' ASN . . . . . . . . . . . . . 4.1 m-20 62.2 35.63 15.41 Favored 'General case' 0 C--N 1.331 -0.212 0 CA-C-O 120.949 0.404 . . . . 0.0 111.441 179.675 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' D' D ' 101' ' ' GLU . . . . . . . . . . . . . 84.2 tt0 -109.04 143.83 37.84 Favored 'General case' 0 C--N 1.331 -0.203 0 N-CA-C 109.595 -0.521 . . . . 0.0 109.595 173.227 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' D' D ' 102' ' ' VAL . . . . . . . . . . . . . 43.0 t -114.94 125.24 72.21 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.292 0 CA-C-N 116.206 -0.452 . . . . 0.0 109.944 -177.399 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' D' D ' 103' ' ' LEU . . . . . . . . . . . . . 16.8 mt -116.13 130.18 56.68 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 115.877 -0.601 . . . . 0.0 110.256 177.532 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' D' D ' 104' ' ' ILE . . . . . . . . . . . . . 70.9 mt -116.98 121.94 68.92 Favored 'Isoleucine or valine' 0 C--O 1.235 0.299 0 N-CA-C 110.286 -0.265 . . . . 0.0 110.286 179.83 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' D' D ' 105' ' ' PHE . . . . . . . . . . . . . 86.7 m-85 -121.67 163.47 18.95 Favored 'General case' 0 CA--C 1.528 0.134 0 O-C-N 124.052 0.845 . . . . 0.0 109.885 179.0 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' D' D ' 106' ' ' ASN . . . . . . . . . . . . . 40.6 p-10 -96.72 -169.94 1.97 Allowed 'General case' 0 C--N 1.33 -0.274 0 N-CA-C 109.913 -0.403 . . . . 0.0 109.913 173.075 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' D' D ' 107' ' ' GLN . . . . . . . . . . . . . 34.3 tt0 -60.59 -30.09 69.6 Favored 'General case' 0 CA--C 1.532 0.269 0 C-N-CA 121.014 -0.275 . . . . 0.0 111.628 179.565 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' D' D ' 108' ' ' ASN . . . . . . . . . . . . . 4.0 t-20 -82.67 4.79 23.5 Favored 'General case' 0 CA--C 1.536 0.421 0 N-CA-C 113.355 0.872 . . . . 0.0 113.355 -178.454 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' D' D ' 109' ' ' LEU . . . . . 0.576 HD21 ' HB2' ' D' ' 78' ' ' ALA . 7.4 tp 63.87 36.69 10.13 Favored 'General case' 0 CA--C 1.53 0.185 0 O-C-N 122.13 -0.356 . . . . 0.0 111.467 177.492 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' D' D ' 110' ' ' GLU . . . . . . . . . . . . . 95.5 mt-10 -105.13 154.49 20.11 Favored 'General case' 0 C--N 1.331 -0.222 0 N-CA-C 109.887 -0.412 . . . . 0.0 109.887 176.401 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' D' D ' 111' ' ' GLU . . . . . . . . . . . . . 83.6 tt0 -80.46 124.87 29.29 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-O 120.952 0.406 . . . . 0.0 110.928 -176.506 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' D' D ' 112' ' ' LEU . . . . . . . . . . . . . 31.8 mt -111.89 -46.08 3.27 Favored 'General case' 0 C--N 1.331 -0.216 0 CA-C-N 115.995 -0.548 . . . . 0.0 110.511 178.355 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' D' D ' 113' ' ' TYR . . . . . . . . . . . . . 58.1 t80 -142.21 140.35 32.3 Favored 'General case' 0 C--N 1.328 -0.331 0 C-N-CA 120.792 -0.363 . . . . 0.0 111.242 -179.644 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' D' D ' 114' ' ' ARG . . . . . . . . . . . . . 33.6 ttp180 -136.82 126.48 25.4 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.202 -0.454 . . . . 0.0 110.419 176.975 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' D' D ' 115' ' ' GLY . . . . . . . . . . . . . . . -150.05 158.93 27.89 Favored Glycine 0 CA--C 1.524 0.636 0 N-CA-C 110.78 -0.928 . . . . 0.0 110.78 178.164 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' D' D ' 116' ' ' LYS . . . . . . . . . . . . . 79.3 tttt -136.02 131.75 35.38 Favored 'General case' 0 C--N 1.328 -0.331 0 N-CA-C 109.925 -0.398 . . . . 0.0 109.925 178.879 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' D' D ' 117' ' ' PHE . . . . . . . . . . . . . 32.4 m-85 -132.72 117.56 18.0 Favored 'General case' 0 N--CA 1.463 0.214 0 CA-C-O 120.929 0.395 . . . . 0.0 110.599 -173.72 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' D' D ' 118' ' ' GLU . . . . . . . . . . . . . 46.5 tp10 -52.88 -50.96 62.79 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.296 -0.411 . . . . 0.0 111.393 -177.577 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' D' D ' 119' ' ' ASN . . . . . . . . . . . . . 79.4 m-20 -93.61 31.07 1.62 Allowed 'General case' 0 C--N 1.33 -0.27 0 N-CA-C 112.202 0.445 . . . . 0.0 112.202 -173.783 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' D' D ' 120' ' ' LEU . . . . . . . . . . . . . 20.2 tp -58.36 124.58 20.01 Favored 'General case' 0 C--N 1.332 -0.195 0 N-CA-C 110.075 -0.343 . . . . 0.0 110.075 177.474 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' D' D ' 121' ' ' ASN . . . . . . . . . . . . . 4.4 m-20 -114.03 -44.09 3.18 Favored 'General case' 0 C--N 1.331 -0.213 0 CA-C-N 116.56 -0.291 . . . . 0.0 110.963 -178.143 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' D' D ' 122' ' ' LYS . . . . . . . . . . . . . 85.1 mttt -146.45 149.98 34.74 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-O 121.156 0.503 . . . . 0.0 111.902 -176.414 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' D' D ' 123' ' ' VAL . . . . . 0.433 ' C ' HD12 ' D' ' 124' ' ' LEU . 44.1 t -124.91 128.88 73.47 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.299 0 N-CA-C 109.211 -0.663 . . . . 0.0 109.211 172.873 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' D' D ' 124' ' ' LEU . . . . . 0.433 HD12 ' C ' ' D' ' 123' ' ' VAL . 6.6 mp -121.89 135.96 54.91 Favored 'General case' 0 C--N 1.332 -0.176 0 CA-C-N 116.609 -0.269 . . . . 0.0 110.732 -176.273 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' D' D ' 125' ' ' VAL . . . . . 0.475 HG11 HG21 ' D' ' 94' ' ' VAL . 35.5 m -136.72 130.21 45.96 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.193 0 CA-C-O 120.955 0.407 . . . . 0.0 110.983 178.734 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' D' D ' 126' ' ' ARG . . . . . . . . . . . . . 95.2 mtt180 -151.69 130.19 12.19 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 115.911 -0.586 . . . . 0.0 109.802 176.901 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' D' D ' 127' ' ' ASN . . . . . . . . . . . . . 4.1 m120 56.6 -152.38 0.39 Allowed 'General case' 0 CA--C 1.539 0.536 0 N-CA-C 109.764 -0.458 . . . . 0.0 109.764 179.68 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' D' D ' 128' ' ' ASP . . . . . . . . . . . . . 15.4 p-10 -80.47 14.59 1.96 Allowed 'General case' 0 CA--C 1.536 0.423 0 N-CA-C 112.876 0.695 . . . . 0.0 112.876 178.662 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' D' D ' 129' ' ' LEU . . . . . 0.541 HD13 ' NE ' ' D' ' 142' ' ' ARG . 11.6 tp -114.17 132.63 56.02 Favored 'General case' 0 N--CA 1.46 0.045 0 CA-C-N 118.09 0.404 . . . . 0.0 109.911 179.049 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' D' D ' 130' ' ' VAL . . . . . 0.404 HG23 ' HB ' ' D' ' 141' ' ' ILE . 34.5 m -132.07 142.39 42.97 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.193 0 CA-C-O 121.086 0.469 . . . . 0.0 110.157 176.763 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' D' D ' 131' ' ' VAL . . . . . . . . . . . . . 34.4 m -136.14 148.79 27.41 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 CA-C-O 121.191 0.519 . . . . 0.0 111.21 -179.255 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' D' D ' 132' ' ' ILE . . . . . . . . . . . . . 75.2 mt -115.44 130.66 69.65 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.383 0 CA-C-N 115.4 -0.818 . . . . 0.0 109.024 178.307 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' D' D ' 133' ' ' ILE . . . . . . . . . . . . . 42.3 mm -115.27 115.2 48.66 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.197 0 CA-C-O 120.884 0.373 . . . . 0.0 110.753 -175.993 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' D' D ' 134' ' ' ASP . . . . . . . . . . . . . 6.1 p-10 -125.88 145.51 50.22 Favored 'General case' 0 C--N 1.333 -0.12 0 N-CA-C 109.371 -0.603 . . . . 0.0 109.371 174.95 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' D' D ' 135' ' ' GLU . . . . . . . . . . . . . 46.2 tp10 -49.75 -26.58 3.98 Favored 'General case' 0 C--N 1.327 -0.388 0 N-CA-C 112.761 0.652 . . . . 0.0 112.761 -169.318 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' D' D ' 136' ' ' GLN . . . . . . . . . . . . . 99.1 mm-40 -92.95 -39.74 10.97 Favored 'General case' 0 C--N 1.332 -0.179 0 N-CA-C 112.293 0.479 . . . . 0.0 112.293 -177.126 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' D' D ' 137' ' ' LYS . . . . . . . . . . . . . 28.0 mtpp -137.99 155.02 49.28 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-O 121.277 0.56 . . . . 0.0 111.698 -170.015 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' D' D ' 138' ' ' LEU . . . . . . . . . . . . . 5.3 tt -116.06 125.34 52.29 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 115.547 -0.752 . . . . 0.0 109.286 174.407 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' D' D ' 139' ' ' THR . . . . . . . . . . . . . 39.9 m -110.67 129.65 55.77 Favored 'General case' 0 C--N 1.332 -0.183 0 CA-C-N 116.406 -0.361 . . . . 0.0 110.993 -177.6 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' D' D ' 140' ' ' LEU . . . . . 0.469 ' C ' HD23 ' D' ' 140' ' ' LEU . 6.5 tt -111.17 123.59 50.5 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 115.499 -0.773 . . . . 0.0 109.322 -179.502 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' D' D ' 141' ' ' ILE . . . . . 0.415 ' N ' HD23 ' D' ' 140' ' ' LEU . 18.8 mt -125.36 118.38 52.4 Favored 'Isoleucine or valine' 0 C--O 1.234 0.255 0 CA-C-O 120.964 0.411 . . . . 0.0 110.404 -177.199 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' D' D ' 142' ' ' ARG . . . . . 0.541 ' NE ' HD13 ' D' ' 129' ' ' LEU . 15.9 mmt180 -102.91 122.75 45.19 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 115.425 -0.807 . . . . 0.0 109.777 175.079 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' D' D ' 143' ' ' THR . . . . . 0.408 HG21 HD21 ' D' ' 92' ' ' LEU . 2.5 p . . . . . 0 C--O 1.22 -0.487 0 CA-C-O 117.983 -1.008 . . . . 0.0 110.568 179.898 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' E' E ' -3' ' ' GLU . . . . . . . . . . . . . 95.8 mt-10 . . . . . 0 N--CA 1.489 1.52 0 N-CA-C 109.366 -0.605 . . . . 0.0 109.366 . . . . . . . . . 0 0 . 1 . 018 nuclear build full ' E' E ' -2' ' ' GLY . . . . . . . . . . . . . . . -70.42 150.03 47.83 Favored Glycine 0 CA--C 1.526 0.719 0 N-CA-C 111.001 -0.84 . . . . 0.0 111.001 179.524 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' E' E ' -1' ' ' VAL . . . . . . . . . . . . . 48.1 t -94.91 138.91 19.7 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.29 0 N-CA-C 110.008 -0.367 . . . . 0.0 110.008 -179.897 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' E' E ' 0' ' ' ILE . . . . . . . . . . . . . 69.7 mt -106.33 140.78 23.34 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.23 0 CA-C-O 121.048 0.451 . . . . 0.0 110.276 -178.465 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' E' E ' 1' ' ' MET . . . . . . . . . . . . . 25.9 ptt? -78.34 135.35 37.46 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 115.804 -0.634 . . . . 0.0 111.083 -178.844 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' E' E ' 2' ' ' SER . . . . . . . . . . . . . 3.9 p -127.32 136.38 51.85 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.141 -0.481 . . . . 0.0 110.287 178.305 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' E' E ' 3' ' ' GLU . . . . . . . . . . . . . 30.4 tp10 -139.14 139.75 37.71 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.244 -0.435 . . . . 0.0 110.79 -176.215 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' E' E ' 4' ' ' LEU . . . . . . . . . . . . . 18.1 tp -126.01 130.79 51.88 Favored 'General case' 0 C--N 1.332 -0.184 0 N-CA-C 109.881 -0.415 . . . . 0.0 109.881 174.809 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' E' E ' 5' ' ' LYS . . . . . . . . . . . . . 99.3 mttt -116.33 123.98 48.99 Favored 'General case' 0 C--O 1.235 0.297 0 CA-C-O 120.734 0.302 . . . . 0.0 111.192 -178.236 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' E' E ' 6' ' ' LEU . . . . . 0.404 HD23 ' HA ' ' E' ' 50' ' ' VAL . 50.8 mt -113.98 147.11 39.14 Favored 'General case' 0 N--CA 1.461 0.117 0 CA-C-N 115.437 -0.801 . . . . 0.0 110.272 178.837 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' E' E ' 7' ' ' LYS . . . . . . . . . . . . . 82.2 tttt -129.37 141.02 40.36 Favored Pre-proline 0 CA--C 1.533 0.302 0 CA-C-O 119.137 -0.459 . . . . 0.0 109.883 175.031 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' E' E ' 8' ' ' PRO . . . . . . . . . . . . . 90.0 Cg_endo -91.84 146.17 3.13 Favored 'Trans proline' 0 N--CA 1.49 1.272 0 C-N-CA 121.916 1.744 . . . . 0.0 112.163 179.392 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' E' E ' 9' ' ' LEU . . . . . . . . . . . . . 37.1 mt -86.79 -49.23 0.48 Allowed Pre-proline 0 CA--C 1.535 0.376 0 CA-C-O 118.682 -0.675 . . . . 0.0 112.562 178.818 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' E' E ' 10' ' ' PRO . . . . . . . . . . . . . 97.2 Cg_endo -77.93 161.65 29.87 Favored 'Trans proline' 0 N--CA 1.497 1.725 0 C-N-CA 121.256 1.304 . . . . 0.0 112.444 -179.665 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' E' E ' 11' ' ' LYS . . . . . . . . . . . . . 25.1 tptp -86.93 95.44 9.9 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-N 116.231 -0.441 . . . . 0.0 110.085 177.536 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' E' E ' 12' ' ' VAL . . . . . . . . . . . . . 12.5 p -142.18 147.63 21.2 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 CA-C-N 116.313 -0.403 . . . . 0.0 110.838 -179.008 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' E' E ' 13' ' ' GLU . . . . . . . . . . . . . 95.9 mt-10 -93.81 122.6 36.45 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.029 -0.532 . . . . 0.0 110.128 177.507 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' E' E ' 14' ' ' LEU . . . . . . . . . . . . . 22.3 mt -97.65 151.26 37.51 Favored Pre-proline 0 CA--C 1.533 0.301 0 CA-C-O 119.329 -0.367 . . . . 0.0 110.464 -178.714 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' E' E ' 15' ' ' PRO . . . . . . . . . . . . . 37.8 Cg_exo -59.46 156.06 38.25 Favored 'Trans proline' 0 N--CA 1.498 1.775 0 C-N-CA 121.241 1.294 . . . . 0.0 111.835 178.391 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' E' E ' 16' ' ' PRO . . . . . . . . . . . . . 31.4 Cg_exo -56.83 -38.99 94.57 Favored 'Trans proline' 0 N--CA 1.497 1.711 0 C-N-CA 121.333 1.355 . . . . 0.0 112.475 -179.856 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' E' E ' 17' ' ' ASP . . . . . . . . . . . . . 23.1 p-10 -93.48 20.18 7.56 Favored 'General case' 0 C--N 1.329 -0.324 0 N-CA-C 112.665 0.617 . . . . 0.0 112.665 -178.242 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' E' E ' 18' ' ' PHE . . . . . 0.53 ' CZ ' HD11 ' E' ' 22' ' ' ILE . 62.5 t80 -57.11 -41.6 79.28 Favored 'General case' 0 C--O 1.227 -0.101 0 O-C-N 122.051 -0.405 . . . . 0.0 110.308 -178.329 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' E' E ' 19' ' ' VAL . . . . . . . . . . . . . 52.2 t -54.91 -45.82 75.84 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.289 0 CA-C-N 116.396 -0.365 . . . . 0.0 110.815 -178.912 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' E' E ' 20' ' ' ASP . . . . . . . . . . . . . 80.8 m-20 -60.28 -41.4 93.25 Favored 'General case' 0 C--N 1.331 -0.222 0 C-N-CA 120.905 -0.318 . . . . 0.0 110.886 -178.165 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' E' E ' 21' ' ' VAL . . . . . . . . . . . . . 47.9 t -63.92 -47.15 91.89 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.306 0 C-N-CA 120.736 -0.386 . . . . 0.0 110.398 -177.931 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' E' E ' 22' ' ' ILE . . . . . 0.615 HG22 HD12 ' E' ' 26' ' ' LEU . 51.3 mm -57.18 -43.83 82.4 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.197 0 C-N-CA 120.856 -0.338 . . . . 0.0 110.529 179.158 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' E' E ' 23' ' ' ARG . . . . . . . . . . . . . 28.7 ttp180 -54.56 -48.24 72.3 Favored 'General case' 0 C--N 1.331 -0.201 0 C-N-CA 121.082 -0.247 . . . . 0.0 111.286 -179.472 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' E' E ' 24' ' ' ILE . . . . . . . . . . . . . 72.9 mt -58.52 -44.44 89.18 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.377 0 C-N-CA 120.959 -0.297 . . . . 0.0 110.708 -177.92 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' E' E ' 25' ' ' LYS . . . . . . . . . . . . . 24.5 mtpp -64.68 -44.01 91.71 Favored 'General case' 0 C--N 1.329 -0.291 0 N-CA-C 112.456 0.539 . . . . 0.0 112.456 -178.046 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' E' E ' 26' ' ' LEU . . . . . 0.615 HD12 HG22 ' E' ' 22' ' ' ILE . 79.1 mt -84.03 -25.29 30.02 Favored 'General case' 0 C--N 1.329 -0.289 0 N-CA-C 113.388 0.884 . . . . 0.0 113.388 -171.667 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' E' E ' 27' ' ' GLN . . . . . . . . . . . . . 6.1 pt20 -46.13 135.84 7.32 Favored 'General case' 0 N--CA 1.467 0.416 0 N-CA-C 112.757 0.651 . . . . 0.0 112.757 -174.41 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' E' E ' 28' ' ' GLY . . . . . . . . . . . . . . . 98.86 -22.3 41.67 Favored Glycine 0 CA--C 1.535 1.291 0 CA-C-N 115.792 -0.64 . . . . 0.0 112.516 -177.474 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' E' E ' 29' ' ' LYS . . . . . . . . . . . . . 8.2 mtpm? -97.53 155.08 17.11 Favored 'General case' 0 C--N 1.331 -0.2 0 CA-C-N 117.474 0.637 . . . . 0.0 110.925 179.523 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' E' E ' 30' ' ' THR . . . . . . . . . . . . . 22.3 m -109.77 139.27 45.02 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.337 177.115 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' E' E ' 31' ' ' VAL . . . . . . . . . . . . . 35.1 m -128.35 157.7 40.67 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.266 0 CA-C-N 116.254 -0.43 . . . . 0.0 110.505 -179.528 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' E' E ' 32' ' ' ARG . . . . . . . . . . . . . 53.0 ttp180 -132.21 150.92 52.04 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-O 121.198 0.523 . . . . 0.0 110.579 179.139 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' E' E ' 33' ' ' THR . . . . . . . . . . . . . 27.6 m -52.81 138.88 28.37 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.264 -0.425 . . . . 0.0 111.471 -177.812 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' E' E ' 34' ' ' GLY . . . . . . . . . . . . . . . 99.36 -17.23 58.1 Favored Glycine 0 CA--C 1.532 1.142 0 CA-C-N 116.151 -0.477 . . . . 0.0 113.2 179.087 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' E' E ' 35' ' ' ASP . . . . . . . . . . . . . 78.7 m-20 -67.46 149.39 50.27 Favored 'General case' 0 C--N 1.334 -0.085 0 CA-C-N 118.059 0.929 . . . . 0.0 111.204 178.539 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' E' E ' 36' ' ' VAL . . . . . . . . . . . . . 43.4 t -119.27 129.1 75.69 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.216 0 CA-C-N 115.945 -0.57 . . . . 0.0 109.582 176.785 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' E' E ' 37' ' ' ILE . . . . . . . . . . . . . 64.3 mt -118.19 138.35 49.19 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 CA-C-N 116.178 -0.464 . . . . 0.0 109.76 -178.967 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' E' E ' 38' ' ' GLY . . . . . . . . . . . . . . . -116.51 127.64 7.57 Favored Glycine 0 CA--C 1.523 0.567 0 N-CA-C 110.88 -0.888 . . . . 0.0 110.88 179.097 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' E' E ' 39' ' ' ILE . . . . . . . . . . . . . 72.0 mt -127.22 126.78 68.49 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.214 0 N-CA-C 110.136 -0.32 . . . . 0.0 110.136 179.135 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' E' E ' 40' ' ' SER . . . . . . . . . . . . . 53.8 p -92.52 122.41 34.93 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.374 -0.375 . . . . 0.0 110.826 176.632 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' E' E ' 41' ' ' ILE . . . . . . . . . . . . . 70.6 mt -132.22 130.55 60.64 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.228 0 CA-C-O 120.808 0.337 . . . . 0.0 110.22 177.502 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' E' E ' 42' ' ' LEU . . . . . . . . . . . . . 64.7 mt 56.87 32.94 22.32 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 116.144 -0.48 . . . . 0.0 111.959 178.176 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' E' E ' 43' ' ' GLY . . . . . . . . . . . . . . . 72.95 23.69 77.39 Favored Glycine 0 CA--C 1.531 1.039 0 C-N-CA 121.067 -0.587 . . . . 0.0 112.71 177.717 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' E' E ' 44' ' ' LYS . . . . . . . . . . . . . 99.4 mttt -138.66 128.65 25.34 Favored 'General case' 0 C--N 1.331 -0.206 0 CA-C-N 117.404 0.602 . . . . 0.0 109.861 178.051 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' E' E ' 45' ' ' GLU . . . . . . . . . . . . . 44.0 tp10 -85.55 132.36 34.2 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.42 -0.354 . . . . 0.0 111.539 -176.835 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' E' E ' 46' ' ' VAL . . . . . . . . . . . . . 8.8 p -121.92 127.93 75.52 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.186 0 N-CA-C 109.343 -0.614 . . . . 0.0 109.343 172.81 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' E' E ' 47' ' ' LYS . . . . . . . . . . . . . 55.4 mtmt -98.42 127.21 44.25 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.142 -0.481 . . . . 0.0 110.833 177.781 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' E' E ' 48' ' ' PHE . . . . . . . . . . . . . 43.0 m-85 -114.21 131.9 56.3 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 115.925 -0.58 . . . . 0.0 109.683 177.333 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' E' E ' 49' ' ' LYS . . . . . . . . . . . . . 75.8 tttt -105.81 134.81 48.33 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 116.417 -0.356 . . . . 0.0 110.102 178.483 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' E' E ' 50' ' ' VAL . . . . . 0.404 ' HA ' HD23 ' E' ' 6' ' ' LEU . 45.8 t -78.7 107.15 10.64 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.339 0 N-CA-C 109.245 -0.65 . . . . 0.0 109.245 177.752 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' E' E ' 51' ' ' VAL . . . . . . . . . . . . . 48.4 t -73.56 -51.11 26.43 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.316 0 CA-C-N 116.152 -0.476 . . . . 0.0 109.769 -174.567 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' E' E ' 52' ' ' GLN . . . . . . . . . . . . . 90.4 mt-30 -152.77 149.61 28.53 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-O 121.249 0.547 . . . . 0.0 111.963 -177.803 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' E' E ' 53' ' ' ALA . . . . . . . . . . . . . . . -130.46 130.63 44.48 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 114.978 -1.01 . . . . 0.0 109.243 173.143 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' E' E ' 54' ' ' TYR . . . . . . . . . . . . . 6.9 t80 -129.14 109.33 18.03 Favored Pre-proline 0 CA--C 1.534 0.361 0 CA-C-O 118.203 -0.903 . . . . 0.0 110.138 179.011 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' E' E ' 55' ' ' PRO . . . . . . . . . . . . . 74.1 Cg_endo -77.07 170.08 72.61 Favored 'Cis proline' 0 N--CA 1.5 1.895 0 CA-C-N 122.012 1.754 . . . . 0.0 112.593 -4.795 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' E' E ' 56' ' ' SER . . . . . . . . . . . . . 13.6 m -116.39 132.67 23.2 Favored Pre-proline 0 CA--C 1.539 0.546 0 CA-C-O 118.359 -0.829 . . . . 0.0 109.579 176.058 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' E' E ' 57' ' ' PRO . . . . . . . . . . . . . 48.3 Cg_endo -70.57 165.34 79.21 Favored 'Cis proline' 0 N--CA 1.496 1.663 0 CA-C-N 121.975 1.741 . . . . 0.0 111.536 -2.572 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' E' E ' 58' ' ' LEU . . . . . . . . . . . . . 22.5 tp -129.9 138.19 50.79 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.2 -0.455 . . . . 0.0 110.273 -179.563 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' E' E ' 59' ' ' ARG . . . . . . . . . . . . . 53.9 ttp180 -105.83 136.24 45.83 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-N 115.924 -0.58 . . . . 0.0 109.463 176.684 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' E' E ' 60' ' ' VAL . . . . . . . . . . . . . 39.9 t -89.62 116.34 30.88 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.264 0 CA-C-O 121.04 0.448 . . . . 0.0 110.638 -175.172 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' E' E ' 61' ' ' GLU . . . . . . . . . . . . . 95.6 mt-10 -131.05 173.28 11.16 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 115.552 -0.749 . . . . 0.0 109.455 175.501 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' E' E ' 62' ' ' ASP . . . . . . . . . . . . . 58.8 m-20 -53.72 -33.96 57.33 Favored 'General case' 0 C--N 1.328 -0.347 0 N-CA-C 111.778 0.288 . . . . 0.0 111.778 -178.821 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' E' E ' 63' ' ' ARG . . . . . . . . . . . . . 26.2 mmm180 -76.57 -17.81 59.01 Favored 'General case' 0 CA--C 1.533 0.317 0 N-CA-C 113.224 0.824 . . . . 0.0 113.224 -176.28 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' E' E ' 64' ' ' THR . . . . . . . . . . . . . 19.0 m -68.95 136.16 52.11 Favored 'General case' 0 C--N 1.331 -0.208 0 CA-C-O 120.896 0.379 . . . . 0.0 110.707 -174.919 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' E' E ' 65' ' ' LYS . . . . . . . . . . . . . 43.4 mtpt -90.06 122.33 32.95 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.098 -0.501 . . . . 0.0 109.9 179.946 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' E' E ' 66' ' ' ILE . . . . . . . . . . . . . 62.3 mt -113.83 131.95 64.23 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.234 0 CA-C-O 120.896 0.379 . . . . 0.0 110.35 -176.975 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' E' E ' 67' ' ' THR . . . . . . . . . . . . . 41.4 m -126.84 139.42 53.1 Favored 'General case' 0 C--O 1.234 0.24 0 CA-C-N 115.923 -0.58 . . . . 0.0 110.59 179.137 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' E' E ' 68' ' ' LEU . . . . . 0.429 ' C ' HD23 ' E' ' 68' ' ' LEU . 5.4 tt -107.05 124.25 49.38 Favored 'General case' 0 C--N 1.327 -0.397 0 CA-C-N 115.787 -0.642 . . . . 0.0 109.894 177.461 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' E' E ' 69' ' ' VAL . . . . . 0.406 ' N ' HD23 ' E' ' 68' ' ' LEU . 44.2 t -99.95 129.46 50.57 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.379 0 N-CA-C 109.644 -0.502 . . . . 0.0 109.644 -179.251 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' E' E ' 70' ' ' THR . . . . . 0.486 HG23 ' O ' ' E' ' 70' ' ' THR . 7.5 t -145.71 115.92 7.47 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-O 121.191 0.519 . . . . 0.0 111.167 -178.76 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' E' E ' 71' ' ' HIS . . . . . . . . . . . . . 17.4 t-80 -144.8 66.27 13.04 Favored Pre-proline 0 CA--C 1.534 0.363 0 CA-C-N 115.886 -0.597 . . . . 0.0 110.205 176.063 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' E' E ' 72' ' ' PRO . . . . . . . . . . . . . 73.5 Cg_endo -94.6 158.06 1.93 Allowed 'Trans proline' 0 N--CA 1.487 1.131 0 C-N-CA 122.154 1.902 . . . . 0.0 112.516 -178.724 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' E' E ' 73' ' ' VAL . . . . . . . . . . . . . 35.1 m -70.04 156.54 7.09 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.302 0 CA-C-N 116.1 -0.5 . . . . 0.0 109.882 176.487 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' E' E ' 74' ' ' ASP . . . . . . . . . . . . . 19.5 t0 -95.41 115.05 26.89 Favored 'General case' 0 C--N 1.332 -0.191 0 N-CA-C 109.764 -0.458 . . . . 0.0 109.764 -178.493 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' E' E ' 75' ' ' VAL . . . . . 0.452 ' C ' HD12 ' E' ' 76' ' ' LEU . 38.4 t -118.6 126.39 75.14 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.218 0 CA-C-O 121.0 0.428 . . . . 0.0 110.655 -176.547 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' E' E ' 76' ' ' LEU . . . . . 0.452 HD12 ' C ' ' E' ' 75' ' ' VAL . 5.8 mp -127.32 147.48 50.25 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 115.646 -0.707 . . . . 0.0 109.863 177.125 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' E' E ' 77' ' ' GLU . . . . . . . . . . . . . 96.3 mt-10 -134.21 133.33 40.77 Favored 'General case' 0 C--N 1.332 -0.19 0 CA-C-O 121.078 0.466 . . . . 0.0 111.27 -178.748 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' E' E ' 78' ' ' ALA . . . . . 0.441 ' HB2' HD21 ' E' ' 109' ' ' LEU . . . -122.3 141.29 51.68 Favored 'General case' 0 C--N 1.331 -0.221 0 CA-C-N 115.7 -0.682 . . . . 0.0 109.739 176.347 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' E' E ' 79' ' ' LYS . . . . . 0.588 ' O ' HD13 ' E' ' 80' ' ' ILE . 82.3 tttt -84.5 117.51 23.73 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-O 120.889 0.376 . . . . 0.0 110.641 -178.262 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' E' E ' 80' ' ' ILE . . . . . 0.588 HD13 ' O ' ' E' ' 79' ' ' LYS . 42.9 mm -137.95 110.74 7.15 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.381 0 N-CA-C 108.953 -0.758 . . . . 0.0 108.953 -178.858 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' E' E ' 81' ' ' LYS . . . . . . . . . . . . . 55.3 pttt -100.18 125.91 46.38 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-O 120.895 0.378 . . . . 0.0 111.336 -176.589 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' E' E ' 82' ' ' GLY . . . . . . . . . . . . . . . 87.85 42.17 6.11 Favored Glycine 0 CA--C 1.525 0.683 0 C-N-CA 120.825 -0.702 . . . . 0.0 111.714 175.072 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' E' E ' 83' ' ' ILE . . . . . . . . . . . . . 73.4 mt -66.77 127.35 28.07 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.271 0 N-CA-C 109.508 -0.552 . . . . 0.0 109.508 177.548 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' E' E ' 84' ' ' LYS . . . . . . . . . . . . . 59.8 tttt -82.58 -48.44 10.97 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 115.928 -0.578 . . . . 0.0 110.145 -178.25 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' E' E ' 85' ' ' ASP . . . . . . . . . . . . . 33.2 t0 -163.94 159.03 20.4 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 115.851 -0.613 . . . . 0.0 110.653 179.022 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' E' E ' 86' ' ' VAL . . . . . 0.446 ' O ' HD13 ' E' ' 87' ' ' ILE . 43.2 t -129.33 136.25 59.86 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.27 0 CA-C-O 121.031 0.443 . . . . 0.0 110.55 -179.606 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' E' E ' 87' ' ' ILE . . . . . 0.446 HD13 ' O ' ' E' ' 86' ' ' VAL . 44.0 mm -123.18 128.55 75.01 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.227 0 CA-C-N 115.821 -0.627 . . . . 0.0 109.685 176.605 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' E' E ' 88' ' ' LEU . . . . . . . . . . . . . 17.4 tp -111.89 133.84 53.83 Favored 'General case' 0 N--CA 1.464 0.227 0 CA-C-O 121.052 0.453 . . . . 0.0 111.43 -175.539 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' E' E ' 89' ' ' ASP . . . . . . . . . . . . . 13.8 t70 -125.66 157.49 37.13 Favored 'General case' 0 C--N 1.331 -0.222 0 CA-C-N 115.688 -0.687 . . . . 0.0 109.679 176.252 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' E' E ' 90' ' ' GLU . . . . . . . . . . . . . 84.1 tt0 -45.56 -42.71 11.31 Favored 'General case' 0 N--CA 1.465 0.314 0 N-CA-C 113.087 0.773 . . . . 0.0 113.087 -171.632 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' E' E ' 91' ' ' ASN . . . . . . . . . . . . . 3.3 t-20 -132.16 25.78 4.55 Favored 'General case' 0 N--CA 1.468 0.446 0 N-CA-C 112.464 0.542 . . . . 0.0 112.464 -178.703 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' E' E ' 92' ' ' LEU . . . . . . . . . . . . . 28.5 mt -149.34 145.22 26.9 Favored 'General case' 0 C--N 1.331 -0.213 0 CA-C-O 120.721 0.296 . . . . 0.0 110.202 -177.376 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' E' E ' 93' ' ' ILE . . . . . . . . . . . . . 66.0 mt -123.71 121.12 61.64 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.292 0 N-CA-C 109.327 -0.62 . . . . 0.0 109.327 178.798 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' E' E ' 94' ' ' VAL . . . . . . . . . . . . . 46.8 t -117.52 126.67 74.82 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.282 0 N-CA-C 109.655 -0.498 . . . . 0.0 109.655 179.956 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' E' E ' 95' ' ' VAL . . . . . . . . . . . . . 38.8 t -121.47 134.15 65.73 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.331 0 CA-C-N 116.102 -0.499 . . . . 0.0 109.731 -178.872 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' E' E ' 96' ' ' ILE . . . . . 0.581 HD11 ' HB ' ' E' ' 123' ' ' VAL . 65.3 mt -113.81 127.07 71.36 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.33 0 N-CA-C 109.267 -0.642 . . . . 0.0 109.267 178.674 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' E' E ' 97' ' ' THR . . . . . . . . . . . . . 68.5 p -98.09 152.38 19.38 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-O 121.108 0.48 . . . . 0.0 111.102 -178.311 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' E' E ' 98' ' ' GLU . . . . . . . . . . . . . 85.0 tt0 -53.95 -23.44 13.08 Favored 'General case' 0 CA--C 1.535 0.377 0 N-CA-C 112.313 0.486 . . . . 0.0 112.313 179.738 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' E' E ' 99' ' ' GLU . . . . . . . . . . . . . 36.6 tt0 -80.94 18.08 1.08 Allowed 'General case' 0 CA--C 1.54 0.571 0 N-CA-C 112.5 0.556 . . . . 0.0 112.5 -177.012 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' E' E ' 100' ' ' ASN . . . . . . . . . . . . . 2.5 m-20 61.54 37.92 16.02 Favored 'General case' 0 CA--C 1.53 0.206 0 O-C-N 121.869 -0.519 . . . . 0.0 110.997 178.365 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' E' E ' 101' ' ' GLU . . . . . . . . . . . . . 85.1 tt0 -119.71 140.71 50.25 Favored 'General case' 0 C--N 1.332 -0.19 0 CA-C-N 116.099 -0.5 . . . . 0.0 109.66 176.703 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' E' E ' 102' ' ' VAL . . . . . . . . . . . . . 41.7 t -115.58 127.86 73.01 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.257 0 N-CA-C 109.732 -0.47 . . . . 0.0 109.732 -177.581 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' E' E ' 103' ' ' LEU . . . . . . . . . . . . . 5.0 mp -124.1 137.94 54.5 Favored 'General case' 0 C--N 1.331 -0.216 0 CA-C-N 116.33 -0.396 . . . . 0.0 110.607 177.506 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' E' E ' 104' ' ' ILE . . . . . . . . . . . . . 64.3 mt -117.63 126.3 74.63 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.274 0 CA-C-N 115.892 -0.594 . . . . 0.0 109.927 -178.893 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' E' E ' 105' ' ' PHE . . . . . . . . . . . . . 98.9 m-85 -120.86 161.35 21.69 Favored 'General case' 0 C--N 1.332 -0.18 0 O-C-N 124.046 0.841 . . . . 0.0 110.275 -179.008 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' E' E ' 106' ' ' ASN . . . . . . . . . . . . . 43.6 p-10 -99.0 -169.8 1.83 Allowed 'General case' 0 CA--C 1.532 0.284 0 CA-C-N 116.351 -0.386 . . . . 0.0 110.123 175.128 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' E' E ' 107' ' ' GLN . . . . . . . . . . . . . 11.9 tt0 -56.33 -30.05 62.1 Favored 'General case' 0 C--N 1.329 -0.303 0 N-CA-C 111.811 0.3 . . . . 0.0 111.811 179.732 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' E' E ' 108' ' ' ASN . . . . . . . . . . . . . 4.8 t-20 -90.72 14.1 14.36 Favored 'General case' 0 CA--C 1.535 0.396 0 N-CA-C 113.197 0.814 . . . . 0.0 113.197 -175.889 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' E' E ' 109' ' ' LEU . . . . . 0.441 HD21 ' HB2' ' E' ' 78' ' ' ALA . 11.0 tp 54.88 36.0 25.64 Favored 'General case' 0 C--N 1.332 -0.191 0 CA-C-O 120.829 0.347 . . . . 0.0 111.506 178.501 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' E' E ' 110' ' ' GLU . . . . . . . . . . . . . 70.6 mm-40 -101.29 151.33 22.02 Favored 'General case' 0 C--N 1.33 -0.271 0 N-CA-C 109.808 -0.442 . . . . 0.0 109.808 176.514 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' E' E ' 111' ' ' GLU . . . . . . . . . . . . . 44.0 tp10 -78.52 122.03 25.35 Favored 'General case' 0 C--N 1.329 -0.296 0 C-N-CA 120.698 -0.401 . . . . 0.0 110.825 -176.901 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' E' E ' 112' ' ' LEU . . . . . . . . . . . . . 15.3 mt -110.58 -45.97 3.45 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.115 -0.493 . . . . 0.0 110.428 177.837 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' E' E ' 113' ' ' TYR . . . . . . . . . . . . . 55.7 t80 -137.27 137.22 38.8 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 116.402 -0.363 . . . . 0.0 110.862 -179.585 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' E' E ' 114' ' ' ARG . . . . . . . . . . . . . 56.0 ttp180 -143.45 119.71 10.85 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.422 -0.354 . . . . 0.0 110.413 179.03 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' E' E ' 115' ' ' GLY . . . . . . . . . . . . . . . -150.16 153.75 25.26 Favored Glycine 0 CA--C 1.525 0.704 0 N-CA-C 111.075 -0.81 . . . . 0.0 111.075 178.376 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' E' E ' 116' ' ' LYS . . . . . . . . . . . . . 27.5 ttpp -116.97 143.7 45.42 Favored 'General case' 0 C--N 1.33 -0.262 0 N-CA-C 109.955 -0.387 . . . . 0.0 109.955 177.662 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' E' E ' 117' ' ' PHE . . . . . . . . . . . . . 51.2 m-85 -139.19 114.63 9.78 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-O 120.935 0.397 . . . . 0.0 110.204 -178.24 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' E' E ' 118' ' ' GLU . . . . . . . . . . . . . 95.6 mt-10 -53.61 -50.15 66.28 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.472 -0.331 . . . . 0.0 111.411 -175.558 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' E' E ' 119' ' ' ASN . . . . . . . . . . . . . 2.6 m120 -93.63 31.02 1.63 Allowed 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.192 -0.458 . . . . 0.0 112.158 -175.222 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' E' E ' 120' ' ' LEU . . . . . . . . . . . . . 16.2 tp -57.11 122.89 13.46 Favored 'General case' 0 C--N 1.333 -0.14 0 CA-C-O 120.721 0.296 . . . . 0.0 110.277 178.563 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' E' E ' 121' ' ' ASN . . . . . . . . . . . . . 13.7 m120 -112.13 -44.17 3.45 Favored 'General case' 0 C--N 1.332 -0.185 0 CA-C-N 116.395 -0.366 . . . . 0.0 110.991 -177.183 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' E' E ' 122' ' ' LYS . . . . . . . . . . . . . 80.2 mttt -146.2 145.7 30.53 Favored 'General case' 0 C--N 1.332 -0.194 0 C-N-CA 120.575 -0.45 . . . . 0.0 111.832 -177.282 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' E' E ' 123' ' ' VAL . . . . . 0.581 ' HB ' HD11 ' E' ' 96' ' ' ILE . 46.9 t -127.89 123.83 61.66 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.291 0 N-CA-C 108.883 -0.784 . . . . 0.0 108.883 171.96 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' E' E ' 124' ' ' LEU . . . . . . . . . . . . . 69.0 mt -132.66 145.9 51.44 Favored 'General case' 0 C--N 1.331 -0.2 0 CA-C-O 121.048 0.451 . . . . 0.0 111.492 -175.036 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' E' E ' 125' ' ' VAL . . . . . 0.565 HG23 HG22 ' E' ' 130' ' ' VAL . 11.9 p -135.17 137.41 50.33 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.238 0 CA-C-N 115.834 -0.621 . . . . 0.0 110.395 178.915 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' E' E ' 126' ' ' ARG . . . . . . . . . . . . . 25.3 mmt180 -140.35 124.64 17.73 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 115.976 -0.556 . . . . 0.0 110.206 178.605 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' E' E ' 127' ' ' ASN . . . . . . . . . . . . . 14.9 m-80 51.4 -106.67 0.27 Allowed 'General case' 0 CA--C 1.543 0.695 0 CA-C-O 118.976 -0.535 . . . . 0.0 111.36 179.739 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' E' E ' 128' ' ' ASP . . . . . . . . . . . . . 14.8 p-10 -114.07 5.93 16.21 Favored 'General case' 0 N--CA 1.468 0.43 0 CA-C-N 119.723 1.147 . . . . 0.0 113.468 -176.948 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' E' E ' 129' ' ' LEU . . . . . . . . . . . . . 15.8 tp -111.56 134.5 53.09 Favored 'General case' 0 C--N 1.333 -0.138 0 CA-C-N 118.261 0.482 . . . . 0.0 110.472 -179.492 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' E' E ' 130' ' ' VAL . . . . . 0.565 HG22 HG23 ' E' ' 125' ' ' VAL . 45.0 t -118.66 134.84 60.99 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.183 0 N-CA-C 109.523 -0.547 . . . . 0.0 109.523 178.657 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' E' E ' 131' ' ' VAL . . . . . . . . . . . . . 39.4 t -136.05 141.01 42.87 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.258 0 CA-C-O 121.119 0.485 . . . . 0.0 110.704 -178.525 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' E' E ' 132' ' ' ILE . . . . . . . . . . . . . 71.5 mt -117.96 132.54 67.5 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.279 0 CA-C-N 115.457 -0.792 . . . . 0.0 109.413 178.669 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' E' E ' 133' ' ' ILE . . . . . . . . . . . . . 44.0 mm -115.8 121.97 68.5 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.246 0 CA-C-O 120.747 0.308 . . . . 0.0 110.675 -176.769 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' E' E ' 134' ' ' ASP . . . . . . . . . . . . . 7.3 p-10 -134.37 149.68 50.84 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.02 -0.536 . . . . 0.0 109.795 175.47 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' E' E ' 135' ' ' GLU . . . . . . . . . . . . . 42.9 tp10 -49.78 -26.71 4.13 Favored 'General case' 0 C--N 1.327 -0.383 0 N-CA-C 112.85 0.685 . . . . 0.0 112.85 -170.442 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' E' E ' 136' ' ' GLN . . . . . . . . . . . . . 55.3 mt-30 -102.78 -25.67 13.43 Favored 'General case' 0 N--CA 1.466 0.367 0 N-CA-C 112.888 0.699 . . . . 0.0 112.888 -174.532 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' E' E ' 137' ' ' LYS . . . . . . . . . . . . . 82.7 mttt -143.21 153.31 42.7 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-O 121.23 0.538 . . . . 0.0 111.714 -170.239 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' E' E ' 138' ' ' LEU . . . . . 0.426 ' C ' HD23 ' E' ' 138' ' ' LEU . 5.8 tt -118.29 121.15 39.7 Favored 'General case' 0 C--N 1.328 -0.352 0 N-CA-C 108.744 -0.836 . . . . 0.0 108.744 171.667 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' E' E ' 139' ' ' THR . . . . . . . . . . . . . 23.8 m -109.27 128.19 54.88 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.452 -0.34 . . . . 0.0 110.54 -176.344 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' E' E ' 140' ' ' LEU . . . . . 0.478 ' C ' HD23 ' E' ' 140' ' ' LEU . 7.1 tt -114.37 122.12 45.69 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 115.724 -0.671 . . . . 0.0 109.494 -178.835 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' E' E ' 141' ' ' ILE . . . . . . . . . . . . . 19.1 mt -122.84 116.81 49.9 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.288 0 N-CA-C 109.601 -0.518 . . . . 0.0 109.601 -176.897 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' E' E ' 142' ' ' ARG . . . . . . . . . . . . . 71.5 ttt180 -101.52 120.67 40.67 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 115.671 -0.695 . . . . 0.0 110.458 -179.107 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' E' E ' 143' ' ' THR . . . . . 0.497 HG22 HG12 ' F' ' 73' ' ' VAL . 16.4 p . . . . . 0 C--O 1.22 -0.472 0 CA-C-O 118.009 -0.996 . . . . 0.0 110.469 179.678 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' F' F ' -3' ' ' GLU . . . . . . . . . . . . . 70.5 mm-40 . . . . . 0 N--CA 1.49 1.574 0 N-CA-C 109.467 -0.568 . . . . 0.0 109.467 . . . . . . . . . 0 0 . 1 . 018 nuclear build full ' F' F ' -2' ' ' GLY . . . . . . . . . . . . . . . -75.39 149.95 39.55 Favored Glycine 0 CA--C 1.527 0.806 0 N-CA-C 111.04 -0.824 . . . . 0.0 111.04 179.953 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' F' F ' -1' ' ' VAL . . . . . . . . . . . . . 43.9 t -88.41 126.26 41.69 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.292 0 N-CA-C 109.871 -0.418 . . . . 0.0 109.871 179.742 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' F' F ' 0' ' ' ILE . . . . . . . . . . . . . 70.8 mt -122.65 130.62 74.37 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.229 0 CA-C-N 116.264 -0.426 . . . . 0.0 110.268 -177.971 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' F' F ' 1' ' ' MET . . . . . . . . . . . . . 25.5 ptp -95.77 149.42 21.52 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.054 -0.521 . . . . 0.0 110.371 177.642 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' F' F ' 2' ' ' SER . . . . . . . . . . . . . 4.9 p -124.28 132.8 53.59 Favored 'General case' 0 C--N 1.332 -0.188 0 CA-C-O 120.908 0.385 . . . . 0.0 110.803 179.754 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' F' F ' 3' ' ' GLU . . . . . . . . . . . . . 85.2 tt0 -142.61 140.38 31.64 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.155 -0.475 . . . . 0.0 111.225 -179.119 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' F' F ' 4' ' ' LEU . . . . . 0.446 HD21 HD21 ' F' ' 6' ' ' LEU . 14.9 tp -125.55 135.09 51.88 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.03 -0.532 . . . . 0.0 110.049 177.163 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' F' F ' 5' ' ' LYS . . . . . . . . . . . . . 69.0 mttm -112.43 120.73 42.65 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.237 -0.438 . . . . 0.0 110.58 178.764 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' F' F ' 6' ' ' LEU . . . . . 0.446 HD21 HD21 ' F' ' 4' ' ' LEU . 73.4 mt -114.93 146.06 41.56 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 115.294 -0.866 . . . . 0.0 110.043 -179.968 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' F' F ' 7' ' ' LYS . . . . . . . . . . . . . 53.4 tttm -133.88 140.2 35.71 Favored Pre-proline 0 CA--C 1.534 0.334 0 CA-C-O 119.115 -0.469 . . . . 0.0 110.245 177.576 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' F' F ' 8' ' ' PRO . . . . . . . . . . . . . 94.4 Cg_endo -91.95 139.07 2.07 Favored 'Trans proline' 0 N--CA 1.489 1.22 0 C-N-CA 121.668 1.578 . . . . 0.0 111.537 176.798 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' F' F ' 9' ' ' LEU . . . . . . . . . . . . . 56.5 mt -71.57 -47.9 12.46 Favored Pre-proline 0 C--N 1.329 -0.315 0 CA-C-O 118.613 -0.708 . . . . 0.0 112.176 -178.889 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' F' F ' 10' ' ' PRO . . . . . . . . . . . . . 97.4 Cg_endo -79.46 157.9 25.55 Favored 'Trans proline' 0 N--CA 1.495 1.616 0 C-N-CA 121.197 1.264 . . . . 0.0 112.291 177.061 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' F' F ' 11' ' ' LYS . . . . . . . . . . . . . 6.6 tmtm? -87.21 97.28 10.68 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.256 178.756 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' F' F ' 12' ' ' VAL . . . . . . . . . . . . . 13.0 p -143.63 146.62 20.93 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.23 0 CA-C-N 116.301 -0.408 . . . . 0.0 110.778 179.607 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' F' F ' 13' ' ' GLU . . . . . . . . . . . . . 94.5 mt-10 -82.71 135.12 35.1 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.079 -0.509 . . . . 0.0 110.256 178.23 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' F' F ' 14' ' ' LEU . . . . . . . . . . . . . 15.2 mt -98.18 141.59 23.21 Favored Pre-proline 0 CA--C 1.534 0.328 0 CA-C-O 118.887 -0.578 . . . . 0.0 110.099 179.536 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' F' F ' 15' ' ' PRO . . . . . . . . . . . . . 26.0 Cg_exo -62.24 159.92 33.09 Favored 'Trans proline' 0 N--CA 1.496 1.658 0 C-N-CA 121.297 1.331 . . . . 0.0 111.711 176.113 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' F' F ' 16' ' ' PRO . . . . . . . . . . . . . 39.6 Cg_exo -58.42 -41.23 67.64 Favored 'Trans proline' 0 N--CA 1.496 1.657 0 C-N-CA 121.499 1.466 . . . . 0.0 112.907 -177.313 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' F' F ' 17' ' ' ASP . . . . . . . . . . . . . 24.2 p-10 -84.71 6.99 22.06 Favored 'General case' 0 CA--C 1.538 0.498 0 N-CA-C 113.261 0.837 . . . . 0.0 113.261 -177.38 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' F' F ' 18' ' ' PHE . . . . . . . . . . . . . 41.2 t80 -57.83 -45.72 85.78 Favored 'General case' 0 C--N 1.334 -0.099 0 O-C-N 122.012 -0.43 . . . . 0.0 110.161 -177.798 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' F' F ' 19' ' ' VAL . . . . . . . . . . . . . 48.7 t -56.71 -44.37 81.28 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.304 0 CA-C-N 116.298 -0.41 . . . . 0.0 110.559 -178.101 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' F' F ' 20' ' ' ASP . . . . . . . . . . . . . 29.2 m-20 -59.67 -42.06 92.01 Favored 'General case' 0 C--N 1.329 -0.296 0 C-N-CA 120.896 -0.322 . . . . 0.0 111.089 -177.711 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' F' F ' 21' ' ' VAL . . . . . . . . . . . . . 46.9 t -63.48 -45.63 97.34 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.285 0 C-N-CA 120.824 -0.35 . . . . 0.0 110.17 -177.738 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' F' F ' 22' ' ' ILE . . . . . 0.611 HG22 HD12 ' F' ' 26' ' ' LEU . 51.7 mm -55.56 -48.2 77.73 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 C-N-CA 121.085 -0.246 . . . . 0.0 110.679 178.568 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' F' F ' 23' ' ' ARG . . . . . . . . . . . . . 41.5 ttp180 -54.97 -47.46 74.53 Favored 'General case' 0 C--N 1.328 -0.339 0 C-N-CA 121.074 -0.25 . . . . 0.0 111.395 -177.937 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' F' F ' 24' ' ' ILE . . . . . . . . . . . . . 82.5 mt -58.8 -45.72 91.25 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.29 0 C-N-CA 121.144 -0.222 . . . . 0.0 111.341 -177.442 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' F' F ' 25' ' ' LYS . . . . . . . . . . . . . 93.0 mttt -67.78 -42.68 81.3 Favored 'General case' 0 C--N 1.328 -0.333 0 N-CA-C 112.538 0.57 . . . . 0.0 112.538 -177.56 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' F' F ' 26' ' ' LEU . . . . . 0.611 HD12 HG22 ' F' ' 22' ' ' ILE . 94.6 mt -77.68 -37.76 49.0 Favored 'General case' 0 C--N 1.329 -0.287 0 N-CA-C 113.288 0.848 . . . . 0.0 113.288 -170.128 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' F' F ' 27' ' ' GLN . . . . . . . . . . . . . 15.4 pt20 -47.19 137.95 7.49 Favored 'General case' 0 N--CA 1.468 0.451 0 N-CA-C 112.698 0.629 . . . . 0.0 112.698 -174.917 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' F' F ' 28' ' ' GLY . . . . . . . . . . . . . . . 100.77 -26.21 25.47 Favored Glycine 0 CA--C 1.533 1.184 0 CA-C-N 115.533 -0.758 . . . . 0.0 112.26 -177.435 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' F' F ' 29' ' ' LYS . . . . . . . . . . . . . 91.4 mttt -97.79 155.06 17.21 Favored 'General case' 0 C--N 1.332 -0.167 0 CA-C-N 117.375 0.588 . . . . 0.0 110.946 178.101 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' F' F ' 30' ' ' THR . . . . . . . . . . . . . 26.2 m -106.06 138.44 42.25 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.006 -0.543 . . . . 0.0 110.152 177.244 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' F' F ' 31' ' ' VAL . . . . . . . . . . . . . 34.1 m -128.64 157.1 41.34 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.267 0 CA-C-N 116.343 -0.39 . . . . 0.0 110.722 -178.792 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' F' F ' 32' ' ' ARG . . . . . . . . . . . . . 98.6 mtt180 -130.15 150.28 51.48 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-O 121.243 0.544 . . . . 0.0 110.654 177.824 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' F' F ' 33' ' ' THR . . . . . . . . . . . . . 15.2 m -53.66 138.34 35.09 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.217 -0.447 . . . . 0.0 111.187 -178.787 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' F' F ' 34' ' ' GLY . . . . . . . . . . . . . . . 100.88 -17.05 56.91 Favored Glycine 0 CA--C 1.532 1.15 0 CA-C-O 119.614 -0.548 . . . . 0.0 113.287 179.381 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' F' F ' 35' ' ' ASP . . . . . . . . . . . . . 73.5 m-20 -65.25 149.43 49.95 Favored 'General case' 0 C--O 1.231 0.13 0 CA-C-N 118.049 0.924 . . . . 0.0 111.264 179.49 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' F' F ' 36' ' ' VAL . . . . . . . . . . . . . 46.6 t -123.13 131.91 72.36 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.171 0 CA-C-N 115.88 -0.6 . . . . 0.0 110.038 178.884 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' F' F ' 37' ' ' ILE . . . . . . . . . . . . . 67.5 mt -123.67 142.66 39.58 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.28 0 CA-C-N 116.156 -0.475 . . . . 0.0 109.811 -179.959 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' F' F ' 38' ' ' GLY . . . . . . . . . . . . . . . -113.09 128.78 8.56 Favored Glycine 0 CA--C 1.527 0.791 0 N-CA-C 111.335 -0.706 . . . . 0.0 111.335 -179.574 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' F' F ' 39' ' ' ILE . . . . . . . . . . . . . 72.0 mt -126.61 127.3 70.1 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.18 0 N-CA-C 109.829 -0.434 . . . . 0.0 109.829 177.862 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' F' F ' 40' ' ' SER . . . . . . . . . . . . . 42.3 t -93.42 116.43 28.97 Favored 'General case' 0 C--N 1.329 -0.29 0 C-N-CA 120.918 -0.313 . . . . 0.0 110.836 175.815 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' F' F ' 41' ' ' ILE . . . . . . . . . . . . . 44.2 mm -122.78 121.91 64.55 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.188 0 CA-C-O 120.934 0.397 . . . . 0.0 110.362 179.853 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' F' F ' 42' ' ' LEU . . . . . 0.541 ' O ' HD23 ' F' ' 42' ' ' LEU . 1.3 tt 54.94 46.44 24.37 Favored 'General case' 0 C--N 1.331 -0.211 0 CA-C-O 121.366 0.603 . . . . 0.0 110.686 177.118 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' F' F ' 43' ' ' GLY . . . . . . . . . . . . . . . 70.5 10.05 65.99 Favored Glycine 0 CA--C 1.534 1.259 0 C-N-CA 121.232 -0.509 . . . . 0.0 113.32 174.522 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' F' F ' 44' ' ' LYS . . . . . . . . . . . . . 43.1 tptt -124.83 127.18 46.76 Favored 'General case' 0 C--N 1.333 -0.146 0 CA-C-N 117.986 0.893 . . . . 0.0 109.767 -178.715 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' F' F ' 45' ' ' GLU . . . . . . . . . . . . . 36.9 tp10 -83.43 127.43 33.68 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-O 120.875 0.369 . . . . 0.0 110.943 -177.148 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' F' F ' 46' ' ' VAL . . . . . . . . . . . . . 7.5 p -124.32 130.59 73.59 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.194 0 N-CA-C 109.491 -0.559 . . . . 0.0 109.491 176.191 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' F' F ' 47' ' ' LYS . . . . . . . . . . . . . 30.0 mtpp -100.7 131.21 46.71 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.054 -0.521 . . . . 0.0 111.221 178.292 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' F' F ' 48' ' ' PHE . . . . . . . . . . . . . 89.1 m-85 -113.26 131.91 55.73 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.242 -0.435 . . . . 0.0 110.367 178.118 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' F' F ' 49' ' ' LYS . . . . . . . . . . . . . 82.1 tttt -107.31 137.21 45.78 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.169 -0.469 . . . . 0.0 110.412 178.492 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' F' F ' 50' ' ' VAL . . . . . 0.404 ' HA ' HD23 ' F' ' 6' ' ' LEU . 47.6 t -80.32 106.89 12.08 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.316 0 N-CA-C 109.138 -0.689 . . . . 0.0 109.138 175.061 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' F' F ' 51' ' ' VAL . . . . . . . . . . . . . 55.2 t -70.51 -48.22 60.58 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.286 0 CA-C-N 116.114 -0.494 . . . . 0.0 109.932 -173.373 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' F' F ' 52' ' ' GLN . . . . . . . . . . . . . 21.4 pt20 -164.64 158.92 18.42 Favored 'General case' 0 C--N 1.331 -0.229 0 C-N-CA 120.156 -0.618 . . . . 0.0 111.859 -179.505 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' F' F ' 53' ' ' ALA . . . . . . . . . . . . . . . -135.46 135.86 40.85 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 115.361 -0.836 . . . . 0.0 110.495 179.347 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' F' F ' 54' ' ' TYR . . . . . . . . . . . . . 59.6 t80 -128.98 110.52 18.4 Favored Pre-proline 0 CA--C 1.534 0.345 0 CA-C-O 118.225 -0.893 . . . . 0.0 110.211 177.232 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' F' F ' 55' ' ' PRO . . . . . . . . . . . . . 72.6 Cg_endo -77.15 166.27 82.72 Favored 'Cis proline' 0 N--CA 1.5 1.859 0 CA-C-N 121.988 1.746 . . . . 0.0 112.322 -6.0 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' F' F ' 56' ' ' SER . . . . . . . . . . . . . 43.5 m -116.03 130.09 24.69 Favored Pre-proline 0 CA--C 1.538 0.488 0 CA-C-O 118.387 -0.816 . . . . 0.0 109.293 174.059 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' F' F ' 57' ' ' PRO . . . . . . . . . . . . . 37.6 Cg_endo -66.72 163.64 70.72 Favored 'Cis proline' 0 N--CA 1.498 1.788 0 CA-C-N 122.054 1.769 . . . . 0.0 111.701 -0.172 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' F' F ' 58' ' ' LEU . . . . . . . . . . . . . 24.7 tp -129.37 137.38 50.92 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.349 -179.025 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' F' F ' 59' ' ' ARG . . . . . . . . . . . . . 74.8 ttt180 -105.18 128.59 53.47 Favored 'General case' 0 C--N 1.327 -0.391 0 N-CA-C 109.272 -0.64 . . . . 0.0 109.272 175.657 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' F' F ' 60' ' ' VAL . . . . . . . . . . . . . 45.5 t -79.01 123.09 35.52 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.306 0 C-N-CA 120.686 -0.405 . . . . 0.0 110.347 -175.432 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' F' F ' 61' ' ' GLU . . . . . . . . . . . . . 95.4 mt-10 -131.09 162.75 29.17 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 115.732 -0.667 . . . . 0.0 109.949 177.894 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' F' F ' 62' ' ' ASP . . . . . . . . . . . . . 16.7 p-10 -56.8 -32.84 66.08 Favored 'General case' 0 C--N 1.328 -0.342 0 C-N-CA 120.941 -0.304 . . . . 0.0 111.522 179.329 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' F' F ' 63' ' ' ARG . . . . . . . . . . . . . 17.0 ptm180 -82.9 5.4 21.98 Favored 'General case' 0 CA--C 1.537 0.462 0 N-CA-C 113.558 0.947 . . . . 0.0 113.558 -176.602 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' F' F ' 64' ' ' THR . . . . . . . . . . . . . 19.4 m -88.53 141.97 28.09 Favored 'General case' 0 C--O 1.231 0.126 0 CA-C-N 118.235 0.471 . . . . 0.0 110.753 -177.66 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' F' F ' 65' ' ' LYS . . . . . . . . . . . . . 97.7 mttt -87.4 125.64 34.39 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.264 -0.425 . . . . 0.0 109.918 178.514 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' F' F ' 66' ' ' ILE . . . . . . . . . . . . . 59.0 mt -116.36 124.92 73.11 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.336 0 N-CA-C 109.712 -0.477 . . . . 0.0 109.712 179.708 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' F' F ' 67' ' ' THR . . . . . . . . . . . . . 19.6 m -123.8 146.03 48.64 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-O 121.043 0.449 . . . . 0.0 111.247 -176.231 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' F' F ' 68' ' ' LEU . . . . . . . . . . . . . 49.8 mt -99.05 134.34 42.03 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 115.77 -0.65 . . . . 0.0 110.486 177.637 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' F' F ' 69' ' ' VAL . . . . . . . . . . . . . 46.6 t -101.86 135.11 40.18 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.328 0 CA-C-N 115.878 -0.601 . . . . 0.0 109.913 179.039 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' F' F ' 70' ' ' THR . . . . . . . . . . . . . 7.7 t -132.01 177.27 7.68 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.073 -0.512 . . . . 0.0 110.3 -179.294 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' F' F ' 71' ' ' HIS . . . . . . . . . . . . . 93.9 m-70 -64.96 150.06 95.72 Favored Pre-proline 0 C--N 1.331 -0.219 0 CA-C-N 116.414 -0.357 . . . . 0.0 110.212 -179.124 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' F' F ' 72' ' ' PRO . . . . . . . . . . . . . 66.8 Cg_endo -74.97 -30.13 7.54 Favored 'Trans proline' 0 N--CA 1.495 1.574 0 C-N-CA 121.321 1.347 . . . . 0.0 112.542 -176.821 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' F' F ' 73' ' ' VAL . . . . . 0.497 HG12 HG22 ' E' ' 143' ' ' THR . 31.0 m -140.09 146.03 25.42 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.226 0 CA-C-O 121.096 0.474 . . . . 0.0 111.213 179.234 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' F' F ' 74' ' ' ASP . . . . . . . . . . . . . 9.6 t0 -101.9 120.86 41.07 Favored 'General case' 0 C--N 1.327 -0.383 0 N-CA-C 109.042 -0.725 . . . . 0.0 109.042 174.724 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' F' F ' 75' ' ' VAL . . . . . . . . . . . . . 40.5 t -109.39 123.16 65.06 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.288 0 CA-C-O 121.207 0.527 . . . . 0.0 110.779 -175.939 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' F' F ' 76' ' ' LEU . . . . . . . . . . . . . 15.4 mt -129.55 144.25 51.19 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 115.477 -0.783 . . . . 0.0 109.127 177.101 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' F' F ' 77' ' ' GLU . . . . . . . . . . . . . 56.2 tt0 -138.86 139.99 38.31 Favored 'General case' 0 C--N 1.332 -0.184 0 C-N-CA 120.671 -0.411 . . . . 0.0 111.269 -175.148 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' F' F ' 78' ' ' ALA . . . . . 0.481 ' HB2' HD21 ' F' ' 109' ' ' LEU . . . -124.4 140.02 53.35 Favored 'General case' 0 C--N 1.331 -0.229 0 CA-C-N 115.947 -0.57 . . . . 0.0 110.308 178.217 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' F' F ' 79' ' ' LYS . . . . . 0.624 ' O ' HD13 ' F' ' 80' ' ' ILE . 3.9 mptp? -82.75 116.36 22.07 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-N 116.427 -0.351 . . . . 0.0 110.685 -178.529 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' F' F ' 80' ' ' ILE . . . . . 0.624 HD13 ' O ' ' F' ' 79' ' ' LYS . 40.0 mm -139.2 107.04 3.08 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.279 0 N-CA-C 109.391 -0.596 . . . . 0.0 109.391 -178.855 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' F' F ' 81' ' ' LYS . . . . . . . . . . . . . 99.3 mttt -105.19 133.61 49.68 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-O 120.902 0.382 . . . . 0.0 110.975 -179.037 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' F' F ' 82' ' ' GLY . . . . . . . . . . . . . . . 88.9 42.23 5.73 Favored Glycine 0 CA--C 1.524 0.63 0 N-CA-C 111.228 -0.749 . . . . 0.0 111.228 176.549 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' F' F ' 83' ' ' ILE . . . . . . . . . . . . . 72.8 mt -72.56 135.91 26.74 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.336 0 N-CA-C 109.964 -0.384 . . . . 0.0 109.964 179.382 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' F' F ' 84' ' ' LYS . . . . . . . . . . . . . 54.7 tttp -98.4 -53.96 3.19 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 115.971 -0.559 . . . . 0.0 110.329 -178.535 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' F' F ' 85' ' ' ASP . . . . . . . . . . . . . 7.4 t0 -149.6 148.31 29.18 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 115.85 -0.613 . . . . 0.0 110.327 -178.808 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' F' F ' 86' ' ' VAL . . . . . . . . . . . . . 42.3 t -129.79 129.39 66.18 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.274 0 CA-C-O 120.906 0.384 . . . . 0.0 110.456 -179.527 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' F' F ' 87' ' ' ILE . . . . . . . . . . . . . 45.6 mm -118.66 125.96 74.82 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.268 0 CA-C-N 116.006 -0.543 . . . . 0.0 109.734 175.809 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' F' F ' 88' ' ' LEU . . . . . . . . . . . . . 38.5 mt -113.02 136.82 52.27 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-O 121.12 0.486 . . . . 0.0 111.303 -177.973 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' F' F ' 89' ' ' ASP . . . . . . . . . . . . . 7.6 t70 -134.85 155.29 50.92 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 115.687 -0.688 . . . . 0.0 109.618 175.538 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' F' F ' 90' ' ' GLU . . . . . . . . . . . . . 95.7 mt-10 -48.78 -33.15 9.82 Favored 'General case' 0 C--N 1.329 -0.324 0 N-CA-C 112.927 0.714 . . . . 0.0 112.927 -172.542 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' F' F ' 91' ' ' ASN . . . . . . . . . . . . . 27.9 t30 -130.44 18.86 5.29 Favored 'General case' 0 N--CA 1.469 0.493 0 N-CA-C 113.063 0.764 . . . . 0.0 113.063 -176.056 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' F' F ' 92' ' ' LEU . . . . . . . . . . . . . 12.0 mt -151.66 143.63 23.83 Favored 'General case' 0 C--N 1.333 -0.151 0 N-CA-C 109.976 -0.379 . . . . 0.0 109.976 -177.225 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' F' F ' 93' ' ' ILE . . . . . . . . . . . . . 71.9 mt -128.82 118.11 46.24 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 N-CA-C 109.278 -0.638 . . . . 0.0 109.278 176.086 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' F' F ' 94' ' ' VAL . . . . . . . . . . . . . 44.5 t -120.84 127.02 75.89 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.344 0 N-CA-C 109.998 -0.371 . . . . 0.0 109.998 -178.538 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' F' F ' 95' ' ' VAL . . . . . . . . . . . . . 44.0 t -123.14 134.11 67.16 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.33 0 CA-C-N 116.064 -0.516 . . . . 0.0 109.95 -179.593 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' F' F ' 96' ' ' ILE . . . . . . . . . . . . . 52.8 mt -113.61 127.54 70.9 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.345 0 N-CA-C 109.006 -0.738 . . . . 0.0 109.006 178.391 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' F' F ' 97' ' ' THR . . . . . . . . . . . . . 66.1 p -99.42 157.15 16.62 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-O 121.204 0.526 . . . . 0.0 111.069 -177.142 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' F' F ' 98' ' ' GLU . . . . . . . . . . . . . 81.9 tt0 -53.98 -27.87 34.22 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 116.127 -0.488 . . . . 0.0 112.056 179.909 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' F' F ' 99' ' ' GLU . . . . . . . . . . . . . 95.9 mt-10 -76.92 12.54 1.32 Allowed 'General case' 0 CA--C 1.536 0.404 0 N-CA-C 113.329 0.863 . . . . 0.0 113.329 -176.737 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' F' F ' 100' ' ' ASN . . . . . . . . . . . . . 3.9 m-20 63.57 34.61 12.37 Favored 'General case' 0 CA--C 1.531 0.248 0 CA-C-O 120.964 0.412 . . . . 0.0 111.369 179.328 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' F' F ' 101' ' ' GLU . . . . . . . . . . . . . 84.0 tt0 -113.96 145.6 41.29 Favored 'General case' 0 C--N 1.333 -0.133 0 N-CA-C 109.52 -0.548 . . . . 0.0 109.52 173.607 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' F' F ' 102' ' ' VAL . . . . . . . . . . . . . 43.9 t -118.12 128.93 75.13 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.253 0 CA-C-O 120.849 0.356 . . . . 0.0 110.096 -177.802 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' F' F ' 103' ' ' LEU . . . . . . . . . . . . . 48.4 mt -115.84 130.43 56.83 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 115.479 -0.782 . . . . 0.0 109.823 178.372 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' F' F ' 104' ' ' ILE . . . . . . . . . . . . . 62.5 mt -119.87 121.59 66.43 Favored 'Isoleucine or valine' 0 C--O 1.233 0.23 0 N-CA-C 110.152 -0.314 . . . . 0.0 110.152 179.597 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' F' F ' 105' ' ' PHE . . . . . . . . . . . . . 30.8 m-85 -124.25 165.78 17.03 Favored 'General case' 0 C--N 1.333 -0.149 0 O-C-N 123.936 0.773 . . . . 0.0 109.521 178.152 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' F' F ' 106' ' ' ASN . . . . . . . . . . . . . 44.1 p-10 -96.99 -170.0 1.96 Allowed 'General case' 0 C--N 1.329 -0.29 0 N-CA-C 109.861 -0.422 . . . . 0.0 109.861 172.858 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' F' F ' 107' ' ' GLN . . . . . . . . . . . . . 47.8 tt0 -60.1 -30.14 69.05 Favored 'General case' 0 CA--C 1.532 0.286 0 N-CA-C 111.873 0.323 . . . . 0.0 111.873 179.532 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' F' F ' 108' ' ' ASN . . . . . . . . . . . . . 7.1 t-20 -82.5 8.19 12.34 Favored 'General case' 0 CA--C 1.537 0.457 0 N-CA-C 113.219 0.822 . . . . 0.0 113.219 -178.31 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' F' F ' 109' ' ' LEU . . . . . 0.481 HD21 ' HB2' ' F' ' 78' ' ' ALA . 11.0 tp 59.76 37.45 22.07 Favored 'General case' 0 CA--C 1.529 0.17 0 CA-C-O 120.977 0.418 . . . . 0.0 111.294 178.255 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' F' F ' 110' ' ' GLU . . . . . . . . . . . . . 70.7 mm-40 -104.04 163.68 12.22 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.416 -0.356 . . . . 0.0 110.109 177.228 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' F' F ' 111' ' ' GLU . . . . . . . . . . . . . 83.6 tt0 -84.86 124.18 31.31 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-N 116.328 -0.397 . . . . 0.0 111.053 -177.215 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' F' F ' 112' ' ' LEU . . . . . . . . . . . . . 15.3 mt -112.64 -46.06 3.18 Favored 'General case' 0 C--N 1.331 -0.197 0 CA-C-N 116.051 -0.522 . . . . 0.0 110.014 175.163 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' F' F ' 113' ' ' TYR . . . . . . . . . . . . . 57.7 t80 -148.25 137.91 22.28 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.228 -0.442 . . . . 0.0 111.036 179.775 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' F' F ' 114' ' ' ARG . . . . . . . . . . . . . 31.1 mtp180 -137.13 123.77 21.05 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.346 -0.388 . . . . 0.0 109.995 174.713 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' F' F ' 115' ' ' GLY . . . . . . . . . . . . . . . -149.46 160.15 28.34 Favored Glycine 0 CA--C 1.523 0.544 0 N-CA-C 110.832 -0.907 . . . . 0.0 110.832 -179.658 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' F' F ' 116' ' ' LYS . . . . . . . . . . . . . 72.5 tttt -133.32 133.64 42.79 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-O 120.844 0.354 . . . . 0.0 110.184 179.622 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' F' F ' 117' ' ' PHE . . . . . . . . . . . . . 23.6 m-85 -132.1 115.64 16.01 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.192 -0.458 . . . . 0.0 109.843 -175.459 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' F' F ' 118' ' ' GLU . . . . . . . . . . . . . 85.2 tt0 -55.4 -40.09 70.99 Favored 'General case' 0 C--N 1.329 -0.324 0 C-N-CA 120.902 -0.319 . . . . 0.0 111.213 -177.152 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' F' F ' 119' ' ' ASN . . . . . . . . . . . . . 4.5 m-80 -97.8 30.99 2.77 Favored 'General case' 0 C--N 1.33 -0.282 0 N-CA-C 112.173 0.434 . . . . 0.0 112.173 -176.084 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' F' F ' 120' ' ' LEU . . . . . . . . . . . . . 11.7 tp -56.54 122.31 11.7 Favored 'General case' 0 C--N 1.333 -0.146 0 C-N-CA 121.065 -0.254 . . . . 0.0 110.641 178.991 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' F' F ' 121' ' ' ASN . . . . . . . . . . . . . 10.5 t-20 -108.16 -44.14 4.22 Favored 'General case' 0 C--O 1.233 0.192 0 CA-C-N 116.578 -0.283 . . . . 0.0 111.05 -177.859 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' F' F ' 122' ' ' LYS . . . . . . . . . . . . . 55.7 pttt -165.94 161.73 17.73 Favored 'General case' 0 C--N 1.332 -0.17 0 C-N-CA 120.398 -0.521 . . . . 0.0 112.218 -179.223 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' F' F ' 123' ' ' VAL . . . . . . . . . . . . . 44.1 t -131.36 137.38 55.61 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.202 0 CA-C-N 115.809 -0.632 . . . . 0.0 109.956 178.959 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' F' F ' 124' ' ' LEU . . . . . . . . . . . . . 88.4 mt -122.38 136.8 54.97 Favored 'General case' 0 C--N 1.331 -0.223 0 CA-C-N 116.498 -0.319 . . . . 0.0 110.944 -179.47 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' F' F ' 125' ' ' VAL . . . . . . . . . . . . . 44.3 t -126.12 129.27 72.19 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.217 0 CA-C-N 116.096 -0.502 . . . . 0.0 109.849 178.576 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' F' F ' 126' ' ' ARG . . . . . . . . . . . . . 27.3 mmt85 -139.85 118.12 12.03 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.408 -0.36 . . . . 0.0 110.701 179.122 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' F' F ' 127' ' ' ASN . . . . . . . . . . . . . 4.9 m-20 49.66 -105.0 0.16 Allowed 'General case' 0 CA--C 1.545 0.759 0 CA-C-O 119.052 -0.499 . . . . 0.0 111.678 178.438 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' F' F ' 128' ' ' ASP . . . . . . . . . . . . . 17.5 p-10 -114.0 1.21 14.6 Favored 'General case' 0 N--CA 1.468 0.429 0 CA-C-N 119.571 1.078 . . . . 0.0 113.401 -178.046 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' F' F ' 129' ' ' LEU . . . . . . . . . . . . . 62.1 mt -107.32 142.86 36.44 Favored 'General case' 0 C--N 1.333 -0.131 0 N-CA-C 109.782 -0.451 . . . . 0.0 109.782 179.508 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' F' F ' 130' ' ' VAL . . . . . . . . . . . . . 41.9 t -129.5 140.31 49.43 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.287 0 CA-C-O 120.911 0.386 . . . . 0.0 110.066 -179.12 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' F' F ' 131' ' ' VAL . . . . . 0.426 HG12 HD12 ' F' ' 140' ' ' LEU . 34.8 m -135.93 142.0 40.23 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.267 0 CA-C-O 121.151 0.5 . . . . 0.0 110.838 178.882 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' F' F ' 132' ' ' ILE . . . . . . . . . . . . . 73.7 mt -118.61 134.0 63.64 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.259 0 CA-C-N 115.649 -0.705 . . . . 0.0 109.37 -179.78 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' F' F ' 133' ' ' ILE . . . . . . . . . . . . . 38.7 mm -116.79 122.51 70.11 Favored 'Isoleucine or valine' 0 C--O 1.234 0.278 0 CA-C-O 120.828 0.347 . . . . 0.0 111.077 -175.161 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' F' F ' 134' ' ' ASP . . . . . . . . . . . . . 6.1 p-10 -134.2 147.24 50.7 Favored 'General case' 0 C--N 1.332 -0.183 0 CA-C-N 115.87 -0.605 . . . . 0.0 109.577 172.693 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' F' F ' 135' ' ' GLU . . . . . . . . . . . . . 81.9 tt0 -49.94 -23.91 2.25 Favored 'General case' 0 C--N 1.328 -0.369 0 N-CA-C 113.088 0.773 . . . . 0.0 113.088 -170.147 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' F' F ' 136' ' ' GLN . . . . . . . . . . . . . 47.6 tt0 -104.69 -26.27 12.37 Favored 'General case' 0 CA--C 1.531 0.238 0 N-CA-C 112.748 0.648 . . . . 0.0 112.748 -174.625 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' F' F ' 137' ' ' LYS . . . . . . . . . . . . . 7.2 ttpm? -143.87 150.14 37.99 Favored 'General case' 0 C--N 1.332 -0.167 0 CA-C-O 121.36 0.6 . . . . 0.0 111.781 -170.5 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' F' F ' 138' ' ' LEU . . . . . . . . . . . . . 5.7 tt -116.87 126.62 53.29 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 115.466 -0.788 . . . . 0.0 109.241 175.183 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' F' F ' 139' ' ' THR . . . . . . . . . . . . . 26.4 m -112.44 128.27 56.27 Favored 'General case' 0 C--N 1.331 -0.208 0 CA-C-N 116.592 -0.276 . . . . 0.0 110.82 -178.106 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' F' F ' 140' ' ' LEU . . . . . 0.426 HD12 HG12 ' F' ' 131' ' ' VAL . 36.5 tp -112.71 120.24 40.85 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 115.573 -0.739 . . . . 0.0 109.263 179.783 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' F' F ' 141' ' ' ILE . . . . . . . . . . . . . 19.3 mt -119.83 119.73 61.17 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.28 0 N-CA-C 109.863 -0.421 . . . . 0.0 109.863 -175.009 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' F' F ' 142' ' ' ARG . . . . . . . . . . . . . 78.9 mtp180 -108.9 130.11 55.43 Favored 'General case' 0 C--N 1.331 -0.23 0 CA-C-N 115.556 -0.747 . . . . 0.0 110.624 -177.948 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' F' F ' 143' ' ' THR . . . . . . . . . . . . . 26.5 p . . . . . 0 C--O 1.22 -0.485 0 CA-C-O 118.106 -0.95 . . . . 0.0 110.532 -179.238 . . . . . . . . 0 0 . 1 . 019 nuclear build full ' A' A ' -3' ' ' GLU . . . . . . . . . . . . . 84.5 tt0 . . . . . 0 N--CA 1.491 1.577 0 N-CA-C 109.463 -0.569 . . . . 0.0 109.463 . . . . . . . . . 0 0 . 1 . 019 nuclear build full ' A' A ' -2' ' ' GLY . . . . . . . . . . . . . . . -64.75 145.38 49.38 Favored Glycine 0 CA--C 1.524 0.62 0 N-CA-C 111.0 -0.84 . . . . 0.0 111.0 -179.969 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' -1' ' ' VAL . . . . . . . . . . . . . 43.4 t -96.09 132.65 39.79 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.34 0 N-CA-C 110.125 -0.324 . . . . 0.0 110.125 -179.618 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 0' ' ' ILE . . . . . . . . . . . . . 46.8 mm -119.01 137.88 51.54 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.207 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.306 179.701 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 14.9 ptm -77.82 129.11 35.03 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 115.932 -0.576 . . . . 0.0 110.49 -179.982 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 3.9 p -129.17 127.35 41.17 Favored 'General case' 0 C--N 1.332 -0.176 0 CA-C-O 121.149 0.5 . . . . 0.0 110.692 -178.597 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 95.7 mt-10 -141.26 144.36 34.63 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 115.593 -0.731 . . . . 0.0 110.996 -176.55 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 4' ' ' LEU . . . . . . . . . . . . . 21.8 tp -122.46 125.6 46.15 Favored 'General case' 0 C--N 1.331 -0.206 0 CA-C-N 115.919 -0.582 . . . . 0.0 109.758 174.431 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 5' ' ' LYS . . . . . . . . . . . . . 90.5 mttt -104.64 120.95 42.52 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.341 -0.391 . . . . 0.0 110.685 -179.51 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 65.9 mt -117.82 147.27 43.19 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 115.575 -0.739 . . . . 0.0 110.7 -178.08 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 56.6 tttt -140.31 139.37 20.66 Favored Pre-proline 0 CA--C 1.533 0.314 0 CA-C-O 119.066 -0.492 . . . . 0.0 109.953 175.103 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 8' ' ' PRO . . . . . . . . . . . . . 94.1 Cg_endo -91.81 146.63 3.18 Favored 'Trans proline' 0 N--CA 1.49 1.319 0 C-N-CA 121.623 1.549 . . . . 0.0 111.834 178.119 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 59.1 mt -78.64 -47.18 1.87 Allowed Pre-proline 0 CA--C 1.534 0.359 0 CA-C-O 118.724 -0.655 . . . . 0.0 112.029 179.96 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 87.8 Cg_endo -81.34 151.37 17.68 Favored 'Trans proline' 0 N--CA 1.495 1.609 0 C-N-CA 121.195 1.264 . . . . 0.0 111.939 175.774 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 34.4 mmtp -84.26 100.43 11.21 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.445 -0.343 . . . . 0.0 110.347 177.703 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 12.5 p -140.28 143.73 29.02 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.275 0 CA-C-N 116.233 -0.439 . . . . 0.0 110.545 -179.794 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 15.0 pt-20 -89.62 130.84 35.86 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.198 -0.455 . . . . 0.0 110.224 177.72 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 14' ' ' LEU . . . . . . . . . . . . . 35.0 mt -98.24 153.72 37.95 Favored Pre-proline 0 C--O 1.234 0.241 0 CA-C-N 116.377 -0.374 . . . . 0.0 111.16 -176.5 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 15' ' ' PRO . . . . . . . . . . . . . 24.8 Cg_exo -63.0 165.44 16.59 Favored 'Trans proline' 0 N--CA 1.496 1.667 0 C-N-CA 121.37 1.38 . . . . 0.0 111.806 174.657 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 16' ' ' PRO . . . . . . . . . . . . . 26.5 Cg_exo -60.71 -46.32 17.36 Favored 'Trans proline' 0 N--CA 1.498 1.763 0 C-N-CA 121.48 1.454 . . . . 0.0 112.912 -177.649 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 17' ' ' ASP . . . . . . . . . . . . . 22.4 p-10 -86.06 11.31 11.96 Favored 'General case' 0 C--N 1.327 -0.412 0 N-CA-C 113.207 0.817 . . . . 0.0 113.207 -176.508 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 18' ' ' PHE . . . . . . . . . . . . . 37.5 t80 -57.03 -40.5 76.86 Favored 'General case' 0 C--N 1.334 -0.091 0 O-C-N 121.877 -0.514 . . . . 0.0 110.461 -179.215 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 19' ' ' VAL . . . . . . . . . . . . . 47.7 t -56.91 -44.06 81.63 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.285 0 CA-C-N 116.344 -0.389 . . . . 0.0 110.412 -179.683 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 18.1 t70 -59.79 -41.55 91.42 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-O 120.892 0.377 . . . . 0.0 110.702 -178.031 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 47.5 t -63.76 -47.74 89.63 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.308 0 CA-C-N 116.422 -0.353 . . . . 0.0 110.487 -178.021 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 22' ' ' ILE . . . . . 0.53 HG22 HD12 ' A' ' 26' ' ' LEU . 50.6 mm -56.16 -44.61 79.58 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.201 0 C-N-CA 120.863 -0.335 . . . . 0.0 110.656 179.07 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 23' ' ' ARG . . . . . . . . . . . . . 51.2 ttp180 -53.62 -49.1 68.59 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-O 120.715 0.293 . . . . 0.0 111.462 -179.393 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 24' ' ' ILE . . . . . . . . . . . . . 71.8 mt -59.24 -44.63 92.45 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.268 0 CA-C-N 116.441 -0.345 . . . . 0.0 111.157 -178.329 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 79.3 mttt -64.06 -41.38 97.37 Favored 'General case' 0 C--N 1.329 -0.318 0 N-CA-C 112.377 0.51 . . . . 0.0 112.377 -177.554 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 26' ' ' LEU . . . . . 0.53 HD12 HG22 ' A' ' 22' ' ' ILE . 65.2 mt -79.48 -42.34 25.51 Favored 'General case' 0 C--N 1.329 -0.307 0 N-CA-C 113.147 0.795 . . . . 0.0 113.147 -171.108 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 27' ' ' GLN . . . . . . . . . . . . . 15.3 pt20 -46.58 138.43 5.91 Favored 'General case' 0 N--CA 1.469 0.491 0 N-CA-C 112.816 0.673 . . . . 0.0 112.816 -175.533 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 100.77 -25.65 27.56 Favored Glycine 0 CA--C 1.531 1.086 0 CA-C-N 115.498 -0.774 . . . . 0.0 112.387 -178.515 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 85.6 mttt -98.68 155.22 17.43 Favored 'General case' 0 C--O 1.233 0.197 0 CA-C-N 117.428 0.614 . . . . 0.0 111.467 179.47 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 30' ' ' THR . . . . . . . . . . . . . 29.9 m -100.79 137.14 39.57 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 115.836 -0.62 . . . . 0.0 109.748 175.125 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 34.0 m -128.81 151.77 36.04 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.24 0 CA-C-O 120.829 0.347 . . . . 0.0 111.076 -177.602 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 32' ' ' ARG . . . . . . . . . . . . . 75.5 mtp180 -131.08 150.23 52.24 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-O 121.294 0.569 . . . . 0.0 110.541 177.241 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 33' ' ' THR . . . . . . . . . . . . . 17.6 m -53.17 138.2 32.2 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.163 -0.471 . . . . 0.0 111.471 -178.611 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 102.07 -17.23 54.63 Favored Glycine 0 CA--C 1.531 1.06 0 CA-C-O 119.67 -0.517 . . . . 0.0 113.333 178.06 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 79.7 m-20 -65.82 146.07 55.2 Favored 'General case' 0 C--O 1.231 0.107 0 CA-C-N 118.075 0.938 . . . . 0.0 110.98 179.268 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 46.9 t -121.19 129.19 75.9 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.197 0 CA-C-N 115.943 -0.571 . . . . 0.0 109.806 178.603 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 37' ' ' ILE . . . . . . . . . . . . . 67.7 mt -119.62 138.23 50.92 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.228 0 CA-C-N 116.211 -0.45 . . . . 0.0 109.835 -179.522 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . -112.15 128.68 8.66 Favored Glycine 0 CA--C 1.525 0.682 0 N-CA-C 111.034 -0.826 . . . . 0.0 111.034 179.963 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 39' ' ' ILE . . . . . . . . . . . . . 72.3 mt -127.41 127.18 68.72 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.206 0 N-CA-C 109.848 -0.427 . . . . 0.0 109.848 178.453 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 40' ' ' SER . . . . . . . . . . . . . 45.7 t -92.72 124.88 37.05 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.476 -0.329 . . . . 0.0 110.79 177.0 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 41' ' ' ILE . . . . . . . . . . . . . 73.9 mt -128.67 116.41 41.22 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.158 0 CA-C-O 120.92 0.391 . . . . 0.0 110.186 178.261 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 42' ' ' LEU . . . . . 0.538 ' O ' HD23 ' A' ' 42' ' ' LEU . 1.3 tt 54.91 46.71 23.83 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-O 121.441 0.639 . . . . 0.0 110.616 177.835 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . 75.97 -10.05 15.87 Favored Glycine 0 CA--C 1.533 1.194 0 CA-C-N 116.042 -0.526 . . . . 0.0 113.667 174.35 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 44' ' ' LYS . . . . . . . . . . . . . 46.6 mtmt -104.41 126.92 51.94 Favored 'General case' 0 C--N 1.332 -0.175 0 CA-C-N 118.178 0.989 . . . . 0.0 110.328 179.224 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 39.5 tp10 -84.83 134.25 34.3 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-O 120.96 0.409 . . . . 0.0 111.34 -177.699 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 46' ' ' VAL . . . . . . . . . . . . . 7.4 p -127.81 130.65 70.14 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.175 0 CA-C-N 116.085 -0.507 . . . . 0.0 109.851 176.075 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 97.7 mttt -100.89 131.54 46.72 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.146 -0.479 . . . . 0.0 111.452 177.59 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 48' ' ' PHE . . . . . . . . . . . . . 90.4 m-85 -113.9 131.77 56.17 Favored 'General case' 0 C--N 1.33 -0.278 0 N-CA-C 109.535 -0.542 . . . . 0.0 109.535 175.246 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 45.3 tttp -108.07 137.23 46.41 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-O 120.715 0.293 . . . . 0.0 110.736 179.405 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 50' ' ' VAL . . . . . . . . . . . . . 45.0 t -78.91 107.04 10.87 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.236 0 N-CA-C 109.157 -0.683 . . . . 0.0 109.157 175.163 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 51' ' ' VAL . . . . . . . . . . . . . 47.5 t -73.23 -47.68 45.94 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.356 0 CA-C-N 116.263 -0.426 . . . . 0.0 110.053 -173.555 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 52' ' ' GLN . . . . . . . . . . . . . 62.0 tt0 -162.69 141.96 9.04 Favored 'General case' 0 C--N 1.331 -0.201 0 C-N-CA 120.158 -0.617 . . . . 0.0 111.838 -178.129 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -114.92 130.7 56.96 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 115.65 -0.705 . . . . 0.0 109.9 176.057 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 54' ' ' TYR . . . . . . . . . . . . . 37.9 t80 -129.15 107.44 17.85 Favored Pre-proline 0 CA--C 1.534 0.338 0 CA-C-O 118.292 -0.861 . . . . 0.0 110.52 -179.726 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 55' ' ' PRO . . . . . . . . . . . . . 72.4 Cg_endo -77.2 169.98 72.71 Favored 'Cis proline' 0 N--CA 1.499 1.85 0 CA-C-N 121.778 1.671 . . . . 0.0 112.562 -5.145 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 56' ' ' SER . . . . . . . . . . . . . 16.1 m -115.34 133.21 22.76 Favored Pre-proline 0 CA--C 1.538 0.506 0 CA-C-O 118.457 -0.782 . . . . 0.0 109.494 174.764 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 57' ' ' PRO . . . . . . . . . . . . . 56.0 Cg_endo -71.62 147.98 89.3 Favored 'Cis proline' 0 N--CA 1.497 1.71 0 CA-C-N 121.851 1.697 . . . . 0.0 111.502 -2.171 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 58' ' ' LEU . . . . . . . . . . . . . 22.2 tp -108.05 137.11 46.61 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-O 120.926 0.393 . . . . 0.0 110.74 -177.952 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 59' ' ' ARG . . . . . . . . . . . . . 77.2 ttt180 -102.89 122.05 43.76 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-N 115.882 -0.599 . . . . 0.0 109.401 175.714 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 43.3 t -79.31 119.81 29.33 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.254 0 C-N-CA 120.633 -0.427 . . . . 0.0 110.331 -176.3 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 75.3 tt0 -130.88 158.72 39.45 Favored 'General case' 0 C--N 1.328 -0.33 0 N-CA-C 109.059 -0.719 . . . . 0.0 109.059 177.435 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 62' ' ' ASP . . . . . . . . . . . . . 68.4 m-20 -50.98 -31.11 16.93 Favored 'General case' 0 C--N 1.327 -0.381 0 N-CA-C 112.211 0.448 . . . . 0.0 112.211 -178.65 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 63' ' ' ARG . . . . . . . . . . . . . 7.1 ptp180 -86.25 4.63 38.01 Favored 'General case' 0 CA--C 1.535 0.383 0 N-CA-C 113.728 1.01 . . . . 0.0 113.728 -175.579 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 17.9 m -86.65 141.85 28.65 Favored 'General case' 0 C--N 1.332 -0.162 0 CA-C-N 118.188 0.449 . . . . 0.0 110.371 -178.667 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 65' ' ' LYS . . . . . . . . . . . . . 37.3 ttpt -89.08 130.74 35.48 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-O 121.0 0.428 . . . . 0.0 110.607 -177.94 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 66' ' ' ILE . . . . . . . . . . . . . 64.7 mt -111.78 131.52 62.93 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.288 0 N-CA-C 109.857 -0.423 . . . . 0.0 109.857 -179.104 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 67' ' ' THR . . . . . . . . . . . . . 28.5 m -125.7 138.25 53.87 Favored 'General case' 0 C--N 1.332 -0.166 0 CA-C-O 121.059 0.457 . . . . 0.0 110.865 -177.928 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 68' ' ' LEU . . . . . 0.496 ' N ' HD12 ' A' ' 68' ' ' LEU . 6.8 mp -102.19 133.13 47.55 Favored 'General case' 0 C--N 1.33 -0.239 0 CA-C-N 115.889 -0.596 . . . . 0.0 110.332 178.132 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 69' ' ' VAL . . . . . . . . . . . . . 45.3 t -98.51 141.57 16.1 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.331 0 CA-C-N 116.065 -0.516 . . . . 0.0 110.097 179.27 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 70' ' ' THR . . . . . . . . . . . . . 76.6 p -129.97 158.21 40.2 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.283 -179.501 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 71' ' ' HIS . . . . . . . . . . . . . 20.8 m-70 -71.41 152.64 94.07 Favored Pre-proline 0 C--N 1.329 -0.314 0 CA-C-N 116.049 -0.523 . . . . 0.0 110.738 -178.782 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 72' ' ' PRO . . . . . . . . . . . . . 91.7 Cg_endo -83.36 -21.04 4.62 Favored 'Trans proline' 0 N--CA 1.494 1.521 0 C-N-CA 121.502 1.468 . . . . 0.0 113.195 -179.94 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 73' ' ' VAL . . . . . . . . . . . . . 35.2 m -88.98 161.38 2.7 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.278 0 CA-C-O 120.81 0.338 . . . . 0.0 110.705 -178.679 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 74' ' ' ASP . . . . . . . . . . . . . 23.9 t0 -101.78 115.92 31.59 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.181 -0.463 . . . . 0.0 109.839 -179.677 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 42.3 t -115.78 124.54 72.29 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.204 0 CA-C-O 121.073 0.463 . . . . 0.0 110.906 -175.712 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 76' ' ' LEU . . . . . . . . . . . . . 5.0 mp -121.08 137.17 54.78 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 115.625 -0.716 . . . . 0.0 109.336 174.162 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 77' ' ' GLU . . . . . 0.442 ' HG2' HG23 ' F' ' 139' ' ' THR . 96.9 mt-10 -131.75 133.11 44.42 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-O 120.967 0.413 . . . . 0.0 111.141 -178.568 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 78' ' ' ALA . . . . . . . . . . . . . . . -122.39 137.74 54.76 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 115.813 -0.631 . . . . 0.0 109.923 176.971 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 79' ' ' LYS . . . . . 0.577 ' O ' HD13 ' A' ' 80' ' ' ILE . 99.2 mttt -75.92 117.25 17.45 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-O 120.983 0.421 . . . . 0.0 110.285 179.541 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 80' ' ' ILE . . . . . 0.577 HD13 ' O ' ' A' ' 79' ' ' LYS . 42.8 mm -139.1 102.6 1.76 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.394 0 N-CA-C 109.382 -0.599 . . . . 0.0 109.382 -176.888 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 81' ' ' LYS . . . . . . . . . . . . . 97.1 mttt -99.7 131.35 45.74 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-O 120.981 0.42 . . . . 0.0 111.198 -177.704 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . 89.02 42.1 5.72 Favored Glycine 0 CA--C 1.526 0.742 0 CA-C-N 115.893 -0.594 . . . . 0.0 111.779 174.866 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 83' ' ' ILE . . . . . . . . . . . . . 70.5 mt -69.3 136.62 25.89 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.354 0 N-CA-C 109.833 -0.432 . . . . 0.0 109.833 178.068 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 84' ' ' LYS . . . . . . . . . . . . . 59.5 tttt -99.11 -53.7 3.18 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.115 -0.493 . . . . 0.0 110.285 -178.395 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 85' ' ' ASP . . . . . . . . . . . . . 8.6 t70 -155.12 154.65 32.69 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 115.857 -0.611 . . . . 0.0 110.4 179.841 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 86' ' ' VAL . . . . . . . . . . . . . 42.2 t -129.41 132.0 66.9 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.225 0 CA-C-O 120.942 0.401 . . . . 0.0 110.642 -178.756 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 87' ' ' ILE . . . . . 0.496 HD12 ' N ' ' A' ' 87' ' ' ILE . 5.0 mp -119.62 126.81 75.68 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.219 0 CA-C-N 115.975 -0.557 . . . . 0.0 109.566 176.81 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 88' ' ' LEU . . . . . . . . . . . . . 66.8 mt -107.02 135.29 48.83 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-O 121.075 0.464 . . . . 0.0 111.322 -177.949 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 89' ' ' ASP . . . . . . . . . . . . . 13.1 t70 -127.89 152.15 48.2 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 115.758 -0.655 . . . . 0.0 109.536 175.532 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 83.3 tt0 -47.28 -39.68 15.06 Favored 'General case' 0 C--N 1.33 -0.266 0 N-CA-C 112.792 0.664 . . . . 0.0 112.792 -172.978 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 91' ' ' ASN . . . . . . . . . . . . . 29.0 p30 -132.03 34.95 3.77 Favored 'General case' 0 N--CA 1.464 0.245 0 N-CA-C 111.695 0.257 . . . . 0.0 111.695 -177.673 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 92' ' ' LEU . . . . . . . . . . . . . 8.0 tp -166.11 147.0 6.59 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-O 120.73 0.3 . . . . 0.0 110.533 -178.718 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 93' ' ' ILE . . . . . . . . . . . . . 74.6 mt -129.72 122.92 55.99 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.267 0 N-CA-C 109.545 -0.539 . . . . 0.0 109.545 179.881 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 94' ' ' VAL . . . . . . . . . . . . . 40.3 t -121.06 128.06 76.0 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.271 0 CA-C-O 120.854 0.359 . . . . 0.0 110.051 -179.519 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 95' ' ' VAL . . . . . . . . . . . . . 42.0 t -120.12 134.29 64.12 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.314 0 CA-C-N 116.031 -0.531 . . . . 0.0 109.804 179.695 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 96' ' ' ILE . . . . . . . . . . . . . 63.3 mt -111.18 128.77 67.42 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.409 0 N-CA-C 109.166 -0.679 . . . . 0.0 109.166 178.856 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 97' ' ' THR . . . . . . . . . . . . . 75.8 p -100.82 157.63 16.57 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-O 121.343 0.592 . . . . 0.0 111.283 -177.412 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 98' ' ' GLU . . . . . . . . . . . . . 84.7 tt0 -53.92 -28.16 35.12 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.001 -0.545 . . . . 0.0 112.066 -179.478 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 99' ' ' GLU . . . . . . . . . . . . . 44.9 mp0 -80.58 17.73 1.07 Allowed 'General case' 0 CA--C 1.534 0.34 0 N-CA-C 112.984 0.735 . . . . 0.0 112.984 -176.339 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 100' ' ' ASN . . . . . . . . . . . . . 4.1 m-20 61.51 37.97 16.08 Favored 'General case' 0 CA--C 1.529 0.157 0 CA-C-O 121.063 0.459 . . . . 0.0 110.938 178.459 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 101' ' ' GLU . . . . . . . . . . . . . 84.9 tt0 -117.83 144.72 45.13 Favored 'General case' 0 C--N 1.331 -0.232 0 N-CA-C 109.671 -0.492 . . . . 0.0 109.671 176.307 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 102' ' ' VAL . . . . . . . . . . . . . 45.6 t -114.98 126.2 72.51 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.257 0 CA-C-O 120.887 0.375 . . . . 0.0 110.152 -177.483 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 103' ' ' LEU . . . . . . . . . . . . . 42.5 mt -114.3 130.98 56.67 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-N 115.592 -0.731 . . . . 0.0 109.822 176.614 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 104' ' ' ILE . . . . . 0.675 HD13 HG11 ' A' ' 130' ' ' VAL . 67.7 mt -122.37 120.96 62.55 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.236 0 N-CA-C 110.436 -0.209 . . . . 0.0 110.436 -177.312 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 105' ' ' PHE . . . . . . . . . . . . . 43.8 m-85 -123.83 166.63 15.28 Favored 'General case' 0 C--N 1.332 -0.193 0 O-C-N 124.041 0.838 . . . . 0.0 109.798 179.64 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 106' ' ' ASN . . . . . . . . . . . . . 41.2 p-10 -96.21 -169.91 2.0 Favored 'General case' 0 C--N 1.329 -0.302 0 N-CA-C 109.377 -0.601 . . . . 0.0 109.377 171.545 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 107' ' ' GLN . . . . . . . . . . . . . 48.0 tt0 -59.61 -30.04 68.42 Favored 'General case' 0 CA--C 1.532 0.256 0 C-N-CA 120.74 -0.384 . . . . 0.0 111.644 177.688 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 108' ' ' ASN . . . . . . . . . . . . . 5.0 t-20 -81.89 6.32 16.18 Favored 'General case' 0 CA--C 1.537 0.476 0 N-CA-C 113.178 0.807 . . . . 0.0 113.178 -178.145 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 109' ' ' LEU . . . . . . . . . . . . . 8.9 tp 61.88 36.94 15.65 Favored 'General case' 0 C--O 1.232 0.155 0 O-C-N 122.123 -0.36 . . . . 0.0 111.526 176.567 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 110' ' ' GLU . . . . . . . . . . . . . 96.0 mt-10 -104.99 149.61 25.62 Favored 'General case' 0 C--N 1.33 -0.267 0 N-CA-C 110.032 -0.358 . . . . 0.0 110.032 176.018 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 111' ' ' GLU . . . . . . . . . . . . . 98.8 mt-10 -76.61 122.62 24.9 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-O 120.99 0.424 . . . . 0.0 111.222 -178.101 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 112' ' ' LEU . . . . . . . . . . . . . 16.1 mt -110.78 -45.94 3.42 Favored 'General case' 0 C--N 1.332 -0.177 0 CA-C-N 115.953 -0.567 . . . . 0.0 110.188 176.986 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 113' ' ' TYR . . . . . 0.412 ' HB3' HD12 ' A' ' 104' ' ' ILE . 34.5 t80 -138.65 140.69 38.96 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.859 179.381 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 114' ' ' ARG . . . . . . . . . . . . . 78.3 mtp180 -143.05 122.4 13.07 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.078 -0.51 . . . . 0.0 110.355 179.074 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 115' ' ' GLY . . . . . . . . . . . . . . . -150.12 153.79 25.29 Favored Glycine 0 CA--C 1.525 0.67 0 N-CA-C 111.22 -0.752 . . . . 0.0 111.22 179.73 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 116' ' ' LYS . . . . . . . . . . . . . 40.3 ttpt -126.47 129.46 48.73 Favored 'General case' 0 C--N 1.331 -0.226 0 N-CA-C 109.72 -0.474 . . . . 0.0 109.72 178.778 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 117' ' ' PHE . . . . . 0.412 ' HE2' HD13 ' A' ' 132' ' ' ILE . 41.6 m-85 -130.56 114.96 16.11 Favored 'General case' 0 C--N 1.333 -0.15 0 CA-C-O 120.851 0.358 . . . . 0.0 110.631 -174.155 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 118' ' ' GLU . . . . . . . . . . . . . 84.7 tt0 -53.93 -46.69 71.6 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.418 -0.355 . . . . 0.0 111.379 -177.875 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 119' ' ' ASN . . . . . . . . . . . . . 33.0 m120 -94.77 30.44 2.06 Favored 'General case' 0 C--N 1.329 -0.299 0 N-CA-C 112.241 0.46 . . . . 0.0 112.241 -175.197 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 120' ' ' LEU . . . . . . . . . . . . . 17.1 tp -58.47 123.4 16.06 Favored 'General case' 0 C--N 1.332 -0.153 0 N-CA-C 110.204 -0.295 . . . . 0.0 110.204 177.575 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 121' ' ' ASN . . . . . . . . . . . . . 14.7 m120 -113.77 -44.19 3.21 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-N 116.678 -0.237 . . . . 0.0 110.989 -178.399 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 122' ' ' LYS . . . . . . . . . . . . . 97.3 mttt -148.28 150.31 33.42 Favored 'General case' 0 C--N 1.331 -0.236 0 C-N-CA 120.549 -0.46 . . . . 0.0 111.523 -178.04 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 123' ' ' VAL . . . . . . . . . . . . . 43.9 t -130.13 132.23 65.4 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.185 0 CA-C-N 115.967 -0.561 . . . . 0.0 109.55 175.825 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 124' ' ' LEU . . . . . . . . . . . . . 17.6 tp -127.62 136.9 52.27 Favored 'General case' 0 C--N 1.332 -0.162 0 CA-C-O 120.808 0.337 . . . . 0.0 110.621 -178.188 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 125' ' ' VAL . . . . . . . . . . . . . 11.4 p -125.59 128.05 72.07 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.22 0 CA-C-N 116.112 -0.495 . . . . 0.0 110.252 178.978 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 126' ' ' ARG . . . . . . . . . . . . . 51.8 mmm-85 -140.84 123.9 16.46 Favored 'General case' 0 C--N 1.33 -0.269 0 N-CA-C 109.19 -0.67 . . . . 0.0 109.19 178.909 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 127' ' ' ASN . . . . . . . . . . . . . 37.1 t30 57.25 -150.99 0.43 Allowed 'General case' 0 CA--C 1.539 0.546 0 N-CA-C 109.56 -0.533 . . . . 0.0 109.56 -179.074 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 128' ' ' ASP . . . . . . . . . . . . . 19.5 p-10 -83.57 14.75 3.54 Favored 'General case' 0 CA--C 1.537 0.46 0 CA-C-N 118.637 0.653 . . . . 0.0 112.694 177.024 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 129' ' ' LEU . . . . . . . . . . . . . 40.2 mt -114.1 145.09 42.1 Favored 'General case' 0 C--O 1.231 0.119 0 O-C-N 121.975 -0.453 . . . . 0.0 109.83 179.06 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 130' ' ' VAL . . . . . 0.675 HG11 HD13 ' A' ' 104' ' ' ILE . 12.3 p -133.73 144.98 34.24 Favored 'Isoleucine or valine' 0 C--O 1.233 0.206 0 CA-C-O 121.248 0.547 . . . . 0.0 110.756 -176.914 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 131' ' ' VAL . . . . . 0.548 HG22 HD12 ' A' ' 140' ' ' LEU . 45.3 t -134.36 137.35 51.74 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.303 0 CA-C-N 115.707 -0.679 . . . . 0.0 110.063 179.695 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 132' ' ' ILE . . . . . 0.412 HD13 ' HE2' ' A' ' 117' ' ' PHE . 72.1 mt -116.53 132.82 65.05 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.367 0 CA-C-N 115.757 -0.656 . . . . 0.0 109.336 179.47 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 133' ' ' ILE . . . . . . . . . . . . . 42.6 mm -114.55 120.18 63.52 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.259 0 CA-C-O 120.693 0.282 . . . . 0.0 110.879 -175.356 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 134' ' ' ASP . . . . . . . . . . . . . 8.4 p-10 -130.62 143.25 50.62 Favored 'General case' 0 C--N 1.33 -0.244 0 N-CA-C 109.351 -0.611 . . . . 0.0 109.351 174.732 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 135' ' ' GLU . . . . . . . . . . . . . 39.6 tp10 -50.0 -26.32 4.18 Favored 'General case' 0 C--N 1.328 -0.328 0 N-CA-C 112.89 0.7 . . . . 0.0 112.89 -171.939 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 136' ' ' GLN . . . . . . . . . . . . . 97.0 mt-30 -80.43 -35.1 35.52 Favored 'General case' 0 C--N 1.331 -0.218 0 N-CA-C 112.022 0.378 . . . . 0.0 112.022 -176.962 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 137' ' ' LYS . . . . . . . . . . . . . 49.7 pttt -167.64 172.61 9.19 Favored 'General case' 0 C--N 1.331 -0.219 0 CA-C-O 121.478 0.656 . . . . 0.0 112.052 -173.828 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 138' ' ' LEU . . . . . 0.411 HD23 ' N ' ' A' ' 139' ' ' THR . 6.1 tt -113.99 129.81 56.58 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 115.164 -0.925 . . . . 0.0 110.114 -179.48 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 139' ' ' THR . . . . . 0.411 ' N ' HD23 ' A' ' 138' ' ' LEU . 24.8 m -108.63 126.41 52.93 Favored 'General case' 0 C--N 1.332 -0.179 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.568 179.964 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 140' ' ' LEU . . . . . 0.548 HD12 HG22 ' A' ' 131' ' ' VAL . 11.1 tp -114.26 122.89 48.14 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-N 115.753 -0.658 . . . . 0.0 109.404 -178.846 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 141' ' ' ILE . . . . . 0.473 ' HB ' HG13 ' A' ' 130' ' ' VAL . 19.9 mt -121.48 120.38 61.69 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.273 0 CA-C-O 120.954 0.407 . . . . 0.0 109.94 -176.41 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 142' ' ' ARG . . . . . . . . . . . . . 72.0 mtp180 -110.61 118.03 35.12 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 115.327 -0.851 . . . . 0.0 110.64 -177.405 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 143' ' ' THR . . . . . . . . . . . . . 33.7 p . . . . . 0 C--O 1.219 -0.502 0 CA-C-O 117.891 -1.052 . . . . 0.0 110.533 179.929 . . . . . . . . 0 0 . 1 . 019 nuclear build full ' B' B ' -3' ' ' GLU . . . . . . . . . . . . . 45.3 mp0 . . . . . 0 N--CA 1.489 1.511 0 N-CA-C 109.28 -0.637 . . . . 0.0 109.28 . . . . . . . . . 0 0 . 1 . 019 nuclear build full ' B' B ' -2' ' ' GLY . . . . . . . . . . . . . . . -69.55 138.5 30.45 Favored Glycine 0 CA--C 1.524 0.643 0 N-CA-C 111.082 -0.807 . . . . 0.0 111.082 -179.69 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' B' B ' -1' ' ' VAL . . . . . . . . . . . . . 44.7 t -142.16 143.92 25.81 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.351 0 CA-C-O 120.871 0.367 . . . . 0.0 110.064 179.899 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' B' B ' 0' ' ' ILE . . . . . . . . . . . . . 69.4 mt -91.52 133.15 34.01 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.281 0 CA-C-N 116.246 -0.434 . . . . 0.0 109.85 179.371 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' B' B ' 1' ' ' MET . . . . . . . . . . . . . 25.2 ptp -78.74 138.13 38.09 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.199 -0.455 . . . . 0.0 111.146 -177.57 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' B' B ' 2' ' ' SER . . . . . . . . . . . . . 7.3 p -122.99 134.4 54.33 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 116.017 -0.538 . . . . 0.0 110.358 178.091 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' B' B ' 3' ' ' GLU . . . . . . . . . . . . . 94.5 mt-10 -140.71 142.96 34.79 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.112 -0.495 . . . . 0.0 111.022 -177.943 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' B' B ' 4' ' ' LEU . . . . . . . . . . . . . 17.7 tp -127.85 127.86 44.2 Favored 'General case' 0 C--N 1.331 -0.205 0 CA-C-N 116.087 -0.506 . . . . 0.0 109.865 175.538 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' B' B ' 5' ' ' LYS . . . . . . . . . . . . . 98.6 mttt -109.02 122.74 47.89 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-O 120.487 0.184 . . . . 0.0 110.87 -179.673 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' B' B ' 6' ' ' LEU . . . . . . . . . . . . . 53.6 mt -114.94 143.89 44.44 Favored 'General case' 0 N--CA 1.463 0.215 0 O-C-N 123.8 0.688 . . . . 0.0 110.946 179.679 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' B' B ' 7' ' ' LYS . . . . . . . . . . . . . 84.3 tttt -129.88 135.47 27.55 Favored Pre-proline 0 CA--C 1.535 0.366 0 CA-C-O 118.811 -0.614 . . . . 0.0 109.643 175.226 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' B' B ' 8' ' ' PRO . . . . . . . . . . . . . 71.8 Cg_endo -90.48 142.85 3.59 Favored 'Trans proline' 0 N--CA 1.492 1.396 0 C-N-CA 121.578 1.519 . . . . 0.0 112.421 179.726 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' B' B ' 9' ' ' LEU . . . . . . . . . . . . . 19.5 mt -87.08 -49.64 0.46 Allowed Pre-proline 0 CA--C 1.535 0.386 0 CA-C-O 118.669 -0.682 . . . . 0.0 112.477 -179.399 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' B' B ' 10' ' ' PRO . . . . . . . . . . . . . 95.7 Cg_endo -79.12 163.03 25.64 Favored 'Trans proline' 0 N--CA 1.496 1.657 0 C-N-CA 121.317 1.344 . . . . 0.0 112.315 -178.995 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' B' B ' 11' ' ' LYS . . . . . . . . . . . . . 26.5 tptp -87.09 104.06 15.98 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.404 178.604 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' B' B ' 12' ' ' VAL . . . . . . . . . . . . . 12.5 p -147.83 147.09 17.57 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.231 0 CA-C-N 116.31 -0.404 . . . . 0.0 110.684 -179.661 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' B' B ' 13' ' ' GLU . . . . . . . . . . . . . 84.7 tt0 -100.34 124.57 45.99 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.158 -0.474 . . . . 0.0 110.079 177.447 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' B' B ' 14' ' ' LEU . . . . . 0.404 HD13 ' CD2' ' B' ' 18' ' ' PHE . 30.3 mt -98.93 151.46 37.4 Favored Pre-proline 0 CA--C 1.533 0.291 0 CA-C-O 119.311 -0.376 . . . . 0.0 111.228 -176.329 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' B' B ' 15' ' ' PRO . . . . . . . . . . . . . 24.2 Cg_exo -63.84 162.25 29.46 Favored 'Trans proline' 0 N--CA 1.498 1.792 0 C-N-CA 121.372 1.382 . . . . 0.0 111.97 175.625 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' B' B ' 16' ' ' PRO . . . . . . . . . . . . . 24.7 Cg_exo -62.41 -37.91 56.82 Favored 'Trans proline' 0 N--CA 1.497 1.694 0 C-N-CA 121.409 1.406 . . . . 0.0 112.469 179.235 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' B' B ' 17' ' ' ASP . . . . . . . . . . . . . 10.0 p-10 -85.25 12.33 8.28 Favored 'General case' 0 CA--C 1.536 0.423 0 N-CA-C 113.012 0.745 . . . . 0.0 113.012 -178.303 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' B' B ' 18' ' ' PHE . . . . . 0.404 ' CD2' HD13 ' B' ' 14' ' ' LEU . 18.7 t80 -56.8 -41.55 77.94 Favored 'General case' 0 C--N 1.334 -0.095 0 O-C-N 121.899 -0.5 . . . . 0.0 110.358 -179.183 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' B' B ' 19' ' ' VAL . . . . . . . . . . . . . 46.8 t -55.63 -41.08 62.99 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.205 0 CA-C-N 116.5 -0.318 . . . . 0.0 110.577 -179.45 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' B' B ' 20' ' ' ASP . . . . . . . . . . . . . 74.6 m-20 -59.33 -41.49 89.26 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-O 121.015 0.436 . . . . 0.0 110.427 179.942 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' B' B ' 21' ' ' VAL . . . . . . . . . . . . . 47.9 t -64.11 -46.0 94.92 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.306 0 CA-C-N 116.136 -0.484 . . . . 0.0 110.386 179.936 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' B' B ' 22' ' ' ILE . . . . . 0.468 HG22 HD12 ' B' ' 26' ' ' LEU . 51.2 mm -53.98 -60.02 1.66 Allowed 'Isoleucine or valine' 0 CA--C 1.53 0.191 0 C-N-CA 120.959 -0.296 . . . . 0.0 111.42 -178.324 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' B' B ' 23' ' ' ARG . . . . . . . . . . . . . 6.0 ptm180 -54.84 -44.75 74.2 Favored 'General case' 0 CA--C 1.53 0.184 0 C-N-CA 120.513 -0.475 . . . . 0.0 111.853 -174.244 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' B' B ' 24' ' ' ILE . . . . . . . . . . . . . 81.0 mt -61.03 -45.12 99.18 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.268 0 C-N-CA 120.836 -0.346 . . . . 0.0 111.663 -176.67 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' B' B ' 25' ' ' LYS . . . . . . . . . . . . . 72.1 mmtt -68.78 -42.56 77.22 Favored 'General case' 0 C--N 1.33 -0.267 0 N-CA-C 112.355 0.502 . . . . 0.0 112.355 -177.186 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' B' B ' 26' ' ' LEU . . . . . 0.468 HD12 HG22 ' B' ' 22' ' ' ILE . 83.0 mt -79.4 -33.97 42.26 Favored 'General case' 0 C--N 1.33 -0.275 0 N-CA-C 113.679 0.992 . . . . 0.0 113.679 -168.571 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' B' B ' 27' ' ' GLN . . . . . . . . . . . . . 17.6 pt20 -46.7 141.27 3.95 Favored 'General case' 0 N--CA 1.469 0.504 0 N-CA-C 112.785 0.661 . . . . 0.0 112.785 -175.577 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' B' B ' 28' ' ' GLY . . . . . . . . . . . . . . . 101.59 -27.16 21.73 Favored Glycine 0 CA--C 1.531 1.077 0 CA-C-N 115.612 -0.722 . . . . 0.0 112.205 -177.389 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' B' B ' 29' ' ' LYS . . . . . . . . . . . . . 68.0 mttm -97.48 155.09 17.09 Favored 'General case' 0 C--O 1.232 0.155 0 CA-C-N 117.451 0.625 . . . . 0.0 111.07 178.051 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' B' B ' 30' ' ' THR . . . . . . . . . . . . . 29.8 m -107.38 139.63 41.57 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.032 -0.531 . . . . 0.0 110.294 177.719 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' B' B ' 31' ' ' VAL . . . . . . . . . . . . . 34.5 m -129.25 152.97 38.0 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.212 0 CA-C-N 116.211 -0.45 . . . . 0.0 110.658 -179.256 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' B' B ' 32' ' ' ARG . . . . . . . . . . . . . 57.8 ttt180 -130.78 151.11 51.58 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-O 121.119 0.485 . . . . 0.0 110.243 178.798 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' B' B ' 33' ' ' THR . . . . . . . . . . . . . 21.6 m -52.12 137.16 28.39 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.366 -0.379 . . . . 0.0 111.676 -176.705 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' B' B ' 34' ' ' GLY . . . . . . . . . . . . . . . 100.61 -17.21 56.92 Favored Glycine 0 CA--C 1.532 1.154 0 CA-C-N 116.042 -0.526 . . . . 0.0 113.39 178.283 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' B' B ' 35' ' ' ASP . . . . . . . . . . . . . 78.3 m-20 -67.4 151.22 47.8 Favored 'General case' 0 C--O 1.231 0.129 0 CA-C-N 118.002 0.901 . . . . 0.0 111.244 179.141 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' B' B ' 36' ' ' VAL . . . . . . . . . . . . . 45.8 t -120.66 130.12 74.88 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.252 0 CA-C-N 115.996 -0.547 . . . . 0.0 109.806 177.429 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' B' B ' 37' ' ' ILE . . . . . . . . . . . . . 63.0 mt -119.53 138.24 50.81 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.256 0 CA-C-N 116.16 -0.473 . . . . 0.0 109.743 -179.132 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' B' B ' 38' ' ' GLY . . . . . . . . . . . . . . . -116.02 128.72 8.13 Favored Glycine 0 CA--C 1.526 0.724 0 N-CA-C 111.096 -0.802 . . . . 0.0 111.096 -179.765 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' B' B ' 39' ' ' ILE . . . . . . . . . . . . . 74.8 mt -130.58 131.0 65.16 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.237 0 N-CA-C 110.134 -0.321 . . . . 0.0 110.134 178.878 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' B' B ' 40' ' ' SER . . . . . . . . . . . . . 68.2 p -92.79 115.22 27.91 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 116.418 -0.355 . . . . 0.0 110.911 176.47 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' B' B ' 41' ' ' ILE . . . . . . . . . . . . . 44.0 mm -122.07 128.86 75.7 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.232 0 CA-C-N 116.476 -0.329 . . . . 0.0 110.276 -179.934 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' B' B ' 42' ' ' LEU . . . . . . . . . . . . . 49.9 mt 55.32 33.52 20.91 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.24 -0.436 . . . . 0.0 111.825 177.263 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' B' B ' 43' ' ' GLY . . . . . . . . . . . . . . . 72.56 27.62 69.09 Favored Glycine 0 CA--C 1.531 1.052 0 C-N-CA 121.203 -0.522 . . . . 0.0 112.393 177.646 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' B' B ' 44' ' ' LYS . . . . . . . . . . . . . 49.4 tptt -141.9 128.32 20.05 Favored 'General case' 0 C--N 1.331 -0.227 0 N-CA-C 109.65 -0.5 . . . . 0.0 109.65 177.832 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' B' B ' 45' ' ' GLU . . . . . . . . . . . . . 44.1 tp10 -82.93 128.06 34.1 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-O 120.891 0.377 . . . . 0.0 111.323 -176.147 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' B' B ' 46' ' ' VAL . . . . . . . . . . . . . 8.5 p -121.86 128.08 75.59 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.255 0 N-CA-C 109.5 -0.556 . . . . 0.0 109.5 174.765 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' B' B ' 47' ' ' LYS . . . . . . . . . . . . . 52.0 mtpt -98.86 127.26 44.74 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.011 -0.54 . . . . 0.0 110.616 177.41 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' B' B ' 48' ' ' PHE . . . . . . . . . . . . . 46.1 m-85 -111.05 131.84 54.74 Favored 'General case' 0 C--N 1.329 -0.309 0 N-CA-C 109.667 -0.494 . . . . 0.0 109.667 177.082 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' B' B ' 49' ' ' LYS . . . . . . . . . . . . . 77.5 tttt -104.71 133.32 49.75 Favored 'General case' 0 C--N 1.328 -0.327 0 N-CA-C 109.926 -0.398 . . . . 0.0 109.926 178.225 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' B' B ' 50' ' ' VAL . . . . . . . . . . . . . 42.3 t -77.76 105.45 6.8 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.28 0 N-CA-C 109.38 -0.6 . . . . 0.0 109.38 178.169 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' B' B ' 51' ' ' VAL . . . . . . . . . . . . . 49.8 t -73.02 -47.28 48.7 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.372 0 CA-C-N 116.061 -0.518 . . . . 0.0 109.879 -174.693 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' B' B ' 52' ' ' GLN . . . . . . . . . . . . . 62.1 tt0 -158.97 138.43 11.59 Favored 'General case' 0 C--N 1.33 -0.274 0 C-N-CA 120.417 -0.513 . . . . 0.0 111.486 -178.241 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' B' B ' 53' ' ' ALA . . . . . . . . . . . . . . . -117.13 130.7 56.8 Favored 'General case' 0 C--N 1.332 -0.193 0 CA-C-N 115.687 -0.688 . . . . 0.0 109.632 172.058 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' B' B ' 54' ' ' TYR . . . . . . . . . . . . . 57.9 t80 -129.18 112.17 18.29 Favored Pre-proline 0 CA--C 1.536 0.432 0 CA-C-O 118.189 -0.91 . . . . 0.0 110.359 178.933 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' B' B ' 55' ' ' PRO . . . . . . . . . . . . . 74.3 Cg_endo -77.11 168.89 75.76 Favored 'Cis proline' 0 N--CA 1.5 1.9 0 CA-C-N 121.973 1.74 . . . . 0.0 112.156 -6.002 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' B' B ' 56' ' ' SER . . . . . . . . . . . . . 13.5 m -116.6 134.88 22.84 Favored Pre-proline 0 CA--C 1.538 0.492 0 CA-C-O 118.478 -0.772 . . . . 0.0 109.456 175.881 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' B' B ' 57' ' ' PRO . . . . . . . . . . . . . 56.0 Cg_endo -72.11 146.73 86.87 Favored 'Cis proline' 0 N--CA 1.497 1.728 0 CA-C-N 121.842 1.694 . . . . 0.0 111.496 -2.229 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' B' B ' 58' ' ' LEU . . . . . . . . . . . . . 25.0 tp -108.35 136.81 47.36 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.378 -0.374 . . . . 0.0 110.832 -177.667 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' B' B ' 59' ' ' ARG . . . . . . . . . . . . . 29.0 ttm180 -100.51 125.9 46.89 Favored 'General case' 0 C--N 1.328 -0.34 0 N-CA-C 109.371 -0.603 . . . . 0.0 109.371 175.521 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' B' B ' 60' ' ' VAL . . . . . . . . . . . . . 40.8 t -78.04 121.73 31.44 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.247 0 C-N-CA 120.828 -0.349 . . . . 0.0 110.848 -174.798 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' B' B ' 61' ' ' GLU . . . . . . . . . . . . . 42.9 mt-10 -130.96 154.05 48.55 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 115.744 -0.662 . . . . 0.0 109.822 175.308 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' B' B ' 62' ' ' ASP . . . . . . . . . . . . . 19.8 p-10 -53.72 -33.64 56.26 Favored 'General case' 0 C--N 1.327 -0.397 0 N-CA-C 111.843 0.312 . . . . 0.0 111.843 -177.792 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' B' B ' 63' ' ' ARG . . . . . . . . . . . . . 36.5 mmt180 -75.66 -18.61 59.59 Favored 'General case' 0 CA--C 1.535 0.371 0 N-CA-C 113.099 0.778 . . . . 0.0 113.099 -175.969 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' B' B ' 64' ' ' THR . . . . . . . . . . . . . 24.0 m -67.2 147.91 52.46 Favored 'General case' 0 C--N 1.332 -0.172 0 CA-C-N 117.724 0.238 . . . . 0.0 110.48 -177.06 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' B' B ' 65' ' ' LYS . . . . . . . . . . . . . 98.4 mttt -87.61 122.95 31.95 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-O 120.937 0.398 . . . . 0.0 110.116 -179.648 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' B' B ' 66' ' ' ILE . . . . . . . . . . . . . 63.4 mt -108.57 120.27 59.64 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.26 0 N-CA-C 109.581 -0.526 . . . . 0.0 109.581 179.183 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' B' B ' 67' ' ' THR . . . . . . . . . . . . . 4.6 m -109.36 140.69 42.73 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-O 121.338 0.59 . . . . 0.0 111.132 -173.511 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' B' B ' 68' ' ' LEU . . . . . . . . . . . . . 7.0 tt -104.38 126.07 51.16 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 115.202 -0.908 . . . . 0.0 110.121 -178.926 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' B' B ' 69' ' ' VAL . . . . . . . . . . . . . 45.1 t -82.91 155.18 3.85 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.19 0 CA-C-N 115.931 -0.577 . . . . 0.0 109.966 178.887 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' B' B ' 70' ' ' THR . . . . . . . . . . . . . 74.4 p -74.66 161.66 29.47 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-O 121.097 0.475 . . . . 0.0 110.274 -172.835 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' B' B ' 71' ' ' HIS . . . . . . . . . . . . . 25.3 m-70 -124.92 174.04 4.23 Favored Pre-proline 0 C--N 1.33 -0.263 0 CA-C-N 115.656 -0.702 . . . . 0.0 110.28 -169.776 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' B' B ' 72' ' ' PRO . . . . . . . . . . . . . 26.3 Cg_exo -64.79 160.38 40.99 Favored 'Trans proline' 0 N--CA 1.494 1.548 0 C-N-CA 121.522 1.481 . . . . 0.0 110.632 171.339 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' B' B ' 73' ' ' VAL . . . . . . . . . . . . . 34.2 m -69.51 167.65 1.76 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.368 0 C-N-CA 120.762 -0.375 . . . . 0.0 110.377 -168.316 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' B' B ' 74' ' ' ASP . . . . . . . . . . . . . 26.4 t0 -78.85 123.89 27.68 Favored 'General case' 0 C--N 1.331 -0.205 0 CA-C-N 116.259 -0.428 . . . . 0.0 111.156 -165.058 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' B' B ' 75' ' ' VAL . . . . . . . . . . . . . 47.0 t -119.7 118.83 58.5 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.218 0 CA-C-N 116.138 -0.483 . . . . 0.0 110.098 -179.571 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' B' B ' 76' ' ' LEU . . . . . . . . . . . . . 23.8 mt -124.33 145.37 49.46 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 115.63 -0.714 . . . . 0.0 109.688 -179.966 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' B' B ' 77' ' ' GLU . . . . . . . . . . . . . 96.0 mt-10 -136.42 134.94 38.28 Favored 'General case' 0 C--N 1.331 -0.227 0 CA-C-O 121.056 0.455 . . . . 0.0 111.184 -178.606 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' B' B ' 78' ' ' ALA . . . . . . . . . . . . . . . -123.57 131.23 53.57 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 115.611 -0.722 . . . . 0.0 109.701 176.462 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' B' B ' 79' ' ' LYS . . . . . 0.608 ' O ' HD13 ' B' ' 80' ' ' ILE . 97.3 mttt -77.32 120.33 22.19 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-O 121.043 0.449 . . . . 0.0 111.266 -175.389 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' B' B ' 80' ' ' ILE . . . . . 0.608 HD13 ' O ' ' B' ' 79' ' ' LYS . 25.9 mm -139.27 101.14 1.49 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.256 0 N-CA-C 109.015 -0.735 . . . . 0.0 109.015 179.11 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' B' B ' 81' ' ' LYS . . . . . . . . . . . . . 68.6 tttt -93.06 124.6 37.15 Favored 'General case' 0 C--N 1.328 -0.332 0 C-N-CA 120.776 -0.37 . . . . 0.0 110.993 -177.01 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' B' B ' 82' ' ' GLY . . . . . . . . . . . . . . . 89.2 42.14 5.65 Favored Glycine 0 CA--C 1.524 0.641 0 C-N-CA 120.738 -0.744 . . . . 0.0 111.416 176.288 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' B' B ' 83' ' ' ILE . . . . . . . . . . . . . 72.1 mt -64.45 137.76 24.31 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.352 0 N-CA-C 109.91 -0.404 . . . . 0.0 109.91 177.884 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' B' B ' 84' ' ' LYS . . . . . . . . . . . . . 80.2 tttt -93.51 -51.38 4.98 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 115.932 -0.576 . . . . 0.0 110.001 -179.426 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' B' B ' 85' ' ' ASP . . . . . . . . . . . . . 9.9 t70 -159.87 153.59 22.78 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 115.514 -0.766 . . . . 0.0 110.062 179.558 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' B' B ' 86' ' ' VAL . . . . . . . . . . . . . 43.9 t -129.94 132.15 65.8 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.212 0 CA-C-O 121.021 0.438 . . . . 0.0 110.479 -179.166 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' B' B ' 87' ' ' ILE . . . . . . . . . . . . . 43.5 mm -120.12 125.38 74.17 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.265 0 CA-C-N 115.665 -0.698 . . . . 0.0 109.221 177.132 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' B' B ' 88' ' ' LEU . . . . . . . . . . . . . 12.0 tp -114.51 127.92 56.06 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-O 121.021 0.439 . . . . 0.0 111.254 -176.788 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' B' B ' 89' ' ' ASP . . . . . . . . . . . . . 11.2 t70 -117.81 153.66 33.1 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 115.702 -0.681 . . . . 0.0 109.407 175.931 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' B' B ' 90' ' ' GLU . . . . . . . . . . . . . 84.6 tt0 -47.78 -35.5 10.12 Favored 'General case' 0 C--N 1.33 -0.282 0 N-CA-C 112.869 0.692 . . . . 0.0 112.869 -172.836 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' B' B ' 91' ' ' ASN . . . . . . . . . . . . . 18.3 p-10 -132.06 31.36 4.16 Favored 'General case' 0 N--CA 1.466 0.326 0 N-CA-C 112.256 0.465 . . . . 0.0 112.256 -175.808 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' B' B ' 92' ' ' LEU . . . . . . . . . . . . . 6.7 tp -166.13 145.1 5.9 Favored 'General case' 0 C--N 1.331 -0.213 0 C-N-CA 120.934 -0.307 . . . . 0.0 110.54 -179.619 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' B' B ' 93' ' ' ILE . . . . . . . . . . . . . 68.8 mt -123.14 123.36 67.67 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.264 0 N-CA-C 109.704 -0.48 . . . . 0.0 109.704 -179.413 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' B' B ' 94' ' ' VAL . . . . . . . . . . . . . 43.5 t -121.38 124.96 73.04 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.239 0 CA-C-O 120.967 0.413 . . . . 0.0 110.024 179.689 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' B' B ' 95' ' ' VAL . . . . . . . . . . . . . 45.9 t -119.68 133.4 66.58 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.283 0 CA-C-N 115.917 -0.583 . . . . 0.0 109.928 -179.071 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' B' B ' 96' ' ' ILE . . . . . 0.666 HD11 ' HB ' ' B' ' 123' ' ' VAL . 61.8 mt -114.59 126.38 72.12 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.366 0 N-CA-C 109.467 -0.568 . . . . 0.0 109.467 178.988 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' B' B ' 97' ' ' THR . . . . . . . . . . . . . 67.4 p -95.94 156.21 16.43 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-O 120.99 0.424 . . . . 0.0 110.812 -179.267 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' B' B ' 98' ' ' GLU . . . . . . . . . . . . . 40.1 tp10 -53.92 -28.66 38.19 Favored 'General case' 0 C--N 1.329 -0.287 0 N-CA-C 112.144 0.424 . . . . 0.0 112.144 -178.401 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' B' B ' 99' ' ' GLU . . . . . . . . . . . . . 14.7 pt-20 -81.54 17.25 1.45 Allowed 'General case' 0 CA--C 1.535 0.373 0 N-CA-C 113.326 0.862 . . . . 0.0 113.326 -176.19 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' B' B ' 100' ' ' ASN . . . . . . . . . . . . . 4.9 m-20 64.89 34.65 9.0 Favored 'General case' 0 N--CA 1.463 0.216 0 CA-C-O 120.793 0.33 . . . . 0.0 111.678 176.959 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' B' B ' 101' ' ' GLU . . . . . . . . . . . . . 84.5 tt0 -108.84 141.78 40.38 Favored 'General case' 0 C--N 1.331 -0.2 0 N-CA-C 109.642 -0.503 . . . . 0.0 109.642 172.226 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' B' B ' 102' ' ' VAL . . . . . . . . . . . . . 46.3 t -114.96 125.9 72.41 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.308 0 N-CA-C 109.967 -0.382 . . . . 0.0 109.967 -177.846 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' B' B ' 103' ' ' LEU . . . . . . . . . . . . . 57.4 mt -117.26 129.79 56.14 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 115.845 -0.616 . . . . 0.0 110.13 177.944 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' B' B ' 104' ' ' ILE . . . . . 0.57 HD13 HG11 ' B' ' 130' ' ' VAL . 67.8 mt -118.31 120.84 65.6 Favored 'Isoleucine or valine' 0 C--O 1.234 0.289 0 N-CA-C 110.161 -0.311 . . . . 0.0 110.161 -178.976 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' B' B ' 105' ' ' PHE . . . . . . . . . . . . . 74.6 m-85 -123.53 165.16 17.6 Favored 'General case' 0 C--N 1.333 -0.15 0 O-C-N 123.92 0.763 . . . . 0.0 109.836 -179.252 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' B' B ' 106' ' ' ASN . . . . . . . . . . . . . 46.7 p-10 -99.51 -170.77 1.95 Allowed 'General case' 0 C--N 1.33 -0.274 0 N-CA-C 109.788 -0.449 . . . . 0.0 109.788 171.832 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' B' B ' 107' ' ' GLN . . . . . . . . . . . . . 51.0 tt0 -57.58 -27.64 62.87 Favored 'General case' 0 C--N 1.327 -0.373 0 N-CA-C 112.305 0.483 . . . . 0.0 112.305 -178.944 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' B' B ' 108' ' ' ASN . . . . . . . . . . . . . 14.4 t30 -93.5 14.31 19.11 Favored 'General case' 0 CA--C 1.535 0.379 0 N-CA-C 113.0 0.741 . . . . 0.0 113.0 -175.43 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' B' B ' 109' ' ' LEU . . . . . . . . . . . . . 71.1 mt 59.12 37.7 24.04 Favored 'General case' 0 C--N 1.332 -0.189 0 CA-C-O 121.067 0.461 . . . . 0.0 111.377 177.596 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' B' B ' 110' ' ' GLU . . . . . . . . . . . . . 43.4 mt-10 -103.46 163.43 12.29 Favored 'General case' 0 C--N 1.331 -0.225 0 CA-C-N 116.388 -0.369 . . . . 0.0 110.223 177.331 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' B' B ' 111' ' ' GLU . . . . . . . . . . . . . 82.6 tt0 -84.58 124.9 31.94 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-O 120.94 0.4 . . . . 0.0 111.243 -177.22 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' B' B ' 112' ' ' LEU . . . . . . . . . . . . . 20.0 mt -113.02 -45.99 3.14 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 115.905 -0.589 . . . . 0.0 109.6 172.84 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' B' B ' 113' ' ' TYR . . . . . 0.487 ' HB3' HD12 ' B' ' 104' ' ' ILE . 34.9 t80 -150.64 137.04 18.72 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.02 -0.536 . . . . 0.0 110.821 179.097 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' B' B ' 114' ' ' ARG . . . . . . . . . . . . . 57.0 mtm180 -140.39 124.4 17.46 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-O 120.733 0.302 . . . . 0.0 110.306 175.242 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' B' B ' 115' ' ' GLY . . . . . . . . . . . . . . . -150.15 162.9 29.36 Favored Glycine 0 CA--C 1.523 0.566 0 N-CA-C 110.632 -0.987 . . . . 0.0 110.632 -179.555 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' B' B ' 116' ' ' LYS . . . . . . . . . . . . . 82.7 tttt -133.37 130.83 39.32 Favored 'General case' 0 C--N 1.33 -0.278 0 N-CA-C 109.918 -0.401 . . . . 0.0 109.918 178.553 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' B' B ' 117' ' ' PHE . . . . . . . . . . . . . 46.5 m-85 -125.79 118.43 25.51 Favored 'General case' 0 C--N 1.331 -0.227 0 CA-C-O 121.015 0.436 . . . . 0.0 110.49 -174.862 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' B' B ' 118' ' ' GLU . . . . . . . . . . . . . 44.5 tp10 -52.83 -49.38 65.82 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.397 -0.365 . . . . 0.0 111.572 -176.979 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' B' B ' 119' ' ' ASN . . . . . . . . . . . . . 20.4 m120 -95.76 31.21 2.12 Favored 'General case' 0 C--N 1.33 -0.253 0 N-CA-C 112.11 0.411 . . . . 0.0 112.11 -174.803 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' B' B ' 120' ' ' LEU . . . . . . . . . . . . . 13.7 tp -55.04 123.38 13.4 Favored 'General case' 0 N--CA 1.462 0.134 0 CA-C-O 120.711 0.291 . . . . 0.0 110.769 178.282 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' B' B ' 121' ' ' ASN . . . . . . . . . . . . . 60.5 t30 -113.58 -44.01 3.25 Favored 'General case' 0 C--N 1.332 -0.184 0 CA-C-N 116.337 -0.392 . . . . 0.0 110.822 -177.742 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' B' B ' 122' ' ' LYS . . . . . . . . . . . . . 97.8 mttt -148.53 150.72 33.87 Favored 'General case' 0 C--N 1.331 -0.229 0 CA-C-O 121.119 0.485 . . . . 0.0 111.562 -178.434 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' B' B ' 123' ' ' VAL . . . . . 0.666 ' HB ' HD11 ' B' ' 96' ' ' ILE . 47.4 t -131.74 129.35 61.19 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.224 0 N-CA-C 109.325 -0.62 . . . . 0.0 109.325 174.812 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' B' B ' 124' ' ' LEU . . . . . . . . . . . . . 67.3 mt -130.87 142.65 50.39 Favored 'General case' 0 C--N 1.331 -0.203 0 CA-C-O 120.959 0.409 . . . . 0.0 110.769 -177.438 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' B' B ' 125' ' ' VAL . . . . . . . . . . . . . 12.1 p -135.7 138.32 48.07 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.255 0 CA-C-N 116.005 -0.543 . . . . 0.0 110.555 179.946 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' B' B ' 126' ' ' ARG . . . . . . . . . . . . . 75.3 mtt180 -148.08 121.95 9.35 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 115.838 -0.619 . . . . 0.0 109.393 178.04 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' B' B ' 127' ' ' ASN . . . . . . . . . . . . . 71.6 m-80 57.04 -147.44 0.52 Allowed 'General case' 0 CA--C 1.541 0.614 0 N-CA-C 109.602 -0.518 . . . . 0.0 109.602 -178.278 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' B' B ' 128' ' ' ASP . . . . . . . . . . . . . 23.1 p-10 -83.44 12.62 5.3 Favored 'General case' 0 CA--C 1.537 0.464 0 CA-C-N 118.845 0.748 . . . . 0.0 112.989 179.199 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' B' B ' 129' ' ' LEU . . . . . . . . . . . . . 19.6 tp -109.03 136.45 48.53 Favored 'General case' 0 C--O 1.231 0.084 0 N-CA-C 109.747 -0.464 . . . . 0.0 109.747 178.32 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' B' B ' 130' ' ' VAL . . . . . 0.57 HG11 HD13 ' B' ' 104' ' ' ILE . 12.3 p -131.3 141.76 45.12 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.213 0 CA-C-O 120.982 0.42 . . . . 0.0 110.637 -178.806 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' B' B ' 131' ' ' VAL . . . . . 0.553 HG22 HD12 ' B' ' 140' ' ' LEU . 41.5 t -136.14 138.37 47.3 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 CA-C-N 116.021 -0.536 . . . . 0.0 110.495 -178.741 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' B' B ' 132' ' ' ILE . . . . . . . . . . . . . 73.1 mt -116.79 133.64 62.82 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.323 0 CA-C-N 115.591 -0.731 . . . . 0.0 109.244 178.448 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' B' B ' 133' ' ' ILE . . . . . . . . . . . . . 41.1 mm -115.94 120.81 65.9 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.268 0 CA-C-O 120.714 0.293 . . . . 0.0 111.018 -175.521 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' B' B ' 134' ' ' ASP . . . . . . . . . . . . . 7.5 p-10 -131.98 144.98 51.19 Favored 'General case' 0 C--N 1.33 -0.262 0 N-CA-C 109.433 -0.58 . . . . 0.0 109.433 175.124 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' B' B ' 135' ' ' GLU . . . . . . . . . . . . . 83.7 tt0 -50.06 -26.23 4.2 Favored 'General case' 0 C--N 1.328 -0.348 0 N-CA-C 112.861 0.689 . . . . 0.0 112.861 -173.682 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' B' B ' 136' ' ' GLN . . . . . . . . . . . . . 97.1 mt-30 -78.51 -35.8 45.81 Favored 'General case' 0 C--O 1.234 0.245 0 N-CA-C 112.058 0.392 . . . . 0.0 112.058 -177.465 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' B' B ' 137' ' ' LYS . . . . . . . . . . . . . 56.2 pttt -170.0 173.66 5.89 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-O 121.426 0.631 . . . . 0.0 111.907 -172.613 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' B' B ' 138' ' ' LEU . . . . . 0.422 ' C ' HD23 ' B' ' 138' ' ' LEU . 8.2 tt -116.31 130.14 56.63 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 115.415 -0.811 . . . . 0.0 110.136 179.557 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' B' B ' 139' ' ' THR . . . . . . . . . . . . . 25.8 m -108.07 124.35 50.07 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.069 -0.514 . . . . 0.0 110.501 179.995 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' B' B ' 140' ' ' LEU . . . . . 0.553 HD12 HG22 ' B' ' 131' ' ' VAL . 49.7 tp -113.08 121.07 43.48 Favored 'General case' 0 C--N 1.328 -0.351 0 N-CA-C 109.094 -0.706 . . . . 0.0 109.094 -179.241 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' B' B ' 141' ' ' ILE . . . . . 0.494 ' HB ' HG13 ' B' ' 130' ' ' VAL . 19.0 mt -121.23 121.1 63.95 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.309 0 CA-C-O 120.985 0.422 . . . . 0.0 110.189 -175.261 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' B' B ' 142' ' ' ARG . . . . . . . . . . . . . 61.4 mtp180 -105.21 120.81 42.45 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 115.15 -0.932 . . . . 0.0 109.985 179.363 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' B' B ' 143' ' ' THR . . . . . . . . . . . . . 35.9 p . . . . . 0 C--O 1.22 -0.486 0 CA-C-O 118.065 -0.969 . . . . 0.0 110.604 -179.697 . . . . . . . . 0 0 . 1 . 019 nuclear build full ' C' C ' -3' ' ' GLU . . . . . . . . . . . . . 84.8 tt0 . . . . . 0 N--CA 1.49 1.541 0 N-CA-C 109.278 -0.638 . . . . 0.0 109.278 . . . . . . . . . 0 0 . 1 . 019 nuclear build full ' C' C ' -2' ' ' GLY . . . . . . . . . . . . . . . -78.59 149.98 34.13 Favored Glycine 0 CA--C 1.526 0.742 0 N-CA-C 111.007 -0.837 . . . . 0.0 111.007 179.391 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' C' C ' -1' ' ' VAL . . . . . . . . . . . . . 43.1 t -94.92 137.46 23.22 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.303 0 N-CA-C 109.998 -0.371 . . . . 0.0 109.998 179.591 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' C' C ' 0' ' ' ILE . . . . . . . . . . . . . 43.8 mm -104.55 131.92 52.4 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.282 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.201 -179.348 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' C' C ' 1' ' ' MET . . . . . . . . . . . . . 26.4 ptm -78.43 139.13 38.75 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.022 -0.535 . . . . 0.0 110.948 -179.286 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' C' C ' 2' ' ' SER . . . . . . . . . . . . . 3.1 p -117.91 127.96 54.36 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.351 177.474 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' C' C ' 3' ' ' GLU . . . . . . . . . . . . . 84.8 tt0 -141.24 141.61 33.99 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 115.89 -0.595 . . . . 0.0 110.954 -178.891 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' C' C ' 4' ' ' LEU . . . . . . . . . . . . . 19.2 tp -126.14 129.08 48.35 Favored 'General case' 0 C--N 1.331 -0.216 0 CA-C-N 115.866 -0.606 . . . . 0.0 110.257 177.73 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' C' C ' 5' ' ' LYS . . . . . . . . . . . . . 66.9 mttm -105.35 120.96 42.88 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.255 -0.429 . . . . 0.0 110.543 178.728 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' C' C ' 6' ' ' LEU . . . . . . . . . . . . . 55.1 mt -116.56 146.53 42.57 Favored 'General case' 0 C--N 1.331 -0.23 0 O-C-N 123.831 0.707 . . . . 0.0 110.109 -179.703 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' C' C ' 7' ' ' LYS . . . . . . . . . . . . . 49.8 tttp -126.83 137.67 30.99 Favored Pre-proline 0 CA--C 1.534 0.329 0 CA-C-O 118.901 -0.571 . . . . 0.0 109.912 175.664 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' C' C ' 8' ' ' PRO . . . . . . . . . . . . . 89.8 Cg_endo -92.1 131.72 1.17 Allowed 'Trans proline' 0 N--CA 1.489 1.257 0 C-N-CA 121.661 1.574 . . . . 0.0 111.673 178.016 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' C' C ' 9' ' ' LEU . . . . . . . . . . . . . 64.8 mt -70.98 -46.59 15.0 Favored Pre-proline 0 CA--C 1.533 0.303 0 CA-C-O 118.808 -0.615 . . . . 0.0 112.191 -179.053 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' C' C ' 10' ' ' PRO . . . . . . . . . . . . . 85.8 Cg_endo -81.79 147.89 15.47 Favored 'Trans proline' 0 N--CA 1.495 1.617 0 C-N-CA 121.237 1.291 . . . . 0.0 111.574 174.26 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' C' C ' 11' ' ' LYS . . . . . . . . . . . . . 60.7 tttm -88.14 96.54 10.57 Favored 'General case' 0 C--N 1.33 -0.254 0 C-N-CA 120.862 -0.335 . . . . 0.0 110.455 179.145 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' C' C ' 12' ' ' VAL . . . . . . . . . . . . . 12.5 p -140.06 146.78 24.35 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.321 0 CA-C-N 116.241 -0.436 . . . . 0.0 110.512 -179.79 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' C' C ' 13' ' ' GLU . . . . . . . . . . . . . 81.4 tt0 -85.86 125.8 33.57 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.243 -0.435 . . . . 0.0 110.008 177.949 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' C' C ' 14' ' ' LEU . . . . . . . . . . . . . 17.6 mt -96.94 149.63 35.94 Favored Pre-proline 0 CA--C 1.532 0.263 0 CA-C-O 119.262 -0.399 . . . . 0.0 110.366 -178.708 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' C' C ' 15' ' ' PRO . . . . . . . . . . . . . 26.1 Cg_exo -61.76 160.65 28.01 Favored 'Trans proline' 0 N--CA 1.497 1.732 0 C-N-CA 121.23 1.287 . . . . 0.0 111.852 177.496 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' C' C ' 16' ' ' PRO . . . . . . . . . . . . . 34.0 Cg_exo -59.5 -34.01 97.07 Favored 'Trans proline' 0 N--CA 1.498 1.754 0 C-N-CA 121.437 1.425 . . . . 0.0 112.714 -178.127 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' C' C ' 17' ' ' ASP . . . . . . . . . . . . . 18.5 p-10 -87.88 3.58 47.91 Favored 'General case' 0 CA--C 1.536 0.435 0 N-CA-C 113.409 0.892 . . . . 0.0 113.409 -177.042 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' C' C ' 18' ' ' PHE . . . . . . . . . . . . . 43.3 t80 -58.18 -46.5 85.64 Favored 'General case' 0 C--N 1.334 -0.091 0 O-C-N 122.046 -0.409 . . . . 0.0 110.098 -177.689 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' C' C ' 19' ' ' VAL . . . . . . . . . . . . . 47.8 t -56.75 -43.0 78.59 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.372 0 CA-C-N 116.27 -0.423 . . . . 0.0 110.608 -177.895 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' C' C ' 20' ' ' ASP . . . . . . . . . . . . . 67.7 m-20 -59.66 -43.0 94.11 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-O 120.786 0.327 . . . . 0.0 110.813 -177.549 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' C' C ' 21' ' ' VAL . . . . . . . . . . . . . 46.2 t -64.01 -45.41 96.78 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.32 0 C-N-CA 120.818 -0.353 . . . . 0.0 110.425 -177.848 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' C' C ' 22' ' ' ILE . . . . . 0.547 HG22 HD12 ' C' ' 26' ' ' LEU . 51.8 mm -54.96 -48.44 75.26 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.276 0 C-N-CA 120.993 -0.283 . . . . 0.0 110.743 179.032 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' C' C ' 23' ' ' ARG . . . . . . . . . . . . . 54.3 ttp180 -54.65 -47.93 72.93 Favored 'General case' 0 C--N 1.33 -0.258 0 C-N-CA 121.022 -0.271 . . . . 0.0 111.355 -178.328 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' C' C ' 24' ' ' ILE . . . . . . . . . . . . . 74.2 mt -59.11 -42.89 87.98 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.34 0 C-N-CA 121.184 -0.206 . . . . 0.0 111.208 -177.901 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' C' C ' 25' ' ' LYS . . . . . . . . . . . . . 73.9 mmtt -66.68 -41.37 88.21 Favored 'General case' 0 C--N 1.328 -0.335 0 N-CA-C 112.253 0.464 . . . . 0.0 112.253 -178.428 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' C' C ' 26' ' ' LEU . . . . . 0.547 HD12 HG22 ' C' ' 22' ' ' ILE . 83.1 mt -79.22 -38.76 34.9 Favored 'General case' 0 C--N 1.328 -0.332 0 N-CA-C 113.283 0.845 . . . . 0.0 113.283 -169.872 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' C' C ' 27' ' ' GLN . . . . . . . . . . . . . 17.2 pt20 -47.06 140.05 5.28 Favored 'General case' 0 N--CA 1.468 0.444 0 N-CA-C 112.78 0.659 . . . . 0.0 112.78 -175.831 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' C' C ' 28' ' ' GLY . . . . . . . . . . . . . . . 99.15 -25.7 27.21 Favored Glycine 0 CA--C 1.533 1.159 0 CA-C-N 115.687 -0.688 . . . . 0.0 112.297 -177.013 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' C' C ' 29' ' ' LYS . . . . . . . . . . . . . 87.5 mttt -97.89 155.11 17.22 Favored 'General case' 0 C--N 1.331 -0.199 0 CA-C-N 117.357 0.579 . . . . 0.0 111.053 179.362 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' C' C ' 30' ' ' THR . . . . . . . . . . . . . 26.2 m -103.79 138.3 40.59 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.133 -0.485 . . . . 0.0 110.1 176.696 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' C' C ' 31' ' ' VAL . . . . . . . . . . . . . 34.4 m -129.85 151.14 35.39 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.201 0 CA-C-O 120.868 0.366 . . . . 0.0 110.986 -178.429 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' C' C ' 32' ' ' ARG . . . . . . . . . . . . . 71.3 mtt85 -127.91 149.19 50.42 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 115.971 -0.558 . . . . 0.0 110.489 178.743 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' C' C ' 33' ' ' THR . . . . . . . . . . . . . 30.3 m -53.18 138.76 30.85 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.43 -0.35 . . . . 0.0 111.375 -179.175 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' C' C ' 34' ' ' GLY . . . . . . . . . . . . . . . 100.23 -17.2 57.32 Favored Glycine 0 CA--C 1.533 1.159 0 C-N-CA 121.307 -0.473 . . . . 0.0 113.223 179.266 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' C' C ' 35' ' ' ASP . . . . . . . . . . . . . 76.2 m-20 -66.63 149.3 50.69 Favored 'General case' 0 N--CA 1.462 0.151 0 CA-C-N 117.967 0.883 . . . . 0.0 111.155 179.361 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' C' C ' 36' ' ' VAL . . . . . . . . . . . . . 44.6 t -119.3 128.99 75.83 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.26 0 CA-C-N 115.845 -0.616 . . . . 0.0 109.674 177.929 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' C' C ' 37' ' ' ILE . . . . . . . . . . . . . 65.6 mt -119.83 138.28 50.95 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.271 0 CA-C-N 116.151 -0.477 . . . . 0.0 109.804 -179.466 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' C' C ' 38' ' ' GLY . . . . . . . . . . . . . . . -116.9 128.71 8.02 Favored Glycine 0 CA--C 1.525 0.667 0 N-CA-C 111.121 -0.792 . . . . 0.0 111.121 -179.653 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' C' C ' 39' ' ' ILE . . . . . . . . . . . . . 70.7 mt -127.0 127.05 69.35 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.256 0 N-CA-C 109.961 -0.385 . . . . 0.0 109.961 178.268 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' C' C ' 40' ' ' SER . . . . . . . . . . . . . 59.6 p -91.41 113.94 26.34 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.561 -0.29 . . . . 0.0 110.988 177.773 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' C' C ' 41' ' ' ILE . . . . . . . . . . . . . 45.5 mm -123.3 128.14 74.69 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.248 0 CA-C-N 116.408 -0.36 . . . . 0.0 110.063 179.694 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' C' C ' 42' ' ' LEU . . . . . . . . . . . . . 69.8 mt 58.02 33.86 23.63 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 116.194 -0.457 . . . . 0.0 111.779 176.934 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' C' C ' 43' ' ' GLY . . . . . . . . . . . . . . . 73.11 21.81 79.5 Favored Glycine 0 CA--C 1.533 1.195 0 C-N-CA 121.227 -0.511 . . . . 0.0 112.89 177.623 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' C' C ' 44' ' ' LYS . . . . . . . . . . . . . 67.6 mttm -138.25 130.54 28.88 Favored 'General case' 0 C--N 1.332 -0.16 0 CA-C-N 117.41 0.605 . . . . 0.0 109.919 177.548 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' C' C ' 45' ' ' GLU . . . . . . . . . . . . . 43.5 tp10 -84.06 127.26 33.78 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.367 -0.379 . . . . 0.0 111.413 -177.545 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' C' C ' 46' ' ' VAL . . . . . . . . . . . . . 8.9 p -116.06 127.3 73.7 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.282 0 N-CA-C 109.249 -0.648 . . . . 0.0 109.249 173.312 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' C' C ' 47' ' ' LYS . . . . . . . . . . . . . 64.8 mttp -98.07 126.16 43.38 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 116.104 -0.498 . . . . 0.0 110.787 178.715 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' C' C ' 48' ' ' PHE . . . . . . . . . . . . . 34.2 m-85 -110.82 131.88 54.67 Favored 'General case' 0 C--N 1.328 -0.345 0 N-CA-C 109.453 -0.573 . . . . 0.0 109.453 177.159 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' C' C ' 49' ' ' LYS . . . . . . . . . . . . . 45.2 tttp -105.65 133.27 50.67 Favored 'General case' 0 C--N 1.328 -0.354 0 N-CA-C 110.085 -0.339 . . . . 0.0 110.085 178.831 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' C' C ' 50' ' ' VAL . . . . . . . . . . . . . 46.2 t -75.79 102.4 2.83 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.324 0 N-CA-C 109.189 -0.671 . . . . 0.0 109.189 176.669 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' C' C ' 51' ' ' VAL . . . . . . . . . . . . . 47.0 t -70.03 -48.18 64.22 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.279 0 CA-C-N 116.005 -0.543 . . . . 0.0 109.895 -174.293 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' C' C ' 52' ' ' GLN . . . . . . . . . . . . . 62.0 tt0 -160.14 138.92 10.54 Favored 'General case' 0 C--N 1.33 -0.252 0 C-N-CA 120.382 -0.527 . . . . 0.0 111.631 -178.8 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' C' C ' 53' ' ' ALA . . . . . 0.447 ' HB3' ' OG ' ' C' ' 56' ' ' SER . . . -111.55 130.97 55.57 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 115.665 -0.698 . . . . 0.0 109.806 176.012 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' C' C ' 54' ' ' TYR . . . . . . . . . . . . . 45.7 t80 -128.93 107.32 18.19 Favored Pre-proline 0 CA--C 1.535 0.395 0 CA-C-O 118.335 -0.841 . . . . 0.0 110.54 -179.04 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' C' C ' 55' ' ' PRO . . . . . . . . . . . . . 73.7 Cg_endo -77.12 170.04 72.65 Favored 'Cis proline' 0 N--CA 1.499 1.81 0 CA-C-N 121.784 1.673 . . . . 0.0 112.355 -6.158 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' C' C ' 56' ' ' SER . . . . . 0.447 ' OG ' ' HB3' ' C' ' 53' ' ' ALA . 69.8 m -117.06 132.33 23.52 Favored Pre-proline 0 CA--C 1.539 0.544 0 CA-C-O 118.492 -0.766 . . . . 0.0 109.476 175.371 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' C' C ' 57' ' ' PRO . . . . . . . . . . . . . 44.2 Cg_endo -69.35 147.4 83.72 Favored 'Cis proline' 0 N--CA 1.498 1.767 0 CA-C-N 121.909 1.718 . . . . 0.0 111.335 -1.46 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' C' C ' 58' ' ' LEU . . . . . . . . . . . . . 27.0 tp -107.06 136.63 46.59 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.372 -0.377 . . . . 0.0 110.68 -178.017 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' C' C ' 59' ' ' ARG . . . . . . . . . . . . . 75.4 ttt180 -102.12 120.79 41.02 Favored 'General case' 0 C--N 1.325 -0.482 0 N-CA-C 109.364 -0.606 . . . . 0.0 109.364 176.27 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' C' C ' 60' ' ' VAL . . . . . . . . . . . . . 40.8 t -74.31 122.09 26.9 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.268 0 C-N-CA 120.633 -0.427 . . . . 0.0 110.09 -176.021 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' C' C ' 61' ' ' GLU . . . . . . . . . . . . . 32.4 tp10 -130.72 157.78 41.87 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 115.994 -0.548 . . . . 0.0 109.759 -178.409 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' C' C ' 62' ' ' ASP . . . . . . . . . . . . . 35.7 m-20 -53.22 -32.5 48.51 Favored 'General case' 0 C--N 1.326 -0.417 0 N-CA-C 111.762 0.282 . . . . 0.0 111.762 179.947 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' C' C ' 63' ' ' ARG . . . . . . . . . . . . . 9.5 ptm180 -86.25 6.56 29.07 Favored 'General case' 0 CA--C 1.535 0.397 0 N-CA-C 113.551 0.945 . . . . 0.0 113.551 -177.522 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' C' C ' 64' ' ' THR . . . . . . . . . . . . . 37.6 m -83.58 137.87 33.64 Favored 'General case' 0 C--N 1.332 -0.166 0 CA-C-N 118.095 0.407 . . . . 0.0 110.569 -178.144 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' C' C ' 65' ' ' LYS . . . . . . . . . . . . . 53.4 mtmt -89.67 127.27 35.9 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 116.016 -0.538 . . . . 0.0 110.279 178.232 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' C' C ' 66' ' ' ILE . . . . . . . . . . . . . 64.1 mt -113.52 125.72 70.84 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.288 0 N-CA-C 109.413 -0.588 . . . . 0.0 109.413 178.957 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' C' C ' 67' ' ' THR . . . . . . . . . . . . . 20.9 m -125.21 143.67 50.83 Favored 'General case' 0 C--N 1.331 -0.208 0 CA-C-O 121.139 0.495 . . . . 0.0 111.221 -175.858 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' C' C ' 68' ' ' LEU . . . . . 0.433 HD12 ' N ' ' C' ' 68' ' ' LEU . 7.8 mp -97.34 132.81 42.71 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 115.738 -0.665 . . . . 0.0 110.129 176.471 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' C' C ' 69' ' ' VAL . . . . . . . . . . . . . 43.1 t -89.94 120.56 38.94 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.38 0 CA-C-N 116.242 -0.435 . . . . 0.0 110.073 179.303 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' C' C ' 70' ' ' THR . . . . . . . . . . . . . 20.5 m -135.12 146.76 49.13 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.059 -0.519 . . . . 0.0 110.496 -178.922 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' C' C ' 71' ' ' HIS . . . . . . . . . . . . . 34.7 t60 -125.23 73.34 66.69 Favored Pre-proline 0 CA--C 1.535 0.367 0 CA-C-N 116.246 -0.434 . . . . 0.0 110.285 179.104 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' C' C ' 72' ' ' PRO . . . . . . . . . . . . . 90.4 Cg_endo -90.2 154.17 4.67 Favored 'Trans proline' 0 N--CA 1.489 1.232 0 C-N-CA 121.946 1.764 . . . . 0.0 112.256 179.788 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' C' C ' 73' ' ' VAL . . . . . . . . . . . . . 35.8 m -76.39 168.55 1.98 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.306 0 CA-C-N 116.151 -0.477 . . . . 0.0 110.354 178.955 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' C' C ' 74' ' ' ASP . . . . . . . . . . . . . 29.4 t0 -101.06 117.53 35.2 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.253 -0.43 . . . . 0.0 110.071 -178.802 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' C' C ' 75' ' ' VAL . . . . . . . . . . . . . 43.5 t -111.48 120.95 63.13 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.241 0 CA-C-O 120.992 0.425 . . . . 0.0 110.315 -179.266 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' C' C ' 76' ' ' LEU . . . . . . . . . . . . . 29.5 mt -123.42 145.41 48.81 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 115.869 -0.605 . . . . 0.0 109.604 179.212 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' C' C ' 77' ' ' GLU . . . . . . . . . . . . . 45.4 mt-10 -136.83 135.47 37.96 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-O 121.035 0.445 . . . . 0.0 111.149 -177.25 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' C' C ' 78' ' ' ALA . . . . . 0.573 ' HB2' HD21 ' C' ' 109' ' ' LEU . . . -122.17 125.84 47.0 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 115.615 -0.721 . . . . 0.0 109.465 176.862 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' C' C ' 79' ' ' LYS . . . . . 0.58 ' O ' HD13 ' C' ' 80' ' ' ILE . 47.4 pttt -78.63 119.86 22.49 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-O 121.437 0.637 . . . . 0.0 111.208 -175.781 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' C' C ' 80' ' ' ILE . . . . . 0.58 HD13 ' O ' ' C' ' 79' ' ' LYS . 38.8 mm -139.39 110.25 4.57 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.246 0 CA-C-N 115.478 -0.783 . . . . 0.0 108.993 -179.832 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' C' C ' 81' ' ' LYS . . . . . . . . . . . . . 25.1 mtpp -97.77 123.99 41.94 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-O 120.894 0.378 . . . . 0.0 111.097 -177.977 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' C' C ' 82' ' ' GLY . . . . . . . . . . . . . . . 89.19 42.22 5.63 Favored Glycine 0 CA--C 1.527 0.839 0 C-N-CA 120.85 -0.691 . . . . 0.0 111.604 175.8 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' C' C ' 83' ' ' ILE . . . . . . . . . . . . . 69.2 mt -65.24 136.58 26.45 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.35 0 N-CA-C 109.732 -0.469 . . . . 0.0 109.732 177.477 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' C' C ' 84' ' ' LYS . . . . . . . . . . . . . 26.9 ttmt -88.64 -48.74 7.33 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.136 -0.484 . . . . 0.0 110.114 -179.508 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' C' C ' 85' ' ' ASP . . . . . . . . . . . . . 4.6 t70 -162.97 157.69 21.34 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 115.799 -0.637 . . . . 0.0 110.537 179.311 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' C' C ' 86' ' ' VAL . . . . . . . . . . . . . 41.1 t -130.22 133.81 63.56 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.277 0 CA-C-O 120.984 0.421 . . . . 0.0 110.469 -178.535 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' C' C ' 87' ' ' ILE . . . . . 0.498 ' N ' HD12 ' C' ' 87' ' ' ILE . 5.0 mp -119.36 125.97 74.91 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.257 0 CA-C-N 115.848 -0.615 . . . . 0.0 109.474 176.993 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' C' C ' 88' ' ' LEU . . . . . . . . . . . . . 54.5 mt -110.52 135.6 50.94 Favored 'General case' 0 C--N 1.332 -0.187 0 CA-C-O 120.998 0.427 . . . . 0.0 111.495 -176.776 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' C' C ' 89' ' ' ASP . . . . . . . . . . . . . 9.0 t70 -131.46 153.16 50.04 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 115.777 -0.647 . . . . 0.0 109.554 174.802 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' C' C ' 90' ' ' GLU . . . . . . . . . . . . . 95.4 mt-10 -48.33 -38.58 19.46 Favored 'General case' 0 C--N 1.33 -0.274 0 N-CA-C 112.666 0.617 . . . . 0.0 112.666 -172.858 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' C' C ' 91' ' ' ASN . . . . . . . . . . . . . 0.8 OUTLIER -132.02 36.82 3.64 Favored 'General case' 0 N--CA 1.463 0.221 0 CA-C-O 120.807 0.336 . . . . 0.0 111.404 -177.294 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' C' C ' 92' ' ' LEU . . . . . . . . . . . . . 13.1 tp -166.07 142.85 5.18 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.578 -0.283 . . . . 0.0 110.626 -179.155 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' C' C ' 93' ' ' ILE . . . . . . . . . . . . . 67.0 mt -127.47 122.16 58.79 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.262 0 N-CA-C 109.461 -0.57 . . . . 0.0 109.461 178.741 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' C' C ' 94' ' ' VAL . . . . . 0.423 HG21 HG21 ' C' ' 125' ' ' VAL . 44.9 t -120.8 125.47 74.1 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.228 0 N-CA-C 109.757 -0.46 . . . . 0.0 109.757 179.252 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' C' C ' 95' ' ' VAL . . . . . . . . . . . . . 45.1 t -119.87 132.61 69.13 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.264 0 CA-C-N 116.015 -0.538 . . . . 0.0 109.77 -179.642 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' C' C ' 96' ' ' ILE . . . . . . . . . . . . . 65.9 mt -113.48 125.19 70.71 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.34 0 N-CA-C 109.106 -0.702 . . . . 0.0 109.106 179.025 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' C' C ' 97' ' ' THR . . . . . . . . . . . . . 73.0 p -99.74 151.43 21.24 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-O 121.118 0.485 . . . . 0.0 111.183 -177.185 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' C' C ' 98' ' ' GLU . . . . . . . . . . . . . 85.6 tt0 -53.87 -24.98 17.69 Favored 'General case' 0 C--N 1.33 -0.265 0 N-CA-C 112.343 0.497 . . . . 0.0 112.343 -179.603 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' C' C ' 99' ' ' GLU . . . . . . . . . . . . . 71.1 mm-40 -79.31 16.35 1.02 Allowed 'General case' 0 CA--C 1.534 0.356 0 N-CA-C 113.033 0.753 . . . . 0.0 113.033 -178.102 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' C' C ' 100' ' ' ASN . . . . . . . . . . . . . 4.5 m-20 64.19 37.95 8.49 Favored 'General case' 0 C--O 1.233 0.222 0 CA-C-O 121.0 0.428 . . . . 0.0 111.076 177.326 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' C' C ' 101' ' ' GLU . . . . . . . . . . . . . 84.2 tt0 -118.29 143.65 46.43 Favored 'General case' 0 C--N 1.333 -0.145 0 CA-C-N 116.1 -0.5 . . . . 0.0 109.795 176.711 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' C' C ' 102' ' ' VAL . . . . . . . . . . . . . 42.8 t -115.04 126.11 72.54 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.335 0 CA-C-N 116.434 -0.348 . . . . 0.0 110.063 -178.689 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' C' C ' 103' ' ' LEU . . . . . 0.434 HD23 ' HG3' ' C' ' 114' ' ' ARG . 15.1 mt -115.57 126.87 54.76 Favored 'General case' 0 C--N 1.331 -0.205 0 CA-C-N 115.484 -0.78 . . . . 0.0 110.028 176.873 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' C' C ' 104' ' ' ILE . . . . . . . . . . . . . 68.4 mt -119.22 121.11 65.8 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.275 0 N-CA-C 110.293 -0.262 . . . . 0.0 110.293 -179.973 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' C' C ' 105' ' ' PHE . . . . . . . . . . . . . 35.7 m-85 -125.35 167.05 15.47 Favored 'General case' 0 C--N 1.334 -0.105 0 O-C-N 123.838 0.711 . . . . 0.0 110.166 179.788 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' C' C ' 106' ' ' ASN . . . . . . . . . . . . . 41.3 p-10 -99.95 -169.79 1.79 Allowed 'General case' 0 C--N 1.33 -0.254 0 N-CA-C 110.01 -0.367 . . . . 0.0 110.01 174.399 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' C' C ' 107' ' ' GLN . . . . . . . . . . . . . 46.5 tt0 -58.36 -29.46 66.01 Favored 'General case' 0 C--N 1.329 -0.318 0 N-CA-C 112.006 0.373 . . . . 0.0 112.006 179.421 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' C' C ' 108' ' ' ASN . . . . . . . . . . . . . 10.3 t30 -86.75 13.01 9.51 Favored 'General case' 0 CA--C 1.536 0.435 0 N-CA-C 113.051 0.76 . . . . 0.0 113.051 -177.977 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' C' C ' 109' ' ' LEU . . . . . 0.573 HD21 ' HB2' ' C' ' 78' ' ' ALA . 7.9 tp 55.67 37.83 29.37 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-O 120.947 0.403 . . . . 0.0 111.36 178.277 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' C' C ' 110' ' ' GLU . . . . . . . . . . . . . 96.0 mt-10 -103.04 156.85 17.39 Favored 'General case' 0 C--N 1.33 -0.255 0 N-CA-C 109.832 -0.433 . . . . 0.0 109.832 175.947 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' C' C ' 111' ' ' GLU . . . . . . . . . . . . . 84.6 tt0 -84.31 121.99 28.29 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-O 120.952 0.406 . . . . 0.0 111.127 -176.852 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' C' C ' 112' ' ' LEU . . . . . . . . . . . . . 27.2 mt -105.72 -46.11 4.23 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-N 115.979 -0.555 . . . . 0.0 110.057 176.586 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' C' C ' 113' ' ' TYR . . . . . . . . . . . . . 59.6 t80 -145.49 138.88 26.42 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.048 -0.523 . . . . 0.0 110.856 -179.689 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' C' C ' 114' ' ' ARG . . . . . 0.434 ' HG3' HD23 ' C' ' 103' ' ' LEU . 27.1 ttm180 -141.88 126.29 17.7 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.32 -0.4 . . . . 0.0 110.266 176.965 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' C' C ' 115' ' ' GLY . . . . . . . . . . . . . . . -150.21 160.82 28.7 Favored Glycine 0 CA--C 1.524 0.597 0 N-CA-C 111.101 -0.799 . . . . 0.0 111.101 179.333 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' C' C ' 116' ' ' LYS . . . . . . . . . . . . . 38.9 ttpt -130.39 134.18 46.95 Favored 'General case' 0 C--N 1.33 -0.253 0 N-CA-C 110.035 -0.357 . . . . 0.0 110.035 177.24 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' C' C ' 117' ' ' PHE . . . . . 0.414 ' HE2' HD13 ' C' ' 132' ' ' ILE . 47.5 m-85 -126.99 118.64 24.9 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.333 -0.394 . . . . 0.0 110.464 -176.337 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' C' C ' 118' ' ' GLU . . . . . . . . . . . . . 95.9 mt-10 -51.86 -51.61 55.48 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.39 -0.368 . . . . 0.0 111.697 -175.629 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' C' C ' 119' ' ' ASN . . . . . . . . . . . . . 70.5 m-80 -98.03 31.01 2.84 Favored 'General case' 0 C--N 1.329 -0.294 0 N-CA-C 112.19 0.441 . . . . 0.0 112.19 -173.485 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' C' C ' 120' ' ' LEU . . . . . 0.477 HD23 ' C ' ' C' ' 120' ' ' LEU . 6.5 tt -56.27 121.3 9.2 Favored 'General case' 0 C--N 1.333 -0.129 0 CA-C-O 120.727 0.299 . . . . 0.0 110.562 178.751 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' C' C ' 121' ' ' ASN . . . . . . . . . . . . . 30.9 m120 -114.03 -44.12 3.18 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 116.364 -0.38 . . . . 0.0 111.159 -176.44 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' C' C ' 122' ' ' LYS . . . . . . . . . . . . . 55.2 mtmt -142.87 150.73 40.24 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-O 121.149 0.499 . . . . 0.0 111.513 -176.379 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' C' C ' 123' ' ' VAL . . . . . . . . . . . . . 45.8 t -130.38 133.46 63.84 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.228 0 CA-C-N 115.863 -0.608 . . . . 0.0 109.653 177.812 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' C' C ' 124' ' ' LEU . . . . . . . . . . . . . 30.1 mt -125.14 127.78 47.38 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.468 -0.333 . . . . 0.0 110.416 -179.852 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' C' C ' 125' ' ' VAL . . . . . 0.423 HG21 HG21 ' C' ' 94' ' ' VAL . 43.0 t -132.57 131.09 60.04 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.262 0 CA-C-N 116.183 -0.462 . . . . 0.0 109.97 -179.829 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' C' C ' 126' ' ' ARG . . . . . . . . . . . . . 78.1 mtt180 -145.95 119.77 9.28 Favored 'General case' 0 C--N 1.331 -0.22 0 CA-C-N 116.348 -0.387 . . . . 0.0 110.79 178.88 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' C' C ' 127' ' ' ASN . . . . . . . . . . . . . 64.1 t30 51.12 -105.75 0.22 Allowed 'General case' 0 CA--C 1.543 0.696 0 CA-C-O 119.023 -0.513 . . . . 0.0 111.476 179.188 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' C' C ' 128' ' ' ASP . . . . . . . . . . . . . 16.1 p-10 -114.08 5.27 15.96 Favored 'General case' 0 N--CA 1.469 0.483 0 CA-C-N 119.602 1.092 . . . . 0.0 113.442 -177.084 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' C' C ' 129' ' ' LEU . . . . . 0.47 HD22 ' NH1' ' C' ' 142' ' ' ARG . 26.1 mt -105.01 133.22 50.17 Favored 'General case' 0 C--N 1.332 -0.184 0 N-CA-C 109.555 -0.535 . . . . 0.0 109.555 177.703 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' C' C ' 130' ' ' VAL . . . . . . . . . . . . . 46.3 t -128.11 132.02 68.85 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.287 0 CA-C-O 120.881 0.372 . . . . 0.0 110.218 -178.508 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' C' C ' 131' ' ' VAL . . . . . 0.472 HG12 HD12 ' C' ' 140' ' ' LEU . 35.2 m -136.15 138.69 46.86 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.228 0 CA-C-O 121.15 0.5 . . . . 0.0 111.059 177.246 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' C' C ' 132' ' ' ILE . . . . . 0.414 HD13 ' HE2' ' C' ' 117' ' ' PHE . 71.4 mt -116.4 131.55 68.62 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.303 0 CA-C-N 115.67 -0.695 . . . . 0.0 109.26 179.189 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' C' C ' 133' ' ' ILE . . . . . . . . . . . . . 33.3 mm -115.09 120.66 65.24 Favored 'Isoleucine or valine' 0 C--O 1.234 0.255 0 CA-C-O 120.762 0.315 . . . . 0.0 111.316 -173.958 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' C' C ' 134' ' ' ASP . . . . . . . . . . . . . 10.0 p-10 -132.94 148.43 52.28 Favored 'General case' 0 C--N 1.33 -0.255 0 N-CA-C 109.538 -0.542 . . . . 0.0 109.538 175.066 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' C' C ' 135' ' ' GLU . . . . . . . . . . . . . 85.3 tt0 -49.94 -25.37 3.21 Favored 'General case' 0 C--N 1.328 -0.355 0 N-CA-C 112.864 0.691 . . . . 0.0 112.864 -172.281 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' C' C ' 136' ' ' GLN . . . . . . . . . . . . . 97.5 mt-30 -84.16 -37.83 21.43 Favored 'General case' 0 C--O 1.234 0.245 0 N-CA-C 112.305 0.483 . . . . 0.0 112.305 -176.588 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' C' C ' 137' ' ' LYS . . . . . . . . . . . . . 22.7 pttm -162.16 174.71 12.55 Favored 'General case' 0 C--N 1.331 -0.224 0 CA-C-O 121.507 0.67 . . . . 0.0 112.402 -170.634 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' C' C ' 138' ' ' LEU . . . . . . . . . . . . . 7.0 tt -122.6 128.1 50.25 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 114.903 -1.044 . . . . 0.0 109.918 178.558 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' C' C ' 139' ' ' THR . . . . . . . . . . . . . 30.1 m -104.15 124.05 48.39 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.121 -0.491 . . . . 0.0 110.236 179.012 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' C' C ' 140' ' ' LEU . . . . . 0.476 HD11 ' NH2' ' C' ' 142' ' ' ARG . 19.4 tp -109.25 119.56 39.87 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 115.719 -0.673 . . . . 0.0 109.674 -177.808 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' C' C ' 141' ' ' ILE . . . . . . . . . . . . . 19.0 mt -121.15 120.93 63.55 Favored 'Isoleucine or valine' 0 C--O 1.235 0.297 0 CA-C-O 120.986 0.422 . . . . 0.0 110.235 -175.093 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' C' C ' 142' ' ' ARG . . . . . 0.476 ' NH2' HD11 ' C' ' 140' ' ' LEU . 1.1 mpt_? -109.94 127.03 54.51 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 115.312 -0.858 . . . . 0.0 110.08 -179.296 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' C' C ' 143' ' ' THR . . . . . 0.409 ' HA ' HG12 ' D' ' 73' ' ' VAL . 40.7 p . . . . . 0 C--O 1.22 -0.464 0 CA-C-O 118.013 -0.994 . . . . 0.0 110.621 179.145 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' D' D ' -3' ' ' GLU . . . . . . . . . . . . . 85.0 tt0 . . . . . 0 N--CA 1.489 1.51 0 N-CA-C 109.335 -0.617 . . . . 0.0 109.335 . . . . . . . . . 0 0 . 1 . 019 nuclear build full ' D' D ' -2' ' ' GLY . . . . . . . . . . . . . . . -87.58 138.91 15.58 Favored Glycine 0 CA--C 1.525 0.664 0 N-CA-C 111.34 -0.704 . . . . 0.0 111.34 -178.3 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' D' D ' -1' ' ' VAL . . . . . . . . . . . . . 44.8 t -96.82 138.33 22.17 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 N-CA-C 110.075 -0.342 . . . . 0.0 110.075 178.812 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' D' D ' 0' ' ' ILE . . . . . . . . . . . . . 46.2 mm -109.33 132.82 56.42 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.276 0 CA-C-N 116.296 -0.411 . . . . 0.0 110.06 179.193 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' D' D ' 1' ' ' MET . . . . . . . . . . . . . 24.6 ptp -143.81 145.76 32.59 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.185 -0.461 . . . . 0.0 110.478 -179.91 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' D' D ' 2' ' ' SER . . . . . . . . . . . . . 7.6 p -131.03 130.11 42.88 Favored 'General case' 0 C--O 1.232 0.16 0 CA-C-O 121.124 0.488 . . . . 0.0 110.917 -178.63 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' D' D ' 3' ' ' GLU . . . . . . . . . . . . . 43.6 mp0 -137.85 142.19 40.75 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 115.619 -0.719 . . . . 0.0 110.571 -178.991 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' D' D ' 4' ' ' LEU . . . . . . . . . . . . . 4.2 tt -123.9 123.13 39.74 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 115.753 -0.658 . . . . 0.0 109.78 177.24 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' D' D ' 5' ' ' LYS . . . . . . . . . . . . . 63.6 mttp -102.63 121.51 42.54 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-O 120.77 0.319 . . . . 0.0 110.825 -179.984 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' D' D ' 6' ' ' LEU . . . . . . . . . . . . . 64.7 mt -114.37 148.3 37.84 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 115.553 -0.748 . . . . 0.0 110.614 179.836 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' D' D ' 7' ' ' LYS . . . . . . . . . . . . . 22.7 ttmm -139.82 141.32 27.17 Favored Pre-proline 0 CA--C 1.534 0.339 0 N-CA-C 109.811 -0.44 . . . . 0.0 109.811 174.826 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' D' D ' 8' ' ' PRO . . . . . . . . . . . . . 96.4 Cg_endo -91.22 139.16 2.41 Favored 'Trans proline' 0 N--CA 1.49 1.316 0 C-N-CA 121.694 1.596 . . . . 0.0 111.663 177.988 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' D' D ' 9' ' ' LEU . . . . . . . . . . . . . 49.2 mt -78.28 -45.84 2.13 Favored Pre-proline 0 CA--C 1.533 0.313 0 CA-C-O 118.838 -0.601 . . . . 0.0 111.788 -179.655 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' D' D ' 10' ' ' PRO . . . . . . . . . . . . . 74.7 Cg_endo -84.63 150.75 11.51 Favored 'Trans proline' 0 N--CA 1.495 1.604 0 C-N-CA 121.224 1.283 . . . . 0.0 111.364 171.804 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' D' D ' 11' ' ' LYS . . . . . . . . . . . . . 19.8 pttp -83.47 117.28 22.98 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-O 121.385 0.612 . . . . 0.0 110.423 178.4 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' D' D ' 12' ' ' VAL . . . . . . . . . . . . . 12.3 p -151.05 148.58 14.84 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.271 0 CA-C-N 115.837 -0.62 . . . . 0.0 110.625 -179.965 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' D' D ' 13' ' ' GLU . . . . . . . . . . . . . 44.7 mp0 -91.07 121.59 33.0 Favored 'General case' 0 C--N 1.328 -0.346 0 N-CA-C 109.866 -0.42 . . . . 0.0 109.866 176.663 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' D' D ' 14' ' ' LEU . . . . . 0.42 HD22 ' CD1' ' D' ' 18' ' ' PHE . 15.7 mt -98.09 147.8 33.6 Favored Pre-proline 0 CA--C 1.533 0.3 0 CA-C-O 119.23 -0.414 . . . . 0.0 110.627 -177.801 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' D' D ' 15' ' ' PRO . . . . . . . . . . . . . 24.4 Cg_exo -63.33 162.41 27.11 Favored 'Trans proline' 0 N--CA 1.497 1.685 0 C-N-CA 121.39 1.393 . . . . 0.0 111.813 175.877 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' D' D ' 16' ' ' PRO . . . . . . . . . . . . . 27.8 Cg_exo -60.27 -33.94 94.21 Favored 'Trans proline' 0 N--CA 1.497 1.723 0 C-N-CA 121.495 1.463 . . . . 0.0 112.687 -178.724 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' D' D ' 17' ' ' ASP . . . . . . . . . . . . . 23.1 p-10 -90.07 6.73 41.11 Favored 'General case' 0 CA--C 1.536 0.421 0 N-CA-C 113.447 0.906 . . . . 0.0 113.447 -176.936 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' D' D ' 18' ' ' PHE . . . . . 0.42 ' CD1' HD22 ' D' ' 14' ' ' LEU . 53.4 t80 -58.04 -42.87 86.31 Favored 'General case' 0 C--N 1.335 -0.036 0 O-C-N 122.045 -0.409 . . . . 0.0 110.171 -178.777 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' D' D ' 19' ' ' VAL . . . . . . . . . . . . . 47.3 t -56.6 -43.46 78.74 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 CA-C-N 116.236 -0.438 . . . . 0.0 110.514 -179.27 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' D' D ' 20' ' ' ASP . . . . . . . . . . . . . 79.3 m-20 -60.26 -42.02 94.48 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-O 120.696 0.284 . . . . 0.0 110.923 -178.276 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' D' D ' 21' ' ' VAL . . . . . . . . . . . . . 46.3 t -64.12 -48.38 86.04 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.294 0 C-N-CA 120.854 -0.339 . . . . 0.0 110.517 -177.871 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' D' D ' 22' ' ' ILE . . . . . 0.502 HG22 HD12 ' D' ' 26' ' ' LEU . 50.3 mm -55.97 -45.45 80.15 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.218 0 CA-C-O 120.867 0.365 . . . . 0.0 110.577 179.087 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' D' D ' 23' ' ' ARG . . . . . . . . . . . . . 53.7 ttp180 -54.13 -49.93 68.07 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.602 -0.272 . . . . 0.0 111.427 -178.86 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' D' D ' 24' ' ' ILE . . . . . . . . . . . . . 77.5 mt -59.78 -41.5 85.73 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.267 0 C-N-CA 121.172 -0.211 . . . . 0.0 111.253 -178.065 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' D' D ' 25' ' ' LYS . . . . . . . . . . . . . 73.2 mmtt -63.51 -42.56 98.48 Favored 'General case' 0 C--N 1.328 -0.346 0 N-CA-C 112.015 0.376 . . . . 0.0 112.015 -179.695 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' D' D ' 26' ' ' LEU . . . . . 0.502 HD12 HG22 ' D' ' 22' ' ' ILE . 74.5 mt -79.87 -40.19 28.88 Favored 'General case' 0 C--N 1.329 -0.311 0 N-CA-C 113.344 0.868 . . . . 0.0 113.344 -170.856 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' D' D ' 27' ' ' GLN . . . . . . . . . . . . . 12.6 pt20 -46.67 140.94 4.12 Favored 'General case' 0 N--CA 1.47 0.526 0 N-CA-C 112.785 0.661 . . . . 0.0 112.785 -174.923 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' D' D ' 28' ' ' GLY . . . . . . . . . . . . . . . 98.57 -27.6 18.84 Favored Glycine 0 CA--C 1.533 1.186 0 CA-C-N 115.527 -0.761 . . . . 0.0 112.123 -177.87 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' D' D ' 29' ' ' LYS . . . . . . . . . . . . . 67.3 mttm -98.39 155.14 17.38 Favored 'General case' 0 C--O 1.232 0.181 0 CA-C-N 117.229 0.515 . . . . 0.0 111.044 179.636 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' D' D ' 30' ' ' THR . . . . . . . . . . . . . 37.9 m -100.7 137.65 38.81 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.075 -0.511 . . . . 0.0 110.062 176.095 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' D' D ' 31' ' ' VAL . . . . . . . . . . . . . 34.6 m -128.4 157.31 40.88 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.282 0 CA-C-O 120.992 0.425 . . . . 0.0 110.716 -178.953 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' D' D ' 32' ' ' ARG . . . . . . . . . . . . . 94.2 mtt180 -133.72 151.26 51.57 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 115.74 -0.664 . . . . 0.0 110.446 177.832 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' D' D ' 33' ' ' THR . . . . . . . . . . . . . 30.0 m -53.12 138.52 31.03 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.496 -0.32 . . . . 0.0 111.317 -179.339 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' D' D ' 34' ' ' GLY . . . . . . . . . . . . . . . 101.28 -17.13 56.19 Favored Glycine 0 CA--C 1.533 1.17 0 CA-C-O 119.593 -0.559 . . . . 0.0 113.305 179.124 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' D' D ' 35' ' ' ASP . . . . . . . . . . . . . 67.9 m-20 -65.26 148.95 50.79 Favored 'General case' 0 N--CA 1.461 0.122 0 CA-C-N 118.039 0.92 . . . . 0.0 110.987 179.332 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' D' D ' 36' ' ' VAL . . . . . . . . . . . . . 44.7 t -124.23 130.86 73.54 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.25 0 CA-C-N 115.858 -0.61 . . . . 0.0 109.916 179.49 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' D' D ' 37' ' ' ILE . . . . . . . . . . . . . 65.4 mt -119.7 138.19 51.12 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.267 0 CA-C-N 116.195 -0.457 . . . . 0.0 109.787 179.396 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' D' D ' 38' ' ' GLY . . . . . . . . . . . . . . . -114.33 128.72 8.34 Favored Glycine 0 CA--C 1.524 0.637 0 N-CA-C 111.096 -0.801 . . . . 0.0 111.096 -179.699 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' D' D ' 39' ' ' ILE . . . . . . . . . . . . . 72.7 mt -127.34 131.03 70.84 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.282 0 N-CA-C 109.863 -0.421 . . . . 0.0 109.863 178.373 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' D' D ' 40' ' ' SER . . . . . . . . . . . . . 51.8 p -91.92 121.1 33.2 Favored 'General case' 0 C--N 1.329 -0.292 0 C-N-CA 120.894 -0.322 . . . . 0.0 110.81 176.348 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' D' D ' 41' ' ' ILE . . . . . . . . . . . . . 71.9 mt -130.02 119.29 46.68 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.201 0 CA-C-O 120.833 0.349 . . . . 0.0 110.295 179.918 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' D' D ' 42' ' ' LEU . . . . . . . . . . . . . 83.5 mt 58.15 33.41 23.14 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.073 -0.512 . . . . 0.0 111.874 177.551 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' D' D ' 43' ' ' GLY . . . . . . . . . . . . . . . 82.57 -10.1 56.8 Favored Glycine 0 CA--C 1.533 1.216 0 C-N-CA 121.22 -0.514 . . . . 0.0 113.468 176.746 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' D' D ' 44' ' ' LYS . . . . . . . . . . . . . 68.2 tttt -103.34 129.51 50.39 Favored 'General case' 0 C--N 1.332 -0.167 0 CA-C-N 117.948 0.874 . . . . 0.0 109.851 176.885 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' D' D ' 45' ' ' GLU . . . . . . . . . . . . . 39.9 tp10 -84.22 131.14 34.78 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-O 120.816 0.341 . . . . 0.0 110.99 -179.47 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' D' D ' 46' ' ' VAL . . . . . . . . . . . . . 7.3 p -120.99 129.03 76.13 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.191 0 N-CA-C 109.69 -0.485 . . . . 0.0 109.69 176.793 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' D' D ' 47' ' ' LYS . . . . . . . . . . . . . 65.2 mmtt -99.59 126.6 45.61 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 115.87 -0.605 . . . . 0.0 110.931 177.075 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' D' D ' 48' ' ' PHE . . . . . . . . . . . . . 95.8 m-85 -108.78 131.74 54.66 Favored 'General case' 0 C--N 1.328 -0.328 0 N-CA-C 109.399 -0.593 . . . . 0.0 109.399 175.193 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' D' D ' 49' ' ' LYS . . . . . . . . . . . . . 74.3 tttt -109.01 135.48 50.11 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.467 -0.333 . . . . 0.0 110.501 179.934 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' D' D ' 50' ' ' VAL . . . . . . . . . . . . . 43.7 t -78.72 106.05 8.95 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.293 0 N-CA-C 109.187 -0.671 . . . . 0.0 109.187 175.73 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' D' D ' 51' ' ' VAL . . . . . . . . . . . . . 52.9 t -68.8 -47.63 75.23 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.315 0 CA-C-N 116.077 -0.511 . . . . 0.0 109.992 -173.251 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' D' D ' 52' ' ' GLN . . . . . . . . . . . . . 62.8 tt0 -170.18 144.2 2.57 Favored 'General case' 0 C--N 1.33 -0.271 0 C-N-CA 120.262 -0.575 . . . . 0.0 111.839 -178.996 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' D' D ' 53' ' ' ALA . . . . . . . . . . . . . . . -116.46 134.32 55.0 Favored 'General case' 0 C--N 1.331 -0.213 0 CA-C-N 115.641 -0.709 . . . . 0.0 109.831 175.948 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' D' D ' 54' ' ' TYR . . . . . . . . . . . . . 48.7 t80 -129.06 112.82 18.52 Favored Pre-proline 0 CA--C 1.534 0.343 0 CA-C-O 118.194 -0.908 . . . . 0.0 110.442 178.578 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' D' D ' 55' ' ' PRO . . . . . . . . . . . . . 74.0 Cg_endo -77.18 167.86 78.5 Favored 'Cis proline' 0 N--CA 1.499 1.84 0 CA-C-N 122.002 1.751 . . . . 0.0 112.14 -7.727 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' D' D ' 56' ' ' SER . . . . . . . . . . . . . 13.6 m -117.11 140.64 27.34 Favored Pre-proline 0 CA--C 1.537 0.454 0 CA-C-O 118.674 -0.679 . . . . 0.0 109.741 174.802 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' D' D ' 57' ' ' PRO . . . . . . . . . . . . . 38.2 Cg_endo -68.0 159.95 82.92 Favored 'Cis proline' 0 N--CA 1.498 1.786 0 CA-C-N 121.596 1.606 . . . . 0.0 111.139 -3.544 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' D' D ' 58' ' ' LEU . . . . . . . . . . . . . 20.7 tp -129.6 137.16 50.55 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-O 120.995 0.426 . . . . 0.0 110.473 -178.136 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' D' D ' 59' ' ' ARG . . . . . . . . . . . . . 41.7 ttp180 -104.57 126.6 51.81 Favored 'General case' 0 C--N 1.327 -0.379 0 N-CA-C 109.24 -0.652 . . . . 0.0 109.24 175.342 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' D' D ' 60' ' ' VAL . . . . . . . . . . . . . 41.4 t -80.06 123.45 36.87 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.291 0 C-N-CA 120.676 -0.409 . . . . 0.0 110.649 -173.411 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' D' D ' 61' ' ' GLU . . . . . . . . . . . . . 95.9 mt-10 -131.05 164.19 25.97 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 115.782 -0.645 . . . . 0.0 109.78 177.34 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' D' D ' 62' ' ' ASP . . . . . . . . . . . . . 76.4 m-20 -53.19 -32.5 48.29 Favored 'General case' 0 C--N 1.328 -0.345 0 N-CA-C 111.81 0.3 . . . . 0.0 111.81 -179.981 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' D' D ' 63' ' ' ARG . . . . . . . . . . . . . 95.7 mtt180 -74.48 -21.99 59.3 Favored 'General case' 0 CA--C 1.533 0.294 0 N-CA-C 112.945 0.72 . . . . 0.0 112.945 -176.986 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' D' D ' 64' ' ' THR . . . . . . . . . . . . . 26.8 m -64.84 137.17 57.61 Favored 'General case' 0 C--N 1.331 -0.223 0 CA-C-O 120.965 0.412 . . . . 0.0 110.572 -175.599 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' D' D ' 65' ' ' LYS . . . . . . . . . . . . . 39.8 ttpt -89.14 123.78 33.72 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 115.903 -0.589 . . . . 0.0 110.317 -179.721 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' D' D ' 66' ' ' ILE . . . . . . . . . . . . . 62.7 mt -111.48 130.2 65.46 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.261 0 N-CA-C 109.94 -0.393 . . . . 0.0 109.94 -178.564 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' D' D ' 67' ' ' THR . . . . . . . . . . . . . 8.1 m -130.1 146.97 51.79 Favored 'General case' 0 C--N 1.332 -0.192 0 CA-C-O 121.068 0.461 . . . . 0.0 111.231 -176.663 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' D' D ' 68' ' ' LEU . . . . . . . . . . . . . 54.0 mt -99.35 135.36 40.88 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 115.836 -0.62 . . . . 0.0 110.266 177.47 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' D' D ' 69' ' ' VAL . . . . . . . . . . . . . 42.0 t -96.04 140.14 17.75 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.299 0 CA-C-N 116.408 -0.36 . . . . 0.0 110.351 179.839 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' D' D ' 70' ' ' THR . . . . . . . . . . . . . 7.0 t -98.45 163.47 12.67 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.226 -0.443 . . . . 0.0 110.719 -179.586 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' D' D ' 71' ' ' HIS . . . . . . . . . . . . . 30.4 m80 -86.98 158.21 53.36 Favored Pre-proline 0 C--N 1.33 -0.253 0 CA-C-N 116.16 -0.473 . . . . 0.0 110.878 -178.718 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' D' D ' 72' ' ' PRO . . . . . . . . . . . . . 46.3 Cg_endo -69.8 158.97 55.1 Favored 'Trans proline' 0 N--CA 1.495 1.581 0 C-N-CA 121.404 1.402 . . . . 0.0 112.184 179.271 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' D' D ' 73' ' ' VAL . . . . . 0.409 HG12 ' HA ' ' C' ' 143' ' ' THR . 34.6 m -72.92 149.66 8.43 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.278 0 CA-C-N 116.095 -0.502 . . . . 0.0 110.874 -179.522 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' D' D ' 74' ' ' ASP . . . . . . . . . . . . . 23.6 t0 -96.84 124.66 40.88 Favored 'General case' 0 C--N 1.33 -0.264 0 N-CA-C 109.548 -0.538 . . . . 0.0 109.548 178.516 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' D' D ' 75' ' ' VAL . . . . . . . . . . . . . 40.6 t -114.31 122.88 69.31 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.258 0 CA-C-O 121.064 0.459 . . . . 0.0 110.7 -177.524 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' D' D ' 76' ' ' LEU . . . . . . . . . . . . . 5.5 mp -124.76 152.41 43.86 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 115.653 -0.703 . . . . 0.0 109.608 175.951 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' D' D ' 77' ' ' GLU . . . . . . . . . . . . . 98.4 mt-10 -137.35 139.66 40.95 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-O 121.068 0.461 . . . . 0.0 111.34 -177.669 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' D' D ' 78' ' ' ALA . . . . . 0.723 ' HB2' HD21 ' D' ' 109' ' ' LEU . . . -125.58 137.99 53.92 Favored 'General case' 0 C--N 1.331 -0.217 0 CA-C-N 115.711 -0.677 . . . . 0.0 109.841 176.778 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' D' D ' 79' ' ' LYS . . . . . 0.652 ' O ' HD13 ' D' ' 80' ' ' ILE . 68.8 mttm -88.94 115.82 26.77 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.39 -0.368 . . . . 0.0 110.848 -177.747 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' D' D ' 80' ' ' ILE . . . . . 0.652 HD13 ' O ' ' D' ' 79' ' ' LYS . 36.2 mm -139.18 111.7 5.8 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.267 0 N-CA-C 109.153 -0.684 . . . . 0.0 109.153 -177.863 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' D' D ' 81' ' ' LYS . . . . . . . . . . . . . 39.7 ttpt -100.7 126.85 47.27 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-O 120.928 0.394 . . . . 0.0 111.279 -176.558 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' D' D ' 82' ' ' GLY . . . . . . . . . . . . . . . 89.18 42.15 5.65 Favored Glycine 0 CA--C 1.526 0.746 0 N-CA-C 111.534 -0.626 . . . . 0.0 111.534 175.548 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' D' D ' 83' ' ' ILE . . . . . . . . . . . . . 67.8 mt -68.26 139.4 20.77 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.348 0 CA-C-O 120.849 0.357 . . . . 0.0 110.111 179.008 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' D' D ' 84' ' ' LYS . . . . . . . . . . . . . 30.3 ttmt -96.66 -53.64 3.49 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.041 -0.527 . . . . 0.0 109.949 179.467 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' D' D ' 85' ' ' ASP . . . . . . . . . . . . . 7.1 t70 -155.41 152.63 29.27 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 115.507 -0.77 . . . . 0.0 110.117 -179.53 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' D' D ' 86' ' ' VAL . . . . . . . . . . . . . 41.6 t -130.13 132.52 65.22 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.215 0 CA-C-O 120.879 0.371 . . . . 0.0 110.533 -179.476 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' D' D ' 87' ' ' ILE . . . . . . . . . . . . . 45.0 mm -119.37 127.61 75.85 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.263 0 CA-C-N 115.902 -0.59 . . . . 0.0 109.643 177.271 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' D' D ' 88' ' ' LEU . . . . . . . . . . . . . 14.7 tp -110.45 131.3 55.17 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.377 -0.374 . . . . 0.0 110.967 -178.16 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' D' D ' 89' ' ' ASP . . . . . . . . . . . . . 13.3 t70 -124.82 152.2 44.22 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.033 -0.531 . . . . 0.0 109.821 177.611 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' D' D ' 90' ' ' GLU . . . . . . . . . . . . . 96.2 mt-10 -48.56 -34.65 11.82 Favored 'General case' 0 C--N 1.328 -0.368 0 N-CA-C 112.605 0.595 . . . . 0.0 112.605 -173.878 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' D' D ' 91' ' ' ASN . . . . . . . . . . . . . 33.6 m120 -132.05 30.99 4.21 Favored 'General case' 0 CA--C 1.531 0.219 0 N-CA-C 112.167 0.432 . . . . 0.0 112.167 -176.179 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' D' D ' 92' ' ' LEU . . . . . . . . . . . . . 10.8 tp -166.06 149.35 7.49 Favored 'General case' 0 C--N 1.331 -0.215 0 CA-C-O 120.795 0.331 . . . . 0.0 111.089 -179.749 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' D' D ' 93' ' ' ILE . . . . . . . . . . . . . 72.6 mt -126.25 120.23 56.13 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.22 0 N-CA-C 109.298 -0.63 . . . . 0.0 109.298 177.426 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' D' D ' 94' ' ' VAL . . . . . 0.711 HG21 HG11 ' D' ' 125' ' ' VAL . 45.1 t -120.39 127.19 75.89 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.233 0 CA-C-O 120.818 0.342 . . . . 0.0 110.092 -178.637 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' D' D ' 95' ' ' VAL . . . . . . . . . . . . . 43.9 t -122.91 134.22 66.7 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.341 0 CA-C-N 116.123 -0.489 . . . . 0.0 109.98 -179.062 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' D' D ' 96' ' ' ILE . . . . . . . . . . . . . 60.9 mt -115.97 128.15 73.34 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.317 0 N-CA-C 109.478 -0.564 . . . . 0.0 109.478 179.143 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' D' D ' 97' ' ' THR . . . . . . . . . . . . . 66.9 p -100.98 154.01 19.05 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-O 121.138 0.494 . . . . 0.0 111.011 -178.171 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' D' D ' 98' ' ' GLU . . . . . . . . . . . . . 96.4 mt-10 -56.94 -23.86 48.5 Favored 'General case' 0 CA--C 1.533 0.325 0 N-CA-C 112.469 0.544 . . . . 0.0 112.469 -178.736 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' D' D ' 99' ' ' GLU . . . . . . . . . . . . . 71.1 mm-40 -80.5 18.08 0.99 Allowed 'General case' 0 CA--C 1.533 0.324 0 N-CA-C 112.961 0.726 . . . . 0.0 112.961 -178.699 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' D' D ' 100' ' ' ASN . . . . . . . . . . . . . 3.8 m-20 64.09 38.12 8.62 Favored 'General case' 0 N--CA 1.463 0.191 0 CA-C-O 121.063 0.459 . . . . 0.0 111.049 176.899 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' D' D ' 101' ' ' GLU . . . . . . . . . . . . . 84.5 tt0 -116.68 143.07 46.08 Favored 'General case' 0 C--N 1.332 -0.162 0 CA-C-N 116.068 -0.515 . . . . 0.0 109.884 177.125 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' D' D ' 102' ' ' VAL . . . . . . . . . . . . . 43.5 t -114.99 126.93 72.71 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.287 0 CA-C-N 116.275 -0.42 . . . . 0.0 109.891 -178.801 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' D' D ' 103' ' ' LEU . . . . . . . . . . . . . 44.9 mt -118.16 134.28 55.14 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 115.668 -0.696 . . . . 0.0 109.632 179.532 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' D' D ' 104' ' ' ILE . . . . . . . . . . . . . 73.2 mt -126.11 122.81 62.48 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.266 0 C-N-CA 121.213 -0.195 . . . . 0.0 110.562 -176.819 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' D' D ' 105' ' ' PHE . . . . . . . . . . . . . 49.7 m-85 -127.36 165.94 18.79 Favored 'General case' 0 C--N 1.333 -0.112 0 O-C-N 123.993 0.808 . . . . 0.0 110.075 -179.781 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' D' D ' 106' ' ' ASN . . . . . . . . . . . . . 45.7 p-10 -101.85 -170.01 1.76 Allowed 'General case' 0 C--N 1.331 -0.227 0 N-CA-C 109.94 -0.392 . . . . 0.0 109.94 174.379 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' D' D ' 107' ' ' GLN . . . . . . . . . . . . . 39.0 tt0 -58.72 -30.1 67.19 Favored 'General case' 0 C--N 1.33 -0.269 0 N-CA-C 111.996 0.369 . . . . 0.0 111.996 179.73 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' D' D ' 108' ' ' ASN . . . . . . . . . . . . . 11.3 t-20 -83.55 7.99 15.5 Favored 'General case' 0 CA--C 1.534 0.357 0 N-CA-C 113.238 0.829 . . . . 0.0 113.238 -176.836 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' D' D ' 109' ' ' LEU . . . . . 0.723 HD21 ' HB2' ' D' ' 78' ' ' ALA . 12.8 tp 61.29 38.55 16.35 Favored 'General case' 0 CA--C 1.529 0.154 0 CA-C-O 120.999 0.428 . . . . 0.0 111.028 178.388 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' D' D ' 110' ' ' GLU . . . . . . . . . . . . . 95.5 mt-10 -108.21 152.81 24.09 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 116.396 -0.365 . . . . 0.0 110.373 177.937 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' D' D ' 111' ' ' GLU . . . . . . . . . . . . . 94.9 mt-10 -77.69 125.31 29.14 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-O 120.913 0.387 . . . . 0.0 111.123 -179.543 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' D' D ' 112' ' ' LEU . . . . . . . . . . . . . 83.4 mt -107.99 -45.36 3.99 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 115.975 -0.557 . . . . 0.0 109.664 173.297 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' D' D ' 113' ' ' TYR . . . . . . . . . . . . . 64.6 t80 -147.31 141.55 26.21 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.133 -0.485 . . . . 0.0 111.555 -179.252 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' D' D ' 114' ' ' ARG . . . . . . . . . . . . . 65.3 mtt180 -139.36 124.65 19.07 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 115.874 -0.603 . . . . 0.0 110.3 173.69 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' D' D ' 115' ' ' GLY . . . . . . . . . . . . . . . -150.06 157.43 27.21 Favored Glycine 0 CA--C 1.525 0.683 0 N-CA-C 110.862 -0.895 . . . . 0.0 110.862 178.69 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' D' D ' 116' ' ' LYS . . . . . . . . . . . . . 39.7 ttpt -129.12 139.04 52.12 Favored 'General case' 0 C--N 1.329 -0.322 0 N-CA-C 110.103 -0.332 . . . . 0.0 110.103 178.195 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' D' D ' 117' ' ' PHE . . . . . . . . . . . . . 47.9 m-85 -132.15 116.01 16.46 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.283 -0.417 . . . . 0.0 110.489 -176.196 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' D' D ' 118' ' ' GLU . . . . . . . . . . . . . 84.7 tt0 -51.95 -52.93 46.88 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.407 -0.36 . . . . 0.0 111.659 -176.853 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' D' D ' 119' ' ' ASN . . . . . . . . . . . . . 96.3 m-20 -93.65 31.14 1.62 Allowed 'General case' 0 C--N 1.329 -0.29 0 N-CA-C 112.227 0.454 . . . . 0.0 112.227 -174.525 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' D' D ' 120' ' ' LEU . . . . . . . . . . . . . 15.8 tp -54.08 122.1 9.48 Favored 'General case' 0 N--CA 1.464 0.231 0 O-C-N 122.289 -0.257 . . . . 0.0 110.671 177.562 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' D' D ' 121' ' ' ASN . . . . . . . . . . . . . 26.7 m120 -114.09 -44.02 3.18 Favored 'General case' 0 C--O 1.232 0.166 0 CA-C-N 116.595 -0.275 . . . . 0.0 111.188 -175.977 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' D' D ' 122' ' ' LYS . . . . . . . . . . . . . 44.4 mtmt -145.68 146.52 31.32 Favored 'General case' 0 C--N 1.331 -0.215 0 C-N-CA 120.538 -0.465 . . . . 0.0 111.665 -176.471 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' D' D ' 123' ' ' VAL . . . . . . . . . . . . . 44.0 t -129.02 130.5 68.31 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.275 0 CA-C-N 115.849 -0.614 . . . . 0.0 109.53 176.096 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' D' D ' 124' ' ' LEU . . . . . . . . . . . . . 14.9 tp -128.34 135.34 49.45 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-O 120.78 0.324 . . . . 0.0 110.612 -178.555 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' D' D ' 125' ' ' VAL . . . . . 0.711 HG11 HG21 ' D' ' 94' ' ' VAL . 34.9 m -133.61 141.0 45.44 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.195 0 CA-C-N 116.328 -0.396 . . . . 0.0 111.031 -178.719 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' D' D ' 126' ' ' ARG . . . . . . . . . . . . . 78.2 mtt180 -149.41 125.19 10.49 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.554 176.267 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' D' D ' 127' ' ' ASN . . . . . . . . . . . . . 18.8 t-20 52.51 -111.37 0.58 Allowed 'General case' 0 CA--C 1.545 0.755 0 CA-C-O 118.734 -0.65 . . . . 0.0 111.046 178.849 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' D' D ' 128' ' ' ASP . . . . . . . . . . . . . 21.5 p-10 -114.15 10.7 17.4 Favored 'General case' 0 N--CA 1.468 0.454 0 CA-C-N 120.044 1.293 . . . . 0.0 113.081 -179.747 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' D' D ' 129' ' ' LEU . . . . . . . . . . . . . 13.1 tp -107.29 135.77 48.25 Favored 'General case' 0 C--N 1.332 -0.165 0 N-CA-C 109.877 -0.416 . . . . 0.0 109.877 178.914 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' D' D ' 130' ' ' VAL . . . . . . . . . . . . . 44.3 t -123.79 136.16 61.12 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.239 0 CA-C-O 120.869 0.366 . . . . 0.0 110.023 -178.127 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' D' D ' 131' ' ' VAL . . . . . . . . . . . . . 43.4 t -133.87 133.71 56.35 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.258 0 CA-C-O 121.027 0.441 . . . . 0.0 110.059 177.561 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' D' D ' 132' ' ' ILE . . . . . . . . . . . . . 71.6 mt -118.01 131.51 70.55 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.335 0 CA-C-N 115.724 -0.671 . . . . 0.0 109.604 -179.273 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' D' D ' 133' ' ' ILE . . . . . . . . . . . . . 36.8 mm -116.19 124.33 72.35 Favored 'Isoleucine or valine' 0 C--O 1.233 0.197 0 CA-C-O 120.804 0.335 . . . . 0.0 111.106 -175.062 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' D' D ' 134' ' ' ASP . . . . . . . . . . . . . 11.6 p-10 -135.22 151.33 50.52 Favored 'General case' 0 C--N 1.332 -0.18 0 CA-C-N 116.104 -0.498 . . . . 0.0 109.916 174.603 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' D' D ' 135' ' ' GLU . . . . . . . . . . . . . 84.6 tt0 -49.95 -26.24 4.01 Favored 'General case' 0 C--O 1.236 0.354 0 N-CA-C 113.571 0.952 . . . . 0.0 113.571 -168.493 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' D' D ' 136' ' ' GLN . . . . . . . . . . . . . 14.3 pt20 -100.15 -19.55 16.39 Favored 'General case' 0 N--CA 1.466 0.352 0 N-CA-C 113.314 0.857 . . . . 0.0 113.314 -172.491 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' D' D ' 137' ' ' LYS . . . . . . . . . . . . . 56.8 pttt -165.88 170.54 13.69 Favored 'General case' 0 C--O 1.232 0.139 0 CA-C-O 121.645 0.736 . . . . 0.0 112.344 -176.693 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' D' D ' 138' ' ' LEU . . . . . . . . . . . . . 7.2 tt -121.23 127.67 51.67 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 114.919 -1.037 . . . . 0.0 109.827 178.938 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' D' D ' 139' ' ' THR . . . . . . . . . . . . . 42.1 m -106.18 126.71 52.55 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.089 -0.505 . . . . 0.0 110.331 179.895 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' D' D ' 140' ' ' LEU . . . . . 0.464 ' C ' HD23 ' D' ' 140' ' ' LEU . 5.7 tt -110.74 122.49 47.94 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 115.748 -0.66 . . . . 0.0 109.27 -179.203 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' D' D ' 141' ' ' ILE . . . . . 0.438 ' N ' HD23 ' D' ' 140' ' ' LEU . 19.1 mt -122.21 116.16 48.32 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.294 0 N-CA-C 109.867 -0.42 . . . . 0.0 109.867 -175.176 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' D' D ' 142' ' ' ARG . . . . . . . . . . . . . 58.9 ttp180 -108.75 129.29 55.37 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 115.64 -0.709 . . . . 0.0 110.507 -178.784 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' D' D ' 143' ' ' THR . . . . . . . . . . . . . 70.2 p . . . . . 0 C--O 1.22 -0.475 0 CA-C-O 118.223 -0.894 . . . . 0.0 110.894 179.695 . . . . . . . . 0 0 . 1 . 019 nuclear build full ' E' E ' -3' ' ' GLU . . . . . . . . . . . . . 70.4 mm-40 . . . . . 0 N--CA 1.489 1.518 0 N-CA-C 109.317 -0.623 . . . . 0.0 109.317 . . . . . . . . . 0 0 . 1 . 019 nuclear build full ' E' E ' -2' ' ' GLY . . . . . . . . . . . . . . . -85.78 124.82 7.02 Favored Glycine 0 CA--C 1.524 0.63 0 N-CA-C 111.013 -0.835 . . . . 0.0 111.013 179.999 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' E' E ' -1' ' ' VAL . . . . . . . . . . . . . 43.3 t -141.81 135.92 30.17 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.337 0 N-CA-C 110.074 -0.343 . . . . 0.0 110.074 179.673 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' E' E ' 0' ' ' ILE . . . . . . . . . . . . . 67.3 mt -116.33 143.32 26.7 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.195 0 CA-C-N 116.245 -0.434 . . . . 0.0 109.933 179.996 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' E' E ' 1' ' ' MET . . . . . . . . . . . . . 26.0 ptm -87.2 142.32 27.99 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.083 -0.508 . . . . 0.0 110.583 179.845 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' E' E ' 2' ' ' SER . . . . . . . . . . . . . 2.1 p -130.29 123.51 30.21 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.026 178.504 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' E' E ' 3' ' ' GLU . . . . . . . . . . . . . 89.2 mt-10 -139.29 140.75 37.71 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.016 -0.538 . . . . 0.0 111.103 -175.374 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' E' E ' 4' ' ' LEU . . . . . . . . . . . . . 16.0 tp -122.89 124.93 44.35 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 115.785 -0.643 . . . . 0.0 109.506 173.979 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' E' E ' 5' ' ' LYS . . . . . . . . . . . . . 60.7 mttp -108.83 120.26 41.98 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 116.397 -0.365 . . . . 0.0 110.573 -179.265 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' E' E ' 6' ' ' LEU . . . . . . . . . . . . . 54.1 mt -113.91 143.43 44.71 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 115.402 -0.817 . . . . 0.0 110.041 -178.796 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' E' E ' 7' ' ' LYS . . . . . . . . . . . . . 78.4 tttt -122.71 135.77 26.04 Favored Pre-proline 0 CA--C 1.535 0.388 0 CA-C-O 118.84 -0.6 . . . . 0.0 109.542 176.087 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' E' E ' 8' ' ' PRO . . . . . . . . . . . . . 72.4 Cg_endo -88.9 131.54 2.27 Favored 'Trans proline' 0 N--CA 1.49 1.309 0 C-N-CA 121.566 1.511 . . . . 0.0 111.814 178.938 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' E' E ' 9' ' ' LEU . . . . . . . . . . . . . 73.9 mt -70.36 -51.22 13.55 Favored Pre-proline 0 C--N 1.329 -0.313 0 CA-C-O 118.694 -0.67 . . . . 0.0 111.817 -178.703 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' E' E ' 10' ' ' PRO . . . . . . . . . . . . . 70.3 Cg_endo -74.66 151.24 41.08 Favored 'Trans proline' 0 N--CA 1.497 1.713 0 C-N-CA 121.076 1.184 . . . . 0.0 111.891 175.226 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' E' E ' 11' ' ' LYS . . . . . . . . . . . . . 70.6 mmtt -83.92 89.11 7.16 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-O 120.879 0.371 . . . . 0.0 110.42 178.511 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' E' E ' 12' ' ' VAL . . . . . . . . . . . . . 12.2 p -140.06 144.81 27.32 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.276 0 CA-C-N 116.024 -0.535 . . . . 0.0 110.359 179.877 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' E' E ' 13' ' ' GLU . . . . . . . . . . . . . 84.9 tt0 -91.79 130.62 37.53 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.275 -0.42 . . . . 0.0 110.241 178.626 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' E' E ' 14' ' ' LEU . . . . . . . . . . . . . 19.9 mt -97.65 152.98 38.45 Favored Pre-proline 0 C--N 1.33 -0.251 0 CA-C-N 116.258 -0.428 . . . . 0.0 110.796 -177.509 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' E' E ' 15' ' ' PRO . . . . . . . . . . . . . 27.9 Cg_exo -60.81 159.28 29.51 Favored 'Trans proline' 0 N--CA 1.497 1.692 0 C-N-CA 121.334 1.356 . . . . 0.0 111.795 176.833 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' E' E ' 16' ' ' PRO . . . . . . . . . . . . . 38.6 Cg_exo -58.48 -37.04 96.58 Favored 'Trans proline' 0 N--CA 1.497 1.727 0 C-N-CA 121.362 1.374 . . . . 0.0 112.704 -178.211 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' E' E ' 17' ' ' ASP . . . . . . . . . . . . . 10.5 p-10 -94.47 15.43 17.83 Favored 'General case' 0 C--N 1.328 -0.345 0 N-CA-C 113.063 0.764 . . . . 0.0 113.063 -177.088 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' E' E ' 18' ' ' PHE . . . . . . . . . . . . . 51.9 t80 -58.03 -44.34 87.28 Favored 'General case' 0 N--CA 1.46 0.06 0 O-C-N 122.0 -0.437 . . . . 0.0 110.085 -178.788 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' E' E ' 19' ' ' VAL . . . . . . . . . . . . . 47.4 t -56.61 -40.83 71.52 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.344 0 CA-C-N 116.255 -0.43 . . . . 0.0 110.35 -179.764 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' E' E ' 20' ' ' ASP . . . . . . . . . . . . . 70.1 m-20 -60.07 -42.69 95.09 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-O 120.801 0.334 . . . . 0.0 110.85 -178.274 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' E' E ' 21' ' ' VAL . . . . . . . . . . . . . 47.5 t -65.38 -52.02 57.0 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.278 0 C-N-CA 120.828 -0.349 . . . . 0.0 110.613 -178.334 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' E' E ' 22' ' ' ILE . . . . . . . . . . . . . 48.7 mm -54.32 -54.57 20.49 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.231 0 CA-C-O 120.743 0.306 . . . . 0.0 111.24 -177.493 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' E' E ' 23' ' ' ARG . . . . . . . . . . . . . 14.4 ptm180 -61.34 -45.29 95.04 Favored 'General case' 0 CA--C 1.532 0.275 0 N-CA-C 112.166 0.432 . . . . 0.0 112.166 -173.656 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' E' E ' 24' ' ' ILE . . . . . . . . . . . . . 73.0 mt -61.85 -38.53 80.78 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.209 0 O-C-N 122.138 -0.352 . . . . 0.0 111.224 -175.474 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' E' E ' 25' ' ' LYS . . . . . . . . . . . . . 66.6 mttm -72.33 -43.81 63.56 Favored 'General case' 0 C--N 1.331 -0.237 0 N-CA-C 112.077 0.399 . . . . 0.0 112.077 -178.971 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' E' E ' 26' ' ' LEU . . . . . . . . . . . . . 56.4 mt -87.03 -8.19 57.38 Favored 'General case' 0 CA--C 1.533 0.303 0 N-CA-C 113.835 1.05 . . . . 0.0 113.835 -173.627 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' E' E ' 27' ' ' GLN . . . . . . . . . . . . . 15.3 pt20 -46.59 143.13 2.82 Favored 'General case' 0 N--CA 1.467 0.412 0 O-C-N 121.592 -0.692 . . . . 0.0 112.451 -179.706 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' E' E ' 28' ' ' GLY . . . . . . . . . . . . . . . 100.07 -22.49 39.92 Favored Glycine 0 CA--C 1.533 1.212 0 CA-C-N 115.885 -0.598 . . . . 0.0 112.467 -177.953 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' E' E ' 29' ' ' LYS . . . . . . . . . . . . . 34.8 mmtp -89.6 154.98 19.55 Favored 'General case' 0 C--O 1.233 0.186 0 CA-C-N 117.599 0.699 . . . . 0.0 110.632 177.994 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' E' E ' 30' ' ' THR . . . . . . . . . . . . . 9.1 m -107.95 139.77 42.07 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.093 -0.503 . . . . 0.0 110.17 178.269 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' E' E ' 31' ' ' VAL . . . . . . . . . . . . . 35.0 m -127.91 152.87 36.55 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.263 0 CA-C-O 120.929 0.395 . . . . 0.0 110.755 -178.963 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' E' E ' 32' ' ' ARG . . . . . . . . . . . . . 83.5 mtt180 -131.68 150.31 52.19 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.025 -0.534 . . . . 0.0 110.366 177.565 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' E' E ' 33' ' ' THR . . . . . . . . . . . . . 22.0 m -52.8 138.64 28.88 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.366 -0.379 . . . . 0.0 111.457 -178.383 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' E' E ' 34' ' ' GLY . . . . . . . . . . . . . . . 100.16 -17.13 57.47 Favored Glycine 0 CA--C 1.532 1.101 0 CA-C-N 116.18 -0.464 . . . . 0.0 113.28 179.485 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' E' E ' 35' ' ' ASP . . . . . . . . . . . . . 77.0 m-20 -67.97 149.51 49.65 Favored 'General case' 0 N--CA 1.462 0.125 0 CA-C-N 117.989 0.894 . . . . 0.0 111.183 178.683 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' E' E ' 36' ' ' VAL . . . . . . . . . . . . . 44.6 t -120.95 128.81 76.13 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.219 0 CA-C-N 116.063 -0.517 . . . . 0.0 109.688 176.775 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' E' E ' 37' ' ' ILE . . . . . . . . . . . . . 62.9 mt -119.08 138.4 49.93 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 CA-C-N 116.089 -0.505 . . . . 0.0 109.923 -178.539 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' E' E ' 38' ' ' GLY . . . . . . . . . . . . . . . -116.42 128.14 7.81 Favored Glycine 0 CA--C 1.526 0.757 0 N-CA-C 110.937 -0.865 . . . . 0.0 110.937 179.285 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' E' E ' 39' ' ' ILE . . . . . . . . . . . . . 73.5 mt -128.82 131.07 68.7 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.216 0 N-CA-C 110.066 -0.346 . . . . 0.0 110.066 178.893 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' E' E ' 40' ' ' SER . . . . . . . . . . . . . 46.8 t -91.79 113.94 26.34 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.392 -0.367 . . . . 0.0 110.965 177.908 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' E' E ' 41' ' ' ILE . . . . . . . . . . . . . 45.9 mm -123.24 123.45 67.76 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.22 0 N-CA-C 109.835 -0.431 . . . . 0.0 109.835 179.467 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' E' E ' 42' ' ' LEU . . . . . . . . . . . . . 68.7 mt 57.85 34.85 24.84 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.307 -0.406 . . . . 0.0 111.683 177.94 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' E' E ' 43' ' ' GLY . . . . . . . . . . . . . . . 78.94 -10.22 34.22 Favored Glycine 0 CA--C 1.534 1.219 0 C-N-CA 121.248 -0.501 . . . . 0.0 113.43 177.094 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' E' E ' 44' ' ' LYS . . . . . . . . . . . . . 30.4 ttmt -102.83 129.36 49.48 Favored 'General case' 0 N--CA 1.461 0.078 0 CA-C-N 117.982 0.891 . . . . 0.0 110.157 177.103 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' E' E ' 45' ' ' GLU . . . . . . . . . . . . . 39.9 tp10 -84.18 127.54 34.0 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 116.283 -0.417 . . . . 0.0 110.93 -179.662 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' E' E ' 46' ' ' VAL . . . . . . . . . . . . . 9.2 p -119.27 125.9 74.86 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.22 0 N-CA-C 109.675 -0.491 . . . . 0.0 109.675 176.468 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' E' E ' 47' ' ' LYS . . . . . . . . . . . . . 62.8 mttp -99.23 126.81 45.12 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.023 -0.535 . . . . 0.0 110.889 177.266 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' E' E ' 48' ' ' PHE . . . . . . . . . . . . . 41.1 m-85 -110.55 131.87 54.68 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.035 -0.529 . . . . 0.0 109.805 177.138 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' E' E ' 49' ' ' LYS . . . . . . . . . . . . . 78.9 tttt -105.95 132.24 52.29 Favored 'General case' 0 C--N 1.328 -0.351 0 N-CA-C 110.074 -0.343 . . . . 0.0 110.074 177.887 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' E' E ' 50' ' ' VAL . . . . . . . . . . . . . 46.6 t -77.1 107.55 8.68 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.331 0 N-CA-C 109.449 -0.574 . . . . 0.0 109.449 178.023 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' E' E ' 51' ' ' VAL . . . . . . . . . . . . . 46.6 t -71.55 -52.71 24.22 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.339 0 N-CA-C 109.545 -0.539 . . . . 0.0 109.545 -175.943 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' E' E ' 52' ' ' GLN . . . . . . . . . . . . . 83.3 mt-30 -154.74 152.5 29.96 Favored 'General case' 0 C--N 1.331 -0.207 0 CA-C-O 121.252 0.549 . . . . 0.0 111.66 -178.105 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' E' E ' 53' ' ' ALA . . . . . . . . . . . . . . . -130.2 131.96 45.8 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 115.313 -0.858 . . . . 0.0 109.545 174.141 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' E' E ' 54' ' ' TYR . . . . . . . . . . . . . 59.8 t80 -129.04 110.29 18.28 Favored Pre-proline 0 CA--C 1.535 0.374 0 CA-C-O 118.205 -0.902 . . . . 0.0 110.32 179.457 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' E' E ' 55' ' ' PRO . . . . . . . . . . . . . 73.9 Cg_endo -77.16 169.82 73.18 Favored 'Cis proline' 0 N--CA 1.5 1.865 0 CA-C-N 121.987 1.745 . . . . 0.0 112.153 -5.638 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' E' E ' 56' ' ' SER . . . . . . . . . . . . . 13.7 m -115.89 132.44 23.2 Favored Pre-proline 0 CA--C 1.538 0.488 0 CA-C-O 118.458 -0.782 . . . . 0.0 109.155 175.416 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' E' E ' 57' ' ' PRO . . . . . . . . . . . . . 50.9 Cg_endo -69.75 164.12 80.01 Favored 'Cis proline' 0 N--CA 1.498 1.753 0 CA-C-N 121.928 1.724 . . . . 0.0 111.684 0.166 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' E' E ' 58' ' ' LEU . . . . . . . . . . . . . 36.8 tp -129.82 139.4 51.24 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.079 179.821 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' E' E ' 59' ' ' ARG . . . . . . . . . . . . . 26.6 ttm180 -103.83 139.11 39.47 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.246 -0.434 . . . . 0.0 110.05 178.983 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' E' E ' 60' ' ' VAL . . . . . . . . . . . . . 42.9 t -86.64 111.22 21.18 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.196 0 CA-C-O 120.84 0.352 . . . . 0.0 110.34 -177.991 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' E' E ' 61' ' ' GLU . . . . . . . . . . . . . 81.3 tt0 -131.17 154.44 48.37 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 115.845 -0.616 . . . . 0.0 109.58 177.407 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' E' E ' 62' ' ' ASP . . . . . . . . . . . . . 9.4 p-10 -52.82 -23.74 7.55 Favored 'General case' 0 C--N 1.326 -0.433 0 N-CA-C 112.467 0.543 . . . . 0.0 112.467 -179.579 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' E' E ' 63' ' ' ARG . . . . . . . . . . . . . 23.8 mmm180 -84.72 -14.22 49.03 Favored 'General case' 0 CA--C 1.534 0.349 0 N-CA-C 113.443 0.905 . . . . 0.0 113.443 -177.066 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' E' E ' 64' ' ' THR . . . . . . . . . . . . . 14.0 m -76.58 151.84 36.15 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-O 120.937 0.399 . . . . 0.0 111.05 -176.066 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' E' E ' 65' ' ' LYS . . . . . . . . . . . . . 45.7 mtpt -90.49 118.7 30.16 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.134 179.063 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' E' E ' 66' ' ' ILE . . . . . . . . . . . . . 72.0 mt -117.62 124.67 73.37 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.219 0 N-CA-C 109.741 -0.466 . . . . 0.0 109.741 -178.344 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' E' E ' 67' ' ' THR . . . . . . . . . . . . . 27.4 m -132.1 151.06 51.98 Favored 'General case' 0 C--N 1.332 -0.182 0 CA-C-O 121.269 0.557 . . . . 0.0 111.876 -173.437 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' E' E ' 68' ' ' LEU . . . . . . . . . . . . . 78.9 mt -98.66 127.99 44.79 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-N 115.548 -0.751 . . . . 0.0 110.126 175.474 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' E' E ' 69' ' ' VAL . . . . . . . . . . . . . 44.3 t -102.57 144.93 12.87 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.268 0 CA-C-N 116.05 -0.523 . . . . 0.0 110.193 -178.729 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' E' E ' 70' ' ' THR . . . . . 0.465 HG23 ' O ' ' E' ' 70' ' ' THR . 8.0 t -131.79 122.62 26.1 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-O 120.924 0.392 . . . . 0.0 110.675 178.645 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' E' E ' 71' ' ' HIS . . . . . . . . . . . . . 32.0 m80 -139.73 160.78 59.72 Favored Pre-proline 0 C--N 1.33 -0.274 0 CA-C-N 116.055 -0.521 . . . . 0.0 109.867 177.796 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' E' E ' 72' ' ' PRO . . . . . . . . . . . . . 4.2 Cg_exo -71.82 -30.11 14.62 Favored 'Trans proline' 0 N--CA 1.495 1.577 0 C-N-CA 121.255 1.303 . . . . 0.0 112.286 -176.765 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' E' E ' 73' ' ' VAL . . . . . . . . . . . . . 31.5 m -155.17 162.25 1.87 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.217 0 CA-C-O 121.174 0.511 . . . . 0.0 111.097 -178.641 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' E' E ' 74' ' ' ASP . . . . . . . . . . . . . 16.6 t0 -106.94 122.55 46.64 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 115.496 -0.775 . . . . 0.0 109.232 174.273 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' E' E ' 75' ' ' VAL . . . . . 0.492 ' C ' HD12 ' E' ' 76' ' ' LEU . 41.2 t -117.83 125.68 74.31 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.294 0 CA-C-O 121.112 0.482 . . . . 0.0 110.809 -176.916 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' E' E ' 76' ' ' LEU . . . . . 0.492 HD12 ' C ' ' E' ' 75' ' ' VAL . 6.1 mp -127.37 151.11 49.21 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-N 115.566 -0.743 . . . . 0.0 109.62 176.437 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' E' E ' 77' ' ' GLU . . . . . . . . . . . . . 97.0 mt-10 -136.48 136.03 39.1 Favored 'General case' 0 C--N 1.332 -0.171 0 CA-C-O 121.068 0.461 . . . . 0.0 111.26 -177.4 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' E' E ' 78' ' ' ALA . . . . . . . . . . . . . . . -121.05 138.85 53.98 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-N 115.737 -0.665 . . . . 0.0 109.819 176.838 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' E' E ' 79' ' ' LYS . . . . . 0.576 ' O ' HD13 ' E' ' 80' ' ' ILE . 99.7 mttt -83.59 118.85 24.09 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-O 120.951 0.405 . . . . 0.0 111.0 -176.982 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' E' E ' 80' ' ' ILE . . . . . 0.576 HD13 ' O ' ' E' ' 79' ' ' LYS . 42.0 mm -139.25 115.43 9.5 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.2 0 N-CA-C 109.346 -0.613 . . . . 0.0 109.346 -178.229 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' E' E ' 81' ' ' LYS . . . . . . . . . . . . . 64.7 mttm -109.44 125.51 52.51 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-O 120.854 0.359 . . . . 0.0 111.09 -177.705 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' E' E ' 82' ' ' GLY . . . . . . . . . . . . . . . 89.09 42.12 5.69 Favored Glycine 0 CA--C 1.523 0.582 0 C-N-CA 120.774 -0.727 . . . . 0.0 111.419 175.994 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' E' E ' 83' ' ' ILE . . . . . . . . . . . . . 72.9 mt -66.06 133.31 31.14 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.297 0 CA-C-O 120.942 0.401 . . . . 0.0 110.01 178.181 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' E' E ' 84' ' ' LYS . . . . . . . . . . . . . 85.9 tttt -91.67 -53.14 4.42 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-N 115.936 -0.574 . . . . 0.0 109.97 -179.633 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' E' E ' 85' ' ' ASP . . . . . . . . . . . . . 13.3 t70 -156.24 151.02 26.03 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 115.553 -0.749 . . . . 0.0 110.059 179.402 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' E' E ' 86' ' ' VAL . . . . . . . . . . . . . 43.3 t -125.87 129.63 72.44 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.287 0 CA-C-O 120.937 0.399 . . . . 0.0 110.439 -178.986 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' E' E ' 87' ' ' ILE . . . . . . . . . . . . . 44.5 mm -118.28 126.15 74.82 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.208 0 CA-C-N 115.979 -0.555 . . . . 0.0 109.714 177.008 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' E' E ' 88' ' ' LEU . . . . . . . . . . . . . 14.2 tp -108.8 131.08 55.32 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-O 120.972 0.415 . . . . 0.0 111.004 -177.591 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' E' E ' 89' ' ' ASP . . . . . . . . . . . . . 7.7 t70 -119.61 154.07 34.52 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 115.787 -0.642 . . . . 0.0 109.5 176.781 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' E' E ' 90' ' ' GLU . . . . . . . . . . . . . 82.4 tt0 -46.28 -43.57 15.8 Favored 'General case' 0 N--CA 1.464 0.263 0 N-CA-C 112.871 0.693 . . . . 0.0 112.871 -173.106 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' E' E ' 91' ' ' ASN . . . . . . . . . . . . . 16.0 t-20 -132.15 39.11 3.44 Favored 'General case' 0 C--N 1.331 -0.217 0 CA-C-O 120.907 0.384 . . . . 0.0 111.195 -178.815 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' E' E ' 92' ' ' LEU . . . . . . . . . . . . . 10.5 tp -166.08 147.26 6.72 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 116.526 -0.307 . . . . 0.0 110.386 -178.708 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' E' E ' 93' ' ' ILE . . . . . . . . . . . . . 65.8 mt -128.78 123.49 59.31 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.214 0 N-CA-C 109.483 -0.562 . . . . 0.0 109.483 -178.972 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' E' E ' 94' ' ' VAL . . . . . 0.647 HG21 HG11 ' E' ' 125' ' ' VAL . 44.1 t -124.24 129.36 74.07 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.216 0 CA-C-O 121.021 0.438 . . . . 0.0 110.035 -179.841 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' E' E ' 95' ' ' VAL . . . . . . . . . . . . . 42.5 t -122.04 135.83 60.89 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.328 0 CA-C-N 115.881 -0.599 . . . . 0.0 109.926 -178.906 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' E' E ' 96' ' ' ILE . . . . . . . . . . . . . 62.0 mt -111.92 126.7 69.33 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.355 0 N-CA-C 109.215 -0.661 . . . . 0.0 109.215 178.068 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' E' E ' 97' ' ' THR . . . . . . . . . . . . . 68.3 p -97.16 155.91 16.63 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-O 121.168 0.509 . . . . 0.0 111.134 -178.176 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' E' E ' 98' ' ' GLU . . . . . . . . . . . . . 82.6 tt0 -53.86 -25.88 21.89 Favored 'General case' 0 C--N 1.327 -0.372 0 N-CA-C 112.304 0.483 . . . . 0.0 112.304 -178.941 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' E' E ' 99' ' ' GLU . . . . . . . . . . . . . 71.2 mm-40 -81.56 16.16 1.83 Allowed 'General case' 0 CA--C 1.536 0.413 0 N-CA-C 113.137 0.791 . . . . 0.0 113.137 -176.74 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' E' E ' 100' ' ' ASN . . . . . . . . . . . . . 3.5 m-20 62.89 34.33 14.37 Favored 'General case' 0 CA--C 1.531 0.227 0 CA-C-O 120.909 0.385 . . . . 0.0 111.519 178.644 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' E' E ' 101' ' ' GLU . . . . . . . . . . . . . 84.6 tt0 -112.65 143.63 43.52 Favored 'General case' 0 C--N 1.334 -0.093 0 N-CA-C 109.69 -0.485 . . . . 0.0 109.69 173.422 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' E' E ' 102' ' ' VAL . . . . . . . . . . . . . 45.6 t -115.21 129.43 71.47 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.322 0 CA-C-N 116.49 -0.323 . . . . 0.0 110.297 -177.414 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' E' E ' 103' ' ' LEU . . . . . . . . . . . . . 51.1 mt -117.85 130.75 56.45 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-N 115.7 -0.682 . . . . 0.0 110.415 177.31 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' E' E ' 104' ' ' ILE . . . . . . . . . . . . . 70.7 mt -117.45 122.86 70.88 Favored 'Isoleucine or valine' 0 C--O 1.233 0.226 0 N-CA-C 110.154 -0.313 . . . . 0.0 110.154 178.373 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' E' E ' 105' ' ' PHE . . . . . . . . . . . . . 74.3 m-85 -123.6 164.36 19.19 Favored 'General case' 0 C--O 1.232 0.132 0 O-C-N 123.905 0.753 . . . . 0.0 109.876 -179.781 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' E' E ' 106' ' ' ASN . . . . . 0.415 ' HB3' HD11 ' E' ' 112' ' ' LEU . 43.5 p-10 -99.07 -170.02 1.86 Allowed 'General case' 0 C--N 1.33 -0.254 0 N-CA-C 109.738 -0.467 . . . . 0.0 109.738 172.381 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' E' E ' 107' ' ' GLN . . . . . . . . . . . . . 48.8 tt0 -57.91 -29.8 65.4 Favored 'General case' 0 C--N 1.329 -0.298 0 N-CA-C 112.025 0.38 . . . . 0.0 112.025 179.982 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' E' E ' 108' ' ' ASN . . . . . . . . . . . . . 22.5 t30 -88.69 13.14 12.99 Favored 'General case' 0 CA--C 1.535 0.388 0 N-CA-C 113.094 0.776 . . . . 0.0 113.094 -176.024 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' E' E ' 109' ' ' LEU . . . . . . . . . . . . . 38.4 mt 57.43 36.18 26.77 Favored 'General case' 0 C--N 1.333 -0.149 0 CA-C-O 120.941 0.4 . . . . 0.0 111.566 177.811 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' E' E ' 110' ' ' GLU . . . . . . . . . . . . . 95.6 mt-10 -100.56 155.26 17.95 Favored 'General case' 0 C--N 1.33 -0.258 0 N-CA-C 109.72 -0.474 . . . . 0.0 109.72 176.191 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' E' E ' 111' ' ' GLU . . . . . . . . . . . . . 84.4 tt0 -82.26 121.91 27.25 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-O 120.883 0.373 . . . . 0.0 110.92 -177.707 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' E' E ' 112' ' ' LEU . . . . . 0.415 HD11 ' HB3' ' E' ' 106' ' ' ASN . 75.2 mt -107.9 -45.99 3.87 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.017 -0.538 . . . . 0.0 110.047 176.416 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' E' E ' 113' ' ' TYR . . . . . . . . . . . . . 63.3 t80 -143.28 135.76 27.32 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.153 -0.476 . . . . 0.0 111.52 -179.395 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' E' E ' 114' ' ' ARG . . . . . . . . . . . . . 21.4 ttm180 -131.13 123.88 29.52 Favored 'General case' 0 C--N 1.331 -0.201 0 CA-C-N 115.775 -0.648 . . . . 0.0 109.623 173.529 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' E' E ' 115' ' ' GLY . . . . . . . . . . . . . . . -150.0 156.41 26.73 Favored Glycine 0 CA--C 1.523 0.539 0 N-CA-C 110.85 -0.9 . . . . 0.0 110.85 178.531 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' E' E ' 116' ' ' LYS . . . . . . . . . . . . . 55.6 tttt -132.68 140.31 48.08 Favored 'General case' 0 C--N 1.329 -0.309 0 O-C-N 122.646 -0.326 . . . . 0.0 110.16 179.245 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' E' E ' 117' ' ' PHE . . . . . . . . . . . . . 18.2 m-85 -139.63 113.82 8.95 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-O 120.887 0.375 . . . . 0.0 110.091 -176.194 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' E' E ' 118' ' ' GLU . . . . . . . . . . . . . 83.2 tt0 -53.3 -47.43 69.22 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.453 -0.339 . . . . 0.0 111.573 -175.84 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' E' E ' 119' ' ' ASN . . . . . . . . . . . . . 74.4 m-20 -95.15 31.12 1.98 Allowed 'General case' 0 C--N 1.332 -0.196 0 N-CA-C 112.265 0.468 . . . . 0.0 112.265 -174.45 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' E' E ' 120' ' ' LEU . . . . . . . . . . . . . 22.1 tp -55.85 122.95 12.66 Favored 'General case' 0 C--N 1.333 -0.136 0 CA-C-O 120.724 0.297 . . . . 0.0 110.52 177.146 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' E' E ' 121' ' ' ASN . . . . . . . . . . . . . 62.7 t30 -112.2 -44.08 3.46 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-N 116.362 -0.381 . . . . 0.0 110.718 -177.977 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' E' E ' 122' ' ' LYS . . . . . . . . . . . . . 98.0 mttt -143.45 144.76 32.15 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-O 120.96 0.409 . . . . 0.0 111.661 -177.476 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' E' E ' 123' ' ' VAL . . . . . . . . . . . . . 46.7 t -123.61 122.37 64.77 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.284 0 N-CA-C 109.136 -0.69 . . . . 0.0 109.136 173.826 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' E' E ' 124' ' ' LEU . . . . . 0.512 HD12 ' N ' ' E' ' 124' ' ' LEU . 5.6 mp -120.59 132.3 55.08 Favored 'General case' 0 C--N 1.331 -0.203 0 CA-C-N 116.483 -0.326 . . . . 0.0 110.389 -177.155 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' E' E ' 125' ' ' VAL . . . . . 0.647 HG11 HG21 ' E' ' 94' ' ' VAL . 35.1 m -135.56 138.74 47.7 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.314 0 CA-C-N 116.379 -0.373 . . . . 0.0 110.736 179.279 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' E' E ' 126' ' ' ARG . . . . . . . . . . . . . 32.8 ptt-85 -150.19 125.23 9.95 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 116.088 -0.506 . . . . 0.0 110.178 177.926 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' E' E ' 127' ' ' ASN . . . . . . . . . . . . . 85.5 m-20 55.07 -123.38 2.03 Favored 'General case' 0 CA--C 1.546 0.804 0 CA-C-O 118.529 -0.748 . . . . 0.0 110.209 -178.191 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' E' E ' 128' ' ' ASP . . . . . . . . . . . . . 23.3 p-10 -106.07 12.29 30.51 Favored 'General case' 0 CA--C 1.536 0.431 0 CA-C-N 120.235 1.379 . . . . 0.0 113.088 179.349 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' E' E ' 129' ' ' LEU . . . . . 0.442 HD23 ' N ' ' E' ' 130' ' ' VAL . 5.0 tt -106.14 132.63 51.98 Favored 'General case' 0 C--O 1.231 0.121 0 N-CA-C 109.653 -0.499 . . . . 0.0 109.653 179.079 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' E' E ' 130' ' ' VAL . . . . . 0.478 HG13 HG12 ' E' ' 125' ' ' VAL . 46.4 t -122.05 136.32 59.3 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.248 0 CA-C-O 120.894 0.378 . . . . 0.0 110.185 -177.926 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' E' E ' 131' ' ' VAL . . . . . 0.515 HG22 HD12 ' E' ' 140' ' ' LEU . 42.1 t -135.11 135.5 52.46 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.19 0 CA-C-O 121.128 0.49 . . . . 0.0 110.076 177.668 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' E' E ' 132' ' ' ILE . . . . . . . . . . . . . 74.7 mt -118.1 132.34 68.21 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.338 0 CA-C-N 115.746 -0.661 . . . . 0.0 109.532 -178.86 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' E' E ' 133' ' ' ILE . . . . . . . . . . . . . 37.5 mm -116.88 121.9 68.78 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.205 0 CA-C-O 120.78 0.324 . . . . 0.0 111.075 -174.694 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' E' E ' 134' ' ' ASP . . . . . . . . . . . . . 10.2 p-10 -135.23 149.84 49.96 Favored 'General case' 0 C--N 1.331 -0.221 0 CA-C-N 116.03 -0.532 . . . . 0.0 109.767 175.225 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' E' E ' 135' ' ' GLU . . . . . . . . . . . . . 85.1 tt0 -49.92 -26.67 4.36 Favored 'General case' 0 C--N 1.329 -0.318 0 N-CA-C 113.019 0.748 . . . . 0.0 113.019 -172.159 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' E' E ' 136' ' ' GLN . . . . . . . . . . . . . 99.7 mm-40 -85.55 -32.11 22.33 Favored 'General case' 0 C--O 1.235 0.299 0 N-CA-C 112.401 0.519 . . . . 0.0 112.401 -174.935 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' E' E ' 137' ' ' LYS . . . . . . . . . . . . . 55.7 pttt -168.54 174.07 7.04 Favored 'General case' 0 C--N 1.332 -0.186 0 CA-C-O 121.5 0.667 . . . . 0.0 112.257 -171.008 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' E' E ' 138' ' ' LEU . . . . . 0.438 ' C ' HD23 ' E' ' 138' ' ' LEU . 8.7 tt -121.88 130.1 53.09 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 115.032 -0.985 . . . . 0.0 110.264 179.8 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' E' E ' 139' ' ' THR . . . . . . . . . . . . . 38.0 m -108.3 130.27 55.19 Favored 'General case' 0 C--N 1.331 -0.23 0 CA-C-N 116.163 -0.471 . . . . 0.0 110.653 -179.546 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' E' E ' 140' ' ' LEU . . . . . 0.515 HD12 HG22 ' E' ' 131' ' ' VAL . 12.3 tp -116.34 121.8 43.02 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 115.724 -0.671 . . . . 0.0 109.332 -179.271 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' E' E ' 141' ' ' ILE . . . . . . . . . . . . . 18.9 mt -120.57 121.65 65.98 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.288 0 CA-C-O 120.976 0.417 . . . . 0.0 110.296 -175.152 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' E' E ' 142' ' ' ARG . . . . . . . . . . . . . 66.4 mtp180 -108.93 130.86 55.46 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 115.264 -0.88 . . . . 0.0 110.438 179.906 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' E' E ' 143' ' ' THR . . . . . . . . . . . . . 19.1 p . . . . . 0 C--O 1.221 -0.417 0 CA-C-O 117.988 -1.006 . . . . 0.0 110.492 178.782 . . . . . . . . 0 0 . 1 . 019 nuclear build full ' F' F ' -3' ' ' GLU . . . . . . . . . . . . . 84.6 tt0 . . . . . 0 N--CA 1.49 1.56 0 N-CA-C 109.473 -0.566 . . . . 0.0 109.473 . . . . . . . . . 0 0 . 1 . 019 nuclear build full ' F' F ' -2' ' ' GLY . . . . . . . . . . . . . . . -68.54 136.97 30.2 Favored Glycine 0 CA--C 1.524 0.627 0 N-CA-C 110.658 -0.977 . . . . 0.0 110.658 178.539 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' F' F ' -1' ' ' VAL . . . . . . . . . . . . . 43.3 t -95.65 133.83 35.3 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.297 0 N-CA-C 110.003 -0.369 . . . . 0.0 110.003 -179.58 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' F' F ' 0' ' ' ILE . . . . . . . . . . . . . 71.5 mt -109.84 123.57 65.84 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.266 0 CA-C-N 116.169 -0.469 . . . . 0.0 110.037 -179.093 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' F' F ' 1' ' ' MET . . . . . . . . . . . . . 16.0 ptm -89.34 132.78 34.78 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.098 -0.501 . . . . 0.0 110.594 -179.987 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' F' F ' 2' ' ' SER . . . . . . . . . . . . . 11.7 p -118.77 132.77 56.15 Favored 'General case' 0 C--N 1.332 -0.182 0 CA-C-O 121.006 0.431 . . . . 0.0 110.824 -179.335 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' F' F ' 3' ' ' GLU . . . . . . . . . . . . . 95.6 mt-10 -141.3 141.08 33.94 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 115.779 -0.646 . . . . 0.0 110.823 -179.284 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' F' F ' 4' ' ' LEU . . . . . . . . . . . . . 12.5 tp -129.38 131.05 46.74 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.235 -0.439 . . . . 0.0 110.267 177.115 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' F' F ' 5' ' ' LYS . . . . . . . . . . . . . 98.7 mttt -113.77 121.62 44.62 Favored 'General case' 0 C--O 1.234 0.247 0 CA-C-N 116.505 -0.316 . . . . 0.0 110.825 -179.708 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' F' F ' 6' ' ' LEU . . . . . 0.442 HD23 ' HA ' ' F' ' 50' ' ' VAL . 66.7 mt -114.05 145.08 42.08 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-N 115.478 -0.783 . . . . 0.0 110.007 179.372 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' F' F ' 7' ' ' LYS . . . . . . . . . . . . . 27.2 ttpp -126.72 141.22 39.7 Favored Pre-proline 0 CA--C 1.534 0.329 0 CA-C-O 119.059 -0.496 . . . . 0.0 109.804 176.134 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' F' F ' 8' ' ' PRO . . . . . . . . . . . . . 97.8 Cg_endo -92.07 137.2 1.76 Allowed 'Trans proline' 0 N--CA 1.49 1.295 0 C-N-CA 121.799 1.666 . . . . 0.0 111.897 178.801 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' F' F ' 9' ' ' LEU . . . . . . . . . . . . . 63.0 mt -75.64 -46.93 4.15 Favored Pre-proline 0 CA--C 1.535 0.384 0 CA-C-O 118.764 -0.636 . . . . 0.0 112.076 179.255 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' F' F ' 10' ' ' PRO . . . . . . . . . . . . . 71.1 Cg_endo -83.44 158.29 14.64 Favored 'Trans proline' 0 N--CA 1.497 1.691 0 C-N-CA 121.294 1.329 . . . . 0.0 112.179 175.583 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' F' F ' 11' ' ' LYS . . . . . . . . . . . . . 37.0 mmtm -79.19 105.33 10.44 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.396 -0.365 . . . . 0.0 110.167 176.044 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' F' F ' 12' ' ' VAL . . . . . . . . . . . . . 12.7 p -145.58 141.18 22.22 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.312 0 CA-C-O 120.833 0.349 . . . . 0.0 110.863 -179.602 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' F' F ' 13' ' ' GLU . . . . . . . . . . . . . 15.2 mm-40 -95.45 124.82 39.67 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.202 -0.454 . . . . 0.0 109.874 175.378 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' F' F ' 14' ' ' LEU . . . . . . . . . . . . . 44.6 mt -96.79 151.49 37.88 Favored Pre-proline 0 C--N 1.328 -0.332 0 CA-C-N 116.411 -0.359 . . . . 0.0 110.497 -177.131 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' F' F ' 15' ' ' PRO . . . . . . . . . . . . . 35.4 Cg_exo -59.3 158.49 26.37 Favored 'Trans proline' 0 N--CA 1.497 1.716 0 C-N-CA 121.27 1.313 . . . . 0.0 111.795 178.715 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' F' F ' 16' ' ' PRO . . . . . . . . . . . . . 37.1 Cg_exo -59.03 -37.75 91.42 Favored 'Trans proline' 0 N--CA 1.497 1.677 0 C-N-CA 121.472 1.448 . . . . 0.0 112.516 -179.485 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' F' F ' 17' ' ' ASP . . . . . . . . . . . . . 18.2 p-10 -89.04 14.02 11.63 Favored 'General case' 0 CA--C 1.536 0.406 0 N-CA-C 112.984 0.735 . . . . 0.0 112.984 -178.77 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' F' F ' 18' ' ' PHE . . . . . 0.502 ' CZ ' HD11 ' F' ' 22' ' ' ILE . 53.0 t80 -58.4 -45.25 88.74 Favored 'General case' 0 N--CA 1.457 -0.082 0 O-C-N 121.975 -0.453 . . . . 0.0 110.122 -177.487 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' F' F ' 19' ' ' VAL . . . . . 0.402 HG13 ' N ' ' F' ' 20' ' ' ASP . 14.6 p -55.15 -41.39 59.89 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.243 0 CA-C-N 116.512 -0.313 . . . . 0.0 111.066 -177.96 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' F' F ' 20' ' ' ASP . . . . . 0.402 ' N ' HG13 ' F' ' 19' ' ' VAL . 68.5 m-20 -60.5 -44.47 95.95 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-O 120.83 0.348 . . . . 0.0 110.852 -179.19 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' F' F ' 21' ' ' VAL . . . . . . . . . . . . . 50.4 t -64.07 -48.37 86.2 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.308 0 CA-C-N 116.43 -0.35 . . . . 0.0 110.568 -177.478 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' F' F ' 22' ' ' ILE . . . . . 0.72 HG22 HD12 ' F' ' 26' ' ' LEU . 49.0 mm -58.01 -43.55 85.21 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.288 0 C-N-CA 120.926 -0.309 . . . . 0.0 110.754 -178.885 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' F' F ' 23' ' ' ARG . . . . . . . . . . . . . 55.7 ttp180 -55.92 -47.56 77.29 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-O 120.654 0.264 . . . . 0.0 110.832 -179.98 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' F' F ' 24' ' ' ILE . . . . . . . . . . . . . 69.0 mt -60.49 -41.03 86.17 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.29 0 CA-C-N 116.578 -0.283 . . . . 0.0 111.643 -178.473 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' F' F ' 25' ' ' LYS . . . . . 0.621 ' HE3' HD13 ' F' ' 22' ' ' ILE . 14.9 ptpt -74.13 -35.14 64.08 Favored 'General case' 0 CA--C 1.534 0.327 0 N-CA-C 112.317 0.488 . . . . 0.0 112.317 -175.063 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' F' F ' 26' ' ' LEU . . . . . 0.72 HD12 HG22 ' F' ' 22' ' ' ILE . 22.7 mt -80.66 -38.89 28.27 Favored 'General case' 0 C--N 1.327 -0.378 0 N-CA-C 113.31 0.855 . . . . 0.0 113.31 -173.662 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' F' F ' 27' ' ' GLN . . . . . . . . . . . . . 16.6 pt20 -46.47 141.23 3.74 Favored 'General case' 0 N--CA 1.47 0.528 0 N-CA-C 112.784 0.661 . . . . 0.0 112.784 -174.411 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' F' F ' 28' ' ' GLY . . . . . . . . . . . . . . . 101.14 -25.92 26.52 Favored Glycine 0 CA--C 1.532 1.122 0 CA-C-N 115.464 -0.789 . . . . 0.0 112.262 -176.477 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' F' F ' 29' ' ' LYS . . . . . . . . . . . . . 55.5 mtpt -98.04 155.04 17.31 Favored 'General case' 0 C--N 1.332 -0.161 0 CA-C-N 117.483 0.642 . . . . 0.0 111.183 178.827 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' F' F ' 30' ' ' THR . . . . . . . . . . . . . 29.9 m -103.63 138.97 39.56 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 115.988 -0.551 . . . . 0.0 109.964 176.127 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' F' F ' 31' ' ' VAL . . . . . . . . . . . . . 35.0 m -129.46 156.25 41.78 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.235 0 CA-C-N 116.382 -0.372 . . . . 0.0 110.972 -178.26 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' F' F ' 32' ' ' ARG . . . . . . . . . . . . . 93.6 mtm-85 -133.31 148.41 51.9 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 115.731 -0.668 . . . . 0.0 110.248 177.439 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' F' F ' 33' ' ' THR . . . . . . . . . . . . . 19.0 m -53.03 140.03 26.35 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.411 -0.359 . . . . 0.0 111.372 -178.442 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' F' F ' 34' ' ' GLY . . . . . . . . . . . . . . . 100.33 -17.14 57.3 Favored Glycine 0 CA--C 1.532 1.144 0 CA-C-O 119.609 -0.55 . . . . 0.0 113.251 179.765 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' F' F ' 35' ' ' ASP . . . . . . . . . . . . . 73.3 m-20 -65.66 149.28 50.36 Favored 'General case' 0 N--CA 1.462 0.151 0 CA-C-N 118.04 0.92 . . . . 0.0 111.094 179.435 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' F' F ' 36' ' ' VAL . . . . . . . . . . . . . 45.6 t -124.83 131.31 72.8 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.174 0 CA-C-N 115.963 -0.562 . . . . 0.0 109.801 178.335 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' F' F ' 37' ' ' ILE . . . . . . . . . . . . . 65.1 mt -122.09 140.0 47.35 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.224 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.027 -178.678 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' F' F ' 38' ' ' GLY . . . . . . . . . . . . . . . -113.76 128.63 8.39 Favored Glycine 0 CA--C 1.524 0.639 0 N-CA-C 110.888 -0.885 . . . . 0.0 110.888 178.329 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' F' F ' 39' ' ' ILE . . . . . . . . . . . . . 71.8 mt -127.52 133.97 66.64 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.197 0 N-CA-C 110.093 -0.336 . . . . 0.0 110.093 179.439 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' F' F ' 40' ' ' SER . . . . . . . . . . . . . 20.4 t -92.35 124.26 36.28 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.376 -0.375 . . . . 0.0 111.298 178.381 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' F' F ' 41' ' ' ILE . . . . . . . . . . . . . 68.9 mt -134.35 121.9 38.46 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.236 0 N-CA-C 110.058 -0.349 . . . . 0.0 110.058 176.436 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' F' F ' 42' ' ' LEU . . . . . . . . . . . . . 45.0 mt 58.84 35.13 24.11 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.087 -0.506 . . . . 0.0 111.694 177.942 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' F' F ' 43' ' ' GLY . . . . . . . . . . . . . . . 74.35 13.13 81.78 Favored Glycine 0 CA--C 1.534 1.231 0 C-N-CA 121.135 -0.555 . . . . 0.0 113.371 176.964 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' F' F ' 44' ' ' LYS . . . . . . . . . . . . . 94.9 mttt -126.21 130.98 52.03 Favored 'General case' 0 C--N 1.332 -0.155 0 CA-C-N 117.847 0.824 . . . . 0.0 109.785 177.191 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' F' F ' 45' ' ' GLU . . . . . . . . . . . . . 83.9 tt0 -84.81 130.5 34.66 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-O 120.887 0.375 . . . . 0.0 111.39 -178.391 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' F' F ' 46' ' ' VAL . . . . . . . . . . . . . 9.8 p -117.96 128.26 75.09 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.236 0 N-CA-C 109.566 -0.531 . . . . 0.0 109.566 174.508 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' F' F ' 47' ' ' LYS . . . . . . . . . . . . . 92.3 mttt -98.13 124.29 42.61 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.157 -0.474 . . . . 0.0 110.693 177.846 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' F' F ' 48' ' ' PHE . . . . . . . . . . . . . 33.5 m-85 -108.43 131.79 54.43 Favored 'General case' 0 C--N 1.329 -0.32 0 N-CA-C 109.571 -0.529 . . . . 0.0 109.571 175.866 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' F' F ' 49' ' ' LYS . . . . . . . . . . . . . 46.6 tttm -108.58 134.2 51.67 Favored 'General case' 0 C--N 1.331 -0.227 0 CA-C-N 116.342 -0.39 . . . . 0.0 110.202 177.678 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' F' F ' 50' ' ' VAL . . . . . 0.442 ' HA ' HD23 ' F' ' 6' ' ' LEU . 45.0 t -78.74 105.68 8.38 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.342 0 N-CA-C 109.368 -0.604 . . . . 0.0 109.368 177.227 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' F' F ' 51' ' ' VAL . . . . . . . . . . . . . 47.8 t -69.68 -52.78 28.65 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.276 0 N-CA-C 109.534 -0.543 . . . . 0.0 109.534 -175.903 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' F' F ' 52' ' ' GLN . . . . . . . . . . . . . 87.8 mt-30 -153.54 151.12 29.42 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 115.889 -0.596 . . . . 0.0 111.544 -178.634 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' F' F ' 53' ' ' ALA . . . . . . . . . . . . . . . -128.82 134.17 48.25 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 115.021 -0.99 . . . . 0.0 109.493 175.089 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' F' F ' 54' ' ' TYR . . . . . . . . . . . . . 84.3 t80 -129.12 111.47 18.31 Favored Pre-proline 0 CA--C 1.535 0.401 0 CA-C-O 118.15 -0.929 . . . . 0.0 110.387 -179.862 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' F' F ' 55' ' ' PRO . . . . . . . . . . . . . 73.4 Cg_endo -77.07 169.18 75.01 Favored 'Cis proline' 0 N--CA 1.5 1.879 0 CA-C-N 121.94 1.729 . . . . 0.0 112.303 -5.952 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' F' F ' 56' ' ' SER . . . . . . . . . . . . . 13.7 m -116.76 128.16 26.21 Favored Pre-proline 0 CA--C 1.538 0.509 0 CA-C-O 118.366 -0.826 . . . . 0.0 109.274 174.686 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' F' F ' 57' ' ' PRO . . . . . . . . . . . . . 37.2 Cg_endo -66.68 165.44 64.93 Favored 'Cis proline' 0 N--CA 1.496 1.647 0 CA-C-N 122.023 1.758 . . . . 0.0 111.78 0.259 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' F' F ' 58' ' ' LEU . . . . . . . . . . . . . 26.6 tp -130.08 135.85 48.69 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.155 -0.475 . . . . 0.0 110.276 179.296 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' F' F ' 59' ' ' ARG . . . . . . . . . . . . . 58.2 ttt-85 -103.82 125.02 49.97 Favored 'General case' 0 C--N 1.327 -0.406 0 N-CA-C 109.278 -0.638 . . . . 0.0 109.278 175.39 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' F' F ' 60' ' ' VAL . . . . . . . . . . . . . 47.6 t -76.86 117.81 22.36 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.318 0 C-N-CA 120.756 -0.378 . . . . 0.0 110.362 -175.127 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' F' F ' 61' ' ' GLU . . . . . . . . . . . . . 95.6 mt-10 -130.95 166.44 20.95 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 115.728 -0.669 . . . . 0.0 109.661 177.917 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' F' F ' 62' ' ' ASP . . . . . . . . . . . . . 82.0 m-20 -53.97 -32.58 54.41 Favored 'General case' 0 C--N 1.329 -0.312 0 C-N-CA 121.012 -0.275 . . . . 0.0 111.688 179.651 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' F' F ' 63' ' ' ARG . . . . . . . . . . . . . 49.8 ptt85 -78.41 -1.0 31.38 Favored 'General case' 0 CA--C 1.537 0.46 0 N-CA-C 113.781 1.03 . . . . 0.0 113.781 -175.838 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' F' F ' 64' ' ' THR . . . . . . . . . . . . . 34.3 m -86.6 134.75 33.61 Favored 'General case' 0 C--O 1.232 0.161 0 CA-C-N 118.164 0.438 . . . . 0.0 110.808 -177.158 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' F' F ' 65' ' ' LYS . . . . . . . . . . . . . 90.9 mttt -90.01 128.11 36.2 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.01 -0.541 . . . . 0.0 110.211 178.208 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' F' F ' 66' ' ' ILE . . . . . . . . . . . . . 63.3 mt -114.04 130.93 67.38 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.252 0 N-CA-C 109.886 -0.412 . . . . 0.0 109.886 -179.682 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' F' F ' 67' ' ' THR . . . . . . . . . . . . . 30.5 m -125.5 143.57 50.94 Favored 'General case' 0 C--N 1.331 -0.227 0 CA-C-N 116.013 -0.54 . . . . 0.0 111.113 -177.977 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' F' F ' 68' ' ' LEU . . . . . . . . . . . . . 20.6 tp -101.48 123.87 46.22 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 115.687 -0.688 . . . . 0.0 110.118 177.431 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' F' F ' 69' ' ' VAL . . . . . . . . . . . . . 44.4 t -101.37 126.74 55.15 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.309 0 CA-C-N 116.281 -0.418 . . . . 0.0 110.034 -179.25 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' F' F ' 70' ' ' THR . . . . . . . . . . . . . 9.0 m -87.93 -39.1 15.03 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.132 -0.485 . . . . 0.0 111.035 -178.871 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' F' F ' 71' ' ' HIS . . . . . . . . . . . . . 98.3 m-70 -74.84 151.17 86.56 Favored Pre-proline 0 C--N 1.33 -0.257 0 CA-C-N 116.481 -0.327 . . . . 0.0 111.099 -176.503 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' F' F ' 72' ' ' PRO . . . . . . . . . . . . . 85.7 Cg_endo -91.81 -4.89 3.88 Favored 'Trans proline' 0 N--CA 1.493 1.462 0 C-N-CA 121.859 1.706 . . . . 0.0 113.866 178.394 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' F' F ' 73' ' ' VAL . . . . . . . . . . . . . 34.3 m -120.26 161.87 19.39 Favored 'Isoleucine or valine' 0 N--CA 1.462 0.164 0 CA-C-O 120.893 0.378 . . . . 0.0 111.002 -177.573 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' F' F ' 74' ' ' ASP . . . . . . . . . . . . . 33.0 t0 -100.79 124.08 45.92 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 115.842 -0.617 . . . . 0.0 110.233 -178.923 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' F' F ' 75' ' ' VAL . . . . . . . . . . . . . 42.5 t -118.1 123.17 71.25 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.24 0 CA-C-O 121.027 0.441 . . . . 0.0 110.594 -178.294 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' F' F ' 76' ' ' LEU . . . . . 0.516 HD12 ' N ' ' F' ' 76' ' ' LEU . 5.5 mp -121.94 147.89 45.47 Favored 'General case' 0 C--N 1.331 -0.217 0 CA-C-N 115.744 -0.662 . . . . 0.0 109.686 175.661 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' F' F ' 77' ' ' GLU . . . . . . . . . . . . . 96.4 mt-10 -137.63 132.17 32.61 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-O 121.005 0.431 . . . . 0.0 111.165 -178.712 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' F' F ' 78' ' ' ALA . . . . . . . . . . . . . . . -115.33 131.01 57.07 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 115.744 -0.662 . . . . 0.0 109.859 177.17 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' F' F ' 79' ' ' LYS . . . . . 0.623 ' O ' HD13 ' F' ' 80' ' ' ILE . 34.3 tptt -85.75 117.42 24.62 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-O 120.798 0.332 . . . . 0.0 110.955 -176.71 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' F' F ' 80' ' ' ILE . . . . . 0.623 HD13 ' O ' ' F' ' 79' ' ' LYS . 39.1 mm -139.23 107.46 3.26 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.272 0 N-CA-C 109.227 -0.657 . . . . 0.0 109.227 -179.314 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' F' F ' 81' ' ' LYS . . . . . . . . . . . . . 38.8 ttpt -89.08 121.47 31.45 Favored 'General case' 0 C--N 1.328 -0.334 0 C-N-CA 120.865 -0.334 . . . . 0.0 111.084 -177.207 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' F' F ' 82' ' ' GLY . . . . . . . . . . . . . . . 89.21 42.19 5.64 Favored Glycine 0 CA--C 1.525 0.698 0 C-N-CA 120.561 -0.828 . . . . 0.0 111.651 174.239 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' F' F ' 83' ' ' ILE . . . . . . . . . . . . . 73.9 mt -65.45 139.79 20.75 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.306 0 N-CA-C 109.623 -0.51 . . . . 0.0 109.623 176.997 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' F' F ' 84' ' ' LYS . . . . . . . . . . . . . 84.3 tttt -94.72 -53.27 3.93 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.028 -0.533 . . . . 0.0 110.49 -176.773 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' F' F ' 85' ' ' ASP . . . . . . . . . . . . . 9.3 t70 -154.12 153.1 31.25 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 115.787 -0.642 . . . . 0.0 110.313 -179.39 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' F' F ' 86' ' ' VAL . . . . . . . . . . . . . 44.4 t -130.79 131.12 64.66 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.247 0 CA-C-O 120.846 0.355 . . . . 0.0 110.616 -179.009 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' F' F ' 87' ' ' ILE . . . . . 0.497 HD12 ' N ' ' F' ' 87' ' ' ILE . 5.1 mp -123.13 126.57 73.76 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.249 0 CA-C-N 115.992 -0.549 . . . . 0.0 109.566 176.892 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' F' F ' 88' ' ' LEU . . . . . . . . . . . . . 53.7 mt -113.18 137.76 50.98 Favored 'General case' 0 C--N 1.331 -0.224 0 CA-C-O 121.12 0.486 . . . . 0.0 111.649 -175.963 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' F' F ' 89' ' ' ASP . . . . . . . . . . . . . 12.3 t0 -133.23 150.76 51.93 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 115.592 -0.731 . . . . 0.0 109.279 174.973 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' F' F ' 90' ' ' GLU . . . . . . . . . . . . . 82.9 tt0 -48.18 -38.01 17.15 Favored 'General case' 0 C--N 1.33 -0.258 0 N-CA-C 112.827 0.677 . . . . 0.0 112.827 -173.385 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' F' F ' 91' ' ' ASN . . . . . . . . . . . . . 26.5 m120 -128.44 32.93 4.77 Favored 'General case' 0 N--CA 1.466 0.361 0 N-CA-C 111.794 0.294 . . . . 0.0 111.794 -177.077 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' F' F ' 92' ' ' LEU . . . . . . . . . . . . . 19.3 tp -166.13 138.9 4.01 Favored 'General case' 0 C--N 1.33 -0.259 0 N-CA-C 110.2 -0.296 . . . . 0.0 110.2 -179.438 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' F' F ' 93' ' ' ILE . . . . . . . . . . . . . 71.0 mt -126.36 122.46 61.3 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.279 0 N-CA-C 109.666 -0.494 . . . . 0.0 109.666 178.368 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' F' F ' 94' ' ' VAL . . . . . 0.558 HG21 HG11 ' F' ' 125' ' ' VAL . 43.8 t -120.78 126.25 75.01 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.265 0 N-CA-C 109.887 -0.412 . . . . 0.0 109.887 179.995 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' F' F ' 95' ' ' VAL . . . . . . . . . . . . . 42.7 t -121.45 133.77 66.92 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.282 0 CA-C-N 115.939 -0.573 . . . . 0.0 109.665 179.849 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' F' F ' 96' ' ' ILE . . . . . . . . . . . . . 60.9 mt -115.5 126.66 73.12 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.323 0 N-CA-C 109.363 -0.606 . . . . 0.0 109.363 179.039 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' F' F ' 97' ' ' THR . . . . . . . . . . . . . 80.8 p -96.5 156.52 16.31 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-O 120.863 0.363 . . . . 0.0 110.765 -179.191 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' F' F ' 98' ' ' GLU . . . . . . . . . . . . . 40.8 tp10 -53.82 -25.54 19.97 Favored 'General case' 0 CA--C 1.533 0.317 0 N-CA-C 112.111 0.411 . . . . 0.0 112.111 -179.461 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' F' F ' 99' ' ' GLU . . . . . . . . . . . . . 18.1 tp10 -80.05 17.42 1.0 Allowed 'General case' 0 CA--C 1.538 0.503 0 N-CA-C 112.858 0.688 . . . . 0.0 112.858 -177.732 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' F' F ' 100' ' ' ASN . . . . . . . . . . . . . 3.6 m-20 63.1 35.59 12.83 Favored 'General case' 0 CA--C 1.531 0.233 0 CA-C-O 120.882 0.372 . . . . 0.0 111.435 176.39 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' F' F ' 101' ' ' GLU . . . . . . . . . . . . . 83.9 tt0 -113.19 142.06 46.23 Favored 'General case' 0 C--N 1.332 -0.173 0 N-CA-C 109.866 -0.42 . . . . 0.0 109.866 175.355 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' F' F ' 102' ' ' VAL . . . . . . . . . . . . . 45.8 t -115.01 126.17 72.53 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.266 0 N-CA-C 109.896 -0.409 . . . . 0.0 109.896 -178.537 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' F' F ' 103' ' ' LEU . . . . . . . . . . . . . 58.2 mt -116.1 133.85 55.57 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 115.685 -0.689 . . . . 0.0 109.796 177.798 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' F' F ' 104' ' ' ILE . . . . . . . . . . . . . 73.8 mt -121.53 119.41 58.87 Favored 'Isoleucine or valine' 0 C--O 1.233 0.23 0 N-CA-C 110.211 -0.292 . . . . 0.0 110.211 -178.939 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' F' F ' 105' ' ' PHE . . . . . . . . . . . . . 35.5 m-85 -121.79 168.2 12.11 Favored 'General case' 0 C--N 1.332 -0.153 0 O-C-N 124.222 0.951 . . . . 0.0 109.907 -179.968 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' F' F ' 106' ' ' ASN . . . . . . . . . . . . . 45.5 p-10 -102.56 -170.03 1.75 Allowed 'General case' 0 C--N 1.33 -0.273 0 N-CA-C 109.509 -0.552 . . . . 0.0 109.509 171.917 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' F' F ' 107' ' ' GLN . . . . . . . . . . . . . 57.1 tt0 -58.21 -26.1 62.4 Favored 'General case' 0 CA--C 1.534 0.337 0 N-CA-C 112.162 0.43 . . . . 0.0 112.162 179.024 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' F' F ' 108' ' ' ASN . . . . . 0.409 ' O ' ' ND2' ' F' ' 108' ' ' ASN . 1.2 t30 -91.16 13.29 17.43 Favored 'General case' 0 CA--C 1.536 0.426 0 N-CA-C 112.974 0.731 . . . . 0.0 112.974 -176.729 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' F' F ' 109' ' ' LEU . . . . . . . . . . . . . 67.7 mt 57.17 35.44 26.24 Favored 'General case' 0 CA--C 1.53 0.178 0 CA-C-O 120.714 0.292 . . . . 0.0 111.543 177.795 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' F' F ' 110' ' ' GLU . . . . . . . . . . . . . 70.8 mm-40 -102.75 149.27 24.63 Favored 'General case' 0 C--N 1.33 -0.282 0 N-CA-C 109.897 -0.409 . . . . 0.0 109.897 176.249 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' F' F ' 111' ' ' GLU . . . . . . . . . . . . . 98.6 mt-10 -81.47 121.97 26.94 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-O 120.997 0.427 . . . . 0.0 111.38 -176.644 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' F' F ' 112' ' ' LEU . . . . . . . . . . . . . 44.7 mt -105.52 -45.69 4.38 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 115.852 -0.613 . . . . 0.0 109.905 175.94 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' F' F ' 113' ' ' TYR . . . . . . . . . . . . . 61.5 t80 -141.92 140.86 32.91 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 115.976 -0.556 . . . . 0.0 110.761 179.928 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' F' F ' 114' ' ' ARG . . . . . . . . . . . . . 71.7 mtm180 -145.17 121.0 10.59 Favored 'General case' 0 C--N 1.331 -0.226 0 CA-C-N 116.358 -0.383 . . . . 0.0 110.557 177.65 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' F' F ' 115' ' ' GLY . . . . . . . . . . . . . . . -150.13 162.67 29.28 Favored Glycine 0 CA--C 1.525 0.677 0 N-CA-C 110.908 -0.877 . . . . 0.0 110.908 -179.603 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' F' F ' 116' ' ' LYS . . . . . . . . . . . . . 1.9 ttmp? -126.43 136.0 52.1 Favored 'General case' 0 C--N 1.33 -0.267 0 N-CA-C 109.933 -0.395 . . . . 0.0 109.933 176.47 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' F' F ' 117' ' ' PHE . . . . . . . . . . . . . 60.6 m-85 -128.91 115.13 17.38 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.237 -0.438 . . . . 0.0 110.264 -176.519 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' F' F ' 118' ' ' GLU . . . . . . . . . . . . . 84.5 tt0 -51.83 -49.16 63.38 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 116.431 -0.349 . . . . 0.0 111.742 -175.718 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' F' F ' 119' ' ' ASN . . . . . . . . . . . . . 5.2 m120 -98.8 31.08 3.06 Favored 'General case' 0 C--N 1.33 -0.249 0 N-CA-C 112.126 0.417 . . . . 0.0 112.126 -174.053 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' F' F ' 120' ' ' LEU . . . . . . . . . . . . . 19.1 tp -54.5 121.29 8.07 Favored 'General case' 0 N--CA 1.462 0.157 0 CA-C-O 120.671 0.272 . . . . 0.0 110.959 179.056 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' F' F ' 121' ' ' ASN . . . . . . . . . . . . . 6.6 t-20 -113.97 -44.08 3.19 Favored 'General case' 0 C--N 1.333 -0.113 0 CA-C-N 116.536 -0.302 . . . . 0.0 111.008 -177.352 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' F' F ' 122' ' ' LYS . . . . . . . . . . . . . 95.8 mttt -146.9 151.36 36.93 Favored 'General case' 0 C--N 1.331 -0.209 0 CA-C-O 121.064 0.459 . . . . 0.0 111.734 -178.416 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' F' F ' 123' ' ' VAL . . . . . . . . . . . . . 46.1 t -129.52 124.41 59.54 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.325 0 N-CA-C 109.181 -0.674 . . . . 0.0 109.181 173.058 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' F' F ' 124' ' ' LEU . . . . . 0.5 HD12 ' N ' ' F' ' 124' ' ' LEU . 6.1 mp -117.1 138.79 51.4 Favored 'General case' 0 C--N 1.331 -0.215 0 CA-C-O 120.818 0.342 . . . . 0.0 110.492 -176.699 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' F' F ' 125' ' ' VAL . . . . . 0.652 HG12 HG23 ' F' ' 130' ' ' VAL . 35.2 m -135.16 140.06 45.84 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.238 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.996 -179.514 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' F' F ' 126' ' ' ARG . . . . . . . . . . . . . 6.7 ptm85 -139.86 118.98 12.69 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 115.938 -0.574 . . . . 0.0 109.966 176.052 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' F' F ' 127' ' ' ASN . . . . . . . . . . . . . 29.9 m120 52.55 -107.65 0.35 Allowed 'General case' 0 CA--C 1.544 0.747 0 CA-C-O 118.968 -0.539 . . . . 0.0 111.053 -178.221 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' F' F ' 128' ' ' ASP . . . . . . . . . . . . . 9.5 p-10 -114.17 3.9 15.36 Favored 'General case' 0 N--CA 1.467 0.4 0 CA-C-N 119.746 1.157 . . . . 0.0 113.476 -178.378 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' F' F ' 129' ' ' LEU . . . . . . . . . . . . . 10.4 tp -105.04 141.81 35.94 Favored 'General case' 0 C--O 1.232 0.142 0 N-CA-C 109.619 -0.512 . . . . 0.0 109.619 179.413 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' F' F ' 130' ' ' VAL . . . . . 0.652 HG23 HG12 ' F' ' 125' ' ' VAL . 14.5 p -133.12 143.4 39.44 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.249 0 CA-C-O 121.312 0.577 . . . . 0.0 111.5 -175.538 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' F' F ' 131' ' ' VAL . . . . . . . . . . . . . 43.8 t -136.06 137.58 48.45 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.232 0 CA-C-N 115.591 -0.732 . . . . 0.0 109.949 177.882 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' F' F ' 132' ' ' ILE . . . . . . . . . . . . . 69.6 mt -114.21 134.08 58.23 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.257 0 CA-C-N 116.075 -0.511 . . . . 0.0 109.628 -179.215 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' F' F ' 133' ' ' ILE . . . . . . . . . . . . . 43.2 mm -117.92 119.53 61.79 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.238 0 CA-C-O 121.007 0.432 . . . . 0.0 110.819 -176.549 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' F' F ' 134' ' ' ASP . . . . . . . . . . . . . 7.3 p-10 -132.84 144.68 50.37 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 115.77 -0.65 . . . . 0.0 109.329 174.834 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' F' F ' 135' ' ' GLU . . . . . . . . . . . . . 85.5 tt0 -49.86 -25.04 2.8 Favored 'General case' 0 C--N 1.328 -0.332 0 N-CA-C 112.942 0.719 . . . . 0.0 112.942 -170.745 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' F' F ' 136' ' ' GLN . . . . . . . . . . . . . 97.4 mt-30 -94.09 -34.47 12.97 Favored 'General case' 0 C--N 1.331 -0.221 0 N-CA-C 112.112 0.412 . . . . 0.0 112.112 -176.953 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' F' F ' 137' ' ' LYS . . . . . . . . . . . . . 78.6 mttt -139.91 153.21 46.91 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-O 121.247 0.546 . . . . 0.0 111.702 -170.149 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' F' F ' 138' ' ' LEU . . . . . 0.441 HD23 ' C ' ' F' ' 138' ' ' LEU . 6.6 tt -117.56 123.07 45.35 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 115.53 -0.759 . . . . 0.0 108.973 170.94 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' F' F ' 139' ' ' THR . . . . . 0.442 HG23 ' HG2' ' A' ' 77' ' ' GLU . 31.3 m -114.55 128.58 56.4 Favored 'General case' 0 C--N 1.331 -0.218 0 CA-C-N 116.327 -0.397 . . . . 0.0 111.053 -175.537 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' F' F ' 140' ' ' LEU . . . . . 0.479 HD23 ' C ' ' F' ' 140' ' ' LEU . 7.3 tt -114.18 125.08 53.53 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 115.619 -0.719 . . . . 0.0 109.308 179.634 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' F' F ' 141' ' ' ILE . . . . . 0.49 ' HB ' HG13 ' F' ' 130' ' ' VAL . 19.0 mt -124.72 119.78 57.07 Favored 'Isoleucine or valine' 0 C--O 1.235 0.31 0 CA-C-O 121.005 0.431 . . . . 0.0 110.52 -175.301 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' F' F ' 142' ' ' ARG . . . . . . . . . . . . . 94.1 mtt180 -94.69 125.25 39.22 Favored 'General case' 0 C--N 1.332 -0.182 0 CA-C-N 115.249 -0.887 . . . . 0.0 109.387 174.527 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' F' F ' 143' ' ' THR . . . . . . . . . . . . . 45.1 p . . . . . 0 C--O 1.221 -0.437 0 CA-C-O 117.982 -1.009 . . . . 0.0 110.61 179.58 . . . . . . . . 0 0 . 1 . 020 nuclear build full ' A' A ' -3' ' ' GLU . . . . . . . . . . . . . 46.3 tp10 . . . . . 0 N--CA 1.49 1.571 0 N-CA-C 109.356 -0.609 . . . . 0.0 109.356 . . . . . . . . . 0 0 . 1 . 020 nuclear build full ' A' A ' -2' ' ' GLY . . . . . . . . . . . . . . . -64.82 149.95 51.49 Favored Glycine 0 CA--C 1.523 0.564 0 N-CA-C 110.83 -0.908 . . . . 0.0 110.83 179.7 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' -1' ' ' VAL . . . . . . . . . . . . . 43.9 t -95.78 133.98 34.92 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.298 0 N-CA-C 109.974 -0.38 . . . . 0.0 109.974 -179.605 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 0' ' ' ILE . . . . . . . . . . . . . 42.9 mm -108.17 128.27 63.75 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.325 0 CA-C-N 116.211 -0.449 . . . . 0.0 109.893 179.856 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 24.0 ptm -86.57 125.23 33.65 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-O 121.053 0.454 . . . . 0.0 110.722 -178.531 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 59.9 p -117.14 145.99 43.46 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 115.93 -0.577 . . . . 0.0 110.063 178.511 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 95.6 mt-10 -139.95 142.75 36.36 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-O 121.08 0.467 . . . . 0.0 111.385 -177.423 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 4' ' ' LEU . . . . . 0.423 HD21 HD23 ' A' ' 58' ' ' LEU . 39.0 mt -120.86 127.52 51.96 Favored 'General case' 0 C--N 1.331 -0.215 0 CA-C-N 115.603 -0.726 . . . . 0.0 110.043 174.978 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 5' ' ' LYS . . . . . . . . . . . . . 88.8 mttt -108.9 119.43 39.54 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-O 120.862 0.363 . . . . 0.0 110.498 176.364 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 45.6 mt -115.55 146.73 41.47 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 115.297 -0.865 . . . . 0.0 110.234 -179.199 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 75.4 tttt -135.91 136.25 22.93 Favored Pre-proline 0 CA--C 1.534 0.328 0 CA-C-O 118.981 -0.533 . . . . 0.0 110.247 176.125 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 8' ' ' PRO . . . . . . . . . . . . . 89.1 Cg_endo -90.81 141.86 3.17 Favored 'Trans proline' 0 N--CA 1.491 1.361 0 C-N-CA 121.553 1.502 . . . . 0.0 111.526 176.281 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 65.1 mt -73.4 -47.42 7.5 Favored Pre-proline 0 CA--C 1.533 0.313 0 CA-C-O 118.711 -0.661 . . . . 0.0 112.235 -178.266 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 83.2 Cg_endo -80.95 153.11 19.21 Favored 'Trans proline' 0 N--CA 1.495 1.608 0 C-N-CA 121.268 1.312 . . . . 0.0 111.767 175.558 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 24.7 ttpp -86.99 102.57 14.52 Favored 'General case' 0 C--N 1.329 -0.295 0 C-N-CA 120.772 -0.371 . . . . 0.0 110.174 178.588 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 11.8 p -141.33 144.05 26.86 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.291 0 CA-C-N 116.275 -0.42 . . . . 0.0 110.368 -179.412 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 95.3 mt-10 -84.5 129.84 34.81 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.062 178.635 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 14' ' ' LEU . . . . . . . . . . . . . 34.7 mt -98.66 148.54 34.69 Favored Pre-proline 0 CA--C 1.533 0.327 0 CA-C-O 119.229 -0.415 . . . . 0.0 110.629 -177.938 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 15' ' ' PRO . . . . . . . . . . . . . 24.5 Cg_exo -63.51 163.64 23.34 Favored 'Trans proline' 0 N--CA 1.498 1.758 0 C-N-CA 121.382 1.388 . . . . 0.0 111.978 175.992 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 16' ' ' PRO . . . . . . . . . . . . . 25.6 Cg_exo -61.29 -39.91 53.79 Favored 'Trans proline' 0 N--CA 1.496 1.651 0 C-N-CA 121.544 1.496 . . . . 0.0 112.836 -178.511 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 17' ' ' ASP . . . . . . . . . . . . . 7.9 p-10 -83.64 4.57 27.88 Favored 'General case' 0 CA--C 1.535 0.394 0 N-CA-C 113.344 0.868 . . . . 0.0 113.344 -176.973 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 18' ' ' PHE . . . . . . . . . . . . . 39.7 t80 -57.28 -46.66 82.89 Favored 'General case' 0 N--CA 1.457 -0.098 0 O-C-N 121.943 -0.473 . . . . 0.0 110.471 -176.494 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 19' ' ' VAL . . . . . . . . . . . . . 45.9 t -56.05 -47.15 80.71 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.362 0 CA-C-N 116.477 -0.328 . . . . 0.0 110.831 -176.527 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 49.3 m-20 -60.13 -41.09 91.95 Favored 'General case' 0 C--N 1.329 -0.302 0 C-N-CA 120.921 -0.312 . . . . 0.0 111.158 -176.954 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 56.1 t -64.74 -45.3 95.56 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.255 0 C-N-CA 120.746 -0.382 . . . . 0.0 110.504 -177.78 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 22' ' ' ILE . . . . . 0.583 HG22 HD12 ' A' ' 26' ' ' LEU . 51.2 mm -56.49 -45.05 81.89 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.235 0 C-N-CA 121.031 -0.268 . . . . 0.0 110.385 178.027 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 23' ' ' ARG . . . . . . . . . . . . . 45.3 ttp180 -53.99 -48.8 70.02 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-O 120.611 0.243 . . . . 0.0 111.375 -179.629 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 24' ' ' ILE . . . . . . . . . . . . . 70.7 mt -60.55 -43.26 94.09 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.349 0 CA-C-O 120.634 0.254 . . . . 0.0 111.025 -178.217 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 74.5 mttt -64.97 -36.48 84.52 Favored 'General case' 0 C--N 1.328 -0.367 0 N-CA-C 112.069 0.396 . . . . 0.0 112.069 -178.804 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 26' ' ' LEU . . . . . 0.583 HD12 HG22 ' A' ' 22' ' ' ILE . 42.6 mt -79.72 -44.19 21.23 Favored 'General case' 0 C--N 1.33 -0.269 0 N-CA-C 113.413 0.894 . . . . 0.0 113.413 -173.396 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 27' ' ' GLN . . . . . . . . . . . . . 16.9 pt20 -46.95 140.08 5.08 Favored 'General case' 0 N--CA 1.469 0.48 0 N-CA-C 112.833 0.679 . . . . 0.0 112.833 -173.619 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 97.55 -26.65 22.18 Favored Glycine 0 CA--C 1.534 1.24 0 CA-C-N 115.525 -0.761 . . . . 0.0 112.169 -176.062 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 65.5 mttm -97.58 155.17 17.09 Favored 'General case' 0 C--O 1.233 0.214 0 CA-C-N 117.108 0.454 . . . . 0.0 110.939 179.009 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 30' ' ' THR . . . . . . . . . . . . . 29.0 m -95.58 136.3 36.15 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.06 -0.518 . . . . 0.0 110.293 176.669 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 35.5 m -121.24 138.87 50.21 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.239 0 CA-C-N 116.352 -0.386 . . . . 0.0 110.612 -179.79 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 32' ' ' ARG . . . . . . . . . . . . . 48.0 tpt85 -134.08 139.11 45.75 Favored 'General case' 0 C--N 1.326 -0.428 0 CA-C-N 115.878 -0.601 . . . . 0.0 110.086 -178.822 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 33' ' ' THR . . . . . . . . . . . . . 19.7 m -51.67 140.58 18.42 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-O 120.922 0.391 . . . . 0.0 111.642 -175.475 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 99.13 -17.34 58.17 Favored Glycine 0 CA--C 1.533 1.181 0 CA-C-N 116.006 -0.543 . . . . 0.0 113.024 -179.372 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 82.0 m-20 -64.95 147.97 52.41 Favored 'General case' 0 C--O 1.231 0.096 0 CA-C-N 118.02 0.91 . . . . 0.0 111.088 179.079 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 46.0 t -120.39 128.18 75.97 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.166 0 CA-C-N 115.712 -0.676 . . . . 0.0 109.66 177.835 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 37' ' ' ILE . . . . . . . . . . . . . 66.9 mt -120.74 138.47 51.09 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.273 0 N-CA-C 109.782 -0.451 . . . . 0.0 109.782 -179.572 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . -114.29 128.68 8.33 Favored Glycine 0 CA--C 1.526 0.762 0 N-CA-C 110.935 -0.866 . . . . 0.0 110.935 179.53 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 39' ' ' ILE . . . . . . . . . . . . . 73.3 mt -126.62 127.01 69.83 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.246 0 N-CA-C 109.936 -0.394 . . . . 0.0 109.936 179.05 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 40' ' ' SER . . . . . . . . . . . . . 45.8 t -93.12 123.24 36.25 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.558 -0.292 . . . . 0.0 110.996 177.31 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 41' ' ' ILE . . . . . . . . . . . . . 73.0 mt -131.16 123.01 52.67 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.21 0 CA-C-O 120.92 0.391 . . . . 0.0 110.059 177.715 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 10.9 tp 56.35 36.8 28.1 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.072 -0.513 . . . . 0.0 111.339 178.847 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . 79.01 -10.08 35.39 Favored Glycine 0 CA--C 1.534 1.227 0 C-N-CA 121.21 -0.519 . . . . 0.0 113.641 175.963 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 44' ' ' LYS . . . . . . . . . . . . . 83.4 tttt -101.15 128.3 47.3 Favored 'General case' 0 C--N 1.334 -0.091 0 CA-C-N 117.968 0.884 . . . . 0.0 109.975 177.699 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 41.2 tp10 -84.94 130.63 34.61 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.373 -0.376 . . . . 0.0 110.921 -178.995 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 46' ' ' VAL . . . . . . . . . . . . . 7.4 p -121.82 132.07 71.69 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.199 0 N-CA-C 109.651 -0.5 . . . . 0.0 109.651 176.419 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 94.1 mttt -100.88 131.1 46.92 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.083 -0.508 . . . . 0.0 111.281 178.982 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 48' ' ' PHE . . . . . . . . . . . . . 92.1 m-85 -115.5 131.88 56.8 Favored 'General case' 0 C--N 1.33 -0.244 0 N-CA-C 109.759 -0.46 . . . . 0.0 109.759 175.598 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 54.4 tttm -108.32 139.32 43.19 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.693 -0.23 . . . . 0.0 110.425 178.022 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 50' ' ' VAL . . . . . . . . . . . . . 44.9 t -79.04 107.84 11.96 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.355 0 N-CA-C 109.262 -0.644 . . . . 0.0 109.262 175.909 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 51' ' ' VAL . . . . . . . . . . . . . 49.2 t -72.06 -48.62 48.82 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.324 0 CA-C-N 116.023 -0.535 . . . . 0.0 109.909 -174.324 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 52' ' ' GLN . . . . . . . . . . . . . 61.8 tt0 -162.95 144.45 9.95 Favored 'General case' 0 C--N 1.331 -0.238 0 C-N-CA 120.345 -0.542 . . . . 0.0 111.917 -178.52 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -121.66 132.61 54.75 Favored 'General case' 0 C--N 1.331 -0.196 0 CA-C-N 115.717 -0.674 . . . . 0.0 109.827 175.913 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 54' ' ' TYR . . . . . . . . . . . . . 22.5 t80 -129.16 110.94 18.2 Favored Pre-proline 0 CA--C 1.535 0.396 0 CA-C-O 118.101 -0.952 . . . . 0.0 110.656 177.787 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 55' ' ' PRO . . . . . . . . . . . . . 71.1 Cg_endo -75.94 170.04 72.86 Favored 'Cis proline' 0 N--CA 1.501 1.929 0 CA-C-N 121.898 1.714 . . . . 0.0 112.578 -7.908 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 56' ' ' SER . . . . . . . . . . . . . 66.3 m -118.36 132.53 23.75 Favored Pre-proline 0 CA--C 1.54 0.58 0 CA-C-O 118.439 -0.791 . . . . 0.0 110.079 178.257 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 57' ' ' PRO . . . . . . . . . . . . . 75.9 Cg_endo -79.22 149.73 84.03 Favored 'Cis proline' 0 N--CA 1.495 1.601 0 CA-C-N 121.932 1.726 . . . . 0.0 111.535 -4.922 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 58' ' ' LEU . . . . . 0.423 HD23 HD21 ' A' ' 4' ' ' LEU . 30.6 tp -108.84 140.89 41.66 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.303 -0.408 . . . . 0.0 110.929 -177.817 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 59' ' ' ARG . . . . . . . . . . . . . 78.2 ttt180 -94.06 119.02 32.34 Favored 'General case' 0 C--N 1.328 -0.331 0 N-CA-C 108.809 -0.812 . . . . 0.0 108.809 170.862 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 45.8 t -72.87 120.3 21.28 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.322 0 C-N-CA 120.55 -0.46 . . . . 0.0 110.667 -173.462 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 95.3 mt-10 -131.14 162.68 29.36 Favored 'General case' 0 C--N 1.331 -0.239 0 CA-C-N 115.63 -0.714 . . . . 0.0 109.78 176.945 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 62' ' ' ASP . . . . . . . . . . . . . 12.6 p-10 -54.28 -31.4 53.69 Favored 'General case' 0 C--N 1.329 -0.315 0 N-CA-C 112.185 0.439 . . . . 0.0 112.185 -177.693 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 63' ' ' ARG . . . . . . . . . . . . . 15.2 mmm180 -71.01 -21.81 62.24 Favored 'General case' 0 C--N 1.329 -0.285 0 N-CA-C 113.02 0.748 . . . . 0.0 113.02 -175.787 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 30.3 m -69.76 140.36 53.41 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-O 120.788 0.327 . . . . 0.0 110.997 -175.679 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 65' ' ' LYS . . . . . . . . . . . . . 12.1 mptt -88.91 134.7 33.87 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.154 -0.475 . . . . 0.0 109.836 179.731 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 66' ' ' ILE . . . . . . . . . . . . . 61.1 mt -117.91 131.81 69.57 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.302 0 CA-C-O 120.844 0.354 . . . . 0.0 110.321 -179.067 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 67' ' ' THR . . . . . . . . . . . . . 19.1 m -128.01 135.5 49.98 Favored 'General case' 0 C--N 1.331 -0.23 0 CA-C-N 116.112 -0.495 . . . . 0.0 110.507 178.517 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 68' ' ' LEU . . . . . 0.484 ' N ' HD12 ' A' ' 68' ' ' LEU . 8.5 mp -107.01 131.39 54.12 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 115.939 -0.573 . . . . 0.0 110.296 177.731 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 69' ' ' VAL . . . . . . . . . . . . . 44.7 t -97.82 116.54 40.66 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.32 0 CA-C-O 121.025 0.44 . . . . 0.0 109.91 178.591 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 70' ' ' THR . . . . . . . . . . . . . 2.8 m -145.06 -43.88 0.23 Allowed 'General case' 0 C--N 1.327 -0.389 0 CA-C-N 115.737 -0.665 . . . . 0.0 110.0 179.437 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 71' ' ' HIS . . . . . . . . . . . . . 96.1 m-70 -134.01 151.7 77.17 Favored Pre-proline 0 C--N 1.33 -0.274 0 CA-C-N 115.864 -0.607 . . . . 0.0 109.928 176.819 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 72' ' ' PRO . . . . . . . . . . . . . 61.0 Cg_endo -73.7 -12.19 24.31 Favored 'Trans proline' 0 N--CA 1.498 1.739 0 C-N-CA 121.346 1.364 . . . . 0.0 113.505 -179.583 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 73' ' ' VAL . . . . . . . . . . . . . 35.2 m -123.88 169.18 15.55 Favored 'Isoleucine or valine' 0 N--CA 1.461 0.108 0 CA-C-O 120.77 0.319 . . . . 0.0 110.395 -178.595 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 74' ' ' ASP . . . . . . . . . . . . . 36.1 t0 -92.86 121.43 34.22 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.228 -0.442 . . . . 0.0 109.998 -177.988 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 40.2 t -118.26 122.64 70.08 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.262 0 CA-C-O 120.922 0.392 . . . . 0.0 110.791 -176.745 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 76' ' ' LEU . . . . . . . . . . . . . 5.6 mp -122.54 146.43 47.42 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 115.869 -0.605 . . . . 0.0 109.832 175.572 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 77' ' ' GLU . . . . . . . . . . . . . 97.9 mt-10 -134.94 141.59 46.31 Favored 'General case' 0 C--N 1.331 -0.218 0 CA-C-O 121.04 0.448 . . . . 0.0 111.419 -179.241 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 78' ' ' ALA . . . . . . . . . . . . . . . -130.62 140.27 50.41 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-N 115.682 -0.69 . . . . 0.0 109.858 175.581 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 79' ' ' LYS . . . . . 0.589 ' O ' HD13 ' A' ' 80' ' ' ILE . 53.0 mttm -87.49 122.77 31.64 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-O 120.994 0.426 . . . . 0.0 111.239 -177.606 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 80' ' ' ILE . . . . . 0.589 HD13 ' O ' ' A' ' 79' ' ' LYS . 39.8 mm -139.2 109.26 4.16 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.298 0 N-CA-C 108.994 -0.743 . . . . 0.0 108.994 179.37 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 81' ' ' LYS . . . . . . . . . . . . . 78.2 tttt -97.8 123.37 41.73 Favored 'General case' 0 C--N 1.329 -0.3 0 C-N-CA 120.788 -0.365 . . . . 0.0 110.935 -176.949 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . 89.17 42.21 5.64 Favored Glycine 0 CA--C 1.526 0.741 0 C-N-CA 120.759 -0.734 . . . . 0.0 111.705 175.292 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 83' ' ' ILE . . . . . . . . . . . . . 71.1 mt -66.12 138.52 22.86 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.218 0 N-CA-C 109.736 -0.468 . . . . 0.0 109.736 177.178 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 84' ' ' LYS . . . . . . . . . . . . . 78.5 tttt -96.17 -52.9 3.83 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.031 -0.531 . . . . 0.0 110.405 -179.192 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 85' ' ' ASP . . . . . . . . . . . . . 7.1 t70 -154.19 153.7 32.23 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 115.906 -0.588 . . . . 0.0 110.567 -178.977 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 86' ' ' VAL . . . . . . . . . . . . . 42.6 t -131.77 131.32 62.13 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.242 0 CA-C-O 120.984 0.421 . . . . 0.0 110.468 -179.821 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 87' ' ' ILE . . . . . 0.498 HD12 ' N ' ' A' ' 87' ' ' ILE . 5.0 mp -119.06 127.91 75.82 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.224 0 N-CA-C 109.301 -0.629 . . . . 0.0 109.301 176.25 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 88' ' ' LEU . . . . . . . . . . . . . 84.8 mt -117.32 138.82 51.52 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-O 121.149 0.499 . . . . 0.0 111.857 -177.071 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 89' ' ' ASP . . . . . . . . . . . . . 13.7 t70 -134.13 157.75 45.4 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-N 115.375 -0.829 . . . . 0.0 109.19 175.014 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 74.0 tt0 -47.5 -38.13 13.28 Favored 'General case' 0 C--N 1.33 -0.244 0 N-CA-C 112.772 0.656 . . . . 0.0 112.772 -172.785 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 91' ' ' ASN . . . . . . . . . . . . . 13.5 p-10 -132.09 35.97 3.68 Favored 'General case' 0 C--N 1.331 -0.207 0 N-CA-C 111.866 0.321 . . . . 0.0 111.866 -176.604 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 92' ' ' LEU . . . . . . . . . . . . . 13.1 tp -163.73 141.72 7.49 Favored 'General case' 0 C--N 1.332 -0.168 0 C-N-CA 120.85 -0.34 . . . . 0.0 110.934 -179.051 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 93' ' ' ILE . . . . . . . . . . . . . 74.8 mt -126.59 120.83 57.19 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.245 0 N-CA-C 109.461 -0.57 . . . . 0.0 109.461 178.268 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 94' ' ' VAL . . . . . 0.48 HG21 HG11 ' A' ' 125' ' ' VAL . 43.7 t -120.96 127.17 75.91 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.271 0 N-CA-C 109.873 -0.418 . . . . 0.0 109.873 179.306 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 95' ' ' VAL . . . . . . . . . . . . . 44.4 t -123.42 134.79 65.29 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.283 0 CA-C-N 116.137 -0.483 . . . . 0.0 109.92 -178.908 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 96' ' ' ILE . . . . . . . . . . . . . 65.3 mt -116.51 128.69 73.79 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.294 0 N-CA-C 109.286 -0.635 . . . . 0.0 109.286 179.157 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 97' ' ' THR . . . . . . . . . . . . . 74.1 p -100.7 156.07 17.54 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-O 121.206 0.527 . . . . 0.0 111.177 -177.606 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 98' ' ' GLU . . . . . . . . . . . . . 79.8 tt0 -54.02 -26.26 25.47 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.166 -0.47 . . . . 0.0 112.129 -178.808 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 99' ' ' GLU . . . . . . . . . . . . . 95.4 mt-10 -81.83 16.62 1.76 Allowed 'General case' 0 CA--C 1.535 0.374 0 N-CA-C 113.232 0.826 . . . . 0.0 113.232 -175.814 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 100' ' ' ASN . . . . . . . . . . . . . 3.7 m-20 62.97 36.03 12.87 Favored 'General case' 0 N--CA 1.464 0.243 0 CA-C-O 120.906 0.384 . . . . 0.0 111.345 178.548 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 101' ' ' GLU . . . . . . . . . . . . . 84.2 tt0 -112.33 144.4 41.82 Favored 'General case' 0 C--N 1.332 -0.188 0 CA-C-N 116.126 -0.488 . . . . 0.0 109.858 173.549 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 102' ' ' VAL . . . . . . . . . . . . . 48.1 t -116.19 128.05 73.61 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.283 0 CA-C-N 116.325 -0.398 . . . . 0.0 110.128 -178.324 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 103' ' ' LEU . . . . . . . . . . . . . 21.3 mt -118.97 131.86 56.04 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 115.693 -0.685 . . . . 0.0 110.094 177.475 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 104' ' ' ILE . . . . . 0.494 ' CD1' HG11 ' A' ' 130' ' ' VAL . 70.1 mt -120.76 123.39 70.17 Favored 'Isoleucine or valine' 0 C--O 1.234 0.248 0 N-CA-C 110.398 -0.223 . . . . 0.0 110.398 -179.735 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 105' ' ' PHE . . . . . . . . . . . . . 66.5 m-85 -122.92 166.15 15.52 Favored 'General case' 0 C--O 1.232 0.162 0 O-C-N 123.915 0.759 . . . . 0.0 109.942 -179.486 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 106' ' ' ASN . . . . . . . . . . . . . 38.0 p-10 -103.71 -171.08 1.88 Allowed 'General case' 0 C--N 1.331 -0.235 0 N-CA-C 109.951 -0.389 . . . . 0.0 109.951 172.662 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 107' ' ' GLN . . . . . . . . . . . . . 62.0 tt0 -59.85 -24.83 64.54 Favored 'General case' 0 CA--C 1.533 0.324 0 N-CA-C 112.156 0.428 . . . . 0.0 112.156 177.199 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 108' ' ' ASN . . . . . . . . . . . . . 28.5 t30 -84.51 4.16 33.18 Favored 'General case' 0 CA--C 1.538 0.498 0 N-CA-C 113.16 0.8 . . . . 0.0 113.16 -178.022 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 109' ' ' LEU . . . . . . . . . . . . . 12.0 tp 60.88 37.68 18.28 Favored 'General case' 0 CA--C 1.531 0.232 0 CA-C-O 120.943 0.401 . . . . 0.0 111.209 179.669 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 110' ' ' GLU . . . . . . . . . . . . . 15.1 mm-40 -106.55 150.14 26.44 Favored 'General case' 0 C--N 1.329 -0.294 0 N-CA-C 109.958 -0.386 . . . . 0.0 109.958 176.598 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 111' ' ' GLU . . . . . . . . . . . . . 43.3 tp10 -80.16 121.91 26.16 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-O 120.889 0.376 . . . . 0.0 110.043 179.776 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 112' ' ' LEU . . . . . . . . . . . . . 14.8 mt -108.34 -45.62 3.87 Favored 'General case' 0 C--N 1.331 -0.201 0 CA-C-N 116.07 -0.514 . . . . 0.0 110.142 178.511 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 113' ' ' TYR . . . . . . . . . . . . . 64.0 t80 -137.29 139.36 40.87 Favored 'General case' 0 C--N 1.331 -0.211 0 CA-C-N 116.248 -0.433 . . . . 0.0 111.221 -179.805 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 114' ' ' ARG . . . . . . . . . . . . . 32.4 ttm180 -140.95 124.26 16.61 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 115.888 -0.596 . . . . 0.0 110.275 177.509 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 115' ' ' GLY . . . . . . . . . . . . . . . -149.98 158.39 27.64 Favored Glycine 0 CA--C 1.524 0.61 0 N-CA-C 110.938 -0.865 . . . . 0.0 110.938 178.967 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 116' ' ' LYS . . . . . . . . . . . . . 77.5 tttt -136.65 133.61 36.42 Favored 'General case' 0 C--N 1.329 -0.311 0 N-CA-C 110.097 -0.335 . . . . 0.0 110.097 178.636 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 117' ' ' PHE . . . . . . . . . . . . . 9.7 m-85 -138.08 118.98 14.23 Favored 'General case' 0 C--N 1.33 -0.25 0 C-N-CA 120.754 -0.379 . . . . 0.0 110.103 -174.208 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 118' ' ' GLU . . . . . . . . . . . . . 70.6 mm-40 -55.18 -43.65 74.53 Favored 'General case' 0 C--N 1.33 -0.279 0 C-N-CA 120.847 -0.341 . . . . 0.0 111.027 -177.935 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 119' ' ' ASN . . . . . . . . . . . . . 65.7 m-80 -93.71 28.41 2.36 Favored 'General case' 0 C--N 1.329 -0.288 0 N-CA-C 112.414 0.524 . . . . 0.0 112.414 -174.248 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 120' ' ' LEU . . . . . . . . . . . . . 19.2 tp -58.65 120.25 8.57 Favored 'General case' 0 C--N 1.333 -0.128 0 N-CA-C 110.028 -0.36 . . . . 0.0 110.028 177.263 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 121' ' ' ASN . . . . . . . . . . . . . 10.4 t-20 -112.46 -44.13 3.41 Favored 'General case' 0 C--O 1.232 0.148 0 CA-C-N 116.655 -0.248 . . . . 0.0 111.058 -176.274 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 122' ' ' LYS . . . . . . . . . . . . . 82.8 mttt -144.52 147.46 33.26 Favored 'General case' 0 C--N 1.332 -0.162 0 CA-C-O 121.177 0.513 . . . . 0.0 111.793 -177.928 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 123' ' ' VAL . . . . . . . . . . . . . 45.8 t -123.24 128.64 74.98 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.193 0 CA-C-N 115.759 -0.655 . . . . 0.0 109.459 175.139 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 124' ' ' LEU . . . . . . . . . . . . . 52.5 mt -123.6 141.09 52.35 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-O 120.798 0.332 . . . . 0.0 110.854 -177.063 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 125' ' ' VAL . . . . . 0.48 HG11 HG21 ' A' ' 94' ' ' VAL . 34.8 m -135.11 140.93 44.2 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.259 0 CA-C-N 116.287 -0.415 . . . . 0.0 110.992 179.446 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 126' ' ' ARG . . . . . . . . . . . . . 77.6 mtp85 -144.91 111.01 5.5 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 115.975 -0.557 . . . . 0.0 110.396 176.47 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 127' ' ' ASN . . . . . . . . . . . . . 55.8 t30 52.3 -108.54 0.4 Allowed 'General case' 0 CA--C 1.545 0.765 0 CA-C-O 118.83 -0.605 . . . . 0.0 111.344 179.691 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 128' ' ' ASP . . . . . . . . . . . . . 22.9 p-10 -108.09 5.8 26.34 Favored 'General case' 0 N--CA 1.468 0.464 0 CA-C-N 119.876 1.216 . . . . 0.0 113.485 -177.79 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 129' ' ' LEU . . . . . . . . . . . . . 12.1 tp -104.99 138.33 41.37 Favored 'General case' 0 C--N 1.332 -0.175 0 N-CA-C 109.883 -0.414 . . . . 0.0 109.883 178.692 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 130' ' ' VAL . . . . . 0.494 HG11 ' CD1' ' A' ' 104' ' ' ILE . 41.5 t -121.76 137.99 53.53 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.23 0 N-CA-C 110.081 -0.34 . . . . 0.0 110.081 -178.584 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 131' ' ' VAL . . . . . 0.5 HG22 HD12 ' A' ' 140' ' ' LEU . 40.0 t -134.71 136.23 52.58 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.248 0 CA-C-O 121.036 0.446 . . . . 0.0 110.45 -179.476 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 132' ' ' ILE . . . . . . . . . . . . . 75.0 mt -118.21 130.69 72.69 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.273 0 CA-C-N 115.738 -0.665 . . . . 0.0 109.49 179.436 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 133' ' ' ILE . . . . . . . . . . . . . 43.0 mm -117.75 123.33 71.55 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.261 0 CA-C-O 120.985 0.422 . . . . 0.0 111.063 -175.907 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 134' ' ' ASP . . . . . . . . . . . . . 7.7 p-10 -135.01 148.18 49.88 Favored 'General case' 0 C--N 1.331 -0.223 0 CA-C-N 115.849 -0.614 . . . . 0.0 109.517 173.92 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 135' ' ' GLU . . . . . . . . . . . . . 43.6 tp10 -49.89 -24.71 2.64 Favored 'General case' 0 C--N 1.326 -0.416 0 N-CA-C 112.797 0.665 . . . . 0.0 112.797 -172.01 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 136' ' ' GLN . . . . . . . . . . . . . 59.7 tp60 -101.11 -27.49 13.22 Favored 'General case' 0 CA--C 1.53 0.211 0 N-CA-C 112.668 0.618 . . . . 0.0 112.668 -174.863 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 137' ' ' LYS . . . . . . . . . . . . . 81.5 mttt -142.36 152.99 43.43 Favored 'General case' 0 C--N 1.332 -0.188 0 CA-C-O 121.17 0.51 . . . . 0.0 111.685 -171.661 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 138' ' ' LEU . . . . . . . . . . . . . 4.7 tt -120.22 122.27 40.56 Favored 'General case' 0 C--N 1.328 -0.346 0 N-CA-C 109.011 -0.737 . . . . 0.0 109.011 171.675 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 139' ' ' THR . . . . . . . . . . . . . 32.8 m -112.62 128.6 56.42 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 116.376 -0.374 . . . . 0.0 110.787 -176.835 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 140' ' ' LEU . . . . . 0.5 HD12 HG22 ' A' ' 131' ' ' VAL . 15.0 tp -115.85 121.63 42.96 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 115.522 -0.763 . . . . 0.0 109.264 -179.292 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 141' ' ' ILE . . . . . . . . . . . . . 19.3 mt -119.29 120.15 62.87 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.266 0 CA-C-O 120.888 0.375 . . . . 0.0 110.354 -174.613 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 142' ' ' ARG . . . . . . . . . . . . . 73.1 mtm180 -106.48 127.51 53.36 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-N 115.498 -0.774 . . . . 0.0 110.166 179.629 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 143' ' ' THR . . . . . . . . . . . . . 77.3 p . . . . . 0 C--O 1.221 -0.398 0 CA-C-O 117.922 -1.037 . . . . 0.0 110.577 -179.419 . . . . . . . . 0 0 . 1 . 020 nuclear build full ' B' B ' -3' ' ' GLU . . . . . . . . . . . . . 70.5 mm-40 . . . . . 0 N--CA 1.49 1.541 0 N-CA-C 109.432 -0.581 . . . . 0.0 109.432 . . . . . . . . . 0 0 . 1 . 020 nuclear build full ' B' B ' -2' ' ' GLY . . . . . . . . . . . . . . . -69.99 119.54 8.95 Favored Glycine 0 CA--C 1.524 0.656 0 N-CA-C 111.035 -0.826 . . . . 0.0 111.035 -179.67 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' B' B ' -1' ' ' VAL . . . . . . . . . . . . . 45.4 t -96.91 142.62 13.76 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.306 0 CA-C-O 120.87 0.367 . . . . 0.0 110.052 179.904 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' B' B ' 0' ' ' ILE . . . . . . . . . . . . . 70.9 mt -97.67 134.61 35.14 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.283 0 CA-C-N 116.084 -0.507 . . . . 0.0 109.929 -179.733 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' B' B ' 1' ' ' MET . . . . . . . . . . . . . 25.2 ptp -86.7 141.26 29.04 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.114 -0.494 . . . . 0.0 110.574 -179.928 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' B' B ' 2' ' ' SER . . . . . . . . . . . . . 36.4 p -107.88 157.74 17.93 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.687 -179.003 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' B' B ' 3' ' ' GLU . . . . . . . . . . . . . 95.2 mt-10 -140.52 145.96 37.52 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-O 121.026 0.441 . . . . 0.0 111.484 -177.106 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' B' B ' 4' ' ' LEU . . . . . . . . . . . . . 17.2 tp -125.47 131.03 52.93 Favored 'General case' 0 C--N 1.332 -0.191 0 CA-C-N 115.82 -0.627 . . . . 0.0 109.859 175.264 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' B' B ' 5' ' ' LYS . . . . . . . . . . . . . 98.6 mttt -108.55 120.86 43.67 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.42 -0.354 . . . . 0.0 110.837 -179.256 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' B' B ' 6' ' ' LEU . . . . . . . . . . . . . 55.2 mt -114.64 148.71 37.76 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 115.35 -0.841 . . . . 0.0 110.225 -179.728 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' B' B ' 7' ' ' LYS . . . . . . . . . . . . . 58.9 tttp -138.47 140.86 29.38 Favored Pre-proline 0 CA--C 1.535 0.379 0 CA-C-O 119.132 -0.461 . . . . 0.0 110.015 175.139 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' B' B ' 8' ' ' PRO . . . . . . . . . . . . . 90.1 Cg_endo -91.98 142.27 2.58 Favored 'Trans proline' 0 N--CA 1.489 1.247 0 C-N-CA 121.76 1.64 . . . . 0.0 111.922 178.229 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' B' B ' 9' ' ' LEU . . . . . . . . . . . . . 68.8 mt -74.22 -47.35 6.09 Favored Pre-proline 0 CA--C 1.533 0.316 0 CA-C-O 118.64 -0.695 . . . . 0.0 112.105 179.244 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' B' B ' 10' ' ' PRO . . . . . . . . . . . . . 84.0 Cg_endo -80.77 150.39 18.61 Favored 'Trans proline' 0 N--CA 1.495 1.6 0 C-N-CA 121.242 1.295 . . . . 0.0 111.816 175.49 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' B' B ' 11' ' ' LYS . . . . . . . . . . . . . 62.3 mtpt -86.67 97.46 10.58 Favored 'General case' 0 C--N 1.331 -0.229 0 CA-C-O 120.82 0.343 . . . . 0.0 110.362 178.74 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' B' B ' 12' ' ' VAL . . . . . . . . . . . . . 12.6 p -142.67 148.91 19.36 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.259 0 CA-C-N 116.102 -0.499 . . . . 0.0 110.568 -179.186 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' B' B ' 13' ' ' GLU . . . . . . . . . . . . . 82.3 tt0 -87.29 131.5 34.22 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 116.307 -0.406 . . . . 0.0 110.09 178.144 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' B' B ' 14' ' ' LEU . . . . . . . . . . . . . 28.0 mt -96.23 150.9 37.76 Favored Pre-proline 0 CA--C 1.532 0.263 0 CA-C-O 119.376 -0.345 . . . . 0.0 110.62 -178.225 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' B' B ' 15' ' ' PRO . . . . . . . . . . . . . 28.4 Cg_exo -60.75 159.43 28.71 Favored 'Trans proline' 0 N--CA 1.497 1.702 0 C-N-CA 121.307 1.338 . . . . 0.0 111.832 177.228 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' B' B ' 16' ' ' PRO . . . . . . . . . . . . . 38.5 Cg_exo -57.94 -45.0 35.2 Favored 'Trans proline' 0 N--CA 1.498 1.776 0 C-N-CA 121.452 1.435 . . . . 0.0 113.061 -176.73 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' B' B ' 17' ' ' ASP . . . . . . . . . . . . . 22.7 p-10 -87.64 12.47 12.54 Favored 'General case' 0 CA--C 1.536 0.413 0 N-CA-C 113.138 0.792 . . . . 0.0 113.138 -177.303 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' B' B ' 18' ' ' PHE . . . . . . . . . . . . . 48.2 t80 -58.26 -42.69 86.99 Favored 'General case' 0 N--CA 1.457 -0.092 0 O-C-N 122.054 -0.404 . . . . 0.0 110.178 -178.297 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' B' B ' 19' ' ' VAL . . . . . . . . . . . . . 46.3 t -56.94 -43.83 81.33 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 CA-C-N 116.308 -0.405 . . . . 0.0 110.533 -178.384 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' B' B ' 20' ' ' ASP . . . . . . . . . . . . . 36.8 m-20 -59.94 -41.95 92.94 Favored 'General case' 0 C--N 1.33 -0.276 0 C-N-CA 120.924 -0.31 . . . . 0.0 110.908 -177.964 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' B' B ' 21' ' ' VAL . . . . . . . . . . . . . 48.9 t -64.29 -46.65 92.63 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.27 0 C-N-CA 120.661 -0.416 . . . . 0.0 110.376 -177.78 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' B' B ' 22' ' ' ILE . . . . . 0.511 HG22 HD12 ' B' ' 26' ' ' LEU . 51.3 mm -56.32 -45.28 81.37 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.275 0 C-N-CA 120.955 -0.298 . . . . 0.0 110.577 179.036 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' B' B ' 23' ' ' ARG . . . . . . . . . . . . . 51.7 ttp180 -54.65 -48.58 72.14 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-O 120.584 0.23 . . . . 0.0 111.224 -178.472 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' B' B ' 24' ' ' ILE . . . . . . . . . . . . . 72.0 mt -59.96 -44.38 94.43 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.268 0 CA-C-N 116.599 -0.273 . . . . 0.0 111.293 -177.675 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' B' B ' 25' ' ' LYS . . . . . . . . . . . . . 35.9 mttm -63.99 -42.16 97.27 Favored 'General case' 0 C--N 1.33 -0.277 0 N-CA-C 112.341 0.496 . . . . 0.0 112.341 -178.82 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' B' B ' 26' ' ' LEU . . . . . 0.511 HD12 HG22 ' B' ' 22' ' ' ILE . 92.0 mt -78.42 -42.2 30.82 Favored 'General case' 0 C--N 1.328 -0.35 0 N-CA-C 113.162 0.801 . . . . 0.0 113.162 -170.911 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' B' B ' 27' ' ' GLN . . . . . . . . . . . . . 4.1 pt20 -47.51 140.93 5.45 Favored 'General case' 0 N--CA 1.468 0.459 0 N-CA-C 112.708 0.633 . . . . 0.0 112.708 -174.726 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' B' B ' 28' ' ' GLY . . . . . . . . . . . . . . . 100.7 -26.93 22.8 Favored Glycine 0 CA--C 1.533 1.168 0 CA-C-N 115.564 -0.744 . . . . 0.0 112.205 -177.521 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' B' B ' 29' ' ' LYS . . . . . . . . . . . . . 99.5 mttt -98.71 155.08 17.51 Favored 'General case' 0 C--N 1.332 -0.168 0 CA-C-N 117.379 0.59 . . . . 0.0 111.269 179.32 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' B' B ' 30' ' ' THR . . . . . . . . . . . . . 34.6 m -103.57 135.65 44.77 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 115.75 -0.659 . . . . 0.0 109.763 174.925 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' B' B ' 31' ' ' VAL . . . . . . . . . . . . . 35.4 m -130.86 161.21 41.25 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.245 0 CA-C-N 116.379 -0.373 . . . . 0.0 110.775 -178.805 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' B' B ' 32' ' ' ARG . . . . . . . . . . . . . 70.5 mtm180 -133.75 151.98 51.75 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 115.848 -0.615 . . . . 0.0 110.981 179.748 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' B' B ' 33' ' ' THR . . . . . . . . . . . . . 20.7 m -53.5 139.53 30.87 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.199 -0.455 . . . . 0.0 111.29 -178.758 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' B' B ' 34' ' ' GLY . . . . . . . . . . . . . . . 100.5 -17.01 57.34 Favored Glycine 0 CA--C 1.531 1.086 0 CA-C-O 119.584 -0.565 . . . . 0.0 113.224 178.9 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' B' B ' 35' ' ' ASP . . . . . . . . . . . . . 71.9 m-20 -64.78 148.29 51.5 Favored 'General case' 0 C--O 1.232 0.147 0 CA-C-N 118.183 0.992 . . . . 0.0 111.251 179.639 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' B' B ' 36' ' ' VAL . . . . . . . . . . . . . 46.3 t -117.92 128.41 75.05 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.22 0 CA-C-N 115.527 -0.76 . . . . 0.0 109.739 178.52 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' B' B ' 37' ' ' ILE . . . . . . . . . . . . . 69.8 mt -121.91 138.99 50.32 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.26 0 CA-C-N 116.259 -0.428 . . . . 0.0 109.977 -179.306 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' B' B ' 38' ' ' GLY . . . . . . . . . . . . . . . -114.22 128.97 8.48 Favored Glycine 0 CA--C 1.526 0.742 0 N-CA-C 111.176 -0.769 . . . . 0.0 111.176 -179.203 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' B' B ' 39' ' ' ILE . . . . . . . . . . . . . 75.6 mt -124.06 134.54 66.29 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.253 0 CA-C-O 120.765 0.317 . . . . 0.0 110.164 179.077 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' B' B ' 40' ' ' SER . . . . . . . . . . . . . 53.3 p -92.88 115.95 28.59 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 116.39 -0.368 . . . . 0.0 111.052 176.345 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' B' B ' 41' ' ' ILE . . . . . . . . . . . . . 44.7 mm -121.42 120.78 62.91 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.257 0 CA-C-O 120.775 0.321 . . . . 0.0 110.305 178.461 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' B' B ' 42' ' ' LEU . . . . . . . . . . . . . 62.6 mt 51.75 35.39 15.13 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-N 116.252 -0.431 . . . . 0.0 111.799 176.688 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' B' B ' 43' ' ' GLY . . . . . . . . . . . . . . . 73.88 31.79 59.7 Favored Glycine 0 CA--C 1.528 0.872 0 C-N-CA 121.073 -0.584 . . . . 0.0 112.141 177.706 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' B' B ' 44' ' ' LYS . . . . . . . . . . . . . 23.6 tptm -136.85 128.0 27.9 Favored 'General case' 0 C--N 1.329 -0.293 0 N-CA-C 109.397 -0.594 . . . . 0.0 109.397 177.736 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' B' B ' 45' ' ' GLU . . . . . . . . . . . . . 81.8 tt0 -82.73 117.42 22.64 Favored 'General case' 0 C--N 1.327 -0.373 0 C-N-CA 120.917 -0.313 . . . . 0.0 110.702 -178.356 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' B' B ' 46' ' ' VAL . . . . . . . . . . . . . 7.3 p -115.84 128.58 73.06 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.192 0 N-CA-C 109.412 -0.588 . . . . 0.0 109.412 176.284 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' B' B ' 47' ' ' LYS . . . . . . . . . . . . . 68.6 mttm -99.55 126.93 45.6 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 115.788 -0.642 . . . . 0.0 110.991 179.451 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' B' B ' 48' ' ' PHE . . . . . . . . . . . . . 91.1 m-85 -111.3 131.93 54.77 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-N 116.078 -0.51 . . . . 0.0 109.816 176.996 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' B' B ' 49' ' ' LYS . . . . . . . . . . . . . 83.5 tttt -106.56 134.97 48.88 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-N 116.365 -0.379 . . . . 0.0 110.269 178.6 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' B' B ' 50' ' ' VAL . . . . . . . . . . . . . 45.3 t -78.92 105.59 8.45 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.329 0 N-CA-C 108.993 -0.743 . . . . 0.0 108.993 175.328 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' B' B ' 51' ' ' VAL . . . . . . . . . . . . . 49.0 t -70.1 -53.42 23.58 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.387 0 N-CA-C 109.479 -0.563 . . . . 0.0 109.479 -174.208 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' B' B ' 52' ' ' GLN . . . . . . . . . . . . . 91.7 mt-30 -153.88 152.51 30.72 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 115.947 -0.57 . . . . 0.0 111.695 -177.617 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' B' B ' 53' ' ' ALA . . . . . . . . . . . . . . . -128.2 132.93 48.81 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 115.313 -0.858 . . . . 0.0 109.62 174.87 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' B' B ' 54' ' ' TYR . . . . . . . . . . . . . 58.2 t80 -129.05 107.61 18.01 Favored Pre-proline 0 CA--C 1.534 0.33 0 CA-C-O 118.219 -0.896 . . . . 0.0 110.354 179.767 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' B' B ' 55' ' ' PRO . . . . . . . . . . . . . 73.8 Cg_endo -77.22 169.75 73.32 Favored 'Cis proline' 0 N--CA 1.501 1.926 0 CA-C-N 121.839 1.692 . . . . 0.0 112.863 -4.419 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' B' B ' 56' ' ' SER . . . . . . . . . . . . . 50.6 m -117.59 132.0 23.81 Favored Pre-proline 0 CA--C 1.539 0.537 0 CA-C-O 118.352 -0.832 . . . . 0.0 109.548 174.361 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' B' B ' 57' ' ' PRO . . . . . . . . . . . . . 32.4 Cg_endo -65.21 164.99 57.4 Favored 'Cis proline' 0 N--CA 1.498 1.769 0 CA-C-N 122.027 1.76 . . . . 0.0 111.554 -2.615 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' B' B ' 58' ' ' LEU . . . . . . . . . . . . . 25.0 tp -129.4 137.51 50.96 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-O 120.997 0.427 . . . . 0.0 110.518 -178.284 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' B' B ' 59' ' ' ARG . . . . . . . . . . . . . 75.0 ttt180 -103.4 127.71 50.7 Favored 'General case' 0 C--N 1.326 -0.443 0 CA-C-N 115.731 -0.668 . . . . 0.0 109.225 175.169 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' B' B ' 60' ' ' VAL . . . . . . . . . . . . . 45.6 t -82.07 116.77 26.9 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.232 0 C-N-CA 120.553 -0.459 . . . . 0.0 110.39 -175.928 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' B' B ' 61' ' ' GLU . . . . . . . . . . . . . 70.6 mm-40 -131.14 162.14 30.57 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 115.905 -0.589 . . . . 0.0 109.877 176.618 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' B' B ' 62' ' ' ASP . . . . . . . . . . . . . 43.7 m-20 -53.15 -32.36 47.22 Favored 'General case' 0 C--N 1.328 -0.331 0 N-CA-C 111.807 0.299 . . . . 0.0 111.807 -179.694 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' B' B ' 63' ' ' ARG . . . . . . . . . . . . . 23.7 mmt180 -71.14 -21.94 62.13 Favored 'General case' 0 CA--C 1.532 0.282 0 N-CA-C 112.858 0.688 . . . . 0.0 112.858 -175.99 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' B' B ' 64' ' ' THR . . . . . . . . . . . . . 26.1 m -77.4 140.95 40.01 Favored 'General case' 0 C--N 1.331 -0.226 0 CA-C-O 121.0 0.429 . . . . 0.0 110.877 -175.315 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' B' B ' 65' ' ' LYS . . . . . . . . . . . . . 3.0 mptp? -89.75 134.67 34.05 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 115.976 -0.556 . . . . 0.0 110.233 179.753 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' B' B ' 66' ' ' ILE . . . . . . . . . . . . . 58.9 mt -114.28 129.0 71.04 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.229 0 N-CA-C 109.649 -0.5 . . . . 0.0 109.649 178.083 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' B' B ' 67' ' ' THR . . . . . . . . . . . . . 32.6 m -124.79 139.65 53.65 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-O 121.001 0.429 . . . . 0.0 111.014 -177.128 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' B' B ' 68' ' ' LEU . . . . . . . . . . . . . 6.8 mp -102.76 124.0 47.48 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 115.886 -0.597 . . . . 0.0 110.171 176.196 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' B' B ' 69' ' ' VAL . . . . . . . . . . . . . 44.3 t -101.54 112.54 34.92 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.284 0 CA-C-N 116.345 -0.389 . . . . 0.0 110.021 -179.855 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' B' B ' 70' ' ' THR . . . . . . . . . . . . . 41.3 p -150.02 165.05 33.89 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.142 -0.481 . . . . 0.0 110.678 179.696 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' B' B ' 71' ' ' HIS . . . . . . . . . . . . . 1.5 t60 -140.4 68.09 31.98 Favored Pre-proline 0 CA--C 1.536 0.417 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.326 178.653 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' B' B ' 72' ' ' PRO . . . . . . . . . . . . . 58.6 Cg_endo -90.67 160.08 4.25 Favored 'Trans proline' 0 N--CA 1.489 1.249 0 C-N-CA 121.959 1.772 . . . . 0.0 112.603 -178.467 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' B' B ' 73' ' ' VAL . . . . . . . . . . . . . 30.4 m -105.12 167.0 3.07 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.269 0 CA-C-N 116.016 -0.538 . . . . 0.0 110.06 178.023 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' B' B ' 74' ' ' ASP . . . . . . . . . . . . . 25.2 t0 -103.44 116.42 32.36 Favored 'General case' 0 C--N 1.33 -0.273 0 N-CA-C 109.819 -0.438 . . . . 0.0 109.819 -178.691 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' B' B ' 75' ' ' VAL . . . . . . . . . . . . . 41.7 t -111.34 122.23 65.39 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.243 0 CA-C-O 121.042 0.448 . . . . 0.0 110.355 -178.354 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' B' B ' 76' ' ' LEU . . . . . . . . . . . . . 35.8 mt -119.09 138.69 52.7 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 115.665 -0.698 . . . . 0.0 109.39 177.341 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' B' B ' 77' ' ' GLU . . . . . . . . . . . . . 46.3 mt-10 -134.32 136.37 43.43 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-O 121.14 0.495 . . . . 0.0 111.265 -176.914 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' B' B ' 78' ' ' ALA . . . . . . . . . . . . . . . -125.87 137.55 53.75 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 115.602 -0.726 . . . . 0.0 109.768 176.258 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' B' B ' 79' ' ' LYS . . . . . . . . . . . . . 93.5 mttt -81.73 119.1 23.43 Favored 'General case' 0 C--N 1.329 -0.311 0 C-N-CA 120.811 -0.356 . . . . 0.0 110.438 -179.16 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' B' B ' 80' ' ' ILE . . . . . . . . . . . . . 29.5 mm -134.65 118.46 26.04 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.292 0 CA-C-N 115.721 -0.672 . . . . 0.0 109.234 -176.652 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' B' B ' 81' ' ' LYS . . . . . . . . . . . . . 17.8 ttpt -108.67 123.92 49.73 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-O 120.818 0.342 . . . . 0.0 111.13 -177.073 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' B' B ' 82' ' ' GLY . . . . . . . . . . . . . . . 89.08 42.19 5.68 Favored Glycine 0 CA--C 1.526 0.779 0 C-N-CA 120.838 -0.696 . . . . 0.0 111.816 173.88 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' B' B ' 83' ' ' ILE . . . . . . . . . . . . . 69.9 mt -67.55 138.41 22.78 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.369 0 N-CA-C 109.883 -0.414 . . . . 0.0 109.883 177.969 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' B' B ' 84' ' ' LYS . . . . . . . . . . . . . 39.8 ttpt -100.39 -52.09 3.46 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-O 121.103 0.477 . . . . 0.0 110.046 179.643 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' B' B ' 85' ' ' ASP . . . . . . . . . . . . . 6.5 t70 -153.04 152.35 31.26 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 115.69 -0.687 . . . . 0.0 110.393 -179.955 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' B' B ' 86' ' ' VAL . . . . . . . . . . . . . 41.2 t -129.07 131.73 67.75 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.207 0 CA-C-O 120.871 0.367 . . . . 0.0 110.426 -179.61 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' B' B ' 87' ' ' ILE . . . . . . . . . . . . . 44.3 mm -119.28 126.37 75.28 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.238 0 N-CA-C 109.301 -0.629 . . . . 0.0 109.301 176.251 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' B' B ' 88' ' ' LEU . . . . . 0.434 HD13 HG21 ' A' ' 131' ' ' VAL . 81.3 mt -120.95 137.22 54.72 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-O 121.236 0.541 . . . . 0.0 111.706 -176.23 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' B' B ' 89' ' ' ASP . . . . . . . . . . . . . 5.2 t0 -133.09 154.83 50.2 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 115.452 -0.795 . . . . 0.0 109.054 174.823 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' B' B ' 90' ' ' GLU . . . . . . . . . . . . . 84.2 tt0 -48.84 -30.92 6.33 Favored 'General case' 0 C--N 1.33 -0.273 0 N-CA-C 112.804 0.668 . . . . 0.0 112.804 -172.891 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' B' B ' 91' ' ' ASN . . . . . . . . . . . . . 78.2 m-20 -131.54 28.78 4.6 Favored 'General case' 0 N--CA 1.466 0.343 0 N-CA-C 112.521 0.563 . . . . 0.0 112.521 -174.46 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' B' B ' 92' ' ' LEU . . . . . . . . . . . . . 16.9 tp -166.11 143.07 5.22 Favored 'General case' 0 C--N 1.331 -0.217 0 C-N-CA 120.765 -0.374 . . . . 0.0 110.923 179.794 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' B' B ' 93' ' ' ILE . . . . . . . . . . . . . 72.3 mt -125.13 123.83 66.17 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.242 0 N-CA-C 109.633 -0.506 . . . . 0.0 109.633 178.548 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' B' B ' 94' ' ' VAL . . . . . 0.591 HG21 HG11 ' B' ' 125' ' ' VAL . 44.1 t -125.41 127.54 71.92 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.238 0 CA-C-O 121.016 0.436 . . . . 0.0 109.996 178.126 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' B' B ' 95' ' ' VAL . . . . . . . . . . . . . 46.1 t -120.7 134.87 62.76 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.312 0 CA-C-N 115.944 -0.571 . . . . 0.0 109.765 179.872 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' B' B ' 96' ' ' ILE . . . . . . . . . . . . . 67.9 mt -115.46 128.46 72.67 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.273 0 N-CA-C 109.416 -0.587 . . . . 0.0 109.416 178.898 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' B' B ' 97' ' ' THR . . . . . . . . . . . . . 74.5 p -102.7 159.11 15.75 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-O 121.283 0.563 . . . . 0.0 111.308 -177.103 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' B' B ' 98' ' ' GLU . . . . . . . . . . . . . 45.0 mt-10 -53.95 -25.01 18.53 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.049 -0.523 . . . . 0.0 112.276 179.736 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' B' B ' 99' ' ' GLU . . . . . . . . . . . . . 33.7 tt0 -80.69 17.37 1.15 Allowed 'General case' 0 CA--C 1.538 0.494 0 N-CA-C 112.519 0.563 . . . . 0.0 112.519 -176.485 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' B' B ' 100' ' ' ASN . . . . . . . . . . . . . 2.4 m-20 60.72 37.97 18.61 Favored 'General case' 0 N--CA 1.463 0.181 0 O-C-N 121.801 -0.562 . . . . 0.0 110.883 179.392 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' B' B ' 101' ' ' GLU . . . . . . . . . . . . . 84.7 tt0 -116.19 144.13 44.59 Favored 'General case' 0 C--N 1.332 -0.169 0 CA-C-N 116.215 -0.448 . . . . 0.0 109.895 178.133 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' B' B ' 102' ' ' VAL . . . . . . . . . . . . . 44.8 t -116.51 127.07 74.22 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.234 0 CA-C-O 120.963 0.411 . . . . 0.0 109.907 -178.724 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' B' B ' 103' ' ' LEU . . . . . . . . . . . . . 51.1 mt -113.33 129.95 56.4 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 115.431 -0.804 . . . . 0.0 110.063 178.2 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' B' B ' 104' ' ' ILE . . . . . 0.41 HD12 ' HB3' ' B' ' 113' ' ' TYR . 67.7 mt -118.82 120.08 62.99 Favored 'Isoleucine or valine' 0 C--O 1.234 0.249 0 N-CA-C 110.213 -0.291 . . . . 0.0 110.213 -179.418 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' B' B ' 105' ' ' PHE . . . . . . . . . . . . . 38.6 m-85 -124.04 163.69 20.91 Favored 'General case' 0 C--N 1.332 -0.168 0 CA-C-N 115.537 -0.756 . . . . 0.0 109.55 178.404 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' B' B ' 106' ' ' ASN . . . . . . . . . . . . . 41.5 p-10 -95.92 -171.68 2.4 Favored 'General case' 0 C--N 1.33 -0.262 0 N-CA-C 109.955 -0.387 . . . . 0.0 109.955 173.949 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' B' B ' 107' ' ' GLN . . . . . . . . . . . . . 39.3 tt0 -59.86 -30.05 68.71 Favored 'General case' 0 C--N 1.328 -0.341 0 N-CA-C 111.806 0.299 . . . . 0.0 111.806 179.782 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' B' B ' 108' ' ' ASN . . . . . . . . . . . . . 3.7 t-20 -83.66 7.54 17.15 Favored 'General case' 0 CA--C 1.535 0.398 0 N-CA-C 113.275 0.843 . . . . 0.0 113.275 -177.366 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' B' B ' 109' ' ' LEU . . . . . . . . . . . . . 12.2 tp 63.01 39.88 9.75 Favored 'General case' 0 C--O 1.232 0.179 0 CA-C-O 121.116 0.484 . . . . 0.0 111.371 176.971 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' B' B ' 110' ' ' GLU . . . . . . . . . . . . . 95.9 mt-10 -108.88 163.44 13.28 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.28 -0.418 . . . . 0.0 110.381 177.064 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' B' B ' 111' ' ' GLU . . . . . . . . . . . . . 82.6 tt0 -84.65 123.63 30.57 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.193 -0.458 . . . . 0.0 111.037 -178.552 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' B' B ' 112' ' ' LEU . . . . . . . . . . . . . 22.7 mt -113.08 -46.02 3.13 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.094 -0.503 . . . . 0.0 110.257 174.374 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' B' B ' 113' ' ' TYR . . . . . 0.41 ' HB3' HD12 ' B' ' 104' ' ' ILE . 53.7 t80 -146.72 140.22 25.74 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.333 -0.394 . . . . 0.0 111.199 -179.998 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' B' B ' 114' ' ' ARG . . . . . . . . . . . . . 33.6 mtp180 -141.7 123.25 15.03 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.381 -0.372 . . . . 0.0 110.276 175.483 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' B' B ' 115' ' ' GLY . . . . . . . . . . . . . . . -150.08 161.08 28.79 Favored Glycine 0 CA--C 1.523 0.576 0 C-N-CA 120.7 -0.762 . . . . 0.0 111.364 179.922 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' B' B ' 116' ' ' LYS . . . . . . . . . . . . . 38.6 ttpt -126.9 138.08 53.25 Favored 'General case' 0 C--N 1.33 -0.25 0 N-CA-C 109.929 -0.397 . . . . 0.0 109.929 177.661 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' B' B ' 117' ' ' PHE . . . . . . . . . . . . . 35.7 m-85 -136.35 113.81 10.86 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-O 120.752 0.311 . . . . 0.0 110.347 -176.556 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' B' B ' 118' ' ' GLU . . . . . . . . . . . . . 44.2 mt-10 -54.83 -45.63 74.49 Favored 'General case' 0 C--N 1.329 -0.29 0 C-N-CA 120.942 -0.303 . . . . 0.0 111.27 -176.986 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' B' B ' 119' ' ' ASN . . . . . . . . . . . . . 34.7 m120 -93.78 28.78 2.25 Favored 'General case' 0 C--N 1.329 -0.287 0 O-C-N 123.554 0.534 . . . . 0.0 112.381 -173.688 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' B' B ' 120' ' ' LEU . . . . . . . . . . . . . 17.9 tp -57.37 119.9 7.26 Favored 'General case' 0 C--N 1.333 -0.141 0 C-N-CA 120.957 -0.297 . . . . 0.0 110.317 177.82 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' B' B ' 121' ' ' ASN . . . . . . . . . . . . . 45.8 t-20 -113.32 -44.06 3.28 Favored 'General case' 0 C--N 1.332 -0.19 0 CA-C-N 116.651 -0.25 . . . . 0.0 111.191 -177.164 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' B' B ' 122' ' ' LYS . . . . . . . . . . . . . 98.7 mttt -143.89 146.37 32.95 Favored 'General case' 0 C--N 1.332 -0.182 0 CA-C-O 121.087 0.47 . . . . 0.0 111.698 -178.351 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' B' B ' 123' ' ' VAL . . . . . . . . . . . . . 47.4 t -127.85 126.08 66.1 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.234 0 CA-C-N 115.756 -0.657 . . . . 0.0 109.375 175.075 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' B' B ' 124' ' ' LEU . . . . . . . . . . . . . 31.2 mt -125.6 134.7 51.83 Favored 'General case' 0 C--N 1.331 -0.212 0 CA-C-O 120.799 0.333 . . . . 0.0 110.675 -178.604 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' B' B ' 125' ' ' VAL . . . . . 0.721 HG12 HG23 ' B' ' 130' ' ' VAL . 35.1 m -132.15 144.22 37.74 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.244 0 CA-C-N 116.075 -0.511 . . . . 0.0 110.801 -179.213 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' B' B ' 126' ' ' ARG . . . . . 0.583 ' NH2' HD23 ' B' ' 129' ' ' LEU . 34.3 ptt-85 -152.51 120.49 6.18 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-O 121.328 0.585 . . . . 0.0 111.147 176.0 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' B' B ' 127' ' ' ASN . . . . . . . . . . . . . 82.3 m-20 52.82 -106.24 0.28 Allowed 'General case' 0 CA--C 1.542 0.637 0 CA-C-N 115.457 -0.792 . . . . 0.0 111.284 -179.439 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' B' B ' 128' ' ' ASP . . . . . . . . . . . . . 16.3 p-10 -114.1 0.87 14.42 Favored 'General case' 0 N--CA 1.468 0.445 0 CA-C-N 119.585 1.084 . . . . 0.0 113.372 -176.239 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' B' B ' 129' ' ' LEU . . . . . 0.583 HD23 ' NH2' ' B' ' 126' ' ' ARG . 18.0 tp -109.71 139.8 44.32 Favored 'General case' 0 C--N 1.332 -0.159 0 N-CA-C 109.699 -0.482 . . . . 0.0 109.699 -179.513 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' B' B ' 130' ' ' VAL . . . . . 0.721 HG23 HG12 ' B' ' 125' ' ' VAL . 13.2 p -134.39 143.1 38.94 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.2 0 CA-C-O 121.229 0.537 . . . . 0.0 110.9 -177.958 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' B' B ' 131' ' ' VAL . . . . . . . . . . . . . 42.9 t -135.97 139.79 45.27 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.246 0 CA-C-N 115.753 -0.658 . . . . 0.0 110.319 179.024 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' B' B ' 132' ' ' ILE . . . . . . . . . . . . . 72.9 mt -117.29 133.85 62.74 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.264 0 CA-C-N 115.599 -0.728 . . . . 0.0 109.481 179.7 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' B' B ' 133' ' ' ILE . . . . . . . . . . . . . 37.3 mm -115.47 124.21 71.74 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.224 0 CA-C-O 120.681 0.277 . . . . 0.0 110.965 -175.877 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' B' B ' 134' ' ' ASP . . . . . . . . . . . . . 9.6 p-10 -136.13 150.68 49.18 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-N 115.996 -0.547 . . . . 0.0 109.837 174.975 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' B' B ' 135' ' ' GLU . . . . . . . . . . . . . 46.7 tp10 -49.88 -28.95 7.26 Favored 'General case' 0 C--N 1.327 -0.393 0 N-CA-C 112.675 0.62 . . . . 0.0 112.675 -172.111 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' B' B ' 136' ' ' GLN . . . . . . . . . . . . . 58.7 tt0 -86.74 -31.55 20.89 Favored 'General case' 0 C--N 1.331 -0.233 0 N-CA-C 112.562 0.579 . . . . 0.0 112.562 -173.394 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' B' B ' 137' ' ' LYS . . . . . . . . . . . . . 56.9 pttt -166.09 174.66 9.12 Favored 'General case' 0 C--O 1.232 0.143 0 CA-C-O 121.545 0.688 . . . . 0.0 112.498 -172.649 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' B' B ' 138' ' ' LEU . . . . . 0.416 HD23 ' N ' ' B' ' 139' ' ' THR . 5.9 tt -120.54 129.84 53.98 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 114.932 -1.031 . . . . 0.0 109.811 179.048 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' B' B ' 139' ' ' THR . . . . . 0.416 ' N ' HD23 ' B' ' 138' ' ' LEU . 28.2 m -108.51 125.85 52.27 Favored 'General case' 0 C--N 1.331 -0.22 0 CA-C-N 116.272 -0.422 . . . . 0.0 110.357 179.446 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' B' B ' 140' ' ' LEU . . . . . 0.482 ' C ' HD23 ' B' ' 140' ' ' LEU . 8.0 tt -113.94 121.7 44.72 Favored 'General case' 0 C--N 1.329 -0.315 0 N-CA-C 109.156 -0.683 . . . . 0.0 109.156 -179.171 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' B' B ' 141' ' ' ILE . . . . . 0.421 ' HB ' HG13 ' B' ' 130' ' ' VAL . 19.0 mt -121.64 119.66 59.5 Favored 'Isoleucine or valine' 0 C--O 1.234 0.26 0 CA-C-O 120.949 0.404 . . . . 0.0 110.074 -176.193 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' B' B ' 142' ' ' ARG . . . . . . . . . . . . . 46.2 ttp180 -107.48 129.79 54.91 Favored 'General case' 0 C--N 1.332 -0.163 0 CA-C-N 115.198 -0.91 . . . . 0.0 110.772 -178.779 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' B' B ' 143' ' ' THR . . . . . . . . . . . . . 38.1 p . . . . . 0 C--O 1.22 -0.468 0 CA-C-O 118.044 -0.979 . . . . 0.0 110.516 178.969 . . . . . . . . 0 0 . 1 . 020 nuclear build full ' C' C ' -3' ' ' GLU . . . . . . . . . . . . . 95.8 mt-10 . . . . . 0 N--CA 1.491 1.619 0 N-CA-C 109.292 -0.633 . . . . 0.0 109.292 . . . . . . . . . 0 0 . 1 . 020 nuclear build full ' C' C ' -2' ' ' GLY . . . . . . . . . . . . . . . -74.2 144.6 33.54 Favored Glycine 0 CA--C 1.526 0.731 0 N-CA-C 111.005 -0.838 . . . . 0.0 111.005 -179.667 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' C' C ' -1' ' ' VAL . . . . . . . . . . . . . 45.4 t -96.2 131.28 43.38 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.282 0 N-CA-C 109.726 -0.472 . . . . 0.0 109.726 178.857 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' C' C ' 0' ' ' ILE . . . . . . . . . . . . . 44.0 mm -115.08 136.97 50.07 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.239 0 CA-C-N 116.323 -0.399 . . . . 0.0 110.365 -178.466 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' C' C ' 1' ' ' MET . . . . . . . . . . . . . 23.7 ptp -143.96 149.11 36.28 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 115.964 -0.562 . . . . 0.0 110.648 179.853 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' C' C ' 2' ' ' SER . . . . . . . . . . . . . 16.6 p -111.04 135.95 50.78 Favored 'General case' 0 C--N 1.332 -0.164 0 CA-C-O 121.014 0.435 . . . . 0.0 110.52 179.696 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' C' C ' 3' ' ' GLU . . . . . . . . . . . . . 95.5 mt-10 -141.48 141.29 33.65 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 115.978 -0.555 . . . . 0.0 111.089 -179.078 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' C' C ' 4' ' ' LEU . . . . . . . . . . . . . 15.3 tp -126.0 127.53 46.04 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 115.931 -0.577 . . . . 0.0 110.032 176.892 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' C' C ' 5' ' ' LYS . . . . . . . . . . . . . 86.8 mttt -106.5 120.57 42.26 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 116.438 -0.347 . . . . 0.0 110.776 178.162 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' C' C ' 6' ' ' LEU . . . . . 0.437 HD23 ' HA ' ' C' ' 50' ' ' VAL . 27.9 mt -115.05 148.82 38.4 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-N 115.295 -0.866 . . . . 0.0 110.381 179.772 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' C' C ' 7' ' ' LYS . . . . . . . . . . . . . 25.7 ttpp -134.62 133.18 21.13 Favored Pre-proline 0 CA--C 1.534 0.331 0 CA-C-O 118.791 -0.623 . . . . 0.0 110.04 176.875 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' C' C ' 8' ' ' PRO . . . . . . . . . . . . . 59.1 Cg_endo -89.7 135.81 2.53 Favored 'Trans proline' 0 N--CA 1.489 1.229 0 C-N-CA 121.69 1.593 . . . . 0.0 111.586 176.656 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' C' C ' 9' ' ' LEU . . . . . . . . . . . . . 34.2 mt -75.36 -47.47 4.33 Favored Pre-proline 0 CA--C 1.534 0.345 0 CA-C-O 118.581 -0.724 . . . . 0.0 112.085 -177.234 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' C' C ' 10' ' ' PRO . . . . . . . . . . . . . 71.8 Cg_endo -78.65 146.82 21.58 Favored 'Trans proline' 0 N--CA 1.495 1.609 0 C-N-CA 121.052 1.168 . . . . 0.0 111.684 175.143 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' C' C ' 11' ' ' LYS . . . . . . . . . . . . . 21.3 tptm -85.92 99.62 11.54 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-O 120.84 0.352 . . . . 0.0 110.349 -178.625 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' C' C ' 12' ' ' VAL . . . . . . . . . . . . . 12.6 p -143.65 150.12 17.5 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.264 0 CA-C-N 116.207 -0.451 . . . . 0.0 110.665 -179.172 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' C' C ' 13' ' ' GLU . . . . . . . . . . . . . 81.2 tt0 -84.55 127.67 34.18 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.281 -0.418 . . . . 0.0 110.13 178.582 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' C' C ' 14' ' ' LEU . . . . . . . . . . . . . 43.7 mt -96.63 150.03 36.51 Favored Pre-proline 0 CA--C 1.532 0.284 0 CA-C-O 119.368 -0.349 . . . . 0.0 110.627 -178.136 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' C' C ' 15' ' ' PRO . . . . . . . . . . . . . 28.0 Cg_exo -61.23 158.95 32.7 Favored 'Trans proline' 0 N--CA 1.497 1.701 0 C-N-CA 121.26 1.307 . . . . 0.0 111.97 177.754 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' C' C ' 16' ' ' PRO . . . . . . . . . . . . . 26.4 Cg_exo -60.79 -39.34 63.47 Favored 'Trans proline' 0 N--CA 1.496 1.671 0 C-N-CA 121.433 1.422 . . . . 0.0 112.732 -179.128 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' C' C ' 17' ' ' ASP . . . . . . . . . . . . . 19.3 p-10 -87.84 12.76 12.22 Favored 'General case' 0 CA--C 1.535 0.385 0 N-CA-C 113.171 0.804 . . . . 0.0 113.171 -177.006 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' C' C ' 18' ' ' PHE . . . . . . . . . . . . . 42.7 t80 -58.29 -45.39 88.05 Favored 'General case' 0 C--N 1.333 -0.117 0 O-C-N 122.135 -0.353 . . . . 0.0 110.089 -177.754 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' C' C ' 19' ' ' VAL . . . . . . . . . . . . . 47.8 t -55.87 -43.25 73.84 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.355 0 CA-C-N 116.523 -0.308 . . . . 0.0 110.779 -177.356 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' C' C ' 20' ' ' ASP . . . . . . . . . . . . . 7.5 t70 -60.09 -47.29 86.5 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-O 120.799 0.333 . . . . 0.0 111.009 -176.676 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' C' C ' 21' ' ' VAL . . . . . . . . . . . . . 46.4 t -64.4 -43.06 96.99 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.259 0 C-N-CA 120.663 -0.415 . . . . 0.0 110.408 -177.1 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' C' C ' 22' ' ' ILE . . . . . . . . . . . . . 43.9 mm -55.76 -48.31 78.2 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.346 0 N-CA-C 110.438 -0.208 . . . . 0.0 110.438 178.488 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' C' C ' 23' ' ' ARG . . . . . . . . . . . . . 53.8 ttp180 -54.97 -44.48 74.43 Favored 'General case' 0 C--N 1.332 -0.175 0 C-N-CA 120.911 -0.316 . . . . 0.0 111.221 -177.988 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' C' C ' 24' ' ' ILE . . . . . . . . . . . . . 75.0 mt -59.23 -46.9 91.89 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.253 0 CA-C-O 120.721 0.296 . . . . 0.0 110.938 -179.658 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' C' C ' 25' ' ' LYS . . . . . . . . . . . . . 44.2 mtmt -64.63 -38.62 91.63 Favored 'General case' 0 C--N 1.328 -0.331 0 N-CA-C 112.483 0.549 . . . . 0.0 112.483 -177.61 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' C' C ' 26' ' ' LEU . . . . . . . . . . . . . 81.1 mt -79.02 -44.74 21.62 Favored 'General case' 0 C--N 1.33 -0.259 0 N-CA-C 113.268 0.84 . . . . 0.0 113.268 -172.282 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' C' C ' 27' ' ' GLN . . . . . . . . . . . . . 18.2 pt20 -47.01 140.39 4.92 Favored 'General case' 0 N--CA 1.467 0.423 0 N-CA-C 112.812 0.671 . . . . 0.0 112.812 -173.548 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' C' C ' 28' ' ' GLY . . . . . . . . . . . . . . . 98.21 -27.09 20.91 Favored Glycine 0 CA--C 1.533 1.199 0 CA-C-N 115.513 -0.767 . . . . 0.0 112.103 -176.774 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' C' C ' 29' ' ' LYS . . . . . . . . . . . . . 29.2 mtpp -98.0 155.18 17.22 Favored 'General case' 0 C--O 1.232 0.154 0 CA-C-N 117.149 0.474 . . . . 0.0 111.072 179.246 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' C' C ' 30' ' ' THR . . . . . . . . . . . . . 28.7 m -100.37 139.59 35.82 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 115.991 -0.55 . . . . 0.0 110.361 177.307 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' C' C ' 31' ' ' VAL . . . . . . . . . . . . . 35.0 m -130.41 149.84 33.99 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.285 0 CA-C-N 116.319 -0.401 . . . . 0.0 110.759 -179.619 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' C' C ' 32' ' ' ARG . . . . . . . . . . . . . 72.2 mtp180 -132.68 154.09 50.48 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-O 121.198 0.523 . . . . 0.0 110.821 177.07 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' C' C ' 33' ' ' THR . . . . . 0.437 HG23 ' HA ' ' C' ' 52' ' ' GLN . 15.3 m -53.5 136.96 37.32 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-N 116.022 -0.536 . . . . 0.0 111.239 -179.026 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' C' C ' 34' ' ' GLY . . . . . . . . . . . . . . . 101.15 -16.99 56.63 Favored Glycine 0 CA--C 1.532 1.142 0 CA-C-O 119.641 -0.533 . . . . 0.0 113.346 178.24 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' C' C ' 35' ' ' ASP . . . . . . . . . . . . . 61.5 m-20 -64.53 149.61 48.35 Favored 'General case' 0 N--CA 1.461 0.116 0 CA-C-N 118.081 0.941 . . . . 0.0 111.1 179.599 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' C' C ' 36' ' ' VAL . . . . . . . . . . . . . 46.0 t -126.34 130.69 71.93 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.277 0 CA-C-N 115.82 -0.627 . . . . 0.0 109.812 178.682 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' C' C ' 37' ' ' ILE . . . . . . . . . . . . . 68.3 mt -122.2 139.39 49.3 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.259 0 CA-C-N 116.137 -0.483 . . . . 0.0 109.952 -179.458 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' C' C ' 38' ' ' GLY . . . . . . . . . . . . . . . -113.34 128.84 8.55 Favored Glycine 0 CA--C 1.527 0.782 0 N-CA-C 110.908 -0.877 . . . . 0.0 110.908 179.294 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' C' C ' 39' ' ' ILE . . . . . . . . . . . . . 72.7 mt -125.07 129.56 73.3 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.212 0 N-CA-C 109.828 -0.434 . . . . 0.0 109.828 179.091 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' C' C ' 40' ' ' SER . . . . . . . . . . . . . 85.7 p -92.97 121.13 33.99 Favored 'General case' 0 C--N 1.329 -0.294 0 C-N-CA 120.915 -0.314 . . . . 0.0 110.946 176.803 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' C' C ' 41' ' ' ILE . . . . . . . . . . . . . 74.5 mt -131.78 122.47 49.73 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.19 0 CA-C-O 120.756 0.312 . . . . 0.0 110.179 178.363 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' C' C ' 42' ' ' LEU . . . . . . . . . . . . . 82.2 mt 57.5 34.18 24.25 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.146 -0.479 . . . . 0.0 111.756 178.59 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' C' C ' 43' ' ' GLY . . . . . . . . . . . . . . . 80.39 -10.14 45.11 Favored Glycine 0 CA--C 1.534 1.264 0 C-N-CA 121.262 -0.494 . . . . 0.0 113.447 176.879 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' C' C ' 44' ' ' LYS . . . . . . . . . . . . . 96.6 mttt -99.19 129.16 45.41 Favored 'General case' 0 C--N 1.333 -0.127 0 CA-C-N 117.917 0.858 . . . . 0.0 110.052 177.327 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' C' C ' 45' ' ' GLU . . . . . . . . . . . . . 37.7 tp10 -85.18 126.92 34.04 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.414 -0.357 . . . . 0.0 110.481 179.321 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' C' C ' 46' ' ' VAL . . . . . . . . . . . . . 7.4 p -119.23 130.69 73.59 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.227 0 CA-C-O 121.203 0.525 . . . . 0.0 109.824 177.484 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' C' C ' 47' ' ' LYS . . . . . . . . . . . . . 44.6 mmtm -99.09 128.4 45.22 Favored 'General case' 0 C--N 1.331 -0.23 0 CA-C-N 115.719 -0.673 . . . . 0.0 111.281 177.746 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' C' C ' 48' ' ' PHE . . . . . . . . . . . . . 95.5 m-85 -112.3 131.8 55.31 Favored 'General case' 0 C--N 1.33 -0.251 0 N-CA-C 109.634 -0.506 . . . . 0.0 109.634 174.676 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' C' C ' 49' ' ' LYS . . . . . . . . . . . . . 79.7 tttt -107.94 137.53 45.77 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.417 -0.356 . . . . 0.0 110.222 179.103 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' C' C ' 50' ' ' VAL . . . . . 0.437 ' HA ' HD23 ' C' ' 6' ' ' LEU . 44.8 t -82.04 107.72 14.35 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.289 0 N-CA-C 109.389 -0.597 . . . . 0.0 109.389 177.065 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' C' C ' 51' ' ' VAL . . . . . . . . . . . . . 51.8 t -69.58 -47.45 71.51 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.335 0 CA-C-N 116.029 -0.532 . . . . 0.0 109.893 -174.335 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' C' C ' 52' ' ' GLN . . . . . 0.437 ' HA ' HG23 ' C' ' 33' ' ' THR . 61.3 tt0 -169.74 144.43 2.86 Favored 'General case' 0 C--N 1.331 -0.217 0 C-N-CA 120.288 -0.565 . . . . 0.0 111.648 -179.978 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' C' C ' 53' ' ' ALA . . . . . . . . . . . . . . . -114.51 134.85 54.71 Favored 'General case' 0 C--N 1.331 -0.227 0 CA-C-N 115.627 -0.715 . . . . 0.0 110.117 176.429 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' C' C ' 54' ' ' TYR . . . . . . . . . . . . . 51.0 t80 -128.99 112.08 18.55 Favored Pre-proline 0 CA--C 1.536 0.408 0 CA-C-O 118.189 -0.91 . . . . 0.0 110.453 178.809 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' C' C ' 55' ' ' PRO . . . . . . . . . . . . . 72.7 Cg_endo -77.15 169.36 74.43 Favored 'Cis proline' 0 N--CA 1.5 1.9 0 CA-C-N 122.053 1.769 . . . . 0.0 112.2 -6.336 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' C' C ' 56' ' ' SER . . . . . . . . . . . . . 14.7 m -117.23 135.87 23.25 Favored Pre-proline 0 CA--C 1.538 0.509 0 CA-C-O 118.591 -0.718 . . . . 0.0 109.605 175.272 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' C' C ' 57' ' ' PRO . . . . . . . . . . . . . 49.1 Cg_endo -70.17 146.76 83.92 Favored 'Cis proline' 0 N--CA 1.496 1.653 0 CA-C-N 121.724 1.651 . . . . 0.0 111.355 -3.484 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' C' C ' 58' ' ' LEU . . . . . . . . . . . . . 17.2 tp -107.81 135.87 48.49 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-O 120.847 0.356 . . . . 0.0 110.798 -177.329 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' C' C ' 59' ' ' ARG . . . . . . . . . . . . . 42.4 ttp180 -102.44 119.85 39.51 Favored 'General case' 0 C--N 1.328 -0.349 0 N-CA-C 108.971 -0.752 . . . . 0.0 108.971 174.418 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' C' C ' 60' ' ' VAL . . . . . . . . . . . . . 41.2 t -76.2 122.73 30.97 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.238 0 C-N-CA 120.661 -0.415 . . . . 0.0 110.674 -173.289 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' C' C ' 61' ' ' GLU . . . . . . . . . . . . . 88.3 mt-10 -131.09 163.13 28.32 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 115.938 -0.573 . . . . 0.0 109.749 175.962 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' C' C ' 62' ' ' ASP . . . . . . . . . . . . . 11.4 p-10 -53.87 -30.4 45.59 Favored 'General case' 0 C--N 1.328 -0.339 0 N-CA-C 111.85 0.315 . . . . 0.0 111.85 178.751 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' C' C ' 63' ' ' ARG . . . . . . . . . . . . . 77.8 mtp180 -71.58 -22.08 61.78 Favored 'General case' 0 CA--C 1.533 0.308 0 N-CA-C 112.952 0.723 . . . . 0.0 112.952 -175.958 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' C' C ' 64' ' ' THR . . . . . . . . . . . . . 31.0 m -71.46 141.79 50.22 Favored 'General case' 0 C--N 1.331 -0.213 0 CA-C-O 120.859 0.362 . . . . 0.0 111.381 -174.173 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' C' C ' 65' ' ' LYS . . . . . . . . . . . . . 2.4 mptp? -88.96 129.66 35.59 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 115.925 -0.579 . . . . 0.0 109.849 177.416 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' C' C ' 66' ' ' ILE . . . . . . . . . . . . . 66.8 mt -116.68 127.84 74.2 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.268 0 N-CA-C 109.913 -0.402 . . . . 0.0 109.913 179.615 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' C' C ' 67' ' ' THR . . . . . . . . . . . . . 32.2 m -127.89 143.69 51.1 Favored 'General case' 0 C--N 1.332 -0.164 0 CA-C-N 116.16 -0.473 . . . . 0.0 111.0 -177.25 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' C' C ' 68' ' ' LEU . . . . . . . . . . . . . 28.2 mt -104.44 134.52 47.5 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 115.877 -0.602 . . . . 0.0 110.404 177.435 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' C' C ' 69' ' ' VAL . . . . . . . . . . . . . 44.1 t -100.31 104.62 16.41 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 CA-C-N 116.275 -0.421 . . . . 0.0 110.075 179.432 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' C' C ' 70' ' ' THR . . . . . . . . . . . . . 8.9 t -149.99 159.0 44.73 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 115.985 -0.552 . . . . 0.0 110.235 178.495 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' C' C ' 71' ' ' HIS . . . . . . . . . . . . . 10.8 t60 -128.49 79.43 74.22 Favored Pre-proline 0 CA--C 1.534 0.365 0 CA-C-N 116.73 -0.214 . . . . 0.0 111.151 -177.713 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' C' C ' 72' ' ' PRO . . . . . . . . . . . . . 66.7 Cg_endo -93.91 159.2 2.24 Favored 'Trans proline' 0 C--N 1.314 -1.241 0 C-N-CA 122.09 1.86 . . . . 0.0 111.537 175.114 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' C' C ' 73' ' ' VAL . . . . . . . . . . . . . 31.5 m -104.76 148.17 9.7 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.231 0 CA-C-O 121.069 0.462 . . . . 0.0 110.741 178.671 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' C' C ' 74' ' ' ASP . . . . . . . . . . . . . 13.7 t0 -97.46 119.64 36.37 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 115.58 -0.736 . . . . 0.0 109.437 178.436 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' C' C ' 75' ' ' VAL . . . . . . . . . . . . . 43.0 t -109.75 122.52 64.49 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.221 0 CA-C-O 121.036 0.446 . . . . 0.0 110.402 -177.906 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' C' C ' 76' ' ' LEU . . . . . . . . . . . . . 28.7 mt -123.1 140.53 52.93 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 115.612 -0.722 . . . . 0.0 109.678 178.568 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' C' C ' 77' ' ' GLU . . . . . . . . . . . . . 97.2 mt-10 -132.83 135.67 45.78 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-O 121.082 0.468 . . . . 0.0 111.12 -179.267 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' C' C ' 78' ' ' ALA . . . . . . . . . . . . . . . -124.55 133.92 53.15 Favored 'General case' 0 C--O 1.233 0.221 0 CA-C-N 115.807 -0.633 . . . . 0.0 109.903 177.013 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' C' C ' 79' ' ' LYS . . . . . 0.683 ' O ' HD13 ' C' ' 80' ' ' ILE . 61.3 mtpt -79.15 118.31 20.98 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-O 120.874 0.369 . . . . 0.0 110.747 -178.068 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' C' C ' 80' ' ' ILE . . . . . 0.683 HD13 ' O ' ' C' ' 79' ' ' LYS . 34.7 mm -139.18 105.98 2.7 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.285 0 N-CA-C 108.886 -0.783 . . . . 0.0 108.886 -178.462 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' C' C ' 81' ' ' LYS . . . . . . . . . . . . . 23.2 tptm -98.99 126.52 44.71 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-O 120.849 0.357 . . . . 0.0 111.137 -175.715 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' C' C ' 82' ' ' GLY . . . . . . . . . . . . . . . 89.17 42.07 5.68 Favored Glycine 0 CA--C 1.526 0.758 0 C-N-CA 120.755 -0.736 . . . . 0.0 111.798 174.816 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' C' C ' 83' ' ' ILE . . . . . . . . . . . . . 72.5 mt -69.73 136.22 26.62 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.338 0 N-CA-C 109.648 -0.501 . . . . 0.0 109.648 177.182 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' C' C ' 84' ' ' LYS . . . . . . . . . . . . . 22.9 ttmt -94.7 -54.1 3.62 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-O 121.123 0.487 . . . . 0.0 110.121 -179.759 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' C' C ' 85' ' ' ASP . . . . . . . . . . . . . 7.6 t70 -152.31 148.09 27.11 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 115.604 -0.725 . . . . 0.0 110.352 -179.005 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' C' C ' 86' ' ' VAL . . . . . . . . . . . . . 45.3 t -126.9 129.32 71.34 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.275 0 CA-C-O 120.976 0.417 . . . . 0.0 110.225 179.999 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' C' C ' 87' ' ' ILE . . . . . 0.498 ' N ' HD12 ' C' ' 87' ' ' ILE . 5.1 mp -118.32 129.41 74.67 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.239 0 CA-C-N 115.898 -0.592 . . . . 0.0 109.524 177.403 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' C' C ' 88' ' ' LEU . . . . . . . . . . . . . 26.9 mt -111.14 140.15 45.92 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-O 120.96 0.409 . . . . 0.0 111.312 -177.277 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' C' C ' 89' ' ' ASP . . . . . . . . . . . . . 36.0 t0 -132.16 157.39 44.4 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 115.811 -0.631 . . . . 0.0 109.542 177.314 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' C' C ' 90' ' ' GLU . . . . . . . . . . . . . 40.5 mp0 -49.66 -34.09 17.45 Favored 'General case' 0 C--N 1.331 -0.222 0 N-CA-C 112.914 0.709 . . . . 0.0 112.914 -171.448 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' C' C ' 91' ' ' ASN . . . . . . . . . . . . . 26.2 m120 -130.23 16.22 5.58 Favored 'General case' 0 N--CA 1.469 0.492 0 N-CA-C 113.256 0.836 . . . . 0.0 113.256 -177.225 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' C' C ' 92' ' ' LEU . . . . . . . . . . . . . 28.9 mt -148.12 149.76 32.61 Favored 'General case' 0 C--N 1.332 -0.188 0 CA-C-O 120.798 0.332 . . . . 0.0 110.763 -175.568 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' C' C ' 93' ' ' ILE . . . . . . . . . . . . . 68.1 mt -126.01 118.25 51.18 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.292 0 N-CA-C 109.041 -0.725 . . . . 0.0 109.041 175.648 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' C' C ' 94' ' ' VAL . . . . . 0.542 HG21 HG11 ' C' ' 125' ' ' VAL . 44.5 t -117.61 125.54 74.15 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.255 0 CA-C-O 121.034 0.445 . . . . 0.0 109.956 -178.727 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' C' C ' 95' ' ' VAL . . . . . . . . . . . . . 42.3 t -120.1 134.64 62.93 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.307 0 CA-C-N 115.859 -0.61 . . . . 0.0 109.852 -178.94 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' C' C ' 96' ' ' ILE . . . . . . . . . . . . . 64.9 mt -114.17 126.03 71.59 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.279 0 N-CA-C 109.016 -0.735 . . . . 0.0 109.016 177.432 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' C' C ' 97' ' ' THR . . . . . . . . . . . . . 76.2 p -100.87 157.49 16.68 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-O 120.908 0.385 . . . . 0.0 111.093 -176.317 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' C' C ' 98' ' ' GLU . . . . . . . . . . . . . 13.0 pt-20 -53.96 -22.57 10.61 Favored 'General case' 0 CA--C 1.535 0.366 0 N-CA-C 112.279 0.474 . . . . 0.0 112.279 178.019 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' C' C ' 99' ' ' GLU . . . . . . . . . . . . . 95.3 mt-10 -78.18 12.51 1.83 Allowed 'General case' 0 CA--C 1.536 0.434 0 N-CA-C 113.022 0.749 . . . . 0.0 113.022 179.605 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' C' C ' 100' ' ' ASN . . . . . . . . . . . . . 2.1 m-20 61.87 38.07 14.86 Favored 'General case' 0 CA--C 1.53 0.207 0 CA-C-O 121.028 0.442 . . . . 0.0 110.923 179.48 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' C' C ' 101' ' ' GLU . . . . . . . . . . . . . 42.0 mt-10 -111.17 148.71 32.17 Favored 'General case' 0 CA--C 1.521 -0.17 0 CA-C-N 115.988 -0.551 . . . . 0.0 110.494 176.019 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' C' C ' 102' ' ' VAL . . . . . . . . . . . . . 46.6 t -114.85 120.9 65.76 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.293 0 CA-C-N 115.487 -0.779 . . . . 0.0 109.126 177.114 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' C' C ' 103' ' ' LEU . . . . . . . . . . . . . 22.1 mt -111.56 126.12 54.65 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 115.68 -0.691 . . . . 0.0 109.994 177.851 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' C' C ' 104' ' ' ILE . . . . . 0.543 HD12 ' HB3' ' C' ' 113' ' ' TYR . 68.4 mt -111.94 114.21 46.39 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.325 0 N-CA-C 109.58 -0.526 . . . . 0.0 109.58 179.318 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' C' C ' 105' ' ' PHE . . . . . . . . . . . . . 95.6 m-85 -117.23 163.12 16.78 Favored 'General case' 0 C--N 1.332 -0.169 0 O-C-N 124.056 0.847 . . . . 0.0 109.956 -179.796 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' C' C ' 106' ' ' ASN . . . . . . . . . . . . . 51.1 p-10 -104.05 -170.73 1.82 Allowed 'General case' 0 C--N 1.328 -0.362 0 N-CA-C 109.661 -0.496 . . . . 0.0 109.661 171.805 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' C' C ' 107' ' ' GLN . . . . . . . . . . . . . 45.4 tt0 -58.39 -28.9 65.6 Favored 'General case' 0 C--N 1.328 -0.35 0 N-CA-C 112.071 0.397 . . . . 0.0 112.071 178.513 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' C' C ' 108' ' ' ASN . . . . . . . . . . . . . 48.6 t30 -89.49 6.86 39.01 Favored 'General case' 0 CA--C 1.536 0.427 0 N-CA-C 113.202 0.815 . . . . 0.0 113.202 -175.857 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' C' C ' 109' ' ' LEU . . . . . . . . . . . . . 89.0 mt 59.09 31.94 21.74 Favored 'General case' 0 C--N 1.332 -0.157 0 N-CA-C 112.034 0.383 . . . . 0.0 112.034 175.968 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' C' C ' 110' ' ' GLU . . . . . . . . . . . . . 14.0 pt-20 -106.09 144.22 33.11 Favored 'General case' 0 C--N 1.332 -0.165 0 N-CA-C 109.616 -0.513 . . . . 0.0 109.616 173.867 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' C' C ' 111' ' ' GLU . . . . . . . . . . . . . 54.5 tt0 -66.79 121.95 16.59 Favored 'General case' 0 C--N 1.327 -0.412 0 CA-C-N 116.12 -0.491 . . . . 0.0 111.528 -172.281 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' C' C ' 112' ' ' LEU . . . . . . . . . . . . . 10.7 mt -101.41 -46.16 5.09 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.039 -0.528 . . . . 0.0 109.653 174.009 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' C' C ' 113' ' ' TYR . . . . . 0.543 ' HB3' HD12 ' C' ' 104' ' ' ILE . 64.0 t80 -148.48 140.55 23.98 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.059 -0.519 . . . . 0.0 111.133 178.023 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' C' C ' 114' ' ' ARG . . . . . . . . . . . . . 29.6 ttm180 -137.61 126.12 23.54 Favored 'General case' 0 C--N 1.329 -0.289 0 N-CA-C 109.819 -0.438 . . . . 0.0 109.819 175.803 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' C' C ' 115' ' ' GLY . . . . . . . . . . . . . . . -150.12 161.56 28.94 Favored Glycine 0 CA--C 1.522 0.505 0 N-CA-C 110.753 -0.939 . . . . 0.0 110.753 -179.089 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' C' C ' 116' ' ' LYS . . . . . . . . . . . . . 26.4 ttpp -127.84 134.35 49.42 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-O 120.755 0.312 . . . . 0.0 110.363 -179.614 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' C' C ' 117' ' ' PHE . . . . . . . . . . . . . 59.2 m-85 -134.37 113.91 12.39 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.249 -0.432 . . . . 0.0 109.982 -178.932 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' C' C ' 118' ' ' GLU . . . . . . . . . . . . . 44.4 mp0 -58.06 -39.47 78.56 Favored 'General case' 0 C--N 1.328 -0.332 0 C-N-CA 120.629 -0.429 . . . . 0.0 110.745 -175.649 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' C' C ' 119' ' ' ASN . . . . . . . . . . . . . 3.5 m120 -100.06 30.73 3.62 Favored 'General case' 0 C--N 1.329 -0.286 0 N-CA-C 112.169 0.433 . . . . 0.0 112.169 -175.341 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' C' C ' 120' ' ' LEU . . . . . . . . . . . . . 18.5 tp -58.85 119.85 7.94 Favored 'General case' 0 C--N 1.332 -0.157 0 N-CA-C 110.029 -0.36 . . . . 0.0 110.029 178.279 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' C' C ' 121' ' ' ASN . . . . . . . . . . . . . 87.0 m-20 -114.16 -44.16 3.16 Favored 'General case' 0 C--N 1.333 -0.137 0 CA-C-N 116.493 -0.322 . . . . 0.0 111.302 -178.272 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' C' C ' 122' ' ' LYS . . . . . . . . . . . . . 62.1 mtpt -143.51 151.27 40.07 Favored 'General case' 0 C--N 1.33 -0.239 0 CA-C-O 120.973 0.416 . . . . 0.0 111.532 -175.258 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' C' C ' 123' ' ' VAL . . . . . . . . . . . . . 43.6 t -135.2 135.16 52.55 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.245 0 CA-C-N 116.143 -0.48 . . . . 0.0 109.866 176.059 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' C' C ' 124' ' ' LEU . . . . . . . . . . . . . 55.8 mt -126.0 141.88 51.77 Favored 'General case' 0 C--N 1.331 -0.221 0 CA-C-O 120.897 0.38 . . . . 0.0 110.839 -177.962 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' C' C ' 125' ' ' VAL . . . . . 0.542 HG11 HG21 ' C' ' 94' ' ' VAL . 34.9 m -135.93 138.72 47.17 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.201 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.74 179.039 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' C' C ' 126' ' ' ARG . . . . . . . . . . . . . 46.6 ptt85 -152.53 131.08 12.23 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-O 120.849 0.357 . . . . 0.0 110.774 175.873 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' C' C ' 127' ' ' ASN . . . . . . . . . . . . . 89.7 m-20 50.71 -115.43 0.86 Allowed 'General case' 0 CA--C 1.546 0.797 0 CA-C-O 118.67 -0.681 . . . . 0.0 111.177 -179.77 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' C' C ' 128' ' ' ASP . . . . . . . . . . . . . 8.7 p-10 -114.11 16.06 18.19 Favored 'General case' 0 CA--C 1.536 0.433 0 CA-C-N 120.17 1.35 . . . . 0.0 112.848 -179.884 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' C' C ' 129' ' ' LEU . . . . . . . . . . . . . 5.7 tt -111.96 136.75 50.89 Favored 'General case' 0 C--O 1.234 0.252 0 N-CA-C 110.024 -0.361 . . . . 0.0 110.024 -179.617 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' C' C ' 130' ' ' VAL . . . . . . . . . . . . . 43.2 t -117.99 135.88 56.97 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.185 0 CA-C-N 116.39 -0.368 . . . . 0.0 110.109 -177.442 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' C' C ' 131' ' ' VAL . . . . . . . . . . . . . 43.4 t -133.79 133.78 56.51 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.214 0 CA-C-O 120.938 0.399 . . . . 0.0 110.289 178.513 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' C' C ' 132' ' ' ILE . . . . . . . . . . . . . 70.6 mt -119.82 133.31 66.99 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.233 0 N-CA-C 109.513 -0.551 . . . . 0.0 109.513 -179.567 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' C' C ' 133' ' ' ILE . . . . . . . . . . . . . 40.9 mm -117.77 120.78 65.7 Favored 'Isoleucine or valine' 0 C--O 1.234 0.266 0 CA-C-O 120.801 0.334 . . . . 0.0 111.102 -175.301 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' C' C ' 134' ' ' ASP . . . . . . . . . . . . . 6.9 p-10 -132.43 148.0 52.39 Favored 'General case' 0 C--N 1.33 -0.251 0 N-CA-C 109.708 -0.478 . . . . 0.0 109.708 176.322 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' C' C ' 135' ' ' GLU . . . . . . . . . . . . . 41.6 tp10 -49.98 -29.42 8.5 Favored 'General case' 0 C--N 1.327 -0.387 0 N-CA-C 112.648 0.61 . . . . 0.0 112.648 -173.667 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' C' C ' 136' ' ' GLN . . . . . . . . . . . . . 93.9 mt-30 -79.96 -33.32 39.63 Favored 'General case' 0 C--O 1.234 0.268 0 N-CA-C 112.321 0.489 . . . . 0.0 112.321 -175.302 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' C' C ' 137' ' ' LYS . . . . . . . . . . . . . 46.8 pttt -169.93 174.65 5.49 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-O 121.403 0.621 . . . . 0.0 112.31 -172.451 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' C' C ' 138' ' ' LEU . . . . . 0.411 HD23 ' N ' ' C' ' 139' ' ' THR . 5.2 tt -116.12 129.88 56.54 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 115.116 -0.947 . . . . 0.0 109.951 179.499 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' C' C ' 139' ' ' THR . . . . . 0.411 ' N ' HD23 ' C' ' 138' ' ' LEU . 27.0 m -108.39 126.61 53.07 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-N 116.318 -0.401 . . . . 0.0 110.366 179.855 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' C' C ' 140' ' ' LEU . . . . . . . . . . . . . 14.3 tp -114.44 121.37 43.33 Favored 'General case' 0 C--N 1.33 -0.273 0 N-CA-C 109.048 -0.723 . . . . 0.0 109.048 -179.463 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' C' C ' 141' ' ' ILE . . . . . . . . . . . . . 19.5 mt -119.91 115.6 47.91 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.279 0 CA-C-O 120.978 0.418 . . . . 0.0 109.906 -175.888 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' C' C ' 142' ' ' ARG . . . . . . . . . . . . . 84.2 mtm180 -105.29 132.04 51.99 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 115.243 -0.889 . . . . 0.0 110.841 -175.933 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' C' C ' 143' ' ' THR . . . . . . . . . . . . . 29.8 p . . . . . 0 C--O 1.221 -0.411 0 CA-C-O 118.188 -0.911 . . . . 0.0 110.844 179.495 . . . . . . . . 0 0 . 1 . 020 nuclear build full ' D' D ' -3' ' ' GLU . . . . . . . . . . . . . 95.8 mt-10 . . . . . 0 N--CA 1.49 1.528 0 N-CA-C 109.369 -0.604 . . . . 0.0 109.369 . . . . . . . . . 0 0 . 1 . 020 nuclear build full ' D' D ' -2' ' ' GLY . . . . . . . . . . . . . . . -77.63 115.81 4.35 Favored Glycine 0 CA--C 1.525 0.69 0 N-CA-C 111.161 -0.776 . . . . 0.0 111.161 -179.286 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' D' D ' -1' ' ' VAL . . . . . . . . . . . . . 43.2 t -141.57 138.22 32.22 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.328 0 N-CA-C 109.961 -0.385 . . . . 0.0 109.961 178.846 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' D' D ' 0' ' ' ILE . . . . . . . . . . . . . 73.5 mt -106.63 117.5 52.54 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.258 0 N-CA-C 109.761 -0.459 . . . . 0.0 109.761 179.192 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' D' D ' 1' ' ' MET . . . . . . . . . . . . . 25.6 ptm -85.17 144.68 28.03 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.583 -179.466 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' D' D ' 2' ' ' SER . . . . . . . . . . . . . 6.8 p -127.5 134.68 49.78 Favored 'General case' 0 C--N 1.333 -0.151 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.718 -179.248 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' D' D ' 3' ' ' GLU . . . . . . . . . . . . . 95.6 mt-10 -140.22 138.23 34.92 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.03 -0.532 . . . . 0.0 110.897 179.236 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' D' D ' 4' ' ' LEU . . . . . 0.414 HD21 HD21 ' D' ' 6' ' ' LEU . 17.2 tp -122.86 128.33 50.21 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 115.911 -0.586 . . . . 0.0 110.249 178.095 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' D' D ' 5' ' ' LYS . . . . . . . . . . . . . 67.6 mttm -105.54 121.4 43.88 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.382 -0.372 . . . . 0.0 110.468 178.219 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' D' D ' 6' ' ' LEU . . . . . 0.414 HD21 HD21 ' D' ' 4' ' ' LEU . 73.8 mt -117.65 149.46 40.68 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 115.622 -0.717 . . . . 0.0 110.778 -178.78 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' D' D ' 7' ' ' LYS . . . . . . . . . . . . . 35.5 ttpt -139.55 139.41 22.29 Favored Pre-proline 0 CA--C 1.535 0.376 0 CA-C-O 119.136 -0.459 . . . . 0.0 110.135 175.704 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' D' D ' 8' ' ' PRO . . . . . . . . . . . . . 94.0 Cg_endo -92.09 144.06 2.76 Favored 'Trans proline' 0 N--CA 1.49 1.267 0 C-N-CA 121.778 1.652 . . . . 0.0 111.659 177.053 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' D' D ' 9' ' ' LEU . . . . . . . . . . . . . 45.1 mt -80.25 -48.23 1.29 Allowed Pre-proline 0 CA--C 1.534 0.349 0 CA-C-O 118.665 -0.683 . . . . 0.0 112.445 -178.602 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' D' D ' 10' ' ' PRO . . . . . . . . . . . . . 86.1 Cg_endo -79.75 152.61 22.52 Favored 'Trans proline' 0 N--CA 1.496 1.632 0 C-N-CA 121.213 1.276 . . . . 0.0 112.055 177.318 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' D' D ' 11' ' ' LYS . . . . . . . . . . . . . 90.2 mttt -85.38 97.85 10.22 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.483 -0.326 . . . . 0.0 110.534 178.374 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' D' D ' 12' ' ' VAL . . . . . . . . . . . . . 12.1 p -144.32 143.12 23.57 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.288 0 CA-C-N 116.222 -0.445 . . . . 0.0 110.524 179.743 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' D' D ' 13' ' ' GLU . . . . . . . . . . . . . 45.8 mp0 -81.89 127.01 32.57 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.342 -0.39 . . . . 0.0 110.037 176.956 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' D' D ' 14' ' ' LEU . . . . . . . . . . . . . 22.5 mt -97.28 144.79 28.53 Favored Pre-proline 0 CA--C 1.533 0.311 0 CA-C-O 119.019 -0.515 . . . . 0.0 110.11 -179.688 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' D' D ' 15' ' ' PRO . . . . . . . . . . . . . 29.8 Cg_exo -59.95 160.32 22.38 Favored 'Trans proline' 0 N--CA 1.497 1.709 0 C-N-CA 121.241 1.294 . . . . 0.0 112.085 179.079 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' D' D ' 16' ' ' PRO . . . . . . . . . . . . . 31.6 Cg_exo -59.3 -37.83 88.56 Favored 'Trans proline' 0 N--CA 1.497 1.691 0 C-N-CA 121.452 1.434 . . . . 0.0 112.905 -177.424 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' D' D ' 17' ' ' ASP . . . . . . . . . . . . . 13.7 p-10 -85.33 4.17 36.34 Favored 'General case' 0 CA--C 1.537 0.46 0 N-CA-C 113.301 0.852 . . . . 0.0 113.301 -177.204 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' D' D ' 18' ' ' PHE . . . . . . . . . . . . . 48.2 t80 -58.29 -47.17 84.52 Favored 'General case' 0 C--N 1.334 -0.102 0 O-C-N 122.03 -0.419 . . . . 0.0 110.151 -177.275 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' D' D ' 19' ' ' VAL . . . . . . . . . . . . . 47.5 t -56.72 -42.94 78.26 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.356 0 CA-C-N 116.335 -0.393 . . . . 0.0 110.504 -177.789 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' D' D ' 20' ' ' ASP . . . . . . . . . . . . . 53.4 m-20 -59.82 -41.79 92.07 Favored 'General case' 0 C--N 1.328 -0.333 0 C-N-CA 120.913 -0.315 . . . . 0.0 110.896 -177.851 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' D' D ' 21' ' ' VAL . . . . . . . . . . . . . 47.7 t -64.63 -46.26 92.97 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.275 0 C-N-CA 120.811 -0.356 . . . . 0.0 110.491 -178.06 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' D' D ' 22' ' ' ILE . . . . . 0.45 HG22 HD12 ' D' ' 26' ' ' LEU . 46.8 mm -57.75 -40.44 75.69 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.317 0 C-N-CA 120.745 -0.382 . . . . 0.0 110.615 179.726 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' D' D ' 23' ' ' ARG . . . . . . . . . . . . . 59.1 ttp180 -55.69 -49.97 71.55 Favored 'General case' 0 C--N 1.331 -0.219 0 CA-C-O 120.969 0.414 . . . . 0.0 110.843 178.11 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' D' D ' 24' ' ' ILE . . . . . . . . . . . . . 74.1 mt -61.36 -40.26 85.57 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.324 0 CA-C-N 115.918 -0.583 . . . . 0.0 111.925 -176.666 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' D' D ' 25' ' ' LYS . . . . . . . . . . . . . 7.7 ptmm? -72.19 -36.46 69.23 Favored 'General case' 0 CA--C 1.531 0.239 0 C-N-CA 120.534 -0.466 . . . . 0.0 111.882 -176.145 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' D' D ' 26' ' ' LEU . . . . . 0.45 HD12 HG22 ' D' ' 22' ' ' ILE . 77.0 mt -77.7 -40.25 41.96 Favored 'General case' 0 C--N 1.33 -0.243 0 N-CA-C 113.194 0.813 . . . . 0.0 113.194 -173.23 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' D' D ' 27' ' ' GLN . . . . . . . . . . . . . 14.7 pt20 -47.53 137.12 9.26 Favored 'General case' 0 N--CA 1.471 0.58 0 N-CA-C 112.661 0.615 . . . . 0.0 112.661 -175.901 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' D' D ' 28' ' ' GLY . . . . . . . . . . . . . . . 99.63 -24.84 30.58 Favored Glycine 0 CA--C 1.533 1.21 0 CA-C-N 115.545 -0.752 . . . . 0.0 112.304 -176.345 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' D' D ' 29' ' ' LYS . . . . . . . . . . . . . 72.9 mmtt -98.11 155.18 17.26 Favored 'General case' 0 C--N 1.331 -0.218 0 CA-C-N 117.318 0.559 . . . . 0.0 111.232 179.352 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' D' D ' 30' ' ' THR . . . . . . . . . . . . . 24.4 m -105.79 135.85 46.47 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 115.784 -0.643 . . . . 0.0 109.859 175.342 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' D' D ' 31' ' ' VAL . . . . . . . . . . . . . 34.8 m -130.83 155.52 41.96 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.276 0 CA-C-O 120.994 0.426 . . . . 0.0 110.926 -178.225 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' D' D ' 32' ' ' ARG . . . . . . . . . . . . . 84.8 mtm180 -131.65 150.78 52.03 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.012 -0.54 . . . . 0.0 110.863 179.143 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' D' D ' 33' ' ' THR . . . . . . . . . . . . . 20.8 m -53.5 140.37 28.36 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.111 -0.495 . . . . 0.0 111.293 -179.09 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' D' D ' 34' ' ' GLY . . . . . . . . . . . . . . . 98.99 -17.17 58.55 Favored Glycine 0 CA--C 1.533 1.189 0 C-N-CA 121.103 -0.57 . . . . 0.0 113.207 179.699 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' D' D ' 35' ' ' ASP . . . . . . . . . . . . . 69.1 m-20 -65.47 148.87 50.99 Favored 'General case' 0 C--O 1.232 0.138 0 CA-C-N 118.013 0.907 . . . . 0.0 111.122 178.99 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' D' D ' 36' ' ' VAL . . . . . . . . . . . . . 45.7 t -122.97 130.03 74.72 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.251 0 CA-C-N 115.774 -0.648 . . . . 0.0 109.704 178.594 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' D' D ' 37' ' ' ILE . . . . . . . . . . . . . 69.7 mt -120.12 137.93 52.33 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.276 0 N-CA-C 109.767 -0.457 . . . . 0.0 109.767 179.442 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' D' D ' 38' ' ' GLY . . . . . . . . . . . . . . . -112.52 128.79 8.65 Favored Glycine 0 CA--C 1.526 0.724 0 N-CA-C 111.11 -0.796 . . . . 0.0 111.11 -179.078 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' D' D ' 39' ' ' ILE . . . . . . . . . . . . . 75.8 mt -124.23 135.55 63.33 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.261 0 CA-C-O 120.795 0.331 . . . . 0.0 110.164 178.999 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' D' D ' 40' ' ' SER . . . . . . . . . . . . . 23.0 t -92.71 120.74 33.41 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.321 -0.399 . . . . 0.0 110.723 176.142 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' D' D ' 41' ' ' ILE . . . . . . . . . . . . . 70.3 mt -132.09 118.16 35.89 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.23 0 N-CA-C 110.107 -0.331 . . . . 0.0 110.107 178.272 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' D' D ' 42' ' ' LEU . . . . . . . . . . . . . 5.4 mp 56.11 36.96 28.32 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.179 -0.464 . . . . 0.0 111.326 179.315 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' D' D ' 43' ' ' GLY . . . . . . . . . . . . . . . 77.48 -10.07 24.99 Favored Glycine 0 CA--C 1.533 1.209 0 C-N-CA 121.279 -0.486 . . . . 0.0 113.531 176.54 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' D' D ' 44' ' ' LYS . . . . . . . . . . . . . 61.9 mttp -97.19 135.96 38.39 Favored 'General case' 0 C--N 1.333 -0.123 0 CA-C-N 117.993 0.897 . . . . 0.0 110.151 177.398 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' D' D ' 45' ' ' GLU . . . . . . . . . . . . . 80.8 tt0 -85.2 126.9 34.03 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.282 -0.417 . . . . 0.0 110.758 179.817 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' D' D ' 46' ' ' VAL . . . . . . . . . . . . . 7.1 p -121.15 127.13 75.81 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.224 0 N-CA-C 109.597 -0.52 . . . . 0.0 109.597 175.895 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' D' D ' 47' ' ' LYS . . . . . . . . . . . . . 58.4 mttm -100.63 129.48 46.56 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 115.862 -0.608 . . . . 0.0 111.139 178.051 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' D' D ' 48' ' ' PHE . . . . . . . . . . . . . 92.5 m-85 -111.12 131.75 54.84 Favored 'General case' 0 C--N 1.329 -0.319 0 N-CA-C 109.61 -0.515 . . . . 0.0 109.61 174.807 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' D' D ' 49' ' ' LYS . . . . . . . . . . . . . 83.3 tttt -108.82 138.15 45.62 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.414 -0.357 . . . . 0.0 110.486 179.76 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' D' D ' 50' ' ' VAL . . . . . . . . . . . . . 44.9 t -80.3 109.56 14.93 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.285 0 N-CA-C 109.292 -0.632 . . . . 0.0 109.292 176.141 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' D' D ' 51' ' ' VAL . . . . . . . . . . . . . 51.2 t -71.81 -47.14 57.94 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.273 0 CA-C-N 115.988 -0.551 . . . . 0.0 109.97 -174.084 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' D' D ' 52' ' ' GLN . . . . . . . . . . . . . 47.6 tt0 -170.93 145.09 2.29 Favored 'General case' 0 C--N 1.33 -0.28 0 C-N-CA 120.433 -0.507 . . . . 0.0 111.439 -179.8 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' D' D ' 53' ' ' ALA . . . . . . . . . . . . . . . -121.14 136.18 55.02 Favored 'General case' 0 C--N 1.331 -0.227 0 CA-C-N 115.903 -0.589 . . . . 0.0 110.474 178.499 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' D' D ' 54' ' ' TYR . . . . . . . . . . . . . 35.6 t80 -129.16 113.59 18.49 Favored Pre-proline 0 CA--C 1.536 0.406 0 CA-C-O 118.24 -0.886 . . . . 0.0 110.117 176.142 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' D' D ' 55' ' ' PRO . . . . . . . . . . . . . 72.8 Cg_endo -77.29 170.08 72.35 Favored 'Cis proline' 0 N--CA 1.499 1.825 0 CA-C-N 122.037 1.763 . . . . 0.0 112.057 -6.089 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' D' D ' 56' ' ' SER . . . . . . . . . . . . . 17.5 m -122.51 134.1 24.74 Favored Pre-proline 0 CA--C 1.538 0.508 0 CA-C-O 118.519 -0.753 . . . . 0.0 109.496 175.204 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' D' D ' 57' ' ' PRO . . . . . . . . . . . . . 38.4 Cg_endo -67.2 145.54 73.63 Favored 'Cis proline' 0 N--CA 1.498 1.777 0 CA-C-N 121.834 1.691 . . . . 0.0 111.562 -1.67 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' D' D ' 58' ' ' LEU . . . . . . . . . . . . . 23.7 tp -106.25 136.05 46.65 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.263 -0.426 . . . . 0.0 110.736 -177.626 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' D' D ' 59' ' ' ARG . . . . . . . . . . . . . 42.1 ttm180 -103.28 127.83 50.5 Favored 'General case' 0 C--N 1.328 -0.367 0 N-CA-C 109.247 -0.649 . . . . 0.0 109.247 174.945 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' D' D ' 60' ' ' VAL . . . . . . . . . . . . . 45.5 t -84.18 120.28 34.73 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.242 0 C-N-CA 120.689 -0.404 . . . . 0.0 110.37 -175.916 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' D' D ' 61' ' ' GLU . . . . . . . . . . . . . 43.9 mt-10 -131.11 167.19 19.53 Favored 'General case' 0 C--N 1.331 -0.214 0 CA-C-N 115.735 -0.666 . . . . 0.0 109.858 177.391 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' D' D ' 62' ' ' ASP . . . . . . . . . . . . . 13.3 t70 -53.81 -32.57 53.19 Favored 'General case' 0 C--N 1.327 -0.377 0 N-CA-C 111.776 0.287 . . . . 0.0 111.776 -179.879 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' D' D ' 63' ' ' ARG . . . . . . . . . . . . . 26.5 ptt180 -82.99 3.79 28.65 Favored 'General case' 0 CA--C 1.536 0.434 0 N-CA-C 113.793 1.034 . . . . 0.0 113.793 -175.629 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' D' D ' 64' ' ' THR . . . . . . . . . . . . . 38.0 m -86.98 135.12 33.4 Favored 'General case' 0 C--N 1.333 -0.148 0 CA-C-N 118.117 0.417 . . . . 0.0 110.584 -178.343 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' D' D ' 65' ' ' LYS . . . . . . . . . . . . . 93.4 mttt -90.24 129.54 36.48 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.066 -0.515 . . . . 0.0 110.237 178.917 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' D' D ' 66' ' ' ILE . . . . . . . . . . . . . 63.4 mt -112.67 129.52 68.12 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.314 0 N-CA-C 109.725 -0.472 . . . . 0.0 109.725 179.641 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' D' D ' 67' ' ' THR . . . . . . . . . . . . . 29.3 m -124.02 138.11 54.5 Favored 'General case' 0 C--N 1.331 -0.204 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.807 -178.267 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' D' D ' 68' ' ' LEU . . . . . 0.496 ' N ' HD12 ' D' ' 68' ' ' LEU . 7.8 mp -102.49 129.73 49.1 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-N 115.845 -0.616 . . . . 0.0 110.219 178.2 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' D' D ' 69' ' ' VAL . . . . . . . . . . . . . 45.4 t -98.46 126.36 51.58 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 N-CA-C 109.86 -0.422 . . . . 0.0 109.86 179.476 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' D' D ' 70' ' ' THR . . . . . 0.435 HG23 ' N ' ' D' ' 71' ' ' HIS . 6.9 t -149.96 -39.83 0.14 Allowed 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 116.277 -0.419 . . . . 0.0 111.035 -178.74 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' D' D ' 71' ' ' HIS . . . . . 0.435 ' N ' HG23 ' D' ' 70' ' ' THR . 46.7 m-70 -125.77 86.48 57.47 Favored Pre-proline 0 CA--C 1.533 0.298 0 CA-C-N 116.389 -0.369 . . . . 0.0 110.576 -178.382 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' D' D ' 72' ' ' PRO . . . . . . . . . . . . . 14.2 Cg_exo -64.99 -30.0 57.06 Favored 'Trans proline' 0 N--CA 1.496 1.669 0 C-N-CA 121.517 1.478 . . . . 0.0 112.585 -177.276 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' D' D ' 73' ' ' VAL . . . . . . . . . . . . . 30.7 m -76.0 160.15 5.1 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.325 0 CA-C-O 121.067 0.46 . . . . 0.0 111.253 -177.038 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' D' D ' 74' ' ' ASP . . . . . . . . . . . . . 8.3 t0 -101.54 118.42 36.91 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 115.696 -0.684 . . . . 0.0 109.598 178.539 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' D' D ' 75' ' ' VAL . . . . . . . . . . . . . 40.8 t -110.2 123.71 66.33 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.244 0 CA-C-O 120.99 0.424 . . . . 0.0 110.481 -177.179 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' D' D ' 76' ' ' LEU . . . . . . . . . . . . . 30.0 mt -128.49 147.41 50.68 Favored 'General case' 0 C--N 1.331 -0.22 0 CA-C-N 115.794 -0.639 . . . . 0.0 110.066 178.854 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' D' D ' 77' ' ' GLU . . . . . . . . . . . . . 97.1 mt-10 -136.75 140.65 42.73 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-O 120.98 0.419 . . . . 0.0 110.99 -177.95 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' D' D ' 78' ' ' ALA . . . . . 0.674 ' HB2' HD21 ' D' ' 109' ' ' LEU . . . -125.67 127.39 46.19 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 115.799 -0.637 . . . . 0.0 109.748 176.878 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' D' D ' 79' ' ' LYS . . . . . 0.581 ' O ' HD13 ' D' ' 80' ' ' ILE . 48.8 mmtm -71.59 119.37 15.66 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-O 120.849 0.357 . . . . 0.0 110.848 -178.096 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' D' D ' 80' ' ' ILE . . . . . 0.581 HD13 ' O ' ' D' ' 79' ' ' LYS . 41.3 mm -139.09 112.73 6.75 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.289 0 N-CA-C 108.885 -0.783 . . . . 0.0 108.885 -179.298 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' D' D ' 81' ' ' LYS . . . . . . . . . . . . . 83.2 tttt -102.65 123.67 46.79 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-O 120.833 0.349 . . . . 0.0 111.205 -174.534 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' D' D ' 82' ' ' GLY . . . . . . . . . . . . . . . 89.22 41.99 5.68 Favored Glycine 0 CA--C 1.526 0.747 0 C-N-CA 120.824 -0.703 . . . . 0.0 112.064 173.702 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' D' D ' 83' ' ' ILE . . . . . . . . . . . . . 67.6 mt -68.25 139.63 20.39 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.311 0 N-CA-C 109.802 -0.444 . . . . 0.0 109.802 177.249 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' D' D ' 84' ' ' LYS . . . . . . . . . . . . . 39.7 ttpt -102.62 -47.9 4.29 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.165 -0.47 . . . . 0.0 110.295 -179.081 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' D' D ' 85' ' ' ASP . . . . . . . . . . . . . 7.5 t70 -152.31 151.04 30.4 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.068 -0.515 . . . . 0.0 110.552 179.903 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' D' D ' 86' ' ' VAL . . . . . . . . . . . . . 42.0 t -129.04 131.5 68.02 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.241 0 CA-C-O 120.917 0.389 . . . . 0.0 110.394 179.513 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' D' D ' 87' ' ' ILE . . . . . 0.499 HD12 ' N ' ' D' ' 87' ' ' ILE . 5.1 mp -118.64 127.35 75.62 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.245 0 N-CA-C 109.472 -0.566 . . . . 0.0 109.472 177.506 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' D' D ' 88' ' ' LEU . . . . . . . . . . . . . 20.6 tp -111.66 123.45 50.26 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.382 -0.372 . . . . 0.0 110.691 -176.963 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' D' D ' 89' ' ' ASP . . . . . . . . . . . . . 12.8 t70 -121.23 156.14 33.1 Favored 'General case' 0 C--N 1.332 -0.184 0 CA-C-N 116.419 -0.355 . . . . 0.0 110.235 -179.983 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' D' D ' 90' ' ' GLU . . . . . . . . . . . . . 68.1 tt0 -46.04 -45.7 16.22 Favored 'General case' 0 N--CA 1.465 0.291 0 N-CA-C 112.972 0.73 . . . . 0.0 112.972 -171.832 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' D' D ' 91' ' ' ASN . . . . . . . . . . . . . 8.4 t-20 -129.59 34.76 4.29 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-O 120.709 0.29 . . . . 0.0 111.665 -176.039 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' D' D ' 92' ' ' LEU . . . . . . . . . . . . . 7.0 tp -166.14 146.38 6.33 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-O 120.944 0.402 . . . . 0.0 110.554 179.68 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' D' D ' 93' ' ' ILE . . . . . . . . . . . . . 66.7 mt -122.26 123.0 67.8 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.366 0 N-CA-C 109.13 -0.693 . . . . 0.0 109.13 179.146 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' D' D ' 94' ' ' VAL . . . . . . . . . . . . . 43.1 t -119.33 128.19 75.84 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.246 0 CA-C-O 120.839 0.352 . . . . 0.0 110.053 -178.122 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' D' D ' 95' ' ' VAL . . . . . . . . . . . . . 42.4 t -123.12 132.59 71.11 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.302 0 CA-C-N 116.043 -0.526 . . . . 0.0 109.882 179.474 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' D' D ' 96' ' ' ILE . . . . . . . . . . . . . 67.5 mt -116.2 127.87 73.67 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.312 0 N-CA-C 109.268 -0.642 . . . . 0.0 109.268 179.077 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' D' D ' 97' ' ' THR . . . . . . . . . . . . . 70.0 p -99.76 158.27 15.91 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-O 121.029 0.442 . . . . 0.0 111.026 -177.664 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' D' D ' 98' ' ' GLU . . . . . . . . . . . . . 44.8 tp10 -54.03 -26.13 24.89 Favored 'General case' 0 CA--C 1.534 0.34 0 CA-C-N 116.224 -0.444 . . . . 0.0 111.916 179.058 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' D' D ' 99' ' ' GLU . . . . . . . . . . . . . 34.5 tt0 -76.3 11.47 1.54 Allowed 'General case' 0 CA--C 1.539 0.533 0 N-CA-C 112.765 0.654 . . . . 0.0 112.765 -177.512 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' D' D ' 100' ' ' ASN . . . . . . . . . . . . . 2.1 m-20 62.81 32.15 16.07 Favored 'General case' 0 CA--C 1.532 0.277 0 O-C-N 121.705 -0.622 . . . . 0.0 111.555 178.983 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' D' D ' 101' ' ' GLU . . . . . . . . . . . . . 78.5 tt0 -109.75 144.66 37.85 Favored 'General case' 0 C--O 1.234 0.241 0 N-CA-C 109.631 -0.507 . . . . 0.0 109.631 172.887 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' D' D ' 102' ' ' VAL . . . . . . . . . . . . . 44.6 t -116.13 128.2 73.5 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.248 0 CA-C-N 116.432 -0.349 . . . . 0.0 110.134 -178.592 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' D' D ' 103' ' ' LEU . . . . . . . . . . . . . 21.1 mt -116.2 130.52 56.83 Favored 'General case' 0 C--N 1.331 -0.208 0 CA-C-N 115.717 -0.674 . . . . 0.0 110.163 176.973 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' D' D ' 104' ' ' ILE . . . . . 0.58 HD13 HG21 ' D' ' 130' ' ' VAL . 66.9 mt -116.82 120.5 65.22 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.299 0 N-CA-C 110.018 -0.364 . . . . 0.0 110.018 179.621 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' D' D ' 105' ' ' PHE . . . . . . . . . . . . . 62.8 m-85 -120.8 165.12 15.59 Favored 'General case' 0 C--N 1.333 -0.123 0 O-C-N 123.893 0.746 . . . . 0.0 109.807 178.777 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' D' D ' 106' ' ' ASN . . . . . . . . . . . . . 42.9 p-10 -98.94 -170.05 1.87 Allowed 'General case' 0 C--N 1.331 -0.229 0 N-CA-C 109.936 -0.394 . . . . 0.0 109.936 173.549 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' D' D ' 107' ' ' GLN . . . . . . . . . . . . . 48.7 tt0 -60.5 -30.03 69.46 Favored 'General case' 0 C--N 1.329 -0.289 0 N-CA-C 111.955 0.354 . . . . 0.0 111.955 179.946 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' D' D ' 108' ' ' ASN . . . . . . . . . . . . . 6.6 t-20 -83.27 6.78 18.46 Favored 'General case' 0 CA--C 1.536 0.425 0 N-CA-C 113.223 0.824 . . . . 0.0 113.223 -178.371 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' D' D ' 109' ' ' LEU . . . . . 0.674 HD21 ' HB2' ' D' ' 78' ' ' ALA . 10.2 tp 62.41 37.69 13.41 Favored 'General case' 0 CA--C 1.529 0.167 0 O-C-N 122.087 -0.383 . . . . 0.0 111.377 178.244 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' D' D ' 110' ' ' GLU . . . . . . . . . . . . . 70.7 mm-40 -105.89 162.24 13.75 Favored 'General case' 0 C--N 1.33 -0.255 0 N-CA-C 109.765 -0.457 . . . . 0.0 109.765 176.014 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' D' D ' 111' ' ' GLU . . . . . . . . . . . . . 83.9 tt0 -86.67 127.45 34.95 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-O 120.938 0.399 . . . . 0.0 111.208 -176.357 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' D' D ' 112' ' ' LEU . . . . . . . . . . . . . 15.6 mt -113.03 -46.09 3.13 Favored 'General case' 0 C--N 1.331 -0.197 0 CA-C-N 115.953 -0.567 . . . . 0.0 110.418 176.579 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' D' D ' 113' ' ' TYR . . . . . 0.563 ' HB3' HD12 ' D' ' 104' ' ' ILE . 38.2 t80 -143.06 138.73 30.13 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.269 -0.423 . . . . 0.0 111.26 -179.295 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' D' D ' 114' ' ' ARG . . . . . . . . . . . . . 27.4 ttm180 -137.42 122.61 19.24 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.338 -0.392 . . . . 0.0 109.968 174.908 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' D' D ' 115' ' ' GLY . . . . . . . . . . . . . . . -150.07 163.1 29.38 Favored Glycine 0 CA--C 1.526 0.775 0 N-CA-C 111.115 -0.794 . . . . 0.0 111.115 179.031 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' D' D ' 116' ' ' LYS . . . . . . . . . . . . . 88.2 tttt -131.69 138.19 48.59 Favored 'General case' 0 C--N 1.33 -0.241 0 N-CA-C 110.046 -0.353 . . . . 0.0 110.046 178.628 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' D' D ' 117' ' ' PHE . . . . . 0.423 ' HE2' HD13 ' D' ' 132' ' ' ILE . 27.6 m-85 -139.05 113.96 9.32 Favored 'General case' 0 C--N 1.331 -0.205 0 CA-C-N 116.26 -0.427 . . . . 0.0 109.963 -176.657 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' D' D ' 118' ' ' GLU . . . . . . . . . . . . . 70.7 mm-40 -54.5 -47.78 72.65 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.564 -0.289 . . . . 0.0 111.542 -174.982 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' D' D ' 119' ' ' ASN . . . . . . . . . . . . . 29.5 m120 -93.59 31.06 1.61 Allowed 'General case' 0 C--N 1.329 -0.315 0 N-CA-C 112.15 0.426 . . . . 0.0 112.15 -174.319 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' D' D ' 120' ' ' LEU . . . . . . . . . . . . . 10.3 tp -56.06 120.69 7.89 Favored 'General case' 0 C--N 1.333 -0.139 0 C-N-CA 121.078 -0.249 . . . . 0.0 110.584 177.864 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' D' D ' 121' ' ' ASN . . . . . . . . . . . . . 36.2 m120 -113.78 -44.05 3.22 Favored 'General case' 0 C--O 1.233 0.204 0 CA-C-N 116.575 -0.284 . . . . 0.0 111.178 -177.582 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' D' D ' 122' ' ' LYS . . . . . . . . . . . . . 98.3 mttt -145.72 150.11 35.65 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-O 121.081 0.467 . . . . 0.0 111.945 -177.978 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' D' D ' 123' ' ' VAL . . . . . . . . . . . . . 44.0 t -127.67 127.56 68.6 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.166 0 CA-C-N 115.811 -0.631 . . . . 0.0 109.485 175.292 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' D' D ' 124' ' ' LEU . . . . . 0.429 HD13 ' HB2' ' E' ' 88' ' ' LEU . 35.6 mt -118.02 136.59 53.44 Favored 'General case' 0 C--N 1.332 -0.161 0 CA-C-N 116.426 -0.352 . . . . 0.0 110.606 -179.231 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' D' D ' 125' ' ' VAL . . . . . . . . . . . . . 34.9 m -121.82 141.95 40.16 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.223 0 CA-C-N 116.128 -0.487 . . . . 0.0 110.608 -179.293 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' D' D ' 126' ' ' ARG . . . . . . . . . . . . . 36.5 ptt180 -148.05 114.78 6.04 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-O 121.292 0.567 . . . . 0.0 110.462 177.725 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' D' D ' 127' ' ' ASN . . . . . . . . . . . . . 60.6 t30 49.48 -107.74 0.26 Allowed 'General case' 0 CA--C 1.546 0.823 0 CA-C-O 118.967 -0.539 . . . . 0.0 111.432 -178.516 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' D' D ' 128' ' ' ASP . . . . . . . . . . . . . 20.4 p-10 -114.08 4.98 15.85 Favored 'General case' 0 N--CA 1.469 0.482 0 CA-C-N 119.813 1.188 . . . . 0.0 113.264 179.726 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' D' D ' 129' ' ' LEU . . . . . . . . . . . . . 25.1 mt -108.82 152.75 24.46 Favored 'General case' 0 C--O 1.233 0.222 0 N-CA-C 109.349 -0.612 . . . . 0.0 109.349 178.332 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' D' D ' 130' ' ' VAL . . . . . 0.58 HG21 HD13 ' D' ' 104' ' ' ILE . 33.3 m -139.34 150.17 22.84 Favored 'Isoleucine or valine' 0 N--CA 1.462 0.153 0 CA-C-O 121.462 0.649 . . . . 0.0 111.804 -177.756 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' D' D ' 131' ' ' VAL . . . . . 0.753 HG22 HD12 ' D' ' 140' ' ' LEU . 43.4 t -136.09 138.49 47.21 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.267 0 CA-C-N 115.321 -0.854 . . . . 0.0 109.891 177.277 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' D' D ' 132' ' ' ILE . . . . . 0.423 HD13 ' HE2' ' D' ' 117' ' ' PHE . 70.6 mt -118.03 133.97 63.14 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.305 0 CA-C-N 116.086 -0.506 . . . . 0.0 109.702 -178.538 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' D' D ' 133' ' ' ILE . . . . . . . . . . . . . 42.9 mm -115.07 124.06 71.34 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.287 0 CA-C-N 116.399 -0.364 . . . . 0.0 110.846 -175.643 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' D' D ' 134' ' ' ASP . . . . . . . . . . . . . 8.9 p-10 -136.6 146.58 46.23 Favored 'General case' 0 C--N 1.332 -0.166 0 N-CA-C 109.651 -0.5 . . . . 0.0 109.651 174.227 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' D' D ' 135' ' ' GLU . . . . . . . . . . . . . 45.7 tp10 -49.9 -28.4 6.58 Favored 'General case' 0 C--N 1.328 -0.346 0 N-CA-C 112.874 0.694 . . . . 0.0 112.874 -172.05 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' D' D ' 136' ' ' GLN . . . . . . . . . . . . . 36.5 tt0 -80.48 -35.6 34.56 Favored 'General case' 0 C--N 1.331 -0.21 0 N-CA-C 112.236 0.458 . . . . 0.0 112.236 -176.048 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' D' D ' 137' ' ' LYS . . . . . . . . . . . . . 58.5 pttt -167.05 172.59 9.98 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-O 121.61 0.719 . . . . 0.0 112.193 -171.994 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' D' D ' 138' ' ' LEU . . . . . . . . . . . . . 5.0 tt -115.8 128.39 55.8 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 115.046 -0.979 . . . . 0.0 109.847 179.749 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' D' D ' 139' ' ' THR . . . . . . . . . . . . . 38.5 m -109.62 130.25 55.53 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.303 -0.408 . . . . 0.0 110.377 -179.459 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' D' D ' 140' ' ' LEU . . . . . 0.753 HD12 HG22 ' D' ' 131' ' ' VAL . 10.0 tp -118.46 127.54 53.75 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.025 -0.534 . . . . 0.0 109.914 -178.26 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' D' D ' 141' ' ' ILE . . . . . 0.475 ' HB ' HG23 ' D' ' 130' ' ' VAL . 19.0 mt -125.71 121.64 60.41 Favored 'Isoleucine or valine' 0 C--O 1.234 0.28 0 N-CA-C 109.898 -0.408 . . . . 0.0 109.898 -176.043 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' D' D ' 142' ' ' ARG . . . . . . . . . . . . . 73.9 mtm180 -115.42 123.48 48.73 Favored 'General case' 0 N--CA 1.463 0.179 0 CA-C-N 116.132 -0.485 . . . . 0.0 109.872 -179.463 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' D' D ' 143' ' ' THR . . . . . . . . . . . . . 25.2 p . . . . . 0 C--O 1.219 -0.526 0 CA-C-O 118.047 -0.977 . . . . 0.0 110.57 -179.263 . . . . . . . . 0 0 . 1 . 020 nuclear build full ' E' E ' -3' ' ' GLU . . . . . . . . . . . . . 95.8 mt-10 . . . . . 0 N--CA 1.49 1.553 0 N-CA-C 109.427 -0.583 . . . . 0.0 109.427 . . . . . . . . . 0 0 . 1 . 020 nuclear build full ' E' E ' -2' ' ' GLY . . . . . . . . . . . . . . . -62.05 127.36 40.44 Favored Glycine 0 CA--C 1.524 0.602 0 N-CA-C 111.166 -0.774 . . . . 0.0 111.166 -178.657 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' E' E ' -1' ' ' VAL . . . . . . . . . . . . . 44.1 t -96.58 140.92 16.38 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 N-CA-C 109.772 -0.455 . . . . 0.0 109.772 178.568 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' E' E ' 0' ' ' ILE . . . . . . . . . . . . . 43.7 mm -88.34 144.42 9.2 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.272 0 CA-C-N 116.266 -0.425 . . . . 0.0 110.508 -177.804 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' E' E ' 1' ' ' MET . . . . . . . . . . . . . 24.5 ptp -76.94 170.31 16.73 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.081 -0.509 . . . . 0.0 110.407 179.311 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' E' E ' 2' ' ' SER . . . . . 0.432 ' OG ' HG23 ' E' ' 64' ' ' THR . 87.3 p -131.08 158.5 40.22 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-O 121.042 0.449 . . . . 0.0 111.173 -177.367 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' E' E ' 3' ' ' GLU . . . . . . . . . . . . . 47.6 mp0 -138.74 144.7 39.6 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 115.855 -0.611 . . . . 0.0 110.986 -178.468 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' E' E ' 4' ' ' LEU . . . . . . . . . . . . . 16.8 tp -125.02 125.13 43.38 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 115.809 -0.632 . . . . 0.0 109.931 176.298 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' E' E ' 5' ' ' LYS . . . . . . . . . . . . . 69.2 mttm -106.39 121.71 44.79 Favored 'General case' 0 C--N 1.331 -0.224 0 CA-C-N 116.362 -0.381 . . . . 0.0 110.634 179.078 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' E' E ' 6' ' ' LEU . . . . . . . . . . . . . 77.1 mt -118.65 147.87 43.32 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 115.492 -0.776 . . . . 0.0 110.522 179.768 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' E' E ' 7' ' ' LYS . . . . . . . . . . . . . 84.9 tttt -140.25 142.46 29.93 Favored Pre-proline 0 C--N 1.329 -0.316 0 N-CA-C 109.666 -0.494 . . . . 0.0 109.666 175.687 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' E' E ' 8' ' ' PRO . . . . . . . . . . . . . 85.1 Cg_endo -90.86 147.45 3.87 Favored 'Trans proline' 0 N--CA 1.492 1.391 0 C-N-CA 121.779 1.653 . . . . 0.0 112.081 179.584 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' E' E ' 9' ' ' LEU . . . . . . . . . . . . . 37.4 mt -84.03 -47.69 0.72 Allowed Pre-proline 0 C--N 1.329 -0.301 0 CA-C-O 118.598 -0.715 . . . . 0.0 112.012 178.929 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' E' E ' 10' ' ' PRO . . . . . . . . . . . . . 97.3 Cg_endo -80.76 154.42 20.27 Favored 'Trans proline' 0 N--CA 1.495 1.602 0 C-N-CA 121.124 1.216 . . . . 0.0 111.667 176.052 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' E' E ' 11' ' ' LYS . . . . . . . . . . . . . 58.2 mtpt -88.71 100.99 13.56 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-O 120.804 0.335 . . . . 0.0 110.471 -179.969 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' E' E ' 12' ' ' VAL . . . . . . . . . . . . . 12.3 p -139.6 143.94 29.67 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.224 0 CA-C-N 116.18 -0.464 . . . . 0.0 110.62 -179.225 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' E' E ' 13' ' ' GLU . . . . . . . . . . . . . 45.5 mp0 -90.98 117.41 29.55 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.31 -0.405 . . . . 0.0 110.018 177.254 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' E' E ' 14' ' ' LEU . . . . . 0.46 HD22 ' CE1' ' E' ' 18' ' ' PHE . 25.3 mt -97.93 155.3 37.23 Favored Pre-proline 0 C--N 1.329 -0.283 0 CA-C-N 116.334 -0.394 . . . . 0.0 111.03 -176.832 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' E' E ' 15' ' ' PRO . . . . . . . . . . . . . 32.9 Cg_exo -60.46 161.27 21.0 Favored 'Trans proline' 0 N--CA 1.496 1.676 0 C-N-CA 121.316 1.344 . . . . 0.0 112.048 177.067 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' E' E ' 16' ' ' PRO . . . . . . . . . . . . . 24.6 Cg_exo -61.82 -34.88 81.45 Favored 'Trans proline' 0 N--CA 1.497 1.725 0 C-N-CA 121.472 1.448 . . . . 0.0 112.753 -178.954 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' E' E ' 17' ' ' ASP . . . . . . . . . . . . . 15.7 p-10 -88.38 11.65 16.27 Favored 'General case' 0 CA--C 1.534 0.336 0 N-CA-C 113.24 0.829 . . . . 0.0 113.24 -176.408 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' E' E ' 18' ' ' PHE . . . . . 0.46 ' CE1' HD22 ' E' ' 14' ' ' LEU . 37.3 t80 -56.91 -45.53 82.57 Favored 'General case' 0 C--O 1.231 0.118 0 O-C-N 122.024 -0.423 . . . . 0.0 110.334 -178.377 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' E' E ' 19' ' ' VAL . . . . . 0.408 HG13 ' N ' ' E' ' 20' ' ' ASP . 13.2 p -56.55 -41.57 73.58 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.317 0 CA-C-N 116.544 -0.298 . . . . 0.0 110.898 -179.013 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' E' E ' 20' ' ' ASP . . . . . 0.408 ' N ' HG13 ' E' ' 19' ' ' VAL . 78.1 m-20 -61.05 -43.12 99.37 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-O 120.837 0.351 . . . . 0.0 110.889 -178.545 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' E' E ' 21' ' ' VAL . . . . . . . . . . . . . 48.8 t -64.3 -44.86 97.34 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.319 0 C-N-CA 120.797 -0.361 . . . . 0.0 110.448 -176.952 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' E' E ' 22' ' ' ILE . . . . . 0.609 HG22 HD12 ' E' ' 26' ' ' LEU . 49.8 mm -55.2 -50.62 62.74 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.247 0 C-N-CA 121.151 -0.22 . . . . 0.0 110.716 178.72 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' E' E ' 23' ' ' ARG . . . . . . . . . . . . . 37.8 ttp180 -55.21 -48.65 73.57 Favored 'General case' 0 C--N 1.329 -0.311 0 C-N-CA 120.949 -0.3 . . . . 0.0 111.567 -177.778 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' E' E ' 24' ' ' ILE . . . . . . . . . . . . . 75.4 mt -58.91 -43.72 89.21 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 C-N-CA 121.054 -0.258 . . . . 0.0 111.368 -176.126 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' E' E ' 25' ' ' LYS . . . . . . . . . . . . . 93.1 mttt -69.34 -39.62 78.04 Favored 'General case' 0 C--N 1.33 -0.268 0 N-CA-C 112.556 0.576 . . . . 0.0 112.556 -178.302 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' E' E ' 26' ' ' LEU . . . . . 0.609 HD12 HG22 ' E' ' 22' ' ' ILE . 79.2 mt -78.98 -33.49 45.07 Favored 'General case' 0 C--N 1.331 -0.219 0 N-CA-C 113.673 0.99 . . . . 0.0 113.673 -170.745 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' E' E ' 27' ' ' GLN . . . . . . . . . . . . . 21.0 pt20 -46.4 137.42 6.5 Favored 'General case' 0 N--CA 1.469 0.5 0 N-CA-C 112.861 0.689 . . . . 0.0 112.861 -174.406 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' E' E ' 28' ' ' GLY . . . . . . . . . . . . . . . 99.99 -23.73 34.89 Favored Glycine 0 CA--C 1.533 1.198 0 CA-C-N 115.68 -0.691 . . . . 0.0 112.53 -177.448 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' E' E ' 29' ' ' LYS . . . . . . . . . . . . . 97.7 mttt -97.59 155.13 17.11 Favored 'General case' 0 C--O 1.233 0.235 0 CA-C-N 117.459 0.63 . . . . 0.0 111.132 179.512 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' E' E ' 30' ' ' THR . . . . . . . . . . . . . 27.0 m -103.28 138.52 39.95 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.085 -0.507 . . . . 0.0 110.272 177.545 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' E' E ' 31' ' ' VAL . . . . . . . . . . . . . 34.9 m -130.23 156.73 42.54 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.239 0 CA-C-N 116.385 -0.371 . . . . 0.0 110.879 -178.923 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' E' E ' 32' ' ' ARG . . . . . . . . . . . . . 79.0 mtm180 -136.1 150.4 49.1 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-O 121.32 0.581 . . . . 0.0 110.819 178.112 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' E' E ' 33' ' ' THR . . . . . . . . . . . . . 17.6 m -53.55 141.43 25.54 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.128 -0.487 . . . . 0.0 111.27 -178.625 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' E' E ' 34' ' ' GLY . . . . . . . . . . . . . . . 99.64 -17.08 58.06 Favored Glycine 0 CA--C 1.532 1.149 0 CA-C-O 119.699 -0.501 . . . . 0.0 113.275 179.609 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' E' E ' 35' ' ' ASP . . . . . . . . . . . . . 76.6 m-20 -66.03 147.69 52.95 Favored 'General case' 0 C--O 1.23 0.071 0 CA-C-N 118.054 0.927 . . . . 0.0 111.152 179.054 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' E' E ' 36' ' ' VAL . . . . . . . . . . . . . 46.4 t -122.54 127.97 75.2 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.204 0 CA-C-N 115.83 -0.623 . . . . 0.0 109.649 177.803 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' E' E ' 37' ' ' ILE . . . . . . . . . . . . . 68.2 mt -119.31 138.66 49.28 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.239 0 CA-C-N 116.247 -0.433 . . . . 0.0 109.928 -179.499 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' E' E ' 38' ' ' GLY . . . . . . . . . . . . . . . -110.34 128.58 8.9 Favored Glycine 0 CA--C 1.525 0.7 0 N-CA-C 111.025 -0.83 . . . . 0.0 111.025 179.891 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' E' E ' 39' ' ' ILE . . . . . . . . . . . . . 75.4 mt -126.13 139.34 51.83 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.2 0 N-CA-C 110.027 -0.36 . . . . 0.0 110.027 178.835 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' E' E ' 40' ' ' SER . . . . . 0.432 ' O ' HD13 ' E' ' 41' ' ' ILE . 31.0 t -92.28 116.66 29.16 Favored 'General case' 0 C--N 1.329 -0.297 0 C-N-CA 120.935 -0.306 . . . . 0.0 110.936 176.107 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' E' E ' 41' ' ' ILE . . . . . 0.432 HD13 ' O ' ' E' ' 40' ' ' SER . 46.0 mm -124.59 115.96 46.06 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.157 0 N-CA-C 110.112 -0.329 . . . . 0.0 110.112 178.584 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' E' E ' 42' ' ' LEU . . . . . . . . . . . . . 70.4 mt 57.58 33.43 23.24 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-N 116.196 -0.457 . . . . 0.0 111.793 179.437 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' E' E ' 43' ' ' GLY . . . . . . . . . . . . . . . 81.78 -10.05 53.44 Favored Glycine 0 CA--C 1.534 1.261 0 C-N-CA 121.26 -0.495 . . . . 0.0 113.435 177.043 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' E' E ' 44' ' ' LYS . . . . . . . . . . . . . 53.1 mtpt -100.45 140.45 34.68 Favored 'General case' 0 C--N 1.333 -0.134 0 CA-C-N 117.892 0.846 . . . . 0.0 110.198 178.321 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' E' E ' 45' ' ' GLU . . . . . . . . . . . . . 80.7 tt0 -83.98 126.05 32.65 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.464 -0.334 . . . . 0.0 110.985 -178.752 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' E' E ' 46' ' ' VAL . . . . . . . . . . . . . 7.6 p -120.68 124.37 72.27 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.224 0 N-CA-C 109.409 -0.589 . . . . 0.0 109.409 175.836 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' E' E ' 47' ' ' LYS . . . . . . . . . . . . . 93.1 mttt -100.51 128.5 46.55 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.011 -0.54 . . . . 0.0 111.132 178.027 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' E' E ' 48' ' ' PHE . . . . . . . . . . . . . 93.5 m-85 -109.56 131.96 54.58 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.249 -0.432 . . . . 0.0 110.015 176.499 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' E' E ' 49' ' ' LYS . . . . . . . . . . . . . 80.0 tttt -107.49 134.59 50.3 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.312 -0.403 . . . . 0.0 110.293 179.53 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' E' E ' 50' ' ' VAL . . . . . . . . . . . . . 46.2 t -77.13 110.01 12.31 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.304 0 N-CA-C 109.287 -0.635 . . . . 0.0 109.287 176.393 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' E' E ' 51' ' ' VAL . . . . . . . . . . . . . 48.4 t -74.28 -47.08 42.29 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.278 0 CA-C-N 116.073 -0.512 . . . . 0.0 110.233 -173.852 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' E' E ' 52' ' ' GLN . . . . . . . . . . . . . 61.9 tt0 -168.01 140.08 3.0 Favored 'General case' 0 C--N 1.331 -0.228 0 C-N-CA 120.409 -0.516 . . . . 0.0 111.351 -177.942 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' E' E ' 53' ' ' ALA . . . . . . . . . . . . . . . -117.18 134.46 54.75 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 115.798 -0.637 . . . . 0.0 110.179 175.62 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' E' E ' 54' ' ' TYR . . . . . . . . . . . . . 55.5 t80 -129.05 112.69 18.53 Favored Pre-proline 0 CA--C 1.535 0.375 0 CA-C-O 118.146 -0.93 . . . . 0.0 110.378 177.877 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' E' E ' 55' ' ' PRO . . . . . . . . . . . . . 74.0 Cg_endo -77.09 168.13 77.89 Favored 'Cis proline' 0 N--CA 1.5 1.902 0 CA-C-N 122.14 1.8 . . . . 0.0 112.273 -6.925 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' E' E ' 56' ' ' SER . . . . . . . . . . . . . 15.5 m -116.89 133.79 23.04 Favored Pre-proline 0 CA--C 1.538 0.506 0 CA-C-O 118.414 -0.803 . . . . 0.0 109.572 175.198 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' E' E ' 57' ' ' PRO . . . . . . . . . . . . . 39.4 Cg_endo -67.54 161.11 79.13 Favored 'Cis proline' 0 N--CA 1.497 1.716 0 CA-C-N 121.864 1.701 . . . . 0.0 111.29 -1.695 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' E' E ' 58' ' ' LEU . . . . . . . . . . . . . 21.3 tp -125.99 138.39 53.74 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-O 120.969 0.414 . . . . 0.0 110.46 -178.967 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' E' E ' 59' ' ' ARG . . . . . . . . . . . . . 74.6 ttt180 -103.25 127.0 50.7 Favored 'General case' 0 C--N 1.327 -0.4 0 CA-C-N 115.737 -0.665 . . . . 0.0 109.355 176.249 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' E' E ' 60' ' ' VAL . . . . . . . . . . . . . 41.8 t -77.35 116.74 21.21 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.26 0 C-N-CA 120.672 -0.411 . . . . 0.0 110.156 -176.441 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' E' E ' 61' ' ' GLU . . . . . . . . . . . . . 95.7 mt-10 -131.15 162.17 30.5 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 115.907 -0.588 . . . . 0.0 110.145 178.423 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' E' E ' 62' ' ' ASP . . . . . . . . . . . . . 79.3 m-20 -54.79 -32.67 60.5 Favored 'General case' 0 C--N 1.328 -0.346 0 C-N-CA 121.065 -0.254 . . . . 0.0 111.667 -179.851 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' E' E ' 63' ' ' ARG . . . . . . . . . . . . . 10.8 ptm180 -82.6 6.82 16.47 Favored 'General case' 0 CA--C 1.534 0.354 0 N-CA-C 113.744 1.016 . . . . 0.0 113.744 -175.887 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' E' E ' 64' ' ' THR . . . . . 0.432 HG23 ' OG ' ' E' ' 2' ' ' SER . 27.6 m -93.43 140.14 29.91 Favored 'General case' 0 C--O 1.232 0.133 0 CA-C-N 118.16 0.436 . . . . 0.0 110.486 -179.62 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' E' E ' 65' ' ' LYS . . . . . . . . . . . . . 68.3 mttm -88.62 124.2 33.83 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.277 -0.42 . . . . 0.0 110.008 179.558 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' E' E ' 66' ' ' ILE . . . . . . . . . . . . . 56.5 mt -113.58 129.8 68.74 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.253 0 N-CA-C 109.815 -0.439 . . . . 0.0 109.815 -179.814 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' E' E ' 67' ' ' THR . . . . . . . . . . . . . 19.0 m -127.21 133.97 50.18 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-O 121.245 0.545 . . . . 0.0 110.767 179.949 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' E' E ' 68' ' ' LEU . . . . . . . . . . . . . 21.7 tp -108.27 122.85 47.8 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 115.737 -0.665 . . . . 0.0 109.72 176.55 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' E' E ' 69' ' ' VAL . . . . . . . . . . . . . 44.6 t -100.89 102.52 13.57 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.209 0 N-CA-C 109.723 -0.473 . . . . 0.0 109.723 179.236 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' E' E ' 70' ' ' THR . . . . . . . . . . . . . 14.5 m -150.23 -44.32 0.13 Allowed 'General case' 0 C--N 1.33 -0.265 0 CA-C-O 121.093 0.473 . . . . 0.0 111.333 178.889 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' E' E ' 71' ' ' HIS . . . . . . . . . . . . . 26.3 m80 -106.52 170.29 5.91 Favored Pre-proline 0 CA--C 1.535 0.369 0 CA-C-N 115.598 -0.728 . . . . 0.0 112.462 -168.031 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' E' E ' 72' ' ' PRO . . . . . . . . . . . . . 23.1 Cg_exo -64.93 160.33 41.78 Favored 'Trans proline' 0 N--CA 1.497 1.72 0 C-N-CA 122.096 1.864 . . . . 0.0 111.943 174.44 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' E' E ' 73' ' ' VAL . . . . . . . . . . . . . 34.3 m -69.49 -173.51 0.1 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.277 0 CA-C-N 116.133 -0.485 . . . . 0.0 110.293 -173.804 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' E' E ' 74' ' ' ASP . . . . . . . . . . . . . 13.9 t70 -77.35 114.98 16.73 Favored 'General case' 0 C--N 1.328 -0.338 0 C-N-CA 120.362 -0.535 . . . . 0.0 110.274 -168.414 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' E' E ' 75' ' ' VAL . . . . . . . . . . . . . 46.8 t -119.38 117.91 55.63 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.273 0 CA-C-O 121.16 0.505 . . . . 0.0 109.733 -179.654 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' E' E ' 76' ' ' LEU . . . . . . . . . . . . . 15.2 mt -124.59 148.57 47.78 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 115.459 -0.791 . . . . 0.0 109.613 -178.329 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' E' E ' 77' ' ' GLU . . . . . . . . . . . . . 45.3 mt-10 -138.77 135.46 34.7 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-O 121.15 0.5 . . . . 0.0 111.266 -177.604 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' E' E ' 78' ' ' ALA . . . . . 0.569 ' HB2' HD21 ' E' ' 109' ' ' LEU . . . -121.78 129.24 52.52 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 115.562 -0.745 . . . . 0.0 109.622 175.708 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' E' E ' 79' ' ' LYS . . . . . 0.652 ' O ' HD13 ' E' ' 80' ' ' ILE . 48.7 mttm -75.83 117.84 18.0 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-O 121.008 0.433 . . . . 0.0 110.875 -178.55 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' E' E ' 80' ' ' ILE . . . . . 0.652 HD13 ' O ' ' E' ' 79' ' ' LYS . 38.4 mm -139.14 102.5 1.73 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.261 0 N-CA-C 108.908 -0.775 . . . . 0.0 108.908 -177.95 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' E' E ' 81' ' ' LYS . . . . . . . . . . . . . 53.5 mttp -96.31 127.82 42.66 Favored 'General case' 0 C--N 1.327 -0.397 0 C-N-CA 120.783 -0.367 . . . . 0.0 111.305 -176.489 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' E' E ' 82' ' ' GLY . . . . . . . . . . . . . . . 89.14 42.18 5.66 Favored Glycine 0 CA--C 1.525 0.703 0 C-N-CA 120.714 -0.755 . . . . 0.0 111.867 173.588 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' E' E ' 83' ' ' ILE . . . . . . . . . . . . . 70.7 mt -70.95 135.0 28.98 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.358 0 N-CA-C 109.477 -0.564 . . . . 0.0 109.477 177.186 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' E' E ' 84' ' ' LYS . . . . . . . . . . . . . 31.1 ttpt -94.34 -51.64 4.7 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-O 121.023 0.44 . . . . 0.0 110.212 -177.521 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' E' E ' 85' ' ' ASP . . . . . . . . . . . . . 8.9 t70 -149.49 149.31 30.57 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 115.696 -0.684 . . . . 0.0 110.068 -179.383 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' E' E ' 86' ' ' VAL . . . . . . . . . . . . . 39.6 t -132.3 133.65 59.99 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.244 0 CA-C-O 120.959 0.409 . . . . 0.0 110.502 -179.671 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' E' E ' 87' ' ' ILE . . . . . 0.5 ' N ' HD12 ' E' ' 87' ' ' ILE . 5.0 mp -118.94 123.48 71.56 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 N-CA-C 109.206 -0.665 . . . . 0.0 109.206 176.717 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' E' E ' 88' ' ' LEU . . . . . 0.429 ' HB2' HD13 ' D' ' 124' ' ' LEU . 14.0 tp -109.43 119.52 39.72 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.401 -0.363 . . . . 0.0 110.475 -179.068 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' E' E ' 89' ' ' ASP . . . . . . . . . . . . . 6.6 t70 -112.28 153.92 26.43 Favored 'General case' 0 C--N 1.33 -0.28 0 N-CA-C 109.628 -0.508 . . . . 0.0 109.628 178.249 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' E' E ' 90' ' ' GLU . . . . . . . . . . . . . 82.0 tt0 -47.76 -36.86 12.22 Favored 'General case' 0 C--N 1.329 -0.296 0 N-CA-C 112.685 0.624 . . . . 0.0 112.685 -173.364 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' E' E ' 91' ' ' ASN . . . . . . . . . . . . . 13.2 p30 -131.97 32.19 4.08 Favored 'General case' 0 N--CA 1.465 0.285 0 N-CA-C 112.29 0.478 . . . . 0.0 112.29 -175.79 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' E' E ' 92' ' ' LEU . . . . . . . . . . . . . 6.4 tp -166.02 144.68 5.87 Favored 'General case' 0 C--N 1.332 -0.183 0 C-N-CA 120.686 -0.406 . . . . 0.0 111.016 -179.656 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' E' E ' 93' ' ' ILE . . . . . . . . . . . . . 62.3 mt -119.82 119.87 61.59 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.24 0 N-CA-C 109.346 -0.613 . . . . 0.0 109.346 -179.787 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' E' E ' 94' ' ' VAL . . . . . . . . . . . . . 45.5 t -122.22 126.44 74.3 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.293 0 CA-C-O 120.849 0.357 . . . . 0.0 110.212 -178.984 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' E' E ' 95' ' ' VAL . . . . . . . . . . . . . 42.9 t -123.65 134.23 66.99 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.209 0 CA-C-N 116.109 -0.496 . . . . 0.0 110.093 -179.356 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' E' E ' 96' ' ' ILE . . . . . . . . . . . . . 66.6 mt -117.13 127.54 74.69 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.257 0 N-CA-C 109.509 -0.552 . . . . 0.0 109.509 178.634 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' E' E ' 97' ' ' THR . . . . . . . . . . . . . 82.0 p -99.28 157.33 16.46 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-O 121.13 0.491 . . . . 0.0 111.282 -177.433 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' E' E ' 98' ' ' GLU . . . . . . . . . . . . . 96.7 mt-10 -54.62 -26.45 32.89 Favored 'General case' 0 C--N 1.328 -0.328 0 N-CA-C 112.236 0.458 . . . . 0.0 112.236 -179.829 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' E' E ' 99' ' ' GLU . . . . . . . . . . . . . 95.7 mt-10 -78.22 14.7 1.11 Allowed 'General case' 0 CA--C 1.536 0.43 0 N-CA-C 113.1 0.778 . . . . 0.0 113.1 -177.425 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' E' E ' 100' ' ' ASN . . . . . . . . . . . . . 4.5 m-20 63.47 38.03 10.19 Favored 'General case' 0 C--O 1.232 0.149 0 CA-C-O 121.055 0.455 . . . . 0.0 110.951 178.11 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' E' E ' 101' ' ' GLU . . . . . . . . . . . . . 83.3 tt0 -119.24 141.31 49.03 Favored 'General case' 0 C--N 1.332 -0.192 0 N-CA-C 109.601 -0.518 . . . . 0.0 109.601 176.178 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' E' E ' 102' ' ' VAL . . . . . . . . . . . . . 41.8 t -115.03 130.9 68.76 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.271 0 CA-C-O 120.812 0.339 . . . . 0.0 110.407 -177.527 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' E' E ' 103' ' ' LEU . . . . . . . . . . . . . 27.1 mt -119.29 130.89 55.64 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 115.454 -0.794 . . . . 0.0 109.992 176.725 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' E' E ' 104' ' ' ILE . . . . . 0.456 HD11 HG11 ' E' ' 130' ' ' VAL . 72.4 mt -119.65 123.56 71.26 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.252 0 N-CA-C 110.096 -0.335 . . . . 0.0 110.096 179.506 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' E' E ' 105' ' ' PHE . . . . . . . . . . . . . 66.9 m-85 -124.86 162.99 23.16 Favored 'General case' 0 C--N 1.332 -0.159 0 O-C-N 123.735 0.647 . . . . 0.0 110.482 -177.792 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' E' E ' 106' ' ' ASN . . . . . . . . . . . . . 40.6 p-10 -100.7 -169.98 1.79 Allowed 'General case' 0 CA--C 1.531 0.218 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.263 175.592 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' E' E ' 107' ' ' GLN . . . . . . . . . . . . . 47.2 tt0 -59.09 -29.97 67.74 Favored 'General case' 0 CA--C 1.531 0.232 0 N-CA-C 112.017 0.377 . . . . 0.0 112.017 179.917 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' E' E ' 108' ' ' ASN . . . . . . . . . . . . . 12.2 t-20 -86.01 9.62 16.57 Favored 'General case' 0 CA--C 1.534 0.348 0 N-CA-C 113.275 0.842 . . . . 0.0 113.275 -177.087 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' E' E ' 109' ' ' LEU . . . . . 0.569 HD21 ' HB2' ' E' ' 78' ' ' ALA . 12.1 tp 57.76 40.11 26.55 Favored 'General case' 0 CA--C 1.529 0.169 0 CA-C-O 121.206 0.527 . . . . 0.0 111.012 178.33 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' E' E ' 110' ' ' GLU . . . . . . . . . . . . . 95.5 mt-10 -108.32 156.93 18.83 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.202 -0.454 . . . . 0.0 109.99 175.953 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' E' E ' 111' ' ' GLU . . . . . . . . . . . . . 35.5 tt0 -81.61 122.08 27.15 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-O 120.892 0.377 . . . . 0.0 110.744 -177.304 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' E' E ' 112' ' ' LEU . . . . . . . . . . . . . 16.8 mt -107.74 -45.94 3.91 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 115.991 -0.549 . . . . 0.0 110.219 175.996 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' E' E ' 113' ' ' TYR . . . . . . . . . . . . . 63.2 t80 -139.5 135.08 33.13 Favored 'General case' 0 C--N 1.332 -0.19 0 C-N-CA 120.814 -0.355 . . . . 0.0 111.456 179.624 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' E' E ' 114' ' ' ARG . . . . . . . . . . . . . 19.4 ttm180 -133.76 123.85 25.61 Favored 'General case' 0 C--N 1.331 -0.224 0 CA-C-N 115.811 -0.631 . . . . 0.0 109.72 175.58 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' E' E ' 115' ' ' GLY . . . . . . . . . . . . . . . -150.11 141.36 8.72 Favored Glycine 0 CA--C 1.524 0.655 0 N-CA-C 111.272 -0.731 . . . . 0.0 111.272 178.906 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' E' E ' 116' ' ' LYS . . . . . . . . . . . . . 17.1 ttpp -116.57 130.72 56.9 Favored 'General case' 0 C--N 1.332 -0.194 0 N-CA-C 109.748 -0.464 . . . . 0.0 109.748 177.443 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' E' E ' 117' ' ' PHE . . . . . . . . . . . . . 38.6 m-85 -130.58 114.04 14.96 Favored 'General case' 0 C--N 1.331 -0.213 0 CA-C-O 120.782 0.325 . . . . 0.0 110.211 -175.696 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' E' E ' 118' ' ' GLU . . . . . . . . . . . . . 96.0 mt-10 -55.54 -41.49 73.29 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.406 -0.361 . . . . 0.0 111.102 -176.695 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' E' E ' 119' ' ' ASN . . . . . . . . . . . . . 34.7 m-80 -99.57 30.96 3.36 Favored 'General case' 0 C--N 1.33 -0.268 0 N-CA-C 112.121 0.415 . . . . 0.0 112.121 -174.123 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' E' E ' 120' ' ' LEU . . . . . . . . . . . . . 13.7 tp -55.33 121.3 8.61 Favored 'General case' 0 C--N 1.333 -0.115 0 CA-C-O 120.747 0.308 . . . . 0.0 110.736 178.382 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' E' E ' 121' ' ' ASN . . . . . . . . . . . . . 30.4 m120 -112.51 -44.13 3.4 Favored 'General case' 0 C--N 1.332 -0.175 0 CA-C-N 116.316 -0.402 . . . . 0.0 110.841 -178.145 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' E' E ' 122' ' ' LYS . . . . . . . . . . . . . 35.4 mtmm -147.47 147.05 29.78 Favored 'General case' 0 C--N 1.331 -0.231 0 C-N-CA 120.6 -0.44 . . . . 0.0 111.783 -177.985 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' E' E ' 123' ' ' VAL . . . . . . . . . . . . . 45.5 t -123.94 127.27 73.54 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.233 0 CA-C-N 115.88 -0.6 . . . . 0.0 109.562 176.133 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' E' E ' 124' ' ' LEU . . . . . . . . . . . . . 51.5 mt -119.73 136.36 54.46 Favored 'General case' 0 C--N 1.331 -0.23 0 CA-C-N 116.355 -0.384 . . . . 0.0 110.673 -177.743 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' E' E ' 125' ' ' VAL . . . . . . . . . . . . . 12.1 p -133.31 135.25 56.58 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.265 0 CA-C-O 120.749 0.309 . . . . 0.0 110.392 178.505 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' E' E ' 126' ' ' ARG . . . . . . . . . . . . . 95.8 mtt-85 -144.5 120.9 10.97 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-N 116.093 -0.503 . . . . 0.0 110.566 179.139 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' E' E ' 127' ' ' ASN . . . . . . . . . . . . . 94.9 m-20 50.4 -108.02 0.31 Allowed 'General case' 0 CA--C 1.544 0.721 0 CA-C-O 118.854 -0.593 . . . . 0.0 111.428 179.662 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' E' E ' 128' ' ' ASP . . . . . . . . . . . . . 11.0 p-10 -114.08 6.85 16.54 Favored 'General case' 0 CA--C 1.536 0.436 0 CA-C-N 119.796 1.18 . . . . 0.0 113.417 -177.776 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' E' E ' 129' ' ' LEU . . . . . . . . . . . . . 6.1 mp -110.75 150.04 29.66 Favored 'General case' 0 C--O 1.233 0.189 0 CA-C-N 118.206 0.457 . . . . 0.0 110.435 178.666 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' E' E ' 130' ' ' VAL . . . . . 0.456 HG11 HD11 ' E' ' 104' ' ' ILE . 40.6 t -130.86 140.98 47.35 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.237 0 CA-C-N 116.271 -0.422 . . . . 0.0 110.406 -178.213 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' E' E ' 131' ' ' VAL . . . . . . . . . . . . . 41.3 t -134.92 135.88 52.51 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 CA-C-N 116.096 -0.502 . . . . 0.0 109.806 177.835 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' E' E ' 132' ' ' ILE . . . . . . . . . . . . . 71.3 mt -119.29 133.68 65.32 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.25 0 N-CA-C 109.737 -0.468 . . . . 0.0 109.737 -179.842 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' E' E ' 133' ' ' ILE . . . . . . . . . . . . . 41.8 mm -115.9 123.58 71.35 Favored 'Isoleucine or valine' 0 C--O 1.233 0.223 0 CA-C-N 116.39 -0.368 . . . . 0.0 110.663 -176.867 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' E' E ' 134' ' ' ASP . . . . . . . . . . . . . 10.1 p-10 -134.88 150.14 50.4 Favored 'General case' 0 C--N 1.331 -0.237 0 N-CA-C 109.75 -0.463 . . . . 0.0 109.75 175.332 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' E' E ' 135' ' ' GLU . . . . . . . . . . . . . 40.6 tp10 -49.95 -27.29 5.14 Favored 'General case' 0 C--N 1.328 -0.347 0 N-CA-C 112.809 0.67 . . . . 0.0 112.809 -171.581 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' E' E ' 136' ' ' GLN . . . . . . . . . . . . . 43.4 tt0 -89.99 -29.97 18.09 Favored 'General case' 0 C--O 1.234 0.266 0 N-CA-C 112.619 0.6 . . . . 0.0 112.619 -173.388 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' E' E ' 137' ' ' LYS . . . . . . . . . . . . . 52.2 pttt -163.86 173.02 13.23 Favored 'General case' 0 C--N 1.332 -0.179 0 CA-C-O 121.528 0.68 . . . . 0.0 112.448 -173.238 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' E' E ' 138' ' ' LEU . . . . . . . . . . . . . 6.4 tt -121.15 129.94 53.49 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 115.03 -0.986 . . . . 0.0 109.928 178.579 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' E' E ' 139' ' ' THR . . . . . . . . . . . . . 27.9 m -111.78 129.49 56.11 Favored 'General case' 0 C--N 1.331 -0.211 0 CA-C-N 116.315 -0.402 . . . . 0.0 110.676 -178.856 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' E' E ' 140' ' ' LEU . . . . . . . . . . . . . 8.7 tp -117.14 120.7 39.1 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 115.748 -0.66 . . . . 0.0 109.363 -177.989 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' E' E ' 141' ' ' ILE . . . . . . . . . . . . . 19.4 mt -119.49 121.42 66.33 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.239 0 CA-C-O 120.818 0.342 . . . . 0.0 110.219 -175.701 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' E' E ' 142' ' ' ARG . . . . . . . . . . . . . 75.1 mtp180 -111.85 130.4 55.83 Favored 'General case' 0 C--N 1.331 -0.222 0 CA-C-N 115.556 -0.747 . . . . 0.0 110.185 -178.666 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' E' E ' 143' ' ' THR . . . . . . . . . . . . . 39.9 p . . . . . 0 C--O 1.219 -0.506 0 CA-C-O 118.011 -0.995 . . . . 0.0 110.598 179.953 . . . . . . . . 0 0 . 1 . 020 nuclear build full ' F' F ' -3' ' ' GLU . . . . . . . . . . . . . 80.1 tt0 . . . . . 0 N--CA 1.49 1.563 0 N-CA-C 109.239 -0.652 . . . . 0.0 109.239 . . . . . . . . . 0 0 . 1 . 020 nuclear build full ' F' F ' -2' ' ' GLY . . . . . . . . . . . . . . . -102.66 138.93 14.2 Favored Glycine 0 CA--C 1.524 0.639 0 N-CA-C 111.025 -0.83 . . . . 0.0 111.025 -179.947 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' F' F ' -1' ' ' VAL . . . . . . . . . . . . . 46.7 t -96.39 138.16 22.37 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.284 0 N-CA-C 109.776 -0.453 . . . . 0.0 109.776 178.702 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' F' F ' 0' ' ' ILE . . . . . . . . . . . . . 70.5 mt -96.2 139.71 18.67 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.269 0 CA-C-N 116.319 -0.401 . . . . 0.0 110.101 -178.24 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' F' F ' 1' ' ' MET . . . . . . . . . . . . . 26.1 ptt? -77.05 130.35 37.3 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.04 -0.527 . . . . 0.0 110.441 -179.557 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' F' F ' 2' ' ' SER . . . . . . . . . . . . . 6.2 p -108.34 139.38 43.13 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-N 116.1 -0.5 . . . . 0.0 110.805 -178.536 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' F' F ' 3' ' ' GLU . . . . . . . . . . . . . 33.1 tp10 -139.18 133.58 31.6 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 115.723 -0.671 . . . . 0.0 110.194 -178.102 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' F' F ' 4' ' ' LEU . . . . . . . . . . . . . 19.7 tp -125.15 127.59 47.08 Favored 'General case' 0 C--N 1.331 -0.196 0 N-CA-C 110.071 -0.344 . . . . 0.0 110.071 175.23 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' F' F ' 5' ' ' LYS . . . . . . . . . . . . . 98.7 mttt -111.14 121.39 45.18 Favored 'General case' 0 C--O 1.235 0.302 0 CA-C-O 120.831 0.348 . . . . 0.0 110.827 179.378 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' F' F ' 6' ' ' LEU . . . . . . . . . . . . . 60.4 mt -114.46 143.31 45.15 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 115.369 -0.832 . . . . 0.0 109.898 179.549 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' F' F ' 7' ' ' LYS . . . . . . . . . . . . . 80.6 tttt -123.43 134.23 25.08 Favored Pre-proline 0 CA--C 1.534 0.339 0 CA-C-O 118.893 -0.575 . . . . 0.0 109.812 175.96 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' F' F ' 8' ' ' PRO . . . . . . . . . . . . . 94.4 Cg_endo -92.03 136.57 1.69 Allowed 'Trans proline' 0 N--CA 1.489 1.261 0 C-N-CA 121.607 1.538 . . . . 0.0 111.703 177.722 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' F' F ' 9' ' ' LEU . . . . . . . . . . . . . 63.0 mt -79.32 -47.53 1.57 Allowed Pre-proline 0 CA--C 1.533 0.301 0 CA-C-O 118.61 -0.71 . . . . 0.0 112.1 -179.486 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' F' F ' 10' ' ' PRO . . . . . . . . . . . . . 90.1 Cg_endo -80.9 149.82 18.04 Favored 'Trans proline' 0 N--CA 1.496 1.63 0 C-N-CA 121.207 1.271 . . . . 0.0 111.87 176.502 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' F' F ' 11' ' ' LYS . . . . . . . . . . . . . 45.3 tttp -88.25 111.2 21.39 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-O 120.753 0.311 . . . . 0.0 110.371 178.99 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' F' F ' 12' ' ' VAL . . . . . . . . . . . . . 12.4 p -145.52 146.78 19.24 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.299 0 CA-C-O 120.898 0.38 . . . . 0.0 110.801 -178.645 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' F' F ' 13' ' ' GLU . . . . . . . . . . . . . 70.3 mm-40 -88.22 108.95 19.55 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.084 -0.507 . . . . 0.0 110.382 175.384 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' F' F ' 14' ' ' LEU . . . . . . . . . . . . . 38.9 mt -91.75 147.04 34.23 Favored Pre-proline 0 C--N 1.328 -0.361 0 CA-C-N 116.125 -0.489 . . . . 0.0 110.012 -179.439 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' F' F ' 15' ' ' PRO . . . . . . . . . . . . . 36.3 Cg_exo -58.37 157.42 26.51 Favored 'Trans proline' 0 N--CA 1.497 1.705 0 C-N-CA 121.237 1.291 . . . . 0.0 111.823 179.024 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' F' F ' 16' ' ' PRO . . . . . . . . . . . . . 36.9 Cg_exo -58.22 -36.79 97.45 Favored 'Trans proline' 0 N--CA 1.497 1.73 0 C-N-CA 121.384 1.389 . . . . 0.0 112.876 -178.505 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' F' F ' 17' ' ' ASP . . . . . . . . . . . . . 8.7 p-10 -83.51 12.19 5.98 Favored 'General case' 0 CA--C 1.536 0.412 0 N-CA-C 113.146 0.795 . . . . 0.0 113.146 -177.803 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' F' F ' 18' ' ' PHE . . . . . . . . . . . . . 45.6 t80 -56.78 -45.86 81.88 Favored 'General case' 0 N--CA 1.457 -0.096 0 O-C-N 122.007 -0.433 . . . . 0.0 110.424 -178.566 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' F' F ' 19' ' ' VAL . . . . . . . . . . . . . 15.0 p -54.85 -41.04 55.24 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.273 0 CA-C-N 116.549 -0.296 . . . . 0.0 111.175 -178.176 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' F' F ' 20' ' ' ASP . . . . . . . . . . . . . 73.7 m-20 -60.72 -45.25 94.99 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-O 120.814 0.34 . . . . 0.0 111.075 -178.429 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' F' F ' 21' ' ' VAL . . . . . . . . . . . . . 47.6 t -64.64 -46.97 90.83 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.328 0 C-N-CA 120.65 -0.42 . . . . 0.0 110.574 -177.273 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' F' F ' 22' ' ' ILE . . . . . 0.622 HG22 HD12 ' F' ' 26' ' ' LEU . 50.8 mm -56.46 -45.73 81.97 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.271 0 CA-C-O 120.875 0.369 . . . . 0.0 110.462 179.443 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' F' F ' 23' ' ' ARG . . . . . . . . . . . . . 32.3 ttp180 -53.64 -49.03 68.78 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.655 -0.248 . . . . 0.0 111.369 -179.076 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' F' F ' 24' ' ' ILE . . . . . . . . . . . . . 67.8 mt -59.27 -48.27 87.55 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.336 0 C-N-CA 121.039 -0.265 . . . . 0.0 111.193 -177.361 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' F' F ' 25' ' ' LYS . . . . . . . . . . . . . 98.8 mttt -64.35 -36.23 83.45 Favored 'General case' 0 C--N 1.329 -0.286 0 N-CA-C 112.538 0.57 . . . . 0.0 112.538 -177.029 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' F' F ' 26' ' ' LEU . . . . . 0.622 HD12 HG22 ' F' ' 22' ' ' ILE . 53.4 mt -77.47 -43.77 31.19 Favored 'General case' 0 C--N 1.33 -0.259 0 N-CA-C 112.869 0.692 . . . . 0.0 112.869 -173.169 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' F' F ' 27' ' ' GLN . . . . . . . . . . . . . 3.7 pt20 -47.4 137.91 8.1 Favored 'General case' 0 N--CA 1.468 0.439 0 N-CA-C 112.714 0.635 . . . . 0.0 112.714 -175.424 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' F' F ' 28' ' ' GLY . . . . . . . . . . . . . . . 101.02 -26.45 24.63 Favored Glycine 0 CA--C 1.533 1.165 0 CA-C-N 115.587 -0.733 . . . . 0.0 112.235 -176.998 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' F' F ' 29' ' ' LYS . . . . . . . . . . . . . 66.7 mmtt -98.14 155.1 17.31 Favored 'General case' 0 C--O 1.233 0.217 0 CA-C-N 117.311 0.556 . . . . 0.0 111.26 178.792 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' F' F ' 30' ' ' THR . . . . . . . . . . . . . 26.9 m -107.95 139.8 42.04 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 115.882 -0.599 . . . . 0.0 110.152 176.741 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' F' F ' 31' ' ' VAL . . . . . . . . . . . . . 34.7 m -129.5 157.67 42.19 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.267 0 CA-C-N 116.373 -0.376 . . . . 0.0 111.08 -178.121 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' F' F ' 32' ' ' ARG . . . . . . . . . . . . . 88.7 mtt180 -131.03 149.02 52.8 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 115.7 -0.682 . . . . 0.0 110.34 177.01 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' F' F ' 33' ' ' THR . . . . . . . . . . . . . 14.1 m -53.5 138.47 33.72 Favored 'General case' 0 C--N 1.332 -0.189 0 CA-C-N 116.489 -0.323 . . . . 0.0 111.271 -177.949 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' F' F ' 34' ' ' GLY . . . . . . . . . . . . . . . 100.72 -17.04 57.06 Favored Glycine 0 CA--C 1.532 1.139 0 CA-C-O 119.632 -0.538 . . . . 0.0 113.298 179.326 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' F' F ' 35' ' ' ASP . . . . . . . . . . . . . 54.1 m-20 -63.0 150.63 41.93 Favored 'General case' 0 C--O 1.233 0.206 0 CA-C-N 118.121 0.961 . . . . 0.0 111.316 -179.926 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' F' F ' 36' ' ' VAL . . . . . . . . . . . . . 45.3 t -123.33 129.48 74.79 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.232 0 CA-C-N 115.76 -0.655 . . . . 0.0 109.822 178.582 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' F' F ' 37' ' ' ILE . . . . . . . . . . . . . 67.5 mt -124.84 140.41 48.08 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.257 0 CA-C-N 116.304 -0.407 . . . . 0.0 110.183 -179.096 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' F' F ' 38' ' ' GLY . . . . . . . . . . . . . . . -118.65 128.71 7.81 Favored Glycine 0 CA--C 1.525 0.689 0 N-CA-C 111.181 -0.768 . . . . 0.0 111.181 179.322 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' F' F ' 39' ' ' ILE . . . . . . . . . . . . . 77.4 mt -127.36 141.25 46.83 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.276 0 N-CA-C 110.234 -0.284 . . . . 0.0 110.234 179.218 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' F' F ' 40' ' ' SER . . . . . . . . . . . . . 76.8 p -92.48 119.11 31.66 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.445 -0.343 . . . . 0.0 110.995 176.068 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' F' F ' 41' ' ' ILE . . . . . . . . . . . . . 43.8 mm -121.05 118.74 57.22 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.195 0 CA-C-N 116.463 -0.335 . . . . 0.0 110.141 178.125 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' F' F ' 42' ' ' LEU . . . . . . . . . . . . . 64.5 mt 52.05 34.42 13.97 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.308 -0.405 . . . . 0.0 111.907 177.194 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' F' F ' 43' ' ' GLY . . . . . . . . . . . . . . . 76.74 28.8 58.52 Favored Glycine 0 CA--C 1.53 1.028 0 C-N-CA 121.185 -0.531 . . . . 0.0 112.523 176.693 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' F' F ' 44' ' ' LYS . . . . . . . . . . . . . 7.8 ttpm? -140.52 131.28 25.79 Favored 'General case' 0 C--N 1.33 -0.242 0 N-CA-C 109.289 -0.634 . . . . 0.0 109.289 176.316 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' F' F ' 45' ' ' GLU . . . . . . . . . . . . . 81.3 tt0 -82.4 126.71 32.5 Favored 'General case' 0 C--N 1.328 -0.332 0 C-N-CA 120.865 -0.334 . . . . 0.0 111.263 -175.806 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' F' F ' 46' ' ' VAL . . . . . . . . . . . . . 10.4 p -118.2 124.96 73.88 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.2 0 N-CA-C 109.532 -0.544 . . . . 0.0 109.532 175.091 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' F' F ' 47' ' ' LYS . . . . . . . . . . . . . 62.0 mttp -99.14 125.53 44.71 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 115.866 -0.606 . . . . 0.0 110.942 178.105 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' F' F ' 48' ' ' PHE . . . . . . . . . . . . . 33.7 m-85 -110.26 131.91 54.64 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.037 -0.529 . . . . 0.0 109.921 177.384 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' F' F ' 49' ' ' LYS . . . . . . . . . . . . . 43.0 tttp -107.67 132.99 52.74 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 116.31 -0.404 . . . . 0.0 109.975 176.402 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' F' F ' 50' ' ' VAL . . . . . . . . . . . . . 44.0 t -76.81 107.82 8.71 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.312 0 N-CA-C 109.483 -0.562 . . . . 0.0 109.483 178.701 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' F' F ' 51' ' ' VAL . . . . . . . . . . . . . 44.7 t -72.43 -50.42 35.31 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.289 0 CA-C-N 116.022 -0.535 . . . . 0.0 109.825 -174.747 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' F' F ' 52' ' ' GLN . . . . . . . . . . . . . 62.8 tt0 -159.06 144.61 16.25 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 115.836 -0.62 . . . . 0.0 111.501 -176.908 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' F' F ' 53' ' ' ALA . . . . . . . . . . . . . . . -123.25 132.43 54.02 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 115.524 -0.762 . . . . 0.0 109.931 175.971 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' F' F ' 54' ' ' TYR . . . . . . . . . . . . . 67.7 t80 -129.13 112.81 18.43 Favored Pre-proline 0 CA--C 1.536 0.407 0 CA-C-O 118.154 -0.927 . . . . 0.0 110.261 177.351 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' F' F ' 55' ' ' PRO . . . . . . . . . . . . . 74.4 Cg_endo -77.05 166.97 81.17 Favored 'Cis proline' 0 N--CA 1.501 1.919 0 CA-C-N 122.09 1.782 . . . . 0.0 112.467 -5.4 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' F' F ' 56' ' ' SER . . . . . . . . . . . . . 13.7 m -114.05 124.99 29.96 Favored Pre-proline 0 CA--C 1.539 0.535 0 CA-C-O 118.369 -0.824 . . . . 0.0 109.381 176.506 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' F' F ' 57' ' ' PRO . . . . . . . . . . . . . 39.5 Cg_endo -67.16 166.24 64.07 Favored 'Cis proline' 0 N--CA 1.498 1.751 0 CA-C-N 122.065 1.773 . . . . 0.0 111.556 0.939 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' F' F ' 58' ' ' LEU . . . . . . . . . . . . . 24.0 tp -127.46 135.0 49.81 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.227 -0.442 . . . . 0.0 110.365 179.958 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' F' F ' 59' ' ' ARG . . . . . . . . . . . . . 57.4 ttp180 -106.63 123.1 47.61 Favored 'General case' 0 C--N 1.328 -0.358 0 N-CA-C 109.244 -0.65 . . . . 0.0 109.244 177.129 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' F' F ' 60' ' ' VAL . . . . . . . . . . . . . 44.5 t -78.12 122.22 32.57 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.347 0 C-N-CA 120.753 -0.379 . . . . 0.0 110.546 -174.049 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' F' F ' 61' ' ' GLU . . . . . . . . . . . . . 95.5 mt-10 -131.06 164.92 24.36 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-N 115.804 -0.635 . . . . 0.0 109.784 176.293 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' F' F ' 62' ' ' ASP . . . . . . . . . . . . . 80.5 m-20 -53.94 -32.66 54.4 Favored 'General case' 0 C--N 1.328 -0.342 0 C-N-CA 121.027 -0.269 . . . . 0.0 111.646 -179.663 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' F' F ' 63' ' ' ARG . . . . . . . . . . . . . 24.4 mmt180 -73.07 -21.39 60.79 Favored 'General case' 0 CA--C 1.533 0.32 0 N-CA-C 113.034 0.753 . . . . 0.0 113.034 -177.519 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' F' F ' 64' ' ' THR . . . . . . . . . . . . . 30.9 m -68.08 137.35 54.91 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-O 120.882 0.373 . . . . 0.0 111.009 -174.201 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' F' F ' 65' ' ' LYS . . . . . . . . . . . . . 97.9 mttt -90.36 132.17 35.73 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.038 -0.528 . . . . 0.0 109.992 178.525 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' F' F ' 66' ' ' ILE . . . . . . . . . . . . . 64.2 mt -119.51 131.39 72.25 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.264 0 CA-C-O 120.934 0.397 . . . . 0.0 110.071 -179.822 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' F' F ' 67' ' ' THR . . . . . . . . . . . . . 22.9 m -123.39 139.03 54.45 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 115.96 -0.563 . . . . 0.0 110.651 -179.412 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' F' F ' 68' ' ' LEU . . . . . 0.478 HD23 ' C ' ' F' ' 68' ' ' LEU . 6.3 tt -107.68 121.13 44.08 Favored 'General case' 0 C--N 1.331 -0.225 0 CA-C-N 116.108 -0.496 . . . . 0.0 110.506 179.673 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' F' F ' 69' ' ' VAL . . . . . . . . . . . . . 46.8 t -102.77 116.99 47.47 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.345 0 N-CA-C 109.594 -0.521 . . . . 0.0 109.594 177.808 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' F' F ' 70' ' ' THR . . . . . . . . . . . . . 7.3 t -150.08 -33.86 0.18 Allowed 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.392 -0.367 . . . . 0.0 111.785 -178.831 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' F' F ' 71' ' ' HIS . . . . . . . . . . . . . 64.5 m-70 -111.69 91.44 14.76 Favored Pre-proline 0 CA--C 1.533 0.3 0 CA-C-O 119.462 -0.304 . . . . 0.0 111.152 -176.361 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' F' F ' 72' ' ' PRO . . . . . . . . . . . . . 30.5 Cg_endo -78.26 -23.04 9.21 Favored 'Trans proline' 0 N--CA 1.494 1.508 0 C-N-CA 121.24 1.293 . . . . 0.0 112.743 175.832 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' F' F ' 73' ' ' VAL . . . . . . . . . . . . . 35.6 m -122.83 178.24 3.32 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.219 0 N-CA-C 109.747 -0.464 . . . . 0.0 109.747 177.314 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' F' F ' 74' ' ' ASP . . . . . . . . . . . . . 12.0 t0 -96.43 117.19 30.37 Favored 'General case' 0 C--N 1.332 -0.192 0 C-N-CA 120.743 -0.383 . . . . 0.0 110.065 -176.284 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' F' F ' 75' ' ' VAL . . . . . . . . . . . . . 41.9 t -116.99 122.21 69.54 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.253 0 CA-C-O 120.985 0.421 . . . . 0.0 110.522 -178.043 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' F' F ' 76' ' ' LEU . . . . . . . . . . . . . 6.2 mp -119.85 144.96 47.08 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 115.675 -0.693 . . . . 0.0 109.782 176.51 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' F' F ' 77' ' ' GLU . . . . . . . . . . . . . 46.3 mt-10 -136.11 136.75 40.38 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-O 121.082 0.468 . . . . 0.0 111.351 -179.278 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' F' F ' 78' ' ' ALA . . . . . . . . . . . . . . . -123.97 132.27 53.68 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-N 115.68 -0.691 . . . . 0.0 109.7 175.873 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' F' F ' 79' ' ' LYS . . . . . 0.618 ' O ' HD13 ' F' ' 80' ' ' ILE . 62.1 mttp -81.17 117.37 21.66 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-O 120.925 0.393 . . . . 0.0 110.669 -178.814 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' F' F ' 80' ' ' ILE . . . . . 0.618 HD13 ' O ' ' F' ' 79' ' ' LYS . 40.3 mm -139.04 112.25 6.44 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.37 0 N-CA-C 109.13 -0.693 . . . . 0.0 109.13 -177.002 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' F' F ' 81' ' ' LYS . . . . . . . . . . . . . 79.0 tttt -102.08 127.49 48.96 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-O 120.852 0.358 . . . . 0.0 111.071 -177.668 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' F' F ' 82' ' ' GLY . . . . . . . . . . . . . . . 89.07 42.15 5.69 Favored Glycine 0 CA--C 1.525 0.691 0 C-N-CA 120.872 -0.68 . . . . 0.0 112.037 174.481 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' F' F ' 83' ' ' ILE . . . . . . . . . . . . . 68.7 mt -71.6 136.93 24.73 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.351 0 N-CA-C 109.281 -0.637 . . . . 0.0 109.281 175.684 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' F' F ' 84' ' ' LYS . . . . . . . . . . . . . 27.7 ttpp -94.94 -48.92 5.79 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-O 121.03 0.443 . . . . 0.0 110.047 -178.717 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' F' F ' 85' ' ' ASP . . . . . . . . . . . . . 10.0 t70 -154.57 153.38 31.32 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 115.756 -0.656 . . . . 0.0 110.562 -179.682 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' F' F ' 86' ' ' VAL . . . . . . . . . . . . . 41.9 t -128.98 133.47 66.01 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.202 0 CA-C-O 121.043 0.449 . . . . 0.0 110.243 179.201 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' F' F ' 87' ' ' ILE . . . . . . . . . . . . . 43.9 mm -117.77 123.69 72.04 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.263 0 CA-C-N 115.777 -0.647 . . . . 0.0 109.277 177.21 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' F' F ' 88' ' ' LEU . . . . . . . . . . . . . 14.7 tp -115.02 125.28 53.4 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-O 121.147 0.498 . . . . 0.0 111.44 -175.701 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' F' F ' 89' ' ' ASP . . . . . . . . . . . . . 13.2 t70 -118.4 154.78 31.86 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 115.525 -0.761 . . . . 0.0 109.147 174.185 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' F' F ' 90' ' ' GLU . . . . . . . . . . . . . 96.0 mt-10 -48.7 -39.92 26.35 Favored 'General case' 0 C--N 1.329 -0.302 0 N-CA-C 112.717 0.636 . . . . 0.0 112.717 -172.187 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' F' F ' 91' ' ' ASN . . . . . . . . . . . . . 21.8 p30 -132.15 38.09 3.52 Favored 'General case' 0 N--CA 1.464 0.259 0 CA-C-O 120.815 0.341 . . . . 0.0 111.477 -178.291 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' F' F ' 92' ' ' LEU . . . . . . . . . . . . . 18.4 tp -165.64 137.99 4.15 Favored 'General case' 0 C--N 1.329 -0.298 0 N-CA-C 110.25 -0.278 . . . . 0.0 110.25 -179.996 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' F' F ' 93' ' ' ILE . . . . . . . . . . . . . 71.5 mt -125.02 126.49 71.24 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.23 0 N-CA-C 109.91 -0.404 . . . . 0.0 109.91 -176.956 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' F' F ' 94' ' ' VAL . . . . . 0.472 HG21 HG11 ' F' ' 125' ' ' VAL . 44.0 t -125.05 128.47 73.04 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.207 0 N-CA-C 109.915 -0.402 . . . . 0.0 109.915 178.212 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' F' F ' 95' ' ' VAL . . . . . . . . . . . . . 44.0 t -120.14 133.4 67.0 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.302 0 CA-C-N 116.096 -0.502 . . . . 0.0 109.749 179.001 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' F' F ' 96' ' ' ILE . . . . . . . . . . . . . 64.3 mt -115.66 128.11 73.02 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.293 0 N-CA-C 109.462 -0.57 . . . . 0.0 109.462 179.545 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' F' F ' 97' ' ' THR . . . . . . . . . . . . . 72.7 p -103.74 157.76 16.85 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-O 121.331 0.586 . . . . 0.0 111.516 -176.392 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' F' F ' 98' ' ' GLU . . . . . . . . . . . . . 70.8 mm-40 -53.9 -26.02 23.04 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 115.994 -0.548 . . . . 0.0 112.397 179.709 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' F' F ' 99' ' ' GLU . . . . . . . . . . . . . 36.1 tt0 -79.99 16.99 1.05 Allowed 'General case' 0 CA--C 1.538 0.51 0 N-CA-C 112.588 0.588 . . . . 0.0 112.588 -176.441 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' F' F ' 100' ' ' ASN . . . . . . . . . . . . . 2.6 m-20 60.85 37.76 18.34 Favored 'General case' 0 C--O 1.232 0.165 0 O-C-N 121.761 -0.587 . . . . 0.0 110.95 178.454 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' F' F ' 101' ' ' GLU . . . . . . . . . . . . . 84.2 tt0 -116.37 144.38 44.34 Favored 'General case' 0 C--N 1.331 -0.225 0 CA-C-N 115.99 -0.55 . . . . 0.0 109.679 176.852 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' F' F ' 102' ' ' VAL . . . . . . . . . . . . . 44.6 t -117.63 126.37 74.68 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.357 0 CA-C-N 116.24 -0.436 . . . . 0.0 109.839 -178.257 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' F' F ' 103' ' ' LEU . . . . . . . . . . . . . 40.7 mt -116.39 129.22 56.13 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 115.717 -0.674 . . . . 0.0 110.121 176.692 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' F' F ' 104' ' ' ILE . . . . . . . . . . . . . 72.2 mt -116.62 122.08 69.09 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.257 0 N-CA-C 110.136 -0.32 . . . . 0.0 110.136 -179.596 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' F' F ' 105' ' ' PHE . . . . . . . . . . . . . 58.6 m-85 -121.21 166.38 14.07 Favored 'General case' 0 C--N 1.332 -0.162 0 O-C-N 124.087 0.867 . . . . 0.0 109.837 -178.968 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' F' F ' 106' ' ' ASN . . . . . . . . . . . . . 42.1 p-10 -102.79 -170.83 1.85 Allowed 'General case' 0 C--N 1.331 -0.231 0 N-CA-C 110.011 -0.366 . . . . 0.0 110.011 172.501 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' F' F ' 107' ' ' GLN . . . . . . . . . . . . . 45.4 tt0 -59.58 -30.16 68.46 Favored 'General case' 0 C--N 1.328 -0.358 0 N-CA-C 111.903 0.335 . . . . 0.0 111.903 179.106 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' F' F ' 108' ' ' ASN . . . . . . . . . . . . . 12.3 t-20 -81.84 6.19 16.45 Favored 'General case' 0 CA--C 1.537 0.467 0 N-CA-C 113.221 0.822 . . . . 0.0 113.221 -177.768 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' F' F ' 109' ' ' LEU . . . . . . . . . . . . . 9.7 tp 61.6 36.82 16.59 Favored 'General case' 0 CA--C 1.53 0.178 0 CA-C-O 120.905 0.383 . . . . 0.0 111.369 178.816 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' F' F ' 110' ' ' GLU . . . . . . . . . . . . . 43.0 mt-10 -106.36 158.44 16.88 Favored 'General case' 0 C--N 1.33 -0.264 0 N-CA-C 109.623 -0.51 . . . . 0.0 109.623 175.805 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' F' F ' 111' ' ' GLU . . . . . . . . . . . . . 44.1 mp0 -87.07 121.97 30.26 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-O 121.106 0.479 . . . . 0.0 111.212 -177.985 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' F' F ' 112' ' ' LEU . . . . . . . . . . . . . 42.9 mt -101.19 -45.95 5.2 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 115.611 -0.722 . . . . 0.0 110.095 175.768 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' F' F ' 113' ' ' TYR . . . . . . . . . . . . . 64.3 t80 -141.79 137.28 31.44 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.049 -0.523 . . . . 0.0 111.613 -178.054 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' F' F ' 114' ' ' ARG . . . . . . . . . . . . . 92.3 mtt180 -129.06 123.65 32.84 Favored 'General case' 0 C--N 1.331 -0.23 0 N-CA-C 109.3 -0.63 . . . . 0.0 109.3 175.245 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' F' F ' 115' ' ' GLY . . . . . . . . . . . . . . . -150.06 157.68 27.33 Favored Glycine 0 CA--C 1.525 0.661 0 C-N-CA 120.447 -0.882 . . . . 0.0 111.807 -179.835 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' F' F ' 116' ' ' LYS . . . . . . . . . . . . . 39.7 ttpt -128.72 140.7 51.61 Favored 'General case' 0 C--N 1.33 -0.263 0 N-CA-C 109.848 -0.427 . . . . 0.0 109.848 176.695 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' F' F ' 117' ' ' PHE . . . . . . . . . . . . . 47.2 m-85 -139.56 114.28 9.33 Favored 'General case' 0 C--N 1.329 -0.283 0 C-N-CA 120.836 -0.346 . . . . 0.0 110.334 -178.257 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' F' F ' 118' ' ' GLU . . . . . . . . . . . . . 84.4 tt0 -53.58 -45.87 70.13 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.523 -0.308 . . . . 0.0 111.405 -176.489 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' F' F ' 119' ' ' ASN . . . . . . . . . . . . . 85.4 m-20 -97.51 31.03 2.66 Favored 'General case' 0 C--N 1.331 -0.22 0 N-CA-C 112.182 0.438 . . . . 0.0 112.182 -174.86 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' F' F ' 120' ' ' LEU . . . . . . . . . . . . . 22.8 tp -57.51 120.44 8.28 Favored 'General case' 0 C--N 1.332 -0.174 0 CA-C-O 120.638 0.256 . . . . 0.0 110.326 178.146 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' F' F ' 121' ' ' ASN . . . . . . . . . . . . . 35.1 m120 -114.13 -44.13 3.17 Favored 'General case' 0 C--N 1.332 -0.188 0 CA-C-N 116.62 -0.263 . . . . 0.0 111.159 -177.521 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' F' F ' 122' ' ' LYS . . . . . . . . . . . . . 92.8 mttt -144.43 150.16 37.23 Favored 'General case' 0 C--N 1.332 -0.189 0 C-N-CA 120.598 -0.441 . . . . 0.0 111.646 -177.448 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' F' F ' 123' ' ' VAL . . . . . . . . . . . . . 42.5 t -132.91 129.32 57.76 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.267 0 N-CA-C 109.526 -0.546 . . . . 0.0 109.526 174.044 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' F' F ' 124' ' ' LEU . . . . . . . . . . . . . 80.4 mt -127.92 144.28 51.1 Favored 'General case' 0 C--N 1.331 -0.209 0 CA-C-O 120.754 0.311 . . . . 0.0 111.23 -176.87 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' F' F ' 125' ' ' VAL . . . . . 0.63 HG12 HG23 ' F' ' 130' ' ' VAL . 34.6 m -132.49 143.95 38.3 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.182 0 CA-C-N 116.173 -0.467 . . . . 0.0 111.18 -179.584 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' F' F ' 126' ' ' ARG . . . . . . . . . . . . . 76.7 mtp85 -145.58 116.49 7.78 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 116.006 -0.543 . . . . 0.0 110.408 176.406 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' F' F ' 127' ' ' ASN . . . . . . . . . . . . . 88.2 m-20 51.52 -104.84 0.19 Allowed 'General case' 0 CA--C 1.544 0.729 0 CA-C-O 119.087 -0.483 . . . . 0.0 111.283 179.824 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' F' F ' 128' ' ' ASP . . . . . . . . . . . . . 11.7 p-10 -114.03 0.19 14.25 Favored 'General case' 0 N--CA 1.468 0.463 0 CA-C-N 119.619 1.1 . . . . 0.0 113.318 -178.079 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' F' F ' 129' ' ' LEU . . . . . . . . . . . . . 17.2 tp -104.93 140.32 38.34 Favored 'General case' 0 C--N 1.332 -0.187 0 N-CA-C 109.565 -0.531 . . . . 0.0 109.565 178.463 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' F' F ' 130' ' ' VAL . . . . . 0.63 HG23 HG12 ' F' ' 125' ' ' VAL . 13.1 p -133.71 143.37 38.91 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.236 0 CA-C-O 121.257 0.551 . . . . 0.0 110.663 -179.357 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' F' F ' 131' ' ' VAL . . . . . 0.498 HG22 HD12 ' F' ' 140' ' ' LEU . 43.4 t -134.67 138.86 48.76 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.259 0 CA-C-N 115.766 -0.652 . . . . 0.0 110.162 -179.372 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' F' F ' 132' ' ' ILE . . . . . . . . . . . . . 69.5 mt -115.26 133.02 62.83 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.345 0 CA-C-N 115.625 -0.716 . . . . 0.0 109.078 179.003 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' F' F ' 133' ' ' ILE . . . . . . . . . . . . . 41.5 mm -117.13 123.55 71.95 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.211 0 CA-C-O 120.727 0.299 . . . . 0.0 110.949 -174.664 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' F' F ' 134' ' ' ASP . . . . . . . . . . . . . 8.1 p-10 -136.68 147.24 46.71 Favored 'General case' 0 C--N 1.331 -0.202 0 N-CA-C 109.654 -0.498 . . . . 0.0 109.654 174.13 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' F' F ' 135' ' ' GLU . . . . . . . . . . . . . 38.6 tp10 -49.89 -26.42 4.08 Favored 'General case' 0 C--N 1.328 -0.334 0 N-CA-C 112.709 0.633 . . . . 0.0 112.709 -172.348 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' F' F ' 136' ' ' GLN . . . . . . . . . . . . . 65.5 tp60 -81.9 -39.07 24.36 Favored 'General case' 0 C--O 1.233 0.21 0 N-CA-C 112.077 0.399 . . . . 0.0 112.077 -176.764 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' F' F ' 137' ' ' LYS . . . . . . . . . . . . . 50.4 pttt -161.48 172.24 16.78 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-O 121.484 0.659 . . . . 0.0 112.2 -171.303 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' F' F ' 138' ' ' LEU . . . . . 0.4 ' C ' HD23 ' F' ' 138' ' ' LEU . 7.2 tt -119.58 129.82 54.83 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 115.111 -0.949 . . . . 0.0 109.664 178.584 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' F' F ' 139' ' ' THR . . . . . . . . . . . . . 21.6 m -109.34 126.64 53.6 Favored 'General case' 0 C--N 1.331 -0.21 0 CA-C-N 116.24 -0.436 . . . . 0.0 110.4 -179.677 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' F' F ' 140' ' ' LEU . . . . . 0.498 HD12 HG22 ' F' ' 131' ' ' VAL . 25.6 tp -112.09 120.06 40.56 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 115.73 -0.668 . . . . 0.0 109.417 -178.665 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' F' F ' 141' ' ' ILE . . . . . 0.499 ' HB ' HG13 ' F' ' 130' ' ' VAL . 19.5 mt -120.91 122.95 69.11 Favored 'Isoleucine or valine' 0 C--O 1.235 0.307 0 CA-C-O 121.022 0.439 . . . . 0.0 110.108 -175.591 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' F' F ' 142' ' ' ARG . . . . . . . . . . . . . 76.9 mtt180 -113.24 131.96 55.7 Favored 'General case' 0 C--O 1.233 0.206 0 CA-C-N 115.302 -0.863 . . . . 0.0 109.961 -175.969 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' F' F ' 143' ' ' THR . . . . . . . . . . . . . 52.0 p . . . . . 0 C--O 1.221 -0.418 0 CA-C-O 118.024 -0.989 . . . . 0.0 110.408 178.275 . . . . . . . . 0 0 . 1 . 001 nuclear nobuild core ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 1.9 p . . . . . 0 C--O 1.231 0.125 0 CA-C-O 120.942 0.401 . . . . 18.2 110.564 . . . . . . . . . 0 0 . 1 . 001 nuclear nobuild core ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 84.7 tt0 -143.85 141.64 30.43 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 116.023 -0.535 . . . . 15.68 111.114 -179.308 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 4' ' ' LEU . . . . . . . . . . . . . 19.0 tp -122.62 127.84 49.89 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-N 116.019 -0.537 . . . . 13.41 110.087 177.485 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 5' ' ' LYS . . . . . . . . . . . . . 72.6 mttt -109.81 121.44 45.23 Favored 'General case' 0 C--O 1.234 0.246 0 CA-C-O 120.916 0.389 . . . . 11.98 110.709 178.94 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 31.1 mt -114.33 149.18 36.41 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 115.205 -0.907 . . . . 10.99 110.371 -178.719 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 19.5 ttmm -133.85 139.41 33.35 Favored Pre-proline 0 CA--C 1.536 0.418 0 CA-C-O 119.095 -0.479 . . . . 9.31 109.799 175.17 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 8' ' ' PRO . . . . . . . . . . . . . 90.3 Cg_endo -91.82 134.47 1.49 Allowed 'Trans proline' 0 N--CA 1.49 1.293 0 C-N-CA 121.718 1.612 . . . . 9.35 111.649 177.427 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 59.0 mt -71.78 -46.54 12.3 Favored Pre-proline 0 C--N 1.329 -0.295 0 CA-C-O 118.723 -0.656 . . . . 13.42 111.838 -179.703 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 92.4 Cg_endo -80.47 146.85 17.5 Favored 'Trans proline' 0 N--CA 1.494 1.556 0 C-N-CA 121.077 1.185 . . . . 13.21 111.582 173.071 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 93.4 mttt -87.09 92.21 8.97 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-O 120.872 0.367 . . . . 12.71 110.561 -179.942 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 12.4 p -138.63 143.74 31.6 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.292 0 CA-C-N 116.111 -0.495 . . . . 13.83 110.414 179.672 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 94.8 mt-10 -82.24 131.35 35.23 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.298 -0.41 . . . . 13.84 110.126 178.055 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 14' ' ' LEU . . . . . . . . . . . . . 30.8 mt -93.92 150.32 38.38 Favored Pre-proline 0 C--N 1.328 -0.328 0 CA-C-N 116.358 -0.383 . . . . 13.0 110.164 -179.483 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 15' ' ' PRO . . . . . . . . . . . . . 39.2 Cg_exo -57.9 159.92 16.59 Favored 'Trans proline' 0 N--CA 1.497 1.684 0 C-N-CA 121.213 1.275 . . . . 15.42 111.624 179.515 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 16' ' ' PRO . . . . . . . . . . . . . 39.7 Cg_exo -58.54 -39.78 80.12 Favored 'Trans proline' 0 N--CA 1.497 1.698 0 C-N-CA 121.479 1.453 . . . . 16.07 112.866 -177.39 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 17' ' ' ASP . . . . . . . . . . . . . 19.5 p-10 -88.4 9.11 24.61 Favored 'General case' 0 C--N 1.326 -0.415 0 N-CA-C 113.22 0.822 . . . . 16.69 113.22 -178.168 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 18' ' ' PHE . . . . . . . . . . . . . 50.3 t80 -58.27 -48.05 81.68 Favored 'General case' 0 N--CA 1.457 -0.103 0 O-C-N 121.91 -0.494 . . . . 13.52 110.19 -176.316 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 19' ' ' VAL . . . . . . . . . . . . . 46.4 t -54.8 -47.95 73.93 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.345 0 CA-C-N 116.446 -0.343 . . . . 12.65 111.167 -175.077 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 2.6 p30 -62.71 -38.24 89.65 Favored 'General case' 0 C--N 1.332 -0.175 0 C-N-CA 120.572 -0.451 . . . . 15.76 111.336 -176.245 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 54.7 t -64.34 -46.79 92.09 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.181 0 C-N-CA 120.582 -0.447 . . . . 15.45 110.213 -179.775 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 22' ' ' ILE . . . . . 0.615 HG22 HD12 ' A' ' 26' ' ' LEU . 51.6 mm -56.71 -45.26 82.72 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.248 0 C-N-CA 121.036 -0.266 . . . . 13.87 110.454 178.96 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 23' ' ' ARG . . . . . . . . . . . . . 59.5 ttp180 -53.98 -48.43 70.36 Favored 'General case' 0 C--N 1.329 -0.295 0 C-N-CA 121.179 -0.208 . . . . 16.33 111.32 -179.273 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 24' ' ' ILE . . . . . . . . . . . . . 76.1 mt -58.97 -46.58 91.47 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.339 0 C-N-CA 120.877 -0.329 . . . . 17.1 110.86 -177.965 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 99.6 mttt -64.25 -38.08 89.77 Favored 'General case' 0 C--N 1.329 -0.324 0 N-CA-C 112.546 0.572 . . . . 16.69 112.546 -177.948 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 26' ' ' LEU . . . . . 0.615 HD12 HG22 ' A' ' 22' ' ' ILE . 49.7 mt -77.89 -41.6 36.09 Favored 'General case' 0 C--N 1.33 -0.247 0 N-CA-C 113.093 0.775 . . . . 16.62 113.093 -172.015 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 27' ' ' GLN . . . . . . . . . . . . . 14.3 pt20 -47.69 139.35 7.33 Favored 'General case' 0 N--CA 1.468 0.462 0 N-CA-C 112.77 0.656 . . . . 18.08 112.77 -174.426 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 100.29 -24.11 33.35 Favored Glycine 0 CA--C 1.535 1.287 0 CA-C-N 115.532 -0.758 . . . . 19.92 112.259 -175.698 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 98.0 mttt -97.78 155.19 17.14 Favored 'General case' 0 C--O 1.233 0.228 0 CA-C-N 117.369 0.585 . . . . 19.41 110.993 178.568 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 30' ' ' THR . . . . . . . . . . . . . 29.5 m -104.01 139.2 39.46 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 115.907 -0.588 . . . . 20.61 110.034 176.141 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 34.8 m -126.34 150.58 32.06 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.221 0 CA-C-N 116.408 -0.36 . . . . 17.93 110.719 -178.997 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 32' ' ' ARG . . . . . . . . . . . . . 32.4 ttm105 -134.94 147.33 49.75 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-O 121.16 0.505 . . . . 23.02 110.31 177.519 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 33' ' ' THR . . . . . . . . . . . . . 15.9 m -52.18 137.93 27.07 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.214 -0.448 . . . . 17.9 111.534 -177.355 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 100.71 -17.0 57.13 Favored Glycine 0 CA--C 1.532 1.147 0 CA-C-O 119.663 -0.52 . . . . 17.01 113.301 178.819 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 78.6 m-20 -65.8 147.8 52.8 Favored 'General case' 0 N--CA 1.462 0.146 0 CA-C-N 118.022 0.911 . . . . 18.86 111.125 179.135 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 44.8 t -123.25 129.76 74.7 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.173 0 CA-C-N 115.927 -0.579 . . . . 17.24 109.852 177.888 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 37' ' ' ILE . . . . . . . . . . . . . 65.0 mt -122.57 139.02 50.74 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.279 0 CA-C-N 116.345 -0.389 . . . . 15.76 109.961 -179.749 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . -112.9 128.79 8.59 Favored Glycine 0 CA--C 1.527 0.787 0 N-CA-C 111.013 -0.835 . . . . 17.43 111.013 179.281 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 39' ' ' ILE . . . . . . . . . . . . . 76.7 mt -123.9 136.25 60.89 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.22 0 N-CA-C 109.994 -0.373 . . . . 17.07 109.994 179.046 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 40' ' ' SER . . . . . . . . . . . . . 34.5 t -91.91 118.16 30.48 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-O 120.696 0.284 . . . . 20.45 111.09 178.181 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 41' ' ' ILE . . . . . . . . . . . . . 45.2 mm -120.93 116.71 50.67 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.237 0 CA-C-N 116.283 -0.417 . . . . 18.94 110.23 178.881 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 7.5 mp 50.92 35.62 12.95 Favored 'General case' 0 N--CA 1.464 0.228 0 CA-C-N 116.345 -0.389 . . . . 21.68 111.751 177.708 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . 76.05 31.13 56.2 Favored Glycine 0 CA--C 1.529 0.946 0 C-N-CA 121.082 -0.58 . . . . 22.22 112.274 177.57 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 44' ' ' LYS . . . . . . . . . . . . . 59.6 tttp -136.64 129.11 30.22 Favored 'General case' 0 C--N 1.33 -0.262 0 N-CA-C 109.484 -0.561 . . . . 20.38 109.484 176.862 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 82.1 tt0 -81.73 115.08 20.8 Favored 'General case' 0 C--N 1.329 -0.324 0 C-N-CA 120.75 -0.38 . . . . 20.21 110.663 -178.22 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 46' ' ' VAL . . . . . . . . . . . . . 6.8 p -110.86 125.17 68.16 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.24 0 N-CA-C 109.061 -0.718 . . . . 16.13 109.061 175.967 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 9.5 mtmp? -99.9 125.61 45.91 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 115.702 -0.681 . . . . 18.68 111.282 -178.568 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 48' ' ' PHE . . . . . . . . . . . . . 96.0 m-85 -111.26 131.9 54.78 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-N 116.188 -0.46 . . . . 13.1 109.899 177.268 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 49.1 tttm -108.31 139.07 43.55 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.357 -0.383 . . . . 14.45 110.513 178.941 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 50' ' ' VAL . . . . . . . . . . . . . 44.2 t -82.46 111.47 18.9 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.298 0 N-CA-C 109.505 -0.554 . . . . 13.58 109.505 176.683 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 51' ' ' VAL . . . . . . . . . . . . . 45.9 t -77.74 -46.54 26.98 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.321 0 CA-C-N 116.129 -0.487 . . . . 13.24 110.27 -174.014 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 52' ' ' GLN . . . . . . . . . . . . . 59.9 tt0 -157.82 135.35 10.43 Favored 'General case' 0 C--N 1.33 -0.276 0 C-N-CA 120.413 -0.515 . . . . 15.29 111.526 -177.0 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -113.2 118.78 35.63 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 115.401 -0.818 . . . . 16.95 109.596 173.497 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 54' ' ' TYR . . . . . . . . . . . . . 16.9 t80 -116.91 107.14 46.53 Favored Pre-proline 0 CA--C 1.534 0.351 0 CA-C-O 118.246 -0.883 . . . . 21.06 110.613 -177.757 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 55' ' ' PRO . . . . . . . . . . . . . 73.0 Cg_endo -76.98 169.98 72.96 Favored 'Cis proline' 0 N--CA 1.499 1.828 0 CA-C-N 121.758 1.664 . . . . 20.7 112.605 -3.775 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 56' ' ' SER . . . . . . . . . . . . . 13.6 m -105.2 117.73 57.7 Favored Pre-proline 0 CA--C 1.538 0.513 0 CA-C-O 118.41 -0.805 . . . . 21.83 109.546 176.92 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 57' ' ' PRO . . . . . . . . . . . . . 72.1 Cg_endo -77.84 171.05 68.85 Favored 'Cis proline' 0 N--CA 1.495 1.604 0 CA-C-N 121.968 1.738 . . . . 22.39 112.422 2.164 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 58' ' ' LEU . . . . . . . . . . . . . 25.6 tp -128.18 138.14 52.35 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 115.789 -0.641 . . . . 18.81 110.348 -178.735 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 59' ' ' ARG . . . . . . . . . . . . . 59.9 ttt85 -101.12 129.74 47.06 Favored 'General case' 0 C--N 1.326 -0.419 0 CA-C-N 115.949 -0.569 . . . . 22.37 109.549 176.441 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 42.1 t -88.79 116.7 30.86 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.229 0 C-N-CA 120.572 -0.451 . . . . 17.4 110.496 -176.631 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 94.8 mt-10 -131.14 168.76 16.9 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 115.967 -0.56 . . . . 20.44 109.581 174.953 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 62' ' ' ASP . . . . . . . . . . . . . 2.1 m-20 -53.91 -34.34 59.25 Favored 'General case' 0 C--N 1.329 -0.312 0 C-N-CA 121.046 -0.262 . . . . 18.68 111.693 -177.783 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 63' ' ' ARG . . . . . . . . . . . . . 28.2 mmm180 -73.87 -17.65 61.02 Favored 'General case' 0 CA--C 1.533 0.313 0 N-CA-C 113.234 0.827 . . . . 22.37 113.234 -176.169 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 18.0 m -69.94 141.72 53.02 Favored 'General case' 0 C--N 1.332 -0.191 0 CA-C-O 120.838 0.351 . . . . 16.58 111.014 -174.887 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 65' ' ' LYS . . . . . . . . . . . . . 93.8 mttt -88.5 132.66 34.41 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.098 -0.501 . . . . 17.07 109.988 178.732 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 66' ' ' ILE . . . . . . . . . . . . . 53.7 mt -117.56 131.91 68.9 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.233 0 N-CA-C 110.012 -0.366 . . . . 12.48 110.012 179.921 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 67' ' ' THR . . . . . . . . . . . . . 18.8 m -130.96 135.86 48.03 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-O 121.011 0.434 . . . . 10.9 110.788 178.796 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 68' ' ' LEU . . . . . 0.497 ' N ' HD12 ' A' ' 68' ' ' LEU . 6.7 mp . . . . . 0 C--N 1.329 -0.314 0 CA-C-N 116.124 -0.489 . . . . 8.22 110.43 176.685 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 74' ' ' ASP . . . . . . . . . . . . . 29.6 t70 . . . . . 0 C--O 1.231 0.115 0 N-CA-C 110.217 -0.29 . . . . 0.96 110.217 . . . . . . . . . 0 0 . 1 . 001 nuclear nobuild core ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 44.7 t -112.72 122.7 67.39 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.228 0 CA-C-O 121.148 0.499 . . . . 0.71 110.243 -179.551 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 76' ' ' LEU . . . . . . . . . . . . . 36.0 mt -124.12 139.24 54.13 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 115.56 -0.745 . . . . 1.13 109.403 177.802 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 77' ' ' GLU . . . . . . . . . . . . . 96.8 mt-10 -129.99 142.24 50.66 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-O 121.136 0.493 . . . . 1.42 111.142 -177.224 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 78' ' ' ALA . . . . . . . . . . . . . . . -131.64 136.56 47.83 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 115.479 -0.782 . . . . 0.57 109.937 177.334 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 79' ' ' LYS . . . . . 0.58 ' O ' HD13 ' A' ' 80' ' ' ILE . 38.0 tttp -81.23 119.57 23.79 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-O 120.91 0.386 . . . . 2.96 110.939 -176.537 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 80' ' ' ILE . . . . . 0.58 HD13 ' O ' ' A' ' 79' ' ' LYS . 42.0 mm -139.13 108.45 3.8 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.324 0 N-CA-C 109.089 -0.708 . . . . 0.56 109.089 -178.347 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 81' ' ' LYS . . . . . . . . . . . . . 37.9 tttp -102.78 125.44 49.52 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-O 120.95 0.405 . . . . 2.85 111.114 -176.818 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . 89.01 42.13 5.71 Favored Glycine 0 CA--C 1.526 0.757 0 C-N-CA 121.057 -0.592 . . . . 0.57 111.93 174.993 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 83' ' ' ILE . . . . . . . . . . . . . 72.2 mt -68.14 136.35 26.68 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 N-CA-C 109.641 -0.503 . . . . 0.55 109.641 177.01 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 84' ' ' LYS . . . . . . . . . . . . . 40.2 ttpt -104.93 -46.94 4.15 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.35 -0.387 . . . . 1.44 110.306 -178.432 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 85' ' ' ASP . . . . . . . . . . . . . 20.7 t70 -149.49 148.48 29.46 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.068 -0.514 . . . . 0.79 110.455 179.319 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 86' ' ' VAL . . . . . . . . . . . . . 43.2 t -130.89 133.31 63.24 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.227 0 CA-C-O 120.955 0.407 . . . . 0.54 110.375 -179.887 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 87' ' ' ILE . . . . . . . . . . . . . 45.1 mm -120.55 127.74 75.95 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.231 0 CA-C-N 115.821 -0.627 . . . . 1.41 109.781 178.537 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 88' ' ' LEU . . . . . . . . . . . . . 54.5 mt -107.82 135.49 49.14 Favored 'General case' 0 C--N 1.331 -0.221 0 CA-C-N 116.276 -0.42 . . . . 1.56 110.974 -179.659 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 89' ' ' ASP . . . . . . . . . . . . . 12.2 t70 -130.78 155.48 46.6 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.005 -0.543 . . . . 0.97 109.655 176.988 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 96.8 mt-10 -48.69 -36.35 15.95 Favored 'General case' 0 C--N 1.329 -0.3 0 N-CA-C 112.818 0.673 . . . . 2.49 112.818 -171.478 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 91' ' ' ASN . . . . . . . . . . . . . 12.6 t-20 -131.99 22.2 4.54 Favored 'General case' 0 N--CA 1.468 0.452 0 N-CA-C 112.781 0.659 . . . . 2.35 112.781 -177.572 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 92' ' ' LEU . . . . . . . . . . . . . 23.1 mt -150.06 147.1 27.4 Favored 'General case' 0 C--N 1.332 -0.153 0 CA-C-O 120.799 0.333 . . . . 1.35 110.395 -177.348 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 93' ' ' ILE . . . . . . . . . . . . . 70.6 mt -124.24 117.94 52.24 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.272 0 N-CA-C 109.104 -0.702 . . . . 0.52 109.104 175.964 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 94' ' ' VAL . . . . . . . . . . . . . 46.4 t -118.96 127.08 75.82 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.268 0 CA-C-O 120.91 0.386 . . . . 0.46 110.028 -178.427 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 95' ' ' VAL . . . . . . . . . . . . . 43.7 t -120.88 132.7 69.72 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.308 0 CA-C-N 115.945 -0.571 . . . . 0.42 109.733 179.912 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 96' ' ' ILE . . . . . . . . . . . . . 67.5 mt -114.21 126.94 71.83 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.24 0 N-CA-C 109.215 -0.661 . . . . 0.51 109.215 178.859 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 97' ' ' THR . . . . . . . . . . . . . 69.6 p -102.6 155.64 18.15 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-O 121.241 0.543 . . . . 0.53 111.228 -176.41 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 98' ' ' GLU . . . . . . . . . . . . . 48.6 mt-10 -54.27 -23.54 15.32 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.017 -0.538 . . . . 2.42 112.275 178.279 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 99' ' ' GLU . . . . . . . . . . . . . 95.0 mt-10 -76.82 13.28 1.07 Allowed 'General case' 0 CA--C 1.536 0.406 0 N-CA-C 113.24 0.829 . . . . 2.34 113.24 -178.278 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 100' ' ' ASN . . . . . . . . . . . . . 1.7 m120 64.35 36.28 9.2 Favored 'General case' 0 CA--C 1.53 0.19 0 CA-C-O 120.944 0.402 . . . . 0.6 110.922 177.545 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 101' ' ' GLU . . . . . . . . . . . . . 84.3 tt0 -122.43 143.93 49.37 Favored 'General case' 0 C--N 1.333 -0.139 0 CA-C-N 116.239 -0.437 . . . . 0.54 109.916 178.586 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 102' ' ' VAL . . . . . . . . . . . . . 45.4 t -115.09 126.79 72.77 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.231 0 N-CA-C 109.811 -0.441 . . . . 0.41 109.811 -179.713 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 103' ' ' LEU . . . . . . . . . . . . . 27.6 mt -114.69 130.11 56.77 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 115.723 -0.671 . . . . 0.77 110.051 177.308 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 104' ' ' ILE . . . . . . . . . . . . . 72.4 mt -116.63 121.44 67.67 Favored 'Isoleucine or valine' 0 C--O 1.234 0.279 0 CA-C-N 116.552 -0.295 . . . . 0.43 110.321 -179.193 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 105' ' ' PHE . . . . . . . . . . . . . 88.3 m-85 -120.9 161.26 21.86 Favored 'General case' 0 C--N 1.333 -0.134 0 O-C-N 123.953 0.783 . . . . 0.48 109.884 -179.856 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 106' ' ' ASN . . . . . . . . . . . . . 39.0 p30 -95.87 -173.19 2.77 Favored 'General case' 0 C--N 1.33 -0.276 0 N-CA-C 110.065 -0.346 . . . . 0.63 110.065 175.314 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 107' ' ' GLN . . . . . . . . . . . . . 61.1 tt0 -60.17 -30.06 69.09 Favored 'General case' 0 C--N 1.329 -0.29 0 N-CA-C 111.936 0.347 . . . . 1.47 111.936 -179.98 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 108' ' ' ASN . . . . . . . . . . . . . 50.7 t30 -82.33 8.66 10.71 Favored 'General case' 0 CA--C 1.537 0.446 0 N-CA-C 113.043 0.757 . . . . 1.35 113.043 -177.831 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 109' ' ' LEU . . . . . . . . . . . . . 13.0 tp 61.47 39.83 14.53 Favored 'General case' 0 C--O 1.233 0.193 0 CA-C-O 121.324 0.583 . . . . 1.14 110.975 179.229 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 110' ' ' GLU . . . . . . . . . . . . . 95.2 mt-10 -109.97 152.2 26.17 Favored 'General case' 0 C--N 1.33 -0.244 0 N-CA-C 109.532 -0.544 . . . . 1.92 109.532 175.535 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 111' ' ' GLU . . . . . . . . . . . . . 81.2 tt0 -88.02 122.3 31.45 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-O 120.828 0.347 . . . . 1.78 110.941 -175.555 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 112' ' ' LEU . . . . . . . . . . . . . 51.8 mt -106.09 -46.1 4.17 Favored 'General case' 0 C--N 1.332 -0.186 0 CA-C-N 116.14 -0.482 . . . . 0.56 111.139 179.539 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 113' ' ' TYR . . . . . . . . . . . . . 61.4 t80 -136.76 138.23 40.71 Favored 'General case' 0 C--N 1.331 -0.213 0 CA-C-O 120.912 0.386 . . . . 0.5 111.545 -176.148 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 114' ' ' ARG . . . . . . . . . . . . . 38.9 ttm180 -132.54 122.89 25.52 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 115.878 -0.601 . . . . 2.76 109.773 175.612 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 115' ' ' GLY . . . . . . . . . . . . . . . -150.1 138.62 6.84 Favored Glycine 0 CA--C 1.523 0.543 0 N-CA-C 111.07 -0.812 . . . . 0.43 111.07 178.779 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 116' ' ' LYS . . . . . . . . . . . . . 34.0 ttmt -114.95 140.22 49.19 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-O 120.818 0.342 . . . . 1.57 110.079 177.256 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 117' ' ' PHE . . . . . . . . . . . . . 32.4 m-85 -136.89 114.93 11.49 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.147 -0.479 . . . . 0.49 109.892 -176.724 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 118' ' ' GLU . . . . . . . . . . . . . 84.2 tt0 -51.39 -49.4 61.61 Favored 'General case' 0 C--N 1.328 -0.358 0 N-CA-C 111.869 0.322 . . . . 2.77 111.869 -176.221 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 119' ' ' ASN . . . . . . . . . . . . . 97.7 m-20 -98.07 31.29 2.77 Favored 'General case' 0 C--N 1.328 -0.335 0 N-CA-C 112.221 0.452 . . . . 1.35 112.221 -174.321 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 120' ' ' LEU . . . . . . . . . . . . . 21.8 tp -54.57 120.74 7.12 Favored 'General case' 0 N--CA 1.463 0.19 0 O-C-N 122.243 -0.286 . . . . 0.56 110.71 178.727 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 121' ' ' ASN . . . . . . . . . . . . . 85.9 m-20 -113.81 -44.0 3.22 Favored 'General case' 0 C--N 1.332 -0.181 0 CA-C-N 116.459 -0.337 . . . . 1.74 111.07 -176.465 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 122' ' ' LYS . . . . . . . . . . . . . 84.9 mttt -142.93 145.3 32.9 Favored 'General case' 0 C--N 1.331 -0.227 0 CA-C-O 121.148 0.499 . . . . 1.94 111.705 -178.129 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 123' ' ' VAL . . . . . . . . . . . . . 46.4 t -121.8 122.57 67.21 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.249 0 N-CA-C 108.978 -0.749 . . . . 0.55 108.978 173.363 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 124' ' ' LEU . . . . . 0.511 HD12 ' N ' ' A' ' 124' ' ' LEU . 6.8 mp -108.9 122.97 48.32 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 116.272 -0.422 . . . . 1.63 110.349 -177.301 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 125' ' ' VAL . . . . . . . . . . . . . 44.2 t -126.16 125.37 67.69 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.307 0 N-CA-C 109.608 -0.516 . . . . 1.58 109.608 178.825 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 126' ' ' ARG . . . . . . . . . . . . . 81.2 mtt-85 -143.94 123.84 13.5 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-O 121.045 0.45 . . . . 3.09 110.774 -179.535 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 127' ' ' ASN . . . . . . . . . . . . . 18.9 t-20 50.91 -105.23 0.19 Allowed 'General case' 0 CA--C 1.543 0.709 0 CA-C-O 118.965 -0.54 . . . . 2.33 111.398 179.764 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 128' ' ' ASP . . . . . . . . . . . . . 9.1 p-10 -114.16 -1.51 13.65 Favored 'General case' 0 CA--C 1.537 0.452 0 CA-C-N 119.697 1.135 . . . . 1.17 113.522 -177.425 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 129' ' ' LEU . . . . . . . . . . . . . 79.3 mt -105.58 144.24 32.62 Favored 'General case' 0 C--O 1.232 0.162 0 CA-C-N 118.207 0.458 . . . . 1.96 110.876 -177.398 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 130' ' ' VAL . . . . . . . . . . . . . 45.1 t -127.35 134.99 64.6 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.169 0 CA-C-O 121.075 0.464 . . . . 1.37 110.251 -179.354 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 131' ' ' VAL . . . . . 0.455 HG22 HD12 ' A' ' 140' ' ' LEU . 45.5 t -133.02 135.35 57.04 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.287 0 CA-C-N 116.088 -0.505 . . . . 1.07 109.906 177.517 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 132' ' ' ILE . . . . . . . . . . . . . 68.5 mt -113.46 131.17 65.97 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.304 0 N-CA-C 109.381 -0.6 . . . . 0.42 109.381 -179.976 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 133' ' ' ILE . . . . . . . . . . . . . 41.9 mm -118.55 120.77 65.26 Favored 'Isoleucine or valine' 0 C--O 1.233 0.22 0 CA-C-O 120.954 0.407 . . . . 0.5 111.111 -175.384 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 134' ' ' ASP . . . . . . . . . . . . . 3.6 p30 -135.59 146.73 48.26 Favored 'General case' 0 C--N 1.332 -0.196 0 N-CA-C 109.362 -0.607 . . . . 0.55 109.362 173.19 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 135' ' ' GLU . . . . . . . . . . . . . 85.9 tt0 -49.88 -23.76 2.1 Favored 'General case' 0 C--N 1.326 -0.454 0 N-CA-C 112.85 0.685 . . . . 2.04 112.85 -172.658 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 136' ' ' GLN . . . . . . . . . . . . . 52.0 mt-30 -87.57 -36.27 17.65 Favored 'General case' 0 C--O 1.234 0.251 0 N-CA-C 112.586 0.587 . . . . 2.11 112.586 -176.203 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 137' ' ' LYS . . . . . . . . . . . . . 40.7 pttt -157.44 167.45 30.18 Favored 'General case' 0 C--N 1.331 -0.197 0 CA-C-O 121.514 0.673 . . . . 1.56 112.277 -172.87 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 138' ' ' LEU . . . . . 0.415 HD23 ' N ' ' A' ' 139' ' ' THR . 6.1 tt -121.31 128.74 52.62 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 115.084 -0.962 . . . . 0.97 109.701 178.006 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 139' ' ' THR . . . . . 0.415 ' N ' HD23 ' A' ' 138' ' ' LEU . 28.6 m -111.78 129.9 55.98 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.41 -0.359 . . . . 0.44 110.46 -179.411 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 140' ' ' LEU . . . . . 0.455 HD12 HG22 ' A' ' 131' ' ' VAL . 21.6 tp -111.75 118.82 36.64 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 115.679 -0.691 . . . . 1.03 109.165 179.734 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 141' ' ' ILE . . . . . . . . . . . . . 19.5 mt -119.09 118.02 56.22 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.314 0 N-CA-C 109.569 -0.53 . . . . 0.5 109.569 -176.794 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 142' ' ' ARG . . . . . . . . . . . . . 49.5 ttp180 -110.84 124.81 52.78 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 115.354 -0.839 . . . . 2.87 110.174 -176.6 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 143' ' ' THR . . . . . . . . . . . . . 27.6 p . . . . . 0 C--O 1.219 -0.525 0 CA-C-O 117.977 -1.011 . . . . 1.48 110.6 -179.242 . . . . . . . . 0 0 . 1 . 001 nuclear nobuild core ' B' B ' 2' ' ' SER . . . . . . . . . . . . . 2.0 p . . . . . 0 C--O 1.232 0.183 0 CA-C-O 121.125 0.488 . . . . 19.08 110.598 . . . . . . . . . 0 0 . 1 . 001 nuclear nobuild core ' B' B ' 3' ' ' GLU . . . . . . . . . . . . . 93.2 mt-10 -140.71 141.86 34.9 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-N 115.781 -0.645 . . . . 16.48 110.956 -178.157 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 4' ' ' LEU . . . . . 0.503 HD21 HD21 ' B' ' 6' ' ' LEU . 12.7 tp -125.6 130.05 50.87 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 115.986 -0.552 . . . . 14.28 109.874 176.336 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' B' B ' 5' ' ' LYS . . . . . . . . . . . . . 94.8 mttt -106.73 119.77 40.22 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.37 -0.377 . . . . 12.15 110.285 179.839 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 6' ' ' LEU . . . . . 0.503 HD21 HD21 ' B' ' 4' ' ' LEU . 75.7 mt -117.13 148.68 41.34 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 115.477 -0.783 . . . . 11.97 110.257 -176.982 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' B' B ' 7' ' ' LYS . . . . . . . . . . . . . 34.1 ttmt -132.76 134.83 25.08 Favored Pre-proline 0 CA--C 1.535 0.385 0 CA-C-O 118.853 -0.594 . . . . 9.81 110.118 177.578 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 8' ' ' PRO . . . . . . . . . . . . . 74.3 Cg_endo -91.61 131.87 1.33 Allowed 'Trans proline' 0 N--CA 1.491 1.329 0 C-N-CA 121.668 1.578 . . . . 9.83 111.606 176.537 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 9' ' ' LEU . . . . . . . . . . . . . 72.8 mt -70.95 -52.12 10.1 Favored Pre-proline 0 CA--C 1.533 0.295 0 CA-C-O 118.591 -0.718 . . . . 13.18 112.106 -177.526 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 10' ' ' PRO . . . . . . . . . . . . . 38.4 Cg_endo -68.59 141.8 51.45 Favored 'Trans proline' 0 N--CA 1.498 1.78 0 CA-C-N 120.287 1.138 . . . . 13.3 111.613 175.072 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 11' ' ' LYS . . . . . . . . . . . . . 69.1 mttm -87.04 97.38 10.69 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.408 -0.36 . . . . 12.9 110.645 -179.921 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 12' ' ' VAL . . . . . . . . . . . . . 11.8 p -139.38 142.08 34.05 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.325 0 CA-C-N 116.021 -0.536 . . . . 14.63 110.385 -179.902 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 13' ' ' GLU . . . . . . . . . . . . . 47.7 mt-10 -73.48 120.44 19.08 Favored 'General case' 0 C--N 1.329 -0.317 0 N-CA-C 110.007 -0.368 . . . . 14.92 110.007 177.64 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 14' ' ' LEU . . . . . . . . . . . . . 26.3 mt -95.84 143.16 25.65 Favored Pre-proline 0 CA--C 1.533 0.303 0 CA-C-O 118.928 -0.558 . . . . 14.87 109.752 179.953 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 15' ' ' PRO . . . . . . . . . . . . . 29.6 Cg_exo -59.82 159.82 23.63 Favored 'Trans proline' 0 N--CA 1.497 1.682 0 C-N-CA 121.253 1.302 . . . . 17.71 111.545 178.764 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 16' ' ' PRO . . . . . . . . . . . . . 37.4 Cg_exo -58.88 -40.11 75.04 Favored 'Trans proline' 0 N--CA 1.498 1.791 0 C-N-CA 121.429 1.419 . . . . 18.26 112.799 -177.813 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 17' ' ' ASP . . . . . . . . . . . . . 3.1 p30 -87.5 10.88 16.26 Favored 'General case' 0 CA--C 1.536 0.409 0 N-CA-C 113.05 0.759 . . . . 19.81 113.05 -178.61 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 18' ' ' PHE . . . . . . . . . . . . . 50.2 t80 -58.62 -44.97 90.13 Favored 'General case' 0 CA--C 1.523 -0.095 0 O-C-N 121.902 -0.499 . . . . 16.3 109.883 -178.348 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 19' ' ' VAL . . . . . . . . . . . . . 13.7 p -56.0 -39.04 55.58 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.283 0 CA-C-N 116.121 -0.491 . . . . 15.53 110.827 179.838 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 20' ' ' ASP . . . . . . . . . . . . . 31.0 t0 -60.11 -44.91 94.51 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-O 120.767 0.318 . . . . 19.22 110.717 -179.032 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 21' ' ' VAL . . . . . . . . . . . . . 47.7 t -64.24 -45.82 95.14 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.293 0 C-N-CA 120.757 -0.377 . . . . 18.61 110.43 -177.813 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 22' ' ' ILE . . . . . 0.659 HG22 HD12 ' B' ' 26' ' ' LEU . 51.0 mm -55.82 -47.3 79.75 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.224 0 C-N-CA 121.002 -0.279 . . . . 16.42 110.651 179.525 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' B' B ' 23' ' ' ARG . . . . . . . . . . . . . 43.7 ttp180 -55.25 -48.11 74.46 Favored 'General case' 0 C--N 1.329 -0.291 0 C-N-CA 121.064 -0.254 . . . . 19.83 111.346 -178.354 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 24' ' ' ILE . . . . . . . . . . . . . 72.9 mt -59.26 -41.28 83.52 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.297 0 C-N-CA 121.076 -0.25 . . . . 20.56 110.96 -177.964 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 25' ' ' LYS . . . . . . . . . . . . . 8.3 mtpm? -69.45 -38.91 78.01 Favored 'General case' 0 C--N 1.328 -0.356 0 N-CA-C 112.274 0.472 . . . . 19.42 112.274 -178.122 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 26' ' ' LEU . . . . . 0.659 HD12 HG22 ' B' ' 22' ' ' ILE . 37.9 mt -79.35 -38.08 35.94 Favored 'General case' 0 C--N 1.329 -0.291 0 N-CA-C 113.587 0.958 . . . . 18.5 113.587 -171.457 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' B' B ' 27' ' ' GLN . . . . . . . . . . . . . 9.7 pt20 -46.77 141.08 4.13 Favored 'General case' 0 N--CA 1.47 0.554 0 N-CA-C 112.747 0.647 . . . . 21.33 112.747 -175.189 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 28' ' ' GLY . . . . . . . . . . . . . . . 100.26 -23.68 34.97 Favored Glycine 0 CA--C 1.533 1.17 0 CA-C-N 115.481 -0.781 . . . . 21.4 112.289 -176.152 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 29' ' ' LYS . . . . . . . . . . . . . 68.5 mttm -98.06 155.11 17.27 Favored 'General case' 0 C--O 1.233 0.194 0 CA-C-N 117.559 0.679 . . . . 20.58 111.212 178.986 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 30' ' ' THR . . . . . . . . . . . . . 30.7 m -104.93 139.46 39.62 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 115.953 -0.567 . . . . 21.06 109.936 176.303 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 31' ' ' VAL . . . . . . . . . . . . . 34.8 m -129.78 149.09 33.28 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.252 0 CA-C-O 120.954 0.407 . . . . 18.25 111.167 -177.957 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 32' ' ' ARG . . . . . . . . . . . . . 75.2 mtt85 -124.69 149.15 47.52 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 115.823 -0.626 . . . . 22.16 110.166 177.427 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 33' ' ' THR . . . . . . . . . . . . . 23.6 m -53.83 136.7 39.94 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.369 -0.378 . . . . 17.28 111.356 -179.053 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 34' ' ' GLY . . . . . . . . . . . . . . . 100.0 -17.11 57.65 Favored Glycine 0 CA--C 1.531 1.053 0 CA-C-O 119.585 -0.564 . . . . 16.47 113.386 177.457 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 35' ' ' ASP . . . . . . . . . . . . . 81.8 m-20 -66.0 146.93 54.11 Favored 'General case' 0 C--O 1.231 0.117 0 CA-C-N 118.111 0.956 . . . . 18.38 111.17 -179.366 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 36' ' ' VAL . . . . . . . . . . . . . 44.5 t -121.17 128.83 76.07 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.235 0 CA-C-N 115.999 -0.546 . . . . 17.19 109.698 176.982 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 37' ' ' ILE . . . . . . . . . . . . . 64.6 mt -120.57 138.81 49.84 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.305 0 CA-C-N 116.238 -0.437 . . . . 16.42 110.019 -178.138 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 38' ' ' GLY . . . . . . . . . . . . . . . -106.63 127.24 8.79 Favored Glycine 0 CA--C 1.524 0.615 0 N-CA-C 110.927 -0.869 . . . . 18.22 110.927 178.424 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 39' ' ' ILE . . . . . . . . . . . . . 76.8 mt -127.72 141.48 46.29 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.264 0 N-CA-C 110.048 -0.353 . . . . 18.12 110.048 179.583 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 40' ' ' SER . . . . . 0.427 ' O ' HD13 ' B' ' 41' ' ' ILE . 40.6 t -91.8 118.83 31.06 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-O 120.813 0.34 . . . . 21.59 110.96 177.189 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' B' B ' 41' ' ' ILE . . . . . 0.438 HG22 HD13 ' B' ' 42' ' ' LEU . 47.3 mm -124.7 120.0 57.65 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.213 0 CA-C-N 116.149 -0.478 . . . . 20.26 110.487 178.989 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' B' B ' 42' ' ' LEU . . . . . 0.438 HD13 HG22 ' B' ' 41' ' ' ILE . 7.8 mp 52.06 35.87 17.37 Favored 'General case' 0 C--N 1.331 -0.2 0 CA-C-N 116.301 -0.409 . . . . 22.74 111.638 177.848 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' B' B ' 43' ' ' GLY . . . . . . . . . . . . . . . 72.8 31.5 62.31 Favored Glycine 0 CA--C 1.529 0.956 0 C-N-CA 121.131 -0.557 . . . . 23.04 112.101 178.375 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 44' ' ' LYS . . . . . . . . . . . . . 85.1 tttt -137.71 131.46 31.39 Favored 'General case' 0 C--N 1.329 -0.311 0 N-CA-C 109.57 -0.53 . . . . 21.05 109.57 178.416 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 45' ' ' GLU . . . . . . . . . . . . . 81.7 tt0 -80.17 111.0 16.12 Favored 'General case' 0 C--N 1.328 -0.337 0 C-N-CA 120.657 -0.417 . . . . 20.06 110.238 -179.222 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 46' ' ' VAL . . . . . . . . . . . . . 7.0 p -109.86 128.2 66.16 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.188 0 N-CA-C 109.332 -0.618 . . . . 16.65 109.332 178.954 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 47' ' ' LYS . . . . . . . . . . . . . 44.0 mttm -98.54 124.28 43.2 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 115.781 -0.645 . . . . 18.21 110.666 178.409 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 48' ' ' PHE . . . . . . . . . . . . . 96.4 m-85 -108.99 131.79 54.73 Favored 'General case' 0 C--N 1.328 -0.351 0 N-CA-C 109.679 -0.489 . . . . 13.38 109.679 176.013 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 49' ' ' LYS . . . . . . . . . . . . . 42.6 tttp -109.18 137.97 46.26 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.484 -0.326 . . . . 14.08 110.593 178.246 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 50' ' ' VAL . . . . . 0.433 ' HA ' HD23 ' B' ' 6' ' ' LEU . 48.1 t -82.41 106.85 13.73 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.369 0 N-CA-C 109.156 -0.683 . . . . 13.85 109.156 175.527 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' B' B ' 51' ' ' VAL . . . . . . . . . . . . . 48.2 t -69.92 -52.35 31.85 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.354 0 N-CA-C 109.476 -0.564 . . . . 12.96 109.476 -176.113 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 52' ' ' GLN . . . . . . . . . . . . . 46.6 mt-30 -155.14 152.72 29.8 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 115.914 -0.584 . . . . 14.9 111.61 -179.401 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 53' ' ' ALA . . . . . . . . . . . . . . . -127.27 131.31 50.56 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 115.327 -0.851 . . . . 16.72 109.847 176.473 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 54' ' ' TYR . . . . . . . . . . . . . 9.8 t80 -129.1 107.5 17.93 Favored Pre-proline 0 CA--C 1.535 0.367 0 CA-C-O 118.337 -0.839 . . . . 20.83 110.496 -179.829 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 55' ' ' PRO . . . . . . . . . . . . . 73.2 Cg_endo -77.11 170.0 72.77 Favored 'Cis proline' 0 N--CA 1.5 1.882 0 CA-C-N 121.781 1.672 . . . . 20.51 112.397 -5.952 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 56' ' ' SER . . . . . . . . . . . . . 18.7 m -116.54 133.21 23.03 Favored Pre-proline 0 CA--C 1.538 0.494 0 CA-C-O 118.445 -0.788 . . . . 21.17 109.433 174.37 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 57' ' ' PRO . . . . . . . . . . . . . 55.4 Cg_endo -71.72 149.04 91.86 Favored 'Cis proline' 0 N--CA 1.497 1.728 0 CA-C-N 121.967 1.738 . . . . 21.75 111.566 -1.057 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 58' ' ' LEU . . . . . . . . . . . . . 26.7 tp -107.63 136.24 47.73 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.438 -0.347 . . . . 18.89 110.467 -178.873 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 59' ' ' ARG . . . . . . . . . . . . . 71.3 ttt-85 -106.64 119.23 38.74 Favored 'General case' 0 C--N 1.327 -0.371 0 N-CA-C 109.131 -0.692 . . . . 23.48 109.131 177.239 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 60' ' ' VAL . . . . . . . . . . . . . 44.7 t -78.05 122.27 32.6 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.286 0 C-N-CA 120.753 -0.379 . . . . 19.33 110.428 -173.96 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 61' ' ' GLU . . . . . . . . . . . . . 46.9 mt-10 -131.0 174.31 10.13 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.065 -0.516 . . . . 21.74 109.882 176.923 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 62' ' ' ASP . . . . . . . . . . . . . 10.9 t70 -54.29 -32.71 57.06 Favored 'General case' 0 C--N 1.327 -0.381 0 C-N-CA 121.037 -0.265 . . . . 21.65 111.668 -178.812 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 63' ' ' ARG . . . . . . . . . . . . . 39.9 ptt180 -89.49 5.14 46.75 Favored 'General case' 0 CA--C 1.537 0.452 0 N-CA-C 113.715 1.006 . . . . 24.12 113.715 -176.152 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 64' ' ' THR . . . . . . . . . . . . . 38.7 m -81.1 130.7 35.14 Favored 'General case' 0 C--N 1.331 -0.2 0 CA-C-N 118.134 0.425 . . . . 18.66 110.386 -179.717 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 65' ' ' LYS . . . . . . . . . . . . . 91.0 mttt -90.47 130.37 36.54 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.353 -0.385 . . . . 18.71 110.469 -179.715 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 66' ' ' ILE . . . . . . . . . . . . . 65.1 mt -116.48 132.35 66.37 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.232 0 CA-C-O 120.923 0.392 . . . . 14.83 110.006 179.456 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 67' ' ' THR . . . . . . . . . . . . . 30.4 m -120.4 139.37 52.91 Favored 'General case' 0 C--N 1.331 -0.22 0 CA-C-N 116.04 -0.527 . . . . 12.49 110.637 -178.938 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 68' ' ' LEU . . . . . . . . . . . . . 6.8 mp . . . . . 0 C--N 1.332 -0.193 0 CA-C-N 116.209 -0.45 . . . . 10.14 110.781 179.692 . . . . . . . . 0 0 . 1 . 001 nuclear nobuild core ' B' B ' 73' ' ' VAL . . . . . . . . . . . . . 34.5 m . . . . . 0 C--O 1.231 0.08 0 CA-C-O 120.675 0.274 . . . . 1.07 110.53 . . . . . . . . . 0 0 . 1 . 001 nuclear nobuild core ' B' B ' 74' ' ' ASP . . . . . . . . . . . . . 29.8 t0 -94.01 120.23 33.98 Favored 'General case' 0 C--N 1.331 -0.229 0 CA-C-N 116.446 -0.343 . . . . 0.93 110.159 -179.631 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 75' ' ' VAL . . . . . . . . . . . . . 43.4 t -118.76 121.77 67.75 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.212 0 CA-C-O 121.046 0.45 . . . . 0.66 110.688 -177.86 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 76' ' ' LEU . . . . . . . . . . . . . 6.0 mp -123.66 146.49 48.18 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-N 115.82 -0.627 . . . . 1.16 109.672 175.284 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 77' ' ' GLU . . . . . . . . . . . . . 98.1 mt-10 -135.54 139.74 44.18 Favored 'General case' 0 N--CA 1.462 0.161 0 CA-C-O 121.015 0.436 . . . . 1.33 111.582 -177.642 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 78' ' ' ALA . . . . . . . . . . . . . . . -127.73 137.79 52.56 Favored 'General case' 0 C--N 1.331 -0.223 0 CA-C-N 115.639 -0.71 . . . . 0.63 109.69 175.474 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 79' ' ' LYS . . . . . 0.605 ' O ' HD13 ' B' ' 80' ' ' ILE . 49.8 pttt -84.64 123.15 30.03 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-O 121.073 0.464 . . . . 3.1 110.937 -179.019 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' B' B ' 80' ' ' ILE . . . . . 0.605 HD13 ' O ' ' B' ' 79' ' ' LYS . 40.0 mm -139.16 117.54 12.51 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.28 0 N-CA-C 109.421 -0.585 . . . . 0.65 109.421 -177.659 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' B' B ' 81' ' ' LYS . . . . . . . . . . . . . 85.4 tttt -104.14 121.79 43.97 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-O 120.795 0.331 . . . . 2.96 111.122 -177.292 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 82' ' ' GLY . . . . . . . . . . . . . . . 89.11 42.2 5.67 Favored Glycine 0 CA--C 1.526 0.733 0 C-N-CA 120.648 -0.786 . . . . 0.68 112.069 173.618 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 83' ' ' ILE . . . . . . . . . . . . . 69.3 mt -67.43 137.92 23.78 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.282 0 N-CA-C 109.669 -0.493 . . . . 0.62 109.669 176.625 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 84' ' ' LYS . . . . . . . . . . . . . 80.5 tttt -93.46 -54.07 3.82 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.078 -0.51 . . . . 1.62 110.379 -178.388 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 85' ' ' ASP . . . . . . . . . . . . . 19.5 t70 -156.43 152.92 28.07 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 115.63 -0.714 . . . . 0.7 110.138 -179.085 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 86' ' ' VAL . . . . . . . . . . . . . 45.1 t -127.5 131.07 70.57 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.25 0 CA-C-O 121.096 0.474 . . . . 0.48 110.543 -179.092 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 87' ' ' ILE . . . . . 0.491 ' N ' HD12 ' B' ' 87' ' ' ILE . 5.1 mp -118.94 125.13 74.23 Favored 'Isoleucine or valine' 0 C--O 1.233 0.23 0 CA-C-N 115.668 -0.696 . . . . 1.38 109.276 176.64 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' B' B ' 88' ' ' LEU . . . . . . . . . . . . . 16.6 tp -110.05 127.28 54.75 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-O 120.926 0.393 . . . . 1.67 110.958 -177.415 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 89' ' ' ASP . . . . . . . . . . . . . 14.6 t70 -118.89 158.17 26.21 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 115.813 -0.631 . . . . 0.85 109.408 177.09 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 90' ' ' GLU . . . . . . . . . . . . . 95.1 mt-10 -47.31 -40.35 16.83 Favored 'General case' 0 C--N 1.33 -0.265 0 N-CA-C 113.0 0.741 . . . . 2.51 113.0 -171.33 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 91' ' ' ASN . . . . . . . . . . . . . 69.9 m-80 -132.09 26.51 4.56 Favored 'General case' 0 N--CA 1.466 0.373 0 N-CA-C 112.469 0.544 . . . . 2.35 112.469 -178.023 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 92' ' ' LEU . . . . . . . . . . . . . 84.9 mt -150.51 143.22 24.57 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-O 120.748 0.308 . . . . 1.45 110.448 -178.731 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 93' ' ' ILE . . . . . . . . . . . . . 74.5 mt -118.53 113.37 41.63 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.346 0 N-CA-C 109.257 -0.646 . . . . 0.54 109.257 178.181 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 94' ' ' VAL . . . . . . . . . . . . . 46.1 t -115.35 124.95 72.41 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.201 0 CA-C-O 120.939 0.4 . . . . 0.45 109.99 -178.43 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 95' ' ' VAL . . . . . . . . . . . . . 42.7 t -121.91 134.34 65.49 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.285 0 CA-C-N 116.07 -0.514 . . . . 0.43 109.881 -179.122 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 96' ' ' ILE . . . . . . . . . . . . . 64.6 mt -112.89 128.71 69.48 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.365 0 N-CA-C 109.075 -0.713 . . . . 0.5 109.075 177.831 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 97' ' ' THR . . . . . . . . . . . . . 69.6 p -98.37 158.72 15.4 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-O 121.153 0.501 . . . . 0.56 111.082 -178.043 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 98' ' ' GLU . . . . . . . . . . . . . 83.6 tt0 -53.93 -27.66 32.18 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.148 -0.478 . . . . 3.05 112.081 -179.819 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 99' ' ' GLU . . . . . . . . . . . . . 95.5 mt-10 -81.31 16.78 1.49 Allowed 'General case' 0 CA--C 1.534 0.363 0 N-CA-C 113.152 0.797 . . . . 2.29 113.152 -176.588 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 100' ' ' ASN . . . . . . . . . . . . . 4.3 m-20 62.89 38.05 11.65 Favored 'General case' 0 N--CA 1.462 0.158 0 CA-C-O 121.073 0.464 . . . . 0.66 111.158 177.265 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 101' ' ' GLU . . . . . . . . . . . . . 84.6 tt0 -115.18 144.46 43.65 Favored 'General case' 0 C--N 1.333 -0.132 0 CA-C-N 116.1 -0.5 . . . . 0.69 109.738 174.937 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 102' ' ' VAL . . . . . . . . . . . . . 45.0 t -115.5 126.23 72.98 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 CA-C-N 116.257 -0.429 . . . . 0.48 110.083 -177.812 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 103' ' ' LEU . . . . . . . . . . . . . 55.6 mt -119.23 132.48 55.93 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 115.789 -0.641 . . . . 1.28 110.014 177.15 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 104' ' ' ILE . . . . . . . . . . . . . 66.7 mt -121.34 121.61 65.18 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.236 0 N-CA-C 110.369 -0.234 . . . . 0.51 110.369 179.047 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 105' ' ' PHE . . . . . . . . . . . . . 76.0 m-85 -115.81 166.32 12.09 Favored 'General case' 0 C--N 1.332 -0.175 0 O-C-N 124.205 0.941 . . . . 0.55 109.643 177.911 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 106' ' ' ASN . . . . . . . . . . . . . 52.0 p-10 -100.08 -171.57 2.07 Favored 'General case' 0 C--N 1.331 -0.213 0 N-CA-C 110.086 -0.338 . . . . 0.71 110.086 173.546 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 107' ' ' GLN . . . . . . . . . . . . . 50.2 tt0 -58.37 -30.15 66.56 Favored 'General case' 0 CA--C 1.532 0.286 0 N-CA-C 111.901 0.334 . . . . 1.83 111.901 178.574 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 108' ' ' ASN . . . . . . . . . . . . . 63.6 t30 -83.03 8.16 13.63 Favored 'General case' 0 CA--C 1.535 0.388 0 N-CA-C 113.212 0.819 . . . . 1.5 113.212 -177.147 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 109' ' ' LEU . . . . . . . . . . . . . 11.9 tp 60.92 37.43 18.33 Favored 'General case' 0 CA--C 1.53 0.186 0 CA-C-O 120.99 0.424 . . . . 1.18 111.197 179.028 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 110' ' ' GLU . . . . . . . . . . . . . 47.6 mt-10 -110.09 153.09 25.16 Favored 'General case' 0 C--N 1.33 -0.24 0 N-CA-C 109.751 -0.463 . . . . 1.97 109.751 176.436 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 111' ' ' GLU . . . . . . . . . . . . . 73.7 tt0 -86.76 123.17 31.61 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-O 120.855 0.359 . . . . 1.84 110.926 -174.931 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 112' ' ' LEU . . . . . . . . . . . . . 32.9 mt -108.9 -46.06 3.69 Favored 'General case' 0 C--N 1.332 -0.186 0 CA-C-N 116.198 -0.455 . . . . 0.75 111.27 -179.55 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 113' ' ' TYR . . . . . . . . . . . . . 71.6 t80 -136.83 142.3 42.87 Favored 'General case' 0 N--CA 1.464 0.244 0 CA-C-O 120.778 0.323 . . . . 0.68 111.064 -178.202 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 114' ' ' ARG . . . . . . . . . . . . . 25.0 ptt180 -144.52 127.25 16.21 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.05 -0.523 . . . . 3.02 110.927 -179.989 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 115' ' ' GLY . . . . . . . . . . . . . . . -150.19 160.46 28.55 Favored Glycine 0 CA--C 1.525 0.659 0 N-CA-C 111.242 -0.743 . . . . 0.53 111.242 178.614 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 116' ' ' LYS . . . . . . . . . . . . . 7.9 ttpm? -129.65 134.45 47.69 Favored 'General case' 0 C--N 1.33 -0.267 0 N-CA-C 109.782 -0.451 . . . . 1.72 109.782 175.911 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 117' ' ' PHE . . . . . . . . . . . . . 38.3 m-85 -134.46 113.97 12.39 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-O 120.815 0.34 . . . . 0.56 110.258 -176.939 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 118' ' ' GLU . . . . . . . . . . . . . 95.9 mt-10 -55.29 -40.94 71.66 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.424 -0.353 . . . . 2.56 111.129 -176.371 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 119' ' ' ASN . . . . . . . . . . . . . 7.2 m120 -102.84 31.12 4.33 Favored 'General case' 0 C--N 1.331 -0.227 0 CA-C-N 116.272 -0.422 . . . . 1.35 112.136 -174.431 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 120' ' ' LEU . . . . . . . . . . . . . 18.8 tp -56.23 120.46 7.6 Favored 'General case' 0 N--CA 1.462 0.156 0 C-N-CA 120.971 -0.292 . . . . 0.57 110.403 178.418 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 121' ' ' ASN . . . . . . . . . . . . . 64.2 t30 -114.08 -44.1 3.18 Favored 'General case' 0 C--O 1.233 0.186 0 CA-C-N 116.504 -0.316 . . . . 1.95 111.239 -175.891 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 122' ' ' LYS . . . . . . . . . . . . . 91.0 mttt -146.22 150.32 35.61 Favored 'General case' 0 C--N 1.331 -0.197 0 CA-C-O 121.192 0.52 . . . . 1.8 111.981 -176.339 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 123' ' ' VAL . . . . . . . . . . . . . 45.4 t -124.73 128.86 73.64 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.245 0 CA-C-N 115.651 -0.704 . . . . 0.57 109.391 174.723 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 124' ' ' LEU . . . . . . . . . . . . . 72.5 mt -120.8 132.43 55.02 Favored 'General case' 0 C--N 1.33 -0.273 0 N-CA-C 110.181 -0.303 . . . . 1.68 110.181 -178.194 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 125' ' ' VAL . . . . . . . . . . . . . 35.1 m -138.43 132.44 41.61 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.25 0 CA-C-O 120.971 0.415 . . . . 1.73 111.085 -179.754 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 126' ' ' ARG . . . . . . . . . . . . . 89.3 mtt-85 -151.58 132.92 14.57 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 115.777 -0.647 . . . . 2.53 109.714 176.605 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 127' ' ' ASN . . . . . . . . . . . . . 32.0 t30 56.67 -147.82 0.51 Allowed 'General case' 0 CA--C 1.541 0.623 0 N-CA-C 109.686 -0.487 . . . . 2.3 109.686 -179.415 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 128' ' ' ASP . . . . . . . . . . . . . 4.5 p30 -88.04 16.89 5.46 Favored 'General case' 0 CA--C 1.536 0.433 0 CA-C-N 118.75 0.705 . . . . 1.02 112.725 178.446 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 129' ' ' LEU . . . . . . . . . . . . . 15.0 tp -115.37 136.08 53.46 Favored 'General case' 0 C--O 1.232 0.167 0 O-C-N 122.118 -0.364 . . . . 1.86 110.073 179.389 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 130' ' ' VAL . . . . . 0.496 HG23 ' HB ' ' B' ' 141' ' ' ILE . 32.6 m -131.53 144.0 38.81 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.27 0 CA-C-O 120.995 0.426 . . . . 1.48 111.0 -178.546 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' B' B ' 131' ' ' VAL . . . . . 0.43 HG13 ' O ' ' B' ' 139' ' ' THR . 42.8 t -136.04 140.07 44.65 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 CA-C-N 116.022 -0.536 . . . . 0.7 110.34 179.796 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' B' B ' 132' ' ' ILE . . . . . . . . . . . . . 72.4 mt -112.95 133.88 57.37 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.323 0 N-CA-C 109.422 -0.584 . . . . 0.45 109.422 178.256 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 133' ' ' ILE . . . . . . . . . . . . . 38.5 mm -114.68 116.97 54.18 Favored 'Isoleucine or valine' 0 C--O 1.233 0.232 0 CA-C-N 116.534 -0.303 . . . . 0.54 110.767 -176.118 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 134' ' ' ASP . . . . . . . . . . . . . 7.6 p-10 -129.61 149.79 51.22 Favored 'General case' 0 C--N 1.331 -0.215 0 N-CA-C 109.594 -0.521 . . . . 0.56 109.594 174.963 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 135' ' ' GLU . . . . . . . . . . . . . 85.0 tt0 -49.9 -25.94 3.65 Favored 'General case' 0 C--N 1.327 -0.372 0 N-CA-C 112.719 0.637 . . . . 1.64 112.719 -172.113 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 136' ' ' GLN . . . . . . . . . . . . . 53.0 mt-30 -101.82 -25.68 13.73 Favored 'General case' 0 C--O 1.233 0.218 0 N-CA-C 112.892 0.701 . . . . 2.0 112.892 -173.939 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 137' ' ' LYS . . . . . . . . . . . . . 86.5 mttt -144.84 150.67 37.52 Favored 'General case' 0 C--N 1.331 -0.227 0 CA-C-O 121.482 0.658 . . . . 1.9 112.559 -168.503 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 138' ' ' LEU . . . . . . . . . . . . . 12.5 tp -112.65 117.6 32.71 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 114.888 -1.051 . . . . 0.74 108.78 172.64 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 139' ' ' THR . . . . . 0.43 ' O ' HG13 ' B' ' 131' ' ' VAL . 22.1 m -110.54 124.97 52.83 Favored 'General case' 0 C--N 1.332 -0.182 0 CA-C-O 120.596 0.236 . . . . 0.47 110.753 -177.266 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' B' B ' 140' ' ' LEU . . . . . 0.464 ' C ' HD23 ' B' ' 140' ' ' LEU . 6.5 tt -116.1 122.73 45.99 Favored 'General case' 0 C--N 1.33 -0.249 0 N-CA-C 109.484 -0.561 . . . . 0.86 109.484 -178.261 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' B' B ' 141' ' ' ILE . . . . . 0.496 ' HB ' HG23 ' B' ' 130' ' ' VAL . 19.8 mt -120.71 122.95 69.26 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.298 0 CA-C-O 120.949 0.404 . . . . 0.56 110.015 -175.397 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' B' B ' 142' ' ' ARG . . . . . . . . . . . . . 67.5 mtm180 -104.4 126.38 51.45 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 115.281 -0.872 . . . . 3.56 109.938 179.78 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 143' ' ' THR . . . . . . . . . . . . . 23.0 p . . . . . 0 C--O 1.22 -0.497 0 CA-C-O 117.963 -1.018 . . . . 1.46 110.645 -179.576 . . . . . . . . 0 0 . 1 . 001 nuclear nobuild core ' C' C ' 2' ' ' SER . . . . . . . . . . . . . 51.0 p . . . . . 0 C--O 1.231 0.099 0 CA-C-O 120.996 0.427 . . . . 21.19 110.875 . . . . . . . . . 0 0 . 1 . 001 nuclear nobuild core ' C' C ' 3' ' ' GLU . . . . . . . . . . . . . 95.2 mt-10 -140.02 142.57 36.22 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 115.832 -0.622 . . . . 18.63 110.711 -179.463 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' C' C ' 4' ' ' LEU . . . . . 0.409 HD12 HD23 ' C' ' 58' ' ' LEU . 4.0 tt -123.78 124.02 41.78 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.083 -0.508 . . . . 16.59 109.788 176.63 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' C' C ' 5' ' ' LYS . . . . . . . . . . . . . 57.3 mttm -100.12 121.7 41.81 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.298 -0.41 . . . . 14.18 110.866 -179.314 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' C' C ' 6' ' ' LEU . . . . . . . . . . . . . 60.6 mt -117.59 146.3 43.72 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 115.557 -0.747 . . . . 13.76 110.67 -179.437 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' C' C ' 7' ' ' LYS . . . . . . . . . . . . . 38.5 ttmt -138.89 139.14 22.8 Favored Pre-proline 0 CA--C 1.533 0.318 0 CA-C-O 119.115 -0.469 . . . . 11.14 109.998 174.779 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' C' C ' 8' ' ' PRO . . . . . . . . . . . . . 94.1 Cg_endo -91.95 146.12 3.05 Favored 'Trans proline' 0 N--CA 1.489 1.258 0 C-N-CA 121.82 1.68 . . . . 10.45 112.098 178.817 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' C' C ' 9' ' ' LEU . . . . . . . . . . . . . 70.2 mt -75.89 -46.34 3.93 Favored Pre-proline 0 CA--C 1.533 0.31 0 CA-C-O 118.742 -0.647 . . . . 14.46 111.596 178.035 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' C' C ' 10' ' ' PRO . . . . . . . . . . . . . 84.6 Cg_endo -81.76 142.68 12.85 Favored 'Trans proline' 0 N--CA 1.495 1.574 0 C-N-CA 121.024 1.15 . . . . 13.28 111.227 172.308 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' C' C ' 11' ' ' LYS . . . . . . . . . . . . . 53.7 tttm -86.33 109.94 19.33 Favored 'General case' 0 C--N 1.331 -0.223 0 C-N-CA 120.68 -0.408 . . . . 12.2 110.524 -179.254 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' C' C ' 12' ' ' VAL . . . . . . . . . . . . . 11.6 p -147.38 145.62 18.95 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.299 0 CA-C-N 116.003 -0.544 . . . . 13.43 110.402 -179.294 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' C' C ' 13' ' ' GLU . . . . . . . . . . . . . 46.1 mt-10 -81.15 130.28 34.95 Favored 'General case' 0 C--N 1.329 -0.286 0 N-CA-C 110.096 -0.335 . . . . 13.26 110.096 177.91 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' C' C ' 14' ' ' LEU . . . . . . . . . . . . . 17.3 mt -98.78 143.94 27.27 Favored Pre-proline 0 CA--C 1.533 0.326 0 CA-C-O 118.987 -0.53 . . . . 13.07 110.336 -178.215 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' C' C ' 15' ' ' PRO . . . . . . . . . . . . . 23.2 Cg_exo -64.49 161.09 36.49 Favored 'Trans proline' 0 N--CA 1.498 1.754 0 C-N-CA 121.36 1.373 . . . . 15.43 111.733 176.333 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' C' C ' 16' ' ' PRO . . . . . . . . . . . . . 35.7 Cg_exo -59.12 -35.32 98.18 Favored 'Trans proline' 0 N--CA 1.498 1.748 0 C-N-CA 121.508 1.472 . . . . 15.95 112.979 -178.545 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' C' C ' 17' ' ' ASP . . . . . . . . . . . . . 11.6 p-10 -83.3 -0.71 50.9 Favored 'General case' 0 CA--C 1.537 0.452 0 N-CA-C 113.35 0.87 . . . . 17.37 113.35 -177.397 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' C' C ' 18' ' ' PHE . . . . . . . . . . . . . 29.2 t80 -58.34 -44.26 88.65 Favored 'General case' 0 C--N 1.334 -0.107 0 O-C-N 121.972 -0.455 . . . . 14.54 110.082 -177.343 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' C' C ' 19' ' ' VAL . . . . . . . . . . . . . 49.7 t -57.14 -43.96 82.47 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.288 0 CA-C-N 116.132 -0.485 . . . . 15.03 110.423 -177.737 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' C' C ' 20' ' ' ASP . . . . . . . . . . . . . 2.0 m-20 -60.07 -43.31 95.54 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.551 -0.295 . . . . 17.45 111.029 -177.653 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' C' C ' 21' ' ' VAL . . . . . . . . . . . . . 46.4 t -63.84 -45.49 96.94 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.289 0 C-N-CA 120.707 -0.397 . . . . 17.27 110.545 -176.94 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' C' C ' 22' ' ' ILE . . . . . 0.599 HG22 HD12 ' C' ' 26' ' ' LEU . 50.6 mm -55.9 -48.58 78.25 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.226 0 C-N-CA 121.038 -0.265 . . . . 16.84 110.71 179.014 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' C' C ' 23' ' ' ARG . . . . . . . . . . . . . 49.3 ttp180 -54.84 -45.76 74.55 Favored 'General case' 0 C--N 1.331 -0.234 0 C-N-CA 120.92 -0.312 . . . . 19.12 111.347 -178.245 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' C' C ' 24' ' ' ILE . . . . . . . . . . . . . 75.5 mt -58.94 -45.33 92.03 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.253 0 C-N-CA 121.013 -0.275 . . . . 20.12 111.073 -178.696 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' C' C ' 25' ' ' LYS . . . . . . . . . . . . . 53.6 mttm -65.81 -38.1 88.04 Favored 'General case' 0 C--N 1.328 -0.349 0 N-CA-C 112.418 0.525 . . . . 20.06 112.418 -178.325 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' C' C ' 26' ' ' LEU . . . . . 0.599 HD12 HG22 ' C' ' 22' ' ' ILE . 62.8 mt -78.51 -39.82 36.99 Favored 'General case' 0 C--N 1.33 -0.25 0 N-CA-C 113.697 0.999 . . . . 20.37 113.697 -170.443 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' C' C ' 27' ' ' GLN . . . . . . . . . . . . . 12.1 pt20 -47.39 138.66 7.29 Favored 'General case' 0 N--CA 1.469 0.478 0 N-CA-C 112.827 0.677 . . . . 21.9 112.827 -174.772 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' C' C ' 28' ' ' GLY . . . . . . . . . . . . . . . 98.62 -22.05 42.86 Favored Glycine 0 CA--C 1.534 1.234 0 CA-C-N 115.772 -0.649 . . . . 24.11 112.683 -177.737 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' C' C ' 29' ' ' LYS . . . . . . . . . . . . . 63.3 mttp -98.26 155.07 17.37 Favored 'General case' 0 C--N 1.333 -0.129 0 CA-C-N 117.521 0.661 . . . . 22.95 111.02 -179.964 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' C' C ' 30' ' ' THR . . . . . . . . . . . . . 41.7 m -105.73 135.25 47.49 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.165 -0.47 . . . . 24.58 109.826 175.33 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' C' C ' 31' ' ' VAL . . . . . . . . . . . . . 34.9 m -130.56 150.5 34.68 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.289 0 CA-C-O 120.979 0.419 . . . . 21.44 111.171 -177.815 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' C' C ' 32' ' ' ARG . . . . . . . . . . . . . 56.0 ttp180 -131.71 151.0 51.97 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 115.772 -0.649 . . . . 25.8 110.182 177.674 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' C' C ' 33' ' ' THR . . . . . . . . . . . . . 23.5 m -52.92 138.82 29.09 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.423 -0.353 . . . . 20.32 111.436 -177.761 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' C' C ' 34' ' ' GLY . . . . . . . . . . . . . . . 101.25 -17.23 56.08 Favored Glycine 0 CA--C 1.533 1.177 0 CA-C-O 119.695 -0.503 . . . . 19.11 113.276 179.24 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' C' C ' 35' ' ' ASP . . . . . . . . . . . . . 75.1 m-20 -67.0 152.48 45.7 Favored 'General case' 0 N--CA 1.461 0.103 0 CA-C-N 118.046 0.923 . . . . 21.47 111.417 178.984 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' C' C ' 36' ' ' VAL . . . . . . . . . . . . . 44.9 t -121.03 130.98 74.12 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.227 0 CA-C-N 115.969 -0.56 . . . . 19.32 109.99 178.423 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' C' C ' 37' ' ' ILE . . . . . . . . . . . . . 71.9 mt -123.61 140.87 45.83 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.23 0 CA-C-N 116.158 -0.474 . . . . 17.81 109.858 179.972 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' C' C ' 38' ' ' GLY . . . . . . . . . . . . . . . -113.42 128.93 8.58 Favored Glycine 0 CA--C 1.528 0.851 0 N-CA-C 111.272 -0.731 . . . . 18.91 111.272 -179.548 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' C' C ' 39' ' ' ILE . . . . . . . . . . . . . 68.7 mt -124.83 132.37 71.41 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.199 0 N-CA-C 109.911 -0.403 . . . . 17.92 109.911 178.395 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' C' C ' 40' ' ' SER . . . . . 0.52 ' O ' HD13 ' C' ' 41' ' ' ILE . 15.7 t -92.78 117.92 30.53 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-N 116.546 -0.297 . . . . 20.9 111.009 177.093 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' C' C ' 41' ' ' ILE . . . . . 0.52 HD13 ' O ' ' C' ' 40' ' ' SER . 47.4 mm -130.89 128.2 62.36 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.217 0 CA-C-O 120.711 0.291 . . . . 18.73 110.223 178.847 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' C' C ' 42' ' ' LEU . . . . . . . . . . . . . 23.1 mt 57.33 33.53 23.42 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.196 -0.456 . . . . 20.86 111.873 177.985 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' C' C ' 43' ' ' GLY . . . . . . . . . . . . . . . 77.64 -10.1 25.89 Favored Glycine 0 CA--C 1.535 1.311 0 C-N-CA 121.188 -0.529 . . . . 21.69 113.421 177.341 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' C' C ' 44' ' ' LYS . . . . . . . . . . . . . 65.6 tttt -104.87 135.46 46.19 Favored 'General case' 0 C--N 1.332 -0.162 0 CA-C-N 117.938 0.869 . . . . 19.99 110.105 177.58 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' C' C ' 45' ' ' GLU . . . . . . . . . . . . . 84.6 tt0 -83.72 131.14 34.95 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.36 -0.382 . . . . 20.5 110.91 -179.734 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' C' C ' 46' ' ' VAL . . . . . . . . . . . . . 7.3 p -120.76 130.64 74.36 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.229 0 N-CA-C 109.369 -0.604 . . . . 16.54 109.369 175.99 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' C' C ' 47' ' ' LYS . . . . . . . . . . . . . 66.8 mttm -99.26 126.89 45.17 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 115.877 -0.601 . . . . 19.31 110.709 178.949 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' C' C ' 48' ' ' PHE . . . . . . . . . . . . . 85.2 m-85 -111.27 131.96 54.74 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.366 -0.379 . . . . 15.05 110.085 177.921 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' C' C ' 49' ' ' LYS . . . . . . . . . . . . . 78.9 tttt -105.16 136.09 45.3 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.228 -0.442 . . . . 16.18 109.913 178.156 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' C' C ' 50' ' ' VAL . . . . . . . . . . . . . 46.6 t -78.22 107.85 10.81 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.312 0 N-CA-C 109.161 -0.681 . . . . 16.26 109.161 177.174 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' C' C ' 51' ' ' VAL . . . . . . . . . . . . . 48.9 t -70.22 -47.87 64.71 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.304 0 CA-C-N 115.964 -0.562 . . . . 15.45 109.956 -174.298 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' C' C ' 52' ' ' GLN . . . . . . . . . . . . . 48.4 tt0 -168.99 140.1 2.43 Favored 'General case' 0 C--N 1.33 -0.255 0 C-N-CA 120.389 -0.524 . . . . 17.03 111.581 -179.004 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' C' C ' 53' ' ' ALA . . . . . . . . . . . . . . . -109.65 133.3 53.28 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 115.85 -0.614 . . . . 19.6 109.799 174.922 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' C' C ' 54' ' ' TYR . . . . . . . . . . . . . 10.0 t80 -129.03 107.39 18.03 Favored Pre-proline 0 CA--C 1.534 0.35 0 CA-C-O 118.27 -0.871 . . . . 23.17 110.389 -179.942 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' C' C ' 55' ' ' PRO . . . . . . . . . . . . . 72.7 Cg_endo -77.21 170.03 72.59 Favored 'Cis proline' 0 N--CA 1.501 1.932 0 CA-C-N 121.798 1.678 . . . . 23.64 112.558 -6.009 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' C' C ' 56' ' ' SER . . . . . . . . . . . . . 20.0 m -116.59 140.21 26.44 Favored Pre-proline 0 CA--C 1.539 0.524 0 CA-C-O 118.616 -0.707 . . . . 24.73 109.737 174.763 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' C' C ' 57' ' ' PRO . . . . . . . . . . . . . 57.0 Cg_endo -73.36 148.01 91.04 Favored 'Cis proline' 0 N--CA 1.499 1.809 0 CA-C-N 121.621 1.615 . . . . 25.61 111.161 -6.123 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' C' C ' 58' ' ' LEU . . . . . 0.409 HD23 HD12 ' C' ' 4' ' ' LEU . 25.1 tp -107.47 139.3 42.18 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-O 120.986 0.422 . . . . 22.18 110.759 -177.487 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' C' C ' 59' ' ' ARG . . . . . . . . . . . . . 54.3 ttp180 -103.91 119.42 38.89 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 115.543 -0.753 . . . . 26.61 109.016 174.598 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' C' C ' 60' ' ' VAL . . . . . . . . . . . . . 40.9 t -72.58 120.18 20.67 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.286 0 C-N-CA 120.872 -0.331 . . . . 21.45 110.726 -173.092 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' C' C ' 61' ' ' GLU . . . . . . . . . . . . . 94.8 mt-10 -131.03 164.9 24.39 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 115.774 -0.648 . . . . 24.7 109.764 175.979 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' C' C ' 62' ' ' ASP . . . . . . . . . . . . . 39.4 m-20 -53.87 -32.49 53.32 Favored 'General case' 0 C--N 1.328 -0.349 0 C-N-CA 120.982 -0.287 . . . . 22.78 111.763 -179.865 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' C' C ' 63' ' ' ARG . . . . . . . . . . . . . 28.5 ptt180 -78.77 0.23 27.73 Favored 'General case' 0 CA--C 1.537 0.468 0 N-CA-C 113.799 1.037 . . . . 25.71 113.799 -175.445 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' C' C ' 64' ' ' THR . . . . . . . . . . . . . 32.5 m -86.28 136.4 33.17 Favored 'General case' 0 C--N 1.333 -0.148 0 CA-C-N 118.146 0.43 . . . . 20.03 110.797 -177.926 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' C' C ' 65' ' ' LYS . . . . . . . . . . . . . 62.8 mttm -89.67 131.08 35.83 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.166 -0.47 . . . . 19.19 110.192 178.924 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' C' C ' 66' ' ' ILE . . . . . . . . . . . . . 58.2 mt -112.2 130.18 66.35 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.254 0 N-CA-C 109.631 -0.507 . . . . 15.6 109.631 -179.808 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' C' C ' 67' ' ' THR . . . . . . . . . . . . . 26.5 m -124.78 137.34 54.33 Favored 'General case' 0 C--N 1.332 -0.167 0 CA-C-O 121.01 0.433 . . . . 13.36 111.022 -177.307 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' C' C ' 68' ' ' LEU . . . . . . . . . . . . . 53.9 mt . . . . . 0 C--N 1.329 -0.305 0 CA-C-N 115.859 -0.61 . . . . 10.54 110.209 177.806 . . . . . . . . 0 0 . 1 . 001 nuclear nobuild core ' C' C ' 73' ' ' VAL . . . . . . . . . . . . . 33.8 m . . . . . 0 N--CA 1.462 0.152 0 CA-C-O 120.87 0.367 . . . . 1.13 110.48 . . . . . . . . . 0 0 . 1 . 001 nuclear nobuild core ' C' C ' 74' ' ' ASP . . . . . 0.408 ' OD2' HD11 ' C' ' 76' ' ' LEU . 6.7 t70 -103.36 128.33 50.48 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 115.978 -0.555 . . . . 0.81 109.778 -179.514 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' C' C ' 75' ' ' VAL . . . . . 0.422 ' C ' HD12 ' C' ' 76' ' ' LEU . 41.0 t -114.63 122.9 69.67 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.209 0 CA-C-O 121.063 0.458 . . . . 0.61 110.745 -176.878 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' C' C ' 76' ' ' LEU . . . . . 0.433 ' N ' HD12 ' C' ' 76' ' ' LEU . 6.8 mp -119.88 139.56 52.2 Favored 'General case' 0 C--N 1.33 -0.277 0 N-CA-C 108.875 -0.787 . . . . 1.07 108.875 173.831 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' C' C ' 77' ' ' GLU . . . . . . . . . . . . . 59.6 tt0 -137.29 136.25 37.86 Favored 'General case' 0 C--N 1.333 -0.14 0 C-N-CA 120.496 -0.482 . . . . 1.18 111.416 -174.237 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' C' C ' 78' ' ' ALA . . . . . 0.516 ' HB2' HD21 ' C' ' 109' ' ' LEU . . . -124.07 137.43 54.57 Favored 'General case' 0 C--N 1.331 -0.199 0 CA-C-N 115.771 -0.65 . . . . 0.56 109.835 177.45 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' C' C ' 79' ' ' LYS . . . . . 0.58 ' O ' HD13 ' C' ' 80' ' ' ILE . 68.1 mttm -79.84 120.27 23.85 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-O 120.976 0.417 . . . . 3.18 110.621 -179.542 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' C' C ' 80' ' ' ILE . . . . . 0.58 HD13 ' O ' ' C' ' 79' ' ' LYS . 43.4 mm -139.11 114.05 8.13 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.311 0 N-CA-C 109.13 -0.693 . . . . 0.53 109.13 -176.95 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' C' C ' 81' ' ' LYS . . . . . . . . . . . . . 41.6 tttp -110.22 130.42 55.55 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-O 120.974 0.416 . . . . 2.98 111.247 -176.362 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' C' C ' 82' ' ' GLY . . . . . . . . . . . . . . . 89.13 42.08 5.69 Favored Glycine 0 CA--C 1.526 0.722 0 CA-C-N 115.857 -0.61 . . . . 0.52 111.692 175.694 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' C' C ' 83' ' ' ILE . . . . . . . . . . . . . 67.7 mt -69.95 138.34 22.26 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.279 0 N-CA-C 109.833 -0.432 . . . . 0.54 109.833 178.54 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' C' C ' 84' ' ' LYS . . . . . . . . . . . . . 35.3 tttp -101.01 -54.03 2.9 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.068 -0.515 . . . . 1.68 110.366 -178.658 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' C' C ' 85' ' ' ASP . . . . . . . . . . . . . 13.3 t70 -151.97 151.33 31.06 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 115.862 -0.608 . . . . 0.76 110.353 -179.7 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' C' C ' 86' ' ' VAL . . . . . . . . . . . . . 44.6 t -131.06 130.43 63.77 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.235 0 CA-C-O 120.93 0.395 . . . . 0.54 110.596 -178.657 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' C' C ' 87' ' ' ILE . . . . . . . . . . . . . 46.1 mm -119.88 127.29 75.88 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.221 0 CA-C-N 115.883 -0.599 . . . . 1.38 109.71 176.297 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' C' C ' 88' ' ' LEU . . . . . . . . . . . . . 14.1 tp -110.02 131.5 55.0 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-O 120.869 0.366 . . . . 1.66 110.969 -178.228 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' C' C ' 89' ' ' ASP . . . . . . . . . . . . . 21.8 t70 -123.42 156.68 35.01 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-N 116.087 -0.506 . . . . 0.95 109.939 178.389 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' C' C ' 90' ' ' GLU . . . . . . . . . . . . . 81.2 tt0 -46.33 -40.17 11.38 Favored 'General case' 0 C--N 1.33 -0.255 0 N-CA-C 113.048 0.758 . . . . 2.43 113.048 -171.738 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' C' C ' 91' ' ' ASN . . . . . . . . . . . . . 6.3 p-10 -132.1 23.03 4.51 Favored 'General case' 0 N--CA 1.468 0.434 0 N-CA-C 112.779 0.659 . . . . 2.22 112.779 -178.546 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' C' C ' 92' ' ' LEU . . . . . . . . . . . . . 15.1 mt -149.26 148.79 29.98 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-O 120.734 0.302 . . . . 1.45 110.262 -176.504 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' C' C ' 93' ' ' ILE . . . . . . . . . . . . . 75.7 mt -125.84 120.23 56.75 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.262 0 N-CA-C 109.41 -0.589 . . . . 0.48 109.41 177.005 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' C' C ' 94' ' ' VAL . . . . . 0.679 HG21 HG21 ' C' ' 125' ' ' VAL . 46.4 t -118.65 124.97 74.01 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.244 0 N-CA-C 109.765 -0.457 . . . . 0.47 109.765 -179.603 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' C' C ' 95' ' ' VAL . . . . . . . . . . . . . 41.6 t -122.02 134.49 65.13 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.328 0 CA-C-N 116.038 -0.528 . . . . 0.41 109.946 -178.226 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' C' C ' 96' ' ' ILE . . . . . . . . . . . . . 62.6 mt -115.85 127.73 73.35 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.341 0 N-CA-C 109.004 -0.739 . . . . 0.46 109.004 178.039 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' C' C ' 97' ' ' THR . . . . . . . . . . . . . 81.4 p -99.56 157.45 16.44 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-O 121.199 0.523 . . . . 0.43 111.1 -178.262 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' C' C ' 98' ' ' GLU . . . . . . . . . . . . . 85.0 tt0 -54.01 -27.82 34.23 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.065 -0.516 . . . . 2.33 112.043 179.771 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' C' C ' 99' ' ' GLU . . . . . . . . . . . . . 94.6 mt-10 -77.49 12.14 1.71 Allowed 'General case' 0 CA--C 1.537 0.458 0 N-CA-C 113.162 0.801 . . . . 2.1 113.162 -177.676 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' C' C ' 100' ' ' ASN . . . . . . . . . . . . . 3.4 m-20 63.57 33.59 13.22 Favored 'General case' 0 CA--C 1.532 0.262 0 CA-C-O 120.904 0.383 . . . . 0.51 111.565 179.174 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' C' C ' 101' ' ' GLU . . . . . . . . . . . . . 85.1 tt0 -107.71 144.74 34.4 Favored 'General case' 0 C--N 1.333 -0.15 0 N-CA-C 109.715 -0.476 . . . . 0.45 109.715 172.833 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' C' C ' 102' ' ' VAL . . . . . . . . . . . . . 45.7 t -115.35 127.08 73.05 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.317 0 CA-C-N 116.255 -0.429 . . . . 0.41 109.851 -177.876 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' C' C ' 103' ' ' LEU . . . . . . . . . . . . . 27.0 mt -117.78 131.41 56.59 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-N 115.883 -0.599 . . . . 0.59 110.407 178.526 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' C' C ' 104' ' ' ILE . . . . . . . . . . . . . 68.9 mt -117.34 119.79 62.92 Favored 'Isoleucine or valine' 0 C--O 1.233 0.219 0 N-CA-C 110.132 -0.321 . . . . 0.45 110.132 178.308 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' C' C ' 105' ' ' PHE . . . . . . . . . . . . . 95.8 m-85 -120.65 166.9 13.04 Favored 'General case' 0 C--N 1.332 -0.158 0 O-C-N 124.136 0.897 . . . . 0.46 110.038 179.676 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' C' C ' 106' ' ' ASN . . . . . . . . . . . . . 35.5 p30 -101.11 -171.94 2.08 Favored 'General case' 0 C--N 1.33 -0.265 0 N-CA-C 110.17 -0.307 . . . . 0.56 110.17 173.073 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' C' C ' 107' ' ' GLN . . . . . . . . . . . . . 63.0 tt0 -60.56 -30.29 69.7 Favored 'General case' 0 CA--C 1.531 0.236 0 N-CA-C 111.803 0.298 . . . . 1.49 111.803 179.633 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' C' C ' 108' ' ' ASN . . . . . . . . . . . . . 6.6 t30 -82.94 9.28 10.39 Favored 'General case' 0 CA--C 1.536 0.426 0 N-CA-C 112.976 0.732 . . . . 1.39 112.976 -178.375 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' C' C ' 109' ' ' LEU . . . . . 0.516 HD21 ' HB2' ' C' ' 78' ' ' ALA . 7.6 tp 61.24 32.99 19.33 Favored 'General case' 0 CA--C 1.53 0.193 0 O-C-N 122.228 -0.295 . . . . 0.96 111.741 179.14 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' C' C ' 110' ' ' GLU . . . . . . . . . . . . . 94.9 mt-10 -100.89 142.3 32.55 Favored 'General case' 0 C--N 1.33 -0.265 0 N-CA-C 109.319 -0.623 . . . . 1.9 109.319 174.724 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' C' C ' 111' ' ' GLU . . . . . . . . . . . . . 60.6 tt0 -85.05 121.99 28.61 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-O 120.893 0.378 . . . . 1.86 110.807 -175.14 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' C' C ' 112' ' ' LEU . . . . . . . . . . . . . 60.3 mt -99.71 -46.13 5.52 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 115.94 -0.573 . . . . 0.63 110.877 179.256 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' C' C ' 113' ' ' TYR . . . . . . . . . . . . . 85.5 t80 -137.15 140.0 41.55 Favored 'General case' 0 N--CA 1.464 0.242 0 CA-C-O 121.078 0.466 . . . . 0.53 111.59 -178.1 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' C' C ' 114' ' ' ARG . . . . . . . . . . . . . 41.1 ttm180 -130.5 124.57 32.24 Favored 'General case' 0 C--N 1.331 -0.23 0 CA-C-N 115.361 -0.836 . . . . 2.7 109.862 175.993 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' C' C ' 115' ' ' GLY . . . . . . . . . . . . . . . -147.18 159.02 27.91 Favored Glycine 0 CA--C 1.523 0.572 0 N-CA-C 110.56 -1.016 . . . . 0.45 110.56 178.474 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' C' C ' 116' ' ' LYS . . . . . . . . . . . . . 77.3 tttt -137.49 133.12 34.25 Favored 'General case' 0 C--N 1.329 -0.305 0 N-CA-C 109.996 -0.372 . . . . 1.58 109.996 179.385 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' C' C ' 117' ' ' PHE . . . . . . . . . . . . . 35.6 m-85 -134.18 115.75 14.56 Favored 'General case' 0 C--N 1.331 -0.223 0 CA-C-N 116.386 -0.37 . . . . 0.56 110.226 -174.82 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' C' C ' 118' ' ' GLU . . . . . . . . . . . . . 95.2 mt-10 -54.64 -40.88 69.43 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.472 -0.331 . . . . 2.11 111.498 -175.623 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' C' C ' 119' ' ' ASN . . . . . . . . . . . . . 30.6 m120 -100.53 31.16 3.58 Favored 'General case' 0 C--N 1.33 -0.244 0 N-CA-C 112.266 0.469 . . . . 1.52 112.266 -173.187 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' C' C ' 120' ' ' LEU . . . . . . . . . . . . . 14.2 tp -53.79 120.03 5.73 Favored 'General case' 0 N--CA 1.464 0.267 0 CA-C-O 120.676 0.274 . . . . 0.49 110.907 178.048 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' C' C ' 121' ' ' ASN . . . . . . . . . . . . . 59.9 m-80 -113.92 -44.15 3.19 Favored 'General case' 0 C--N 1.331 -0.2 0 CA-C-N 116.441 -0.345 . . . . 1.98 110.992 -177.699 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' C' C ' 122' ' ' LYS . . . . . . . . . . . . . 97.9 mttt -146.44 150.31 35.38 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-O 121.059 0.457 . . . . 1.85 111.644 -178.022 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' C' C ' 123' ' ' VAL . . . . . . . . . . . . . 44.7 t -129.78 127.58 64.31 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.303 0 N-CA-C 109.383 -0.599 . . . . 0.62 109.383 174.536 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' C' C ' 124' ' ' LEU . . . . . . . . . . . . . 71.0 mt -117.18 132.34 56.67 Favored 'General case' 0 N--CA 1.463 0.223 0 CA-C-N 116.547 -0.297 . . . . 1.7 110.663 -178.066 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' C' C ' 125' ' ' VAL . . . . . 0.679 HG21 HG21 ' C' ' 94' ' ' VAL . 43.7 t -132.63 121.8 45.81 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.206 0 CA-C-N 116.234 -0.439 . . . . 1.65 110.283 -179.411 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' C' C ' 126' ' ' ARG . . . . . . . . . . . . . 80.5 mtt85 -152.69 137.31 16.89 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.287 -0.415 . . . . 3.27 110.152 176.647 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' C' C ' 127' ' ' ASN . . . . . . . . . . . . . 20.1 m120 54.82 -154.44 0.28 Allowed 'General case' 0 CA--C 1.539 0.53 0 N-CA-C 110.102 -0.332 . . . . 2.28 110.102 178.562 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' C' C ' 128' ' ' ASP . . . . . . . . . . . . . 4.2 p30 -82.9 19.71 1.32 Allowed 'General case' 0 CA--C 1.534 0.332 0 N-CA-C 112.483 0.549 . . . . 1.11 112.483 178.543 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' C' C ' 129' ' ' LEU . . . . . . . . . . . . . 15.5 tp -122.75 137.09 55.02 Favored 'General case' 0 C--O 1.233 0.193 0 O-C-N 122.019 -0.426 . . . . 2.08 110.381 179.935 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' C' C ' 130' ' ' VAL . . . . . 0.553 HG23 ' HB ' ' C' ' 141' ' ' ILE . 32.1 m -132.8 143.68 38.89 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.215 0 CA-C-O 120.957 0.408 . . . . 1.44 110.379 178.527 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' C' C ' 131' ' ' VAL . . . . . 0.503 HG12 HD22 ' D' ' 88' ' ' LEU . 14.1 p -136.05 141.15 42.48 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.283 0 CA-C-N 116.349 -0.387 . . . . 0.91 110.683 179.9 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' C' C ' 132' ' ' ILE . . . . . . . . . . . . . 74.1 mt -114.64 131.84 65.57 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.354 0 N-CA-C 109.196 -0.668 . . . . 0.49 109.196 178.751 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' C' C ' 133' ' ' ILE . . . . . . . . . . . . . 42.7 mm -117.37 120.14 63.98 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.232 0 CA-C-O 120.946 0.403 . . . . 0.47 110.901 -175.659 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' C' C ' 134' ' ' ASP . . . . . . . . . . . . . 7.2 p-10 -130.79 144.29 51.34 Favored 'General case' 0 C--N 1.33 -0.257 0 N-CA-C 109.072 -0.714 . . . . 0.53 109.072 173.689 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' C' C ' 135' ' ' GLU . . . . . . . . . . . . . 84.4 tt0 -49.78 -25.35 2.97 Favored 'General case' 0 C--N 1.327 -0.379 0 N-CA-C 112.852 0.686 . . . . 2.0 112.852 -170.559 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' C' C ' 136' ' ' GLN . . . . . . . . . . . . . 94.7 mt-30 -92.78 -36.97 12.59 Favored 'General case' 0 C--N 1.332 -0.183 0 N-CA-C 112.105 0.409 . . . . 2.24 112.105 -177.499 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' C' C ' 137' ' ' LYS . . . . . . . . . . . . . 41.6 mttp -136.83 151.53 49.24 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-O 121.03 0.443 . . . . 1.48 111.1 -168.453 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' C' C ' 138' ' ' LEU . . . . . . . . . . . . . 5.2 tt -118.91 121.47 40.05 Favored 'General case' 0 C--N 1.332 -0.19 0 N-CA-C 109.047 -0.723 . . . . 0.81 109.047 173.133 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' C' C ' 139' ' ' THR . . . . . 0.454 ' O ' HG23 ' C' ' 131' ' ' VAL . 33.1 m -114.19 127.38 55.87 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-O 120.711 0.291 . . . . 0.54 111.066 -176.565 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' C' C ' 140' ' ' LEU . . . . . . . . . . . . . 21.6 tp -111.03 123.84 50.98 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 115.599 -0.728 . . . . 1.11 109.158 179.922 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' C' C ' 141' ' ' ILE . . . . . 0.553 ' HB ' HG23 ' C' ' 130' ' ' VAL . 19.5 mt -122.19 121.61 64.38 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.298 0 CA-C-O 120.981 0.419 . . . . 0.65 110.073 -173.906 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' C' C ' 142' ' ' ARG . . . . . . . . . . . . . 59.3 mtp180 . . . . . 0 C--N 1.329 -0.299 0 CA-C-N 115.419 -0.809 . . . . 4.0 110.001 178.762 . . . . . . . . 0 0 . 1 . 001 nuclear nobuild core ' D' D ' 2' ' ' SER . . . . . . . . . . . . . 3.6 p . . . . . 0 C--O 1.232 0.143 0 CA-C-O 120.844 0.354 . . . . 19.86 110.477 . . . . . . . . . 0 0 . 1 . 001 nuclear nobuild core ' D' D ' 3' ' ' GLU . . . . . . . . . . . . . 84.7 tt0 -139.71 139.57 36.6 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.137 -0.483 . . . . 17.06 110.807 -179.434 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' D' D ' 4' ' ' LEU . . . . . 0.426 HD21 HD21 ' D' ' 6' ' ' LEU . 15.3 tp -124.42 126.09 45.36 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 115.912 -0.585 . . . . 14.92 110.117 177.695 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' D' D ' 5' ' ' LYS . . . . . . . . . . . . . 46.5 mttm -102.49 120.48 40.59 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.328 -0.396 . . . . 12.31 110.389 177.795 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' D' D ' 6' ' ' LEU . . . . . 0.426 HD21 HD21 ' D' ' 4' ' ' LEU . 78.4 mt -117.63 149.25 41.01 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 115.564 -0.744 . . . . 12.66 110.663 -179.145 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' D' D ' 7' ' ' LYS . . . . . . . . . . . . . 77.5 tttt -136.77 135.68 20.54 Favored Pre-proline 0 CA--C 1.534 0.359 0 CA-C-O 118.764 -0.636 . . . . 10.07 109.792 176.266 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' D' D ' 8' ' ' PRO . . . . . . . . . . . . . 86.9 Cg_endo -87.83 143.91 6.17 Favored 'Trans proline' 0 N--CA 1.492 1.395 0 C-N-CA 121.546 1.497 . . . . 10.15 111.635 178.43 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' D' D ' 9' ' ' LEU . . . . . . . . . . . . . 21.7 mt -79.86 -46.99 1.46 Allowed Pre-proline 0 CA--C 1.533 0.305 0 CA-C-O 118.746 -0.645 . . . . 13.43 111.91 -178.884 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' D' D ' 10' ' ' PRO . . . . . . . . . . . . . 92.3 Cg_endo -80.69 148.9 18.14 Favored 'Trans proline' 0 N--CA 1.495 1.603 0 C-N-CA 121.194 1.263 . . . . 13.55 111.646 174.127 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' D' D ' 11' ' ' LYS . . . . . . . . . . . . . 96.0 mttt -88.71 102.1 14.65 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-O 120.886 0.374 . . . . 13.05 110.767 179.961 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' D' D ' 12' ' ' VAL . . . . . . . . . . . . . 12.2 p -141.03 143.85 27.61 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 CA-C-N 116.108 -0.496 . . . . 14.73 110.391 179.145 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' D' D ' 13' ' ' GLU . . . . . . . . . . . . . 45.9 mt-10 -79.72 124.65 28.78 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.408 -0.36 . . . . 15.06 110.38 179.245 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' D' D ' 14' ' ' LEU . . . . . . . . . . . . . 22.7 mt -99.52 147.78 33.81 Favored Pre-proline 0 CA--C 1.534 0.332 0 CA-C-O 119.185 -0.436 . . . . 15.04 110.534 -178.139 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' D' D ' 15' ' ' PRO . . . . . . . . . . . . . 23.8 Cg_exo -64.1 160.82 36.28 Favored 'Trans proline' 0 N--CA 1.499 1.821 0 C-N-CA 121.298 1.332 . . . . 17.83 111.816 175.018 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' D' D ' 16' ' ' PRO . . . . . . . . . . . . . 28.1 Cg_exo -60.02 -36.76 88.53 Favored 'Trans proline' 0 N--CA 1.496 1.64 0 C-N-CA 121.486 1.457 . . . . 18.35 112.795 -178.408 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' D' D ' 17' ' ' ASP . . . . . . . . . . . . . 2.9 p30 -88.27 9.22 23.85 Favored 'General case' 0 CA--C 1.535 0.402 0 N-CA-C 113.189 0.811 . . . . 20.13 113.189 -177.775 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' D' D ' 18' ' ' PHE . . . . . . . . . . . . . 61.8 t80 -57.53 -42.44 82.87 Favored 'General case' 0 N--CA 1.46 0.042 0 O-C-N 121.983 -0.448 . . . . 16.67 110.172 -179.443 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' D' D ' 19' ' ' VAL . . . . . . . . . . . . . 48.0 t -56.91 -42.53 78.67 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.321 0 CA-C-N 116.264 -0.426 . . . . 16.27 110.428 -179.353 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' D' D ' 20' ' ' ASP . . . . . . . . . . . . . 18.4 t70 -59.98 -42.16 93.57 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-O 120.8 0.333 . . . . 19.6 110.89 -178.12 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' D' D ' 21' ' ' VAL . . . . . . . . . . . . . 46.2 t -64.26 -46.61 92.82 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.269 0 C-N-CA 120.793 -0.363 . . . . 19.26 110.452 -177.938 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' D' D ' 22' ' ' ILE . . . . . 0.503 HG22 HD12 ' D' ' 26' ' ' LEU . 49.0 mm -56.23 -44.41 79.25 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.211 0 C-N-CA 120.962 -0.295 . . . . 17.48 110.565 178.651 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' D' D ' 23' ' ' ARG . . . . . . . . . . . . . 55.9 ttp180 -54.15 -49.38 69.39 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-O 120.673 0.273 . . . . 20.79 111.444 -179.689 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' D' D ' 24' ' ' ILE . . . . . . . . . . . . . 76.9 mt -58.88 -43.01 87.45 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.308 0 CA-C-N 116.48 -0.327 . . . . 21.9 111.135 -177.474 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' D' D ' 25' ' ' LYS . . . . . . . . . . . . . 63.4 mttm -66.39 -43.25 86.36 Favored 'General case' 0 C--N 1.328 -0.355 0 N-CA-C 112.619 0.6 . . . . 20.64 112.619 -178.438 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' D' D ' 26' ' ' LEU . . . . . 0.503 HD12 HG22 ' D' ' 22' ' ' ILE . 92.8 mt -78.71 -37.54 41.29 Favored 'General case' 0 C--N 1.331 -0.228 0 N-CA-C 113.55 0.944 . . . . 19.88 113.55 -170.385 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' D' D ' 27' ' ' GLN . . . . . . . . . . . . . 9.7 pt20 -46.75 138.99 5.67 Favored 'General case' 0 N--CA 1.469 0.488 0 N-CA-C 112.765 0.654 . . . . 22.91 112.765 -175.305 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' D' D ' 28' ' ' GLY . . . . . . . . . . . . . . . 100.3 -23.42 35.94 Favored Glycine 0 CA--C 1.534 1.263 0 CA-C-N 115.606 -0.725 . . . . 23.12 112.393 -176.572 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' D' D ' 29' ' ' LYS . . . . . . . . . . . . . 68.8 mttm -98.44 155.11 17.41 Favored 'General case' 0 C--O 1.233 0.2 0 CA-C-N 117.441 0.621 . . . . 21.77 111.253 179.436 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' D' D ' 30' ' ' THR . . . . . . . . . . . . . 40.8 m -102.98 137.88 40.58 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.034 -0.53 . . . . 22.51 109.938 175.362 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' D' D ' 31' ' ' VAL . . . . . . . . . . . . . 34.8 m -128.19 154.38 38.79 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.249 0 CA-C-O 120.911 0.386 . . . . 19.36 110.854 -178.708 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' D' D ' 32' ' ' ARG . . . . . . . . . . . . . 43.6 mtm180 -133.46 151.53 51.8 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 115.742 -0.663 . . . . 23.0 110.307 177.908 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' D' D ' 33' ' ' THR . . . . . . . . . . . . . 31.9 m -53.2 137.77 33.47 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.498 -0.319 . . . . 17.54 111.458 -178.155 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' D' D ' 34' ' ' GLY . . . . . . . . . . . . . . . 98.91 -17.02 58.8 Favored Glycine 0 CA--C 1.532 1.147 0 CA-C-O 119.65 -0.528 . . . . 16.71 113.365 177.927 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' D' D ' 35' ' ' ASP . . . . . . . . . . . . . 75.2 m-20 -65.72 149.69 49.72 Favored 'General case' 0 C--O 1.231 0.108 0 CA-C-N 118.012 0.906 . . . . 19.02 111.198 179.96 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' D' D ' 36' ' ' VAL . . . . . . . . . . . . . 46.3 t -118.66 130.11 73.96 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.251 0 CA-C-N 115.847 -0.615 . . . . 17.79 109.682 177.304 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' D' D ' 37' ' ' ILE . . . . . . . . . . . . . 64.1 mt -115.55 136.98 50.62 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.298 0 CA-C-N 116.11 -0.496 . . . . 17.21 109.764 179.912 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' D' D ' 38' ' ' GLY . . . . . . . . . . . . . . . -109.53 127.61 8.55 Favored Glycine 0 CA--C 1.524 0.635 0 N-CA-C 110.73 -0.948 . . . . 18.84 110.73 178.945 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' D' D ' 39' ' ' ILE . . . . . . . . . . . . . 72.2 mt -121.19 130.73 74.37 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.206 0 N-CA-C 109.911 -0.403 . . . . 18.53 109.911 179.222 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' D' D ' 40' ' ' SER . . . . . . . . . . . . . 78.0 p -92.24 119.18 31.6 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.233 -0.44 . . . . 21.82 110.74 176.506 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' D' D ' 41' ' ' ILE . . . . . . . . . . . . . 72.6 mt -129.59 116.91 40.53 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.244 0 N-CA-C 109.954 -0.387 . . . . 20.47 109.954 177.938 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' D' D ' 42' ' ' LEU . . . . . . . . . . . . . 69.8 mt 58.08 33.23 22.96 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.269 -0.423 . . . . 22.9 111.698 179.173 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' D' D ' 43' ' ' GLY . . . . . . . . . . . . . . . 80.9 -10.13 48.82 Favored Glycine 0 CA--C 1.535 1.293 0 C-N-CA 121.188 -0.53 . . . . 23.16 113.433 177.303 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' D' D ' 44' ' ' LYS . . . . . . . . . . . . . 94.6 mttt -99.05 137.33 37.73 Favored 'General case' 0 C--N 1.332 -0.173 0 CA-C-N 117.966 0.883 . . . . 21.23 110.285 178.622 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' D' D ' 45' ' ' GLU . . . . . . . . . . . . . 84.7 tt0 -85.21 130.61 34.57 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.257 -0.429 . . . . 20.64 111.474 -178.686 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' D' D ' 46' ' ' VAL . . . . . . . . . . . . . 7.4 p -125.37 126.2 70.26 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.22 0 N-CA-C 109.275 -0.639 . . . . 16.96 109.275 173.333 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' D' D ' 47' ' ' LYS . . . . . . . . . . . . . 9.7 mtmp? -101.46 131.27 47.67 Favored 'General case' 0 C--N 1.331 -0.23 0 CA-C-N 116.165 -0.47 . . . . 18.29 111.688 179.204 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' D' D ' 48' ' ' PHE . . . . . . . . . . . . . 92.2 m-85 -114.58 133.63 55.67 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 115.893 -0.594 . . . . 13.84 109.985 176.32 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' D' D ' 49' ' ' LYS . . . . . . . . . . . . . 60.7 tttm -105.33 137.61 42.86 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.743 -0.208 . . . . 13.73 110.559 179.065 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' D' D ' 50' ' ' VAL . . . . . . . . . . . . . 44.2 t -81.04 108.35 14.28 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.268 0 N-CA-C 109.275 -0.639 . . . . 14.42 109.275 175.862 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' D' D ' 51' ' ' VAL . . . . . . . . . . . . . 48.4 t -73.23 -47.35 47.23 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.351 0 CA-C-N 116.224 -0.443 . . . . 12.84 110.107 -173.821 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' D' D ' 52' ' ' GLN . . . . . . . . . . . . . 48.4 tt0 -162.54 136.82 6.5 Favored 'General case' 0 C--N 1.331 -0.234 0 C-N-CA 120.354 -0.538 . . . . 14.45 111.648 -178.378 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' D' D ' 53' ' ' ALA . . . . . . . . . . . . . . . -110.06 131.3 55.18 Favored 'General case' 0 C--N 1.332 -0.19 0 CA-C-N 115.852 -0.613 . . . . 16.93 109.891 175.482 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' D' D ' 54' ' ' TYR . . . . . . . . . . . . . 8.9 t80 -129.02 108.34 18.12 Favored Pre-proline 0 CA--C 1.534 0.361 0 CA-C-O 118.333 -0.842 . . . . 20.68 110.47 179.8 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' D' D ' 55' ' ' PRO . . . . . . . . . . . . . 74.2 Cg_endo -77.14 170.05 72.6 Favored 'Cis proline' 0 N--CA 1.5 1.858 0 CA-C-N 121.831 1.689 . . . . 21.15 112.481 -5.288 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' D' D ' 56' ' ' SER . . . . . . . . . . . . . 50.1 m -117.29 133.62 23.17 Favored Pre-proline 0 CA--C 1.538 0.515 0 CA-C-O 118.511 -0.757 . . . . 21.68 109.714 175.307 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' D' D ' 57' ' ' PRO . . . . . . . . . . . . . 38.0 Cg_endo -68.09 165.15 72.06 Favored 'Cis proline' 0 N--CA 1.496 1.666 0 CA-C-N 121.828 1.689 . . . . 22.71 111.217 -3.535 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' D' D ' 58' ' ' LEU . . . . . . . . . . . . . 25.0 tp -130.2 136.29 49.08 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-O 120.937 0.399 . . . . 19.85 110.891 -179.001 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' D' D ' 59' ' ' ARG . . . . . . . . . . . . . 55.8 ttp180 -101.73 124.39 47.3 Favored 'General case' 0 C--N 1.327 -0.377 0 N-CA-C 109.08 -0.711 . . . . 25.3 109.08 174.383 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' D' D ' 60' ' ' VAL . . . . . . . . . . . . . 41.3 t -82.12 122.49 36.96 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.304 0 C-N-CA 120.677 -0.409 . . . . 20.84 110.491 -174.538 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' D' D ' 61' ' ' GLU . . . . . . . . . . . . . 45.2 mt-10 -131.13 169.72 15.51 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 115.972 -0.558 . . . . 23.88 109.74 177.415 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' D' D ' 62' ' ' ASP . . . . . . . . . . . . . 6.9 p-10 -55.3 -32.32 62.34 Favored 'General case' 0 C--N 1.328 -0.366 0 N-CA-C 111.743 0.275 . . . . 23.34 111.743 -179.123 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' D' D ' 63' ' ' ARG . . . . . . . . . . . . . 40.2 ptt180 -77.63 -8.44 57.88 Favored 'General case' 0 CA--C 1.537 0.451 0 N-CA-C 113.669 0.988 . . . . 25.78 113.669 -176.415 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' D' D ' 64' ' ' THR . . . . . . . . . . . . . 36.9 m -77.29 136.68 38.51 Favored 'General case' 0 C--N 1.333 -0.116 0 CA-C-O 120.902 0.382 . . . . 19.75 110.73 -176.149 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' D' D ' 65' ' ' LYS . . . . . . . . . . . . . 61.2 mttm -89.51 127.6 35.88 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.026 -0.534 . . . . 18.76 110.031 178.043 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' D' D ' 66' ' ' ILE . . . . . . . . . . . . . 62.5 mt -113.31 127.78 70.44 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.284 0 N-CA-C 109.66 -0.496 . . . . 15.71 109.66 179.376 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' D' D ' 67' ' ' THR . . . . . . . . . . . . . 18.3 m -124.37 141.74 51.83 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.226 -0.443 . . . . 12.72 110.825 -176.925 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' D' D ' 68' ' ' LEU . . . . . . . . . . . . . 16.6 tp . . . . . 0 C--N 1.329 -0.313 0 CA-C-N 115.938 -0.574 . . . . 10.78 110.038 178.545 . . . . . . . . 0 0 . 1 . 001 nuclear nobuild core ' D' D ' 73' ' ' VAL . . . . . . . . . . . . . 34.9 m . . . . . 0 N--CA 1.461 0.122 0 CA-C-O 120.841 0.353 . . . . 1.1 110.578 . . . . . . . . . 0 0 . 1 . 001 nuclear nobuild core ' D' D ' 74' ' ' ASP . . . . . . . . . . . . . 21.5 t70 -100.57 118.49 36.85 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.088 -0.506 . . . . 0.93 109.947 179.648 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' D' D ' 75' ' ' VAL . . . . . . . . . . . . . 43.9 t -113.97 122.38 67.97 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.213 0 CA-C-O 121.118 0.485 . . . . 0.71 110.555 -177.654 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' D' D ' 76' ' ' LEU . . . . . . . . . . . . . 14.1 mt -125.92 138.26 53.76 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 115.52 -0.764 . . . . 1.2 109.059 175.77 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' D' D ' 77' ' ' GLU . . . . . . . . . . . . . 73.3 tt0 -136.43 141.93 43.62 Favored 'General case' 0 C--N 1.332 -0.17 0 CA-C-O 121.118 0.485 . . . . 1.29 111.591 -173.762 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' D' D ' 78' ' ' ALA . . . . . . . . . . . . . . . -127.88 145.12 51.05 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 115.52 -0.764 . . . . 0.68 109.94 177.476 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' D' D ' 79' ' ' LYS . . . . . 0.563 ' O ' HD13 ' D' ' 80' ' ' ILE . 45.8 mttm -81.48 123.86 28.97 Favored 'General case' 0 C--N 1.331 -0.234 0 C-N-CA 120.753 -0.379 . . . . 3.12 110.688 178.913 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' D' D ' 80' ' ' ILE . . . . . 0.563 HD13 ' O ' ' D' ' 79' ' ' LYS . 42.8 mm -138.46 113.7 9.23 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.343 0 N-CA-C 109.212 -0.662 . . . . 0.59 109.212 -179.15 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' D' D ' 81' ' ' LYS . . . . . . . . . . . . . 58.6 mttp -102.04 121.94 43.14 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-O 120.784 0.326 . . . . 3.19 111.243 -176.536 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' D' D ' 82' ' ' GLY . . . . . . . . . . . . . . . 89.07 42.14 5.69 Favored Glycine 0 CA--C 1.525 0.702 0 C-N-CA 120.935 -0.65 . . . . 0.48 112.006 173.702 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' D' D ' 83' ' ' ILE . . . . . . . . . . . . . 76.3 mt -65.69 136.93 25.88 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.257 0 N-CA-C 109.765 -0.457 . . . . 0.52 109.765 177.113 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' D' D ' 84' ' ' LYS . . . . . . . . . . . . . 55.2 tttp -98.66 -53.63 3.25 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.21 -0.45 . . . . 1.6 110.275 -178.757 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' D' D ' 85' ' ' ASP . . . . . . . . . . . . . 20.9 t0 -152.86 149.72 28.57 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 115.755 -0.657 . . . . 0.83 110.28 -179.756 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' D' D ' 86' ' ' VAL . . . . . . . . . . . . . 40.5 t -133.79 131.16 56.42 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.286 0 CA-C-O 120.973 0.416 . . . . 0.47 110.56 -179.702 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' D' D ' 87' ' ' ILE . . . . . . . . . . . . . 45.3 mm -119.85 129.54 75.27 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.243 0 CA-C-N 115.795 -0.639 . . . . 1.31 109.695 176.857 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' D' D ' 88' ' ' LEU . . . . . 0.503 HD22 HG12 ' C' ' 131' ' ' VAL . 17.0 tp -112.6 135.75 52.96 Favored 'General case' 0 C--N 1.331 -0.203 0 CA-C-O 121.083 0.468 . . . . 1.72 111.289 -177.354 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' D' D ' 89' ' ' ASP . . . . . . . . . . . . . 20.6 t70 -128.62 155.11 45.48 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 115.545 -0.752 . . . . 0.88 109.253 174.587 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' D' D ' 90' ' ' GLU . . . . . . . . . . . . . 82.6 tt0 -46.97 -39.95 13.43 Favored 'General case' 0 C--N 1.33 -0.243 0 N-CA-C 112.964 0.727 . . . . 2.54 112.964 -171.887 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' D' D ' 91' ' ' ASN . . . . . . . . . . . . . 7.4 t-20 -132.07 37.85 3.55 Favored 'General case' 0 N--CA 1.463 0.189 0 CA-C-O 120.836 0.351 . . . . 2.21 111.437 -177.223 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' D' D ' 92' ' ' LEU . . . . . . . . . . . . . 11.7 tp -166.09 140.37 4.43 Favored 'General case' 0 C--N 1.33 -0.246 0 C-N-CA 121.01 -0.276 . . . . 1.41 110.602 -179.038 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' D' D ' 93' ' ' ILE . . . . . . . . . . . . . 71.3 mt -124.14 122.62 64.75 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.188 0 N-CA-C 109.653 -0.499 . . . . 0.47 109.653 178.679 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' D' D ' 94' ' ' VAL . . . . . 0.706 HG21 HG11 ' D' ' 125' ' ' VAL . 42.9 t -120.77 125.07 73.64 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.214 0 N-CA-C 109.901 -0.407 . . . . 0.44 109.901 179.52 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' D' D ' 95' ' ' VAL . . . . . . . . . . . . . 42.9 t -123.88 135.16 64.42 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.25 0 CA-C-N 116.097 -0.502 . . . . 0.38 110.109 -178.448 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' D' D ' 96' ' ' ILE . . . . . . . . . . . . . 58.3 mt -116.59 128.49 73.94 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.28 0 N-CA-C 109.256 -0.646 . . . . 0.51 109.256 178.37 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' D' D ' 97' ' ' THR . . . . . . . . . . . . . 81.2 p -103.7 155.79 18.3 Favored 'General case' 0 C--N 1.331 -0.222 0 CA-C-O 121.356 0.598 . . . . 0.48 111.561 -176.74 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' D' D ' 98' ' ' GLU . . . . . . . . . . . . . 84.8 tt0 -54.0 -27.26 30.6 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 115.836 -0.62 . . . . 2.67 112.191 179.504 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' D' D ' 99' ' ' GLU . . . . . . . . . . . . . 46.0 mp0 -78.93 16.2 0.94 Allowed 'General case' 0 CA--C 1.536 0.406 0 N-CA-C 113.123 0.786 . . . . 2.3 113.123 -177.474 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' D' D ' 100' ' ' ASN . . . . . . . . . . . . . 1.8 m-20 63.59 37.34 10.37 Favored 'General case' 0 CA--C 1.529 0.147 0 CA-C-O 121.007 0.432 . . . . 0.62 110.945 176.757 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' D' D ' 101' ' ' GLU . . . . . . . . . . . . . 84.9 tt0 -116.52 144.69 44.03 Favored 'General case' 0 C--N 1.332 -0.157 0 CA-C-N 116.187 -0.461 . . . . 1.1 109.892 176.88 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' D' D ' 102' ' ' VAL . . . . . . . . . . . . . 46.7 t -114.98 125.36 72.28 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.32 0 CA-C-N 116.116 -0.493 . . . . 0.43 109.815 -179.206 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' D' D ' 103' ' ' LEU . . . . . 0.408 HD23 ' HG3' ' D' ' 114' ' ' ARG . 19.2 mt -117.36 128.93 55.52 Favored 'General case' 0 C--N 1.331 -0.219 0 CA-C-N 115.789 -0.642 . . . . 0.97 110.19 178.08 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' D' D ' 104' ' ' ILE . . . . . . . . . . . . . 71.9 mt -119.09 120.69 64.68 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.278 0 N-CA-C 110.042 -0.355 . . . . 0.39 110.042 177.807 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' D' D ' 105' ' ' PHE . . . . . . . . . . . . . 97.4 m-85 -118.47 161.23 20.34 Favored 'General case' 0 C--N 1.332 -0.187 0 O-C-N 124.084 0.865 . . . . 0.42 110.129 -178.627 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' D' D ' 106' ' ' ASN . . . . . . . . . . . . . 18.4 p-10 -93.26 -170.63 2.44 Favored 'General case' 0 C--N 1.329 -0.315 0 N-CA-C 109.805 -0.443 . . . . 0.53 109.805 172.278 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' D' D ' 107' ' ' GLN . . . . . . . . . . . . . 48.8 tt0 -59.63 -30.2 68.54 Favored 'General case' 0 C--N 1.328 -0.336 0 N-CA-C 112.0 0.37 . . . . 1.77 112.0 -179.849 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' D' D ' 108' ' ' ASN . . . . . . . . . . . . . 13.1 t30 -85.55 8.29 19.86 Favored 'General case' 0 CA--C 1.536 0.428 0 N-CA-C 113.293 0.849 . . . . 1.37 113.293 -177.292 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' D' D ' 109' ' ' LEU . . . . . . . . . . . . . 13.6 tp 61.97 43.76 8.84 Favored 'General case' 0 C--N 1.332 -0.18 0 CA-C-O 121.377 0.608 . . . . 1.37 110.854 178.797 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' D' D ' 110' ' ' GLU . . . . . . . . . . . . . 77.7 mm-40 -114.23 143.66 44.48 Favored 'General case' 0 C--N 1.331 -0.224 0 CA-C-N 116.035 -0.53 . . . . 2.08 109.998 176.557 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' D' D ' 111' ' ' GLU . . . . . . . . . . . . . 96.3 mt-10 -72.03 123.02 21.9 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-O 120.908 0.385 . . . . 1.92 111.197 -177.392 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' D' D ' 112' ' ' LEU . . . . . . . . . . . . . 12.3 mt -108.09 -44.89 4.06 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 115.932 -0.576 . . . . 0.62 109.795 175.0 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' D' D ' 113' ' ' TYR . . . . . . . . . . . . . 71.9 t80 -136.62 132.32 34.9 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 115.969 -0.56 . . . . 0.58 110.549 178.785 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' D' D ' 114' ' ' ARG . . . . . 0.408 ' HG3' HD23 ' D' ' 103' ' ' LEU . 56.3 ttp180 -139.74 121.75 15.66 Favored 'General case' 0 C--N 1.331 -0.225 0 CA-C-O 120.823 0.344 . . . . 3.47 110.498 178.662 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' D' D ' 115' ' ' GLY . . . . . . . . . . . . . . . -150.12 163.07 29.39 Favored Glycine 0 CA--C 1.524 0.604 0 N-CA-C 110.949 -0.86 . . . . 0.52 110.949 179.779 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' D' D ' 116' ' ' LYS . . . . . . . . . . . . . 40.2 ttpt -128.84 138.1 51.86 Favored 'General case' 0 C--N 1.331 -0.237 0 N-CA-C 110.098 -0.334 . . . . 1.54 110.098 177.84 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' D' D ' 117' ' ' PHE . . . . . . . . . . . . . 42.6 m-85 -135.81 113.89 11.34 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-N 116.334 -0.394 . . . . 0.55 110.148 -177.757 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' D' D ' 118' ' ' GLU . . . . . . . . . . . . . 96.9 mt-10 -56.97 -43.74 81.93 Favored 'General case' 0 C--N 1.328 -0.338 0 C-N-CA 120.883 -0.327 . . . . 2.59 110.832 -177.0 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' D' D ' 119' ' ' ASN . . . . . . . . . . . . . 10.1 m120 -96.44 30.98 2.36 Favored 'General case' 0 C--N 1.328 -0.349 0 N-CA-C 112.116 0.413 . . . . 1.6 112.116 -174.765 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' D' D ' 120' ' ' LEU . . . . . . . . . . . . . 20.2 tp -57.7 120.0 7.61 Favored 'General case' 0 N--CA 1.461 0.104 0 N-CA-C 110.009 -0.367 . . . . 0.63 110.009 176.854 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' D' D ' 121' ' ' ASN . . . . . . . . . . . . . 8.4 t-20 -111.95 -44.1 3.5 Favored 'General case' 0 C--N 1.332 -0.156 0 CA-C-N 116.597 -0.274 . . . . 2.02 111.132 -175.423 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' D' D ' 122' ' ' LYS . . . . . . . . . . . . . 98.4 mttt -143.82 145.17 32.15 Favored 'General case' 0 C--N 1.33 -0.274 0 C-N-CA 120.691 -0.404 . . . . 1.81 111.728 -177.316 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' D' D ' 123' ' ' VAL . . . . . . . . . . . . . 45.0 t -127.92 128.73 69.41 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.295 0 N-CA-C 109.383 -0.599 . . . . 0.62 109.383 175.318 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' D' D ' 124' ' ' LEU . . . . . . . . . . . . . 8.2 tp -130.81 134.73 47.09 Favored 'General case' 0 C--N 1.332 -0.179 0 CA-C-O 120.932 0.396 . . . . 1.62 110.367 -178.292 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' D' D ' 125' ' ' VAL . . . . . 0.706 HG11 HG21 ' D' ' 94' ' ' VAL . 35.1 m -130.66 137.53 55.87 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.208 0 CA-C-N 116.251 -0.431 . . . . 1.73 110.991 -178.551 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' D' D ' 126' ' ' ARG . . . . . . . . . . . . . 96.7 mtt-85 -148.71 119.21 7.4 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 115.947 -0.57 . . . . 3.32 109.934 176.097 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' D' D ' 127' ' ' ASN . . . . . . . . . . . . . 2.0 t30 56.29 -149.06 0.47 Allowed 'General case' 0 CA--C 1.541 0.632 0 N-CA-C 109.723 -0.473 . . . . 2.38 109.723 179.669 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' D' D ' 128' ' ' ASP . . . . . . . . . . . . . 11.8 p-10 -80.43 13.06 2.61 Favored 'General case' 0 CA--C 1.537 0.444 0 CA-C-N 118.78 0.718 . . . . 1.18 112.93 -179.993 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' D' D ' 129' ' ' LEU . . . . . . . . . . . . . 15.7 tp -110.02 133.15 53.5 Favored 'General case' 0 C--O 1.232 0.175 0 CA-C-N 118.217 0.462 . . . . 1.83 110.085 178.423 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' D' D ' 130' ' ' VAL . . . . . . . . . . . . . 41.4 t -122.65 139.81 48.37 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.308 0 CA-C-N 116.578 -0.283 . . . . 1.36 110.498 -176.987 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' D' D ' 131' ' ' VAL . . . . . 0.413 HG22 HD12 ' D' ' 140' ' ' LEU . 40.7 t -133.93 134.86 55.62 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.192 0 CA-C-O 121.087 0.47 . . . . 0.64 110.484 177.536 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' D' D ' 132' ' ' ILE . . . . . . . . . . . . . 72.3 mt -117.95 134.07 62.74 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.269 0 CA-C-N 115.61 -0.723 . . . . 0.49 109.424 179.294 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' D' D ' 133' ' ' ILE . . . . . . . . . . . . . 29.7 mm -115.35 120.57 65.06 Favored 'Isoleucine or valine' 0 C--O 1.234 0.262 0 CA-C-N 116.5 -0.318 . . . . 0.52 110.763 -175.254 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' D' D ' 134' ' ' ASP . . . . . . . . . . . . . 5.6 p-10 -136.41 148.14 47.63 Favored 'General case' 0 C--N 1.331 -0.203 0 CA-C-N 116.327 -0.397 . . . . 0.59 109.946 176.331 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' D' D ' 135' ' ' GLU . . . . . . . . . . . . . 84.6 tt0 -49.85 -28.46 6.51 Favored 'General case' 0 C--O 1.236 0.352 0 N-CA-C 112.582 0.586 . . . . 1.68 112.582 -175.277 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' D' D ' 136' ' ' GLN . . . . . . . . . . . . . 94.8 mt-30 -78.26 -36.12 47.29 Favored 'General case' 0 C--N 1.331 -0.223 0 N-CA-C 112.414 0.524 . . . . 2.43 112.414 -176.458 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' D' D ' 137' ' ' LYS . . . . . . . . . . . . . 35.3 pttt -170.06 177.0 4.44 Favored 'General case' 0 C--O 1.233 0.217 0 CA-C-O 121.827 0.822 . . . . 1.39 113.117 -170.821 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' D' D ' 138' ' ' LEU . . . . . . . . . . . . . 9.5 tp -113.18 129.2 56.59 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 114.233 -1.348 . . . . 0.76 109.797 178.311 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' D' D ' 139' ' ' THR . . . . . . . . . . . . . 36.9 m -112.09 126.02 54.73 Favored 'General case' 0 C--N 1.331 -0.22 0 CA-C-O 120.673 0.273 . . . . 0.47 110.616 179.197 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' D' D ' 140' ' ' LEU . . . . . 0.413 HD12 HG22 ' D' ' 131' ' ' VAL . 17.1 tp -115.01 124.28 51.23 Favored 'General case' 0 C--N 1.329 -0.299 0 N-CA-C 108.905 -0.776 . . . . 1.08 108.905 179.261 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' D' D ' 141' ' ' ILE . . . . . . . . . . . . . 20.0 mt -119.91 118.54 57.37 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.375 0 N-CA-C 109.808 -0.441 . . . . 0.53 109.808 -175.796 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' D' D ' 142' ' ' ARG . . . . . . . . . . . . . 74.3 ttt180 -109.75 124.02 50.53 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-N 115.141 -0.936 . . . . 2.96 110.453 -175.472 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' D' D ' 143' ' ' THR . . . . . . . . . . . . . 22.6 p . . . . . 0 C--O 1.22 -0.485 0 CA-C-O 118.015 -0.993 . . . . 1.86 110.601 -179.75 . . . . . . . . 0 0 . 1 . 001 nuclear nobuild core ' E' E ' 2' ' ' SER . . . . . . . . . . . . . 2.0 p . . . . . 0 N--CA 1.461 0.12 0 CA-C-O 121.075 0.464 . . . . 17.92 110.299 . . . . . . . . . 0 0 . 1 . 001 nuclear nobuild core ' E' E ' 3' ' ' GLU . . . . . . . . . . . . . 85.0 tt0 -140.33 139.14 35.37 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-N 115.711 -0.677 . . . . 15.6 110.869 -178.485 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' E' E ' 4' ' ' LEU . . . . . 0.428 HD21 HD21 ' E' ' 6' ' ' LEU . 18.8 tp -122.56 126.34 47.55 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 115.987 -0.551 . . . . 14.43 110.154 177.248 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' E' E ' 5' ' ' LYS . . . . . . . . . . . . . 91.4 mttt -103.43 120.31 40.58 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.238 -0.437 . . . . 11.5 110.319 178.028 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' E' E ' 6' ' ' LEU . . . . . 0.43 HD23 ' HA ' ' E' ' 50' ' ' VAL . 69.6 mt -118.32 149.9 40.4 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 115.565 -0.743 . . . . 12.06 110.437 -178.68 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' E' E ' 7' ' ' LYS . . . . . . . . . . . . . 59.8 tttm -135.67 141.69 38.06 Favored Pre-proline 0 CA--C 1.534 0.351 0 CA-C-O 119.192 -0.432 . . . . 10.04 110.039 176.976 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' E' E ' 8' ' ' PRO . . . . . . . . . . . . . 75.1 Cg_endo -88.52 136.97 3.39 Favored 'Trans proline' 0 N--CA 1.49 1.295 0 C-N-CA 121.643 1.562 . . . . 9.88 111.568 178.924 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' E' E ' 9' ' ' LEU . . . . . . . . . . . . . 81.8 mt -77.72 -52.17 1.7 Allowed Pre-proline 0 C--N 1.33 -0.258 0 CA-C-O 119.057 -0.497 . . . . 13.89 111.587 -177.95 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' E' E ' 10' ' ' PRO . . . . . . . . . . . . . 57.2 Cg_endo -73.19 148.3 43.9 Favored 'Trans proline' 0 N--CA 1.496 1.67 0 C-N-CA 121.049 1.166 . . . . 13.57 111.439 172.399 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' E' E ' 11' ' ' LYS . . . . . . . . . . . . . 63.9 mttp -82.91 97.34 8.63 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-O 120.84 0.352 . . . . 12.82 110.853 -179.124 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' E' E ' 12' ' ' VAL . . . . . . . . . . . . . 12.3 p -142.72 144.25 24.6 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.334 0 CA-C-N 116.09 -0.505 . . . . 14.34 110.422 178.802 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' E' E ' 13' ' ' GLU . . . . . . . . . . . . . 85.0 tt0 -87.0 129.39 34.9 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.312 -0.403 . . . . 14.37 109.947 177.539 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' E' E ' 14' ' ' LEU . . . . . . . . . . . . . 21.3 mt -91.36 148.19 37.07 Favored Pre-proline 0 CA--C 1.533 0.309 0 C-N-CA 120.804 -0.358 . . . . 13.43 110.51 -176.701 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' E' E ' 15' ' ' PRO . . . . . . . . . . . . . 26.5 Cg_exo -62.22 161.2 27.62 Favored 'Trans proline' 0 N--CA 1.496 1.632 0 C-N-CA 121.321 1.348 . . . . 15.98 111.84 175.497 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' E' E ' 16' ' ' PRO . . . . . . . . . . . . . 35.7 Cg_exo -59.08 -31.88 96.38 Favored 'Trans proline' 0 N--CA 1.496 1.673 0 C-N-CA 121.45 1.433 . . . . 15.78 112.704 -178.779 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' E' E ' 17' ' ' ASP . . . . . . . . . . . . . 3.0 p30 -93.58 8.5 40.54 Favored 'General case' 0 CA--C 1.535 0.403 0 N-CA-C 113.302 0.853 . . . . 17.13 113.302 -176.847 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' E' E ' 18' ' ' PHE . . . . . . . . . . . . . 47.4 t80 -57.93 -44.47 86.93 Favored 'General case' 0 C--N 1.334 -0.105 0 CA-C-N 118.098 0.408 . . . . 14.38 110.184 -178.074 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' E' E ' 19' ' ' VAL . . . . . . . . . . . . . 47.8 t -57.35 -42.95 81.44 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 CA-C-N 116.311 -0.404 . . . . 13.57 110.345 -178.624 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' E' E ' 20' ' ' ASP . . . . . . . . . . . . . 8.5 m-20 -59.2 -41.98 89.86 Favored 'General case' 0 C--N 1.329 -0.32 0 C-N-CA 120.85 -0.34 . . . . 15.68 110.554 -178.268 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' E' E ' 21' ' ' VAL . . . . . . . . . . . . . 47.1 t -64.78 -46.78 91.03 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.347 0 C-N-CA 120.829 -0.348 . . . . 17.06 110.612 -178.079 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' E' E ' 22' ' ' ILE . . . . . 0.655 HG22 HD12 ' E' ' 26' ' ' LEU . 48.3 mm -61.22 -34.65 61.48 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 C-N-CA 120.981 -0.287 . . . . 15.74 111.253 -178.303 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' E' E ' 23' ' ' ARG . . . . . . . . . . . . . 58.3 ttp180 -60.52 -51.58 68.82 Favored 'General case' 0 C--N 1.331 -0.235 0 C-N-CA 120.537 -0.465 . . . . 16.75 110.164 176.135 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' E' E ' 24' ' ' ILE . . . . . . . . . . . . . 78.5 mt -60.76 -39.3 81.3 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.323 0 CA-C-N 115.968 -0.56 . . . . 18.88 111.985 -176.467 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' E' E ' 25' ' ' LYS . . . . . . . . . . . . . 11.7 ptmm? -76.67 -39.39 52.28 Favored 'General case' 0 CA--C 1.535 0.37 0 N-CA-C 112.003 0.371 . . . . 19.21 112.003 -174.615 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' E' E ' 26' ' ' LEU . . . . . 0.655 HD12 HG22 ' E' ' 22' ' ' ILE . 30.6 mt -78.82 -32.34 46.19 Favored 'General case' 0 C--N 1.332 -0.183 0 N-CA-C 113.51 0.93 . . . . 18.9 113.51 -172.267 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' E' E ' 27' ' ' GLN . . . . . . . . . . . . . 10.6 pt20 -46.69 139.02 5.57 Favored 'General case' 0 N--CA 1.471 0.593 0 N-CA-C 112.862 0.689 . . . . 20.23 112.862 -175.481 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' E' E ' 28' ' ' GLY . . . . . . . . . . . . . . . 97.17 -22.17 42.2 Favored Glycine 0 CA--C 1.534 1.245 0 CA-C-N 115.554 -0.748 . . . . 22.39 112.554 -177.284 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' E' E ' 29' ' ' LYS . . . . . . . . . . . . . 93.1 mttt -98.29 155.14 17.34 Favored 'General case' 0 C--O 1.232 0.176 0 CA-C-N 117.419 0.609 . . . . 22.36 111.136 -179.469 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' E' E ' 30' ' ' THR . . . . . . . . . . . . . 30.5 m -105.68 139.33 40.44 Favored 'General case' 0 C--N 1.332 -0.191 0 CA-C-N 116.029 -0.532 . . . . 22.55 110.341 177.659 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' E' E ' 31' ' ' VAL . . . . . . . . . . . . . 34.8 m -131.15 154.11 40.15 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.21 0 CA-C-N 116.33 -0.395 . . . . 19.56 110.821 -179.766 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' E' E ' 32' ' ' ARG . . . . . . . . . . . . . 22.2 ttp180 -136.15 151.32 49.63 Favored 'General case' 0 C--N 1.331 -0.219 0 CA-C-O 121.225 0.535 . . . . 24.48 110.439 177.004 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' E' E ' 33' ' ' THR . . . . . . . . . . . . . 41.9 m -52.78 138.64 28.75 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 116.258 -0.428 . . . . 18.58 111.417 -179.228 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' E' E ' 34' ' ' GLY . . . . . . . . . . . . . . . 98.68 -17.1 58.84 Favored Glycine 0 CA--C 1.531 1.092 0 CA-C-N 116.048 -0.524 . . . . 17.78 113.369 177.312 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' E' E ' 35' ' ' ASP . . . . . . . . . . . . . 80.9 m-20 -66.6 147.39 53.34 Favored 'General case' 0 C--O 1.231 0.129 0 CA-C-N 118.015 0.907 . . . . 20.26 111.232 179.488 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' E' E ' 36' ' ' VAL . . . . . . . . . . . . . 44.1 t -121.13 128.2 75.99 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.264 0 N-CA-C 109.443 -0.577 . . . . 18.85 109.443 175.96 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' E' E ' 37' ' ' ILE . . . . . . . . . . . . . 66.4 mt -120.32 139.72 46.71 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.271 0 CA-C-N 116.328 -0.396 . . . . 17.65 110.156 -177.96 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' E' E ' 38' ' ' GLY . . . . . . . . . . . . . . . -108.22 128.57 9.18 Favored Glycine 0 CA--C 1.524 0.653 0 N-CA-C 110.884 -0.887 . . . . 19.38 110.884 177.739 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' E' E ' 39' ' ' ILE . . . . . . . . . . . . . 74.4 mt -124.48 135.31 64.22 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.193 0 N-CA-C 110.085 -0.339 . . . . 18.73 110.085 179.479 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' E' E ' 40' ' ' SER . . . . . 0.51 ' O ' HD13 ' E' ' 41' ' ' ILE . 34.6 t -92.56 116.96 29.46 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.433 -0.349 . . . . 22.11 110.86 176.241 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' E' E ' 41' ' ' ILE . . . . . 0.51 HD13 ' O ' ' E' ' 40' ' ' SER . 48.5 mm -128.94 128.16 67.03 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.19 0 CA-C-O 120.778 0.323 . . . . 20.19 110.407 179.37 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' E' E ' 42' ' ' LEU . . . . . . . . . . . . . 56.7 mt 54.59 33.03 18.24 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.194 -0.457 . . . . 22.67 111.856 177.824 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' E' E ' 43' ' ' GLY . . . . . . . . . . . . . . . 71.16 28.74 69.68 Favored Glycine 0 CA--C 1.532 1.106 0 C-N-CA 121.109 -0.567 . . . . 23.39 112.176 177.872 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' E' E ' 44' ' ' LYS . . . . . . . . . . . . . 45.9 tttp -141.75 137.7 31.81 Favored 'General case' 0 C--N 1.33 -0.263 0 N-CA-C 109.773 -0.454 . . . . 21.45 109.773 179.464 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' E' E ' 45' ' ' GLU . . . . . . . . . . . . . 83.7 tt0 -82.36 126.64 32.4 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-O 120.934 0.397 . . . . 21.32 111.18 -176.993 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' E' E ' 46' ' ' VAL . . . . . . . . . . . . . 7.6 p -124.32 129.83 73.84 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.222 0 N-CA-C 109.367 -0.605 . . . . 17.3 109.367 175.822 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' E' E ' 47' ' ' LYS . . . . . . . . . . . . . 98.7 mttt -101.07 132.61 46.43 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.087 -0.506 . . . . 19.29 111.364 179.799 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' E' E ' 48' ' ' PHE . . . . . . . . . . . . . 92.3 m-85 -117.01 132.02 56.8 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.267 -0.424 . . . . 14.33 110.364 176.952 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' E' E ' 49' ' ' LYS . . . . . . . . . . . . . 84.6 tttt -106.78 137.28 45.11 Favored 'General case' 0 C--N 1.331 -0.23 0 CA-C-N 116.503 -0.317 . . . . 14.41 110.45 178.045 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' E' E ' 50' ' ' VAL . . . . . 0.43 ' HA ' HD23 ' E' ' 6' ' ' LEU . 44.7 t -84.29 111.13 19.68 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.258 0 N-CA-C 109.245 -0.65 . . . . 14.75 109.245 175.701 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' E' E ' 51' ' ' VAL . . . . . . . . . . . . . 46.8 t -72.66 -46.72 53.37 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.317 0 CA-C-N 116.265 -0.425 . . . . 13.28 110.053 -174.269 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' E' E ' 52' ' ' GLN . . . . . . . . . . . . . 46.9 tt0 -169.04 142.6 2.87 Favored 'General case' 0 C--N 1.331 -0.205 0 C-N-CA 120.295 -0.562 . . . . 14.71 111.776 -178.922 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' E' E ' 53' ' ' ALA . . . . . . . . . . . . . . . -116.13 135.41 53.95 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-N 115.714 -0.675 . . . . 17.09 110.106 176.589 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' E' E ' 54' ' ' TYR . . . . . . . . . . . . . 62.5 t80 -128.94 109.23 18.34 Favored Pre-proline 0 CA--C 1.536 0.427 0 CA-C-O 118.26 -0.876 . . . . 20.27 110.181 178.688 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' E' E ' 55' ' ' PRO . . . . . . . . . . . . . 74.0 Cg_endo -77.09 170.06 72.65 Favored 'Cis proline' 0 N--CA 1.499 1.826 0 CA-C-N 121.81 1.682 . . . . 20.84 112.445 -4.544 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' E' E ' 56' ' ' SER . . . . . . . . . . . . . 13.6 m -113.99 126.96 27.34 Favored Pre-proline 0 CA--C 1.538 0.498 0 CA-C-O 118.405 -0.807 . . . . 22.33 109.476 176.28 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' E' E ' 57' ' ' PRO . . . . . . . . . . . . . 56.9 Cg_endo -72.64 169.04 73.39 Favored 'Cis proline' 0 N--CA 1.497 1.704 0 CA-C-N 122.083 1.78 . . . . 23.32 111.848 -0.096 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' E' E ' 58' ' ' LEU . . . . . . . . . . . . . 28.9 tp -130.0 137.7 50.42 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.139 -0.482 . . . . 19.78 110.294 179.95 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' E' E ' 59' ' ' ARG . . . . . . . . . . . . . 52.2 ttp180 -105.19 128.75 53.55 Favored 'General case' 0 C--N 1.328 -0.35 0 N-CA-C 109.239 -0.652 . . . . 24.23 109.239 176.106 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' E' E ' 60' ' ' VAL . . . . . . . . . . . . . 41.9 t -85.39 119.08 33.38 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.272 0 C-N-CA 120.607 -0.437 . . . . 18.94 110.919 -173.992 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' E' E ' 61' ' ' GLU . . . . . . . . . . . . . 47.2 mt-10 -131.03 170.11 14.94 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 115.703 -0.68 . . . . 21.28 109.492 174.29 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' E' E ' 62' ' ' ASP . . . . . . . . . . . . . 4.5 m-20 -53.23 -32.67 49.46 Favored 'General case' 0 C--N 1.329 -0.308 0 N-CA-C 111.925 0.343 . . . . 19.55 111.925 -177.609 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' E' E ' 63' ' ' ARG . . . . . . . . . . . . . 98.2 mtt180 -73.13 -22.0 60.62 Favored 'General case' 0 CA--C 1.533 0.289 0 N-CA-C 113.038 0.755 . . . . 21.98 113.038 -176.188 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' E' E ' 64' ' ' THR . . . . . . . . . . . . . 26.7 m -66.42 137.24 56.71 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-O 120.983 0.42 . . . . 17.14 111.061 -174.692 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' E' E ' 65' ' ' LYS . . . . . . . . . . . . . 67.5 mttm -89.71 129.79 36.08 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 115.927 -0.579 . . . . 16.15 109.967 177.207 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' E' E ' 66' ' ' ILE . . . . . . . . . . . . . 63.2 mt -118.83 129.57 74.86 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.287 0 N-CA-C 109.849 -0.426 . . . . 13.46 109.849 -179.775 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' E' E ' 67' ' ' THR . . . . . . . . . . . . . 25.9 m -127.38 139.82 52.59 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-O 120.95 0.405 . . . . 10.58 110.994 -178.165 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' E' E ' 68' ' ' LEU . . . . . . . . . . . . . 65.4 mt . . . . . 0 C--N 1.331 -0.226 0 CA-C-N 116.056 -0.52 . . . . 8.76 110.528 177.912 . . . . . . . . 0 0 . 1 . 001 nuclear nobuild core ' E' E ' 73' ' ' VAL . . . . . . . . . . . . . 26.9 m . . . . . 0 C--O 1.232 0.138 0 CA-C-O 120.972 0.415 . . . . 1.03 110.452 . . . . . . . . . 0 0 . 1 . 001 nuclear nobuild core ' E' E ' 74' ' ' ASP . . . . . . . . . . . . . 21.6 t0 -96.08 119.91 35.42 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 115.907 -0.588 . . . . 0.96 109.544 179.853 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' E' E ' 75' ' ' VAL . . . . . . . . . . . . . 41.8 t -107.54 119.32 56.93 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.268 0 CA-C-O 121.071 0.462 . . . . 0.72 110.233 -178.973 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' E' E ' 76' ' ' LEU . . . . . . . . . . . . . 34.8 mt -115.11 137.86 51.54 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 115.592 -0.731 . . . . 1.25 109.435 177.232 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' E' E ' 77' ' ' GLU . . . . . . . . . . . . . 98.0 mt-10 -134.06 131.45 38.84 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-O 121.064 0.459 . . . . 1.17 111.061 -177.769 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' E' E ' 78' ' ' ALA . . . . . . . . . . . . . . . -119.1 124.07 45.99 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 115.654 -0.703 . . . . 0.61 109.625 176.419 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' E' E ' 79' ' ' LYS . . . . . 0.606 ' O ' HD13 ' E' ' 80' ' ' ILE . 7.8 ttpm? -74.58 122.82 23.73 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-O 120.876 0.369 . . . . 2.97 110.615 -177.162 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' E' E ' 80' ' ' ILE . . . . . 0.606 HD13 ' O ' ' E' ' 79' ' ' LYS . 39.6 mm -139.06 113.72 7.84 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.298 0 N-CA-C 109.009 -0.737 . . . . 0.63 109.009 -178.443 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' E' E ' 81' ' ' LYS . . . . . . . . . . . . . 29.2 tttp -98.94 118.12 35.0 Favored 'General case' 0 C--N 1.327 -0.397 0 CA-C-N 116.524 -0.307 . . . . 2.98 110.646 -175.381 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' E' E ' 82' ' ' GLY . . . . . . . . . . . . . . . 89.16 42.32 5.62 Favored Glycine 0 CA--C 1.527 0.818 0 C-N-CA 120.421 -0.895 . . . . 0.62 112.058 175.282 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' E' E ' 83' ' ' ILE . . . . . . . . . . . . . 77.1 mt -61.67 142.37 16.37 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.293 0 N-CA-C 109.704 -0.48 . . . . 0.62 109.704 175.994 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' E' E ' 84' ' ' LYS . . . . . . . . . . . . . 84.9 tttt -98.68 -54.02 3.14 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.11 -0.495 . . . . 1.64 110.536 -178.293 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' E' E ' 85' ' ' ASP . . . . . . . . . . . . . 11.6 t70 -156.37 155.67 32.58 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 115.769 -0.651 . . . . 0.83 110.254 -178.912 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' E' E ' 86' ' ' VAL . . . . . . . . . . . . . 43.5 t -129.28 130.86 67.86 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.268 0 CA-C-O 121.048 0.451 . . . . 0.58 110.622 -178.308 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' E' E ' 87' ' ' ILE . . . . . . . . . . . . . 44.1 mm -118.74 122.81 70.34 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.281 0 CA-C-N 115.651 -0.704 . . . . 1.46 109.249 175.653 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' E' E ' 88' ' ' LEU . . . . . . . . . . . . . 14.4 tp -115.03 131.7 56.84 Favored 'General case' 0 C--N 1.331 -0.217 0 CA-C-O 121.014 0.435 . . . . 1.69 111.256 -176.072 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' E' E ' 89' ' ' ASP . . . . . . . . . . . . . 21.3 t70 -125.5 154.41 42.12 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 115.788 -0.642 . . . . 0.91 109.472 175.427 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' E' E ' 90' ' ' GLU . . . . . . . . . . . . . 48.1 mt-10 -49.46 -34.43 16.79 Favored 'General case' 0 C--N 1.328 -0.336 0 N-CA-C 112.845 0.683 . . . . 2.25 112.845 -171.653 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' E' E ' 91' ' ' ASN . . . . . . . . . . . . . 37.6 p-10 -132.0 32.2 4.07 Favored 'General case' 0 N--CA 1.466 0.33 0 N-CA-C 112.17 0.433 . . . . 2.37 112.17 -176.096 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' E' E ' 92' ' ' LEU . . . . . . . . . . . . . 16.0 tp -166.04 141.75 4.87 Favored 'General case' 0 C--N 1.329 -0.292 0 C-N-CA 120.886 -0.326 . . . . 1.45 110.668 179.56 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' E' E ' 93' ' ' ILE . . . . . . . . . . . . . 69.1 mt -121.45 121.75 65.43 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.217 0 N-CA-C 109.722 -0.473 . . . . 0.57 109.722 -179.583 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' E' E ' 94' ' ' VAL . . . . . . . . . . . . . 45.1 t -122.74 126.64 74.21 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.202 0 N-CA-C 109.969 -0.382 . . . . 0.53 109.969 179.212 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' E' E ' 95' ' ' VAL . . . . . . . . . . . . . 42.2 t -124.0 135.88 62.15 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.307 0 CA-C-N 116.276 -0.42 . . . . 0.75 110.01 -179.377 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' E' E ' 96' ' ' ILE . . . . . . . . . . . . . 59.2 mt -115.38 132.46 64.66 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.248 0 N-CA-C 109.429 -0.582 . . . . 0.54 109.429 179.408 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' E' E ' 97' ' ' THR . . . . . . . . . . . . . 68.9 p -103.56 158.92 16.03 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-O 120.906 0.384 . . . . 0.59 110.782 -179.579 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' E' E ' 98' ' ' GLU . . . . . . . . . . . . . 96.9 mt-10 -53.85 -24.21 15.04 Favored 'General case' 0 CA--C 1.533 0.327 0 N-CA-C 112.413 0.523 . . . . 2.63 112.413 -179.983 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' E' E ' 99' ' ' GLU . . . . . . . . . . . . . 95.3 mt-10 -78.43 14.36 1.27 Allowed 'General case' 0 CA--C 1.535 0.385 0 N-CA-C 113.218 0.821 . . . . 2.62 113.218 -176.7 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' E' E ' 100' ' ' ASN . . . . . . . . . . . . . 2.7 m-20 61.8 38.03 15.11 Favored 'General case' 0 N--CA 1.463 0.193 0 CA-C-O 121.148 0.499 . . . . 0.76 110.922 179.221 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' E' E ' 101' ' ' GLU . . . . . . . . . . . . . 61.2 tt0 -119.98 142.35 48.86 Favored 'General case' 0 C--N 1.331 -0.217 0 CA-C-N 116.093 -0.503 . . . . 0.85 109.673 176.404 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' E' E ' 102' ' ' VAL . . . . . . . . . . . . . 46.3 t -115.25 130.19 70.22 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.291 0 CA-C-N 116.227 -0.442 . . . . 0.49 110.162 -178.521 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' E' E ' 103' ' ' LEU . . . . . . . . . . . . . 20.0 mt -117.35 133.93 55.41 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 115.502 -0.772 . . . . 1.1 110.066 176.221 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' E' E ' 104' ' ' ILE . . . . . 0.604 HD13 HG11 ' E' ' 130' ' ' VAL . 67.0 mt -119.48 124.91 73.81 Favored 'Isoleucine or valine' 0 C--O 1.234 0.284 0 N-CA-C 110.192 -0.299 . . . . 0.49 110.192 179.912 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' E' E ' 105' ' ' PHE . . . . . . . . . . . . . 67.4 m-85 -123.92 163.4 21.39 Favored 'General case' 0 C--O 1.232 0.151 0 O-C-N 124.013 0.821 . . . . 0.56 110.182 -179.444 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' E' E ' 106' ' ' ASN . . . . . . . . . . . . . 40.1 p30 -98.39 -171.94 2.23 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.421 -0.354 . . . . 0.71 110.327 175.651 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' E' E ' 107' ' ' GLN . . . . . . . . . . . . . 59.5 tt0 -58.37 -29.53 66.08 Favored 'General case' 0 CA--C 1.534 0.329 0 N-CA-C 111.858 0.318 . . . . 1.69 111.858 178.774 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' E' E ' 108' ' ' ASN . . . . . . . . . . . . . 7.5 t-20 -83.24 10.95 7.29 Favored 'General case' 0 CA--C 1.536 0.422 0 N-CA-C 112.933 0.716 . . . . 1.39 112.933 -177.729 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' E' E ' 109' ' ' LEU . . . . . . . . . . . . . 12.5 tp 54.82 37.66 28.91 Favored 'General case' 0 C--N 1.332 -0.169 0 CA-C-O 121.023 0.44 . . . . 1.41 111.08 -179.509 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' E' E ' 110' ' ' GLU . . . . . . . . . . . . . 95.4 mt-10 -104.78 145.91 29.7 Favored 'General case' 0 C--N 1.331 -0.224 0 N-CA-C 109.704 -0.48 . . . . 1.89 109.704 175.275 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' E' E ' 111' ' ' GLU . . . . . . . . . . . . . 80.2 tt0 -83.69 122.15 28.24 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.401 -0.363 . . . . 1.32 110.747 -175.783 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' E' E ' 112' ' ' LEU . . . . . . . . . . . . . 49.4 mt -109.14 -45.26 3.79 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-N 116.095 -0.502 . . . . 0.64 111.128 -179.275 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' E' E ' 113' ' ' TYR . . . . . . . . . . . . . 58.0 t80 -132.96 137.58 46.62 Favored 'General case' 0 N--CA 1.464 0.238 0 CA-C-O 120.839 0.352 . . . . 0.47 111.36 -176.828 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' E' E ' 114' ' ' ARG . . . . . . . . . . . . . 47.5 ttp180 -138.73 123.66 18.88 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 115.831 -0.622 . . . . 2.83 110.123 177.361 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' E' E ' 115' ' ' GLY . . . . . . . . . . . . . . . -150.14 140.09 7.78 Favored Glycine 0 CA--C 1.526 0.719 0 C-N-CA 120.737 -0.744 . . . . 0.48 111.356 178.732 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' E' E ' 116' ' ' LYS . . . . . . . . . . . . . 27.5 ttpp -110.37 134.59 52.15 Favored 'General case' 0 C--N 1.33 -0.24 0 N-CA-C 109.748 -0.464 . . . . 1.84 109.748 176.618 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' E' E ' 117' ' ' PHE . . . . . . . . . . . . . 31.7 m-85 -135.57 113.9 11.52 Favored 'General case' 0 C--N 1.332 -0.191 0 C-N-CA 120.871 -0.331 . . . . 0.59 110.158 -176.817 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' E' E ' 118' ' ' GLU . . . . . . . . . . . . . 96.3 mt-10 -55.59 -45.71 77.36 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.519 -0.31 . . . . 2.45 111.176 -176.191 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' E' E ' 119' ' ' ASN . . . . . . . . . . . . . 68.3 m-80 -95.99 30.0 2.56 Favored 'General case' 0 C--N 1.329 -0.287 0 N-CA-C 112.22 0.452 . . . . 1.54 112.22 -174.172 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' E' E ' 120' ' ' LEU . . . . . . . . . . . . . 22.0 tp -58.39 122.13 12.54 Favored 'General case' 0 C--N 1.333 -0.149 0 N-CA-C 110.027 -0.36 . . . . 0.64 110.027 177.509 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' E' E ' 121' ' ' ASN . . . . . . . . . . . . . 68.2 m-20 -113.99 -44.07 3.19 Favored 'General case' 0 C--O 1.232 0.147 0 CA-C-N 116.534 -0.303 . . . . 1.89 111.094 -178.081 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' E' E ' 122' ' ' LYS . . . . . . . . . . . . . 60.7 mttm -145.1 149.51 35.16 Favored 'General case' 0 C--N 1.332 -0.18 0 CA-C-O 121.28 0.562 . . . . 1.81 112.064 -177.028 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' E' E ' 123' ' ' VAL . . . . . . . . . . . . . 47.3 t -126.68 129.66 71.59 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.239 0 CA-C-N 115.627 -0.715 . . . . 0.54 109.461 175.536 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' E' E ' 124' ' ' LEU . . . . . . . . . . . . . 57.6 mt -121.98 139.56 53.53 Favored 'General case' 0 N--CA 1.463 0.212 0 CA-C-N 116.551 -0.295 . . . . 1.39 110.792 -178.114 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' E' E ' 125' ' ' VAL . . . . . 0.585 HG12 HG23 ' E' ' 130' ' ' VAL . 34.3 m -137.23 139.87 43.25 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.239 0 CA-C-O 121.042 0.448 . . . . 1.56 111.603 -178.723 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' E' E ' 126' ' ' ARG . . . . . . . . . . . . . 93.4 mtt-85 -147.77 115.57 6.41 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 115.687 -0.688 . . . . 3.5 110.19 174.207 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' E' E ' 127' ' ' ASN . . . . . . . . . . . . . 93.4 m-20 53.79 -129.92 2.21 Favored 'General case' 0 CA--C 1.545 0.786 0 CA-C-O 118.557 -0.735 . . . . 2.24 110.552 179.578 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' E' E ' 128' ' ' ASP . . . . . . . . . . . . . 5.1 p30 -91.82 5.78 48.6 Favored 'General case' 0 CA--C 1.536 0.42 0 CA-C-N 120.078 1.308 . . . . 1.0 113.457 -178.216 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' E' E ' 129' ' ' LEU . . . . . . . . . . . . . 15.3 tp -105.41 134.51 48.41 Favored 'General case' 0 C--N 1.333 -0.115 0 CA-C-N 118.17 0.441 . . . . 1.81 109.834 178.555 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' E' E ' 130' ' ' VAL . . . . . 0.604 HG11 HD13 ' E' ' 104' ' ' ILE . 12.4 p -132.17 143.32 40.37 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.165 0 CA-C-O 121.019 0.438 . . . . 1.29 110.705 -177.943 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' E' E ' 131' ' ' VAL . . . . . 0.581 HG22 HD12 ' E' ' 140' ' ' LEU . 38.9 t -136.0 140.09 44.66 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.278 0 CA-C-N 116.034 -0.53 . . . . 0.91 110.437 -179.086 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' E' E ' 132' ' ' ILE . . . . . . . . . . . . . 76.3 mt -114.98 133.88 59.78 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.288 0 CA-C-N 115.67 -0.695 . . . . 0.53 109.472 179.515 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' E' E ' 133' ' ' ILE . . . . . . . . . . . . . 38.0 mm -116.57 119.16 61.14 Favored 'Isoleucine or valine' 0 C--O 1.236 0.345 0 CA-C-N 116.537 -0.301 . . . . 0.46 110.989 -175.58 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' E' E ' 134' ' ' ASP . . . . . . . . . . . . . 5.8 p-10 -135.21 148.5 49.65 Favored 'General case' 0 C--N 1.332 -0.167 0 N-CA-C 109.809 -0.441 . . . . 0.56 109.809 174.753 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' E' E ' 135' ' ' GLU . . . . . . . . . . . . . 44.6 tp10 -50.01 -28.06 6.41 Favored 'General case' 0 C--N 1.329 -0.323 0 N-CA-C 112.702 0.63 . . . . 2.01 112.702 -172.222 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' E' E ' 136' ' ' GLN . . . . . . . . . . . . . 95.9 mt-30 -81.98 -37.63 26.33 Favored 'General case' 0 C--O 1.234 0.272 0 N-CA-C 112.683 0.623 . . . . 2.44 112.683 -175.694 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' E' E ' 137' ' ' LYS . . . . . . . . . . . . . 20.3 pttp -160.47 169.52 22.85 Favored 'General case' 0 C--O 1.234 0.251 0 CA-C-O 121.825 0.821 . . . . 1.77 113.192 -169.801 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' E' E ' 138' ' ' LEU . . . . . . . . . . . . . 7.7 tp -111.96 127.83 55.98 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 114.085 -1.416 . . . . 0.51 109.459 177.859 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' E' E ' 139' ' ' THR . . . . . . . . . . . . . 27.3 m -113.59 123.59 50.33 Favored 'General case' 0 C--N 1.331 -0.221 0 CA-C-O 120.614 0.245 . . . . 0.42 110.39 178.699 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' E' E ' 140' ' ' LEU . . . . . 0.581 HD12 HG22 ' E' ' 131' ' ' VAL . 8.1 tp -113.36 121.39 44.21 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 115.884 -0.598 . . . . 1.01 109.44 -179.439 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' E' E ' 141' ' ' ILE . . . . . 0.514 ' HB ' HG13 ' E' ' 130' ' ' VAL . 19.4 mt -121.14 122.79 68.46 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.307 0 CA-C-O 121.053 0.454 . . . . 0.49 109.791 -176.218 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' E' E ' 142' ' ' ARG . . . . . . . . . . . . . 50.6 ttp180 -117.35 129.46 55.89 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 115.382 -0.826 . . . . 3.09 110.587 -175.51 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' E' E ' 143' ' ' THR . . . . . . . . . . . . . 11.6 p . . . . . 0 C--O 1.22 -0.458 0 CA-C-O 117.938 -1.03 . . . . 1.57 110.603 179.642 . . . . . . . . 0 0 . 1 . 001 nuclear nobuild core ' F' F ' 1' ' ' MET . . . . . . . . . . . . . 26.2 ptt? . . . . . 0 C--O 1.231 0.102 0 CA-C-O 120.945 0.402 . . . . 22.8 111.283 . . . . . . . . . 0 0 . 1 . 001 nuclear nobuild core ' F' F ' 2' ' ' SER . . . . . . . . . . . . . 4.4 p -121.85 135.71 54.91 Favored 'General case' 0 C--N 1.332 -0.187 0 CA-C-N 116.001 -0.545 . . . . 20.13 110.4 177.243 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' F' F ' 3' ' ' GLU . . . . . . . . . . . . . 46.0 mt-10 -141.25 142.74 33.9 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.218 -0.446 . . . . 17.46 111.133 -178.055 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' F' F ' 4' ' ' LEU . . . . . . . . . . . . . 13.5 tp -127.24 133.25 50.24 Favored 'General case' 0 C--N 1.331 -0.202 0 CA-C-N 115.886 -0.597 . . . . 15.24 109.989 176.813 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' F' F ' 5' ' ' LYS . . . . . . . . . . . . . 92.6 mttt -112.99 120.68 42.22 Favored 'General case' 0 C--O 1.234 0.273 0 CA-C-N 116.409 -0.359 . . . . 13.01 110.952 -179.573 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' F' F ' 6' ' ' LEU . . . . . . . . . . . . . 35.6 mt -113.91 149.06 35.73 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 115.289 -0.869 . . . . 12.6 110.23 179.713 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' F' F ' 7' ' ' LYS . . . . . . . . . . . . . 42.6 tttt -139.71 142.01 29.9 Favored Pre-proline 0 CA--C 1.533 0.307 0 CA-C-O 119.176 -0.44 . . . . 10.04 110.248 174.553 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' F' F ' 8' ' ' PRO . . . . . . . . . . . . . 85.5 Cg_endo -91.62 139.58 2.32 Favored 'Trans proline' 0 N--CA 1.489 1.241 0 C-N-CA 121.838 1.692 . . . . 9.67 111.782 177.997 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' F' F ' 9' ' ' LEU . . . . . . . . . . . . . 83.6 mt -70.1 -47.57 21.38 Favored Pre-proline 0 CA--C 1.533 0.293 0 CA-C-O 118.656 -0.688 . . . . 13.6 111.975 179.612 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' F' F ' 10' ' ' PRO . . . . . . . . . . . . . 84.4 Cg_endo -80.52 151.52 19.79 Favored 'Trans proline' 0 N--CA 1.495 1.586 0 C-N-CA 121.172 1.248 . . . . 13.17 111.859 175.615 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' F' F ' 11' ' ' LYS . . . . . . . . . . . . . 28.0 ttpt -83.69 103.75 13.25 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-O 120.81 0.338 . . . . 12.33 110.183 178.286 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' F' F ' 12' ' ' VAL . . . . . . . . . . . . . 12.7 p -141.02 147.41 22.59 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.258 0 CA-C-N 116.164 -0.471 . . . . 14.09 110.574 -178.589 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' F' F ' 13' ' ' GLU . . . . . . . . . . . . . 95.2 mt-10 -85.92 124.89 32.89 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 116.349 -0.387 . . . . 14.23 110.376 179.152 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' F' F ' 14' ' ' LEU . . . . . . . . . . . . . 30.9 mt -99.48 147.37 33.25 Favored Pre-proline 0 CA--C 1.532 0.284 0 CA-C-O 119.163 -0.446 . . . . 14.0 110.471 -179.186 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' F' F ' 15' ' ' PRO . . . . . . . . . . . . . 24.0 Cg_exo -63.85 154.65 68.55 Favored 'Trans proline' 0 N--CA 1.499 1.836 0 C-N-CA 121.354 1.369 . . . . 16.72 112.07 176.964 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' F' F ' 16' ' ' PRO . . . . . . . . . . . . . 39.8 Cg_exo -59.45 -35.58 95.78 Favored 'Trans proline' 0 N--CA 1.498 1.738 0 C-N-CA 121.368 1.379 . . . . 17.12 112.381 177.836 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' F' F ' 17' ' ' ASP . . . . . . . . . . . . . 6.1 p-10 -82.92 11.87 5.59 Favored 'General case' 0 C--N 1.327 -0.398 0 N-CA-C 112.95 0.722 . . . . 18.76 112.95 -179.341 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' F' F ' 18' ' ' PHE . . . . . . . . . . . . . 36.7 t80 -57.34 -44.17 84.05 Favored 'General case' 0 C--O 1.227 -0.11 0 O-C-N 121.914 -0.491 . . . . 15.4 110.196 -178.523 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' F' F ' 19' ' ' VAL . . . . . . . . . . . . . 47.4 t -55.55 -42.1 66.84 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.29 0 CA-C-N 116.417 -0.356 . . . . 15.15 110.786 -177.825 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' F' F ' 20' ' ' ASP . . . . . . . . . . . . . 5.2 t70 -60.14 -44.1 95.2 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-O 120.9 0.381 . . . . 18.08 110.969 -177.498 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' F' F ' 21' ' ' VAL . . . . . . . . . . . . . 47.5 t -65.6 -47.91 84.58 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.307 0 C-N-CA 120.576 -0.449 . . . . 18.15 110.593 -178.625 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' F' F ' 22' ' ' ILE . . . . . 0.456 ' CG2' HD12 ' F' ' 26' ' ' LEU . 49.1 mm -55.45 -58.46 4.53 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.315 0 C-N-CA 121.119 -0.232 . . . . 16.72 111.151 -177.976 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' F' F ' 23' ' ' ARG . . . . . . . . . . . . . 6.1 ptm180 -54.99 -44.0 74.06 Favored 'General case' 0 CA--C 1.53 0.189 0 C-N-CA 120.54 -0.464 . . . . 19.2 111.632 -173.696 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' F' F ' 24' ' ' ILE . . . . . . . . . . . . . 85.0 mt -60.06 -43.46 92.76 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.223 0 C-N-CA 120.796 -0.361 . . . . 20.65 111.404 -177.362 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' F' F ' 25' ' ' LYS . . . . . . . . . . . . . 93.3 mttt -71.55 -43.85 65.63 Favored 'General case' 0 C--N 1.33 -0.281 0 N-CA-C 112.823 0.675 . . . . 19.9 112.823 -177.933 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' F' F ' 26' ' ' LEU . . . . . 0.456 HD12 ' CG2' ' F' ' 22' ' ' ILE . 79.0 mt -79.04 -27.36 43.16 Favored 'General case' 0 C--N 1.329 -0.289 0 N-CA-C 113.777 1.029 . . . . 19.69 113.777 -169.301 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' F' F ' 27' ' ' GLN . . . . . . . . . . . . . 10.4 pt20 -46.78 139.83 5.07 Favored 'General case' 0 N--CA 1.469 0.523 0 N-CA-C 112.894 0.702 . . . . 21.81 112.894 -175.741 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' F' F ' 28' ' ' GLY . . . . . . . . . . . . . . . 100.66 -20.41 48.28 Favored Glycine 0 CA--C 1.534 1.221 0 CA-C-N 115.501 -0.772 . . . . 23.21 112.744 -179.0 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' F' F ' 29' ' ' LYS . . . . . . . . . . . . . 62.0 mttp -96.34 155.08 16.91 Favored 'General case' 0 C--O 1.231 0.101 0 CA-C-N 117.843 0.821 . . . . 22.44 110.99 177.726 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' F' F ' 30' ' ' THR . . . . . . . . . . . . . 30.1 m -107.02 138.97 42.17 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 115.96 -0.564 . . . . 23.24 109.948 177.584 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' F' F ' 31' ' ' VAL . . . . . . . . . . . . . 35.1 m -128.33 152.61 36.68 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.172 0 CA-C-N 116.352 -0.386 . . . . 20.1 110.779 -179.045 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' F' F ' 32' ' ' ARG . . . . . . . . . . . . . 2.8 mpt_? -131.37 150.72 52.04 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.009 -0.541 . . . . 24.75 109.976 177.195 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' F' F ' 33' ' ' THR . . . . . . . . . . . . . 14.6 m -53.68 137.39 37.53 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.426 -0.352 . . . . 18.77 111.394 -177.953 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' F' F ' 34' ' ' GLY . . . . . . . . . . . . . . . 99.88 -17.08 57.81 Favored Glycine 0 CA--C 1.533 1.198 0 C-N-CA 121.186 -0.531 . . . . 17.72 113.348 178.869 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' F' F ' 35' ' ' ASP . . . . . . . . . . . . . 60.1 m-20 -64.92 150.71 47.37 Favored 'General case' 0 C--O 1.231 0.091 0 CA-C-N 117.977 0.888 . . . . 20.13 111.487 -179.253 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' F' F ' 36' ' ' VAL . . . . . . . . . . . . . 47.7 t -121.91 129.14 75.68 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.205 0 CA-C-N 115.641 -0.709 . . . . 18.53 109.844 178.037 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' F' F ' 37' ' ' ILE . . . . . . . . . . . . . 73.9 mt -122.09 140.48 45.89 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.245 0 CA-C-N 116.299 -0.41 . . . . 17.49 110.068 -179.731 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' F' F ' 38' ' ' GLY . . . . . . . . . . . . . . . -110.52 128.68 8.92 Favored Glycine 0 CA--C 1.526 0.761 0 N-CA-C 111.092 -0.803 . . . . 19.07 111.092 179.476 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' F' F ' 39' ' ' ILE . . . . . . . . . . . . . 74.7 mt -123.47 133.35 69.43 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.262 0 N-CA-C 110.087 -0.338 . . . . 18.48 110.087 178.845 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' F' F ' 40' ' ' SER . . . . . . . . . . . . . 25.0 t -93.46 123.03 36.49 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.509 -0.314 . . . . 21.9 111.352 177.584 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' F' F ' 41' ' ' ILE . . . . . . . . . . . . . 73.2 mt -123.79 116.41 48.03 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.214 0 CA-C-N 116.348 -0.387 . . . . 20.06 110.136 176.667 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' F' F ' 42' ' ' LEU . . . . . . . . . . . . . 8.7 mp 51.06 37.08 16.98 Favored 'General case' 0 N--CA 1.465 0.313 0 CA-C-O 121.174 0.511 . . . . 22.47 111.507 178.694 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' F' F ' 43' ' ' GLY . . . . . . . . . . . . . . . 74.06 32.21 58.82 Favored Glycine 0 CA--C 1.529 0.948 0 C-N-CA 121.163 -0.541 . . . . 23.1 112.016 178.95 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' F' F ' 44' ' ' LYS . . . . . . . . . . . . . 87.6 tttt -130.62 125.9 35.27 Favored 'General case' 0 C--N 1.331 -0.232 0 N-CA-C 109.535 -0.543 . . . . 21.12 109.535 177.227 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' F' F ' 45' ' ' GLU . . . . . . . . . . . . . 82.1 tt0 -84.39 115.6 22.61 Favored 'General case' 0 C--N 1.328 -0.369 0 C-N-CA 120.811 -0.356 . . . . 20.71 110.966 -178.891 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' F' F ' 46' ' ' VAL . . . . . . . . . . . . . 7.3 p -115.25 130.36 69.93 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.243 0 N-CA-C 109.191 -0.67 . . . . 16.87 109.191 175.38 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' F' F ' 47' ' ' LYS . . . . . . . . . . . . . 63.5 mttp -99.48 125.81 45.3 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 115.97 -0.559 . . . . 18.86 111.119 179.089 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' F' F ' 48' ' ' PHE . . . . . . . . . . . . . 87.6 m-85 -108.9 131.95 54.53 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.078 -0.51 . . . . 14.18 109.899 176.735 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' F' F ' 49' ' ' LYS . . . . . . . . . . . . . 46.8 tttm -106.31 137.34 44.44 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.222 -0.445 . . . . 14.73 110.326 179.483 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' F' F ' 50' ' ' VAL . . . . . . . . . . . . . 47.6 t -81.04 107.09 13.0 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.333 0 N-CA-C 109.324 -0.621 . . . . 14.98 109.324 175.769 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' F' F ' 51' ' ' VAL . . . . . . . . . . . . . 56.6 t -70.57 -53.49 22.22 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.312 0 CA-C-N 115.864 -0.607 . . . . 13.92 109.452 -175.282 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' F' F ' 52' ' ' GLN . . . . . . . . . . . . . 88.1 mt-30 -154.34 151.96 29.68 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 115.99 -0.55 . . . . 15.71 111.822 -178.31 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' F' F ' 53' ' ' ALA . . . . . . . . . . . . . . . -129.68 130.79 45.98 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 115.21 -0.905 . . . . 18.15 109.552 174.06 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' F' F ' 54' ' ' TYR . . . . . . . . . . . . . 8.3 t80 -129.18 110.55 18.12 Favored Pre-proline 0 CA--C 1.535 0.383 0 CA-C-O 118.214 -0.898 . . . . 22.12 110.038 177.652 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' F' F ' 55' ' ' PRO . . . . . . . . . . . . . 74.0 Cg_endo -77.16 169.75 73.37 Favored 'Cis proline' 0 N--CA 1.5 1.857 0 CA-C-N 121.999 1.75 . . . . 22.21 112.666 -2.796 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' F' F ' 56' ' ' SER . . . . . . . . . . . . . 13.6 m -116.82 127.95 26.37 Favored Pre-proline 0 CA--C 1.539 0.554 0 CA-C-O 118.383 -0.818 . . . . 23.18 109.474 176.643 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' F' F ' 57' ' ' PRO . . . . . . . . . . . . . 37.6 Cg_endo -66.95 167.94 55.24 Favored 'Cis proline' 0 N--CA 1.497 1.726 0 CA-C-N 121.994 1.748 . . . . 24.03 111.466 -1.103 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' F' F ' 58' ' ' LEU . . . . . . . . . . . . . 33.5 tp -129.43 135.82 49.15 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-O 120.935 0.398 . . . . 20.69 110.507 -179.834 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' F' F ' 59' ' ' ARG . . . . . . . . . . . . . 52.5 ttt85 -97.56 127.23 43.35 Favored 'General case' 0 C--N 1.326 -0.417 0 N-CA-C 109.259 -0.645 . . . . 25.29 109.259 177.237 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' F' F ' 60' ' ' VAL . . . . . . . . . . . . . 42.6 t -82.52 114.68 23.77 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.208 0 C-N-CA 120.564 -0.454 . . . . 20.51 110.2 -176.169 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' F' F ' 61' ' ' GLU . . . . . . . . . . . . . 95.7 mt-10 -131.14 158.15 41.24 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 115.806 -0.634 . . . . 23.66 110.117 177.844 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' F' F ' 62' ' ' ASP . . . . . . . . . . . . . 4.6 p-10 -55.51 -32.46 62.91 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-N 116.511 -0.313 . . . . 21.75 111.513 177.951 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' F' F ' 63' ' ' ARG . . . . . . . . . . . . . 14.4 ptp180 -75.59 -4.94 42.84 Favored 'General case' 0 CA--C 1.535 0.389 0 N-CA-C 113.578 0.955 . . . . 25.02 113.578 -177.177 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' F' F ' 64' ' ' THR . . . . . . . . . . . . . 30.5 m -91.76 145.97 24.14 Favored 'General case' 0 C--N 1.332 -0.156 0 CA-C-N 118.271 0.487 . . . . 19.14 110.376 -178.036 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' F' F ' 65' ' ' LYS . . . . . . . . . . . . . 51.9 mtmt -87.55 124.9 33.97 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-O 121.109 0.481 . . . . 19.04 110.328 179.998 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' F' F ' 66' ' ' ILE . . . . . . . . . . . . . 71.5 mt -116.29 124.38 72.46 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.289 0 N-CA-C 109.704 -0.48 . . . . 15.12 109.704 -179.555 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' F' F ' 67' ' ' THR . . . . . . . . . . . . . 25.3 m -123.59 146.27 48.28 Favored 'General case' 0 C--N 1.331 -0.223 0 CA-C-O 121.054 0.455 . . . . 12.47 111.201 -175.776 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' F' F ' 68' ' ' LEU . . . . . 0.49 HD12 ' N ' ' F' ' 68' ' ' LEU . 8.2 mp . . . . . 0 C--N 1.329 -0.291 0 CA-C-N 115.902 -0.59 . . . . 9.77 110.664 178.796 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' F' F ' 73' ' ' VAL . . . . . . . . . . . . . 33.4 m . . . . . 0 C--O 1.231 0.093 0 CA-C-O 120.88 0.371 . . . . 1.16 110.737 . . . . . . . . . 0 0 . 1 . 001 nuclear nobuild core ' F' F ' 74' ' ' ASP . . . . . 0.431 ' OD1' HD11 ' F' ' 76' ' ' LEU . 2.5 t70 -101.35 127.96 47.74 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 115.954 -0.567 . . . . 1.06 109.947 179.825 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' F' F ' 75' ' ' VAL . . . . . . . . . . . . . 42.2 t -119.59 124.31 72.68 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.277 0 CA-C-O 120.935 0.398 . . . . 0.62 110.607 -178.273 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' F' F ' 76' ' ' LEU . . . . . 0.431 HD11 ' OD1' ' F' ' 74' ' ' ASP . 5.8 mp -122.48 140.72 52.42 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 115.825 -0.625 . . . . 1.06 109.79 175.689 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' F' F ' 77' ' ' GLU . . . . . . . . . . . . . 98.2 mt-10 -133.69 140.75 47.23 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-O 121.075 0.464 . . . . 1.24 111.324 -178.442 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' F' F ' 78' ' ' ALA . . . . . . . . . . . . . . . -130.9 130.2 43.21 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 115.8 -0.636 . . . . 0.61 109.971 176.326 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' F' F ' 79' ' ' LYS . . . . . 0.584 ' O ' HD13 ' F' ' 80' ' ' ILE . 35.5 mmtt -76.55 119.43 20.37 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-O 121.05 0.452 . . . . 2.99 110.847 179.334 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' F' F ' 80' ' ' ILE . . . . . 0.584 HD13 ' O ' ' F' ' 79' ' ' LYS . 41.1 mm -139.26 100.86 1.45 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.285 0 N-CA-C 108.814 -0.81 . . . . 0.65 108.814 -179.093 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' F' F ' 81' ' ' LYS . . . . . . . . . . . . . 81.3 tttt -91.41 127.5 36.88 Favored 'General case' 0 C--N 1.327 -0.388 0 C-N-CA 120.804 -0.358 . . . . 3.19 111.085 -174.967 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' F' F ' 82' ' ' GLY . . . . . . . . . . . . . . . 89.16 42.16 5.66 Favored Glycine 0 CA--C 1.525 0.715 0 C-N-CA 120.772 -0.728 . . . . 0.65 111.974 174.961 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' F' F ' 83' ' ' ILE . . . . . . . . . . . . . 70.4 mt -72.78 138.02 22.28 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.241 0 N-CA-C 109.611 -0.514 . . . . 0.6 109.611 175.802 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' F' F ' 84' ' ' LYS . . . . . . . . . . . . . 55.7 tttp -97.89 -53.99 3.23 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.13 -0.486 . . . . 1.54 110.377 -178.325 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' F' F ' 85' ' ' ASP . . . . . . . . . . . . . 22.5 t70 -148.88 148.5 29.93 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 115.92 -0.582 . . . . 0.75 110.54 -177.381 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' F' F ' 86' ' ' VAL . . . . . . . . . . . . . 43.8 t -129.77 130.25 66.58 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.259 0 CA-C-O 120.924 0.393 . . . . 0.48 110.49 -179.518 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' F' F ' 87' ' ' ILE . . . . . 0.496 HD12 ' N ' ' F' ' 87' ' ' ILE . 5.1 mp -115.59 125.66 72.86 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.283 0 CA-C-N 115.8 -0.636 . . . . 1.33 109.352 176.51 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' F' F ' 88' ' ' LEU . . . . . . . . . . . . . 18.1 tp -111.49 131.2 55.39 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-O 121.056 0.455 . . . . 1.67 111.297 -176.465 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' F' F ' 89' ' ' ASP . . . . . . . . . . . . . 31.4 t0 -130.99 153.97 48.66 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 115.718 -0.674 . . . . 0.83 109.546 176.225 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' F' F ' 90' ' ' GLU . . . . . . . . . . . . . 95.9 mt-10 -49.34 -37.98 26.49 Favored 'General case' 0 C--N 1.328 -0.331 0 N-CA-C 112.749 0.648 . . . . 2.21 112.749 -171.959 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' F' F ' 91' ' ' ASN . . . . . . . . . . . . . 25.6 m120 -122.57 14.54 10.23 Favored 'General case' 0 N--CA 1.469 0.5 0 N-CA-C 113.193 0.812 . . . . 2.27 113.193 -176.84 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' F' F ' 92' ' ' LEU . . . . . . . . . . . . . 49.0 mt -148.74 141.52 24.6 Favored 'General case' 0 C--N 1.332 -0.195 0 CA-C-O 120.838 0.351 . . . . 1.42 110.516 -175.919 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' F' F ' 93' ' ' ILE . . . . . . . . . . . . . 73.2 mt -124.65 116.17 46.63 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.37 0 N-CA-C 109.063 -0.717 . . . . 0.46 109.063 176.256 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' F' F ' 94' ' ' VAL . . . . . 0.558 HG11 HG11 ' F' ' 123' ' ' VAL . 45.0 t -117.36 125.16 73.84 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.249 0 N-CA-C 109.907 -0.405 . . . . 0.46 109.907 -178.439 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' F' F ' 95' ' ' VAL . . . . . . . . . . . . . 42.2 t -120.84 133.41 67.6 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.344 0 CA-C-N 116.055 -0.52 . . . . 0.42 109.766 -179.739 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' F' F ' 96' ' ' ILE . . . . . . . . . . . . . 59.1 mt -114.01 128.11 71.12 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.297 0 N-CA-C 109.124 -0.695 . . . . 0.46 109.124 178.353 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' F' F ' 97' ' ' THR . . . . . . . . . . . . . 62.7 p -101.1 161.37 13.65 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-O 121.034 0.445 . . . . 0.5 110.999 -177.65 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' F' F ' 98' ' ' GLU . . . . . . . . . . . . . 97.3 mt-10 -54.03 -26.09 24.71 Favored 'General case' 0 CA--C 1.532 0.284 0 N-CA-C 112.345 0.498 . . . . 2.47 112.345 179.958 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' F' F ' 99' ' ' GLU . . . . . . . . . . . . . 95.1 mt-10 -77.69 13.08 1.4 Allowed 'General case' 0 CA--C 1.535 0.384 0 N-CA-C 113.24 0.829 . . . . 2.06 113.24 -177.748 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' F' F ' 100' ' ' ASN . . . . . . . . . . . . . 2.9 m-20 61.23 37.61 17.22 Favored 'General case' 0 CA--C 1.529 0.169 0 CA-C-O 121.106 0.479 . . . . 0.74 110.955 179.442 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' F' F ' 101' ' ' GLU . . . . . . . . . . . . . 84.0 tt0 -115.93 144.72 43.67 Favored 'General case' 0 C--N 1.334 -0.108 0 CA-C-N 116.062 -0.517 . . . . 0.54 109.606 176.182 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' F' F ' 102' ' ' VAL . . . . . . . . . . . . . 45.5 t -114.97 125.35 72.27 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.261 0 CA-C-N 116.291 -0.413 . . . . 0.44 109.963 -178.092 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' F' F ' 103' ' ' LEU . . . . . . . . . . . . . 26.4 mt -113.44 128.84 56.59 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 115.621 -0.718 . . . . 0.86 109.909 175.883 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' F' F ' 104' ' ' ILE . . . . . . . . . . . . . 65.3 mt -118.42 119.16 60.37 Favored 'Isoleucine or valine' 0 C--O 1.233 0.229 0 N-CA-C 110.308 -0.256 . . . . 0.45 110.308 -179.25 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' F' F ' 105' ' ' PHE . . . . . . . . . . . . . 49.0 m-85 -118.99 169.45 9.89 Favored 'General case' 0 C--N 1.332 -0.157 0 CA-C-N 115.423 -0.808 . . . . 0.49 109.71 177.152 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' F' F ' 106' ' ' ASN . . . . . . . . . . . . . 51.2 p-10 -102.03 -170.15 1.78 Allowed 'General case' 0 C--N 1.33 -0.277 0 N-CA-C 109.886 -0.413 . . . . 0.62 109.886 172.987 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' F' F ' 107' ' ' GLN . . . . . 0.423 ' O ' HD21 ' E' ' 140' ' ' LEU . 48.5 tt0 -59.79 -29.96 68.58 Favored 'General case' 0 C--N 1.33 -0.264 0 N-CA-C 111.766 0.284 . . . . 1.17 111.766 178.535 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' F' F ' 108' ' ' ASN . . . . . . . . . . . . . 3.6 t-20 -81.9 9.88 7.39 Favored 'General case' 0 CA--C 1.537 0.459 0 N-CA-C 112.976 0.732 . . . . 1.23 112.976 -178.496 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' F' F ' 109' ' ' LEU . . . . . . . . . . . . . 8.1 tp 58.12 36.38 25.85 Favored 'General case' 0 CA--C 1.529 0.164 0 CA-C-O 120.874 0.369 . . . . 1.33 111.461 177.9 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' F' F ' 110' ' ' GLU . . . . . . . . . . . . . 47.2 mt-10 -105.1 151.22 24.28 Favored 'General case' 0 C--N 1.33 -0.241 0 N-CA-C 109.781 -0.451 . . . . 1.71 109.781 176.67 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' F' F ' 111' ' ' GLU . . . . . . . . . . . . . 83.1 tt0 -83.92 121.92 28.03 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-O 120.858 0.361 . . . . 1.71 110.73 -176.634 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' F' F ' 112' ' ' LEU . . . . . . . . . . . . . 37.4 mt -107.77 -46.2 3.85 Favored 'General case' 0 C--N 1.332 -0.181 0 CA-C-N 116.112 -0.494 . . . . 0.69 110.809 179.241 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' F' F ' 113' ' ' TYR . . . . . . . . . . . . . 42.9 t80 -138.82 139.66 38.27 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-N 116.385 -0.37 . . . . 0.57 111.377 -178.249 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' F' F ' 114' ' ' ARG . . . . . . . . . . . . . 23.7 ttp-105 -136.15 123.75 22.29 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 115.913 -0.585 . . . . 2.6 110.167 176.234 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' F' F ' 115' ' ' GLY . . . . . . . . . . . . . . . -150.06 155.4 26.22 Favored Glycine 0 CA--C 1.521 0.446 0 N-CA-C 110.855 -0.898 . . . . 0.53 110.855 178.677 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' F' F ' 116' ' ' LYS . . . . . . . . . . . . . 33.9 ttmt -127.44 137.78 52.8 Favored 'General case' 0 C--N 1.329 -0.284 0 N-CA-C 109.925 -0.398 . . . . 1.66 109.925 177.009 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' F' F ' 117' ' ' PHE . . . . . . . . . . . . . 31.9 m-85 -137.42 114.51 10.77 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.254 -0.43 . . . . 0.53 109.932 -176.002 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' F' F ' 118' ' ' GLU . . . . . . . . . . . . . 84.4 tt0 -53.77 -42.36 68.16 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.557 -0.292 . . . . 2.71 111.349 -177.134 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' F' F ' 119' ' ' ASN . . . . . . . . . . . . . 30.8 m-80 -99.51 31.14 3.26 Favored 'General case' 0 C--N 1.33 -0.272 0 N-CA-C 112.075 0.398 . . . . 1.32 112.075 -175.062 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' F' F ' 120' ' ' LEU . . . . . . . . . . . . . 25.8 tp -58.53 119.94 7.94 Favored 'General case' 0 C--N 1.332 -0.171 0 N-CA-C 110.033 -0.358 . . . . 0.48 110.033 178.34 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' F' F ' 121' ' ' ASN . . . . . . . . . . . . . 48.3 t30 -114.16 -43.98 3.18 Favored 'General case' 0 C--N 1.332 -0.173 0 CA-C-N 116.372 -0.376 . . . . 1.85 110.909 -178.146 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' F' F ' 122' ' ' LYS . . . . . . . . . . . . . 57.1 mttm -141.62 146.81 36.66 Favored 'General case' 0 C--N 1.331 -0.227 0 CA-C-O 121.111 0.481 . . . . 1.96 111.577 -176.011 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' F' F ' 123' ' ' VAL . . . . . 0.558 HG11 HG11 ' F' ' 94' ' ' VAL . 46.7 t -130.12 129.53 65.47 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.307 0 N-CA-C 109.177 -0.675 . . . . 0.49 109.177 173.82 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' F' F ' 124' ' ' LEU . . . . . . . . . . . . . 81.8 mt -130.95 139.81 50.09 Favored 'General case' 0 C--N 1.332 -0.192 0 CA-C-O 121.086 0.469 . . . . 1.57 111.322 -175.613 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' F' F ' 125' ' ' VAL . . . . . 0.619 HG12 HG23 ' F' ' 130' ' ' VAL . 35.8 m -128.0 131.54 69.43 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.216 0 CA-C-N 115.696 -0.683 . . . . 1.64 110.213 177.689 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' F' F ' 126' ' ' ARG . . . . . . . . . . . . . 77.6 mtt180 -147.39 124.29 11.3 Favored 'General case' 0 C--N 1.327 -0.372 0 N-CA-C 109.656 -0.498 . . . . 3.24 109.656 178.639 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' F' F ' 127' ' ' ASN . . . . . . . . . . . . . 18.4 t30 56.85 -152.3 0.39 Allowed 'General case' 0 CA--C 1.54 0.565 0 N-CA-C 109.57 -0.53 . . . . 2.21 109.57 -178.828 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' F' F ' 128' ' ' ASP . . . . . . . . . . . . . 20.7 p-10 -81.13 14.65 2.22 Favored 'General case' 0 CA--C 1.537 0.46 0 N-CA-C 112.772 0.656 . . . . 1.07 112.772 178.235 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' F' F ' 129' ' ' LEU . . . . . . . . . . . . . 16.5 tp -114.33 137.24 52.06 Favored 'General case' 0 C--O 1.232 0.166 0 O-C-N 122.027 -0.42 . . . . 1.85 109.953 179.315 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' F' F ' 130' ' ' VAL . . . . . 0.619 HG23 HG12 ' F' ' 125' ' ' VAL . 12.3 p -130.22 141.81 45.39 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.268 0 CA-C-O 120.842 0.353 . . . . 1.29 110.528 -178.18 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' F' F ' 131' ' ' VAL . . . . . 0.401 ' CG2' HD21 ' F' ' 138' ' ' LEU . 14.7 p -136.17 143.01 37.1 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.207 0 CA-C-O 121.063 0.458 . . . . 0.89 111.386 -179.584 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' F' F ' 132' ' ' ILE . . . . . . . . . . . . . 70.2 mt -116.15 132.68 64.97 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.32 0 CA-C-N 115.577 -0.738 . . . . 0.41 109.044 176.188 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' F' F ' 133' ' ' ILE . . . . . . . . . . . . . 37.3 mm -116.05 121.75 68.12 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.296 0 CA-C-O 120.785 0.326 . . . . 0.39 111.386 -173.601 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' F' F ' 134' ' ' ASP . . . . . . . . . . . . . 2.8 p30 -130.68 148.64 52.49 Favored 'General case' 0 C--N 1.331 -0.219 0 N-CA-C 109.534 -0.543 . . . . 0.51 109.534 174.294 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' F' F ' 135' ' ' GLU . . . . . . . . . . . . . 84.4 tt0 -50.96 -27.53 7.86 Favored 'General case' 0 C--N 1.326 -0.424 0 N-CA-C 112.955 0.724 . . . . 1.83 112.955 -171.939 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' F' F ' 136' ' ' GLN . . . . . . . . . . . . . 98.1 mt-30 -86.18 -27.82 24.31 Favored 'General case' 0 C--O 1.234 0.24 0 N-CA-C 112.845 0.683 . . . . 1.86 112.845 -175.251 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' F' F ' 137' ' ' LYS . . . . . . . . . . . . . 33.2 pttt -170.01 172.72 6.35 Favored 'General case' 0 C--N 1.331 -0.208 0 CA-C-O 121.588 0.708 . . . . 1.76 112.378 -173.178 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' F' F ' 138' ' ' LEU . . . . . 0.401 HD21 ' CG2' ' F' ' 131' ' ' VAL . 7.1 tt -120.06 130.17 54.56 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 114.998 -1.001 . . . . 0.78 110.048 -179.428 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' F' F ' 139' ' ' THR . . . . . . . . . . . . . 46.5 m -108.51 120.59 42.88 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 116.207 -0.451 . . . . 0.45 109.92 177.786 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' F' F ' 140' ' ' LEU . . . . . . . . . . . . . 17.6 tp -109.71 125.85 53.08 Favored 'General case' 0 C--N 1.329 -0.291 0 N-CA-C 109.31 -0.626 . . . . 1.13 109.31 -178.015 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' F' F ' 141' ' ' ILE . . . . . 0.538 ' HB ' HG13 ' F' ' 130' ' ' VAL . 19.4 mt -123.46 122.76 65.89 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.275 0 CA-C-O 120.843 0.354 . . . . 0.53 110.19 -172.918 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' F' F ' 142' ' ' ARG . . . . . . . . . . . . . 80.6 mtp180 -108.04 126.64 52.97 Favored 'General case' 0 C--N 1.331 -0.219 0 CA-C-N 115.491 -0.777 . . . . 3.85 110.269 -179.466 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' F' F ' 143' ' ' THR . . . . . . . . . . . . . 66.5 p . . . . . 0 C--O 1.22 -0.472 0 CA-C-O 118.09 -0.957 . . . . 1.61 110.493 179.749 . . . . . . . . 0 0 . 1 . 002 nuclear nobuild core ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 2.8 p . . . . . 0 N--CA 1.461 0.119 0 CA-C-O 120.896 0.379 . . . . 0.0 110.479 . . . . . . . . . 0 0 . 1 . 002 nuclear nobuild core ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 84.4 tt0 -140.17 143.36 36.08 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.187 -0.46 . . . . 0.0 110.988 -178.721 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 4' ' ' LEU . . . . . 0.437 HD12 HD23 ' A' ' 58' ' ' LEU . 4.9 tt -127.88 127.24 43.06 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 115.864 -0.607 . . . . 0.0 109.997 177.964 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 5' ' ' LYS . . . . . 0.418 ' N ' HD23 ' A' ' 4' ' ' LEU . 98.0 mttt -108.7 122.8 47.87 Favored 'General case' 0 C--O 1.234 0.249 0 CA-C-O 120.771 0.32 . . . . 0.0 110.909 -179.586 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 22.4 mt -113.99 150.06 34.4 Favored 'General case' 0 C--N 1.332 -0.177 0 CA-C-N 115.393 -0.821 . . . . 0.0 110.065 179.552 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 61.0 tttt -137.95 137.2 20.8 Favored Pre-proline 0 CA--C 1.535 0.377 0 CA-C-O 118.942 -0.552 . . . . 0.0 110.007 175.852 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 8' ' ' PRO . . . . . . . . . . . . . 85.9 Cg_endo -87.61 141.7 5.66 Favored 'Trans proline' 0 N--CA 1.492 1.386 0 C-N-CA 121.541 1.494 . . . . 0.0 111.792 177.575 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 46.7 mt -78.23 -47.07 2.11 Favored Pre-proline 0 CA--C 1.533 0.305 0 CA-C-O 118.745 -0.645 . . . . 0.0 112.275 -179.118 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 92.4 Cg_endo -81.98 153.9 17.05 Favored 'Trans proline' 0 N--CA 1.496 1.655 0 C-N-CA 121.269 1.313 . . . . 0.0 111.901 175.353 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 59.8 mttp -89.38 99.93 12.83 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.458 -0.337 . . . . 0.0 110.82 179.513 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 12.0 p -145.76 143.08 21.78 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.268 0 CA-C-N 116.236 -0.438 . . . . 0.0 110.493 179.198 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 43.9 mp0 -79.88 125.87 30.27 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.379 -0.373 . . . . 0.0 110.148 177.687 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 14' ' ' LEU . . . . . . . . . . . . . 29.5 mt -97.89 154.59 37.75 Favored Pre-proline 0 C--N 1.329 -0.284 0 CA-C-N 116.487 -0.324 . . . . 0.0 111.02 -177.651 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 15' ' ' PRO . . . . . . . . . . . . . 35.4 Cg_exo -59.88 160.6 21.17 Favored 'Trans proline' 0 N--CA 1.497 1.686 0 C-N-CA 121.364 1.376 . . . . 0.0 111.872 177.957 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 16' ' ' PRO . . . . . . . . . . . . . 25.7 Cg_exo -61.33 -43.19 29.74 Favored 'Trans proline' 0 N--CA 1.497 1.686 0 C-N-CA 121.571 1.514 . . . . 0.0 112.571 -179.031 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 17' ' ' ASP . . . . . . . . . . . . . 17.9 p-10 -88.34 17.0 5.57 Favored 'General case' 0 CA--C 1.535 0.371 0 N-CA-C 112.953 0.723 . . . . 0.0 112.953 -177.219 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 18' ' ' PHE . . . . . . . . . . . . . 42.7 t80 -58.27 -45.87 87.07 Favored 'General case' 0 C--N 1.334 -0.087 0 O-C-N 122.142 -0.349 . . . . 0.0 110.081 -178.489 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 19' ' ' VAL . . . . . . . . . . . . . 13.3 p -55.59 -39.69 55.72 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 CA-C-N 116.423 -0.353 . . . . 0.0 110.937 -179.532 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 77.5 m-20 -60.42 -46.65 89.27 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-O 120.926 0.393 . . . . 0.0 110.876 -178.378 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 46.4 t -64.27 -47.25 90.59 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.347 0 CA-C-N 116.365 -0.38 . . . . 0.0 110.561 -177.229 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 22' ' ' ILE . . . . . 0.506 HG22 HD12 ' A' ' 26' ' ' LEU . 50.9 mm -56.36 -45.33 81.5 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.218 0 C-N-CA 120.947 -0.301 . . . . 0.0 110.58 179.335 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 23' ' ' ARG . . . . . . . . . . . . . 59.2 ttp180 -54.24 -46.5 72.57 Favored 'General case' 0 C--N 1.33 -0.27 0 C-N-CA 121.164 -0.215 . . . . 0.0 111.366 -179.062 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 24' ' ' ILE . . . . . . . . . . . . . 74.7 mt -58.91 -45.09 92.03 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 C-N-CA 121.137 -0.225 . . . . 0.0 111.057 -179.467 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 93.8 mttt -65.22 -40.66 94.39 Favored 'General case' 0 C--N 1.329 -0.302 0 N-CA-C 112.352 0.501 . . . . 0.0 112.352 -177.89 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 26' ' ' LEU . . . . . 0.506 HD12 HG22 ' A' ' 22' ' ' ILE . 80.1 mt -79.64 -42.19 25.37 Favored 'General case' 0 C--N 1.33 -0.274 0 N-CA-C 112.898 0.703 . . . . 0.0 112.898 -171.575 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 27' ' ' GLN . . . . . . . . . . . . . 9.8 pt20 -46.05 139.51 4.41 Favored 'General case' 0 N--CA 1.469 0.49 0 N-CA-C 112.79 0.663 . . . . 0.0 112.79 -175.292 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 101.33 -28.61 15.21 Favored Glycine 0 CA--C 1.531 1.058 0 CA-C-N 115.483 -0.781 . . . . 0.0 111.973 -176.779 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 90.4 mttt -98.16 155.23 17.26 Favored 'General case' 0 C--O 1.233 0.203 0 CA-C-N 117.267 0.533 . . . . 0.0 111.055 178.452 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 30' ' ' THR . . . . . . . . . . . . . 38.0 m -101.6 138.36 38.69 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.235 -0.438 . . . . 0.0 109.831 175.026 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 34.5 m -126.31 156.45 36.8 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.191 0 CA-C-N 116.45 -0.341 . . . . 0.0 110.675 -178.822 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 32' ' ' ARG . . . . . . . . . . . . . 90.4 mtt180 -132.93 150.39 52.16 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.0 -0.545 . . . . 0.0 110.683 178.858 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 33' ' ' THR . . . . . . . . . . . . . 24.5 m -52.5 139.07 26.24 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.177 -0.465 . . . . 0.0 111.453 -178.643 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 99.47 -17.14 58.13 Favored Glycine 0 CA--C 1.533 1.175 0 CA-C-O 119.631 -0.538 . . . . 0.0 113.29 178.598 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 74.7 m-20 -65.6 148.72 51.27 Favored 'General case' 0 C--N 1.334 -0.073 0 CA-C-N 118.081 0.941 . . . . 0.0 110.954 179.463 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 46.9 t -123.13 130.1 74.58 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.249 0 CA-C-N 115.87 -0.605 . . . . 0.0 109.797 178.241 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 37' ' ' ILE . . . . . . . . . . . . . 63.3 mt -117.57 137.97 49.76 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.275 0 N-CA-C 109.844 -0.428 . . . . 0.0 109.844 -179.742 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . -108.3 128.75 9.25 Favored Glycine 0 CA--C 1.525 0.701 0 N-CA-C 110.957 -0.857 . . . . 0.0 110.957 179.885 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 39' ' ' ILE . . . . . . . . . . . . . 75.8 mt -127.02 135.51 63.41 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.244 0 N-CA-C 110.12 -0.326 . . . . 0.0 110.12 179.4 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 40' ' ' SER . . . . . . . . . . . . . 11.1 p -92.04 115.15 27.82 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.218 -0.447 . . . . 0.0 110.751 176.085 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 41' ' ' ILE . . . . . . . . . . . . . 43.7 mm -120.82 116.78 50.98 Favored 'Isoleucine or valine' 0 N--CA 1.462 0.171 0 CA-C-O 120.772 0.32 . . . . 0.0 110.498 -179.81 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 6.8 mp 50.9 37.12 16.51 Favored 'General case' 0 C--N 1.331 -0.219 0 CA-C-O 121.081 0.467 . . . . 0.0 111.656 177.301 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . 75.16 30.71 58.52 Favored Glycine 0 CA--C 1.528 0.886 0 C-N-CA 121.072 -0.585 . . . . 0.0 112.345 176.67 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 44' ' ' LYS . . . . . . . . . . . . . 16.5 ttmm -136.04 132.69 36.56 Favored 'General case' 0 C--N 1.33 -0.274 0 N-CA-C 109.861 -0.422 . . . . 0.0 109.861 176.652 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 79.0 tt0 -81.79 113.34 19.68 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.408 -0.36 . . . . 0.0 110.747 -178.844 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 46' ' ' VAL . . . . . . . . . . . . . 7.3 p -116.01 125.92 73.31 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.195 0 N-CA-C 109.628 -0.508 . . . . 0.0 109.628 177.936 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 97.1 mttt -100.48 130.0 46.5 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 115.965 -0.561 . . . . 0.0 111.287 178.445 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 48' ' ' PHE . . . . . . . . . . . . . 80.7 m-85 -111.2 131.95 54.71 Favored 'General case' 0 C--N 1.329 -0.296 0 N-CA-C 109.749 -0.463 . . . . 0.0 109.749 175.902 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 85.5 tttt -107.04 137.01 45.92 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.288 -0.415 . . . . 0.0 110.674 -179.172 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 50' ' ' VAL . . . . . . . . . . . . . 42.9 t -81.26 108.78 14.86 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.262 0 N-CA-C 109.462 -0.57 . . . . 0.0 109.462 176.094 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 51' ' ' VAL . . . . . . . . . . . . . 45.2 t -70.2 -49.29 55.97 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.288 0 CA-C-N 115.971 -0.559 . . . . 0.0 109.924 -174.116 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 52' ' ' GLN . . . . . . . . . . . . . 46.6 tt0 -168.13 142.5 3.45 Favored 'General case' 0 C--N 1.33 -0.273 0 C-N-CA 120.082 -0.647 . . . . 0.0 112.009 -177.378 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 53' ' ' ALA . . . . . 0.453 ' HB3' ' OG ' ' A' ' 56' ' ' SER . . . -113.08 133.39 55.02 Favored 'General case' 0 C--N 1.331 -0.215 0 CA-C-N 115.395 -0.82 . . . . 0.0 109.81 175.496 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 54' ' ' TYR . . . . . . . . . . . . . 50.5 t80 -129.03 107.29 18.02 Favored Pre-proline 0 CA--C 1.534 0.351 0 CA-C-O 118.314 -0.85 . . . . 0.0 110.41 179.709 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 55' ' ' PRO . . . . . . . . . . . . . 72.6 Cg_endo -77.14 169.19 74.92 Favored 'Cis proline' 0 N--CA 1.5 1.884 0 CA-C-N 121.764 1.666 . . . . 0.0 112.291 -4.827 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 56' ' ' SER . . . . . 0.453 ' OG ' ' HB3' ' A' ' 53' ' ' ALA . 74.7 m -117.3 137.31 23.9 Favored Pre-proline 0 CA--C 1.538 0.49 0 CA-C-O 118.494 -0.765 . . . . 0.0 109.691 175.114 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 57' ' ' PRO . . . . . . . . . . . . . 36.5 Cg_endo -66.72 161.66 75.03 Favored 'Cis proline' 0 N--CA 1.499 1.797 0 CA-C-N 121.746 1.659 . . . . 0.0 111.388 -3.385 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 58' ' ' LEU . . . . . 0.437 HD23 HD12 ' A' ' 4' ' ' LEU . 28.8 tp -130.03 137.29 50.18 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-O 120.945 0.403 . . . . 0.0 110.676 -178.785 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 59' ' ' ARG . . . . . . . . . . . . . 73.8 ttt180 -99.11 135.4 40.56 Favored 'General case' 0 C--N 1.327 -0.394 0 N-CA-C 109.513 -0.551 . . . . 0.0 109.513 175.395 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 40.3 t -84.93 116.33 28.28 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.287 0 C-N-CA 120.652 -0.419 . . . . 0.0 110.453 -177.398 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 34.6 tp10 -131.03 155.49 46.78 Favored 'General case' 0 C--N 1.329 -0.288 0 N-CA-C 109.088 -0.708 . . . . 0.0 109.088 177.138 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 62' ' ' ASP . . . . . . . . . . . . . 77.4 m-20 -51.68 -32.26 29.15 Favored 'General case' 0 C--N 1.326 -0.438 0 N-CA-C 112.134 0.42 . . . . 0.0 112.134 -175.787 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 63' ' ' ARG . . . . . . . . . . . . . 34.5 mmt180 -74.48 -21.61 59.49 Favored 'General case' 0 C--N 1.33 -0.281 0 N-CA-C 113.022 0.749 . . . . 0.0 113.022 -175.447 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 20.8 m -63.29 141.44 58.76 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-O 120.849 0.357 . . . . 0.0 110.824 -176.148 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 65' ' ' LYS . . . . . . . . . . . . . 94.4 mttt -84.06 123.96 30.59 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.191 -0.459 . . . . 0.0 109.796 178.013 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 66' ' ' ILE . . . . . . . . . . . . . 54.9 mt -113.83 129.7 69.25 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.247 0 N-CA-C 109.994 -0.373 . . . . 0.0 109.994 -178.803 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 67' ' ' THR . . . . . . . . . . . . . 12.0 m -125.16 136.63 53.78 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-N 116.234 -0.439 . . . . 0.0 110.736 -179.058 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 68' ' ' LEU . . . . . 0.433 ' N ' HD12 ' A' ' 68' ' ' LEU . 7.4 mp . . . . . 0 C--N 1.331 -0.231 0 CA-C-N 116.04 -0.527 . . . . 0.0 110.906 179.397 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 74' ' ' ASP . . . . . . . . . . . . . 15.9 t0 . . . . . 0 CA--C 1.523 -0.064 0 N-CA-C 109.93 -0.396 . . . . 0.0 109.93 . . . . . . . . . 0 0 . 1 . 002 nuclear nobuild core ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 40.9 t -112.98 122.52 67.28 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.271 0 CA-C-O 121.164 0.507 . . . . 0.0 110.432 -178.877 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 76' ' ' LEU . . . . . . . . . . . . . 23.4 mt -119.77 140.52 50.61 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 115.507 -0.77 . . . . 0.0 109.242 178.44 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 77' ' ' GLU . . . . . . . . . . . . . 98.4 mt-10 -136.18 136.96 40.42 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-O 121.102 0.477 . . . . 0.0 111.492 -177.204 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 78' ' ' ALA . . . . . 0.571 ' HB2' HD21 ' A' ' 109' ' ' LEU . . . -125.76 136.15 52.84 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 115.554 -0.748 . . . . 0.0 109.947 176.842 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 79' ' ' LYS . . . . . 0.601 ' O ' HD13 ' A' ' 80' ' ' ILE . 43.3 mmtm -81.52 113.62 19.69 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.405 -0.361 . . . . 0.0 110.562 -179.48 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 80' ' ' ILE . . . . . 0.601 HD13 ' O ' ' A' ' 79' ' ' LYS . 28.5 mm -139.22 104.12 2.09 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.355 0 N-CA-C 109.26 -0.644 . . . . 0.0 109.26 -179.633 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 81' ' ' LYS . . . . . . . . . . . . . 60.4 mtpt -99.71 131.42 45.71 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-O 120.851 0.357 . . . . 0.0 110.81 -177.307 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . 89.2 42.07 5.67 Favored Glycine 0 CA--C 1.525 0.707 0 N-CA-C 111.194 -0.762 . . . . 0.0 111.194 178.34 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 83' ' ' ILE . . . . . . . . . . . . . 70.1 mt -71.08 137.54 23.59 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.308 0 N-CA-C 109.486 -0.561 . . . . 0.0 109.486 176.801 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 84' ' ' LYS . . . . . . . . . . . . . 38.1 ttpt -98.91 -52.62 3.51 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-O 120.843 0.354 . . . . 0.0 110.379 -178.687 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 85' ' ' ASP . . . . . . . . . . . . . 12.6 t70 -151.76 153.16 33.77 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.039 -0.528 . . . . 0.0 110.692 -179.167 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 86' ' ' VAL . . . . . . . . . . . . . 41.9 t -131.4 132.97 62.59 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.248 0 CA-C-O 120.964 0.412 . . . . 0.0 110.421 -178.763 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 87' ' ' ILE . . . . . 0.494 HD12 ' N ' ' A' ' 87' ' ' ILE . 5.1 mp -122.31 129.66 75.13 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.225 0 CA-C-N 115.819 -0.628 . . . . 0.0 109.358 177.351 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 88' ' ' LEU . . . . . . . . . . . . . 25.5 tp -116.28 132.52 56.64 Favored 'General case' 0 C--N 1.331 -0.219 0 CA-C-O 120.995 0.426 . . . . 0.0 111.433 -176.4 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 89' ' ' ASP . . . . . . . . . . . . . 13.4 t70 -127.04 154.84 44.14 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 115.764 -0.653 . . . . 0.0 109.511 175.668 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 96.1 mt-10 -46.72 -39.36 11.42 Favored 'General case' 0 C--N 1.329 -0.288 0 N-CA-C 113.222 0.823 . . . . 0.0 113.222 -171.735 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 91' ' ' ASN . . . . . . . . . . . . . 12.8 m120 -129.56 22.25 5.52 Favored 'General case' 0 N--CA 1.469 0.496 0 N-CA-C 112.802 0.667 . . . . 0.0 112.802 -177.409 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 92' ' ' LEU . . . . . . . . . . . . . 10.1 mt -150.09 141.91 23.74 Favored 'General case' 0 C--N 1.331 -0.209 0 N-CA-C 109.564 -0.532 . . . . 0.0 109.564 -178.094 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 93' ' ' ILE . . . . . . . . . . . . . 72.2 mt -123.99 121.28 61.73 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 N-CA-C 109.412 -0.588 . . . . 0.0 109.412 178.382 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 94' ' ' VAL . . . . . . . . . . . . . 46.3 t -120.3 126.86 75.72 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.264 0 CA-C-O 120.853 0.359 . . . . 0.0 110.145 -178.215 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 95' ' ' VAL . . . . . . . . . . . . . 41.5 t -122.48 134.3 66.1 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.316 0 CA-C-N 116.001 -0.545 . . . . 0.0 109.801 -179.731 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 96' ' ' ILE . . . . . . . . . . . . . 64.4 mt -115.9 126.73 73.53 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.255 0 N-CA-C 109.405 -0.591 . . . . 0.0 109.405 179.221 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 97' ' ' THR . . . . . . . . . . . . . 70.9 p -103.26 157.34 17.08 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-O 121.356 0.598 . . . . 0.0 111.639 -175.505 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 98' ' ' GLU . . . . . . . . . . . . . 81.5 tt0 -53.96 -26.83 27.63 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 115.893 -0.594 . . . . 0.0 112.303 -178.832 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 99' ' ' GLU . . . . . . . . . . . . . 43.2 mt-10 -80.33 17.62 1.03 Allowed 'General case' 0 CA--C 1.533 0.317 0 N-CA-C 113.069 0.766 . . . . 0.0 113.069 -177.096 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 100' ' ' ASN . . . . . . . . . . . . . 3.2 m-20 61.65 37.37 16.08 Favored 'General case' 0 CA--C 1.53 0.174 0 CA-C-O 121.09 0.472 . . . . 0.0 111.014 178.292 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 101' ' ' GLU . . . . . . . . . . . . . 84.2 tt0 -113.12 143.5 44.25 Favored 'General case' 0 C--O 1.232 0.139 0 CA-C-N 116.083 -0.508 . . . . 0.0 109.966 176.52 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 102' ' ' VAL . . . . . . . . . . . . . 46.2 t -114.98 123.8 71.03 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.27 0 N-CA-C 109.658 -0.497 . . . . 0.0 109.658 -179.653 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 103' ' ' LEU . . . . . . . . . . . . . 22.4 mt -115.98 129.51 56.41 Favored 'General case' 0 C--N 1.331 -0.199 0 CA-C-N 115.696 -0.684 . . . . 0.0 110.355 178.36 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 104' ' ' ILE . . . . . 0.519 HD13 HG21 ' A' ' 130' ' ' VAL . 70.5 mt -118.29 120.27 63.87 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.246 0 CA-C-N 116.446 -0.343 . . . . 0.0 110.189 179.081 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 105' ' ' PHE . . . . . . . . . . . . . 57.9 m-85 -121.3 165.4 15.55 Favored 'General case' 0 C--N 1.332 -0.168 0 O-C-N 123.932 0.77 . . . . 0.0 110.155 179.478 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 106' ' ' ASN . . . . . . . . . . . . . 40.9 p-10 -96.88 -169.93 1.96 Allowed 'General case' 0 C--N 1.331 -0.205 0 N-CA-C 109.913 -0.403 . . . . 0.0 109.913 173.636 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 107' ' ' GLN . . . . . . . . . . . . . 63.3 tt0 -58.96 -30.1 67.66 Favored 'General case' 0 C--N 1.329 -0.306 0 N-CA-C 111.781 0.289 . . . . 0.0 111.781 178.38 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 108' ' ' ASN . . . . . . . . . . . . . 52.2 t30 -83.47 7.22 17.59 Favored 'General case' 0 CA--C 1.536 0.437 0 N-CA-C 113.304 0.853 . . . . 0.0 113.304 -177.698 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 109' ' ' LEU . . . . . 0.571 HD21 ' HB2' ' A' ' 78' ' ' ALA . 11.4 tp 59.6 37.24 22.65 Favored 'General case' 0 C--N 1.332 -0.165 0 CA-C-O 121.017 0.437 . . . . 0.0 111.349 178.409 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 110' ' ' GLU . . . . . . . . . . . . . 70.7 mm-40 -103.55 152.12 22.09 Favored 'General case' 0 C--N 1.331 -0.216 0 N-CA-C 109.886 -0.413 . . . . 0.0 109.886 176.019 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 111' ' ' GLU . . . . . . . . . . . . . 83.4 tt0 -79.35 121.98 25.8 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-O 120.944 0.402 . . . . 0.0 110.73 -177.598 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 112' ' ' LEU . . . . . . . . . . . . . 28.8 mt -111.32 -46.04 3.34 Favored 'General case' 0 C--N 1.331 -0.229 0 CA-C-N 116.063 -0.517 . . . . 0.0 110.145 178.1 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 113' ' ' TYR . . . . . . . . . . . . . 59.8 t80 -138.99 133.43 31.73 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-N 116.115 -0.493 . . . . 0.0 111.009 179.59 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 114' ' ' ARG . . . . . . . . . . . . . 60.1 ttp180 -137.19 122.91 19.9 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.167 -0.469 . . . . 0.0 110.179 176.692 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 115' ' ' GLY . . . . . . . . . . . . . . . -150.07 146.66 16.06 Favored Glycine 0 CA--C 1.524 0.618 0 N-CA-C 110.91 -0.876 . . . . 0.0 110.91 178.974 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 116' ' ' LYS . . . . . . . . . . . . . 14.1 ttmm -116.42 134.93 54.3 Favored 'General case' 0 C--N 1.33 -0.271 0 N-CA-C 109.932 -0.396 . . . . 0.0 109.932 178.663 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 117' ' ' PHE . . . . . . . . . . . . . 48.8 m-85 -132.55 116.92 17.32 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-O 121.01 0.433 . . . . 0.0 110.331 -176.123 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 118' ' ' GLU . . . . . . . . . . . . . 43.8 mp0 -55.22 -45.06 75.96 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 116.246 -0.434 . . . . 0.0 111.133 -175.529 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 119' ' ' ASN . . . . . . . . . . . . . 35.1 m120 -98.71 31.0 3.06 Favored 'General case' 0 C--N 1.33 -0.24 0 N-CA-C 112.208 0.447 . . . . 0.0 112.208 -174.331 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 120' ' ' LEU . . . . . . . . . . . . . 31.5 tp -56.79 121.4 9.76 Favored 'General case' 0 C--N 1.333 -0.14 0 CA-C-O 120.752 0.31 . . . . 0.0 110.471 178.028 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 121' ' ' ASN . . . . . . . . . . . . . 20.3 m120 -114.05 -44.12 3.18 Favored 'General case' 0 C--N 1.333 -0.146 0 CA-C-N 116.414 -0.357 . . . . 0.0 111.204 -177.328 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 122' ' ' LYS . . . . . . . . . . . . . 96.1 mttt -144.1 149.85 37.2 Favored 'General case' 0 C--N 1.331 -0.205 0 CA-C-O 121.01 0.433 . . . . 0.0 111.72 -175.609 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 123' ' ' VAL . . . . . . . . . . . . . 47.1 t -129.69 130.4 66.81 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.27 0 N-CA-C 109.399 -0.593 . . . . 0.0 109.399 174.658 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 124' ' ' LEU . . . . . . . . . . . . . 69.9 mt -125.07 140.04 53.25 Favored 'General case' 0 N--CA 1.464 0.267 0 CA-C-O 120.782 0.325 . . . . 0.0 111.094 -177.237 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 125' ' ' VAL . . . . . . . . . . . . . 10.4 p -132.22 131.21 60.97 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.19 0 CA-C-N 116.009 -0.541 . . . . 0.0 110.332 -179.928 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 126' ' ' ARG . . . . . . . . . . . . . 35.3 mmt180 -142.3 118.03 10.45 Favored 'General case' 0 C--N 1.332 -0.192 0 CA-C-O 120.841 0.353 . . . . 0.0 110.733 178.44 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 127' ' ' ASN . . . . . . . . . . . . . 18.3 t-20 50.07 -104.89 0.16 Allowed 'General case' 0 CA--C 1.543 0.702 0 CA-C-O 119.098 -0.477 . . . . 0.0 111.664 178.017 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 128' ' ' ASP . . . . . . . . . . . . . 22.6 p-10 -114.08 3.8 15.41 Favored 'General case' 0 CA--C 1.537 0.478 0 CA-C-N 119.562 1.074 . . . . 0.0 113.451 -176.689 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 129' ' ' LEU . . . . . . . . . . . . . 14.4 tp -110.91 139.76 45.96 Favored 'General case' 0 C--N 1.332 -0.191 0 N-CA-C 109.673 -0.491 . . . . 0.0 109.673 178.374 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 130' ' ' VAL . . . . . 0.519 HG21 HD13 ' A' ' 104' ' ' ILE . 30.1 m -128.64 140.75 48.4 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.226 0 CA-C-O 120.892 0.377 . . . . 0.0 110.176 178.792 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 131' ' ' VAL . . . . . . . . . . . . . 43.8 t -136.06 140.52 43.78 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 CA-C-O 121.257 0.551 . . . . 0.0 110.458 -178.754 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 132' ' ' ILE . . . . . . . . . . . . . 71.8 mt -114.87 132.17 64.88 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.336 0 CA-C-N 115.415 -0.811 . . . . 0.0 109.302 179.28 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 133' ' ' ILE . . . . . . . . . . . . . 39.0 mm -114.25 118.76 59.44 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.236 0 CA-C-N 116.53 -0.304 . . . . 0.0 110.74 -175.604 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 134' ' ' ASP . . . . . . . . . . . . . 8.1 p-10 -133.63 146.31 50.79 Favored 'General case' 0 C--N 1.33 -0.254 0 N-CA-C 109.587 -0.523 . . . . 0.0 109.587 174.95 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 135' ' ' GLU . . . . . . . . . . . . . 80.1 tt0 -49.85 -24.21 2.32 Favored 'General case' 0 C--N 1.328 -0.359 0 N-CA-C 112.782 0.66 . . . . 0.0 112.782 -172.644 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 136' ' ' GLN . . . . . . . . . . . . . 98.7 mt-30 -93.73 -35.35 12.83 Favored 'General case' 0 C--N 1.333 -0.126 0 N-CA-C 112.294 0.479 . . . . 0.0 112.294 -176.243 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 137' ' ' LYS . . . . . . . . . . . . . 88.6 mttt -142.32 153.62 44.02 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-O 121.59 0.709 . . . . 0.0 112.622 -167.788 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 138' ' ' LEU . . . . . . . . . . . . . 14.3 tp -110.7 116.87 32.06 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 114.725 -1.125 . . . . 0.0 108.76 170.725 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 139' ' ' THR . . . . . . . . . . . . . 31.7 m -107.68 121.14 44.09 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-O 120.558 0.218 . . . . 0.0 110.775 -178.165 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 140' ' ' LEU . . . . . 0.475 HD23 ' C ' ' A' ' 140' ' ' LEU . 7.4 tt -112.85 122.83 48.82 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 115.885 -0.598 . . . . 0.0 109.426 -179.372 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 141' ' ' ILE . . . . . 0.514 ' HB ' HG23 ' A' ' 130' ' ' VAL . 18.9 mt -124.09 122.57 64.7 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.254 0 CA-C-O 121.007 0.432 . . . . 0.0 109.891 -175.863 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 142' ' ' ARG . . . . . . . . . . . . . 71.4 ttt180 -108.86 125.24 51.78 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 115.443 -0.799 . . . . 0.0 110.468 -179.196 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 143' ' ' THR . . . . . . . . . . . . . 5.6 p . . . . . 0 C--O 1.219 -0.536 0 CA-C-O 118.028 -0.986 . . . . 0.0 110.457 179.799 . . . . . . . . 0 0 . 1 . 002 nuclear nobuild core ' B' B ' 2' ' ' SER . . . . . . . . . . . . . 90.2 p . . . . . 0 C--O 1.231 0.13 0 CA-C-O 120.795 0.331 . . . . 0.0 110.269 . . . . . . . . . 0 0 . 1 . 002 nuclear nobuild core ' B' B ' 3' ' ' GLU . . . . . . . . . . . . . 95.2 mt-10 -140.41 143.74 35.8 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.274 -0.421 . . . . 0.0 111.147 -177.712 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 4' ' ' LEU . . . . . . . . . . . . . 38.9 mt -121.32 127.01 50.88 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 115.811 -0.631 . . . . 0.0 110.037 175.939 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 5' ' ' LYS . . . . . . . . . . . . . 91.8 mttt -104.64 120.46 41.37 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.29 -0.414 . . . . 0.0 110.468 178.843 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 6' ' ' LEU . . . . . . . . . . . . . 57.8 mt -115.46 148.03 39.91 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 115.564 -0.744 . . . . 0.0 110.406 -179.171 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 7' ' ' LYS . . . . . . . . . . . . . 82.2 tttt -139.95 137.85 18.84 Favored Pre-proline 0 CA--C 1.534 0.357 0 CA-C-O 119.046 -0.502 . . . . 0.0 109.976 176.86 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 8' ' ' PRO . . . . . . . . . . . . . 98.0 Cg_endo -91.44 142.48 2.9 Favored 'Trans proline' 0 N--CA 1.49 1.295 0 C-N-CA 121.734 1.623 . . . . 0.0 111.718 177.719 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 9' ' ' LEU . . . . . . . . . . . . . 52.8 mt -79.23 -46.71 1.64 Allowed Pre-proline 0 CA--C 1.532 0.278 0 CA-C-O 118.847 -0.597 . . . . 0.0 112.105 -179.055 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 10' ' ' PRO . . . . . 0.443 ' HG2' HG23 ' B' ' 46' ' ' VAL . 65.7 Cg_endo -84.36 156.57 12.63 Favored 'Trans proline' 0 N--CA 1.496 1.663 0 C-N-CA 121.309 1.339 . . . . 0.0 111.631 174.488 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' B' B ' 11' ' ' LYS . . . . . . . . . . . . . 20.0 pttm -86.16 120.85 27.97 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-O 120.998 0.428 . . . . 0.0 110.045 176.494 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 12' ' ' VAL . . . . . . . . . . . . . 12.0 p -151.02 148.79 14.7 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.327 0 CA-C-N 116.081 -0.509 . . . . 0.0 110.637 -178.26 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 13' ' ' GLU . . . . . . . . . . . . . 84.7 tt0 -91.62 116.58 28.99 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.279 -0.419 . . . . 0.0 110.132 177.464 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 14' ' ' LEU . . . . . . . . . . . . . 29.5 mt -98.15 146.52 31.66 Favored Pre-proline 0 CA--C 1.532 0.287 0 CA-C-O 119.171 -0.442 . . . . 0.0 110.425 -177.491 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 15' ' ' PRO . . . . . . . . . . . . . 24.0 Cg_exo -64.01 162.18 30.3 Favored 'Trans proline' 0 N--CA 1.498 1.769 0 C-N-CA 121.335 1.357 . . . . 0.0 111.86 176.409 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 16' ' ' PRO . . . . . . . . . . . . . 27.0 Cg_exo -61.14 -35.34 86.64 Favored 'Trans proline' 0 N--CA 1.497 1.699 0 C-N-CA 121.484 1.456 . . . . 0.0 112.511 -179.585 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 17' ' ' ASP . . . . . . . . . . . . . 7.1 p-10 -85.86 6.27 28.98 Favored 'General case' 0 CA--C 1.535 0.388 0 N-CA-C 113.302 0.852 . . . . 0.0 113.302 -177.226 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 18' ' ' PHE . . . . . . . . . . . . . 51.5 t80 -57.48 -43.41 84.07 Favored 'General case' 0 C--N 1.334 -0.105 0 O-C-N 121.891 -0.506 . . . . 0.0 110.152 -179.038 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 19' ' ' VAL . . . . . 0.412 HG13 ' N ' ' B' ' 20' ' ' ASP . 12.3 p -56.85 -41.76 76.62 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.345 0 CA-C-N 116.304 -0.407 . . . . 0.0 110.763 -179.509 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' B' B ' 20' ' ' ASP . . . . . 0.412 ' N ' HG13 ' B' ' 19' ' ' VAL . 71.5 m-20 -60.68 -42.04 96.32 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-O 120.893 0.378 . . . . 0.0 110.881 -178.203 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' B' B ' 21' ' ' VAL . . . . . . . . . . . . . 50.6 t -64.42 -47.17 90.56 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.332 0 CA-C-N 116.314 -0.403 . . . . 0.0 110.512 -178.488 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 22' ' ' ILE . . . . . 0.586 HG22 HD12 ' B' ' 26' ' ' LEU . 50.5 mm -57.5 -40.21 73.43 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.281 0 C-N-CA 120.916 -0.313 . . . . 0.0 110.675 179.95 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' B' B ' 23' ' ' ARG . . . . . . . . . . . . . 46.4 ttp180 -55.95 -50.75 69.92 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-O 120.927 0.394 . . . . 0.0 110.774 177.571 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 24' ' ' ILE . . . . . . . . . . . . . 67.7 mt -62.17 -41.23 90.52 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.278 0 CA-C-N 116.047 -0.524 . . . . 0.0 112.078 -176.667 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 25' ' ' LYS . . . . . 0.469 ' HE2' HD11 ' B' ' 39' ' ' ILE . 14.9 pttp -73.32 -34.88 65.93 Favored 'General case' 0 CA--C 1.533 0.324 0 C-N-CA 120.687 -0.405 . . . . 0.0 111.79 -174.125 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' B' B ' 26' ' ' LEU . . . . . 0.586 HD12 HG22 ' B' ' 22' ' ' ILE . 75.6 mt -79.86 -43.09 22.94 Favored 'General case' 0 C--N 1.33 -0.255 0 N-CA-C 112.426 0.528 . . . . 0.0 112.426 -174.912 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' B' B ' 27' ' ' GLN . . . . . . . . . . . . . 9.6 pt20 -46.36 139.21 5.0 Favored 'General case' 0 N--CA 1.469 0.478 0 N-CA-C 112.838 0.681 . . . . 0.0 112.838 -175.554 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 28' ' ' GLY . . . . . . . . . . . . . . . 101.35 -29.53 12.32 Favored Glycine 0 CA--C 1.531 1.078 0 CA-C-N 115.355 -0.838 . . . . 0.0 112.031 -177.289 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 29' ' ' LYS . . . . . . . . . . . . . 73.7 mmtt -98.16 155.17 17.29 Favored 'General case' 0 C--N 1.332 -0.196 0 CA-C-N 117.194 0.497 . . . . 0.0 110.964 178.466 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 30' ' ' THR . . . . . . . . . . . . . 27.9 m -92.2 135.43 34.01 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.081 -0.509 . . . . 0.0 109.906 175.107 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 31' ' ' VAL . . . . . . . . . . . . . 34.9 m -122.51 145.09 29.84 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.227 0 CA-C-O 120.896 0.379 . . . . 0.0 110.57 -179.152 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 32' ' ' ARG . . . . . . . . . . . . . 73.1 ttt-85 -136.0 148.86 48.61 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 115.863 -0.608 . . . . 0.0 110.383 178.436 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 33' ' ' THR . . . . . . . . . . . . . 26.8 m -52.62 140.7 22.5 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.357 -0.383 . . . . 0.0 111.493 -178.543 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 34' ' ' GLY . . . . . . . . . . . . . . . 100.17 -17.3 57.23 Favored Glycine 0 CA--C 1.533 1.187 0 CA-C-O 119.675 -0.514 . . . . 0.0 113.159 179.678 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 35' ' ' ASP . . . . . . . . . . . . . 75.5 m-20 -65.96 148.87 51.12 Favored 'General case' 0 C--O 1.231 0.092 0 CA-C-N 118.091 0.946 . . . . 0.0 111.054 178.648 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 36' ' ' VAL . . . . . . . . . . . . . 43.4 t -126.44 130.92 71.85 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.2 0 CA-C-N 116.199 -0.455 . . . . 0.0 109.91 178.414 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 37' ' ' ILE . . . . . . . . . . . . . 65.5 mt -122.73 139.69 48.79 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.237 0 CA-C-N 116.174 -0.466 . . . . 0.0 109.984 -179.758 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 38' ' ' GLY . . . . . . . . . . . . . . . -109.31 128.76 9.13 Favored Glycine 0 CA--C 1.526 0.738 0 N-CA-C 111.086 -0.805 . . . . 0.0 111.086 179.518 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 39' ' ' ILE . . . . . 0.469 HD11 ' HE2' ' B' ' 25' ' ' LYS . 65.5 mt -125.69 126.82 70.82 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.249 0 N-CA-C 109.802 -0.444 . . . . 0.0 109.802 178.621 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' B' B ' 40' ' ' SER . . . . . 0.55 ' O ' HD13 ' B' ' 41' ' ' ILE . 41.2 t -92.44 117.32 29.81 Favored 'General case' 0 C--N 1.329 -0.307 0 C-N-CA 120.961 -0.296 . . . . 0.0 110.914 177.075 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' B' B ' 41' ' ' ILE . . . . . 0.55 HD13 ' O ' ' B' ' 40' ' ' SER . 45.3 mm -130.32 124.64 58.08 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.227 0 CA-C-O 120.722 0.296 . . . . 0.0 110.288 179.45 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' B' B ' 42' ' ' LEU . . . . . . . . . . . . . 77.9 mt 58.54 35.1 24.4 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.19 -0.459 . . . . 0.0 111.678 177.307 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 43' ' ' GLY . . . . . . . . . . . . . . . 77.54 -10.12 25.09 Favored Glycine 0 CA--C 1.534 1.261 0 C-N-CA 121.212 -0.518 . . . . 0.0 113.479 177.586 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 44' ' ' LYS . . . . . . . . . . . . . 60.3 mttp -102.49 130.13 49.21 Favored 'General case' 0 C--O 1.232 0.154 0 CA-C-N 117.977 0.888 . . . . 0.0 110.175 177.505 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 45' ' ' GLU . . . . . . . . . . . . . 38.1 tp10 -84.48 128.14 34.42 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-O 120.797 0.332 . . . . 0.0 110.887 179.552 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 46' ' ' VAL . . . . . 0.443 HG23 ' HG2' ' B' ' 10' ' ' PRO . 7.3 p -119.56 129.44 75.32 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.235 0 N-CA-C 109.617 -0.512 . . . . 0.0 109.617 176.741 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' B' B ' 47' ' ' LYS . . . . . . . . . . . . . 35.0 mmtp -99.78 126.91 45.93 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.074 -0.512 . . . . 0.0 110.885 177.833 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 48' ' ' PHE . . . . . . . . . . . . . 91.2 m-85 -108.68 131.81 54.54 Favored 'General case' 0 C--N 1.33 -0.247 0 N-CA-C 109.824 -0.435 . . . . 0.0 109.824 176.461 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 49' ' ' LYS . . . . . . . . . . . . . 85.0 tttt -108.29 136.83 47.29 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.274 -0.421 . . . . 0.0 110.276 178.698 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 50' ' ' VAL . . . . . . . . . . . . . 44.2 t -78.37 108.47 11.83 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.368 0 N-CA-C 109.318 -0.623 . . . . 0.0 109.318 176.304 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 51' ' ' VAL . . . . . . . . . . . . . 48.0 t -69.68 -48.32 65.9 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.298 0 CA-C-N 116.044 -0.525 . . . . 0.0 109.898 -174.27 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 52' ' ' GLN . . . . . . . . . . . . . 47.5 tt0 -169.2 142.56 2.78 Favored 'General case' 0 C--N 1.33 -0.266 0 C-N-CA 120.256 -0.578 . . . . 0.0 111.774 -178.551 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 53' ' ' ALA . . . . . . . . . . . . . . . -111.83 134.17 53.57 Favored 'General case' 0 C--N 1.332 -0.191 0 CA-C-N 115.594 -0.73 . . . . 0.0 109.867 175.572 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 54' ' ' TYR . . . . . . . . . . . . . 41.8 t80 -129.04 108.01 18.07 Favored Pre-proline 0 CA--C 1.534 0.36 0 CA-C-O 118.279 -0.867 . . . . 0.0 110.387 179.823 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 55' ' ' PRO . . . . . . . . . . . . . 73.7 Cg_endo -77.16 170.11 72.4 Favored 'Cis proline' 0 N--CA 1.5 1.863 0 CA-C-N 121.826 1.688 . . . . 0.0 112.396 -6.059 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 56' ' ' SER . . . . . . . . . . . . . 20.9 m -116.1 135.19 22.74 Favored Pre-proline 0 CA--C 1.539 0.544 0 CA-C-O 118.489 -0.767 . . . . 0.0 109.709 175.874 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 57' ' ' PRO . . . . . . . . . . . . . 60.8 Cg_endo -75.15 161.62 94.38 Favored 'Cis proline' 0 N--CA 1.497 1.714 0 CA-C-N 121.792 1.676 . . . . 0.0 111.346 -4.982 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 58' ' ' LEU . . . . . . . . . . . . . 40.4 tp -129.98 138.54 50.88 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-O 120.922 0.392 . . . . 0.0 110.335 -179.791 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 59' ' ' ARG . . . . . . . . . . . . . 74.3 ttt180 -95.52 125.99 40.5 Favored 'General case' 0 C--N 1.326 -0.456 0 N-CA-C 109.229 -0.656 . . . . 0.0 109.229 175.235 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 60' ' ' VAL . . . . . . . . . . . . . 49.9 t -74.76 114.49 14.76 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.331 0 C-N-CA 120.709 -0.396 . . . . 0.0 110.392 -174.587 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 61' ' ' GLU . . . . . . . . . . . . . 70.9 mm-40 -131.1 164.53 25.26 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 115.901 -0.59 . . . . 0.0 110.021 176.542 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 62' ' ' ASP . . . . . . . . . . . . . 13.4 t70 -52.34 -30.32 27.97 Favored 'General case' 0 C--N 1.328 -0.345 0 N-CA-C 112.149 0.426 . . . . 0.0 112.149 -179.408 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 63' ' ' ARG . . . . . . . . . . . . . 39.9 mmt180 -72.05 -20.8 61.62 Favored 'General case' 0 CA--C 1.533 0.301 0 N-CA-C 112.968 0.729 . . . . 0.0 112.968 -174.837 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 64' ' ' THR . . . . . . . . . . . . . 32.9 m -75.66 139.44 41.98 Favored 'General case' 0 C--N 1.331 -0.207 0 CA-C-O 120.947 0.403 . . . . 0.0 111.0 -175.896 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 65' ' ' LYS . . . . . . . . . . . . . 2.3 mptm? -89.4 137.56 32.22 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 115.882 -0.599 . . . . 0.0 109.994 177.457 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 66' ' ' ILE . . . . . . . . . . . . . 60.3 mt -116.51 130.88 70.59 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.29 0 N-CA-C 110.047 -0.353 . . . . 0.0 110.047 179.602 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 67' ' ' THR . . . . . . . . . . . . . 25.5 m -125.06 137.76 54.2 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 116.241 -0.436 . . . . 0.0 110.932 -178.631 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 68' ' ' LEU . . . . . 0.417 HD12 ' N ' ' B' ' 68' ' ' LEU . 8.4 mp . . . . . 0 C--N 1.33 -0.275 0 CA-C-N 115.99 -0.55 . . . . 0.0 110.588 178.835 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 73' ' ' VAL . . . . . . . . . . . . . 28.9 m . . . . . 0 C--O 1.232 0.142 0 N-CA-C 109.909 -0.404 . . . . 0.0 109.909 . . . . . . . . . 0 0 . 1 . 002 nuclear nobuild core ' B' B ' 74' ' ' ASP . . . . . . . . . . . . . 8.8 t70 -97.28 115.01 26.86 Favored 'General case' 0 C--N 1.329 -0.292 0 N-CA-C 109.803 -0.443 . . . . 0.0 109.803 -178.924 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 75' ' ' VAL . . . . . . . . . . . . . 46.3 t -113.08 120.29 62.71 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.242 0 CA-C-O 121.059 0.457 . . . . 0.0 110.223 -178.164 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 76' ' ' LEU . . . . . . . . . . . . . 26.9 mt -123.45 139.74 53.72 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 115.586 -0.734 . . . . 0.0 109.588 178.739 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 77' ' ' GLU . . . . . . . . . . . . . 97.5 mt-10 -134.61 130.97 37.25 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-O 121.101 0.477 . . . . 0.0 111.18 -178.134 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 78' ' ' ALA . . . . . 0.588 ' HB2' HD21 ' B' ' 109' ' ' LEU . . . -120.97 130.46 53.83 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 115.582 -0.736 . . . . 0.0 109.702 177.005 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' B' B ' 79' ' ' LYS . . . . . 0.646 ' O ' HD13 ' B' ' 80' ' ' ILE . 9.1 ptpp? -73.7 120.97 20.04 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-O 121.201 0.524 . . . . 0.0 110.381 -179.306 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' B' B ' 80' ' ' ILE . . . . . 0.646 HD13 ' O ' ' B' ' 79' ' ' LYS . 36.8 mm -139.12 108.66 3.9 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.288 0 N-CA-C 109.133 -0.691 . . . . 0.0 109.133 -177.648 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' B' B ' 81' ' ' LYS . . . . . . . . . . . . . 45.6 tttm -107.52 125.93 51.89 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-O 120.877 0.37 . . . . 0.0 111.205 -175.827 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 82' ' ' GLY . . . . . . . . . . . . . . . 89.18 42.0 5.69 Favored Glycine 0 CA--C 1.525 0.665 0 C-N-CA 120.773 -0.727 . . . . 0.0 111.811 175.005 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 83' ' ' ILE . . . . . . . . . . . . . 69.7 mt -69.15 139.94 19.64 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.315 0 N-CA-C 109.936 -0.394 . . . . 0.0 109.936 178.206 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 84' ' ' LYS . . . . . . . . . . . . . 53.1 tttp -96.74 -51.98 4.09 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.158 -0.474 . . . . 0.0 110.221 -179.199 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 85' ' ' ASP . . . . . . . . . . . . . 3.8 t70 -155.62 155.13 32.73 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 115.784 -0.644 . . . . 0.0 110.386 -179.902 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 86' ' ' VAL . . . . . . . . . . . . . 44.2 t -133.51 132.33 57.53 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.198 0 CA-C-O 121.05 0.452 . . . . 0.0 110.715 -177.957 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 87' ' ' ILE . . . . . . . . . . . . . 46.5 mm -121.26 128.12 75.91 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.194 0 CA-C-N 115.693 -0.685 . . . . 0.0 109.439 175.361 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 88' ' ' LEU . . . . . . . . . . . . . 12.8 tp -113.84 133.17 55.58 Favored 'General case' 0 C--N 1.331 -0.212 0 CA-C-O 120.997 0.427 . . . . 0.0 111.298 -176.793 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 89' ' ' ASP . . . . . . . . . . . . . 6.8 t70 -124.96 157.88 34.99 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-N 115.863 -0.608 . . . . 0.0 109.684 176.375 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 90' ' ' GLU . . . . . . . . . . . . . 44.3 mt-10 -44.99 -45.87 10.83 Favored 'General case' 0 N--CA 1.465 0.285 0 N-CA-C 113.272 0.841 . . . . 0.0 113.272 -172.025 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 91' ' ' ASN . . . . . . . . . . . . . 7.7 p-10 -131.97 37.7 3.58 Favored 'General case' 0 N--CA 1.463 0.22 0 CA-C-O 120.801 0.334 . . . . 0.0 111.373 -176.836 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 92' ' ' LEU . . . . . . . . . . . . . 4.3 tp -166.0 144.09 5.68 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-O 120.812 0.339 . . . . 0.0 110.33 179.916 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 93' ' ' ILE . . . . . . . . . . . . . 62.9 mt -125.42 124.74 67.65 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.279 0 N-CA-C 109.709 -0.478 . . . . 0.0 109.709 -177.658 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 94' ' ' VAL . . . . . . . . . . . . . 46.5 t -122.4 125.92 73.43 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.242 0 N-CA-C 109.917 -0.401 . . . . 0.0 109.917 179.527 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 95' ' ' VAL . . . . . . . . . . . . . 45.4 t -124.01 138.09 54.84 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.32 0 CA-C-N 116.131 -0.486 . . . . 0.0 110.113 -178.749 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 96' ' ' ILE . . . . . . . . . . . . . 61.8 mt -116.44 128.51 73.76 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.315 0 N-CA-C 109.255 -0.646 . . . . 0.0 109.255 178.556 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 97' ' ' THR . . . . . . . . . . . . . 71.8 p -102.9 159.61 15.34 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-O 121.265 0.555 . . . . 0.0 111.436 -175.888 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 98' ' ' GLU . . . . . . . . . . . . . 84.9 tt0 -53.91 -25.73 21.64 Favored 'General case' 0 CA--C 1.532 0.272 0 CA-C-N 116.083 -0.508 . . . . 0.0 112.161 179.327 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 99' ' ' GLU . . . . . . . . . . . . . 41.2 mt-10 -78.66 14.93 1.14 Allowed 'General case' 0 CA--C 1.535 0.39 0 N-CA-C 113.097 0.777 . . . . 0.0 113.097 -177.773 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 100' ' ' ASN . . . . . . . . . . . . . 2.4 m-20 60.63 38.01 18.89 Favored 'General case' 0 CA--C 1.529 0.167 0 CA-C-O 121.018 0.437 . . . . 0.0 110.713 179.481 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 101' ' ' GLU . . . . . . . . . . . . . 84.9 tt0 -117.29 146.31 43.41 Favored 'General case' 0 C--N 1.332 -0.173 0 CA-C-N 116.078 -0.51 . . . . 0.0 109.795 178.189 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 102' ' ' VAL . . . . . . . . . . . . . 44.9 t -114.95 124.74 71.91 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.275 0 CA-C-N 116.258 -0.428 . . . . 0.0 109.85 -178.158 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 103' ' ' LEU . . . . . . . . . . . . . 50.9 mt -115.15 132.69 56.52 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 115.715 -0.675 . . . . 0.0 109.996 178.594 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 104' ' ' ILE . . . . . 0.449 HD12 ' HB3' ' B' ' 113' ' ' TYR . 66.6 mt -123.22 119.59 58.02 Favored 'Isoleucine or valine' 0 C--O 1.233 0.2 0 N-CA-C 110.375 -0.231 . . . . 0.0 110.375 -178.334 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' B' B ' 105' ' ' PHE . . . . . . . . . . . . . 47.1 m-85 -121.17 164.61 16.62 Favored 'General case' 0 C--N 1.331 -0.211 0 CA-C-N 115.471 -0.786 . . . . 0.0 109.809 178.841 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 106' ' ' ASN . . . . . . . . . . . . . 47.4 p-10 -97.67 -169.98 1.92 Allowed 'General case' 0 C--N 1.33 -0.282 0 N-CA-C 109.652 -0.499 . . . . 0.0 109.652 172.851 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 107' ' ' GLN . . . . . . . . . . . . . 62.6 tt0 -59.67 -30.07 68.5 Favored 'General case' 0 C--N 1.33 -0.27 0 N-CA-C 111.879 0.325 . . . . 0.0 111.879 179.81 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 108' ' ' ASN . . . . . . . . . . . . . 7.0 t30 -83.24 8.76 12.39 Favored 'General case' 0 CA--C 1.536 0.432 0 N-CA-C 113.148 0.796 . . . . 0.0 113.148 -177.535 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 109' ' ' LEU . . . . . 0.588 HD21 ' HB2' ' B' ' 78' ' ' ALA . 11.1 tp 60.99 36.21 18.71 Favored 'General case' 0 CA--C 1.53 0.198 0 CA-C-O 120.838 0.351 . . . . 0.0 111.434 178.845 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' B' B ' 110' ' ' GLU . . . . . . . . . . . . . 95.3 mt-10 -105.9 151.2 24.86 Favored 'General case' 0 C--N 1.33 -0.264 0 N-CA-C 109.898 -0.408 . . . . 0.0 109.898 176.884 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 111' ' ' GLU . . . . . . . . . . . . . 99.4 mt-10 -79.77 121.97 26.03 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-O 120.961 0.41 . . . . 0.0 111.34 -177.107 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 112' ' ' LEU . . . . . . . . . . . . . 16.3 mt -106.6 -45.74 4.16 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 115.894 -0.593 . . . . 0.0 110.086 176.418 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 113' ' ' TYR . . . . . 0.449 ' HB3' HD12 ' B' ' 104' ' ' ILE . 61.1 t80 -141.16 142.92 34.0 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 116.104 -0.498 . . . . 0.0 111.006 -179.488 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' B' B ' 114' ' ' ARG . . . . . . . . . . . . . 83.7 mtp180 -144.86 122.12 11.55 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.097 -0.502 . . . . 0.0 110.285 177.388 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 115' ' ' GLY . . . . . . . . . . . . . . . -150.05 162.59 29.23 Favored Glycine 0 CA--C 1.524 0.646 0 N-CA-C 111.006 -0.837 . . . . 0.0 111.006 179.881 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 116' ' ' LYS . . . . . . . . . . . . . 21.6 ttpt -129.1 140.8 51.42 Favored 'General case' 0 C--N 1.33 -0.267 0 N-CA-C 110.204 -0.295 . . . . 0.0 110.204 179.376 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 117' ' ' PHE . . . . . . . . . . . . . 29.1 m-85 -140.8 113.91 8.48 Favored 'General case' 0 C--N 1.331 -0.215 0 N-CA-C 109.927 -0.397 . . . . 0.0 109.927 -178.919 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 118' ' ' GLU . . . . . . . . . . . . . 70.8 mm-40 -56.19 -40.1 73.44 Favored 'General case' 0 C--N 1.329 -0.304 0 C-N-CA 120.912 -0.315 . . . . 0.0 110.944 -177.164 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 119' ' ' ASN . . . . . . . . . . . . . 80.7 m-20 -98.02 30.73 2.95 Favored 'General case' 0 C--N 1.33 -0.261 0 N-CA-C 112.168 0.432 . . . . 0.0 112.168 -175.502 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 120' ' ' LEU . . . . . . . . . . . . . 15.3 tp -58.29 123.69 16.92 Favored 'General case' 0 C--N 1.332 -0.184 0 N-CA-C 110.177 -0.305 . . . . 0.0 110.177 177.051 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 121' ' ' ASN . . . . . . . . . . . . . 77.7 m-20 -114.09 -44.08 3.18 Favored 'General case' 0 C--N 1.332 -0.195 0 CA-C-N 116.545 -0.298 . . . . 0.0 110.866 -178.475 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 122' ' ' LYS . . . . . . . . . . . . . 97.2 mttt -148.58 153.69 38.71 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-O 121.052 0.453 . . . . 0.0 111.569 -178.288 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 123' ' ' VAL . . . . . . . . . . . . . 46.1 t -133.91 130.87 55.9 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.228 0 CA-C-N 115.95 -0.568 . . . . 0.0 109.658 175.13 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 124' ' ' LEU . . . . . . . . . . . . . 64.5 mt -120.56 138.67 53.74 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.176 -0.465 . . . . 0.0 110.476 -178.206 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 125' ' ' VAL . . . . . . . . . . . . . 11.9 p -133.19 127.35 54.36 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.254 0 CA-C-N 116.463 -0.335 . . . . 0.0 110.266 178.413 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 126' ' ' ARG . . . . . . . . . . . . . 40.8 mmt180 -136.84 116.11 12.61 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.3 -0.409 . . . . 0.0 110.339 -179.707 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 127' ' ' ASN . . . . . . . . . . . . . 47.8 t30 52.67 -106.27 0.28 Allowed 'General case' 0 CA--C 1.543 0.71 0 CA-C-O 119.039 -0.505 . . . . 0.0 111.058 -179.986 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 128' ' ' ASP . . . . . . . . . . . . . 19.0 p-10 -114.09 2.92 15.07 Favored 'General case' 0 CA--C 1.536 0.426 0 CA-C-N 119.665 1.12 . . . . 0.0 113.422 -178.449 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 129' ' ' LEU . . . . . 0.547 HD23 ' N ' ' B' ' 130' ' ' VAL . 2.5 tt -104.86 135.72 45.7 Favored 'General case' 0 C--N 1.332 -0.17 0 N-CA-C 109.583 -0.525 . . . . 0.0 109.583 179.324 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' B' B ' 130' ' ' VAL . . . . . 0.547 ' N ' HD23 ' B' ' 129' ' ' LEU . 42.0 t -123.13 139.64 49.25 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.298 0 CA-C-O 120.799 0.333 . . . . 0.0 110.176 -177.678 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' B' B ' 131' ' ' VAL . . . . . . . . . . . . . 39.9 t -135.8 135.17 51.07 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.284 0 CA-C-N 116.235 -0.438 . . . . 0.0 110.162 179.561 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 132' ' ' ILE . . . . . . . . . . . . . 71.1 mt -117.52 132.45 67.3 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 N-CA-C 109.37 -0.604 . . . . 0.0 109.37 178.493 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 133' ' ' ILE . . . . . . . . . . . . . 37.7 mm -117.79 122.31 69.46 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.268 0 CA-C-O 120.617 0.246 . . . . 0.0 111.09 -174.272 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 134' ' ' ASP . . . . . . . . . . . . . 9.1 p-10 -137.38 147.82 45.76 Favored 'General case' 0 C--N 1.331 -0.207 0 CA-C-N 116.179 -0.464 . . . . 0.0 109.794 174.862 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 135' ' ' GLU . . . . . . . . . . . . . 85.5 tt0 -49.78 -24.67 2.5 Favored 'General case' 0 C--N 1.328 -0.333 0 N-CA-C 112.875 0.695 . . . . 0.0 112.875 -173.239 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 136' ' ' GLN . . . . . . . . . . . . . 56.1 tp60 -83.91 -37.64 22.11 Favored 'General case' 0 C--O 1.235 0.316 0 N-CA-C 111.959 0.355 . . . . 0.0 111.959 -175.762 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 137' ' ' LYS . . . . . . . . . . . . . 54.0 pttt -161.28 171.92 17.53 Favored 'General case' 0 C--N 1.331 -0.239 0 CA-C-O 121.558 0.694 . . . . 0.0 112.072 -172.394 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 138' ' ' LEU . . . . . . . . . . . . . 4.7 tt -118.36 126.21 51.62 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 114.962 -1.017 . . . . 0.0 109.649 177.425 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 139' ' ' THR . . . . . . . . . . . . . 16.9 m -106.88 126.19 51.99 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-N 116.24 -0.436 . . . . 0.0 110.616 -178.735 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 140' ' ' LEU . . . . . . . . . . . . . 30.8 tp -114.98 122.51 46.46 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 115.655 -0.702 . . . . 0.0 109.456 -178.405 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 141' ' ' ILE . . . . . . . . . . . . . 19.3 mt -121.86 119.79 59.71 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.282 0 N-CA-C 110.142 -0.318 . . . . 0.0 110.142 -175.039 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 142' ' ' ARG . . . . . . . . . . . . . 82.0 mtm180 -110.18 127.45 54.94 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 115.661 -0.699 . . . . 0.0 110.286 -179.585 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 143' ' ' THR . . . . . . . . . . . . . 41.6 p . . . . . 0 C--O 1.22 -0.467 0 CA-C-O 118.037 -0.982 . . . . 0.0 110.68 -179.436 . . . . . . . . 0 0 . 1 . 002 nuclear nobuild core ' C' C ' 2' ' ' SER . . . . . . . . . . . . . 2.6 p . . . . . 0 N--CA 1.461 0.113 0 CA-C-O 120.902 0.382 . . . . 0.0 110.336 . . . . . . . . . 0 0 . 1 . 002 nuclear nobuild core ' C' C ' 3' ' ' GLU . . . . . . . . . . . . . 95.5 mt-10 -140.99 140.34 34.33 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 116.049 -0.523 . . . . 0.0 111.063 -177.9 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' C' C ' 4' ' ' LEU . . . . . . . . . . . . . 16.1 tp -126.62 128.52 46.91 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 115.996 -0.547 . . . . 0.0 110.098 176.508 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' C' C ' 5' ' ' LYS . . . . . . . . . . . . . 97.4 mttt -109.27 121.5 45.31 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.4 -0.363 . . . . 0.0 110.478 179.531 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' C' C ' 6' ' ' LEU . . . . . . . . . . . . . 62.1 mt -116.21 148.8 40.05 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 115.616 -0.72 . . . . 0.0 110.293 -178.398 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' C' C ' 7' ' ' LYS . . . . . . . . . . . . . 75.6 tttt -136.4 138.54 27.16 Favored Pre-proline 0 CA--C 1.535 0.374 0 CA-C-O 118.996 -0.526 . . . . 0.0 110.2 176.774 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' C' C ' 8' ' ' PRO . . . . . . . . . . . . . 94.2 Cg_endo -91.81 142.76 2.74 Favored 'Trans proline' 0 N--CA 1.489 1.263 0 C-N-CA 121.725 1.617 . . . . 0.0 111.664 176.959 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' C' C ' 9' ' ' LEU . . . . . . . . . . . . . 36.9 mt -82.52 -47.83 0.88 Allowed Pre-proline 0 CA--C 1.534 0.343 0 CA-C-O 118.74 -0.647 . . . . 0.0 112.495 -177.681 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' C' C ' 10' ' ' PRO . . . . . . . . . . . . . 94.5 Cg_endo -81.65 161.13 19.2 Favored 'Trans proline' 0 N--CA 1.497 1.694 0 C-N-CA 121.24 1.293 . . . . 0.0 111.969 177.101 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' C' C ' 11' ' ' LYS . . . . . . . . . . . . . 91.0 mttt -86.52 103.11 14.73 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.389 -0.368 . . . . 0.0 110.38 177.825 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' C' C ' 12' ' ' VAL . . . . . . . . . . . . . 11.9 p -141.71 143.61 26.93 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.276 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.371 179.847 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' C' C ' 13' ' ' GLU . . . . . . . . . . . . . 82.5 tt0 -90.82 122.81 33.86 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 116.323 -0.399 . . . . 0.0 109.987 177.967 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' C' C ' 14' ' ' LEU . . . . . . . . . . . . . 25.3 mt -96.9 152.38 38.36 Favored Pre-proline 0 C--N 1.329 -0.311 0 CA-C-N 116.458 -0.337 . . . . 0.0 111.03 -175.973 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' C' C ' 15' ' ' PRO . . . . . . . . . . . . . 26.6 Cg_exo -61.72 163.11 19.48 Favored 'Trans proline' 0 N--CA 1.497 1.711 0 C-N-CA 121.255 1.303 . . . . 0.0 111.892 176.634 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' C' C ' 16' ' ' PRO . . . . . . . . . . . . . 25.2 Cg_exo -61.64 -44.44 21.77 Favored 'Trans proline' 0 N--CA 1.497 1.713 0 C-N-CA 121.516 1.478 . . . . 0.0 112.668 -178.472 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' C' C ' 17' ' ' ASP . . . . . . . . . . . . . 22.3 p-10 -88.72 16.23 7.07 Favored 'General case' 0 C--N 1.327 -0.385 0 N-CA-C 112.994 0.738 . . . . 0.0 112.994 -177.13 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' C' C ' 18' ' ' PHE . . . . . 0.522 ' CZ ' HD11 ' C' ' 22' ' ' ILE . 63.4 t80 -57.6 -41.53 81.43 Favored 'General case' 0 C--N 1.335 -0.064 0 O-C-N 122.053 -0.404 . . . . 0.0 110.315 -178.59 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' C' C ' 19' ' ' VAL . . . . . . . . . . . . . 44.3 t -56.26 -45.56 81.22 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.338 0 CA-C-N 116.47 -0.332 . . . . 0.0 110.624 -178.173 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' C' C ' 20' ' ' ASP . . . . . . . . . . . . . 51.4 m-20 -60.6 -40.43 91.77 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-O 120.763 0.316 . . . . 0.0 111.021 -178.295 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' C' C ' 21' ' ' VAL . . . . . . . . . . . . . 48.2 t -64.0 -48.46 85.91 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.328 0 C-N-CA 120.769 -0.373 . . . . 0.0 110.421 -178.373 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' C' C ' 22' ' ' ILE . . . . . 0.542 HG22 HD12 ' C' ' 26' ' ' LEU . 51.5 mm -55.61 -44.37 76.41 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.299 0 CA-C-O 120.895 0.379 . . . . 0.0 110.461 178.29 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' C' C ' 23' ' ' ARG . . . . . . . . . . . . . 56.6 ttp180 -52.51 -52.26 55.44 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-O 120.717 0.294 . . . . 0.0 111.609 -179.955 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' C' C ' 24' ' ' ILE . . . . . . . . . . . . . 71.1 mt -59.4 -40.63 82.12 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.294 0 CA-C-N 116.407 -0.361 . . . . 0.0 111.389 -176.338 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' C' C ' 25' ' ' LYS . . . . . . . . . . . . . 91.3 mttt -67.2 -37.83 84.31 Favored 'General case' 0 C--N 1.329 -0.288 0 N-CA-C 112.179 0.437 . . . . 0.0 112.179 -179.53 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' C' C ' 26' ' ' LEU . . . . . 0.542 HD12 HG22 ' C' ' 22' ' ' ILE . 68.2 mt -79.13 -41.18 29.15 Favored 'General case' 0 C--N 1.329 -0.295 0 N-CA-C 113.125 0.787 . . . . 0.0 113.125 -171.297 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' C' C ' 27' ' ' GLN . . . . . . . . . . . . . 9.9 pt20 -46.68 139.0 5.57 Favored 'General case' 0 N--CA 1.47 0.558 0 N-CA-C 112.659 0.614 . . . . 0.0 112.659 -176.151 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' C' C ' 28' ' ' GLY . . . . . . . . . . . . . . . 101.13 -26.87 23.07 Favored Glycine 0 CA--C 1.532 1.114 0 CA-C-N 115.536 -0.756 . . . . 0.0 112.213 -177.441 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' C' C ' 29' ' ' LYS . . . . . . . . . . . . . 61.7 mtpt -98.22 155.2 17.29 Favored 'General case' 0 C--N 1.333 -0.138 0 CA-C-N 117.32 0.56 . . . . 0.0 111.2 179.595 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' C' C ' 30' ' ' THR . . . . . . . . . . . . . 36.0 m -105.91 135.63 47.0 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 115.962 -0.563 . . . . 0.0 109.939 175.705 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' C' C ' 31' ' ' VAL . . . . . . . . . . . . . 34.5 m -132.87 158.32 43.24 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.271 0 CA-C-O 120.947 0.403 . . . . 0.0 111.019 -177.587 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' C' C ' 32' ' ' ARG . . . . . . . . . . . . . 50.7 mtp180 -134.89 152.71 51.97 Favored 'General case' 0 C--N 1.331 -0.219 0 CA-C-O 121.353 0.597 . . . . 0.0 110.706 178.736 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' C' C ' 33' ' ' THR . . . . . . . . . . . . . 22.1 m -52.57 140.17 23.68 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 115.997 -0.547 . . . . 0.0 111.509 -178.347 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' C' C ' 34' ' ' GLY . . . . . . . . . . . . . . . 100.0 -17.22 57.51 Favored Glycine 0 CA--C 1.532 1.117 0 CA-C-O 119.553 -0.582 . . . . 0.0 113.258 178.092 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' C' C ' 35' ' ' ASP . . . . . . . . . . . . . 77.5 m-20 -66.06 148.08 52.36 Favored 'General case' 0 N--CA 1.461 0.109 0 CA-C-N 118.148 0.974 . . . . 0.0 110.897 178.836 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' C' C ' 36' ' ' VAL . . . . . . . . . . . . . 44.2 t -124.92 132.8 70.85 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.238 0 CA-C-N 116.169 -0.468 . . . . 0.0 109.955 178.648 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' C' C ' 37' ' ' ILE . . . . . . . . . . . . . 67.8 mt -123.43 141.64 42.97 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.286 0 CA-C-N 116.072 -0.513 . . . . 0.0 110.04 -178.714 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' C' C ' 38' ' ' GLY . . . . . . . . . . . . . . . -111.56 129.0 8.91 Favored Glycine 0 CA--C 1.525 0.673 0 N-CA-C 111.021 -0.832 . . . . 0.0 111.021 179.667 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' C' C ' 39' ' ' ILE . . . . . . . . . . . . . 76.3 mt -125.39 137.34 57.96 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.193 0 CA-C-O 120.731 0.3 . . . . 0.0 110.205 179.805 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' C' C ' 40' ' ' SER . . . . . . . . . . . . . 35.8 t -93.4 124.6 37.5 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.273 -0.421 . . . . 0.0 110.903 175.643 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' C' C ' 41' ' ' ILE . . . . . 0.432 HD12 HG11 ' C' ' 46' ' ' VAL . 73.1 mt -130.56 119.59 46.21 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.181 0 CA-C-O 120.845 0.355 . . . . 0.0 110.336 177.757 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' C' C ' 42' ' ' LEU . . . . . . . . . . . . . 7.3 mp 51.71 37.24 19.66 Favored 'General case' 0 C--N 1.331 -0.221 0 CA-C-N 116.06 -0.518 . . . . 0.0 111.489 177.306 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' C' C ' 43' ' ' GLY . . . . . . . . . . . . . . . 72.58 30.88 63.58 Favored Glycine 0 CA--C 1.528 0.892 0 C-N-CA 121.07 -0.586 . . . . 0.0 112.309 176.837 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' C' C ' 44' ' ' LYS . . . . . . . . . . . . . 82.4 tttt -137.75 131.62 31.56 Favored 'General case' 0 C--N 1.33 -0.265 0 N-CA-C 109.692 -0.484 . . . . 0.0 109.692 177.085 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' C' C ' 45' ' ' GLU . . . . . . . . . . . . . 81.2 tt0 -82.91 123.08 29.07 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-O 120.725 0.298 . . . . 0.0 111.179 -177.345 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' C' C ' 46' ' ' VAL . . . . . 0.432 HG11 HD12 ' C' ' 41' ' ' ILE . 7.3 p -121.58 128.24 75.77 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.223 0 N-CA-C 109.624 -0.51 . . . . 0.0 109.624 176.212 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' C' C ' 47' ' ' LYS . . . . . . . . . . . . . 66.8 mttm -99.45 129.99 45.68 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.008 -0.542 . . . . 0.0 111.138 178.668 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' C' C ' 48' ' ' PHE . . . . . . . . . . . . . 91.6 m-85 -113.82 131.86 56.09 Favored 'General case' 0 C--N 1.33 -0.269 0 N-CA-C 109.873 -0.418 . . . . 0.0 109.873 176.255 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' C' C ' 49' ' ' LYS . . . . . . . . . . . . . 63.6 tttm -109.28 139.23 44.48 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.528 -0.305 . . . . 0.0 110.7 178.323 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' C' C ' 50' ' ' VAL . . . . . . . . . . . . . 45.7 t -81.17 108.54 14.56 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.352 0 N-CA-C 109.327 -0.62 . . . . 0.0 109.327 175.614 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' C' C ' 51' ' ' VAL . . . . . . . . . . . . . 46.7 t -70.04 -48.66 61.37 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.316 0 CA-C-N 116.131 -0.486 . . . . 0.0 109.8 -174.494 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' C' C ' 52' ' ' GLN . . . . . . . . . . . . . 61.6 tt0 -165.72 148.21 7.51 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.063 -0.517 . . . . 0.0 111.691 -178.964 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' C' C ' 53' ' ' ALA . . . . . . . . . . . . . . . -123.35 133.55 54.11 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 115.655 -0.702 . . . . 0.0 110.01 177.928 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' C' C ' 54' ' ' TYR . . . . . . . . . . . . . 10.3 t80 -129.02 111.98 18.5 Favored Pre-proline 0 CA--C 1.536 0.409 0 CA-C-O 118.179 -0.915 . . . . 0.0 110.483 178.977 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' C' C ' 55' ' ' PRO . . . . . . . . . . . . . 73.2 Cg_endo -77.23 168.27 77.32 Favored 'Cis proline' 0 N--CA 1.501 1.918 0 CA-C-N 122.028 1.76 . . . . 0.0 112.278 -6.782 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' C' C ' 56' ' ' SER . . . . . . . . . . . . . 13.5 m -117.35 132.33 23.59 Favored Pre-proline 0 CA--C 1.539 0.533 0 CA-C-O 118.453 -0.784 . . . . 0.0 109.292 174.21 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' C' C ' 57' ' ' PRO . . . . . . . . . . . . . 54.2 Cg_endo -70.08 147.15 84.72 Favored 'Cis proline' 0 N--CA 1.497 1.735 0 CA-C-N 121.834 1.691 . . . . 0.0 111.573 -0.109 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' C' C ' 58' ' ' LEU . . . . . . . . . . . . . 24.6 tp -108.51 136.51 48.0 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.409 -0.359 . . . . 0.0 110.843 -178.427 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' C' C ' 59' ' ' ARG . . . . . . . . . . . . . 59.2 ttt85 -102.95 121.11 41.86 Favored 'General case' 0 C--N 1.326 -0.421 0 N-CA-C 109.288 -0.634 . . . . 0.0 109.288 175.15 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' C' C ' 60' ' ' VAL . . . . . . . . . . . . . 42.5 t -76.42 118.42 22.78 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.28 0 C-N-CA 120.728 -0.389 . . . . 0.0 110.559 -174.881 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' C' C ' 61' ' ' GLU . . . . . . . . . . . . . 71.0 mm-40 -130.99 162.7 29.18 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 115.984 -0.553 . . . . 0.0 109.779 176.377 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' C' C ' 62' ' ' ASP . . . . . . . . . . . . . 80.3 m-20 -52.41 -30.5 29.66 Favored 'General case' 0 C--N 1.329 -0.302 0 N-CA-C 112.05 0.389 . . . . 0.0 112.05 179.758 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' C' C ' 63' ' ' ARG . . . . . . . . . . . . . 77.1 mtp85 -72.61 -21.85 61.05 Favored 'General case' 0 CA--C 1.533 0.294 0 N-CA-C 112.894 0.702 . . . . 0.0 112.894 -175.956 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' C' C ' 64' ' ' THR . . . . . . . . . . . . . 26.4 m -69.52 137.7 52.72 Favored 'General case' 0 C--N 1.331 -0.215 0 CA-C-O 120.993 0.425 . . . . 0.0 111.292 -174.683 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' C' C ' 65' ' ' LYS . . . . . . . . . . . . . 98.7 mttt -90.08 135.61 33.55 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 115.832 -0.622 . . . . 0.0 110.111 177.561 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' C' C ' 66' ' ' ILE . . . . . . . . . . . . . 64.4 mt -117.66 132.89 66.14 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.224 0 CA-C-O 120.868 0.366 . . . . 0.0 110.166 -179.787 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' C' C ' 67' ' ' THR . . . . . . . . . . . . . 30.1 m -122.39 139.61 53.64 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 115.988 -0.551 . . . . 0.0 110.813 -179.188 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' C' C ' 68' ' ' LEU . . . . . . . . . . . . . 4.1 tt . . . . . 0 C--N 1.329 -0.299 0 CA-C-N 115.982 -0.554 . . . . 0.0 110.29 178.971 . . . . . . . . 0 0 . 1 . 002 nuclear nobuild core ' C' C ' 73' ' ' VAL . . . . . . . . . . . . . 30.2 m . . . . . 0 N--CA 1.461 0.088 0 CA-C-O 120.658 0.265 . . . . 0.0 110.382 . . . . . . . . . 0 0 . 1 . 002 nuclear nobuild core ' C' C ' 74' ' ' ASP . . . . . . . . . . . . . 25.8 t0 -98.59 119.91 38.13 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.463 -0.335 . . . . 0.0 110.243 -177.552 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' C' C ' 75' ' ' VAL . . . . . . . . . . . . . 44.2 t -114.84 121.79 67.64 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.222 0 CA-C-O 121.176 0.513 . . . . 0.0 110.379 -179.277 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' C' C ' 76' ' ' LEU . . . . . . . . . . . . . 24.3 mt -118.92 146.58 44.83 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 115.553 -0.749 . . . . 0.0 109.628 178.119 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' C' C ' 77' ' ' GLU . . . . . . . . . . . . . 97.6 mt-10 -138.62 129.35 26.39 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-O 121.051 0.453 . . . . 0.0 111.204 -179.214 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' C' C ' 78' ' ' ALA . . . . . 0.746 ' HB2' HD21 ' C' ' 109' ' ' LEU . . . -116.94 136.5 52.9 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 115.797 -0.638 . . . . 0.0 109.787 177.345 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' C' C ' 79' ' ' LYS . . . . . 0.627 ' O ' HD13 ' C' ' 80' ' ' ILE . 52.2 pttt -84.79 119.4 25.26 Favored 'General case' 0 C--N 1.331 -0.218 0 CA-C-O 121.237 0.541 . . . . 0.0 111.006 -177.247 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' C' C ' 80' ' ' ILE . . . . . 0.627 HD13 ' O ' ' C' ' 79' ' ' LYS . 36.0 mm -139.43 117.98 12.26 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.212 0 N-CA-C 109.277 -0.638 . . . . 0.0 109.277 179.946 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' C' C ' 81' ' ' LYS . . . . . . . . . . . . . 57.2 tttm -103.36 122.54 45.05 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-O 120.777 0.322 . . . . 0.0 111.031 -178.037 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' C' C ' 82' ' ' GLY . . . . . . . . . . . . . . . 89.24 42.13 5.64 Favored Glycine 0 CA--C 1.526 0.719 0 C-N-CA 120.819 -0.705 . . . . 0.0 111.831 175.044 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' C' C ' 83' ' ' ILE . . . . . . . . . . . . . 75.3 mt -66.97 137.42 24.87 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.312 0 N-CA-C 109.858 -0.423 . . . . 0.0 109.858 177.318 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' C' C ' 84' ' ' LYS . . . . . . . . . . . . . 80.0 tttt -96.74 -54.02 3.36 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 115.971 -0.558 . . . . 0.0 110.326 -177.727 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' C' C ' 85' ' ' ASP . . . . . . . . . . . . . 8.1 t70 -151.14 150.01 30.15 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 115.748 -0.66 . . . . 0.0 110.407 -177.648 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' C' C ' 86' ' ' VAL . . . . . . . . . . . . . 44.6 t -129.04 129.18 67.87 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.266 0 CA-C-O 120.896 0.379 . . . . 0.0 110.435 -179.483 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' C' C ' 87' ' ' ILE . . . . . 0.497 ' N ' HD12 ' C' ' 87' ' ' ILE . 5.0 mp -117.45 125.56 74.11 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.288 0 CA-C-N 115.909 -0.587 . . . . 0.0 109.481 176.872 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' C' C ' 88' ' ' LEU . . . . . . . . . . . . . 16.7 tp -110.5 129.68 55.73 Favored 'General case' 0 C--N 1.331 -0.221 0 CA-C-N 116.373 -0.376 . . . . 0.0 110.719 -179.025 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' C' C ' 89' ' ' ASP . . . . . . . . . . . . . 11.9 t70 -126.63 154.75 43.58 Favored 'General case' 0 C--N 1.331 -0.222 0 CA-C-N 116.119 -0.491 . . . . 0.0 109.945 178.0 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' C' C ' 90' ' ' GLU . . . . . . . . . . . . . 77.8 tt0 -45.73 -35.14 4.04 Favored 'General case' 0 C--N 1.329 -0.299 0 N-CA-C 113.332 0.864 . . . . 0.0 113.332 -172.218 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' C' C ' 91' ' ' ASN . . . . . . . . . . . . . 56.7 m-80 -130.87 15.27 5.28 Favored 'General case' 0 N--CA 1.469 0.488 0 N-CA-C 113.309 0.855 . . . . 0.0 113.309 -175.587 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' C' C ' 92' ' ' LEU . . . . . . . . . . . . . 8.5 mt -150.34 151.97 33.71 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 118.131 0.423 . . . . 0.0 110.33 -176.414 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' C' C ' 93' ' ' ILE . . . . . . . . . . . . . 70.1 mt -129.15 119.29 48.63 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.316 0 N-CA-C 109.172 -0.677 . . . . 0.0 109.172 177.342 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' C' C ' 94' ' ' VAL . . . . . 0.56 HG21 HG11 ' C' ' 125' ' ' VAL . 45.7 t -119.91 127.98 75.91 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.252 0 CA-C-O 120.875 0.369 . . . . 0.0 110.08 -178.364 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' C' C ' 95' ' ' VAL . . . . . . . . . . . . . 42.5 t -122.46 134.02 66.93 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.25 0 CA-C-N 116.045 -0.525 . . . . 0.0 109.899 -179.984 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' C' C ' 96' ' ' ILE . . . . . . . . . . . . . 64.9 mt -114.54 127.65 71.93 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.386 0 N-CA-C 109.384 -0.599 . . . . 0.0 109.384 179.435 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' C' C ' 97' ' ' THR . . . . . . . . . . . . . 68.1 p -97.8 156.46 16.57 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-O 120.92 0.391 . . . . 0.0 110.732 -179.495 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' C' C ' 98' ' ' GLU . . . . . . . . . . . . . 45.6 tp10 -53.82 -26.5 24.44 Favored 'General case' 0 CA--C 1.534 0.336 0 N-CA-C 112.1 0.407 . . . . 0.0 112.1 -179.531 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' C' C ' 99' ' ' GLU . . . . . . . . . . . . . 28.3 tt0 -79.74 17.26 0.95 Allowed 'General case' 0 CA--C 1.536 0.417 0 N-CA-C 113.004 0.742 . . . . 0.0 113.004 -176.467 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' C' C ' 100' ' ' ASN . . . . . . . . . . . . . 3.0 m-20 62.74 31.39 16.6 Favored 'General case' 0 CA--C 1.532 0.272 0 O-C-N 122.11 -0.369 . . . . 0.0 111.908 176.765 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' C' C ' 101' ' ' GLU . . . . . . . . . . . . . 84.8 tt0 -111.92 142.55 44.18 Favored 'General case' 0 C--N 1.332 -0.165 0 N-CA-C 109.594 -0.521 . . . . 0.0 109.594 173.762 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' C' C ' 102' ' ' VAL . . . . . . . . . . . . . 43.3 t -115.42 129.33 71.87 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.306 0 CA-C-N 116.368 -0.378 . . . . 0.0 110.213 -177.449 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' C' C ' 103' ' ' LEU . . . . . . . . . . . . . 39.9 mt -115.96 129.7 56.5 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 115.601 -0.727 . . . . 0.0 109.822 176.9 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' C' C ' 104' ' ' ILE . . . . . . . . . . . . . 67.4 mt -117.97 121.19 66.73 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.228 0 N-CA-C 110.343 -0.243 . . . . 0.0 110.343 -178.784 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' C' C ' 105' ' ' PHE . . . . . . . . . . . . . 52.7 m-85 -122.66 166.95 14.06 Favored 'General case' 0 C--N 1.333 -0.139 0 O-C-N 123.872 0.732 . . . . 0.0 109.948 179.625 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' C' C ' 106' ' ' ASN . . . . . . . . . . . . . 43.9 p-10 -102.23 -169.97 1.75 Allowed 'General case' 0 C--N 1.33 -0.245 0 N-CA-C 109.972 -0.381 . . . . 0.0 109.972 174.883 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' C' C ' 107' ' ' GLN . . . . . . . . . . . . . 43.2 tt0 -57.19 -29.52 63.75 Favored 'General case' 0 C--N 1.33 -0.274 0 N-CA-C 111.915 0.339 . . . . 0.0 111.915 178.19 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' C' C ' 108' ' ' ASN . . . . . . . . . . . . . 4.0 t-20 -84.67 11.5 8.85 Favored 'General case' 0 CA--C 1.535 0.384 0 N-CA-C 113.009 0.744 . . . . 0.0 113.009 -176.96 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' C' C ' 109' ' ' LEU . . . . . 0.746 HD21 ' HB2' ' C' ' 78' ' ' ALA . 9.7 tp 53.65 37.23 25.56 Favored 'General case' 0 C--O 1.233 0.19 0 CA-C-O 121.064 0.459 . . . . 0.0 111.254 -179.809 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' C' C ' 110' ' ' GLU . . . . . . . . . . . . . 95.8 mt-10 -104.8 145.36 30.48 Favored 'General case' 0 C--N 1.33 -0.25 0 N-CA-C 109.566 -0.531 . . . . 0.0 109.566 175.499 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' C' C ' 111' ' ' GLU . . . . . . . . . . . . . 71.0 tt0 -80.01 121.93 26.1 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-O 120.893 0.377 . . . . 0.0 110.576 -176.738 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' C' C ' 112' ' ' LEU . . . . . . . . . . . . . 10.8 mt -107.66 -46.05 3.9 Favored 'General case' 0 C--N 1.331 -0.218 0 CA-C-N 116.066 -0.515 . . . . 0.0 110.386 -179.54 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' C' C ' 113' ' ' TYR . . . . . . . . . . . . . 55.6 t80 -136.79 142.2 42.94 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-N 116.336 -0.393 . . . . 0.0 111.085 -178.784 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' C' C ' 114' ' ' ARG . . . . . . . . . . . . . 35.9 ptt-85 -142.52 124.59 15.34 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.063 -0.517 . . . . 0.0 110.363 177.507 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' C' C ' 115' ' ' GLY . . . . . . . . . . . . . . . -150.11 162.6 29.25 Favored Glycine 0 CA--C 1.524 0.629 0 N-CA-C 111.123 -0.791 . . . . 0.0 111.123 -179.765 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' C' C ' 116' ' ' LYS . . . . . . . . . . . . . 69.2 tttt -132.09 136.73 47.38 Favored 'General case' 0 C--N 1.329 -0.319 0 N-CA-C 109.797 -0.445 . . . . 0.0 109.797 177.266 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' C' C ' 117' ' ' PHE . . . . . . . . . . . . . 38.2 m-85 -133.67 114.8 13.88 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-O 120.905 0.383 . . . . 0.0 110.179 -175.595 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' C' C ' 118' ' ' GLU . . . . . . . . . . . . . 71.0 mm-40 -51.07 -52.42 43.59 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.454 -0.339 . . . . 0.0 111.792 -176.042 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' C' C ' 119' ' ' ASN . . . . . . . . . . . . . 1.8 m-80 -95.63 31.18 2.09 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.274 -0.421 . . . . 0.0 112.024 -174.193 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' C' C ' 120' ' ' LEU . . . . . . . . . . . . . 18.3 tp -53.57 121.24 7.36 Favored 'General case' 0 N--CA 1.463 0.22 0 O-C-N 122.234 -0.291 . . . . 0.0 110.929 178.704 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' C' C ' 121' ' ' ASN . . . . . . . . . . . . . 69.2 m-20 -113.75 -43.85 3.25 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.341 -0.391 . . . . 0.0 110.929 -177.096 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' C' C ' 122' ' ' LYS . . . . . . . . . . . . . 97.1 mttt -144.69 147.47 33.05 Favored 'General case' 0 C--N 1.332 -0.177 0 CA-C-O 121.154 0.502 . . . . 0.0 111.946 -176.993 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' C' C ' 123' ' ' VAL . . . . . . . . . . . . . 45.6 t -125.82 125.43 68.31 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.259 0 N-CA-C 109.079 -0.711 . . . . 0.0 109.079 173.351 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' C' C ' 124' ' ' LEU . . . . . . . . . . . . . 59.9 mt -123.9 138.76 54.43 Favored 'General case' 0 C--N 1.331 -0.216 0 CA-C-O 120.877 0.37 . . . . 0.0 110.99 -176.232 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' C' C ' 125' ' ' VAL . . . . . 0.56 HG11 HG21 ' C' ' 94' ' ' VAL . 35.7 m -133.97 140.51 46.16 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.28 0 CA-C-N 116.018 -0.537 . . . . 0.0 110.365 178.399 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' C' C ' 126' ' ' ARG . . . . . . . . . . . . . 38.9 ttt180 -151.09 122.66 7.95 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-O 120.98 0.419 . . . . 0.0 110.67 177.634 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' C' C ' 127' ' ' ASN . . . . . . . . . . . . . 20.3 t-20 52.08 -107.29 0.32 Allowed 'General case' 0 CA--C 1.543 0.687 0 CA-C-O 118.968 -0.539 . . . . 0.0 111.177 -179.048 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' C' C ' 128' ' ' ASP . . . . . . . . . . . . . 17.7 p-10 -114.17 5.07 15.78 Favored 'General case' 0 N--CA 1.467 0.413 0 CA-C-N 119.654 1.116 . . . . 0.0 113.468 -177.223 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' C' C ' 129' ' ' LEU . . . . . . . . . . . . . 18.3 tp -106.66 138.62 42.49 Favored 'General case' 0 C--O 1.232 0.147 0 O-C-N 122.008 -0.432 . . . . 0.0 110.362 -179.419 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' C' C ' 130' ' ' VAL . . . . . . . . . . . . . 40.4 t -121.33 135.36 61.75 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.227 0 N-CA-C 109.724 -0.472 . . . . 0.0 109.724 179.938 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' C' C ' 131' ' ' VAL . . . . . 0.436 HG22 HD12 ' C' ' 140' ' ' LEU . 43.0 t -136.01 136.82 49.42 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.24 0 CA-C-O 120.997 0.427 . . . . 0.0 110.419 179.985 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' C' C ' 132' ' ' ILE . . . . . . . . . . . . . 68.5 mt -118.42 133.87 63.86 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.314 0 CA-C-N 115.853 -0.612 . . . . 0.0 109.491 179.058 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' C' C ' 133' ' ' ILE . . . . . . . . . . . . . 37.6 mm -116.78 119.31 61.62 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.231 0 CA-C-N 116.52 -0.309 . . . . 0.0 110.941 -175.361 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' C' C ' 134' ' ' ASP . . . . . . . . . . . . . 7.4 p-10 -130.13 148.95 52.03 Favored 'General case' 0 C--N 1.332 -0.182 0 N-CA-C 109.727 -0.471 . . . . 0.0 109.727 174.258 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' C' C ' 135' ' ' GLU . . . . . . . . . . . . . 39.2 tp10 -49.95 -24.57 2.63 Favored 'General case' 0 C--N 1.329 -0.302 0 N-CA-C 112.996 0.739 . . . . 0.0 112.996 -170.471 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' C' C ' 136' ' ' GLN . . . . . . . . . . . . . 52.8 mt-30 -104.76 -26.63 12.19 Favored 'General case' 0 N--CA 1.464 0.248 0 N-CA-C 112.773 0.657 . . . . 0.0 112.773 -174.113 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' C' C ' 137' ' ' LYS . . . . . . . . . . . . . 56.6 mtpt -141.15 150.0 42.23 Favored 'General case' 0 C--N 1.332 -0.194 0 CA-C-O 121.404 0.621 . . . . 0.0 112.099 -169.038 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' C' C ' 138' ' ' LEU . . . . . . . . . . . . . 18.1 tp -111.12 120.6 42.86 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 115.054 -0.975 . . . . 0.0 109.045 173.259 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' C' C ' 139' ' ' THR . . . . . . . . . . . . . 27.0 m -109.82 126.02 53.36 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-O 120.82 0.343 . . . . 0.0 110.973 -178.23 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' C' C ' 140' ' ' LEU . . . . . 0.436 HD12 HG22 ' C' ' 131' ' ' VAL . 17.7 tp -115.61 122.71 46.42 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 115.471 -0.786 . . . . 0.0 109.309 -179.361 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' C' C ' 141' ' ' ILE . . . . . . . . . . . . . 19.5 mt -121.76 119.42 58.74 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 N-CA-C 109.763 -0.458 . . . . 0.0 109.763 -176.37 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' C' C ' 142' ' ' ARG . . . . . . . . . . . . . 82.6 mtm180 . . . . . 0 C--N 1.33 -0.271 0 CA-C-N 115.691 -0.686 . . . . 0.0 110.721 -177.769 . . . . . . . . 0 0 . 1 . 002 nuclear nobuild core ' D' D ' 2' ' ' SER . . . . . . . . . . . . . 92.7 p . . . . . 0 C--O 1.231 0.085 0 CA-C-O 121.01 0.433 . . . . 0.0 110.742 . . . . . . . . . 0 0 . 1 . 002 nuclear nobuild core ' D' D ' 3' ' ' GLU . . . . . . . . . . . . . 47.1 mp0 -139.41 144.58 38.17 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 115.933 -0.576 . . . . 0.0 111.227 -176.669 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' D' D ' 4' ' ' LEU . . . . . . . . . . . . . 16.4 tp -123.32 126.8 47.54 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 115.777 -0.647 . . . . 0.0 109.685 175.187 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' D' D ' 5' ' ' LYS . . . . . . . . . . . . . 88.3 mttt -109.02 121.0 44.21 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.384 -0.371 . . . . 0.0 110.642 -178.542 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' D' D ' 6' ' ' LEU . . . . . . . . . . . . . 47.8 mt -115.48 144.5 43.75 Favored 'General case' 0 C--N 1.331 -0.21 0 CA-C-N 115.87 -0.605 . . . . 0.0 110.256 -179.844 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' D' D ' 7' ' ' LYS . . . . . . . . . . . . . 45.4 tttp -127.37 136.89 29.59 Favored Pre-proline 0 CA--C 1.532 0.278 0 CA-C-O 118.886 -0.578 . . . . 0.0 109.465 175.17 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' D' D ' 8' ' ' PRO . . . . . . . . . . . . . 71.9 Cg_endo -90.41 132.99 1.82 Allowed 'Trans proline' 0 N--CA 1.49 1.319 0 C-N-CA 121.619 1.546 . . . . 0.0 111.858 178.548 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' D' D ' 9' ' ' LEU . . . . . . . . . . . . . 43.0 mt -72.26 -46.99 10.77 Favored Pre-proline 0 C--N 1.329 -0.313 0 CA-C-O 118.69 -0.671 . . . . 0.0 111.963 -179.956 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' D' D ' 10' ' ' PRO . . . . . . . . . . . . . 93.2 Cg_endo -82.37 146.63 13.94 Favored 'Trans proline' 0 N--CA 1.496 1.62 0 C-N-CA 121.178 1.252 . . . . 0.0 111.635 174.978 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' D' D ' 11' ' ' LYS . . . . . . . . . . . . . 25.1 pttm -71.67 119.2 15.49 Favored 'General case' 0 C--N 1.331 -0.203 0 N-CA-C 109.692 -0.484 . . . . 0.0 109.692 177.19 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' D' D ' 12' ' ' VAL . . . . . . . . . . . . . 12.2 p -151.17 149.51 14.07 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.288 0 CA-C-N 116.094 -0.503 . . . . 0.0 111.127 -176.414 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' D' D ' 13' ' ' GLU . . . . . . . . . . . . . 42.5 mt-10 -108.46 109.98 21.38 Favored 'General case' 0 C--N 1.331 -0.227 0 CA-C-N 115.985 -0.552 . . . . 0.0 109.81 175.466 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' D' D ' 14' ' ' LEU . . . . . . . . . . . . . 16.1 mt -97.6 152.1 37.98 Favored Pre-proline 0 CA--C 1.532 0.282 0 CA-C-O 119.398 -0.334 . . . . 0.0 110.915 -176.724 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' D' D ' 15' ' ' PRO . . . . . . . . . . . . . 25.5 Cg_exo -62.36 160.41 31.39 Favored 'Trans proline' 0 N--CA 1.498 1.769 0 C-N-CA 121.337 1.358 . . . . 0.0 111.894 176.999 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' D' D ' 16' ' ' PRO . . . . . . . . . . . . . 27.2 Cg_exo -60.98 -37.79 73.91 Favored 'Trans proline' 0 N--CA 1.498 1.758 0 C-N-CA 121.479 1.453 . . . . 0.0 112.643 -179.7 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' D' D ' 17' ' ' ASP . . . . . . . . . . . . . 11.1 p-10 -81.63 4.9 19.93 Favored 'General case' 0 CA--C 1.536 0.429 0 N-CA-C 113.303 0.853 . . . . 0.0 113.303 -177.501 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' D' D ' 18' ' ' PHE . . . . . . . . . . . . . 52.4 t80 -57.5 -44.26 84.85 Favored 'General case' 0 C--N 1.335 -0.059 0 O-C-N 121.929 -0.482 . . . . 0.0 110.272 -178.286 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' D' D ' 19' ' ' VAL . . . . . . . . . . . . . 44.0 t -55.52 -44.16 75.17 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.289 0 CA-C-N 116.396 -0.365 . . . . 0.0 110.804 -178.144 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' D' D ' 20' ' ' ASP . . . . . . . . . . . . . 13.4 t70 -59.8 -42.2 92.93 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-O 120.888 0.375 . . . . 0.0 110.809 -177.761 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' D' D ' 21' ' ' VAL . . . . . . . . . . . . . 45.2 t -64.31 -46.48 93.08 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.28 0 C-N-CA 120.742 -0.383 . . . . 0.0 110.534 -178.3 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' D' D ' 22' ' ' ILE . . . . . 0.604 HG22 HD12 ' D' ' 26' ' ' LEU . 51.4 mm -55.12 -47.38 77.32 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.232 0 C-N-CA 121.087 -0.245 . . . . 0.0 110.662 178.931 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' D' D ' 23' ' ' ARG . . . . . . . . . . . . . 52.6 ttp180 -53.74 -51.92 61.81 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-O 120.659 0.266 . . . . 0.0 111.418 -178.792 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' D' D ' 24' ' ' ILE . . . . . . . . . . . . . 71.2 mt -58.54 -43.15 86.45 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.344 0 C-N-CA 121.034 -0.266 . . . . 0.0 111.451 -175.705 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' D' D ' 25' ' ' LYS . . . . . . . . . . . . . 60.1 mttm -66.67 -43.68 83.82 Favored 'General case' 0 C--N 1.33 -0.269 0 N-CA-C 112.183 0.438 . . . . 0.0 112.183 -177.768 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' D' D ' 26' ' ' LEU . . . . . 0.604 HD12 HG22 ' D' ' 22' ' ' ILE . 27.1 mt -81.73 -25.95 34.98 Favored 'General case' 0 C--N 1.329 -0.298 0 N-CA-C 113.1 0.778 . . . . 0.0 113.1 -172.825 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' D' D ' 27' ' ' GLN . . . . . . . . . . . . . 5.8 pt20 -45.76 139.28 4.19 Favored 'General case' 0 N--CA 1.467 0.412 0 N-CA-C 112.819 0.674 . . . . 0.0 112.819 -174.666 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' D' D ' 28' ' ' GLY . . . . . . . . . . . . . . . 100.43 -26.95 22.63 Favored Glycine 0 CA--C 1.532 1.14 0 CA-C-N 115.755 -0.657 . . . . 0.0 112.116 -177.671 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' D' D ' 29' ' ' LYS . . . . . . . . . . . . . 64.0 mttp -96.72 155.09 16.92 Favored 'General case' 0 C--N 1.332 -0.175 0 CA-C-N 117.376 0.588 . . . . 0.0 110.788 178.525 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' D' D ' 30' ' ' THR . . . . . . . . . . . . . 35.3 m -108.11 141.24 40.11 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.196 -0.456 . . . . 0.0 110.489 178.993 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' D' D ' 31' ' ' VAL . . . . . . . . . . . . . 35.4 m -127.96 156.5 39.99 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.234 0 CA-C-N 116.097 -0.501 . . . . 0.0 110.32 179.147 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' D' D ' 32' ' ' ARG . . . . . . . . . . . . . 72.9 ttt-85 -130.17 150.28 51.49 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-O 121.116 0.484 . . . . 0.0 110.456 179.703 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' D' D ' 33' ' ' THR . . . . . . . . . . . . . 14.9 m -52.39 137.15 30.03 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.376 -0.375 . . . . 0.0 111.478 -178.148 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' D' D ' 34' ' ' GLY . . . . . . . . . . . . . . . 100.84 -17.17 56.77 Favored Glycine 0 CA--C 1.533 1.175 0 CA-C-O 119.691 -0.505 . . . . 0.0 113.241 179.021 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' D' D ' 35' ' ' ASP . . . . . . . . . . . . . 73.4 m-20 -66.58 150.96 48.24 Favored 'General case' 0 C--O 1.231 0.124 0 CA-C-N 118.083 0.941 . . . . 0.0 111.364 179.992 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' D' D ' 36' ' ' VAL . . . . . . . . . . . . . 41.9 t -122.01 127.81 75.44 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.228 0 CA-C-N 115.934 -0.575 . . . . 0.0 109.684 177.652 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' D' D ' 37' ' ' ILE . . . . . . . . . . . . . 61.8 mt -121.33 138.53 51.39 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.256 0 N-CA-C 109.882 -0.414 . . . . 0.0 109.882 -179.253 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' D' D ' 38' ' ' GLY . . . . . . . . . . . . . . . -117.52 128.85 8.01 Favored Glycine 0 CA--C 1.526 0.764 0 N-CA-C 111.123 -0.791 . . . . 0.0 111.123 -179.892 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' D' D ' 39' ' ' ILE . . . . . . . . . . . . . 74.5 mt -126.21 136.62 60.29 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.176 0 CA-C-O 120.785 0.326 . . . . 0.0 110.179 178.903 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' D' D ' 40' ' ' SER . . . . . . . . . . . . . 63.7 p -91.59 122.44 34.16 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.219 -0.446 . . . . 0.0 110.816 176.216 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' D' D ' 41' ' ' ILE . . . . . . . . . . . . . 68.3 mt -130.46 117.55 39.78 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.231 0 CA-C-O 120.89 0.376 . . . . 0.0 110.244 178.262 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' D' D ' 42' ' ' LEU . . . . . 0.555 HD23 ' O ' ' D' ' 42' ' ' LEU . 1.3 tt 54.62 43.73 29.75 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-O 121.419 0.628 . . . . 0.0 110.401 177.603 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' D' D ' 43' ' ' GLY . . . . . . . . . . . . . . . 71.12 19.0 76.96 Favored Glycine 0 CA--C 1.533 1.157 0 C-N-CA 121.211 -0.519 . . . . 0.0 113.089 175.411 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' D' D ' 44' ' ' LYS . . . . . . . . . . . . . 53.1 mttm -131.05 130.5 43.33 Favored 'General case' 0 C--N 1.333 -0.137 0 CA-C-N 117.774 0.787 . . . . 0.0 110.342 178.836 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' D' D ' 45' ' ' GLU . . . . . . . . . . . . . 84.8 tt0 -84.1 124.93 31.63 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 116.499 -0.319 . . . . 0.0 111.258 -178.917 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' D' D ' 46' ' ' VAL . . . . . 0.412 HG13 ' O ' ' D' ' 46' ' ' VAL . 10.1 p -117.84 124.71 73.46 Favored 'Isoleucine or valine' 0 N--CA 1.462 0.172 0 N-CA-C 109.577 -0.527 . . . . 0.0 109.577 174.549 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' D' D ' 47' ' ' LYS . . . . . . . . . . . . . 64.7 mttp -98.52 124.11 43.07 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.076 -0.511 . . . . 0.0 110.859 178.529 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' D' D ' 48' ' ' PHE . . . . . . . . . . . . . 34.3 m-85 -108.49 131.87 54.39 Favored 'General case' 0 C--N 1.329 -0.324 0 N-CA-C 109.563 -0.532 . . . . 0.0 109.563 176.545 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' D' D ' 49' ' ' LYS . . . . . . . . . . . . . 46.6 tttp -107.48 133.65 51.66 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.367 -0.379 . . . . 0.0 110.137 178.202 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' D' D ' 50' ' ' VAL . . . . . . . . . . . . . 44.1 t -76.63 104.4 4.64 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.325 0 N-CA-C 109.414 -0.587 . . . . 0.0 109.414 177.802 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' D' D ' 51' ' ' VAL . . . . . . . . . . . . . 52.5 t -69.83 -53.38 24.38 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.324 0 CA-C-N 115.985 -0.552 . . . . 0.0 109.646 -175.732 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' D' D ' 52' ' ' GLN . . . . . . . . . . . . . 87.9 mt-30 -153.73 152.2 30.49 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 115.949 -0.569 . . . . 0.0 111.377 -177.752 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' D' D ' 53' ' ' ALA . . . . . . . . . . . . . . . -131.04 129.9 42.58 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 115.231 -0.895 . . . . 0.0 109.55 175.198 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' D' D ' 54' ' ' TYR . . . . . . . . . . . . . 54.3 t80 -128.35 108.01 19.36 Favored Pre-proline 0 CA--C 1.534 0.339 0 CA-C-O 118.179 -0.915 . . . . 0.0 110.276 -179.536 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' D' D ' 55' ' ' PRO . . . . . . . . . . . . . 74.0 Cg_endo -77.09 170.08 72.59 Favored 'Cis proline' 0 N--CA 1.5 1.859 0 CA-C-N 121.754 1.662 . . . . 0.0 112.608 -3.981 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' D' D ' 56' ' ' SER . . . . . . . . . . . . . 13.6 m -112.88 131.72 22.64 Favored Pre-proline 0 CA--C 1.539 0.53 0 CA-C-O 118.438 -0.791 . . . . 0.0 109.666 176.17 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' D' D ' 57' ' ' PRO . . . . . . . . . . . . . 42.2 Cg_endo -69.42 168.17 67.25 Favored 'Cis proline' 0 N--CA 1.496 1.66 0 CA-C-N 121.929 1.725 . . . . 0.0 111.374 -3.732 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' D' D ' 58' ' ' LEU . . . . . . . . . . . . . 44.9 tp -130.24 137.67 50.15 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-O 120.955 0.407 . . . . 0.0 110.256 -179.804 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' D' D ' 59' ' ' ARG . . . . . . . . . . . . . 74.0 ttt180 -104.2 134.47 47.38 Favored 'General case' 0 C--N 1.327 -0.396 0 CA-C-N 115.918 -0.583 . . . . 0.0 109.767 178.033 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' D' D ' 60' ' ' VAL . . . . . . . . . . . . . 42.6 t -76.98 112.91 15.43 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.316 0 C-N-CA 120.821 -0.351 . . . . 0.0 110.183 -177.545 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' D' D ' 61' ' ' GLU . . . . . . . . . . . . . 96.0 mt-10 -131.08 162.05 30.69 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.001 -0.545 . . . . 0.0 110.077 178.944 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' D' D ' 62' ' ' ASP . . . . . . . . . . . . . 6.4 t70 -53.63 -31.86 48.98 Favored 'General case' 0 C--N 1.327 -0.375 0 N-CA-C 111.862 0.319 . . . . 0.0 111.862 -179.092 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' D' D ' 63' ' ' ARG . . . . . . . . . . . . . 39.4 ptt180 -84.66 3.91 34.9 Favored 'General case' 0 CA--C 1.537 0.449 0 N-CA-C 113.774 1.027 . . . . 0.0 113.774 -174.555 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' D' D ' 64' ' ' THR . . . . . . . . . . . . . 25.7 m -92.02 138.84 31.21 Favored 'General case' 0 C--N 1.333 -0.152 0 CA-C-N 118.155 0.434 . . . . 0.0 110.854 -177.805 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' D' D ' 65' ' ' LYS . . . . . . . . . . . . . 68.0 mttm -88.62 127.84 35.57 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.069 -0.514 . . . . 0.0 109.894 177.834 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' D' D ' 66' ' ' ILE . . . . . . . . . . . . . 59.8 mt -115.65 126.43 73.18 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.228 0 N-CA-C 109.684 -0.487 . . . . 0.0 109.684 179.314 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' D' D ' 67' ' ' THR . . . . . . . . . . . . . 28.4 m -126.8 145.04 50.78 Favored 'General case' 0 C--O 1.233 0.216 0 CA-C-O 121.271 0.558 . . . . 0.0 111.637 -175.448 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' D' D ' 68' ' ' LEU . . . . . 0.464 ' C ' HD23 ' D' ' 68' ' ' LEU . 6.1 tt . . . . . 0 C--N 1.33 -0.281 0 CA-C-N 115.435 -0.802 . . . . 0.0 109.528 175.366 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' D' D ' 73' ' ' VAL . . . . . . . . . . . . . 35.1 m . . . . . 0 C--O 1.231 0.101 0 CA-C-O 120.966 0.413 . . . . 0.0 111.18 . . . . . . . . . 0 0 . 1 . 002 nuclear nobuild core ' D' D ' 74' ' ' ASP . . . . . . . . . . . . . 12.5 t0 -94.89 123.24 38.24 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 115.893 -0.594 . . . . 0.0 110.294 -176.873 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' D' D ' 75' ' ' VAL . . . . . . . . . . . . . 47.1 t -116.33 121.9 68.57 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.209 0 CA-C-O 121.143 0.496 . . . . 0.0 110.204 -179.323 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' D' D ' 76' ' ' LEU . . . . . . . . . . . . . 36.8 mt -123.67 144.6 49.54 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 115.547 -0.751 . . . . 0.0 109.68 -179.54 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' D' D ' 77' ' ' GLU . . . . . . . . . . . . . 97.2 mt-10 -137.74 131.29 31.09 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-O 121.096 0.474 . . . . 0.0 111.274 -178.946 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' D' D ' 78' ' ' ALA . . . . . . . . . . . . . . . -118.94 139.82 51.02 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 115.693 -0.685 . . . . 0.0 109.974 177.183 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' D' D ' 79' ' ' LYS . . . . . 0.603 ' O ' HD13 ' D' ' 80' ' ' ILE . 35.2 tptt -80.47 116.43 20.51 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.513 -0.312 . . . . 0.0 110.818 -177.586 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' D' D ' 80' ' ' ILE . . . . . 0.603 HD13 ' O ' ' D' ' 79' ' ' LYS . 40.7 mm -139.11 108.18 3.69 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.237 0 CA-C-N 116.325 -0.398 . . . . 0.0 109.971 -176.542 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' D' D ' 81' ' ' LYS . . . . . . . . . . . . . 51.1 mttm -103.56 129.09 50.71 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-O 120.761 0.315 . . . . 0.0 111.18 -179.088 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' D' D ' 82' ' ' GLY . . . . . . . . . . . . . . . 89.05 42.16 5.69 Favored Glycine 0 CA--C 1.524 0.656 0 C-N-CA 120.828 -0.701 . . . . 0.0 111.545 173.64 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' D' D ' 83' ' ' ILE . . . . . . . . . . . . . 72.7 mt -67.15 131.1 32.93 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.365 0 N-CA-C 109.915 -0.402 . . . . 0.0 109.915 178.646 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' D' D ' 84' ' ' LYS . . . . . . . . . . . . . 76.3 tttt -91.15 -50.45 5.83 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-O 121.198 0.523 . . . . 0.0 109.665 179.619 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' D' D ' 85' ' ' ASP . . . . . . . . . . . . . 5.1 t70 -160.43 155.3 24.25 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 115.448 -0.796 . . . . 0.0 110.193 178.939 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' D' D ' 86' ' ' VAL . . . . . . . . . . . . . 40.1 t -131.54 133.31 61.91 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.285 0 CA-C-O 121.039 0.447 . . . . 0.0 110.175 179.699 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' D' D ' 87' ' ' ILE . . . . . . . . . . . . . 44.7 mm -119.05 128.46 75.8 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.294 0 CA-C-N 115.79 -0.641 . . . . 0.0 109.584 178.659 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' D' D ' 88' ' ' LEU . . . . . . . . . . . . . 21.8 tp -108.53 130.14 55.29 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-N 116.282 -0.417 . . . . 0.0 111.117 -177.638 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' D' D ' 89' ' ' ASP . . . . . . . . . . . . . 13.6 t70 -121.68 150.89 41.1 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 115.846 -0.616 . . . . 0.0 109.352 175.691 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' D' D ' 90' ' ' GLU . . . . . . . . . . . . . 43.8 tp10 -47.29 -36.34 9.07 Favored 'General case' 0 C--N 1.331 -0.206 0 N-CA-C 112.868 0.692 . . . . 0.0 112.868 -173.327 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' D' D ' 91' ' ' ASN . . . . . . . . . . . . . 86.9 m-20 -132.14 32.4 4.01 Favored 'General case' 0 N--CA 1.463 0.209 0 N-CA-C 112.097 0.406 . . . . 0.0 112.097 -176.332 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' D' D ' 92' ' ' LEU . . . . . . . . . . . . . 9.0 tp -166.15 151.23 8.32 Favored 'General case' 0 C--N 1.331 -0.223 0 C-N-CA 120.871 -0.332 . . . . 0.0 111.016 179.929 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' D' D ' 93' ' ' ILE . . . . . . . . . . . . . 71.2 mt -125.84 122.7 62.64 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.234 0 N-CA-C 109.429 -0.582 . . . . 0.0 109.429 179.707 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' D' D ' 94' ' ' VAL . . . . . . . . . . . . . 41.9 t -120.1 127.59 75.9 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.186 0 N-CA-C 110.09 -0.337 . . . . 0.0 110.09 -179.201 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' D' D ' 95' ' ' VAL . . . . . . . . . . . . . 44.4 t -123.27 133.47 69.02 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.275 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.042 -179.797 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' D' D ' 96' ' ' ILE . . . . . . . . . . . . . 65.5 mt -115.61 127.52 73.16 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.225 0 N-CA-C 109.559 -0.534 . . . . 0.0 109.559 179.231 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' D' D ' 97' ' ' THR . . . . . . . . . . . . . 66.4 p -100.47 153.58 19.24 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-O 121.081 0.467 . . . . 0.0 110.882 -178.656 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' D' D ' 98' ' ' GLU . . . . . . . . . . . . . 12.7 pt-20 -53.96 -21.71 8.65 Favored 'General case' 0 CA--C 1.534 0.362 0 N-CA-C 112.532 0.567 . . . . 0.0 112.532 -179.409 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' D' D ' 99' ' ' GLU . . . . . . . . . . . . . 96.2 mt-10 -81.34 14.99 2.16 Favored 'General case' 0 CA--C 1.534 0.364 0 N-CA-C 113.077 0.769 . . . . 0.0 113.077 -177.071 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' D' D ' 100' ' ' ASN . . . . . . . . . . . . . 4.7 m-20 62.18 34.86 15.91 Favored 'General case' 0 CA--C 1.53 0.203 0 CA-C-N 118.085 0.402 . . . . 0.0 111.182 -179.904 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' D' D ' 101' ' ' GLU . . . . . . . . . . . . . 83.5 tt0 -112.37 142.04 45.38 Favored 'General case' 0 C--N 1.333 -0.148 0 N-CA-C 109.534 -0.543 . . . . 0.0 109.534 174.552 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' D' D ' 102' ' ' VAL . . . . . . . . . . . . . 46.7 t -115.0 126.57 72.62 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.277 0 N-CA-C 109.847 -0.427 . . . . 0.0 109.847 -178.239 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' D' D ' 103' ' ' LEU . . . . . . . . . . . . . 26.0 mt -116.64 127.87 54.84 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 115.658 -0.701 . . . . 0.0 110.022 177.703 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' D' D ' 104' ' ' ILE . . . . . . . . . . . . . 67.9 mt -117.61 122.68 70.39 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.262 0 CA-C-N 116.408 -0.36 . . . . 0.0 110.219 -179.336 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' D' D ' 105' ' ' PHE . . . . . . . . . . . . . 66.2 m-85 -124.5 163.16 22.45 Favored 'General case' 0 C--N 1.331 -0.202 0 O-C-N 123.804 0.69 . . . . 0.0 109.757 179.521 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' D' D ' 106' ' ' ASN . . . . . . . . . . . . . 45.8 p-10 -96.83 -173.11 2.62 Favored 'General case' 0 C--N 1.329 -0.308 0 N-CA-C 109.59 -0.522 . . . . 0.0 109.59 173.889 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' D' D ' 107' ' ' GLN . . . . . . . . . . . . . 28.6 tt0 -60.85 -23.99 65.55 Favored 'General case' 0 CA--C 1.534 0.337 0 N-CA-C 112.312 0.486 . . . . 0.0 112.312 179.862 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' D' D ' 108' ' ' ASN . . . . . . . . . . . . . 60.6 t30 -86.53 10.22 16.0 Favored 'General case' 0 CA--C 1.536 0.43 0 N-CA-C 113.037 0.754 . . . . 0.0 113.037 -178.737 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' D' D ' 109' ' ' LEU . . . . . . . . . . . . . 12.3 tp 57.04 38.94 29.54 Favored 'General case' 0 C--N 1.332 -0.194 0 CA-C-O 121.152 0.501 . . . . 0.0 111.206 178.885 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' D' D ' 110' ' ' GLU . . . . . . . . . . . . . 70.9 mm-40 -107.1 148.82 28.32 Favored 'General case' 0 C--N 1.33 -0.265 0 N-CA-C 109.832 -0.432 . . . . 0.0 109.832 175.566 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' D' D ' 111' ' ' GLU . . . . . . . . . . . . . 83.1 tt0 -78.16 121.89 24.92 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.27 -0.423 . . . . 0.0 110.821 -177.683 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' D' D ' 112' ' ' LEU . . . . . . . . . . . . . 31.4 mt -109.6 -46.05 3.58 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-N 116.256 -0.429 . . . . 0.0 110.686 179.564 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' D' D ' 113' ' ' TYR . . . . . . . . . . . . . 58.0 t80 -140.71 135.31 31.45 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 116.264 -0.425 . . . . 0.0 110.927 -179.2 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' D' D ' 114' ' ' ARG . . . . . . . . . . . . . 69.6 ttp85 -136.42 122.03 19.65 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.138 -0.483 . . . . 0.0 110.117 178.035 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' D' D ' 115' ' ' GLY . . . . . . . . . . . . . . . -150.03 153.14 24.91 Favored Glycine 0 CA--C 1.524 0.652 0 N-CA-C 110.996 -0.842 . . . . 0.0 110.996 179.015 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' D' D ' 116' ' ' LYS . . . . . . . . . . . . . 63.4 tttt -129.5 132.13 46.82 Favored 'General case' 0 C--N 1.329 -0.321 0 N-CA-C 109.825 -0.435 . . . . 0.0 109.825 177.941 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' D' D ' 117' ' ' PHE . . . . . . . . . . . . . 37.3 m-85 -128.13 117.25 21.27 Favored 'General case' 0 C--N 1.332 -0.187 0 CA-C-O 120.963 0.411 . . . . 0.0 110.232 -175.11 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' D' D ' 118' ' ' GLU . . . . . . . . . . . . . 44.9 tp10 -51.67 -51.21 57.68 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.403 -0.362 . . . . 0.0 111.61 -177.078 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' D' D ' 119' ' ' ASN . . . . . . . . . . . . . 3.6 m120 -94.48 30.95 1.85 Allowed 'General case' 0 C--N 1.329 -0.287 0 N-CA-C 112.249 0.463 . . . . 0.0 112.249 -174.927 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' D' D ' 120' ' ' LEU . . . . . . . . . . . . . 15.6 tp -56.7 121.09 8.97 Favored 'General case' 0 C--N 1.332 -0.167 0 CA-C-O 120.597 0.237 . . . . 0.0 110.41 178.032 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' D' D ' 121' ' ' ASN . . . . . . . . . . . . . 33.1 m120 -114.08 -44.0 3.19 Favored 'General case' 0 C--O 1.232 0.171 0 CA-C-N 116.723 -0.217 . . . . 0.0 111.147 -176.649 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' D' D ' 122' ' ' LYS . . . . . . . . . . . . . 61.4 mtpt -139.13 138.58 37.13 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-O 120.92 0.391 . . . . 0.0 111.314 -176.674 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' D' D ' 123' ' ' VAL . . . . . . . . . . . . . 45.1 t -126.93 126.2 67.98 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.326 0 N-CA-C 109.375 -0.602 . . . . 0.0 109.375 175.26 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' D' D ' 124' ' ' LEU . . . . . . . . . . . . . 59.5 mt -131.21 136.43 48.24 Favored 'General case' 0 C--N 1.332 -0.194 0 CA-C-O 120.95 0.405 . . . . 0.0 110.781 -177.444 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' D' D ' 125' ' ' VAL . . . . . 0.413 HG23 HG22 ' D' ' 130' ' ' VAL . 11.6 p -133.95 138.57 50.17 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.284 0 CA-C-N 116.113 -0.494 . . . . 0.0 110.355 178.863 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' D' D ' 126' ' ' ARG . . . . . . . . . . . . . 96.7 mtt180 -149.1 126.82 11.74 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 115.769 -0.65 . . . . 0.0 109.425 177.778 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' D' D ' 127' ' ' ASN . . . . . . . . . . . . . 1.8 t-20 57.63 -147.47 0.51 Allowed 'General case' 0 CA--C 1.541 0.62 0 N-CA-C 109.418 -0.586 . . . . 0.0 109.418 -178.352 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' D' D ' 128' ' ' ASP . . . . . . . . . . . . . 8.7 p-10 -87.32 17.38 4.44 Favored 'General case' 0 CA--C 1.534 0.36 0 CA-C-N 118.892 0.769 . . . . 0.0 112.657 178.03 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' D' D ' 129' ' ' LEU . . . . . . . . . . . . . 13.3 tp -112.5 136.16 52.35 Favored 'General case' 0 C--O 1.231 0.098 0 O-C-N 122.003 -0.435 . . . . 0.0 109.988 179.001 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' D' D ' 130' ' ' VAL . . . . . 0.413 HG22 HG23 ' D' ' 125' ' ' VAL . 39.0 t -124.89 140.05 49.19 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.338 0 CA-C-O 120.768 0.318 . . . . 0.0 110.354 -176.646 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' D' D ' 131' ' ' VAL . . . . . . . . . . . . . 44.2 t -136.07 136.48 49.52 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.206 0 CA-C-O 121.144 0.497 . . . . 0.0 110.309 177.459 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' D' D ' 132' ' ' ILE . . . . . . . . . . . . . 71.3 mt -120.41 134.16 64.78 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.229 0 CA-C-N 115.69 -0.686 . . . . 0.0 109.645 -179.105 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' D' D ' 133' ' ' ILE . . . . . . . . . . . . . 43.5 mm -117.44 120.96 66.44 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.215 0 CA-C-O 121.142 0.496 . . . . 0.0 111.045 -175.915 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' D' D ' 134' ' ' ASP . . . . . . . . . . . . . 6.7 p-10 -131.71 145.82 51.84 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 115.671 -0.695 . . . . 0.0 109.449 174.216 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' D' D ' 135' ' ' GLU . . . . . . . . . . . . . 41.2 tp10 -49.74 -24.63 2.43 Favored 'General case' 0 C--N 1.328 -0.361 0 N-CA-C 112.872 0.693 . . . . 0.0 112.872 -171.584 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' D' D ' 136' ' ' GLN . . . . . . . . . . . . . 96.9 mt-30 -94.25 -33.23 13.33 Favored 'General case' 0 C--O 1.232 0.166 0 N-CA-C 112.356 0.502 . . . . 0.0 112.356 -175.932 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' D' D ' 137' ' ' LYS . . . . . . . . . . . . . 54.4 mtmt -148.17 158.11 43.89 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-O 121.388 0.613 . . . . 0.0 112.114 -170.445 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' D' D ' 138' ' ' LEU . . . . . 0.412 ' C ' HD23 ' D' ' 138' ' ' LEU . 5.6 tt -116.6 124.77 50.62 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 115.219 -0.9 . . . . 0.0 109.323 174.783 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' D' D ' 139' ' ' THR . . . . . . . . . . . . . 34.5 m -110.12 131.1 55.36 Favored 'General case' 0 C--N 1.331 -0.208 0 CA-C-N 116.366 -0.379 . . . . 0.0 110.863 -176.735 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' D' D ' 140' ' ' LEU . . . . . 0.472 ' C ' HD23 ' D' ' 140' ' ' LEU . 6.1 tt -119.79 124.02 45.12 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 115.543 -0.753 . . . . 0.0 109.303 -178.735 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' D' D ' 141' ' ' ILE . . . . . 0.437 ' N ' HD23 ' D' ' 140' ' ' LEU . 19.1 mt -121.28 120.25 61.49 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.314 0 CA-C-O 120.779 0.323 . . . . 0.0 110.131 -174.723 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' D' D ' 142' ' ' ARG . . . . . . . . . . . . . 82.8 mtp180 -110.32 127.66 55.15 Favored 'General case' 0 C--N 1.331 -0.226 0 CA-C-N 115.613 -0.722 . . . . 0.0 110.426 -179.039 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' D' D ' 143' ' ' THR . . . . . . . . . . . . . 59.8 p . . . . . 0 C--O 1.22 -0.463 0 CA-C-O 117.942 -1.028 . . . . 0.0 110.575 179.73 . . . . . . . . 0 0 . 1 . 002 nuclear nobuild core ' E' E ' 2' ' ' SER . . . . . . . . . . . . . 3.6 p . . . . . 0 C--O 1.231 0.084 0 CA-C-O 120.955 0.407 . . . . 0.0 110.46 . . . . . . . . . 0 0 . 1 . 002 nuclear nobuild core ' E' E ' 3' ' ' GLU . . . . . . . . . . . . . 28.6 tp10 -139.44 137.55 35.71 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 115.745 -0.661 . . . . 0.0 110.503 -176.511 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' E' E ' 4' ' ' LEU . . . . . . . . . . . . . 17.8 tp -124.12 126.15 45.71 Favored 'General case' 0 C--N 1.33 -0.244 0 N-CA-C 109.564 -0.532 . . . . 0.0 109.564 174.525 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' E' E ' 5' ' ' LYS . . . . . . . . . . . . . 66.4 mttm -112.85 122.13 46.75 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-O 120.948 0.404 . . . . 0.0 110.87 -177.668 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' E' E ' 6' ' ' LEU . . . . . 0.461 HD23 ' HA ' ' E' ' 50' ' ' VAL . 59.2 mt -113.89 143.87 43.97 Favored 'General case' 0 C--N 1.331 -0.23 0 CA-C-N 115.199 -0.909 . . . . 0.0 110.161 -179.421 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' E' E ' 7' ' ' LYS . . . . . . . . . . . . . 84.8 tttt -121.05 135.22 24.68 Favored Pre-proline 0 CA--C 1.535 0.398 0 CA-C-O 118.858 -0.591 . . . . 0.0 109.529 176.167 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' E' E ' 8' ' ' PRO . . . . . . . . . . . . . 97.6 Cg_endo -91.19 132.65 1.5 Allowed 'Trans proline' 0 N--CA 1.49 1.275 0 C-N-CA 121.683 1.589 . . . . 0.0 111.765 178.484 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' E' E ' 9' ' ' LEU . . . . . . . . . . . . . 46.9 mt -74.31 -47.02 6.02 Favored Pre-proline 0 CA--C 1.533 0.32 0 CA-C-O 118.709 -0.662 . . . . 0.0 112.176 -177.55 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' E' E ' 10' ' ' PRO . . . . . . . . . . . . . 84.4 Cg_endo -81.41 153.37 18.2 Favored 'Trans proline' 0 N--CA 1.496 1.671 0 C-N-CA 121.158 1.239 . . . . 0.0 111.726 174.95 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' E' E ' 11' ' ' LYS . . . . . . . . . . . . . 57.1 tttm -86.77 99.44 11.8 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.418 -0.356 . . . . 0.0 110.3 178.747 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' E' E ' 12' ' ' VAL . . . . . . . . . . . . . 12.0 p -141.5 147.54 21.98 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.254 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.571 -178.59 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' E' E ' 13' ' ' GLU . . . . . . . . . . . . . 43.1 tp10 -93.76 122.36 36.15 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.059 -0.519 . . . . 0.0 110.045 177.61 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' E' E ' 14' ' ' LEU . . . . . . . . . . . . . 20.7 mt -95.94 148.94 35.33 Favored Pre-proline 0 C--N 1.329 -0.292 0 CA-C-O 119.328 -0.368 . . . . 0.0 110.465 -178.161 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' E' E ' 15' ' ' PRO . . . . . . . . . . . . . 24.8 Cg_exo -62.46 160.25 32.54 Favored 'Trans proline' 0 N--CA 1.497 1.731 0 C-N-CA 121.214 1.276 . . . . 0.0 111.722 177.404 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' E' E ' 16' ' ' PRO . . . . . . . . . . . . . 29.9 Cg_exo -60.06 -32.37 94.7 Favored 'Trans proline' 0 N--CA 1.497 1.685 0 C-N-CA 121.385 1.39 . . . . 0.0 112.718 -178.659 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' E' E ' 17' ' ' ASP . . . . . . . . . . . . . 18.1 p-10 -88.39 4.73 45.25 Favored 'General case' 0 CA--C 1.536 0.422 0 N-CA-C 113.326 0.861 . . . . 0.0 113.326 -177.414 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' E' E ' 18' ' ' PHE . . . . . . . . . . . . . 52.4 t80 -58.23 -43.2 87.64 Favored 'General case' 0 C--N 1.334 -0.077 0 O-C-N 121.998 -0.439 . . . . 0.0 110.042 -178.606 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' E' E ' 19' ' ' VAL . . . . . . . . . . . . . 47.2 t -55.54 -42.81 69.99 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.28 0 CA-C-N 116.33 -0.395 . . . . 0.0 110.585 -179.425 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' E' E ' 20' ' ' ASP . . . . . . . . . . . . . 76.7 m-20 -60.57 -42.99 97.76 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-O 120.801 0.334 . . . . 0.0 110.926 -178.485 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' E' E ' 21' ' ' VAL . . . . . . . . . . . . . 45.7 t -64.01 -46.32 94.24 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.265 0 C-N-CA 120.792 -0.363 . . . . 0.0 110.463 -177.757 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' E' E ' 22' ' ' ILE . . . . . 0.68 HG22 HD12 ' E' ' 26' ' ' LEU . 51.5 mm -55.67 -46.29 79.4 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.234 0 CA-C-O 120.788 0.328 . . . . 0.0 110.548 178.45 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' E' E ' 23' ' ' ARG . . . . . . . . . . . . . 54.6 ttp180 -53.1 -50.97 63.35 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-O 120.669 0.271 . . . . 0.0 111.569 -179.887 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' E' E ' 24' ' ' ILE . . . . . . . . . . . . . 74.6 mt -58.35 -47.28 88.22 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.312 0 CA-C-N 116.505 -0.316 . . . . 0.0 111.452 -176.3 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' E' E ' 25' ' ' LYS . . . . . . . . . . . . . 76.0 mttt -65.49 -40.59 93.26 Favored 'General case' 0 C--N 1.329 -0.298 0 N-CA-C 112.428 0.529 . . . . 0.0 112.428 -176.613 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' E' E ' 26' ' ' LEU . . . . . 0.68 HD12 HG22 ' E' ' 22' ' ' ILE . 40.6 mt -79.65 -38.6 33.35 Favored 'General case' 0 C--N 1.33 -0.245 0 N-CA-C 113.19 0.811 . . . . 0.0 113.19 -171.143 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' E' E ' 27' ' ' GLN . . . . . . . . . . . . . 13.1 pt20 -46.88 139.46 5.47 Favored 'General case' 0 N--CA 1.468 0.443 0 N-CA-C 112.785 0.661 . . . . 0.0 112.785 -174.976 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' E' E ' 28' ' ' GLY . . . . . . . . . . . . . . . 99.61 -25.54 27.86 Favored Glycine 0 CA--C 1.534 1.229 0 CA-C-N 115.559 -0.746 . . . . 0.0 112.178 -176.209 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' E' E ' 29' ' ' LYS . . . . . . . . . . . . . 95.6 mttt -97.21 155.19 16.95 Favored 'General case' 0 C--O 1.233 0.186 0 CA-C-N 117.324 0.562 . . . . 0.0 110.918 178.935 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' E' E ' 30' ' ' THR . . . . . . . . . . . . . 23.6 m -104.68 137.66 42.16 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 115.922 -0.581 . . . . 0.0 110.035 175.83 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' E' E ' 31' ' ' VAL . . . . . . . . . . . . . 35.2 m -127.82 155.69 39.36 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.235 0 CA-C-N 116.381 -0.372 . . . . 0.0 110.685 -179.235 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' E' E ' 32' ' ' ARG . . . . . . . . . . . . . 78.2 mtt85 -132.6 150.49 52.15 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.079 -0.51 . . . . 0.0 110.402 177.821 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' E' E ' 33' ' ' THR . . . . . . . . . . . . . 22.3 m -52.8 139.1 27.71 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.302 -0.408 . . . . 0.0 111.419 -179.194 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' E' E ' 34' ' ' GLY . . . . . . . . . . . . . . . 101.03 -17.21 56.49 Favored Glycine 0 CA--C 1.532 1.141 0 CA-C-O 119.69 -0.505 . . . . 0.0 113.165 179.751 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' E' E ' 35' ' ' ASP . . . . . . . . . . . . . 73.5 m-20 -66.95 149.64 50.33 Favored 'General case' 0 C--O 1.231 0.104 0 CA-C-N 118.08 0.94 . . . . 0.0 111.147 178.859 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' E' E ' 36' ' ' VAL . . . . . . . . . . . . . 43.1 t -121.83 130.89 74.19 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.24 0 CA-C-N 116.107 -0.497 . . . . 0.0 109.843 178.188 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' E' E ' 37' ' ' ILE . . . . . . . . . . . . . 65.1 mt -121.32 139.18 49.28 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.194 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.0 -178.971 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' E' E ' 38' ' ' GLY . . . . . . . . . . . . . . . -116.66 129.0 8.18 Favored Glycine 0 CA--C 1.525 0.676 0 N-CA-C 111.137 -0.785 . . . . 0.0 111.137 -179.873 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' E' E ' 39' ' ' ILE . . . . . . . . . . . . . 76.5 mt -127.26 139.96 50.44 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.224 0 CA-C-O 120.755 0.312 . . . . 0.0 110.243 179.351 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' E' E ' 40' ' ' SER . . . . . . . . . . . . . 13.3 t -92.6 126.02 37.5 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.288 -0.414 . . . . 0.0 111.059 177.0 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' E' E ' 41' ' ' ILE . . . . . . . . . . . . . 65.5 mt -129.53 117.0 41.12 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.193 0 CA-C-O 120.863 0.363 . . . . 0.0 110.126 177.088 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' E' E ' 42' ' ' LEU . . . . . . . . . . . . . 7.2 mp 51.78 38.18 22.44 Favored 'General case' 0 CA--C 1.53 0.195 0 CA-C-N 116.101 -0.499 . . . . 0.0 111.598 176.747 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' E' E ' 43' ' ' GLY . . . . . . . . . . . . . . . 74.17 29.1 62.96 Favored Glycine 0 CA--C 1.529 0.969 0 C-N-CA 121.156 -0.545 . . . . 0.0 112.51 176.663 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' E' E ' 44' ' ' LYS . . . . . . . . . . . . . 30.0 ttpt -139.13 128.39 24.07 Favored 'General case' 0 C--N 1.33 -0.281 0 N-CA-C 109.523 -0.547 . . . . 0.0 109.523 176.578 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' E' E ' 45' ' ' GLU . . . . . . . . . . . . . 84.3 tt0 -83.1 125.66 31.73 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-O 120.799 0.333 . . . . 0.0 111.305 -177.111 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' E' E ' 46' ' ' VAL . . . . . 0.402 HG13 ' O ' ' E' ' 46' ' ' VAL . 9.2 p -117.38 124.96 73.7 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.183 0 N-CA-C 109.558 -0.534 . . . . 0.0 109.558 174.852 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' E' E ' 47' ' ' LYS . . . . . . . . . . . . . 62.5 mttp -98.16 126.46 43.64 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.06 -0.518 . . . . 0.0 110.904 177.973 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' E' E ' 48' ' ' PHE . . . . . . . . . . . . . 33.0 m-85 -110.13 131.86 54.68 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.025 -0.534 . . . . 0.0 109.679 176.568 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' E' E ' 49' ' ' LYS . . . . . . . . . . . . . 70.2 tttt -106.53 130.55 54.29 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.378 -0.373 . . . . 0.0 110.159 178.581 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' E' E ' 50' ' ' VAL . . . . . 0.461 ' HA ' HD23 ' E' ' 6' ' ' LEU . 46.4 t -74.73 103.16 2.52 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.258 0 N-CA-C 109.151 -0.685 . . . . 0.0 109.151 176.821 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' E' E ' 51' ' ' VAL . . . . . . . . . . . . . 47.3 t -69.58 -52.97 27.12 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.289 0 N-CA-C 109.478 -0.564 . . . . 0.0 109.478 -174.687 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' E' E ' 52' ' ' GLN . . . . . . . . . . . . . 81.3 mt-30 -154.49 149.93 27.27 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 115.986 -0.552 . . . . 0.0 111.624 -178.101 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' E' E ' 53' ' ' ALA . . . . . . . . . . . . . . . -128.26 133.21 48.75 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 115.305 -0.861 . . . . 0.0 109.542 175.046 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' E' E ' 54' ' ' TYR . . . . . . . . . . . . . 58.8 t80 -129.03 110.44 18.32 Favored Pre-proline 0 C--N 1.327 -0.372 0 CA-C-O 118.202 -0.904 . . . . 0.0 110.191 179.123 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' E' E ' 55' ' ' PRO . . . . . . . . . . . . . 73.7 Cg_endo -77.21 168.36 77.08 Favored 'Cis proline' 0 N--CA 1.5 1.865 0 CA-C-N 121.828 1.689 . . . . 0.0 112.511 -5.453 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' E' E ' 56' ' ' SER . . . . . . . . . . . . . 17.7 m -116.76 131.36 23.96 Favored Pre-proline 0 CA--C 1.537 0.479 0 CA-C-O 118.392 -0.813 . . . . 0.0 109.361 174.104 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' E' E ' 57' ' ' PRO . . . . . . . . . . . . . 38.6 Cg_endo -67.13 164.98 69.45 Favored 'Cis proline' 0 N--CA 1.497 1.72 0 CA-C-N 121.96 1.736 . . . . 0.0 111.522 -0.919 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' E' E ' 58' ' ' LEU . . . . . . . . . . . . . 27.0 tp -130.44 137.0 49.59 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.218 -0.447 . . . . 0.0 110.316 -179.535 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' E' E ' 59' ' ' ARG . . . . . . . . . . . . . 41.1 ttm180 -103.05 132.67 49.14 Favored 'General case' 0 C--N 1.327 -0.373 0 N-CA-C 109.525 -0.546 . . . . 0.0 109.525 176.65 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' E' E ' 60' ' ' VAL . . . . . . . . . . . . . 45.8 t -83.24 115.44 25.65 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.284 0 C-N-CA 120.751 -0.379 . . . . 0.0 110.532 -176.9 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' E' E ' 61' ' ' GLU . . . . . . . . . . . . . 15.6 mm-40 -131.06 163.54 27.41 Favored 'General case' 0 C--N 1.331 -0.23 0 CA-C-N 115.75 -0.659 . . . . 0.0 109.714 175.165 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' E' E ' 62' ' ' ASP . . . . . . . . . . . . . 78.4 m-20 -53.13 -32.35 47.1 Favored 'General case' 0 C--N 1.328 -0.35 0 N-CA-C 111.917 0.34 . . . . 0.0 111.917 -178.95 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' E' E ' 63' ' ' ARG . . . . . . . . . . . . . 84.0 mtt180 -74.03 -22.02 59.72 Favored 'General case' 0 C--N 1.33 -0.26 0 N-CA-C 112.992 0.738 . . . . 0.0 112.992 -176.619 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' E' E ' 64' ' ' THR . . . . . . . . . . . . . 37.8 m -64.78 140.07 58.83 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-O 120.913 0.387 . . . . 0.0 110.835 -175.947 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' E' E ' 65' ' ' LYS . . . . . . . . . . . . . 25.0 mtpp -90.05 123.17 33.7 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.061 -0.518 . . . . 0.0 109.995 179.567 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' E' E ' 66' ' ' ILE . . . . . . . . . . . . . 57.3 mt -113.79 131.13 66.53 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.241 0 CA-C-O 120.85 0.357 . . . . 0.0 110.351 -177.623 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' E' E ' 67' ' ' THR . . . . . . . . . . . . . 30.9 m -132.49 139.84 48.12 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.127 -0.488 . . . . 0.0 111.012 -179.122 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' E' E ' 68' ' ' LEU . . . . . 0.446 HD12 ' N ' ' E' ' 68' ' ' LEU . 8.1 mp . . . . . 0 C--N 1.329 -0.295 0 CA-C-N 116.039 -0.528 . . . . 0.0 110.203 176.836 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' E' E ' 73' ' ' VAL . . . . . . . . . . . . . 34.6 m . . . . . 0 C--O 1.232 0.155 0 CA-C-O 120.804 0.335 . . . . 0.0 110.663 . . . . . . . . . 0 0 . 1 . 002 nuclear nobuild core ' E' E ' 74' ' ' ASP . . . . . . . . . . . . . 26.4 t0 -99.33 120.57 39.78 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.222 -0.445 . . . . 0.0 109.998 -178.901 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' E' E ' 75' ' ' VAL . . . . . . . . . . . . . 46.8 t -112.61 121.3 64.66 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.19 0 CA-C-O 121.031 0.443 . . . . 0.0 110.358 -178.477 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' E' E ' 76' ' ' LEU . . . . . . . . . . . . . 41.2 mt -118.42 144.75 45.72 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 115.626 -0.716 . . . . 0.0 109.737 178.713 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' E' E ' 77' ' ' GLU . . . . . . . . . . . . . 97.3 mt-10 -139.43 130.2 26.07 Favored 'General case' 0 C--N 1.331 -0.205 0 CA-C-O 120.999 0.428 . . . . 0.0 111.327 -179.416 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' E' E ' 78' ' ' ALA . . . . . 0.557 ' HB2' HD21 ' E' ' 109' ' ' LEU . . . -119.16 135.28 54.74 Favored 'General case' 0 C--N 1.331 -0.212 0 CA-C-N 115.797 -0.638 . . . . 0.0 109.775 176.689 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' E' E ' 79' ' ' LYS . . . . . 0.591 ' O ' HD13 ' E' ' 80' ' ' ILE . 91.0 mttt -77.13 118.62 19.85 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-O 120.882 0.373 . . . . 0.0 110.711 -179.452 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' E' E ' 80' ' ' ILE . . . . . 0.591 HD13 ' O ' ' E' ' 79' ' ' LYS . 41.1 mm -139.13 106.04 2.75 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.39 0 N-CA-C 109.138 -0.69 . . . . 0.0 109.138 -178.077 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' E' E ' 81' ' ' LYS . . . . . . . . . . . . . 76.0 tttt -105.24 127.34 52.88 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-O 120.895 0.379 . . . . 0.0 111.164 -176.0 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' E' E ' 82' ' ' GLY . . . . . . . . . . . . . . . 89.13 42.09 5.69 Favored Glycine 0 CA--C 1.524 0.638 0 N-CA-C 111.615 -0.594 . . . . 0.0 111.615 176.346 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' E' E ' 83' ' ' ILE . . . . . . . . . . . . . 72.4 mt -69.64 140.18 19.1 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.294 0 N-CA-C 109.836 -0.431 . . . . 0.0 109.836 177.446 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' E' E ' 84' ' ' LYS . . . . . . . . . . . . . 49.4 tttp -98.17 -51.06 4.14 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 115.9 -0.591 . . . . 0.0 110.263 -178.733 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' E' E ' 85' ' ' ASP . . . . . . . . . . . . . 6.5 t70 -155.27 151.72 28.39 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 115.764 -0.653 . . . . 0.0 110.316 179.67 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' E' E ' 86' ' ' VAL . . . . . . . . . . . . . 44.2 t -130.44 131.41 65.24 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.221 0 CA-C-O 120.931 0.395 . . . . 0.0 110.553 -178.719 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' E' E ' 87' ' ' ILE . . . . . 0.49 ' N ' HD12 ' E' ' 87' ' ' ILE . 5.0 mp -120.6 126.65 75.49 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.22 0 CA-C-N 115.889 -0.596 . . . . 0.0 109.494 176.382 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' E' E ' 88' ' ' LEU . . . . . . . . . . . . . 47.2 mt -116.0 137.76 51.82 Favored 'General case' 0 N--CA 1.462 0.167 0 CA-C-O 121.045 0.45 . . . . 0.0 111.468 -176.88 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' E' E ' 89' ' ' ASP . . . . . . . . . . . . . 8.7 t70 -136.14 156.73 48.27 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 115.655 -0.702 . . . . 0.0 109.584 175.202 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' E' E ' 90' ' ' GLU . . . . . . . . . . . . . 40.8 mp0 -51.23 -34.01 30.45 Favored 'General case' 0 C--N 1.328 -0.326 0 N-CA-C 112.507 0.558 . . . . 0.0 112.507 -171.919 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' E' E ' 91' ' ' ASN . . . . . . . . . . . . . 7.8 m120 -130.28 32.01 4.54 Favored 'General case' 0 N--CA 1.465 0.313 0 N-CA-C 112.062 0.393 . . . . 0.0 112.062 -175.897 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' E' E ' 92' ' ' LEU . . . . . . . . . . . . . 13.8 tp -166.11 141.77 4.82 Favored 'General case' 0 C--N 1.331 -0.239 0 C-N-CA 120.945 -0.302 . . . . 0.0 110.526 179.242 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' E' E ' 93' ' ' ILE . . . . . . . . . . . . . 71.9 mt -128.73 119.48 49.94 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.207 0 N-CA-C 109.121 -0.696 . . . . 0.0 109.121 176.686 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' E' E ' 94' ' ' VAL . . . . . . . . . . . . . 47.6 t -123.53 128.27 74.52 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.286 0 CA-C-O 121.037 0.446 . . . . 0.0 110.019 -178.898 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' E' E ' 95' ' ' VAL . . . . . . . . . . . . . 41.6 t -121.04 135.5 61.02 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.347 0 CA-C-N 115.807 -0.633 . . . . 0.0 109.821 -179.831 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' E' E ' 96' ' ' ILE . . . . . . . . . . . . . 49.9 mt -111.18 126.31 68.56 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.36 0 N-CA-C 108.959 -0.756 . . . . 0.0 108.959 178.041 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' E' E ' 97' ' ' THR . . . . . . . . . . . . . 74.7 p -96.27 155.73 16.64 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-O 121.114 0.483 . . . . 0.0 111.005 -177.747 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' E' E ' 98' ' ' GLU . . . . . . . . . . . . . 79.2 tt0 -53.84 -27.37 29.29 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.153 -0.476 . . . . 0.0 112.1 -179.143 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' E' E ' 99' ' ' GLU . . . . . . . . . . . . . 12.7 pt-20 -81.08 18.01 1.14 Allowed 'General case' 0 CA--C 1.535 0.374 0 N-CA-C 113.181 0.808 . . . . 0.0 113.181 -176.946 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' E' E ' 100' ' ' ASN . . . . . . . . . . . . . 3.4 m-20 63.52 37.43 10.49 Favored 'General case' 0 N--CA 1.463 0.179 0 CA-C-O 121.063 0.459 . . . . 0.0 111.204 176.831 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' E' E ' 101' ' ' GLU . . . . . . . . . . . . . 84.6 tt0 -116.22 146.02 42.67 Favored 'General case' 0 C--N 1.333 -0.131 0 CA-C-N 116.202 -0.454 . . . . 0.0 109.982 175.981 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' E' E ' 102' ' ' VAL . . . . . . . . . . . . . 46.8 t -115.08 126.1 72.57 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.346 0 CA-C-N 116.34 -0.391 . . . . 0.0 110.144 -177.668 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' E' E ' 103' ' ' LEU . . . . . . . . . . . . . 35.1 mt -117.82 128.54 54.95 Favored 'General case' 0 C--N 1.332 -0.169 0 CA-C-N 115.777 -0.647 . . . . 0.0 110.083 176.832 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' E' E ' 104' ' ' ILE . . . . . 0.599 HD13 HG11 ' E' ' 130' ' ' VAL . 68.9 mt -119.13 122.71 69.9 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.225 0 CA-C-N 116.722 -0.217 . . . . 0.0 110.422 -179.072 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' E' E ' 105' ' ' PHE . . . . . . . . . . . . . 55.5 m-85 -122.8 166.8 14.39 Favored 'General case' 0 C--O 1.232 0.137 0 O-C-N 123.917 0.76 . . . . 0.0 109.753 179.494 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' E' E ' 106' ' ' ASN . . . . . . . . . . . . . 45.9 p-10 -99.11 -170.04 1.86 Allowed 'General case' 0 C--N 1.33 -0.276 0 N-CA-C 109.758 -0.46 . . . . 0.0 109.758 173.079 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' E' E ' 107' ' ' GLN . . . . . . . . . . . . . 46.9 tt0 -60.61 -30.0 69.57 Favored 'General case' 0 C--N 1.329 -0.289 0 N-CA-C 111.932 0.345 . . . . 0.0 111.932 -179.675 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' E' E ' 108' ' ' ASN . . . . . . . . . . . . . 5.3 t30 -81.96 7.84 12.05 Favored 'General case' 0 CA--C 1.536 0.416 0 N-CA-C 113.108 0.781 . . . . 0.0 113.108 -177.891 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' E' E ' 109' ' ' LEU . . . . . 0.557 HD21 ' HB2' ' E' ' 78' ' ' ALA . 11.4 tp 61.42 35.97 17.53 Favored 'General case' 0 CA--C 1.53 0.19 0 O-C-N 122.106 -0.371 . . . . 0.0 111.442 178.724 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' E' E ' 110' ' ' GLU . . . . . . . . . . . . . 42.8 mt-10 -104.9 143.15 33.55 Favored 'General case' 0 C--N 1.33 -0.256 0 N-CA-C 109.586 -0.524 . . . . 0.0 109.586 175.288 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' E' E ' 111' ' ' GLU . . . . . . . . . . . . . 61.0 tt0 -79.72 121.98 26.01 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-O 120.877 0.37 . . . . 0.0 110.727 -176.661 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' E' E ' 112' ' ' LEU . . . . . . . . . . . . . 20.3 mt -105.98 -46.13 4.18 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 116.123 -0.489 . . . . 0.0 110.665 179.864 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' E' E ' 113' ' ' TYR . . . . . . . . . . . . . 57.1 t80 -134.31 138.26 44.83 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-O 120.901 0.382 . . . . 0.0 111.26 -178.077 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' E' E ' 114' ' ' ARG . . . . . . . . . . . . . 52.7 ttp180 -136.09 123.49 22.0 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 115.842 -0.617 . . . . 0.0 110.325 177.494 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' E' E ' 115' ' ' GLY . . . . . . . . . . . . . . . -150.0 157.98 27.46 Favored Glycine 0 CA--C 1.524 0.601 0 N-CA-C 110.915 -0.874 . . . . 0.0 110.915 179.0 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' E' E ' 116' ' ' LYS . . . . . . . . . . . . . 31.9 ttmt -131.83 138.95 48.7 Favored 'General case' 0 C--N 1.329 -0.303 0 N-CA-C 109.886 -0.413 . . . . 0.0 109.886 177.317 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' E' E ' 117' ' ' PHE . . . . . . . . . . . . . 39.1 m-85 -137.74 114.61 10.65 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-O 120.867 0.365 . . . . 0.0 110.208 -175.769 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' E' E ' 118' ' ' GLU . . . . . . . . . . . . . 81.2 tt0 -52.81 -44.51 66.7 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.493 -0.321 . . . . 0.0 111.503 -177.078 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' E' E ' 119' ' ' ASN . . . . . . . . . . . . . 36.5 m120 -95.77 30.69 2.27 Favored 'General case' 0 C--N 1.33 -0.248 0 N-CA-C 112.262 0.467 . . . . 0.0 112.262 -174.938 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' E' E ' 120' ' ' LEU . . . . . . . . . . . . . 13.9 tp -57.35 121.02 9.19 Favored 'General case' 0 C--N 1.332 -0.169 0 CA-C-O 120.631 0.253 . . . . 0.0 110.385 178.068 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' E' E ' 121' ' ' ASN . . . . . . . . . . . . . 66.7 m-20 -114.09 -44.12 3.17 Favored 'General case' 0 C--N 1.332 -0.188 0 CA-C-N 116.471 -0.331 . . . . 0.0 111.101 -178.794 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' E' E ' 122' ' ' LYS . . . . . . . . . . . . . 63.2 mtpt -145.5 152.12 39.27 Favored 'General case' 0 C--N 1.332 -0.171 0 CA-C-O 121.041 0.448 . . . . 0.0 111.714 -176.447 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' E' E ' 123' ' ' VAL . . . . . . . . . . . . . 47.2 t -130.85 131.95 64.19 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.252 0 CA-C-N 115.943 -0.571 . . . . 0.0 109.482 174.461 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' E' E ' 124' ' ' LEU . . . . . . . . . . . . . 83.0 mt -125.72 140.48 52.66 Favored 'General case' 0 C--N 1.332 -0.181 0 CA-C-O 120.827 0.346 . . . . 0.0 110.911 -177.549 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' E' E ' 125' ' ' VAL . . . . . . . . . . . . . 34.5 m -132.89 142.79 41.37 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.182 0 CA-C-N 116.127 -0.488 . . . . 0.0 110.764 179.878 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' E' E ' 126' ' ' ARG . . . . . . . . . . . . . 96.2 mtt-85 -148.05 112.15 5.18 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.443 177.105 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' E' E ' 127' ' ' ASN . . . . . . . . . . . . . 17.1 m120 53.85 -104.93 0.23 Allowed 'General case' 0 CA--C 1.543 0.699 0 CA-C-O 119.078 -0.487 . . . . 0.0 111.017 179.542 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' E' E ' 128' ' ' ASP . . . . . . . . . . . . . 18.7 p-10 -113.98 3.5 15.38 Favored 'General case' 0 N--CA 1.468 0.453 0 CA-C-N 119.508 1.049 . . . . 0.0 113.473 -177.487 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' E' E ' 129' ' ' LEU . . . . . . . . . . . . . 12.4 tp -104.92 140.47 38.1 Favored 'General case' 0 C--N 1.331 -0.215 0 N-CA-C 109.609 -0.515 . . . . 0.0 109.609 178.034 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' E' E ' 130' ' ' VAL . . . . . 0.599 HG11 HD13 ' E' ' 104' ' ' ILE . 13.4 p -132.92 139.2 50.14 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.184 0 CA-C-O 121.132 0.491 . . . . 0.0 110.742 -178.28 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' E' E ' 131' ' ' VAL . . . . . 0.589 HG22 HD12 ' E' ' 140' ' ' LEU . 38.4 t -136.11 140.85 43.11 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.267 0 CA-C-N 115.96 -0.564 . . . . 0.0 110.565 -179.792 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' E' E ' 132' ' ' ILE . . . . . . . . . . . . . 70.0 mt -116.17 133.08 63.8 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.27 0 CA-C-N 115.747 -0.66 . . . . 0.0 109.433 178.957 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' E' E ' 133' ' ' ILE . . . . . . . . . . . . . 39.0 mm -116.1 123.26 71.13 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.228 0 CA-C-O 120.678 0.275 . . . . 0.0 111.1 -174.898 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' E' E ' 134' ' ' ASP . . . . . . . . . . . . . 9.3 p-10 -136.18 149.73 48.72 Favored 'General case' 0 C--N 1.331 -0.226 0 CA-C-N 116.253 -0.431 . . . . 0.0 110.101 175.428 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' E' E ' 135' ' ' GLU . . . . . . . . . . . . . 81.5 tt0 -49.96 -27.33 5.22 Favored 'General case' 0 C--N 1.329 -0.299 0 N-CA-C 112.878 0.696 . . . . 0.0 112.878 -173.753 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' E' E ' 136' ' ' GLN . . . . . . . . . . . . . 94.8 mt-30 -83.24 -34.48 25.83 Favored 'General case' 0 C--O 1.233 0.232 0 N-CA-C 112.304 0.483 . . . . 0.0 112.304 -175.621 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' E' E ' 137' ' ' LYS . . . . . . . . . . . . . 15.2 pttp -167.51 174.23 8.04 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-O 121.597 0.713 . . . . 0.0 112.194 -170.941 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' E' E ' 138' ' ' LEU . . . . . 0.427 ' C ' HD23 ' E' ' 138' ' ' LEU . 6.3 tt -119.42 126.65 51.86 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 114.951 -1.022 . . . . 0.0 109.923 178.652 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' E' E ' 139' ' ' THR . . . . . . . . . . . . . 25.9 m -105.82 122.91 47.06 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.139 -0.482 . . . . 0.0 110.217 179.367 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' E' E ' 140' ' ' LEU . . . . . 0.589 HD12 HG22 ' E' ' 131' ' ' VAL . 10.6 tp -111.91 121.48 45.14 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 115.94 -0.573 . . . . 0.0 109.619 -177.428 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' E' E ' 141' ' ' ILE . . . . . 0.522 ' HB ' HG13 ' E' ' 130' ' ' VAL . 19.4 mt -122.0 118.68 56.31 Favored 'Isoleucine or valine' 0 C--O 1.234 0.265 0 CA-C-O 121.168 0.509 . . . . 0.0 110.121 -176.799 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' E' E ' 142' ' ' ARG . . . . . . . . . . . . . 78.6 mtp180 -102.75 110.13 21.96 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 115.058 -0.973 . . . . 0.0 110.114 178.985 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' E' E ' 143' ' ' THR . . . . . . . . . . . . . 69.6 p . . . . . 0 C--O 1.219 -0.538 0 CA-C-O 118.041 -0.98 . . . . 0.0 110.558 -178.561 . . . . . . . . 0 0 . 1 . 002 nuclear nobuild core ' F' F ' 1' ' ' MET . . . . . . . . . . . . . 25.3 ptp . . . . . 0 C--O 1.232 0.156 0 CA-C-O 120.806 0.336 . . . . 0.0 110.778 . . . . . . . . . 0 0 . 1 . 002 nuclear nobuild core ' F' F ' 2' ' ' SER . . . . . . . . . . . . . 10.1 p -112.22 134.47 53.75 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.562 179.319 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' F' F ' 3' ' ' GLU . . . . . . . . . . . . . 40.6 mt-10 -139.61 141.6 37.11 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 115.991 -0.55 . . . . 0.0 110.653 -179.544 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' F' F ' 4' ' ' LEU . . . . . 0.427 HD12 HD23 ' F' ' 58' ' ' LEU . 3.1 tt -128.01 125.63 39.77 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-N 115.896 -0.593 . . . . 0.0 109.945 179.11 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' F' F ' 5' ' ' LYS . . . . . . . . . . . . . 97.9 mttt -106.28 120.05 40.84 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.297 -0.411 . . . . 0.0 110.655 -179.811 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' F' F ' 6' ' ' LEU . . . . . . . . . . . . . 64.1 mt -114.01 150.06 34.46 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 115.538 -0.756 . . . . 0.0 110.485 -178.88 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' F' F ' 7' ' ' LYS . . . . . . . . . . . . . 82.3 tttt -137.15 134.74 19.03 Favored Pre-proline 0 CA--C 1.534 0.365 0 CA-C-O 118.806 -0.616 . . . . 0.0 109.676 175.021 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' F' F ' 8' ' ' PRO . . . . . . . . . . . . . 71.8 Cg_endo -89.6 135.97 2.61 Favored 'Trans proline' 0 N--CA 1.49 1.319 0 C-N-CA 121.615 1.544 . . . . 0.0 111.483 177.838 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' F' F ' 9' ' ' LEU . . . . . . . . . . . . . 37.9 mt -72.93 -47.1 8.54 Favored Pre-proline 0 CA--C 1.533 0.325 0 CA-C-O 118.689 -0.672 . . . . 0.0 112.318 -177.538 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' F' F ' 10' ' ' PRO . . . . . . . . . . . . . 92.5 Cg_endo -80.68 149.87 18.61 Favored 'Trans proline' 0 N--CA 1.495 1.576 0 C-N-CA 121.104 1.203 . . . . 0.0 111.757 175.586 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' F' F ' 11' ' ' LYS . . . . . . . . . . . . . 83.6 tttt -84.1 96.9 9.06 Favored 'General case' 0 C--N 1.33 -0.275 0 C-N-CA 120.836 -0.346 . . . . 0.0 110.49 179.358 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' F' F ' 12' ' ' VAL . . . . . . . . . . . . . 12.1 p -142.77 144.39 24.36 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.364 0 CA-C-N 116.123 -0.49 . . . . 0.0 110.434 179.678 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' F' F ' 13' ' ' GLU . . . . . . . . . . . . . 43.7 mp0 -85.67 125.37 33.12 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.224 -0.444 . . . . 0.0 110.045 177.666 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' F' F ' 14' ' ' LEU . . . . . . . . . . . . . 45.7 mt -95.15 153.52 39.73 Favored Pre-proline 0 C--N 1.329 -0.303 0 CA-C-N 116.444 -0.344 . . . . 0.0 110.81 -177.8 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' F' F ' 15' ' ' PRO . . . . . . . . . . . . . 36.8 Cg_exo -59.33 160.14 20.67 Favored 'Trans proline' 0 N--CA 1.497 1.7 0 C-N-CA 121.296 1.331 . . . . 0.0 111.704 177.743 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' F' F ' 16' ' ' PRO . . . . . . . . . . . . . 27.5 Cg_exo -60.25 -43.13 36.98 Favored 'Trans proline' 0 N--CA 1.498 1.737 0 C-N-CA 121.381 1.388 . . . . 0.0 112.802 -177.628 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' F' F ' 17' ' ' ASP . . . . . . . . . . . . . 16.3 p-10 -87.72 12.5 12.65 Favored 'General case' 0 C--N 1.326 -0.422 0 N-CA-C 113.182 0.808 . . . . 0.0 113.182 -176.377 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' F' F ' 18' ' ' PHE . . . . . . . . . . . . . 48.1 t80 -58.0 -44.64 87.33 Favored 'General case' 0 C--N 1.334 -0.074 0 O-C-N 122.04 -0.413 . . . . 0.0 110.151 -178.241 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' F' F ' 19' ' ' VAL . . . . . 0.41 HG13 ' N ' ' F' ' 20' ' ' ASP . 14.6 p -56.46 -42.08 74.18 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.333 0 CA-C-N 116.36 -0.382 . . . . 0.0 110.941 -178.474 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' F' F ' 20' ' ' ASP . . . . . 0.41 ' N ' HG13 ' F' ' 19' ' ' VAL . 79.9 m-20 -60.98 -42.12 97.77 Favored 'General case' 0 C--O 1.233 0.234 0 CA-C-O 120.884 0.373 . . . . 0.0 110.957 -178.051 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' F' F ' 21' ' ' VAL . . . . . . . . . . . . . 46.9 t -64.0 -47.37 90.74 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 CA-C-N 116.343 -0.39 . . . . 0.0 110.406 -178.395 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' F' F ' 22' ' ' ILE . . . . . 0.51 HG22 HD12 ' F' ' 26' ' ' LEU . 50.1 mm -55.96 -43.96 76.67 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.182 0 CA-C-O 120.774 0.321 . . . . 0.0 110.66 178.769 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' F' F ' 23' ' ' ARG . . . . . . . . . . . . . 56.0 ttp180 -52.86 -52.36 57.57 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-O 120.709 0.29 . . . . 0.0 111.519 179.986 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' F' F ' 24' ' ' ILE . . . . . . . . . . . . . 69.3 mt -59.63 -40.62 82.68 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.268 0 CA-C-N 116.414 -0.357 . . . . 0.0 111.273 -177.051 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' F' F ' 25' ' ' LYS . . . . . . . . . . . . . 46.4 mttm -65.46 -42.06 92.7 Favored 'General case' 0 C--N 1.327 -0.377 0 N-CA-C 112.192 0.442 . . . . 0.0 112.192 -178.626 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' F' F ' 26' ' ' LEU . . . . . 0.51 HD12 HG22 ' F' ' 22' ' ' ILE . 74.4 mt -80.58 -38.03 30.21 Favored 'General case' 0 C--N 1.33 -0.261 0 N-CA-C 113.39 0.885 . . . . 0.0 113.39 -170.841 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' F' F ' 27' ' ' GLN . . . . . . . . . . . . . 8.6 pt20 -46.48 139.78 4.74 Favored 'General case' 0 N--CA 1.469 0.479 0 N-CA-C 112.871 0.693 . . . . 0.0 112.871 -174.946 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' F' F ' 28' ' ' GLY . . . . . . . . . . . . . . . 99.29 -25.4 28.37 Favored Glycine 0 CA--C 1.533 1.193 0 CA-C-N 115.507 -0.77 . . . . 0.0 112.264 -177.035 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' F' F ' 29' ' ' LYS . . . . . . . . . . . . . 33.5 mmtp -97.61 155.15 17.1 Favored 'General case' 0 C--O 1.233 0.198 0 CA-C-N 117.335 0.568 . . . . 0.0 110.771 178.982 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' F' F ' 30' ' ' THR . . . . . . . . . . . . . 25.2 m -107.21 136.65 46.68 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 115.928 -0.578 . . . . 0.0 109.827 175.428 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' F' F ' 31' ' ' VAL . . . . . . . . . . . . . 35.0 m -129.78 161.15 39.94 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.267 0 CA-C-N 116.473 -0.33 . . . . 0.0 110.814 -177.959 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' F' F ' 32' ' ' ARG . . . . . . . . . . . . . 92.7 mtt180 -132.56 151.22 52.0 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-O 121.307 0.575 . . . . 0.0 110.595 178.88 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' F' F ' 33' ' ' THR . . . . . . . . . . . . . 24.1 m -52.45 140.54 22.18 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.112 -0.494 . . . . 0.0 111.396 -178.467 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' F' F ' 34' ' ' GLY . . . . . . . . . . . . . . . 99.28 -17.09 58.39 Favored Glycine 0 CA--C 1.532 1.135 0 CA-C-O 119.596 -0.558 . . . . 0.0 113.218 178.977 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' F' F ' 35' ' ' ASP . . . . . . . . . . . . . 54.3 m-20 -63.3 150.48 43.18 Favored 'General case' 0 C--O 1.232 0.142 0 CA-C-N 118.09 0.945 . . . . 0.0 111.0 179.365 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' F' F ' 36' ' ' VAL . . . . . . . . . . . . . 42.4 t -125.72 130.44 72.53 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.293 0 CA-C-N 115.801 -0.636 . . . . 0.0 109.706 178.763 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' F' F ' 37' ' ' ILE . . . . . . . . . . . . . 65.2 mt -120.66 138.92 49.57 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.294 0 CA-C-N 116.336 -0.393 . . . . 0.0 110.098 -178.921 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' F' F ' 38' ' ' GLY . . . . . . . . . . . . . . . -109.13 128.86 9.21 Favored Glycine 0 CA--C 1.525 0.689 0 N-CA-C 110.872 -0.891 . . . . 0.0 110.872 179.02 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' F' F ' 39' ' ' ILE . . . . . . . . . . . . . 74.4 mt -123.57 134.91 65.03 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.256 0 N-CA-C 110.176 -0.305 . . . . 0.0 110.176 179.828 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' F' F ' 40' ' ' SER . . . . . . . . . . . . . 88.0 p -92.65 118.63 31.24 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.895 176.383 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' F' F ' 41' ' ' ILE . . . . . . . . . . . . . 44.5 mm -120.48 113.01 38.68 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.263 0 CA-C-O 120.751 0.31 . . . . 0.0 110.247 178.799 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' F' F ' 42' ' ' LEU . . . . . 0.409 HD12 ' N ' ' F' ' 42' ' ' LEU . 7.9 mp 51.21 37.4 18.37 Favored 'General case' 0 C--N 1.331 -0.223 0 CA-C-N 116.151 -0.477 . . . . 0.0 111.748 177.006 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' F' F ' 43' ' ' GLY . . . . . . . . . . . . . . . 75.95 29.84 58.4 Favored Glycine 0 CA--C 1.53 1.03 0 C-N-CA 121.151 -0.547 . . . . 0.0 112.33 177.606 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' F' F ' 44' ' ' LYS . . . . . . . . . . . . . 60.0 mtpt -135.29 127.88 30.76 Favored 'General case' 0 C--N 1.329 -0.295 0 N-CA-C 109.65 -0.5 . . . . 0.0 109.65 177.062 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' F' F ' 45' ' ' GLU . . . . . . . . . . . . . 84.2 tt0 -82.73 123.42 29.29 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-O 120.822 0.344 . . . . 0.0 111.322 -176.738 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' F' F ' 46' ' ' VAL . . . . . . . . . . . . . 7.1 p -123.23 128.4 74.89 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.202 0 N-CA-C 109.592 -0.521 . . . . 0.0 109.592 175.386 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' F' F ' 47' ' ' LYS . . . . . . . . . . . . . 63.6 mttp -99.53 128.79 45.65 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.125 -0.489 . . . . 0.0 111.229 178.099 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' F' F ' 48' ' ' PHE . . . . . . . . . . . . . 91.5 m-85 -111.64 131.9 54.96 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.023 -0.535 . . . . 0.0 109.746 176.196 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' F' F ' 49' ' ' LYS . . . . . . . . . . . . . 71.9 tttt -106.6 136.18 46.83 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.4 -0.364 . . . . 0.0 110.455 -179.654 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' F' F ' 50' ' ' VAL . . . . . . . . . . . . . 45.4 t -81.11 105.62 11.25 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.292 0 N-CA-C 109.53 -0.544 . . . . 0.0 109.53 176.691 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' F' F ' 51' ' ' VAL . . . . . . . . . . . . . 47.6 t -70.21 -51.96 34.34 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.33 0 CA-C-N 115.879 -0.6 . . . . 0.0 109.73 -174.387 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' F' F ' 52' ' ' GLN . . . . . . . . . . . . . 77.8 mt-30 -154.62 147.67 24.68 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-O 121.175 0.512 . . . . 0.0 111.756 -177.261 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' F' F ' 53' ' ' ALA . . . . . 0.456 ' HB1' ' HB2' ' F' ' 58' ' ' LEU . . . -122.39 128.84 51.46 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 115.19 -0.914 . . . . 0.0 109.317 175.282 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' F' F ' 54' ' ' TYR . . . . . . . . . . . . . 45.7 t80 -126.77 109.53 22.51 Favored Pre-proline 0 CA--C 1.534 0.335 0 CA-C-O 118.383 -0.817 . . . . 0.0 110.443 -178.479 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' F' F ' 55' ' ' PRO . . . . . . . . . . . . . 74.4 Cg_endo -77.09 170.04 72.69 Favored 'Cis proline' 0 N--CA 1.5 1.902 0 CA-C-N 121.768 1.667 . . . . 0.0 112.536 -5.091 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' F' F ' 56' ' ' SER . . . . . . . . . . . . . 13.7 m -112.27 126.91 27.6 Favored Pre-proline 0 CA--C 1.539 0.542 0 CA-C-O 118.409 -0.805 . . . . 0.0 109.642 176.52 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' F' F ' 57' ' ' PRO . . . . . . . . . . . . . 33.7 Cg_endo -65.27 169.15 41.16 Favored 'Cis proline' 0 N--CA 1.498 1.791 0 CA-C-N 122.083 1.78 . . . . 0.0 111.475 -1.543 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' F' F ' 58' ' ' LEU . . . . . 0.456 ' HB2' ' HB1' ' F' ' 53' ' ' ALA . 34.0 tp -130.61 137.05 49.45 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-O 120.971 0.415 . . . . 0.0 110.574 -179.313 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' F' F ' 59' ' ' ARG . . . . . . . . . . . . . 71.1 ttt180 -104.68 129.24 52.88 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 115.773 -0.648 . . . . 0.0 109.575 177.695 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' F' F ' 60' ' ' VAL . . . . . . . . . . . . . 42.3 t -86.74 119.17 34.23 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.272 0 C-N-CA 120.744 -0.382 . . . . 0.0 110.353 -176.131 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' F' F ' 61' ' ' GLU . . . . . . . . . . . . . 95.3 mt-10 -131.08 168.04 18.07 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.329 178.28 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' F' F ' 62' ' ' ASP . . . . . . . . . . . . . 55.8 m-20 -54.01 -32.51 54.43 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.641 -0.254 . . . . 0.0 111.641 179.259 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' F' F ' 63' ' ' ARG . . . . . . . . . . . . . 6.8 ptp180 -85.5 9.08 16.85 Favored 'General case' 0 CA--C 1.537 0.447 0 N-CA-C 113.508 0.929 . . . . 0.0 113.508 -175.892 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' F' F ' 64' ' ' THR . . . . . . . . . . . . . 30.1 m -85.43 134.81 34.05 Favored 'General case' 0 C--N 1.333 -0.124 0 CA-C-N 118.085 0.402 . . . . 0.0 110.813 -178.749 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' F' F ' 65' ' ' LYS . . . . . . . . . . . . . 52.4 mtmt -88.74 124.6 34.28 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.234 -0.439 . . . . 0.0 109.932 177.426 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' F' F ' 66' ' ' ILE . . . . . . . . . . . . . 62.3 mt -112.51 128.54 69.12 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.325 0 N-CA-C 109.835 -0.431 . . . . 0.0 109.835 -178.572 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' F' F ' 67' ' ' THR . . . . . . . . . . . . . 28.5 m -126.15 141.82 51.78 Favored 'General case' 0 C--N 1.331 -0.222 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.972 -177.05 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' F' F ' 68' ' ' LEU . . . . . 0.476 HD12 ' N ' ' F' ' 68' ' ' LEU . 8.5 mp . . . . . 0 C--N 1.329 -0.312 0 CA-C-N 115.966 -0.561 . . . . 0.0 110.104 178.061 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' F' F ' 73' ' ' VAL . . . . . . . . . . . . . 35.6 m . . . . . 0 C--O 1.232 0.156 0 N-CA-C 109.681 -0.489 . . . . 0.0 109.681 . . . . . . . . . 0 0 . 1 . 002 nuclear nobuild core ' F' F ' 74' ' ' ASP . . . . . . . . . . . . . 39.7 t0 -88.85 114.91 25.98 Favored 'General case' 0 C--N 1.328 -0.343 0 N-CA-C 109.982 -0.377 . . . . 0.0 109.982 -177.596 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' F' F ' 75' ' ' VAL . . . . . . . . . . . . . 41.4 t -111.05 120.79 62.47 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.287 0 CA-C-O 121.07 0.462 . . . . 0.0 110.242 -178.784 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' F' F ' 76' ' ' LEU . . . . . . . . . . . . . 15.3 mt -128.55 143.81 51.03 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 115.732 -0.667 . . . . 0.0 109.692 179.097 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' F' F ' 77' ' ' GLU . . . . . . . . . . . . . 97.3 mt-10 -131.94 131.26 42.5 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-O 120.989 0.424 . . . . 0.0 111.093 -177.153 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' F' F ' 78' ' ' ALA . . . . . . . . . . . . . . . -117.94 128.38 54.75 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 115.747 -0.661 . . . . 0.0 109.621 177.148 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' F' F ' 79' ' ' LYS . . . . . 0.595 ' O ' HD13 ' F' ' 80' ' ' ILE . 95.2 mttt -79.93 120.63 24.41 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-O 120.904 0.383 . . . . 0.0 110.857 -177.085 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' F' F ' 80' ' ' ILE . . . . . 0.595 HD13 ' O ' ' F' ' 79' ' ' LYS . 41.4 mm -139.1 108.68 3.93 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.309 0 N-CA-C 109.072 -0.714 . . . . 0.0 109.072 -177.322 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' F' F ' 81' ' ' LYS . . . . . . . . . . . . . 82.7 tttt -97.53 123.79 41.54 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-O 120.868 0.366 . . . . 0.0 111.239 -175.913 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' F' F ' 82' ' ' GLY . . . . . . . . . . . . . . . 89.22 42.02 5.68 Favored Glycine 0 CA--C 1.526 0.724 0 C-N-CA 120.884 -0.674 . . . . 0.0 111.907 174.647 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' F' F ' 83' ' ' ILE . . . . . . . . . . . . . 71.4 mt -68.7 136.71 25.85 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.304 0 N-CA-C 109.661 -0.496 . . . . 0.0 109.661 176.571 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' F' F ' 84' ' ' LYS . . . . . . . . . . . . . 36.7 ttpt -101.36 -51.31 3.52 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-O 120.868 0.366 . . . . 0.0 110.262 -178.908 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' F' F ' 85' ' ' ASP . . . . . . . . . . . . . 11.9 t70 -148.22 148.65 30.74 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 115.874 -0.603 . . . . 0.0 110.385 -179.752 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' F' F ' 86' ' ' VAL . . . . . . . . . . . . . 46.3 t -133.56 132.95 57.52 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.269 0 CA-C-O 121.0 0.429 . . . . 0.0 110.494 -178.98 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' F' F ' 87' ' ' ILE . . . . . 0.498 HD12 ' N ' ' F' ' 87' ' ' ILE . 5.0 mp -119.82 127.25 75.87 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.202 0 CA-C-N 115.859 -0.61 . . . . 0.0 109.474 175.901 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' F' F ' 88' ' ' LEU . . . . . . . . . . . . . 12.8 tp -112.6 129.94 56.2 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.3 -0.409 . . . . 0.0 111.022 -177.453 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' F' F ' 89' ' ' ASP . . . . . . . . . . . . . 6.2 t70 -123.94 156.36 36.49 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 115.868 -0.606 . . . . 0.0 109.747 176.794 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' F' F ' 90' ' ' GLU . . . . . . . . . . . . . 96.3 mt-10 -46.15 -41.93 13.21 Favored 'General case' 0 C--N 1.332 -0.192 0 N-CA-C 113.15 0.796 . . . . 0.0 113.15 -172.58 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' F' F ' 91' ' ' ASN . . . . . . . . . . . . . 54.0 m-80 -132.09 36.6 3.64 Favored 'General case' 0 N--CA 1.464 0.259 0 CA-C-O 120.732 0.301 . . . . 0.0 111.569 -176.575 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' F' F ' 92' ' ' LEU . . . . . . . . . . . . . 12.6 tp -166.07 144.98 5.91 Favored 'General case' 0 C--N 1.331 -0.232 0 C-N-CA 120.927 -0.309 . . . . 0.0 110.746 -179.752 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' F' F ' 93' ' ' ILE . . . . . . . . . . . . . 68.7 mt -127.3 123.63 62.31 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.253 0 N-CA-C 109.584 -0.524 . . . . 0.0 109.584 179.795 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' F' F ' 94' ' ' VAL . . . . . 0.446 HG21 HG11 ' F' ' 125' ' ' VAL . 47.2 t -123.09 125.4 72.02 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.27 0 N-CA-C 109.907 -0.405 . . . . 0.0 109.907 -179.92 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' F' F ' 95' ' ' VAL . . . . . . . . . . . . . 43.4 t -121.16 135.81 60.13 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.325 0 CA-C-N 115.902 -0.59 . . . . 0.0 109.97 -177.877 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' F' F ' 96' ' ' ILE . . . . . . . . . . . . . 60.3 mt -117.62 126.51 74.76 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.286 0 N-CA-C 109.258 -0.645 . . . . 0.0 109.258 178.58 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' F' F ' 97' ' ' THR . . . . . . . . . . . . . 64.0 p -102.6 157.61 16.81 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-O 121.081 0.467 . . . . 0.0 111.36 -176.432 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' F' F ' 98' ' ' GLU . . . . . . . . . . . . . 12.5 pt-20 -53.88 -22.17 9.33 Favored 'General case' 0 CA--C 1.534 0.345 0 N-CA-C 112.51 0.559 . . . . 0.0 112.51 -179.936 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' F' F ' 99' ' ' GLU . . . . . . . . . . . . . 16.9 tt0 -78.94 14.56 1.34 Allowed 'General case' 0 CA--C 1.537 0.444 0 N-CA-C 112.855 0.687 . . . . 0.0 112.855 -178.061 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' F' F ' 100' ' ' ASN . . . . . . . . . . . . . 3.6 m-20 59.92 38.09 21.23 Favored 'General case' 0 CA--C 1.531 0.214 0 CA-C-O 121.027 0.441 . . . . 0.0 110.599 -179.536 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' F' F ' 101' ' ' GLU . . . . . . . . . . . . . 84.7 tt0 -118.24 143.49 46.51 Favored 'General case' 0 C--N 1.332 -0.163 0 CA-C-N 116.014 -0.539 . . . . 0.0 109.776 178.429 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' F' F ' 102' ' ' VAL . . . . . . . . . . . . . 43.6 t -114.95 126.75 72.61 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.269 0 CA-C-N 116.182 -0.463 . . . . 0.0 109.946 -177.862 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' F' F ' 103' ' ' LEU . . . . . . . . . . . . . 27.0 mt -116.53 130.78 56.94 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 115.665 -0.698 . . . . 0.0 110.267 177.704 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' F' F ' 104' ' ' ILE . . . . . . . . . . . . . 66.5 mt -118.38 120.75 65.28 Favored 'Isoleucine or valine' 0 C--O 1.234 0.25 0 N-CA-C 110.053 -0.351 . . . . 0.0 110.053 179.669 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' F' F ' 105' ' ' PHE . . . . . . . . . . . . . 84.3 m-85 -123.47 164.87 18.08 Favored 'General case' 0 C--N 1.333 -0.15 0 O-C-N 123.928 0.768 . . . . 0.0 109.91 179.742 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' F' F ' 106' ' ' ASN . . . . . . . . . . . . . 45.4 p-10 -100.07 -171.31 2.02 Favored 'General case' 0 C--N 1.331 -0.229 0 N-CA-C 109.88 -0.415 . . . . 0.0 109.88 172.934 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' F' F ' 107' ' ' GLN . . . . . . . . . . . . . 48.7 tt0 -58.67 -28.23 65.54 Favored 'General case' 0 C--N 1.328 -0.365 0 N-CA-C 112.278 0.473 . . . . 0.0 112.278 -178.693 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' F' F ' 108' ' ' ASN . . . . . . . . . . . . . 14.0 t30 -91.4 14.11 15.59 Favored 'General case' 0 CA--C 1.534 0.359 0 N-CA-C 113.177 0.806 . . . . 0.0 113.177 -176.336 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' F' F ' 109' ' ' LEU . . . . . . . . . . . . . 28.2 mt 59.15 37.2 24.09 Favored 'General case' 0 CA--C 1.529 0.144 0 CA-C-O 121.03 0.443 . . . . 0.0 111.551 177.122 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' F' F ' 110' ' ' GLU . . . . . . . . . . . . . 95.7 mt-10 -100.6 150.15 23.01 Favored 'General case' 0 C--N 1.329 -0.285 0 N-CA-C 109.818 -0.438 . . . . 0.0 109.818 176.058 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' F' F ' 111' ' ' GLU . . . . . . . . . . . . . 84.9 tt0 -82.38 122.01 27.45 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-O 120.918 0.389 . . . . 0.0 110.713 -178.255 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' F' F ' 112' ' ' LEU . . . . . . . . . . . . . 60.6 mt -110.91 -46.02 3.39 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.029 -0.532 . . . . 0.0 110.334 178.872 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' F' F ' 113' ' ' TYR . . . . . . . . . . . . . 52.6 t80 -140.96 138.58 33.87 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-O 120.874 0.368 . . . . 0.0 111.393 -179.791 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' F' F ' 114' ' ' ARG . . . . . . . . . . . . . 31.4 ttp180 -138.61 123.02 18.34 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 115.863 -0.608 . . . . 0.0 109.955 176.29 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' F' F ' 115' ' ' GLY . . . . . . . . . . . . . . . -150.08 157.78 27.37 Favored Glycine 0 CA--C 1.523 0.581 0 C-N-CA 120.794 -0.717 . . . . 0.0 111.35 179.002 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' F' F ' 116' ' ' LYS . . . . . . . . . . . . . 39.8 ttpt -127.7 140.74 51.88 Favored 'General case' 0 C--N 1.331 -0.228 0 N-CA-C 110.139 -0.319 . . . . 0.0 110.139 178.446 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' F' F ' 117' ' ' PHE . . . . . 0.472 ' HE2' HD13 ' F' ' 132' ' ' ILE . 44.2 m-85 -136.16 115.01 12.13 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-O 120.865 0.364 . . . . 0.0 110.292 -178.331 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' F' F ' 118' ' ' GLU . . . . . . . . . . . . . 84.9 tt0 -52.23 -46.9 65.89 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.43 -0.35 . . . . 0.0 111.561 -177.515 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' F' F ' 119' ' ' ASN . . . . . . . . . . . . . 18.0 m120 -97.01 31.02 2.51 Favored 'General case' 0 C--N 1.329 -0.285 0 N-CA-C 112.105 0.409 . . . . 0.0 112.105 -175.213 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' F' F ' 120' ' ' LEU . . . . . . . . . . . . . 15.5 tp -56.29 120.11 7.07 Favored 'General case' 0 C--N 1.331 -0.202 0 CA-C-O 120.694 0.283 . . . . 0.0 110.543 178.392 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' F' F ' 121' ' ' ASN . . . . . . . . . . . . . 12.5 m120 -114.06 -44.02 3.19 Favored 'General case' 0 C--N 1.332 -0.181 0 CA-C-N 116.499 -0.319 . . . . 0.0 111.225 -177.53 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' F' F ' 122' ' ' LYS . . . . . . . . . . . . . 88.4 mttt -144.7 153.84 42.14 Favored 'General case' 0 C--N 1.332 -0.195 0 CA-C-O 121.096 0.474 . . . . 0.0 111.912 -176.104 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' F' F ' 123' ' ' VAL . . . . . . . . . . . . . 44.3 t -129.29 129.04 67.23 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.261 0 CA-C-N 115.735 -0.666 . . . . 0.0 109.621 175.428 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' F' F ' 124' ' ' LEU . . . . . . . . . . . . . 34.0 mt -116.69 133.25 56.24 Favored 'General case' 0 C--N 1.331 -0.208 0 CA-C-N 116.305 -0.407 . . . . 0.0 110.275 -179.251 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' F' F ' 125' ' ' VAL . . . . . 0.446 HG11 HG21 ' F' ' 94' ' ' VAL . 34.3 m -136.21 139.03 46.33 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.298 0 CA-C-N 116.506 -0.315 . . . . 0.0 110.831 -179.032 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' F' F ' 126' ' ' ARG . . . . . . . . . . . . . 19.2 ttm180 -157.63 127.46 6.11 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-O 120.974 0.416 . . . . 0.0 110.88 175.913 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' F' F ' 127' ' ' ASN . . . . . . . . . . . . . 78.8 m-20 52.9 -113.09 0.74 Allowed 'General case' 0 CA--C 1.544 0.73 0 CA-C-O 118.748 -0.644 . . . . 0.0 110.858 -179.77 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' F' F ' 128' ' ' ASP . . . . . . . . . . . . . 18.9 p-10 -114.17 9.84 17.21 Favored 'General case' 0 CA--C 1.536 0.42 0 CA-C-N 119.978 1.263 . . . . 0.0 113.074 -178.233 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' F' F ' 129' ' ' LEU . . . . . . . . . . . . . 15.1 tp -109.02 138.69 44.97 Favored 'General case' 0 C--O 1.233 0.211 0 O-C-N 122.056 -0.403 . . . . 0.0 109.93 179.123 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' F' F ' 130' ' ' VAL . . . . . . . . . . . . . 43.0 t -125.36 139.49 51.1 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.24 0 CA-C-N 116.311 -0.404 . . . . 0.0 110.002 -178.968 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' F' F ' 131' ' ' VAL . . . . . . . . . . . . . 43.6 t -135.62 135.62 51.14 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.338 0 CA-C-N 116.239 -0.437 . . . . 0.0 109.959 178.287 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' F' F ' 132' ' ' ILE . . . . . 0.472 HD13 ' HE2' ' F' ' 117' ' ' PHE . 69.3 mt -114.41 134.13 58.31 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.323 0 N-CA-C 109.41 -0.589 . . . . 0.0 109.41 -179.926 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' F' F ' 133' ' ' ILE . . . . . . . . . . . . . 39.2 mm -116.22 117.88 56.97 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.211 0 CA-C-N 116.295 -0.411 . . . . 0.0 111.006 -174.594 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' F' F ' 134' ' ' ASP . . . . . . . . . . . . . 7.0 p-10 -129.81 149.64 51.47 Favored 'General case' 0 C--N 1.332 -0.177 0 N-CA-C 109.582 -0.525 . . . . 0.0 109.582 174.085 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' F' F ' 135' ' ' GLU . . . . . . . . . . . . . 39.7 tp10 -49.87 -26.17 3.83 Favored 'General case' 0 C--N 1.327 -0.39 0 N-CA-C 112.988 0.736 . . . . 0.0 112.988 -169.676 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' F' F ' 136' ' ' GLN . . . . . . . . . . . . . 96.9 mt-30 -105.09 -24.27 12.8 Favored 'General case' 0 N--CA 1.466 0.353 0 N-CA-C 113.178 0.807 . . . . 0.0 113.178 -174.654 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' F' F ' 137' ' ' LYS . . . . . . . . . . . . . 38.6 ttpt -140.86 147.75 39.44 Favored 'General case' 0 C--N 1.331 -0.21 0 CA-C-O 121.515 0.674 . . . . 0.0 112.35 -168.32 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' F' F ' 138' ' ' LEU . . . . . . . . . . . . . 16.3 tp -111.67 121.19 44.46 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 114.863 -1.062 . . . . 0.0 109.069 173.567 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' F' F ' 139' ' ' THR . . . . . . . . . . . . . 21.7 m -110.88 126.39 54.64 Favored 'General case' 0 C--N 1.332 -0.179 0 CA-C-O 120.689 0.28 . . . . 0.0 110.963 -178.328 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' F' F ' 140' ' ' LEU . . . . . 0.479 HD23 ' C ' ' F' ' 140' ' ' LEU . 7.8 tt -114.56 123.45 49.38 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 115.592 -0.731 . . . . 0.0 109.247 179.701 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' F' F ' 141' ' ' ILE . . . . . . . . . . . . . 19.5 mt -122.09 121.42 63.99 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.326 0 CA-C-O 120.988 0.423 . . . . 0.0 109.929 -175.545 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' F' F ' 142' ' ' ARG . . . . . . . . . . . . . 72.3 ttt-85 -113.91 131.43 56.3 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 115.268 -0.878 . . . . 0.0 110.452 -176.917 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' F' F ' 143' ' ' THR . . . . . . . . . . . . . 20.1 p . . . . . 0 C--O 1.221 -0.422 0 CA-C-O 117.991 -1.005 . . . . 0.0 110.522 179.458 . . . . . . . . 0 0 . 1 . 003 nuclear nobuild core ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 6.7 p . . . . . 0 C--O 1.232 0.169 0 CA-C-O 120.901 0.381 . . . . 0.0 110.96 . . . . . . . . . 0 0 . 1 . 003 nuclear nobuild core ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 53.7 mp0 -140.96 141.48 34.45 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.065 -0.516 . . . . 0.0 111.005 179.04 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 4' ' ' LEU . . . . . . . . . . . . . 15.8 tp -128.22 130.44 47.97 Favored 'General case' 0 C--N 1.331 -0.206 0 CA-C-N 116.067 -0.515 . . . . 0.0 110.106 175.833 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 5' ' ' LYS . . . . . . . . . . . . . 66.8 mttm -113.71 121.58 44.54 Favored 'General case' 0 C--O 1.235 0.308 0 CA-C-N 116.356 -0.384 . . . . 0.0 110.845 -179.765 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 45.1 mt -114.17 145.46 41.64 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 115.413 -0.812 . . . . 0.0 110.3 -179.271 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 78.6 tttt -131.75 136.96 29.27 Favored Pre-proline 0 CA--C 1.535 0.374 0 CA-C-O 119.011 -0.519 . . . . 0.0 109.934 176.573 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 8' ' ' PRO . . . . . . . . . . . . . 85.5 Cg_endo -91.9 143.32 2.77 Favored 'Trans proline' 0 N--CA 1.491 1.358 0 C-N-CA 121.786 1.657 . . . . 0.0 111.864 178.623 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 43.4 mt -77.94 -47.79 2.19 Favored Pre-proline 0 CA--C 1.534 0.349 0 CA-C-O 118.657 -0.687 . . . . 0.0 112.22 179.787 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 95.0 Cg_endo -81.19 156.21 19.66 Favored 'Trans proline' 0 N--CA 1.496 1.649 0 C-N-CA 121.253 1.302 . . . . 0.0 112.128 177.075 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 62.9 tttm -88.96 107.33 18.96 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.358 -0.383 . . . . 0.0 110.435 177.908 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 12.7 p -147.83 146.29 18.16 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.336 0 CA-C-O 120.814 0.34 . . . . 0.0 110.763 -179.855 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 70.7 mm-40 -84.47 130.28 34.78 Favored 'General case' 0 C--N 1.33 -0.275 0 N-CA-C 109.874 -0.417 . . . . 0.0 109.874 177.033 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 14' ' ' LEU . . . . . . . . . . . . . 32.9 mt -98.56 145.04 29.21 Favored Pre-proline 0 CA--C 1.534 0.357 0 CA-C-O 119.042 -0.504 . . . . 0.0 110.472 -178.653 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 15' ' ' PRO . . . . . . . . . . . . . 24.7 Cg_exo -62.85 160.37 33.61 Favored 'Trans proline' 0 N--CA 1.497 1.722 0 C-N-CA 121.359 1.373 . . . . 0.0 112.053 176.749 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 16' ' ' PRO . . . . . . . . . . . . . 27.8 Cg_exo -60.4 -33.04 94.58 Favored 'Trans proline' 0 N--CA 1.497 1.7 0 C-N-CA 121.556 1.504 . . . . 0.0 112.693 -179.637 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 17' ' ' ASP . . . . . . . . . . . . . 11.0 p-10 -86.16 4.42 38.54 Favored 'General case' 0 CA--C 1.536 0.42 0 N-CA-C 113.264 0.839 . . . . 0.0 113.264 -177.583 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 18' ' ' PHE . . . . . . . . . . . . . 23.0 t80 -57.45 -44.79 85.05 Favored 'General case' 0 N--CA 1.457 -0.093 0 O-C-N 121.878 -0.514 . . . . 0.0 110.252 -177.374 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 19' ' ' VAL . . . . . . . . . . . . . 48.4 t -55.9 -46.07 80.12 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.36 0 CA-C-N 116.449 -0.342 . . . . 0.0 110.823 -177.532 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 79.8 m-20 -59.59 -42.01 91.57 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-O 120.771 0.319 . . . . 0.0 110.951 -176.855 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 48.0 t -64.13 -47.48 89.93 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.25 0 C-N-CA 120.645 -0.422 . . . . 0.0 110.495 -177.701 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 22' ' ' ILE . . . . . 0.528 HG22 HD12 ' A' ' 26' ' ' LEU . 51.6 mm -55.82 -47.05 80.1 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.237 0 C-N-CA 120.978 -0.289 . . . . 0.0 110.684 179.631 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 23' ' ' ARG . . . . . . . . . . . . . 50.9 ttp180 -54.35 -49.39 69.89 Favored 'General case' 0 C--N 1.329 -0.286 0 C-N-CA 121.005 -0.278 . . . . 0.0 111.419 -177.626 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 24' ' ' ILE . . . . . . . . . . . . . 74.0 mt -60.32 -45.12 96.87 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.235 0 C-N-CA 121.117 -0.233 . . . . 0.0 111.26 -177.197 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 56.2 mmtt -64.67 -38.7 91.91 Favored 'General case' 0 C--N 1.328 -0.334 0 N-CA-C 112.259 0.466 . . . . 0.0 112.259 -177.571 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 26' ' ' LEU . . . . . 0.528 HD12 HG22 ' A' ' 22' ' ' ILE . 91.2 mt -78.33 -44.8 24.25 Favored 'General case' 0 C--N 1.33 -0.273 0 N-CA-C 112.983 0.734 . . . . 0.0 112.983 -172.27 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 27' ' ' GLN . . . . . . . . . . . . . 11.1 pt20 -47.23 139.41 6.2 Favored 'General case' 0 N--CA 1.469 0.492 0 N-CA-C 112.714 0.635 . . . . 0.0 112.714 -175.495 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 99.37 -26.34 24.74 Favored Glycine 0 CA--C 1.533 1.17 0 CA-C-N 115.613 -0.721 . . . . 0.0 112.245 -177.744 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 89.9 mttt -98.5 155.1 17.43 Favored 'General case' 0 C--O 1.233 0.191 0 CA-C-N 117.248 0.524 . . . . 0.0 111.439 179.756 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 30' ' ' THR . . . . . . . . . . . . . 24.2 m -105.78 135.17 47.68 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 115.717 -0.674 . . . . 0.0 109.774 174.906 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 34.8 m -131.73 157.13 43.1 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.276 0 CA-C-N 116.353 -0.385 . . . . 0.0 111.006 -177.739 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 32' ' ' ARG . . . . . . . . . . . . . 91.6 mtm-85 -130.61 150.42 51.82 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-O 121.289 0.566 . . . . 0.0 110.902 179.43 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 33' ' ' THR . . . . . . . . . . . . . 20.3 m -53.47 140.63 27.43 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.076 -0.511 . . . . 0.0 111.299 -178.634 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 99.63 -17.08 58.06 Favored Glycine 0 CA--C 1.534 1.278 0 C-N-CA 121.116 -0.564 . . . . 0.0 113.155 179.252 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 73.0 m-20 -64.68 148.46 50.96 Favored 'General case' 0 C--O 1.232 0.136 0 CA-C-N 118.081 0.941 . . . . 0.0 111.127 179.278 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 46.5 t -118.94 129.43 75.14 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.208 0 CA-C-N 115.721 -0.672 . . . . 0.0 109.686 178.529 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 37' ' ' ILE . . . . . . . . . . . . . 69.0 mt -121.22 138.73 50.63 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.265 0 CA-C-N 116.14 -0.482 . . . . 0.0 109.907 -179.158 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . -113.53 128.94 8.57 Favored Glycine 0 CA--C 1.526 0.758 0 N-CA-C 110.989 -0.844 . . . . 0.0 110.989 -179.976 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 39' ' ' ILE . . . . . . . . . . . . . 70.7 mt -123.43 136.99 58.22 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.218 0 N-CA-C 110.041 -0.355 . . . . 0.0 110.041 179.478 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 40' ' ' SER . . . . . . . . . . . . . 13.4 p -92.83 121.68 34.45 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.344 -0.389 . . . . 0.0 110.961 176.406 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 41' ' ' ILE . . . . . 0.413 HG22 HD13 ' A' ' 42' ' ' LEU . 70.6 mt -129.42 114.1 30.19 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.218 0 N-CA-C 109.756 -0.461 . . . . 0.0 109.756 177.136 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 42' ' ' LEU . . . . . 0.413 HD13 HG22 ' A' ' 41' ' ' ILE . 8.6 mp 57.22 35.29 25.98 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-O 120.954 0.407 . . . . 0.0 111.337 -178.973 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . 77.79 -10.13 26.77 Favored Glycine 0 CA--C 1.536 1.359 0 C-N-CA 121.275 -0.488 . . . . 0.0 113.414 178.218 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 44' ' ' LYS . . . . . . . . . . . . . 25.5 ttpt -91.77 129.97 37.64 Favored 'General case' 0 C--N 1.331 -0.226 0 CA-C-N 117.915 0.858 . . . . 0.0 109.811 176.693 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 84.4 tt0 -84.05 125.97 32.61 Favored 'General case' 0 C--N 1.327 -0.392 0 C-N-CA 120.874 -0.33 . . . . 0.0 110.805 -179.731 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 46' ' ' VAL . . . . . . . . . . . . . 7.5 p -119.4 129.25 75.52 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.187 0 N-CA-C 109.553 -0.536 . . . . 0.0 109.553 176.147 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 59.0 mtpt -100.34 126.39 46.68 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 115.704 -0.68 . . . . 0.0 111.059 179.238 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 48' ' ' PHE . . . . . . . . . . . . . 94.0 m-85 -111.33 131.9 54.81 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.198 -0.456 . . . . 0.0 109.918 176.361 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 78.4 tttt -107.28 135.61 48.5 Favored 'General case' 0 C--N 1.329 -0.322 0 N-CA-C 110.155 -0.313 . . . . 0.0 110.155 178.265 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 50' ' ' VAL . . . . . . . . . . . . . 45.0 t -79.7 109.56 14.41 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.285 0 N-CA-C 109.333 -0.617 . . . . 0.0 109.333 177.047 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 51' ' ' VAL . . . . . . . . . . . . . 49.1 t -72.4 -52.37 24.18 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.321 0 CA-C-N 115.993 -0.548 . . . . 0.0 109.626 -174.885 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 52' ' ' GLN . . . . . . . . . . . . . 90.8 mt-30 -153.42 150.27 28.64 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.061 -0.518 . . . . 0.0 111.769 -177.821 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -130.16 132.81 46.22 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 115.208 -0.905 . . . . 0.0 109.611 174.725 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 54' ' ' TYR . . . . . . . . . . . . . 37.4 t80 -129.07 113.02 18.53 Favored Pre-proline 0 CA--C 1.535 0.392 0 CA-C-O 118.144 -0.931 . . . . 0.0 110.496 179.092 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 55' ' ' PRO . . . . . . . . . . . . . 74.4 Cg_endo -77.11 167.37 79.96 Favored 'Cis proline' 0 N--CA 1.5 1.854 0 CA-C-N 121.97 1.739 . . . . 0.0 112.475 -6.872 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 56' ' ' SER . . . . . . . . . . . . . 13.6 m -116.09 127.02 27.09 Favored Pre-proline 0 CA--C 1.538 0.502 0 CA-C-O 118.427 -0.797 . . . . 0.0 109.239 175.859 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 57' ' ' PRO . . . . . . . . . . . . . 46.7 Cg_endo -69.7 148.65 87.03 Favored 'Cis proline' 0 N--CA 1.498 1.741 0 CA-C-N 122.067 1.774 . . . . 0.0 111.862 0.497 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 58' ' ' LEU . . . . . . . . . . . . . 23.2 tp -107.52 137.18 46.02 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.014 -0.539 . . . . 0.0 110.742 -178.898 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 59' ' ' ARG . . . . . . . . . . . . . 56.9 ttp180 -104.04 120.12 40.39 Favored 'General case' 0 C--N 1.327 -0.383 0 N-CA-C 109.205 -0.665 . . . . 0.0 109.205 174.513 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 40.3 t -81.37 122.35 36.28 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.232 0 C-N-CA 120.626 -0.429 . . . . 0.0 110.74 -173.453 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 91.1 mt-10 -131.07 164.15 26.06 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 115.96 -0.564 . . . . 0.0 109.675 176.567 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 62' ' ' ASP . . . . . . . . . . . . . 44.5 m-20 -53.04 -32.8 48.79 Favored 'General case' 0 C--N 1.328 -0.347 0 N-CA-C 111.852 0.316 . . . . 0.0 111.852 -179.739 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 63' ' ' ARG . . . . . . . . . . . . . 68.4 mtp180 -72.47 -21.79 61.16 Favored 'General case' 0 CA--C 1.534 0.335 0 N-CA-C 112.907 0.706 . . . . 0.0 112.907 -176.354 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 31.1 m -68.77 140.14 55.32 Favored 'General case' 0 C--N 1.331 -0.2 0 CA-C-O 120.86 0.362 . . . . 0.0 111.057 -175.675 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 65' ' ' LYS . . . . . . . . . . . . . 50.3 mtmt -89.5 134.24 34.2 Favored 'General case' 0 C--N 1.331 -0.23 0 CA-C-N 116.11 -0.496 . . . . 0.0 110.444 178.316 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 66' ' ' ILE . . . . . . . . . . . . . 61.0 mt -118.27 132.59 67.67 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.254 0 N-CA-C 109.98 -0.378 . . . . 0.0 109.98 179.917 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 67' ' ' THR . . . . . . . . . . . . . 20.5 m -124.18 136.81 54.46 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-O 121.028 0.442 . . . . 0.0 110.918 -179.362 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 68' ' ' LEU . . . . . . . . . . . . . 30.6 mt . . . . . 0 C--N 1.329 -0.294 0 CA-C-N 115.881 -0.599 . . . . 0.0 110.431 177.498 . . . . . . . . 0 0 . 1 . 003 nuclear nobuild core ' A' A ' 74' ' ' ASP . . . . . 0.509 ' OD1' HD11 ' A' ' 76' ' ' LEU . 4.9 t70 . . . . . 0 C--O 1.231 0.099 0 N-CA-C 110.275 -0.269 . . . . 0.0 110.275 . . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 42.8 t -117.8 123.65 71.98 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.26 0 CA-C-O 120.931 0.396 . . . . 0.0 110.646 -177.937 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 76' ' ' LEU . . . . . 0.509 HD11 ' OD1' ' A' ' 74' ' ' ASP . 5.8 mp -121.81 148.48 44.63 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 115.848 -0.615 . . . . 0.0 109.679 175.537 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 77' ' ' GLU . . . . . . . . . . . . . 96.6 mt-10 -137.68 134.93 35.99 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-O 120.991 0.424 . . . . 0.0 111.354 -178.308 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 78' ' ' ALA . . . . . . . . . . . . . . . -119.95 135.44 54.9 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 115.718 -0.674 . . . . 0.0 109.679 176.266 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 79' ' ' LYS . . . . . 0.612 ' O ' HD13 ' A' ' 80' ' ' ILE . 62.0 mttp -84.78 115.56 22.79 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-O 120.816 0.341 . . . . 0.0 111.078 -176.578 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 80' ' ' ILE . . . . . 0.612 HD13 ' O ' ' A' ' 79' ' ' LYS . 39.6 mm -139.3 108.56 3.71 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.27 0 N-CA-C 109.301 -0.629 . . . . 0.0 109.301 -178.082 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 81' ' ' LYS . . . . . . . . . . . . . 63.6 mttp -94.53 126.25 39.69 Favored 'General case' 0 C--N 1.33 -0.249 0 C-N-CA 120.629 -0.428 . . . . 0.0 111.175 -179.734 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . 89.08 42.1 5.7 Favored Glycine 0 CA--C 1.527 0.821 0 C-N-CA 120.679 -0.772 . . . . 0.0 112.119 173.798 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 83' ' ' ILE . . . . . . . . . . . . . 72.9 mt -68.84 137.91 23.42 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.291 0 N-CA-C 109.597 -0.52 . . . . 0.0 109.597 176.19 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 84' ' ' LYS . . . . . . . . . . . . . 14.2 ttmm -93.08 -54.05 3.88 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-O 121.104 0.478 . . . . 0.0 110.216 -178.029 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 85' ' ' ASP . . . . . . . . . . . . . 13.1 t70 -151.22 151.41 31.83 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 115.611 -0.722 . . . . 0.0 110.55 -178.725 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 86' ' ' VAL . . . . . . . . . . . . . 44.1 t -128.58 129.43 68.72 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.255 0 CA-C-O 121.016 0.436 . . . . 0.0 110.083 178.914 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 87' ' ' ILE . . . . . 0.493 HD12 ' N ' ' A' ' 87' ' ' ILE . 5.1 mp -119.33 124.04 72.31 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.207 0 N-CA-C 109.229 -0.656 . . . . 0.0 109.229 178.22 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 88' ' ' LEU . . . . . . . . . . . . . 15.9 tp -113.79 126.74 55.54 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-O 121.077 0.465 . . . . 0.0 111.259 -175.758 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 89' ' ' ASP . . . . . . . . . . . . . 13.0 t70 -121.87 152.45 39.57 Favored 'General case' 0 C--N 1.331 -0.223 0 N-CA-C 109.232 -0.655 . . . . 0.0 109.232 174.994 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 44.4 mt-10 -49.83 -35.18 22.08 Favored 'General case' 0 C--N 1.328 -0.348 0 N-CA-C 112.812 0.671 . . . . 0.0 112.812 -172.179 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 91' ' ' ASN . . . . . . . . . . . . . 87.9 m-20 -126.87 26.77 6.11 Favored 'General case' 0 N--CA 1.467 0.391 0 N-CA-C 112.596 0.591 . . . . 0.0 112.596 -175.272 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 92' ' ' LEU . . . . . . . . . . . . . 7.2 tp -166.2 141.39 4.61 Favored 'General case' 0 C--N 1.33 -0.239 0 CA-C-O 120.728 0.299 . . . . 0.0 110.387 178.233 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 93' ' ' ILE . . . . . . . . . . . . . 68.1 mt -120.61 122.4 67.9 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.267 0 N-CA-C 109.407 -0.59 . . . . 0.0 109.407 179.327 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 94' ' ' VAL . . . . . . . . . . . . . 48.0 t -120.92 125.81 74.47 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.267 0 CA-C-O 120.981 0.419 . . . . 0.0 109.993 -179.864 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 95' ' ' VAL . . . . . . . . . . . . . 44.9 t -119.81 132.25 70.04 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.249 0 CA-C-N 115.867 -0.606 . . . . 0.0 109.543 178.872 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 96' ' ' ILE . . . . . . . . . . . . . 63.3 mt -114.0 125.56 71.31 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.293 0 N-CA-C 109.077 -0.712 . . . . 0.0 109.077 179.069 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 97' ' ' THR . . . . . . . . . . . . . 80.3 p -97.66 156.46 16.53 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-O 121.011 0.434 . . . . 0.0 110.864 -177.78 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 98' ' ' GLU . . . . . . . . . . . . . 84.4 tt0 -53.88 -24.32 15.61 Favored 'General case' 0 CA--C 1.534 0.343 0 N-CA-C 112.163 0.431 . . . . 0.0 112.163 179.348 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 99' ' ' GLU . . . . . . . . . . . . . 96.0 mt-10 -76.4 11.69 1.49 Allowed 'General case' 0 CA--C 1.537 0.451 0 N-CA-C 113.227 0.825 . . . . 0.0 113.227 -178.597 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 100' ' ' ASN . . . . . . . . . . . . . 2.1 m-20 63.2 37.16 11.45 Favored 'General case' 0 CA--C 1.53 0.203 0 CA-C-O 121.005 0.431 . . . . 0.0 111.093 178.601 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 101' ' ' GLU . . . . . . . . . . . . . 68.5 tt0 -117.08 145.41 43.76 Favored 'General case' 0 C--N 1.332 -0.173 0 N-CA-C 109.386 -0.598 . . . . 0.0 109.386 175.654 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 102' ' ' VAL . . . . . . . . . . . . . 43.6 t -117.19 126.2 74.38 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.249 0 N-CA-C 109.869 -0.419 . . . . 0.0 109.869 -178.308 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 103' ' ' LEU . . . . . . . . . . . . . 28.7 mt -115.68 130.53 56.89 Favored 'General case' 0 C--N 1.331 -0.225 0 CA-C-N 115.552 -0.749 . . . . 0.0 110.157 176.409 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 104' ' ' ILE . . . . . 0.418 HD13 HG11 ' A' ' 130' ' ' VAL . 67.2 mt -116.78 120.45 65.08 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.294 0 N-CA-C 109.972 -0.381 . . . . 0.0 109.972 179.606 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 105' ' ' PHE . . . . . . . . . . . . . 66.3 m-85 -120.03 166.34 13.51 Favored 'General case' 0 C--N 1.333 -0.143 0 CA-C-N 115.323 -0.853 . . . . 0.0 109.622 179.754 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 106' ' ' ASN . . . . . . . . . . . . . 51.9 p-10 -101.49 -170.96 1.9 Allowed 'General case' 0 C--N 1.33 -0.257 0 N-CA-C 109.976 -0.379 . . . . 0.0 109.976 174.159 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 107' ' ' GLN . . . . . . . . . . . . . 50.4 tt0 -59.6 -28.02 66.81 Favored 'General case' 0 CA--C 1.533 0.301 0 N-CA-C 112.131 0.419 . . . . 0.0 112.131 179.997 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 108' ' ' ASN . . . . . . . . . . . . . 6.0 t-20 -85.22 13.37 6.46 Favored 'General case' 0 CA--C 1.536 0.418 0 N-CA-C 112.81 0.671 . . . . 0.0 112.81 -178.891 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 109' ' ' LEU . . . . . . . . . . . . . 7.1 tp 54.64 37.03 27.42 Favored 'General case' 0 CA--C 1.529 0.161 0 CA-C-O 120.935 0.398 . . . . 0.0 111.385 179.212 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 110' ' ' GLU . . . . . . . . . . . . . 95.6 mt-10 -104.33 148.6 26.2 Favored 'General case' 0 C--N 1.331 -0.216 0 N-CA-C 109.742 -0.466 . . . . 0.0 109.742 175.717 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 111' ' ' GLU . . . . . . . . . . . . . 61.3 tt0 -85.06 121.86 28.45 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-O 120.798 0.332 . . . . 0.0 110.611 -176.434 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 112' ' ' LEU . . . . . . . . . . . . . 15.0 mt -107.48 -46.13 3.91 Favored 'General case' 0 C--N 1.331 -0.225 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.699 179.886 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 113' ' ' TYR . . . . . . . . . . . . . 57.5 t80 -133.05 139.28 47.1 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.399 -0.364 . . . . 0.0 110.802 -178.101 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 114' ' ' ARG . . . . . . . . . . . . . 26.4 ptt180 -141.36 123.07 15.21 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.769 -179.923 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 115' ' ' GLY . . . . . . . . . . . . . . . -150.13 158.81 27.84 Favored Glycine 0 CA--C 1.522 0.471 0 N-CA-C 110.931 -0.868 . . . . 0.0 110.931 179.892 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 116' ' ' LYS . . . . . . . . . . . . . 33.0 ttmt -131.44 135.85 47.48 Favored 'General case' 0 C--N 1.327 -0.379 0 N-CA-C 109.868 -0.419 . . . . 0.0 109.868 177.464 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 117' ' ' PHE . . . . . . . . . . . . . 25.2 m-85 -137.91 113.86 9.9 Favored 'General case' 0 C--N 1.329 -0.319 0 N-CA-C 109.8 -0.444 . . . . 0.0 109.8 -175.805 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 118' ' ' GLU . . . . . . . . . . . . . 84.7 tt0 -56.31 -40.5 74.47 Favored 'General case' 0 C--N 1.33 -0.272 0 C-N-CA 120.787 -0.365 . . . . 0.0 110.959 -177.362 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 119' ' ' ASN . . . . . . . . . . . . . 5.4 m120 -97.5 30.62 2.82 Favored 'General case' 0 C--N 1.33 -0.263 0 N-CA-C 112.251 0.463 . . . . 0.0 112.251 -175.034 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 120' ' ' LEU . . . . . . . . . . . . . 23.9 tp -59.21 120.26 8.89 Favored 'General case' 0 C--N 1.332 -0.167 0 N-CA-C 109.859 -0.422 . . . . 0.0 109.859 176.545 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 121' ' ' ASN . . . . . . . . . . . . . 31.8 m120 -113.49 -44.18 3.24 Favored 'General case' 0 C--N 1.331 -0.223 0 CA-C-N 116.609 -0.268 . . . . 0.0 111.032 -177.162 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 122' ' ' LYS . . . . . . . . . . . . . 60.6 mtpt -143.52 144.42 31.96 Favored 'General case' 0 C--N 1.331 -0.22 0 CA-C-O 121.015 0.435 . . . . 0.0 111.383 -178.46 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 123' ' ' VAL . . . . . . . . . . . . . 47.7 t -128.9 127.53 66.35 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.297 0 N-CA-C 109.298 -0.63 . . . . 0.0 109.298 174.897 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 124' ' ' LEU . . . . . . . . . . . . . 51.8 mt -126.23 132.58 51.71 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-O 120.791 0.329 . . . . 0.0 110.654 -178.636 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 125' ' ' VAL . . . . . . . . . . . . . 11.6 p -134.45 136.0 53.3 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.34 0 CA-C-N 116.111 -0.495 . . . . 0.0 110.375 179.32 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 126' ' ' ARG . . . . . . . . . . . . . 76.2 mtt180 -143.91 127.79 17.35 Favored 'General case' 0 C--N 1.327 -0.395 0 CA-C-N 115.846 -0.615 . . . . 0.0 109.365 178.158 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 127' ' ' ASN . . . . . . . . . . . . . 79.9 m-20 56.83 -134.72 1.24 Allowed 'General case' 0 CA--C 1.544 0.743 0 CA-C-O 118.679 -0.677 . . . . 0.0 109.65 -178.285 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 128' ' ' ASP . . . . . . . . . . . . . 8.4 p-10 -99.06 15.81 24.64 Favored 'General case' 0 CA--C 1.535 0.389 0 CA-C-N 119.923 1.238 . . . . 0.0 113.057 178.641 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 129' ' ' LEU . . . . . 0.512 HD12 ' N ' ' A' ' 129' ' ' LEU . 7.0 mp -114.27 141.23 47.84 Favored 'General case' 0 N--CA 1.463 0.224 0 N-CA-C 109.874 -0.417 . . . . 0.0 109.874 178.346 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 130' ' ' VAL . . . . . 0.479 HG13 ' HB ' ' A' ' 141' ' ' ILE . 14.6 p -140.06 146.47 24.81 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.234 0 CA-C-O 121.312 0.577 . . . . 0.0 111.682 -176.432 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 131' ' ' VAL . . . . . 0.463 HG22 HD12 ' A' ' 140' ' ' LEU . 44.2 t -136.02 139.52 45.7 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.264 0 CA-C-N 115.712 -0.677 . . . . 0.0 110.196 177.105 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 132' ' ' ILE . . . . . . . . . . . . . 70.9 mt -115.58 132.68 64.25 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.335 0 CA-C-N 115.998 -0.547 . . . . 0.0 109.673 -179.82 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 133' ' ' ILE . . . . . . . . . . . . . 41.1 mm -116.94 123.43 71.79 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.241 0 CA-C-O 120.781 0.324 . . . . 0.0 111.078 -175.127 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 134' ' ' ASP . . . . . . . . . . . . . 10.3 p-10 -136.61 149.4 48.0 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-N 116.227 -0.442 . . . . 0.0 109.981 175.255 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 135' ' ' GLU . . . . . . . . . . . . . 41.8 tp10 -49.95 -28.36 6.66 Favored 'General case' 0 C--N 1.327 -0.385 0 N-CA-C 112.673 0.62 . . . . 0.0 112.673 -171.986 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 136' ' ' GLN . . . . . . . . . . . . . 97.6 mt-30 -83.47 -34.96 25.27 Favored 'General case' 0 C--O 1.234 0.242 0 N-CA-C 112.707 0.632 . . . . 0.0 112.707 -175.96 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 137' ' ' LYS . . . . . . . . . . . . . 56.3 pttt -164.08 174.51 11.24 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-O 121.6 0.714 . . . . 0.0 112.529 -171.055 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 138' ' ' LEU . . . . . 0.409 ' C ' HD23 ' A' ' 138' ' ' LEU . 6.9 tt -121.33 128.43 52.28 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 114.889 -1.05 . . . . 0.0 109.881 177.716 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 139' ' ' THR . . . . . . . . . . . . . 47.0 m -109.26 127.98 54.7 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-N 116.117 -0.492 . . . . 0.0 109.882 178.282 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 140' ' ' LEU . . . . . 0.463 HD12 HG22 ' A' ' 131' ' ' VAL . 6.9 tp -114.56 121.36 43.24 Favored 'General case' 0 C--N 1.327 -0.395 0 CA-C-N 115.983 -0.553 . . . . 0.0 109.608 -176.574 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 141' ' ' ILE . . . . . 0.479 ' HB ' HG13 ' A' ' 130' ' ' VAL . 18.9 mt -121.75 118.49 55.91 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.245 0 N-CA-C 109.885 -0.413 . . . . 0.0 109.885 -175.817 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 142' ' ' ARG . . . . . . . . . . . . . 34.4 mmt180 -116.21 134.81 54.51 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 115.557 -0.747 . . . . 0.0 110.054 -178.248 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 143' ' ' THR . . . . . . . . . . . . . 48.8 p . . . . . 0 C--O 1.221 -0.444 0 CA-C-O 118.041 -0.98 . . . . 0.0 110.775 179.363 . . . . . . . . 0 0 . 1 . 003 nuclear nobuild core ' B' B ' 2' ' ' SER . . . . . . . . . . . . . 96.8 p . . . . . 0 C--O 1.231 0.119 0 CA-C-O 121.003 0.43 . . . . 0.0 110.627 . . . . . . . . . 0 0 . 1 . 003 nuclear nobuild core ' B' B ' 3' ' ' GLU . . . . . . . . . . . . . 95.3 mt-10 -139.4 141.27 37.54 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 115.879 -0.6 . . . . 0.0 110.804 -179.223 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B ' 4' ' ' LEU . . . . . . . . . . . . . 5.2 tt -126.14 128.01 46.64 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.131 -0.486 . . . . 0.0 109.803 177.342 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B ' 5' ' ' LYS . . . . . . . . . . . . . 92.5 mttt -110.19 122.28 47.27 Favored 'General case' 0 C--O 1.235 0.315 0 CA-C-O 120.873 0.368 . . . . 0.0 111.034 -178.313 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B ' 6' ' ' LEU . . . . . . . . . . . . . 48.9 mt -114.02 148.42 37.02 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 115.296 -0.866 . . . . 0.0 110.536 -179.5 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B ' 7' ' ' LYS . . . . . . . . . . . . . 35.8 ttpt -134.63 139.5 32.7 Favored Pre-proline 0 CA--C 1.534 0.356 0 CA-C-O 119.023 -0.513 . . . . 0.0 110.022 175.683 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B ' 8' ' ' PRO . . . . . . . . . . . . . 84.9 Cg_endo -91.76 141.72 2.62 Favored 'Trans proline' 0 N--CA 1.489 1.257 0 C-N-CA 121.754 1.636 . . . . 0.0 111.61 177.731 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B ' 9' ' ' LEU . . . . . . . . . . . . . 24.1 mt -79.35 -47.62 1.56 Allowed Pre-proline 0 CA--C 1.534 0.343 0 CA-C-O 118.696 -0.669 . . . . 0.0 112.203 -178.397 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B ' 10' ' ' PRO . . . . . . . . . . . . . 89.6 Cg_endo -81.22 155.53 19.37 Favored 'Trans proline' 0 N--CA 1.495 1.581 0 C-N-CA 121.213 1.275 . . . . 0.0 111.95 176.059 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B ' 11' ' ' LYS . . . . . . . . . . . . . 85.5 tttt -83.71 96.02 8.58 Favored 'General case' 0 C--N 1.33 -0.282 0 C-N-CA 120.832 -0.347 . . . . 0.0 110.099 177.465 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B ' 12' ' ' VAL . . . . . . . . . . . . . 12.1 p -136.28 145.64 30.39 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.276 0 CA-C-N 116.1 -0.5 . . . . 0.0 110.411 -178.64 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B ' 13' ' ' GLU . . . . . . . . . . . . . 81.9 tt0 -91.72 126.32 36.76 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.152 -0.476 . . . . 0.0 110.109 178.562 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B ' 14' ' ' LEU . . . . . . . . . . . . . 27.5 mt -98.1 145.25 29.47 Favored Pre-proline 0 CA--C 1.532 0.281 0 CA-C-O 119.167 -0.444 . . . . 0.0 110.365 -177.932 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B ' 15' ' ' PRO . . . . . . . . . . . . . 24.0 Cg_exo -63.71 160.0 38.68 Favored 'Trans proline' 0 N--CA 1.497 1.695 0 C-N-CA 121.331 1.354 . . . . 0.0 111.694 176.144 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B ' 16' ' ' PRO . . . . . . . . . . . . . 37.5 Cg_exo -59.22 -31.6 95.53 Favored 'Trans proline' 0 N--CA 1.495 1.613 0 C-N-CA 121.474 1.45 . . . . 0.0 112.737 -179.747 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B ' 17' ' ' ASP . . . . . . . . . . . . . 10.0 p-10 -88.1 3.97 47.11 Favored 'General case' 0 CA--C 1.536 0.404 0 N-CA-C 113.319 0.859 . . . . 0.0 113.319 -177.323 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B ' 18' ' ' PHE . . . . . . . . . . . . . 39.2 t80 -58.26 -47.03 84.86 Favored 'General case' 0 C--N 1.334 -0.107 0 O-C-N 121.931 -0.481 . . . . 0.0 110.121 -177.64 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B ' 19' ' ' VAL . . . . . . . . . . . . . 47.3 t -56.6 -40.83 71.5 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 CA-C-N 116.249 -0.432 . . . . 0.0 110.54 -178.236 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B ' 20' ' ' ASP . . . . . . . . . . . . . 74.3 m-20 -59.63 -44.79 93.35 Favored 'General case' 0 C--N 1.33 -0.269 0 C-N-CA 120.919 -0.312 . . . . 0.0 110.797 -177.398 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B ' 21' ' ' VAL . . . . . . . . . . . . . 46.9 t -64.69 -45.48 95.14 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.255 0 C-N-CA 120.702 -0.399 . . . . 0.0 110.522 -177.61 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B ' 22' ' ' ILE . . . . . 0.588 HG22 HD12 ' B' ' 26' ' ' LEU . 50.7 mm -58.71 -40.59 79.96 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.299 0 C-N-CA 120.98 -0.288 . . . . 0.0 110.826 -179.803 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' B' B ' 23' ' ' ARG . . . . . . . . . . . . . 52.2 ttp180 -56.73 -47.07 80.82 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-O 120.891 0.377 . . . . 0.0 110.515 178.713 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B ' 24' ' ' ILE . . . . . . . . . . . . . 77.3 mt -60.87 -44.8 98.51 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.261 0 CA-C-N 115.979 -0.555 . . . . 0.0 111.822 -178.852 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B ' 25' ' ' LYS . . . . . . . . . . . . . 12.5 pttp -71.69 -36.56 70.63 Favored 'General case' 0 CA--C 1.533 0.309 0 C-N-CA 120.372 -0.531 . . . . 0.0 111.851 -173.042 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B ' 26' ' ' LEU . . . . . 0.588 HD12 HG22 ' B' ' 22' ' ' ILE . 24.8 mt -78.94 -42.68 26.33 Favored 'General case' 0 C--N 1.331 -0.228 0 N-CA-C 113.186 0.81 . . . . 0.0 113.186 -173.435 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' B' B ' 27' ' ' GLN . . . . . . . . . . . . . 11.2 pt20 -47.17 138.24 7.16 Favored 'General case' 0 N--CA 1.47 0.553 0 N-CA-C 112.696 0.628 . . . . 0.0 112.696 -175.356 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B ' 28' ' ' GLY . . . . . . . . . . . . . . . 101.5 -25.95 26.26 Favored Glycine 0 CA--C 1.532 1.122 0 CA-C-N 115.669 -0.696 . . . . 0.0 112.295 -176.391 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B ' 29' ' ' LYS . . . . . . . . . . . . . 63.8 mttp -98.14 155.15 17.28 Favored 'General case' 0 C--O 1.232 0.175 0 CA-C-N 117.5 0.65 . . . . 0.0 111.256 178.219 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B ' 30' ' ' THR . . . . . . . . . . . . . 41.3 m -100.49 136.23 40.68 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.015 -0.539 . . . . 0.0 109.83 175.157 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B ' 31' ' ' VAL . . . . . . . . . . . . . 35.2 m -125.78 153.72 33.98 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.314 0 CA-C-O 120.902 0.382 . . . . 0.0 110.622 -178.738 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B ' 32' ' ' ARG . . . . . . . . . . . . . 34.2 ttp180 -132.39 147.55 52.39 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 115.897 -0.592 . . . . 0.0 110.242 178.118 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B ' 33' ' ' THR . . . . . . . . . . . . . 17.0 m -53.42 139.37 30.8 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.394 -0.366 . . . . 0.0 111.355 -178.342 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B ' 34' ' ' GLY . . . . . . . . . . . . . . . 101.1 -17.18 56.42 Favored Glycine 0 CA--C 1.534 1.219 0 CA-C-O 119.69 -0.505 . . . . 0.0 113.274 179.842 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B ' 35' ' ' ASP . . . . . . . . . . . . . 70.5 m-20 -64.46 149.34 48.71 Favored 'General case' 0 C--O 1.232 0.148 0 CA-C-N 118.017 0.908 . . . . 0.0 111.478 179.506 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B ' 36' ' ' VAL . . . . . . . . . . . . . 44.9 t -121.4 130.25 74.82 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.216 0 CA-C-N 115.752 -0.658 . . . . 0.0 109.791 178.148 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B ' 37' ' ' ILE . . . . . . . . . . . . . 69.7 mt -121.7 139.59 48.3 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.267 0 CA-C-N 116.294 -0.412 . . . . 0.0 110.095 -179.548 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B ' 38' ' ' GLY . . . . . . . . . . . . . . . -111.52 128.85 8.85 Favored Glycine 0 CA--C 1.525 0.712 0 N-CA-C 111.017 -0.833 . . . . 0.0 111.017 179.634 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B ' 39' ' ' ILE . . . . . . . . . . . . . 73.9 mt -123.3 137.12 57.71 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.201 0 N-CA-C 110.072 -0.344 . . . . 0.0 110.072 179.521 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B ' 40' ' ' SER . . . . . . . . . . . . . 59.6 p -91.78 115.91 28.45 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.559 -0.291 . . . . 0.0 111.117 177.612 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B ' 41' ' ' ILE . . . . . . . . . . . . . 44.7 mm -121.39 114.2 42.27 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.231 0 N-CA-C 109.772 -0.455 . . . . 0.0 109.772 178.159 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B ' 42' ' ' LEU . . . . . . . . . . . . . 6.4 mp 56.9 35.5 26.44 Favored 'General case' 0 CA--C 1.532 0.26 0 CA-C-O 120.973 0.416 . . . . 0.0 111.342 -179.378 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B ' 43' ' ' GLY . . . . . . . . . . . . . . . 77.91 -10.06 27.93 Favored Glycine 0 CA--C 1.534 1.276 0 C-N-CA 121.249 -0.5 . . . . 0.0 113.472 177.725 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B ' 44' ' ' LYS . . . . . . . . . . . . . 61.1 tttm -96.32 134.33 39.6 Favored 'General case' 0 C--N 1.331 -0.197 0 CA-C-N 117.901 0.851 . . . . 0.0 109.819 176.651 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B ' 45' ' ' GLU . . . . . . . . . . . . . 82.9 tt0 -83.5 127.94 34.11 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-O 120.867 0.365 . . . . 0.0 111.084 -177.863 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B ' 46' ' ' VAL . . . . . . . . . . . . . 7.3 p -120.53 130.07 74.89 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.265 0 N-CA-C 109.315 -0.624 . . . . 0.0 109.315 175.541 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B ' 47' ' ' LYS . . . . . . . . . . . . . 79.8 mttt -100.4 128.64 46.41 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.076 -0.511 . . . . 0.0 111.366 179.317 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B ' 48' ' ' PHE . . . . . . . . . . . . . 92.1 m-85 -112.89 131.91 55.53 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 115.88 -0.6 . . . . 0.0 109.78 176.705 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B ' 49' ' ' LYS . . . . . . . . . . . . . 66.8 tttt -107.19 137.45 45.22 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.48 -0.327 . . . . 0.0 110.64 179.68 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B ' 50' ' ' VAL . . . . . . . . . . . . . 45.0 t -80.71 107.22 12.82 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.241 0 N-CA-C 109.17 -0.678 . . . . 0.0 109.17 175.613 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B ' 51' ' ' VAL . . . . . . . . . . . . . 49.4 t -71.47 -54.14 18.29 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.292 0 N-CA-C 109.493 -0.558 . . . . 0.0 109.493 -174.516 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B ' 52' ' ' GLN . . . . . . . . . . . . . 90.8 mt-30 -154.7 154.07 32.31 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 115.93 -0.577 . . . . 0.0 112.097 -176.74 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B ' 53' ' ' ALA . . . . . 0.518 ' HB3' ' OG ' ' B' ' 56' ' ' SER . . . -132.6 134.37 44.83 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 115.191 -0.913 . . . . 0.0 109.784 174.421 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' B' B ' 54' ' ' TYR . . . . . . . . . . . . . 58.6 t80 -129.21 111.31 18.16 Favored Pre-proline 0 CA--C 1.533 0.309 0 CA-C-O 118.147 -0.93 . . . . 0.0 110.344 178.007 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B ' 55' ' ' PRO . . . . . . . . . . . . . 74.4 Cg_endo -77.14 170.15 72.34 Favored 'Cis proline' 0 N--CA 1.5 1.907 0 CA-C-N 121.996 1.749 . . . . 0.0 111.957 -6.859 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B ' 56' ' ' SER . . . . . 0.518 ' OG ' ' HB3' ' B' ' 53' ' ' ALA . 68.8 m -125.02 136.24 27.85 Favored Pre-proline 0 CA--C 1.538 0.491 0 CA-C-O 118.556 -0.735 . . . . 0.0 109.457 175.969 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' B' B ' 57' ' ' PRO . . . . . . . . . . . . . 37.2 Cg_endo -67.32 160.67 79.1 Favored 'Cis proline' 0 N--CA 1.499 1.852 0 CA-C-N 121.771 1.668 . . . . 0.0 111.689 -2.129 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B ' 58' ' ' LEU . . . . . . . . . . . . . 29.4 tp -129.27 138.07 51.42 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-O 120.993 0.425 . . . . 0.0 110.593 -178.558 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B ' 59' ' ' ARG . . . . . . . . . . . . . 57.2 ttp180 -101.02 121.22 41.39 Favored 'General case' 0 C--N 1.327 -0.38 0 N-CA-C 109.12 -0.696 . . . . 0.0 109.12 174.325 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B ' 60' ' ' VAL . . . . . . . . . . . . . 47.4 t -72.14 122.07 23.77 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.361 0 C-N-CA 120.848 -0.341 . . . . 0.0 110.365 -173.969 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B ' 61' ' ' GLU . . . . . . . . . . . . . 95.4 mt-10 -131.04 165.73 22.57 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.0 -0.546 . . . . 0.0 110.206 179.213 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B ' 62' ' ' ASP . . . . . . . . . . . . . 48.2 m-20 -55.01 -32.61 61.94 Favored 'General case' 0 C--N 1.329 -0.324 0 N-CA-C 111.766 0.284 . . . . 0.0 111.766 -179.25 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B ' 63' ' ' ARG . . . . . . . . . . . . . 32.5 ptt180 -83.35 3.36 31.95 Favored 'General case' 0 CA--C 1.538 0.487 0 N-CA-C 113.583 0.957 . . . . 0.0 113.583 -175.36 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B ' 64' ' ' THR . . . . . . . . . . . . . 40.1 m -85.01 135.29 34.08 Favored 'General case' 0 C--N 1.331 -0.217 0 CA-C-N 118.137 0.426 . . . . 0.0 110.258 -178.997 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B ' 65' ' ' LYS . . . . . . . . . . . . . 99.1 mttt -88.97 127.36 35.66 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.012 179.245 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B ' 66' ' ' ILE . . . . . . . . . . . . . 58.4 mt -112.74 129.48 68.27 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.328 0 N-CA-C 109.859 -0.422 . . . . 0.0 109.859 -178.531 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B ' 67' ' ' THR . . . . . . . . . . . . . 23.9 m -124.46 138.7 54.33 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-O 121.045 0.45 . . . . 0.0 110.801 -177.527 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B ' 68' ' ' LEU . . . . . 0.415 HD12 ' N ' ' B' ' 68' ' ' LEU . 7.6 mp . . . . . 0 C--N 1.33 -0.281 0 CA-C-N 115.972 -0.558 . . . . 0.0 110.242 177.025 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B ' 73' ' ' VAL . . . . . . . . . . . . . 33.1 m . . . . . 0 N--CA 1.461 0.097 0 CA-C-O 121.018 0.437 . . . . 0.0 110.983 . . . . . . . . . 0 0 . 1 . 003 nuclear nobuild core ' B' B ' 74' ' ' ASP . . . . . . . . . . . . . 4.8 t0 -98.93 125.59 44.39 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 115.828 -0.623 . . . . 0.0 110.101 -179.601 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B ' 75' ' ' VAL . . . . . . . . . . . . . 42.9 t -119.14 123.35 71.23 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.286 0 CA-C-O 121.084 0.468 . . . . 0.0 110.509 -179.402 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B ' 76' ' ' LEU . . . . . . . . . . . . . 6.6 mp -120.39 148.38 43.84 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-N 115.691 -0.686 . . . . 0.0 109.741 176.043 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B ' 77' ' ' GLU . . . . . . . . . . . . . 98.5 mt-10 -137.86 138.3 38.97 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-O 121.015 0.436 . . . . 0.0 111.577 -179.024 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B ' 78' ' ' ALA . . . . . 0.613 ' HB2' HD21 ' B' ' 109' ' ' LEU . . . -130.47 134.29 46.97 Favored 'General case' 0 C--N 1.331 -0.227 0 CA-C-N 115.755 -0.657 . . . . 0.0 109.728 175.541 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' B' B ' 79' ' ' LYS . . . . . 0.603 ' O ' HD13 ' B' ' 80' ' ' ILE . 30.0 ttmt -81.2 119.53 23.72 Favored 'General case' 0 C--N 1.331 -0.204 0 CA-C-O 120.925 0.393 . . . . 0.0 110.603 -179.38 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' B' B ' 80' ' ' ILE . . . . . 0.603 HD13 ' O ' ' B' ' 79' ' ' LYS . 41.7 mm -139.15 108.43 3.77 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.367 0 N-CA-C 109.201 -0.666 . . . . 0.0 109.201 -177.439 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' B' B ' 81' ' ' LYS . . . . . . . . . . . . . 55.6 mtpt -100.49 129.16 46.4 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-O 120.941 0.4 . . . . 0.0 111.257 -176.642 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B ' 82' ' ' GLY . . . . . . . . . . . . . . . 89.16 42.11 5.67 Favored Glycine 0 CA--C 1.526 0.725 0 C-N-CA 120.956 -0.64 . . . . 0.0 111.726 174.344 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B ' 83' ' ' ILE . . . . . . . . . . . . . 68.2 mt -69.13 136.02 27.16 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.407 0 N-CA-C 109.563 -0.532 . . . . 0.0 109.563 177.625 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B ' 84' ' ' LYS . . . . . . . . . . . . . 25.2 ttpp -100.5 -51.66 3.56 Favored 'General case' 0 C--N 1.332 -0.195 0 CA-C-O 121.002 0.429 . . . . 0.0 110.082 179.938 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B ' 85' ' ' ASP . . . . . . . . . . . . . 13.4 t70 -149.16 147.16 28.11 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 115.812 -0.631 . . . . 0.0 110.358 179.754 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B ' 86' ' ' VAL . . . . . . . . . . . . . 42.7 t -129.34 130.29 67.53 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.24 0 CA-C-O 120.969 0.414 . . . . 0.0 110.251 179.427 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B ' 87' ' ' ILE . . . . . . . . . . . . . 44.6 mm -118.25 125.04 73.99 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.28 0 CA-C-N 115.847 -0.615 . . . . 0.0 109.555 177.347 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B ' 88' ' ' LEU . . . . . . . . . . . . . 44.5 mt -116.84 135.56 53.64 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-O 121.292 0.568 . . . . 0.0 111.688 -177.025 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B ' 89' ' ' ASP . . . . . . . . . . . . . 7.3 t0 -128.58 155.96 44.1 Favored 'General case' 0 C--N 1.327 -0.403 0 CA-C-N 115.156 -0.929 . . . . 0.0 108.642 174.78 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B ' 90' ' ' GLU . . . . . . . . . . . . . 76.9 tt0 -48.67 -36.09 15.27 Favored 'General case' 0 C--N 1.329 -0.285 0 N-CA-C 112.562 0.578 . . . . 0.0 112.562 -172.749 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B ' 91' ' ' ASN . . . . . . . . . . . . . 26.3 m120 -132.07 37.23 3.6 Favored 'General case' 0 CA--C 1.531 0.248 0 N-CA-C 111.757 0.281 . . . . 0.0 111.757 -176.953 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B ' 92' ' ' LEU . . . . . 0.41 HD21 ' CG2' ' B' ' 130' ' ' VAL . 26.3 tp -166.06 139.72 4.28 Favored 'General case' 0 C--N 1.33 -0.265 0 C-N-CA 121.005 -0.278 . . . . 0.0 110.801 -179.377 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' B' B ' 93' ' ' ILE . . . . . . . . . . . . . 72.3 mt -126.39 122.48 61.31 Favored 'Isoleucine or valine' 0 N--CA 1.462 0.157 0 N-CA-C 109.648 -0.501 . . . . 0.0 109.648 178.605 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B ' 94' ' ' VAL . . . . . 0.428 HG21 HG11 ' B' ' 125' ' ' VAL . 43.8 t -124.61 126.19 71.28 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.239 0 N-CA-C 109.774 -0.454 . . . . 0.0 109.774 177.994 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' B' B ' 95' ' ' VAL . . . . . . . . . . . . . 44.6 t -120.73 133.59 66.9 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.336 0 CA-C-N 116.009 -0.541 . . . . 0.0 109.806 -179.165 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B ' 96' ' ' ILE . . . . . . . . . . . . . 61.1 mt -115.4 128.29 72.66 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.25 0 N-CA-C 109.257 -0.646 . . . . 0.0 109.257 178.788 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B ' 97' ' ' THR . . . . . . . . . . . . . 82.1 p -102.96 155.62 18.23 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-O 121.279 0.561 . . . . 0.0 111.343 -176.368 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B ' 98' ' ' GLU . . . . . . . . . . . . . 13.2 pt-20 -55.08 -17.02 3.43 Favored 'General case' 0 CA--C 1.535 0.382 0 N-CA-C 112.814 0.672 . . . . 0.0 112.814 179.277 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B ' 99' ' ' GLU . . . . . . . . . . . . . 41.7 mt-10 -85.36 16.29 3.81 Favored 'General case' 0 CA--C 1.535 0.402 0 N-CA-C 112.952 0.723 . . . . 0.0 112.952 -178.674 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B ' 100' ' ' ASN . . . . . . . . . . . . . 3.6 m-20 62.36 38.02 13.34 Favored 'General case' 0 CA--C 1.529 0.166 0 CA-C-O 121.046 0.451 . . . . 0.0 110.869 178.505 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B ' 101' ' ' GLU . . . . . . . . . . . . . 84.3 tt0 -121.26 143.63 49.05 Favored 'General case' 0 C--N 1.332 -0.187 0 CA-C-N 116.2 -0.455 . . . . 0.0 110.045 177.955 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B ' 102' ' ' VAL . . . . . . . . . . . . . 43.9 t -116.73 127.59 74.31 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.28 0 CA-C-N 116.341 -0.39 . . . . 0.0 110.102 -178.671 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B ' 103' ' ' LEU . . . . . 0.511 ' N ' HD12 ' B' ' 103' ' ' LEU . 6.2 mp -116.86 134.31 54.93 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 115.747 -0.66 . . . . 0.0 110.285 176.745 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' B' B ' 104' ' ' ILE . . . . . . . . . . . . . 71.3 mt -120.87 123.24 69.78 Favored 'Isoleucine or valine' 0 C--O 1.234 0.285 0 CA-C-N 116.612 -0.267 . . . . 0.0 110.56 -178.885 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B ' 105' ' ' PHE . . . . . . . . . . . . . 60.0 m-85 -124.98 167.24 14.99 Favored 'General case' 0 C--O 1.232 0.178 0 O-C-N 124.07 0.856 . . . . 0.0 109.736 -179.665 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B ' 106' ' ' ASN . . . . . . . . . . . . . 44.8 p-10 -104.11 -170.23 1.74 Allowed 'General case' 0 C--N 1.331 -0.237 0 N-CA-C 110.15 -0.315 . . . . 0.0 110.15 174.218 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B ' 107' ' ' GLN . . . . . . . . . . . . . 37.9 tt0 -58.64 -30.11 67.04 Favored 'General case' 0 C--N 1.33 -0.278 0 N-CA-C 112.047 0.388 . . . . 0.0 112.047 -179.603 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B ' 108' ' ' ASN . . . . . . . . . . . . . 5.4 t30 -86.02 10.6 13.74 Favored 'General case' 0 CA--C 1.536 0.43 0 N-CA-C 113.116 0.784 . . . . 0.0 113.116 -176.699 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B ' 109' ' ' LEU . . . . . 0.613 HD21 ' HB2' ' B' ' 78' ' ' ALA . 8.5 tp 59.38 37.63 23.21 Favored 'General case' 0 C--N 1.332 -0.173 0 CA-C-O 121.034 0.445 . . . . 0.0 111.315 178.69 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' B' B ' 110' ' ' GLU . . . . . . . . . . . . . 94.9 mt-10 -105.18 138.5 41.28 Favored 'General case' 0 C--N 1.329 -0.3 0 N-CA-C 109.222 -0.659 . . . . 0.0 109.222 173.718 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B ' 111' ' ' GLU . . . . . . . . . . . . . 47.8 tt0 -85.54 121.77 28.7 Favored 'General case' 0 C--N 1.329 -0.308 0 C-N-CA 120.708 -0.397 . . . . 0.0 110.249 -176.492 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B ' 112' ' ' LEU . . . . . . . . . . . . . 58.2 mt -103.06 -42.89 5.65 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.074 -0.512 . . . . 0.0 110.527 179.687 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B ' 113' ' ' TYR . . . . . . . . . . . . . 64.3 t80 -133.02 141.23 48.16 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.297 -0.411 . . . . 0.0 111.254 -177.1 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B ' 114' ' ' ARG . . . . . . . . . . . . . 36.5 ptt180 -149.27 124.09 9.91 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.092 -0.504 . . . . 0.0 110.541 177.407 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B ' 115' ' ' GLY . . . . . . . . . . . . . . . -150.02 158.9 27.87 Favored Glycine 0 CA--C 1.524 0.601 0 N-CA-C 111.254 -0.739 . . . . 0.0 111.254 179.933 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B ' 116' ' ' LYS . . . . . . . . . . . . . 34.4 ttpt -125.07 134.92 52.32 Favored 'General case' 0 C--N 1.33 -0.257 0 N-CA-C 110.02 -0.363 . . . . 0.0 110.02 178.491 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B ' 117' ' ' PHE . . . . . . . . . . . . . 51.5 m-85 -129.08 115.21 17.38 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-O 120.97 0.414 . . . . 0.0 110.155 -177.064 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B ' 118' ' ' GLU . . . . . . . . . . . . . 95.8 mt-10 -53.6 -49.79 67.03 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.387 -0.37 . . . . 0.0 111.526 -175.633 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B ' 119' ' ' ASN . . . . . . . . . . . . . 87.2 m-20 -96.7 31.13 2.4 Favored 'General case' 0 C--N 1.328 -0.342 0 N-CA-C 112.207 0.447 . . . . 0.0 112.207 -174.169 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B ' 120' ' ' LEU . . . . . . . . . . . . . 17.1 tp -53.44 121.84 8.48 Favored 'General case' 0 N--CA 1.464 0.271 0 CA-C-O 120.599 0.238 . . . . 0.0 110.88 178.062 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B ' 121' ' ' ASN . . . . . . . . . . . . . 34.4 m120 -114.07 -44.17 3.17 Favored 'General case' 0 N--CA 1.463 0.203 0 CA-C-N 116.547 -0.297 . . . . 0.0 111.213 -176.289 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B ' 122' ' ' LYS . . . . . . . . . . . . . 97.2 mttt -144.61 150.7 37.88 Favored 'General case' 0 C--N 1.331 -0.206 0 CA-C-O 120.982 0.42 . . . . 0.0 111.591 -177.386 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B ' 123' ' ' VAL . . . . . . . . . . . . . 45.9 t -130.44 127.94 63.13 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.298 0 N-CA-C 109.437 -0.579 . . . . 0.0 109.437 174.929 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B ' 124' ' ' LEU . . . . . . . . . . . . . 52.7 mt -127.35 138.09 52.94 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-O 120.871 0.367 . . . . 0.0 110.633 -178.067 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B ' 125' ' ' VAL . . . . . 0.428 HG11 HG21 ' B' ' 94' ' ' VAL . 34.7 m -135.73 140.09 45.01 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.24 0 CA-C-N 116.221 -0.445 . . . . 0.0 110.885 -179.53 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' B' B ' 126' ' ' ARG . . . . . . . . . . . . . 90.5 mtt-85 -140.69 112.12 7.36 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 115.889 -0.596 . . . . 0.0 110.199 177.117 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B ' 127' ' ' ASN . . . . . . . . . . . . . 26.2 m-20 48.96 -105.01 0.14 Allowed 'General case' 0 CA--C 1.541 0.618 0 CA-C-O 119.299 -0.381 . . . . 0.0 111.79 -179.964 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B ' 128' ' ' ASP . . . . . . . . . . . . . 13.0 p-10 -106.08 1.02 26.01 Favored 'General case' 0 CA--C 1.536 0.414 0 N-CA-C 113.692 0.997 . . . . 0.0 113.692 -174.957 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B ' 129' ' ' LEU . . . . . . . . . . . . . 14.5 tp -104.94 131.82 51.96 Favored 'General case' 0 C--N 1.332 -0.188 0 CA-C-N 118.125 0.421 . . . . 0.0 109.996 178.479 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B ' 130' ' ' VAL . . . . . 0.41 ' CG2' HD21 ' B' ' 92' ' ' LEU . 46.8 t -118.95 132.97 67.3 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.252 0 N-CA-C 109.828 -0.434 . . . . 0.0 109.828 -179.618 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' B' B ' 131' ' ' VAL . . . . . . . . . . . . . 42.1 t -134.96 134.37 53.44 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.196 0 CA-C-O 121.042 0.449 . . . . 0.0 110.416 179.396 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B ' 132' ' ' ILE . . . . . . . . . . . . . 74.0 mt -117.25 133.78 62.91 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 CA-C-N 115.773 -0.649 . . . . 0.0 109.294 -179.799 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B ' 133' ' ' ILE . . . . . . . . . . . . . 43.0 mm -117.62 123.86 72.29 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.224 0 CA-C-O 121.031 0.443 . . . . 0.0 111.086 -173.931 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B ' 134' ' ' ASP . . . . . . . . . . . . . 9.1 p-10 -135.03 144.67 47.43 Favored 'General case' 0 C--N 1.33 -0.242 0 N-CA-C 109.228 -0.656 . . . . 0.0 109.228 173.777 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B ' 135' ' ' GLU . . . . . . . . . . . . . 38.0 tp10 -49.93 -25.56 3.36 Favored 'General case' 0 C--N 1.326 -0.439 0 N-CA-C 112.719 0.637 . . . . 0.0 112.719 -174.553 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B ' 136' ' ' GLN . . . . . . . . . . . . . 47.6 tt0 -80.43 -33.77 36.62 Favored 'General case' 0 C--O 1.233 0.212 0 N-CA-C 112.364 0.505 . . . . 0.0 112.364 -176.705 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B ' 137' ' ' LYS . . . . . . . . . . . . . 57.7 pttt -169.98 175.3 5.16 Favored 'General case' 0 C--N 1.332 -0.182 0 CA-C-O 121.461 0.648 . . . . 0.0 112.182 -174.901 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B ' 138' ' ' LEU . . . . . . . . . . . . . 6.1 tt -120.28 129.47 54.04 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-N 115.221 -0.9 . . . . 0.0 110.188 -179.96 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B ' 139' ' ' THR . . . . . . . . . . . . . 36.2 m -110.19 128.21 55.36 Favored 'General case' 0 C--N 1.332 -0.181 0 CA-C-N 116.341 -0.391 . . . . 0.0 110.656 179.995 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B ' 140' ' ' LEU . . . . . 0.477 ' C ' HD23 ' B' ' 140' ' ' LEU . 7.4 tt -112.27 124.36 52.29 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 115.656 -0.702 . . . . 0.0 109.2 -179.428 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' B' B ' 141' ' ' ILE . . . . . . . . . . . . . 19.5 mt -124.08 117.46 50.92 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.36 0 CA-C-O 121.053 0.454 . . . . 0.0 109.959 -176.439 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B ' 142' ' ' ARG . . . . . . . . . . . . . 60.0 ttt-85 -107.54 126.51 52.62 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 115.594 -0.73 . . . . 0.0 110.698 -179.195 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B ' 143' ' ' THR . . . . . . . . . . . . . 25.3 p . . . . . 0 C--O 1.221 -0.409 0 CA-C-O 118.248 -0.882 . . . . 0.0 110.938 179.138 . . . . . . . . 0 0 . 1 . 003 nuclear nobuild core ' C' C ' 2' ' ' SER . . . . . . . . . . . . . 6.9 p . . . . . 0 N--CA 1.461 0.087 0 CA-C-O 120.843 0.354 . . . . 0.0 110.054 . . . . . . . . . 0 0 . 1 . 003 nuclear nobuild core ' C' C ' 3' ' ' GLU . . . . . . . . . . . . . 95.6 mt-10 -140.77 141.14 34.85 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.107 -0.497 . . . . 0.0 111.134 -177.388 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' C' C ' 4' ' ' LEU . . . . . . . . . . . . . 19.7 tp -125.38 130.38 51.8 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 115.713 -0.676 . . . . 0.0 110.122 176.799 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' C' C ' 5' ' ' LYS . . . . . . . . . . . . . 61.4 mttp -108.4 120.16 41.6 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.483 -0.326 . . . . 0.0 110.66 179.534 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' C' C ' 6' ' ' LEU . . . . . . . . . . . . . 46.6 mt -114.36 147.17 39.57 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 115.499 -0.773 . . . . 0.0 110.459 -178.642 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' C' C ' 7' ' ' LYS . . . . . . . . . . . . . 83.2 tttt -135.15 135.97 23.82 Favored Pre-proline 0 CA--C 1.535 0.402 0 CA-C-O 118.87 -0.586 . . . . 0.0 109.88 175.901 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' C' C ' 8' ' ' PRO . . . . . . . . . . . . . 79.1 Cg_endo -90.5 143.25 3.65 Favored 'Trans proline' 0 N--CA 1.49 1.313 0 C-N-CA 121.745 1.63 . . . . 0.0 111.794 178.255 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' C' C ' 9' ' ' LEU . . . . . . . . . . . . . 41.2 mt -81.59 -48.75 0.99 Allowed Pre-proline 0 CA--C 1.534 0.359 0 CA-C-O 118.706 -0.664 . . . . 0.0 112.527 -178.601 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' C' C ' 10' ' ' PRO . . . . . . . . . . . . . 91.5 Cg_endo -78.97 154.68 25.96 Favored 'Trans proline' 0 N--CA 1.498 1.755 0 C-N-CA 121.113 1.209 . . . . 0.0 111.983 178.161 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' C' C ' 11' ' ' LYS . . . . . . . . . . . . . 72.4 tttt -88.46 94.26 9.81 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-N 116.345 -0.389 . . . . 0.0 110.499 179.47 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' C' C ' 12' ' ' VAL . . . . . . . . . . . . . 13.0 p -141.96 147.99 21.05 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.282 0 CA-C-N 116.236 -0.438 . . . . 0.0 110.533 -179.989 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' C' C ' 13' ' ' GLU . . . . . . . . . . . . . 84.3 tt0 -87.98 128.76 35.39 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.246 -0.434 . . . . 0.0 110.403 179.151 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' C' C ' 14' ' ' LEU . . . . . . . . . . . . . 19.2 mt -98.5 151.39 37.45 Favored Pre-proline 0 CA--C 1.533 0.296 0 CA-C-N 116.467 -0.333 . . . . 0.0 110.677 -178.438 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' C' C ' 15' ' ' PRO . . . . . . . . . . . . . 27.4 Cg_exo -61.84 161.25 26.02 Favored 'Trans proline' 0 N--CA 1.497 1.714 0 C-N-CA 121.395 1.397 . . . . 0.0 112.042 177.298 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' C' C ' 16' ' ' PRO . . . . . . . . . . . . . 26.0 Cg_exo -61.51 -38.55 62.13 Favored 'Trans proline' 0 N--CA 1.497 1.705 0 C-N-CA 121.412 1.408 . . . . 0.0 112.699 179.97 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' C' C ' 17' ' ' ASP . . . . . . . . . . . . . 21.3 p-10 -84.84 9.26 14.71 Favored 'General case' 0 CA--C 1.535 0.403 0 N-CA-C 113.232 0.827 . . . . 0.0 113.232 -176.951 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' C' C ' 18' ' ' PHE . . . . . . . . . . . . . 45.1 t80 -56.83 -48.06 78.89 Favored 'General case' 0 N--CA 1.456 -0.14 0 O-C-N 121.978 -0.451 . . . . 0.0 110.662 -177.287 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' C' C ' 19' ' ' VAL . . . . . 0.416 HG13 ' N ' ' C' ' 20' ' ' ASP . 14.9 p -54.82 -43.15 66.19 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.259 0 C-N-CA 121.007 -0.277 . . . . 0.0 111.441 -176.404 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' C' C ' 20' ' ' ASP . . . . . 0.416 ' N ' HG13 ' C' ' 19' ' ' VAL . 42.1 m-20 -62.37 -43.28 99.19 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-O 120.759 0.314 . . . . 0.0 111.217 -177.637 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' C' C ' 21' ' ' VAL . . . . . . . . . . . . . 47.9 t -64.63 -44.38 96.7 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.288 0 C-N-CA 120.637 -0.425 . . . . 0.0 110.534 -177.199 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' C' C ' 22' ' ' ILE . . . . . 0.684 HG22 HD12 ' C' ' 26' ' ' LEU . 50.8 mm -56.16 -46.7 81.23 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.21 0 C-N-CA 121.029 -0.268 . . . . 0.0 110.477 178.313 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' C' C ' 23' ' ' ARG . . . . . . . . . . . . . 55.3 ttp180 -54.21 -48.45 71.02 Favored 'General case' 0 C--N 1.33 -0.28 0 C-N-CA 121.06 -0.256 . . . . 0.0 111.336 -178.754 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' C' C ' 24' ' ' ILE . . . . . . . . . . . . . 73.8 mt -59.89 -43.93 93.21 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.331 0 CA-C-N 116.685 -0.234 . . . . 0.0 111.249 -177.815 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' C' C ' 25' ' ' LYS . . . . . . . . . . . . . 80.6 mttt -67.66 -40.43 84.49 Favored 'General case' 0 C--N 1.328 -0.352 0 N-CA-C 112.666 0.617 . . . . 0.0 112.666 -177.164 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' C' C ' 26' ' ' LEU . . . . . 0.684 HD12 HG22 ' C' ' 22' ' ' ILE . 36.8 mt -79.19 -39.43 33.38 Favored 'General case' 0 C--N 1.33 -0.274 0 N-CA-C 113.303 0.853 . . . . 0.0 113.303 -171.849 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' C' C ' 27' ' ' GLN . . . . . . . . . . . . . 9.8 pt20 -46.62 140.76 4.2 Favored 'General case' 0 N--CA 1.47 0.533 0 N-CA-C 112.732 0.641 . . . . 0.0 112.732 -175.088 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' C' C ' 28' ' ' GLY . . . . . . . . . . . . . . . 100.97 -24.82 30.61 Favored Glycine 0 CA--C 1.532 1.136 0 CA-C-N 115.388 -0.824 . . . . 0.0 112.31 -177.2 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' C' C ' 29' ' ' LYS . . . . . . . . . . . . . 69.0 mttm -97.42 155.07 17.08 Favored 'General case' 0 C--N 1.331 -0.202 0 CA-C-N 117.609 0.705 . . . . 0.0 110.904 177.317 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' C' C ' 30' ' ' THR . . . . . . . . . . . . . 13.8 m -106.6 133.69 50.9 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.07 -0.514 . . . . 0.0 109.624 175.257 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' C' C ' 31' ' ' VAL . . . . . . . . . . . . . 34.4 m -130.2 156.63 42.45 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.278 0 CA-C-O 120.982 0.42 . . . . 0.0 110.94 -176.823 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' C' C ' 32' ' ' ARG . . . . . . . . . . . . . 36.0 mtp180 -129.77 153.59 48.07 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-O 121.433 0.635 . . . . 0.0 110.84 179.476 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' C' C ' 33' ' ' THR . . . . . . . . . . . . . 24.5 m -53.84 138.85 35.09 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-N 115.907 -0.588 . . . . 0.0 111.231 -179.664 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' C' C ' 34' ' ' GLY . . . . . . . . . . . . . . . 100.95 -17.04 56.85 Favored Glycine 0 CA--C 1.532 1.136 0 CA-C-O 119.678 -0.512 . . . . 0.0 113.307 179.411 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' C' C ' 35' ' ' ASP . . . . . . . . . . . . . 62.7 m-20 -65.58 149.9 49.32 Favored 'General case' 0 C--O 1.232 0.155 0 CA-C-N 118.036 0.918 . . . . 0.0 111.315 179.496 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' C' C ' 36' ' ' VAL . . . . . . . . . . . . . 46.3 t -119.01 128.97 75.78 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.232 0 CA-C-N 115.779 -0.646 . . . . 0.0 109.686 177.836 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' C' C ' 37' ' ' ILE . . . . . . . . . . . . . 70.1 mt -120.35 139.42 47.7 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.255 0 CA-C-N 116.274 -0.421 . . . . 0.0 109.939 -178.568 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' C' C ' 38' ' ' GLY . . . . . . . . . . . . . . . -113.03 128.88 8.61 Favored Glycine 0 CA--C 1.526 0.763 0 N-CA-C 110.977 -0.849 . . . . 0.0 110.977 -179.924 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' C' C ' 39' ' ' ILE . . . . . . . . . . . . . 75.1 mt -123.24 136.97 58.18 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.243 0 N-CA-C 110.085 -0.339 . . . . 0.0 110.085 179.16 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' C' C ' 40' ' ' SER . . . . . . . . . . . . . 84.0 p -93.13 124.24 36.97 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.359 -0.382 . . . . 0.0 110.95 175.883 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' C' C ' 41' ' ' ILE . . . . . . . . . . . . . 72.7 mt -127.5 113.1 30.25 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.225 0 CA-C-O 120.925 0.393 . . . . 0.0 110.213 177.262 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' C' C ' 42' ' ' LEU . . . . . 0.535 ' O ' HD23 ' C' ' 42' ' ' LEU . 1.3 tt 49.4 47.46 22.38 Favored 'General case' 0 CA--C 1.533 0.318 0 CA-C-O 121.529 0.68 . . . . 0.0 111.357 177.73 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' C' C ' 43' ' ' GLY . . . . . . . . . . . . . . . 70.68 24.16 77.16 Favored Glycine 0 CA--C 1.53 1.01 0 C-N-CA 121.116 -0.564 . . . . 0.0 112.563 175.946 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' C' C ' 44' ' ' LYS . . . . . . . . . . . . . 17.0 ttmm -132.14 129.5 39.93 Favored 'General case' 0 C--N 1.331 -0.215 0 CA-C-N 117.515 0.658 . . . . 0.0 109.956 179.049 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' C' C ' 45' ' ' GLU . . . . . . . . . . . . . 81.6 tt0 -84.07 125.79 32.45 Favored 'General case' 0 C--N 1.327 -0.381 0 C-N-CA 120.856 -0.338 . . . . 0.0 111.148 -177.787 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' C' C ' 46' ' ' VAL . . . . . . . . . . . . . 7.4 p -123.22 129.68 74.76 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.19 0 N-CA-C 109.614 -0.513 . . . . 0.0 109.614 174.773 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' C' C ' 47' ' ' LYS . . . . . . . . . . . . . 64.1 mttp -99.67 129.98 45.85 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.117 -0.492 . . . . 0.0 111.157 177.757 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' C' C ' 48' ' ' PHE . . . . . . . . . . . . . 92.8 m-85 -113.04 132.05 55.55 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 115.792 -0.64 . . . . 0.0 109.769 175.276 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' C' C ' 49' ' ' LYS . . . . . . . . . . . . . 84.1 tttt -106.13 135.43 47.61 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.412 -0.358 . . . . 0.0 110.142 179.359 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' C' C ' 50' ' ' VAL . . . . . . . . . . . . . 44.9 t -81.41 108.13 14.31 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.321 0 N-CA-C 109.304 -0.628 . . . . 0.0 109.304 176.749 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' C' C ' 51' ' ' VAL . . . . . . . . . . . . . 44.0 t -73.31 -51.23 26.6 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.333 0 CA-C-N 116.079 -0.51 . . . . 0.0 109.843 -174.302 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' C' C ' 52' ' ' GLN . . . . . . . . . . . . . 91.3 mt-30 -152.9 151.84 30.83 Favored 'General case' 0 C--N 1.333 -0.148 0 CA-C-O 121.095 0.474 . . . . 0.0 111.743 -178.104 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' C' C ' 53' ' ' ALA . . . . . . . . . . . . . . . -130.05 131.95 46.0 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 115.374 -0.83 . . . . 0.0 109.841 174.525 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' C' C ' 54' ' ' TYR . . . . . . . . . . . . . 15.5 t80 -129.16 111.34 18.24 Favored Pre-proline 0 CA--C 1.536 0.41 0 CA-C-O 118.159 -0.924 . . . . 0.0 110.33 177.423 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' C' C ' 55' ' ' PRO . . . . . . . . . . . . . 73.4 Cg_endo -77.26 167.0 80.73 Favored 'Cis proline' 0 N--CA 1.501 1.92 0 CA-C-N 122.03 1.761 . . . . 0.0 112.356 -6.056 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' C' C ' 56' ' ' SER . . . . . . . . . . . . . 13.6 m -116.89 130.73 24.37 Favored Pre-proline 0 CA--C 1.538 0.503 0 CA-C-O 118.384 -0.817 . . . . 0.0 109.158 174.086 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' C' C ' 57' ' ' PRO . . . . . . . . . . . . . 42.7 Cg_endo -68.42 146.99 80.38 Favored 'Cis proline' 0 N--CA 1.497 1.706 0 CA-C-N 122.011 1.754 . . . . 0.0 111.527 -0.353 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' C' C ' 58' ' ' LEU . . . . . . . . . . . . . 22.7 tp -107.36 135.44 48.84 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.145 -0.479 . . . . 0.0 110.403 -178.876 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' C' C ' 59' ' ' ARG . . . . . . . . . . . . . 48.6 ttt180 -102.08 122.92 45.05 Favored 'General case' 0 C--N 1.326 -0.433 0 N-CA-C 109.134 -0.691 . . . . 0.0 109.134 176.707 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' C' C ' 60' ' ' VAL . . . . . . . . . . . . . 43.8 t -78.26 117.53 23.77 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.207 0 C-N-CA 120.633 -0.427 . . . . 0.0 110.084 -175.565 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' C' C ' 61' ' ' GLU . . . . . . . . . . . . . 95.8 mt-10 -131.06 162.92 28.77 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.025 -0.534 . . . . 0.0 109.992 178.355 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' C' C ' 62' ' ' ASP . . . . . . . . . . . . . 10.0 t0 -53.55 -32.16 49.58 Favored 'General case' 0 C--N 1.327 -0.402 0 N-CA-C 111.834 0.309 . . . . 0.0 111.834 -179.117 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' C' C ' 63' ' ' ARG . . . . . . . . . . . . . 33.6 ptt180 -84.11 3.43 34.81 Favored 'General case' 0 CA--C 1.536 0.424 0 N-CA-C 113.762 1.023 . . . . 0.0 113.762 -174.972 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' C' C ' 64' ' ' THR . . . . . . . . . . . . . 34.8 m -86.53 139.26 31.03 Favored 'General case' 0 C--O 1.232 0.144 0 CA-C-N 118.171 0.442 . . . . 0.0 110.742 -178.003 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' C' C ' 65' ' ' LYS . . . . . . . . . . . . . 98.7 mttt -89.35 127.67 35.83 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.157 -0.474 . . . . 0.0 110.205 178.918 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' C' C ' 66' ' ' ILE . . . . . . . . . . . . . 63.8 mt -114.06 127.46 71.46 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.269 0 N-CA-C 109.638 -0.505 . . . . 0.0 109.638 179.995 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' C' C ' 67' ' ' THR . . . . . . . . . . . . . 22.6 m -123.5 139.24 54.22 Favored 'General case' 0 C--N 1.331 -0.216 0 CA-C-N 116.223 -0.444 . . . . 0.0 110.818 -177.459 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' C' C ' 68' ' ' LEU . . . . . . . . . . . . . 30.4 mt . . . . . 0 C--N 1.329 -0.299 0 CA-C-N 115.881 -0.6 . . . . 0.0 110.124 178.126 . . . . . . . . 0 0 . 1 . 003 nuclear nobuild core ' C' C ' 73' ' ' VAL . . . . . . . . . . . . . 27.6 m . . . . . 0 C--O 1.23 0.064 0 CA-C-O 121.118 0.485 . . . . 0.0 110.348 . . . . . . . . . 0 0 . 1 . 003 nuclear nobuild core ' C' C ' 74' ' ' ASP . . . . . . . . . . . . . 13.6 t70 -89.76 119.85 30.51 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 115.743 -0.662 . . . . 0.0 109.717 179.854 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' C' C ' 75' ' ' VAL . . . . . . . . . . . . . 45.1 t -110.43 121.15 62.72 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.203 0 CA-C-O 121.204 0.526 . . . . 0.0 110.327 -178.56 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' C' C ' 76' ' ' LEU . . . . . . . . . . . . . 18.6 mt -121.08 141.69 50.54 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 115.377 -0.829 . . . . 0.0 109.192 177.468 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' C' C ' 77' ' ' GLU . . . . . . . . . . . . . 97.9 mt-10 -134.14 134.02 41.71 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-O 121.204 0.526 . . . . 0.0 111.338 -177.425 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' C' C ' 78' ' ' ALA . . . . . 0.517 ' HB2' HD21 ' C' ' 109' ' ' LEU . . . -122.9 129.51 51.7 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 115.455 -0.793 . . . . 0.0 109.654 176.593 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' C' C ' 79' ' ' LYS . . . . . 0.676 ' O ' HD13 ' C' ' 80' ' ' ILE . 80.6 tttt -73.98 119.7 18.55 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.477 -0.328 . . . . 0.0 110.241 -179.013 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' C' C ' 80' ' ' ILE . . . . . 0.676 HD13 ' O ' ' C' ' 79' ' ' LYS . 35.7 mm -139.13 116.21 10.86 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.304 0 N-CA-C 109.403 -0.591 . . . . 0.0 109.403 -176.279 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' C' C ' 81' ' ' LYS . . . . . . . . . . . . . 21.1 pttp -110.73 124.18 51.47 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-O 121.246 0.546 . . . . 0.0 111.284 -177.033 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' C' C ' 82' ' ' GLY . . . . . . . . . . . . . . . 89.2 42.09 5.67 Favored Glycine 0 CA--C 1.528 0.854 0 CA-C-N 115.675 -0.693 . . . . 0.0 112.053 175.677 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' C' C ' 83' ' ' ILE . . . . . . . . . . . . . 68.2 mt -69.56 137.09 24.87 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.248 0 N-CA-C 109.487 -0.56 . . . . 0.0 109.487 176.498 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' C' C ' 84' ' ' LYS . . . . . . . . . . . . . 28.1 ttpp -103.68 -52.13 3.04 Favored 'General case' 0 C--N 1.331 -0.201 0 CA-C-O 120.852 0.358 . . . . 0.0 110.524 -179.104 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' C' C ' 85' ' ' ASP . . . . . . . . . . . . . 13.3 t70 -143.54 145.31 32.44 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.077 -0.511 . . . . 0.0 110.653 -178.597 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' C' C ' 86' ' ' VAL . . . . . . . . . . . . . 44.4 t -127.66 129.2 70.15 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.234 0 CA-C-O 120.871 0.367 . . . . 0.0 110.382 179.89 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' C' C ' 87' ' ' ILE . . . . . . . . . . . . . 43.9 mm -118.5 123.98 72.41 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.26 0 CA-C-N 116.041 -0.527 . . . . 0.0 109.604 176.598 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' C' C ' 88' ' ' LEU . . . . . . . . . . . . . 68.2 mt -113.66 137.22 51.91 Favored 'General case' 0 C--N 1.331 -0.201 0 CA-C-O 121.081 0.467 . . . . 0.0 111.687 -176.347 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' C' C ' 89' ' ' ASP . . . . . . . . . . . . . 10.2 t70 -132.62 156.35 47.08 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 115.631 -0.713 . . . . 0.0 109.204 174.352 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' C' C ' 90' ' ' GLU . . . . . . . . . . . . . 82.0 tt0 -47.4 -41.62 20.35 Favored 'General case' 0 N--CA 1.464 0.228 0 N-CA-C 112.95 0.722 . . . . 0.0 112.95 -171.633 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' C' C ' 91' ' ' ASN . . . . . . . . . . . . . 15.7 p-10 -132.14 38.49 3.49 Favored 'General case' 0 N--CA 1.465 0.298 0 CA-C-O 120.821 0.343 . . . . 0.0 111.345 -177.934 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' C' C ' 92' ' ' LEU . . . . . . . . . . . . . 20.7 tp -164.74 139.88 5.5 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.59 -0.277 . . . . 0.0 110.258 -178.872 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' C' C ' 93' ' ' ILE . . . . . . . . . . . . . 66.3 mt -130.18 124.2 57.53 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.221 0 N-CA-C 109.576 -0.527 . . . . 0.0 109.576 -177.886 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' C' C ' 94' ' ' VAL . . . . . 0.579 HG21 HG11 ' C' ' 125' ' ' VAL . 46.7 t -125.81 127.91 71.69 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.265 0 N-CA-C 109.848 -0.427 . . . . 0.0 109.848 178.551 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' C' C ' 95' ' ' VAL . . . . . . . . . . . . . 42.4 t -122.08 136.09 60.06 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.283 0 CA-C-N 115.979 -0.555 . . . . 0.0 109.852 -179.089 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' C' C ' 96' ' ' ILE . . . . . . . . . . . . . 60.4 mt -116.12 127.61 73.66 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.328 0 N-CA-C 109.348 -0.612 . . . . 0.0 109.348 179.51 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' C' C ' 97' ' ' THR . . . . . . . . . . . . . 80.6 p -99.3 157.7 16.22 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-O 120.983 0.42 . . . . 0.0 110.952 -177.81 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' C' C ' 98' ' ' GLU . . . . . . . . . . . . . 96.2 mt-10 -53.98 -25.54 21.41 Favored 'General case' 0 CA--C 1.534 0.336 0 N-CA-C 112.306 0.484 . . . . 0.0 112.306 -179.03 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' C' C ' 99' ' ' GLU . . . . . . . . . . . . . 95.7 mt-10 -79.39 15.79 1.17 Allowed 'General case' 0 CA--C 1.535 0.379 0 N-CA-C 113.197 0.814 . . . . 0.0 113.197 -177.541 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' C' C ' 100' ' ' ASN . . . . . . . . . . . . . 2.6 m-20 62.05 37.27 14.87 Favored 'General case' 0 C--O 1.233 0.216 0 CA-C-O 121.076 0.465 . . . . 0.0 111.064 178.948 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' C' C ' 101' ' ' GLU . . . . . . . . . . . . . 83.6 tt0 -111.96 143.04 43.6 Favored 'General case' 0 C--N 1.333 -0.147 0 N-CA-C 109.611 -0.514 . . . . 0.0 109.611 176.436 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' C' C ' 102' ' ' VAL . . . . . . . . . . . . . 43.7 t -114.97 123.76 70.97 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.275 0 CA-C-N 116.123 -0.489 . . . . 0.0 109.833 -178.753 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' C' C ' 103' ' ' LEU . . . . . . . . . . . . . 69.1 mt -116.58 127.53 54.58 Favored 'General case' 0 C--N 1.331 -0.207 0 CA-C-N 115.76 -0.654 . . . . 0.0 109.902 176.086 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' C' C ' 104' ' ' ILE . . . . . . . . . . . . . 65.2 mt -114.84 123.41 70.49 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.289 0 N-CA-C 109.855 -0.424 . . . . 0.0 109.855 -179.665 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' C' C ' 105' ' ' PHE . . . . . . . . . . . . . 81.9 m-85 -123.53 162.1 23.58 Favored 'General case' 0 C--N 1.331 -0.226 0 O-C-N 123.864 0.728 . . . . 0.0 109.788 -178.333 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' C' C ' 106' ' ' ASN . . . . . . . . . . . . . 38.9 p30 -98.03 -173.98 2.74 Favored 'General case' 0 C--N 1.328 -0.334 0 N-CA-C 109.553 -0.536 . . . . 0.0 109.553 173.942 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' C' C ' 107' ' ' GLN . . . . . . . . . . . . . 45.7 tt0 -59.37 -29.06 67.42 Favored 'General case' 0 CA--C 1.532 0.264 0 N-CA-C 112.004 0.372 . . . . 0.0 112.004 -179.836 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' C' C ' 108' ' ' ASN . . . . . . . . . . . . . 52.9 t30 -81.94 8.59 10.07 Favored 'General case' 0 CA--C 1.537 0.472 0 N-CA-C 113.14 0.792 . . . . 0.0 113.14 -177.485 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' C' C ' 109' ' ' LEU . . . . . 0.517 HD21 ' HB2' ' C' ' 78' ' ' ALA . 13.2 tp 58.9 40.45 22.63 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-O 121.293 0.568 . . . . 0.0 110.981 178.425 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' C' C ' 110' ' ' GLU . . . . . . . . . . . . . 95.9 mt-10 -110.26 147.39 33.92 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.05 -0.523 . . . . 0.0 109.711 174.089 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' C' C ' 111' ' ' GLU . . . . . . . . . . . . . 55.5 tt0 -82.58 121.96 27.48 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.402 -0.363 . . . . 0.0 110.497 -176.043 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' C' C ' 112' ' ' LEU . . . . . . . . . . . . . 24.3 mt -105.37 -46.09 4.3 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.079 -0.51 . . . . 0.0 110.892 -179.549 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' C' C ' 113' ' ' TYR . . . . . . . . . . . . . 55.3 t80 -135.54 140.45 44.73 Favored 'General case' 0 C--N 1.331 -0.239 0 CA-C-N 116.221 -0.445 . . . . 0.0 110.805 -178.881 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' C' C ' 114' ' ' ARG . . . . . . . . . . . . . 36.1 ptt180 -143.61 120.88 11.56 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-O 121.183 0.516 . . . . 0.0 110.902 178.327 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' C' C ' 115' ' ' GLY . . . . . . . . . . . . . . . -150.19 163.04 29.4 Favored Glycine 0 CA--C 1.524 0.631 0 N-CA-C 110.866 -0.894 . . . . 0.0 110.866 -179.328 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' C' C ' 116' ' ' LYS . . . . . . . . . . . . . 40.0 ttpt -128.75 136.13 50.15 Favored 'General case' 0 C--N 1.33 -0.266 0 O-C-N 122.616 -0.343 . . . . 0.0 110.082 177.439 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' C' C ' 117' ' ' PHE . . . . . . . . . . . . . 61.9 m-85 -132.2 114.24 14.24 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-O 120.902 0.382 . . . . 0.0 110.448 -176.263 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' C' C ' 118' ' ' GLU . . . . . . . . . . . . . 70.8 mm-40 -53.47 -50.88 64.38 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.447 -0.342 . . . . 0.0 111.499 -176.205 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' C' C ' 119' ' ' ASN . . . . . . . . . . . . . 83.1 m-20 -94.73 31.06 1.88 Allowed 'General case' 0 C--N 1.329 -0.31 0 N-CA-C 112.187 0.44 . . . . 0.0 112.187 -174.083 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' C' C ' 120' ' ' LEU . . . . . . . . . . . . . 16.7 tp -56.46 124.71 19.1 Favored 'General case' 0 C--O 1.232 0.161 0 CA-C-O 120.659 0.266 . . . . 0.0 110.556 178.484 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' C' C ' 121' ' ' ASN . . . . . . . . . . . . . 35.5 m120 -114.03 -43.97 3.2 Favored 'General case' 0 C--N 1.332 -0.167 0 CA-C-N 116.483 -0.326 . . . . 0.0 111.044 -177.871 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' C' C ' 122' ' ' LYS . . . . . . . . . . . . . 55.5 mttm -145.3 148.09 33.06 Favored 'General case' 0 C--N 1.33 -0.239 0 CA-C-O 121.071 0.463 . . . . 0.0 111.815 -176.937 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' C' C ' 123' ' ' VAL . . . . . . . . . . . . . 45.4 t -128.0 124.23 62.29 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 N-CA-C 108.909 -0.774 . . . . 0.0 108.909 171.965 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' C' C ' 124' ' ' LEU . . . . . . . . . . . . . 11.3 tp -123.29 135.66 54.33 Favored 'General case' 0 C--N 1.332 -0.185 0 CA-C-O 120.765 0.317 . . . . 0.0 110.914 -174.941 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' C' C ' 125' ' ' VAL . . . . . 0.773 HG12 HG23 ' C' ' 130' ' ' VAL . 35.7 m -131.34 139.18 51.46 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.229 0 CA-C-N 116.225 -0.443 . . . . 0.0 110.886 -179.507 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' C' C ' 126' ' ' ARG . . . . . . . . . . . . . 89.0 mtt180 -146.6 125.07 12.37 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.167 -0.469 . . . . 0.0 110.51 175.83 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' C' C ' 127' ' ' ASN . . . . . . . . . . . . . 13.4 t-20 51.62 -109.31 0.43 Allowed 'General case' 0 CA--C 1.545 0.753 0 CA-C-O 118.824 -0.608 . . . . 0.0 111.199 -179.989 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' C' C ' 128' ' ' ASP . . . . . . . . . . . . . 14.3 p-10 -114.01 5.76 16.22 Favored 'General case' 0 N--CA 1.468 0.438 0 CA-C-N 119.818 1.19 . . . . 0.0 113.413 -177.918 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' C' C ' 129' ' ' LEU . . . . . . . . . . . . . 13.2 tp -109.89 136.6 48.93 Favored 'General case' 0 C--N 1.334 -0.108 0 N-CA-C 109.718 -0.475 . . . . 0.0 109.718 179.445 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' C' C ' 130' ' ' VAL . . . . . 0.773 HG23 HG12 ' C' ' 125' ' ' VAL . 12.9 p -129.54 140.7 48.42 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.205 0 CA-C-O 121.047 0.451 . . . . 0.0 110.46 -179.521 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' C' C ' 131' ' ' VAL . . . . . . . . . . . . . 43.0 t -135.72 138.29 48.07 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.314 0 CA-C-O 121.125 0.488 . . . . 0.0 110.18 179.689 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' C' C ' 132' ' ' ILE . . . . . . . . . . . . . 69.2 mt -110.64 131.23 62.34 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.328 0 CA-C-N 115.527 -0.76 . . . . 0.0 109.11 179.335 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' C' C ' 133' ' ' ILE . . . . . . . . . . . . . 42.4 mm -115.22 119.75 62.69 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.222 0 CA-C-O 120.859 0.361 . . . . 0.0 110.893 -174.716 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' C' C ' 134' ' ' ASP . . . . . . . . . . . . . 8.0 p-10 -132.17 144.24 50.53 Favored 'General case' 0 C--N 1.33 -0.253 0 N-CA-C 109.271 -0.64 . . . . 0.0 109.271 174.7 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' C' C ' 135' ' ' GLU . . . . . . . . . . . . . 84.2 tt0 -49.97 -26.41 4.2 Favored 'General case' 0 C--N 1.327 -0.395 0 N-CA-C 112.774 0.657 . . . . 0.0 112.774 -173.643 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' C' C ' 136' ' ' GLN . . . . . . . . . . . . . 62.8 tt0 -78.95 -36.59 41.39 Favored 'General case' 0 CA--C 1.531 0.217 0 N-CA-C 112.196 0.443 . . . . 0.0 112.196 -177.237 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' C' C ' 137' ' ' LYS . . . . . . . . . . . . . 34.5 pttt -167.27 172.29 9.96 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-O 121.482 0.658 . . . . 0.0 112.025 -173.258 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' C' C ' 138' ' ' LEU . . . . . 0.433 HD23 ' C ' ' C' ' 138' ' ' LEU . 7.1 tt -117.01 128.78 55.52 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 115.223 -0.899 . . . . 0.0 109.953 179.213 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' C' C ' 139' ' ' THR . . . . . . . . . . . . . 32.7 m -110.46 123.47 49.97 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.164 178.885 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' C' C ' 140' ' ' LEU . . . . . 0.479 ' C ' HD23 ' C' ' 140' ' ' LEU . 7.0 tt -107.95 123.11 48.13 Favored 'General case' 0 C--N 1.327 -0.408 0 N-CA-C 108.947 -0.76 . . . . 0.0 108.947 -179.49 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' C' C ' 141' ' ' ILE . . . . . 0.456 ' HB ' HG13 ' C' ' 130' ' ' VAL . 20.0 mt -124.96 118.64 53.71 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.248 0 CA-C-O 121.205 0.526 . . . . 0.0 109.944 -176.448 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' C' C ' 142' ' ' ARG . . . . . . . . . . . . . 67.1 ttt-85 . . . . . 0 C--N 1.328 -0.344 0 CA-C-N 115.221 -0.9 . . . . 0.0 109.929 178.919 . . . . . . . . 0 0 . 1 . 003 nuclear nobuild core ' D' D ' 2' ' ' SER . . . . . . . . . . . . . 2.3 p . . . . . 0 C--O 1.233 0.187 0 CA-C-O 121.002 0.43 . . . . 0.0 110.271 . . . . . . . . . 0 0 . 1 . 003 nuclear nobuild core ' D' D ' 3' ' ' GLU . . . . . . . . . . . . . 84.3 tt0 -140.03 141.24 36.3 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 115.778 -0.646 . . . . 0.0 110.983 -176.666 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' D' D ' 4' ' ' LEU . . . . . . . . . . . . . 12.6 tp -125.38 127.64 46.9 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-N 115.927 -0.579 . . . . 0.0 110.18 176.568 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' D' D ' 5' ' ' LYS . . . . . . . . . . . . . 98.8 mttt -108.8 121.58 45.38 Favored 'General case' 0 C--O 1.235 0.322 0 CA-C-N 116.532 -0.304 . . . . 0.0 110.905 179.931 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' D' D ' 6' ' ' LEU . . . . . . . . . . . . . 40.5 mt -114.02 148.32 37.19 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-N 115.352 -0.84 . . . . 0.0 110.289 179.989 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' D' D ' 7' ' ' LYS . . . . . . . . . . . . . 57.8 tttm -128.72 137.04 30.1 Favored Pre-proline 0 CA--C 1.535 0.383 0 CA-C-O 118.831 -0.604 . . . . 0.0 109.703 173.62 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' D' D ' 8' ' ' PRO . . . . . . . . . . . . . 90.8 Cg_endo -90.84 134.05 1.77 Allowed 'Trans proline' 0 N--CA 1.491 1.344 0 C-N-CA 121.7 1.6 . . . . 0.0 111.694 178.081 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' D' D ' 9' ' ' LEU . . . . . . . . . . . . . 35.5 mt -73.38 -46.98 7.69 Favored Pre-proline 0 CA--C 1.532 0.277 0 CA-C-O 118.701 -0.666 . . . . 0.0 112.056 -178.845 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' D' D ' 10' ' ' PRO . . . . . . . . . . . . . 91.7 Cg_endo -81.78 150.38 16.42 Favored 'Trans proline' 0 N--CA 1.495 1.614 0 C-N-CA 121.267 1.311 . . . . 0.0 111.64 174.61 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' D' D ' 11' ' ' LYS . . . . . . . . . . . . . 49.9 pttt -85.38 111.29 19.79 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-O 121.626 0.727 . . . . 0.0 110.606 178.367 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' D' D ' 12' ' ' VAL . . . . . . . . . . . . . 12.3 p -151.12 148.28 15.01 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.309 0 CA-C-N 115.57 -0.741 . . . . 0.0 110.348 179.339 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' D' D ' 13' ' ' GLU . . . . . . . . . . . . . 45.5 tp10 -94.0 122.16 36.23 Favored 'General case' 0 C--N 1.33 -0.282 0 N-CA-C 110.002 -0.37 . . . . 0.0 110.002 177.584 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' D' D ' 14' ' ' LEU . . . . . . . . . . . . . 46.4 mt -98.02 152.44 38.05 Favored Pre-proline 0 CA--C 1.532 0.272 0 CA-C-O 119.439 -0.315 . . . . 0.0 110.758 -177.558 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' D' D ' 15' ' ' PRO . . . . . . . . . . . . . 27.8 Cg_exo -61.13 159.84 28.69 Favored 'Trans proline' 0 N--CA 1.497 1.684 0 C-N-CA 121.315 1.343 . . . . 0.0 111.977 177.499 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' D' D ' 16' ' ' PRO . . . . . . . . . . . . . 29.8 Cg_exo -59.96 -36.36 90.31 Favored 'Trans proline' 0 N--CA 1.497 1.692 0 C-N-CA 121.434 1.423 . . . . 0.0 112.742 -178.536 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' D' D ' 17' ' ' ASP . . . . . . . . . . . . . 8.2 p-10 -88.18 8.88 24.95 Favored 'General case' 0 CA--C 1.536 0.404 0 N-CA-C 113.24 0.829 . . . . 0.0 113.24 -177.388 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' D' D ' 18' ' ' PHE . . . . . . . . . . . . . 43.6 t80 -58.16 -46.13 86.22 Favored 'General case' 0 CA--C 1.524 -0.031 0 O-C-N 121.887 -0.508 . . . . 0.0 109.973 -178.391 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' D' D ' 19' ' ' VAL . . . . . . . . . . . . . 13.8 p -57.47 -40.6 75.58 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.34 0 CA-C-N 116.121 -0.49 . . . . 0.0 110.723 -179.519 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' D' D ' 20' ' ' ASP . . . . . . . . . . . . . 22.2 m-20 -59.49 -43.14 93.39 Favored 'General case' 0 C--N 1.331 -0.228 0 C-N-CA 120.88 -0.328 . . . . 0.0 110.846 -178.143 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' D' D ' 21' ' ' VAL . . . . . . . . . . . . . 47.7 t -64.92 -46.3 92.14 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.246 0 C-N-CA 120.717 -0.393 . . . . 0.0 110.472 -178.192 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' D' D ' 22' ' ' ILE . . . . . 0.51 HG22 HD12 ' D' ' 26' ' ' LEU . 45.2 mm -59.33 -35.82 60.4 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.256 0 C-N-CA 120.843 -0.343 . . . . 0.0 110.98 -179.872 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' D' D ' 23' ' ' ARG . . . . . . . . . . . . . 33.1 ttp180 -59.45 -49.74 76.63 Favored 'General case' 0 C--N 1.33 -0.242 0 C-N-CA 120.621 -0.432 . . . . 0.0 110.19 176.789 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' D' D ' 24' ' ' ILE . . . . . . . . . . . . . 75.6 mt -61.34 -39.8 83.94 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.322 0 CA-C-N 116.155 -0.475 . . . . 0.0 112.085 -177.034 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' D' D ' 25' ' ' LYS . . . . . . . . . . . . . 10.2 ptmt -75.06 -40.43 60.29 Favored 'General case' 0 CA--C 1.535 0.38 0 C-N-CA 120.537 -0.465 . . . . 0.0 111.98 -175.144 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' D' D ' 26' ' ' LEU . . . . . 0.51 HD12 HG22 ' D' ' 22' ' ' ILE . 24.2 mt -79.04 -33.92 44.32 Favored 'General case' 0 C--N 1.331 -0.225 0 N-CA-C 113.337 0.866 . . . . 0.0 113.337 -172.978 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' D' D ' 27' ' ' GLN . . . . . . . . . . . . . 8.7 pt20 -46.55 139.66 4.91 Favored 'General case' 0 N--CA 1.47 0.527 0 N-CA-C 112.726 0.639 . . . . 0.0 112.726 -176.3 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' D' D ' 28' ' ' GLY . . . . . . . . . . . . . . . 100.24 -24.59 31.53 Favored Glycine 0 CA--C 1.534 1.231 0 CA-C-N 115.688 -0.687 . . . . 0.0 112.134 -174.287 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' D' D ' 29' ' ' LYS . . . . . . . . . . . . . 99.4 mttt -97.83 155.22 17.15 Favored 'General case' 0 C--N 1.333 -0.113 0 CA-C-N 117.334 0.567 . . . . 0.0 110.985 178.791 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' D' D ' 30' ' ' THR . . . . . . . . . . . . . 17.8 m -105.56 140.52 38.52 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 115.949 -0.569 . . . . 0.0 110.179 176.447 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' D' D ' 31' ' ' VAL . . . . . . . . . . . . . 35.1 m -126.66 149.51 31.73 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.224 0 CA-C-N 116.398 -0.365 . . . . 0.0 110.793 -179.393 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' D' D ' 32' ' ' ARG . . . . . . . . . . . . . 93.1 mtt180 -129.91 149.18 51.75 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-O 121.29 0.567 . . . . 0.0 110.431 179.348 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' D' D ' 33' ' ' THR . . . . . . . . . . . . . 21.2 m -53.24 137.49 34.37 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.169 -0.468 . . . . 0.0 111.546 -176.671 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' D' D ' 34' ' ' GLY . . . . . . . . . . . . . . . 99.31 -16.98 58.5 Favored Glycine 0 CA--C 1.531 1.067 0 C-N-CA 121.243 -0.503 . . . . 0.0 113.358 177.278 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' D' D ' 35' ' ' ASP . . . . . . . . . . . . . 81.3 m-20 -65.89 147.98 52.51 Favored 'General case' 0 C--O 1.231 0.117 0 CA-C-N 118.045 0.923 . . . . 0.0 111.127 -179.879 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' D' D ' 36' ' ' VAL . . . . . . . . . . . . . 46.4 t -119.95 129.5 75.36 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.266 0 CA-C-N 115.971 -0.559 . . . . 0.0 109.646 176.891 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' D' D ' 37' ' ' ILE . . . . . . . . . . . . . 63.0 mt -119.33 138.02 51.38 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.267 0 N-CA-C 109.864 -0.421 . . . . 0.0 109.864 -178.306 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' D' D ' 38' ' ' GLY . . . . . . . . . . . . . . . -115.77 128.2 7.92 Favored Glycine 0 CA--C 1.526 0.763 0 N-CA-C 110.881 -0.888 . . . . 0.0 110.881 179.04 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' D' D ' 39' ' ' ILE . . . . . . . . . . . . . 68.7 mt -126.15 127.42 70.85 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.223 0 N-CA-C 110.011 -0.366 . . . . 0.0 110.011 179.036 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' D' D ' 40' ' ' SER . . . . . . . . . . . . . 42.5 t -93.12 119.92 32.85 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.509 -0.314 . . . . 0.0 111.03 176.935 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' D' D ' 41' ' ' ILE . . . . . . . . . . . . . 71.6 mt -132.93 129.96 58.21 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.206 0 CA-C-O 120.795 0.331 . . . . 0.0 110.441 178.144 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' D' D ' 42' ' ' LEU . . . . . . . . . . . . . 74.0 mt 56.74 33.01 22.24 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.204 -0.453 . . . . 0.0 111.853 177.401 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' D' D ' 43' ' ' GLY . . . . . . . . . . . . . . . 72.85 24.81 75.34 Favored Glycine 0 CA--C 1.532 1.129 0 C-N-CA 121.149 -0.548 . . . . 0.0 112.55 177.712 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' D' D ' 44' ' ' LYS . . . . . . . . . . . . . 67.3 mttm -136.85 127.01 26.2 Favored 'General case' 0 C--N 1.331 -0.214 0 CA-C-N 117.162 0.481 . . . . 0.0 109.899 178.001 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' D' D ' 45' ' ' GLU . . . . . . . . . . . . . 39.2 tp10 -85.53 126.29 33.74 Favored 'General case' 0 C--N 1.328 -0.349 0 C-N-CA 120.776 -0.369 . . . . 0.0 110.968 -178.979 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' D' D ' 46' ' ' VAL . . . . . . . . . . . . . 9.0 p -118.14 126.43 74.96 Favored 'Isoleucine or valine' 0 C--O 1.233 0.224 0 N-CA-C 109.417 -0.586 . . . . 0.0 109.417 174.778 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' D' D ' 47' ' ' LYS . . . . . . . . . . . . . 62.0 mttp -98.89 125.62 44.35 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 116.111 -0.495 . . . . 0.0 110.886 177.762 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' D' D ' 48' ' ' PHE . . . . . . . . . . . . . 38.4 m-85 -111.22 131.86 54.79 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 115.79 -0.641 . . . . 0.0 109.458 177.166 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' D' D ' 49' ' ' LYS . . . . . . . . . . . . . 46.0 tttp -105.44 133.33 50.37 Favored 'General case' 0 C--N 1.328 -0.355 0 N-CA-C 110.174 -0.306 . . . . 0.0 110.174 178.823 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' D' D ' 50' ' ' VAL . . . . . . . . . . . . . 44.0 t -77.94 103.44 5.01 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.299 0 N-CA-C 109.243 -0.651 . . . . 0.0 109.243 177.894 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' D' D ' 51' ' ' VAL . . . . . . . . . . . . . 48.1 t -72.21 -48.36 49.19 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.324 0 CA-C-N 116.105 -0.498 . . . . 0.0 110.068 -173.664 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' D' D ' 52' ' ' GLN . . . . . . . . . . . . . 62.6 tt0 -159.13 141.44 13.86 Favored 'General case' 0 C--N 1.33 -0.27 0 C-N-CA 120.298 -0.561 . . . . 0.0 111.749 -178.542 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' D' D ' 53' ' ' ALA . . . . . . . . . . . . . . . -120.66 132.41 55.09 Favored 'General case' 0 C--N 1.331 -0.2 0 CA-C-N 115.96 -0.564 . . . . 0.0 109.889 175.172 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' D' D ' 54' ' ' TYR . . . . . . . . . . . . . 71.5 t80 -129.05 111.17 18.37 Favored Pre-proline 0 CA--C 1.534 0.355 0 CA-C-O 118.231 -0.89 . . . . 0.0 110.522 179.522 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' D' D ' 55' ' ' PRO . . . . . . . . . . . . . 72.7 Cg_endo -77.24 169.9 72.89 Favored 'Cis proline' 0 N--CA 1.5 1.872 0 CA-C-N 121.945 1.73 . . . . 0.0 112.086 -7.417 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' D' D ' 56' ' ' SER . . . . . . . . . . . . . 13.7 m -119.27 134.32 23.73 Favored Pre-proline 0 CA--C 1.538 0.507 0 CA-C-O 118.51 -0.757 . . . . 0.0 109.403 174.219 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' D' D ' 57' ' ' PRO . . . . . . . . . . . . . 48.7 Cg_endo -69.85 144.7 77.56 Favored 'Cis proline' 0 N--CA 1.498 1.745 0 CA-C-N 121.857 1.699 . . . . 0.0 111.496 -0.695 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' D' D ' 58' ' ' LEU . . . . . . . . . . . . . 19.6 tp -106.75 134.55 49.72 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.369 -0.378 . . . . 0.0 110.57 -178.756 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' D' D ' 59' ' ' ARG . . . . . . . . . . . . . 19.9 ttm180 -103.59 125.52 50.17 Favored 'General case' 0 C--N 1.327 -0.395 0 N-CA-C 109.158 -0.682 . . . . 0.0 109.158 175.823 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' D' D ' 60' ' ' VAL . . . . . . . . . . . . . 43.1 t -82.23 123.51 38.29 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.25 0 C-N-CA 120.557 -0.457 . . . . 0.0 110.491 -175.659 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' D' D ' 61' ' ' GLU . . . . . . . . . . . . . 95.3 mt-10 -129.71 172.3 11.77 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 115.721 -0.672 . . . . 0.0 109.36 176.689 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' D' D ' 62' ' ' ASP . . . . . . . . . . . . . 69.2 m-20 -53.89 -32.37 53.11 Favored 'General case' 0 C--N 1.328 -0.332 0 C-N-CA 121.068 -0.253 . . . . 0.0 111.636 178.595 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' D' D ' 63' ' ' ARG . . . . . . . . . . . . . 40.7 ptt180 -83.86 -0.38 50.97 Favored 'General case' 0 CA--C 1.537 0.475 0 N-CA-C 113.754 1.02 . . . . 0.0 113.754 -176.037 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' D' D ' 64' ' ' THR . . . . . . . . . . . . . 25.3 m -76.31 132.11 39.61 Favored 'General case' 0 C--N 1.333 -0.127 0 CA-C-N 118.158 0.435 . . . . 0.0 110.733 -176.234 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' D' D ' 65' ' ' LYS . . . . . . . . . . . . . 36.5 ttpt -89.78 122.62 33.03 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.191 -0.459 . . . . 0.0 110.136 179.249 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' D' D ' 66' ' ' ILE . . . . . . . . . . . . . 61.9 mt -112.8 131.98 62.85 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.268 0 N-CA-C 109.918 -0.401 . . . . 0.0 109.918 -178.229 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' D' D ' 67' ' ' THR . . . . . . . . . . . . . 24.4 m -130.05 143.82 51.0 Favored 'General case' 0 C--O 1.234 0.268 0 CA-C-O 121.172 0.51 . . . . 0.0 111.496 -177.835 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' D' D ' 68' ' ' LEU . . . . . 0.475 ' C ' HD23 ' D' ' 68' ' ' LEU . 8.2 tt . . . . . 0 C--N 1.328 -0.347 0 CA-C-N 115.656 -0.702 . . . . 0.0 109.553 175.908 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' D' D ' 73' ' ' VAL . . . . . . . . . . . . . 27.4 m . . . . . 0 C--O 1.232 0.132 0 CA-C-O 120.85 0.357 . . . . 0.0 110.41 . . . . . . . . . 0 0 . 1 . 003 nuclear nobuild core ' D' D ' 74' ' ' ASP . . . . . . . . . . . . . 42.6 t0 -90.87 115.08 27.64 Favored 'General case' 0 C--N 1.326 -0.44 0 CA-C-N 115.981 -0.554 . . . . 0.0 109.719 179.471 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' D' D ' 75' ' ' VAL . . . . . . . . . . . . . 46.0 t -112.27 120.11 61.77 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.264 0 CA-C-O 121.238 0.542 . . . . 0.0 110.279 -178.943 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' D' D ' 76' ' ' LEU . . . . . . . . . . . . . 23.4 mt -122.67 144.33 49.21 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 115.408 -0.815 . . . . 0.0 109.446 179.53 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' D' D ' 77' ' ' GLU . . . . . . . . . . . . . 45.9 mt-10 -135.64 137.31 41.74 Favored 'General case' 0 N--CA 1.463 0.212 0 CA-C-O 121.219 0.533 . . . . 0.0 111.688 -176.914 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' D' D ' 78' ' ' ALA . . . . . 0.606 ' HB2' HD21 ' D' ' 109' ' ' LEU . . . -126.52 131.6 51.56 Favored 'General case' 0 C--N 1.332 -0.184 0 CA-C-N 115.507 -0.77 . . . . 0.0 109.725 175.558 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' D' D ' 79' ' ' LYS . . . . . 0.522 ' O ' HD13 ' D' ' 80' ' ' ILE . 64.7 mttp -81.32 118.46 22.66 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-O 120.832 0.349 . . . . 0.0 110.718 -177.913 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' D' D ' 80' ' ' ILE . . . . . 0.522 HD13 ' O ' ' D' ' 79' ' ' LYS . 24.8 mm -139.26 114.71 8.57 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.306 0 N-CA-C 109.57 -0.53 . . . . 0.0 109.57 -177.91 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' D' D ' 81' ' ' LYS . . . . . . . . . . . . . 97.9 mttt -98.64 123.71 43.0 Favored 'General case' 0 C--N 1.33 -0.28 0 C-N-CA 120.907 -0.317 . . . . 0.0 110.993 -179.938 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' D' D ' 82' ' ' GLY . . . . . . . . . . . . . . . 89.21 42.18 5.64 Favored Glycine 0 CA--C 1.524 0.654 0 C-N-CA 120.676 -0.773 . . . . 0.0 112.168 173.057 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' D' D ' 83' ' ' ILE . . . . . . . . . . . . . 73.5 mt -65.4 133.23 30.85 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.279 0 N-CA-C 109.314 -0.625 . . . . 0.0 109.314 175.194 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' D' D ' 84' ' ' LYS . . . . . . . . . . . . . 28.2 ttpp -97.71 -53.14 3.51 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-O 120.981 0.42 . . . . 0.0 110.51 -176.734 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' D' D ' 85' ' ' ASP . . . . . . . . . . . . . 13.9 t70 -147.54 146.67 29.53 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 115.868 -0.606 . . . . 0.0 110.396 -179.475 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' D' D ' 86' ' ' VAL . . . . . . . . . . . . . 45.0 t -128.91 129.39 68.17 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.299 0 CA-C-O 121.01 0.433 . . . . 0.0 110.545 -179.53 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' D' D ' 87' ' ' ILE . . . . . . . . . . . . . 43.6 mm -116.46 121.87 68.55 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.274 0 N-CA-C 109.087 -0.709 . . . . 0.0 109.087 175.451 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' D' D ' 88' ' ' LEU . . . . . . . . . . . . . 10.0 tp -114.93 131.58 56.84 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-O 121.047 0.451 . . . . 0.0 111.327 -174.907 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' D' D ' 89' ' ' ASP . . . . . . . . . . . . . 12.8 t70 -129.62 152.28 49.3 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 115.697 -0.683 . . . . 0.0 109.358 175.359 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' D' D ' 90' ' ' GLU . . . . . . . . . . . . . 95.9 mt-10 -50.65 -31.61 16.72 Favored 'General case' 0 C--N 1.328 -0.366 0 N-CA-C 112.477 0.547 . . . . 0.0 112.477 -173.115 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' D' D ' 91' ' ' ASN . . . . . . . . . . . . . 23.6 p30 -128.54 27.69 5.51 Favored 'General case' 0 N--CA 1.465 0.32 0 N-CA-C 112.607 0.595 . . . . 0.0 112.607 -175.779 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' D' D ' 92' ' ' LEU . . . . . . . . . . . . . 15.1 tp -166.11 143.11 5.24 Favored 'General case' 0 C--N 1.331 -0.196 0 C-N-CA 121.074 -0.25 . . . . 0.0 110.662 179.445 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' D' D ' 93' ' ' ILE . . . . . . . . . . . . . 75.6 mt -126.17 119.66 54.78 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.263 0 N-CA-C 109.552 -0.536 . . . . 0.0 109.552 178.082 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' D' D ' 94' ' ' VAL . . . . . . . . . . . . . 43.8 t -118.3 124.16 72.69 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.255 0 N-CA-C 109.627 -0.509 . . . . 0.0 109.627 178.954 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' D' D ' 95' ' ' VAL . . . . . . . . . . . . . 44.7 t -121.38 132.65 70.15 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.275 0 CA-C-N 116.233 -0.44 . . . . 0.0 109.934 -178.586 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' D' D ' 96' ' ' ILE . . . . . . . . . . . . . 67.7 mt -115.58 127.36 73.18 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 N-CA-C 109.244 -0.65 . . . . 0.0 109.244 179.128 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' D' D ' 97' ' ' THR . . . . . . . . . . . . . 80.5 p -101.47 159.68 15.08 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-O 121.364 0.602 . . . . 0.0 111.48 -176.18 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' D' D ' 98' ' ' GLU . . . . . . . . . . . . . 84.4 tt0 -53.95 -26.46 25.75 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 115.836 -0.62 . . . . 0.0 112.264 179.965 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' D' D ' 99' ' ' GLU . . . . . . . . . . . . . 43.3 mt-10 -79.49 15.64 1.24 Allowed 'General case' 0 CA--C 1.534 0.35 0 N-CA-C 113.115 0.783 . . . . 0.0 113.115 -177.169 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' D' D ' 100' ' ' ASN . . . . . . . . . . . . . 3.2 m-20 61.3 38.02 16.7 Favored 'General case' 0 N--CA 1.463 0.183 0 CA-C-O 121.16 0.505 . . . . 0.0 110.962 178.948 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' D' D ' 101' ' ' GLU . . . . . . . . . . . . . 84.1 tt0 -117.47 142.1 47.55 Favored 'General case' 0 C--N 1.333 -0.14 0 N-CA-C 109.636 -0.505 . . . . 0.0 109.636 176.308 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' D' D ' 102' ' ' VAL . . . . . . . . . . . . . 43.0 t -114.94 126.15 72.44 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.351 0 N-CA-C 109.947 -0.39 . . . . 0.0 109.947 -179.149 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' D' D ' 103' ' ' LEU . . . . . . . . . . . . . 45.7 mt -115.95 133.34 56.13 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 115.728 -0.669 . . . . 0.0 109.948 177.179 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' D' D ' 104' ' ' ILE . . . . . 0.641 HD13 HG11 ' D' ' 130' ' ' VAL . 68.2 mt -118.35 120.71 65.18 Favored 'Isoleucine or valine' 0 C--O 1.233 0.221 0 N-CA-C 110.112 -0.329 . . . . 0.0 110.112 -179.475 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' D' D ' 105' ' ' PHE . . . . . . . . . . . . . 55.8 m-85 -122.8 167.35 13.62 Favored 'General case' 0 C--N 1.332 -0.158 0 O-C-N 124.011 0.82 . . . . 0.0 109.933 -179.694 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' D' D ' 106' ' ' ASN . . . . . . . . . . . . . 41.2 p-10 -101.48 -170.84 1.89 Allowed 'General case' 0 C--N 1.331 -0.205 0 N-CA-C 109.95 -0.389 . . . . 0.0 109.95 172.922 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' D' D ' 107' ' ' GLN . . . . . . . . . . . . . 47.4 tt0 -60.57 -29.99 69.51 Favored 'General case' 0 C--N 1.33 -0.273 0 N-CA-C 111.904 0.335 . . . . 0.0 111.904 179.754 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' D' D ' 108' ' ' ASN . . . . . . . . . . . . . 10.8 t30 -82.18 7.41 13.7 Favored 'General case' 0 CA--C 1.537 0.443 0 N-CA-C 113.143 0.794 . . . . 0.0 113.143 -178.026 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' D' D ' 109' ' ' LEU . . . . . 0.606 HD21 ' HB2' ' D' ' 78' ' ' ALA . 10.0 tp 62.31 36.67 14.45 Favored 'General case' 0 CA--C 1.53 0.204 0 CA-C-O 120.881 0.372 . . . . 0.0 111.393 178.082 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' D' D ' 110' ' ' GLU . . . . . . . . . . . . . 70.7 mm-40 -104.57 155.55 18.73 Favored 'General case' 0 C--N 1.33 -0.243 0 N-CA-C 109.503 -0.554 . . . . 0.0 109.503 175.348 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' D' D ' 111' ' ' GLU . . . . . . . . . . . . . 66.2 tt0 -91.07 124.68 35.48 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-O 120.982 0.42 . . . . 0.0 111.0 -176.003 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' D' D ' 112' ' ' LEU . . . . . . . . . . . . . 23.8 mt -108.77 -45.93 3.73 Favored 'General case' 0 C--N 1.331 -0.204 0 CA-C-N 116.097 -0.501 . . . . 0.0 110.861 179.264 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' D' D ' 113' ' ' TYR . . . . . 0.463 ' HB3' HD12 ' D' ' 104' ' ' ILE . 51.1 t80 -138.32 143.18 39.83 Favored 'General case' 0 N--CA 1.462 0.174 0 C-N-CA 120.835 -0.346 . . . . 0.0 111.074 -178.027 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' D' D ' 114' ' ' ARG . . . . . . . . . . . . . 36.2 ptt-85 -142.57 127.8 18.7 Favored 'General case' 0 C--N 1.331 -0.217 0 CA-C-N 116.274 -0.421 . . . . 0.0 110.85 177.094 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' D' D ' 115' ' ' GLY . . . . . . . . . . . . . . . -150.15 141.72 9.04 Favored Glycine 0 CA--C 1.524 0.621 0 N-CA-C 111.439 -0.665 . . . . 0.0 111.439 178.559 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' D' D ' 116' ' ' LYS . . . . . . . . . . . . . 39.5 ttpt -111.74 134.38 53.34 Favored 'General case' 0 C--N 1.331 -0.198 0 N-CA-C 109.485 -0.561 . . . . 0.0 109.485 175.101 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' D' D ' 117' ' ' PHE . . . . . . . . . . . . . 42.1 m-85 -135.79 113.95 11.4 Favored 'General case' 0 C--N 1.331 -0.225 0 CA-C-O 120.967 0.413 . . . . 0.0 110.394 -175.912 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' D' D ' 118' ' ' GLU . . . . . . . . . . . . . 70.7 mm-40 -55.13 -48.76 73.2 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.313 -0.403 . . . . 0.0 111.257 -175.811 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' D' D ' 119' ' ' ASN . . . . . . . . . . . . . 11.7 m-80 -96.01 31.05 2.23 Favored 'General case' 0 C--N 1.328 -0.344 0 N-CA-C 112.149 0.426 . . . . 0.0 112.149 -174.04 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' D' D ' 120' ' ' LEU . . . . . . . . . . . . . 15.7 tp -56.48 122.23 11.48 Favored 'General case' 0 C--N 1.332 -0.175 0 CA-C-O 120.686 0.279 . . . . 0.0 110.391 177.538 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' D' D ' 121' ' ' ASN . . . . . . . . . . . . . 12.5 t-20 -112.17 -44.12 3.46 Favored 'General case' 0 C--N 1.332 -0.18 0 CA-C-N 116.488 -0.323 . . . . 0.0 110.846 -176.027 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' D' D ' 122' ' ' LYS . . . . . . . . . . . . . 98.3 mttt -146.37 149.61 34.1 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-O 121.112 0.482 . . . . 0.0 111.51 -178.489 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' D' D ' 123' ' ' VAL . . . . . . . . . . . . . 46.4 t -130.31 126.33 61.14 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.289 0 N-CA-C 109.25 -0.648 . . . . 0.0 109.25 172.928 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' D' D ' 124' ' ' LEU . . . . . 0.453 HD22 HD12 ' E' ' 88' ' ' LEU . 6.2 mp -114.71 137.09 52.34 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-O 120.824 0.345 . . . . 0.0 111.0 -176.52 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' D' D ' 125' ' ' VAL . . . . . . . . . . . . . 44.3 t -122.83 132.15 71.88 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.179 0 CA-C-N 115.911 -0.586 . . . . 0.0 109.939 179.861 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' D' D ' 126' ' ' ARG . . . . . . . . . . . . . 25.7 mmt180 -134.86 104.66 6.08 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 116.124 -0.489 . . . . 0.0 110.215 178.021 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' D' D ' 127' ' ' ASN . . . . . . . . . . . . . 35.0 m120 53.98 -104.98 0.23 Allowed 'General case' 0 CA--C 1.544 0.733 0 CA-C-O 119.053 -0.499 . . . . 0.0 110.922 179.75 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' D' D ' 128' ' ' ASP . . . . . . . . . . . . . 13.8 p-10 -112.33 2.65 16.6 Favored 'General case' 0 CA--C 1.536 0.431 0 CA-C-N 119.579 1.081 . . . . 0.0 113.498 -177.574 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' D' D ' 129' ' ' LEU . . . . . . . . . . . . . 26.1 mt -105.01 148.66 26.51 Favored 'General case' 0 C--O 1.231 0.124 0 N-CA-C 109.726 -0.472 . . . . 0.0 109.726 177.263 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' D' D ' 130' ' ' VAL . . . . . 0.641 HG11 HD13 ' D' ' 104' ' ' ILE . 12.7 p -133.04 141.03 45.87 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.233 0 CA-C-O 121.301 0.572 . . . . 0.0 110.784 -177.682 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' D' D ' 131' ' ' VAL . . . . . 0.571 HG22 HD12 ' D' ' 140' ' ' LEU . 38.9 t -134.43 135.96 53.4 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 CA-C-N 115.716 -0.675 . . . . 0.0 109.924 178.909 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' D' D ' 132' ' ' ILE . . . . . . . . . . . . . 70.6 mt -113.87 132.21 63.53 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.366 0 N-CA-C 109.394 -0.595 . . . . 0.0 109.394 -178.717 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' D' D ' 133' ' ' ILE . . . . . . . . . . . . . 35.4 mm -117.31 120.39 64.78 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.261 0 CA-C-O 120.837 0.351 . . . . 0.0 110.78 -176.06 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' D' D ' 134' ' ' ASP . . . . . . . . . . . . . 9.3 p-10 -129.89 148.95 51.81 Favored 'General case' 0 C--N 1.329 -0.284 0 N-CA-C 109.419 -0.586 . . . . 0.0 109.419 175.179 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' D' D ' 135' ' ' GLU . . . . . . . . . . . . . 54.6 tt0 -50.03 -25.43 3.38 Favored 'General case' 0 C--N 1.327 -0.39 0 N-CA-C 112.746 0.647 . . . . 0.0 112.746 -172.414 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' D' D ' 136' ' ' GLN . . . . . . . . . . . . . 43.0 tt0 -89.86 -31.1 17.49 Favored 'General case' 0 C--O 1.233 0.208 0 N-CA-C 112.542 0.571 . . . . 0.0 112.542 -174.058 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' D' D ' 137' ' ' LYS . . . . . . . . . . . . . 25.1 pttm -164.07 174.09 11.74 Favored 'General case' 0 C--O 1.232 0.176 0 CA-C-O 121.434 0.635 . . . . 0.0 112.57 -174.373 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' D' D ' 138' ' ' LEU . . . . . 0.401 ' C ' HD23 ' D' ' 138' ' ' LEU . 7.4 tt -122.44 130.33 52.98 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 115.197 -0.91 . . . . 0.0 110.109 179.564 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' D' D ' 139' ' ' THR . . . . . 0.407 HG23 ' HG2' ' E' ' 77' ' ' GLU . 34.9 m -112.68 129.77 56.28 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-N 116.341 -0.39 . . . . 0.0 110.677 179.914 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' D' D ' 140' ' ' LEU . . . . . 0.571 HD12 HG22 ' D' ' 131' ' ' VAL . 19.5 tp -113.98 120.41 40.55 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 115.567 -0.742 . . . . 0.0 109.462 -178.241 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' D' D ' 141' ' ' ILE . . . . . 0.482 ' HB ' HG13 ' D' ' 130' ' ' VAL . 20.1 mt -120.3 119.49 60.07 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.281 0 CA-C-O 121.193 0.52 . . . . 0.0 109.93 -177.589 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' D' D ' 142' ' ' ARG . . . . . . . . . . . . . 84.6 mtm180 -111.17 133.29 53.64 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 114.941 -1.027 . . . . 0.0 110.689 -174.699 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' D' D ' 143' ' ' THR . . . . . . . . . . . . . 48.7 p . . . . . 0 C--O 1.22 -0.465 0 CA-C-O 118.03 -0.986 . . . . 0.0 110.371 179.588 . . . . . . . . 0 0 . 1 . 003 nuclear nobuild core ' E' E ' 2' ' ' SER . . . . . . . . . . . . . 15.9 p . . . . . 0 N--CA 1.461 0.084 0 CA-C-O 120.92 0.391 . . . . 0.0 110.949 . . . . . . . . . 0 0 . 1 . 003 nuclear nobuild core ' E' E ' 3' ' ' GLU . . . . . . . . . . . . . 95.7 mt-10 -140.61 139.33 34.88 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 115.992 -0.549 . . . . 0.0 110.927 -179.864 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' E' E ' 4' ' ' LEU . . . . . . . . . . . . . 17.4 tp -122.94 126.76 47.84 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-N 116.071 -0.513 . . . . 0.0 110.155 176.533 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' E' E ' 5' ' ' LYS . . . . . . . . . . . . . 86.4 mttt -106.96 121.6 44.76 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.3 -0.409 . . . . 0.0 110.711 179.024 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' E' E ' 6' ' ' LEU . . . . . . . . . . . . . 75.9 mt -116.78 151.3 36.74 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 115.46 -0.791 . . . . 0.0 110.58 -179.394 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' E' E ' 7' ' ' LYS . . . . . . . . . . . . . 33.9 ttpt -140.32 142.14 28.58 Favored Pre-proline 0 CA--C 1.534 0.338 0 N-CA-C 109.764 -0.458 . . . . 0.0 109.764 175.088 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' E' E ' 8' ' ' PRO . . . . . . . . . . . . . 92.2 Cg_endo -89.03 147.91 5.6 Favored 'Trans proline' 0 N--CA 1.491 1.372 0 C-N-CA 121.654 1.569 . . . . 0.0 112.024 -179.896 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' E' E ' 9' ' ' LEU . . . . . . . . . . . . . 84.3 mt -84.23 -52.07 0.56 Allowed Pre-proline 0 C--N 1.329 -0.284 0 CA-C-O 118.855 -0.593 . . . . 0.0 111.551 -179.94 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' E' E ' 10' ' ' PRO . . . . . . . . . . . . . 61.6 Cg_endo -73.43 155.66 50.56 Favored 'Trans proline' 0 N--CA 1.498 1.762 0 C-N-CA 121.093 1.196 . . . . 0.0 111.898 173.469 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' E' E ' 11' ' ' LYS . . . . . . . . . . . . . 62.1 mtpt -89.07 98.93 12.04 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.433 -0.349 . . . . 0.0 110.749 179.207 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' E' E ' 12' ' ' VAL . . . . . . . . . . . . . 12.6 p -142.68 142.58 26.5 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.288 0 CA-C-N 116.335 -0.393 . . . . 0.0 110.667 179.809 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' E' E ' 13' ' ' GLU . . . . . . . . . . . . . 45.1 mp0 -84.74 128.28 34.53 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 116.267 -0.424 . . . . 0.0 109.86 176.754 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' E' E ' 14' ' ' LEU . . . . . . . . . . . . . 32.3 mt -98.5 148.99 35.29 Favored Pre-proline 0 CA--C 1.533 0.293 0 CA-C-O 119.197 -0.43 . . . . 0.0 110.499 -177.585 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' E' E ' 15' ' ' PRO . . . . . . . . . . . . . 26.3 Cg_exo -62.37 159.96 33.44 Favored 'Trans proline' 0 N--CA 1.497 1.71 0 C-N-CA 121.245 1.296 . . . . 0.0 111.478 174.869 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' E' E ' 16' ' ' PRO . . . . . . . . . . . . . 38.6 Cg_exo -58.68 -34.34 98.86 Favored 'Trans proline' 0 N--CA 1.496 1.666 0 C-N-CA 121.413 1.409 . . . . 0.0 112.899 -178.32 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' E' E ' 17' ' ' ASP . . . . . . . . . . . . . 22.9 p-10 -91.4 8.43 36.3 Favored 'General case' 0 CA--C 1.534 0.362 0 N-CA-C 113.341 0.867 . . . . 0.0 113.341 -177.193 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' E' E ' 18' ' ' PHE . . . . . . . . . . . . . 52.3 t80 -58.19 -43.85 87.77 Favored 'General case' 0 N--CA 1.457 -0.093 0 O-C-N 121.944 -0.472 . . . . 0.0 110.058 -178.162 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' E' E ' 19' ' ' VAL . . . . . . . . . . . . . 48.7 t -58.17 -42.52 83.51 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.304 0 CA-C-N 116.207 -0.452 . . . . 0.0 110.234 -178.909 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' E' E ' 20' ' ' ASP . . . . . . . . . . . . . 7.5 t70 -59.92 -42.09 93.15 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-O 120.833 0.349 . . . . 0.0 110.83 -177.92 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' E' E ' 21' ' ' VAL . . . . . . . . . . . . . 48.3 t -64.73 -46.18 92.94 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.332 0 CA-C-N 116.405 -0.361 . . . . 0.0 110.483 -177.723 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' E' E ' 22' ' ' ILE . . . . . 0.627 HG22 HD12 ' E' ' 26' ' ' LEU . 29.3 mm -57.0 -45.13 83.74 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.257 0 N-CA-C 110.172 -0.307 . . . . 0.0 110.172 179.266 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' E' E ' 23' ' ' ARG . . . . . . . . . . . . . 2.3 tmm_? -54.39 -48.77 71.18 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-O 120.573 0.225 . . . . 0.0 111.246 -178.935 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' E' E ' 24' ' ' ILE . . . . . . . . . . . . . 72.8 mt -59.02 -42.98 87.91 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.316 0 C-N-CA 120.943 -0.303 . . . . 0.0 110.963 -177.828 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' E' E ' 25' ' ' LYS . . . . . . . . . . . . . 96.2 mttt -66.34 -41.7 89.21 Favored 'General case' 0 C--N 1.329 -0.293 0 N-CA-C 112.759 0.652 . . . . 0.0 112.759 -178.874 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' E' E ' 26' ' ' LEU . . . . . 0.627 HD12 HG22 ' E' ' 22' ' ' ILE . 48.6 mt -78.48 -37.31 43.65 Favored 'General case' 0 C--N 1.327 -0.372 0 N-CA-C 113.689 0.996 . . . . 0.0 113.689 -169.812 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' E' E ' 27' ' ' GLN . . . . . . . . . . . . . 10.4 pt20 -47.23 138.85 6.7 Favored 'General case' 0 N--CA 1.467 0.422 0 N-CA-C 112.765 0.654 . . . . 0.0 112.765 -175.261 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' E' E ' 28' ' ' GLY . . . . . . . . . . . . . . . 101.17 -24.53 31.52 Favored Glycine 0 CA--C 1.532 1.139 0 CA-C-N 115.552 -0.749 . . . . 0.0 112.405 -177.182 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' E' E ' 29' ' ' LYS . . . . . . . . . . . . . 86.5 mttt -98.4 155.06 17.42 Favored 'General case' 0 C--O 1.233 0.198 0 CA-C-N 117.594 0.697 . . . . 0.0 111.381 179.376 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' E' E ' 30' ' ' THR . . . . . . . . . . . . . 30.5 m -104.39 136.7 43.49 Favored 'General case' 0 C--N 1.331 -0.226 0 CA-C-N 116.011 -0.54 . . . . 0.0 110.268 177.42 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' E' E ' 31' ' ' VAL . . . . . . . . . . . . . 35.0 m -132.29 157.06 43.0 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.329 0 CA-C-N 116.327 -0.397 . . . . 0.0 110.831 -179.123 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' E' E ' 32' ' ' ARG . . . . . . . . . . . . . 96.9 mtt180 -132.12 154.84 49.08 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 115.954 -0.566 . . . . 0.0 110.44 176.673 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' E' E ' 33' ' ' THR . . . . . . . . . . . . . 29.1 m -53.53 138.13 34.71 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.307 -0.406 . . . . 0.0 111.279 -178.978 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' E' E ' 34' ' ' GLY . . . . . . . . . . . . . . . 100.16 -17.11 57.51 Favored Glycine 0 CA--C 1.532 1.107 0 CA-C-O 119.616 -0.547 . . . . 0.0 113.295 178.744 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' E' E ' 35' ' ' ASP . . . . . . . . . . . . . 54.1 m-20 -65.37 150.18 48.73 Favored 'General case' 0 C--N 1.334 -0.077 0 CA-C-N 118.019 0.909 . . . . 0.0 111.137 179.818 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' E' E ' 36' ' ' VAL . . . . . . . . . . . . . 44.6 t -121.56 130.0 75.02 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.233 0 CA-C-N 115.67 -0.696 . . . . 0.0 109.76 178.536 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' E' E ' 37' ' ' ILE . . . . . . . . . . . . . 69.7 mt -119.31 138.66 49.27 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.29 0 CA-C-N 116.275 -0.421 . . . . 0.0 109.923 -179.636 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' E' E ' 38' ' ' GLY . . . . . . . . . . . . . . . -112.27 128.95 8.77 Favored Glycine 0 CA--C 1.526 0.77 0 N-CA-C 111.086 -0.806 . . . . 0.0 111.086 -179.505 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' E' E ' 39' ' ' ILE . . . . . . . . . . . . . 71.1 mt -122.03 134.14 66.21 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.275 0 N-CA-C 109.899 -0.408 . . . . 0.0 109.899 178.895 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' E' E ' 40' ' ' SER . . . . . . . . . . . . . 53.8 p -93.39 122.71 36.08 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.323 -0.398 . . . . 0.0 110.857 175.509 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' E' E ' 41' ' ' ILE . . . . . . . . . . . . . 71.4 mt -131.85 114.37 24.57 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.225 0 N-CA-C 110.021 -0.363 . . . . 0.0 110.021 177.678 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' E' E ' 42' ' ' LEU . . . . . . . . . . . . . 7.9 mp 56.6 37.57 28.92 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-O 121.086 0.47 . . . . 0.0 111.074 -179.707 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' E' E ' 43' ' ' GLY . . . . . . . . . . . . . . . 77.42 -10.08 24.53 Favored Glycine 0 CA--C 1.534 1.219 0 C-N-CA 121.296 -0.478 . . . . 0.0 113.473 177.043 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' E' E ' 44' ' ' LYS . . . . . . . . . . . . . 68.7 mttm -93.99 132.97 37.93 Favored 'General case' 0 C--N 1.333 -0.121 0 CA-C-N 118.005 0.903 . . . . 0.0 110.069 178.093 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' E' E ' 45' ' ' GLU . . . . . . . . . . . . . 69.3 tt0 -86.46 127.28 34.83 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.172 -0.467 . . . . 0.0 111.04 -177.816 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' E' E ' 46' ' ' VAL . . . . . . . . . . . . . 7.2 p -124.84 128.13 73.04 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.198 0 CA-C-O 120.943 0.401 . . . . 0.0 109.98 176.627 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' E' E ' 47' ' ' LYS . . . . . . . . . . . . . 72.6 mmtt -100.08 133.91 43.78 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-N 115.972 -0.558 . . . . 0.0 111.525 177.631 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' E' E ' 48' ' ' PHE . . . . . . . . . . . . . 91.1 m-85 -116.34 131.98 56.79 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 115.907 -0.588 . . . . 0.0 109.782 174.046 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' E' E ' 49' ' ' LYS . . . . . . . . . . . . . 82.4 tttt -105.73 136.34 45.53 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.488 -0.324 . . . . 0.0 110.527 -179.927 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' E' E ' 50' ' ' VAL . . . . . . . . . . . . . 45.0 t -80.53 108.67 14.16 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.331 0 N-CA-C 109.196 -0.668 . . . . 0.0 109.196 176.089 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' E' E ' 51' ' ' VAL . . . . . . . . . . . . . 47.5 t -74.63 -47.21 39.75 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.289 0 CA-C-N 116.139 -0.482 . . . . 0.0 110.174 -172.968 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' E' E ' 52' ' ' GLN . . . . . . . . . . . . . 48.2 tt0 -164.85 138.49 4.9 Favored 'General case' 0 C--N 1.331 -0.236 0 C-N-CA 120.155 -0.618 . . . . 0.0 111.749 -177.954 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' E' E ' 53' ' ' ALA . . . . . . . . . . . . . . . -116.46 133.6 55.82 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 115.9 -0.591 . . . . 0.0 110.169 176.835 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' E' E ' 54' ' ' TYR . . . . . . . . . . . . . 38.5 t80 -129.13 112.47 18.4 Favored Pre-proline 0 CA--C 1.535 0.398 0 CA-C-O 118.154 -0.927 . . . . 0.0 110.171 177.607 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' E' E ' 55' ' ' PRO . . . . . . . . . . . . . 72.2 Cg_endo -77.09 168.72 76.23 Favored 'Cis proline' 0 N--CA 1.5 1.904 0 CA-C-N 122.082 1.779 . . . . 0.0 112.426 -5.346 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' E' E ' 56' ' ' SER . . . . . . . . . . . . . 13.6 m -117.57 134.08 23.21 Favored Pre-proline 0 CA--C 1.54 0.562 0 CA-C-O 118.455 -0.783 . . . . 0.0 109.595 174.764 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' E' E ' 57' ' ' PRO . . . . . . . . . . . . . 36.0 Cg_endo -66.36 164.7 65.68 Favored 'Cis proline' 0 N--CA 1.498 1.751 0 CA-C-N 121.862 1.701 . . . . 0.0 111.299 -3.177 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' E' E ' 58' ' ' LEU . . . . . . . . . . . . . 23.4 tp -129.96 138.82 51.06 Favored 'General case' 0 C--N 1.331 -0.222 0 CA-C-O 121.081 0.467 . . . . 0.0 110.584 179.61 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' E' E ' 59' ' ' ARG . . . . . . . . . . . . . 75.1 ttt180 -106.06 123.31 47.8 Favored 'General case' 0 C--N 1.329 -0.295 0 N-CA-C 109.084 -0.71 . . . . 0.0 109.084 174.115 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' E' E ' 60' ' ' VAL . . . . . . . . . . . . . 44.3 t -73.52 118.95 19.69 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.351 0 C-N-CA 120.735 -0.386 . . . . 0.0 110.166 -175.198 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' E' E ' 61' ' ' GLU . . . . . . . . . . . . . 95.0 mt-10 -131.05 162.43 29.84 Favored 'General case' 0 C--N 1.331 -0.222 0 CA-C-N 116.107 -0.497 . . . . 0.0 110.109 178.455 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' E' E ' 62' ' ' ASP . . . . . . . . . . . . . 65.2 m-20 -53.57 -32.84 52.58 Favored 'General case' 0 C--N 1.326 -0.427 0 N-CA-C 111.751 0.278 . . . . 0.0 111.751 -178.898 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' E' E ' 63' ' ' ARG . . . . . . . . . . . . . 27.6 mmm180 -72.69 -21.35 61.07 Favored 'General case' 0 C--N 1.33 -0.267 0 N-CA-C 113.054 0.761 . . . . 0.0 113.054 -176.159 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' E' E ' 64' ' ' THR . . . . . . . . . . . . . 29.6 m -72.56 139.37 47.47 Favored 'General case' 0 C--N 1.331 -0.21 0 CA-C-O 120.869 0.366 . . . . 0.0 111.183 -174.409 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' E' E ' 65' ' ' LYS . . . . . . . . . . . . . 13.1 mptt -89.04 134.34 34.03 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.009 -0.541 . . . . 0.0 109.982 178.68 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' E' E ' 66' ' ' ILE . . . . . . . . . . . . . 64.4 mt -116.96 131.75 68.72 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.326 0 CA-C-O 120.885 0.374 . . . . 0.0 110.076 -179.772 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' E' E ' 67' ' ' THR . . . . . . . . . . . . . 32.5 m -127.6 140.44 52.1 Favored 'General case' 0 C--N 1.332 -0.19 0 CA-C-N 116.047 -0.524 . . . . 0.0 110.821 -178.559 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' E' E ' 68' ' ' LEU . . . . . 0.428 ' C ' HD23 ' E' ' 68' ' ' LEU . 5.0 tt . . . . . 0 C--N 1.33 -0.243 0 CA-C-N 115.994 -0.548 . . . . 0.0 109.649 177.044 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' E' E ' 73' ' ' VAL . . . . . . . . . . . . . 33.9 m . . . . . 0 C--O 1.232 0.149 0 CA-C-O 120.866 0.365 . . . . 0.0 110.41 . . . . . . . . . 0 0 . 1 . 003 nuclear nobuild core ' E' E ' 74' ' ' ASP . . . . . . . . . . . . . 7.3 t0 -95.34 126.44 40.65 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.009 -0.542 . . . . 0.0 110.228 -176.924 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' E' E ' 75' ' ' VAL . . . . . 0.444 ' C ' HD12 ' E' ' 76' ' ' LEU . 40.4 t -119.17 123.79 71.96 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.205 0 CA-C-O 121.025 0.44 . . . . 0.0 110.583 -178.514 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' E' E ' 76' ' ' LEU . . . . . 0.444 HD12 ' C ' ' E' ' 75' ' ' VAL . 6.3 mp -123.94 146.24 48.6 Favored 'General case' 0 C--N 1.331 -0.224 0 CA-C-N 115.828 -0.624 . . . . 0.0 109.908 176.195 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' E' E ' 77' ' ' GLU . . . . . 0.407 ' HG2' HG23 ' D' ' 139' ' ' THR . 45.9 mt-10 -135.69 136.86 41.22 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-O 121.011 0.434 . . . . 0.0 111.22 -178.883 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' E' E ' 78' ' ' ALA . . . . . 0.424 ' HB2' HD21 ' E' ' 109' ' ' LEU . . . -125.95 133.44 51.83 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 115.816 -0.629 . . . . 0.0 109.674 176.145 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' E' E ' 79' ' ' LYS . . . . . 0.565 ' O ' HD13 ' E' ' 80' ' ' ILE . 84.0 mttt -80.51 120.3 24.31 Favored 'General case' 0 C--N 1.331 -0.215 0 CA-C-O 121.091 0.472 . . . . 0.0 110.754 -178.199 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' E' E ' 80' ' ' ILE . . . . . 0.565 HD13 ' O ' ' E' ' 79' ' ' LYS . 43.1 mm -139.18 108.68 3.86 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.335 0 N-CA-C 108.961 -0.755 . . . . 0.0 108.961 -176.991 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' E' E ' 81' ' ' LYS . . . . . . . . . . . . . 68.8 mttm -97.84 126.73 43.36 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-O 120.877 0.37 . . . . 0.0 111.199 -176.265 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' E' E ' 82' ' ' GLY . . . . . . . . . . . . . . . 89.08 42.14 5.69 Favored Glycine 0 CA--C 1.527 0.791 0 C-N-CA 120.911 -0.662 . . . . 0.0 111.725 174.992 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' E' E ' 83' ' ' ILE . . . . . . . . . . . . . 75.5 mt -66.83 138.52 22.75 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.314 0 CA-C-O 120.945 0.402 . . . . 0.0 109.94 178.34 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' E' E ' 84' ' ' LYS . . . . . . . . . . . . . 83.8 tttt -99.22 -53.97 3.09 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 115.989 -0.55 . . . . 0.0 110.34 -178.815 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' E' E ' 85' ' ' ASP . . . . . . . . . . . . . 5.9 t0 -154.69 151.4 28.71 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-N 115.746 -0.661 . . . . 0.0 110.044 -178.943 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' E' E ' 86' ' ' VAL . . . . . . . . . . . . . 42.8 t -131.9 130.77 61.7 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.233 0 CA-C-O 120.961 0.41 . . . . 0.0 110.537 -179.181 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' E' E ' 87' ' ' ILE . . . . . . . . . . . . . 44.5 mm -119.04 128.89 75.78 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.221 0 CA-C-N 115.863 -0.608 . . . . 0.0 109.705 177.011 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' E' E ' 88' ' ' LEU . . . . . 0.453 HD12 HD22 ' D' ' 124' ' ' LEU . 27.5 mt -114.54 139.33 49.67 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-O 121.151 0.501 . . . . 0.0 111.463 -177.635 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' E' E ' 89' ' ' ASP . . . . . . . . . . . . . 11.6 t70 -132.96 156.83 46.56 Favored 'General case' 0 C--N 1.331 -0.23 0 CA-C-N 115.517 -0.765 . . . . 0.0 109.388 175.39 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' E' E ' 90' ' ' GLU . . . . . . . . . . . . . 96.0 mt-10 -48.44 -38.52 20.0 Favored 'General case' 0 C--N 1.327 -0.371 0 N-CA-C 112.796 0.665 . . . . 0.0 112.796 -171.507 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' E' E ' 91' ' ' ASN . . . . . . . . . . . . . 33.5 m120 -132.11 34.73 3.77 Favored 'General case' 0 N--CA 1.465 0.278 0 C-N-CA 120.961 -0.296 . . . . 0.0 111.703 -176.494 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' E' E ' 92' ' ' LEU . . . . . . . . . . . . . 9.7 tp -166.16 145.55 6.02 Favored 'General case' 0 C--N 1.33 -0.258 0 C-N-CA 120.885 -0.326 . . . . 0.0 110.717 -179.66 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' E' E ' 93' ' ' ILE . . . . . . . . . . . . . 67.7 mt -127.79 125.96 65.98 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.222 0 N-CA-C 109.711 -0.477 . . . . 0.0 109.711 178.989 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' E' E ' 94' ' ' VAL . . . . . . . . . . . . . 47.1 t -122.99 127.14 74.62 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.267 0 N-CA-C 109.797 -0.446 . . . . 0.0 109.797 178.868 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' E' E ' 95' ' ' VAL . . . . . . . . . . . . . 44.2 t -122.93 135.38 63.18 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.294 0 CA-C-N 116.328 -0.396 . . . . 0.0 110.061 -179.252 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' E' E ' 96' ' ' ILE . . . . . . . . . . . . . 61.9 mt -116.31 128.75 73.54 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.326 0 N-CA-C 109.304 -0.628 . . . . 0.0 109.304 179.341 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' E' E ' 97' ' ' THR . . . . . . . . . . . . . 75.7 p -101.67 157.09 17.08 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-O 121.191 0.52 . . . . 0.0 111.371 -177.353 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' E' E ' 98' ' ' GLU . . . . . . . . . . . . . 84.6 tt0 -53.99 -26.66 27.14 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-N 116.008 -0.542 . . . . 0.0 112.133 -179.793 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' E' E ' 99' ' ' GLU . . . . . . . . . . . . . 45.7 mp0 -79.14 16.25 0.99 Allowed 'General case' 0 CA--C 1.536 0.426 0 N-CA-C 113.013 0.746 . . . . 0.0 113.013 -177.931 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' E' E ' 100' ' ' ASN . . . . . . . . . . . . . 3.8 m-20 62.95 38.08 11.44 Favored 'General case' 0 C--O 1.233 0.186 0 CA-C-O 120.952 0.406 . . . . 0.0 110.939 177.397 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' E' E ' 101' ' ' GLU . . . . . . . . . . . . . 84.5 tt0 -116.49 142.5 46.78 Favored 'General case' 0 C--N 1.331 -0.221 0 CA-C-N 116.078 -0.51 . . . . 0.0 109.801 177.124 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' E' E ' 102' ' ' VAL . . . . . . . . . . . . . 46.4 t -115.12 126.46 72.71 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.22 0 N-CA-C 109.87 -0.419 . . . . 0.0 109.87 -178.615 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' E' E ' 103' ' ' LEU . . . . . . . . . . . . . 42.5 mt -118.29 133.43 55.9 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-N 115.692 -0.685 . . . . 0.0 110.249 177.098 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' E' E ' 104' ' ' ILE . . . . . . . . . . . . . 68.5 mt -118.1 123.36 71.53 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.316 0 N-CA-C 109.986 -0.375 . . . . 0.0 109.986 179.632 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' E' E ' 105' ' ' PHE . . . . . . . . . . . . . 75.4 m-85 -122.43 165.69 15.94 Favored 'General case' 0 C--N 1.332 -0.157 0 O-C-N 124.047 0.842 . . . . 0.0 109.607 -179.964 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' E' E ' 106' ' ' ASN . . . . . . . . . . . . . 50.5 p-10 -101.54 -171.23 1.95 Allowed 'General case' 0 C--N 1.331 -0.204 0 N-CA-C 110.002 -0.37 . . . . 0.0 110.002 174.996 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' E' E ' 107' ' ' GLN . . . . . . . . . . . . . 45.8 tt0 -59.13 -29.3 67.29 Favored 'General case' 0 C--N 1.329 -0.3 0 N-CA-C 112.003 0.372 . . . . 0.0 112.003 -179.733 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' E' E ' 108' ' ' ASN . . . . . . . . . . . . . 14.4 t-20 -84.55 10.48 10.89 Favored 'General case' 0 CA--C 1.536 0.42 0 N-CA-C 113.035 0.754 . . . . 0.0 113.035 -177.508 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' E' E ' 109' ' ' LEU . . . . . 0.424 HD21 ' HB2' ' E' ' 78' ' ' ALA . 8.7 tp 58.33 36.77 25.79 Favored 'General case' 0 CA--C 1.531 0.226 0 CA-C-O 121.046 0.45 . . . . 0.0 111.373 179.711 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' E' E ' 110' ' ' GLU . . . . . . . . . . . . . 43.4 mt-10 -103.65 152.84 21.31 Favored 'General case' 0 C--N 1.33 -0.244 0 N-CA-C 109.662 -0.496 . . . . 0.0 109.662 175.676 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' E' E ' 111' ' ' GLU . . . . . . . . . . . . . 58.9 tt0 -87.29 121.91 30.36 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-O 120.914 0.387 . . . . 0.0 110.763 -176.315 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' E' E ' 112' ' ' LEU . . . . . . . . . . . . . 13.8 mt -105.18 -46.06 4.34 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 115.978 -0.556 . . . . 0.0 110.834 -179.895 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' E' E ' 113' ' ' TYR . . . . . 0.413 ' CE1' HG21 ' F' ' 75' ' ' VAL . 65.3 t80 -139.91 143.75 36.79 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.299 -0.41 . . . . 0.0 111.221 -178.431 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' E' E ' 114' ' ' ARG . . . . . . . . . . . . . 38.8 ptt180 -144.55 123.28 12.59 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.096 -0.502 . . . . 0.0 110.796 178.128 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' E' E ' 115' ' ' GLY . . . . . . . . . . . . . . . -150.13 158.81 27.84 Favored Glycine 0 CA--C 1.525 0.703 0 N-CA-C 110.934 -0.866 . . . . 0.0 110.934 178.205 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' E' E ' 116' ' ' LYS . . . . . . . . . . . . . 37.4 ttpt -127.87 139.01 52.88 Favored 'General case' 0 C--N 1.331 -0.224 0 O-C-N 122.634 -0.333 . . . . 0.0 110.29 178.118 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' E' E ' 117' ' ' PHE . . . . . . . . . . . . . 39.8 m-85 -133.75 114.96 13.99 Favored 'General case' 0 C--N 1.329 -0.296 0 N-CA-C 110.0 -0.37 . . . . 0.0 110.0 -178.153 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' E' E ' 118' ' ' GLU . . . . . . . . . . . . . 84.3 tt0 -53.57 -43.2 68.33 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.64 -0.255 . . . . 0.0 111.542 -175.97 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' E' E ' 119' ' ' ASN . . . . . . . . . . . . . 82.3 m-20 -100.17 31.0 3.53 Favored 'General case' 0 C--N 1.33 -0.24 0 N-CA-C 112.154 0.428 . . . . 0.0 112.154 -174.185 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' E' E ' 120' ' ' LEU . . . . . 0.421 HD11 HG23 ' E' ' 132' ' ' ILE . 13.9 tp -54.97 121.04 7.82 Favored 'General case' 0 C--N 1.331 -0.207 0 CA-C-O 120.663 0.268 . . . . 0.0 110.745 178.716 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' E' E ' 121' ' ' ASN . . . . . . . . . . . . . 46.1 t30 -114.03 -43.93 3.2 Favored 'General case' 0 C--O 1.232 0.167 0 CA-C-N 116.598 -0.273 . . . . 0.0 111.516 -176.184 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' E' E ' 122' ' ' LYS . . . . . . . . . . . . . 57.9 mtpt -140.08 144.55 36.88 Favored 'General case' 0 C--N 1.332 -0.159 0 CA-C-O 120.938 0.399 . . . . 0.0 111.741 -176.084 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' E' E ' 123' ' ' VAL . . . . . . . . . . . . . 46.7 t -127.1 124.9 65.34 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 N-CA-C 109.381 -0.6 . . . . 0.0 109.381 174.078 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' E' E ' 124' ' ' LEU . . . . . . . . . . . . . 51.6 mt -126.73 139.32 53.23 Favored 'General case' 0 C--N 1.331 -0.201 0 CA-C-O 120.95 0.405 . . . . 0.0 110.967 -177.186 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' E' E ' 125' ' ' VAL . . . . . . . . . . . . . 34.9 m -132.01 139.03 51.28 Favored 'Isoleucine or valine' 0 C--N 1.333 -0.145 0 CA-C-N 116.017 -0.538 . . . . 0.0 110.911 -179.871 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' E' E ' 126' ' ' ARG . . . . . . . . . . . . . 77.1 mtp85 -140.52 109.41 6.04 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 115.958 -0.565 . . . . 0.0 110.29 175.422 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' E' E ' 127' ' ' ASN . . . . . . . . . . . . . 94.5 m-20 53.32 -104.9 0.22 Allowed 'General case' 0 CA--C 1.542 0.663 0 CA-C-O 119.067 -0.492 . . . . 0.0 111.136 -179.897 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' E' E ' 128' ' ' ASP . . . . . . . . . . . . . 14.6 p-10 -113.69 5.41 16.44 Favored 'General case' 0 CA--C 1.537 0.447 0 CA-C-N 119.496 1.044 . . . . 0.0 113.393 -177.334 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' E' E ' 129' ' ' LEU . . . . . . . . . . . . . 3.9 tt -105.11 131.51 52.51 Favored 'General case' 0 C--N 1.332 -0.154 0 N-CA-C 109.367 -0.605 . . . . 0.0 109.367 177.809 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' E' E ' 130' ' ' VAL . . . . . . . . . . . . . 44.2 t -120.6 137.05 55.64 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.218 0 CA-C-O 120.765 0.317 . . . . 0.0 110.165 -177.236 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' E' E ' 131' ' ' VAL . . . . . . . . . . . . . 41.8 t -135.95 138.07 48.0 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.249 0 CA-C-O 121.203 0.525 . . . . 0.0 110.459 178.926 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' E' E ' 132' ' ' ILE . . . . . 0.421 HG23 HD11 ' E' ' 120' ' ' LEU . 76.4 mt -119.93 134.0 64.87 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.324 0 CA-C-N 115.513 -0.767 . . . . 0.0 109.51 -179.739 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' E' E ' 133' ' ' ILE . . . . . . . . . . . . . 42.8 mm -117.21 125.32 73.89 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.23 0 CA-C-O 120.798 0.332 . . . . 0.0 110.865 -176.142 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' E' E ' 134' ' ' ASP . . . . . . . . . . . . . 7.7 p-10 -137.03 148.72 47.0 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.0 -0.545 . . . . 0.0 109.568 174.187 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' E' E ' 135' ' ' GLU . . . . . . . . . . . . . 43.5 tp10 -49.81 -25.88 3.48 Favored 'General case' 0 C--N 1.327 -0.377 0 N-CA-C 112.792 0.664 . . . . 0.0 112.792 -171.585 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' E' E ' 136' ' ' GLN . . . . . . . . . . . . . 97.3 mt-30 -96.5 -33.06 11.98 Favored 'General case' 0 CA--C 1.53 0.178 0 N-CA-C 112.476 0.547 . . . . 0.0 112.476 -175.995 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' E' E ' 137' ' ' LYS . . . . . . . . . . . . . 84.5 mttt -141.37 154.56 45.72 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-O 121.233 0.54 . . . . 0.0 111.697 -168.427 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' E' E ' 138' ' ' LEU . . . . . 0.407 ' C ' HD23 ' E' ' 138' ' ' LEU . 4.5 tt -117.56 119.68 35.74 Favored 'General case' 0 C--N 1.33 -0.246 0 N-CA-C 108.965 -0.754 . . . . 0.0 108.965 171.071 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' E' E ' 139' ' ' THR . . . . . . . . . . . . . 25.3 m -106.05 128.8 54.1 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.454 -0.339 . . . . 0.0 110.712 -176.53 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' E' E ' 140' ' ' LEU . . . . . 0.468 HD23 ' N ' ' E' ' 141' ' ' ILE . 5.4 tt -116.56 122.85 45.88 Favored 'General case' 0 C--N 1.329 -0.322 0 N-CA-C 109.068 -0.716 . . . . 0.0 109.068 -179.221 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' E' E ' 141' ' ' ILE . . . . . 0.468 ' N ' HD23 ' E' ' 140' ' ' LEU . 18.9 mt -121.99 118.79 56.69 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.288 0 CA-C-O 121.025 0.44 . . . . 0.0 109.981 -176.757 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' E' E ' 142' ' ' ARG . . . . . . . . . . . . . 84.4 mtp180 -103.7 125.27 50.08 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 115.285 -0.871 . . . . 0.0 110.341 -179.576 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' E' E ' 143' ' ' THR . . . . . . . . . . . . . 43.2 p . . . . . 0 C--O 1.22 -0.472 0 CA-C-O 118.015 -0.993 . . . . 0.0 110.527 -179.781 . . . . . . . . 0 0 . 1 . 003 nuclear nobuild core ' F' F ' 1' ' ' MET . . . . . . . . . . . . . 27.3 ptm . . . . . 0 C--O 1.232 0.15 0 CA-C-O 120.903 0.383 . . . . 0.0 110.564 . . . . . . . . . 0 0 . 1 . 003 nuclear nobuild core ' F' F ' 2' ' ' SER . . . . . . . . . . . . . 4.5 p -117.78 130.1 56.09 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.135 177.686 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' F' F ' 3' ' ' GLU . . . . . . . . . . . . . 83.3 tt0 -142.08 137.74 31.23 Favored 'General case' 0 C--N 1.327 -0.4 0 CA-C-N 115.988 -0.551 . . . . 0.0 111.062 -177.928 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' F' F ' 4' ' ' LEU . . . . . . . . . . . . . 17.1 tp -124.54 131.1 53.49 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.059 176.816 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' F' F ' 5' ' ' LYS . . . . . . . . . . . . . 69.0 mttm -110.28 122.29 47.3 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.305 -0.407 . . . . 0.0 110.602 179.962 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' F' F ' 6' ' ' LEU . . . . . . . . . . . . . 30.3 mt -113.88 149.44 35.12 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 115.234 -0.893 . . . . 0.0 109.954 -178.895 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' F' F ' 7' ' ' LYS . . . . . . . . . . . . . 52.4 tttp -137.11 137.15 22.03 Favored Pre-proline 0 CA--C 1.534 0.34 0 CA-C-O 118.857 -0.592 . . . . 0.0 109.994 175.569 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' F' F ' 8' ' ' PRO . . . . . . . . . . . . . 74.3 Cg_endo -91.45 138.41 2.18 Favored 'Trans proline' 0 N--CA 1.49 1.276 0 C-N-CA 121.675 1.583 . . . . 0.0 111.708 177.259 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' F' F ' 9' ' ' LEU . . . . . . . . . . . . . 58.1 mt -74.78 -48.18 4.92 Favored Pre-proline 0 CA--C 1.534 0.336 0 CA-C-O 118.629 -0.7 . . . . 0.0 112.277 -178.881 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' F' F ' 10' ' ' PRO . . . . . . . . . . . . . 95.3 Cg_endo -78.79 156.8 27.6 Favored 'Trans proline' 0 N--CA 1.496 1.653 0 C-N-CA 121.081 1.187 . . . . 0.0 112.008 177.381 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' F' F ' 11' ' ' LYS . . . . . . . . . . . . . 81.8 tttt -87.92 101.76 14.06 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.396 -0.365 . . . . 0.0 110.266 179.32 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' F' F ' 12' ' ' VAL . . . . . . . . . . . . . 12.3 p -143.57 149.3 18.2 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.295 0 CA-C-N 116.2 -0.454 . . . . 0.0 110.744 -178.313 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' F' F ' 13' ' ' GLU . . . . . . . . . . . . . 84.0 tt0 -91.43 127.6 36.94 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.302 -0.408 . . . . 0.0 109.989 177.598 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' F' F ' 14' ' ' LEU . . . . . . . . . . . . . 29.9 mt -98.83 146.04 30.97 Favored Pre-proline 0 CA--C 1.534 0.333 0 CA-C-O 119.183 -0.437 . . . . 0.0 110.632 -177.711 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' F' F ' 15' ' ' PRO . . . . . . . . . . . . . 23.8 Cg_exo -64.44 158.61 48.44 Favored 'Trans proline' 0 N--CA 1.497 1.707 0 C-N-CA 121.401 1.4 . . . . 0.0 111.777 174.309 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' F' F ' 16' ' ' PRO . . . . . . . . . . . . . 37.8 Cg_exo -57.98 -43.51 47.93 Favored 'Trans proline' 0 N--CA 1.496 1.648 0 C-N-CA 121.477 1.451 . . . . 0.0 112.97 -177.834 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' F' F ' 17' ' ' ASP . . . . . . . . . . . . . 23.2 p-10 -82.42 7.73 13.41 Favored 'General case' 0 CA--C 1.536 0.429 0 N-CA-C 113.252 0.834 . . . . 0.0 113.252 -177.615 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' F' F ' 18' ' ' PHE . . . . . . . . . . . . . 45.7 t80 -58.05 -45.11 87.57 Favored 'General case' 0 N--CA 1.458 -0.069 0 O-C-N 121.996 -0.44 . . . . 0.0 110.183 -178.179 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' F' F ' 19' ' ' VAL . . . . . 0.407 HG13 ' N ' ' F' ' 20' ' ' ASP . 14.4 p -56.98 -41.96 78.12 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.35 0 CA-C-N 116.34 -0.391 . . . . 0.0 110.935 -178.585 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' F' F ' 20' ' ' ASP . . . . . 0.407 ' N ' HG13 ' F' ' 19' ' ' VAL . 67.6 m-20 -60.85 -42.13 97.23 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-O 120.884 0.373 . . . . 0.0 110.9 -178.125 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' F' F ' 21' ' ' VAL . . . . . . . . . . . . . 52.9 t -64.36 -47.37 89.84 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.32 0 CA-C-N 116.374 -0.376 . . . . 0.0 110.353 -178.107 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' F' F ' 22' ' ' ILE . . . . . . . . . . . . . 51.0 mm -56.72 -43.49 79.47 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.283 0 CA-C-O 120.773 0.32 . . . . 0.0 110.479 178.764 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' F' F ' 23' ' ' ARG . . . . . . . . . . . . . 42.2 ttp180 -54.4 -49.12 70.66 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.632 -0.258 . . . . 0.0 111.432 -179.003 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' F' F ' 24' ' ' ILE . . . . . . . . . . . . . 73.4 mt -59.37 -43.72 90.88 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.284 0 C-N-CA 121.072 -0.251 . . . . 0.0 111.019 -178.071 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' F' F ' 25' ' ' LYS . . . . . . . . . . . . . 99.0 mttt -63.79 -41.8 97.87 Favored 'General case' 0 C--N 1.327 -0.382 0 N-CA-C 112.526 0.565 . . . . 0.0 112.526 -178.255 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' F' F ' 26' ' ' LEU . . . . . . . . . . . . . 93.3 mt -79.49 -41.64 26.98 Favored 'General case' 0 C--N 1.329 -0.318 0 N-CA-C 113.14 0.793 . . . . 0.0 113.14 -172.511 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' F' F ' 27' ' ' GLN . . . . . . . . . . . . . 9.5 pt20 -46.41 142.16 3.19 Favored 'General case' 0 N--CA 1.469 0.482 0 N-CA-C 112.9 0.704 . . . . 0.0 112.9 -173.581 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' F' F ' 28' ' ' GLY . . . . . . . . . . . . . . . 101.26 -29.85 11.64 Favored Glycine 0 CA--C 1.529 0.953 0 CA-C-N 115.15 -0.932 . . . . 0.0 111.941 -177.182 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' F' F ' 29' ' ' LYS . . . . . . . . . . . . . 93.3 mttt -98.62 155.18 17.43 Favored 'General case' 0 C--N 1.332 -0.173 0 CA-C-N 117.329 0.564 . . . . 0.0 111.129 177.981 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' F' F ' 30' ' ' THR . . . . . . . . . . . . . 34.8 m -102.58 138.91 38.86 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.163 -0.471 . . . . 0.0 110.063 176.657 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' F' F ' 31' ' ' VAL . . . . . . . . . . . . . 34.9 m -128.91 158.6 41.47 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.186 0 CA-C-N 116.413 -0.358 . . . . 0.0 110.808 -178.8 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' F' F ' 32' ' ' ARG . . . . . . . . . . . . . 96.9 mtt180 -130.79 151.74 50.89 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 115.922 -0.581 . . . . 0.0 110.5 178.735 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' F' F ' 33' ' ' THR . . . . . . . . . . . . . 18.4 m -53.97 138.78 36.13 Favored 'General case' 0 C--N 1.331 -0.239 0 CA-C-N 116.19 -0.459 . . . . 0.0 111.153 -179.519 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' F' F ' 34' ' ' GLY . . . . . . . . . . . . . . . 101.82 -17.12 55.29 Favored Glycine 0 CA--C 1.534 1.225 0 CA-C-O 119.618 -0.546 . . . . 0.0 113.191 -179.915 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' F' F ' 35' ' ' ASP . . . . . . . . . . . . . 56.7 m-20 -64.71 149.57 48.89 Favored 'General case' 0 C--O 1.232 0.14 0 CA-C-N 118.146 0.973 . . . . 0.0 111.29 179.434 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' F' F ' 36' ' ' VAL . . . . . . . . . . . . . 46.3 t -124.32 130.07 73.76 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.303 0 CA-C-N 115.698 -0.683 . . . . 0.0 109.845 179.565 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' F' F ' 37' ' ' ILE . . . . . . . . . . . . . 69.1 mt -121.97 139.42 49.05 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.219 0 CA-C-N 116.216 -0.447 . . . . 0.0 109.835 179.95 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' F' F ' 38' ' ' GLY . . . . . . . . . . . . . . . -114.41 128.88 8.41 Favored Glycine 0 CA--C 1.526 0.75 0 N-CA-C 110.943 -0.863 . . . . 0.0 110.943 -179.974 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' F' F ' 39' ' ' ILE . . . . . . . . . . . . . 70.8 mt -119.37 129.89 74.69 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.245 0 N-CA-C 109.929 -0.397 . . . . 0.0 109.929 179.059 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' F' F ' 40' ' ' SER . . . . . . . . . . . . . 22.8 t -93.74 118.9 32.03 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.437 -0.347 . . . . 0.0 110.788 175.732 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' F' F ' 41' ' ' ILE . . . . . . . . . . . . . 71.4 mt -124.76 117.06 49.2 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.269 0 CA-C-O 120.787 0.327 . . . . 0.0 110.315 178.808 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' F' F ' 42' ' ' LEU . . . . . . . . . . . . . 6.9 mp 51.04 36.93 16.52 Favored 'General case' 0 N--CA 1.463 0.21 0 CA-C-O 121.143 0.497 . . . . 0.0 111.548 178.17 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' F' F ' 43' ' ' GLY . . . . . . . . . . . . . . . 73.88 30.79 60.95 Favored Glycine 0 CA--C 1.529 0.941 0 C-N-CA 121.184 -0.531 . . . . 0.0 112.324 177.636 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' F' F ' 44' ' ' LYS . . . . . . . . . . . . . 64.1 mttp -132.5 127.21 34.71 Favored 'General case' 0 C--N 1.331 -0.233 0 N-CA-C 109.679 -0.489 . . . . 0.0 109.679 177.231 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' F' F ' 45' ' ' GLU . . . . . . . . . . . . . 80.2 tt0 -84.79 122.77 29.61 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-O 120.843 0.354 . . . . 0.0 111.215 -177.535 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' F' F ' 46' ' ' VAL . . . . . . . . . . . . . 7.6 p -122.2 126.45 74.34 Favored 'Isoleucine or valine' 0 C--O 1.233 0.186 0 N-CA-C 109.329 -0.619 . . . . 0.0 109.329 174.625 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' F' F ' 47' ' ' LYS . . . . . . . . . . . . . 93.7 mttt -100.33 130.48 46.44 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.123 -0.49 . . . . 0.0 111.342 179.871 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' F' F ' 48' ' ' PHE . . . . . . . . . . . . . 91.7 m-85 -114.21 131.79 56.34 Favored 'General case' 0 C--N 1.33 -0.267 0 N-CA-C 109.637 -0.505 . . . . 0.0 109.637 175.095 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' F' F ' 49' ' ' LYS . . . . . . . . . . . . . 37.2 tttp -109.38 139.9 43.76 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.452 -0.34 . . . . 0.0 110.542 179.846 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' F' F ' 50' ' ' VAL . . . . . . . . . . . . . 43.4 t -82.96 108.22 15.5 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.225 0 N-CA-C 109.267 -0.642 . . . . 0.0 109.267 175.513 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' F' F ' 51' ' ' VAL . . . . . . . . . . . . . 48.0 t -73.08 -53.08 19.48 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.32 0 CA-C-N 115.926 -0.579 . . . . 0.0 109.615 -174.404 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' F' F ' 52' ' ' GLN . . . . . . . . . . . . . 88.7 mt-30 -154.09 151.44 29.29 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.022 -0.535 . . . . 0.0 111.972 -177.493 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' F' F ' 53' ' ' ALA . . . . . . . . . . . . . . . -128.18 132.96 48.84 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 115.214 -0.903 . . . . 0.0 109.683 174.975 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' F' F ' 54' ' ' TYR . . . . . . . . . . . . . 25.7 t80 -129.07 108.41 18.06 Favored Pre-proline 0 CA--C 1.535 0.4 0 CA-C-O 118.327 -0.844 . . . . 0.0 110.256 179.07 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' F' F ' 55' ' ' PRO . . . . . . . . . . . . . 73.2 Cg_endo -77.16 169.0 75.4 Favored 'Cis proline' 0 N--CA 1.501 1.919 0 CA-C-N 121.853 1.698 . . . . 0.0 112.453 -5.205 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' F' F ' 56' ' ' SER . . . . . . . . . . . . . 54.3 m -116.72 130.42 24.56 Favored Pre-proline 0 CA--C 1.539 0.536 0 CA-C-O 118.413 -0.803 . . . . 0.0 109.229 174.819 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' F' F ' 57' ' ' PRO . . . . . . . . . . . . . 38.1 Cg_endo -67.15 164.65 70.31 Favored 'Cis proline' 0 N--CA 1.498 1.741 0 CA-C-N 121.991 1.747 . . . . 0.0 111.584 -0.282 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' F' F ' 58' ' ' LEU . . . . . . . . . . . . . 29.7 tp -129.75 136.2 49.35 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-N 116.26 -0.427 . . . . 0.0 110.297 179.702 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' F' F ' 59' ' ' ARG . . . . . . . . . . . . . 70.5 ttt180 -100.42 128.57 46.44 Favored 'General case' 0 C--N 1.326 -0.423 0 N-CA-C 109.188 -0.671 . . . . 0.0 109.188 176.244 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' F' F ' 60' ' ' VAL . . . . . . . . . . . . . 46.9 t -80.65 115.01 22.45 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.254 0 C-N-CA 120.588 -0.445 . . . . 0.0 110.096 -175.075 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' F' F ' 61' ' ' GLU . . . . . . . . . . . . . 95.3 mt-10 -130.99 160.53 34.29 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 115.841 -0.618 . . . . 0.0 109.758 178.221 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' F' F ' 62' ' ' ASP . . . . . . . . . . . . . 15.0 p-10 -53.25 -31.45 43.56 Favored 'General case' 0 C--N 1.327 -0.387 0 N-CA-C 111.925 0.343 . . . . 0.0 111.925 179.944 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' F' F ' 63' ' ' ARG . . . . . . . . . . . . . 39.7 mtp180 -71.86 -22.11 61.57 Favored 'General case' 0 CA--C 1.532 0.27 0 N-CA-C 112.894 0.701 . . . . 0.0 112.894 -176.095 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' F' F ' 64' ' ' THR . . . . . . . . . . . . . 34.2 m -72.73 141.13 48.16 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-O 121.013 0.435 . . . . 0.0 111.013 -175.612 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' F' F ' 65' ' ' LYS . . . . . . . . . . . . . 97.5 mttt -89.18 131.2 35.42 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 115.851 -0.613 . . . . 0.0 109.84 177.635 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' F' F ' 66' ' ' ILE . . . . . . . . . . . . . 59.9 mt -116.01 129.03 73.06 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.228 0 N-CA-C 109.798 -0.445 . . . . 0.0 109.798 179.37 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' F' F ' 67' ' ' THR . . . . . . . . . . . . . 23.8 m -127.05 142.63 51.49 Favored 'General case' 0 C--N 1.331 -0.227 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.892 -178.148 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' F' F ' 68' ' ' LEU . . . . . . . . . . . . . 6.7 mp . . . . . 0 C--N 1.329 -0.314 0 CA-C-N 116.023 -0.535 . . . . 0.0 110.321 176.948 . . . . . . . . 0 0 . 1 . 003 nuclear nobuild core ' F' F ' 73' ' ' VAL . . . . . . . . . . . . . 24.5 m . . . . . 0 C--O 1.231 0.117 0 CA-C-O 121.356 0.598 . . . . 0.0 110.933 . . . . . . . . . 0 0 . 1 . 003 nuclear nobuild core ' F' F ' 74' ' ' ASP . . . . . . . . . . . . . 12.3 t0 -99.41 124.1 44.25 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 115.404 -0.816 . . . . 0.0 108.981 176.053 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' F' F ' 75' ' ' VAL . . . . . 0.413 HG21 ' CE1' ' E' ' 113' ' ' TYR . 41.8 t -112.83 124.08 69.13 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.245 0 CA-C-O 121.072 0.463 . . . . 0.0 110.839 -174.35 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' F' F ' 76' ' ' LEU . . . . . . . . . . . . . 5.8 mp -125.76 146.87 49.59 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 115.549 -0.75 . . . . 0.0 109.638 175.394 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' F' F ' 77' ' ' GLU . . . . . . . . . . . . . 97.7 mt-10 -134.22 130.88 37.84 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-O 120.977 0.418 . . . . 0.0 110.889 -178.075 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' F' F ' 78' ' ' ALA . . . . . . . . . . . . . . . -114.47 134.21 55.18 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 115.709 -0.678 . . . . 0.0 109.502 176.806 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' F' F ' 79' ' ' LYS . . . . . 0.648 ' O ' HD13 ' F' ' 80' ' ' ILE . 25.7 pttm -77.55 119.31 20.95 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-O 121.472 0.653 . . . . 0.0 110.792 -178.644 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' F' F ' 80' ' ' ILE . . . . . 0.648 HD13 ' O ' ' F' ' 79' ' ' LYS . 36.6 mm -139.26 113.87 7.66 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.282 0 CA-C-N 115.546 -0.752 . . . . 0.0 109.103 -178.795 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' F' F ' 81' ' ' LYS . . . . . . . . . . . . . 24.5 pttm -114.32 128.01 56.14 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-O 120.991 0.424 . . . . 0.0 111.269 -177.252 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' F' F ' 82' ' ' GLY . . . . . . . . . . . . . . . 88.89 42.21 5.73 Favored Glycine 0 CA--C 1.527 0.794 0 N-CA-C 111.483 -0.647 . . . . 0.0 111.483 177.078 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' F' F ' 83' ' ' ILE . . . . . . . . . . . . . 72.9 mt -69.88 140.95 17.79 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 CA-C-O 120.871 0.367 . . . . 0.0 110.197 179.633 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' F' F ' 84' ' ' LYS . . . . . . . . . . . . . 54.7 tttp -101.6 -50.88 3.59 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-N 115.951 -0.568 . . . . 0.0 109.984 178.746 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' F' F ' 85' ' ' ASP . . . . . . . . . . . . . 6.5 t0 -153.71 149.26 27.31 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 115.792 -0.64 . . . . 0.0 110.402 -179.543 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' F' F ' 86' ' ' VAL . . . . . . . . . . . . . 42.1 t -132.2 129.73 60.13 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.185 0 CA-C-O 120.882 0.372 . . . . 0.0 110.319 -179.852 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' F' F ' 87' ' ' ILE . . . . . 0.494 HD12 ' N ' ' F' ' 87' ' ' ILE . 4.9 mp -120.1 126.65 75.5 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.245 0 N-CA-C 109.548 -0.538 . . . . 0.0 109.548 176.321 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' F' F ' 88' ' ' LEU . . . . . . . . . . . . . 59.0 mt -111.59 136.9 50.17 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-O 121.103 0.478 . . . . 0.0 111.263 -177.798 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' F' F ' 89' ' ' ASP . . . . . . . . . . . . . 12.6 t70 -129.49 153.66 47.77 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 115.646 -0.706 . . . . 0.0 109.285 175.742 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' F' F ' 90' ' ' GLU . . . . . . . . . . . . . 43.6 tp10 -48.47 -33.99 10.33 Favored 'General case' 0 C--N 1.329 -0.326 0 N-CA-C 112.918 0.71 . . . . 0.0 112.918 -172.011 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' F' F ' 91' ' ' ASN . . . . . . . . . . . . . 83.3 m-20 -131.25 27.54 4.79 Favored 'General case' 0 N--CA 1.466 0.343 0 N-CA-C 112.514 0.561 . . . . 0.0 112.514 -175.381 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' F' F ' 92' ' ' LEU . . . . . . . . . . . . . 6.6 tp -166.13 150.46 7.94 Favored 'General case' 0 C--N 1.331 -0.199 0 C-N-CA 120.83 -0.348 . . . . 0.0 110.752 -179.981 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' F' F ' 93' ' ' ILE . . . . . . . . . . . . . 71.8 mt -129.03 126.14 63.95 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.216 0 N-CA-C 109.693 -0.484 . . . . 0.0 109.693 178.927 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' F' F ' 94' ' ' VAL . . . . . . . . . . . . . 44.8 t -121.8 127.16 75.39 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.258 0 N-CA-C 109.735 -0.468 . . . . 0.0 109.735 178.8 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' F' F ' 95' ' ' VAL . . . . . . . . . . . . . 42.4 t -124.16 136.3 60.86 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.25 0 CA-C-N 116.091 -0.504 . . . . 0.0 110.054 -178.361 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' F' F ' 96' ' ' ILE . . . . . 0.559 HD11 ' HB ' ' F' ' 123' ' ' VAL . 47.3 mt -118.27 130.93 72.41 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.235 0 N-CA-C 109.37 -0.604 . . . . 0.0 109.37 179.306 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' F' F ' 97' ' ' THR . . . . . . . . . . . . . 67.3 p -103.16 157.21 17.16 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-O 121.1 0.476 . . . . 0.0 111.101 -178.586 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' F' F ' 98' ' ' GLU . . . . . . . . . . . . . 96.5 mt-10 -53.84 -26.01 22.35 Favored 'General case' 0 C--N 1.328 -0.354 0 N-CA-C 112.424 0.527 . . . . 0.0 112.424 -178.79 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' F' F ' 99' ' ' GLU . . . . . . . . . . . . . 95.7 mt-10 -79.62 16.8 1.0 Allowed 'General case' 0 CA--C 1.534 0.352 0 N-CA-C 113.213 0.82 . . . . 0.0 113.213 -176.126 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' F' F ' 100' ' ' ASN . . . . . . . . . . . . . 3.6 m-20 62.72 37.4 12.68 Favored 'General case' 0 C--O 1.234 0.24 0 CA-C-O 121.212 0.53 . . . . 0.0 111.038 178.136 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' F' F ' 101' ' ' GLU . . . . . . . . . . . . . 84.5 tt0 -117.65 139.85 50.44 Favored 'General case' 0 C--N 1.333 -0.142 0 N-CA-C 109.378 -0.601 . . . . 0.0 109.378 176.217 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' F' F ' 102' ' ' VAL . . . . . . . . . . . . . 45.0 t -117.57 129.89 73.32 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 N-CA-C 109.847 -0.427 . . . . 0.0 109.847 -177.377 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' F' F ' 103' ' ' LEU . . . . . . . . . . . . . 4.7 mp -123.09 137.99 54.78 Favored 'General case' 0 C--N 1.331 -0.219 0 CA-C-N 116.144 -0.48 . . . . 0.0 110.715 178.288 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' F' F ' 104' ' ' ILE . . . . . . . . . . . . . 65.5 mt -117.8 124.7 73.44 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.255 0 CA-C-N 115.802 -0.635 . . . . 0.0 109.882 179.989 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' F' F ' 105' ' ' PHE . . . . . . . . . . . . . 89.9 m-85 -122.43 161.47 23.45 Favored 'General case' 0 C--N 1.332 -0.187 0 O-C-N 123.969 0.793 . . . . 0.0 109.817 179.458 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' F' F ' 106' ' ' ASN . . . . . . . . . . . . . 47.2 p-10 -97.5 -171.35 2.17 Favored 'General case' 0 C--N 1.331 -0.209 0 N-CA-C 109.932 -0.396 . . . . 0.0 109.932 173.132 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' F' F ' 107' ' ' GLN . . . . . . . . . . . . . 48.4 tt0 -57.3 -30.12 64.47 Favored 'General case' 0 C--N 1.328 -0.348 0 N-CA-C 112.043 0.386 . . . . 0.0 112.043 -179.188 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' F' F ' 108' ' ' ASN . . . . . . . . . . . . . 13.0 t-20 -88.73 14.02 11.09 Favored 'General case' 0 CA--C 1.534 0.349 0 N-CA-C 112.973 0.731 . . . . 0.0 112.973 -175.612 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' F' F ' 109' ' ' LEU . . . . . . . . . . . . . 33.5 mt 57.97 33.4 23.15 Favored 'General case' 0 C--O 1.233 0.19 0 N-CA-C 111.756 0.28 . . . . 0.0 111.756 179.247 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' F' F ' 110' ' ' GLU . . . . . . . . . . . . . 43.3 mt-10 -98.05 145.24 26.73 Favored 'General case' 0 C--N 1.33 -0.277 0 N-CA-C 109.594 -0.521 . . . . 0.0 109.594 175.924 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' F' F ' 111' ' ' GLU . . . . . . . . . . . . . 53.7 tt0 -81.24 122.02 26.89 Favored 'General case' 0 C--N 1.328 -0.351 0 C-N-CA 120.725 -0.39 . . . . 0.0 110.487 -176.992 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' F' F ' 112' ' ' LEU . . . . . . . . . . . . . 58.2 mt -106.53 -46.09 4.09 Favored 'General case' 0 C--N 1.331 -0.226 0 CA-C-N 116.135 -0.484 . . . . 0.0 110.42 178.178 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' F' F ' 113' ' ' TYR . . . . . . . . . . . . . 64.6 t80 -138.36 137.08 36.98 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.134 -0.485 . . . . 0.0 111.169 -179.017 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' F' F ' 114' ' ' ARG . . . . . . . . . . . . . 56.1 ttp180 -141.45 121.29 13.55 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.277 -0.419 . . . . 0.0 109.949 174.848 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' F' F ' 115' ' ' GLY . . . . . . . . . . . . . . . -148.52 160.96 28.54 Favored Glycine 0 CA--C 1.524 0.595 0 N-CA-C 111.069 -0.812 . . . . 0.0 111.069 179.826 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' F' F ' 116' ' ' LYS . . . . . . . . . . . . . 40.2 ttpt -124.36 141.93 51.69 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-O 120.64 0.257 . . . . 0.0 110.385 -179.901 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' F' F ' 117' ' ' PHE . . . . . . . . . . . . . 47.4 m-85 -135.24 113.9 11.76 Favored 'General case' 0 C--N 1.332 -0.184 0 CA-C-O 120.907 0.384 . . . . 0.0 110.019 179.459 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' F' F ' 118' ' ' GLU . . . . . . . . . . . . . 82.1 tt0 -53.95 -51.69 63.03 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.457 -0.338 . . . . 0.0 111.376 -176.348 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' F' F ' 119' ' ' ASN . . . . . . . . . . . . . 87.6 m-20 -93.84 31.19 1.65 Allowed 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.052 -0.522 . . . . 0.0 112.19 -174.712 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' F' F ' 120' ' ' LEU . . . . . . . . . . . . . 12.9 tp -54.2 124.08 14.69 Favored 'General case' 0 N--CA 1.462 0.153 0 CA-C-O 120.624 0.249 . . . . 0.0 110.738 178.348 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' F' F ' 121' ' ' ASN . . . . . . . . . . . . . 12.4 m120 -112.15 -44.06 3.47 Favored 'General case' 0 C--O 1.232 0.137 0 CA-C-N 116.62 -0.264 . . . . 0.0 110.944 -176.679 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' F' F ' 122' ' ' LYS . . . . . . . . . . . . . 98.2 mttt -146.66 143.16 28.57 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-O 120.917 0.389 . . . . 0.0 111.387 -178.875 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' F' F ' 123' ' ' VAL . . . . . 0.559 ' HB ' HD11 ' F' ' 96' ' ' ILE . 46.5 t -126.77 127.43 70.01 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.314 0 N-CA-C 109.19 -0.67 . . . . 0.0 109.19 175.049 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' F' F ' 124' ' ' LEU . . . . . . . . . . . . . 13.9 tp -134.05 140.05 46.41 Favored 'General case' 0 C--N 1.331 -0.227 0 CA-C-O 120.947 0.403 . . . . 0.0 110.805 -176.797 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' F' F ' 125' ' ' VAL . . . . . . . . . . . . . 12.2 p -131.51 140.03 49.26 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.215 0 CA-C-N 116.239 -0.437 . . . . 0.0 110.335 178.492 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' F' F ' 126' ' ' ARG . . . . . . . . . . . . . 96.6 mtt-85 -136.97 124.24 21.85 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.064 -0.516 . . . . 0.0 110.402 179.297 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' F' F ' 127' ' ' ASN . . . . . . . . . . . . . 67.7 m-80 52.02 -106.46 0.27 Allowed 'General case' 0 CA--C 1.544 0.73 0 CA-C-O 119.044 -0.503 . . . . 0.0 111.104 179.997 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' F' F ' 128' ' ' ASP . . . . . . . . . . . . . 8.1 p-10 -114.09 1.67 14.68 Favored 'General case' 0 CA--C 1.536 0.414 0 CA-C-N 119.629 1.104 . . . . 0.0 113.459 -177.86 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' F' F ' 129' ' ' LEU . . . . . . . . . . . . . 29.3 mt -107.35 145.12 33.26 Favored 'General case' 0 C--N 1.333 -0.11 0 O-C-N 121.962 -0.461 . . . . 0.0 110.383 -178.571 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' F' F ' 130' ' ' VAL . . . . . . . . . . . . . 43.3 t -122.18 136.31 59.44 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.231 0 CA-C-O 120.909 0.385 . . . . 0.0 110.072 -178.109 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' F' F ' 131' ' ' VAL . . . . . . . . . . . . . 42.4 t -131.69 133.61 61.27 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.247 0 CA-C-N 116.209 -0.451 . . . . 0.0 109.812 177.651 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' F' F ' 132' ' ' ILE . . . . . . . . . . . . . 71.0 mt -119.68 132.14 70.25 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.317 0 CA-C-N 115.966 -0.561 . . . . 0.0 109.536 -179.143 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' F' F ' 133' ' ' ILE . . . . . . . . . . . . . 37.4 mm -116.84 123.39 71.69 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.331 0 CA-C-O 120.916 0.388 . . . . 0.0 110.855 -175.274 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' F' F ' 134' ' ' ASP . . . . . . . . . . . . . 9.3 p-10 -134.07 149.12 51.12 Favored 'General case' 0 C--N 1.329 -0.298 0 N-CA-C 109.606 -0.516 . . . . 0.0 109.606 174.661 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' F' F ' 135' ' ' GLU . . . . . . . . . . . . . 84.3 tt0 -49.87 -26.58 4.19 Favored 'General case' 0 C--N 1.327 -0.386 0 N-CA-C 112.71 0.633 . . . . 0.0 112.71 -173.283 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' F' F ' 136' ' ' GLN . . . . . . . . . . . . . 36.3 tt0 -84.72 -36.47 21.8 Favored 'General case' 0 C--O 1.234 0.289 0 N-CA-C 112.19 0.441 . . . . 0.0 112.19 -174.729 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' F' F ' 137' ' ' LYS . . . . . . . . . . . . . 20.4 pttp -163.08 171.7 16.02 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-O 121.539 0.685 . . . . 0.0 112.375 -171.32 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' F' F ' 138' ' ' LEU . . . . . 0.513 HD23 ' N ' ' F' ' 139' ' ' THR . 3.9 tt -116.33 127.64 54.86 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 114.995 -1.002 . . . . 0.0 109.661 178.808 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' F' F ' 139' ' ' THR . . . . . 0.513 ' N ' HD23 ' F' ' 138' ' ' LEU . 28.4 m -108.46 127.82 54.25 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-O 120.772 0.32 . . . . 0.0 110.676 -179.88 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' F' F ' 140' ' ' LEU . . . . . . . . . . . . . 10.0 tp -113.57 120.48 41.11 Favored 'General case' 0 C--N 1.328 -0.339 0 N-CA-C 109.175 -0.676 . . . . 0.0 109.175 -179.367 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' F' F ' 141' ' ' ILE . . . . . . . . . . . . . 18.9 mt -120.56 118.36 56.29 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.299 0 CA-C-O 120.986 0.422 . . . . 0.0 109.966 -174.76 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' F' F ' 142' ' ' ARG . . . . . . . . . . . . . 83.9 mtm180 -108.86 128.18 54.69 Favored 'General case' 0 C--N 1.332 -0.19 0 CA-C-N 115.543 -0.753 . . . . 0.0 110.318 -179.255 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' F' F ' 143' ' ' THR . . . . . . . . . . . . . 22.6 p . . . . . 0 C--O 1.22 -0.462 0 CA-C-O 117.94 -1.028 . . . . 0.0 110.669 -179.42 . . . . . . . . 0 0 . 1 . 004 nuclear nobuild core ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 3.8 p . . . . . 0 N--CA 1.463 0.206 0 CA-C-O 121.065 0.459 . . . . 0.0 110.875 . . . . . . . . . 0 0 . 1 . 004 nuclear nobuild core ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 95.6 mt-10 -140.32 139.57 35.46 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 115.737 -0.665 . . . . 0.0 110.904 -179.974 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 4' ' ' LEU . . . . . . . . . . . . . 18.6 tp -125.91 129.54 49.52 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 115.922 -0.581 . . . . 0.0 110.19 177.641 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 5' ' ' LYS . . . . . . . . . . . . . 64.0 mttp -111.65 121.12 44.29 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.393 -0.367 . . . . 0.0 110.784 179.892 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 18.8 mt -114.09 148.17 37.55 Favored 'General case' 0 C--N 1.332 -0.193 0 CA-C-N 115.52 -0.764 . . . . 0.0 109.771 179.449 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 48.4 tttp -126.09 137.88 31.06 Favored Pre-proline 0 CA--C 1.533 0.3 0 CA-C-O 118.863 -0.589 . . . . 0.0 109.842 174.954 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 8' ' ' PRO . . . . . . . . . . . . . 91.6 Cg_endo -90.51 134.93 2.02 Favored 'Trans proline' 0 N--CA 1.489 1.219 0 C-N-CA 121.729 1.619 . . . . 0.0 111.791 179.182 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 22.1 mt -80.16 -47.92 1.33 Allowed Pre-proline 0 CA--C 1.533 0.307 0 CA-C-O 118.654 -0.688 . . . . 0.0 112.238 -178.844 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 90.8 Cg_endo -79.53 152.26 22.98 Favored 'Trans proline' 0 N--CA 1.497 1.677 0 C-N-CA 121.065 1.176 . . . . 0.0 111.914 176.977 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 22.9 tptm -84.35 92.38 8.01 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.39 -0.368 . . . . 0.0 110.312 178.841 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 12.0 p -139.97 144.11 28.77 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.339 0 CA-C-N 116.151 -0.477 . . . . 0.0 110.441 179.957 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 95.5 mt-10 -89.18 122.23 32.26 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.339 -0.391 . . . . 0.0 110.194 178.063 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 14' ' ' LEU . . . . . . . . . . . . . 28.5 mt -93.91 144.77 28.67 Favored Pre-proline 0 C--N 1.329 -0.29 0 CA-C-O 118.971 -0.538 . . . . 0.0 109.99 -179.354 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 15' ' ' PRO . . . . . . . . . . . . . 31.0 Cg_exo -59.53 159.92 22.19 Favored 'Trans proline' 0 N--CA 1.498 1.757 0 C-N-CA 121.256 1.304 . . . . 0.0 111.713 179.095 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 16' ' ' PRO . . . . . . . . . . . . . 37.0 Cg_exo -58.59 -41.21 66.64 Favored 'Trans proline' 0 N--CA 1.496 1.648 0 C-N-CA 121.477 1.451 . . . . 0.0 112.757 -178.226 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 17' ' ' ASP . . . . . . . . . . . . . 19.1 p-10 -82.34 6.14 18.0 Favored 'General case' 0 CA--C 1.536 0.434 0 N-CA-C 113.274 0.842 . . . . 0.0 113.274 -178.008 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 18' ' ' PHE . . . . . . . . . . . . . 58.1 t80 -57.99 -45.18 87.22 Favored 'General case' 0 C--N 1.334 -0.084 0 O-C-N 121.938 -0.476 . . . . 0.0 110.119 -178.389 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 19' ' ' VAL . . . . . . . . . . . . . 48.3 t -56.33 -43.77 77.98 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.297 0 CA-C-N 116.291 -0.413 . . . . 0.0 110.628 -177.959 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 80.6 m-20 -60.31 -42.61 95.93 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.497 -0.32 . . . . 0.0 110.964 -178.068 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 45.6 t -64.01 -46.48 93.79 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.282 0 C-N-CA 120.846 -0.342 . . . . 0.0 110.56 -177.711 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 22' ' ' ILE . . . . . 0.517 HG22 HD12 ' A' ' 26' ' ' LEU . 50.8 mm -55.54 -46.02 78.85 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.241 0 CA-C-O 120.727 0.299 . . . . 0.0 110.549 178.649 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 23' ' ' ARG . . . . . . . . . . . . . 53.7 ttp180 -53.36 -49.15 67.74 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-O 120.711 0.291 . . . . 0.0 111.412 179.959 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 24' ' ' ILE . . . . . . . . . . . . . 73.9 mt -58.81 -40.54 80.18 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.306 0 CA-C-N 116.483 -0.326 . . . . 0.0 111.133 -178.345 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 51.4 mttm -70.91 -37.54 72.94 Favored 'General case' 0 C--N 1.329 -0.308 0 N-CA-C 112.511 0.56 . . . . 0.0 112.511 -178.272 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 26' ' ' LEU . . . . . 0.517 HD12 HG22 ' A' ' 22' ' ' ILE . 67.6 mt -78.73 -35.85 44.14 Favored 'General case' 0 C--N 1.33 -0.265 0 N-CA-C 113.199 0.814 . . . . 0.0 113.199 -170.062 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 27' ' ' GLN . . . . . . . . . . . . . 7.3 pt20 -46.57 135.98 8.07 Favored 'General case' 0 N--CA 1.468 0.426 0 N-CA-C 112.822 0.675 . . . . 0.0 112.822 -176.319 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 101.15 -20.69 46.35 Favored Glycine 0 CA--C 1.535 1.294 0 CA-C-N 115.759 -0.655 . . . . 0.0 112.644 -177.84 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 56.5 mtpt -97.12 155.11 16.96 Favored 'General case' 0 C--O 1.233 0.196 0 CA-C-N 117.695 0.747 . . . . 0.0 111.061 178.84 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 30' ' ' THR . . . . . . . . . . . . . 44.5 m -106.96 133.76 51.13 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 115.95 -0.568 . . . . 0.0 109.613 174.356 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 34.7 m -128.81 153.19 38.02 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.241 0 CA-C-O 121.017 0.437 . . . . 0.0 110.961 -177.43 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 32' ' ' ARG . . . . . . . . . . . . . 96.9 mtt180 -132.81 150.92 52.11 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 115.897 -0.592 . . . . 0.0 110.623 179.365 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 33' ' ' THR . . . . . . . . . . . . . 12.5 m -53.03 139.01 29.23 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.232 -0.44 . . . . 0.0 111.295 -178.638 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 100.65 -17.14 56.99 Favored Glycine 0 CA--C 1.532 1.109 0 C-N-CA 121.205 -0.521 . . . . 0.0 113.232 179.275 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 54.4 m-20 -64.48 151.07 45.3 Favored 'General case' 0 C--O 1.232 0.136 0 CA-C-N 118.099 0.949 . . . . 0.0 111.308 -179.621 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 47.5 t -125.04 128.33 72.96 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.258 0 CA-C-N 115.767 -0.651 . . . . 0.0 109.621 178.223 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 37' ' ' ILE . . . . . . . . . . . . . 64.1 mt -123.41 140.43 47.03 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.173 0 CA-C-N 116.29 -0.414 . . . . 0.0 110.039 -178.656 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . -115.07 128.77 8.26 Favored Glycine 0 CA--C 1.526 0.752 0 N-CA-C 110.815 -0.914 . . . . 0.0 110.815 178.179 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 39' ' ' ILE . . . . . . . . . . . . . 74.5 mt -126.42 138.08 55.79 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.221 0 CA-C-O 120.75 0.31 . . . . 0.0 110.205 -179.907 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 40' ' ' SER . . . . . . . . . . . . . 35.1 t -91.51 113.94 26.34 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.616 175.491 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 41' ' ' ILE . . . . . . . . . . . . . 45.3 mm -119.66 119.99 62.08 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.214 0 CA-C-O 120.76 0.314 . . . . 0.0 110.415 -179.852 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 37.3 mt 52.74 35.08 17.62 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.192 -0.458 . . . . 0.0 111.744 177.007 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . 73.25 31.0 61.91 Favored Glycine 0 CA--C 1.529 0.947 0 C-N-CA 121.106 -0.569 . . . . 0.0 112.264 177.976 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 44' ' ' LYS . . . . . . . . . . . . . 21.0 tptp -141.36 130.8 23.79 Favored 'General case' 0 C--N 1.329 -0.315 0 N-CA-C 109.548 -0.538 . . . . 0.0 109.548 178.142 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 82.7 tt0 -81.53 121.62 26.53 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-O 120.883 0.373 . . . . 0.0 111.277 -176.397 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 46' ' ' VAL . . . . . . . . . . . . . 9.0 p -119.61 124.5 73.02 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.175 0 N-CA-C 109.564 -0.532 . . . . 0.0 109.564 175.754 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 97.7 mttt -98.83 128.71 45.11 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 116.09 -0.505 . . . . 0.0 110.843 178.326 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 48' ' ' PHE . . . . . . . . . . . . . 30.1 m-85 -113.63 131.81 55.99 Favored 'General case' 0 C--N 1.33 -0.267 0 N-CA-C 109.86 -0.422 . . . . 0.0 109.86 177.862 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 83.1 tttt -107.24 135.79 48.16 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 116.39 -0.368 . . . . 0.0 110.193 177.629 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 50' ' ' VAL . . . . . . . . . . . . . 43.9 t -79.52 107.64 12.17 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.33 0 N-CA-C 109.682 -0.488 . . . . 0.0 109.682 178.228 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 51' ' ' VAL . . . . . . . . . . . . . 47.5 t -72.51 -51.95 26.07 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.354 0 CA-C-N 115.872 -0.604 . . . . 0.0 109.619 -176.046 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 52' ' ' GLN . . . . . . . . . . . . . 63.0 mt-30 -155.59 147.62 23.44 Favored 'General case' 0 C--N 1.331 -0.225 0 C-N-CA 120.346 -0.541 . . . . 0.0 111.698 -177.672 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -124.38 132.08 53.52 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 115.231 -0.895 . . . . 0.0 109.419 174.512 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 54' ' ' TYR . . . . . . . . . . . . . 38.3 t80 -129.03 110.69 18.34 Favored Pre-proline 0 CA--C 1.535 0.368 0 CA-C-O 118.181 -0.914 . . . . 0.0 110.353 179.836 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 55' ' ' PRO . . . . . . . . . . . . . 73.8 Cg_endo -77.15 170.01 72.71 Favored 'Cis proline' 0 N--CA 1.501 1.914 0 CA-C-N 121.947 1.731 . . . . 0.0 112.335 -6.405 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 56' ' ' SER . . . . . . . . . . . . . 13.6 m -117.48 132.73 23.43 Favored Pre-proline 0 CA--C 1.539 0.555 0 CA-C-O 118.476 -0.773 . . . . 0.0 109.487 175.185 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 57' ' ' PRO . . . . . . . . . . . . . 43.5 Cg_endo -69.53 148.59 86.52 Favored 'Cis proline' 0 N--CA 1.498 1.785 0 CA-C-N 121.823 1.687 . . . . 0.0 111.348 -2.082 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 58' ' ' LEU . . . . . . . . . . . . . 19.0 tp -107.65 135.83 48.44 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.327 -0.397 . . . . 0.0 110.591 -178.168 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 59' ' ' ARG . . . . . . . . . . . . . 23.0 ttm180 -102.83 123.54 46.68 Favored 'General case' 0 C--N 1.327 -0.4 0 N-CA-C 109.293 -0.632 . . . . 0.0 109.293 175.751 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 40.5 t -82.14 119.8 32.38 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.359 0 CA-C-O 120.933 0.396 . . . . 0.0 110.807 -174.067 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 95.6 mt-10 -130.98 165.33 23.41 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 115.817 -0.629 . . . . 0.0 109.417 175.12 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 62' ' ' ASP . . . . . . . . . . . . . 64.1 m-20 -52.37 -32.01 36.44 Favored 'General case' 0 C--N 1.328 -0.332 0 N-CA-C 111.948 0.351 . . . . 0.0 111.948 -178.548 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 63' ' ' ARG . . . . . . . . . . . . . 74.4 mtt180 -73.41 -21.96 60.35 Favored 'General case' 0 CA--C 1.533 0.291 0 N-CA-C 112.84 0.682 . . . . 0.0 112.84 -175.719 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 30.6 m -69.52 134.58 49.04 Favored 'General case' 0 C--N 1.331 -0.208 0 CA-C-O 120.787 0.327 . . . . 0.0 110.952 -175.823 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 65' ' ' LYS . . . . . . . . . . . . . 57.6 mtmt -90.55 133.77 34.85 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.52 179.206 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 66' ' ' ILE . . . . . . . . . . . . . 65.4 mt -117.12 131.14 70.7 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.234 0 N-CA-C 109.995 -0.372 . . . . 0.0 109.995 -179.84 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 67' ' ' THR . . . . . . . . . . . . . 31.6 m -127.19 143.55 51.23 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.876 -178.645 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 68' ' ' LEU . . . . . . . . . . . . . 15.4 tp . . . . . 0 C--N 1.33 -0.243 0 CA-C-N 116.119 -0.491 . . . . 0.0 110.127 177.596 . . . . . . . . 0 0 . 1 . 004 nuclear nobuild core ' A' A ' 74' ' ' ASP . . . . . . . . . . . . . 7.1 t70 . . . . . 0 N--CA 1.457 -0.109 0 N-CA-C 109.806 -0.442 . . . . 0.0 109.806 . . . . . . . . . 0 0 . 1 . 004 nuclear nobuild core ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 42.7 t -113.94 125.04 71.15 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.268 0 CA-C-O 121.154 0.502 . . . . 0.0 110.508 -177.424 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 76' ' ' LEU . . . . . . . . . . . . . 37.7 mt -125.77 140.08 52.98 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 115.578 -0.737 . . . . 0.0 109.73 177.787 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 77' ' ' GLU . . . . . . . . . . . . . 45.9 mt-10 -132.75 136.41 46.34 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-O 120.983 0.42 . . . . 0.0 111.193 -178.751 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 78' ' ' ALA . . . . . . . . . . . . . . . -124.92 136.96 54.25 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-N 115.76 -0.654 . . . . 0.0 110.01 177.128 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 79' ' ' LYS . . . . . 0.511 ' O ' HD13 ' A' ' 80' ' ' ILE . 74.6 mmtt -78.86 119.55 22.22 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-O 120.808 0.337 . . . . 0.0 110.516 -178.54 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 80' ' ' ILE . . . . . 0.511 HD13 ' O ' ' A' ' 79' ' ' LYS . 24.2 mm -139.27 113.33 7.05 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.267 0 N-CA-C 109.303 -0.629 . . . . 0.0 109.303 -177.237 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 81' ' ' LYS . . . . . . . . . . . . . 38.5 ttpt -105.86 124.24 49.26 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-O 120.855 0.36 . . . . 0.0 111.226 -177.809 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . 89.12 42.16 5.67 Favored Glycine 0 CA--C 1.525 0.663 0 C-N-CA 120.758 -0.734 . . . . 0.0 111.886 173.655 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 83' ' ' ILE . . . . . . . . . . . . . 72.1 mt -65.64 132.79 31.26 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 CA-C-O 120.973 0.416 . . . . 0.0 110.019 178.185 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 84' ' ' LYS . . . . . . . . . . . . . 30.3 ttmt -91.87 -50.67 5.6 Favored 'General case' 0 C--N 1.331 -0.204 0 CA-C-N 116.067 -0.515 . . . . 0.0 109.883 179.493 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 85' ' ' ASP . . . . . . . . . . . . . 5.7 t70 -159.75 157.0 28.6 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 115.715 -0.675 . . . . 0.0 110.474 179.73 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 86' ' ' VAL . . . . . . . . . . . . . 42.1 t -127.86 132.46 68.78 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.221 0 CA-C-O 121.049 0.452 . . . . 0.0 110.457 -179.038 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 87' ' ' ILE . . . . . . . . . . . . . 43.2 mm -119.64 124.4 72.82 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.216 0 CA-C-N 115.863 -0.608 . . . . 0.0 109.731 177.463 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 88' ' ' LEU . . . . . . . . . . . . . 50.5 mt -108.42 136.68 47.64 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-O 120.986 0.422 . . . . 0.0 111.286 -178.521 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 89' ' ' ASP . . . . . . . . . . . . . 6.5 t70 -130.41 155.36 46.53 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 115.72 -0.673 . . . . 0.0 109.546 176.177 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 96.2 mt-10 -47.29 -36.66 9.51 Favored 'General case' 0 C--N 1.33 -0.253 0 N-CA-C 113.099 0.777 . . . . 0.0 113.099 -172.148 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 91' ' ' ASN . . . . . . . . . . . . . 35.9 t30 -132.1 21.24 4.48 Favored 'General case' 0 N--CA 1.467 0.417 0 N-CA-C 112.95 0.722 . . . . 0.0 112.95 -177.429 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 92' ' ' LEU . . . . . . . . . . . . . 20.2 mt -151.25 150.43 30.56 Favored 'General case' 0 C--N 1.333 -0.152 0 N-CA-C 110.138 -0.319 . . . . 0.0 110.138 -176.597 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 93' ' ' ILE . . . . . . . . . . . . . 76.2 mt -129.09 120.41 51.57 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.186 0 N-CA-C 109.325 -0.62 . . . . 0.0 109.325 176.159 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 94' ' ' VAL . . . . . . . . . . . . . 43.2 t -118.02 127.01 75.3 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.282 0 N-CA-C 109.68 -0.489 . . . . 0.0 109.68 -179.863 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 95' ' ' VAL . . . . . . . . . . . . . 42.8 t -120.78 135.08 62.11 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.36 0 CA-C-N 116.171 -0.468 . . . . 0.0 109.819 -179.258 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 96' ' ' ILE . . . . . . . . . . . . . 58.6 mt -113.99 128.23 71.03 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.338 0 N-CA-C 109.258 -0.645 . . . . 0.0 109.258 179.594 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 97' ' ' THR . . . . . . . . . . . . . 70.6 p -99.67 154.12 18.54 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-O 120.856 0.36 . . . . 0.0 110.686 -179.09 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 98' ' ' GLU . . . . . . . . . . . . . 96.0 mt-10 -54.76 -23.21 16.86 Favored 'General case' 0 CA--C 1.533 0.319 0 N-CA-C 112.451 0.537 . . . . 0.0 112.451 -179.701 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 99' ' ' GLU . . . . . . . . . . . . . 43.0 mt-10 -79.6 16.14 1.16 Allowed 'General case' 0 CA--C 1.535 0.379 0 N-CA-C 113.05 0.759 . . . . 0.0 113.05 -179.458 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 100' ' ' ASN . . . . . . . . . . . . . 3.6 m-20 63.57 37.97 9.97 Favored 'General case' 0 CA--C 1.529 0.144 0 CA-C-O 121.05 0.452 . . . . 0.0 110.967 177.694 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 101' ' ' GLU . . . . . . . . . . . . . 83.0 tt0 -114.38 142.36 46.45 Favored 'General case' 0 C--N 1.332 -0.162 0 CA-C-N 116.118 -0.492 . . . . 0.0 109.731 176.618 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 102' ' ' VAL . . . . . . . . . . . . . 43.6 t -115.14 123.72 71.04 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 N-CA-C 109.693 -0.484 . . . . 0.0 109.693 -179.731 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 103' ' ' LEU . . . . . . . . . . . . . 36.4 mt -116.57 130.6 56.84 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 115.877 -0.601 . . . . 0.0 110.05 178.294 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 104' ' ' ILE . . . . . 0.595 HD13 HG11 ' A' ' 130' ' ' VAL . 65.5 mt -115.35 118.95 60.41 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.324 0 N-CA-C 109.934 -0.395 . . . . 0.0 109.934 -179.591 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 105' ' ' PHE . . . . . . . . . . . . . 96.9 m-85 -118.29 162.86 17.57 Favored 'General case' 0 C--O 1.233 0.192 0 O-C-N 124.061 0.851 . . . . 0.0 110.079 -178.643 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 106' ' ' ASN . . . . . . . . . . . . . 53.2 p-10 -96.36 -169.95 2.0 Favored 'General case' 0 C--N 1.329 -0.285 0 N-CA-C 109.297 -0.631 . . . . 0.0 109.297 170.664 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 107' ' ' GLN . . . . . . . . . . . . . 44.1 tt0 -57.82 -27.53 63.25 Favored 'General case' 0 C--N 1.328 -0.335 0 N-CA-C 112.405 0.52 . . . . 0.0 112.405 -178.067 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 108' ' ' ASN . . . . . . . . . . . . . 19.6 t30 -94.63 14.25 21.65 Favored 'General case' 0 CA--C 1.534 0.333 0 N-CA-C 113.033 0.753 . . . . 0.0 113.033 -175.149 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 109' ' ' LEU . . . . . . . . . . . . . 91.4 mt 60.4 34.65 20.6 Favored 'General case' 0 CA--C 1.529 0.162 0 CA-C-O 120.756 0.312 . . . . 0.0 111.679 178.169 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 110' ' ' GLU . . . . . . . . . . . . . 96.2 mt-10 -101.47 141.16 34.75 Favored 'General case' 0 C--N 1.33 -0.265 0 N-CA-C 109.717 -0.475 . . . . 0.0 109.717 175.973 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 111' ' ' GLU . . . . . . . . . . . . . 96.4 mt-10 -73.13 121.86 20.91 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-O 120.945 0.402 . . . . 0.0 111.242 -176.719 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 112' ' ' LEU . . . . . . . . . . . . . 17.3 mt -103.43 -45.04 4.98 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 115.861 -0.608 . . . . 0.0 109.737 173.718 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 113' ' ' TYR . . . . . 0.432 ' HB3' HD12 ' A' ' 104' ' ' ILE . 61.8 t80 -142.03 142.48 32.89 Favored 'General case' 0 C--N 1.331 -0.224 0 CA-C-N 115.8 -0.636 . . . . 0.0 110.158 178.251 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 114' ' ' ARG . . . . . . . . . . . . . 33.6 ptt180 -150.65 123.59 8.71 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-O 120.957 0.408 . . . . 0.0 110.966 178.699 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 115' ' ' GLY . . . . . . . . . . . . . . . -150.2 163.03 29.4 Favored Glycine 0 CA--C 1.524 0.624 0 N-CA-C 110.664 -0.974 . . . . 0.0 110.664 -179.385 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 116' ' ' LYS . . . . . . . . . . . . . 29.8 ttmt -127.51 136.23 51.46 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-O 120.883 0.373 . . . . 0.0 110.185 178.604 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 117' ' ' PHE . . . . . . . . . . . . . 43.0 m-85 -131.44 115.15 15.81 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.12 -0.491 . . . . 0.0 110.161 -177.051 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 118' ' ' GLU . . . . . . . . . . . . . 96.2 mt-10 -54.0 -42.08 68.65 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.564 -0.289 . . . . 0.0 111.356 -176.895 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 119' ' ' ASN . . . . . . . . . . . . . 33.6 m120 -99.75 31.02 3.38 Favored 'General case' 0 CA--C 1.531 0.215 0 N-CA-C 112.132 0.419 . . . . 0.0 112.132 -174.809 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 120' ' ' LEU . . . . . . . . . . . . . 13.4 tp -56.83 121.19 9.28 Favored 'General case' 0 C--N 1.332 -0.177 0 CA-C-O 120.756 0.312 . . . . 0.0 110.562 178.41 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 121' ' ' ASN . . . . . . . . . . . . . 6.2 m120 -113.97 -44.01 3.2 Favored 'General case' 0 C--N 1.331 -0.204 0 CA-C-N 116.324 -0.398 . . . . 0.0 110.876 -178.981 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 122' ' ' LYS . . . . . . . . . . . . . 63.9 mtpt -139.68 144.54 37.64 Favored 'General case' 0 C--N 1.331 -0.211 0 CA-C-O 120.972 0.415 . . . . 0.0 111.631 -175.989 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 123' ' ' VAL . . . . . . . . . . . . . 45.2 t -131.36 122.52 51.02 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.305 0 N-CA-C 109.126 -0.694 . . . . 0.0 109.126 172.788 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 124' ' ' LEU . . . . . . . . . . . . . 14.3 tp -127.87 136.04 50.85 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-O 120.82 0.343 . . . . 0.0 110.813 -176.057 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 125' ' ' VAL . . . . . . . . . . . . . 12.6 p -134.03 137.01 52.88 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.205 0 CA-C-N 116.288 -0.414 . . . . 0.0 110.412 178.938 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 126' ' ' ARG . . . . . . . . . . . . . 26.3 mmt180 -141.77 124.99 16.39 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.118 -0.492 . . . . 0.0 110.368 179.43 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 127' ' ' ASN . . . . . . . . . . . . . 81.8 m-20 51.87 -105.02 0.2 Allowed 'General case' 0 CA--C 1.543 0.691 0 CA-C-N 115.982 -0.554 . . . . 0.0 111.356 178.949 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 128' ' ' ASP . . . . . . . . . . . . . 10.3 p-10 -114.21 0.45 14.22 Favored 'General case' 0 N--CA 1.466 0.368 0 CA-C-N 119.506 1.048 . . . . 0.0 113.656 -175.77 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 129' ' ' LEU . . . . . . . . . . . . . 47.4 mt -111.85 145.71 38.99 Favored 'General case' 0 C--O 1.231 0.117 0 CA-C-N 118.166 0.439 . . . . 0.0 110.344 -179.417 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 130' ' ' VAL . . . . . 0.595 HG11 HD13 ' A' ' 104' ' ' ILE . 12.5 p -134.16 141.21 44.38 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.217 0 CA-C-O 121.15 0.5 . . . . 0.0 110.559 -179.843 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 131' ' ' VAL . . . . . . . . . . . . . 44.3 t -135.84 139.6 45.78 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.271 0 CA-C-N 115.985 -0.552 . . . . 0.0 110.109 -179.784 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 132' ' ' ILE . . . . . . . . . . . . . 74.4 mt -118.65 133.42 65.54 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.268 0 CA-C-N 115.708 -0.678 . . . . 0.0 109.49 179.883 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 133' ' ' ILE . . . . . . . . . . . . . 38.1 mm -116.2 121.37 67.35 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.256 0 CA-C-N 116.39 -0.368 . . . . 0.0 110.78 -175.156 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 134' ' ' ASP . . . . . . . . . . . . . 8.4 p-10 -131.94 147.93 52.49 Favored 'General case' 0 C--N 1.332 -0.183 0 N-CA-C 109.871 -0.418 . . . . 0.0 109.871 175.33 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 135' ' ' GLU . . . . . . . . . . . . . 78.8 tt0 -49.86 -26.64 4.22 Favored 'General case' 0 C--N 1.328 -0.336 0 N-CA-C 113.02 0.748 . . . . 0.0 113.02 -172.742 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 136' ' ' GLN . . . . . . . . . . . . . 98.5 mt-30 -85.43 -32.04 22.54 Favored 'General case' 0 C--O 1.234 0.243 0 N-CA-C 112.425 0.528 . . . . 0.0 112.425 -175.428 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 137' ' ' LYS . . . . . . . . . . . . . 48.3 pttt -168.31 173.24 7.86 Favored 'General case' 0 C--N 1.332 -0.161 0 CA-C-O 121.646 0.736 . . . . 0.0 112.417 -173.226 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 138' ' ' LEU . . . . . 0.459 HD23 ' N ' ' A' ' 139' ' ' THR . 3.6 tt -115.7 129.11 56.35 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 114.831 -1.077 . . . . 0.0 109.996 -179.572 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 139' ' ' THR . . . . . 0.459 ' N ' HD23 ' A' ' 138' ' ' LEU . 39.0 m -110.67 123.51 50.16 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 116.221 -0.445 . . . . 0.0 110.223 179.358 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 140' ' ' LEU . . . . . 0.477 HD23 ' C ' ' A' ' 140' ' ' LEU . 6.1 tt -113.28 122.33 47.09 Favored 'General case' 0 C--N 1.328 -0.351 0 N-CA-C 109.567 -0.531 . . . . 0.0 109.567 -178.961 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 141' ' ' ILE . . . . . 0.542 ' HB ' HG13 ' A' ' 130' ' ' VAL . 19.6 mt -121.67 118.5 55.98 Favored 'Isoleucine or valine' 0 C--O 1.235 0.303 0 CA-C-O 121.104 0.478 . . . . 0.0 109.899 -175.938 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 142' ' ' ARG . . . . . . . . . . . . . 58.9 ttt180 -108.31 132.28 53.87 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 115.298 -0.864 . . . . 0.0 110.734 -177.198 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 143' ' ' THR . . . . . . . . . . . . . 56.0 p . . . . . 0 C--O 1.22 -0.483 0 CA-C-O 118.026 -0.988 . . . . 0.0 110.601 178.934 . . . . . . . . 0 0 . 1 . 004 nuclear nobuild core ' B' B ' 2' ' ' SER . . . . . . . . . . . . . 6.7 p . . . . . 0 N--CA 1.462 0.171 0 CA-C-O 121.072 0.463 . . . . 0.0 110.88 . . . . . . . . . 0 0 . 1 . 004 nuclear nobuild core ' B' B ' 3' ' ' GLU . . . . . . . . . . . . . 95.5 mt-10 -141.15 141.56 34.14 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 115.79 -0.641 . . . . 0.0 110.897 -179.226 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' B' B ' 4' ' ' LEU . . . . . . . . . . . . . 18.8 tp -127.15 128.33 45.99 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 115.955 -0.566 . . . . 0.0 110.12 177.056 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' B' B ' 5' ' ' LYS . . . . . . . . . . . . . 83.1 mttt -104.93 119.62 39.45 Favored 'General case' 0 C--O 1.234 0.267 0 CA-C-N 116.084 -0.507 . . . . 0.0 110.462 178.828 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' B' B ' 6' ' ' LEU . . . . . . . . . . . . . 45.1 mt -116.57 144.38 44.44 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 115.458 -0.792 . . . . 0.0 110.313 -178.967 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' B' B ' 7' ' ' LYS . . . . . . . . . . . . . 82.9 tttt -133.05 138.36 31.59 Favored Pre-proline 0 CA--C 1.534 0.328 0 CA-C-O 119.007 -0.521 . . . . 0.0 109.988 177.247 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' B' B ' 8' ' ' PRO . . . . . . . . . . . . . 89.7 Cg_endo -92.09 144.19 2.78 Favored 'Trans proline' 0 N--CA 1.489 1.223 0 C-N-CA 121.717 1.611 . . . . 0.0 111.97 178.155 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' B' B ' 9' ' ' LEU . . . . . . . . . . . . . 62.4 mt -81.09 -47.65 1.11 Allowed Pre-proline 0 CA--C 1.534 0.36 0 CA-C-O 118.637 -0.697 . . . . 0.0 112.319 -179.946 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' B' B ' 10' ' ' PRO . . . . . . . . . . . . . 86.8 Cg_endo -80.3 151.43 20.36 Favored 'Trans proline' 0 N--CA 1.496 1.656 0 C-N-CA 121.125 1.217 . . . . 0.0 111.888 176.999 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' B' B ' 11' ' ' LYS . . . . . . . . . . . . . 96.5 mttt -87.47 96.98 10.58 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.432 -0.349 . . . . 0.0 110.492 178.79 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' B' B ' 12' ' ' VAL . . . . . . . . . . . . . 12.6 p -142.06 147.07 21.9 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.328 0 CA-C-N 116.237 -0.438 . . . . 0.0 110.5 -179.932 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' B' B ' 13' ' ' GLU . . . . . . . . . . . . . 84.4 tt0 -84.92 127.9 34.37 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.253 -0.43 . . . . 0.0 110.055 178.069 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' B' B ' 14' ' ' LEU . . . . . . . . . . . . . 36.5 mt -96.41 149.96 36.51 Favored Pre-proline 0 CA--C 1.533 0.309 0 CA-C-O 119.311 -0.376 . . . . 0.0 110.713 -177.154 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' B' B ' 15' ' ' PRO . . . . . . . . . . . . . 27.8 Cg_exo -60.99 158.39 34.27 Favored 'Trans proline' 0 N--CA 1.499 1.797 0 C-N-CA 121.269 1.313 . . . . 0.0 111.964 178.272 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' B' B ' 16' ' ' PRO . . . . . . . . . . . . . 35.7 Cg_exo -59.09 -41.02 64.85 Favored 'Trans proline' 0 N--CA 1.497 1.692 0 C-N-CA 121.439 1.426 . . . . 0.0 112.714 -179.218 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' B' B ' 17' ' ' ASP . . . . . . . . . . . . . 15.8 p-10 -84.73 11.59 8.79 Favored 'General case' 0 CA--C 1.535 0.388 0 N-CA-C 113.155 0.798 . . . . 0.0 113.155 -178.183 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' B' B ' 18' ' ' PHE . . . . . . . . . . . . . 44.9 t80 -57.6 -45.73 84.94 Favored 'General case' 0 C--N 1.335 -0.064 0 O-C-N 121.949 -0.47 . . . . 0.0 110.305 -177.833 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' B' B ' 19' ' ' VAL . . . . . 0.413 HG13 ' N ' ' B' ' 20' ' ' ASP . 15.0 p -55.88 -42.21 69.98 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.326 0 CA-C-N 116.475 -0.329 . . . . 0.0 111.075 -177.599 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' B' B ' 20' ' ' ASP . . . . . 0.413 ' N ' HG13 ' B' ' 19' ' ' VAL . 32.8 m-20 -60.76 -42.85 98.27 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-O 120.9 0.381 . . . . 0.0 110.923 -178.397 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' B' B ' 21' ' ' VAL . . . . . . . . . . . . . 46.9 t -63.8 -45.41 97.25 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.264 0 C-N-CA 120.735 -0.386 . . . . 0.0 110.4 -178.52 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' B' B ' 22' ' ' ILE . . . . . 0.566 HG22 HD12 ' B' ' 26' ' ' LEU . 50.7 mm -55.7 -47.13 79.57 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.262 0 C-N-CA 121.001 -0.28 . . . . 0.0 110.592 178.366 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' B' B ' 23' ' ' ARG . . . . . . . . . . . . . 47.0 ttp180 -53.41 -51.66 61.87 Favored 'General case' 0 C--N 1.329 -0.292 0 C-N-CA 121.13 -0.228 . . . . 0.0 111.534 -178.615 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' B' B ' 24' ' ' ILE . . . . . . . . . . . . . 71.9 mt -59.52 -44.24 92.56 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.319 0 C-N-CA 121.112 -0.235 . . . . 0.0 111.163 -177.293 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' B' B ' 25' ' ' LYS . . . . . . . . . . . . . 8.7 mtpm? -64.94 -40.1 94.51 Favored 'General case' 0 C--N 1.328 -0.357 0 N-CA-C 112.178 0.436 . . . . 0.0 112.178 -176.946 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' B' B ' 26' ' ' LEU . . . . . 0.566 HD12 HG22 ' B' ' 22' ' ' ILE . 74.6 mt -80.09 -43.41 21.8 Favored 'General case' 0 C--N 1.33 -0.276 0 N-CA-C 112.945 0.72 . . . . 0.0 112.945 -172.106 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' B' B ' 27' ' ' GLN . . . . . . . . . . . . . 10.3 pt20 -46.39 137.67 6.27 Favored 'General case' 0 N--CA 1.469 0.487 0 N-CA-C 112.81 0.67 . . . . 0.0 112.81 -174.996 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' B' B ' 28' ' ' GLY . . . . . . . . . . . . . . . 100.85 -26.31 25.11 Favored Glycine 0 CA--C 1.533 1.196 0 CA-C-N 115.518 -0.765 . . . . 0.0 112.216 -176.575 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' B' B ' 29' ' ' LYS . . . . . . . . . . . . . 35.2 mmtp -97.79 155.08 17.2 Favored 'General case' 0 C--N 1.332 -0.159 0 CA-C-N 117.251 0.526 . . . . 0.0 111.012 179.28 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' B' B ' 30' ' ' THR . . . . . . . . . . . . . 43.5 m -108.01 134.4 50.97 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 115.934 -0.576 . . . . 0.0 109.869 175.202 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' B' B ' 31' ' ' VAL . . . . . . . . . . . . . 34.5 m -129.39 155.56 41.31 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.251 0 CA-C-O 120.9 0.381 . . . . 0.0 111.049 -177.363 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' B' B ' 32' ' ' ARG . . . . . . . . . . . . . 92.5 mtt180 -129.9 152.9 48.87 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-O 121.291 0.567 . . . . 0.0 110.604 179.16 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' B' B ' 33' ' ' THR . . . . . . . . . . . . . 18.2 m -52.82 139.02 28.03 Favored 'General case' 0 C--N 1.331 -0.225 0 CA-C-N 116.228 -0.442 . . . . 0.0 111.39 -179.001 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' B' B ' 34' ' ' GLY . . . . . . . . . . . . . . . 100.31 -17.12 57.34 Favored Glycine 0 CA--C 1.533 1.172 0 C-N-CA 121.219 -0.515 . . . . 0.0 113.224 179.346 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' B' B ' 35' ' ' ASP . . . . . . . . . . . . . 56.1 m-20 -66.04 150.5 48.59 Favored 'General case' 0 C--O 1.23 0.041 0 CA-C-N 118.043 0.922 . . . . 0.0 111.055 179.443 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' B' B ' 36' ' ' VAL . . . . . . . . . . . . . 46.5 t -123.06 129.72 74.86 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.207 0 CA-C-N 115.748 -0.66 . . . . 0.0 109.677 178.39 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' B' B ' 37' ' ' ILE . . . . . . . . . . . . . 64.8 mt -120.1 138.34 50.98 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.297 0 N-CA-C 109.755 -0.461 . . . . 0.0 109.755 179.816 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' B' B ' 38' ' ' GLY . . . . . . . . . . . . . . . -112.36 128.86 8.71 Favored Glycine 0 CA--C 1.525 0.716 0 N-CA-C 110.731 -0.948 . . . . 0.0 110.731 179.552 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' B' B ' 39' ' ' ILE . . . . . . . . . . . . . 73.4 mt -121.12 136.18 58.91 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.277 0 N-CA-C 110.043 -0.354 . . . . 0.0 110.043 179.831 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' B' B ' 40' ' ' SER . . . . . 0.527 ' O ' HD13 ' B' ' 41' ' ' ILE . 74.6 p -91.65 116.16 28.64 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.246 -0.434 . . . . 0.0 110.78 176.185 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' B' B ' 41' ' ' ILE . . . . . 0.527 HD13 ' O ' ' B' ' 40' ' ' SER . 48.1 mm -128.74 118.13 46.42 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.165 0 N-CA-C 110.063 -0.347 . . . . 0.0 110.063 178.711 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' B' B ' 42' ' ' LEU . . . . . . . . . . . . . 38.7 mt 58.1 34.53 24.29 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.212 -0.449 . . . . 0.0 111.52 179.325 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' B' B ' 43' ' ' GLY . . . . . . . . . . . . . . . 77.47 -10.14 24.54 Favored Glycine 0 CA--C 1.535 1.286 0 C-N-CA 121.315 -0.469 . . . . 0.0 113.424 178.047 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' B' B ' 44' ' ' LYS . . . . . . . . . . . . . 47.7 mtmt -98.85 137.47 37.38 Favored 'General case' 0 C--N 1.333 -0.144 0 CA-C-N 117.897 0.848 . . . . 0.0 110.198 177.965 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' B' B ' 45' ' ' GLU . . . . . . . . . . . . . 83.8 tt0 -84.46 128.18 34.44 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.293 -0.412 . . . . 0.0 111.287 -179.409 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' B' B ' 46' ' ' VAL . . . . . . . . . . . . . 7.2 p -120.61 129.14 75.93 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.197 0 N-CA-C 109.508 -0.553 . . . . 0.0 109.508 175.465 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' B' B ' 47' ' ' LYS . . . . . . . . . . . . . 98.8 mttt -99.4 128.32 45.51 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.009 -0.541 . . . . 0.0 111.007 179.001 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' B' B ' 48' ' ' PHE . . . . . . . . . . . . . 93.2 m-85 -113.08 131.85 55.65 Favored 'General case' 0 C--N 1.331 -0.232 0 N-CA-C 109.67 -0.493 . . . . 0.0 109.67 175.041 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' B' B ' 49' ' ' LYS . . . . . . . . . . . . . 79.2 tttt -106.98 136.14 47.35 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.304 -0.407 . . . . 0.0 110.426 -179.777 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' B' B ' 50' ' ' VAL . . . . . . . . . . . . . 42.2 t -80.08 106.99 11.99 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 N-CA-C 109.433 -0.58 . . . . 0.0 109.433 176.799 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' B' B ' 51' ' ' VAL . . . . . . . . . . . . . 46.7 t -75.15 -48.21 32.83 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.286 0 CA-C-N 116.064 -0.516 . . . . 0.0 110.077 -174.044 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' B' B ' 52' ' ' GLN . . . . . . . . . . . . . 62.6 tt0 -159.46 137.05 9.96 Favored 'General case' 0 C--N 1.33 -0.251 0 C-N-CA 120.475 -0.49 . . . . 0.0 111.397 -177.692 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' B' B ' 53' ' ' ALA . . . . . 0.484 ' HB1' ' HB2' ' B' ' 58' ' ' LEU . . . -114.23 130.76 56.63 Favored 'General case' 0 C--N 1.331 -0.23 0 CA-C-N 115.783 -0.644 . . . . 0.0 109.755 174.561 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' B' B ' 54' ' ' TYR . . . . . . . . . . . . . 30.2 t80 -129.08 110.76 18.29 Favored Pre-proline 0 CA--C 1.535 0.399 0 CA-C-O 118.334 -0.841 . . . . 0.0 110.329 179.495 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' B' B ' 55' ' ' PRO . . . . . . . . . . . . . 73.9 Cg_endo -77.11 170.08 72.56 Favored 'Cis proline' 0 N--CA 1.499 1.823 0 CA-C-N 121.918 1.721 . . . . 0.0 112.44 -4.554 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' B' B ' 56' ' ' SER . . . . . . . . . . . . . 13.7 m -116.18 129.46 25.2 Favored Pre-proline 0 CA--C 1.539 0.548 0 CA-C-O 118.347 -0.835 . . . . 0.0 109.37 175.96 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' B' B ' 57' ' ' PRO . . . . . . . . . . . . . 50.8 Cg_endo -69.99 148.18 86.7 Favored 'Cis proline' 0 N--CA 1.497 1.735 0 CA-C-N 122.053 1.769 . . . . 0.0 111.561 -0.771 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' B' B ' 58' ' ' LEU . . . . . 0.484 ' HB2' ' HB1' ' B' ' 53' ' ' ALA . 22.4 tp -106.48 135.44 47.97 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-O 120.851 0.357 . . . . 0.0 110.454 -178.994 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' B' B ' 59' ' ' ARG . . . . . . . . . . . . . 52.9 ttp180 -105.82 121.85 44.9 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-N 115.873 -0.603 . . . . 0.0 109.377 177.307 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' B' B ' 60' ' ' VAL . . . . . . . . . . . . . 42.6 t -79.09 122.92 35.31 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.287 0 C-N-CA 120.807 -0.357 . . . . 0.0 110.591 -173.848 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' B' B ' 61' ' ' GLU . . . . . . . . . . . . . 95.5 mt-10 -131.03 165.62 22.8 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.021 -0.536 . . . . 0.0 110.149 178.195 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' B' B ' 62' ' ' ASP . . . . . . . . . . . . . 14.9 p-10 -55.87 -32.59 63.8 Favored 'General case' 0 C--N 1.329 -0.324 0 N-CA-C 111.781 0.289 . . . . 0.0 111.781 -179.147 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' B' B ' 63' ' ' ARG . . . . . . . . . . . . . 11.0 ptm180 -86.41 4.58 38.87 Favored 'General case' 0 CA--C 1.537 0.47 0 N-CA-C 113.527 0.936 . . . . 0.0 113.527 -176.15 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' B' B ' 64' ' ' THR . . . . . . . . . . . . . 31.5 m -83.54 137.86 33.66 Favored 'General case' 0 C--N 1.332 -0.166 0 CA-C-N 118.231 0.469 . . . . 0.0 110.443 -178.22 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' B' B ' 65' ' ' LYS . . . . . . . . . . . . . 67.7 mttm -88.24 123.72 33.15 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.219 -179.911 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' B' B ' 66' ' ' ILE . . . . . . . . . . . . . 62.6 mt -111.94 126.59 69.35 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.283 0 N-CA-C 109.574 -0.528 . . . . 0.0 109.574 179.63 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' B' B ' 67' ' ' THR . . . . . . . . . . . . . 18.4 m -122.08 139.32 53.86 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 116.176 -0.465 . . . . 0.0 110.908 -177.119 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' B' B ' 68' ' ' LEU . . . . . . . . . . . . . 15.7 tp . . . . . 0 C--N 1.329 -0.304 0 CA-C-N 115.841 -0.618 . . . . 0.0 110.236 178.624 . . . . . . . . 0 0 . 1 . 004 nuclear nobuild core ' B' B ' 73' ' ' VAL . . . . . . . . . . . . . 34.2 m . . . . . 0 C--O 1.232 0.162 0 CA-C-O 120.836 0.35 . . . . 0.0 110.703 . . . . . . . . . 0 0 . 1 . 004 nuclear nobuild core ' B' B ' 74' ' ' ASP . . . . . . . . . . . . . 13.8 t0 -99.53 123.52 43.87 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.152 -0.476 . . . . 0.0 110.051 -179.444 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' B' B ' 75' ' ' VAL . . . . . . . . . . . . . 41.5 t -115.24 123.89 71.28 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.261 0 CA-C-O 120.905 0.383 . . . . 0.0 110.617 -177.788 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' B' B ' 76' ' ' LEU . . . . . . . . . . . . . 4.4 mp -124.84 144.99 50.01 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 115.934 -0.576 . . . . 0.0 109.697 176.261 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' B' B ' 77' ' ' GLU . . . . . . . . . . . . . 97.4 mt-10 -134.96 138.53 44.13 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-O 121.0 0.429 . . . . 0.0 111.243 -178.068 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' B' B ' 78' ' ' ALA . . . . . . . . . . . . . . . -125.76 130.5 51.61 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 115.697 -0.683 . . . . 0.0 109.674 176.229 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' B' B ' 79' ' ' LYS . . . . . 0.597 ' O ' HD13 ' B' ' 80' ' ' ILE . 62.1 mtpt -79.02 119.44 22.17 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-O 120.865 0.364 . . . . 0.0 110.898 -177.481 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' B' B ' 80' ' ' ILE . . . . . 0.597 HD13 ' O ' ' B' ' 79' ' ' LYS . 41.6 mm -139.19 109.31 4.2 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.311 0 N-CA-C 109.138 -0.69 . . . . 0.0 109.138 -177.721 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' B' B ' 81' ' ' LYS . . . . . . . . . . . . . 60.6 tttm -101.81 126.55 48.71 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-O 120.842 0.353 . . . . 0.0 111.223 -176.642 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' B' B ' 82' ' ' GLY . . . . . . . . . . . . . . . 89.2 42.11 5.66 Favored Glycine 0 CA--C 1.527 0.784 0 C-N-CA 120.885 -0.674 . . . . 0.0 112.017 174.193 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' B' B ' 83' ' ' ILE . . . . . . . . . . . . . 72.5 mt -70.13 136.34 26.29 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.269 0 N-CA-C 109.676 -0.49 . . . . 0.0 109.676 176.407 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' B' B ' 84' ' ' LYS . . . . . . . . . . . . . 19.7 ttpp -101.0 -50.14 3.9 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-O 120.9 0.381 . . . . 0.0 110.461 -178.176 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' B' B ' 85' ' ' ASP . . . . . . . . . . . . . 10.8 t70 -147.1 148.13 31.29 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 115.987 -0.551 . . . . 0.0 110.348 -179.729 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' B' B ' 86' ' ' VAL . . . . . . . . . . . . . 42.2 t -130.71 132.62 64.12 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.232 0 CA-C-O 121.05 0.452 . . . . 0.0 110.578 -178.365 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' B' B ' 87' ' ' ILE . . . . . 0.5 ' N ' HD12 ' B' ' 87' ' ' ILE . 5.1 mp -122.62 123.02 67.47 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.217 0 N-CA-C 109.208 -0.664 . . . . 0.0 109.208 176.102 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' B' B ' 88' ' ' LEU . . . . . . . . . . . . . 33.8 mt -111.66 136.29 51.08 Favored 'General case' 0 C--N 1.332 -0.182 0 CA-C-O 121.223 0.535 . . . . 0.0 111.352 -176.129 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' B' B ' 89' ' ' ASP . . . . . . . . . . . . . 11.3 t70 -129.19 146.25 51.15 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 115.511 -0.768 . . . . 0.0 109.296 175.333 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' B' B ' 90' ' ' GLU . . . . . . . . . . . . . 12.8 pt-20 -51.09 -28.8 11.42 Favored 'General case' 0 C--N 1.328 -0.347 0 N-CA-C 112.522 0.564 . . . . 0.0 112.522 -174.017 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' B' B ' 91' ' ' ASN . . . . . . . . . . . . . 92.1 m-20 -127.26 22.67 6.54 Favored 'General case' 0 N--CA 1.469 0.486 0 N-CA-C 112.8 0.667 . . . . 0.0 112.8 -176.558 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' B' B ' 92' ' ' LEU . . . . . . . . . . . . . 7.4 tp -166.24 148.54 6.94 Favored 'General case' 0 C--N 1.331 -0.237 0 N-CA-C 110.302 -0.258 . . . . 0.0 110.302 179.471 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' B' B ' 93' ' ' ILE . . . . . . . . . . . . . 71.0 mt -128.18 123.97 61.42 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.285 0 N-CA-C 109.848 -0.427 . . . . 0.0 109.848 179.145 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' B' B ' 94' ' ' VAL . . . . . . . . . . . . . 40.8 t -122.13 125.88 73.61 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.182 0 N-CA-C 109.98 -0.378 . . . . 0.0 109.98 179.038 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' B' B ' 95' ' ' VAL . . . . . . . . . . . . . 41.8 t -120.82 134.66 63.54 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.329 0 CA-C-N 116.026 -0.533 . . . . 0.0 109.815 -179.959 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' B' B ' 96' ' ' ILE . . . . . 0.418 HD11 ' HB ' ' B' ' 123' ' ' VAL . 67.4 mt -115.76 126.15 73.18 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.209 0 N-CA-C 109.381 -0.6 . . . . 0.0 109.381 179.071 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' B' B ' 97' ' ' THR . . . . . . . . . . . . . 73.5 p -99.89 158.36 15.86 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-O 121.307 0.575 . . . . 0.0 111.326 -176.404 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' B' B ' 98' ' ' GLU . . . . . . . . . . . . . 43.7 tp10 -53.83 -26.62 25.21 Favored 'General case' 0 CA--C 1.533 0.311 0 CA-C-N 116.052 -0.522 . . . . 0.0 112.267 -179.174 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' B' B ' 99' ' ' GLU . . . . . . . . . . . . . 95.7 mt-10 -79.91 17.6 0.94 Allowed 'General case' 0 CA--C 1.535 0.377 0 N-CA-C 113.151 0.797 . . . . 0.0 113.151 -176.212 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' B' B ' 100' ' ' ASN . . . . . . . . . . . . . 4.2 m-20 62.42 38.1 13.1 Favored 'General case' 0 N--CA 1.463 0.175 0 CA-C-O 121.115 0.484 . . . . 0.0 110.894 177.954 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' B' B ' 101' ' ' GLU . . . . . . . . . . . . . 84.4 tt0 -119.04 141.86 48.34 Favored 'General case' 0 C--N 1.332 -0.184 0 CA-C-N 116.208 -0.451 . . . . 0.0 109.869 177.562 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' B' B ' 102' ' ' VAL . . . . . . . . . . . . . 46.2 t -115.08 127.54 72.6 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.264 0 N-CA-C 109.895 -0.409 . . . . 0.0 109.895 -178.915 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' B' B ' 103' ' ' LEU . . . . . . . . . . . . . 28.8 mt -118.58 131.9 56.2 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-N 115.78 -0.646 . . . . 0.0 110.306 177.845 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' B' B ' 104' ' ' ILE . . . . . . . . . . . . . 71.4 mt -119.52 121.85 67.39 Favored 'Isoleucine or valine' 0 C--O 1.234 0.283 0 CA-C-N 116.606 -0.27 . . . . 0.0 110.426 -179.106 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' B' B ' 105' ' ' PHE . . . . . . . . . . . . . 53.2 m-85 -123.18 168.44 12.42 Favored 'General case' 0 C--N 1.333 -0.122 0 O-C-N 124.115 0.885 . . . . 0.0 109.901 179.499 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' B' B ' 106' ' ' ASN . . . . . . . . . . . . . 44.0 p-10 -100.38 -170.61 1.89 Allowed 'General case' 0 CA--C 1.531 0.217 0 N-CA-C 109.789 -0.448 . . . . 0.0 109.789 171.754 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' B' B ' 107' ' ' GLN . . . . . . . . . . . . . 63.3 tt0 -58.55 -30.06 66.83 Favored 'General case' 0 C--N 1.328 -0.339 0 N-CA-C 111.858 0.318 . . . . 0.0 111.858 179.567 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' B' B ' 108' ' ' ASN . . . . . . . . . . . . . 59.8 t30 -86.85 14.06 7.88 Favored 'General case' 0 CA--C 1.534 0.343 0 N-CA-C 112.923 0.712 . . . . 0.0 112.923 -176.757 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' B' B ' 109' ' ' LEU . . . . . . . . . . . . . 34.5 mt 58.35 33.19 22.91 Favored 'General case' 0 C--N 1.332 -0.188 0 N-CA-C 111.877 0.325 . . . . 0.0 111.877 177.262 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' B' B ' 110' ' ' GLU . . . . . . . . . . . . . 70.5 mm-40 -98.97 138.82 35.52 Favored 'General case' 0 C--N 1.331 -0.226 0 N-CA-C 109.21 -0.663 . . . . 0.0 109.21 174.426 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' B' B ' 111' ' ' GLU . . . . . . . . . . . . . 42.2 tt0 -85.72 121.81 28.91 Favored 'General case' 0 C--N 1.327 -0.408 0 CA-C-O 120.942 0.401 . . . . 0.0 110.574 -176.243 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' B' B ' 112' ' ' LEU . . . . . . . . . . . . . 38.6 mt -105.73 -42.4 5.18 Favored 'General case' 0 C--N 1.331 -0.227 0 CA-C-N 116.007 -0.542 . . . . 0.0 110.466 179.745 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' B' B ' 113' ' ' TYR . . . . . . . . . . . . . 63.9 t80 -132.89 138.7 47.07 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-N 116.274 -0.421 . . . . 0.0 110.883 -178.452 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' B' B ' 114' ' ' ARG . . . . . . . . . . . . . 24.6 ptt180 -147.89 122.22 9.65 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.3 -0.409 . . . . 0.0 110.619 179.126 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' B' B ' 115' ' ' GLY . . . . . . . . . . . . . . . -150.13 148.15 19.1 Favored Glycine 0 CA--C 1.525 0.701 0 C-N-CA 120.682 -0.77 . . . . 0.0 111.451 179.761 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' B' B ' 116' ' ' LYS . . . . . . . . . . . . . 21.3 ttpp -116.44 131.93 56.81 Favored 'General case' 0 C--N 1.33 -0.26 0 N-CA-C 109.717 -0.475 . . . . 0.0 109.717 176.517 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' B' B ' 117' ' ' PHE . . . . . 0.477 ' HE2' HD13 ' B' ' 132' ' ' ILE . 47.5 m-85 -127.12 116.85 21.29 Favored 'General case' 0 C--N 1.331 -0.216 0 CA-C-O 120.945 0.403 . . . . 0.0 110.243 -176.47 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' B' B ' 118' ' ' GLU . . . . . . . . . . . . . 95.8 mt-10 -52.97 -47.03 68.47 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.309 -0.405 . . . . 0.0 111.476 -176.293 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' B' B ' 119' ' ' ASN . . . . . . . . . . . . . 82.6 m-20 -98.16 31.02 2.88 Favored 'General case' 0 C--N 1.33 -0.256 0 N-CA-C 112.173 0.435 . . . . 0.0 112.173 -173.805 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' B' B ' 120' ' ' LEU . . . . . . . . . . . . . 21.4 tp -56.72 121.82 10.69 Favored 'General case' 0 C--N 1.332 -0.184 0 CA-C-O 120.677 0.275 . . . . 0.0 110.466 177.778 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' B' B ' 121' ' ' ASN . . . . . . . . . . . . . 31.4 m120 -113.98 -44.14 3.19 Favored 'General case' 0 N--CA 1.462 0.155 0 CA-C-N 116.554 -0.294 . . . . 0.0 111.323 -176.684 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' B' B ' 122' ' ' LYS . . . . . . . . . . . . . 55.4 mtmt -147.67 152.7 38.28 Favored 'General case' 0 C--N 1.332 -0.172 0 C-N-CA 120.651 -0.42 . . . . 0.0 111.62 -177.701 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' B' B ' 123' ' ' VAL . . . . . 0.418 ' HB ' HD11 ' B' ' 96' ' ' ILE . 46.2 t -132.77 132.18 59.52 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.243 0 CA-C-N 115.919 -0.582 . . . . 0.0 109.862 177.715 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' B' B ' 124' ' ' LEU . . . . . . . . . . . . . 23.9 mt -121.15 136.13 55.03 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.231 -0.44 . . . . 0.0 110.548 -179.059 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' B' B ' 125' ' ' VAL . . . . . . . . . . . . . 43.5 t -130.46 130.73 65.28 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.262 0 CA-C-N 116.335 -0.393 . . . . 0.0 110.019 179.078 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' B' B ' 126' ' ' ARG . . . . . . . . . . . . . 89.8 mtt-85 -142.05 121.14 12.93 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-O 120.935 0.398 . . . . 0.0 110.642 178.578 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' B' B ' 127' ' ' ASN . . . . . . . . . . . . . 58.4 m-80 51.46 -107.75 0.33 Allowed 'General case' 0 CA--C 1.545 0.761 0 CA-C-O 118.881 -0.581 . . . . 0.0 111.146 179.404 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' B' B ' 128' ' ' ASP . . . . . . . . . . . . . 14.7 p-10 -114.19 4.26 15.47 Favored 'General case' 0 CA--C 1.537 0.445 0 CA-C-N 119.802 1.183 . . . . 0.0 113.257 -178.111 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' B' B ' 129' ' ' LEU . . . . . . . . . . . . . 72.6 mt -107.75 144.93 34.21 Favored 'General case' 0 C--O 1.231 0.109 0 CA-C-N 118.142 0.428 . . . . 0.0 110.09 -179.916 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' B' B ' 130' ' ' VAL . . . . . . . . . . . . . 41.4 t -127.67 140.22 49.73 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.185 0 CA-C-O 120.98 0.419 . . . . 0.0 110.156 -177.739 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' B' B ' 131' ' ' VAL . . . . . 0.505 HG22 HD12 ' B' ' 140' ' ' LEU . 41.0 t -135.01 134.84 53.23 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.277 0 CA-C-N 116.15 -0.477 . . . . 0.0 110.025 178.317 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' B' B ' 132' ' ' ILE . . . . . 0.477 HD13 ' HE2' ' B' ' 117' ' ' PHE . 69.9 mt -118.07 132.84 66.72 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.274 0 CA-C-N 115.984 -0.553 . . . . 0.0 109.606 -179.468 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' B' B ' 133' ' ' ILE . . . . . . . . . . . . . 34.0 mm -116.0 123.49 71.32 Favored 'Isoleucine or valine' 0 C--O 1.234 0.262 0 CA-C-N 116.511 -0.313 . . . . 0.0 110.894 -175.598 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' B' B ' 134' ' ' ASP . . . . . . . . . . . . . 7.9 p-10 -132.61 155.11 49.31 Favored 'General case' 0 C--N 1.332 -0.196 0 CA-C-N 116.434 -0.348 . . . . 0.0 110.089 174.371 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' B' B ' 135' ' ' GLU . . . . . . . . . . . . . 80.7 tt0 -49.83 -28.66 6.71 Favored 'General case' 0 C--N 1.328 -0.364 0 N-CA-C 113.17 0.804 . . . . 0.0 113.17 -169.951 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' B' B ' 136' ' ' GLN . . . . . . . . . . . . . 97.5 mt-30 -99.22 -24.78 14.73 Favored 'General case' 0 C--O 1.233 0.227 0 N-CA-C 113.096 0.776 . . . . 0.0 113.096 -171.761 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' B' B ' 137' ' ' LYS . . . . . . . . . . . . . 57.0 pttt -161.01 168.25 24.89 Favored 'General case' 0 C--O 1.232 0.163 0 CA-C-O 121.619 0.723 . . . . 0.0 112.56 -173.23 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' B' B ' 138' ' ' LEU . . . . . 0.413 ' C ' HD23 ' B' ' 138' ' ' LEU . 6.9 tt -120.07 128.36 53.41 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 114.848 -1.069 . . . . 0.0 110.009 178.219 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' B' B ' 139' ' ' THR . . . . . . . . . . . . . 43.1 m -106.49 127.82 53.6 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.068 -0.515 . . . . 0.0 110.28 179.562 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' B' B ' 140' ' ' LEU . . . . . 0.505 HD12 HG22 ' B' ' 131' ' ' VAL . 19.3 tp -114.92 119.26 35.95 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 115.795 -0.639 . . . . 0.0 109.674 -177.969 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' B' B ' 141' ' ' ILE . . . . . . . . . . . . . 19.3 mt -119.35 119.91 62.07 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.221 0 CA-C-O 120.95 0.405 . . . . 0.0 110.015 -174.516 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' B' B ' 142' ' ' ARG . . . . . . . . . . . . . 76.2 mtm180 -113.77 126.21 54.96 Favored 'General case' 0 C--N 1.332 -0.166 0 CA-C-N 115.44 -0.8 . . . . 0.0 110.369 -177.97 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' B' B ' 143' ' ' THR . . . . . . . . . . . . . 52.0 p . . . . . 0 C--O 1.22 -0.493 0 CA-C-O 118.123 -0.942 . . . . 0.0 110.527 -179.564 . . . . . . . . 0 0 . 1 . 004 nuclear nobuild core ' C' C ' 2' ' ' SER . . . . . 0.435 ' HB2' HD11 ' C' ' 58' ' ' LEU . 3.9 p . . . . . 0 N--CA 1.462 0.151 0 CA-C-O 120.861 0.362 . . . . 0.0 110.597 . . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' C' C ' 3' ' ' GLU . . . . . . . . . . . . . 93.6 mt-10 -141.04 140.9 34.33 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 115.974 -0.557 . . . . 0.0 110.879 -179.292 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' C' C ' 4' ' ' LEU . . . . . . . . . . . . . 15.5 tp -125.21 130.29 51.8 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 116.151 -0.477 . . . . 0.0 110.01 175.629 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' C' C ' 5' ' ' LYS . . . . . . . . . . . . . 96.5 mttt -111.77 121.85 46.21 Favored 'General case' 0 C--N 1.332 -0.192 0 CA-C-N 116.686 -0.234 . . . . 0.0 110.939 -178.512 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' C' C ' 6' ' ' LEU . . . . . . . . . . . . . 27.7 mt -114.3 140.91 48.23 Favored 'General case' 0 C--O 1.234 0.27 0 CA-C-N 115.504 -0.771 . . . . 0.0 110.591 -179.506 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' C' C ' 7' ' ' LYS . . . . . . . . . . . . . 41.1 tttp -121.54 137.88 27.6 Favored Pre-proline 0 CA--C 1.534 0.351 0 CA-C-O 118.935 -0.555 . . . . 0.0 109.592 174.934 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' C' C ' 8' ' ' PRO . . . . . . . . . . . . . 86.9 Cg_endo -91.93 134.68 1.49 Allowed 'Trans proline' 0 N--CA 1.488 1.193 0 C-N-CA 121.682 1.588 . . . . 0.0 111.831 178.858 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' C' C ' 9' ' ' LEU . . . . . . . . . . . . . 49.0 mt -76.66 -46.26 3.15 Favored Pre-proline 0 CA--C 1.533 0.319 0 CA-C-O 118.791 -0.623 . . . . 0.0 111.764 -179.908 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' C' C ' 10' ' ' PRO . . . . . . . . . . . . . 79.2 Cg_endo -83.78 140.46 9.19 Favored 'Trans proline' 0 N--CA 1.495 1.575 0 C-N-CA 121.288 1.325 . . . . 0.0 111.408 173.259 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' C' C ' 11' ' ' LYS . . . . . . . . . . . . . 48.8 pttt -78.96 111.34 15.05 Favored 'General case' 0 C--N 1.331 -0.214 0 CA-C-O 121.449 0.642 . . . . 0.0 110.174 178.414 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' C' C ' 12' ' ' VAL . . . . . . . . . . . . . 11.6 p -151.1 151.99 11.79 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.373 0 CA-C-N 115.711 -0.677 . . . . 0.0 110.589 -178.553 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' C' C ' 13' ' ' GLU . . . . . . . . . . . . . 80.6 tt0 -91.04 124.51 35.33 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.303 -0.408 . . . . 0.0 110.082 177.241 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' C' C ' 14' ' ' LEU . . . . . . . . . . . . . 23.8 mt -95.16 150.87 38.29 Favored Pre-proline 0 C--N 1.329 -0.284 0 CA-C-O 119.332 -0.366 . . . . 0.0 110.511 -179.141 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' C' C ' 15' ' ' PRO . . . . . . . . . . . . . 28.2 Cg_exo -60.51 157.86 34.56 Favored 'Trans proline' 0 N--CA 1.496 1.673 0 C-N-CA 121.257 1.305 . . . . 0.0 111.65 177.623 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' C' C ' 16' ' ' PRO . . . . . . . . . . . . . 38.4 Cg_exo -58.27 -39.79 81.52 Favored 'Trans proline' 0 N--CA 1.497 1.722 0 C-N-CA 121.428 1.419 . . . . 0.0 112.634 -178.718 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' C' C ' 17' ' ' ASP . . . . . . . . . . . . . 19.5 p-10 -87.79 12.76 12.13 Favored 'General case' 0 CA--C 1.536 0.421 0 N-CA-C 113.027 0.751 . . . . 0.0 113.027 -177.896 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' C' C ' 18' ' ' PHE . . . . . . . . . . . . . 45.9 t80 -57.85 -41.29 82.05 Favored 'General case' 0 C--O 1.228 -0.046 0 O-C-N 122.008 -0.432 . . . . 0.0 110.271 -178.664 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' C' C ' 19' ' ' VAL . . . . . . . . . . . . . 48.5 t -56.49 -43.83 79.0 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.271 0 CA-C-N 116.529 -0.305 . . . . 0.0 110.429 -179.484 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' C' C ' 20' ' ' ASP . . . . . . . . . . . . . 35.3 m-20 -60.31 -41.18 92.95 Favored 'General case' 0 C--N 1.33 -0.282 0 C-N-CA 120.872 -0.331 . . . . 0.0 110.719 -178.935 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' C' C ' 21' ' ' VAL . . . . . . . . . . . . . 47.9 t -63.33 -49.23 83.77 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 C-N-CA 120.836 -0.346 . . . . 0.0 110.344 -178.232 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' C' C ' 22' ' ' ILE . . . . . 0.478 HG22 HD12 ' C' ' 26' ' ' LEU . 50.6 mm -55.63 -47.57 78.79 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.268 0 CA-C-O 120.696 0.284 . . . . 0.0 110.828 179.482 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' C' C ' 23' ' ' ARG . . . . . . . . . . . . . 50.8 ttp180 -53.97 -50.65 66.06 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-O 120.619 0.247 . . . . 0.0 111.444 -177.832 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' C' C ' 24' ' ' ILE . . . . . . . . . . . . . 75.5 mt -58.66 -43.0 86.58 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.286 0 CA-C-N 116.688 -0.233 . . . . 0.0 111.139 -177.454 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' C' C ' 25' ' ' LYS . . . . . . . . . . . . . 42.8 mttm -65.37 -40.88 94.08 Favored 'General case' 0 C--N 1.328 -0.348 0 N-CA-C 112.223 0.453 . . . . 0.0 112.223 -178.264 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' C' C ' 26' ' ' LEU . . . . . 0.478 HD12 HG22 ' C' ' 22' ' ' ILE . 91.9 mt -79.98 -39.4 30.16 Favored 'General case' 0 C--N 1.33 -0.253 0 N-CA-C 113.546 0.943 . . . . 0.0 113.546 -170.061 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' C' C ' 27' ' ' GLN . . . . . . . . . . . . . 10.4 pt20 -46.35 138.71 5.36 Favored 'General case' 0 N--CA 1.47 0.527 0 N-CA-C 112.922 0.712 . . . . 0.0 112.922 -174.162 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' C' C ' 28' ' ' GLY . . . . . . . . . . . . . . . 99.95 -27.27 21.06 Favored Glycine 0 CA--C 1.534 1.263 0 CA-C-N 115.47 -0.786 . . . . 0.0 112.175 -177.074 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' C' C ' 29' ' ' LYS . . . . . . . . . . . . . 99.0 mttt -97.83 155.15 17.18 Favored 'General case' 0 C--O 1.234 0.272 0 CA-C-O 121.107 0.48 . . . . 0.0 111.26 179.457 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' C' C ' 30' ' ' THR . . . . . . . . . . . . . 36.2 m -104.82 138.93 40.33 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 115.903 -0.59 . . . . 0.0 110.057 176.14 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' C' C ' 31' ' ' VAL . . . . . . . . . . . . . 35.3 m -126.76 149.94 32.2 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.197 0 CA-C-O 120.878 0.37 . . . . 0.0 110.814 -178.702 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' C' C ' 32' ' ' ARG . . . . . . . . . . . . . 73.8 mtt85 -128.28 148.1 50.63 Favored 'General case' 0 C--N 1.331 -0.239 0 CA-C-N 116.041 -0.527 . . . . 0.0 110.481 178.788 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' C' C ' 33' ' ' THR . . . . . . . . . . . . . 11.2 m -52.68 137.89 29.96 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.292 -0.413 . . . . 0.0 111.497 -177.763 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' C' C ' 34' ' ' GLY . . . . . . . . . . . . . . . 101.31 -17.16 56.09 Favored Glycine 0 CA--C 1.532 1.134 0 CA-C-O 119.643 -0.532 . . . . 0.0 113.241 179.221 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' C' C ' 35' ' ' ASP . . . . . . . . . . . . . 77.9 m-20 -66.47 150.49 48.87 Favored 'General case' 0 N--CA 1.462 0.168 0 CA-C-N 118.062 0.931 . . . . 0.0 110.912 178.917 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' C' C ' 36' ' ' VAL . . . . . . . . . . . . . 43.9 t -124.49 132.57 71.15 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.264 0 CA-C-N 116.107 -0.497 . . . . 0.0 109.908 178.503 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' C' C ' 37' ' ' ILE . . . . . . . . . . . . . 64.3 mt -120.82 139.21 48.79 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.187 0 CA-C-N 116.065 -0.516 . . . . 0.0 109.863 -179.53 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' C' C ' 38' ' ' GLY . . . . . . . . . . . . . . . -116.16 128.7 8.1 Favored Glycine 0 CA--C 1.526 0.752 0 N-CA-C 110.922 -0.871 . . . . 0.0 110.922 178.826 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' C' C ' 39' ' ' ILE . . . . . . . . . . . . . 71.2 mt -124.53 135.27 64.4 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.215 0 CA-C-O 120.733 0.302 . . . . 0.0 110.209 179.806 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' C' C ' 40' ' ' SER . . . . . . . . . . . . . 78.9 p -92.05 121.99 34.12 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.2 -0.455 . . . . 0.0 110.885 176.942 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' C' C ' 41' ' ' ILE . . . . . . . . . . . . . 71.0 mt -130.68 120.69 48.62 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.166 0 CA-C-O 120.772 0.32 . . . . 0.0 110.461 178.07 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' C' C ' 42' ' ' LEU . . . . . . . . . . . . . 76.4 mt 53.21 35.32 19.66 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.141 -0.481 . . . . 0.0 111.703 177.349 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' C' C ' 43' ' ' GLY . . . . . . . . . . . . . . . 72.47 30.44 64.49 Favored Glycine 0 CA--C 1.53 0.994 0 C-N-CA 121.051 -0.595 . . . . 0.0 112.173 178.015 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' C' C ' 44' ' ' LYS . . . . . . . . . . . . . 29.5 ttmt -138.78 128.7 25.16 Favored 'General case' 0 C--N 1.33 -0.258 0 N-CA-C 109.616 -0.513 . . . . 0.0 109.616 178.195 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' C' C ' 45' ' ' GLU . . . . . . . . . . . . . 83.1 tt0 -83.8 124.25 30.73 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-O 120.705 0.288 . . . . 0.0 111.41 -177.566 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' C' C ' 46' ' ' VAL . . . . . 0.417 ' O ' HG13 ' C' ' 46' ' ' VAL . 10.2 p -115.89 123.1 70.84 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.245 0 N-CA-C 109.485 -0.561 . . . . 0.0 109.485 173.618 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' C' C ' 47' ' ' LYS . . . . . . . . . . . . . 61.9 mtpt -98.3 124.35 42.88 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.03 -0.532 . . . . 0.0 110.76 179.016 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' C' C ' 48' ' ' PHE . . . . . . . . . . . . . 32.7 m-85 -110.78 131.84 54.71 Favored 'General case' 0 C--N 1.33 -0.247 0 N-CA-C 109.659 -0.497 . . . . 0.0 109.659 177.178 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' C' C ' 49' ' ' LYS . . . . . . . . . . . . . 82.8 tttt -106.51 132.36 52.61 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.224 179.068 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' C' C ' 50' ' ' VAL . . . . . . . . . . . . . 42.7 t -75.92 103.54 3.52 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.335 0 N-CA-C 109.432 -0.581 . . . . 0.0 109.432 178.021 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' C' C ' 51' ' ' VAL . . . . . . . . . . . . . 44.9 t -69.47 -54.07 21.56 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 CA-C-N 115.898 -0.592 . . . . 0.0 109.449 -175.437 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' C' C ' 52' ' ' GLN . . . . . . . . . . . . . 89.1 mt-30 -153.27 150.73 29.26 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.007 -0.542 . . . . 0.0 111.531 -177.961 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' C' C ' 53' ' ' ALA . . . . . . . . . . . . . . . -126.92 131.65 51.06 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 115.157 -0.929 . . . . 0.0 109.478 174.637 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' C' C ' 54' ' ' TYR . . . . . . . . . . . . . 78.0 t80 -129.1 109.62 18.13 Favored Pre-proline 0 CA--C 1.534 0.359 0 CA-C-O 118.281 -0.866 . . . . 0.0 110.464 -179.17 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' C' C ' 55' ' ' PRO . . . . . . . . . . . . . 73.6 Cg_endo -77.15 170.02 72.68 Favored 'Cis proline' 0 N--CA 1.501 1.936 0 CA-C-N 121.895 1.713 . . . . 0.0 112.269 -6.057 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' C' C ' 56' ' ' SER . . . . . . . . . . . . . 13.6 m -116.28 131.15 23.96 Favored Pre-proline 0 CA--C 1.538 0.487 0 CA-C-O 118.46 -0.781 . . . . 0.0 109.36 174.972 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' C' C ' 57' ' ' PRO . . . . . . . . . . . . . 55.3 Cg_endo -71.38 146.83 86.3 Favored 'Cis proline' 0 N--CA 1.497 1.73 0 CA-C-N 121.996 1.749 . . . . 0.0 111.531 -1.055 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' C' C ' 58' ' ' LEU . . . . . 0.435 HD11 ' HB2' ' C' ' 2' ' ' SER . 14.4 tp -105.97 136.59 45.36 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.286 -0.416 . . . . 0.0 110.651 -178.422 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' C' C ' 59' ' ' ARG . . . . . . . . . . . . . 78.6 ttt180 -103.58 122.46 45.02 Favored 'General case' 0 C--N 1.327 -0.394 0 N-CA-C 109.308 -0.627 . . . . 0.0 109.308 175.788 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' C' C ' 60' ' ' VAL . . . . . . . . . . . . . 42.2 t -80.09 123.71 37.21 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.315 0 C-N-CA 120.704 -0.398 . . . . 0.0 110.48 -175.346 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' C' C ' 61' ' ' GLU . . . . . . . . . . . . . 95.6 mt-10 -130.84 164.25 25.62 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 115.705 -0.679 . . . . 0.0 109.745 177.645 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' C' C ' 62' ' ' ASP . . . . . . . . . . . . . 48.1 m-20 -53.37 -32.1 47.76 Favored 'General case' 0 C--N 1.327 -0.371 0 N-CA-C 111.895 0.331 . . . . 0.0 111.895 -179.178 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' C' C ' 63' ' ' ARG . . . . . . . . . . . . . 35.9 ptt180 -88.5 5.17 43.86 Favored 'General case' 0 CA--C 1.537 0.46 0 N-CA-C 113.676 0.991 . . . . 0.0 113.676 -174.929 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' C' C ' 64' ' ' THR . . . . . . . . . . . . . 26.0 m -84.59 141.66 30.52 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-N 118.19 0.45 . . . . 0.0 110.653 -178.7 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' C' C ' 65' ' ' LYS . . . . . . . . . . . . . 98.8 mttt -89.52 133.53 34.54 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-O 121.092 0.473 . . . . 0.0 110.646 -179.195 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' C' C ' 66' ' ' ILE . . . . . . . . . . . . . 60.4 mt -114.15 127.26 71.66 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.237 0 N-CA-C 109.579 -0.526 . . . . 0.0 109.579 179.482 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' C' C ' 67' ' ' THR . . . . . . . . . . . . . 15.1 m -120.5 142.66 49.1 Favored 'General case' 0 C--N 1.331 -0.214 0 CA-C-O 121.176 0.512 . . . . 0.0 111.149 -175.597 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' C' C ' 68' ' ' LEU . . . . . . . . . . . . . 34.2 mt . . . . . 0 C--N 1.329 -0.301 0 CA-C-N 115.761 -0.654 . . . . 0.0 110.534 179.605 . . . . . . . . 0 0 . 1 . 004 nuclear nobuild core ' C' C ' 73' ' ' VAL . . . . . . . . . . . . . 34.6 m . . . . . 0 CA--C 1.528 0.129 0 CA-C-O 120.469 0.176 . . . . 0.0 110.618 . . . . . . . . . 0 0 . 1 . 004 nuclear nobuild core ' C' C ' 74' ' ' ASP . . . . . . . . . . . . . 15.7 t0 -96.06 122.75 39.22 Favored 'General case' 0 C--N 1.333 -0.147 0 C-N-CA 120.753 -0.379 . . . . 0.0 110.489 -174.094 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' C' C ' 75' ' ' VAL . . . . . . . . . . . . . 41.2 t -121.07 121.17 64.28 Favored 'Isoleucine or valine' 0 N--CA 1.462 0.166 0 CA-C-O 121.119 0.485 . . . . 0.0 110.498 -179.364 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' C' C ' 76' ' ' LEU . . . . . . . . . . . . . 5.4 mp -118.01 150.78 38.71 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 115.651 -0.704 . . . . 0.0 109.501 175.833 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' C' C ' 77' ' ' GLU . . . . . . . . . . . . . 97.7 mt-10 -136.87 136.59 38.84 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-O 121.042 0.449 . . . . 0.0 111.214 -177.769 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' C' C ' 78' ' ' ALA . . . . . 0.618 ' HB2' HD21 ' C' ' 109' ' ' LEU . . . -124.77 135.91 53.39 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 115.669 -0.696 . . . . 0.0 109.712 176.353 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' C' C ' 79' ' ' LYS . . . . . 0.664 ' O ' HD13 ' C' ' 80' ' ' ILE . 99.0 mttt -81.73 119.04 23.35 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-O 120.913 0.387 . . . . 0.0 110.757 -178.498 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' C' C ' 80' ' ' ILE . . . . . 0.664 HD13 ' O ' ' C' ' 79' ' ' LYS . 35.5 mm -139.1 105.6 2.61 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.334 0 N-CA-C 109.22 -0.659 . . . . 0.0 109.22 -178.013 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' C' C ' 81' ' ' LYS . . . . . . . . . . . . . 53.4 mtmt -98.12 125.24 43.04 Favored 'General case' 0 C--N 1.329 -0.314 0 C-N-CA 120.95 -0.3 . . . . 0.0 111.167 -176.934 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' C' C ' 82' ' ' GLY . . . . . . . . . . . . . . . 89.17 42.04 5.69 Favored Glycine 0 CA--C 1.526 0.728 0 C-N-CA 120.786 -0.721 . . . . 0.0 112.048 174.816 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' C' C ' 83' ' ' ILE . . . . . . . . . . . . . 76.5 mt -69.8 138.3 22.38 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.336 0 N-CA-C 109.676 -0.491 . . . . 0.0 109.676 176.749 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' C' C ' 84' ' ' LYS . . . . . . . . . . . . . 38.0 ttpt -101.58 -50.56 3.69 Favored 'General case' 0 C--N 1.331 -0.23 0 CA-C-O 120.942 0.401 . . . . 0.0 110.381 -178.77 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' C' C ' 85' ' ' ASP . . . . . . . . . . . . . 6.6 t0 -149.65 147.51 28.19 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 115.938 -0.574 . . . . 0.0 110.509 -178.572 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' C' C ' 86' ' ' VAL . . . . . . . . . . . . . 43.7 t -129.35 133.64 65.12 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.215 0 CA-C-O 120.925 0.393 . . . . 0.0 110.414 -179.043 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' C' C ' 87' ' ' ILE . . . . . 0.502 ' N ' HD12 ' C' ' 87' ' ' ILE . 4.9 mp -121.94 127.6 75.42 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.215 0 CA-C-N 115.854 -0.612 . . . . 0.0 109.449 176.62 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' C' C ' 88' ' ' LEU . . . . . . . . . . . . . 22.3 tp -118.07 131.52 56.44 Favored 'General case' 0 C--N 1.331 -0.221 0 CA-C-O 121.078 0.466 . . . . 0.0 111.339 -177.279 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' C' C ' 89' ' ' ASP . . . . . . . . . . . . . 14.0 t70 -130.84 152.02 50.63 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 115.616 -0.72 . . . . 0.0 109.293 174.987 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' C' C ' 90' ' ' GLU . . . . . . . . . . . . . 84.9 tt0 -47.81 -35.73 10.62 Favored 'General case' 0 C--N 1.329 -0.286 0 N-CA-C 113.079 0.77 . . . . 0.0 113.079 -172.299 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' C' C ' 91' ' ' ASN . . . . . . . . . . . . . 35.9 m120 -115.4 2.88 14.03 Favored 'General case' 0 N--CA 1.468 0.462 0 N-CA-C 113.734 1.012 . . . . 0.0 113.734 -174.664 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' C' C ' 92' ' ' LEU . . . . . . . . . . . . . 40.7 mt -148.77 147.31 28.66 Favored 'General case' 0 C--N 1.332 -0.196 0 CA-C-N 118.305 0.502 . . . . 0.0 110.972 -175.228 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' C' C ' 93' ' ' ILE . . . . . . . . . . . . . 69.4 mt -125.18 122.05 62.16 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.278 0 N-CA-C 109.383 -0.599 . . . . 0.0 109.383 176.998 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' C' C ' 94' ' ' VAL . . . . . 0.433 HG21 HG21 ' C' ' 125' ' ' VAL . 42.9 t -121.87 127.12 75.34 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.267 0 CA-C-O 120.802 0.334 . . . . 0.0 110.155 -179.448 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' C' C ' 95' ' ' VAL . . . . . . . . . . . . . 45.8 t -122.7 132.64 70.86 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.249 0 CA-C-N 116.094 -0.503 . . . . 0.0 109.786 179.151 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' C' C ' 96' ' ' ILE . . . . . . . . . . . . . 62.7 mt -115.77 128.37 73.05 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.247 0 N-CA-C 109.433 -0.581 . . . . 0.0 109.433 179.75 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' C' C ' 97' ' ' THR . . . . . . . . . . . . . 64.9 p -105.3 163.16 12.82 Favored 'General case' 0 N--CA 1.464 0.233 0 CA-C-O 121.244 0.545 . . . . 0.0 111.68 -174.636 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' C' C ' 98' ' ' GLU . . . . . . . . . . . . . 14.9 mm-40 -53.78 -27.29 28.11 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 115.933 -0.576 . . . . 0.0 112.203 177.676 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' C' C ' 99' ' ' GLU . . . . . . . . . . . . . 71.1 mm-40 -75.26 9.74 1.93 Allowed 'General case' 0 CA--C 1.535 0.395 0 N-CA-C 113.284 0.846 . . . . 0.0 113.284 -177.681 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' C' C ' 100' ' ' ASN . . . . . . . . . . . . . 3.1 m-20 61.03 31.63 19.86 Favored 'General case' 0 CA--C 1.534 0.342 0 CA-C-N 118.268 0.485 . . . . 0.0 111.302 -178.611 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' C' C ' 101' ' ' GLU . . . . . . . . . . . . . 84.5 tt0 -109.63 145.14 36.95 Favored 'General case' 0 C--O 1.233 0.199 0 N-CA-C 109.729 -0.471 . . . . 0.0 109.729 174.569 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' C' C ' 102' ' ' VAL . . . . . . . . . . . . . 45.2 t -114.99 124.12 71.34 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.302 0 CA-C-N 116.137 -0.483 . . . . 0.0 109.783 -179.834 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' C' C ' 103' ' ' LEU . . . . . . . . . . . . . 21.5 mt -112.26 127.69 56.05 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 115.845 -0.616 . . . . 0.0 109.982 176.902 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' C' C ' 104' ' ' ILE . . . . . . . . . . . . . 66.3 mt -116.88 119.74 62.92 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.261 0 N-CA-C 110.268 -0.271 . . . . 0.0 110.268 -179.728 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' C' C ' 105' ' ' PHE . . . . . . . . . . . . . 44.7 m-85 -119.83 168.87 10.66 Favored 'General case' 0 C--N 1.332 -0.158 0 CA-C-N 115.421 -0.809 . . . . 0.0 110.078 179.183 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' C' C ' 106' ' ' ASN . . . . . . . . . . . . . 46.9 p-10 -103.02 -170.48 1.8 Allowed 'General case' 0 CA--C 1.53 0.187 0 N-CA-C 110.018 -0.364 . . . . 0.0 110.018 174.46 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' C' C ' 107' ' ' GLN . . . . . . . . . . . . . 57.0 tt0 -60.94 -23.2 65.12 Favored 'General case' 0 CA--C 1.532 0.272 0 N-CA-C 112.52 0.563 . . . . 0.0 112.52 -179.803 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' C' C ' 108' ' ' ASN . . . . . . . . . . . . . 37.5 t30 -89.88 14.02 13.12 Favored 'General case' 0 CA--C 1.536 0.406 0 N-CA-C 112.89 0.7 . . . . 0.0 112.89 -179.413 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' C' C ' 109' ' ' LEU . . . . . 0.618 HD21 ' HB2' ' C' ' 78' ' ' ALA . 10.4 tp 54.96 37.95 29.68 Favored 'General case' 0 C--O 1.232 0.144 0 CA-C-O 121.036 0.446 . . . . 0.0 111.225 178.732 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' C' C ' 110' ' ' GLU . . . . . . . . . . . . . 70.7 mm-40 -107.98 155.93 19.79 Favored 'General case' 0 C--N 1.331 -0.237 0 N-CA-C 109.921 -0.4 . . . . 0.0 109.921 175.423 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' C' C ' 111' ' ' GLU . . . . . . . . . . . . . 65.8 tt0 -84.56 122.02 28.43 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-N 116.278 -0.419 . . . . 0.0 111.053 -176.245 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' C' C ' 112' ' ' LEU . . . . . . . . . . . . . 36.2 mt -105.44 -46.04 4.3 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.343 -0.39 . . . . 0.0 110.376 177.58 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' C' C ' 113' ' ' TYR . . . . . . . . . . . . . 56.8 t80 -143.68 141.35 30.5 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.301 -0.409 . . . . 0.0 110.966 -179.487 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' C' C ' 114' ' ' ARG . . . . . . . . . . . . . 58.2 ttp180 -139.45 125.27 19.6 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.248 -0.433 . . . . 0.0 110.332 177.642 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' C' C ' 115' ' ' GLY . . . . . . . . . . . . . . . -149.97 151.11 23.23 Favored Glycine 0 CA--C 1.524 0.624 0 N-CA-C 110.905 -0.878 . . . . 0.0 110.905 -179.963 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' C' C ' 116' ' ' LYS . . . . . . . . . . . . . 53.3 tttt -122.09 134.85 54.76 Favored 'General case' 0 C--N 1.328 -0.355 0 N-CA-C 110.021 -0.363 . . . . 0.0 110.021 179.03 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' C' C ' 117' ' ' PHE . . . . . . . . . . . . . 40.9 m-85 -132.31 114.95 15.01 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-N 116.256 -0.429 . . . . 0.0 110.2 -175.921 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' C' C ' 118' ' ' GLU . . . . . . . . . . . . . 43.2 mt-10 -53.32 -44.95 68.8 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.478 -0.328 . . . . 0.0 111.599 -176.625 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' C' C ' 119' ' ' ASN . . . . . . . . . . . . . 30.4 m120 -100.06 31.07 3.46 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.238 -0.437 . . . . 0.0 112.098 -174.271 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' C' C ' 120' ' ' LEU . . . . . . . . . . . . . 13.2 tp -55.39 119.83 6.19 Favored 'General case' 0 N--CA 1.462 0.174 0 C-N-CA 120.984 -0.286 . . . . 0.0 110.696 178.456 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' C' C ' 121' ' ' ASN . . . . . . . . . . . . . 8.2 t-20 -113.98 -44.07 3.19 Favored 'General case' 0 C--N 1.331 -0.209 0 CA-C-N 116.477 -0.329 . . . . 0.0 111.257 -175.884 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' C' C ' 122' ' ' LYS . . . . . . . . . . . . . 95.1 mttt -142.13 148.74 38.8 Favored 'General case' 0 C--N 1.331 -0.216 0 CA-C-O 121.055 0.455 . . . . 0.0 111.602 -176.255 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' C' C ' 123' ' ' VAL . . . . . . . . . . . . . 47.1 t -132.04 124.58 53.21 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.267 0 CA-C-N 115.846 -0.616 . . . . 0.0 109.418 174.222 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' C' C ' 124' ' ' LEU . . . . . . . . . . . . . 6.3 mp -119.71 134.72 55.12 Favored 'General case' 0 N--CA 1.463 0.191 0 CA-C-N 116.453 -0.34 . . . . 0.0 110.711 -178.118 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' C' C ' 125' ' ' VAL . . . . . 0.519 HG22 HG23 ' C' ' 130' ' ' VAL . 43.5 t -132.58 124.23 50.95 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.254 0 CA-C-N 116.144 -0.48 . . . . 0.0 110.183 -179.82 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' C' C ' 126' ' ' ARG . . . . . . . . . . . . . 59.9 mtm180 -151.86 135.74 16.42 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.32 -0.4 . . . . 0.0 109.95 176.7 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' C' C ' 127' ' ' ASN . . . . . . . . . . . . . 5.5 m120 55.0 -154.22 0.3 Allowed 'General case' 0 CA--C 1.54 0.559 0 N-CA-C 110.073 -0.343 . . . . 0.0 110.073 177.852 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' C' C ' 128' ' ' ASP . . . . . . . . . . . . . 15.1 p-10 -83.05 20.74 1.16 Allowed 'General case' 0 CA--C 1.533 0.309 0 N-CA-C 112.509 0.559 . . . . 0.0 112.509 178.13 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' C' C ' 129' ' ' LEU . . . . . . . . . . . . . 14.5 tp -123.15 137.1 54.99 Favored 'General case' 0 C--O 1.234 0.269 0 O-C-N 122.052 -0.405 . . . . 0.0 110.311 179.091 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' C' C ' 130' ' ' VAL . . . . . 0.519 HG23 HG22 ' C' ' 125' ' ' VAL . 12.3 p -132.74 143.29 40.07 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.255 0 CA-C-O 120.999 0.428 . . . . 0.0 110.2 179.412 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' C' C ' 131' ' ' VAL . . . . . . . . . . . . . 41.5 t -136.04 138.93 46.72 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.37 0 CA-C-N 116.032 -0.531 . . . . 0.0 110.339 -178.436 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' C' C ' 132' ' ' ILE . . . . . . . . . . . . . 71.3 mt -116.09 132.45 65.59 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.323 0 CA-C-N 115.614 -0.721 . . . . 0.0 109.141 177.683 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' C' C ' 133' ' ' ILE . . . . . . . . . . . . . 41.4 mm -116.8 121.61 68.12 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.237 0 CA-C-O 120.753 0.311 . . . . 0.0 110.927 -174.464 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' C' C ' 134' ' ' ASP . . . . . . . . . . . . . 8.1 p-10 -135.42 146.48 48.31 Favored 'General case' 0 C--N 1.332 -0.18 0 CA-C-N 116.006 -0.543 . . . . 0.0 109.589 175.316 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' C' C ' 135' ' ' GLU . . . . . . . . . . . . . 83.2 tt0 -50.53 -27.67 7.09 Favored 'General case' 0 C--N 1.329 -0.321 0 N-CA-C 112.827 0.677 . . . . 0.0 112.827 -172.967 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' C' C ' 136' ' ' GLN . . . . . . . . . . . . . 98.4 mt-30 -79.7 -33.24 41.19 Favored 'General case' 0 C--N 1.331 -0.203 0 N-CA-C 112.263 0.468 . . . . 0.0 112.263 -176.226 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' C' C ' 137' ' ' LYS . . . . . . . . . . . . . 56.1 pttt -169.74 174.7 5.61 Favored 'General case' 0 C--N 1.331 -0.21 0 CA-C-O 121.524 0.678 . . . . 0.0 112.257 -172.894 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' C' C ' 138' ' ' LEU . . . . . 0.41 HD23 ' N ' ' C' ' 139' ' ' THR . 6.0 tt -119.14 130.38 55.51 Favored 'General case' 0 C--N 1.331 -0.226 0 CA-C-N 114.973 -1.012 . . . . 0.0 110.236 -179.109 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' C' C ' 139' ' ' THR . . . . . 0.41 ' N ' HD23 ' C' ' 138' ' ' LEU . 21.7 m -108.52 121.76 45.65 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.141 -0.482 . . . . 0.0 110.755 179.551 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' C' C ' 140' ' ' LEU . . . . . . . . . . . . . 33.3 tp -109.59 118.9 37.8 Favored 'General case' 0 C--N 1.329 -0.283 0 N-CA-C 109.058 -0.719 . . . . 0.0 109.058 -179.975 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' C' C ' 141' ' ' ILE . . . . . 0.516 ' HB ' HG13 ' C' ' 130' ' ' VAL . 22.1 mt -121.82 121.61 64.72 Favored 'Isoleucine or valine' 0 C--O 1.234 0.259 0 CA-C-O 121.089 0.471 . . . . 0.0 110.225 -175.627 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' C' C ' 142' ' ' ARG . . . . . . . . . . . . . 80.6 mtp180 . . . . . 0 C--N 1.33 -0.25 0 CA-C-N 115.273 -0.876 . . . . 0.0 110.111 178.265 . . . . . . . . 0 0 . 1 . 004 nuclear nobuild core ' D' D ' 2' ' ' SER . . . . . . . . . . . . . 18.2 p . . . . . 0 C--O 1.231 0.131 0 CA-C-O 120.88 0.371 . . . . 0.0 110.274 . . . . . . . . . 0 0 . 1 . 004 nuclear nobuild core ' D' D ' 3' ' ' GLU . . . . . . . . . . . . . 75.4 tt0 -148.0 139.23 23.46 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.235 -0.439 . . . . 0.0 111.305 -176.816 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' D' D ' 4' ' ' LEU . . . . . . . . . . . . . 16.1 tp -124.01 130.2 52.18 Favored 'General case' 0 C--N 1.331 -0.214 0 CA-C-N 116.051 -0.522 . . . . 0.0 110.031 176.477 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' D' D ' 5' ' ' LYS . . . . . . . . . . . . . 65.3 mttm -112.66 123.22 49.81 Favored 'General case' 0 C--O 1.233 0.215 0 CA-C-N 116.516 -0.311 . . . . 0.0 110.944 -179.734 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' D' D ' 6' ' ' LEU . . . . . . . . . . . . . 55.0 mt -115.72 143.19 45.72 Favored 'General case' 0 N--CA 1.463 0.206 0 CA-C-N 115.609 -0.723 . . . . 0.0 110.63 -179.299 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' D' D ' 7' ' ' LYS . . . . . . . . . . . . . 52.1 tttm -124.36 139.37 32.77 Favored Pre-proline 0 CA--C 1.536 0.409 0 CA-C-O 118.88 -0.581 . . . . 0.0 109.434 175.474 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' D' D ' 8' ' ' PRO . . . . . . . . . . . . . 86.4 Cg_endo -91.72 143.07 2.84 Favored 'Trans proline' 0 N--CA 1.491 1.363 0 C-N-CA 121.707 1.605 . . . . 0.0 112.026 179.647 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' D' D ' 9' ' ' LEU . . . . . . . . . . . . . 48.9 mt -81.98 -46.59 1.01 Allowed Pre-proline 0 CA--C 1.533 0.302 0 CA-C-O 118.757 -0.64 . . . . 0.0 112.113 178.595 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' D' D ' 10' ' ' PRO . . . . . . . . . . . . . 83.6 Cg_endo -83.46 151.5 13.43 Favored 'Trans proline' 0 N--CA 1.495 1.57 0 C-N-CA 121.316 1.344 . . . . 0.0 111.693 174.928 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' D' D ' 11' ' ' LYS . . . . . . . . . . . . . 53.4 pttt -84.98 116.68 23.51 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-O 121.234 0.54 . . . . 0.0 110.144 177.41 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' D' D ' 12' ' ' VAL . . . . . . . . . . . . . 12.1 p -151.06 149.63 14.01 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.223 0 CA-C-N 116.023 -0.535 . . . . 0.0 110.777 -178.457 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' D' D ' 13' ' ' GLU . . . . . . . . . . . . . 84.7 tt0 -99.16 111.69 24.02 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.262 -0.426 . . . . 0.0 110.225 177.164 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' D' D ' 14' ' ' LEU . . . . . . . . . . . . . 20.0 mt -98.37 158.05 33.32 Favored Pre-proline 0 C--N 1.33 -0.274 0 CA-C-N 116.513 -0.312 . . . . 0.0 111.27 -177.469 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' D' D ' 15' ' ' PRO . . . . . . . . . . . . . 23.1 Cg_exo -64.72 161.53 35.48 Favored 'Trans proline' 0 N--CA 1.496 1.671 0 C-N-CA 121.424 1.416 . . . . 0.0 111.876 176.973 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' D' D ' 16' ' ' PRO . . . . . . . . . . . . . 24.6 Cg_exo -62.2 -39.8 45.81 Favored 'Trans proline' 0 N--CA 1.496 1.667 0 C-N-CA 121.53 1.487 . . . . 0.0 112.622 -179.182 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' D' D ' 17' ' ' ASP . . . . . . . . . . . . . 16.2 p-10 -84.66 9.58 13.46 Favored 'General case' 0 CA--C 1.537 0.446 0 N-CA-C 113.175 0.805 . . . . 0.0 113.175 -177.109 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' D' D ' 18' ' ' PHE . . . . . 0.434 ' HE1' HD13 ' D' ' 41' ' ' ILE . 48.0 t80 -56.64 -46.47 81.0 Favored 'General case' 0 C--N 1.334 -0.097 0 O-C-N 121.983 -0.448 . . . . 0.0 110.465 -178.397 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' D' D ' 19' ' ' VAL . . . . . . . . . . . . . 48.0 t -56.65 -42.7 77.22 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.338 0 CA-C-N 116.354 -0.385 . . . . 0.0 110.595 -178.006 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' D' D ' 20' ' ' ASP . . . . . . . . . . . . . 9.9 t0 -59.63 -42.46 92.76 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-O 120.79 0.329 . . . . 0.0 110.839 -177.82 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' D' D ' 21' ' ' VAL . . . . . . . . . . . . . 46.5 t -64.02 -45.96 95.21 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.257 0 C-N-CA 120.806 -0.358 . . . . 0.0 110.479 -178.524 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' D' D ' 22' ' ' ILE . . . . . 0.446 HG22 HD12 ' D' ' 26' ' ' LEU . 51.4 mm -54.33 -48.49 67.86 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.258 0 O-C-N 122.289 -0.257 . . . . 0.0 110.812 178.812 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' D' D ' 23' ' ' ARG . . . . . . . . . . . . . 54.1 ttp180 -54.24 -52.12 62.35 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-O 120.793 0.33 . . . . 0.0 111.43 -178.905 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' D' D ' 24' ' ' ILE . . . . . . . . . . . . . 71.4 mt -56.85 -44.2 81.58 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.315 0 CA-C-N 116.541 -0.299 . . . . 0.0 111.271 -174.703 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' D' D ' 25' ' ' LYS . . . . . . . . . . . . . 80.9 mttt -69.34 -43.95 72.64 Favored 'General case' 0 C--N 1.329 -0.311 0 N-CA-C 112.428 0.529 . . . . 0.0 112.428 -177.466 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' D' D ' 26' ' ' LEU . . . . . 0.446 HD12 HG22 ' D' ' 22' ' ' ILE . 59.3 mt -83.35 -16.15 47.17 Favored 'General case' 0 C--N 1.329 -0.307 0 N-CA-C 113.786 1.032 . . . . 0.0 113.786 -170.12 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' D' D ' 27' ' ' GLN . . . . . . . . . . . . . 11.0 pt20 -46.65 151.44 0.58 Allowed 'General case' 0 N--CA 1.468 0.439 0 N-CA-C 112.837 0.68 . . . . 0.0 112.837 -177.013 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' D' D ' 28' ' ' GLY . . . . . . . . . . . . . . . 84.74 -18.18 27.07 Favored Glycine 0 CA--C 1.537 1.438 0 CA-C-N 114.937 -1.029 . . . . 0.0 113.055 -173.636 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' D' D ' 29' ' ' LYS . . . . . . . . . . . . . 51.7 mttm -86.5 134.81 33.64 Favored 'General case' 0 CA--C 1.535 0.371 0 CA-C-N 118.273 1.037 . . . . 0.0 112.596 179.343 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' D' D ' 30' ' ' THR . . . . . . . . . . . . . 26.7 m -88.73 132.77 34.46 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 115.531 -0.759 . . . . 0.0 109.593 175.791 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' D' D ' 31' ' ' VAL . . . . . . . . . . . . . 35.0 m -126.46 148.8 31.14 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.29 0 CA-C-O 120.767 0.318 . . . . 0.0 111.066 -177.532 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' D' D ' 32' ' ' ARG . . . . . . . . . . . . . 75.6 mtt180 -131.29 151.07 51.85 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 116.056 -0.52 . . . . 0.0 110.381 177.764 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' D' D ' 33' ' ' THR . . . . . . . . . . . . . 12.6 m -52.93 137.63 32.02 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.243 -0.435 . . . . 0.0 111.43 -178.49 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' D' D ' 34' ' ' GLY . . . . . . . . . . . . . . . 100.74 -17.1 56.97 Favored Glycine 0 CA--C 1.533 1.177 0 CA-C-O 119.642 -0.532 . . . . 0.0 113.228 178.779 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' D' D ' 35' ' ' ASP . . . . . . . . . . . . . 62.1 m-20 -65.34 150.32 48.48 Favored 'General case' 0 C--O 1.232 0.156 0 CA-C-N 118.038 0.919 . . . . 0.0 111.224 -179.733 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' D' D ' 36' ' ' VAL . . . . . . . . . . . . . 46.8 t -121.22 128.27 75.95 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.272 0 CA-C-N 115.776 -0.647 . . . . 0.0 109.682 178.031 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' D' D ' 37' ' ' ILE . . . . . . . . . . . . . 65.2 mt -122.25 139.24 49.8 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.243 0 CA-C-N 116.159 -0.473 . . . . 0.0 109.807 -179.29 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' D' D ' 38' ' ' GLY . . . . . . . . . . . . . . . -118.47 128.9 7.92 Favored Glycine 0 CA--C 1.526 0.721 0 N-CA-C 111.2 -0.76 . . . . 0.0 111.2 -179.613 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' D' D ' 39' ' ' ILE . . . . . . . . . . . . . 70.3 mt -124.7 130.51 73.39 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.179 0 N-CA-C 109.881 -0.414 . . . . 0.0 109.881 178.196 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' D' D ' 40' ' ' SER . . . . . . . . . . . . . 18.4 m -92.47 124.83 36.8 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.301 -0.409 . . . . 0.0 111.116 177.634 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' D' D ' 41' ' ' ILE . . . . . 0.434 HD13 ' HE1' ' D' ' 18' ' ' PHE . 66.8 mt -135.65 122.84 34.97 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.204 0 N-CA-C 110.02 -0.363 . . . . 0.0 110.02 177.749 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' D' D ' 42' ' ' LEU . . . . . . . . . . . . . 68.2 mt 58.2 35.2 24.83 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.176 -0.465 . . . . 0.0 111.522 178.124 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' D' D ' 43' ' ' GLY . . . . . . . . . . . . . . . 77.88 -10.19 27.05 Favored Glycine 0 CA--C 1.534 1.261 0 C-N-CA 121.235 -0.507 . . . . 0.0 113.418 177.278 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' D' D ' 44' ' ' LYS . . . . . . . . . . . . . 57.7 tttm -102.91 131.52 49.78 Favored 'General case' 0 C--N 1.334 -0.071 0 CA-C-N 118.007 0.903 . . . . 0.0 110.144 177.857 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' D' D ' 45' ' ' GLU . . . . . . . . . . . . . 83.6 tt0 -85.77 133.23 34.01 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.328 -0.396 . . . . 0.0 111.539 -179.318 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' D' D ' 46' ' ' VAL . . . . . . . . . . . . . 9.6 p -120.24 123.96 71.67 Favored 'Isoleucine or valine' 0 C--O 1.233 0.208 0 N-CA-C 109.42 -0.585 . . . . 0.0 109.42 173.206 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' D' D ' 47' ' ' LYS . . . . . . . . . . . . . 98.2 mttt -98.72 127.73 44.74 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.092 -0.504 . . . . 0.0 110.79 178.594 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' D' D ' 48' ' ' PHE . . . . . . . . . . . . . 35.9 m-85 -112.17 131.92 55.19 Favored 'General case' 0 C--N 1.33 -0.263 0 N-CA-C 109.714 -0.476 . . . . 0.0 109.714 177.362 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' D' D ' 49' ' ' LYS . . . . . . . . . . . . . 79.5 tttt -107.07 133.04 52.29 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.325 -0.398 . . . . 0.0 109.967 177.531 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' D' D ' 50' ' ' VAL . . . . . . . . . . . . . 43.2 t -76.71 109.83 11.49 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.339 0 N-CA-C 109.631 -0.507 . . . . 0.0 109.631 179.001 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' D' D ' 51' ' ' VAL . . . . . . . . . . . . . 47.3 t -74.17 -48.37 37.65 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.35 0 CA-C-N 116.057 -0.52 . . . . 0.0 109.918 -175.179 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' D' D ' 52' ' ' GLN . . . . . . . . . . . . . 48.4 tt0 -160.72 137.75 9.03 Favored 'General case' 0 C--N 1.33 -0.266 0 C-N-CA 120.299 -0.56 . . . . 0.0 111.595 -178.121 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' D' D ' 53' ' ' ALA . . . . . . . . . . . . . . . -116.64 132.12 56.77 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 115.975 -0.557 . . . . 0.0 109.744 174.619 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' D' D ' 54' ' ' TYR . . . . . . . . . . . . . 50.7 t80 -129.01 112.02 18.51 Favored Pre-proline 0 CA--C 1.535 0.385 0 CA-C-O 118.166 -0.921 . . . . 0.0 110.346 179.12 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' D' D ' 55' ' ' PRO . . . . . . . . . . . . . 73.8 Cg_endo -77.18 168.73 76.1 Favored 'Cis proline' 0 N--CA 1.499 1.822 0 CA-C-N 122.061 1.772 . . . . 0.0 112.368 -6.223 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' D' D ' 56' ' ' SER . . . . . . . . . . . . . 13.5 m -117.11 126.57 27.34 Favored Pre-proline 0 CA--C 1.538 0.505 0 CA-C-O 118.347 -0.835 . . . . 0.0 109.108 174.732 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' D' D ' 57' ' ' PRO . . . . . . . . . . . . . 49.6 Cg_endo -69.55 146.66 82.37 Favored 'Cis proline' 0 N--CA 1.497 1.683 0 CA-C-N 122.063 1.772 . . . . 0.0 112.044 1.934 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' D' D ' 58' ' ' LEU . . . . . . . . . . . . . 17.5 tp -106.28 135.09 48.38 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 115.99 -0.55 . . . . 0.0 110.641 179.745 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' D' D ' 59' ' ' ARG . . . . . . . . . . . . . 1.5 tpm_? -104.58 107.59 18.6 Favored 'General case' 0 C--N 1.327 -0.401 0 N-CA-C 109.01 -0.737 . . . . 0.0 109.01 178.473 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' D' D ' 60' ' ' VAL . . . . . . . . . . . . . 43.1 t -72.69 108.72 4.25 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.378 0 CA-C-O 121.449 0.642 . . . . 0.0 112.005 -174.643 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' D' D ' 61' ' ' GLU . . . . . . . . . . . . . 95.7 mt-10 -125.16 167.21 15.13 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.269 -0.423 . . . . 0.0 109.892 175.624 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' D' D ' 62' ' ' ASP . . . . . . . . . . . . . 7.6 t0 -52.85 -32.36 44.12 Favored 'General case' 0 C--N 1.328 -0.36 0 N-CA-C 112.066 0.395 . . . . 0.0 112.066 -177.035 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' D' D ' 63' ' ' ARG . . . . . . . . . . . . . 34.5 ptt180 -73.66 -17.32 61.16 Favored 'General case' 0 CA--C 1.535 0.38 0 N-CA-C 113.282 0.845 . . . . 0.0 113.282 -175.743 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' D' D ' 64' ' ' THR . . . . . . . . . . . . . 32.6 m -77.54 143.75 38.16 Favored 'General case' 0 C--N 1.331 -0.229 0 CA-C-O 120.872 0.368 . . . . 0.0 111.048 -175.511 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' D' D ' 65' ' ' LYS . . . . . . . . . . . . . 99.1 mttt -89.17 134.62 33.95 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 115.977 -0.556 . . . . 0.0 110.313 178.591 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' D' D ' 66' ' ' ILE . . . . . . . . . . . . . 69.2 mt -118.7 127.66 75.64 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.228 0 N-CA-C 109.733 -0.469 . . . . 0.0 109.733 178.625 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' D' D ' 67' ' ' THR . . . . . . . . . . . . . 20.2 m -116.02 135.87 53.56 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.113 -0.494 . . . . 0.0 110.948 -176.72 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' D' D ' 68' ' ' LEU . . . . . . . . . . . . . 16.7 tp . . . . . 0 C--N 1.33 -0.249 0 CA-C-N 115.726 -0.67 . . . . 0.0 110.319 178.553 . . . . . . . . 0 0 . 1 . 004 nuclear nobuild core ' D' D ' 73' ' ' VAL . . . . . . . . . . . . . 36.0 m . . . . . 0 C--O 1.231 0.13 0 CA-C-O 120.743 0.306 . . . . 0.0 110.182 . . . . . . . . . 0 0 . 1 . 004 nuclear nobuild core ' D' D ' 74' ' ' ASP . . . . . . . . . . . . . 18.5 t0 -95.21 116.66 29.04 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.152 -0.477 . . . . 0.0 109.831 -178.45 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' D' D ' 75' ' ' VAL . . . . . . . . . . . . . 44.6 t -111.68 121.95 65.15 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.227 0 CA-C-O 121.164 0.507 . . . . 0.0 110.547 -177.02 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' D' D ' 76' ' ' LEU . . . . . . . . . . . . . 21.7 mt -122.13 140.47 52.5 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 115.563 -0.744 . . . . 0.0 109.514 177.543 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' D' D ' 77' ' ' GLU . . . . . . . . . . . . . 46.7 mt-10 -133.77 135.88 44.19 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-O 120.92 0.39 . . . . 0.0 111.126 -178.136 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' D' D ' 78' ' ' ALA . . . . . 0.403 ' HB2' HD21 ' D' ' 109' ' ' LEU . . . -124.59 127.18 46.98 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 115.729 -0.669 . . . . 0.0 109.998 177.771 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' D' D ' 79' ' ' LYS . . . . . 0.619 ' O ' HD13 ' D' ' 80' ' ' ILE . 37.0 tptt -75.9 115.72 15.88 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-O 120.864 0.364 . . . . 0.0 110.535 -177.89 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' D' D ' 80' ' ' ILE . . . . . 0.619 HD13 ' O ' ' D' ' 79' ' ' LYS . 40.4 mm -139.26 111.59 5.62 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.287 0 N-CA-C 109.493 -0.558 . . . . 0.0 109.493 -176.355 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' D' D ' 81' ' ' LYS . . . . . . . . . . . . . 99.1 mttt -101.14 123.82 45.89 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-O 120.855 0.36 . . . . 0.0 110.96 -178.091 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' D' D ' 82' ' ' GLY . . . . . . . . . . . . . . . 89.0 42.35 5.66 Favored Glycine 0 CA--C 1.524 0.647 0 C-N-CA 120.791 -0.718 . . . . 0.0 111.826 175.05 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' D' D ' 83' ' ' ILE . . . . . . . . . . . . . 71.8 mt -63.77 136.73 25.89 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.33 0 N-CA-C 109.607 -0.516 . . . . 0.0 109.607 176.338 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' D' D ' 84' ' ' LYS . . . . . . . . . . . . . 76.7 tttt -95.78 -53.95 3.52 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.107 -0.497 . . . . 0.0 110.412 -177.567 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' D' D ' 85' ' ' ASP . . . . . . . . . . . . . 12.9 t70 -151.43 148.87 28.62 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 115.878 -0.601 . . . . 0.0 110.379 -179.21 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' D' D ' 86' ' ' VAL . . . . . . . . . . . . . 42.2 t -127.84 128.17 68.96 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.28 0 CA-C-O 120.886 0.374 . . . . 0.0 110.379 -179.078 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' D' D ' 87' ' ' ILE . . . . . 0.493 HD12 ' N ' ' D' ' 87' ' ' ILE . 4.9 mp -122.36 127.39 75.11 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.153 0 CA-C-N 115.994 -0.548 . . . . 0.0 109.634 176.993 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' D' D ' 88' ' ' LEU . . . . . . . . . . . . . 58.5 mt -110.22 134.96 51.7 Favored 'General case' 0 C--N 1.331 -0.204 0 CA-C-O 121.025 0.441 . . . . 0.0 110.802 -179.784 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' D' D ' 89' ' ' ASP . . . . . . . . . . . . . 4.4 t70 -123.82 163.12 21.85 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 115.775 -0.648 . . . . 0.0 109.526 178.265 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' D' D ' 90' ' ' GLU . . . . . . . . . . . . . 43.6 tp10 -44.92 -46.02 10.72 Favored 'General case' 0 N--CA 1.464 0.255 0 N-CA-C 113.158 0.799 . . . . 0.0 113.158 -171.495 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' D' D ' 91' ' ' ASN . . . . . . . . . . . . . 25.5 p30 -132.1 26.93 4.55 Favored 'General case' 0 N--CA 1.465 0.276 0 N-CA-C 112.408 0.521 . . . . 0.0 112.408 -178.837 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' D' D ' 92' ' ' LEU . . . . . . . . . . . . . 15.3 mt -147.72 150.44 34.32 Favored 'General case' 0 C--N 1.332 -0.164 0 CA-C-O 120.738 0.304 . . . . 0.0 110.493 -176.352 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' D' D ' 93' ' ' ILE . . . . . . . . . . . . . 69.0 mt -126.38 119.55 54.2 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.272 0 N-CA-C 109.363 -0.606 . . . . 0.0 109.363 177.785 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' D' D ' 94' ' ' VAL . . . . . 0.468 HG21 HG11 ' D' ' 125' ' ' VAL . 45.2 t -119.69 126.28 75.16 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.282 0 CA-C-O 120.99 0.424 . . . . 0.0 109.892 -179.743 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' D' D ' 95' ' ' VAL . . . . . . . . . . . . . 45.6 t -124.15 136.22 61.1 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.265 0 CA-C-N 116.003 -0.544 . . . . 0.0 110.046 -179.392 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' D' D ' 96' ' ' ILE . . . . . . . . . . . . . 54.4 mt -114.75 128.52 71.82 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.343 0 N-CA-C 108.979 -0.749 . . . . 0.0 108.979 178.539 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' D' D ' 97' ' ' THR . . . . . . . . . . . . . 55.1 p -101.11 160.53 14.31 Favored 'General case' 0 C--N 1.331 -0.216 0 CA-C-O 121.115 0.484 . . . . 0.0 111.416 -175.824 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' D' D ' 98' ' ' GLU . . . . . . . . . . . . . 84.2 tt0 -53.86 -26.97 27.12 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.192 -0.458 . . . . 0.0 112.094 178.399 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' D' D ' 99' ' ' GLU . . . . . . . . . . . . . 43.6 mt-10 -77.83 14.34 1.11 Allowed 'General case' 0 CA--C 1.536 0.409 0 N-CA-C 113.01 0.744 . . . . 0.0 113.01 -178.921 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' D' D ' 100' ' ' ASN . . . . . . . . . . . . . 1.9 m120 63.58 37.87 10.03 Favored 'General case' 0 CA--C 1.529 0.155 0 CA-C-N 118.103 0.411 . . . . 0.0 110.731 177.288 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' D' D ' 101' ' ' GLU . . . . . . . . . . . . . 96.7 mt-10 -113.12 148.21 35.76 Favored 'General case' 0 C--O 1.232 0.152 0 CA-C-N 116.268 -0.424 . . . . 0.0 110.377 177.356 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' D' D ' 102' ' ' VAL . . . . . . . . . . . . . 45.5 t -114.88 121.73 67.55 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.367 0 CA-C-N 115.662 -0.699 . . . . 0.0 109.412 177.811 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' D' D ' 103' ' ' LEU . . . . . . . . . . . . . 21.1 mt -115.0 125.66 53.85 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 115.811 -0.631 . . . . 0.0 109.889 177.531 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' D' D ' 104' ' ' ILE . . . . . 0.401 HD12 ' HB3' ' D' ' 113' ' ' TYR . 69.5 mt -114.77 118.77 59.7 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 N-CA-C 110.038 -0.356 . . . . 0.0 110.038 -179.648 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' D' D ' 105' ' ' PHE . . . . . . . . . . . . . 27.9 m-85 -119.88 166.1 13.74 Favored 'General case' 0 C--N 1.331 -0.216 0 O-C-N 123.972 0.795 . . . . 0.0 109.929 178.513 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' D' D ' 106' ' ' ASN . . . . . . . . . . . . . 41.3 p-10 -98.27 -170.33 1.95 Allowed 'General case' 0 C--N 1.329 -0.313 0 N-CA-C 109.791 -0.448 . . . . 0.0 109.791 174.614 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' D' D ' 107' ' ' GLN . . . . . . . . . . . . . 58.1 tt0 -59.77 -29.79 68.42 Favored 'General case' 0 CA--C 1.532 0.285 0 N-CA-C 111.827 0.306 . . . . 0.0 111.827 178.675 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' D' D ' 108' ' ' ASN . . . . . . . . . . . . . 5.1 t-20 -81.99 3.19 27.49 Favored 'General case' 0 CA--C 1.536 0.442 0 N-CA-C 113.283 0.846 . . . . 0.0 113.283 -177.443 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' D' D ' 109' ' ' LEU . . . . . 0.403 HD21 ' HB2' ' D' ' 78' ' ' ALA . 9.5 tp 64.48 40.94 5.91 Favored 'General case' 0 CA--C 1.53 0.182 0 CA-C-O 121.13 0.491 . . . . 0.0 111.364 177.543 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' D' D ' 110' ' ' GLU . . . . . . . . . . . . . 70.7 mm-40 -111.11 160.97 16.4 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-N 116.226 -0.443 . . . . 0.0 109.954 175.243 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' D' D ' 111' ' ' GLU . . . . . . . . . . . . . 45.1 tp10 -84.55 127.14 33.89 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-O 120.881 0.372 . . . . 0.0 111.065 -177.113 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' D' D ' 112' ' ' LEU . . . . . . . . . . . . . 18.9 mt -113.05 -46.11 3.12 Favored 'General case' 0 C--O 1.233 0.213 0 CA-C-N 116.017 -0.538 . . . . 0.0 110.388 176.825 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' D' D ' 113' ' ' TYR . . . . . 0.401 ' HB3' HD12 ' D' ' 104' ' ' ILE . 59.3 t80 -141.13 140.32 34.1 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.303 -0.408 . . . . 0.0 111.003 -179.939 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' D' D ' 114' ' ' ARG . . . . . . . . . . . . . 36.5 ttp180 -141.83 125.1 16.46 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 116.443 -0.344 . . . . 0.0 110.543 177.95 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' D' D ' 115' ' ' GLY . . . . . . . . . . . . . . . -150.1 160.95 28.75 Favored Glycine 0 CA--C 1.523 0.56 0 N-CA-C 111.124 -0.79 . . . . 0.0 111.124 178.867 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' D' D ' 116' ' ' LYS . . . . . . . . . . . . . 39.4 ttpt -127.25 134.34 50.09 Favored 'General case' 0 C--N 1.33 -0.281 0 N-CA-C 110.119 -0.326 . . . . 0.0 110.119 177.287 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' D' D ' 117' ' ' PHE . . . . . . . . . . . . . 31.5 m-85 -138.32 113.89 9.69 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.241 -0.436 . . . . 0.0 110.059 -176.739 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' D' D ' 118' ' ' GLU . . . . . . . . . . . . . 41.6 mp0 -55.18 -49.22 72.43 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-N 116.45 -0.341 . . . . 0.0 111.436 -174.504 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' D' D ' 119' ' ' ASN . . . . . . . . . . . . . 2.7 p30 -94.5 31.16 1.81 Allowed 'General case' 0 C--N 1.331 -0.216 0 N-CA-C 112.168 0.433 . . . . 0.0 112.168 -175.337 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' D' D ' 120' ' ' LEU . . . . . . . . . . . . . 26.8 tp -55.7 119.91 6.46 Favored 'General case' 0 C--N 1.332 -0.175 0 N-CA-C 110.344 -0.243 . . . . 0.0 110.344 175.831 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' D' D ' 121' ' ' ASN . . . . . . . . . . . . . 86.6 m-20 -114.19 -44.0 3.17 Favored 'General case' 0 N--CA 1.463 0.202 0 N-CA-C 111.569 0.211 . . . . 0.0 111.569 -175.37 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' D' D ' 122' ' ' LYS . . . . . . . . . . . . . 53.4 mtpt -138.59 149.02 44.83 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-O 121.11 0.481 . . . . 0.0 111.534 -175.419 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' D' D ' 123' ' ' VAL . . . . . 0.431 ' C ' HD12 ' D' ' 124' ' ' LEU . 46.4 t -133.92 126.49 50.55 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.268 0 CA-C-N 116.0 -0.545 . . . . 0.0 109.588 174.108 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' D' D ' 124' ' ' LEU . . . . . 0.431 HD12 ' C ' ' D' ' 123' ' ' VAL . 7.2 mp -116.99 134.44 54.73 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.311 -0.404 . . . . 0.0 110.571 -177.48 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' D' D ' 125' ' ' VAL . . . . . 0.468 HG11 HG21 ' D' ' 94' ' ' VAL . 34.8 m -131.32 125.85 57.65 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.283 0 CA-C-N 116.389 -0.368 . . . . 0.0 110.36 178.492 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' D' D ' 126' ' ' ARG . . . . . . . . . . . . . 91.2 mtt-85 -150.42 126.44 10.51 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.258 -0.428 . . . . 0.0 110.003 179.468 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' D' D ' 127' ' ' ASN . . . . . . . . . . . . . 10.9 t30 55.57 -148.94 0.47 Allowed 'General case' 0 CA--C 1.54 0.575 0 N-CA-C 110.001 -0.37 . . . . 0.0 110.001 179.502 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' D' D ' 128' ' ' ASP . . . . . . . . . . . . . 17.3 p-10 -82.84 15.35 2.73 Favored 'General case' 0 CA--C 1.535 0.388 0 CA-C-N 118.782 0.719 . . . . 0.0 112.931 179.459 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' D' D ' 129' ' ' LEU . . . . . . . . . . . . . 58.6 mt -112.49 138.2 49.59 Favored 'General case' 0 C--O 1.233 0.216 0 CA-C-N 118.171 0.441 . . . . 0.0 110.7 -179.991 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' D' D ' 130' ' ' VAL . . . . . . . . . . . . . 44.7 t -124.16 136.18 61.25 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.217 0 CA-C-N 115.924 -0.58 . . . . 0.0 109.744 179.638 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' D' D ' 131' ' ' VAL . . . . . 0.43 HG22 HD12 ' D' ' 140' ' ' LEU . 42.6 t -134.71 134.21 54.09 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.215 0 CA-C-O 120.964 0.411 . . . . 0.0 110.339 179.645 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' D' D ' 132' ' ' ILE . . . . . . . . . . . . . 73.6 mt -115.86 132.83 64.15 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.321 0 CA-C-N 115.963 -0.562 . . . . 0.0 109.509 -179.805 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' D' D ' 133' ' ' ILE . . . . . . . . . . . . . 35.7 mm -118.46 120.04 63.05 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.247 0 CA-C-O 120.847 0.356 . . . . 0.0 110.943 -174.043 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' D' D ' 134' ' ' ASP . . . . . . . . . . . . . 8.1 p-10 -133.11 147.95 52.14 Favored 'General case' 0 C--N 1.332 -0.185 0 N-CA-C 109.801 -0.444 . . . . 0.0 109.801 174.789 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' D' D ' 135' ' ' GLU . . . . . . . . . . . . . 84.1 tt0 -49.76 -23.86 2.04 Favored 'General case' 0 C--N 1.329 -0.32 0 N-CA-C 113.049 0.759 . . . . 0.0 113.049 -170.962 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' D' D ' 136' ' ' GLN . . . . . . . . . . . . . 39.3 tp60 -89.4 -37.68 14.66 Favored 'General case' 0 C--N 1.33 -0.241 0 N-CA-C 112.146 0.425 . . . . 0.0 112.146 -175.366 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' D' D ' 137' ' ' LYS . . . . . . . . . . . . . 57.0 pttt -156.41 166.0 34.69 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-O 121.525 0.679 . . . . 0.0 112.077 -171.185 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' D' D ' 138' ' ' LEU . . . . . 0.455 HD23 ' N ' ' D' ' 139' ' ' THR . 4.8 tt -117.7 128.4 54.86 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 115.065 -0.97 . . . . 0.0 109.793 178.115 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' D' D ' 139' ' ' THR . . . . . 0.455 ' N ' HD23 ' D' ' 138' ' ' LEU . 29.8 m -110.43 127.4 55.1 Favored 'General case' 0 C--N 1.331 -0.224 0 CA-C-N 116.421 -0.354 . . . . 0.0 110.809 -179.59 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' D' D ' 140' ' ' LEU . . . . . 0.43 HD12 HG22 ' D' ' 131' ' ' VAL . 9.9 tp -112.61 120.12 40.47 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 115.567 -0.742 . . . . 0.0 109.056 -179.912 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' D' D ' 141' ' ' ILE . . . . . . . . . . . . . 19.6 mt -119.66 117.12 52.77 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.283 0 CA-C-O 121.077 0.465 . . . . 0.0 109.933 -175.823 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' D' D ' 142' ' ' ARG . . . . . . . . . . . . . 58.8 ttp180 -108.85 119.1 38.55 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 115.28 -0.873 . . . . 0.0 110.13 -178.344 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' D' D ' 143' ' ' THR . . . . . . . . . . . . . 54.6 p . . . . . 0 C--O 1.22 -0.465 0 CA-C-O 117.983 -1.008 . . . . 0.0 110.749 -178.596 . . . . . . . . 0 0 . 1 . 004 nuclear nobuild core ' E' E ' 2' ' ' SER . . . . . . . . . . . . . 3.0 p . . . . . 0 C--O 1.233 0.197 0 CA-C-O 120.944 0.402 . . . . 0.0 110.629 . . . . . . . . . 0 0 . 1 . 004 nuclear nobuild core ' E' E ' 3' ' ' GLU . . . . . . . . . . . . . 83.4 tt0 -142.27 142.35 32.57 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.034 -0.53 . . . . 0.0 111.203 -178.579 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' E' E ' 4' ' ' LEU . . . . . . . . . . . . . 14.4 tp -123.24 128.58 50.19 Favored 'General case' 0 C--N 1.332 -0.187 0 CA-C-N 115.958 -0.565 . . . . 0.0 110.281 176.85 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' E' E ' 5' ' ' LYS . . . . . . . . . . . . . 75.1 mttt -105.86 121.4 44.0 Favored 'General case' 0 C--O 1.235 0.293 0 CA-C-N 116.306 -0.406 . . . . 0.0 110.57 178.065 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' E' E ' 6' ' ' LEU . . . . . . . . . . . . . 29.3 mt -115.3 149.82 37.22 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 115.531 -0.759 . . . . 0.0 110.251 -179.735 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' E' E ' 7' ' ' LYS . . . . . . . . . . . . . 58.4 tttm -139.6 138.08 19.66 Favored Pre-proline 0 CA--C 1.533 0.305 0 CA-C-O 119.031 -0.509 . . . . 0.0 110.086 175.088 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' E' E ' 8' ' ' PRO . . . . . . . . . . . . . 98.7 Cg_endo -91.44 139.28 2.34 Favored 'Trans proline' 0 N--CA 1.489 1.258 0 C-N-CA 121.716 1.611 . . . . 0.0 111.728 177.396 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' E' E ' 9' ' ' LEU . . . . . . . . . . . . . 57.5 mt -71.46 -46.65 13.36 Favored Pre-proline 0 CA--C 1.533 0.312 0 CA-C-O 118.644 -0.693 . . . . 0.0 112.033 -179.026 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' E' E ' 10' ' ' PRO . . . . . . . . . . . . . 89.9 Cg_endo -82.31 147.36 14.35 Favored 'Trans proline' 0 N--CA 1.495 1.596 0 C-N-CA 121.147 1.231 . . . . 0.0 111.509 174.419 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' E' E ' 11' ' ' LYS . . . . . . . . . . . . . 50.3 pttt -86.51 115.06 23.76 Favored 'General case' 0 C--N 1.331 -0.222 0 CA-C-O 121.383 0.611 . . . . 0.0 110.217 178.122 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' E' E ' 12' ' ' VAL . . . . . . . . . . . . . 11.6 p -151.11 146.59 16.06 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 CA-C-N 115.879 -0.6 . . . . 0.0 110.544 -178.89 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' E' E ' 13' ' ' GLU . . . . . . . . . . . . . 95.8 mt-10 -83.23 118.03 23.35 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.347 -0.388 . . . . 0.0 110.042 177.126 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' E' E ' 14' ' ' LEU . . . . . . . . . . . . . 48.6 mt -96.53 148.8 35.01 Favored Pre-proline 0 C--N 1.33 -0.265 0 CA-C-O 119.282 -0.39 . . . . 0.0 110.665 -177.881 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' E' E ' 15' ' ' PRO . . . . . . . . . . . . . 27.9 Cg_exo -61.31 163.61 16.98 Favored 'Trans proline' 0 N--CA 1.497 1.704 0 C-N-CA 121.339 1.36 . . . . 0.0 112.093 177.015 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' E' E ' 16' ' ' PRO . . . . . . . . . . . . . 24.4 Cg_exo -62.25 -39.58 46.82 Favored 'Trans proline' 0 N--CA 1.497 1.69 0 C-N-CA 121.561 1.508 . . . . 0.0 112.987 -178.296 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' E' E ' 17' ' ' ASP . . . . . . . . . . . . . 22.1 p-10 -85.39 8.42 18.94 Favored 'General case' 0 CA--C 1.535 0.396 0 N-CA-C 113.302 0.853 . . . . 0.0 113.302 -176.304 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' E' E ' 18' ' ' PHE . . . . . . . . . . . . . 32.4 t80 -55.97 -47.87 76.86 Favored 'General case' 0 C--N 1.334 -0.107 0 O-C-N 121.904 -0.498 . . . . 0.0 110.506 -179.359 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' E' E ' 19' ' ' VAL . . . . . . . . . . . . . 14.0 p -56.3 -40.77 68.13 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.272 0 CA-C-N 116.227 -0.442 . . . . 0.0 111.037 -178.985 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' E' E ' 20' ' ' ASP . . . . . . . . . . . . . 20.2 t0 -60.54 -43.78 96.81 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-O 120.793 0.33 . . . . 0.0 111.15 -177.312 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' E' E ' 21' ' ' VAL . . . . . . . . . . . . . 49.1 t -63.67 -46.33 95.0 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.332 0 C-N-CA 120.834 -0.346 . . . . 0.0 110.296 -178.488 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' E' E ' 22' ' ' ILE . . . . . 0.677 HG22 HD12 ' E' ' 26' ' ' LEU . 49.3 mm -55.54 -45.79 78.77 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.227 0 C-N-CA 120.956 -0.298 . . . . 0.0 110.707 178.377 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' E' E ' 23' ' ' ARG . . . . . . . . . . . . . 54.7 ttp180 -53.33 -51.0 63.79 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-O 120.584 0.23 . . . . 0.0 111.538 -178.544 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' E' E ' 24' ' ' ILE . . . . . . . . . . . . . 68.5 mt -59.64 -43.71 91.82 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.287 0 C-N-CA 121.138 -0.225 . . . . 0.0 111.349 -177.221 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' E' E ' 25' ' ' LYS . . . . . . . . . . . . . 97.9 mttt -64.85 -38.45 91.02 Favored 'General case' 0 C--N 1.329 -0.314 0 N-CA-C 112.208 0.447 . . . . 0.0 112.208 -178.247 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' E' E ' 26' ' ' LEU . . . . . 0.677 HD12 HG22 ' E' ' 22' ' ' ILE . 37.5 mt -80.47 -41.77 23.79 Favored 'General case' 0 C--N 1.329 -0.302 0 N-CA-C 113.258 0.836 . . . . 0.0 113.258 -171.675 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' E' E ' 27' ' ' GLN . . . . . . . . . . . . . 11.0 pt20 -46.42 142.68 2.91 Favored 'General case' 0 N--CA 1.469 0.486 0 N-CA-C 112.869 0.692 . . . . 0.0 112.869 -174.325 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' E' E ' 28' ' ' GLY . . . . . . . . . . . . . . . 98.75 -28.68 13.98 Favored Glycine 0 CA--C 1.531 1.066 0 CA-C-N 115.479 -0.782 . . . . 0.0 112.02 -177.467 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' E' E ' 29' ' ' LYS . . . . . . . . . . . . . 87.7 mttt -98.07 155.08 17.29 Favored 'General case' 0 C--N 1.331 -0.224 0 CA-C-N 117.235 0.517 . . . . 0.0 111.08 178.808 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' E' E ' 30' ' ' THR . . . . . . . . . . . . . 40.1 m -102.4 137.39 40.71 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.002 -0.544 . . . . 0.0 109.949 175.679 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' E' E ' 31' ' ' VAL . . . . . . . . . . . . . 34.6 m -127.92 152.81 36.48 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.256 0 CA-C-O 120.939 0.4 . . . . 0.0 110.729 -178.23 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' E' E ' 32' ' ' ARG . . . . . . . . . . . . . 61.1 ttt180 -131.09 147.82 52.66 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-O 121.215 0.531 . . . . 0.0 110.628 -179.527 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' E' E ' 33' ' ' THR . . . . . . . . . . . . . 31.4 m -52.56 140.7 22.25 Favored 'General case' 0 C--N 1.331 -0.23 0 CA-C-N 116.293 -0.412 . . . . 0.0 111.453 -178.552 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' E' E ' 34' ' ' GLY . . . . . . . . . . . . . . . 99.51 -17.2 58.01 Favored Glycine 0 CA--C 1.531 1.087 0 CA-C-O 119.681 -0.511 . . . . 0.0 113.247 179.502 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' E' E ' 35' ' ' ASP . . . . . . . . . . . . . 80.0 m-20 -66.88 147.52 53.13 Favored 'General case' 0 C--O 1.232 0.138 0 CA-C-N 118.013 0.906 . . . . 0.0 111.028 178.531 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' E' E ' 36' ' ' VAL . . . . . . . . . . . . . 44.2 t -120.9 129.31 75.81 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.208 0 CA-C-N 116.082 -0.508 . . . . 0.0 109.713 177.527 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' E' E ' 37' ' ' ILE . . . . . . . . . . . . . 67.2 mt -121.01 138.83 50.16 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.289 0 CA-C-N 116.246 -0.434 . . . . 0.0 109.937 -178.951 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' E' E ' 38' ' ' GLY . . . . . . . . . . . . . . . -109.78 128.86 9.11 Favored Glycine 0 CA--C 1.524 0.656 0 N-CA-C 111.159 -0.776 . . . . 0.0 111.159 -179.64 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' E' E ' 39' ' ' ILE . . . . . . . . . . . . . 74.4 mt -123.61 133.73 68.38 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.203 0 N-CA-C 109.976 -0.379 . . . . 0.0 109.976 179.017 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' E' E ' 40' ' ' SER . . . . . . . . . . . . . 59.7 p -92.87 117.4 30.0 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.284 -0.417 . . . . 0.0 110.797 175.465 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' E' E ' 41' ' ' ILE . . . . . . . . . . . . . 43.8 mm -121.05 118.0 54.76 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.224 0 CA-C-O 120.802 0.334 . . . . 0.0 110.379 -179.864 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' E' E ' 42' ' ' LEU . . . . . . . . . . . . . 61.1 mt 52.65 36.3 20.51 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 116.194 -0.457 . . . . 0.0 111.604 176.646 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' E' E ' 43' ' ' GLY . . . . . . . . . . . . . . . 73.04 30.51 63.08 Favored Glycine 0 CA--C 1.529 0.911 0 C-N-CA 121.135 -0.555 . . . . 0.0 112.275 177.816 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' E' E ' 44' ' ' LYS . . . . . . . . . . . . . 68.7 mttm -138.31 134.27 34.08 Favored 'General case' 0 C--N 1.331 -0.234 0 N-CA-C 109.759 -0.46 . . . . 0.0 109.759 177.757 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' E' E ' 45' ' ' GLU . . . . . . . . . . . . . 80.6 tt0 -83.02 124.46 30.44 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-O 120.839 0.352 . . . . 0.0 111.6 -176.192 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' E' E ' 46' ' ' VAL . . . . . . . . . . . . . 7.2 p -124.61 126.44 71.68 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.19 0 N-CA-C 109.478 -0.564 . . . . 0.0 109.478 173.863 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' E' E ' 47' ' ' LYS . . . . . . . . . . . . . 98.9 mttt -99.91 129.66 46.01 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.064 -0.516 . . . . 0.0 111.081 178.994 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' E' E ' 48' ' ' PHE . . . . . . . . . . . . . 91.1 m-85 -112.69 131.9 55.44 Favored 'General case' 0 C--N 1.33 -0.271 0 N-CA-C 109.872 -0.418 . . . . 0.0 109.872 177.035 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' E' E ' 49' ' ' LYS . . . . . . . . . . . . . 80.0 tttt -106.96 135.99 47.57 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.294 -0.412 . . . . 0.0 110.279 179.067 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' E' E ' 50' ' ' VAL . . . . . . . . . . . . . 46.0 t -77.14 105.02 5.56 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.218 0 N-CA-C 109.192 -0.67 . . . . 0.0 109.192 175.585 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' E' E ' 51' ' ' VAL . . . . . . . . . . . . . 48.6 t -68.71 -47.97 73.75 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.362 0 O-C-N 123.563 0.539 . . . . 0.0 109.744 -173.179 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' E' E ' 52' ' ' GLN . . . . . . . . . . . . . 43.2 tt0 -171.03 142.12 1.78 Allowed 'General case' 0 C--N 1.329 -0.318 0 C-N-CA 120.313 -0.555 . . . . 0.0 111.423 -179.709 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' E' E ' 53' ' ' ALA . . . . . . . . . . . . . . . -114.41 136.03 53.45 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 115.697 -0.683 . . . . 0.0 110.14 177.517 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' E' E ' 54' ' ' TYR . . . . . . . . . . . . . 37.0 t80 -128.99 108.6 18.18 Favored Pre-proline 0 CA--C 1.535 0.374 0 CA-C-O 118.245 -0.883 . . . . 0.0 110.206 178.558 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' E' E ' 55' ' ' PRO . . . . . . . . . . . . . 73.4 Cg_endo -77.15 170.01 72.71 Favored 'Cis proline' 0 N--CA 1.499 1.841 0 CA-C-N 121.769 1.667 . . . . 0.0 112.486 -5.025 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' E' E ' 56' ' ' SER . . . . . . . . . . . . . 41.2 m -117.21 131.39 24.03 Favored Pre-proline 0 CA--C 1.539 0.524 0 CA-C-O 118.399 -0.81 . . . . 0.0 109.509 174.768 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' E' E ' 57' ' ' PRO . . . . . . . . . . . . . 57.0 Cg_endo -72.36 148.26 90.9 Favored 'Cis proline' 0 N--CA 1.497 1.719 0 CA-C-N 121.917 1.72 . . . . 0.0 111.54 -1.173 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' E' E ' 58' ' ' LEU . . . . . . . . . . . . . 23.8 tp -108.26 137.11 46.79 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.561 -178.622 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' E' E ' 59' ' ' ARG . . . . . . . . . . . . . 54.0 ttp180 -99.92 126.06 46.01 Favored 'General case' 0 C--N 1.328 -0.341 0 N-CA-C 109.334 -0.617 . . . . 0.0 109.334 174.92 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' E' E ' 60' ' ' VAL . . . . . . . . . . . . . 40.5 t -83.03 120.43 34.36 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.269 0 C-N-CA 120.599 -0.44 . . . . 0.0 110.578 -174.955 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' E' E ' 61' ' ' GLU . . . . . . . . . . . . . 74.7 tt0 -130.8 156.01 45.72 Favored 'General case' 0 C--N 1.329 -0.326 0 N-CA-C 108.989 -0.745 . . . . 0.0 108.989 176.252 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' E' E ' 62' ' ' ASP . . . . . . . . . . . . . 9.8 p-10 -51.01 -30.62 15.78 Favored 'General case' 0 C--N 1.327 -0.385 0 N-CA-C 112.369 0.507 . . . . 0.0 112.369 -175.312 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' E' E ' 63' ' ' ARG . . . . . . . . . . . . . 76.0 mtt180 -77.89 -22.07 50.3 Favored 'General case' 0 CA--C 1.533 0.322 0 N-CA-C 113.149 0.796 . . . . 0.0 113.149 -174.987 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' E' E ' 64' ' ' THR . . . . . . . . . . . . . 28.3 m -63.37 146.16 54.1 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-O 120.872 0.367 . . . . 0.0 110.964 -175.841 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' E' E ' 65' ' ' LYS . . . . . . . . . . . . . 67.5 mttm -89.2 134.37 34.06 Favored 'General case' 0 C--N 1.331 -0.212 0 CA-C-N 116.121 -0.49 . . . . 0.0 110.662 -179.733 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' E' E ' 66' ' ' ILE . . . . . . . . . . . . . 62.4 mt -120.9 130.97 74.08 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.238 0 N-CA-C 109.993 -0.373 . . . . 0.0 109.993 179.224 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' E' E ' 67' ' ' THR . . . . . . . . . . . . . 19.1 m -129.72 142.82 50.64 Favored 'General case' 0 C--N 1.332 -0.175 0 CA-C-O 120.979 0.418 . . . . 0.0 111.042 -178.403 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' E' E ' 68' ' ' LEU . . . . . 0.506 HD12 ' N ' ' E' ' 68' ' ' LEU . 6.7 mp . . . . . 0 C--N 1.33 -0.24 0 CA-C-N 116.106 -0.497 . . . . 0.0 110.601 177.702 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' E' E ' 73' ' ' VAL . . . . . . . . . . . . . 36.0 m . . . . . 0 C--O 1.231 0.091 0 N-CA-C 110.008 -0.367 . . . . 0.0 110.008 . . . . . . . . . 0 0 . 1 . 004 nuclear nobuild core ' E' E ' 74' ' ' ASP . . . . . . . . . . . . . 18.9 t0 -93.85 118.78 31.91 Favored 'General case' 0 C--N 1.328 -0.331 0 N-CA-C 109.978 -0.378 . . . . 0.0 109.978 -177.84 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' E' E ' 75' ' ' VAL . . . . . 0.419 ' C ' HD12 ' E' ' 76' ' ' LEU . 42.2 t -116.57 121.0 66.66 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.224 0 CA-C-O 121.055 0.455 . . . . 0.0 110.468 -178.445 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' E' E ' 76' ' ' LEU . . . . . 0.419 HD12 ' C ' ' E' ' 75' ' ' VAL . 7.0 mp -119.01 149.06 42.28 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 115.778 -0.646 . . . . 0.0 109.788 176.961 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' E' E ' 77' ' ' GLU . . . . . . . . . . . . . 96.3 mt-10 -136.97 134.63 36.89 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-O 121.006 0.432 . . . . 0.0 111.333 -178.975 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' E' E ' 78' ' ' ALA . . . . . . . . . . . . . . . -121.28 136.63 54.94 Favored 'General case' 0 C--N 1.331 -0.225 0 CA-C-N 115.671 -0.695 . . . . 0.0 109.85 176.959 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' E' E ' 79' ' ' LYS . . . . . 0.452 ' O ' HD13 ' E' ' 80' ' ' ILE . 46.3 mmtm -78.48 119.25 21.51 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-O 120.798 0.332 . . . . 0.0 110.611 179.859 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' E' E ' 80' ' ' ILE . . . . . 0.452 HD13 ' O ' ' E' ' 79' ' ' LYS . 26.4 mm -139.25 110.45 4.85 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.28 0 N-CA-C 108.967 -0.753 . . . . 0.0 108.967 -179.351 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' E' E ' 81' ' ' LYS . . . . . . . . . . . . . 54.8 pttt -103.24 124.56 48.85 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-O 120.948 0.404 . . . . 0.0 111.194 -176.753 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' E' E ' 82' ' ' GLY . . . . . . . . . . . . . . . 88.94 42.2 5.72 Favored Glycine 0 CA--C 1.525 0.695 0 C-N-CA 120.713 -0.756 . . . . 0.0 111.616 174.622 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' E' E ' 83' ' ' ILE . . . . . . . . . . . . . 68.2 mt -66.35 139.7 20.74 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.362 0 N-CA-C 109.779 -0.452 . . . . 0.0 109.779 178.247 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' E' E ' 84' ' ' LYS . . . . . . . . . . . . . 87.6 tttt -101.05 -53.96 2.91 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-N 116.011 -0.54 . . . . 0.0 110.311 -178.217 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' E' E ' 85' ' ' ASP . . . . . . . . . . . . . 9.6 t70 -149.97 146.98 27.33 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 115.754 -0.657 . . . . 0.0 110.187 -178.373 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' E' E ' 86' ' ' VAL . . . . . . . . . . . . . 43.0 t -131.69 129.78 61.61 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.228 0 CA-C-O 121.006 0.431 . . . . 0.0 110.476 -178.495 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' E' E ' 87' ' ' ILE . . . . . 0.495 ' N ' HD12 ' E' ' 87' ' ' ILE . 4.9 mp -119.94 125.05 73.88 Favored 'Isoleucine or valine' 0 C--O 1.233 0.198 0 CA-C-N 115.943 -0.571 . . . . 0.0 109.481 176.2 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' E' E ' 88' ' ' LEU . . . . . . . . . . . . . 16.8 tp -110.54 129.19 55.85 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-O 120.911 0.386 . . . . 0.0 110.737 -179.185 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' E' E ' 89' ' ' ASP . . . . . . . . . . . . . 9.5 t70 -123.79 154.18 39.92 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-N 116.01 -0.541 . . . . 0.0 109.815 178.709 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' E' E ' 90' ' ' GLU . . . . . . . . . . . . . 43.1 mt-10 -47.82 -38.43 15.89 Favored 'General case' 0 C--N 1.33 -0.241 0 N-CA-C 112.71 0.633 . . . . 0.0 112.71 -172.643 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' E' E ' 91' ' ' ASN . . . . . . . . . . . . . 6.6 t-20 -132.1 34.58 3.79 Favored 'General case' 0 N--CA 1.463 0.217 0 N-CA-C 111.738 0.273 . . . . 0.0 111.738 -176.455 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' E' E ' 92' ' ' LEU . . . . . . . . . . . . . 12.5 tp -166.16 148.76 7.11 Favored 'General case' 0 C--N 1.329 -0.286 0 C-N-CA 120.937 -0.305 . . . . 0.0 110.906 -178.991 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' E' E ' 93' ' ' ILE . . . . . . . . . . . . . 72.9 mt -128.18 123.28 59.98 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.178 0 N-CA-C 109.491 -0.559 . . . . 0.0 109.491 178.222 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' E' E ' 94' ' ' VAL . . . . . . . . . . . . . 44.8 t -123.96 126.12 72.0 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.277 0 CA-C-O 120.875 0.369 . . . . 0.0 110.035 -179.66 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' E' E ' 95' ' ' VAL . . . . . . . . . . . . . 41.8 t -123.77 134.73 65.64 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.252 0 CA-C-N 116.104 -0.498 . . . . 0.0 110.21 -178.419 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' E' E ' 96' ' ' ILE . . . . . . . . . . . . . 58.1 mt -115.51 130.06 70.75 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 N-CA-C 109.287 -0.634 . . . . 0.0 109.287 178.359 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' E' E ' 97' ' ' THR . . . . . . . . . . . . . 80.3 p -102.09 158.44 16.16 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-O 121.257 0.551 . . . . 0.0 111.324 -177.034 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' E' E ' 98' ' ' GLU . . . . . . . . . . . . . 83.5 tt0 -53.86 -27.05 27.61 Favored 'General case' 0 CA--C 1.533 0.313 0 N-CA-C 112.3 0.481 . . . . 0.0 112.3 -179.529 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' E' E ' 99' ' ' GLU . . . . . . . . . . . . . 34.7 tt0 -80.77 18.06 1.05 Allowed 'General case' 0 CA--C 1.536 0.418 0 N-CA-C 112.728 0.64 . . . . 0.0 112.728 -176.619 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' E' E ' 100' ' ' ASN . . . . . . . . . . . . . 3.2 m-20 61.06 37.96 17.52 Favored 'General case' 0 N--CA 1.463 0.176 0 O-C-N 121.955 -0.466 . . . . 0.0 110.819 178.366 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' E' E ' 101' ' ' GLU . . . . . . . . . . . . . 84.2 tt0 -116.74 143.11 46.05 Favored 'General case' 0 C--N 1.331 -0.203 0 CA-C-N 116.159 -0.473 . . . . 0.0 109.75 177.379 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' E' E ' 102' ' ' VAL . . . . . . . . . . . . . 44.0 t -115.52 127.55 73.05 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.367 0 CA-C-N 116.419 -0.355 . . . . 0.0 110.132 -177.804 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' E' E ' 103' ' ' LEU . . . . . . . . . . . . . 28.9 mt -117.96 131.14 56.53 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-N 115.677 -0.692 . . . . 0.0 109.889 177.123 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' E' E ' 104' ' ' ILE . . . . . . . . . . . . . 67.4 mt -117.66 122.17 69.19 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.26 0 N-CA-C 110.107 -0.331 . . . . 0.0 110.107 -178.336 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' E' E ' 105' ' ' PHE . . . . . . . . . . . . . 91.5 m-85 -124.11 166.4 15.86 Favored 'General case' 0 C--O 1.232 0.151 0 O-C-N 123.985 0.803 . . . . 0.0 110.131 -178.52 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' E' E ' 106' ' ' ASN . . . . . . . . . . . . . 45.6 p-10 -104.04 -172.51 2.12 Favored 'General case' 0 C--N 1.332 -0.172 0 N-CA-C 109.755 -0.461 . . . . 0.0 109.755 171.131 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' E' E ' 107' ' ' GLN . . . . . . . . . . . . . 49.4 tt0 -58.76 -29.99 67.18 Favored 'General case' 0 CA--C 1.532 0.255 0 N-CA-C 112.065 0.394 . . . . 0.0 112.065 -179.72 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' E' E ' 108' ' ' ASN . . . . . . . . . . . . . 48.4 t30 -86.72 12.7 10.15 Favored 'General case' 0 CA--C 1.534 0.34 0 N-CA-C 113.001 0.741 . . . . 0.0 113.001 -176.384 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' E' E ' 109' ' ' LEU . . . . . . . . . . . . . 34.4 mt 58.2 33.34 23.06 Favored 'General case' 0 C--O 1.232 0.168 0 N-CA-C 111.998 0.37 . . . . 0.0 111.998 176.912 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' E' E ' 110' ' ' GLU . . . . . . . . . . . . . 95.5 mt-10 -101.86 129.94 48.21 Favored 'General case' 0 C--N 1.33 -0.25 0 N-CA-C 109.182 -0.673 . . . . 0.0 109.182 174.582 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' E' E ' 111' ' ' GLU . . . . . . . . . . . . . 45.5 tt0 -74.11 121.99 22.02 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-O 121.073 0.463 . . . . 0.0 110.352 -176.108 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' E' E ' 112' ' ' LEU . . . . . . . . . . . . . 35.4 mt -99.62 -46.07 5.57 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 115.795 -0.639 . . . . 0.0 110.461 -179.612 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' E' E ' 113' ' ' TYR . . . . . . . . . . . . . 57.8 t80 -139.22 145.66 39.53 Favored 'General case' 0 C--N 1.331 -0.208 0 CA-C-N 116.317 -0.402 . . . . 0.0 111.197 -178.166 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' E' E ' 114' ' ' ARG . . . . . . . . . . . . . 45.3 ptt85 -147.35 125.27 11.98 Favored 'General case' 0 C--N 1.33 -0.239 0 CA-C-N 116.07 -0.514 . . . . 0.0 110.663 179.062 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' E' E ' 115' ' ' GLY . . . . . . . . . . . . . . . -150.07 159.11 27.96 Favored Glycine 0 CA--C 1.523 0.538 0 N-CA-C 111.105 -0.798 . . . . 0.0 111.105 178.96 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' E' E ' 116' ' ' LYS . . . . . . . . . . . . . 38.4 ttpt -127.07 132.46 50.66 Favored 'General case' 0 C--N 1.33 -0.268 0 N-CA-C 109.809 -0.441 . . . . 0.0 109.809 178.077 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' E' E ' 117' ' ' PHE . . . . . . . . . . . . . 36.6 m-85 -132.14 113.82 13.77 Favored 'General case' 0 C--N 1.331 -0.213 0 CA-C-O 121.014 0.435 . . . . 0.0 110.376 -175.582 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' E' E ' 118' ' ' GLU . . . . . . . . . . . . . 96.3 mt-10 -54.77 -46.93 74.45 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 116.268 -0.424 . . . . 0.0 111.254 -176.728 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' E' E ' 119' ' ' ASN . . . . . . . . . . . . . 24.4 m120 -95.62 31.01 2.13 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.165 -0.471 . . . . 0.0 112.139 -173.523 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' E' E ' 120' ' ' LEU . . . . . . . . . . . . . 14.7 tp -54.92 119.94 6.14 Favored 'General case' 0 N--CA 1.463 0.191 0 C-N-CA 121.019 -0.272 . . . . 0.0 110.752 177.449 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' E' E ' 121' ' ' ASN . . . . . . . . . . . . . 33.3 t-20 -114.09 -43.97 3.19 Favored 'General case' 0 C--N 1.331 -0.22 0 CA-C-N 116.599 -0.273 . . . . 0.0 111.359 -175.181 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' E' E ' 122' ' ' LYS . . . . . . . . . . . . . 36.5 mtmm -143.3 145.22 32.53 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-O 121.121 0.486 . . . . 0.0 111.63 -176.628 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' E' E ' 123' ' ' VAL . . . . . . . . . . . . . 46.8 t -126.67 127.54 70.25 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.22 0 CA-C-N 115.873 -0.603 . . . . 0.0 109.63 176.525 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' E' E ' 124' ' ' LEU . . . . . . . . . . . . . 50.2 mt -130.33 123.56 30.27 Favored 'General case' 0 C--N 1.331 -0.222 0 CA-C-N 116.441 -0.345 . . . . 0.0 110.186 179.751 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' E' E ' 125' ' ' VAL . . . . . 0.486 HG12 HG13 ' E' ' 130' ' ' VAL . 33.0 m -143.14 136.43 25.58 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.305 0 CA-C-O 120.816 0.341 . . . . 0.0 111.125 -178.937 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' E' E ' 126' ' ' ARG . . . . . . . . . . . . . 63.3 mtm180 -151.02 131.15 13.49 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-O 121.152 0.501 . . . . 0.0 110.876 177.82 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' E' E ' 127' ' ' ASN . . . . . . . . . . . . . 3.7 m120 52.01 -105.05 0.2 Allowed 'General case' 0 CA--C 1.543 0.677 0 CA-C-N 115.827 -0.624 . . . . 0.0 111.489 178.629 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' E' E ' 128' ' ' ASP . . . . . . . . . . . . . 22.8 p-10 -114.13 1.45 14.59 Favored 'General case' 0 N--CA 1.467 0.409 0 CA-C-N 119.345 0.975 . . . . 0.0 113.461 -174.895 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' E' E ' 129' ' ' LEU . . . . . . . . . . . . . 68.7 mt -105.55 128.91 53.86 Favored 'General case' 0 C--N 1.333 -0.126 0 CA-C-N 118.28 0.491 . . . . 0.0 110.301 179.215 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' E' E ' 130' ' ' VAL . . . . . 0.486 HG13 HG12 ' E' ' 125' ' ' VAL . 60.3 t -122.06 128.75 75.67 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.273 0 CA-C-N 115.95 -0.568 . . . . 0.0 109.544 -179.571 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' E' E ' 131' ' ' VAL . . . . . . . . . . . . . 41.8 t -136.03 132.38 50.13 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.227 0 CA-C-O 121.186 0.517 . . . . 0.0 110.288 177.493 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' E' E ' 132' ' ' ILE . . . . . . . . . . . . . 73.5 mt -117.25 131.78 68.96 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.316 0 CA-C-N 115.625 -0.716 . . . . 0.0 109.393 179.784 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' E' E ' 133' ' ' ILE . . . . . . . . . . . . . 36.9 mm -113.04 121.07 64.56 Favored 'Isoleucine or valine' 0 C--O 1.233 0.206 0 CA-C-O 120.741 0.305 . . . . 0.0 111.009 -174.935 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' E' E ' 134' ' ' ASP . . . . . . . . . . . . . 9.7 p-10 -131.73 148.23 52.56 Favored 'General case' 0 C--N 1.332 -0.18 0 N-CA-C 109.727 -0.472 . . . . 0.0 109.727 175.2 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' E' E ' 135' ' ' GLU . . . . . . . . . . . . . 78.2 tt0 -49.9 -26.61 4.27 Favored 'General case' 0 C--N 1.328 -0.331 0 N-CA-C 113.019 0.748 . . . . 0.0 113.019 -171.515 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' E' E ' 136' ' ' GLN . . . . . . . . . . . . . 99.4 mm-40 -86.26 -32.07 21.32 Favored 'General case' 0 C--N 1.331 -0.234 0 N-CA-C 112.411 0.522 . . . . 0.0 112.411 -174.932 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' E' E ' 137' ' ' LYS . . . . . . . . . . . . . 23.8 pttm -167.21 174.04 8.51 Favored 'General case' 0 C--O 1.233 0.191 0 CA-C-O 121.472 0.653 . . . . 0.0 112.429 -172.488 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' E' E ' 138' ' ' LEU . . . . . 0.401 ' C ' HD23 ' E' ' 138' ' ' LEU . 5.6 tt -118.52 127.32 53.51 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 114.925 -1.034 . . . . 0.0 110.033 179.867 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' E' E ' 139' ' ' THR . . . . . . . . . . . . . 28.4 m -104.51 120.39 41.15 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.042 -0.526 . . . . 0.0 110.257 179.439 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' E' E ' 140' ' ' LEU . . . . . 0.473 ' C ' HD23 ' E' ' 140' ' ' LEU . 7.7 tt -108.65 120.65 43.08 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 115.824 -0.626 . . . . 0.0 109.427 -179.974 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' E' E ' 141' ' ' ILE . . . . . . . . . . . . . 18.4 mt -123.84 121.2 61.69 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.265 0 CA-C-O 121.012 0.434 . . . . 0.0 109.833 -175.041 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' E' E ' 142' ' ' ARG . . . . . . . . . . . . . 64.5 ttt180 -109.11 124.12 50.29 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 115.689 -0.687 . . . . 0.0 110.22 179.218 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' E' E ' 143' ' ' THR . . . . . . . . . . . . . 55.9 p . . . . . 0 C--O 1.22 -0.467 0 CA-C-O 118.19 -0.909 . . . . 0.0 110.822 -179.542 . . . . . . . . 0 0 . 1 . 004 nuclear nobuild core ' F' F ' 1' ' ' MET . . . . . . . . . . . . . 27.6 ptm . . . . . 0 C--O 1.23 0.065 0 CA-C-O 120.848 0.356 . . . . 0.0 110.638 . . . . . . . . . 0 0 . 1 . 004 nuclear nobuild core ' F' F ' 2' ' ' SER . . . . . . . . . . . . . 2.5 p -129.32 128.1 42.45 Favored 'General case' 0 C--N 1.331 -0.198 0 CA-C-N 116.113 -0.494 . . . . 0.0 110.596 179.59 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' F' F ' 3' ' ' GLU . . . . . . . . . . . . . 83.8 tt0 -142.29 141.24 32.41 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.151 -0.477 . . . . 0.0 111.293 -179.984 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' F' F ' 4' ' ' LEU . . . . . . . . . . . . . 17.5 tp -127.31 133.23 50.14 Favored 'General case' 0 C--N 1.331 -0.201 0 CA-C-N 116.04 -0.527 . . . . 0.0 110.272 177.782 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' F' F ' 5' ' ' LYS . . . . . . . . . . . . . 98.5 mttt -112.06 121.32 44.66 Favored 'General case' 0 C--N 1.331 -0.212 0 CA-C-N 116.241 -0.436 . . . . 0.0 110.638 179.829 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' F' F ' 6' ' ' LEU . . . . . . . . . . . . . 69.8 mt -115.02 145.86 41.85 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 115.446 -0.797 . . . . 0.0 110.058 179.948 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' F' F ' 7' ' ' LYS . . . . . . . . . . . . . 40.2 ttmt -128.45 138.58 33.36 Favored Pre-proline 0 CA--C 1.533 0.295 0 CA-C-O 119.052 -0.499 . . . . 0.0 109.879 176.166 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' F' F ' 8' ' ' PRO . . . . . . . . . . . . . 94.4 Cg_endo -92.03 139.38 2.09 Favored 'Trans proline' 0 N--CA 1.488 1.197 0 C-N-CA 121.786 1.658 . . . . 0.0 111.963 178.694 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' F' F ' 9' ' ' LEU . . . . . . . . . . . . . 66.3 mt -74.46 -46.6 5.77 Favored Pre-proline 0 CA--C 1.533 0.314 0 CA-C-O 118.691 -0.671 . . . . 0.0 111.967 178.942 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' F' F ' 10' ' ' PRO . . . . . . . . . . . . . 90.0 Cg_endo -81.04 142.29 13.6 Favored 'Trans proline' 0 N--CA 1.496 1.635 0 C-N-CA 121.076 1.184 . . . . 0.0 111.561 174.035 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' F' F ' 11' ' ' LYS . . . . . . . . . . . . . 80.6 tttt -80.98 101.95 9.84 Favored 'General case' 0 C--N 1.329 -0.295 0 C-N-CA 120.802 -0.359 . . . . 0.0 110.441 179.317 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' F' F ' 12' ' ' VAL . . . . . . . . . . . . . 11.9 p -145.35 147.57 18.55 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.291 0 CA-C-N 116.233 -0.439 . . . . 0.0 110.715 -178.592 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' F' F ' 13' ' ' GLU . . . . . . . . . . . . . 70.7 mm-40 -92.9 123.74 36.38 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.033 176.687 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' F' F ' 14' ' ' LEU . . . . . . . . . . . . . 26.1 mt -96.81 154.48 38.32 Favored Pre-proline 0 C--N 1.329 -0.322 0 CA-C-N 116.426 -0.352 . . . . 0.0 110.69 -178.689 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' F' F ' 15' ' ' PRO . . . . . . . . . . . . . 31.3 Cg_exo -57.04 156.2 25.33 Favored 'Trans proline' 0 N--CA 1.496 1.659 0 C-N-CA 121.335 1.356 . . . . 0.0 111.777 179.636 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' F' F ' 16' ' ' PRO . . . . . . . . . . . . . 35.0 Cg_exo -57.81 -37.76 95.24 Favored 'Trans proline' 0 N--CA 1.497 1.677 0 C-N-CA 121.46 1.44 . . . . 0.0 112.802 -178.627 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' F' F ' 17' ' ' ASP . . . . . . . . . . . . . 19.1 p-10 -90.29 13.36 15.54 Favored 'General case' 0 CA--C 1.537 0.445 0 N-CA-C 113.116 0.784 . . . . 0.0 113.116 -177.38 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' F' F ' 18' ' ' PHE . . . . . . . . . . . . . 46.1 t80 -58.11 -45.32 87.46 Favored 'General case' 0 C--N 1.333 -0.126 0 CA-C-O 120.876 0.37 . . . . 0.0 110.089 -178.512 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' F' F ' 19' ' ' VAL . . . . . . . . . . . . . 48.4 t -57.18 -39.67 68.54 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.322 0 CA-C-N 116.25 -0.432 . . . . 0.0 110.505 -178.131 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' F' F ' 20' ' ' ASP . . . . . . . . . . . . . 10.2 t70 -59.85 -46.46 89.2 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-O 121.095 0.474 . . . . 0.0 110.875 -178.315 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' F' F ' 21' ' ' VAL . . . . . . . . . . . . . 49.5 t -64.19 -48.74 84.34 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.305 0 CA-C-N 116.207 -0.451 . . . . 0.0 110.624 -177.925 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' F' F ' 22' ' ' ILE . . . . . 0.565 HG22 HD12 ' F' ' 26' ' ' LEU . 51.0 mm -56.36 -43.45 77.35 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.297 0 CA-C-O 120.888 0.375 . . . . 0.0 110.51 179.135 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' F' F ' 23' ' ' ARG . . . . . . . . . . . . . 41.0 ttp180 -54.2 -47.52 72.0 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.545 -0.298 . . . . 0.0 111.337 -178.535 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' F' F ' 24' ' ' ILE . . . . . . . . . . . . . 73.8 mt -58.68 -44.17 89.26 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.307 0 CA-C-N 116.578 -0.283 . . . . 0.0 111.082 -179.068 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' F' F ' 25' ' ' LYS . . . . . . . . . . . . . 55.8 mttp -64.81 -39.33 93.41 Favored 'General case' 0 N--CA 1.464 0.24 0 N-CA-C 112.461 0.541 . . . . 0.0 112.461 -179.632 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' F' F ' 26' ' ' LEU . . . . . 0.565 HD12 HG22 ' F' ' 22' ' ' ILE . 49.7 mt -78.9 -41.72 29.0 Favored 'General case' 0 C--N 1.33 -0.28 0 N-CA-C 113.299 0.851 . . . . 0.0 113.299 -170.114 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' F' F ' 27' ' ' GLN . . . . . . . . . . . . . 10.9 pt20 -46.66 139.65 5.05 Favored 'General case' 0 N--CA 1.469 0.508 0 N-CA-C 112.817 0.673 . . . . 0.0 112.817 -175.11 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' F' F ' 28' ' ' GLY . . . . . . . . . . . . . . . 100.63 -27.97 18.04 Favored Glycine 0 CA--C 1.53 0.995 0 CA-C-N 115.494 -0.775 . . . . 0.0 112.218 -177.382 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' F' F ' 29' ' ' LYS . . . . . . . . . . . . . 98.2 mttt -97.9 155.07 17.24 Favored 'General case' 0 C--O 1.232 0.18 0 CA-C-N 117.33 0.565 . . . . 0.0 111.247 179.056 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' F' F ' 30' ' ' THR . . . . . . . . . . . . . 42.0 m -103.67 140.28 37.8 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 115.892 -0.594 . . . . 0.0 110.162 176.839 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' F' F ' 31' ' ' VAL . . . . . . . . . . . . . 35.5 m -127.48 155.06 38.53 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.303 0 CA-C-N 116.272 -0.422 . . . . 0.0 110.374 179.429 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' F' F ' 32' ' ' ARG . . . . . . . . . . . . . 35.9 ttp180 -134.03 149.31 51.17 Favored 'General case' 0 C--N 1.331 -0.207 0 CA-C-O 121.305 0.574 . . . . 0.0 110.603 178.678 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' F' F ' 33' ' ' THR . . . . . 0.417 HG23 ' HA ' ' F' ' 52' ' ' GLN . 16.3 m -52.51 139.61 24.85 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-N 116.073 -0.512 . . . . 0.0 111.544 -177.939 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' F' F ' 34' ' ' GLY . . . . . . . . . . . . . . . 98.75 -17.23 58.61 Favored Glycine 0 CA--C 1.533 1.175 0 C-N-CA 121.236 -0.507 . . . . 0.0 113.366 178.947 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' F' F ' 35' ' ' ASP . . . . . . . . . . . . . 76.3 m-20 -65.79 150.17 48.97 Favored 'General case' 0 N--CA 1.462 0.161 0 CA-C-N 117.942 0.871 . . . . 0.0 111.291 -179.891 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' F' F ' 36' ' ' VAL . . . . . . . . . . . . . 44.3 t -119.73 128.93 75.91 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.222 0 CA-C-N 115.798 -0.637 . . . . 0.0 109.725 177.882 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' F' F ' 37' ' ' ILE . . . . . . . . . . . . . 68.8 mt -122.22 139.19 49.94 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.248 0 CA-C-N 116.261 -0.427 . . . . 0.0 109.928 -179.275 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' F' F ' 38' ' ' GLY . . . . . . . . . . . . . . . -115.3 128.35 8.04 Favored Glycine 0 CA--C 1.525 0.693 0 N-CA-C 110.859 -0.896 . . . . 0.0 110.859 178.853 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' F' F ' 39' ' ' ILE . . . . . . . . . . . . . 76.3 mt -127.44 138.6 54.29 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.217 0 CA-C-O 120.74 0.305 . . . . 0.0 110.197 179.921 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' F' F ' 40' ' ' SER . . . . . . . . . . . . . 42.6 t -91.96 114.05 26.48 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.274 -0.421 . . . . 0.0 110.981 176.849 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' F' F ' 41' ' ' ILE . . . . . . . . . . . . . 44.3 mm -122.94 121.06 62.3 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.234 0 N-CA-C 109.665 -0.494 . . . . 0.0 109.665 178.645 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' F' F ' 42' ' ' LEU . . . . . . . . . . . . . 84.2 mt 57.71 33.67 23.51 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 116.454 -0.339 . . . . 0.0 111.662 179.606 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' F' F ' 43' ' ' GLY . . . . . . . . . . . . . . . 77.64 -10.2 25.37 Favored Glycine 0 CA--C 1.535 1.288 0 C-N-CA 121.311 -0.471 . . . . 0.0 113.47 178.114 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' F' F ' 44' ' ' LYS . . . . . . . . . . . . . 98.3 mttt -101.05 138.76 37.66 Favored 'General case' 0 C--N 1.334 -0.108 0 CA-C-N 117.898 0.849 . . . . 0.0 110.05 177.436 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' F' F ' 45' ' ' GLU . . . . . . . . . . . . . 80.9 tt0 -83.75 130.08 34.95 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.431 -0.35 . . . . 0.0 111.263 -178.945 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' F' F ' 46' ' ' VAL . . . . . . . . . . . . . 10.4 p -120.55 125.87 74.61 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.209 0 N-CA-C 109.653 -0.499 . . . . 0.0 109.653 174.512 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' F' F ' 47' ' ' LYS . . . . . . . . . . . . . 29.2 mtpp -98.0 124.98 42.74 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 115.984 -0.553 . . . . 0.0 110.622 177.979 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' F' F ' 48' ' ' PHE . . . . . . . . . . . . . 40.8 m-85 -110.15 131.89 54.65 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.251 -0.431 . . . . 0.0 109.893 177.534 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' F' F ' 49' ' ' LYS . . . . . . . . . . . . . 85.6 tttt -106.34 131.39 53.61 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.209 -0.451 . . . . 0.0 109.811 177.158 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' F' F ' 50' ' ' VAL . . . . . . . . . . . . . 43.8 t -75.59 105.92 4.95 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.335 0 N-CA-C 109.384 -0.598 . . . . 0.0 109.384 177.911 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' F' F ' 51' ' ' VAL . . . . . . . . . . . . . 48.1 t -69.17 -48.01 71.23 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.27 0 CA-C-N 116.062 -0.517 . . . . 0.0 109.761 -174.354 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' F' F ' 52' ' ' GLN . . . . . 0.417 ' HA ' HG23 ' F' ' 33' ' ' THR . 21.4 pt20 -167.01 158.56 12.47 Favored 'General case' 0 C--N 1.331 -0.199 0 C-N-CA 120.249 -0.58 . . . . 0.0 111.79 179.167 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' F' F ' 53' ' ' ALA . . . . . . . . . . . . . . . -133.5 137.04 45.44 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 115.485 -0.779 . . . . 0.0 110.243 179.07 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' F' F ' 54' ' ' TYR . . . . . . . . . . . . . 38.4 t80 -128.98 109.43 18.29 Favored Pre-proline 0 CA--C 1.535 0.372 0 CA-C-O 118.274 -0.87 . . . . 0.0 110.359 -179.425 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' F' F ' 55' ' ' PRO . . . . . . . . . . . . . 74.0 Cg_endo -77.17 169.97 72.77 Favored 'Cis proline' 0 N--CA 1.502 2.002 0 CA-C-N 121.855 1.698 . . . . 0.0 112.145 -7.375 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' F' F ' 56' ' ' SER . . . . . . . . . . . . . 49.0 m -117.82 132.8 23.48 Favored Pre-proline 0 CA--C 1.538 0.483 0 CA-C-O 118.492 -0.766 . . . . 0.0 109.616 175.057 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' F' F ' 57' ' ' PRO . . . . . . . . . . . . . 40.4 Cg_endo -68.56 165.45 72.8 Favored 'Cis proline' 0 N--CA 1.497 1.731 0 CA-C-N 121.88 1.707 . . . . 0.0 111.328 -1.657 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' F' F ' 58' ' ' LEU . . . . . . . . . . . . . 23.4 tp -130.62 137.45 49.63 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-O 120.871 0.367 . . . . 0.0 110.691 -178.049 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' F' F ' 59' ' ' ARG . . . . . . . . . . . . . 57.6 ttt85 -104.05 128.4 51.65 Favored 'General case' 0 C--N 1.328 -0.35 0 N-CA-C 109.464 -0.569 . . . . 0.0 109.464 176.35 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' F' F ' 60' ' ' VAL . . . . . . . . . . . . . 41.1 t -81.48 122.61 36.77 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.267 0 C-N-CA 120.769 -0.372 . . . . 0.0 110.69 -175.159 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' F' F ' 61' ' ' GLU . . . . . . . . . . . . . 44.3 mt-10 -131.12 168.0 18.18 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 115.842 -0.617 . . . . 0.0 109.77 176.892 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' F' F ' 62' ' ' ASP . . . . . . . . . . . . . 10.0 p-10 -55.91 -32.67 63.97 Favored 'General case' 0 C--N 1.329 -0.316 0 N-CA-C 111.803 0.297 . . . . 0.0 111.803 -178.484 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' F' F ' 63' ' ' ARG . . . . . . . . . . . . . 24.5 mmt180 -78.77 -9.33 59.4 Favored 'General case' 0 N--CA 1.467 0.383 0 N-CA-C 113.347 0.869 . . . . 0.0 113.347 -176.772 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' F' F ' 64' ' ' THR . . . . . . . . . . . . . 31.4 m -70.85 138.93 50.67 Favored 'General case' 0 C--N 1.332 -0.165 0 CA-C-O 121.007 0.432 . . . . 0.0 111.148 -175.356 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' F' F ' 65' ' ' LYS . . . . . . . . . . . . . 62.2 mttm -88.95 123.12 32.99 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 115.862 -0.608 . . . . 0.0 109.881 176.425 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' F' F ' 66' ' ' ILE . . . . . . . . . . . . . 61.7 mt -115.2 126.61 72.82 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 N-CA-C 109.779 -0.452 . . . . 0.0 109.779 179.758 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' F' F ' 67' ' ' THR . . . . . . . . . . . . . 28.4 m -125.38 138.76 54.04 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-O 121.126 0.488 . . . . 0.0 111.175 -177.351 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' F' F ' 68' ' ' LEU . . . . . . . . . . . . . 46.3 mt . . . . . 0 C--N 1.329 -0.306 0 CA-C-N 115.753 -0.658 . . . . 0.0 109.959 176.161 . . . . . . . . 0 0 . 1 . 004 nuclear nobuild core ' F' F ' 73' ' ' VAL . . . . . . . . . . . . . 35.9 m . . . . . 0 C--O 1.231 0.08 0 CA-C-O 121.027 0.441 . . . . 0.0 110.814 . . . . . . . . . 0 0 . 1 . 004 nuclear nobuild core ' F' F ' 74' ' ' ASP . . . . . . . . . . . . . 13.5 t0 -105.11 117.9 35.18 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 115.849 -0.614 . . . . 0.0 109.741 177.748 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' F' F ' 75' ' ' VAL . . . . . 0.429 ' C ' HD12 ' F' ' 76' ' ' LEU . 40.1 t -118.06 125.61 74.34 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.267 0 CA-C-O 121.048 0.451 . . . . 0.0 110.61 -178.08 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' F' F ' 76' ' ' LEU . . . . . 0.429 HD12 ' C ' ' F' ' 75' ' ' VAL . 5.7 mp -126.3 145.42 50.43 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 115.672 -0.695 . . . . 0.0 109.559 176.206 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' F' F ' 77' ' ' GLU . . . . . . . . . . . . . 96.7 mt-10 -132.04 129.11 39.62 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-O 121.02 0.438 . . . . 0.0 110.715 -178.064 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' F' F ' 78' ' ' ALA . . . . . . . . . . . . . . . -115.4 132.62 56.56 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 115.75 -0.659 . . . . 0.0 109.999 178.869 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' F' F ' 79' ' ' LYS . . . . . 0.584 ' O ' HD13 ' F' ' 80' ' ' ILE . 20.2 tptm -76.91 116.38 17.52 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-O 120.916 0.389 . . . . 0.0 110.791 -177.424 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' F' F ' 80' ' ' ILE . . . . . 0.584 HD13 ' O ' ' F' ' 79' ' ' LYS . 42.3 mm -139.28 98.45 1.16 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.282 0 N-CA-C 109.152 -0.684 . . . . 0.0 109.152 -176.938 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' F' F ' 81' ' ' LYS . . . . . . . . . . . . . 17.8 pttp -98.4 131.26 44.82 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-O 120.956 0.408 . . . . 0.0 111.454 -175.72 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' F' F ' 82' ' ' GLY . . . . . . . . . . . . . . . 89.12 41.98 5.72 Favored Glycine 0 CA--C 1.524 0.643 0 CA-C-N 115.82 -0.627 . . . . 0.0 111.57 176.076 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' F' F ' 83' ' ' ILE . . . . . . . . . . . . . 65.8 mt -74.59 135.5 27.24 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 N-CA-C 109.453 -0.573 . . . . 0.0 109.453 176.719 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' F' F ' 84' ' ' LYS . . . . . . . . . . . . . 38.0 ttpt -106.94 -42.48 4.91 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-O 120.782 0.325 . . . . 0.0 110.634 -177.805 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' F' F ' 85' ' ' ASP . . . . . . . . . . . . . 9.2 t70 -149.23 149.83 31.6 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.311 -0.404 . . . . 0.0 110.433 179.336 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' F' F ' 86' ' ' VAL . . . . . . . . . . . . . 41.9 t -137.64 136.76 45.9 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.231 0 CA-C-O 120.936 0.398 . . . . 0.0 110.74 -178.915 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' F' F ' 87' ' ' ILE . . . . . . . . . . . . . 4.9 mp -123.83 126.86 73.32 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.251 0 CA-C-N 115.828 -0.624 . . . . 0.0 109.522 176.171 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' F' F ' 88' ' ' LEU . . . . . . . . . . . . . 19.2 tp -114.89 130.26 56.86 Favored 'General case' 0 N--CA 1.463 0.184 0 CA-C-O 121.088 0.47 . . . . 0.0 111.187 -177.525 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' F' F ' 89' ' ' ASP . . . . . . . . . . . . . 4.2 t0 -125.42 156.58 38.6 Favored 'General case' 0 C--N 1.331 -0.207 0 CA-C-N 115.638 -0.71 . . . . 0.0 109.388 175.399 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' F' F ' 90' ' ' GLU . . . . . . . . . . . . . 81.9 tt0 -46.53 -40.89 13.39 Favored 'General case' 0 N--CA 1.463 0.211 0 N-CA-C 113.11 0.781 . . . . 0.0 113.11 -172.445 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' F' F ' 91' ' ' ASN . . . . . . . . . . . . . 71.1 m-80 -132.14 37.75 3.55 Favored 'General case' 0 N--CA 1.465 0.28 0 CA-C-O 120.785 0.326 . . . . 0.0 111.554 -176.479 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' F' F ' 92' ' ' LEU . . . . . . . . . . . . . 17.3 tp -166.08 138.85 4.04 Favored 'General case' 0 C--N 1.33 -0.281 0 C-N-CA 120.931 -0.308 . . . . 0.0 110.589 -179.563 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' F' F ' 93' ' ' ILE . . . . . . . . . . . . . 67.0 mt -124.02 122.42 64.42 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.187 0 N-CA-C 109.769 -0.456 . . . . 0.0 109.769 179.724 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' F' F ' 94' ' ' VAL . . . . . . . . . . . . . 44.8 t -120.92 125.18 73.73 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.222 0 N-CA-C 109.789 -0.448 . . . . 0.0 109.789 178.59 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' F' F ' 95' ' ' VAL . . . . . . . . . . . . . 43.1 t -120.11 134.04 64.88 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.379 0 CA-C-N 116.071 -0.513 . . . . 0.0 109.746 -179.422 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' F' F ' 96' ' ' ILE . . . . . 0.432 HD11 HG21 ' F' ' 123' ' ' VAL . 68.4 mt -116.6 127.88 74.1 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.232 0 N-CA-C 109.458 -0.571 . . . . 0.0 109.458 179.31 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' F' F ' 97' ' ' THR . . . . . . . . . . . . . 77.8 p -101.92 162.23 13.06 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-O 121.5 0.667 . . . . 0.0 111.704 -175.362 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' F' F ' 98' ' ' GLU . . . . . . . . . . . . . 82.1 tt0 -53.82 -28.51 35.92 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 115.442 -0.799 . . . . 0.0 112.361 -178.947 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' F' F ' 99' ' ' GLU . . . . . . . . . . . . . 96.0 mt-10 -81.97 18.04 1.42 Allowed 'General case' 0 CA--C 1.534 0.354 0 N-CA-C 113.116 0.784 . . . . 0.0 113.116 -176.356 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' F' F ' 100' ' ' ASN . . . . . . . . . . . . . 2.7 m-20 62.22 37.65 14.07 Favored 'General case' 0 CA--C 1.53 0.185 0 CA-C-O 121.036 0.446 . . . . 0.0 111.047 177.591 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' F' F ' 101' ' ' GLU . . . . . . . . . . . . . 84.7 tt0 -117.1 144.61 44.48 Favored 'General case' 0 C--N 1.332 -0.193 0 N-CA-C 109.719 -0.475 . . . . 0.0 109.719 177.342 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' F' F ' 102' ' ' VAL . . . . . . . . . . . . . 42.4 t -117.47 127.29 74.94 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.23 0 N-CA-C 109.962 -0.385 . . . . 0.0 109.962 -178.446 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' F' F ' 103' ' ' LEU . . . . . . . . . . . . . 31.5 mt -116.33 132.07 56.77 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 115.572 -0.74 . . . . 0.0 110.036 176.699 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' F' F ' 104' ' ' ILE . . . . . 0.528 HD13 HG11 ' F' ' 130' ' ' VAL . 66.4 mt -117.73 122.21 69.26 Favored 'Isoleucine or valine' 0 C--O 1.234 0.265 0 N-CA-C 110.238 -0.282 . . . . 0.0 110.238 -178.939 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' F' F ' 105' ' ' PHE . . . . . . . . . . . . . 86.5 m-85 -123.48 164.27 19.27 Favored 'General case' 0 C--N 1.332 -0.165 0 O-C-N 123.936 0.773 . . . . 0.0 110.3 -178.857 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' F' F ' 106' ' ' ASN . . . . . . . . . . . . . 46.0 p-10 -99.73 -169.92 1.82 Allowed 'General case' 0 CA--C 1.53 0.2 0 N-CA-C 109.655 -0.498 . . . . 0.0 109.655 171.849 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' F' F ' 107' ' ' GLN . . . . . . . . . . . . . 41.4 tt0 -57.86 -30.06 65.49 Favored 'General case' 0 C--N 1.327 -0.379 0 N-CA-C 112.117 0.414 . . . . 0.0 112.117 -178.767 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' F' F ' 108' ' ' ASN . . . . . . . . . . . . . 8.8 t30 -91.24 14.11 15.29 Favored 'General case' 0 CA--C 1.535 0.398 0 N-CA-C 113.106 0.78 . . . . 0.0 113.106 -175.558 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' F' F ' 109' ' ' LEU . . . . . . . . . . . . . 40.8 mt 58.12 34.01 23.75 Favored 'General case' 0 CA--C 1.53 0.204 0 CA-C-O 120.718 0.294 . . . . 0.0 111.723 177.914 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' F' F ' 110' ' ' GLU . . . . . . . . . . . . . 96.0 mt-10 -98.92 134.75 41.33 Favored 'General case' 0 C--N 1.329 -0.288 0 N-CA-C 109.408 -0.59 . . . . 0.0 109.408 175.434 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' F' F ' 111' ' ' GLU . . . . . . . . . . . . . 48.4 tt0 -71.7 121.97 19.8 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-O 121.009 0.433 . . . . 0.0 110.729 -175.751 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' F' F ' 112' ' ' LEU . . . . . . . . . . . . . 25.6 mt -105.87 -46.04 4.22 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-N 115.898 -0.592 . . . . 0.0 110.327 178.994 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' F' F ' 113' ' ' TYR . . . . . 0.405 ' HB3' HD12 ' F' ' 104' ' ' ILE . 31.2 t80 -137.95 141.54 40.53 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.11 -0.495 . . . . 0.0 111.05 -179.036 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' F' F ' 114' ' ' ARG . . . . . . . . . . . . . 32.7 ptt180 -141.69 123.58 15.31 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.247 -0.433 . . . . 0.0 110.392 177.206 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' F' F ' 115' ' ' GLY . . . . . . . . . . . . . . . -150.14 160.08 28.38 Favored Glycine 0 CA--C 1.524 0.601 0 N-CA-C 111.16 -0.776 . . . . 0.0 111.16 179.821 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' F' F ' 116' ' ' LYS . . . . . . . . . . . . . 33.4 ttpt -128.96 136.91 50.99 Favored 'General case' 0 C--N 1.33 -0.276 0 N-CA-C 109.908 -0.405 . . . . 0.0 109.908 177.333 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' F' F ' 117' ' ' PHE . . . . . . . . . . . . . 43.4 m-85 -134.1 113.79 12.45 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-O 120.971 0.415 . . . . 0.0 110.238 -177.124 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' F' F ' 118' ' ' GLU . . . . . . . . . . . . . 45.7 tp10 -54.69 -48.88 71.89 Favored 'General case' 0 C--N 1.326 -0.449 0 CA-C-N 116.289 -0.414 . . . . 0.0 111.277 -176.188 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' F' F ' 119' ' ' ASN . . . . . . . . . . . . . 73.3 m-20 -95.17 31.1 1.99 Allowed 'General case' 0 C--N 1.33 -0.275 0 N-CA-C 112.155 0.428 . . . . 0.0 112.155 -173.836 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' F' F ' 120' ' ' LEU . . . . . . . . . . . . . 20.0 tp -54.18 119.91 5.76 Favored 'General case' 0 N--CA 1.464 0.233 0 O-C-N 122.207 -0.308 . . . . 0.0 110.738 177.29 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' F' F ' 121' ' ' ASN . . . . . . . . . . . . . 13.6 t-20 -114.11 -44.03 3.18 Favored 'General case' 0 C--N 1.331 -0.214 0 CA-C-N 116.455 -0.339 . . . . 0.0 110.962 -177.009 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' F' F ' 122' ' ' LYS . . . . . . . . . . . . . 61.9 mtpt -142.0 147.29 36.67 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-O 121.168 0.509 . . . . 0.0 111.233 -177.059 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' F' F ' 123' ' ' VAL . . . . . 0.432 HG21 HD11 ' F' ' 96' ' ' ILE . 44.2 t -128.66 125.98 64.39 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.191 0 N-CA-C 109.312 -0.625 . . . . 0.0 109.312 174.679 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' F' F ' 124' ' ' LEU . . . . . 0.517 HD12 ' N ' ' F' ' 124' ' ' LEU . 6.0 mp -118.17 132.82 56.3 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-O 120.766 0.317 . . . . 0.0 110.696 -177.019 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' F' F ' 125' ' ' VAL . . . . . . . . . . . . . 43.9 t -125.57 127.51 71.69 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.241 0 CA-C-N 116.051 -0.522 . . . . 0.0 110.178 179.918 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' F' F ' 126' ' ' ARG . . . . . . . . . . . . . 40.8 mmt180 -145.22 119.88 9.8 Favored 'General case' 0 C--N 1.328 -0.336 0 N-CA-C 109.478 -0.564 . . . . 0.0 109.478 177.193 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' F' F ' 127' ' ' ASN . . . . . . . . . . . . . 13.8 m120 56.38 -152.73 0.37 Allowed 'General case' 0 CA--C 1.54 0.564 0 N-CA-C 109.737 -0.468 . . . . 0.0 109.737 -179.164 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' F' F ' 128' ' ' ASP . . . . . . . . . . . . . 23.3 p-10 -79.95 14.29 1.87 Allowed 'General case' 0 CA--C 1.537 0.448 0 N-CA-C 112.759 0.652 . . . . 0.0 112.759 177.799 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' F' F ' 129' ' ' LEU . . . . . . . . . . . . . 60.9 mt -109.37 139.75 43.93 Favored 'General case' 0 C--O 1.232 0.181 0 O-C-N 121.955 -0.465 . . . . 0.0 109.747 178.254 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' F' F ' 130' ' ' VAL . . . . . 0.528 HG11 HD13 ' F' ' 104' ' ' ILE . 12.1 p -132.34 141.75 44.45 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.235 0 CA-C-O 121.202 0.525 . . . . 0.0 110.562 -177.746 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' F' F ' 131' ' ' VAL . . . . . . . . . . . . . 42.8 t -135.99 135.2 50.58 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.299 0 CA-C-N 115.794 -0.639 . . . . 0.0 110.035 178.63 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' F' F ' 132' ' ' ILE . . . . . . . . . . . . . 69.0 mt -113.52 130.76 66.98 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.332 0 CA-C-N 115.815 -0.629 . . . . 0.0 109.348 -179.784 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' F' F ' 133' ' ' ILE . . . . . . . . . . . . . 36.8 mm -114.59 120.41 64.19 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.216 0 CA-C-O 120.989 0.423 . . . . 0.0 110.914 -175.044 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' F' F ' 134' ' ' ASP . . . . . . . . . . . . . 6.9 p-10 -132.56 147.45 52.35 Favored 'General case' 0 C--N 1.332 -0.181 0 N-CA-C 109.519 -0.549 . . . . 0.0 109.519 176.007 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' F' F ' 135' ' ' GLU . . . . . . . . . . . . . 84.5 tt0 -49.94 -27.57 5.51 Favored 'General case' 0 C--N 1.329 -0.298 0 N-CA-C 112.703 0.631 . . . . 0.0 112.703 -173.008 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' F' F ' 136' ' ' GLN . . . . . . . . . . . . . 98.5 mt-30 -81.36 -34.48 31.71 Favored 'General case' 0 C--O 1.232 0.183 0 N-CA-C 112.181 0.438 . . . . 0.0 112.181 -176.158 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' F' F ' 137' ' ' LYS . . . . . . . . . . . . . 56.3 pttt -168.01 175.04 6.92 Favored 'General case' 0 C--N 1.332 -0.188 0 CA-C-O 121.506 0.669 . . . . 0.0 112.14 -172.482 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' F' F ' 138' ' ' LEU . . . . . 0.462 HD23 ' C ' ' F' ' 138' ' ' LEU . 8.5 tt -120.13 128.59 53.58 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 115.174 -0.921 . . . . 0.0 110.135 179.205 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' F' F ' 139' ' ' THR . . . . . . . . . . . . . 33.2 m -107.64 122.41 46.65 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-N 116.116 -0.493 . . . . 0.0 110.239 178.906 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' F' F ' 140' ' ' LEU . . . . . 0.463 HD23 ' C ' ' F' ' 140' ' ' LEU . 6.2 tt -111.03 122.27 47.47 Favored 'General case' 0 C--N 1.329 -0.326 0 N-CA-C 109.189 -0.671 . . . . 0.0 109.189 -179.432 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' F' F ' 141' ' ' ILE . . . . . 0.456 ' HB ' HG13 ' F' ' 130' ' ' VAL . 19.8 mt -121.63 116.36 49.25 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.275 0 CA-C-O 121.086 0.47 . . . . 0.0 109.927 -176.113 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' F' F ' 142' ' ' ARG . . . . . . . . . . . . . 61.6 ttt180 -106.07 127.46 53.2 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 114.921 -1.036 . . . . 0.0 110.619 -176.259 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' F' F ' 143' ' ' THR . . . . . . . . . . . . . 75.8 p . . . . . 0 C--O 1.22 -0.46 0 CA-C-O 118.001 -1.0 . . . . 0.0 110.589 179.192 . . . . . . . . 0 0 . 1 . 005 nuclear nobuild core ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 13.7 p . . . . . 0 C--O 1.231 0.108 0 CA-C-O 121.11 0.481 . . . . 0.0 110.618 . . . . . . . . . 0 0 . 1 . 005 nuclear nobuild core ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 84.9 tt0 -140.02 138.94 35.84 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-N 115.724 -0.671 . . . . 0.0 110.676 179.64 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 4' ' ' LEU . . . . . 0.49 HD23 ' N ' ' A' ' 5' ' ' LYS . 3.0 tt -125.7 126.51 44.76 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 115.734 -0.666 . . . . 0.0 109.698 178.579 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 5' ' ' LYS . . . . . 0.49 ' N ' HD23 ' A' ' 4' ' ' LEU . 87.8 mttt -108.99 124.34 50.56 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-O 120.655 0.265 . . . . 0.0 110.864 -179.119 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 6' ' ' LEU . . . . . 0.475 HD23 ' HA ' ' A' ' 50' ' ' VAL . 18.3 mt -122.01 150.29 42.28 Favored 'General case' 0 C--O 1.232 0.163 0 CA-C-N 115.811 -0.631 . . . . 0.0 111.254 -178.879 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 49.3 tttm -138.27 143.47 39.1 Favored Pre-proline 0 C--N 1.329 -0.304 0 CA-C-N 115.757 -0.656 . . . . 0.0 109.792 175.199 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 8' ' ' PRO . . . . . . . . . . . . . 97.5 Cg_endo -89.8 136.72 2.65 Favored 'Trans proline' 0 N--CA 1.489 1.234 0 C-N-CA 121.741 1.628 . . . . 0.0 111.766 178.537 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 40.9 mt -75.9 -45.68 3.93 Favored Pre-proline 0 CA--C 1.532 0.285 0 CA-C-O 119.064 -0.493 . . . . 0.0 111.524 -179.253 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 71.1 Cg_endo -85.1 152.12 10.93 Favored 'Trans proline' 0 N--CA 1.494 1.519 0 C-N-CA 121.234 1.289 . . . . 0.0 111.31 170.534 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 27.5 ttpp -86.23 109.78 19.16 Favored 'General case' 0 C--N 1.33 -0.271 0 C-N-CA 120.702 -0.399 . . . . 0.0 110.235 178.692 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 11.8 p -142.77 145.09 23.55 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.291 0 CA-C-N 116.092 -0.504 . . . . 0.0 110.62 -178.576 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 84.8 tt0 -88.47 121.32 30.72 Favored 'General case' 0 C--N 1.328 -0.344 0 N-CA-C 109.913 -0.403 . . . . 0.0 109.913 176.886 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 14' ' ' LEU . . . . . . . . . . . . . 29.6 mt -98.01 151.56 37.61 Favored Pre-proline 0 C--N 1.33 -0.268 0 CA-C-N 116.354 -0.384 . . . . 0.0 110.976 -176.277 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 15' ' ' PRO . . . . . . . . . . . . . 24.5 Cg_exo -63.31 161.13 31.95 Favored 'Trans proline' 0 N--CA 1.497 1.723 0 C-N-CA 121.322 1.348 . . . . 0.0 111.666 175.436 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 16' ' ' PRO . . . . . . . . . . . . . 26.6 Cg_exo -60.73 -34.0 92.39 Favored 'Trans proline' 0 N--CA 1.496 1.646 0 C-N-CA 121.478 1.452 . . . . 0.0 112.966 -177.722 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 17' ' ' ASP . . . . . . . . . . . . . 18.8 p-10 -90.62 6.6 43.17 Favored 'General case' 0 CA--C 1.537 0.465 0 N-CA-C 113.402 0.89 . . . . 0.0 113.402 -176.833 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 18' ' ' PHE . . . . . . . . . . . . . 49.6 t80 -57.59 -42.93 84.18 Favored 'General case' 0 C--N 1.334 -0.105 0 CA-C-O 120.952 0.406 . . . . 0.0 110.291 -178.021 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 19' ' ' VAL . . . . . . . . . . . . . 47.8 t -57.16 -43.57 81.84 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.346 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.358 -178.827 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 4.2 m-20 -60.15 -41.33 92.54 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.525 -0.307 . . . . 0.0 110.882 -178.381 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 47.0 t -63.58 -46.17 95.66 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 C-N-CA 120.85 -0.34 . . . . 0.0 110.296 -177.385 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 22' ' ' ILE . . . . . 0.564 HG22 HD12 ' A' ' 26' ' ' LEU . 51.0 mm -55.54 -48.63 77.13 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.237 0 CA-C-O 120.81 0.338 . . . . 0.0 110.714 178.778 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 23' ' ' ARG . . . . . . . . . . . . . 55.9 ttp180 -54.31 -48.77 70.93 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.629 -0.26 . . . . 0.0 111.568 -178.057 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 24' ' ' ILE . . . . . . . . . . . . . 78.5 mt -60.11 -42.7 90.92 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.269 0 C-N-CA 121.052 -0.259 . . . . 0.0 111.54 -176.791 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 51.1 mttm -65.13 -40.49 94.52 Favored 'General case' 0 C--N 1.328 -0.327 0 N-CA-C 112.21 0.448 . . . . 0.0 112.21 -179.12 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 26' ' ' LEU . . . . . 0.564 HD12 HG22 ' A' ' 22' ' ' ILE . 37.6 mt -78.96 -40.06 32.83 Favored 'General case' 0 C--N 1.33 -0.271 0 N-CA-C 113.526 0.935 . . . . 0.0 113.526 -171.366 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 27' ' ' GLN . . . . . . . . . . . . . 9.8 pt20 -46.88 141.91 3.75 Favored 'General case' 0 N--CA 1.47 0.545 0 N-CA-C 112.82 0.674 . . . . 0.0 112.82 -175.207 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 97.72 -30.0 10.06 Favored Glycine 0 CA--C 1.531 1.044 0 CA-C-N 115.652 -0.703 . . . . 0.0 111.984 -177.529 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 48.8 mtmt -99.3 155.3 17.58 Favored 'General case' 0 C--O 1.233 0.227 0 CA-C-O 120.993 0.425 . . . . 0.0 111.324 179.304 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 30' ' ' THR . . . . . . . . . . . . . 20.8 m -105.57 140.55 38.49 Favored 'General case' 0 C--N 1.331 -0.212 0 CA-C-N 115.91 -0.586 . . . . 0.0 110.166 176.657 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 35.5 m -129.54 161.43 39.08 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.187 0 CA-C-N 116.41 -0.359 . . . . 0.0 110.848 -179.138 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 32' ' ' ARG . . . . . . . . . . . . . 79.7 mtt85 -127.28 147.37 50.23 Favored 'General case' 0 C--N 1.331 -0.212 0 CA-C-O 121.291 0.567 . . . . 0.0 110.776 179.093 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 33' ' ' THR . . . . . . . . . . . . . 29.2 m -53.91 140.69 29.98 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.248 -0.433 . . . . 0.0 111.146 -179.879 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 98.83 -17.13 58.69 Favored Glycine 0 CA--C 1.532 1.144 0 C-N-CA 121.131 -0.557 . . . . 0.0 113.232 179.33 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 76.1 m-20 -64.63 150.26 47.37 Favored 'General case' 0 C--O 1.232 0.147 0 CA-C-N 118.096 0.948 . . . . 0.0 111.241 179.813 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 45.0 t -119.07 129.65 74.91 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.247 0 CA-C-N 115.713 -0.676 . . . . 0.0 109.81 178.85 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 37' ' ' ILE . . . . . . . . . . . . . 69.2 mt -119.94 138.28 51.03 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.273 0 CA-C-N 116.171 -0.468 . . . . 0.0 109.759 179.414 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . -113.74 128.98 8.56 Favored Glycine 0 CA--C 1.525 0.707 0 N-CA-C 111.029 -0.828 . . . . 0.0 111.029 -179.255 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 39' ' ' ILE . . . . . . . . . . . . . 72.4 mt -123.55 133.97 67.69 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.231 0 N-CA-C 110.188 -0.301 . . . . 0.0 110.188 179.079 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 40' ' ' SER . . . . . . . . . . . . . 45.2 t -93.0 113.93 26.34 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.455 -0.338 . . . . 0.0 110.776 175.597 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 41' ' ' ILE . . . . . . . . . . . . . 44.9 mm -121.51 123.44 69.59 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.265 0 CA-C-O 120.778 0.323 . . . . 0.0 110.45 179.997 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 34.5 mt 52.57 34.09 14.91 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.235 -0.438 . . . . 0.0 111.791 177.292 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . 72.52 32.16 62.28 Favored Glycine 0 CA--C 1.53 0.988 0 C-N-CA 121.113 -0.565 . . . . 0.0 111.889 178.747 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 44' ' ' LYS . . . . . . . . . . . . . 33.7 ttmt -139.21 130.48 26.82 Favored 'General case' 0 C--N 1.329 -0.314 0 N-CA-C 109.767 -0.457 . . . . 0.0 109.767 179.188 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 84.0 tt0 -82.62 122.38 28.03 Favored 'General case' 0 C--N 1.329 -0.29 0 C-N-CA 120.755 -0.378 . . . . 0.0 111.003 -177.848 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 46' ' ' VAL . . . . . . . . . . . . . 7.1 p -120.64 129.1 75.98 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.227 0 N-CA-C 109.338 -0.616 . . . . 0.0 109.338 174.682 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 59.7 mtpt -100.32 127.05 46.71 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 115.748 -0.66 . . . . 0.0 110.858 179.624 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 48' ' ' PHE . . . . . . . . . . . . . 89.5 m-85 -110.44 131.87 54.68 Favored 'General case' 0 C--N 1.33 -0.275 0 N-CA-C 110.017 -0.364 . . . . 0.0 110.017 176.919 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 86.2 tttt -106.33 133.94 50.24 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.258 -0.428 . . . . 0.0 110.415 179.892 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 50' ' ' VAL . . . . . 0.475 ' HA ' HD23 ' A' ' 6' ' ' LEU . 42.1 t -77.76 105.38 6.7 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.236 0 N-CA-C 109.165 -0.68 . . . . 0.0 109.165 176.177 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 51' ' ' VAL . . . . . . . . . . . . . 48.9 t -69.79 -48.52 63.97 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.295 0 CA-C-N 116.022 -0.535 . . . . 0.0 110.146 -173.16 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 52' ' ' GLN . . . . . . . . . . . . . 61.8 tt0 -163.96 144.62 8.51 Favored 'General case' 0 C--N 1.329 -0.296 0 C-N-CA 120.288 -0.565 . . . . 0.0 111.811 -177.911 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 53' ' ' ALA . . . . . 0.442 ' HB1' ' HB2' ' A' ' 58' ' ' LEU . . . -115.18 133.04 56.39 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 115.559 -0.746 . . . . 0.0 109.79 176.016 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 54' ' ' TYR . . . . . . . . . . . . . 9.5 t80 -129.04 108.41 18.09 Favored Pre-proline 0 CA--C 1.535 0.379 0 CA-C-O 118.182 -0.914 . . . . 0.0 110.464 178.499 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 55' ' ' PRO . . . . . . . . . . . . . 72.0 Cg_endo -76.96 168.89 75.87 Favored 'Cis proline' 0 N--CA 1.501 1.952 0 CA-C-N 121.941 1.729 . . . . 0.0 112.408 -4.945 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 56' ' ' SER . . . . . . . . . . . . . 14.4 m -112.33 128.0 26.1 Favored Pre-proline 0 CA--C 1.539 0.535 0 CA-C-O 118.366 -0.826 . . . . 0.0 109.673 176.961 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 57' ' ' PRO . . . . . . . . . . . . . 35.2 Cg_endo -65.72 168.86 44.6 Favored 'Cis proline' 0 N--CA 1.497 1.715 0 CA-C-N 122.029 1.76 . . . . 0.0 111.45 -2.862 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 58' ' ' LEU . . . . . 0.442 ' HB2' ' HB1' ' A' ' 53' ' ' ALA . 30.0 tp -129.95 135.71 48.63 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-O 120.887 0.375 . . . . 0.0 110.707 -179.41 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 59' ' ' ARG . . . . . . . . . . . . . 52.9 ttt180 -106.99 129.12 54.83 Favored 'General case' 0 C--N 1.328 -0.335 0 N-CA-C 108.688 -0.856 . . . . 0.0 108.688 176.521 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 40.6 t -89.85 126.23 42.75 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.183 0 C-N-CA 120.385 -0.526 . . . . 0.0 111.36 -172.607 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 49.8 mp0 -131.07 168.55 17.21 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 115.58 -0.737 . . . . 0.0 109.077 171.917 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 62' ' ' ASP . . . . . . . . . . . . . 18.2 p-10 -53.87 -32.6 53.72 Favored 'General case' 0 C--N 1.329 -0.323 0 C-N-CA 120.931 -0.308 . . . . 0.0 111.815 -178.449 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 63' ' ' ARG . . . . . . . . . . . . . 98.4 mtt180 -71.97 -22.14 61.49 Favored 'General case' 0 CA--C 1.532 0.273 0 N-CA-C 112.896 0.702 . . . . 0.0 112.896 -177.299 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 50.9 m -67.37 130.24 42.43 Favored 'General case' 0 C--N 1.332 -0.193 0 N-CA-C 110.125 -0.324 . . . . 0.0 110.125 -178.275 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 65' ' ' LYS . . . . . . . . . . . . . 50.3 mtmt -89.23 135.79 33.38 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.222 -0.445 . . . . 0.0 110.538 179.825 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 66' ' ' ILE . . . . . . . . . . . . . 65.1 mt -114.8 130.95 68.36 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.229 0 N-CA-C 109.736 -0.468 . . . . 0.0 109.736 -178.408 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 67' ' ' THR . . . . . . . . . . . . . 23.4 m -117.63 134.73 54.57 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.123 -0.49 . . . . 0.0 110.608 -178.524 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 68' ' ' LEU . . . . . . . . . . . . . 15.4 tp . . . . . 0 C--N 1.329 -0.309 0 CA-C-N 115.891 -0.595 . . . . 0.0 110.472 179.585 . . . . . . . . 0 0 . 1 . 005 nuclear nobuild core ' A' A ' 74' ' ' ASP . . . . . . . . . . . . . 13.6 t70 . . . . . 0 N--CA 1.459 0.023 0 N-CA-C 109.557 -0.535 . . . . 0.0 109.557 . . . . . . . . . 0 0 . 1 . 005 nuclear nobuild core ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 41.4 t -122.59 124.26 70.28 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.203 0 CA-C-O 121.077 0.465 . . . . 0.0 110.909 -175.203 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 76' ' ' LEU . . . . . . . . . . . . . 5.1 mp -126.38 147.05 49.83 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 115.664 -0.698 . . . . 0.0 109.603 174.852 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 77' ' ' GLU . . . . . . . . . . . . . 45.9 mt-10 -135.1 140.52 45.55 Favored 'General case' 0 C--N 1.331 -0.207 0 CA-C-O 121.015 0.436 . . . . 0.0 111.425 -178.443 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 78' ' ' ALA . . . . . 0.42 ' HB2' HD21 ' A' ' 109' ' ' LEU . . . -129.92 131.33 45.96 Favored 'General case' 0 C--N 1.331 -0.22 0 CA-C-N 115.774 -0.648 . . . . 0.0 109.842 176.513 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 79' ' ' LYS . . . . . 0.583 ' O ' HD13 ' A' ' 80' ' ' ILE . 16.3 ptpt -74.94 122.57 23.65 Favored 'General case' 0 C--N 1.331 -0.222 0 CA-C-O 121.281 0.562 . . . . 0.0 111.087 -176.801 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 80' ' ' ILE . . . . . 0.583 HD13 ' O ' ' A' ' 79' ' ' LYS . 41.2 mm -139.22 110.57 4.95 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.318 0 CA-C-N 115.779 -0.646 . . . . 0.0 109.289 -177.875 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 81' ' ' LYS . . . . . . . . . . . . . 60.6 mttp -101.37 125.56 48.03 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-O 120.914 0.388 . . . . 0.0 111.293 -178.234 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . 89.15 42.07 5.69 Favored Glycine 0 CA--C 1.525 0.702 0 C-N-CA 121.105 -0.569 . . . . 0.0 111.894 174.254 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 83' ' ' ILE . . . . . . . . . . . . . 71.4 mt -69.55 133.3 32.09 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.33 0 N-CA-C 109.489 -0.56 . . . . 0.0 109.489 175.999 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 84' ' ' LYS . . . . . . . . . . . . . 35.7 ttpt -101.58 -49.58 3.97 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-O 120.742 0.306 . . . . 0.0 110.398 -177.881 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 85' ' ' ASP . . . . . . . . . . . . . 5.6 t70 -150.87 151.26 31.97 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.242 -0.435 . . . . 0.0 110.483 -179.972 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 86' ' ' VAL . . . . . . . . . . . . . 41.0 t -133.89 137.62 52.0 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.261 0 CA-C-O 121.014 0.435 . . . . 0.0 110.537 -179.061 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 87' ' ' ILE . . . . . 0.497 HD12 ' N ' ' A' ' 87' ' ' ILE . 5.0 mp -121.0 130.69 74.42 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.21 0 CA-C-N 115.701 -0.681 . . . . 0.0 109.699 178.134 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 88' ' ' LEU . . . . . . . . . . . . . 15.9 tp -111.79 132.83 54.4 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-O 120.858 0.361 . . . . 0.0 110.743 -178.893 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 89' ' ' ASP . . . . . . . . . . . . . 46.4 t0 -130.6 160.31 34.58 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.161 178.584 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 84.6 tt0 -45.77 -43.1 12.83 Favored 'General case' 0 CA--C 1.532 0.257 0 N-CA-C 113.06 0.763 . . . . 0.0 113.06 -171.392 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 91' ' ' ASN . . . . . . . . . . . . . 3.0 m120 -131.96 26.49 4.6 Favored 'General case' 0 N--CA 1.467 0.394 0 N-CA-C 112.471 0.545 . . . . 0.0 112.471 -178.286 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 92' ' ' LEU . . . . . . . . . . . . . 18.6 mt -148.58 144.47 27.28 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-O 120.759 0.314 . . . . 0.0 110.508 -176.693 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 93' ' ' ILE . . . . . . . . . . . . . 69.3 mt -125.23 116.69 47.65 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.306 0 N-CA-C 108.822 -0.807 . . . . 0.0 108.822 175.694 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 94' ' ' VAL . . . . . . . . . . . . . 44.3 t -117.62 127.85 74.93 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.286 0 N-CA-C 109.904 -0.406 . . . . 0.0 109.904 -177.807 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 95' ' ' VAL . . . . . . . . . . . . . 43.1 t -121.38 133.94 66.31 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.339 0 CA-C-N 116.027 -0.533 . . . . 0.0 109.813 -179.822 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 96' ' ' ILE . . . . . 0.52 HD11 ' HB ' ' A' ' 123' ' ' VAL . 66.8 mt -114.57 125.17 71.82 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.355 0 N-CA-C 109.254 -0.647 . . . . 0.0 109.254 178.63 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 97' ' ' THR . . . . . . . . . . . . . 74.7 p -97.37 156.29 16.52 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-O 121.401 0.62 . . . . 0.0 111.091 -177.388 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 98' ' ' GLU . . . . . . . . . . . . . 84.9 tt0 -53.86 -27.25 28.84 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 115.831 -0.622 . . . . 0.0 112.242 -179.163 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 99' ' ' GLU . . . . . . . . . . . . . 18.8 tp10 -80.8 16.71 1.34 Allowed 'General case' 0 CA--C 1.538 0.491 0 N-CA-C 112.741 0.645 . . . . 0.0 112.741 -176.538 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 100' ' ' ASN . . . . . . . . . . . . . 4.5 m-20 63.43 33.33 13.79 Favored 'General case' 0 C--O 1.233 0.233 0 O-C-N 122.013 -0.43 . . . . 0.0 111.694 177.478 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 101' ' ' GLU . . . . . . . . . . . . . 84.6 tt0 -111.3 142.72 43.16 Favored 'General case' 0 C--N 1.333 -0.147 0 N-CA-C 109.654 -0.498 . . . . 0.0 109.654 173.754 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 102' ' ' VAL . . . . . . . . . . . . . 46.7 t -115.06 127.3 72.67 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.294 0 CA-C-N 116.167 -0.47 . . . . 0.0 109.942 -177.711 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 103' ' ' LEU . . . . . . . . . . . . . 30.5 mt -117.8 129.55 55.74 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 115.809 -0.632 . . . . 0.0 110.279 177.267 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 104' ' ' ILE . . . . . . . . . . . . . 70.9 mt -118.35 120.86 65.65 Favored 'Isoleucine or valine' 0 C--O 1.234 0.244 0 N-CA-C 110.198 -0.297 . . . . 0.0 110.198 179.927 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 105' ' ' PHE . . . . . . . . . . . . . 54.3 m-85 -121.99 164.8 17.03 Favored 'General case' 0 C--N 1.333 -0.15 0 O-C-N 123.87 0.731 . . . . 0.0 109.781 179.377 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 106' ' ' ASN . . . . . 0.414 ' HB3' HD11 ' A' ' 112' ' ' LEU . 45.9 p-10 -99.04 -169.95 1.85 Allowed 'General case' 0 C--N 1.331 -0.219 0 N-CA-C 110.021 -0.363 . . . . 0.0 110.021 174.563 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 107' ' ' GLN . . . . . . . . . . . . . 40.0 tt0 -59.73 -30.1 68.59 Favored 'General case' 0 C--N 1.33 -0.268 0 N-CA-C 111.988 0.366 . . . . 0.0 111.988 -179.744 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 108' ' ' ASN . . . . . . . . . . . . . 51.7 t30 -82.85 8.83 11.29 Favored 'General case' 0 CA--C 1.536 0.425 0 N-CA-C 113.19 0.811 . . . . 0.0 113.19 -178.0 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 109' ' ' LEU . . . . . 0.42 HD21 ' HB2' ' A' ' 78' ' ' ALA . 12.2 tp 58.98 39.02 24.06 Favored 'General case' 0 C--N 1.332 -0.184 0 CA-C-O 121.162 0.506 . . . . 0.0 111.009 178.966 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 110' ' ' GLU . . . . . . . . . . . . . 70.7 mm-40 -106.91 155.41 19.79 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 116.299 -0.41 . . . . 0.0 109.998 176.595 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 111' ' ' GLU . . . . . . . . . . . . . 84.4 tt0 -83.54 121.92 27.87 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-O 120.835 0.35 . . . . 0.0 110.787 -177.364 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 112' ' ' LEU . . . . . 0.414 HD11 ' HB3' ' A' ' 106' ' ' ASN . 38.5 mt -109.02 -46.0 3.68 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 116.178 -0.465 . . . . 0.0 110.495 177.949 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 113' ' ' TYR . . . . . . . . . . . . . 63.0 t80 -140.29 138.01 34.63 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-O 120.804 0.335 . . . . 0.0 111.388 -179.383 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 114' ' ' ARG . . . . . . . . . . . . . 68.9 ttp85 -136.37 124.82 23.46 Favored 'General case' 0 C--N 1.331 -0.239 0 CA-C-N 115.946 -0.57 . . . . 0.0 110.274 177.535 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 115' ' ' GLY . . . . . . . . . . . . . . . -150.03 157.12 27.08 Favored Glycine 0 CA--C 1.522 0.524 0 N-CA-C 110.784 -0.926 . . . . 0.0 110.784 179.099 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 116' ' ' LYS . . . . . . . . . . . . . 69.8 tttt -134.68 132.23 38.65 Favored 'General case' 0 C--N 1.329 -0.305 0 N-CA-C 109.958 -0.386 . . . . 0.0 109.958 177.641 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 117' ' ' PHE . . . . . . . . . . . . . 39.9 m-85 -127.41 120.6 28.8 Favored 'General case' 0 N--CA 1.463 0.2 0 CA-C-N 116.308 -0.406 . . . . 0.0 110.073 -174.761 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 118' ' ' GLU . . . . . . . . . . . . . 95.6 mt-10 -54.35 -45.89 72.82 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 116.421 -0.354 . . . . 0.0 111.314 -175.851 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 119' ' ' ASN . . . . . . . . . . . . . 88.3 m-20 -101.31 31.11 3.84 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.137 -0.483 . . . . 0.0 112.076 -174.285 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 120' ' ' LEU . . . . . . . . . . . . . 15.0 tp -54.98 119.97 6.21 Favored 'General case' 0 N--CA 1.463 0.214 0 O-C-N 122.264 -0.272 . . . . 0.0 110.615 179.724 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 121' ' ' ASN . . . . . . . . . . . . . 23.9 t-20 -114.18 -44.07 3.17 Favored 'General case' 0 C--O 1.232 0.143 0 CA-C-N 116.487 -0.324 . . . . 0.0 111.151 -177.072 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 122' ' ' LYS . . . . . . . . . . . . . 63.6 mtpt -139.26 142.16 37.78 Favored 'General case' 0 C--N 1.331 -0.225 0 CA-C-O 120.99 0.424 . . . . 0.0 111.594 -175.59 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 123' ' ' VAL . . . . . 0.52 ' HB ' HD11 ' A' ' 96' ' ' ILE . 48.0 t -126.17 125.75 68.32 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 N-CA-C 109.01 -0.737 . . . . 0.0 109.01 173.001 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 124' ' ' LEU . . . . . . . . . . . . . 78.5 mt -121.42 131.13 53.99 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-O 120.843 0.354 . . . . 0.0 110.77 -175.853 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 125' ' ' VAL . . . . . . . . . . . . . 44.5 t -126.15 126.29 69.27 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.239 0 CA-C-N 115.98 -0.555 . . . . 0.0 109.742 178.52 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 126' ' ' ARG . . . . . 0.494 HH11 HD23 ' B' ' 88' ' ' LEU . 82.4 mtt85 -150.9 129.24 12.03 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.299 -0.41 . . . . 0.0 110.045 177.729 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 127' ' ' ASN . . . . . . . . . . . . . 8.8 t-20 56.21 -152.42 0.38 Allowed 'General case' 0 CA--C 1.54 0.581 0 N-CA-C 109.736 -0.468 . . . . 0.0 109.736 179.755 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 128' ' ' ASP . . . . . . . . . . . . . 23.4 p-10 -83.06 18.13 1.76 Allowed 'General case' 0 CA--C 1.536 0.414 0 N-CA-C 112.628 0.603 . . . . 0.0 112.628 178.303 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 129' ' ' LEU . . . . . . . . . . . . . 11.7 tp -117.35 137.2 52.61 Favored 'General case' 0 C--O 1.234 0.241 0 O-C-N 122.079 -0.388 . . . . 0.0 110.472 179.765 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 130' ' ' VAL . . . . . . . . . . . . . 42.0 t -125.84 138.73 53.59 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.188 0 CA-C-N 116.276 -0.42 . . . . 0.0 109.963 -179.424 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 131' ' ' VAL . . . . . . . . . . . . . 35.1 m -136.1 143.98 34.49 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.282 0 CA-C-O 121.152 0.501 . . . . 0.0 111.163 178.143 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 132' ' ' ILE . . . . . . . . . . . . . 69.9 mt -120.9 134.03 65.63 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 CA-C-N 115.657 -0.702 . . . . 0.0 109.606 179.966 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 133' ' ' ILE . . . . . . . . . . . . . 40.8 mm -116.68 117.83 56.75 Favored 'Isoleucine or valine' 0 C--O 1.233 0.224 0 CA-C-O 120.965 0.412 . . . . 0.0 110.711 -176.684 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 134' ' ' ASP . . . . . . . . . . . . . 8.0 p-10 -131.49 148.47 52.64 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 115.844 -0.616 . . . . 0.0 109.408 174.717 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 135' ' ' GLU . . . . . . . . . . . . . 84.8 tt0 -49.76 -24.44 2.35 Favored 'General case' 0 C--N 1.327 -0.399 0 N-CA-C 112.835 0.68 . . . . 0.0 112.835 -171.947 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 136' ' ' GLN . . . . . . . . . . . . . 51.2 tt0 -101.67 -27.72 12.9 Favored 'General case' 0 C--O 1.233 0.212 0 N-CA-C 112.58 0.585 . . . . 0.0 112.58 -173.789 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 137' ' ' LYS . . . . . . . . . . . . . 49.6 mttm -142.13 149.23 39.53 Favored 'General case' 0 C--N 1.332 -0.17 0 N-CA-C 112.766 0.654 . . . . 0.0 112.766 -170.51 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 138' ' ' LEU . . . . . . . . . . . . . 9.9 tp -110.4 118.66 36.87 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 114.891 -1.049 . . . . 0.0 108.732 170.973 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 139' ' ' THR . . . . . . . . . . . . . 31.5 m -111.05 127.47 55.55 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-O 120.67 0.271 . . . . 0.0 110.86 -177.283 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 140' ' ' LEU . . . . . 0.48 HD23 ' C ' ' A' ' 140' ' ' LEU . 7.3 tt -116.05 122.66 45.84 Favored 'General case' 0 C--N 1.329 -0.292 0 N-CA-C 109.251 -0.648 . . . . 0.0 109.251 179.913 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 141' ' ' ILE . . . . . . . . . . . . . 19.0 mt -120.6 123.45 70.41 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.273 0 CA-C-O 120.87 0.367 . . . . 0.0 110.112 -174.378 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 142' ' ' ARG . . . . . . . . . . . . . 76.4 mtp180 -110.94 127.61 55.54 Favored 'General case' 0 C--N 1.331 -0.229 0 CA-C-N 115.521 -0.763 . . . . 0.0 110.164 -178.507 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 143' ' ' THR . . . . . . . . . . . . . 42.0 p . . . . . 0 C--O 1.219 -0.505 0 CA-C-O 118.024 -0.988 . . . . 0.0 110.593 -179.524 . . . . . . . . 0 0 . 1 . 005 nuclear nobuild core ' B' B ' 2' ' ' SER . . . . . . . . . . . . . 5.2 p . . . . . 0 C--O 1.233 0.191 0 CA-C-O 121.034 0.445 . . . . 0.0 111.03 . . . . . . . . . 0 0 . 1 . 005 nuclear nobuild core ' B' B ' 3' ' ' GLU . . . . . . . . . . . . . 33.8 tp10 -139.55 136.4 34.43 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 115.786 -0.643 . . . . 0.0 110.402 -178.52 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B ' 4' ' ' LEU . . . . . . . . . . . . . 21.3 tp -124.49 128.77 49.48 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-O 120.714 0.292 . . . . 0.0 110.355 176.028 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B ' 5' ' ' LYS . . . . . . . . . . . . . 98.3 mttt -105.5 120.94 42.89 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.344 -0.389 . . . . 0.0 110.539 179.074 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B ' 6' ' ' LEU . . . . . . . . . . . . . 79.8 mt -118.21 147.62 43.2 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 115.587 -0.733 . . . . 0.0 110.549 -179.474 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B ' 7' ' ' LYS . . . . . . . . . . . . . 73.5 tttt -134.79 140.11 34.3 Favored Pre-proline 0 CA--C 1.534 0.332 0 CA-C-O 118.985 -0.531 . . . . 0.0 110.038 176.193 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B ' 8' ' ' PRO . . . . . . . . . . . . . 88.1 Cg_endo -91.79 137.17 1.86 Allowed 'Trans proline' 0 N--CA 1.489 1.25 0 C-N-CA 121.649 1.566 . . . . 0.0 111.559 177.804 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B ' 9' ' ' LEU . . . . . . . . . . . . . 68.3 mt -72.32 -46.21 10.55 Favored Pre-proline 0 CA--C 1.533 0.32 0 CA-C-O 118.937 -0.554 . . . . 0.0 111.905 -178.682 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B ' 10' ' ' PRO . . . . . . . . . . . . . 78.1 Cg_endo -84.37 152.09 12.08 Favored 'Trans proline' 0 N--CA 1.495 1.575 0 C-N-CA 121.318 1.345 . . . . 0.0 111.734 172.597 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B ' 11' ' ' LYS . . . . . . . . . . . . . 67.5 mttm -88.91 99.9 12.76 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-O 120.81 0.338 . . . . 0.0 110.614 178.104 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B ' 12' ' ' VAL . . . . . . . . . . . . . 12.6 p -140.91 142.42 30.09 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.28 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.362 179.239 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B ' 13' ' ' GLU . . . . . . . . . . . . . 96.1 mt-10 -78.62 129.26 34.56 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.365 -0.379 . . . . 0.0 110.168 178.166 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B ' 14' ' ' LEU . . . . . . . . . . . . . 29.9 mt -98.03 148.66 34.8 Favored Pre-proline 0 C--N 1.329 -0.301 0 CA-C-O 119.223 -0.417 . . . . 0.0 110.282 -179.016 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B ' 15' ' ' PRO . . . . . . . . . . . . . 30.0 Cg_exo -60.67 160.46 24.55 Favored 'Trans proline' 0 N--CA 1.497 1.681 0 C-N-CA 121.322 1.348 . . . . 0.0 111.492 176.117 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B ' 16' ' ' PRO . . . . . . . . . . . . . 38.8 Cg_exo -58.72 -33.81 98.57 Favored 'Trans proline' 0 N--CA 1.497 1.704 0 C-N-CA 121.375 1.384 . . . . 0.0 112.795 -177.993 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B ' 17' ' ' ASP . . . . . . . . . . . . . 11.6 p-10 -93.76 9.83 35.5 Favored 'General case' 0 CA--C 1.535 0.381 0 N-CA-C 113.287 0.847 . . . . 0.0 113.287 -177.147 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B ' 18' ' ' PHE . . . . . . . . . . . . . 44.4 t80 -58.49 -47.21 84.82 Favored 'General case' 0 C--N 1.334 -0.082 0 CA-C-O 120.963 0.411 . . . . 0.0 110.084 -177.961 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B ' 19' ' ' VAL . . . . . . . . . . . . . 49.0 t -57.41 -40.65 75.66 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.339 0 CA-C-N 116.277 -0.42 . . . . 0.0 110.361 -178.737 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B ' 20' ' ' ASP . . . . . . . . . . . . . 79.8 m-20 -60.4 -43.73 96.38 Favored 'General case' 0 C--N 1.331 -0.205 0 C-N-CA 120.936 -0.306 . . . . 0.0 110.968 -178.272 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B ' 21' ' ' VAL . . . . . . . . . . . . . 49.1 t -64.4 -47.35 89.88 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.262 0 C-N-CA 120.753 -0.379 . . . . 0.0 110.359 -177.448 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B ' 22' ' ' ILE . . . . . . . . . . . . . 48.9 mm -56.29 -46.53 81.61 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.258 0 CA-C-O 120.813 0.34 . . . . 0.0 110.598 179.501 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B ' 23' ' ' ARG . . . . . . . . . . . . . 47.9 ttp180 -54.64 -50.61 67.74 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.532 -0.304 . . . . 0.0 111.391 -178.6 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B ' 24' ' ' ILE . . . . . . . . . . . . . 76.1 mt -60.06 -40.5 83.43 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.268 0 C-N-CA 121.073 -0.251 . . . . 0.0 111.432 -176.78 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B ' 25' ' ' LYS . . . . . . . . . . . . . 52.2 mtmt -66.9 -38.93 87.17 Favored 'General case' 0 C--N 1.328 -0.329 0 N-CA-C 112.114 0.413 . . . . 0.0 112.114 -179.833 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B ' 26' ' ' LEU . . . . . . . . . . . . . 93.3 mt -78.49 -40.49 35.22 Favored 'General case' 0 C--N 1.331 -0.21 0 N-CA-C 113.175 0.806 . . . . 0.0 113.175 -172.441 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B ' 27' ' ' GLN . . . . . . . . . . . . . 9.5 pt20 -46.83 139.06 5.71 Favored 'General case' 0 N--CA 1.471 0.591 0 N-CA-C 112.635 0.605 . . . . 0.0 112.635 -175.467 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B ' 28' ' ' GLY . . . . . . . . . . . . . . . 97.68 -23.08 37.48 Favored Glycine 0 CA--C 1.535 1.283 0 CA-C-N 115.573 -0.74 . . . . 0.0 112.319 -175.931 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B ' 29' ' ' LYS . . . . . . . . . . . . . 96.3 mttt -98.41 155.08 17.41 Favored 'General case' 0 C--O 1.233 0.234 0 CA-C-N 117.486 0.643 . . . . 0.0 111.143 179.135 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B ' 30' ' ' THR . . . . . . . . . . . . . 38.6 m -98.38 137.88 36.44 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-N 116.073 -0.512 . . . . 0.0 110.07 176.091 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B ' 31' ' ' VAL . . . . . . . . . . . . . 34.7 m -128.04 148.48 32.6 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.267 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.902 -178.349 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B ' 32' ' ' ARG . . . . . . . . . . . . . 80.3 mtt180 -133.4 150.72 51.79 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-O 121.326 0.584 . . . . 0.0 110.627 177.83 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B ' 33' ' ' THR . . . . . . . . . . . . . 23.1 m -53.39 138.57 32.77 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.034 -0.53 . . . . 0.0 111.279 -178.369 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B ' 34' ' ' GLY . . . . . . . . . . . . . . . 100.35 -17.22 57.17 Favored Glycine 0 CA--C 1.533 1.178 0 CA-C-O 119.537 -0.591 . . . . 0.0 113.243 178.252 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B ' 35' ' ' ASP . . . . . . . . . . . . . 77.7 m-20 -65.33 148.26 52.0 Favored 'General case' 0 C--N 1.333 -0.132 0 CA-C-N 118.131 0.965 . . . . 0.0 111.043 179.808 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B ' 36' ' ' VAL . . . . . . . . . . . . . 44.5 t -121.06 129.72 75.41 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.228 0 CA-C-N 115.852 -0.613 . . . . 0.0 109.842 178.387 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B ' 37' ' ' ILE . . . . . . . . . . . . . 65.3 mt -117.82 137.84 50.44 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.261 0 CA-C-N 116.19 -0.459 . . . . 0.0 109.843 -179.83 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B ' 38' ' ' GLY . . . . . . . . . . . . . . . -110.6 128.58 8.86 Favored Glycine 0 CA--C 1.526 0.764 0 N-CA-C 110.986 -0.845 . . . . 0.0 110.986 179.561 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B ' 39' ' ' ILE . . . . . . . . . . . . . 73.6 mt -124.34 134.66 66.06 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.178 0 N-CA-C 110.015 -0.365 . . . . 0.0 110.015 179.039 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B ' 40' ' ' SER . . . . . . . . . . . . . 43.0 t -92.62 117.56 30.1 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.535 -0.302 . . . . 0.0 110.873 176.201 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B ' 41' ' ' ILE . . . . . . . . . . . . . 45.3 mm -122.75 114.38 42.06 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.159 0 CA-C-O 120.897 0.38 . . . . 0.0 110.546 179.261 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B ' 42' ' ' LEU . . . . . . . . . . . . . 9.2 tp 53.58 37.84 26.82 Favored 'General case' 0 C--N 1.331 -0.216 0 CA-C-N 116.094 -0.503 . . . . 0.0 111.399 176.862 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B ' 43' ' ' GLY . . . . . . . . . . . . . . . 74.62 25.28 70.38 Favored Glycine 0 CA--C 1.531 1.075 0 C-N-CA 121.126 -0.559 . . . . 0.0 112.725 177.563 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B ' 44' ' ' LYS . . . . . . . . . . . . . 34.6 mmtp -130.18 129.31 43.28 Favored 'General case' 0 C--N 1.331 -0.207 0 N-CA-C 109.546 -0.538 . . . . 0.0 109.546 177.682 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B ' 45' ' ' GLU . . . . . . . . . . . . . 81.1 tt0 -83.1 118.98 23.93 Favored 'General case' 0 C--N 1.329 -0.295 0 C-N-CA 120.762 -0.375 . . . . 0.0 110.762 -179.173 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B ' 46' ' ' VAL . . . . . . . . . . . . . 7.4 p -118.6 126.75 75.42 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.216 0 N-CA-C 109.288 -0.634 . . . . 0.0 109.288 176.489 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B ' 47' ' ' LYS . . . . . . . . . . . . . 56.3 mtmt -100.67 128.73 46.61 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 115.84 -0.618 . . . . 0.0 111.304 178.85 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B ' 48' ' ' PHE . . . . . . . . . . . . . 94.3 m-85 -110.73 131.87 54.68 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 115.999 -0.546 . . . . 0.0 109.774 176.089 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B ' 49' ' ' LYS . . . . . . . . . . . . . 36.1 tttp -106.58 135.64 47.75 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.407 -0.36 . . . . 0.0 110.407 -179.498 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B ' 50' ' ' VAL . . . . . . . . . . . . . 43.7 t -80.18 108.76 13.96 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.207 0 N-CA-C 109.257 -0.646 . . . . 0.0 109.257 176.488 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B ' 51' ' ' VAL . . . . . . . . . . . . . 46.0 t -73.39 -47.94 43.93 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.273 0 CA-C-N 116.141 -0.481 . . . . 0.0 110.11 -174.125 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B ' 52' ' ' GLN . . . . . . . . . . . . . 59.8 tt0 -162.6 140.84 8.57 Favored 'General case' 0 C--N 1.33 -0.262 0 C-N-CA 120.401 -0.52 . . . . 0.0 111.343 -177.37 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B ' 53' ' ' ALA . . . . . . . . . . . . . . . -114.82 131.67 56.74 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 115.45 -0.795 . . . . 0.0 109.971 175.56 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B ' 54' ' ' TYR . . . . . . . . . . . . . 30.9 t80 -129.12 111.54 18.31 Favored Pre-proline 0 CA--C 1.535 0.386 0 CA-C-O 118.302 -0.856 . . . . 0.0 110.232 177.598 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B ' 55' ' ' PRO . . . . . . . . . . . . . 73.5 Cg_endo -77.18 167.94 78.3 Favored 'Cis proline' 0 N--CA 1.499 1.835 0 CA-C-N 121.985 1.745 . . . . 0.0 112.373 -5.955 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B ' 56' ' ' SER . . . . . . . . . . . . . 13.6 m -117.34 134.87 23.06 Favored Pre-proline 0 CA--C 1.538 0.51 0 CA-C-O 118.574 -0.727 . . . . 0.0 109.493 174.049 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B ' 57' ' ' PRO . . . . . . . . . . . . . 39.8 Cg_endo -68.11 146.66 78.64 Favored 'Cis proline' 0 N--CA 1.498 1.744 0 CA-C-N 121.87 1.704 . . . . 0.0 111.329 -3.06 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B ' 58' ' ' LEU . . . . . . . . . . . . . 16.3 tp -107.2 136.8 46.41 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.282 -0.417 . . . . 0.0 110.584 -177.599 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B ' 59' ' ' ARG . . . . . . . . . . . . . 51.2 ttp180 -104.64 119.9 40.07 Favored 'General case' 0 C--N 1.328 -0.342 0 N-CA-C 109.315 -0.624 . . . . 0.0 109.315 175.975 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B ' 60' ' ' VAL . . . . . . . . . . . . . 48.7 t -73.37 122.53 26.47 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.252 0 C-N-CA 120.662 -0.415 . . . . 0.0 110.154 -175.214 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B ' 61' ' ' GLU . . . . . . . . . . . . . 95.8 mt-10 -131.05 163.39 27.71 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 115.934 -0.575 . . . . 0.0 110.422 -179.21 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B ' 62' ' ' ASP . . . . . . . . . . . . . 12.5 t70 -55.15 -32.73 62.34 Favored 'General case' 0 C--N 1.327 -0.401 0 CA-C-N 116.426 -0.352 . . . . 0.0 111.523 178.59 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B ' 63' ' ' ARG . . . . . . . . . . . . . 13.1 ptp180 -89.84 9.6 26.86 Favored 'General case' 0 CA--C 1.534 0.337 0 N-CA-C 113.522 0.934 . . . . 0.0 113.522 -176.016 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B ' 64' ' ' THR . . . . . . . . . . . . . 39.4 m -91.41 133.41 35.49 Favored 'General case' 0 C--N 1.332 -0.16 0 CA-C-N 118.198 0.454 . . . . 0.0 110.087 179.667 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B ' 65' ' ' LYS . . . . . . . . . . . . . 57.6 mtmt -90.0 132.55 35.3 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-O 120.987 0.422 . . . . 0.0 110.648 -177.664 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B ' 66' ' ' ILE . . . . . . . . . . . . . 60.7 mt -114.84 127.84 72.21 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.358 0 N-CA-C 109.755 -0.461 . . . . 0.0 109.755 -179.269 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B ' 67' ' ' THR . . . . . . . . . . . . . 30.6 m -119.12 138.84 52.63 Favored 'General case' 0 C--N 1.332 -0.186 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.941 -176.91 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B ' 68' ' ' LEU . . . . . . . . . . . . . 14.8 tp . . . . . 0 C--N 1.329 -0.324 0 CA-C-N 115.913 -0.585 . . . . 0.0 110.065 178.223 . . . . . . . . 0 0 . 1 . 005 nuclear nobuild core ' B' B ' 73' ' ' VAL . . . . . . . . . . . . . 35.1 m . . . . . 0 N--CA 1.463 0.214 0 CA-C-O 120.859 0.361 . . . . 0.0 111.091 . . . . . . . . . 0 0 . 1 . 005 nuclear nobuild core ' B' B ' 74' ' ' ASP . . . . . . . . . . . . . 38.7 t0 -99.11 122.95 43.02 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 115.963 -0.562 . . . . 0.0 109.94 -178.975 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B ' 75' ' ' VAL . . . . . . . . . . . . . 40.0 t -119.9 124.13 72.18 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.264 0 CA-C-O 121.063 0.459 . . . . 0.0 110.802 -177.609 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B ' 76' ' ' LEU . . . . . . . . . . . . . 5.7 mp -119.65 142.12 48.74 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 115.687 -0.688 . . . . 0.0 109.426 174.696 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B ' 77' ' ' GLU . . . . . . . . . . . . . 97.4 mt-10 -135.6 130.75 34.93 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-O 121.117 0.484 . . . . 0.0 111.011 -177.789 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B ' 78' ' ' ALA . . . . . . . . . . . . . . . -117.46 134.93 54.29 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 115.619 -0.718 . . . . 0.0 109.725 177.007 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B ' 79' ' ' LYS . . . . . 0.568 ' O ' HD13 ' B' ' 80' ' ' ILE . 90.0 mttt -75.49 115.87 15.61 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-O 120.903 0.382 . . . . 0.0 110.236 -179.041 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' B' B ' 80' ' ' ILE . . . . . 0.568 HD13 ' O ' ' B' ' 79' ' ' LYS . 44.0 mm -139.09 119.35 14.69 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.328 0 N-CA-C 109.346 -0.613 . . . . 0.0 109.346 -176.836 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' B' B ' 81' ' ' LYS . . . . . . . . . . . . . 60.0 tttm -117.92 129.67 55.76 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-O 120.924 0.392 . . . . 0.0 111.088 -176.964 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B ' 82' ' ' GLY . . . . . . . . . . . . . . . 88.96 42.13 5.73 Favored Glycine 0 CA--C 1.524 0.651 0 CA-C-N 115.883 -0.599 . . . . 0.0 112.089 175.687 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B ' 83' ' ' ILE . . . . . . . . . . . . . 73.9 mt -73.72 133.01 32.52 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.249 0 N-CA-C 109.229 -0.656 . . . . 0.0 109.229 175.398 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B ' 84' ' ' LYS . . . . . . . . . . . . . 38.4 ttpt -102.47 -45.1 5.17 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.567 -0.288 . . . . 0.0 110.567 -176.94 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B ' 85' ' ' ASP . . . . . . . . . . . . . 9.1 t70 -147.68 149.44 32.46 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.293 -0.412 . . . . 0.0 110.518 -179.914 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B ' 86' ' ' VAL . . . . . . . . . . . . . 40.3 t -130.79 134.55 61.71 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.251 0 CA-C-O 121.002 0.429 . . . . 0.0 110.485 -179.208 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B ' 87' ' ' ILE . . . . . 0.494 ' N ' HD12 ' B' ' 87' ' ' ILE . 5.0 mp -121.8 125.89 73.89 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.214 0 CA-C-N 115.841 -0.618 . . . . 0.0 109.385 176.51 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' B' B ' 88' ' ' LEU . . . . . 0.494 HD23 HH11 ' A' ' 126' ' ' ARG . 8.3 tp -117.91 134.19 55.18 Favored 'General case' 0 C--N 1.331 -0.224 0 CA-C-O 120.9 0.381 . . . . 0.0 111.088 -176.058 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' B' B ' 89' ' ' ASP . . . . . . . . . . . . . 12.4 t70 -134.84 160.12 39.24 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 115.948 -0.569 . . . . 0.0 109.859 177.943 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B ' 90' ' ' GLU . . . . . . . . . . . . . 95.6 mt-10 -48.14 -37.75 16.25 Favored 'General case' 0 C--N 1.331 -0.226 0 N-CA-C 112.991 0.737 . . . . 0.0 112.991 -171.637 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B ' 91' ' ' ASN . . . . . . . . . . . . . 12.2 m120 -130.01 22.35 5.33 Favored 'General case' 0 N--CA 1.468 0.468 0 N-CA-C 112.813 0.672 . . . . 0.0 112.813 -176.621 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B ' 92' ' ' LEU . . . . . . . . . . . . . 51.0 mt -148.45 141.23 24.63 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-O 120.773 0.32 . . . . 0.0 110.599 -178.237 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B ' 93' ' ' ILE . . . . . . . . . . . . . 73.2 mt -124.42 112.78 33.65 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.322 0 N-CA-C 108.858 -0.793 . . . . 0.0 108.858 176.195 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B ' 94' ' ' VAL . . . . . 0.432 HG21 HG21 ' B' ' 125' ' ' VAL . 46.1 t -116.58 127.85 74.09 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.284 0 CA-C-O 120.923 0.392 . . . . 0.0 110.038 -177.681 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' B' B ' 95' ' ' VAL . . . . . . . . . . . . . 42.3 t -121.08 132.7 69.86 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.388 0 CA-C-N 115.885 -0.598 . . . . 0.0 109.595 -179.556 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B ' 96' ' ' ILE . . . . . . . . . . . . . 72.4 mt -115.11 125.16 72.33 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.251 0 N-CA-C 109.192 -0.67 . . . . 0.0 109.192 178.259 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B ' 97' ' ' THR . . . . . . . . . . . . . 80.7 p -98.67 160.42 14.29 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-O 121.33 0.586 . . . . 0.0 111.302 -175.868 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B ' 98' ' ' GLU . . . . . . . . . . . . . 84.3 tt0 -53.84 -26.72 25.77 Favored 'General case' 0 C--N 1.327 -0.385 0 CA-C-N 115.683 -0.69 . . . . 0.0 112.249 179.843 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B ' 99' ' ' GLU . . . . . . . . . . . . . 69.4 mm-40 -79.04 11.59 2.67 Favored 'General case' 0 CA--C 1.536 0.432 0 N-CA-C 113.227 0.825 . . . . 0.0 113.227 -177.36 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B ' 100' ' ' ASN . . . . . . . . . . . . . 3.3 m-20 62.71 32.31 16.2 Favored 'General case' 0 CA--C 1.533 0.29 0 CA-C-N 118.233 0.469 . . . . 0.0 111.756 -179.796 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B ' 101' ' ' GLU . . . . . . . . . . . . . 84.2 tt0 -107.79 144.18 35.31 Favored 'General case' 0 C--N 1.332 -0.187 0 N-CA-C 109.714 -0.476 . . . . 0.0 109.714 171.559 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B ' 102' ' ' VAL . . . . . . . . . . . . . 44.5 t -116.28 126.49 73.78 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.246 0 N-CA-C 110.055 -0.35 . . . . 0.0 110.055 -178.957 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B ' 103' ' ' LEU . . . . . . . . . . . . . 63.7 mt -114.48 131.77 56.51 Favored 'General case' 0 C--N 1.331 -0.23 0 CA-C-N 115.641 -0.709 . . . . 0.0 109.58 178.112 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B ' 104' ' ' ILE . . . . . 0.476 HD12 ' HB3' ' B' ' 113' ' ' TYR . 62.3 mt -122.17 118.64 56.07 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.242 0 N-CA-C 110.293 -0.262 . . . . 0.0 110.293 -178.857 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' B' B ' 105' ' ' PHE . . . . . . . . . . . . . 41.3 m-85 -119.84 165.31 14.76 Favored 'General case' 0 C--N 1.331 -0.196 0 O-C-N 123.986 0.804 . . . . 0.0 109.717 178.032 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B ' 106' ' ' ASN . . . . . . . . . . . . . 46.8 p-10 -98.07 -169.89 1.89 Allowed 'General case' 0 C--N 1.329 -0.313 0 N-CA-C 109.664 -0.495 . . . . 0.0 109.664 172.591 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B ' 107' ' ' GLN . . . . . . . . . . . . . 28.0 tt0 -59.83 -30.21 68.78 Favored 'General case' 0 C--N 1.329 -0.29 0 N-CA-C 111.938 0.347 . . . . 0.0 111.938 -179.905 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B ' 108' ' ' ASN . . . . . . . . . . . . . 14.8 t-20 -83.59 9.32 11.74 Favored 'General case' 0 CA--C 1.538 0.515 0 N-CA-C 113.09 0.774 . . . . 0.0 113.09 -178.354 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B ' 109' ' ' LEU . . . . . . . . . . . . . 9.2 tp 60.38 36.32 20.41 Favored 'General case' 0 C--N 1.332 -0.179 0 CA-C-O 120.918 0.39 . . . . 0.0 111.495 178.921 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B ' 110' ' ' GLU . . . . . . . . . . . . . 70.7 mm-40 -105.65 149.82 26.0 Favored 'General case' 0 C--N 1.33 -0.24 0 N-CA-C 109.978 -0.378 . . . . 0.0 109.978 177.094 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B ' 111' ' ' GLU . . . . . . . . . . . . . 47.2 mp0 -76.86 126.41 30.93 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-O 121.035 0.445 . . . . 0.0 111.357 -177.249 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B ' 112' ' ' LEU . . . . . . . . . . . . . 39.5 mt -110.07 -46.05 3.51 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 115.821 -0.627 . . . . 0.0 109.967 174.974 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B ' 113' ' ' TYR . . . . . 0.476 ' HB3' HD12 ' B' ' 104' ' ' ILE . 65.5 t80 -143.62 140.52 30.17 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 115.975 -0.557 . . . . 0.0 111.134 179.752 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' B' B ' 114' ' ' ARG . . . . . . . . . . . . . 93.2 mtt180 -139.51 125.66 19.98 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.54 173.665 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B ' 115' ' ' GLY . . . . . . . . . . . . . . . -150.16 162.92 29.36 Favored Glycine 0 CA--C 1.524 0.623 0 N-CA-C 111.083 -0.807 . . . . 0.0 111.083 179.491 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B ' 116' ' ' LYS . . . . . . . . . . . . . 87.6 tttt -131.22 135.14 47.12 Favored 'General case' 0 C--N 1.33 -0.277 0 N-CA-C 109.832 -0.432 . . . . 0.0 109.832 177.412 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B ' 117' ' ' PHE . . . . . . . . . . . . . 33.4 m-85 -136.46 114.16 11.12 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.327 -0.397 . . . . 0.0 110.393 -174.789 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B ' 118' ' ' GLU . . . . . . . . . . . . . 83.4 tt0 -52.3 -47.68 65.8 Favored 'General case' 0 C--N 1.327 -0.408 0 CA-C-N 116.475 -0.33 . . . . 0.0 111.618 -176.999 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B ' 119' ' ' ASN . . . . . . . . . . . . . 50.3 m-80 -97.4 30.94 2.66 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.192 -0.458 . . . . 0.0 112.175 -173.826 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B ' 120' ' ' LEU . . . . . . . . . . . . . 12.8 tp -57.15 122.31 12.11 Favored 'General case' 0 C--N 1.332 -0.19 0 C-N-CA 120.987 -0.285 . . . . 0.0 110.318 177.98 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B ' 121' ' ' ASN . . . . . . . . . . . . . 26.3 m120 -113.29 -44.2 3.27 Favored 'General case' 0 C--O 1.232 0.162 0 CA-C-N 116.652 -0.249 . . . . 0.0 111.101 -176.965 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B ' 122' ' ' LYS . . . . . . . . . . . . . 97.1 mttt -148.22 150.65 34.11 Favored 'General case' 0 C--N 1.331 -0.208 0 CA-C-O 121.061 0.458 . . . . 0.0 111.701 -178.684 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B ' 123' ' ' VAL . . . . . . . . . . . . . 43.9 t -127.38 129.09 70.58 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.233 0 N-CA-C 109.447 -0.575 . . . . 0.0 109.447 174.716 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B ' 124' ' ' LEU . . . . . 0.403 ' N ' HD12 ' B' ' 124' ' ' LEU . 6.1 mp -122.06 134.57 54.78 Favored 'General case' 0 C--N 1.332 -0.184 0 CA-C-O 120.863 0.363 . . . . 0.0 110.757 -178.538 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' B' B ' 125' ' ' VAL . . . . . 0.432 HG21 HG21 ' B' ' 94' ' ' VAL . 43.2 t -125.28 128.23 72.59 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.283 0 CA-C-N 115.933 -0.576 . . . . 0.0 109.765 178.21 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' B' B ' 126' ' ' ARG . . . . . . . . . . . . . 30.5 ttm180 -149.15 122.01 8.74 Favored 'General case' 0 C--N 1.33 -0.276 0 N-CA-C 109.809 -0.441 . . . . 0.0 109.809 178.368 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B ' 127' ' ' ASN . . . . . . . . . . . . . 76.9 m-20 56.37 -151.55 0.4 Allowed 'General case' 0 CA--C 1.541 0.609 0 N-CA-C 109.771 -0.455 . . . . 0.0 109.771 179.742 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B ' 128' ' ' ASP . . . . . . . . . . . . . 19.7 p-10 -80.18 15.43 1.54 Allowed 'General case' 0 CA--C 1.535 0.383 0 N-CA-C 112.861 0.689 . . . . 0.0 112.861 178.797 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B ' 129' ' ' LEU . . . . . . . . . . . . . 15.6 tp -111.84 133.66 53.9 Favored 'General case' 0 C--O 1.232 0.133 0 O-C-N 122.0 -0.438 . . . . 0.0 110.287 179.158 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B ' 130' ' ' VAL . . . . . . . . . . . . . 47.7 t -121.91 135.3 62.47 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.222 0 N-CA-C 109.759 -0.46 . . . . 0.0 109.759 -179.953 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B ' 131' ' ' VAL . . . . . . . . . . . . . 42.8 t -134.83 135.62 52.95 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.253 0 CA-C-O 121.029 0.442 . . . . 0.0 110.594 -179.533 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B ' 132' ' ' ILE . . . . . . . . . . . . . 73.1 mt -117.51 132.69 66.57 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.26 0 CA-C-N 115.676 -0.693 . . . . 0.0 109.392 178.84 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B ' 133' ' ' ILE . . . . . . . . . . . . . 44.6 mm -116.34 122.32 69.49 Favored 'Isoleucine or valine' 0 C--O 1.234 0.251 0 CA-C-N 116.55 -0.296 . . . . 0.0 110.931 -176.014 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B ' 134' ' ' ASP . . . . . . . . . . . . . 7.2 p-10 -133.0 146.7 52.01 Favored 'General case' 0 C--N 1.33 -0.258 0 N-CA-C 109.714 -0.476 . . . . 0.0 109.714 174.628 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B ' 135' ' ' GLU . . . . . . . . . . . . . 84.7 tt0 -49.87 -26.27 3.91 Favored 'General case' 0 C--N 1.326 -0.445 0 N-CA-C 112.916 0.71 . . . . 0.0 112.916 -173.321 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B ' 136' ' ' GLN . . . . . . . . . . . . . 61.4 tt0 -84.55 -32.4 23.86 Favored 'General case' 0 C--N 1.331 -0.231 0 N-CA-C 112.42 0.526 . . . . 0.0 112.42 -175.488 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B ' 137' ' ' LYS . . . . . . . . . . . . . 18.1 pttp -168.64 172.74 7.81 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-O 121.436 0.636 . . . . 0.0 112.245 -172.536 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B ' 138' ' ' LEU . . . . . 0.426 HD23 ' N ' ' B' ' 139' ' ' THR . 5.3 tt -117.72 130.1 56.11 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 115.113 -0.948 . . . . 0.0 110.025 -179.217 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' B' B ' 139' ' ' THR . . . . . 0.426 ' N ' HD23 ' B' ' 138' ' ' LEU . 42.2 m -111.53 126.74 55.3 Favored 'General case' 0 C--N 1.331 -0.223 0 CA-C-N 116.147 -0.479 . . . . 0.0 110.384 179.833 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' B' B ' 140' ' ' LEU . . . . . 0.473 HD23 ' N ' ' B' ' 141' ' ' ILE . 5.6 tt -114.18 124.02 51.03 Favored 'General case' 0 C--N 1.329 -0.322 0 N-CA-C 109.261 -0.644 . . . . 0.0 109.261 -179.65 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' B' B ' 141' ' ' ILE . . . . . 0.473 ' N ' HD23 ' B' ' 140' ' ' LEU . 19.1 mt -121.94 125.71 73.53 Favored 'Isoleucine or valine' 0 C--O 1.234 0.266 0 CA-C-O 120.818 0.342 . . . . 0.0 110.15 -173.783 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' B' B ' 142' ' ' ARG . . . . . . . . . . . . . 72.0 mtm180 -114.23 133.94 55.27 Favored 'General case' 0 C--O 1.233 0.233 0 CA-C-N 115.66 -0.7 . . . . 0.0 109.82 -179.267 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B ' 143' ' ' THR . . . . . . . . . . . . . 60.6 p . . . . . 0 C--O 1.219 -0.514 0 CA-C-O 117.957 -1.02 . . . . 0.0 110.449 179.207 . . . . . . . . 0 0 . 1 . 005 nuclear nobuild core ' C' C ' 2' ' ' SER . . . . . . . . . . . . . 2.9 p . . . . . 0 C--O 1.232 0.173 0 CA-C-O 120.862 0.363 . . . . 0.0 110.329 . . . . . . . . . 0 0 . 1 . 005 nuclear nobuild core ' C' C ' 3' ' ' GLU . . . . . . . . . . . . . 94.2 mt-10 -138.51 141.54 39.36 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 115.902 -0.59 . . . . 0.0 110.721 -176.769 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' C' C ' 4' ' ' LEU . . . . . . . . . . . . . 25.2 tp -126.37 126.73 44.36 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.054 -0.521 . . . . 0.0 110.039 176.198 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' C' C ' 5' ' ' LYS . . . . . . . . . . . . . 62.7 mttp -103.83 120.96 42.07 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.508 -0.315 . . . . 0.0 110.647 179.354 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' C' C ' 6' ' ' LEU . . . . . . . . . . . . . 43.1 mt -116.79 143.03 46.16 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 115.536 -0.756 . . . . 0.0 110.556 -178.598 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' C' C ' 7' ' ' LYS . . . . . . . . . . . . . 54.8 tttm -134.3 139.58 33.31 Favored Pre-proline 0 CA--C 1.534 0.349 0 CA-C-O 119.117 -0.468 . . . . 0.0 109.997 176.164 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' C' C ' 8' ' ' PRO . . . . . . . . . . . . . 88.7 Cg_endo -91.94 143.79 2.81 Favored 'Trans proline' 0 N--CA 1.491 1.35 0 C-N-CA 121.721 1.614 . . . . 0.0 111.888 177.812 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' C' C ' 9' ' ' LEU . . . . . . . . . . . . . 63.9 mt -79.2 -48.28 1.55 Allowed Pre-proline 0 CA--C 1.535 0.385 0 CA-C-O 118.638 -0.696 . . . . 0.0 112.242 -179.93 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' C' C ' 10' ' ' PRO . . . . . . . . . . . . . 94.0 Cg_endo -79.51 153.78 23.82 Favored 'Trans proline' 0 N--CA 1.497 1.697 0 C-N-CA 121.149 1.232 . . . . 0.0 111.819 176.949 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' C' C ' 11' ' ' LYS . . . . . . . . . . . . . 51.6 tptt -87.19 96.64 10.39 Favored 'General case' 0 C--N 1.331 -0.226 0 CA-C-N 116.373 -0.376 . . . . 0.0 110.315 178.861 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' C' C ' 12' ' ' VAL . . . . . . . . . . . . . 12.0 p -143.86 143.44 23.93 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.284 0 CA-C-N 116.219 -0.446 . . . . 0.0 110.462 179.019 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' C' C ' 13' ' ' GLU . . . . . . . . . . . . . 12.8 pt-20 -88.09 128.15 35.42 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.351 -0.386 . . . . 0.0 110.296 177.751 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' C' C ' 14' ' ' LEU . . . . . . . . . . . . . 24.4 mt -98.22 153.01 38.26 Favored Pre-proline 0 C--N 1.329 -0.291 0 CA-C-N 116.232 -0.44 . . . . 0.0 110.369 -178.473 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' C' C ' 15' ' ' PRO . . . . . . . . . . . . . 33.6 Cg_exo -59.66 159.97 22.52 Favored 'Trans proline' 0 N--CA 1.495 1.616 0 C-N-CA 121.31 1.34 . . . . 0.0 111.621 178.082 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' C' C ' 16' ' ' PRO . . . . . . . . . . . . . 32.2 Cg_exo -59.42 -32.56 96.68 Favored 'Trans proline' 0 N--CA 1.498 1.743 0 C-N-CA 121.435 1.423 . . . . 0.0 112.714 -177.855 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' C' C ' 17' ' ' ASP . . . . . . . . . . . . . 9.5 p-10 -94.13 9.96 35.7 Favored 'General case' 0 CA--C 1.535 0.388 0 N-CA-C 113.211 0.819 . . . . 0.0 113.211 -177.301 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' C' C ' 18' ' ' PHE . . . . . . . . . . . . . 48.9 t80 -58.13 -42.67 86.33 Favored 'General case' 0 C--O 1.231 0.091 0 O-C-N 121.987 -0.446 . . . . 0.0 110.111 -178.511 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' C' C ' 19' ' ' VAL . . . . . . . . . . . . . 48.7 t -57.7 -42.13 80.96 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.352 0 CA-C-N 116.332 -0.395 . . . . 0.0 110.311 -179.311 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' C' C ' 20' ' ' ASP . . . . . . . . . . . . . 13.6 t70 -60.64 -42.09 96.22 Favored 'General case' 0 C--N 1.329 -0.304 0 C-N-CA 120.988 -0.285 . . . . 0.0 110.99 -178.642 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' C' C ' 21' ' ' VAL . . . . . . . . . . . . . 47.5 t -64.04 -47.56 89.8 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.284 0 C-N-CA 120.713 -0.395 . . . . 0.0 110.38 -177.973 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' C' C ' 22' ' ' ILE . . . . . 0.507 HG22 HD12 ' C' ' 26' ' ' LEU . 51.0 mm -56.67 -43.99 80.28 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.279 0 CA-C-O 120.668 0.27 . . . . 0.0 110.456 178.689 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' C' C ' 23' ' ' ARG . . . . . . . . . . . . . 60.3 ttp180 -54.11 -49.03 70.08 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-O 120.627 0.251 . . . . 0.0 111.419 -179.373 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' C' C ' 24' ' ' ILE . . . . . . . . . . . . . 75.7 mt -59.96 -42.35 89.2 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.295 0 CA-C-N 116.592 -0.276 . . . . 0.0 111.003 -178.348 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' C' C ' 25' ' ' LYS . . . . . . . . . . . . . 54.9 mtmt -67.2 -36.49 81.85 Favored 'General case' 0 C--N 1.328 -0.355 0 N-CA-C 112.299 0.481 . . . . 0.0 112.299 -179.088 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' C' C ' 26' ' ' LEU . . . . . 0.507 HD12 HG22 ' C' ' 22' ' ' ILE . 46.9 mt -77.74 -43.62 30.33 Favored 'General case' 0 C--N 1.33 -0.26 0 N-CA-C 112.899 0.703 . . . . 0.0 112.899 -172.373 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' C' C ' 27' ' ' GLN . . . . . . . . . . . . . 10.6 pt20 -46.91 138.13 6.68 Favored 'General case' 0 N--CA 1.47 0.539 0 N-CA-C 112.564 0.579 . . . . 0.0 112.564 -175.673 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' C' C ' 28' ' ' GLY . . . . . . . . . . . . . . . 100.6 -26.12 25.79 Favored Glycine 0 CA--C 1.533 1.172 0 CA-C-N 115.645 -0.707 . . . . 0.0 112.174 -176.652 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' C' C ' 29' ' ' LYS . . . . . . . . . . . . . 60.3 mmtt -98.06 155.17 17.25 Favored 'General case' 0 C--O 1.232 0.145 0 CA-C-N 117.257 0.529 . . . . 0.0 111.174 178.327 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' C' C ' 30' ' ' THR . . . . . . . . . . . . . 37.7 m -105.94 136.4 45.66 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 115.807 -0.633 . . . . 0.0 109.561 174.26 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' C' C ' 31' ' ' VAL . . . . . . . . . . . . . 34.9 m -127.4 153.75 36.97 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.234 0 CA-C-O 121.172 0.51 . . . . 0.0 111.169 -176.442 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' C' C ' 32' ' ' ARG . . . . . . . . . . . . . 78.2 mtm180 -130.53 150.07 51.91 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 115.537 -0.756 . . . . 0.0 110.26 178.663 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' C' C ' 33' ' ' THR . . . . . . . . . . . . . 24.3 m -53.68 138.95 33.74 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-N 116.453 -0.34 . . . . 0.0 111.285 -178.863 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' C' C ' 34' ' ' GLY . . . . . . . . . . . . . . . 101.0 -17.14 56.66 Favored Glycine 0 CA--C 1.532 1.154 0 CA-C-O 119.621 -0.544 . . . . 0.0 113.306 179.209 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' C' C ' 35' ' ' ASP . . . . . . . . . . . . . 72.5 m-20 -65.25 148.41 51.73 Favored 'General case' 0 C--O 1.232 0.166 0 CA-C-N 118.054 0.927 . . . . 0.0 111.069 179.421 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' C' C ' 36' ' ' VAL . . . . . . . . . . . . . 43.8 t -122.42 131.68 72.69 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.237 0 CA-C-N 115.933 -0.576 . . . . 0.0 109.871 179.111 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' C' C ' 37' ' ' ILE . . . . . . . . . . . . . 67.1 mt -121.06 138.16 52.4 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 CA-C-N 116.114 -0.494 . . . . 0.0 109.902 179.794 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' C' C ' 38' ' ' GLY . . . . . . . . . . . . . . . -112.42 128.63 8.59 Favored Glycine 0 CA--C 1.525 0.692 0 N-CA-C 111.071 -0.812 . . . . 0.0 111.071 179.562 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' C' C ' 39' ' ' ILE . . . . . . . . . . . . . 74.7 mt -124.85 137.13 58.53 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.184 0 N-CA-C 110.128 -0.323 . . . . 0.0 110.128 179.449 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' C' C ' 40' ' ' SER . . . . . . . . . . . . . 41.4 t -92.44 114.06 26.51 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 116.445 -0.343 . . . . 0.0 110.755 176.213 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' C' C ' 41' ' ' ILE . . . . . . . . . . . . . 42.7 mm -119.99 120.67 63.84 Favored 'Isoleucine or valine' 0 N--CA 1.462 0.167 0 CA-C-O 120.737 0.304 . . . . 0.0 110.59 179.879 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' C' C ' 42' ' ' LEU . . . . . . . . . . . . . 47.3 mt 51.85 34.84 14.17 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-N 116.308 -0.405 . . . . 0.0 111.856 176.435 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' C' C ' 43' ' ' GLY . . . . . . . . . . . . . . . 72.88 33.24 60.17 Favored Glycine 0 CA--C 1.529 0.907 0 C-N-CA 121.017 -0.611 . . . . 0.0 111.961 178.665 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' C' C ' 44' ' ' LYS . . . . . . . . . . . . . 55.6 tptt -140.7 129.61 23.2 Favored 'General case' 0 C--N 1.33 -0.268 0 N-CA-C 109.4 -0.593 . . . . 0.0 109.4 178.622 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' C' C ' 45' ' ' GLU . . . . . . . . . . . . . 83.6 tt0 -81.71 119.39 23.78 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-O 120.928 0.394 . . . . 0.0 110.658 -177.782 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' C' C ' 46' ' ' VAL . . . . . . . . . . . . . 7.4 p -117.56 127.06 75.03 Favored 'Isoleucine or valine' 0 C--N 1.333 -0.12 0 N-CA-C 109.303 -0.629 . . . . 0.0 109.303 176.765 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' C' C ' 47' ' ' LYS . . . . . . . . . . . . . 68.0 mttm -100.37 127.36 46.7 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 115.827 -0.624 . . . . 0.0 111.001 179.312 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' C' C ' 48' ' ' PHE . . . . . . . . . . . . . 93.8 m-85 -109.94 131.92 54.62 Favored 'General case' 0 C--N 1.328 -0.347 0 N-CA-C 109.81 -0.441 . . . . 0.0 109.81 175.632 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' C' C ' 49' ' ' LYS . . . . . . . . . . . . . 85.6 tttt -107.75 135.63 48.84 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.437 -0.347 . . . . 0.0 110.385 178.857 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' C' C ' 50' ' ' VAL . . . . . . . . . . . . . 44.6 t -79.76 107.25 11.97 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 N-CA-C 109.198 -0.668 . . . . 0.0 109.198 176.261 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' C' C ' 51' ' ' VAL . . . . . . . . . . . . . 48.4 t -70.36 -46.96 68.97 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.316 0 N-CA-C 109.856 -0.424 . . . . 0.0 109.856 -174.339 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' C' C ' 52' ' ' GLN . . . . . . . . . . . . . 37.4 tt0 -167.14 142.44 4.09 Favored 'General case' 0 C--N 1.33 -0.241 0 C-N-CA 120.314 -0.554 . . . . 0.0 111.711 -179.887 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' C' C ' 53' ' ' ALA . . . . . . . . . . . . . . . -114.69 133.79 55.6 Favored 'General case' 0 C--N 1.331 -0.227 0 CA-C-N 115.761 -0.654 . . . . 0.0 109.745 175.113 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' C' C ' 54' ' ' TYR . . . . . . . . . . . . . 64.2 t80 -129.08 112.81 18.5 Favored Pre-proline 0 CA--C 1.534 0.348 0 CA-C-O 118.259 -0.877 . . . . 0.0 110.52 -179.963 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' C' C ' 55' ' ' PRO . . . . . . . . . . . . . 73.4 Cg_endo -77.18 168.19 77.58 Favored 'Cis proline' 0 N--CA 1.501 1.964 0 CA-C-N 122.05 1.768 . . . . 0.0 112.083 -7.607 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' C' C ' 56' ' ' SER . . . . . . . . . . . . . 14.0 m -117.22 140.42 27.16 Favored Pre-proline 0 CA--C 1.539 0.52 0 CA-C-O 118.599 -0.715 . . . . 0.0 109.828 174.518 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' C' C ' 57' ' ' PRO . . . . . . . . . . . . . 51.5 Cg_endo -70.82 144.2 78.18 Favored 'Cis proline' 0 N--CA 1.498 1.742 0 CA-C-N 121.575 1.598 . . . . 0.0 111.2 -3.742 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' C' C ' 58' ' ' LEU . . . . . . . . . . . . . 16.9 tp -107.49 135.88 48.22 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-O 120.796 0.331 . . . . 0.0 110.981 -176.199 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' C' C ' 59' ' ' ARG . . . . . . . . . . . . . 55.7 ttt180 -101.68 126.06 48.45 Favored 'General case' 0 C--N 1.327 -0.405 0 N-CA-C 109.15 -0.685 . . . . 0.0 109.15 174.254 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' C' C ' 60' ' ' VAL . . . . . . . . . . . . . 42.5 t -83.65 124.48 39.69 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.264 0 C-N-CA 120.64 -0.424 . . . . 0.0 110.549 -175.426 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' C' C ' 61' ' ' GLU . . . . . . . . . . . . . 95.6 mt-10 -129.02 170.74 13.1 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 115.68 -0.691 . . . . 0.0 109.881 177.238 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' C' C ' 62' ' ' ASP . . . . . . . . . . . . . 81.6 m-20 -54.81 -32.51 60.45 Favored 'General case' 0 C--N 1.327 -0.372 0 C-N-CA 121.048 -0.261 . . . . 0.0 111.695 -178.877 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' C' C ' 63' ' ' ARG . . . . . . . . . . . . . 9.2 ptm180 -86.73 6.21 32.47 Favored 'General case' 0 CA--C 1.536 0.415 0 N-CA-C 113.623 0.972 . . . . 0.0 113.623 -175.474 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' C' C ' 64' ' ' THR . . . . . . . . . . . . . 19.8 m -73.36 135.91 44.34 Favored 'General case' 0 C--N 1.332 -0.186 0 CA-C-N 118.138 0.427 . . . . 0.0 110.799 -177.814 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' C' C ' 65' ' ' LYS . . . . . . . . . . . . . 25.3 mtpp -89.94 119.21 30.11 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.098 -0.501 . . . . 0.0 110.001 178.062 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' C' C ' 66' ' ' ILE . . . . . . . . . . . . . 65.6 mt -114.56 131.18 67.41 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.277 0 CA-C-O 120.83 0.348 . . . . 0.0 110.07 -178.681 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' C' C ' 67' ' ' THR . . . . . . . . . . . . . 21.3 m -123.01 134.65 54.3 Favored 'General case' 0 C--N 1.331 -0.224 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.478 -179.253 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' C' C ' 68' ' ' LEU . . . . . . . . . . . . . 21.5 tp . . . . . 0 C--N 1.33 -0.275 0 CA-C-N 115.876 -0.602 . . . . 0.0 110.802 -179.809 . . . . . . . . 0 0 . 1 . 005 nuclear nobuild core ' C' C ' 73' ' ' VAL . . . . . . . . . . . . . 33.0 m . . . . . 0 C--O 1.233 0.236 0 N-CA-C 109.243 -0.651 . . . . 0.0 109.243 . . . . . . . . . 0 0 . 1 . 005 nuclear nobuild core ' C' C ' 74' ' ' ASP . . . . . . . . . . . . . 7.4 t0 -89.13 114.88 26.2 Favored 'General case' 0 C--N 1.331 -0.211 0 N-CA-C 109.09 -0.707 . . . . 0.0 109.09 -178.753 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' C' C ' 75' ' ' VAL . . . . . . . . . . . . . 42.3 t -124.52 122.0 62.85 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.266 0 CA-C-O 121.054 0.454 . . . . 0.0 110.652 -175.109 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' C' C ' 76' ' ' LEU . . . . . 0.455 ' N ' HD12 ' C' ' 76' ' ' LEU . 6.4 mp -118.92 144.54 46.37 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 115.584 -0.735 . . . . 0.0 109.378 175.332 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' C' C ' 77' ' ' GLU . . . . . . . . . . . . . 96.3 mt-10 -134.07 137.49 44.68 Favored 'General case' 0 C--N 1.331 -0.219 0 CA-C-O 120.998 0.428 . . . . 0.0 111.081 -177.653 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' C' C ' 78' ' ' ALA . . . . . 0.579 ' HB2' HD21 ' C' ' 109' ' ' LEU . . . -125.1 135.69 52.93 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 115.738 -0.665 . . . . 0.0 109.79 176.568 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' C' C ' 79' ' ' LYS . . . . . 0.598 ' O ' HD13 ' C' ' 80' ' ' ILE . 61.6 mmtt -78.0 118.5 20.35 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-O 121.002 0.43 . . . . 0.0 110.949 -177.815 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' C' C ' 80' ' ' ILE . . . . . 0.598 HD13 ' O ' ' C' ' 79' ' ' LYS . 41.5 mm -139.1 106.55 2.96 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.327 0 N-CA-C 109.107 -0.701 . . . . 0.0 109.107 -178.951 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' C' C ' 81' ' ' LYS . . . . . . . . . . . . . 99.4 mttt -100.2 127.34 46.48 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-O 120.928 0.394 . . . . 0.0 110.949 -178.145 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' C' C ' 82' ' ' GLY . . . . . . . . . . . . . . . 89.04 42.1 5.71 Favored Glycine 0 CA--C 1.524 0.634 0 C-N-CA 120.968 -0.634 . . . . 0.0 111.722 176.057 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' C' C ' 83' ' ' ILE . . . . . . . . . . . . . 72.5 mt -66.47 137.26 25.21 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.321 0 N-CA-C 109.634 -0.506 . . . . 0.0 109.634 176.339 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' C' C ' 84' ' ' LYS . . . . . . . . . . . . . 39.6 ttpt -101.02 -50.66 3.74 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-O 120.894 0.378 . . . . 0.0 110.389 -179.066 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' C' C ' 85' ' ' ASP . . . . . . . . . . . . . 12.7 t70 -152.44 151.1 30.37 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.078 -0.51 . . . . 0.0 110.783 -179.894 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' C' C ' 86' ' ' VAL . . . . . . . . . . . . . 42.4 t -128.15 131.19 69.54 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.222 0 CA-C-O 120.895 0.379 . . . . 0.0 110.261 179.362 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' C' C ' 87' ' ' ILE . . . . . 0.5 ' N ' HD12 ' C' ' 87' ' ' ILE . 5.0 mp -122.98 131.58 73.01 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.251 0 CA-C-N 116.178 -0.464 . . . . 0.0 109.781 178.884 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' C' C ' 88' ' ' LEU . . . . . . . . . . . . . 80.8 mt -109.31 139.61 44.04 Favored 'General case' 0 C--N 1.331 -0.212 0 CA-C-O 121.03 0.443 . . . . 0.0 111.181 -179.354 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' C' C ' 89' ' ' ASP . . . . . . . . . . . . . 13.6 t70 -129.23 156.25 44.26 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 115.667 -0.697 . . . . 0.0 109.624 177.562 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' C' C ' 90' ' ' GLU . . . . . . . . . . . . . 85.3 tt0 -45.93 -38.77 7.93 Favored 'General case' 0 CA--C 1.532 0.265 0 N-CA-C 113.101 0.778 . . . . 0.0 113.101 -172.151 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' C' C ' 91' ' ' ASN . . . . . . . . . . . . . 78.9 m-20 -132.07 21.48 4.49 Favored 'General case' 0 N--CA 1.469 0.485 0 N-CA-C 112.799 0.666 . . . . 0.0 112.799 -178.035 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' C' C ' 92' ' ' LEU . . . . . . . . . . . . . 40.4 mt -150.59 152.26 33.81 Favored 'General case' 0 C--N 1.331 -0.217 0 CA-C-O 120.997 0.427 . . . . 0.0 110.678 -176.423 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' C' C ' 93' ' ' ILE . . . . . . . . . . . . . 69.8 mt -125.35 123.33 64.79 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.335 0 N-CA-C 109.141 -0.689 . . . . 0.0 109.141 175.727 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' C' C ' 94' ' ' VAL . . . . . . . . . . . . . 42.3 t -119.74 128.78 75.91 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.284 0 CA-C-O 120.964 0.411 . . . . 0.0 110.079 -179.192 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' C' C ' 95' ' ' VAL . . . . . . . . . . . . . 45.5 t -120.48 134.18 64.78 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.322 0 CA-C-N 115.94 -0.573 . . . . 0.0 109.655 179.89 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' C' C ' 96' ' ' ILE . . . . . . . . . . . . . 66.9 mt -115.59 127.05 73.3 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.309 0 N-CA-C 109.283 -0.636 . . . . 0.0 109.283 178.845 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' C' C ' 97' ' ' THR . . . . . . . . . . . . . 68.6 p -100.87 158.22 16.14 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-O 121.139 0.495 . . . . 0.0 111.115 -176.819 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' C' C ' 98' ' ' GLU . . . . . . . . . . . . . 84.6 tt0 -53.85 -26.31 23.87 Favored 'General case' 0 CA--C 1.534 0.335 0 CA-C-N 116.22 -0.445 . . . . 0.0 112.172 179.861 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' C' C ' 99' ' ' GLU . . . . . . . . . . . . . 18.2 tp10 -76.8 9.97 2.52 Favored 'General case' 0 CA--C 1.538 0.517 0 N-CA-C 113.007 0.743 . . . . 0.0 113.007 -177.929 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' C' C ' 100' ' ' ASN . . . . . . . . . . . . . 3.6 m-20 63.32 33.48 13.96 Favored 'General case' 0 N--CA 1.464 0.258 0 O-C-N 121.984 -0.447 . . . . 0.0 111.57 -179.812 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' C' C ' 101' ' ' GLU . . . . . . . . . . . . . 84.7 tt0 -108.64 143.99 36.97 Favored 'General case' 0 C--N 1.332 -0.167 0 N-CA-C 109.666 -0.494 . . . . 0.0 109.666 172.038 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' C' C ' 102' ' ' VAL . . . . . . . . . . . . . 46.9 t -115.61 126.1 73.03 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.27 0 N-CA-C 109.72 -0.474 . . . . 0.0 109.72 -177.958 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' C' C ' 103' ' ' LEU . . . . . . . . . . . . . 30.9 mt -117.3 130.77 56.76 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-N 115.856 -0.611 . . . . 0.0 110.334 177.845 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' C' C ' 104' ' ' ILE . . . . . 0.449 HD13 HG21 ' C' ' 130' ' ' VAL . 64.0 mt -118.28 121.29 66.82 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.207 0 N-CA-C 110.07 -0.345 . . . . 0.0 110.07 179.383 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' C' C ' 105' ' ' PHE . . . . . . . . . . . . . 45.4 m-85 -121.63 167.55 12.78 Favored 'General case' 0 C--N 1.332 -0.182 0 O-C-N 123.851 0.719 . . . . 0.0 109.883 177.993 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' C' C ' 106' ' ' ASN . . . . . . . . . . . . . 45.2 p-10 -97.29 -169.93 1.93 Allowed 'General case' 0 C--N 1.331 -0.209 0 N-CA-C 109.879 -0.415 . . . . 0.0 109.879 173.677 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' C' C ' 107' ' ' GLN . . . . . . . . . . . . . 48.9 tt0 -59.57 -30.13 68.43 Favored 'General case' 0 CA--C 1.532 0.251 0 N-CA-C 111.9 0.333 . . . . 0.0 111.9 179.84 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' C' C ' 108' ' ' ASN . . . . . . . . . . . . . 51.6 t30 -83.78 9.85 10.91 Favored 'General case' 0 CA--C 1.536 0.424 0 N-CA-C 113.062 0.764 . . . . 0.0 113.062 -178.195 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' C' C ' 109' ' ' LEU . . . . . 0.579 HD21 ' HB2' ' C' ' 78' ' ' ALA . 8.0 tp 59.85 36.29 21.93 Favored 'General case' 0 C--N 1.331 -0.223 0 CA-C-O 120.853 0.359 . . . . 0.0 111.366 179.085 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' C' C ' 110' ' ' GLU . . . . . . . . . . . . . 96.0 mt-10 -103.38 150.1 24.13 Favored 'General case' 0 C--N 1.33 -0.26 0 N-CA-C 109.957 -0.386 . . . . 0.0 109.957 176.06 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' C' C ' 111' ' ' GLU . . . . . . . . . . . . . 71.6 tt0 -81.98 121.99 27.21 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-O 120.886 0.374 . . . . 0.0 111.111 -174.713 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' C' C ' 112' ' ' LEU . . . . . . . . . . . . . 34.1 mt -107.08 -46.09 3.99 Favored 'General case' 0 C--N 1.331 -0.21 0 CA-C-N 116.16 -0.473 . . . . 0.0 110.76 178.049 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' C' C ' 113' ' ' TYR . . . . . . . . . . . . . 60.7 t80 -139.34 139.72 37.33 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.201 -0.454 . . . . 0.0 111.14 -178.047 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' C' C ' 114' ' ' ARG . . . . . . . . . . . . . 59.1 ttp180 -137.6 125.53 22.69 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 115.956 -0.565 . . . . 0.0 110.224 177.321 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' C' C ' 115' ' ' GLY . . . . . . . . . . . . . . . -149.98 153.25 24.98 Favored Glycine 0 CA--C 1.523 0.573 0 N-CA-C 110.262 -1.135 . . . . 0.0 110.262 178.505 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' C' C ' 116' ' ' LYS . . . . . . . . . . . . . 59.0 tttm -131.5 128.98 40.48 Favored 'General case' 0 C--N 1.329 -0.325 0 N-CA-C 109.65 -0.5 . . . . 0.0 109.65 179.388 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' C' C ' 117' ' ' PHE . . . . . . . . . . . . . 26.1 m-85 -132.91 117.64 17.94 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.329 -0.396 . . . . 0.0 110.029 -173.153 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' C' C ' 118' ' ' GLU . . . . . . . . . . . . . 95.8 mt-10 -55.18 -39.46 69.58 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.521 -0.308 . . . . 0.0 111.043 -177.774 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' C' C ' 119' ' ' ASN . . . . . . . . . . . . . 29.5 m120 -100.7 30.98 3.7 Favored 'General case' 0 C--N 1.33 -0.271 0 N-CA-C 112.229 0.455 . . . . 0.0 112.229 -173.896 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' C' C ' 120' ' ' LEU . . . . . . . . . . . . . 17.1 tp -57.76 122.56 13.14 Favored 'General case' 0 N--CA 1.462 0.16 0 C-N-CA 120.845 -0.342 . . . . 0.0 110.121 177.462 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' C' C ' 121' ' ' ASN . . . . . . . . . . . . . 21.9 t-20 -112.79 -44.03 3.36 Favored 'General case' 0 C--N 1.332 -0.183 0 CA-C-N 116.554 -0.294 . . . . 0.0 111.41 -175.968 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' C' C ' 122' ' ' LYS . . . . . . . . . . . . . 31.4 ttmt -158.57 151.04 21.84 Favored 'General case' 0 C--N 1.332 -0.188 0 C-N-CA 120.546 -0.462 . . . . 0.0 111.156 -176.721 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' C' C ' 123' ' ' VAL . . . . . 0.439 ' C ' HD12 ' C' ' 124' ' ' LEU . 41.9 t -122.42 131.91 72.22 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.218 0 CA-C-N 116.19 -0.459 . . . . 0.0 109.957 177.687 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' C' C ' 124' ' ' LEU . . . . . 0.463 HD12 ' N ' ' C' ' 124' ' ' LEU . 7.2 mp -116.76 133.67 55.74 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-N 116.147 -0.479 . . . . 0.0 109.999 179.28 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' C' C ' 125' ' ' VAL . . . . . . . . . . . . . 35.2 m -135.25 139.68 46.46 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.289 0 CA-C-O 120.843 0.354 . . . . 0.0 110.922 -179.479 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' C' C ' 126' ' ' ARG . . . . . . . . . . . . . 38.8 ttt180 -163.32 133.63 4.44 Favored 'General case' 0 C--N 1.329 -0.298 0 N-CA-C 109.525 -0.546 . . . . 0.0 109.525 177.015 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' C' C ' 127' ' ' ASN . . . . . . . . . . . . . 33.4 m120 56.85 -155.13 0.32 Allowed 'General case' 0 CA--C 1.538 0.503 0 N-CA-C 109.627 -0.508 . . . . 0.0 109.627 -177.843 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' C' C ' 128' ' ' ASP . . . . . . . . . . . . . 11.6 p-10 -82.31 16.92 1.84 Allowed 'General case' 0 CA--C 1.536 0.421 0 N-CA-C 112.642 0.608 . . . . 0.0 112.642 177.705 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' C' C ' 129' ' ' LEU . . . . . . . . . . . . . 49.3 mt -115.74 142.45 46.73 Favored 'General case' 0 C--O 1.231 0.116 0 O-C-N 122.077 -0.39 . . . . 0.0 110.279 179.723 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' C' C ' 130' ' ' VAL . . . . . 0.498 HG23 ' HB ' ' C' ' 141' ' ' ILE . 32.5 m -134.77 146.8 30.12 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.249 0 CA-C-O 120.986 0.422 . . . . 0.0 110.947 -179.333 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' C' C ' 131' ' ' VAL . . . . . 0.401 ' CG1' HD21 ' C' ' 138' ' ' LEU . 39.1 t -135.99 137.86 48.2 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.299 0 CA-C-N 116.087 -0.506 . . . . 0.0 110.157 178.43 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' C' C ' 132' ' ' ILE . . . . . . . . . . . . . 70.2 mt -112.96 131.75 63.68 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.357 0 N-CA-C 109.341 -0.614 . . . . 0.0 109.341 179.933 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' C' C ' 133' ' ' ILE . . . . . . . . . . . . . 36.6 mm -113.64 122.33 67.57 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.256 0 CA-C-O 120.837 0.351 . . . . 0.0 110.79 -176.15 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' C' C ' 134' ' ' ASP . . . . . . . . . . . . . 9.4 p-10 -132.97 150.06 52.19 Favored 'General case' 0 C--N 1.331 -0.222 0 CA-C-N 116.107 -0.497 . . . . 0.0 109.66 174.741 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' C' C ' 135' ' ' GLU . . . . . . . . . . . . . 40.3 tp10 -50.0 -29.02 7.79 Favored 'General case' 0 C--N 1.327 -0.398 0 N-CA-C 112.715 0.635 . . . . 0.0 112.715 -171.873 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' C' C ' 136' ' ' GLN . . . . . . . . . . . . . 99.6 mm-40 -85.87 -29.52 23.62 Favored 'General case' 0 C--N 1.33 -0.247 0 N-CA-C 112.896 0.702 . . . . 0.0 112.896 -174.086 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' C' C ' 137' ' ' LYS . . . . . . . . . . . . . 21.0 pttm -168.97 173.16 7.12 Favored 'General case' 0 C--O 1.234 0.242 0 CA-C-O 121.496 0.665 . . . . 0.0 112.477 -171.975 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' C' C ' 138' ' ' LEU . . . . . 0.431 HD23 ' C ' ' C' ' 138' ' ' LEU . 7.3 tt -120.71 129.38 53.63 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 115.088 -0.96 . . . . 0.0 109.869 179.594 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' C' C ' 139' ' ' THR . . . . . . . . . . . . . 38.0 m -109.76 128.5 55.33 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 116.112 -0.495 . . . . 0.0 110.444 179.703 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' C' C ' 140' ' ' LEU . . . . . 0.464 ' C ' HD23 ' C' ' 140' ' ' LEU . 5.9 tt -112.01 122.64 48.33 Favored 'General case' 0 C--N 1.329 -0.305 0 N-CA-C 109.039 -0.726 . . . . 0.0 109.039 -179.39 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' C' C ' 141' ' ' ILE . . . . . 0.498 ' HB ' HG23 ' C' ' 130' ' ' VAL . 19.5 mt -121.86 121.39 64.13 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.333 0 CA-C-O 120.98 0.419 . . . . 0.0 109.93 -176.298 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' C' C ' 142' ' ' ARG . . . . . . . . . . . . . 78.9 mtm180 . . . . . 0 C--N 1.329 -0.295 0 CA-C-N 115.463 -0.79 . . . . 0.0 110.169 -178.379 . . . . . . . . 0 0 . 1 . 005 nuclear nobuild core ' D' D ' 2' ' ' SER . . . . . . . . . . . . . 6.5 p . . . . . 0 N--CA 1.462 0.156 0 CA-C-O 120.774 0.321 . . . . 0.0 110.752 . . . . . . . . . 0 0 . 1 . 005 nuclear nobuild core ' D' D ' 3' ' ' GLU . . . . . . . . . . . . . 94.9 mt-10 -140.54 140.14 35.15 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.14 -0.482 . . . . 0.0 110.986 -179.044 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' D' D ' 4' ' ' LEU . . . . . . . . . . . . . 21.0 tp -126.31 128.01 46.46 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 116.129 -0.487 . . . . 0.0 110.223 176.912 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' D' D ' 5' ' ' LYS . . . . . . . . . . . . . 64.1 mttp -107.39 122.19 46.11 Favored 'General case' 0 C--O 1.234 0.274 0 CA-C-N 116.456 -0.338 . . . . 0.0 110.696 178.726 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' D' D ' 6' ' ' LEU . . . . . . . . . . . . . 73.3 mt -118.32 144.12 46.1 Favored 'General case' 0 C--N 1.331 -0.223 0 CA-C-N 115.683 -0.69 . . . . 0.0 110.778 -178.947 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' D' D ' 7' ' ' LYS . . . . . . . . . . . . . 59.3 tttm -133.95 141.76 40.91 Favored Pre-proline 0 CA--C 1.535 0.382 0 CA-C-O 119.12 -0.466 . . . . 0.0 110.158 176.727 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' D' D ' 8' ' ' PRO . . . . . . . . . . . . . 87.5 Cg_endo -91.52 140.64 2.57 Favored 'Trans proline' 0 N--CA 1.49 1.273 0 C-N-CA 121.748 1.632 . . . . 0.0 111.711 177.759 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' D' D ' 9' ' ' LEU . . . . . . . . . . . . . 53.5 mt -77.08 -48.06 2.6 Favored Pre-proline 0 CA--C 1.533 0.301 0 CA-C-O 118.799 -0.619 . . . . 0.0 112.464 -178.707 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' D' D ' 10' ' ' PRO . . . . . 0.42 ' CG ' HG23 ' D' ' 46' ' ' VAL . 85.2 Cg_endo -80.3 160.54 23.03 Favored 'Trans proline' 0 N--CA 1.495 1.605 0 C-N-CA 121.187 1.258 . . . . 0.0 112.071 176.92 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' D' D ' 11' ' ' LYS . . . . . . . . . . . . . 52.6 mttm -88.69 100.62 13.26 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.317 -0.402 . . . . 0.0 110.151 178.241 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' D' D ' 12' ' ' VAL . . . . . . . . . . . . . 12.9 p -145.77 147.34 18.53 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.263 0 CA-C-N 116.363 -0.38 . . . . 0.0 110.882 -178.888 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' D' D ' 13' ' ' GLU . . . . . . . . . . . . . 70.7 mm-40 -92.12 124.0 35.88 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.069 177.526 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' D' D ' 14' ' ' LEU . . . . . . . . . . . . . 36.4 mt -98.02 154.73 37.63 Favored Pre-proline 0 C--N 1.33 -0.258 0 CA-C-N 116.426 -0.352 . . . . 0.0 110.958 -177.88 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' D' D ' 15' ' ' PRO . . . . . . . . . . . . . 28.7 Cg_exo -60.6 154.82 51.74 Favored 'Trans proline' 0 N--CA 1.496 1.661 0 C-N-CA 121.405 1.403 . . . . 0.0 111.857 177.941 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' D' D ' 16' ' ' PRO . . . . . . . . . . . . . 36.4 Cg_exo -58.21 -37.13 96.72 Favored 'Trans proline' 0 N--CA 1.496 1.65 0 C-N-CA 121.4 1.4 . . . . 0.0 112.703 179.749 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' D' D ' 17' ' ' ASP . . . . . . . . . . . . . 15.0 p-10 -87.38 13.46 9.84 Favored 'General case' 0 CA--C 1.536 0.414 0 N-CA-C 112.981 0.734 . . . . 0.0 112.981 -178.384 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' D' D ' 18' ' ' PHE . . . . . . . . . . . . . 48.3 t80 -58.24 -45.09 88.39 Favored 'General case' 0 C--N 1.334 -0.104 0 O-C-N 122.145 -0.347 . . . . 0.0 110.14 -177.997 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' D' D ' 19' ' ' VAL . . . . . 0.402 HG13 ' N ' ' D' ' 20' ' ' ASP . 14.6 p -55.7 -41.38 64.99 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.305 0 CA-C-N 116.478 -0.328 . . . . 0.0 111.073 -178.364 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' D' D ' 20' ' ' ASP . . . . . 0.402 ' N ' HG13 ' D' ' 19' ' ' VAL . 71.5 m-20 -61.09 -43.76 98.4 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-O 120.818 0.342 . . . . 0.0 111.06 -178.329 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' D' D ' 21' ' ' VAL . . . . . . . . . . . . . 46.8 t -65.04 -46.78 90.36 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.318 0 C-N-CA 120.71 -0.396 . . . . 0.0 110.565 -177.285 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' D' D ' 22' ' ' ILE . . . . . 0.686 HG22 HD12 ' D' ' 26' ' ' LEU . 50.1 mm -56.7 -43.69 79.77 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.207 0 C-N-CA 120.959 -0.297 . . . . 0.0 110.493 179.378 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' D' D ' 23' ' ' ARG . . . . . . . . . . . . . 26.8 ttm-85 -52.93 -53.96 41.84 Favored 'General case' 0 C--N 1.331 -0.213 0 CA-C-O 121.413 0.625 . . . . 0.0 111.393 179.293 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' D' D ' 24' ' ' ILE . . . . . . . . . . . . . 78.8 mt -59.34 -41.06 83.06 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.356 0 CA-C-N 115.282 -0.872 . . . . 0.0 111.368 -173.524 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' D' D ' 25' ' ' LYS . . . . . . . . . . . . . 68.0 mttm -69.55 -41.63 75.66 Favored 'General case' 0 C--N 1.33 -0.278 0 N-CA-C 112.651 0.611 . . . . 0.0 112.651 -179.434 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' D' D ' 26' ' ' LEU . . . . . 0.686 HD12 HG22 ' D' ' 22' ' ' ILE . 60.4 mt -78.62 -33.86 47.05 Favored 'General case' 0 C--N 1.33 -0.262 0 N-CA-C 113.674 0.99 . . . . 0.0 113.674 -170.323 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' D' D ' 27' ' ' GLN . . . . . . . . . . . . . 10.4 pt20 -46.74 139.95 4.93 Favored 'General case' 0 N--CA 1.469 0.505 0 N-CA-C 112.863 0.69 . . . . 0.0 112.863 -174.884 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' D' D ' 28' ' ' GLY . . . . . . . . . . . . . . . 96.82 -21.39 46.27 Favored Glycine 0 CA--C 1.534 1.239 0 CA-C-N 115.728 -0.669 . . . . 0.0 112.531 -177.458 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' D' D ' 29' ' ' LYS . . . . . . . . . . . . . 35.1 mmtp -97.34 155.07 17.05 Favored 'General case' 0 C--O 1.232 0.16 0 CA-C-N 117.605 0.703 . . . . 0.0 110.783 179.407 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' D' D ' 30' ' ' THR . . . . . . . . . . . . . 32.0 m -106.0 137.1 44.49 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.043 -0.526 . . . . 0.0 109.868 176.165 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' D' D ' 31' ' ' VAL . . . . . . . . . . . . . 35.1 m -128.5 152.78 37.11 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.243 0 CA-C-O 121.026 0.441 . . . . 0.0 111.057 -178.088 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' D' D ' 32' ' ' ARG . . . . . . . . . . . . . 76.5 mtm180 -130.6 149.37 52.29 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 115.767 -0.652 . . . . 0.0 110.44 178.084 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' D' D ' 33' ' ' THR . . . . . . . . . . . . . 19.4 m -53.44 139.16 31.53 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.449 -0.342 . . . . 0.0 111.392 -178.238 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' D' D ' 34' ' ' GLY . . . . . . . . . . . . . . . 99.58 -17.02 58.2 Favored Glycine 0 CA--C 1.531 1.084 0 CA-C-O 119.684 -0.509 . . . . 0.0 113.296 179.378 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' D' D ' 35' ' ' ASP . . . . . . . . . . . . . 76.7 m-20 -66.17 148.74 51.38 Favored 'General case' 0 N--CA 1.461 0.107 0 CA-C-N 118.056 0.928 . . . . 0.0 111.074 179.145 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' D' D ' 36' ' ' VAL . . . . . . . . . . . . . 44.4 t -120.19 130.56 74.19 Favored 'Isoleucine or valine' 0 C--N 1.333 -0.133 0 CA-C-N 115.811 -0.631 . . . . 0.0 109.981 179.042 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' D' D ' 37' ' ' ILE . . . . . . . . . . . . . 68.3 mt -119.75 137.76 52.56 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.262 0 N-CA-C 109.721 -0.474 . . . . 0.0 109.721 179.103 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' D' D ' 38' ' ' GLY . . . . . . . . . . . . . . . -111.05 128.57 8.79 Favored Glycine 0 CA--C 1.524 0.633 0 N-CA-C 111.394 -0.682 . . . . 0.0 111.394 -178.955 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' D' D ' 39' ' ' ILE . . . . . . . . . . . . . 73.9 mt -129.99 130.47 66.18 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.217 0 N-CA-C 109.817 -0.438 . . . . 0.0 109.817 177.838 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' D' D ' 40' ' ' SER . . . . . . . . . . . . . 59.6 p -92.28 115.19 27.86 Favored 'General case' 0 C--N 1.33 -0.281 0 C-N-CA 120.912 -0.315 . . . . 0.0 110.875 176.968 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' D' D ' 41' ' ' ILE . . . . . . . . . . . . . 44.1 mm -123.39 124.48 69.85 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.223 0 N-CA-C 109.996 -0.372 . . . . 0.0 109.996 -179.754 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' D' D ' 42' ' ' LEU . . . . . . . . . . . . . 56.1 mt 57.67 34.16 24.14 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.362 -0.381 . . . . 0.0 111.729 178.274 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' D' D ' 43' ' ' GLY . . . . . . . . . . . . . . . 77.94 -10.05 28.25 Favored Glycine 0 CA--C 1.535 1.308 0 C-N-CA 121.28 -0.486 . . . . 0.0 113.407 177.713 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' D' D ' 44' ' ' LYS . . . . . . . . . . . . . 61.0 tttm -101.31 130.99 47.57 Favored 'General case' 0 C--N 1.331 -0.211 0 CA-C-N 117.914 0.857 . . . . 0.0 109.846 176.869 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' D' D ' 45' ' ' GLU . . . . . . . . . . . . . 43.3 tp10 -83.23 128.17 34.26 Favored 'General case' 0 C--N 1.329 -0.293 0 C-N-CA 120.817 -0.353 . . . . 0.0 110.727 -179.113 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' D' D ' 46' ' ' VAL . . . . . 0.42 HG23 ' CG ' ' D' ' 10' ' ' PRO . 7.3 p -121.67 131.2 73.63 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.227 0 CA-C-O 121.11 0.481 . . . . 0.0 109.704 177.363 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' D' D ' 47' ' ' LYS . . . . . . . . . . . . . 37.1 mtmm -100.47 128.06 46.64 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 115.879 -0.601 . . . . 0.0 111.069 176.349 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' D' D ' 48' ' ' PHE . . . . . . . . . . . . . 89.9 m-85 -107.97 131.96 54.0 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.077 -0.51 . . . . 0.0 109.75 176.125 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' D' D ' 49' ' ' LYS . . . . . . . . . . . . . 82.8 tttt -107.17 134.57 50.09 Favored 'General case' 0 C--N 1.327 -0.385 0 CA-C-N 116.289 -0.414 . . . . 0.0 110.379 179.856 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' D' D ' 50' ' ' VAL . . . . . . . . . . . . . 46.8 t -76.95 108.68 10.39 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.297 0 N-CA-C 109.037 -0.727 . . . . 0.0 109.037 175.709 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' D' D ' 51' ' ' VAL . . . . . . . . . . . . . 51.0 t -70.67 -47.16 65.82 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.329 0 CA-C-N 116.131 -0.486 . . . . 0.0 109.868 -174.338 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' D' D ' 52' ' ' GLN . . . . . . . . . . . . . 49.6 tt0 -167.94 142.08 3.47 Favored 'General case' 0 C--N 1.33 -0.275 0 C-N-CA 120.308 -0.557 . . . . 0.0 111.567 -179.907 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' D' D ' 53' ' ' ALA . . . . . 0.478 ' HB1' ' HB2' ' D' ' 58' ' ' LEU . . . -115.76 132.87 56.51 Favored 'General case' 0 C--N 1.331 -0.196 0 CA-C-N 115.745 -0.661 . . . . 0.0 110.024 176.255 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' D' D ' 54' ' ' TYR . . . . . . . . . . . . . 75.4 t80 -129.14 112.19 18.35 Favored Pre-proline 0 CA--C 1.536 0.413 0 CA-C-O 118.291 -0.861 . . . . 0.0 110.319 178.503 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' D' D ' 55' ' ' PRO . . . . . . . . . . . . . 73.0 Cg_endo -77.21 170.01 72.62 Favored 'Cis proline' 0 N--CA 1.499 1.836 0 CA-C-N 121.995 1.748 . . . . 0.0 112.119 -5.61 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' D' D ' 56' ' ' SER . . . . . . . . . . . . . 13.5 m -117.2 132.05 23.7 Favored Pre-proline 0 CA--C 1.538 0.502 0 CA-C-O 118.464 -0.779 . . . . 0.0 109.454 175.666 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' D' D ' 57' ' ' PRO . . . . . . . . . . . . . 45.3 Cg_endo -69.37 146.86 82.54 Favored 'Cis proline' 0 N--CA 1.496 1.667 0 CA-C-N 121.902 1.715 . . . . 0.0 111.532 -0.835 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' D' D ' 58' ' ' LEU . . . . . 0.478 ' HB2' ' HB1' ' D' ' 53' ' ' ALA . 27.2 tp -107.61 135.23 49.4 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.275 -0.421 . . . . 0.0 110.527 -179.035 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' D' D ' 59' ' ' ARG . . . . . . . . . . . . . 52.7 ttp180 -102.43 125.28 49.09 Favored 'General case' 0 C--N 1.328 -0.356 0 N-CA-C 109.482 -0.562 . . . . 0.0 109.482 177.101 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' D' D ' 60' ' ' VAL . . . . . . . . . . . . . 41.2 t -81.44 121.37 34.74 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.2 0 C-N-CA 120.745 -0.382 . . . . 0.0 110.505 -174.917 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' D' D ' 61' ' ' GLU . . . . . . . . . . . . . 96.1 mt-10 -131.13 159.92 36.25 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 115.73 -0.668 . . . . 0.0 109.929 177.213 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' D' D ' 62' ' ' ASP . . . . . . . . . . . . . 10.8 t70 -53.66 -32.3 51.02 Favored 'General case' 0 C--N 1.327 -0.376 0 N-CA-C 111.722 0.268 . . . . 0.0 111.722 179.648 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' D' D ' 63' ' ' ARG . . . . . . . . . . . . . 27.8 ptt180 -85.78 5.05 34.19 Favored 'General case' 0 CA--C 1.537 0.459 0 N-CA-C 113.771 1.026 . . . . 0.0 113.771 -175.634 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' D' D ' 64' ' ' THR . . . . . . . . . . . . . 39.9 m -86.19 143.67 27.86 Favored 'General case' 0 C--N 1.332 -0.184 0 CA-C-N 118.002 0.365 . . . . 0.0 110.411 -179.728 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' D' D ' 65' ' ' LYS . . . . . . . . . . . . . 98.7 mttt -87.21 126.08 34.58 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.438 -0.346 . . . . 0.0 110.104 179.968 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' D' D ' 66' ' ' ILE . . . . . . . . . . . . . 65.5 mt -117.71 128.33 74.91 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.295 0 N-CA-C 109.862 -0.422 . . . . 0.0 109.862 -178.969 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' D' D ' 67' ' ' THR . . . . . . . . . . . . . 25.4 m -121.86 136.8 54.94 Favored 'General case' 0 C--N 1.331 -0.202 0 CA-C-O 121.05 0.452 . . . . 0.0 110.981 -177.65 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' D' D ' 68' ' ' LEU . . . . . . . . . . . . . 19.0 tp . . . . . 0 C--N 1.331 -0.231 0 CA-C-N 115.914 -0.585 . . . . 0.0 110.635 179.593 . . . . . . . . 0 0 . 1 . 005 nuclear nobuild core ' D' D ' 73' ' ' VAL . . . . . . . . . . . . . 35.4 m . . . . . 0 C--O 1.231 0.098 0 N-CA-C 109.984 -0.376 . . . . 0.0 109.984 . . . . . . . . . 0 0 . 1 . 005 nuclear nobuild core ' D' D ' 74' ' ' ASP . . . . . . . . . . . . . 12.8 t70 -91.47 118.56 30.67 Favored 'General case' 0 C--N 1.331 -0.217 0 N-CA-C 109.953 -0.388 . . . . 0.0 109.953 -178.832 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' D' D ' 75' ' ' VAL . . . . . . . . . . . . . 45.8 t -117.36 123.67 72.06 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.239 0 CA-C-O 121.184 0.516 . . . . 0.0 110.507 -177.328 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' D' D ' 76' ' ' LEU . . . . . . . . . . . . . 14.6 mt -125.85 144.61 50.59 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-N 115.463 -0.79 . . . . 0.0 109.347 177.726 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' D' D ' 77' ' ' GLU . . . . . . . . . . . . . 97.0 mt-10 -135.67 138.33 42.7 Favored 'General case' 0 C--N 1.332 -0.183 0 CA-C-O 121.029 0.443 . . . . 0.0 111.583 -176.739 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' D' D ' 78' ' ' ALA . . . . . 0.559 ' HB2' HD21 ' D' ' 109' ' ' LEU . . . -127.14 135.28 50.49 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 115.627 -0.715 . . . . 0.0 109.675 175.772 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' D' D ' 79' ' ' LYS . . . . . 0.568 ' O ' HD13 ' D' ' 80' ' ' ILE . 22.7 tptm -78.08 121.83 24.8 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-O 120.914 0.388 . . . . 0.0 110.647 -177.604 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' D' D ' 80' ' ' ILE . . . . . 0.568 HD13 ' O ' ' D' ' 79' ' ' LYS . 43.2 mm -139.22 113.21 7.0 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.325 0 N-CA-C 108.995 -0.743 . . . . 0.0 108.995 -178.358 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' D' D ' 81' ' ' LYS . . . . . . . . . . . . . 76.2 tttt -103.09 123.24 46.27 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-O 120.749 0.309 . . . . 0.0 111.134 -175.809 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' D' D ' 82' ' ' GLY . . . . . . . . . . . . . . . 89.15 42.19 5.65 Favored Glycine 0 CA--C 1.528 0.871 0 C-N-CA 120.925 -0.655 . . . . 0.0 112.356 173.422 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' D' D ' 83' ' ' ILE . . . . . . . . . . . . . 71.4 mt -70.84 139.43 19.99 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.245 0 N-CA-C 109.706 -0.479 . . . . 0.0 109.706 176.359 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' D' D ' 84' ' ' LYS . . . . . . . . . . . . . 38.9 ttpt -107.16 -47.28 3.71 Favored 'General case' 0 C--N 1.331 -0.197 0 CA-C-N 116.451 -0.34 . . . . 0.0 110.631 -178.316 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' D' D ' 85' ' ' ASP . . . . . . . . . . . . . 9.9 t70 -148.35 148.13 30.02 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.253 -0.43 . . . . 0.0 110.489 -179.439 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' D' D ' 86' ' ' VAL . . . . . . . . . . . . . 42.4 t -133.25 134.48 57.39 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.252 0 CA-C-O 121.032 0.444 . . . . 0.0 110.425 179.442 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' D' D ' 87' ' ' ILE . . . . . . . . . . . . . 46.0 mm -120.09 127.52 75.9 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.29 0 CA-C-N 115.799 -0.637 . . . . 0.0 109.658 178.403 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' D' D ' 88' ' ' LEU . . . . . . . . . . . . . 18.2 tp -109.66 127.06 54.3 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-O 120.937 0.398 . . . . 0.0 110.898 -178.612 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' D' D ' 89' ' ' ASP . . . . . . . . . . . . . 13.7 t70 -117.96 154.68 31.54 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 115.926 -0.579 . . . . 0.0 109.559 177.124 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' D' D ' 90' ' ' GLU . . . . . . . . . . . . . 96.3 mt-10 -49.0 -38.63 23.95 Favored 'General case' 0 C--N 1.329 -0.311 0 N-CA-C 112.748 0.648 . . . . 0.0 112.748 -172.195 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' D' D ' 91' ' ' ASN . . . . . . . . . . . . . 37.5 t30 -132.06 35.64 3.71 Favored 'General case' 0 N--CA 1.464 0.258 0 C-N-CA 120.91 -0.316 . . . . 0.0 111.654 -177.797 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' D' D ' 92' ' ' LEU . . . . . . . . . . . . . 9.2 tp -166.06 146.66 6.53 Favored 'General case' 0 C--N 1.33 -0.244 0 C-N-CA 120.8 -0.36 . . . . 0.0 110.815 -179.304 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' D' D ' 93' ' ' ILE . . . . . . . . . . . . . 71.2 mt -125.71 123.66 64.93 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.262 0 N-CA-C 109.501 -0.555 . . . . 0.0 109.501 179.975 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' D' D ' 94' ' ' VAL . . . . . 0.516 HG21 HG11 ' D' ' 125' ' ' VAL . 46.4 t -124.41 129.69 73.82 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.24 0 CA-C-O 121.011 0.434 . . . . 0.0 110.236 179.893 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' D' D ' 95' ' ' VAL . . . . . . . . . . . . . 42.8 t -121.8 135.68 61.14 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.294 0 CA-C-N 115.86 -0.609 . . . . 0.0 109.821 -179.255 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' D' D ' 96' ' ' ILE . . . . . . . . . . . . . 67.8 mt -117.93 128.03 75.11 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.239 0 N-CA-C 109.561 -0.533 . . . . 0.0 109.561 179.043 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' D' D ' 97' ' ' THR . . . . . . . . . . . . . 65.8 p -100.12 159.53 15.03 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-O 121.102 0.477 . . . . 0.0 111.067 -178.16 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' D' D ' 98' ' ' GLU . . . . . . . . . . . . . 44.4 mt-10 -54.49 -26.32 30.71 Favored 'General case' 0 C--N 1.329 -0.319 0 N-CA-C 112.296 0.48 . . . . 0.0 112.296 -179.89 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' D' D ' 99' ' ' GLU . . . . . . . . . . . . . 95.4 mt-10 -76.08 10.77 1.74 Allowed 'General case' 0 CA--C 1.536 0.427 0 N-CA-C 113.326 0.862 . . . . 0.0 113.326 -177.557 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' D' D ' 100' ' ' ASN . . . . . . . . . . . . . 4.4 m-20 64.16 34.64 10.86 Favored 'General case' 0 N--CA 1.463 0.22 0 CA-C-O 120.971 0.415 . . . . 0.0 111.418 179.836 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' D' D ' 101' ' ' GLU . . . . . . . . . . . . . 84.7 tt0 -112.38 141.8 45.67 Favored 'General case' 0 C--N 1.334 -0.102 0 N-CA-C 109.778 -0.453 . . . . 0.0 109.778 173.72 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' D' D ' 102' ' ' VAL . . . . . . . . . . . . . 44.1 t -116.62 128.95 73.85 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.336 0 N-CA-C 109.988 -0.375 . . . . 0.0 109.988 -178.643 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' D' D ' 103' ' ' LEU . . . . . . . . . . . . . 52.9 mt -117.7 134.43 54.91 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 115.747 -0.661 . . . . 0.0 110.202 177.509 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' D' D ' 104' ' ' ILE . . . . . 0.5 HD13 HG21 ' D' ' 130' ' ' VAL . 67.9 mt -119.67 123.41 70.96 Favored 'Isoleucine or valine' 0 C--O 1.234 0.288 0 N-CA-C 110.35 -0.241 . . . . 0.0 110.35 -179.39 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' D' D ' 105' ' ' PHE . . . . . . . . . . . . . 63.9 m-85 -123.69 166.56 15.32 Favored 'General case' 0 C--N 1.333 -0.133 0 O-C-N 123.913 0.758 . . . . 0.0 109.666 179.577 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' D' D ' 106' ' ' ASN . . . . . . . . . . . . . 44.7 p-10 -101.45 -169.97 1.77 Allowed 'General case' 0 C--N 1.331 -0.235 0 N-CA-C 109.82 -0.437 . . . . 0.0 109.82 174.474 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' D' D ' 107' ' ' GLN . . . . . . . . . . . . . 62.2 tt0 -59.73 -30.14 68.63 Favored 'General case' 0 C--N 1.33 -0.273 0 N-CA-C 111.887 0.329 . . . . 0.0 111.887 179.82 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' D' D ' 108' ' ' ASN . . . . . . . . . . . . . 13.1 t-20 -82.05 7.02 14.41 Favored 'General case' 0 CA--C 1.537 0.46 0 N-CA-C 113.067 0.766 . . . . 0.0 113.067 -177.723 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' D' D ' 109' ' ' LEU . . . . . 0.559 HD21 ' HB2' ' D' ' 78' ' ' ALA . 8.0 tp 60.29 36.28 20.67 Favored 'General case' 0 C--N 1.332 -0.163 0 CA-C-O 120.878 0.371 . . . . 0.0 111.488 179.246 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' D' D ' 110' ' ' GLU . . . . . . . . . . . . . 43.1 mt-10 -104.83 150.77 24.54 Favored 'General case' 0 C--N 1.332 -0.176 0 N-CA-C 109.603 -0.517 . . . . 0.0 109.603 175.424 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' D' D ' 111' ' ' GLU . . . . . . . . . . . . . 67.8 tt0 -84.68 121.87 28.28 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-O 120.907 0.384 . . . . 0.0 110.722 -175.774 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' D' D ' 112' ' ' LEU . . . . . . . . . . . . . 11.4 mt -104.29 -46.07 4.51 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.016 -0.538 . . . . 0.0 110.489 179.36 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' D' D ' 113' ' ' TYR . . . . . . . . . . . . . 64.9 t80 -140.95 145.01 35.47 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.189 -0.46 . . . . 0.0 111.319 -178.236 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' D' D ' 114' ' ' ARG . . . . . . . . . . . . . 39.0 ptt85 -142.5 127.75 18.71 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 115.994 -0.548 . . . . 0.0 110.615 177.134 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' D' D ' 115' ' ' GLY . . . . . . . . . . . . . . . -150.06 151.79 23.8 Favored Glycine 0 CA--C 1.522 0.48 0 N-CA-C 110.724 -0.95 . . . . 0.0 110.724 178.788 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' D' D ' 116' ' ' LYS . . . . . . . . . . . . . 79.1 tttt -128.37 128.82 45.24 Favored 'General case' 0 C--N 1.328 -0.335 0 N-CA-C 109.842 -0.429 . . . . 0.0 109.842 178.531 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' D' D ' 117' ' ' PHE . . . . . . . . . . . . . 33.3 m-85 -125.86 117.97 24.48 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.283 -0.417 . . . . 0.0 110.154 -174.302 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' D' D ' 118' ' ' GLU . . . . . . . . . . . . . 96.0 mt-10 -55.02 -43.01 73.3 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.558 -0.292 . . . . 0.0 111.144 -176.615 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' D' D ' 119' ' ' ASN . . . . . . . . . . . . . 26.7 m120 -99.93 30.98 3.46 Favored 'General case' 0 C--N 1.331 -0.235 0 N-CA-C 112.176 0.435 . . . . 0.0 112.176 -174.273 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' D' D ' 120' ' ' LEU . . . . . . . . . . . . . 17.3 tp -56.11 119.87 6.6 Favored 'General case' 0 C--O 1.232 0.136 0 C-N-CA 120.925 -0.31 . . . . 0.0 110.613 178.539 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' D' D ' 121' ' ' ASN . . . . . . . . . . . . . 15.8 t-20 -114.16 -44.09 3.17 Favored 'General case' 0 C--N 1.332 -0.183 0 CA-C-N 116.592 -0.276 . . . . 0.0 111.416 -177.648 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' D' D ' 122' ' ' LYS . . . . . . . . . . . . . 96.5 mttt -145.23 150.38 36.59 Favored 'General case' 0 C--N 1.332 -0.153 0 C-N-CA 120.54 -0.464 . . . . 0.0 111.828 -176.671 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' D' D ' 123' ' ' VAL . . . . . . . . . . . . . 43.8 t -130.59 130.46 64.86 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.275 0 CA-C-N 115.951 -0.568 . . . . 0.0 109.753 176.318 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' D' D ' 124' ' ' LEU . . . . . . . . . . . . . 75.5 mt -131.1 135.61 47.65 Favored 'General case' 0 C--N 1.331 -0.208 0 CA-C-N 116.628 -0.26 . . . . 0.0 110.536 -179.643 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' D' D ' 125' ' ' VAL . . . . . 0.516 HG11 HG21 ' D' ' 94' ' ' VAL . 34.2 m -141.66 151.32 19.18 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.306 0 CA-C-O 121.007 0.432 . . . . 0.0 111.337 -179.09 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' D' D ' 126' ' ' ARG . . . . . 0.499 ' NH1' HD21 ' E' ' 88' ' ' LEU . 35.8 ptt-85 -154.15 129.75 9.97 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 115.873 -0.603 . . . . 0.0 110.549 175.965 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' D' D ' 127' ' ' ASN . . . . . . . . . . . . . 6.8 m120 51.91 -109.39 0.44 Allowed 'General case' 0 CA--C 1.546 0.809 0 CA-C-O 118.925 -0.559 . . . . 0.0 111.154 -179.927 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' D' D ' 128' ' ' ASP . . . . . . . . . . . . . 18.5 p-10 -114.13 2.92 15.04 Favored 'General case' 0 N--CA 1.468 0.438 0 CA-C-N 119.755 1.161 . . . . 0.0 113.443 -177.998 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' D' D ' 129' ' ' LEU . . . . . . . . . . . . . 48.7 mt -106.82 139.26 41.52 Favored 'General case' 0 C--N 1.333 -0.115 0 N-CA-C 109.558 -0.534 . . . . 0.0 109.558 179.12 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' D' D ' 130' ' ' VAL . . . . . 0.5 HG21 HD13 ' D' ' 104' ' ' ILE . 32.7 m -137.25 144.26 32.29 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.246 0 CA-C-O 121.167 0.508 . . . . 0.0 111.263 -178.322 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' D' D ' 131' ' ' VAL . . . . . . . . . . . . . 41.7 t -136.04 139.69 45.34 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.286 0 CA-C-N 115.878 -0.601 . . . . 0.0 110.243 178.199 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' D' D ' 132' ' ' ILE . . . . . . . . . . . . . 73.7 mt -117.14 133.31 64.28 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 CA-C-N 115.496 -0.774 . . . . 0.0 109.28 179.997 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' D' D ' 133' ' ' ILE . . . . . . . . . . . . . 40.8 mm -115.73 124.27 71.98 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.236 0 CA-C-O 120.72 0.295 . . . . 0.0 110.966 -175.034 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' D' D ' 134' ' ' ASP . . . . . . . . . . . . . 9.5 p-10 -136.46 146.4 46.29 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 115.972 -0.558 . . . . 0.0 109.719 175.548 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' D' D ' 135' ' ' GLU . . . . . . . . . . . . . 86.2 tt0 -50.27 -24.63 3.03 Favored 'General case' 0 C--N 1.327 -0.379 0 N-CA-C 112.85 0.685 . . . . 0.0 112.85 -175.014 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' D' D ' 136' ' ' GLN . . . . . . . . . . . . . 53.1 mt-30 -82.89 -32.48 27.32 Favored 'General case' 0 C--O 1.234 0.241 0 N-CA-C 112.384 0.512 . . . . 0.0 112.384 -177.15 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' D' D ' 137' ' ' LYS . . . . . . . . . . . . . 52.5 pttt -170.09 175.63 4.95 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-O 121.474 0.654 . . . . 0.0 112.295 -173.567 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' D' D ' 138' ' ' LEU . . . . . 0.45 ' C ' HD23 ' D' ' 138' ' ' LEU . 7.5 tt -119.68 127.5 52.95 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 115.184 -0.916 . . . . 0.0 109.944 177.65 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' D' D ' 139' ' ' THR . . . . . . . . . . . . . 44.6 m -110.16 127.3 54.84 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 116.243 -0.435 . . . . 0.0 110.129 -179.896 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' D' D ' 140' ' ' LEU . . . . . 0.469 ' C ' HD23 ' D' ' 140' ' ' LEU . 8.1 tt -117.07 126.23 52.53 Favored 'General case' 0 C--N 1.329 -0.311 0 N-CA-C 109.498 -0.556 . . . . 0.0 109.498 -178.708 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' D' D ' 141' ' ' ILE . . . . . 0.494 ' HB ' HG23 ' D' ' 130' ' ' VAL . 19.1 mt -123.37 121.4 62.67 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.281 0 N-CA-C 109.733 -0.469 . . . . 0.0 109.733 -175.627 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' D' D ' 142' ' ' ARG . . . . . . . . . . . . . 29.5 ttp180 -115.66 128.07 55.64 Favored 'General case' 0 C--N 1.331 -0.212 0 CA-C-N 115.696 -0.683 . . . . 0.0 110.331 -177.205 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' D' D ' 143' ' ' THR . . . . . . . . . . . . . 35.4 p . . . . . 0 C--O 1.22 -0.487 0 CA-C-O 117.976 -1.011 . . . . 0.0 110.53 -179.7 . . . . . . . . 0 0 . 1 . 005 nuclear nobuild core ' E' E ' 2' ' ' SER . . . . . . . . . . . . . 5.3 p . . . . . 0 C--O 1.231 0.094 0 CA-C-O 120.818 0.342 . . . . 0.0 110.129 . . . . . . . . . 0 0 . 1 . 005 nuclear nobuild core ' E' E ' 3' ' ' GLU . . . . . . . . . . . . . 84.9 tt0 -144.41 141.35 29.58 Favored 'General case' 0 C--N 1.327 -0.409 0 CA-C-N 116.198 -0.456 . . . . 0.0 111.182 -178.63 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' E' E ' 4' ' ' LEU . . . . . . . . . . . . . 20.1 tp -122.73 132.07 54.07 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-N 116.04 -0.527 . . . . 0.0 110.102 176.235 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' E' E ' 5' ' ' LYS . . . . . . . . . . . . . 50.2 mtmt -108.27 119.02 38.28 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 116.353 -0.385 . . . . 0.0 110.69 -179.604 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' E' E ' 6' ' ' LEU . . . . . . . . . . . . . 54.8 mt -114.15 142.19 46.55 Favored 'General case' 0 C--N 1.331 -0.229 0 O-C-N 123.86 0.725 . . . . 0.0 111.169 -178.165 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' E' E ' 7' ' ' LYS . . . . . . . . . . . . . 65.5 tttt -132.97 138.48 31.94 Favored Pre-proline 0 CA--C 1.534 0.356 0 CA-C-O 118.922 -0.561 . . . . 0.0 109.672 176.152 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' E' E ' 8' ' ' PRO . . . . . . . . . . . . . 78.1 Cg_endo -90.99 146.55 3.68 Favored 'Trans proline' 0 N--CA 1.49 1.317 0 C-N-CA 121.691 1.594 . . . . 0.0 112.083 178.671 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' E' E ' 9' ' ' LEU . . . . . . . . . . . . . 54.8 mt -86.0 -48.55 0.55 Allowed Pre-proline 0 CA--C 1.535 0.392 0 CA-C-O 118.518 -0.753 . . . . 0.0 112.499 -179.845 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' E' E ' 10' ' ' PRO . . . . . . . . . . . . . 95.6 Cg_endo -78.41 157.13 29.14 Favored 'Trans proline' 0 N--CA 1.496 1.645 0 C-N-CA 121.22 1.28 . . . . 0.0 112.002 178.651 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' E' E ' 11' ' ' LYS . . . . . . . . . . . . . 92.5 mttt -85.18 92.2 8.34 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.311 -0.404 . . . . 0.0 110.539 179.383 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' E' E ' 12' ' ' VAL . . . . . . . . . . . . . 12.6 p -142.5 143.42 25.93 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.281 0 CA-C-N 116.372 -0.376 . . . . 0.0 110.61 179.819 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' E' E ' 13' ' ' GLU . . . . . . . . . . . . . 41.7 mt-10 -93.28 132.49 37.42 Favored 'General case' 0 C--N 1.329 -0.307 0 N-CA-C 109.926 -0.398 . . . . 0.0 109.926 177.349 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' E' E ' 14' ' ' LEU . . . . . . . . . . . . . 21.2 mt -98.5 149.76 36.05 Favored Pre-proline 0 CA--C 1.534 0.342 0 CA-C-O 119.318 -0.373 . . . . 0.0 110.737 -176.351 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' E' E ' 15' ' ' PRO . . . . . . . . . . . . . 23.5 Cg_exo -64.26 161.21 35.16 Favored 'Trans proline' 0 N--CA 1.498 1.791 0 C-N-CA 121.291 1.328 . . . . 0.0 111.971 175.841 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' E' E ' 16' ' ' PRO . . . . . . . . . . . . . 29.7 Cg_exo -59.9 -34.81 95.16 Favored 'Trans proline' 0 N--CA 1.498 1.774 0 C-N-CA 121.451 1.434 . . . . 0.0 112.938 -178.536 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' E' E ' 17' ' ' ASP . . . . . . . . . . . . . 16.5 p-10 -83.91 0.99 45.53 Favored 'General case' 0 CA--C 1.538 0.488 0 N-CA-C 113.375 0.88 . . . . 0.0 113.375 -177.738 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' E' E ' 18' ' ' PHE . . . . . . . . . . . . . 45.9 t80 -57.92 -42.27 84.46 Favored 'General case' 0 C--N 1.333 -0.124 0 O-C-N 121.938 -0.476 . . . . 0.0 110.228 -177.426 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' E' E ' 19' ' ' VAL . . . . . . . . . . . . . 46.7 t -56.19 -45.74 81.05 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.244 0 CA-C-N 116.44 -0.346 . . . . 0.0 110.62 -178.003 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' E' E ' 20' ' ' ASP . . . . . . . . . . . . . 81.3 m-20 -60.14 -40.18 88.92 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-O 120.833 0.349 . . . . 0.0 110.936 -178.217 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' E' E ' 21' ' ' VAL . . . . . . . . . . . . . 46.2 t -63.78 -47.02 92.8 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.265 0 C-N-CA 120.675 -0.41 . . . . 0.0 110.381 -178.262 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' E' E ' 22' ' ' ILE . . . . . 0.642 HG22 HD12 ' E' ' 26' ' ' LEU . 51.7 mm -55.28 -46.74 78.22 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.274 0 C-N-CA 121.131 -0.228 . . . . 0.0 110.771 179.304 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' E' E ' 23' ' ' ARG . . . . . . . . . . . . . 34.6 ttp180 -54.42 -49.36 70.14 Favored 'General case' 0 C--N 1.33 -0.267 0 C-N-CA 121.023 -0.271 . . . . 0.0 111.454 -178.841 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' E' E ' 24' ' ' ILE . . . . . . . . . . . . . 70.3 mt -59.88 -44.13 93.6 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.257 0 CA-C-N 116.549 -0.296 . . . . 0.0 111.223 -177.172 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' E' E ' 25' ' ' LYS . . . . . . . . . . . . . 50.9 mmtt -64.46 -41.85 96.28 Favored 'General case' 0 C--N 1.328 -0.336 0 N-CA-C 112.406 0.521 . . . . 0.0 112.406 -178.027 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' E' E ' 26' ' ' LEU . . . . . 0.642 HD12 HG22 ' E' ' 22' ' ' ILE . 28.8 mt -78.54 -41.59 31.76 Favored 'General case' 0 C--N 1.33 -0.269 0 N-CA-C 113.252 0.834 . . . . 0.0 113.252 -171.181 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' E' E ' 27' ' ' GLN . . . . . . . . . . . . . 10.2 pt20 -46.58 139.03 5.4 Favored 'General case' 0 N--CA 1.469 0.502 0 N-CA-C 112.787 0.662 . . . . 0.0 112.787 -175.056 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' E' E ' 28' ' ' GLY . . . . . . . . . . . . . . . 98.77 -27.04 21.61 Favored Glycine 0 CA--C 1.533 1.174 0 CA-C-N 115.528 -0.76 . . . . 0.0 112.226 -177.247 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' E' E ' 29' ' ' LYS . . . . . . . . . . . . . 46.0 mtmt -98.12 155.16 17.28 Favored 'General case' 0 C--N 1.331 -0.203 0 CA-C-N 117.168 0.484 . . . . 0.0 111.182 179.35 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' E' E ' 30' ' ' THR . . . . . . . . . . . . . 28.8 m -104.15 137.71 41.7 Favored 'General case' 0 C--N 1.331 -0.222 0 CA-C-N 115.908 -0.587 . . . . 0.0 110.149 175.957 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' E' E ' 31' ' ' VAL . . . . . . . . . . . . . 35.2 m -130.6 153.51 39.18 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 CA-C-N 116.361 -0.381 . . . . 0.0 110.94 -178.709 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' E' E ' 32' ' ' ARG . . . . . . . . . . . . . 87.8 mtm-85 -128.1 149.21 50.51 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.138 -0.483 . . . . 0.0 110.653 179.432 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' E' E ' 33' ' ' THR . . . . . . . . . . . . . 29.9 m -53.46 139.22 31.51 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.372 -0.376 . . . . 0.0 111.376 -178.524 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' E' E ' 34' ' ' GLY . . . . . . . . . . . . . . . 99.35 -17.14 58.24 Favored Glycine 0 CA--C 1.532 1.111 0 CA-C-O 119.707 -0.496 . . . . 0.0 113.312 179.217 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' E' E ' 35' ' ' ASP . . . . . . . . . . . . . 77.8 m-20 -66.3 148.62 51.58 Favored 'General case' 0 C--O 1.231 0.129 0 CA-C-N 118.02 0.91 . . . . 0.0 111.078 179.189 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' E' E ' 36' ' ' VAL . . . . . . . . . . . . . 43.9 t -119.91 129.68 75.13 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.2 0 CA-C-N 115.78 -0.645 . . . . 0.0 109.822 178.267 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' E' E ' 37' ' ' ILE . . . . . . . . . . . . . 67.5 mt -116.88 137.51 50.53 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.272 0 N-CA-C 109.739 -0.467 . . . . 0.0 109.739 179.437 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' E' E ' 38' ' ' GLY . . . . . . . . . . . . . . . -114.72 128.67 8.26 Favored Glycine 0 CA--C 1.525 0.672 0 N-CA-C 111.143 -0.783 . . . . 0.0 111.143 -179.164 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' E' E ' 39' ' ' ILE . . . . . . . . . . . . . 77.2 mt -122.41 134.4 65.73 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.249 0 N-CA-C 109.974 -0.38 . . . . 0.0 109.974 178.787 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' E' E ' 40' ' ' SER . . . . . . . . . . . . . 59.8 p -92.74 119.04 31.72 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.441 -0.345 . . . . 0.0 110.829 175.7 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' E' E ' 41' ' ' ILE . . . . . . . . . . . . . 72.3 mt -126.37 122.23 60.76 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.215 0 CA-C-N 116.553 -0.294 . . . . 0.0 110.32 178.652 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' E' E ' 42' ' ' LEU . . . . . . . . . . . . . 44.4 mt 52.11 34.25 13.8 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.251 -0.431 . . . . 0.0 111.853 177.675 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' E' E ' 43' ' ' GLY . . . . . . . . . . . . . . . 72.23 33.2 62.05 Favored Glycine 0 CA--C 1.529 0.935 0 C-N-CA 121.053 -0.594 . . . . 0.0 111.796 179.002 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' E' E ' 44' ' ' LYS . . . . . . . . . . . . . 44.2 tttp -138.35 128.76 26.13 Favored 'General case' 0 C--N 1.328 -0.33 0 N-CA-C 109.696 -0.483 . . . . 0.0 109.696 179.711 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' E' E ' 45' ' ' GLU . . . . . . . . . . . . . 83.7 tt0 -83.03 121.78 27.46 Favored 'General case' 0 C--N 1.328 -0.347 0 C-N-CA 120.786 -0.366 . . . . 0.0 111.127 -177.639 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' E' E ' 46' ' ' VAL . . . . . . . . . . . . . 7.5 p -119.94 125.88 74.73 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.194 0 N-CA-C 109.298 -0.63 . . . . 0.0 109.298 175.087 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' E' E ' 47' ' ' LYS . . . . . . . . . . . . . 96.5 mttt -100.87 129.78 46.78 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 115.964 -0.562 . . . . 0.0 111.437 179.442 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' E' E ' 48' ' ' PHE . . . . . . . . . . . . . 91.7 m-85 -112.73 131.81 55.5 Favored 'General case' 0 C--N 1.33 -0.253 0 N-CA-C 109.612 -0.514 . . . . 0.0 109.612 174.507 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' E' E ' 49' ' ' LYS . . . . . . . . . . . . . 68.5 tttt -107.87 137.42 45.91 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.643 -0.253 . . . . 0.0 110.715 179.817 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' E' E ' 50' ' ' VAL . . . . . . . . . . . . . 46.7 t -81.04 106.57 12.37 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.281 0 N-CA-C 109.175 -0.676 . . . . 0.0 109.175 175.148 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' E' E ' 51' ' ' VAL . . . . . . . . . . . . . 48.0 t -69.68 -53.99 21.64 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.324 0 N-CA-C 109.479 -0.563 . . . . 0.0 109.479 -176.302 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' E' E ' 52' ' ' GLN . . . . . . . . . . . . . 93.7 mt-30 -152.53 154.55 35.67 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.097 -0.501 . . . . 0.0 111.714 -179.226 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' E' E ' 53' ' ' ALA . . . . . 0.41 ' HB1' ' HB2' ' E' ' 58' ' ' LEU . . . -130.49 132.33 45.59 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 115.168 -0.924 . . . . 0.0 109.764 176.056 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' E' E ' 54' ' ' TYR . . . . . . . . . . . . . 57.9 t80 -129.1 108.82 18.04 Favored Pre-proline 0 CA--C 1.534 0.351 0 CA-C-O 118.312 -0.851 . . . . 0.0 110.368 -179.767 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' E' E ' 55' ' ' PRO . . . . . . . . . . . . . 73.8 Cg_endo -77.21 170.03 72.57 Favored 'Cis proline' 0 N--CA 1.499 1.813 0 CA-C-N 121.808 1.682 . . . . 0.0 112.583 -5.154 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' E' E ' 56' ' ' SER . . . . . . . . . . . . . 13.8 m -116.12 128.97 25.57 Favored Pre-proline 0 CA--C 1.539 0.53 0 CA-C-O 118.356 -0.83 . . . . 0.0 109.139 174.425 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' E' E ' 57' ' ' PRO . . . . . . . . . . . . . 54.3 Cg_endo -70.7 149.63 91.18 Favored 'Cis proline' 0 N--CA 1.497 1.684 0 CA-C-N 121.993 1.747 . . . . 0.0 111.733 0.454 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' E' E ' 58' ' ' LEU . . . . . 0.41 ' HB2' ' HB1' ' E' ' 53' ' ' ALA . 25.3 tp -108.39 136.53 47.86 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.572 -179.426 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' E' E ' 59' ' ' ARG . . . . . . . . . . . . . 72.8 ttt180 -104.55 125.96 51.19 Favored 'General case' 0 C--N 1.326 -0.438 0 N-CA-C 109.14 -0.689 . . . . 0.0 109.14 176.0 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' E' E ' 60' ' ' VAL . . . . . . . . . . . . . 45.8 t -80.44 118.07 27.48 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.213 0 C-N-CA 120.521 -0.471 . . . . 0.0 110.48 -174.765 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' E' E ' 61' ' ' GLU . . . . . . . . . . . . . 95.0 mt-10 -131.02 162.81 28.97 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 115.786 -0.643 . . . . 0.0 109.563 176.326 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' E' E ' 62' ' ' ASP . . . . . . . . . . . . . 21.1 p-10 -56.27 -33.12 65.17 Favored 'General case' 0 C--N 1.328 -0.328 0 N-CA-C 111.854 0.316 . . . . 0.0 111.854 -177.15 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' E' E ' 63' ' ' ARG . . . . . . . . . . . . . 27.1 mmm180 -73.31 -17.36 61.32 Favored 'General case' 0 CA--C 1.533 0.317 0 N-CA-C 113.178 0.807 . . . . 0.0 113.178 -177.08 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' E' E ' 64' ' ' THR . . . . . . . . . . . . . 25.7 m -70.07 139.25 52.56 Favored 'General case' 0 C--N 1.332 -0.156 0 CA-C-O 120.865 0.364 . . . . 0.0 110.987 -175.235 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' E' E ' 65' ' ' LYS . . . . . . . . . . . . . 64.4 mttm -86.06 133.94 33.86 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.041 -0.527 . . . . 0.0 109.922 178.167 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' E' E ' 66' ' ' ILE . . . . . . . . . . . . . 64.3 mt -114.31 125.59 71.65 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.29 0 N-CA-C 109.57 -0.53 . . . . 0.0 109.57 178.839 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' E' E ' 67' ' ' THR . . . . . . . . . . . . . 29.5 m -118.12 137.53 52.89 Favored 'General case' 0 C--N 1.331 -0.213 0 CA-C-N 116.06 -0.518 . . . . 0.0 110.555 -178.013 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' E' E ' 68' ' ' LEU . . . . . . . . . . . . . 19.6 tp . . . . . 0 C--N 1.327 -0.37 0 CA-C-N 115.79 -0.641 . . . . 0.0 110.466 -179.222 . . . . . . . . 0 0 . 1 . 005 nuclear nobuild core ' E' E ' 73' ' ' VAL . . . . . . . . . . . . . 34.2 m . . . . . 0 C--O 1.232 0.134 0 CA-C-O 120.621 0.248 . . . . 0.0 110.597 . . . . . . . . . 0 0 . 1 . 005 nuclear nobuild core ' E' E ' 74' ' ' ASP . . . . . . . . . . . . . 33.7 t0 -86.46 117.59 25.35 Favored 'General case' 0 C--N 1.33 -0.259 0 C-N-CA 120.933 -0.307 . . . . 0.0 110.187 -173.862 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' E' E ' 75' ' ' VAL . . . . . . . . . . . . . 46.4 t -117.28 120.78 65.99 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.235 0 CA-C-O 121.126 0.489 . . . . 0.0 110.191 -178.439 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' E' E ' 76' ' ' LEU . . . . . . . . . . . . . 15.7 mt -123.32 142.22 51.17 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 115.559 -0.746 . . . . 0.0 109.502 178.688 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' E' E ' 77' ' ' GLU . . . . . . . . . . . . . 97.1 mt-10 -135.4 129.58 33.53 Favored 'General case' 0 C--N 1.331 -0.227 0 CA-C-O 121.064 0.459 . . . . 0.0 111.058 -177.221 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' E' E ' 78' ' ' ALA . . . . . 0.606 ' HB2' HD21 ' E' ' 109' ' ' LEU . . . -116.25 126.54 53.73 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 115.649 -0.705 . . . . 0.0 109.586 177.24 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' E' E ' 79' ' ' LYS . . . . . 0.436 ' O ' HD13 ' E' ' 80' ' ' ILE . 48.0 pttt -76.72 119.18 20.16 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-O 121.284 0.564 . . . . 0.0 110.962 -177.386 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' E' E ' 80' ' ' ILE . . . . . 0.436 HD13 ' O ' ' E' ' 79' ' ' LYS . 26.8 mm -139.25 106.11 2.71 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.244 0 CA-C-N 115.563 -0.744 . . . . 0.0 109.09 -178.932 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' E' E ' 81' ' ' LYS . . . . . . . . . . . . . 53.1 mtmt -99.5 129.19 45.65 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-O 120.925 0.393 . . . . 0.0 110.865 -178.678 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' E' E ' 82' ' ' GLY . . . . . . . . . . . . . . . 89.16 42.18 5.65 Favored Glycine 0 CA--C 1.525 0.666 0 C-N-CA 120.915 -0.66 . . . . 0.0 111.701 175.423 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' E' E ' 83' ' ' ILE . . . . . . . . . . . . . 75.2 mt -67.95 138.16 23.16 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.302 0 N-CA-C 109.771 -0.455 . . . . 0.0 109.771 176.48 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' E' E ' 84' ' ' LYS . . . . . . . . . . . . . 58.6 tttp -95.06 -52.76 4.08 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.122 -0.49 . . . . 0.0 109.956 -179.702 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' E' E ' 85' ' ' ASP . . . . . . . . . . . . . 6.5 t70 -155.72 153.58 30.15 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 115.792 -0.64 . . . . 0.0 110.371 -179.458 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' E' E ' 86' ' ' VAL . . . . . . . . . . . . . 43.0 t -130.29 132.67 64.86 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.258 0 CA-C-O 120.991 0.424 . . . . 0.0 110.498 -179.628 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' E' E ' 87' ' ' ILE . . . . . . . . . . . . . 45.2 mm -116.95 125.72 74.0 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.252 0 CA-C-N 115.722 -0.672 . . . . 0.0 109.55 176.745 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' E' E ' 88' ' ' LEU . . . . . 0.499 HD21 ' NH1' ' D' ' 126' ' ' ARG . 16.8 tp -110.11 129.87 55.63 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-O 120.852 0.358 . . . . 0.0 110.946 -177.436 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' E' E ' 89' ' ' ASP . . . . . . . . . . . . . 13.9 t70 -125.47 155.7 40.08 Favored 'General case' 0 C--N 1.331 -0.221 0 CA-C-N 116.085 -0.507 . . . . 0.0 109.936 177.637 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' E' E ' 90' ' ' GLU . . . . . . . . . . . . . 45.3 tp10 -45.84 -38.84 7.75 Favored 'General case' 0 C--N 1.33 -0.282 0 N-CA-C 113.132 0.79 . . . . 0.0 113.132 -172.167 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' E' E ' 91' ' ' ASN . . . . . . . . . . . . . 20.9 t30 -132.04 22.37 4.52 Favored 'General case' 0 N--CA 1.468 0.462 0 N-CA-C 112.87 0.692 . . . . 0.0 112.87 -177.147 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' E' E ' 92' ' ' LEU . . . . . 0.413 HD12 ' O ' ' E' ' 127' ' ' ASN . 10.2 mt -149.48 147.14 27.87 Favored 'General case' 0 C--N 1.332 -0.167 0 N-CA-C 110.191 -0.3 . . . . 0.0 110.191 -177.025 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' E' E ' 93' ' ' ILE . . . . . . . . . . . . . 67.6 mt -124.34 119.57 56.88 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.203 0 N-CA-C 109.199 -0.667 . . . . 0.0 109.199 176.213 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' E' E ' 94' ' ' VAL . . . . . . . . . . . . . 45.7 t -118.84 127.44 75.74 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.252 0 N-CA-C 109.849 -0.426 . . . . 0.0 109.849 -179.482 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' E' E ' 95' ' ' VAL . . . . . . . . . . . . . 44.0 t -123.99 135.8 62.38 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.324 0 CA-C-N 116.135 -0.484 . . . . 0.0 110.177 -178.404 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' E' E ' 96' ' ' ILE . . . . . . . . . . . . . 57.7 mt -117.19 129.19 74.12 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.287 0 N-CA-C 109.269 -0.641 . . . . 0.0 109.269 178.117 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' E' E ' 97' ' ' THR . . . . . . . . . . . . . 78.5 p -103.63 158.16 16.56 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-O 121.185 0.517 . . . . 0.0 111.282 -177.431 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' E' E ' 98' ' ' GLU . . . . . . . . . . . . . 70.6 mm-40 -54.23 -25.62 24.12 Favored 'General case' 0 C--N 1.33 -0.247 0 N-CA-C 112.408 0.521 . . . . 0.0 112.408 -179.754 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' E' E ' 99' ' ' GLU . . . . . . . . . . . . . 47.2 mp0 -78.19 14.33 1.21 Allowed 'General case' 0 CA--C 1.535 0.402 0 N-CA-C 113.136 0.791 . . . . 0.0 113.136 -178.032 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' E' E ' 100' ' ' ASN . . . . . . . . . . . . . 3.6 m-20 62.21 37.33 14.32 Favored 'General case' 0 CA--C 1.53 0.201 0 CA-C-O 120.994 0.426 . . . . 0.0 110.997 178.741 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' E' E ' 101' ' ' GLU . . . . . . . . . . . . . 84.7 tt0 -113.99 144.14 43.58 Favored 'General case' 0 C--N 1.331 -0.198 0 CA-C-N 116.02 -0.536 . . . . 0.0 109.735 176.244 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' E' E ' 102' ' ' VAL . . . . . . . . . . . . . 44.3 t -114.98 126.0 72.45 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.299 0 CA-C-N 116.225 -0.443 . . . . 0.0 109.914 -178.803 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' E' E ' 103' ' ' LEU . . . . . . . . . . . . . 21.5 mt -118.29 132.08 56.31 Favored 'General case' 0 C--N 1.331 -0.217 0 CA-C-N 115.662 -0.699 . . . . 0.0 110.31 178.778 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' E' E ' 104' ' ' ILE . . . . . . . . . . . . . 69.7 mt -120.14 123.57 70.96 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.266 0 N-CA-C 110.063 -0.347 . . . . 0.0 110.063 178.601 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' E' E ' 105' ' ' PHE . . . . . . . . . . . . . 70.8 m-85 -124.88 162.43 24.41 Favored 'General case' 0 C--N 1.333 -0.15 0 O-C-N 123.848 0.718 . . . . 0.0 109.89 179.336 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' E' E ' 106' ' ' ASN . . . . . . . . . . . . . 46.0 p-10 -97.22 -170.46 2.03 Favored 'General case' 0 C--N 1.33 -0.266 0 N-CA-C 109.981 -0.377 . . . . 0.0 109.981 174.143 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' E' E ' 107' ' ' GLN . . . . . . . . . . . . . 55.6 tp60 -59.71 -30.07 68.55 Favored 'General case' 0 CA--C 1.531 0.214 0 N-CA-C 111.911 0.337 . . . . 0.0 111.911 179.911 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' E' E ' 108' ' ' ASN . . . . . . . . . . . . . 52.0 t30 -81.92 8.21 11.01 Favored 'General case' 0 CA--C 1.535 0.384 0 N-CA-C 113.109 0.781 . . . . 0.0 113.109 -177.601 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' E' E ' 109' ' ' LEU . . . . . 0.606 HD21 ' HB2' ' E' ' 78' ' ' ALA . 12.7 tp 58.39 38.79 25.75 Favored 'General case' 0 C--N 1.332 -0.183 0 CA-C-O 121.105 0.479 . . . . 0.0 110.901 179.339 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' E' E ' 110' ' ' GLU . . . . . . . . . . . . . 70.8 mm-40 -105.23 149.14 26.22 Favored 'General case' 0 C--N 1.332 -0.192 0 N-CA-C 109.925 -0.398 . . . . 0.0 109.925 176.798 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' E' E ' 111' ' ' GLU . . . . . . . . . . . . . 84.5 tt0 -78.39 121.83 25.01 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 116.419 -0.355 . . . . 0.0 110.616 -177.402 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' E' E ' 112' ' ' LEU . . . . . . . . . . . . . 18.4 mt -110.17 -46.11 3.49 Favored 'General case' 0 C--N 1.331 -0.21 0 CA-C-N 116.283 -0.417 . . . . 0.0 110.697 179.174 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' E' E ' 113' ' ' TYR . . . . . . . . . . . . . 64.3 t80 -138.89 136.27 35.35 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.262 -0.426 . . . . 0.0 111.045 -179.147 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' E' E ' 114' ' ' ARG . . . . . . . . . . . . . 70.1 ttp85 -138.53 120.37 15.37 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-N 116.025 -0.534 . . . . 0.0 110.277 176.695 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' E' E ' 115' ' ' GLY . . . . . . . . . . . . . . . -150.14 145.65 13.95 Favored Glycine 0 CA--C 1.524 0.641 0 N-CA-C 110.842 -0.903 . . . . 0.0 110.842 178.118 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' E' E ' 116' ' ' LYS . . . . . . . . . . . . . 28.4 ttmt -115.26 136.59 52.95 Favored 'General case' 0 C--N 1.331 -0.23 0 O-C-N 122.565 -0.374 . . . . 0.0 110.171 177.94 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' E' E ' 117' ' ' PHE . . . . . . . . . . . . . 58.5 m-85 -131.46 117.37 18.74 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 116.15 -0.477 . . . . 0.0 110.129 -177.018 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' E' E ' 118' ' ' GLU . . . . . . . . . . . . . 96.2 mt-10 -54.43 -41.64 69.6 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.507 -0.315 . . . . 0.0 111.486 -175.31 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' E' E ' 119' ' ' ASN . . . . . . . . . . . . . 19.0 m120 -104.05 31.1 4.73 Favored 'General case' 0 C--N 1.33 -0.249 0 N-CA-C 112.129 0.418 . . . . 0.0 112.129 -173.885 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' E' E ' 120' ' ' LEU . . . . . . . . . . . . . 21.3 tp -56.65 123.29 14.36 Favored 'General case' 0 C--N 1.332 -0.16 0 C-N-CA 121.118 -0.233 . . . . 0.0 110.412 178.555 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' E' E ' 121' ' ' ASN . . . . . . . . . . . . . 27.2 m120 -114.13 -44.28 3.15 Favored 'General case' 0 N--CA 1.462 0.165 0 CA-C-N 116.759 -0.201 . . . . 0.0 111.353 -176.829 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' E' E ' 122' ' ' LYS . . . . . . . . . . . . . 94.4 mttt -147.73 151.52 36.23 Favored 'General case' 0 C--N 1.332 -0.191 0 CA-C-O 121.03 0.443 . . . . 0.0 111.715 -176.963 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' E' E ' 123' ' ' VAL . . . . . . . . . . . . . 42.7 t -132.91 133.13 59.14 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.181 0 N-CA-C 109.633 -0.506 . . . . 0.0 109.633 175.249 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' E' E ' 124' ' ' LEU . . . . . . . . . . . . . 69.9 mt -130.09 137.72 50.33 Favored 'General case' 0 C--N 1.331 -0.197 0 CA-C-N 116.452 -0.34 . . . . 0.0 110.842 -178.772 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' E' E ' 125' ' ' VAL . . . . . . . . . . . . . 11.8 p -136.95 137.17 47.24 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.262 0 CA-C-N 116.385 -0.37 . . . . 0.0 110.651 179.669 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' E' E ' 126' ' ' ARG . . . . . . . . . . . . . 83.3 mtt180 -146.06 130.28 17.54 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.679 177.226 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' E' E ' 127' ' ' ASN . . . . . 0.413 ' O ' HD12 ' E' ' 92' ' ' LEU . 36.3 t30 50.64 -112.22 0.59 Allowed 'General case' 0 CA--C 1.545 0.761 0 CA-C-O 118.64 -0.695 . . . . 0.0 111.46 178.751 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' E' E ' 128' ' ' ASP . . . . . . . . . . . . . 17.3 p-10 -112.59 8.16 19.07 Favored 'General case' 0 N--CA 1.468 0.435 0 CA-C-N 120.157 1.344 . . . . 0.0 113.317 -177.317 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' E' E ' 129' ' ' LEU . . . . . . . . . . . . . 15.5 tp -116.38 137.49 52.11 Favored 'General case' 0 C--N 1.333 -0.139 0 N-CA-C 109.745 -0.465 . . . . 0.0 109.745 178.89 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' E' E ' 130' ' ' VAL . . . . . 0.532 HG13 ' HB ' ' E' ' 141' ' ' ILE . 12.7 p -132.62 143.39 39.86 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.198 0 CA-C-O 121.143 0.497 . . . . 0.0 110.563 -179.556 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' E' E ' 131' ' ' VAL . . . . . . . . . . . . . 39.3 t -135.53 140.72 44.08 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.246 0 CA-C-N 115.969 -0.559 . . . . 0.0 110.383 -178.941 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' E' E ' 132' ' ' ILE . . . . . . . . . . . . . 70.3 mt -115.93 132.86 64.17 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.316 0 CA-C-N 115.752 -0.658 . . . . 0.0 109.355 179.292 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' E' E ' 133' ' ' ILE . . . . . . . . . . . . . 41.9 mm -116.24 124.15 72.18 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.238 0 CA-C-O 120.896 0.379 . . . . 0.0 111.064 -175.061 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' E' E ' 134' ' ' ASP . . . . . . . . . . . . . 7.8 p-10 -135.35 149.76 49.79 Favored 'General case' 0 C--N 1.331 -0.205 0 CA-C-N 116.075 -0.511 . . . . 0.0 109.677 174.574 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' E' E ' 135' ' ' GLU . . . . . . . . . . . . . 40.2 tp10 -50.76 -28.38 9.09 Favored 'General case' 0 C--N 1.327 -0.377 0 N-CA-C 112.709 0.633 . . . . 0.0 112.709 -173.088 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' E' E ' 136' ' ' GLN . . . . . . . . . . . . . 98.3 mt-30 -84.55 -29.82 25.58 Favored 'General case' 0 C--O 1.233 0.229 0 N-CA-C 112.882 0.697 . . . . 0.0 112.882 -175.432 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' E' E ' 137' ' ' LYS . . . . . . . . . . . . . 58.9 pttt -168.86 175.35 5.98 Favored 'General case' 0 C--N 1.332 -0.171 0 CA-C-O 121.609 0.719 . . . . 0.0 112.449 -172.879 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' E' E ' 138' ' ' LEU . . . . . 0.457 ' C ' HD23 ' E' ' 138' ' ' LEU . 8.6 tt -121.62 129.42 52.81 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 114.997 -1.001 . . . . 0.0 109.958 178.475 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' E' E ' 139' ' ' THR . . . . . . . . . . . . . 43.7 m -109.1 128.22 54.82 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.188 179.316 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' E' E ' 140' ' ' LEU . . . . . 0.48 ' C ' HD23 ' E' ' 140' ' ' LEU . 7.2 tt -112.81 125.25 54.14 Favored 'General case' 0 C--N 1.328 -0.35 0 N-CA-C 109.174 -0.676 . . . . 0.0 109.174 -178.828 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' E' E ' 141' ' ' ILE . . . . . 0.532 ' HB ' HG13 ' E' ' 130' ' ' VAL . 19.4 mt -123.57 119.29 56.86 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.277 0 CA-C-O 121.132 0.492 . . . . 0.0 110.09 -176.469 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' E' E ' 142' ' ' ARG . . . . . . . . . . . . . 77.6 ttt-85 -106.39 130.0 54.28 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 115.001 -1.0 . . . . 0.0 110.226 -179.882 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' E' E ' 143' ' ' THR . . . . . . . . . . . . . 44.6 p . . . . . 0 C--O 1.219 -0.514 0 CA-C-O 117.959 -1.02 . . . . 0.0 110.547 179.112 . . . . . . . . 0 0 . 1 . 005 nuclear nobuild core ' F' F ' 1' ' ' MET . . . . . . . . . . . . . 26.2 ptt? . . . . . 0 C--O 1.232 0.154 0 CA-C-O 120.841 0.353 . . . . 0.0 110.957 . . . . . . . . . 0 0 . 1 . 005 nuclear nobuild core ' F' F ' 2' ' ' SER . . . . . . . . . . . . . 14.3 p -130.8 135.33 47.65 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.083 -0.508 . . . . 0.0 110.082 178.419 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' F' F ' 3' ' ' GLU . . . . . . . . . . . . . 46.8 mp0 -139.45 141.15 37.45 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.146 -0.479 . . . . 0.0 111.321 -176.615 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' F' F ' 4' ' ' LEU . . . . . . . . . . . . . 57.6 mt -118.94 124.97 48.35 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 115.606 -0.725 . . . . 0.0 109.85 173.96 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' F' F ' 5' ' ' LYS . . . . . . . . . . . . . 98.3 mttt -102.36 119.81 39.44 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.459 -0.337 . . . . 0.0 110.144 177.646 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' F' F ' 6' ' ' LEU . . . . . . . . . . . . . 70.5 mt -119.45 144.32 47.03 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 115.416 -0.811 . . . . 0.0 110.421 -177.9 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' F' F ' 7' ' ' LYS . . . . . . . . . . . . . 47.4 tttm -134.64 142.78 43.86 Favored Pre-proline 0 CA--C 1.534 0.354 0 CA-C-O 119.2 -0.428 . . . . 0.0 110.142 177.331 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' F' F ' 8' ' ' PRO . . . . . . . . . . . . . 85.0 Cg_endo -92.16 143.35 2.63 Favored 'Trans proline' 0 N--CA 1.49 1.319 0 C-N-CA 121.749 1.633 . . . . 0.0 111.714 176.997 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' F' F ' 9' ' ' LEU . . . . . . . . . . . . . 62.0 mt -76.74 -47.02 3.04 Favored Pre-proline 0 CA--C 1.535 0.367 0 CA-C-O 118.691 -0.671 . . . . 0.0 112.041 179.735 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' F' F ' 10' ' ' PRO . . . . . . . . . . . . . 85.4 Cg_endo -81.71 150.2 16.5 Favored 'Trans proline' 0 N--CA 1.495 1.59 0 C-N-CA 121.185 1.257 . . . . 0.0 111.54 174.604 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' F' F ' 11' ' ' LYS . . . . . . . . . . . . . 54.0 pttt -86.95 113.12 22.45 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-O 121.552 0.692 . . . . 0.0 110.949 179.981 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' F' F ' 12' ' ' VAL . . . . . . . . . . . . . 13.3 p -151.09 148.34 14.99 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.194 0 CA-C-N 115.736 -0.666 . . . . 0.0 110.458 178.901 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' F' F ' 13' ' ' GLU . . . . . . . . . . . . . 45.3 mt-10 -88.0 124.19 33.48 Favored 'General case' 0 C--N 1.331 -0.224 0 CA-C-O 120.759 0.314 . . . . 0.0 110.595 177.836 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' F' F ' 14' ' ' LEU . . . . . . . . . . . . . 22.8 mt -99.77 154.61 37.16 Favored Pre-proline 0 CA--C 1.532 0.285 0 CA-C-N 116.276 -0.42 . . . . 0.0 111.012 -178.282 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' F' F ' 15' ' ' PRO . . . . . . . . . . . . . 27.7 Cg_exo -62.05 162.99 20.83 Favored 'Trans proline' 0 N--CA 1.498 1.736 0 C-N-CA 121.423 1.415 . . . . 0.0 111.963 176.07 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' F' F ' 16' ' ' PRO . . . . . . . . . . . . . 21.5 Cg_exo -64.61 -37.07 39.07 Favored 'Trans proline' 0 N--CA 1.497 1.705 0 C-N-CA 121.592 1.528 . . . . 0.0 112.724 -179.512 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' F' F ' 17' ' ' ASP . . . . . . . . . . . . . 12.7 p-10 -87.09 12.11 12.25 Favored 'General case' 0 CA--C 1.535 0.391 0 N-CA-C 113.142 0.793 . . . . 0.0 113.142 -177.149 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' F' F ' 18' ' ' PHE . . . . . . . . . . . . . 41.1 t80 -56.44 -41.85 77.15 Favored 'General case' 0 CA--C 1.526 0.047 0 O-C-N 121.939 -0.476 . . . . 0.0 110.375 -179.56 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' F' F ' 19' ' ' VAL . . . . . . . . . . . . . 44.3 t -55.98 -43.51 75.28 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.285 0 CA-C-N 116.399 -0.364 . . . . 0.0 110.579 -178.627 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' F' F ' 20' ' ' ASP . . . . . . . . . . . . . 29.8 t0 -59.88 -43.09 94.95 Favored 'General case' 0 C--N 1.33 -0.274 0 C-N-CA 120.915 -0.314 . . . . 0.0 110.784 -177.811 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' F' F ' 21' ' ' VAL . . . . . . . . . . . . . 45.4 t -63.33 -46.44 95.51 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.277 0 C-N-CA 120.63 -0.428 . . . . 0.0 110.437 -177.748 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' F' F ' 22' ' ' ILE . . . . . 0.437 HG22 ' CD1' ' F' ' 26' ' ' LEU . 51.4 mm -55.98 -47.11 80.54 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.275 0 C-N-CA 120.905 -0.318 . . . . 0.0 110.808 179.793 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' F' F ' 23' ' ' ARG . . . . . . . . . . . . . 55.4 ttp180 -55.02 -47.19 75.03 Favored 'General case' 0 C--N 1.331 -0.239 0 C-N-CA 120.932 -0.307 . . . . 0.0 111.303 -178.194 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' F' F ' 24' ' ' ILE . . . . . . . . . . . . . 75.5 mt -59.17 -42.58 87.23 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.268 0 C-N-CA 120.939 -0.304 . . . . 0.0 111.212 -177.672 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' F' F ' 25' ' ' LYS . . . . . . . . . . . . . 50.3 mttm -67.74 -39.57 84.23 Favored 'General case' 0 C--N 1.33 -0.266 0 N-CA-C 112.67 0.619 . . . . 0.0 112.67 -179.51 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' F' F ' 26' ' ' LEU . . . . . 0.437 ' CD1' HG22 ' F' ' 22' ' ' ILE . 95.8 mt -77.37 -39.85 45.96 Favored 'General case' 0 C--N 1.329 -0.307 0 N-CA-C 113.17 0.804 . . . . 0.0 113.17 -170.486 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' F' F ' 27' ' ' GLN . . . . . . . . . . . . . 10.4 pt20 -46.7 139.99 4.86 Favored 'General case' 0 N--CA 1.469 0.476 0 N-CA-C 112.785 0.661 . . . . 0.0 112.785 -174.501 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' F' F ' 28' ' ' GLY . . . . . . . . . . . . . . . 100.56 -29.29 12.67 Favored Glycine 0 CA--C 1.531 1.045 0 CA-C-N 115.592 -0.731 . . . . 0.0 112.016 -177.642 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' F' F ' 29' ' ' LYS . . . . . . . . . . . . . 72.8 mttt -97.92 155.08 17.25 Favored 'General case' 0 C--O 1.233 0.199 0 CA-C-N 117.203 0.501 . . . . 0.0 111.163 178.236 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' F' F ' 30' ' ' THR . . . . . . . . . . . . . 29.6 m -100.67 139.16 36.74 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 115.899 -0.591 . . . . 0.0 109.822 175.272 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' F' F ' 31' ' ' VAL . . . . . . . . . . . . . 35.0 m -122.08 149.55 25.45 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.259 0 CA-C-O 120.926 0.393 . . . . 0.0 110.823 -178.105 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' F' F ' 32' ' ' ARG . . . . . . . . . . . . . 39.1 ttp180 -132.95 147.86 52.28 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-N 115.669 -0.696 . . . . 0.0 110.314 177.582 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' F' F ' 33' ' ' THR . . . . . . . . . . . . . 27.4 m -53.61 137.34 37.16 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.418 -0.355 . . . . 0.0 111.281 -179.348 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' F' F ' 34' ' ' GLY . . . . . . . . . . . . . . . 101.76 -17.22 55.2 Favored Glycine 0 CA--C 1.532 1.108 0 CA-C-O 119.7 -0.5 . . . . 0.0 113.348 178.813 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' F' F ' 35' ' ' ASP . . . . . . . . . . . . . 78.8 m-20 -65.79 147.73 52.91 Favored 'General case' 0 N--CA 1.462 0.147 0 CA-C-N 118.015 0.907 . . . . 0.0 111.058 179.472 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' F' F ' 36' ' ' VAL . . . . . . . . . . . . . 44.3 t -122.97 129.62 74.99 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.267 0 CA-C-N 116.115 -0.493 . . . . 0.0 109.815 178.431 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' F' F ' 37' ' ' ILE . . . . . . . . . . . . . 68.0 mt -119.62 138.64 49.58 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.184 0 CA-C-N 116.123 -0.489 . . . . 0.0 109.846 -179.972 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' F' F ' 38' ' ' GLY . . . . . . . . . . . . . . . -110.58 128.65 8.9 Favored Glycine 0 CA--C 1.525 0.683 0 N-CA-C 111.19 -0.764 . . . . 0.0 111.19 -179.653 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' F' F ' 39' ' ' ILE . . . . . . . . . . . . . 72.5 mt -127.13 128.07 70.09 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.233 0 N-CA-C 109.922 -0.399 . . . . 0.0 109.922 178.537 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' F' F ' 40' ' ' SER . . . . . . . . . . . . . 30.8 t -92.42 121.19 33.65 Favored 'General case' 0 C--N 1.329 -0.305 0 C-N-CA 120.823 -0.351 . . . . 0.0 110.677 175.967 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' F' F ' 41' ' ' ILE . . . . . . . . . . . . . 71.1 mt -127.45 123.99 62.81 Favored 'Isoleucine or valine' 0 N--CA 1.462 0.159 0 CA-C-O 120.935 0.398 . . . . 0.0 110.582 -179.226 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' F' F ' 42' ' ' LEU . . . . . . . . . . . . . 7.0 tp 52.58 37.65 23.78 Favored 'General case' 0 C--N 1.331 -0.219 0 CA-C-N 116.062 -0.517 . . . . 0.0 111.671 175.661 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' F' F ' 43' ' ' GLY . . . . . . . . . . . . . . . 73.18 28.16 66.84 Favored Glycine 0 CA--C 1.53 1.025 0 C-N-CA 121.073 -0.584 . . . . 0.0 112.567 176.569 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' F' F ' 44' ' ' LYS . . . . . . . . . . . . . 62.8 tttm -140.59 126.38 19.28 Favored 'General case' 0 C--N 1.33 -0.272 0 N-CA-C 109.474 -0.565 . . . . 0.0 109.474 177.234 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' F' F ' 45' ' ' GLU . . . . . . . . . . . . . 34.7 tp10 -82.82 124.31 30.18 Favored 'General case' 0 C--N 1.328 -0.331 0 C-N-CA 120.718 -0.393 . . . . 0.0 110.836 -176.876 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' F' F ' 46' ' ' VAL . . . . . . . . . . . . . 7.6 p -120.8 129.45 75.64 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.204 0 N-CA-C 109.561 -0.533 . . . . 0.0 109.561 177.285 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' F' F ' 47' ' ' LYS . . . . . . . . . . . . . 61.3 mmtt -100.23 130.09 46.32 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 115.935 -0.575 . . . . 0.0 111.104 178.572 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' F' F ' 48' ' ' PHE . . . . . . . . . . . . . 94.2 m-85 -112.61 131.86 55.42 Favored 'General case' 0 C--N 1.331 -0.233 0 N-CA-C 109.638 -0.504 . . . . 0.0 109.638 175.795 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' F' F ' 49' ' ' LYS . . . . . . . . . . . . . 48.9 tttp -108.7 136.71 47.83 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.314 -0.403 . . . . 0.0 110.612 179.936 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' F' F ' 50' ' ' VAL . . . . . . . . . . . . . 46.8 t -78.92 106.46 9.92 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.333 0 N-CA-C 108.91 -0.774 . . . . 0.0 108.91 175.155 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' F' F ' 51' ' ' VAL . . . . . . . . . . . . . 47.3 t -74.81 -47.43 37.8 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.327 0 CA-C-N 116.075 -0.511 . . . . 0.0 110.139 -172.957 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' F' F ' 52' ' ' GLN . . . . . . . . . . . . . 57.5 tt0 -160.72 137.84 9.1 Favored 'General case' 0 C--N 1.33 -0.281 0 C-N-CA 120.465 -0.494 . . . . 0.0 111.351 -177.466 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' F' F ' 53' ' ' ALA . . . . . . . . . . . . . . . -114.75 131.79 56.66 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 115.964 -0.562 . . . . 0.0 109.983 174.494 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' F' F ' 54' ' ' TYR . . . . . . . . . . . . . 33.7 t80 -129.01 109.16 18.2 Favored Pre-proline 0 C--N 1.328 -0.334 0 CA-C-O 118.302 -0.856 . . . . 0.0 110.492 179.271 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' F' F ' 55' ' ' PRO . . . . . . . . . . . . . 74.0 Cg_endo -77.14 168.51 76.76 Favored 'Cis proline' 0 N--CA 1.499 1.841 0 CA-C-N 121.951 1.733 . . . . 0.0 112.292 -5.819 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' F' F ' 56' ' ' SER . . . . . . . . . . . . . 69.2 m -117.5 134.78 23.12 Favored Pre-proline 0 CA--C 1.539 0.524 0 CA-C-O 118.466 -0.778 . . . . 0.0 109.704 175.126 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' F' F ' 57' ' ' PRO . . . . . . . . . . . . . 57.6 Cg_endo -73.14 162.82 90.92 Favored 'Cis proline' 0 N--CA 1.496 1.619 0 CA-C-N 121.806 1.681 . . . . 0.0 111.375 -3.501 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' F' F ' 58' ' ' LEU . . . . . . . . . . . . . 33.6 tp -130.0 137.84 50.5 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-O 120.851 0.357 . . . . 0.0 110.793 -178.658 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' F' F ' 59' ' ' ARG . . . . . . . . . . . . . 32.2 ttp180 -99.65 127.52 45.76 Favored 'General case' 0 C--N 1.327 -0.374 0 N-CA-C 109.335 -0.617 . . . . 0.0 109.335 175.459 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' F' F ' 60' ' ' VAL . . . . . . . . . . . . . 41.2 t -80.96 123.15 37.27 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.266 0 C-N-CA 120.598 -0.441 . . . . 0.0 110.506 -175.073 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' F' F ' 61' ' ' GLU . . . . . . . . . . . . . 42.9 mt-10 -131.13 171.38 13.34 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 115.608 -0.724 . . . . 0.0 109.674 176.483 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' F' F ' 62' ' ' ASP . . . . . . . . . . . . . 83.8 m-20 -54.27 -32.59 56.58 Favored 'General case' 0 C--N 1.329 -0.308 0 C-N-CA 120.968 -0.293 . . . . 0.0 111.752 -179.279 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' F' F ' 63' ' ' ARG . . . . . . . . . . . . . 25.0 ptt180 -83.9 2.25 39.46 Favored 'General case' 0 CA--C 1.537 0.455 0 N-CA-C 113.727 1.01 . . . . 0.0 113.727 -175.263 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' F' F ' 64' ' ' THR . . . . . . . . . . . . . 28.4 m -78.44 136.8 37.71 Favored 'General case' 0 C--N 1.333 -0.133 0 CA-C-N 118.119 0.418 . . . . 0.0 110.705 -177.621 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' F' F ' 65' ' ' LYS . . . . . . . . . . . . . 24.6 mtpp -90.35 127.04 36.07 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.037 -0.529 . . . . 0.0 110.218 179.275 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' F' F ' 66' ' ' ILE . . . . . . . . . . . . . 4.3 mp -113.87 131.47 65.65 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.262 0 N-CA-C 110.012 -0.366 . . . . 0.0 110.012 179.628 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' F' F ' 67' ' ' THR . . . . . . . . . . . . . 20.9 m -122.19 132.62 54.54 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-O 121.069 0.462 . . . . 0.0 110.331 178.525 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' F' F ' 68' ' ' LEU . . . . . 0.435 HD23 ' C ' ' F' ' 68' ' ' LEU . 6.2 tt . . . . . 0 C--N 1.328 -0.337 0 CA-C-N 115.825 -0.625 . . . . 0.0 110.002 -179.982 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' F' F ' 73' ' ' VAL . . . . . . . . . . . . . 34.8 m . . . . . 0 N--CA 1.46 0.045 0 CA-C-O 121.109 0.481 . . . . 0.0 111.154 . . . . . . . . . 0 0 . 1 . 005 nuclear nobuild core ' F' F ' 74' ' ' ASP . . . . . . . . . . . . . 12.8 t70 -101.82 123.72 46.24 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 115.542 -0.754 . . . . 0.0 109.594 177.464 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' F' F ' 75' ' ' VAL . . . . . . . . . . . . . 45.1 t -111.86 123.92 68.1 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.253 0 CA-C-O 121.145 0.498 . . . . 0.0 110.527 -178.105 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' F' F ' 76' ' ' LEU . . . . . . . . . . . . . 29.1 mt -123.86 142.23 51.31 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 115.533 -0.758 . . . . 0.0 109.418 177.661 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' F' F ' 77' ' ' GLU . . . . . . . . . . . . . 97.8 mt-10 -133.92 137.98 45.24 Favored 'General case' 0 C--N 1.331 -0.227 0 CA-C-O 121.018 0.437 . . . . 0.0 111.312 -178.145 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' F' F ' 78' ' ' ALA . . . . . 0.688 ' HB2' HD21 ' F' ' 109' ' ' LEU . . . -128.11 136.36 51.06 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 115.718 -0.673 . . . . 0.0 109.722 176.35 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' F' F ' 79' ' ' LYS . . . . . 0.593 ' O ' HD13 ' F' ' 80' ' ' ILE . 19.8 pttp -79.46 123.76 27.83 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-O 121.187 0.518 . . . . 0.0 111.142 -177.893 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' F' F ' 80' ' ' ILE . . . . . 0.593 HD13 ' O ' ' F' ' 79' ' ' LYS . 40.6 mm -139.21 112.73 6.57 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.279 0 CA-C-N 115.725 -0.671 . . . . 0.0 109.278 -178.199 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' F' F ' 81' ' ' LYS . . . . . . . . . . . . . 47.0 tptt -102.1 123.43 45.96 Favored 'General case' 0 C--N 1.329 -0.287 0 C-N-CA 120.921 -0.312 . . . . 0.0 111.072 -177.474 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' F' F ' 82' ' ' GLY . . . . . . . . . . . . . . . 89.07 42.15 5.69 Favored Glycine 0 CA--C 1.525 0.657 0 C-N-CA 120.722 -0.752 . . . . 0.0 111.954 173.551 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' F' F ' 83' ' ' ILE . . . . . . . . . . . . . 72.4 mt -64.04 137.47 24.75 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.29 0 N-CA-C 109.915 -0.402 . . . . 0.0 109.915 178.139 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' F' F ' 84' ' ' LYS . . . . . . . . . . . . . 82.2 tttt -99.43 -53.8 3.12 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 115.999 -0.546 . . . . 0.0 110.42 -178.975 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' F' F ' 85' ' ' ASP . . . . . . . . . . . . . 8.6 t0 -154.96 153.01 30.39 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 115.748 -0.66 . . . . 0.0 109.972 -179.706 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' F' F ' 86' ' ' VAL . . . . . . . . . . . . . 43.2 t -128.85 131.59 68.22 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.24 0 CA-C-O 120.9 0.381 . . . . 0.0 110.767 -178.016 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' F' F ' 87' ' ' ILE . . . . . . . . . . . . . 42.4 mm -118.22 124.26 72.84 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.245 0 CA-C-N 115.782 -0.644 . . . . 0.0 109.503 175.164 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' F' F ' 88' ' ' LEU . . . . . . . . . . . . . 14.8 tp -112.96 131.9 55.56 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-O 120.938 0.399 . . . . 0.0 111.36 -176.185 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' F' F ' 89' ' ' ASP . . . . . . . . . . . . . 13.5 t70 -131.08 151.52 51.35 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 115.861 -0.609 . . . . 0.0 109.442 175.932 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' F' F ' 90' ' ' GLU . . . . . . . . . . . . . 46.6 tp10 -48.96 -35.05 14.19 Favored 'General case' 0 C--N 1.329 -0.32 0 N-CA-C 112.712 0.634 . . . . 0.0 112.712 -172.49 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' F' F ' 91' ' ' ASN . . . . . . . . . . . . . 12.7 p30 -123.36 14.58 9.64 Favored 'General case' 0 N--CA 1.47 0.534 0 N-CA-C 113.452 0.908 . . . . 0.0 113.452 -175.883 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' F' F ' 92' ' ' LEU . . . . . . . . . . . . . 8.1 mt -151.66 143.17 23.53 Favored 'General case' 0 C--N 1.332 -0.171 0 N-CA-C 109.797 -0.446 . . . . 0.0 109.797 -177.101 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' F' F ' 93' ' ' ILE . . . . . . . . . . . . . 71.0 mt -127.26 117.13 46.39 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.346 0 N-CA-C 108.892 -0.781 . . . . 0.0 108.892 176.186 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' F' F ' 94' ' ' VAL . . . . . 0.468 HG21 HG21 ' F' ' 125' ' ' VAL . 48.4 t -121.71 128.11 75.67 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.257 0 CA-C-O 121.147 0.498 . . . . 0.0 110.189 -178.174 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' F' F ' 95' ' ' VAL . . . . . . . . . . . . . 45.2 t -120.78 135.08 62.12 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.358 0 CA-C-N 115.524 -0.762 . . . . 0.0 109.644 -179.168 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' F' F ' 96' ' ' ILE . . . . . . . . . . . . . 62.0 mt -111.66 129.03 67.8 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.358 0 N-CA-C 108.789 -0.819 . . . . 0.0 108.789 178.137 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' F' F ' 97' ' ' THR . . . . . . . . . . . . . 58.1 p -103.93 157.08 17.34 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-O 121.335 0.588 . . . . 0.0 111.235 -176.77 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' F' F ' 98' ' ' GLU . . . . . . . . . . . . . 85.4 tt0 -53.93 -24.03 14.97 Favored 'General case' 0 CA--C 1.534 0.36 0 CA-C-N 115.866 -0.606 . . . . 0.0 112.314 179.581 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' F' F ' 99' ' ' GLU . . . . . . . . . . . . . 41.3 tt0 -79.74 16.69 1.06 Allowed 'General case' 0 CA--C 1.54 0.561 0 N-CA-C 112.401 0.519 . . . . 0.0 112.401 -178.354 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' F' F ' 100' ' ' ASN . . . . . . . . . . . . . 2.2 m-20 60.05 37.39 21.14 Favored 'General case' 0 CA--C 1.53 0.209 0 O-C-N 121.675 -0.64 . . . . 0.0 110.818 178.367 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' F' F ' 101' ' ' GLU . . . . . . . . . . . . . 85.1 tt0 -117.1 145.38 43.81 Favored 'General case' 0 C--N 1.332 -0.186 0 CA-C-N 116.018 -0.537 . . . . 0.0 109.876 178.075 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' F' F ' 102' ' ' VAL . . . . . . . . . . . . . 46.2 t -115.51 124.79 72.36 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.372 0 N-CA-C 109.776 -0.453 . . . . 0.0 109.776 -178.83 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' F' F ' 103' ' ' LEU . . . . . . . . . . . . . 56.3 mt -114.47 129.92 56.69 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 115.83 -0.623 . . . . 0.0 110.016 176.961 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' F' F ' 104' ' ' ILE . . . . . . . . . . . . . 68.9 mt -117.93 118.43 58.25 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.27 0 N-CA-C 109.909 -0.404 . . . . 0.0 109.909 -179.811 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' F' F ' 105' ' ' PHE . . . . . . . . . . . . . 36.0 m-85 -119.36 164.18 16.08 Favored 'General case' 0 C--N 1.332 -0.163 0 O-C-N 123.898 0.749 . . . . 0.0 109.647 179.715 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' F' F ' 106' ' ' ASN . . . . . 0.446 ' HB3' HD11 ' F' ' 112' ' ' LEU . 44.3 p-10 -100.03 -170.65 1.91 Allowed 'General case' 0 C--N 1.33 -0.259 0 N-CA-C 109.808 -0.441 . . . . 0.0 109.808 173.575 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' F' F ' 107' ' ' GLN . . . . . . . . . . . . . 27.7 tt0 -59.75 -29.88 68.47 Favored 'General case' 0 C--N 1.329 -0.29 0 N-CA-C 111.944 0.35 . . . . 0.0 111.944 179.201 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' F' F ' 108' ' ' ASN . . . . . . . . . . . . . 16.6 t-20 -81.88 6.92 14.28 Favored 'General case' 0 CA--C 1.537 0.445 0 N-CA-C 113.232 0.827 . . . . 0.0 113.232 -177.948 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' F' F ' 109' ' ' LEU . . . . . 0.688 HD21 ' HB2' ' F' ' 78' ' ' ALA . 11.1 tp 62.4 36.68 14.18 Favored 'General case' 0 C--O 1.233 0.186 0 O-C-N 122.054 -0.404 . . . . 0.0 111.436 177.248 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' F' F ' 110' ' ' GLU . . . . . . . . . . . . . 70.9 mm-40 -109.58 156.96 19.53 Favored 'General case' 0 C--N 1.331 -0.237 0 N-CA-C 110.107 -0.331 . . . . 0.0 110.107 177.127 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' F' F ' 111' ' ' GLU . . . . . . . . . . . . . 46.4 mp0 -83.69 122.03 28.07 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-O 120.941 0.401 . . . . 0.0 111.053 -178.501 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' F' F ' 112' ' ' LEU . . . . . 0.446 HD11 ' HB3' ' F' ' 106' ' ' ASN . 29.5 mt -104.87 -45.97 4.42 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 115.987 -0.552 . . . . 0.0 109.941 175.117 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' F' F ' 113' ' ' TYR . . . . . . . . . . . . . 64.5 t80 -138.6 137.42 36.93 Favored 'General case' 0 C--N 1.33 -0.239 0 CA-C-N 115.988 -0.551 . . . . 0.0 110.842 -179.7 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' F' F ' 114' ' ' ARG . . . . . . . . . . . . . 83.4 mtm180 -139.61 122.66 16.77 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.448 -0.342 . . . . 0.0 110.315 176.254 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' F' F ' 115' ' ' GLY . . . . . . . . . . . . . . . -150.05 163.0 29.36 Favored Glycine 0 CA--C 1.526 0.722 0 N-CA-C 111.211 -0.756 . . . . 0.0 111.211 -179.937 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' F' F ' 116' ' ' LYS . . . . . . . . . . . . . 8.0 ttpm? -127.47 139.76 52.6 Favored 'General case' 0 C--N 1.33 -0.248 0 N-CA-C 110.074 -0.343 . . . . 0.0 110.074 178.368 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' F' F ' 117' ' ' PHE . . . . . . . . . . . . . 51.8 m-85 -136.44 113.96 10.95 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 116.397 -0.365 . . . . 0.0 110.054 -178.679 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' F' F ' 118' ' ' GLU . . . . . . . . . . . . . 96.1 mt-10 -55.1 -42.9 73.5 Favored 'General case' 0 C--N 1.33 -0.268 0 C-N-CA 121.0 -0.28 . . . . 0.0 111.13 -176.35 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' F' F ' 119' ' ' ASN . . . . . . . . . . . . . 2.4 m120 -97.97 31.0 2.83 Favored 'General case' 0 C--N 1.33 -0.258 0 N-CA-C 112.096 0.406 . . . . 0.0 112.096 -175.107 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' F' F ' 120' ' ' LEU . . . . . . . . . . . . . 14.8 tp -57.6 119.99 7.54 Favored 'General case' 0 C--N 1.333 -0.139 0 N-CA-C 110.264 -0.273 . . . . 0.0 110.264 178.166 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' F' F ' 121' ' ' ASN . . . . . . . . . . . . . 26.5 m120 -114.0 -43.95 3.2 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-N 116.487 -0.324 . . . . 0.0 110.832 -178.376 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' F' F ' 122' ' ' LYS . . . . . . . . . . . . . 38.3 ttpt -144.76 141.5 29.27 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-O 120.87 0.367 . . . . 0.0 111.28 -176.773 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' F' F ' 123' ' ' VAL . . . . . . . . . . . . . 46.1 t -126.69 127.19 69.9 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.315 0 N-CA-C 109.21 -0.663 . . . . 0.0 109.21 173.255 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' F' F ' 124' ' ' LEU . . . . . . . . . . . . . 16.2 tp -129.08 137.67 51.4 Favored 'General case' 0 C--N 1.331 -0.225 0 CA-C-O 121.034 0.445 . . . . 0.0 111.013 -176.344 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' F' F ' 125' ' ' VAL . . . . . 0.468 HG21 HG21 ' F' ' 94' ' ' VAL . 42.3 t -125.14 131.26 72.67 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.259 0 CA-C-N 115.844 -0.616 . . . . 0.0 109.624 177.864 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' F' F ' 126' ' ' ARG . . . . . . . . . . . . . 57.9 ttt180 -147.45 126.79 13.08 Favored 'General case' 0 C--N 1.329 -0.284 0 N-CA-C 109.46 -0.571 . . . . 0.0 109.46 178.858 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' F' F ' 127' ' ' ASN . . . . . . . . . . . . . 79.7 m-20 56.49 -147.13 0.53 Allowed 'General case' 0 CA--C 1.541 0.61 0 N-CA-C 109.682 -0.488 . . . . 0.0 109.682 -178.033 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' F' F ' 128' ' ' ASP . . . . . . . . . . . . . 24.1 p-10 -87.91 18.15 4.38 Favored 'General case' 0 CA--C 1.537 0.46 0 CA-C-N 118.901 0.773 . . . . 0.0 112.605 178.639 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' F' F ' 129' ' ' LEU . . . . . . . . . . . . . 15.6 tp -113.63 137.35 51.71 Favored 'General case' 0 N--CA 1.461 0.116 0 CA-C-N 117.99 0.359 . . . . 0.0 110.315 178.65 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' F' F ' 130' ' ' VAL . . . . . . . . . . . . . 46.1 t -121.89 135.9 60.53 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.215 0 CA-C-N 116.086 -0.506 . . . . 0.0 109.732 -179.963 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' F' F ' 131' ' ' VAL . . . . . . . . . . . . . 41.4 t -134.8 136.35 52.28 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.264 0 CA-C-O 121.104 0.478 . . . . 0.0 110.697 -179.454 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' F' F ' 132' ' ' ILE . . . . . . . . . . . . . 72.2 mt -116.62 132.93 64.84 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.234 0 CA-C-N 115.667 -0.697 . . . . 0.0 109.49 178.598 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' F' F ' 133' ' ' ILE . . . . . . . . . . . . . 42.7 mm -116.83 122.01 69.02 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.242 0 CA-C-O 120.764 0.316 . . . . 0.0 110.802 -176.629 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' F' F ' 134' ' ' ASP . . . . . . . . . . . . . 7.8 p-10 -133.42 146.23 51.0 Favored 'General case' 0 C--N 1.329 -0.29 0 N-CA-C 109.297 -0.631 . . . . 0.0 109.297 174.338 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' F' F ' 135' ' ' GLU . . . . . . . . . . . . . 84.6 tt0 -50.07 -27.79 6.15 Favored 'General case' 0 C--N 1.328 -0.333 0 N-CA-C 112.645 0.609 . . . . 0.0 112.645 -174.212 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' F' F ' 136' ' ' GLN . . . . . . . . . . . . . 95.7 mt-30 -79.09 -34.65 43.39 Favored 'General case' 0 C--O 1.232 0.174 0 N-CA-C 112.35 0.5 . . . . 0.0 112.35 -176.847 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' F' F ' 137' ' ' LYS . . . . . . . . . . . . . 49.8 pttt -170.06 176.2 4.75 Favored 'General case' 0 C--N 1.331 -0.227 0 CA-C-O 121.489 0.661 . . . . 0.0 112.577 -173.143 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' F' F ' 138' ' ' LEU . . . . . . . . . . . . . 6.7 tt -119.36 130.99 55.63 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 115.107 -0.951 . . . . 0.0 110.111 179.875 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' F' F ' 139' ' ' THR . . . . . . . . . . . . . 39.7 m -111.42 129.67 55.95 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.198 -0.455 . . . . 0.0 110.359 179.412 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' F' F ' 140' ' ' LEU . . . . . 0.468 HD23 ' C ' ' F' ' 140' ' ' LEU . 8.5 tt -113.73 125.42 54.1 Favored 'General case' 0 C--N 1.328 -0.365 0 N-CA-C 109.515 -0.55 . . . . 0.0 109.515 -178.867 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' F' F ' 141' ' ' ILE . . . . . . . . . . . . . 19.0 mt -124.55 125.91 70.91 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.371 0 N-CA-C 109.873 -0.417 . . . . 0.0 109.873 -175.64 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' F' F ' 142' ' ' ARG . . . . . . . . . . . . . 23.4 tpt180 -120.37 135.42 55.03 Favored 'General case' 0 C--N 1.332 -0.193 0 CA-C-N 115.973 -0.558 . . . . 0.0 109.936 -178.458 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' F' F ' 143' ' ' THR . . . . . . . . . . . . . 23.9 p . . . . . 0 C--O 1.22 -0.49 0 CA-C-O 118.025 -0.988 . . . . 0.0 110.485 179.776 . . . . . . . . 0 0 . 1 . 006 nuclear nobuild core ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 2.9 p . . . . . 0 C--O 1.232 0.148 0 CA-C-O 120.941 0.401 . . . . 0.0 110.677 . . . . . . . . . 0 0 . 1 . 006 nuclear nobuild core ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 85.4 tt0 -139.71 139.97 36.7 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.092 -0.503 . . . . 0.0 110.909 -179.333 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 4' ' ' LEU . . . . . . . . . . . . . 22.1 tp -121.74 125.7 47.18 Favored 'General case' 0 C--N 1.332 -0.185 0 CA-C-N 115.781 -0.645 . . . . 0.0 110.065 178.256 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 5' ' ' LYS . . . . . . . . . . . . . 64.7 mttp -101.73 121.24 41.7 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.437 -0.347 . . . . 0.0 110.656 178.923 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 85.8 mt -116.34 145.96 42.8 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 115.622 -0.717 . . . . 0.0 110.574 -179.76 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 82.6 tttt -139.34 135.31 17.05 Favored Pre-proline 0 CA--C 1.533 0.326 0 CA-C-O 118.905 -0.569 . . . . 0.0 109.723 177.01 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 8' ' ' PRO . . . . . . . . . . . . . 96.1 Cg_endo -89.49 142.87 4.35 Favored 'Trans proline' 0 N--CA 1.491 1.333 0 C-N-CA 121.621 1.547 . . . . 0.0 111.728 177.954 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 46.3 mt -77.07 -46.44 2.77 Favored Pre-proline 0 C--N 1.329 -0.317 0 CA-C-O 118.889 -0.577 . . . . 0.0 111.644 -179.374 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 94.8 Cg_endo -82.67 144.87 12.71 Favored 'Trans proline' 0 N--CA 1.493 1.497 0 C-N-CA 121.174 1.249 . . . . 0.0 111.361 172.159 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 64.4 mttp -86.58 100.63 12.55 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-O 121.037 0.446 . . . . 0.0 110.596 178.967 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 11.6 p -137.52 145.36 29.42 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.26 0 CA-C-N 115.762 -0.654 . . . . 0.0 110.022 179.765 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 84.1 tt0 -82.13 116.42 21.69 Favored 'General case' 0 C--N 1.329 -0.299 0 N-CA-C 109.973 -0.38 . . . . 0.0 109.973 178.938 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 14' ' ' LEU . . . . . . . . . . . . . 17.9 mt -92.82 153.18 42.12 Favored Pre-proline 0 C--N 1.33 -0.25 0 CA-C-N 116.224 -0.443 . . . . 0.0 110.864 -176.387 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 15' ' ' PRO . . . . . . . . . . . . . 31.1 Cg_exo -60.22 156.58 39.46 Favored 'Trans proline' 0 N--CA 1.495 1.578 0 C-N-CA 121.314 1.343 . . . . 0.0 111.876 177.744 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 16' ' ' PRO . . . . . . . . . . . . . 38.0 Cg_exo -58.02 -38.07 93.38 Favored 'Trans proline' 0 N--CA 1.497 1.714 0 C-N-CA 121.441 1.427 . . . . 0.0 112.777 -177.681 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 17' ' ' ASP . . . . . . . . . . . . . 18.7 p-10 -89.72 10.51 23.08 Favored 'General case' 0 CA--C 1.535 0.393 0 N-CA-C 113.313 0.857 . . . . 0.0 113.313 -176.482 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 18' ' ' PHE . . . . . . . . . . . . . 44.1 t80 -58.09 -44.58 87.68 Favored 'General case' 0 C--N 1.334 -0.068 0 O-C-N 122.047 -0.408 . . . . 0.0 110.121 -177.624 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 19' ' ' VAL . . . . . . . . . . . . . 47.2 t -57.96 -44.6 87.13 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.318 0 CA-C-N 116.251 -0.431 . . . . 0.0 110.4 -178.647 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 14.7 t70 -59.52 -40.23 86.46 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-O 120.829 0.347 . . . . 0.0 110.75 -177.462 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 47.2 t -64.53 -48.61 84.27 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.304 0 CA-C-N 116.382 -0.372 . . . . 0.0 110.251 -178.514 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 22' ' ' ILE . . . . . 0.541 HG22 HD12 ' A' ' 26' ' ' LEU . 51.5 mm -55.18 -42.26 64.69 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.242 0 CA-C-O 120.833 0.349 . . . . 0.0 110.605 179.441 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 23' ' ' ARG . . . . . . . . . . . . . 54.5 ttp180 -53.89 -53.58 50.6 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.464 -0.335 . . . . 0.0 111.49 179.577 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 24' ' ' ILE . . . . . . . . . . . . . 71.9 mt -61.24 -38.76 80.52 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.335 0 CA-C-N 116.56 -0.291 . . . . 0.0 111.508 -177.18 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 59.9 mmtt -65.88 -40.94 92.07 Favored 'General case' 0 C--N 1.329 -0.311 0 N-CA-C 112.104 0.409 . . . . 0.0 112.104 179.884 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 26' ' ' LEU . . . . . 0.541 HD12 HG22 ' A' ' 22' ' ' ILE . 75.7 mt -78.41 -38.18 42.15 Favored 'General case' 0 C--N 1.33 -0.266 0 N-CA-C 113.312 0.856 . . . . 0.0 113.312 -171.205 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 27' ' ' GLN . . . . . . . . . . . . . 9.4 pt20 -46.99 140.22 5.01 Favored 'General case' 0 N--CA 1.47 0.552 0 N-CA-C 112.732 0.641 . . . . 0.0 112.732 -175.541 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 98.22 -26.08 25.09 Favored Glycine 0 CA--C 1.533 1.18 0 CA-C-N 115.58 -0.737 . . . . 0.0 112.242 -176.194 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 58.6 mtpt -98.07 155.12 17.28 Favored 'General case' 0 C--O 1.232 0.177 0 CA-C-N 117.117 0.458 . . . . 0.0 110.764 179.358 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 30' ' ' THR . . . . . . . . . . . . . 25.9 m -103.3 138.35 40.2 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.293 -0.412 . . . . 0.0 110.021 176.63 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 34.3 m -129.19 150.9 35.06 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.215 0 CA-C-O 121.066 0.46 . . . . 0.0 111.145 -178.179 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 32' ' ' ARG . . . . . . . . . . . . . 83.7 mtt180 -132.64 152.85 51.55 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 115.589 -0.732 . . . . 0.0 110.168 177.492 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 33' ' ' THR . . . . . . . . . . . . . 20.9 m -53.35 137.23 35.73 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.3 -0.409 . . . . 0.0 111.359 -177.685 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 102.06 -16.94 55.21 Favored Glycine 0 CA--C 1.532 1.122 0 CA-C-O 119.655 -0.525 . . . . 0.0 113.386 177.619 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 72.3 m-20 -64.26 148.31 50.48 Favored 'General case' 0 N--CA 1.461 0.112 0 CA-C-N 118.125 0.963 . . . . 0.0 110.987 179.494 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 44.7 t -125.83 133.23 69.54 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.19 0 CA-C-N 116.017 -0.538 . . . . 0.0 110.001 179.52 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 37' ' ' ILE . . . . . . . . . . . . . 68.6 mt -122.43 140.18 47.07 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.255 0 CA-C-N 116.081 -0.509 . . . . 0.0 109.981 179.849 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . -113.17 128.91 8.61 Favored Glycine 0 CA--C 1.527 0.815 0 N-CA-C 110.978 -0.849 . . . . 0.0 110.978 179.485 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 39' ' ' ILE . . . . . . . . . . . . . 71.9 mt -122.97 130.14 74.65 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.2 0 N-CA-C 110.091 -0.337 . . . . 0.0 110.091 179.793 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 40' ' ' SER . . . . . . . . . . . . . 35.8 t -94.58 124.79 38.82 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.483 -0.326 . . . . 0.0 111.007 175.377 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 41' ' ' ILE . . . . . . . . . . . . . 71.9 mt -133.42 123.79 47.34 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.247 0 CA-C-O 120.907 0.384 . . . . 0.0 110.567 177.183 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 10.9 tp 52.51 35.93 19.06 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 115.994 -0.548 . . . . 0.0 111.695 177.319 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . 73.23 28.38 66.31 Favored Glycine 0 CA--C 1.53 1.007 0 C-N-CA 121.169 -0.539 . . . . 0.0 112.46 176.6 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 44' ' ' LYS . . . . . . . . . . . . . 94.5 mttt -134.9 129.98 35.19 Favored 'General case' 0 C--N 1.332 -0.189 0 CA-C-N 117.044 0.422 . . . . 0.0 110.01 177.268 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 68.0 tt0 -86.96 125.78 34.29 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 116.067 -0.515 . . . . 0.0 111.371 -175.8 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 46' ' ' VAL . . . . . . . . . . . . . 7.1 p -125.17 129.77 73.16 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.19 0 CA-C-O 120.926 0.393 . . . . 0.0 110.02 175.744 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 56.5 mmtt -100.53 130.91 46.66 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 115.865 -0.607 . . . . 0.0 111.768 177.896 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 48' ' ' PHE . . . . . . . . . . . . . 93.8 m-85 -113.86 131.89 56.1 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.071 -0.513 . . . . 0.0 109.929 175.022 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 83.1 tttt -106.62 137.76 44.03 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.382 -0.372 . . . . 0.0 110.492 179.357 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 50' ' ' VAL . . . . . . . . . . . . . 44.5 t -81.3 105.98 11.86 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.297 0 N-CA-C 108.991 -0.744 . . . . 0.0 108.991 174.735 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 51' ' ' VAL . . . . . . . . . . . . . 45.6 t -69.54 -48.13 67.95 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.349 0 CA-C-N 116.05 -0.523 . . . . 0.0 110.016 -173.075 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 52' ' ' GLN . . . . . . . . . . . . . 48.0 tt0 -167.89 139.9 3.04 Favored 'General case' 0 C--N 1.328 -0.348 0 C-N-CA 120.362 -0.535 . . . . 0.0 111.651 -177.816 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 53' ' ' ALA . . . . . 0.484 ' HB3' ' OG ' ' A' ' 56' ' ' SER . . . -110.47 131.93 54.62 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 115.839 -0.619 . . . . 0.0 109.882 174.776 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 54' ' ' TYR . . . . . . . . . . . . . 40.7 t80 -129.07 110.66 18.28 Favored Pre-proline 0 CA--C 1.535 0.381 0 CA-C-O 118.292 -0.861 . . . . 0.0 110.546 179.769 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 55' ' ' PRO . . . . . . . . . . . . . 71.7 Cg_endo -77.22 166.96 80.91 Favored 'Cis proline' 0 N--CA 1.5 1.866 0 CA-C-N 121.874 1.705 . . . . 0.0 111.978 -7.102 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 56' ' ' SER . . . . . 0.484 ' OG ' ' HB3' ' A' ' 53' ' ' ALA . 51.3 m -118.02 141.97 30.18 Favored Pre-proline 0 CA--C 1.538 0.519 0 CA-C-O 118.699 -0.667 . . . . 0.0 109.596 174.132 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 57' ' ' PRO . . . . . . . . . . . . . 43.9 Cg_endo -68.96 142.87 70.55 Favored 'Cis proline' 0 N--CA 1.499 1.807 0 CA-C-N 121.484 1.566 . . . . 0.0 111.205 -3.006 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 58' ' ' LEU . . . . . . . . . . . . . 29.7 tp -107.75 136.05 48.14 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-O 120.729 0.3 . . . . 0.0 110.877 -177.849 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 59' ' ' ARG . . . . . . . . . . . . . 66.5 ttt180 -101.79 122.2 43.51 Favored 'General case' 0 C--N 1.326 -0.426 0 N-CA-C 109.099 -0.704 . . . . 0.0 109.099 175.919 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 43.9 t -76.18 120.88 27.03 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.263 0 C-N-CA 120.68 -0.408 . . . . 0.0 110.639 -173.964 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 43.7 mt-10 -131.04 165.38 23.34 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 115.954 -0.566 . . . . 0.0 109.838 175.181 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 62' ' ' ASP . . . . . . . . . . . . . 9.5 p-10 -55.51 -32.55 62.97 Favored 'General case' 0 C--N 1.329 -0.311 0 N-CA-C 111.89 0.33 . . . . 0.0 111.89 -177.289 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 63' ' ' ARG . . . . . . . . . . . . . 24.3 ptt180 -79.76 -4.4 51.79 Favored 'General case' 0 CA--C 1.536 0.441 0 N-CA-C 113.753 1.02 . . . . 0.0 113.753 -174.945 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 24.6 m -75.08 136.07 41.18 Favored 'General case' 0 C--N 1.333 -0.118 0 CA-C-N 118.118 0.417 . . . . 0.0 110.453 -177.943 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 65' ' ' LYS . . . . . . . . . . . . . 3.0 mptp? -88.35 128.12 35.5 Favored 'General case' 0 C--N 1.328 -0.329 0 N-CA-C 109.689 -0.486 . . . . 0.0 109.689 -179.86 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 66' ' ' ILE . . . . . . . . . . . . . 59.2 mt -112.03 131.96 62.01 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.244 0 N-CA-C 109.807 -0.442 . . . . 0.0 109.807 -179.223 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 67' ' ' THR . . . . . . . . . . . . . 27.5 m -123.95 137.15 54.66 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.138 -0.483 . . . . 0.0 110.744 -179.142 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 68' ' ' LEU . . . . . . . . . . . . . 3.6 tt . . . . . 0 C--N 1.329 -0.302 0 N-CA-C 109.37 -0.604 . . . . 0.0 109.37 178.072 . . . . . . . . 0 0 . 1 . 006 nuclear nobuild core ' A' A ' 74' ' ' ASP . . . . . . . . . . . . . 40.5 t0 . . . . . 0 N--CA 1.46 0.036 0 N-CA-C 110.11 -0.33 . . . . 0.0 110.11 . . . . . . . . . 0 0 . 1 . 006 nuclear nobuild core ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 44.8 t -112.52 121.64 65.24 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.211 0 CA-C-O 121.081 0.467 . . . . 0.0 110.259 179.961 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 76' ' ' LEU . . . . . . . . . . . . . 35.1 mt -125.42 140.59 52.66 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 115.571 -0.74 . . . . 0.0 109.539 179.381 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 77' ' ' GLU . . . . . . . . . . . . . 96.8 mt-10 -133.94 143.96 48.52 Favored 'General case' 0 C--N 1.332 -0.185 0 CA-C-O 121.153 0.501 . . . . 0.0 111.622 -177.166 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 78' ' ' ALA . . . . . . . . . . . . . . . -130.62 133.64 46.32 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 115.435 -0.802 . . . . 0.0 109.886 175.574 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 79' ' ' LYS . . . . . 0.564 ' O ' HD13 ' A' ' 80' ' ' ILE . 36.6 ttpt -82.26 117.83 22.66 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.358 -0.383 . . . . 0.0 110.634 -178.019 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 80' ' ' ILE . . . . . 0.564 HD13 ' O ' ' A' ' 79' ' ' LYS . 42.7 mm -139.06 113.07 7.1 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.285 0 N-CA-C 109.156 -0.683 . . . . 0.0 109.156 -178.142 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 81' ' ' LYS . . . . . . . . . . . . . 6.3 mtmp? -100.5 124.69 46.37 Favored 'General case' 0 C--N 1.327 -0.409 0 CA-C-O 120.913 0.387 . . . . 0.0 111.116 -176.637 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . 89.25 42.05 5.66 Favored Glycine 0 CA--C 1.525 0.691 0 C-N-CA 120.961 -0.638 . . . . 0.0 111.642 176.259 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 83' ' ' ILE . . . . . . . . . . . . . 74.9 mt -68.06 132.58 32.6 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.309 0 N-CA-C 109.575 -0.528 . . . . 0.0 109.575 176.694 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 84' ' ' LYS . . . . . . . . . . . . . 39.6 ttpt -95.05 -53.41 3.82 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-O 120.986 0.422 . . . . 0.0 110.365 -177.96 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 85' ' ' ASP . . . . . . . . . . . . . 7.9 t70 -149.69 151.87 34.39 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 115.944 -0.571 . . . . 0.0 110.696 -179.131 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 86' ' ' VAL . . . . . . . . . . . . . 44.1 t -130.67 131.65 64.66 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.267 0 CA-C-N 116.339 -0.392 . . . . 0.0 110.305 179.444 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 87' ' ' ILE . . . . . 0.499 HD12 ' N ' ' A' ' 87' ' ' ILE . 5.1 mp -118.47 126.1 74.86 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.273 0 N-CA-C 109.564 -0.532 . . . . 0.0 109.564 177.027 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 88' ' ' LEU . . . . . . . . . . . . . 15.7 tp -109.79 130.41 55.52 Favored 'General case' 0 C--N 1.332 -0.191 0 CA-C-N 116.34 -0.391 . . . . 0.0 110.687 -178.534 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 89' ' ' ASP . . . . . . . . . . . . . 9.8 t70 -125.88 156.94 38.86 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 116.107 -0.497 . . . . 0.0 109.964 179.091 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 84.8 tt0 -46.48 -38.24 8.94 Favored 'General case' 0 C--N 1.33 -0.248 0 N-CA-C 113.088 0.773 . . . . 0.0 113.088 -172.068 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 91' ' ' ASN . . . . . . . . . . . . . 2.7 t-20 -132.06 20.99 4.49 Favored 'General case' 0 N--CA 1.47 0.532 0 N-CA-C 112.925 0.713 . . . . 0.0 112.925 -177.518 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 92' ' ' LEU . . . . . . . . . . . . . 28.4 mt -149.55 147.71 28.5 Favored 'General case' 0 C--N 1.331 -0.225 0 CA-C-O 120.78 0.324 . . . . 0.0 110.617 -175.938 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 93' ' ' ILE . . . . . . . . . . . . . 70.1 mt -126.22 119.47 54.21 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.264 0 N-CA-C 109.197 -0.668 . . . . 0.0 109.197 176.538 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 94' ' ' VAL . . . . . . . . . . . . . 44.1 t -120.11 127.77 75.91 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.253 0 N-CA-C 109.957 -0.386 . . . . 0.0 109.957 -179.275 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 95' ' ' VAL . . . . . . . . . . . . . 45.9 t -123.32 134.58 65.86 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.208 0 CA-C-N 116.082 -0.508 . . . . 0.0 109.939 -179.433 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 96' ' ' ILE . . . . . . . . . . . . . 63.4 mt -116.86 128.03 74.34 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.284 0 N-CA-C 109.434 -0.58 . . . . 0.0 109.434 -179.726 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 97' ' ' THR . . . . . . . . . . . . . 75.3 p -100.36 155.57 17.73 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-O 121.214 0.531 . . . . 0.0 111.286 -177.501 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 98' ' ' GLU . . . . . . . . . . . . . 84.9 tt0 -53.94 -25.84 22.48 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-N 115.954 -0.566 . . . . 0.0 112.34 179.851 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 99' ' ' GLU . . . . . . . . . . . . . 34.4 tt0 -80.41 17.95 0.99 Allowed 'General case' 0 CA--C 1.54 0.594 0 N-CA-C 112.553 0.575 . . . . 0.0 112.553 -177.164 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 100' ' ' ASN . . . . . . . . . . . . . 3.5 m-20 63.11 36.44 12.2 Favored 'General case' 0 CA--C 1.53 0.174 0 O-C-N 121.931 -0.481 . . . . 0.0 111.221 176.077 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 101' ' ' GLU . . . . . . . . . . . . . 84.8 tt0 -116.72 142.88 46.33 Favored 'General case' 0 C--N 1.332 -0.189 0 CA-C-N 116.318 -0.401 . . . . 0.0 109.942 175.788 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 102' ' ' VAL . . . . . . . . . . . . . 45.0 t -117.11 126.55 74.53 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.262 0 CA-C-N 116.193 -0.458 . . . . 0.0 109.947 -178.06 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 103' ' ' LEU . . . . . 0.407 HD12 ' N ' ' A' ' 103' ' ' LEU . 6.3 mp -118.43 133.73 55.64 Favored 'General case' 0 C--N 1.331 -0.227 0 CA-C-N 116.045 -0.525 . . . . 0.0 110.283 176.759 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 104' ' ' ILE . . . . . . . . . . . . . 70.4 mt -121.27 122.6 67.82 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.235 0 CA-C-N 116.542 -0.299 . . . . 0.0 110.21 -179.045 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 105' ' ' PHE . . . . . . . . . . . . . 39.0 m-85 -123.41 164.52 18.72 Favored 'General case' 0 C--N 1.332 -0.173 0 O-C-N 123.839 0.712 . . . . 0.0 109.809 179.754 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 106' ' ' ASN . . . . . . . . . . . . . 41.7 p-10 -97.55 -169.9 1.92 Allowed 'General case' 0 C--N 1.33 -0.254 0 N-CA-C 109.989 -0.374 . . . . 0.0 109.989 174.315 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 107' ' ' GLN . . . . . . . . . . . . . 27.5 tt0 -60.2 -27.29 67.04 Favored 'General case' 0 CA--C 1.533 0.308 0 N-CA-C 112.002 0.371 . . . . 0.0 112.002 177.925 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 108' ' ' ASN . . . . . . . . . . . . . 10.2 t-20 -81.87 4.21 23.23 Favored 'General case' 0 CA--C 1.536 0.419 0 N-CA-C 113.232 0.827 . . . . 0.0 113.232 -178.95 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 109' ' ' LEU . . . . . . . . . . . . . 12.5 tp 61.03 38.26 17.38 Favored 'General case' 0 C--O 1.234 0.26 0 CA-C-O 120.973 0.415 . . . . 0.0 111.072 179.109 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 110' ' ' GLU . . . . . . . . . . . . . 95.2 mt-10 -111.16 149.89 30.26 Favored 'General case' 0 C--N 1.332 -0.189 0 CA-C-N 116.539 -0.3 . . . . 0.0 110.332 177.086 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 111' ' ' GLU . . . . . . . . . . . . . 98.4 mt-10 -73.12 125.04 26.78 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-O 120.977 0.418 . . . . 0.0 111.48 -178.823 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 112' ' ' LEU . . . . . . . . . . . . . 21.7 mt -109.95 -45.95 3.55 Favored 'General case' 0 C--N 1.331 -0.221 0 CA-C-N 115.819 -0.628 . . . . 0.0 109.917 174.669 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 113' ' ' TYR . . . . . . . . . . . . . 63.7 t80 -141.55 142.55 33.52 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 115.877 -0.601 . . . . 0.0 110.608 178.782 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 114' ' ' ARG . . . . . . . . . . . . . 33.8 ptt-85 -149.14 124.07 9.99 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-O 121.059 0.457 . . . . 0.0 110.789 177.325 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 115' ' ' GLY . . . . . . . . . . . . . . . -150.11 163.03 29.38 Favored Glycine 0 CA--C 1.524 0.636 0 N-CA-C 110.964 -0.854 . . . . 0.0 110.964 -179.12 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 116' ' ' LYS . . . . . . . . . . . . . 34.5 ttmt -130.07 134.98 47.74 Favored 'General case' 0 C--N 1.33 -0.244 0 N-CA-C 110.088 -0.338 . . . . 0.0 110.088 177.928 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 117' ' ' PHE . . . . . 0.425 ' HE2' HD13 ' A' ' 132' ' ' ILE . 33.4 m-85 -130.93 117.39 19.17 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.403 -0.362 . . . . 0.0 110.297 -175.711 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 118' ' ' GLU . . . . . . . . . . . . . 48.9 mp0 -56.08 -43.37 77.95 Favored 'General case' 0 C--N 1.328 -0.352 0 C-N-CA 120.759 -0.376 . . . . 0.0 111.104 -175.025 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 119' ' ' ASN . . . . . . . . . . . . . 71.1 m-80 -100.26 31.08 3.52 Favored 'General case' 0 C--N 1.329 -0.299 0 N-CA-C 112.259 0.466 . . . . 0.0 112.259 -172.737 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 120' ' ' LEU . . . . . . . . . . . . . 11.1 tp -55.82 120.76 7.86 Favored 'General case' 0 C--O 1.232 0.138 0 C-N-CA 121.078 -0.249 . . . . 0.0 110.491 177.199 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 121' ' ' ASN . . . . . . . . . . . . . 33.1 m120 -114.02 -44.06 3.19 Favored 'General case' 0 N--CA 1.463 0.205 0 CA-C-N 116.654 -0.248 . . . . 0.0 111.035 -176.793 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 122' ' ' LYS . . . . . . . . . . . . . 89.0 mttt -143.58 144.89 32.12 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-O 120.942 0.401 . . . . 0.0 111.352 -177.628 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 123' ' ' VAL . . . . . . . . . . . . . 45.7 t -130.53 131.17 65.18 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.27 0 N-CA-C 109.387 -0.597 . . . . 0.0 109.387 175.27 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 124' ' ' LEU . . . . . . . . . . . . . 10.1 tp -131.43 136.27 47.84 Favored 'General case' 0 C--N 1.331 -0.199 0 CA-C-O 120.824 0.345 . . . . 0.0 111.151 -176.857 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 125' ' ' VAL . . . . . . . . . . . . . 45.0 t -127.58 129.96 70.38 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.232 0 CA-C-N 116.059 -0.519 . . . . 0.0 109.751 177.061 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 126' ' ' ARG . . . . . . . . . . . . . 63.0 ttm-85 -141.63 124.73 16.32 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-O 120.944 0.402 . . . . 0.0 110.603 179.851 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 127' ' ' ASN . . . . . . . . . . . . . 23.1 m120 50.58 -109.79 0.42 Allowed 'General case' 0 CA--C 1.545 0.754 0 CA-C-O 118.832 -0.604 . . . . 0.0 111.293 179.738 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 128' ' ' ASP . . . . . . . . . . . . . 9.9 p-10 -114.08 8.67 17.09 Favored 'General case' 0 N--CA 1.469 0.516 0 CA-C-N 119.875 1.216 . . . . 0.0 113.158 -179.124 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 129' ' ' LEU . . . . . . . . . . . . . 18.1 tp -107.75 134.99 49.92 Favored 'General case' 0 C--N 1.332 -0.166 0 CA-C-N 117.956 0.344 . . . . 0.0 110.123 179.643 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 130' ' ' VAL . . . . . . . . . . . . . 44.0 t -116.69 132.69 65.64 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.253 0 N-CA-C 109.583 -0.525 . . . . 0.0 109.583 179.617 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 131' ' ' VAL . . . . . . . . . . . . . 40.7 t -132.89 133.99 58.55 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.253 0 CA-C-O 121.034 0.445 . . . . 0.0 110.474 -179.258 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 132' ' ' ILE . . . . . 0.425 HD13 ' HE2' ' A' ' 117' ' ' PHE . 74.6 mt -118.45 130.66 72.99 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 CA-C-N 115.72 -0.673 . . . . 0.0 109.204 177.718 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 133' ' ' ILE . . . . . . . . . . . . . 40.0 mm -116.68 123.39 71.6 Favored 'Isoleucine or valine' 0 C--O 1.234 0.262 0 CA-C-O 120.933 0.397 . . . . 0.0 111.071 -174.228 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 134' ' ' ASP . . . . . . . . . . . . . 6.8 p-10 -136.45 146.33 46.23 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-N 116.006 -0.543 . . . . 0.0 109.557 175.227 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 135' ' ' GLU . . . . . . . . . . . . . 38.9 tp10 -50.32 -27.94 7.04 Favored 'General case' 0 C--N 1.328 -0.36 0 N-CA-C 112.598 0.592 . . . . 0.0 112.598 -173.592 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 136' ' ' GLN . . . . . . . . . . . . . 97.8 mt-30 -76.04 -37.23 58.59 Favored 'General case' 0 C--O 1.234 0.246 0 N-CA-C 112.34 0.496 . . . . 0.0 112.34 -177.903 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 137' ' ' LYS . . . . . . . . . . . . . 47.5 pttt -168.02 175.0 6.93 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-O 121.607 0.718 . . . . 0.0 112.19 -171.593 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 138' ' ' LEU . . . . . 0.412 ' C ' HD23 ' A' ' 138' ' ' LEU . 6.3 tt -118.94 128.57 54.54 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 115.13 -0.941 . . . . 0.0 110.039 179.247 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 139' ' ' THR . . . . . 0.403 ' N ' HD23 ' A' ' 138' ' ' LEU . 31.5 m -108.03 126.02 52.24 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.285 -0.416 . . . . 0.0 110.291 179.885 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 140' ' ' LEU . . . . . . . . . . . . . 36.5 tp -113.04 122.95 49.13 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 115.722 -0.672 . . . . 0.0 109.305 -179.364 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 141' ' ' ILE . . . . . . . . . . . . . 19.0 mt -121.84 119.82 59.81 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 CA-C-O 120.955 0.407 . . . . 0.0 110.052 -174.411 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 142' ' ' ARG . . . . . . . . . . . . . 54.8 mtp180 -105.09 123.22 47.44 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 115.583 -0.735 . . . . 0.0 110.165 178.856 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 143' ' ' THR . . . . . . . . . . . . . 31.8 p . . . . . 0 C--O 1.221 -0.446 0 CA-C-O 117.98 -1.01 . . . . 0.0 110.515 -179.672 . . . . . . . . 0 0 . 1 . 006 nuclear nobuild core ' B' B ' 2' ' ' SER . . . . . . . . . . . . . 13.5 p . . . . . 0 C--O 1.233 0.197 0 CA-C-O 120.923 0.392 . . . . 0.0 110.9 . . . . . . . . . 0 0 . 1 . 006 nuclear nobuild core ' B' B ' 3' ' ' GLU . . . . . . . . . . . . . 46.9 mp0 -140.65 147.37 39.21 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.181 -0.463 . . . . 0.0 111.33 -178.746 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' B' B ' 4' ' ' LEU . . . . . . . . . . . . . 17.8 tp -127.02 127.71 45.19 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 115.702 -0.681 . . . . 0.0 109.947 174.718 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' B' B ' 5' ' ' LYS . . . . . . . . . . . . . 92.5 mttt -109.51 121.23 44.72 Favored 'General case' 0 C--O 1.234 0.27 0 CA-C-O 120.815 0.34 . . . . 0.0 110.855 178.919 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' B' B ' 6' ' ' LEU . . . . . . . . . . . . . 58.1 mt -115.08 147.24 40.44 Favored 'General case' 0 C--N 1.331 -0.211 0 CA-C-N 115.375 -0.83 . . . . 0.0 110.716 -179.097 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' B' B ' 7' ' ' LYS . . . . . . . . . . . . . 69.5 tttt -134.89 138.02 28.63 Favored Pre-proline 0 CA--C 1.534 0.355 0 CA-C-O 118.955 -0.545 . . . . 0.0 109.989 175.78 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' B' B ' 8' ' ' PRO . . . . . . . . . . . . . 75.1 Cg_endo -90.06 139.67 3.16 Favored 'Trans proline' 0 N--CA 1.489 1.249 0 C-N-CA 121.7 1.6 . . . . 0.0 111.574 178.213 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' B' B ' 9' ' ' LEU . . . . . . . . . . . . . 26.8 mt -77.27 -51.91 1.91 Allowed Pre-proline 0 CA--C 1.531 0.239 0 CA-C-O 119.138 -0.458 . . . . 0.0 111.313 -177.488 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' B' B ' 10' ' ' PRO . . . . . . . . . . . . . 71.7 Cg_endo -76.56 149.86 31.03 Favored 'Trans proline' 0 N--CA 1.497 1.682 0 C-N-CA 121.156 1.238 . . . . 0.0 111.399 170.671 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' B' B ' 11' ' ' LYS . . . . . . . . . . . . . 25.1 pttm -84.91 117.02 23.66 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-O 121.45 0.643 . . . . 0.0 110.61 178.254 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' B' B ' 12' ' ' VAL . . . . . . . . . . . . . 12.8 p -151.06 148.04 15.2 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 CA-C-N 115.653 -0.703 . . . . 0.0 110.493 -179.44 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' B' B ' 13' ' ' GLU . . . . . . . . . . . . . 84.7 tt0 -91.03 125.5 35.84 Favored 'General case' 0 C--N 1.329 -0.321 0 N-CA-C 110.034 -0.358 . . . . 0.0 110.034 177.827 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' B' B ' 14' ' ' LEU . . . . . . . . . . . . . 28.2 mt -97.87 149.86 36.17 Favored Pre-proline 0 CA--C 1.533 0.291 0 CA-C-N 116.357 -0.383 . . . . 0.0 110.718 -176.583 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' B' B ' 15' ' ' PRO . . . . . . . . . . . . . 24.0 Cg_exo -63.69 161.28 32.75 Favored 'Trans proline' 0 N--CA 1.497 1.689 0 C-N-CA 121.402 1.401 . . . . 0.0 111.866 175.648 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' B' B ' 16' ' ' PRO . . . . . . . . . . . . . 27.4 Cg_exo -60.35 -35.64 90.42 Favored 'Trans proline' 0 N--CA 1.498 1.745 0 C-N-CA 121.451 1.434 . . . . 0.0 112.789 -178.535 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' B' B ' 17' ' ' ASP . . . . . . . . . . . . . 9.4 p-10 -89.13 8.07 31.85 Favored 'General case' 0 CA--C 1.536 0.426 0 N-CA-C 113.245 0.831 . . . . 0.0 113.245 -177.428 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' B' B ' 18' ' ' PHE . . . . . . . . . . . . . 47.5 t80 -58.27 -44.97 88.67 Favored 'General case' 0 C--N 1.334 -0.108 0 O-C-N 122.041 -0.412 . . . . 0.0 110.031 -178.017 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' B' B ' 19' ' ' VAL . . . . . 0.407 HG13 ' N ' ' B' ' 20' ' ' ASP . 13.8 p -55.66 -41.27 64.19 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.36 0 CA-C-N 116.283 -0.417 . . . . 0.0 111.058 -178.984 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' B' B ' 20' ' ' ASP . . . . . 0.407 ' N ' HG13 ' B' ' 19' ' ' VAL . 75.6 m-20 -60.9 -43.49 98.44 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-O 120.951 0.405 . . . . 0.0 110.888 -178.154 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' B' B ' 21' ' ' VAL . . . . . . . . . . . . . 47.4 t -65.07 -46.39 91.46 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.281 0 CA-C-N 116.331 -0.395 . . . . 0.0 110.555 -177.556 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' B' B ' 22' ' ' ILE . . . . . 0.626 HG22 HD12 ' B' ' 26' ' ' LEU . 50.9 mm -55.15 -46.52 77.68 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.259 0 CA-C-O 120.817 0.341 . . . . 0.0 110.645 179.483 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' B' B ' 23' ' ' ARG . . . . . . . . . . . . . 26.8 ttm-85 -53.65 -54.08 42.87 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-O 121.16 0.505 . . . . 0.0 111.385 -179.727 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' B' B ' 24' ' ' ILE . . . . . . . . . . . . . 77.3 mt -60.66 -36.72 72.47 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.373 0 CA-C-N 115.61 -0.723 . . . . 0.0 111.581 -173.675 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' B' B ' 25' ' ' LYS . . . . . . . . . . . . . 57.5 mttm -70.71 -42.86 70.07 Favored 'General case' 0 C--N 1.33 -0.281 0 N-CA-C 112.551 0.574 . . . . 0.0 112.551 179.781 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' B' B ' 26' ' ' LEU . . . . . 0.626 HD12 HG22 ' B' ' 22' ' ' ILE . 34.3 mt -77.75 -35.84 51.34 Favored 'General case' 0 C--N 1.331 -0.23 0 N-CA-C 113.15 0.796 . . . . 0.0 113.15 -170.748 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' B' B ' 27' ' ' GLN . . . . . . . . . . . . . 5.3 pt20 -46.97 140.91 4.44 Favored 'General case' 0 N--CA 1.468 0.462 0 N-CA-C 112.747 0.647 . . . . 0.0 112.747 -175.808 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' B' B ' 28' ' ' GLY . . . . . . . . . . . . . . . 99.96 -24.79 30.76 Favored Glycine 0 CA--C 1.534 1.223 0 CA-C-N 115.624 -0.716 . . . . 0.0 112.261 -176.733 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' B' B ' 29' ' ' LYS . . . . . . . . . . . . . 47.2 mtmt -98.24 155.15 17.32 Favored 'General case' 0 C--N 1.332 -0.187 0 CA-C-N 117.339 0.57 . . . . 0.0 111.269 179.64 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' B' B ' 30' ' ' THR . . . . . . . . . . . . . 38.9 m -107.19 138.48 43.3 Favored 'General case' 0 C--N 1.331 -0.209 0 CA-C-N 115.914 -0.585 . . . . 0.0 109.901 176.62 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' B' B ' 31' ' ' VAL . . . . . . . . . . . . . 34.1 m -131.72 155.89 42.09 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.206 0 CA-C-O 120.99 0.424 . . . . 0.0 111.551 -176.866 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' B' B ' 32' ' ' ARG . . . . . . . . . . . . . 36.3 mtp180 -129.28 152.69 48.57 Favored 'General case' 0 C--O 1.233 0.236 0 CA-C-N 115.667 -0.697 . . . . 0.0 110.688 176.802 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' B' B ' 33' ' ' THR . . . . . . . . . . . . . 24.6 m -53.57 139.71 30.77 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.203 -0.453 . . . . 0.0 111.253 -179.075 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' B' B ' 34' ' ' GLY . . . . . . . . . . . . . . . 99.43 -17.13 58.18 Favored Glycine 0 CA--C 1.532 1.109 0 CA-C-O 119.486 -0.619 . . . . 0.0 113.304 177.69 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' B' B ' 35' ' ' ASP . . . . . . . . . . . . . 76.1 m-20 -65.09 148.25 52.0 Favored 'General case' 0 C--O 1.232 0.178 0 CA-C-N 118.116 0.958 . . . . 0.0 110.97 179.346 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' B' B ' 36' ' ' VAL . . . . . . . . . . . . . 45.7 t -122.52 131.52 73.05 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.241 0 CA-C-N 115.969 -0.559 . . . . 0.0 109.85 178.58 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' B' B ' 37' ' ' ILE . . . . . . . . . . . . . 66.7 mt -118.68 138.52 49.12 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 CA-C-N 116.128 -0.487 . . . . 0.0 109.89 -179.462 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' B' B ' 38' ' ' GLY . . . . . . . . . . . . . . . -109.83 128.69 9.02 Favored Glycine 0 CA--C 1.526 0.757 0 N-CA-C 110.871 -0.892 . . . . 0.0 110.871 179.5 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' B' B ' 39' ' ' ILE . . . . . . . . . . . . . 71.7 mt -124.62 131.46 72.67 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.246 0 N-CA-C 110.047 -0.353 . . . . 0.0 110.047 179.437 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' B' B ' 40' ' ' SER . . . . . . . . . . . . . 31.5 t -92.86 119.99 32.75 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.332 -0.395 . . . . 0.0 110.675 175.819 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' B' B ' 41' ' ' ILE . . . . . . . . . . . . . 70.4 mt -131.54 119.99 44.23 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.202 0 N-CA-C 110.223 -0.288 . . . . 0.0 110.223 178.418 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' B' B ' 42' ' ' LEU . . . . . . . . . . . . . 30.1 mt 56.87 33.83 23.8 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.227 -0.442 . . . . 0.0 111.84 178.729 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' B' B ' 43' ' ' GLY . . . . . . . . . . . . . . . 81.05 -10.13 49.78 Favored Glycine 0 CA--C 1.535 1.302 0 C-N-CA 121.24 -0.505 . . . . 0.0 113.584 176.482 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' B' B ' 44' ' ' LYS . . . . . . . . . . . . . 93.4 mttt -100.03 134.43 42.96 Favored 'General case' 0 C--N 1.333 -0.126 0 CA-C-N 117.821 0.81 . . . . 0.0 110.188 177.563 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' B' B ' 45' ' ' GLU . . . . . . . . . . . . . 85.0 tt0 -85.71 130.5 34.55 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 116.213 -0.449 . . . . 0.0 111.217 -179.815 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' B' B ' 46' ' ' VAL . . . . . . . . . . . . . 7.3 p -124.46 129.85 73.73 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.211 0 N-CA-C 109.605 -0.517 . . . . 0.0 109.605 175.714 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' B' B ' 47' ' ' LYS . . . . . . . . . . . . . 79.9 mttt -101.08 130.75 47.16 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.006 -0.543 . . . . 0.0 111.171 177.674 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' B' B ' 48' ' ' PHE . . . . . . . . . . . . . 93.5 m-85 -112.46 132.0 55.28 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 116.478 -0.328 . . . . 0.0 110.131 176.102 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' B' B ' 49' ' ' LYS . . . . . . . . . . . . . 68.5 tttt -106.04 135.54 47.3 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.352 -0.386 . . . . 0.0 110.398 179.123 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' B' B ' 50' ' ' VAL . . . . . . . . . . . . . 43.4 t -81.96 110.18 16.92 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.243 0 N-CA-C 109.435 -0.58 . . . . 0.0 109.435 177.001 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' B' B ' 51' ' ' VAL . . . . . . . . . . . . . 47.5 t -75.53 -47.04 35.63 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.295 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.092 -173.964 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' B' B ' 52' ' ' GLN . . . . . . . . . . . . . 62.8 tt0 -160.83 137.26 8.57 Favored 'General case' 0 C--N 1.332 -0.186 0 C-N-CA 120.165 -0.614 . . . . 0.0 112.193 -177.917 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' B' B ' 53' ' ' ALA . . . . . . . . . . . . . . . -112.51 130.35 56.03 Favored 'General case' 0 C--N 1.331 -0.211 0 CA-C-N 115.741 -0.663 . . . . 0.0 109.312 172.295 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' B' B ' 54' ' ' TYR . . . . . . . . . . . . . 47.4 t80 -129.05 110.22 18.26 Favored Pre-proline 0 C--N 1.328 -0.341 0 CA-C-O 118.22 -0.895 . . . . 0.0 110.689 -178.342 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' B' B ' 55' ' ' PRO . . . . . . . . . . . . . 72.8 Cg_endo -77.31 170.11 72.23 Favored 'Cis proline' 0 N--CA 1.5 1.909 0 CA-C-N 121.949 1.732 . . . . 0.0 112.22 -6.177 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' B' B ' 56' ' ' SER . . . . . . . . . . . . . 13.7 m -116.24 135.88 22.91 Favored Pre-proline 0 CA--C 1.539 0.536 0 CA-C-O 118.491 -0.766 . . . . 0.0 109.329 175.143 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' B' B ' 57' ' ' PRO . . . . . . . . . . . . . 53.1 Cg_endo -70.34 145.57 81.06 Favored 'Cis proline' 0 N--CA 1.498 1.755 0 CA-C-N 121.795 1.677 . . . . 0.0 111.452 -1.546 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' B' B ' 58' ' ' LEU . . . . . . . . . . . . . 29.2 tp -108.34 138.3 44.85 Favored 'General case' 0 C--N 1.331 -0.225 0 CA-C-N 116.271 -0.422 . . . . 0.0 110.866 -177.865 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' B' B ' 59' ' ' ARG . . . . . . . . . . . . . 55.7 ttt180 -103.52 127.05 50.99 Favored 'General case' 0 C--N 1.328 -0.333 0 N-CA-C 109.341 -0.614 . . . . 0.0 109.341 174.543 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' B' B ' 60' ' ' VAL . . . . . . . . . . . . . 42.2 t -82.2 117.27 27.88 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.285 0 C-N-CA 120.74 -0.384 . . . . 0.0 110.327 -176.486 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' B' B ' 61' ' ' GLU . . . . . . . . . . . . . 77.5 tt0 -131.2 156.83 44.68 Favored 'General case' 0 C--N 1.329 -0.302 0 N-CA-C 109.12 -0.696 . . . . 0.0 109.12 176.158 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' B' B ' 62' ' ' ASP . . . . . . . . . . . . . 5.6 t70 -50.11 -30.99 12.24 Favored 'General case' 0 C--N 1.328 -0.363 0 N-CA-C 112.223 0.453 . . . . 0.0 112.223 -178.987 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' B' B ' 63' ' ' ARG . . . . . . . . . . . . . 20.5 mtp-105 -72.12 -22.08 61.38 Favored 'General case' 0 CA--C 1.533 0.311 0 N-CA-C 113.063 0.764 . . . . 0.0 113.063 -176.398 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' B' B ' 64' ' ' THR . . . . . . . . . . . . . 27.1 m -69.55 144.05 53.21 Favored 'General case' 0 C--N 1.331 -0.209 0 CA-C-O 120.92 0.39 . . . . 0.0 111.122 -174.989 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' B' B ' 65' ' ' LYS . . . . . . . . . . . . . 85.1 mttt -89.18 130.08 35.66 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.062 -0.517 . . . . 0.0 110.126 178.739 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' B' B ' 66' ' ' ILE . . . . . . . . . . . . . 67.6 mt -115.53 131.94 66.4 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.223 0 N-CA-C 109.886 -0.413 . . . . 0.0 109.886 -179.762 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' B' B ' 67' ' ' THR . . . . . . . . . . . . . 32.7 m -127.54 140.44 52.13 Favored 'General case' 0 C--N 1.331 -0.225 0 CA-C-O 121.232 0.539 . . . . 0.0 110.999 -178.235 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' B' B ' 68' ' ' LEU . . . . . . . . . . . . . 41.5 mt . . . . . 0 C--N 1.33 -0.276 0 CA-C-N 115.768 -0.651 . . . . 0.0 109.978 177.349 . . . . . . . . 0 0 . 1 . 006 nuclear nobuild core ' B' B ' 73' ' ' VAL . . . . . . . . . . . . . 27.7 m . . . . . 0 C--O 1.231 0.098 0 CA-C-O 120.874 0.368 . . . . 0.0 110.488 . . . . . . . . . 0 0 . 1 . 006 nuclear nobuild core ' B' B ' 74' ' ' ASP . . . . . . . . . . . . . 31.9 t0 -102.88 116.96 33.57 Favored 'General case' 0 C--N 1.33 -0.27 0 N-CA-C 109.467 -0.568 . . . . 0.0 109.467 176.867 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' B' B ' 75' ' ' VAL . . . . . 0.492 ' C ' HD12 ' B' ' 76' ' ' LEU . 42.1 t -114.04 124.41 70.67 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.26 0 CA-C-O 121.057 0.456 . . . . 0.0 110.704 -176.148 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' B' B ' 76' ' ' LEU . . . . . 0.492 HD12 ' C ' ' B' ' 75' ' ' VAL . 7.3 mp -122.39 144.25 49.15 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 115.71 -0.677 . . . . 0.0 109.841 175.864 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' B' B ' 77' ' ' GLU . . . . . . . . . . . . . 97.7 mt-10 -134.6 130.28 36.24 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-O 121.07 0.462 . . . . 0.0 110.837 -178.887 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' B' B ' 78' ' ' ALA . . . . . 0.646 ' HB2' HD21 ' B' ' 109' ' ' LEU . . . -117.68 128.24 54.72 Favored 'General case' 0 C--N 1.331 -0.221 0 CA-C-N 115.8 -0.636 . . . . 0.0 109.938 177.966 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' B' B ' 79' ' ' LYS . . . . . 0.648 ' O ' HD13 ' B' ' 80' ' ' ILE . 49.0 tptt -75.65 118.75 18.81 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.306 -0.406 . . . . 0.0 110.62 -177.37 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' B' B ' 80' ' ' ILE . . . . . 0.648 HD13 ' O ' ' B' ' 79' ' ' LYS . 38.1 mm -139.11 106.24 2.84 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.325 0 N-CA-C 109.278 -0.638 . . . . 0.0 109.278 -177.588 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' B' B ' 81' ' ' LYS . . . . . . . . . . . . . 86.1 mttt -93.56 126.85 38.94 Favored 'General case' 0 C--N 1.328 -0.368 0 C-N-CA 120.709 -0.397 . . . . 0.0 111.086 -178.636 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' B' B ' 82' ' ' GLY . . . . . . . . . . . . . . . 89.04 42.14 5.7 Favored Glycine 0 CA--C 1.525 0.71 0 C-N-CA 120.811 -0.709 . . . . 0.0 111.839 174.092 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' B' B ' 83' ' ' ILE . . . . . . . . . . . . . 71.6 mt -70.28 131.46 34.22 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.312 0 N-CA-C 109.339 -0.615 . . . . 0.0 109.339 176.128 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' B' B ' 84' ' ' LYS . . . . . . . . . . . . . 38.5 ttpt -99.05 -43.99 6.47 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.568 -0.287 . . . . 0.0 110.389 -178.272 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' B' B ' 85' ' ' ASP . . . . . . . . . . . . . 9.7 t70 -155.48 154.26 31.56 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.356 -0.384 . . . . 0.0 110.792 179.348 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' B' B ' 86' ' ' VAL . . . . . . . . . . . . . 44.5 t -132.93 134.36 58.2 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.183 0 CA-C-O 120.959 0.409 . . . . 0.0 110.502 -179.476 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' B' B ' 87' ' ' ILE . . . . . . . . . . . . . 44.3 mm -121.03 128.47 76.07 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.274 0 CA-C-N 115.798 -0.637 . . . . 0.0 109.593 178.7 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' B' B ' 88' ' ' LEU . . . . . . . . . . . . . 17.4 tp -115.17 133.19 56.26 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-O 120.985 0.421 . . . . 0.0 111.116 -178.04 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' B' B ' 89' ' ' ASP . . . . . . . . . . . . . 7.0 t70 -127.42 159.9 33.08 Favored 'General case' 0 C--N 1.332 -0.17 0 CA-C-N 115.898 -0.592 . . . . 0.0 109.574 176.822 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' B' B ' 90' ' ' GLU . . . . . . . . . . . . . 96.3 mt-10 -47.15 -38.07 11.04 Favored 'General case' 0 C--N 1.33 -0.272 0 N-CA-C 113.2 0.815 . . . . 0.0 113.2 -171.009 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' B' B ' 91' ' ' ASN . . . . . . . . . . . . . 1.2 p30 -132.04 20.69 4.5 Favored 'General case' 0 N--CA 1.468 0.442 0 N-CA-C 113.038 0.755 . . . . 0.0 113.038 -176.736 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' B' B ' 92' ' ' LEU . . . . . . . . . . . . . 57.5 mt -149.01 146.93 28.0 Favored 'General case' 0 C--N 1.331 -0.204 0 CA-C-O 120.767 0.318 . . . . 0.0 110.64 -177.038 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' B' B ' 93' ' ' ILE . . . . . . . . . . . . . 67.1 mt -123.89 119.86 58.08 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.291 0 N-CA-C 109.236 -0.653 . . . . 0.0 109.236 178.231 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' B' B ' 94' ' ' VAL . . . . . . . . . . . . . 44.7 t -118.76 128.28 75.64 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.257 0 N-CA-C 109.829 -0.434 . . . . 0.0 109.829 -179.076 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' B' B ' 95' ' ' VAL . . . . . . . . . . . . . 42.6 t -121.73 134.1 66.08 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.304 0 CA-C-N 116.138 -0.483 . . . . 0.0 109.829 -179.882 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' B' B ' 96' ' ' ILE . . . . . . . . . . . . . 63.7 mt -115.13 127.1 72.82 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.21 0 N-CA-C 109.411 -0.589 . . . . 0.0 109.411 179.95 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' B' B ' 97' ' ' THR . . . . . . . . . . . . . 66.4 p -102.6 157.71 16.75 Favored 'General case' 0 C--N 1.331 -0.222 0 CA-C-O 121.394 0.616 . . . . 0.0 111.376 -176.74 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' B' B ' 98' ' ' GLU . . . . . . . . . . . . . 84.0 tt0 -53.9 -25.54 20.61 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 115.867 -0.606 . . . . 0.0 112.317 179.834 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' B' B ' 99' ' ' GLU . . . . . . . . . . . . . 45.8 mp0 -77.69 14.37 1.06 Allowed 'General case' 0 CA--C 1.535 0.403 0 N-CA-C 113.161 0.8 . . . . 0.0 113.161 -177.206 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' B' B ' 100' ' ' ASN . . . . . . . . . . . . . 3.2 m-20 62.32 38.04 13.45 Favored 'General case' 0 CA--C 1.529 0.169 0 CA-C-O 121.05 0.453 . . . . 0.0 110.747 178.699 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' B' B ' 101' ' ' GLU . . . . . . . . . . . . . 84.7 tt0 -120.61 141.76 50.03 Favored 'General case' 0 C--N 1.332 -0.163 0 CA-C-N 116.098 -0.501 . . . . 0.0 109.75 177.214 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' B' B ' 102' ' ' VAL . . . . . . . . . . . . . 44.9 t -114.97 127.63 72.45 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.297 0 CA-C-N 116.331 -0.395 . . . . 0.0 109.972 -178.297 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' B' B ' 103' ' ' LEU . . . . . . . . . . . . . 6.7 mp -117.25 132.83 56.54 Favored 'General case' 0 C--N 1.331 -0.227 0 CA-C-N 115.763 -0.653 . . . . 0.0 110.273 176.988 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' B' B ' 104' ' ' ILE . . . . . 0.556 HD13 HG21 ' B' ' 130' ' ' VAL . 67.3 mt -118.24 121.69 67.79 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.24 0 CA-C-N 116.037 -0.529 . . . . 0.0 110.031 179.662 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' B' B ' 105' ' ' PHE . . . . . . . . . . . . . 56.7 m-85 -120.37 161.72 20.71 Favored 'General case' 0 C--N 1.331 -0.219 0 O-C-N 123.98 0.8 . . . . 0.0 109.651 178.64 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' B' B ' 106' ' ' ASN . . . . . . . . . . . . . 44.2 p-10 -93.97 -169.95 2.2 Favored 'General case' 0 C--N 1.33 -0.249 0 N-CA-C 110.053 -0.351 . . . . 0.0 110.053 175.019 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' B' B ' 107' ' ' GLN . . . . . . . . . . . . . 61.4 tt0 -58.91 -30.03 67.51 Favored 'General case' 0 C--N 1.33 -0.258 0 N-CA-C 111.876 0.324 . . . . 0.0 111.876 179.333 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' B' B ' 108' ' ' ASN . . . . . . . . . . . . . 6.8 t30 -83.66 7.94 15.96 Favored 'General case' 0 CA--C 1.536 0.406 0 N-CA-C 113.193 0.812 . . . . 0.0 113.193 -177.274 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' B' B ' 109' ' ' LEU . . . . . 0.646 HD21 ' HB2' ' B' ' 78' ' ' ALA . 12.0 tp 60.78 37.66 18.64 Favored 'General case' 0 C--O 1.232 0.181 0 CA-C-O 120.962 0.41 . . . . 0.0 111.211 179.074 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' B' B ' 110' ' ' GLU . . . . . . . . . . . . . 95.4 mt-10 -107.34 151.24 25.76 Favored 'General case' 0 C--N 1.331 -0.238 0 N-CA-C 109.925 -0.398 . . . . 0.0 109.925 176.174 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' B' B ' 111' ' ' GLU . . . . . . . . . . . . . 84.8 tt0 -82.01 123.24 28.73 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-O 120.939 0.399 . . . . 0.0 111.175 -175.626 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' B' B ' 112' ' ' LEU . . . . . . . . . . . . . 33.7 mt -108.36 -46.0 3.79 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 115.933 -0.576 . . . . 0.0 110.481 177.443 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' B' B ' 113' ' ' TYR . . . . . . . . . . . . . 60.5 t80 -140.61 137.68 33.84 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.163 -0.471 . . . . 0.0 110.921 -179.053 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' B' B ' 114' ' ' ARG . . . . . . . . . . . . . 56.9 ttp180 -147.0 124.98 12.0 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-O 120.991 0.424 . . . . 0.0 110.386 175.866 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' B' B ' 115' ' ' GLY . . . . . . . . . . . . . . . -150.15 156.53 26.78 Favored Glycine 0 CA--C 1.526 0.737 0 N-CA-C 110.95 -0.86 . . . . 0.0 110.95 179.164 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' B' B ' 116' ' ' LYS . . . . . . . . . . . . . 35.0 ttpt -118.69 138.45 52.62 Favored 'General case' 0 C--O 1.233 0.189 0 CA-C-O 120.73 0.3 . . . . 0.0 110.288 179.18 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' B' B ' 117' ' ' PHE . . . . . . . . . . . . . 24.0 m-85 -135.78 114.07 11.53 Favored 'General case' 0 C--N 1.329 -0.299 0 N-CA-C 109.733 -0.469 . . . . 0.0 109.733 -178.973 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' B' B ' 118' ' ' GLU . . . . . . . . . . . . . 96.3 mt-10 -54.97 -42.22 72.12 Favored 'General case' 0 C--N 1.329 -0.29 0 C-N-CA 120.874 -0.33 . . . . 0.0 111.223 -176.234 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' B' B ' 119' ' ' ASN . . . . . . . . . . . . . 2.5 m120 -97.32 31.13 2.58 Favored 'General case' 0 C--N 1.33 -0.257 0 N-CA-C 112.148 0.425 . . . . 0.0 112.148 -174.97 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' B' B ' 120' ' ' LEU . . . . . . . . . . . . . 18.7 tp -57.13 121.85 11.03 Favored 'General case' 0 C--N 1.332 -0.174 0 N-CA-C 110.278 -0.268 . . . . 0.0 110.278 177.253 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' B' B ' 121' ' ' ASN . . . . . . . . . . . . . 57.9 m-20 -113.98 -44.17 3.18 Favored 'General case' 0 C--N 1.332 -0.186 0 CA-C-N 116.667 -0.242 . . . . 0.0 111.309 -176.766 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' B' B ' 122' ' ' LYS . . . . . . . . . . . . . 98.3 mttt -146.67 149.76 34.09 Favored 'General case' 0 C--O 1.232 0.171 0 C-N-CA 120.442 -0.503 . . . . 0.0 112.008 -177.951 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' B' B ' 123' ' ' VAL . . . . . . . . . . . . . 48.8 t -119.41 127.78 75.85 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.218 0 CA-C-N 115.697 -0.683 . . . . 0.0 109.163 174.326 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' B' B ' 124' ' ' LEU . . . . . . . . . . . . . 31.6 mt -120.89 136.01 55.04 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 116.531 -0.304 . . . . 0.0 110.633 -176.255 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' B' B ' 125' ' ' VAL . . . . . . . . . . . . . 42.6 t -131.1 131.45 63.84 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.264 0 CA-C-N 116.306 -0.406 . . . . 0.0 110.266 179.121 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' B' B ' 126' ' ' ARG . . . . . . . . . . . . . 27.7 mtp180 -151.55 129.73 11.93 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.113 -0.494 . . . . 0.0 109.842 176.619 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' B' B ' 127' ' ' ASN . . . . . . . . . . . . . 32.5 t30 56.2 -152.45 0.38 Allowed 'General case' 0 CA--C 1.54 0.565 0 N-CA-C 109.7 -0.481 . . . . 0.0 109.7 -179.119 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' B' B ' 128' ' ' ASP . . . . . . . . . . . . . 15.9 p-10 -83.6 18.04 2.03 Favored 'General case' 0 CA--C 1.537 0.45 0 CA-C-N 118.526 0.603 . . . . 0.0 112.562 177.558 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' B' B ' 129' ' ' LEU . . . . . . . . . . . . . 41.1 mt -115.24 144.92 42.99 Favored 'General case' 0 C--O 1.232 0.179 0 CA-C-N 117.956 0.344 . . . . 0.0 110.24 179.69 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' B' B ' 130' ' ' VAL . . . . . 0.556 HG21 HD13 ' B' ' 104' ' ' ILE . 32.3 m -129.31 143.21 41.89 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.232 0 CA-C-O 120.93 0.395 . . . . 0.0 110.6 -178.512 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' B' B ' 131' ' ' VAL . . . . . 0.587 HG22 HD12 ' B' ' 140' ' ' LEU . 38.0 t -136.1 141.34 41.87 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.254 0 CA-C-O 121.079 0.466 . . . . 0.0 110.551 -178.844 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' B' B ' 132' ' ' ILE . . . . . . . . . . . . . 74.1 mt -118.39 131.38 71.34 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.262 0 CA-C-N 115.805 -0.634 . . . . 0.0 109.396 178.726 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' B' B ' 133' ' ' ILE . . . . . . . . . . . . . 41.8 mm -117.11 125.12 73.75 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.235 0 CA-C-O 120.785 0.326 . . . . 0.0 111.158 -174.035 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' B' B ' 134' ' ' ASP . . . . . . . . . . . . . 9.7 p-10 -136.09 148.01 48.09 Favored 'General case' 0 C--N 1.332 -0.167 0 N-CA-C 109.514 -0.55 . . . . 0.0 109.514 172.89 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' B' B ' 135' ' ' GLU . . . . . . . . . . . . . 44.3 tp10 -49.92 -27.26 5.02 Favored 'General case' 0 C--N 1.326 -0.45 0 N-CA-C 112.873 0.694 . . . . 0.0 112.873 -172.668 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' B' B ' 136' ' ' GLN . . . . . . . . . . . . . 53.8 mt-30 -85.23 -30.46 23.82 Favored 'General case' 0 C--N 1.33 -0.24 0 N-CA-C 112.694 0.627 . . . . 0.0 112.694 -175.113 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' B' B ' 137' ' ' LYS . . . . . . . . . . . . . 22.9 pttm -167.62 171.18 10.44 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-O 121.518 0.675 . . . . 0.0 112.483 -173.024 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' B' B ' 138' ' ' LEU . . . . . 0.406 HD23 ' N ' ' B' ' 139' ' ' THR . 6.4 tt -121.11 130.02 53.56 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 115.059 -0.973 . . . . 0.0 110.164 -178.521 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' B' B ' 139' ' ' THR . . . . . 0.406 ' N ' HD23 ' B' ' 138' ' ' LEU . 29.2 m -109.57 125.38 52.47 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-N 116.26 -0.427 . . . . 0.0 110.291 178.593 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' B' B ' 140' ' ' LEU . . . . . 0.587 HD12 HG22 ' B' ' 131' ' ' VAL . 15.0 tp -114.24 119.24 36.35 Favored 'General case' 0 C--N 1.328 -0.328 0 N-CA-C 109.412 -0.588 . . . . 0.0 109.412 -178.015 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' B' B ' 141' ' ' ILE . . . . . 0.518 ' HB ' HG23 ' B' ' 130' ' ' VAL . 22.1 mt -120.08 121.18 65.2 Favored 'Isoleucine or valine' 0 C--O 1.234 0.248 0 CA-C-O 121.067 0.461 . . . . 0.0 110.217 -175.731 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' B' B ' 142' ' ' ARG . . . . . . . . . . . . . 85.3 mtm180 -107.13 127.23 53.31 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 115.219 -0.9 . . . . 0.0 110.435 -178.748 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' B' B ' 143' ' ' THR . . . . . . . . . . . . . 76.5 p . . . . . 0 C--O 1.22 -0.472 0 CA-C-O 117.976 -1.011 . . . . 0.0 110.537 179.778 . . . . . . . . 0 0 . 1 . 006 nuclear nobuild core ' C' C ' 2' ' ' SER . . . . . . . . . . . . . 5.7 p . . . . . 0 N--CA 1.461 0.104 0 CA-C-O 121.071 0.463 . . . . 0.0 110.818 . . . . . . . . . 0 0 . 1 . 006 nuclear nobuild core ' C' C ' 3' ' ' GLU . . . . . . . . . . . . . 85.1 tt0 -142.12 140.44 32.48 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 115.801 -0.636 . . . . 0.0 111.001 -179.832 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' C' C ' 4' ' ' LEU . . . . . 0.438 HD21 HD21 ' C' ' 6' ' ' LEU . 15.9 tp -121.89 126.53 48.9 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 115.887 -0.597 . . . . 0.0 110.093 177.171 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' C' C ' 5' ' ' LYS . . . . . . . . . . . . . 99.0 mttt -104.64 121.0 42.65 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.414 -0.357 . . . . 0.0 110.572 178.577 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' C' C ' 6' ' ' LEU . . . . . 0.438 HD21 HD21 ' C' ' 4' ' ' LEU . 75.7 mt -116.63 148.71 40.71 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 115.43 -0.804 . . . . 0.0 110.284 -178.959 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' C' C ' 7' ' ' LYS . . . . . . . . . . . . . 64.2 tttm -133.18 136.04 26.68 Favored Pre-proline 0 CA--C 1.534 0.365 0 CA-C-O 118.929 -0.558 . . . . 0.0 109.91 177.084 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' C' C ' 8' ' ' PRO . . . . . . . . . . . . . 84.7 Cg_endo -90.61 140.64 3.07 Favored 'Trans proline' 0 N--CA 1.491 1.365 0 C-N-CA 121.716 1.611 . . . . 0.0 111.571 178.063 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' C' C ' 9' ' ' LEU . . . . . . . . . . . . . 68.6 mt -75.13 -47.53 4.55 Favored Pre-proline 0 CA--C 1.534 0.345 0 CA-C-O 118.712 -0.661 . . . . 0.0 112.311 -178.689 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' C' C ' 10' ' ' PRO . . . . . . . . . . . . . 91.4 Cg_endo -81.49 152.57 17.76 Favored 'Trans proline' 0 N--CA 1.497 1.715 0 C-N-CA 121.312 1.341 . . . . 0.0 111.987 176.038 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' C' C ' 11' ' ' LYS . . . . . . . . . . . . . 50.0 tttm -89.23 102.2 14.86 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.426 -0.352 . . . . 0.0 110.373 178.282 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' C' C ' 12' ' ' VAL . . . . . . . . . . . . . 12.8 p -147.36 145.7 18.89 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.359 0 CA-C-N 116.313 -0.403 . . . . 0.0 110.802 -179.461 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' C' C ' 13' ' ' GLU . . . . . . . . . . . . . 39.6 mt-10 -83.72 122.15 28.25 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.324 -0.398 . . . . 0.0 109.99 175.613 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' C' C ' 14' ' ' LEU . . . . . . . . . . . . . 27.4 mt -94.68 153.92 40.08 Favored Pre-proline 0 C--N 1.329 -0.288 0 CA-C-N 116.456 -0.338 . . . . 0.0 110.83 -177.699 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' C' C ' 15' ' ' PRO . . . . . . . . . . . . . 36.0 Cg_exo -58.35 154.96 37.84 Favored 'Trans proline' 0 N--CA 1.495 1.588 0 C-N-CA 121.268 1.312 . . . . 0.0 111.724 178.576 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' C' C ' 16' ' ' PRO . . . . . . . . . . . . . 34.2 Cg_exo -57.85 -33.61 97.21 Favored 'Trans proline' 0 N--CA 1.497 1.701 0 C-N-CA 121.483 1.455 . . . . 0.0 112.817 -179.098 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' C' C ' 17' ' ' ASP . . . . . . . . . . . . . 20.8 p-10 -90.1 8.79 30.98 Favored 'General case' 0 CA--C 1.536 0.41 0 N-CA-C 113.45 0.907 . . . . 0.0 113.45 -176.671 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' C' C ' 18' ' ' PHE . . . . . . . . . . . . . 35.4 t80 -58.4 -45.8 87.65 Favored 'General case' 0 N--CA 1.457 -0.094 0 O-C-N 121.972 -0.455 . . . . 0.0 110.122 -177.212 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' C' C ' 19' ' ' VAL . . . . . 0.408 HG13 ' N ' ' C' ' 20' ' ' ASP . 14.2 p -56.51 -41.33 72.47 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.411 0 CA-C-N 116.269 -0.423 . . . . 0.0 110.889 -178.916 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' C' C ' 20' ' ' ASP . . . . . 0.408 ' N ' HG13 ' C' ' 19' ' ' VAL . 68.8 m-20 -60.73 -42.83 98.09 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-O 120.83 0.348 . . . . 0.0 111.076 -178.191 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' C' C ' 21' ' ' VAL . . . . . . . . . . . . . 48.7 t -64.44 -48.52 84.78 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.32 0 CA-C-N 116.311 -0.404 . . . . 0.0 110.403 -177.566 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' C' C ' 22' ' ' ILE . . . . . 0.438 HG22 HD12 ' C' ' 26' ' ' LEU . 48.8 mm -55.73 -46.37 79.64 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.221 0 CA-C-O 120.869 0.366 . . . . 0.0 110.738 -179.742 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' C' C ' 23' ' ' ARG . . . . . . . . . . . . . 59.9 ttp180 -53.48 -51.7 61.91 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-O 120.777 0.323 . . . . 0.0 111.566 -178.719 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' C' C ' 24' ' ' ILE . . . . . . . . . . . . . 74.9 mt -60.12 -41.42 86.49 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.269 0 CA-C-N 116.6 -0.273 . . . . 0.0 111.214 -176.631 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' C' C ' 25' ' ' LYS . . . . . . . . . . . . . 53.6 mmtt -63.78 -39.97 95.54 Favored 'General case' 0 C--N 1.328 -0.33 0 N-CA-C 112.107 0.41 . . . . 0.0 112.107 -179.948 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' C' C ' 26' ' ' LEU . . . . . 0.438 HD12 HG22 ' C' ' 22' ' ' ILE . 87.7 mt -78.48 -41.12 33.47 Favored 'General case' 0 C--N 1.33 -0.252 0 N-CA-C 113.539 0.94 . . . . 0.0 113.539 -170.715 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' C' C ' 27' ' ' GLN . . . . . . . . . . . . . 11.3 pt20 -47.24 139.85 5.85 Favored 'General case' 0 N--CA 1.469 0.509 0 N-CA-C 112.75 0.648 . . . . 0.0 112.75 -174.237 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' C' C ' 28' ' ' GLY . . . . . . . . . . . . . . . 99.33 -26.75 23.12 Favored Glycine 0 CA--C 1.532 1.127 0 CA-C-N 115.633 -0.712 . . . . 0.0 112.217 -177.723 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' C' C ' 29' ' ' LYS . . . . . . . . . . . . . 98.9 mttt -98.51 155.06 17.45 Favored 'General case' 0 C--O 1.232 0.181 0 CA-C-N 117.273 0.536 . . . . 0.0 111.254 179.662 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' C' C ' 30' ' ' THR . . . . . . . . . . . . . 23.5 m -103.88 137.3 42.08 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-N 115.957 -0.565 . . . . 0.0 110.092 176.392 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' C' C ' 31' ' ' VAL . . . . . . . . . . . . . 34.8 m -130.51 154.07 40.01 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.245 0 CA-C-O 120.947 0.403 . . . . 0.0 110.971 -178.523 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' C' C ' 32' ' ' ARG . . . . . . . . . . . . . 95.6 mtt180 -130.11 151.58 50.49 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 116.013 -0.539 . . . . 0.0 110.466 178.502 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' C' C ' 33' ' ' THR . . . . . . . . . . . . . 29.3 m -53.4 139.25 31.07 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-O 120.851 0.358 . . . . 0.0 111.225 -178.314 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' C' C ' 34' ' ' GLY . . . . . . . . . . . . . . . 100.63 -17.05 57.14 Favored Glycine 0 CA--C 1.532 1.136 0 CA-C-O 119.671 -0.516 . . . . 0.0 113.244 179.732 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' C' C ' 35' ' ' ASP . . . . . . . . . . . . . 64.4 m-20 -65.65 150.81 47.85 Favored 'General case' 0 C--O 1.231 0.089 0 CA-C-N 118.028 0.914 . . . . 0.0 110.891 178.461 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' C' C ' 36' ' ' VAL . . . . . . . . . . . . . 43.7 t -124.38 133.61 68.89 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.188 0 CA-C-N 116.044 -0.526 . . . . 0.0 110.027 179.056 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' C' C ' 37' ' ' ILE . . . . . . . . . . . . . 69.9 mt -119.98 139.73 46.35 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.25 0 CA-C-N 116.087 -0.506 . . . . 0.0 109.842 179.882 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' C' C ' 38' ' ' GLY . . . . . . . . . . . . . . . -114.22 128.73 8.37 Favored Glycine 0 CA--C 1.526 0.727 0 N-CA-C 111.214 -0.754 . . . . 0.0 111.214 -179.82 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' C' C ' 39' ' ' ILE . . . . . . . . . . . . . 70.8 mt -125.34 130.84 72.84 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.267 0 N-CA-C 109.791 -0.448 . . . . 0.0 109.791 178.371 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' C' C ' 40' ' ' SER . . . . . . . . . . . . . 31.3 t -93.18 113.95 26.32 Favored 'General case' 0 C--N 1.33 -0.24 0 C-N-CA 120.747 -0.381 . . . . 0.0 110.817 176.185 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' C' C ' 41' ' ' ILE . . . . . . . . . . . . . 43.9 mm -123.82 121.79 63.12 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.204 0 CA-C-N 116.484 -0.326 . . . . 0.0 110.237 -179.413 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' C' C ' 42' ' ' LEU . . . . . . . . . . . . . 72.4 mt 57.68 35.33 25.51 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-N 116.349 -0.387 . . . . 0.0 111.8 177.118 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' C' C ' 43' ' ' GLY . . . . . . . . . . . . . . . 78.3 -10.18 30.01 Favored Glycine 0 CA--C 1.533 1.169 0 C-N-CA 121.178 -0.534 . . . . 0.0 113.449 177.248 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' C' C ' 44' ' ' LYS . . . . . . . . . . . . . 68.7 mttm -100.24 131.71 46.02 Favored 'General case' 0 C--N 1.333 -0.125 0 CA-C-N 118.016 0.908 . . . . 0.0 110.078 176.51 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' C' C ' 45' ' ' GLU . . . . . . . . . . . . . 31.5 tp10 -84.37 127.02 33.75 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.396 -0.366 . . . . 0.0 110.459 -179.905 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' C' C ' 46' ' ' VAL . . . . . . . . . . . . . 7.6 p -121.09 128.15 76.0 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.243 0 CA-C-O 121.116 0.484 . . . . 0.0 109.807 178.36 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' C' C ' 47' ' ' LYS . . . . . . . . . . . . . 62.8 mttp -100.57 130.66 46.66 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 115.903 -0.59 . . . . 0.0 111.459 178.058 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' C' C ' 48' ' ' PHE . . . . . . . . . . . . . 94.9 m-85 -113.95 131.95 56.13 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 115.915 -0.584 . . . . 0.0 109.873 176.023 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' C' C ' 49' ' ' LYS . . . . . . . . . . . . . 84.4 tttt -106.53 136.53 46.14 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.471 -0.331 . . . . 0.0 110.518 179.975 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' C' C ' 50' ' ' VAL . . . . . . . . . . . . . 43.6 t -80.99 109.3 15.21 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.302 0 N-CA-C 109.311 -0.626 . . . . 0.0 109.311 177.252 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' C' C ' 51' ' ' VAL . . . . . . . . . . . . . 47.9 t -73.96 -47.55 42.24 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.39 0 CA-C-N 116.148 -0.478 . . . . 0.0 110.11 -173.781 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' C' C ' 52' ' ' GLN . . . . . . . . . . . . . 61.9 tt0 -163.86 139.43 6.31 Favored 'General case' 0 C--N 1.331 -0.222 0 C-N-CA 120.218 -0.593 . . . . 0.0 111.912 -177.724 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' C' C ' 53' ' ' ALA . . . . . 0.421 ' HB1' ' HB2' ' C' ' 58' ' ' LEU . . . -112.94 133.67 54.8 Favored 'General case' 0 C--N 1.332 -0.195 0 CA-C-N 115.66 -0.7 . . . . 0.0 109.853 175.445 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' C' C ' 54' ' ' TYR . . . . . . . . . . . . . 48.9 t80 -129.08 111.14 18.33 Favored Pre-proline 0 CA--C 1.536 0.415 0 CA-C-O 118.172 -0.918 . . . . 0.0 110.456 179.263 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' C' C ' 55' ' ' PRO . . . . . . . . . . . . . 72.5 Cg_endo -77.17 168.09 77.89 Favored 'Cis proline' 0 N--CA 1.497 1.726 0 CA-C-N 121.883 1.708 . . . . 0.0 112.213 -6.24 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' C' C ' 56' ' ' SER . . . . . . . . . . . . . 48.1 m -117.32 136.5 23.48 Favored Pre-proline 0 CA--C 1.539 0.525 0 CA-C-O 118.518 -0.754 . . . . 0.0 109.683 174.652 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' C' C ' 57' ' ' PRO . . . . . . . . . . . . . 36.8 Cg_endo -66.95 145.99 73.87 Favored 'Cis proline' 0 N--CA 1.499 1.795 0 CA-C-N 121.822 1.687 . . . . 0.0 111.383 -3.473 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' C' C ' 58' ' ' LEU . . . . . 0.421 ' HB2' ' HB1' ' C' ' 53' ' ' ALA . 20.6 tp -107.76 136.17 47.95 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.505 -0.316 . . . . 0.0 110.699 -177.796 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' C' C ' 59' ' ' ARG . . . . . . . . . . . . . 71.3 ttt180 -104.58 124.42 49.29 Favored 'General case' 0 C--N 1.328 -0.355 0 N-CA-C 109.247 -0.649 . . . . 0.0 109.247 175.462 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' C' C ' 60' ' ' VAL . . . . . . . . . . . . . 42.3 t -79.73 126.23 39.14 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.251 0 C-N-CA 120.663 -0.415 . . . . 0.0 110.492 -174.459 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' C' C ' 61' ' ' GLU . . . . . . . . . . . . . 96.4 mt-10 -131.05 160.97 33.07 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 115.712 -0.676 . . . . 0.0 109.967 178.507 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' C' C ' 62' ' ' ASP . . . . . . . . . . . . . 11.7 t70 -53.76 -32.49 52.49 Favored 'General case' 0 C--N 1.328 -0.363 0 N-CA-C 111.822 0.304 . . . . 0.0 111.822 -179.154 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' C' C ' 63' ' ' ARG . . . . . . . . . . . . . 38.0 ptt180 -88.38 6.19 38.55 Favored 'General case' 0 CA--C 1.537 0.447 0 N-CA-C 113.688 0.996 . . . . 0.0 113.688 -175.616 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' C' C ' 64' ' ' THR . . . . . . . . . . . . . 38.2 m -81.12 142.51 33.22 Favored 'General case' 0 C--N 1.331 -0.2 0 CA-C-N 118.03 0.377 . . . . 0.0 110.549 -179.404 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' C' C ' 65' ' ' LYS . . . . . . . . . . . . . 68.4 mttm -89.26 129.9 35.75 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.237 179.543 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' C' C ' 66' ' ' ILE . . . . . . . . . . . . . 64.7 mt -116.93 130.1 72.4 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.217 0 N-CA-C 109.758 -0.46 . . . . 0.0 109.758 178.86 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' C' C ' 67' ' ' THR . . . . . . . . . . . . . 36.0 m -126.47 140.23 52.63 Favored 'General case' 0 C--N 1.331 -0.22 0 CA-C-O 121.069 0.461 . . . . 0.0 111.065 -177.119 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' C' C ' 68' ' ' LEU . . . . . 0.441 HD23 ' C ' ' C' ' 68' ' ' LEU . 6.4 tt . . . . . 0 C--N 1.33 -0.276 0 CA-C-N 115.763 -0.653 . . . . 0.0 109.446 176.562 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' C' C ' 73' ' ' VAL . . . . . . . . . . . . . 18.7 m . . . . . 0 N--CA 1.461 0.12 0 CA-C-O 121.201 0.524 . . . . 0.0 110.541 . . . . . . . . . 0 0 . 1 . 006 nuclear nobuild core ' C' C ' 74' ' ' ASP . . . . . . . . . . . . . 13.7 t0 -97.52 123.72 41.49 Favored 'General case' 0 C--N 1.326 -0.417 0 CA-C-N 115.508 -0.769 . . . . 0.0 109.34 178.262 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' C' C ' 75' ' ' VAL . . . . . 0.478 ' C ' HD12 ' C' ' 76' ' ' LEU . 42.1 t -112.65 121.23 64.56 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.257 0 CA-C-O 121.187 0.518 . . . . 0.0 110.621 -176.221 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' C' C ' 76' ' ' LEU . . . . . 0.478 HD12 ' C ' ' C' ' 75' ' ' VAL . 7.6 mp -119.09 141.32 48.87 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 115.58 -0.737 . . . . 0.0 109.496 175.673 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' C' C ' 77' ' ' GLU . . . . . . . . . . . . . 46.3 mt-10 -132.23 137.0 47.38 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-O 121.059 0.457 . . . . 0.0 110.994 -178.515 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' C' C ' 78' ' ' ALA . . . . . 0.584 ' HB2' HD21 ' C' ' 109' ' ' LEU . . . -127.39 135.68 50.81 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 115.727 -0.67 . . . . 0.0 109.889 177.152 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' C' C ' 79' ' ' LYS . . . . . 0.6 ' O ' HD13 ' C' ' 80' ' ' ILE . 54.9 pttt -83.85 120.87 26.58 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-O 121.31 0.576 . . . . 0.0 110.932 -178.516 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' C' C ' 80' ' ' ILE . . . . . 0.6 HD13 ' O ' ' C' ' 79' ' ' LYS . 39.6 mm -139.18 115.92 10.34 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.274 0 CA-C-N 115.738 -0.665 . . . . 0.0 109.359 -177.769 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' C' C ' 81' ' ' LYS . . . . . . . . . . . . . 99.3 mttt -101.09 125.48 47.71 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-O 120.828 0.347 . . . . 0.0 111.156 -178.172 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' C' C ' 82' ' ' GLY . . . . . . . . . . . . . . . 89.13 42.2 5.66 Favored Glycine 0 CA--C 1.524 0.624 0 C-N-CA 120.714 -0.755 . . . . 0.0 111.772 173.117 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' C' C ' 83' ' ' ILE . . . . . . . . . . . . . 74.8 mt -65.61 134.91 29.18 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.374 0 N-CA-C 109.606 -0.516 . . . . 0.0 109.606 176.841 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' C' C ' 84' ' ' LYS . . . . . . . . . . . . . 51.0 tttp -99.09 -53.96 3.11 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-O 121.061 0.458 . . . . 0.0 110.375 -179.148 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' C' C ' 85' ' ' ASP . . . . . . . . . . . . . 10.1 t70 -148.78 146.37 28.0 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 115.786 -0.643 . . . . 0.0 110.284 -179.082 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' C' C ' 86' ' ' VAL . . . . . . . . . . . . . 43.7 t -127.14 127.61 69.63 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.196 0 CA-C-O 120.783 0.325 . . . . 0.0 110.414 -179.558 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' C' C ' 87' ' ' ILE . . . . . . . . . . . . . 44.6 mm -120.53 126.71 75.55 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.27 0 CA-C-N 115.996 -0.547 . . . . 0.0 109.766 177.935 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' C' C ' 88' ' ' LEU . . . . . . . . . . . . . 74.6 mt -107.25 139.61 41.44 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-O 121.006 0.432 . . . . 0.0 111.037 -179.314 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' C' C ' 89' ' ' ASP . . . . . . . . . . . . . 6.0 t70 -130.3 154.06 48.01 Favored 'General case' 0 C--N 1.328 -0.328 0 N-CA-C 109.302 -0.629 . . . . 0.0 109.302 176.253 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' C' C ' 90' ' ' GLU . . . . . . . . . . . . . 84.9 tt0 -47.91 -34.79 9.53 Favored 'General case' 0 C--N 1.33 -0.253 0 N-CA-C 112.972 0.73 . . . . 0.0 112.972 -172.07 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' C' C ' 91' ' ' ASN . . . . . . . . . . . . . 86.9 m-20 -132.03 19.51 4.53 Favored 'General case' 0 N--CA 1.468 0.464 0 N-CA-C 113.124 0.787 . . . . 0.0 113.124 -178.437 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' C' C ' 92' ' ' LEU . . . . . . . . . . . . . 48.5 mt -148.66 148.55 30.21 Favored 'General case' 0 C--N 1.331 -0.218 0 CA-C-O 120.644 0.259 . . . . 0.0 110.35 -177.702 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' C' C ' 93' ' ' ILE . . . . . . . . . . . . . 70.5 mt -126.94 118.39 50.33 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.345 0 N-CA-C 109.148 -0.686 . . . . 0.0 109.148 176.42 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' C' C ' 94' ' ' VAL . . . . . . . . . . . . . 46.3 t -118.89 126.29 75.19 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.281 0 CA-C-O 121.028 0.442 . . . . 0.0 110.022 -179.035 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' C' C ' 95' ' ' VAL . . . . . . . . . . . . . 44.7 t -119.91 133.1 67.77 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.382 0 CA-C-N 115.788 -0.642 . . . . 0.0 109.648 179.386 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' C' C ' 96' ' ' ILE . . . . . . . . . . . . . 63.9 mt -111.77 127.74 68.76 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.349 0 N-CA-C 109.089 -0.708 . . . . 0.0 109.089 178.016 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' C' C ' 97' ' ' THR . . . . . . . . . . . . . 80.9 p -97.83 157.91 15.82 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-O 121.159 0.504 . . . . 0.0 110.979 -178.071 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' C' C ' 98' ' ' GLU . . . . . . . . . . . . . 82.1 tt0 -53.73 -25.53 19.02 Favored 'General case' 0 CA--C 1.533 0.323 0 CA-C-N 116.105 -0.498 . . . . 0.0 112.145 179.509 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' C' C ' 99' ' ' GLU . . . . . . . . . . . . . 95.4 mt-10 -80.12 15.34 1.54 Allowed 'General case' 0 CA--C 1.535 0.398 0 N-CA-C 113.191 0.811 . . . . 0.0 113.191 -176.714 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' C' C ' 100' ' ' ASN . . . . . . . . . . . . . 3.3 m-20 61.96 37.89 14.71 Favored 'General case' 0 N--CA 1.463 0.198 0 CA-C-O 121.105 0.479 . . . . 0.0 110.939 179.001 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' C' C ' 101' ' ' GLU . . . . . . . . . . . . . 84.5 tt0 -117.99 144.43 45.54 Favored 'General case' 0 C--N 1.332 -0.172 0 CA-C-N 116.074 -0.512 . . . . 0.0 109.755 176.764 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' C' C ' 102' ' ' VAL . . . . . . . . . . . . . 44.7 t -115.14 126.26 72.67 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.253 0 CA-C-N 116.284 -0.416 . . . . 0.0 110.14 -176.75 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' C' C ' 103' ' ' LEU . . . . . . . . . . . . . 29.5 mt -115.25 127.14 55.29 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-N 115.686 -0.688 . . . . 0.0 109.932 175.905 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' C' C ' 104' ' ' ILE . . . . . . . . . . . . . 66.7 mt -116.33 120.32 64.57 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.225 0 N-CA-C 110.15 -0.315 . . . . 0.0 110.15 179.737 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' C' C ' 105' ' ' PHE . . . . . . . . . . . . . 47.8 m-85 -119.8 166.41 13.3 Favored 'General case' 0 C--N 1.332 -0.178 0 CA-C-N 115.415 -0.812 . . . . 0.0 109.535 178.364 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' C' C ' 106' ' ' ASN . . . . . . . . . . . . . 43.0 p-10 -99.5 -170.07 1.85 Allowed 'General case' 0 C--N 1.33 -0.261 0 N-CA-C 109.993 -0.373 . . . . 0.0 109.993 174.988 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' C' C ' 107' ' ' GLN . . . . . . . . . . . . . 29.7 tt0 -58.51 -30.07 66.77 Favored 'General case' 0 C--N 1.329 -0.313 0 N-CA-C 111.984 0.365 . . . . 0.0 111.984 179.287 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' C' C ' 108' ' ' ASN . . . . . . . . . . . . . 13.5 t-20 -84.05 7.57 18.16 Favored 'General case' 0 CA--C 1.536 0.439 0 N-CA-C 113.204 0.816 . . . . 0.0 113.204 -176.903 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' C' C ' 109' ' ' LEU . . . . . 0.584 HD21 ' HB2' ' C' ' 78' ' ' ALA . 10.6 tp 61.39 38.39 16.15 Favored 'General case' 0 C--N 1.332 -0.189 0 CA-C-O 121.131 0.491 . . . . 0.0 111.19 179.192 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' C' C ' 110' ' ' GLU . . . . . . . . . . . . . 96.8 mt-10 -105.38 153.29 21.86 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.219 -0.446 . . . . 0.0 109.928 176.85 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' C' C ' 111' ' ' GLU . . . . . . . . . . . . . 83.2 tt0 -85.67 121.9 29.01 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-O 120.768 0.318 . . . . 0.0 110.587 -178.508 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' C' C ' 112' ' ' LEU . . . . . . . . . . . . . 61.6 mt -111.61 -46.14 3.29 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.258 -0.428 . . . . 0.0 110.741 179.623 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' C' C ' 113' ' ' TYR . . . . . . . . . . . . . 55.8 t80 -137.17 134.72 36.64 Favored 'General case' 0 C--N 1.331 -0.223 0 CA-C-N 116.434 -0.348 . . . . 0.0 110.966 -179.094 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' C' C ' 114' ' ' ARG . . . . . . . . . . . . . 31.6 ttp180 -135.62 124.03 23.39 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.34 -0.391 . . . . 0.0 110.164 176.604 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' C' C ' 115' ' ' GLY . . . . . . . . . . . . . . . -150.05 162.68 29.26 Favored Glycine 0 CA--C 1.523 0.567 0 N-CA-C 111.038 -0.825 . . . . 0.0 111.038 179.334 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' C' C ' 116' ' ' LYS . . . . . . . . . . . . . 30.0 ttpt -131.28 137.85 49.02 Favored 'General case' 0 C--N 1.33 -0.248 0 N-CA-C 109.941 -0.392 . . . . 0.0 109.941 178.42 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' C' C ' 117' ' ' PHE . . . . . . . . . . . . . 39.2 m-85 -135.11 113.93 11.89 Favored 'General case' 0 C--N 1.331 -0.23 0 N-CA-C 109.919 -0.4 . . . . 0.0 109.919 -178.55 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' C' C ' 118' ' ' GLU . . . . . . . . . . . . . 44.1 mt-10 -57.07 -42.12 80.07 Favored 'General case' 0 C--N 1.328 -0.34 0 C-N-CA 120.774 -0.37 . . . . 0.0 110.886 -176.324 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' C' C ' 119' ' ' ASN . . . . . . . . . . . . . 3.9 p30 -100.51 31.19 3.56 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.232 -0.44 . . . . 0.0 111.964 -175.674 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' C' C ' 120' ' ' LEU . . . . . . . . . . . . . 14.2 tp -54.03 125.9 20.6 Favored 'General case' 0 N--CA 1.463 0.195 0 CA-C-O 120.487 0.184 . . . . 0.0 110.776 177.996 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' C' C ' 121' ' ' ASN . . . . . . . . . . . . . 16.6 m120 -112.72 -44.14 3.36 Favored 'General case' 0 C--O 1.231 0.12 0 C-N-CA 121.125 -0.23 . . . . 0.0 111.415 -176.422 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' C' C ' 122' ' ' LYS . . . . . . . . . . . . . 97.7 mttt -148.3 149.38 31.75 Favored 'General case' 0 C--N 1.332 -0.189 0 C-N-CA 120.557 -0.457 . . . . 0.0 111.879 -177.593 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' C' C ' 123' ' ' VAL . . . . . . . . . . . . . 44.3 t -130.18 126.92 62.47 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.325 0 N-CA-C 109.117 -0.697 . . . . 0.0 109.117 172.908 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' C' C ' 124' ' ' LEU . . . . . . . . . . . . . 12.1 tp -127.97 138.38 52.6 Favored 'General case' 0 N--CA 1.463 0.208 0 CA-C-O 120.859 0.362 . . . . 0.0 111.371 -175.661 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' C' C ' 125' ' ' VAL . . . . . 0.489 HG12 HG23 ' C' ' 130' ' ' VAL . 35.6 m -126.19 133.02 69.82 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.241 0 CA-C-N 115.942 -0.572 . . . . 0.0 110.436 177.715 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' C' C ' 126' ' ' ARG . . . . . . . . . . . . . 24.4 mmt180 -139.38 116.48 11.05 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.312 -0.404 . . . . 0.0 110.537 178.367 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' C' C ' 127' ' ' ASN . . . . . . . . . . . . . 17.8 m-80 52.1 -105.03 0.2 Allowed 'General case' 0 CA--C 1.543 0.68 0 CA-C-O 119.173 -0.441 . . . . 0.0 111.255 178.578 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' C' C ' 128' ' ' ASP . . . . . . . . . . . . . 21.2 p-10 -113.95 1.19 14.63 Favored 'General case' 0 N--CA 1.469 0.487 0 CA-C-N 119.501 1.046 . . . . 0.0 113.423 -176.916 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' C' C ' 129' ' ' LEU . . . . . . . . . . . . . 12.1 tp -108.13 137.77 45.54 Favored 'General case' 0 C--N 1.332 -0.166 0 N-CA-C 109.728 -0.471 . . . . 0.0 109.728 179.155 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' C' C ' 130' ' ' VAL . . . . . 0.507 HG13 ' HB ' ' C' ' 141' ' ' ILE . 13.0 p -126.74 137.97 56.21 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.235 0 CA-C-O 121.035 0.445 . . . . 0.0 110.131 179.906 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' C' C ' 131' ' ' VAL . . . . . . . . . . . . . 42.3 t -135.73 141.14 42.9 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.274 0 CA-C-O 121.16 0.505 . . . . 0.0 110.495 -177.358 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' C' C ' 132' ' ' ILE . . . . . . . . . . . . . 73.6 mt -115.92 132.1 66.4 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.345 0 CA-C-N 115.477 -0.783 . . . . 0.0 109.051 177.838 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' C' C ' 133' ' ' ILE . . . . . . . . . . . . . 43.3 mm -113.36 122.21 67.04 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.242 0 CA-C-O 120.9 0.381 . . . . 0.0 110.494 -175.715 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' C' C ' 134' ' ' ASP . . . . . . . . . . . . . 7.4 p-10 -135.17 146.98 49.26 Favored 'General case' 0 C--N 1.331 -0.209 0 CA-C-N 116.045 -0.525 . . . . 0.0 109.892 178.063 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' C' C ' 135' ' ' GLU . . . . . . . . . . . . . 85.2 tt0 -50.01 -27.9 6.16 Favored 'General case' 0 C--N 1.326 -0.417 0 N-CA-C 112.738 0.644 . . . . 0.0 112.738 -174.536 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' C' C ' 136' ' ' GLN . . . . . . . . . . . . . 97.3 mt-30 -79.81 -34.23 39.71 Favored 'General case' 0 C--O 1.233 0.232 0 N-CA-C 112.456 0.539 . . . . 0.0 112.456 -176.818 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' C' C ' 137' ' ' LYS . . . . . . . . . . . . . 53.1 pttt -169.99 177.06 4.46 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-O 121.551 0.691 . . . . 0.0 112.31 -172.289 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' C' C ' 138' ' ' LEU . . . . . 0.418 HD23 ' N ' ' C' ' 139' ' ' THR . 5.7 tt -116.32 126.38 53.44 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 115.126 -0.943 . . . . 0.0 109.634 176.547 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' C' C ' 139' ' ' THR . . . . . 0.418 ' N ' HD23 ' C' ' 138' ' ' LEU . 28.4 m -106.65 123.24 47.82 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.305 -0.407 . . . . 0.0 110.158 -179.638 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' C' C ' 140' ' ' LEU . . . . . 0.457 ' C ' HD23 ' C' ' 140' ' ' LEU . 5.7 tt -108.78 120.77 43.46 Favored 'General case' 0 C--N 1.329 -0.321 0 N-CA-C 109.114 -0.699 . . . . 0.0 109.114 -178.311 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' C' C ' 141' ' ' ILE . . . . . 0.507 ' HB ' HG13 ' C' ' 130' ' ' VAL . 21.1 mt -123.38 118.91 55.98 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.286 0 CA-C-O 121.211 0.529 . . . . 0.0 109.833 -177.153 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' C' C ' 142' ' ' ARG . . . . . . . . . . . . . 47.0 ttt180 . . . . . 0 C--N 1.328 -0.333 0 CA-C-N 115.207 -0.906 . . . . 0.0 110.002 179.838 . . . . . . . . 0 0 . 1 . 006 nuclear nobuild core ' D' D ' 2' ' ' SER . . . . . . . . . . . . . 3.2 p . . . . . 0 C--O 1.23 0.068 0 CA-C-O 120.788 0.327 . . . . 0.0 110.219 . . . . . . . . . 0 0 . 1 . 006 nuclear nobuild core ' D' D ' 3' ' ' GLU . . . . . . . . . . . . . 95.6 mt-10 -141.02 139.67 34.17 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-O 120.971 0.415 . . . . 0.0 111.074 -178.985 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' D' D ' 4' ' ' LEU . . . . . . . . . . . . . 20.1 tp -123.55 125.21 44.46 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 115.889 -0.596 . . . . 0.0 110.108 176.402 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' D' D ' 5' ' ' LYS . . . . . . . . . . . . . 54.2 mtmt -104.22 118.06 35.72 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.156 -0.474 . . . . 0.0 110.725 179.493 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' D' D ' 6' ' ' LEU . . . . . 0.404 HD23 ' HA ' ' D' ' 50' ' ' VAL . 26.3 mt -115.15 146.0 41.81 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 115.632 -0.713 . . . . 0.0 110.087 179.877 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' D' D ' 7' ' ' LYS . . . . . . . . . . . . . 74.2 tttt -131.93 139.56 35.44 Favored Pre-proline 0 CA--C 1.534 0.347 0 CA-C-O 119.164 -0.446 . . . . 0.0 109.841 176.763 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' D' D ' 8' ' ' PRO . . . . . . . . . . . . . 84.4 Cg_endo -91.96 139.23 2.1 Favored 'Trans proline' 0 N--CA 1.49 1.306 0 C-N-CA 121.776 1.651 . . . . 0.0 111.802 177.782 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' D' D ' 9' ' ' LEU . . . . . . . . . . . . . 59.0 mt -76.14 -46.93 3.65 Favored Pre-proline 0 CA--C 1.533 0.313 0 CA-C-O 118.818 -0.611 . . . . 0.0 112.146 -179.59 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' D' D ' 10' ' ' PRO . . . . . . . . . . . . . 89.1 Cg_endo -81.88 147.06 14.98 Favored 'Trans proline' 0 N--CA 1.495 1.582 0 C-N-CA 121.269 1.313 . . . . 0.0 111.614 174.175 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' D' D ' 11' ' ' LYS . . . . . . . . . . . . . 83.9 tttt -85.07 99.81 11.28 Favored 'General case' 0 C--N 1.33 -0.263 0 C-N-CA 120.801 -0.36 . . . . 0.0 110.136 178.84 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' D' D ' 12' ' ' VAL . . . . . . . . . . . . . 12.2 p -140.84 144.38 27.03 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.257 0 CA-C-N 116.219 -0.446 . . . . 0.0 110.65 -177.788 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' D' D ' 13' ' ' GLU . . . . . . . . . . . . . 43.4 mt-10 -77.69 130.32 36.65 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.253 -0.43 . . . . 0.0 110.02 176.687 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' D' D ' 14' ' ' LEU . . . . . . . . . . . . . 27.3 mt -97.88 146.1 30.89 Favored Pre-proline 0 C--N 1.329 -0.286 0 CA-C-O 119.096 -0.478 . . . . 0.0 109.996 -179.717 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' D' D ' 15' ' ' PRO . . . . . . . . . . . . . 26.9 Cg_exo -61.83 158.69 36.73 Favored 'Trans proline' 0 N--CA 1.498 1.741 0 C-N-CA 121.261 1.307 . . . . 0.0 111.693 177.144 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' D' D ' 16' ' ' PRO . . . . . . . . . . . . . 38.7 Cg_exo -58.79 -34.06 98.79 Favored 'Trans proline' 0 N--CA 1.497 1.711 0 C-N-CA 121.516 1.477 . . . . 0.0 112.898 -178.196 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' D' D ' 17' ' ' ASP . . . . . . . . . . . . . 17.3 p-10 -92.45 9.65 33.43 Favored 'General case' 0 CA--C 1.535 0.389 0 N-CA-C 113.322 0.86 . . . . 0.0 113.322 -177.348 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' D' D ' 18' ' ' PHE . . . . . . . . . . . . . 50.7 t80 -58.15 -45.71 86.93 Favored 'General case' 0 N--CA 1.457 -0.115 0 CA-C-O 121.04 0.448 . . . . 0.0 110.219 -177.709 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' D' D ' 19' ' ' VAL . . . . . . . . . . . . . 47.3 t -56.24 -44.01 78.17 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.337 0 CA-C-N 116.085 -0.507 . . . . 0.0 110.557 -177.493 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' D' D ' 20' ' ' ASP . . . . . . . . . . . . . 44.4 t0 -59.86 -43.41 94.7 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-O 120.729 0.3 . . . . 0.0 110.95 -177.338 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' D' D ' 21' ' ' VAL . . . . . . . . . . . . . 47.5 t -63.93 -46.65 93.49 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.305 0 C-N-CA 120.702 -0.399 . . . . 0.0 110.506 -177.086 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' D' D ' 22' ' ' ILE . . . . . 0.503 HG22 HD12 ' D' ' 26' ' ' LEU . 51.4 mm -55.87 -47.95 79.01 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.275 0 C-N-CA 120.946 -0.301 . . . . 0.0 110.774 179.937 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' D' D ' 23' ' ' ARG . . . . . . . . . . . . . 60.8 ttp180 -54.93 -48.76 72.7 Favored 'General case' 0 C--N 1.331 -0.233 0 C-N-CA 121.06 -0.256 . . . . 0.0 111.347 -178.143 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' D' D ' 24' ' ' ILE . . . . . . . . . . . . . 77.0 mt -59.33 -41.96 85.85 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.357 0 C-N-CA 121.027 -0.269 . . . . 0.0 111.21 -177.126 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' D' D ' 25' ' ' LYS . . . . . . . . . . . . . 73.5 mmtt -65.49 -43.58 89.75 Favored 'General case' 0 C--N 1.329 -0.312 0 N-CA-C 112.445 0.535 . . . . 0.0 112.445 -179.54 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' D' D ' 26' ' ' LEU . . . . . 0.503 HD12 HG22 ' D' ' 22' ' ' ILE . 83.8 mt -78.26 -36.15 47.19 Favored 'General case' 0 C--N 1.329 -0.308 0 N-CA-C 113.287 0.847 . . . . 0.0 113.287 -170.181 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' D' D ' 27' ' ' GLN . . . . . . . . . . . . . 4.6 pt20 -46.3 137.08 6.61 Favored 'General case' 0 N--CA 1.467 0.391 0 N-CA-C 112.871 0.693 . . . . 0.0 112.871 -174.709 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' D' D ' 28' ' ' GLY . . . . . . . . . . . . . . . 99.43 -25.37 28.52 Favored Glycine 0 CA--C 1.533 1.186 0 CA-C-N 115.883 -0.598 . . . . 0.0 112.374 -178.383 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' D' D ' 29' ' ' LYS . . . . . . . . . . . . . 54.7 mtmt -97.88 155.2 17.18 Favored 'General case' 0 C--N 1.332 -0.187 0 CA-C-N 117.341 0.57 . . . . 0.0 111.253 179.76 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' D' D ' 30' ' ' THR . . . . . . . . . . . . . 25.0 m -106.46 138.39 42.72 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 115.908 -0.587 . . . . 0.0 109.992 176.654 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' D' D ' 31' ' ' VAL . . . . . . . . . . . . . 35.8 m -128.85 155.96 41.12 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.239 0 CA-C-N 116.303 -0.408 . . . . 0.0 110.876 -178.486 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' D' D ' 32' ' ' ARG . . . . . . . . . . . . . 77.5 mtt85 -129.46 148.09 51.34 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-N 116.06 -0.518 . . . . 0.0 110.697 178.811 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' D' D ' 33' ' ' THR . . . . . . . . . . . . . 26.7 m -53.87 140.15 31.38 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.34 -0.391 . . . . 0.0 111.27 -179.703 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' D' D ' 34' ' ' GLY . . . . . . . . . . . . . . . 100.71 -17.1 56.99 Favored Glycine 0 CA--C 1.532 1.118 0 CA-C-O 119.618 -0.545 . . . . 0.0 113.306 179.541 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' D' D ' 35' ' ' ASP . . . . . . . . . . . . . 78.7 m-20 -66.51 147.87 52.68 Favored 'General case' 0 C--O 1.232 0.167 0 CA-C-N 118.017 0.909 . . . . 0.0 111.179 178.881 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' D' D ' 36' ' ' VAL . . . . . . . . . . . . . 45.1 t -121.63 129.81 75.18 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.206 0 CA-C-N 116.003 -0.544 . . . . 0.0 109.728 177.317 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' D' D ' 37' ' ' ILE . . . . . . . . . . . . . 68.0 mt -122.64 140.14 47.35 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.264 0 CA-C-N 116.293 -0.412 . . . . 0.0 110.109 -178.332 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' D' D ' 38' ' ' GLY . . . . . . . . . . . . . . . -108.96 128.74 9.18 Favored Glycine 0 CA--C 1.526 0.719 0 N-CA-C 111.086 -0.806 . . . . 0.0 111.086 179.166 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' D' D ' 39' ' ' ILE . . . . . . . . . . . . . 74.6 mt -125.54 140.81 47.29 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.258 0 N-CA-C 110.104 -0.332 . . . . 0.0 110.104 179.445 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' D' D ' 40' ' ' SER . . . . . 0.531 ' O ' HD13 ' D' ' 41' ' ' ILE . 36.3 t -92.13 117.57 29.98 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.41 -0.359 . . . . 0.0 110.828 175.998 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' D' D ' 41' ' ' ILE . . . . . 0.531 HD13 ' O ' ' D' ' 40' ' ' SER . 48.1 mm -130.03 123.35 56.13 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.243 0 N-CA-C 110.174 -0.306 . . . . 0.0 110.174 178.852 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' D' D ' 42' ' ' LEU . . . . . . . . . . . . . 9.0 tp 58.09 33.45 23.18 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.241 -0.436 . . . . 0.0 111.68 178.674 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' D' D ' 43' ' ' GLY . . . . . . . . . . . . . . . 77.02 -10.04 21.96 Favored Glycine 0 CA--C 1.534 1.262 0 C-N-CA 121.258 -0.496 . . . . 0.0 113.517 178.152 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' D' D ' 44' ' ' LYS . . . . . . . . . . . . . 99.2 mttt -103.06 146.26 28.64 Favored 'General case' 0 C--N 1.334 -0.081 0 CA-C-N 117.884 0.842 . . . . 0.0 110.081 178.443 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' D' D ' 45' ' ' GLU . . . . . . . . . . . . . 81.8 tt0 -83.85 127.42 33.82 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.377 -0.374 . . . . 0.0 110.797 -179.51 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' D' D ' 46' ' ' VAL . . . . . . . . . . . . . 7.4 p -122.11 128.8 75.66 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.183 0 N-CA-C 109.521 -0.548 . . . . 0.0 109.521 176.393 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' D' D ' 47' ' ' LYS . . . . . . . . . . . . . 89.8 mttt -100.1 130.0 46.2 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 115.993 -0.549 . . . . 0.0 111.28 178.969 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' D' D ' 48' ' ' PHE . . . . . . . . . . . . . 92.0 m-85 -113.43 131.77 55.89 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.01 176.541 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' D' D ' 49' ' ' LYS . . . . . . . . . . . . . 80.7 tttt -108.34 137.6 46.04 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 116.309 -0.405 . . . . 0.0 110.337 178.797 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' D' D ' 50' ' ' VAL . . . . . 0.404 ' HA ' HD23 ' D' ' 6' ' ' LEU . 44.1 t -82.39 109.71 16.7 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.288 0 N-CA-C 109.521 -0.548 . . . . 0.0 109.521 176.81 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' D' D ' 51' ' ' VAL . . . . . . . . . . . . . 47.8 t -72.82 -48.79 43.91 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.326 0 CA-C-N 115.794 -0.639 . . . . 0.0 110.043 -175.228 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' D' D ' 52' ' ' GLN . . . . . . . . . . . . . 49.7 tt0 -162.96 142.09 8.7 Favored 'General case' 0 C--N 1.332 -0.168 0 C-N-CA 120.037 -0.665 . . . . 0.0 111.941 -178.663 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' D' D ' 53' ' ' ALA . . . . . 0.414 ' HB1' ' HB2' ' D' ' 58' ' ' LEU . . . -116.83 132.63 56.65 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 115.766 -0.652 . . . . 0.0 109.998 175.577 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' D' D ' 54' ' ' TYR . . . . . . . . . . . . . 67.1 t80 -129.01 111.97 18.51 Favored Pre-proline 0 CA--C 1.535 0.379 0 CA-C-O 118.204 -0.903 . . . . 0.0 110.487 179.384 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' D' D ' 55' ' ' PRO . . . . . . . . . . . . . 74.4 Cg_endo -77.2 169.32 74.5 Favored 'Cis proline' 0 N--CA 1.499 1.848 0 CA-C-N 122.027 1.76 . . . . 0.0 112.198 -5.979 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' D' D ' 56' ' ' SER . . . . . . . . . . . . . 13.6 m -115.24 128.96 25.49 Favored Pre-proline 0 CA--C 1.539 0.525 0 CA-C-O 118.388 -0.815 . . . . 0.0 109.424 176.521 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' D' D ' 57' ' ' PRO . . . . . . . . . . . . . 56.7 Cg_endo -71.77 148.13 89.82 Favored 'Cis proline' 0 N--CA 1.497 1.688 0 CA-C-N 121.958 1.735 . . . . 0.0 111.62 0.19 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' D' D ' 58' ' ' LEU . . . . . 0.414 ' HB2' ' HB1' ' D' ' 53' ' ' ALA . 14.2 tp -107.69 135.73 48.63 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 116.296 -0.411 . . . . 0.0 110.559 -178.567 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' D' D ' 59' ' ' ARG . . . . . . . . . . . . . 43.6 ttp180 -106.19 124.47 49.64 Favored 'General case' 0 C--N 1.327 -0.41 0 N-CA-C 109.324 -0.621 . . . . 0.0 109.324 175.891 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' D' D ' 60' ' ' VAL . . . . . . . . . . . . . 41.4 t -79.98 120.99 32.47 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.299 0 C-N-CA 120.741 -0.384 . . . . 0.0 110.352 -175.46 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' D' D ' 61' ' ' GLU . . . . . . . . . . . . . 42.6 mt-10 -130.97 170.22 14.77 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.066 -0.515 . . . . 0.0 110.129 178.425 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' D' D ' 62' ' ' ASP . . . . . . . . . . . . . 45.1 m-20 -54.31 -32.54 56.79 Favored 'General case' 0 C--N 1.327 -0.379 0 N-CA-C 111.847 0.314 . . . . 0.0 111.847 -178.151 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' D' D ' 63' ' ' ARG . . . . . . . . . . . . . 30.7 ptt180 -88.47 4.41 46.64 Favored 'General case' 0 CA--C 1.537 0.446 0 N-CA-C 113.751 1.019 . . . . 0.0 113.751 -175.011 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' D' D ' 64' ' ' THR . . . . . . . . . . . . . 32.3 m -85.4 136.97 33.23 Favored 'General case' 0 C--N 1.332 -0.163 0 CA-C-O 120.934 0.397 . . . . 0.0 110.628 -178.609 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' D' D ' 65' ' ' LYS . . . . . . . . . . . . . 90.5 mttt -89.61 129.79 36.01 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.096 -0.502 . . . . 0.0 110.223 179.306 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' D' D ' 66' ' ' ILE . . . . . . . . . . . . . 62.5 mt -113.55 128.6 70.33 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.26 0 N-CA-C 109.575 -0.528 . . . . 0.0 109.575 178.684 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' D' D ' 67' ' ' THR . . . . . . . . . . . . . 27.0 m -122.3 138.73 54.41 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-O 120.991 0.424 . . . . 0.0 111.118 -176.31 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' D' D ' 68' ' ' LEU . . . . . . . . . . . . . 7.3 mp . . . . . 0 C--N 1.33 -0.264 0 CA-C-N 115.863 -0.608 . . . . 0.0 110.282 177.706 . . . . . . . . 0 0 . 1 . 006 nuclear nobuild core ' D' D ' 73' ' ' VAL . . . . . . . . . . . . . 15.6 m . . . . . 0 N--CA 1.462 0.161 0 CA-C-O 120.993 0.425 . . . . 0.0 110.667 . . . . . . . . . 0 0 . 1 . 006 nuclear nobuild core ' D' D ' 74' ' ' ASP . . . . . . . . . . . . . 5.0 t70 -108.77 118.87 37.92 Favored 'General case' 0 C--N 1.328 -0.362 0 N-CA-C 109.288 -0.634 . . . . 0.0 109.288 174.541 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' D' D ' 75' ' ' VAL . . . . . 0.407 ' C ' HD12 ' D' ' 76' ' ' LEU . 41.9 t -113.74 125.68 71.06 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.214 0 CA-C-O 121.059 0.457 . . . . 0.0 110.898 -175.854 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' D' D ' 76' ' ' LEU . . . . . 0.407 HD12 ' C ' ' D' ' 75' ' ' VAL . 5.6 mp -125.56 146.42 49.69 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 115.581 -0.736 . . . . 0.0 109.538 174.953 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' D' D ' 77' ' ' GLU . . . . . . . . . . . . . 99.2 mt-10 -134.23 131.23 38.27 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-O 121.134 0.492 . . . . 0.0 111.291 -176.95 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' D' D ' 78' ' ' ALA . . . . . . . . . . . . . . . -118.38 121.72 41.06 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 115.69 -0.686 . . . . 0.0 109.558 176.647 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' D' D ' 79' ' ' LYS . . . . . 0.644 ' O ' HD13 ' D' ' 80' ' ' ILE . 19.2 pttp -71.77 122.65 21.04 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-O 121.134 0.492 . . . . 0.0 110.96 -178.091 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' D' D ' 80' ' ' ILE . . . . . 0.644 HD13 ' O ' ' D' ' 79' ' ' LYS . 37.4 mm -139.19 108.87 3.94 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.355 0 N-CA-C 109.023 -0.732 . . . . 0.0 109.023 -178.122 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' D' D ' 81' ' ' LYS . . . . . . . . . . . . . 50.7 pttt -97.59 123.7 41.58 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-O 120.941 0.401 . . . . 0.0 111.152 -177.617 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' D' D ' 82' ' ' GLY . . . . . . . . . . . . . . . 88.97 42.26 5.69 Favored Glycine 0 CA--C 1.525 0.699 0 C-N-CA 120.718 -0.753 . . . . 0.0 111.533 174.649 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' D' D ' 83' ' ' ILE . . . . . . . . . . . . . 75.3 mt -65.91 137.17 25.41 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.332 0 N-CA-C 109.809 -0.441 . . . . 0.0 109.809 178.106 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' D' D ' 84' ' ' LYS . . . . . . . . . . . . . 50.9 tttp -98.59 -54.18 3.1 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.246 -0.434 . . . . 0.0 110.283 -179.469 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' D' D ' 85' ' ' ASP . . . . . . . . . . . . . 13.4 t70 -151.77 150.89 30.67 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 115.902 -0.59 . . . . 0.0 110.456 -179.474 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' D' D ' 86' ' ' VAL . . . . . . . . . . . . . 42.5 t -129.86 129.79 66.18 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.248 0 CA-C-O 120.974 0.416 . . . . 0.0 110.598 -179.058 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' D' D ' 87' ' ' ILE . . . . . . . . . . . . . 45.2 mm -118.83 125.79 74.75 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.286 0 CA-C-N 115.826 -0.625 . . . . 0.0 109.373 175.31 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' D' D ' 88' ' ' LEU . . . . . . . . . . . . . 30.8 mt -118.65 138.84 52.33 Favored 'General case' 0 C--N 1.332 -0.188 0 CA-C-O 121.316 0.579 . . . . 0.0 111.941 -175.427 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' D' D ' 89' ' ' ASP . . . . . . . . . . . . . 12.2 t0 -136.09 151.72 50.11 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 115.171 -0.922 . . . . 0.0 108.764 174.725 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' D' D ' 90' ' ' GLU . . . . . . . . . . . . . 83.5 tt0 -49.0 -31.8 8.13 Favored 'General case' 0 C--N 1.329 -0.32 0 N-CA-C 112.876 0.695 . . . . 0.0 112.876 -172.829 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' D' D ' 91' ' ' ASN . . . . . . . . . . . . . 12.4 p30 -117.24 3.07 12.62 Favored 'General case' 0 N--CA 1.469 0.513 0 N-CA-C 113.815 1.043 . . . . 0.0 113.815 -174.867 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' D' D ' 92' ' ' LEU . . . . . . . . . . . . . 17.7 mt -148.47 148.45 30.29 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 118.241 0.473 . . . . 0.0 110.647 -175.421 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' D' D ' 93' ' ' ILE . . . . . . . . . . . . . 75.9 mt -129.65 118.36 44.84 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.285 0 N-CA-C 109.233 -0.654 . . . . 0.0 109.233 176.949 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' D' D ' 94' ' ' VAL . . . . . . . . . . . . . 44.7 t -118.29 125.12 74.05 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.288 0 N-CA-C 109.884 -0.413 . . . . 0.0 109.884 -178.786 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' D' D ' 95' ' ' VAL . . . . . . . . . . . . . 43.5 t -120.91 134.09 65.45 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.343 0 CA-C-N 116.133 -0.485 . . . . 0.0 109.841 -179.703 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' D' D ' 96' ' ' ILE . . . . . . . . . . . . . 68.6 mt -114.42 126.71 72.01 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.339 0 N-CA-C 109.042 -0.725 . . . . 0.0 109.042 178.439 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' D' D ' 97' ' ' THR . . . . . . . . . . . . . 79.7 p -98.82 158.15 15.82 Favored 'General case' 0 C--N 1.331 -0.239 0 CA-C-O 121.176 0.512 . . . . 0.0 111.124 -176.965 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' D' D ' 98' ' ' GLU . . . . . . . . . . . . . 83.1 tt0 -53.98 -27.3 30.61 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-N 116.093 -0.503 . . . . 0.0 112.065 179.843 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' D' D ' 99' ' ' GLU . . . . . . . . . . . . . 96.6 mt-10 -78.07 13.48 1.43 Allowed 'General case' 0 CA--C 1.536 0.421 0 N-CA-C 113.294 0.85 . . . . 0.0 113.294 -176.852 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' D' D ' 100' ' ' ASN . . . . . . . . . . . . . 3.2 m-20 62.49 32.93 16.4 Favored 'General case' 0 N--CA 1.464 0.266 0 CA-C-O 120.898 0.38 . . . . 0.0 111.637 179.155 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' D' D ' 101' ' ' GLU . . . . . . . . . . . . . 84.6 tt0 -109.59 144.4 37.95 Favored 'General case' 0 C--N 1.334 -0.105 0 N-CA-C 109.709 -0.478 . . . . 0.0 109.709 173.247 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' D' D ' 102' ' ' VAL . . . . . . . . . . . . . 45.9 t -114.94 125.88 72.37 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.331 0 CA-C-N 116.113 -0.494 . . . . 0.0 109.858 -178.181 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' D' D ' 103' ' ' LEU . . . . . . . . . . . . . 53.1 mt -117.71 129.77 55.92 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 115.998 -0.546 . . . . 0.0 110.331 177.553 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' D' D ' 104' ' ' ILE . . . . . . . . . . . . . 70.3 mt -118.15 119.58 61.83 Favored 'Isoleucine or valine' 0 C--O 1.234 0.256 0 CA-C-N 116.393 -0.367 . . . . 0.0 110.173 -179.692 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' D' D ' 105' ' ' PHE . . . . . . . . . . . . . 46.6 m-85 -121.55 168.15 12.07 Favored 'General case' 0 C--N 1.332 -0.194 0 O-C-N 123.879 0.737 . . . . 0.0 109.738 179.794 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' D' D ' 106' ' ' ASN . . . . . . . . . . . . . 44.0 p-10 -99.42 -170.2 1.87 Allowed 'General case' 0 C--N 1.331 -0.217 0 N-CA-C 109.734 -0.469 . . . . 0.0 109.734 172.036 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' D' D ' 107' ' ' GLN . . . . . . . . . . . . . 59.3 tt0 -59.37 -30.03 68.12 Favored 'General case' 0 C--N 1.329 -0.31 0 N-CA-C 111.824 0.305 . . . . 0.0 111.824 -179.724 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' D' D ' 108' ' ' ASN . . . . . . . . . . . . . 11.8 t-20 -86.56 13.53 8.34 Favored 'General case' 0 CA--C 1.535 0.399 0 N-CA-C 112.904 0.705 . . . . 0.0 112.904 -177.152 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' D' D ' 109' ' ' LEU . . . . . . . . . . . . . 21.7 mt 58.51 34.03 23.58 Favored 'General case' 0 C--O 1.233 0.198 0 CA-C-O 120.73 0.3 . . . . 0.0 111.747 177.563 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' D' D ' 110' ' ' GLU . . . . . . . . . . . . . 96.1 mt-10 -99.73 138.8 36.31 Favored 'General case' 0 C--N 1.33 -0.28 0 N-CA-C 109.455 -0.572 . . . . 0.0 109.455 175.222 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' D' D ' 111' ' ' GLU . . . . . . . . . . . . . 48.3 tt0 -79.67 121.86 25.83 Favored 'General case' 0 C--N 1.327 -0.373 0 C-N-CA 120.759 -0.376 . . . . 0.0 110.293 -176.402 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' D' D ' 112' ' ' LEU . . . . . . . . . . . . . 26.6 mt -105.79 -46.01 4.24 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.019 -0.537 . . . . 0.0 110.432 179.656 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' D' D ' 113' ' ' TYR . . . . . . . . . . . . . 61.3 t80 -135.91 138.85 42.83 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.089 -0.505 . . . . 0.0 110.838 -179.041 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' D' D ' 114' ' ' ARG . . . . . . . . . . . . . 39.6 ptt180 -141.6 126.38 18.07 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-O 120.941 0.401 . . . . 0.0 110.681 176.913 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' D' D ' 115' ' ' GLY . . . . . . . . . . . . . . . -150.06 163.08 29.38 Favored Glycine 0 CA--C 1.522 0.515 0 N-CA-C 110.604 -0.999 . . . . 0.0 110.604 -179.723 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' D' D ' 116' ' ' LYS . . . . . . . . . . . . . 72.4 tttt -134.35 134.07 41.35 Favored 'General case' 0 C--N 1.33 -0.257 0 N-CA-C 110.093 -0.336 . . . . 0.0 110.093 179.192 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' D' D ' 117' ' ' PHE . . . . . . . . . . . . . 39.2 m-85 -134.03 114.01 12.74 Favored 'General case' 0 C--N 1.331 -0.209 0 CA-C-N 116.328 -0.396 . . . . 0.0 110.124 -175.18 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' D' D ' 118' ' ' GLU . . . . . . . . . . . . . 45.0 tp10 -53.49 -43.82 68.54 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.467 -0.333 . . . . 0.0 111.526 -175.665 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' D' D ' 119' ' ' ASN . . . . . . . . . . . . . 80.4 m-20 -99.69 31.04 3.36 Favored 'General case' 0 C--N 1.332 -0.175 0 N-CA-C 112.319 0.489 . . . . 0.0 112.319 -173.875 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' D' D ' 120' ' ' LEU . . . . . . . . . . . . . 15.0 tp -57.44 122.72 13.31 Favored 'General case' 0 C--N 1.331 -0.213 0 N-CA-C 110.162 -0.31 . . . . 0.0 110.162 177.386 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' D' D ' 121' ' ' ASN . . . . . . . . . . . . . 73.8 m-20 -114.02 -44.15 3.18 Favored 'General case' 0 C--O 1.232 0.153 0 CA-C-N 116.689 -0.232 . . . . 0.0 111.378 -176.883 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' D' D ' 122' ' ' LYS . . . . . . . . . . . . . 98.0 mttt -143.83 147.02 33.5 Favored 'General case' 0 C--N 1.333 -0.15 0 CA-C-O 121.072 0.463 . . . . 0.0 111.657 -178.36 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' D' D ' 123' ' ' VAL . . . . . 0.44 ' C ' HD12 ' D' ' 124' ' ' LEU . 45.4 t -127.21 124.33 63.96 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.256 0 N-CA-C 109.302 -0.629 . . . . 0.0 109.302 174.158 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' D' D ' 124' ' ' LEU . . . . . 0.485 ' N ' HD12 ' D' ' 124' ' ' LEU . 7.2 mp -115.39 131.49 56.91 Favored 'General case' 0 C--N 1.331 -0.229 0 CA-C-N 116.306 -0.406 . . . . 0.0 110.617 -177.898 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' D' D ' 125' ' ' VAL . . . . . . . . . . . . . 45.9 t -126.72 126.83 69.39 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.243 0 CA-C-N 116.128 -0.487 . . . . 0.0 109.999 179.49 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' D' D ' 126' ' ' ARG . . . . . . . . . . . . . 69.6 ttt180 -155.22 141.13 18.22 Favored 'General case' 0 C--N 1.328 -0.356 0 N-CA-C 109.527 -0.545 . . . . 0.0 109.527 177.542 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' D' D ' 127' ' ' ASN . . . . . . . . . . . . . 9.7 p30 48.73 -151.84 0.13 Allowed 'General case' 0 CA--C 1.54 0.593 0 CA-C-O 119.299 -0.381 . . . . 0.0 110.897 178.989 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' D' D ' 128' ' ' ASP . . . . . . . . . . . . . 12.7 p-10 -84.49 22.71 1.23 Allowed 'General case' 0 CA--C 1.535 0.385 0 CA-C-N 118.61 0.641 . . . . 0.0 112.264 177.705 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' D' D ' 129' ' ' LEU . . . . . . . . . . . . . 13.4 tp -120.72 137.02 54.7 Favored 'General case' 0 C--O 1.233 0.216 0 CA-C-O 121.061 0.458 . . . . 0.0 110.508 -179.605 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' D' D ' 130' ' ' VAL . . . . . . . . . . . . . 45.0 t -123.24 136.01 61.32 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.218 0 CA-C-N 115.949 -0.569 . . . . 0.0 109.61 178.26 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' D' D ' 131' ' ' VAL . . . . . . . . . . . . . 42.2 t -134.9 136.82 51.63 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.238 0 CA-C-O 121.186 0.517 . . . . 0.0 110.516 179.957 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' D' D ' 132' ' ' ILE . . . . . . . . . . . . . 72.1 mt -117.55 133.89 62.87 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.295 0 CA-C-N 115.639 -0.71 . . . . 0.0 109.63 -179.579 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' D' D ' 133' ' ' ILE . . . . . . . . . . . . . 43.1 mm -118.55 122.21 68.92 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.19 0 CA-C-O 120.961 0.41 . . . . 0.0 110.947 -176.221 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' D' D ' 134' ' ' ASP . . . . . . . . . . . . . 8.0 p-10 -135.11 148.04 49.69 Favored 'General case' 0 C--N 1.329 -0.299 0 N-CA-C 109.3 -0.63 . . . . 0.0 109.3 173.029 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' D' D ' 135' ' ' GLU . . . . . . . . . . . . . 43.5 tp10 -49.83 -24.74 2.59 Favored 'General case' 0 C--N 1.327 -0.386 0 N-CA-C 112.768 0.655 . . . . 0.0 112.768 -171.671 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' D' D ' 136' ' ' GLN . . . . . . . . . . . . . 46.5 tt0 -102.83 -24.65 13.69 Favored 'General case' 0 CA--C 1.533 0.298 0 N-CA-C 112.96 0.726 . . . . 0.0 112.96 -173.995 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' D' D ' 137' ' ' LYS . . . . . . . . . . . . . 97.3 mttt -143.65 152.77 41.77 Favored 'General case' 0 C--N 1.331 -0.201 0 CA-C-O 121.168 0.508 . . . . 0.0 111.821 -172.574 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' D' D ' 138' ' ' LEU . . . . . . . . . . . . . 4.4 tt -120.41 121.8 39.32 Favored 'General case' 0 C--N 1.33 -0.262 0 N-CA-C 109.079 -0.712 . . . . 0.0 109.079 172.434 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' D' D ' 139' ' ' THR . . . . . . . . . . . . . 34.3 m -111.23 130.4 55.66 Favored 'General case' 0 C--N 1.332 -0.193 0 CA-C-O 120.734 0.302 . . . . 0.0 111.036 -175.683 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' D' D ' 140' ' ' LEU . . . . . 0.462 ' C ' HD23 ' D' ' 140' ' ' LEU . 5.6 tt -116.98 122.54 44.53 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 115.618 -0.719 . . . . 0.0 109.238 -179.683 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' D' D ' 141' ' ' ILE . . . . . 0.455 ' N ' HD23 ' D' ' 140' ' ' LEU . 18.8 mt -121.6 122.74 67.83 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.248 0 CA-C-O 120.888 0.375 . . . . 0.0 110.085 -175.663 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' D' D ' 142' ' ' ARG . . . . . . . . . . . . . 73.4 mtp180 -110.9 125.95 54.2 Favored 'General case' 0 C--N 1.331 -0.22 0 CA-C-N 115.682 -0.69 . . . . 0.0 110.16 -179.534 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' D' D ' 143' ' ' THR . . . . . . . . . . . . . 66.6 p . . . . . 0 C--O 1.219 -0.503 0 CA-C-O 118.074 -0.965 . . . . 0.0 110.492 -179.796 . . . . . . . . 0 0 . 1 . 006 nuclear nobuild core ' E' E ' 2' ' ' SER . . . . . . . . . . . . . 6.4 p . . . . . 0 N--CA 1.462 0.166 0 CA-C-O 121.033 0.444 . . . . 0.0 110.994 . . . . . . . . . 0 0 . 1 . 006 nuclear nobuild core ' E' E ' 3' ' ' GLU . . . . . . . . . . . . . 95.1 mt-10 -140.91 141.95 34.49 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 115.876 -0.602 . . . . 0.0 110.961 -179.238 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' E' E ' 4' ' ' LEU . . . . . . . . . . . . . 15.0 tp -126.77 126.16 42.95 Favored 'General case' 0 C--N 1.331 -0.206 0 CA-C-N 116.091 -0.504 . . . . 0.0 109.97 176.516 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' E' E ' 5' ' ' LYS . . . . . . . . . . . . . 68.6 mttm -106.11 122.2 45.7 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-O 120.844 0.355 . . . . 0.0 110.826 178.426 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' E' E ' 6' ' ' LEU . . . . . . . . . . . . . 74.6 mt -118.59 146.56 44.52 Favored 'General case' 0 C--N 1.331 -0.209 0 CA-C-N 115.535 -0.757 . . . . 0.0 110.311 179.765 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' E' E ' 7' ' ' LYS . . . . . . . . . . . . . 80.0 tttt -135.66 140.24 33.26 Favored Pre-proline 0 CA--C 1.534 0.335 0 CA-C-O 119.093 -0.479 . . . . 0.0 110.254 176.985 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' E' E ' 8' ' ' PRO . . . . . . . . . . . . . 88.8 Cg_endo -91.98 143.39 2.74 Favored 'Trans proline' 0 N--CA 1.49 1.311 0 C-N-CA 121.827 1.685 . . . . 0.0 111.934 177.773 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' E' E ' 9' ' ' LEU . . . . . . . . . . . . . 60.8 mt -77.37 -47.51 2.52 Favored Pre-proline 0 CA--C 1.533 0.317 0 CA-C-O 118.688 -0.673 . . . . 0.0 112.226 179.533 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' E' E ' 10' ' ' PRO . . . . . . . . . . . . . 94.8 Cg_endo -80.26 142.82 15.31 Favored 'Trans proline' 0 N--CA 1.495 1.582 0 C-N-CA 121.133 1.222 . . . . 0.0 111.518 175.905 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' E' E ' 11' ' ' LYS . . . . . . . . . . . . . 46.0 pttt -83.76 113.38 20.86 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-O 121.496 0.665 . . . . 0.0 110.879 -179.74 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' E' E ' 12' ' ' VAL . . . . . . . . . . . . . 12.2 p -151.18 148.54 14.8 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.284 0 CA-C-N 115.649 -0.705 . . . . 0.0 110.377 179.873 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' E' E ' 13' ' ' GLU . . . . . . . . . . . . . 43.0 mt-10 -83.78 116.03 22.51 Favored 'General case' 0 C--N 1.329 -0.313 0 N-CA-C 110.144 -0.317 . . . . 0.0 110.144 177.658 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' E' E ' 14' ' ' LEU . . . . . . . . . . . . . 31.1 mt -99.33 143.53 26.59 Favored Pre-proline 0 CA--C 1.533 0.309 0 CA-C-O 119.09 -0.481 . . . . 0.0 110.279 -179.439 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' E' E ' 15' ' ' PRO . . . . . . . . . . . . . 25.7 Cg_exo -62.55 157.34 47.11 Favored 'Trans proline' 0 N--CA 1.498 1.774 0 C-N-CA 121.342 1.361 . . . . 0.0 112.013 177.682 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' E' E ' 16' ' ' PRO . . . . . . . . . . . . . 31.4 Cg_exo -59.76 -34.43 95.93 Favored 'Trans proline' 0 N--CA 1.498 1.752 0 C-N-CA 121.452 1.435 . . . . 0.0 112.782 179.969 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' E' E ' 17' ' ' ASP . . . . . . . . . . . . . 9.1 p-10 -83.32 4.43 27.24 Favored 'General case' 0 CA--C 1.537 0.465 0 N-CA-C 113.26 0.837 . . . . 0.0 113.26 -177.462 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' E' E ' 18' ' ' PHE . . . . . . . . . . . . . 33.8 t80 -58.06 -44.69 87.63 Favored 'General case' 0 C--N 1.334 -0.07 0 O-C-N 121.884 -0.51 . . . . 0.0 109.898 -178.574 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' E' E ' 19' ' ' VAL . . . . . . . . . . . . . 48.5 t -58.3 -40.33 77.45 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.361 0 CA-C-N 116.037 -0.529 . . . . 0.0 110.525 -178.725 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' E' E ' 20' ' ' ASP . . . . . . . . . . . . . 11.8 t70 -58.85 -43.74 90.86 Favored 'General case' 0 C--O 1.234 0.268 0 CA-C-O 120.947 0.403 . . . . 0.0 110.772 -177.223 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' E' E ' 21' ' ' VAL . . . . . . . . . . . . . 48.4 t -65.8 -51.98 55.24 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.291 0 C-N-CA 120.662 -0.415 . . . . 0.0 110.517 -179.011 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' E' E ' 22' ' ' ILE . . . . . 0.473 HG22 HD12 ' E' ' 26' ' ' LEU . 50.4 mm -55.24 -54.09 28.29 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.295 0 C-N-CA 120.901 -0.32 . . . . 0.0 111.168 -176.665 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' E' E ' 23' ' ' ARG . . . . . . . . . . . . . 13.8 ptm180 -58.52 -44.45 89.52 Favored 'General case' 0 C--N 1.33 -0.249 0 C-N-CA 120.773 -0.371 . . . . 0.0 111.721 -172.973 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' E' E ' 24' ' ' ILE . . . . . . . . . . . . . 86.9 mt -64.18 -34.97 72.29 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.303 0 C-N-CA 120.767 -0.373 . . . . 0.0 111.355 -177.714 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' E' E ' 25' ' ' LYS . . . . . . . . . . . . . 34.4 mmtp -67.87 -44.07 77.93 Favored 'General case' 0 C--N 1.33 -0.27 0 N-CA-C 112.09 0.404 . . . . 0.0 112.09 177.365 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' E' E ' 26' ' ' LEU . . . . . 0.473 HD12 HG22 ' E' ' 22' ' ' ILE . 75.8 mt -85.49 -23.79 27.63 Favored 'General case' 0 C--N 1.329 -0.294 0 N-CA-C 114.065 1.135 . . . . 0.0 114.065 -170.266 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' E' E ' 27' ' ' GLN . . . . . . . . . . . . . 8.3 pt20 -47.63 145.66 2.58 Favored 'General case' 0 N--CA 1.47 0.535 0 N-CA-C 112.553 0.575 . . . . 0.0 112.553 -176.152 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' E' E ' 28' ' ' GLY . . . . . . . . . . . . . . . 99.77 -23.82 34.58 Favored Glycine 0 CA--C 1.532 1.121 0 CA-C-N 115.512 -0.767 . . . . 0.0 112.2 -175.28 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' E' E ' 29' ' ' LYS . . . . . . . . . . . . . 79.9 mttt -94.54 155.06 17.09 Favored 'General case' 0 C--O 1.233 0.212 0 CA-C-N 117.577 0.689 . . . . 0.0 110.518 177.153 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' E' E ' 30' ' ' THR . . . . . . . . . . . . . 26.9 m -107.48 138.5 43.57 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 116.116 -0.493 . . . . 0.0 110.128 178.056 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' E' E ' 31' ' ' VAL . . . . . . . . . . . . . 34.7 m -127.24 151.66 34.36 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.199 0 CA-C-O 121.005 0.431 . . . . 0.0 110.893 -179.161 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' E' E ' 32' ' ' ARG . . . . . . . . . . . . . 55.0 ttt180 -128.32 150.09 50.23 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 115.893 -0.594 . . . . 0.0 110.073 179.389 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' E' E ' 33' ' ' THR . . . . . . . . . . . . . 23.2 m -52.59 137.62 30.08 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-O 120.733 0.302 . . . . 0.0 111.528 -177.357 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' E' E ' 34' ' ' GLY . . . . . . . . . . . . . . . 100.03 -17.04 57.73 Favored Glycine 0 CA--C 1.533 1.183 0 CA-C-O 119.671 -0.516 . . . . 0.0 113.313 178.763 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' E' E ' 35' ' ' ASP . . . . . . . . . . . . . 76.7 m-20 -67.22 149.88 49.83 Favored 'General case' 0 N--CA 1.462 0.144 0 CA-C-N 117.983 0.891 . . . . 0.0 111.266 179.043 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' E' E ' 36' ' ' VAL . . . . . . . . . . . . . 44.8 t -121.23 130.5 74.59 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.186 0 CA-C-N 115.966 -0.561 . . . . 0.0 109.956 178.464 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' E' E ' 37' ' ' ILE . . . . . . . . . . . . . 69.9 mt -121.27 139.09 49.52 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.279 0 CA-C-N 116.139 -0.482 . . . . 0.0 109.85 179.839 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' E' E ' 38' ' ' GLY . . . . . . . . . . . . . . . -114.33 129.38 8.68 Favored Glycine 0 CA--C 1.527 0.784 0 N-CA-C 111.53 -0.628 . . . . 0.0 111.53 -177.791 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' E' E ' 39' ' ' ILE . . . . . . . . . . . . . 69.9 mt -121.85 136.76 57.71 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.189 0 N-CA-C 109.829 -0.434 . . . . 0.0 109.829 177.765 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' E' E ' 40' ' ' SER . . . . . . . . . . . . . 39.7 t -92.88 113.98 26.41 Favored 'General case' 0 C--N 1.33 -0.264 0 C-N-CA 120.935 -0.306 . . . . 0.0 110.895 176.167 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' E' E ' 41' ' ' ILE . . . . . . . . . . . . . 47.9 mm -120.87 113.2 39.01 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.167 0 N-CA-C 110.157 -0.312 . . . . 0.0 110.157 179.196 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' E' E ' 42' ' ' LEU . . . . . . . . . . . . . 7.0 mp 57.01 36.17 27.41 Favored 'General case' 0 CA--C 1.533 0.298 0 CA-C-O 120.84 0.352 . . . . 0.0 111.232 179.681 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' E' E ' 43' ' ' GLY . . . . . . . . . . . . . . . 77.74 -10.17 26.21 Favored Glycine 0 CA--C 1.535 1.29 0 C-N-CA 121.245 -0.502 . . . . 0.0 113.566 177.708 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' E' E ' 44' ' ' LYS . . . . . . . . . . . . . 49.4 tptt -94.95 132.91 39.27 Favored 'General case' 0 C--N 1.332 -0.19 0 CA-C-N 117.763 0.781 . . . . 0.0 109.695 176.821 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' E' E ' 45' ' ' GLU . . . . . . . . . . . . . 84.5 tt0 -83.49 125.82 32.14 Favored 'General case' 0 C--N 1.328 -0.359 0 C-N-CA 120.838 -0.345 . . . . 0.0 111.003 -178.796 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' E' E ' 46' ' ' VAL . . . . . . . . . . . . . 7.2 p -119.44 124.68 73.42 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.231 0 N-CA-C 109.311 -0.626 . . . . 0.0 109.311 175.268 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' E' E ' 47' ' ' LYS . . . . . . . . . . . . . 60.6 mttp -99.36 128.34 45.47 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 115.976 -0.557 . . . . 0.0 111.11 178.486 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' E' E ' 48' ' ' PHE . . . . . . . . . . . . . 95.7 m-85 -110.2 131.87 54.67 Favored 'General case' 0 C--N 1.329 -0.321 0 N-CA-C 109.687 -0.486 . . . . 0.0 109.687 175.44 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' E' E ' 49' ' ' LYS . . . . . . . . . . . . . 61.9 tttm -106.99 136.6 46.58 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.485 -0.325 . . . . 0.0 110.283 178.984 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' E' E ' 50' ' ' VAL . . . . . . . . . . . . . 45.7 t -75.4 107.29 5.98 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.34 0 N-CA-C 109.023 -0.732 . . . . 0.0 109.023 175.715 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' E' E ' 51' ' ' VAL . . . . . . . . . . . . . 47.0 t -71.34 -48.07 55.98 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.261 0 O-C-N 123.511 0.507 . . . . 0.0 109.856 -174.063 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' E' E ' 52' ' ' GLN . . . . . . . . . . . . . 48.2 tt0 -168.11 135.65 2.19 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 116.051 -0.522 . . . . 0.0 111.445 -179.142 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' E' E ' 53' ' ' ALA . . . . . . . . . . . . . . . -110.34 131.44 55.05 Favored 'General case' 0 C--N 1.331 -0.23 0 CA-C-N 115.943 -0.571 . . . . 0.0 109.865 176.114 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' E' E ' 54' ' ' TYR . . . . . . . . . . . . . 34.0 t80 -129.07 108.0 18.01 Favored Pre-proline 0 CA--C 1.535 0.389 0 CA-C-O 118.28 -0.867 . . . . 0.0 110.379 -179.735 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' E' E ' 55' ' ' PRO . . . . . . . . . . . . . 73.9 Cg_endo -77.09 170.02 72.74 Favored 'Cis proline' 0 N--CA 1.499 1.833 0 CA-C-N 121.85 1.697 . . . . 0.0 112.369 -5.351 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' E' E ' 56' ' ' SER . . . . . . . . . . . . . 48.9 m -115.9 137.12 23.1 Favored Pre-proline 0 CA--C 1.538 0.518 0 CA-C-O 118.51 -0.757 . . . . 0.0 109.565 175.547 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' E' E ' 57' ' ' PRO . . . . . . . . . . . . . 59.7 Cg_endo -73.76 146.79 87.89 Favored 'Cis proline' 0 N--CA 1.497 1.712 0 CA-C-N 121.705 1.644 . . . . 0.0 111.553 -2.481 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' E' E ' 58' ' ' LEU . . . . . . . . . . . . . 31.1 tp -108.38 138.3 44.91 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.375 -0.375 . . . . 0.0 110.762 -177.509 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' E' E ' 59' ' ' ARG . . . . . . . . . . . . . 55.8 ttp180 -102.04 128.71 48.37 Favored 'General case' 0 C--N 1.327 -0.387 0 N-CA-C 109.266 -0.642 . . . . 0.0 109.266 175.837 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' E' E ' 60' ' ' VAL . . . . . . . . . . . . . 42.3 t -84.88 116.36 28.31 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.233 0 C-N-CA 120.743 -0.383 . . . . 0.0 110.815 -173.235 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' E' E ' 61' ' ' GLU . . . . . . . . . . . . . 95.8 mt-10 -131.25 159.47 37.72 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 115.909 -0.587 . . . . 0.0 110.139 175.095 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' E' E ' 62' ' ' ASP . . . . . . . . . . . . . 81.4 m-20 -54.43 -30.79 53.75 Favored 'General case' 0 C--N 1.329 -0.319 0 N-CA-C 111.893 0.331 . . . . 0.0 111.893 179.507 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' E' E ' 63' ' ' ARG . . . . . . . . . . . . . 39.0 ptt180 -78.4 -1.18 32.2 Favored 'General case' 0 CA--C 1.538 0.487 0 N-CA-C 113.72 1.007 . . . . 0.0 113.72 -175.8 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' E' E ' 64' ' ' THR . . . . . . . . . . . . . 31.6 m -93.4 148.25 22.23 Favored 'General case' 0 C--N 1.331 -0.199 0 CA-C-N 118.168 0.44 . . . . 0.0 110.305 -179.134 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' E' E ' 65' ' ' LYS . . . . . . . . . . . . . 43.7 mtmt -86.31 122.44 30.29 Favored 'General case' 0 C--N 1.329 -0.287 0 C-N-CA 120.654 -0.419 . . . . 0.0 110.213 179.413 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' E' E ' 66' ' ' ILE . . . . . . . . . . . . . 61.0 mt -112.26 125.71 69.57 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.246 0 N-CA-C 109.393 -0.595 . . . . 0.0 109.393 179.91 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' E' E ' 67' ' ' THR . . . . . . . . . . . . . 27.8 m -119.33 138.12 53.25 Favored 'General case' 0 C--N 1.331 -0.202 0 CA-C-N 116.235 -0.439 . . . . 0.0 110.891 -175.749 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' E' E ' 68' ' ' LEU . . . . . . . . . . . . . 4.4 tt . . . . . 0 C--N 1.329 -0.31 0 CA-C-N 115.788 -0.642 . . . . 0.0 109.725 178.191 . . . . . . . . 0 0 . 1 . 006 nuclear nobuild core ' E' E ' 73' ' ' VAL . . . . . . . . . . . . . 35.9 m . . . . . 0 C--O 1.233 0.187 0 CA-C-O 120.8 0.333 . . . . 0.0 110.667 . . . . . . . . . 0 0 . 1 . 006 nuclear nobuild core ' E' E ' 74' ' ' ASP . . . . . . . . . . . . . 6.0 t70 -103.04 122.3 44.35 Favored 'General case' 0 C--N 1.329 -0.296 0 N-CA-C 109.614 -0.513 . . . . 0.0 109.614 -178.937 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' E' E ' 75' ' ' VAL . . . . . . . . . . . . . 40.5 t -119.37 125.73 74.68 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.241 0 CA-C-O 121.095 0.474 . . . . 0.0 110.808 -176.699 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' E' E ' 76' ' ' LEU . . . . . . . . . . . . . 6.0 mp -120.51 143.37 48.59 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 115.659 -0.7 . . . . 0.0 109.586 174.701 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' E' E ' 77' ' ' GLU . . . . . . . . . . . . . 47.1 mt-10 -134.99 129.05 33.57 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-O 121.022 0.439 . . . . 0.0 110.768 -178.563 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' E' E ' 78' ' ' ALA . . . . . 0.538 ' HB2' HD21 ' E' ' 109' ' ' LEU . . . -114.47 133.6 55.63 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 115.802 -0.635 . . . . 0.0 109.865 177.854 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' E' E ' 79' ' ' LYS . . . . . 0.58 ' O ' HD13 ' E' ' 80' ' ' ILE . 83.3 tttt -78.8 114.87 18.09 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.332 -0.395 . . . . 0.0 109.981 -179.792 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' E' E ' 80' ' ' ILE . . . . . 0.58 HD13 ' O ' ' E' ' 79' ' ' LYS . 41.9 mm -138.14 121.16 19.77 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.255 0 N-CA-C 109.864 -0.421 . . . . 0.0 109.864 -175.551 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' E' E ' 81' ' ' LYS . . . . . . . . . . . . . 9.6 mtmp? -110.92 126.9 55.22 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-O 120.962 0.41 . . . . 0.0 111.02 -178.426 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' E' E ' 82' ' ' GLY . . . . . . . . . . . . . . . 89.06 42.12 5.7 Favored Glycine 0 CA--C 1.525 0.679 0 C-N-CA 121.003 -0.618 . . . . 0.0 112.025 174.403 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' E' E ' 83' ' ' ILE . . . . . . . . . . . . . 74.7 mt -67.78 133.26 31.88 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.246 0 N-CA-C 109.719 -0.474 . . . . 0.0 109.719 177.329 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' E' E ' 84' ' ' LYS . . . . . . . . . . . . . 83.0 tttt -97.21 -54.15 3.25 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 115.999 -0.546 . . . . 0.0 110.465 -176.979 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' E' E ' 85' ' ' ASP . . . . . . . . . . . . . 13.8 t70 -152.15 149.87 29.24 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 115.604 -0.726 . . . . 0.0 110.163 -179.226 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' E' E ' 86' ' ' VAL . . . . . . . . . . . . . 44.0 t -133.5 131.08 57.31 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.297 0 CA-C-O 120.97 0.414 . . . . 0.0 110.523 -179.66 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' E' E ' 87' ' ' ILE . . . . . . . . . . . . . 46.9 mm -120.07 126.53 75.38 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.254 0 CA-C-N 115.846 -0.616 . . . . 0.0 109.585 176.241 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' E' E ' 88' ' ' LEU . . . . . . . . . . . . . 53.6 mt -110.96 135.75 51.0 Favored 'General case' 0 C--N 1.331 -0.218 0 CA-C-O 121.153 0.501 . . . . 0.0 111.375 -176.243 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' E' E ' 89' ' ' ASP . . . . . . . . . . . . . 7.8 t0 -128.84 150.52 50.3 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 115.596 -0.729 . . . . 0.0 109.034 175.045 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' E' E ' 90' ' ' GLU . . . . . . . . . . . . . 44.1 mt-10 -49.12 -32.82 10.65 Favored 'General case' 0 C--N 1.329 -0.31 0 N-CA-C 112.864 0.69 . . . . 0.0 112.864 -172.339 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' E' E ' 91' ' ' ASN . . . . . . . . . . . . . 65.7 m-80 -131.86 28.68 4.51 Favored 'General case' 0 N--CA 1.467 0.388 0 N-CA-C 112.412 0.523 . . . . 0.0 112.412 -176.208 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' E' E ' 92' ' ' LEU . . . . . . . . . . . . . 9.0 tp -166.2 145.7 6.02 Favored 'General case' 0 C--N 1.33 -0.258 0 N-CA-C 110.207 -0.294 . . . . 0.0 110.207 179.623 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' E' E ' 93' ' ' ILE . . . . . 0.409 HD11 HD11 ' D' ' 140' ' ' LEU . 69.2 mt -127.72 125.17 64.72 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.202 0 N-CA-C 109.795 -0.446 . . . . 0.0 109.795 179.857 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' E' E ' 94' ' ' VAL . . . . . . . . . . . . . 45.8 t -120.88 125.91 74.6 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.22 0 N-CA-C 109.688 -0.486 . . . . 0.0 109.688 179.255 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' E' E ' 95' ' ' VAL . . . . . . . . . . . . . 43.3 t -122.52 135.18 63.44 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.236 0 CA-C-N 116.205 -0.452 . . . . 0.0 109.979 -178.471 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' E' E ' 96' ' ' ILE . . . . . . . . . . . . . 57.1 mt -116.27 130.11 71.57 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 N-CA-C 109.372 -0.603 . . . . 0.0 109.372 179.224 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' E' E ' 97' ' ' THR . . . . . . . . . . . . . 72.9 p -102.23 154.85 18.64 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-O 121.184 0.516 . . . . 0.0 111.056 -178.778 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' E' E ' 98' ' ' GLU . . . . . . . . . . . . . 96.8 mt-10 -54.23 -23.26 14.07 Favored 'General case' 0 CA--C 1.533 0.318 0 N-CA-C 112.366 0.506 . . . . 0.0 112.366 178.932 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' E' E ' 99' ' ' GLU . . . . . . . . . . . . . 32.5 tt0 -79.09 14.69 1.35 Allowed 'General case' 0 CA--C 1.539 0.523 0 N-CA-C 112.688 0.625 . . . . 0.0 112.688 -177.97 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' E' E ' 100' ' ' ASN . . . . . . . . . . . . . 4.4 m-20 62.35 38.06 13.35 Favored 'General case' 0 C--O 1.231 0.117 0 O-C-N 121.801 -0.562 . . . . 0.0 111.002 178.817 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' E' E ' 101' ' ' GLU . . . . . . . . . . . . . 84.9 tt0 -118.01 142.64 47.16 Favored 'General case' 0 C--N 1.331 -0.212 0 CA-C-N 115.996 -0.547 . . . . 0.0 109.845 176.263 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' E' E ' 102' ' ' VAL . . . . . . . . . . . . . 45.5 t -114.97 128.51 72.09 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.306 0 N-CA-C 109.811 -0.44 . . . . 0.0 109.811 -178.688 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' E' E ' 103' ' ' LEU . . . . . . . . . . . . . 51.0 mt -120.29 134.85 55.18 Favored 'General case' 0 C--N 1.331 -0.219 0 CA-C-N 115.865 -0.607 . . . . 0.0 110.382 178.222 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' E' E ' 104' ' ' ILE . . . . . . . . . . . . . 67.8 mt -118.78 124.36 73.03 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.304 0 N-CA-C 110.077 -0.342 . . . . 0.0 110.077 -179.745 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' E' E ' 105' ' ' PHE . . . . . . . . . . . . . 92.2 m-85 -124.07 162.77 22.84 Favored 'General case' 0 C--N 1.332 -0.194 0 O-C-N 123.912 0.758 . . . . 0.0 109.984 -179.981 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' E' E ' 106' ' ' ASN . . . . . . . . . . . . . 47.7 p-10 -98.59 -170.5 1.95 Allowed 'General case' 0 C--N 1.33 -0.279 0 N-CA-C 109.871 -0.418 . . . . 0.0 109.871 174.551 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' E' E ' 107' ' ' GLN . . . . . . . . . . . . . 46.0 tt0 -60.18 -30.07 69.1 Favored 'General case' 0 C--N 1.329 -0.297 0 N-CA-C 111.987 0.366 . . . . 0.0 111.987 -178.827 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' E' E ' 108' ' ' ASN . . . . . . . . . . . . . 59.9 t30 -84.86 10.16 12.34 Favored 'General case' 0 CA--C 1.536 0.439 0 N-CA-C 113.154 0.798 . . . . 0.0 113.154 -177.632 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' E' E ' 109' ' ' LEU . . . . . 0.538 HD21 ' HB2' ' E' ' 78' ' ' ALA . 8.4 tp 58.6 37.18 25.4 Favored 'General case' 0 C--N 1.331 -0.198 0 CA-C-O 121.065 0.459 . . . . 0.0 111.232 179.476 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' E' E ' 110' ' ' GLU . . . . . . . . . . . . . 70.5 mm-40 -103.4 142.16 34.71 Favored 'General case' 0 C--N 1.329 -0.303 0 N-CA-C 109.358 -0.608 . . . . 0.0 109.358 174.908 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' E' E ' 111' ' ' GLU . . . . . . . . . . . . . 71.6 tt0 -78.36 121.77 24.9 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-O 120.94 0.4 . . . . 0.0 110.387 -175.199 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' E' E ' 112' ' ' LEU . . . . . . . . . . . . . 15.3 mt -106.21 -46.02 4.16 Favored 'General case' 0 C--N 1.331 -0.196 0 CA-C-N 116.08 -0.509 . . . . 0.0 110.778 -178.913 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' E' E ' 113' ' ' TYR . . . . . . . . . . . . . 59.0 t80 -137.31 144.38 42.58 Favored 'General case' 0 C--N 1.331 -0.223 0 CA-C-N 116.204 -0.453 . . . . 0.0 111.012 -178.4 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' E' E ' 114' ' ' ARG . . . . . . . . . . . . . 48.1 ptt85 -147.12 125.75 12.53 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.271 -0.422 . . . . 0.0 111.003 179.073 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' E' E ' 115' ' ' GLY . . . . . . . . . . . . . . . -149.98 153.95 25.4 Favored Glycine 0 CA--C 1.525 0.678 0 N-CA-C 111.231 -0.748 . . . . 0.0 111.231 178.206 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' E' E ' 116' ' ' LYS . . . . . . . . . . . . . 25.9 ttpp -124.83 132.49 53.33 Favored 'General case' 0 C--N 1.331 -0.212 0 N-CA-C 109.942 -0.392 . . . . 0.0 109.942 178.352 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' E' E ' 117' ' ' PHE . . . . . . . . . . . . . 48.5 m-85 -130.68 115.9 17.32 Favored 'General case' 0 C--N 1.331 -0.206 0 CA-C-O 120.928 0.394 . . . . 0.0 110.373 -175.568 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' E' E ' 118' ' ' GLU . . . . . . . . . . . . . 46.1 tp10 -52.84 -51.11 62.2 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.36 -0.382 . . . . 0.0 111.784 -174.734 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' E' E ' 119' ' ' ASN . . . . . . . . . . . . . 3.2 p30 -98.45 31.31 2.88 Favored 'General case' 0 C--N 1.33 -0.274 0 N-CA-C 112.197 0.443 . . . . 0.0 112.197 -174.418 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' E' E ' 120' ' ' LEU . . . . . . . . . . . . . 14.5 tp -51.71 124.81 13.24 Favored 'General case' 0 N--CA 1.464 0.237 0 CA-C-O 120.535 0.207 . . . . 0.0 111.057 178.025 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' E' E ' 121' ' ' ASN . . . . . . . . . . . . . 15.6 m120 -113.55 -44.06 3.25 Favored 'General case' 0 C--O 1.232 0.183 0 CA-C-N 116.727 -0.215 . . . . 0.0 111.285 -176.495 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' E' E ' 122' ' ' LYS . . . . . . . . . . . . . 98.8 mttt -145.36 148.53 33.48 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-O 121.049 0.452 . . . . 0.0 111.826 -176.737 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' E' E ' 123' ' ' VAL . . . . . . . . . . . . . 45.6 t -129.41 130.93 67.6 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.293 0 N-CA-C 109.396 -0.594 . . . . 0.0 109.396 175.462 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' E' E ' 124' ' ' LEU . . . . . . . . . . . . . 19.7 tp -130.26 133.97 46.9 Favored 'General case' 0 C--N 1.332 -0.163 0 CA-C-O 120.791 0.329 . . . . 0.0 110.748 -177.179 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' E' E ' 125' ' ' VAL . . . . . . . . . . . . . 11.1 p -133.67 135.49 55.49 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.25 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.303 179.776 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' E' E ' 126' ' ' ARG . . . . . . . . . . . . . 20.8 ttm180 -144.39 121.86 11.71 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.307 -0.406 . . . . 0.0 110.626 178.331 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' E' E ' 127' ' ' ASN . . . . . . . . . . . . . 4.3 m120 49.41 -106.39 0.2 Allowed 'General case' 0 CA--C 1.545 0.77 0 CA-C-O 118.957 -0.544 . . . . 0.0 111.639 178.994 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' E' E ' 128' ' ' ASP . . . . . . . . . . . . . 11.6 p-10 -114.09 4.0 15.47 Favored 'General case' 0 N--CA 1.468 0.468 0 CA-C-N 119.693 1.133 . . . . 0.0 113.408 -177.21 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' E' E ' 129' ' ' LEU . . . . . . . . . . . . . 15.5 tp -107.13 132.67 52.75 Favored 'General case' 0 C--N 1.333 -0.147 0 N-CA-C 109.561 -0.533 . . . . 0.0 109.561 178.617 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' E' E ' 130' ' ' VAL . . . . . . . . . . . . . 41.5 t -122.92 136.55 59.35 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.243 0 CA-C-O 120.668 0.271 . . . . 0.0 110.349 -177.309 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' E' E ' 131' ' ' VAL . . . . . 0.521 HG12 HD12 ' E' ' 140' ' ' LEU . 27.1 m -136.07 140.81 43.23 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.236 0 CA-C-O 121.166 0.508 . . . . 0.0 111.274 177.579 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' E' E ' 132' ' ' ILE . . . . . . . . . . . . . 75.5 mt -121.22 132.4 70.67 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.384 0 CA-C-N 115.39 -0.823 . . . . 0.0 109.171 178.125 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' E' E ' 133' ' ' ILE . . . . . . . . . . . . . 33.2 mm -115.37 121.17 66.65 Favored 'Isoleucine or valine' 0 C--O 1.234 0.251 0 CA-C-O 120.898 0.38 . . . . 0.0 111.237 -173.464 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' E' E ' 134' ' ' ASP . . . . . . . . . . . . . 7.3 p-10 -133.59 146.53 51.05 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 115.904 -0.589 . . . . 0.0 109.584 175.724 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' E' E ' 135' ' ' GLU . . . . . . . . . . . . . 39.2 tp10 -49.93 -26.8 4.49 Favored 'General case' 0 C--N 1.326 -0.422 0 N-CA-C 112.815 0.672 . . . . 0.0 112.815 -173.407 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' E' E ' 136' ' ' GLN . . . . . . . . . . . . . 49.7 tt0 -81.91 -32.99 30.66 Favored 'General case' 0 C--O 1.234 0.274 0 N-CA-C 112.328 0.492 . . . . 0.0 112.328 -175.968 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' E' E ' 137' ' ' LYS . . . . . . . . . . . . . 50.7 pttt -170.06 173.04 6.14 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-O 121.451 0.643 . . . . 0.0 112.27 -172.967 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' E' E ' 138' ' ' LEU . . . . . 0.405 ' C ' HD23 ' E' ' 138' ' ' LEU . 6.6 tt -118.33 129.13 55.26 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 115.212 -0.904 . . . . 0.0 110.055 179.521 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' E' E ' 139' ' ' THR . . . . . . . . . . . . . 24.4 m -106.87 130.25 54.58 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.439 -0.346 . . . . 0.0 110.516 -179.803 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' E' E ' 140' ' ' LEU . . . . . 0.521 HD12 HG12 ' E' ' 131' ' ' VAL . 51.2 tp -118.34 127.21 53.48 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 115.784 -0.644 . . . . 0.0 109.413 -177.766 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' E' E ' 141' ' ' ILE . . . . . . . . . . . . . 19.1 mt -123.49 122.38 64.92 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 CA-C-N 116.397 -0.365 . . . . 0.0 110.143 -174.996 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' E' E ' 142' ' ' ARG . . . . . . . . . . . . . 84.4 mtp180 -108.77 129.41 55.38 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-N 115.523 -0.762 . . . . 0.0 110.455 179.46 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' E' E ' 143' ' ' THR . . . . . . . . . . . . . 40.0 p . . . . . 0 C--O 1.221 -0.442 0 CA-C-O 117.961 -1.018 . . . . 0.0 110.605 179.145 . . . . . . . . 0 0 . 1 . 006 nuclear nobuild core ' F' F ' 1' ' ' MET . . . . . . . . . . . . . 24.2 ptp . . . . . 0 C--O 1.231 0.125 0 CA-C-O 120.784 0.326 . . . . 0.0 110.728 . . . . . . . . . 0 0 . 1 . 006 nuclear nobuild core ' F' F ' 2' ' ' SER . . . . . . . . . . . . . 4.5 p -115.79 131.19 57.01 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.107 -0.497 . . . . 0.0 110.098 177.249 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' F' F ' 3' ' ' GLU . . . . . . . . . . . . . 84.8 tt0 -142.75 141.07 31.67 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.054 -0.521 . . . . 0.0 111.08 -178.304 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' F' F ' 4' ' ' LEU . . . . . . . . . . . . . 18.0 tp -127.41 132.52 50.1 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 115.883 -0.599 . . . . 0.0 110.216 178.097 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' F' F ' 5' ' ' LYS . . . . . . . . . . . . . 68.6 mttm -112.03 121.06 43.95 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-N 116.338 -0.392 . . . . 0.0 110.665 179.477 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' F' F ' 6' ' ' LEU . . . . . . . . . . . . . 68.4 mt -116.61 144.76 44.0 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 115.451 -0.795 . . . . 0.0 110.158 -178.394 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' F' F ' 7' ' ' LYS . . . . . . . . . . . . . 1.7 ttmp? -130.56 135.25 27.1 Favored Pre-proline 0 CA--C 1.534 0.351 0 CA-C-O 118.848 -0.596 . . . . 0.0 110.293 177.627 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' F' F ' 8' ' ' PRO . . . . . . . . . . . . . 62.9 Cg_endo -91.03 137.91 2.26 Favored 'Trans proline' 0 N--CA 1.49 1.265 0 C-N-CA 121.715 1.61 . . . . 0.0 111.348 175.75 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' F' F ' 9' ' ' LEU . . . . . . . . . . . . . 50.6 mt -77.01 -47.45 2.72 Favored Pre-proline 0 CA--C 1.532 0.274 0 CA-C-O 118.762 -0.637 . . . . 0.0 112.241 -176.693 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' F' F ' 10' ' ' PRO . . . . . . . . . . . . . 93.0 Cg_endo -82.03 151.21 16.17 Favored 'Trans proline' 0 N--CA 1.498 1.744 0 C-N-CA 121.178 1.252 . . . . 0.0 111.607 174.956 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' F' F ' 11' ' ' LYS . . . . . . . . . . . . . 19.5 pttp -84.6 114.02 21.68 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-O 121.623 0.725 . . . . 0.0 110.682 178.166 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' F' F ' 12' ' ' VAL . . . . . . . . . . . . . 11.5 p -151.05 148.79 14.69 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.241 0 CA-C-N 115.534 -0.757 . . . . 0.0 110.059 179.918 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' F' F ' 13' ' ' GLU . . . . . . . . . . . . . 84.8 tt0 -89.58 122.87 33.15 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-O 120.822 0.344 . . . . 0.0 110.246 178.458 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' F' F ' 14' ' ' LEU . . . . . . . . . . . . . 21.1 mt -97.61 151.48 37.64 Favored Pre-proline 0 C--N 1.33 -0.266 0 CA-C-N 116.293 -0.412 . . . . 0.0 110.431 -178.342 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' F' F ' 15' ' ' PRO . . . . . . . . . . . . . 27.0 Cg_exo -61.17 156.58 44.38 Favored 'Trans proline' 0 N--CA 1.496 1.676 0 C-N-CA 121.21 1.273 . . . . 0.0 111.577 177.381 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' F' F ' 16' ' ' PRO . . . . . . . . . . . . . 39.5 Cg_exo -58.78 -35.66 98.27 Favored 'Trans proline' 0 N--CA 1.496 1.621 0 C-N-CA 121.436 1.424 . . . . 0.0 112.708 -179.62 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' F' F ' 17' ' ' ASP . . . . . . . . . . . . . 12.4 p-10 -88.24 11.17 17.2 Favored 'General case' 0 CA--C 1.536 0.427 0 N-CA-C 113.12 0.785 . . . . 0.0 113.12 -178.211 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' F' F ' 18' ' ' PHE . . . . . . . . . . . . . 61.6 t80 -58.06 -43.52 86.95 Favored 'General case' 0 C--N 1.333 -0.111 0 O-C-N 121.994 -0.441 . . . . 0.0 110.131 -178.232 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' F' F ' 19' ' ' VAL . . . . . . . . . . . . . 48.5 t -57.01 -42.06 78.54 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.308 0 CA-C-N 116.256 -0.429 . . . . 0.0 110.416 -178.568 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' F' F ' 20' ' ' ASP . . . . . . . . . . . . . 17.0 t0 -59.95 -42.59 94.36 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-O 120.872 0.368 . . . . 0.0 110.882 -178.303 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' F' F ' 21' ' ' VAL . . . . . . . . . . . . . 48.0 t -64.55 -46.23 93.23 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.285 0 C-N-CA 120.84 -0.344 . . . . 0.0 110.518 -177.988 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' F' F ' 22' ' ' ILE . . . . . 0.603 HG22 HD12 ' F' ' 26' ' ' LEU . 48.5 mm -56.34 -45.04 81.35 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.177 0 C-N-CA 120.92 -0.312 . . . . 0.0 110.583 178.968 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' F' F ' 23' ' ' ARG . . . . . . . . . . . . . 56.6 ttp180 -54.39 -48.55 71.42 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-O 120.738 0.304 . . . . 0.0 111.305 -179.27 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' F' F ' 24' ' ' ILE . . . . . . . . . . . . . 72.4 mt -59.19 -44.3 91.54 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.21 0 CA-C-N 116.493 -0.321 . . . . 0.0 110.935 -178.047 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' F' F ' 25' ' ' LYS . . . . . . . . . . . . . 44.8 mtpt -63.91 -43.31 96.33 Favored 'General case' 0 C--N 1.328 -0.347 0 N-CA-C 112.357 0.502 . . . . 0.0 112.357 -177.997 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' F' F ' 26' ' ' LEU . . . . . 0.603 HD12 HG22 ' F' ' 22' ' ' ILE . 67.7 mt -79.18 -40.95 29.55 Favored 'General case' 0 C--N 1.33 -0.273 0 N-CA-C 113.428 0.899 . . . . 0.0 113.428 -170.551 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' F' F ' 27' ' ' GLN . . . . . . . . . . . . . 9.9 pt20 -46.67 137.66 6.73 Favored 'General case' 0 N--CA 1.468 0.449 0 N-CA-C 112.871 0.693 . . . . 0.0 112.871 -174.607 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' F' F ' 28' ' ' GLY . . . . . . . . . . . . . . . 100.47 -25.85 26.76 Favored Glycine 0 CA--C 1.533 1.181 0 CA-C-N 115.571 -0.741 . . . . 0.0 112.312 -177.589 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' F' F ' 29' ' ' LYS . . . . . . . . . . . . . 55.1 mmtt -97.4 155.17 17.03 Favored 'General case' 0 C--O 1.232 0.169 0 CA-C-N 117.272 0.536 . . . . 0.0 111.304 178.253 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' F' F ' 30' ' ' THR . . . . . . . . . . . . . 26.6 m -107.09 134.28 50.45 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 115.517 -0.765 . . . . 0.0 109.577 174.802 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' F' F ' 31' ' ' VAL . . . . . . . . . . . . . 35.0 m -130.1 158.94 42.54 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.226 0 CA-C-O 120.926 0.393 . . . . 0.0 110.918 -177.086 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' F' F ' 32' ' ' ARG . . . . . . . . . . . . . 34.9 mtp180 -131.46 152.82 50.36 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-O 121.458 0.647 . . . . 0.0 110.94 179.095 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' F' F ' 33' ' ' THR . . . . . 0.41 HG23 ' O ' ' F' ' 51' ' ' VAL . 16.8 m -53.53 139.67 30.64 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 115.786 -0.643 . . . . 0.0 111.22 -179.417 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' F' F ' 34' ' ' GLY . . . . . . . . . . . . . . . 101.81 -17.05 55.45 Favored Glycine 0 CA--C 1.533 1.181 0 CA-C-O 119.635 -0.536 . . . . 0.0 113.287 179.261 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' F' F ' 35' ' ' ASP . . . . . . . . . . . . . 72.0 m-20 -64.9 148.4 51.53 Favored 'General case' 0 N--CA 1.461 0.106 0 CA-C-N 118.073 0.936 . . . . 0.0 111.19 178.98 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' F' F ' 36' ' ' VAL . . . . . . . . . . . . . 44.3 t -124.01 131.82 72.32 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.179 0 CA-C-N 115.929 -0.578 . . . . 0.0 109.906 179.844 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' F' F ' 37' ' ' ILE . . . . . . . . . . . . . 68.4 mt -122.93 139.9 48.32 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.195 0 CA-C-N 116.076 -0.511 . . . . 0.0 109.777 179.702 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' F' F ' 38' ' ' GLY . . . . . . . . . . . . . . . -115.2 128.99 8.35 Favored Glycine 0 CA--C 1.526 0.742 0 N-CA-C 110.904 -0.878 . . . . 0.0 110.904 179.508 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' F' F ' 39' ' ' ILE . . . . . . . . . . . . . 72.6 mt -123.69 136.21 60.91 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.229 0 CA-C-O 120.722 0.296 . . . . 0.0 110.359 -179.18 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' F' F ' 40' ' ' SER . . . . . . . . . . . . . 48.0 t -93.77 120.3 33.86 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.326 -0.397 . . . . 0.0 110.654 173.833 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' F' F ' 41' ' ' ILE . . . . . . . . . . . . . 72.3 mt -125.84 121.07 58.91 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.243 0 CA-C-O 120.817 0.341 . . . . 0.0 110.343 178.337 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' F' F ' 42' ' ' LEU . . . . . . . . . . . . . 7.0 mp 50.94 35.09 11.72 Favored 'General case' 0 CA--C 1.532 0.256 0 CA-C-O 121.131 0.491 . . . . 0.0 111.636 178.326 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' F' F ' 43' ' ' GLY . . . . . . . . . . . . . . . 73.03 32.84 60.18 Favored Glycine 0 CA--C 1.527 0.839 0 C-N-CA 121.132 -0.556 . . . . 0.0 112.076 177.842 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' F' F ' 44' ' ' LYS . . . . . . . . . . . . . 44.7 tttp -137.54 130.01 29.65 Favored 'General case' 0 C--N 1.329 -0.288 0 N-CA-C 109.539 -0.541 . . . . 0.0 109.539 178.318 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' F' F ' 45' ' ' GLU . . . . . . . . . . . . . 77.5 tt0 -84.15 123.59 30.25 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.529 -0.305 . . . . 0.0 111.336 -175.462 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' F' F ' 46' ' ' VAL . . . . . . . . . . . . . 7.2 p -124.7 130.31 73.44 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.207 0 CA-C-O 120.918 0.389 . . . . 0.0 109.994 176.876 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' F' F ' 47' ' ' LYS . . . . . . . . . . . . . 33.8 mmtp -99.75 132.22 45.23 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 115.906 -0.588 . . . . 0.0 111.298 177.647 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' F' F ' 48' ' ' PHE . . . . . . . . . . . . . 95.4 m-85 -115.8 131.87 56.81 Favored 'General case' 0 C--N 1.331 -0.208 0 N-CA-C 109.603 -0.517 . . . . 0.0 109.603 174.449 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' F' F ' 49' ' ' LYS . . . . . . . . . . . . . 82.4 tttt -108.92 135.88 49.38 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.338 -0.392 . . . . 0.0 110.51 179.553 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' F' F ' 50' ' ' VAL . . . . . . . . . . . . . 47.1 t -79.03 105.82 8.98 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.253 0 N-CA-C 109.127 -0.694 . . . . 0.0 109.127 176.061 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' F' F ' 51' ' ' VAL . . . . . 0.41 ' O ' HG23 ' F' ' 33' ' ' THR . 46.3 t -70.54 -53.48 22.33 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.298 0 CA-C-N 115.887 -0.597 . . . . 0.0 109.579 -174.271 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' F' F ' 52' ' ' GLN . . . . . . . . . . . . . 90.9 mt-30 -153.75 152.05 30.3 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 115.974 -0.557 . . . . 0.0 111.742 -178.114 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' F' F ' 53' ' ' ALA . . . . . 0.463 ' HB1' ' HB2' ' F' ' 58' ' ' LEU . . . -128.42 132.92 48.47 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 115.317 -0.856 . . . . 0.0 109.765 174.547 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' F' F ' 54' ' ' TYR . . . . . . . . . . . . . 82.3 t80 -129.13 111.67 18.31 Favored Pre-proline 0 CA--C 1.535 0.368 0 CA-C-O 118.298 -0.858 . . . . 0.0 110.402 179.473 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' F' F ' 55' ' ' PRO . . . . . . . . . . . . . 73.6 Cg_endo -77.05 169.6 73.93 Favored 'Cis proline' 0 N--CA 1.5 1.854 0 CA-C-N 122.023 1.758 . . . . 0.0 112.226 -6.227 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' F' F ' 56' ' ' SER . . . . . . . . . . . . . 13.6 m -116.43 124.66 29.26 Favored Pre-proline 0 CA--C 1.539 0.554 0 CA-C-O 118.37 -0.824 . . . . 0.0 109.219 176.102 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' F' F ' 57' ' ' PRO . . . . . . . . . . . . . 53.9 Cg_endo -69.55 149.32 87.88 Favored 'Cis proline' 0 N--CA 1.498 1.754 0 CA-C-N 122.063 1.773 . . . . 0.0 112.086 2.128 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' F' F ' 58' ' ' LEU . . . . . 0.463 ' HB2' ' HB1' ' F' ' 53' ' ' ALA . 21.4 tp -108.63 136.3 48.45 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.111 -0.495 . . . . 0.0 110.619 -179.569 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' F' F ' 59' ' ' ARG . . . . . . . . . . . . . 40.9 ttm180 -103.75 123.4 46.98 Favored 'General case' 0 C--N 1.329 -0.291 0 N-CA-C 109.346 -0.613 . . . . 0.0 109.346 175.867 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' F' F ' 60' ' ' VAL . . . . . . . . . . . . . 42.1 t -81.91 124.09 38.73 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.269 0 C-N-CA 120.638 -0.425 . . . . 0.0 110.362 -175.581 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' F' F ' 61' ' ' GLU . . . . . . . . . . . . . 79.3 tt0 -131.09 157.47 43.0 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 115.74 -0.664 . . . . 0.0 109.27 179.367 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' F' F ' 62' ' ' ASP . . . . . . . . . . . . . 10.5 t0 -51.56 -32.48 28.39 Favored 'General case' 0 C--N 1.328 -0.368 0 N-CA-C 112.138 0.422 . . . . 0.0 112.138 -176.692 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' F' F ' 63' ' ' ARG . . . . . . . . . . . . . 16.7 ptp180 -89.4 10.05 23.98 Favored 'General case' 0 N--CA 1.466 0.36 0 N-CA-C 113.613 0.968 . . . . 0.0 113.613 -176.157 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' F' F ' 64' ' ' THR . . . . . . . . . . . . . 22.4 m -80.15 143.34 33.95 Favored 'General case' 0 C--N 1.331 -0.21 0 CA-C-N 118.001 0.364 . . . . 0.0 110.63 -178.508 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' F' F ' 65' ' ' LYS . . . . . . . . . . . . . 95.9 mttt -87.47 126.69 35.05 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.169 -0.468 . . . . 0.0 110.008 179.372 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' F' F ' 66' ' ' ILE . . . . . . . . . . . . . 66.6 mt -118.2 129.52 74.41 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.288 0 N-CA-C 109.903 -0.406 . . . . 0.0 109.903 -179.404 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' F' F ' 67' ' ' THR . . . . . . . . . . . . . 24.4 m -121.0 138.97 53.91 Favored 'General case' 0 C--N 1.331 -0.207 0 CA-C-N 116.248 -0.433 . . . . 0.0 110.856 -178.189 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' F' F ' 68' ' ' LEU . . . . . . . . . . . . . 15.2 tp . . . . . 0 C--N 1.332 -0.172 0 CA-C-N 115.929 -0.578 . . . . 0.0 110.347 179.155 . . . . . . . . 0 0 . 1 . 006 nuclear nobuild core ' F' F ' 73' ' ' VAL . . . . . . . . . . . . . 34.6 m . . . . . 0 C--O 1.231 0.091 0 CA-C-O 120.861 0.362 . . . . 0.0 110.193 . . . . . . . . . 0 0 . 1 . 006 nuclear nobuild core ' F' F ' 74' ' ' ASP . . . . . . . . . . . . . 7.5 t0 -97.6 124.77 42.0 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.138 -0.483 . . . . 0.0 110.157 -177.769 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' F' F ' 75' ' ' VAL . . . . . . . . . . . . . 42.7 t -113.42 125.93 70.77 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.247 0 CA-C-O 121.078 0.466 . . . . 0.0 110.446 -178.745 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' F' F ' 76' ' ' LEU . . . . . . . . . . . . . 27.0 mt -128.78 149.54 50.68 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 115.671 -0.695 . . . . 0.0 109.727 178.737 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' F' F ' 77' ' ' GLU . . . . . . . . . . . . . 47.2 mt-10 -136.05 140.31 43.73 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-O 121.004 0.43 . . . . 0.0 111.44 -176.526 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' F' F ' 78' ' ' ALA . . . . . . . . . . . . . . . -124.03 126.62 46.58 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 115.663 -0.698 . . . . 0.0 109.56 175.906 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' F' F ' 79' ' ' LYS . . . . . 0.587 ' O ' HD13 ' F' ' 80' ' ' ILE . 53.7 pttt -80.06 123.93 28.29 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-O 121.133 0.492 . . . . 0.0 111.341 -176.714 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' F' F ' 80' ' ' ILE . . . . . 0.587 HD13 ' O ' ' F' ' 79' ' ' LYS . 39.5 mm -139.14 118.49 13.58 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.238 0 CA-C-N 115.901 -0.591 . . . . 0.0 109.692 -178.287 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' F' F ' 81' ' ' LYS . . . . . . . . . . . . . 40.2 mmtt -96.1 118.87 33.55 Favored 'General case' 0 C--N 1.327 -0.374 0 C-N-CA 120.905 -0.318 . . . . 0.0 111.205 179.667 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' F' F ' 82' ' ' GLY . . . . . . . . . . . . . . . 89.19 42.17 5.65 Favored Glycine 0 CA--C 1.526 0.747 0 C-N-CA 120.654 -0.784 . . . . 0.0 112.027 172.202 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' F' F ' 83' ' ' ILE . . . . . . . . . . . . . 73.1 mt -64.47 134.21 29.35 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.294 0 N-CA-C 109.505 -0.554 . . . . 0.0 109.505 175.835 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' F' F ' 84' ' ' LYS . . . . . . . . . . . . . 36.5 ttpt -97.73 -53.97 3.26 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-O 120.992 0.425 . . . . 0.0 110.14 -179.346 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' F' F ' 85' ' ' ASP . . . . . . . . . . . . . 9.1 t70 -149.35 151.56 34.33 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 115.745 -0.661 . . . . 0.0 110.503 -179.472 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' F' F ' 86' ' ' VAL . . . . . . . . . . . . . 44.6 t -126.67 130.58 71.63 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.218 0 CA-C-O 120.952 0.406 . . . . 0.0 110.321 -178.986 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' F' F ' 87' ' ' ILE . . . . . . . . . . . . . 43.4 mm -119.2 126.2 75.14 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.304 0 CA-C-N 115.84 -0.618 . . . . 0.0 109.388 177.961 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' F' F ' 88' ' ' LEU . . . . . . . . . . . . . 13.0 tp -116.94 135.32 53.8 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-O 120.976 0.417 . . . . 0.0 111.394 -175.943 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' F' F ' 89' ' ' ASP . . . . . . . . . . . . . 6.1 t70 -132.17 156.31 46.65 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 115.812 -0.631 . . . . 0.0 109.457 175.228 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' F' F ' 90' ' ' GLU . . . . . . . . . . . . . 96.6 mt-10 -48.03 -36.95 13.78 Favored 'General case' 0 C--N 1.33 -0.28 0 N-CA-C 113.176 0.806 . . . . 0.0 113.176 -171.123 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' F' F ' 91' ' ' ASN . . . . . . . . . . . . . 35.3 m120 -123.44 13.14 9.45 Favored 'General case' 0 N--CA 1.468 0.466 0 N-CA-C 113.555 0.946 . . . . 0.0 113.555 -174.763 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' F' F ' 92' ' ' LEU . . . . . . . . . . . . . 44.3 mt -149.73 147.98 28.69 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-N 117.925 0.33 . . . . 0.0 110.721 -176.577 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' F' F ' 93' ' ' ILE . . . . . . . . . . . . . 74.0 mt -122.71 118.3 54.62 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.268 0 N-CA-C 109.102 -0.703 . . . . 0.0 109.102 175.736 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' F' F ' 94' ' ' VAL . . . . . . . . . . . . . 45.5 t -117.42 127.28 74.91 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.249 0 N-CA-C 109.743 -0.466 . . . . 0.0 109.743 -179.054 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' F' F ' 95' ' ' VAL . . . . . . . . . . . . . 43.0 t -123.21 134.94 64.77 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.364 0 CA-C-N 116.1 -0.5 . . . . 0.0 109.964 -178.958 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' F' F ' 96' ' ' ILE . . . . . 0.406 HD11 ' HB ' ' F' ' 123' ' ' VAL . 65.8 mt -115.45 126.28 72.95 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.308 0 N-CA-C 109.259 -0.645 . . . . 0.0 109.259 178.718 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' F' F ' 97' ' ' THR . . . . . . . . . . . . . 69.4 p -99.75 155.93 17.37 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-O 121.228 0.537 . . . . 0.0 110.957 -177.341 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' F' F ' 98' ' ' GLU . . . . . . . . . . . . . 84.9 tt0 -53.87 -24.91 17.45 Favored 'General case' 0 CA--C 1.536 0.422 0 CA-C-N 116.057 -0.519 . . . . 0.0 112.267 179.658 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' F' F ' 99' ' ' GLU . . . . . . . . . . . . . 96.8 mt-10 -77.55 12.89 1.42 Allowed 'General case' 0 CA--C 1.537 0.45 0 N-CA-C 113.301 0.852 . . . . 0.0 113.301 -177.924 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' F' F ' 100' ' ' ASN . . . . . . . . . . . . . 2.2 m-20 61.84 33.62 17.55 Favored 'General case' 0 N--CA 1.464 0.262 0 CA-C-N 118.099 0.409 . . . . 0.0 111.315 -179.74 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' F' F ' 101' ' ' GLU . . . . . . . . . . . . . 54.4 tt0 -110.27 143.69 40.07 Favored 'General case' 0 C--N 1.333 -0.137 0 N-CA-C 109.571 -0.529 . . . . 0.0 109.571 174.189 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' F' F ' 102' ' ' VAL . . . . . . . . . . . . . 46.7 t -115.39 127.16 73.06 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.295 0 N-CA-C 109.84 -0.429 . . . . 0.0 109.84 -178.39 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' F' F ' 103' ' ' LEU . . . . . . . . . . . . . 19.7 mt -118.64 132.58 56.18 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 115.864 -0.607 . . . . 0.0 110.715 178.711 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' F' F ' 104' ' ' ILE . . . . . 0.575 HD13 HG11 ' F' ' 130' ' ' VAL . 63.8 mt -116.85 120.65 65.68 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.277 0 N-CA-C 109.81 -0.441 . . . . 0.0 109.81 177.921 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' F' F ' 105' ' ' PHE . . . . . . . . . . . . . 92.3 m-85 -120.43 162.78 18.95 Favored 'General case' 0 C--N 1.332 -0.157 0 O-C-N 123.859 0.724 . . . . 0.0 109.91 -179.906 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' F' F ' 106' ' ' ASN . . . . . . . . . . . . . 45.6 p-10 -97.62 -174.09 2.81 Favored 'General case' 0 C--N 1.33 -0.268 0 N-CA-C 109.593 -0.521 . . . . 0.0 109.593 172.214 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' F' F ' 107' ' ' GLN . . . . . . . . . . . . . 21.6 tt0 -62.21 -19.24 62.95 Favored 'General case' 0 CA--C 1.536 0.429 0 N-CA-C 112.586 0.588 . . . . 0.0 112.586 -178.725 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' F' F ' 108' ' ' ASN . . . . . . . . . . . . . 17.2 t30 -95.68 14.09 24.23 Favored 'General case' 0 CA--C 1.535 0.393 0 N-CA-C 113.124 0.787 . . . . 0.0 113.124 -178.259 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' F' F ' 109' ' ' LEU . . . . . . . . . . . . . 52.5 mt 58.98 38.92 24.1 Favored 'General case' 0 C--O 1.232 0.155 0 CA-C-O 121.139 0.495 . . . . 0.0 111.395 178.095 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' F' F ' 110' ' ' GLU . . . . . . . . . . . . . 96.5 mt-10 -106.14 156.9 17.97 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.15 -0.477 . . . . 0.0 109.95 176.055 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' F' F ' 111' ' ' GLU . . . . . . . . . . . . . 84.5 tt0 -86.98 121.91 30.1 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-O 120.884 0.374 . . . . 0.0 111.107 -177.258 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' F' F ' 112' ' ' LEU . . . . . . . . . . . . . 31.4 mt -108.43 -45.95 3.79 Favored 'General case' 0 C--N 1.332 -0.189 0 CA-C-N 116.054 -0.521 . . . . 0.0 110.448 176.735 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' F' F ' 113' ' ' TYR . . . . . 0.455 ' HB3' HD12 ' F' ' 104' ' ' ILE . 55.5 t80 -141.86 138.55 32.21 Favored 'General case' 0 C--N 1.331 -0.229 0 C-N-CA 120.614 -0.434 . . . . 0.0 111.319 179.947 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' F' F ' 114' ' ' ARG . . . . . . . . . . . . . 23.7 ttm180 -138.1 124.2 20.28 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.232 -0.44 . . . . 0.0 110.195 176.539 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' F' F ' 115' ' ' GLY . . . . . . . . . . . . . . . -150.17 159.64 28.2 Favored Glycine 0 CA--C 1.525 0.676 0 N-CA-C 110.798 -0.921 . . . . 0.0 110.798 178.283 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' F' F ' 116' ' ' LYS . . . . . . . . . . . . . 55.4 tttt -132.6 135.33 45.83 Favored 'General case' 0 C--N 1.329 -0.305 0 N-CA-C 110.098 -0.334 . . . . 0.0 110.098 178.714 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' F' F ' 117' ' ' PHE . . . . . . . . . . . . . 26.3 m-85 -137.72 116.31 12.11 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-O 120.799 0.333 . . . . 0.0 110.309 -174.611 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' F' F ' 118' ' ' GLU . . . . . . . . . . . . . 46.0 tp10 -53.96 -44.58 70.85 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.594 -0.276 . . . . 0.0 111.309 -177.621 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' F' F ' 119' ' ' ASN . . . . . . . . . . . . . 11.7 m120 -97.09 31.1 2.51 Favored 'General case' 0 C--N 1.329 -0.309 0 N-CA-C 112.202 0.445 . . . . 0.0 112.202 -174.497 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' F' F ' 120' ' ' LEU . . . . . . . . . . . . . 15.5 tp -57.76 122.53 13.06 Favored 'General case' 0 C--N 1.333 -0.126 0 N-CA-C 110.225 -0.287 . . . . 0.0 110.225 177.744 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' F' F ' 121' ' ' ASN . . . . . . . . . . . . . 88.6 m-20 -113.75 -43.95 3.23 Favored 'General case' 0 C--N 1.333 -0.124 0 CA-C-N 116.66 -0.246 . . . . 0.0 111.232 -176.729 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' F' F ' 122' ' ' LYS . . . . . . . . . . . . . 51.2 mttm -143.74 144.73 31.96 Favored 'General case' 0 C--N 1.33 -0.25 0 C-N-CA 120.629 -0.428 . . . . 0.0 111.669 -177.408 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' F' F ' 123' ' ' VAL . . . . . 0.406 ' HB ' HD11 ' F' ' 96' ' ' ILE . 43.9 t -127.18 127.84 69.77 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.249 0 N-CA-C 109.328 -0.619 . . . . 0.0 109.328 174.795 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' F' F ' 124' ' ' LEU . . . . . . . . . . . . . 56.5 mt -128.78 139.2 52.3 Favored 'General case' 0 C--N 1.331 -0.211 0 CA-C-O 120.792 0.33 . . . . 0.0 110.933 -176.653 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' F' F ' 125' ' ' VAL . . . . . . . . . . . . . 12.8 p -137.88 137.72 44.63 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.249 0 CA-C-N 116.344 -0.389 . . . . 0.0 110.569 178.487 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' F' F ' 126' ' ' ARG . . . . . . . . . . . . . 55.2 ttt180 -163.87 135.31 4.68 Favored 'General case' 0 C--N 1.33 -0.243 0 N-CA-C 109.803 -0.443 . . . . 0.0 109.803 177.775 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' F' F ' 127' ' ' ASN . . . . . . . . . . . . . 77.7 m-20 55.39 -153.34 0.33 Allowed 'General case' 0 CA--C 1.541 0.607 0 N-CA-C 109.974 -0.38 . . . . 0.0 109.974 -179.791 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' F' F ' 128' ' ' ASP . . . . . . . . . . . . . 10.4 p-10 -80.76 16.06 1.54 Allowed 'General case' 0 CA--C 1.535 0.386 0 N-CA-C 112.815 0.672 . . . . 0.0 112.815 179.439 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' F' F ' 129' ' ' LEU . . . . . . . . . . . . . 38.5 mt -117.51 138.32 51.97 Favored 'General case' 0 C--O 1.231 0.106 0 CA-C-N 118.131 0.423 . . . . 0.0 110.371 179.778 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' F' F ' 130' ' ' VAL . . . . . 0.575 HG11 HD13 ' F' ' 104' ' ' ILE . 12.9 p -132.07 141.0 46.59 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.217 0 N-CA-C 109.919 -0.4 . . . . 0.0 109.919 175.983 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' F' F ' 131' ' ' VAL . . . . . 0.417 HG22 HD12 ' F' ' 140' ' ' LEU . 39.4 t -134.58 140.77 45.03 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.218 0 CA-C-O 121.13 0.491 . . . . 0.0 110.636 -175.24 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' F' F ' 132' ' ' ILE . . . . . . . . . . . . . 71.4 mt -119.28 130.75 73.53 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.316 0 CA-C-N 115.526 -0.761 . . . . 0.0 109.133 177.451 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' F' F ' 133' ' ' ILE . . . . . . . . . . . . . 41.4 mm -117.87 123.49 71.75 Favored 'Isoleucine or valine' 0 C--O 1.233 0.221 0 CA-C-O 120.773 0.321 . . . . 0.0 111.041 -175.184 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' F' F ' 134' ' ' ASP . . . . . . . . . . . . . 8.5 p-10 -135.63 146.51 47.94 Favored 'General case' 0 C--N 1.33 -0.25 0 N-CA-C 109.57 -0.53 . . . . 0.0 109.57 173.268 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' F' F ' 135' ' ' GLU . . . . . . . . . . . . . 40.6 tp10 -49.87 -25.83 3.51 Favored 'General case' 0 C--N 1.327 -0.387 0 N-CA-C 112.725 0.639 . . . . 0.0 112.725 -173.259 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' F' F ' 136' ' ' GLN . . . . . . . . . . . . . 61.7 tt0 -82.39 -35.7 27.44 Favored 'General case' 0 C--O 1.233 0.236 0 N-CA-C 112.269 0.47 . . . . 0.0 112.269 -176.333 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' F' F ' 137' ' ' LYS . . . . . . . . . . . . . 45.6 pttt -165.12 167.98 17.68 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-O 121.486 0.66 . . . . 0.0 112.12 -172.315 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' F' F ' 138' ' ' LEU . . . . . 0.412 HD23 ' C ' ' F' ' 138' ' ' LEU . 7.3 tt -118.34 130.79 56.22 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 115.169 -0.923 . . . . 0.0 109.866 -179.526 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' F' F ' 139' ' ' THR . . . . . . . . . . . . . 38.0 m -113.1 126.22 55.23 Favored 'General case' 0 C--N 1.331 -0.21 0 CA-C-N 116.328 -0.396 . . . . 0.0 110.773 179.92 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' F' F ' 140' ' ' LEU . . . . . 0.417 HD12 HG22 ' F' ' 131' ' ' VAL . 18.7 tp -109.85 122.77 48.28 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 115.526 -0.761 . . . . 0.0 108.973 178.745 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' F' F ' 141' ' ' ILE . . . . . 0.535 ' HB ' HG13 ' F' ' 130' ' ' VAL . 19.6 mt -122.04 119.48 58.69 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.32 0 N-CA-C 109.594 -0.521 . . . . 0.0 109.594 -177.158 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' F' F ' 142' ' ' ARG . . . . . . . . . . . . . 66.4 ttp85 -110.92 128.85 55.96 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 115.488 -0.778 . . . . 0.0 110.57 -176.415 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' F' F ' 143' ' ' THR . . . . . . . . . . . . . 39.4 p . . . . . 0 C--O 1.222 -0.37 0 CA-C-O 117.952 -1.023 . . . . 0.0 110.558 -179.983 . . . . . . . . 0 0 . 1 . 007 nuclear nobuild core ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 88.8 p . . . . . 0 C--O 1.231 0.107 0 CA-C-O 120.849 0.356 . . . . 0.0 110.48 . . . . . . . . . 0 0 . 1 . 007 nuclear nobuild core ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 85.2 tt0 -140.5 142.53 35.25 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-N 116.149 -0.478 . . . . 0.0 111.057 -177.527 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 4' ' ' LEU . . . . . . . . . . . . . 19.0 tp -122.99 127.57 49.0 Favored 'General case' 0 C--N 1.331 -0.198 0 CA-C-N 115.964 -0.562 . . . . 0.0 110.148 177.046 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 5' ' ' LYS . . . . . . . . . . . . . 98.8 mttt -106.71 122.88 47.24 Favored 'General case' 0 C--O 1.234 0.244 0 CA-C-N 116.543 -0.299 . . . . 0.0 110.641 179.275 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 63.5 mt -116.08 144.65 43.85 Favored 'General case' 0 N--CA 1.464 0.235 0 CA-C-N 115.859 -0.609 . . . . 0.0 110.692 -179.241 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 85.0 tttt -125.81 131.22 23.94 Favored Pre-proline 0 CA--C 1.536 0.433 0 CA-C-O 118.583 -0.722 . . . . 0.0 109.523 175.758 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 8' ' ' PRO . . . . . . . . . . . . . 96.1 Cg_endo -83.56 137.79 8.12 Favored 'Trans proline' 0 N--CA 1.494 1.529 0 C-N-CA 121.295 1.33 . . . . 0.0 112.078 177.851 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 67.4 mt -77.95 -47.87 2.18 Favored Pre-proline 0 CA--C 1.534 0.352 0 CA-C-O 118.548 -0.739 . . . . 0.0 112.084 179.165 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 72.2 Cg_endo -77.8 151.34 27.99 Favored 'Trans proline' 0 N--CA 1.497 1.679 0 CA-C-N 120.28 1.136 . . . . 0.0 111.642 176.36 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 23.2 tptm -85.67 95.15 9.27 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.421 -0.354 . . . . 0.0 110.55 -179.336 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 12.1 p -143.7 144.33 23.29 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.319 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.552 -179.92 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 45.6 mp0 -90.4 127.23 36.14 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.334 -0.393 . . . . 0.0 109.963 177.58 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 14' ' ' LEU . . . . . . . . . . . . . 37.2 mt -97.87 146.89 32.24 Favored Pre-proline 0 CA--C 1.533 0.29 0 CA-C-O 119.19 -0.433 . . . . 0.0 110.371 -177.44 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 15' ' ' PRO . . . . . . . . . . . . . 26.2 Cg_exo -61.29 162.32 20.55 Favored 'Trans proline' 0 N--CA 1.498 1.759 0 C-N-CA 121.345 1.363 . . . . 0.0 111.939 178.148 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 16' ' ' PRO . . . . . . . . . . . . . 34.8 Cg_exo -59.34 -38.64 83.42 Favored 'Trans proline' 0 N--CA 1.496 1.629 0 C-N-CA 121.541 1.494 . . . . 0.0 112.907 -177.699 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 17' ' ' ASP . . . . . . . . . . . . . 18.9 p-10 -86.52 6.34 31.09 Favored 'General case' 0 CA--C 1.537 0.443 0 N-CA-C 113.303 0.853 . . . . 0.0 113.303 -178.161 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 18' ' ' PHE . . . . . . . . . . . . . 39.2 t80 -58.33 -43.09 88.07 Favored 'General case' 0 C--N 1.334 -0.108 0 O-C-N 121.982 -0.449 . . . . 0.0 110.103 -178.212 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 19' ' ' VAL . . . . . . . . . . . . . 47.5 t -56.69 -41.14 73.79 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.282 0 CA-C-N 116.243 -0.435 . . . . 0.0 110.468 -179.405 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 5.7 t70 -59.77 -42.0 92.33 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-O 120.873 0.368 . . . . 0.0 110.534 -179.002 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 47.9 t -63.86 -46.18 94.97 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.325 0 CA-C-N 116.242 -0.435 . . . . 0.0 110.301 -178.971 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 22' ' ' ILE . . . . . 0.558 HG22 HD12 ' A' ' 26' ' ' LEU . 51.6 mm -55.03 -47.93 76.41 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.282 0 CA-C-O 120.572 0.225 . . . . 0.0 110.819 179.241 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 23' ' ' ARG . . . . . . . . . . . . . 30.8 ttp180 -54.53 -51.5 64.97 Favored 'General case' 0 C--N 1.329 -0.307 0 C-N-CA 121.121 -0.232 . . . . 0.0 111.332 -177.813 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 24' ' ' ILE . . . . . . . . . . . . . 72.9 mt -59.53 -41.3 84.37 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.277 0 C-N-CA 121.031 -0.267 . . . . 0.0 111.232 -176.881 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 60.7 mtpt -68.67 -41.9 78.64 Favored 'General case' 0 C--N 1.328 -0.333 0 N-CA-C 112.45 0.537 . . . . 0.0 112.45 -177.324 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 26' ' ' LEU . . . . . 0.558 HD12 HG22 ' A' ' 22' ' ' ILE . 95.3 mt -79.57 -37.46 36.32 Favored 'General case' 0 C--N 1.33 -0.266 0 N-CA-C 113.152 0.797 . . . . 0.0 113.152 -171.365 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 27' ' ' GLN . . . . . . . . . . . . . 9.1 pt20 -46.33 140.48 4.09 Favored 'General case' 0 N--CA 1.47 0.544 0 N-CA-C 112.802 0.667 . . . . 0.0 112.802 -175.273 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 100.97 -25.44 28.33 Favored Glycine 0 CA--C 1.532 1.14 0 CA-C-N 115.575 -0.739 . . . . 0.0 112.229 -176.089 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 96.9 mttt -98.18 155.1 17.33 Favored 'General case' 0 C--O 1.233 0.185 0 CA-C-N 117.451 0.625 . . . . 0.0 111.192 179.267 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 30' ' ' THR . . . . . . . . . . . . . 41.5 m -100.96 138.73 37.62 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.138 -0.483 . . . . 0.0 110.273 177.154 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 34.7 m -131.3 148.52 32.81 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.247 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.79 -178.971 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 32' ' ' ARG . . . . . . . . . . . . . 23.0 ttm180 -130.06 146.69 51.74 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.163 -0.471 . . . . 0.0 110.26 178.166 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 33' ' ' THR . . . . . . . . . . . . . 29.6 m -52.39 139.18 25.36 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-O 120.777 0.323 . . . . 0.0 111.469 -178.285 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 98.91 -17.25 58.48 Favored Glycine 0 CA--C 1.534 1.23 0 CA-C-O 119.737 -0.479 . . . . 0.0 113.135 -179.907 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 78.1 m-20 -67.67 149.19 50.35 Favored 'General case' 0 C--N 1.334 -0.09 0 CA-C-N 117.948 0.874 . . . . 0.0 111.346 179.065 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 46.3 t -117.01 126.45 74.44 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.179 0 CA-C-N 115.652 -0.703 . . . . 0.0 109.441 176.513 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 37' ' ' ILE . . . . . . . . . . . . . 64.0 mt -118.36 137.15 53.25 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.297 0 N-CA-C 109.866 -0.42 . . . . 0.0 109.866 -179.118 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . -114.74 128.51 8.19 Favored Glycine 0 CA--C 1.524 0.656 0 N-CA-C 110.876 -0.889 . . . . 0.0 110.876 179.304 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 39' ' ' ILE . . . . . . . . . . . . . 70.4 mt -124.45 127.36 72.99 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.224 0 N-CA-C 110.08 -0.341 . . . . 0.0 110.08 179.223 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 40' ' ' SER . . . . . . . . . . . . . 27.5 t -92.84 119.04 31.76 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.312 -0.403 . . . . 0.0 110.931 176.727 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 41' ' ' ILE . . . . . . . . . . . . . 71.7 mt -134.02 129.13 53.92 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.211 0 CA-C-O 121.017 0.436 . . . . 0.0 110.462 178.491 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 8.3 tp 54.75 33.4 19.5 Favored 'General case' 0 CA--C 1.531 0.244 0 CA-C-N 115.958 -0.565 . . . . 0.0 111.737 177.523 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . 71.52 29.02 68.48 Favored Glycine 0 CA--C 1.53 0.996 0 C-N-CA 121.046 -0.597 . . . . 0.0 112.253 177.794 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 44' ' ' LYS . . . . . . . . . . . . . 81.3 tttt -139.1 127.4 22.75 Favored 'General case' 0 C--N 1.33 -0.255 0 N-CA-C 109.739 -0.467 . . . . 0.0 109.739 178.833 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 84.8 tt0 -85.24 125.78 33.15 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-N 116.375 -0.375 . . . . 0.0 111.423 -178.395 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 46' ' ' VAL . . . . . 0.405 ' O ' HG13 ' A' ' 46' ' ' VAL . 9.6 p -118.69 124.41 73.1 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.172 0 N-CA-C 109.434 -0.58 . . . . 0.0 109.434 173.587 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 61.9 mtpt -98.49 124.27 43.12 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 116.046 -0.525 . . . . 0.0 110.523 177.726 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 48' ' ' PHE . . . . . . . . . . . . . 38.9 m-85 -111.1 131.81 54.78 Favored 'General case' 0 C--N 1.328 -0.344 0 N-CA-C 109.555 -0.535 . . . . 0.0 109.555 177.573 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 43.0 tttp -106.42 131.92 53.06 Favored 'General case' 0 C--N 1.328 -0.345 0 N-CA-C 109.936 -0.394 . . . . 0.0 109.936 178.638 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 50' ' ' VAL . . . . . . . . . . . . . 46.0 t -75.38 106.58 5.27 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.332 0 N-CA-C 109.336 -0.616 . . . . 0.0 109.336 178.068 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 51' ' ' VAL . . . . . . . . . . . . . 44.6 t -71.17 -49.65 47.12 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.288 0 CA-C-N 116.165 -0.471 . . . . 0.0 109.79 -174.789 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 52' ' ' GLN . . . . . . . . . . . . . 43.3 tt0 -162.73 136.88 6.33 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 115.88 -0.6 . . . . 0.0 111.289 -178.102 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 53' ' ' ALA . . . . . 0.412 ' HB3' ' OG ' ' A' ' 56' ' ' SER . . . -115.9 132.84 56.53 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 115.968 -0.56 . . . . 0.0 109.999 176.119 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 54' ' ' TYR . . . . . . . . . . . . . 11.6 t80 -129.06 110.64 18.3 Favored Pre-proline 0 CA--C 1.534 0.346 0 CA-C-O 118.157 -0.925 . . . . 0.0 110.192 178.466 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 55' ' ' PRO . . . . . . . . . . . . . 72.7 Cg_endo -77.22 170.13 72.29 Favored 'Cis proline' 0 N--CA 1.501 1.931 0 CA-C-N 122.024 1.758 . . . . 0.0 112.49 -6.054 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 56' ' ' SER . . . . . 0.412 ' OG ' ' HB3' ' A' ' 53' ' ' ALA . 48.9 m -124.01 137.55 29.11 Favored Pre-proline 0 CA--C 1.538 0.514 0 CA-C-O 118.532 -0.747 . . . . 0.0 109.546 174.904 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 57' ' ' PRO . . . . . . . . . . . . . 37.8 Cg_endo -67.52 145.52 74.37 Favored 'Cis proline' 0 N--CA 1.498 1.778 0 CA-C-N 121.687 1.638 . . . . 0.0 111.487 -2.894 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 58' ' ' LEU . . . . . . . . . . . . . 20.7 tp -107.99 137.95 45.09 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.256 -0.429 . . . . 0.0 110.47 -178.768 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 59' ' ' ARG . . . . . . . . . . . . . 56.7 ttp180 -103.31 120.61 41.1 Favored 'General case' 0 C--N 1.328 -0.366 0 N-CA-C 109.133 -0.691 . . . . 0.0 109.133 174.917 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 42.2 t -72.95 118.53 18.29 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.276 0 C-N-CA 120.766 -0.374 . . . . 0.0 110.647 -173.8 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 70.6 mm-40 -131.02 159.12 38.45 Favored 'General case' 0 C--N 1.331 -0.216 0 CA-C-N 115.951 -0.568 . . . . 0.0 109.734 176.909 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 62' ' ' ASP . . . . . . . . . . . . . 11.0 p-10 -53.34 -31.43 44.3 Favored 'General case' 0 C--N 1.328 -0.343 0 N-CA-C 112.034 0.383 . . . . 0.0 112.034 -178.27 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 63' ' ' ARG . . . . . . . . . . . . . 86.2 mtt-85 -72.02 -21.94 61.48 Favored 'General case' 0 CA--C 1.533 0.324 0 N-CA-C 112.888 0.699 . . . . 0.0 112.888 -175.444 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 33.3 m -70.1 143.75 52.31 Favored 'General case' 0 C--N 1.332 -0.191 0 CA-C-O 120.988 0.423 . . . . 0.0 111.209 -174.479 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 65' ' ' LYS . . . . . . . . . . . . . 1.1 mptm? -89.54 134.8 33.95 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 115.839 -0.619 . . . . 0.0 110.013 177.827 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 66' ' ' ILE . . . . . . . . . . . . . 58.9 mt -114.82 130.36 69.39 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.27 0 N-CA-C 109.771 -0.455 . . . . 0.0 109.771 178.394 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 67' ' ' THR . . . . . . . . . . . . . 30.8 m -124.47 142.1 51.58 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-O 121.247 0.546 . . . . 0.0 111.136 -177.253 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 68' ' ' LEU . . . . . . . . . . . . . 2.6 tt . . . . . 0 C--N 1.331 -0.224 0 CA-C-N 115.544 -0.753 . . . . 0.0 109.68 178.485 . . . . . . . . 0 0 . 1 . 007 nuclear nobuild core ' A' A ' 74' ' ' ASP . . . . . . . . . . . . . 13.0 t70 . . . . . 0 CA--C 1.521 -0.166 0 N-CA-C 110.229 -0.285 . . . . 0.0 110.229 . . . . . . . . . 0 0 . 1 . 007 nuclear nobuild core ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 45.7 t -117.37 117.92 56.82 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 CA-C-O 121.192 0.52 . . . . 0.0 109.919 -179.439 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 76' ' ' LEU . . . . . . . . . . . . . 14.9 mt -120.9 142.92 49.25 Favored 'General case' 0 C--N 1.327 -0.403 0 CA-C-N 115.453 -0.794 . . . . 0.0 109.3 178.552 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 77' ' ' GLU . . . . . . . . . . . . . 96.8 mt-10 -135.31 128.91 32.66 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-O 121.16 0.505 . . . . 0.0 110.527 -177.548 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 78' ' ' ALA . . . . . 0.746 ' HB2' HD21 ' A' ' 109' ' ' LEU . . . -113.0 130.71 56.04 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 115.582 -0.735 . . . . 0.0 109.478 177.353 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 79' ' ' LYS . . . . . 0.581 ' O ' HD13 ' A' ' 80' ' ' ILE . 84.2 tttt -76.07 112.7 12.79 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-O 120.963 0.411 . . . . 0.0 110.532 -177.193 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 80' ' ' ILE . . . . . 0.581 HD13 ' O ' ' A' ' 79' ' ' LYS . 42.4 mm -139.08 109.95 4.7 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.346 0 CA-C-N 115.768 -0.651 . . . . 0.0 109.316 -177.727 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 81' ' ' LYS . . . . . . . . . . . . . 48.5 mtmt -108.64 130.76 55.32 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-O 120.875 0.369 . . . . 0.0 110.728 -178.321 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . 89.06 42.18 5.68 Favored Glycine 0 CA--C 1.525 0.708 0 C-N-CA 120.794 -0.717 . . . . 0.0 111.434 176.806 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 83' ' ' ILE . . . . . . . . . . . . . 73.5 mt -68.49 136.16 26.99 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.297 0 N-CA-C 109.872 -0.418 . . . . 0.0 109.872 177.423 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 84' ' ' LYS . . . . . . . . . . . . . 50.0 tttp -93.05 -50.45 5.52 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.213 -0.448 . . . . 0.0 110.18 -179.341 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 85' ' ' ASP . . . . . . . . . . . . . 6.6 t0 -157.22 154.97 30.05 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 115.908 -0.587 . . . . 0.0 110.517 179.734 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 86' ' ' VAL . . . . . . . . . . . . . 42.7 t -129.81 132.34 65.91 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.201 0 CA-C-O 120.974 0.416 . . . . 0.0 110.552 -178.862 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 87' ' ' ILE . . . . . 0.494 HD12 ' N ' ' A' ' 87' ' ' ILE . 5.0 mp -121.84 128.83 75.79 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.193 0 CA-C-N 115.957 -0.565 . . . . 0.0 109.629 176.887 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 88' ' ' LEU . . . . . . . . . . . . . 75.2 mt -112.6 135.96 52.7 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-O 120.997 0.427 . . . . 0.0 111.268 -177.826 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 89' ' ' ASP . . . . . . . . . . . . . 13.6 t70 -133.02 152.4 51.97 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 115.754 -0.657 . . . . 0.0 109.532 175.613 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 97.4 mt-10 -48.56 -36.27 15.14 Favored 'General case' 0 C--N 1.329 -0.319 0 N-CA-C 113.036 0.754 . . . . 0.0 113.036 -172.678 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 91' ' ' ASN . . . . . . . . . . . . . 81.8 m-20 -121.96 12.19 10.42 Favored 'General case' 0 N--CA 1.468 0.473 0 N-CA-C 113.379 0.881 . . . . 0.0 113.379 -176.268 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 92' ' ' LEU . . . . . . . . . . . . . 11.8 mt -148.68 145.3 27.64 Favored 'General case' 0 C--N 1.332 -0.185 0 CA-C-N 118.101 0.41 . . . . 0.0 110.455 -175.701 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 93' ' ' ILE . . . . . . . . . . . . . 66.8 mt -120.95 117.81 54.21 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.294 0 N-CA-C 108.942 -0.762 . . . . 0.0 108.942 174.499 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 94' ' ' VAL . . . . . 0.456 HG11 HG11 ' A' ' 123' ' ' VAL . 46.2 t -118.83 128.2 75.69 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.24 0 CA-C-O 120.82 0.343 . . . . 0.0 110.224 -177.097 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 95' ' ' VAL . . . . . . . . . . . . . 44.2 t -125.63 137.25 58.28 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.334 0 CA-C-N 116.115 -0.493 . . . . 0.0 109.916 179.977 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 96' ' ' ILE . . . . . . . . . . . . . 57.0 mt -116.6 128.45 73.95 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.325 0 N-CA-C 109.098 -0.705 . . . . 0.0 109.098 178.575 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 97' ' ' THR . . . . . . . . . . . . . 81.7 p -102.59 159.96 14.99 Favored 'General case' 0 C--N 1.331 -0.223 0 CA-C-O 121.099 0.476 . . . . 0.0 111.471 -175.202 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 98' ' ' GLU . . . . . . . . . . . . . 84.8 tt0 -53.86 -27.5 30.37 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.168 -0.469 . . . . 0.0 112.037 179.443 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 99' ' ' GLU . . . . . . . . . . . . . 42.8 mt-10 -79.62 15.83 1.24 Allowed 'General case' 0 CA--C 1.535 0.398 0 N-CA-C 113.07 0.767 . . . . 0.0 113.07 -178.393 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 100' ' ' ASN . . . . . . . . . . . . . 3.3 m-20 62.37 30.97 17.46 Favored 'General case' 0 CA--C 1.532 0.279 0 N-CA-C 111.832 0.308 . . . . 0.0 111.832 177.663 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 101' ' ' GLU . . . . . . . . . . . . . 98.5 mt-10 -101.28 150.58 22.84 Favored 'General case' 0 C--N 1.333 -0.128 0 CA-C-O 120.78 0.324 . . . . 0.0 110.851 171.687 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 102' ' ' VAL . . . . . . . . . . . . . 47.3 t -117.83 124.44 73.08 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.379 0 CA-C-N 115.469 -0.787 . . . . 0.0 109.208 176.442 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 103' ' ' LEU . . . . . . . . . . . . . 40.2 mt -116.44 130.06 56.56 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 115.925 -0.58 . . . . 0.0 110.261 178.602 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 104' ' ' ILE . . . . . 0.434 HD12 ' HB3' ' A' ' 113' ' ' TYR . 68.0 mt -118.76 117.94 56.13 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.291 0 N-CA-C 109.948 -0.39 . . . . 0.0 109.948 179.194 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 105' ' ' PHE . . . . . . . . . . . . . 40.1 m-85 -118.5 163.96 16.0 Favored 'General case' 0 C--N 1.332 -0.19 0 O-C-N 124.086 0.866 . . . . 0.0 110.255 179.282 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 106' ' ' ASN . . . . . . . . . . . . . 43.6 p-10 -98.69 -169.91 1.86 Allowed 'General case' 0 C--N 1.33 -0.263 0 N-CA-C 109.898 -0.408 . . . . 0.0 109.898 173.506 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 107' ' ' GLN . . . . . . . . . . . . . 41.2 tt0 -58.67 -29.89 66.93 Favored 'General case' 0 C--N 1.329 -0.322 0 N-CA-C 112.01 0.374 . . . . 0.0 112.01 179.242 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 108' ' ' ASN . . . . . . . . . . . . . 8.3 t-20 -83.55 6.61 19.91 Favored 'General case' 0 CA--C 1.537 0.458 0 N-CA-C 113.298 0.851 . . . . 0.0 113.298 -177.509 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 109' ' ' LEU . . . . . 0.746 HD21 ' HB2' ' A' ' 78' ' ' ALA . 9.1 tp 61.98 36.24 15.72 Favored 'General case' 0 CA--C 1.53 0.2 0 CA-C-O 120.877 0.37 . . . . 0.0 111.536 178.595 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 110' ' ' GLU . . . . . . . . . . . . . 70.8 mm-40 -105.6 152.27 23.31 Favored 'General case' 0 C--N 1.332 -0.189 0 CA-C-N 116.516 -0.311 . . . . 0.0 110.196 177.443 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 111' ' ' GLU . . . . . . . . . . . . . 98.6 mt-10 -80.9 122.06 26.76 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-O 120.878 0.371 . . . . 0.0 111.193 -178.486 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 112' ' ' LEU . . . . . . . . . . . . . 19.2 mt -108.55 -46.01 3.76 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 115.969 -0.56 . . . . 0.0 110.054 176.165 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 113' ' ' TYR . . . . . 0.434 ' HB3' HD12 ' A' ' 104' ' ' ILE . 57.7 t80 -134.74 133.06 39.52 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 116.284 -0.416 . . . . 0.0 110.735 179.184 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 114' ' ' ARG . . . . . . . . . . . . . 55.1 ttp180 -138.11 123.44 19.42 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.262 -0.426 . . . . 0.0 110.006 178.089 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 115' ' ' GLY . . . . . . . . . . . . . . . -150.12 162.84 29.33 Favored Glycine 0 CA--C 1.523 0.553 0 N-CA-C 110.902 -0.879 . . . . 0.0 110.902 -178.522 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 116' ' ' LYS . . . . . . . . . . . . . 76.3 tttt -131.9 131.02 42.36 Favored 'General case' 0 C--N 1.33 -0.278 0 N-CA-C 110.082 -0.34 . . . . 0.0 110.082 178.184 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 117' ' ' PHE . . . . . . . . . . . . . 47.9 m-85 -130.03 117.34 19.88 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 116.238 -0.437 . . . . 0.0 110.25 -177.196 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 118' ' ' GLU . . . . . . . . . . . . . 97.5 mt-10 -53.81 -43.69 69.57 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 116.433 -0.349 . . . . 0.0 111.363 -176.803 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 119' ' ' ASN . . . . . . . . . . . . . 2.8 m-20 -101.98 31.09 4.06 Favored 'General case' 0 C--N 1.331 -0.214 0 N-CA-C 112.089 0.403 . . . . 0.0 112.089 -174.786 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 120' ' ' LEU . . . . . . . . . . . . . 13.8 tp -55.04 120.07 6.38 Favored 'General case' 0 N--CA 1.462 0.169 0 CA-C-O 120.62 0.248 . . . . 0.0 110.666 178.65 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 121' ' ' ASN . . . . . . . . . . . . . 32.7 t-20 -110.77 -44.11 3.7 Favored 'General case' 0 C--N 1.332 -0.189 0 CA-C-N 116.565 -0.288 . . . . 0.0 111.137 -176.543 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 122' ' ' LYS . . . . . . . . . . . . . 90.6 mttt -148.23 152.03 36.49 Favored 'General case' 0 C--N 1.331 -0.204 0 CA-C-O 121.129 0.49 . . . . 0.0 111.955 -177.996 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 123' ' ' VAL . . . . . 0.456 HG11 HG11 ' A' ' 94' ' ' VAL . 42.2 t -129.45 124.66 60.24 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.268 0 CA-C-N 115.685 -0.689 . . . . 0.0 109.158 172.407 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 124' ' ' LEU . . . . . 0.496 HD12 ' N ' ' A' ' 124' ' ' LEU . 6.2 mp -118.1 141.67 48.23 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-O 120.765 0.316 . . . . 0.0 111.004 -175.65 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 125' ' ' VAL . . . . . 0.412 ' CG2' HG21 ' A' ' 94' ' ' VAL . 41.2 t -129.17 135.66 61.39 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.209 0 CA-C-N 116.24 -0.436 . . . . 0.0 110.427 -179.901 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 126' ' ' ARG . . . . . . . . . . . . . 26.3 mmt85 -139.48 109.92 6.6 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.081 -0.509 . . . . 0.0 110.215 176.712 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 127' ' ' ASN . . . . . . . . . . . . . 79.1 m-20 51.96 -104.83 0.19 Allowed 'General case' 0 CA--C 1.543 0.691 0 CA-C-O 119.1 -0.476 . . . . 0.0 111.341 179.521 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 128' ' ' ASP . . . . . . . . . . . . . 18.7 p-10 -110.3 -2.13 16.88 Favored 'General case' 0 CA--C 1.536 0.439 0 CA-C-N 119.513 1.051 . . . . 0.0 113.459 -176.105 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 129' ' ' LEU . . . . . . . . . . . . . 27.5 mt -104.99 143.89 32.56 Favored 'General case' 0 C--N 1.332 -0.17 0 N-CA-C 109.721 -0.474 . . . . 0.0 109.721 178.557 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 130' ' ' VAL . . . . . 0.525 HG13 ' HB ' ' A' ' 141' ' ' ILE . 12.2 p -132.23 142.06 43.72 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.212 0 CA-C-O 121.147 0.499 . . . . 0.0 110.507 -178.92 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 131' ' ' VAL . . . . . 0.576 HG22 HD12 ' A' ' 140' ' ' LEU . 40.9 t -134.39 138.09 50.43 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.252 0 CA-C-N 115.917 -0.583 . . . . 0.0 110.315 -178.236 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 132' ' ' ILE . . . . . . . . . . . . . 70.7 mt -113.98 131.52 65.67 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.341 0 N-CA-C 109.137 -0.69 . . . . 0.0 109.137 178.308 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 133' ' ' ILE . . . . . . . . . . . . . 40.2 mm -115.65 121.02 66.43 Favored 'Isoleucine or valine' 0 C--O 1.234 0.257 0 CA-C-O 120.665 0.269 . . . . 0.0 110.993 -174.501 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 134' ' ' ASP . . . . . . . . . . . . . 9.7 p-10 -134.72 146.39 49.39 Favored 'General case' 0 C--N 1.331 -0.215 0 CA-C-N 115.984 -0.553 . . . . 0.0 109.66 174.509 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 135' ' ' GLU . . . . . . . . . . . . . 85.2 tt0 -49.89 -26.49 4.13 Favored 'General case' 0 C--N 1.328 -0.33 0 N-CA-C 112.792 0.664 . . . . 0.0 112.792 -173.946 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 136' ' ' GLN . . . . . . . . . . . . . 43.2 tt0 -80.03 -35.19 37.58 Favored 'General case' 0 C--O 1.233 0.205 0 N-CA-C 112.124 0.416 . . . . 0.0 112.124 -176.644 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 137' ' ' LYS . . . . . . . . . . . . . 50.3 pttt -167.61 171.47 10.21 Favored 'General case' 0 C--N 1.331 -0.208 0 CA-C-O 121.527 0.68 . . . . 0.0 112.244 -172.5 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 138' ' ' LEU . . . . . 0.466 HD23 ' N ' ' A' ' 139' ' ' THR . 4.3 tt -114.83 127.34 55.66 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 115.053 -0.976 . . . . 0.0 109.821 178.269 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 139' ' ' THR . . . . . 0.466 ' N ' HD23 ' A' ' 138' ' ' LEU . 22.8 m -107.08 125.41 51.01 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.323 -0.399 . . . . 0.0 110.458 179.609 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 140' ' ' LEU . . . . . 0.576 HD12 HG22 ' A' ' 131' ' ' VAL . 14.9 tp -113.49 119.64 38.25 Favored 'General case' 0 C--N 1.328 -0.365 0 N-CA-C 109.252 -0.647 . . . . 0.0 109.252 -178.371 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 141' ' ' ILE . . . . . 0.525 ' HB ' HG13 ' A' ' 130' ' ' VAL . 19.4 mt -119.65 120.91 64.86 Favored 'Isoleucine or valine' 0 C--O 1.234 0.269 0 CA-C-O 120.949 0.404 . . . . 0.0 110.046 -175.977 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 142' ' ' ARG . . . . . . . . . . . . . 73.3 mtm180 -107.32 129.48 54.89 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 115.38 -0.827 . . . . 0.0 110.258 179.575 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 143' ' ' THR . . . . . . . . . . . . . 32.1 p . . . . . 0 C--O 1.22 -0.448 0 CA-C-O 118.045 -0.979 . . . . 0.0 110.618 179.691 . . . . . . . . 0 0 . 1 . 007 nuclear nobuild core ' B' B ' 2' ' ' SER . . . . . . . . . . . . . 3.6 p . . . . . 0 C--O 1.232 0.183 0 CA-C-O 120.895 0.379 . . . . 0.0 110.411 . . . . . . . . . 0 0 . 1 . 007 nuclear nobuild core ' B' B ' 3' ' ' GLU . . . . . . . . . . . . . 95.1 mt-10 -140.62 140.63 35.1 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-N 116.094 -0.503 . . . . 0.0 110.882 -178.445 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B ' 4' ' ' LEU . . . . . 0.475 HD21 HD21 ' B' ' 6' ' ' LEU . 16.5 tp -126.21 127.5 45.76 Favored 'General case' 0 C--N 1.331 -0.216 0 CA-C-N 115.971 -0.559 . . . . 0.0 110.36 177.441 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' B' B ' 5' ' ' LYS . . . . . . . . . . . . . 98.1 mttt -104.37 120.95 42.37 Favored 'General case' 0 C--O 1.234 0.237 0 CA-C-N 116.287 -0.415 . . . . 0.0 110.336 177.727 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B ' 6' ' ' LEU . . . . . 0.475 HD21 HD21 ' B' ' 4' ' ' LEU . 54.3 mt -117.14 148.0 41.94 Favored 'General case' 0 C--N 1.331 -0.227 0 CA-C-N 115.499 -0.773 . . . . 0.0 110.613 -178.501 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' B' B ' 7' ' ' LYS . . . . . . . . . . . . . 79.4 tttt -138.84 141.04 29.14 Favored Pre-proline 0 CA--C 1.534 0.344 0 CA-C-O 119.135 -0.46 . . . . 0.0 110.163 175.505 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B ' 8' ' ' PRO . . . . . . . . . . . . . 88.0 Cg_endo -92.04 142.11 2.53 Favored 'Trans proline' 0 N--CA 1.49 1.287 0 C-N-CA 121.792 1.661 . . . . 0.0 111.723 177.438 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B ' 9' ' ' LEU . . . . . . . . . . . . . 57.8 mt -77.36 -46.78 2.6 Favored Pre-proline 0 CA--C 1.534 0.348 0 CA-C-O 118.671 -0.68 . . . . 0.0 112.175 -179.736 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B ' 10' ' ' PRO . . . . . . . . . . . . . 86.5 Cg_endo -81.75 150.47 16.51 Favored 'Trans proline' 0 N--CA 1.495 1.612 0 C-N-CA 121.266 1.311 . . . . 0.0 111.79 175.232 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B ' 11' ' ' LYS . . . . . . . . . . . . . 28.2 ttpp -88.87 99.72 12.61 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-O 120.778 0.323 . . . . 0.0 110.541 179.742 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B ' 12' ' ' VAL . . . . . . . . . . . . . 12.6 p -143.68 148.02 19.39 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.29 0 CA-C-N 116.261 -0.427 . . . . 0.0 110.559 -179.398 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B ' 13' ' ' GLU . . . . . . . . . . . . . 44.5 mp0 -84.51 126.09 32.98 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.315 -0.402 . . . . 0.0 110.298 178.676 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B ' 14' ' ' LEU . . . . . . . . . . . . . 47.9 mt -98.63 148.27 34.32 Favored Pre-proline 0 CA--C 1.532 0.284 0 CA-C-O 119.168 -0.444 . . . . 0.0 110.498 -179.415 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B ' 15' ' ' PRO . . . . . . . . . . . . . 24.7 Cg_exo -63.16 159.62 38.24 Favored 'Trans proline' 0 N--CA 1.497 1.73 0 C-N-CA 121.301 1.334 . . . . 0.0 111.831 176.518 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B ' 16' ' ' PRO . . . . . . . . . . . . . 28.8 Cg_exo -60.18 -33.69 94.73 Favored 'Trans proline' 0 N--CA 1.497 1.722 0 C-N-CA 121.52 1.48 . . . . 0.0 112.677 -178.998 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B ' 17' ' ' ASP . . . . . . . . . . . . . 10.6 p-10 -82.79 1.07 40.86 Favored 'General case' 0 CA--C 1.537 0.458 0 N-CA-C 113.281 0.845 . . . . 0.0 113.281 -177.617 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B ' 18' ' ' PHE . . . . . . . . . . . . . 36.2 t80 -57.61 -45.04 85.84 Favored 'General case' 0 C--N 1.334 -0.106 0 O-C-N 121.962 -0.461 . . . . 0.0 110.23 -178.182 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B ' 19' ' ' VAL . . . . . . . . . . . . . 46.9 t -57.08 -43.99 82.24 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.349 0 CA-C-N 116.263 -0.426 . . . . 0.0 110.492 -178.407 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B ' 20' ' ' ASP . . . . . . . . . . . . . 40.8 m-20 -59.76 -42.54 93.5 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-O 120.742 0.306 . . . . 0.0 110.948 -177.467 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B ' 21' ' ' VAL . . . . . . . . . . . . . 46.8 t -63.85 -48.31 86.86 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.241 0 C-N-CA 120.724 -0.391 . . . . 0.0 110.515 -177.792 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B ' 22' ' ' ILE . . . . . 0.479 HG22 HD12 ' B' ' 26' ' ' LEU . 50.4 mm -55.57 -46.92 79.25 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.258 0 C-N-CA 120.997 -0.281 . . . . 0.0 110.798 179.639 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' B' B ' 23' ' ' ARG . . . . . . . . . . . . . 57.8 ttp180 -53.8 -50.39 66.23 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-O 120.594 0.235 . . . . 0.0 111.449 -178.152 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B ' 24' ' ' ILE . . . . . . . . . . . . . 74.8 mt -60.13 -42.96 91.89 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.317 0 CA-C-N 116.57 -0.286 . . . . 0.0 111.304 -177.462 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B ' 25' ' ' LYS . . . . . . . . . . . . . 70.7 mmtt -65.13 -38.44 90.65 Favored 'General case' 0 C--N 1.33 -0.265 0 N-CA-C 112.127 0.417 . . . . 0.0 112.127 -178.73 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B ' 26' ' ' LEU . . . . . 0.479 HD12 HG22 ' B' ' 22' ' ' ILE . 83.4 mt -77.9 -44.77 26.02 Favored 'General case' 0 C--N 1.329 -0.307 0 N-CA-C 112.747 0.647 . . . . 0.0 112.747 -172.119 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' B' B ' 27' ' ' GLN . . . . . . . . . . . . . 10.7 pt20 -46.98 137.88 7.01 Favored 'General case' 0 N--CA 1.469 0.489 0 N-CA-C 112.751 0.648 . . . . 0.0 112.751 -176.168 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B ' 28' ' ' GLY . . . . . . . . . . . . . . . 100.66 -28.82 14.15 Favored Glycine 0 CA--C 1.533 1.195 0 CA-C-N 115.619 -0.718 . . . . 0.0 111.978 -177.066 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B ' 29' ' ' LYS . . . . . . . . . . . . . 93.3 mttt -98.84 155.19 17.5 Favored 'General case' 0 C--O 1.233 0.216 0 CA-C-O 121.053 0.454 . . . . 0.0 111.133 179.285 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B ' 30' ' ' THR . . . . . . . . . . . . . 27.3 m -104.28 137.39 42.26 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.136 -0.484 . . . . 0.0 110.065 175.884 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B ' 31' ' ' VAL . . . . . . . . . . . . . 34.9 m -130.56 155.84 42.07 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.308 0 CA-C-N 116.375 -0.375 . . . . 0.0 110.927 -178.133 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B ' 32' ' ' ARG . . . . . . . . . . . . . 66.2 mtp180 -132.29 152.9 51.16 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-O 121.334 0.588 . . . . 0.0 110.835 179.084 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B ' 33' ' ' THR . . . . . . . . . . . . . 23.9 m -53.27 140.06 27.77 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 115.985 -0.552 . . . . 0.0 111.378 -178.245 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B ' 34' ' ' GLY . . . . . . . . . . . . . . . 99.28 -17.02 58.48 Favored Glycine 0 CA--C 1.532 1.121 0 CA-C-O 119.611 -0.549 . . . . 0.0 113.279 178.273 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B ' 35' ' ' ASP . . . . . . . . . . . . . 77.0 m-20 -66.1 147.71 52.92 Favored 'General case' 0 C--O 1.231 0.109 0 CA-C-N 118.06 0.93 . . . . 0.0 110.888 178.6 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B ' 36' ' ' VAL . . . . . . . . . . . . . 44.3 t -124.58 131.06 73.24 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.271 0 CA-C-N 116.07 -0.514 . . . . 0.0 109.927 178.853 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B ' 37' ' ' ILE . . . . . . . . . . . . . 64.8 mt -120.47 138.97 49.22 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.277 0 CA-C-N 116.197 -0.456 . . . . 0.0 109.951 -179.69 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B ' 38' ' ' GLY . . . . . . . . . . . . . . . -109.22 128.7 9.12 Favored Glycine 0 CA--C 1.526 0.729 0 N-CA-C 111.171 -0.772 . . . . 0.0 111.171 179.969 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B ' 39' ' ' ILE . . . . . . . . . . . . . 72.1 mt -124.38 130.12 73.7 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.256 0 N-CA-C 109.779 -0.452 . . . . 0.0 109.779 178.422 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B ' 40' ' ' SER . . . . . 0.535 ' O ' HD13 ' B' ' 41' ' ' ILE . 78.6 p -91.42 117.02 29.32 Favored 'General case' 0 C--N 1.329 -0.294 0 C-N-CA 120.973 -0.291 . . . . 0.0 111.02 178.512 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' B' B ' 41' ' ' ILE . . . . . 0.535 HD13 ' O ' ' B' ' 40' ' ' SER . 47.1 mm -130.32 125.07 58.94 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.23 0 CA-C-O 120.778 0.323 . . . . 0.0 110.191 179.512 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' B' B ' 42' ' ' LEU . . . . . . . . . . . . . 52.8 mt 57.8 34.23 24.16 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.246 -0.433 . . . . 0.0 111.782 177.802 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B ' 43' ' ' GLY . . . . . . . . . . . . . . . 77.7 -10.08 26.42 Favored Glycine 0 CA--C 1.534 1.279 0 C-N-CA 121.265 -0.493 . . . . 0.0 113.456 177.525 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B ' 44' ' ' LYS . . . . . . . . . . . . . 39.1 mtpt -104.83 133.93 48.81 Favored 'General case' 0 C--N 1.333 -0.121 0 CA-C-N 117.952 0.876 . . . . 0.0 109.855 177.086 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B ' 45' ' ' GLU . . . . . . . . . . . . . 36.3 tp10 -84.6 129.25 34.87 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.425 -0.352 . . . . 0.0 110.864 -179.475 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B ' 46' ' ' VAL . . . . . . . . . . . . . 7.5 p -116.79 129.62 73.0 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.224 0 N-CA-C 109.312 -0.625 . . . . 0.0 109.312 176.599 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B ' 47' ' ' LYS . . . . . . . . . . . . . 58.9 mtpt -99.99 126.8 46.22 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 115.912 -0.585 . . . . 0.0 111.032 179.134 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B ' 48' ' ' PHE . . . . . . . . . . . . . 92.4 m-85 -109.86 131.88 54.66 Favored 'General case' 0 C--N 1.331 -0.213 0 CA-C-N 116.318 -0.401 . . . . 0.0 110.047 176.454 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B ' 49' ' ' LYS . . . . . . . . . . . . . 62.4 tttm -107.64 137.42 45.7 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 116.276 -0.42 . . . . 0.0 110.509 179.2 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B ' 50' ' ' VAL . . . . . . . . . . . . . 45.5 t -80.29 107.42 12.65 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.286 0 N-CA-C 109.135 -0.691 . . . . 0.0 109.135 174.615 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B ' 51' ' ' VAL . . . . . . . . . . . . . 47.8 t -73.5 -47.3 45.9 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.374 0 CA-C-N 116.35 -0.386 . . . . 0.0 110.024 -173.773 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B ' 52' ' ' GLN . . . . . . . . . . . . . 43.3 tt0 -162.17 137.07 7.02 Favored 'General case' 0 C--N 1.33 -0.279 0 C-N-CA 120.418 -0.513 . . . . 0.0 111.606 -178.964 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B ' 53' ' ' ALA . . . . . . . . . . . . . . . -113.47 133.01 55.44 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 115.782 -0.645 . . . . 0.0 109.987 175.35 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B ' 54' ' ' TYR . . . . . . . . . . . . . 12.5 t80 -129.11 112.65 18.44 Favored Pre-proline 0 CA--C 1.534 0.358 0 CA-C-O 118.32 -0.848 . . . . 0.0 110.469 179.208 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B ' 55' ' ' PRO . . . . . . . . . . . . . 73.9 Cg_endo -77.07 169.61 73.87 Favored 'Cis proline' 0 N--CA 1.499 1.8 0 CA-C-N 121.934 1.726 . . . . 0.0 112.195 -6.412 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B ' 56' ' ' SER . . . . . . . . . . . . . 13.6 m -116.83 131.02 24.15 Favored Pre-proline 0 CA--C 1.54 0.559 0 CA-C-O 118.37 -0.824 . . . . 0.0 109.474 176.097 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B ' 57' ' ' PRO . . . . . . . . . . . . . 48.4 Cg_endo -69.99 148.2 86.74 Favored 'Cis proline' 0 N--CA 1.497 1.683 0 CA-C-N 121.937 1.728 . . . . 0.0 111.573 -1.349 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B ' 58' ' ' LEU . . . . . . . . . . . . . 25.8 tp -107.74 135.38 49.25 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.384 -0.371 . . . . 0.0 110.744 -178.399 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B ' 59' ' ' ARG . . . . . . . . . . . . . 55.0 ttt180 -101.96 121.15 41.6 Favored 'General case' 0 C--N 1.327 -0.382 0 N-CA-C 109.297 -0.631 . . . . 0.0 109.297 176.14 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B ' 60' ' ' VAL . . . . . . . . . . . . . 44.4 t -78.97 123.19 35.62 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.263 0 C-N-CA 120.694 -0.402 . . . . 0.0 110.36 -174.987 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B ' 61' ' ' GLU . . . . . . . . . . . . . 95.7 mt-10 -131.03 165.57 22.93 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.062 -0.517 . . . . 0.0 110.057 178.269 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B ' 62' ' ' ASP . . . . . . . . . . . . . 18.0 p-10 -54.61 -32.64 59.19 Favored 'General case' 0 C--N 1.328 -0.329 0 C-N-CA 120.975 -0.29 . . . . 0.0 111.675 179.872 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B ' 63' ' ' ARG . . . . . . . . . . . . . 10.8 ptm180 -85.21 7.29 22.52 Favored 'General case' 0 CA--C 1.537 0.452 0 N-CA-C 113.523 0.934 . . . . 0.0 113.523 -176.273 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B ' 64' ' ' THR . . . . . . . . . . . . . 33.0 m -83.84 138.48 33.19 Favored 'General case' 0 C--N 1.332 -0.17 0 CA-C-N 118.135 0.425 . . . . 0.0 110.76 -178.319 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B ' 65' ' ' LYS . . . . . . . . . . . . . 69.2 mttm -89.99 129.27 36.34 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.106 -0.497 . . . . 0.0 110.281 178.541 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B ' 66' ' ' ILE . . . . . . . . . . . . . 63.0 mt -116.84 130.37 71.83 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.292 0 N-CA-C 109.935 -0.395 . . . . 0.0 109.935 179.454 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B ' 67' ' ' THR . . . . . . . . . . . . . 25.5 m -123.3 136.69 54.81 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.596 -179.513 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B ' 68' ' ' LEU . . . . . . . . . . . . . 17.7 tp . . . . . 0 C--N 1.33 -0.275 0 CA-C-N 116.039 -0.528 . . . . 0.0 110.551 179.515 . . . . . . . . 0 0 . 1 . 007 nuclear nobuild core ' B' B ' 73' ' ' VAL . . . . . . . . . . . . . 31.0 m . . . . . 0 C--O 1.231 0.123 0 CA-C-O 120.902 0.382 . . . . 0.0 110.668 . . . . . . . . . 0 0 . 1 . 007 nuclear nobuild core ' B' B ' 74' ' ' ASP . . . . . . . . . . . . . 7.5 t70 -102.84 120.69 41.05 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.041 -0.527 . . . . 0.0 109.731 179.695 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B ' 75' ' ' VAL . . . . . . . . . . . . . 42.5 t -113.74 122.21 67.42 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.219 0 CA-C-O 121.087 0.47 . . . . 0.0 110.531 -177.76 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B ' 76' ' ' LEU . . . . . . . . . . . . . 32.6 mt -119.85 145.57 46.53 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 115.575 -0.739 . . . . 0.0 109.434 177.471 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B ' 77' ' ' GLU . . . . . . . . . . . . . 98.0 mt-10 -136.46 134.24 37.46 Favored 'General case' 0 C--N 1.332 -0.187 0 CA-C-O 121.189 0.518 . . . . 0.0 111.18 -178.095 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B ' 78' ' ' ALA . . . . . 0.662 ' HB2' HD21 ' B' ' 109' ' ' LEU . . . -122.22 123.76 42.22 Favored 'General case' 0 C--N 1.331 -0.224 0 CA-C-N 115.62 -0.718 . . . . 0.0 109.666 176.471 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' B' B ' 79' ' ' LYS . . . . . 0.566 ' O ' HD13 ' B' ' 80' ' ' ILE . 45.9 pttt -73.6 121.04 20.03 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-O 121.295 0.569 . . . . 0.0 110.811 -177.832 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' B' B ' 80' ' ' ILE . . . . . 0.566 HD13 ' O ' ' B' ' 79' ' ' LYS . 40.4 mm -139.33 112.49 6.22 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.267 0 CA-C-N 115.658 -0.701 . . . . 0.0 109.267 -177.799 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' B' B ' 81' ' ' LYS . . . . . . . . . . . . . 28.9 mtpt -99.46 122.31 42.38 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-O 120.845 0.355 . . . . 0.0 111.113 -177.789 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B ' 82' ' ' GLY . . . . . . . . . . . . . . . 89.22 42.2 5.63 Favored Glycine 0 CA--C 1.525 0.694 0 C-N-CA 120.738 -0.744 . . . . 0.0 111.808 174.362 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B ' 83' ' ' ILE . . . . . . . . . . . . . 68.5 mt -61.92 135.39 26.55 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.33 0 N-CA-C 109.727 -0.472 . . . . 0.0 109.727 176.938 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B ' 84' ' ' LYS . . . . . . . . . . . . . 75.6 tttt -94.39 -51.6 4.71 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.129 -0.487 . . . . 0.0 109.988 -179.312 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B ' 85' ' ' ASP . . . . . . . . . . . . . 11.6 t70 -157.86 152.14 24.57 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 115.666 -0.697 . . . . 0.0 110.347 178.979 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B ' 86' ' ' VAL . . . . . . . . . . . . . 42.6 t -127.41 129.46 70.58 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.275 0 CA-C-O 120.897 0.38 . . . . 0.0 110.313 -179.541 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B ' 87' ' ' ILE . . . . . . . . . . . . . 44.7 mm -119.55 128.95 75.88 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.312 0 CA-C-N 115.985 -0.552 . . . . 0.0 109.755 177.984 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B ' 88' ' ' LEU . . . . . 0.447 HD12 HD22 ' A' ' 124' ' ' LEU . 47.7 mt -111.85 138.12 48.88 Favored 'General case' 0 C--N 1.332 -0.185 0 CA-C-O 121.057 0.456 . . . . 0.0 111.791 -176.645 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' B' B ' 89' ' ' ASP . . . . . . . . . . . . . 13.4 t70 -132.87 155.34 49.2 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 115.401 -0.818 . . . . 0.0 109.226 174.876 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B ' 90' ' ' GLU . . . . . . . . . . . . . 35.0 tt0 -47.54 -37.21 11.72 Favored 'General case' 0 N--CA 1.465 0.301 0 N-CA-C 113.005 0.743 . . . . 0.0 113.005 -171.409 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B ' 91' ' ' ASN . . . . . . . . . . . . . 4.1 t-20 -129.59 20.3 5.63 Favored 'General case' 0 N--CA 1.469 0.507 0 N-CA-C 112.823 0.675 . . . . 0.0 112.823 -177.005 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B ' 92' ' ' LEU . . . . . . . . . . . . . 19.6 mt -148.73 143.25 26.29 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-O 120.822 0.344 . . . . 0.0 110.288 -177.427 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B ' 93' ' ' ILE . . . . . . . . . . . . . 71.3 mt -121.54 117.0 51.2 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.331 0 N-CA-C 108.947 -0.76 . . . . 0.0 108.947 175.755 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B ' 94' ' ' VAL . . . . . . . . . . . . . 46.8 t -114.37 123.51 70.12 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.292 0 N-CA-C 109.728 -0.471 . . . . 0.0 109.728 -179.102 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B ' 95' ' ' VAL . . . . . . . . . . . . . 44.1 t -119.95 132.0 70.83 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.321 0 CA-C-N 116.032 -0.531 . . . . 0.0 109.767 -179.447 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B ' 96' ' ' ILE . . . . . . . . . . . . . 66.1 mt -114.48 127.93 71.76 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.33 0 N-CA-C 109.073 -0.714 . . . . 0.0 109.073 178.471 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B ' 97' ' ' THR . . . . . . . . . . . . . 61.3 p -102.31 154.9 18.61 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-O 121.061 0.457 . . . . 0.0 111.094 -177.644 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B ' 98' ' ' GLU . . . . . . . . . . . . . 98.0 mt-10 -53.96 -22.2 9.77 Favored 'General case' 0 CA--C 1.533 0.302 0 N-CA-C 112.355 0.502 . . . . 0.0 112.355 178.177 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B ' 99' ' ' GLU . . . . . . . . . . . . . 95.9 mt-10 -76.54 11.67 1.54 Allowed 'General case' 0 CA--C 1.537 0.468 0 N-CA-C 113.149 0.796 . . . . 0.0 113.149 -178.939 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B ' 100' ' ' ASN . . . . . . . . . . . . . 2.4 m-20 61.96 37.94 14.66 Favored 'General case' 0 CA--C 1.529 0.172 0 CA-C-O 121.077 0.465 . . . . 0.0 110.836 179.785 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B ' 101' ' ' GLU . . . . . . . . . . . . . 84.6 tt0 -120.39 142.02 49.57 Favored 'General case' 0 C--N 1.332 -0.193 0 N-CA-C 109.564 -0.532 . . . . 0.0 109.564 176.215 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B ' 102' ' ' VAL . . . . . . . . . . . . . 45.9 t -114.92 127.57 72.41 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.238 0 N-CA-C 109.976 -0.379 . . . . 0.0 109.976 -178.362 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B ' 103' ' ' LEU . . . . . . . . . . . . . 55.6 mt -116.77 131.89 56.84 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 115.641 -0.709 . . . . 0.0 110.335 177.771 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B ' 104' ' ' ILE . . . . . 0.414 HD12 ' HB3' ' B' ' 113' ' ' TYR . 66.2 mt -115.97 119.35 61.63 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.256 0 CA-C-N 116.375 -0.375 . . . . 0.0 110.03 178.511 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' B' B ' 105' ' ' PHE . . . . . . . . . . . . . 34.7 m-85 -119.59 167.1 12.33 Favored 'General case' 0 C--N 1.333 -0.142 0 O-C-N 123.995 0.809 . . . . 0.0 109.994 178.657 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B ' 106' ' ' ASN . . . . . . . . . . . . . 44.3 p-10 -104.02 -169.98 1.71 Allowed 'General case' 0 C--N 1.331 -0.232 0 N-CA-C 110.078 -0.341 . . . . 0.0 110.078 174.631 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B ' 107' ' ' GLN . . . . . . . . . . . . . 41.0 tt0 -59.64 -29.9 68.35 Favored 'General case' 0 CA--C 1.531 0.244 0 N-CA-C 111.963 0.357 . . . . 0.0 111.963 179.612 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B ' 108' ' ' ASN . . . . . . . . . . . . . 4.9 t-20 -82.87 6.77 17.34 Favored 'General case' 0 CA--C 1.537 0.45 0 N-CA-C 113.171 0.804 . . . . 0.0 113.171 -177.749 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B ' 109' ' ' LEU . . . . . 0.662 HD21 ' HB2' ' B' ' 78' ' ' ALA . 12.0 tp 61.85 37.76 15.15 Favored 'General case' 0 CA--C 1.53 0.18 0 CA-C-O 120.948 0.404 . . . . 0.0 111.294 178.188 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' B' B ' 110' ' ' GLU . . . . . . . . . . . . . 96.0 mt-10 -107.66 165.59 11.32 Favored 'General case' 0 C--N 1.331 -0.218 0 CA-C-N 116.342 -0.39 . . . . 0.0 110.123 176.9 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B ' 111' ' ' GLU . . . . . . . . . . . . . 45.4 tp10 -89.1 125.51 35.06 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-O 120.928 0.394 . . . . 0.0 111.0 -177.452 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B ' 112' ' ' LEU . . . . . . . . . . . . . 17.4 mt -109.62 -46.05 3.58 Favored 'General case' 0 C--N 1.332 -0.19 0 CA-C-N 115.991 -0.55 . . . . 0.0 110.404 177.201 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B ' 113' ' ' TYR . . . . . 0.414 ' HB3' HD12 ' B' ' 104' ' ' ILE . 64.4 t80 -145.42 140.31 27.53 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.226 -0.443 . . . . 0.0 111.382 -179.398 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' B' B ' 114' ' ' ARG . . . . . . . . . . . . . 21.3 ttm180 -132.39 127.8 36.21 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-N 116.006 -0.543 . . . . 0.0 109.842 175.627 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B ' 115' ' ' GLY . . . . . . . . . . . . . . . -150.1 131.35 3.58 Favored Glycine 0 CA--C 1.523 0.573 0 N-CA-C 111.137 -0.785 . . . . 0.0 111.137 178.334 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B ' 116' ' ' LYS . . . . . . . . . . . . . 28.4 ttpp -106.68 133.24 51.65 Favored 'General case' 0 C--N 1.331 -0.235 0 N-CA-C 109.664 -0.495 . . . . 0.0 109.664 176.85 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B ' 117' ' ' PHE . . . . . . . . . . . . . 39.4 m-85 -136.01 113.92 11.23 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-O 120.903 0.382 . . . . 0.0 110.246 -175.591 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B ' 118' ' ' GLU . . . . . . . . . . . . . 97.0 mt-10 -54.34 -44.01 71.73 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.485 -0.325 . . . . 0.0 111.279 -177.628 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B ' 119' ' ' ASN . . . . . . . . . . . . . 83.9 m-20 -96.67 31.03 2.41 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 116.182 -0.463 . . . . 0.0 112.146 -174.661 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B ' 120' ' ' LEU . . . . . . . . . . . . . 14.9 tp -57.04 120.25 7.68 Favored 'General case' 0 C--N 1.333 -0.137 0 CA-C-O 120.641 0.258 . . . . 0.0 110.33 177.447 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B ' 121' ' ' ASN . . . . . . . . . . . . . 61.1 m-80 -113.6 -44.0 3.25 Favored 'General case' 0 C--N 1.332 -0.156 0 CA-C-N 116.627 -0.26 . . . . 0.0 111.084 -177.357 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B ' 122' ' ' LYS . . . . . . . . . . . . . 88.6 mttt -147.4 149.8 33.43 Favored 'General case' 0 C--N 1.331 -0.197 0 CA-C-O 121.221 0.534 . . . . 0.0 111.744 -178.035 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B ' 123' ' ' VAL . . . . . . . . . . . . . 44.6 t -128.19 129.2 69.29 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.263 0 CA-C-N 115.71 -0.677 . . . . 0.0 109.589 175.506 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B ' 124' ' ' LEU . . . . . . . . . . . . . 83.8 mt -123.63 131.93 53.74 Favored 'General case' 0 C--N 1.331 -0.224 0 CA-C-N 116.396 -0.366 . . . . 0.0 110.573 -179.041 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B ' 125' ' ' VAL . . . . . 0.452 ' O ' HG13 ' B' ' 125' ' ' VAL . 11.2 p -131.12 122.86 52.46 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.232 0 CA-C-N 116.163 -0.471 . . . . 0.0 109.835 177.161 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' B' B ' 126' ' ' ARG . . . . . . . . . . . . . 88.8 mtt180 -147.45 128.82 14.86 Favored 'General case' 0 C--N 1.33 -0.252 0 N-CA-C 109.62 -0.511 . . . . 0.0 109.62 -179.802 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B ' 127' ' ' ASN . . . . . . . . . . . . . 32.0 m120 55.95 -151.94 0.39 Allowed 'General case' 0 CA--C 1.541 0.616 0 N-CA-C 109.784 -0.451 . . . . 0.0 109.784 -178.749 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B ' 128' ' ' ASP . . . . . . . . . . . . . 19.4 p-10 -83.69 19.73 1.59 Allowed 'General case' 0 CA--C 1.536 0.412 0 CA-C-N 118.67 0.668 . . . . 0.0 112.49 177.337 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B ' 129' ' ' LEU . . . . . . . . . . . . . 2.0 tt -116.41 131.81 56.85 Favored 'General case' 0 C--O 1.232 0.156 0 N-CA-C 109.96 -0.385 . . . . 0.0 109.96 -179.92 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B ' 130' ' ' VAL . . . . . . . . . . . . . 44.7 t -124.19 138.26 54.38 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.228 0 CA-C-O 120.765 0.317 . . . . 0.0 110.146 -178.826 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B ' 131' ' ' VAL . . . . . 0.434 HG22 HD12 ' B' ' 140' ' ' LEU . 41.2 t -136.1 137.75 48.14 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.261 0 CA-C-O 121.037 0.446 . . . . 0.0 110.444 179.851 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' B' B ' 132' ' ' ILE . . . . . . . . . . . . . 73.5 mt -119.84 133.39 66.76 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.254 0 N-CA-C 109.342 -0.614 . . . . 0.0 109.342 178.68 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B ' 133' ' ' ILE . . . . . . . . . . . . . 40.1 mm -117.44 121.71 68.22 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.29 0 CA-C-O 120.824 0.345 . . . . 0.0 111.205 -174.498 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B ' 134' ' ' ASP . . . . . . . . . . . . . 6.8 p-10 -132.07 147.25 52.43 Favored 'General case' 0 C--N 1.332 -0.178 0 CA-C-N 115.852 -0.613 . . . . 0.0 109.521 173.831 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B ' 135' ' ' GLU . . . . . . . . . . . . . 43.7 tp10 -49.9 -26.72 4.37 Favored 'General case' 0 C--N 1.328 -0.33 0 N-CA-C 112.904 0.705 . . . . 0.0 112.904 -170.756 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B ' 136' ' ' GLN . . . . . . . . . . . . . 96.9 mt-30 -92.88 -34.76 13.69 Favored 'General case' 0 C--N 1.331 -0.232 0 N-CA-C 112.381 0.511 . . . . 0.0 112.381 -175.475 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B ' 137' ' ' LYS . . . . . . . . . . . . . 55.4 mtmt -145.49 154.98 42.81 Favored 'General case' 0 C--N 1.33 -0.239 0 CA-C-O 121.474 0.654 . . . . 0.0 111.856 -170.141 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B ' 138' ' ' LEU . . . . . 0.454 HD23 ' N ' ' B' ' 139' ' ' THR . 4.2 tt -113.31 123.05 49.22 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 115.144 -0.935 . . . . 0.0 108.981 174.403 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' B' B ' 139' ' ' THR . . . . . 0.454 ' N ' HD23 ' B' ' 138' ' ' LEU . 33.1 m -107.61 128.48 54.58 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-O 120.848 0.356 . . . . 0.0 110.852 -177.218 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' B' B ' 140' ' ' LEU . . . . . 0.434 HD12 HG22 ' B' ' 131' ' ' VAL . 18.8 tp -114.08 121.53 44.09 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 115.45 -0.796 . . . . 0.0 109.355 -179.28 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' B' B ' 141' ' ' ILE . . . . . . . . . . . . . 19.5 mt -120.86 120.13 61.5 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.342 0 N-CA-C 109.855 -0.424 . . . . 0.0 109.855 -175.733 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B ' 142' ' ' ARG . . . . . . . . . . . . . 73.5 mtm180 -111.01 129.23 55.96 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 115.55 -0.75 . . . . 0.0 110.547 -179.401 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B ' 143' ' ' THR . . . . . . . . . . . . . 39.9 p . . . . . 0 C--O 1.222 -0.373 0 CA-C-O 117.959 -1.02 . . . . 0.0 110.56 179.939 . . . . . . . . 0 0 . 1 . 007 nuclear nobuild core ' C' C ' 2' ' ' SER . . . . . . . . . . . . . 25.9 p . . . . . 0 C--O 1.231 0.086 0 CA-C-O 120.911 0.386 . . . . 0.0 110.312 . . . . . . . . . 0 0 . 1 . 007 nuclear nobuild core ' C' C ' 3' ' ' GLU . . . . . . . . . . . . . 95.7 mt-10 -139.42 141.8 37.48 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.191 -0.459 . . . . 0.0 111.014 -178.021 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' C' C ' 4' ' ' LEU . . . . . 0.4 HD11 HG13 ' C' ' 50' ' ' VAL . 16.9 tp -125.11 125.83 44.37 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 115.724 -0.671 . . . . 0.0 110.197 177.165 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' C' C ' 5' ' ' LYS . . . . . . . . . . . . . 60.5 mttp -105.23 121.53 44.04 Favored 'General case' 0 C--O 1.234 0.25 0 CA-C-N 116.505 -0.316 . . . . 0.0 110.282 177.632 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' C' C ' 6' ' ' LEU . . . . . . . . . . . . . 53.2 mt -114.46 145.71 41.55 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-N 115.623 -0.717 . . . . 0.0 110.917 -178.058 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' C' C ' 7' ' ' LYS . . . . . . . . . . . . . 25.9 ttpt -132.7 134.53 24.77 Favored Pre-proline 0 CA--C 1.536 0.412 0 CA-C-O 118.884 -0.579 . . . . 0.0 109.64 176.449 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' C' C ' 8' ' ' PRO . . . . . . . . . . . . . 86.5 Cg_endo -90.67 133.3 1.75 Allowed 'Trans proline' 0 N--CA 1.489 1.228 0 C-N-CA 121.624 1.55 . . . . 0.0 111.343 174.095 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' C' C ' 9' ' ' LEU . . . . . . . . . . . . . 62.1 mt -69.13 -48.21 27.59 Favored Pre-proline 0 CA--C 1.533 0.325 0 CA-C-O 118.608 -0.711 . . . . 0.0 112.48 -177.085 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' C' C ' 10' ' ' PRO . . . . . . . . . . . . . 90.0 Cg_endo -78.81 146.83 21.17 Favored 'Trans proline' 0 N--CA 1.495 1.59 0 C-N-CA 121.109 1.206 . . . . 0.0 111.817 177.367 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' C' C ' 11' ' ' LYS . . . . . . . . . . . . . 62.0 tttm -78.55 91.39 4.57 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.436 -0.347 . . . . 0.0 110.424 179.185 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' C' C ' 12' ' ' VAL . . . . . . . . . . . . . 12.4 p -139.63 146.15 25.77 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.308 0 CA-C-N 116.297 -0.41 . . . . 0.0 110.485 -179.705 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' C' C ' 13' ' ' GLU . . . . . . . . . . . . . 44.7 tp10 -90.26 129.37 36.51 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.33 -0.396 . . . . 0.0 110.298 179.351 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' C' C ' 14' ' ' LEU . . . . . . . . . . . . . 27.3 mt -97.99 152.36 38.02 Favored Pre-proline 0 CA--C 1.531 0.246 0 CA-C-N 116.33 -0.395 . . . . 0.0 110.653 -178.323 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' C' C ' 15' ' ' PRO . . . . . . . . . . . . . 27.2 Cg_exo -61.31 159.01 32.77 Favored 'Trans proline' 0 N--CA 1.499 1.795 0 C-N-CA 121.307 1.338 . . . . 0.0 111.815 177.265 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' C' C ' 16' ' ' PRO . . . . . . . . . . . . . 39.8 Cg_exo -58.63 -39.37 83.27 Favored 'Trans proline' 0 N--CA 1.498 1.74 0 C-N-CA 121.483 1.455 . . . . 0.0 112.871 -178.481 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' C' C ' 17' ' ' ASP . . . . . . . . . . . . . 12.9 p-10 -85.81 8.51 19.73 Favored 'General case' 0 CA--C 1.536 0.44 0 N-CA-C 113.176 0.806 . . . . 0.0 113.176 -177.738 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' C' C ' 18' ' ' PHE . . . . . . . . . . . . . 55.0 t80 -58.1 -45.53 87.06 Favored 'General case' 0 C--N 1.333 -0.118 0 O-C-N 122.077 -0.389 . . . . 0.0 110.178 -177.925 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' C' C ' 19' ' ' VAL . . . . . 0.414 HG13 ' N ' ' C' ' 20' ' ' ASP . 13.8 p -55.88 -41.69 67.9 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.371 0 CA-C-N 116.336 -0.393 . . . . 0.0 111.006 -178.244 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' C' C ' 20' ' ' ASP . . . . . 0.414 ' N ' HG13 ' C' ' 19' ' ' VAL . 11.3 t70 -60.82 -42.03 96.91 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-O 120.977 0.418 . . . . 0.0 110.655 -178.831 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' C' C ' 21' ' ' VAL . . . . . . . . . . . . . 47.3 t -64.04 -45.47 96.58 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.248 0 CA-C-N 116.244 -0.434 . . . . 0.0 110.442 -178.138 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' C' C ' 22' ' ' ILE . . . . . 0.45 HG22 HD12 ' C' ' 26' ' ' LEU . 51.5 mm -55.4 -47.25 78.41 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.265 0 C-N-CA 121.056 -0.258 . . . . 0.0 110.661 179.037 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' C' C ' 23' ' ' ARG . . . . . . . . . . . . . 54.0 ttp180 -54.35 -49.83 68.86 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-O 120.671 0.272 . . . . 0.0 111.411 -179.068 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' C' C ' 24' ' ' ILE . . . . . . . . . . . . . 73.1 mt -59.34 -41.76 85.26 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.314 0 CA-C-N 116.566 -0.288 . . . . 0.0 111.422 -176.889 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' C' C ' 25' ' ' LYS . . . . . . . . . . . . . 49.6 mttm -67.28 -42.64 83.46 Favored 'General case' 0 C--N 1.329 -0.32 0 N-CA-C 112.351 0.5 . . . . 0.0 112.351 -178.791 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' C' C ' 26' ' ' LEU . . . . . 0.45 HD12 HG22 ' C' ' 22' ' ' ILE . 92.6 mt -78.34 -37.91 43.38 Favored 'General case' 0 C--N 1.33 -0.272 0 N-CA-C 113.116 0.784 . . . . 0.0 113.116 -170.651 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' C' C ' 27' ' ' GLN . . . . . . . . . . . . . 9.3 pt20 -46.87 139.12 5.72 Favored 'General case' 0 N--CA 1.47 0.531 0 N-CA-C 112.918 0.71 . . . . 0.0 112.918 -175.016 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' C' C ' 28' ' ' GLY . . . . . . . . . . . . . . . 100.01 -26.69 23.51 Favored Glycine 0 CA--C 1.533 1.17 0 CA-C-N 115.493 -0.776 . . . . 0.0 112.207 -177.505 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' C' C ' 29' ' ' LYS . . . . . . . . . . . . . 60.8 mttp -98.24 155.12 17.34 Favored 'General case' 0 C--O 1.232 0.169 0 CA-C-N 117.264 0.532 . . . . 0.0 111.071 179.555 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' C' C ' 30' ' ' THR . . . . . . . . . . . . . 32.8 m -110.0 133.52 53.1 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-N 116.048 -0.523 . . . . 0.0 110.186 176.823 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' C' C ' 31' ' ' VAL . . . . . . . . . . . . . 35.0 m -133.45 164.3 35.32 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.267 0 CA-C-N 116.265 -0.425 . . . . 0.0 110.364 -179.641 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' C' C ' 32' ' ' ARG . . . . . . . . . . . . . 29.9 ttp180 -132.53 153.59 50.8 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-O 121.294 0.569 . . . . 0.0 110.605 179.232 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' C' C ' 33' ' ' THR . . . . . . . . . . . . . 28.8 m -52.41 140.35 22.46 Favored 'General case' 0 C--N 1.331 -0.227 0 CA-C-N 116.127 -0.488 . . . . 0.0 111.561 -178.327 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' C' C ' 34' ' ' GLY . . . . . . . . . . . . . . . 100.02 -17.2 57.52 Favored Glycine 0 CA--C 1.533 1.181 0 CA-C-O 119.713 -0.493 . . . . 0.0 113.199 179.875 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' C' C ' 35' ' ' ASP . . . . . . . . . . . . . 60.7 m-20 -66.77 149.73 50.12 Favored 'General case' 0 C--O 1.232 0.164 0 CA-C-N 118.074 0.937 . . . . 0.0 111.2 178.918 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' C' C ' 36' ' ' VAL . . . . . . . . . . . . . 45.2 t -123.65 130.44 74.05 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.261 0 CA-C-N 115.897 -0.592 . . . . 0.0 109.825 178.905 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' C' C ' 37' ' ' ILE . . . . . . . . . . . . . 62.1 mt -122.15 139.2 49.84 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.265 0 CA-C-N 116.259 -0.428 . . . . 0.0 109.898 -178.84 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' C' C ' 38' ' ' GLY . . . . . . . . . . . . . . . -109.83 128.74 9.05 Favored Glycine 0 CA--C 1.525 0.696 0 N-CA-C 111.192 -0.763 . . . . 0.0 111.192 179.744 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' C' C ' 39' ' ' ILE . . . . . . . . . . . . . 68.8 mt -120.76 130.96 74.02 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.19 0 N-CA-C 109.944 -0.391 . . . . 0.0 109.944 178.406 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' C' C ' 40' ' ' SER . . . . . . . . . . . . . 32.8 t -93.12 122.58 35.65 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.423 -0.353 . . . . 0.0 111.099 177.324 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' C' C ' 41' ' ' ILE . . . . . . . . . . . . . 70.3 mt -129.75 120.24 49.66 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.206 0 CA-C-O 120.881 0.372 . . . . 0.0 110.325 177.405 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' C' C ' 42' ' ' LEU . . . . . . . . . . . . . 62.6 mt 52.84 36.13 20.67 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 116.02 -0.536 . . . . 0.0 111.677 177.163 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' C' C ' 43' ' ' GLY . . . . . . . . . . . . . . . 72.64 30.0 64.74 Favored Glycine 0 CA--C 1.529 0.967 0 C-N-CA 121.108 -0.567 . . . . 0.0 112.284 177.615 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' C' C ' 44' ' ' LYS . . . . . . . . . . . . . 62.3 mtpt -134.65 129.06 34.27 Favored 'General case' 0 C--N 1.331 -0.222 0 N-CA-C 109.645 -0.502 . . . . 0.0 109.645 177.809 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' C' C ' 45' ' ' GLU . . . . . . . . . . . . . 84.5 tt0 -84.23 122.2 28.55 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-O 120.871 0.367 . . . . 0.0 111.304 -178.255 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' C' C ' 46' ' ' VAL . . . . . . . . . . . . . 7.6 p -119.03 125.6 74.64 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.168 0 N-CA-C 109.06 -0.718 . . . . 0.0 109.06 173.643 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' C' C ' 47' ' ' LYS . . . . . . . . . . . . . 97.9 mttt -99.62 126.87 45.7 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.099 -0.5 . . . . 0.0 111.151 -179.843 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' C' C ' 48' ' ' PHE . . . . . . . . . . . . . 93.6 m-85 -110.39 131.78 54.75 Favored 'General case' 0 C--N 1.329 -0.289 0 N-CA-C 109.624 -0.51 . . . . 0.0 109.624 176.76 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' C' C ' 49' ' ' LYS . . . . . . . . . . . . . 71.4 tttt -108.79 136.83 47.71 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.388 -0.369 . . . . 0.0 110.459 179.075 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' C' C ' 50' ' ' VAL . . . . . 0.4 HG13 HD11 ' C' ' 4' ' ' LEU . 48.0 t -78.87 105.36 8.0 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.278 0 N-CA-C 109.087 -0.709 . . . . 0.0 109.087 175.899 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' C' C ' 51' ' ' VAL . . . . . . . . . . . . . 46.8 t -69.19 -48.96 65.75 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.291 0 CA-C-N 116.07 -0.514 . . . . 0.0 109.843 -173.922 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' C' C ' 52' ' ' GLN . . . . . . . . . . . . . 32.3 tt0 -162.43 143.23 10.12 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-N 115.949 -0.569 . . . . 0.0 111.522 -179.1 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' C' C ' 53' ' ' ALA . . . . . . . . . . . . . . . -122.58 133.85 54.54 Favored 'General case' 0 C--N 1.331 -0.212 0 CA-C-N 115.786 -0.643 . . . . 0.0 109.718 176.714 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' C' C ' 54' ' ' TYR . . . . . . . . . . . . . 14.9 t80 -129.08 113.08 18.52 Favored Pre-proline 0 CA--C 1.535 0.397 0 CA-C-O 118.041 -0.981 . . . . 0.0 110.345 179.265 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' C' C ' 55' ' ' PRO . . . . . . . . . . . . . 73.7 Cg_endo -77.08 169.15 75.09 Favored 'Cis proline' 0 N--CA 1.501 1.967 0 CA-C-N 122.017 1.756 . . . . 0.0 112.214 -6.95 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' C' C ' 56' ' ' SER . . . . . . . . . . . . . 13.5 m -117.74 135.95 23.51 Favored Pre-proline 0 CA--C 1.539 0.533 0 CA-C-O 118.549 -0.738 . . . . 0.0 109.825 175.681 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' C' C ' 57' ' ' PRO . . . . . . . . . . . . . 36.5 Cg_endo -67.22 164.68 70.47 Favored 'Cis proline' 0 N--CA 1.496 1.665 0 CA-C-N 121.743 1.658 . . . . 0.0 111.231 -4.318 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' C' C ' 58' ' ' LEU . . . . . . . . . . . . . 42.4 tp -130.71 138.4 49.99 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-O 121.126 0.489 . . . . 0.0 110.777 -178.737 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' C' C ' 59' ' ' ARG . . . . . . . . . . . . . 51.1 ttt180 -104.1 125.81 50.72 Favored 'General case' 0 C--N 1.327 -0.395 0 N-CA-C 108.939 -0.763 . . . . 0.0 108.939 173.297 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' C' C ' 60' ' ' VAL . . . . . . . . . . . . . 44.1 t -78.94 122.46 34.2 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.319 0 CA-C-O 120.937 0.398 . . . . 0.0 110.609 -174.135 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' C' C ' 61' ' ' GLU . . . . . . . . . . . . . 43.1 mt-10 -131.03 166.04 21.89 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 115.79 -0.641 . . . . 0.0 109.697 174.739 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' C' C ' 62' ' ' ASP . . . . . . . . . . . . . 81.0 m-20 -52.87 -31.85 41.69 Favored 'General case' 0 C--N 1.328 -0.369 0 N-CA-C 111.971 0.36 . . . . 0.0 111.971 -179.883 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' C' C ' 63' ' ' ARG . . . . . . . . . . . . . 21.0 mmm180 -71.17 -21.88 62.11 Favored 'General case' 0 CA--C 1.534 0.351 0 N-CA-C 112.76 0.652 . . . . 0.0 112.76 -176.128 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' C' C ' 64' ' ' THR . . . . . . . . . . . . . 25.3 m -72.12 136.3 46.49 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-O 120.933 0.397 . . . . 0.0 110.947 -175.829 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' C' C ' 65' ' ' LYS . . . . . . . . . . . . . 96.9 mttt -89.8 131.45 35.74 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.011 -0.54 . . . . 0.0 110.144 179.221 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' C' C ' 66' ' ' ILE . . . . . . . . . . . . . 64.0 mt -116.67 130.52 71.38 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.256 0 CA-C-O 120.89 0.376 . . . . 0.0 110.121 -179.892 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' C' C ' 67' ' ' THR . . . . . . . . . . . . . 21.7 m -129.19 142.5 50.85 Favored 'General case' 0 C--N 1.332 -0.185 0 CA-C-N 116.084 -0.507 . . . . 0.0 110.787 -178.846 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' C' C ' 68' ' ' LEU . . . . . 0.5 HD12 ' N ' ' C' ' 68' ' ' LEU . 7.1 mp . . . . . 0 C--N 1.33 -0.248 0 CA-C-N 116.081 -0.509 . . . . 0.0 110.417 178.631 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' C' C ' 73' ' ' VAL . . . . . . . . . . . . . 26.8 m . . . . . 0 C--O 1.231 0.121 0 N-CA-C 109.802 -0.444 . . . . 0.0 109.802 . . . . . . . . . 0 0 . 1 . 007 nuclear nobuild core ' C' C ' 74' ' ' ASP . . . . . . . . . . . . . 14.0 t70 -91.35 115.24 27.87 Favored 'General case' 0 C--N 1.328 -0.33 0 N-CA-C 109.921 -0.4 . . . . 0.0 109.921 -178.351 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' C' C ' 75' ' ' VAL . . . . . . . . . . . . . 45.6 t -113.1 120.29 62.72 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.268 0 CA-C-O 121.094 0.473 . . . . 0.0 110.216 -178.446 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' C' C ' 76' ' ' LEU . . . . . . . . . . . . . 19.8 mt -123.18 144.94 49.02 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 115.605 -0.725 . . . . 0.0 109.585 179.452 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' C' C ' 77' ' ' GLU . . . . . . . . . . . . . 46.2 mt-10 -134.31 133.5 40.78 Favored 'General case' 0 C--N 1.332 -0.188 0 CA-C-O 121.042 0.449 . . . . 0.0 111.149 -178.804 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' C' C ' 78' ' ' ALA . . . . . . . . . . . . . . . -118.94 135.75 54.43 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 115.713 -0.676 . . . . 0.0 109.808 176.461 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' C' C ' 79' ' ' LYS . . . . . 0.664 ' O ' HD13 ' C' ' 80' ' ' ILE . 62.5 mtpt -80.7 115.3 20.13 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-O 120.813 0.34 . . . . 0.0 110.869 -177.627 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' C' C ' 80' ' ' ILE . . . . . 0.664 HD13 ' O ' ' C' ' 79' ' ' LYS . 37.2 mm -139.23 104.61 2.22 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.281 0 N-CA-C 109.284 -0.636 . . . . 0.0 109.284 -178.527 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' C' C ' 81' ' ' LYS . . . . . . . . . . . . . 93.1 mttt -97.65 128.48 44.38 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-O 120.782 0.325 . . . . 0.0 110.839 -178.766 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' C' C ' 82' ' ' GLY . . . . . . . . . . . . . . . 89.08 42.25 5.66 Favored Glycine 0 CA--C 1.524 0.655 0 N-CA-C 111.176 -0.77 . . . . 0.0 111.176 176.685 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' C' C ' 83' ' ' ILE . . . . . . . . . . . . . 73.6 mt -67.37 132.3 32.5 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.306 0 N-CA-C 109.771 -0.455 . . . . 0.0 109.771 177.689 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' C' C ' 84' ' ' LYS . . . . . . . . . . . . . 76.4 tttt -95.42 -54.06 3.53 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.22 -0.445 . . . . 0.0 110.311 -178.736 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' C' C ' 85' ' ' ASP . . . . . . . . . . . . . 7.4 t0 -149.81 146.3 27.07 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 115.806 -0.634 . . . . 0.0 110.39 -178.652 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' C' C ' 86' ' ' VAL . . . . . . . . . . . . . 42.6 t -124.31 129.5 73.96 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.216 0 CA-C-O 120.858 0.361 . . . . 0.0 110.291 -179.597 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' C' C ' 87' ' ' ILE . . . . . . . . . . . . . 45.1 mm -120.18 126.15 74.97 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.268 0 CA-C-N 115.957 -0.565 . . . . 0.0 109.738 177.637 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' C' C ' 88' ' ' LEU . . . . . . . . . . . . . 19.9 tp -115.15 134.72 54.91 Favored 'General case' 0 C--N 1.332 -0.171 0 CA-C-O 120.992 0.425 . . . . 0.0 111.222 -177.736 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' C' C ' 89' ' ' ASP . . . . . . . . . . . . . 5.6 t70 -131.53 162.23 30.77 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 115.861 -0.609 . . . . 0.0 109.562 176.43 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' C' C ' 90' ' ' GLU . . . . . . . . . . . . . 43.2 mt-10 -46.94 -41.9 16.83 Favored 'General case' 0 N--CA 1.464 0.26 0 N-CA-C 113.015 0.746 . . . . 0.0 113.015 -171.224 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' C' C ' 91' ' ' ASN . . . . . . . . . . . . . 1.8 p30 -132.04 28.29 4.48 Favored 'General case' 0 N--CA 1.466 0.329 0 N-CA-C 112.301 0.482 . . . . 0.0 112.301 -177.773 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' C' C ' 92' ' ' LEU . . . . . . . . . . . . . 16.1 mt -148.62 142.33 25.57 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-O 120.689 0.281 . . . . 0.0 110.35 -177.38 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' C' C ' 93' ' ' ILE . . . . . . . . . . . . . 72.9 mt -125.25 116.58 47.27 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.286 0 N-CA-C 109.143 -0.688 . . . . 0.0 109.143 176.11 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' C' C ' 94' ' ' VAL . . . . . 0.588 HG21 HG11 ' C' ' 125' ' ' VAL . 45.2 t -118.54 127.73 75.53 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.29 0 CA-C-O 120.959 0.409 . . . . 0.0 109.939 -178.795 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' C' C ' 95' ' ' VAL . . . . . . . . . . . . . 44.0 t -122.59 132.78 70.53 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.373 0 CA-C-N 115.96 -0.564 . . . . 0.0 109.854 -179.524 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' C' C ' 96' ' ' ILE . . . . . . . . . . . . . 58.6 mt -113.12 125.58 70.4 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.327 0 N-CA-C 109.058 -0.719 . . . . 0.0 109.058 178.066 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' C' C ' 97' ' ' THR . . . . . . . . . . . . . 71.5 p -98.95 154.53 17.99 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-O 121.197 0.522 . . . . 0.0 111.108 -177.758 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' C' C ' 98' ' ' GLU . . . . . . . . . . . . . 85.1 tt0 -53.82 -25.48 19.62 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 115.959 -0.564 . . . . 0.0 112.341 179.771 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' C' C ' 99' ' ' GLU . . . . . . . . . . . . . 37.0 tt0 -81.07 17.96 1.14 Allowed 'General case' 0 CA--C 1.539 0.525 0 N-CA-C 112.625 0.602 . . . . 0.0 112.625 -177.436 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' C' C ' 100' ' ' ASN . . . . . . . . . . . . . 2.7 m-20 62.39 32.77 16.72 Favored 'General case' 0 N--CA 1.464 0.259 0 O-C-N 121.85 -0.531 . . . . 0.0 111.836 176.276 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' C' C ' 101' ' ' GLU . . . . . . . . . . . . . 84.8 tt0 -113.06 144.82 41.96 Favored 'General case' 0 C--N 1.332 -0.155 0 N-CA-C 109.812 -0.44 . . . . 0.0 109.812 174.14 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' C' C ' 102' ' ' VAL . . . . . . . . . . . . . 45.7 t -115.09 127.43 72.65 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.293 0 CA-C-N 116.244 -0.435 . . . . 0.0 109.926 -177.695 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' C' C ' 103' ' ' LEU . . . . . . . . . . . . . 50.6 mt -117.38 131.53 56.76 Favored 'General case' 0 C--N 1.331 -0.215 0 CA-C-N 115.881 -0.6 . . . . 0.0 110.132 178.531 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' C' C ' 104' ' ' ILE . . . . . . . . . . . . . 65.1 mt -122.56 122.65 66.61 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.227 0 CA-C-O 120.568 0.223 . . . . 0.0 110.46 -179.657 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' C' C ' 105' ' ' PHE . . . . . . . . . . . . . 47.7 m-85 -124.07 164.64 19.0 Favored 'General case' 0 C--N 1.331 -0.225 0 CA-C-N 115.596 -0.729 . . . . 0.0 109.843 178.432 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' C' C ' 106' ' ' ASN . . . . . . . . . . . . . 42.9 p-10 -96.29 -171.41 2.29 Favored 'General case' 0 C--N 1.331 -0.212 0 N-CA-C 109.992 -0.373 . . . . 0.0 109.992 174.929 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' C' C ' 107' ' ' GLN . . . . . . . . . . . . . 40.1 tt0 -60.23 -29.46 68.77 Favored 'General case' 0 C--N 1.329 -0.32 0 N-CA-C 111.96 0.355 . . . . 0.0 111.96 -179.659 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' C' C ' 108' ' ' ASN . . . . . . . . . . . . . 12.1 t30 -83.95 6.16 22.83 Favored 'General case' 0 CA--C 1.536 0.441 0 N-CA-C 113.277 0.843 . . . . 0.0 113.277 -177.468 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' C' C ' 109' ' ' LEU . . . . . . . . . . . . . 12.0 tp 62.09 41.67 10.64 Favored 'General case' 0 C--N 1.332 -0.164 0 CA-C-O 121.383 0.611 . . . . 0.0 110.98 178.657 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' C' C ' 110' ' ' GLU . . . . . . . . . . . . . 96.2 mt-10 -108.55 155.97 20.04 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.139 -0.482 . . . . 0.0 110.014 176.094 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' C' C ' 111' ' ' GLU . . . . . . . . . . . . . 83.7 tt0 -79.97 121.93 26.09 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.394 -0.366 . . . . 0.0 110.683 -179.121 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' C' C ' 112' ' ' LEU . . . . . . . . . . . . . 17.9 mt -112.44 -46.03 3.2 Favored 'General case' 0 C--N 1.331 -0.212 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.306 177.026 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' C' C ' 113' ' ' TYR . . . . . . . . . . . . . 62.7 t80 -147.07 137.2 23.35 Favored 'General case' 0 C--N 1.33 -0.243 0 C-N-CA 120.606 -0.438 . . . . 0.0 111.462 179.991 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' C' C ' 114' ' ' ARG . . . . . . . . . . . . . 93.2 mtt180 -137.67 127.83 26.05 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.131 -0.486 . . . . 0.0 110.096 173.876 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' C' C ' 115' ' ' GLY . . . . . . . . . . . . . . . -149.99 162.89 29.31 Favored Glycine 0 CA--C 1.524 0.596 0 N-CA-C 110.682 -0.967 . . . . 0.0 110.682 179.337 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' C' C ' 116' ' ' LYS . . . . . . . . . . . . . 75.2 tttt -132.31 138.5 47.84 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-O 120.856 0.36 . . . . 0.0 110.143 179.287 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' C' C ' 117' ' ' PHE . . . . . . . . . . . . . 33.4 m-85 -136.28 116.72 13.71 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.158 -0.474 . . . . 0.0 109.812 -177.113 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' C' C ' 118' ' ' GLU . . . . . . . . . . . . . 45.7 mp0 -56.01 -40.62 73.65 Favored 'General case' 0 C--N 1.329 -0.304 0 C-N-CA 120.803 -0.359 . . . . 0.0 110.92 -175.758 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' C' C ' 119' ' ' ASN . . . . . . . . . . . . . 30.5 m120 -100.07 31.19 3.42 Favored 'General case' 0 CA--C 1.53 0.21 0 N-CA-C 112.103 0.408 . . . . 0.0 112.103 -174.912 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' C' C ' 120' ' ' LEU . . . . . . . . . . . . . 15.0 tp -57.34 119.9 7.25 Favored 'General case' 0 C--N 1.333 -0.148 0 C-N-CA 121.005 -0.278 . . . . 0.0 110.352 178.087 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' C' C ' 121' ' ' ASN . . . . . . . . . . . . . 46.8 m-80 -114.15 -44.1 3.17 Favored 'General case' 0 C--N 1.332 -0.195 0 CA-C-N 116.571 -0.286 . . . . 0.0 111.245 -177.705 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' C' C ' 122' ' ' LYS . . . . . . . . . . . . . 75.7 mttt -143.35 149.22 37.44 Favored 'General case' 0 C--N 1.331 -0.222 0 CA-C-O 121.066 0.46 . . . . 0.0 111.834 -176.312 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' C' C ' 123' ' ' VAL . . . . . . . . . . . . . 43.1 t -128.62 130.96 69.03 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.227 0 N-CA-C 109.266 -0.642 . . . . 0.0 109.266 174.847 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' C' C ' 124' ' ' LEU . . . . . . . . . . . . . 13.3 tp -130.27 138.3 50.43 Favored 'General case' 0 C--N 1.332 -0.184 0 CA-C-O 120.837 0.351 . . . . 0.0 110.916 -177.484 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' C' C ' 125' ' ' VAL . . . . . 0.588 HG11 HG21 ' C' ' 94' ' ' VAL . 34.9 m -129.74 138.82 53.19 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.229 0 CA-C-N 116.127 -0.488 . . . . 0.0 110.603 179.939 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' C' C ' 126' ' ' ARG . . . . . . . . . . . . . 77.9 mtp85 -147.17 121.88 9.87 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-O 120.868 0.366 . . . . 0.0 110.938 178.162 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' C' C ' 127' ' ' ASN . . . . . . . . . . . . . 9.5 m120 51.02 -105.11 0.19 Allowed 'General case' 0 CA--C 1.544 0.739 0 CA-C-N 116.113 -0.494 . . . . 0.0 111.437 178.684 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' C' C ' 128' ' ' ASP . . . . . . . . . . . . . 12.6 p-10 -114.13 -0.32 14.02 Favored 'General case' 0 CA--C 1.537 0.461 0 CA-C-N 119.504 1.047 . . . . 0.0 113.372 -177.37 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' C' C ' 129' ' ' LEU . . . . . . . . . . . . . 58.3 mt -105.01 143.65 32.89 Favored 'General case' 0 C--O 1.232 0.166 0 CA-C-N 118.135 0.425 . . . . 0.0 110.373 -179.465 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' C' C ' 130' ' ' VAL . . . . . . . . . . . . . 44.9 t -124.4 136.97 58.81 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.284 0 N-CA-C 109.642 -0.503 . . . . 0.0 109.642 -179.956 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' C' C ' 131' ' ' VAL . . . . . 0.496 HG22 HD12 ' C' ' 140' ' ' LEU . 41.3 t -134.55 137.62 51.0 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.248 0 CA-C-O 121.194 0.521 . . . . 0.0 110.376 179.974 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' C' C ' 132' ' ' ILE . . . . . . . . . . . . . 73.3 mt -118.85 133.71 64.82 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.29 0 CA-C-N 115.54 -0.755 . . . . 0.0 109.366 179.565 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' C' C ' 133' ' ' ILE . . . . . . . . . . . . . 37.7 mm -117.02 121.62 68.21 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.229 0 CA-C-N 116.462 -0.336 . . . . 0.0 110.889 -175.035 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' C' C ' 134' ' ' ASP . . . . . . . . . . . . . 7.9 p-10 -133.57 145.86 50.46 Favored 'General case' 0 C--N 1.332 -0.163 0 N-CA-C 109.652 -0.499 . . . . 0.0 109.652 174.067 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' C' C ' 135' ' ' GLU . . . . . . . . . . . . . 80.4 tt0 -49.75 -23.0 1.58 Allowed 'General case' 0 C--N 1.327 -0.403 0 N-CA-C 113.055 0.761 . . . . 0.0 113.055 -171.356 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' C' C ' 136' ' ' GLN . . . . . . . . . . . . . 44.6 tt0 -105.0 -22.56 13.1 Favored 'General case' 0 N--CA 1.465 0.294 0 N-CA-C 113.075 0.769 . . . . 0.0 113.075 -174.976 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' C' C ' 137' ' ' LYS . . . . . . . . . . . . . 78.4 mttt -145.37 153.09 40.85 Favored 'General case' 0 C--N 1.333 -0.143 0 CA-C-O 121.538 0.685 . . . . 0.0 112.22 -172.342 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' C' C ' 138' ' ' LEU . . . . . . . . . . . . . 14.6 tp -115.2 122.16 45.18 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 115.064 -0.971 . . . . 0.0 109.237 173.743 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' C' C ' 139' ' ' THR . . . . . . . . . . . . . 24.4 m -111.79 126.5 55.14 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-O 120.584 0.23 . . . . 0.0 111.011 -177.817 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' C' C ' 140' ' ' LEU . . . . . 0.496 HD12 HG22 ' C' ' 131' ' ' VAL . 15.0 tp -117.84 122.5 43.54 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 115.796 -0.638 . . . . 0.0 109.387 -178.976 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' C' C ' 141' ' ' ILE . . . . . . . . . . . . . 19.1 mt -121.7 123.05 68.51 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.252 0 CA-C-O 120.853 0.359 . . . . 0.0 110.127 -176.317 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' C' C ' 142' ' ' ARG . . . . . . . . . . . . . 84.2 mtp180 . . . . . 0 C--N 1.329 -0.293 0 CA-C-N 115.521 -0.763 . . . . 0.0 110.536 -178.696 . . . . . . . . 0 0 . 1 . 007 nuclear nobuild core ' D' D ' 2' ' ' SER . . . . . . . . . . . . . 1.8 p . . . . . 0 C--O 1.231 0.119 0 CA-C-O 120.863 0.363 . . . . 0.0 110.178 . . . . . . . . . 0 0 . 1 . 007 nuclear nobuild core ' D' D ' 3' ' ' GLU . . . . . . . . . . . . . 93.3 mt-10 -139.99 143.17 36.34 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-N 116.042 -0.526 . . . . 0.0 111.403 -175.819 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' D' D ' 4' ' ' LEU . . . . . . . . . . . . . 20.9 tp -126.53 129.52 48.77 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 115.776 -0.647 . . . . 0.0 109.751 175.49 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' D' D ' 5' ' ' LYS . . . . . . . . . . . . . 99.7 mttt -113.43 122.43 47.3 Favored 'General case' 0 C--O 1.235 0.336 0 CA-C-N 116.581 -0.281 . . . . 0.0 111.069 -178.624 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' D' D ' 6' ' ' LEU . . . . . . . . . . . . . 43.7 mt -114.0 143.34 44.91 Favored 'General case' 0 C--N 1.332 -0.19 0 CA-C-N 115.49 -0.777 . . . . 0.0 110.202 -179.958 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' D' D ' 7' ' ' LYS . . . . . . . . . . . . . 31.3 ttpt -125.88 138.57 32.32 Favored Pre-proline 0 CA--C 1.534 0.346 0 CA-C-O 118.917 -0.564 . . . . 0.0 109.637 175.601 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' D' D ' 8' ' ' PRO . . . . . . . . . . . . . 85.9 Cg_endo -91.14 135.22 1.8 Allowed 'Trans proline' 0 N--CA 1.489 1.23 0 C-N-CA 121.71 1.607 . . . . 0.0 112.049 179.537 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' D' D ' 9' ' ' LEU . . . . . . . . . . . . . 35.3 mt -73.81 -46.78 6.91 Favored Pre-proline 0 C--N 1.329 -0.313 0 CA-C-O 118.715 -0.66 . . . . 0.0 111.865 179.527 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' D' D ' 10' ' ' PRO . . . . . . . . . . . . . 89.4 Cg_endo -81.77 153.17 17.32 Favored 'Trans proline' 0 N--CA 1.495 1.588 0 C-N-CA 121.179 1.253 . . . . 0.0 111.574 174.71 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' D' D ' 11' ' ' LYS . . . . . . . . . . . . . 62.7 tttm -87.6 99.08 11.78 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-O 120.893 0.378 . . . . 0.0 110.443 178.863 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' D' D ' 12' ' ' VAL . . . . . . . . . . . . . 12.2 p -140.47 145.46 25.8 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.293 0 CA-C-N 116.108 -0.496 . . . . 0.0 110.352 179.971 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' D' D ' 13' ' ' GLU . . . . . . . . . . . . . 84.6 tt0 -90.1 125.45 35.43 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.317 -0.401 . . . . 0.0 110.029 178.588 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' D' D ' 14' ' ' LEU . . . . . 0.407 HD22 ' CD1' ' D' ' 18' ' ' PHE . 21.1 mt -96.77 151.17 37.7 Favored Pre-proline 0 C--N 1.329 -0.309 0 CA-C-N 116.404 -0.362 . . . . 0.0 110.692 -177.669 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' D' D ' 15' ' ' PRO . . . . . . . . . . . . . 26.7 Cg_exo -61.61 157.38 42.29 Favored 'Trans proline' 0 N--CA 1.497 1.697 0 C-N-CA 121.225 1.283 . . . . 0.0 111.669 176.812 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' D' D ' 16' ' ' PRO . . . . . . . . . . . . . 37.2 Cg_exo -57.59 -36.21 98.63 Favored 'Trans proline' 0 N--CA 1.496 1.66 0 C-N-CA 121.461 1.441 . . . . 0.0 112.981 -177.466 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' D' D ' 17' ' ' ASP . . . . . . . . . . . . . 22.4 p-10 -92.03 9.06 34.86 Favored 'General case' 0 CA--C 1.535 0.403 0 N-CA-C 113.418 0.896 . . . . 0.0 113.418 -175.988 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' D' D ' 18' ' ' PHE . . . . . 0.407 ' CD1' HD22 ' D' ' 14' ' ' LEU . 62.4 t80 -57.09 -47.61 80.63 Favored 'General case' 0 C--N 1.333 -0.145 0 O-C-N 121.837 -0.539 . . . . 0.0 110.483 -177.585 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' D' D ' 19' ' ' VAL . . . . . . . . . . . . . 44.3 t -55.57 -51.0 62.7 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.382 0 CA-C-N 116.281 -0.418 . . . . 0.0 111.235 -174.429 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' D' D ' 20' ' ' ASP . . . . . . . . . . . . . 2.3 p-10 -59.33 -37.27 77.39 Favored 'General case' 0 N--CA 1.464 0.228 0 C-N-CA 120.381 -0.527 . . . . 0.0 111.252 -176.32 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' D' D ' 21' ' ' VAL . . . . . . . . . . . . . 59.7 t -63.0 -45.15 99.61 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.266 0 C-N-CA 120.314 -0.555 . . . . 0.0 110.191 179.885 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' D' D ' 22' ' ' ILE . . . . . 0.534 HG22 HD12 ' D' ' 26' ' ' LEU . 46.1 mm -57.39 -39.46 68.45 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.317 0 C-N-CA 120.961 -0.296 . . . . 0.0 110.475 178.36 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' D' D ' 23' ' ' ARG . . . . . . . . . . . . . 55.5 ttp180 -57.26 -49.97 74.38 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-O 121.057 0.456 . . . . 0.0 110.437 176.751 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' D' D ' 24' ' ' ILE . . . . . . . . . . . . . 76.6 mt -60.0 -38.89 78.56 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.34 0 CA-C-N 116.028 -0.533 . . . . 0.0 111.858 -176.884 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' D' D ' 25' ' ' LYS . . . . . . . . . . . . . 25.9 pttt -76.64 -40.82 47.97 Favored 'General case' 0 CA--C 1.534 0.36 0 C-N-CA 120.343 -0.543 . . . . 0.0 112.112 -174.426 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' D' D ' 26' ' ' LEU . . . . . 0.534 HD12 HG22 ' D' ' 22' ' ' ILE . 14.7 mt -79.35 -28.39 42.0 Favored 'General case' 0 CA--C 1.53 0.211 0 N-CA-C 113.172 0.804 . . . . 0.0 113.172 -171.828 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' D' D ' 27' ' ' GLN . . . . . . . . . . . . . 10.2 pt20 -46.37 141.68 3.4 Favored 'General case' 0 N--CA 1.471 0.589 0 N-CA-C 112.931 0.715 . . . . 0.0 112.931 -175.518 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' D' D ' 28' ' ' GLY . . . . . . . . . . . . . . . 100.36 -25.85 26.74 Favored Glycine 0 CA--C 1.532 1.117 0 CA-C-N 115.58 -0.736 . . . . 0.0 112.189 -176.55 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' D' D ' 29' ' ' LYS . . . . . . . . . . . . . 53.2 mttm -97.65 155.13 17.13 Favored 'General case' 0 C--N 1.332 -0.162 0 CA-C-N 117.422 0.611 . . . . 0.0 110.854 178.45 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' D' D ' 30' ' ' THR . . . . . . . . . . . . . 33.4 m -106.19 140.64 38.83 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.235 -0.438 . . . . 0.0 110.24 176.946 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' D' D ' 31' ' ' VAL . . . . . . . . . . . . . 35.0 m -127.82 155.03 39.03 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.198 0 CA-C-O 120.819 0.342 . . . . 0.0 110.875 -178.581 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' D' D ' 32' ' ' ARG . . . . . . . . . . . . . 43.6 mtp180 -133.31 152.57 51.93 Favored 'General case' 0 C--N 1.331 -0.203 0 CA-C-N 115.854 -0.612 . . . . 0.0 110.675 177.719 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' D' D ' 33' ' ' THR . . . . . . . . . . . . . 18.8 m -53.46 139.14 31.72 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.034 -0.53 . . . . 0.0 111.387 -179.256 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' D' D ' 34' ' ' GLY . . . . . . . . . . . . . . . 99.84 -17.2 57.69 Favored Glycine 0 CA--C 1.533 1.202 0 C-N-CA 121.123 -0.56 . . . . 0.0 113.284 178.13 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' D' D ' 35' ' ' ASP . . . . . . . . . . . . . 77.3 m-20 -66.12 147.79 52.8 Favored 'General case' 0 C--O 1.231 0.112 0 CA-C-N 118.053 0.927 . . . . 0.0 111.064 179.444 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' D' D ' 36' ' ' VAL . . . . . . . . . . . . . 45.0 t -122.23 129.61 75.19 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.241 0 CA-C-N 115.933 -0.576 . . . . 0.0 109.751 177.775 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' D' D ' 37' ' ' ILE . . . . . . . . . . . . . 63.9 mt -120.14 137.91 52.44 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.254 0 CA-C-N 116.289 -0.414 . . . . 0.0 110.031 -179.381 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' D' D ' 38' ' ' GLY . . . . . . . . . . . . . . . -112.65 127.72 8.12 Favored Glycine 0 CA--C 1.526 0.746 0 N-CA-C 110.828 -0.909 . . . . 0.0 110.828 178.557 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' D' D ' 39' ' ' ILE . . . . . . . . . . . . . 70.8 mt -124.76 131.0 73.24 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.282 0 N-CA-C 110.113 -0.329 . . . . 0.0 110.113 179.58 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' D' D ' 40' ' ' SER . . . . . . . . . . . . . 53.1 p -91.94 123.05 35.02 Favored 'General case' 0 C--N 1.331 -0.2 0 CA-C-N 116.292 -0.413 . . . . 0.0 110.928 177.555 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' D' D ' 41' ' ' ILE . . . . . . . . . . . . . 72.9 mt -132.34 122.43 48.03 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.229 0 CA-C-N 116.469 -0.332 . . . . 0.0 110.344 177.756 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' D' D ' 42' ' ' LEU . . . . . . . . . . . . . 52.9 mt 53.87 35.9 22.84 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.161 -0.472 . . . . 0.0 111.742 176.821 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' D' D ' 43' ' ' GLY . . . . . . . . . . . . . . . 72.85 28.03 67.75 Favored Glycine 0 CA--C 1.53 1.031 0 C-N-CA 121.171 -0.537 . . . . 0.0 112.457 177.241 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' D' D ' 44' ' ' LYS . . . . . . . . . . . . . 48.7 mtmt -138.12 128.24 25.8 Favored 'General case' 0 C--N 1.331 -0.206 0 N-CA-C 109.778 -0.453 . . . . 0.0 109.778 177.77 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' D' D ' 45' ' ' GLU . . . . . . . . . . . . . 84.5 tt0 -84.62 125.92 32.89 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.515 -0.311 . . . . 0.0 111.444 -177.939 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' D' D ' 46' ' ' VAL . . . . . 0.417 HG13 ' O ' ' D' ' 46' ' ' VAL . 8.9 p -118.58 124.39 73.06 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.23 0 N-CA-C 109.22 -0.659 . . . . 0.0 109.22 173.553 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' D' D ' 47' ' ' LYS . . . . . . . . . . . . . 91.8 mttt -98.96 124.86 44.21 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 116.087 -0.506 . . . . 0.0 110.845 178.362 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' D' D ' 48' ' ' PHE . . . . . . . . . . . . . 31.7 m-85 -108.03 131.86 54.15 Favored 'General case' 0 C--N 1.329 -0.32 0 N-CA-C 109.626 -0.509 . . . . 0.0 109.626 176.812 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' D' D ' 49' ' ' LYS . . . . . . . . . . . . . 82.2 tttt -106.79 132.08 53.17 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.246 -0.434 . . . . 0.0 110.123 178.718 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' D' D ' 50' ' ' VAL . . . . . . . . . . . . . 45.7 t -75.65 105.02 4.24 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.323 0 N-CA-C 109.257 -0.645 . . . . 0.0 109.257 177.5 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' D' D ' 51' ' ' VAL . . . . . . . . . . . . . 47.7 t -71.61 -51.43 32.7 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.273 0 CA-C-N 116.04 -0.527 . . . . 0.0 109.774 -174.687 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' D' D ' 52' ' ' GLN . . . . . . . . . . . . . 55.0 mt-30 -155.35 147.48 23.62 Favored 'General case' 0 C--N 1.33 -0.256 0 C-N-CA 120.343 -0.543 . . . . 0.0 111.789 -177.862 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' D' D ' 53' ' ' ALA . . . . . . . . . . . . . . . -124.47 130.8 53.14 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 115.291 -0.868 . . . . 0.0 109.51 173.909 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' D' D ' 54' ' ' TYR . . . . . . . . . . . . . 16.0 t80 -128.97 108.19 18.19 Favored Pre-proline 0 CA--C 1.534 0.341 0 CA-C-O 118.272 -0.871 . . . . 0.0 110.458 -179.465 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' D' D ' 55' ' ' PRO . . . . . . . . . . . . . 74.2 Cg_endo -77.16 170.0 72.71 Favored 'Cis proline' 0 N--CA 1.499 1.845 0 CA-C-N 121.86 1.7 . . . . 0.0 112.422 -5.915 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' D' D ' 56' ' ' SER . . . . . . . . . . . . . 19.6 m -116.85 133.19 23.1 Favored Pre-proline 0 CA--C 1.539 0.533 0 CA-C-O 118.465 -0.778 . . . . 0.0 109.487 174.826 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' D' D ' 57' ' ' PRO . . . . . . . . . . . . . 49.0 Cg_endo -69.91 164.18 80.32 Favored 'Cis proline' 0 N--CA 1.497 1.726 0 CA-C-N 121.848 1.696 . . . . 0.0 111.485 -1.898 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' D' D ' 58' ' ' LEU . . . . . . . . . . . . . 37.4 tp -130.23 138.05 50.35 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-O 120.886 0.374 . . . . 0.0 110.589 -179.355 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' D' D ' 59' ' ' ARG . . . . . . . . . . . . . 30.1 ttm180 -99.66 132.51 44.96 Favored 'General case' 0 C--N 1.327 -0.396 0 CA-C-N 115.85 -0.614 . . . . 0.0 109.617 176.236 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' D' D ' 60' ' ' VAL . . . . . . . . . . . . . 42.9 t -82.34 114.79 23.78 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.259 0 C-N-CA 120.787 -0.365 . . . . 0.0 110.238 -178.092 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' D' D ' 61' ' ' GLU . . . . . . . . . . . . . 96.0 mt-10 -131.19 169.43 15.93 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.079 -0.51 . . . . 0.0 109.928 176.709 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' D' D ' 62' ' ' ASP . . . . . . . . . . . . . 10.1 p-10 -55.26 -32.58 62.45 Favored 'General case' 0 C--N 1.329 -0.3 0 C-N-CA 120.904 -0.319 . . . . 0.0 111.572 178.716 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' D' D ' 63' ' ' ARG . . . . . . . . . . . . . 16.8 ptp180 -82.51 7.66 13.82 Favored 'General case' 0 CA--C 1.536 0.407 0 N-CA-C 113.504 0.927 . . . . 0.0 113.504 -176.743 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' D' D ' 64' ' ' THR . . . . . . . . . . . . . 28.5 m -91.65 134.31 34.81 Favored 'General case' 0 C--N 1.333 -0.133 0 CA-C-N 118.167 0.439 . . . . 0.0 110.618 -179.385 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' D' D ' 65' ' ' LYS . . . . . . . . . . . . . 23.0 mtpp -89.86 127.6 36.03 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.034 -0.53 . . . . 0.0 110.268 179.589 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' D' D ' 66' ' ' ILE . . . . . . . . . . . . . 65.0 mt -117.35 132.84 65.97 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.25 0 CA-C-O 120.805 0.336 . . . . 0.0 110.291 -178.327 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' D' D ' 67' ' ' THR . . . . . . . . . . . . . 23.1 m -128.7 144.19 51.1 Favored 'General case' 0 N--CA 1.463 0.217 0 CA-C-N 116.094 -0.503 . . . . 0.0 110.941 -179.139 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' D' D ' 68' ' ' LEU . . . . . . . . . . . . . 15.8 tp . . . . . 0 C--N 1.331 -0.225 0 CA-C-N 115.916 -0.584 . . . . 0.0 110.622 179.348 . . . . . . . . 0 0 . 1 . 007 nuclear nobuild core ' D' D ' 73' ' ' VAL . . . . . . . . . . . . . 34.7 m . . . . . 0 CA--C 1.528 0.113 0 N-CA-C 109.801 -0.444 . . . . 0.0 109.801 . . . . . . . . . 0 0 . 1 . 007 nuclear nobuild core ' D' D ' 74' ' ' ASP . . . . . . . . . . . . . 13.7 t70 -97.75 116.88 30.83 Favored 'General case' 0 C--N 1.33 -0.259 0 C-N-CA 120.86 -0.336 . . . . 0.0 110.149 -177.257 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' D' D ' 75' ' ' VAL . . . . . . . . . . . . . 45.3 t -112.76 122.09 66.27 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.212 0 CA-C-O 121.086 0.469 . . . . 0.0 110.218 -178.617 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' D' D ' 76' ' ' LEU . . . . . . . . . . . . . 29.7 mt -126.78 143.2 51.32 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 115.623 -0.717 . . . . 0.0 109.433 179.28 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' D' D ' 77' ' ' GLU . . . . . . . . . . . . . 39.4 tt0 -138.44 138.97 38.67 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-O 121.052 0.453 . . . . 0.0 111.228 -177.156 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' D' D ' 78' ' ' ALA . . . . . . . . . . . . . . . -122.94 142.01 51.29 Favored 'General case' 0 C--N 1.331 -0.239 0 CA-C-N 115.881 -0.6 . . . . 0.0 110.063 177.613 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' D' D ' 79' ' ' LYS . . . . . 0.639 ' O ' HD13 ' D' ' 80' ' ' ILE . 84.4 tttt -84.7 119.2 24.98 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-O 120.743 0.306 . . . . 0.0 110.741 -178.263 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' D' D ' 80' ' ' ILE . . . . . 0.639 HD13 ' O ' ' D' ' 79' ' ' LYS . 38.2 mm -139.13 113.33 7.27 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.283 0 N-CA-C 109.763 -0.458 . . . . 0.0 109.763 -178.302 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' D' D ' 81' ' ' LYS . . . . . . . . . . . . . 39.2 tptt -105.12 125.56 51.11 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-O 120.734 0.302 . . . . 0.0 110.814 -178.275 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' D' D ' 82' ' ' GLY . . . . . . . . . . . . . . . 89.16 42.16 5.66 Favored Glycine 0 CA--C 1.526 0.726 0 C-N-CA 120.83 -0.7 . . . . 0.0 111.473 174.986 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' D' D ' 83' ' ' ILE . . . . . . . . . . . . . 71.5 mt -67.92 137.02 25.41 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.286 0 N-CA-C 109.897 -0.408 . . . . 0.0 109.897 177.78 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' D' D ' 84' ' ' LYS . . . . . . . . . . . . . 42.8 tttp -95.11 -52.31 4.26 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 116.139 -0.482 . . . . 0.0 110.075 -179.63 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' D' D ' 85' ' ' ASP . . . . . . . . . . . . . 10.9 t70 -158.48 154.32 26.6 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 115.694 -0.685 . . . . 0.0 110.252 178.632 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' D' D ' 86' ' ' VAL . . . . . . . . . . . . . 43.3 t -130.11 132.86 65.05 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.223 0 CA-C-O 120.935 0.398 . . . . 0.0 110.563 -178.939 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' D' D ' 87' ' ' ILE . . . . . 0.492 HD12 ' N ' ' D' ' 87' ' ' ILE . 5.0 mp -120.48 128.37 76.0 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.272 0 CA-C-N 115.851 -0.613 . . . . 0.0 109.516 176.752 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' D' D ' 88' ' ' LEU . . . . . . . . . . . . . 16.6 tp -114.17 134.46 54.89 Favored 'General case' 0 C--N 1.331 -0.218 0 CA-C-O 121.066 0.46 . . . . 0.0 110.949 -177.652 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' D' D ' 89' ' ' ASP . . . . . . . . . . . . . 7.6 t70 -130.49 160.93 32.62 Favored 'General case' 0 C--N 1.332 -0.187 0 CA-C-N 115.849 -0.614 . . . . 0.0 109.734 177.046 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' D' D ' 90' ' ' GLU . . . . . . . . . . . . . 71.0 mm-40 -46.63 -40.11 12.45 Favored 'General case' 0 C--N 1.329 -0.289 0 N-CA-C 113.117 0.784 . . . . 0.0 113.117 -171.517 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' D' D ' 91' ' ' ASN . . . . . . . . . . . . . 82.4 m-20 -132.04 25.44 4.59 Favored 'General case' 0 N--CA 1.467 0.403 0 N-CA-C 112.665 0.617 . . . . 0.0 112.665 -177.015 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' D' D ' 92' ' ' LEU . . . . . . . . . . . . . 18.1 mt -149.76 143.36 25.36 Favored 'General case' 0 C--N 1.331 -0.223 0 CA-C-O 120.622 0.249 . . . . 0.0 110.382 -177.361 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' D' D ' 93' ' ' ILE . . . . . . . . . . . . . 73.4 mt -126.19 115.1 41.39 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.345 0 N-CA-C 109.19 -0.67 . . . . 0.0 109.19 176.022 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' D' D ' 94' ' ' VAL . . . . . 0.623 HG21 HG11 ' D' ' 125' ' ' VAL . 45.1 t -117.82 126.4 74.79 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.267 0 CA-C-O 120.878 0.371 . . . . 0.0 110.049 -177.857 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' D' D ' 95' ' ' VAL . . . . . . . . . . . . . 43.4 t -120.63 134.01 65.46 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 CA-C-N 115.918 -0.583 . . . . 0.0 109.824 179.978 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' D' D ' 96' ' ' ILE . . . . . 0.459 HD11 ' HB ' ' D' ' 123' ' ' VAL . 63.3 mt -112.58 126.88 70.03 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 N-CA-C 108.951 -0.759 . . . . 0.0 108.951 178.466 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' D' D ' 97' ' ' THR . . . . . . . . . . . . . 81.7 p -99.34 156.95 16.73 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-O 121.21 0.529 . . . . 0.0 111.154 -177.036 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' D' D ' 98' ' ' GLU . . . . . . . . . . . . . 45.9 tp10 -53.85 -27.61 30.9 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.193 -0.458 . . . . 0.0 112.182 -179.529 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' D' D ' 99' ' ' GLU . . . . . . . . . . . . . 40.8 tt0 -79.78 16.31 1.17 Allowed 'General case' 0 CA--C 1.538 0.517 0 N-CA-C 112.666 0.617 . . . . 0.0 112.666 -176.808 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' D' D ' 100' ' ' ASN . . . . . . . . . . . . . 4.2 m-20 61.24 34.37 18.74 Favored 'General case' 0 CA--C 1.531 0.245 0 O-C-N 121.749 -0.595 . . . . 0.0 111.399 177.828 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' D' D ' 101' ' ' GLU . . . . . . . . . . . . . 84.9 tt0 -111.79 145.65 39.02 Favored 'General case' 0 C--N 1.331 -0.2 0 N-CA-C 109.594 -0.521 . . . . 0.0 109.594 173.604 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' D' D ' 102' ' ' VAL . . . . . . . . . . . . . 45.5 t -114.93 125.98 72.39 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.356 0 CA-C-N 116.275 -0.421 . . . . 0.0 110.125 -177.502 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' D' D ' 103' ' ' LEU . . . . . . . . . . . . . 29.8 mt -117.55 128.28 54.81 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 115.794 -0.639 . . . . 0.0 110.232 177.441 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' D' D ' 104' ' ' ILE . . . . . . . . . . . . . 67.3 mt -119.45 122.18 68.3 Favored 'Isoleucine or valine' 0 C--O 1.235 0.299 0 N-CA-C 110.403 -0.221 . . . . 0.0 110.403 -179.612 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' D' D ' 105' ' ' PHE . . . . . . . . . . . . . 62.4 m-85 -120.78 165.16 15.53 Favored 'General case' 0 C--O 1.232 0.147 0 O-C-N 123.95 0.781 . . . . 0.0 109.804 179.126 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' D' D ' 106' ' ' ASN . . . . . . . . . . . . . 43.3 p-10 -99.56 -170.1 1.85 Allowed 'General case' 0 C--N 1.33 -0.249 0 N-CA-C 109.78 -0.452 . . . . 0.0 109.78 172.708 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' D' D ' 107' ' ' GLN . . . . . . . . . . . . . 50.9 tt0 -57.65 -29.79 64.88 Favored 'General case' 0 C--N 1.328 -0.337 0 N-CA-C 112.033 0.383 . . . . 0.0 112.033 179.707 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' D' D ' 108' ' ' ASN . . . . . . . . . . . . . 15.1 t-20 -88.07 13.43 11.18 Favored 'General case' 0 CA--C 1.535 0.386 0 N-CA-C 112.917 0.71 . . . . 0.0 112.917 -176.215 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' D' D ' 109' ' ' LEU . . . . . . . . . . . . . 29.4 mt 57.64 34.81 24.97 Favored 'General case' 0 CA--C 1.53 0.182 0 O-C-N 122.108 -0.37 . . . . 0.0 111.661 177.98 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' D' D ' 110' ' ' GLU . . . . . . . . . . . . . 43.3 mt-10 -101.3 153.99 19.17 Favored 'General case' 0 C--N 1.331 -0.235 0 N-CA-C 109.984 -0.376 . . . . 0.0 109.984 176.991 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' D' D ' 111' ' ' GLU . . . . . . . . . . . . . 80.6 tt0 -82.7 121.96 27.54 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.383 -0.371 . . . . 0.0 110.589 -178.246 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' D' D ' 112' ' ' LEU . . . . . . . . . . . . . 25.5 mt -110.92 -46.05 3.39 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 116.293 -0.412 . . . . 0.0 110.444 178.354 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' D' D ' 113' ' ' TYR . . . . . . . . . . . . . 46.8 t80 -137.93 136.3 36.89 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-O 120.839 0.352 . . . . 0.0 111.061 -179.679 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' D' D ' 114' ' ' ARG . . . . . . . . . . . . . 60.1 ttt180 -138.01 121.45 17.17 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 115.931 -0.577 . . . . 0.0 110.257 177.034 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' D' D ' 115' ' ' GLY . . . . . . . . . . . . . . . -150.07 162.44 29.19 Favored Glycine 0 CA--C 1.525 0.677 0 N-CA-C 110.977 -0.849 . . . . 0.0 110.977 179.506 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' D' D ' 116' ' ' LYS . . . . . . . . . . . . . 70.3 tttt -136.72 137.5 40.0 Favored 'General case' 0 C--N 1.328 -0.36 0 N-CA-C 110.124 -0.324 . . . . 0.0 110.124 178.762 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' D' D ' 117' ' ' PHE . . . . . . . . . . . . . 26.3 m-85 -135.61 117.59 15.29 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 116.403 -0.362 . . . . 0.0 110.198 -176.135 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' D' D ' 118' ' ' GLU . . . . . . . . . . . . . 96.0 mt-10 -54.17 -44.96 71.94 Favored 'General case' 0 C--N 1.33 -0.27 0 C-N-CA 120.937 -0.305 . . . . 0.0 111.392 -176.316 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' D' D ' 119' ' ' ASN . . . . . . . . . . . . . 3.2 m-20 -97.78 31.04 2.75 Favored 'General case' 0 C--N 1.329 -0.317 0 N-CA-C 112.143 0.423 . . . . 0.0 112.143 -174.838 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' D' D ' 120' ' ' LEU . . . . . . . . . . . . . 20.3 tp -56.48 122.61 12.35 Favored 'General case' 0 C--O 1.233 0.197 0 CA-C-O 120.587 0.232 . . . . 0.0 110.407 178.01 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' D' D ' 121' ' ' ASN . . . . . . . . . . . . . 53.4 m-20 -114.11 -44.13 3.17 Favored 'General case' 0 C--N 1.332 -0.18 0 CA-C-N 116.707 -0.224 . . . . 0.0 111.394 -176.325 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' D' D ' 122' ' ' LYS . . . . . . . . . . . . . 26.1 ttmt -149.97 147.52 27.97 Favored 'General case' 0 C--N 1.332 -0.177 0 C-N-CA 120.417 -0.513 . . . . 0.0 111.563 -176.312 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' D' D ' 123' ' ' VAL . . . . . 0.459 ' HB ' HD11 ' D' ' 96' ' ' ILE . 43.9 t -126.73 134.35 66.45 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.181 0 CA-C-N 116.038 -0.528 . . . . 0.0 109.731 177.742 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' D' D ' 124' ' ' LEU . . . . . . . . . . . . . 65.7 mt -130.08 142.7 50.58 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-O 120.809 0.338 . . . . 0.0 110.986 -178.275 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' D' D ' 125' ' ' VAL . . . . . 0.623 HG11 HG21 ' D' ' 94' ' ' VAL . 35.1 m -132.79 140.25 47.84 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.243 0 CA-C-N 116.26 -0.427 . . . . 0.0 110.569 178.416 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' D' D ' 126' ' ' ARG . . . . . . . . . . . . . 95.3 mtt-85 -144.26 119.09 9.89 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.443 -0.344 . . . . 0.0 110.617 178.74 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' D' D ' 127' ' ' ASN . . . . . . . . . . . . . 84.9 m-20 51.36 -104.98 0.19 Allowed 'General case' 0 CA--C 1.543 0.697 0 CA-C-O 119.095 -0.479 . . . . 0.0 111.334 179.707 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' D' D ' 128' ' ' ASP . . . . . . . . . . . . . 18.9 p-10 -114.19 1.35 14.51 Favored 'General case' 0 N--CA 1.468 0.442 0 CA-C-N 119.548 1.067 . . . . 0.0 113.371 -177.794 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' D' D ' 129' ' ' LEU . . . . . . . . . . . . . 58.8 mt -104.96 144.84 31.24 Favored 'General case' 0 C--N 1.334 -0.108 0 O-C-N 121.961 -0.462 . . . . 0.0 110.246 179.881 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' D' D ' 130' ' ' VAL . . . . . . . . . . . . . 42.4 t -124.48 139.56 50.38 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.214 0 CA-C-N 116.375 -0.375 . . . . 0.0 110.009 -178.107 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' D' D ' 131' ' ' VAL . . . . . 0.516 HG22 HD12 ' D' ' 140' ' ' LEU . 42.6 t -134.55 135.37 53.8 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.24 0 CA-C-O 121.065 0.459 . . . . 0.0 110.271 179.275 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' D' D ' 132' ' ' ILE . . . . . . . . . . . . . 73.2 mt -118.47 130.82 72.77 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.282 0 CA-C-N 115.657 -0.701 . . . . 0.0 109.354 179.068 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' D' D ' 133' ' ' ILE . . . . . 0.412 HG21 HG21 ' E' ' 86' ' ' VAL . 43.1 mm -115.83 121.95 68.45 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.249 0 CA-C-O 120.975 0.417 . . . . 0.0 110.912 -175.992 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' D' D ' 134' ' ' ASP . . . . . . . . . . . . . 7.2 p-10 -133.43 146.08 50.86 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 115.826 -0.625 . . . . 0.0 109.507 174.615 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' D' D ' 135' ' ' GLU . . . . . . . . . . . . . 85.9 tt0 -49.8 -23.02 1.64 Allowed 'General case' 0 C--N 1.328 -0.36 0 N-CA-C 113.022 0.749 . . . . 0.0 113.022 -171.573 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' D' D ' 136' ' ' GLN . . . . . . . . . . . . . 50.2 tt0 -100.18 -31.57 11.33 Favored 'General case' 0 N--CA 1.462 0.175 0 N-CA-C 112.342 0.497 . . . . 0.0 112.342 -176.07 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' D' D ' 137' ' ' LYS . . . . . . . . . . . . . 88.4 mttt -140.45 153.11 46.16 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-O 121.288 0.566 . . . . 0.0 111.644 -171.057 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' D' D ' 138' ' ' LEU . . . . . 0.418 ' C ' HD23 ' D' ' 138' ' ' LEU . 5.5 tt -116.87 120.52 38.72 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 115.488 -0.778 . . . . 0.0 109.017 171.733 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' D' D ' 139' ' ' THR . . . . . . . . . . . . . 30.5 m -108.38 128.11 54.48 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 116.322 -0.399 . . . . 0.0 110.744 -176.451 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' D' D ' 140' ' ' LEU . . . . . 0.516 HD12 HG22 ' D' ' 131' ' ' VAL . 14.0 tp -117.54 122.6 44.1 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 115.619 -0.719 . . . . 0.0 109.354 -178.811 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' D' D ' 141' ' ' ILE . . . . . . . . . . . . . 19.1 mt -120.92 119.64 60.02 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.274 0 N-CA-C 109.964 -0.384 . . . . 0.0 109.964 -175.404 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' D' D ' 142' ' ' ARG . . . . . . . . . . . . . 74.3 mtm180 -106.93 131.31 54.15 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 115.782 -0.645 . . . . 0.0 110.481 -178.318 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' D' D ' 143' ' ' THR . . . . . . . . . . . . . 44.6 p . . . . . 0 C--O 1.22 -0.466 0 CA-C-O 117.984 -1.008 . . . . 0.0 110.591 179.798 . . . . . . . . 0 0 . 1 . 007 nuclear nobuild core ' E' E ' 2' ' ' SER . . . . . . . . . . . . . 98.5 p . . . . . 0 C--O 1.232 0.155 0 CA-C-O 120.952 0.406 . . . . 0.0 110.664 . . . . . . . . . 0 0 . 1 . 007 nuclear nobuild core ' E' E ' 3' ' ' GLU . . . . . . . . . . . . . 85.0 tt0 -140.33 144.73 36.48 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.107 -0.497 . . . . 0.0 111.109 -178.025 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' E' E ' 4' ' ' LEU . . . . . . . . . . . . . 16.3 tp -127.56 134.59 49.72 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 115.852 -0.613 . . . . 0.0 110.131 177.426 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' E' E ' 5' ' ' LYS . . . . . . . . . . . . . 68.9 mttm -115.23 122.67 46.7 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.635 -0.257 . . . . 0.0 110.997 -178.808 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' E' E ' 6' ' ' LEU . . . . . 0.429 HD23 ' HA ' ' E' ' 50' ' ' VAL . 58.5 mt -114.34 142.52 46.21 Favored 'General case' 0 N--CA 1.462 0.163 0 CA-C-N 115.564 -0.744 . . . . 0.0 110.095 178.601 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' E' E ' 7' ' ' LYS . . . . . . . . . . . . . 79.3 tttt -122.49 136.19 26.33 Favored Pre-proline 0 CA--C 1.534 0.348 0 CA-C-O 118.775 -0.631 . . . . 0.0 109.781 176.634 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' E' E ' 8' ' ' PRO . . . . . . . . . . . . . 89.4 Cg_endo -91.36 131.49 1.38 Allowed 'Trans proline' 0 N--CA 1.49 1.279 0 C-N-CA 121.741 1.627 . . . . 0.0 111.705 178.089 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' E' E ' 9' ' ' LEU . . . . . 0.406 HD12 ' HB2' ' E' ' 47' ' ' LYS . 59.4 mt -72.01 -47.86 11.11 Favored Pre-proline 0 CA--C 1.534 0.335 0 CA-C-O 118.563 -0.732 . . . . 0.0 112.286 -178.642 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' E' E ' 10' ' ' PRO . . . . . . . . . . . . . 95.1 Cg_endo -79.61 152.37 22.81 Favored 'Trans proline' 0 N--CA 1.497 1.713 0 C-N-CA 121.166 1.244 . . . . 0.0 111.916 177.145 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' E' E ' 11' ' ' LYS . . . . . . . . . . . . . 97.7 mttt -83.86 91.92 7.67 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.366 -0.379 . . . . 0.0 110.262 178.34 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' E' E ' 12' ' ' VAL . . . . . . . . . . . . . 12.2 p -139.0 145.15 28.05 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.257 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.476 -178.931 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' E' E ' 13' ' ' GLU . . . . . . . . . . . . . 44.6 mp0 -91.6 125.93 36.51 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.235 -0.439 . . . . 0.0 110.179 178.671 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' E' E ' 14' ' ' LEU . . . . . . . . . . . . . 20.8 mt -97.93 149.99 36.29 Favored Pre-proline 0 CA--C 1.532 0.287 0 CA-C-O 119.331 -0.366 . . . . 0.0 110.562 -178.843 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' E' E ' 15' ' ' PRO . . . . . . . . . . . . . 27.4 Cg_exo -61.02 158.74 32.76 Favored 'Trans proline' 0 N--CA 1.496 1.675 0 C-N-CA 121.317 1.345 . . . . 0.0 111.943 177.979 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' E' E ' 16' ' ' PRO . . . . . . . . . . . . . 29.8 Cg_exo -59.68 -34.85 96.15 Favored 'Trans proline' 0 N--CA 1.496 1.675 0 C-N-CA 121.403 1.402 . . . . 0.0 112.76 -178.938 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' E' E ' 17' ' ' ASP . . . . . . . . . . . . . 8.3 p-10 -85.03 4.73 32.49 Favored 'General case' 0 C--N 1.327 -0.401 0 N-CA-C 113.322 0.86 . . . . 0.0 113.322 -177.497 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' E' E ' 18' ' ' PHE . . . . . . . . . . . . . 44.0 t80 -57.95 -44.85 87.24 Favored 'General case' 0 N--CA 1.457 -0.091 0 O-C-N 121.836 -0.54 . . . . 0.0 110.187 -178.315 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' E' E ' 19' ' ' VAL . . . . . . . . . . . . . 46.6 t -56.78 -44.99 82.88 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 CA-C-N 116.152 -0.476 . . . . 0.0 110.544 -178.304 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' E' E ' 20' ' ' ASP . . . . . . . . . . . . . 80.1 m-20 -59.54 -41.9 91.12 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-O 120.772 0.32 . . . . 0.0 110.808 -177.233 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' E' E ' 21' ' ' VAL . . . . . . . . . . . . . 46.9 t -64.55 -46.79 91.6 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.284 0 C-N-CA 120.809 -0.356 . . . . 0.0 110.621 -177.801 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' E' E ' 22' ' ' ILE . . . . . 0.662 HG22 HD12 ' E' ' 26' ' ' LEU . 51.4 mm -57.26 -39.98 70.97 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.217 0 C-N-CA 120.902 -0.319 . . . . 0.0 110.774 -179.562 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' E' E ' 23' ' ' ARG . . . . . . . . . . . . . 34.2 ttp180 -56.91 -50.28 73.02 Favored 'General case' 0 N--CA 1.464 0.255 0 CA-C-O 121.08 0.466 . . . . 0.0 110.443 177.326 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' E' E ' 24' ' ' ILE . . . . . . . . . . . . . 70.6 mt -61.16 -38.65 80.17 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.327 0 CA-C-N 115.807 -0.633 . . . . 0.0 112.072 -176.739 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' E' E ' 25' ' ' LYS . . . . . . . . . . . . . 14.7 pttp -78.34 -36.42 46.29 Favored 'General case' 0 CA--C 1.534 0.348 0 C-N-CA 120.606 -0.437 . . . . 0.0 112.007 -174.049 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' E' E ' 26' ' ' LEU . . . . . 0.662 HD12 HG22 ' E' ' 22' ' ' ILE . 47.6 mt -79.74 -35.06 39.38 Favored 'General case' 0 C--N 1.33 -0.266 0 N-CA-C 113.046 0.758 . . . . 0.0 113.046 -173.022 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' E' E ' 27' ' ' GLN . . . . . . . . . . . . . 9.6 pt20 -46.82 139.75 5.18 Favored 'General case' 0 N--CA 1.468 0.465 0 N-CA-C 112.906 0.706 . . . . 0.0 112.906 -175.49 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' E' E ' 28' ' ' GLY . . . . . . . . . . . . . . . 100.54 -25.94 26.44 Favored Glycine 0 CA--C 1.533 1.166 0 CA-C-N 115.511 -0.768 . . . . 0.0 112.304 -177.991 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' E' E ' 29' ' ' LYS . . . . . . . . . . . . . 98.9 mttt -98.3 155.12 17.36 Favored 'General case' 0 C--N 1.332 -0.167 0 CA-C-N 117.423 0.611 . . . . 0.0 111.175 179.439 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' E' E ' 30' ' ' THR . . . . . . . . . . . . . 31.2 m -102.72 137.14 41.33 Favored 'General case' 0 C--N 1.331 -0.199 0 CA-C-N 116.105 -0.498 . . . . 0.0 110.204 177.069 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' E' E ' 31' ' ' VAL . . . . . . . . . . . . . 34.9 m -128.98 154.27 39.74 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.26 0 CA-C-N 116.444 -0.344 . . . . 0.0 110.816 -179.226 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' E' E ' 32' ' ' ARG . . . . . . . . . . . . . 94.8 mtt180 -131.67 149.08 52.61 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-O 121.179 0.514 . . . . 0.0 110.611 178.332 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' E' E ' 33' ' ' THR . . . . . . . . . . . . . 22.3 m -53.44 139.74 29.84 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.22 -0.446 . . . . 0.0 111.357 -179.382 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' E' E ' 34' ' ' GLY . . . . . . . . . . . . . . . 99.69 -17.12 57.94 Favored Glycine 0 CA--C 1.532 1.126 0 CA-C-O 119.62 -0.545 . . . . 0.0 113.263 179.36 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' E' E ' 35' ' ' ASP . . . . . . . . . . . . . 78.3 m-20 -66.67 148.5 51.82 Favored 'General case' 0 C--N 1.333 -0.152 0 CA-C-N 118.041 0.921 . . . . 0.0 111.078 178.934 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' E' E ' 36' ' ' VAL . . . . . . . . . . . . . 44.3 t -120.97 129.91 75.21 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.262 0 CA-C-N 115.933 -0.576 . . . . 0.0 109.785 178.236 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' E' E ' 37' ' ' ILE . . . . . . . . . . . . . 63.8 mt -119.79 136.96 55.23 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.257 0 N-CA-C 109.751 -0.463 . . . . 0.0 109.751 -179.636 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' E' E ' 38' ' ' GLY . . . . . . . . . . . . . . . -114.97 128.72 8.25 Favored Glycine 0 CA--C 1.524 0.644 0 N-CA-C 111.006 -0.838 . . . . 0.0 111.006 -179.77 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' E' E ' 39' ' ' ILE . . . . . . . . . . . . . 72.5 mt -126.47 127.67 70.63 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.232 0 N-CA-C 110.143 -0.317 . . . . 0.0 110.143 179.142 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' E' E ' 40' ' ' SER . . . . . . . . . . . . . 7.4 m -92.7 119.35 32.01 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.295 -0.411 . . . . 0.0 110.595 175.423 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' E' E ' 41' ' ' ILE . . . . . . . . . . . . . 69.3 mt -129.73 126.57 62.98 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.175 0 CA-C-O 120.951 0.405 . . . . 0.0 110.49 179.769 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' E' E ' 42' ' ' LEU . . . . . . . . . . . . . 30.7 mt 54.1 33.8 18.57 Favored 'General case' 0 C--N 1.331 -0.223 0 CA-C-N 116.033 -0.53 . . . . 0.0 111.781 177.395 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' E' E ' 43' ' ' GLY . . . . . . . . . . . . . . . 72.36 29.54 66.04 Favored Glycine 0 CA--C 1.529 0.936 0 C-N-CA 121.127 -0.559 . . . . 0.0 112.296 177.811 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' E' E ' 44' ' ' LYS . . . . . . . . . . . . . 83.6 tttt -139.43 126.92 21.61 Favored 'General case' 0 C--N 1.331 -0.225 0 N-CA-C 109.637 -0.505 . . . . 0.0 109.637 178.217 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' E' E ' 45' ' ' GLU . . . . . . . . . . . . . 47.1 tt0 -85.65 126.59 34.05 Favored 'General case' 0 C--N 1.327 -0.397 0 CA-C-N 116.229 -0.441 . . . . 0.0 111.539 -175.483 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' E' E ' 46' ' ' VAL . . . . . . . . . . . . . 9.9 p -123.21 126.08 72.9 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.198 0 N-CA-C 109.966 -0.383 . . . . 0.0 109.966 174.457 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' E' E ' 47' ' ' LYS . . . . . 0.406 ' HB2' HD12 ' E' ' 9' ' ' LEU . 33.8 mmtp -99.48 127.44 45.54 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 115.967 -0.561 . . . . 0.0 110.877 176.223 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' E' E ' 48' ' ' PHE . . . . . . . . . . . . . 34.6 m-85 -109.78 131.7 54.82 Favored 'General case' 0 C--N 1.329 -0.289 0 N-CA-C 109.444 -0.576 . . . . 0.0 109.444 175.506 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' E' E ' 49' ' ' LYS . . . . . . . . . . . . . 46.2 tttp -107.67 132.12 53.67 Favored 'General case' 0 C--N 1.327 -0.38 0 N-CA-C 110.08 -0.341 . . . . 0.0 110.08 178.081 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' E' E ' 50' ' ' VAL . . . . . 0.429 ' HA ' HD23 ' E' ' 6' ' ' LEU . 46.7 t -76.58 104.42 4.61 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.268 0 N-CA-C 109.188 -0.671 . . . . 0.0 109.188 177.022 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' E' E ' 51' ' ' VAL . . . . . . . . . . . . . 48.3 t -69.74 -52.94 27.02 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.363 0 N-CA-C 109.609 -0.515 . . . . 0.0 109.609 -174.959 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' E' E ' 52' ' ' GLN . . . . . . . . . . . . . 91.1 mt-30 -153.64 153.69 32.79 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-O 121.253 0.549 . . . . 0.0 111.783 -178.08 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' E' E ' 53' ' ' ALA . . . . . 0.444 ' HB3' ' OG ' ' E' ' 56' ' ' SER . . . -130.57 132.69 45.68 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 115.02 -0.991 . . . . 0.0 109.621 174.978 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' E' E ' 54' ' ' TYR . . . . . . . . . . . . . 40.4 t80 -129.0 107.65 18.1 Favored Pre-proline 0 CA--C 1.535 0.397 0 CA-C-O 118.138 -0.934 . . . . 0.0 110.36 179.893 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' E' E ' 55' ' ' PRO . . . . . . . . . . . . . 72.8 Cg_endo -77.17 168.07 77.94 Favored 'Cis proline' 0 N--CA 1.5 1.891 0 CA-C-N 121.783 1.672 . . . . 0.0 112.713 -5.278 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' E' E ' 56' ' ' SER . . . . . 0.444 ' OG ' ' HB3' ' E' ' 53' ' ' ALA . 68.4 m -118.2 132.89 23.54 Favored Pre-proline 0 CA--C 1.539 0.553 0 CA-C-O 118.377 -0.821 . . . . 0.0 109.463 173.77 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' E' E ' 57' ' ' PRO . . . . . . . . . . . . . 34.4 Cg_endo -66.19 163.97 66.91 Favored 'Cis proline' 0 N--CA 1.496 1.675 0 CA-C-N 121.95 1.732 . . . . 0.0 111.66 -1.788 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' E' E ' 58' ' ' LEU . . . . . . . . . . . . . 33.5 tp -130.07 136.83 49.79 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.104 -0.498 . . . . 0.0 110.281 -179.537 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' E' E ' 59' ' ' ARG . . . . . . . . . . . . . 41.8 ttm180 -102.72 123.58 46.67 Favored 'General case' 0 C--N 1.327 -0.403 0 CA-C-N 115.791 -0.64 . . . . 0.0 109.31 176.349 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' E' E ' 60' ' ' VAL . . . . . . . . . . . . . 45.8 t -71.99 116.97 14.7 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.294 0 C-N-CA 120.803 -0.359 . . . . 0.0 110.331 -174.584 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' E' E ' 61' ' ' GLU . . . . . . . . . . . . . 95.7 mt-10 -131.05 159.5 37.36 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 115.816 -0.629 . . . . 0.0 109.761 176.475 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' E' E ' 62' ' ' ASP . . . . . . . . . . . . . 13.8 t70 -52.48 -31.94 37.57 Favored 'General case' 0 C--N 1.328 -0.357 0 N-CA-C 111.953 0.353 . . . . 0.0 111.953 -179.209 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' E' E ' 63' ' ' ARG . . . . . . . . . . . . . 37.3 mtp180 -72.22 -21.89 61.34 Favored 'General case' 0 C--N 1.33 -0.281 0 N-CA-C 112.954 0.724 . . . . 0.0 112.954 -175.935 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' E' E ' 64' ' ' THR . . . . . . . . . . . . . 28.4 m -69.33 136.77 52.25 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-O 120.93 0.395 . . . . 0.0 110.865 -175.988 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' E' E ' 65' ' ' LYS . . . . . . . . . . . . . 92.1 mttt -89.31 127.91 35.83 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-N 115.97 -0.559 . . . . 0.0 109.917 177.987 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' E' E ' 66' ' ' ILE . . . . . . . . . . . . . 64.4 mt -114.49 129.33 70.73 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 N-CA-C 110.008 -0.368 . . . . 0.0 110.008 -179.705 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' E' E ' 67' ' ' THR . . . . . . . . . . . . . 30.2 m -122.74 142.27 50.89 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-O 121.16 0.505 . . . . 0.0 111.11 -177.644 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' E' E ' 68' ' ' LEU . . . . . . . . . . . . . 17.6 tp . . . . . 0 C--N 1.33 -0.25 0 CA-C-N 115.563 -0.744 . . . . 0.0 109.898 177.491 . . . . . . . . 0 0 . 1 . 007 nuclear nobuild core ' E' E ' 73' ' ' VAL . . . . . . . . . . . . . 27.0 m . . . . . 0 C--O 1.231 0.102 0 CA-C-O 120.893 0.378 . . . . 0.0 110.752 . . . . . . . . . 0 0 . 1 . 007 nuclear nobuild core ' E' E ' 74' ' ' ASP . . . . . . . . . . . . . 28.2 t0 -98.77 119.6 37.78 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.028 -0.533 . . . . 0.0 110.023 -178.762 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' E' E ' 75' ' ' VAL . . . . . . . . . . . . . 42.7 t -112.64 123.43 68.32 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.256 0 CA-C-O 120.987 0.422 . . . . 0.0 110.427 -178.263 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' E' E ' 76' ' ' LEU . . . . . . . . . . . . . 27.0 mt -125.02 142.64 51.36 Favored 'General case' 0 C--N 1.331 -0.239 0 CA-C-N 115.842 -0.617 . . . . 0.0 109.772 177.492 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' E' E ' 77' ' ' GLU . . . . . . . . . . . . . 97.6 mt-10 -135.22 131.24 36.42 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-O 121.005 0.431 . . . . 0.0 111.123 -177.747 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' E' E ' 78' ' ' ALA . . . . . . . . . . . . . . . -118.06 135.86 53.92 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 115.814 -0.63 . . . . 0.0 109.67 176.588 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' E' E ' 79' ' ' LYS . . . . . 0.594 ' O ' HD13 ' E' ' 80' ' ' ILE . 90.0 mttt -79.65 118.46 21.5 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-O 121.003 0.43 . . . . 0.0 110.677 -178.864 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' E' E ' 80' ' ' ILE . . . . . 0.594 HD13 ' O ' ' E' ' 79' ' ' LYS . 41.1 mm -139.12 114.09 8.15 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.376 0 N-CA-C 108.944 -0.761 . . . . 0.0 108.944 -178.502 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' E' E ' 81' ' ' LYS . . . . . . . . . . . . . 56.2 pttt -111.06 129.46 55.91 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-O 121.009 0.433 . . . . 0.0 111.628 -174.253 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' E' E ' 82' ' ' GLY . . . . . . . . . . . . . . . 89.13 42.04 5.7 Favored Glycine 0 CA--C 1.526 0.728 0 N-CA-C 111.524 -0.63 . . . . 0.0 111.524 175.974 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' E' E ' 83' ' ' ILE . . . . . . . . . . . . . 69.1 mt -74.23 138.62 20.76 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.342 0 N-CA-C 109.833 -0.432 . . . . 0.0 109.833 178.145 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' E' E ' 84' ' ' LYS . . . . . . . . . . . . . 39.4 ttpt -102.49 -47.4 4.47 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.302 -0.408 . . . . 0.0 110.163 -179.756 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' E' E ' 85' ' ' ASP . . . . . . . . . . . . . 45.5 t0 -148.91 147.06 28.21 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 115.987 -0.551 . . . . 0.0 110.608 179.876 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' E' E ' 86' ' ' VAL . . . . . 0.412 HG21 HG21 ' D' ' 133' ' ' ILE . 42.4 t -127.84 131.46 69.73 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.266 0 CA-C-O 120.902 0.382 . . . . 0.0 110.404 -179.208 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' E' E ' 87' ' ' ILE . . . . . . . . . . . . . 46.7 mm -121.4 125.12 73.26 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.271 0 CA-C-N 115.955 -0.566 . . . . 0.0 109.686 176.772 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' E' E ' 88' ' ' LEU . . . . . . . . . . . . . 18.3 tp -114.26 130.49 56.65 Favored 'General case' 0 C--N 1.332 -0.163 0 CA-C-O 120.924 0.392 . . . . 0.0 111.074 -177.445 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' E' E ' 89' ' ' ASP . . . . . . . . . . . . . 13.0 t70 -127.33 154.79 44.52 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 115.957 -0.565 . . . . 0.0 109.896 177.16 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' E' E ' 90' ' ' GLU . . . . . . . . . . . . . 96.8 mt-10 -48.1 -36.93 14.15 Favored 'General case' 0 C--N 1.329 -0.313 0 N-CA-C 112.923 0.712 . . . . 0.0 112.923 -172.722 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' E' E ' 91' ' ' ASN . . . . . . . . . . . . . 87.6 m-20 -132.0 33.76 3.89 Favored 'General case' 0 N--CA 1.465 0.31 0 N-CA-C 111.939 0.348 . . . . 0.0 111.939 -175.942 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' E' E ' 92' ' ' LEU . . . . . . . . . . . . . 17.3 tp -166.12 141.66 4.77 Favored 'General case' 0 C--N 1.329 -0.308 0 C-N-CA 121.027 -0.269 . . . . 0.0 110.719 179.46 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' E' E ' 93' ' ' ILE . . . . . . . . . . . . . 72.8 mt -121.86 120.42 61.48 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.27 0 N-CA-C 109.138 -0.69 . . . . 0.0 109.138 178.017 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' E' E ' 94' ' ' VAL . . . . . . . . . . . . . 47.1 t -121.4 125.74 74.03 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.261 0 CA-C-O 121.052 0.453 . . . . 0.0 109.986 -177.763 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' E' E ' 95' ' ' VAL . . . . . . . . . . . . . 43.0 t -121.27 132.81 69.7 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.245 0 CA-C-N 115.873 -0.603 . . . . 0.0 109.847 -179.257 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' E' E ' 96' ' ' ILE . . . . . . . . . . . . . 66.7 mt -115.48 124.19 71.72 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.273 0 N-CA-C 109.147 -0.686 . . . . 0.0 109.147 178.395 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' E' E ' 97' ' ' THR . . . . . . . . . . . . . 77.1 p -99.9 155.02 17.9 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-O 121.523 0.678 . . . . 0.0 111.595 -174.657 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' E' E ' 98' ' ' GLU . . . . . . . . . . . . . 84.7 tt0 -54.03 -26.72 27.87 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 115.548 -0.751 . . . . 0.0 112.141 179.726 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' E' E ' 99' ' ' GLU . . . . . . . . . . . . . 96.3 mt-10 -79.76 16.72 1.06 Allowed 'General case' 0 CA--C 1.537 0.454 0 N-CA-C 113.126 0.788 . . . . 0.0 113.126 -177.369 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' E' E ' 100' ' ' ASN . . . . . . . . . . . . . 4.2 m-20 62.81 37.38 12.39 Favored 'General case' 0 CA--C 1.53 0.198 0 CA-C-O 121.073 0.463 . . . . 0.0 111.048 178.168 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' E' E ' 101' ' ' GLU . . . . . . . . . . . . . 84.7 tt0 -116.46 143.98 44.89 Favored 'General case' 0 C--N 1.333 -0.139 0 CA-C-N 116.159 -0.473 . . . . 0.0 109.909 176.939 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' E' E ' 102' ' ' VAL . . . . . . . . . . . . . 46.4 t -115.0 125.68 72.38 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.27 0 N-CA-C 109.803 -0.443 . . . . 0.0 109.803 -179.468 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' E' E ' 103' ' ' LEU . . . . . . . . . . . . . 27.7 mt -118.94 128.69 54.65 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-N 115.732 -0.667 . . . . 0.0 110.251 177.783 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' E' E ' 104' ' ' ILE . . . . . 0.61 HD13 HG21 ' E' ' 130' ' ' VAL . 66.4 mt -117.66 122.67 70.36 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.2 0 N-CA-C 110.028 -0.36 . . . . 0.0 110.028 179.787 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' E' E ' 105' ' ' PHE . . . . . . . . . . . . . 91.6 m-85 -122.75 166.08 15.53 Favored 'General case' 0 N--CA 1.462 0.129 0 O-C-N 123.999 0.812 . . . . 0.0 110.131 -179.464 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' E' E ' 106' ' ' ASN . . . . . . . . . . . . . 48.7 p-10 -102.94 -172.59 2.14 Favored 'General case' 0 C--N 1.331 -0.196 0 N-CA-C 109.888 -0.412 . . . . 0.0 109.888 172.378 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' E' E ' 107' ' ' GLN . . . . . . . . . . . . . 53.3 tp60 -59.16 -27.9 66.1 Favored 'General case' 0 C--N 1.329 -0.294 0 N-CA-C 112.239 0.459 . . . . 0.0 112.239 -178.586 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' E' E ' 108' ' ' ASN . . . . . . . . . . . . . 8.4 t-20 -88.24 14.06 10.17 Favored 'General case' 0 CA--C 1.533 0.306 0 N-CA-C 112.92 0.711 . . . . 0.0 112.92 -176.918 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' E' E ' 109' ' ' LEU . . . . . . . . . . . . . 41.4 mt 57.99 34.53 24.36 Favored 'General case' 0 CA--C 1.531 0.224 0 CA-C-O 120.718 0.294 . . . . 0.0 111.643 178.514 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' E' E ' 110' ' ' GLU . . . . . . . . . . . . . 43.5 mt-10 -101.49 154.51 18.76 Favored 'General case' 0 C--N 1.33 -0.272 0 N-CA-C 109.28 -0.637 . . . . 0.0 109.28 174.968 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' E' E ' 111' ' ' GLU . . . . . . . . . . . . . 41.6 tt0 -90.96 121.83 33.12 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-O 121.048 0.451 . . . . 0.0 110.987 -175.444 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' E' E ' 112' ' ' LEU . . . . . . . . . . . . . 90.4 mt -101.23 -46.15 5.13 Favored 'General case' 0 C--N 1.332 -0.195 0 CA-C-N 115.803 -0.635 . . . . 0.0 110.388 178.675 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' E' E ' 113' ' ' TYR . . . . . 0.402 ' HB3' HD12 ' E' ' 104' ' ' ILE . 59.8 t80 -139.17 136.56 35.2 Favored 'General case' 0 C--N 1.331 -0.211 0 CA-C-N 116.174 -0.467 . . . . 0.0 111.355 -177.475 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' E' E ' 114' ' ' ARG . . . . . . . . . . . . . 57.3 ttp180 -135.05 120.15 18.75 Favored 'General case' 0 C--N 1.331 -0.22 0 CA-C-N 115.943 -0.572 . . . . 0.0 110.107 177.239 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' E' E ' 115' ' ' GLY . . . . . . . . . . . . . . . -150.07 149.39 21.29 Favored Glycine 0 CA--C 1.524 0.617 0 N-CA-C 111.073 -0.811 . . . . 0.0 111.073 178.281 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' E' E ' 116' ' ' LYS . . . . . . . . . . . . . 34.3 ttmt -125.8 136.45 53.13 Favored 'General case' 0 C--N 1.33 -0.266 0 N-CA-C 109.977 -0.379 . . . . 0.0 109.977 176.042 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' E' E ' 117' ' ' PHE . . . . . . . . . . . . . 40.1 m-85 -129.65 115.97 18.14 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.167 -0.47 . . . . 0.0 110.136 -176.584 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' E' E ' 118' ' ' GLU . . . . . . . . . . . . . 85.4 tt0 -53.7 -46.18 70.63 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.493 -0.322 . . . . 0.0 111.451 -177.133 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' E' E ' 119' ' ' ASN . . . . . . . . . . . . . 86.7 m-20 -96.99 31.07 2.49 Favored 'General case' 0 C--N 1.331 -0.2 0 N-CA-C 112.11 0.411 . . . . 0.0 112.11 -175.8 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' E' E ' 120' ' ' LEU . . . . . . . . . . . . . 10.4 tp -56.12 121.06 8.55 Favored 'General case' 0 C--N 1.332 -0.161 0 O-C-N 122.313 -0.242 . . . . 0.0 110.449 178.343 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' E' E ' 121' ' ' ASN . . . . . . . . . . . . . 31.1 m120 -113.82 -44.07 3.21 Favored 'General case' 0 C--N 1.331 -0.217 0 CA-C-N 116.734 -0.212 . . . . 0.0 111.245 -175.765 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' E' E ' 122' ' ' LYS . . . . . . . . . . . . . 97.9 mttt -146.5 147.3 31.04 Favored 'General case' 0 C--N 1.332 -0.194 0 C-N-CA 120.488 -0.485 . . . . 0.0 111.389 -177.705 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' E' E ' 123' ' ' VAL . . . . . 0.512 ' C ' HD12 ' E' ' 124' ' ' LEU . 44.6 t -130.61 129.11 64.11 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.252 0 CA-C-N 115.982 -0.554 . . . . 0.0 109.678 176.759 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' E' E ' 124' ' ' LEU . . . . . 0.512 HD12 ' C ' ' E' ' 123' ' ' VAL . 6.5 mp -126.49 131.06 51.71 Favored 'General case' 0 C--N 1.331 -0.205 0 N-CA-C 109.999 -0.371 . . . . 0.0 109.999 -179.513 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' E' E ' 125' ' ' VAL . . . . . . . . . . . . . 33.7 m -139.7 137.02 39.8 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.342 0 CA-C-O 120.766 0.317 . . . . 0.0 110.792 -179.071 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' E' E ' 126' ' ' ARG . . . . . . . . . . . . . 74.5 ttt-85 -143.91 127.73 17.28 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.708 -179.683 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' E' E ' 127' ' ' ASN . . . . . . . . . . . . . 4.6 m120 51.24 -106.62 0.26 Allowed 'General case' 0 CA--C 1.544 0.713 0 CA-C-O 118.982 -0.532 . . . . 0.0 111.594 179.064 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' E' E ' 128' ' ' ASP . . . . . . . . . . . . . 23.7 p-10 -114.16 1.86 14.69 Favored 'General case' 0 CA--C 1.536 0.406 0 CA-C-N 119.675 1.125 . . . . 0.0 113.582 -175.854 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' E' E ' 129' ' ' LEU . . . . . . . . . . . . . 13.5 tp -112.79 136.43 52.41 Favored 'General case' 0 C--N 1.333 -0.135 0 N-CA-C 109.771 -0.455 . . . . 0.0 109.771 179.605 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' E' E ' 130' ' ' VAL . . . . . 0.61 HG21 HD13 ' E' ' 104' ' ' ILE . 32.4 m -132.74 142.89 41.22 Favored 'Isoleucine or valine' 0 C--O 1.233 0.198 0 CA-C-O 121.115 0.484 . . . . 0.0 110.976 -179.18 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' E' E ' 131' ' ' VAL . . . . . . . . . . . . . 41.4 t -136.12 138.63 46.98 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.338 0 CA-C-N 115.986 -0.552 . . . . 0.0 109.981 178.37 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' E' E ' 132' ' ' ILE . . . . . . . . . . . . . 74.1 mt -113.57 133.75 58.52 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.312 0 CA-C-N 115.665 -0.698 . . . . 0.0 109.508 -179.568 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' E' E ' 133' ' ' ILE . . . . . . . . . . . . . 42.6 mm -116.04 122.62 69.99 Favored 'Isoleucine or valine' 0 C--O 1.233 0.225 0 CA-C-O 120.991 0.424 . . . . 0.0 110.928 -176.18 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' E' E ' 134' ' ' ASP . . . . . . . . . . . . . 10.5 p-10 -134.86 147.59 49.92 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 115.84 -0.618 . . . . 0.0 109.537 174.625 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' E' E ' 135' ' ' GLU . . . . . . . . . . . . . 84.6 tt0 -49.76 -26.64 4.04 Favored 'General case' 0 C--N 1.325 -0.463 0 N-CA-C 112.811 0.671 . . . . 0.0 112.811 -171.627 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' E' E ' 136' ' ' GLN . . . . . . . . . . . . . 96.8 mt-30 -83.6 -37.88 22.34 Favored 'General case' 0 C--O 1.234 0.243 0 N-CA-C 112.332 0.493 . . . . 0.0 112.332 -176.243 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' E' E ' 137' ' ' LYS . . . . . . . . . . . . . 19.5 pttp -159.91 174.09 14.93 Favored 'General case' 0 C--N 1.331 -0.209 0 CA-C-O 121.51 0.671 . . . . 0.0 112.296 -171.834 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' E' E ' 138' ' ' LEU . . . . . 0.424 ' C ' HD23 ' E' ' 138' ' ' LEU . 8.1 tt -121.91 130.5 53.39 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 114.926 -1.034 . . . . 0.0 109.732 177.599 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' E' E ' 139' ' ' THR . . . . . . . . . . . . . 40.8 m -113.07 125.51 54.46 Favored 'General case' 0 C--N 1.331 -0.23 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.716 -178.558 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' E' E ' 140' ' ' LEU . . . . . 0.484 ' C ' HD23 ' E' ' 140' ' ' LEU . 8.7 tt -107.65 122.57 46.98 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 115.636 -0.711 . . . . 0.0 109.288 -179.502 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' E' E ' 141' ' ' ILE . . . . . 0.509 ' HB ' HG23 ' E' ' 130' ' ' VAL . 19.2 mt -125.07 118.87 54.25 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.288 0 CA-C-O 121.066 0.46 . . . . 0.0 109.886 -177.692 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' E' E ' 142' ' ' ARG . . . . . . . . . . . . . 77.4 ttt-85 -110.94 119.3 38.62 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 115.474 -0.785 . . . . 0.0 109.822 -179.428 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' E' E ' 143' ' ' THR . . . . . . . . . . . . . 71.4 p . . . . . 0 C--O 1.221 -0.442 0 CA-C-O 117.951 -1.023 . . . . 0.0 110.623 -178.14 . . . . . . . . 0 0 . 1 . 007 nuclear nobuild core ' F' F ' 1' ' ' MET . . . . . . . . . . . . . 25.3 ptp . . . . . 0 C--O 1.23 0.076 0 CA-C-O 120.687 0.279 . . . . 0.0 110.691 . . . . . . . . . 0 0 . 1 . 007 nuclear nobuild core ' F' F ' 2' ' ' SER . . . . . . . . . . . . . 2.2 p -122.52 125.24 45.35 Favored 'General case' 0 C--N 1.331 -0.227 0 CA-C-O 121.096 0.474 . . . . 0.0 110.564 178.426 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' F' F ' 3' ' ' GLU . . . . . . . . . . . . . 85.1 tt0 -144.49 144.56 31.41 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-N 115.942 -0.572 . . . . 0.0 111.184 -178.973 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' F' F ' 4' ' ' LEU . . . . . 0.444 HD21 HD21 ' F' ' 6' ' ' LEU . 12.1 tp -126.11 135.32 51.57 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 115.782 -0.645 . . . . 0.0 110.292 178.092 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' F' F ' 5' ' ' LYS . . . . . . . . . . . . . 98.9 mttt -111.37 121.57 45.59 Favored 'General case' 0 C--O 1.235 0.316 0 CA-C-N 116.345 -0.389 . . . . 0.0 110.505 179.764 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' F' F ' 6' ' ' LEU . . . . . 0.444 HD21 HD21 ' F' ' 4' ' ' LEU . 78.7 mt -116.93 147.24 42.4 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 115.735 -0.666 . . . . 0.0 110.538 -178.981 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' F' F ' 7' ' ' LYS . . . . . . . . . . . . . 55.0 tttt -137.45 140.38 30.27 Favored Pre-proline 0 CA--C 1.534 0.328 0 CA-C-O 119.201 -0.428 . . . . 0.0 110.1 177.035 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' F' F ' 8' ' ' PRO . . . . . . . . . . . . . 93.5 Cg_endo -91.55 143.2 2.95 Favored 'Trans proline' 0 N--CA 1.49 1.303 0 C-N-CA 121.764 1.643 . . . . 0.0 111.717 177.781 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' F' F ' 9' ' ' LEU . . . . . . . . . . . . . 41.6 mt -79.81 -47.41 1.45 Allowed Pre-proline 0 CA--C 1.535 0.373 0 CA-C-O 118.686 -0.673 . . . . 0.0 112.42 -178.594 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' F' F ' 10' ' ' PRO . . . . . . . . . . . . . 86.1 Cg_endo -80.67 155.98 21.11 Favored 'Trans proline' 0 N--CA 1.496 1.638 0 C-N-CA 121.243 1.296 . . . . 0.0 111.951 176.252 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' F' F ' 11' ' ' LYS . . . . . . . . . . . . . 53.9 tptt -88.01 99.32 12.07 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.393 -0.367 . . . . 0.0 110.39 179.094 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' F' F ' 12' ' ' VAL . . . . . . . . . . . . . 11.9 p -145.94 143.21 21.51 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.305 0 CA-C-N 116.118 -0.492 . . . . 0.0 110.378 179.03 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' F' F ' 13' ' ' GLU . . . . . . . . . . . . . 43.8 mt-10 -85.91 124.27 32.19 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.373 -0.376 . . . . 0.0 110.219 177.677 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' F' F ' 14' ' ' LEU . . . . . . . . . . . . . 18.7 mt -94.76 152.19 39.59 Favored Pre-proline 0 C--N 1.329 -0.298 0 CA-C-N 116.315 -0.402 . . . . 0.0 110.544 -178.695 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' F' F ' 15' ' ' PRO . . . . . . . . . . . . . 39.7 Cg_exo -58.43 157.31 27.19 Favored 'Trans proline' 0 N--CA 1.498 1.752 0 C-N-CA 121.235 1.29 . . . . 0.0 111.796 179.586 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' F' F ' 16' ' ' PRO . . . . . . . . . . . . . 32.1 Cg_exo -59.5 -37.92 86.21 Favored 'Trans proline' 0 N--CA 1.497 1.729 0 C-N-CA 121.42 1.414 . . . . 0.0 112.672 -178.182 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' F' F ' 17' ' ' ASP . . . . . . . . . . . . . 15.2 p-10 -87.59 11.25 15.48 Favored 'General case' 0 CA--C 1.535 0.387 0 N-CA-C 113.074 0.768 . . . . 0.0 113.074 -178.149 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' F' F ' 18' ' ' PHE . . . . . . . . . . . . . 45.2 t80 -58.28 -43.33 87.92 Favored 'General case' 0 CA--C 1.522 -0.114 0 O-C-N 121.863 -0.523 . . . . 0.0 110.089 -178.524 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' F' F ' 19' ' ' VAL . . . . . . . . . . . . . 46.8 t -55.54 -42.77 69.81 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.323 0 CA-C-N 116.354 -0.384 . . . . 0.0 110.675 -178.583 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' F' F ' 20' ' ' ASP . . . . . . . . . . . . . 81.2 m-20 -60.2 -44.94 94.71 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-O 120.859 0.362 . . . . 0.0 110.857 -177.97 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' F' F ' 21' ' ' VAL . . . . . . . . . . . . . 48.7 t -64.13 -46.71 92.83 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.309 0 C-N-CA 120.788 -0.365 . . . . 0.0 110.547 -177.52 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' F' F ' 22' ' ' ILE . . . . . 0.461 HG22 HD12 ' F' ' 26' ' ' LEU . 49.4 mm -55.88 -46.63 80.25 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.257 0 CA-C-O 120.633 0.254 . . . . 0.0 110.597 179.375 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' F' F ' 23' ' ' ARG . . . . . . . . . . . . . 53.9 ttp180 -54.11 -47.91 71.32 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-O 120.607 0.242 . . . . 0.0 111.349 -178.502 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' F' F ' 24' ' ' ILE . . . . . . . . . . . . . 72.2 mt -59.12 -44.51 91.76 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.285 0 CA-C-N 116.677 -0.238 . . . . 0.0 111.098 -178.405 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' F' F ' 25' ' ' LYS . . . . . . . . . . . . . 67.6 mttm -65.05 -39.75 93.75 Favored 'General case' 0 C--N 1.328 -0.339 0 N-CA-C 112.429 0.529 . . . . 0.0 112.429 -177.977 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' F' F ' 26' ' ' LEU . . . . . 0.461 HD12 HG22 ' F' ' 22' ' ' ILE . 63.6 mt -78.62 -43.27 26.71 Favored 'General case' 0 C--N 1.331 -0.229 0 N-CA-C 112.882 0.697 . . . . 0.0 112.882 -171.824 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' F' F ' 27' ' ' GLN . . . . . . . . . . . . . 10.5 pt20 -46.73 139.4 5.33 Favored 'General case' 0 N--CA 1.467 0.41 0 N-CA-C 112.883 0.697 . . . . 0.0 112.883 -174.641 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' F' F ' 28' ' ' GLY . . . . . . . . . . . . . . . 99.82 -25.57 27.76 Favored Glycine 0 CA--C 1.533 1.199 0 CA-C-N 115.472 -0.786 . . . . 0.0 112.197 -176.154 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' F' F ' 29' ' ' LYS . . . . . . . . . . . . . 91.4 mttt -98.0 155.22 17.21 Favored 'General case' 0 C--O 1.233 0.197 0 CA-C-N 117.242 0.521 . . . . 0.0 110.929 178.091 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' F' F ' 30' ' ' THR . . . . . . . . . . . . . 26.0 m -107.28 134.57 50.16 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 115.894 -0.594 . . . . 0.0 109.565 173.9 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' F' F ' 31' ' ' VAL . . . . . . . . . . . . . 34.9 m -125.98 153.5 34.18 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.214 0 CA-C-O 120.924 0.393 . . . . 0.0 110.938 -176.978 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' F' F ' 32' ' ' ARG . . . . . . . . . . . . . 47.8 ttp180 -126.46 147.07 49.86 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 116.044 -0.525 . . . . 0.0 110.334 179.421 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' F' F ' 33' ' ' THR . . . . . . . . . . . . . 15.8 m -52.84 138.74 28.86 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.323 -0.399 . . . . 0.0 111.46 -177.514 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' F' F ' 34' ' ' GLY . . . . . . . . . . . . . . . 101.17 -17.22 56.23 Favored Glycine 0 CA--C 1.535 1.287 0 CA-C-O 119.662 -0.521 . . . . 0.0 113.253 179.248 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' F' F ' 35' ' ' ASP . . . . . . . . . . . . . 78.5 m-20 -66.06 149.06 50.85 Favored 'General case' 0 N--CA 1.461 0.11 0 CA-C-N 117.947 0.873 . . . . 0.0 110.938 178.645 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' F' F ' 36' ' ' VAL . . . . . . . . . . . . . 44.1 t -122.25 131.99 72.01 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.219 0 CA-C-N 116.034 -0.53 . . . . 0.0 109.967 179.178 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' F' F ' 37' ' ' ILE . . . . . . . . . . . . . 66.0 mt -120.76 139.3 48.43 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.247 0 CA-C-N 115.973 -0.558 . . . . 0.0 109.667 179.7 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' F' F ' 38' ' ' GLY . . . . . . . . . . . . . . . -114.49 128.9 8.41 Favored Glycine 0 CA--C 1.525 0.686 0 N-CA-C 111.371 -0.692 . . . . 0.0 111.371 -178.536 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' F' F ' 39' ' ' ILE . . . . . . . . . . . . . 72.1 mt -125.19 129.41 73.2 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.188 0 N-CA-C 109.896 -0.409 . . . . 0.0 109.896 178.014 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' F' F ' 40' ' ' SER . . . . . . . . . . . . . 28.8 t -92.47 121.82 34.31 Favored 'General case' 0 C--N 1.329 -0.301 0 C-N-CA 120.997 -0.281 . . . . 0.0 110.834 176.935 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' F' F ' 41' ' ' ILE . . . . . . . . . . . . . 72.9 mt -133.98 124.96 47.84 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.224 0 CA-C-O 120.774 0.321 . . . . 0.0 110.253 179.304 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' F' F ' 42' ' ' LEU . . . . . . . . . . . . . 60.6 mt 58.29 33.65 23.33 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-N 116.145 -0.48 . . . . 0.0 111.798 178.082 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' F' F ' 43' ' ' GLY . . . . . . . . . . . . . . . 77.66 -10.23 25.37 Favored Glycine 0 CA--C 1.536 1.361 0 C-N-CA 121.268 -0.492 . . . . 0.0 113.456 178.203 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' F' F ' 44' ' ' LYS . . . . . . . . . . . . . 27.1 mtpp -100.52 130.58 46.61 Favored 'General case' 0 C--N 1.332 -0.171 0 CA-C-N 117.852 0.826 . . . . 0.0 109.891 176.937 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' F' F ' 45' ' ' GLU . . . . . . . . . . . . . 38.2 tp10 -84.53 128.46 34.61 Favored 'General case' 0 C--N 1.33 -0.271 0 C-N-CA 120.884 -0.326 . . . . 0.0 110.808 179.877 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' F' F ' 46' ' ' VAL . . . . . . . . . . . . . 7.6 p -119.89 128.57 75.93 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.242 0 N-CA-C 109.702 -0.481 . . . . 0.0 109.702 177.543 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' F' F ' 47' ' ' LYS . . . . . . . . . . . . . 64.9 mttp -100.25 130.17 46.34 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 115.948 -0.569 . . . . 0.0 111.214 178.975 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' F' F ' 48' ' ' PHE . . . . . . . . . . . . . 92.2 m-85 -113.46 131.87 55.87 Favored 'General case' 0 C--N 1.33 -0.267 0 N-CA-C 109.721 -0.474 . . . . 0.0 109.721 176.024 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' F' F ' 49' ' ' LYS . . . . . . . . . . . . . 54.1 tttm -107.83 137.79 45.22 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.545 -0.298 . . . . 0.0 110.622 179.197 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' F' F ' 50' ' ' VAL . . . . . . . . . . . . . 44.5 t -79.17 107.23 11.39 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.282 0 N-CA-C 109.179 -0.674 . . . . 0.0 109.179 175.22 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' F' F ' 51' ' ' VAL . . . . . . . . . . . . . 46.0 t -70.52 -52.78 26.24 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.339 0 CA-C-N 115.934 -0.576 . . . . 0.0 109.585 -174.664 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' F' F ' 52' ' ' GLN . . . . . . . . . . . . . 46.9 mt-30 -155.73 153.6 30.18 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.058 -0.519 . . . . 0.0 111.669 -177.527 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' F' F ' 53' ' ' ALA . . . . . 0.446 ' HB1' ' HB2' ' F' ' 58' ' ' LEU . . . -128.97 132.44 47.57 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 115.292 -0.867 . . . . 0.0 109.889 175.546 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' F' F ' 54' ' ' TYR . . . . . . . . . . . . . 27.1 t80 -129.01 107.71 18.08 Favored Pre-proline 0 CA--C 1.535 0.378 0 CA-C-O 118.238 -0.887 . . . . 0.0 110.43 -179.849 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' F' F ' 55' ' ' PRO . . . . . . . . . . . . . 73.7 Cg_endo -77.1 170.1 72.53 Favored 'Cis proline' 0 N--CA 1.5 1.862 0 CA-C-N 121.787 1.674 . . . . 0.0 112.364 -5.812 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' F' F ' 56' ' ' SER . . . . . . . . . . . . . 45.5 m -115.61 131.44 23.65 Favored Pre-proline 0 CA--C 1.538 0.507 0 CA-C-O 118.499 -0.763 . . . . 0.0 109.448 175.74 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' F' F ' 57' ' ' PRO . . . . . . . . . . . . . 53.7 Cg_endo -70.88 149.04 90.61 Favored 'Cis proline' 0 N--CA 1.496 1.675 0 CA-C-N 121.955 1.734 . . . . 0.0 111.577 -1.899 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' F' F ' 58' ' ' LEU . . . . . 0.446 ' HB2' ' HB1' ' F' ' 53' ' ' ALA . 23.8 tp -108.29 136.43 47.95 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.219 -0.446 . . . . 0.0 110.725 -177.449 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' F' F ' 59' ' ' ARG . . . . . . . . . . . . . 70.7 ttt180 -103.02 126.12 50.06 Favored 'General case' 0 C--N 1.327 -0.384 0 N-CA-C 109.117 -0.697 . . . . 0.0 109.117 175.744 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' F' F ' 60' ' ' VAL . . . . . . . . . . . . . 41.2 t -91.07 123.21 43.12 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.303 0 C-N-CA 120.663 -0.415 . . . . 0.0 111.014 -174.059 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' F' F ' 61' ' ' GLU . . . . . . . . . . . . . 96.1 mt-10 -131.13 172.06 12.55 Favored 'General case' 0 C--N 1.329 -0.317 0 N-CA-C 109.407 -0.59 . . . . 0.0 109.407 173.055 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' F' F ' 62' ' ' ASP . . . . . . . . . . . . . 73.3 m-20 -54.22 -32.67 56.47 Favored 'General case' 0 C--N 1.328 -0.334 0 C-N-CA 121.029 -0.268 . . . . 0.0 111.583 179.299 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' F' F ' 63' ' ' ARG . . . . . . . . . . . . . 13.5 ptm180 -74.56 -11.91 60.33 Favored 'General case' 0 CA--C 1.535 0.394 0 N-CA-C 113.409 0.892 . . . . 0.0 113.409 -177.298 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' F' F ' 64' ' ' THR . . . . . . . . . . . . . 37.6 m -74.67 138.72 43.04 Favored 'General case' 0 C--O 1.233 0.193 0 O-C-N 122.096 -0.377 . . . . 0.0 110.75 -176.09 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' F' F ' 65' ' ' LYS . . . . . . . . . . . . . 55.5 mtmt -89.24 129.12 35.86 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.149 -0.478 . . . . 0.0 110.141 177.863 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' F' F ' 66' ' ' ILE . . . . . . . . . . . . . 65.3 mt -114.75 129.84 70.19 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.295 0 N-CA-C 109.899 -0.408 . . . . 0.0 109.899 -179.835 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' F' F ' 67' ' ' THR . . . . . . . . . . . . . 24.8 m -118.82 135.51 54.5 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-N 116.076 -0.511 . . . . 0.0 110.464 179.862 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' F' F ' 68' ' ' LEU . . . . . 0.479 HD23 ' C ' ' F' ' 68' ' ' LEU . 6.5 tt . . . . . 0 C--N 1.329 -0.295 0 CA-C-N 115.912 -0.586 . . . . 0.0 110.01 179.062 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' F' F ' 73' ' ' VAL . . . . . . . . . . . . . 34.4 m . . . . . 0 C--O 1.231 0.131 0 N-CA-C 110.118 -0.327 . . . . 0.0 110.118 . . . . . . . . . 0 0 . 1 . 007 nuclear nobuild core ' F' F ' 74' ' ' ASP . . . . . . . . . . . . . 24.1 t0 -96.37 121.9 38.67 Favored 'General case' 0 C--N 1.33 -0.263 0 C-N-CA 120.941 -0.304 . . . . 0.0 110.186 -177.302 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' F' F ' 75' ' ' VAL . . . . . 0.49 ' C ' HD12 ' F' ' 76' ' ' LEU . 41.0 t -121.29 124.68 72.52 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.214 0 CA-C-O 121.039 0.447 . . . . 0.0 110.913 -177.781 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' F' F ' 76' ' ' LEU . . . . . 0.49 HD12 ' C ' ' F' ' 75' ' ' VAL . 7.5 mp -121.57 143.73 49.13 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 115.61 -0.723 . . . . 0.0 109.512 176.473 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' F' F ' 77' ' ' GLU . . . . . . . . . . . . . 98.3 mt-10 -134.78 140.83 46.2 Favored 'General case' 0 N--CA 1.463 0.186 0 CA-C-O 121.091 0.472 . . . . 0.0 111.617 -178.16 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' F' F ' 78' ' ' ALA . . . . . 0.608 ' HB2' HD21 ' F' ' 109' ' ' LEU . . . -133.95 141.2 47.21 Favored 'General case' 0 C--N 1.331 -0.223 0 CA-C-N 115.706 -0.679 . . . . 0.0 110.229 176.248 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' F' F ' 79' ' ' LYS . . . . . 0.571 ' O ' HD13 ' F' ' 80' ' ' ILE . 10.0 mtpm? -82.19 119.96 24.74 Favored 'General case' 0 C--N 1.331 -0.225 0 CA-C-O 120.934 0.397 . . . . 0.0 110.801 -178.868 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' F' F ' 80' ' ' ILE . . . . . 0.571 HD13 ' O ' ' F' ' 79' ' ' LYS . 42.2 mm -139.23 102.09 1.65 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 N-CA-C 109.165 -0.679 . . . . 0.0 109.165 -178.705 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' F' F ' 81' ' ' LYS . . . . . . . . . . . . . 54.6 mtpt -97.21 127.71 43.42 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-O 120.957 0.408 . . . . 0.0 111.133 -176.92 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' F' F ' 82' ' ' GLY . . . . . . . . . . . . . . . 89.16 42.12 5.67 Favored Glycine 0 CA--C 1.525 0.695 0 C-N-CA 120.937 -0.649 . . . . 0.0 111.522 175.793 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' F' F ' 83' ' ' ILE . . . . . . . . . . . . . 71.9 mt -67.49 138.03 23.55 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.297 0 N-CA-C 109.89 -0.411 . . . . 0.0 109.89 178.407 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' F' F ' 84' ' ' LYS . . . . . . . . . . . . . 56.3 tttp -99.63 -51.91 3.62 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.02 -0.536 . . . . 0.0 110.173 -179.726 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' F' F ' 85' ' ' ASP . . . . . . . . . . . . . 7.9 t70 -156.85 153.31 28.02 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 115.811 -0.632 . . . . 0.0 110.293 -179.914 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' F' F ' 86' ' ' VAL . . . . . . . . . . . . . 41.9 t -133.36 134.75 56.96 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.246 0 CA-C-O 121.083 0.468 . . . . 0.0 110.548 -179.128 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' F' F ' 87' ' ' ILE . . . . . . . . . . . . . 45.1 mm -119.36 128.16 75.85 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.25 0 CA-C-N 115.666 -0.697 . . . . 0.0 109.733 176.892 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' F' F ' 88' ' ' LEU . . . . . . . . . . . . . 63.9 mt -114.54 133.62 55.65 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-O 121.078 0.466 . . . . 0.0 111.173 -178.754 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' F' F ' 89' ' ' ASP . . . . . . . . . . . . . 8.8 t70 -131.89 154.62 49.03 Favored 'General case' 0 C--N 1.327 -0.385 0 CA-C-N 115.667 -0.697 . . . . 0.0 109.425 177.094 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' F' F ' 90' ' ' GLU . . . . . . . . . . . . . 83.9 tt0 -47.49 -32.98 5.73 Favored 'General case' 0 C--N 1.328 -0.33 0 N-CA-C 113.031 0.752 . . . . 0.0 113.031 -172.483 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' F' F ' 91' ' ' ASN . . . . . . . . . . . . . 35.0 m120 -124.47 7.82 8.34 Favored 'General case' 0 N--CA 1.469 0.489 0 N-CA-C 113.613 0.968 . . . . 0.0 113.613 -175.128 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' F' F ' 92' ' ' LEU . . . . . . . . . . . . . 27.5 mt -147.15 148.57 31.69 Favored 'General case' 0 C--N 1.333 -0.14 0 CA-C-N 118.247 0.476 . . . . 0.0 110.965 -175.464 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' F' F ' 93' ' ' ILE . . . . . . . . . . . . . 74.0 mt -126.52 116.45 45.26 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.286 0 N-CA-C 109.105 -0.702 . . . . 0.0 109.105 175.846 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' F' F ' 94' ' ' VAL . . . . . 0.402 HG21 HG21 ' F' ' 125' ' ' VAL . 46.1 t -118.79 128.59 75.64 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.193 0 CA-C-O 120.827 0.346 . . . . 0.0 110.101 -177.967 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' F' F ' 95' ' ' VAL . . . . . . . . . . . . . 42.1 t -123.27 134.98 64.68 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.317 0 CA-C-N 116.079 -0.509 . . . . 0.0 109.871 -179.853 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' F' F ' 96' ' ' ILE . . . . . . . . . . . . . 59.8 mt -115.25 129.22 71.85 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.282 0 N-CA-C 109.324 -0.621 . . . . 0.0 109.324 178.822 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' F' F ' 97' ' ' THR . . . . . . . . . . . . . 82.5 p -100.72 158.83 15.66 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-O 121.298 0.571 . . . . 0.0 111.157 -177.95 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' F' F ' 98' ' ' GLU . . . . . . . . . . . . . 46.4 tp10 -53.74 -27.2 27.02 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.011 -0.541 . . . . 0.0 112.259 -179.436 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' F' F ' 99' ' ' GLU . . . . . . . . . . . . . 39.4 tt0 -80.25 17.87 0.97 Allowed 'General case' 0 CA--C 1.539 0.555 0 N-CA-C 112.679 0.622 . . . . 0.0 112.679 -176.822 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' F' F ' 100' ' ' ASN . . . . . . . . . . . . . 4.1 m-20 61.05 38.0 17.52 Favored 'General case' 0 N--CA 1.462 0.166 0 O-C-N 121.857 -0.527 . . . . 0.0 111.017 176.792 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' F' F ' 101' ' ' GLU . . . . . . . . . . . . . 84.8 tt0 -117.66 143.08 46.51 Favored 'General case' 0 C--N 1.331 -0.226 0 N-CA-C 109.574 -0.528 . . . . 0.0 109.574 175.838 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' F' F ' 102' ' ' VAL . . . . . . . . . . . . . 44.9 t -116.73 126.59 74.25 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.353 0 CA-C-N 116.319 -0.4 . . . . 0.0 110.107 -176.986 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' F' F ' 103' ' ' LEU . . . . . . . . . . . . . 6.8 mp -118.42 135.31 54.42 Favored 'General case' 0 C--N 1.331 -0.215 0 CA-C-N 115.752 -0.658 . . . . 0.0 110.01 176.446 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' F' F ' 104' ' ' ILE . . . . . . . . . . . . . 72.4 mt -123.67 122.24 64.39 Favored 'Isoleucine or valine' 0 C--O 1.234 0.246 0 CA-C-N 116.503 -0.317 . . . . 0.0 110.29 -178.525 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' F' F ' 105' ' ' PHE . . . . . . . . . . . . . 47.5 m-85 -121.16 166.5 13.85 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 115.314 -0.857 . . . . 0.0 109.92 179.778 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' F' F ' 106' ' ' ASN . . . . . . . . . . . . . 42.3 p-10 -99.7 -169.89 1.81 Allowed 'General case' 0 C--N 1.33 -0.25 0 N-CA-C 109.821 -0.437 . . . . 0.0 109.821 172.992 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' F' F ' 107' ' ' GLN . . . . . . . . . . . . . 29.5 tt0 -60.44 -30.07 69.42 Favored 'General case' 0 C--N 1.329 -0.317 0 N-CA-C 111.734 0.272 . . . . 0.0 111.734 178.857 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' F' F ' 108' ' ' ASN . . . . . . . . . . . . . 10.1 t-20 -81.96 4.93 20.79 Favored 'General case' 0 CA--C 1.537 0.458 0 N-CA-C 113.305 0.854 . . . . 0.0 113.305 -178.833 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' F' F ' 109' ' ' LEU . . . . . 0.608 HD21 ' HB2' ' F' ' 78' ' ' ALA . 6.0 tp 63.4 38.51 10.02 Favored 'General case' 0 C--O 1.232 0.167 0 CA-C-O 121.107 0.479 . . . . 0.0 111.377 177.158 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' F' F ' 110' ' ' GLU . . . . . . . . . . . . . 70.7 mm-40 -107.76 152.44 24.36 Favored 'General case' 0 C--N 1.331 -0.23 0 CA-C-N 116.256 -0.429 . . . . 0.0 110.12 176.03 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' F' F ' 111' ' ' GLU . . . . . . . . . . . . . 98.6 mt-10 -78.58 125.83 29.91 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-O 120.944 0.402 . . . . 0.0 111.188 -178.542 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' F' F ' 112' ' ' LEU . . . . . . . . . . . . . 8.4 mt -111.97 -46.04 3.26 Favored 'General case' 0 C--N 1.332 -0.159 0 CA-C-N 116.012 -0.54 . . . . 0.0 109.905 176.336 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' F' F ' 113' ' ' TYR . . . . . . . . . . . . . 49.5 t80 -139.69 140.94 36.97 Favored 'General case' 0 C--N 1.332 -0.19 0 CA-C-N 116.128 -0.487 . . . . 0.0 110.773 -179.637 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' F' F ' 114' ' ' ARG . . . . . . . . . . . . . 42.4 ptt85 -150.96 118.75 6.16 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-O 121.043 0.449 . . . . 0.0 110.959 179.731 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' F' F ' 115' ' ' GLY . . . . . . . . . . . . . . . -150.28 162.98 29.41 Favored Glycine 0 CA--C 1.527 0.786 0 N-CA-C 111.177 -0.769 . . . . 0.0 111.177 -178.846 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' F' F ' 116' ' ' LYS . . . . . . . . . . . . . 26.6 ttpp -122.41 144.84 48.79 Favored 'General case' 0 C--N 1.33 -0.245 0 O-C-N 122.644 -0.327 . . . . 0.0 110.172 176.457 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' F' F ' 117' ' ' PHE . . . . . . . . . . . . . 45.4 m-85 -138.22 113.9 9.76 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-O 121.035 0.445 . . . . 0.0 110.278 179.771 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' F' F ' 118' ' ' GLU . . . . . . . . . . . . . 84.7 tt0 -52.53 -50.17 63.39 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-N 116.385 -0.371 . . . . 0.0 111.702 -176.016 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' F' F ' 119' ' ' ASN . . . . . . . . . . . . . 72.2 m-80 -95.78 30.98 2.18 Favored 'General case' 0 C--N 1.329 -0.285 0 N-CA-C 112.246 0.462 . . . . 0.0 112.246 -174.458 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' F' F ' 120' ' ' LEU . . . . . . . . . . . . . 17.3 tp -55.29 120.75 7.54 Favored 'General case' 0 C--N 1.332 -0.163 0 CA-C-O 120.703 0.287 . . . . 0.0 110.77 178.392 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' F' F ' 121' ' ' ASN . . . . . . . . . . . . . 37.2 t30 -114.16 -44.05 3.17 Favored 'General case' 0 C--N 1.333 -0.125 0 CA-C-N 116.6 -0.273 . . . . 0.0 111.039 -177.995 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' F' F ' 122' ' ' LYS . . . . . . . . . . . . . 61.2 mtpt -140.6 148.54 41.1 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-O 121.045 0.45 . . . . 0.0 111.584 -175.461 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' F' F ' 123' ' ' VAL . . . . . . . . . . . . . 45.0 t -132.6 133.19 59.76 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.274 0 N-CA-C 109.374 -0.602 . . . . 0.0 109.374 174.761 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' F' F ' 124' ' ' LEU . . . . . . . . . . . . . 66.8 mt -131.74 136.05 47.3 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-O 120.988 0.423 . . . . 0.0 111.201 -176.415 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' F' F ' 125' ' ' VAL . . . . . 0.402 HG21 HG21 ' F' ' 94' ' ' VAL . 38.7 t -129.2 135.19 62.48 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.207 0 CA-C-N 115.73 -0.668 . . . . 0.0 110.067 -179.582 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' F' F ' 126' ' ' ARG . . . . . . . . . . . . . 17.1 ptp180 -165.18 142.78 6.02 Favored 'General case' 0 C--N 1.331 -0.202 0 CA-C-O 121.004 0.431 . . . . 0.0 110.414 176.31 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' F' F ' 127' ' ' ASN . . . . . . . . . . . . . 1.3 t-20 54.74 -155.13 0.26 Allowed 'General case' 0 CA--C 1.538 0.517 0 N-CA-C 110.104 -0.332 . . . . 0.0 110.104 -179.656 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' F' F ' 128' ' ' ASP . . . . . . . . . . . . . 23.1 p-10 -84.12 20.71 1.51 Allowed 'General case' 0 CA--C 1.534 0.35 0 CA-C-N 118.325 0.511 . . . . 0.0 112.347 176.481 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' F' F ' 129' ' ' LEU . . . . . . . . . . . . . 46.2 mt -121.09 144.47 48.54 Favored 'General case' 0 C--O 1.234 0.246 0 O-C-N 122.053 -0.405 . . . . 0.0 110.438 -179.376 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' F' F ' 130' ' ' VAL . . . . . 0.532 HG13 ' HB ' ' F' ' 141' ' ' ILE . 11.1 p -134.19 139.76 47.51 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.268 0 CA-C-N 116.286 -0.415 . . . . 0.0 110.016 178.832 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' F' F ' 131' ' ' VAL . . . . . 0.554 HG12 HD12 ' F' ' 140' ' ' LEU . 34.6 m -136.06 146.49 29.23 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.254 0 CA-C-O 121.268 0.556 . . . . 0.0 111.286 -178.265 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' F' F ' 132' ' ' ILE . . . . . . . . . . . . . 68.2 mt -121.91 133.97 66.64 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.299 0 CA-C-N 115.389 -0.823 . . . . 0.0 109.497 179.645 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' F' F ' 133' ' ' ILE . . . . . . . . . . . . . 37.3 mm -115.57 117.52 55.85 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.267 0 CA-C-N 116.463 -0.335 . . . . 0.0 110.828 -175.984 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' F' F ' 134' ' ' ASP . . . . . . . . . . . . . 8.0 p-10 -129.92 146.65 51.63 Favored 'General case' 0 C--N 1.33 -0.245 0 N-CA-C 109.649 -0.501 . . . . 0.0 109.649 175.526 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' F' F ' 135' ' ' GLU . . . . . . . . . . . . . 41.5 tp10 -49.93 -23.04 1.75 Allowed 'General case' 0 C--N 1.327 -0.371 0 N-CA-C 112.799 0.666 . . . . 0.0 112.799 -172.207 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' F' F ' 136' ' ' GLN . . . . . . . . . . . . . 48.1 tt0 -101.38 -28.73 12.43 Favored 'General case' 0 CA--C 1.531 0.215 0 N-CA-C 112.481 0.549 . . . . 0.0 112.481 -174.801 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' F' F ' 137' ' ' LYS . . . . . . . . . . . . . 76.6 mttt -141.95 151.74 42.85 Favored 'General case' 0 C--O 1.233 0.22 0 CA-C-O 121.363 0.601 . . . . 0.0 112.378 -170.714 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' F' F ' 138' ' ' LEU . . . . . . . . . . . . . 24.3 tp -109.14 119.14 38.63 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 115.011 -0.995 . . . . 0.0 108.941 170.251 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' F' F ' 139' ' ' THR . . . . . . . . . . . . . 33.0 m -108.19 123.73 49.2 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-O 120.751 0.31 . . . . 0.0 110.914 -177.263 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' F' F ' 140' ' ' LEU . . . . . 0.554 HD12 HG12 ' F' ' 131' ' ' VAL . 12.4 tp -115.82 120.61 39.81 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 115.601 -0.727 . . . . 0.0 109.503 -179.219 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' F' F ' 141' ' ' ILE . . . . . 0.532 ' HB ' HG13 ' F' ' 130' ' ' VAL . 19.7 mt -118.97 121.18 66.19 Favored 'Isoleucine or valine' 0 C--O 1.235 0.302 0 N-CA-C 109.801 -0.444 . . . . 0.0 109.801 -176.676 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' F' F ' 142' ' ' ARG . . . . . . . . . . . . . 73.8 mtm180 -111.56 126.82 55.4 Favored 'General case' 0 C--N 1.332 -0.175 0 CA-C-N 115.798 -0.637 . . . . 0.0 110.125 -178.348 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' F' F ' 143' ' ' THR . . . . . . . . . . . . . 25.8 p . . . . . 0 C--O 1.221 -0.443 0 CA-C-O 118.235 -0.888 . . . . 0.0 110.998 -179.368 . . . . . . . . 0 0 . 1 . 008 nuclear nobuild core ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 5.0 p . . . . . 0 N--CA 1.461 0.112 0 CA-C-O 120.988 0.423 . . . . 0.0 110.781 . . . . . . . . . 0 0 . 1 . 008 nuclear nobuild core ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 41.2 mt-10 -140.4 140.74 35.53 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 115.985 -0.552 . . . . 0.0 111.029 -179.332 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 4' ' ' LEU . . . . . 0.425 HD12 HD23 ' A' ' 58' ' ' LEU . 3.0 tt -124.2 126.3 45.89 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 115.918 -0.583 . . . . 0.0 109.707 177.338 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 5' ' ' LYS . . . . . . . . . . . . . 63.9 mttp -106.91 120.24 41.51 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-O 120.69 0.281 . . . . 0.0 110.807 -179.791 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 37.2 mt -114.66 145.64 41.79 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 115.502 -0.772 . . . . 0.0 110.742 -178.573 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 53.6 tttm -137.78 140.56 30.05 Favored Pre-proline 0 CA--C 1.534 0.35 0 CA-C-O 119.104 -0.474 . . . . 0.0 109.791 174.36 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 8' ' ' PRO . . . . . . . . . . . . . 88.4 Cg_endo -91.81 144.71 3.01 Favored 'Trans proline' 0 N--CA 1.489 1.23 0 C-N-CA 121.775 1.65 . . . . 0.0 111.83 177.931 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 62.7 mt -78.64 -46.51 1.91 Allowed Pre-proline 0 CA--C 1.532 0.277 0 CA-C-O 118.859 -0.591 . . . . 0.0 111.906 179.663 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 75.5 Cg_endo -83.93 144.98 11.11 Favored 'Trans proline' 0 N--CA 1.494 1.543 0 C-N-CA 121.219 1.28 . . . . 0.0 111.516 173.362 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 22.3 pttm -74.53 116.44 15.22 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-O 121.319 0.58 . . . . 0.0 110.437 177.639 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 12.3 p -150.41 147.32 16.04 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.359 0 CA-C-N 115.682 -0.69 . . . . 0.0 110.56 -177.966 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 84.6 tt0 -95.73 121.98 38.02 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.394 -0.366 . . . . 0.0 110.099 177.881 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 14' ' ' LEU . . . . . . . . . . . . . 21.9 mt -99.14 144.03 27.48 Favored Pre-proline 0 CA--C 1.533 0.324 0 CA-C-O 119.093 -0.48 . . . . 0.0 110.521 -176.718 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 15' ' ' PRO . . . . . . . . . . . . . 23.6 Cg_exo -64.76 161.66 35.08 Favored 'Trans proline' 0 N--CA 1.498 1.754 0 C-N-CA 121.292 1.328 . . . . 0.0 111.933 175.209 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 16' ' ' PRO . . . . . . . . . . . . . 27.1 Cg_exo -60.67 -31.97 92.67 Favored 'Trans proline' 0 N--CA 1.496 1.643 0 C-N-CA 121.538 1.492 . . . . 0.0 112.79 -178.96 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 17' ' ' ASP . . . . . . . . . . . . . 10.0 p-10 -83.16 -2.41 55.42 Favored 'General case' 0 CA--C 1.535 0.386 0 N-CA-C 113.351 0.871 . . . . 0.0 113.351 -176.556 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 18' ' ' PHE . . . . . . . . . . . . . 45.5 t80 -57.45 -43.76 84.2 Favored 'General case' 0 C--O 1.23 0.035 0 O-C-N 121.913 -0.492 . . . . 0.0 110.236 -178.478 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 19' ' ' VAL . . . . . . . . . . . . . 48.5 t -57.02 -44.1 82.18 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.314 0 CA-C-N 116.269 -0.423 . . . . 0.0 110.485 -178.497 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 18.2 t70 -59.69 -41.81 91.55 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-O 120.757 0.313 . . . . 0.0 110.902 -177.651 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 43.8 t -64.32 -47.28 90.32 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.274 0 C-N-CA 120.692 -0.403 . . . . 0.0 110.459 -177.948 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 22' ' ' ILE . . . . . 0.581 HG22 HD12 ' A' ' 26' ' ' LEU . 50.2 mm -57.3 -42.05 79.48 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.244 0 C-N-CA 120.801 -0.359 . . . . 0.0 110.591 179.942 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 23' ' ' ARG . . . . . . . . . . . . . 56.5 ttp180 -55.8 -50.31 70.85 Favored 'General case' 0 C--N 1.331 -0.211 0 CA-C-O 120.928 0.394 . . . . 0.0 110.899 179.73 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 24' ' ' ILE . . . . . . . . . . . . . 77.5 mt -60.44 -41.02 86.01 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.251 0 CA-C-N 116.09 -0.505 . . . . 0.0 111.67 -176.961 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 25' ' ' LYS . . . . . 0.574 ' HE3' HD13 ' A' ' 22' ' ' ILE . 16.5 ptpt -72.49 -37.57 68.41 Favored 'General case' 0 CA--C 1.535 0.376 0 C-N-CA 120.622 -0.431 . . . . 0.0 112.115 -175.15 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 26' ' ' LEU . . . . . 0.581 HD12 HG22 ' A' ' 22' ' ' ILE . 43.9 mt -79.84 -39.5 30.52 Favored 'General case' 0 C--N 1.331 -0.209 0 N-CA-C 113.383 0.883 . . . . 0.0 113.383 -173.406 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 27' ' ' GLN . . . . . . . . . . . . . 9.9 pt20 -46.49 141.24 3.76 Favored 'General case' 0 N--CA 1.469 0.503 0 N-CA-C 112.958 0.725 . . . . 0.0 112.958 -173.492 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 97.26 -25.97 24.82 Favored Glycine 0 CA--C 1.534 1.262 0 CA-C-N 115.553 -0.749 . . . . 0.0 112.164 -177.304 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 84.0 mttt -97.94 155.14 17.22 Favored 'General case' 0 C--O 1.233 0.21 0 CA-C-N 117.232 0.516 . . . . 0.0 110.943 179.812 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 30' ' ' THR . . . . . . . . . . . . . 29.1 m -106.86 137.62 44.57 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.142 -0.481 . . . . 0.0 110.101 177.168 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 34.8 m -130.2 159.45 42.21 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.202 0 CA-C-N 116.321 -0.4 . . . . 0.0 110.84 -178.8 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 32' ' ' ARG . . . . . . . . . . . . . 82.2 mtm180 -132.82 150.93 52.11 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-O 121.31 0.576 . . . . 0.0 110.682 178.357 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 33' ' ' THR . . . . . . . . . . . . . 22.0 m -53.4 139.82 29.34 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.074 -0.512 . . . . 0.0 111.312 -178.764 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 100.11 -17.15 57.49 Favored Glycine 0 CA--C 1.532 1.119 0 CA-C-O 119.591 -0.561 . . . . 0.0 113.226 178.881 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 76.6 m-20 -66.08 147.98 52.52 Favored 'General case' 0 C--O 1.233 0.187 0 CA-C-N 118.078 0.939 . . . . 0.0 111.155 178.857 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 44.0 t -122.79 131.53 73.08 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.224 0 CA-C-N 115.937 -0.574 . . . . 0.0 109.906 178.871 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 37' ' ' ILE . . . . . . . . . . . . . 69.0 mt -120.95 139.01 49.5 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.253 0 CA-C-N 116.167 -0.469 . . . . 0.0 110.008 -179.683 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . -109.43 128.85 9.16 Favored Glycine 0 CA--C 1.527 0.785 0 N-CA-C 110.975 -0.85 . . . . 0.0 110.975 179.663 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 39' ' ' ILE . . . . . . . . . . . . . 77.6 mt -126.06 135.9 62.46 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.229 0 CA-C-O 120.765 0.317 . . . . 0.0 110.181 179.612 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 40' ' ' SER . . . . . . . . . . . . . 36.6 t -93.87 122.28 36.19 Favored 'General case' 0 C--N 1.331 -0.239 0 CA-C-N 116.309 -0.405 . . . . 0.0 110.902 175.149 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 41' ' ' ILE . . . . . . . . . . . . . 70.6 mt -133.36 127.43 53.89 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.202 0 CA-C-O 120.841 0.353 . . . . 0.0 110.376 178.662 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 83.4 mt 53.66 33.04 15.71 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 116.203 -0.453 . . . . 0.0 111.959 177.788 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . 72.39 29.37 66.22 Favored Glycine 0 CA--C 1.529 0.952 0 C-N-CA 121.112 -0.566 . . . . 0.0 112.313 177.839 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 44' ' ' LYS . . . . . . . . . . . . . 60.3 mttm -137.36 136.5 37.98 Favored 'General case' 0 C--N 1.331 -0.215 0 N-CA-C 109.862 -0.422 . . . . 0.0 109.862 178.723 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 84.4 tt0 -83.81 122.02 28.11 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.459 -0.337 . . . . 0.0 110.899 -179.688 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 46' ' ' VAL . . . . . . . . . . . . . 7.3 p -122.07 130.06 74.87 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.212 0 N-CA-C 109.547 -0.538 . . . . 0.0 109.547 176.221 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 64.3 mttp -100.66 128.4 46.72 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.011 -0.541 . . . . 0.0 110.994 178.935 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 48' ' ' PHE . . . . . . . . . . . . . 91.0 m-85 -111.12 131.89 54.72 Favored 'General case' 0 C--N 1.33 -0.272 0 N-CA-C 109.698 -0.482 . . . . 0.0 109.698 176.035 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 84.5 tttt -109.12 136.89 47.87 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.356 -0.383 . . . . 0.0 110.729 -179.558 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 50' ' ' VAL . . . . . . . . . . . . . 44.0 t -80.49 106.22 11.33 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.317 0 N-CA-C 109.178 -0.675 . . . . 0.0 109.178 175.159 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 51' ' ' VAL . . . . . . . . . . . . . 47.0 t -70.55 -53.21 23.47 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.354 0 N-CA-C 109.493 -0.558 . . . . 0.0 109.493 -175.035 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 52' ' ' GLN . . . . . . . . . . . . . 90.5 mt-30 -153.85 153.55 32.31 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-O 121.258 0.552 . . . . 0.0 111.796 -178.575 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -129.06 132.11 47.4 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 115.072 -0.967 . . . . 0.0 109.552 175.041 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 54' ' ' TYR . . . . . . . . . . . . . 25.1 t80 -129.03 110.1 18.28 Favored Pre-proline 0 CA--C 1.536 0.41 0 CA-C-O 118.197 -0.906 . . . . 0.0 110.048 179.391 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 55' ' ' PRO . . . . . . . . . . . . . 74.2 Cg_endo -77.17 170.01 72.67 Favored 'Cis proline' 0 N--CA 1.499 1.851 0 CA-C-N 121.877 1.706 . . . . 0.0 112.542 -4.103 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 56' ' ' SER . . . . . . . . . . . . . 13.6 m -115.55 127.61 26.65 Favored Pre-proline 0 CA--C 1.538 0.485 0 CA-C-O 118.344 -0.836 . . . . 0.0 109.506 176.214 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 57' ' ' PRO . . . . . . . . . . . . . 38.0 Cg_endo -66.6 168.5 50.82 Favored 'Cis proline' 0 N--CA 1.498 1.739 0 CA-C-N 122.081 1.779 . . . . 0.0 111.41 -0.657 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 58' ' ' LEU . . . . . 0.425 HD23 HD12 ' A' ' 4' ' ' LEU . 32.7 tp -130.55 136.15 48.63 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-O 120.926 0.393 . . . . 0.0 110.622 -178.997 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 59' ' ' ARG . . . . . . . . . . . . . 49.3 ttp180 -103.69 127.65 51.12 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 115.974 -0.557 . . . . 0.0 109.554 177.303 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 41.7 t -79.67 120.89 31.89 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.181 0 C-N-CA 120.57 -0.452 . . . . 0.0 110.143 -176.247 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 90.7 mt-10 -131.05 161.16 32.63 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 115.86 -0.609 . . . . 0.0 109.88 179.956 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 62' ' ' ASP . . . . . . . . . . . . . 12.7 t70 -54.34 -32.26 56.37 Favored 'General case' 0 C--N 1.328 -0.345 0 C-N-CA 120.926 -0.309 . . . . 0.0 111.714 177.728 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 63' ' ' ARG . . . . . . . . . . . . . 8.1 ptp180 -87.79 9.86 20.35 Favored 'General case' 0 CA--C 1.535 0.391 0 N-CA-C 113.568 0.951 . . . . 0.0 113.568 -175.405 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 39.5 m -92.2 141.0 29.06 Favored 'General case' 0 C--N 1.334 -0.085 0 CA-C-N 118.199 0.454 . . . . 0.0 110.437 -179.426 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 65' ' ' LYS . . . . . . . . . . . . . 67.0 mttm -88.82 127.16 35.61 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.151 -0.477 . . . . 0.0 110.258 179.915 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 66' ' ' ILE . . . . . . . . . . . . . 67.2 mt -115.18 129.13 71.93 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.236 0 N-CA-C 109.87 -0.419 . . . . 0.0 109.87 179.741 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 67' ' ' THR . . . . . . . . . . . . . 31.0 m -126.7 139.4 53.18 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-O 121.076 0.465 . . . . 0.0 111.107 -177.404 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 68' ' ' LEU . . . . . . . . . . . . . 33.8 mt . . . . . 0 C--N 1.33 -0.253 0 CA-C-N 115.825 -0.625 . . . . 0.0 110.229 176.481 . . . . . . . . 0 0 . 1 . 008 nuclear nobuild core ' A' A ' 74' ' ' ASP . . . . . . . . . . . . . 12.1 t70 . . . . . 0 CA--C 1.523 -0.062 0 N-CA-C 109.713 -0.477 . . . . 0.0 109.713 . . . . . . . . . 0 0 . 1 . 008 nuclear nobuild core ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 42.4 t -110.98 121.06 62.99 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.263 0 CA-C-O 121.17 0.509 . . . . 0.0 110.534 -177.671 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 76' ' ' LEU . . . . . . . . . . . . . 29.7 mt -123.9 137.48 54.63 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 115.483 -0.781 . . . . 0.0 109.083 177.149 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 77' ' ' GLU . . . . . . . . . . . . . 33.5 tt0 -136.7 135.84 38.53 Favored 'General case' 0 C--N 1.33 -0.257 0 C-N-CA 120.745 -0.382 . . . . 0.0 111.111 -175.727 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 78' ' ' ALA . . . . . 0.592 ' HB2' HD21 ' A' ' 109' ' ' LEU . . . -124.72 140.77 52.63 Favored 'General case' 0 N--CA 1.463 0.211 0 CA-C-N 116.059 -0.518 . . . . 0.0 110.281 179.064 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 79' ' ' LYS . . . . . 0.589 ' O ' HD13 ' A' ' 80' ' ' ILE . 63.6 mttp -83.25 123.66 29.81 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.358 -0.383 . . . . 0.0 110.546 -179.501 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 80' ' ' ILE . . . . . 0.589 HD13 ' O ' ' A' ' 79' ' ' LYS . 23.3 mm -139.23 114.1 7.96 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.247 0 N-CA-C 108.967 -0.753 . . . . 0.0 108.967 -178.822 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 81' ' ' LYS . . . . . . . . . . . . . 84.2 tttt -103.16 123.92 47.62 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-O 120.92 0.39 . . . . 0.0 111.35 -175.696 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . 89.1 42.17 5.68 Favored Glycine 0 CA--C 1.525 0.707 0 C-N-CA 120.95 -0.643 . . . . 0.0 111.933 173.185 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 83' ' ' ILE . . . . . . . . . . . . . 71.2 mt -68.33 136.9 25.54 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.287 0 N-CA-C 109.847 -0.427 . . . . 0.0 109.847 177.925 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 84' ' ' LYS . . . . . . . . . . . . . 28.6 ttpp -99.66 -48.29 4.78 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.086 -0.506 . . . . 0.0 109.999 179.858 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 85' ' ' ASP . . . . . . . . . . . . . 8.9 t70 -153.36 149.09 27.48 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 115.842 -0.617 . . . . 0.0 110.542 179.303 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 86' ' ' VAL . . . . . . . . . . . . . 45.0 t -128.16 130.51 69.6 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.218 0 CA-C-O 120.917 0.389 . . . . 0.0 110.245 179.558 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 87' ' ' ILE . . . . . 0.492 HD12 ' N ' ' A' ' 87' ' ' ILE . 5.1 mp -122.1 126.18 74.03 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.23 0 CA-C-N 116.007 -0.542 . . . . 0.0 109.58 177.721 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 88' ' ' LEU . . . . . . . . . . . . . 39.0 mt -113.21 137.99 50.64 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-O 121.207 0.527 . . . . 0.0 111.294 -178.104 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 89' ' ' ASP . . . . . . . . . . . . . 13.0 t70 -128.8 157.75 40.59 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 115.376 -0.829 . . . . 0.0 109.008 175.781 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 85.0 tt0 -46.79 -37.9 9.32 Favored 'General case' 0 C--N 1.33 -0.271 0 N-CA-C 112.97 0.73 . . . . 0.0 112.97 -172.07 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 91' ' ' ASN . . . . . . . . . . . . . 28.7 p30 -132.06 23.91 4.56 Favored 'General case' 0 N--CA 1.465 0.306 0 N-CA-C 112.863 0.69 . . . . 0.0 112.863 -177.89 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 92' ' ' LEU . . . . . . . . . . . . . 9.8 mt -149.24 144.45 26.54 Favored 'General case' 0 C--N 1.331 -0.206 0 N-CA-C 110.131 -0.322 . . . . 0.0 110.131 -177.547 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 93' ' ' ILE . . . . . . . . . . . . . 75.8 mt -127.69 119.0 50.63 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.247 0 N-CA-C 109.428 -0.582 . . . . 0.0 109.428 177.757 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 94' ' ' VAL . . . . . 0.427 HG21 HG21 ' A' ' 125' ' ' VAL . 45.5 t -121.39 128.3 75.87 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.261 0 CA-C-O 120.925 0.393 . . . . 0.0 110.133 179.984 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 95' ' ' VAL . . . . . . . . . . . . . 47.2 t -122.63 134.1 66.82 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.298 0 CA-C-N 115.863 -0.608 . . . . 0.0 109.754 -179.307 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 96' ' ' ILE . . . . . . . . . . . . . 60.0 mt -115.21 130.02 70.45 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.294 0 N-CA-C 109.273 -0.64 . . . . 0.0 109.273 179.127 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 97' ' ' THR . . . . . . . . . . . . . 73.1 p -103.81 156.28 17.94 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-O 121.253 0.549 . . . . 0.0 111.243 -178.107 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 98' ' ' GLU . . . . . . . . . . . . . 96.2 mt-10 -54.95 -26.89 39.45 Favored 'General case' 0 CA--C 1.532 0.276 0 CA-C-N 116.091 -0.504 . . . . 0.0 112.325 -179.041 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 99' ' ' GLU . . . . . . . . . . . . . 12.7 pt-20 -78.9 16.67 0.85 Allowed 'General case' 0 CA--C 1.535 0.382 0 N-CA-C 113.261 0.838 . . . . 0.0 113.261 -177.638 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 100' ' ' ASN . . . . . . . . . . . . . 3.1 m-20 63.53 37.59 10.35 Favored 'General case' 0 C--O 1.232 0.147 0 CA-C-O 121.072 0.463 . . . . 0.0 111.106 176.992 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 101' ' ' GLU . . . . . . . . . . . . . 85.0 tt0 -116.36 142.63 46.59 Favored 'General case' 0 C--N 1.331 -0.238 0 N-CA-C 109.709 -0.478 . . . . 0.0 109.709 175.819 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 102' ' ' VAL . . . . . . . . . . . . . 46.6 t -117.4 125.79 74.23 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.29 0 CA-C-N 116.179 -0.464 . . . . 0.0 109.908 -178.057 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 103' ' ' LEU . . . . . 0.483 HD12 ' N ' ' A' ' 103' ' ' LEU . 6.3 mp -116.5 134.57 54.7 Favored 'General case' 0 N--CA 1.463 0.185 0 CA-C-N 115.813 -0.631 . . . . 0.0 110.287 177.311 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 104' ' ' ILE . . . . . 0.43 HD12 ' HB3' ' A' ' 113' ' ' TYR . 66.0 mt -121.39 120.94 63.37 Favored 'Isoleucine or valine' 0 C--O 1.234 0.261 0 N-CA-C 110.051 -0.352 . . . . 0.0 110.051 -179.065 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 105' ' ' PHE . . . . . . . . . . . . . 66.3 m-85 -120.89 164.7 16.28 Favored 'General case' 0 C--N 1.331 -0.234 0 O-C-N 124.012 0.82 . . . . 0.0 109.688 179.593 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 106' ' ' ASN . . . . . . . . . . . . . 44.2 p-10 -100.88 -171.13 1.95 Allowed 'General case' 0 C--N 1.33 -0.276 0 N-CA-C 109.737 -0.468 . . . . 0.0 109.737 172.842 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 107' ' ' GLN . . . . . . . . . . . . . 29.7 tt0 -60.83 -27.59 68.19 Favored 'General case' 0 CA--C 1.533 0.31 0 N-CA-C 111.96 0.355 . . . . 0.0 111.96 178.785 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 108' ' ' ASN . . . . . . . . . . . . . 6.3 t-20 -81.97 6.0 17.4 Favored 'General case' 0 CA--C 1.538 0.501 0 N-CA-C 113.06 0.763 . . . . 0.0 113.06 -178.693 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 109' ' ' LEU . . . . . 0.592 HD21 ' HB2' ' A' ' 78' ' ' ALA . 11.2 tp 61.58 37.52 16.17 Favored 'General case' 0 C--O 1.233 0.204 0 CA-C-O 120.952 0.406 . . . . 0.0 111.3 178.319 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 110' ' ' GLU . . . . . . . . . . . . . 43.2 mt-10 -109.02 153.97 22.87 Favored 'General case' 0 C--N 1.33 -0.245 0 N-CA-C 110.091 -0.337 . . . . 0.0 110.091 177.375 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 111' ' ' GLU . . . . . . . . . . . . . 98.3 mt-10 -81.7 121.94 27.02 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-O 120.974 0.416 . . . . 0.0 111.098 -179.814 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 112' ' ' LEU . . . . . . . . . . . . . 21.3 mt -107.45 -45.47 4.07 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 115.887 -0.597 . . . . 0.0 109.963 175.835 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 113' ' ' TYR . . . . . 0.43 ' HB3' HD12 ' A' ' 104' ' ' ILE . 50.4 t80 -139.37 140.51 37.48 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 115.944 -0.571 . . . . 0.0 110.502 179.678 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 114' ' ' ARG . . . . . . . . . . . . . 32.0 ptt180 -150.92 120.74 7.06 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-O 120.917 0.389 . . . . 0.0 110.818 178.476 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 115' ' ' GLY . . . . . . . . . . . . . . . -150.24 163.04 29.42 Favored Glycine 0 CA--C 1.525 0.7 0 N-CA-C 111.314 -0.714 . . . . 0.0 111.314 -179.309 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 116' ' ' LYS . . . . . . . . . . . . . 36.2 ttpt -122.87 136.63 54.93 Favored 'General case' 0 C--N 1.33 -0.261 0 N-CA-C 109.671 -0.492 . . . . 0.0 109.671 175.988 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 117' ' ' PHE . . . . . . . . . . . . . 43.9 m-85 -134.21 115.55 14.3 Favored 'General case' 0 C--N 1.331 -0.22 0 CA-C-O 121.006 0.431 . . . . 0.0 110.343 -176.791 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 118' ' ' GLU . . . . . . . . . . . . . 84.2 tt0 -52.31 -49.16 64.75 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.271 -0.422 . . . . 0.0 111.785 -175.574 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 119' ' ' ASN . . . . . . . . . . . . . 86.2 m-20 -97.57 31.02 2.69 Favored 'General case' 0 C--N 1.33 -0.273 0 N-CA-C 112.284 0.475 . . . . 0.0 112.284 -173.791 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 120' ' ' LEU . . . . . . . . . . . . . 14.7 tp -58.24 121.8 11.63 Favored 'General case' 0 C--N 1.332 -0.177 0 N-CA-C 110.039 -0.356 . . . . 0.0 110.039 177.354 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 121' ' ' ASN . . . . . . . . . . . . . 72.7 m-20 -113.47 -44.05 3.26 Favored 'General case' 0 C--N 1.331 -0.203 0 CA-C-N 116.537 -0.301 . . . . 0.0 111.044 -177.176 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 122' ' ' LYS . . . . . . . . . . . . . 98.9 mttt -144.62 149.07 35.12 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-O 121.068 0.461 . . . . 0.0 111.689 -177.409 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 123' ' ' VAL . . . . . . . . . . . . . 40.3 t -128.81 129.63 68.4 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.305 0 N-CA-C 109.124 -0.695 . . . . 0.0 109.124 173.723 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 124' ' ' LEU . . . . . . . . . . . . . 66.2 mt -124.6 133.68 53.19 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-O 120.892 0.377 . . . . 0.0 111.017 -176.162 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 125' ' ' VAL . . . . . 0.427 HG21 HG21 ' A' ' 94' ' ' VAL . 42.0 t -124.92 125.07 69.08 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.239 0 CA-C-N 115.866 -0.606 . . . . 0.0 109.619 177.257 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 126' ' ' ARG . . . . . . . . . . . . . 84.7 mtt180 -149.08 130.35 14.62 Favored 'General case' 0 C--N 1.328 -0.35 0 N-CA-C 110.034 -0.358 . . . . 0.0 110.034 179.058 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 127' ' ' ASN . . . . . . . . . . . . . 3.4 t-20 55.75 -151.72 0.39 Allowed 'General case' 0 CA--C 1.54 0.57 0 N-CA-C 109.841 -0.429 . . . . 0.0 109.841 -179.514 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 128' ' ' ASP . . . . . . . . . . . . . 18.8 p-10 -83.64 17.27 2.31 Favored 'General case' 0 CA--C 1.535 0.37 0 N-CA-C 112.695 0.628 . . . . 0.0 112.695 178.44 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 129' ' ' LEU . . . . . . . . . . . . . 47.4 mt -116.96 138.87 51.27 Favored 'General case' 0 C--O 1.232 0.133 0 CA-C-N 118.1 0.409 . . . . 0.0 110.697 179.563 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 130' ' ' VAL . . . . . . . . . . . . . 45.6 t -124.66 138.64 53.39 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.215 0 CA-C-N 116.127 -0.488 . . . . 0.0 109.814 179.419 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 131' ' ' VAL . . . . . 0.489 HG12 HD12 ' A' ' 140' ' ' LEU . 35.3 m -136.0 144.36 33.56 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.24 0 CA-C-O 121.236 0.541 . . . . 0.0 111.359 -179.738 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 132' ' ' ILE . . . . . . . . . . . . . 73.9 mt -117.36 133.64 63.49 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.297 0 CA-C-N 115.326 -0.852 . . . . 0.0 109.269 179.202 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 133' ' ' ILE . . . . . . . . . . . . . 40.9 mm -116.03 119.09 60.87 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.255 0 CA-C-O 120.806 0.336 . . . . 0.0 111.159 -175.204 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 134' ' ' ASP . . . . . . . . . . . . . 8.0 p-10 -133.85 145.59 49.83 Favored 'General case' 0 C--N 1.331 -0.212 0 N-CA-C 109.365 -0.605 . . . . 0.0 109.365 174.181 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 135' ' ' GLU . . . . . . . . . . . . . 43.3 tp10 -50.03 -28.01 6.38 Favored 'General case' 0 C--N 1.327 -0.375 0 N-CA-C 112.616 0.598 . . . . 0.0 112.616 -172.755 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 136' ' ' GLN . . . . . . . . . . . . . 97.4 mt-30 -78.11 -37.19 46.88 Favored 'General case' 0 C--N 1.331 -0.221 0 N-CA-C 112.35 0.5 . . . . 0.0 112.35 -177.188 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 137' ' ' LYS . . . . . . . . . . . . . 53.4 pttt -165.85 172.87 11.17 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-O 121.683 0.754 . . . . 0.0 112.271 -171.964 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 138' ' ' LEU . . . . . . . . . . . . . 6.5 tt -118.14 130.93 56.4 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 114.902 -1.045 . . . . 0.0 109.787 178.359 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 139' ' ' THR . . . . . . . . . . . . . 37.2 m -108.16 129.93 55.15 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.353 179.727 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 140' ' ' LEU . . . . . 0.489 HD12 HG12 ' A' ' 131' ' ' VAL . 36.7 tp -113.46 121.83 45.47 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 115.478 -0.783 . . . . 0.0 109.254 -178.298 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 141' ' ' ILE . . . . . . . . . . . . . 19.8 mt -119.65 116.26 50.11 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.292 0 N-CA-C 109.797 -0.446 . . . . 0.0 109.797 -176.42 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 142' ' ' ARG . . . . . . . . . . . . . 84.3 mtp180 -104.88 124.17 49.0 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 115.329 -0.851 . . . . 0.0 110.537 -178.832 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 143' ' ' THR . . . . . . . . . . . . . 37.0 p . . . . . 0 C--O 1.221 -0.412 0 CA-C-O 117.972 -1.013 . . . . 0.0 110.595 -179.912 . . . . . . . . 0 0 . 1 . 008 nuclear nobuild core ' B' B ' 2' ' ' SER . . . . . . . . . . . . . 6.1 p . . . . . 0 C--O 1.233 0.193 0 CA-C-O 121.026 0.441 . . . . 0.0 110.481 . . . . . . . . . 0 0 . 1 . 008 nuclear nobuild core ' B' B ' 3' ' ' GLU . . . . . . . . . . . . . 84.6 tt0 -141.24 139.35 33.74 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 115.901 -0.591 . . . . 0.0 111.188 -179.108 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' B' B ' 4' ' ' LEU . . . . . . . . . . . . . 48.4 mt -119.75 129.77 54.65 Favored 'General case' 0 C--N 1.331 -0.212 0 CA-C-N 115.791 -0.64 . . . . 0.0 110.37 176.814 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' B' B ' 5' ' ' LYS . . . . . . . . . . . . . 59.9 mttp -104.75 119.22 38.48 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.167 -0.47 . . . . 0.0 110.257 177.187 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' B' B ' 6' ' ' LEU . . . . . . . . . . . . . 62.4 mt -117.46 144.16 45.3 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 115.516 -0.766 . . . . 0.0 110.075 -178.395 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' B' B ' 7' ' ' LYS . . . . . . . . . . . . . 33.7 ttpt -132.71 140.26 37.2 Favored Pre-proline 0 CA--C 1.532 0.279 0 CA-C-O 119.176 -0.44 . . . . 0.0 110.231 176.549 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' B' B ' 8' ' ' PRO . . . . . . . . . . . . . 91.5 Cg_endo -91.98 134.74 1.47 Allowed 'Trans proline' 0 N--CA 1.488 1.191 0 C-N-CA 121.795 1.663 . . . . 0.0 111.543 176.864 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' B' B ' 9' ' ' LEU . . . . . 0.436 HD12 ' HB2' ' B' ' 47' ' ' LYS . 26.8 mt -70.19 -46.99 21.33 Favored Pre-proline 0 CA--C 1.533 0.308 0 CA-C-O 118.683 -0.675 . . . . 0.0 112.026 -178.855 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' B' B ' 10' ' ' PRO . . . . . . . . . . . . . 94.6 Cg_endo -81.89 155.26 17.66 Favored 'Trans proline' 0 N--CA 1.496 1.631 0 C-N-CA 121.29 1.327 . . . . 0.0 111.883 175.372 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' B' B ' 11' ' ' LYS . . . . . . . . . . . . . 38.6 mmtm -88.18 102.6 14.96 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-O 120.793 0.33 . . . . 0.0 110.65 178.105 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' B' B ' 12' ' ' VAL . . . . . . . . . . . . . 12.2 p -146.45 146.47 18.89 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.26 0 CA-C-N 116.207 -0.451 . . . . 0.0 110.267 178.946 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' B' B ' 13' ' ' GLU . . . . . . . . . . . . . 80.6 tt0 -86.54 131.32 34.2 Favored 'General case' 0 C--N 1.33 -0.269 0 N-CA-C 109.941 -0.392 . . . . 0.0 109.941 178.312 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' B' B ' 14' ' ' LEU . . . . . . . . . . . . . 29.5 mt -96.57 151.67 38.11 Favored Pre-proline 0 CA--C 1.533 0.32 0 CA-C-N 116.402 -0.363 . . . . 0.0 110.814 -176.703 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' B' B ' 15' ' ' PRO . . . . . . . . . . . . . 25.8 Cg_exo -62.03 158.64 37.93 Favored 'Trans proline' 0 N--CA 1.497 1.735 0 C-N-CA 121.273 1.315 . . . . 0.0 111.93 176.793 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' B' B ' 16' ' ' PRO . . . . . . . . . . . . . 37.9 Cg_exo -58.71 -38.99 86.29 Favored 'Trans proline' 0 N--CA 1.498 1.741 0 C-N-CA 121.388 1.392 . . . . 0.0 112.835 -178.899 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' B' B ' 17' ' ' ASP . . . . . . . . . . . . . 10.7 p-10 -87.67 10.26 18.71 Favored 'General case' 0 CA--C 1.535 0.371 0 N-CA-C 113.279 0.844 . . . . 0.0 113.279 -176.951 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' B' B ' 18' ' ' PHE . . . . . . . . . . . . . 42.7 t80 -58.0 -44.95 87.5 Favored 'General case' 0 N--CA 1.457 -0.087 0 O-C-N 121.973 -0.454 . . . . 0.0 110.26 -177.489 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' B' B ' 19' ' ' VAL . . . . . 0.41 HG13 ' N ' ' B' ' 20' ' ' ASP . 13.6 p -56.15 -41.68 70.27 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.327 0 CA-C-N 116.62 -0.263 . . . . 0.0 110.958 -178.589 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' B' B ' 20' ' ' ASP . . . . . 0.41 ' N ' HG13 ' B' ' 19' ' ' VAL . 82.5 m-20 -60.83 -43.53 98.14 Favored 'General case' 0 C--N 1.331 -0.21 0 CA-C-O 120.799 0.333 . . . . 0.0 110.82 -178.278 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' B' B ' 21' ' ' VAL . . . . . . . . . . . . . 49.1 t -63.94 -48.46 86.05 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.285 0 C-N-CA 120.744 -0.383 . . . . 0.0 110.509 -177.347 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' B' B ' 22' ' ' ILE . . . . . 0.496 HG22 HD12 ' B' ' 26' ' ' LEU . 49.8 mm -55.61 -47.06 79.35 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.274 0 C-N-CA 120.978 -0.289 . . . . 0.0 110.892 -179.34 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' B' B ' 23' ' ' ARG . . . . . . . . . . . . . 45.7 ttp180 -55.69 -48.94 74.25 Favored 'General case' 0 C--N 1.33 -0.255 0 C-N-CA 120.83 -0.348 . . . . 0.0 111.234 -177.841 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' B' B ' 24' ' ' ILE . . . . . . . . . . . . . 76.3 mt -59.85 -41.63 86.39 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.215 0 C-N-CA 121.081 -0.248 . . . . 0.0 111.203 -177.407 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' B' B ' 25' ' ' LYS . . . . . . . . . . . . . 40.3 mmtm -64.08 -43.03 96.67 Favored 'General case' 0 C--N 1.329 -0.3 0 N-CA-C 112.216 0.451 . . . . 0.0 112.216 -179.593 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' B' B ' 26' ' ' LEU . . . . . 0.496 HD12 HG22 ' B' ' 22' ' ' ILE . 71.4 mt -78.69 -38.51 39.05 Favored 'General case' 0 C--N 1.328 -0.327 0 N-CA-C 113.502 0.927 . . . . 0.0 113.502 -169.888 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' B' B ' 27' ' ' GLN . . . . . . . . . . . . . 10.3 pt20 -47.52 140.13 6.21 Favored 'General case' 0 N--CA 1.469 0.51 0 N-CA-C 112.704 0.631 . . . . 0.0 112.704 -174.788 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' B' B ' 28' ' ' GLY . . . . . . . . . . . . . . . 98.73 -27.46 19.64 Favored Glycine 0 CA--C 1.532 1.137 0 CA-C-N 115.53 -0.759 . . . . 0.0 112.179 -178.438 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' B' B ' 29' ' ' LYS . . . . . . . . . . . . . 61.3 mtpt -98.25 155.03 17.38 Favored 'General case' 0 C--N 1.332 -0.181 0 CA-C-N 117.314 0.557 . . . . 0.0 111.06 179.602 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' B' B ' 30' ' ' THR . . . . . . . . . . . . . 30.1 m -94.54 136.73 34.51 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.032 -0.531 . . . . 0.0 110.003 176.321 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' B' B ' 31' ' ' VAL . . . . . . . . . . . . . 35.1 m -124.87 148.4 29.28 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.228 0 CA-C-N 116.308 -0.406 . . . . 0.0 110.549 -179.798 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' B' B ' 32' ' ' ARG . . . . . . . . . . . . . 33.6 ttm180 -136.02 146.52 47.24 Favored 'General case' 0 C--N 1.331 -0.219 0 CA-C-O 121.267 0.555 . . . . 0.0 110.583 178.501 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' B' B ' 33' ' ' THR . . . . . . . . . . . . . 22.8 m -53.04 139.93 26.72 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.206 -0.452 . . . . 0.0 111.317 -178.56 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' B' B ' 34' ' ' GLY . . . . . . . . . . . . . . . 101.23 -17.18 56.19 Favored Glycine 0 CA--C 1.534 1.254 0 CA-C-O 119.669 -0.517 . . . . 0.0 113.172 -179.989 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' B' B ' 35' ' ' ASP . . . . . . . . . . . . . 80.2 m-20 -66.57 146.99 53.9 Favored 'General case' 0 N--CA 1.461 0.108 0 CA-C-N 118.024 0.912 . . . . 0.0 111.086 178.421 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' B' B ' 36' ' ' VAL . . . . . . . . . . . . . 43.6 t -123.1 130.99 74.06 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.258 0 CA-C-N 116.009 -0.541 . . . . 0.0 109.781 177.898 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' B' B ' 37' ' ' ILE . . . . . . . . . . . . . 66.7 mt -122.17 138.84 51.02 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.289 0 CA-C-N 116.285 -0.416 . . . . 0.0 110.093 -179.401 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' B' B ' 38' ' ' GLY . . . . . . . . . . . . . . . -108.76 128.63 9.15 Favored Glycine 0 CA--C 1.526 0.746 0 N-CA-C 110.995 -0.842 . . . . 0.0 110.995 178.878 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' B' B ' 39' ' ' ILE . . . . . . . . . . . . . 74.6 mt -125.77 136.84 59.61 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.21 0 N-CA-C 110.16 -0.311 . . . . 0.0 110.16 179.766 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' B' B ' 40' ' ' SER . . . . . . . . . . . . . 38.0 t -92.59 115.33 28.0 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.363 -0.38 . . . . 0.0 110.832 175.822 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' B' B ' 41' ' ' ILE . . . . . . . . . . . . . 44.3 mm -121.48 119.1 58.03 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.198 0 CA-C-N 116.509 -0.314 . . . . 0.0 110.412 -179.905 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' B' B ' 42' ' ' LEU . . . . . . . . . . . . . 9.6 tp 53.27 36.88 23.86 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.194 -0.457 . . . . 0.0 111.576 176.964 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' B' B ' 43' ' ' GLY . . . . . . . . . . . . . . . 72.99 27.26 69.06 Favored Glycine 0 CA--C 1.53 0.993 0 C-N-CA 121.145 -0.55 . . . . 0.0 112.591 177.02 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' B' B ' 44' ' ' LYS . . . . . . . . . . . . . 97.8 mttt -136.67 134.91 37.76 Favored 'General case' 0 C--N 1.331 -0.212 0 N-CA-C 109.58 -0.526 . . . . 0.0 109.58 177.47 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' B' B ' 45' ' ' GLU . . . . . . . . . . . . . 84.3 tt0 -82.82 122.55 28.36 Favored 'General case' 0 C--N 1.329 -0.321 0 C-N-CA 120.701 -0.4 . . . . 0.0 111.066 -177.726 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' B' B ' 46' ' ' VAL . . . . . . . . . . . . . 7.1 p -121.04 128.53 76.08 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.206 0 N-CA-C 109.391 -0.596 . . . . 0.0 109.391 175.768 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' B' B ' 47' ' ' LYS . . . . . 0.436 ' HB2' HD12 ' B' ' 9' ' ' LEU . 68.5 mttm -100.31 126.87 46.69 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 115.979 -0.555 . . . . 0.0 110.971 178.335 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' B' B ' 48' ' ' PHE . . . . . . . . . . . . . 90.3 m-85 -109.14 131.95 54.58 Favored 'General case' 0 C--N 1.331 -0.228 0 N-CA-C 109.697 -0.483 . . . . 0.0 109.697 176.661 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' B' B ' 49' ' ' LYS . . . . . . . . . . . . . 83.1 tttt -108.54 135.5 49.7 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.282 -0.417 . . . . 0.0 110.371 179.037 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' B' B ' 50' ' ' VAL . . . . . . . . . . . . . 47.4 t -79.8 106.84 11.49 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.273 0 N-CA-C 109.164 -0.68 . . . . 0.0 109.164 175.906 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' B' B ' 51' ' ' VAL . . . . . . . . . . . . . 47.9 t -72.65 -48.62 45.55 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.273 0 CA-C-N 115.961 -0.563 . . . . 0.0 110.098 -173.547 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' B' B ' 52' ' ' GLN . . . . . . . . . . . . . 62.5 tt0 -161.83 145.58 12.4 Favored 'General case' 0 C--N 1.33 -0.246 0 C-N-CA 120.207 -0.597 . . . . 0.0 111.597 -177.341 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' B' B ' 53' ' ' ALA . . . . . . . . . . . . . . . -122.71 134.73 54.45 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 115.877 -0.602 . . . . 0.0 109.852 175.852 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' B' B ' 54' ' ' TYR . . . . . . . . . . . . . 31.2 t80 -129.07 111.71 18.4 Favored Pre-proline 0 CA--C 1.534 0.361 0 CA-C-O 118.331 -0.842 . . . . 0.0 110.506 -179.716 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' B' B ' 55' ' ' PRO . . . . . . . . . . . . . 74.3 Cg_endo -77.18 168.28 77.37 Favored 'Cis proline' 0 N--CA 1.5 1.882 0 CA-C-N 121.832 1.69 . . . . 0.0 112.005 -8.089 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' B' B ' 56' ' ' SER . . . . . . . . . . . . . 49.8 m -117.03 136.38 23.3 Favored Pre-proline 0 CA--C 1.537 0.468 0 CA-C-O 118.525 -0.75 . . . . 0.0 109.796 175.952 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' B' B ' 57' ' ' PRO . . . . . . . . . . . . . 43.1 Cg_endo -69.61 163.52 81.22 Favored 'Cis proline' 0 N--CA 1.497 1.714 0 CA-C-N 121.794 1.677 . . . . 0.0 111.259 -4.277 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' B' B ' 58' ' ' LEU . . . . . . . . . . . . . 20.8 tp -130.4 138.95 50.61 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-O 120.811 0.338 . . . . 0.0 110.829 -178.583 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' B' B ' 59' ' ' ARG . . . . . . . . . . . . . 55.9 ttp180 -99.18 124.17 44.02 Favored 'General case' 0 C--N 1.328 -0.352 0 N-CA-C 109.2 -0.667 . . . . 0.0 109.2 174.035 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' B' B ' 60' ' ' VAL . . . . . . . . . . . . . 40.7 t -73.77 125.35 32.77 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.289 0 C-N-CA 120.595 -0.442 . . . . 0.0 110.341 -175.113 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' B' B ' 61' ' ' GLU . . . . . . . . . . . . . 95.9 mt-10 -130.26 160.9 32.48 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 115.837 -0.619 . . . . 0.0 110.092 179.699 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' B' B ' 62' ' ' ASP . . . . . . . . . . . . . 7.3 p-10 -56.08 -32.9 64.56 Favored 'General case' 0 C--N 1.328 -0.349 0 C-N-CA 120.852 -0.339 . . . . 0.0 111.435 178.69 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' B' B ' 63' ' ' ARG . . . . . . . . . . . . . 15.5 ptm180 -82.59 6.7 16.82 Favored 'General case' 0 CA--C 1.537 0.473 0 N-CA-C 113.52 0.933 . . . . 0.0 113.52 -177.361 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' B' B ' 64' ' ' THR . . . . . . . . . . . . . 21.3 m -87.2 139.39 30.61 Favored 'General case' 0 C--N 1.333 -0.13 0 CA-C-N 118.119 0.418 . . . . 0.0 110.611 -178.262 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' B' B ' 65' ' ' LYS . . . . . . . . . . . . . 48.7 mtmt -88.89 128.71 35.68 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.082 -0.508 . . . . 0.0 110.373 179.291 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' B' B ' 66' ' ' ILE . . . . . . . . . . . . . 66.9 mt -117.73 128.31 74.94 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.261 0 N-CA-C 109.783 -0.451 . . . . 0.0 109.783 179.928 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' B' B ' 67' ' ' THR . . . . . . . . . . . . . 25.2 m -122.2 135.88 54.83 Favored 'General case' 0 C--N 1.332 -0.172 0 CA-C-O 121.074 0.464 . . . . 0.0 110.727 -179.096 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' B' B ' 68' ' ' LEU . . . . . 0.478 HD12 ' N ' ' B' ' 68' ' ' LEU . 8.0 mp . . . . . 0 C--N 1.33 -0.276 0 CA-C-N 115.815 -0.63 . . . . 0.0 110.344 178.781 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' B' B ' 73' ' ' VAL . . . . . . . . . . . . . 34.9 m . . . . . 0 C--O 1.23 0.074 0 CA-C-O 121.052 0.453 . . . . 0.0 110.828 . . . . . . . . . 0 0 . 1 . 008 nuclear nobuild core ' B' B ' 74' ' ' ASP . . . . . . . . . . . . . 12.8 t70 -94.07 121.33 35.45 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 115.679 -0.691 . . . . 0.0 109.686 178.067 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' B' B ' 75' ' ' VAL . . . . . . . . . . . . . 45.8 t -110.29 122.57 65.06 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.236 0 CA-C-O 121.246 0.545 . . . . 0.0 110.42 -178.378 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' B' B ' 76' ' ' LEU . . . . . . . . . . . . . 26.7 mt -126.93 146.56 50.27 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 115.39 -0.823 . . . . 0.0 109.422 178.687 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' B' B ' 77' ' ' GLU . . . . . . . . . . . . . 97.6 mt-10 -134.35 138.8 45.18 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-O 121.089 0.471 . . . . 0.0 111.193 -177.346 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' B' B ' 78' ' ' ALA . . . . . 0.533 ' HB2' HD21 ' B' ' 109' ' ' LEU . . . -125.29 130.54 52.22 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 115.636 -0.711 . . . . 0.0 109.607 176.203 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' B' B ' 79' ' ' LYS . . . . . 0.66 ' O ' HD13 ' B' ' 80' ' ' ILE . 79.4 tttt -78.45 119.48 21.81 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-O 120.906 0.384 . . . . 0.0 110.636 -176.508 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' B' B ' 80' ' ' ILE . . . . . 0.66 HD13 ' O ' ' B' ' 79' ' ' LYS . 37.6 mm -139.24 105.02 2.32 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.325 0 N-CA-C 108.926 -0.768 . . . . 0.0 108.926 -178.807 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' B' B ' 81' ' ' LYS . . . . . . . . . . . . . 56.1 pttt -98.54 127.98 44.68 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-O 120.936 0.398 . . . . 0.0 111.557 -176.71 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' B' B ' 82' ' ' GLY . . . . . . . . . . . . . . . 89.14 42.12 5.67 Favored Glycine 0 CA--C 1.526 0.766 0 C-N-CA 121.036 -0.602 . . . . 0.0 111.975 175.148 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' B' B ' 83' ' ' ILE . . . . . . . . . . . . . 74.2 mt -71.81 138.88 20.72 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 N-CA-C 109.646 -0.502 . . . . 0.0 109.646 176.478 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' B' B ' 84' ' ' LYS . . . . . . . . . . . . . 33.1 ttpt -99.88 -52.94 3.3 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-O 120.938 0.399 . . . . 0.0 110.177 -179.802 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' B' B ' 85' ' ' ASP . . . . . . . . . . . . . 11.1 t70 -145.88 147.43 31.77 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 115.915 -0.584 . . . . 0.0 110.518 -178.813 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' B' B ' 86' ' ' VAL . . . . . . . . . . . . . 44.9 t -128.06 131.88 69.04 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.254 0 CA-C-O 120.81 0.338 . . . . 0.0 110.496 -179.105 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' B' B ' 87' ' ' ILE . . . . . 0.496 ' N ' HD12 ' B' ' 87' ' ' ILE . 5.1 mp -122.26 127.15 75.1 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.168 0 N-CA-C 109.692 -0.485 . . . . 0.0 109.692 177.434 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' B' B ' 88' ' ' LEU . . . . . . . . . . . . . 17.4 tp -111.22 131.63 54.97 Favored 'General case' 0 C--N 1.331 -0.201 0 CA-C-O 120.954 0.407 . . . . 0.0 110.934 -178.471 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' B' B ' 89' ' ' ASP . . . . . . . . . . . . . 5.9 t70 -126.09 155.33 41.77 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.014 -0.539 . . . . 0.0 109.73 178.039 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' B' B ' 90' ' ' GLU . . . . . . . . . . . . . 84.2 tt0 -47.12 -38.52 11.68 Favored 'General case' 0 CA--C 1.531 0.248 0 N-CA-C 112.888 0.699 . . . . 0.0 112.888 -172.181 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' B' B ' 91' ' ' ASN . . . . . . . . . . . . . 14.7 m120 -128.09 17.42 6.66 Favored 'General case' 0 N--CA 1.469 0.482 0 N-CA-C 113.007 0.743 . . . . 0.0 113.007 -177.085 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' B' B ' 92' ' ' LEU . . . . . . . . . . . . . 35.6 mt -147.91 144.46 28.09 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-O 120.801 0.334 . . . . 0.0 110.433 -176.171 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' B' B ' 93' ' ' ILE . . . . . . . . . . . . . 70.5 mt -122.84 115.32 45.49 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.373 0 N-CA-C 109.056 -0.72 . . . . 0.0 109.056 177.376 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' B' B ' 94' ' ' VAL . . . . . . . . . . . . . 42.6 t -117.32 126.84 74.81 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.283 0 CA-C-O 120.901 0.381 . . . . 0.0 110.178 -177.111 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' B' B ' 95' ' ' VAL . . . . . . . . . . . . . 46.5 t -122.39 133.18 69.41 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.337 0 CA-C-N 115.933 -0.576 . . . . 0.0 109.773 179.874 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' B' B ' 96' ' ' ILE . . . . . 0.51 HD11 ' HB ' ' B' ' 123' ' ' VAL . 66.0 mt -115.21 125.22 72.43 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.329 0 N-CA-C 109.315 -0.624 . . . . 0.0 109.315 179.097 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' B' B ' 97' ' ' THR . . . . . . . . . . . . . 80.4 p -99.75 158.0 16.09 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-O 121.202 0.525 . . . . 0.0 111.191 -176.127 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' B' B ' 98' ' ' GLU . . . . . . . . . . . . . 44.9 mt-10 -53.95 -26.12 24.03 Favored 'General case' 0 C--N 1.329 -0.319 0 N-CA-C 112.308 0.485 . . . . 0.0 112.308 -179.268 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' B' B ' 99' ' ' GLU . . . . . . . . . . . . . 70.0 mm-40 -78.84 15.73 1.02 Allowed 'General case' 0 CA--C 1.535 0.371 0 N-CA-C 113.203 0.816 . . . . 0.0 113.203 -176.829 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' B' B ' 100' ' ' ASN . . . . . . . . . . . . . 2.4 m-20 62.24 38.01 13.74 Favored 'General case' 0 N--CA 1.463 0.2 0 CA-C-O 121.118 0.485 . . . . 0.0 110.996 178.647 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' B' B ' 101' ' ' GLU . . . . . . . . . . . . . 84.6 tt0 -116.77 142.79 46.46 Favored 'General case' 0 C--N 1.331 -0.224 0 CA-C-N 116.021 -0.536 . . . . 0.0 109.917 176.486 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' B' B ' 102' ' ' VAL . . . . . . . . . . . . . 43.2 t -114.96 125.0 72.17 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.327 0 N-CA-C 109.738 -0.467 . . . . 0.0 109.738 -178.957 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' B' B ' 103' ' ' LEU . . . . . . . . . . . . . 57.5 mt -115.23 131.52 56.9 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 115.637 -0.71 . . . . 0.0 109.906 177.819 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' B' B ' 104' ' ' ILE . . . . . 0.419 HD12 ' HB3' ' B' ' 113' ' ' TYR . 67.4 mt -118.82 118.39 57.61 Favored 'Isoleucine or valine' 0 C--O 1.234 0.271 0 N-CA-C 110.096 -0.335 . . . . 0.0 110.096 -178.831 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' B' B ' 105' ' ' PHE . . . . . . . . . . . . . 68.8 m-85 -115.07 162.95 16.31 Favored 'General case' 0 C--N 1.332 -0.191 0 O-C-N 124.196 0.935 . . . . 0.0 109.893 179.265 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' B' B ' 106' ' ' ASN . . . . . . . . . . . . . 45.0 p-10 -102.62 -170.11 1.76 Allowed 'General case' 0 C--N 1.329 -0.3 0 N-CA-C 109.801 -0.444 . . . . 0.0 109.801 174.392 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' B' B ' 107' ' ' GLN . . . . . . . . . . . . . 60.3 tt0 -58.52 -28.27 65.28 Favored 'General case' 0 C--N 1.33 -0.248 0 N-CA-C 111.968 0.359 . . . . 0.0 111.968 177.682 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' B' B ' 108' ' ' ASN . . . . . . . . . . . . . 10.6 t-20 -84.11 7.09 19.9 Favored 'General case' 0 CA--C 1.536 0.439 0 N-CA-C 113.235 0.828 . . . . 0.0 113.235 -177.625 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' B' B ' 109' ' ' LEU . . . . . 0.533 HD21 ' HB2' ' B' ' 78' ' ' ALA . 6.5 tp 60.52 36.61 19.97 Favored 'General case' 0 C--O 1.233 0.197 0 CA-C-O 120.891 0.377 . . . . 0.0 111.414 178.745 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' B' B ' 110' ' ' GLU . . . . . . . . . . . . . 70.8 mm-40 -115.45 150.64 36.14 Favored 'General case' 0 C--N 1.331 -0.215 0 CA-C-O 120.723 0.297 . . . . 0.0 110.321 177.117 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' B' B ' 111' ' ' GLU . . . . . . . . . . . . . 24.7 mm-40 -78.14 122.69 25.97 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-O 121.188 0.518 . . . . 0.0 111.762 -177.752 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' B' B ' 112' ' ' LEU . . . . . . . . . . . . . 57.7 mt -102.94 -42.63 5.76 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 115.449 -0.796 . . . . 0.0 110.137 173.622 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' B' B ' 113' ' ' TYR . . . . . 0.419 ' HB3' HD12 ' B' ' 104' ' ' ILE . 56.3 t80 -139.12 140.81 38.05 Favored 'General case' 0 N--CA 1.463 0.205 0 CA-C-O 120.978 0.418 . . . . 0.0 111.329 -179.677 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' B' B ' 114' ' ' ARG . . . . . . . . . . . . . 66.4 mtm180 -139.85 125.27 19.06 Favored 'General case' 0 C--N 1.331 -0.22 0 CA-C-N 115.794 -0.639 . . . . 0.0 110.247 177.515 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' B' B ' 115' ' ' GLY . . . . . . . . . . . . . . . -150.03 153.12 24.9 Favored Glycine 0 CA--C 1.524 0.604 0 C-N-CA 120.697 -0.763 . . . . 0.0 111.581 179.46 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' B' B ' 116' ' ' LYS . . . . . . . . . . . . . 39.8 ttpt -122.16 135.15 54.75 Favored 'General case' 0 C--N 1.33 -0.258 0 N-CA-C 109.602 -0.518 . . . . 0.0 109.602 176.104 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' B' B ' 117' ' ' PHE . . . . . . . . . . . . . 47.1 m-85 -134.92 113.96 12.06 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-O 121.037 0.446 . . . . 0.0 110.335 -176.611 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' B' B ' 118' ' ' GLU . . . . . . . . . . . . . 84.8 tt0 -53.41 -49.87 66.38 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.384 -0.371 . . . . 0.0 111.485 -176.771 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' B' B ' 119' ' ' ASN . . . . . . . . . . . . . 19.6 m-80 -94.21 30.99 1.77 Allowed 'General case' 0 C--N 1.329 -0.284 0 N-CA-C 112.111 0.412 . . . . 0.0 112.111 -174.591 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' B' B ' 120' ' ' LEU . . . . . . . . . . . . . 14.9 tp -57.42 122.88 13.65 Favored 'General case' 0 C--N 1.332 -0.188 0 N-CA-C 110.28 -0.267 . . . . 0.0 110.28 178.289 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' B' B ' 121' ' ' ASN . . . . . . . . . . . . . 80.9 m-20 -114.01 -44.07 3.19 Favored 'General case' 0 C--N 1.331 -0.204 0 CA-C-N 116.628 -0.26 . . . . 0.0 111.215 -176.617 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' B' B ' 122' ' ' LYS . . . . . . . . . . . . . 54.0 mttm -143.34 145.71 32.92 Favored 'General case' 0 C--N 1.331 -0.199 0 C-N-CA 120.593 -0.443 . . . . 0.0 111.478 -177.406 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' B' B ' 123' ' ' VAL . . . . . 0.51 ' HB ' HD11 ' B' ' 96' ' ' ILE . 46.3 t -126.31 128.54 71.59 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.259 0 N-CA-C 109.38 -0.6 . . . . 0.0 109.38 175.522 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' B' B ' 124' ' ' LEU . . . . . . . . . . . . . 40.4 mt -126.84 136.45 52.37 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-O 120.812 0.339 . . . . 0.0 110.773 -177.292 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' B' B ' 125' ' ' VAL . . . . . . . . . . . . . 11.4 p -136.23 130.39 47.83 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.298 0 CA-C-N 116.338 -0.392 . . . . 0.0 110.134 177.244 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' B' B ' 126' ' ' ARG . . . . . . . . . . . . . 29.5 mmm180 -138.17 119.91 15.2 Favored 'General case' 0 C--N 1.331 -0.201 0 CA-C-N 116.281 -0.418 . . . . 0.0 110.417 -178.977 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' B' B ' 127' ' ' ASN . . . . . . . . . . . . . 78.3 m-20 50.14 -104.85 0.16 Allowed 'General case' 0 CA--C 1.544 0.713 0 CA-C-O 119.176 -0.44 . . . . 0.0 111.794 176.622 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' B' B ' 128' ' ' ASP . . . . . . . . . . . . . 18.1 p-10 -110.54 -0.43 17.34 Favored 'General case' 0 CA--C 1.536 0.415 0 N-CA-C 113.752 1.019 . . . . 0.0 113.752 -174.759 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' B' B ' 129' ' ' LEU . . . . . . . . . . . . . 83.7 mt -111.01 144.22 40.47 Favored 'General case' 0 C--N 1.332 -0.175 0 O-C-N 121.972 -0.455 . . . . 0.0 110.273 179.349 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' B' B ' 130' ' ' VAL . . . . . 0.566 HG13 ' HB ' ' B' ' 141' ' ' ILE . 13.6 p -130.81 138.58 53.25 Favored 'Isoleucine or valine' 0 C--O 1.233 0.214 0 CA-C-O 121.188 0.518 . . . . 0.0 110.423 178.706 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' B' B ' 131' ' ' VAL . . . . . . . . . . . . . 37.5 t -135.11 138.95 48.06 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.263 0 CA-C-N 115.858 -0.61 . . . . 0.0 110.47 -175.773 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' B' B ' 132' ' ' ILE . . . . . . . . . . . . . 70.1 mt -117.22 129.77 73.21 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.283 0 CA-C-N 115.866 -0.606 . . . . 0.0 109.409 178.869 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' B' B ' 133' ' ' ILE . . . . . . . . . . . . . 43.5 mm -114.0 119.46 61.22 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.244 0 CA-C-O 120.815 0.34 . . . . 0.0 110.652 -176.183 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' B' B ' 134' ' ' ASP . . . . . . . . . . . . . 9.0 p-10 -134.43 143.04 47.33 Favored 'General case' 0 C--N 1.33 -0.27 0 N-CA-C 109.586 -0.524 . . . . 0.0 109.586 177.05 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' B' B ' 135' ' ' GLU . . . . . . . . . . . . . 85.7 tt0 -49.93 -25.84 3.63 Favored 'General case' 0 C--N 1.328 -0.347 0 N-CA-C 112.594 0.59 . . . . 0.0 112.594 -174.316 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' B' B ' 136' ' ' GLN . . . . . . . . . . . . . 53.2 mt-30 -78.95 -38.28 37.48 Favored 'General case' 0 CA--C 1.531 0.216 0 N-CA-C 112.138 0.422 . . . . 0.0 112.138 -178.016 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' B' B ' 137' ' ' LYS . . . . . . . . . . . . . 19.6 ptpt -162.77 174.46 12.44 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-O 121.49 0.662 . . . . 0.0 111.958 -173.458 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' B' B ' 138' ' ' LEU . . . . . . . . . . . . . 6.1 tt -117.88 126.77 53.0 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 115.098 -0.956 . . . . 0.0 109.568 177.007 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' B' B ' 139' ' ' THR . . . . . . . . . . . . . 28.6 m -108.78 124.86 51.26 Favored 'General case' 0 C--N 1.331 -0.204 0 CA-C-N 116.372 -0.376 . . . . 0.0 110.619 -178.882 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' B' B ' 140' ' ' LEU . . . . . . . . . . . . . 17.9 tp -112.17 119.02 36.95 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 115.579 -0.737 . . . . 0.0 109.124 -179.449 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' B' B ' 141' ' ' ILE . . . . . 0.566 ' HB ' HG13 ' B' ' 130' ' ' VAL . 19.9 mt -119.29 121.11 65.74 Favored 'Isoleucine or valine' 0 C--O 1.235 0.309 0 CA-C-O 121.236 0.541 . . . . 0.0 110.375 -176.209 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' B' B ' 142' ' ' ARG . . . . . . . . . . . . . 7.8 mmm180 -94.75 117.34 29.97 Favored 'General case' 0 C--N 1.331 -0.224 0 CA-C-N 114.861 -1.063 . . . . 0.0 109.718 177.86 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' B' B ' 143' ' ' THR . . . . . . . . . . . . . 6.0 p . . . . . 0 C--O 1.221 -0.444 0 CA-C-O 117.929 -1.034 . . . . 0.0 110.523 -177.914 . . . . . . . . 0 0 . 1 . 008 nuclear nobuild core ' C' C ' 2' ' ' SER . . . . . . . . . . . . . 3.1 p . . . . . 0 C--O 1.232 0.135 0 CA-C-O 121.041 0.448 . . . . 0.0 110.41 . . . . . . . . . 0 0 . 1 . 008 nuclear nobuild core ' C' C ' 3' ' ' GLU . . . . . . . . . . . . . 96.0 mt-10 -140.35 141.1 35.68 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 115.72 -0.673 . . . . 0.0 110.951 -177.886 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' C' C ' 4' ' ' LEU . . . . . . . . . . . . . 18.3 tp -123.19 127.06 48.12 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 115.771 -0.65 . . . . 0.0 109.799 175.795 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' C' C ' 5' ' ' LYS . . . . . . . . . . . . . 98.8 mttt -110.41 119.77 40.28 Favored 'General case' 0 C--O 1.234 0.26 0 CA-C-N 116.427 -0.352 . . . . 0.0 110.789 -179.257 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' C' C ' 6' ' ' LEU . . . . . . . . . . . . . 70.9 mt -114.8 143.98 44.23 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 115.302 -0.863 . . . . 0.0 110.277 -179.187 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' C' C ' 7' ' ' LYS . . . . . . . . . . . . . 51.3 tttm -128.26 133.29 24.99 Favored Pre-proline 0 CA--C 1.535 0.39 0 CA-C-O 118.777 -0.63 . . . . 0.0 110.102 177.442 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' C' C ' 8' ' ' PRO . . . . . . . . . . . . . 73.4 Cg_endo -89.01 136.32 2.95 Favored 'Trans proline' 0 N--CA 1.491 1.378 0 C-N-CA 121.61 1.54 . . . . 0.0 111.501 176.699 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' C' C ' 9' ' ' LEU . . . . . . . . . . . . . 75.8 mt -75.29 -52.08 3.16 Favored Pre-proline 0 CA--C 1.533 0.32 0 CA-C-O 118.712 -0.661 . . . . 0.0 112.02 -177.312 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' C' C ' 10' ' ' PRO . . . . . . . . . . . . . 60.4 Cg_endo -72.95 150.23 48.54 Favored 'Trans proline' 0 N--CA 1.5 1.866 0 C-N-CA 121.085 1.19 . . . . 0.0 111.948 174.375 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' C' C ' 11' ' ' LYS . . . . . . . . . . . . . 41.0 mtpt -89.13 100.78 13.49 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.502 -0.317 . . . . 0.0 110.825 179.391 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' C' C ' 12' ' ' VAL . . . . . . . . . . . . . 12.4 p -146.24 143.39 21.09 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.336 0 CA-C-N 116.265 -0.425 . . . . 0.0 110.579 179.223 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' C' C ' 13' ' ' GLU . . . . . . . . . . . . . 95.0 mt-10 -81.09 123.99 28.85 Favored 'General case' 0 C--N 1.33 -0.274 0 N-CA-C 109.98 -0.378 . . . . 0.0 109.98 177.916 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' C' C ' 14' ' ' LEU . . . . . . . . . . . . . 28.2 mt -98.27 152.31 37.92 Favored Pre-proline 0 CA--C 1.532 0.287 0 CA-C-N 116.425 -0.352 . . . . 0.0 110.601 -179.046 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' C' C ' 15' ' ' PRO . . . . . . . . . . . . . 34.3 Cg_exo -58.41 156.07 32.74 Favored 'Trans proline' 0 N--CA 1.497 1.693 0 C-N-CA 121.323 1.348 . . . . 0.0 111.854 178.088 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' C' C ' 16' ' ' PRO . . . . . . . . . . . . . 39.3 Cg_exo -58.85 -34.36 99.01 Favored 'Trans proline' 0 N--CA 1.496 1.64 0 C-N-CA 121.475 1.45 . . . . 0.0 112.677 -179.821 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' C' C ' 17' ' ' ASP . . . . . . . . . . . . . 19.4 p-10 -85.3 9.78 14.37 Favored 'General case' 0 CA--C 1.535 0.375 0 N-CA-C 113.081 0.771 . . . . 0.0 113.081 -177.545 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' C' C ' 18' ' ' PHE . . . . . . . . . . . . . 34.7 t80 -56.79 -42.15 78.96 Favored 'General case' 0 C--N 1.333 -0.118 0 O-C-N 121.939 -0.476 . . . . 0.0 110.365 -179.378 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' C' C ' 19' ' ' VAL . . . . . . . . . . . . . 53.1 t -56.43 -44.47 80.34 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 CA-C-N 116.361 -0.381 . . . . 0.0 110.469 -179.335 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' C' C ' 20' ' ' ASP . . . . . . . . . . . . . 82.8 m-20 -59.8 -42.5 93.55 Favored 'General case' 0 C--N 1.329 -0.308 0 C-N-CA 120.817 -0.353 . . . . 0.0 110.785 -178.271 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' C' C ' 21' ' ' VAL . . . . . . . . . . . . . 56.2 t -63.37 -47.75 90.45 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.303 0 C-N-CA 120.736 -0.385 . . . . 0.0 110.464 -177.294 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' C' C ' 22' ' ' ILE . . . . . 0.569 HG22 HD12 ' C' ' 26' ' ' LEU . 51.3 mm -55.42 -48.75 76.64 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.326 0 C-N-CA 121.077 -0.249 . . . . 0.0 110.8 -179.976 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' C' C ' 23' ' ' ARG . . . . . . . . . . . . . 55.4 ttp180 -55.66 -47.8 76.09 Favored 'General case' 0 C--N 1.33 -0.276 0 C-N-CA 120.806 -0.358 . . . . 0.0 111.415 -177.314 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' C' C ' 24' ' ' ILE . . . . . . . . . . . . . 75.8 mt -59.29 -42.01 85.87 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.311 0 C-N-CA 121.089 -0.244 . . . . 0.0 111.315 -177.284 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' C' C ' 25' ' ' LYS . . . . . . . . . . . . . 93.3 mttt -67.82 -43.79 78.78 Favored 'General case' 0 C--N 1.331 -0.219 0 N-CA-C 112.6 0.592 . . . . 0.0 112.6 -178.903 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' C' C ' 26' ' ' LEU . . . . . 0.569 HD12 HG22 ' C' ' 22' ' ' ILE . 70.6 mt -78.31 -33.96 48.98 Favored 'General case' 0 C--N 1.329 -0.313 0 N-CA-C 113.548 0.944 . . . . 0.0 113.548 -169.967 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' C' C ' 27' ' ' GLN . . . . . . . . . . . . . 6.2 pt20 -46.76 138.79 5.86 Favored 'General case' 0 N--CA 1.467 0.385 0 N-CA-C 112.971 0.73 . . . . 0.0 112.971 -173.925 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' C' C ' 28' ' ' GLY . . . . . . . . . . . . . . . 100.05 -27.18 21.51 Favored Glycine 0 CA--C 1.532 1.116 0 CA-C-N 115.614 -0.721 . . . . 0.0 112.214 -178.906 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' C' C ' 29' ' ' LYS . . . . . . . . . . . . . 61.8 mttp -97.96 155.21 17.2 Favored 'General case' 0 C--O 1.232 0.159 0 CA-C-N 117.341 0.571 . . . . 0.0 111.301 179.475 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' C' C ' 30' ' ' THR . . . . . . . . . . . . . 37.3 m -104.92 139.95 38.89 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-N 115.954 -0.566 . . . . 0.0 109.898 175.817 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' C' C ' 31' ' ' VAL . . . . . . . . . . . . . 34.7 m -127.31 152.26 35.13 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.218 0 CA-C-O 120.947 0.403 . . . . 0.0 111.077 -178.048 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' C' C ' 32' ' ' ARG . . . . . . . . . . . . . 97.1 mtt180 -126.35 149.47 49.17 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 115.834 -0.621 . . . . 0.0 110.622 177.912 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' C' C ' 33' ' ' THR . . . . . 0.401 HG23 ' O ' ' C' ' 51' ' ' VAL . 17.6 m -53.65 138.81 33.93 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-N 116.118 -0.492 . . . . 0.0 111.308 -178.658 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' C' C ' 34' ' ' GLY . . . . . . . . . . . . . . . 100.2 -17.15 57.4 Favored Glycine 0 CA--C 1.533 1.194 0 CA-C-O 119.672 -0.515 . . . . 0.0 113.333 178.967 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' C' C ' 35' ' ' ASP . . . . . . . . . . . . . 77.5 m-20 -65.53 148.35 51.88 Favored 'General case' 0 N--CA 1.462 0.142 0 CA-C-N 117.965 0.883 . . . . 0.0 110.922 178.869 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' C' C ' 36' ' ' VAL . . . . . . . . . . . . . 41.4 t -120.53 131.52 72.49 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.258 0 CA-C-N 116.007 -0.542 . . . . 0.0 109.858 178.943 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' C' C ' 37' ' ' ILE . . . . . . . . . . . . . 67.1 mt -118.68 138.11 50.46 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.225 0 CA-C-N 116.082 -0.508 . . . . 0.0 109.682 179.276 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' C' C ' 38' ' ' GLY . . . . . . . . . . . . . . . -114.85 128.75 8.28 Favored Glycine 0 CA--C 1.525 0.67 0 N-CA-C 111.006 -0.838 . . . . 0.0 111.006 -179.878 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' C' C ' 39' ' ' ILE . . . . . . . . . . . . . 73.0 mt -123.21 137.35 56.89 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.186 0 N-CA-C 110.252 -0.277 . . . . 0.0 110.252 179.585 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' C' C ' 40' ' ' SER . . . . . . . . . . . . . 99.5 p -91.69 117.71 30.0 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.329 -0.396 . . . . 0.0 110.713 175.767 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' C' C ' 41' ' ' ILE . . . . . 0.426 HD12 HG11 ' C' ' 46' ' ' VAL . 72.0 mt -127.79 121.48 56.64 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.202 0 CA-C-O 120.902 0.382 . . . . 0.0 110.397 178.82 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' C' C ' 42' ' ' LEU . . . . . . . . . . . . . 10.8 tp 52.3 35.61 17.5 Favored 'General case' 0 CA--C 1.531 0.23 0 CA-C-N 116.036 -0.529 . . . . 0.0 111.614 177.087 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' C' C ' 43' ' ' GLY . . . . . . . . . . . . . . . 72.07 31.88 63.73 Favored Glycine 0 CA--C 1.529 0.92 0 C-N-CA 121.183 -0.532 . . . . 0.0 111.972 178.047 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' C' C ' 44' ' ' LYS . . . . . . . . . . . . . 40.7 ttpt -138.79 129.75 26.58 Favored 'General case' 0 C--N 1.329 -0.313 0 N-CA-C 109.609 -0.515 . . . . 0.0 109.609 178.743 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' C' C ' 45' ' ' GLU . . . . . . . . . . . . . 84.6 tt0 -82.6 118.23 23.14 Favored 'General case' 0 C--N 1.328 -0.335 0 C-N-CA 120.753 -0.379 . . . . 0.0 110.673 -178.768 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' C' C ' 46' ' ' VAL . . . . . 0.426 HG11 HD12 ' C' ' 41' ' ' ILE . 7.5 p -114.94 127.36 72.52 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.153 0 N-CA-C 109.285 -0.635 . . . . 0.0 109.285 176.795 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' C' C ' 47' ' ' LYS . . . . . . . . . . . . . 64.2 mttp -100.45 128.15 46.59 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 115.817 -0.629 . . . . 0.0 111.306 179.724 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' C' C ' 48' ' ' PHE . . . . . . . . . . . . . 94.9 m-85 -111.83 131.86 55.07 Favored 'General case' 0 C--N 1.329 -0.283 0 N-CA-C 109.652 -0.499 . . . . 0.0 109.652 174.956 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' C' C ' 49' ' ' LYS . . . . . . . . . . . . . 41.8 tttp -107.57 136.57 47.12 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.619 -0.264 . . . . 0.0 110.427 179.287 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' C' C ' 50' ' ' VAL . . . . . . . . . . . . . 46.4 t -79.87 108.75 13.69 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.305 0 N-CA-C 109.164 -0.68 . . . . 0.0 109.164 176.273 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' C' C ' 51' ' ' VAL . . . . . 0.401 ' O ' HG23 ' C' ' 33' ' ' THR . 46.8 t -73.24 -51.63 25.13 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.293 0 CA-C-N 116.153 -0.476 . . . . 0.0 109.737 -175.336 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' C' C ' 52' ' ' GLN . . . . . . . . . . . . . 86.2 mt-30 -154.03 149.17 26.91 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-O 121.334 0.587 . . . . 0.0 112.077 -178.007 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' C' C ' 53' ' ' ALA . . . . . 0.531 ' HB3' ' OG ' ' C' ' 56' ' ' SER . . . -124.25 130.31 52.3 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 115.091 -0.958 . . . . 0.0 109.5 172.885 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' C' C ' 54' ' ' TYR . . . . . . . . . . . . . 45.5 t80 -128.97 107.08 18.1 Favored Pre-proline 0 CA--C 1.535 0.386 0 CA-C-O 118.24 -0.886 . . . . 0.0 110.593 -179.383 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' C' C ' 55' ' ' PRO . . . . . . . . . . . . . 73.3 Cg_endo -77.1 168.68 76.34 Favored 'Cis proline' 0 N--CA 1.499 1.827 0 CA-C-N 121.821 1.686 . . . . 0.0 112.243 -5.413 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' C' C ' 56' ' ' SER . . . . . 0.531 ' OG ' ' HB3' ' C' ' 53' ' ' ALA . 71.1 m -116.57 133.26 23.03 Favored Pre-proline 0 CA--C 1.537 0.472 0 CA-C-O 118.544 -0.741 . . . . 0.0 109.342 174.989 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' C' C ' 57' ' ' PRO . . . . . . . . . . . . . 55.3 Cg_endo -70.79 146.27 83.94 Favored 'Cis proline' 0 N--CA 1.498 1.745 0 CA-C-N 121.844 1.694 . . . . 0.0 111.688 -0.561 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' C' C ' 58' ' ' LEU . . . . . . . . . . . . . 31.4 tp -108.03 137.63 45.7 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.085 -0.507 . . . . 0.0 110.605 -178.7 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' C' C ' 59' ' ' ARG . . . . . . . . . . . . . 37.1 ttm180 -98.91 133.56 43.02 Favored 'General case' 0 C--N 1.328 -0.355 0 N-CA-C 109.453 -0.573 . . . . 0.0 109.453 175.273 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' C' C ' 60' ' ' VAL . . . . . . . . . . . . . 40.1 t -87.01 113.8 25.16 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.236 0 C-N-CA 120.616 -0.434 . . . . 0.0 110.386 -178.112 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' C' C ' 61' ' ' GLU . . . . . . . . . . . . . 15.7 mm-40 -131.1 163.66 27.17 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 115.944 -0.571 . . . . 0.0 109.769 174.246 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' C' C ' 62' ' ' ASP . . . . . . . . . . . . . 81.8 m-20 -52.32 -32.21 36.79 Favored 'General case' 0 C--N 1.329 -0.309 0 N-CA-C 111.802 0.297 . . . . 0.0 111.802 177.743 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' C' C ' 63' ' ' ARG . . . . . . . . . . . . . 41.4 mtp180 -72.07 -22.07 61.42 Favored 'General case' 0 CA--C 1.533 0.299 0 N-CA-C 112.884 0.698 . . . . 0.0 112.884 -176.484 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' C' C ' 64' ' ' THR . . . . . . . . . . . . . 40.5 m -72.27 138.12 47.22 Favored 'General case' 0 C--N 1.332 -0.186 0 CA-C-O 120.918 0.39 . . . . 0.0 110.657 -176.467 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' C' C ' 65' ' ' LYS . . . . . . . . . . . . . 38.8 ttpt -88.63 127.11 35.56 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 115.989 -0.551 . . . . 0.0 110.239 179.549 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' C' C ' 66' ' ' ILE . . . . . . . . . . . . . 72.5 mt -112.96 132.09 62.72 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.28 0 CA-C-O 120.892 0.377 . . . . 0.0 110.064 -178.053 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' C' C ' 67' ' ' THR . . . . . . . . . . . . . 23.4 m -125.29 137.26 54.07 Favored 'General case' 0 C--N 1.331 -0.212 0 CA-C-N 116.091 -0.504 . . . . 0.0 110.655 -179.239 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' C' C ' 68' ' ' LEU . . . . . . . . . . . . . 13.8 tp . . . . . 0 C--N 1.33 -0.245 0 CA-C-N 115.887 -0.597 . . . . 0.0 110.527 179.841 . . . . . . . . 0 0 . 1 . 008 nuclear nobuild core ' C' C ' 73' ' ' VAL . . . . . . . . . . . . . 34.6 m . . . . . 0 N--CA 1.462 0.159 0 CA-C-O 120.752 0.31 . . . . 0.0 110.369 . . . . . . . . . 0 0 . 1 . 008 nuclear nobuild core ' C' C ' 74' ' ' ASP . . . . . . . . . . . . . 42.3 t0 -104.55 121.52 43.66 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-N 116.332 -0.394 . . . . 0.0 110.183 -177.966 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' C' C ' 75' ' ' VAL . . . . . 0.44 ' C ' HD12 ' C' ' 76' ' ' LEU . 40.6 t -118.24 125.91 74.62 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.326 0 CA-C-O 121.107 0.479 . . . . 0.0 111.005 -176.462 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' C' C ' 76' ' ' LEU . . . . . 0.44 HD12 ' C ' ' C' ' 75' ' ' VAL . 6.8 mp -121.53 143.99 48.96 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 115.601 -0.727 . . . . 0.0 109.732 174.681 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' C' C ' 77' ' ' GLU . . . . . . . . . . . . . 97.0 mt-10 -134.47 130.67 37.06 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-O 120.988 0.423 . . . . 0.0 111.016 -177.995 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' C' C ' 78' ' ' ALA . . . . . . . . . . . . . . . -117.98 134.09 55.29 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 115.663 -0.699 . . . . 0.0 109.766 176.933 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' C' C ' 79' ' ' LYS . . . . . 0.58 ' O ' HD13 ' C' ' 80' ' ' ILE . 49.2 mtmt -77.47 120.71 22.85 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-O 120.967 0.413 . . . . 0.0 110.967 -177.956 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' C' C ' 80' ' ' ILE . . . . . 0.58 HD13 ' O ' ' C' ' 79' ' ' LYS . 42.1 mm -139.09 108.54 3.87 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.322 0 N-CA-C 108.933 -0.765 . . . . 0.0 108.933 -179.009 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' C' C ' 81' ' ' LYS . . . . . . . . . . . . . 44.0 mtmt -101.44 123.34 45.34 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-O 120.723 0.297 . . . . 0.0 111.257 -176.382 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' C' C ' 82' ' ' GLY . . . . . . . . . . . . . . . 89.07 42.43 5.62 Favored Glycine 0 CA--C 1.526 0.738 0 C-N-CA 120.652 -0.785 . . . . 0.0 111.794 174.674 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' C' C ' 83' ' ' ILE . . . . . . . . . . . . . 68.0 mt -65.29 137.03 25.73 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 CA-C-O 121.001 0.429 . . . . 0.0 109.862 177.733 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' C' C ' 84' ' ' LYS . . . . . . . . . . . . . 46.3 tttp -92.94 -52.52 4.55 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 115.942 -0.572 . . . . 0.0 109.94 179.891 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' C' C ' 85' ' ' ASP . . . . . . . . . . . . . 7.0 t70 -154.33 151.98 29.71 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 115.478 -0.783 . . . . 0.0 110.321 -179.225 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' C' C ' 86' ' ' VAL . . . . . . . . . . . . . 43.4 t -130.46 129.76 64.8 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.287 0 CA-C-N 116.47 -0.332 . . . . 0.0 110.495 -179.485 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' C' C ' 87' ' ' ILE . . . . . 0.501 ' N ' HD12 ' C' ' 87' ' ' ILE . 5.1 mp -119.37 128.78 75.85 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.285 0 N-CA-C 109.405 -0.591 . . . . 0.0 109.405 176.184 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' C' C ' 88' ' ' LEU . . . . . . . . . . . . . 23.7 tp -117.58 135.96 53.61 Favored 'General case' 0 C--N 1.331 -0.216 0 CA-C-O 121.014 0.435 . . . . 0.0 111.556 -176.126 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' C' C ' 89' ' ' ASP . . . . . . . . . . . . . 10.9 t70 -130.01 154.31 47.53 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 115.665 -0.698 . . . . 0.0 109.19 174.537 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' C' C ' 90' ' ' GLU . . . . . . . . . . . . . 96.6 mt-10 -49.81 -35.0 21.26 Favored 'General case' 0 C--N 1.33 -0.261 0 N-CA-C 112.718 0.636 . . . . 0.0 112.718 -172.277 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' C' C ' 91' ' ' ASN . . . . . . . . . . . . . 86.2 m-20 -130.29 32.61 4.44 Favored 'General case' 0 N--CA 1.465 0.294 0 N-CA-C 111.99 0.367 . . . . 0.0 111.99 -175.902 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' C' C ' 92' ' ' LEU . . . . . . . . . . . . . 8.7 tp -166.1 145.75 6.15 Favored 'General case' 0 C--N 1.331 -0.228 0 C-N-CA 120.933 -0.307 . . . . 0.0 110.782 178.67 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' C' C ' 93' ' ' ILE . . . . . . . . . . . . . 68.0 mt -125.93 124.08 65.47 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.181 0 N-CA-C 109.586 -0.524 . . . . 0.0 109.586 179.391 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' C' C ' 94' ' ' VAL . . . . . . . . . . . . . 43.3 t -122.64 125.21 72.21 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.223 0 N-CA-C 109.937 -0.394 . . . . 0.0 109.937 179.344 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' C' C ' 95' ' ' VAL . . . . . . . . . . . . . 43.8 t -124.08 134.67 65.94 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.299 0 CA-C-N 116.305 -0.407 . . . . 0.0 110.168 -179.461 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' C' C ' 96' ' ' ILE . . . . . . . . . . . . . 61.1 mt -118.99 130.52 73.7 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.238 0 N-CA-C 109.457 -0.571 . . . . 0.0 109.457 179.54 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' C' C ' 97' ' ' THR . . . . . . . . . . . . . 81.1 p -103.46 158.44 16.35 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-O 121.088 0.47 . . . . 0.0 111.44 -177.295 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' C' C ' 98' ' ' GLU . . . . . . . . . . . . . 98.1 mt-10 -53.97 -26.5 26.09 Favored 'General case' 0 CA--C 1.532 0.257 0 N-CA-C 112.392 0.516 . . . . 0.0 112.392 179.998 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' C' C ' 99' ' ' GLU . . . . . . . . . . . . . 95.8 mt-10 -77.78 14.05 1.18 Allowed 'General case' 0 CA--C 1.535 0.391 0 N-CA-C 113.302 0.853 . . . . 0.0 113.302 -177.23 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' C' C ' 100' ' ' ASN . . . . . . . . . . . . . 4.6 m-20 63.01 37.95 11.35 Favored 'General case' 0 C--O 1.232 0.142 0 CA-C-O 121.08 0.467 . . . . 0.0 111.033 178.489 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' C' C ' 101' ' ' GLU . . . . . . . . . . . . . 84.9 tt0 -117.65 140.11 50.1 Favored 'General case' 0 C--N 1.333 -0.151 0 CA-C-N 116.083 -0.508 . . . . 0.0 109.646 175.697 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' C' C ' 102' ' ' VAL . . . . . . . . . . . . . 45.7 t -115.16 128.83 72.18 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.263 0 CA-C-N 116.311 -0.404 . . . . 0.0 110.063 -178.667 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' C' C ' 103' ' ' LEU . . . . . 0.514 HD12 ' N ' ' C' ' 103' ' ' LEU . 6.1 mp -118.4 132.94 56.24 Favored 'General case' 0 C--N 1.331 -0.201 0 CA-C-N 115.695 -0.684 . . . . 0.0 110.131 176.904 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' C' C ' 104' ' ' ILE . . . . . . . . . . . . . 67.9 mt -117.92 122.48 69.82 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.228 0 CA-C-N 116.328 -0.397 . . . . 0.0 109.972 -179.766 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' C' C ' 105' ' ' PHE . . . . . . . . . . . . . 67.1 m-85 -123.16 164.67 18.24 Favored 'General case' 0 C--N 1.333 -0.132 0 O-C-N 123.916 0.76 . . . . 0.0 109.777 -179.972 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' C' C ' 106' ' ' ASN . . . . . . . . . . . . . 47.3 p-10 -102.42 -172.08 2.07 Favored 'General case' 0 C--N 1.33 -0.246 0 N-CA-C 110.151 -0.315 . . . . 0.0 110.151 174.688 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' C' C ' 107' ' ' GLN . . . . . . . . . . . . . 29.1 tt0 -58.81 -28.07 65.67 Favored 'General case' 0 C--N 1.329 -0.311 0 N-CA-C 112.086 0.402 . . . . 0.0 112.086 179.166 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' C' C ' 108' ' ' ASN . . . . . . . . . . . . . 7.9 t-20 -84.75 12.12 7.85 Favored 'General case' 0 CA--C 1.537 0.453 0 N-CA-C 112.89 0.7 . . . . 0.0 112.89 -177.956 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' C' C ' 109' ' ' LEU . . . . . . . . . . . . . 10.7 tp 53.8 37.22 25.89 Favored 'General case' 0 C--N 1.333 -0.148 0 CA-C-O 121.089 0.471 . . . . 0.0 111.315 179.409 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' C' C ' 110' ' ' GLU . . . . . . . . . . . . . 96.0 mt-10 -105.98 141.88 36.64 Favored 'General case' 0 C--N 1.33 -0.272 0 N-CA-C 109.325 -0.62 . . . . 0.0 109.325 174.528 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' C' C ' 111' ' ' GLU . . . . . . . . . . . . . 51.4 tt0 -79.61 121.92 25.87 Favored 'General case' 0 C--N 1.328 -0.332 0 C-N-CA 120.693 -0.403 . . . . 0.0 110.286 -176.478 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' C' C ' 112' ' ' LEU . . . . . . . . . . . . . 34.3 mt -102.85 -46.11 4.79 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.034 -0.53 . . . . 0.0 110.72 -179.668 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' C' C ' 113' ' ' TYR . . . . . . . . . . . . . 59.1 t80 -137.45 140.8 41.46 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.034 -0.53 . . . . 0.0 110.927 -177.824 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' C' C ' 114' ' ' ARG . . . . . . . . . . . . . 28.5 ptt180 -144.83 126.08 14.75 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-O 120.93 0.395 . . . . 0.0 110.664 176.56 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' C' C ' 115' ' ' GLY . . . . . . . . . . . . . . . -150.01 151.8 23.82 Favored Glycine 0 CA--C 1.524 0.61 0 N-CA-C 111.131 -0.788 . . . . 0.0 111.131 179.297 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' C' C ' 116' ' ' LYS . . . . . . . . . . . . . 39.7 ttpt -119.53 132.55 55.78 Favored 'General case' 0 C--N 1.329 -0.296 0 N-CA-C 110.006 -0.368 . . . . 0.0 110.006 178.185 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' C' C ' 117' ' ' PHE . . . . . . . . . . . . . 37.5 m-85 -128.93 113.8 15.66 Favored 'General case' 0 C--N 1.329 -0.286 0 N-CA-C 109.878 -0.416 . . . . 0.0 109.878 -178.257 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' C' C ' 118' ' ' GLU . . . . . . . . . . . . . 85.1 tt0 -55.54 -38.49 69.35 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-N 116.398 -0.364 . . . . 0.0 111.339 -175.308 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' C' C ' 119' ' ' ASN . . . . . . . . . . . . . 10.5 p-10 -108.73 31.14 5.87 Favored 'General case' 0 N--CA 1.463 0.196 0 N-CA-C 112.237 0.458 . . . . 0.0 112.237 -173.106 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' C' C ' 120' ' ' LEU . . . . . . . . . . . . . 15.0 tp -54.36 126.81 24.71 Favored 'General case' 0 N--CA 1.463 0.21 0 O-C-N 122.358 -0.213 . . . . 0.0 110.683 177.024 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' C' C ' 121' ' ' ASN . . . . . . . . . . . . . 27.1 m120 -110.56 -44.22 3.72 Favored 'General case' 0 C--N 1.332 -0.187 0 C-N-CA 121.169 -0.212 . . . . 0.0 111.173 -177.06 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' C' C ' 122' ' ' LYS . . . . . . . . . . . . . 95.2 mttt -148.36 148.15 30.05 Favored 'General case' 0 C--N 1.331 -0.229 0 CA-C-O 121.028 0.442 . . . . 0.0 111.44 -178.266 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' C' C ' 123' ' ' VAL . . . . . . . . . . . . . 47.0 t -127.42 128.33 69.83 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.223 0 N-CA-C 109.569 -0.53 . . . . 0.0 109.569 174.769 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' C' C ' 124' ' ' LEU . . . . . . . . . . . . . 67.9 mt -126.45 135.22 51.1 Favored 'General case' 0 C--N 1.331 -0.217 0 CA-C-N 116.494 -0.321 . . . . 0.0 110.626 -178.785 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' C' C ' 125' ' ' VAL . . . . . 0.515 HG23 HG22 ' C' ' 130' ' ' VAL . 12.4 p -138.05 137.45 44.5 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.284 0 CA-C-N 116.442 -0.345 . . . . 0.0 110.524 179.141 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' C' C ' 126' ' ' ARG . . . . . . . . . . . . . 90.6 mtt180 -143.96 123.32 13.08 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.565 178.676 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' C' C ' 127' ' ' ASN . . . . . . . . . . . . . 1.9 m-80 51.67 -105.02 0.19 Allowed 'General case' 0 CA--C 1.544 0.723 0 CA-C-O 119.134 -0.46 . . . . 0.0 111.279 -179.814 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' C' C ' 128' ' ' ASP . . . . . . . . . . . . . 8.9 p-10 -114.11 1.99 14.77 Favored 'General case' 0 CA--C 1.536 0.406 0 CA-C-N 119.538 1.063 . . . . 0.0 113.49 -176.53 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' C' C ' 129' ' ' LEU . . . . . . . . . . . . . 54.4 mt -104.97 135.49 46.21 Favored 'General case' 0 C--N 1.332 -0.185 0 CA-C-N 118.193 0.451 . . . . 0.0 110.401 179.618 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' C' C ' 130' ' ' VAL . . . . . 0.515 HG22 HG23 ' C' ' 125' ' ' VAL . 47.2 t -123.35 135.16 64.15 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.22 0 N-CA-C 109.913 -0.403 . . . . 0.0 109.913 179.991 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' C' C ' 131' ' ' VAL . . . . . 0.48 HG22 HD12 ' C' ' 140' ' ' LEU . 42.0 t -134.32 135.37 54.29 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.344 0 CA-C-O 121.125 0.488 . . . . 0.0 110.103 178.257 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' C' C ' 132' ' ' ILE . . . . . . . . . . . . . 72.5 mt -115.35 130.2 70.31 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.361 0 CA-C-N 115.498 -0.774 . . . . 0.0 109.179 -179.682 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' C' C ' 133' ' ' ILE . . . . . . . . . . . . . 44.6 mm -114.06 120.03 62.78 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.248 0 CA-C-O 120.981 0.419 . . . . 0.0 110.631 -176.226 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' C' C ' 134' ' ' ASP . . . . . . . . . . . . . 6.7 p-10 -129.58 149.51 51.31 Favored 'General case' 0 C--N 1.331 -0.23 0 CA-C-N 115.97 -0.559 . . . . 0.0 109.539 176.117 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' C' C ' 135' ' ' GLU . . . . . . . . . . . . . 41.4 tp10 -49.96 -27.05 4.81 Favored 'General case' 0 C--N 1.327 -0.378 0 N-CA-C 112.806 0.669 . . . . 0.0 112.806 -169.927 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' C' C ' 136' ' ' GLN . . . . . . . . . . . . . 30.7 tt0 -103.67 -22.82 13.51 Favored 'General case' 0 N--CA 1.465 0.282 0 N-CA-C 113.093 0.775 . . . . 0.0 113.093 -173.402 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' C' C ' 137' ' ' LYS . . . . . . . . . . . . . 54.0 mtmt -148.77 157.16 43.24 Favored 'General case' 0 C--N 1.332 -0.153 0 CA-C-O 121.212 0.529 . . . . 0.0 112.008 -170.649 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' C' C ' 138' ' ' LEU . . . . . 0.415 HD23 ' C ' ' C' ' 138' ' ' LEU . 5.5 tt -120.18 125.48 48.29 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 115.568 -0.742 . . . . 0.0 109.444 175.312 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' C' C ' 139' ' ' THR . . . . . . . . . . . . . 37.6 m -111.57 131.57 55.15 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-O 120.762 0.315 . . . . 0.0 111.126 -176.463 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' C' C ' 140' ' ' LEU . . . . . 0.48 HD12 HG22 ' C' ' 131' ' ' VAL . 14.3 tp -116.35 122.5 45.06 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 115.527 -0.761 . . . . 0.0 109.428 -179.67 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' C' C ' 141' ' ' ILE . . . . . . . . . . . . . 19.5 mt -120.77 119.45 59.59 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.29 0 N-CA-C 109.687 -0.486 . . . . 0.0 109.687 -177.258 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' C' C ' 142' ' ' ARG . . . . . . . . . . . . . 53.2 ttt180 . . . . . 0 C--N 1.328 -0.349 0 CA-C-N 115.301 -0.863 . . . . 0.0 110.501 -176.341 . . . . . . . . 0 0 . 1 . 008 nuclear nobuild core ' D' D ' 2' ' ' SER . . . . . . . . . . . . . 4.2 p . . . . . 0 C--O 1.232 0.143 0 CA-C-O 121.167 0.508 . . . . 0.0 110.698 . . . . . . . . . 0 0 . 1 . 008 nuclear nobuild core ' D' D ' 3' ' ' GLU . . . . . . . . . . . . . 84.8 tt0 -141.28 141.97 33.92 Favored 'General case' 0 C--N 1.326 -0.423 0 CA-C-N 115.578 -0.737 . . . . 0.0 111.121 -178.25 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' D' D ' 4' ' ' LEU . . . . . . . . . . . . . 65.2 mt -119.9 128.98 54.14 Favored 'General case' 0 C--N 1.331 -0.224 0 CA-C-N 115.739 -0.664 . . . . 0.0 110.436 176.303 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' D' D ' 5' ' ' LYS . . . . . . . . . . . . . 61.1 mttp -106.02 119.55 39.49 Favored 'General case' 0 C--O 1.235 0.322 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.303 176.62 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' D' D ' 6' ' ' LEU . . . . . . . . . . . . . 73.2 mt -118.18 152.08 36.36 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-N 115.457 -0.792 . . . . 0.0 110.726 -177.72 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' D' D ' 7' ' ' LYS . . . . . . . . . . . . . 29.2 ttpt -143.27 140.92 18.28 Favored Pre-proline 0 CA--C 1.534 0.354 0 CA-C-O 119.19 -0.434 . . . . 0.0 110.067 174.33 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' D' D ' 8' ' ' PRO . . . . . . . . . . . . . 93.9 Cg_endo -89.27 138.23 3.25 Favored 'Trans proline' 0 N--CA 1.489 1.23 0 C-N-CA 121.752 1.635 . . . . 0.0 111.555 177.875 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' D' D ' 9' ' ' LEU . . . . . . . . . . . . . 84.9 mt -70.85 -48.81 14.59 Favored Pre-proline 0 C--N 1.329 -0.306 0 CA-C-O 119.143 -0.456 . . . . 0.0 111.045 -178.824 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' D' D ' 10' ' ' PRO . . . . . . . . . . . . . 95.6 Cg_endo -79.75 138.44 13.36 Favored 'Trans proline' 0 N--CA 1.495 1.57 0 C-N-CA 121.098 1.198 . . . . 0.0 111.228 169.398 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' D' D ' 11' ' ' LYS . . . . . . . . . . . . . 82.3 tttt -87.88 102.86 15.11 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-O 120.886 0.375 . . . . 0.0 110.472 -178.923 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' D' D ' 12' ' ' VAL . . . . . . . . . . . . . 12.1 p -140.77 147.86 22.43 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.248 0 CA-C-N 116.127 -0.488 . . . . 0.0 110.518 -179.391 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' D' D ' 13' ' ' GLU . . . . . . . . . . . . . 95.2 mt-10 -78.93 123.36 27.19 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 116.3 -0.409 . . . . 0.0 110.041 178.392 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' D' D ' 14' ' ' LEU . . . . . . . . . . . . . 21.8 mt -98.55 153.88 37.76 Favored Pre-proline 0 C--N 1.33 -0.24 0 CA-C-N 116.427 -0.351 . . . . 0.0 111.103 -178.072 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' D' D ' 15' ' ' PRO . . . . . . . . . . . . . 37.9 Cg_exo -59.72 158.8 26.85 Favored 'Trans proline' 0 N--CA 1.497 1.717 0 C-N-CA 121.359 1.373 . . . . 0.0 111.83 178.295 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' D' D ' 16' ' ' PRO . . . . . . . . . . . . . 26.4 Cg_exo -60.47 -37.96 77.21 Favored 'Trans proline' 0 N--CA 1.498 1.787 0 C-N-CA 121.424 1.416 . . . . 0.0 112.911 -177.347 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' D' D ' 17' ' ' ASP . . . . . . . . . . . . . 22.6 p-10 -89.93 11.01 21.71 Favored 'General case' 0 CA--C 1.537 0.464 0 N-CA-C 113.303 0.853 . . . . 0.0 113.303 -176.47 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' D' D ' 18' ' ' PHE . . . . . . . . . . . . . 51.2 t80 -57.97 -42.81 85.83 Favored 'General case' 0 C--O 1.227 -0.081 0 O-C-N 121.996 -0.44 . . . . 0.0 110.113 -178.933 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' D' D ' 19' ' ' VAL . . . . . . . . . . . . . 48.2 t -57.34 -41.22 77.93 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.306 0 CA-C-N 116.234 -0.439 . . . . 0.0 110.391 -178.624 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' D' D ' 20' ' ' ASP . . . . . . . . . . . . . 79.7 m-20 -59.9 -43.53 94.77 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-O 120.798 0.333 . . . . 0.0 110.876 -177.916 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' D' D ' 21' ' ' VAL . . . . . . . . . . . . . 45.4 t -64.63 -46.46 92.37 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.312 0 C-N-CA 120.719 -0.392 . . . . 0.0 110.527 -177.801 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' D' D ' 22' ' ' ILE . . . . . 0.646 HG22 HD12 ' D' ' 26' ' ' LEU . 50.3 mm -56.44 -45.6 81.86 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.276 0 CA-C-O 120.727 0.299 . . . . 0.0 110.571 179.215 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' D' D ' 23' ' ' ARG . . . . . . . . . . . . . 59.4 ttp180 -53.34 -49.7 66.56 Favored 'General case' 0 C--N 1.331 -0.224 0 CA-C-O 120.835 0.35 . . . . 0.0 111.412 -178.704 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' D' D ' 24' ' ' ILE . . . . . . . . . . . . . 72.9 mt -59.61 -45.76 93.83 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.262 0 CA-C-N 116.281 -0.418 . . . . 0.0 111.136 -177.32 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' D' D ' 25' ' ' LYS . . . . . . . . . . . . . 59.4 mtpt -65.32 -37.35 86.83 Favored 'General case' 0 C--N 1.33 -0.263 0 N-CA-C 112.354 0.502 . . . . 0.0 112.354 -177.121 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' D' D ' 26' ' ' LEU . . . . . 0.646 HD12 HG22 ' D' ' 22' ' ' ILE . 25.9 mt -78.25 -45.68 22.26 Favored 'General case' 0 C--N 1.329 -0.296 0 N-CA-C 112.979 0.733 . . . . 0.0 112.979 -172.781 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' D' D ' 27' ' ' GLN . . . . . . . . . . . . . 11.3 pt20 -46.89 138.52 6.29 Favored 'General case' 0 N--CA 1.468 0.452 0 N-CA-C 112.728 0.64 . . . . 0.0 112.728 -175.68 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' D' D ' 28' ' ' GLY . . . . . . . . . . . . . . . 100.89 -26.6 24.04 Favored Glycine 0 CA--C 1.534 1.223 0 CA-C-N 115.542 -0.754 . . . . 0.0 112.274 -176.596 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' D' D ' 29' ' ' LYS . . . . . . . . . . . . . 65.8 mttm -98.74 155.12 17.51 Favored 'General case' 0 C--N 1.332 -0.154 0 CA-C-N 117.261 0.53 . . . . 0.0 111.217 179.259 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' D' D ' 30' ' ' THR . . . . . . . . . . . . . 17.7 m -102.73 137.13 41.35 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.185 -0.461 . . . . 0.0 110.084 176.128 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' D' D ' 31' ' ' VAL . . . . . . . . . . . . . 33.8 m -130.87 156.88 43.04 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.263 0 CA-C-O 120.816 0.341 . . . . 0.0 110.857 -179.158 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' D' D ' 32' ' ' ARG . . . . . . . . . . . . . 60.9 ttt180 -134.62 150.0 50.63 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 115.992 -0.549 . . . . 0.0 110.218 178.283 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' D' D ' 33' ' ' THR . . . . . . . . . . . . . 31.7 m -52.38 140.17 22.79 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-O 120.826 0.346 . . . . 0.0 111.421 -177.737 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' D' D ' 34' ' ' GLY . . . . . . . . . . . . . . . 99.68 -17.1 57.99 Favored Glycine 0 CA--C 1.531 1.053 0 C-N-CA 121.199 -0.524 . . . . 0.0 113.286 179.105 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' D' D ' 35' ' ' ASP . . . . . . . . . . . . . 72.5 m-20 -65.16 149.1 50.49 Favored 'General case' 0 C--O 1.231 0.101 0 CA-C-N 118.086 0.943 . . . . 0.0 111.141 179.427 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' D' D ' 36' ' ' VAL . . . . . . . . . . . . . 46.1 t -123.1 131.13 73.81 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.223 0 CA-C-N 115.683 -0.69 . . . . 0.0 109.798 178.409 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' D' D ' 37' ' ' ILE . . . . . . . . . . . . . 71.5 mt -119.59 139.79 45.75 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.251 0 CA-C-N 116.166 -0.47 . . . . 0.0 109.958 -179.709 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' D' D ' 38' ' ' GLY . . . . . . . . . . . . . . . -113.01 128.74 8.55 Favored Glycine 0 CA--C 1.526 0.721 0 N-CA-C 111.051 -0.82 . . . . 0.0 111.051 179.492 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' D' D ' 39' ' ' ILE . . . . . . . . . . . . . 68.3 mt -123.28 133.65 68.53 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.185 0 N-CA-C 110.103 -0.332 . . . . 0.0 110.103 179.241 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' D' D ' 40' ' ' SER . . . . . . . . . . . . . 93.4 p -92.69 122.67 35.32 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.394 -0.366 . . . . 0.0 110.729 175.859 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' D' D ' 41' ' ' ILE . . . . . . . . . . . . . 68.2 mt -129.04 119.64 49.76 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.219 0 CA-C-O 120.754 0.312 . . . . 0.0 110.482 178.218 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' D' D ' 42' ' ' LEU . . . . . . . . . . . . . 10.4 tp 51.94 37.21 20.4 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.143 -0.48 . . . . 0.0 111.594 176.907 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' D' D ' 43' ' ' GLY . . . . . . . . . . . . . . . 72.96 30.13 63.84 Favored Glycine 0 CA--C 1.528 0.886 0 C-N-CA 121.007 -0.616 . . . . 0.0 112.34 177.512 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' D' D ' 44' ' ' LYS . . . . . . . . . . . . . 81.9 mttt -136.57 129.39 30.78 Favored 'General case' 0 C--N 1.329 -0.313 0 N-CA-C 109.667 -0.494 . . . . 0.0 109.667 177.925 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' D' D ' 45' ' ' GLU . . . . . . . . . . . . . 85.2 tt0 -83.56 123.42 29.74 Favored 'General case' 0 C--N 1.329 -0.3 0 C-N-CA 120.812 -0.355 . . . . 0.0 111.141 -177.854 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' D' D ' 46' ' ' VAL . . . . . . . . . . . . . 7.7 p -120.97 128.3 76.06 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.231 0 N-CA-C 109.481 -0.563 . . . . 0.0 109.481 175.972 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' D' D ' 47' ' ' LYS . . . . . . . . . . . . . 35.3 mtmm -102.11 129.72 48.52 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 115.809 -0.632 . . . . 0.0 111.645 -179.892 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' D' D ' 48' ' ' PHE . . . . . . . . . . . . . 88.3 m-85 -112.8 131.97 55.46 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.368 -0.378 . . . . 0.0 110.37 177.224 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' D' D ' 49' ' ' LYS . . . . . . . . . . . . . 60.5 tttt -106.01 137.39 44.0 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.517 -0.31 . . . . 0.0 110.576 178.796 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' D' D ' 50' ' ' VAL . . . . . . . . . . . . . 45.5 t -84.82 107.84 16.24 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.241 0 N-CA-C 109.198 -0.667 . . . . 0.0 109.198 174.735 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' D' D ' 51' ' ' VAL . . . . . . . . . . . . . 47.2 t -73.07 -47.61 47.1 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.302 0 CA-C-N 116.153 -0.476 . . . . 0.0 110.159 -173.099 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' D' D ' 52' ' ' GLN . . . . . . . . . . . . . 62.8 tt0 -161.4 139.18 9.16 Favored 'General case' 0 C--N 1.331 -0.226 0 C-N-CA 120.231 -0.588 . . . . 0.0 111.884 -177.321 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' D' D ' 53' ' ' ALA . . . . . . . . . . . . . . . -115.96 133.61 55.85 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 115.655 -0.702 . . . . 0.0 109.609 174.144 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' D' D ' 54' ' ' TYR . . . . . . . . . . . . . 44.3 t80 -128.94 110.77 18.49 Favored Pre-proline 0 CA--C 1.537 0.449 0 CA-C-O 118.112 -0.947 . . . . 0.0 110.489 -179.531 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' D' D ' 55' ' ' PRO . . . . . . . . . . . . . 73.6 Cg_endo -77.13 169.9 73.03 Favored 'Cis proline' 0 N--CA 1.5 1.869 0 CA-C-N 121.853 1.698 . . . . 0.0 112.155 -6.987 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' D' D ' 56' ' ' SER . . . . . . . . . . . . . 49.1 m -117.79 135.01 23.19 Favored Pre-proline 0 CA--C 1.54 0.574 0 CA-C-O 118.42 -0.8 . . . . 0.0 109.949 175.901 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' D' D ' 57' ' ' PRO . . . . . . . . . . . . . 38.3 Cg_endo -68.45 163.73 77.04 Favored 'Cis proline' 0 N--CA 1.498 1.773 0 CA-C-N 121.875 1.705 . . . . 0.0 111.361 -3.754 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' D' D ' 58' ' ' LEU . . . . . . . . . . . . . 37.4 tp -129.78 137.94 50.79 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-O 120.877 0.37 . . . . 0.0 110.595 -179.866 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' D' D ' 59' ' ' ARG . . . . . . . . . . . . . 62.0 ttm-85 -100.62 121.28 41.35 Favored 'General case' 0 C--N 1.326 -0.414 0 N-CA-C 109.142 -0.688 . . . . 0.0 109.142 174.593 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' D' D ' 60' ' ' VAL . . . . . . . . . . . . . 42.3 t -74.54 124.81 32.92 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 C-N-CA 120.778 -0.369 . . . . 0.0 110.391 -173.786 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' D' D ' 61' ' ' GLU . . . . . . . . . . . . . 70.5 mm-40 -131.01 163.39 27.68 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 115.913 -0.585 . . . . 0.0 109.868 177.569 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' D' D ' 62' ' ' ASP . . . . . . . . . . . . . 14.9 p-10 -55.67 -31.64 62.56 Favored 'General case' 0 C--N 1.328 -0.346 0 N-CA-C 111.749 0.278 . . . . 0.0 111.749 -178.898 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' D' D ' 63' ' ' ARG . . . . . . . . . . . . . 10.0 ptm180 -83.68 6.75 19.81 Favored 'General case' 0 CA--C 1.536 0.438 0 N-CA-C 113.553 0.946 . . . . 0.0 113.553 -176.121 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' D' D ' 64' ' ' THR . . . . . . . . . . . . . 29.3 m -85.64 139.68 31.2 Favored 'General case' 0 C--N 1.332 -0.184 0 CA-C-N 118.192 0.451 . . . . 0.0 110.651 -179.074 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' D' D ' 65' ' ' LYS . . . . . . . . . . . . . 38.1 mtmt -89.07 132.6 34.7 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.273 -0.421 . . . . 0.0 110.419 179.657 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' D' D ' 66' ' ' ILE . . . . . . . . . . . . . 61.6 mt -120.38 128.16 75.97 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.221 0 CA-C-N 116.366 -0.379 . . . . 0.0 110.046 -177.244 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' D' D ' 67' ' ' THR . . . . . . . . . . . . . 27.8 m -130.21 142.65 50.55 Favored 'General case' 0 C--N 1.332 -0.177 0 CA-C-O 120.978 0.418 . . . . 0.0 111.234 -178.638 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' D' D ' 68' ' ' LEU . . . . . 0.456 ' N ' HD12 ' D' ' 68' ' ' LEU . 7.2 mp . . . . . 0 C--N 1.329 -0.297 0 CA-C-N 116.049 -0.523 . . . . 0.0 110.65 177.827 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' D' D ' 73' ' ' VAL . . . . . . . . . . . . . 2.5 m . . . . . 0 N--CA 1.463 0.202 0 CA-C-O 120.98 0.419 . . . . 0.0 110.262 . . . . . . . . . 0 0 . 1 . 008 nuclear nobuild core ' D' D ' 74' ' ' ASP . . . . . . . . . . . . . 15.3 t0 -99.06 118.81 36.67 Favored 'General case' 0 C--N 1.325 -0.497 0 N-CA-C 108.829 -0.804 . . . . 0.0 108.829 173.894 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' D' D ' 75' ' ' VAL . . . . . . . . . . . . . 47.8 t -110.19 122.04 64.07 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.218 0 CA-C-O 121.132 0.491 . . . . 0.0 110.671 -176.325 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' D' D ' 76' ' ' LEU . . . . . . . . . . . . . 5.1 mp -124.08 138.66 54.41 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 115.657 -0.701 . . . . 0.0 109.28 174.5 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' D' D ' 77' ' ' GLU . . . . . . . . . . . . . 69.3 tt0 -134.37 136.9 43.71 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-O 120.955 0.407 . . . . 0.0 110.803 -177.801 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' D' D ' 78' ' ' ALA . . . . . . . . . . . . . . . -121.52 138.59 54.23 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 115.959 -0.564 . . . . 0.0 110.434 178.774 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' D' D ' 79' ' ' LYS . . . . . 0.581 ' O ' HD13 ' D' ' 80' ' ' ILE . 7.6 ttpm? -77.75 115.38 17.46 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 116.438 -0.346 . . . . 0.0 110.419 179.582 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' D' D ' 80' ' ' ILE . . . . . 0.581 HD13 ' O ' ' D' ' 79' ' ' LYS . 42.1 mm -139.06 108.09 3.68 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.273 0 N-CA-C 109.328 -0.619 . . . . 0.0 109.328 -178.369 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' D' D ' 81' ' ' LYS . . . . . . . . . . . . . 55.1 pttt -106.76 129.82 54.57 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-O 120.921 0.391 . . . . 0.0 111.518 -176.33 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' D' D ' 82' ' ' GLY . . . . . . . . . . . . . . . 88.95 42.19 5.72 Favored Glycine 0 CA--C 1.526 0.778 0 N-CA-C 111.529 -0.628 . . . . 0.0 111.529 176.752 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' D' D ' 83' ' ' ILE . . . . . . . . . . . . . 73.3 mt -71.92 138.76 20.95 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.32 0 N-CA-C 109.718 -0.475 . . . . 0.0 109.718 178.064 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' D' D ' 84' ' ' LYS . . . . . . . . . . . . . 50.4 tttp -95.7 -53.87 3.56 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 116.023 -0.535 . . . . 0.0 110.207 -178.136 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' D' D ' 85' ' ' ASP . . . . . . . . . . . . . 8.3 t70 -152.55 152.26 31.66 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 115.795 -0.639 . . . . 0.0 110.14 -179.594 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' D' D ' 86' ' ' VAL . . . . . . . . . . . . . 46.6 t -127.74 129.07 70.01 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.224 0 CA-C-O 120.883 0.373 . . . . 0.0 110.44 -179.041 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' D' D ' 87' ' ' ILE . . . . . . . . . . . . . 44.5 mm -117.97 127.5 75.2 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.217 0 CA-C-N 115.941 -0.572 . . . . 0.0 109.461 176.682 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' D' D ' 88' ' ' LEU . . . . . . . . . . . . . 12.5 tp -113.98 131.63 56.26 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-O 120.998 0.427 . . . . 0.0 111.154 -176.861 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' D' D ' 89' ' ' ASP . . . . . . . . . . . . . 13.8 t70 -123.88 152.08 42.76 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 115.78 -0.646 . . . . 0.0 109.432 176.837 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' D' D ' 90' ' ' GLU . . . . . . . . . . . . . 46.2 tp10 -47.84 -36.85 12.65 Favored 'General case' 0 CA--C 1.531 0.242 0 N-CA-C 112.735 0.643 . . . . 0.0 112.735 -172.967 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' D' D ' 91' ' ' ASN . . . . . . . . . . . . . 28.7 m120 -132.02 32.39 4.04 Favored 'General case' 0 N--CA 1.466 0.338 0 C-N-CA 120.846 -0.342 . . . . 0.0 111.916 -176.508 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' D' D ' 92' ' ' LEU . . . . . . . . . . . . . 9.7 tp -166.11 148.14 6.97 Favored 'General case' 0 C--N 1.329 -0.291 0 C-N-CA 121.008 -0.277 . . . . 0.0 110.591 -179.839 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' D' D ' 93' ' ' ILE . . . . . . . . . . . . . 64.1 mt -127.06 124.54 64.68 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.284 0 N-CA-C 109.58 -0.526 . . . . 0.0 109.58 -179.356 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' D' D ' 94' ' ' VAL . . . . . 0.624 HG21 HG11 ' D' ' 125' ' ' VAL . 46.7 t -124.08 127.74 73.64 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.234 0 CA-C-O 121.004 0.431 . . . . 0.0 110.181 179.99 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' D' D ' 95' ' ' VAL . . . . . . . . . . . . . 44.6 t -121.88 135.47 61.9 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.261 0 CA-C-N 116.054 -0.521 . . . . 0.0 109.931 179.984 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' D' D ' 96' ' ' ILE . . . . . . . . . . . . . 66.2 mt -116.3 129.49 72.64 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 N-CA-C 109.356 -0.609 . . . . 0.0 109.356 178.82 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' D' D ' 97' ' ' THR . . . . . . . . . . . . . 79.6 p -100.0 158.48 15.8 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-O 121.02 0.438 . . . . 0.0 111.105 -177.334 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' D' D ' 98' ' ' GLU . . . . . . . . . . . . . 97.1 mt-10 -54.06 -26.36 26.43 Favored 'General case' 0 C--N 1.329 -0.288 0 N-CA-C 112.219 0.451 . . . . 0.0 112.219 -179.795 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' D' D ' 99' ' ' GLU . . . . . . . . . . . . . 41.0 mt-10 -80.04 16.85 1.1 Allowed 'General case' 0 CA--C 1.536 0.412 0 N-CA-C 112.99 0.737 . . . . 0.0 112.99 -177.759 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' D' D ' 100' ' ' ASN . . . . . . . . . . . . . 3.3 m-20 63.16 37.94 10.99 Favored 'General case' 0 N--CA 1.463 0.197 0 CA-C-O 121.05 0.452 . . . . 0.0 111.085 177.453 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' D' D ' 101' ' ' GLU . . . . . . . . . . . . . 98.2 mt-10 -112.18 146.0 38.87 Favored 'General case' 0 C--N 1.332 -0.162 0 CA-C-N 116.2 -0.455 . . . . 0.0 110.419 174.981 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' D' D ' 102' ' ' VAL . . . . . 0.449 ' C ' HD12 ' D' ' 103' ' ' LEU . 45.3 t -117.01 127.18 74.69 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.363 0 CA-C-N 115.762 -0.654 . . . . 0.0 109.606 179.134 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' D' D ' 103' ' ' LEU . . . . . 0.449 HD12 ' C ' ' D' ' 102' ' ' VAL . 7.4 mp -119.45 129.76 54.92 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 115.883 -0.599 . . . . 0.0 110.207 175.716 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' D' D ' 104' ' ' ILE . . . . . . . . . . . . . 73.8 mt -114.13 122.22 67.81 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.335 0 CA-C-N 116.024 -0.534 . . . . 0.0 109.885 -179.341 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' D' D ' 105' ' ' PHE . . . . . . . . . . . . . 85.8 m-85 -119.23 160.03 22.94 Favored 'General case' 0 C--N 1.331 -0.229 0 O-C-N 124.17 0.919 . . . . 0.0 109.894 179.96 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' D' D ' 106' ' ' ASN . . . . . . . . . . . . . 42.8 p-10 -95.04 -170.22 2.15 Favored 'General case' 0 C--N 1.329 -0.321 0 N-CA-C 109.557 -0.534 . . . . 0.0 109.557 172.799 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' D' D ' 107' ' ' GLN . . . . . . . . . . . . . 58.2 tt0 -61.07 -25.57 67.03 Favored 'General case' 0 C--N 1.329 -0.314 0 N-CA-C 112.123 0.416 . . . . 0.0 112.123 178.54 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' D' D ' 108' ' ' ASN . . . . . . . . . . . . . 5.7 t-20 -83.66 3.2 33.93 Favored 'General case' 0 CA--C 1.538 0.518 0 N-CA-C 113.133 0.79 . . . . 0.0 113.133 -178.703 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' D' D ' 109' ' ' LEU . . . . . . . . . . . . . 9.1 tp 62.86 37.23 12.35 Favored 'General case' 0 C--O 1.232 0.151 0 CA-C-O 120.945 0.402 . . . . 0.0 111.36 179.39 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' D' D ' 110' ' ' GLU . . . . . . . . . . . . . 96.3 mt-10 -106.82 149.95 26.86 Favored 'General case' 0 C--N 1.331 -0.216 0 N-CA-C 110.025 -0.361 . . . . 0.0 110.025 176.458 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' D' D ' 111' ' ' GLU . . . . . . . . . . . . . 43.0 tp10 -79.67 121.98 25.98 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-O 121.114 0.483 . . . . 0.0 110.803 -176.889 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' D' D ' 112' ' ' LEU . . . . . . . . . . . . . 28.4 mt -103.93 -46.08 4.58 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 115.747 -0.661 . . . . 0.0 110.119 176.541 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' D' D ' 113' ' ' TYR . . . . . . . . . . . . . 65.2 t80 -142.53 135.5 28.37 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.226 -0.443 . . . . 0.0 111.33 -179.614 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' D' D ' 114' ' ' ARG . . . . . . . . . . . . . 79.0 ttt-85 -139.98 121.94 15.62 Favored 'General case' 0 C--N 1.331 -0.229 0 CA-C-N 116.321 -0.399 . . . . 0.0 110.121 177.17 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' D' D ' 115' ' ' GLY . . . . . . . . . . . . . . . -150.15 161.98 29.07 Favored Glycine 0 CA--C 1.525 0.656 0 N-CA-C 110.982 -0.847 . . . . 0.0 110.982 -178.761 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' D' D ' 116' ' ' LYS . . . . . . . . . . . . . 39.0 ttpt -120.08 137.32 54.2 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-O 120.741 0.305 . . . . 0.0 110.307 178.622 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' D' D ' 117' ' ' PHE . . . . . . . . . . . . . 31.6 m-85 -133.39 113.95 13.13 Favored 'General case' 0 C--N 1.33 -0.244 0 N-CA-C 109.859 -0.423 . . . . 0.0 109.859 179.224 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' D' D ' 118' ' ' GLU . . . . . . . . . . . . . 95.9 mt-10 -55.72 -44.8 77.83 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.33 -0.396 . . . . 0.0 111.228 -174.898 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' D' D ' 119' ' ' ASN . . . . . . . . . . . . . 20.2 m120 -95.89 30.93 2.23 Favored 'General case' 0 C--N 1.33 -0.275 0 N-CA-C 112.132 0.419 . . . . 0.0 112.132 -174.11 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' D' D ' 120' ' ' LEU . . . . . . . . . . . . . 13.3 tp -57.35 119.74 6.99 Favored 'General case' 0 C--N 1.334 -0.083 0 C-N-CA 120.984 -0.287 . . . . 0.0 110.259 178.078 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' D' D ' 121' ' ' ASN . . . . . . . . . . . . . 73.4 m-20 -114.12 -44.06 3.17 Favored 'General case' 0 C--N 1.332 -0.156 0 CA-C-N 116.409 -0.359 . . . . 0.0 111.118 -178.405 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' D' D ' 122' ' ' LYS . . . . . . . . . . . . . 63.1 mtpt -141.96 148.73 39.09 Favored 'General case' 0 C--N 1.331 -0.219 0 CA-C-O 121.079 0.466 . . . . 0.0 111.607 -176.611 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' D' D ' 123' ' ' VAL . . . . . . . . . . . . . 43.9 t -131.53 125.9 57.1 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.252 0 CA-C-N 115.854 -0.612 . . . . 0.0 109.512 174.565 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' D' D ' 124' ' ' LEU . . . . . . . . . . . . . 49.7 mt -122.79 137.46 54.92 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-O 120.74 0.305 . . . . 0.0 110.697 -178.157 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' D' D ' 125' ' ' VAL . . . . . 0.624 HG11 HG21 ' D' ' 94' ' ' VAL . 34.8 m -129.69 130.1 66.69 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.25 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.789 179.735 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' D' D ' 126' ' ' ARG . . . . . . . . . . . . . 83.0 mtt180 -144.94 118.96 9.37 Favored 'General case' 0 C--N 1.328 -0.348 0 N-CA-C 109.56 -0.533 . . . . 0.0 109.56 177.164 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' D' D ' 127' ' ' ASN . . . . . . . . . . . . . 30.8 m120 56.73 -149.05 0.47 Allowed 'General case' 0 CA--C 1.54 0.596 0 N-CA-C 109.648 -0.501 . . . . 0.0 109.648 -178.229 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' D' D ' 128' ' ' ASP . . . . . . . . . . . . . 23.3 p-10 -82.41 12.96 3.92 Favored 'General case' 0 CA--C 1.536 0.429 0 CA-C-N 118.773 0.715 . . . . 0.0 112.88 178.364 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' D' D ' 129' ' ' LEU . . . . . . . . . . . . . 16.1 tp -108.64 134.98 50.64 Favored 'General case' 0 C--O 1.233 0.196 0 CA-C-N 118.261 0.482 . . . . 0.0 110.088 178.637 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' D' D ' 130' ' ' VAL . . . . . . . . . . . . . 44.0 t -126.26 141.36 46.05 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.303 0 CA-C-O 120.929 0.395 . . . . 0.0 110.623 -177.539 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' D' D ' 131' ' ' VAL . . . . . . . . . . . . . 42.6 t -133.63 133.99 56.8 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.305 0 CA-C-N 116.049 -0.523 . . . . 0.0 110.126 177.994 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' D' D ' 132' ' ' ILE . . . . . . . . . . . . . 65.8 mt -118.41 134.0 63.42 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.343 0 N-CA-C 109.364 -0.606 . . . . 0.0 109.364 178.834 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' D' D ' 133' ' ' ILE . . . . . . . . . . . . . 37.6 mm -117.14 123.56 71.96 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.254 0 CA-C-O 120.619 0.247 . . . . 0.0 111.122 -174.367 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' D' D ' 134' ' ' ASP . . . . . . . . . . . . . 9.8 p-10 -135.82 147.62 48.36 Favored 'General case' 0 C--N 1.331 -0.202 0 N-CA-C 109.537 -0.542 . . . . 0.0 109.537 173.295 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' D' D ' 135' ' ' GLU . . . . . . . . . . . . . 85.2 tt0 -49.9 -27.7 5.58 Favored 'General case' 0 C--N 1.328 -0.356 0 N-CA-C 112.89 0.7 . . . . 0.0 112.89 -170.184 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' D' D ' 136' ' ' GLN . . . . . . . . . . . . . 98.0 mt-30 -82.21 -40.03 22.26 Favored 'General case' 0 C--O 1.235 0.297 0 N-CA-C 112.185 0.439 . . . . 0.0 112.185 -176.92 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' D' D ' 137' ' ' LYS . . . . . . . . . . . . . 56.6 pttt -156.73 167.04 31.66 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-O 121.523 0.678 . . . . 0.0 112.294 -169.745 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' D' D ' 138' ' ' LEU . . . . . . . . . . . . . 6.0 tt -116.24 127.74 55.01 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 115.06 -0.973 . . . . 0.0 109.664 178.156 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' D' D ' 139' ' ' THR . . . . . . . . . . . . . 29.0 m -106.71 126.62 52.52 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-N 116.281 -0.418 . . . . 0.0 110.712 -178.313 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' D' D ' 140' ' ' LEU . . . . . . . . . . . . . 21.1 tp -111.51 122.83 48.86 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 115.664 -0.698 . . . . 0.0 109.191 179.553 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' D' D ' 141' ' ' ILE . . . . . . . . . . . . . 19.5 mt -121.16 118.89 57.61 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.279 0 N-CA-C 109.87 -0.419 . . . . 0.0 109.87 -174.664 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' D' D ' 142' ' ' ARG . . . . . . . . . . . . . 48.5 mtm180 -109.0 127.97 54.55 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 115.481 -0.781 . . . . 0.0 110.098 -178.527 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' D' D ' 143' ' ' THR . . . . . . . . . . . . . 6.9 p . . . . . 0 C--O 1.22 -0.497 0 CA-C-O 117.989 -1.005 . . . . 0.0 110.61 -179.472 . . . . . . . . 0 0 . 1 . 008 nuclear nobuild core ' E' E ' 2' ' ' SER . . . . . . . . . . . . . 2.9 p . . . . . 0 C--O 1.231 0.107 0 CA-C-O 120.99 0.424 . . . . 0.0 110.449 . . . . . . . . . 0 0 . 1 . 008 nuclear nobuild core ' E' E ' 3' ' ' GLU . . . . . . . . . . . . . 84.7 tt0 -141.99 141.59 32.88 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.089 -0.505 . . . . 0.0 111.06 -179.302 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' E' E ' 4' ' ' LEU . . . . . . . . . . . . . 17.0 tp -126.12 126.86 44.85 Favored 'General case' 0 C--N 1.332 -0.195 0 CA-C-N 116.136 -0.483 . . . . 0.0 110.257 177.664 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' E' E ' 5' ' ' LYS . . . . . . . . . . . . . 61.6 mttp -107.06 121.39 44.39 Favored 'General case' 0 C--O 1.235 0.319 0 CA-C-N 116.251 -0.431 . . . . 0.0 110.7 178.5 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' E' E ' 6' ' ' LEU . . . . . . . . . . . . . 72.6 mt -116.84 146.25 43.02 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 115.326 -0.852 . . . . 0.0 110.46 -178.784 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' E' E ' 7' ' ' LYS . . . . . . . . . . . . . 55.6 tttm -135.24 139.75 32.55 Favored Pre-proline 0 CA--C 1.534 0.351 0 CA-C-O 119.135 -0.459 . . . . 0.0 110.361 176.927 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' E' E ' 8' ' ' PRO . . . . . . . . . . . . . 84.7 Cg_endo -91.85 139.46 2.19 Favored 'Trans proline' 0 N--CA 1.489 1.262 0 C-N-CA 121.694 1.596 . . . . 0.0 111.632 176.602 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' E' E ' 9' ' ' LEU . . . . . . . . . . . . . 38.7 mt -76.03 -48.4 3.52 Favored Pre-proline 0 CA--C 1.534 0.363 0 CA-C-O 118.631 -0.7 . . . . 0.0 112.569 -178.036 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' E' E ' 10' ' ' PRO . . . . . . . . . . . . . 91.3 Cg_endo -80.06 157.13 23.49 Favored 'Trans proline' 0 N--CA 1.497 1.723 0 C-N-CA 121.315 1.343 . . . . 0.0 111.912 178.126 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' E' E ' 11' ' ' LYS . . . . . . . . . . . . . 17.4 pttp -83.17 112.54 19.93 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-O 121.55 0.691 . . . . 0.0 110.428 176.84 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' E' E ' 12' ' ' VAL . . . . . . . . . . . . . 12.5 p -151.13 151.19 12.65 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.248 0 CA-C-N 115.629 -0.714 . . . . 0.0 110.58 -178.769 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' E' E ' 13' ' ' GLU . . . . . . . . . . . . . 96.5 mt-10 -97.71 121.68 39.9 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.3 -0.409 . . . . 0.0 110.351 177.679 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' E' E ' 14' ' ' LEU . . . . . . . . . . . . . 39.4 mt -98.45 137.65 20.72 Favored Pre-proline 0 CA--C 1.534 0.351 0 CA-C-O 118.808 -0.615 . . . . 0.0 110.213 -179.377 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' E' E ' 15' ' ' PRO . . . . . . . . . . . . . 25.3 Cg_exo -62.59 162.24 25.25 Favored 'Trans proline' 0 N--CA 1.498 1.765 0 C-N-CA 121.299 1.333 . . . . 0.0 112.013 176.942 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' E' E ' 16' ' ' PRO . . . . . . . . . . . . . 28.1 Cg_exo -59.95 -32.71 95.48 Favored 'Trans proline' 0 N--CA 1.497 1.691 0 C-N-CA 121.568 1.512 . . . . 0.0 112.931 -178.219 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' E' E ' 17' ' ' ASP . . . . . . . . . . . . . 10.1 p-10 -81.52 -3.93 54.54 Favored 'General case' 0 CA--C 1.535 0.383 0 N-CA-C 113.357 0.873 . . . . 0.0 113.357 -177.451 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' E' E ' 18' ' ' PHE . . . . . . . . . . . . . 30.0 t80 -56.62 -44.49 81.24 Favored 'General case' 0 C--N 1.334 -0.09 0 O-C-N 121.885 -0.509 . . . . 0.0 110.242 -179.182 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' E' E ' 19' ' ' VAL . . . . . . . . . . . . . 14.4 p -57.38 -40.67 75.66 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.329 0 CA-C-N 116.346 -0.388 . . . . 0.0 110.698 -179.707 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' E' E ' 20' ' ' ASP . . . . . . . . . . . . . 8.2 t70 -60.33 -42.74 96.29 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-O 120.921 0.391 . . . . 0.0 110.781 -177.827 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' E' E ' 21' ' ' VAL . . . . . . . . . . . . . 46.4 t -64.46 -47.33 89.78 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.297 0 CA-C-N 116.331 -0.395 . . . . 0.0 110.476 -177.751 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' E' E ' 22' ' ' ILE . . . . . 0.448 HG22 HD12 ' E' ' 26' ' ' LEU . 49.1 mm -57.5 -42.04 80.11 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.362 0 C-N-CA 120.934 -0.306 . . . . 0.0 110.673 -179.633 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' E' E ' 23' ' ' ARG . . . . . . . . . . . . . 61.9 ttp180 -54.8 -51.09 66.87 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-O 120.981 0.42 . . . . 0.0 110.9 178.935 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' E' E ' 24' ' ' ILE . . . . . . . . . . . . . 73.0 mt -60.85 -41.64 89.47 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.355 0 CA-C-N 115.92 -0.582 . . . . 0.0 111.764 -176.564 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' E' E ' 25' ' ' LYS . . . . . . . . . . . . . 15.1 ptpt -70.39 -39.64 74.4 Favored 'General case' 0 CA--C 1.535 0.373 0 N-CA-C 112.174 0.435 . . . . 0.0 112.174 -174.804 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' E' E ' 26' ' ' LEU . . . . . 0.448 HD12 HG22 ' E' ' 22' ' ' ILE . 15.4 mt -78.87 -39.27 35.61 Favored 'General case' 0 C--N 1.33 -0.278 0 N-CA-C 113.268 0.84 . . . . 0.0 113.268 -171.291 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' E' E ' 27' ' ' GLN . . . . . . . . . . . . . 10.5 pt20 -47.0 135.69 9.21 Favored 'General case' 0 N--CA 1.469 0.499 0 N-CA-C 112.763 0.653 . . . . 0.0 112.763 -175.13 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' E' E ' 28' ' ' GLY . . . . . . . . . . . . . . . 101.05 -24.02 33.44 Favored Glycine 0 CA--C 1.534 1.259 0 CA-C-N 115.606 -0.725 . . . . 0.0 112.378 -176.784 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' E' E ' 29' ' ' LYS . . . . . . . . . . . . . 91.8 mttt -98.82 155.17 17.51 Favored 'General case' 0 C--O 1.233 0.208 0 CA-C-N 117.443 0.622 . . . . 0.0 111.311 179.534 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' E' E ' 30' ' ' THR . . . . . . . . . . . . . 28.8 m -109.39 138.57 45.55 Favored 'General case' 0 C--N 1.331 -0.209 0 CA-C-N 116.27 -0.423 . . . . 0.0 110.005 175.841 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' E' E ' 31' ' ' VAL . . . . . . . . . . . . . 34.5 m -132.13 160.92 42.16 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.22 0 CA-C-N 116.392 -0.367 . . . . 0.0 110.857 -178.95 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' E' E ' 32' ' ' ARG . . . . . . . . . . . . . 63.5 mtt85 -130.44 149.04 52.3 Favored 'General case' 0 C--N 1.332 -0.19 0 CA-C-O 121.199 0.523 . . . . 0.0 110.667 177.303 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' E' E ' 33' ' ' THR . . . . . . . . . . . . . 31.5 m -53.59 141.38 25.91 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.129 -0.487 . . . . 0.0 111.259 -179.581 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' E' E ' 34' ' ' GLY . . . . . . . . . . . . . . . 99.28 -17.16 58.27 Favored Glycine 0 CA--C 1.533 1.2 0 CA-C-O 119.643 -0.532 . . . . 0.0 113.156 179.874 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' E' E ' 35' ' ' ASP . . . . . . . . . . . . . 78.8 m-20 -66.5 147.72 52.9 Favored 'General case' 0 C--O 1.232 0.145 0 CA-C-N 118.026 0.913 . . . . 0.0 110.999 178.163 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' E' E ' 36' ' ' VAL . . . . . . . . . . . . . 46.9 t -119.85 129.78 74.99 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.212 0 CA-C-N 115.829 -0.623 . . . . 0.0 109.829 178.611 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' E' E ' 37' ' ' ILE . . . . . . . . . . . . . 66.7 mt -120.13 138.18 51.55 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.269 0 N-CA-C 109.748 -0.464 . . . . 0.0 109.748 179.833 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' E' E ' 38' ' ' GLY . . . . . . . . . . . . . . . -113.77 128.78 8.46 Favored Glycine 0 CA--C 1.524 0.624 0 N-CA-C 111.389 -0.684 . . . . 0.0 111.389 -179.024 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' E' E ' 39' ' ' ILE . . . . . . . . . . . . . 71.2 mt -122.51 126.74 74.52 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.24 0 N-CA-C 109.747 -0.464 . . . . 0.0 109.747 177.336 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' E' E ' 40' ' ' SER . . . . . . . . . . . . . 43.1 t -92.16 119.51 31.88 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.442 -0.344 . . . . 0.0 110.786 177.162 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' E' E ' 41' ' ' ILE . . . . . . . . . . . . . 71.8 mt -131.47 123.9 53.55 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.225 0 N-CA-C 110.052 -0.351 . . . . 0.0 110.052 178.594 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' E' E ' 42' ' ' LEU . . . . . . . . . . . . . 82.6 mt 57.8 33.74 23.58 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.2 -0.455 . . . . 0.0 111.87 178.485 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' E' E ' 43' ' ' GLY . . . . . . . . . . . . . . . 77.87 -10.15 27.25 Favored Glycine 0 CA--C 1.535 1.306 0 C-N-CA 121.274 -0.489 . . . . 0.0 113.431 177.79 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' E' E ' 44' ' ' LYS . . . . . . . . . . . . . 62.8 tttm -98.78 127.24 44.65 Favored 'General case' 0 C--O 1.232 0.138 0 CA-C-N 117.808 0.804 . . . . 0.0 109.696 176.723 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' E' E ' 45' ' ' GLU . . . . . . . . . . . . . 39.2 tp10 -84.76 126.84 33.77 Favored 'General case' 0 C--N 1.328 -0.336 0 C-N-CA 120.811 -0.356 . . . . 0.0 110.662 -179.935 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' E' E ' 46' ' ' VAL . . . . . . . . . . . . . 7.6 p -117.09 128.71 74.41 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.199 0 N-CA-C 109.368 -0.604 . . . . 0.0 109.368 176.585 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' E' E ' 47' ' ' LYS . . . . . . . . . . . . . 64.6 mttp -100.32 129.35 46.29 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 115.884 -0.598 . . . . 0.0 111.142 179.052 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' E' E ' 48' ' ' PHE . . . . . . . . . . . . . 93.5 m-85 -112.19 131.86 55.23 Favored 'General case' 0 C--N 1.33 -0.27 0 N-CA-C 109.604 -0.517 . . . . 0.0 109.604 175.889 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' E' E ' 49' ' ' LYS . . . . . . . . . . . . . 52.5 tttp -108.05 135.46 49.37 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 116.434 -0.348 . . . . 0.0 110.332 179.244 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' E' E ' 50' ' ' VAL . . . . . . . . . . . . . 46.2 t -78.43 106.53 9.29 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.281 0 N-CA-C 108.954 -0.758 . . . . 0.0 108.954 175.317 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' E' E ' 51' ' ' VAL . . . . . . . . . . . . . 51.5 t -71.74 -47.05 58.89 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.319 0 CA-C-N 116.18 -0.464 . . . . 0.0 110.106 -172.98 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' E' E ' 52' ' ' GLN . . . . . . . . . . . . . 46.9 tt0 -163.5 136.86 5.6 Favored 'General case' 0 C--N 1.329 -0.297 0 C-N-CA 120.175 -0.61 . . . . 0.0 111.834 -178.281 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' E' E ' 53' ' ' ALA . . . . . . . . . . . . . . . -113.01 134.36 54.55 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 115.721 -0.672 . . . . 0.0 109.699 174.566 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' E' E ' 54' ' ' TYR . . . . . . . . . . . . . 24.8 t80 -129.03 111.28 18.4 Favored Pre-proline 0 CA--C 1.536 0.419 0 CA-C-O 118.17 -0.919 . . . . 0.0 110.555 -179.889 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' E' E ' 55' ' ' PRO . . . . . . . . . . . . . 73.6 Cg_endo -77.08 168.8 76.03 Favored 'Cis proline' 0 N--CA 1.501 1.946 0 CA-C-N 121.899 1.714 . . . . 0.0 112.068 -7.245 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' E' E ' 56' ' ' SER . . . . . . . . . . . . . 27.0 m -115.04 131.27 23.61 Favored Pre-proline 0 CA--C 1.539 0.525 0 CA-C-O 118.456 -0.783 . . . . 0.0 109.533 176.24 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' E' E ' 57' ' ' PRO . . . . . . . . . . . . . 36.5 Cg_endo -66.6 164.17 68.67 Favored 'Cis proline' 0 N--CA 1.496 1.671 0 CA-C-N 121.957 1.734 . . . . 0.0 111.503 -1.501 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' E' E ' 58' ' ' LEU . . . . . . . . . . . . . 28.7 tp -129.45 135.47 48.7 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.436 -0.347 . . . . 0.0 110.623 -179.693 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' E' E ' 59' ' ' ARG . . . . . . . . . . . . . 73.5 ttt-85 -103.21 127.2 50.59 Favored 'General case' 0 C--N 1.327 -0.4 0 N-CA-C 109.028 -0.73 . . . . 0.0 109.028 175.504 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' E' E ' 60' ' ' VAL . . . . . . . . . . . . . 40.1 t -87.41 124.39 40.75 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.305 0 C-N-CA 120.767 -0.373 . . . . 0.0 110.878 -173.071 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' E' E ' 61' ' ' GLU . . . . . . . . . . . . . 40.6 mt-10 -131.01 166.52 20.82 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.01 -0.541 . . . . 0.0 109.703 176.002 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' E' E ' 62' ' ' ASP . . . . . . . . . . . . . 5.5 t70 -53.57 -32.92 52.87 Favored 'General case' 0 C--N 1.329 -0.318 0 N-CA-C 111.746 0.276 . . . . 0.0 111.746 -179.166 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' E' E ' 63' ' ' ARG . . . . . . . . . . . . . 35.2 mmt180 -73.51 -19.07 61.02 Favored 'General case' 0 N--CA 1.465 0.318 0 N-CA-C 113.023 0.749 . . . . 0.0 113.023 -176.863 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' E' E ' 64' ' ' THR . . . . . . . . . . . . . 25.0 m -66.23 141.9 57.89 Favored 'General case' 0 C--N 1.331 -0.2 0 CA-C-O 120.862 0.363 . . . . 0.0 110.876 -174.935 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' E' E ' 65' ' ' LYS . . . . . . . . . . . . . 92.1 mttt -87.83 128.71 35.34 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 115.995 -0.548 . . . . 0.0 109.893 178.285 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' E' E ' 66' ' ' ILE . . . . . . . . . . . . . 51.7 mt -116.18 131.24 69.27 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 N-CA-C 110.036 -0.357 . . . . 0.0 110.036 179.82 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' E' E ' 67' ' ' THR . . . . . . . . . . . . . 22.5 m -127.26 135.82 51.13 Favored 'General case' 0 C--N 1.332 -0.157 0 CA-C-O 121.036 0.446 . . . . 0.0 110.948 -179.89 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' E' E ' 68' ' ' LEU . . . . . . . . . . . . . 32.8 mt . . . . . 0 C--N 1.329 -0.283 0 CA-C-N 115.938 -0.574 . . . . 0.0 110.337 176.918 . . . . . . . . 0 0 . 1 . 008 nuclear nobuild core ' E' E ' 73' ' ' VAL . . . . . . . . . . . . . 33.5 m . . . . . 0 N--CA 1.465 0.281 0 CA-C-O 121.019 0.438 . . . . 0.0 110.784 . . . . . . . . . 0 0 . 1 . 008 nuclear nobuild core ' E' E ' 74' ' ' ASP . . . . . . . . . . . . . 5.0 t70 -100.13 120.12 39.38 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 115.859 -0.609 . . . . 0.0 109.795 -178.613 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' E' E ' 75' ' ' VAL . . . . . . . . . . . . . 44.0 t -119.75 126.4 75.27 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.246 0 CA-C-O 121.014 0.435 . . . . 0.0 110.749 -176.262 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' E' E ' 76' ' ' LEU . . . . . . . . . . . . . 5.9 mp -124.03 149.65 45.83 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 115.671 -0.695 . . . . 0.0 109.683 175.503 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' E' E ' 77' ' ' GLU . . . . . . . . . . . . . 96.2 mt-10 -136.01 131.54 35.14 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-O 121.022 0.439 . . . . 0.0 110.989 -178.646 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' E' E ' 78' ' ' ALA . . . . . . . . . . . . . . . -115.12 140.8 48.77 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 115.71 -0.677 . . . . 0.0 109.822 177.367 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' E' E ' 79' ' ' LYS . . . . . 0.58 ' O ' HD13 ' E' ' 80' ' ' ILE . 69.4 mttm -87.99 116.73 26.36 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-O 120.846 0.355 . . . . 0.0 111.223 -176.442 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' E' E ' 80' ' ' ILE . . . . . 0.58 HD13 ' O ' ' E' ' 79' ' ' LYS . 40.1 mm -139.19 102.32 1.69 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.312 0 N-CA-C 109.074 -0.713 . . . . 0.0 109.074 179.438 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' E' E ' 81' ' ' LYS . . . . . . . . . . . . . 41.0 tttp -91.3 126.15 36.29 Favored 'General case' 0 C--N 1.328 -0.351 0 C-N-CA 120.695 -0.402 . . . . 0.0 110.892 -177.171 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' E' E ' 82' ' ' GLY . . . . . . . . . . . . . . . 89.12 42.08 5.69 Favored Glycine 0 CA--C 1.524 0.629 0 C-N-CA 120.885 -0.674 . . . . 0.0 111.721 176.038 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' E' E ' 83' ' ' ILE . . . . . . . . . . . . . 72.6 mt -69.61 137.95 23.12 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.37 0 N-CA-C 109.711 -0.478 . . . . 0.0 109.711 177.027 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' E' E ' 84' ' ' LYS . . . . . . . . . . . . . 38.9 ttpt -100.87 -49.27 4.19 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-O 120.752 0.31 . . . . 0.0 110.234 -179.378 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' E' E ' 85' ' ' ASP . . . . . . . . . . . . . 9.0 t70 -151.85 154.06 35.42 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.243 -0.435 . . . . 0.0 110.7 -178.771 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' E' E ' 86' ' ' VAL . . . . . . . . . . . . . 44.6 t -132.57 136.36 56.14 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.22 0 CA-C-O 121.003 0.43 . . . . 0.0 110.392 -179.812 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' E' E ' 87' ' ' ILE . . . . . . . . . . . . . 47.4 mm -122.74 128.14 75.15 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.289 0 CA-C-N 115.71 -0.677 . . . . 0.0 109.674 178.919 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' E' E ' 88' ' ' LEU . . . . . . . . . . . . . 70.3 mt -111.99 136.52 51.22 Favored 'General case' 0 C--N 1.332 -0.185 0 CA-C-O 121.094 0.473 . . . . 0.0 111.396 -177.759 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' E' E ' 89' ' ' ASP . . . . . . . . . . . . . 9.5 t70 -127.2 154.87 44.28 Favored 'General case' 0 C--N 1.33 -0.274 0 N-CA-C 109.067 -0.716 . . . . 0.0 109.067 175.576 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' E' E ' 90' ' ' GLU . . . . . . . . . . . . . 82.9 tt0 -48.04 -34.32 9.34 Favored 'General case' 0 C--N 1.331 -0.235 0 N-CA-C 112.933 0.716 . . . . 0.0 112.933 -171.74 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' E' E ' 91' ' ' ASN . . . . . . . . . . . . . 13.6 p30 -131.99 18.25 4.59 Favored 'General case' 0 N--CA 1.468 0.454 0 N-CA-C 113.207 0.818 . . . . 0.0 113.207 -177.717 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' E' E ' 92' ' ' LEU . . . . . . . . . . . . . 25.3 mt -146.98 151.08 36.39 Favored 'General case' 0 C--N 1.332 -0.175 0 CA-C-N 117.861 0.301 . . . . 0.0 110.404 -177.069 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' E' E ' 93' ' ' ILE . . . . . . . . . . . . . 67.1 mt -127.1 121.73 58.49 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.213 0 N-CA-C 109.43 -0.582 . . . . 0.0 109.43 178.189 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' E' E ' 94' ' ' VAL . . . . . . . . . . . . . 45.9 t -120.62 129.91 75.1 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.291 0 CA-C-O 120.889 0.376 . . . . 0.0 110.013 -179.816 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' E' E ' 95' ' ' VAL . . . . . . . . . . . . . 44.3 t -122.7 136.0 60.94 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 CA-C-N 116.015 -0.539 . . . . 0.0 109.867 -179.562 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' E' E ' 96' ' ' ILE . . . . . . . . . . . . . 63.1 mt -118.26 127.18 75.41 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.232 0 N-CA-C 109.402 -0.592 . . . . 0.0 109.402 178.896 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' E' E ' 97' ' ' THR . . . . . . . . . . . . . 77.8 p -100.75 158.52 15.9 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-O 121.083 0.468 . . . . 0.0 111.106 -177.464 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' E' E ' 98' ' ' GLU . . . . . . . . . . . . . 47.1 tp10 -53.85 -26.32 23.93 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.279 -0.419 . . . . 0.0 112.105 -179.861 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' E' E ' 99' ' ' GLU . . . . . . . . . . . . . 96.0 mt-10 -76.1 11.61 1.42 Allowed 'General case' 0 CA--C 1.535 0.381 0 N-CA-C 113.404 0.89 . . . . 0.0 113.404 -177.204 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' E' E ' 100' ' ' ASN . . . . . . . . . . . . . 4.0 m-20 63.42 37.67 10.55 Favored 'General case' 0 CA--C 1.529 0.156 0 CA-C-O 121.143 0.497 . . . . 0.0 111.023 179.792 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' E' E ' 101' ' ' GLU . . . . . . . . . . . . . 85.0 tt0 -114.97 140.07 49.32 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.025 -0.534 . . . . 0.0 109.6 175.559 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' E' E ' 102' ' ' VAL . . . . . . . . . . . . . 47.5 t -114.88 126.1 72.37 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.243 0 N-CA-C 109.795 -0.446 . . . . 0.0 109.795 -178.508 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' E' E ' 103' ' ' LEU . . . . . . . . . . . . . 45.7 mt -119.15 133.15 55.95 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 115.768 -0.651 . . . . 0.0 110.483 178.233 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' E' E ' 104' ' ' ILE . . . . . . . . . . . . . 69.4 mt -119.0 122.42 69.28 Favored 'Isoleucine or valine' 0 C--O 1.235 0.296 0 CA-C-N 116.399 -0.364 . . . . 0.0 110.41 -179.618 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' E' E ' 105' ' ' PHE . . . . . . . . . . . . . 61.9 m-85 -121.72 167.1 13.34 Favored 'General case' 0 C--N 1.333 -0.142 0 O-C-N 124.013 0.821 . . . . 0.0 109.498 178.208 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' E' E ' 106' ' ' ASN . . . . . . . . . . . . . 46.3 p-10 -101.05 -170.36 1.83 Allowed 'General case' 0 C--N 1.33 -0.261 0 N-CA-C 109.95 -0.389 . . . . 0.0 109.95 172.99 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' E' E ' 107' ' ' GLN . . . . . . . . . . . . . 58.6 tt0 -58.99 -29.82 67.5 Favored 'General case' 0 C--N 1.328 -0.327 0 N-CA-C 111.902 0.334 . . . . 0.0 111.902 -179.998 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' E' E ' 108' ' ' ASN . . . . . . . . . . . . . 51.3 t30 -84.77 11.32 9.35 Favored 'General case' 0 CA--C 1.535 0.4 0 N-CA-C 112.838 0.681 . . . . 0.0 112.838 -177.307 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' E' E ' 109' ' ' LEU . . . . . . . . . . . . . 17.8 mt 57.58 36.46 26.82 Favored 'General case' 0 CA--C 1.53 0.185 0 CA-C-O 120.898 0.38 . . . . 0.0 111.342 178.63 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' E' E ' 110' ' ' GLU . . . . . . . . . . . . . 70.4 mm-40 -101.87 138.18 39.18 Favored 'General case' 0 C--N 1.33 -0.281 0 N-CA-C 109.172 -0.677 . . . . 0.0 109.172 174.909 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' E' E ' 111' ' ' GLU . . . . . . . . . . . . . 73.1 tt0 -82.55 121.81 27.27 Favored 'General case' 0 C--N 1.33 -0.28 0 C-N-CA 120.665 -0.414 . . . . 0.0 110.029 -176.655 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' E' E ' 112' ' ' LEU . . . . . . . . . . . . . 22.5 mt -108.95 -44.76 3.92 Favored 'General case' 0 C--N 1.332 -0.195 0 CA-C-N 116.129 -0.487 . . . . 0.0 110.789 -177.655 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' E' E ' 113' ' ' TYR . . . . . . . . . . . . . 50.9 t80 -132.91 137.07 46.51 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.365 -0.38 . . . . 0.0 110.911 -177.739 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' E' E ' 114' ' ' ARG . . . . . . . . . . . . . 16.3 ptm180 -143.31 126.95 17.0 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-O 121.034 0.445 . . . . 0.0 110.664 176.57 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' E' E ' 115' ' ' GLY . . . . . . . . . . . . . . . -150.11 140.27 7.9 Favored Glycine 0 CA--C 1.524 0.64 0 N-CA-C 111.147 -0.781 . . . . 0.0 111.147 178.599 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' E' E ' 116' ' ' LYS . . . . . . . . . . . . . 39.6 ttpt -104.89 128.98 53.33 Favored 'General case' 0 C--N 1.33 -0.269 0 N-CA-C 109.721 -0.474 . . . . 0.0 109.721 175.67 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' E' E ' 117' ' ' PHE . . . . . . . . . . . . . 69.8 m-85 -125.68 114.96 19.36 Favored 'General case' 0 C--N 1.331 -0.22 0 CA-C-O 121.019 0.438 . . . . 0.0 110.129 -177.268 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' E' E ' 118' ' ' GLU . . . . . . . . . . . . . 96.0 mt-10 -54.55 -41.35 69.68 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.462 -0.336 . . . . 0.0 111.265 -175.825 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' E' E ' 119' ' ' ASN . . . . . . . . . . . . . 69.9 m-80 -104.07 31.07 4.76 Favored 'General case' 0 C--O 1.234 0.246 0 CA-C-N 116.229 -0.441 . . . . 0.0 112.111 -173.92 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' E' E ' 120' ' ' LEU . . . . . . . . . . . . . 11.7 tp -56.24 120.05 6.95 Favored 'General case' 0 N--CA 1.462 0.147 0 CA-C-O 120.715 0.293 . . . . 0.0 110.311 178.884 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' E' E ' 121' ' ' ASN . . . . . . . . . . . . . 45.7 m-80 -114.34 -44.03 3.15 Favored 'General case' 0 C--O 1.232 0.153 0 CA-C-N 116.385 -0.37 . . . . 0.0 111.169 -176.655 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' E' E ' 122' ' ' LYS . . . . . . . . . . . . . 97.8 mttt -142.59 147.62 36.16 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-O 121.021 0.439 . . . . 0.0 111.596 -175.915 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' E' E ' 123' ' ' VAL . . . . . . . . . . . . . 44.1 t -127.09 129.16 71.07 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.275 0 N-CA-C 109.278 -0.638 . . . . 0.0 109.278 174.126 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' E' E ' 124' ' ' LEU . . . . . . . . . . . . . 38.1 mt -129.52 137.06 50.58 Favored 'General case' 0 C--N 1.331 -0.202 0 CA-C-O 120.838 0.352 . . . . 0.0 110.948 -178.394 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' E' E ' 125' ' ' VAL . . . . . . . . . . . . . 12.8 p -137.55 138.22 44.88 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.255 0 CA-C-N 116.282 -0.417 . . . . 0.0 110.329 177.908 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' E' E ' 126' ' ' ARG . . . . . . . . . . . . . 37.8 mtp180 -146.2 127.67 15.01 Favored 'General case' 0 C--N 1.331 -0.229 0 CA-C-O 120.954 0.406 . . . . 0.0 110.839 179.159 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' E' E ' 127' ' ' ASN . . . . . . . . . . . . . 62.1 t30 49.55 -104.93 0.15 Allowed 'General case' 0 CA--C 1.543 0.684 0 CA-C-O 118.953 -0.546 . . . . 0.0 111.826 179.157 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' E' E ' 128' ' ' ASP . . . . . . . . . . . . . 12.0 p-10 -114.19 0.61 14.28 Favored 'General case' 0 CA--C 1.537 0.445 0 CA-C-N 119.612 1.096 . . . . 0.0 113.591 -175.148 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' E' E ' 129' ' ' LEU . . . . . . . . . . . . . 84.3 mt -112.32 145.16 40.52 Favored 'General case' 0 C--N 1.333 -0.133 0 CA-C-N 118.203 0.456 . . . . 0.0 110.03 179.839 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' E' E ' 130' ' ' VAL . . . . . 0.507 HG13 ' HB ' ' E' ' 141' ' ' ILE . 12.0 p -131.95 141.93 44.26 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.175 0 CA-C-O 121.059 0.457 . . . . 0.0 110.25 179.954 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' E' E ' 131' ' ' VAL . . . . . 0.673 HG22 HD12 ' E' ' 140' ' ' LEU . 27.0 t -135.42 139.32 46.92 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.315 0 CA-C-N 115.961 -0.563 . . . . 0.0 110.397 -177.348 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' E' E ' 132' ' ' ILE . . . . . . . . . . . . . 74.6 mt -115.97 130.45 70.65 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.332 0 N-CA-C 109.215 -0.661 . . . . 0.0 109.215 178.582 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' E' E ' 133' ' ' ILE . . . . . . . . . . . . . 39.5 mm -116.47 123.08 71.14 Favored 'Isoleucine or valine' 0 N--CA 1.462 0.159 0 CA-C-O 120.727 0.299 . . . . 0.0 110.923 -174.662 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' E' E ' 134' ' ' ASP . . . . . . . . . . . . . 12.1 p-10 -136.47 151.71 49.76 Favored 'General case' 0 C--N 1.332 -0.173 0 N-CA-C 109.883 -0.414 . . . . 0.0 109.883 174.422 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' E' E ' 135' ' ' GLU . . . . . . . . . . . . . 41.2 tp10 -50.05 -26.42 4.35 Favored 'General case' 0 C--N 1.328 -0.343 0 N-CA-C 113.025 0.75 . . . . 0.0 113.025 -171.781 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' E' E ' 136' ' ' GLN . . . . . . . . . . . . . 47.1 tt0 -91.47 -25.11 19.46 Favored 'General case' 0 C--O 1.234 0.264 0 N-CA-C 112.977 0.732 . . . . 0.0 112.977 -173.121 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' E' E ' 137' ' ' LYS . . . . . . . . . . . . . 22.6 pttm -170.06 171.36 7.02 Favored 'General case' 0 C--O 1.232 0.148 0 CA-C-O 121.501 0.667 . . . . 0.0 112.659 -172.522 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' E' E ' 138' ' ' LEU . . . . . 0.439 HD23 ' N ' ' E' ' 139' ' ' THR . 5.1 tt -122.28 129.01 51.78 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 115.009 -0.996 . . . . 0.0 109.817 179.727 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' E' E ' 139' ' ' THR . . . . . 0.439 ' N ' HD23 ' E' ' 138' ' ' LEU . 43.5 m -111.46 127.61 55.74 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.528 -0.306 . . . . 0.0 110.354 179.288 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' E' E ' 140' ' ' LEU . . . . . 0.673 HD12 HG22 ' E' ' 131' ' ' VAL . 11.9 tp -114.27 123.34 49.3 Favored 'General case' 0 C--N 1.33 -0.268 0 N-CA-C 109.554 -0.535 . . . . 0.0 109.554 -178.976 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' E' E ' 141' ' ' ILE . . . . . 0.507 ' HB ' HG13 ' E' ' 130' ' ' VAL . 19.6 mt -121.5 124.79 72.54 Favored 'Isoleucine or valine' 0 C--O 1.234 0.253 0 CA-C-O 120.943 0.401 . . . . 0.0 110.261 -174.648 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' E' E ' 142' ' ' ARG . . . . . . . . . . . . . 82.2 mtp180 -108.68 128.13 54.59 Favored 'General case' 0 C--N 1.331 -0.222 0 CA-C-N 115.229 -0.896 . . . . 0.0 110.181 -178.654 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' E' E ' 143' ' ' THR . . . . . . . . . . . . . 24.9 p . . . . . 0 C--O 1.221 -0.412 0 CA-C-O 117.964 -1.017 . . . . 0.0 110.52 -179.754 . . . . . . . . 0 0 . 1 . 008 nuclear nobuild core ' F' F ' 1' ' ' MET . . . . . . . . . . . . . 25.2 ptp . . . . . 0 CA--C 1.527 0.084 0 CA-C-O 120.725 0.298 . . . . 0.0 110.789 . . . . . . . . . 0 0 . 1 . 008 nuclear nobuild core ' F' F ' 2' ' ' SER . . . . . . . . . . . . . 2.5 p -131.03 125.44 33.28 Favored 'General case' 0 C--N 1.331 -0.224 0 CA-C-N 116.461 -0.336 . . . . 0.0 110.358 178.738 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' F' F ' 3' ' ' GLU . . . . . . . . . . . . . 93.9 mt-10 -139.47 139.66 37.07 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 116.144 -0.48 . . . . 0.0 111.056 -176.439 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' F' F ' 4' ' ' LEU . . . . . . . . . . . . . 20.6 tp -123.24 127.66 48.9 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 115.805 -0.634 . . . . 0.0 109.91 175.387 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' F' F ' 5' ' ' LYS . . . . . . . . . . . . . 90.9 mttt -109.76 122.25 47.07 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 116.466 -0.334 . . . . 0.0 110.829 179.891 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' F' F ' 6' ' ' LEU . . . . . . . . . . . . . 71.7 mt -116.69 147.2 42.2 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 115.551 -0.75 . . . . 0.0 110.094 179.274 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' F' F ' 7' ' ' LYS . . . . . . . . . . . . . 39.4 ttmt -137.44 142.29 36.8 Favored Pre-proline 0 CA--C 1.533 0.319 0 CA-C-O 119.298 -0.382 . . . . 0.0 110.043 175.845 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' F' F ' 8' ' ' PRO . . . . . . . . . . . . . 87.7 Cg_endo -90.51 143.89 3.75 Favored 'Trans proline' 0 N--CA 1.489 1.244 0 C-N-CA 121.761 1.641 . . . . 0.0 111.846 178.376 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' F' F ' 9' ' ' LEU . . . . . . . . . . . . . 50.4 mt -76.84 -47.97 2.81 Favored Pre-proline 0 CA--C 1.534 0.347 0 CA-C-O 118.709 -0.663 . . . . 0.0 112.27 -179.652 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' F' F ' 10' ' ' PRO . . . . . . . . . . . . . 84.5 Cg_endo -80.41 157.76 22.48 Favored 'Trans proline' 0 N--CA 1.497 1.702 0 C-N-CA 121.237 1.291 . . . . 0.0 111.967 176.561 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' F' F ' 11' ' ' LYS . . . . . . . . . . . . . 53.3 mttm -87.48 100.54 12.84 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-O 120.817 0.341 . . . . 0.0 110.539 178.049 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' F' F ' 12' ' ' VAL . . . . . . . . . . . . . 11.4 p -139.97 144.2 28.62 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.275 0 CA-C-N 116.05 -0.523 . . . . 0.0 110.071 179.281 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' F' F ' 13' ' ' GLU . . . . . . . . . . . . . 41.6 tp10 -91.01 116.67 28.97 Favored 'General case' 0 C--N 1.329 -0.325 0 N-CA-C 109.989 -0.374 . . . . 0.0 109.989 178.611 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' F' F ' 14' ' ' LEU . . . . . . . . . . . . . 23.0 mt -98.24 153.67 37.98 Favored Pre-proline 0 C--N 1.33 -0.269 0 CA-C-N 116.251 -0.431 . . . . 0.0 111.177 -176.124 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' F' F ' 15' ' ' PRO . . . . . . . . . . . . . 37.4 Cg_exo -59.7 156.88 35.11 Favored 'Trans proline' 0 N--CA 1.497 1.733 0 C-N-CA 121.332 1.355 . . . . 0.0 112.132 179.065 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' F' F ' 16' ' ' PRO . . . . . . . . . . . . . 28.1 Cg_exo -60.68 -34.34 92.17 Favored 'Trans proline' 0 N--CA 1.497 1.701 0 C-N-CA 121.404 1.403 . . . . 0.0 112.187 178.043 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' F' F ' 17' ' ' ASP . . . . . . . . . . . . . 15.1 p-10 -85.11 12.29 8.07 Favored 'General case' 0 CA--C 1.536 0.427 0 N-CA-C 113.113 0.783 . . . . 0.0 113.113 -177.939 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' F' F ' 18' ' ' PHE . . . . . . . . . . . . . 33.4 t80 -57.83 -42.36 84.2 Favored 'General case' 0 C--N 1.333 -0.115 0 O-C-N 121.988 -0.445 . . . . 0.0 110.142 -179.678 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' F' F ' 19' ' ' VAL . . . . . . . . . . . . . 49.8 t -55.89 -52.98 43.18 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.316 0 CA-C-N 116.352 -0.385 . . . . 0.0 111.102 -176.675 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' F' F ' 20' ' ' ASP . . . . . . . . . . . . . 2.5 p-10 -59.82 -36.25 76.38 Favored 'General case' 0 N--CA 1.464 0.268 0 C-N-CA 120.582 -0.447 . . . . 0.0 111.342 -176.452 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' F' F ' 21' ' ' VAL . . . . . . . . . . . . . 51.7 t -63.93 -47.13 91.96 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.239 0 C-N-CA 120.575 -0.45 . . . . 0.0 110.34 -179.853 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' F' F ' 22' ' ' ILE . . . . . 0.446 HG22 HD12 ' F' ' 26' ' ' LEU . 49.2 mm -55.54 -48.35 77.48 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.219 0 CA-C-O 120.736 0.303 . . . . 0.0 110.505 178.129 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' F' F ' 23' ' ' ARG . . . . . . . . . . . . . 53.2 ttp180 -54.41 -49.54 69.7 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.521 -0.309 . . . . 0.0 111.572 -177.109 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' F' F ' 24' ' ' ILE . . . . . . . . . . . . . 78.0 mt -59.16 -46.15 92.24 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.316 0 C-N-CA 120.971 -0.291 . . . . 0.0 111.166 -176.7 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' F' F ' 25' ' ' LYS . . . . . . . . . . . . . 90.8 mttt -64.76 -44.05 91.34 Favored 'General case' 0 C--N 1.33 -0.275 0 N-CA-C 112.54 0.57 . . . . 0.0 112.54 -177.25 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' F' F ' 26' ' ' LEU . . . . . 0.446 HD12 HG22 ' F' ' 22' ' ' ILE . 61.4 mt -83.67 -24.16 31.44 Favored 'General case' 0 C--N 1.329 -0.302 0 N-CA-C 113.467 0.914 . . . . 0.0 113.467 -171.508 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' F' F ' 27' ' ' GLN . . . . . . . . . . . . . 6.4 pt20 -46.15 136.58 6.76 Favored 'General case' 0 CA--C 1.534 0.351 0 N-CA-C 112.813 0.671 . . . . 0.0 112.813 -174.633 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' F' F ' 28' ' ' GLY . . . . . . . . . . . . . . . 100.53 -21.56 43.58 Favored Glycine 0 CA--C 1.533 1.214 0 CA-C-N 115.701 -0.681 . . . . 0.0 112.786 -178.623 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' F' F ' 29' ' ' LYS . . . . . . . . . . . . . 63.2 mttp -97.79 155.08 17.2 Favored 'General case' 0 C--N 1.331 -0.199 0 CA-C-N 117.604 0.702 . . . . 0.0 111.144 179.125 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' F' F ' 30' ' ' THR . . . . . . . . . . . . . 24.2 m -104.7 139.23 39.82 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.196 177.366 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' F' F ' 31' ' ' VAL . . . . . . . . . . . . . 34.3 m -129.33 157.45 42.1 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.19 0 CA-C-O 120.856 0.36 . . . . 0.0 110.915 -178.741 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' F' F ' 32' ' ' ARG . . . . . . . . . . . . . 93.4 mtt180 -133.74 152.33 51.85 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 115.959 -0.564 . . . . 0.0 110.779 177.934 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' F' F ' 33' ' ' THR . . . . . . . . . . . . . 28.5 m -53.31 139.97 28.33 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.133 -0.485 . . . . 0.0 111.399 -178.852 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' F' F ' 34' ' ' GLY . . . . . . . . . . . . . . . 99.21 -17.17 58.33 Favored Glycine 0 CA--C 1.532 1.118 0 C-N-CA 121.16 -0.543 . . . . 0.0 113.222 178.81 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' F' F ' 35' ' ' ASP . . . . . . . . . . . . . 76.0 m-20 -65.83 148.66 51.42 Favored 'General case' 0 C--O 1.232 0.176 0 CA-C-N 118.065 0.933 . . . . 0.0 111.188 179.092 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' F' F ' 36' ' ' VAL . . . . . . . . . . . . . 45.0 t -122.3 129.76 75.06 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.243 0 CA-C-N 115.981 -0.554 . . . . 0.0 109.874 178.468 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' F' F ' 37' ' ' ILE . . . . . . . . . . . . . 66.1 mt -119.77 138.79 49.24 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.201 0 CA-C-N 116.21 -0.45 . . . . 0.0 109.933 -179.776 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' F' F ' 38' ' ' GLY . . . . . . . . . . . . . . . -110.76 128.78 8.93 Favored Glycine 0 CA--C 1.525 0.691 0 N-CA-C 111.193 -0.763 . . . . 0.0 111.193 -179.331 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' F' F ' 39' ' ' ILE . . . . . . . . . . . . . 72.9 mt -123.85 132.69 70.96 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.216 0 N-CA-C 110.137 -0.32 . . . . 0.0 110.137 178.89 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' F' F ' 40' ' ' SER . . . . . . . . . . . . . 23.0 t -92.7 118.86 31.51 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.332 -0.394 . . . . 0.0 110.685 175.34 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' F' F ' 41' ' ' ILE . . . . . . . . . . . . . 70.5 mt -130.69 125.33 58.47 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.229 0 CA-C-O 120.884 0.374 . . . . 0.0 110.469 179.219 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' F' F ' 42' ' ' LEU . . . . . . . . . . . . . 48.3 mt 51.94 34.46 13.69 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 115.994 -0.548 . . . . 0.0 111.913 176.833 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' F' F ' 43' ' ' GLY . . . . . . . . . . . . . . . 72.92 31.36 62.18 Favored Glycine 0 CA--C 1.53 0.993 0 C-N-CA 121.076 -0.583 . . . . 0.0 112.187 177.089 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' F' F ' 44' ' ' LYS . . . . . . . . . . . . . 40.6 ttpt -138.31 130.89 29.23 Favored 'General case' 0 C--N 1.329 -0.314 0 N-CA-C 109.613 -0.514 . . . . 0.0 109.613 178.081 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' F' F ' 45' ' ' GLU . . . . . . . . . . . . . 84.6 tt0 -83.06 118.91 23.86 Favored 'General case' 0 C--N 1.328 -0.351 0 C-N-CA 120.815 -0.354 . . . . 0.0 110.847 -179.66 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' F' F ' 46' ' ' VAL . . . . . . . . . . . . . 7.6 p -119.13 126.74 75.62 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.27 0 N-CA-C 109.375 -0.602 . . . . 0.0 109.375 176.623 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' F' F ' 47' ' ' LYS . . . . . . . . . . . . . 61.0 mttm -100.12 130.61 46.28 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.033 -0.53 . . . . 0.0 111.342 177.813 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' F' F ' 48' ' ' PHE . . . . . . . . . . . . . 90.0 m-85 -111.03 131.91 54.67 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 115.969 -0.559 . . . . 0.0 109.777 175.589 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' F' F ' 49' ' ' LYS . . . . . . . . . . . . . 83.6 tttt -106.81 134.68 49.6 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 116.213 -0.448 . . . . 0.0 110.379 -179.559 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' F' F ' 50' ' ' VAL . . . . . . . . . . . . . 46.8 t -77.07 106.98 7.68 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.283 0 N-CA-C 109.142 -0.688 . . . . 0.0 109.142 176.368 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' F' F ' 51' ' ' VAL . . . . . . . . . . . . . 47.9 t -69.57 -47.95 68.76 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.325 0 CA-C-N 115.932 -0.577 . . . . 0.0 109.979 -173.278 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' F' F ' 52' ' ' GLN . . . . . . . . . . . . . 61.1 tt0 -168.22 148.39 4.8 Favored 'General case' 0 C--N 1.331 -0.22 0 C-N-CA 120.228 -0.589 . . . . 0.0 111.678 -178.838 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' F' F ' 53' ' ' ALA . . . . . . . . . . . . . . . -123.25 132.07 53.9 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 115.651 -0.704 . . . . 0.0 109.86 176.492 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' F' F ' 54' ' ' TYR . . . . . . . . . . . . . 54.3 t80 -129.04 110.11 18.27 Favored Pre-proline 0 CA--C 1.535 0.385 0 CA-C-O 118.317 -0.849 . . . . 0.0 110.166 179.92 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' F' F ' 55' ' ' PRO . . . . . . . . . . . . . 73.9 Cg_endo -77.07 170.03 72.74 Favored 'Cis proline' 0 N--CA 1.497 1.713 0 CA-C-N 121.861 1.7 . . . . 0.0 112.27 -4.661 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' F' F ' 56' ' ' SER . . . . . . . . . . . . . 13.5 m -113.93 131.91 22.91 Favored Pre-proline 0 CA--C 1.538 0.484 0 CA-C-O 118.513 -0.756 . . . . 0.0 109.326 175.652 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' F' F ' 57' ' ' PRO . . . . . . . . . . . . . 55.6 Cg_endo -71.33 166.88 76.79 Favored 'Cis proline' 0 N--CA 1.498 1.757 0 CA-C-N 121.923 1.722 . . . . 0.0 111.643 -0.321 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' F' F ' 58' ' ' LEU . . . . . . . . . . . . . 35.3 tp -129.54 137.34 50.72 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.271 -0.422 . . . . 0.0 110.152 179.491 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' F' F ' 59' ' ' ARG . . . . . . . . . . . . . 38.5 ttm180 -103.71 133.89 47.95 Favored 'General case' 0 C--N 1.327 -0.381 0 N-CA-C 109.706 -0.479 . . . . 0.0 109.706 177.836 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' F' F ' 60' ' ' VAL . . . . . . . . . . . . . 44.1 t -85.28 111.38 20.65 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.264 0 C-N-CA 120.761 -0.376 . . . . 0.0 110.36 -176.428 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' F' F ' 61' ' ' GLU . . . . . . . . . . . . . 95.5 mt-10 -131.06 165.26 23.63 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 115.835 -0.621 . . . . 0.0 109.677 176.043 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' F' F ' 62' ' ' ASP . . . . . . . . . . . . . 19.9 p-10 -53.7 -32.47 51.98 Favored 'General case' 0 C--N 1.328 -0.365 0 N-CA-C 111.85 0.315 . . . . 0.0 111.85 -179.42 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' F' F ' 63' ' ' ARG . . . . . . . . . . . . . 81.3 mtp180 -72.97 -21.93 60.78 Favored 'General case' 0 CA--C 1.533 0.299 0 N-CA-C 113.041 0.756 . . . . 0.0 113.041 -176.313 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' F' F ' 64' ' ' THR . . . . . . . . . . . . . 17.8 m -71.17 142.01 50.7 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-O 120.952 0.406 . . . . 0.0 111.09 -174.568 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' F' F ' 65' ' ' LYS . . . . . . . . . . . . . 39.7 mtpt -89.48 125.46 35.19 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 115.883 -0.599 . . . . 0.0 109.925 178.784 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' F' F ' 66' ' ' ILE . . . . . . . . . . . . . 68.1 mt -119.07 131.64 71.25 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.339 0 CA-C-O 120.874 0.368 . . . . 0.0 110.277 -178.15 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' F' F ' 67' ' ' THR . . . . . . . . . . . . . 26.1 m -123.98 136.89 54.6 Favored 'General case' 0 C--N 1.331 -0.215 0 CA-C-N 116.015 -0.539 . . . . 0.0 110.742 -179.048 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' F' F ' 68' ' ' LEU . . . . . 0.472 HD23 ' C ' ' F' ' 68' ' ' LEU . 5.7 tt . . . . . 0 C--N 1.33 -0.25 0 CA-C-N 115.968 -0.56 . . . . 0.0 110.515 179.485 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' F' F ' 73' ' ' VAL . . . . . . . . . . . . . 35.9 m . . . . . 0 C--O 1.232 0.132 0 CA-C-O 120.837 0.351 . . . . 0.0 110.686 . . . . . . . . . 0 0 . 1 . 008 nuclear nobuild core ' F' F ' 74' ' ' ASP . . . . . . . . . . . . . 19.5 t0 -107.05 123.04 47.64 Favored 'General case' 0 C--N 1.328 -0.329 0 N-CA-C 109.584 -0.525 . . . . 0.0 109.584 179.156 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' F' F ' 75' ' ' VAL . . . . . 0.429 ' C ' HD12 ' F' ' 76' ' ' LEU . 46.2 t -117.34 126.26 74.48 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.233 0 CA-C-O 121.173 0.511 . . . . 0.0 110.771 -177.43 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' F' F ' 76' ' ' LEU . . . . . 0.429 HD12 ' C ' ' F' ' 75' ' ' VAL . 6.5 mp -122.82 143.66 49.7 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 115.463 -0.79 . . . . 0.0 109.128 174.546 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' F' F ' 77' ' ' GLU . . . . . . . . . . . . . 30.1 tt0 -135.85 140.76 44.42 Favored 'General case' 0 C--N 1.331 -0.225 0 C-N-CA 120.734 -0.386 . . . . 0.0 111.273 -174.73 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' F' F ' 78' ' ' ALA . . . . . . . . . . . . . . . -130.16 134.96 47.68 Favored 'General case' 0 C--N 1.331 -0.239 0 CA-C-N 115.933 -0.576 . . . . 0.0 110.013 176.762 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' F' F ' 79' ' ' LYS . . . . . 0.403 ' O ' HD13 ' F' ' 80' ' ' ILE . 31.1 ttmt -82.4 125.71 31.36 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-O 120.74 0.305 . . . . 0.0 110.822 -178.607 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' F' F ' 80' ' ' ILE . . . . . 0.403 HD13 ' O ' ' F' ' 79' ' ' LYS . 28.0 mm -139.12 114.81 8.98 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.265 0 N-CA-C 109.062 -0.718 . . . . 0.0 109.062 -177.8 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' F' F ' 81' ' ' LYS . . . . . . . . . . . . . 70.1 tttt -103.69 122.11 44.36 Favored 'General case' 0 C--N 1.328 -0.334 0 C-N-CA 121.027 -0.269 . . . . 0.0 111.116 -175.884 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' F' F ' 82' ' ' GLY . . . . . . . . . . . . . . . 89.09 42.18 5.68 Favored Glycine 0 CA--C 1.525 0.66 0 C-N-CA 120.715 -0.755 . . . . 0.0 111.892 174.789 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' F' F ' 83' ' ' ILE . . . . . . . . . . . . . 69.0 mt -65.27 136.49 26.6 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.243 0 N-CA-C 109.91 -0.404 . . . . 0.0 109.91 178.044 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' F' F ' 84' ' ' LYS . . . . . . . . . . . . . 29.0 ttmt -94.32 -51.78 4.64 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.088 -0.506 . . . . 0.0 109.93 179.482 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' F' F ' 85' ' ' ASP . . . . . . . . . . . . . 4.3 t70 -157.29 153.59 27.7 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 115.621 -0.718 . . . . 0.0 110.504 -179.659 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' F' F ' 86' ' ' VAL . . . . . . . . . . . . . 43.8 t -131.52 133.41 61.85 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.232 0 CA-C-O 120.98 0.419 . . . . 0.0 110.356 -179.181 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' F' F ' 87' ' ' ILE . . . . . 0.497 HD12 ' N ' ' F' ' 87' ' ' ILE . 5.0 mp -120.37 126.29 75.1 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.241 0 CA-C-N 115.943 -0.572 . . . . 0.0 109.528 177.765 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' F' F ' 88' ' ' LEU . . . . . . . . . . . . . 10.7 tp -109.5 128.2 55.0 Favored 'General case' 0 C--N 1.331 -0.226 0 CA-C-O 120.902 0.382 . . . . 0.0 110.895 -177.929 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' F' F ' 89' ' ' ASP . . . . . . . . . . . . . 4.2 t0 -120.69 158.14 28.1 Favored 'General case' 0 C--N 1.329 -0.286 0 N-CA-C 109.497 -0.557 . . . . 0.0 109.497 177.441 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' F' F ' 90' ' ' GLU . . . . . . . . . . . . . 84.0 tt0 -45.12 -46.19 11.68 Favored 'General case' 0 N--CA 1.465 0.291 0 N-CA-C 112.985 0.735 . . . . 0.0 112.985 -172.484 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' F' F ' 91' ' ' ASN . . . . . . . . . . . . . 79.4 m-20 -132.05 30.84 4.22 Favored 'General case' 0 N--CA 1.465 0.29 0 N-CA-C 112.189 0.44 . . . . 0.0 112.189 -179.608 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' F' F ' 92' ' ' LEU . . . . . . . . . . . . . 7.2 mt -150.35 140.94 22.56 Favored 'General case' 0 C--N 1.331 -0.204 0 N-CA-C 109.564 -0.532 . . . . 0.0 109.564 -178.088 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' F' F ' 93' ' ' ILE . . . . . . . . . . . . . 73.5 mt -124.01 119.45 56.87 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.289 0 N-CA-C 109.338 -0.616 . . . . 0.0 109.338 178.997 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' F' F ' 94' ' ' VAL . . . . . . . . . . . . . 44.0 t -119.55 126.59 75.46 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.198 0 CA-C-O 120.892 0.377 . . . . 0.0 109.998 -179.648 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' F' F ' 95' ' ' VAL . . . . . . . . . . . . . 44.1 t -121.58 133.14 69.01 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.298 0 CA-C-N 116.101 -0.5 . . . . 0.0 109.738 179.623 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' F' F ' 96' ' ' ILE . . . . . . . . . . . . . 64.3 mt -114.26 126.15 71.71 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.326 0 N-CA-C 109.234 -0.654 . . . . 0.0 109.234 178.88 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' F' F ' 97' ' ' THR . . . . . . . . . . . . . 64.6 p -98.62 154.8 17.67 Favored 'General case' 0 C--N 1.327 -0.385 0 CA-C-O 121.109 0.48 . . . . 0.0 110.952 -178.311 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' F' F ' 98' ' ' GLU . . . . . . . . . . . . . 83.4 tt0 -53.89 -23.5 12.91 Favored 'General case' 0 CA--C 1.535 0.371 0 N-CA-C 112.419 0.525 . . . . 0.0 112.419 179.966 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' F' F ' 99' ' ' GLU . . . . . . . . . . . . . 13.8 mm-40 -77.54 13.92 1.14 Allowed 'General case' 0 CA--C 1.536 0.431 0 N-CA-C 113.272 0.841 . . . . 0.0 113.272 -178.444 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' F' F ' 100' ' ' ASN . . . . . . . . . . . . . 2.2 m-20 63.65 37.73 9.95 Favored 'General case' 0 N--CA 1.463 0.212 0 CA-C-O 121.111 0.481 . . . . 0.0 110.948 178.322 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' F' F ' 101' ' ' GLU . . . . . . . . . . . . . 84.9 tt0 -120.09 140.93 50.3 Favored 'General case' 0 C--N 1.333 -0.151 0 CA-C-N 116.203 -0.453 . . . . 0.0 109.853 176.68 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' F' F ' 102' ' ' VAL . . . . . . . . . . . . . 43.2 t -115.03 126.74 72.7 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 CA-C-N 116.197 -0.456 . . . . 0.0 109.881 -178.32 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' F' F ' 103' ' ' LEU . . . . . 0.516 HD12 ' N ' ' F' ' 103' ' ' LEU . 6.2 mp -117.29 134.89 54.27 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 115.994 -0.548 . . . . 0.0 110.294 177.784 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' F' F ' 104' ' ' ILE . . . . . . . . . . . . . 66.3 mt -119.0 122.22 68.78 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.218 0 CA-C-N 116.422 -0.354 . . . . 0.0 110.217 -179.147 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' F' F ' 105' ' ' PHE . . . . . . . . . . . . . 79.3 m-85 -120.54 161.46 21.27 Favored 'General case' 0 C--N 1.331 -0.235 0 O-C-N 124.046 0.841 . . . . 0.0 109.987 179.614 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' F' F ' 106' ' ' ASN . . . . . . . . . . . . . 46.8 p-10 -97.4 -169.85 1.92 Allowed 'General case' 0 CA--C 1.531 0.228 0 N-CA-C 110.19 -0.3 . . . . 0.0 110.19 175.559 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' F' F ' 107' ' ' GLN . . . . . . . . . . . . . 63.0 tt0 -59.0 -30.09 67.72 Favored 'General case' 0 C--N 1.33 -0.271 0 N-CA-C 111.954 0.353 . . . . 0.0 111.954 179.618 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' F' F ' 108' ' ' ASN . . . . . . . . . . . . . 8.5 t-20 -83.98 11.76 7.32 Favored 'General case' 0 CA--C 1.536 0.428 0 N-CA-C 112.877 0.695 . . . . 0.0 112.877 -178.124 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' F' F ' 109' ' ' LEU . . . . . . . . . . . . . 10.5 tp 54.96 35.41 24.49 Favored 'General case' 0 C--N 1.331 -0.201 0 CA-C-O 120.902 0.382 . . . . 0.0 111.431 -179.602 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' F' F ' 110' ' ' GLU . . . . . . . . . . . . . 94.9 mt-10 -104.46 147.06 28.0 Favored 'General case' 0 C--N 1.331 -0.233 0 N-CA-C 109.335 -0.617 . . . . 0.0 109.335 175.38 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' F' F ' 111' ' ' GLU . . . . . . . . . . . . . 64.8 tt0 -81.47 121.95 26.92 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-O 120.913 0.387 . . . . 0.0 110.639 -174.97 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' F' F ' 112' ' ' LEU . . . . . . . . . . . . . 16.9 mt -104.7 -46.04 4.44 Favored 'General case' 0 C--N 1.331 -0.227 0 CA-C-N 116.04 -0.527 . . . . 0.0 110.623 179.513 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' F' F ' 113' ' ' TYR . . . . . . . . . . . . . 49.5 t80 -137.25 146.04 44.28 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.166 -0.47 . . . . 0.0 111.026 -177.919 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' F' F ' 114' ' ' ARG . . . . . . . . . . . . . 37.6 ptt180 -148.58 126.58 12.0 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.141 -0.481 . . . . 0.0 110.779 178.505 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' F' F ' 115' ' ' GLY . . . . . . . . . . . . . . . -150.16 142.78 9.98 Favored Glycine 0 CA--C 1.524 0.641 0 N-CA-C 111.062 -0.815 . . . . 0.0 111.062 179.159 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' F' F ' 116' ' ' LYS . . . . . . . . . . . . . 39.1 ttpt -112.37 134.09 54.09 Favored 'General case' 0 C--N 1.331 -0.236 0 N-CA-C 109.694 -0.484 . . . . 0.0 109.694 176.908 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' F' F ' 117' ' ' PHE . . . . . . . . . . . . . 28.1 m-85 -136.54 114.38 11.25 Favored 'General case' 0 C--N 1.329 -0.313 0 N-CA-C 110.055 -0.35 . . . . 0.0 110.055 -175.351 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' F' F ' 118' ' ' GLU . . . . . . . . . . . . . 43.7 mt-10 -54.94 -44.1 74.0 Favored 'General case' 0 C--N 1.33 -0.274 0 C-N-CA 120.883 -0.327 . . . . 0.0 111.348 -176.618 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' F' F ' 119' ' ' ASN . . . . . . . . . . . . . 30.6 m120 -94.87 30.49 2.07 Favored 'General case' 0 C--N 1.33 -0.263 0 N-CA-C 112.161 0.43 . . . . 0.0 112.161 -174.659 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' F' F ' 120' ' ' LEU . . . . . . . . . . . . . 22.0 tp -57.5 120.08 7.65 Favored 'General case' 0 C--N 1.331 -0.211 0 C-N-CA 120.925 -0.31 . . . . 0.0 110.293 177.577 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' F' F ' 121' ' ' ASN . . . . . . . . . . . . . 76.2 m-20 -111.63 -44.1 3.55 Favored 'General case' 0 C--N 1.331 -0.221 0 CA-C-N 116.425 -0.352 . . . . 0.0 110.711 -179.273 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' F' F ' 122' ' ' LYS . . . . . . . . . . . . . 97.0 mttt -146.93 145.08 29.67 Favored 'General case' 0 C--N 1.331 -0.216 0 C-N-CA 120.536 -0.466 . . . . 0.0 111.899 -179.316 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' F' F ' 123' ' ' VAL . . . . . . . . . . . . . 45.1 t -122.95 125.86 72.89 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.234 0 N-CA-C 108.998 -0.742 . . . . 0.0 108.998 171.531 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' F' F ' 124' ' ' LEU . . . . . 0.462 HD23 ' N ' ' F' ' 125' ' ' VAL . 3.3 tt -125.26 131.86 53.03 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.461 -0.336 . . . . 0.0 110.482 -175.28 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' F' F ' 125' ' ' VAL . . . . . 0.462 ' N ' HD23 ' F' ' 124' ' ' LEU . 11.7 p -131.14 135.95 58.78 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.224 0 CA-C-N 116.377 -0.374 . . . . 0.0 110.502 178.961 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' F' F ' 126' ' ' ARG . . . . . . . . . . . . . 96.6 mtt180 -149.43 128.37 12.63 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 116.109 -0.496 . . . . 0.0 110.873 177.333 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' F' F ' 127' ' ' ASN . . . . . . . . . . . . . 17.3 t-20 50.46 -106.77 0.24 Allowed 'General case' 0 CA--C 1.543 0.677 0 CA-C-O 118.975 -0.536 . . . . 0.0 111.543 178.85 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' F' F ' 128' ' ' ASP . . . . . . . . . . . . . 18.7 p-10 -114.14 5.17 15.85 Favored 'General case' 0 N--CA 1.469 0.476 0 CA-C-N 119.667 1.121 . . . . 0.0 113.531 -176.332 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' F' F ' 129' ' ' LEU . . . . . . . . . . . . . 61.9 mt -109.39 137.52 47.12 Favored 'General case' 0 C--O 1.232 0.159 0 CA-C-N 118.155 0.434 . . . . 0.0 110.702 -179.428 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' F' F ' 130' ' ' VAL . . . . . . . . . . . . . 44.4 t -124.02 132.0 72.05 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.194 0 N-CA-C 109.609 -0.515 . . . . 0.0 109.609 177.596 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' F' F ' 131' ' ' VAL . . . . . 0.464 HG22 HD12 ' F' ' 140' ' ' LEU . 41.4 t -135.56 137.08 50.06 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.208 0 CA-C-O 121.091 0.472 . . . . 0.0 110.511 -179.452 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' F' F ' 132' ' ' ILE . . . . . . . . . . . . . 71.0 mt -118.26 132.82 66.99 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.239 0 CA-C-N 115.815 -0.629 . . . . 0.0 109.542 178.717 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' F' F ' 133' ' ' ILE . . . . . . . . . . . . . 43.1 mm -118.31 124.6 73.37 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.238 0 CA-C-N 116.519 -0.31 . . . . 0.0 111.205 -174.758 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' F' F ' 134' ' ' ASP . . . . . . . . . . . . . 13.9 p-10 -140.52 151.42 44.76 Favored 'General case' 0 C--N 1.332 -0.19 0 N-CA-C 109.737 -0.468 . . . . 0.0 109.737 172.655 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' F' F ' 135' ' ' GLU . . . . . . . . . . . . . 42.5 tp10 -50.89 -27.44 7.5 Favored 'General case' 0 C--N 1.328 -0.357 0 N-CA-C 112.971 0.73 . . . . 0.0 112.971 -171.028 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' F' F ' 136' ' ' GLN . . . . . . . . . . . . . 99.3 mm-40 -86.28 -29.62 22.93 Favored 'General case' 0 C--O 1.233 0.23 0 N-CA-C 112.705 0.631 . . . . 0.0 112.705 -174.332 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' F' F ' 137' ' ' LYS . . . . . . . . . . . . . 55.7 pttt -164.95 169.11 16.84 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-O 121.524 0.678 . . . . 0.0 112.545 -170.605 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' F' F ' 138' ' ' LEU . . . . . 0.417 HD23 ' N ' ' F' ' 139' ' ' THR . 5.3 tt -122.26 127.52 50.01 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 114.986 -1.006 . . . . 0.0 109.598 178.565 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' F' F ' 139' ' ' THR . . . . . 0.417 ' N ' HD23 ' F' ' 138' ' ' LEU . 35.0 m -108.07 124.59 50.43 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.423 -0.353 . . . . 0.0 110.333 -179.299 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' F' F ' 140' ' ' LEU . . . . . 0.464 HD12 HG22 ' F' ' 131' ' ' VAL . 14.5 tp -113.0 120.2 40.56 Favored 'General case' 0 C--N 1.329 -0.284 0 N-CA-C 109.337 -0.616 . . . . 0.0 109.337 -179.069 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' F' F ' 141' ' ' ILE . . . . . . . . . . . . . 18.9 mt -120.94 121.96 66.48 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.28 0 CA-C-O 120.961 0.41 . . . . 0.0 110.052 -175.364 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' F' F ' 142' ' ' ARG . . . . . . . . . . . . . 75.3 mtp180 -105.84 117.18 33.37 Favored 'General case' 0 C--O 1.232 0.163 0 CA-C-N 115.548 -0.751 . . . . 0.0 109.945 179.113 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' F' F ' 143' ' ' THR . . . . . . . . . . . . . 18.8 p . . . . . 0 C--O 1.219 -0.505 0 CA-C-O 118.029 -0.986 . . . . 0.0 110.663 -179.015 . . . . . . . . 0 0 . 1 . 009 nuclear nobuild core ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 5.3 p . . . . . 0 CA--C 1.523 -0.081 0 N-CA-C 110.013 -0.365 . . . . 0.0 110.013 . . . . . . . . . 0 0 . 1 . 009 nuclear nobuild core ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 84.9 tt0 -146.14 143.85 29.59 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.27 -0.423 . . . . 0.0 111.371 -178.232 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 4' ' ' LEU . . . . . . . . . . . . . 16.8 tp -127.54 132.84 49.84 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 115.937 -0.574 . . . . 0.0 110.079 176.934 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 5' ' ' LYS . . . . . . . . . . . . . 91.6 mttt -112.05 120.64 42.55 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.589 -179.555 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 6' ' ' LEU . . . . . 0.465 HD23 ' HA ' ' A' ' 50' ' ' VAL . 71.5 mt -115.95 142.67 46.47 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 115.471 -0.786 . . . . 0.0 110.305 -178.685 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 39.4 ttmt -122.71 138.42 29.42 Favored Pre-proline 0 CA--C 1.532 0.286 0 CA-C-O 118.991 -0.528 . . . . 0.0 109.807 176.013 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 8' ' ' PRO . . . . . . . . . . . . . 91.3 Cg_endo -91.44 131.76 1.37 Allowed 'Trans proline' 0 N--CA 1.489 1.229 0 C-N-CA 121.702 1.602 . . . . 0.0 111.803 178.688 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 41.2 mt -71.91 -46.98 11.88 Favored Pre-proline 0 C--N 1.327 -0.376 0 CA-C-O 118.648 -0.691 . . . . 0.0 112.004 -179.388 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 83.6 Cg_endo -81.05 150.42 17.93 Favored 'Trans proline' 0 N--CA 1.495 1.581 0 C-N-CA 121.213 1.276 . . . . 0.0 111.878 175.412 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 68.8 mttm -88.85 99.33 12.3 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.401 -0.363 . . . . 0.0 110.496 178.932 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 12.4 p -144.52 149.16 17.52 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.282 0 CA-C-N 116.239 -0.437 . . . . 0.0 110.522 -179.494 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 44.2 mp0 -90.48 120.61 31.72 Favored 'General case' 0 C--N 1.331 -0.208 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.436 179.064 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 14' ' ' LEU . . . . . . . . . . . . . 24.2 mt -98.24 154.23 37.74 Favored Pre-proline 0 C--N 1.329 -0.291 0 CA-C-N 116.351 -0.386 . . . . 0.0 110.867 -179.744 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 15' ' ' PRO . . . . . . . . . . . . . 37.5 Cg_exo -59.63 155.93 39.84 Favored 'Trans proline' 0 N--CA 1.497 1.729 0 C-N-CA 121.272 1.315 . . . . 0.0 111.615 177.742 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 16' ' ' PRO . . . . . . . . . . . . . 35.8 Cg_exo -58.18 -38.29 91.84 Favored 'Trans proline' 0 N--CA 1.496 1.643 0 C-N-CA 121.491 1.461 . . . . 0.0 112.697 -179.514 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 17' ' ' ASP . . . . . . . . . . . . . 15.9 p-10 -85.18 10.69 11.59 Favored 'General case' 0 CA--C 1.534 0.363 0 N-CA-C 113.215 0.82 . . . . 0.0 113.215 -177.816 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 18' ' ' PHE . . . . . . . . . . . . . 42.1 t80 -58.2 -42.3 85.86 Favored 'General case' 0 N--CA 1.458 -0.046 0 O-C-N 121.95 -0.469 . . . . 0.0 110.116 -179.158 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 19' ' ' VAL . . . . . 0.403 HG13 ' N ' ' A' ' 20' ' ' ASP . 12.6 p -55.9 -40.51 62.74 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.287 0 CA-C-N 116.436 -0.347 . . . . 0.0 110.709 179.65 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 20' ' ' ASP . . . . . 0.403 ' N ' HG13 ' A' ' 19' ' ' VAL . 53.9 m-20 -60.59 -44.0 96.74 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-O 120.83 0.348 . . . . 0.0 110.722 -179.394 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 47.0 t -63.64 -47.13 92.67 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.324 0 CA-C-N 116.358 -0.383 . . . . 0.0 110.587 -177.643 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 22' ' ' ILE . . . . . 0.581 HG22 HD12 ' A' ' 26' ' ' LEU . 50.7 mm -54.97 -49.51 70.52 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.204 0 O-C-N 122.227 -0.296 . . . . 0.0 110.835 179.3 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 23' ' ' ARG . . . . . . . . . . . . . 34.8 ttp180 -54.04 -49.32 69.21 Favored 'General case' 0 C--N 1.33 -0.247 0 C-N-CA 121.043 -0.263 . . . . 0.0 111.53 -178.339 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 24' ' ' ILE . . . . . . . . . . . . . 79.1 mt -58.85 -42.0 84.45 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.281 0 C-N-CA 121.181 -0.208 . . . . 0.0 111.428 -177.147 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 45.2 mttm -67.97 -42.13 81.33 Favored 'General case' 0 C--N 1.328 -0.347 0 N-CA-C 112.212 0.449 . . . . 0.0 112.212 -178.442 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 26' ' ' LEU . . . . . 0.581 HD12 HG22 ' A' ' 22' ' ' ILE . 81.6 mt -80.19 -34.72 37.22 Favored 'General case' 0 C--N 1.328 -0.34 0 N-CA-C 113.501 0.926 . . . . 0.0 113.501 -169.64 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 27' ' ' GLN . . . . . . . . . . . . . 9.7 pt20 -46.64 141.52 3.75 Favored 'General case' 0 N--CA 1.467 0.412 0 N-CA-C 112.876 0.695 . . . . 0.0 112.876 -174.84 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 100.25 -26.89 22.83 Favored Glycine 0 CA--C 1.534 1.225 0 CA-C-N 115.644 -0.707 . . . . 0.0 112.166 -177.485 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 49.2 mtpt -97.52 155.04 17.13 Favored 'General case' 0 C--O 1.233 0.205 0 CA-C-N 117.322 0.561 . . . . 0.0 110.976 178.802 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 30' ' ' THR . . . . . . . . . . . . . 25.6 m -106.21 137.71 43.67 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.189 -0.459 . . . . 0.0 110.007 176.436 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 34.9 m -129.14 159.21 41.43 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.275 0 CA-C-N 116.409 -0.359 . . . . 0.0 110.866 -178.286 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 32' ' ' ARG . . . . . . . . . . . . . 76.7 mtm180 -133.46 150.82 51.73 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-O 121.209 0.528 . . . . 0.0 110.564 178.391 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 33' ' ' THR . . . . . . . . . . . . . 13.6 m -52.69 140.23 24.12 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.203 -0.453 . . . . 0.0 111.416 -178.148 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 100.53 -17.16 57.08 Favored Glycine 0 CA--C 1.532 1.111 0 CA-C-O 119.805 -0.442 . . . . 0.0 113.315 179.673 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 74.1 m-20 -66.82 149.31 50.76 Favored 'General case' 0 N--CA 1.461 0.098 0 CA-C-N 118.021 0.91 . . . . 0.0 111.205 178.931 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 45.3 t -119.42 129.87 74.74 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.2 0 CA-C-N 115.915 -0.584 . . . . 0.0 109.737 178.007 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 37' ' ' ILE . . . . . . . . . . . . . 64.1 mt -120.48 138.71 50.1 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.238 0 CA-C-N 116.091 -0.504 . . . . 0.0 109.854 -179.332 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . -116.52 128.8 8.11 Favored Glycine 0 CA--C 1.525 0.701 0 N-CA-C 111.052 -0.819 . . . . 0.0 111.052 179.953 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 39' ' ' ILE . . . . . . . . . . . . . 71.1 mt -126.72 134.24 66.71 Favored 'Isoleucine or valine' 0 C--N 1.333 -0.138 0 CA-C-O 120.822 0.344 . . . . 0.0 110.219 178.988 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 40' ' ' SER . . . . . . . . . . . . . 8.6 t -92.79 114.52 27.1 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.224 -0.444 . . . . 0.0 110.938 175.139 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 41' ' ' ILE . . . . . . . . . . . . . 44.3 mm -121.79 119.37 58.57 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.232 0 CA-C-O 120.87 0.367 . . . . 0.0 110.353 179.912 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 9.4 tp 55.45 36.63 27.52 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.182 -0.463 . . . . 0.0 111.483 177.254 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . 72.43 24.9 75.53 Favored Glycine 0 CA--C 1.532 1.111 0 C-N-CA 121.14 -0.553 . . . . 0.0 112.659 177.929 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 44' ' ' LYS . . . . . . . . . . . . . 43.4 mmtm -132.02 130.9 41.98 Favored 'General case' 0 C--N 1.332 -0.174 0 CA-C-N 117.28 0.54 . . . . 0.0 109.748 178.609 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 84.0 tt0 -83.32 121.22 26.84 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.479 -0.328 . . . . 0.0 111.154 -178.286 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 46' ' ' VAL . . . . . 0.429 HG13 ' O ' ' A' ' 46' ' ' VAL . 11.2 p -119.73 121.41 66.09 Favored 'Isoleucine or valine' 0 C--O 1.232 0.166 0 N-CA-C 109.6 -0.518 . . . . 0.0 109.6 173.935 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 51.9 mtmt -98.72 126.48 44.35 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 115.968 -0.56 . . . . 0.0 110.657 178.243 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 48' ' ' PHE . . . . . . . . . . . . . 46.2 m-85 -110.99 131.85 54.7 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.201 -0.454 . . . . 0.0 109.816 178.631 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 80.9 tttt -106.43 130.89 54.16 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.362 -0.381 . . . . 0.0 110.044 178.329 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 50' ' ' VAL . . . . . 0.465 ' HA ' HD23 ' A' ' 6' ' ' LEU . 43.3 t -75.04 105.54 4.1 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.322 0 N-CA-C 109.414 -0.587 . . . . 0.0 109.414 177.785 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 51' ' ' VAL . . . . . . . . . . . . . 45.8 t -71.24 -51.95 30.54 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.363 0 CA-C-N 116.053 -0.521 . . . . 0.0 109.713 -175.015 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 52' ' ' GLN . . . . . . . . . . . . . 87.1 mt-30 -153.74 151.91 30.16 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-O 121.146 0.498 . . . . 0.0 111.44 -178.313 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -128.08 133.69 49.08 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 115.253 -0.885 . . . . 0.0 109.828 175.819 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 54' ' ' TYR . . . . . . . . . . . . . 58.1 t80 -129.03 108.81 18.15 Favored Pre-proline 0 CA--C 1.535 0.373 0 CA-C-O 118.363 -0.827 . . . . 0.0 110.324 -179.421 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 55' ' ' PRO . . . . . . . . . . . . . 73.5 Cg_endo -77.14 170.13 72.39 Favored 'Cis proline' 0 N--CA 1.499 1.845 0 CA-C-N 121.766 1.666 . . . . 0.0 112.372 -5.47 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 56' ' ' SER . . . . . . . . . . . . . 32.3 m -115.54 127.2 26.99 Favored Pre-proline 0 CA--C 1.538 0.494 0 CA-C-O 118.384 -0.817 . . . . 0.0 109.322 175.495 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 57' ' ' PRO . . . . . . . . . . . . . 36.9 Cg_endo -66.28 167.43 53.59 Favored 'Cis proline' 0 N--CA 1.497 1.682 0 CA-C-N 121.977 1.742 . . . . 0.0 111.708 0.063 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 58' ' ' LEU . . . . . . . . . . . . . 28.5 tp -130.98 137.26 49.16 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.136 -0.484 . . . . 0.0 110.447 -179.912 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 59' ' ' ARG . . . . . . . . . . . . . 70.8 ttt180 -102.44 130.94 49.38 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 116.149 -0.478 . . . . 0.0 109.791 177.163 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 40.8 t -80.43 112.39 18.39 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 CA-C-O 120.878 0.37 . . . . 0.0 110.397 -177.101 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 83.0 tt0 -131.0 155.41 46.87 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 115.84 -0.618 . . . . 0.0 109.461 177.433 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 62' ' ' ASP . . . . . . . . . . . . . 76.3 m-20 -50.5 -30.38 12.72 Favored 'General case' 0 C--N 1.328 -0.356 0 N-CA-C 112.208 0.447 . . . . 0.0 112.208 179.733 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 63' ' ' ARG . . . . . . . . . . . . . 77.2 mtp180 -71.99 -21.6 61.55 Favored 'General case' 0 CA--C 1.534 0.352 0 N-CA-C 112.843 0.682 . . . . 0.0 112.843 -176.768 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 27.5 m -71.59 139.3 49.33 Favored 'General case' 0 C--N 1.332 -0.159 0 CA-C-O 120.971 0.415 . . . . 0.0 111.0 -176.687 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 65' ' ' LYS . . . . . . . . . . . . . 55.0 mtmt -89.09 134.51 33.97 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-N 115.902 -0.59 . . . . 0.0 109.896 176.714 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 66' ' ' ILE . . . . . . . . . . . . . 63.3 mt -115.55 129.83 71.18 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.259 0 N-CA-C 109.925 -0.398 . . . . 0.0 109.925 -178.643 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 67' ' ' THR . . . . . . . . . . . . . 24.5 m -120.02 135.78 54.8 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.851 -179.148 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 68' ' ' LEU . . . . . 0.478 HD23 ' C ' ' A' ' 68' ' ' LEU . 6.6 tt . . . . . 0 C--N 1.329 -0.309 0 CA-C-N 115.701 -0.681 . . . . 0.0 110.039 178.168 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 74' ' ' ASP . . . . . . . . . . . . . 9.0 t0 . . . . . 0 C--O 1.231 0.103 0 N-CA-C 109.904 -0.406 . . . . 0.0 109.904 . . . . . . . . . 0 0 . 1 . 009 nuclear nobuild core ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 41.0 t -114.26 121.98 67.46 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.255 0 CA-C-O 121.213 0.53 . . . . 0.0 110.521 -178.321 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 76' ' ' LEU . . . . . . . . . . . . . 29.9 mt -117.74 141.29 48.57 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 115.446 -0.797 . . . . 0.0 109.165 176.28 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 77' ' ' GLU . . . . . . . . . . . . . 16.8 tt0 -137.31 133.53 35.05 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-O 120.851 0.358 . . . . 0.0 111.135 -176.11 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 78' ' ' ALA . . . . . . . . . . . . . . . -125.99 141.06 52.13 Favored 'General case' 0 C--N 1.331 -0.202 0 CA-C-N 116.058 -0.519 . . . . 0.0 110.457 178.913 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 79' ' ' LYS . . . . . 0.638 ' O ' HD13 ' A' ' 80' ' ' ILE . 45.0 mmtt -79.63 121.89 25.85 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.382 -0.372 . . . . 0.0 110.38 177.992 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 80' ' ' ILE . . . . . 0.638 HD13 ' O ' ' A' ' 79' ' ' LYS . 38.5 mm -138.9 107.41 3.5 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.343 0 N-CA-C 109.386 -0.598 . . . . 0.0 109.386 -179.413 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 81' ' ' LYS . . . . . . . . . . . . . 28.7 ttpp -103.25 125.22 49.8 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-O 120.811 0.339 . . . . 0.0 111.64 -175.321 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . 89.19 42.05 5.68 Favored Glycine 0 CA--C 1.524 0.646 0 C-N-CA 121.102 -0.57 . . . . 0.0 112.012 172.48 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 83' ' ' ILE . . . . . . . . . . . . . 71.3 mt -72.85 136.75 24.87 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 N-CA-C 109.851 -0.426 . . . . 0.0 109.851 176.965 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 84' ' ' LYS . . . . . . . . . . . . . 39.6 ttpt -100.54 -48.14 4.64 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-O 120.966 0.412 . . . . 0.0 110.105 -179.438 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 85' ' ' ASP . . . . . . . . . . . . . 6.3 t70 -151.41 152.51 33.17 Favored 'General case' 0 C--N 1.331 -0.23 0 CA-C-N 115.891 -0.595 . . . . 0.0 110.548 179.1 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 86' ' ' VAL . . . . . . . . . . . . . 41.5 t -131.16 133.64 62.3 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.266 0 CA-C-O 121.034 0.445 . . . . 0.0 110.664 -178.461 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 87' ' ' ILE . . . . . . . . . . . . . 44.2 mm -119.75 125.48 74.36 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.247 0 CA-C-N 115.757 -0.656 . . . . 0.0 109.434 175.924 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 88' ' ' LEU . . . . . . . . . . . . . 14.5 tp -110.74 134.2 52.68 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-O 121.018 0.437 . . . . 0.0 111.309 -176.069 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 89' ' ' ASP . . . . . . . . . . . . . 12.9 t70 -127.5 155.1 44.28 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 115.875 -0.602 . . . . 0.0 109.829 177.497 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 43.1 tp10 -45.61 -44.09 12.78 Favored 'General case' 0 N--CA 1.465 0.308 0 N-CA-C 113.105 0.78 . . . . 0.0 113.105 -172.432 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 91' ' ' ASN . . . . . . . . . . . . . 66.0 m-80 -128.3 24.42 5.9 Favored 'General case' 0 N--CA 1.467 0.42 0 N-CA-C 112.547 0.573 . . . . 0.0 112.547 -178.421 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 92' ' ' LEU . . . . . . . . . . . . . 13.8 mt -149.78 145.68 26.76 Favored 'General case' 0 C--N 1.332 -0.169 0 N-CA-C 109.689 -0.486 . . . . 0.0 109.689 -176.832 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 93' ' ' ILE . . . . . . . . . . . . . 68.2 mt -128.47 118.54 48.0 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.306 0 N-CA-C 109.491 -0.559 . . . . 0.0 109.491 179.003 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 94' ' ' VAL . . . . . 0.451 HG21 HG11 ' A' ' 125' ' ' VAL . 46.4 t -118.53 126.14 74.91 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.252 0 N-CA-C 109.92 -0.4 . . . . 0.0 109.92 -179.6 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 95' ' ' VAL . . . . . . . . . . . . . 42.1 t -122.21 135.15 63.25 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.317 0 CA-C-N 116.054 -0.521 . . . . 0.0 109.988 -179.336 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 96' ' ' ILE . . . . . 0.423 HD11 ' HB ' ' A' ' 123' ' ' VAL . 67.1 mt -114.07 127.1 71.64 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.291 0 N-CA-C 109.366 -0.605 . . . . 0.0 109.366 179.075 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 97' ' ' THR . . . . . . . . . . . . . 68.0 p -100.08 156.73 17.02 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-O 121.397 0.617 . . . . 0.0 111.442 -176.879 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 98' ' ' GLU . . . . . . . . . . . . . 97.5 mt-10 -53.93 -25.79 22.13 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 115.822 -0.626 . . . . 0.0 112.312 -179.983 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 99' ' ' GLU . . . . . . . . . . . . . 41.5 mt-10 -80.4 18.11 0.96 Allowed 'General case' 0 CA--C 1.534 0.353 0 N-CA-C 113.003 0.742 . . . . 0.0 113.003 -177.148 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 100' ' ' ASN . . . . . . . . . . . . . 1.8 m120 63.87 35.48 10.95 Favored 'General case' 0 CA--C 1.531 0.222 0 CA-C-O 120.93 0.395 . . . . 0.0 111.145 176.634 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 101' ' ' GLU . . . . . . . . . . . . . 85.0 tt0 -118.47 142.33 47.68 Favored 'General case' 0 C--N 1.333 -0.14 0 N-CA-C 110.018 -0.364 . . . . 0.0 110.018 178.369 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 102' ' ' VAL . . . . . . . . . . . . . 45.6 t -116.39 126.67 73.97 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.297 0 N-CA-C 109.851 -0.425 . . . . 0.0 109.851 -178.686 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 103' ' ' LEU . . . . . . . . . . . . . 6.1 mp -118.37 133.48 55.84 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-N 115.807 -0.633 . . . . 0.0 110.458 177.95 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 104' ' ' ILE . . . . . . . . . . . . . 64.5 mt -117.88 119.54 61.85 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.22 0 CA-C-N 116.441 -0.345 . . . . 0.0 110.216 -179.761 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 105' ' ' PHE . . . . . . . . . . . . . 85.3 m-85 -114.87 165.26 13.04 Favored 'General case' 0 C--N 1.333 -0.146 0 O-C-N 124.042 0.839 . . . . 0.0 109.873 178.194 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 106' ' ' ASN . . . . . . . . . . . . . 49.3 p-10 -100.93 -170.27 1.82 Allowed 'General case' 0 C--N 1.331 -0.236 0 N-CA-C 109.636 -0.505 . . . . 0.0 109.636 171.727 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 107' ' ' GLN . . . . . . . . . . . . . 28.8 tt0 -58.06 -28.63 64.71 Favored 'General case' 0 C--N 1.328 -0.347 0 N-CA-C 112.261 0.467 . . . . 0.0 112.261 -179.201 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 108' ' ' ASN . . . . . . . . . . . . . 12.1 t-20 -90.88 14.19 14.4 Favored 'General case' 0 CA--C 1.533 0.314 0 N-CA-C 112.942 0.719 . . . . 0.0 112.942 -176.059 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 109' ' ' LEU . . . . . . . . . . . . . 63.4 mt 57.68 33.76 23.63 Favored 'General case' 0 CA--C 1.53 0.176 0 O-C-N 122.211 -0.306 . . . . 0.0 111.738 179.193 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 110' ' ' GLU . . . . . . . . . . . . . 70.6 mm-40 -99.66 140.83 33.29 Favored 'General case' 0 C--N 1.331 -0.225 0 N-CA-C 109.334 -0.617 . . . . 0.0 109.334 174.527 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 111' ' ' GLU . . . . . . . . . . . . . 47.5 tt0 -81.06 121.89 26.63 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-O 120.889 0.376 . . . . 0.0 110.714 -176.04 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 112' ' ' LEU . . . . . . . . . . . . . 30.9 mt -104.72 -46.02 4.44 Favored 'General case' 0 C--N 1.331 -0.219 0 CA-C-N 115.992 -0.549 . . . . 0.0 110.588 -179.857 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 113' ' ' TYR . . . . . . . . . . . . . 59.4 t80 -135.31 141.12 45.58 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.235 -0.439 . . . . 0.0 110.813 -178.682 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 114' ' ' ARG . . . . . . . . . . . . . 44.5 ptt85 -146.54 121.18 9.8 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.396 -0.366 . . . . 0.0 110.7 178.962 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 115' ' ' GLY . . . . . . . . . . . . . . . -150.15 160.4 28.52 Favored Glycine 0 CA--C 1.525 0.665 0 N-CA-C 111.008 -0.837 . . . . 0.0 111.008 179.296 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 116' ' ' LYS . . . . . . . . . . . . . 27.8 ttmt -125.59 137.41 53.9 Favored 'General case' 0 C--N 1.33 -0.248 0 N-CA-C 109.883 -0.414 . . . . 0.0 109.883 176.966 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 117' ' ' PHE . . . . . . . . . . . . . 44.1 m-85 -134.34 114.93 13.48 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.265 -0.425 . . . . 0.0 110.351 -175.513 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 118' ' ' GLU . . . . . . . . . . . . . 84.1 tt0 -50.62 -53.07 33.73 Favored 'General case' 0 C--N 1.329 -0.305 0 N-CA-C 111.98 0.363 . . . . 0.0 111.98 -176.019 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 119' ' ' ASN . . . . . . . . . . . . . 73.5 m-20 -94.94 31.01 1.94 Allowed 'General case' 0 C--N 1.33 -0.246 0 N-CA-C 112.308 0.484 . . . . 0.0 112.308 -173.505 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 120' ' ' LEU . . . . . . . . . . . . . 16.9 tp -56.4 123.07 13.42 Favored 'General case' 0 C--N 1.332 -0.178 0 C-N-CA 120.87 -0.332 . . . . 0.0 110.528 177.281 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 121' ' ' ASN . . . . . . . . . . . . . 9.9 m120 -114.09 -44.12 3.17 Favored 'General case' 0 C--N 1.331 -0.212 0 CA-C-N 116.55 -0.296 . . . . 0.0 110.985 -177.494 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 122' ' ' LYS . . . . . . . . . . . . . 91.4 mttt -145.15 148.78 33.97 Favored 'General case' 0 C--N 1.331 -0.209 0 CA-C-O 121.028 0.442 . . . . 0.0 111.728 -177.362 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 123' ' ' VAL . . . . . 0.423 ' HB ' HD11 ' A' ' 96' ' ' ILE . 44.6 t -128.63 125.73 64.0 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 N-CA-C 109.071 -0.714 . . . . 0.0 109.071 173.403 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 124' ' ' LEU . . . . . . . . . . . . . 5.8 mp -122.65 142.83 50.24 Favored 'General case' 0 C--N 1.332 -0.188 0 CA-C-O 120.836 0.351 . . . . 0.0 111.014 -175.68 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 125' ' ' VAL . . . . . 0.451 HG11 HG21 ' A' ' 94' ' ' VAL . 35.5 m -137.37 140.58 41.7 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.265 0 CA-C-N 115.999 -0.546 . . . . 0.0 110.581 179.053 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 126' ' ' ARG . . . . . . . . . . . . . 7.2 ptm85 -153.18 131.1 11.73 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-O 120.906 0.384 . . . . 0.0 110.577 176.068 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 127' ' ' ASN . . . . . . . . . . . . . 30.5 m120 50.6 -110.54 0.47 Allowed 'General case' 0 CA--C 1.545 0.763 0 CA-C-O 118.86 -0.591 . . . . 0.0 111.229 -179.691 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 128' ' ' ASP . . . . . . . . . . . . . 8.9 p-10 -114.11 7.79 16.8 Favored 'General case' 0 N--CA 1.468 0.428 0 CA-C-N 119.878 1.217 . . . . 0.0 113.314 -178.081 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 129' ' ' LEU . . . . . . . . . . . . . 11.8 tp -108.92 138.5 45.16 Favored 'General case' 0 C--N 1.332 -0.167 0 CA-C-N 118.153 0.433 . . . . 0.0 110.423 -178.825 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 130' ' ' VAL . . . . . . . . . . . . . 44.5 t -121.56 136.29 58.96 Favored 'Isoleucine or valine' 0 N--CA 1.462 0.169 0 N-CA-C 109.691 -0.485 . . . . 0.0 109.691 179.843 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 131' ' ' VAL . . . . . 0.512 HG22 HD12 ' A' ' 140' ' ' LEU . 39.0 t -134.46 136.31 52.95 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.235 0 CA-C-O 120.974 0.416 . . . . 0.0 110.504 -178.84 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 132' ' ' ILE . . . . . . . . . . . . . 71.0 mt -116.77 131.39 69.56 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 CA-C-N 115.746 -0.661 . . . . 0.0 109.267 178.722 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 133' ' ' ILE . . . . . . . . . . . . . 42.7 mm -119.36 122.3 68.69 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.223 0 CA-C-O 120.746 0.308 . . . . 0.0 110.987 -174.793 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 134' ' ' ASP . . . . . . . . . . . . . 16.6 p-10 -138.82 146.86 41.8 Favored 'General case' 0 C--N 1.332 -0.163 0 CA-C-N 116.272 -0.422 . . . . 0.0 109.872 173.744 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 135' ' ' GLU . . . . . . . . . . . . . 77.8 tt0 -49.9 -23.05 1.73 Allowed 'General case' 0 C--N 1.329 -0.305 0 N-CA-C 113.606 0.965 . . . . 0.0 113.606 -168.013 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 136' ' ' GLN . . . . . . . . . . . . . 22.3 pt20 -96.69 -27.21 14.88 Favored 'General case' 0 C--O 1.235 0.293 0 N-CA-C 112.551 0.574 . . . . 0.0 112.551 -174.011 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 137' ' ' LYS . . . . . . . . . . . . . 53.7 pttt -156.01 165.32 36.8 Favored 'General case' 0 C--O 1.233 0.205 0 CA-C-O 121.599 0.714 . . . . 0.0 112.125 -176.95 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 138' ' ' LEU . . . . . 0.408 ' C ' HD23 ' A' ' 138' ' ' LEU . 6.0 tt -119.58 127.04 52.6 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 115.02 -0.991 . . . . 0.0 109.416 176.375 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 139' ' ' THR . . . . . 0.407 ' N ' HD23 ' A' ' 138' ' ' LEU . 34.1 m -111.78 131.08 55.57 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.368 -0.378 . . . . 0.0 110.572 -178.458 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 140' ' ' LEU . . . . . 0.512 HD12 HG22 ' A' ' 131' ' ' VAL . 12.7 tp -117.31 123.81 47.44 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 115.657 -0.701 . . . . 0.0 109.273 -178.328 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 141' ' ' ILE . . . . . . . . . . . . . 19.5 mt -120.28 118.76 57.84 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.332 0 CA-C-O 120.983 0.42 . . . . 0.0 109.88 -174.859 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 142' ' ' ARG . . . . . . . . . . . . . 29.6 tpt85 -105.3 122.08 45.2 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 115.302 -0.863 . . . . 0.0 109.932 -178.251 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 143' ' ' THR . . . . . . . . . . . . . 57.2 p . . . . . 0 C--O 1.221 -0.445 0 CA-C-O 117.949 -1.024 . . . . 0.0 110.632 -178.721 . . . . . . . . 0 0 . 1 . 009 nuclear nobuild core ' B' B ' 2' ' ' SER . . . . . . . . . . . . . 2.9 p . . . . . 0 N--CA 1.462 0.171 0 CA-C-O 120.881 0.372 . . . . 0.0 110.913 . . . . . . . . . 0 0 . 1 . 009 nuclear nobuild core ' B' B ' 3' ' ' GLU . . . . . . . . . . . . . 84.9 tt0 -144.21 143.15 30.92 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.14 -0.482 . . . . 0.0 111.206 179.998 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' B' B ' 4' ' ' LEU . . . . . . . . . . . . . 15.5 tp -127.04 132.88 50.61 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 115.892 -0.595 . . . . 0.0 110.187 177.264 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' B' B ' 5' ' ' LYS . . . . . . . . . . . . . 95.8 mttt -112.61 122.25 47.13 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.326 -0.397 . . . . 0.0 110.799 -179.279 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' B' B ' 6' ' ' LEU . . . . . . . . . . . . . 38.7 mt -114.05 141.0 47.99 Favored 'General case' 0 C--N 1.332 -0.19 0 CA-C-N 115.506 -0.77 . . . . 0.0 110.266 -179.452 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' B' B ' 7' ' ' LYS . . . . . . . . . . . . . 74.6 tttt -121.97 136.26 26.08 Favored Pre-proline 0 CA--C 1.535 0.385 0 CA-C-O 118.839 -0.601 . . . . 0.0 109.697 176.304 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' B' B ' 8' ' ' PRO . . . . . . . . . . . . . 84.4 Cg_endo -90.47 135.31 2.1 Favored 'Trans proline' 0 N--CA 1.491 1.349 0 C-N-CA 121.656 1.57 . . . . 0.0 112.011 178.357 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' B' B ' 9' ' ' LEU . . . . . . . . . . . . . 53.9 mt -74.2 -47.93 5.96 Favored Pre-proline 0 CA--C 1.535 0.366 0 CA-C-O 118.628 -0.701 . . . . 0.0 112.336 -179.738 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' B' B ' 10' ' ' PRO . . . . . . . . . . . . . 97.4 Cg_endo -79.11 151.98 24.01 Favored 'Trans proline' 0 N--CA 1.497 1.677 0 C-N-CA 121.092 1.195 . . . . 0.0 111.882 177.563 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' B' B ' 11' ' ' LYS . . . . . . . . . . . . . 62.1 tttm -81.27 95.7 7.05 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.333 -0.394 . . . . 0.0 110.167 178.341 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' B' B ' 12' ' ' VAL . . . . . . . . . . . . . 12.3 p -141.69 146.43 23.09 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.321 0 CA-C-N 116.273 -0.421 . . . . 0.0 110.752 -177.629 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' B' B ' 13' ' ' GLU . . . . . . . . . . . . . 85.2 tt0 -99.5 114.61 27.69 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.067 -0.515 . . . . 0.0 109.895 176.581 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' B' B ' 14' ' ' LEU . . . . . . . . . . . . . 32.2 mt -92.46 160.6 34.48 Favored Pre-proline 0 C--N 1.328 -0.33 0 CA-C-N 116.328 -0.396 . . . . 0.0 111.115 -176.341 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' B' B ' 15' ' ' PRO . . . . . . . . . . . . . 35.3 Cg_exo -57.64 155.26 32.51 Favored 'Trans proline' 0 N--CA 1.496 1.62 0 C-N-CA 121.341 1.361 . . . . 0.0 111.874 -179.464 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' B' B ' 16' ' ' PRO . . . . . . . . . . . . . 33.7 Cg_exo -57.19 -40.91 79.22 Favored 'Trans proline' 0 N--CA 1.498 1.74 0 C-N-CA 121.347 1.364 . . . . 0.0 112.734 -178.262 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' B' B ' 17' ' ' ASP . . . . . . . . . . . . . 16.9 p-10 -89.46 15.69 8.85 Favored 'General case' 0 CA--C 1.534 0.362 0 N-CA-C 112.929 0.714 . . . . 0.0 112.929 -177.239 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' B' B ' 18' ' ' PHE . . . . . 0.447 ' CE2' HD11 ' B' ' 22' ' ' ILE . 27.3 t80 -57.14 -39.9 76.11 Favored 'General case' 0 C--O 1.227 -0.089 0 O-C-N 122.052 -0.405 . . . . 0.0 110.438 -179.07 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' B' B ' 19' ' ' VAL . . . . . . . . . . . . . 46.0 t -54.91 -44.59 73.57 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.201 0 CA-C-O 120.762 0.315 . . . . 0.0 110.584 -179.96 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' B' B ' 20' ' ' ASP . . . . . . . . . . . . . 74.8 m-20 -59.92 -40.99 90.76 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.482 -0.326 . . . . 0.0 110.631 -179.738 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' B' B ' 21' ' ' VAL . . . . . . . . . . . . . 47.5 t -62.69 -45.08 99.7 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.305 0 CA-C-N 116.448 -0.342 . . . . 0.0 110.265 -178.526 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' B' B ' 22' ' ' ILE . . . . . 0.714 HG22 HD12 ' B' ' 26' ' ' LEU . 51.0 mm -55.14 -49.74 69.52 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.332 0 C-N-CA 121.136 -0.226 . . . . 0.0 110.649 178.224 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' B' B ' 23' ' ' ARG . . . . . 0.46 ' HB2' HD12 ' B' ' 66' ' ' ILE . 58.7 ttp180 -53.83 -47.05 71.29 Favored 'General case' 0 C--N 1.33 -0.281 0 C-N-CA 121.079 -0.248 . . . . 0.0 111.538 -179.019 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' B' B ' 24' ' ' ILE . . . . . . . . . . . . . 70.9 mt -57.88 -45.42 87.53 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.322 0 C-N-CA 121.065 -0.254 . . . . 0.0 111.067 -177.224 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' B' B ' 25' ' ' LYS . . . . . . . . . . . . . 46.1 mtmt -70.21 -34.19 72.61 Favored 'General case' 0 C--N 1.328 -0.34 0 N-CA-C 112.378 0.51 . . . . 0.0 112.378 -177.607 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' B' B ' 26' ' ' LEU . . . . . 0.714 HD12 HG22 ' B' ' 22' ' ' ILE . 31.2 mt -80.87 -38.17 28.59 Favored 'General case' 0 C--N 1.331 -0.232 0 N-CA-C 113.579 0.955 . . . . 0.0 113.579 -171.514 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' B' B ' 27' ' ' GLN . . . . . . . . . . . . . 11.3 pt20 -45.39 139.42 3.64 Favored 'General case' 0 N--CA 1.47 0.557 0 N-CA-C 113.071 0.767 . . . . 0.0 113.071 -173.2 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' B' B ' 28' ' ' GLY . . . . . . . . . . . . . . . 98.27 -27.17 20.58 Favored Glycine 0 CA--C 1.532 1.124 0 CA-C-N 115.53 -0.759 . . . . 0.0 112.257 -178.003 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' B' B ' 29' ' ' LYS . . . . . . . . . . . . . 99.1 mttt -97.46 155.18 17.05 Favored 'General case' 0 C--O 1.233 0.22 0 CA-C-N 117.257 0.529 . . . . 0.0 111.066 179.159 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' B' B ' 30' ' ' THR . . . . . . . . . . . . . 34.7 m -105.26 138.57 41.25 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 115.879 -0.601 . . . . 0.0 110.035 176.108 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' B' B ' 31' ' ' VAL . . . . . . . . . . . . . 34.6 m -127.52 151.38 34.29 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.225 0 CA-C-O 120.925 0.393 . . . . 0.0 110.855 -178.634 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' B' B ' 32' ' ' ARG . . . . . . . . . . . . . 58.3 ttp180 -127.18 148.8 50.18 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.042 -0.526 . . . . 0.0 110.551 179.43 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' B' B ' 33' ' ' THR . . . . . . . . . . . . . 25.4 m -52.93 137.43 32.56 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.339 -0.391 . . . . 0.0 111.289 179.985 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' B' B ' 34' ' ' GLY . . . . . . . . . . . . . . . 100.96 -17.17 56.64 Favored Glycine 0 CA--C 1.533 1.175 0 C-N-CA 121.191 -0.528 . . . . 0.0 113.202 179.764 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' B' B ' 35' ' ' ASP . . . . . . . . . . . . . 57.3 m-20 -65.75 151.26 47.0 Favored 'General case' 0 C--O 1.232 0.168 0 CA-C-N 118.007 0.903 . . . . 0.0 111.089 179.86 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' B' B ' 36' ' ' VAL . . . . . . . . . . . . . 45.1 t -123.93 130.36 73.91 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.245 0 CA-C-N 116.048 -0.524 . . . . 0.0 109.868 178.717 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' B' B ' 37' ' ' ILE . . . . . . . . . . . . . 62.1 mt -120.09 137.63 53.29 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.206 0 CA-C-N 116.136 -0.484 . . . . 0.0 109.919 -179.969 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' B' B ' 38' ' ' GLY . . . . . . . . . . . . . . . -118.72 128.78 7.84 Favored Glycine 0 CA--C 1.525 0.712 0 N-CA-C 111.028 -0.829 . . . . 0.0 111.028 179.597 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' B' B ' 39' ' ' ILE . . . . . . . . . . . . . 70.8 mt -126.7 131.85 70.74 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.245 0 CA-C-O 120.825 0.345 . . . . 0.0 110.158 178.87 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' B' B ' 40' ' ' SER . . . . . . . . . . . . . 33.6 t -91.66 120.9 32.84 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.28 -0.418 . . . . 0.0 110.797 177.039 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' B' B ' 41' ' ' ILE . . . . . . . . . . . . . 72.7 mt -133.84 126.49 50.83 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.18 0 CA-C-O 120.884 0.373 . . . . 0.0 110.539 178.772 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' B' B ' 42' ' ' LEU . . . . . . . . . . . . . 42.7 mt 54.79 34.64 22.31 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-N 116.018 -0.537 . . . . 0.0 111.79 176.15 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' B' B ' 43' ' ' GLY . . . . . . . . . . . . . . . 71.89 29.36 67.28 Favored Glycine 0 CA--C 1.531 1.053 0 C-N-CA 121.027 -0.606 . . . . 0.0 112.311 177.683 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' B' B ' 44' ' ' LYS . . . . . . . . . . . . . 53.6 tttm -141.53 127.11 18.95 Favored 'General case' 0 C--N 1.33 -0.259 0 N-CA-C 109.754 -0.461 . . . . 0.0 109.754 178.144 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' B' B ' 45' ' ' GLU . . . . . . . . . . . . . 80.4 tt0 -84.07 123.36 29.95 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 116.441 -0.345 . . . . 0.0 111.133 -178.386 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' B' B ' 46' ' ' VAL . . . . . 0.43 ' O ' HG13 ' B' ' 46' ' ' VAL . 10.6 p -115.59 120.83 65.86 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.195 0 N-CA-C 109.473 -0.566 . . . . 0.0 109.473 175.034 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' B' B ' 47' ' ' LYS . . . . . . . . . . . . . 52.2 mtpt -99.2 126.98 45.11 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.047 -0.524 . . . . 0.0 110.968 178.248 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' B' B ' 48' ' ' PHE . . . . . . . . . . . . . 37.7 m-85 -110.12 132.0 54.55 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.049 -0.523 . . . . 0.0 109.746 176.7 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' B' B ' 49' ' ' LYS . . . . . . . . . . . . . 85.6 tttt -106.21 132.05 52.73 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.319 -0.401 . . . . 0.0 110.002 178.407 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' B' B ' 50' ' ' VAL . . . . . . . . . . . . . 44.4 t -76.19 105.46 5.12 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.392 0 N-CA-C 109.471 -0.566 . . . . 0.0 109.471 178.252 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' B' B ' 51' ' ' VAL . . . . . . . . . . . . . 50.6 t -73.41 -46.42 49.27 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.261 0 CA-C-N 116.042 -0.526 . . . . 0.0 110.089 -174.05 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' B' B ' 52' ' ' GLN . . . . . . . . . . . . . 30.6 tt0 -157.87 144.4 17.72 Favored 'General case' 0 C--N 1.332 -0.166 0 C-N-CA 120.09 -0.644 . . . . 0.0 111.894 -178.085 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' B' B ' 53' ' ' ALA . . . . . . . . . . . . . . . -123.5 130.91 53.38 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 115.442 -0.799 . . . . 0.0 109.775 176.364 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' B' B ' 54' ' ' TYR . . . . . . . . . . . . . 64.8 t80 -128.95 109.84 18.37 Favored Pre-proline 0 CA--C 1.535 0.377 0 CA-C-O 118.15 -0.928 . . . . 0.0 110.449 179.99 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' B' B ' 55' ' ' PRO . . . . . . . . . . . . . 74.1 Cg_endo -77.05 169.94 73.01 Favored 'Cis proline' 0 N--CA 1.499 1.841 0 CA-C-N 121.993 1.748 . . . . 0.0 112.436 -5.299 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' B' B ' 56' ' ' SER . . . . . . . . . . . . . 13.6 m -114.95 126.14 28.19 Favored Pre-proline 0 CA--C 1.537 0.463 0 CA-C-O 118.416 -0.802 . . . . 0.0 109.241 175.824 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' B' B ' 57' ' ' PRO . . . . . . . . . . . . . 61.3 Cg_endo -74.18 152.65 98.5 Favored 'Cis proline' 0 N--CA 1.495 1.61 0 CA-C-N 121.976 1.741 . . . . 0.0 111.873 1.36 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' B' B ' 58' ' ' LEU . . . . . . . . . . . . . 17.8 tp -109.44 136.09 49.41 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.165 -0.471 . . . . 0.0 110.819 -178.292 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' B' B ' 59' ' ' ARG . . . . . . . . . . . . . 57.4 ttp180 -105.2 126.2 51.82 Favored 'General case' 0 C--N 1.329 -0.319 0 N-CA-C 109.509 -0.552 . . . . 0.0 109.509 176.076 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' B' B ' 60' ' ' VAL . . . . . . . . . . . . . 40.4 t -83.23 121.03 35.58 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.315 0 C-N-CA 120.694 -0.402 . . . . 0.0 111.046 -174.498 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' B' B ' 61' ' ' GLU . . . . . . . . . . . . . 95.4 mt-10 -131.01 165.68 22.65 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 115.674 -0.694 . . . . 0.0 109.424 175.243 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' B' B ' 62' ' ' ASP . . . . . . . . . . . . . 79.8 m-20 -52.47 -33.45 44.6 Favored 'General case' 0 C--N 1.329 -0.324 0 N-CA-C 112.056 0.391 . . . . 0.0 112.056 -175.64 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' B' B ' 63' ' ' ARG . . . . . . . . . . . . . 65.8 mtp180 -76.58 -21.97 54.89 Favored 'General case' 0 C--N 1.329 -0.297 0 N-CA-C 113.088 0.773 . . . . 0.0 113.088 -175.512 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' B' B ' 64' ' ' THR . . . . . . . . . . . . . 29.8 m -61.1 138.28 58.21 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-O 120.915 0.388 . . . . 0.0 111.164 -175.137 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' B' B ' 65' ' ' LYS . . . . . . . . . . . . . 55.6 mttm -89.99 133.32 34.87 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 115.913 -0.585 . . . . 0.0 110.38 179.129 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' B' B ' 66' ' ' ILE . . . . . 0.46 HD12 ' HB2' ' B' ' 23' ' ' ARG . 66.8 mt -120.05 129.84 74.98 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.202 0 N-CA-C 109.93 -0.396 . . . . 0.0 109.93 178.0 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' B' B ' 67' ' ' THR . . . . . . . . . . . . . 31.4 m -121.33 140.13 52.5 Favored 'General case' 0 C--N 1.331 -0.213 0 CA-C-N 116.062 -0.517 . . . . 0.0 111.002 -178.352 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' B' B ' 68' ' ' LEU . . . . . 0.476 ' C ' HD23 ' B' ' 68' ' ' LEU . 6.1 tt . . . . . 0 C--N 1.331 -0.225 0 CA-C-N 115.863 -0.608 . . . . 0.0 110.238 178.882 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' B' B ' 73' ' ' VAL . . . . . . . . . . . . . 35.5 m . . . . . 0 C--O 1.232 0.179 0 N-CA-C 109.882 -0.414 . . . . 0.0 109.882 . . . . . . . . . 0 0 . 1 . 009 nuclear nobuild core ' B' B ' 74' ' ' ASP . . . . . . . . . . . . . 27.6 t0 -99.86 116.46 31.98 Favored 'General case' 0 C--N 1.331 -0.217 0 C-N-CA 120.794 -0.363 . . . . 0.0 110.041 -178.804 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' B' B ' 75' ' ' VAL . . . . . . . . . . . . . 44.4 t -114.97 123.13 70.36 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.217 0 CA-C-O 120.96 0.41 . . . . 0.0 110.401 -177.658 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' B' B ' 76' ' ' LEU . . . . . . . . . . . . . 26.0 mt -125.31 146.95 49.33 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 115.775 -0.648 . . . . 0.0 109.65 178.806 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' B' B ' 77' ' ' GLU . . . . . . . . . . . . . 96.8 mt-10 -138.48 141.95 39.42 Favored 'General case' 0 C--N 1.332 -0.188 0 CA-C-O 121.016 0.436 . . . . 0.0 111.57 -177.656 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' B' B ' 78' ' ' ALA . . . . . 0.58 ' HB2' HD21 ' B' ' 109' ' ' LEU . . . -129.81 139.41 51.24 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 115.801 -0.636 . . . . 0.0 110.003 175.827 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' B' B ' 79' ' ' LYS . . . . . 0.45 ' O ' HD13 ' B' ' 80' ' ' ILE . 98.2 mttt -79.4 119.54 22.56 Favored 'General case' 0 C--N 1.331 -0.198 0 CA-C-O 120.78 0.324 . . . . 0.0 110.937 -178.128 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' B' B ' 80' ' ' ILE . . . . . 0.45 HD13 ' O ' ' B' ' 79' ' ' LYS . 25.9 mm -139.19 113.08 6.91 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 N-CA-C 109.171 -0.678 . . . . 0.0 109.171 -178.673 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' B' B ' 81' ' ' LYS . . . . . . . . . . . . . 62.4 mttm -108.99 127.27 53.93 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-O 121.04 0.448 . . . . 0.0 111.376 -177.173 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' B' B ' 82' ' ' GLY . . . . . . . . . . . . . . . 89.15 41.99 5.71 Favored Glycine 0 CA--C 1.526 0.747 0 CA-C-N 115.833 -0.621 . . . . 0.0 111.823 174.199 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' B' B ' 83' ' ' ILE . . . . . . . . . . . . . 71.0 mt -72.95 140.44 17.88 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.318 0 N-CA-C 110.099 -0.334 . . . . 0.0 110.099 178.329 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' B' B ' 84' ' ' LYS . . . . . . . . . . . . . 28.5 ttmt -97.53 -53.22 3.51 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.174 -0.466 . . . . 0.0 109.94 179.175 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' B' B ' 85' ' ' ASP . . . . . . . . . . . . . 7.0 t70 -152.38 151.51 30.92 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 115.76 -0.655 . . . . 0.0 110.556 -179.535 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' B' B ' 86' ' ' VAL . . . . . . . . . . . . . 42.8 t -128.82 130.11 68.52 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.24 0 CA-C-O 120.912 0.387 . . . . 0.0 110.289 -179.238 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' B' B ' 87' ' ' ILE . . . . . 0.498 ' N ' HD12 ' B' ' 87' ' ' ILE . 5.1 mp -119.44 128.26 75.86 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.178 0 N-CA-C 109.531 -0.544 . . . . 0.0 109.531 177.134 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' B' B ' 88' ' ' LEU . . . . . . . . . . . . . 57.0 mt -114.34 140.89 48.26 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-O 121.204 0.526 . . . . 0.0 111.263 -177.764 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' B' B ' 89' ' ' ASP . . . . . . . . . . . . . 5.0 t70 -132.27 158.94 40.53 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 115.376 -0.829 . . . . 0.0 109.457 176.517 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' B' B ' 90' ' ' GLU . . . . . . . . . . . . . 83.0 tt0 -46.33 -41.68 13.7 Favored 'General case' 0 C--N 1.331 -0.238 0 N-CA-C 112.975 0.731 . . . . 0.0 112.975 -173.19 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' B' B ' 91' ' ' ASN . . . . . . . . . . . . . 9.5 p-10 -132.19 38.01 3.52 Favored 'General case' 0 N--CA 1.464 0.231 0 CA-C-O 120.704 0.288 . . . . 0.0 111.391 -177.696 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' B' B ' 92' ' ' LEU . . . . . . . . . . . . . 11.6 tp -163.45 142.23 8.11 Favored 'General case' 0 C--N 1.331 -0.226 0 C-N-CA 120.865 -0.334 . . . . 0.0 110.89 -177.978 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' B' B ' 93' ' ' ILE . . . . . . . . . . . . . 76.9 mt -127.65 119.08 50.92 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 N-CA-C 109.284 -0.635 . . . . 0.0 109.284 177.715 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' B' B ' 94' ' ' VAL . . . . . 0.749 HG21 HG11 ' B' ' 125' ' ' VAL . 47.3 t -123.44 127.11 74.07 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.234 0 CA-C-O 120.978 0.418 . . . . 0.0 110.123 -179.8 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' B' B ' 95' ' ' VAL . . . . . . . . . . . . . 41.9 t -121.97 137.18 56.43 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.337 0 CA-C-N 115.741 -0.663 . . . . 0.0 109.91 -178.377 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' B' B ' 96' ' ' ILE . . . . . 0.522 HD11 ' HB ' ' B' ' 123' ' ' VAL . 58.0 mt -114.75 127.8 72.12 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.263 0 N-CA-C 109.362 -0.607 . . . . 0.0 109.362 179.126 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' B' B ' 97' ' ' THR . . . . . . . . . . . . . 67.6 p -102.5 154.34 19.19 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-O 121.199 0.524 . . . . 0.0 111.383 -177.626 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' B' B ' 98' ' ' GLU . . . . . . . . . . . . . 46.5 tp10 -53.95 -25.56 21.24 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 115.984 -0.553 . . . . 0.0 112.207 179.751 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' B' B ' 99' ' ' GLU . . . . . . . . . . . . . 32.6 tt0 -78.82 16.74 0.82 Allowed 'General case' 0 CA--C 1.537 0.469 0 N-CA-C 112.812 0.671 . . . . 0.0 112.812 -177.82 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' B' B ' 100' ' ' ASN . . . . . . . . . . . . . 4.1 m-20 61.67 37.94 15.59 Favored 'General case' 0 CA--C 1.53 0.181 0 O-C-N 121.894 -0.503 . . . . 0.0 110.855 178.066 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' B' B ' 101' ' ' GLU . . . . . . . . . . . . . 84.5 tt0 -116.54 143.35 45.71 Favored 'General case' 0 C--N 1.333 -0.149 0 CA-C-N 115.935 -0.575 . . . . 0.0 109.724 177.603 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' B' B ' 102' ' ' VAL . . . . . . . . . . . . . 44.7 t -114.98 125.05 72.2 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.331 0 CA-C-N 116.206 -0.452 . . . . 0.0 109.857 -178.822 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' B' B ' 103' ' ' LEU . . . . . . . . . . . . . 24.2 mt -116.84 128.26 55.09 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 115.807 -0.633 . . . . 0.0 110.348 177.84 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' B' B ' 104' ' ' ILE . . . . . . . . . . . . . 68.1 mt -120.39 121.04 64.57 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.26 0 CA-C-N 116.64 -0.254 . . . . 0.0 110.428 179.688 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' B' B ' 105' ' ' PHE . . . . . . . . . . . . . 52.5 m-85 -121.85 166.77 13.88 Favored 'General case' 0 C--N 1.333 -0.139 0 CA-C-N 115.674 -0.693 . . . . 0.0 109.678 178.611 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' B' B ' 106' ' ' ASN . . . . . . . . . . . . . 45.1 p-10 -99.57 -171.02 1.99 Allowed 'General case' 0 C--N 1.329 -0.285 0 N-CA-C 109.876 -0.416 . . . . 0.0 109.876 173.318 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' B' B ' 107' ' ' GLN . . . . . . . . . . . . . 45.4 tt0 -60.23 -29.63 68.87 Favored 'General case' 0 C--N 1.329 -0.293 0 N-CA-C 112.001 0.371 . . . . 0.0 112.001 179.979 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' B' B ' 108' ' ' ASN . . . . . . . . . . . . . 4.5 t-20 -82.49 7.34 14.64 Favored 'General case' 0 CA--C 1.536 0.431 0 N-CA-C 113.163 0.801 . . . . 0.0 113.163 -177.633 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' B' B ' 109' ' ' LEU . . . . . 0.58 HD21 ' HB2' ' B' ' 78' ' ' ALA . 12.5 tp 61.63 38.18 15.53 Favored 'General case' 0 C--N 1.333 -0.139 0 CA-C-O 121.165 0.507 . . . . 0.0 111.205 179.073 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' B' B ' 110' ' ' GLU . . . . . . . . . . . . . 95.7 mt-10 -108.07 148.13 30.21 Favored 'General case' 0 C--N 1.33 -0.281 0 N-CA-C 109.539 -0.541 . . . . 0.0 109.539 174.871 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' B' B ' 111' ' ' GLU . . . . . . . . . . . . . 49.3 tt0 -83.21 122.03 27.87 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-O 120.896 0.379 . . . . 0.0 111.023 -175.624 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' B' B ' 112' ' ' LEU . . . . . . . . . . . . . 84.8 mt -104.83 -46.03 4.41 Favored 'General case' 0 C--N 1.331 -0.203 0 CA-C-N 116.025 -0.534 . . . . 0.0 110.591 178.844 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' B' B ' 113' ' ' TYR . . . . . . . . . . . . . 42.3 t80 -137.15 136.71 38.48 Favored 'General case' 0 C--N 1.331 -0.223 0 CA-C-N 116.357 -0.383 . . . . 0.0 111.363 -177.823 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' B' B ' 114' ' ' ARG . . . . . . . . . . . . . 46.2 ttp180 -137.17 125.64 23.51 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 115.913 -0.585 . . . . 0.0 110.039 176.474 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' B' B ' 115' ' ' GLY . . . . . . . . . . . . . . . -150.03 154.71 25.85 Favored Glycine 0 CA--C 1.525 0.667 0 C-N-CA 120.756 -0.735 . . . . 0.0 111.271 178.932 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' B' B ' 116' ' ' LYS . . . . . . . . . . . . . 30.8 ttpt -128.62 130.67 47.62 Favored 'General case' 0 C--N 1.329 -0.304 0 N-CA-C 109.797 -0.446 . . . . 0.0 109.797 177.778 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' B' B ' 117' ' ' PHE . . . . . . . . . . . . . 46.1 m-85 -128.79 116.21 19.13 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-O 120.926 0.393 . . . . 0.0 110.464 -175.987 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' B' B ' 118' ' ' GLU . . . . . . . . . . . . . 95.9 mt-10 -52.65 -46.76 67.29 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.361 -0.381 . . . . 0.0 111.573 -176.942 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' B' B ' 119' ' ' ASN . . . . . . . . . . . . . 9.8 m120 -99.57 30.97 3.35 Favored 'General case' 0 C--N 1.33 -0.272 0 N-CA-C 112.22 0.452 . . . . 0.0 112.22 -174.35 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' B' B ' 120' ' ' LEU . . . . . . . . . . . . . 15.8 tp -54.21 125.78 20.47 Favored 'General case' 0 N--CA 1.462 0.17 0 CA-C-O 120.718 0.294 . . . . 0.0 110.984 179.22 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' B' B ' 121' ' ' ASN . . . . . . . . . . . . . 31.3 m120 -107.92 -44.1 4.28 Favored 'General case' 0 C--N 1.331 -0.212 0 CA-C-N 116.367 -0.379 . . . . 0.0 110.806 -177.98 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' B' B ' 122' ' ' LYS . . . . . . . . . . . . . 1.2 ptpm? -160.29 157.35 27.9 Favored 'General case' 0 C--N 1.332 -0.19 0 CA-C-O 121.231 0.538 . . . . 0.0 112.056 -179.348 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' B' B ' 123' ' ' VAL . . . . . 0.522 ' HB ' HD11 ' B' ' 96' ' ' ILE . 46.8 t -127.23 131.51 70.53 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.224 0 CA-C-N 115.587 -0.733 . . . . 0.0 109.526 176.707 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' B' B ' 124' ' ' LEU . . . . . . . . . . . . . 14.4 tp -126.8 138.81 53.41 Favored 'General case' 0 N--CA 1.463 0.19 0 CA-C-N 116.496 -0.32 . . . . 0.0 110.541 -177.988 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' B' B ' 125' ' ' VAL . . . . . 0.749 HG11 HG21 ' B' ' 94' ' ' VAL . 34.7 m -132.68 141.99 43.6 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.182 0 CA-C-O 120.835 0.35 . . . . 0.0 111.328 -177.654 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' B' B ' 126' ' ' ARG . . . . . . . . . . . . . 88.9 mtt180 -146.57 118.07 7.97 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.658 175.128 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' B' B ' 127' ' ' ASN . . . . . . . . . . . . . 75.2 m-80 52.0 -106.43 0.27 Allowed 'General case' 0 CA--C 1.544 0.715 0 CA-C-O 118.97 -0.538 . . . . 0.0 111.256 178.996 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' B' B ' 128' ' ' ASP . . . . . . . . . . . . . 15.5 p-10 -114.07 3.16 15.18 Favored 'General case' 0 N--CA 1.469 0.484 0 CA-C-N 119.649 1.113 . . . . 0.0 113.295 -177.893 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' B' B ' 129' ' ' LEU . . . . . . . . . . . . . 15.6 tp -105.34 135.48 46.65 Favored 'General case' 0 C--N 1.332 -0.184 0 N-CA-C 109.553 -0.536 . . . . 0.0 109.553 178.084 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' B' B ' 130' ' ' VAL . . . . . . . . . . . . . 41.1 t -124.63 140.46 47.79 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.235 0 N-CA-C 110.136 -0.32 . . . . 0.0 110.136 -177.751 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' B' B ' 131' ' ' VAL . . . . . 0.403 HG22 HD12 ' B' ' 140' ' ' LEU . 41.5 t -133.51 135.07 56.39 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 CA-C-O 120.963 0.411 . . . . 0.0 110.145 178.788 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' B' B ' 132' ' ' ILE . . . . . . . . . . . . . 70.1 mt -116.92 131.41 69.68 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.314 0 N-CA-C 109.197 -0.668 . . . . 0.0 109.197 178.297 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' B' B ' 133' ' ' ILE . . . . . . . . . . . . . 43.3 mm -115.94 120.94 66.3 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.316 0 CA-C-N 116.406 -0.361 . . . . 0.0 110.819 -174.901 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' B' B ' 134' ' ' ASP . . . . . . . . . . . . . 8.6 p-10 -134.37 147.48 50.52 Favored 'General case' 0 C--N 1.331 -0.2 0 N-CA-C 109.545 -0.539 . . . . 0.0 109.545 174.346 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' B' B ' 135' ' ' GLU . . . . . . . . . . . . . 84.9 tt0 -49.84 -24.36 2.39 Favored 'General case' 0 C--N 1.328 -0.357 0 N-CA-C 112.894 0.702 . . . . 0.0 112.894 -172.537 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' B' B ' 136' ' ' GLN . . . . . . . . . . . . . 96.1 mt-30 -99.81 -27.93 13.39 Favored 'General case' 0 N--CA 1.463 0.182 0 N-CA-C 112.727 0.64 . . . . 0.0 112.727 -174.672 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' B' B ' 137' ' ' LYS . . . . . . . . . . . . . 94.4 mttt -141.94 150.66 41.73 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-O 121.467 0.651 . . . . 0.0 112.296 -169.531 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' B' B ' 138' ' ' LEU . . . . . . . . . . . . . 11.3 tp -112.06 118.48 35.53 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 114.988 -1.005 . . . . 0.0 108.987 170.945 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' B' B ' 139' ' ' THR . . . . . . . . . . . . . 25.6 m -110.38 125.22 52.98 Favored 'General case' 0 C--N 1.331 -0.216 0 CA-C-O 120.644 0.259 . . . . 0.0 111.127 -177.014 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' B' B ' 140' ' ' LEU . . . . . 0.403 HD12 HG22 ' B' ' 131' ' ' VAL . 23.3 tp -114.56 122.8 47.65 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 115.652 -0.704 . . . . 0.0 109.354 179.586 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' B' B ' 141' ' ' ILE . . . . . . . . . . . . . 19.3 mt -121.87 125.16 72.86 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.247 0 CA-C-O 120.856 0.36 . . . . 0.0 110.199 -174.094 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' B' B ' 142' ' ' ARG . . . . . . . . . . . . . 79.0 mtp180 -114.53 129.38 56.66 Favored 'General case' 0 C--N 1.331 -0.212 0 CA-C-N 115.67 -0.695 . . . . 0.0 110.351 -179.34 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' B' B ' 143' ' ' THR . . . . . . . . . . . . . 26.0 p . . . . . 0 C--O 1.221 -0.424 0 CA-C-O 118.015 -0.993 . . . . 0.0 110.525 179.749 . . . . . . . . 0 0 . 1 . 009 nuclear nobuild core ' C' C ' 2' ' ' SER . . . . . . . . . . . . . 2.3 p . . . . . 0 C--O 1.232 0.15 0 CA-C-O 121.008 0.433 . . . . 0.0 110.36 . . . . . . . . . 0 0 . 1 . 009 nuclear nobuild core ' C' C ' 3' ' ' GLU . . . . . . . . . . . . . 85.3 tt0 -140.12 141.6 36.09 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 115.795 -0.639 . . . . 0.0 111.088 -177.001 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' C' C ' 4' ' ' LEU . . . . . 0.422 HD21 HD21 ' C' ' 6' ' ' LEU . 13.2 tp -124.11 130.39 52.46 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 115.765 -0.652 . . . . 0.0 110.116 177.497 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' C' C ' 5' ' ' LYS . . . . . . . . . . . . . 53.5 mttp -108.65 120.35 42.21 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.185 -0.462 . . . . 0.0 110.541 179.817 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' C' C ' 6' ' ' LEU . . . . . 0.422 HD21 HD21 ' C' ' 4' ' ' LEU . 55.4 mt -114.48 147.93 38.6 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 115.427 -0.806 . . . . 0.0 110.45 -178.827 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' C' C ' 7' ' ' LYS . . . . . . . . . . . . . 78.7 tttt -139.85 138.87 20.4 Favored Pre-proline 0 CA--C 1.534 0.328 0 CA-C-O 119.081 -0.485 . . . . 0.0 110.162 176.249 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' C' C ' 8' ' ' PRO . . . . . . . . . . . . . 98.2 Cg_endo -92.08 144.43 2.81 Favored 'Trans proline' 0 N--CA 1.49 1.267 0 C-N-CA 121.69 1.593 . . . . 0.0 111.812 177.482 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' C' C ' 9' ' ' LEU . . . . . . . . . . . . . 53.0 mt -74.94 -47.1 4.88 Favored Pre-proline 0 CA--C 1.534 0.353 0 CA-C-O 118.699 -0.667 . . . . 0.0 112.051 -179.524 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' C' C ' 10' ' ' PRO . . . . . . . . . . . . . 96.5 Cg_endo -82.28 156.56 17.04 Favored 'Trans proline' 0 N--CA 1.496 1.64 0 C-N-CA 121.221 1.281 . . . . 0.0 111.808 175.27 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' C' C ' 11' ' ' LYS . . . . . . . . . . . . . 59.3 tttm -88.7 106.57 18.42 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.428 -0.351 . . . . 0.0 110.24 178.32 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' C' C ' 12' ' ' VAL . . . . . . . . . . . . . 12.4 p -140.46 148.47 22.19 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.243 0 CA-C-N 116.248 -0.433 . . . . 0.0 110.632 -178.659 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' C' C ' 13' ' ' GLU . . . . . . . . . . . . . 83.2 tt0 -90.91 122.0 33.23 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 116.131 -0.486 . . . . 0.0 110.21 178.522 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' C' C ' 14' ' ' LEU . . . . . . . . . . . . . 35.5 mt -98.55 151.84 37.64 Favored Pre-proline 0 CA--C 1.532 0.282 0 CA-C-N 116.383 -0.371 . . . . 0.0 110.948 -176.706 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' C' C ' 15' ' ' PRO . . . . . . . . . . . . . 24.2 Cg_exo -63.96 158.01 49.75 Favored 'Trans proline' 0 N--CA 1.497 1.722 0 C-N-CA 121.266 1.311 . . . . 0.0 111.721 174.871 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' C' C ' 16' ' ' PRO . . . . . . . . . . . . . 39.4 Cg_exo -58.72 -38.87 86.86 Favored 'Trans proline' 0 N--CA 1.496 1.665 0 C-N-CA 121.409 1.406 . . . . 0.0 112.776 -178.965 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' C' C ' 17' ' ' ASP . . . . . . . . . . . . . 12.7 p-10 -87.95 11.94 14.54 Favored 'General case' 0 CA--C 1.536 0.424 0 N-CA-C 113.148 0.796 . . . . 0.0 113.148 -177.402 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' C' C ' 18' ' ' PHE . . . . . . . . . . . . . 44.9 t80 -57.95 -44.74 87.17 Favored 'General case' 0 C--N 1.335 -0.065 0 O-C-N 122.007 -0.433 . . . . 0.0 110.113 -178.826 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' C' C ' 19' ' ' VAL . . . . . 0.413 HG13 ' N ' ' C' ' 20' ' ' ASP . 12.7 p -56.94 -41.61 77.15 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.357 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.726 -179.145 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' C' C ' 20' ' ' ASP . . . . . 0.413 ' N ' HG13 ' C' ' 19' ' ' VAL . 79.6 m-20 -60.65 -42.93 97.97 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-O 120.843 0.354 . . . . 0.0 111.015 -177.709 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' C' C ' 21' ' ' VAL . . . . . . . . . . . . . 47.1 t -63.94 -47.98 88.18 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.338 0 C-N-CA 120.782 -0.367 . . . . 0.0 110.383 -178.076 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' C' C ' 22' ' ' ILE . . . . . 0.485 HG22 HD12 ' C' ' 26' ' ' LEU . 46.4 mm -58.11 -38.49 67.96 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.298 0 CA-C-O 120.841 0.353 . . . . 0.0 110.56 179.407 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' C' C ' 23' ' ' ARG . . . . . . . . . . . . . 56.3 ttp180 -55.53 -48.24 75.01 Favored 'General case' 0 C--N 1.33 -0.253 0 O-C-N 122.094 -0.379 . . . . 0.0 110.845 177.429 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' C' C ' 24' ' ' ILE . . . . . . . . . . . . . 67.2 mt -60.24 -41.9 88.54 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.358 0 CA-C-N 116.148 -0.478 . . . . 0.0 111.75 -177.776 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' C' C ' 25' ' ' LYS . . . . . . . . . . . . . 16.1 ptmt -72.33 -36.08 68.76 Favored 'General case' 0 CA--C 1.534 0.328 0 C-N-CA 120.561 -0.455 . . . . 0.0 112.077 -176.044 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' C' C ' 26' ' ' LEU . . . . . 0.485 HD12 HG22 ' C' ' 22' ' ' ILE . 78.3 mt -78.54 -41.78 31.19 Favored 'General case' 0 C--N 1.33 -0.247 0 N-CA-C 112.887 0.699 . . . . 0.0 112.887 -172.952 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' C' C ' 27' ' ' GLN . . . . . . . . . . . . . 9.9 pt20 -46.38 138.53 5.56 Favored 'General case' 0 N--CA 1.468 0.466 0 N-CA-C 112.812 0.671 . . . . 0.0 112.812 -175.338 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' C' C ' 28' ' ' GLY . . . . . . . . . . . . . . . 100.62 -26.65 23.82 Favored Glycine 0 CA--C 1.532 1.119 0 CA-C-N 115.55 -0.75 . . . . 0.0 112.135 -177.891 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' C' C ' 29' ' ' LYS . . . . . . . . . . . . . 59.7 mmtt -97.82 155.23 17.14 Favored 'General case' 0 C--O 1.233 0.217 0 CA-C-N 117.445 0.623 . . . . 0.0 111.019 178.699 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' C' C ' 30' ' ' THR . . . . . . . . . . . . . 40.5 m -100.08 135.79 40.97 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 115.883 -0.599 . . . . 0.0 109.688 174.24 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' C' C ' 31' ' ' VAL . . . . . . . . . . . . . 34.9 m -125.91 154.8 35.23 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.211 0 CA-C-N 116.5 -0.318 . . . . 0.0 110.602 -178.367 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' C' C ' 32' ' ' ARG . . . . . . . . . . . . . 46.3 ttt180 -135.71 149.13 49.13 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-O 121.225 0.536 . . . . 0.0 110.667 179.624 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' C' C ' 33' ' ' THR . . . . . . . . . . . . . 18.2 m -52.48 140.51 22.35 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.286 -0.415 . . . . 0.0 111.426 -178.339 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' C' C ' 34' ' ' GLY . . . . . . . . . . . . . . . 99.71 -17.04 58.03 Favored Glycine 0 CA--C 1.532 1.11 0 CA-C-O 119.656 -0.524 . . . . 0.0 113.224 179.073 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' C' C ' 35' ' ' ASP . . . . . . . . . . . . . 72.6 m-20 -64.59 149.19 49.33 Favored 'General case' 0 C--O 1.231 0.1 0 CA-C-N 118.13 0.965 . . . . 0.0 111.081 179.426 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' C' C ' 36' ' ' VAL . . . . . . . . . . . . . 45.6 t -126.01 130.69 72.24 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.249 0 CA-C-N 115.995 -0.548 . . . . 0.0 109.838 178.477 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' C' C ' 37' ' ' ILE . . . . . . . . . . . . . 66.6 mt -121.93 139.69 48.2 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.299 0 CA-C-N 116.292 -0.413 . . . . 0.0 110.194 -178.953 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' C' C ' 38' ' ' GLY . . . . . . . . . . . . . . . -108.7 128.85 9.25 Favored Glycine 0 CA--C 1.526 0.748 0 N-CA-C 110.96 -0.856 . . . . 0.0 110.96 179.285 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' C' C ' 39' ' ' ILE . . . . . . . . . . . . . 72.6 mt -125.78 132.22 71.02 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.181 0 N-CA-C 110.191 -0.3 . . . . 0.0 110.191 179.829 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' C' C ' 40' ' ' SER . . . . . . . . . . . . . 27.6 t -92.78 122.16 34.9 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.418 -0.356 . . . . 0.0 110.886 175.581 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' C' C ' 41' ' ' ILE . . . . . . . . . . . . . 72.3 mt -131.01 116.89 35.43 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.223 0 CA-C-O 121.031 0.443 . . . . 0.0 110.55 178.699 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' C' C ' 42' ' ' LEU . . . . . 0.532 ' O ' HD23 ' C' ' 42' ' ' LEU . 1.3 tt 51.46 47.4 24.89 Favored 'General case' 0 CA--C 1.531 0.217 0 CA-C-N 115.768 -0.651 . . . . 0.0 111.208 175.996 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' C' C ' 43' ' ' GLY . . . . . . . . . . . . . . . 70.17 21.38 77.09 Favored Glycine 0 CA--C 1.531 1.075 0 C-N-CA 121.081 -0.58 . . . . 0.0 112.79 175.016 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' C' C ' 44' ' ' LYS . . . . . . . . . . . . . 59.4 mtpt -131.65 128.35 38.88 Favored 'General case' 0 C--N 1.331 -0.212 0 CA-C-N 117.692 0.746 . . . . 0.0 110.098 179.068 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' C' C ' 45' ' ' GLU . . . . . . . . . . . . . 83.2 tt0 -83.8 123.14 29.58 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 116.441 -0.345 . . . . 0.0 110.997 -179.68 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' C' C ' 46' ' ' VAL . . . . . . . . . . . . . 7.2 p -123.15 128.26 74.92 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.204 0 N-CA-C 109.722 -0.473 . . . . 0.0 109.722 176.669 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' C' C ' 47' ' ' LYS . . . . . . . . . . . . . 63.2 mttp -100.19 128.65 46.23 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.085 -0.507 . . . . 0.0 111.089 177.664 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' C' C ' 48' ' ' PHE . . . . . . . . . . . . . 91.1 m-85 -110.5 131.83 54.71 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.206 -0.452 . . . . 0.0 109.863 176.346 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' C' C ' 49' ' ' LYS . . . . . . . . . . . . . 79.2 tttt -108.61 137.99 45.66 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.377 -0.374 . . . . 0.0 110.424 178.978 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' C' C ' 50' ' ' VAL . . . . . . . . . . . . . 44.9 t -79.73 106.28 10.55 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.335 0 N-CA-C 109.335 -0.617 . . . . 0.0 109.335 175.828 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' C' C ' 51' ' ' VAL . . . . . . . . . . . . . 48.2 t -69.81 -47.67 68.69 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.284 0 CA-C-N 116.052 -0.522 . . . . 0.0 109.863 -173.486 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' C' C ' 52' ' ' GLN . . . . . . . . . . . . . 21.4 pt20 -167.85 158.88 11.11 Favored 'General case' 0 C--N 1.332 -0.192 0 C-N-CA 120.165 -0.614 . . . . 0.0 111.643 179.482 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' C' C ' 53' ' ' ALA . . . . . . . . . . . . . . . -135.56 138.68 43.24 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 115.564 -0.743 . . . . 0.0 110.229 178.94 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' C' C ' 54' ' ' TYR . . . . . . . . . . . . . 63.6 t80 -128.9 110.31 18.52 Favored Pre-proline 0 CA--C 1.534 0.36 0 CA-C-O 118.156 -0.926 . . . . 0.0 110.259 179.772 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' C' C ' 55' ' ' PRO . . . . . . . . . . . . . 73.4 Cg_endo -77.17 170.06 72.55 Favored 'Cis proline' 0 N--CA 1.501 1.926 0 CA-C-N 121.908 1.717 . . . . 0.0 112.236 -7.91 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' C' C ' 56' ' ' SER . . . . . . . . . . . . . 51.1 m -121.24 134.6 24.49 Favored Pre-proline 0 CA--C 1.537 0.457 0 CA-C-O 118.582 -0.723 . . . . 0.0 109.619 175.09 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' C' C ' 57' ' ' PRO . . . . . . . . . . . . . 36.3 Cg_endo -66.41 164.68 66.05 Favored 'Cis proline' 0 N--CA 1.499 1.799 0 CA-C-N 121.841 1.693 . . . . 0.0 111.521 -2.944 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' C' C ' 58' ' ' LEU . . . . . . . . . . . . . 32.8 tp -130.77 139.68 50.25 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-O 120.947 0.403 . . . . 0.0 110.663 -178.338 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' C' C ' 59' ' ' ARG . . . . . . . . . . . . . 55.2 ttm-85 -96.1 129.5 43.37 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-N 115.762 -0.654 . . . . 0.0 109.338 174.367 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' C' C ' 60' ' ' VAL . . . . . . . . . . . . . 40.9 t -86.14 121.11 37.02 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.268 0 C-N-CA 120.624 -0.431 . . . . 0.0 110.4 -177.917 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' C' C ' 61' ' ' GLU . . . . . . . . . . . . . 71.6 tt0 -130.57 157.66 42.1 Favored 'General case' 0 C--N 1.329 -0.31 0 N-CA-C 109.113 -0.699 . . . . 0.0 109.113 177.523 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' C' C ' 62' ' ' ASP . . . . . . . . . . . . . 12.8 t70 -51.22 -32.28 23.45 Favored 'General case' 0 C--N 1.327 -0.404 0 N-CA-C 112.07 0.396 . . . . 0.0 112.07 -178.282 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' C' C ' 63' ' ' ARG . . . . . . . . . . . . . 98.2 mtt180 -77.18 -21.94 53.21 Favored 'General case' 0 CA--C 1.533 0.29 0 N-CA-C 112.857 0.688 . . . . 0.0 112.857 -177.812 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' C' C ' 64' ' ' THR . . . . . . . . . . . . . 20.0 m -57.46 141.8 46.27 Favored 'General case' 0 C--N 1.331 -0.207 0 CA-C-O 120.842 0.353 . . . . 0.0 110.642 -176.478 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' C' C ' 65' ' ' LYS . . . . . . . . . . . . . 40.2 ttpt -89.13 121.44 31.45 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.1 -0.5 . . . . 0.0 110.279 -179.63 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' C' C ' 66' ' ' ILE . . . . . . . . . . . . . 63.1 mt -113.5 129.15 69.82 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.241 0 N-CA-C 109.87 -0.418 . . . . 0.0 109.87 -179.718 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' C' C ' 67' ' ' THR . . . . . . . . . . . . . 18.8 m -129.08 143.86 51.0 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-O 121.142 0.496 . . . . 0.0 111.236 -177.433 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' C' C ' 68' ' ' LEU . . . . . . . . . . . . . 17.1 tp . . . . . 0 C--N 1.329 -0.323 0 CA-C-N 115.827 -0.624 . . . . 0.0 110.092 177.58 . . . . . . . . 0 0 . 1 . 009 nuclear nobuild core ' C' C ' 73' ' ' VAL . . . . . . . . . . . . . 35.5 m . . . . . 0 C--O 1.232 0.15 0 N-CA-C 109.598 -0.519 . . . . 0.0 109.598 . . . . . . . . . 0 0 . 1 . 009 nuclear nobuild core ' C' C ' 74' ' ' ASP . . . . . . . . . . . . . 27.6 t0 -98.71 119.81 38.08 Favored 'General case' 0 C--N 1.331 -0.203 0 C-N-CA 120.805 -0.358 . . . . 0.0 110.193 -176.185 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' C' C ' 75' ' ' VAL . . . . . 0.402 ' C ' HD12 ' C' ' 76' ' ' LEU . 40.6 t -119.13 121.9 67.87 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.237 0 CA-C-O 121.094 0.473 . . . . 0.0 110.63 -178.009 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' C' C ' 76' ' ' LEU . . . . . 0.402 HD12 ' C ' ' C' ' 75' ' ' VAL . 7.1 mp -117.25 139.78 50.37 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 115.669 -0.696 . . . . 0.0 109.402 175.437 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' C' C ' 77' ' ' GLU . . . . . . . . . . . . . 98.0 mt-10 -135.47 129.08 32.6 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-O 121.072 0.463 . . . . 0.0 111.007 -178.401 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' C' C ' 78' ' ' ALA . . . . . 0.481 ' HB2' HD21 ' C' ' 109' ' ' LEU . . . -117.66 136.69 53.15 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 115.638 -0.71 . . . . 0.0 109.957 177.778 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' C' C ' 79' ' ' LYS . . . . . 0.612 ' O ' HD13 ' C' ' 80' ' ' ILE . 68.4 mmtt -73.37 116.01 13.42 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.512 -0.313 . . . . 0.0 110.16 -179.107 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' C' C ' 80' ' ' ILE . . . . . 0.612 HD13 ' O ' ' C' ' 79' ' ' LYS . 39.7 mm -139.09 110.63 5.13 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.303 0 N-CA-C 109.56 -0.533 . . . . 0.0 109.56 -177.433 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' C' C ' 81' ' ' LYS . . . . . . . . . . . . . 99.5 mttt -112.56 128.73 56.44 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-O 120.95 0.405 . . . . 0.0 110.775 -178.852 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' C' C ' 82' ' ' GLY . . . . . . . . . . . . . . . 89.08 42.16 5.68 Favored Glycine 0 CA--C 1.525 0.679 0 C-N-CA 121.024 -0.608 . . . . 0.0 111.649 176.835 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' C' C ' 83' ' ' ILE . . . . . . . . . . . . . 72.0 mt -69.51 136.17 26.78 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.22 0 N-CA-C 109.718 -0.475 . . . . 0.0 109.718 177.23 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' C' C ' 84' ' ' LYS . . . . . . . . . . . . . 60.2 tttp -97.81 -53.56 3.37 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.054 -0.521 . . . . 0.0 110.195 -178.187 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' C' C ' 85' ' ' ASP . . . . . . . . . . . . . 13.1 t70 -151.17 148.67 28.54 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 115.746 -0.661 . . . . 0.0 110.232 -179.342 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' C' C ' 86' ' ' VAL . . . . . . . . . . . . . 41.4 t -129.2 129.62 67.63 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.264 0 CA-C-O 120.944 0.402 . . . . 0.0 110.397 -179.294 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' C' C ' 87' ' ' ILE . . . . . . . . . . . . . 44.6 mm -119.14 126.0 74.97 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.263 0 CA-C-N 115.923 -0.58 . . . . 0.0 109.657 177.097 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' C' C ' 88' ' ' LEU . . . . . . . . . . . . . 19.4 tp -109.82 123.4 49.49 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-O 121.005 0.431 . . . . 0.0 110.826 -178.333 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' C' C ' 89' ' ' ASP . . . . . . . . . . . . . 13.6 t70 -113.61 156.86 22.92 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 115.81 -0.632 . . . . 0.0 109.336 176.325 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' C' C ' 90' ' ' GLU . . . . . . . . . . . . . 81.8 tt0 -45.14 -42.28 8.82 Favored 'General case' 0 N--CA 1.465 0.282 0 N-CA-C 113.266 0.839 . . . . 0.0 113.266 -171.694 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' C' C ' 91' ' ' ASN . . . . . . . . . . . . . 73.1 m-20 -132.02 25.19 4.6 Favored 'General case' 0 N--CA 1.467 0.377 0 N-CA-C 112.652 0.612 . . . . 0.0 112.652 -178.539 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' C' C ' 92' ' ' LEU . . . . . . . . . . . . . 38.1 mt -148.17 142.02 25.74 Favored 'General case' 0 C--N 1.332 -0.19 0 N-CA-C 110.171 -0.307 . . . . 0.0 110.171 -177.635 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' C' C ' 93' ' ' ILE . . . . . . . . . . . . . 62.7 mt -118.62 116.9 52.72 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.266 0 N-CA-C 109.425 -0.583 . . . . 0.0 109.425 179.986 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' C' C ' 94' ' ' VAL . . . . . 0.506 HG21 HG11 ' C' ' 125' ' ' VAL . 44.2 t -119.39 124.13 72.45 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.2 0 CA-C-O 121.026 0.441 . . . . 0.0 110.075 -179.671 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' C' C ' 95' ' ' VAL . . . . . . . . . . . . . 42.7 t -121.23 135.35 61.68 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.297 0 CA-C-N 115.803 -0.635 . . . . 0.0 109.96 -179.258 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' C' C ' 96' ' ' ILE . . . . . . . . . . . . . 60.4 mt -115.9 128.86 73.04 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.288 0 N-CA-C 109.411 -0.588 . . . . 0.0 109.411 178.264 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' C' C ' 97' ' ' THR . . . . . . . . . . . . . 80.5 p -98.67 160.08 14.51 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-O 121.08 0.467 . . . . 0.0 110.828 -179.184 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' C' C ' 98' ' ' GLU . . . . . . . . . . . . . 97.6 mt-10 -53.82 -25.73 20.86 Favored 'General case' 0 CA--C 1.532 0.265 0 N-CA-C 112.257 0.465 . . . . 0.0 112.257 -179.927 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' C' C ' 99' ' ' GLU . . . . . . . . . . . . . 43.2 mt-10 -79.86 16.37 1.18 Allowed 'General case' 0 CA--C 1.535 0.375 0 N-CA-C 113.071 0.767 . . . . 0.0 113.071 -177.732 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' C' C ' 100' ' ' ASN . . . . . . . . . . . . . 3.9 m-20 61.83 38.07 15.0 Favored 'General case' 0 CA--C 1.529 0.155 0 CA-C-O 121.12 0.486 . . . . 0.0 110.91 178.27 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' C' C ' 101' ' ' GLU . . . . . . . . . . . . . 84.7 tt0 -113.18 141.42 46.96 Favored 'General case' 0 C--N 1.331 -0.199 0 CA-C-N 116.159 -0.473 . . . . 0.0 109.854 176.55 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' C' C ' 102' ' ' VAL . . . . . . . . . . . . . 46.1 t -114.86 125.08 72.09 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.272 0 CA-C-N 116.221 -0.445 . . . . 0.0 109.917 -178.55 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' C' C ' 103' ' ' LEU . . . . . . . . . . . . . 16.8 mt -116.65 129.83 56.38 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 115.616 -0.72 . . . . 0.0 110.182 177.763 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' C' C ' 104' ' ' ILE . . . . . . . . . . . . . 61.5 mt -117.7 120.71 65.53 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.286 0 N-CA-C 110.296 -0.261 . . . . 0.0 110.296 179.028 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' C' C ' 105' ' ' PHE . . . . . . . . . . . . . 46.0 m-85 -120.75 163.28 18.35 Favored 'General case' 0 C--N 1.332 -0.171 0 O-C-N 123.97 0.794 . . . . 0.0 109.654 177.86 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' C' C ' 106' ' ' ASN . . . . . . . . . . . . . 45.8 p-10 -97.42 -171.02 2.11 Favored 'General case' 0 C--N 1.331 -0.219 0 N-CA-C 109.783 -0.451 . . . . 0.0 109.783 173.719 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' C' C ' 107' ' ' GLN . . . . . . . . . . . . . 51.1 tt0 -59.67 -28.69 67.49 Favored 'General case' 0 C--N 1.329 -0.309 0 N-CA-C 112.043 0.386 . . . . 0.0 112.043 179.687 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' C' C ' 108' ' ' ASN . . . . . . . . . . . . . 24.6 t30 -84.88 11.94 8.37 Favored 'General case' 0 CA--C 1.537 0.447 0 N-CA-C 112.955 0.724 . . . . 0.0 112.955 -178.012 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' C' C ' 109' ' ' LEU . . . . . 0.481 HD21 ' HB2' ' C' ' 78' ' ' ALA . 11.6 tp 55.76 38.19 29.79 Favored 'General case' 0 C--O 1.232 0.154 0 CA-C-O 121.099 0.476 . . . . 0.0 111.338 178.722 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' C' C ' 110' ' ' GLU . . . . . . . . . . . . . 70.7 mm-40 -101.97 148.91 24.78 Favored 'General case' 0 C--N 1.328 -0.336 0 N-CA-C 109.636 -0.505 . . . . 0.0 109.636 175.707 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' C' C ' 111' ' ' GLU . . . . . . . . . . . . . 82.8 tt0 -81.85 121.91 27.05 Favored 'General case' 0 C--N 1.326 -0.415 0 CA-C-O 120.834 0.349 . . . . 0.0 110.357 -179.45 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' C' C ' 112' ' ' LEU . . . . . . . . . . . . . 34.1 mt -111.56 -46.04 3.31 Favored 'General case' 0 C--N 1.331 -0.203 0 CA-C-N 116.107 -0.497 . . . . 0.0 110.595 -179.689 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' C' C ' 113' ' ' TYR . . . . . . . . . . . . . 56.9 t80 -138.58 135.29 34.83 Favored 'General case' 0 C--N 1.33 -0.259 0 C-N-CA 120.772 -0.371 . . . . 0.0 111.332 -179.154 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' C' C ' 114' ' ' ARG . . . . . . . . . . . . . 63.8 ttp85 -137.88 122.08 18.07 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 115.949 -0.569 . . . . 0.0 110.026 178.956 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' C' C ' 115' ' ' GLY . . . . . . . . . . . . . . . -150.12 142.81 10.02 Favored Glycine 0 CA--C 1.525 0.671 0 C-N-CA 120.79 -0.719 . . . . 0.0 111.336 178.826 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' C' C ' 116' ' ' LYS . . . . . . . . . . . . . 38.8 ttpt -111.49 132.94 54.13 Favored 'General case' 0 C--N 1.33 -0.25 0 N-CA-C 109.782 -0.451 . . . . 0.0 109.782 176.379 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' C' C ' 117' ' ' PHE . . . . . . . . . . . . . 57.8 m-85 -130.69 113.97 14.82 Favored 'General case' 0 C--N 1.332 -0.193 0 CA-C-O 120.983 0.421 . . . . 0.0 110.385 -176.631 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' C' C ' 118' ' ' GLU . . . . . . . . . . . . . 71.0 mm-40 -54.28 -47.52 72.27 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.284 -0.416 . . . . 0.0 111.283 -177.276 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' C' C ' 119' ' ' ASN . . . . . . . . . . . . . 33.3 m120 -94.63 30.99 1.87 Allowed 'General case' 0 C--N 1.33 -0.251 0 N-CA-C 112.194 0.442 . . . . 0.0 112.194 -175.043 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' C' C ' 120' ' ' LEU . . . . . . . . . . . . . 13.7 tp -57.64 121.21 9.82 Favored 'General case' 0 C--N 1.332 -0.165 0 N-CA-C 110.204 -0.295 . . . . 0.0 110.204 177.163 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' C' C ' 121' ' ' ASN . . . . . . . . . . . . . 94.2 m-20 -114.01 -43.91 3.2 Favored 'General case' 0 C--O 1.232 0.171 0 CA-C-N 116.484 -0.326 . . . . 0.0 111.338 -176.113 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' C' C ' 122' ' ' LYS . . . . . . . . . . . . . 39.5 ttpt -150.97 148.88 28.93 Favored 'General case' 0 C--N 1.331 -0.227 0 CA-C-O 121.04 0.448 . . . . 0.0 111.637 -176.617 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' C' C ' 123' ' ' VAL . . . . . . . . . . . . . 44.9 t -128.65 133.87 65.62 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.227 0 CA-C-N 116.007 -0.542 . . . . 0.0 109.737 177.417 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' C' C ' 124' ' ' LEU . . . . . . . . . . . . . 79.5 mt -128.93 139.35 52.16 Favored 'General case' 0 C--N 1.331 -0.201 0 CA-C-O 120.759 0.314 . . . . 0.0 110.942 -178.595 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' C' C ' 125' ' ' VAL . . . . . 0.506 HG11 HG21 ' C' ' 94' ' ' VAL . 35.6 m -133.17 128.93 56.58 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.206 0 CA-C-N 116.254 -0.43 . . . . 0.0 110.53 178.242 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' C' C ' 126' ' ' ARG . . . . . . . . . . . . . 91.0 mtt180 -150.78 128.33 11.48 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.419 -0.355 . . . . 0.0 110.177 178.199 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' C' C ' 127' ' ' ASN . . . . . . . . . . . . . 77.5 m-20 54.52 -151.58 0.36 Allowed 'General case' 0 CA--C 1.541 0.6 0 CA-C-O 119.449 -0.31 . . . . 0.0 110.228 178.017 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' C' C ' 128' ' ' ASP . . . . . . . . . . . . . 23.5 p-10 -81.03 18.14 1.09 Allowed 'General case' 0 CA--C 1.536 0.405 0 N-CA-C 112.881 0.697 . . . . 0.0 112.881 -179.62 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' C' C ' 129' ' ' LEU . . . . . . . . . . . . . 15.9 tp -123.92 137.02 54.69 Favored 'General case' 0 C--O 1.232 0.165 0 CA-C-N 117.983 0.356 . . . . 0.0 110.185 178.715 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' C' C ' 130' ' ' VAL . . . . . 0.496 HG23 ' HB ' ' C' ' 141' ' ' ILE . 32.1 m -131.78 145.81 34.4 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.197 0 CA-C-O 120.905 0.383 . . . . 0.0 110.327 178.575 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' C' C ' 131' ' ' VAL . . . . . 0.515 HG22 HD12 ' C' ' 140' ' ' LEU . 40.7 t -136.1 140.49 43.8 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.325 0 CA-C-O 121.058 0.456 . . . . 0.0 110.553 -177.704 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' C' C ' 132' ' ' ILE . . . . . . . . . . . . . 73.9 mt -116.8 129.68 72.92 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 CA-C-N 115.585 -0.734 . . . . 0.0 109.032 177.45 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' C' C ' 133' ' ' ILE . . . . . . . . . . . . . 40.3 mm -114.06 121.84 66.99 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.275 0 CA-C-O 120.698 0.285 . . . . 0.0 110.942 -174.428 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' C' C ' 134' ' ' ASP . . . . . . . . . . . . . 9.0 p-10 -135.23 146.54 48.72 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.116 -0.493 . . . . 0.0 109.786 175.501 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' C' C ' 135' ' ' GLU . . . . . . . . . . . . . 81.2 tt0 -49.92 -25.41 3.21 Favored 'General case' 0 CA--C 1.533 0.325 0 N-CA-C 112.77 0.656 . . . . 0.0 112.77 -175.465 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' C' C ' 136' ' ' GLN . . . . . . . . . . . . . 58.3 tp60 -80.88 -34.28 33.7 Favored 'General case' 0 C--O 1.233 0.2 0 N-CA-C 112.036 0.384 . . . . 0.0 112.036 -176.032 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' C' C ' 137' ' ' LYS . . . . . . . . . . . . . 40.3 pttt -169.57 175.49 5.38 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-O 121.522 0.677 . . . . 0.0 112.085 -173.597 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' C' C ' 138' ' ' LEU . . . . . 0.479 HD23 ' N ' ' C' ' 139' ' ' THR . 4.8 tt -117.74 125.34 50.47 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 115.05 -0.977 . . . . 0.0 109.81 177.931 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' C' C ' 139' ' ' THR . . . . . 0.479 ' N ' HD23 ' C' ' 138' ' ' LEU . 28.6 m -105.18 124.01 48.81 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.312 -0.404 . . . . 0.0 110.497 179.701 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' C' C ' 140' ' ' LEU . . . . . 0.515 HD12 HG22 ' C' ' 131' ' ' VAL . 19.6 tp -110.68 117.89 34.71 Favored 'General case' 0 C--N 1.329 -0.302 0 N-CA-C 109.046 -0.724 . . . . 0.0 109.046 -179.496 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' C' C ' 141' ' ' ILE . . . . . 0.496 ' HB ' HG23 ' C' ' 130' ' ' VAL . 19.9 mt -118.63 121.29 66.63 Favored 'Isoleucine or valine' 0 C--O 1.234 0.25 0 CA-C-O 121.24 0.543 . . . . 0.0 109.877 -175.496 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' C' C ' 142' ' ' ARG . . . . . . . . . . . . . 70.5 mtt180 . . . . . 0 C--N 1.33 -0.274 0 CA-C-N 115.042 -0.981 . . . . 0.0 110.112 -177.952 . . . . . . . . 0 0 . 1 . 009 nuclear nobuild core ' D' D ' 2' ' ' SER . . . . . . . . . . . . . 12.7 p . . . . . 0 N--CA 1.462 0.156 0 CA-C-O 121.164 0.507 . . . . 0.0 110.677 . . . . . . . . . 0 0 . 1 . 009 nuclear nobuild core ' D' D ' 3' ' ' GLU . . . . . . . . . . . . . 84.9 tt0 -143.99 140.87 29.85 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 115.748 -0.66 . . . . 0.0 111.161 -178.709 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' D' D ' 4' ' ' LEU . . . . . . . . . . . . . 19.2 tp -124.56 131.74 53.47 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.014 -0.539 . . . . 0.0 110.06 177.093 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' D' D ' 5' ' ' LYS . . . . . . . . . . . . . 77.9 mttt -111.93 120.91 43.51 Favored 'General case' 0 C--O 1.234 0.259 0 CA-C-N 116.365 -0.379 . . . . 0.0 110.767 -179.406 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' D' D ' 6' ' ' LEU . . . . . . . . . . . . . 54.5 mt -114.57 142.47 46.39 Favored 'General case' 0 C--N 1.332 -0.174 0 CA-C-N 115.553 -0.749 . . . . 0.0 110.163 -179.563 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' D' D ' 7' ' ' LYS . . . . . . . . . . . . . 31.0 ttpt -122.3 136.87 26.86 Favored Pre-proline 0 CA--C 1.534 0.351 0 CA-C-O 118.84 -0.6 . . . . 0.0 109.602 175.794 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' D' D ' 8' ' ' PRO . . . . . . . . . . . . . 98.8 Cg_endo -91.22 131.78 1.44 Allowed 'Trans proline' 0 N--CA 1.489 1.255 0 C-N-CA 121.687 1.591 . . . . 0.0 111.799 178.215 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' D' D ' 9' ' ' LEU . . . . . . . . . . . . . 36.1 mt -72.8 -47.48 8.83 Favored Pre-proline 0 CA--C 1.535 0.38 0 CA-C-O 118.49 -0.767 . . . . 0.0 112.128 -178.593 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' D' D ' 10' ' ' PRO . . . . . . . . . . . . . 75.8 Cg_endo -78.62 149.1 23.53 Favored 'Trans proline' 0 N--CA 1.496 1.623 0 CA-C-N 120.347 1.159 . . . . 0.0 111.794 176.397 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' D' D ' 11' ' ' LYS . . . . . . . . . . . . . 53.7 mttp -85.51 95.85 9.43 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.481 -0.327 . . . . 0.0 110.693 -179.721 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' D' D ' 12' ' ' VAL . . . . . . . . . . . . . 12.1 p -144.35 145.19 21.79 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.278 0 CA-C-N 116.285 -0.416 . . . . 0.0 110.43 179.361 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' D' D ' 13' ' ' GLU . . . . . . . . . . . . . 95.7 mt-10 -90.11 122.09 32.76 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.254 -0.43 . . . . 0.0 110.271 178.681 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' D' D ' 14' ' ' LEU . . . . . . . . . . . . . 23.1 mt -98.07 154.34 37.77 Favored Pre-proline 0 CA--C 1.532 0.265 0 CA-C-N 116.283 -0.417 . . . . 0.0 111.174 -177.874 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' D' D ' 15' ' ' PRO . . . . . . . . . . . . . 36.6 Cg_exo -59.35 162.29 14.88 Favored 'Trans proline' 0 N--CA 1.496 1.669 0 C-N-CA 121.4 1.4 . . . . 0.0 112.079 178.581 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' D' D ' 16' ' ' PRO . . . . . . . . . . . . . 23.7 Cg_exo -63.01 -41.42 28.83 Favored 'Trans proline' 0 N--CA 1.497 1.703 0 C-N-CA 121.493 1.462 . . . . 0.0 112.815 -179.175 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' D' D ' 17' ' ' ASP . . . . . . . . . . . . . 22.8 p-10 -82.91 9.53 9.81 Favored 'General case' 0 CA--C 1.537 0.47 0 N-CA-C 113.241 0.83 . . . . 0.0 113.241 -176.859 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' D' D ' 18' ' ' PHE . . . . . . . . . . . . . 29.3 t80 -56.98 -41.81 79.09 Favored 'General case' 0 C--N 1.334 -0.09 0 O-C-N 121.986 -0.446 . . . . 0.0 110.369 -179.562 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' D' D ' 19' ' ' VAL . . . . . . . . . . . . . 46.5 t -56.23 -44.44 79.35 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.252 0 CA-C-N 116.327 -0.397 . . . . 0.0 110.599 -179.379 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' D' D ' 20' ' ' ASP . . . . . . . . . . . . . 41.6 m-20 -59.81 -41.26 90.87 Favored 'General case' 0 C--N 1.33 -0.247 0 C-N-CA 120.84 -0.344 . . . . 0.0 110.943 -178.091 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' D' D ' 21' ' ' VAL . . . . . . . . . . . . . 47.2 t -63.66 -47.54 90.78 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 C-N-CA 120.759 -0.377 . . . . 0.0 110.494 -178.357 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' D' D ' 22' ' ' ILE . . . . . 0.667 HG22 HD12 ' D' ' 26' ' ' LEU . 49.8 mm -54.78 -47.28 74.55 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.273 0 C-N-CA 120.97 -0.292 . . . . 0.0 110.798 178.907 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' D' D ' 23' ' ' ARG . . . . . . . . . . . . . 53.2 ttp180 -53.74 -52.0 61.55 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-O 120.609 0.242 . . . . 0.0 111.533 -178.953 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' D' D ' 24' ' ' ILE . . . . . . . . . . . . . 76.7 mt -58.61 -41.26 81.6 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.377 0 CA-C-N 116.749 -0.205 . . . . 0.0 111.367 -176.339 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' D' D ' 25' ' ' LYS . . . . . . . . . . . . . 73.0 mmtt -68.4 -42.29 79.23 Favored 'General case' 0 C--N 1.329 -0.292 0 N-CA-C 112.277 0.473 . . . . 0.0 112.277 -178.338 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' D' D ' 26' ' ' LEU . . . . . 0.667 HD12 HG22 ' D' ' 22' ' ' ILE . 33.1 mt -80.47 -34.31 35.99 Favored 'General case' 0 C--N 1.33 -0.258 0 N-CA-C 113.661 0.986 . . . . 0.0 113.661 -169.41 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' D' D ' 27' ' ' GLN . . . . . . . . . . . . . 9.1 pt20 -46.1 139.71 4.34 Favored 'General case' 0 N--CA 1.469 0.489 0 N-CA-C 112.853 0.686 . . . . 0.0 112.853 -175.17 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' D' D ' 28' ' ' GLY . . . . . . . . . . . . . . . 101.05 -27.01 22.54 Favored Glycine 0 CA--C 1.532 1.144 0 CA-C-N 115.657 -0.701 . . . . 0.0 112.163 -175.99 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' D' D ' 29' ' ' LYS . . . . . . . . . . . . . 64.9 mttp -97.65 155.09 17.15 Favored 'General case' 0 C--O 1.233 0.226 0 CA-C-N 117.336 0.568 . . . . 0.0 110.986 178.751 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' D' D ' 30' ' ' THR . . . . . . . . . . . . . 40.1 m -106.77 140.63 39.32 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.232 -0.44 . . . . 0.0 110.151 177.251 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' D' D ' 31' ' ' VAL . . . . . . . . . . . . . 34.9 m -128.22 156.12 40.21 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.19 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.851 -179.125 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' D' D ' 32' ' ' ARG . . . . . . . . . . . . . 67.3 ttt180 -131.65 147.0 52.48 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 115.974 -0.557 . . . . 0.0 110.314 178.285 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' D' D ' 33' ' ' THR . . . . . . . . . . . . . 22.8 m -52.52 139.22 25.94 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-O 120.762 0.315 . . . . 0.0 111.502 -178.329 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' D' D ' 34' ' ' GLY . . . . . . . . . . . . . . . 99.67 -17.05 58.07 Favored Glycine 0 CA--C 1.533 1.159 0 CA-C-O 119.762 -0.466 . . . . 0.0 113.32 179.26 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' D' D ' 35' ' ' ASP . . . . . . . . . . . . . 76.7 m-20 -66.44 149.24 50.72 Favored 'General case' 0 N--CA 1.46 0.074 0 CA-C-N 117.992 0.896 . . . . 0.0 111.17 179.787 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' D' D ' 36' ' ' VAL . . . . . . . . . . . . . 45.6 t -120.18 128.9 76.0 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.202 0 CA-C-N 115.749 -0.66 . . . . 0.0 109.687 177.439 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' D' D ' 37' ' ' ILE . . . . . . . . . . . . . 64.1 mt -121.37 138.85 50.38 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.229 0 CA-C-N 116.194 -0.457 . . . . 0.0 109.889 -179.145 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' D' D ' 38' ' ' GLY . . . . . . . . . . . . . . . -117.97 128.87 7.97 Favored Glycine 0 CA--C 1.526 0.749 0 N-CA-C 110.97 -0.852 . . . . 0.0 110.97 -179.943 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' D' D ' 39' ' ' ILE . . . . . . . . . . . . . 71.5 mt -128.05 129.83 69.64 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.198 0 N-CA-C 110.036 -0.357 . . . . 0.0 110.036 178.815 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' D' D ' 40' ' ' SER . . . . . . . . . . . . . 87.2 p -92.16 123.73 35.72 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.267 -0.424 . . . . 0.0 110.861 176.804 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' D' D ' 41' ' ' ILE . . . . . . . . . . . . . 71.9 mt -134.14 121.04 36.83 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.263 0 CA-C-O 120.993 0.425 . . . . 0.0 110.278 177.82 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' D' D ' 42' ' ' LEU . . . . . 0.546 HD23 ' O ' ' D' ' 42' ' ' LEU . 1.3 tt 57.81 44.78 19.66 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-O 121.42 0.629 . . . . 0.0 110.187 178.46 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' D' D ' 43' ' ' GLY . . . . . . . . . . . . . . . 72.36 -5.75 13.89 Favored Glycine 0 CA--C 1.534 1.276 0 C-N-CA 121.146 -0.549 . . . . 0.0 113.644 175.897 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' D' D ' 44' ' ' LYS . . . . . . . . . . . . . 22.9 tptm -109.27 126.05 52.93 Favored 'General case' 0 N--CA 1.462 0.129 0 CA-C-N 118.141 0.971 . . . . 0.0 110.183 -178.908 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' D' D ' 45' ' ' GLU . . . . . . . . . . . . . 43.6 tp10 -84.69 130.31 34.72 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-O 120.816 0.341 . . . . 0.0 111.124 -179.482 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' D' D ' 46' ' ' VAL . . . . . . . . . . . . . 10.3 p -120.3 126.99 75.86 Favored 'Isoleucine or valine' 0 N--CA 1.462 0.167 0 N-CA-C 109.818 -0.438 . . . . 0.0 109.818 175.25 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' D' D ' 47' ' ' LYS . . . . . . . . . . . . . 86.4 mttt -99.09 126.16 44.77 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 115.912 -0.585 . . . . 0.0 110.931 178.248 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' D' D ' 48' ' ' PHE . . . . . . . . . . . . . 34.2 m-85 -111.43 131.97 54.8 Favored 'General case' 0 C--N 1.331 -0.207 0 N-CA-C 109.812 -0.44 . . . . 0.0 109.812 177.665 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' D' D ' 49' ' ' LYS . . . . . . . . . . . . . 38.4 tttp -107.71 132.15 53.66 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.362 -0.381 . . . . 0.0 110.274 177.655 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' D' D ' 50' ' ' VAL . . . . . . . . . . . . . 45.5 t -76.56 104.11 4.38 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.332 0 N-CA-C 109.361 -0.607 . . . . 0.0 109.361 177.06 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' D' D ' 51' ' ' VAL . . . . . . . . . . . . . 47.5 t -69.48 -53.2 26.11 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.341 0 N-CA-C 109.554 -0.536 . . . . 0.0 109.554 -175.692 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' D' D ' 52' ' ' GLN . . . . . . . . . . . . . 81.8 mt-30 -154.86 152.45 29.79 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.053 -0.522 . . . . 0.0 111.677 -178.381 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' D' D ' 53' ' ' ALA . . . . . 0.44 ' HB3' ' OG ' ' D' ' 56' ' ' SER . . . -129.29 133.29 47.4 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 115.361 -0.836 . . . . 0.0 109.703 175.539 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' D' D ' 54' ' ' TYR . . . . . . . . . . . . . 45.8 t80 -129.0 109.69 18.28 Favored Pre-proline 0 CA--C 1.535 0.397 0 CA-C-O 118.162 -0.923 . . . . 0.0 110.463 179.217 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' D' D ' 55' ' ' PRO . . . . . . . . . . . . . 73.7 Cg_endo -77.17 167.47 79.58 Favored 'Cis proline' 0 N--CA 1.5 1.871 0 CA-C-N 121.808 1.681 . . . . 0.0 112.103 -6.676 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' D' D ' 56' ' ' SER . . . . . 0.44 ' OG ' ' HB3' ' D' ' 53' ' ' ALA . 62.7 m -117.41 133.04 23.27 Favored Pre-proline 0 CA--C 1.54 0.567 0 CA-C-O 118.437 -0.792 . . . . 0.0 109.458 174.803 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' D' D ' 57' ' ' PRO . . . . . . . . . . . . . 38.4 Cg_endo -67.7 164.5 72.51 Favored 'Cis proline' 0 N--CA 1.498 1.774 0 CA-C-N 121.881 1.707 . . . . 0.0 111.433 -1.407 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' D' D ' 58' ' ' LEU . . . . . . . . . . . . . 24.0 tp -130.73 138.05 49.8 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 116.321 -0.399 . . . . 0.0 110.612 -179.478 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' D' D ' 59' ' ' ARG . . . . . . . . . . . . . 56.7 ttp180 -103.24 127.96 50.4 Favored 'General case' 0 C--N 1.328 -0.342 0 N-CA-C 109.362 -0.607 . . . . 0.0 109.362 174.882 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' D' D ' 60' ' ' VAL . . . . . . . . . . . . . 43.5 t -78.48 119.47 27.57 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.28 0 C-N-CA 120.75 -0.38 . . . . 0.0 110.836 -174.591 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' D' D ' 61' ' ' GLU . . . . . . . . . . . . . 15.6 mm-40 -131.09 161.33 32.31 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 115.729 -0.669 . . . . 0.0 109.666 175.378 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' D' D ' 62' ' ' ASP . . . . . . . . . . . . . 54.0 m-20 -52.6 -31.65 37.51 Favored 'General case' 0 C--N 1.328 -0.343 0 N-CA-C 112.085 0.402 . . . . 0.0 112.085 -178.252 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' D' D ' 63' ' ' ARG . . . . . . . . . . . . . 79.7 mtp180 -73.2 -21.91 60.57 Favored 'General case' 0 CA--C 1.532 0.256 0 N-CA-C 112.949 0.722 . . . . 0.0 112.949 -175.41 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' D' D ' 64' ' ' THR . . . . . . . . . . . . . 25.7 m -69.31 139.96 54.33 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-O 120.951 0.405 . . . . 0.0 110.965 -175.752 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' D' D ' 65' ' ' LYS . . . . . . . . . . . . . 67.5 mttm -89.34 132.14 35.09 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 115.945 -0.57 . . . . 0.0 110.134 178.341 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' D' D ' 66' ' ' ILE . . . . . . . . . . . . . 62.7 mt -117.51 129.52 73.85 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.261 0 N-CA-C 109.893 -0.41 . . . . 0.0 109.893 179.446 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' D' D ' 67' ' ' THR . . . . . . . . . . . . . 25.5 m -122.86 137.47 54.93 Favored 'General case' 0 C--N 1.332 -0.181 0 CA-C-N 116.128 -0.487 . . . . 0.0 110.769 -178.872 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' D' D ' 68' ' ' LEU . . . . . . . . . . . . . 14.9 tp . . . . . 0 C--N 1.33 -0.241 0 CA-C-N 115.964 -0.562 . . . . 0.0 110.348 178.805 . . . . . . . . 0 0 . 1 . 009 nuclear nobuild core ' D' D ' 73' ' ' VAL . . . . . . . . . . . . . 30.3 m . . . . . 0 C--O 1.231 0.128 0 CA-C-O 120.936 0.398 . . . . 0.0 110.404 . . . . . . . . . 0 0 . 1 . 009 nuclear nobuild core ' D' D ' 74' ' ' ASP . . . . . . . . . . . . . 15.2 t0 -97.04 124.46 41.04 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 115.997 -0.547 . . . . 0.0 109.59 178.905 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' D' D ' 75' ' ' VAL . . . . . . . . . . . . . 41.9 t -116.75 125.29 73.62 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.211 0 CA-C-O 121.091 0.472 . . . . 0.0 110.891 -175.29 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' D' D ' 76' ' ' LEU . . . . . . . . . . . . . 5.7 mp -125.73 144.71 50.5 Favored 'General case' 0 C--N 1.331 -0.205 0 CA-C-N 115.704 -0.68 . . . . 0.0 109.55 173.896 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' D' D ' 77' ' ' GLU . . . . . . . . . . . . . 98.0 mt-10 -133.52 131.03 39.31 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-O 120.961 0.41 . . . . 0.0 111.007 -177.666 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' D' D ' 78' ' ' ALA . . . . . . . . . . . . . . . -116.13 130.95 57.04 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 115.833 -0.621 . . . . 0.0 109.697 177.516 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' D' D ' 79' ' ' LYS . . . . . 0.614 ' O ' HD13 ' D' ' 80' ' ' ILE . 88.1 mttt -77.34 123.85 27.07 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-O 120.854 0.359 . . . . 0.0 110.906 -177.059 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' D' D ' 80' ' ' ILE . . . . . 0.614 HD13 ' O ' ' D' ' 79' ' ' LYS . 39.5 mm -139.1 114.4 8.56 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.277 0 N-CA-C 109.309 -0.626 . . . . 0.0 109.309 -177.858 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' D' D ' 81' ' ' LYS . . . . . . . . . . . . . 69.3 mttm -100.48 118.93 37.68 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-O 120.793 0.33 . . . . 0.0 111.245 -177.234 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' D' D ' 82' ' ' GLY . . . . . . . . . . . . . . . 89.17 42.22 5.64 Favored Glycine 0 CA--C 1.526 0.738 0 C-N-CA 120.668 -0.777 . . . . 0.0 111.989 172.888 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' D' D ' 83' ' ' ILE . . . . . . . . . . . . . 72.3 mt -61.99 135.92 25.97 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.341 0 N-CA-C 109.835 -0.431 . . . . 0.0 109.835 176.434 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' D' D ' 84' ' ' LYS . . . . . . . . . . . . . 15.5 ttmm -95.21 -51.45 4.61 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-O 121.118 0.485 . . . . 0.0 109.744 179.115 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' D' D ' 85' ' ' ASP . . . . . . . . . . . . . 7.5 t70 -158.38 154.9 27.73 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 115.548 -0.751 . . . . 0.0 110.145 179.105 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' D' D ' 86' ' ' VAL . . . . . . . . . . . . . 44.4 t -130.56 133.98 62.81 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.176 0 CA-C-O 121.055 0.455 . . . . 0.0 110.459 -179.436 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' D' D ' 87' ' ' ILE . . . . . . . . . . . . . 44.3 mm -119.25 125.72 74.7 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.253 0 CA-C-N 115.653 -0.703 . . . . 0.0 109.664 177.657 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' D' D ' 88' ' ' LEU . . . . . . . . . . . . . 14.2 tp -108.14 127.17 53.58 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.299 -0.409 . . . . 0.0 110.848 -178.331 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' D' D ' 89' ' ' ASP . . . . . . . . . . . . . 13.6 t70 -121.22 154.41 36.32 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.002 -0.545 . . . . 0.0 109.843 178.23 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' D' D ' 90' ' ' GLU . . . . . . . . . . . . . 82.3 tt0 -46.32 -37.58 7.61 Favored 'General case' 0 C--N 1.33 -0.271 0 N-CA-C 113.079 0.77 . . . . 0.0 113.079 -172.754 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' D' D ' 91' ' ' ASN . . . . . . . . . . . . . 13.4 t-20 -132.0 22.02 4.53 Favored 'General case' 0 N--CA 1.469 0.477 0 N-CA-C 112.779 0.659 . . . . 0.0 112.779 -177.446 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' D' D ' 92' ' ' LEU . . . . . . . . . . . . . 19.9 mt -150.49 144.15 25.19 Favored 'General case' 0 C--N 1.331 -0.204 0 CA-C-O 120.773 0.321 . . . . 0.0 110.269 -176.59 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' D' D ' 93' ' ' ILE . . . . . . . . . . . . . 74.6 mt -121.78 115.08 45.33 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.276 0 N-CA-C 109.168 -0.678 . . . . 0.0 109.168 176.944 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' D' D ' 94' ' ' VAL . . . . . . . . . . . . . 46.8 t -118.06 127.04 75.32 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.217 0 CA-C-O 121.071 0.462 . . . . 0.0 110.111 -177.883 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' D' D ' 95' ' ' VAL . . . . . . . . . . . . . 41.1 t -121.42 134.55 64.41 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.277 0 CA-C-N 115.769 -0.651 . . . . 0.0 109.772 -179.678 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' D' D ' 96' ' ' ILE . . . . . . . . . . . . . 63.4 mt -113.57 127.58 70.84 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.287 0 N-CA-C 109.209 -0.663 . . . . 0.0 109.209 178.381 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' D' D ' 97' ' ' THR . . . . . . . . . . . . . 59.9 p -101.44 156.15 17.63 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-O 121.289 0.566 . . . . 0.0 111.379 -177.106 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' D' D ' 98' ' ' GLU . . . . . . . . . . . . . 45.5 tp10 -53.81 -26.65 25.1 Favored 'General case' 0 CA--C 1.533 0.32 0 CA-C-N 116.009 -0.542 . . . . 0.0 112.075 179.309 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' D' D ' 99' ' ' GLU . . . . . . . . . . . . . 96.7 mt-10 -79.97 17.49 0.96 Allowed 'General case' 0 CA--C 1.534 0.357 0 N-CA-C 113.084 0.772 . . . . 0.0 113.084 -177.217 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' D' D ' 100' ' ' ASN . . . . . . . . . . . . . 2.7 m-20 62.41 37.65 13.45 Favored 'General case' 0 C--O 1.233 0.19 0 CA-C-O 121.004 0.43 . . . . 0.0 110.959 177.456 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' D' D ' 101' ' ' GLU . . . . . . . . . . . . . 84.5 tt0 -116.27 143.64 45.26 Favored 'General case' 0 C--N 1.332 -0.173 0 CA-C-N 116.22 -0.445 . . . . 0.0 109.864 177.356 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' D' D ' 102' ' ' VAL . . . . . . . . . . . . . 45.3 t -114.93 124.37 71.52 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.267 0 CA-C-N 116.103 -0.499 . . . . 0.0 109.842 -179.122 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' D' D ' 103' ' ' LEU . . . . . . . . . . . . . 30.9 mt -115.88 131.31 56.98 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-N 115.815 -0.63 . . . . 0.0 110.464 178.075 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' D' D ' 104' ' ' ILE . . . . . 0.51 HD13 HG11 ' D' ' 130' ' ' VAL . 68.9 mt -120.77 120.1 61.49 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.302 0 N-CA-C 110.268 -0.271 . . . . 0.0 110.268 179.425 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' D' D ' 105' ' ' PHE . . . . . . . . . . . . . 59.1 m-85 -121.64 166.95 13.49 Favored 'General case' 0 C--N 1.333 -0.149 0 O-C-N 123.886 0.741 . . . . 0.0 110.043 178.494 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' D' D ' 106' ' ' ASN . . . . . . . . . . . . . 45.2 p-10 -104.1 -170.63 1.8 Allowed 'General case' 0 CA--C 1.531 0.227 0 N-CA-C 110.088 -0.338 . . . . 0.0 110.088 173.187 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' D' D ' 107' ' ' GLN . . . . . . . . . . . . . 63.3 tt0 -57.56 -29.77 64.69 Favored 'General case' 0 C--N 1.33 -0.255 0 N-CA-C 112.071 0.396 . . . . 0.0 112.071 179.338 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' D' D ' 108' ' ' ASN . . . . . . . . . . . . . 10.8 t30 -87.3 12.62 11.46 Favored 'General case' 0 CA--C 1.536 0.415 0 N-CA-C 113.045 0.757 . . . . 0.0 113.045 -176.295 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' D' D ' 109' ' ' LEU . . . . . . . . . . . . . 24.9 mt 55.1 36.75 27.66 Favored 'General case' 0 CA--C 1.528 0.132 0 CA-C-O 120.943 0.401 . . . . 0.0 111.43 178.665 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' D' D ' 110' ' ' GLU . . . . . . . . . . . . . 95.8 mt-10 -102.28 148.86 24.93 Favored 'General case' 0 C--N 1.33 -0.251 0 N-CA-C 109.689 -0.485 . . . . 0.0 109.689 175.917 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' D' D ' 111' ' ' GLU . . . . . . . . . . . . . 79.9 tt0 -79.34 122.0 25.82 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.339 -0.392 . . . . 0.0 110.565 -178.027 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' D' D ' 112' ' ' LEU . . . . . . . . . . . . . 43.4 mt -109.05 -46.01 3.67 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-N 116.128 -0.487 . . . . 0.0 110.245 178.677 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' D' D ' 113' ' ' TYR . . . . . . . . . . . . . 60.3 t80 -140.94 137.49 33.14 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.32 -0.4 . . . . 0.0 111.147 -179.959 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' D' D ' 114' ' ' ARG . . . . . . . . . . . . . 68.5 ttp85 -140.72 119.25 12.3 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 115.881 -0.6 . . . . 0.0 109.98 177.377 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' D' D ' 115' ' ' GLY . . . . . . . . . . . . . . . -150.08 151.13 23.24 Favored Glycine 0 CA--C 1.523 0.588 0 N-CA-C 110.919 -0.872 . . . . 0.0 110.919 179.554 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' D' D ' 116' ' ' LYS . . . . . . . . . . . . . 35.2 ttmt -124.29 140.0 53.38 Favored 'General case' 0 C--N 1.329 -0.298 0 N-CA-C 109.968 -0.382 . . . . 0.0 109.968 177.449 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' D' D ' 117' ' ' PHE . . . . . . . . . . . . . 28.9 m-85 -136.16 118.89 16.08 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.04 -176.232 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' D' D ' 118' ' ' GLU . . . . . . . . . . . . . 96.1 mt-10 -53.45 -46.55 69.91 Favored 'General case' 0 C--N 1.33 -0.278 0 C-N-CA 121.041 -0.264 . . . . 0.0 111.307 -177.88 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' D' D ' 119' ' ' ASN . . . . . . . . . . . . . 24.3 m120 -95.87 31.04 2.19 Favored 'General case' 0 C--N 1.331 -0.216 0 CA-C-N 116.149 -0.478 . . . . 0.0 112.198 -175.891 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' D' D ' 120' ' ' LEU . . . . . . . . . . . . . 19.4 tp -57.59 122.04 11.78 Favored 'General case' 0 C--O 1.231 0.123 0 N-CA-C 110.077 -0.342 . . . . 0.0 110.077 177.271 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' D' D ' 121' ' ' ASN . . . . . . . . . . . . . 29.2 t-20 -113.56 -44.0 3.26 Favored 'General case' 0 C--O 1.233 0.199 0 CA-C-N 116.683 -0.235 . . . . 0.0 111.329 -175.37 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' D' D ' 122' ' ' LYS . . . . . . . . . . . . . 34.7 ttmt -150.98 141.81 22.85 Favored 'General case' 0 C--N 1.331 -0.201 0 C-N-CA 120.513 -0.475 . . . . 0.0 111.703 -177.457 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' D' D ' 123' ' ' VAL . . . . . . . . . . . . . 46.5 t -119.57 127.87 75.87 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.231 0 N-CA-C 108.972 -0.751 . . . . 0.0 108.972 173.539 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' D' D ' 124' ' ' LEU . . . . . . . . . . . . . 17.7 tp -127.16 140.72 52.05 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-O 120.867 0.365 . . . . 0.0 110.924 -175.506 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' D' D ' 125' ' ' VAL . . . . . 0.585 HG12 HG23 ' D' ' 130' ' ' VAL . 35.6 m -126.82 140.91 47.65 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.276 0 CA-C-N 116.065 -0.516 . . . . 0.0 110.629 179.787 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' D' D ' 126' ' ' ARG . . . . . . . . . . . . . 47.7 ttt180 -159.34 134.08 7.98 Favored 'General case' 0 C--N 1.329 -0.318 0 N-CA-C 109.53 -0.544 . . . . 0.0 109.53 178.287 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' D' D ' 127' ' ' ASN . . . . . . . . . . . . . 1.6 t-20 56.68 -154.0 0.35 Allowed 'General case' 0 CA--C 1.537 0.47 0 N-CA-C 109.588 -0.523 . . . . 0.0 109.588 -178.333 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' D' D ' 128' ' ' ASP . . . . . . . . . . . . . 13.7 p-10 -84.99 20.7 1.79 Allowed 'General case' 0 CA--C 1.535 0.381 0 CA-C-N 118.433 0.561 . . . . 0.0 112.346 177.178 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' D' D ' 129' ' ' LEU . . . . . . . . . . . . . 59.1 mt -122.87 150.3 43.07 Favored 'General case' 0 C--O 1.233 0.228 0 O-C-N 122.119 -0.363 . . . . 0.0 110.307 -179.699 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' D' D ' 130' ' ' VAL . . . . . 0.585 HG23 HG12 ' D' ' 125' ' ' VAL . 12.9 p -134.46 147.15 30.07 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.205 0 CA-C-O 120.891 0.377 . . . . 0.0 110.412 -179.16 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' D' D ' 131' ' ' VAL . . . . . . . . . . . . . 14.9 p -136.23 142.84 37.48 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.211 0 CA-C-O 121.121 0.486 . . . . 0.0 110.904 -179.528 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' D' D ' 132' ' ' ILE . . . . . . . . . . . . . 72.4 mt -115.63 131.41 68.09 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.231 0 CA-C-N 115.689 -0.687 . . . . 0.0 109.374 178.333 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' D' D ' 133' ' ' ILE . . . . . . . . . . . . . 42.5 mm -115.61 124.23 71.85 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.307 0 CA-C-O 120.878 0.371 . . . . 0.0 110.911 -175.597 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' D' D ' 134' ' ' ASP . . . . . . . . . . . . . 10.3 p-10 -137.46 146.33 44.17 Favored 'General case' 0 C--N 1.331 -0.201 0 CA-C-N 116.103 -0.499 . . . . 0.0 109.762 174.294 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' D' D ' 135' ' ' GLU . . . . . . . . . . . . . 84.9 tt0 -49.87 -25.95 3.63 Favored 'General case' 0 C--N 1.329 -0.309 0 N-CA-C 112.776 0.658 . . . . 0.0 112.776 -173.798 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' D' D ' 136' ' ' GLN . . . . . . . . . . . . . 48.0 tt0 -81.91 -34.04 30.12 Favored 'General case' 0 C--N 1.331 -0.231 0 N-CA-C 111.939 0.348 . . . . 0.0 111.939 -175.828 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' D' D ' 137' ' ' LYS . . . . . . . . . . . . . 53.7 pttt -167.78 175.3 6.99 Favored 'General case' 0 C--N 1.331 -0.223 0 CA-C-O 121.561 0.696 . . . . 0.0 112.079 -173.396 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' D' D ' 138' ' ' LEU . . . . . 0.454 HD23 ' N ' ' D' ' 139' ' ' THR . 5.5 tt -119.2 129.6 55.05 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 115.095 -0.957 . . . . 0.0 109.853 179.07 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' D' D ' 139' ' ' THR . . . . . 0.454 ' N ' HD23 ' D' ' 138' ' ' LEU . 39.1 m -112.49 124.22 52.02 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.289 -0.414 . . . . 0.0 110.353 178.829 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' D' D ' 140' ' ' LEU . . . . . . . . . . . . . 31.7 tp -112.07 124.97 53.57 Favored 'General case' 0 C--N 1.327 -0.378 0 N-CA-C 109.186 -0.672 . . . . 0.0 109.186 -178.663 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' D' D ' 141' ' ' ILE . . . . . 0.416 ' HB ' HG13 ' D' ' 130' ' ' VAL . 19.7 mt -121.99 117.16 51.44 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.292 0 CA-C-O 120.954 0.406 . . . . 0.0 109.983 -173.071 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' D' D ' 142' ' ' ARG . . . . . . . . . . . . . 78.6 mtp180 -107.11 125.26 50.83 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-N 115.382 -0.826 . . . . 0.0 110.445 -177.35 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' D' D ' 143' ' ' THR . . . . . . . . . . . . . 25.4 p . . . . . 0 C--O 1.219 -0.544 0 CA-C-O 118.004 -0.998 . . . . 0.0 110.61 -179.748 . . . . . . . . 0 0 . 1 . 009 nuclear nobuild core ' E' E ' 2' ' ' SER . . . . . . . . . . . . . 2.0 p . . . . . 0 C--O 1.233 0.207 0 CA-C-O 121.014 0.435 . . . . 0.0 110.67 . . . . . . . . . 0 0 . 1 . 009 nuclear nobuild core ' E' E ' 3' ' ' GLU . . . . . . . . . . . . . 66.3 tt0 -144.87 142.52 29.98 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-N 115.794 -0.639 . . . . 0.0 111.251 -175.29 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' E' E ' 4' ' ' LEU . . . . . . . . . . . . . 15.9 tp -123.37 135.0 53.94 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 115.918 -0.583 . . . . 0.0 110.001 175.583 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' E' E ' 5' ' ' LYS . . . . . . . . . . . . . 89.9 mttt -115.42 121.98 44.41 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.581 -0.281 . . . . 0.0 110.89 -179.125 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' E' E ' 6' ' ' LEU . . . . . . . . . . . . . 69.4 mt -114.48 145.93 41.3 Favored 'General case' 0 C--N 1.331 -0.225 0 CA-C-N 115.808 -0.633 . . . . 0.0 110.19 178.227 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' E' E ' 7' ' ' LYS . . . . . . . . . . . . . 26.3 ttpp -127.76 142.58 44.69 Favored Pre-proline 0 CA--C 1.533 0.323 0 CA-C-O 119.129 -0.462 . . . . 0.0 109.826 175.928 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' E' E ' 8' ' ' PRO . . . . . . . . . . . . . 87.2 Cg_endo -91.04 132.49 1.54 Allowed 'Trans proline' 0 N--CA 1.489 1.234 0 C-N-CA 121.652 1.568 . . . . 0.0 111.843 178.769 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' E' E ' 9' ' ' LEU . . . . . . . . . . . . . 71.6 mt -71.0 -47.17 14.73 Favored Pre-proline 0 CA--C 1.534 0.331 0 CA-C-O 118.663 -0.684 . . . . 0.0 112.111 -179.696 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' E' E ' 10' ' ' PRO . . . . . . . . . . . . . 98.3 Cg_endo -79.96 155.95 23.37 Favored 'Trans proline' 0 N--CA 1.495 1.614 0 C-N-CA 121.106 1.204 . . . . 0.0 111.878 175.573 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' E' E ' 11' ' ' LYS . . . . . . . . . . . . . 62.4 mttp -88.14 96.03 10.38 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-O 120.774 0.321 . . . . 0.0 110.695 179.696 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' E' E ' 12' ' ' VAL . . . . . . . . . . . . . 12.5 p -143.35 147.01 20.74 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.248 0 CA-C-N 116.231 -0.44 . . . . 0.0 110.37 179.228 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' E' E ' 13' ' ' GLU . . . . . . . . . . . . . 84.8 tt0 -92.06 123.59 35.53 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.321 -0.399 . . . . 0.0 110.276 179.175 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' E' E ' 14' ' ' LEU . . . . . . . . . . . . . 41.7 mt -97.9 149.01 35.28 Favored Pre-proline 0 CA--C 1.533 0.307 0 CA-C-O 119.352 -0.356 . . . . 0.0 110.6 -178.099 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' E' E ' 15' ' ' PRO . . . . . . . . . . . . . 26.1 Cg_exo -62.08 157.57 43.58 Favored 'Trans proline' 0 N--CA 1.498 1.751 0 C-N-CA 121.349 1.366 . . . . 0.0 111.906 177.412 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' E' E ' 16' ' ' PRO . . . . . . . . . . . . . 34.0 Cg_exo -59.36 -37.85 87.89 Favored 'Trans proline' 0 N--CA 1.498 1.758 0 C-N-CA 121.49 1.46 . . . . 0.0 112.875 -179.228 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' E' E ' 17' ' ' ASP . . . . . . . . . . . . . 18.2 p-10 -79.43 1.86 23.95 Favored 'General case' 0 CA--C 1.538 0.499 0 N-CA-C 113.327 0.862 . . . . 0.0 113.327 -177.34 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' E' E ' 18' ' ' PHE . . . . . . . . . . . . . 46.9 t80 -57.61 -47.18 82.88 Favored 'General case' 0 N--CA 1.458 -0.074 0 O-C-N 121.97 -0.456 . . . . 0.0 110.142 -178.605 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' E' E ' 19' ' ' VAL . . . . . 0.41 HG13 ' N ' ' E' ' 20' ' ' ASP . 13.8 p -55.34 -41.49 62.11 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.319 0 CA-C-N 116.26 -0.427 . . . . 0.0 111.095 -178.553 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' E' E ' 20' ' ' ASP . . . . . 0.41 ' N ' HG13 ' E' ' 19' ' ' VAL . 9.5 t0 -60.44 -43.16 97.11 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-O 120.925 0.393 . . . . 0.0 110.899 -177.977 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' E' E ' 21' ' ' VAL . . . . . . . . . . . . . 47.2 t -64.34 -45.98 94.45 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.287 0 CA-C-N 116.272 -0.422 . . . . 0.0 110.496 -178.177 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' E' E ' 22' ' ' ILE . . . . . 0.62 HG22 HD12 ' E' ' 26' ' ' LEU . 50.2 mm -54.63 -47.09 73.05 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.287 0 CA-C-O 120.676 0.275 . . . . 0.0 110.753 178.809 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' E' E ' 23' ' ' ARG . . . . . . . . . . . . . 25.1 ttm-85 -53.3 -54.17 40.28 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-O 121.258 0.551 . . . . 0.0 111.677 179.963 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' E' E ' 24' ' ' ILE . . . . . . . . . . . . . 76.4 mt -61.0 -36.52 72.94 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.38 0 CA-C-N 115.67 -0.696 . . . . 0.0 111.59 -172.857 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' E' E ' 25' ' ' LYS . . . . . . . . . . . . . 64.1 mttm -75.22 -40.66 58.91 Favored 'General case' 0 C--N 1.33 -0.267 0 N-CA-C 112.349 0.5 . . . . 0.0 112.349 -178.855 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' E' E ' 26' ' ' LEU . . . . . 0.62 HD12 HG22 ' E' ' 22' ' ' ILE . 75.9 mt -80.22 -25.64 39.52 Favored 'General case' 0 C--N 1.331 -0.201 0 N-CA-C 113.195 0.813 . . . . 0.0 113.195 -171.112 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' E' E ' 27' ' ' GLN . . . . . . . . . . . . . 4.2 pt20 -46.38 136.67 7.1 Favored 'General case' 0 N--CA 1.469 0.495 0 N-CA-C 112.594 0.59 . . . . 0.0 112.594 -177.368 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' E' E ' 28' ' ' GLY . . . . . . . . . . . . . . . 99.8 -21.06 46.67 Favored Glycine 0 CA--C 1.535 1.305 0 CA-C-N 115.824 -0.626 . . . . 0.0 112.661 -177.162 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' E' E ' 29' ' ' LYS . . . . . . . . . . . . . 61.1 mttp -97.02 155.14 16.91 Favored 'General case' 0 C--O 1.233 0.218 0 CA-C-N 117.471 0.636 . . . . 0.0 110.935 179.492 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' E' E ' 30' ' ' THR . . . . . . . . . . . . . 28.5 m -108.65 137.45 46.57 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.042 -0.526 . . . . 0.0 110.031 176.748 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' E' E ' 31' ' ' VAL . . . . . . . . . . . . . 35.3 m -130.35 152.77 37.98 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.223 0 CA-C-O 120.919 0.39 . . . . 0.0 110.778 -178.751 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' E' E ' 32' ' ' ARG . . . . . . . . . . . . . 37.9 ttm180 -133.23 148.23 51.99 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-O 121.246 0.546 . . . . 0.0 110.398 179.568 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' E' E ' 33' ' ' THR . . . . . . . . . . . . . 16.4 m -52.11 139.33 23.49 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.244 -0.434 . . . . 0.0 111.624 -177.145 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' E' E ' 34' ' ' GLY . . . . . . . . . . . . . . . 101.03 -17.24 56.45 Favored Glycine 0 CA--C 1.534 1.235 0 CA-C-O 119.667 -0.519 . . . . 0.0 113.201 179.051 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' E' E ' 35' ' ' ASP . . . . . . . . . . . . . 79.2 m-20 -66.78 147.3 53.43 Favored 'General case' 0 N--CA 1.462 0.163 0 CA-C-N 118.026 0.913 . . . . 0.0 111.229 179.25 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' E' E ' 36' ' ' VAL . . . . . . . . . . . . . 45.8 t -122.51 129.1 75.49 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.204 0 CA-C-N 115.779 -0.646 . . . . 0.0 109.737 177.802 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' E' E ' 37' ' ' ILE . . . . . . . . . . . . . 63.2 mt -123.16 139.23 50.53 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.256 0 CA-C-N 116.286 -0.416 . . . . 0.0 109.953 -179.011 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' E' E ' 38' ' ' GLY . . . . . . . . . . . . . . . -115.46 128.65 8.16 Favored Glycine 0 CA--C 1.524 0.605 0 N-CA-C 110.982 -0.847 . . . . 0.0 110.982 178.661 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' E' E ' 39' ' ' ILE . . . . . . . . . . . . . 68.7 mt -126.98 125.71 67.05 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.271 0 N-CA-C 110.019 -0.363 . . . . 0.0 110.019 179.501 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' E' E ' 40' ' ' SER . . . . . . . . . . . . . 24.0 t -91.99 118.66 30.99 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.388 -0.369 . . . . 0.0 110.794 176.545 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' E' E ' 41' ' ' ILE . . . . . . . . . . . . . 70.9 mt -130.35 131.05 65.63 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.227 0 CA-C-O 120.927 0.394 . . . . 0.0 110.299 179.283 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' E' E ' 42' ' ' LEU . . . . . . . . . . . . . 47.3 mt 54.94 33.47 20.15 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-N 116.039 -0.528 . . . . 0.0 111.817 177.954 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' E' E ' 43' ' ' GLY . . . . . . . . . . . . . . . 71.77 28.99 68.03 Favored Glycine 0 CA--C 1.53 0.983 0 C-N-CA 121.075 -0.583 . . . . 0.0 112.299 178.094 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' E' E ' 44' ' ' LYS . . . . . . . . . . . . . 20.0 tptm -142.43 125.92 16.75 Favored 'General case' 0 C--N 1.331 -0.205 0 N-CA-C 109.748 -0.464 . . . . 0.0 109.748 178.46 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' E' E ' 45' ' ' GLU . . . . . . . . . . . . . 41.0 tp10 -85.21 128.6 34.74 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-O 120.843 0.354 . . . . 0.0 111.589 -177.413 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' E' E ' 46' ' ' VAL . . . . . . . . . . . . . 8.9 p -120.15 127.74 75.92 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.188 0 N-CA-C 109.525 -0.546 . . . . 0.0 109.525 174.261 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' E' E ' 47' ' ' LYS . . . . . . . . . . . . . 52.7 mtpt -98.55 124.41 43.28 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.035 -0.529 . . . . 0.0 110.792 178.01 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' E' E ' 48' ' ' PHE . . . . . . . . . . . . . 37.6 m-85 -109.27 131.82 54.7 Favored 'General case' 0 C--N 1.33 -0.265 0 N-CA-C 109.782 -0.451 . . . . 0.0 109.782 178.069 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' E' E ' 49' ' ' LYS . . . . . . . . . . . . . 76.8 tttt -108.63 132.58 53.75 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.417 -0.356 . . . . 0.0 110.344 178.009 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' E' E ' 50' ' ' VAL . . . . . . . . . . . . . 45.6 t -76.29 105.07 4.83 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.367 0 N-CA-C 109.249 -0.649 . . . . 0.0 109.249 176.087 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' E' E ' 51' ' ' VAL . . . . . . . . . . . . . 47.0 t -68.64 -53.92 24.32 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.351 0 N-CA-C 109.401 -0.592 . . . . 0.0 109.401 -175.64 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' E' E ' 52' ' ' GLN . . . . . . . . . . . . . 80.8 mt-30 -155.7 154.61 31.78 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 115.967 -0.561 . . . . 0.0 111.584 -178.163 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' E' E ' 53' ' ' ALA . . . . . . . . . . . . . . . -130.9 132.17 44.97 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 115.371 -0.831 . . . . 0.0 109.667 174.91 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' E' E ' 54' ' ' TYR . . . . . . . . . . . . . 39.7 t80 -129.07 108.92 18.1 Favored Pre-proline 0 CA--C 1.534 0.353 0 CA-C-O 118.273 -0.87 . . . . 0.0 110.421 179.892 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' E' E ' 55' ' ' PRO . . . . . . . . . . . . . 73.2 Cg_endo -77.21 169.89 72.94 Favored 'Cis proline' 0 N--CA 1.5 1.866 0 CA-C-N 121.84 1.693 . . . . 0.0 112.32 -6.428 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' E' E ' 56' ' ' SER . . . . . . . . . . . . . 13.6 m -117.22 134.71 23.03 Favored Pre-proline 0 CA--C 1.539 0.528 0 CA-C-O 118.401 -0.809 . . . . 0.0 109.45 174.031 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' E' E ' 57' ' ' PRO . . . . . . . . . . . . . 50.8 Cg_endo -70.07 146.79 83.81 Favored 'Cis proline' 0 N--CA 1.496 1.672 0 CA-C-N 121.85 1.696 . . . . 0.0 111.519 -1.379 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' E' E ' 58' ' ' LEU . . . . . . . . . . . . . 33.6 tp -107.89 138.76 43.57 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-O 120.87 0.367 . . . . 0.0 110.689 -177.838 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' E' E ' 59' ' ' ARG . . . . . . . . . . . . . 72.7 ttt180 -102.66 131.59 49.34 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 115.813 -0.63 . . . . 0.0 109.679 176.952 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' E' E ' 60' ' ' VAL . . . . . . . . . . . . . 41.7 t -86.29 118.65 33.08 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.213 0 C-N-CA 120.775 -0.37 . . . . 0.0 110.602 -177.167 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' E' E ' 61' ' ' GLU . . . . . . . . . . . . . 96.6 mt-10 -131.11 158.17 41.13 Favored 'General case' 0 C--N 1.331 -0.229 0 CA-C-N 115.874 -0.603 . . . . 0.0 109.748 177.302 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' E' E ' 62' ' ' ASP . . . . . . . . . . . . . 48.5 m-20 -52.44 -32.94 41.92 Favored 'General case' 0 C--N 1.329 -0.324 0 N-CA-C 111.816 0.302 . . . . 0.0 111.816 -178.663 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' E' E ' 63' ' ' ARG . . . . . . . . . . . . . 75.5 mtp180 -78.91 -19.96 50.53 Favored 'General case' 0 CA--C 1.533 0.301 0 N-CA-C 113.153 0.797 . . . . 0.0 113.153 -176.258 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' E' E ' 64' ' ' THR . . . . . . . . . . . . . 24.9 m -66.34 149.2 50.74 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-O 120.993 0.425 . . . . 0.0 111.117 -174.739 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' E' E ' 65' ' ' LYS . . . . . . . . . . . . . 24.6 mtpp -89.67 127.26 35.9 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 115.964 -0.562 . . . . 0.0 110.651 179.997 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' E' E ' 66' ' ' ILE . . . . . . . . . . . . . 64.1 mt -117.64 128.52 74.84 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.272 0 N-CA-C 109.842 -0.429 . . . . 0.0 109.842 177.476 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' E' E ' 67' ' ' THR . . . . . . . . . . . . . 28.8 m -120.56 137.76 54.23 Favored 'General case' 0 C--N 1.331 -0.229 0 CA-C-O 121.123 0.487 . . . . 0.0 110.928 -178.587 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' E' E ' 68' ' ' LEU . . . . . . . . . . . . . 13.3 tp . . . . . 0 C--N 1.33 -0.279 0 CA-C-N 115.706 -0.679 . . . . 0.0 110.254 178.44 . . . . . . . . 0 0 . 1 . 009 nuclear nobuild core ' E' E ' 73' ' ' VAL . . . . . . . . . . . . . 35.2 m . . . . . 0 N--CA 1.462 0.125 0 CA-C-O 120.709 0.29 . . . . 0.0 110.466 . . . . . . . . . 0 0 . 1 . 009 nuclear nobuild core ' E' E ' 74' ' ' ASP . . . . . . . . . . . . . 10.8 t70 -98.04 118.04 33.74 Favored 'General case' 0 C--N 1.33 -0.274 0 N-CA-C 109.935 -0.394 . . . . 0.0 109.935 -178.471 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' E' E ' 75' ' ' VAL . . . . . . . . . . . . . 42.0 t -112.32 122.65 66.97 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.2 0 CA-C-O 121.09 0.471 . . . . 0.0 110.369 -178.31 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' E' E ' 76' ' ' LEU . . . . . . . . . . . . . 29.9 mt -122.79 137.62 54.87 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 115.63 -0.713 . . . . 0.0 109.432 178.398 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' E' E ' 77' ' ' GLU . . . . . . . . . . . . . 96.4 mt-10 -133.27 140.3 47.39 Favored 'General case' 0 C--N 1.331 -0.217 0 CA-C-O 121.035 0.445 . . . . 0.0 111.301 -177.29 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' E' E ' 78' ' ' ALA . . . . . 0.577 ' HB2' HD21 ' E' ' 109' ' ' LEU . . . -130.12 129.62 43.76 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 115.678 -0.692 . . . . 0.0 109.957 176.377 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' E' E ' 79' ' ' LYS . . . . . 0.583 ' O ' HD13 ' E' ' 80' ' ' ILE . 32.7 mmtp -75.24 119.09 18.9 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-O 120.949 0.404 . . . . 0.0 110.58 -179.428 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' E' E ' 80' ' ' ILE . . . . . 0.583 HD13 ' O ' ' E' ' 79' ' ' LYS . 22.7 mm -139.25 112.53 6.36 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.269 0 N-CA-C 108.947 -0.76 . . . . 0.0 108.947 -178.578 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' E' E ' 81' ' ' LYS . . . . . . . . . . . . . 40.6 mttp -99.72 126.75 45.82 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-O 120.875 0.369 . . . . 0.0 111.293 -176.07 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' E' E ' 82' ' ' GLY . . . . . . . . . . . . . . . 89.11 42.21 5.66 Favored Glycine 0 CA--C 1.526 0.744 0 C-N-CA 120.989 -0.624 . . . . 0.0 111.892 174.119 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' E' E ' 83' ' ' ILE . . . . . . . . . . . . . 69.8 mt -67.93 137.99 23.5 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.34 0 N-CA-C 109.793 -0.447 . . . . 0.0 109.793 177.099 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' E' E ' 84' ' ' LYS . . . . . . . . . . . . . 70.4 tttt -100.24 -53.63 3.08 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.165 -0.471 . . . . 0.0 110.226 -178.58 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' E' E ' 85' ' ' ASP . . . . . . . . . . . . . 8.5 t70 -151.23 148.45 28.23 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 115.837 -0.619 . . . . 0.0 110.387 -178.985 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' E' E ' 86' ' ' VAL . . . . . . . . . . . . . 43.7 t -129.47 129.42 66.93 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.269 0 CA-C-O 120.928 0.394 . . . . 0.0 110.377 -179.648 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' E' E ' 87' ' ' ILE . . . . . . . . . . . . . 4.6 mp -122.19 134.28 65.93 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.255 0 CA-C-N 115.972 -0.558 . . . . 0.0 109.709 178.593 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' E' E ' 88' ' ' LEU . . . . . . . . . . . . . 10.2 tp -111.59 134.89 52.85 Favored 'General case' 0 C--N 1.331 -0.205 0 CA-C-O 121.105 0.479 . . . . 0.0 111.059 -178.206 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' E' E ' 89' ' ' ASP . . . . . . . . . . . . . 4.7 t70 -121.53 159.12 27.01 Favored 'General case' 0 C--N 1.331 -0.205 0 CA-C-N 115.651 -0.704 . . . . 0.0 109.634 177.515 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' E' E ' 90' ' ' GLU . . . . . . . . . . . . . 84.3 tt0 -44.97 -44.37 9.8 Favored 'General case' 0 N--CA 1.465 0.301 0 N-CA-C 113.094 0.775 . . . . 0.0 113.094 -172.224 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' E' E ' 91' ' ' ASN . . . . . . . . . . . . . 23.8 m120 -132.02 26.34 4.59 Favored 'General case' 0 N--CA 1.467 0.419 0 N-CA-C 112.401 0.519 . . . . 0.0 112.401 -179.427 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' E' E ' 92' ' ' LEU . . . . . . . . . . . . . 12.8 mt -149.24 151.88 35.02 Favored 'General case' 0 C--N 1.333 -0.143 0 N-CA-C 110.105 -0.332 . . . . 0.0 110.105 -176.159 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' E' E ' 93' ' ' ILE . . . . . . . . . . . . . 72.2 mt -127.71 121.98 57.93 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.28 0 N-CA-C 109.349 -0.612 . . . . 0.0 109.349 177.812 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' E' E ' 94' ' ' VAL . . . . . 0.46 HG21 HG11 ' E' ' 125' ' ' VAL . 44.6 t -118.07 128.1 75.19 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.294 0 CA-C-O 120.813 0.34 . . . . 0.0 110.119 -178.343 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' E' E ' 95' ' ' VAL . . . . . . . . . . . . . 43.6 t -122.19 135.11 63.37 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.381 0 CA-C-N 115.986 -0.552 . . . . 0.0 109.996 -179.238 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' E' E ' 96' ' ' ILE . . . . . . . . . . . . . 62.2 mt -115.3 128.04 72.65 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.346 0 N-CA-C 109.241 -0.652 . . . . 0.0 109.241 178.392 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' E' E ' 97' ' ' THR . . . . . . . . . . . . . 66.5 p -101.32 155.74 17.86 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-O 121.056 0.455 . . . . 0.0 111.04 -177.521 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' E' E ' 98' ' ' GLU . . . . . . . . . . . . . 97.1 mt-10 -53.91 -26.22 24.08 Favored 'General case' 0 CA--C 1.532 0.265 0 N-CA-C 112.194 0.442 . . . . 0.0 112.194 179.874 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' E' E ' 99' ' ' GLU . . . . . . . . . . . . . 97.0 mt-10 -78.86 15.53 1.06 Allowed 'General case' 0 CA--C 1.535 0.37 0 N-CA-C 113.167 0.803 . . . . 0.0 113.167 -177.383 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' E' E ' 100' ' ' ASN . . . . . . . . . . . . . 3.6 m-20 61.54 37.41 16.4 Favored 'General case' 0 CA--C 1.529 0.17 0 CA-C-O 120.974 0.416 . . . . 0.0 111.124 178.728 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' E' E ' 101' ' ' GLU . . . . . . . . . . . . . 80.9 tt0 -115.23 145.45 42.41 Favored 'General case' 0 C--N 1.332 -0.173 0 CA-C-N 115.951 -0.568 . . . . 0.0 109.616 175.803 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' E' E ' 102' ' ' VAL . . . . . . . . . . . . . 43.4 t -115.59 125.98 72.97 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.335 0 CA-C-N 116.318 -0.401 . . . . 0.0 110.143 -177.043 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' E' E ' 103' ' ' LEU . . . . . . . . . . . . . 23.4 mt -117.92 130.5 56.26 Favored 'General case' 0 C--N 1.331 -0.226 0 CA-C-N 115.888 -0.596 . . . . 0.0 110.15 177.747 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' E' E ' 104' ' ' ILE . . . . . 0.556 HD13 HG21 ' E' ' 130' ' ' VAL . 68.8 mt -119.9 120.85 64.45 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.189 0 CA-C-O 120.646 0.26 . . . . 0.0 110.308 179.02 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' E' E ' 105' ' ' PHE . . . . . . . . . . . . . 55.6 m-85 -119.86 166.5 13.21 Favored 'General case' 0 C--N 1.332 -0.18 0 CA-C-N 115.352 -0.84 . . . . 0.0 109.796 178.618 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' E' E ' 106' ' ' ASN . . . . . . . . . . . . . 47.1 p-10 -97.87 -169.94 1.91 Allowed 'General case' 0 C--N 1.331 -0.231 0 N-CA-C 109.708 -0.478 . . . . 0.0 109.708 172.972 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' E' E ' 107' ' ' GLN . . . . . . . . . . . . . 39.0 tp60 -60.89 -28.17 68.69 Favored 'General case' 0 CA--C 1.533 0.295 0 N-CA-C 112.012 0.375 . . . . 0.0 112.012 179.564 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' E' E ' 108' ' ' ASN . . . . . . . . . . . . . 15.6 t-20 -82.94 9.43 10.07 Favored 'General case' 0 CA--C 1.536 0.42 0 N-CA-C 112.94 0.718 . . . . 0.0 112.94 -179.125 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' E' E ' 109' ' ' LEU . . . . . 0.577 HD21 ' HB2' ' E' ' 78' ' ' ALA . 9.4 tp 57.78 36.92 26.94 Favored 'General case' 0 C--O 1.232 0.164 0 CA-C-O 120.877 0.37 . . . . 0.0 111.278 179.973 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' E' E ' 110' ' ' GLU . . . . . . . . . . . . . 96.6 mt-10 -102.14 150.07 23.64 Favored 'General case' 0 C--N 1.331 -0.23 0 N-CA-C 109.788 -0.449 . . . . 0.0 109.788 176.364 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' E' E ' 111' ' ' GLU . . . . . . . . . . . . . 68.0 tt0 -83.24 121.93 27.75 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 116.47 -0.332 . . . . 0.0 110.846 -176.509 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' E' E ' 112' ' ' LEU . . . . . . . . . . . . . 13.4 mt -110.47 -45.99 3.46 Favored 'General case' 0 C--N 1.332 -0.182 0 CA-C-N 116.228 -0.442 . . . . 0.0 110.553 179.685 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' E' E ' 113' ' ' TYR . . . . . . . . . . . . . 57.3 t80 -135.77 133.74 38.26 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.341 -0.391 . . . . 0.0 110.936 -178.346 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' E' E ' 114' ' ' ARG . . . . . . . . . . . . . 76.7 ttt180 -134.57 120.18 19.32 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.14 -0.482 . . . . 0.0 110.054 176.938 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' E' E ' 115' ' ' GLY . . . . . . . . . . . . . . . -148.32 162.46 28.82 Favored Glycine 0 CA--C 1.524 0.635 0 N-CA-C 110.694 -0.962 . . . . 0.0 110.694 -179.773 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' E' E ' 116' ' ' LYS . . . . . . . . . . . . . 33.6 ttmt -136.81 139.09 41.5 Favored 'General case' 0 C--N 1.327 -0.371 0 N-CA-C 110.224 -0.287 . . . . 0.0 110.224 -179.623 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' E' E ' 117' ' ' PHE . . . . . . . . . . . . . 32.9 m-85 -137.51 113.94 10.21 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-O 121.047 0.451 . . . . 0.0 110.272 -176.487 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' E' E ' 118' ' ' GLU . . . . . . . . . . . . . 96.5 mt-10 -53.59 -45.6 70.07 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.142 -0.481 . . . . 0.0 111.514 -176.425 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' E' E ' 119' ' ' ASN . . . . . . . . . . . . . 32.7 m120 -96.55 30.93 2.41 Favored 'General case' 0 C--N 1.329 -0.299 0 N-CA-C 112.306 0.484 . . . . 0.0 112.306 -174.316 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' E' E ' 120' ' ' LEU . . . . . . . . . . . . . 12.9 tp -56.24 122.94 12.94 Favored 'General case' 0 C--N 1.332 -0.191 0 C-N-CA 121.139 -0.224 . . . . 0.0 110.559 177.645 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' E' E ' 121' ' ' ASN . . . . . . . . . . . . . 44.7 t30 -114.07 -44.01 3.19 Favored 'General case' 0 C--N 1.333 -0.131 0 CA-C-N 116.684 -0.235 . . . . 0.0 111.559 -176.641 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' E' E ' 122' ' ' LYS . . . . . 0.424 ' HE3' HD11 ' E' ' 124' ' ' LEU . 33.6 ttpt -149.1 149.16 30.61 Favored 'General case' 0 C--N 1.332 -0.158 0 CA-C-O 121.077 0.465 . . . . 0.0 111.431 -174.647 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' E' E ' 123' ' ' VAL . . . . . . . . . . . . . 45.7 t -126.52 136.49 60.67 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.265 0 CA-C-N 116.11 -0.495 . . . . 0.0 109.935 179.126 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' E' E ' 124' ' ' LEU . . . . . 0.424 HD11 ' HE3' ' E' ' 122' ' ' LYS . 57.3 mt -129.86 138.32 50.91 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-O 120.714 0.292 . . . . 0.0 110.655 -178.926 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' E' E ' 125' ' ' VAL . . . . . 0.46 HG11 HG21 ' E' ' 94' ' ' VAL . 35.7 m -135.9 143.67 35.58 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.269 0 CA-C-N 116.341 -0.391 . . . . 0.0 110.644 178.509 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' E' E ' 126' ' ' ARG . . . . . . . . . . . . . 67.6 ttt180 -162.02 122.09 2.51 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 116.128 -0.487 . . . . 0.0 110.103 177.921 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' E' E ' 127' ' ' ASN . . . . . . . . . . . . . 3.7 t-20 56.02 -149.58 0.45 Allowed 'General case' 0 CA--C 1.54 0.591 0 N-CA-C 109.973 -0.38 . . . . 0.0 109.973 179.822 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' E' E ' 128' ' ' ASP . . . . . . . . . . . . . 14.2 p-10 -80.01 13.54 2.21 Favored 'General case' 0 CA--C 1.536 0.441 0 N-CA-C 112.879 0.696 . . . . 0.0 112.879 -179.792 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' E' E ' 129' ' ' LEU . . . . . . . . . . . . . 39.6 mt -110.82 138.58 47.03 Favored 'General case' 0 C--O 1.231 0.129 0 CA-C-N 118.143 0.429 . . . . 0.0 109.981 178.053 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' E' E ' 130' ' ' VAL . . . . . 0.556 HG21 HD13 ' E' ' 104' ' ' ILE . 30.6 m -132.63 140.76 46.78 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.185 0 CA-C-O 120.957 0.408 . . . . 0.0 110.377 178.478 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' E' E ' 131' ' ' VAL . . . . . 0.537 HG22 HD12 ' E' ' 140' ' ' LEU . 39.7 t -136.06 139.31 46.02 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.256 0 CA-C-O 121.166 0.507 . . . . 0.0 110.392 -178.419 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' E' E ' 132' ' ' ILE . . . . . . . . . . . . . 68.1 mt -116.63 130.95 70.62 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.325 0 CA-C-N 115.552 -0.749 . . . . 0.0 109.379 179.932 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' E' E ' 133' ' ' ILE . . . . . . . . . . . . . 41.8 mm -114.47 119.12 60.59 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.214 0 CA-C-O 121.026 0.441 . . . . 0.0 110.797 -176.07 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' E' E ' 134' ' ' ASP . . . . . . . . . . . . . 7.0 p-10 -128.18 147.44 50.57 Favored 'General case' 0 C--N 1.33 -0.259 0 N-CA-C 109.649 -0.5 . . . . 0.0 109.649 175.684 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' E' E ' 135' ' ' GLU . . . . . . . . . . . . . 85.6 tt0 -49.81 -24.21 2.28 Favored 'General case' 0 C--N 1.327 -0.371 0 N-CA-C 112.971 0.73 . . . . 0.0 112.971 -171.084 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' E' E ' 136' ' ' GLN . . . . . . . . . . . . . 63.0 tt0 -100.03 -31.16 11.58 Favored 'General case' 0 CA--C 1.529 0.165 0 N-CA-C 112.145 0.424 . . . . 0.0 112.145 -175.318 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' E' E ' 137' ' ' LYS . . . . . . . . . . . . . 74.5 mttt -142.23 155.52 45.26 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-O 121.384 0.612 . . . . 0.0 111.818 -169.66 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' E' E ' 138' ' ' LEU . . . . . 0.407 ' C ' HD23 ' E' ' 138' ' ' LEU . 4.4 tt -116.47 120.98 40.51 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 115.323 -0.853 . . . . 0.0 109.054 171.772 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' E' E ' 139' ' ' THR . . . . . . . . . . . . . 26.3 m -108.39 126.39 52.82 Favored 'General case' 0 C--N 1.331 -0.204 0 CA-C-N 116.381 -0.372 . . . . 0.0 110.974 -176.764 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' E' E ' 140' ' ' LEU . . . . . 0.537 HD12 HG22 ' E' ' 131' ' ' VAL . 15.4 tp -112.34 122.43 47.71 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 115.486 -0.779 . . . . 0.0 109.418 -179.618 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' E' E ' 141' ' ' ILE . . . . . 0.523 ' HB ' HG23 ' E' ' 130' ' ' VAL . 19.2 mt -123.14 121.36 62.83 Favored 'Isoleucine or valine' 0 C--O 1.234 0.259 0 N-CA-C 109.778 -0.452 . . . . 0.0 109.778 -177.339 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' E' E ' 142' ' ' ARG . . . . . . . . . . . . . 29.2 ttp180 -118.68 127.06 53.22 Favored 'General case' 0 C--N 1.331 -0.22 0 CA-C-N 115.437 -0.801 . . . . 0.0 110.276 -177.7 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' E' E ' 143' ' ' THR . . . . . . . . . . . . . 72.9 p . . . . . 0 C--O 1.221 -0.432 0 CA-C-O 118.108 -0.948 . . . . 0.0 110.677 -179.265 . . . . . . . . 0 0 . 1 . 009 nuclear nobuild core ' F' F ' 1' ' ' MET . . . . . . . . . . . . . 26.2 ptt? . . . . . 0 C--O 1.231 0.082 0 CA-C-O 120.782 0.325 . . . . 0.0 110.7 . . . . . . . . . 0 0 . 1 . 009 nuclear nobuild core ' F' F ' 2' ' ' SER . . . . . 0.566 ' HB2' HD11 ' F' ' 58' ' ' LEU . 9.1 p -126.83 147.62 50.01 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-N 116.261 -0.427 . . . . 0.0 110.684 179.985 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' F' F ' 3' ' ' GLU . . . . . . . . . . . . . 81.9 tt0 -140.78 140.13 34.71 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.068 -0.515 . . . . 0.0 111.132 -178.424 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' F' F ' 4' ' ' LEU . . . . . . . . . . . . . 18.1 tp -122.1 131.11 53.8 Favored 'General case' 0 C--N 1.332 -0.185 0 CA-C-N 115.971 -0.559 . . . . 0.0 109.907 176.418 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' F' F ' 5' ' ' LYS . . . . . . . . . . . . . 64.1 mttp -109.72 121.14 44.54 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.238 -0.437 . . . . 0.0 110.576 -179.041 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' F' F ' 6' ' ' LEU . . . . . . . . . . . . . 63.0 mt -114.0 149.33 35.51 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 115.467 -0.788 . . . . 0.0 110.811 -177.878 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' F' F ' 7' ' ' LYS . . . . . . . . . . . . . 29.6 ttpt -135.0 134.87 22.07 Favored Pre-proline 0 CA--C 1.534 0.357 0 CA-C-O 118.929 -0.558 . . . . 0.0 109.728 176.72 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' F' F ' 8' ' ' PRO . . . . . . . . . . . . . 97.1 Cg_endo -91.05 131.2 1.46 Allowed 'Trans proline' 0 N--CA 1.49 1.265 0 C-N-CA 121.73 1.62 . . . . 0.0 111.396 175.331 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' F' F ' 9' ' ' LEU . . . . . . . . . . . . . 27.9 mt -68.63 -46.84 35.11 Favored Pre-proline 0 CA--C 1.532 0.28 0 CA-C-O 118.791 -0.623 . . . . 0.0 111.509 -177.067 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' F' F ' 10' ' ' PRO . . . . . . . . . . . . . 98.4 Cg_endo -80.71 140.96 13.37 Favored 'Trans proline' 0 N--CA 1.496 1.643 0 C-N-CA 121.012 1.141 . . . . 0.0 111.25 171.542 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' F' F ' 11' ' ' LYS . . . . . . . . . . . . . 54.0 tttp -84.82 106.47 16.38 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-O 120.86 0.362 . . . . 0.0 110.586 -179.433 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' F' F ' 12' ' ' VAL . . . . . . . . . . . . . 12.2 p -142.98 148.72 19.23 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.344 0 CA-C-N 116.101 -0.5 . . . . 0.0 110.497 -179.758 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' F' F ' 13' ' ' GLU . . . . . . . . . . . . . 43.8 tp10 -82.18 117.07 22.04 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.211 -0.449 . . . . 0.0 109.984 177.74 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' F' F ' 14' ' ' LEU . . . . . . . . . . . . . 32.3 mt -89.61 149.79 43.0 Favored Pre-proline 0 C--N 1.33 -0.263 0 CA-C-O 119.326 -0.369 . . . . 0.0 110.618 -177.62 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' F' F ' 15' ' ' PRO . . . . . . . . . . . . . 26.0 Cg_exo -61.67 159.12 33.94 Favored 'Trans proline' 0 N--CA 1.496 1.631 0 C-N-CA 121.186 1.257 . . . . 0.0 111.627 176.756 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' F' F ' 16' ' ' PRO . . . . . . . . . . . . . 38.5 Cg_exo -58.52 -36.17 97.73 Favored 'Trans proline' 0 N--CA 1.497 1.712 0 C-N-CA 121.386 1.391 . . . . 0.0 112.931 -177.499 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' F' F ' 17' ' ' ASP . . . . . . . . . . . . . 7.2 p-10 -90.77 8.42 34.76 Favored 'General case' 0 CA--C 1.535 0.372 0 N-CA-C 113.393 0.886 . . . . 0.0 113.393 -176.867 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' F' F ' 18' ' ' PHE . . . . . . . . . . . . . 34.9 t80 -58.42 -45.45 88.42 Favored 'General case' 0 C--O 1.231 0.102 0 O-C-N 121.983 -0.448 . . . . 0.0 110.018 -178.187 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' F' F ' 19' ' ' VAL . . . . . 0.4 HG13 ' N ' ' F' ' 20' ' ' ASP . 13.2 p -57.22 -40.66 75.04 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.372 0 CA-C-N 116.156 -0.475 . . . . 0.0 110.571 179.939 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' F' F ' 20' ' ' ASP . . . . . 0.4 ' N ' HG13 ' F' ' 19' ' ' VAL . 65.8 m-20 -60.02 -43.12 95.48 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-O 120.798 0.333 . . . . 0.0 110.84 -178.013 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' F' F ' 21' ' ' VAL . . . . . . . . . . . . . 46.6 t -64.06 -47.33 90.76 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.284 0 CA-C-N 116.398 -0.365 . . . . 0.0 110.377 -178.183 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' F' F ' 22' ' ' ILE . . . . . 0.446 HG22 HD12 ' F' ' 26' ' ' LEU . 49.9 mm -57.73 -39.24 69.43 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.353 0 CA-C-O 120.793 0.33 . . . . 0.0 110.896 -179.941 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' F' F ' 23' ' ' ARG . . . . . . . . . . . . . 54.6 ttp180 -57.13 -50.55 72.45 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-O 120.904 0.383 . . . . 0.0 110.562 177.243 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' F' F ' 24' ' ' ILE . . . . . . . . . . . . . 72.8 mt -61.0 -40.1 84.44 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.287 0 CA-C-N 115.986 -0.552 . . . . 0.0 111.968 -176.979 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' F' F ' 25' ' ' LYS . . . . . . . . . . . . . 13.8 pttp -75.48 -35.18 60.9 Favored 'General case' 0 CA--C 1.534 0.348 0 C-N-CA 120.671 -0.412 . . . . 0.0 112.046 -174.03 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' F' F ' 26' ' ' LEU . . . . . 0.446 HD12 HG22 ' F' ' 22' ' ' ILE . 34.3 mt -80.32 -41.42 24.89 Favored 'General case' 0 C--N 1.33 -0.256 0 N-CA-C 112.841 0.682 . . . . 0.0 112.841 -174.762 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' F' F ' 27' ' ' GLN . . . . . . . . . . . . . 9.0 pt20 -46.3 139.63 4.63 Favored 'General case' 0 N--CA 1.467 0.392 0 N-CA-C 113.006 0.743 . . . . 0.0 113.006 -174.551 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' F' F ' 28' ' ' GLY . . . . . . . . . . . . . . . 99.61 -25.85 26.66 Favored Glycine 0 CA--C 1.534 1.243 0 CA-C-N 115.539 -0.755 . . . . 0.0 112.199 -175.362 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' F' F ' 29' ' ' LYS . . . . . . . . . . . . . 25.7 mtpp -98.43 155.18 17.37 Favored 'General case' 0 C--N 1.333 -0.146 0 CA-C-N 117.18 0.49 . . . . 0.0 111.167 179.648 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' F' F ' 30' ' ' THR . . . . . . . . . . . . . 29.8 m -101.17 137.73 39.14 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.036 -0.529 . . . . 0.0 109.96 175.657 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' F' F ' 31' ' ' VAL . . . . . . . . . . . . . 35.3 m -129.26 154.24 39.82 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.254 0 CA-C-O 120.94 0.4 . . . . 0.0 110.742 -179.754 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' F' F ' 32' ' ' ARG . . . . . . . . . . . . . 80.8 mtm180 -132.53 148.29 52.38 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 115.849 -0.614 . . . . 0.0 110.335 178.395 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' F' F ' 33' ' ' THR . . . . . . . . . . . . . 25.3 m -52.79 138.01 30.33 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.344 -0.389 . . . . 0.0 111.418 -178.688 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' F' F ' 34' ' ' GLY . . . . . . . . . . . . . . . 101.64 -17.14 55.56 Favored Glycine 0 CA--C 1.532 1.155 0 CA-C-O 119.697 -0.501 . . . . 0.0 113.28 179.369 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' F' F ' 35' ' ' ASP . . . . . . . . . . . . . 73.3 m-20 -65.84 149.17 50.61 Favored 'General case' 0 C--O 1.232 0.136 0 CA-C-N 117.981 0.89 . . . . 0.0 110.952 179.23 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' F' F ' 36' ' ' VAL . . . . . . . . . . . . . 45.8 t -126.0 131.61 71.54 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.289 0 CA-C-N 116.049 -0.523 . . . . 0.0 109.854 178.302 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' F' F ' 37' ' ' ILE . . . . . . . . . . . . . 65.2 mt -121.06 139.15 49.18 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.233 0 CA-C-N 116.162 -0.472 . . . . 0.0 109.891 -178.995 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' F' F ' 38' ' ' GLY . . . . . . . . . . . . . . . -110.36 128.8 9.0 Favored Glycine 0 CA--C 1.525 0.662 0 N-CA-C 111.059 -0.816 . . . . 0.0 111.059 179.916 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' F' F ' 39' ' ' ILE . . . . . . . . . . . . . 73.7 mt -123.9 133.68 68.59 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.185 0 N-CA-C 110.049 -0.352 . . . . 0.0 110.049 179.347 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' F' F ' 40' ' ' SER . . . . . . . . . . . . . 99.8 p -93.23 123.66 36.66 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.398 -0.364 . . . . 0.0 111.0 176.298 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' F' F ' 41' ' ' ILE . . . . . . . . . . . . . 70.9 mt -131.21 120.69 47.28 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.209 0 CA-C-O 120.918 0.39 . . . . 0.0 110.345 177.869 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' F' F ' 42' ' ' LEU . . . . . . . . . . . . . 48.9 mt 52.76 35.45 18.64 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.011 -0.54 . . . . 0.0 111.699 177.166 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' F' F ' 43' ' ' GLY . . . . . . . . . . . . . . . 72.31 31.48 63.55 Favored Glycine 0 CA--C 1.53 1.027 0 C-N-CA 121.139 -0.553 . . . . 0.0 112.142 178.064 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' F' F ' 44' ' ' LYS . . . . . . . . . . . . . 58.8 mtpt -135.91 131.49 35.28 Favored 'General case' 0 C--N 1.33 -0.278 0 N-CA-C 109.714 -0.476 . . . . 0.0 109.714 177.783 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' F' F ' 45' ' ' GLU . . . . . . . . . . . . . 83.8 tt0 -83.6 119.39 24.68 Favored 'General case' 0 C--N 1.328 -0.343 0 C-N-CA 120.844 -0.342 . . . . 0.0 111.219 -178.631 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' F' F ' 46' ' ' VAL . . . . . . . . . . . . . 7.7 p -118.66 122.75 70.21 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.198 0 N-CA-C 109.195 -0.669 . . . . 0.0 109.195 174.824 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' F' F ' 47' ' ' LYS . . . . . . . . . . . . . 55.5 mtmt -100.22 128.64 46.25 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 115.999 -0.546 . . . . 0.0 111.303 -179.815 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' F' F ' 48' ' ' PHE . . . . . . . . . . . . . 93.6 m-85 -110.55 131.92 54.64 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-N 116.099 -0.501 . . . . 0.0 109.872 177.529 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' F' F ' 49' ' ' LYS . . . . . . . . . . . . . 84.3 tttt -107.77 137.09 46.4 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.281 -0.418 . . . . 0.0 110.683 179.339 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' F' F ' 50' ' ' VAL . . . . . . . . . . . . . 43.5 t -82.32 106.29 13.07 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.24 0 N-CA-C 109.279 -0.637 . . . . 0.0 109.279 175.389 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' F' F ' 51' ' ' VAL . . . . . . . . . . . . . 47.7 t -71.06 -52.58 26.32 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.373 0 N-CA-C 109.707 -0.479 . . . . 0.0 109.707 -174.475 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' F' F ' 52' ' ' GLN . . . . . . . . . . . . . 88.5 mt-30 -154.81 153.67 31.56 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-O 121.206 0.527 . . . . 0.0 111.748 -176.64 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' F' F ' 53' ' ' ALA . . . . . . . . . . . . . . . -132.17 133.01 43.72 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 115.333 -0.849 . . . . 0.0 109.526 174.42 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' F' F ' 54' ' ' TYR . . . . . . . . . . . . . 17.2 t80 -129.13 111.47 18.29 Favored Pre-proline 0 CA--C 1.535 0.385 0 CA-C-O 118.16 -0.924 . . . . 0.0 110.204 179.088 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' F' F ' 55' ' ' PRO . . . . . . . . . . . . . 73.9 Cg_endo -77.14 168.88 75.76 Favored 'Cis proline' 0 N--CA 1.5 1.876 0 CA-C-N 121.872 1.704 . . . . 0.0 112.321 -6.644 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' F' F ' 56' ' ' SER . . . . . . . . . . . . . 13.4 m -117.32 135.04 23.05 Favored Pre-proline 0 CA--C 1.539 0.531 0 CA-C-O 118.477 -0.773 . . . . 0.0 109.627 175.243 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' F' F ' 57' ' ' PRO . . . . . . . . . . . . . 35.4 Cg_endo -66.38 164.68 65.91 Favored 'Cis proline' 0 N--CA 1.498 1.774 0 CA-C-N 121.809 1.682 . . . . 0.0 111.338 -3.225 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' F' F ' 58' ' ' LEU . . . . . 0.566 HD11 ' HB2' ' F' ' 2' ' ' SER . 16.4 tp -130.77 139.08 50.21 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-O 120.996 0.427 . . . . 0.0 110.38 179.738 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' F' F ' 59' ' ' ARG . . . . . . . . . . . . . 60.3 ttm-85 -104.48 127.93 52.29 Favored 'General case' 0 C--N 1.327 -0.397 0 N-CA-C 109.152 -0.685 . . . . 0.0 109.152 174.986 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' F' F ' 60' ' ' VAL . . . . . . . . . . . . . 41.6 t -81.0 119.38 30.55 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.271 0 C-N-CA 120.732 -0.387 . . . . 0.0 110.604 -174.941 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' F' F ' 61' ' ' GLU . . . . . . . . . . . . . 95.5 mt-10 -131.05 163.07 28.43 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 115.853 -0.612 . . . . 0.0 109.689 175.301 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' F' F ' 62' ' ' ASP . . . . . . . . . . . . . 41.2 m-20 -52.51 -31.64 36.35 Favored 'General case' 0 C--N 1.328 -0.354 0 N-CA-C 112.045 0.387 . . . . 0.0 112.045 -178.942 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' F' F ' 63' ' ' ARG . . . . . . . . . . . . . 79.3 mtt85 -72.94 -22.03 60.79 Favored 'General case' 0 CA--C 1.533 0.324 0 N-CA-C 112.896 0.702 . . . . 0.0 112.896 -176.205 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' F' F ' 64' ' ' THR . . . . . . . . . . . . . 20.3 m -72.54 141.48 48.47 Favored 'General case' 0 C--N 1.331 -0.206 0 CA-C-O 120.833 0.349 . . . . 0.0 110.999 -175.755 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' F' F ' 65' ' ' LYS . . . . . . . . . . . . . 67.1 mttm -90.01 137.09 32.63 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.009 -0.541 . . . . 0.0 110.49 179.578 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' F' F ' 66' ' ' ILE . . . . . . . . . . . . . 60.4 mt -119.33 130.03 74.5 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.268 0 N-CA-C 109.68 -0.489 . . . . 0.0 109.68 177.856 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' F' F ' 67' ' ' THR . . . . . . . . . . . . . 31.9 m -125.97 145.33 50.33 Favored 'General case' 0 C--N 1.331 -0.21 0 CA-C-O 121.089 0.471 . . . . 0.0 111.37 -176.81 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' F' F ' 68' ' ' LEU . . . . . 0.412 HD23 ' C ' ' F' ' 68' ' ' LEU . 4.8 tt . . . . . 0 C--N 1.33 -0.25 0 CA-C-N 115.721 -0.672 . . . . 0.0 109.786 176.553 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' F' F ' 73' ' ' VAL . . . . . . . . . . . . . 34.9 m . . . . . 0 C--O 1.232 0.162 0 N-CA-C 110.305 -0.258 . . . . 0.0 110.305 . . . . . . . . . 0 0 . 1 . 009 nuclear nobuild core ' F' F ' 74' ' ' ASP . . . . . . . . . . . . . 47.4 t0 -84.98 114.92 22.51 Favored 'General case' 0 C--N 1.33 -0.264 0 C-N-CA 120.524 -0.47 . . . . 0.0 110.381 -171.112 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' F' F ' 75' ' ' VAL . . . . . . . . . . . . . 46.5 t -118.16 117.89 56.28 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.27 0 CA-C-O 121.178 0.513 . . . . 0.0 109.74 178.643 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' F' F ' 76' ' ' LEU . . . . . . . . . . . . . 13.9 mt -120.86 142.44 49.66 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 115.453 -0.794 . . . . 0.0 109.216 179.385 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' F' F ' 77' ' ' GLU . . . . . . . . . . . . . 97.7 mt-10 -135.49 130.05 34.08 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-O 121.225 0.536 . . . . 0.0 111.343 -176.713 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' F' F ' 78' ' ' ALA . . . . . . . . . . . . . . . -118.7 134.46 55.11 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-N 115.47 -0.786 . . . . 0.0 109.649 176.373 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' F' F ' 79' ' ' LYS . . . . . 0.512 ' O ' HD13 ' F' ' 80' ' ' ILE . 39.7 mtmt -83.81 115.44 22.24 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-O 120.958 0.408 . . . . 0.0 110.751 -178.784 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' F' F ' 80' ' ' ILE . . . . . 0.512 HD13 ' O ' ' F' ' 79' ' ' LYS . 24.0 mm -139.19 114.73 8.74 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.323 0 CA-C-N 115.722 -0.672 . . . . 0.0 109.266 -177.93 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' F' F ' 81' ' ' LYS . . . . . . . . . . . . . 75.6 mttt -101.65 126.49 48.5 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-O 120.802 0.334 . . . . 0.0 111.029 -178.086 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' F' F ' 82' ' ' GLY . . . . . . . . . . . . . . . 89.04 42.14 5.7 Favored Glycine 0 CA--C 1.525 0.718 0 C-N-CA 120.905 -0.665 . . . . 0.0 111.933 175.423 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' F' F ' 83' ' ' ILE . . . . . . . . . . . . . 74.1 mt -66.69 138.41 22.98 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 N-CA-C 109.634 -0.506 . . . . 0.0 109.634 176.461 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' F' F ' 84' ' ' LYS . . . . . . . . . . . . . 53.8 tttp -99.34 -51.85 3.68 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.597 -176.729 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' F' F ' 85' ' ' ASP . . . . . . . . . . . . . 7.3 t70 -154.7 154.81 33.49 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.024 -0.534 . . . . 0.0 110.633 -179.807 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' F' F ' 86' ' ' VAL . . . . . . . . . . . . . 41.4 t -130.68 132.6 64.2 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.258 0 CA-C-O 121.032 0.444 . . . . 0.0 110.535 -179.516 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' F' F ' 87' ' ' ILE . . . . . . . . . . . . . 45.1 mm -120.76 128.37 76.04 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.229 0 CA-C-N 115.72 -0.673 . . . . 0.0 109.582 177.738 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' F' F ' 88' ' ' LEU . . . . . . . . . . . . . 37.4 mt -109.39 138.72 45.33 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-O 121.159 0.504 . . . . 0.0 111.312 -178.389 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' F' F ' 89' ' ' ASP . . . . . . . . . . . . . 11.7 t70 -130.07 154.89 47.0 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 115.485 -0.78 . . . . 0.0 109.197 175.319 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' F' F ' 90' ' ' GLU . . . . . . . . . . . . . 84.8 tt0 -46.12 -39.1 8.98 Favored 'General case' 0 N--CA 1.465 0.276 0 N-CA-C 113.175 0.806 . . . . 0.0 113.175 -172.315 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' F' F ' 91' ' ' ASN . . . . . . . . . . . . . 14.5 p30 -132.09 25.03 4.58 Favored 'General case' 0 N--CA 1.467 0.393 0 N-CA-C 112.71 0.633 . . . . 0.0 112.71 -178.391 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' F' F ' 92' ' ' LEU . . . . . . . . . . . . . 13.6 mt -150.38 147.22 27.32 Favored 'General case' 0 C--N 1.331 -0.218 0 N-CA-C 109.963 -0.384 . . . . 0.0 109.963 -177.398 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' F' F ' 93' ' ' ILE . . . . . . . . . . . . . 71.3 mt -126.98 117.79 48.66 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.269 0 N-CA-C 109.294 -0.632 . . . . 0.0 109.294 178.705 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' F' F ' 94' ' ' VAL . . . . . . . . . . . . . 44.3 t -118.09 127.98 75.22 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.217 0 N-CA-C 109.955 -0.387 . . . . 0.0 109.955 -178.584 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' F' F ' 95' ' ' VAL . . . . . . . . . . . . . 42.7 t -124.31 134.35 66.9 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.293 0 CA-C-N 116.18 -0.463 . . . . 0.0 109.992 -179.409 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' F' F ' 96' ' ' ILE . . . . . . . . . . . . . 57.5 mt -113.27 129.9 68.18 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.284 0 N-CA-C 109.423 -0.584 . . . . 0.0 109.423 178.722 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' F' F ' 97' ' ' THR . . . . . . . . . . . . . 59.7 p -102.1 156.92 17.24 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-O 120.946 0.403 . . . . 0.0 110.782 179.958 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' F' F ' 98' ' ' GLU . . . . . . . . . . . . . 97.8 mt-10 -53.95 -24.42 16.45 Favored 'General case' 0 CA--C 1.533 0.304 0 N-CA-C 112.344 0.498 . . . . 0.0 112.344 179.854 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' F' F ' 99' ' ' GLU . . . . . . . . . . . . . 97.1 mt-10 -75.49 9.07 2.38 Favored 'General case' 0 CA--C 1.536 0.435 0 N-CA-C 113.402 0.889 . . . . 0.0 113.402 -178.22 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' F' F ' 100' ' ' ASN . . . . . . . . . . . . . 4.2 m-20 63.07 33.94 14.2 Favored 'General case' 0 CA--C 1.532 0.263 0 CA-C-N 118.131 0.423 . . . . 0.0 111.332 -178.512 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' F' F ' 101' ' ' GLU . . . . . . . . . . . . . 84.0 tt0 -110.1 142.29 41.77 Favored 'General case' 0 C--N 1.333 -0.146 0 N-CA-C 109.475 -0.565 . . . . 0.0 109.475 172.39 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' F' F ' 102' ' ' VAL . . . . . . . . . . . . . 45.6 t -114.9 124.57 71.68 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.319 0 CA-C-N 116.226 -0.443 . . . . 0.0 109.814 -179.242 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' F' F ' 103' ' ' LEU . . . . . . . . . . . . . 26.1 mt -112.27 132.55 54.89 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 115.508 -0.769 . . . . 0.0 109.798 177.245 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' F' F ' 104' ' ' ILE . . . . . . . . . . . . . 69.9 mt -123.02 117.8 52.84 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.286 0 N-CA-C 109.983 -0.377 . . . . 0.0 109.983 -178.84 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' F' F ' 105' ' ' PHE . . . . . . . . . . . . . 20.8 m-85 -120.3 165.68 14.53 Favored 'General case' 0 C--N 1.331 -0.221 0 CA-C-N 115.568 -0.742 . . . . 0.0 109.892 179.838 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' F' F ' 106' ' ' ASN . . . . . . . . . . . . . 45.8 p-10 -98.67 -169.96 1.87 Allowed 'General case' 0 C--N 1.329 -0.288 0 N-CA-C 109.702 -0.481 . . . . 0.0 109.702 173.993 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' F' F ' 107' ' ' GLN . . . . . . . . . . . . . 45.4 tt0 -58.85 -28.09 65.75 Favored 'General case' 0 C--N 1.327 -0.379 0 N-CA-C 112.168 0.433 . . . . 0.0 112.168 179.272 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' F' F ' 108' ' ' ASN . . . . . . . . . . . . . 14.1 t30 -86.22 10.24 15.23 Favored 'General case' 0 CA--C 1.535 0.377 0 N-CA-C 113.136 0.791 . . . . 0.0 113.136 -177.72 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' F' F ' 109' ' ' LEU . . . . . . . . . . . . . 9.9 tp 59.7 35.89 22.34 Favored 'General case' 0 C--O 1.233 0.187 0 O-C-N 122.106 -0.371 . . . . 0.0 111.426 178.612 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' F' F ' 110' ' ' GLU . . . . . . . . . . . . . 70.9 mm-40 -106.79 149.9 26.88 Favored 'General case' 0 C--N 1.33 -0.275 0 N-CA-C 110.207 -0.294 . . . . 0.0 110.207 177.168 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' F' F ' 111' ' ' GLU . . . . . . . . . . . . . 98.5 mt-10 -77.85 122.11 25.01 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.264 -0.426 . . . . 0.0 111.389 -176.944 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' F' F ' 112' ' ' LEU . . . . . . . . . . . . . 17.8 mt -107.45 -44.71 4.24 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 115.928 -0.578 . . . . 0.0 109.954 176.21 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' F' F ' 113' ' ' TYR . . . . . . . . . . . . . 42.1 t80 -141.59 137.44 31.91 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.054 -0.521 . . . . 0.0 110.987 -179.3 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' F' F ' 114' ' ' ARG . . . . . . . . . . . . . 23.9 ttm180 -138.13 125.76 22.19 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.109 -0.496 . . . . 0.0 109.869 175.823 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' F' F ' 115' ' ' GLY . . . . . . . . . . . . . . . -150.12 142.07 9.36 Favored Glycine 0 CA--C 1.524 0.597 0 N-CA-C 110.756 -0.938 . . . . 0.0 110.756 178.454 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' F' F ' 116' ' ' LYS . . . . . . . . . . . . . 84.8 tttt -118.76 128.06 54.13 Favored 'General case' 0 C--N 1.33 -0.25 0 N-CA-C 109.693 -0.484 . . . . 0.0 109.693 177.754 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' F' F ' 117' ' ' PHE . . . . . . . . . . . . . 22.7 m-85 -129.57 117.48 20.49 Favored 'General case' 0 C--N 1.332 -0.166 0 CA-C-O 120.921 0.391 . . . . 0.0 110.32 -172.954 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' F' F ' 118' ' ' GLU . . . . . . . . . . . . . 43.4 mt-10 -52.35 -49.27 64.66 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.349 -0.387 . . . . 0.0 111.765 -176.242 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' F' F ' 119' ' ' ASN . . . . . . . . . . . . . 90.3 m-20 -97.32 31.06 2.6 Favored 'General case' 0 C--N 1.33 -0.24 0 N-CA-C 112.164 0.431 . . . . 0.0 112.164 -174.293 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' F' F ' 120' ' ' LEU . . . . . . . . . . . . . 12.5 tp -56.33 124.32 17.64 Favored 'General case' 0 C--N 1.331 -0.21 0 CA-C-O 120.588 0.233 . . . . 0.0 110.604 178.273 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' F' F ' 121' ' ' ASN . . . . . . . . . . . . . 31.4 m120 -114.08 -44.04 3.18 Favored 'General case' 0 C--N 1.331 -0.198 0 CA-C-N 116.524 -0.307 . . . . 0.0 111.149 -177.327 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' F' F ' 122' ' ' LYS . . . . . . . . . . . . . 98.6 mttt -144.35 148.79 35.18 Favored 'General case' 0 C--N 1.332 -0.194 0 CA-C-O 121.198 0.523 . . . . 0.0 112.028 -175.921 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' F' F ' 123' ' ' VAL . . . . . . . . . . . . . 45.6 t -127.42 124.5 63.92 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.239 0 CA-C-N 115.624 -0.716 . . . . 0.0 109.078 172.711 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' F' F ' 124' ' ' LEU . . . . . . . . . . . . . 57.9 mt -118.93 138.8 52.53 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-O 120.837 0.351 . . . . 0.0 111.078 -175.567 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' F' F ' 125' ' ' VAL . . . . . . . . . . . . . 34.3 m -130.34 129.58 64.99 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.273 0 CA-C-N 115.961 -0.563 . . . . 0.0 110.284 177.888 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' F' F ' 126' ' ' ARG . . . . . . . . . . . . . 31.1 mmt180 -135.9 108.11 7.26 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.224 -0.444 . . . . 0.0 110.29 179.074 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' F' F ' 127' ' ' ASN . . . . . . . . . . . . . 42.1 m-80 54.26 -104.81 0.23 Allowed 'General case' 0 CA--C 1.541 0.628 0 CA-C-O 119.163 -0.446 . . . . 0.0 110.934 179.403 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' F' F ' 128' ' ' ASP . . . . . . . . . . . . . 7.5 p-10 -111.41 1.6 17.1 Favored 'General case' 0 N--CA 1.468 0.437 0 CA-C-N 119.45 1.023 . . . . 0.0 113.447 -176.053 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' F' F ' 129' ' ' LEU . . . . . . . . . . . . . 38.2 mt -104.97 141.82 35.88 Favored 'General case' 0 C--O 1.231 0.131 0 CA-C-N 118.195 0.452 . . . . 0.0 110.257 178.915 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' F' F ' 130' ' ' VAL . . . . . . . . . . . . . 44.0 t -123.37 137.08 57.9 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.224 0 CA-C-N 116.268 -0.424 . . . . 0.0 109.916 -179.275 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' F' F ' 131' ' ' VAL . . . . . . . . . . . . . 42.7 t -135.69 136.44 50.35 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.29 0 CA-C-O 121.041 0.448 . . . . 0.0 110.408 179.326 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' F' F ' 132' ' ' ILE . . . . . . . . . . . . . 67.7 mt -117.71 130.2 72.96 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.232 0 CA-C-N 115.74 -0.664 . . . . 0.0 109.286 179.567 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' F' F ' 133' ' ' ILE . . . . . . . . . . . . . 41.9 mm -118.06 120.02 63.22 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.227 0 CA-C-O 120.831 0.348 . . . . 0.0 111.221 -174.329 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' F' F ' 134' ' ' ASP . . . . . . . . . . . . . 7.1 p-10 -131.58 145.59 51.78 Favored 'General case' 0 C--N 1.332 -0.173 0 N-CA-C 109.422 -0.584 . . . . 0.0 109.422 173.403 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' F' F ' 135' ' ' GLU . . . . . . . . . . . . . 73.6 tt0 -49.92 -22.97 1.71 Allowed 'General case' 0 C--N 1.329 -0.322 0 N-CA-C 113.286 0.847 . . . . 0.0 113.286 -170.615 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' F' F ' 136' ' ' GLN . . . . . . . . . . . . . 57.1 tp60 -99.04 -34.08 10.55 Favored 'General case' 0 C--N 1.331 -0.225 0 N-CA-C 111.94 0.348 . . . . 0.0 111.94 -176.135 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' F' F ' 137' ' ' LYS . . . . . . . . . . . . . 57.5 mtpt -138.77 151.84 47.43 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-O 121.13 0.491 . . . . 0.0 111.128 -169.612 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' F' F ' 138' ' ' LEU . . . . . 0.441 HD23 ' C ' ' F' ' 138' ' ' LEU . 5.2 tt -119.29 122.76 42.63 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 115.809 -0.632 . . . . 0.0 109.437 174.445 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' F' F ' 139' ' ' THR . . . . . 0.413 ' N ' HD23 ' F' ' 138' ' ' LEU . 19.8 m -110.36 130.39 55.56 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-N 116.323 -0.399 . . . . 0.0 110.838 -177.27 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' F' F ' 140' ' ' LEU . . . . . 0.476 HD23 ' C ' ' F' ' 140' ' ' LEU . 8.9 tt -118.75 123.58 45.2 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 115.821 -0.627 . . . . 0.0 109.404 -179.232 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' F' F ' 141' ' ' ILE . . . . . . . . . . . . . 19.8 mt -120.47 120.72 63.56 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.309 0 CA-C-O 121.039 0.447 . . . . 0.0 109.887 -175.698 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' F' F ' 142' ' ' ARG . . . . . . . . . . . . . 68.9 ttt180 -110.69 130.77 55.48 Favored 'General case' 0 C--N 1.331 -0.22 0 CA-C-N 115.2 -0.909 . . . . 0.0 110.717 -175.494 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' F' F ' 143' ' ' THR . . . . . . . . . . . . . 41.2 p . . . . . 0 C--O 1.22 -0.475 0 CA-C-O 118.158 -0.925 . . . . 0.0 110.958 179.469 . . . . . . . . 0 0 . 1 . 010 nuclear nobuild core ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 10.5 p . . . . . 0 CA--C 1.523 -0.085 0 CA-C-O 120.867 0.365 . . . . 0.0 110.588 . . . . . . . . . 0 0 . 1 . 010 nuclear nobuild core ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 95.7 mt-10 -141.06 136.8 32.37 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.111 -0.495 . . . . 0.0 110.746 179.836 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 4' ' ' LEU . . . . . 0.477 HD21 HD21 ' A' ' 6' ' ' LEU . 14.5 tp -125.42 132.05 52.81 Favored 'General case' 0 C--N 1.332 -0.176 0 CA-C-N 116.114 -0.494 . . . . 0.0 110.218 177.616 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 5' ' ' LYS . . . . . . . . . . . . . 97.9 mttt -110.26 120.88 43.87 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.145 -0.479 . . . . 0.0 110.403 179.342 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 6' ' ' LEU . . . . . 0.477 HD21 HD21 ' A' ' 4' ' ' LEU . 66.3 mt -117.44 145.81 43.89 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 115.535 -0.757 . . . . 0.0 110.157 -178.864 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 25.8 ttpp -135.69 139.78 31.86 Favored Pre-proline 0 CA--C 1.534 0.334 0 CA-C-O 119.087 -0.483 . . . . 0.0 110.156 176.929 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 8' ' ' PRO . . . . . . . . . . . . . 92.7 Cg_endo -91.84 141.12 2.49 Favored 'Trans proline' 0 N--CA 1.489 1.227 0 C-N-CA 121.806 1.67 . . . . 0.0 111.766 177.157 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 58.8 mt -75.8 -49.65 3.46 Favored Pre-proline 0 CA--C 1.533 0.324 0 CA-C-O 118.507 -0.759 . . . . 0.0 112.588 -178.588 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 74.2 Cg_endo -76.33 155.56 36.94 Favored 'Trans proline' 0 N--CA 1.498 1.751 0 C-N-CA 121.062 1.175 . . . . 0.0 112.171 -179.436 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 27.0 tptp -87.74 92.47 9.12 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.117 -0.492 . . . . 0.0 110.468 179.42 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 12.6 p -143.63 148.75 18.66 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.32 0 CA-C-O 120.889 0.376 . . . . 0.0 110.837 -179.181 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 42.4 mp0 -87.68 129.6 35.09 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.1 -0.5 . . . . 0.0 110.332 178.47 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 14' ' ' LEU . . . . . . . . . . . . . 34.5 mt -99.24 151.66 37.49 Favored Pre-proline 0 C--N 1.33 -0.281 0 CA-C-N 116.41 -0.359 . . . . 0.0 110.813 -179.38 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 15' ' ' PRO . . . . . . . . . . . . . 27.4 Cg_exo -61.24 155.67 50.13 Favored 'Trans proline' 0 N--CA 1.497 1.717 0 C-N-CA 121.348 1.365 . . . . 0.0 111.624 177.051 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 16' ' ' PRO . . . . . . . . . . . . . 39.4 Cg_exo -58.58 -38.0 91.71 Favored 'Trans proline' 0 N--CA 1.498 1.74 0 C-N-CA 121.347 1.365 . . . . 0.0 112.798 -178.398 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 17' ' ' ASP . . . . . . . . . . . . . 12.3 p-10 -87.12 10.56 16.33 Favored 'General case' 0 CA--C 1.535 0.402 0 N-CA-C 113.231 0.826 . . . . 0.0 113.231 -177.476 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 18' ' ' PHE . . . . . . . . . . . . . 44.1 t80 -57.76 -43.14 85.26 Favored 'General case' 0 C--N 1.334 -0.085 0 O-C-N 121.942 -0.474 . . . . 0.0 110.229 -178.327 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 19' ' ' VAL . . . . . . . . . . . . . 48.1 t -56.32 -43.97 78.5 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.325 0 CA-C-N 116.291 -0.413 . . . . 0.0 110.64 -178.399 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 66.4 m-20 -59.57 -42.99 93.72 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-O 121.059 0.457 . . . . 0.0 110.815 -177.681 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 46.0 t -64.21 -48.79 84.09 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.253 0 CA-C-N 116.349 -0.387 . . . . 0.0 110.669 -177.856 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 22' ' ' ILE . . . . . 0.55 HG22 HD12 ' A' ' 26' ' ' LEU . 50.1 mm -55.65 -43.66 73.99 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.211 0 C-N-CA 120.911 -0.316 . . . . 0.0 110.689 179.861 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 23' ' ' ARG . . . . . . . . . . . . . 53.8 ttp180 -52.92 -51.92 59.62 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-O 120.55 0.214 . . . . 0.0 111.554 -179.367 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 24' ' ' ILE . . . . . . . . . . . . . 73.1 mt -60.01 -41.47 86.32 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.37 0 C-N-CA 121.095 -0.242 . . . . 0.0 111.295 -178.218 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 69.6 mmtt -64.19 -40.76 96.78 Favored 'General case' 0 C--N 1.328 -0.345 0 N-CA-C 112.187 0.44 . . . . 0.0 112.187 -178.516 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 26' ' ' LEU . . . . . 0.55 HD12 HG22 ' A' ' 22' ' ' ILE . 36.1 mt -79.61 -42.45 24.89 Favored 'General case' 0 C--N 1.329 -0.307 0 N-CA-C 113.025 0.75 . . . . 0.0 113.025 -171.289 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 27' ' ' GLN . . . . . . . . . . . . . 9.6 pt20 -46.4 140.08 4.45 Favored 'General case' 0 N--CA 1.469 0.492 0 N-CA-C 112.808 0.67 . . . . 0.0 112.808 -175.447 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 101.19 -27.93 18.35 Favored Glycine 0 CA--C 1.531 1.05 0 CA-C-N 115.591 -0.731 . . . . 0.0 112.214 -177.67 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 99.2 mttt -98.57 155.06 17.48 Favored 'General case' 0 C--O 1.232 0.18 0 CA-C-N 117.338 0.569 . . . . 0.0 111.228 179.095 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 30' ' ' THR . . . . . . . . . . . . . 49.3 m -105.29 135.54 46.48 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.117 -0.492 . . . . 0.0 109.709 174.994 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 34.4 m -129.26 159.99 40.67 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.206 0 CA-C-O 120.803 0.335 . . . . 0.0 110.996 -177.768 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 32' ' ' ARG . . . . . . . . . . . . . 38.2 ttm180 -130.66 147.88 52.39 Favored 'General case' 0 C--N 1.331 -0.217 0 CA-C-N 116.008 -0.542 . . . . 0.0 110.357 179.17 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 33' ' ' THR . . . . . . . . . . . . . 30.6 m -52.2 140.73 20.51 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-O 120.849 0.357 . . . . 0.0 111.386 -179.099 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 99.65 -17.13 57.96 Favored Glycine 0 CA--C 1.533 1.207 0 C-N-CA 121.156 -0.545 . . . . 0.0 113.202 -179.455 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 60.7 m-20 -64.92 150.1 48.47 Favored 'General case' 0 C--O 1.231 0.129 0 CA-C-N 118.059 0.93 . . . . 0.0 111.205 179.686 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 45.8 t -124.44 130.88 73.43 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.221 0 CA-C-N 115.762 -0.654 . . . . 0.0 109.838 178.963 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 37' ' ' ILE . . . . . . . . . . . . . 66.9 mt -122.89 139.86 48.4 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.221 0 CA-C-N 116.181 -0.463 . . . . 0.0 109.929 -179.647 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . -108.93 128.87 9.24 Favored Glycine 0 CA--C 1.525 0.668 0 N-CA-C 111.034 -0.826 . . . . 0.0 111.034 179.456 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 39' ' ' ILE . . . . . . . . . . . . . 70.3 mt -124.93 137.67 56.79 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.282 0 N-CA-C 110.008 -0.367 . . . . 0.0 110.008 179.59 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 40' ' ' SER . . . . . . . . . . . . . 53.6 p -91.37 114.28 26.76 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.443 -0.344 . . . . 0.0 110.789 176.697 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 41' ' ' ILE . . . . . . . . . . . . . 43.3 mm -121.69 113.44 39.17 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.185 0 N-CA-C 109.939 -0.393 . . . . 0.0 109.939 179.075 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 85.6 mt 58.83 35.46 24.26 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.36 -0.382 . . . . 0.0 111.475 178.61 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . 77.57 -10.14 25.24 Favored Glycine 0 CA--C 1.534 1.264 0 C-N-CA 121.283 -0.484 . . . . 0.0 113.434 178.419 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 44' ' ' LYS . . . . . . . . . . . . . 18.7 tptm -97.13 135.17 39.48 Favored 'General case' 0 C--N 1.333 -0.149 0 CA-C-N 117.941 0.87 . . . . 0.0 109.767 176.918 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 85.9 tt0 -82.38 123.96 29.58 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-O 120.802 0.334 . . . . 0.0 110.959 -178.977 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 46' ' ' VAL . . . . . . . . . . . . . 7.4 p -118.64 127.44 75.62 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.217 0 N-CA-C 109.465 -0.568 . . . . 0.0 109.465 176.765 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 62.3 mtpt -99.57 127.73 45.66 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.027 -0.533 . . . . 0.0 110.981 179.318 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 48' ' ' PHE . . . . . . . . . . . . . 86.8 m-85 -110.65 131.85 54.7 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.41 -0.359 . . . . 0.0 110.132 177.425 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 77.7 tttt -108.93 136.59 48.23 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.115 -0.493 . . . . 0.0 110.464 179.117 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 50' ' ' VAL . . . . . . . . . . . . . 44.6 t -81.0 106.19 11.86 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.288 0 N-CA-C 109.357 -0.609 . . . . 0.0 109.357 175.612 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 51' ' ' VAL . . . . . . . . . . . . . 55.3 t -69.38 -48.29 68.15 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.255 0 CA-C-N 116.065 -0.516 . . . . 0.0 109.89 -173.896 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 52' ' ' GLN . . . . . . . . . . . . . 21.5 pt20 -164.34 158.21 18.44 Favored 'General case' 0 C--N 1.331 -0.215 0 C-N-CA 120.198 -0.601 . . . . 0.0 111.786 179.549 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -135.87 136.4 40.53 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-N 115.292 -0.867 . . . . 0.0 110.062 179.126 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 54' ' ' TYR . . . . . . . . . . . . . 41.5 t80 -129.15 113.23 18.45 Favored Pre-proline 0 CA--C 1.535 0.368 0 CA-C-O 118.164 -0.922 . . . . 0.0 110.126 177.5 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 55' ' ' PRO . . . . . . . . . . . . . 74.3 Cg_endo -77.11 167.82 78.7 Favored 'Cis proline' 0 N--CA 1.499 1.804 0 CA-C-N 122.01 1.754 . . . . 0.0 112.343 -6.878 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 56' ' ' SER . . . . . . . . . . . . . 13.7 m -117.6 131.53 24.04 Favored Pre-proline 0 CA--C 1.539 0.531 0 CA-C-O 118.389 -0.815 . . . . 0.0 109.609 175.526 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 57' ' ' PRO . . . . . . . . . . . . . 36.6 Cg_endo -66.73 167.28 56.98 Favored 'Cis proline' 0 N--CA 1.498 1.756 0 CA-C-N 121.937 1.727 . . . . 0.0 111.253 -2.472 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 58' ' ' LEU . . . . . . . . . . . . . 34.5 tp -130.47 136.48 49.04 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.348 -0.387 . . . . 0.0 110.525 -179.831 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 59' ' ' ARG . . . . . . . . . . . . . 58.2 ttp180 -101.67 121.0 41.22 Favored 'General case' 0 C--N 1.326 -0.422 0 N-CA-C 109.164 -0.68 . . . . 0.0 109.164 175.721 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 43.7 t -76.28 120.29 26.05 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.308 0 C-N-CA 120.723 -0.391 . . . . 0.0 110.637 -173.049 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 95.0 mt-10 -131.02 163.21 28.09 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 115.78 -0.646 . . . . 0.0 109.726 176.891 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 62' ' ' ASP . . . . . . . . . . . . . 77.8 m-20 -53.99 -32.27 53.57 Favored 'General case' 0 C--N 1.329 -0.318 0 C-N-CA 120.981 -0.288 . . . . 0.0 111.695 -179.793 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 63' ' ' ARG . . . . . . . . . . . . . 39.7 ptt180 -78.47 2.35 19.25 Favored 'General case' 0 CA--C 1.537 0.465 0 N-CA-C 113.682 0.993 . . . . 0.0 113.682 -175.738 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 29.0 m -89.55 139.49 30.48 Favored 'General case' 0 C--N 1.333 -0.121 0 CA-C-N 118.131 0.423 . . . . 0.0 110.91 -178.446 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 65' ' ' LYS . . . . . . . . . . . . . 98.2 mttt -88.83 129.71 35.53 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.076 -0.511 . . . . 0.0 110.2 178.579 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 66' ' ' ILE . . . . . . . . . . . . . 60.6 mt -115.27 129.75 70.99 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.275 0 N-CA-C 109.903 -0.406 . . . . 0.0 109.903 179.296 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 67' ' ' THR . . . . . . . . . . . . . 25.7 m -120.25 136.97 54.48 Favored 'General case' 0 C--N 1.331 -0.224 0 CA-C-N 116.061 -0.518 . . . . 0.0 110.674 -179.587 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 68' ' ' LEU . . . . . 0.468 HD23 ' C ' ' A' ' 68' ' ' LEU . 6.6 tt . . . . . 0 C--N 1.329 -0.312 0 CA-C-N 115.863 -0.608 . . . . 0.0 110.158 178.778 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 74' ' ' ASP . . . . . . . . . . . . . 30.7 t0 . . . . . 0 C--O 1.229 -0.019 0 N-CA-C 109.617 -0.512 . . . . 0.0 109.617 . . . . . . . . . 0 0 . 1 . 010 nuclear nobuild core ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 39.4 t -112.71 122.76 67.51 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.207 0 CA-C-O 120.953 0.406 . . . . 0.0 110.481 -177.897 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 76' ' ' LEU . . . . . . . . . . . . . 25.0 mt -125.64 149.27 48.57 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 115.844 -0.616 . . . . 0.0 109.829 178.195 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 77' ' ' GLU . . . . . . . . . . . . . 96.8 mt-10 -137.03 138.04 40.04 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-O 121.015 0.436 . . . . 0.0 111.213 -177.986 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 78' ' ' ALA . . . . . . . . . . . . . . . -123.1 136.61 54.87 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 115.642 -0.708 . . . . 0.0 109.813 177.076 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 79' ' ' LYS . . . . . 0.62 ' O ' HD13 ' A' ' 80' ' ' ILE . 24.9 pttm -79.3 119.82 22.9 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-O 121.262 0.553 . . . . 0.0 111.018 -177.479 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 80' ' ' ILE . . . . . 0.62 HD13 ' O ' ' A' ' 79' ' ' LYS . 35.7 mm -139.28 104.67 2.21 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.252 0 CA-C-N 115.75 -0.659 . . . . 0.0 109.33 179.822 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 81' ' ' LYS . . . . . . . . . . . . . 99.3 mttt -102.21 127.03 49.33 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-O 120.958 0.409 . . . . 0.0 111.211 -176.726 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . 89.29 42.03 5.65 Favored Glycine 0 CA--C 1.525 0.673 0 N-CA-C 111.504 -0.638 . . . . 0.0 111.504 175.883 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 83' ' ' ILE . . . . . . . . . . . . . 71.0 mt -69.66 137.49 24.04 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.298 0 N-CA-C 109.77 -0.455 . . . . 0.0 109.77 176.749 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 84' ' ' LYS . . . . . . . . . . . . . 6.9 ttpm? -101.96 -48.56 4.21 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.102 179.362 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 85' ' ' ASP . . . . . . . . . . . . . 11.1 t70 -150.44 151.39 32.69 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 115.85 -0.614 . . . . 0.0 110.38 -179.721 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 86' ' ' VAL . . . . . 0.402 HG21 HG21 ' F' ' 133' ' ' ILE . 45.1 t -131.33 132.88 62.78 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.283 0 CA-C-O 120.958 0.409 . . . . 0.0 110.447 -179.134 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 87' ' ' ILE . . . . . 0.494 HD12 ' N ' ' A' ' 87' ' ' ILE . 5.1 mp -119.31 123.64 71.62 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.206 0 N-CA-C 109.169 -0.678 . . . . 0.0 109.169 175.891 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 88' ' ' LEU . . . . . 0.709 HD13 HG21 ' F' ' 131' ' ' VAL . 23.2 mt -114.0 129.71 56.59 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.164 -0.471 . . . . 0.0 111.148 -176.089 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 89' ' ' ASP . . . . . . . . . . . . . 13.6 t70 -124.02 154.6 39.64 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 115.83 -0.623 . . . . 0.0 109.677 176.709 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 41.6 mp0 -50.69 -37.33 40.66 Favored 'General case' 0 C--N 1.329 -0.316 0 N-CA-C 112.396 0.517 . . . . 0.0 112.396 -171.789 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 91' ' ' ASN . . . . . . . . . . . . . 20.2 p-10 -132.23 35.64 3.68 Favored 'General case' 0 N--CA 1.464 0.268 0 CA-C-O 120.679 0.276 . . . . 0.0 111.727 -177.112 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 92' ' ' LEU . . . . . . . . . . . . . 7.1 tp -166.12 139.76 4.24 Favored 'General case' 0 C--N 1.33 -0.282 0 N-CA-C 110.08 -0.341 . . . . 0.0 110.08 179.792 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 93' ' ' ILE . . . . . . . . . . . . . 66.7 mt -124.93 122.96 64.63 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.178 0 N-CA-C 109.749 -0.463 . . . . 0.0 109.749 -178.758 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 94' ' ' VAL . . . . . 0.486 HG11 HG11 ' A' ' 123' ' ' VAL . 41.8 t -125.6 127.84 71.9 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.181 0 CA-C-O 120.958 0.408 . . . . 0.0 110.142 179.44 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 95' ' ' VAL . . . . . . . . . . . . . 47.7 t -120.58 135.41 60.9 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.343 0 CA-C-N 115.909 -0.587 . . . . 0.0 109.875 -179.951 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 96' ' ' ILE . . . . . . . . . . . . . 65.7 mt -114.08 127.04 71.68 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.279 0 N-CA-C 109.341 -0.615 . . . . 0.0 109.341 178.388 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 97' ' ' THR . . . . . . . . . . . . . 67.8 p -97.72 162.8 13.1 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-O 121.331 0.586 . . . . 0.0 111.316 -176.918 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 98' ' ' GLU . . . . . . . . . . . . . 79.7 tt0 -53.84 -29.05 39.36 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 115.86 -0.609 . . . . 0.0 112.1 -178.993 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 99' ' ' GLU . . . . . . . . . . . . . 95.6 mt-10 -79.2 13.38 1.88 Allowed 'General case' 0 CA--C 1.534 0.365 0 N-CA-C 113.224 0.824 . . . . 0.0 113.224 -176.936 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 100' ' ' ASN . . . . . . . . . . . . . 4.0 m-20 61.18 34.41 18.88 Favored 'General case' 0 CA--C 1.53 0.179 0 CA-C-N 118.058 0.39 . . . . 0.0 111.414 -179.388 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 101' ' ' GLU . . . . . . . . . . . . . 84.0 tt0 -107.74 143.99 35.5 Favored 'General case' 0 C--N 1.333 -0.138 0 N-CA-C 109.537 -0.542 . . . . 0.0 109.537 172.993 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 102' ' ' VAL . . . . . . . . . . . . . 42.6 t -115.52 125.98 72.91 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.302 0 CA-C-N 116.273 -0.421 . . . . 0.0 110.007 -177.195 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 103' ' ' LEU . . . . . . . . . . . . . 66.2 mt -116.72 130.77 56.93 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 115.767 -0.651 . . . . 0.0 110.189 176.749 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 104' ' ' ILE . . . . . . . . . . . . . 68.6 mt -118.63 123.33 71.38 Favored 'Isoleucine or valine' 0 C--O 1.234 0.247 0 N-CA-C 110.26 -0.274 . . . . 0.0 110.26 -178.854 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 105' ' ' PHE . . . . . . . . . . . . . 67.6 m-85 -122.99 163.7 19.94 Favored 'General case' 0 C--O 1.232 0.148 0 O-C-N 124.003 0.815 . . . . 0.0 110.136 -178.176 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 106' ' ' ASN . . . . . . . . . . . . . 43.5 p-10 -97.77 -169.9 1.9 Allowed 'General case' 0 C--N 1.329 -0.283 0 N-CA-C 109.566 -0.531 . . . . 0.0 109.566 171.93 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 107' ' ' GLN . . . . . . . . . . . . . 31.7 tt0 -57.38 -29.68 64.26 Favored 'General case' 0 C--N 1.328 -0.348 0 N-CA-C 111.988 0.366 . . . . 0.0 111.988 178.983 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 108' ' ' ASN . . . . . . . . . . . . . 6.1 t-20 -86.98 11.57 13.29 Favored 'General case' 0 CA--C 1.536 0.421 0 N-CA-C 113.09 0.774 . . . . 0.0 113.09 -175.792 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 109' ' ' LEU . . . . . . . . . . . . . 41.6 mt 57.69 37.03 27.21 Favored 'General case' 0 C--N 1.332 -0.181 0 CA-C-O 120.88 0.372 . . . . 0.0 111.475 177.303 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 110' ' ' GLU . . . . . . . . . . . . . 43.5 mt-10 -104.73 146.72 28.56 Favored 'General case' 0 C--N 1.331 -0.228 0 N-CA-C 110.108 -0.33 . . . . 0.0 110.108 176.475 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 111' ' ' GLU . . . . . . . . . . . . . 99.3 mt-10 -76.89 121.98 24.19 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-O 120.92 0.39 . . . . 0.0 110.928 -178.57 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 112' ' ' LEU . . . . . . . . . . . . . 49.0 mt -110.12 -45.69 3.56 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 115.941 -0.572 . . . . 0.0 110.158 177.575 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 113' ' ' TYR . . . . . . . . . . . . . 64.8 t80 -134.15 135.86 43.4 Favored 'General case' 0 C--N 1.332 -0.187 0 CA-C-N 116.119 -0.491 . . . . 0.0 110.99 179.845 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 114' ' ' ARG . . . . . . . . . . . . . 83.3 mtp180 -135.17 123.25 22.81 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 116.043 -0.526 . . . . 0.0 110.248 177.937 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 115' ' ' GLY . . . . . . . . . . . . . . . -150.08 158.8 27.83 Favored Glycine 0 CA--C 1.524 0.625 0 N-CA-C 110.854 -0.898 . . . . 0.0 110.854 178.761 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 116' ' ' LYS . . . . . . . . . . . . . 79.8 tttt -134.18 131.76 38.99 Favored 'General case' 0 C--N 1.329 -0.32 0 N-CA-C 110.016 -0.365 . . . . 0.0 110.016 178.199 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 117' ' ' PHE . . . . . . . . . . . . . 20.0 m-85 -136.36 114.07 11.1 Favored 'General case' 0 C--N 1.331 -0.216 0 CA-C-N 116.362 -0.381 . . . . 0.0 110.066 -174.65 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 118' ' ' GLU . . . . . . . . . . . . . 96.1 mt-10 -54.5 -38.57 66.63 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.557 -0.292 . . . . 0.0 111.283 -177.945 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 119' ' ' ASN . . . . . . . . . . . . . 7.9 m-80 -100.44 30.53 3.85 Favored 'General case' 0 C--N 1.331 -0.232 0 N-CA-C 112.142 0.423 . . . . 0.0 112.142 -175.24 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 120' ' ' LEU . . . . . . . . . . . . . 16.3 tp -58.33 122.27 12.83 Favored 'General case' 0 C--N 1.331 -0.196 0 N-CA-C 110.084 -0.339 . . . . 0.0 110.084 177.322 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 121' ' ' ASN . . . . . . . . . . . . . 60.8 t30 -114.13 -44.09 3.17 Favored 'General case' 0 N--CA 1.462 0.169 0 CA-C-N 116.712 -0.222 . . . . 0.0 111.426 -176.986 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 122' ' ' LYS . . . . . . . . . . . . . 98.5 mttt -147.02 150.69 35.6 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-O 121.016 0.436 . . . . 0.0 111.665 -176.39 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 123' ' ' VAL . . . . . 0.486 HG11 HG11 ' A' ' 94' ' ' VAL . 40.9 t -128.79 129.16 68.31 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.319 0 CA-C-N 115.89 -0.596 . . . . 0.0 109.414 174.691 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 124' ' ' LEU . . . . . . . . . . . . . 52.6 mt -117.2 132.94 56.53 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-O 120.723 0.297 . . . . 0.0 110.372 -178.787 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 125' ' ' VAL . . . . . 0.473 HG12 HG23 ' A' ' 130' ' ' VAL . 34.9 m -134.32 133.75 55.19 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.252 0 CA-C-N 116.152 -0.477 . . . . 0.0 111.045 -178.092 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 126' ' ' ARG . . . . . . . . . . . . . 14.9 ptm180 -163.4 137.19 5.82 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.185 -0.461 . . . . 0.0 109.85 175.291 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 127' ' ' ASN . . . . . . . . . . . . . 69.4 m-20 55.56 -154.82 0.29 Allowed 'General case' 0 CA--C 1.539 0.531 0 N-CA-C 109.818 -0.438 . . . . 0.0 109.818 -178.77 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 128' ' ' ASP . . . . . . . . . . . . . 23.8 p-10 -84.65 22.25 1.36 Allowed 'General case' 0 CA--C 1.534 0.334 0 CA-C-N 118.383 0.538 . . . . 0.0 112.339 177.419 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 129' ' ' LEU . . . . . . . . . . . . . 16.5 tp -118.58 138.92 52.23 Favored 'General case' 0 C--O 1.234 0.249 0 O-C-N 122.112 -0.367 . . . . 0.0 110.178 178.764 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 130' ' ' VAL . . . . . 0.515 HG13 ' HB ' ' A' ' 141' ' ' ILE . 12.3 p -135.37 140.35 44.99 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.2 0 CA-C-O 120.96 0.41 . . . . 0.0 110.396 -178.773 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 131' ' ' VAL . . . . . 0.461 HG23 ' O ' ' A' ' 139' ' ' THR . 14.6 p -136.17 141.12 42.42 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.233 0 CA-C-O 120.981 0.42 . . . . 0.0 110.891 179.29 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 132' ' ' ILE . . . . . . . . . . . . . 73.4 mt -112.96 134.02 56.93 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.292 0 CA-C-N 115.859 -0.61 . . . . 0.0 109.637 179.756 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 133' ' ' ILE . . . . . . . . . . . . . 41.7 mm -117.66 124.35 72.94 Favored 'Isoleucine or valine' 0 C--O 1.233 0.198 0 CA-C-O 120.806 0.336 . . . . 0.0 110.976 -176.192 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 134' ' ' ASP . . . . . . . . . . . . . 7.1 p-10 -136.61 148.46 47.49 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.253 -0.43 . . . . 0.0 109.85 175.747 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 135' ' ' GLU . . . . . . . . . . . . . 83.0 tt0 -50.02 -26.9 4.76 Favored 'General case' 0 C--N 1.328 -0.341 0 N-CA-C 112.67 0.619 . . . . 0.0 112.67 -174.66 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 136' ' ' GLN . . . . . . . . . . . . . 94.3 mt-30 -82.67 -32.44 28.14 Favored 'General case' 0 C--N 1.33 -0.251 0 N-CA-C 112.344 0.498 . . . . 0.0 112.344 -175.596 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 137' ' ' LYS . . . . . . . . . . . . . 56.5 pttt -170.01 176.63 4.62 Favored 'General case' 0 C--N 1.333 -0.133 0 CA-C-O 121.592 0.71 . . . . 0.0 112.29 -172.795 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 138' ' ' LEU . . . . . 0.427 ' C ' HD23 ' A' ' 138' ' ' LEU . 7.5 tt -122.18 130.17 52.96 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-N 115.006 -0.997 . . . . 0.0 110.045 179.201 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 139' ' ' THR . . . . . 0.461 ' O ' HG23 ' A' ' 131' ' ' VAL . 85.2 m -115.42 124.54 51.43 Favored 'General case' 0 C--N 1.331 -0.224 0 CA-C-N 116.253 -0.431 . . . . 0.0 110.212 179.206 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 140' ' ' LEU . . . . . . . . . . . . . 21.0 tp -111.86 125.93 54.55 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.005 -0.543 . . . . 0.0 109.606 -178.979 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 141' ' ' ILE . . . . . 0.515 ' HB ' HG13 ' A' ' 130' ' ' VAL . 19.6 mt -123.31 124.56 70.14 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.252 0 CA-C-O 120.996 0.427 . . . . 0.0 110.234 -172.814 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 142' ' ' ARG . . . . . . . . . . . . . 81.1 mtp180 -111.84 125.78 54.38 Favored 'General case' 0 C--O 1.233 0.22 0 CA-C-N 115.429 -0.805 . . . . 0.0 109.843 -178.895 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 143' ' ' THR . . . . . . . . . . . . . 40.0 p . . . . . 0 C--O 1.22 -0.452 0 CA-C-O 118.014 -0.994 . . . . 0.0 110.555 -179.226 . . . . . . . . 0 0 . 1 . 010 nuclear nobuild core ' B' B ' 2' ' ' SER . . . . . . . . . . . . . 4.9 p . . . . . 0 N--CA 1.461 0.096 0 CA-C-O 120.797 0.332 . . . . 0.0 110.585 . . . . . . . . . 0 0 . 1 . 010 nuclear nobuild core ' B' B ' 3' ' ' GLU . . . . . . . . . . . . . 40.7 mt-10 -141.08 141.44 34.25 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.243 -0.435 . . . . 0.0 111.09 -178.962 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B ' 4' ' ' LEU . . . . . . . . . . . . . 16.4 tp -125.9 129.82 50.09 Favored 'General case' 0 C--N 1.333 -0.143 0 CA-C-N 116.011 -0.541 . . . . 0.0 109.912 176.047 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B ' 5' ' ' LYS . . . . . . . . . . . . . 57.1 mttp -108.79 123.24 48.71 Favored 'General case' 0 C--O 1.236 0.359 0 CA-C-N 116.625 -0.262 . . . . 0.0 110.891 -179.394 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B ' 6' ' ' LEU . . . . . . . . . . . . . 66.6 mt -114.62 145.88 41.48 Favored 'General case' 0 C--N 1.331 -0.223 0 CA-C-N 115.71 -0.677 . . . . 0.0 110.557 179.646 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B ' 7' ' ' LYS . . . . . . . . . . . . . 83.7 tttt -128.12 142.0 43.08 Favored Pre-proline 0 CA--C 1.533 0.303 0 CA-C-O 119.057 -0.497 . . . . 0.0 109.787 175.569 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B ' 8' ' ' PRO . . . . . . . . . . . . . 93.7 Cg_endo -90.37 136.06 2.26 Favored 'Trans proline' 0 N--CA 1.49 1.318 0 C-N-CA 121.717 1.611 . . . . 0.0 111.832 179.131 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B ' 9' ' ' LEU . . . . . . . . . . . . . 28.0 mt -82.96 -47.2 0.84 Allowed Pre-proline 0 CA--C 1.535 0.401 0 CA-C-O 118.631 -0.699 . . . . 0.0 112.061 -179.358 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B ' 10' ' ' PRO . . . . . . . . . . . . . 83.8 Cg_endo -82.53 157.03 16.52 Favored 'Trans proline' 0 N--CA 1.495 1.592 0 C-N-CA 121.29 1.326 . . . . 0.0 111.802 175.688 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B ' 11' ' ' LYS . . . . . . . . . . . . . 18.2 pttp -86.03 110.38 19.46 Favored 'General case' 0 C--N 1.331 -0.216 0 CA-C-O 121.523 0.677 . . . . 0.0 110.329 177.42 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B ' 12' ' ' VAL . . . . . . . . . . . . . 12.0 p -151.07 149.53 14.09 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.359 0 CA-C-N 115.72 -0.673 . . . . 0.0 110.329 -179.978 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B ' 13' ' ' GLU . . . . . . . . . . . . . 42.0 tp10 -95.73 120.6 36.28 Favored 'General case' 0 C--N 1.329 -0.293 0 C-N-CA 120.853 -0.339 . . . . 0.0 110.217 177.714 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B ' 14' ' ' LEU . . . . . . . . . . . . . 37.2 mt -97.94 149.05 35.32 Favored Pre-proline 0 CA--C 1.533 0.316 0 CA-C-O 119.318 -0.372 . . . . 0.0 110.592 -177.736 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B ' 15' ' ' PRO . . . . . . . . . . . . . 26.7 Cg_exo -61.8 157.11 44.55 Favored 'Trans proline' 0 N--CA 1.499 1.83 0 C-N-CA 121.286 1.324 . . . . 0.0 111.663 176.998 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B ' 16' ' ' PRO . . . . . . . . . . . . . 39.1 Cg_exo -58.97 -33.95 98.94 Favored 'Trans proline' 0 N--CA 1.497 1.685 0 C-N-CA 121.416 1.411 . . . . 0.0 112.498 179.584 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B ' 17' ' ' ASP . . . . . . . . . . . . . 18.7 p-10 -88.02 9.69 21.54 Favored 'General case' 0 CA--C 1.536 0.413 0 N-CA-C 113.234 0.828 . . . . 0.0 113.234 -177.791 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B ' 18' ' ' PHE . . . . . . . . . . . . . 43.5 t80 -58.32 -46.49 86.08 Favored 'General case' 0 CA--C 1.523 -0.06 0 O-C-N 121.965 -0.459 . . . . 0.0 109.996 -177.983 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B ' 19' ' ' VAL . . . . . 0.417 HG13 ' N ' ' B' ' 20' ' ' ASP . 12.9 p -53.91 -41.4 48.95 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.328 0 CA-C-N 116.501 -0.318 . . . . 0.0 111.188 -178.422 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' B' B ' 20' ' ' ASP . . . . . 0.417 ' N ' HG13 ' B' ' 19' ' ' VAL . 81.2 m-20 -60.82 -45.15 95.57 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-O 120.935 0.398 . . . . 0.0 110.83 -178.841 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' B' B ' 21' ' ' VAL . . . . . . . . . . . . . 40.7 t -64.16 -44.32 97.54 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.287 0 CA-C-N 116.272 -0.422 . . . . 0.0 110.654 -177.614 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B ' 22' ' ' ILE . . . . . 0.553 HG22 HD12 ' B' ' 26' ' ' LEU . 50.3 mm -59.68 -40.01 81.16 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.199 0 C-N-CA 120.816 -0.354 . . . . 0.0 110.829 -179.65 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' B' B ' 23' ' ' ARG . . . . . . . . . . . . . 57.7 ttp180 -55.16 -49.14 72.6 Favored 'General case' 0 N--CA 1.463 0.219 0 CA-C-O 121.103 0.478 . . . . 0.0 110.692 177.736 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B ' 24' ' ' ILE . . . . . . . . . . . . . 72.4 mt -60.39 -42.85 92.43 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 CA-C-N 115.729 -0.668 . . . . 0.0 111.845 -177.047 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B ' 25' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -72.01 -37.43 69.79 Favored 'General case' 0 CA--C 1.535 0.37 0 N-CA-C 112.103 0.409 . . . . 0.0 112.103 -175.157 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' B' B ' 26' ' ' LEU . . . . . 0.553 HD12 HG22 ' B' ' 22' ' ' ILE . 40.4 mt -79.54 -39.7 31.25 Favored 'General case' 0 C--N 1.331 -0.231 0 N-CA-C 112.91 0.707 . . . . 0.0 112.91 -172.569 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' B' B ' 27' ' ' GLN . . . . . . . . . . . . . 9.6 pt20 -45.78 139.03 4.36 Favored 'General case' 0 N--CA 1.469 0.523 0 N-CA-C 112.84 0.682 . . . . 0.0 112.84 -175.095 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B ' 28' ' ' GLY . . . . . . . . . . . . . . . 102.01 -26.65 23.57 Favored Glycine 0 CA--C 1.531 1.066 0 CA-C-N 115.367 -0.833 . . . . 0.0 112.191 -176.737 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B ' 29' ' ' LYS . . . . . . . . . . . . . 54.8 mtpt -98.59 155.18 17.42 Favored 'General case' 0 C--O 1.233 0.198 0 CA-C-N 117.523 0.661 . . . . 0.0 111.237 179.058 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B ' 30' ' ' THR . . . . . . . . . . . . . 53.7 m -101.03 139.43 36.73 Favored 'General case' 0 C--N 1.331 -0.216 0 CA-C-N 116.045 -0.525 . . . . 0.0 110.1 176.03 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B ' 31' ' ' VAL . . . . . . . . . . . . . 34.5 m -130.47 155.4 41.7 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.305 0 CA-C-N 116.142 -0.481 . . . . 0.0 110.413 179.394 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B ' 32' ' ' ARG . . . . . . . . . . . . . 71.5 ttt-85 -135.41 150.25 49.84 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-O 121.048 0.451 . . . . 0.0 110.24 178.211 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B ' 33' ' ' THR . . . . . . . . . . . . . 19.8 m -52.28 137.67 28.2 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-O 120.894 0.378 . . . . 0.0 111.634 -177.068 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B ' 34' ' ' GLY . . . . . . . . . . . . . . . 101.97 -17.2 54.86 Favored Glycine 0 CA--C 1.533 1.179 0 CA-C-O 119.622 -0.543 . . . . 0.0 113.21 179.087 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B ' 35' ' ' ASP . . . . . . . . . . . . . 76.3 m-20 -67.28 148.58 51.51 Favored 'General case' 0 N--CA 1.462 0.128 0 CA-C-N 118.087 0.943 . . . . 0.0 111.299 179.514 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B ' 36' ' ' VAL . . . . . . . . . . . . . 46.3 t -121.44 131.15 73.74 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.198 0 CA-C-N 115.935 -0.575 . . . . 0.0 109.873 177.737 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B ' 37' ' ' ILE . . . . . . . . . . . . . 63.8 mt -121.27 138.57 51.21 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.299 0 CA-C-N 116.26 -0.427 . . . . 0.0 109.957 -179.921 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B ' 38' ' ' GLY . . . . . . . . . . . . . . . -114.42 127.52 7.78 Favored Glycine 0 CA--C 1.524 0.636 0 N-CA-C 111.01 -0.836 . . . . 0.0 111.01 179.126 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B ' 39' ' ' ILE . . . . . . . . . . . . . 70.8 mt -128.94 130.92 68.57 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.213 0 N-CA-C 110.003 -0.369 . . . . 0.0 110.003 178.685 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B ' 40' ' ' SER . . . . . 0.428 ' O ' HD13 ' B' ' 41' ' ' ILE . 59.7 p -90.93 118.19 30.12 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.422 -0.354 . . . . 0.0 110.693 176.959 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' B' B ' 41' ' ' ILE . . . . . 0.428 HD13 ' O ' ' B' ' 40' ' ' SER . 48.2 mm -125.08 116.95 48.58 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.19 0 CA-C-O 120.974 0.416 . . . . 0.0 110.237 179.686 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' B' B ' 42' ' ' LEU . . . . . 0.542 ' O ' HD23 ' B' ' 42' ' ' LEU . 1.3 tt 56.65 45.58 21.8 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-O 121.414 0.626 . . . . 0.0 110.366 178.217 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' B' B ' 43' ' ' GLY . . . . . . . . . . . . . . . 75.16 -9.65 12.21 Favored Glycine 0 CA--C 1.534 1.238 0 CA-C-N 116.062 -0.517 . . . . 0.0 113.726 175.378 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B ' 44' ' ' LYS . . . . . . . . . . . . . 46.8 tttp -107.29 126.9 53.03 Favored 'General case' 0 C--N 1.333 -0.121 0 CA-C-N 118.064 0.932 . . . . 0.0 110.189 -179.216 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B ' 45' ' ' GLU . . . . . . . . . . . . . 42.6 tp10 -83.51 128.84 34.83 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-O 120.829 0.347 . . . . 0.0 111.222 -178.781 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B ' 46' ' ' VAL . . . . . . . . . . . . . 8.7 p -120.18 127.08 75.88 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.198 0 N-CA-C 109.574 -0.528 . . . . 0.0 109.574 176.004 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B ' 47' ' ' LYS . . . . . . . . . . . . . 87.0 mttt -98.94 124.82 44.16 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.03 -0.532 . . . . 0.0 110.603 177.092 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B ' 48' ' ' PHE . . . . . . . . . . . . . 40.5 m-85 -108.96 131.8 54.71 Favored 'General case' 0 C--N 1.327 -0.379 0 N-CA-C 109.698 -0.482 . . . . 0.0 109.698 177.145 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B ' 49' ' ' LYS . . . . . . . . . . . . . 84.3 tttt -107.89 134.71 50.44 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.452 -0.34 . . . . 0.0 110.406 178.21 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B ' 50' ' ' VAL . . . . . . . . . . . . . 43.4 t -76.34 104.86 4.72 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.303 0 N-CA-C 109.25 -0.648 . . . . 0.0 109.25 176.729 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B ' 51' ' ' VAL . . . . . . . . . . . . . 47.0 t -69.6 -49.79 55.87 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.275 0 CA-C-N 116.088 -0.505 . . . . 0.0 109.799 -174.428 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B ' 52' ' ' GLN . . . . . . . . . . . . . 34.2 tt0 -161.91 145.05 11.99 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 115.928 -0.578 . . . . 0.0 111.569 -178.458 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B ' 53' ' ' ALA . . . . . . . . . . . . . . . -120.71 133.57 55.34 Favored 'General case' 0 C--N 1.331 -0.219 0 CA-C-N 115.792 -0.64 . . . . 0.0 110.051 176.963 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B ' 54' ' ' TYR . . . . . . . . . . . . . 45.9 t80 -129.06 109.63 18.19 Favored Pre-proline 0 CA--C 1.534 0.362 0 CA-C-O 118.27 -0.871 . . . . 0.0 110.243 178.276 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B ' 55' ' ' PRO . . . . . . . . . . . . . 73.6 Cg_endo -77.11 168.24 77.54 Favored 'Cis proline' 0 N--CA 1.5 1.862 0 CA-C-N 121.818 1.685 . . . . 0.0 112.518 -5.921 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B ' 56' ' ' SER . . . . . . . . . . . . . 50.5 m -117.3 134.02 23.13 Favored Pre-proline 0 CA--C 1.539 0.532 0 CA-C-O 118.418 -0.801 . . . . 0.0 109.557 174.851 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B ' 57' ' ' PRO . . . . . . . . . . . . . 35.2 Cg_endo -66.27 164.37 66.14 Favored 'Cis proline' 0 N--CA 1.497 1.713 0 CA-C-N 121.838 1.692 . . . . 0.0 111.341 -2.547 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B ' 58' ' ' LEU . . . . . . . . . . . . . 20.7 tp -129.78 136.05 49.16 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-O 120.966 0.413 . . . . 0.0 110.321 -179.061 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B ' 59' ' ' ARG . . . . . . . . . . . . . 36.4 ttm180 -104.47 126.89 51.98 Favored 'General case' 0 C--N 1.326 -0.455 0 N-CA-C 109.169 -0.678 . . . . 0.0 109.169 175.69 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B ' 60' ' ' VAL . . . . . . . . . . . . . 49.3 t -77.3 117.51 22.43 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.243 0 C-N-CA 120.638 -0.425 . . . . 0.0 109.933 -176.159 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B ' 61' ' ' GLU . . . . . . . . . . . . . 94.9 mt-10 -130.99 167.9 18.27 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.088 -0.505 . . . . 0.0 110.247 -179.789 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B ' 62' ' ' ASP . . . . . . . . . . . . . 24.6 t0 -54.26 -32.5 56.28 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-N 116.506 -0.315 . . . . 0.0 111.799 -178.816 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B ' 63' ' ' ARG . . . . . . . . . . . . . 5.0 ptp180 -88.9 10.14 22.35 Favored 'General case' 0 CA--C 1.534 0.353 0 N-CA-C 113.499 0.926 . . . . 0.0 113.499 -175.147 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B ' 64' ' ' THR . . . . . . . . . . . . . 27.2 m -94.02 134.4 36.46 Favored 'General case' 0 C--N 1.333 -0.122 0 CA-C-N 118.199 0.454 . . . . 0.0 110.507 -179.557 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B ' 65' ' ' LYS . . . . . . . . . . . . . 67.2 mttm -90.7 133.31 35.24 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.011 -0.54 . . . . 0.0 110.616 179.706 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B ' 66' ' ' ILE . . . . . . . . . . . . . 61.5 mt -110.75 129.6 65.64 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.21 0 N-CA-C 109.737 -0.468 . . . . 0.0 109.737 178.959 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B ' 67' ' ' THR . . . . . . . . . . . . . 27.5 m -123.47 145.52 48.76 Favored 'General case' 0 C--N 1.331 -0.23 0 CA-C-N 116.055 -0.52 . . . . 0.0 110.644 -178.277 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B ' 68' ' ' LEU . . . . . . . . . . . . . 52.9 mt . . . . . 0 C--N 1.331 -0.228 0 CA-C-N 115.931 -0.577 . . . . 0.0 111.135 -178.442 . . . . . . . . 0 0 . 1 . 010 nuclear nobuild core ' B' B ' 73' ' ' VAL . . . . . . . . . . . . . 34.5 m . . . . . 0 C--O 1.233 0.201 0 N-CA-C 109.629 -0.508 . . . . 0.0 109.629 . . . . . . . . . 0 0 . 1 . 010 nuclear nobuild core ' B' B ' 74' ' ' ASP . . . . . . . . . . . . . 28.9 t0 -84.85 115.35 22.7 Favored 'General case' 0 C--N 1.329 -0.323 0 C-N-CA 120.474 -0.49 . . . . 0.0 110.242 -170.972 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B ' 75' ' ' VAL . . . . . . . . . . . . . 40.8 t -120.26 122.19 67.66 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.211 0 CA-C-O 121.099 0.476 . . . . 0.0 110.55 -177.842 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B ' 76' ' ' LEU . . . . . . . . . . . . . 5.9 mp -119.25 137.64 53.53 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 115.609 -0.723 . . . . 0.0 109.288 174.627 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B ' 77' ' ' GLU . . . . . . . . . . . . . 96.8 mt-10 -129.6 138.11 51.08 Favored 'General case' 0 C--N 1.331 -0.208 0 CA-C-O 121.159 0.504 . . . . 0.0 111.106 -176.405 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B ' 78' ' ' ALA . . . . . . . . . . . . . . . -127.35 129.19 47.17 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 115.591 -0.731 . . . . 0.0 109.681 176.785 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B ' 79' ' ' LYS . . . . . 0.611 ' O ' HD13 ' B' ' 80' ' ' ILE . 79.9 tttt -76.35 119.34 20.09 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.413 -0.358 . . . . 0.0 110.304 -178.294 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' B' B ' 80' ' ' ILE . . . . . 0.611 HD13 ' O ' ' B' ' 79' ' ' LYS . 40.6 mm -139.2 113.86 7.75 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.306 0 N-CA-C 109.469 -0.567 . . . . 0.0 109.469 -175.027 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' B' B ' 81' ' ' LYS . . . . . . . . . . . . . 86.9 tttt -99.33 122.89 43.1 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-O 120.82 0.343 . . . . 0.0 111.214 -177.219 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B ' 82' ' ' GLY . . . . . . . . . . . . . . . 89.15 42.18 5.66 Favored Glycine 0 CA--C 1.526 0.752 0 C-N-CA 120.683 -0.77 . . . . 0.0 112.413 171.715 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B ' 83' ' ' ILE . . . . . . . . . . . . . 71.3 mt -63.83 137.93 23.9 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.283 0 N-CA-C 109.484 -0.562 . . . . 0.0 109.484 174.818 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B ' 84' ' ' LYS . . . . . . . . . . . . . 36.7 ttpt -106.58 -51.22 2.98 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-O 120.878 0.37 . . . . 0.0 110.352 -178.152 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B ' 85' ' ' ASP . . . . . . . . . . . . . 13.1 t70 -145.25 146.16 31.58 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 115.969 -0.559 . . . . 0.0 110.54 -178.108 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B ' 86' ' ' VAL . . . . . . . . . . . . . 46.2 t -129.97 131.89 65.89 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.263 0 CA-C-O 120.996 0.427 . . . . 0.0 110.448 -179.098 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B ' 87' ' ' ILE . . . . . 0.489 ' N ' HD12 ' B' ' 87' ' ' ILE . 5.0 mp -120.47 127.29 75.9 Favored 'Isoleucine or valine' 0 C--O 1.233 0.22 0 CA-C-N 115.86 -0.609 . . . . 0.0 109.494 176.846 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' B' B ' 88' ' ' LEU . . . . . . . . . . . . . 13.7 tp -113.68 132.93 55.61 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-O 120.963 0.411 . . . . 0.0 111.284 -177.036 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B ' 89' ' ' ASP . . . . . . . . . . . . . 11.4 t70 -130.38 155.25 46.69 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 115.745 -0.661 . . . . 0.0 109.675 176.602 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B ' 90' ' ' GLU . . . . . . . . . . . . . 84.4 tt0 -45.74 -48.56 15.27 Favored 'General case' 0 N--CA 1.466 0.34 0 N-CA-C 112.798 0.666 . . . . 0.0 112.798 -173.194 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B ' 91' ' ' ASN . . . . . . . . . . . . . 2.6 p30 -126.04 39.33 3.97 Favored 'General case' 0 N--CA 1.465 0.294 0 CA-C-O 120.958 0.409 . . . . 0.0 110.966 -177.904 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B ' 92' ' ' LEU . . . . . . . . . . . . . 10.8 tp -165.5 140.17 4.87 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.312 -0.404 . . . . 0.0 110.383 -179.376 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B ' 93' ' ' ILE . . . . . . . . . . . . . 69.6 mt -128.77 122.56 57.3 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.289 0 N-CA-C 109.294 -0.632 . . . . 0.0 109.294 179.55 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B ' 94' ' ' VAL . . . . . . . . . . . . . 46.4 t -122.54 128.62 75.42 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.229 0 CA-C-O 120.947 0.403 . . . . 0.0 110.147 -178.838 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B ' 95' ' ' VAL . . . . . . . . . . . . . 42.1 t -123.16 134.28 66.67 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.283 0 CA-C-N 116.017 -0.538 . . . . 0.0 109.834 -179.785 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B ' 96' ' ' ILE . . . . . . . . . . . . . 62.1 mt -117.8 129.92 73.47 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.237 0 N-CA-C 109.464 -0.569 . . . . 0.0 109.464 179.845 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B ' 97' ' ' THR . . . . . . . . . . . . . 70.8 p -103.38 161.2 14.04 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-O 121.23 0.538 . . . . 0.0 111.547 -176.522 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B ' 98' ' ' GLU . . . . . . . . . . . . . 71.0 mm-40 -53.79 -27.42 29.06 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 115.97 -0.559 . . . . 0.0 112.149 178.679 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B ' 99' ' ' GLU . . . . . . . . . . . . . 95.5 mt-10 -76.6 11.8 1.51 Allowed 'General case' 0 CA--C 1.536 0.433 0 N-CA-C 113.235 0.828 . . . . 0.0 113.235 -178.113 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B ' 100' ' ' ASN . . . . . . . . . . . . . 6.2 m-20 61.24 37.61 17.19 Favored 'General case' 0 CA--C 1.528 0.116 0 CA-C-O 120.912 0.387 . . . . 0.0 110.984 179.524 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B ' 101' ' ' GLU . . . . . . . . . . . . . 85.0 tt0 -113.44 142.89 45.36 Favored 'General case' 0 C--N 1.331 -0.197 0 N-CA-C 109.606 -0.516 . . . . 0.0 109.606 174.321 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B ' 102' ' ' VAL . . . . . . . . . . . . . 40.3 t -115.69 125.67 72.95 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.312 0 CA-C-N 116.158 -0.474 . . . . 0.0 109.968 -178.173 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B ' 103' ' ' LEU . . . . . . . . . . . . . 23.5 mt -115.87 126.97 54.64 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 115.736 -0.665 . . . . 0.0 109.959 176.296 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B ' 104' ' ' ILE . . . . . . . . . . . . . 66.2 mt -117.38 120.26 64.32 Favored 'Isoleucine or valine' 0 C--O 1.235 0.29 0 CA-C-N 116.612 -0.267 . . . . 0.0 110.355 -179.429 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B ' 105' ' ' PHE . . . . . . . . . . . . . 17.7 m-85 -122.97 168.4 12.37 Favored 'General case' 0 C--N 1.332 -0.188 0 O-C-N 123.797 0.686 . . . . 0.0 109.949 178.686 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B ' 106' ' ' ASN . . . . . . . . . . . . . 41.7 p-10 -96.93 -169.86 1.94 Allowed 'General case' 0 C--N 1.329 -0.316 0 N-CA-C 109.627 -0.508 . . . . 0.0 109.627 173.485 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B ' 107' ' ' GLN . . . . . . . . . . . . . 60.4 tt0 -59.5 -30.04 68.28 Favored 'General case' 0 CA--C 1.532 0.274 0 C-N-CA 120.968 -0.293 . . . . 0.0 111.775 178.438 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B ' 108' ' ' ASN . . . . . . . . . . . . . 4.8 t-20 -82.0 5.76 18.22 Favored 'General case' 0 CA--C 1.537 0.47 0 N-CA-C 113.167 0.803 . . . . 0.0 113.167 -178.053 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B ' 109' ' ' LEU . . . . . . . . . . . . . 10.2 tp 61.97 37.8 14.73 Favored 'General case' 0 C--N 1.332 -0.166 0 O-C-N 122.047 -0.408 . . . . 0.0 111.377 178.106 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B ' 110' ' ' GLU . . . . . . . . . . . . . 70.9 mm-40 -103.17 159.41 15.56 Favored 'General case' 0 C--N 1.33 -0.277 0 N-CA-C 109.749 -0.463 . . . . 0.0 109.749 175.688 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B ' 111' ' ' GLU . . . . . . . . . . . . . 84.0 tt0 -85.17 123.31 30.53 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-O 120.974 0.416 . . . . 0.0 111.053 -177.397 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B ' 112' ' ' LEU . . . . . . . . . . . . . 12.7 mt -110.04 -45.96 3.53 Favored 'General case' 0 C--N 1.331 -0.216 0 CA-C-N 115.884 -0.598 . . . . 0.0 110.144 176.776 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B ' 113' ' ' TYR . . . . . . . . . . . . . 63.8 t80 -141.46 138.23 32.71 Favored 'General case' 0 C--N 1.331 -0.217 0 CA-C-N 116.212 -0.449 . . . . 0.0 111.152 179.977 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B ' 114' ' ' ARG . . . . . . . . . . . . . 67.0 ttt180 -138.62 119.58 14.37 Favored 'General case' 0 C--N 1.332 -0.191 0 CA-C-N 116.015 -0.539 . . . . 0.0 110.132 178.41 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B ' 115' ' ' GLY . . . . . . . . . . . . . . . -150.15 158.04 27.49 Favored Glycine 0 CA--C 1.525 0.696 0 C-N-CA 120.666 -0.778 . . . . 0.0 111.367 179.342 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B ' 116' ' ' LYS . . . . . . . . . . . . . 29.8 ttmt -130.81 139.31 50.17 Favored 'General case' 0 C--N 1.331 -0.231 0 N-CA-C 109.898 -0.408 . . . . 0.0 109.898 176.643 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B ' 117' ' ' PHE . . . . . . . . . . . . . 30.7 m-85 -135.84 114.5 11.9 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.329 -0.396 . . . . 0.0 110.372 -176.047 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B ' 118' ' ' GLU . . . . . . . . . . . . . 96.0 mt-10 -52.82 -47.63 67.52 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.351 -0.386 . . . . 0.0 111.579 -176.473 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B ' 119' ' ' ASN . . . . . . . . . . . . . 32.4 m120 -94.91 31.03 1.93 Allowed 'General case' 0 C--N 1.331 -0.238 0 N-CA-C 112.199 0.444 . . . . 0.0 112.199 -174.553 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B ' 120' ' ' LEU . . . . . . . . . . . . . 11.8 tp -56.48 120.46 7.75 Favored 'General case' 0 C--N 1.332 -0.156 0 CA-C-O 120.728 0.299 . . . . 0.0 110.504 177.68 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B ' 121' ' ' ASN . . . . . . . . . . . . . 64.3 t30 -112.53 -44.09 3.4 Favored 'General case' 0 C--N 1.331 -0.23 0 CA-C-N 116.317 -0.401 . . . . 0.0 110.874 -176.502 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B ' 122' ' ' LYS . . . . . . . . . . . . . 34.2 mtmm -147.45 145.97 29.37 Favored 'General case' 0 C--N 1.331 -0.217 0 CA-C-O 121.08 0.467 . . . . 0.0 111.445 -178.191 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B ' 123' ' ' VAL . . . . . . . . . . . . . 46.6 t -125.92 129.64 72.39 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.24 0 CA-C-N 115.831 -0.622 . . . . 0.0 109.409 176.395 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B ' 124' ' ' LEU . . . . . . . . . . . . . 44.9 mt -118.88 128.33 54.34 Favored 'General case' 0 C--N 1.331 -0.239 0 CA-C-N 116.308 -0.405 . . . . 0.0 110.431 -179.204 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B ' 125' ' ' VAL . . . . . . . . . . . . . 47.7 t -130.61 124.35 56.78 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.324 0 CA-C-N 116.141 -0.481 . . . . 0.0 109.824 179.105 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B ' 126' ' ' ARG . . . . . . . . . . . . . 37.0 mtm105 -145.0 119.72 9.83 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-O 120.973 0.416 . . . . 0.0 110.195 178.248 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B ' 127' ' ' ASN . . . . . . . . . . . . . 89.8 m-20 55.44 -130.17 1.99 Allowed 'General case' 0 CA--C 1.545 0.759 0 CA-C-O 118.516 -0.754 . . . . 0.0 110.196 -179.398 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B ' 128' ' ' ASP . . . . . . . . . . . . . 11.5 p-10 -97.23 10.05 40.55 Favored 'General case' 0 CA--C 1.536 0.417 0 CA-C-N 120.04 1.291 . . . . 0.0 113.237 -178.1 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B ' 129' ' ' LEU . . . . . . . . . . . . . 6.2 tt -109.05 133.57 52.82 Favored 'General case' 0 C--O 1.232 0.178 0 CA-C-N 118.28 0.491 . . . . 0.0 110.065 -179.923 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B ' 130' ' ' VAL . . . . . . . . . . . . . 46.4 t -125.89 137.35 57.99 Favored 'Isoleucine or valine' 0 N--CA 1.462 0.175 0 CA-C-O 120.953 0.406 . . . . 0.0 110.453 -176.947 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B ' 131' ' ' VAL . . . . . 0.538 HG22 HD12 ' B' ' 140' ' ' LEU . 46.9 t -136.1 135.4 50.15 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.277 0 CA-C-N 116.137 -0.483 . . . . 0.0 110.187 178.414 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' B' B ' 132' ' ' ILE . . . . . . . . . . . . . 74.1 mt -120.28 131.65 71.99 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.271 0 N-CA-C 109.708 -0.479 . . . . 0.0 109.708 -179.833 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B ' 133' ' ' ILE . . . . . . . . . . . . . 39.0 mm -117.83 121.47 67.46 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.271 0 CA-C-N 116.493 -0.321 . . . . 0.0 110.868 -176.989 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B ' 134' ' ' ASP . . . . . . . . . . . . . 8.8 p-10 -132.69 149.43 52.29 Favored 'General case' 0 CA--C 1.528 0.128 0 N-CA-C 109.898 -0.408 . . . . 0.0 109.898 173.837 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B ' 135' ' ' GLU . . . . . . . . . . . . . 85.4 tt0 -49.89 -25.5 3.25 Favored 'General case' 0 C--N 1.328 -0.357 0 N-CA-C 113.083 0.771 . . . . 0.0 113.083 -170.315 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B ' 136' ' ' GLN . . . . . . . . . . . . . 97.5 mt-30 -92.86 -29.95 15.68 Favored 'General case' 0 C--N 1.33 -0.269 0 N-CA-C 112.581 0.585 . . . . 0.0 112.581 -173.932 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B ' 137' ' ' LYS . . . . . . . . . . . . . 43.8 pttt -161.11 165.69 29.22 Favored 'General case' 0 C--O 1.233 0.212 0 CA-C-O 121.475 0.655 . . . . 0.0 112.19 -173.221 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B ' 138' ' ' LEU . . . . . . . . . . . . . 7.0 tt -117.44 129.92 56.14 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 115.103 -0.953 . . . . 0.0 110.01 178.798 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B ' 139' ' ' THR . . . . . . . . . . . . . 31.0 m -112.57 128.18 56.29 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.157 -0.474 . . . . 0.0 110.51 -179.888 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B ' 140' ' ' LEU . . . . . 0.538 HD12 HG22 ' B' ' 131' ' ' VAL . 11.5 tp -117.1 120.82 39.51 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 115.814 -0.63 . . . . 0.0 109.352 -178.761 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' B' B ' 141' ' ' ILE . . . . . . . . . . . . . 19.9 mt -116.96 119.69 62.78 Favored 'Isoleucine or valine' 0 C--O 1.233 0.193 0 CA-C-O 121.037 0.446 . . . . 0.0 110.417 -173.657 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B ' 142' ' ' ARG . . . . . . . . . . . . . 84.2 mtp180 -108.06 133.77 51.89 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 115.009 -0.996 . . . . 0.0 110.507 -177.565 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B ' 143' ' ' THR . . . . . . . . . . . . . 15.1 p . . . . . 0 C--O 1.219 -0.503 0 CA-C-O 117.907 -1.044 . . . . 0.0 110.984 179.886 . . . . . . . . 0 0 . 1 . 010 nuclear nobuild core ' C' C ' 2' ' ' SER . . . . . . . . . . . . . 3.3 p . . . . . 0 C--O 1.231 0.126 0 CA-C-O 120.935 0.398 . . . . 0.0 110.487 . . . . . . . . . 0 0 . 1 . 010 nuclear nobuild core ' C' C ' 3' ' ' GLU . . . . . . . . . . . . . 95.3 mt-10 -140.29 139.34 35.47 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.057 -0.52 . . . . 0.0 110.953 -178.34 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' C' C ' 4' ' ' LEU . . . . . . . . . . . . . 20.2 tp -127.05 128.48 46.35 Favored 'General case' 0 C--N 1.331 -0.221 0 CA-C-N 115.891 -0.595 . . . . 0.0 109.838 176.067 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' C' C ' 5' ' ' LYS . . . . . . . . . . . . . 96.3 mttt -112.48 122.8 48.73 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-O 120.769 0.318 . . . . 0.0 110.872 -178.581 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' C' C ' 6' ' ' LEU . . . . . . . . . . . . . 47.8 mt -114.24 142.61 46.05 Favored 'General case' 0 N--CA 1.462 0.143 0 CA-C-N 115.404 -0.817 . . . . 0.0 110.271 -179.451 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' C' C ' 7' ' ' LYS . . . . . . . . . . . . . 40.1 ttmt -123.45 137.16 28.05 Favored Pre-proline 0 CA--C 1.533 0.305 0 CA-C-O 119.001 -0.523 . . . . 0.0 109.622 175.545 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' C' C ' 8' ' ' PRO . . . . . . . . . . . . . 85.4 Cg_endo -91.83 136.01 1.69 Allowed 'Trans proline' 0 N--CA 1.489 1.231 0 C-N-CA 121.692 1.595 . . . . 0.0 111.895 179.314 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' C' C ' 9' ' ' LEU . . . . . . . . . . . . . 71.1 mt -74.62 -47.65 5.3 Favored Pre-proline 0 CA--C 1.534 0.35 0 CA-C-O 118.578 -0.725 . . . . 0.0 112.283 -179.744 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' C' C ' 10' ' ' PRO . . . . . . . . . . . . . 85.4 Cg_endo -80.15 151.49 20.81 Favored 'Trans proline' 0 N--CA 1.496 1.623 0 C-N-CA 121.162 1.241 . . . . 0.0 111.898 176.82 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' C' C ' 11' ' ' LYS . . . . . . . . . . . . . 50.5 tttp -87.21 98.25 11.22 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-O 120.752 0.311 . . . . 0.0 110.444 178.813 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' C' C ' 12' ' ' VAL . . . . . . . . . . . . . 11.9 p -144.55 144.88 21.86 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.289 0 CA-C-N 116.198 -0.455 . . . . 0.0 110.433 179.954 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' C' C ' 13' ' ' GLU . . . . . . . . . . . . . 95.2 mt-10 -82.05 126.76 32.37 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-N 116.352 -0.385 . . . . 0.0 110.041 177.846 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' C' C ' 14' ' ' LEU . . . . . . . . . . . . . 46.3 mt -95.48 148.48 34.68 Favored Pre-proline 0 C--N 1.329 -0.29 0 CA-C-O 119.235 -0.412 . . . . 0.0 110.4 -179.11 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' C' C ' 15' ' ' PRO . . . . . . . . . . . . . 38.8 Cg_exo -58.65 156.86 30.03 Favored 'Trans proline' 0 N--CA 1.496 1.651 0 C-N-CA 121.187 1.258 . . . . 0.0 111.772 178.97 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' C' C ' 16' ' ' PRO . . . . . . . . . . . . . 35.5 Cg_exo -58.49 -42.84 50.97 Favored 'Trans proline' 0 N--CA 1.498 1.762 0 C-N-CA 121.315 1.344 . . . . 0.0 112.703 -177.206 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' C' C ' 17' ' ' ASP . . . . . . . . . . . . . 12.8 p-10 -86.86 13.21 9.35 Favored 'General case' 0 C--N 1.327 -0.402 0 N-CA-C 112.999 0.741 . . . . 0.0 112.999 -177.961 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' C' C ' 18' ' ' PHE . . . . . . . . . . . . . 44.2 t80 -57.63 -50.52 72.87 Favored 'General case' 0 N--CA 1.456 -0.166 0 O-C-N 121.991 -0.443 . . . . 0.0 110.459 -176.958 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' C' C ' 19' ' ' VAL . . . . . . . . . . . . . 13.9 p -54.25 -40.46 47.62 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.285 0 CA-C-N 116.493 -0.321 . . . . 0.0 111.209 -177.911 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' C' C ' 20' ' ' ASP . . . . . . . . . . . . . 82.5 m-20 -60.53 -44.75 95.75 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-O 120.969 0.414 . . . . 0.0 110.86 -178.566 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' C' C ' 21' ' ' VAL . . . . . . . . . . . . . 46.4 t -64.16 -44.48 97.56 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.319 0 CA-C-N 116.291 -0.413 . . . . 0.0 110.396 -178.141 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' C' C ' 22' ' ' ILE . . . . . 0.669 HG22 HD12 ' C' ' 26' ' ' LEU . 50.6 mm -55.9 -44.71 78.8 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.248 0 C-N-CA 121.026 -0.269 . . . . 0.0 110.712 179.019 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' C' C ' 23' ' ' ARG . . . . . . . . . . . . . 55.5 ttp180 -53.8 -50.61 65.74 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-O 120.674 0.274 . . . . 0.0 111.439 179.727 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' C' C ' 24' ' ' ILE . . . . . . . . . . . . . 66.9 mt -58.34 -42.18 83.24 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.274 0 CA-C-N 116.558 -0.292 . . . . 0.0 110.884 -178.183 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' C' C ' 25' ' ' LYS . . . . . . . . . . . . . 53.1 mtpt -66.71 -43.82 83.29 Favored 'General case' 0 C--N 1.328 -0.367 0 N-CA-C 112.531 0.567 . . . . 0.0 112.531 -177.481 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' C' C ' 26' ' ' LEU . . . . . 0.669 HD12 HG22 ' C' ' 22' ' ' ILE . 62.9 mt -80.47 -36.23 33.74 Favored 'General case' 0 C--N 1.33 -0.256 0 N-CA-C 113.542 0.941 . . . . 0.0 113.542 -169.117 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' C' C ' 27' ' ' GLN . . . . . . . . . . . . . 10.0 pt20 -46.81 141.01 4.21 Favored 'General case' 0 N--CA 1.47 0.573 0 N-CA-C 112.674 0.62 . . . . 0.0 112.674 -176.006 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' C' C ' 28' ' ' GLY . . . . . . . . . . . . . . . 101.23 -25.77 27.02 Favored Glycine 0 CA--C 1.532 1.107 0 CA-C-N 115.752 -0.658 . . . . 0.0 112.235 -175.959 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' C' C ' 29' ' ' LYS . . . . . . . . . . . . . 73.3 mmtt -97.24 155.11 17.0 Favored 'General case' 0 C--O 1.234 0.247 0 CA-C-N 117.462 0.631 . . . . 0.0 111.191 178.46 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' C' C ' 30' ' ' THR . . . . . . . . . . . . . 23.7 m -104.8 136.01 45.11 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 115.807 -0.633 . . . . 0.0 109.785 174.841 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' C' C ' 31' ' ' VAL . . . . . . . . . . . . . 34.3 m -128.34 154.79 39.53 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.254 0 CA-C-O 120.918 0.39 . . . . 0.0 111.022 -176.916 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' C' C ' 32' ' ' ARG . . . . . . . . . . . . . 94.3 mtm-85 -133.32 150.37 51.87 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-O 121.249 0.547 . . . . 0.0 110.625 178.351 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' C' C ' 33' ' ' THR . . . . . . . . . . . . . 25.9 m -52.45 139.89 23.8 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 116.188 -0.46 . . . . 0.0 111.513 -178.327 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' C' C ' 34' ' ' GLY . . . . . . . . . . . . . . . 99.29 -17.06 58.4 Favored Glycine 0 CA--C 1.532 1.143 0 CA-C-O 119.533 -0.593 . . . . 0.0 113.214 179.228 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' C' C ' 35' ' ' ASP . . . . . . . . . . . . . 59.6 m-20 -63.15 149.76 44.48 Favored 'General case' 0 C--O 1.231 0.126 0 CA-C-N 118.138 0.969 . . . . 0.0 110.911 179.205 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' C' C ' 36' ' ' VAL . . . . . . . . . . . . . 42.0 t -122.45 129.33 75.34 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.251 0 CA-C-N 115.897 -0.592 . . . . 0.0 109.766 179.068 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' C' C ' 37' ' ' ILE . . . . . . . . . . . . . 66.2 mt -122.93 138.65 52.28 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.226 0 CA-C-N 116.265 -0.425 . . . . 0.0 109.968 179.815 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' C' C ' 38' ' ' GLY . . . . . . . . . . . . . . . -118.93 129.0 7.91 Favored Glycine 0 CA--C 1.525 0.683 0 N-CA-C 110.891 -0.884 . . . . 0.0 110.891 178.978 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' C' C ' 39' ' ' ILE . . . . . . . . . . . . . 70.2 mt -125.07 134.53 66.66 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.241 0 CA-C-O 120.764 0.316 . . . . 0.0 110.297 179.269 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' C' C ' 40' ' ' SER . . . . . . . . . . . . . 36.3 t -91.3 117.87 30.02 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.078 -0.51 . . . . 0.0 110.723 176.196 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' C' C ' 41' ' ' ILE . . . . . . . . . . . . . 65.7 mt -126.5 122.25 60.63 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.164 0 CA-C-O 120.816 0.341 . . . . 0.0 110.209 179.506 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' C' C ' 42' ' ' LEU . . . . . . . . . . . . . 5.5 mp 52.9 35.88 20.25 Favored 'General case' 0 CA--C 1.532 0.279 0 CA-C-N 116.186 -0.461 . . . . 0.0 111.399 178.099 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' C' C ' 43' ' ' GLY . . . . . . . . . . . . . . . 73.87 27.99 65.73 Favored Glycine 0 CA--C 1.531 1.087 0 C-N-CA 121.15 -0.548 . . . . 0.0 112.542 176.528 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' C' C ' 44' ' ' LYS . . . . . . . . . . . . . 95.7 mttt -139.52 128.71 23.9 Favored 'General case' 0 C--N 1.33 -0.282 0 N-CA-C 109.744 -0.465 . . . . 0.0 109.744 176.971 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' C' C ' 45' ' ' GLU . . . . . . . . . . . . . 85.2 tt0 -84.08 127.75 34.11 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-O 120.882 0.372 . . . . 0.0 111.533 -177.473 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' C' C ' 46' ' ' VAL . . . . . . . . . . . . . 9.3 p -118.41 126.76 75.34 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.21 0 N-CA-C 109.569 -0.53 . . . . 0.0 109.569 174.342 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' C' C ' 47' ' ' LYS . . . . . . . . . . . . . 75.9 mttt -98.28 123.89 42.61 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.044 -0.526 . . . . 0.0 110.808 178.315 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' C' C ' 48' ' ' PHE . . . . . . . . . . . . . 34.5 m-85 -109.18 131.77 54.75 Favored 'General case' 0 C--N 1.329 -0.299 0 N-CA-C 109.691 -0.485 . . . . 0.0 109.691 176.75 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' C' C ' 49' ' ' LYS . . . . . . . . . . . . . 49.1 tttp -107.37 132.54 53.04 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.432 -0.349 . . . . 0.0 110.164 177.638 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' C' C ' 50' ' ' VAL . . . . . . . . . . . . . 44.5 t -75.6 107.25 6.19 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.327 0 N-CA-C 109.594 -0.521 . . . . 0.0 109.594 178.314 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' C' C ' 51' ' ' VAL . . . . . . . . . . . . . 47.1 t -68.94 -49.12 66.12 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.305 0 CA-C-N 116.116 -0.493 . . . . 0.0 109.721 -175.594 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' C' C ' 52' ' ' GLN . . . . . . . . . . . . . 49.1 tt0 -162.84 143.03 9.38 Favored 'General case' 0 C--N 1.329 -0.291 0 C-N-CA 120.211 -0.596 . . . . 0.0 111.773 -178.836 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' C' C ' 53' ' ' ALA . . . . . . . . . . . . . . . -114.86 130.92 56.97 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 115.32 -0.855 . . . . 0.0 109.456 174.096 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' C' C ' 54' ' ' TYR . . . . . . . . . . . . . 22.2 t80 -128.62 110.27 19.0 Favored Pre-proline 0 CA--C 1.534 0.363 0 CA-C-O 118.34 -0.838 . . . . 0.0 110.306 -178.891 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' C' C ' 55' ' ' PRO . . . . . . . . . . . . . 74.5 Cg_endo -77.23 170.06 72.46 Favored 'Cis proline' 0 N--CA 1.499 1.831 0 CA-C-N 121.827 1.688 . . . . 0.0 112.367 -5.623 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' C' C ' 56' ' ' SER . . . . . . . . . . . . . 13.8 m -114.73 129.13 25.25 Favored Pre-proline 0 CA--C 1.538 0.496 0 CA-C-O 118.451 -0.785 . . . . 0.0 109.451 175.855 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' C' C ' 57' ' ' PRO . . . . . . . . . . . . . 59.6 Cg_endo -73.61 148.95 93.29 Favored 'Cis proline' 0 N--CA 1.497 1.689 0 CA-C-N 121.99 1.747 . . . . 0.0 111.759 -0.352 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' C' C ' 58' ' ' LEU . . . . . . . . . . . . . 23.8 tp -108.3 136.6 47.68 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.376 -0.374 . . . . 0.0 110.836 -178.174 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' C' C ' 59' ' ' ARG . . . . . . . . . . . . . 60.1 ttm-85 -103.13 123.21 46.25 Favored 'General case' 0 C--N 1.329 -0.323 0 N-CA-C 109.242 -0.651 . . . . 0.0 109.242 174.779 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' C' C ' 60' ' ' VAL . . . . . . . . . . . . . 44.1 t -80.56 121.6 34.28 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.264 0 C-N-CA 120.712 -0.395 . . . . 0.0 110.246 -176.94 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' C' C ' 61' ' ' GLU . . . . . . . . . . . . . 40.3 mt-10 -130.72 172.37 12.05 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 115.958 -0.565 . . . . 0.0 109.863 178.821 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' C' C ' 62' ' ' ASP . . . . . . . . . . . . . 60.1 m-20 -54.92 -32.52 61.28 Favored 'General case' 0 C--N 1.328 -0.365 0 N-CA-C 111.773 0.286 . . . . 0.0 111.773 -178.978 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' C' C ' 63' ' ' ARG . . . . . . . . . . . . . 17.5 ptm180 -88.92 6.31 39.94 Favored 'General case' 0 CA--C 1.536 0.437 0 N-CA-C 113.507 0.929 . . . . 0.0 113.507 -176.226 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' C' C ' 64' ' ' THR . . . . . . . . . . . . . 32.8 m -82.39 131.53 35.22 Favored 'General case' 0 C--N 1.331 -0.203 0 CA-C-N 118.143 0.429 . . . . 0.0 110.559 -178.874 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' C' C ' 65' ' ' LYS . . . . . . . . . . . . . 96.6 mttt -88.77 129.34 35.58 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.155 -0.475 . . . . 0.0 110.104 179.744 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' C' C ' 66' ' ' ILE . . . . . . . . . . . . . 64.2 mt -114.17 130.36 68.52 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.252 0 N-CA-C 109.82 -0.437 . . . . 0.0 109.82 179.305 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' C' C ' 67' ' ' THR . . . . . . . . . . . . . 22.4 m -121.53 140.09 52.66 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-N 116.118 -0.492 . . . . 0.0 111.0 -177.732 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' C' C ' 68' ' ' LEU . . . . . . . . . . . . . 44.1 mt . . . . . 0 C--N 1.33 -0.267 0 CA-C-N 115.832 -0.622 . . . . 0.0 110.415 178.173 . . . . . . . . 0 0 . 1 . 010 nuclear nobuild core ' C' C ' 73' ' ' VAL . . . . . . . . . . . . . 27.6 m . . . . . 0 C--O 1.232 0.133 0 CA-C-O 120.815 0.34 . . . . 0.0 110.191 . . . . . . . . . 0 0 . 1 . 010 nuclear nobuild core ' C' C ' 74' ' ' ASP . . . . . 0.436 ' OD1' HD11 ' C' ' 76' ' ' LEU . 3.1 t70 -105.53 121.68 44.44 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.273 -0.421 . . . . 0.0 109.964 -178.563 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' C' C ' 75' ' ' VAL . . . . . 0.42 ' C ' HD12 ' C' ' 76' ' ' LEU . 40.4 t -117.47 123.77 72.19 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.229 0 CA-C-O 121.095 0.474 . . . . 0.0 110.566 -177.41 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' C' C ' 76' ' ' LEU . . . . . 0.455 ' N ' HD12 ' C' ' 76' ' ' LEU . 7.0 mp -117.86 142.0 47.8 Favored 'General case' 0 C--N 1.332 -0.189 0 CA-C-N 115.683 -0.689 . . . . 0.0 109.468 176.147 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' C' C ' 77' ' ' GLU . . . . . . . . . . . . . 96.5 mt-10 -133.02 136.94 46.3 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-O 121.022 0.439 . . . . 0.0 111.259 -178.261 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' C' C ' 78' ' ' ALA . . . . . . . . . . . . . . . -126.84 135.44 51.0 Favored 'General case' 0 C--N 1.331 -0.225 0 CA-C-N 115.8 -0.636 . . . . 0.0 109.877 176.428 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' C' C ' 79' ' ' LYS . . . . . 0.477 ' O ' HD13 ' C' ' 80' ' ' ILE . 90.6 mttt -74.72 122.82 23.85 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-O 120.802 0.334 . . . . 0.0 110.553 -179.678 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' C' C ' 80' ' ' ILE . . . . . 0.477 HD13 ' O ' ' C' ' 79' ' ' LYS . 26.0 mm -139.16 113.36 7.27 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.306 0 N-CA-C 109.059 -0.719 . . . . 0.0 109.059 -178.47 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' C' C ' 81' ' ' LYS . . . . . . . . . . . . . 19.5 pttp -105.88 124.69 49.97 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-O 121.02 0.438 . . . . 0.0 111.363 -176.225 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' C' C ' 82' ' ' GLY . . . . . . . . . . . . . . . 88.99 42.09 5.73 Favored Glycine 0 CA--C 1.525 0.702 0 C-N-CA 120.73 -0.748 . . . . 0.0 111.75 173.152 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' C' C ' 83' ' ' ILE . . . . . . . . . . . . . 72.9 mt -65.75 136.14 27.2 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.311 0 CA-C-O 121.001 0.429 . . . . 0.0 110.081 178.668 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' C' C ' 84' ' ' LYS . . . . . . . . . . . . . 33.8 tttp -97.42 -53.54 3.43 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 115.824 -0.625 . . . . 0.0 110.128 -178.988 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' C' C ' 85' ' ' ASP . . . . . . . . . . . . . 12.7 t70 -153.99 153.16 31.48 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 115.596 -0.729 . . . . 0.0 110.251 179.569 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' C' C ' 86' ' ' VAL . . . . . . . . . . . . . 47.2 t -129.75 131.32 66.69 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.258 0 CA-C-O 121.003 0.43 . . . . 0.0 110.552 -179.312 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' C' C ' 87' ' ' ILE . . . . . . . . . . . . . 4.8 mp -119.92 127.28 75.88 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.236 0 CA-C-N 115.738 -0.664 . . . . 0.0 109.509 175.529 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' C' C ' 88' ' ' LEU . . . . . . . . . . . . . 11.0 tp -112.66 130.19 56.13 Favored 'General case' 0 C--N 1.331 -0.198 0 CA-C-O 120.994 0.425 . . . . 0.0 111.083 -177.144 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' C' C ' 89' ' ' ASP . . . . . . . . . . . . . 6.3 t70 -128.64 154.25 46.45 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 115.884 -0.598 . . . . 0.0 109.749 177.087 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' C' C ' 90' ' ' GLU . . . . . . . . . . . . . 81.4 tt0 -47.52 -41.41 20.95 Favored 'General case' 0 N--CA 1.464 0.229 0 N-CA-C 112.915 0.709 . . . . 0.0 112.915 -172.952 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' C' C ' 91' ' ' ASN . . . . . . . . . . . . . 19.7 m120 -121.54 16.79 11.25 Favored 'General case' 0 N--CA 1.467 0.401 0 N-CA-C 113.255 0.835 . . . . 0.0 113.255 -175.938 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' C' C ' 92' ' ' LEU . . . . . . . . . . . . . 55.2 mt -150.97 142.78 23.8 Favored 'General case' 0 C--N 1.332 -0.193 0 CA-C-O 120.818 0.342 . . . . 0.0 110.33 -177.096 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' C' C ' 93' ' ' ILE . . . . . . . . . . . . . 69.1 mt -123.28 115.41 45.45 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.32 0 N-CA-C 108.904 -0.776 . . . . 0.0 108.904 175.767 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' C' C ' 94' ' ' VAL . . . . . . . . . . . . . 45.2 t -116.58 123.9 72.11 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.308 0 CA-C-O 120.886 0.374 . . . . 0.0 110.085 -176.765 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' C' C ' 95' ' ' VAL . . . . . . . . . . . . . 42.2 t -121.04 131.92 71.79 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 CA-C-N 116.001 -0.545 . . . . 0.0 109.788 -179.815 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' C' C ' 96' ' ' ILE . . . . . 0.508 HD11 ' HB ' ' C' ' 123' ' ' VAL . 62.9 mt -112.94 127.16 70.33 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.284 0 N-CA-C 109.366 -0.605 . . . . 0.0 109.366 179.439 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' C' C ' 97' ' ' THR . . . . . . . . . . . . . 81.0 p -96.89 154.36 17.34 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-O 120.896 0.379 . . . . 0.0 110.733 -178.965 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' C' C ' 98' ' ' GLU . . . . . . . . . . . . . 97.3 mt-10 -53.91 -25.85 22.27 Favored 'General case' 0 C--N 1.328 -0.329 0 N-CA-C 112.335 0.495 . . . . 0.0 112.335 -179.722 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' C' C ' 99' ' ' GLU . . . . . . . . . . . . . 94.3 mt-10 -77.11 12.27 1.5 Allowed 'General case' 0 CA--C 1.537 0.466 0 N-CA-C 113.218 0.822 . . . . 0.0 113.218 -178.147 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' C' C ' 100' ' ' ASN . . . . . . . . . . . . . 4.0 m-20 65.08 32.81 10.03 Favored 'General case' 0 CA--C 1.531 0.248 0 CA-C-N 117.998 0.363 . . . . 0.0 111.68 178.242 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' C' C ' 101' ' ' GLU . . . . . . . . . . . . . 84.6 tt0 -112.26 143.48 43.27 Favored 'General case' 0 C--O 1.232 0.162 0 N-CA-C 109.457 -0.572 . . . . 0.0 109.457 173.149 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' C' C ' 102' ' ' VAL . . . . . . . . . . . . . 45.3 t -115.52 127.76 72.99 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.336 0 CA-C-O 120.886 0.374 . . . . 0.0 110.165 -177.591 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' C' C ' 103' ' ' LEU . . . . . . . . . . . . . 42.0 mt -114.8 127.42 55.72 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 115.489 -0.778 . . . . 0.0 109.874 176.518 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' C' C ' 104' ' ' ILE . . . . . 0.464 HD12 ' HB3' ' C' ' 113' ' ' TYR . 66.7 mt -116.48 118.52 59.05 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.292 0 N-CA-C 110.054 -0.351 . . . . 0.0 110.054 179.955 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' C' C ' 105' ' ' PHE . . . . . . . . . . . . . 63.8 m-85 -118.37 164.85 14.63 Favored 'General case' 0 C--N 1.333 -0.146 0 O-C-N 123.952 0.782 . . . . 0.0 110.523 179.613 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' C' C ' 106' ' ' ASN . . . . . . . . . . . . . 45.8 p-10 -97.96 -169.97 1.91 Allowed 'General case' 0 C--N 1.33 -0.28 0 N-CA-C 109.699 -0.482 . . . . 0.0 109.699 171.868 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' C' C ' 107' ' ' GLN . . . . . . . . . . . . . 58.7 tt0 -57.66 -29.11 64.35 Favored 'General case' 0 C--N 1.329 -0.291 0 N-CA-C 112.044 0.387 . . . . 0.0 112.044 -179.682 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' C' C ' 108' ' ' ASN . . . . . . . . . . . . . 50.8 t30 -90.4 14.08 13.85 Favored 'General case' 0 CA--C 1.534 0.329 0 N-CA-C 113.103 0.779 . . . . 0.0 113.103 -175.661 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' C' C ' 109' ' ' LEU . . . . . . . . . . . . . 59.9 mt 58.43 35.69 24.89 Favored 'General case' 0 CA--C 1.529 0.165 0 CA-C-O 120.775 0.321 . . . . 0.0 111.651 176.783 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' C' C ' 110' ' ' GLU . . . . . . . . . . . . . 95.4 mt-10 -101.78 152.85 20.38 Favored 'General case' 0 C--N 1.33 -0.254 0 N-CA-C 109.566 -0.531 . . . . 0.0 109.566 175.313 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' C' C ' 111' ' ' GLU . . . . . . . . . . . . . 44.0 tp10 -82.21 121.93 27.25 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-O 120.903 0.382 . . . . 0.0 110.954 -177.673 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' C' C ' 112' ' ' LEU . . . . . . . . . . . . . 17.6 mt -106.53 -45.94 4.12 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.006 -0.543 . . . . 0.0 110.147 177.319 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' C' C ' 113' ' ' TYR . . . . . 0.464 ' HB3' HD12 ' C' ' 104' ' ' ILE . 59.6 t80 -137.88 135.56 36.26 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.079 -0.51 . . . . 0.0 110.929 179.153 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' C' C ' 114' ' ' ARG . . . . . . . . . . . . . 41.1 ttm180 -135.7 119.82 17.67 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.027 -0.533 . . . . 0.0 110.038 177.474 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' C' C ' 115' ' ' GLY . . . . . . . . . . . . . . . -150.03 159.14 27.98 Favored Glycine 0 CA--C 1.525 0.664 0 N-CA-C 111.016 -0.834 . . . . 0.0 111.016 179.168 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' C' C ' 116' ' ' LYS . . . . . . . . . . . . . 69.4 tttt -131.15 130.32 42.91 Favored 'General case' 0 C--N 1.329 -0.316 0 N-CA-C 109.963 -0.384 . . . . 0.0 109.963 178.122 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' C' C ' 117' ' ' PHE . . . . . 0.422 ' CE2' HG21 ' C' ' 132' ' ' ILE . 41.7 m-85 -125.83 117.3 23.09 Favored 'General case' 0 C--N 1.331 -0.215 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.228 -175.271 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' C' C ' 118' ' ' GLU . . . . . . . . . . . . . 81.9 tt0 -51.94 -46.68 64.82 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.428 -0.351 . . . . 0.0 111.702 -176.422 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' C' C ' 119' ' ' ASN . . . . . . . . . . . . . 83.6 m-20 -101.47 31.26 3.82 Favored 'General case' 0 C--N 1.33 -0.239 0 N-CA-C 112.174 0.435 . . . . 0.0 112.174 -173.971 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' C' C ' 120' ' ' LEU . . . . . . . . . . . . . 13.8 tp -53.53 122.97 10.83 Favored 'General case' 0 N--CA 1.464 0.254 0 CA-C-O 120.832 0.349 . . . . 0.0 111.078 179.506 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' C' C ' 121' ' ' ASN . . . . . . . . . . . . . 9.9 t-20 -112.86 -44.07 3.35 Favored 'General case' 0 C--N 1.331 -0.199 0 CA-C-N 116.257 -0.429 . . . . 0.0 110.746 -177.507 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' C' C ' 122' ' ' LYS . . . . . . . . . . . . . 98.4 mttt -147.98 148.53 30.84 Favored 'General case' 0 C--N 1.332 -0.181 0 CA-C-O 121.061 0.458 . . . . 0.0 111.855 -178.593 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' C' C ' 123' ' ' VAL . . . . . 0.508 ' HB ' HD11 ' C' ' 96' ' ' ILE . 45.1 t -129.41 124.58 60.17 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.316 0 N-CA-C 109.175 -0.676 . . . . 0.0 109.175 173.278 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' C' C ' 124' ' ' LEU . . . . . . . . . . . . . 48.0 mt -129.55 143.79 50.98 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-O 120.946 0.403 . . . . 0.0 110.988 -176.175 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' C' C ' 125' ' ' VAL . . . . . . . . . . . . . 11.4 p -135.95 138.64 47.23 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.249 0 CA-C-N 115.881 -0.599 . . . . 0.0 110.235 178.752 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' C' C ' 126' ' ' ARG . . . . . . . . . . . . . 26.8 ttm180 -144.46 127.64 16.66 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-N 116.209 -0.45 . . . . 0.0 110.224 178.557 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' C' C ' 127' ' ' ASN . . . . . . . . . . . . . 80.7 m-20 53.16 -110.4 0.53 Allowed 'General case' 0 CA--C 1.545 0.772 0 CA-C-O 118.843 -0.599 . . . . 0.0 110.927 -179.402 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' C' C ' 128' ' ' ASP . . . . . . . . . . . . . 19.0 p-10 -114.2 5.64 15.96 Favored 'General case' 0 CA--C 1.536 0.416 0 CA-C-N 119.893 1.224 . . . . 0.0 113.384 -177.819 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' C' C ' 129' ' ' LEU . . . . . . . . . . . . . 58.4 mt -108.6 141.11 41.01 Favored 'General case' 0 C--N 1.334 -0.093 0 CA-C-N 118.133 0.424 . . . . 0.0 110.351 -179.185 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' C' C ' 130' ' ' VAL . . . . . 0.403 HG11 HD13 ' C' ' 104' ' ' ILE . 42.5 t -122.69 136.73 58.54 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.246 0 N-CA-C 109.884 -0.413 . . . . 0.0 109.884 -179.806 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' C' C ' 131' ' ' VAL . . . . . 0.447 HG22 HD12 ' C' ' 140' ' ' LEU . 44.3 t -134.63 135.14 53.88 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.214 0 CA-C-O 121.066 0.46 . . . . 0.0 110.342 -179.591 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' C' C ' 132' ' ' ILE . . . . . 0.422 HG21 ' CE2' ' C' ' 117' ' ' PHE . 68.9 mt -118.43 131.21 71.86 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.264 0 CA-C-N 115.753 -0.658 . . . . 0.0 109.371 178.854 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' C' C ' 133' ' ' ILE . . . . . . . . . . . . . 40.4 mm -116.07 122.77 70.33 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.237 0 CA-C-N 116.515 -0.311 . . . . 0.0 110.913 -175.301 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' C' C ' 134' ' ' ASP . . . . . . . . . . . . . 7.1 p-10 -133.62 148.74 51.58 Favored 'General case' 0 C--N 1.331 -0.224 0 N-CA-C 110.043 -0.354 . . . . 0.0 110.043 174.934 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' C' C ' 135' ' ' GLU . . . . . . . . . . . . . 81.3 tt0 -49.72 -25.11 2.69 Favored 'General case' 0 C--N 1.327 -0.384 0 N-CA-C 112.99 0.737 . . . . 0.0 112.99 -172.206 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' C' C ' 136' ' ' GLN . . . . . . . . . . . . . 63.1 tt0 -88.51 -37.52 15.69 Favored 'General case' 0 C--O 1.234 0.24 0 N-CA-C 112.111 0.411 . . . . 0.0 112.111 -175.656 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' C' C ' 137' ' ' LYS . . . . . . . . . . . . . 45.0 pttt -159.44 169.08 24.7 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-O 121.568 0.699 . . . . 0.0 112.252 -171.34 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' C' C ' 138' ' ' LEU . . . . . 0.449 HD23 ' C ' ' C' ' 138' ' ' LEU . 6.4 tt -116.33 126.43 53.51 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 114.942 -1.027 . . . . 0.0 109.829 178.362 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' C' C ' 139' ' ' THR . . . . . 0.411 ' N ' HD23 ' C' ' 138' ' ' LEU . 49.8 m -107.73 128.4 54.54 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.178 -0.464 . . . . 0.0 110.357 179.928 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' C' C ' 140' ' ' LEU . . . . . 0.447 HD12 HG22 ' C' ' 131' ' ' VAL . 9.5 tp -114.36 122.65 47.34 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 115.736 -0.665 . . . . 0.0 109.368 -178.748 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' C' C ' 141' ' ' ILE . . . . . . . . . . . . . 19.6 mt -120.18 124.57 72.9 Favored 'Isoleucine or valine' 0 C--O 1.234 0.238 0 CA-C-O 120.912 0.387 . . . . 0.0 110.034 -173.402 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' C' C ' 142' ' ' ARG . . . . . . . . . . . . . 64.9 mtt180 . . . . . 0 C--O 1.233 0.19 0 CA-C-N 115.574 -0.739 . . . . 0.0 110.05 -175.77 . . . . . . . . 0 0 . 1 . 010 nuclear nobuild core ' D' D ' 2' ' ' SER . . . . . . . . . . . . . 99.1 p . . . . . 0 N--CA 1.462 0.149 0 CA-C-O 120.998 0.428 . . . . 0.0 110.761 . . . . . . . . . 0 0 . 1 . 010 nuclear nobuild core ' D' D ' 3' ' ' GLU . . . . . . . . . . . . . 95.7 mt-10 -141.65 145.28 34.77 Favored 'General case' 0 C--N 1.331 -0.223 0 CA-C-N 116.031 -0.531 . . . . 0.0 111.246 -177.56 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' D' D ' 4' ' ' LEU . . . . . . . . . . . . . 15.4 tp -125.58 129.45 49.71 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-N 116.047 -0.524 . . . . 0.0 109.936 174.828 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' D' D ' 5' ' ' LYS . . . . . . . . . . . . . 52.4 mttm -110.63 123.63 50.37 Favored 'General case' 0 C--O 1.233 0.235 0 CA-C-O 120.71 0.291 . . . . 0.0 110.857 -179.248 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' D' D ' 6' ' ' LEU . . . . . . . . . . . . . 68.9 mt -116.63 144.57 44.24 Favored 'General case' 0 C--N 1.333 -0.148 0 CA-C-N 115.739 -0.664 . . . . 0.0 110.554 179.838 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' D' D ' 7' ' ' LYS . . . . . . . . . . . . . 55.3 tttm -126.93 141.84 41.79 Favored Pre-proline 0 CA--C 1.533 0.305 0 N-CA-C 109.704 -0.48 . . . . 0.0 109.704 175.293 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' D' D ' 8' ' ' PRO . . . . . . . . . . . . . 87.5 Cg_endo -91.4 144.15 3.17 Favored 'Trans proline' 0 N--CA 1.49 1.308 0 C-N-CA 121.645 1.563 . . . . 0.0 112.271 179.577 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' D' D ' 9' ' ' LEU . . . . . . . . . . . . . 49.6 mt -85.46 -47.17 0.61 Allowed Pre-proline 0 C--N 1.328 -0.334 0 CA-C-O 118.645 -0.693 . . . . 0.0 112.024 178.131 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' D' D ' 10' ' ' PRO . . . . . . . . . . . . . 86.4 Cg_endo -81.03 154.88 19.62 Favored 'Trans proline' 0 N--CA 1.495 1.605 0 C-N-CA 121.244 1.296 . . . . 0.0 111.8 175.956 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' D' D ' 11' ' ' LYS . . . . . . . . . . . . . 60.3 mttp -87.79 95.16 9.98 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-O 120.846 0.355 . . . . 0.0 110.654 178.824 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' D' D ' 12' ' ' VAL . . . . . . . . . . . . . 11.3 p -142.08 139.07 30.51 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.268 0 CA-C-N 116.133 -0.485 . . . . 0.0 110.303 178.691 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' D' D ' 13' ' ' GLU . . . . . . . . . . . . . 42.2 mp0 -82.5 127.15 33.04 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.311 -0.404 . . . . 0.0 110.06 178.313 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' D' D ' 14' ' ' LEU . . . . . . . . . . . . . 47.0 mt -93.68 149.69 37.53 Favored Pre-proline 0 C--N 1.329 -0.288 0 CA-C-O 119.207 -0.425 . . . . 0.0 110.27 -178.917 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' D' D ' 15' ' ' PRO . . . . . . . . . . . . . 25.6 Cg_exo -61.74 159.41 33.05 Favored 'Trans proline' 0 N--CA 1.497 1.7 0 C-N-CA 121.158 1.238 . . . . 0.0 111.381 177.007 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' D' D ' 16' ' ' PRO . . . . . . . . . . . . . 26.5 Cg_exo -60.78 -31.98 92.42 Favored 'Trans proline' 0 N--CA 1.497 1.731 0 C-N-CA 121.368 1.378 . . . . 0.0 112.362 -179.343 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' D' D ' 17' ' ' ASP . . . . . . . . . . . . . 10.2 p-10 -90.38 9.19 29.94 Favored 'General case' 0 CA--C 1.536 0.423 0 N-CA-C 113.166 0.802 . . . . 0.0 113.166 -178.506 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' D' D ' 18' ' ' PHE . . . . . . . . . . . . . 41.2 t80 -57.86 -46.73 84.38 Favored 'General case' 0 CA--C 1.522 -0.108 0 O-C-N 122.006 -0.434 . . . . 0.0 110.298 -176.915 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' D' D ' 19' ' ' VAL . . . . . . . . . . . . . 45.9 t -55.33 -44.25 74.67 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.259 0 CA-C-N 116.379 -0.373 . . . . 0.0 110.8 -177.555 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' D' D ' 20' ' ' ASP . . . . . . . . . . . . . 75.6 m-20 -59.87 -43.63 94.61 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-O 120.86 0.362 . . . . 0.0 110.965 -176.918 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' D' D ' 21' ' ' VAL . . . . . . . . . . . . . 48.9 t -64.62 -47.68 87.93 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.251 0 C-N-CA 120.817 -0.353 . . . . 0.0 110.54 -177.861 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' D' D ' 22' ' ' ILE . . . . . 0.544 HG22 HD12 ' D' ' 26' ' ' LEU . 47.1 mm -56.05 -44.4 78.47 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.282 0 CA-C-O 120.796 0.332 . . . . 0.0 110.557 179.3 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' D' D ' 23' ' ' ARG . . . . . . . . . . . . . 54.6 ttp180 -53.22 -52.29 59.4 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-O 120.848 0.356 . . . . 0.0 111.378 -179.662 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' D' D ' 24' ' ' ILE . . . . . . . . . . . . . 71.8 mt -59.08 -40.94 82.02 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.268 0 CA-C-N 116.232 -0.44 . . . . 0.0 111.404 -176.561 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' D' D ' 25' ' ' LYS . . . . . . . . . . . . . 55.8 mmtt -67.89 -39.88 83.57 Favored 'General case' 0 C--N 1.33 -0.279 0 N-CA-C 112.462 0.541 . . . . 0.0 112.462 -178.796 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' D' D ' 26' ' ' LEU . . . . . 0.544 HD12 HG22 ' D' ' 22' ' ' ILE . 76.2 mt -78.29 -39.29 40.31 Favored 'General case' 0 C--N 1.329 -0.284 0 N-CA-C 113.255 0.835 . . . . 0.0 113.255 -169.825 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' D' D ' 27' ' ' GLN . . . . . . . . . . . . . 10.1 pt20 -46.6 138.67 5.74 Favored 'General case' 0 N--CA 1.47 0.559 0 N-CA-C 112.742 0.645 . . . . 0.0 112.742 -175.81 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' D' D ' 28' ' ' GLY . . . . . . . . . . . . . . . 102.34 -26.3 24.71 Favored Glycine 0 CA--C 1.533 1.174 0 CA-C-N 115.638 -0.71 . . . . 0.0 112.297 -176.767 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' D' D ' 29' ' ' LYS . . . . . . . . . . . . . 61.5 mttm -98.45 155.19 17.37 Favored 'General case' 0 CA--C 1.528 0.105 0 CA-C-N 117.364 0.582 . . . . 0.0 111.045 178.191 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' D' D ' 30' ' ' THR . . . . . . . . . . . . . 55.5 m -107.2 138.72 42.87 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-N 116.155 -0.475 . . . . 0.0 109.906 175.937 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' D' D ' 31' ' ' VAL . . . . . . . . . . . . . 34.7 m -130.43 159.07 42.78 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.232 0 CA-C-O 120.817 0.341 . . . . 0.0 111.019 -178.016 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' D' D ' 32' ' ' ARG . . . . . . . . . . . . . 96.8 mtt180 -132.58 149.07 52.37 Favored 'General case' 0 C--N 1.332 -0.176 0 CA-C-N 115.934 -0.576 . . . . 0.0 110.662 178.65 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' D' D ' 33' ' ' THR . . . . . . . . . . . . . 18.7 m -52.96 140.4 24.93 Favored 'General case' 0 C--N 1.331 -0.23 0 CA-C-N 116.33 -0.396 . . . . 0.0 111.412 -179.387 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' D' D ' 34' ' ' GLY . . . . . . . . . . . . . . . 99.17 -17.1 58.48 Favored Glycine 0 CA--C 1.532 1.13 0 CA-C-O 119.62 -0.545 . . . . 0.0 113.274 179.335 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' D' D ' 35' ' ' ASP . . . . . . . . . . . . . 77.9 m-20 -66.61 148.9 51.26 Favored 'General case' 0 C--O 1.231 0.112 0 CA-C-N 118.037 0.919 . . . . 0.0 111.131 179.076 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' D' D ' 36' ' ' VAL . . . . . . . . . . . . . 45.5 t -119.56 128.7 75.88 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.213 0 CA-C-N 115.931 -0.577 . . . . 0.0 109.734 177.962 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' D' D ' 37' ' ' ILE . . . . . . . . . . . . . 63.3 mt -120.1 138.25 51.29 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.271 0 CA-C-N 116.158 -0.474 . . . . 0.0 109.83 -179.179 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' D' D ' 38' ' ' GLY . . . . . . . . . . . . . . . -118.38 128.86 7.91 Favored Glycine 0 CA--C 1.524 0.638 0 N-CA-C 111.058 -0.817 . . . . 0.0 111.058 -179.859 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' D' D ' 39' ' ' ILE . . . . . . . . . . . . . 68.0 mt -123.88 129.78 74.2 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.196 0 N-CA-C 110.026 -0.361 . . . . 0.0 110.026 178.808 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' D' D ' 40' ' ' SER . . . . . . . . . . . . . 20.3 t -92.09 117.42 29.82 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.142 -0.481 . . . . 0.0 110.734 176.453 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' D' D ' 41' ' ' ILE . . . . . . . . . . . . . 72.6 mt -131.95 122.56 49.43 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.232 0 CA-C-O 120.813 0.34 . . . . 0.0 110.095 178.376 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' D' D ' 42' ' ' LEU . . . . . . . . . . . . . 76.3 mt 58.3 34.9 24.48 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.023 -0.535 . . . . 0.0 111.506 179.012 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' D' D ' 43' ' ' GLY . . . . . . . . . . . . . . . 77.23 -10.15 22.8 Favored Glycine 0 CA--C 1.535 1.342 0 CA-C-O 119.785 -0.453 . . . . 0.0 113.427 178.123 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' D' D ' 44' ' ' LYS . . . . . . . . . . . . . 21.4 tptm -99.86 128.21 45.97 Favored 'General case' 0 C--N 1.332 -0.175 0 CA-C-N 117.915 0.858 . . . . 0.0 110.064 178.452 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' D' D ' 45' ' ' GLU . . . . . . . . . . . . . 85.0 tt0 -85.25 129.65 34.76 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.393 -0.367 . . . . 0.0 111.239 179.911 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' D' D ' 46' ' ' VAL . . . . . 0.423 HG13 ' O ' ' D' ' 46' ' ' VAL . 10.3 p -119.14 124.19 72.69 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.16 0 N-CA-C 109.654 -0.499 . . . . 0.0 109.654 174.82 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' D' D ' 47' ' ' LYS . . . . . . . . . . . . . 63.6 mttp -98.19 125.07 43.08 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.072 -0.513 . . . . 0.0 110.614 177.24 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' D' D ' 48' ' ' PHE . . . . . . . . . . . . . 40.0 m-85 -111.4 131.83 54.9 Favored 'General case' 0 C--N 1.329 -0.29 0 N-CA-C 109.481 -0.562 . . . . 0.0 109.481 176.985 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' D' D ' 49' ' ' LYS . . . . . . . . . . . . . 42.2 tttp -107.36 132.1 53.52 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.29 -0.413 . . . . 0.0 110.206 179.08 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' D' D ' 50' ' ' VAL . . . . . . . . . . . . . 41.9 t -74.86 105.03 3.59 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.289 0 N-CA-C 109.34 -0.615 . . . . 0.0 109.34 177.495 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' D' D ' 51' ' ' VAL . . . . . . . . . . . . . 51.4 t -72.3 -48.6 47.55 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.331 0 CA-C-N 116.182 -0.463 . . . . 0.0 109.996 -174.038 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' D' D ' 52' ' ' GLN . . . . . . . . . . . . . 60.2 tt0 -162.21 148.21 13.13 Favored 'General case' 0 C--N 1.329 -0.29 0 C-N-CA 120.242 -0.583 . . . . 0.0 111.757 -179.21 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' D' D ' 53' ' ' ALA . . . . . . . . . . . . . . . -126.33 134.47 51.09 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 115.597 -0.729 . . . . 0.0 110.117 177.892 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' D' D ' 54' ' ' TYR . . . . . . . . . . . . . 59.9 t80 -129.09 111.06 18.3 Favored Pre-proline 0 CA--C 1.535 0.376 0 CA-C-O 118.198 -0.906 . . . . 0.0 110.086 177.879 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' D' D ' 55' ' ' PRO . . . . . . . . . . . . . 72.5 Cg_endo -77.19 169.93 72.86 Favored 'Cis proline' 0 N--CA 1.5 1.887 0 CA-C-N 121.932 1.726 . . . . 0.0 112.643 -4.822 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' D' D ' 56' ' ' SER . . . . . . . . . . . . . 13.6 m -118.49 130.82 24.55 Favored Pre-proline 0 CA--C 1.539 0.545 0 CA-C-O 118.431 -0.795 . . . . 0.0 109.743 174.737 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' D' D ' 57' ' ' PRO . . . . . . . . . . . . . 32.9 Cg_endo -65.16 167.65 46.12 Favored 'Cis proline' 0 N--CA 1.498 1.753 0 CA-C-N 121.953 1.733 . . . . 0.0 111.147 -2.952 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' D' D ' 58' ' ' LEU . . . . . . . . . . . . . 14.9 tp -128.38 134.79 48.9 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-O 121.069 0.461 . . . . 0.0 110.255 -179.812 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' D' D ' 59' ' ' ARG . . . . . . . . . . . . . 58.6 ttt-85 -103.05 119.58 39.11 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 115.406 -0.815 . . . . 0.0 109.133 176.817 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' D' D ' 60' ' ' VAL . . . . . . . . . . . . . 40.6 t -74.17 117.07 17.57 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.315 0 C-N-CA 120.867 -0.333 . . . . 0.0 110.731 -172.939 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' D' D ' 61' ' ' GLU . . . . . . . . . . . . . 40.5 mt-10 -131.08 161.18 32.62 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 115.982 -0.554 . . . . 0.0 109.952 175.977 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' D' D ' 62' ' ' ASP . . . . . . . . . . . . . 61.6 m-20 -52.09 -31.43 30.44 Favored 'General case' 0 C--N 1.328 -0.33 0 N-CA-C 112.157 0.428 . . . . 0.0 112.157 -177.664 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' D' D ' 63' ' ' ARG . . . . . . . . . . . . . 78.3 mtp180 -72.58 -22.04 61.05 Favored 'General case' 0 CA--C 1.532 0.268 0 N-CA-C 113.091 0.775 . . . . 0.0 113.091 -174.607 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' D' D ' 64' ' ' THR . . . . . . . . . . . . . 34.5 m -71.2 140.39 50.45 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-O 120.888 0.375 . . . . 0.0 111.244 -175.118 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' D' D ' 65' ' ' LYS . . . . . . . . . . . . . 3.9 mptp? -90.06 138.76 31.24 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 115.85 -0.614 . . . . 0.0 110.261 178.196 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' D' D ' 66' ' ' ILE . . . . . . . . . . . . . 60.6 mt -114.1 128.25 71.15 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.231 0 N-CA-C 109.658 -0.497 . . . . 0.0 109.658 178.754 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' D' D ' 67' ' ' THR . . . . . . . . . . . . . 15.5 m -122.35 146.71 47.07 Favored 'General case' 0 C--N 1.332 -0.159 0 CA-C-O 121.233 0.54 . . . . 0.0 111.133 -176.253 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' D' D ' 68' ' ' LEU . . . . . . . . . . . . . 15.1 tp . . . . . 0 C--N 1.33 -0.268 0 CA-C-N 115.647 -0.706 . . . . 0.0 110.765 -179.467 . . . . . . . . 0 0 . 1 . 010 nuclear nobuild core ' D' D ' 73' ' ' VAL . . . . . . . . . . . . . 33.5 m . . . . . 0 C--O 1.232 0.134 0 N-CA-C 110.124 -0.324 . . . . 0.0 110.124 . . . . . . . . . 0 0 . 1 . 010 nuclear nobuild core ' D' D ' 74' ' ' ASP . . . . . . . . . . . . . 22.4 t0 -84.56 118.36 24.29 Favored 'General case' 0 C--N 1.33 -0.258 0 C-N-CA 120.601 -0.44 . . . . 0.0 110.295 -172.538 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' D' D ' 75' ' ' VAL . . . . . . . . . . . . . 39.4 t -122.22 121.93 65.15 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.271 0 CA-C-O 120.961 0.41 . . . . 0.0 110.659 -176.948 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' D' D ' 76' ' ' LEU . . . . . . . . . . . . . 5.8 mp -122.03 149.13 43.94 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 115.735 -0.666 . . . . 0.0 109.39 174.861 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' D' D ' 77' ' ' GLU . . . . . . . . . . . . . 96.5 mt-10 -136.68 137.12 39.67 Favored 'General case' 0 C--N 1.332 -0.189 0 CA-C-O 121.16 0.505 . . . . 0.0 111.516 -176.644 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' D' D ' 78' ' ' ALA . . . . . . . . . . . . . . . -123.58 135.37 53.94 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 115.587 -0.733 . . . . 0.0 109.414 175.156 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' D' D ' 79' ' ' LYS . . . . . 0.597 ' O ' HD13 ' D' ' 80' ' ' ILE . 59.4 mtpt -82.73 120.63 25.84 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-O 120.907 0.384 . . . . 0.0 111.129 -176.42 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' D' D ' 80' ' ' ILE . . . . . 0.597 HD13 ' O ' ' D' ' 79' ' ' LYS . 40.2 mm -139.19 105.8 2.63 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.305 0 N-CA-C 109.103 -0.703 . . . . 0.0 109.103 -178.769 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' D' D ' 81' ' ' LYS . . . . . . . . . . . . . 19.2 pttp -98.14 128.69 44.77 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-O 120.869 0.366 . . . . 0.0 111.225 -176.544 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' D' D ' 82' ' ' GLY . . . . . . . . . . . . . . . 89.21 41.99 5.69 Favored Glycine 0 CA--C 1.524 0.651 0 C-N-CA 120.685 -0.769 . . . . 0.0 111.52 176.2 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' D' D ' 83' ' ' ILE . . . . . . . . . . . . . 71.7 mt -65.3 139.25 21.67 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.328 0 CA-C-O 121.009 0.433 . . . . 0.0 110.046 178.86 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' D' D ' 84' ' ' LYS . . . . . . . . . . . . . 59.5 tttm -99.17 -53.93 3.11 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 115.89 -0.595 . . . . 0.0 109.906 -179.609 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' D' D ' 85' ' ' ASP . . . . . . . . . . . . . 13.4 t70 -156.7 150.11 24.37 Favored 'General case' 0 C--N 1.326 -0.42 0 CA-C-N 115.646 -0.706 . . . . 0.0 110.187 -179.991 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' D' D ' 86' ' ' VAL . . . . . . . . . . . . . 42.8 t -128.41 128.74 68.6 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.279 0 CA-C-O 120.93 0.395 . . . . 0.0 110.41 -179.227 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' D' D ' 87' ' ' ILE . . . . . . . . . . . . . 44.1 mm -118.08 127.63 75.26 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.284 0 CA-C-N 115.824 -0.626 . . . . 0.0 109.488 176.679 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' D' D ' 88' ' ' LEU . . . . . . . . . . . . . 18.7 tp -112.74 133.65 54.65 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-O 121.137 0.494 . . . . 0.0 111.123 -177.64 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' D' D ' 89' ' ' ASP . . . . . . . . . . . . . 10.7 t70 -125.35 158.51 34.07 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 115.587 -0.733 . . . . 0.0 109.431 176.256 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' D' D ' 90' ' ' GLU . . . . . . . . . . . . . 96.0 mt-10 -46.74 -37.74 8.96 Favored 'General case' 0 C--N 1.331 -0.237 0 N-CA-C 113.17 0.804 . . . . 0.0 113.17 -172.138 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' D' D ' 91' ' ' ASN . . . . . . . . . . . . . 4.7 p-10 -132.04 23.35 4.54 Favored 'General case' 0 N--CA 1.467 0.413 0 N-CA-C 112.815 0.672 . . . . 0.0 112.815 -177.747 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' D' D ' 92' ' ' LEU . . . . . . . . . . . . . 16.5 mt -148.97 144.45 26.79 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-O 120.858 0.361 . . . . 0.0 110.56 -176.522 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' D' D ' 93' ' ' ILE . . . . . . . . . . . . . 71.4 mt -122.6 115.31 45.61 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.316 0 N-CA-C 109.224 -0.658 . . . . 0.0 109.224 176.728 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' D' D ' 94' ' ' VAL . . . . . . . . . . . . . 44.9 t -117.06 123.0 71.31 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.267 0 N-CA-C 109.867 -0.42 . . . . 0.0 109.867 -178.932 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' D' D ' 95' ' ' VAL . . . . . . . . . . . . . 42.0 t -120.18 133.75 65.89 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.236 0 CA-C-N 116.021 -0.536 . . . . 0.0 110.025 -178.039 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' D' D ' 96' ' ' ILE . . . . . . . . . . . . . 56.1 mt -113.88 130.76 67.46 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 N-CA-C 109.124 -0.695 . . . . 0.0 109.124 177.145 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' D' D ' 97' ' ' THR . . . . . . . . . . . . . 68.6 p -103.48 157.18 17.21 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-O 120.872 0.368 . . . . 0.0 110.988 -178.638 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' D' D ' 98' ' ' GLU . . . . . . . . . . . . . 97.4 mt-10 -53.89 -22.89 10.96 Favored 'General case' 0 CA--C 1.535 0.375 0 N-CA-C 112.307 0.484 . . . . 0.0 112.307 179.121 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' D' D ' 99' ' ' GLU . . . . . . . . . . . . . 95.6 mt-10 -77.49 12.55 1.54 Allowed 'General case' 0 CA--C 1.536 0.441 0 N-CA-C 113.208 0.818 . . . . 0.0 113.208 -178.714 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' D' D ' 100' ' ' ASN . . . . . . . . . . . . . 3.0 m-20 61.85 37.46 15.36 Favored 'General case' 0 CA--C 1.531 0.217 0 CA-C-O 121.023 0.439 . . . . 0.0 110.979 179.833 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' D' D ' 101' ' ' GLU . . . . . . . . . . . . . 85.4 tt0 -116.84 145.63 43.43 Favored 'General case' 0 C--N 1.333 -0.137 0 CA-C-N 116.086 -0.506 . . . . 0.0 109.886 176.239 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' D' D ' 102' ' ' VAL . . . . . . . . . . . . . 42.9 t -117.64 127.1 75.07 Favored 'Isoleucine or valine' 0 C--O 1.233 0.224 0 CA-C-N 116.277 -0.42 . . . . 0.0 109.929 -178.284 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' D' D ' 103' ' ' LEU . . . . . . . . . . . . . 63.0 mt -119.57 134.61 55.15 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 115.991 -0.549 . . . . 0.0 110.511 178.058 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' D' D ' 104' ' ' ILE . . . . . . . . . . . . . 66.1 mt -120.99 120.18 61.52 Favored 'Isoleucine or valine' 0 C--O 1.234 0.252 0 CA-C-N 116.567 -0.288 . . . . 0.0 110.513 -179.09 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' D' D ' 105' ' ' PHE . . . . . . . . . . . . . 54.2 m-85 -120.53 167.71 12.11 Favored 'General case' 0 N--CA 1.462 0.146 0 O-C-N 124.066 0.854 . . . . 0.0 109.829 177.707 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' D' D ' 106' ' ' ASN . . . . . . . . . . . . . 47.5 p-10 -104.04 -170.39 1.77 Allowed 'General case' 0 CA--C 1.532 0.264 0 N-CA-C 110.221 -0.288 . . . . 0.0 110.221 173.091 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' D' D ' 107' ' ' GLN . . . . . . . . . . . . . 61.7 tt0 -57.75 -29.85 65.12 Favored 'General case' 0 CA--C 1.532 0.286 0 N-CA-C 111.97 0.359 . . . . 0.0 111.97 178.987 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' D' D ' 108' ' ' ASN . . . . . . . . . . . . . 10.2 t-20 -86.52 12.7 9.81 Favored 'General case' 0 CA--C 1.535 0.367 0 N-CA-C 112.922 0.712 . . . . 0.0 112.922 -176.681 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' D' D ' 109' ' ' LEU . . . . . . . . . . . . . 26.4 mt 56.76 32.34 21.06 Favored 'General case' 0 CA--C 1.53 0.211 0 N-CA-C 111.75 0.278 . . . . 0.0 111.75 179.356 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' D' D ' 110' ' ' GLU . . . . . . . . . . . . . 69.3 mm-40 -98.27 143.38 28.81 Favored 'General case' 0 C--N 1.33 -0.28 0 N-CA-C 109.258 -0.645 . . . . 0.0 109.258 175.372 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' D' D ' 111' ' ' GLU . . . . . . . . . . . . . 58.9 tt0 -83.33 121.88 27.72 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-O 121.082 0.467 . . . . 0.0 110.344 -177.162 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' D' D ' 112' ' ' LEU . . . . . . . . . . . . . 23.7 mt -104.31 -45.83 4.57 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 115.816 -0.629 . . . . 0.0 110.413 -178.759 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' D' D ' 113' ' ' TYR . . . . . . . . . . . . . 61.1 t80 -140.39 140.75 35.56 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.096 -0.502 . . . . 0.0 111.008 -178.361 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' D' D ' 114' ' ' ARG . . . . . . . . . . . . . 35.6 ptt-85 -142.21 125.41 16.41 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.305 -0.407 . . . . 0.0 110.489 176.427 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' D' D ' 115' ' ' GLY . . . . . . . . . . . . . . . -150.14 159.79 28.26 Favored Glycine 0 CA--C 1.522 0.522 0 N-CA-C 110.691 -0.964 . . . . 0.0 110.691 179.203 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' D' D ' 116' ' ' LYS . . . . . . . . . . . . . 2.1 ttmp? -127.84 138.95 52.88 Favored 'General case' 0 C--N 1.329 -0.312 0 N-CA-C 110.027 -0.361 . . . . 0.0 110.027 177.566 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' D' D ' 117' ' ' PHE . . . . . . . . . . . . . 43.8 m-85 -135.68 113.89 11.43 Favored 'General case' 0 C--N 1.331 -0.23 0 CA-C-N 116.207 -0.451 . . . . 0.0 109.895 -177.032 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' D' D ' 118' ' ' GLU . . . . . . . . . . . . . 70.8 mm-40 -54.69 -42.66 71.68 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.448 -0.342 . . . . 0.0 111.294 -176.3 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' D' D ' 119' ' ' ASN . . . . . . . . . . . . . 19.9 m120 -100.94 31.03 3.75 Favored 'General case' 0 C--N 1.331 -0.227 0 N-CA-C 112.188 0.44 . . . . 0.0 112.188 -174.287 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' D' D ' 120' ' ' LEU . . . . . . . . . . . . . 16.3 tp -56.96 121.1 9.14 Favored 'General case' 0 N--CA 1.462 0.167 0 C-N-CA 121.009 -0.276 . . . . 0.0 110.345 177.727 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' D' D ' 121' ' ' ASN . . . . . . . . . . . . . 60.5 m-20 -114.2 -44.06 3.16 Favored 'General case' 0 C--N 1.332 -0.154 0 CA-C-N 116.678 -0.237 . . . . 0.0 111.26 -176.898 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' D' D ' 122' ' ' LYS . . . . . 0.446 ' HE3' HD11 ' D' ' 124' ' ' LEU . 39.0 ttpt -144.82 143.12 30.47 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-O 120.953 0.406 . . . . 0.0 111.343 -175.976 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' D' D ' 123' ' ' VAL . . . . . . . . . . . . . 43.6 t -128.77 134.23 64.8 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.219 0 CA-C-N 116.172 -0.467 . . . . 0.0 109.762 177.18 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' D' D ' 124' ' ' LEU . . . . . 0.446 HD11 ' HE3' ' D' ' 122' ' ' LYS . 59.0 mt -129.51 135.27 48.41 Favored 'General case' 0 C--N 1.331 -0.196 0 CA-C-O 120.815 0.341 . . . . 0.0 110.949 -179.048 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' D' D ' 125' ' ' VAL . . . . . . . . . . . . . 10.6 p -132.33 131.12 60.67 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.274 0 CA-C-N 116.11 -0.496 . . . . 0.0 109.958 177.526 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' D' D ' 126' ' ' ARG . . . . . . . . . . . . . 53.8 ttm-85 -143.08 116.04 8.83 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.462 -0.335 . . . . 0.0 110.815 -178.72 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' D' D ' 127' ' ' ASN . . . . . . . . . . . . . 3.1 m120 51.97 -105.0 0.2 Allowed 'General case' 0 CA--C 1.544 0.721 0 CA-C-O 119.172 -0.442 . . . . 0.0 111.323 178.214 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' D' D ' 128' ' ' ASP . . . . . . . . . . . . . 19.1 p-10 -113.9 3.95 15.62 Favored 'General case' 0 CA--C 1.538 0.496 0 CA-C-N 119.42 1.009 . . . . 0.0 113.426 -176.208 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' D' D ' 129' ' ' LEU . . . . . . . . . . . . . 21.6 tp -110.43 137.01 48.71 Favored 'General case' 0 C--N 1.331 -0.222 0 CA-C-N 118.047 0.385 . . . . 0.0 110.05 178.857 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' D' D ' 130' ' ' VAL . . . . . . . . . . . . . 54.6 t -124.99 137.25 58.2 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.284 0 CA-C-O 120.833 0.349 . . . . 0.0 110.15 -179.475 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' D' D ' 131' ' ' VAL . . . . . . . . . . . . . 42.9 t -135.98 136.27 49.84 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.274 0 CA-C-N 116.271 -0.422 . . . . 0.0 110.363 179.698 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' D' D ' 132' ' ' ILE . . . . . . . . . . . . . 74.1 mt -119.33 133.37 66.35 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.298 0 N-CA-C 109.52 -0.548 . . . . 0.0 109.52 178.784 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' D' D ' 133' ' ' ILE . . . . . . . . . . . . . 40.4 mm -119.12 124.3 72.88 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.223 0 CA-C-O 120.829 0.347 . . . . 0.0 111.315 -174.831 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' D' D ' 134' ' ' ASP . . . . . . . . . . . . . 9.7 p-10 -137.68 150.1 47.07 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-N 116.307 -0.406 . . . . 0.0 109.932 173.637 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' D' D ' 135' ' ' GLU . . . . . . . . . . . . . 86.0 tt0 -49.77 -22.93 1.57 Allowed 'General case' 0 C--N 1.328 -0.359 0 N-CA-C 113.067 0.765 . . . . 0.0 113.067 -174.21 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' D' D ' 136' ' ' GLN . . . . . . . . . . . . . 63.1 tt0 -93.16 -28.76 16.11 Favored 'General case' 0 C--O 1.234 0.265 0 N-CA-C 112.384 0.512 . . . . 0.0 112.384 -174.004 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' D' D ' 137' ' ' LYS . . . . . . . . . . . . . 47.7 pttt -166.04 170.58 13.4 Favored 'General case' 0 C--N 1.332 -0.185 0 CA-C-O 121.55 0.69 . . . . 0.0 112.317 -172.849 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' D' D ' 138' ' ' LEU . . . . . 0.406 HD23 ' N ' ' D' ' 139' ' ' THR . 5.6 tt -121.96 128.61 51.7 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 114.882 -1.053 . . . . 0.0 109.836 178.797 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' D' D ' 139' ' ' THR . . . . . 0.406 ' N ' HD23 ' D' ' 138' ' ' LEU . 26.4 m -109.69 132.65 53.95 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-N 116.198 -0.455 . . . . 0.0 110.629 -179.254 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' D' D ' 140' ' ' LEU . . . . . 0.464 HD21 ' O ' ' E' ' 107' ' ' GLN . 12.1 tp -118.58 124.14 46.74 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 115.583 -0.735 . . . . 0.0 109.381 -178.425 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' D' D ' 141' ' ' ILE . . . . . . . . . . . . . 19.6 mt -120.48 119.62 60.32 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.344 0 N-CA-C 109.87 -0.418 . . . . 0.0 109.87 -175.795 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' D' D ' 142' ' ' ARG . . . . . . . . . . . . . 7.8 mmm180 -109.03 126.13 52.81 Favored 'General case' 0 C--N 1.331 -0.227 0 CA-C-N 115.496 -0.775 . . . . 0.0 110.508 -177.857 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' D' D ' 143' ' ' THR . . . . . . . . . . . . . 49.5 p . . . . . 0 C--O 1.219 -0.501 0 CA-C-O 117.998 -1.001 . . . . 0.0 110.627 -179.864 . . . . . . . . 0 0 . 1 . 010 nuclear nobuild core ' E' E ' 2' ' ' SER . . . . . . . . . . . . . 94.5 p . . . . . 0 C--O 1.233 0.19 0 CA-C-O 121.106 0.479 . . . . 0.0 110.637 . . . . . . . . . 0 0 . 1 . 010 nuclear nobuild core ' E' E ' 3' ' ' GLU . . . . . . . . . . . . . 82.4 tt0 -140.63 143.99 35.49 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 115.935 -0.575 . . . . 0.0 110.851 -177.842 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' E' E ' 4' ' ' LEU . . . . . . . . . . . . . 20.6 tp -124.86 130.87 53.24 Favored 'General case' 0 C--N 1.331 -0.216 0 CA-C-N 116.016 -0.538 . . . . 0.0 110.176 177.673 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' E' E ' 5' ' ' LYS . . . . . . . . . . . . . 61.3 mttp -108.44 121.84 45.78 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-O 120.876 0.37 . . . . 0.0 110.616 178.856 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' E' E ' 6' ' ' LEU . . . . . . . . . . . . . 67.2 mt -114.05 150.21 34.31 Favored 'General case' 0 C--N 1.331 -0.217 0 CA-C-N 115.548 -0.751 . . . . 0.0 110.702 -179.982 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' E' E ' 7' ' ' LYS . . . . . . . . . . . . . 84.6 tttt -140.46 140.11 22.06 Favored Pre-proline 0 CA--C 1.534 0.354 0 CA-C-O 119.09 -0.481 . . . . 0.0 110.02 175.189 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' E' E ' 8' ' ' PRO . . . . . . . . . . . . . 95.2 Cg_endo -92.01 143.7 2.76 Favored 'Trans proline' 0 N--CA 1.49 1.315 0 C-N-CA 121.765 1.643 . . . . 0.0 111.73 177.593 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' E' E ' 9' ' ' LEU . . . . . . . . . . . . . 60.7 mt -78.36 -47.51 1.99 Allowed Pre-proline 0 CA--C 1.533 0.298 0 CA-C-O 118.715 -0.66 . . . . 0.0 112.242 -179.257 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' E' E ' 10' ' ' PRO . . . . . . . . . . . . . 92.9 Cg_endo -80.36 153.84 21.26 Favored 'Trans proline' 0 N--CA 1.496 1.63 0 C-N-CA 121.067 1.178 . . . . 0.0 111.904 176.129 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' E' E ' 11' ' ' LYS . . . . . . . . . . . . . 55.7 mtmt -88.35 98.95 11.89 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.376 -0.374 . . . . 0.0 110.604 179.312 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' E' E ' 12' ' ' VAL . . . . . . . . . . . . . 11.2 p -145.06 144.04 21.91 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.294 0 CA-C-N 116.111 -0.495 . . . . 0.0 110.357 -179.718 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' E' E ' 13' ' ' GLU . . . . . . . . . . . . . 95.4 mt-10 -85.02 121.51 27.9 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.176 -0.465 . . . . 0.0 109.972 177.774 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' E' E ' 14' ' ' LEU . . . . . . . . . . . . . 20.0 mt -93.62 156.5 39.58 Favored Pre-proline 0 C--N 1.329 -0.323 0 CA-C-N 116.349 -0.387 . . . . 0.0 110.784 -177.188 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' E' E ' 15' ' ' PRO . . . . . . . . . . . . . 27.0 Cg_exo -60.73 155.07 50.8 Favored 'Trans proline' 0 N--CA 1.496 1.625 0 C-N-CA 121.354 1.369 . . . . 0.0 111.764 179.614 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' E' E ' 16' ' ' PRO . . . . . . . . . . . . . 32.3 Cg_exo -57.63 -36.48 98.51 Favored 'Trans proline' 0 N--CA 1.497 1.689 0 C-N-CA 121.328 1.352 . . . . 0.0 112.572 179.598 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' E' E ' 17' ' ' ASP . . . . . . . . . . . . . 8.8 p-10 -88.74 13.78 11.65 Favored 'General case' 0 CA--C 1.535 0.389 0 N-CA-C 113.027 0.751 . . . . 0.0 113.027 -177.74 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' E' E ' 18' ' ' PHE . . . . . . . . . . . . . 40.8 t80 -58.43 -44.37 89.08 Favored 'General case' 0 C--N 1.333 -0.134 0 O-C-N 121.968 -0.457 . . . . 0.0 110.198 -178.599 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' E' E ' 19' ' ' VAL . . . . . 0.44 HG13 ' N ' ' E' ' 20' ' ' ASP . 14.4 p -58.42 -46.42 89.46 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.354 0 CA-C-N 116.459 -0.337 . . . . 0.0 111.807 -174.83 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' E' E ' 20' ' ' ASP . . . . . 0.44 ' N ' HG13 ' E' ' 19' ' ' VAL . 2.7 p-10 -64.75 -36.17 83.44 Favored 'General case' 0 N--CA 1.463 0.224 0 C-N-CA 120.655 -0.418 . . . . 0.0 111.169 -177.383 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' E' E ' 21' ' ' VAL . . . . . . . . . . . . . 48.2 t -63.95 -48.19 87.2 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.217 0 C-N-CA 120.632 -0.427 . . . . 0.0 110.193 179.374 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' E' E ' 22' ' ' ILE . . . . . 0.483 HG22 HD12 ' E' ' 26' ' ' LEU . 51.0 mm -56.17 -43.09 75.15 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.216 0 C-N-CA 121.019 -0.272 . . . . 0.0 110.416 177.321 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' E' E ' 23' ' ' ARG . . . . . . . . . . . . . 43.2 ttp180 -52.1 -51.11 59.84 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-O 120.723 0.297 . . . . 0.0 111.498 -179.457 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' E' E ' 24' ' ' ILE . . . . . . . . . . . . . 70.3 mt -59.78 -41.69 86.4 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.256 0 CA-C-N 116.471 -0.331 . . . . 0.0 110.963 -179.047 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' E' E ' 25' ' ' LYS . . . . . . . . . . . . . 60.6 mtpt -62.98 -41.85 99.68 Favored 'General case' 0 C--N 1.327 -0.388 0 N-CA-C 112.076 0.399 . . . . 0.0 112.076 -178.598 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' E' E ' 26' ' ' LEU . . . . . 0.483 HD12 HG22 ' E' ' 22' ' ' ILE . 72.4 mt -80.42 -39.65 27.88 Favored 'General case' 0 C--N 1.33 -0.256 0 N-CA-C 113.27 0.841 . . . . 0.0 113.27 -170.916 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' E' E ' 27' ' ' GLN . . . . . . . . . . . . . 9.1 pt20 -46.59 135.08 8.93 Favored 'General case' 0 N--CA 1.468 0.462 0 N-CA-C 113.003 0.742 . . . . 0.0 113.003 -174.768 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' E' E ' 28' ' ' GLY . . . . . . . . . . . . . . . 100.44 -21.79 42.68 Favored Glycine 0 CA--C 1.534 1.251 0 CA-C-N 115.523 -0.762 . . . . 0.0 112.719 -178.416 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' E' E ' 29' ' ' LYS . . . . . . . . . . . . . 65.6 mttm -98.79 155.12 17.52 Favored 'General case' 0 C--O 1.232 0.177 0 CA-C-N 117.512 0.656 . . . . 0.0 111.29 -179.767 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' E' E ' 30' ' ' THR . . . . . . . . . . . . . 38.1 m -104.07 133.64 48.66 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 115.901 -0.591 . . . . 0.0 109.73 175.223 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' E' E ' 31' ' ' VAL . . . . . . . . . . . . . 33.6 m -131.72 154.91 41.14 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.211 0 CA-C-O 121.03 0.443 . . . . 0.0 111.343 -176.984 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' E' E ' 32' ' ' ARG . . . . . . . . . . . . . 55.7 mtp180 -132.25 152.33 51.4 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 115.771 -0.65 . . . . 0.0 110.436 177.553 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' E' E ' 33' ' ' THR . . . . . . . . . . . . . 20.5 m -53.18 139.68 28.36 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.271 -0.422 . . . . 0.0 111.322 -179.121 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' E' E ' 34' ' ' GLY . . . . . . . . . . . . . . . 100.82 -17.28 56.61 Favored Glycine 0 CA--C 1.532 1.126 0 CA-C-O 119.608 -0.551 . . . . 0.0 113.279 179.709 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' E' E ' 35' ' ' ASP . . . . . . . . . . . . . 66.7 m-20 -65.93 149.58 49.99 Favored 'General case' 0 C--O 1.231 0.131 0 CA-C-N 118.036 0.918 . . . . 0.0 110.998 179.059 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' E' E ' 36' ' ' VAL . . . . . . . . . . . . . 46.4 t -122.1 131.75 72.48 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.196 0 CA-C-N 115.911 -0.586 . . . . 0.0 110.134 179.825 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' E' E ' 37' ' ' ILE . . . . . . . . . . . . . 67.7 mt -119.92 139.02 48.62 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.245 0 CA-C-N 116.086 -0.506 . . . . 0.0 109.797 178.637 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' E' E ' 38' ' ' GLY . . . . . . . . . . . . . . . -113.48 128.99 8.6 Favored Glycine 0 CA--C 1.526 0.741 0 N-CA-C 111.139 -0.784 . . . . 0.0 111.139 -179.614 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' E' E ' 39' ' ' ILE . . . . . . . . . . . . . 72.1 mt -123.43 135.78 62.15 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.186 0 N-CA-C 110.015 -0.365 . . . . 0.0 110.015 178.656 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' E' E ' 40' ' ' SER . . . . . . . . . . . . . 30.0 t -92.67 123.02 35.65 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.225 -0.443 . . . . 0.0 110.835 175.8 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' E' E ' 41' ' ' ILE . . . . . . . . . . . . . 71.4 mt -131.34 114.57 26.36 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.214 0 N-CA-C 110.08 -0.341 . . . . 0.0 110.08 177.69 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' E' E ' 42' ' ' LEU . . . . . . . . . . . . . 84.4 mt 58.11 33.28 23.01 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.038 -0.528 . . . . 0.0 111.797 178.893 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' E' E ' 43' ' ' GLY . . . . . . . . . . . . . . . 83.24 -10.18 59.18 Favored Glycine 0 CA--C 1.535 1.283 0 C-N-CA 121.156 -0.545 . . . . 0.0 113.497 177.018 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' E' E ' 44' ' ' LYS . . . . . . . . . . . . . 64.6 mttp -98.46 136.18 38.96 Favored 'General case' 0 C--N 1.333 -0.115 0 CA-C-N 117.892 0.846 . . . . 0.0 110.271 177.785 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' E' E ' 45' ' ' GLU . . . . . . . . . . . . . 84.3 tt0 -85.26 128.87 34.85 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-N 116.464 -0.334 . . . . 0.0 111.373 179.946 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' E' E ' 46' ' ' VAL . . . . . . . . . . . . . 7.4 p -121.8 126.33 74.47 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.18 0 N-CA-C 109.457 -0.571 . . . . 0.0 109.457 174.697 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' E' E ' 47' ' ' LYS . . . . . . . . . . . . . 61.6 mttm -100.06 129.18 46.08 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-N 116.052 -0.522 . . . . 0.0 111.162 179.004 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' E' E ' 48' ' ' PHE . . . . . . . . . . . . . 92.6 m-85 -111.43 131.93 54.83 Favored 'General case' 0 C--N 1.332 -0.182 0 CA-C-N 116.28 -0.418 . . . . 0.0 109.954 176.28 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' E' E ' 49' ' ' LYS . . . . . . . . . . . . . 54.8 tttp -107.68 137.17 46.17 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.464 -0.335 . . . . 0.0 110.564 179.368 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' E' E ' 50' ' ' VAL . . . . . . . . . . . . . 45.6 t -79.92 108.25 13.2 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.25 0 N-CA-C 109.258 -0.645 . . . . 0.0 109.258 174.894 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' E' E ' 51' ' ' VAL . . . . . . . . . . . . . 48.7 t -71.46 -47.62 57.74 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.326 0 CA-C-N 116.223 -0.444 . . . . 0.0 110.004 -173.795 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' E' E ' 52' ' ' GLN . . . . . . . . . . . . . 62.3 tt0 -166.13 143.83 5.45 Favored 'General case' 0 C--N 1.329 -0.307 0 C-N-CA 120.441 -0.504 . . . . 0.0 111.847 -178.952 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' E' E ' 53' ' ' ALA . . . . . . . . . . . . . . . -119.66 134.11 55.36 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 115.915 -0.584 . . . . 0.0 109.774 175.599 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' E' E ' 54' ' ' TYR . . . . . . . . . . . . . 10.9 t80 -129.1 112.33 18.42 Favored Pre-proline 0 CA--C 1.534 0.348 0 CA-C-O 118.191 -0.909 . . . . 0.0 110.028 177.917 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' E' E ' 55' ' ' PRO . . . . . . . . . . . . . 71.7 Cg_endo -77.2 170.17 72.2 Favored 'Cis proline' 0 N--CA 1.5 1.911 0 CA-C-N 122.002 1.751 . . . . 0.0 112.527 -5.94 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' E' E ' 56' ' ' SER . . . . . . . . . . . . . 15.8 m -123.47 139.02 31.12 Favored Pre-proline 0 CA--C 1.539 0.545 0 CA-C-O 118.553 -0.737 . . . . 0.0 109.443 174.06 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' E' E ' 57' ' ' PRO . . . . . . . . . . . . . 37.6 Cg_endo -67.45 145.2 73.48 Favored 'Cis proline' 0 N--CA 1.498 1.773 0 CA-C-N 121.616 1.613 . . . . 0.0 111.53 -3.128 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' E' E ' 58' ' ' LEU . . . . . . . . . . . . . 16.2 tp -107.99 139.05 43.19 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-O 120.999 0.428 . . . . 0.0 110.837 -177.331 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' E' E ' 59' ' ' ARG . . . . . . . . . . . . . 21.3 ttm180 -102.45 122.54 44.52 Favored 'General case' 0 C--N 1.327 -0.389 0 N-CA-C 108.985 -0.746 . . . . 0.0 108.985 173.393 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' E' E ' 60' ' ' VAL . . . . . . . . . . . . . 45.6 t -81.55 119.17 30.62 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.35 0 C-N-CA 120.689 -0.404 . . . . 0.0 110.634 -174.281 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' E' E ' 61' ' ' GLU . . . . . . . . . . . . . 95.5 mt-10 -131.19 160.96 33.3 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 115.765 -0.652 . . . . 0.0 109.71 175.422 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' E' E ' 62' ' ' ASP . . . . . . . . . . . . . 10.9 p-10 -52.77 -29.93 30.08 Favored 'General case' 0 C--N 1.328 -0.363 0 N-CA-C 112.067 0.395 . . . . 0.0 112.067 -179.302 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' E' E ' 63' ' ' ARG . . . . . . . . . . . . . 60.0 mtp180 -72.35 -22.06 61.22 Favored 'General case' 0 CA--C 1.533 0.295 0 N-CA-C 113.002 0.742 . . . . 0.0 113.002 -175.616 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' E' E ' 64' ' ' THR . . . . . . . . . . . . . 36.8 m -66.7 142.27 57.48 Favored 'General case' 0 C--N 1.331 -0.225 0 CA-C-O 120.983 0.421 . . . . 0.0 110.913 -176.444 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' E' E ' 65' ' ' LYS . . . . . . . . . . . . . 46.6 mtmt -88.4 129.52 35.4 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 115.938 -0.574 . . . . 0.0 109.912 177.684 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' E' E ' 66' ' ' ILE . . . . . . . . . . . . . 60.7 mt -113.54 126.65 71.03 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.347 0 N-CA-C 109.976 -0.379 . . . . 0.0 109.976 -178.089 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' E' E ' 67' ' ' THR . . . . . . . . . . . . . 25.8 m -127.14 149.73 49.82 Favored 'General case' 0 C--N 1.331 -0.226 0 CA-C-O 121.147 0.498 . . . . 0.0 111.112 -176.896 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' E' E ' 68' ' ' LEU . . . . . . . . . . . . . 72.3 mt . . . . . 0 C--N 1.33 -0.282 0 CA-C-N 115.909 -0.587 . . . . 0.0 110.791 179.543 . . . . . . . . 0 0 . 1 . 010 nuclear nobuild core ' E' E ' 73' ' ' VAL . . . . . . . . . . . . . 32.6 m . . . . . 0 C--O 1.231 0.105 0 CA-C-O 120.775 0.321 . . . . 0.0 110.634 . . . . . . . . . 0 0 . 1 . 010 nuclear nobuild core ' E' E ' 74' ' ' ASP . . . . . . . . . . . . . 42.1 t0 -93.3 122.54 35.8 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-N 116.348 -0.387 . . . . 0.0 110.264 -175.607 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' E' E ' 75' ' ' VAL . . . . . . . . . . . . . 41.3 t -116.97 123.34 71.71 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.237 0 CA-C-O 121.051 0.453 . . . . 0.0 110.345 -178.845 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' E' E ' 76' ' ' LEU . . . . . . . . . . . . . 20.4 mt -123.82 148.73 46.47 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 115.659 -0.701 . . . . 0.0 109.64 178.518 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' E' E ' 77' ' ' GLU . . . . . . . . . . . . . 46.0 mt-10 -139.1 136.39 35.14 Favored 'General case' 0 C--N 1.331 -0.208 0 CA-C-O 121.052 0.453 . . . . 0.0 111.334 -177.946 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' E' E ' 78' ' ' ALA . . . . . 0.599 ' HB2' HD21 ' E' ' 109' ' ' LEU . . . -123.42 134.82 53.91 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 115.707 -0.678 . . . . 0.0 109.724 176.28 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' E' E ' 79' ' ' LYS . . . . . 0.642 ' O ' HD13 ' E' ' 80' ' ' ILE . 77.8 mttt -77.98 121.51 24.3 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-O 120.791 0.329 . . . . 0.0 110.837 -177.065 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' E' E ' 80' ' ' ILE . . . . . 0.642 HD13 ' O ' ' E' ' 79' ' ' LYS . 38.2 mm -139.21 109.95 4.57 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.327 0 N-CA-C 109.538 -0.541 . . . . 0.0 109.538 -178.571 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' E' E ' 81' ' ' LYS . . . . . . . . . . . . . 15.4 ptpt -103.85 126.84 51.26 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-O 121.114 0.483 . . . . 0.0 111.102 -177.808 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' E' E ' 82' ' ' GLY . . . . . . . . . . . . . . . 89.13 42.11 5.68 Favored Glycine 0 CA--C 1.524 0.624 0 N-CA-C 111.512 -0.635 . . . . 0.0 111.512 175.047 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' E' E ' 83' ' ' ILE . . . . . . . . . . . . . 72.0 mt -67.63 140.24 19.57 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.293 0 CA-C-O 120.889 0.376 . . . . 0.0 110.132 179.252 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' E' E ' 84' ' ' LYS . . . . . . . . . . . . . 82.6 tttt -100.82 -53.85 2.96 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 115.895 -0.593 . . . . 0.0 110.089 -179.403 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' E' E ' 85' ' ' ASP . . . . . . . . . . . . . 5.8 t70 -157.57 155.66 30.58 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 115.731 -0.668 . . . . 0.0 110.477 -178.577 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' E' E ' 86' ' ' VAL . . . . . . . . . . . . . 42.9 t -133.27 132.67 58.26 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.258 0 CA-C-O 121.02 0.438 . . . . 0.0 110.533 -178.662 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' E' E ' 87' ' ' ILE . . . . . 0.401 HG21 ' CG1' ' E' ' 125' ' ' VAL . 43.3 mm -117.63 130.5 72.42 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.259 0 CA-C-N 115.813 -0.631 . . . . 0.0 109.503 174.714 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' E' E ' 88' ' ' LEU . . . . . . . . . . . . . 18.6 tp -114.7 134.61 54.95 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-O 121.127 0.489 . . . . 0.0 111.493 -175.995 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' E' E ' 89' ' ' ASP . . . . . . . . . . . . . 7.0 t70 -127.39 155.37 43.74 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 115.605 -0.725 . . . . 0.0 109.426 174.931 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' E' E ' 90' ' ' GLU . . . . . . . . . . . . . 96.0 mt-10 -47.49 -42.07 22.16 Favored 'General case' 0 N--CA 1.463 0.217 0 N-CA-C 112.781 0.659 . . . . 0.0 112.781 -172.862 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' E' E ' 91' ' ' ASN . . . . . . . . . . . . . 87.2 m-20 -132.02 39.9 3.39 Favored 'General case' 0 C--O 1.233 0.227 0 CA-C-O 120.871 0.367 . . . . 0.0 111.161 -178.279 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' E' E ' 92' ' ' LEU . . . . . . . . . . . . . 10.5 tp -166.11 141.77 4.82 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.517 -0.311 . . . . 0.0 110.521 -179.579 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' E' E ' 93' ' ' ILE . . . . . . . . . . . . . 65.1 mt -126.98 124.34 64.4 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.283 0 N-CA-C 109.695 -0.483 . . . . 0.0 109.695 -178.965 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' E' E ' 94' ' ' VAL . . . . . . . . . . . . . 41.9 t -121.64 124.7 72.2 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.28 0 N-CA-C 109.794 -0.447 . . . . 0.0 109.794 179.71 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' E' E ' 95' ' ' VAL . . . . . . . . . . . . . 45.6 t -122.53 135.5 62.43 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.237 0 CA-C-N 116.443 -0.344 . . . . 0.0 110.147 -178.952 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' E' E ' 96' ' ' ILE . . . . . . . . . . . . . 60.0 mt -117.54 130.99 71.56 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.294 0 CA-C-N 115.954 -0.566 . . . . 0.0 109.476 179.155 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' E' E ' 97' ' ' THR . . . . . . . . . . . . . 40.7 p -101.01 157.37 16.8 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-O 121.095 0.474 . . . . 0.0 111.127 -179.403 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' E' E ' 98' ' ' GLU . . . . . . . . . . . . . 46.0 mt-10 -54.85 -29.49 55.4 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.231 -0.44 . . . . 0.0 112.138 -179.216 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' E' E ' 99' ' ' GLU . . . . . . . . . . . . . 71.2 mm-40 -78.64 14.18 1.39 Allowed 'General case' 0 CA--C 1.536 0.409 0 N-CA-C 113.124 0.787 . . . . 0.0 113.124 -177.361 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' E' E ' 100' ' ' ASN . . . . . . . . . . . . . 38.1 m-20 63.46 36.23 11.46 Favored 'General case' 0 N--CA 1.462 0.141 0 CA-C-O 120.947 0.403 . . . . 0.0 111.585 178.728 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' E' E ' 101' ' ' GLU . . . . . . . . . . . . . 84.8 tt0 -107.38 140.21 40.67 Favored 'General case' 0 C--N 1.331 -0.201 0 N-CA-C 109.372 -0.603 . . . . 0.0 109.372 170.989 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' E' E ' 102' ' ' VAL . . . . . . . . . . . . . 47.9 t -115.1 128.53 72.24 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.269 0 CA-C-N 116.256 -0.429 . . . . 0.0 109.9 -178.187 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' E' E ' 103' ' ' LEU . . . . . . . . . . . . . 31.0 mt -120.42 131.31 54.73 Favored 'General case' 0 C--N 1.331 -0.215 0 CA-C-N 115.757 -0.656 . . . . 0.0 110.368 177.43 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' E' E ' 104' ' ' ILE . . . . . . . . . . . . . 65.8 mt -117.64 121.61 67.87 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.241 0 CA-C-N 116.346 -0.388 . . . . 0.0 110.007 179.038 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' E' E ' 105' ' ' PHE . . . . . . . . . . . . . 75.6 m-85 -121.87 165.24 16.21 Favored 'General case' 0 C--N 1.332 -0.158 0 O-C-N 123.885 0.741 . . . . 0.0 109.823 179.819 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' E' E ' 106' ' ' ASN . . . . . . . . . . . . . 46.6 p-10 -100.21 -169.99 1.81 Allowed 'General case' 0 C--N 1.329 -0.291 0 N-CA-C 109.716 -0.476 . . . . 0.0 109.716 173.437 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' E' E ' 107' ' ' GLN . . . . . 0.464 ' O ' HD21 ' D' ' 140' ' ' LEU . 46.7 tt0 -59.27 -30.06 68.02 Favored 'General case' 0 C--N 1.329 -0.301 0 N-CA-C 111.89 0.33 . . . . 0.0 111.89 179.2 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' E' E ' 108' ' ' ASN . . . . . . . . . . . . . 58.6 t30 -82.19 6.94 15.01 Favored 'General case' 0 CA--C 1.536 0.429 0 N-CA-C 113.161 0.8 . . . . 0.0 113.161 -177.536 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' E' E ' 109' ' ' LEU . . . . . 0.599 HD21 ' HB2' ' E' ' 78' ' ' ALA . 7.4 tp 59.69 34.79 22.21 Favored 'General case' 0 C--O 1.232 0.167 0 O-C-N 122.07 -0.394 . . . . 0.0 111.602 179.42 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' E' E ' 110' ' ' GLU . . . . . . . . . . . . . 42.7 mt-10 -101.9 148.67 25.05 Favored 'General case' 0 C--N 1.33 -0.282 0 N-CA-C 109.52 -0.548 . . . . 0.0 109.52 175.118 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' E' E ' 111' ' ' GLU . . . . . . . . . . . . . 53.0 tt0 -81.98 121.97 27.2 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-O 120.849 0.357 . . . . 0.0 110.759 -176.288 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' E' E ' 112' ' ' LEU . . . . . . . . . . . . . 14.5 mt -106.91 -45.89 4.07 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.071 -0.513 . . . . 0.0 110.594 -179.958 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' E' E ' 113' ' ' TYR . . . . . . . . . . . . . 49.4 t80 -134.88 134.85 41.13 Favored 'General case' 0 C--N 1.331 -0.209 0 CA-C-N 116.28 -0.418 . . . . 0.0 111.026 -178.489 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' E' E ' 114' ' ' ARG . . . . . . . . . . . . . 78.7 ttt-85 -134.06 121.74 21.97 Favored 'General case' 0 C--N 1.331 -0.2 0 CA-C-N 116.04 -0.527 . . . . 0.0 110.262 179.655 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' E' E ' 115' ' ' GLY . . . . . . . . . . . . . . . -150.11 146.67 16.06 Favored Glycine 0 CA--C 1.523 0.553 0 N-CA-C 111.114 -0.794 . . . . 0.0 111.114 179.007 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' E' E ' 116' ' ' LYS . . . . . . . . . . . . . 61.8 tttm -128.04 126.88 42.13 Favored 'General case' 0 C--N 1.33 -0.267 0 N-CA-C 109.734 -0.469 . . . . 0.0 109.734 177.087 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' E' E ' 117' ' ' PHE . . . . . . . . . . . . . 33.6 m-85 -125.22 117.28 23.5 Favored 'General case' 0 N--CA 1.463 0.203 0 CA-C-O 121.037 0.446 . . . . 0.0 110.455 -174.47 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' E' E ' 118' ' ' GLU . . . . . . . . . . . . . 84.0 tt0 -52.08 -50.76 60.93 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.367 -0.379 . . . . 0.0 111.537 -177.891 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' E' E ' 119' ' ' ASN . . . . . . . . . . . . . 23.9 m120 -94.53 31.17 1.82 Allowed 'General case' 0 C--N 1.33 -0.243 0 N-CA-C 112.2 0.444 . . . . 0.0 112.2 -174.735 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' E' E ' 120' ' ' LEU . . . . . . . . . . . . . 20.5 tp -56.4 124.51 18.34 Favored 'General case' 0 N--CA 1.462 0.136 0 C-N-CA 120.992 -0.283 . . . . 0.0 110.448 177.789 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' E' E ' 121' ' ' ASN . . . . . . . . . . . . . 33.6 m120 -113.58 -43.97 3.26 Favored 'General case' 0 C--N 1.331 -0.217 0 CA-C-N 116.588 -0.278 . . . . 0.0 111.137 -175.948 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' E' E ' 122' ' ' LYS . . . . . . . . . . . . . 39.6 ttpt -148.59 147.29 28.83 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-O 121.016 0.436 . . . . 0.0 111.419 -176.888 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' E' E ' 123' ' ' VAL . . . . . . . . . . . . . 46.2 t -132.41 135.71 57.41 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.281 0 CA-C-N 116.021 -0.536 . . . . 0.0 109.644 176.06 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' E' E ' 124' ' ' LEU . . . . . . . . . . . . . 37.8 mt -132.8 141.63 48.58 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-O 120.791 0.329 . . . . 0.0 110.973 -178.567 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' E' E ' 125' ' ' VAL . . . . . 0.653 HG23 HG22 ' E' ' 130' ' ' VAL . 10.6 p -139.26 141.54 35.55 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.23 0 CA-C-N 116.258 -0.428 . . . . 0.0 110.309 177.964 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' E' E ' 126' ' ' ARG . . . . . . . . . . . . . 35.0 ptt-85 -150.88 126.77 10.36 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.09 -0.505 . . . . 0.0 110.579 178.486 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' E' E ' 127' ' ' ASN . . . . . . . . . . . . . 39.2 m-20 49.17 -107.37 0.23 Allowed 'General case' 0 CA--C 1.546 0.807 0 CA-C-O 119.033 -0.508 . . . . 0.0 111.792 178.715 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' E' E ' 128' ' ' ASP . . . . . . . . . . . . . 11.2 p-10 -114.06 11.88 17.78 Favored 'General case' 0 N--CA 1.467 0.408 0 CA-C-N 119.627 1.103 . . . . 0.0 113.416 -175.33 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' E' E ' 129' ' ' LEU . . . . . . . . . . . . . 81.9 mt -120.04 140.74 50.53 Favored 'General case' 0 C--N 1.333 -0.143 0 CA-C-N 118.058 0.39 . . . . 0.0 110.274 178.978 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' E' E ' 130' ' ' VAL . . . . . 0.653 HG22 HG23 ' E' ' 125' ' ' VAL . 46.2 t -128.25 138.91 53.35 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.212 0 N-CA-C 109.741 -0.466 . . . . 0.0 109.741 -179.988 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' E' E ' 131' ' ' VAL . . . . . . . . . . . . . 41.6 t -134.53 138.03 50.34 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.321 0 CA-C-N 116.287 -0.415 . . . . 0.0 110.242 -179.725 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' E' E ' 132' ' ' ILE . . . . . . . . . . . . . 72.9 mt -119.55 132.61 68.85 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.306 0 N-CA-C 109.374 -0.602 . . . . 0.0 109.374 179.942 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' E' E ' 133' ' ' ILE . . . . . . . . . . . . . 39.7 mm -117.64 119.23 61.02 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.253 0 CA-C-N 116.307 -0.406 . . . . 0.0 110.883 -175.991 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' E' E ' 134' ' ' ASP . . . . . . . . . . . . . 8.1 p-10 -131.68 146.46 52.19 Favored 'General case' 0 C--N 1.331 -0.217 0 N-CA-C 109.536 -0.542 . . . . 0.0 109.536 174.504 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' E' E ' 135' ' ' GLU . . . . . . . . . . . . . 43.5 tp10 -49.88 -23.66 2.05 Favored 'General case' 0 C--N 1.328 -0.344 0 N-CA-C 112.941 0.719 . . . . 0.0 112.941 -172.061 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' E' E ' 136' ' ' GLN . . . . . . . . . . . . . 55.6 tp60 -100.97 -27.91 13.03 Favored 'General case' 0 C--O 1.233 0.237 0 N-CA-C 112.46 0.541 . . . . 0.0 112.46 -174.838 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' E' E ' 137' ' ' LYS . . . . . . . . . . . . . 86.6 mttt -142.39 151.35 41.76 Favored 'General case' 0 C--N 1.332 -0.193 0 CA-C-O 121.464 0.649 . . . . 0.0 112.188 -170.396 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' E' E ' 138' ' ' LEU . . . . . . . . . . . . . 14.3 tp -112.49 122.21 47.05 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 115.11 -0.95 . . . . 0.0 108.925 171.977 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' E' E ' 139' ' ' THR . . . . . . . . . . . . . 24.0 m -114.61 124.08 50.95 Favored 'General case' 0 C--N 1.331 -0.212 0 CA-C-O 120.82 0.343 . . . . 0.0 110.868 -177.92 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' E' E ' 140' ' ' LEU . . . . . . . . . . . . . 13.2 tp -111.48 118.48 35.88 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 115.5 -0.773 . . . . 0.0 108.926 178.73 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' E' E ' 141' ' ' ILE . . . . . . . . . . . . . 19.6 mt -119.77 114.31 43.8 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.193 0 N-CA-C 109.726 -0.472 . . . . 0.0 109.726 -176.009 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' E' E ' 142' ' ' ARG . . . . . . . . . . . . . 79.5 mtm180 -90.98 113.67 25.98 Favored 'General case' 0 C--N 1.326 -0.43 0 CA-C-N 115.882 -0.599 . . . . 0.0 110.621 178.039 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' E' E ' 143' ' ' THR . . . . . . . . . . . . . 2.4 p . . . . . 0 C--O 1.221 -0.447 0 CA-C-O 117.951 -1.023 . . . . 0.0 110.559 -179.229 . . . . . . . . 0 0 . 1 . 010 nuclear nobuild core ' F' F ' 1' ' ' MET . . . . . . . . . . . . . 25.1 ptt? . . . . . 0 C--O 1.233 0.199 0 CA-C-O 120.835 0.35 . . . . 0.0 110.772 . . . . . . . . . 0 0 . 1 . 010 nuclear nobuild core ' F' F ' 2' ' ' SER . . . . . . . . . . . . . 6.3 p -116.12 132.9 56.53 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 116.255 -0.429 . . . . 0.0 110.142 178.42 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' F' F ' 3' ' ' GLU . . . . . . . . . . . . . 95.7 mt-10 -140.8 138.04 33.78 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.095 -0.502 . . . . 0.0 110.829 -178.351 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' F' F ' 4' ' ' LEU . . . . . 0.485 HD21 HD21 ' F' ' 6' ' ' LEU . 23.4 tp -123.92 125.31 44.4 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 115.994 -0.548 . . . . 0.0 109.971 175.956 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' F' F ' 5' ' ' LYS . . . . . . . . . . . . . 62.2 mttp -103.78 119.14 38.31 Favored 'General case' 0 C--O 1.234 0.281 0 CA-C-N 116.32 -0.4 . . . . 0.0 110.457 178.395 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' F' F ' 6' ' ' LEU . . . . . 0.485 HD21 HD21 ' F' ' 4' ' ' LEU . 58.1 mt -115.08 141.6 47.79 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 115.398 -0.819 . . . . 0.0 110.223 -178.488 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' F' F ' 7' ' ' LYS . . . . . . . . . . . . . 35.3 ttpt -121.45 136.24 25.73 Favored Pre-proline 0 CA--C 1.534 0.359 0 CA-C-O 118.784 -0.627 . . . . 0.0 109.896 176.627 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' F' F ' 8' ' ' PRO . . . . . . . . . . . . . 95.8 Cg_endo -91.92 133.23 1.32 Allowed 'Trans proline' 0 N--CA 1.489 1.25 0 C-N-CA 121.698 1.599 . . . . 0.0 111.901 178.048 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' F' F ' 9' ' ' LEU . . . . . . . . . . . . . 57.6 mt -73.31 -47.2 7.74 Favored Pre-proline 0 CA--C 1.534 0.336 0 CA-C-O 118.616 -0.707 . . . . 0.0 112.13 -179.117 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' F' F ' 10' ' ' PRO . . . . . . . . . . . . . 97.2 Cg_endo -81.54 147.6 15.78 Favored 'Trans proline' 0 N--CA 1.496 1.622 0 C-N-CA 121.226 1.284 . . . . 0.0 111.504 175.817 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' F' F ' 11' ' ' LYS . . . . . . . . . . . . . 32.3 ttmt -86.51 90.7 8.31 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-O 120.941 0.401 . . . . 0.0 110.498 179.469 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' F' F ' 12' ' ' VAL . . . . . . . . . . . . . 12.6 p -136.11 147.57 28.04 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.252 0 CA-C-N 116.064 -0.517 . . . . 0.0 110.29 179.562 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' F' F ' 13' ' ' GLU . . . . . . . . . . . . . 84.9 tt0 -85.55 130.08 34.66 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.391 -0.368 . . . . 0.0 110.464 179.685 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' F' F ' 14' ' ' LEU . . . . . . . . . . . . . 22.9 mt -97.72 150.7 37.05 Favored Pre-proline 0 C--N 1.33 -0.252 0 CA-C-N 116.207 -0.451 . . . . 0.0 110.354 -179.506 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' F' F ' 15' ' ' PRO . . . . . . . . . . . . . 29.9 Cg_exo -60.36 158.56 30.71 Favored 'Trans proline' 0 N--CA 1.496 1.653 0 C-N-CA 121.199 1.266 . . . . 0.0 111.9 178.096 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' F' F ' 16' ' ' PRO . . . . . . . . . . . . . 39.0 Cg_exo -58.54 -44.37 37.77 Favored 'Trans proline' 0 N--CA 1.497 1.713 0 C-N-CA 121.445 1.43 . . . . 0.0 112.662 -178.373 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' F' F ' 17' ' ' ASP . . . . . . . . . . . . . 12.3 p-10 -83.29 12.89 4.74 Favored 'General case' 0 CA--C 1.536 0.426 0 N-CA-C 112.973 0.731 . . . . 0.0 112.973 -178.718 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' F' F ' 18' ' ' PHE . . . . . 0.505 ' CZ ' HD11 ' F' ' 22' ' ' ILE . 51.4 t80 -56.98 -41.18 77.93 Favored 'General case' 0 C--O 1.227 -0.108 0 O-C-N 122.016 -0.427 . . . . 0.0 110.477 -178.537 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' F' F ' 19' ' ' VAL . . . . . . . . . . . . . 47.0 t -55.78 -44.95 79.17 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.244 0 CA-C-N 116.57 -0.287 . . . . 0.0 110.649 -178.726 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' F' F ' 20' ' ' ASP . . . . . . . . . . . . . 83.1 m-20 -59.95 -41.91 92.92 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-O 120.847 0.356 . . . . 0.0 110.723 -178.851 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' F' F ' 21' ' ' VAL . . . . . . . . . . . . . 57.6 t -63.86 -46.91 92.94 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.303 0 CA-C-N 116.377 -0.374 . . . . 0.0 110.727 -177.809 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' F' F ' 22' ' ' ILE . . . . . 0.616 HG22 HD12 ' F' ' 26' ' ' LEU . 51.6 mm -55.59 -46.37 79.15 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.206 0 CA-C-O 120.694 0.283 . . . . 0.0 110.566 178.628 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' F' F ' 23' ' ' ARG . . . . . . . . . . . . . 41.6 ttp180 -54.39 -51.62 64.27 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.71 -0.223 . . . . 0.0 111.489 -179.502 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' F' F ' 24' ' ' ILE . . . . . . . . . . . . . 75.9 mt -58.65 -44.36 89.52 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.323 0 CA-C-N 116.652 -0.249 . . . . 0.0 111.433 -175.861 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' F' F ' 25' ' ' LYS . . . . . . . . . . . . . 95.3 mttt -68.14 -42.7 79.74 Favored 'General case' 0 C--N 1.328 -0.337 0 N-CA-C 112.331 0.493 . . . . 0.0 112.331 -176.928 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' F' F ' 26' ' ' LEU . . . . . 0.616 HD12 HG22 ' F' ' 22' ' ' ILE . 80.0 mt -78.81 -38.19 38.86 Favored 'General case' 0 C--N 1.329 -0.326 0 N-CA-C 112.984 0.735 . . . . 0.0 112.984 -170.636 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' F' F ' 27' ' ' GLN . . . . . . . . . . . . . 9.7 pt20 -46.97 139.42 5.62 Favored 'General case' 0 N--CA 1.47 0.547 0 N-CA-C 112.633 0.605 . . . . 0.0 112.633 -176.431 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' F' F ' 28' ' ' GLY . . . . . . . . . . . . . . . 101.05 -25.36 28.62 Favored Glycine 0 CA--C 1.533 1.202 0 CA-C-N 115.437 -0.801 . . . . 0.0 112.197 -176.058 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' F' F ' 29' ' ' LYS . . . . . . . . . . . . . 95.1 mttt -97.98 155.2 17.21 Favored 'General case' 0 C--O 1.233 0.192 0 CA-C-N 117.427 0.614 . . . . 0.0 111.01 178.5 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' F' F ' 30' ' ' THR . . . . . . . . . . . . . 21.7 m -107.13 135.93 47.83 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 115.882 -0.599 . . . . 0.0 109.913 175.41 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' F' F ' 31' ' ' VAL . . . . . . . . . . . . . 34.5 m -132.12 156.73 42.76 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.207 0 CA-C-O 120.876 0.369 . . . . 0.0 111.159 -177.107 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' F' F ' 32' ' ' ARG . . . . . . . . . . . . . 82.8 mtt180 -132.18 152.53 51.24 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-O 121.333 0.587 . . . . 0.0 110.673 179.214 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' F' F ' 33' ' ' THR . . . . . . . . . . . . . 18.3 m -52.87 139.95 25.72 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.096 -0.502 . . . . 0.0 111.311 -178.758 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' F' F ' 34' ' ' GLY . . . . . . . . . . . . . . . 100.18 -17.3 57.21 Favored Glycine 0 CA--C 1.533 1.172 0 CA-C-O 119.619 -0.545 . . . . 0.0 113.242 179.274 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' F' F ' 35' ' ' ASP . . . . . . . . . . . . . 74.3 m-20 -67.15 150.03 49.69 Favored 'General case' 0 N--CA 1.46 0.07 0 CA-C-N 118.086 0.943 . . . . 0.0 110.991 178.774 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' F' F ' 36' ' ' VAL . . . . . . . . . . . . . 44.3 t -122.47 130.3 74.62 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.205 0 CA-C-N 116.055 -0.52 . . . . 0.0 109.909 178.44 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' F' F ' 37' ' ' ILE . . . . . . . . . . . . . 69.6 mt -122.34 140.87 44.88 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.218 0 CA-C-N 116.105 -0.498 . . . . 0.0 110.017 -178.527 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' F' F ' 38' ' ' GLY . . . . . . . . . . . . . . . -115.82 128.85 8.21 Favored Glycine 0 CA--C 1.526 0.744 0 N-CA-C 111.179 -0.768 . . . . 0.0 111.179 179.736 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' F' F ' 39' ' ' ILE . . . . . . . . . . . . . 76.3 mt -127.63 140.23 49.7 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.228 0 CA-C-O 120.746 0.308 . . . . 0.0 110.218 179.247 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' F' F ' 40' ' ' SER . . . . . . . . . . . . . 52.8 p -93.32 115.85 28.42 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 116.298 -0.41 . . . . 0.0 111.19 176.229 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' F' F ' 41' ' ' ILE . . . . . . . . . . . . . 44.8 mm -122.58 118.99 56.91 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.214 0 N-CA-C 110.19 -0.3 . . . . 0.0 110.19 178.72 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' F' F ' 42' ' ' LEU . . . . . . . . . . . . . 69.2 mt 55.89 35.64 25.82 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.191 -0.458 . . . . 0.0 111.63 177.412 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' F' F ' 43' ' ' GLY . . . . . . . . . . . . . . . 73.22 23.75 76.88 Favored Glycine 0 CA--C 1.532 1.144 0 C-N-CA 121.151 -0.547 . . . . 0.0 112.795 177.818 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' F' F ' 44' ' ' LYS . . . . . . . . . . . . . 34.7 mmtp -131.5 133.81 45.49 Favored 'General case' 0 C--N 1.331 -0.206 0 CA-C-N 117.264 0.532 . . . . 0.0 109.572 177.538 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' F' F ' 45' ' ' GLU . . . . . . . . . . . . . 85.9 tt0 -82.7 120.21 25.3 Favored 'General case' 0 C--N 1.329 -0.322 0 C-N-CA 120.745 -0.382 . . . . 0.0 110.89 -179.331 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' F' F ' 46' ' ' VAL . . . . . . . . . . . . . 11.2 p -116.83 124.28 72.71 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.154 0 N-CA-C 109.647 -0.501 . . . . 0.0 109.647 175.724 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' F' F ' 47' ' ' LYS . . . . . . . . . . . . . 55.3 mttp -98.58 126.5 44.18 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-N 116.101 -0.5 . . . . 0.0 110.955 179.208 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' F' F ' 48' ' ' PHE . . . . . . . . . . . . . 29.1 m-85 -109.3 131.82 54.71 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.168 -0.469 . . . . 0.0 109.971 177.056 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' F' F ' 49' ' ' LYS . . . . . . . . . . . . . 37.5 tttp -107.66 132.31 53.46 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-N 116.24 -0.436 . . . . 0.0 110.091 177.751 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' F' F ' 50' ' ' VAL . . . . . 0.44 HG13 HD11 ' F' ' 4' ' ' LEU . 42.4 t -75.53 107.05 5.86 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.345 0 N-CA-C 109.453 -0.573 . . . . 0.0 109.453 178.151 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' F' F ' 51' ' ' VAL . . . . . . . . . . . . . 47.4 t -74.5 -48.75 34.09 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.309 0 N-CA-C 109.759 -0.46 . . . . 0.0 109.759 -175.661 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' F' F ' 52' ' ' GLN . . . . . . . . . . . . . 49.4 tt0 -160.11 137.15 9.3 Favored 'General case' 0 C--N 1.33 -0.28 0 C-N-CA 120.316 -0.553 . . . . 0.0 111.568 -179.262 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' F' F ' 53' ' ' ALA . . . . . 0.484 ' HB1' ' HB2' ' F' ' 58' ' ' LEU . . . -113.46 133.06 55.41 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 115.708 -0.678 . . . . 0.0 109.81 175.94 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' F' F ' 54' ' ' TYR . . . . . . . . . . . . . 65.3 t80 -129.18 112.63 18.35 Favored Pre-proline 0 CA--C 1.535 0.386 0 CA-C-O 118.292 -0.861 . . . . 0.0 110.294 178.219 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' F' F ' 55' ' ' PRO . . . . . . . . . . . . . 73.2 Cg_endo -77.18 168.08 77.89 Favored 'Cis proline' 0 N--CA 1.499 1.822 0 CA-C-N 121.935 1.727 . . . . 0.0 112.238 -5.903 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' F' F ' 56' ' ' SER . . . . . . . . . . . . . 13.9 m -116.66 130.51 24.49 Favored Pre-proline 0 CA--C 1.538 0.484 0 CA-C-O 118.536 -0.745 . . . . 0.0 109.413 174.906 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' F' F ' 57' ' ' PRO . . . . . . . . . . . . . 39.3 Cg_endo -67.46 146.74 76.93 Favored 'Cis proline' 0 N--CA 1.498 1.76 0 CA-C-N 121.898 1.713 . . . . 0.0 111.434 -0.786 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' F' F ' 58' ' ' LEU . . . . . 0.484 ' HB2' ' HB1' ' F' ' 53' ' ' ALA . 20.6 tp -106.12 135.82 46.91 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.409 -0.359 . . . . 0.0 110.492 -178.634 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' F' F ' 59' ' ' ARG . . . . . . . . . . . . . 39.3 ttm180 -105.76 126.55 52.29 Favored 'General case' 0 C--N 1.326 -0.438 0 N-CA-C 109.211 -0.663 . . . . 0.0 109.211 175.889 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' F' F ' 60' ' ' VAL . . . . . . . . . . . . . 46.6 t -83.58 119.6 33.15 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.27 0 C-N-CA 120.665 -0.414 . . . . 0.0 110.514 -175.624 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' F' F ' 61' ' ' GLU . . . . . . . . . . . . . 91.6 mt-10 -130.98 165.72 22.55 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 115.926 -0.579 . . . . 0.0 109.775 177.507 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' F' F ' 62' ' ' ASP . . . . . . . . . . . . . 59.7 m-20 -53.34 -32.46 49.25 Favored 'General case' 0 C--N 1.329 -0.303 0 N-CA-C 111.858 0.318 . . . . 0.0 111.858 -178.563 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' F' F ' 63' ' ' ARG . . . . . . . . . . . . . 92.7 mtt180 -74.72 -22.06 59.03 Favored 'General case' 0 C--N 1.33 -0.25 0 N-CA-C 113.02 0.748 . . . . 0.0 113.02 -176.796 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' F' F ' 64' ' ' THR . . . . . . . . . . . . . 39.5 m -65.89 136.52 56.24 Favored 'General case' 0 C--N 1.331 -0.197 0 CA-C-O 120.894 0.378 . . . . 0.0 110.95 -174.547 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' F' F ' 65' ' ' LYS . . . . . . . . . . . . . 96.8 mttt -89.75 133.01 34.92 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 115.912 -0.586 . . . . 0.0 110.153 177.512 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' F' F ' 66' ' ' ILE . . . . . 0.486 HD12 ' N ' ' F' ' 66' ' ' ILE . 4.7 mp -113.29 125.54 70.57 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.284 0 N-CA-C 109.596 -0.52 . . . . 0.0 109.596 178.65 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' F' F ' 67' ' ' THR . . . . . . . . . . . . . 25.6 m -120.59 141.89 49.89 Favored 'General case' 0 C--N 1.331 -0.204 0 CA-C-N 116.111 -0.495 . . . . 0.0 110.997 -176.235 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' F' F ' 68' ' ' LEU . . . . . . . . . . . . . 25.4 tp . . . . . 0 C--N 1.329 -0.315 0 CA-C-N 115.823 -0.626 . . . . 0.0 110.344 179.021 . . . . . . . . 0 0 . 1 . 010 nuclear nobuild core ' F' F ' 73' ' ' VAL . . . . . . . . . . . . . 3.1 m . . . . . 0 C--O 1.232 0.154 0 CA-C-O 121.227 0.537 . . . . 0.0 111.25 . . . . . . . . . 0 0 . 1 . 010 nuclear nobuild core ' F' F ' 74' ' ' ASP . . . . . . . . . . . . . 13.2 t0 -96.42 115.81 28.03 Favored 'General case' 0 C--N 1.325 -0.469 0 N-CA-C 108.271 -1.011 . . . . 0.0 108.271 171.175 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' F' F ' 75' ' ' VAL . . . . . . . . . . . . . 42.9 t -107.39 124.77 63.53 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.268 0 CA-C-O 121.156 0.503 . . . . 0.0 111.064 -171.235 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' F' F ' 76' ' ' LEU . . . . . . . . . . . . . 24.3 mt -125.24 133.59 52.65 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 115.399 -0.819 . . . . 0.0 109.442 176.452 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' F' F ' 77' ' ' GLU . . . . . . . . . . . . . 98.3 mt-10 -129.35 136.41 49.96 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-O 121.046 0.451 . . . . 0.0 111.126 -178.147 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' F' F ' 78' ' ' ALA . . . . . . . . . . . . . . . -128.2 138.14 52.34 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 115.748 -0.66 . . . . 0.0 109.868 177.124 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' F' F ' 79' ' ' LYS . . . . . 0.603 ' O ' HD13 ' F' ' 80' ' ' ILE . 19.9 pttp -76.07 121.9 23.47 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-O 121.193 0.52 . . . . 0.0 110.599 -179.025 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' F' F ' 80' ' ' ILE . . . . . 0.603 HD13 ' O ' ' F' ' 79' ' ' LYS . 39.1 mm -139.22 116.58 11.18 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.282 0 N-CA-C 109.25 -0.648 . . . . 0.0 109.25 -178.242 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' F' F ' 81' ' ' LYS . . . . . . . . . . . . . 83.7 tttt -112.56 126.39 55.29 Favored 'General case' 0 C--N 1.331 -0.215 0 CA-C-O 120.958 0.408 . . . . 0.0 111.206 -176.139 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' F' F ' 82' ' ' GLY . . . . . . . . . . . . . . . 89.0 42.24 5.69 Favored Glycine 0 CA--C 1.525 0.714 0 C-N-CA 120.86 -0.686 . . . . 0.0 111.569 174.652 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' F' F ' 83' ' ' ILE . . . . . . . . . . . . . 72.8 mt -69.15 141.81 16.89 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.342 0 CA-C-O 120.975 0.417 . . . . 0.0 110.001 178.446 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' F' F ' 84' ' ' LYS . . . . . . . . . . . . . 57.0 tttp -103.59 -52.57 2.96 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 115.884 -0.598 . . . . 0.0 110.356 -178.663 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' F' F ' 85' ' ' ASP . . . . . . . . . . . . . 11.1 t70 -153.55 155.56 36.4 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 115.988 -0.551 . . . . 0.0 110.587 -178.904 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' F' F ' 86' ' ' VAL . . . . . 0.45 ' O ' HD13 ' F' ' 87' ' ' ILE . 45.1 t -130.72 133.39 63.41 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.236 0 CA-C-O 120.976 0.417 . . . . 0.0 110.682 -177.765 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' F' F ' 87' ' ' ILE . . . . . 0.45 HD13 ' O ' ' F' ' 86' ' ' VAL . 46.1 mm -124.76 126.61 71.77 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.221 0 CA-C-N 115.883 -0.599 . . . . 0.0 109.748 176.432 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' F' F ' 88' ' ' LEU . . . . . . . . . . . . . 36.4 mt -116.22 136.54 52.92 Favored 'General case' 0 N--CA 1.464 0.239 0 CA-C-O 121.129 0.49 . . . . 0.0 111.504 -177.02 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' F' F ' 89' ' ' ASP . . . . . . . . . . . . . 10.6 t70 -130.01 159.33 37.04 Favored 'General case' 0 C--N 1.331 -0.221 0 CA-C-N 115.566 -0.743 . . . . 0.0 109.605 175.439 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' F' F ' 90' ' ' GLU . . . . . . . . . . . . . 95.4 mt-10 -46.7 -39.34 11.32 Favored 'General case' 0 CA--C 1.531 0.237 0 N-CA-C 113.118 0.784 . . . . 0.0 113.118 -171.68 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' F' F ' 91' ' ' ASN . . . . . . . . . . . . . 23.9 p30 -131.73 23.55 4.66 Favored 'General case' 0 N--CA 1.466 0.35 0 N-CA-C 112.725 0.639 . . . . 0.0 112.725 -177.383 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' F' F ' 92' ' ' LEU . . . . . . . . . . . . . 16.3 mt -148.7 141.13 24.24 Favored 'General case' 0 C--N 1.33 -0.243 0 N-CA-C 110.137 -0.32 . . . . 0.0 110.137 -176.691 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' F' F ' 93' ' ' ILE . . . . . . . . . . . . . 69.6 mt -124.93 117.39 50.02 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.362 0 N-CA-C 109.604 -0.517 . . . . 0.0 109.604 179.029 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' F' F ' 94' ' ' VAL . . . . . 0.428 HG21 HG21 ' F' ' 125' ' ' VAL . 46.7 t -117.13 127.07 74.78 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.242 0 CA-C-O 120.959 0.409 . . . . 0.0 110.106 179.844 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' F' F ' 95' ' ' VAL . . . . . . . . . . . . . 47.7 t -121.59 132.51 70.58 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.322 0 CA-C-N 115.844 -0.616 . . . . 0.0 109.626 178.799 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' F' F ' 96' ' ' ILE . . . . . . . . . . . . . 63.0 mt -113.71 129.09 70.18 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.269 0 N-CA-C 109.351 -0.611 . . . . 0.0 109.351 179.476 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' F' F ' 97' ' ' THR . . . . . . . . . . . . . 72.8 p -101.21 158.34 16.11 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-O 121.136 0.493 . . . . 0.0 111.121 -178.299 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' F' F ' 98' ' ' GLU . . . . . . . . . . . . . 96.9 mt-10 -54.0 -25.79 22.8 Favored 'General case' 0 CA--C 1.532 0.274 0 N-CA-C 112.316 0.487 . . . . 0.0 112.316 -179.037 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' F' F ' 99' ' ' GLU . . . . . . . . . . . . . 71.4 mm-40 -80.7 16.68 1.32 Allowed 'General case' 0 CA--C 1.535 0.385 0 N-CA-C 113.031 0.752 . . . . 0.0 113.031 -177.298 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' F' F ' 100' ' ' ASN . . . . . . . . . . . . . 3.8 m-20 62.11 37.57 14.48 Favored 'General case' 0 C--N 1.332 -0.156 0 CA-C-O 121.076 0.465 . . . . 0.0 111.088 177.847 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' F' F ' 101' ' ' GLU . . . . . . . . . . . . . 84.0 tt0 -114.79 143.12 45.59 Favored 'General case' 0 C--N 1.333 -0.111 0 N-CA-C 109.704 -0.48 . . . . 0.0 109.704 175.922 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' F' F ' 102' ' ' VAL . . . . . . . . . . . . . 43.0 t -115.22 125.02 72.37 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 CA-C-N 116.146 -0.479 . . . . 0.0 110.055 -178.184 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' F' F ' 103' ' ' LEU . . . . . . . . . . . . . 20.2 mt -114.1 128.64 56.47 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 115.695 -0.684 . . . . 0.0 109.973 176.251 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' F' F ' 104' ' ' ILE . . . . . . . . . . . . . 71.2 mt -117.49 118.97 60.31 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.253 0 N-CA-C 110.371 -0.233 . . . . 0.0 110.371 179.999 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' F' F ' 105' ' ' PHE . . . . . . . . . . . . . 66.0 m-85 -117.54 166.3 12.53 Favored 'General case' 0 C--N 1.333 -0.152 0 CA-C-N 115.455 -0.793 . . . . 0.0 109.898 178.401 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' F' F ' 106' ' ' ASN . . . . . . . . . . . . . 44.4 p-10 -100.4 -169.98 1.8 Allowed 'General case' 0 C--N 1.33 -0.275 0 N-CA-C 109.91 -0.404 . . . . 0.0 109.91 173.988 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' F' F ' 107' ' ' GLN . . . . . . . . . . . . . 30.1 tt0 -59.38 -29.99 68.1 Favored 'General case' 0 C--N 1.329 -0.298 0 N-CA-C 111.855 0.317 . . . . 0.0 111.855 178.221 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' F' F ' 108' ' ' ASN . . . . . . . . . . . . . 14.1 t-20 -81.98 5.17 20.05 Favored 'General case' 0 CA--C 1.537 0.448 0 N-CA-C 113.276 0.843 . . . . 0.0 113.276 -177.796 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' F' F ' 109' ' ' LEU . . . . . . . . . . . . . 9.9 tp 62.61 36.28 13.77 Favored 'General case' 0 CA--C 1.53 0.2 0 O-C-N 122.073 -0.392 . . . . 0.0 111.476 178.119 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' F' F ' 110' ' ' GLU . . . . . . . . . . . . . 96.0 mt-10 -108.1 156.24 19.5 Favored 'General case' 0 C--N 1.332 -0.193 0 N-CA-C 109.894 -0.41 . . . . 0.0 109.894 176.304 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' F' F ' 111' ' ' GLU . . . . . . . . . . . . . 46.2 tp10 -82.91 123.05 29.03 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-O 121.02 0.438 . . . . 0.0 110.852 -177.479 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' F' F ' 112' ' ' LEU . . . . . . . . . . . . . 12.5 mt -108.3 -46.01 3.8 Favored 'General case' 0 C--N 1.332 -0.184 0 CA-C-N 115.93 -0.577 . . . . 0.0 110.136 177.577 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' F' F ' 113' ' ' TYR . . . . . . . . . . . . . 62.3 t80 -140.67 136.54 32.75 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.443 -0.344 . . . . 0.0 110.981 179.863 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' F' F ' 114' ' ' ARG . . . . . . . . . . . . . 59.6 ttp180 -137.97 125.25 21.74 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.28 -0.418 . . . . 0.0 110.169 177.536 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' F' F ' 115' ' ' GLY . . . . . . . . . . . . . . . -150.2 161.87 29.05 Favored Glycine 0 CA--C 1.524 0.613 0 N-CA-C 111.167 -0.773 . . . . 0.0 111.167 179.94 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' F' F ' 116' ' ' LYS . . . . . . . . . . . . . 36.3 ttpt -128.27 134.55 48.97 Favored 'General case' 0 C--N 1.33 -0.273 0 N-CA-C 109.855 -0.424 . . . . 0.0 109.855 178.09 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' F' F ' 117' ' ' PHE . . . . . . . . . . . . . 39.9 m-85 -133.33 113.84 13.04 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-O 120.968 0.414 . . . . 0.0 110.404 -176.412 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' F' F ' 118' ' ' GLU . . . . . . . . . . . . . 44.0 mp0 -57.55 -44.1 84.93 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.088 -0.505 . . . . 0.0 110.71 -175.011 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' F' F ' 119' ' ' ASN . . . . . . . . . . . . . 14.8 m120 -99.12 30.99 3.2 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.201 -0.454 . . . . 0.0 112.192 -173.722 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' F' F ' 120' ' ' LEU . . . . . . . . . . . . . 14.2 tp -55.49 121.6 9.38 Favored 'General case' 0 C--O 1.232 0.16 0 O-C-N 122.235 -0.29 . . . . 0.0 110.671 177.78 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' F' F ' 121' ' ' ASN . . . . . . . . . . . . . 38.6 m-80 -113.9 -44.14 3.2 Favored 'General case' 0 C--N 1.332 -0.183 0 CA-C-N 116.544 -0.298 . . . . 0.0 111.301 -177.756 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' F' F ' 122' ' ' LYS . . . . . . . . . . . . . 33.6 ttpt -145.27 143.5 30.26 Favored 'General case' 0 C--N 1.331 -0.21 0 C-N-CA 120.66 -0.416 . . . . 0.0 111.639 -176.514 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' F' F ' 123' ' ' VAL . . . . . . . . . . . . . 42.1 t -124.86 131.65 72.34 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.237 0 N-CA-C 109.385 -0.598 . . . . 0.0 109.385 175.15 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' F' F ' 124' ' ' LEU . . . . . 0.569 HD13 HD12 ' A' ' 88' ' ' LEU . 9.6 tt -133.9 130.75 38.22 Favored 'General case' 0 C--N 1.332 -0.194 0 CA-C-O 121.073 0.464 . . . . 0.0 111.105 -178.402 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' F' F ' 125' ' ' VAL . . . . . 0.428 HG21 HG21 ' F' ' 94' ' ' VAL . 43.3 t -121.16 133.54 67.44 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.233 0 CA-C-N 115.783 -0.644 . . . . 0.0 109.543 176.867 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' F' F ' 126' ' ' ARG . . . . . . . . . . . . . 36.6 ptt-85 -142.83 125.03 15.4 Favored 'General case' 0 C--N 1.331 -0.226 0 CA-C-O 121.021 0.438 . . . . 0.0 111.087 179.759 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' F' F ' 127' ' ' ASN . . . . . . . . . . . . . 58.8 m-80 49.21 -105.06 0.15 Allowed 'General case' 0 CA--C 1.544 0.738 0 CA-C-N 116.126 -0.488 . . . . 0.0 111.748 177.42 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' F' F ' 128' ' ' ASP . . . . . . . . . . . . . 8.8 p-10 -114.15 1.79 14.67 Favored 'General case' 0 CA--C 1.534 0.359 0 CA-C-N 119.524 1.057 . . . . 0.0 113.57 -176.366 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' F' F ' 129' ' ' LEU . . . . . . . . . . . . . 82.9 mt -113.7 145.7 40.94 Favored 'General case' 0 C--N 1.333 -0.131 0 O-C-N 121.92 -0.488 . . . . 0.0 110.5 -178.805 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' F' F ' 130' ' ' VAL . . . . . . . . . . . . . 45.7 t -125.41 135.78 62.91 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.22 0 CA-C-N 116.123 -0.49 . . . . 0.0 109.769 179.955 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' F' F ' 131' ' ' VAL . . . . . 0.709 HG21 HD13 ' A' ' 88' ' ' LEU . 27.5 m -136.03 143.1 37.01 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.251 0 CA-C-O 121.356 0.598 . . . . 0.0 111.126 178.774 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' F' F ' 132' ' ' ILE . . . . . . . . . . . . . 70.7 mt -123.6 133.95 67.74 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.288 0 CA-C-N 115.219 -0.9 . . . . 0.0 109.502 -179.336 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' F' F ' 133' ' ' ILE . . . . . 0.402 HG21 HG21 ' A' ' 86' ' ' VAL . 39.6 mm -115.57 122.01 68.48 Favored 'Isoleucine or valine' 0 C--O 1.233 0.225 0 CA-C-O 120.735 0.302 . . . . 0.0 110.89 -176.165 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' F' F ' 134' ' ' ASP . . . . . . . . . . . . . 6.7 p-10 -131.98 146.39 52.06 Favored 'General case' 0 C--N 1.331 -0.216 0 N-CA-C 109.457 -0.571 . . . . 0.0 109.457 174.098 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' F' F ' 135' ' ' GLU . . . . . . . . . . . . . 42.7 tp10 -49.82 -23.9 2.12 Favored 'General case' 0 C--N 1.328 -0.348 0 N-CA-C 112.883 0.697 . . . . 0.0 112.883 -171.406 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' F' F ' 136' ' ' GLN . . . . . . . . . . . . . 94.3 mt-30 -92.73 -37.21 12.49 Favored 'General case' 0 C--N 1.332 -0.185 0 N-CA-C 112.115 0.413 . . . . 0.0 112.115 -176.284 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' F' F ' 137' ' ' LYS . . . . . . . . . . . . . 45.9 mtmt -148.48 159.17 44.31 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-O 121.512 0.672 . . . . 0.0 111.819 -168.968 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' F' F ' 138' ' ' LEU . . . . . . . . . . . . . 5.0 tt -115.43 124.74 51.93 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 115.173 -0.921 . . . . 0.0 109.365 175.737 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' F' F ' 139' ' ' THR . . . . . . . . . . . . . 27.5 m -108.27 129.52 55.21 Favored 'General case' 0 C--N 1.331 -0.22 0 CA-C-N 116.437 -0.347 . . . . 0.0 110.878 -177.523 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' F' F ' 140' ' ' LEU . . . . . 0.455 HD23 ' C ' ' F' ' 140' ' ' LEU . 5.9 tt -117.31 122.56 44.25 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 115.607 -0.724 . . . . 0.0 109.109 -178.427 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' F' F ' 141' ' ' ILE . . . . . 0.444 ' N ' HD23 ' F' ' 140' ' ' LEU . 19.3 mt -120.06 116.97 52.02 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.345 0 N-CA-C 109.815 -0.439 . . . . 0.0 109.815 -175.969 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' F' F ' 142' ' ' ARG . . . . . . . . . . . . . 56.4 ttp180 -104.67 129.04 52.9 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 115.445 -0.798 . . . . 0.0 110.638 -178.829 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' F' F ' 143' ' ' THR . . . . . . . . . . . . . 55.8 p . . . . . 0 C--O 1.221 -0.427 0 CA-C-O 117.962 -1.018 . . . . 0.0 110.467 178.603 . . . . . . . . 0 0 . 1 . 011 nuclear nobuild core ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 2.8 p . . . . . 0 C--O 1.232 0.14 0 CA-C-O 120.867 0.365 . . . . 0.0 110.609 . . . . . . . . . 0 0 . 1 . 011 nuclear nobuild core ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 84.9 tt0 -141.74 138.14 32.15 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.097 -0.501 . . . . 0.0 110.856 179.501 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 4' ' ' LEU . . . . . 0.445 HD21 HD21 ' A' ' 6' ' ' LEU . 12.7 tp -123.27 133.19 54.2 Favored 'General case' 0 C--N 1.332 -0.155 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.166 177.157 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 5' ' ' LYS . . . . . . . . . . . . . 95.6 mttt -108.48 120.62 42.94 Favored 'General case' 0 C--O 1.234 0.271 0 CA-C-N 116.421 -0.354 . . . . 0.0 110.417 179.737 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 6' ' ' LEU . . . . . 0.445 HD21 HD21 ' A' ' 4' ' ' LEU . 56.2 mt -115.89 148.23 40.22 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 115.457 -0.792 . . . . 0.0 110.715 -177.755 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 31.9 ttpt -138.57 140.59 28.29 Favored Pre-proline 0 CA--C 1.534 0.357 0 CA-C-O 119.164 -0.446 . . . . 0.0 110.075 175.421 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 8' ' ' PRO . . . . . . . . . . . . . 85.5 Cg_endo -92.02 141.96 2.52 Favored 'Trans proline' 0 N--CA 1.491 1.332 0 C-N-CA 121.734 1.622 . . . . 0.0 111.802 177.794 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 51.2 mt -77.4 -48.19 2.42 Favored Pre-proline 0 CA--C 1.534 0.338 0 CA-C-O 118.649 -0.691 . . . . 0.0 112.435 -179.459 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 90.1 Cg_endo -79.82 156.66 24.1 Favored 'Trans proline' 0 N--CA 1.496 1.636 0 C-N-CA 121.15 1.233 . . . . 0.0 111.812 177.292 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 61.6 tttm -87.97 95.66 10.21 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.378 -0.374 . . . . 0.0 110.281 178.292 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 12.4 p -140.14 144.57 27.68 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.263 0 CA-C-N 116.145 -0.479 . . . . 0.0 110.532 -179.43 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 95.6 mt-10 -82.18 127.13 32.85 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.234 -0.439 . . . . 0.0 110.07 177.392 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 14' ' ' LEU . . . . . . . . . . . . . 23.9 mt -97.94 139.42 21.28 Favored Pre-proline 0 CA--C 1.533 0.318 0 CA-C-O 118.796 -0.621 . . . . 0.0 109.767 179.871 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 15' ' ' PRO . . . . . . . . . . . . . 26.6 Cg_exo -60.99 160.57 25.27 Favored 'Trans proline' 0 N--CA 1.498 1.758 0 C-N-CA 121.161 1.241 . . . . 0.0 111.713 178.348 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 16' ' ' PRO . . . . . . . . . . . . . 30.7 Cg_exo -59.66 -32.71 96.29 Favored 'Trans proline' 0 N--CA 1.499 1.794 0 C-N-CA 121.396 1.397 . . . . 0.0 112.863 -177.618 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 17' ' ' ASP . . . . . . . . . . . . . 9.6 p-10 -91.56 6.1 47.0 Favored 'General case' 0 CA--C 1.538 0.498 0 N-CA-C 113.254 0.835 . . . . 0.0 113.254 -177.275 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 18' ' ' PHE . . . . . . . . . . . . . 47.1 t80 -58.54 -46.08 87.55 Favored 'General case' 0 C--N 1.333 -0.122 0 CA-C-O 120.985 0.421 . . . . 0.0 109.975 -178.356 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 19' ' ' VAL . . . . . . . . . . . . . 48.5 t -57.37 -40.9 76.95 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.328 0 CA-C-N 116.074 -0.512 . . . . 0.0 110.41 -178.784 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 9.2 t70 -60.07 -44.11 94.98 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-O 120.743 0.306 . . . . 0.0 111.099 -177.613 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 49.0 t -64.66 -46.71 91.53 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.248 0 C-N-CA 120.694 -0.402 . . . . 0.0 110.512 -177.893 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 22' ' ' ILE . . . . . 0.504 HG22 HD12 ' A' ' 26' ' ' LEU . 50.7 mm -56.19 -45.19 80.85 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.246 0 C-N-CA 120.915 -0.314 . . . . 0.0 110.626 178.912 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 23' ' ' ARG . . . . . . . . . . . . . 55.7 ttp180 -54.76 -49.82 69.92 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-O 120.658 0.266 . . . . 0.0 111.296 -178.626 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 24' ' ' ILE . . . . . . . . . . . . . 75.9 mt -59.72 -42.22 87.92 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.249 0 CA-C-N 116.574 -0.285 . . . . 0.0 111.178 -177.522 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 99.4 mttt -67.6 -38.16 83.6 Favored 'General case' 0 C--N 1.328 -0.362 0 N-CA-C 112.604 0.594 . . . . 0.0 112.604 -178.686 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 26' ' ' LEU . . . . . 0.504 HD12 HG22 ' A' ' 22' ' ' ILE . 83.1 mt -78.13 -41.27 35.55 Favored 'General case' 0 C--N 1.33 -0.261 0 N-CA-C 113.144 0.794 . . . . 0.0 113.144 -172.168 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 27' ' ' GLN . . . . . . . . . . . . . 10.5 pt20 -46.98 138.06 6.85 Favored 'General case' 0 N--CA 1.47 0.551 0 N-CA-C 112.704 0.631 . . . . 0.0 112.704 -175.675 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 101.63 -26.43 24.48 Favored Glycine 0 CA--C 1.532 1.115 0 CA-C-N 115.571 -0.74 . . . . 0.0 112.306 -177.331 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 71.6 mmtt -98.17 155.14 17.3 Favored 'General case' 0 C--N 1.331 -0.209 0 CA-C-N 117.51 0.655 . . . . 0.0 111.097 177.802 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 30' ' ' THR . . . . . . . . . . . . . 41.4 m -105.33 137.52 43.01 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 115.895 -0.593 . . . . 0.0 109.862 176.068 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 34.8 m -129.51 157.38 42.24 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.245 0 CA-C-N 116.354 -0.385 . . . . 0.0 110.798 -178.468 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 32' ' ' ARG . . . . . . . . . . . . . 73.5 mtt85 -131.37 153.13 49.97 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-O 121.282 0.563 . . . . 0.0 110.701 177.899 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 33' ' ' THR . . . . . . . . . . . . . 22.7 m -53.02 139.66 27.32 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.051 -0.522 . . . . 0.0 111.397 -177.84 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 99.13 -16.99 58.66 Favored Glycine 0 CA--C 1.533 1.17 0 CA-C-O 119.593 -0.56 . . . . 0.0 113.327 178.345 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 61.3 m-20 -62.81 148.82 45.81 Favored 'General case' 0 C--O 1.231 0.11 0 CA-C-N 118.044 0.922 . . . . 0.0 111.084 179.696 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 45.1 t -123.66 130.69 73.93 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.257 0 CA-C-N 115.585 -0.734 . . . . 0.0 109.853 179.343 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 37' ' ' ILE . . . . . . . . . . . . . 69.6 mt -122.71 139.19 50.32 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.237 0 CA-C-N 116.248 -0.433 . . . . 0.0 110.04 -179.773 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . -110.72 128.78 8.94 Favored Glycine 0 CA--C 1.525 0.665 0 N-CA-C 111.037 -0.825 . . . . 0.0 111.037 179.556 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 39' ' ' ILE . . . . . . . . . . . . . 72.1 mt -123.06 135.62 62.51 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.257 0 N-CA-C 110.109 -0.33 . . . . 0.0 110.109 179.33 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 40' ' ' SER . . . . . . . . . . . . . 41.5 t -93.6 116.91 29.44 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.394 -0.366 . . . . 0.0 111.039 176.01 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 41' ' ' ILE . . . . . . . . . . . . . 44.2 mm -121.53 115.26 45.99 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.241 0 CA-C-N 116.476 -0.329 . . . . 0.0 110.333 179.34 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 78.5 mt 54.38 37.07 26.89 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-O 120.93 0.395 . . . . 0.0 111.548 176.942 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . 74.13 24.46 73.54 Favored Glycine 0 CA--C 1.532 1.123 0 C-N-CA 121.061 -0.59 . . . . 0.0 112.797 177.622 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 44' ' ' LYS . . . . . . . . . . . . . 70.0 mmtt -130.36 132.54 45.85 Favored 'General case' 0 C--N 1.331 -0.223 0 N-CA-C 109.57 -0.529 . . . . 0.0 109.57 177.74 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 81.3 tt0 -84.02 122.5 28.87 Favored 'General case' 0 C--N 1.329 -0.308 0 C-N-CA 120.74 -0.384 . . . . 0.0 111.099 -178.142 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 46' ' ' VAL . . . . . . . . . . . . . 7.1 p -120.86 128.15 76.03 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.194 0 N-CA-C 109.356 -0.609 . . . . 0.0 109.356 175.241 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 60.3 mttp -100.48 127.78 46.73 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 115.988 -0.551 . . . . 0.0 111.015 179.277 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 48' ' ' PHE . . . . . . . . . . . . . 92.2 m-85 -110.48 131.83 54.71 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.368 -0.378 . . . . 0.0 110.099 176.44 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 45.5 tttp -108.46 136.96 47.21 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.246 -0.433 . . . . 0.0 110.598 179.158 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 50' ' ' VAL . . . . . . . . . . . . . 47.0 t -82.33 107.35 14.18 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.33 0 N-CA-C 109.161 -0.681 . . . . 0.0 109.161 175.416 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 51' ' ' VAL . . . . . . . . . . . . . 47.8 t -71.68 -52.26 26.96 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.364 0 CA-C-N 115.952 -0.567 . . . . 0.0 109.668 -174.295 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 52' ' ' GLN . . . . . . . . . . . . . 90.8 mt-30 -152.94 151.09 29.93 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-O 121.182 0.515 . . . . 0.0 111.572 -177.755 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -126.46 131.88 51.57 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 115.214 -0.903 . . . . 0.0 109.639 175.087 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 54' ' ' TYR . . . . . . . . . . . . . 51.7 t80 -128.93 108.43 18.29 Favored Pre-proline 0 CA--C 1.533 0.323 0 CA-C-O 118.294 -0.86 . . . . 0.0 110.421 -179.826 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 55' ' ' PRO . . . . . . . . . . . . . 73.4 Cg_endo -77.12 170.0 72.77 Favored 'Cis proline' 0 N--CA 1.499 1.837 0 CA-C-N 121.809 1.682 . . . . 0.0 112.501 -5.54 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 56' ' ' SER . . . . . . . . . . . . . 15.2 m -115.27 129.05 25.41 Favored Pre-proline 0 CA--C 1.539 0.554 0 CA-C-O 118.448 -0.787 . . . . 0.0 109.462 174.994 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 57' ' ' PRO . . . . . . . . . . . . . 38.4 Cg_endo -67.48 165.73 67.61 Favored 'Cis proline' 0 N--CA 1.498 1.741 0 CA-C-N 121.979 1.742 . . . . 0.0 111.517 -0.601 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 58' ' ' LEU . . . . . . . . . . . . . 27.9 tp -129.28 135.89 49.35 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.268 179.646 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 59' ' ' ARG . . . . . . . . . . . . . 74.0 ttt180 -104.72 128.69 52.89 Favored 'General case' 0 C--N 1.326 -0.421 0 N-CA-C 109.188 -0.671 . . . . 0.0 109.188 176.562 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 46.2 t -79.92 122.4 35.06 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.212 0 C-N-CA 120.566 -0.453 . . . . 0.0 109.982 -175.945 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 78.9 tt0 -130.75 157.82 41.78 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 115.713 -0.676 . . . . 0.0 109.264 -179.511 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 62' ' ' ASP . . . . . . . . . . . . . 79.9 m-20 -51.58 -32.21 27.62 Favored 'General case' 0 C--N 1.328 -0.339 0 N-CA-C 112.125 0.417 . . . . 0.0 112.125 -177.642 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 63' ' ' ARG . . . . . . . . . . . . . 46.8 ptt85 -88.97 5.11 45.69 Favored 'General case' 0 CA--C 1.538 0.518 0 N-CA-C 113.767 1.025 . . . . 0.0 113.767 -175.598 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 30.4 m -80.14 141.03 36.12 Favored 'General case' 0 C--N 1.331 -0.206 0 CA-C-N 117.981 0.355 . . . . 0.0 110.742 -178.483 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 65' ' ' LYS . . . . . . . . . . . . . 97.0 mttt -88.67 131.36 35.03 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.237 -0.438 . . . . 0.0 110.262 178.895 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 66' ' ' ILE . . . . . . . . . . . . . 59.1 mt -115.26 126.45 72.83 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.297 0 N-CA-C 109.502 -0.555 . . . . 0.0 109.502 179.061 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 67' ' ' THR . . . . . . . . . . . . . 26.4 m -117.56 136.61 53.15 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-O 121.05 0.452 . . . . 0.0 110.731 -177.756 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 68' ' ' LEU . . . . . 0.462 HD23 ' C ' ' A' ' 68' ' ' LEU . 6.3 tt . . . . . 0 C--N 1.329 -0.307 0 CA-C-N 115.782 -0.645 . . . . 0.0 109.69 178.277 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 74' ' ' ASP . . . . . . . . . . . . . 30.2 t0 . . . . . 0 C--O 1.23 0.06 0 N-CA-C 109.845 -0.428 . . . . 0.0 109.845 . . . . . . . . . 0 0 . 1 . 011 nuclear nobuild core ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 43.5 t -115.7 124.27 71.95 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.215 0 CA-C-O 121.071 0.462 . . . . 0.0 110.467 -178.62 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 76' ' ' LEU . . . . . . . . . . . . . 6.3 mp -118.35 138.52 52.36 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 115.692 -0.685 . . . . 0.0 109.501 175.569 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 77' ' ' GLU . . . . . . . . . . . . . 96.8 mt-10 -134.15 136.3 43.71 Favored 'General case' 0 C--N 1.331 -0.204 0 CA-C-O 121.079 0.466 . . . . 0.0 111.017 -179.222 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 78' ' ' ALA . . . . . . . . . . . . . . . -124.81 141.68 51.95 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 115.632 -0.713 . . . . 0.0 110.077 177.704 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 79' ' ' LYS . . . . . 0.596 ' O ' HD13 ' A' ' 80' ' ' ILE . 11.4 mptt -81.52 109.83 16.35 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-O 120.858 0.361 . . . . 0.0 110.379 -179.922 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 80' ' ' ILE . . . . . 0.596 HD13 ' O ' ' A' ' 79' ' ' LYS . 41.5 mm -139.09 103.77 2.04 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.356 0 N-CA-C 109.2 -0.667 . . . . 0.0 109.2 -178.122 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 81' ' ' LYS . . . . . . . . . . . . . 19.7 pttp -112.38 140.39 47.15 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-O 121.002 0.429 . . . . 0.0 111.335 -176.857 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . 89.2 42.07 5.67 Favored Glycine 0 CA--C 1.526 0.724 0 N-CA-C 110.865 -0.894 . . . . 0.0 110.865 178.599 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 83' ' ' ILE . . . . . . . . . . . . . 70.7 mt -75.79 140.94 16.5 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.333 0 CA-C-O 120.88 0.372 . . . . 0.0 110.205 -179.139 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 84' ' ' LYS . . . . . . . . . . . . . 58.0 tttp -95.13 -53.4 3.82 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 115.904 -0.589 . . . . 0.0 109.991 179.597 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 85' ' ' ASP . . . . . . . . . . . . . 10.2 t70 -155.04 154.16 32.06 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 115.629 -0.714 . . . . 0.0 110.349 -179.627 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 86' ' ' VAL . . . . . . . . . . . . . 41.6 t -126.01 131.09 72.12 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.205 0 CA-C-O 120.925 0.393 . . . . 0.0 110.422 -179.197 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 87' ' ' ILE . . . . . . . . . . . . . 46.0 mm -120.33 124.75 73.19 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.285 0 CA-C-N 115.849 -0.614 . . . . 0.0 109.39 177.423 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 88' ' ' LEU . . . . . 0.458 HD13 HG21 ' F' ' 131' ' ' VAL . 30.1 mt -118.66 136.1 54.1 Favored 'General case' 0 C--N 1.331 -0.22 0 CA-C-O 121.209 0.528 . . . . 0.0 111.29 -176.147 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 89' ' ' ASP . . . . . . . . . . . . . 6.6 t0 -131.13 157.91 41.87 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 115.448 -0.796 . . . . 0.0 109.533 177.759 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 14.2 pt-20 -46.4 -36.93 6.96 Favored 'General case' 0 C--N 1.33 -0.272 0 N-CA-C 113.218 0.822 . . . . 0.0 113.218 -172.326 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 91' ' ' ASN . . . . . . . . . . . . . 11.9 t-20 -131.99 20.81 4.52 Favored 'General case' 0 N--CA 1.468 0.467 0 N-CA-C 112.93 0.715 . . . . 0.0 112.93 -177.083 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 92' ' ' LEU . . . . . . . . . . . . . 35.2 mt -147.52 142.61 27.09 Favored 'General case' 0 C--N 1.33 -0.267 0 N-CA-C 110.323 -0.251 . . . . 0.0 110.323 -177.625 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 93' ' ' ILE . . . . . . . . . . . . . 71.5 mt -125.34 116.02 45.48 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.336 0 N-CA-C 109.416 -0.587 . . . . 0.0 109.416 179.09 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 94' ' ' VAL . . . . . 0.437 HG21 HG11 ' A' ' 125' ' ' VAL . 46.7 t -119.13 126.79 75.67 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.295 0 CA-C-O 121.001 0.429 . . . . 0.0 110.114 -178.814 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 95' ' ' VAL . . . . . . . . . . . . . 47.3 t -118.66 131.16 72.26 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.376 0 CA-C-N 115.704 -0.68 . . . . 0.0 109.455 178.982 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 96' ' ' ILE . . . . . . . . . . . . . 65.6 mt -112.04 125.82 69.37 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.299 0 N-CA-C 109.127 -0.694 . . . . 0.0 109.127 178.699 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 97' ' ' THR . . . . . . . . . . . . . 71.2 p -98.25 157.1 16.37 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-O 121.216 0.532 . . . . 0.0 111.06 -177.22 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 98' ' ' GLU . . . . . . . . . . . . . 97.1 mt-10 -54.34 -24.25 18.61 Favored 'General case' 0 C--N 1.329 -0.322 0 N-CA-C 112.434 0.531 . . . . 0.0 112.434 -179.571 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 99' ' ' GLU . . . . . . . . . . . . . 35.3 tt0 -80.78 16.74 1.33 Allowed 'General case' 0 CA--C 1.538 0.51 0 N-CA-C 112.642 0.608 . . . . 0.0 112.642 -177.551 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 100' ' ' ASN . . . . . . . . . . . . . 3.4 m-20 61.83 37.91 15.1 Favored 'General case' 0 C--O 1.232 0.153 0 O-C-N 121.91 -0.494 . . . . 0.0 111.151 178.129 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 101' ' ' GLU . . . . . . . . . . . . . 84.7 tt0 -116.31 144.55 44.1 Favored 'General case' 0 C--N 1.331 -0.214 0 CA-C-N 116.165 -0.471 . . . . 0.0 109.858 176.501 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 102' ' ' VAL . . . . . . . . . . . . . 41.3 t -115.8 125.54 72.99 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.26 0 CA-C-N 116.207 -0.451 . . . . 0.0 110.177 -178.299 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 103' ' ' LEU . . . . . . . . . . . . . 22.6 mt -116.25 127.86 55.1 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 115.782 -0.645 . . . . 0.0 109.867 175.811 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 104' ' ' ILE . . . . . . . . . . . . . 62.4 mt -118.15 122.55 69.91 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.295 0 N-CA-C 110.342 -0.244 . . . . 0.0 110.342 179.639 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 105' ' ' PHE . . . . . . . . . . . . . 62.4 m-85 -120.18 163.58 17.52 Favored 'General case' 0 C--N 1.332 -0.182 0 O-C-N 124.136 0.897 . . . . 0.0 109.679 178.689 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 106' ' ' ASN . . . . . . . . . . . . . 46.8 p-10 -95.24 -170.69 2.23 Favored 'General case' 0 C--N 1.331 -0.232 0 N-CA-C 109.752 -0.462 . . . . 0.0 109.752 173.23 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 107' ' ' GLN . . . . . . . . . . . . . 49.3 tt0 -59.32 -30.1 68.12 Favored 'General case' 0 C--N 1.33 -0.278 0 N-CA-C 111.879 0.326 . . . . 0.0 111.879 179.144 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 108' ' ' ASN . . . . . . . . . . . . . 6.8 t-20 -82.23 9.68 8.31 Favored 'General case' 0 CA--C 1.536 0.438 0 N-CA-C 113.052 0.76 . . . . 0.0 113.052 -177.809 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 109' ' ' LEU . . . . . . . . . . . . . 11.1 tp 58.03 35.71 25.43 Favored 'General case' 0 CA--C 1.531 0.215 0 CA-C-O 120.965 0.412 . . . . 0.0 111.409 179.203 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 110' ' ' GLU . . . . . . . . . . . . . 70.7 mm-40 -104.98 143.53 33.05 Favored 'General case' 0 C--N 1.331 -0.222 0 N-CA-C 109.264 -0.643 . . . . 0.0 109.264 174.812 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 111' ' ' GLU . . . . . . . . . . . . . 62.6 tt0 -81.64 121.97 27.02 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-O 121.058 0.456 . . . . 0.0 110.678 -175.144 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 112' ' ' LEU . . . . . . . . . . . . . 29.5 mt -104.58 -45.62 4.57 Favored 'General case' 0 C--N 1.331 -0.211 0 CA-C-N 115.935 -0.575 . . . . 0.0 110.736 179.716 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 113' ' ' TYR . . . . . . . . . . . . . 63.6 t80 -133.02 135.69 45.57 Favored 'General case' 0 C--N 1.331 -0.218 0 CA-C-N 116.376 -0.375 . . . . 0.0 111.277 -177.604 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 114' ' ' ARG . . . . . . . . . . . . . 55.6 ttp180 -133.98 121.22 21.31 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 115.868 -0.605 . . . . 0.0 110.109 177.333 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 115' ' ' GLY . . . . . . . . . . . . . . . -150.12 160.8 28.68 Favored Glycine 0 CA--C 1.524 0.642 0 N-CA-C 111.013 -0.835 . . . . 0.0 111.013 -179.987 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 116' ' ' LYS . . . . . . . . . . . . . 33.4 ttmt -135.97 139.43 43.2 Favored 'General case' 0 C--N 1.328 -0.368 0 N-CA-C 109.971 -0.381 . . . . 0.0 109.971 177.312 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 117' ' ' PHE . . . . . . . . . . . . . 39.9 m-85 -136.88 114.68 11.28 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-O 121.053 0.454 . . . . 0.0 110.312 -175.127 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 118' ' ' GLU . . . . . . . . . . . . . 96.6 mt-10 -53.38 -45.06 69.1 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 116.287 -0.415 . . . . 0.0 111.664 -175.413 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 119' ' ' ASN . . . . . . . . . . . . . 69.5 m-80 -98.66 31.08 3.02 Favored 'General case' 0 C--N 1.33 -0.271 0 N-CA-C 112.255 0.465 . . . . 0.0 112.255 -173.035 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 120' ' ' LEU . . . . . . . . . . . . . 26.8 tp -56.44 122.53 12.15 Favored 'General case' 0 C--N 1.332 -0.171 0 C-N-CA 121.059 -0.256 . . . . 0.0 110.494 177.638 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 121' ' ' ASN . . . . . . . . . . . . . 34.9 m120 -114.0 -44.15 3.18 Favored 'General case' 0 C--O 1.232 0.149 0 CA-C-N 116.687 -0.233 . . . . 0.0 111.181 -178.373 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 122' ' ' LYS . . . . . . . . . . . . . 97.3 mttt -148.31 152.92 37.92 Favored 'General case' 0 C--N 1.332 -0.156 0 CA-C-O 121.126 0.489 . . . . 0.0 111.468 -177.896 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 123' ' ' VAL . . . . . . . . . . . . . 45.0 t -127.19 132.41 69.72 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.217 0 CA-C-N 115.897 -0.592 . . . . 0.0 109.679 176.931 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 124' ' ' LEU . . . . . . . . . . . . . 75.8 mt -126.67 131.04 51.5 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.455 -0.339 . . . . 0.0 110.307 -179.993 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 125' ' ' VAL . . . . . 0.437 HG11 HG21 ' A' ' 94' ' ' VAL . 35.3 m -136.59 138.85 46.02 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.258 0 CA-C-O 120.844 0.354 . . . . 0.0 110.829 -179.748 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 126' ' ' ARG . . . . . . . . . . . . . 14.5 ptm180 -165.96 143.55 5.53 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.066 -0.515 . . . . 0.0 110.081 177.216 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 127' ' ' ASN . . . . . . . . . . . . . 4.3 t30 55.24 -153.82 0.31 Allowed 'General case' 0 CA--C 1.539 0.539 0 N-CA-C 110.017 -0.364 . . . . 0.0 110.017 -179.844 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 128' ' ' ASP . . . . . . . . . . . . . 8.2 p-10 -83.66 18.53 1.89 Allowed 'General case' 0 CA--C 1.535 0.37 0 N-CA-C 112.679 0.622 . . . . 0.0 112.679 179.269 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 129' ' ' LEU . . . . . . . . . . . . . 15.5 tp -122.94 138.25 54.72 Favored 'General case' 0 C--O 1.232 0.157 0 O-C-N 121.983 -0.448 . . . . 0.0 110.503 -179.608 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 130' ' ' VAL . . . . . 0.478 HG23 ' HB ' ' A' ' 141' ' ' ILE . 32.7 m -131.23 141.75 45.19 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.184 0 CA-C-O 120.805 0.336 . . . . 0.0 110.449 177.578 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 131' ' ' VAL . . . . . . . . . . . . . 47.9 t -136.14 138.61 46.99 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.285 0 CA-C-O 121.274 0.559 . . . . 0.0 110.682 -179.526 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 132' ' ' ILE . . . . . . . . . . . . . 72.1 mt -111.74 133.27 57.92 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.329 0 CA-C-N 115.41 -0.814 . . . . 0.0 109.135 178.089 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 133' ' ' ILE . . . . . . . . . . . . . 43.4 mm -114.82 120.04 63.35 Favored 'Isoleucine or valine' 0 C--O 1.233 0.229 0 CA-C-O 120.884 0.373 . . . . 0.0 110.964 -175.294 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 134' ' ' ASP . . . . . . . . . . . . . 6.2 p-10 -130.46 144.83 51.65 Favored 'General case' 0 C--N 1.331 -0.227 0 N-CA-C 109.366 -0.605 . . . . 0.0 109.366 173.83 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 135' ' ' GLU . . . . . . . . . . . . . 43.4 tp10 -49.78 -24.97 2.65 Favored 'General case' 0 C--N 1.328 -0.334 0 N-CA-C 112.793 0.664 . . . . 0.0 112.793 -170.799 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 136' ' ' GLN . . . . . . . . . . . . . 96.0 mt-30 -91.53 -40.08 11.57 Favored 'General case' 0 C--N 1.331 -0.231 0 N-CA-C 112.305 0.483 . . . . 0.0 112.305 -177.389 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 137' ' ' LYS . . . . . . . . . . . . . 61.2 mtpt -141.96 155.81 45.47 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-O 121.34 0.59 . . . . 0.0 111.718 -167.989 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 138' ' ' LEU . . . . . 0.426 ' C ' HD23 ' A' ' 138' ' ' LEU . 5.9 tt -116.0 124.69 51.13 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 115.519 -0.764 . . . . 0.0 109.177 173.832 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 139' ' ' THR . . . . . . . . . . . . . 31.1 m -111.12 124.38 52.08 Favored 'General case' 0 C--N 1.331 -0.196 0 CA-C-N 116.438 -0.346 . . . . 0.0 110.794 -176.993 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 140' ' ' LEU . . . . . 0.479 HD23 ' C ' ' A' ' 140' ' ' LEU . 9.9 tt -112.07 126.85 55.62 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 115.762 -0.653 . . . . 0.0 109.591 -178.468 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 141' ' ' ILE . . . . . 0.478 ' HB ' HG23 ' A' ' 130' ' ' VAL . 19.5 mt -125.21 123.88 66.15 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.302 0 CA-C-O 121.008 0.432 . . . . 0.0 109.873 -176.543 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 142' ' ' ARG . . . . . . . . . . . . . 61.5 ttt180 -110.06 124.88 52.27 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 115.119 -0.946 . . . . 0.0 110.459 -177.794 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 143' ' ' THR . . . . . . . . . . . . . 9.3 p . . . . . 0 C--O 1.22 -0.49 0 CA-C-O 117.979 -1.01 . . . . 0.0 110.592 179.959 . . . . . . . . 0 0 . 1 . 011 nuclear nobuild core ' B' B ' 2' ' ' SER . . . . . . . . . . . . . 11.6 p . . . . . 0 C--O 1.231 0.125 0 CA-C-O 120.953 0.406 . . . . 0.0 110.549 . . . . . . . . . 0 0 . 1 . 011 nuclear nobuild core ' B' B ' 3' ' ' GLU . . . . . . . . . . . . . 95.0 mt-10 -140.91 140.48 34.5 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 115.941 -0.572 . . . . 0.0 111.0 -178.762 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' B' B ' 4' ' ' LEU . . . . . . . . . . . . . 18.2 tp -125.23 130.73 52.68 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 115.915 -0.584 . . . . 0.0 110.119 176.558 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' B' B ' 5' ' ' LYS . . . . . . . . . . . . . 93.6 mttt -112.19 121.43 44.9 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-O 120.843 0.354 . . . . 0.0 110.569 179.588 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' B' B ' 6' ' ' LEU . . . . . . . . . . . . . 62.7 mt -114.1 147.16 39.22 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 115.388 -0.823 . . . . 0.0 111.157 -177.869 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' B' B ' 7' ' ' LYS . . . . . . . . . . . . . 79.4 tttt -137.0 140.26 31.0 Favored Pre-proline 0 CA--C 1.534 0.333 0 CA-C-N 116.07 -0.514 . . . . 0.0 109.724 175.715 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' B' B ' 8' ' ' PRO . . . . . . . . . . . . . 89.4 Cg_endo -91.58 146.45 3.31 Favored 'Trans proline' 0 N--CA 1.491 1.333 0 C-N-CA 121.735 1.624 . . . . 0.0 111.972 178.968 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' B' B ' 9' ' ' LEU . . . . . . . . . . . . . 41.4 mt -82.57 -46.84 0.91 Allowed Pre-proline 0 CA--C 1.534 0.353 0 CA-C-O 118.78 -0.628 . . . . 0.0 111.909 179.317 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' B' B ' 10' ' ' PRO . . . . . . . . . . . . . 94.3 Cg_endo -82.05 155.84 17.42 Favored 'Trans proline' 0 N--CA 1.495 1.56 0 C-N-CA 121.253 1.302 . . . . 0.0 111.767 174.433 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' B' B ' 11' ' ' LYS . . . . . . . . . . . . . 92.2 mttt -88.53 98.43 11.64 Favored 'General case' 0 C--N 1.329 -0.316 0 C-N-CA 120.883 -0.327 . . . . 0.0 110.513 178.725 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' B' B ' 12' ' ' VAL . . . . . . . . . . . . . 12.2 p -140.34 147.4 23.34 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.302 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.433 -179.976 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' B' B ' 13' ' ' GLU . . . . . . . . . . . . . 43.0 tp10 -89.21 129.93 35.7 Favored 'General case' 0 C--N 1.329 -0.298 0 N-CA-C 109.862 -0.421 . . . . 0.0 109.862 178.298 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' B' B ' 14' ' ' LEU . . . . . . . . . . . . . 53.8 mt -97.33 147.58 33.16 Favored Pre-proline 0 CA--C 1.532 0.286 0 CA-C-O 119.196 -0.43 . . . . 0.0 110.727 -176.94 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' B' B ' 15' ' ' PRO . . . . . . . . . . . . . 24.4 Cg_exo -63.31 161.11 32.03 Favored 'Trans proline' 0 N--CA 1.498 1.738 0 C-N-CA 121.248 1.299 . . . . 0.0 111.762 175.881 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' B' B ' 16' ' ' PRO . . . . . . . . . . . . . 31.2 Cg_exo -59.24 -38.15 87.22 Favored 'Trans proline' 0 N--CA 1.497 1.721 0 C-N-CA 121.471 1.447 . . . . 0.0 112.78 -177.706 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' B' B ' 17' ' ' ASP . . . . . . . . . . . . . 18.2 p-10 -88.79 9.44 24.58 Favored 'General case' 0 CA--C 1.536 0.419 0 N-CA-C 113.243 0.831 . . . . 0.0 113.243 -177.735 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' B' B ' 18' ' ' PHE . . . . . . . . . . . . . 34.2 t80 -58.25 -43.74 88.01 Favored 'General case' 0 C--N 1.334 -0.081 0 O-C-N 122.023 -0.423 . . . . 0.0 109.9 -178.446 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' B' B ' 19' ' ' VAL . . . . . . . . . . . . . 53.9 t -56.92 -42.91 79.54 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.369 0 CA-C-N 116.18 -0.464 . . . . 0.0 110.494 -179.479 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' B' B ' 20' ' ' ASP . . . . . . . . . . . . . 10.4 t0 -60.04 -42.6 94.77 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-O 120.847 0.356 . . . . 0.0 111.049 -177.796 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' B' B ' 21' ' ' VAL . . . . . . . . . . . . . 51.3 t -64.25 -47.01 91.67 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.335 0 CA-C-N 116.448 -0.342 . . . . 0.0 110.515 -177.685 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' B' B ' 22' ' ' ILE . . . . . 0.507 HG22 HD12 ' B' ' 26' ' ' LEU . 49.7 mm -56.48 -45.42 81.97 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.252 0 C-N-CA 120.982 -0.287 . . . . 0.0 110.572 178.819 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' B' B ' 23' ' ' ARG . . . . . . . . . . . . . 24.8 ttp180 -53.8 -50.16 66.75 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-O 120.58 0.229 . . . . 0.0 111.48 -178.446 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' B' B ' 24' ' ' ILE . . . . . . . . . . . . . 73.9 mt -59.86 -45.15 95.27 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.316 0 CA-C-N 116.574 -0.284 . . . . 0.0 111.281 -176.536 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' B' B ' 25' ' ' LYS . . . . . . . . . . . . . 50.2 mttm -65.44 -39.28 91.86 Favored 'General case' 0 C--N 1.329 -0.289 0 N-CA-C 112.607 0.595 . . . . 0.0 112.607 -177.629 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' B' B ' 26' ' ' LEU . . . . . 0.507 HD12 HG22 ' B' ' 22' ' ' ILE . 26.8 mt -77.55 -43.19 32.69 Favored 'General case' 0 C--N 1.33 -0.272 0 N-CA-C 112.763 0.653 . . . . 0.0 112.763 -172.838 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' B' B ' 27' ' ' GLN . . . . . . . . . . . . . 10.6 pt20 -47.0 137.49 7.42 Favored 'General case' 0 N--CA 1.469 0.51 0 N-CA-C 112.629 0.603 . . . . 0.0 112.629 -177.071 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' B' B ' 28' ' ' GLY . . . . . . . . . . . . . . . 100.72 -26.84 23.13 Favored Glycine 0 CA--C 1.533 1.183 0 CA-C-N 115.565 -0.743 . . . . 0.0 112.209 -176.477 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' B' B ' 29' ' ' LYS . . . . . . . . . . . . . 94.8 mttt -98.38 155.13 17.38 Favored 'General case' 0 C--O 1.232 0.166 0 CA-C-N 117.219 0.509 . . . . 0.0 110.842 178.555 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' B' B ' 30' ' ' THR . . . . . . . . . . . . . 28.5 m -103.04 136.45 42.82 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.279 -0.419 . . . . 0.0 109.962 175.269 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' B' B ' 31' ' ' VAL . . . . . . . . . . . . . 35.5 m -128.99 153.39 38.52 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.216 0 CA-C-O 121.047 0.451 . . . . 0.0 111.019 -177.856 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' B' B ' 32' ' ' ARG . . . . . . . . . . . . . 90.0 mtm-85 -128.81 148.98 50.92 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 115.905 -0.589 . . . . 0.0 110.457 178.877 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' B' B ' 33' ' ' THR . . . . . . . . . . . . . 18.7 m -53.42 138.6 32.86 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.326 -0.397 . . . . 0.0 111.279 -177.978 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' B' B ' 34' ' ' GLY . . . . . . . . . . . . . . . 101.06 -17.1 56.62 Favored Glycine 0 CA--C 1.533 1.167 0 CA-C-O 119.609 -0.55 . . . . 0.0 113.284 179.574 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' B' B ' 35' ' ' ASP . . . . . . . . . . . . . 69.0 m-20 -64.26 148.88 49.18 Favored 'General case' 0 C--N 1.334 -0.106 0 CA-C-N 118.07 0.935 . . . . 0.0 111.029 179.537 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' B' B ' 36' ' ' VAL . . . . . . . . . . . . . 45.6 t -123.8 131.58 72.77 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.215 0 CA-C-N 115.774 -0.648 . . . . 0.0 109.8 178.899 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' B' B ' 37' ' ' ILE . . . . . . . . . . . . . 65.6 mt -121.2 139.23 49.04 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.217 0 CA-C-N 116.197 -0.456 . . . . 0.0 109.973 -179.925 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' B' B ' 38' ' ' GLY . . . . . . . . . . . . . . . -112.31 128.78 8.68 Favored Glycine 0 CA--C 1.526 0.767 0 N-CA-C 111.033 -0.827 . . . . 0.0 111.033 179.799 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' B' B ' 39' ' ' ILE . . . . . . . . . . . . . 71.6 mt -124.12 134.81 65.56 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.21 0 N-CA-C 110.091 -0.337 . . . . 0.0 110.091 179.199 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' B' B ' 40' ' ' SER . . . . . . . . . . . . . 95.0 p -93.64 124.49 37.66 Favored 'General case' 0 C--N 1.331 -0.225 0 CA-C-N 116.338 -0.392 . . . . 0.0 111.096 176.24 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' B' B ' 41' ' ' ILE . . . . . . . . . . . . . 75.0 mt -130.63 122.5 52.87 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.254 0 CA-C-N 116.488 -0.324 . . . . 0.0 110.331 176.749 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' B' B ' 42' ' ' LEU . . . . . . . . . . . . . 6.6 tp 52.16 36.03 18.11 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 116.279 -0.419 . . . . 0.0 111.652 176.823 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' B' B ' 43' ' ' GLY . . . . . . . . . . . . . . . 71.84 32.56 63.7 Favored Glycine 0 CA--C 1.529 0.964 0 C-N-CA 121.085 -0.578 . . . . 0.0 112.033 178.543 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' B' B ' 44' ' ' LYS . . . . . . . . . . . . . 84.8 tttt -137.19 127.18 25.87 Favored 'General case' 0 C--N 1.328 -0.356 0 N-CA-C 109.74 -0.467 . . . . 0.0 109.74 178.915 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' B' B ' 45' ' ' GLU . . . . . . . . . . . . . 84.7 tt0 -83.01 122.84 28.83 Favored 'General case' 0 C--N 1.327 -0.409 0 CA-C-O 120.802 0.334 . . . . 0.0 110.923 -178.874 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' B' B ' 46' ' ' VAL . . . . . . . . . . . . . 7.6 p -120.16 127.74 75.92 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.229 0 N-CA-C 109.35 -0.611 . . . . 0.0 109.35 175.35 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' B' B ' 47' ' ' LYS . . . . . . . . . . . . . 58.2 mtpt -101.26 128.14 47.53 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 115.798 -0.637 . . . . 0.0 111.148 -179.658 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' B' B ' 48' ' ' PHE . . . . . . . . . . . . . 95.6 m-85 -112.44 131.94 55.3 Favored 'General case' 0 C--N 1.331 -0.223 0 CA-C-N 116.335 -0.393 . . . . 0.0 110.196 176.946 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' B' B ' 49' ' ' LYS . . . . . . . . . . . . . 74.4 tttt -108.39 137.45 46.33 Favored 'General case' 0 C--N 1.331 -0.229 0 CA-C-N 116.449 -0.342 . . . . 0.0 110.664 179.022 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' B' B ' 50' ' ' VAL . . . . . . . . . . . . . 47.1 t -82.88 110.59 18.1 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.254 0 N-CA-C 109.434 -0.58 . . . . 0.0 109.434 176.265 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' B' B ' 51' ' ' VAL . . . . . . . . . . . . . 47.5 t -73.78 -51.53 24.27 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.231 0 CA-C-N 116.108 -0.496 . . . . 0.0 109.754 -174.774 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' B' B ' 52' ' ' GLN . . . . . . . . . . . . . 92.6 mt-30 -153.26 152.82 31.61 Favored 'General case' 0 C--N 1.331 -0.211 0 CA-C-O 121.176 0.513 . . . . 0.0 111.82 -177.739 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' B' B ' 53' ' ' ALA . . . . . . . . . . . . . . . -132.27 133.59 44.28 Favored 'General case' 0 C--N 1.327 -0.404 0 CA-C-N 115.113 -0.949 . . . . 0.0 109.677 174.9 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' B' B ' 54' ' ' TYR . . . . . . . . . . . . . 63.1 t80 -129.2 113.6 18.43 Favored Pre-proline 0 CA--C 1.536 0.411 0 CA-C-O 118.077 -0.963 . . . . 0.0 110.569 179.07 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' B' B ' 55' ' ' PRO . . . . . . . . . . . . . 71.8 Cg_endo -77.25 164.11 87.57 Favored 'Cis proline' 0 N--CA 1.5 1.879 0 CA-C-N 121.993 1.748 . . . . 0.0 112.123 -8.831 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' B' B ' 56' ' ' SER . . . . . . . . . . . . . 13.7 m -114.03 132.82 22.51 Favored Pre-proline 0 CA--C 1.539 0.52 0 CA-C-O 118.495 -0.764 . . . . 0.0 109.388 175.173 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' B' B ' 57' ' ' PRO . . . . . . . . . . . . . 43.5 Cg_endo -69.02 143.81 73.45 Favored 'Cis proline' 0 N--CA 1.498 1.763 0 CA-C-N 121.865 1.702 . . . . 0.0 111.439 -0.713 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' B' B ' 58' ' ' LEU . . . . . . . . . . . . . 24.2 tp -105.68 135.51 46.96 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.382 -0.372 . . . . 0.0 110.667 -178.282 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' B' B ' 59' ' ' ARG . . . . . . . . . . . . . 41.7 ttm180 -99.98 121.54 41.51 Favored 'General case' 0 C--N 1.326 -0.438 0 N-CA-C 108.983 -0.747 . . . . 0.0 108.983 174.133 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' B' B ' 60' ' ' VAL . . . . . . . . . . . . . 39.9 t -79.53 122.57 35.02 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.225 0 C-N-CA 120.587 -0.445 . . . . 0.0 110.205 -174.107 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' B' B ' 61' ' ' GLU . . . . . . . . . . . . . 34.9 tp10 -130.89 156.7 44.61 Favored 'General case' 0 C--N 1.329 -0.32 0 N-CA-C 109.071 -0.715 . . . . 0.0 109.071 179.131 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' B' B ' 62' ' ' ASP . . . . . . . . . . . . . 5.5 t70 -51.42 -32.53 26.83 Favored 'General case' 0 C--N 1.326 -0.454 0 N-CA-C 111.946 0.35 . . . . 0.0 111.946 -178.945 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' B' B ' 63' ' ' ARG . . . . . . . . . . . . . 48.0 mmm-85 -73.91 -19.17 60.78 Favored 'General case' 0 CA--C 1.536 0.431 0 N-CA-C 113.095 0.776 . . . . 0.0 113.095 -176.928 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' B' B ' 64' ' ' THR . . . . . . . . . . . . . 32.0 m -67.9 141.69 56.3 Favored 'General case' 0 C--N 1.331 -0.209 0 CA-C-O 120.978 0.418 . . . . 0.0 111.114 -175.307 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' B' B ' 65' ' ' LYS . . . . . . . . . . . . . 68.4 mttm -90.23 132.88 35.26 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 115.833 -0.621 . . . . 0.0 110.322 179.639 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' B' B ' 66' ' ' ILE . . . . . . . . . . . . . 66.4 mt -112.56 131.2 64.75 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.239 0 N-CA-C 109.865 -0.42 . . . . 0.0 109.865 179.574 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' B' B ' 67' ' ' THR . . . . . . . . . . . . . 22.6 m -126.05 142.84 51.35 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-N 115.989 -0.551 . . . . 0.0 110.917 -177.723 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' B' B ' 68' ' ' LEU . . . . . . . . . . . . . 16.5 tp . . . . . 0 C--N 1.328 -0.336 0 CA-C-N 115.845 -0.616 . . . . 0.0 109.829 177.282 . . . . . . . . 0 0 . 1 . 011 nuclear nobuild core ' B' B ' 73' ' ' VAL . . . . . . . . . . . . . 27.6 m . . . . . 0 C--O 1.232 0.164 0 N-CA-C 109.422 -0.584 . . . . 0.0 109.422 . . . . . . . . . 0 0 . 1 . 011 nuclear nobuild core ' B' B ' 74' ' ' ASP . . . . . . . . . . . . . 36.2 t0 -92.62 123.71 36.12 Favored 'General case' 0 C--N 1.327 -0.397 0 CA-C-N 116.252 -0.431 . . . . 0.0 110.195 -176.764 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' B' B ' 75' ' ' VAL . . . . . . . . . . . . . 43.0 t -118.23 123.64 71.92 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.267 0 CA-C-O 121.16 0.505 . . . . 0.0 110.455 -178.592 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' B' B ' 76' ' ' LEU . . . . . . . . . . . . . 5.7 mp -123.48 146.04 48.36 Favored 'General case' 0 C--N 1.331 -0.22 0 CA-C-N 115.572 -0.74 . . . . 0.0 109.554 175.812 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' B' B ' 77' ' ' GLU . . . . . . . . . . . . . 96.9 mt-10 -134.5 132.29 39.05 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-O 121.085 0.469 . . . . 0.0 111.106 -178.267 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' B' B ' 78' ' ' ALA . . . . . . . . . . . . . . . -117.18 136.81 52.77 Favored 'General case' 0 C--N 1.331 -0.229 0 CA-C-N 115.657 -0.701 . . . . 0.0 109.91 176.898 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' B' B ' 79' ' ' LYS . . . . . 0.61 ' O ' HD13 ' B' ' 80' ' ' ILE . 55.6 mtmt -85.37 112.8 21.16 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.501 -0.318 . . . . 0.0 110.721 -178.359 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' B' B ' 80' ' ' ILE . . . . . 0.61 HD13 ' O ' ' B' ' 79' ' ' LYS . 41.0 mm -139.04 104.2 2.18 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.302 0 N-CA-C 109.33 -0.619 . . . . 0.0 109.33 -178.164 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' B' B ' 81' ' ' LYS . . . . . . . . . . . . . 52.9 pttt -98.99 130.87 45.36 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-O 120.923 0.392 . . . . 0.0 111.123 -178.497 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' B' B ' 82' ' ' GLY . . . . . . . . . . . . . . . 89.22 42.1 5.66 Favored Glycine 0 CA--C 1.524 0.649 0 N-CA-C 111.191 -0.764 . . . . 0.0 111.191 178.087 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' B' B ' 83' ' ' ILE . . . . . . . . . . . . . 66.6 mt -70.23 135.55 27.94 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.342 0 N-CA-C 109.539 -0.541 . . . . 0.0 109.539 177.676 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' B' B ' 84' ' ' LYS . . . . . . . . . . . . . 16.4 ttmm -89.37 -52.24 5.14 Favored 'General case' 0 C--N 1.328 -0.36 0 N-CA-C 109.734 -0.469 . . . . 0.0 109.734 179.687 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' B' B ' 85' ' ' ASP . . . . . . . . . . . . . 8.5 t70 -160.46 154.39 22.84 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 115.615 -0.72 . . . . 0.0 110.476 178.845 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' B' B ' 86' ' ' VAL . . . . . . . . . . . . . 40.5 t -128.34 131.47 69.03 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.259 0 CA-C-O 120.89 0.376 . . . . 0.0 110.194 179.985 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' B' B ' 87' ' ' ILE . . . . . 0.491 ' N ' HD12 ' B' ' 87' ' ' ILE . 5.0 mp -120.54 127.12 75.89 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.238 0 CA-C-N 116.021 -0.536 . . . . 0.0 109.755 177.855 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' B' B ' 88' ' ' LEU . . . . . . . . . . . . . 42.4 mt -104.75 139.78 39.04 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 116.248 -0.433 . . . . 0.0 111.0 -179.842 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' B' B ' 89' ' ' ASP . . . . . . . . . . . . . 9.5 t70 -132.98 158.4 42.77 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 115.922 -0.581 . . . . 0.0 109.672 176.917 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' B' B ' 90' ' ' GLU . . . . . . . . . . . . . 43.0 mt-10 -46.83 -39.69 12.43 Favored 'General case' 0 C--N 1.329 -0.306 0 N-CA-C 113.139 0.792 . . . . 0.0 113.139 -170.469 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' B' B ' 91' ' ' ASN . . . . . . . . . . . . . 29.2 m-80 -131.99 21.33 4.52 Favored 'General case' 0 N--CA 1.468 0.444 0 N-CA-C 113.044 0.757 . . . . 0.0 113.044 -177.591 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' B' B ' 92' ' ' LEU . . . . . . . . . . . . . 34.1 mt -150.37 150.34 31.28 Favored 'General case' 0 C--N 1.331 -0.222 0 CA-C-O 120.766 0.317 . . . . 0.0 110.451 -176.923 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' B' B ' 93' ' ' ILE . . . . . . . . . . . . . 73.3 mt -127.07 121.48 57.97 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.251 0 N-CA-C 109.133 -0.691 . . . . 0.0 109.133 175.361 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' B' B ' 94' ' ' VAL . . . . . . . . . . . . . 46.9 t -118.64 126.25 75.05 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.215 0 N-CA-C 109.814 -0.439 . . . . 0.0 109.814 -179.192 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' B' B ' 95' ' ' VAL . . . . . . . . . . . . . 46.5 t -118.91 133.19 66.56 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.316 0 CA-C-N 115.901 -0.591 . . . . 0.0 109.643 -179.951 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' B' B ' 96' ' ' ILE . . . . . . . . . . . . . 64.4 mt -111.91 126.22 69.28 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.317 0 N-CA-C 109.081 -0.711 . . . . 0.0 109.081 178.982 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' B' B ' 97' ' ' THR . . . . . . . . . . . . . 74.3 p -99.34 154.12 18.44 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-O 121.192 0.52 . . . . 0.0 111.117 -176.877 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' B' B ' 98' ' ' GLU . . . . . . . . . . . . . 84.9 tt0 -53.88 -25.51 20.34 Favored 'General case' 0 CA--C 1.535 0.372 0 CA-C-N 116.069 -0.514 . . . . 0.0 112.231 -179.513 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' B' B ' 99' ' ' GLU . . . . . . . . . . . . . 45.5 mp0 -80.91 18.08 1.08 Allowed 'General case' 0 CA--C 1.535 0.386 0 N-CA-C 112.989 0.737 . . . . 0.0 112.989 -176.619 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' B' B ' 100' ' ' ASN . . . . . . . . . . . . . 3.1 m-20 62.4 37.97 13.24 Favored 'General case' 0 C--O 1.232 0.171 0 CA-C-O 121.193 0.52 . . . . 0.0 110.997 178.121 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' B' B ' 101' ' ' GLU . . . . . . . . . . . . . 84.8 tt0 -118.77 144.77 46.08 Favored 'General case' 0 C--N 1.332 -0.175 0 CA-C-N 116.211 -0.449 . . . . 0.0 109.954 177.136 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' B' B ' 102' ' ' VAL . . . . . . . . . . . . . 44.1 t -115.09 125.34 72.37 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.29 0 N-CA-C 109.797 -0.445 . . . . 0.0 109.797 -178.034 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' B' B ' 103' ' ' LEU . . . . . . . . . . . . . 34.6 mt -117.07 130.23 56.52 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-N 115.814 -0.63 . . . . 0.0 110.006 177.874 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' B' B ' 104' ' ' ILE . . . . . . . . . . . . . 69.7 mt -118.05 122.73 70.37 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.249 0 N-CA-C 110.222 -0.288 . . . . 0.0 110.222 -179.115 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' B' B ' 105' ' ' PHE . . . . . . . . . . . . . 90.9 m-85 -122.77 164.31 18.59 Favored 'General case' 0 C--N 1.332 -0.168 0 O-C-N 123.783 0.677 . . . . 0.0 110.236 -178.496 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' B' B ' 106' ' ' ASN . . . . . . . . . . . . . 49.6 p-10 -98.14 -170.74 2.02 Favored 'General case' 0 C--N 1.33 -0.28 0 N-CA-C 109.866 -0.42 . . . . 0.0 109.866 174.933 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' B' B ' 107' ' ' GLN . . . . . . . . . . . . . 58.9 tt0 -58.24 -30.01 66.2 Favored 'General case' 0 C--N 1.328 -0.332 0 N-CA-C 112.038 0.384 . . . . 0.0 112.038 -178.407 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' B' B ' 108' ' ' ASN . . . . . . . . . . . . . 10.6 t-20 -89.88 14.02 13.11 Favored 'General case' 0 CA--C 1.534 0.348 0 N-CA-C 113.098 0.777 . . . . 0.0 113.098 -176.033 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' B' B ' 109' ' ' LEU . . . . . . . . . . . . . 14.5 mt 58.61 35.38 24.49 Favored 'General case' 0 C--N 1.331 -0.201 0 CA-C-O 120.924 0.392 . . . . 0.0 111.502 179.628 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' B' B ' 110' ' ' GLU . . . . . . . . . . . . . 96.5 mt-10 -101.92 143.3 31.97 Favored 'General case' 0 C--N 1.328 -0.34 0 N-CA-C 109.189 -0.671 . . . . 0.0 109.189 174.392 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' B' B ' 111' ' ' GLU . . . . . . . . . . . . . 51.1 tt0 -81.23 121.83 26.65 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-O 120.97 0.414 . . . . 0.0 110.653 -175.299 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' B' B ' 112' ' ' LEU . . . . . . . . . . . . . 23.2 mt -103.67 -46.09 4.63 Favored 'General case' 0 C--N 1.331 -0.212 0 CA-C-N 115.88 -0.6 . . . . 0.0 110.691 179.668 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' B' B ' 113' ' ' TYR . . . . . . . . . . . . . 58.7 t80 -137.67 146.73 44.19 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.961 -178.929 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' B' B ' 114' ' ' ARG . . . . . . . . . . . . . 30.4 ptt180 -149.69 124.58 9.92 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-N 116.158 -0.473 . . . . 0.0 111.051 -178.527 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' B' B ' 115' ' ' GLY . . . . . . . . . . . . . . . -150.16 162.42 29.21 Favored Glycine 0 CA--C 1.525 0.692 0 N-CA-C 110.928 -0.869 . . . . 0.0 110.928 178.806 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' B' B ' 116' ' ' LYS . . . . . . . . . . . . . 38.3 ttpt -131.95 138.67 48.42 Favored 'General case' 0 C--N 1.33 -0.259 0 N-CA-C 109.979 -0.378 . . . . 0.0 109.979 177.13 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' B' B ' 117' ' ' PHE . . . . . . . . . . . . . 41.8 m-85 -136.37 117.31 14.23 Favored 'General case' 0 C--N 1.331 -0.227 0 C-N-CA 120.874 -0.331 . . . . 0.0 110.362 -175.716 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' B' B ' 118' ' ' GLU . . . . . . . . . . . . . 70.6 mm-40 -54.11 -45.23 71.82 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.616 -0.265 . . . . 0.0 111.246 -177.515 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' B' B ' 119' ' ' ASN . . . . . . . . . . . . . 84.1 m-20 -98.87 31.06 3.09 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.181 -0.463 . . . . 0.0 112.171 -174.479 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' B' B ' 120' ' ' LEU . . . . . . . . . . . . . 23.0 tp -56.23 120.78 8.13 Favored 'General case' 0 C--N 1.332 -0.17 0 CA-C-O 120.626 0.25 . . . . 0.0 110.393 178.512 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' B' B ' 121' ' ' ASN . . . . . . . . . . . . . 34.3 m120 -109.66 -44.21 3.9 Favored 'General case' 0 N--CA 1.462 0.152 0 CA-C-N 116.649 -0.251 . . . . 0.0 111.211 -176.118 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' B' B ' 122' ' ' LYS . . . . . . . . . . . . . 94.3 mttt -147.94 148.14 30.47 Favored 'General case' 0 C--N 1.333 -0.139 0 C-N-CA 120.392 -0.523 . . . . 0.0 111.966 -177.918 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' B' B ' 123' ' ' VAL . . . . . . . . . . . . . 48.0 t -124.09 128.17 73.88 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.255 0 N-CA-C 109.251 -0.648 . . . . 0.0 109.251 173.792 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' B' B ' 124' ' ' LEU . . . . . . . . . . . . . 12.9 tp -129.07 132.42 47.43 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-O 120.651 0.262 . . . . 0.0 110.729 -177.092 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' B' B ' 125' ' ' VAL . . . . . . . . . . . . . 12.3 p -135.45 136.08 51.17 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.23 0 CA-C-O 120.735 0.302 . . . . 0.0 110.393 179.095 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' B' B ' 126' ' ' ARG . . . . . . . . . . . . . 96.4 mtt180 -148.72 134.16 18.58 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-O 120.977 0.418 . . . . 0.0 111.052 179.583 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' B' B ' 127' ' ' ASN . . . . . . . . . . . . . 86.3 m-20 50.32 -111.52 0.52 Allowed 'General case' 0 CA--C 1.545 0.778 0 CA-C-O 118.786 -0.626 . . . . 0.0 111.398 178.827 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' B' B ' 128' ' ' ASP . . . . . . . . . . . . . 8.2 p-10 -114.12 8.62 17.01 Favored 'General case' 0 CA--C 1.536 0.423 0 CA-C-N 119.908 1.231 . . . . 0.0 113.322 -176.934 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' B' B ' 129' ' ' LEU . . . . . . . . . . . . . 42.3 mt -117.72 144.75 44.99 Favored 'General case' 0 C--O 1.232 0.134 0 CA-C-N 118.028 0.376 . . . . 0.0 110.197 179.73 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' B' B ' 130' ' ' VAL . . . . . 0.506 HG13 ' HB ' ' B' ' 141' ' ' ILE . 12.1 p -132.97 140.31 47.58 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.212 0 CA-C-O 120.967 0.413 . . . . 0.0 110.366 -179.572 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' B' B ' 131' ' ' VAL . . . . . 0.565 HG22 HD12 ' B' ' 140' ' ' LEU . 44.1 t -136.01 139.95 44.9 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.287 0 CA-C-N 116.046 -0.524 . . . . 0.0 110.337 -178.531 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' B' B ' 132' ' ' ILE . . . . . . . . . . . . . 74.4 mt -115.92 131.43 68.39 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.364 0 CA-C-N 115.548 -0.751 . . . . 0.0 109.05 177.735 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' B' B ' 133' ' ' ILE . . . . . . . . . . . . . 42.9 mm -114.86 121.07 66.2 Favored 'Isoleucine or valine' 0 C--O 1.234 0.252 0 CA-C-O 120.867 0.365 . . . . 0.0 111.027 -174.744 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' B' B ' 134' ' ' ASP . . . . . . . . . . . . . 6.3 p-10 -129.74 146.41 51.5 Favored 'General case' 0 C--N 1.332 -0.191 0 CA-C-N 115.834 -0.621 . . . . 0.0 109.485 174.605 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' B' B ' 135' ' ' GLU . . . . . . . . . . . . . 41.7 tp10 -49.9 -24.25 2.4 Favored 'General case' 0 C--N 1.328 -0.369 0 N-CA-C 112.976 0.732 . . . . 0.0 112.976 -169.808 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' B' B ' 136' ' ' GLN . . . . . . . . . . . . . 21.3 pt20 -102.4 -30.45 11.02 Favored 'General case' 0 CA--C 1.532 0.255 0 N-CA-C 112.709 0.633 . . . . 0.0 112.709 -174.603 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' B' B ' 137' ' ' LYS . . . . . . . . . . . . . 27.4 mtpp -141.48 153.86 45.2 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-O 121.278 0.561 . . . . 0.0 111.519 -172.044 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' B' B ' 138' ' ' LEU . . . . . . . . . . . . . 5.0 tt -114.94 124.43 51.66 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 115.615 -0.72 . . . . 0.0 109.382 174.72 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' B' B ' 139' ' ' THR . . . . . . . . . . . . . 44.0 m -108.04 122.97 47.96 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.471 -0.331 . . . . 0.0 110.727 -177.994 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' B' B ' 140' ' ' LEU . . . . . 0.565 HD12 HG22 ' B' ' 131' ' ' VAL . 38.8 tp -112.97 121.56 45.0 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 115.665 -0.698 . . . . 0.0 109.322 -179.294 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' B' B ' 141' ' ' ILE . . . . . 0.506 ' HB ' HG13 ' B' ' 130' ' ' VAL . 19.2 mt -123.91 125.84 71.63 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.268 0 CA-C-O 121.012 0.434 . . . . 0.0 109.937 -176.991 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' B' B ' 142' ' ' ARG . . . . . . . . . . . . . 72.7 mtp180 -108.53 124.01 49.8 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 115.304 -0.862 . . . . 0.0 110.344 179.716 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' B' B ' 143' ' ' THR . . . . . . . . . . . . . 77.2 p . . . . . 0 C--O 1.219 -0.501 0 CA-C-O 118.016 -0.992 . . . . 0.0 110.522 -179.316 . . . . . . . . 0 0 . 1 . 011 nuclear nobuild core ' C' C ' 2' ' ' SER . . . . . . . . . . . . . 5.5 p . . . . . 0 C--O 1.231 0.09 0 CA-C-O 120.799 0.333 . . . . 0.0 110.128 . . . . . . . . . 0 0 . 1 . 011 nuclear nobuild core ' C' C ' 3' ' ' GLU . . . . . . . . . . . . . 94.7 mt-10 -141.28 136.6 31.78 Favored 'General case' 0 C--N 1.327 -0.407 0 CA-C-N 116.129 -0.487 . . . . 0.0 111.066 -178.681 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' C' C ' 4' ' ' LEU . . . . . . . . . . . . . 15.2 tp -123.04 126.38 46.99 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 115.983 -0.553 . . . . 0.0 109.806 175.554 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' C' C ' 5' ' ' LYS . . . . . . . . . . . . . 69.2 mttm -113.49 121.49 44.41 Favored 'General case' 0 C--N 1.331 -0.221 0 CA-C-N 116.371 -0.377 . . . . 0.0 110.669 -179.267 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' C' C ' 6' ' ' LEU . . . . . . . . . . . . . 58.2 mt -115.83 143.57 45.22 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 115.415 -0.812 . . . . 0.0 110.264 -178.726 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' C' C ' 7' ' ' LYS . . . . . . . . . . . . . 82.8 tttt -124.19 135.17 26.09 Favored Pre-proline 0 CA--C 1.534 0.359 0 CA-C-O 118.792 -0.623 . . . . 0.0 109.575 175.098 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' C' C ' 8' ' ' PRO . . . . . . . . . . . . . 88.3 Cg_endo -91.27 137.99 2.18 Favored 'Trans proline' 0 N--CA 1.49 1.317 0 C-N-CA 121.665 1.577 . . . . 0.0 111.901 179.357 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' C' C ' 9' ' ' LEU . . . . . . . . . . . . . 65.1 mt -71.8 -47.44 12.02 Favored Pre-proline 0 CA--C 1.533 0.312 0 CA-C-O 118.725 -0.655 . . . . 0.0 112.071 179.628 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' C' C ' 10' ' ' PRO . . . . . . . . . . . . . 98.7 Cg_endo -79.53 151.95 22.78 Favored 'Trans proline' 0 N--CA 1.495 1.57 0 C-N-CA 121.156 1.237 . . . . 0.0 111.779 175.696 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' C' C ' 11' ' ' LYS . . . . . . . . . . . . . 64.3 mttp -88.32 91.83 8.93 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-O 120.783 0.325 . . . . 0.0 110.69 179.807 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' C' C ' 12' ' ' VAL . . . . . . . . . . . . . 12.6 p -140.47 145.93 25.13 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.325 0 CA-C-N 116.16 -0.473 . . . . 0.0 110.34 178.684 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' C' C ' 13' ' ' GLU . . . . . . . . . . . . . 13.9 pt-20 -86.81 134.07 33.59 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.784 179.828 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' C' C ' 14' ' ' LEU . . . . . . . . . . . . . 50.0 mt -97.65 149.33 35.6 Favored Pre-proline 0 CA--C 1.532 0.28 0 CA-C-O 119.244 -0.407 . . . . 0.0 110.27 179.492 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' C' C ' 15' ' ' PRO . . . . . . . . . . . . . 26.8 Cg_exo -60.7 160.23 25.49 Favored 'Trans proline' 0 N--CA 1.498 1.786 0 C-N-CA 121.321 1.347 . . . . 0.0 111.834 178.584 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' C' C ' 16' ' ' PRO . . . . . . . . . . . . . 33.7 Cg_exo -59.17 -41.99 54.81 Favored 'Trans proline' 0 N--CA 1.497 1.705 0 C-N-CA 121.5 1.467 . . . . 0.0 112.587 -178.16 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' C' C ' 17' ' ' ASP . . . . . . . . . . . . . 8.7 p-10 -85.27 11.07 10.78 Favored 'General case' 0 CA--C 1.537 0.456 0 N-CA-C 113.065 0.765 . . . . 0.0 113.065 -178.816 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' C' C ' 18' ' ' PHE . . . . . . . . . . . . . 51.3 t80 -58.21 -42.96 87.36 Favored 'General case' 0 C--N 1.333 -0.109 0 O-C-N 122.06 -0.4 . . . . 0.0 110.082 -177.54 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' C' C ' 19' ' ' VAL . . . . . . . . . . . . . 48.3 t -57.54 -42.09 80.34 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.319 0 CA-C-N 116.385 -0.37 . . . . 0.0 110.522 -177.919 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' C' C ' 20' ' ' ASP . . . . . . . . . . . . . 83.4 m-20 -59.86 -43.52 94.65 Favored 'General case' 0 C--O 1.234 0.261 0 CA-C-O 120.96 0.409 . . . . 0.0 110.848 -178.493 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' C' C ' 21' ' ' VAL . . . . . . . . . . . . . 49.1 t -64.39 -48.54 84.81 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.251 0 CA-C-N 116.376 -0.374 . . . . 0.0 110.433 -178.097 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' C' C ' 22' ' ' ILE . . . . . . . . . . . . . 51.7 mm -56.68 -43.05 78.31 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.254 0 C-N-CA 121.079 -0.248 . . . . 0.0 110.574 179.175 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' C' C ' 23' ' ' ARG . . . . . . . . . . . . . 47.3 ttp180 -55.06 -46.64 75.38 Favored 'General case' 0 C--N 1.33 -0.255 0 C-N-CA 121.065 -0.254 . . . . 0.0 111.212 -178.495 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' C' C ' 24' ' ' ILE . . . . . . . . . . . . . 72.4 mt -59.57 -42.95 89.8 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.229 0 C-N-CA 120.869 -0.333 . . . . 0.0 110.758 179.571 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' C' C ' 25' ' ' LYS . . . . . . . . . . . . . 45.9 mmtt -62.0 -43.35 99.03 Favored 'General case' 0 C--N 1.328 -0.36 0 N-CA-C 112.037 0.384 . . . . 0.0 112.037 -179.425 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' C' C ' 26' ' ' LEU . . . . . . . . . . . . . 92.8 mt -79.67 -39.28 31.73 Favored 'General case' 0 C--N 1.329 -0.288 0 N-CA-C 113.646 0.98 . . . . 0.0 113.646 -169.899 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' C' C ' 27' ' ' GLN . . . . . . . . . . . . . 9.9 pt20 -46.77 137.51 7.02 Favored 'General case' 0 N--CA 1.469 0.502 0 N-CA-C 112.925 0.713 . . . . 0.0 112.925 -173.627 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' C' C ' 28' ' ' GLY . . . . . . . . . . . . . . . 99.47 -25.53 27.9 Favored Glycine 0 CA--C 1.533 1.179 0 CA-C-N 115.45 -0.796 . . . . 0.0 112.367 -176.934 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' C' C ' 29' ' ' LYS . . . . . . . . . . . . . 68.5 mttm -98.38 155.16 17.36 Favored 'General case' 0 C--O 1.233 0.187 0 CA-C-N 117.256 0.528 . . . . 0.0 111.061 179.537 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' C' C ' 30' ' ' THR . . . . . . . . . . . . . 25.9 m -108.59 139.92 42.69 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.149 176.267 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' C' C ' 31' ' ' VAL . . . . . . . . . . . . . 34.6 m -130.06 153.92 39.63 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.277 0 CA-C-N 116.292 -0.413 . . . . 0.0 110.9 -178.738 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' C' C ' 32' ' ' ARG . . . . . . . . . . . . . 84.3 mtm180 -128.82 147.55 50.81 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-O 121.325 0.583 . . . . 0.0 110.702 179.436 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' C' C ' 33' ' ' THR . . . . . . . . . . . . . 19.0 m -53.58 139.8 30.57 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.133 -0.485 . . . . 0.0 111.329 -178.902 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' C' C ' 34' ' ' GLY . . . . . . . . . . . . . . . 98.45 -17.13 58.92 Favored Glycine 0 CA--C 1.533 1.207 0 CA-C-O 119.706 -0.496 . . . . 0.0 113.266 178.969 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' C' C ' 35' ' ' ASP . . . . . . . . . . . . . 81.9 m-20 -66.75 149.34 50.69 Favored 'General case' 0 N--CA 1.461 0.109 0 CA-C-N 118.017 0.908 . . . . 0.0 111.044 178.978 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' C' C ' 36' ' ' VAL . . . . . . . . . . . . . 43.6 t -118.71 128.27 75.6 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.211 0 CA-C-N 116.154 -0.475 . . . . 0.0 109.725 176.832 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' C' C ' 37' ' ' ILE . . . . . . . . . . . . . 61.6 mt -119.46 137.47 53.27 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.251 0 CA-C-N 116.105 -0.498 . . . . 0.0 109.867 -179.515 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' C' C ' 38' ' ' GLY . . . . . . . . . . . . . . . -115.45 127.9 7.82 Favored Glycine 0 CA--C 1.525 0.668 0 N-CA-C 110.95 -0.86 . . . . 0.0 110.95 178.971 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' C' C ' 39' ' ' ILE . . . . . . . . . . . . . 70.5 mt -126.72 127.78 70.41 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.232 0 N-CA-C 109.905 -0.405 . . . . 0.0 109.905 178.493 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' C' C ' 40' ' ' SER . . . . . . . . . . . . . 60.4 p -91.97 119.63 31.88 Favored 'General case' 0 C--N 1.33 -0.264 0 C-N-CA 120.968 -0.293 . . . . 0.0 110.667 176.463 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' C' C ' 41' ' ' ILE . . . . . . . . . . . . . 73.3 mt -131.45 130.33 62.62 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.215 0 CA-C-O 120.868 0.366 . . . . 0.0 110.367 179.708 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' C' C ' 42' ' ' LEU . . . . . . . . . . . . . 72.8 mt 57.38 33.06 22.76 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 116.105 -0.498 . . . . 0.0 111.895 177.589 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' C' C ' 43' ' ' GLY . . . . . . . . . . . . . . . 72.55 23.06 78.57 Favored Glycine 0 CA--C 1.532 1.138 0 C-N-CA 121.132 -0.556 . . . . 0.0 112.727 177.882 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' C' C ' 44' ' ' LYS . . . . . . . . . . . . . 33.4 ttmt -139.09 129.56 25.73 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 117.315 0.557 . . . . 0.0 109.746 178.379 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' C' C ' 45' ' ' GLU . . . . . . . . . . . . . 45.9 tp10 -84.14 129.66 34.89 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-O 120.836 0.35 . . . . 0.0 111.279 -177.172 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' C' C ' 46' ' ' VAL . . . . . . . . . . . . . 9.1 p -122.75 126.12 73.43 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.246 0 N-CA-C 109.409 -0.589 . . . . 0.0 109.409 174.578 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' C' C ' 47' ' ' LYS . . . . . . . . . . . . . 64.3 mttm -100.03 128.76 46.07 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.03 -0.532 . . . . 0.0 111.339 179.068 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' C' C ' 48' ' ' PHE . . . . . . . . . . . . . 28.4 m-85 -112.51 131.97 55.32 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 116.015 -0.539 . . . . 0.0 109.795 177.549 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' C' C ' 49' ' ' LYS . . . . . . . . . . . . . 46.2 tttp -105.45 132.21 51.91 Favored 'General case' 0 C--N 1.329 -0.315 0 N-CA-C 109.812 -0.44 . . . . 0.0 109.812 177.741 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' C' C ' 50' ' ' VAL . . . . . . . . . . . . . 46.2 t -72.86 106.03 2.74 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.324 0 N-CA-C 109.454 -0.573 . . . . 0.0 109.454 178.454 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' C' C ' 51' ' ' VAL . . . . . . . . . . . . . 49.0 t -68.5 -50.61 54.8 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.279 0 N-CA-C 109.5 -0.556 . . . . 0.0 109.5 -176.357 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' C' C ' 52' ' ' GLN . . . . . . . . . . . . . 21.5 pt20 -162.67 157.81 22.31 Favored 'General case' 0 C--N 1.331 -0.201 0 CA-C-N 115.908 -0.587 . . . . 0.0 111.649 179.239 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' C' C ' 53' ' ' ALA . . . . . . . . . . . . . . . -130.97 132.61 45.16 Favored 'General case' 0 C--N 1.326 -0.422 0 CA-C-N 115.176 -0.92 . . . . 0.0 109.817 178.165 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' C' C ' 54' ' ' TYR . . . . . . . . . . . . . 29.3 t80 -128.98 108.37 18.19 Favored Pre-proline 0 CA--C 1.534 0.358 0 CA-C-O 118.204 -0.903 . . . . 0.0 110.413 -179.008 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' C' C ' 55' ' ' PRO . . . . . . . . . . . . . 73.1 Cg_endo -77.16 170.03 72.63 Favored 'Cis proline' 0 N--CA 1.501 1.916 0 CA-C-N 121.833 1.69 . . . . 0.0 112.451 -5.776 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' C' C ' 56' ' ' SER . . . . . . . . . . . . . 14.5 m -114.23 128.34 25.91 Favored Pre-proline 0 CA--C 1.54 0.568 0 CA-C-O 118.368 -0.825 . . . . 0.0 109.348 175.356 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' C' C ' 57' ' ' PRO . . . . . . . . . . . . . 57.0 Cg_endo -71.97 149.5 92.95 Favored 'Cis proline' 0 N--CA 1.497 1.689 0 CA-C-N 121.98 1.743 . . . . 0.0 111.857 -0.556 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' C' C ' 58' ' ' LEU . . . . . . . . . . . . . 24.9 tp -108.64 137.03 47.26 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.294 -0.412 . . . . 0.0 110.643 -178.622 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' C' C ' 59' ' ' ARG . . . . . . . . . . . . . 57.0 ttm-85 -107.11 127.53 53.57 Favored 'General case' 0 C--N 1.329 -0.321 0 N-CA-C 109.322 -0.621 . . . . 0.0 109.322 175.95 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' C' C ' 60' ' ' VAL . . . . . . . . . . . . . 40.9 t -81.71 120.69 33.75 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.231 0 CA-C-O 121.074 0.464 . . . . 0.0 110.968 -173.733 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' C' C ' 61' ' ' GLU . . . . . . . . . . . . . 80.4 tt0 -131.15 158.21 41.08 Favored 'General case' 0 C--N 1.33 -0.275 0 N-CA-C 108.73 -0.841 . . . . 0.0 108.73 174.729 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' C' C ' 62' ' ' ASP . . . . . . . . . . . . . 52.8 m-20 -49.82 -32.2 13.56 Favored 'General case' 0 C--N 1.329 -0.294 0 N-CA-C 112.352 0.501 . . . . 0.0 112.352 -178.146 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' C' C ' 63' ' ' ARG . . . . . . . . . . . . . 26.7 mmm180 -71.25 -20.79 62.19 Favored 'General case' 0 CA--C 1.536 0.415 0 N-CA-C 112.999 0.741 . . . . 0.0 112.999 -176.357 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' C' C ' 64' ' ' THR . . . . . . . . . . . . . 36.8 m -67.87 141.76 56.31 Favored 'General case' 0 C--N 1.331 -0.239 0 CA-C-O 121.051 0.453 . . . . 0.0 111.222 -175.592 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' C' C ' 65' ' ' LYS . . . . . . . . . . . . . 63.6 mttm -89.65 132.94 34.89 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 115.749 -0.66 . . . . 0.0 109.86 177.35 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' C' C ' 66' ' ' ILE . . . . . . . . . . . . . 63.1 mt -118.59 132.04 69.61 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.22 0 N-CA-C 110.055 -0.35 . . . . 0.0 110.055 -179.276 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' C' C ' 67' ' ' THR . . . . . . . . . . . . . 25.9 m -129.24 139.08 51.97 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-O 121.048 0.451 . . . . 0.0 111.26 -178.348 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' C' C ' 68' ' ' LEU . . . . . . . . . . . . . 39.3 mt . . . . . 0 C--N 1.33 -0.248 0 CA-C-N 115.891 -0.595 . . . . 0.0 110.165 176.066 . . . . . . . . 0 0 . 1 . 011 nuclear nobuild core ' C' C ' 73' ' ' VAL . . . . . . . . . . . . . 32.9 m . . . . . 0 C--O 1.23 0.068 0 CA-C-O 120.888 0.375 . . . . 0.0 110.782 . . . . . . . . . 0 0 . 1 . 011 nuclear nobuild core ' C' C ' 74' ' ' ASP . . . . . . . . . . . . . 10.8 t70 -97.04 122.29 39.87 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.109 -0.496 . . . . 0.0 109.734 179.222 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' C' C ' 75' ' ' VAL . . . . . . . . . . . . . 46.0 t -116.98 125.54 73.93 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.196 0 CA-C-O 120.879 0.371 . . . . 0.0 110.698 -175.27 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' C' C ' 76' ' ' LEU . . . . . . . . . . . . . 19.4 mt -131.51 145.57 51.82 Favored 'General case' 0 C--N 1.333 -0.148 0 CA-C-N 116.012 -0.54 . . . . 0.0 110.488 179.559 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' C' C ' 77' ' ' GLU . . . . . . . . . . . . . 33.1 mp0 -135.48 141.92 45.42 Favored 'General case' 0 C--N 1.331 -0.225 0 CA-C-O 121.136 0.493 . . . . 0.0 111.046 178.345 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' C' C ' 78' ' ' ALA . . . . . 0.697 ' HB2' HD21 ' C' ' 109' ' ' LEU . . . -126.57 135.03 50.73 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 115.677 -0.692 . . . . 0.0 109.86 176.184 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' C' C ' 79' ' ' LYS . . . . . 0.58 ' O ' HD13 ' C' ' 80' ' ' ILE . 76.5 tttt -81.73 111.19 17.76 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.315 -0.402 . . . . 0.0 110.57 -177.57 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' C' C ' 80' ' ' ILE . . . . . 0.58 HD13 ' O ' ' C' ' 79' ' ' LYS . 42.8 mm -139.14 105.92 2.7 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.341 0 N-CA-C 109.15 -0.685 . . . . 0.0 109.15 -177.45 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' C' C ' 81' ' ' LYS . . . . . . . . . . . . . 32.1 ttpt -102.24 132.29 48.27 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-O 120.921 0.391 . . . . 0.0 110.845 -176.213 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' C' C ' 82' ' ' GLY . . . . . . . . . . . . . . . 89.19 42.09 5.67 Favored Glycine 0 CA--C 1.526 0.78 0 N-CA-C 111.563 -0.615 . . . . 0.0 111.563 177.623 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' C' C ' 83' ' ' ILE . . . . . 0.403 HD11 ' HB ' ' C' ' 80' ' ' ILE . 69.1 mt -79.26 141.87 14.78 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.284 0 N-CA-C 109.717 -0.475 . . . . 0.0 109.717 177.562 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' C' C ' 84' ' ' LYS . . . . . . . . . . . . . 38.8 ttpt -101.08 -54.02 2.89 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.309 -0.405 . . . . 0.0 110.464 -178.454 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' C' C ' 85' ' ' ASP . . . . . . . . . . . . . 7.2 t0 -146.46 150.61 35.94 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.097 -0.501 . . . . 0.0 110.781 -176.949 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' C' C ' 86' ' ' VAL . . . . . . . . . . . . . 44.1 t -128.12 131.2 69.58 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.259 0 CA-C-N 116.34 -0.391 . . . . 0.0 110.275 -179.065 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' C' C ' 87' ' ' ILE . . . . . . . . . . . . . 44.9 mm -118.61 126.84 75.5 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.254 0 N-CA-C 109.696 -0.483 . . . . 0.0 109.696 176.827 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' C' C ' 88' ' ' LEU . . . . . . . . . . . . . 13.7 tp -115.61 130.21 56.78 Favored 'General case' 0 C--N 1.331 -0.227 0 CA-C-O 120.964 0.411 . . . . 0.0 111.067 -177.014 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' C' C ' 89' ' ' ASP . . . . . . . . . . . . . 6.1 t0 -126.1 152.57 45.71 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 115.836 -0.62 . . . . 0.0 109.449 176.829 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' C' C ' 90' ' ' GLU . . . . . . . . . . . . . 84.8 tt0 -48.23 -35.72 12.5 Favored 'General case' 0 C--N 1.329 -0.312 0 N-CA-C 112.751 0.648 . . . . 0.0 112.751 -173.219 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' C' C ' 91' ' ' ASN . . . . . . . . . . . . . 85.1 m-20 -131.97 33.59 3.92 Favored 'General case' 0 N--CA 1.465 0.314 0 N-CA-C 111.877 0.325 . . . . 0.0 111.877 -176.804 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' C' C ' 92' ' ' LEU . . . . . . . . . . . . . 8.2 tp -166.07 142.6 5.11 Favored 'General case' 0 C--N 1.331 -0.215 0 C-N-CA 121.014 -0.274 . . . . 0.0 110.566 -179.002 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' C' C ' 93' ' ' ILE . . . . . . . . . . . . . 74.0 mt -127.14 125.17 65.8 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.26 0 N-CA-C 109.493 -0.558 . . . . 0.0 109.493 178.227 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' C' C ' 94' ' ' VAL . . . . . 0.578 HG21 HG11 ' C' ' 125' ' ' VAL . 45.2 t -127.1 129.83 71.11 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.259 0 CA-C-O 120.968 0.414 . . . . 0.0 110.197 179.914 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' C' C ' 95' ' ' VAL . . . . . . . . . . . . . 42.3 t -121.35 134.4 64.84 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.339 0 CA-C-N 115.936 -0.574 . . . . 0.0 109.76 179.324 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' C' C ' 96' ' ' ILE . . . . . . . . . . . . . 64.1 mt -116.15 128.71 73.37 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 N-CA-C 109.371 -0.604 . . . . 0.0 109.371 179.64 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' C' C ' 97' ' ' THR . . . . . . . . . . . . . 73.3 p -101.82 160.56 14.37 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-O 121.185 0.517 . . . . 0.0 111.13 -177.577 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' C' C ' 98' ' ' GLU . . . . . . . . . . . . . 12.5 pt-20 -54.04 -25.94 24.0 Favored 'General case' 0 C--N 1.328 -0.337 0 N-CA-C 112.39 0.515 . . . . 0.0 112.39 -178.108 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' C' C ' 99' ' ' GLU . . . . . . . . . . . . . 95.5 mt-10 -79.87 15.44 1.43 Allowed 'General case' 0 CA--C 1.536 0.404 0 N-CA-C 113.131 0.789 . . . . 0.0 113.131 -176.164 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' C' C ' 100' ' ' ASN . . . . . . . . . . . . . 3.5 m-20 61.82 37.35 15.54 Favored 'General case' 0 CA--C 1.531 0.245 0 CA-C-O 121.047 0.451 . . . . 0.0 110.995 179.499 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' C' C ' 101' ' ' GLU . . . . . . . . . . . . . 84.9 tt0 -114.82 141.27 48.12 Favored 'General case' 0 C--N 1.332 -0.159 0 CA-C-N 116.071 -0.513 . . . . 0.0 109.62 175.98 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' C' C ' 102' ' ' VAL . . . . . . . . . . . . . 43.7 t -116.46 127.01 74.19 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.341 0 CA-C-N 116.298 -0.41 . . . . 0.0 110.047 -178.122 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' C' C ' 103' ' ' LEU . . . . . . . . . . . . . 40.6 mt -114.85 130.14 56.83 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 115.719 -0.673 . . . . 0.0 110.071 176.496 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' C' C ' 104' ' ' ILE . . . . . . . . . . . . . 66.4 mt -114.95 122.22 68.62 Favored 'Isoleucine or valine' 0 C--O 1.234 0.254 0 N-CA-C 110.161 -0.311 . . . . 0.0 110.161 -178.693 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' C' C ' 105' ' ' PHE . . . . . . . . . . . . . 81.2 m-85 -123.24 163.57 20.41 Favored 'General case' 0 C--O 1.231 0.121 0 O-C-N 124.02 0.825 . . . . 0.0 109.591 -179.17 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' C' C ' 106' ' ' ASN . . . . . . . . . . . . . 47.4 p-10 -98.32 -170.61 1.99 Allowed 'General case' 0 C--N 1.33 -0.265 0 N-CA-C 109.828 -0.434 . . . . 0.0 109.828 173.525 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' C' C ' 107' ' ' GLN . . . . . . . . . . . . . 49.0 tt0 -59.44 -30.1 68.25 Favored 'General case' 0 C--N 1.33 -0.273 0 N-CA-C 112.128 0.418 . . . . 0.0 112.128 -179.252 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' C' C ' 108' ' ' ASN . . . . . . . . . . . . . 30.7 t30 -84.75 9.2 14.67 Favored 'General case' 0 CA--C 1.536 0.419 0 N-CA-C 113.181 0.808 . . . . 0.0 113.181 -177.009 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' C' C ' 109' ' ' LEU . . . . . 0.697 HD21 ' HB2' ' C' ' 78' ' ' ALA . 12.4 tp 61.56 37.51 16.24 Favored 'General case' 0 CA--C 1.53 0.188 0 CA-C-O 120.993 0.425 . . . . 0.0 111.249 178.573 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' C' C ' 110' ' ' GLU . . . . . . . . . . . . . 95.3 mt-10 -105.12 149.55 25.78 Favored 'General case' 0 C--N 1.33 -0.254 0 N-CA-C 109.687 -0.486 . . . . 0.0 109.687 175.584 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' C' C ' 111' ' ' GLU . . . . . . . . . . . . . 74.1 tt0 -87.45 121.92 30.52 Favored 'General case' 0 C--N 1.33 -0.272 0 C-N-CA 120.77 -0.372 . . . . 0.0 110.583 -175.31 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' C' C ' 112' ' ' LEU . . . . . . . . . . . . . 17.8 mt -108.01 -45.98 3.86 Favored 'General case' 0 C--N 1.332 -0.176 0 CA-C-N 115.992 -0.549 . . . . 0.0 110.78 -179.856 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' C' C ' 113' ' ' TYR . . . . . . . . . . . . . 46.8 t80 -135.55 141.89 45.27 Favored 'General case' 0 C--N 1.331 -0.23 0 CA-C-N 116.361 -0.381 . . . . 0.0 111.213 -178.179 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' C' C ' 114' ' ' ARG . . . . . . . . . . . . . 38.8 ptt180 -142.48 125.26 15.99 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.254 -0.43 . . . . 0.0 110.475 176.757 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' C' C ' 115' ' ' GLY . . . . . . . . . . . . . . . -150.09 162.25 29.14 Favored Glycine 0 CA--C 1.524 0.628 0 C-N-CA 120.693 -0.765 . . . . 0.0 111.55 -179.92 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' C' C ' 116' ' ' LYS . . . . . . . . . . . . . 39.1 ttpt -125.83 135.52 52.07 Favored 'General case' 0 C--N 1.332 -0.185 0 N-CA-C 109.866 -0.42 . . . . 0.0 109.866 176.994 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' C' C ' 117' ' ' PHE . . . . . . . . . . . . . 64.3 m-85 -130.65 113.81 14.64 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-O 120.856 0.36 . . . . 0.0 110.365 -178.256 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' C' C ' 118' ' ' GLU . . . . . . . . . . . . . 14.3 mm-40 -55.76 -48.19 75.71 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 116.397 -0.365 . . . . 0.0 111.056 -175.916 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' C' C ' 119' ' ' ASN . . . . . . . . . . . . . 68.1 m-80 -97.19 31.11 2.54 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.005 -0.543 . . . . 0.0 112.12 -174.185 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' C' C ' 120' ' ' LEU . . . . . . . . . . . . . 13.8 tp -52.63 119.88 5.04 Favored 'General case' 0 N--CA 1.466 0.325 0 O-C-N 122.238 -0.289 . . . . 0.0 111.029 178.999 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' C' C ' 121' ' ' ASN . . . . . . . . . . . . . 90.9 m-20 -113.93 -44.05 3.2 Favored 'General case' 0 C--N 1.331 -0.226 0 CA-C-N 116.317 -0.401 . . . . 0.0 111.242 -177.959 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' C' C ' 122' ' ' LYS . . . . . . . . . . . . . 38.4 ttpt -143.9 143.44 31.28 Favored 'General case' 0 C--N 1.333 -0.113 0 C-N-CA 120.507 -0.477 . . . . 0.0 111.577 -177.163 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' C' C ' 123' ' ' VAL . . . . . . . . . . . . . 43.9 t -126.41 127.44 70.5 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.285 0 N-CA-C 109.148 -0.686 . . . . 0.0 109.148 173.773 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' C' C ' 124' ' ' LEU . . . . . 0.652 HD13 HD12 ' D' ' 88' ' ' LEU . 8.7 tt -131.39 133.03 44.84 Favored 'General case' 0 N--CA 1.463 0.219 0 CA-C-O 120.961 0.41 . . . . 0.0 111.142 -176.377 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' C' C ' 125' ' ' VAL . . . . . 0.729 HG12 HG23 ' C' ' 130' ' ' VAL . 35.8 m -126.68 144.96 35.11 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.238 0 CA-C-N 115.798 -0.637 . . . . 0.0 110.441 179.607 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' C' C ' 126' ' ' ARG . . . . . . . . . . . . . 34.8 ttm180 -150.0 117.04 5.95 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-O 120.996 0.427 . . . . 0.0 110.412 177.819 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' C' C ' 127' ' ' ASN . . . . . . . . . . . . . 96.2 m-20 53.77 -107.6 0.37 Allowed 'General case' 0 CA--C 1.542 0.651 0 CA-C-N 116.0 -0.546 . . . . 0.0 110.859 -178.268 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' C' C ' 128' ' ' ASP . . . . . . . . . . . . . 8.4 p-10 -114.13 1.9 14.73 Favored 'General case' 0 CA--C 1.537 0.447 0 CA-C-N 119.742 1.156 . . . . 0.0 113.271 -177.994 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' C' C ' 129' ' ' LEU . . . . . . . . . . . . . 12.7 tp -105.15 139.59 39.58 Favored 'General case' 0 C--O 1.232 0.156 0 N-CA-C 109.429 -0.582 . . . . 0.0 109.429 178.789 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' C' C ' 130' ' ' VAL . . . . . 0.729 HG23 HG12 ' C' ' 125' ' ' VAL . 12.2 p -135.81 140.29 44.54 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.21 0 CA-C-O 121.295 0.569 . . . . 0.0 110.869 -177.564 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' C' C ' 131' ' ' VAL . . . . . . . . . . . . . 35.6 m -136.11 146.43 29.26 Favored 'Isoleucine or valine' 0 C--O 1.234 0.251 0 CA-C-N 115.793 -0.64 . . . . 0.0 110.935 178.782 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' C' C ' 132' ' ' ILE . . . . . . . . . . . . . 68.1 mt -122.88 134.0 67.32 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.293 0 CA-C-N 115.596 -0.729 . . . . 0.0 109.521 179.69 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' C' C ' 133' ' ' ILE . . . . . . . . . . . . . 42.7 mm -116.26 120.43 64.89 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.212 0 CA-C-N 116.548 -0.297 . . . . 0.0 110.733 -176.996 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' C' C ' 134' ' ' ASP . . . . . . . . . . . . . 6.1 p-10 -131.83 146.56 52.21 Favored 'General case' 0 C--N 1.331 -0.214 0 CA-C-N 116.21 -0.45 . . . . 0.0 109.806 176.379 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' C' C ' 135' ' ' GLU . . . . . . . . . . . . . 84.2 tt0 -50.0 -26.31 4.17 Favored 'General case' 0 C--N 1.328 -0.359 0 N-CA-C 112.937 0.718 . . . . 0.0 112.937 -170.779 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' C' C ' 136' ' ' GLN . . . . . . . . . . . . . 97.4 mt-30 -92.6 -35.47 13.53 Favored 'General case' 0 C--N 1.331 -0.196 0 N-CA-C 112.461 0.541 . . . . 0.0 112.461 -176.819 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' C' C ' 137' ' ' LYS . . . . . . . . . . . . . 54.4 mtmt -147.14 157.97 43.79 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-O 121.501 0.667 . . . . 0.0 112.048 -169.543 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' C' C ' 138' ' ' LEU . . . . . 0.444 HD23 ' C ' ' C' ' 138' ' ' LEU . 6.9 tt -116.08 126.26 53.5 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 115.203 -0.908 . . . . 0.0 109.317 174.621 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' C' C ' 139' ' ' THR . . . . . . . . . . . . . 33.8 m -111.47 127.98 55.86 Favored 'General case' 0 C--N 1.331 -0.212 0 CA-C-N 116.401 -0.363 . . . . 0.0 110.713 -177.831 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' C' C ' 140' ' ' LEU . . . . . 0.481 ' C ' HD23 ' C' ' 140' ' ' LEU . 9.0 tt -115.39 122.84 47.06 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 115.48 -0.782 . . . . 0.0 109.203 -179.781 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' C' C ' 141' ' ' ILE . . . . . 0.529 ' HB ' HG13 ' C' ' 130' ' ' VAL . 20.2 mt -120.5 117.72 54.24 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.27 0 CA-C-O 120.973 0.416 . . . . 0.0 110.046 -176.309 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' C' C ' 142' ' ' ARG . . . . . . . . . . . . . 62.6 ttp85 . . . . . 0 C--N 1.331 -0.205 0 CA-C-N 115.096 -0.956 . . . . 0.0 110.621 -177.72 . . . . . . . . 0 0 . 1 . 011 nuclear nobuild core ' D' D ' 2' ' ' SER . . . . . . . . . . . . . 5.8 p . . . . . 0 N--CA 1.461 0.087 0 CA-C-O 120.822 0.344 . . . . 0.0 110.354 . . . . . . . . . 0 0 . 1 . 011 nuclear nobuild core ' D' D ' 3' ' ' GLU . . . . . . . . . . . . . 94.2 mt-10 -141.28 137.92 32.82 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-N 116.072 -0.513 . . . . 0.0 111.014 -178.376 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' D' D ' 4' ' ' LEU . . . . . 0.407 HD21 HD21 ' D' ' 6' ' ' LEU . 15.5 tp -122.49 128.69 51.15 Favored 'General case' 0 C--N 1.33 -0.282 0 N-CA-C 109.86 -0.422 . . . . 0.0 109.86 175.695 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' D' D ' 5' ' ' LYS . . . . . . . . . . . . . 55.7 mttp -107.93 119.13 38.6 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.432 -0.349 . . . . 0.0 110.48 179.699 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' D' D ' 6' ' ' LEU . . . . . 0.407 HD21 HD21 ' D' ' 4' ' ' LEU . 71.3 mt -114.8 145.7 41.84 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 115.464 -0.789 . . . . 0.0 110.386 -177.698 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' D' D ' 7' ' ' LYS . . . . . . . . . . . . . 52.3 tttm -135.0 137.66 27.64 Favored Pre-proline 0 CA--C 1.534 0.329 0 CA-C-O 118.966 -0.54 . . . . 0.0 109.818 176.757 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' D' D ' 8' ' ' PRO . . . . . . . . . . . . . 94.0 Cg_endo -91.48 143.92 3.09 Favored 'Trans proline' 0 N--CA 1.49 1.322 0 C-N-CA 121.652 1.568 . . . . 0.0 111.877 178.495 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' D' D ' 9' ' ' LEU . . . . . . . . . . . . . 69.5 mt -80.31 -48.46 1.26 Allowed Pre-proline 0 C--N 1.328 -0.331 0 CA-C-O 118.467 -0.778 . . . . 0.0 112.372 -179.488 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' D' D ' 10' ' ' PRO . . . . . . . . . . . . . 77.7 Cg_endo -77.64 151.73 28.85 Favored 'Trans proline' 0 N--CA 1.496 1.635 0 C-N-CA 121.09 1.193 . . . . 0.0 112.009 177.618 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' D' D ' 11' ' ' LYS . . . . . . . . . . . . . 24.8 mtmt -88.29 92.32 9.12 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.311 -0.404 . . . . 0.0 110.616 179.965 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' D' D ' 12' ' ' VAL . . . . . . . . . . . . . 12.4 p -139.61 148.67 23.02 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.242 0 CA-C-N 116.073 -0.512 . . . . 0.0 110.454 -179.972 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' D' D ' 13' ' ' GLU . . . . . . . . . . . . . 84.6 tt0 -88.38 125.34 34.66 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.251 -0.431 . . . . 0.0 109.962 177.321 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' D' D ' 14' ' ' LEU . . . . . . . . . . . . . 38.2 mt -97.94 150.79 37.12 Favored Pre-proline 0 CA--C 1.531 0.249 0 CA-C-N 116.297 -0.41 . . . . 0.0 110.719 -176.328 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' D' D ' 15' ' ' PRO . . . . . . . . . . . . . 25.3 Cg_exo -62.66 155.61 57.88 Favored 'Trans proline' 0 N--CA 1.497 1.722 0 C-N-CA 121.347 1.365 . . . . 0.0 111.939 176.732 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' D' D ' 16' ' ' PRO . . . . . . . . . . . . . 35.4 Cg_exo -59.8 -30.65 92.47 Favored 'Trans proline' 0 N--CA 1.498 1.736 0 C-N-CA 121.345 1.363 . . . . 0.0 112.57 179.331 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' D' D ' 17' ' ' ASP . . . . . . . . . . . . . 7.9 p-10 -84.09 3.26 35.51 Favored 'General case' 0 C--N 1.327 -0.384 0 N-CA-C 113.329 0.862 . . . . 0.0 113.329 -177.448 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' D' D ' 18' ' ' PHE . . . . . . . . . . . . . 10.8 t80 -57.99 -45.98 85.93 Favored 'General case' 0 C--O 1.227 -0.118 0 O-C-N 121.871 -0.518 . . . . 0.0 110.058 -177.819 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' D' D ' 19' ' ' VAL . . . . . . . . . . . . . 48.6 t -56.23 -42.82 74.71 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.273 0 CA-C-N 116.168 -0.469 . . . . 0.0 110.61 -178.075 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' D' D ' 20' ' ' ASP . . . . . . . . . . . . . 83.3 m-20 -60.05 -44.05 94.94 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-O 120.782 0.325 . . . . 0.0 111.231 -177.338 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' D' D ' 21' ' ' VAL . . . . . . . . . . . . . 46.7 t -64.8 -45.6 94.55 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 C-N-CA 120.72 -0.392 . . . . 0.0 110.528 -177.532 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' D' D ' 22' ' ' ILE . . . . . 0.631 HG22 HD12 ' D' ' 26' ' ' LEU . 51.3 mm -56.63 -45.83 82.62 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.168 0 C-N-CA 120.87 -0.332 . . . . 0.0 110.547 179.386 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' D' D ' 23' ' ' ARG . . . . . . . . . . . . . 54.8 ttp180 -54.2 -49.52 69.18 Favored 'General case' 0 C--N 1.33 -0.258 0 C-N-CA 121.09 -0.244 . . . . 0.0 111.315 -178.165 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' D' D ' 24' ' ' ILE . . . . . . . . . . . . . 71.8 mt -60.32 -43.1 92.92 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.216 0 C-N-CA 121.059 -0.256 . . . . 0.0 111.32 -178.478 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' D' D ' 25' ' ' LYS . . . . . . . . . . . . . 62.4 mtpt -65.13 -40.99 95.22 Favored 'General case' 0 C--N 1.329 -0.323 0 N-CA-C 112.32 0.489 . . . . 0.0 112.32 -177.499 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' D' D ' 26' ' ' LEU . . . . . 0.631 HD12 HG22 ' D' ' 22' ' ' ILE . 45.2 mt -79.15 -41.61 28.09 Favored 'General case' 0 C--N 1.329 -0.324 0 N-CA-C 113.354 0.872 . . . . 0.0 113.354 -171.202 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' D' D ' 27' ' ' GLN . . . . . . . . . . . . . 10.2 pt20 -46.43 137.52 6.47 Favored 'General case' 0 N--CA 1.469 0.512 0 N-CA-C 112.823 0.675 . . . . 0.0 112.823 -174.882 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' D' D ' 28' ' ' GLY . . . . . . . . . . . . . . . 100.17 -27.27 21.12 Favored Glycine 0 CA--C 1.532 1.146 0 CA-C-N 115.591 -0.731 . . . . 0.0 112.249 -177.765 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' D' D ' 29' ' ' LYS . . . . . . . . . . . . . 97.2 mttt -98.21 155.24 17.27 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 117.142 0.471 . . . . 0.0 111.123 179.218 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' D' D ' 30' ' ' THR . . . . . . . . . . . . . 28.2 m -101.0 138.52 37.94 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 115.953 -0.567 . . . . 0.0 110.172 176.044 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' D' D ' 31' ' ' VAL . . . . . . . . . . . . . 34.9 m -131.07 152.57 37.76 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.255 0 CA-C-N 116.32 -0.4 . . . . 0.0 110.759 -179.586 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' D' D ' 32' ' ' ARG . . . . . . . . . . . . . 58.5 ttp180 -129.28 148.98 51.26 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-O 121.202 0.525 . . . . 0.0 110.673 179.676 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' D' D ' 33' ' ' THR . . . . . . . . . . . . . 27.4 m -53.52 138.96 32.65 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 116.276 -0.42 . . . . 0.0 111.24 179.964 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' D' D ' 34' ' ' GLY . . . . . . . . . . . . . . . 100.51 -17.11 57.17 Favored Glycine 0 CA--C 1.531 1.077 0 C-N-CA 121.272 -0.489 . . . . 0.0 113.225 -179.871 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' D' D ' 35' ' ' ASP . . . . . . . . . . . . . 69.3 m-20 -65.67 149.76 49.58 Favored 'General case' 0 C--O 1.232 0.147 0 CA-C-N 118.014 0.907 . . . . 0.0 111.314 179.564 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' D' D ' 36' ' ' VAL . . . . . . . . . . . . . 45.6 t -121.72 129.58 75.36 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.23 0 CA-C-N 115.774 -0.648 . . . . 0.0 109.771 177.511 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' D' D ' 37' ' ' ILE . . . . . . . . . . . . . 69.2 mt -121.41 138.98 49.97 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.282 0 CA-C-N 116.3 -0.409 . . . . 0.0 109.956 -179.504 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' D' D ' 38' ' ' GLY . . . . . . . . . . . . . . . -109.08 128.79 9.18 Favored Glycine 0 CA--C 1.526 0.762 0 N-CA-C 111.073 -0.811 . . . . 0.0 111.073 179.914 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' D' D ' 39' ' ' ILE . . . . . . . . . . . . . 71.7 mt -123.83 136.08 61.39 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.234 0 CA-C-O 120.842 0.353 . . . . 0.0 110.091 179.728 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' D' D ' 40' ' ' SER . . . . . . . . . . . . . 59.9 p -92.88 114.23 26.73 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.245 -0.434 . . . . 0.0 110.641 174.335 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' D' D ' 41' ' ' ILE . . . . . . . . . . . . . 47.0 mm -122.91 112.85 35.65 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.211 0 CA-C-O 120.724 0.297 . . . . 0.0 110.379 179.473 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' D' D ' 42' ' ' LEU . . . . . 0.529 HD23 ' O ' ' D' ' 42' ' ' LEU . 1.3 tt 55.23 45.79 25.05 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-O 121.443 0.639 . . . . 0.0 110.521 178.111 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' D' D ' 43' ' ' GLY . . . . . . . . . . . . . . . 74.99 -9.67 11.15 Favored Glycine 0 CA--C 1.535 1.324 0 C-N-CA 121.342 -0.456 . . . . 0.0 113.712 175.687 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' D' D ' 44' ' ' LYS . . . . . . . . . . . . . 22.0 tptp -100.37 134.19 43.68 Favored 'General case' 0 C--N 1.331 -0.206 0 CA-C-N 117.927 0.863 . . . . 0.0 110.153 -178.998 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' D' D ' 45' ' ' GLU . . . . . . . . . . . . . 84.8 tt0 -83.29 123.03 29.21 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 116.458 -0.337 . . . . 0.0 110.732 -179.869 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' D' D ' 46' ' ' VAL . . . . . . . . . . . . . 7.1 p -123.49 127.64 74.26 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.182 0 N-CA-C 109.715 -0.476 . . . . 0.0 109.715 177.643 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' D' D ' 47' ' ' LYS . . . . . . . . . . . . . 63.7 mttp -100.23 129.98 46.3 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 115.954 -0.566 . . . . 0.0 111.172 178.59 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' D' D ' 48' ' ' PHE . . . . . . . . . . . . . 90.7 m-85 -113.19 131.89 55.7 Favored 'General case' 0 C--N 1.331 -0.213 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.09 177.054 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' D' D ' 49' ' ' LYS . . . . . . . . . . . . . 82.5 tttt -107.92 137.14 46.44 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.489 179.262 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' D' D ' 50' ' ' VAL . . . . . . . . . . . . . 46.4 t -83.04 108.79 16.13 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.312 0 N-CA-C 109.311 -0.625 . . . . 0.0 109.311 176.219 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' D' D ' 51' ' ' VAL . . . . . . . . . . . . . 46.1 t -73.4 -50.76 28.78 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.328 0 CA-C-N 116.142 -0.481 . . . . 0.0 109.907 -174.573 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' D' D ' 52' ' ' GLN . . . . . . . . . . . . . 92.4 mt-30 -152.72 154.22 34.81 Favored 'General case' 0 C--N 1.332 -0.18 0 CA-C-O 121.285 0.564 . . . . 0.0 111.552 -178.167 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' D' D ' 53' ' ' ALA . . . . . . . . . . . . . . . -132.56 132.59 42.74 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 115.212 -0.904 . . . . 0.0 109.788 175.832 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' D' D ' 54' ' ' TYR . . . . . . . . . . . . . 41.7 t80 -129.08 109.23 18.11 Favored Pre-proline 0 CA--C 1.534 0.364 0 CA-C-O 118.251 -0.88 . . . . 0.0 110.355 179.509 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' D' D ' 55' ' ' PRO . . . . . . . . . . . . . 73.2 Cg_endo -77.18 168.91 75.62 Favored 'Cis proline' 0 N--CA 1.5 1.873 0 CA-C-N 121.839 1.692 . . . . 0.0 112.43 -6.826 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' D' D ' 56' ' ' SER . . . . . . . . . . . . . 13.6 m -116.98 129.49 25.28 Favored Pre-proline 0 CA--C 1.538 0.49 0 CA-C-O 118.459 -0.781 . . . . 0.0 109.262 173.911 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' D' D ' 57' ' ' PRO . . . . . . . . . . . . . 56.1 Cg_endo -71.65 149.4 92.36 Favored 'Cis proline' 0 N--CA 1.498 1.768 0 CA-C-N 122.002 1.751 . . . . 0.0 111.691 0.37 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' D' D ' 58' ' ' LEU . . . . . . . . . . . . . 23.7 tp -108.98 137.99 46.03 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.176 -0.466 . . . . 0.0 110.843 -177.723 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' D' D ' 59' ' ' ARG . . . . . . . . . . . . . 31.7 ttp180 -102.23 122.87 45.03 Favored 'General case' 0 C--N 1.329 -0.315 0 N-CA-C 109.158 -0.682 . . . . 0.0 109.158 175.111 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' D' D ' 60' ' ' VAL . . . . . . . . . . . . . 43.3 t -79.84 122.37 34.93 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.262 0 C-N-CA 120.703 -0.399 . . . . 0.0 110.802 -173.36 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' D' D ' 61' ' ' GLU . . . . . . . . . . . . . 84.1 mt-10 -131.1 161.18 32.66 Favored 'General case' 0 C--N 1.332 -0.184 0 CA-C-N 115.91 -0.586 . . . . 0.0 109.562 177.214 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' D' D ' 62' ' ' ASP . . . . . . . . . . . . . 79.0 m-20 -53.3 -33.16 52.15 Favored 'General case' 0 C--N 1.329 -0.291 0 N-CA-C 111.782 0.29 . . . . 0.0 111.782 178.319 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' D' D ' 63' ' ' ARG . . . . . . . . . . . . . 92.8 mtt-85 -72.97 -21.97 60.77 Favored 'General case' 0 CA--C 1.533 0.324 0 N-CA-C 113.004 0.742 . . . . 0.0 113.004 -176.004 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' D' D ' 64' ' ' THR . . . . . . . . . . . . . 30.8 m -65.2 141.72 58.56 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-O 120.974 0.416 . . . . 0.0 111.085 -174.509 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' D' D ' 65' ' ' LYS . . . . . . . . . . . . . 68.9 mttm -87.7 131.31 34.51 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 115.787 -0.642 . . . . 0.0 109.915 178.17 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' D' D ' 66' ' ' ILE . . . . . . . . . . . . . 60.0 mt -116.27 124.93 73.05 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.272 0 N-CA-C 109.552 -0.536 . . . . 0.0 109.552 179.375 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' D' D ' 67' ' ' THR . . . . . . . . . . . . . 22.7 m -121.28 144.0 48.86 Favored 'General case' 0 C--O 1.233 0.218 0 CA-C-O 121.035 0.445 . . . . 0.0 111.242 -175.307 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' D' D ' 68' ' ' LEU . . . . . . . . . . . . . 14.2 tp . . . . . 0 C--N 1.33 -0.245 0 CA-C-N 115.834 -0.621 . . . . 0.0 110.465 179.486 . . . . . . . . 0 0 . 1 . 011 nuclear nobuild core ' D' D ' 73' ' ' VAL . . . . . . . . . . . . . 33.5 m . . . . . 0 C--O 1.233 0.196 0 CA-C-O 120.978 0.418 . . . . 0.0 111.003 . . . . . . . . . 0 0 . 1 . 011 nuclear nobuild core ' D' D ' 74' ' ' ASP . . . . . . . . . . . . . 27.4 t0 -95.56 120.91 36.63 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 115.834 -0.621 . . . . 0.0 109.838 179.872 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' D' D ' 75' ' ' VAL . . . . . . . . . . . . . 42.9 t -112.02 122.76 66.92 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.234 0 CA-C-O 121.245 0.545 . . . . 0.0 110.337 -178.454 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' D' D ' 76' ' ' LEU . . . . . . . . . . . . . 33.7 mt -120.79 142.36 49.66 Favored 'General case' 0 C--N 1.331 -0.225 0 CA-C-N 115.555 -0.748 . . . . 0.0 109.617 177.814 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' D' D ' 77' ' ' GLU . . . . . . . . . . . . . 97.5 mt-10 -135.23 136.98 42.15 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-O 121.091 0.472 . . . . 0.0 111.382 -178.091 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' D' D ' 78' ' ' ALA . . . . . 0.534 ' HB2' HD21 ' D' ' 109' ' ' LEU . . . -124.83 138.37 54.27 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 115.706 -0.679 . . . . 0.0 109.816 176.804 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' D' D ' 79' ' ' LYS . . . . . 0.58 ' O ' HD13 ' D' ' 80' ' ' ILE . 62.0 mttp -81.54 118.07 22.45 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-O 120.871 0.367 . . . . 0.0 110.666 -178.568 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' D' D ' 80' ' ' ILE . . . . . 0.58 HD13 ' O ' ' D' ' 79' ' ' LYS . 42.3 mm -139.07 107.27 3.28 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.306 0 N-CA-C 109.264 -0.643 . . . . 0.0 109.264 -178.408 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' D' D ' 81' ' ' LYS . . . . . . . . . . . . . 38.0 ttpt -102.13 128.12 48.76 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-O 120.817 0.341 . . . . 0.0 110.932 -178.054 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' D' D ' 82' ' ' GLY . . . . . . . . . . . . . . . 89.05 42.17 5.69 Favored Glycine 0 CA--C 1.524 0.615 0 C-N-CA 120.725 -0.75 . . . . 0.0 111.444 174.817 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' D' D ' 83' ' ' ILE . . . . . . . . . . . . . 72.4 mt -68.25 134.88 29.5 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.264 0 N-CA-C 109.838 -0.43 . . . . 0.0 109.838 178.319 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' D' D ' 84' ' ' LYS . . . . . . . . . . . . . 30.8 tttp -94.15 -52.71 4.26 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 115.886 -0.597 . . . . 0.0 110.046 -178.22 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' D' D ' 85' ' ' ASP . . . . . . . . . . . . . 6.4 t70 -156.98 154.84 30.28 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 115.767 -0.651 . . . . 0.0 110.167 179.021 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' D' D ' 86' ' ' VAL . . . . . . . . . . . . . 44.5 t -128.72 133.61 66.05 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.219 0 CA-C-O 121.046 0.451 . . . . 0.0 110.791 179.964 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' D' D ' 87' ' ' ILE . . . . . . . . . . . . . 44.2 mm -114.62 122.39 68.64 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.249 0 CA-C-N 115.619 -0.718 . . . . 0.0 109.216 175.304 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' D' D ' 88' ' ' LEU . . . . . 0.652 HD12 HD13 ' C' ' 124' ' ' LEU . 34.8 mt -110.92 134.07 52.86 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-O 121.085 0.469 . . . . 0.0 111.34 -176.013 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' D' D ' 89' ' ' ASP . . . . . . . . . . . . . 9.8 t70 -131.92 154.94 48.74 Favored 'General case' 0 C--N 1.331 -0.211 0 CA-C-N 115.793 -0.639 . . . . 0.0 109.508 175.686 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' D' D ' 90' ' ' GLU . . . . . . . . . . . . . 84.7 tt0 -48.33 -38.13 18.31 Favored 'General case' 0 C--N 1.329 -0.284 0 N-CA-C 112.802 0.668 . . . . 0.0 112.802 -171.902 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' D' D ' 91' ' ' ASN . . . . . . . . . . . . . 35.0 m120 -132.0 36.74 3.64 Favored 'General case' 0 N--CA 1.466 0.328 0 N-CA-C 111.782 0.29 . . . . 0.0 111.782 -177.167 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' D' D ' 92' ' ' LEU . . . . . . . . . . . . . 12.9 tp -166.0 145.31 6.11 Favored 'General case' 0 C--N 1.332 -0.195 0 C-N-CA 120.827 -0.349 . . . . 0.0 110.91 -179.393 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' D' D ' 93' ' ' ILE . . . . . . . . . . . . . 68.1 mt -130.26 120.48 49.08 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.189 0 N-CA-C 109.579 -0.526 . . . . 0.0 109.579 -179.684 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' D' D ' 94' ' ' VAL . . . . . . . . . . . . . 46.9 t -121.66 126.13 74.31 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.253 0 N-CA-C 109.723 -0.473 . . . . 0.0 109.723 179.038 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' D' D ' 95' ' ' VAL . . . . . . . . . . . . . 44.1 t -121.16 134.79 63.4 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.236 0 CA-C-N 116.354 -0.385 . . . . 0.0 110.125 -178.902 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' D' D ' 96' ' ' ILE . . . . . . . . . . . . . 63.8 mt -113.68 128.63 70.47 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.316 0 N-CA-C 109.257 -0.646 . . . . 0.0 109.257 178.841 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' D' D ' 97' ' ' THR . . . . . . . . . . . . . 65.8 p -95.35 159.17 15.13 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-O 120.865 0.364 . . . . 0.0 110.443 179.746 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' D' D ' 98' ' ' GLU . . . . . . . . . . . . . 97.4 mt-10 -53.98 -27.5 31.91 Favored 'General case' 0 C--N 1.328 -0.36 0 N-CA-C 112.215 0.45 . . . . 0.0 112.215 -179.372 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' D' D ' 99' ' ' GLU . . . . . . . . . . . . . 45.8 mp0 -76.59 7.92 4.07 Favored 'General case' 0 CA--C 1.536 0.41 0 N-CA-C 113.502 0.927 . . . . 0.0 113.502 -176.733 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' D' D ' 100' ' ' ASN . . . . . . . . . . . . . 4.1 m-20 65.7 35.95 6.62 Favored 'General case' 0 N--CA 1.464 0.238 0 CA-C-N 118.133 0.424 . . . . 0.0 111.335 -178.064 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' D' D ' 101' ' ' GLU . . . . . . . . . . . . . 85.2 tt0 -109.93 142.68 40.94 Favored 'General case' 0 C--N 1.332 -0.179 0 N-CA-C 109.361 -0.607 . . . . 0.0 109.361 172.187 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' D' D ' 102' ' ' VAL . . . . . . . . . . . . . 44.5 t -115.02 126.86 72.72 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.312 0 CA-C-N 116.39 -0.368 . . . . 0.0 110.229 -175.84 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' D' D ' 103' ' ' LEU . . . . . . . . . . . . . 39.3 mt -116.62 129.91 56.43 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 115.678 -0.692 . . . . 0.0 109.897 175.629 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' D' D ' 104' ' ' ILE . . . . . . . . . . . . . 66.6 mt -117.7 124.41 73.02 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.259 0 N-CA-C 110.079 -0.341 . . . . 0.0 110.079 -179.996 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' D' D ' 105' ' ' PHE . . . . . . . . . . . . . 52.9 m-85 -123.72 163.54 20.91 Favored 'General case' 0 C--N 1.333 -0.142 0 O-C-N 123.963 0.79 . . . . 0.0 109.72 -179.376 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' D' D ' 106' ' ' ASN . . . . . . . . . . . . . 45.1 p-10 -97.86 -170.41 1.98 Allowed 'General case' 0 C--N 1.33 -0.281 0 N-CA-C 109.859 -0.422 . . . . 0.0 109.859 175.073 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' D' D ' 107' ' ' GLN . . . . . . . . . . . . . 62.4 tt0 -58.37 -30.04 66.46 Favored 'General case' 0 C--N 1.329 -0.297 0 N-CA-C 111.771 0.286 . . . . 0.0 111.771 179.097 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' D' D ' 108' ' ' ASN . . . . . . . . . . . . . 18.0 t30 -83.8 6.86 19.78 Favored 'General case' 0 CA--C 1.537 0.442 0 N-CA-C 113.389 0.885 . . . . 0.0 113.389 -176.53 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' D' D ' 109' ' ' LEU . . . . . 0.534 HD21 ' HB2' ' D' ' 78' ' ' ALA . 11.0 tp 62.37 37.54 13.68 Favored 'General case' 0 C--O 1.232 0.152 0 CA-C-O 120.957 0.408 . . . . 0.0 111.29 177.972 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' D' D ' 110' ' ' GLU . . . . . . . . . . . . . 95.5 mt-10 -106.44 153.99 21.47 Favored 'General case' 0 C--N 1.331 -0.198 0 CA-C-N 116.518 -0.31 . . . . 0.0 110.198 176.487 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' D' D ' 111' ' ' GLU . . . . . . . . . . . . . 85.0 tt0 -82.31 121.89 27.26 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.366 -0.379 . . . . 0.0 110.761 -177.721 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' D' D ' 112' ' ' LEU . . . . . . . . . . . . . 16.1 mt -110.44 -46.13 3.45 Favored 'General case' 0 C--N 1.331 -0.214 0 CA-C-N 116.198 -0.456 . . . . 0.0 110.723 179.367 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' D' D ' 113' ' ' TYR . . . . . . . . . . . . . 49.2 t80 -136.4 138.25 41.36 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-N 116.361 -0.381 . . . . 0.0 111.106 -179.104 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' D' D ' 114' ' ' ARG . . . . . . . . . . . . . 60.2 ttp180 -137.25 121.72 18.33 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 115.995 -0.548 . . . . 0.0 110.205 176.438 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' D' D ' 115' ' ' GLY . . . . . . . . . . . . . . . -150.05 162.2 29.12 Favored Glycine 0 CA--C 1.523 0.548 0 N-CA-C 110.481 -1.048 . . . . 0.0 110.481 178.903 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' D' D ' 116' ' ' LYS . . . . . . . . . . . . . 54.6 tttm -137.61 133.81 34.81 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.917 0.359 . . . . 0.0 110.219 -179.824 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' D' D ' 117' ' ' PHE . . . . . . . . . . . . . 38.5 m-85 -129.27 115.43 17.6 Favored 'General case' 0 C--N 1.331 -0.2 0 CA-C-O 120.901 0.381 . . . . 0.0 110.393 -175.689 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' D' D ' 118' ' ' GLU . . . . . . . . . . . . . 46.0 tp10 -52.86 -49.86 64.94 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.462 -0.336 . . . . 0.0 111.492 -176.792 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' D' D ' 119' ' ' ASN . . . . . . . . . . . . . 31.3 m120 -94.75 31.07 1.89 Allowed 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.257 -0.429 . . . . 0.0 112.138 -174.099 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' D' D ' 120' ' ' LEU . . . . . . . . . . . . . 17.9 tp -54.87 121.67 9.15 Favored 'General case' 0 C--N 1.332 -0.166 0 CA-C-O 120.698 0.285 . . . . 0.0 110.809 179.078 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' D' D ' 121' ' ' ASN . . . . . . . . . . . . . 15.0 m120 -114.03 -44.07 3.19 Favored 'General case' 0 C--N 1.331 -0.217 0 CA-C-N 116.356 -0.384 . . . . 0.0 110.909 -178.3 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' D' D ' 122' ' ' LYS . . . . . . . . . . . . . 59.9 mtpt -142.91 148.77 37.49 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-O 121.066 0.46 . . . . 0.0 111.74 -176.98 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' D' D ' 123' ' ' VAL . . . . . . . . . . . . . 44.5 t -131.33 128.2 61.11 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.246 0 CA-C-N 115.857 -0.611 . . . . 0.0 109.428 173.765 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' D' D ' 124' ' ' LEU . . . . . . . . . . . . . 60.8 mt -121.52 134.89 55.05 Favored 'General case' 0 C--N 1.331 -0.203 0 CA-C-N 116.357 -0.383 . . . . 0.0 110.558 -178.417 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' D' D ' 125' ' ' VAL . . . . . . . . . . . . . 40.8 t -130.19 131.8 65.54 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.266 0 CA-C-N 116.315 -0.402 . . . . 0.0 110.129 -179.785 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' D' D ' 126' ' ' ARG . . . . . . . . . . . . . 96.2 mtt-85 -140.08 117.69 11.55 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.333 -0.394 . . . . 0.0 110.627 178.487 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' D' D ' 127' ' ' ASN . . . . . . . . . . . . . 82.8 m-20 51.27 -104.96 0.18 Allowed 'General case' 0 CA--C 1.544 0.746 0 CA-C-O 119.032 -0.509 . . . . 0.0 111.408 178.718 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' D' D ' 128' ' ' ASP . . . . . . . . . . . . . 22.8 p-10 -114.03 1.1 14.54 Favored 'General case' 0 N--CA 1.468 0.473 0 CA-C-N 119.518 1.054 . . . . 0.0 113.489 -177.467 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' D' D ' 129' ' ' LEU . . . . . . . . . . . . . 44.7 mt -105.01 141.03 37.32 Favored 'General case' 0 C--O 1.231 0.129 0 CA-C-N 118.105 0.411 . . . . 0.0 110.078 179.245 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' D' D ' 130' ' ' VAL . . . . . . . . . . . . . 44.3 t -126.15 137.63 57.14 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.247 0 CA-C-N 116.388 -0.369 . . . . 0.0 110.153 -178.203 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' D' D ' 131' ' ' VAL . . . . . 0.463 HG21 ' CD1' ' E' ' 88' ' ' LEU . 44.2 t -134.13 134.17 55.48 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.324 0 CA-C-O 121.005 0.431 . . . . 0.0 110.011 177.629 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' D' D ' 132' ' ' ILE . . . . . . . . . . . . . 68.0 mt -117.28 133.61 63.48 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.297 0 CA-C-N 115.919 -0.582 . . . . 0.0 109.49 179.927 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' D' D ' 133' ' ' ILE . . . . . . . . . . . . . 37.1 mm -117.05 120.89 66.43 Favored 'Isoleucine or valine' 0 C--O 1.233 0.206 0 CA-C-O 120.682 0.277 . . . . 0.0 111.093 -175.218 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' D' D ' 134' ' ' ASP . . . . . . . . . . . . . 8.1 p-10 -132.91 147.06 52.29 Favored 'General case' 0 C--N 1.331 -0.234 0 N-CA-C 109.276 -0.638 . . . . 0.0 109.276 174.403 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' D' D ' 135' ' ' GLU . . . . . . . . . . . . . 84.4 tt0 -49.91 -26.42 4.11 Favored 'General case' 0 C--N 1.329 -0.316 0 N-CA-C 112.9 0.704 . . . . 0.0 112.9 -172.222 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' D' D ' 136' ' ' GLN . . . . . . . . . . . . . 31.4 tt0 -83.61 -34.29 25.15 Favored 'General case' 0 C--N 1.331 -0.224 0 N-CA-C 112.399 0.518 . . . . 0.0 112.399 -175.559 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' D' D ' 137' ' ' LYS . . . . . . . . . . . . . 20.5 pttp -168.35 172.37 8.47 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-O 121.544 0.688 . . . . 0.0 112.221 -172.076 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' D' D ' 138' ' ' LEU . . . . . 0.403 ' C ' HD23 ' D' ' 138' ' ' LEU . 7.7 tt -120.03 131.16 55.03 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 115.093 -0.958 . . . . 0.0 110.258 -178.46 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' D' D ' 139' ' ' THR . . . . . . . . . . . . . 33.8 m -109.04 130.08 55.47 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 116.133 -0.485 . . . . 0.0 110.675 -179.497 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' D' D ' 140' ' ' LEU . . . . . 0.428 HD12 HG22 ' D' ' 131' ' ' VAL . 27.1 tp -114.9 121.15 42.32 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 115.765 -0.652 . . . . 0.0 109.315 -179.201 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' D' D ' 141' ' ' ILE . . . . . . . . . . . . . 19.5 mt -119.85 121.96 67.41 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.222 0 N-CA-C 109.858 -0.423 . . . . 0.0 109.858 -175.158 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' D' D ' 142' ' ' ARG . . . . . . . . . . . . . 81.5 mtm180 -116.61 131.59 56.91 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 115.496 -0.775 . . . . 0.0 110.299 -176.823 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' D' D ' 143' ' ' THR . . . . . . . . . . . . . 59.5 p . . . . . 0 C--O 1.221 -0.421 0 CA-C-O 118.044 -0.979 . . . . 0.0 110.62 -179.819 . . . . . . . . 0 0 . 1 . 011 nuclear nobuild core ' E' E ' 2' ' ' SER . . . . . . . . . . . . . 2.1 p . . . . . 0 C--O 1.232 0.142 0 N-CA-C 109.944 -0.391 . . . . 0.0 109.944 . . . . . . . . . 0 0 . 1 . 011 nuclear nobuild core ' E' E ' 3' ' ' GLU . . . . . . . . . . . . . 80.4 tt0 -143.48 142.3 31.11 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 116.149 -0.478 . . . . 0.0 111.246 -175.384 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' E' E ' 4' ' ' LEU . . . . . . . . . . . . . 16.8 tp -122.26 132.24 54.33 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-N 116.079 -0.509 . . . . 0.0 110.163 176.172 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' E' E ' 5' ' ' LYS . . . . . . . . . . . . . 52.0 mttp -107.25 119.61 39.85 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.469 -0.332 . . . . 0.0 110.51 178.597 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' E' E ' 6' ' ' LEU . . . . . . . . . . . . . 37.6 mt -114.19 147.33 39.09 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 115.354 -0.839 . . . . 0.0 110.669 -178.571 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' E' E ' 7' ' ' LYS . . . . . . . . . . . . . 47.6 tttp -138.47 141.3 30.85 Favored Pre-proline 0 CA--C 1.534 0.343 0 CA-C-O 119.128 -0.463 . . . . 0.0 110.075 174.811 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' E' E ' 8' ' ' PRO . . . . . . . . . . . . . 73.7 Cg_endo -91.51 141.36 2.7 Favored 'Trans proline' 0 N--CA 1.49 1.298 0 C-N-CA 121.664 1.576 . . . . 0.0 111.561 176.047 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' E' E ' 9' ' ' LEU . . . . . . . . . . . . . 67.7 mt -77.2 -47.68 2.59 Favored Pre-proline 0 CA--C 1.533 0.322 0 CA-C-O 118.645 -0.693 . . . . 0.0 112.428 -179.288 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' E' E ' 10' ' ' PRO . . . . . . . . . . . . . 90.6 Cg_endo -79.98 155.36 23.09 Favored 'Trans proline' 0 N--CA 1.496 1.642 0 C-N-CA 121.282 1.321 . . . . 0.0 111.892 176.733 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' E' E ' 11' ' ' LYS . . . . . . . . . . . . . 28.2 ttpt -88.29 92.33 9.12 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-O 120.833 0.349 . . . . 0.0 110.532 178.876 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' E' E ' 12' ' ' VAL . . . . . . . . . . . . . 12.5 p -141.39 143.88 27.02 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.283 0 CA-C-N 116.241 -0.436 . . . . 0.0 110.343 178.68 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' E' E ' 13' ' ' GLU . . . . . . . . . . . . . 15.2 pt-20 -87.13 131.13 34.25 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.362 -0.381 . . . . 0.0 110.704 179.345 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' E' E ' 14' ' ' LEU . . . . . . . . . . . . . 17.5 mt -98.41 155.08 37.25 Favored Pre-proline 0 C--N 1.33 -0.266 0 CA-C-N 116.246 -0.433 . . . . 0.0 110.686 -179.967 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' E' E ' 15' ' ' PRO . . . . . . . . . . . . . 26.5 Cg_exo -61.57 160.07 29.62 Favored 'Trans proline' 0 N--CA 1.496 1.647 0 C-N-CA 121.363 1.375 . . . . 0.0 111.667 176.233 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' E' E ' 16' ' ' PRO . . . . . . . . . . . . . 34.7 Cg_exo -58.87 -40.76 68.97 Favored 'Trans proline' 0 N--CA 1.496 1.667 0 C-N-CA 121.4 1.4 . . . . 0.0 112.963 -177.304 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' E' E ' 17' ' ' ASP . . . . . . . . . . . . . 23.5 p-10 -89.01 11.33 18.58 Favored 'General case' 0 C--N 1.326 -0.417 0 N-CA-C 113.156 0.799 . . . . 0.0 113.156 -177.175 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' E' E ' 18' ' ' PHE . . . . . . . . . . . . . 47.1 t80 -58.04 -43.75 87.0 Favored 'General case' 0 C--N 1.334 -0.1 0 O-C-N 121.944 -0.473 . . . . 0.0 109.972 -179.619 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' E' E ' 19' ' ' VAL . . . . . . . . . . . . . 47.8 t -57.54 -39.3 68.51 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.309 0 CA-C-N 116.028 -0.533 . . . . 0.0 110.406 179.206 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' E' E ' 20' ' ' ASP . . . . . . . . . . . . . 28.3 t0 -58.94 -43.61 91.26 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-O 120.691 0.281 . . . . 0.0 110.579 -178.507 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' E' E ' 21' ' ' VAL . . . . . . . . . . . . . 52.4 t -64.22 -45.14 97.13 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.326 0 C-N-CA 120.689 -0.404 . . . . 0.0 110.354 -178.642 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' E' E ' 22' ' ' ILE . . . . . 0.687 HG22 HD12 ' E' ' 26' ' ' LEU . 49.3 mm -58.93 -41.59 83.48 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.327 0 C-N-CA 120.969 -0.292 . . . . 0.0 110.908 -179.929 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' E' E ' 23' ' ' ARG . . . . . . . . . . . . . 42.6 ttp180 -57.07 -47.02 82.01 Favored 'General case' 0 C--N 1.331 -0.209 0 C-N-CA 120.7 -0.4 . . . . 0.0 110.522 178.899 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' E' E ' 24' ' ' ILE . . . . . . . . . . . . . 79.6 mt -61.63 -44.95 99.5 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.302 0 CA-C-N 116.153 -0.476 . . . . 0.0 111.88 -178.559 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' E' E ' 25' ' ' LYS . . . . . . . . . . . . . 13.6 pttp -70.1 -36.21 74.71 Favored 'General case' 0 CA--C 1.533 0.307 0 C-N-CA 120.487 -0.485 . . . . 0.0 111.61 -173.729 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' E' E ' 26' ' ' LEU . . . . . 0.687 HD12 HG22 ' E' ' 22' ' ' ILE . 20.7 mt -79.05 -40.52 31.11 Favored 'General case' 0 C--N 1.33 -0.254 0 N-CA-C 112.86 0.689 . . . . 0.0 112.86 -174.482 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' E' E ' 27' ' ' GLN . . . . . . . . . . . . . 8.4 pt20 -47.32 139.47 6.36 Favored 'General case' 0 N--CA 1.467 0.4 0 N-CA-C 112.795 0.665 . . . . 0.0 112.795 -174.644 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' E' E ' 28' ' ' GLY . . . . . . . . . . . . . . . 98.77 -26.63 23.29 Favored Glycine 0 CA--C 1.534 1.239 0 CA-C-N 115.582 -0.736 . . . . 0.0 112.184 -176.021 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' E' E ' 29' ' ' LYS . . . . . . . . . . . . . 98.8 mttt -98.07 155.2 17.24 Favored 'General case' 0 C--O 1.233 0.202 0 CA-C-N 117.116 0.458 . . . . 0.0 111.154 179.21 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' E' E ' 30' ' ' THR . . . . . . . . . . . . . 24.6 m -104.82 137.11 43.1 Favored 'General case' 0 C--N 1.332 -0.186 0 CA-C-N 115.851 -0.613 . . . . 0.0 109.79 174.643 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' E' E ' 31' ' ' VAL . . . . . . . . . . . . . 34.9 m -127.94 159.37 39.01 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.19 0 CA-C-N 116.416 -0.356 . . . . 0.0 110.747 -178.185 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' E' E ' 32' ' ' ARG . . . . . . . . . . . . . 73.9 mtt85 -133.79 149.42 51.42 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-O 121.394 0.616 . . . . 0.0 110.773 179.241 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' E' E ' 33' ' ' THR . . . . . . . . . . . . . 18.4 m -53.54 140.09 29.47 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.143 -0.48 . . . . 0.0 111.18 -179.327 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' E' E ' 34' ' ' GLY . . . . . . . . . . . . . . . 100.69 -17.23 56.82 Favored Glycine 0 CA--C 1.533 1.164 0 CA-C-O 119.622 -0.544 . . . . 0.0 113.151 179.517 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' E' E ' 35' ' ' ASP . . . . . . . . . . . . . 77.1 m-20 -65.78 147.51 53.27 Favored 'General case' 0 C--N 1.333 -0.121 0 CA-C-N 118.058 0.929 . . . . 0.0 111.067 178.764 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' E' E ' 36' ' ' VAL . . . . . . . . . . . . . 45.3 t -125.02 131.71 72.21 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.245 0 CA-C-N 115.843 -0.617 . . . . 0.0 109.874 178.455 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' E' E ' 37' ' ' ILE . . . . . . . . . . . . . 68.1 mt -122.46 139.18 50.17 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.26 0 CA-C-N 116.331 -0.395 . . . . 0.0 109.948 -179.79 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' E' E ' 38' ' ' GLY . . . . . . . . . . . . . . . -111.79 128.63 8.7 Favored Glycine 0 CA--C 1.525 0.714 0 N-CA-C 111.243 -0.743 . . . . 0.0 111.243 179.928 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' E' E ' 39' ' ' ILE . . . . . . . . . . . . . 73.1 mt -127.74 129.94 70.14 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.229 0 N-CA-C 109.984 -0.376 . . . . 0.0 109.984 178.512 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' E' E ' 40' ' ' SER . . . . . . . . . . . . . 43.4 t -92.25 113.91 26.31 Favored 'General case' 0 C--N 1.329 -0.303 0 C-N-CA 120.997 -0.281 . . . . 0.0 110.92 177.501 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' E' E ' 41' ' ' ILE . . . . . . . . . . . . . 45.2 mm -123.06 124.45 70.24 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.207 0 N-CA-C 109.864 -0.421 . . . . 0.0 109.864 179.853 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' E' E ' 42' ' ' LEU . . . . . . . . . . . . . 55.6 mt 57.48 34.47 24.66 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.35 -0.387 . . . . 0.0 111.681 178.755 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' E' E ' 43' ' ' GLY . . . . . . . . . . . . . . . 77.6 -10.1 25.67 Favored Glycine 0 CA--C 1.535 1.314 0 C-N-CA 121.297 -0.478 . . . . 0.0 113.396 177.601 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' E' E ' 44' ' ' LYS . . . . . . . . . . . . . 60.2 tttm -101.65 130.29 47.97 Favored 'General case' 0 C--N 1.332 -0.172 0 CA-C-N 117.976 0.888 . . . . 0.0 109.814 177.396 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' E' E ' 45' ' ' GLU . . . . . . . . . . . . . 39.6 tp10 -83.8 128.72 34.74 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.389 -0.369 . . . . 0.0 110.813 -178.57 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' E' E ' 46' ' ' VAL . . . . . . . . . . . . . 7.3 p -120.64 132.24 70.72 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.277 0 N-CA-C 109.659 -0.497 . . . . 0.0 109.659 177.509 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' E' E ' 47' ' ' LYS . . . . . . . . . . . . . 62.5 mttp -100.72 127.95 46.95 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 115.929 -0.578 . . . . 0.0 111.088 177.245 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' E' E ' 48' ' ' PHE . . . . . . . . . . . . . 92.4 m-85 -109.61 131.73 54.79 Favored 'General case' 0 C--N 1.329 -0.298 0 N-CA-C 109.57 -0.53 . . . . 0.0 109.57 175.304 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' E' E ' 49' ' ' LYS . . . . . . . . . . . . . 47.5 tttp -111.57 139.12 47.28 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.661 -0.245 . . . . 0.0 110.656 -179.953 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' E' E ' 50' ' ' VAL . . . . . . . . . . . . . 45.1 t -83.49 108.42 16.03 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.307 0 N-CA-C 109.34 -0.615 . . . . 0.0 109.34 175.731 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' E' E ' 51' ' ' VAL . . . . . . . . . . . . . 46.7 t -74.2 -50.84 25.83 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.305 0 CA-C-N 116.117 -0.492 . . . . 0.0 109.955 -174.461 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' E' E ' 52' ' ' GLN . . . . . . . . . . . . . 92.2 mt-30 -152.69 152.7 32.03 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-O 121.18 0.514 . . . . 0.0 111.766 -178.54 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' E' E ' 53' ' ' ALA . . . . . . . . . . . . . . . -130.69 131.89 45.08 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 115.213 -0.903 . . . . 0.0 109.762 175.644 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' E' E ' 54' ' ' TYR . . . . . . . . . . . . . 39.5 t80 -129.07 108.96 18.09 Favored Pre-proline 0 CA--C 1.535 0.398 0 CA-C-O 118.306 -0.854 . . . . 0.0 110.277 179.348 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' E' E ' 55' ' ' PRO . . . . . . . . . . . . . 73.7 Cg_endo -77.27 169.28 74.53 Favored 'Cis proline' 0 N--CA 1.499 1.825 0 CA-C-N 121.829 1.689 . . . . 0.0 112.384 -4.473 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' E' E ' 56' ' ' SER . . . . . . . . . . . . . 14.5 m -113.88 122.62 34.44 Favored Pre-proline 0 CA--C 1.539 0.535 0 CA-C-O 118.309 -0.853 . . . . 0.0 109.372 175.275 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' E' E ' 57' ' ' PRO . . . . . . . . . . . . . 42.0 Cg_endo -67.72 167.96 59.48 Favored 'Cis proline' 0 N--CA 1.498 1.787 0 CA-C-N 122.104 1.787 . . . . 0.0 112.076 2.004 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' E' E ' 58' ' ' LEU . . . . . . . . . . . . . 25.6 tp -130.05 137.96 50.5 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-N 115.915 -0.584 . . . . 0.0 110.317 179.875 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' E' E ' 59' ' ' ARG . . . . . . . . . . . . . 66.6 ttt180 -102.36 134.34 45.82 Favored 'General case' 0 C--N 1.329 -0.298 0 N-CA-C 109.671 -0.492 . . . . 0.0 109.671 176.267 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' E' E ' 60' ' ' VAL . . . . . . . . . . . . . 41.1 t -90.34 122.53 41.81 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.192 0 C-N-CA 120.586 -0.446 . . . . 0.0 110.614 -177.851 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' E' E ' 61' ' ' GLU . . . . . . . . . . . . . 77.5 tt0 -131.06 158.14 41.17 Favored 'General case' 0 C--N 1.33 -0.269 0 N-CA-C 109.069 -0.715 . . . . 0.0 109.069 176.696 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' E' E ' 62' ' ' ASP . . . . . . . . . . . . . 64.2 m-20 -52.98 -34.3 55.46 Favored 'General case' 0 C--N 1.328 -0.355 0 N-CA-C 111.686 0.254 . . . . 0.0 111.686 -179.03 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' E' E ' 63' ' ' ARG . . . . . . . . . . . . . 22.6 mmt85 -78.67 -13.02 60.03 Favored 'General case' 0 CA--C 1.535 0.37 0 N-CA-C 113.384 0.883 . . . . 0.0 113.384 -178.549 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' E' E ' 64' ' ' THR . . . . . . . . . . . . . 18.2 m -64.58 146.71 54.23 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-O 120.977 0.417 . . . . 0.0 111.022 -175.654 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' E' E ' 65' ' ' LYS . . . . . . . . . . . . . 22.6 mtpp -86.32 127.2 34.76 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 115.736 -0.665 . . . . 0.0 110.32 -179.883 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' E' E ' 66' ' ' ILE . . . . . . . . . . . . . 60.4 mt -118.2 128.09 75.28 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.307 0 N-CA-C 109.774 -0.454 . . . . 0.0 109.774 178.458 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' E' E ' 67' ' ' THR . . . . . . . . . . . . . 30.7 m -125.88 144.16 50.78 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-O 121.052 0.453 . . . . 0.0 111.168 -176.989 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' E' E ' 68' ' ' LEU . . . . . . . . . . . . . 13.4 tp . . . . . 0 C--N 1.33 -0.255 0 CA-C-N 115.754 -0.657 . . . . 0.0 110.192 179.098 . . . . . . . . 0 0 . 1 . 011 nuclear nobuild core ' E' E ' 73' ' ' VAL . . . . . . . . . . . . . 35.3 m . . . . . 0 CA--C 1.527 0.086 0 N-CA-C 110.315 -0.254 . . . . 0.0 110.315 . . . . . . . . . 0 0 . 1 . 011 nuclear nobuild core ' E' E ' 74' ' ' ASP . . . . . . . . . . . . . 22.0 t0 -104.04 125.04 50.09 Favored 'General case' 0 C--N 1.332 -0.191 0 C-N-CA 121.02 -0.272 . . . . 0.0 110.27 -178.885 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' E' E ' 75' ' ' VAL . . . . . . . . . . . . . 46.3 t -121.48 124.12 71.09 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.258 0 CA-C-O 121.049 0.452 . . . . 0.0 110.691 -178.86 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' E' E ' 76' ' ' LEU . . . . . 0.438 ' N ' HD12 ' E' ' 76' ' ' LEU . 6.4 mp -121.39 149.21 43.31 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-N 115.764 -0.653 . . . . 0.0 109.787 176.027 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' E' E ' 77' ' ' GLU . . . . . . . . . . . . . 97.1 mt-10 -138.38 134.45 34.18 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-O 121.028 0.442 . . . . 0.0 111.214 -179.604 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' E' E ' 78' ' ' ALA . . . . . 0.656 ' HB2' HD21 ' E' ' 109' ' ' LEU . . . -121.33 136.18 55.0 Favored 'General case' 0 C--N 1.331 -0.21 0 CA-C-N 115.763 -0.653 . . . . 0.0 109.773 176.709 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' E' E ' 79' ' ' LYS . . . . . 0.635 ' O ' HD13 ' E' ' 80' ' ' ILE . 40.7 mttm -81.4 117.3 21.74 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-O 120.828 0.347 . . . . 0.0 110.949 -177.478 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' E' E ' 80' ' ' ILE . . . . . 0.635 HD13 ' O ' ' E' ' 79' ' ' LYS . 38.4 mm -139.28 106.07 2.68 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.27 0 N-CA-C 109.164 -0.68 . . . . 0.0 109.164 -179.475 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' E' E ' 81' ' ' LYS . . . . . . . . . . . . . 42.4 mtmt -99.61 126.74 45.66 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-O 121.041 0.448 . . . . 0.0 111.056 -177.992 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' E' E ' 82' ' ' GLY . . . . . . . . . . . . . . . 89.1 42.23 5.66 Favored Glycine 0 CA--C 1.525 0.695 0 C-N-CA 120.881 -0.676 . . . . 0.0 111.615 176.34 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' E' E ' 83' ' ' ILE . . . . . . . . . . . . . 75.3 mt -68.93 137.09 25.03 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.271 0 N-CA-C 109.734 -0.469 . . . . 0.0 109.734 177.149 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' E' E ' 84' ' ' LYS . . . . . . . . . . . . . 29.8 ttmt -92.49 -51.65 5.03 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-O 121.091 0.472 . . . . 0.0 109.8 -179.958 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' E' E ' 85' ' ' ASP . . . . . . . . . . . . . 5.8 t70 -156.19 152.26 27.63 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 115.492 -0.776 . . . . 0.0 110.234 -179.93 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' E' E ' 86' ' ' VAL . . . . . . . . . . . . . 44.1 t -128.07 130.62 69.75 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.27 0 CA-C-O 120.866 0.365 . . . . 0.0 110.258 179.718 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' E' E ' 87' ' ' ILE . . . . . . . . . . . . . 45.4 mm -117.3 124.19 72.73 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.291 0 CA-C-N 115.907 -0.588 . . . . 0.0 109.5 176.771 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' E' E ' 88' ' ' LEU . . . . . 0.463 ' CD1' HG21 ' D' ' 131' ' ' VAL . 13.4 tp -113.64 131.92 55.96 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-O 121.144 0.497 . . . . 0.0 111.218 -175.75 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' E' E ' 89' ' ' ASP . . . . . . . . . . . . . 9.5 t70 -125.94 153.92 43.58 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 115.63 -0.714 . . . . 0.0 109.312 174.679 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' E' E ' 90' ' ' GLU . . . . . . . . . . . . . 96.2 mt-10 -49.05 -34.55 13.77 Favored 'General case' 0 C--N 1.328 -0.367 0 N-CA-C 112.804 0.668 . . . . 0.0 112.804 -172.402 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' E' E ' 91' ' ' ASN . . . . . . . . . . . . . 85.1 m-20 -132.08 33.03 3.95 Favored 'General case' 0 N--CA 1.465 0.3 0 N-CA-C 112.099 0.407 . . . . 0.0 112.099 -176.285 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' E' E ' 92' ' ' LEU . . . . . . . . . . . . . 14.2 tp -166.05 143.8 5.53 Favored 'General case' 0 C--N 1.331 -0.231 0 C-N-CA 120.994 -0.282 . . . . 0.0 110.819 179.767 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' E' E ' 93' ' ' ILE . . . . . . . . . . . . . 69.9 mt -124.45 118.6 54.05 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.244 0 N-CA-C 109.577 -0.527 . . . . 0.0 109.577 179.863 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' E' E ' 94' ' ' VAL . . . . . 0.489 HG21 HG21 ' E' ' 125' ' ' VAL . 46.4 t -118.75 125.77 74.7 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.213 0 N-CA-C 109.73 -0.47 . . . . 0.0 109.73 179.333 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' E' E ' 95' ' ' VAL . . . . . . . . . . . . . 41.8 t -122.97 133.71 68.25 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.356 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.03 -179.08 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' E' E ' 96' ' ' ILE . . . . . . . . . . . . . 60.9 mt -115.42 127.79 72.87 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.324 0 N-CA-C 109.217 -0.66 . . . . 0.0 109.217 178.658 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' E' E ' 97' ' ' THR . . . . . . . . . . . . . 68.2 p -99.56 155.42 17.59 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-O 120.98 0.419 . . . . 0.0 110.678 -178.876 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' E' E ' 98' ' ' GLU . . . . . . . . . . . . . 45.2 mt-10 -55.64 -23.58 28.72 Favored 'General case' 0 CA--C 1.533 0.325 0 N-CA-C 112.366 0.506 . . . . 0.0 112.366 -179.717 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' E' E ' 99' ' ' GLU . . . . . . . . . . . . . 96.4 mt-10 -76.95 13.06 1.14 Allowed 'General case' 0 CA--C 1.536 0.431 0 N-CA-C 113.192 0.812 . . . . 0.0 113.192 -179.273 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' E' E ' 100' ' ' ASN . . . . . . . . . . . . . 4.0 m-20 63.69 38.07 9.63 Favored 'General case' 0 CA--C 1.529 0.149 0 CA-C-O 121.065 0.459 . . . . 0.0 111.076 178.129 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' E' E ' 101' ' ' GLU . . . . . . . . . . . . . 85.3 tt0 -118.58 144.15 46.3 Favored 'General case' 0 C--N 1.333 -0.134 0 CA-C-N 115.922 -0.581 . . . . 0.0 109.731 176.064 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' E' E ' 102' ' ' VAL . . . . . . . . . . . . . 47.2 t -116.13 127.58 73.69 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.238 0 CA-C-N 116.307 -0.406 . . . . 0.0 110.221 -177.244 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' E' E ' 103' ' ' LEU . . . . . . . . . . . . . 27.9 mt -117.73 132.99 56.39 Favored 'General case' 0 C--N 1.331 -0.213 0 CA-C-N 115.632 -0.713 . . . . 0.0 110.196 176.768 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' E' E ' 104' ' ' ILE . . . . . . . . . . . . . 67.6 mt -120.99 123.35 69.92 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.238 0 N-CA-C 110.198 -0.297 . . . . 0.0 110.198 179.378 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' E' E ' 105' ' ' PHE . . . . . . . . . . . . . 55.8 m-85 -124.91 165.69 17.64 Favored 'General case' 0 C--N 1.332 -0.164 0 O-C-N 123.896 0.748 . . . . 0.0 109.813 179.278 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' E' E ' 106' ' ' ASN . . . . . . . . . . . . . 47.3 p-10 -101.84 -170.96 1.9 Allowed 'General case' 0 C--N 1.331 -0.237 0 N-CA-C 109.966 -0.383 . . . . 0.0 109.966 173.568 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' E' E ' 107' ' ' GLN . . . . . . . . . . . . . 50.3 tt0 -58.57 -30.2 66.98 Favored 'General case' 0 C--N 1.329 -0.299 0 N-CA-C 111.998 0.37 . . . . 0.0 111.998 179.638 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' E' E ' 108' ' ' ASN . . . . . . . . . . . . . 58.1 t30 -83.11 10.79 7.39 Favored 'General case' 0 CA--C 1.537 0.463 0 N-CA-C 112.987 0.736 . . . . 0.0 112.987 -177.422 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' E' E ' 109' ' ' LEU . . . . . 0.656 HD21 ' HB2' ' E' ' 78' ' ' ALA . 8.6 tp 55.09 37.61 29.18 Favored 'General case' 0 C--N 1.332 -0.186 0 CA-C-O 121.039 0.447 . . . . 0.0 111.277 179.006 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' E' E ' 110' ' ' GLU . . . . . . . . . . . . . 70.6 mm-40 -102.9 154.94 18.71 Favored 'General case' 0 C--N 1.331 -0.235 0 N-CA-C 109.771 -0.455 . . . . 0.0 109.771 176.319 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' E' E ' 111' ' ' GLU . . . . . . . . . . . . . 85.0 tt0 -82.84 121.94 27.59 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-O 120.908 0.385 . . . . 0.0 110.598 -177.924 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' E' E ' 112' ' ' LEU . . . . . . . . . . . . . 18.8 mt -108.6 -45.92 3.76 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 115.964 -0.562 . . . . 0.0 110.38 178.34 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' E' E ' 113' ' ' TYR . . . . . . . . . . . . . 64.2 t80 -142.03 139.96 32.48 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.37 -0.377 . . . . 0.0 111.573 -179.9 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' E' E ' 114' ' ' ARG . . . . . . . . . . . . . 59.3 ttp180 -140.71 121.93 14.83 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.031 -0.531 . . . . 0.0 110.104 176.835 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' E' E ' 115' ' ' GLY . . . . . . . . . . . . . . . -150.06 161.35 28.87 Favored Glycine 0 CA--C 1.525 0.698 0 N-CA-C 111.296 -0.721 . . . . 0.0 111.296 178.563 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' E' E ' 116' ' ' LYS . . . . . . . . . . . . . 40.0 ttpt -130.9 140.7 50.23 Favored 'General case' 0 C--N 1.331 -0.215 0 N-CA-C 110.253 -0.277 . . . . 0.0 110.253 179.002 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' E' E ' 117' ' ' PHE . . . . . . . . . . . . . 30.3 m-85 -139.11 114.01 9.33 Favored 'General case' 0 C--N 1.331 -0.214 0 C-N-CA 120.839 -0.344 . . . . 0.0 110.188 -178.517 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' E' E ' 118' ' ' GLU . . . . . . . . . . . . . 95.9 mt-10 -54.83 -41.44 70.7 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 116.47 -0.332 . . . . 0.0 111.216 -176.401 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' E' E ' 119' ' ' ASN . . . . . . . . . . . . . 28.4 m120 -100.36 30.96 3.6 Favored 'General case' 0 C--N 1.33 -0.249 0 N-CA-C 112.176 0.435 . . . . 0.0 112.176 -174.016 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' E' E ' 120' ' ' LEU . . . . . . . . . . . . . 24.8 tp -57.57 119.98 7.51 Favored 'General case' 0 C--N 1.332 -0.155 0 C-N-CA 120.903 -0.319 . . . . 0.0 110.179 177.546 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' E' E ' 121' ' ' ASN . . . . . . . . . . . . . 21.1 m120 -114.19 -44.02 3.17 Favored 'General case' 0 N--CA 1.462 0.149 0 CA-C-N 116.553 -0.294 . . . . 0.0 111.319 -176.708 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' E' E ' 122' ' ' LYS . . . . . . . . . . . . . 35.8 mtmm -140.17 146.29 38.57 Favored 'General case' 0 C--N 1.331 -0.224 0 CA-C-O 121.032 0.444 . . . . 0.0 111.618 -175.825 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' E' E ' 123' ' ' VAL . . . . . . . . . . . . . 44.3 t -128.58 130.81 69.05 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.269 0 CA-C-N 115.998 -0.547 . . . . 0.0 109.796 177.038 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' E' E ' 124' ' ' LEU . . . . . . . . . . . . . 45.9 mt -123.39 129.7 51.66 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-N 116.49 -0.323 . . . . 0.0 110.597 179.645 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' E' E ' 125' ' ' VAL . . . . . 0.489 HG21 HG21 ' E' ' 94' ' ' VAL . 42.2 t -132.71 126.72 54.94 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.248 0 CA-C-N 116.231 -0.44 . . . . 0.0 109.982 178.68 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' E' E ' 126' ' ' ARG . . . . . . . . . . . . . 51.8 mmm-85 -140.05 125.14 18.63 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-O 120.918 0.389 . . . . 0.0 110.329 177.996 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' E' E ' 127' ' ' ASN . . . . . . . . . . . . . 67.3 m-80 51.25 -111.61 0.56 Allowed 'General case' 0 CA--C 1.546 0.794 0 CA-C-O 118.598 -0.715 . . . . 0.0 111.172 179.817 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' E' E ' 128' ' ' ASP . . . . . . . . . . . . . 11.6 p-10 -114.14 9.97 17.28 Favored 'General case' 0 CA--C 1.535 0.384 0 CA-C-N 120.089 1.313 . . . . 0.0 113.26 -178.357 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' E' E ' 129' ' ' LEU . . . . . . . . . . . . . 17.2 tp -109.52 138.33 46.05 Favored 'General case' 0 C--O 1.233 0.216 0 O-C-N 121.987 -0.445 . . . . 0.0 110.053 179.199 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' E' E ' 130' ' ' VAL . . . . . . . . . . . . . 41.2 t -125.02 137.19 58.43 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.226 0 CA-C-O 120.958 0.409 . . . . 0.0 110.494 -176.802 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' E' E ' 131' ' ' VAL . . . . . 0.517 HG22 HD12 ' E' ' 140' ' ' LEU . 41.8 t -135.82 136.68 49.9 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.259 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.242 177.39 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' E' E ' 132' ' ' ILE . . . . . . . . . . . . . 71.6 mt -118.3 132.98 66.58 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.337 0 CA-C-N 115.886 -0.597 . . . . 0.0 109.446 -179.031 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' E' E ' 133' ' ' ILE . . . . . . . . . . . . . 40.3 mm -117.16 123.77 72.22 Favored 'Isoleucine or valine' 0 C--O 1.233 0.214 0 CA-C-O 121.001 0.429 . . . . 0.0 111.053 -174.914 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' E' E ' 134' ' ' ASP . . . . . . . . . . . . . 6.7 p-10 -131.07 152.75 50.04 Favored 'General case' 0 C--N 1.332 -0.157 0 CA-C-N 116.048 -0.524 . . . . 0.0 109.786 174.723 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' E' E ' 135' ' ' GLU . . . . . . . . . . . . . 46.4 tp10 -49.93 -28.33 6.58 Favored 'General case' 0 C--N 1.328 -0.356 0 N-CA-C 112.91 0.707 . . . . 0.0 112.91 -169.263 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' E' E ' 136' ' ' GLN . . . . . . . . . . . . . 52.7 mt-30 -105.03 -24.96 12.73 Favored 'General case' 0 N--CA 1.464 0.275 0 N-CA-C 112.982 0.734 . . . . 0.0 112.982 -173.767 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' E' E ' 137' ' ' LYS . . . . . . . . . . . . . 59.6 mtpt -143.11 154.14 43.62 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-O 121.229 0.538 . . . . 0.0 111.891 -169.589 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' E' E ' 138' ' ' LEU . . . . . 0.423 ' C ' HD23 ' E' ' 138' ' ' LEU . 5.7 tt -119.09 124.18 46.27 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 115.546 -0.752 . . . . 0.0 109.378 174.587 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' E' E ' 139' ' ' THR . . . . . . . . . . . . . 30.6 m -110.39 130.54 55.53 Favored 'General case' 0 C--N 1.331 -0.229 0 CA-C-O 120.795 0.331 . . . . 0.0 110.774 -177.173 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' E' E ' 140' ' ' LEU . . . . . 0.517 HD12 HG22 ' E' ' 131' ' ' VAL . 12.6 tp -116.52 125.29 51.7 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 115.664 -0.698 . . . . 0.0 109.429 -178.093 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' E' E ' 141' ' ' ILE . . . . . . . . . . . . . 19.3 mt -122.56 117.75 52.99 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.308 0 N-CA-C 109.736 -0.468 . . . . 0.0 109.736 -177.205 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' E' E ' 142' ' ' ARG . . . . . . . . . . . . . 81.2 mtp180 -108.1 128.45 54.69 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 115.39 -0.823 . . . . 0.0 110.398 -176.473 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' E' E ' 143' ' ' THR . . . . . . . . . . . . . 77.8 p . . . . . 0 C--O 1.22 -0.459 0 CA-C-O 118.058 -0.972 . . . . 0.0 110.48 -179.994 . . . . . . . . 0 0 . 1 . 011 nuclear nobuild core ' F' F ' 1' ' ' MET . . . . . . . . . . . . . 27.4 ptm . . . . . 0 C--O 1.231 0.116 0 CA-C-O 120.814 0.34 . . . . 0.0 110.756 . . . . . . . . . 0 0 . 1 . 011 nuclear nobuild core ' F' F ' 2' ' ' SER . . . . . . . . . . . . . 7.4 p -118.99 133.92 55.52 Favored 'General case' 0 C--N 1.331 -0.21 0 CA-C-O 121.157 0.503 . . . . 0.0 110.356 177.9 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' F' F ' 3' ' ' GLU . . . . . . . . . . . . . 84.7 tt0 -145.19 142.32 29.46 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 115.878 -0.601 . . . . 0.0 110.965 179.951 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' F' F ' 4' ' ' LEU . . . . . . . . . . . . . 17.5 tp -121.34 128.21 52.05 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 115.84 -0.618 . . . . 0.0 109.998 176.597 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' F' F ' 5' ' ' LYS . . . . . . . . . . . . . 62.4 mttp -108.3 121.0 44.0 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.415 -0.357 . . . . 0.0 110.745 179.407 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' F' F ' 6' ' ' LEU . . . . . 0.461 HD23 ' HA ' ' F' ' 50' ' ' VAL . 23.8 mt -114.23 148.47 37.33 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 115.331 -0.85 . . . . 0.0 110.46 -179.461 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' F' F ' 7' ' ' LYS . . . . . . . . . . . . . 77.1 tttt -128.5 138.27 32.7 Favored Pre-proline 0 CA--C 1.533 0.302 0 CA-C-O 118.85 -0.595 . . . . 0.0 109.681 173.518 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' F' F ' 8' ' ' PRO . . . . . . . . . . . . . 95.7 Cg_endo -91.48 135.38 1.72 Allowed 'Trans proline' 0 N--CA 1.49 1.288 0 C-N-CA 121.727 1.618 . . . . 0.0 111.953 178.373 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' F' F ' 9' ' ' LEU . . . . . . . . . . . . . 55.6 mt -75.94 -46.98 3.85 Favored Pre-proline 0 CA--C 1.534 0.338 0 CA-C-O 118.777 -0.63 . . . . 0.0 111.725 179.639 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' F' F ' 10' ' ' PRO . . . . . . . . . . . . . 78.9 Cg_endo -82.86 149.04 13.9 Favored 'Trans proline' 0 N--CA 1.495 1.579 0 C-N-CA 121.246 1.297 . . . . 0.0 111.531 174.098 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' F' F ' 11' ' ' LYS . . . . . . . . . . . . . 53.8 pttt -86.59 112.17 21.32 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-O 121.588 0.709 . . . . 0.0 110.592 178.035 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' F' F ' 12' ' ' VAL . . . . . . . . . . . . . 12.2 p -151.15 149.22 14.32 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.253 0 CA-C-N 115.621 -0.718 . . . . 0.0 110.545 -179.673 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' F' F ' 13' ' ' GLU . . . . . . . . . . . . . 95.7 mt-10 -87.74 125.74 34.59 Favored 'General case' 0 C--N 1.329 -0.283 0 N-CA-C 109.85 -0.426 . . . . 0.0 109.85 176.224 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' F' F ' 14' ' ' LEU . . . . . . . . . . . . . 31.4 mt -97.86 150.71 37.04 Favored Pre-proline 0 C--N 1.33 -0.254 0 CA-C-O 119.407 -0.33 . . . . 0.0 110.679 -178.378 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' F' F ' 15' ' ' PRO . . . . . . . . . . . . . 28.1 Cg_exo -60.69 159.56 27.98 Favored 'Trans proline' 0 N--CA 1.497 1.702 0 C-N-CA 121.297 1.331 . . . . 0.0 112.007 177.826 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' F' F ' 16' ' ' PRO . . . . . . . . . . . . . 31.6 Cg_exo -59.76 -44.27 32.26 Favored 'Trans proline' 0 N--CA 1.497 1.689 0 C-N-CA 121.495 1.463 . . . . 0.0 112.688 -178.594 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' F' F ' 17' ' ' ASP . . . . . . . . . . . . . 9.1 p-10 -83.8 12.55 5.86 Favored 'General case' 0 CA--C 1.534 0.345 0 N-CA-C 113.156 0.799 . . . . 0.0 113.156 -177.709 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' F' F ' 18' ' ' PHE . . . . . . . . . . . . . 52.6 t80 -57.46 -43.77 84.28 Favored 'General case' 0 N--CA 1.458 -0.07 0 O-C-N 121.986 -0.447 . . . . 0.0 110.332 -178.39 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' F' F ' 19' ' ' VAL . . . . . . . . . . . . . 47.7 t -56.48 -44.06 79.5 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.302 0 CA-C-N 116.332 -0.394 . . . . 0.0 110.54 -178.11 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' F' F ' 20' ' ' ASP . . . . . . . . . . . . . 64.0 m-20 -60.01 -42.52 94.48 Favored 'General case' 0 C--N 1.329 -0.288 0 C-N-CA 120.905 -0.318 . . . . 0.0 110.951 -178.115 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' F' F ' 21' ' ' VAL . . . . . . . . . . . . . 50.6 t -64.5 -46.75 91.81 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.246 0 C-N-CA 120.745 -0.382 . . . . 0.0 110.691 -177.556 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' F' F ' 22' ' ' ILE . . . . . 0.514 HG22 HD12 ' F' ' 26' ' ' LEU . 51.4 mm -55.49 -46.79 78.95 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.224 0 C-N-CA 120.957 -0.297 . . . . 0.0 110.625 179.623 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' F' F ' 23' ' ' ARG . . . . . . . . . . . . . 55.9 ttp180 -54.8 -50.8 67.63 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-O 120.645 0.26 . . . . 0.0 111.314 -178.707 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' F' F ' 24' ' ' ILE . . . . . . . . . . . . . 75.6 mt -59.48 -41.86 86.0 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.268 0 CA-C-N 116.536 -0.302 . . . . 0.0 111.499 -176.266 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' F' F ' 25' ' ' LYS . . . . . . . . . . . . . 40.5 mmtt -66.41 -43.93 84.41 Favored 'General case' 0 C--N 1.329 -0.291 0 N-CA-C 112.468 0.544 . . . . 0.0 112.468 -178.655 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' F' F ' 26' ' ' LEU . . . . . 0.514 HD12 HG22 ' F' ' 22' ' ' ILE . 58.0 mt -78.77 -35.1 45.03 Favored 'General case' 0 C--N 1.33 -0.271 0 N-CA-C 113.77 1.026 . . . . 0.0 113.77 -169.837 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' F' F ' 27' ' ' GLN . . . . . . . . . . . . . 10.3 pt20 -47.39 139.41 6.58 Favored 'General case' 0 N--CA 1.469 0.524 0 N-CA-C 112.758 0.651 . . . . 0.0 112.758 -175.653 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' F' F ' 28' ' ' GLY . . . . . . . . . . . . . . . 101.22 -24.46 31.74 Favored Glycine 0 CA--C 1.534 1.274 0 CA-C-N 115.536 -0.756 . . . . 0.0 112.308 -176.242 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' F' F ' 29' ' ' LYS . . . . . . . . . . . . . 55.2 mttp -97.35 155.1 17.04 Favored 'General case' 0 C--O 1.231 0.129 0 CA-C-N 117.535 0.667 . . . . 0.0 111.253 178.589 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' F' F ' 30' ' ' THR . . . . . . . . . . . . . 41.2 m -106.17 137.49 44.02 Favored 'General case' 0 C--N 1.331 -0.23 0 CA-C-N 116.02 -0.536 . . . . 0.0 109.854 175.828 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' F' F ' 31' ' ' VAL . . . . . . . . . . . . . 34.6 m -130.21 153.08 38.42 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.243 0 CA-C-O 121.055 0.455 . . . . 0.0 111.192 -177.49 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' F' F ' 32' ' ' ARG . . . . . . . . . . . . . 55.5 mtp180 -128.92 152.53 48.46 Favored 'General case' 0 C--N 1.332 -0.187 0 CA-C-N 115.749 -0.66 . . . . 0.0 110.668 177.885 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' F' F ' 33' ' ' THR . . . . . . . . . . . . . 14.0 m -54.09 137.83 39.18 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 115.98 -0.554 . . . . 0.0 111.26 -179.206 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' F' F ' 34' ' ' GLY . . . . . . . . . . . . . . . 101.68 -17.17 55.44 Favored Glycine 0 CA--C 1.533 1.159 0 CA-C-O 119.59 -0.561 . . . . 0.0 113.354 178.804 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' F' F ' 35' ' ' ASP . . . . . . . . . . . . . 75.2 m-20 -65.88 148.03 52.43 Favored 'General case' 0 N--CA 1.461 0.091 0 CA-C-N 118.09 0.945 . . . . 0.0 111.192 179.469 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' F' F ' 36' ' ' VAL . . . . . . . . . . . . . 47.2 t -120.48 129.07 75.98 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.196 0 CA-C-N 115.872 -0.604 . . . . 0.0 109.829 178.789 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' F' F ' 37' ' ' ILE . . . . . . . . . . . . . 63.3 mt -122.29 138.85 51.08 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.226 0 CA-C-N 116.19 -0.459 . . . . 0.0 109.963 -178.958 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' F' F ' 38' ' ' GLY . . . . . . . . . . . . . . . -115.03 128.74 8.25 Favored Glycine 0 CA--C 1.526 0.72 0 N-CA-C 111.143 -0.783 . . . . 0.0 111.143 179.411 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' F' F ' 39' ' ' ILE . . . . . . . . . . . . . 76.6 mt -125.91 138.32 54.91 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.212 0 CA-C-O 120.808 0.337 . . . . 0.0 110.421 179.659 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' F' F ' 40' ' ' SER . . . . . . . . . . . . . 23.0 t -92.71 114.69 27.32 Favored 'General case' 0 C--N 1.332 -0.192 0 CA-C-N 116.335 -0.393 . . . . 0.0 111.059 176.131 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' F' F ' 41' ' ' ILE . . . . . . . . . . . . . 44.6 mm -121.43 122.75 68.05 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.215 0 CA-C-O 120.846 0.355 . . . . 0.0 110.303 179.274 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' F' F ' 42' ' ' LEU . . . . . . . . . . . . . 9.1 tp 52.84 35.38 18.73 Favored 'General case' 0 CA--C 1.532 0.252 0 CA-C-N 116.254 -0.43 . . . . 0.0 111.643 177.128 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' F' F ' 43' ' ' GLY . . . . . . . . . . . . . . . 72.15 30.41 65.26 Favored Glycine 0 CA--C 1.529 0.966 0 C-N-CA 121.058 -0.591 . . . . 0.0 112.165 178.066 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' F' F ' 44' ' ' LYS . . . . . . . . . . . . . 85.9 tttt -139.71 130.66 26.24 Favored 'General case' 0 C--N 1.33 -0.259 0 N-CA-C 109.564 -0.532 . . . . 0.0 109.564 178.886 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' F' F ' 45' ' ' GLU . . . . . . . . . . . . . 85.1 tt0 -82.5 121.66 27.05 Favored 'General case' 0 C--N 1.326 -0.425 0 CA-C-O 120.9 0.381 . . . . 0.0 110.985 -177.496 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' F' F ' 46' ' ' VAL . . . . . . . . . . . . . 9.7 p -118.2 125.74 74.48 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.171 0 N-CA-C 109.385 -0.598 . . . . 0.0 109.385 175.434 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' F' F ' 47' ' ' LYS . . . . . . . . . . . . . 98.8 mttt -98.84 125.56 44.26 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 115.948 -0.569 . . . . 0.0 110.705 179.1 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' F' F ' 48' ' ' PHE . . . . . . . . . . . . . 31.5 m-85 -110.56 131.89 54.66 Favored 'General case' 0 C--N 1.33 -0.267 0 N-CA-C 109.8 -0.444 . . . . 0.0 109.8 178.062 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' F' F ' 49' ' ' LYS . . . . . . . . . . . . . 46.1 tttp -107.05 132.75 52.61 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.26 -0.427 . . . . 0.0 110.081 178.337 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' F' F ' 50' ' ' VAL . . . . . 0.461 ' HA ' HD23 ' F' ' 6' ' ' LEU . 46.5 t -76.47 104.22 4.38 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.295 0 N-CA-C 109.263 -0.644 . . . . 0.0 109.263 177.215 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' F' F ' 51' ' ' VAL . . . . . . . . . . . . . 49.0 t -72.45 -52.41 23.86 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.298 0 N-CA-C 109.538 -0.541 . . . . 0.0 109.538 -175.239 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' F' F ' 52' ' ' GLN . . . . . . . . . . . . . 86.6 mt-30 -151.77 140.73 21.09 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-O 121.245 0.545 . . . . 0.0 111.675 -178.99 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' F' F ' 53' ' ' ALA . . . . . 0.424 ' HB1' ' HB2' ' F' ' 58' ' ' LEU . . . -116.22 127.58 54.88 Favored 'General case' 0 C--N 1.325 -0.46 0 CA-C-N 114.918 -1.037 . . . . 0.0 109.491 174.712 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' F' F ' 54' ' ' TYR . . . . . . . . . . . . . 27.4 t80 -125.92 109.06 25.02 Favored Pre-proline 0 CA--C 1.534 0.359 0 CA-C-O 118.21 -0.9 . . . . 0.0 110.511 -179.342 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' F' F ' 55' ' ' PRO . . . . . . . . . . . . . 73.3 Cg_endo -77.24 170.09 72.39 Favored 'Cis proline' 0 N--CA 1.501 1.914 0 CA-C-N 121.852 1.697 . . . . 0.0 112.658 -4.617 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' F' F ' 56' ' ' SER . . . . . . . . . . . . . 13.5 m -113.51 126.88 27.49 Favored Pre-proline 0 CA--C 1.54 0.585 0 CA-C-O 118.32 -0.848 . . . . 0.0 109.271 174.511 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' F' F ' 57' ' ' PRO . . . . . . . . . . . . . 57.3 Cg_endo -72.47 150.4 95.01 Favored 'Cis proline' 0 N--CA 1.496 1.66 0 CA-C-N 122.053 1.769 . . . . 0.0 111.692 0.043 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' F' F ' 58' ' ' LEU . . . . . 0.424 ' HB2' ' HB1' ' F' ' 53' ' ' ALA . 29.6 tp -107.9 137.36 46.03 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.221 -0.445 . . . . 0.0 110.659 -178.143 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' F' F ' 59' ' ' ARG . . . . . . . . . . . . . 73.6 ttt-85 -101.67 123.86 46.36 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 115.845 -0.616 . . . . 0.0 109.498 176.034 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' F' F ' 60' ' ' VAL . . . . . . . . . . . . . 44.6 t -76.51 114.9 17.38 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.239 0 C-N-CA 120.658 -0.417 . . . . 0.0 110.109 -177.426 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' F' F ' 61' ' ' GLU . . . . . . . . . . . . . 84.6 tt0 -131.11 154.21 48.54 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 115.759 -0.655 . . . . 0.0 109.503 179.532 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' F' F ' 62' ' ' ASP . . . . . . . . . . . . . 9.7 t0 -51.54 -32.59 28.6 Favored 'General case' 0 C--N 1.327 -0.376 0 N-CA-C 112.0 0.37 . . . . 0.0 112.0 -177.924 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' F' F ' 63' ' ' ARG . . . . . . . . . . . . . 27.2 mmm180 -72.4 -22.03 61.18 Favored 'General case' 0 N--CA 1.466 0.353 0 N-CA-C 112.934 0.716 . . . . 0.0 112.934 -177.627 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' F' F ' 64' ' ' THR . . . . . . . . . . . . . 21.6 m -67.84 137.87 55.65 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-O 120.825 0.345 . . . . 0.0 110.979 -175.461 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' F' F ' 65' ' ' LYS . . . . . . . . . . . . . 55.9 mtmt -88.95 140.21 29.67 Favored 'General case' 0 C--N 1.331 -0.224 0 CA-C-N 116.224 -0.444 . . . . 0.0 110.573 178.351 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' F' F ' 66' ' ' ILE . . . . . . . . . . . . . 4.3 mp -116.13 127.4 73.74 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.244 0 N-CA-C 109.755 -0.461 . . . . 0.0 109.755 -179.184 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' F' F ' 67' ' ' THR . . . . . . . . . . . . . 21.4 m -124.82 136.95 54.28 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-O 121.002 0.429 . . . . 0.0 110.873 -177.431 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' F' F ' 68' ' ' LEU . . . . . . . . . . . . . 15.9 tp . . . . . 0 C--N 1.33 -0.271 0 CA-C-N 116.099 -0.501 . . . . 0.0 110.561 178.241 . . . . . . . . 0 0 . 1 . 011 nuclear nobuild core ' F' F ' 73' ' ' VAL . . . . . . . . . . . . . 31.1 m . . . . . 0 N--CA 1.462 0.168 0 CA-C-O 120.789 0.328 . . . . 0.0 110.165 . . . . . . . . . 0 0 . 1 . 011 nuclear nobuild core ' F' F ' 74' ' ' ASP . . . . . . . . . . . . . 13.5 t70 -95.49 118.72 32.71 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.296 -0.411 . . . . 0.0 110.24 -177.575 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' F' F ' 75' ' ' VAL . . . . . . . . . . . . . 40.3 t -114.82 124.59 71.63 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.241 0 CA-C-O 121.043 0.449 . . . . 0.0 110.297 -178.746 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' F' F ' 76' ' ' LEU . . . . . . . . . . . . . 15.0 mt -128.78 146.15 50.99 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 115.661 -0.7 . . . . 0.0 109.723 178.88 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' F' F ' 77' ' ' GLU . . . . . . . . . . . . . 97.6 mt-10 -135.38 135.94 41.07 Favored 'General case' 0 C--N 1.331 -0.198 0 CA-C-O 121.075 0.464 . . . . 0.0 111.32 -178.502 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' F' F ' 78' ' ' ALA . . . . . . . . . . . . . . . -121.51 140.97 51.51 Favored 'General case' 0 C--N 1.332 -0.184 0 CA-C-N 115.775 -0.648 . . . . 0.0 109.735 176.09 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' F' F ' 79' ' ' LYS . . . . . 0.628 ' O ' HD13 ' F' ' 80' ' ' ILE . 96.1 mttt -85.26 115.1 22.84 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-O 120.909 0.385 . . . . 0.0 110.865 -178.3 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' F' F ' 80' ' ' ILE . . . . . 0.628 HD13 ' O ' ' F' ' 79' ' ' LYS . 39.7 mm -139.09 108.39 3.8 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.325 0 N-CA-C 109.239 -0.652 . . . . 0.0 109.239 -178.197 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' F' F ' 81' ' ' LYS . . . . . . . . . . . . . 39.2 ttpt -106.66 134.91 49.07 Favored 'General case' 0 C--N 1.331 -0.226 0 CA-C-O 120.939 0.4 . . . . 0.0 111.178 -177.242 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' F' F ' 82' ' ' GLY . . . . . . . . . . . . . . . 89.09 41.92 5.74 Favored Glycine 0 CA--C 1.523 0.556 0 N-CA-C 111.114 -0.795 . . . . 0.0 111.114 176.404 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' F' F ' 83' ' ' ILE . . . . . . . . . . . . . 68.0 mt -78.13 130.69 35.88 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.363 0 N-CA-C 109.525 -0.546 . . . . 0.0 109.525 178.398 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' F' F ' 84' ' ' LYS . . . . . . . . . . . . . 38.2 ttpt -95.73 -46.35 6.63 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-O 120.863 0.363 . . . . 0.0 110.147 -178.783 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' F' F ' 85' ' ' ASP . . . . . . . . . . . . . 7.2 t70 -152.08 149.15 28.51 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.111 -0.495 . . . . 0.0 110.629 178.581 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' F' F ' 86' ' ' VAL . . . . . . . . . . . . . 42.1 t -126.84 132.7 69.77 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.26 0 CA-C-O 120.859 0.361 . . . . 0.0 110.448 -179.524 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' F' F ' 87' ' ' ILE . . . . . . . . . . . . . 45.5 mm -119.27 124.59 73.33 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.223 0 N-CA-C 109.412 -0.588 . . . . 0.0 109.412 176.439 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' F' F ' 88' ' ' LEU . . . . . . . . . . . . . 16.8 tp -112.36 130.51 55.94 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-O 121.116 0.484 . . . . 0.0 111.19 -176.912 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' F' F ' 89' ' ' ASP . . . . . . . . . . . . . 9.1 t70 -123.64 155.15 38.27 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-N 115.754 -0.657 . . . . 0.0 109.388 175.443 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' F' F ' 90' ' ' GLU . . . . . . . . . . . . . 84.5 tt0 -47.59 -40.55 19.57 Favored 'General case' 0 C--N 1.329 -0.287 0 N-CA-C 112.818 0.673 . . . . 0.0 112.818 -172.07 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' F' F ' 91' ' ' ASN . . . . . . . . . . . . . 33.6 m120 -132.16 38.96 3.45 Favored 'General case' 0 CA--C 1.53 0.187 0 CA-C-O 120.856 0.36 . . . . 0.0 111.496 -178.208 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' F' F ' 92' ' ' LEU . . . . . . . . . . . . . 12.5 tp -166.0 139.63 4.3 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.593 -0.276 . . . . 0.0 110.325 -178.613 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' F' F ' 93' ' ' ILE . . . . . . . . . . . . . 68.2 mt -125.65 122.76 63.08 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.18 0 N-CA-C 109.588 -0.523 . . . . 0.0 109.588 179.851 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' F' F ' 94' ' ' VAL . . . . . 0.486 HG21 HG21 ' F' ' 125' ' ' VAL . 45.1 t -122.2 128.41 75.51 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.206 0 CA-C-O 120.977 0.417 . . . . 0.0 109.957 179.703 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' F' F ' 95' ' ' VAL . . . . . . . . . . . . . 41.3 t -119.91 132.93 68.26 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.323 0 CA-C-N 115.899 -0.591 . . . . 0.0 109.744 179.951 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' F' F ' 96' ' ' ILE . . . . . . . . . . . . . 69.5 mt -112.85 124.03 69.1 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 N-CA-C 108.96 -0.756 . . . . 0.0 108.96 177.912 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' F' F ' 97' ' ' THR . . . . . . . . . . . . . 43.6 p -98.51 155.89 17.05 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-O 121.544 0.688 . . . . 0.0 111.545 -175.424 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' F' F ' 98' ' ' GLU . . . . . . . . . . . . . 84.5 tt0 -54.11 -27.38 32.72 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 115.54 -0.755 . . . . 0.0 112.151 -179.864 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' F' F ' 99' ' ' GLU . . . . . . . . . . . . . 95.4 mt-10 -80.32 14.98 1.73 Allowed 'General case' 0 CA--C 1.535 0.381 0 N-CA-C 113.173 0.805 . . . . 0.0 113.173 -176.538 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' F' F ' 100' ' ' ASN . . . . . . . . . . . . . 3.6 m-20 63.0 35.38 13.22 Favored 'General case' 0 C--O 1.233 0.236 0 CA-C-N 118.126 0.421 . . . . 0.0 111.392 179.229 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' F' F ' 101' ' ' GLU . . . . . . . . . . . . . 85.0 tt0 -113.64 145.03 41.92 Favored 'General case' 0 C--N 1.331 -0.238 0 N-CA-C 109.633 -0.506 . . . . 0.0 109.633 174.393 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' F' F ' 102' ' ' VAL . . . . . . . . . . . . . 45.4 t -115.1 125.75 72.49 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.281 0 CA-C-N 116.22 -0.445 . . . . 0.0 109.929 -178.202 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' F' F ' 103' ' ' LEU . . . . . . . . . . . . . 61.2 mt -117.46 129.12 55.63 Favored 'General case' 0 C--N 1.332 -0.191 0 CA-C-N 115.743 -0.662 . . . . 0.0 110.325 177.445 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' F' F ' 104' ' ' ILE . . . . . . . . . . . . . 67.1 mt -119.04 124.49 73.25 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.181 0 N-CA-C 110.11 -0.33 . . . . 0.0 110.11 179.494 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' F' F ' 105' ' ' PHE . . . . . . . . . . . . . 88.9 m-85 -123.41 163.39 20.92 Favored 'General case' 0 C--O 1.232 0.168 0 O-C-N 123.954 0.784 . . . . 0.0 109.937 -179.497 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' F' F ' 106' ' ' ASN . . . . . . . . . . . . . 46.3 p-10 -97.66 -173.09 2.54 Favored 'General case' 0 C--N 1.33 -0.252 0 N-CA-C 109.821 -0.437 . . . . 0.0 109.821 171.821 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' F' F ' 107' ' ' GLN . . . . . . . . . . . . . 55.4 tt0 -60.12 -26.4 66.22 Favored 'General case' 0 C--N 1.328 -0.332 0 N-CA-C 112.19 0.441 . . . . 0.0 112.19 -178.823 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' F' F ' 108' ' ' ASN . . . . . . . . . . . . . 11.9 t-20 -88.68 13.99 11.08 Favored 'General case' 0 CA--C 1.535 0.389 0 N-CA-C 112.865 0.691 . . . . 0.0 112.865 -177.824 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' F' F ' 109' ' ' LEU . . . . . . . . . . . . . 43.2 mt 58.25 34.17 23.84 Favored 'General case' 0 CA--C 1.53 0.202 0 O-C-N 122.138 -0.351 . . . . 0.0 111.84 177.464 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' F' F ' 110' ' ' GLU . . . . . . . . . . . . . 70.5 mm-40 -103.14 142.95 33.27 Favored 'General case' 0 C--N 1.329 -0.31 0 N-CA-C 109.006 -0.738 . . . . 0.0 109.006 173.315 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' F' F ' 111' ' ' GLU . . . . . . . . . . . . . 51.1 tt0 -85.28 121.78 28.51 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-O 121.017 0.437 . . . . 0.0 110.538 -175.41 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' F' F ' 112' ' ' LEU . . . . . . . . . . . . . 44.8 mt -100.95 -42.96 6.21 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 115.708 -0.678 . . . . 0.0 110.68 179.636 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' F' F ' 113' ' ' TYR . . . . . . . . . . . . . 57.5 t80 -133.09 136.54 45.92 Favored 'General case' 0 C--N 1.331 -0.2 0 CA-C-N 116.329 -0.396 . . . . 0.0 111.221 -177.85 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' F' F ' 114' ' ' ARG . . . . . . . . . . . . . 69.8 ttt180 -137.53 118.61 14.41 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 115.716 -0.675 . . . . 0.0 110.142 178.197 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' F' F ' 115' ' ' GLY . . . . . . . . . . . . . . . -149.99 162.3 29.13 Favored Glycine 0 CA--C 1.524 0.605 0 C-N-CA 120.693 -0.765 . . . . 0.0 111.405 179.746 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' F' F ' 116' ' ' LYS . . . . . . . . . . . . . 74.2 tttt -136.97 140.42 42.17 Favored 'General case' 0 C--N 1.328 -0.338 0 N-CA-C 110.085 -0.339 . . . . 0.0 110.085 178.401 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' F' F ' 117' ' ' PHE . . . . . . . . . . . . . 34.8 m-85 -136.6 113.88 10.76 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.309 -0.405 . . . . 0.0 110.214 -177.45 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' F' F ' 118' ' ' GLU . . . . . . . . . . . . . 84.9 tt0 -53.79 -48.93 69.32 Favored 'General case' 0 C--N 1.329 -0.307 0 C-N-CA 121.112 -0.235 . . . . 0.0 111.292 -177.39 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' F' F ' 119' ' ' ASN . . . . . . . . . . . . . 6.0 m120 -92.98 31.12 1.46 Allowed 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 116.273 -0.421 . . . . 0.0 111.999 -175.464 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' F' F ' 120' ' ' LEU . . . . . . . . . . . . . 25.2 tp -55.56 122.77 12.05 Favored 'General case' 0 N--CA 1.462 0.173 0 CA-C-O 120.698 0.285 . . . . 0.0 110.535 178.413 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' F' F ' 121' ' ' ASN . . . . . . . . . . . . . 3.8 m-20 -113.86 -44.03 3.21 Favored 'General case' 0 C--O 1.232 0.146 0 CA-C-N 116.426 -0.352 . . . . 0.0 111.162 -176.189 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' F' F ' 122' ' ' LYS . . . . . . . . . . . . . 39.2 ttpt -146.01 141.6 27.83 Favored 'General case' 0 C--N 1.33 -0.24 0 C-N-CA 120.689 -0.404 . . . . 0.0 111.531 -175.1 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' F' F ' 123' ' ' VAL . . . . . . . . . . . . . 43.9 t -129.28 131.45 67.56 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.267 0 N-CA-C 109.486 -0.561 . . . . 0.0 109.486 174.786 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' F' F ' 124' ' ' LEU . . . . . 0.41 HD22 HD12 ' A' ' 88' ' ' LEU . 14.6 tp -127.37 131.85 50.28 Favored 'General case' 0 N--CA 1.464 0.227 0 CA-C-O 120.859 0.362 . . . . 0.0 110.919 -178.718 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' F' F ' 125' ' ' VAL . . . . . 0.522 HG22 HG23 ' F' ' 130' ' ' VAL . 45.4 t -126.13 129.43 72.17 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.218 0 CA-C-N 115.992 -0.549 . . . . 0.0 110.059 179.362 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' F' F ' 126' ' ' ARG . . . . . . . . . . . . . 42.0 ttm180 -154.22 131.26 10.99 Favored 'General case' 0 C--N 1.33 -0.27 0 N-CA-C 109.808 -0.441 . . . . 0.0 109.808 177.306 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' F' F ' 127' ' ' ASN . . . . . . . . . . . . . 3.4 t-20 56.67 -155.02 0.32 Allowed 'General case' 0 CA--C 1.538 0.507 0 N-CA-C 109.595 -0.521 . . . . 0.0 109.595 -178.319 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' F' F ' 128' ' ' ASP . . . . . . . . . . . . . 22.1 p-10 -82.5 17.24 1.81 Allowed 'General case' 0 CA--C 1.539 0.52 0 N-CA-C 112.491 0.552 . . . . 0.0 112.491 176.879 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' F' F ' 129' ' ' LEU . . . . . . . . . . . . . 16.5 tp -116.37 137.36 52.22 Favored 'General case' 0 C--O 1.232 0.18 0 N-CA-C 109.934 -0.395 . . . . 0.0 109.934 179.148 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' F' F ' 130' ' ' VAL . . . . . 0.522 HG23 HG22 ' F' ' 125' ' ' VAL . 12.6 p -136.9 143.37 35.19 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.25 0 CA-C-O 121.033 0.444 . . . . 0.0 110.663 -179.951 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' F' F ' 131' ' ' VAL . . . . . 0.458 HG21 HD13 ' A' ' 88' ' ' LEU . 32.5 m -136.09 146.94 28.42 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.275 0 CA-C-O 121.238 0.542 . . . . 0.0 110.912 178.804 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' F' F ' 132' ' ' ILE . . . . . . . . . . . . . 73.2 mt -122.36 134.01 66.88 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.228 0 CA-C-N 115.505 -0.771 . . . . 0.0 109.581 -179.572 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' F' F ' 133' ' ' ILE . . . . . . . . . . . . . 40.1 mm -115.91 122.79 70.3 Favored 'Isoleucine or valine' 0 C--O 1.234 0.262 0 CA-C-N 116.353 -0.385 . . . . 0.0 110.86 -176.304 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' F' F ' 134' ' ' ASP . . . . . . . . . . . . . 7.3 p-10 -131.88 150.97 52.0 Favored 'General case' 0 C--N 1.331 -0.23 0 CA-C-N 116.128 -0.487 . . . . 0.0 109.744 174.441 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' F' F ' 135' ' ' GLU . . . . . . . . . . . . . 85.6 tt0 -49.92 -25.86 3.62 Favored 'General case' 0 C--N 1.327 -0.378 0 N-CA-C 112.896 0.702 . . . . 0.0 112.896 -170.738 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' F' F ' 136' ' ' GLN . . . . . . . . . . . . . 97.8 mt-30 -105.05 -25.22 12.62 Favored 'General case' 0 N--CA 1.464 0.266 0 N-CA-C 113.015 0.746 . . . . 0.0 113.015 -175.081 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' F' F ' 137' ' ' LYS . . . . . . . . . . . . . 66.2 mttm -140.27 150.21 43.77 Favored 'General case' 0 C--N 1.331 -0.217 0 CA-C-O 121.587 0.708 . . . . 0.0 112.529 -167.529 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' F' F ' 138' ' ' LEU . . . . . . . . . . . . . 13.0 tp -112.99 121.55 44.98 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 114.787 -1.097 . . . . 0.0 109.003 173.103 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' F' F ' 139' ' ' THR . . . . . . . . . . . . . 31.8 m -113.95 126.96 55.73 Favored 'General case' 0 C--N 1.331 -0.215 0 CA-C-O 120.837 0.351 . . . . 0.0 110.862 -178.761 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' F' F ' 140' ' ' LEU . . . . . 0.485 HD23 ' C ' ' F' ' 140' ' ' LEU . 8.8 tt -116.34 124.13 49.34 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 115.577 -0.738 . . . . 0.0 109.354 179.913 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' F' F ' 141' ' ' ILE . . . . . 0.509 ' HB ' HG13 ' F' ' 130' ' ' VAL . 19.3 mt -121.48 120.88 63.11 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.275 0 CA-C-O 120.923 0.392 . . . . 0.0 109.971 -175.199 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' F' F ' 142' ' ' ARG . . . . . . . . . . . . . 34.7 tpt85 -110.22 127.07 54.77 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-N 115.337 -0.847 . . . . 0.0 109.965 -178.136 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' F' F ' 143' ' ' THR . . . . . . . . . . . . . 34.4 p . . . . . 0 C--O 1.22 -0.458 0 CA-C-O 118.02 -0.991 . . . . 0.0 110.656 -179.748 . . . . . . . . 0 0 . 1 . 012 nuclear nobuild core ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 1.7 p . . . . . 0 C--O 1.233 0.19 0 CA-C-O 121.377 0.608 . . . . 0.0 110.336 . . . . . . . . . 0 0 . 1 . 012 nuclear nobuild core ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 85.1 tt0 -143.05 142.1 31.47 Favored 'General case' 0 C--N 1.327 -0.399 0 CA-C-N 115.451 -0.795 . . . . 0.0 111.114 -178.325 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 4' ' ' LEU . . . . . . . . . . . . . 18.9 tp -123.93 128.18 49.05 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 115.887 -0.597 . . . . 0.0 109.952 176.922 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 5' ' ' LYS . . . . . . . . . . . . . 95.2 mttt -107.24 122.56 46.79 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.572 -0.285 . . . . 0.0 110.71 -179.873 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 58.1 mt -115.54 147.65 40.45 Favored 'General case' 0 C--N 1.331 -0.215 0 CA-C-N 115.577 -0.738 . . . . 0.0 110.244 -179.123 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 26.5 ttpp -125.98 139.7 34.98 Favored Pre-proline 0 CA--C 1.532 0.284 0 CA-C-O 118.983 -0.532 . . . . 0.0 109.725 174.244 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 8' ' ' PRO . . . . . . . . . . . . . 83.7 Cg_endo -91.75 133.61 1.42 Allowed 'Trans proline' 0 N--CA 1.489 1.224 0 C-N-CA 121.786 1.657 . . . . 0.0 111.808 178.275 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 73.2 mt -75.64 -47.01 4.14 Favored Pre-proline 0 CA--C 1.534 0.339 0 CA-C-O 118.527 -0.749 . . . . 0.0 111.948 179.03 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 73.9 Cg_endo -77.88 145.66 22.71 Favored 'Trans proline' 0 N--CA 1.496 1.635 0 CA-C-N 120.427 1.188 . . . . 0.0 111.656 175.154 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 58.1 mttm -84.76 89.53 7.54 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-O 120.815 0.34 . . . . 0.0 110.701 -179.781 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 12.3 p -139.55 146.24 25.72 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.293 0 CA-C-N 116.096 -0.502 . . . . 0.0 110.289 178.989 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 45.4 tp10 -89.47 129.35 35.97 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.342 -0.39 . . . . 0.0 110.254 178.554 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 14' ' ' LEU . . . . . . . . . . . . . 35.2 mt -97.36 144.88 28.69 Favored Pre-proline 0 C--N 1.329 -0.3 0 CA-C-O 119.14 -0.457 . . . . 0.0 110.05 -179.01 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 15' ' ' PRO . . . . . . . . . . . . . 24.8 Cg_exo -61.83 163.03 20.03 Favored 'Trans proline' 0 N--CA 1.498 1.783 0 C-N-CA 121.268 1.312 . . . . 0.0 111.751 178.447 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 16' ' ' PRO . . . . . . . . . . . . . 31.7 Cg_exo -59.52 -36.07 94.1 Favored 'Trans proline' 0 N--CA 1.497 1.698 0 C-N-CA 121.562 1.508 . . . . 0.0 112.971 -177.502 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 17' ' ' ASP . . . . . . . . . . . . . 7.9 p-10 -84.64 0.16 51.24 Favored 'General case' 0 CA--C 1.537 0.459 0 N-CA-C 113.274 0.842 . . . . 0.0 113.274 -177.748 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 18' ' ' PHE . . . . . . . . . . . . . 35.3 t80 -58.64 -43.75 89.85 Favored 'General case' 0 C--N 1.333 -0.128 0 O-C-N 121.95 -0.469 . . . . 0.0 109.963 -177.75 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 19' ' ' VAL . . . . . . . . . . . . . 53.3 t -57.19 -42.51 80.0 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.253 0 CA-C-N 116.155 -0.475 . . . . 0.0 110.383 -179.366 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 19.1 t0 -60.02 -42.89 95.33 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-O 120.775 0.322 . . . . 0.0 111.057 -177.869 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 45.4 t -64.38 -46.49 92.86 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.269 0 C-N-CA 120.784 -0.367 . . . . 0.0 110.361 -177.693 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 22' ' ' ILE . . . . . 0.411 HG22 HD12 ' A' ' 26' ' ' LEU . 51.9 mm -56.27 -44.23 78.97 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.223 0 CA-C-O 120.73 0.3 . . . . 0.0 110.54 178.633 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 23' ' ' ARG . . . . . . . . . . . . . 57.3 ttp180 -54.53 -47.82 72.71 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-O 120.774 0.321 . . . . 0.0 111.305 -179.934 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 24' ' ' ILE . . . . . . . . . . . . . 79.9 mt -59.15 -41.41 83.62 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.295 0 CA-C-N 116.438 -0.346 . . . . 0.0 111.022 -178.574 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 58.3 mttm -67.48 -41.0 85.31 Favored 'General case' 0 C--N 1.328 -0.343 0 N-CA-C 112.571 0.582 . . . . 0.0 112.571 -179.006 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 26' ' ' LEU . . . . . 0.411 HD12 HG22 ' A' ' 22' ' ' ILE . 79.5 mt -77.92 -38.67 45.05 Favored 'General case' 0 C--N 1.331 -0.233 0 N-CA-C 113.512 0.93 . . . . 0.0 113.512 -170.227 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 27' ' ' GLN . . . . . . . . . . . . . 9.7 pt20 -46.94 138.62 6.26 Favored 'General case' 0 N--CA 1.468 0.429 0 N-CA-C 112.796 0.665 . . . . 0.0 112.796 -174.722 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 101.13 -25.69 27.36 Favored Glycine 0 CA--C 1.533 1.165 0 CA-C-N 115.609 -0.723 . . . . 0.0 112.341 -177.865 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 69.8 mmtt -98.31 155.18 17.33 Favored 'General case' 0 C--N 1.333 -0.128 0 CA-C-N 117.4 0.6 . . . . 0.0 111.31 178.443 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 30' ' ' THR . . . . . . . . . . . . . 40.2 m -108.88 139.87 43.13 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 115.804 -0.634 . . . . 0.0 109.792 175.244 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 33.6 m -130.69 155.77 42.08 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.222 0 CA-C-O 121.032 0.444 . . . . 0.0 111.144 -177.542 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 32' ' ' ARG . . . . . . . . . . . . . 61.5 mtt85 -129.02 150.58 50.37 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-N 115.862 -0.608 . . . . 0.0 110.733 178.36 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 33' ' ' THR . . . . . . . . . . . . . 23.3 m -53.26 138.91 31.09 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.054 -0.521 . . . . 0.0 111.39 -178.087 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 100.65 -17.2 56.91 Favored Glycine 0 CA--C 1.534 1.266 0 CA-C-O 119.607 -0.552 . . . . 0.0 113.232 178.526 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 79.5 m-20 -66.44 147.31 53.48 Favored 'General case' 0 N--CA 1.461 0.097 0 CA-C-N 118.008 0.904 . . . . 0.0 111.117 178.63 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 42.1 t -121.74 130.35 74.68 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.288 0 CA-C-N 116.083 -0.508 . . . . 0.0 109.865 178.403 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 37' ' ' ILE . . . . . . . . . . . . . 68.4 mt -120.4 138.55 50.56 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.279 0 CA-C-N 116.161 -0.472 . . . . 0.0 109.877 -179.813 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . -117.48 128.72 7.96 Favored Glycine 0 CA--C 1.526 0.735 0 N-CA-C 110.636 -0.986 . . . . 0.0 110.636 178.611 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 39' ' ' ILE . . . . . . . . . . . . . 69.9 mt -123.75 132.46 71.34 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.24 0 CA-C-O 120.735 0.302 . . . . 0.0 110.3 -179.986 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 40' ' ' SER . . . . . . . . . . . . . 30.1 t -92.37 118.35 30.83 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.14 -0.482 . . . . 0.0 110.605 175.698 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 41' ' ' ILE . . . . . . . . . . . . . 69.2 mt -130.71 122.5 52.67 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.234 0 CA-C-O 120.849 0.357 . . . . 0.0 110.499 178.612 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 45.8 mt 55.12 33.91 21.45 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.033 -0.53 . . . . 0.0 111.897 176.666 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . 72.81 28.4 67.09 Favored Glycine 0 CA--C 1.531 1.046 0 C-N-CA 121.016 -0.611 . . . . 0.0 112.375 178.026 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 44' ' ' LYS . . . . . . . . . . . . . 26.4 ttpp -137.24 127.61 26.5 Favored 'General case' 0 C--N 1.331 -0.228 0 N-CA-C 109.54 -0.541 . . . . 0.0 109.54 177.288 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 67.6 tt0 -86.05 126.68 34.35 Favored 'General case' 0 C--N 1.327 -0.392 0 CA-C-N 116.336 -0.393 . . . . 0.0 111.12 -176.851 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 46' ' ' VAL . . . . . . . . . . . . . 10.2 p -119.55 126.81 75.68 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.172 0 N-CA-C 109.909 -0.404 . . . . 0.0 109.909 175.436 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 72.7 mmtt -98.2 125.54 43.29 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 115.927 -0.579 . . . . 0.0 110.752 176.148 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 48' ' ' PHE . . . . . . . . . . . . . 32.8 m-85 -112.16 131.61 55.36 Favored 'General case' 0 C--N 1.329 -0.295 0 N-CA-C 109.185 -0.672 . . . . 0.0 109.185 174.651 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 42.2 tttp -108.4 132.92 53.27 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.484 -0.325 . . . . 0.0 110.208 178.931 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 50' ' ' VAL . . . . . . . . . . . . . 41.3 t -76.23 103.99 4.04 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.332 0 N-CA-C 109.21 -0.663 . . . . 0.0 109.21 177.427 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 51' ' ' VAL . . . . . . . . . . . . . 47.8 t -69.65 -50.19 52.21 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.347 0 CA-C-N 116.086 -0.506 . . . . 0.0 109.801 -174.722 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 52' ' ' GLN . . . . . . . . . . . . . 62.2 tt0 -160.3 140.15 11.25 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 115.875 -0.602 . . . . 0.0 111.724 -177.84 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 53' ' ' ALA . . . . . 0.411 ' HB1' ' HB2' ' A' ' 58' ' ' LEU . . . -112.76 130.67 55.99 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-N 115.735 -0.666 . . . . 0.0 109.709 175.017 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 54' ' ' TYR . . . . . . . . . . . . . 59.5 t80 -129.16 107.94 17.89 Favored Pre-proline 0 CA--C 1.535 0.394 0 CA-C-O 118.324 -0.846 . . . . 0.0 110.457 -179.661 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 55' ' ' PRO . . . . . . . . . . . . . 73.7 Cg_endo -77.1 170.09 72.56 Favored 'Cis proline' 0 N--CA 1.499 1.821 0 CA-C-N 121.829 1.689 . . . . 0.0 112.339 -5.624 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 56' ' ' SER . . . . . . . . . . . . . 20.1 m -114.5 130.71 23.8 Favored Pre-proline 0 CA--C 1.539 0.526 0 CA-C-O 118.412 -0.804 . . . . 0.0 109.506 175.441 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 57' ' ' PRO . . . . . . . . . . . . . 55.2 Cg_endo -71.44 146.99 86.78 Favored 'Cis proline' 0 N--CA 1.496 1.664 0 CA-C-N 121.947 1.731 . . . . 0.0 111.622 -0.914 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 58' ' ' LEU . . . . . 0.411 ' HB2' ' HB1' ' A' ' 53' ' ' ALA . 22.3 tp -106.53 135.28 48.31 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.28 -0.418 . . . . 0.0 110.22 -179.506 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 59' ' ' ARG . . . . . . . . . . . . . 56.7 ttt85 -105.55 127.12 52.85 Favored 'General case' 0 C--N 1.326 -0.426 0 N-CA-C 109.2 -0.667 . . . . 0.0 109.2 176.639 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 43.4 t -86.03 124.1 40.01 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.234 0 C-N-CA 120.588 -0.445 . . . . 0.0 110.61 -174.528 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 96.0 mt-10 -131.02 172.48 12.04 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 115.774 -0.648 . . . . 0.0 109.877 177.999 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 62' ' ' ASP . . . . . . . . . . . . . 7.5 p-10 -55.56 -32.75 63.25 Favored 'General case' 0 C--N 1.328 -0.339 0 C-N-CA 120.922 -0.311 . . . . 0.0 111.557 179.42 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 63' ' ' ARG . . . . . . . . . . . . . 25.8 ptt180 -86.33 3.74 42.18 Favored 'General case' 0 CA--C 1.537 0.477 0 N-CA-C 113.724 1.009 . . . . 0.0 113.724 -176.94 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 30.7 m -83.51 135.29 34.71 Favored 'General case' 0 C--N 1.333 -0.135 0 CA-C-N 118.04 0.382 . . . . 0.0 110.612 -177.427 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 65' ' ' LYS . . . . . . . . . . . . . 52.1 mtmt -89.72 129.28 36.15 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.064 -0.517 . . . . 0.0 110.503 179.556 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 66' ' ' ILE . . . . . . . . . . . . . 66.4 mt -114.45 129.08 71.1 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.309 0 N-CA-C 109.41 -0.589 . . . . 0.0 109.41 177.61 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 67' ' ' THR . . . . . . . . . . . . . 22.0 m -125.74 144.64 50.54 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.215 -0.448 . . . . 0.0 111.345 -175.66 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 68' ' ' LEU . . . . . 0.425 HD23 ' C ' ' A' ' 68' ' ' LEU . 5.6 tt . . . . . 0 C--N 1.329 -0.299 0 CA-C-N 115.805 -0.634 . . . . 0.0 109.43 175.788 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 74' ' ' ASP . . . . . . . . . . . . . 25.1 t0 . . . . . 0 CA--C 1.524 -0.027 0 N-CA-C 110.507 -0.183 . . . . 0.0 110.507 . . . . . . . . . 0 0 . 1 . 012 nuclear nobuild core ' A' A ' 75' ' ' VAL . . . . . 0.45 ' C ' HD12 ' A' ' 76' ' ' LEU . 40.0 t -118.67 121.01 65.91 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.212 0 CA-C-O 120.955 0.407 . . . . 0.0 110.52 -178.561 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 76' ' ' LEU . . . . . 0.45 HD12 ' C ' ' A' ' 75' ' ' VAL . 7.5 mp -117.3 141.31 48.46 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 115.79 -0.641 . . . . 0.0 109.502 175.608 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 77' ' ' GLU . . . . . . . . . . . . . 97.0 mt-10 -132.56 136.13 46.39 Favored 'General case' 0 C--N 1.331 -0.197 0 CA-C-O 121.151 0.5 . . . . 0.0 111.465 -177.724 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 78' ' ' ALA . . . . . . . . . . . . . . . -124.24 131.45 53.53 Favored 'General case' 0 C--N 1.332 -0.185 0 CA-C-N 115.482 -0.781 . . . . 0.0 109.7 176.079 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 79' ' ' LYS . . . . . 0.645 ' O ' HD13 ' A' ' 80' ' ' ILE . 99.2 mttt -78.31 117.48 19.6 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-O 120.918 0.39 . . . . 0.0 110.714 -177.533 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 80' ' ' ILE . . . . . 0.645 HD13 ' O ' ' A' ' 79' ' ' LYS . 38.7 mm -139.24 111.47 5.55 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.311 0 N-CA-C 109.241 -0.652 . . . . 0.0 109.241 -177.448 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 81' ' ' LYS . . . . . . . . . . . . . 20.0 pttp -106.31 127.41 53.23 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-O 121.165 0.507 . . . . 0.0 111.608 -176.721 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . 89.01 42.16 5.71 Favored Glycine 0 CA--C 1.525 0.691 0 C-N-CA 120.883 -0.675 . . . . 0.0 111.832 174.267 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 83' ' ' ILE . . . . . . . . . . . . . 71.1 mt -71.49 138.0 22.58 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.231 0 N-CA-C 109.921 -0.4 . . . . 0.0 109.921 178.314 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 84' ' ' LYS . . . . . . . . . . . . . 31.0 ttmt -88.96 -53.09 4.75 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 115.943 -0.572 . . . . 0.0 109.788 -179.605 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 85' ' ' ASP . . . . . . . . . . . . . 7.2 t0 -157.39 151.91 25.19 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 115.51 -0.768 . . . . 0.0 110.136 179.637 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 86' ' ' VAL . . . . . . . . . . . . . 41.9 t -126.59 131.7 70.99 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.187 0 CA-C-O 120.956 0.408 . . . . 0.0 110.375 -179.138 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 87' ' ' ILE . . . . . 0.494 HD12 ' N ' ' A' ' 87' ' ' ILE . 5.0 mp -117.37 124.75 73.43 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.224 0 N-CA-C 109.351 -0.611 . . . . 0.0 109.351 175.998 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 88' ' ' LEU . . . . . . . . . . . . . 10.6 tp -111.88 129.54 56.13 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-O 120.991 0.424 . . . . 0.0 111.098 -176.15 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 89' ' ' ASP . . . . . . . . . . . . . 13.4 t70 -125.22 150.55 46.9 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-N 115.789 -0.641 . . . . 0.0 109.535 175.428 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 84.4 tt0 -48.67 -34.88 12.68 Favored 'General case' 0 C--N 1.328 -0.351 0 N-CA-C 112.772 0.656 . . . . 0.0 112.772 -172.946 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 91' ' ' ASN . . . . . . . . . . . . . 25.1 m120 -130.48 29.79 4.79 Favored 'General case' 0 N--CA 1.468 0.459 0 N-CA-C 112.184 0.439 . . . . 0.0 112.184 -176.559 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 92' ' ' LEU . . . . . . . . . . . . . 12.4 tp -166.09 141.99 4.9 Favored 'General case' 0 C--N 1.33 -0.275 0 C-N-CA 121.103 -0.239 . . . . 0.0 110.384 179.569 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 93' ' ' ILE . . . . . . . . . . . . . 74.2 mt -124.79 123.49 65.93 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.23 0 N-CA-C 109.609 -0.515 . . . . 0.0 109.609 179.191 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 94' ' ' VAL . . . . . . . . . . . . . 45.5 t -122.56 126.87 74.66 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.241 0 N-CA-C 109.876 -0.416 . . . . 0.0 109.876 179.856 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 95' ' ' VAL . . . . . . . . . . . . . 47.8 t -121.46 132.53 70.47 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.292 0 CA-C-N 116.028 -0.533 . . . . 0.0 109.862 -179.293 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 96' ' ' ILE . . . . . . . . . . . . . 57.3 mt -112.83 126.42 70.22 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.337 0 N-CA-C 109.021 -0.733 . . . . 0.0 109.021 178.62 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 97' ' ' THR . . . . . . . . . . . . . 72.9 p -101.73 154.27 19.05 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-O 121.265 0.555 . . . . 0.0 111.137 -176.426 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 98' ' ' GLU . . . . . . . . . . . . . 48.0 tp10 -54.14 -25.92 24.84 Favored 'General case' 0 CA--C 1.535 0.366 0 CA-C-N 116.111 -0.495 . . . . 0.0 112.107 -179.809 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 99' ' ' GLU . . . . . . . . . . . . . 40.0 tt0 -80.13 18.11 0.91 Allowed 'General case' 0 CA--C 1.539 0.522 0 N-CA-C 112.573 0.582 . . . . 0.0 112.573 -176.688 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 100' ' ' ASN . . . . . . . . . . . . . 2.9 m-20 62.97 37.12 12.09 Favored 'General case' 0 CA--C 1.529 0.163 0 O-C-N 121.738 -0.601 . . . . 0.0 111.141 176.378 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 101' ' ' GLU . . . . . . . . . . . . . 84.5 tt0 -118.71 143.09 47.09 Favored 'General case' 0 C--N 1.332 -0.182 0 CA-C-N 116.072 -0.513 . . . . 0.0 109.925 176.231 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 102' ' ' VAL . . . . . . . . . . . . . 47.0 t -114.97 125.57 72.33 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.278 0 N-CA-C 109.761 -0.459 . . . . 0.0 109.761 179.858 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 103' ' ' LEU . . . . . . . . . . . . . 54.4 mt -116.71 135.12 54.03 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 115.732 -0.667 . . . . 0.0 109.955 178.886 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 104' ' ' ILE . . . . . . . . . . . . . 72.9 mt -122.97 123.09 67.25 Favored 'Isoleucine or valine' 0 C--O 1.234 0.246 0 N-CA-C 110.349 -0.241 . . . . 0.0 110.349 -178.674 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 105' ' ' PHE . . . . . . . . . . . . . 85.5 m-85 -123.82 165.43 17.35 Favored 'General case' 0 C--O 1.232 0.184 0 O-C-N 123.996 0.81 . . . . 0.0 110.071 -178.618 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 106' ' ' ASN . . . . . . . . . . . . . 47.4 p-10 -101.3 -169.96 1.77 Allowed 'General case' 0 C--N 1.329 -0.317 0 N-CA-C 109.577 -0.527 . . . . 0.0 109.577 171.769 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 107' ' ' GLN . . . . . . . . . . . . . 47.7 tt0 -59.01 -29.97 67.65 Favored 'General case' 0 C--N 1.329 -0.312 0 N-CA-C 112.006 0.373 . . . . 0.0 112.006 -178.975 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 108' ' ' ASN . . . . . . . . . . . . . 6.7 t-20 -87.07 12.31 11.73 Favored 'General case' 0 CA--C 1.533 0.321 0 N-CA-C 113.015 0.746 . . . . 0.0 113.015 -176.653 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 109' ' ' LEU . . . . . . . . . . . . . 24.9 mt 58.56 37.03 25.5 Favored 'General case' 0 C--O 1.233 0.191 0 CA-C-O 120.828 0.346 . . . . 0.0 111.497 177.245 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 110' ' ' GLU . . . . . . . . . . . . . 95.4 mt-10 -104.66 146.87 28.32 Favored 'General case' 0 C--N 1.329 -0.293 0 N-CA-C 110.013 -0.365 . . . . 0.0 110.013 176.513 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 111' ' ' GLU . . . . . . . . . . . . . 98.8 mt-10 -76.16 121.94 23.59 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-O 120.989 0.423 . . . . 0.0 111.204 -178.304 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 112' ' ' LEU . . . . . . . . . . . . . 50.3 mt -107.47 -45.81 3.99 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 115.767 -0.651 . . . . 0.0 110.033 175.985 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 113' ' ' TYR . . . . . . . . . . . . . 63.2 t80 -140.64 138.71 34.55 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.012 -0.54 . . . . 0.0 110.859 179.973 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 114' ' ' ARG . . . . . . . . . . . . . 36.5 mtm105 -144.03 124.15 13.67 Favored 'General case' 0 C--N 1.331 -0.221 0 CA-C-N 116.388 -0.369 . . . . 0.0 110.494 176.309 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 115' ' ' GLY . . . . . . . . . . . . . . . -150.15 143.66 10.98 Favored Glycine 0 CA--C 1.524 0.614 0 N-CA-C 110.939 -0.864 . . . . 0.0 110.939 179.345 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 116' ' ' LYS . . . . . . . . . . . . . 35.3 ttmt -114.15 140.43 48.53 Favored 'General case' 0 C--N 1.331 -0.201 0 CA-C-O 120.861 0.362 . . . . 0.0 110.054 177.032 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 117' ' ' PHE . . . . . . . . . . . . . 32.5 m-85 -137.63 115.04 11.09 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.19 -0.459 . . . . 0.0 109.889 -176.487 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 118' ' ' GLU . . . . . . . . . . . . . 96.0 mt-10 -54.64 -44.12 72.91 Favored 'General case' 0 C--N 1.328 -0.335 0 C-N-CA 120.965 -0.294 . . . . 0.0 111.321 -175.698 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 119' ' ' ASN . . . . . . . . . . . . . 25.1 m120 -96.44 30.58 2.5 Favored 'General case' 0 C--N 1.33 -0.248 0 N-CA-C 112.29 0.478 . . . . 0.0 112.29 -174.878 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 120' ' ' LEU . . . . . . . . . . . . . 28.7 tp -60.6 126.74 28.55 Favored 'General case' 0 C--N 1.332 -0.189 0 N-CA-C 109.83 -0.433 . . . . 0.0 109.83 177.287 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 121' ' ' ASN . . . . . . . . . . . . . 55.8 m-80 -110.88 -44.09 3.68 Favored 'General case' 0 C--N 1.331 -0.225 0 CA-C-N 116.361 -0.381 . . . . 0.0 111.128 -176.863 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 122' ' ' LYS . . . . . . . . . . . . . 56.2 pttt -161.44 159.21 27.82 Favored 'General case' 0 C--N 1.332 -0.167 0 C-N-CA 120.428 -0.509 . . . . 0.0 111.84 -179.266 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 123' ' ' VAL . . . . . . . . . . . . . 38.0 t -131.18 135.86 58.89 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.221 0 CA-C-N 116.094 -0.503 . . . . 0.0 110.321 -179.481 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 124' ' ' LEU . . . . . . . . . . . . . 46.0 mt -119.85 130.53 54.92 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.068 -0.514 . . . . 0.0 109.788 177.773 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 125' ' ' VAL . . . . . 0.409 ' CG1' HG21 ' A' ' 87' ' ' ILE . 13.6 p -138.29 137.49 43.91 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.2 0 CA-C-O 121.073 0.464 . . . . 0.0 111.166 -179.026 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 126' ' ' ARG . . . . . . . . . . . . . 14.0 ptm180 -163.28 135.97 5.41 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 115.804 -0.634 . . . . 0.0 109.776 175.673 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 127' ' ' ASN . . . . . . . . . . . . . 78.6 m-20 55.34 -154.55 0.3 Allowed 'General case' 0 CA--C 1.539 0.544 0 N-CA-C 110.074 -0.343 . . . . 0.0 110.074 179.875 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 128' ' ' ASP . . . . . . . . . . . . . 20.0 p-10 -80.15 15.49 1.51 Allowed 'General case' 0 CA--C 1.536 0.411 0 N-CA-C 112.938 0.718 . . . . 0.0 112.938 179.394 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 129' ' ' LEU . . . . . . . . . . . . . 13.9 tp -119.68 132.42 55.67 Favored 'General case' 0 C--O 1.232 0.142 0 CA-C-N 118.154 0.434 . . . . 0.0 110.223 179.575 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 130' ' ' VAL . . . . . 0.402 HG13 ' HB ' ' A' ' 141' ' ' ILE . 14.1 p -138.87 145.36 27.88 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.292 0 CA-C-O 120.979 0.418 . . . . 0.0 110.604 178.912 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 131' ' ' VAL . . . . . . . . . . . . . 43.1 t -135.04 138.68 48.57 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.252 0 CA-C-N 116.18 -0.464 . . . . 0.0 110.223 179.3 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 132' ' ' ILE . . . . . . . . . . . . . 67.6 mt -112.52 131.68 63.36 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.331 0 N-CA-C 109.349 -0.611 . . . . 0.0 109.349 179.849 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 133' ' ' ILE . . . . . . . . . . . . . 43.8 mm -115.02 123.21 70.48 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.254 0 CA-C-O 120.667 0.27 . . . . 0.0 111.083 -174.945 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 134' ' ' ASP . . . . . . . . . . . . . 7.2 p-10 -135.93 147.64 48.2 Favored 'General case' 0 C--N 1.332 -0.186 0 N-CA-C 109.584 -0.524 . . . . 0.0 109.584 172.896 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 135' ' ' GLU . . . . . . . . . . . . . 84.6 tt0 -49.81 -27.65 5.3 Favored 'General case' 0 C--N 1.327 -0.409 0 N-CA-C 112.767 0.654 . . . . 0.0 112.767 -172.749 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 136' ' ' GLN . . . . . . . . . . . . . 48.2 tt0 -83.57 -32.76 25.63 Favored 'General case' 0 C--O 1.235 0.323 0 N-CA-C 112.34 0.496 . . . . 0.0 112.34 -174.967 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 137' ' ' LYS . . . . . . . . . . . . . 52.0 pttt -167.04 169.88 12.49 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-O 121.497 0.665 . . . . 0.0 112.098 -172.365 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 138' ' ' LEU . . . . . 0.466 ' C ' HD23 ' A' ' 138' ' ' LEU . 8.8 tt -119.87 129.25 54.3 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 115.273 -0.876 . . . . 0.0 110.065 179.439 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 139' ' ' THR . . . . . . . . . . . . . 44.4 m -110.03 127.01 54.57 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.084 -0.507 . . . . 0.0 110.294 179.657 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 140' ' ' LEU . . . . . 0.475 HD23 ' C ' ' A' ' 140' ' ' LEU . 8.7 tt -110.8 123.33 49.87 Favored 'General case' 0 C--N 1.328 -0.329 0 N-CA-C 109.421 -0.585 . . . . 0.0 109.421 179.782 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 141' ' ' ILE . . . . . 0.402 ' HB ' HG13 ' A' ' 130' ' ' VAL . 18.9 mt -124.64 123.59 66.33 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.259 0 CA-C-O 120.964 0.412 . . . . 0.0 109.933 -175.336 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 142' ' ' ARG . . . . . . . . . . . . . 69.4 ttt180 -111.59 119.73 39.69 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 115.75 -0.659 . . . . 0.0 109.587 178.598 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 143' ' ' THR . . . . . . . . . . . . . 71.0 p . . . . . 0 C--O 1.22 -0.46 0 CA-C-O 117.981 -1.009 . . . . 0.0 110.606 -178.451 . . . . . . . . 0 0 . 1 . 012 nuclear nobuild core ' B' B ' 2' ' ' SER . . . . . . . . . . . . . 9.6 p . . . . . 0 C--O 1.233 0.212 0 CA-C-O 120.963 0.411 . . . . 0.0 110.558 . . . . . . . . . 0 0 . 1 . 012 nuclear nobuild core ' B' B ' 3' ' ' GLU . . . . . . . . . . . . . 95.0 mt-10 -139.84 142.39 36.6 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.021 -0.536 . . . . 0.0 110.954 -178.532 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' B' B ' 4' ' ' LEU . . . . . 0.404 HD23 ' N ' ' B' ' 5' ' ' LYS . 4.3 tt -126.14 124.73 41.19 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 115.829 -0.623 . . . . 0.0 109.559 176.899 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' B' B ' 5' ' ' LYS . . . . . 0.404 ' N ' HD23 ' B' ' 4' ' ' LEU . 96.1 mttt -108.12 120.87 43.58 Favored 'General case' 0 C--O 1.234 0.265 0 CA-C-O 120.755 0.312 . . . . 0.0 110.913 -178.2 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' B' B ' 6' ' ' LEU . . . . . 0.412 HD23 ' HA ' ' B' ' 50' ' ' VAL . 54.4 mt -114.82 148.96 37.79 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 115.439 -0.8 . . . . 0.0 110.656 -178.992 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' B' B ' 7' ' ' LYS . . . . . . . . . . . . . 26.3 ttpp -136.53 140.78 33.33 Favored Pre-proline 0 CA--C 1.532 0.267 0 CA-C-O 119.166 -0.445 . . . . 0.0 109.991 174.701 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' B' B ' 8' ' ' PRO . . . . . . . . . . . . . 87.9 Cg_endo -91.88 138.98 2.09 Favored 'Trans proline' 0 N--CA 1.49 1.274 0 C-N-CA 121.756 1.638 . . . . 0.0 111.638 177.645 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' B' B ' 9' ' ' LEU . . . . . . . . . . . . . 69.0 mt -73.65 -46.99 7.2 Favored Pre-proline 0 CA--C 1.534 0.357 0 CA-C-O 118.682 -0.675 . . . . 0.0 111.961 -179.991 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' B' B ' 10' ' ' PRO . . . . . . . . . . . . . 83.1 Cg_endo -81.36 150.81 17.43 Favored 'Trans proline' 0 N--CA 1.497 1.7 0 C-N-CA 121.166 1.244 . . . . 0.0 111.824 174.738 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' B' B ' 11' ' ' LYS . . . . . . . . . . . . . 39.4 ttpt -87.6 94.26 9.67 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.442 -0.345 . . . . 0.0 110.325 178.648 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' B' B ' 12' ' ' VAL . . . . . . . . . . . . . 12.0 p -140.07 142.19 32.29 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.297 0 CA-C-N 116.211 -0.449 . . . . 0.0 110.394 179.252 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' B' B ' 13' ' ' GLU . . . . . . . . . . . . . 41.9 mt-10 -75.69 132.24 40.41 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-O 120.802 0.335 . . . . 0.0 110.251 178.623 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' B' B ' 14' ' ' LEU . . . . . . . . . . . . . 30.5 mt -98.32 153.16 38.16 Favored Pre-proline 0 C--N 1.33 -0.253 0 CA-C-N 116.346 -0.388 . . . . 0.0 110.666 -179.224 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' B' B ' 15' ' ' PRO . . . . . . . . . . . . . 27.7 Cg_exo -61.12 154.12 59.66 Favored 'Trans proline' 0 N--CA 1.496 1.667 0 C-N-CA 121.276 1.317 . . . . 0.0 111.599 177.626 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' B' B ' 16' ' ' PRO . . . . . . . . . . . . . 33.9 Cg_exo -57.74 -36.44 98.39 Favored 'Trans proline' 0 N--CA 1.498 1.751 0 C-N-CA 121.389 1.393 . . . . 0.0 112.793 -178.896 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' B' B ' 17' ' ' ASP . . . . . . . . . . . . . 18.0 p-10 -92.43 15.04 14.89 Favored 'General case' 0 C--N 1.327 -0.383 0 N-CA-C 113.02 0.748 . . . . 0.0 113.02 -177.489 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' B' B ' 18' ' ' PHE . . . . . . . . . . . . . 44.4 t80 -58.38 -44.69 89.0 Favored 'General case' 0 C--O 1.228 -0.078 0 O-C-N 122.008 -0.432 . . . . 0.0 110.057 -177.722 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' B' B ' 19' ' ' VAL . . . . . . . . . . . . . 48.4 t -56.91 -42.97 79.59 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.305 0 CA-C-N 116.055 -0.521 . . . . 0.0 110.53 -178.346 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' B' B ' 20' ' ' ASP . . . . . . . . . . . . . 32.9 t0 -59.59 -43.49 93.67 Favored 'General case' 0 C--N 1.329 -0.315 0 C-N-CA 120.887 -0.325 . . . . 0.0 111.026 -177.22 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' B' B ' 21' ' ' VAL . . . . . . . . . . . . . 45.1 t -64.88 -46.52 91.58 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.248 0 C-N-CA 120.716 -0.393 . . . . 0.0 110.43 -178.116 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' B' B ' 22' ' ' ILE . . . . . 0.632 HG22 HD12 ' B' ' 26' ' ' LEU . 50.9 mm -57.8 -38.87 67.98 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.324 0 CA-C-O 120.668 0.271 . . . . 0.0 110.407 179.272 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' B' B ' 23' ' ' ARG . . . . . . . . . . . . . 57.1 ttp180 -55.84 -49.87 72.11 Favored 'General case' 0 C--N 1.331 -0.216 0 CA-C-O 120.976 0.417 . . . . 0.0 110.558 177.861 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' B' B ' 24' ' ' ILE . . . . . . . . . . . . . 74.0 mt -60.85 -43.85 96.45 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.334 0 CA-C-N 115.834 -0.621 . . . . 0.0 111.73 -177.398 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' B' B ' 25' ' ' LYS . . . . . . . . . . . . . 14.8 pttp -72.97 -36.62 67.14 Favored 'General case' 0 CA--C 1.533 0.298 0 C-N-CA 120.526 -0.47 . . . . 0.0 111.901 -172.933 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' B' B ' 26' ' ' LEU . . . . . 0.632 HD12 HG22 ' B' ' 22' ' ' ILE . 42.0 mt -80.21 -41.78 24.53 Favored 'General case' 0 C--N 1.331 -0.22 0 N-CA-C 113.185 0.809 . . . . 0.0 113.185 -173.796 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' B' B ' 27' ' ' GLN . . . . . . . . . . . . . 10.6 pt20 -47.18 139.28 6.19 Favored 'General case' 0 N--CA 1.469 0.484 0 N-CA-C 112.73 0.641 . . . . 0.0 112.73 -174.539 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' B' B ' 28' ' ' GLY . . . . . . . . . . . . . . . 99.48 -26.0 26.08 Favored Glycine 0 CA--C 1.533 1.179 0 CA-C-N 115.687 -0.688 . . . . 0.0 112.255 -176.877 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' B' B ' 29' ' ' LYS . . . . . . . . . . . . . 56.4 mtmt -98.9 155.16 17.54 Favored 'General case' 0 C--O 1.232 0.164 0 CA-C-N 117.247 0.523 . . . . 0.0 111.103 179.425 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' B' B ' 30' ' ' THR . . . . . . . . . . . . . 31.4 m -105.38 137.73 42.72 Favored 'General case' 0 C--N 1.332 -0.195 0 CA-C-N 116.101 -0.499 . . . . 0.0 110.094 176.949 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' B' B ' 31' ' ' VAL . . . . . . . . . . . . . 34.3 m -130.71 160.41 41.93 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.236 0 CA-C-O 120.911 0.386 . . . . 0.0 110.971 -178.372 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' B' B ' 32' ' ' ARG . . . . . . . . . . . . . 80.3 mtm180 -134.24 149.26 50.95 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 115.907 -0.588 . . . . 0.0 110.477 177.844 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' B' B ' 33' ' ' THR . . . . . . . . . . . . . 24.7 m -53.41 141.63 24.11 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.443 -0.344 . . . . 0.0 111.39 -178.363 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' B' B ' 34' ' ' GLY . . . . . . . . . . . . . . . 99.49 -17.13 58.12 Favored Glycine 0 CA--C 1.533 1.194 0 CA-C-O 119.687 -0.507 . . . . 0.0 113.23 179.762 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' B' B ' 35' ' ' ASP . . . . . . . . . . . . . 76.1 m-20 -65.33 147.99 52.47 Favored 'General case' 0 C--O 1.231 0.123 0 CA-C-N 118.037 0.919 . . . . 0.0 111.041 178.739 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' B' B ' 36' ' ' VAL . . . . . . . . . . . . . 46.7 t -120.58 129.96 75.03 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.204 0 CA-C-N 115.829 -0.623 . . . . 0.0 109.887 179.099 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' B' B ' 37' ' ' ILE . . . . . . . . . . . . . 69.9 mt -120.31 139.18 48.42 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.219 0 N-CA-C 109.841 -0.429 . . . . 0.0 109.841 179.848 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' B' B ' 38' ' ' GLY . . . . . . . . . . . . . . . -114.04 128.74 8.4 Favored Glycine 0 CA--C 1.525 0.691 0 N-CA-C 111.256 -0.738 . . . . 0.0 111.256 -179.683 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' B' B ' 39' ' ' ILE . . . . . . . . . . . . . 69.4 mt -122.9 127.97 75.01 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.218 0 N-CA-C 109.64 -0.504 . . . . 0.0 109.64 177.418 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' B' B ' 40' ' ' SER . . . . . . . . . . . . . 56.3 p -91.95 118.12 30.45 Favored 'General case' 0 C--N 1.33 -0.257 0 C-N-CA 120.908 -0.317 . . . . 0.0 110.75 177.527 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' B' B ' 41' ' ' ILE . . . . . . . . . . . . . 73.8 mt -134.63 128.25 50.68 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.234 0 CA-C-O 120.732 0.301 . . . . 0.0 110.266 178.786 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' B' B ' 42' ' ' LEU . . . . . . . . . . . . . 49.3 mt 57.76 33.08 22.8 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.24 -0.436 . . . . 0.0 111.858 178.543 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' B' B ' 43' ' ' GLY . . . . . . . . . . . . . . . 77.29 -10.05 23.77 Favored Glycine 0 CA--C 1.535 1.334 0 C-N-CA 121.276 -0.487 . . . . 0.0 113.472 178.03 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' B' B ' 44' ' ' LYS . . . . . . . . . . . . . 65.3 tttm -102.22 129.91 48.75 Favored 'General case' 0 C--O 1.233 0.195 0 CA-C-N 117.948 0.874 . . . . 0.0 109.964 177.224 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' B' B ' 45' ' ' GLU . . . . . . . . . . . . . 44.7 tp10 -84.7 125.66 32.71 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.43 -0.35 . . . . 0.0 110.55 178.998 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' B' B ' 46' ' ' VAL . . . . . . . . . . . . . 7.5 p -113.74 128.77 70.48 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.258 0 N-CA-C 109.336 -0.616 . . . . 0.0 109.336 177.108 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' B' B ' 47' ' ' LYS . . . . . . . . . . . . . 93.5 mttt -100.05 126.58 46.27 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 115.849 -0.614 . . . . 0.0 111.12 178.725 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' B' B ' 48' ' ' PHE . . . . . . . . . . . . . 95.3 m-85 -109.48 131.9 54.64 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.079 -0.51 . . . . 0.0 109.679 176.358 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' B' B ' 49' ' ' LYS . . . . . . . . . . . . . 86.4 tttt -107.12 134.73 49.8 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.18 -0.463 . . . . 0.0 110.366 179.25 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' B' B ' 50' ' ' VAL . . . . . 0.412 ' HA ' HD23 ' B' ' 6' ' ' LEU . 46.2 t -79.0 106.42 9.97 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.336 0 N-CA-C 109.167 -0.679 . . . . 0.0 109.167 175.695 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' B' B ' 51' ' ' VAL . . . . . . . . . . . . . 52.5 t -69.9 -52.81 27.73 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.354 0 N-CA-C 109.613 -0.514 . . . . 0.0 109.613 -174.844 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' B' B ' 52' ' ' GLN . . . . . . . . . . . . . 90.7 mt-30 -153.75 151.64 29.82 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-O 121.274 0.559 . . . . 0.0 111.86 -178.114 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' B' B ' 53' ' ' ALA . . . . . . . . . . . . . . . -127.29 132.55 50.29 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 115.065 -0.971 . . . . 0.0 109.323 174.561 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' B' B ' 54' ' ' TYR . . . . . . . . . . . . . 39.7 t80 -129.06 109.78 18.2 Favored Pre-proline 0 CA--C 1.533 0.318 0 CA-C-O 118.183 -0.913 . . . . 0.0 110.381 -179.697 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' B' B ' 55' ' ' PRO . . . . . . . . . . . . . 73.6 Cg_endo -77.1 170.1 72.53 Favored 'Cis proline' 0 N--CA 1.502 2.006 0 CA-C-N 121.907 1.717 . . . . 0.0 112.594 -5.443 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' B' B ' 56' ' ' SER . . . . . . . . . . . . . 15.5 m -116.56 128.05 26.29 Favored Pre-proline 0 CA--C 1.539 0.537 0 CA-C-O 118.409 -0.805 . . . . 0.0 109.37 175.276 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' B' B ' 57' ' ' PRO . . . . . . . . . . . . . 36.6 Cg_endo -66.2 166.04 59.15 Favored 'Cis proline' 0 N--CA 1.499 1.799 0 CA-C-N 121.986 1.745 . . . . 0.0 111.662 -0.113 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' B' B ' 58' ' ' LEU . . . . . . . . . . . . . 29.7 tp -130.21 135.92 48.66 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.318 -0.401 . . . . 0.0 110.734 -179.716 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' B' B ' 59' ' ' ARG . . . . . . . . . . . . . 58.2 ttp180 -101.82 126.75 48.76 Favored 'General case' 0 C--N 1.328 -0.366 0 N-CA-C 109.237 -0.653 . . . . 0.0 109.237 175.815 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' B' B ' 60' ' ' VAL . . . . . . . . . . . . . 46.9 t -78.56 117.98 24.96 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.192 0 C-N-CA 120.546 -0.462 . . . . 0.0 109.915 -177.352 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' B' B ' 61' ' ' GLU . . . . . . . . . . . . . 74.4 tt0 -131.12 159.6 37.16 Favored 'General case' 0 C--N 1.328 -0.337 0 N-CA-C 109.422 -0.584 . . . . 0.0 109.422 -179.504 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' B' B ' 62' ' ' ASP . . . . . . . . . . . . . 52.2 m-20 -51.51 -32.17 26.62 Favored 'General case' 0 C--N 1.328 -0.355 0 N-CA-C 112.074 0.398 . . . . 0.0 112.074 -179.367 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' B' B ' 63' ' ' ARG . . . . . . . . . . . . . 14.5 ptm180 -85.15 5.4 30.06 Favored 'General case' 0 CA--C 1.535 0.403 0 N-CA-C 113.733 1.012 . . . . 0.0 113.733 -175.739 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' B' B ' 64' ' ' THR . . . . . . . . . . . . . 24.4 m -89.72 136.4 33.06 Favored 'General case' 0 C--N 1.332 -0.18 0 CA-C-N 118.151 0.432 . . . . 0.0 110.401 -178.647 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' B' B ' 65' ' ' LYS . . . . . . . . . . . . . 55.1 mtmt -89.1 128.38 35.76 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.299 -0.41 . . . . 0.0 110.31 -179.994 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' B' B ' 66' ' ' ILE . . . . . . . . . . . . . 66.1 mt -113.68 127.18 71.16 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.294 0 N-CA-C 109.638 -0.504 . . . . 0.0 109.638 179.998 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' B' B ' 67' ' ' THR . . . . . . . . . . . . . 23.4 m -126.97 144.09 51.11 Favored 'General case' 0 C--N 1.332 -0.185 0 CA-C-N 116.122 -0.49 . . . . 0.0 111.069 -175.903 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' B' B ' 68' ' ' LEU . . . . . . . . . . . . . 42.8 mt . . . . . 0 C--N 1.329 -0.316 0 CA-C-N 115.942 -0.572 . . . . 0.0 110.61 177.887 . . . . . . . . 0 0 . 1 . 012 nuclear nobuild core ' B' B ' 73' ' ' VAL . . . . . . . . . . . . . 33.8 m . . . . . 0 C--O 1.23 0.058 0 CA-C-O 120.66 0.267 . . . . 0.0 110.376 . . . . . . . . . 0 0 . 1 . 012 nuclear nobuild core ' B' B ' 74' ' ' ASP . . . . . . . . . . . . . 38.8 t0 -95.66 119.28 33.89 Favored 'General case' 0 C--N 1.329 -0.287 0 N-CA-C 110.121 -0.326 . . . . 0.0 110.121 -177.644 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' B' B ' 75' ' ' VAL . . . . . . . . . . . . . 40.6 t -122.52 125.2 72.31 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.295 0 CA-C-O 121.142 0.496 . . . . 0.0 110.818 -177.652 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' B' B ' 76' ' ' LEU . . . . . . . . . . . . . 5.9 mp -121.99 145.29 48.27 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 115.67 -0.695 . . . . 0.0 109.619 175.361 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' B' B ' 77' ' ' GLU . . . . . . . . . . . . . 97.3 mt-10 -134.38 132.06 38.97 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-O 121.061 0.458 . . . . 0.0 111.133 -178.634 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' B' B ' 78' ' ' ALA . . . . . . . . . . . . . . . -120.84 134.28 55.29 Favored 'General case' 0 C--N 1.33 -0.239 0 CA-C-N 115.761 -0.654 . . . . 0.0 109.84 177.028 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' B' B ' 79' ' ' LYS . . . . . 0.438 ' O ' HD13 ' B' ' 80' ' ' ILE . 94.4 mttt -79.1 120.79 24.14 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-O 120.809 0.337 . . . . 0.0 110.566 -178.575 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' B' B ' 80' ' ' ILE . . . . . 0.438 HD13 ' O ' ' B' ' 79' ' ' LYS . 26.8 mm -139.09 110.06 4.76 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.28 0 N-CA-C 109.148 -0.686 . . . . 0.0 109.148 -177.465 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' B' B ' 81' ' ' LYS . . . . . . . . . . . . . 49.0 pttt -99.42 123.39 43.66 Favored 'General case' 0 C--N 1.33 -0.283 0 CA-C-O 121.104 0.478 . . . . 0.0 111.419 -176.778 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' B' B ' 82' ' ' GLY . . . . . . . . . . . . . . . 88.85 42.18 5.76 Favored Glycine 0 CA--C 1.524 0.617 0 C-N-CA 120.769 -0.729 . . . . 0.0 111.664 173.404 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' B' B ' 83' ' ' ILE . . . . . . . . . . . . . 76.8 mt -64.38 135.13 28.45 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.285 0 N-CA-C 109.861 -0.422 . . . . 0.0 109.861 178.669 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' B' B ' 84' ' ' LYS . . . . . . . . . . . . . 84.7 tttt -92.63 -53.85 4.02 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 115.903 -0.589 . . . . 0.0 110.348 -177.326 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' B' B ' 85' ' ' ASP . . . . . . . . . . . . . 3.7 t70 -158.29 158.01 33.58 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 115.678 -0.692 . . . . 0.0 110.147 -178.783 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' B' B ' 86' ' ' VAL . . . . . . . . . . . . . 40.3 t -135.56 134.08 51.87 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.248 0 CA-C-O 121.023 0.44 . . . . 0.0 110.746 -177.69 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' B' B ' 87' ' ' ILE . . . . . . . . . . . . . 44.2 mm -117.48 127.68 74.88 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.226 0 CA-C-N 115.751 -0.659 . . . . 0.0 109.389 174.386 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' B' B ' 88' ' ' LEU . . . . . . . . . . . . . 17.3 tp -112.55 133.06 54.81 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-O 121.01 0.434 . . . . 0.0 111.19 -176.673 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' B' B ' 89' ' ' ASP . . . . . . . . . . . . . 9.0 t0 -128.22 150.51 50.0 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 115.743 -0.662 . . . . 0.0 109.43 176.591 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' B' B ' 90' ' ' GLU . . . . . . . . . . . . . 84.3 tt0 -48.03 -37.63 15.32 Favored 'General case' 0 CA--C 1.531 0.25 0 N-CA-C 112.612 0.597 . . . . 0.0 112.612 -173.336 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' B' B ' 91' ' ' ASN . . . . . . . . . . . . . 84.9 m-20 -131.6 35.07 3.85 Favored 'General case' 0 N--CA 1.465 0.285 0 CA-C-O 120.816 0.341 . . . . 0.0 111.639 -177.301 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' B' B ' 92' ' ' LEU . . . . . . . . . . . . . 11.6 tp -166.07 142.41 5.05 Favored 'General case' 0 C--N 1.331 -0.22 0 CA-C-O 120.673 0.273 . . . . 0.0 110.339 179.723 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' B' B ' 93' ' ' ILE . . . . . . . . . . . . . 70.1 mt -125.47 124.36 66.77 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.343 0 N-CA-C 109.622 -0.51 . . . . 0.0 109.622 -179.896 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' B' B ' 94' ' ' VAL . . . . . . . . . . . . . 41.0 t -124.79 127.33 72.58 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.252 0 N-CA-C 110.008 -0.368 . . . . 0.0 110.008 179.39 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' B' B ' 95' ' ' VAL . . . . . . . . . . . . . 40.1 t -123.37 137.67 55.88 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.293 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.036 -179.48 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' B' B ' 96' ' ' ILE . . . . . . . . . . . . . 65.1 mt -116.46 130.43 71.29 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.256 0 N-CA-C 109.158 -0.682 . . . . 0.0 109.158 178.254 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' B' B ' 97' ' ' THR . . . . . . . . . . . . . 65.4 p -103.96 155.78 18.38 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-O 121.029 0.443 . . . . 0.0 111.255 -177.324 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' B' B ' 98' ' ' GLU . . . . . . . . . . . . . 85.1 tt0 -54.04 -24.54 17.49 Favored 'General case' 0 CA--C 1.534 0.332 0 N-CA-C 112.068 0.396 . . . . 0.0 112.068 178.922 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' B' B ' 99' ' ' GLU . . . . . . . . . . . . . 70.9 mm-40 -76.4 13.49 0.94 Allowed 'General case' 0 CA--C 1.535 0.4 0 N-CA-C 113.2 0.815 . . . . 0.0 113.2 -179.333 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' B' B ' 100' ' ' ASN . . . . . . . . . . . . . 2.3 m-20 64.62 38.1 7.37 Favored 'General case' 0 C--O 1.232 0.15 0 CA-C-O 120.988 0.423 . . . . 0.0 110.788 177.813 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' B' B ' 101' ' ' GLU . . . . . . . . . . . . . 46.2 mt-10 -115.84 143.94 44.72 Favored 'General case' 0 C--N 1.332 -0.16 0 CA-C-N 116.074 -0.512 . . . . 0.0 110.399 177.078 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' B' B ' 102' ' ' VAL . . . . . 0.435 ' C ' HD12 ' B' ' 103' ' ' LEU . 47.2 t -115.11 126.46 72.7 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.357 0 N-CA-C 109.245 -0.65 . . . . 0.0 109.245 176.864 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' B' B ' 103' ' ' LEU . . . . . 0.435 HD12 ' C ' ' B' ' 102' ' ' VAL . 6.4 mp -121.9 132.88 54.8 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-N 116.008 -0.542 . . . . 0.0 110.386 177.796 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' B' B ' 104' ' ' ILE . . . . . . . . . . . . . 71.6 mt -117.62 124.77 73.5 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.315 0 CA-C-N 115.834 -0.621 . . . . 0.0 109.914 -179.092 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' B' B ' 105' ' ' PHE . . . . . . . . . . . . . 75.9 m-85 -123.46 162.23 23.25 Favored 'General case' 0 C--N 1.331 -0.222 0 O-C-N 123.985 0.803 . . . . 0.0 109.823 179.786 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' B' B ' 106' ' ' ASN . . . . . . . . . . . . . 47.9 p-10 -97.22 -170.41 2.02 Favored 'General case' 0 C--N 1.329 -0.31 0 N-CA-C 109.919 -0.4 . . . . 0.0 109.919 173.939 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' B' B ' 107' ' ' GLN . . . . . . . . . . . . . 47.5 tt0 -59.0 -30.05 67.69 Favored 'General case' 0 C--N 1.329 -0.287 0 N-CA-C 111.888 0.329 . . . . 0.0 111.888 179.607 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' B' B ' 108' ' ' ASN . . . . . . . . . . . . . 56.4 t30 -83.96 7.76 17.32 Favored 'General case' 0 CA--C 1.536 0.412 0 N-CA-C 113.259 0.837 . . . . 0.0 113.259 -177.022 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' B' B ' 109' ' ' LEU . . . . . . . . . . . . . 9.8 tp 60.52 36.35 20.0 Favored 'General case' 0 CA--C 1.529 0.165 0 CA-C-O 120.965 0.412 . . . . 0.0 111.413 178.613 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' B' B ' 110' ' ' GLU . . . . . . . . . . . . . 70.6 mm-40 -101.35 147.5 26.25 Favored 'General case' 0 C--N 1.329 -0.322 0 N-CA-C 109.685 -0.487 . . . . 0.0 109.685 175.837 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' B' B ' 111' ' ' GLU . . . . . . . . . . . . . 85.2 tt0 -79.51 121.95 25.85 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-O 120.94 0.4 . . . . 0.0 110.483 -177.508 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' B' B ' 112' ' ' LEU . . . . . . . . . . . . . 20.5 mt -108.26 -46.04 3.8 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 115.911 -0.586 . . . . 0.0 110.548 179.379 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' B' B ' 113' ' ' TYR . . . . . . . . . . . . . 64.4 t80 -140.27 135.17 32.01 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.145 -0.48 . . . . 0.0 111.364 -178.667 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' B' B ' 114' ' ' ARG . . . . . . . . . . . . . 71.6 ttt180 -142.16 125.16 16.2 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.306 -0.406 . . . . 0.0 110.158 176.141 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' B' B ' 115' ' ' GLY . . . . . . . . . . . . . . . -150.04 149.14 21.0 Favored Glycine 0 CA--C 1.523 0.582 0 N-CA-C 111.175 -0.77 . . . . 0.0 111.175 179.115 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' B' B ' 116' ' ' LYS . . . . . . . . . . . . . 35.3 ttpt -114.22 131.75 56.36 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-O 120.732 0.301 . . . . 0.0 110.422 178.283 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' B' B ' 117' ' ' PHE . . . . . 0.426 ' HE2' HD13 ' B' ' 132' ' ' ILE . 43.1 m-85 -129.46 113.94 15.52 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.279 -0.419 . . . . 0.0 109.938 -179.244 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' B' B ' 118' ' ' GLU . . . . . . . . . . . . . 84.6 tt0 -54.91 -48.5 73.0 Favored 'General case' 0 C--N 1.329 -0.318 0 C-N-CA 120.901 -0.319 . . . . 0.0 111.419 -175.601 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' B' B ' 119' ' ' ASN . . . . . . . . . . . . . 91.0 m-20 -94.44 31.2 1.79 Allowed 'General case' 0 C--N 1.33 -0.279 0 N-CA-C 112.187 0.44 . . . . 0.0 112.187 -174.199 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' B' B ' 120' ' ' LEU . . . . . . . . . . . . . 21.9 tp -53.28 123.67 12.51 Favored 'General case' 0 N--CA 1.464 0.254 0 CA-C-O 120.713 0.292 . . . . 0.0 110.953 178.221 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' B' B ' 121' ' ' ASN . . . . . . . . . . . . . 43.2 m-20 -106.37 -44.16 4.59 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-N 116.337 -0.392 . . . . 0.0 110.909 -177.533 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' B' B ' 122' ' ' LYS . . . . . . . . . . . . . 50.7 pttt -161.14 157.73 26.41 Favored 'General case' 0 C--N 1.331 -0.225 0 C-N-CA 120.454 -0.498 . . . . 0.0 112.204 -179.462 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' B' B ' 123' ' ' VAL . . . . . . . . . . . . . 44.0 t -125.6 131.16 72.4 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.246 0 CA-C-N 115.805 -0.634 . . . . 0.0 109.845 177.522 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' B' B ' 124' ' ' LEU . . . . . . . . . . . . . 76.8 mt -116.73 133.3 56.17 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.301 -0.408 . . . . 0.0 110.392 179.979 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' B' B ' 125' ' ' VAL . . . . . . . . . . . . . 47.3 t -131.74 129.51 61.27 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.215 0 CA-C-N 116.284 -0.417 . . . . 0.0 110.228 -179.057 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' B' B ' 126' ' ' ARG . . . . . . . . . . . . . 77.0 mtt180 -141.3 119.79 12.36 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-O 121.076 0.465 . . . . 0.0 110.458 176.538 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' B' B ' 127' ' ' ASN . . . . . . . . . . . . . 42.4 t-20 50.63 -106.47 0.24 Allowed 'General case' 0 CA--C 1.543 0.711 0 CA-C-O 119.003 -0.523 . . . . 0.0 111.37 -179.106 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' B' B ' 128' ' ' ASP . . . . . . . . . . . . . 11.7 p-10 -114.12 2.51 14.92 Favored 'General case' 0 N--CA 1.467 0.407 0 CA-C-N 119.642 1.11 . . . . 0.0 113.466 -177.334 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' B' B ' 129' ' ' LEU . . . . . . . . . . . . . 11.6 tp -104.96 136.85 43.68 Favored 'General case' 0 C--O 1.232 0.134 0 CA-C-N 118.267 0.485 . . . . 0.0 109.849 -179.916 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' B' B ' 130' ' ' VAL . . . . . . . . . . . . . 43.0 t -125.14 138.08 55.51 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.268 0 CA-C-O 121.061 0.457 . . . . 0.0 110.406 -176.885 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' B' B ' 131' ' ' VAL . . . . . 0.461 HG22 HD12 ' B' ' 140' ' ' LEU . 44.2 t -134.52 135.24 54.01 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.34 0 CA-C-N 115.895 -0.593 . . . . 0.0 110.008 177.915 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' B' B ' 132' ' ' ILE . . . . . 0.426 HD13 ' HE2' ' B' ' 117' ' ' PHE . 73.7 mt -115.79 132.28 65.69 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.281 0 N-CA-C 109.501 -0.555 . . . . 0.0 109.501 179.752 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' B' B ' 133' ' ' ILE . . . . . . . . . . . . . 42.7 mm -116.33 125.14 73.24 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.226 0 CA-C-N 116.569 -0.287 . . . . 0.0 111.074 -174.624 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' B' B ' 134' ' ' ASP . . . . . . . . . . . . . 10.1 p-10 -137.45 150.07 47.34 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 116.19 -0.459 . . . . 0.0 109.846 173.378 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' B' B ' 135' ' ' GLU . . . . . . . . . . . . . 40.1 tp10 -49.91 -27.2 4.91 Favored 'General case' 0 C--N 1.327 -0.371 0 N-CA-C 112.791 0.663 . . . . 0.0 112.791 -172.066 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' B' B ' 136' ' ' GLN . . . . . . . . . . . . . 63.2 tt0 -87.14 -33.72 19.32 Favored 'General case' 0 C--N 1.331 -0.221 0 N-CA-C 112.497 0.554 . . . . 0.0 112.497 -174.747 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' B' B ' 137' ' ' LYS . . . . . . . . . . . . . 48.3 pttt -162.1 171.22 17.84 Favored 'General case' 0 C--N 1.332 -0.181 0 CA-C-O 121.537 0.684 . . . . 0.0 112.525 -171.445 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' B' B ' 138' ' ' LEU . . . . . 0.427 ' C ' HD23 ' B' ' 138' ' ' LEU . 7.2 tt -121.45 128.74 52.45 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 114.918 -1.037 . . . . 0.0 109.896 178.531 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' B' B ' 139' ' ' THR . . . . . . . . . . . . . 39.4 m -108.18 127.13 53.55 Favored 'General case' 0 C--N 1.331 -0.221 0 CA-C-N 116.292 -0.413 . . . . 0.0 110.425 -179.929 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' B' B ' 140' ' ' LEU . . . . . 0.461 HD12 HG22 ' B' ' 131' ' ' VAL . 29.6 tp -112.2 120.9 43.35 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 115.788 -0.642 . . . . 0.0 109.531 -179.09 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' B' B ' 141' ' ' ILE . . . . . . . . . . . . . 19.1 mt -121.72 119.63 59.35 Favored 'Isoleucine or valine' 0 C--O 1.233 0.198 0 CA-C-O 121.09 0.471 . . . . 0.0 110.282 -175.249 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' B' B ' 142' ' ' ARG . . . . . . . . . . . . . 83.1 mtp180 -108.03 125.87 52.06 Favored 'General case' 0 C--N 1.331 -0.217 0 CA-C-N 115.206 -0.906 . . . . 0.0 110.091 179.044 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' B' B ' 143' ' ' THR . . . . . . . . . . . . . 15.2 p . . . . . 0 C--O 1.219 -0.501 0 CA-C-O 118.046 -0.978 . . . . 0.0 110.495 179.831 . . . . . . . . 0 0 . 1 . 012 nuclear nobuild core ' C' C ' 2' ' ' SER . . . . . . . . . . . . . 4.1 p . . . . . 0 C--O 1.231 0.103 0 CA-C-O 120.85 0.357 . . . . 0.0 110.826 . . . . . . . . . 0 0 . 1 . 012 nuclear nobuild core ' C' C ' 3' ' ' GLU . . . . . . . . . . . . . 57.0 mp0 -140.49 140.35 35.3 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.074 -0.512 . . . . 0.0 110.867 179.267 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' C' C ' 4' ' ' LEU . . . . . . . . . . . . . 14.8 tp -125.17 127.94 47.6 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.046 -0.525 . . . . 0.0 110.111 176.46 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' C' C ' 5' ' ' LYS . . . . . . . . . . . . . 87.9 mttt -109.3 122.93 48.41 Favored 'General case' 0 C--O 1.235 0.294 0 CA-C-O 120.66 0.267 . . . . 0.0 110.888 178.929 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' C' C ' 6' ' ' LEU . . . . . . . . . . . . . 67.2 mt -114.72 145.07 42.49 Favored 'General case' 0 N--CA 1.463 0.216 0 CA-C-N 115.676 -0.693 . . . . 0.0 110.362 179.491 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' C' C ' 7' ' ' LYS . . . . . . . . . . . . . 73.6 tttt -125.25 137.02 28.99 Favored Pre-proline 0 CA--C 1.534 0.335 0 CA-C-O 118.866 -0.588 . . . . 0.0 109.703 174.635 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' C' C ' 8' ' ' PRO . . . . . . . . . . . . . 83.5 Cg_endo -92.04 132.68 1.24 Allowed 'Trans proline' 0 N--CA 1.489 1.249 0 C-N-CA 121.663 1.575 . . . . 0.0 111.759 178.528 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' C' C ' 9' ' ' LEU . . . . . . . . . . . . . 55.7 mt -69.63 -46.74 25.76 Favored Pre-proline 0 CA--C 1.532 0.272 0 CA-C-O 118.742 -0.647 . . . . 0.0 112.079 -179.557 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' C' C ' 10' ' ' PRO . . . . . . . . . . . . . 88.4 Cg_endo -80.79 155.65 20.61 Favored 'Trans proline' 0 N--CA 1.495 1.611 0 C-N-CA 121.184 1.256 . . . . 0.0 111.78 174.769 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' C' C ' 11' ' ' LYS . . . . . . . . . . . . . 79.1 mttt -87.7 101.37 13.6 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.415 -0.357 . . . . 0.0 110.503 178.978 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' C' C ' 12' ' ' VAL . . . . . . . . . . . . . 12.2 p -145.33 144.36 21.45 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.299 0 CA-C-N 116.299 -0.41 . . . . 0.0 110.836 -179.251 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' C' C ' 13' ' ' GLU . . . . . . . . . . . . . 43.5 mt-10 -92.36 126.23 37.35 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.252 -0.431 . . . . 0.0 109.879 176.25 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' C' C ' 14' ' ' LEU . . . . . . . . . . . . . 17.3 mt -97.22 152.81 38.49 Favored Pre-proline 0 C--N 1.33 -0.267 0 CA-C-N 116.501 -0.318 . . . . 0.0 110.742 -177.649 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' C' C ' 15' ' ' PRO . . . . . . . . . . . . . 33.6 Cg_exo -59.77 159.23 25.44 Favored 'Trans proline' 0 N--CA 1.496 1.67 0 C-N-CA 121.311 1.341 . . . . 0.0 111.884 178.348 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' C' C ' 16' ' ' PRO . . . . . . . . . . . . . 29.6 Cg_exo -59.9 -34.84 95.15 Favored 'Trans proline' 0 N--CA 1.497 1.725 0 C-N-CA 121.383 1.389 . . . . 0.0 112.811 -177.675 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' C' C ' 17' ' ' ASP . . . . . . . . . . . . . 10.7 p-10 -90.18 8.74 31.46 Favored 'General case' 0 CA--C 1.536 0.423 0 N-CA-C 113.284 0.846 . . . . 0.0 113.284 -176.896 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' C' C ' 18' ' ' PHE . . . . . . . . . . . . . 53.6 t80 -57.8 -45.55 85.91 Favored 'General case' 0 C--N 1.334 -0.101 0 O-C-N 122.057 -0.402 . . . . 0.0 110.33 -178.516 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' C' C ' 19' ' ' VAL . . . . . . . . . . . . . 48.7 t -56.75 -42.11 76.62 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.289 0 CA-C-N 116.523 -0.308 . . . . 0.0 110.414 -178.633 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' C' C ' 20' ' ' ASP . . . . . . . . . . . . . 14.9 t0 -59.7 -44.0 93.87 Favored 'General case' 0 C--N 1.328 -0.352 0 C-N-CA 120.841 -0.343 . . . . 0.0 110.762 -177.939 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' C' C ' 21' ' ' VAL . . . . . . . . . . . . . 45.3 t -64.8 -46.28 92.51 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.279 0 C-N-CA 120.753 -0.379 . . . . 0.0 110.498 -177.636 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' C' C ' 22' ' ' ILE . . . . . 0.597 HG22 HD12 ' C' ' 26' ' ' LEU . 50.3 mm -56.9 -39.98 68.76 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.333 0 C-N-CA 120.983 -0.287 . . . . 0.0 110.637 179.957 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' C' C ' 23' ' ' ARG . . . . . . . . . . . . . 45.1 ttp180 -57.26 -50.38 73.09 Favored 'General case' 0 C--N 1.331 -0.21 0 C-N-CA 120.673 -0.411 . . . . 0.0 110.386 177.194 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' C' C ' 24' ' ' ILE . . . . . . . . . . . . . 71.8 mt -60.44 -39.84 82.35 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.335 0 CA-C-N 115.995 -0.548 . . . . 0.0 111.827 -176.824 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' C' C ' 25' ' ' LYS . . . . . . . . . . . . . 14.9 pttp -77.11 -37.28 54.56 Favored 'General case' 0 CA--C 1.534 0.33 0 C-N-CA 120.592 -0.443 . . . . 0.0 111.938 -173.597 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' C' C ' 26' ' ' LEU . . . . . 0.597 HD12 HG22 ' C' ' 22' ' ' ILE . 49.0 mt -79.43 -32.42 42.82 Favored 'General case' 0 C--N 1.333 -0.146 0 N-CA-C 113.479 0.918 . . . . 0.0 113.479 -173.083 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' C' C ' 27' ' ' GLN . . . . . . . . . . . . . 11.0 pt20 -46.32 139.54 4.72 Favored 'General case' 0 N--CA 1.47 0.538 0 N-CA-C 112.922 0.712 . . . . 0.0 112.922 -174.839 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' C' C ' 28' ' ' GLY . . . . . . . . . . . . . . . 99.86 -26.66 23.58 Favored Glycine 0 CA--C 1.531 1.084 0 CA-C-N 115.697 -0.683 . . . . 0.0 112.255 -177.528 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' C' C ' 29' ' ' LYS . . . . . . . . . . . . . 94.0 mttt -97.09 155.09 16.96 Favored 'General case' 0 C--N 1.332 -0.193 0 CA-C-N 117.351 0.575 . . . . 0.0 110.854 178.237 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' C' C ' 30' ' ' THR . . . . . . . . . . . . . 28.5 m -107.27 138.13 44.02 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 116.104 -0.498 . . . . 0.0 110.104 177.072 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' C' C ' 31' ' ' VAL . . . . . . . . . . . . . 34.4 m -127.51 151.97 34.99 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.244 0 CA-C-N 116.242 -0.435 . . . . 0.0 110.571 -179.393 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' C' C ' 32' ' ' ARG . . . . . . . . . . . . . 67.0 ttt180 -132.74 149.83 52.23 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-O 121.179 0.514 . . . . 0.0 110.267 179.809 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' C' C ' 33' ' ' THR . . . . . . . . . . . . . 26.1 m -52.82 138.4 29.56 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.368 -0.378 . . . . 0.0 111.499 -177.394 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' C' C ' 34' ' ' GLY . . . . . . . . . . . . . . . 101.42 -17.21 55.81 Favored Glycine 0 CA--C 1.534 1.278 0 CA-C-O 119.651 -0.527 . . . . 0.0 113.17 179.444 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' C' C ' 35' ' ' ASP . . . . . . . . . . . . . 75.2 m-20 -66.56 148.34 52.03 Favored 'General case' 0 N--CA 1.461 0.111 0 CA-C-N 118.072 0.936 . . . . 0.0 111.224 178.869 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' C' C ' 36' ' ' VAL . . . . . . . . . . . . . 42.5 t -121.5 129.0 75.97 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.247 0 CA-C-N 115.88 -0.6 . . . . 0.0 109.809 177.638 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' C' C ' 37' ' ' ILE . . . . . . . . . . . . . 64.5 mt -120.92 138.15 52.32 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.244 0 CA-C-N 116.237 -0.438 . . . . 0.0 109.948 -179.811 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' C' C ' 38' ' ' GLY . . . . . . . . . . . . . . . -116.47 126.93 7.25 Favored Glycine 0 CA--C 1.524 0.645 0 N-CA-C 110.828 -0.909 . . . . 0.0 110.828 178.402 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' C' C ' 39' ' ' ILE . . . . . . . . . . . . . 72.1 mt -123.71 131.18 73.45 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.247 0 N-CA-C 110.136 -0.32 . . . . 0.0 110.136 179.395 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' C' C ' 40' ' ' SER . . . . . . . . . . . . . 54.4 p -91.33 117.51 29.72 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.43 -0.35 . . . . 0.0 110.823 177.615 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' C' C ' 41' ' ' ILE . . . . . . . . . . . . . 72.6 mt -134.4 127.51 50.47 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.197 0 N-CA-C 110.067 -0.346 . . . . 0.0 110.067 177.857 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' C' C ' 42' ' ' LEU . . . . . . . . . . . . . 9.5 tp 57.73 34.72 24.8 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.163 -0.471 . . . . 0.0 111.562 178.258 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' C' C ' 43' ' ' GLY . . . . . . . . . . . . . . . 77.42 -10.08 24.52 Favored Glycine 0 CA--C 1.534 1.261 0 C-N-CA 121.334 -0.46 . . . . 0.0 113.467 177.32 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' C' C ' 44' ' ' LYS . . . . . . . . . . . . . 95.0 mttt -104.65 134.26 48.12 Favored 'General case' 0 C--N 1.333 -0.11 0 CA-C-N 117.993 0.897 . . . . 0.0 110.361 178.357 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' C' C ' 45' ' ' GLU . . . . . . . . . . . . . 84.8 tt0 -85.85 128.68 34.88 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.337 -0.392 . . . . 0.0 110.866 178.275 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' C' C ' 46' ' ' VAL . . . . . 0.403 ' O ' HG13 ' C' ' 46' ' ' VAL . 9.7 p -115.38 124.57 72.05 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.167 0 N-CA-C 109.417 -0.586 . . . . 0.0 109.417 175.219 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' C' C ' 47' ' ' LYS . . . . . . . . . . . . . 98.5 mttt -98.96 122.91 42.84 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.021 -0.536 . . . . 0.0 110.673 178.562 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' C' C ' 48' ' ' PHE . . . . . . . . . . . . . 40.2 m-85 -109.78 131.86 54.68 Favored 'General case' 0 C--N 1.329 -0.283 0 N-CA-C 109.607 -0.516 . . . . 0.0 109.607 177.5 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' C' C ' 49' ' ' LYS . . . . . . . . . . . . . 48.5 tttp -108.12 133.64 52.11 Favored 'General case' 0 C--N 1.329 -0.285 0 N-CA-C 109.96 -0.385 . . . . 0.0 109.96 178.201 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' C' C ' 50' ' ' VAL . . . . . . . . . . . . . 44.5 t -74.91 107.04 5.1 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.322 0 N-CA-C 109.261 -0.644 . . . . 0.0 109.261 177.854 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' C' C ' 51' ' ' VAL . . . . . . . . . . . . . 46.4 t -71.14 -48.91 52.29 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.252 0 CA-C-N 116.155 -0.475 . . . . 0.0 109.731 -174.735 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' C' C ' 52' ' ' GLN . . . . . . . . . . . . . 50.3 tt0 -163.73 139.49 6.49 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 115.823 -0.626 . . . . 0.0 111.442 -178.859 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' C' C ' 53' ' ' ALA . . . . . . . . . . . . . . . -116.13 132.88 56.53 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-N 115.78 -0.646 . . . . 0.0 109.728 174.863 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' C' C ' 54' ' ' TYR . . . . . . . . . . . . . 46.8 t80 -129.02 111.88 18.48 Favored Pre-proline 0 CA--C 1.535 0.397 0 CA-C-O 118.22 -0.895 . . . . 0.0 110.395 179.455 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' C' C ' 55' ' ' PRO . . . . . . . . . . . . . 73.2 Cg_endo -77.27 169.04 75.18 Favored 'Cis proline' 0 N--CA 1.501 1.912 0 CA-C-N 121.897 1.713 . . . . 0.0 112.22 -6.949 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' C' C ' 56' ' ' SER . . . . . . . . . . . . . 15.4 m -116.84 137.21 23.57 Favored Pre-proline 0 CA--C 1.538 0.495 0 CA-C-O 118.552 -0.737 . . . . 0.0 109.667 175.477 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' C' C ' 57' ' ' PRO . . . . . . . . . . . . . 48.6 Cg_endo -70.38 145.67 81.44 Favored 'Cis proline' 0 N--CA 1.497 1.701 0 CA-C-N 121.683 1.637 . . . . 0.0 111.334 -3.955 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' C' C ' 58' ' ' LEU . . . . . . . . . . . . . 19.3 tp -106.89 135.91 47.64 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.469 -0.332 . . . . 0.0 110.659 -177.402 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' C' C ' 59' ' ' ARG . . . . . . . . . . . . . 28.6 ttm180 -100.97 126.77 47.65 Favored 'General case' 0 C--N 1.327 -0.409 0 N-CA-C 109.51 -0.552 . . . . 0.0 109.51 176.134 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' C' C ' 60' ' ' VAL . . . . . . . . . . . . . 43.3 t -76.01 116.4 18.96 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.249 0 C-N-CA 120.729 -0.388 . . . . 0.0 110.047 -177.202 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' C' C ' 61' ' ' GLU . . . . . . . . . . . . . 95.8 mt-10 -131.02 167.32 19.24 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 115.84 -0.618 . . . . 0.0 110.104 178.994 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' C' C ' 62' ' ' ASP . . . . . . . . . . . . . 12.1 p-10 -55.65 -32.47 63.22 Favored 'General case' 0 C--N 1.328 -0.351 0 N-CA-C 111.837 0.31 . . . . 0.0 111.837 -178.46 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' C' C ' 63' ' ' ARG . . . . . . . . . . . . . 40.4 ptt180 -82.52 0.52 42.17 Favored 'General case' 0 CA--C 1.537 0.463 0 N-CA-C 113.749 1.018 . . . . 0.0 113.749 -175.068 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' C' C ' 64' ' ' THR . . . . . . . . . . . . . 33.2 m -82.55 134.33 35.19 Favored 'General case' 0 C--N 1.333 -0.151 0 CA-C-N 118.159 0.436 . . . . 0.0 110.903 -176.258 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' C' C ' 65' ' ' LYS . . . . . . . . . . . . . 53.6 mtmt -89.26 127.35 35.76 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 115.935 -0.575 . . . . 0.0 109.879 177.017 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' C' C ' 66' ' ' ILE . . . . . . . . . . . . . 64.5 mt -111.82 126.6 69.23 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.314 0 N-CA-C 109.656 -0.498 . . . . 0.0 109.656 -179.115 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' C' C ' 67' ' ' THR . . . . . . . . . . . . . 23.5 m -124.49 144.69 49.96 Favored 'General case' 0 C--N 1.331 -0.229 0 CA-C-O 121.281 0.562 . . . . 0.0 111.227 -175.453 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' C' C ' 68' ' ' LEU . . . . . . . . . . . . . 20.6 tp . . . . . 0 C--N 1.328 -0.352 0 CA-C-N 115.573 -0.74 . . . . 0.0 110.243 177.731 . . . . . . . . 0 0 . 1 . 012 nuclear nobuild core ' C' C ' 73' ' ' VAL . . . . . . . . . . . . . 31.5 m . . . . . 0 N--CA 1.463 0.184 0 CA-C-O 121.077 0.465 . . . . 0.0 110.844 . . . . . . . . . 0 0 . 1 . 012 nuclear nobuild core ' C' C ' 74' ' ' ASP . . . . . . . . . . . . . 26.0 t0 -98.47 122.07 41.2 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-N 115.571 -0.741 . . . . 0.0 109.411 177.19 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' C' C ' 75' ' ' VAL . . . . . 0.403 ' C ' HD12 ' C' ' 76' ' ' LEU . 44.3 t -114.09 123.78 70.09 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.226 0 CA-C-O 121.095 0.474 . . . . 0.0 110.742 -176.38 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' C' C ' 76' ' ' LEU . . . . . 0.403 HD12 ' C ' ' C' ' 75' ' ' VAL . 5.9 mp -124.93 144.8 50.16 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 115.669 -0.696 . . . . 0.0 109.696 175.288 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' C' C ' 77' ' ' GLU . . . . . . . . . . . . . 97.3 mt-10 -134.12 134.92 42.78 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-O 120.98 0.419 . . . . 0.0 111.141 -178.219 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' C' C ' 78' ' ' ALA . . . . . . . . . . . . . . . -120.19 135.44 54.98 Favored 'General case' 0 C--N 1.331 -0.219 0 CA-C-N 115.825 -0.625 . . . . 0.0 109.953 177.166 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' C' C ' 79' ' ' LYS . . . . . 0.606 ' O ' HD13 ' C' ' 80' ' ' ILE . 28.9 mtpp -84.0 117.1 23.17 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-O 120.81 0.338 . . . . 0.0 110.79 -177.91 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' C' C ' 80' ' ' ILE . . . . . 0.606 HD13 ' O ' ' C' ' 79' ' ' LYS . 41.6 mm -139.15 112.15 6.2 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.28 0 N-CA-C 109.355 -0.609 . . . . 0.0 109.355 -177.877 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' C' C ' 81' ' ' LYS . . . . . . . . . . . . . 49.6 pttt -98.72 125.96 44.19 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-O 120.969 0.414 . . . . 0.0 111.402 -177.922 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' C' C ' 82' ' ' GLY . . . . . . . . . . . . . . . 89.05 42.18 5.69 Favored Glycine 0 CA--C 1.526 0.73 0 C-N-CA 121.003 -0.618 . . . . 0.0 112.013 174.25 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' C' C ' 83' ' ' ILE . . . . . . . . . . . . . 72.7 mt -71.23 135.57 27.71 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.281 0 N-CA-C 109.326 -0.62 . . . . 0.0 109.326 176.038 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' C' C ' 84' ' ' LYS . . . . . . . . . . . . . 28.4 ttpp -102.68 -51.27 3.35 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-O 120.913 0.387 . . . . 0.0 110.597 -177.289 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' C' C ' 85' ' ' ASP . . . . . . . . . . . . . 8.5 t0 -143.69 144.07 31.7 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.008 -0.542 . . . . 0.0 110.545 -178.651 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' C' C ' 86' ' ' VAL . . . . . . . . . . . . . 42.9 t -125.91 131.19 72.1 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 CA-C-O 120.897 0.38 . . . . 0.0 110.24 179.742 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' C' C ' 87' ' ' ILE . . . . . 0.49 ' N ' HD12 ' C' ' 87' ' ' ILE . 5.1 mp -119.23 125.39 74.41 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.261 0 N-CA-C 109.573 -0.528 . . . . 0.0 109.573 176.808 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' C' C ' 88' ' ' LEU . . . . . . . . . . . . . 11.6 tp -115.91 131.35 56.96 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-O 120.992 0.425 . . . . 0.0 110.992 -177.159 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' C' C ' 89' ' ' ASP . . . . . . . . . . . . . 9.5 t70 -128.19 158.86 36.93 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-N 115.906 -0.588 . . . . 0.0 109.495 176.625 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' C' C ' 90' ' ' GLU . . . . . . . . . . . . . 83.7 tt0 -46.92 -38.81 11.12 Favored 'General case' 0 CA--C 1.531 0.217 0 N-CA-C 113.029 0.752 . . . . 0.0 113.029 -171.905 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' C' C ' 91' ' ' ASN . . . . . . . . . . . . . 30.5 t30 -132.09 26.36 4.56 Favored 'General case' 0 N--CA 1.467 0.416 0 N-CA-C 112.552 0.575 . . . . 0.0 112.552 -177.553 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' C' C ' 92' ' ' LEU . . . . . . . . . . . . . 9.2 mt -149.32 142.38 24.91 Favored 'General case' 0 C--N 1.331 -0.238 0 N-CA-C 109.98 -0.378 . . . . 0.0 109.98 -177.843 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' C' C ' 93' ' ' ILE . . . . . . . . . . . . . 75.3 mt -127.43 117.71 47.66 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.283 0 N-CA-C 109.38 -0.6 . . . . 0.0 109.38 177.256 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' C' C ' 94' ' ' VAL . . . . . 0.53 HG21 HG11 ' C' ' 125' ' ' VAL . 44.1 t -122.9 127.55 74.84 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.225 0 CA-C-O 120.959 0.409 . . . . 0.0 110.066 -179.229 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' C' C ' 95' ' ' VAL . . . . . . . . . . . . . 44.8 t -120.34 132.62 69.47 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.355 0 CA-C-N 115.886 -0.597 . . . . 0.0 109.688 -179.982 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' C' C ' 96' ' ' ILE . . . . . . . . . . . . . 66.3 mt -115.58 128.5 72.79 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.243 0 N-CA-C 109.218 -0.66 . . . . 0.0 109.218 178.789 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' C' C ' 97' ' ' THR . . . . . . . . . . . . . 67.6 p -101.53 160.46 14.42 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-O 121.144 0.497 . . . . 0.0 111.131 -176.949 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' C' C ' 98' ' ' GLU . . . . . . . . . . . . . 96.8 mt-10 -54.01 -26.6 27.14 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.117 -0.492 . . . . 0.0 112.284 -179.318 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' C' C ' 99' ' ' GLU . . . . . . . . . . . . . 71.0 mm-40 -79.18 15.65 1.13 Allowed 'General case' 0 CA--C 1.534 0.342 0 N-CA-C 113.183 0.808 . . . . 0.0 113.183 -177.549 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' C' C ' 100' ' ' ASN . . . . . . . . . . . . . 3.2 m-20 61.6 38.08 15.7 Favored 'General case' 0 N--CA 1.463 0.191 0 CA-C-O 121.14 0.495 . . . . 0.0 110.978 178.476 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' C' C ' 101' ' ' GLU . . . . . . . . . . . . . 84.6 tt0 -114.44 141.14 48.05 Favored 'General case' 0 C--N 1.332 -0.169 0 CA-C-N 116.108 -0.496 . . . . 0.0 109.762 176.306 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' C' C ' 102' ' ' VAL . . . . . . . . . . . . . 43.0 t -115.13 125.79 72.52 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.324 0 CA-C-N 116.17 -0.468 . . . . 0.0 109.894 -178.234 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' C' C ' 103' ' ' LEU . . . . . . . . . . . . . 34.9 mt -115.41 129.0 56.44 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 115.732 -0.667 . . . . 0.0 109.9 175.821 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' C' C ' 104' ' ' ILE . . . . . 0.609 HD13 HG11 ' C' ' 130' ' ' VAL . 65.1 mt -117.19 120.56 65.37 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.193 0 N-CA-C 110.261 -0.274 . . . . 0.0 110.261 -178.273 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' C' C ' 105' ' ' PHE . . . . . . . . . . . . . 56.9 m-85 -122.12 166.27 14.82 Favored 'General case' 0 C--N 1.333 -0.119 0 O-C-N 124.009 0.818 . . . . 0.0 109.722 178.931 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' C' C ' 106' ' ' ASN . . . . . . . . . . . . . 46.3 p-10 -101.07 -171.15 1.95 Allowed 'General case' 0 C--N 1.331 -0.203 0 N-CA-C 110.062 -0.347 . . . . 0.0 110.062 173.714 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' C' C ' 107' ' ' GLN . . . . . . . . . . . . . 46.2 tt0 -60.34 -26.97 66.98 Favored 'General case' 0 CA--C 1.533 0.31 0 N-CA-C 112.142 0.423 . . . . 0.0 112.142 179.494 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' C' C ' 108' ' ' ASN . . . . . . . . . . . . . 53.3 t30 -84.2 6.96 20.62 Favored 'General case' 0 CA--C 1.537 0.459 0 N-CA-C 113.159 0.8 . . . . 0.0 113.159 -178.343 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' C' C ' 109' ' ' LEU . . . . . . . . . . . . . 11.9 tp 61.64 36.86 16.42 Favored 'General case' 0 C--O 1.232 0.177 0 CA-C-O 120.932 0.396 . . . . 0.0 111.405 179.013 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' C' C ' 110' ' ' GLU . . . . . . . . . . . . . 95.7 mt-10 -108.01 153.46 23.06 Favored 'General case' 0 C--N 1.33 -0.262 0 N-CA-C 109.6 -0.519 . . . . 0.0 109.6 175.059 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' C' C ' 111' ' ' GLU . . . . . . . . . . . . . 55.8 tt0 -90.73 124.14 34.87 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-O 121.017 0.437 . . . . 0.0 111.146 -174.694 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' C' C ' 112' ' ' LEU . . . . . . . . . . . . . 25.6 mt -106.84 -46.07 4.04 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 115.87 -0.604 . . . . 0.0 110.914 179.787 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' C' C ' 113' ' ' TYR . . . . . 0.504 ' HB3' HD12 ' C' ' 104' ' ' ILE . 49.0 t80 -137.63 141.44 41.21 Favored 'General case' 0 C--N 1.331 -0.209 0 CA-C-N 116.319 -0.401 . . . . 0.0 110.802 -177.367 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' C' C ' 114' ' ' ARG . . . . . . . . . . . . . 36.7 ptt-85 -145.39 125.03 13.25 Favored 'General case' 0 C--N 1.331 -0.235 0 C-N-CA 120.94 -0.304 . . . . 0.0 110.825 178.002 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' C' C ' 115' ' ' GLY . . . . . . . . . . . . . . . -150.19 160.78 28.69 Favored Glycine 0 CA--C 1.525 0.666 0 C-N-CA 120.699 -0.762 . . . . 0.0 111.408 179.791 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' C' C ' 116' ' ' LYS . . . . . . . . . . . . . 36.7 ttpt -125.75 130.15 50.91 Favored 'General case' 0 C--N 1.331 -0.219 0 N-CA-C 109.412 -0.588 . . . . 0.0 109.412 174.344 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' C' C ' 117' ' ' PHE . . . . . . . . . . . . . 49.9 m-85 -130.56 114.64 15.72 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-O 120.958 0.409 . . . . 0.0 110.598 -174.215 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' C' C ' 118' ' ' GLU . . . . . . . . . . . . . 46.2 tp10 -52.88 -51.28 61.72 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.301 -0.409 . . . . 0.0 111.622 -176.086 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' C' C ' 119' ' ' ASN . . . . . . . . . . . . . 28.9 m120 -95.41 31.01 2.07 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.259 -0.428 . . . . 0.0 112.075 -174.103 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' C' C ' 120' ' ' LEU . . . . . . . . . . . . . 19.3 tp -54.94 122.54 11.09 Favored 'General case' 0 C--O 1.232 0.157 0 CA-C-O 120.729 0.299 . . . . 0.0 110.813 179.228 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' C' C ' 121' ' ' ASN . . . . . . . . . . . . . 17.3 m120 -103.26 -44.07 5.28 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.399 -0.364 . . . . 0.0 110.681 -177.316 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' C' C ' 122' ' ' LYS . . . . . . . . . . . . . 24.2 pttm -166.96 155.11 9.71 Favored 'General case' 0 C--N 1.331 -0.219 0 C-N-CA 120.572 -0.451 . . . . 0.0 111.843 -179.732 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' C' C ' 123' ' ' VAL . . . . . . . . . . . . . 43.0 t -123.33 135.26 63.82 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.284 0 CA-C-N 116.021 -0.536 . . . . 0.0 109.626 176.82 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' C' C ' 124' ' ' LEU . . . . . . . . . . . . . 31.5 mt -128.19 142.19 51.25 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-O 120.954 0.407 . . . . 0.0 110.977 -177.604 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' C' C ' 125' ' ' VAL . . . . . 0.53 HG11 HG21 ' C' ' 94' ' ' VAL . 35.9 m -133.48 141.18 45.07 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.293 0 CA-C-N 115.994 -0.548 . . . . 0.0 110.55 178.16 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' C' C ' 126' ' ' ARG . . . . . . . . . . . . . 19.6 ttm180 -162.86 127.61 3.1 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.122 -0.49 . . . . 0.0 109.72 178.196 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' C' C ' 127' ' ' ASN . . . . . . . . . . . . . 36.0 m120 56.4 -150.78 0.43 Allowed 'General case' 0 CA--C 1.541 0.627 0 N-CA-C 109.519 -0.548 . . . . 0.0 109.519 -176.494 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' C' C ' 128' ' ' ASP . . . . . . . . . . . . . 12.7 p-10 -82.35 16.32 2.1 Favored 'General case' 0 CA--C 1.535 0.393 0 CA-C-N 118.875 0.761 . . . . 0.0 112.762 178.725 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' C' C ' 129' ' ' LEU . . . . . . . . . . . . . 17.9 tp -107.22 133.31 51.98 Favored 'General case' 0 C--O 1.232 0.141 0 CA-C-N 118.084 0.402 . . . . 0.0 110.51 179.845 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' C' C ' 130' ' ' VAL . . . . . 0.609 HG11 HD13 ' C' ' 104' ' ' ILE . 45.2 t -121.71 133.25 68.72 Favored 'Isoleucine or valine' 0 C--N 1.333 -0.144 0 N-CA-C 109.374 -0.602 . . . . 0.0 109.374 177.787 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' C' C ' 131' ' ' VAL . . . . . 0.548 HG22 HD12 ' C' ' 140' ' ' LEU . 43.9 t -135.28 136.61 51.09 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.208 0 CA-C-O 121.084 0.468 . . . . 0.0 110.919 -177.904 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' C' C ' 132' ' ' ILE . . . . . . . . . . . . . 69.8 mt -116.69 128.91 73.94 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.292 0 CA-C-N 115.658 -0.701 . . . . 0.0 109.231 178.302 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' C' C ' 133' ' ' ILE . . . . . . . . . . . . . 42.1 mm -114.49 123.58 70.3 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.213 0 CA-C-O 120.741 0.305 . . . . 0.0 110.947 -175.239 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' C' C ' 134' ' ' ASP . . . . . . . . . . . . . 8.9 p-10 -135.31 146.65 48.68 Favored 'General case' 0 C--N 1.331 -0.2 0 N-CA-C 109.553 -0.536 . . . . 0.0 109.553 173.396 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' C' C ' 135' ' ' GLU . . . . . . . . . . . . . 85.4 tt0 -50.09 -26.17 4.18 Favored 'General case' 0 C--N 1.327 -0.405 0 N-CA-C 112.878 0.695 . . . . 0.0 112.878 -172.696 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' C' C ' 136' ' ' GLN . . . . . . . . . . . . . 96.1 mt-30 -85.18 -30.63 23.77 Favored 'General case' 0 C--O 1.234 0.278 0 N-CA-C 112.581 0.585 . . . . 0.0 112.581 -175.384 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' C' C ' 137' ' ' LYS . . . . . . . . . . . . . 19.8 pttp -168.19 170.14 10.41 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-O 121.513 0.673 . . . . 0.0 112.242 -173.29 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' C' C ' 138' ' ' LEU . . . . . 0.453 HD23 ' C ' ' C' ' 138' ' ' LEU . 7.4 tt -118.89 128.16 54.17 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 115.126 -0.943 . . . . 0.0 109.933 -179.9 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' C' C ' 139' ' ' THR . . . . . . . . . . . . . 39.1 m -109.03 126.11 52.78 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-N 116.246 -0.434 . . . . 0.0 110.09 178.63 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' C' C ' 140' ' ' LEU . . . . . 0.548 HD12 HG22 ' C' ' 131' ' ' VAL . 9.0 tp -112.77 123.4 50.22 Favored 'General case' 0 C--N 1.329 -0.303 0 N-CA-C 109.292 -0.633 . . . . 0.0 109.292 -178.588 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' C' C ' 141' ' ' ILE . . . . . . . . . . . . . 19.0 mt -121.9 125.53 73.33 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.29 0 CA-C-O 121.085 0.469 . . . . 0.0 110.303 -173.887 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' C' C ' 142' ' ' ARG . . . . . . . . . . . . . 23.2 mmm180 . . . . . 0 C--N 1.33 -0.27 0 CA-C-N 115.459 -0.791 . . . . 0.0 109.93 179.13 . . . . . . . . 0 0 . 1 . 012 nuclear nobuild core ' D' D ' 2' ' ' SER . . . . . . . . . . . . . 4.4 p . . . . . 0 C--O 1.231 0.091 0 CA-C-O 121.009 0.433 . . . . 0.0 110.374 . . . . . . . . . 0 0 . 1 . 012 nuclear nobuild core ' D' D ' 3' ' ' GLU . . . . . . . . . . . . . 85.0 tt0 -141.12 139.65 34.0 Favored 'General case' 0 C--N 1.326 -0.424 0 CA-C-N 115.873 -0.603 . . . . 0.0 111.147 -177.957 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' D' D ' 4' ' ' LEU . . . . . . . . . . . . . 18.0 tp -123.68 125.61 45.09 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 115.936 -0.575 . . . . 0.0 110.084 176.956 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' D' D ' 5' ' ' LYS . . . . . . . . . . . . . 67.1 mttm -104.22 119.91 40.0 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.218 -0.446 . . . . 0.0 110.401 178.768 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' D' D ' 6' ' ' LEU . . . . . . . . . . . . . 59.1 mt -116.32 147.31 41.69 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 115.393 -0.821 . . . . 0.0 110.324 -178.241 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' D' D ' 7' ' ' LYS . . . . . . . . . . . . . 83.7 tttt -134.67 136.23 25.03 Favored Pre-proline 0 CA--C 1.535 0.372 0 CA-C-O 118.931 -0.557 . . . . 0.0 109.844 176.254 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' D' D ' 8' ' ' PRO . . . . . . . . . . . . . 90.2 Cg_endo -91.6 140.59 2.52 Favored 'Trans proline' 0 N--CA 1.488 1.195 0 C-N-CA 121.751 1.634 . . . . 0.0 111.506 177.323 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' D' D ' 9' ' ' LEU . . . . . . . . . . . . . 62.3 mt -75.55 -47.9 4.07 Favored Pre-proline 0 CA--C 1.534 0.355 0 CA-C-O 118.586 -0.721 . . . . 0.0 112.336 -178.525 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' D' D ' 10' ' ' PRO . . . . . . . . . . . . . 88.1 Cg_endo -80.01 154.92 22.81 Favored 'Trans proline' 0 N--CA 1.497 1.689 0 C-N-CA 121.224 1.282 . . . . 0.0 112.187 177.166 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' D' D ' 11' ' ' LYS . . . . . . . . . . . . . 55.0 tptt -85.97 100.0 11.83 Favored 'General case' 0 C--N 1.328 -0.329 0 N-CA-C 109.914 -0.402 . . . . 0.0 109.914 176.767 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' D' D ' 12' ' ' VAL . . . . . . . . . . . . . 12.2 p -141.17 146.14 24.04 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.346 0 CA-C-O 120.956 0.408 . . . . 0.0 110.819 -178.386 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' D' D ' 13' ' ' GLU . . . . . . . . . . . . . 95.6 mt-10 -93.57 114.86 27.31 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 115.99 -0.55 . . . . 0.0 109.76 176.324 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' D' D ' 14' ' ' LEU . . . . . . . . . . . . . 38.8 mt -87.75 151.96 50.8 Favored Pre-proline 0 C--N 1.329 -0.304 0 CA-C-N 116.442 -0.344 . . . . 0.0 110.718 -177.164 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' D' D ' 15' ' ' PRO . . . . . . . . . . . . . 33.7 Cg_exo -57.34 158.66 18.07 Favored 'Trans proline' 0 N--CA 1.496 1.62 0 C-N-CA 121.26 1.306 . . . . 0.0 111.809 179.511 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' D' D ' 16' ' ' PRO . . . . . . . . . . . . . 30.7 Cg_exo -59.31 -36.64 94.15 Favored 'Trans proline' 0 N--CA 1.497 1.701 0 C-N-CA 121.432 1.421 . . . . 0.0 112.845 -177.776 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' D' D ' 17' ' ' ASP . . . . . . . . . . . . . 22.0 p-10 -89.96 11.29 20.94 Favored 'General case' 0 CA--C 1.537 0.46 0 N-CA-C 113.139 0.792 . . . . 0.0 113.139 -177.939 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' D' D ' 18' ' ' PHE . . . . . . . . . . . . . 47.7 t80 -58.0 -42.97 86.34 Favored 'General case' 0 N--CA 1.457 -0.108 0 O-C-N 121.983 -0.448 . . . . 0.0 110.16 -178.451 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' D' D ' 19' ' ' VAL . . . . . . . . . . . . . 48.1 t -57.51 -42.48 81.06 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.326 0 CA-C-N 116.244 -0.435 . . . . 0.0 110.376 -179.067 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' D' D ' 20' ' ' ASP . . . . . . . . . . . . . 11.7 t70 -59.62 -42.8 93.48 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-O 120.756 0.313 . . . . 0.0 110.857 -177.802 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' D' D ' 21' ' ' VAL . . . . . . . . . . . . . 46.5 t -64.42 -47.6 88.74 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.303 0 C-N-CA 120.74 -0.384 . . . . 0.0 110.507 -177.999 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' D' D ' 22' ' ' ILE . . . . . 0.72 HG22 HD12 ' D' ' 26' ' ' LEU . 49.9 mm -58.53 -38.46 70.72 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.283 0 C-N-CA 120.904 -0.319 . . . . 0.0 110.734 -179.644 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' D' D ' 23' ' ' ARG . . . . . . . . . . . . . 55.1 ttp180 -56.62 -49.23 75.56 Favored 'General case' 0 C--N 1.331 -0.22 0 CA-C-O 120.837 0.351 . . . . 0.0 110.533 178.066 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' D' D ' 24' ' ' ILE . . . . . . . . . . . . . 74.5 mt -61.26 -43.45 96.53 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.272 0 CA-C-N 116.04 -0.527 . . . . 0.0 111.968 -177.883 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' D' D ' 25' ' ' LYS . . . . . . . . . . . . . 15.1 pttp -71.65 -36.59 70.75 Favored 'General case' 0 CA--C 1.533 0.315 0 C-N-CA 120.364 -0.534 . . . . 0.0 111.702 -173.621 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' D' D ' 26' ' ' LEU . . . . . 0.72 HD12 HG22 ' D' ' 22' ' ' ILE . 18.9 mt -78.16 -43.38 28.86 Favored 'General case' 0 C--N 1.332 -0.177 0 N-CA-C 112.735 0.643 . . . . 0.0 112.735 -173.558 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' D' D ' 27' ' ' GLN . . . . . . . . . . . . . 11.1 pt20 -47.58 137.86 8.62 Favored 'General case' 0 N--CA 1.468 0.472 0 N-CA-C 112.647 0.61 . . . . 0.0 112.647 -175.946 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' D' D ' 28' ' ' GLY . . . . . . . . . . . . . . . 100.17 -27.38 20.6 Favored Glycine 0 CA--C 1.534 1.231 0 CA-C-N 115.631 -0.713 . . . . 0.0 112.013 -176.35 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' D' D ' 29' ' ' LYS . . . . . . . . . . . . . 56.1 mttm -98.52 155.16 17.41 Favored 'General case' 0 C--O 1.233 0.215 0 CA-C-N 117.144 0.472 . . . . 0.0 110.979 179.267 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' D' D ' 30' ' ' THR . . . . . . . . . . . . . 39.5 m -106.38 139.46 40.83 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 116.13 -0.486 . . . . 0.0 110.03 175.668 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' D' D ' 31' ' ' VAL . . . . . . . . . . . . . 34.5 m -128.66 158.67 40.97 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.289 0 CA-C-N 116.305 -0.407 . . . . 0.0 110.847 -178.304 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' D' D ' 32' ' ' ARG . . . . . . . . . . . . . 59.7 mtm180 -135.5 149.48 49.52 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.048 -0.523 . . . . 0.0 110.587 178.415 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' D' D ' 33' ' ' THR . . . . . . . . . . . . . 25.6 m -53.67 139.88 30.94 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.346 -0.388 . . . . 0.0 111.323 -178.186 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' D' D ' 34' ' ' GLY . . . . . . . . . . . . . . . 100.47 -17.13 57.18 Favored Glycine 0 CA--C 1.533 1.185 0 CA-C-O 119.702 -0.499 . . . . 0.0 113.304 178.672 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' D' D ' 35' ' ' ASP . . . . . . . . . . . . . 79.9 m-20 -66.2 147.88 52.66 Favored 'General case' 0 C--O 1.232 0.143 0 CA-C-N 118.053 0.926 . . . . 0.0 111.14 178.931 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' D' D ' 36' ' ' VAL . . . . . . . . . . . . . 45.1 t -123.42 131.13 73.68 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.224 0 CA-C-N 116.007 -0.542 . . . . 0.0 109.908 178.111 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' D' D ' 37' ' ' ILE . . . . . . . . . . . . . 66.4 mt -122.36 139.69 48.52 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.268 0 CA-C-N 116.28 -0.418 . . . . 0.0 110.042 -178.454 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' D' D ' 38' ' ' GLY . . . . . . . . . . . . . . . -111.81 128.77 8.76 Favored Glycine 0 CA--C 1.526 0.759 0 N-CA-C 111.08 -0.808 . . . . 0.0 111.08 179.472 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' D' D ' 39' ' ' ILE . . . . . . . . . . . . . 71.2 mt -122.54 134.18 66.5 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.187 0 N-CA-C 110.077 -0.342 . . . . 0.0 110.077 179.071 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' D' D ' 40' ' ' SER . . . . . . . . . . . . . 35.0 t -93.58 124.32 37.49 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.412 -0.358 . . . . 0.0 111.009 176.6 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' D' D ' 41' ' ' ILE . . . . . . . . . . . . . 71.3 mt -129.22 118.41 46.13 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.171 0 CA-C-O 120.826 0.346 . . . . 0.0 110.371 177.954 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' D' D ' 42' ' ' LEU . . . . . . . . . . . . . 56.2 mt 51.94 35.96 17.2 Favored 'General case' 0 C--O 1.233 0.201 0 CA-C-N 116.182 -0.463 . . . . 0.0 111.882 176.107 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' D' D ' 43' ' ' GLY . . . . . . . . . . . . . . . 73.98 31.65 59.65 Favored Glycine 0 CA--C 1.53 0.988 0 C-N-CA 121.115 -0.564 . . . . 0.0 112.123 178.162 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' D' D ' 44' ' ' LYS . . . . . . . . . . . . . 53.4 tttm -137.21 128.28 27.66 Favored 'General case' 0 C--N 1.329 -0.316 0 N-CA-C 109.536 -0.542 . . . . 0.0 109.536 177.94 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' D' D ' 45' ' ' GLU . . . . . . . . . . . . . 84.4 tt0 -83.83 123.14 29.6 Favored 'General case' 0 C--N 1.329 -0.318 0 C-N-CA 120.748 -0.381 . . . . 0.0 111.244 -177.766 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' D' D ' 46' ' ' VAL . . . . . . . . . . . . . 7.5 p -121.06 127.2 75.88 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.226 0 N-CA-C 109.342 -0.614 . . . . 0.0 109.342 175.497 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' D' D ' 47' ' ' LYS . . . . . . . . . . . . . 97.9 mttt -100.83 130.28 46.82 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.121 -0.491 . . . . 0.0 111.486 179.702 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' D' D ' 48' ' ' PHE . . . . . . . . . . . . . 93.6 m-85 -114.13 131.84 56.28 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.11 -0.495 . . . . 0.0 109.72 176.1 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' D' D ' 49' ' ' LYS . . . . . . . . . . . . . 71.5 tttt -108.66 138.66 44.62 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.628 -0.26 . . . . 0.0 110.494 179.148 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' D' D ' 50' ' ' VAL . . . . . . . . . . . . . 45.4 t -81.55 109.87 16.27 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.259 0 N-CA-C 109.443 -0.577 . . . . 0.0 109.443 177.047 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' D' D ' 51' ' ' VAL . . . . . . . . . . . . . 47.6 t -73.92 -47.63 42.11 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.304 0 CA-C-N 116.131 -0.486 . . . . 0.0 110.11 -174.322 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' D' D ' 52' ' ' GLN . . . . . . . . . . . . . 49.5 tt0 -162.65 139.09 7.54 Favored 'General case' 0 C--N 1.331 -0.219 0 C-N-CA 120.21 -0.596 . . . . 0.0 111.731 -178.126 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' D' D ' 53' ' ' ALA . . . . . . . . . . . . . . . -110.09 130.77 55.48 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 115.573 -0.739 . . . . 0.0 109.49 173.764 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' D' D ' 54' ' ' TYR . . . . . . . . . . . . . 24.9 t80 -126.76 108.09 22.67 Favored Pre-proline 0 CA--C 1.534 0.353 0 CA-C-O 118.379 -0.819 . . . . 0.0 110.553 -177.669 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' D' D ' 55' ' ' PRO . . . . . . . . . . . . . 73.3 Cg_endo -77.17 170.02 72.66 Favored 'Cis proline' 0 N--CA 1.5 1.896 0 CA-C-N 121.747 1.66 . . . . 0.0 112.139 -6.248 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' D' D ' 56' ' ' SER . . . . . . . . . . . . . 20.3 m -110.56 128.35 25.49 Favored Pre-proline 0 CA--C 1.538 0.511 0 CA-C-O 118.435 -0.793 . . . . 0.0 109.674 176.441 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' D' D ' 57' ' ' PRO . . . . . . . . . . . . . 46.6 Cg_endo -70.21 165.44 77.92 Favored 'Cis proline' 0 N--CA 1.496 1.676 0 CA-C-N 121.932 1.726 . . . . 0.0 111.677 -0.455 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' D' D ' 58' ' ' LEU . . . . . . . . . . . . . 25.0 tp -129.92 135.99 48.97 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.441 -0.345 . . . . 0.0 110.538 -179.234 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' D' D ' 59' ' ' ARG . . . . . . . . . . . . . 76.3 ttt180 -105.31 134.37 48.53 Favored 'General case' 0 C--N 1.327 -0.388 0 N-CA-C 109.419 -0.586 . . . . 0.0 109.419 175.725 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' D' D ' 60' ' ' VAL . . . . . . . . . . . . . 43.9 t -88.58 123.07 40.75 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.275 0 C-N-CA 120.644 -0.423 . . . . 0.0 110.359 -177.062 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' D' D ' 61' ' ' GLU . . . . . . . . . . . . . 94.7 mt-10 -131.09 173.42 11.03 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.077 -0.51 . . . . 0.0 109.962 177.242 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' D' D ' 62' ' ' ASP . . . . . . . . . . . . . 75.9 m-20 -54.39 -32.81 57.95 Favored 'General case' 0 C--N 1.327 -0.376 0 C-N-CA 120.964 -0.294 . . . . 0.0 111.635 179.786 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' D' D ' 63' ' ' ARG . . . . . . . . . . . . . 26.4 ptt180 -87.41 5.25 39.74 Favored 'General case' 0 CA--C 1.537 0.476 0 N-CA-C 113.652 0.982 . . . . 0.0 113.652 -176.32 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' D' D ' 64' ' ' THR . . . . . . . . . . . . . 28.5 m -82.3 133.74 35.25 Favored 'General case' 0 C--N 1.331 -0.211 0 CA-C-N 118.027 0.376 . . . . 0.0 110.602 -178.724 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' D' D ' 65' ' ' LYS . . . . . . . . . . . . . 87.1 mttt -89.71 124.62 34.77 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 116.106 -0.497 . . . . 0.0 110.02 178.75 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' D' D ' 66' ' ' ILE . . . . . . . . . . . . . 58.8 mt -113.6 129.4 69.49 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.305 0 N-CA-C 109.68 -0.489 . . . . 0.0 109.68 179.329 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' D' D ' 67' ' ' THR . . . . . . . . . . . . . 24.4 m -127.82 138.55 52.75 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-O 121.063 0.458 . . . . 0.0 111.124 -177.672 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' D' D ' 68' ' ' LEU . . . . . 0.509 ' N ' HD12 ' D' ' 68' ' ' LEU . 7.0 mp . . . . . 0 C--N 1.331 -0.206 0 CA-C-N 115.927 -0.579 . . . . 0.0 109.908 176.217 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' D' D ' 73' ' ' VAL . . . . . . . . . . . . . 26.9 m . . . . . 0 C--O 1.23 0.071 0 N-CA-C 109.815 -0.439 . . . . 0.0 109.815 . . . . . . . . . 0 0 . 1 . 012 nuclear nobuild core ' D' D ' 74' ' ' ASP . . . . . . . . . . . . . 30.3 t0 -104.21 117.22 33.7 Favored 'General case' 0 C--N 1.33 -0.274 0 N-CA-C 109.884 -0.413 . . . . 0.0 109.884 179.466 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' D' D ' 75' ' ' VAL . . . . . . . . . . . . . 46.7 t -119.63 126.15 75.04 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.281 0 CA-C-O 121.066 0.46 . . . . 0.0 110.817 -176.91 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' D' D ' 76' ' ' LEU . . . . . . . . . . . . . 5.5 mp -125.23 143.97 50.69 Favored 'General case' 0 C--N 1.332 -0.178 0 CA-C-N 115.71 -0.677 . . . . 0.0 109.787 175.388 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' D' D ' 77' ' ' GLU . . . . . . . . . . . . . 97.1 mt-10 -133.63 136.42 44.8 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-O 120.986 0.422 . . . . 0.0 111.074 -178.31 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' D' D ' 78' ' ' ALA . . . . . . . . . . . . . . . -124.31 132.85 53.58 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 115.883 -0.598 . . . . 0.0 109.919 176.953 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' D' D ' 79' ' ' LYS . . . . . 0.578 ' O ' HD13 ' D' ' 80' ' ' ILE . 59.5 mtpt -79.26 117.09 19.94 Favored 'General case' 0 C--N 1.331 -0.225 0 CA-C-N 116.312 -0.404 . . . . 0.0 110.644 -178.027 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' D' D ' 80' ' ' ILE . . . . . 0.578 HD13 ' O ' ' D' ' 79' ' ' LYS . 43.3 mm -139.16 112.16 6.2 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.322 0 N-CA-C 109.079 -0.711 . . . . 0.0 109.079 -177.426 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' D' D ' 81' ' ' LYS . . . . . . . . . . . . . 55.4 pttt -104.6 129.44 52.71 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-O 120.995 0.426 . . . . 0.0 111.65 -175.909 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' D' D ' 82' ' ' GLY . . . . . . . . . . . . . . . 89.12 42.11 5.68 Favored Glycine 0 CA--C 1.524 0.653 0 CA-C-N 115.835 -0.621 . . . . 0.0 111.701 174.478 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' D' D ' 83' ' ' ILE . . . . . . . . . . . . . 69.2 mt -73.21 136.87 24.55 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.27 0 N-CA-C 109.526 -0.546 . . . . 0.0 109.526 177.207 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' D' D ' 84' ' ' LYS . . . . . . . . . . . . . 39.7 ttpt -102.25 -48.42 4.2 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-O 120.849 0.357 . . . . 0.0 110.517 -178.348 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' D' D ' 85' ' ' ASP . . . . . . . . . . . . . 12.8 t70 -146.8 145.2 29.83 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.7 -179.33 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' D' D ' 86' ' ' VAL . . . . . . . . . . . . . 43.7 t -126.38 129.56 71.9 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.223 0 CA-C-N 116.325 -0.398 . . . . 0.0 110.204 179.855 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' D' D ' 87' ' ' ILE . . . . . 0.498 HD12 ' N ' ' D' ' 87' ' ' ILE . 5.0 mp -122.27 128.16 75.4 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.227 0 N-CA-C 109.865 -0.42 . . . . 0.0 109.865 177.689 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' D' D ' 88' ' ' LEU . . . . . . . . . . . . . 68.4 mt -112.01 136.18 51.68 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-O 121.011 0.434 . . . . 0.0 111.211 -178.814 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' D' D ' 89' ' ' ASP . . . . . . . . . . . . . 9.1 t70 -130.12 154.28 47.65 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 115.812 -0.631 . . . . 0.0 109.55 175.334 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' D' D ' 90' ' ' GLU . . . . . . . . . . . . . 96.2 mt-10 -48.92 -37.4 19.76 Favored 'General case' 0 C--N 1.329 -0.325 0 N-CA-C 112.773 0.657 . . . . 0.0 112.773 -172.207 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' D' D ' 91' ' ' ASN . . . . . . . . . . . . . 86.5 m-20 -132.03 33.39 3.92 Favored 'General case' 0 N--CA 1.465 0.297 0 N-CA-C 111.914 0.338 . . . . 0.0 111.914 -176.966 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' D' D ' 92' ' ' LEU . . . . . . . . . . . . . 7.4 tp -166.06 142.37 5.04 Favored 'General case' 0 C--N 1.332 -0.17 0 C-N-CA 120.952 -0.299 . . . . 0.0 110.635 -179.344 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' D' D ' 93' ' ' ILE . . . . . . . . . . . . . 73.8 mt -124.05 124.81 69.72 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.261 0 N-CA-C 109.479 -0.563 . . . . 0.0 109.479 178.605 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' D' D ' 94' ' ' VAL . . . . . . . . . . . . . 43.8 t -123.34 125.89 72.45 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.188 0 CA-C-O 120.972 0.415 . . . . 0.0 109.96 -179.798 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' D' D ' 95' ' ' VAL . . . . . . . . . . . . . 44.6 t -120.78 131.46 72.8 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.261 0 CA-C-N 115.964 -0.562 . . . . 0.0 109.643 179.31 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' D' D ' 96' ' ' ILE . . . . . . . . . . . . . 63.2 mt -115.72 128.04 73.11 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.256 0 N-CA-C 109.446 -0.575 . . . . 0.0 109.446 -179.282 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' D' D ' 97' ' ' THR . . . . . . . . . . . . . 70.7 p -100.9 159.15 15.44 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-O 121.152 0.501 . . . . 0.0 111.111 -177.307 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' D' D ' 98' ' ' GLU . . . . . . . . . . . . . 46.5 tp10 -53.9 -26.53 25.55 Favored 'General case' 0 C--N 1.327 -0.392 0 CA-C-N 116.079 -0.509 . . . . 0.0 112.098 179.751 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' D' D ' 99' ' ' GLU . . . . . . . . . . . . . 19.9 tp10 -79.72 16.76 1.04 Allowed 'General case' 0 CA--C 1.539 0.524 0 N-CA-C 112.777 0.658 . . . . 0.0 112.777 -175.998 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' D' D ' 100' ' ' ASN . . . . . . . . . . . . . 3.7 m-20 60.88 30.87 19.91 Favored 'General case' 0 CA--C 1.532 0.285 0 O-C-N 121.958 -0.464 . . . . 0.0 111.682 178.424 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' D' D ' 101' ' ' GLU . . . . . . . . . . . . . 84.7 tt0 -112.53 144.21 42.39 Favored 'General case' 0 C--N 1.332 -0.157 0 N-CA-C 109.548 -0.538 . . . . 0.0 109.548 175.045 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' D' D ' 102' ' ' VAL . . . . . . . . . . . . . 44.3 t -118.71 130.12 73.99 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.252 0 CA-C-O 120.954 0.407 . . . . 0.0 110.16 -176.587 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' D' D ' 103' ' ' LEU . . . . . . . . . . . . . 21.2 mt -113.01 129.65 56.42 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 115.435 -0.802 . . . . 0.0 109.989 176.359 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' D' D ' 104' ' ' ILE . . . . . . . . . . . . . 66.3 mt -115.46 120.14 63.85 Favored 'Isoleucine or valine' 0 C--O 1.234 0.248 0 N-CA-C 110.169 -0.308 . . . . 0.0 110.169 -179.604 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' D' D ' 105' ' ' PHE . . . . . . . . . . . . . 73.5 m-85 -123.83 167.08 14.55 Favored 'General case' 0 C--N 1.333 -0.117 0 O-C-N 123.876 0.735 . . . . 0.0 109.976 -179.736 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' D' D ' 106' ' ' ASN . . . . . . . . . . . . . 48.8 p-10 -102.97 -170.81 1.85 Allowed 'General case' 0 C--N 1.33 -0.256 0 N-CA-C 109.903 -0.406 . . . . 0.0 109.903 172.762 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' D' D ' 107' ' ' GLN . . . . . . . . . . . . . 42.9 tt0 -61.23 -29.25 69.72 Favored 'General case' 0 N--CA 1.464 0.249 0 N-CA-C 111.902 0.334 . . . . 0.0 111.902 -179.893 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' D' D ' 108' ' ' ASN . . . . . . . . . . . . . 4.2 t-20 -81.9 11.7 4.77 Favored 'General case' 0 CA--C 1.538 0.511 0 N-CA-C 112.771 0.656 . . . . 0.0 112.771 -179.498 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' D' D ' 109' ' ' LEU . . . . . . . . . . . . . 10.9 tp 54.58 36.72 26.56 Favored 'General case' 0 C--O 1.233 0.202 0 CA-C-O 120.982 0.42 . . . . 0.0 111.4 178.554 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' D' D ' 110' ' ' GLU . . . . . . . . . . . . . 95.3 mt-10 -103.02 143.22 32.86 Favored 'General case' 0 C--N 1.328 -0.328 0 N-CA-C 109.369 -0.604 . . . . 0.0 109.369 175.091 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' D' D ' 111' ' ' GLU . . . . . . . . . . . . . 73.7 tt0 -82.67 121.87 27.41 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-O 121.017 0.437 . . . . 0.0 110.296 -176.479 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' D' D ' 112' ' ' LEU . . . . . . . . . . . . . 45.9 mt -107.0 -45.96 4.03 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-N 115.86 -0.609 . . . . 0.0 110.65 -179.137 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' D' D ' 113' ' ' TYR . . . . . . . . . . . . . 55.3 t80 -135.23 138.53 43.65 Favored 'General case' 0 C--N 1.332 -0.188 0 CA-C-O 120.845 0.355 . . . . 0.0 111.278 -178.567 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' D' D ' 114' ' ' ARG . . . . . . . . . . . . . 70.1 ttt180 -136.13 123.81 22.41 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 115.914 -0.584 . . . . 0.0 110.077 177.67 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' D' D ' 115' ' ' GLY . . . . . . . . . . . . . . . -149.96 157.46 27.23 Favored Glycine 0 CA--C 1.523 0.591 0 N-CA-C 111.136 -0.786 . . . . 0.0 111.136 -179.91 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' D' D ' 116' ' ' LYS . . . . . . . . . . . . . 67.3 tttt -131.77 129.79 41.02 Favored 'General case' 0 C--N 1.328 -0.352 0 N-CA-C 109.734 -0.469 . . . . 0.0 109.734 178.846 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' D' D ' 117' ' ' PHE . . . . . . . . . . . . . 49.0 m-85 -125.17 114.23 18.72 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.289 -0.414 . . . . 0.0 110.184 -174.837 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' D' D ' 118' ' ' GLU . . . . . . . . . . . . . 48.7 mp0 -56.9 -46.14 82.12 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.344 -0.389 . . . . 0.0 110.851 -175.297 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' D' D ' 119' ' ' ASN . . . . . . . . . . . . . 23.9 m120 -97.36 31.1 2.6 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.099 -0.5 . . . . 0.0 112.109 -174.678 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' D' D ' 120' ' ' LEU . . . . . 0.473 ' C ' HD23 ' D' ' 120' ' ' LEU . 7.2 tt -54.91 120.1 6.37 Favored 'General case' 0 N--CA 1.462 0.148 0 CA-C-O 120.817 0.341 . . . . 0.0 110.598 178.337 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' D' D ' 121' ' ' ASN . . . . . . . . . . . . . 43.3 m-20 -105.11 -44.03 4.88 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 116.303 -0.408 . . . . 0.0 110.874 -176.731 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' D' D ' 122' ' ' LYS . . . . . . . . . . . . . 55.8 pttt -162.41 153.89 18.14 Favored 'General case' 0 C--N 1.331 -0.204 0 C-N-CA 120.427 -0.509 . . . . 0.0 112.028 -179.118 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' D' D ' 123' ' ' VAL . . . . . . . . . . . . . 42.0 t -125.81 136.49 60.67 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.248 0 CA-C-N 115.806 -0.633 . . . . 0.0 109.948 179.663 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' D' D ' 124' ' ' LEU . . . . . . . . . . . . . 48.4 mt -125.72 131.13 52.61 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.278 -0.419 . . . . 0.0 110.133 178.782 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' D' D ' 125' ' ' VAL . . . . . . . . . . . . . 13.5 p -134.88 134.06 53.7 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.259 0 CA-C-O 121.113 0.482 . . . . 0.0 110.809 179.616 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' D' D ' 126' ' ' ARG . . . . . . . . . . . . . 79.0 mtp180 -147.6 122.69 10.13 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 115.513 -0.767 . . . . 0.0 109.301 177.969 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' D' D ' 127' ' ' ASN . . . . . . . . . . . . . 1.5 t-20 57.03 -148.65 0.49 Allowed 'General case' 0 CA--C 1.542 0.643 0 N-CA-C 109.579 -0.526 . . . . 0.0 109.579 -178.371 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' D' D ' 128' ' ' ASP . . . . . . . . . . . . . 19.7 p-10 -81.44 12.99 3.23 Favored 'General case' 0 CA--C 1.538 0.488 0 N-CA-C 113.044 0.757 . . . . 0.0 113.044 178.507 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' D' D ' 129' ' ' LEU . . . . . . . . . . . . . 32.9 mt -107.41 133.0 52.57 Favored 'General case' 0 C--O 1.231 0.128 0 N-CA-C 109.542 -0.54 . . . . 0.0 109.542 178.545 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' D' D ' 130' ' ' VAL . . . . . 0.531 HG13 ' HB ' ' D' ' 141' ' ' ILE . 14.7 p -138.32 139.69 41.31 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.204 0 CA-C-O 121.273 0.559 . . . . 0.0 111.314 -179.758 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' D' D ' 131' ' ' VAL . . . . . . . . . . . . . 46.4 t -136.08 140.16 44.43 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.237 0 CA-C-N 115.784 -0.644 . . . . 0.0 110.271 179.446 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' D' D ' 132' ' ' ILE . . . . . . . . . . . . . 72.4 mt -116.78 133.99 61.73 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.263 0 CA-C-N 115.966 -0.561 . . . . 0.0 109.754 -179.717 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' D' D ' 133' ' ' ILE . . . . . . . . . . . . . 42.8 mm -114.25 123.64 70.11 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.222 0 CA-C-N 116.603 -0.271 . . . . 0.0 110.926 -176.434 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' D' D ' 134' ' ' ASP . . . . . . . . . . . . . 7.0 p-10 -135.21 147.95 49.49 Favored 'General case' 0 C--N 1.332 -0.16 0 N-CA-C 109.637 -0.505 . . . . 0.0 109.637 174.459 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' D' D ' 135' ' ' GLU . . . . . . . . . . . . . 84.9 tt0 -50.06 -28.2 6.74 Favored 'General case' 0 C--N 1.328 -0.355 0 N-CA-C 112.923 0.712 . . . . 0.0 112.923 -171.287 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' D' D ' 136' ' ' GLN . . . . . . . . . . . . . 97.2 mt-30 -83.26 -35.11 25.59 Favored 'General case' 0 C--O 1.234 0.253 0 N-CA-C 112.538 0.569 . . . . 0.0 112.538 -175.829 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' D' D ' 137' ' ' LYS . . . . . . . . . . . . . 24.8 pttm -163.36 172.07 15.14 Favored 'General case' 0 C--N 1.331 -0.217 0 CA-C-O 121.525 0.678 . . . . 0.0 112.413 -171.455 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' D' D ' 138' ' ' LEU . . . . . 0.407 ' C ' HD23 ' D' ' 138' ' ' LEU . 5.9 tt -117.36 127.6 54.21 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 114.938 -1.028 . . . . 0.0 109.748 178.512 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' D' D ' 139' ' ' THR . . . . . . . . . . . . . 36.9 m -107.64 125.76 51.74 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.207 -0.451 . . . . 0.0 110.187 -179.414 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' D' D ' 140' ' ' LEU . . . . . 0.541 HD21 ' NE ' ' D' ' 142' ' ' ARG . 6.1 tt -113.06 119.34 37.52 Favored 'General case' 0 C--N 1.327 -0.392 0 CA-C-N 115.824 -0.626 . . . . 0.0 109.651 -176.951 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' D' D ' 141' ' ' ILE . . . . . 0.531 ' HB ' HG13 ' D' ' 130' ' ' VAL . 22.2 mt -123.05 125.48 72.21 Favored 'Isoleucine or valine' 0 C--O 1.234 0.244 0 CA-C-O 121.033 0.444 . . . . 0.0 110.396 -175.03 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' D' D ' 142' ' ' ARG . . . . . 0.541 ' NE ' HD21 ' D' ' 140' ' ' LEU . 61.4 mmt-85 -121.96 129.33 52.41 Favored 'General case' 0 C--N 1.331 -0.203 0 CA-C-N 115.548 -0.751 . . . . 0.0 110.466 -178.62 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' D' D ' 143' ' ' THR . . . . . . . . . . . . . 41.1 p . . . . . 0 C--O 1.219 -0.55 0 CA-C-O 118.046 -0.978 . . . . 0.0 110.6 -179.874 . . . . . . . . 0 0 . 1 . 012 nuclear nobuild core ' E' E ' 2' ' ' SER . . . . . . . . . . . . . 2.4 p . . . . . 0 C--O 1.231 0.082 0 CA-C-O 120.958 0.409 . . . . 0.0 110.395 . . . . . . . . . 0 0 . 1 . 012 nuclear nobuild core ' E' E ' 3' ' ' GLU . . . . . . . . . . . . . 84.8 tt0 -142.6 142.84 32.2 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.083 -0.508 . . . . 0.0 111.045 179.238 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' E' E ' 4' ' ' LEU . . . . . . . . . . . . . 21.4 tp -122.01 128.19 51.14 Favored 'General case' 0 C--N 1.331 -0.21 0 CA-C-N 115.875 -0.602 . . . . 0.0 110.183 177.918 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' E' E ' 5' ' ' LYS . . . . . . . . . . . . . 89.2 mttt -105.43 121.11 43.24 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.3 -0.409 . . . . 0.0 110.485 178.298 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' E' E ' 6' ' ' LEU . . . . . . . . . . . . . 29.6 mt -116.79 150.29 38.56 Favored 'General case' 0 C--N 1.332 -0.187 0 CA-C-N 115.289 -0.869 . . . . 0.0 110.735 -178.097 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' E' E ' 7' ' ' LYS . . . . . . . . . . . . . 23.7 ttmt -138.35 135.32 18.16 Favored Pre-proline 0 CA--C 1.535 0.392 0 CA-C-O 118.846 -0.597 . . . . 0.0 109.933 174.984 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' E' E ' 8' ' ' PRO . . . . . . . . . . . . . 93.1 Cg_endo -90.72 143.11 3.45 Favored 'Trans proline' 0 N--CA 1.492 1.43 0 C-N-CA 121.602 1.535 . . . . 0.0 111.837 178.394 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' E' E ' 9' ' ' LEU . . . . . . . . . . . . . 35.3 mt -78.14 -47.67 2.09 Favored Pre-proline 0 CA--C 1.533 0.307 0 CA-C-O 118.759 -0.638 . . . . 0.0 112.099 -179.179 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' E' E ' 10' ' ' PRO . . . . . . . . . . . . . 76.8 Cg_endo -82.31 145.38 13.48 Favored 'Trans proline' 0 N--CA 1.495 1.593 0 C-N-CA 121.235 1.29 . . . . 0.0 111.681 175.689 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' E' E ' 11' ' ' LYS . . . . . . . . . . . . . 53.3 pttt -85.27 114.72 22.57 Favored 'General case' 0 C--N 1.331 -0.214 0 CA-C-O 121.453 0.644 . . . . 0.0 110.326 177.426 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' E' E ' 12' ' ' VAL . . . . . . . . . . . . . 12.1 p -151.11 150.93 12.92 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.299 0 CA-C-N 115.732 -0.667 . . . . 0.0 110.83 -177.538 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' E' E ' 13' ' ' GLU . . . . . . . . . . . . . 14.6 mm-40 -86.93 122.38 30.72 Favored 'General case' 0 C--N 1.331 -0.239 0 N-CA-C 110.019 -0.363 . . . . 0.0 110.019 175.901 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' E' E ' 14' ' ' LEU . . . . . . . . . . . . . 46.3 mt -98.7 149.54 35.84 Favored Pre-proline 0 CA--C 1.533 0.308 0 CA-C-O 119.318 -0.372 . . . . 0.0 110.632 -178.533 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' E' E ' 15' ' ' PRO . . . . . . . . . . . . . 24.6 Cg_exo -62.94 161.7 28.46 Favored 'Trans proline' 0 N--CA 1.499 1.818 0 C-N-CA 121.297 1.331 . . . . 0.0 111.876 176.81 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' E' E ' 16' ' ' PRO . . . . . . . . . . . . . 25.8 Cg_exo -61.28 -37.46 73.09 Favored 'Trans proline' 0 N--CA 1.499 1.807 0 C-N-CA 121.546 1.498 . . . . 0.0 112.967 -177.719 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' E' E ' 17' ' ' ASP . . . . . . . . . . . . . 13.0 p-10 -89.34 8.2 31.81 Favored 'General case' 0 CA--C 1.536 0.406 0 N-CA-C 113.351 0.871 . . . . 0.0 113.351 -176.786 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' E' E ' 18' ' ' PHE . . . . . . . . . . . . . 42.7 t80 -58.18 -42.78 86.82 Favored 'General case' 0 C--N 1.334 -0.086 0 O-C-N 121.925 -0.485 . . . . 0.0 110.099 -178.267 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' E' E ' 19' ' ' VAL . . . . . . . . . . . . . 54.9 t -57.12 -43.09 80.8 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.352 0 CA-C-N 116.225 -0.443 . . . . 0.0 110.306 -179.678 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' E' E ' 20' ' ' ASP . . . . . . . . . . . . . 75.2 m-20 -59.83 -41.74 91.99 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-O 120.782 0.325 . . . . 0.0 110.928 -177.846 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' E' E ' 21' ' ' VAL . . . . . . . . . . . . . 44.7 t -63.81 -46.36 94.61 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 C-N-CA 120.79 -0.364 . . . . 0.0 110.328 -177.76 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' E' E ' 22' ' ' ILE . . . . . 0.62 HG22 HD12 ' E' ' 26' ' ' LEU . 49.7 mm -55.95 -47.0 80.6 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.275 0 C-N-CA 120.971 -0.292 . . . . 0.0 110.827 178.932 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' E' E ' 23' ' ' ARG . . . . . . . . . . . . . 55.5 ttp180 -54.8 -48.73 72.38 Favored 'General case' 0 C--N 1.33 -0.275 0 C-N-CA 120.982 -0.287 . . . . 0.0 111.461 -178.323 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' E' E ' 24' ' ' ILE . . . . . . . . . . . . . 81.2 mt -59.0 -44.68 91.72 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.332 0 C-N-CA 121.102 -0.239 . . . . 0.0 111.179 -177.035 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' E' E ' 25' ' ' LYS . . . . . . . . . . . . . 57.3 mttm -64.5 -40.07 94.97 Favored 'General case' 0 C--N 1.327 -0.406 0 N-CA-C 112.356 0.502 . . . . 0.0 112.356 -178.48 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' E' E ' 26' ' ' LEU . . . . . 0.62 HD12 HG22 ' E' ' 22' ' ' ILE . 47.2 mt -79.27 -40.65 29.98 Favored 'General case' 0 C--N 1.33 -0.271 0 N-CA-C 113.573 0.953 . . . . 0.0 113.573 -171.367 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' E' E ' 27' ' ' GLN . . . . . . . . . . . . . 10.3 pt20 -46.7 137.04 7.33 Favored 'General case' 0 N--CA 1.47 0.544 0 N-CA-C 112.75 0.648 . . . . 0.0 112.75 -174.591 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' E' E ' 28' ' ' GLY . . . . . . . . . . . . . . . 100.52 -25.86 26.73 Favored Glycine 0 CA--C 1.534 1.222 0 CA-C-N 115.531 -0.759 . . . . 0.0 112.252 -176.082 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' E' E ' 29' ' ' LYS . . . . . . . . . . . . . 62.2 mttp -97.94 155.22 17.19 Favored 'General case' 0 C--N 1.332 -0.175 0 CA-C-N 117.265 0.532 . . . . 0.0 111.148 179.073 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' E' E ' 30' ' ' THR . . . . . . . . . . . . . 34.4 m -105.2 140.79 37.82 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 115.78 -0.645 . . . . 0.0 110.075 176.184 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' E' E ' 31' ' ' VAL . . . . . . . . . . . . . 35.0 m -126.44 151.16 32.67 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.234 0 CA-C-O 121.004 0.43 . . . . 0.0 111.229 -177.791 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' E' E ' 32' ' ' ARG . . . . . . . . . . . . . 67.0 mtp85 -128.12 151.04 49.69 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 115.68 -0.691 . . . . 0.0 110.846 177.362 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' E' E ' 33' ' ' THR . . . . . . . . . . . . . 15.2 m -54.29 139.34 36.67 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 115.987 -0.552 . . . . 0.0 111.186 -178.817 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' E' E ' 34' ' ' GLY . . . . . . . . . . . . . . . 98.77 -17.16 58.68 Favored Glycine 0 CA--C 1.533 1.162 0 C-N-CA 121.019 -0.61 . . . . 0.0 113.306 178.27 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' E' E ' 35' ' ' ASP . . . . . . . . . . . . . 73.3 m-20 -63.88 149.86 46.16 Favored 'General case' 0 C--O 1.231 0.09 0 CA-C-N 118.081 0.941 . . . . 0.0 111.016 179.685 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' E' E ' 36' ' ' VAL . . . . . . . . . . . . . 44.6 t -124.08 130.16 73.89 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.217 0 CA-C-N 116.05 -0.523 . . . . 0.0 109.923 178.971 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' E' E ' 37' ' ' ILE . . . . . . . . . . . . . 62.6 mt -122.03 140.41 46.04 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.244 0 CA-C-N 116.378 -0.374 . . . . 0.0 110.069 -179.465 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' E' E ' 38' ' ' GLY . . . . . . . . . . . . . . . -114.06 128.84 8.44 Favored Glycine 0 CA--C 1.524 0.638 0 N-CA-C 111.086 -0.806 . . . . 0.0 111.086 178.766 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' E' E ' 39' ' ' ILE . . . . . . . . . . . . . 71.7 mt -122.59 135.87 61.25 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.217 0 N-CA-C 110.075 -0.343 . . . . 0.0 110.075 178.935 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' E' E ' 40' ' ' SER . . . . . . . . . . . . . 53.0 p -93.4 117.37 29.99 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.519 -0.31 . . . . 0.0 111.202 176.015 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' E' E ' 41' ' ' ILE . . . . . . . . . . . . . 44.4 mm -121.71 121.61 64.83 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.181 0 CA-C-N 116.469 -0.332 . . . . 0.0 110.118 178.176 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' E' E ' 42' ' ' LEU . . . . . . . . . . . . . 83.8 mt 52.53 33.66 13.87 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.43 -0.35 . . . . 0.0 111.853 177.41 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' E' E ' 43' ' ' GLY . . . . . . . . . . . . . . . 73.22 32.09 60.68 Favored Glycine 0 CA--C 1.529 0.915 0 C-N-CA 121.049 -0.596 . . . . 0.0 112.125 178.797 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' E' E ' 44' ' ' LYS . . . . . . . . . . . . . 80.2 tttt -138.72 130.37 27.61 Favored 'General case' 0 C--N 1.33 -0.257 0 N-CA-C 109.482 -0.562 . . . . 0.0 109.482 179.064 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' E' E ' 45' ' ' GLU . . . . . . . . . . . . . 82.0 tt0 -83.1 124.83 30.85 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-O 120.799 0.333 . . . . 0.0 111.248 -176.144 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' E' E ' 46' ' ' VAL . . . . . . . . . . . . . 7.3 p -122.09 128.11 75.48 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.175 0 N-CA-C 109.493 -0.558 . . . . 0.0 109.493 174.909 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' E' E ' 47' ' ' LYS . . . . . . . . . . . . . 94.6 mttt -100.27 129.56 46.29 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.035 -0.53 . . . . 0.0 111.38 179.099 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' E' E ' 48' ' ' PHE . . . . . . . . . . . . . 95.3 m-85 -113.27 132.01 55.7 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.088 -0.505 . . . . 0.0 109.826 175.383 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' E' E ' 49' ' ' LYS . . . . . . . . . . . . . 80.6 tttt -105.51 137.74 42.84 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.41 -0.359 . . . . 0.0 110.21 179.278 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' E' E ' 50' ' ' VAL . . . . . . . . . . . . . 42.1 t -78.06 107.3 9.8 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.332 0 N-CA-C 109.533 -0.543 . . . . 0.0 109.533 177.427 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' E' E ' 51' ' ' VAL . . . . . . . . . . . . . 52.1 t -71.54 -48.76 50.96 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.288 0 CA-C-N 116.082 -0.508 . . . . 0.0 109.882 -174.557 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' E' E ' 52' ' ' GLN . . . . . . . . . . . . . 62.5 tt0 -167.46 138.68 3.05 Favored 'General case' 0 C--N 1.331 -0.211 0 C-N-CA 120.323 -0.551 . . . . 0.0 111.682 -179.271 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' E' E ' 53' ' ' ALA . . . . . 0.52 ' HB1' ' HB2' ' E' ' 58' ' ' LEU . . . -107.19 130.82 54.67 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 115.669 -0.696 . . . . 0.0 109.642 175.098 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' E' E ' 54' ' ' TYR . . . . . . . . . . . . . 30.1 t80 -127.65 106.9 20.76 Favored Pre-proline 0 CA--C 1.534 0.348 0 CA-C-O 118.39 -0.814 . . . . 0.0 110.598 -177.975 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' E' E ' 55' ' ' PRO . . . . . . . . . . . . . 73.1 Cg_endo -77.19 170.07 72.49 Favored 'Cis proline' 0 N--CA 1.5 1.867 0 CA-C-N 121.725 1.652 . . . . 0.0 112.323 -5.726 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' E' E ' 56' ' ' SER . . . . . . . . . . . . . 16.3 m -111.39 129.99 23.52 Favored Pre-proline 0 CA--C 1.538 0.502 0 CA-C-O 118.414 -0.803 . . . . 0.0 109.48 175.272 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' E' E ' 57' ' ' PRO . . . . . . . . . . . . . 56.9 Cg_endo -72.36 147.7 89.56 Favored 'Cis proline' 0 N--CA 1.497 1.702 0 CA-C-N 121.956 1.734 . . . . 0.0 111.792 -0.918 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' E' E ' 58' ' ' LEU . . . . . 0.52 ' HB2' ' HB1' ' E' ' 53' ' ' ALA . 18.1 tp -108.08 136.6 47.49 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.32 -0.4 . . . . 0.0 110.534 -179.203 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' E' E ' 59' ' ' ARG . . . . . . . . . . . . . 32.2 ttm180 -106.1 130.02 54.08 Favored 'General case' 0 C--N 1.328 -0.329 0 N-CA-C 109.565 -0.532 . . . . 0.0 109.565 176.35 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' E' E ' 60' ' ' VAL . . . . . . . . . . . . . 40.4 t -86.71 123.0 39.47 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.219 0 C-N-CA 120.544 -0.463 . . . . 0.0 110.487 -176.904 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' E' E ' 61' ' ' GLU . . . . . . . . . . . . . 95.0 mt-10 -131.01 170.79 14.01 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 115.895 -0.593 . . . . 0.0 109.909 177.727 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' E' E ' 62' ' ' ASP . . . . . . . . . . . . . 60.3 m-20 -55.0 -33.63 62.73 Favored 'General case' 0 C--N 1.328 -0.361 0 N-CA-C 111.827 0.306 . . . . 0.0 111.827 -177.627 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' E' E ' 63' ' ' ARG . . . . . . . . . . . . . 40.0 ptt180 -89.55 5.28 46.25 Favored 'General case' 0 CA--C 1.536 0.438 0 N-CA-C 113.818 1.044 . . . . 0.0 113.818 -175.496 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' E' E ' 64' ' ' THR . . . . . . . . . . . . . 31.4 m -76.27 139.85 41.3 Favored 'General case' 0 C--N 1.332 -0.184 0 CA-C-O 120.851 0.358 . . . . 0.0 110.859 -177.874 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' E' E ' 65' ' ' LYS . . . . . . . . . . . . . 99.6 mttt -88.32 129.4 35.4 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.05 -0.523 . . . . 0.0 110.192 178.601 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' E' E ' 66' ' ' ILE . . . . . . . . . . . . . 57.7 mt -114.04 127.34 71.49 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.312 0 N-CA-C 109.728 -0.471 . . . . 0.0 109.728 -179.705 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' E' E ' 67' ' ' THR . . . . . . . . . . . . . 26.9 m -128.26 139.11 52.61 Favored 'General case' 0 C--N 1.331 -0.221 0 CA-C-O 121.063 0.459 . . . . 0.0 111.001 -177.426 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' E' E ' 68' ' ' LEU . . . . . 0.475 HD12 ' N ' ' E' ' 68' ' ' LEU . 7.7 mp . . . . . 0 C--N 1.328 -0.331 0 CA-C-N 115.922 -0.581 . . . . 0.0 110.28 176.778 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' E' E ' 73' ' ' VAL . . . . . . . . . . . . . 32.8 m . . . . . 0 C--O 1.231 0.121 0 CA-C-O 120.808 0.337 . . . . 0.0 110.421 . . . . . . . . . 0 0 . 1 . 012 nuclear nobuild core ' E' E ' 74' ' ' ASP . . . . . . . . . . . . . 46.8 t0 -92.29 118.82 31.28 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.161 -0.472 . . . . 0.0 109.925 -179.615 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' E' E ' 75' ' ' VAL . . . . . . . . . . . . . 38.9 t -119.35 121.22 65.94 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.208 0 CA-C-O 120.988 0.423 . . . . 0.0 110.373 -179.756 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' E' E ' 76' ' ' LEU . . . . . . . . . . . . . 5.1 mp -122.26 146.41 47.31 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 115.851 -0.613 . . . . 0.0 109.752 176.527 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' E' E ' 77' ' ' GLU . . . . . . . . . . . . . 97.9 mt-10 -135.8 133.39 37.83 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-O 121.021 0.439 . . . . 0.0 111.125 -179.208 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' E' E ' 78' ' ' ALA . . . . . 0.632 ' HB2' HD21 ' E' ' 109' ' ' LEU . . . -121.81 133.28 54.9 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 115.729 -0.669 . . . . 0.0 109.727 176.364 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' E' E ' 79' ' ' LYS . . . . . 0.607 ' O ' HD13 ' E' ' 80' ' ' ILE . 49.1 tptt -80.01 118.04 21.39 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-O 120.899 0.38 . . . . 0.0 110.477 -177.3 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' E' E ' 80' ' ' ILE . . . . . 0.607 HD13 ' O ' ' E' ' 79' ' ' LYS . 41.2 mm -139.17 109.25 4.18 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.288 0 N-CA-C 109.235 -0.654 . . . . 0.0 109.235 -177.369 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' E' E ' 81' ' ' LYS . . . . . . . . . . . . . 57.5 pttt -102.23 127.31 49.24 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-O 120.938 0.399 . . . . 0.0 111.493 -177.283 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' E' E ' 82' ' ' GLY . . . . . . . . . . . . . . . 89.09 42.09 5.7 Favored Glycine 0 CA--C 1.526 0.735 0 C-N-CA 120.637 -0.792 . . . . 0.0 111.78 173.852 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' E' E ' 83' ' ' ILE . . . . . . . . . . . . . 74.0 mt -68.28 138.61 22.19 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.28 0 N-CA-C 109.932 -0.396 . . . . 0.0 109.932 178.203 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' E' E ' 84' ' ' LYS . . . . . . . . . . . . . 23.5 ttmt -95.92 -53.58 3.63 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.09 -0.505 . . . . 0.0 110.306 -179.721 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' E' E ' 85' ' ' ASP . . . . . . . . . . . . . 12.4 t70 -154.49 157.67 38.73 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 115.724 -0.671 . . . . 0.0 110.33 -178.401 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' E' E ' 86' ' ' VAL . . . . . . . . . . . . . 42.0 t -137.02 136.13 47.63 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.307 0 CA-C-O 120.939 0.4 . . . . 0.0 110.67 -178.172 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' E' E ' 87' ' ' ILE . . . . . 0.487 ' N ' HD12 ' E' ' 87' ' ' ILE . 5.1 mp -119.78 127.58 75.88 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 CA-C-N 115.774 -0.648 . . . . 0.0 109.42 176.608 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' E' E ' 88' ' ' LEU . . . . . . . . . . . . . 18.8 tp -115.69 136.41 53.09 Favored 'General case' 0 C--N 1.332 -0.192 0 CA-C-O 121.02 0.438 . . . . 0.0 111.406 -177.0 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' E' E ' 89' ' ' ASP . . . . . . . . . . . . . 42.0 t0 -134.87 160.75 37.26 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 115.777 -0.647 . . . . 0.0 109.729 176.532 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' E' E ' 90' ' ' GLU . . . . . . . . . . . . . 96.3 mt-10 -47.65 -37.6 13.15 Favored 'General case' 0 N--CA 1.463 0.179 0 N-CA-C 113.064 0.764 . . . . 0.0 113.064 -171.82 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' E' E ' 91' ' ' ASN . . . . . . . . . . . . . 5.2 p30 -132.06 23.89 4.56 Favored 'General case' 0 N--CA 1.469 0.483 0 N-CA-C 112.79 0.663 . . . . 0.0 112.79 -176.833 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' E' E ' 92' ' ' LEU . . . . . . . . . . . . . 44.5 mt -148.39 141.2 24.66 Favored 'General case' 0 C--N 1.331 -0.225 0 CA-C-O 120.823 0.344 . . . . 0.0 110.589 -178.556 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' E' E ' 93' ' ' ILE . . . . . . . . . . . . . 72.1 mt -123.7 114.27 40.79 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.362 0 N-CA-C 109.098 -0.705 . . . . 0.0 109.098 176.288 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' E' E ' 94' ' ' VAL . . . . . . . . . . . . . 43.7 t -116.55 127.02 74.28 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.236 0 N-CA-C 109.823 -0.436 . . . . 0.0 109.823 -178.741 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' E' E ' 95' ' ' VAL . . . . . . . . . . . . . 43.9 t -123.21 135.02 64.55 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 CA-C-N 116.217 -0.447 . . . . 0.0 109.934 -179.059 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' E' E ' 96' ' ' ILE . . . . . . . . . . . . . 65.2 mt -115.31 127.4 72.9 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.351 0 N-CA-C 109.391 -0.596 . . . . 0.0 109.391 178.506 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' E' E ' 97' ' ' THR . . . . . . . . . . . . . 66.7 p -101.8 157.29 16.95 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-O 121.05 0.452 . . . . 0.0 111.077 -177.852 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' E' E ' 98' ' ' GLU . . . . . . . . . . . . . 12.8 pt-20 -55.63 -21.7 19.1 Favored 'General case' 0 CA--C 1.533 0.314 0 N-CA-C 112.669 0.618 . . . . 0.0 112.669 -179.42 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' E' E ' 99' ' ' GLU . . . . . . . . . . . . . 48.4 mp0 -78.74 14.29 1.38 Allowed 'General case' 0 CA--C 1.537 0.463 0 N-CA-C 113.04 0.755 . . . . 0.0 113.04 -179.68 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' E' E ' 100' ' ' ASN . . . . . . . . . . . . . 3.0 m-20 62.76 37.88 12.2 Favored 'General case' 0 C--O 1.233 0.201 0 CA-C-O 121.068 0.461 . . . . 0.0 110.949 178.24 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' E' E ' 101' ' ' GLU . . . . . . . . . . . . . 84.9 tt0 -118.99 141.69 48.45 Favored 'General case' 0 C--N 1.332 -0.164 0 CA-C-N 116.014 -0.539 . . . . 0.0 109.895 177.223 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' E' E ' 102' ' ' VAL . . . . . . . . . . . . . 46.5 t -114.93 127.47 72.46 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.293 0 CA-C-N 116.324 -0.398 . . . . 0.0 110.041 -178.68 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' E' E ' 103' ' ' LEU . . . . . . . . . . . . . 25.7 mt -117.08 132.54 56.66 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 115.561 -0.745 . . . . 0.0 110.503 177.82 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' E' E ' 104' ' ' ILE . . . . . 0.434 HD13 HG11 ' E' ' 130' ' ' VAL . 65.9 mt -119.53 122.16 68.17 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.237 0 N-CA-C 110.22 -0.289 . . . . 0.0 110.22 178.782 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' E' E ' 105' ' ' PHE . . . . . . . . . . . . . 47.2 m-85 -122.26 162.3 21.71 Favored 'General case' 0 C--N 1.333 -0.146 0 O-C-N 124.005 0.815 . . . . 0.0 109.981 177.748 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' E' E ' 106' ' ' ASN . . . . . . . . . . . . . 41.4 p-10 -97.03 -169.93 1.95 Allowed 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.606 -0.27 . . . . 0.0 110.499 175.554 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' E' E ' 107' ' ' GLN . . . . . . . . . . . . . 46.4 tt0 -56.15 -30.2 61.83 Favored 'General case' 0 CA--C 1.531 0.247 0 N-CA-C 112.05 0.389 . . . . 0.0 112.05 -179.516 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' E' E ' 108' ' ' ASN . . . . . . . . . . . . . 30.6 t30 -90.79 12.9 17.82 Favored 'General case' 0 CA--C 1.535 0.373 0 N-CA-C 113.41 0.893 . . . . 0.0 113.41 -175.356 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' E' E ' 109' ' ' LEU . . . . . 0.632 HD21 ' HB2' ' E' ' 78' ' ' ALA . 11.3 tp 58.8 38.92 24.61 Favored 'General case' 0 C--N 1.331 -0.212 0 CA-C-O 121.168 0.508 . . . . 0.0 111.103 178.552 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' E' E ' 110' ' ' GLU . . . . . . . . . . . . . 96.0 mt-10 -102.64 151.93 21.78 Favored 'General case' 0 C--N 1.329 -0.292 0 N-CA-C 109.788 -0.449 . . . . 0.0 109.788 175.419 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' E' E ' 111' ' ' GLU . . . . . . . . . . . . . 85.1 tt0 -81.68 121.98 27.05 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-O 120.922 0.391 . . . . 0.0 110.507 -178.872 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' E' E ' 112' ' ' LEU . . . . . . . . . . . . . 17.5 mt -110.04 -45.98 3.53 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 115.962 -0.563 . . . . 0.0 110.518 179.185 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' E' E ' 113' ' ' TYR . . . . . . . . . . . . . 58.7 t80 -140.72 136.87 33.02 Favored 'General case' 0 C--N 1.331 -0.227 0 C-N-CA 120.771 -0.372 . . . . 0.0 111.398 -179.06 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' E' E ' 114' ' ' ARG . . . . . . . . . . . . . 22.0 ttm180 -135.69 124.77 24.36 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 115.958 -0.564 . . . . 0.0 109.721 174.979 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' E' E ' 115' ' ' GLY . . . . . . . . . . . . . . . -149.38 148.79 20.48 Favored Glycine 0 CA--C 1.525 0.701 0 N-CA-C 111.12 -0.792 . . . . 0.0 111.12 178.758 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' E' E ' 116' ' ' LYS . . . . . . . . . . . . . 40.3 ttpt -119.86 136.85 54.33 Favored 'General case' 0 C--N 1.33 -0.266 0 N-CA-C 110.096 -0.335 . . . . 0.0 110.096 179.172 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' E' E ' 117' ' ' PHE . . . . . . . . . . . . . 46.1 m-85 -134.49 116.11 14.72 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-N 116.302 -0.408 . . . . 0.0 110.229 -177.148 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' E' E ' 118' ' ' GLU . . . . . . . . . . . . . 84.8 tt0 -53.64 -45.07 70.07 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 116.597 -0.274 . . . . 0.0 111.515 -177.252 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' E' E ' 119' ' ' ASN . . . . . . . . . . . . . 4.2 m-80 -99.27 31.12 3.2 Favored 'General case' 0 C--N 1.33 -0.263 0 N-CA-C 112.156 0.428 . . . . 0.0 112.156 -175.225 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' E' E ' 120' ' ' LEU . . . . . . . . . . . . . 15.0 tp -55.22 120.69 7.42 Favored 'General case' 0 C--N 1.333 -0.151 0 O-C-N 122.308 -0.245 . . . . 0.0 110.694 178.465 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' E' E ' 121' ' ' ASN . . . . . . . . . . . . . 72.1 m-20 -108.82 -44.05 4.1 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.478 -0.328 . . . . 0.0 111.084 -176.728 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' E' E ' 122' ' ' LYS . . . . . . . . . . . . . 57.2 pttt -162.4 160.21 26.14 Favored 'General case' 0 CA--C 1.529 0.143 0 C-N-CA 120.43 -0.508 . . . . 0.0 112.064 -178.59 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' E' E ' 123' ' ' VAL . . . . . . . . . . . . . 42.1 t -129.08 137.87 55.99 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.201 0 CA-C-N 115.947 -0.57 . . . . 0.0 109.86 179.011 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' E' E ' 124' ' ' LEU . . . . . . . . . . . . . 80.9 mt -124.94 140.35 53.0 Favored 'General case' 0 C--N 1.332 -0.189 0 CA-C-O 120.87 0.367 . . . . 0.0 110.794 -179.007 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' E' E ' 125' ' ' VAL . . . . . . . . . . . . . 46.5 t -127.55 133.95 66.66 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.234 0 CA-C-N 116.105 -0.498 . . . . 0.0 109.822 178.118 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' E' E ' 126' ' ' ARG . . . . . . . . . . . . . 49.3 ttt85 -138.57 113.76 9.43 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-O 120.884 0.374 . . . . 0.0 110.28 -179.647 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' E' E ' 127' ' ' ASN . . . . . . . . . . . . . 12.1 m120 53.04 -104.82 0.21 Allowed 'General case' 0 CA--C 1.543 0.68 0 CA-C-O 119.2 -0.429 . . . . 0.0 111.196 179.513 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' E' E ' 128' ' ' ASP . . . . . . . . . . . . . 13.5 p-10 -113.57 0.78 14.76 Favored 'General case' 0 N--CA 1.467 0.422 0 CA-C-N 119.447 1.021 . . . . 0.0 113.549 -176.108 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' E' E ' 129' ' ' LEU . . . . . . . . . . . . . 71.4 mt -108.18 147.36 31.43 Favored 'General case' 0 C--N 1.332 -0.174 0 O-C-N 121.952 -0.467 . . . . 0.0 110.061 179.454 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' E' E ' 130' ' ' VAL . . . . . 0.469 HG13 ' HB ' ' E' ' 141' ' ' ILE . 12.4 p -129.42 140.05 50.15 Favored 'Isoleucine or valine' 0 C--O 1.233 0.22 0 CA-C-O 120.981 0.42 . . . . 0.0 110.595 -178.831 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' E' E ' 131' ' ' VAL . . . . . 0.589 HG22 HD12 ' E' ' 140' ' ' LEU . 40.7 t -135.94 139.28 46.25 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.25 0 CA-C-N 115.953 -0.567 . . . . 0.0 110.425 -178.506 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' E' E ' 132' ' ' ILE . . . . . . . . . . . . . 73.2 mt -114.09 133.51 59.88 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 N-CA-C 109.406 -0.59 . . . . 0.0 109.406 178.838 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' E' E ' 133' ' ' ILE . . . . . . . . . . . . . 43.3 mm -115.34 123.3 70.75 Favored 'Isoleucine or valine' 0 C--O 1.234 0.251 0 CA-C-O 120.936 0.398 . . . . 0.0 111.113 -174.36 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' E' E ' 134' ' ' ASP . . . . . . . . . . . . . 9.5 p-10 -136.18 147.41 47.66 Favored 'General case' 0 C--N 1.331 -0.224 0 N-CA-C 109.337 -0.616 . . . . 0.0 109.337 173.666 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' E' E ' 135' ' ' GLU . . . . . . . . . . . . . 43.3 tp10 -51.33 -28.06 11.28 Favored 'General case' 0 C--N 1.327 -0.408 0 N-CA-C 112.641 0.608 . . . . 0.0 112.641 -172.893 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' E' E ' 136' ' ' GLN . . . . . . . . . . . . . 97.6 mt-30 -80.48 -31.62 37.28 Favored 'General case' 0 C--N 1.33 -0.239 0 N-CA-C 112.629 0.603 . . . . 0.0 112.629 -176.63 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' E' E ' 137' ' ' LYS . . . . . . . . . . . . . 17.6 ptpt -170.08 175.26 5.1 Favored 'General case' 0 C--N 1.331 -0.227 0 CA-C-O 121.526 0.679 . . . . 0.0 112.374 -171.669 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' E' E ' 138' ' ' LEU . . . . . 0.417 ' C ' HD23 ' E' ' 138' ' ' LEU . 7.8 tt -123.16 130.16 52.39 Favored 'General case' 0 C--N 1.331 -0.199 0 CA-C-N 115.145 -0.934 . . . . 0.0 110.23 -179.524 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' E' E ' 139' ' ' THR . . . . . . . . . . . . . 35.1 m -107.26 125.88 51.71 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.245 -0.434 . . . . 0.0 110.442 179.518 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' E' E ' 140' ' ' LEU . . . . . 0.589 HD12 HG22 ' E' ' 131' ' ' VAL . 19.0 tp -113.84 121.37 43.81 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 115.788 -0.642 . . . . 0.0 109.555 -177.594 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' E' E ' 141' ' ' ILE . . . . . 0.469 ' HB ' HG13 ' E' ' 130' ' ' VAL . 19.3 mt -122.01 119.9 59.89 Favored 'Isoleucine or valine' 0 C--O 1.235 0.296 0 CA-C-O 120.974 0.416 . . . . 0.0 110.081 -177.229 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' E' E ' 142' ' ' ARG . . . . . . . . . . . . . 78.0 mtp180 -103.9 123.85 47.88 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 115.264 -0.88 . . . . 0.0 110.382 179.644 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' E' E ' 143' ' ' THR . . . . . . . . . . . . . 37.3 p . . . . . 0 C--O 1.22 -0.456 0 CA-C-O 118.028 -0.987 . . . . 0.0 110.648 -179.989 . . . . . . . . 0 0 . 1 . 012 nuclear nobuild core ' F' F ' 1' ' ' MET . . . . . . . . . . . . . 25.6 ptp . . . . . 0 C--O 1.233 0.203 0 CA-C-O 120.803 0.335 . . . . 0.0 111.006 . . . . . . . . . 0 0 . 1 . 012 nuclear nobuild core ' F' F ' 2' ' ' SER . . . . . . . . . . . . . 11.8 p -111.89 135.46 52.48 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.135 -0.484 . . . . 0.0 110.403 178.676 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' F' F ' 3' ' ' GLU . . . . . . . . . . . . . 95.5 mt-10 -140.81 141.87 34.7 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.117 -0.492 . . . . 0.0 110.982 -177.817 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' F' F ' 4' ' ' LEU . . . . . . . . . . . . . 28.6 tp -128.42 128.62 44.8 Favored 'General case' 0 C--N 1.331 -0.22 0 CA-C-N 115.928 -0.578 . . . . 0.0 110.22 176.869 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' F' F ' 5' ' ' LYS . . . . . . . . . . . . . 99.0 mttt -108.16 121.61 45.21 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-O 120.954 0.407 . . . . 0.0 110.538 178.376 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' F' F ' 6' ' ' LEU . . . . . . . . . . . . . 70.3 mt -116.41 148.49 40.63 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 115.364 -0.835 . . . . 0.0 110.483 -179.122 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' F' F ' 7' ' ' LYS . . . . . . . . . . . . . 78.0 tttt -139.57 139.02 21.11 Favored Pre-proline 0 CA--C 1.533 0.305 0 CA-C-O 119.086 -0.483 . . . . 0.0 109.924 175.894 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' F' F ' 8' ' ' PRO . . . . . . . . . . . . . 93.5 Cg_endo -91.41 145.11 3.3 Favored 'Trans proline' 0 N--CA 1.491 1.34 0 C-N-CA 121.724 1.616 . . . . 0.0 111.944 178.414 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' F' F ' 9' ' ' LEU . . . . . . . . . . . . . 64.4 mt -80.89 -47.67 1.15 Allowed Pre-proline 0 CA--C 1.534 0.331 0 CA-C-O 118.671 -0.68 . . . . 0.0 112.078 179.805 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' F' F ' 10' ' ' PRO . . . . . . . . . . . . . 88.5 Cg_endo -80.81 145.24 15.84 Favored 'Trans proline' 0 N--CA 1.497 1.686 0 C-N-CA 121.104 1.203 . . . . 0.0 111.555 175.995 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' F' F ' 11' ' ' LYS . . . . . . . . . . . . . 39.0 pttt -78.56 111.33 14.51 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-O 121.563 0.697 . . . . 0.0 110.382 177.873 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' F' F ' 12' ' ' VAL . . . . . . . . . . . . . 11.7 p -151.02 144.83 16.76 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.351 0 CA-C-N 115.629 -0.714 . . . . 0.0 110.512 -178.292 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' F' F ' 13' ' ' GLU . . . . . . . . . . . . . 40.1 mt-10 -86.25 124.55 32.75 Favored 'General case' 0 C--N 1.33 -0.26 0 N-CA-C 109.965 -0.383 . . . . 0.0 109.965 177.015 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' F' F ' 14' ' ' LEU . . . . . . . . . . . . . 19.3 mt -96.76 148.05 33.85 Favored Pre-proline 0 C--N 1.33 -0.273 0 CA-C-O 119.184 -0.436 . . . . 0.0 110.072 -179.263 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' F' F ' 15' ' ' PRO . . . . . . . . . . . . . 28.3 Cg_exo -60.54 159.13 28.99 Favored 'Trans proline' 0 N--CA 1.497 1.705 0 C-N-CA 121.28 1.32 . . . . 0.0 111.439 177.318 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' F' F ' 16' ' ' PRO . . . . . . . . . . . . . 38.7 Cg_exo -58.49 -35.95 98.04 Favored 'Trans proline' 0 N--CA 1.496 1.668 0 C-N-CA 121.418 1.412 . . . . 0.0 112.639 -178.617 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' F' F ' 17' ' ' ASP . . . . . . . . . . . . . 7.3 p-10 -91.66 11.55 24.06 Favored 'General case' 0 CA--C 1.535 0.396 0 N-CA-C 113.152 0.797 . . . . 0.0 113.152 -177.637 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' F' F ' 18' ' ' PHE . . . . . . . . . . . . . 52.2 t80 -58.29 -45.47 87.89 Favored 'General case' 0 C--N 1.333 -0.112 0 O-C-N 122.02 -0.425 . . . . 0.0 110.075 -177.67 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' F' F ' 19' ' ' VAL . . . . . 0.411 HG13 ' N ' ' F' ' 20' ' ' ASP . 13.7 p -55.89 -40.99 65.21 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 CA-C-N 116.114 -0.494 . . . . 0.0 110.904 -179.125 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' F' F ' 20' ' ' ASP . . . . . 0.411 ' N ' HG13 ' F' ' 19' ' ' VAL . 80.7 m-20 -61.22 -42.84 99.29 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-O 120.818 0.342 . . . . 0.0 110.975 -178.558 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' F' F ' 21' ' ' VAL . . . . . . . . . . . . . 48.1 t -63.84 -46.07 95.32 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.291 0 C-N-CA 120.759 -0.376 . . . . 0.0 110.318 -178.03 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' F' F ' 22' ' ' ILE . . . . . 0.621 HG22 HD12 ' F' ' 26' ' ' LEU . 49.2 mm -56.58 -46.02 82.47 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.258 0 C-N-CA 120.948 -0.301 . . . . 0.0 110.622 178.917 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' F' F ' 23' ' ' ARG . . . . . . . . . . . . . 25.8 ttp180 -54.33 -49.43 69.75 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-O 120.594 0.235 . . . . 0.0 111.418 -178.843 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' F' F ' 24' ' ' ILE . . . . . . . . . . . . . 77.1 mt -59.71 -44.07 92.87 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.368 0 CA-C-N 116.629 -0.259 . . . . 0.0 111.291 -177.194 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' F' F ' 25' ' ' LYS . . . . . . . . . . . . . 62.8 mttm -66.18 -38.18 87.41 Favored 'General case' 0 C--N 1.327 -0.371 0 N-CA-C 112.28 0.474 . . . . 0.0 112.28 -178.455 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' F' F ' 26' ' ' LEU . . . . . 0.621 HD12 HG22 ' F' ' 22' ' ' ILE . 58.2 mt -79.13 -40.52 30.8 Favored 'General case' 0 C--N 1.33 -0.241 0 N-CA-C 113.349 0.87 . . . . 0.0 113.349 -172.446 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' F' F ' 27' ' ' GLN . . . . . . . . . . . . . 11.2 pt20 -47.1 141.49 4.28 Favored 'General case' 0 N--CA 1.47 0.534 0 N-CA-C 112.726 0.639 . . . . 0.0 112.726 -174.359 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' F' F ' 28' ' ' GLY . . . . . . . . . . . . . . . 96.91 -25.76 25.39 Favored Glycine 0 CA--C 1.534 1.227 0 CA-C-N 115.626 -0.715 . . . . 0.0 112.1 -176.638 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' F' F ' 29' ' ' LYS . . . . . . . . . . . . . 59.1 mtpt -98.33 155.1 17.37 Favored 'General case' 0 C--O 1.233 0.217 0 CA-C-N 117.275 0.538 . . . . 0.0 111.002 179.284 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' F' F ' 30' ' ' THR . . . . . . . . . . . . . 31.4 m -111.45 139.27 47.0 Favored 'General case' 0 C--N 1.331 -0.217 0 CA-C-N 116.093 -0.503 . . . . 0.0 110.217 175.743 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' F' F ' 31' ' ' VAL . . . . . . . . . . . . . 35.2 m -134.37 164.43 34.26 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.225 0 CA-C-O 120.796 0.331 . . . . 0.0 110.981 -179.22 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' F' F ' 32' ' ' ARG . . . . . . . . . . . . . 77.9 mtp180 -131.3 153.97 49.01 Favored 'General case' 0 C--N 1.331 -0.223 0 CA-C-O 121.227 0.537 . . . . 0.0 110.735 177.908 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' F' F ' 33' ' ' THR . . . . . . . . . . . . . 32.3 m -53.78 140.94 28.41 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.221 -0.445 . . . . 0.0 111.222 -179.603 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' F' F ' 34' ' ' GLY . . . . . . . . . . . . . . . 99.9 -17.13 57.72 Favored Glycine 0 CA--C 1.531 1.068 0 C-N-CA 121.211 -0.519 . . . . 0.0 113.26 179.371 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' F' F ' 35' ' ' ASP . . . . . . . . . . . . . 65.6 m-20 -65.23 149.34 50.1 Favored 'General case' 0 C--O 1.231 0.121 0 CA-C-N 118.089 0.945 . . . . 0.0 111.188 179.044 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' F' F ' 36' ' ' VAL . . . . . . . . . . . . . 46.4 t -122.71 130.16 74.69 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.256 0 CA-C-N 115.78 -0.645 . . . . 0.0 109.867 178.909 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' F' F ' 37' ' ' ILE . . . . . . . . . . . . . 69.7 mt -122.07 139.47 48.95 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.234 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.044 -179.524 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' F' F ' 38' ' ' GLY . . . . . . . . . . . . . . . -113.86 129.17 8.64 Favored Glycine 0 CA--C 1.525 0.703 0 N-CA-C 111.115 -0.794 . . . . 0.0 111.115 -179.933 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' F' F ' 39' ' ' ILE . . . . . . . . . . . . . 67.7 mt -120.0 133.73 65.79 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.216 0 N-CA-C 110.084 -0.339 . . . . 0.0 110.084 178.964 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' F' F ' 40' ' ' SER . . . . . . . . . . . . . 53.6 p -93.4 120.04 33.21 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.343 -0.389 . . . . 0.0 110.844 175.399 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' F' F ' 41' ' ' ILE . . . . . . . . . . . . . 68.9 mt -129.81 122.55 54.94 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.179 0 CA-C-O 120.787 0.327 . . . . 0.0 110.462 177.903 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' F' F ' 42' ' ' LEU . . . . . . . . . . . . . 8.9 tp 52.23 35.11 16.0 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-N 116.131 -0.486 . . . . 0.0 111.628 177.308 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' F' F ' 43' ' ' GLY . . . . . . . . . . . . . . . 72.07 32.32 63.32 Favored Glycine 0 CA--C 1.529 0.952 0 C-N-CA 121.05 -0.595 . . . . 0.0 111.907 178.253 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' F' F ' 44' ' ' LYS . . . . . . . . . . . . . 54.4 tttp -137.94 128.79 27.02 Favored 'General case' 0 C--N 1.329 -0.296 0 N-CA-C 109.668 -0.493 . . . . 0.0 109.668 179.259 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' F' F ' 45' ' ' GLU . . . . . . . . . . . . . 84.6 tt0 -84.23 124.68 31.46 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-O 120.878 0.37 . . . . 0.0 111.298 -178.215 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' F' F ' 46' ' ' VAL . . . . . . . . . . . . . 7.1 p -121.0 127.74 75.99 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.209 0 N-CA-C 109.299 -0.63 . . . . 0.0 109.299 174.261 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' F' F ' 47' ' ' LYS . . . . . . . . . . . . . 93.1 mttt -99.98 127.24 46.21 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.062 -0.517 . . . . 0.0 111.006 179.583 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' F' F ' 48' ' ' PHE . . . . . . . . . . . . . 94.0 m-85 -111.07 131.96 54.65 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.305 -0.407 . . . . 0.0 109.951 175.961 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' F' F ' 49' ' ' LYS . . . . . . . . . . . . . 84.0 tttt -107.24 135.5 48.65 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.281 -0.418 . . . . 0.0 110.218 179.457 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' F' F ' 50' ' ' VAL . . . . . . . . . . . . . 46.4 t -79.38 108.02 12.47 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.295 0 N-CA-C 109.22 -0.659 . . . . 0.0 109.22 176.541 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' F' F ' 51' ' ' VAL . . . . . . . . . . . . . 47.8 t -70.9 -48.11 58.54 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.267 0 CA-C-N 115.991 -0.549 . . . . 0.0 109.974 -173.768 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' F' F ' 52' ' ' GLN . . . . . . . . . . . . . 63.2 tt0 -163.67 140.08 6.83 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.05 -0.523 . . . . 0.0 111.553 -178.233 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' F' F ' 53' ' ' ALA . . . . . 0.49 ' HB1' ' HB2' ' F' ' 58' ' ' LEU . . . -111.9 130.49 55.81 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-N 115.565 -0.743 . . . . 0.0 109.54 174.137 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' F' F ' 54' ' ' TYR . . . . . . . . . . . . . 41.8 t80 -129.06 110.16 18.24 Favored Pre-proline 0 C--N 1.327 -0.38 0 CA-C-O 118.358 -0.829 . . . . 0.0 110.484 -179.3 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' F' F ' 55' ' ' PRO . . . . . . . . . . . . . 73.8 Cg_endo -76.99 169.69 73.74 Favored 'Cis proline' 0 N--CA 1.498 1.783 0 CA-C-N 121.906 1.716 . . . . 0.0 112.296 -4.343 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' F' F ' 56' ' ' SER . . . . . . . . . . . . . 13.7 m -113.45 128.03 26.16 Favored Pre-proline 0 CA--C 1.539 0.553 0 CA-C-O 118.448 -0.787 . . . . 0.0 109.383 176.706 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' F' F ' 57' ' ' PRO . . . . . . . . . . . . . 38.5 Cg_endo -66.96 165.35 67.11 Favored 'Cis proline' 0 N--CA 1.497 1.693 0 CA-C-N 121.924 1.723 . . . . 0.0 111.463 0.388 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' F' F ' 58' ' ' LEU . . . . . 0.49 ' HB2' ' HB1' ' F' ' 53' ' ' ALA . 27.7 tp -129.26 135.76 49.2 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-O 120.934 0.397 . . . . 0.0 110.612 -179.31 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' F' F ' 59' ' ' ARG . . . . . . . . . . . . . 40.6 ttm180 -106.56 137.21 44.98 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-N 115.897 -0.592 . . . . 0.0 109.569 176.309 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' F' F ' 60' ' ' VAL . . . . . . . . . . . . . 44.2 t -91.0 122.7 42.66 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 C-N-CA 120.601 -0.44 . . . . 0.0 110.272 -178.178 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' F' F ' 61' ' ' GLU . . . . . . . . . . . . . 70.6 mm-40 -131.09 167.76 18.57 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 115.938 -0.574 . . . . 0.0 110.006 177.208 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' F' F ' 62' ' ' ASP . . . . . . . . . . . . . 75.1 m-20 -54.68 -32.95 60.16 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-N 116.58 -0.282 . . . . 0.0 111.748 -178.715 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' F' F ' 63' ' ' ARG . . . . . . . . . . . . . 7.0 ptp180 -89.45 8.55 30.36 Favored 'General case' 0 CA--C 1.536 0.413 0 N-CA-C 113.527 0.936 . . . . 0.0 113.527 -175.499 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' F' F ' 64' ' ' THR . . . . . . . . . . . . . 30.3 m -85.2 137.77 32.79 Favored 'General case' 0 C--O 1.232 0.155 0 CA-C-N 118.115 0.416 . . . . 0.0 110.343 -178.644 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' F' F ' 65' ' ' LYS . . . . . . . . . . . . . 97.3 mttt -88.58 125.94 35.03 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-N 116.27 -0.423 . . . . 0.0 110.041 -179.899 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' F' F ' 66' ' ' ILE . . . . . . . . . . . . . 64.9 mt -115.24 128.77 72.3 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.279 0 N-CA-C 109.812 -0.44 . . . . 0.0 109.812 -179.825 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' F' F ' 67' ' ' THR . . . . . . . . . . . . . 18.6 m -124.65 138.7 54.29 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.74 -177.726 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' F' F ' 68' ' ' LEU . . . . . 0.504 HD12 ' N ' ' F' ' 68' ' ' LEU . 7.1 mp . . . . . 0 C--N 1.329 -0.288 0 CA-C-N 115.895 -0.593 . . . . 0.0 110.226 177.218 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' F' F ' 73' ' ' VAL . . . . . . . . . . . . . 27.5 m . . . . . 0 C--O 1.232 0.172 0 CA-C-O 121.248 0.547 . . . . 0.0 111.079 . . . . . . . . . 0 0 . 1 . 012 nuclear nobuild core ' F' F ' 74' ' ' ASP . . . . . . . . . . . . . 33.5 t0 -96.61 119.83 35.81 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 115.477 -0.783 . . . . 0.0 109.236 176.583 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' F' F ' 75' ' ' VAL . . . . . . . . . . . . . 42.0 t -109.6 123.15 65.25 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.247 0 CA-C-O 121.178 0.514 . . . . 0.0 110.521 -176.73 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' F' F ' 76' ' ' LEU . . . . . . . . . . . . . 23.8 mt -128.9 141.27 51.33 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 115.485 -0.78 . . . . 0.0 109.281 177.508 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' F' F ' 77' ' ' GLU . . . . . . . . . . . . . 45.7 tt0 -136.76 133.07 35.62 Favored 'General case' 0 C--N 1.331 -0.225 0 C-N-CA 120.736 -0.386 . . . . 0.0 110.978 -176.354 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' F' F ' 78' ' ' ALA . . . . . . . . . . . . . . . -120.6 135.55 55.07 Favored 'General case' 0 C--N 1.332 -0.177 0 CA-C-N 116.259 -0.428 . . . . 0.0 110.281 179.796 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' F' F ' 79' ' ' LYS . . . . . 0.655 ' O ' HD13 ' F' ' 80' ' ' ILE . 87.1 mttt -79.49 120.87 24.48 Favored 'General case' 0 C--N 1.331 -0.209 0 CA-C-O 120.853 0.359 . . . . 0.0 110.787 -179.242 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' F' F ' 80' ' ' ILE . . . . . 0.655 HD13 ' O ' ' F' ' 79' ' ' LYS . 37.2 mm -139.14 108.16 3.65 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.314 0 N-CA-C 108.869 -0.789 . . . . 0.0 108.869 -177.78 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' F' F ' 81' ' ' LYS . . . . . . . . . . . . . 79.5 tttt -99.96 125.79 46.02 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-O 120.837 0.351 . . . . 0.0 111.43 -174.834 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' F' F ' 82' ' ' GLY . . . . . . . . . . . . . . . 89.05 42.14 5.7 Favored Glycine 0 CA--C 1.525 0.683 0 C-N-CA 120.956 -0.64 . . . . 0.0 111.617 174.417 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' F' F ' 83' ' ' ILE . . . . . . . . . . . . . 68.5 mt -68.83 138.23 22.78 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.29 0 CA-C-O 120.921 0.391 . . . . 0.0 110.019 179.695 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' F' F ' 84' ' ' LYS . . . . . . . . . . . . . 38.2 tttp -99.91 -53.12 3.25 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 115.924 -0.58 . . . . 0.0 110.158 -179.475 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' F' F ' 85' ' ' ASP . . . . . . . . . . . . . 11.1 t0 -151.85 148.31 27.66 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 115.748 -0.66 . . . . 0.0 110.241 179.72 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' F' F ' 86' ' ' VAL . . . . . . . . . . . . . 45.3 t -125.94 130.24 72.33 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.191 0 CA-C-O 120.898 0.38 . . . . 0.0 110.308 -179.309 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' F' F ' 87' ' ' ILE . . . . . . . . . . . . . 46.2 mm -121.75 130.21 74.8 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.246 0 CA-C-N 115.926 -0.579 . . . . 0.0 109.948 177.365 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' F' F ' 88' ' ' LEU . . . . . . . . . . . . . 58.5 mt -108.17 137.25 46.47 Favored 'General case' 0 C--N 1.332 -0.194 0 CA-C-O 121.04 0.448 . . . . 0.0 111.361 -177.966 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' F' F ' 89' ' ' ASP . . . . . . . . . . . . . 13.8 t70 -126.58 153.14 45.67 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 115.653 -0.703 . . . . 0.0 109.489 176.695 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' F' F ' 90' ' ' GLU . . . . . . . . . . . . . 84.8 tt0 -47.54 -36.12 10.0 Favored 'General case' 0 C--N 1.329 -0.288 0 N-CA-C 112.851 0.686 . . . . 0.0 112.851 -172.259 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' F' F ' 91' ' ' ASN . . . . . . . . . . . . . 16.9 t30 -131.96 19.99 4.55 Favored 'General case' 0 N--CA 1.468 0.435 0 N-CA-C 112.995 0.739 . . . . 0.0 112.995 -178.411 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' F' F ' 92' ' ' LEU . . . . . . . . . . . . . 35.7 mt -150.28 152.83 35.12 Favored 'General case' 0 C--N 1.331 -0.209 0 CA-C-O 120.824 0.345 . . . . 0.0 110.513 -177.114 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' F' F ' 93' ' ' ILE . . . . . . . . . . . . . 71.9 mt -126.77 121.27 57.99 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.379 0 N-CA-C 109.319 -0.623 . . . . 0.0 109.319 177.206 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' F' F ' 94' ' ' VAL . . . . . . . . . . . . . 45.4 t -117.47 125.83 74.27 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.268 0 N-CA-C 109.829 -0.434 . . . . 0.0 109.829 -178.907 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' F' F ' 95' ' ' VAL . . . . . . . . . . . . . 46.1 t -122.16 133.03 69.72 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.291 0 CA-C-N 116.071 -0.513 . . . . 0.0 109.919 -179.468 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' F' F ' 96' ' ' ILE . . . . . . . . . . . . . 57.4 mt -114.77 127.77 72.15 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.323 0 N-CA-C 109.141 -0.689 . . . . 0.0 109.141 178.473 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' F' F ' 97' ' ' THR . . . . . . . . . . . . . 74.0 p -99.33 159.34 15.08 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-O 121.139 0.495 . . . . 0.0 111.423 -177.303 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' F' F ' 98' ' ' GLU . . . . . . . . . . . . . 12.6 pt-20 -54.69 -28.02 44.62 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.091 -0.504 . . . . 0.0 112.263 -179.135 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' F' F ' 99' ' ' GLU . . . . . . . . . . . . . 70.9 mm-40 -80.28 14.39 1.97 Allowed 'General case' 0 CA--C 1.535 0.397 0 N-CA-C 113.084 0.772 . . . . 0.0 113.084 -177.684 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' F' F ' 100' ' ' ASN . . . . . . . . . . . . . 5.3 m-20 62.09 35.25 15.91 Favored 'General case' 0 C--N 1.332 -0.164 0 CA-C-O 120.96 0.41 . . . . 0.0 111.354 179.56 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' F' F ' 101' ' ' GLU . . . . . . . . . . . . . 84.5 tt0 -106.61 143.0 35.35 Favored 'General case' 0 C--N 1.333 -0.145 0 N-CA-C 109.513 -0.551 . . . . 0.0 109.513 172.008 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' F' F ' 102' ' ' VAL . . . . . . . . . . . . . 43.2 t -115.02 125.45 72.34 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.311 0 N-CA-C 109.823 -0.436 . . . . 0.0 109.823 -177.867 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' F' F ' 103' ' ' LEU . . . . . . . . . . . . . 42.5 mt -116.81 129.13 55.9 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 115.762 -0.654 . . . . 0.0 110.17 177.508 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' F' F ' 104' ' ' ILE . . . . . . . . . . . . . 70.3 mt -118.36 119.43 61.24 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.261 0 N-CA-C 110.118 -0.327 . . . . 0.0 110.118 179.187 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' F' F ' 105' ' ' PHE . . . . . . . . . . . . . 65.8 m-85 -119.81 166.32 13.42 Favored 'General case' 0 C--N 1.331 -0.202 0 O-C-N 124.169 0.918 . . . . 0.0 109.591 178.858 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' F' F ' 106' ' ' ASN . . . . . . . . . . . . . 43.6 p-10 -99.3 -170.91 1.98 Allowed 'General case' 0 C--N 1.329 -0.284 0 N-CA-C 109.756 -0.461 . . . . 0.0 109.756 171.834 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' F' F ' 107' ' ' GLN . . . . . . . . . . . . . 43.0 tp60 -57.82 -27.91 63.58 Favored 'General case' 0 CA--C 1.533 0.323 0 N-CA-C 112.005 0.372 . . . . 0.0 112.005 -179.815 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' F' F ' 108' ' ' ASN . . . . . . . . . . . . . 23.5 t30 -90.47 13.85 14.6 Favored 'General case' 0 CA--C 1.534 0.336 0 N-CA-C 113.067 0.766 . . . . 0.0 113.067 -175.997 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' F' F ' 109' ' ' LEU . . . . . . . . . . . . . 47.5 mt 57.95 38.0 26.85 Favored 'General case' 0 C--O 1.232 0.144 0 CA-C-O 120.975 0.416 . . . . 0.0 111.468 177.292 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' F' F ' 110' ' ' GLU . . . . . . . . . . . . . 95.7 mt-10 -102.07 155.12 18.39 Favored 'General case' 0 C--N 1.329 -0.319 0 N-CA-C 109.939 -0.393 . . . . 0.0 109.939 176.076 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' F' F ' 111' ' ' GLU . . . . . . . . . . . . . 84.9 tt0 -85.85 121.91 29.17 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-O 120.914 0.388 . . . . 0.0 110.698 -178.067 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' F' F ' 112' ' ' LEU . . . . . . . . . . . . . 32.5 mt -111.8 -45.97 3.29 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.043 -0.526 . . . . 0.0 110.414 178.297 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' F' F ' 113' ' ' TYR . . . . . . . . . . . . . 63.3 t80 -138.79 135.79 35.0 Favored 'General case' 0 C--N 1.331 -0.213 0 CA-C-N 116.43 -0.35 . . . . 0.0 111.117 179.351 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' F' F ' 114' ' ' ARG . . . . . . . . . . . . . 59.6 ttp180 -137.69 122.3 18.55 Favored 'General case' 0 C--N 1.331 -0.227 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.308 177.65 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' F' F ' 115' ' ' GLY . . . . . . . . . . . . . . . -150.08 161.1 28.79 Favored Glycine 0 CA--C 1.525 0.668 0 N-CA-C 111.053 -0.819 . . . . 0.0 111.053 177.943 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' F' F ' 116' ' ' LYS . . . . . . . . . . . . . 83.4 tttt -134.9 128.97 33.59 Favored 'General case' 0 C--N 1.33 -0.274 0 N-CA-C 109.972 -0.381 . . . . 0.0 109.972 177.703 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' F' F ' 117' ' ' PHE . . . . . . . . . . . . . 30.8 m-85 -129.03 118.85 23.23 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 116.402 -0.363 . . . . 0.0 110.047 -174.778 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' F' F ' 118' ' ' GLU . . . . . . . . . . . . . 95.9 mt-10 -55.59 -40.25 71.77 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.469 -0.332 . . . . 0.0 110.987 -177.264 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' F' F ' 119' ' ' ASN . . . . . . . . . . . . . 19.1 m120 -101.28 30.99 3.88 Favored 'General case' 0 C--N 1.33 -0.257 0 N-CA-C 112.047 0.388 . . . . 0.0 112.047 -175.022 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' F' F ' 120' ' ' LEU . . . . . . . . . . . . . 17.5 tp -58.08 124.48 19.5 Favored 'General case' 0 C--N 1.333 -0.15 0 CA-C-O 120.752 0.311 . . . . 0.0 110.221 178.781 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' F' F ' 121' ' ' ASN . . . . . . . . . . . . . 17.6 m120 -109.23 -44.19 3.99 Favored 'General case' 0 C--N 1.331 -0.222 0 CA-C-N 116.328 -0.396 . . . . 0.0 111.116 -176.962 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' F' F ' 122' ' ' LYS . . . . . . . . . . . . . 19.5 ptpt -163.65 163.15 24.42 Favored 'General case' 0 C--N 1.331 -0.199 0 CA-C-O 121.099 0.476 . . . . 0.0 111.726 -179.043 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' F' F ' 123' ' ' VAL . . . . . . . . . . . . . 42.2 t -132.95 137.15 54.38 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.251 0 CA-C-N 116.023 -0.535 . . . . 0.0 110.006 178.613 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' F' F ' 124' ' ' LEU . . . . . . . . . . . . . 80.0 mt -120.77 138.52 53.97 Favored 'General case' 0 C--N 1.331 -0.224 0 CA-C-N 116.293 -0.412 . . . . 0.0 110.535 -179.418 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' F' F ' 125' ' ' VAL . . . . . 0.53 HG23 HG12 ' F' ' 130' ' ' VAL . 12.0 p -133.63 130.28 56.25 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.246 0 CA-C-O 120.938 0.399 . . . . 0.0 110.785 179.641 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' F' F ' 126' ' ' ARG . . . . . . . . . . . . . 79.4 mtt85 -151.32 125.12 9.1 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 115.851 -0.613 . . . . 0.0 109.948 175.469 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' F' F ' 127' ' ' ASN . . . . . . . . . . . . . 17.3 m120 55.99 -149.32 0.46 Allowed 'General case' 0 CA--C 1.54 0.579 0 N-CA-C 109.897 -0.408 . . . . 0.0 109.897 178.99 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' F' F ' 128' ' ' ASP . . . . . . . . . . . . . 24.3 p-10 -82.17 13.08 3.67 Favored 'General case' 0 CA--C 1.537 0.446 0 N-CA-C 112.995 0.739 . . . . 0.0 112.995 -179.96 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' F' F ' 129' ' ' LEU . . . . . . . . . . . . . 19.9 tp -112.5 133.45 54.56 Favored 'General case' 0 C--O 1.232 0.182 0 CA-C-N 118.171 0.441 . . . . 0.0 110.104 179.196 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' F' F ' 130' ' ' VAL . . . . . 0.53 HG12 HG23 ' F' ' 125' ' ' VAL . 33.7 m -131.55 141.56 45.46 Favored 'Isoleucine or valine' 0 C--O 1.232 0.136 0 CA-C-O 120.782 0.325 . . . . 0.0 110.506 -179.651 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' F' F ' 131' ' ' VAL . . . . . 0.428 ' CG1' HD21 ' F' ' 138' ' ' LEU . 40.0 t -136.09 140.29 44.17 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.305 0 CA-C-O 120.986 0.422 . . . . 0.0 110.525 -179.104 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' F' F ' 132' ' ' ILE . . . . . . . . . . . . . 69.4 mt -115.16 133.8 60.28 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.249 0 N-CA-C 109.255 -0.646 . . . . 0.0 109.255 178.035 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' F' F ' 133' ' ' ILE . . . . . . . . . . . . . 42.7 mm -115.11 124.4 71.7 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.229 0 CA-C-N 116.568 -0.287 . . . . 0.0 110.859 -175.051 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' F' F ' 134' ' ' ASP . . . . . . . . . . . . . 7.2 p-10 -134.6 147.5 50.23 Favored 'General case' 0 C--N 1.332 -0.195 0 N-CA-C 109.605 -0.517 . . . . 0.0 109.605 174.089 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' F' F ' 135' ' ' GLU . . . . . . . . . . . . . 85.2 tt0 -50.7 -27.55 7.3 Favored 'General case' 0 C--N 1.328 -0.335 0 N-CA-C 112.822 0.675 . . . . 0.0 112.822 -173.129 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' F' F ' 136' ' ' GLN . . . . . . . . . . . . . 97.5 mt-30 -81.55 -32.47 32.2 Favored 'General case' 0 C--N 1.331 -0.239 0 N-CA-C 112.663 0.616 . . . . 0.0 112.663 -176.784 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' F' F ' 137' ' ' LYS . . . . . . . . . . . . . 53.3 pttt -169.02 173.54 6.83 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-O 121.562 0.696 . . . . 0.0 112.576 -172.458 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' F' F ' 138' ' ' LEU . . . . . 0.463 HD23 ' N ' ' F' ' 139' ' ' THR . 4.6 tt -117.07 129.74 56.19 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 115.113 -0.949 . . . . 0.0 109.923 179.622 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' F' F ' 139' ' ' THR . . . . . 0.463 ' N ' HD23 ' F' ' 138' ' ' LEU . 33.2 m -112.22 124.68 52.97 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.421 -0.354 . . . . 0.0 110.199 178.917 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' F' F ' 140' ' ' LEU . . . . . 0.482 HD23 ' C ' ' F' ' 140' ' ' LEU . 7.8 tt -113.86 125.19 53.79 Favored 'General case' 0 C--N 1.33 -0.281 0 N-CA-C 109.326 -0.62 . . . . 0.0 109.326 -178.724 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' F' F ' 141' ' ' ILE . . . . . 0.509 ' HB ' HG23 ' F' ' 130' ' ' VAL . 20.1 mt -121.98 125.32 72.97 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.272 0 CA-C-O 121.03 0.443 . . . . 0.0 110.022 -175.39 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' F' F ' 142' ' ' ARG . . . . . . . . . . . . . 39.1 tpt85 -113.8 128.04 56.25 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 115.132 -0.94 . . . . 0.0 109.944 -177.403 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' F' F ' 143' ' ' THR . . . . . . . . . . . . . 23.5 p . . . . . 0 C--O 1.22 -0.49 0 CA-C-O 117.953 -1.023 . . . . 0.0 110.516 -179.328 . . . . . . . . 0 0 . 1 . 013 nuclear nobuild core ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 2.6 p . . . . . 0 N--CA 1.461 0.095 0 CA-C-O 120.924 0.392 . . . . 0.0 110.711 . . . . . . . . . 0 0 . 1 . 013 nuclear nobuild core ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 82.8 tt0 -145.87 144.03 29.96 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.169 -0.469 . . . . 0.0 111.011 179.58 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 4' ' ' LEU . . . . . . . . . . . . . 14.8 tp -125.9 132.43 52.14 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.069 -0.514 . . . . 0.0 110.109 177.227 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 5' ' ' LYS . . . . . . . . . . . . . 68.3 mttm -109.75 122.74 48.18 Favored 'General case' 0 C--O 1.233 0.195 0 CA-C-N 116.345 -0.389 . . . . 0.0 110.823 179.941 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 31.2 mt -113.84 150.0 34.21 Favored 'General case' 0 C--N 1.331 -0.217 0 CA-C-N 115.349 -0.841 . . . . 0.0 110.196 -179.781 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 81.9 tttt -133.0 138.8 32.65 Favored Pre-proline 0 CA--C 1.534 0.332 0 CA-C-O 118.949 -0.548 . . . . 0.0 109.525 174.077 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 8' ' ' PRO . . . . . . . . . . . . . 88.5 Cg_endo -91.66 141.3 2.61 Favored 'Trans proline' 0 N--CA 1.489 1.253 0 C-N-CA 121.747 1.631 . . . . 0.0 112.16 179.741 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 62.5 mt -77.41 -47.4 2.51 Favored Pre-proline 0 CA--C 1.535 0.393 0 CA-C-O 118.69 -0.672 . . . . 0.0 112.074 178.729 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 97.8 Cg_endo -81.77 152.98 17.26 Favored 'Trans proline' 0 N--CA 1.495 1.604 0 C-N-CA 121.293 1.329 . . . . 0.0 111.995 176.088 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 46.3 tttp -88.68 98.08 11.49 Favored 'General case' 0 C--N 1.331 -0.237 0 C-N-CA 120.89 -0.324 . . . . 0.0 110.189 177.682 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 12.3 p -141.47 147.94 21.6 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.308 0 CA-C-N 116.283 -0.417 . . . . 0.0 110.673 -178.48 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 93.6 mt-10 -88.94 124.35 34.15 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.259 -0.428 . . . . 0.0 109.993 177.904 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 14' ' ' LEU . . . . . . . . . . . . . 26.2 mt -98.15 149.81 36.1 Favored Pre-proline 0 CA--C 1.534 0.335 0 CA-C-O 119.266 -0.397 . . . . 0.0 110.508 -179.25 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 15' ' ' PRO . . . . . . . . . . . . . 26.9 Cg_exo -62.06 158.55 38.52 Favored 'Trans proline' 0 N--CA 1.498 1.744 0 C-N-CA 121.282 1.322 . . . . 0.0 112.015 177.416 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 16' ' ' PRO . . . . . . . . . . . . . 32.9 Cg_exo -59.78 -35.66 93.64 Favored 'Trans proline' 0 N--CA 1.498 1.765 0 C-N-CA 121.384 1.389 . . . . 0.0 112.676 -179.739 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 17' ' ' ASP . . . . . . . . . . . . . 18.7 p-10 -86.91 8.81 21.5 Favored 'General case' 0 C--N 1.327 -0.376 0 N-CA-C 113.276 0.843 . . . . 0.0 113.276 -177.644 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 18' ' ' PHE . . . . . . . . . . . . . 37.9 t80 -58.12 -47.86 81.99 Favored 'General case' 0 N--CA 1.457 -0.081 0 O-C-N 121.963 -0.46 . . . . 0.0 110.194 -177.158 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 19' ' ' VAL . . . . . 0.408 HG13 ' N ' ' A' ' 20' ' ' ASP . 14.8 p -55.92 -41.3 66.79 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.339 0 CA-C-N 116.359 -0.382 . . . . 0.0 111.141 -177.614 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 20' ' ' ASP . . . . . 0.408 ' N ' HG13 ' A' ' 19' ' ' VAL . 49.8 m-20 -60.26 -44.74 95.04 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-O 120.805 0.336 . . . . 0.0 111.045 -177.387 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 47.0 t -64.78 -48.44 84.47 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.283 0 C-N-CA 120.726 -0.39 . . . . 0.0 110.495 -177.648 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 22' ' ' ILE . . . . . 0.542 HG22 HD12 ' A' ' 26' ' ' LEU . 44.5 mm -56.92 -43.86 81.3 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.247 0 CA-C-O 120.777 0.322 . . . . 0.0 110.489 179.957 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 23' ' ' ARG . . . . . . . . . . . . . 32.1 ttp180 -54.58 -49.76 69.62 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.65 -0.25 . . . . 0.0 111.283 -178.637 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 24' ' ' ILE . . . . . . . . . . . . . 75.9 mt -59.41 -41.39 84.3 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.238 0 C-N-CA 120.971 -0.291 . . . . 0.0 111.148 -177.622 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 91.9 mttt -64.97 -43.47 92.56 Favored 'General case' 0 C--N 1.329 -0.295 0 N-CA-C 112.439 0.533 . . . . 0.0 112.439 -179.437 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 26' ' ' LEU . . . . . 0.542 HD12 HG22 ' A' ' 22' ' ' ILE . 88.7 mt -79.75 -36.81 36.74 Favored 'General case' 0 C--N 1.331 -0.217 0 N-CA-C 113.589 0.959 . . . . 0.0 113.589 -170.541 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 27' ' ' GLN . . . . . . . . . . . . . 9.1 pt20 -47.13 142.17 3.9 Favored 'General case' 0 N--CA 1.469 0.508 0 N-CA-C 112.699 0.629 . . . . 0.0 112.699 -175.04 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 99.15 -24.99 30.02 Favored Glycine 0 CA--C 1.534 1.237 0 CA-C-N 115.591 -0.732 . . . . 0.0 112.251 -176.155 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 68.3 mttm -97.52 155.15 17.08 Favored 'General case' 0 C--O 1.232 0.177 0 CA-C-N 117.399 0.599 . . . . 0.0 111.028 178.635 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 30' ' ' THR . . . . . . . . . . . . . 30.2 m -103.25 137.68 41.06 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 115.887 -0.597 . . . . 0.0 109.933 176.13 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 35.2 m -126.33 153.52 34.89 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.248 0 CA-C-N 116.404 -0.362 . . . . 0.0 110.468 -179.4 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 32' ' ' ARG . . . . . . . . . . . . . 60.3 ttp180 -131.23 148.58 52.71 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.048 -0.524 . . . . 0.0 110.458 179.293 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 33' ' ' THR . . . . . . . . . . . . . 17.2 m -53.12 138.7 30.61 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.266 -0.425 . . . . 0.0 111.365 -177.936 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 99.91 -17.2 57.62 Favored Glycine 0 CA--C 1.532 1.155 0 CA-C-O 119.718 -0.49 . . . . 0.0 113.228 179.873 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 72.9 m-20 -66.2 151.73 46.35 Favored 'General case' 0 C--N 1.334 -0.107 0 CA-C-N 118.039 0.92 . . . . 0.0 111.288 179.404 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 45.2 t -122.73 130.46 74.47 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.198 0 CA-C-N 115.756 -0.656 . . . . 0.0 109.884 177.784 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 37' ' ' ILE . . . . . . . . . . . . . 65.3 mt -120.66 138.06 52.37 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.231 0 CA-C-N 116.18 -0.464 . . . . 0.0 109.834 -179.921 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . -116.04 128.55 8.05 Favored Glycine 0 CA--C 1.525 0.665 0 N-CA-C 110.991 -0.844 . . . . 0.0 110.991 179.582 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 39' ' ' ILE . . . . . . . . . . . . . 75.1 mt -126.82 134.28 66.59 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.226 0 CA-C-O 120.695 0.283 . . . . 0.0 110.285 179.445 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 40' ' ' SER . . . . . . . . . . . . . 53.2 p -92.39 114.61 27.2 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-N 116.225 -0.443 . . . . 0.0 110.758 175.949 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 41' ' ' ILE . . . . . . . . . . . . . 43.1 mm -120.47 117.42 53.26 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.26 0 CA-C-O 120.937 0.398 . . . . 0.0 110.601 179.545 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 42' ' ' LEU . . . . . 0.546 ' O ' HD23 ' A' ' 42' ' ' LEU . 1.3 tt 51.66 45.96 27.29 Favored 'General case' 0 CA--C 1.531 0.248 0 CA-C-O 121.404 0.621 . . . . 0.0 111.004 176.701 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . 70.76 21.68 78.01 Favored Glycine 0 CA--C 1.532 1.138 0 C-N-CA 121.175 -0.536 . . . . 0.0 112.851 175.523 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 44' ' ' LYS . . . . . . . . . . . . . 56.5 mttm -133.14 129.31 37.71 Favored 'General case' 0 C--N 1.332 -0.178 0 CA-C-N 117.55 0.675 . . . . 0.0 110.09 179.195 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 84.5 tt0 -83.95 123.81 30.36 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 116.552 -0.294 . . . . 0.0 111.067 -178.568 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 46' ' ' VAL . . . . . 0.415 HG13 ' O ' ' A' ' 46' ' ' VAL . 10.4 p -121.21 124.17 71.49 Favored 'Isoleucine or valine' 0 C--O 1.233 0.194 0 N-CA-C 109.687 -0.486 . . . . 0.0 109.687 174.674 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 93.8 mttt -99.6 127.18 45.69 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.095 -0.502 . . . . 0.0 110.783 177.702 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 48' ' ' PHE . . . . . . . . . . . . . 35.8 m-85 -110.81 131.95 54.61 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 115.855 -0.612 . . . . 0.0 109.666 177.593 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 84.2 tttt -106.52 135.78 47.44 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.246 -0.434 . . . . 0.0 110.215 179.058 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 50' ' ' VAL . . . . . . . . . . . . . 45.1 t -79.21 105.33 8.38 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.317 0 N-CA-C 109.549 -0.537 . . . . 0.0 109.549 177.622 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 51' ' ' VAL . . . . . . . . . . . . . 50.5 t -70.14 -54.32 19.33 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.366 0 N-CA-C 109.36 -0.607 . . . . 0.0 109.36 -176.347 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 52' ' ' GLN . . . . . . . . . . . . . 91.7 mt-30 -153.52 154.35 34.16 Favored 'General case' 0 C--N 1.331 -0.22 0 CA-C-N 115.913 -0.585 . . . . 0.0 111.595 -178.864 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -129.35 134.34 47.85 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 115.148 -0.933 . . . . 0.0 109.779 175.984 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 54' ' ' TYR . . . . . . . . . . . . . 57.3 t80 -128.75 107.24 18.54 Favored Pre-proline 0 CA--C 1.534 0.345 0 CA-C-O 118.281 -0.866 . . . . 0.0 110.449 -178.891 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 55' ' ' PRO . . . . . . . . . . . . . 73.5 Cg_endo -77.16 170.07 72.52 Favored 'Cis proline' 0 N--CA 1.5 1.854 0 CA-C-N 121.688 1.639 . . . . 0.0 112.405 -5.77 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 56' ' ' SER . . . . . . . . . . . . . 32.6 m -113.93 126.94 27.38 Favored Pre-proline 0 CA--C 1.54 0.57 0 CA-C-O 118.31 -0.852 . . . . 0.0 109.51 175.486 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 57' ' ' PRO . . . . . . . . . . . . . 52.7 Cg_endo -71.06 167.21 75.33 Favored 'Cis proline' 0 N--CA 1.497 1.677 0 CA-C-N 122.084 1.78 . . . . 0.0 111.89 -0.387 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 58' ' ' LEU . . . . . . . . . . . . . 18.9 tp -130.57 138.27 50.09 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.232 -0.44 . . . . 0.0 110.542 -179.426 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 59' ' ' ARG . . . . . . . . . . . . . 55.2 ttp180 -105.38 128.17 53.36 Favored 'General case' 0 C--N 1.329 -0.317 0 N-CA-C 109.118 -0.697 . . . . 0.0 109.118 175.031 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 40.2 t -82.84 123.12 38.22 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.196 0 C-N-CA 120.581 -0.448 . . . . 0.0 110.638 -173.835 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 95.1 mt-10 -131.07 168.76 16.87 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 115.78 -0.646 . . . . 0.0 109.998 177.958 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 62' ' ' ASP . . . . . . . . . . . . . 51.7 m-20 -54.36 -32.4 56.83 Favored 'General case' 0 C--N 1.329 -0.283 0 N-CA-C 111.747 0.277 . . . . 0.0 111.747 -179.712 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 63' ' ' ARG . . . . . . . . . . . . . 41.0 ptt180 -87.45 5.65 37.87 Favored 'General case' 0 CA--C 1.537 0.473 0 N-CA-C 113.712 1.004 . . . . 0.0 113.712 -174.999 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 28.8 m -87.4 139.14 30.85 Favored 'General case' 0 C--N 1.332 -0.179 0 CA-C-N 117.994 0.361 . . . . 0.0 110.537 -179.867 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 65' ' ' LYS . . . . . . . . . . . . . 61.8 mttm -87.63 130.44 34.77 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.096 -0.502 . . . . 0.0 110.281 179.154 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 66' ' ' ILE . . . . . . . . . . . . . 57.7 mt -115.47 124.93 72.47 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.316 0 N-CA-C 109.436 -0.579 . . . . 0.0 109.436 178.231 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 67' ' ' THR . . . . . . . . . . . . . 24.9 m -129.42 148.3 51.32 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-O 121.189 0.518 . . . . 0.0 111.531 -175.608 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 68' ' ' LEU . . . . . . . . . . . . . 4.0 tt . . . . . 0 C--N 1.329 -0.294 0 CA-C-N 115.764 -0.653 . . . . 0.0 109.589 176.52 . . . . . . . . 0 0 . 1 . 013 nuclear nobuild core ' A' A ' 74' ' ' ASP . . . . . . . . . . . . . 5.3 t0 . . . . . 0 N--CA 1.457 -0.106 0 N-CA-C 109.655 -0.498 . . . . 0.0 109.655 . . . . . . . . . 0 0 . 1 . 013 nuclear nobuild core ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 42.4 t -115.09 122.36 69.0 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.178 0 CA-C-O 121.038 0.446 . . . . 0.0 110.572 -177.783 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 76' ' ' LEU . . . . . . . . . . . . . 5.2 mp -121.09 142.87 49.44 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 115.623 -0.717 . . . . 0.0 109.739 176.386 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 77' ' ' GLU . . . . . . . . . . . . . 45.9 mt-10 -134.65 137.54 43.71 Favored 'General case' 0 C--N 1.331 -0.196 0 CA-C-O 120.955 0.407 . . . . 0.0 111.158 -179.355 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 78' ' ' ALA . . . . . 0.603 ' HB2' HD21 ' A' ' 109' ' ' LEU . . . -126.68 144.32 50.96 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 115.934 -0.576 . . . . 0.0 110.299 177.92 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 79' ' ' LYS . . . . . 0.624 ' O ' HD13 ' A' ' 80' ' ' ILE . 40.8 mmtm -82.99 116.04 22.09 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.392 -0.367 . . . . 0.0 110.688 -179.541 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 80' ' ' ILE . . . . . 0.624 HD13 ' O ' ' A' ' 79' ' ' LYS . 39.5 mm -139.09 110.69 5.16 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.286 0 N-CA-C 109.42 -0.585 . . . . 0.0 109.42 -179.288 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 81' ' ' LYS . . . . . . . . . . . . . 63.8 tttt -111.26 132.59 54.24 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-O 120.877 0.37 . . . . 0.0 111.064 -178.05 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . 89.04 42.11 5.71 Favored Glycine 0 CA--C 1.524 0.654 0 N-CA-C 111.432 -0.667 . . . . 0.0 111.432 175.46 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 83' ' ' ILE . . . . . . . . . . . . . 72.4 mt -76.54 137.68 22.12 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.326 0 N-CA-C 109.673 -0.491 . . . . 0.0 109.673 178.364 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 84' ' ' LYS . . . . . . . . . . . . . 39.3 ttpt -98.27 -48.14 5.18 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-N 116.241 -0.436 . . . . 0.0 110.036 -179.07 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 85' ' ' ASP . . . . . . . . . . . . . 5.5 t70 -155.12 155.77 34.58 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.089 -0.505 . . . . 0.0 110.814 179.357 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 86' ' ' VAL . . . . . . . . . . . . . 41.6 t -132.24 135.79 57.51 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.222 0 CA-C-O 120.962 0.411 . . . . 0.0 110.803 -178.423 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 87' ' ' ILE . . . . . . . . . . . . . 47.9 mm -119.22 123.59 71.6 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.308 0 CA-C-N 115.883 -0.599 . . . . 0.0 109.632 175.027 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 88' ' ' LEU . . . . . . . . . . . . . 14.2 tp -111.46 130.58 55.67 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-O 120.816 0.341 . . . . 0.0 110.89 -177.798 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 89' ' ' ASP . . . . . . . . . . . . . 6.9 t0 -130.89 156.02 45.76 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.048 -0.523 . . . . 0.0 109.704 178.328 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 79.5 tt0 -47.86 -39.61 19.12 Favored 'General case' 0 C--N 1.33 -0.27 0 N-CA-C 112.845 0.683 . . . . 0.0 112.845 -171.675 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 91' ' ' ASN . . . . . . . . . . . . . 16.4 m120 -123.58 14.98 9.52 Favored 'General case' 0 N--CA 1.467 0.406 0 N-CA-C 113.312 0.856 . . . . 0.0 113.312 -175.884 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 92' ' ' LEU . . . . . . . . . . . . . 33.4 mt -149.82 146.03 26.92 Favored 'General case' 0 C--N 1.331 -0.225 0 CA-C-N 117.93 0.332 . . . . 0.0 110.52 -176.214 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 93' ' ' ILE . . . . . . . . . . . . . 73.6 mt -127.62 116.92 45.12 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.331 0 N-CA-C 109.113 -0.699 . . . . 0.0 109.113 175.913 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 94' ' ' VAL . . . . . . . . . . . . . 45.0 t -116.7 126.87 74.36 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.278 0 N-CA-C 109.889 -0.412 . . . . 0.0 109.889 -177.941 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 95' ' ' VAL . . . . . . . . . . . . . 43.0 t -121.06 133.93 66.11 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.293 0 CA-C-N 116.177 -0.465 . . . . 0.0 109.807 179.465 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 96' ' ' ILE . . . . . 0.402 HD11 ' HB ' ' A' ' 123' ' ' VAL . 66.3 mt -113.52 126.1 70.9 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.365 0 N-CA-C 109.071 -0.714 . . . . 0.0 109.071 178.818 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 97' ' ' THR . . . . . . . . . . . . . 72.5 p -101.75 158.24 16.26 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-O 121.519 0.676 . . . . 0.0 111.593 -175.701 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 98' ' ' GLU . . . . . . . . . . . . . 82.4 tt0 -53.83 -27.3 28.73 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 115.549 -0.75 . . . . 0.0 112.295 179.991 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 99' ' ' GLU . . . . . . . . . . . . . 95.3 mt-10 -78.83 14.42 1.36 Allowed 'General case' 0 CA--C 1.535 0.369 0 N-CA-C 113.282 0.845 . . . . 0.0 113.282 -176.866 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 100' ' ' ASN . . . . . . . . . . . . . 3.2 m-20 61.03 37.5 17.92 Favored 'General case' 0 CA--C 1.53 0.211 0 CA-C-O 121.08 0.467 . . . . 0.0 110.891 -179.782 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 101' ' ' GLU . . . . . . . . . . . . . 84.3 tt0 -115.78 145.78 42.51 Favored 'General case' 0 C--O 1.232 0.16 0 CA-C-N 116.142 -0.481 . . . . 0.0 109.732 176.473 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 102' ' ' VAL . . . . . . . . . . . . . 45.7 t -114.95 125.3 72.24 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.298 0 N-CA-C 109.805 -0.442 . . . . 0.0 109.805 -177.332 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 103' ' ' LEU . . . . . . . . . . . . . 39.0 mt -116.3 126.48 53.6 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 115.634 -0.712 . . . . 0.0 110.185 177.263 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 104' ' ' ILE . . . . . 0.402 HD13 HG11 ' A' ' 130' ' ' VAL . 64.3 mt -117.59 120.11 63.75 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.214 0 N-CA-C 110.142 -0.318 . . . . 0.0 110.142 -179.993 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 105' ' ' PHE . . . . . . . . . . . . . 68.6 m-85 -119.95 165.57 14.47 Favored 'General case' 0 C--N 1.332 -0.19 0 O-C-N 123.818 0.698 . . . . 0.0 109.526 178.94 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 106' ' ' ASN . . . . . . . . . . . . . 36.7 p-10 -99.59 -170.33 1.88 Allowed 'General case' 0 C--N 1.331 -0.218 0 N-CA-C 109.952 -0.388 . . . . 0.0 109.952 174.926 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 107' ' ' GLN . . . . . . . . . . . . . 48.6 tp60 -59.47 -30.15 68.32 Favored 'General case' 0 C--N 1.328 -0.328 0 N-CA-C 111.94 0.348 . . . . 0.0 111.94 179.474 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 108' ' ' ASN . . . . . . . . . . . . . 4.7 t-20 -84.35 9.19 13.78 Favored 'General case' 0 CA--C 1.537 0.477 0 N-CA-C 113.204 0.816 . . . . 0.0 113.204 -177.326 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 109' ' ' LEU . . . . . 0.603 HD21 ' HB2' ' A' ' 78' ' ' ALA . 9.8 tp 61.67 35.04 17.23 Favored 'General case' 0 CA--C 1.531 0.222 0 CA-C-O 120.868 0.366 . . . . 0.0 111.545 178.64 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 110' ' ' GLU . . . . . . . . . . . . . 70.6 mm-40 -104.86 142.92 33.89 Favored 'General case' 0 C--N 1.33 -0.276 0 N-CA-C 109.373 -0.603 . . . . 0.0 109.373 174.719 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 111' ' ' GLU . . . . . . . . . . . . . 48.7 tt0 -83.63 121.85 27.81 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-O 120.892 0.377 . . . . 0.0 110.201 -176.725 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 112' ' ' LEU . . . . . . . . . . . . . 52.2 mt -105.1 -42.25 5.35 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 115.86 -0.609 . . . . 0.0 110.619 -179.526 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 113' ' ' TYR . . . . . . . . . . . . . 51.7 t80 -133.05 131.61 40.84 Favored 'General case' 0 C--N 1.331 -0.204 0 CA-C-O 121.01 0.433 . . . . 0.0 111.042 -179.095 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 114' ' ' ARG . . . . . . . . . . . . . 57.1 ttt180 -132.48 119.01 20.02 Favored 'General case' 0 C--N 1.331 -0.226 0 CA-C-N 115.745 -0.661 . . . . 0.0 109.812 177.242 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 115' ' ' GLY . . . . . . . . . . . . . . . -150.14 159.28 28.04 Favored Glycine 0 CA--C 1.522 0.522 0 N-CA-C 110.766 -0.934 . . . . 0.0 110.766 179.136 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 116' ' ' LYS . . . . . . . . . . . . . 34.3 ttmt -130.24 139.61 50.78 Favored 'General case' 0 C--N 1.329 -0.296 0 N-CA-C 110.03 -0.359 . . . . 0.0 110.03 177.646 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 117' ' ' PHE . . . . . . . . . . . . . 49.1 m-85 -134.87 113.96 12.09 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.288 -0.415 . . . . 0.0 110.012 -176.832 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 118' ' ' GLU . . . . . . . . . . . . . 79.6 tt0 -53.72 -43.28 68.91 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.64 -0.254 . . . . 0.0 111.263 -176.47 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 119' ' ' ASN . . . . . . . . . . . . . 32.5 m120 -99.31 30.99 3.26 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.091 -0.504 . . . . 0.0 112.119 -174.781 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 120' ' ' LEU . . . . . . . . . . . . . 15.4 tp -55.24 122.83 11.96 Favored 'General case' 0 N--CA 1.462 0.171 0 CA-C-O 120.751 0.31 . . . . 0.0 110.66 179.22 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 121' ' ' ASN . . . . . . . . . . . . . 64.9 t30 -113.33 -44.15 3.27 Favored 'General case' 0 C--N 1.331 -0.197 0 CA-C-N 116.362 -0.381 . . . . 0.0 111.046 -176.871 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 122' ' ' LYS . . . . . . . . . . . . . 93.4 mttt -144.26 148.1 34.43 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-O 121.057 0.456 . . . . 0.0 112.014 -177.869 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 123' ' ' VAL . . . . . 0.402 ' HB ' HD11 ' A' ' 96' ' ' ILE . 45.6 t -126.66 123.59 63.33 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.288 0 N-CA-C 109.066 -0.716 . . . . 0.0 109.066 172.567 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 124' ' ' LEU . . . . . . . . . . . . . 62.1 mt -125.74 136.93 53.72 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-O 120.855 0.36 . . . . 0.0 111.047 -176.954 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 125' ' ' VAL . . . . . . . . . . . . . 11.4 p -134.75 130.31 52.69 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.308 0 CA-C-N 115.967 -0.56 . . . . 0.0 110.148 178.196 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 126' ' ' ARG . . . . . . . . . . . . . 35.7 mmt180 -140.46 127.2 20.42 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.186 179.14 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 127' ' ' ASN . . . . . . . . . . . . . 12.5 t-20 52.04 -111.58 0.59 Allowed 'General case' 0 CA--C 1.544 0.742 0 CA-C-O 118.696 -0.668 . . . . 0.0 110.933 -179.969 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 128' ' ' ASP . . . . . . . . . . . . . 13.3 p-10 -114.06 8.6 17.09 Favored 'General case' 0 CA--C 1.537 0.45 0 CA-C-N 120.073 1.306 . . . . 0.0 113.23 179.918 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 129' ' ' LEU . . . . . . . . . . . . . 14.3 tp -106.41 135.61 47.61 Favored 'General case' 0 C--O 1.231 0.115 0 CA-C-N 118.037 0.38 . . . . 0.0 110.144 -179.993 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 130' ' ' VAL . . . . . 0.402 HG11 HD13 ' A' ' 104' ' ' ILE . 43.1 t -119.82 135.86 58.79 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.202 0 N-CA-C 109.831 -0.433 . . . . 0.0 109.831 -179.475 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 131' ' ' VAL . . . . . 0.498 HG12 HD12 ' A' ' 140' ' ' LEU . 21.0 m -136.04 138.8 46.88 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.239 0 CA-C-O 121.314 0.578 . . . . 0.0 110.94 177.928 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 132' ' ' ILE . . . . . . . . . . . . . 72.2 mt -118.86 131.12 72.58 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.319 0 CA-C-N 115.353 -0.84 . . . . 0.0 109.001 178.871 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 133' ' ' ILE . . . . . . . . . . . . . 39.3 mm -115.86 123.96 71.73 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.271 0 CA-C-N 116.596 -0.275 . . . . 0.0 110.747 -174.211 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 134' ' ' ASP . . . . . . . . . . . . . 13.4 p-10 -136.02 154.57 51.02 Favored 'General case' 0 C--N 1.332 -0.181 0 CA-C-N 116.295 -0.412 . . . . 0.0 110.086 176.409 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 135' ' ' GLU . . . . . . . . . . . . . 75.9 tt0 -50.02 -29.27 8.38 Favored 'General case' 0 C--N 1.328 -0.346 0 N-CA-C 113.4 0.889 . . . . 0.0 113.4 -168.815 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 136' ' ' GLN . . . . . . . . . . . . . 14.5 pt20 -99.83 -17.01 17.86 Favored 'General case' 0 C--O 1.235 0.34 0 N-CA-C 113.596 0.962 . . . . 0.0 113.596 -171.233 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 137' ' ' LYS . . . . . . . . . . . . . 19.2 pttp -168.04 172.2 9.01 Favored 'General case' 0 C--O 1.232 0.152 0 CA-C-O 121.692 0.758 . . . . 0.0 112.661 -175.41 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 138' ' ' LEU . . . . . . . . . . . . . 7.0 tt -123.26 129.55 51.52 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 114.71 -1.132 . . . . 0.0 110.01 178.985 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 139' ' ' THR . . . . . . . . . . . . . 30.4 m -108.3 127.99 54.35 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-N 116.247 -0.433 . . . . 0.0 110.579 179.69 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 140' ' ' LEU . . . . . 0.498 HD12 HG12 ' A' ' 131' ' ' VAL . 29.1 tp -111.93 123.33 50.02 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 115.61 -0.723 . . . . 0.0 109.159 -179.074 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 141' ' ' ILE . . . . . . . . . . . . . 19.6 mt -122.13 121.57 64.34 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.354 0 CA-C-O 120.911 0.386 . . . . 0.0 110.07 -174.662 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 142' ' ' ARG . . . . . . . . . . . . . 77.6 mtp180 -105.04 118.51 36.71 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 115.588 -0.733 . . . . 0.0 109.836 179.413 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 143' ' ' THR . . . . . . . . . . . . . 73.0 p . . . . . 0 C--O 1.221 -0.428 0 CA-C-O 117.976 -1.011 . . . . 0.0 110.592 -178.69 . . . . . . . . 0 0 . 1 . 013 nuclear nobuild core ' B' B ' 2' ' ' SER . . . . . . . . . . . . . 3.1 p . . . . . 0 C--O 1.23 0.06 0 N-CA-C 110.077 -0.342 . . . . 0.0 110.077 . . . . . . . . . 0 0 . 1 . 013 nuclear nobuild core ' B' B ' 3' ' ' GLU . . . . . . . . . . . . . 78.2 tt0 -140.64 137.57 33.7 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.622 -179.4 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' B' B ' 4' ' ' LEU . . . . . . . . . . . . . 12.6 tp -121.77 127.67 50.89 Favored 'General case' 0 C--N 1.331 -0.2 0 CA-C-N 116.096 -0.502 . . . . 0.0 110.143 177.501 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' B' B ' 5' ' ' LYS . . . . . . . . . . . . . 94.9 mttt -102.44 121.27 42.01 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.34 -0.391 . . . . 0.0 110.422 178.2 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' B' B ' 6' ' ' LEU . . . . . . . . . . . . . 59.5 mt -116.34 148.43 40.6 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-N 115.538 -0.756 . . . . 0.0 110.507 -178.98 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' B' B ' 7' ' ' LYS . . . . . . . . . . . . . 47.8 tttp -137.67 138.3 23.91 Favored Pre-proline 0 CA--C 1.534 0.341 0 CA-C-O 118.935 -0.555 . . . . 0.0 110.14 175.502 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' B' B ' 8' ' ' PRO . . . . . . . . . . . . . 98.9 Cg_endo -91.98 138.31 1.95 Allowed 'Trans proline' 0 N--CA 1.491 1.326 0 C-N-CA 121.803 1.669 . . . . 0.0 111.544 176.51 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' B' B ' 9' ' ' LEU . . . . . . . . . . . . . 65.7 mt -73.27 -47.33 7.77 Favored Pre-proline 0 CA--C 1.533 0.326 0 CA-C-O 118.751 -0.642 . . . . 0.0 112.238 -178.583 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' B' B ' 10' ' ' PRO . . . . . . . . . . . . . 87.8 Cg_endo -81.16 152.58 18.51 Favored 'Trans proline' 0 N--CA 1.496 1.672 0 C-N-CA 121.234 1.29 . . . . 0.0 111.894 175.807 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' B' B ' 11' ' ' LYS . . . . . . . . . . . . . 68.1 mttm -85.54 102.91 13.92 Favored 'General case' 0 C--N 1.33 -0.24 0 N-CA-C 110.106 -0.331 . . . . 0.0 110.106 177.459 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' B' B ' 12' ' ' VAL . . . . . . . . . . . . . 12.2 p -139.79 145.31 26.84 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.281 0 CA-C-N 116.335 -0.393 . . . . 0.0 110.722 -178.242 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' B' B ' 13' ' ' GLU . . . . . . . . . . . . . 95.5 mt-10 -87.83 121.32 30.11 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.094 -0.503 . . . . 0.0 109.887 177.13 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' B' B ' 14' ' ' LEU . . . . . . . . . . . . . 16.3 mt -97.71 153.0 38.43 Favored Pre-proline 0 C--N 1.329 -0.321 0 CA-C-N 116.498 -0.319 . . . . 0.0 110.678 -176.931 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' B' B ' 15' ' ' PRO . . . . . . . . . . . . . 26.0 Cg_exo -62.24 155.67 55.34 Favored 'Trans proline' 0 N--CA 1.497 1.713 0 C-N-CA 121.288 1.325 . . . . 0.0 111.581 176.076 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' B' B ' 16' ' ' PRO . . . . . . . . . . . . . 35.0 Cg_exo -58.0 -35.75 98.54 Favored 'Trans proline' 0 N--CA 1.498 1.742 0 C-N-CA 121.418 1.412 . . . . 0.0 112.704 -179.619 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' B' B ' 17' ' ' ASP . . . . . . . . . . . . . 17.8 p-10 -89.15 11.53 18.36 Favored 'General case' 0 C--N 1.327 -0.39 0 N-CA-C 113.202 0.816 . . . . 0.0 113.202 -177.462 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' B' B ' 18' ' ' PHE . . . . . . . . . . . . . 47.3 t80 -58.1 -42.64 86.13 Favored 'General case' 0 C--N 1.334 -0.088 0 O-C-N 121.905 -0.497 . . . . 0.0 110.023 -178.174 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' B' B ' 19' ' ' VAL . . . . . . . . . . . . . 49.1 t -58.0 -42.89 83.8 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.319 0 CA-C-N 116.438 -0.346 . . . . 0.0 110.283 -178.42 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' B' B ' 20' ' ' ASP . . . . . . . . . . . . . 81.2 m-20 -59.66 -42.16 92.19 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-O 120.796 0.331 . . . . 0.0 110.91 -177.955 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' B' B ' 21' ' ' VAL . . . . . . . . . . . . . 47.0 t -64.35 -49.31 81.53 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.321 0 CA-C-N 116.361 -0.381 . . . . 0.0 110.412 -178.215 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' B' B ' 22' ' ' ILE . . . . . 0.456 HG22 HD12 ' B' ' 26' ' ' LEU . 49.5 mm -56.89 -43.29 80.06 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.271 0 C-N-CA 120.993 -0.283 . . . . 0.0 110.542 179.592 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' B' B ' 23' ' ' ARG . . . . . . . . . . . . . 38.3 ttp180 -54.17 -49.63 68.86 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-O 120.732 0.301 . . . . 0.0 111.303 -178.73 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' B' B ' 24' ' ' ILE . . . . . . . . . . . . . 69.6 mt -60.44 -41.92 89.22 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.265 0 CA-C-N 116.416 -0.357 . . . . 0.0 110.899 -178.573 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' B' B ' 25' ' ' LYS . . . . . . . . . . . . . 88.4 mttt -64.91 -40.17 94.66 Favored 'General case' 0 C--N 1.328 -0.344 0 N-CA-C 112.469 0.544 . . . . 0.0 112.469 -179.096 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' B' B ' 26' ' ' LEU . . . . . 0.456 HD12 HG22 ' B' ' 22' ' ' ILE . 57.8 mt -77.81 -41.81 35.95 Favored 'General case' 0 C--N 1.33 -0.276 0 N-CA-C 113.141 0.793 . . . . 0.0 113.141 -171.408 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' B' B ' 27' ' ' GLN . . . . . . . . . . . . . 10.3 pt20 -46.86 135.62 9.0 Favored 'General case' 0 N--CA 1.469 0.516 0 N-CA-C 112.717 0.636 . . . . 0.0 112.717 -175.929 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' B' B ' 28' ' ' GLY . . . . . . . . . . . . . . . 101.06 -25.38 28.51 Favored Glycine 0 CA--C 1.533 1.161 0 CA-C-N 115.671 -0.695 . . . . 0.0 112.483 -177.792 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' B' B ' 29' ' ' LYS . . . . . . . . . . . . . 97.5 mttt -98.63 155.09 17.48 Favored 'General case' 0 C--N 1.331 -0.207 0 CA-C-N 117.398 0.599 . . . . 0.0 111.163 178.78 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' B' B ' 30' ' ' THR . . . . . . . . . . . . . 25.7 m -104.65 137.71 42.06 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.076 -0.511 . . . . 0.0 109.921 175.186 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' B' B ' 31' ' ' VAL . . . . . . . . . . . . . 34.5 m -128.26 155.64 40.02 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.254 0 CA-C-O 120.824 0.345 . . . . 0.0 110.894 -178.798 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' B' B ' 32' ' ' ARG . . . . . . . . . . . . . 97.1 mtt180 -133.51 149.93 51.7 Favored 'General case' 0 C--N 1.331 -0.225 0 CA-C-O 121.193 0.521 . . . . 0.0 110.654 177.823 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' B' B ' 33' ' ' THR . . . . . . . . . . . . . 23.6 m -53.21 139.64 28.65 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.237 -0.438 . . . . 0.0 111.419 -178.2 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' B' B ' 34' ' ' GLY . . . . . . . . . . . . . . . 99.4 -17.12 58.22 Favored Glycine 0 CA--C 1.531 1.092 0 C-N-CA 121.18 -0.533 . . . . 0.0 113.28 178.891 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' B' B ' 35' ' ' ASP . . . . . . . . . . . . . 75.6 m-20 -65.79 148.95 50.95 Favored 'General case' 0 C--O 1.232 0.145 0 CA-C-N 118.109 0.954 . . . . 0.0 111.152 179.631 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' B' B ' 36' ' ' VAL . . . . . . . . . . . . . 42.5 t -122.71 130.59 74.39 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.207 0 CA-C-N 115.938 -0.574 . . . . 0.0 109.966 177.7 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' B' B ' 37' ' ' ILE . . . . . . . . . . . . . 66.4 mt -121.63 139.23 49.36 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.305 0 N-CA-C 109.772 -0.455 . . . . 0.0 109.772 -179.721 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' B' B ' 38' ' ' GLY . . . . . . . . . . . . . . . -113.37 128.8 8.53 Favored Glycine 0 CA--C 1.526 0.77 0 N-CA-C 111.384 -0.686 . . . . 0.0 111.384 -178.673 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' B' B ' 39' ' ' ILE . . . . . . . . . . . . . 68.5 mt -123.89 127.91 73.95 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.204 0 N-CA-C 109.771 -0.455 . . . . 0.0 109.771 178.084 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' B' B ' 40' ' ' SER . . . . . . . . . . . . . 30.6 t -93.81 123.15 36.96 Favored 'General case' 0 C--N 1.329 -0.294 0 C-N-CA 120.923 -0.311 . . . . 0.0 111.005 176.589 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' B' B ' 41' ' ' ILE . . . . . . . . . . . . . 70.4 mt -131.73 125.67 56.09 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.233 0 CA-C-O 120.877 0.37 . . . . 0.0 110.588 178.834 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' B' B ' 42' ' ' LEU . . . . . . . . . . . . . 9.9 tp 54.62 35.45 23.69 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.067 -0.515 . . . . 0.0 111.623 176.88 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' B' B ' 43' ' ' GLY . . . . . . . . . . . . . . . 71.96 27.29 70.75 Favored Glycine 0 CA--C 1.531 1.087 0 C-N-CA 121.078 -0.582 . . . . 0.0 112.392 177.34 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' B' B ' 44' ' ' LYS . . . . . . . . . . . . . 91.4 mttt -138.05 126.84 23.82 Favored 'General case' 0 C--N 1.331 -0.211 0 N-CA-C 109.434 -0.58 . . . . 0.0 109.434 178.292 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' B' B ' 45' ' ' GLU . . . . . . . . . . . . . 29.1 tp10 -85.25 129.22 34.85 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-O 120.801 0.334 . . . . 0.0 111.233 -175.887 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' B' B ' 46' ' ' VAL . . . . . . . . . . . . . 7.4 p -122.36 129.48 75.26 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.2 0 N-CA-C 109.435 -0.58 . . . . 0.0 109.435 174.865 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' B' B ' 47' ' ' LYS . . . . . . . . . . . . . 69.0 mmtt -100.42 128.26 46.53 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.023 -0.535 . . . . 0.0 111.336 177.545 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' B' B ' 48' ' ' PHE . . . . . . . . . . . . . 91.7 m-85 -109.93 131.84 54.69 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 115.954 -0.566 . . . . 0.0 109.58 175.096 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' B' B ' 49' ' ' LYS . . . . . . . . . . . . . 41.5 tttp -108.62 137.63 46.25 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.422 -0.353 . . . . 0.0 110.365 179.638 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' B' B ' 50' ' ' VAL . . . . . . . . . . . . . 44.8 t -78.98 107.1 11.05 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.213 0 N-CA-C 109.326 -0.62 . . . . 0.0 109.326 176.352 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' B' B ' 51' ' ' VAL . . . . . . . . . . . . . 46.4 t -69.0 -48.97 67.06 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.329 0 CA-C-N 115.935 -0.575 . . . . 0.0 109.8 -174.097 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' B' B ' 52' ' ' GLN . . . . . . . . . . . . . 60.1 tt0 -170.1 147.93 3.28 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 115.838 -0.619 . . . . 0.0 111.274 -178.863 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' B' B ' 53' ' ' ALA . . . . . . . . . . . . . . . -122.77 136.78 54.98 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.085 -0.507 . . . . 0.0 110.34 178.843 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' B' B ' 54' ' ' TYR . . . . . . . . . . . . . 47.0 t80 -129.16 111.84 18.29 Favored Pre-proline 0 CA--C 1.535 0.387 0 CA-C-O 118.265 -0.874 . . . . 0.0 110.212 177.995 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' B' B ' 55' ' ' PRO . . . . . . . . . . . . . 73.4 Cg_endo -77.17 167.88 78.46 Favored 'Cis proline' 0 N--CA 1.5 1.901 0 CA-C-N 121.932 1.726 . . . . 0.0 112.127 -6.991 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' B' B ' 56' ' ' SER . . . . . . . . . . . . . 24.0 m -117.22 133.12 23.21 Favored Pre-proline 0 CA--C 1.537 0.476 0 CA-C-O 118.492 -0.766 . . . . 0.0 109.576 175.102 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' B' B ' 57' ' ' PRO . . . . . . . . . . . . . 36.4 Cg_endo -66.34 164.0 67.66 Favored 'Cis proline' 0 N--CA 1.499 1.809 0 CA-C-N 121.953 1.733 . . . . 0.0 111.375 -2.504 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' B' B ' 58' ' ' LEU . . . . . . . . . . . . . 23.0 tp -129.27 135.72 49.15 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.328 -0.396 . . . . 0.0 110.513 -179.217 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' B' B ' 59' ' ' ARG . . . . . . . . . . . . . 74.7 ttt180 -102.45 126.86 49.62 Favored 'General case' 0 C--N 1.327 -0.376 0 N-CA-C 109.241 -0.652 . . . . 0.0 109.241 175.362 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' B' B ' 60' ' ' VAL . . . . . . . . . . . . . 40.7 t -81.35 121.81 35.39 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.322 0 C-N-CA 120.634 -0.426 . . . . 0.0 110.402 -175.045 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' B' B ' 61' ' ' GLU . . . . . . . . . . . . . 95.1 mt-10 -131.11 165.38 23.4 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 115.803 -0.635 . . . . 0.0 109.634 176.698 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' B' B ' 62' ' ' ASP . . . . . . . . . . . . . 80.0 m-20 -53.82 -32.62 53.41 Favored 'General case' 0 C--N 1.328 -0.364 0 N-CA-C 111.787 0.291 . . . . 0.0 111.787 -179.852 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' B' B ' 63' ' ' ARG . . . . . . . . . . . . . 24.7 mmm180 -72.82 -18.96 61.41 Favored 'General case' 0 CA--C 1.535 0.379 0 N-CA-C 113.092 0.775 . . . . 0.0 113.092 -177.085 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' B' B ' 64' ' ' THR . . . . . . . . . . . . . 25.8 m -72.44 138.98 47.47 Favored 'General case' 0 C--N 1.331 -0.204 0 CA-C-O 120.962 0.411 . . . . 0.0 111.24 -174.642 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' B' B ' 65' ' ' LYS . . . . . . . . . . . . . 98.4 mttt -90.81 136.45 33.06 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 115.887 -0.597 . . . . 0.0 110.429 178.615 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' B' B ' 66' ' ' ILE . . . . . . . . . . . . . 60.6 mt -117.1 129.33 73.82 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.233 0 N-CA-C 109.662 -0.496 . . . . 0.0 109.662 179.147 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' B' B ' 67' ' ' THR . . . . . . . . . . . . . 28.0 m -125.74 144.85 50.45 Favored 'General case' 0 N--CA 1.463 0.205 0 CA-C-O 121.133 0.492 . . . . 0.0 111.581 -175.581 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' B' B ' 68' ' ' LEU . . . . . . . . . . . . . 4.4 tt . . . . . 0 C--N 1.33 -0.252 0 CA-C-N 115.614 -0.721 . . . . 0.0 109.559 177.026 . . . . . . . . 0 0 . 1 . 013 nuclear nobuild core ' B' B ' 73' ' ' VAL . . . . . . . . . . . . . 33.8 m . . . . . 0 C--O 1.232 0.151 0 N-CA-C 109.616 -0.512 . . . . 0.0 109.616 . . . . . . . . . 0 0 . 1 . 013 nuclear nobuild core ' B' B ' 74' ' ' ASP . . . . . . . . . . . . . 12.6 t70 -96.62 121.2 38.19 Favored 'General case' 0 C--N 1.33 -0.264 0 C-N-CA 120.779 -0.369 . . . . 0.0 110.346 -176.082 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' B' B ' 75' ' ' VAL . . . . . . . . . . . . . 41.3 t -115.87 126.04 73.23 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.184 0 CA-C-O 121.057 0.456 . . . . 0.0 110.66 -178.263 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' B' B ' 76' ' ' LEU . . . . . . . . . . . . . 15.6 mt -127.59 148.16 50.36 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 115.587 -0.733 . . . . 0.0 109.367 176.929 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' B' B ' 77' ' ' GLU . . . . . . . . . . . . . 98.0 mt-10 -136.87 141.44 42.78 Favored 'General case' 0 C--N 1.333 -0.125 0 CA-C-O 121.173 0.511 . . . . 0.0 111.532 -176.423 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' B' B ' 78' ' ' ALA . . . . . . . . . . . . . . . -127.01 133.5 50.52 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 115.529 -0.76 . . . . 0.0 109.794 176.394 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' B' B ' 79' ' ' LYS . . . . . 0.637 ' O ' HD13 ' B' ' 80' ' ' ILE . 85.8 tttt -78.12 116.68 18.76 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-O 120.891 0.377 . . . . 0.0 110.728 -177.608 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' B' B ' 80' ' ' ILE . . . . . 0.637 HD13 ' O ' ' B' ' 79' ' ' LYS . 37.9 mm -139.15 108.43 3.77 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.302 0 N-CA-C 109.432 -0.581 . . . . 0.0 109.432 -176.447 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' B' B ' 81' ' ' LYS . . . . . . . . . . . . . 38.6 ttpt -104.36 127.7 52.07 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-O 120.839 0.352 . . . . 0.0 110.939 -177.629 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' B' B ' 82' ' ' GLY . . . . . . . . . . . . . . . 89.05 42.13 5.7 Favored Glycine 0 CA--C 1.525 0.675 0 C-N-CA 120.847 -0.692 . . . . 0.0 111.687 175.522 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' B' B ' 83' ' ' ILE . . . . . . . . . . . . . 72.2 mt -70.12 136.05 26.9 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.339 0 N-CA-C 109.669 -0.493 . . . . 0.0 109.669 177.515 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' B' B ' 84' ' ' LYS . . . . . . . . . . . . . 81.1 tttt -94.19 -52.12 4.51 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 115.996 -0.547 . . . . 0.0 110.307 -179.025 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' B' B ' 85' ' ' ASP . . . . . . . . . . . . . 9.5 t70 -156.33 155.79 32.85 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 115.838 -0.619 . . . . 0.0 110.439 179.936 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' B' B ' 86' ' ' VAL . . . . . . . . . . . . . 42.5 t -126.35 133.67 68.21 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.18 0 CA-C-O 121.048 0.451 . . . . 0.0 110.67 -178.338 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' B' B ' 87' ' ' ILE . . . . . . . . . . . . . 44.7 mm -118.42 121.15 66.4 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.282 0 CA-C-N 115.644 -0.707 . . . . 0.0 109.245 175.264 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' B' B ' 88' ' ' LEU . . . . . 0.405 HD22 ' CG2' ' A' ' 131' ' ' VAL . 17.7 tp -109.98 132.51 54.09 Favored 'General case' 0 C--N 1.332 -0.194 0 CA-C-O 120.907 0.384 . . . . 0.0 111.428 -175.055 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' B' B ' 89' ' ' ASP . . . . . . . . . . . . . 9.8 t70 -129.49 153.33 48.09 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 115.91 -0.586 . . . . 0.0 109.56 175.869 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' B' B ' 90' ' ' GLU . . . . . . . . . . . . . 83.5 tt0 -48.21 -36.33 13.54 Favored 'General case' 0 C--N 1.329 -0.294 0 N-CA-C 112.738 0.644 . . . . 0.0 112.738 -172.641 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' B' B ' 91' ' ' ASN . . . . . . . . . . . . . 7.1 p30 -132.09 29.37 4.37 Favored 'General case' 0 N--CA 1.466 0.341 0 N-CA-C 112.301 0.482 . . . . 0.0 112.301 -177.378 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' B' B ' 92' ' ' LEU . . . . . . . . . . . . . 5.0 mt -154.78 143.16 20.48 Favored 'General case' 0 C--N 1.331 -0.213 0 N-CA-C 109.809 -0.441 . . . . 0.0 109.809 -178.474 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' B' B ' 93' ' ' ILE . . . . . . . . . . . . . 70.6 mt -123.38 112.26 32.75 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.213 0 N-CA-C 108.926 -0.768 . . . . 0.0 108.926 176.752 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' B' B ' 94' ' ' VAL . . . . . . . . . . . . . 46.3 t -116.05 125.56 73.2 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.258 0 N-CA-C 109.589 -0.523 . . . . 0.0 109.589 -179.599 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' B' B ' 95' ' ' VAL . . . . . . . . . . . . . 43.2 t -122.93 135.81 61.79 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.349 0 CA-C-N 116.127 -0.488 . . . . 0.0 109.976 -178.141 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' B' B ' 96' ' ' ILE . . . . . . . . . . . . . 63.8 mt -111.6 127.58 68.67 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.355 0 N-CA-C 109.075 -0.713 . . . . 0.0 109.075 178.145 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' B' B ' 97' ' ' THR . . . . . . . . . . . . . 78.4 p -101.18 156.79 17.22 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-O 120.967 0.413 . . . . 0.0 111.136 -177.479 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' B' B ' 98' ' ' GLU . . . . . . . . . . . . . 13.5 pt-20 -53.87 -23.62 13.16 Favored 'General case' 0 CA--C 1.533 0.319 0 N-CA-C 112.434 0.531 . . . . 0.0 112.434 -179.97 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' B' B ' 99' ' ' GLU . . . . . . . . . . . . . 95.6 mt-10 -79.24 14.5 1.48 Allowed 'General case' 0 CA--C 1.536 0.433 0 N-CA-C 112.969 0.729 . . . . 0.0 112.969 -178.212 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' B' B ' 100' ' ' ASN . . . . . . . . . . . . . 2.4 m-20 61.71 37.95 15.47 Favored 'General case' 0 CA--C 1.529 0.169 0 CA-C-O 121.081 0.467 . . . . 0.0 110.893 178.9 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' B' B ' 101' ' ' GLU . . . . . . . . . . . . . 83.5 tt0 -116.53 144.74 43.98 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-N 116.039 -0.528 . . . . 0.0 109.728 176.561 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' B' B ' 102' ' ' VAL . . . . . . . . . . . . . 46.1 t -114.94 123.6 70.78 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.314 0 N-CA-C 109.592 -0.521 . . . . 0.0 109.592 -179.942 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' B' B ' 103' ' ' LEU . . . . . . . . . . . . . 70.9 mt -114.34 131.78 56.43 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 115.806 -0.634 . . . . 0.0 110.255 178.411 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' B' B ' 104' ' ' ILE . . . . . 0.612 HD12 ' HB3' ' B' ' 113' ' ' TYR . 66.7 mt -117.9 117.54 55.26 Favored 'Isoleucine or valine' 0 C--O 1.234 0.252 0 CA-C-N 116.441 -0.345 . . . . 0.0 110.247 -178.756 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' B' B ' 105' ' ' PHE . . . . . . . . . . . . . 82.7 m-85 -117.43 163.29 16.6 Favored 'General case' 0 C--N 1.332 -0.157 0 O-C-N 124.241 0.963 . . . . 0.0 109.846 -179.906 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' B' B ' 106' ' ' ASN . . . . . . . . . . . . . 52.9 p-10 -102.41 -172.26 2.1 Favored 'General case' 0 C--N 1.331 -0.211 0 N-CA-C 109.757 -0.46 . . . . 0.0 109.757 171.256 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' B' B ' 107' ' ' GLN . . . . . . . . . . . . . 48.9 tt0 -58.45 -29.73 66.4 Favored 'General case' 0 C--N 1.328 -0.329 0 N-CA-C 112.227 0.454 . . . . 0.0 112.227 -178.066 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' B' B ' 108' ' ' ASN . . . . . . . . . . . . . 11.7 t-20 -88.74 14.16 10.8 Favored 'General case' 0 CA--C 1.535 0.385 0 N-CA-C 112.862 0.69 . . . . 0.0 112.862 -176.22 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' B' B ' 109' ' ' LEU . . . . . . . . . . . . . 71.6 mt 58.61 35.53 24.56 Favored 'General case' 0 C--O 1.234 0.238 0 CA-C-O 120.822 0.344 . . . . 0.0 111.547 178.771 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' B' B ' 110' ' ' GLU . . . . . . . . . . . . . 43.3 mt-10 -105.27 141.32 37.0 Favored 'General case' 0 C--N 1.329 -0.299 0 N-CA-C 109.771 -0.455 . . . . 0.0 109.771 176.35 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' B' B ' 111' ' ' GLU . . . . . . . . . . . . . 97.7 mt-10 -77.29 125.51 29.44 Favored 'General case' 0 C--N 1.327 -0.399 0 CA-C-N 116.331 -0.395 . . . . 0.0 111.257 -176.77 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' B' B ' 112' ' ' LEU . . . . . . . . . . . . . 11.6 mt -106.71 -45.99 4.08 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.041 -0.527 . . . . 0.0 110.176 176.889 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' B' B ' 113' ' ' TYR . . . . . 0.612 ' HB3' HD12 ' B' ' 104' ' ' ILE . 55.9 t80 -140.45 140.69 35.43 Favored 'General case' 0 C--N 1.33 -0.243 0 C-N-CA 120.74 -0.384 . . . . 0.0 110.956 -178.84 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' B' B ' 114' ' ' ARG . . . . . . . . . . . . . 21.0 mtp-105 -139.36 126.22 20.88 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.244 -0.435 . . . . 0.0 110.209 176.04 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' B' B ' 115' ' ' GLY . . . . . . . . . . . . . . . -150.07 142.81 10.03 Favored Glycine 0 CA--C 1.523 0.532 0 N-CA-C 111.229 -0.748 . . . . 0.0 111.229 179.826 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' B' B ' 116' ' ' LYS . . . . . . . . . . . . . 39.1 ttpt -112.02 132.82 54.57 Favored 'General case' 0 C--N 1.33 -0.245 0 N-CA-C 109.774 -0.454 . . . . 0.0 109.774 177.955 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' B' B ' 117' ' ' PHE . . . . . . . . . . . . . 40.9 m-85 -134.27 113.87 12.42 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-O 120.942 0.401 . . . . 0.0 110.198 -176.532 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' B' B ' 118' ' ' GLU . . . . . . . . . . . . . 95.8 mt-10 -56.34 -41.93 76.9 Favored 'General case' 0 C--N 1.326 -0.426 0 CA-C-N 116.13 -0.487 . . . . 0.0 111.196 -174.594 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' B' B ' 119' ' ' ASN . . . . . . . . . . . . . 88.5 m-20 -100.6 31.12 3.61 Favored 'General case' 0 C--N 1.329 -0.295 0 N-CA-C 112.213 0.449 . . . . 0.0 112.213 -173.853 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' B' B ' 120' ' ' LEU . . . . . . . . . . . . . 9.7 tp -55.25 122.03 10.18 Favored 'General case' 0 N--CA 1.462 0.158 0 C-N-CA 121.044 -0.262 . . . . 0.0 110.674 178.062 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' B' B ' 121' ' ' ASN . . . . . . . . . . . . . 3.5 m-20 -114.09 -44.14 3.17 Favored 'General case' 0 C--N 1.332 -0.153 0 CA-C-N 116.63 -0.259 . . . . 0.0 111.18 -176.242 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' B' B ' 122' ' ' LYS . . . . . . . . . . . . . 16.1 ttmm -151.79 142.65 22.97 Favored 'General case' 0 C--N 1.331 -0.206 0 C-N-CA 120.363 -0.535 . . . . 0.0 111.712 -176.828 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' B' B ' 123' ' ' VAL . . . . . . . . . . . . . 46.2 t -120.72 130.79 74.18 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.256 0 CA-C-N 115.825 -0.625 . . . . 0.0 109.628 177.139 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' B' B ' 124' ' ' LEU . . . . . . . . . . . . . 75.4 mt -127.83 138.48 52.72 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-O 120.831 0.348 . . . . 0.0 110.692 -178.424 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' B' B ' 125' ' ' VAL . . . . . . . . . . . . . 35.0 m -130.7 143.15 41.78 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.245 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.909 -179.567 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' B' B ' 126' ' ' ARG . . . . . . . . . . . . . 94.3 mtt-85 -148.34 117.72 6.94 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 115.832 -0.622 . . . . 0.0 109.397 176.205 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' B' B ' 127' ' ' ASN . . . . . . . . . . . . . 79.8 m-20 56.61 -143.35 0.71 Allowed 'General case' 0 CA--C 1.541 0.615 0 CA-C-O 119.138 -0.458 . . . . 0.0 109.773 -179.39 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' B' B ' 128' ' ' ASP . . . . . . . . . . . . . 12.0 p-10 -85.76 10.28 14.06 Favored 'General case' 0 CA--C 1.535 0.396 0 CA-C-N 119.248 0.931 . . . . 0.0 113.229 179.953 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' B' B ' 129' ' ' LEU . . . . . 0.47 HD13 HH21 ' B' ' 142' ' ' ARG . 28.2 mt -111.22 145.15 39.22 Favored 'General case' 0 N--CA 1.463 0.189 0 O-C-N 121.841 -0.537 . . . . 0.0 109.762 179.112 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' B' B ' 130' ' ' VAL . . . . . 0.475 HG23 ' HB ' ' B' ' 141' ' ' ILE . 32.6 m -137.13 148.09 26.53 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.262 0 CA-C-O 121.315 0.578 . . . . 0.0 111.923 -175.943 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' B' B ' 131' ' ' VAL . . . . . 0.461 HG22 HD12 ' B' ' 140' ' ' LEU . 43.9 t -136.14 137.7 48.14 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.225 0 CA-C-N 115.535 -0.757 . . . . 0.0 110.087 177.504 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' B' B ' 132' ' ' ILE . . . . . . . . . . . . . 75.3 mt -118.77 132.02 69.87 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.287 0 CA-C-N 116.028 -0.533 . . . . 0.0 109.669 -179.757 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' B' B ' 133' ' ' ILE . . . . . . . . . . . . . 41.0 mm -115.62 122.83 70.23 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.251 0 CA-C-N 116.414 -0.357 . . . . 0.0 110.883 -175.339 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' B' B ' 134' ' ' ASP . . . . . . . . . . . . . 9.3 p-10 -136.91 144.24 43.37 Favored 'General case' 0 C--N 1.331 -0.222 0 N-CA-C 109.691 -0.485 . . . . 0.0 109.691 173.282 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' B' B ' 135' ' ' GLU . . . . . . . . . . . . . 33.0 tp10 -49.91 -24.38 2.48 Favored 'General case' 0 C--N 1.326 -0.431 0 N-CA-C 112.806 0.669 . . . . 0.0 112.806 -172.394 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' B' B ' 136' ' ' GLN . . . . . . . . . . . . . 48.1 tt0 -82.51 -38.57 23.65 Favored 'General case' 0 C--N 1.332 -0.168 0 N-CA-C 112.082 0.401 . . . . 0.0 112.082 -176.934 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' B' B ' 137' ' ' LYS . . . . . . . . . . . . . 58.7 pttt -160.01 168.55 25.37 Favored 'General case' 0 C--O 1.234 0.256 0 CA-C-O 121.495 0.664 . . . . 0.0 112.119 -173.1 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' B' B ' 138' ' ' LEU . . . . . 0.445 HD23 ' N ' ' B' ' 139' ' ' THR . 5.1 tt -116.39 127.45 54.65 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 115.155 -0.93 . . . . 0.0 109.781 178.38 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' B' B ' 139' ' ' THR . . . . . 0.445 ' N ' HD23 ' B' ' 138' ' ' LEU . 31.8 m -109.79 124.83 51.96 Favored 'General case' 0 C--N 1.331 -0.217 0 CA-C-O 120.738 0.304 . . . . 0.0 110.381 179.926 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' B' B ' 140' ' ' LEU . . . . . 0.461 HD12 HG22 ' B' ' 131' ' ' VAL . 11.2 tp -114.86 117.27 30.23 Favored 'General case' 0 C--N 1.328 -0.367 0 N-CA-C 108.897 -0.779 . . . . 0.0 108.897 -179.183 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' B' B ' 141' ' ' ILE . . . . . 0.475 ' HB ' HG23 ' B' ' 130' ' ' VAL . 18.9 mt -117.22 117.01 53.85 Favored 'Isoleucine or valine' 0 C--O 1.236 0.361 0 CA-C-O 121.129 0.49 . . . . 0.0 110.069 -174.373 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' B' B ' 142' ' ' ARG . . . . . 0.47 HH21 HD13 ' B' ' 129' ' ' LEU . 2.0 mtp85 -103.72 135.01 46.09 Favored 'General case' 0 C--N 1.331 -0.201 0 CA-C-N 115.033 -0.985 . . . . 0.0 109.824 -177.353 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' B' B ' 143' ' ' THR . . . . . . . . . . . . . 72.7 p . . . . . 0 C--O 1.22 -0.478 0 CA-C-O 118.241 -0.885 . . . . 0.0 110.763 -179.722 . . . . . . . . 0 0 . 1 . 013 nuclear nobuild core ' C' C ' 2' ' ' SER . . . . . . . . . . . . . 2.4 p . . . . . 0 N--CA 1.462 0.149 0 CA-C-O 120.902 0.382 . . . . 0.0 110.274 . . . . . . . . . 0 0 . 1 . 013 nuclear nobuild core ' C' C ' 3' ' ' GLU . . . . . . . . . . . . . 84.2 tt0 -139.77 140.1 36.62 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 115.918 -0.583 . . . . 0.0 111.045 -177.244 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' C' C ' 4' ' ' LEU . . . . . . . . . . . . . 18.0 tp -126.7 130.16 49.83 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.028 -0.533 . . . . 0.0 110.203 177.752 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' C' C ' 5' ' ' LYS . . . . . . . . . . . . . 61.4 mttp -109.06 119.8 40.63 Favored 'General case' 0 C--O 1.233 0.22 0 CA-C-O 120.9 0.381 . . . . 0.0 110.693 179.054 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' C' C ' 6' ' ' LEU . . . . . 0.473 HD23 ' HA ' ' C' ' 50' ' ' VAL . 36.6 mt -115.04 148.82 38.38 Favored 'General case' 0 C--N 1.331 -0.211 0 CA-C-N 115.359 -0.837 . . . . 0.0 110.554 179.495 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' C' C ' 7' ' ' LYS . . . . . . . . . . . . . 25.9 ttpp -135.25 135.29 22.36 Favored Pre-proline 0 CA--C 1.535 0.392 0 CA-C-O 118.773 -0.632 . . . . 0.0 109.966 176.418 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' C' C ' 8' ' ' PRO . . . . . . . . . . . . . 89.7 Cg_endo -88.82 136.6 3.12 Favored 'Trans proline' 0 N--CA 1.492 1.383 0 C-N-CA 121.534 1.489 . . . . 0.0 111.515 176.344 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' C' C ' 9' ' ' LEU . . . . . . . . . . . . . 51.1 mt -73.32 -47.62 7.57 Favored Pre-proline 0 CA--C 1.534 0.335 0 CA-C-O 118.616 -0.707 . . . . 0.0 112.17 -178.237 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' C' C ' 10' ' ' PRO . . . . . . . . . . . . . 97.8 Cg_endo -79.8 145.57 18.06 Favored 'Trans proline' 0 N--CA 1.495 1.598 0 C-N-CA 121.104 1.202 . . . . 0.0 111.639 175.381 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' C' C ' 11' ' ' LYS . . . . . . . . . . . . . 52.9 pttt -78.43 111.88 14.9 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-O 121.601 0.715 . . . . 0.0 110.561 179.026 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' C' C ' 12' ' ' VAL . . . . . . . . . . . . . 12.4 p -151.11 148.32 14.99 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.295 0 CA-C-N 115.609 -0.723 . . . . 0.0 110.612 -179.437 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' C' C ' 13' ' ' GLU . . . . . . . . . . . . . 49.1 mp0 -91.65 120.78 32.72 Favored 'General case' 0 C--N 1.331 -0.236 0 N-CA-C 109.752 -0.462 . . . . 0.0 109.752 174.997 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' C' C ' 14' ' ' LEU . . . . . . . . . . . . . 14.7 mt -89.01 152.11 47.88 Favored Pre-proline 0 C--N 1.329 -0.287 0 CA-C-N 116.501 -0.318 . . . . 0.0 110.768 -176.984 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' C' C ' 15' ' ' PRO . . . . . . . . . . . . . 37.0 Cg_exo -59.8 162.33 16.11 Favored 'Trans proline' 0 N--CA 1.498 1.768 0 C-N-CA 121.329 1.353 . . . . 0.0 111.835 176.771 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' C' C ' 16' ' ' PRO . . . . . . . . . . . . . 37.9 Cg_exo -58.46 -44.02 41.13 Favored 'Trans proline' 0 N--CA 1.497 1.731 0 C-N-CA 121.444 1.429 . . . . 0.0 112.861 -177.242 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' C' C ' 17' ' ' ASP . . . . . . . . . . . . . 23.3 p-10 -92.44 17.05 10.53 Favored 'General case' 0 CA--C 1.536 0.433 0 N-CA-C 112.924 0.712 . . . . 0.0 112.924 -176.964 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' C' C ' 18' ' ' PHE . . . . . . . . . . . . . 52.8 t80 -57.24 -41.8 80.25 Favored 'General case' 0 C--N 1.333 -0.128 0 O-C-N 122.106 -0.371 . . . . 0.0 110.227 -179.193 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' C' C ' 19' ' ' VAL . . . . . . . . . . . . . 48.7 t -56.93 -43.41 80.51 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.303 0 CA-C-N 116.434 -0.348 . . . . 0.0 110.317 -179.468 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' C' C ' 20' ' ' ASP . . . . . . . . . . . . . 16.4 m-20 -60.1 -42.57 94.97 Favored 'General case' 0 C--N 1.33 -0.272 0 C-N-CA 120.98 -0.288 . . . . 0.0 111.173 -178.821 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' C' C ' 21' ' ' VAL . . . . . . . . . . . . . 48.3 t -63.96 -46.62 93.52 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.278 0 C-N-CA 120.794 -0.362 . . . . 0.0 110.37 -177.491 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' C' C ' 22' ' ' ILE . . . . . 0.562 HG22 HD12 ' C' ' 26' ' ' LEU . 51.4 mm -56.42 -45.82 81.88 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.208 0 CA-C-O 120.747 0.308 . . . . 0.0 110.423 178.221 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' C' C ' 23' ' ' ARG . . . . . . . . . . . . . 50.6 ttp180 -54.6 -47.83 72.9 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.589 -0.278 . . . . 0.0 111.488 -178.501 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' C' C ' 24' ' ' ILE . . . . . . . . . . . . . 76.5 mt -59.85 -44.09 93.38 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.362 0 CA-C-O 120.606 0.241 . . . . 0.0 111.045 -178.376 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' C' C ' 25' ' ' LYS . . . . . . . . . . . . . 54.7 mtmt -64.62 -41.44 96.19 Favored 'General case' 0 C--N 1.327 -0.377 0 N-CA-C 112.367 0.506 . . . . 0.0 112.367 -178.332 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' C' C ' 26' ' ' LEU . . . . . 0.562 HD12 HG22 ' C' ' 22' ' ' ILE . 79.6 mt -79.2 -40.35 31.0 Favored 'General case' 0 C--N 1.33 -0.266 0 N-CA-C 113.416 0.895 . . . . 0.0 113.416 -171.397 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' C' C ' 27' ' ' GLN . . . . . . . . . . . . . 9.9 pt20 -46.78 139.5 5.32 Favored 'General case' 0 N--CA 1.47 0.526 0 N-CA-C 112.703 0.631 . . . . 0.0 112.703 -175.041 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' C' C ' 28' ' ' GLY . . . . . . . . . . . . . . . 100.72 -26.19 25.54 Favored Glycine 0 CA--C 1.534 1.271 0 CA-C-N 115.467 -0.788 . . . . 0.0 112.179 -176.586 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' C' C ' 29' ' ' LYS . . . . . . . . . . . . . 99.1 mttt -98.6 155.12 17.46 Favored 'General case' 0 C--N 1.331 -0.198 0 CA-C-N 117.411 0.605 . . . . 0.0 111.365 179.277 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' C' C ' 30' ' ' THR . . . . . . . . . . . . . 38.1 m -103.28 135.91 44.03 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 115.886 -0.597 . . . . 0.0 109.979 175.758 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' C' C ' 31' ' ' VAL . . . . . . . . . . . . . 34.7 m -130.01 152.95 38.17 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.229 0 CA-C-O 120.934 0.397 . . . . 0.0 110.867 -178.597 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' C' C ' 32' ' ' ARG . . . . . . . . . . . . . 34.5 ttp180 -130.59 149.84 52.07 Favored 'General case' 0 C--N 1.331 -0.221 0 CA-C-N 116.027 -0.533 . . . . 0.0 110.452 179.519 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' C' C ' 33' ' ' THR . . . . . . . . . . . . . 19.1 m -52.65 139.17 26.77 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.241 -0.436 . . . . 0.0 111.498 -177.111 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' C' C ' 34' ' ' GLY . . . . . . . . . . . . . . . 100.21 -17.19 57.34 Favored Glycine 0 CA--C 1.533 1.165 0 CA-C-O 119.644 -0.531 . . . . 0.0 113.179 179.321 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' C' C ' 35' ' ' ASP . . . . . . . . . . . . . 70.9 m-20 -65.41 149.24 50.35 Favored 'General case' 0 C--O 1.231 0.083 0 CA-C-N 118.087 0.944 . . . . 0.0 111.276 179.303 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' C' C ' 36' ' ' VAL . . . . . . . . . . . . . 45.2 t -123.3 130.71 74.12 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.215 0 CA-C-N 115.735 -0.666 . . . . 0.0 109.658 178.065 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' C' C ' 37' ' ' ILE . . . . . . . . . . . . . 67.8 mt -121.06 138.57 51.04 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.24 0 CA-C-N 116.306 -0.406 . . . . 0.0 110.05 -179.609 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' C' C ' 38' ' ' GLY . . . . . . . . . . . . . . . -110.47 128.77 8.97 Favored Glycine 0 CA--C 1.525 0.703 0 N-CA-C 110.859 -0.896 . . . . 0.0 110.859 179.263 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' C' C ' 39' ' ' ILE . . . . . . . . . . . . . 73.2 mt -122.68 129.56 75.11 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.226 0 N-CA-C 110.069 -0.345 . . . . 0.0 110.069 179.812 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' C' C ' 40' ' ' SER . . . . . . . . . . . . . 87.3 p -93.15 120.34 33.34 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.425 -0.352 . . . . 0.0 110.991 176.744 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' C' C ' 41' ' ' ILE . . . . . . . . . . . . . 70.2 mt -133.3 127.49 54.17 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.258 0 CA-C-O 120.886 0.374 . . . . 0.0 110.446 177.955 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' C' C ' 42' ' ' LEU . . . . . . . . . . . . . 11.2 tp 53.23 34.53 17.85 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.035 -0.53 . . . . 0.0 111.593 177.1 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' C' C ' 43' ' ' GLY . . . . . . . . . . . . . . . 71.2 31.07 66.62 Favored Glycine 0 CA--C 1.531 1.061 0 C-N-CA 121.094 -0.574 . . . . 0.0 111.941 177.907 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' C' C ' 44' ' ' LYS . . . . . . . . . . . . . 80.5 tttt -138.43 126.83 23.14 Favored 'General case' 0 C--N 1.329 -0.296 0 N-CA-C 109.751 -0.463 . . . . 0.0 109.751 179.834 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' C' C ' 45' ' ' GLU . . . . . . . . . . . . . 81.9 tt0 -84.37 122.83 29.49 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-N 116.45 -0.341 . . . . 0.0 111.003 -178.398 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' C' C ' 46' ' ' VAL . . . . . . . . . . . . . 7.2 p -119.88 130.29 74.38 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.302 0 N-CA-C 109.449 -0.574 . . . . 0.0 109.449 175.877 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' C' C ' 47' ' ' LYS . . . . . . . . . . . . . 64.9 mttp -100.27 127.86 46.47 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 115.979 -0.555 . . . . 0.0 111.356 178.768 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' C' C ' 48' ' ' PHE . . . . . . . . . . . . . 94.6 m-85 -111.33 131.88 54.83 Favored 'General case' 0 C--N 1.33 -0.273 0 N-CA-C 109.674 -0.491 . . . . 0.0 109.674 175.495 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' C' C ' 49' ' ' LYS . . . . . . . . . . . . . 83.3 tttt -108.48 137.06 47.06 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.401 -0.363 . . . . 0.0 110.654 179.869 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' C' C ' 50' ' ' VAL . . . . . 0.473 ' HA ' HD23 ' C' ' 6' ' ' LEU . 41.0 t -83.21 107.57 15.01 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.243 0 N-CA-C 109.421 -0.585 . . . . 0.0 109.421 176.465 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' C' C ' 51' ' ' VAL . . . . . . . . . . . . . 48.9 t -72.46 -53.48 19.23 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.275 0 N-CA-C 109.581 -0.525 . . . . 0.0 109.581 -175.455 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' C' C ' 52' ' ' GLN . . . . . . . . . . . . . 90.9 mt-30 -154.07 151.6 29.5 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.02 -0.536 . . . . 0.0 111.832 -177.647 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' C' C ' 53' ' ' ALA . . . . . . . . . . . . . . . -130.12 133.78 46.88 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 115.318 -0.855 . . . . 0.0 109.827 174.463 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' C' C ' 54' ' ' TYR . . . . . . . . . . . . . 53.7 t80 -129.16 111.27 18.22 Favored Pre-proline 0 CA--C 1.535 0.377 0 CA-C-O 118.267 -0.873 . . . . 0.0 110.395 178.662 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' C' C ' 55' ' ' PRO . . . . . . . . . . . . . 73.3 Cg_endo -77.1 166.33 82.64 Favored 'Cis proline' 0 N--CA 1.499 1.84 0 CA-C-N 121.919 1.721 . . . . 0.0 112.348 -6.855 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' C' C ' 56' ' ' SER . . . . . . . . . . . . . 20.3 m -116.74 135.94 23.09 Favored Pre-proline 0 CA--C 1.538 0.519 0 CA-C-O 118.423 -0.798 . . . . 0.0 109.363 173.775 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' C' C ' 57' ' ' PRO . . . . . . . . . . . . . 49.4 Cg_endo -70.0 146.03 81.58 Favored 'Cis proline' 0 N--CA 1.497 1.733 0 CA-C-N 121.832 1.69 . . . . 0.0 111.473 -1.837 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' C' C ' 58' ' ' LEU . . . . . . . . . . . . . 31.9 tp -108.16 137.65 45.77 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.331 -0.395 . . . . 0.0 110.696 -177.704 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' C' C ' 59' ' ' ARG . . . . . . . . . . . . . 55.6 ttp180 -102.89 125.23 49.56 Favored 'General case' 0 C--N 1.327 -0.377 0 N-CA-C 109.227 -0.657 . . . . 0.0 109.227 174.653 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' C' C ' 60' ' ' VAL . . . . . . . . . . . . . 45.8 t -79.66 120.78 31.66 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.293 0 C-N-CA 120.689 -0.404 . . . . 0.0 110.65 -174.717 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' C' C ' 61' ' ' GLU . . . . . . . . . . . . . 43.3 mt-10 -131.03 163.05 28.44 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 115.747 -0.661 . . . . 0.0 109.675 176.542 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' C' C ' 62' ' ' ASP . . . . . . . . . . . . . 9.3 p-10 -53.36 -32.58 49.93 Favored 'General case' 0 C--N 1.328 -0.342 0 N-CA-C 111.894 0.331 . . . . 0.0 111.894 -178.634 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' C' C ' 63' ' ' ARG . . . . . . . . . . . . . 47.8 mtp180 -73.52 -21.5 60.37 Favored 'General case' 0 CA--C 1.534 0.335 0 N-CA-C 113.033 0.753 . . . . 0.0 113.033 -176.216 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' C' C ' 64' ' ' THR . . . . . . . . . . . . . 30.2 m -61.53 138.53 58.29 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-O 120.973 0.416 . . . . 0.0 111.341 -174.02 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' C' C ' 65' ' ' LYS . . . . . . . . . . . . . 40.5 ttpt -89.34 120.37 30.62 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 115.821 -0.627 . . . . 0.0 109.946 177.631 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' C' C ' 66' ' ' ILE . . . . . . . . . . . . . 64.0 mt -113.19 130.26 67.42 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.201 0 CA-C-O 120.894 0.378 . . . . 0.0 109.989 -178.434 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' C' C ' 67' ' ' THR . . . . . . . . . . . . . 25.5 m -129.41 147.36 51.22 Favored 'General case' 0 C--N 1.332 -0.186 0 CA-C-N 116.106 -0.497 . . . . 0.0 111.173 -177.815 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' C' C ' 68' ' ' LEU . . . . . . . . . . . . . 62.8 mt . . . . . 0 C--N 1.329 -0.303 0 CA-C-N 115.851 -0.613 . . . . 0.0 110.381 177.038 . . . . . . . . 0 0 . 1 . 013 nuclear nobuild core ' C' C ' 73' ' ' VAL . . . . . . . . . . . . . 33.2 m . . . . . 0 C--O 1.231 0.093 0 CA-C-O 120.978 0.418 . . . . 0.0 110.718 . . . . . . . . . 0 0 . 1 . 013 nuclear nobuild core ' C' C ' 74' ' ' ASP . . . . . . . . . . . . . 27.7 t0 -102.16 121.62 42.58 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 115.698 -0.683 . . . . 0.0 109.405 176.745 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' C' C ' 75' ' ' VAL . . . . . . . . . . . . . 43.1 t -110.82 121.32 63.33 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.249 0 CA-C-O 121.056 0.455 . . . . 0.0 110.825 -175.543 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' C' C ' 76' ' ' LEU . . . . . . . . . . . . . 21.9 mt -117.86 141.9 47.91 Favored 'General case' 0 C--N 1.331 -0.206 0 CA-C-N 115.598 -0.728 . . . . 0.0 109.693 176.114 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' C' C ' 77' ' ' GLU . . . . . . . . . . . . . 97.9 mt-10 -136.2 135.53 39.2 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-O 120.98 0.419 . . . . 0.0 111.307 -178.168 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' C' C ' 78' ' ' ALA . . . . . 0.595 ' HB2' HD21 ' C' ' 109' ' ' LEU . . . -124.61 134.56 52.88 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 115.627 -0.715 . . . . 0.0 109.882 176.801 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' C' C ' 79' ' ' LYS . . . . . 0.582 ' O ' HD13 ' C' ' 80' ' ' ILE . 66.3 mmtt -78.54 121.25 24.36 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-O 120.976 0.417 . . . . 0.0 110.597 179.851 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' C' C ' 80' ' ' ILE . . . . . 0.582 HD13 ' O ' ' C' ' 79' ' ' LYS . 42.2 mm -139.06 115.06 9.41 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.305 0 N-CA-C 109.291 -0.633 . . . . 0.0 109.291 -178.422 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' C' C ' 81' ' ' LYS . . . . . . . . . . . . . 46.7 pttt -104.11 123.37 47.13 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-O 121.085 0.469 . . . . 0.0 111.096 -178.437 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' C' C ' 82' ' ' GLY . . . . . . . . . . . . . . . 89.07 42.13 5.69 Favored Glycine 0 CA--C 1.525 0.697 0 C-N-CA 120.701 -0.761 . . . . 0.0 111.838 174.358 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' C' C ' 83' ' ' ILE . . . . . . . . . . . . . 70.6 mt -64.22 138.45 23.04 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.272 0 N-CA-C 109.73 -0.471 . . . . 0.0 109.73 177.691 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' C' C ' 84' ' ' LYS . . . . . . . . . . . . . 77.4 tttt -100.14 -51.15 3.75 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 115.995 -0.548 . . . . 0.0 110.465 -177.325 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' C' C ' 85' ' ' ASP . . . . . . . . . . . . . 5.1 t0 -156.51 152.26 27.13 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.014 -0.539 . . . . 0.0 110.319 -179.707 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' C' C ' 86' ' ' VAL . . . . . 0.42 ' O ' HD13 ' C' ' 87' ' ' ILE . 44.0 t -130.16 132.73 65.04 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.229 0 CA-C-O 121.021 0.438 . . . . 0.0 110.622 -179.461 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' C' C ' 87' ' ' ILE . . . . . 0.42 HD13 ' O ' ' C' ' 86' ' ' VAL . 43.5 mm -122.04 125.19 72.75 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.29 0 CA-C-N 115.948 -0.569 . . . . 0.0 109.604 176.098 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' C' C ' 88' ' ' LEU . . . . . . . . . . . . . 14.8 tp -111.03 129.27 55.96 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-O 120.84 0.352 . . . . 0.0 111.139 -177.145 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' C' C ' 89' ' ' ASP . . . . . . . . . . . . . 12.6 t70 -121.38 151.25 40.36 Favored 'General case' 0 C--N 1.33 -0.258 0 N-CA-C 109.555 -0.535 . . . . 0.0 109.555 176.67 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' C' C ' 90' ' ' GLU . . . . . . . . . . . . . 83.5 tt0 -48.86 -33.24 10.24 Favored 'General case' 0 C--N 1.328 -0.342 0 N-CA-C 112.64 0.607 . . . . 0.0 112.64 -173.082 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' C' C ' 91' ' ' ASN . . . . . . . . . . . . . 79.2 m-20 -131.99 28.14 4.5 Favored 'General case' 0 N--CA 1.466 0.333 0 N-CA-C 112.411 0.523 . . . . 0.0 112.411 -175.764 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' C' C ' 92' ' ' LEU . . . . . . . . . . . . . 11.7 tp -166.2 150.94 8.05 Favored 'General case' 0 C--N 1.33 -0.245 0 C-N-CA 120.835 -0.346 . . . . 0.0 110.851 -179.281 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' C' C ' 93' ' ' ILE . . . . . . . . . . . . . 69.0 mt -126.87 125.72 67.21 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.173 0 N-CA-C 109.757 -0.46 . . . . 0.0 109.757 179.629 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' C' C ' 94' ' ' VAL . . . . . . . . . . . . . 43.2 t -123.14 128.67 75.1 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.238 0 N-CA-C 110.077 -0.342 . . . . 0.0 110.077 178.957 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' C' C ' 95' ' ' VAL . . . . . . . . . . . . . 40.9 t -124.23 136.86 59.08 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.235 0 CA-C-O 120.933 0.397 . . . . 0.0 110.072 -179.406 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' C' C ' 96' ' ' ILE . . . . . . . . . . . . . 59.7 mt -114.31 130.11 69.16 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.335 0 N-CA-C 109.266 -0.642 . . . . 0.0 109.266 179.035 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' C' C ' 97' ' ' THR . . . . . . . . . . . . . 68.1 p -102.93 154.36 19.29 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-O 121.253 0.549 . . . . 0.0 111.192 -177.704 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' C' C ' 98' ' ' GLU . . . . . . . . . . . . . 84.0 tt0 -53.86 -24.61 16.41 Favored 'General case' 0 CA--C 1.533 0.322 0 N-CA-C 112.299 0.481 . . . . 0.0 112.299 179.625 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' C' C ' 99' ' ' GLU . . . . . . . . . . . . . 13.8 mm-40 -77.67 14.71 0.97 Allowed 'General case' 0 CA--C 1.535 0.391 0 N-CA-C 113.266 0.839 . . . . 0.0 113.266 -177.471 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' C' C ' 100' ' ' ASN . . . . . . . . . . . . . 2.9 m-20 62.89 38.05 11.64 Favored 'General case' 0 N--CA 1.464 0.245 0 CA-C-O 121.116 0.484 . . . . 0.0 110.757 178.686 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' C' C ' 101' ' ' GLU . . . . . . . . . . . . . 83.6 tt0 -122.36 145.97 47.77 Favored 'General case' 0 C--N 1.331 -0.217 0 CA-C-N 116.182 -0.463 . . . . 0.0 109.924 177.773 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' C' C ' 102' ' ' VAL . . . . . . . . . . . . . 44.1 t -114.95 129.26 71.44 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.232 0 CA-C-N 116.302 -0.408 . . . . 0.0 110.047 -177.396 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' C' C ' 103' ' ' LEU . . . . . . . . . . . . . 27.6 mt -119.63 131.55 55.49 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 115.59 -0.732 . . . . 0.0 110.131 177.06 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' C' C ' 104' ' ' ILE . . . . . . . . . . . . . 72.3 mt -117.15 125.07 73.73 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.276 0 N-CA-C 109.816 -0.438 . . . . 0.0 109.816 178.872 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' C' C ' 105' ' ' PHE . . . . . . . . . . . . . 93.8 m-85 -122.49 163.44 19.89 Favored 'General case' 0 C--O 1.232 0.144 0 O-C-N 123.904 0.752 . . . . 0.0 109.945 -177.909 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' C' C ' 106' ' ' ASN . . . . . . . . . . . . . 44.9 p-10 -101.08 -171.25 1.96 Allowed 'General case' 0 C--N 1.332 -0.19 0 CA-C-N 116.549 -0.296 . . . . 0.0 110.249 174.755 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' C' C ' 107' ' ' GLN . . . . . . . . . . . . . 40.4 tt0 -58.32 -29.51 65.97 Favored 'General case' 0 CA--C 1.533 0.297 0 N-CA-C 112.027 0.38 . . . . 0.0 112.027 -179.972 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' C' C ' 108' ' ' ASN . . . . . . . . . . . . . 5.1 t-20 -85.27 7.9 20.51 Favored 'General case' 0 CA--C 1.538 0.506 0 N-CA-C 113.279 0.844 . . . . 0.0 113.279 -176.559 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' C' C ' 109' ' ' LEU . . . . . 0.595 HD21 ' HB2' ' C' ' 78' ' ' ALA . 10.7 tp 60.07 36.97 21.3 Favored 'General case' 0 CA--C 1.531 0.225 0 CA-C-O 120.98 0.419 . . . . 0.0 111.28 179.513 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' C' C ' 110' ' ' GLU . . . . . . . . . . . . . 70.6 mm-40 -108.83 147.96 31.3 Favored 'General case' 0 C--N 1.33 -0.269 0 N-CA-C 109.653 -0.499 . . . . 0.0 109.653 175.199 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' C' C ' 111' ' ' GLU . . . . . . . . . . . . . 55.4 tt0 -82.57 121.92 27.42 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-O 120.958 0.409 . . . . 0.0 111.022 -174.122 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' C' C ' 112' ' ' LEU . . . . . . . . . . . . . 11.8 mt -103.28 -46.2 4.67 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 115.936 -0.574 . . . . 0.0 110.888 179.47 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' C' C ' 113' ' ' TYR . . . . . . . . . . . . . 64.2 t80 -133.34 136.6 45.48 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 116.464 -0.335 . . . . 0.0 111.397 -177.444 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' C' C ' 114' ' ' ARG . . . . . . . . . . . . . 35.8 ttp180 -135.44 121.0 19.36 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 115.918 -0.583 . . . . 0.0 110.316 177.841 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' C' C ' 115' ' ' GLY . . . . . . . . . . . . . . . -150.01 145.44 13.54 Favored Glycine 0 CA--C 1.524 0.638 0 N-CA-C 111.062 -0.815 . . . . 0.0 111.062 178.122 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' C' C ' 116' ' ' LYS . . . . . . . . . . . . . 34.6 ttpt -117.16 138.34 51.73 Favored 'General case' 0 C--N 1.33 -0.249 0 N-CA-C 109.9 -0.407 . . . . 0.0 109.9 177.974 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' C' C ' 117' ' ' PHE . . . . . 0.403 ' HE2' HD13 ' C' ' 132' ' ' ILE . 46.1 m-85 -135.47 113.97 11.66 Favored 'General case' 0 C--N 1.33 -0.264 0 N-CA-C 109.941 -0.392 . . . . 0.0 109.941 -178.573 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' C' C ' 118' ' ' GLU . . . . . . . . . . . . . 45.8 tp10 -55.05 -42.66 72.98 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.391 -0.368 . . . . 0.0 111.211 -176.304 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' C' C ' 119' ' ' ASN . . . . . . . . . . . . . 4.7 m120 -99.81 31.11 3.37 Favored 'General case' 0 C--N 1.33 -0.247 0 N-CA-C 112.255 0.465 . . . . 0.0 112.255 -173.852 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' C' C ' 120' ' ' LEU . . . . . . . . . . . . . 15.9 tp -56.02 119.99 6.75 Favored 'General case' 0 N--CA 1.461 0.118 0 CA-C-O 120.783 0.325 . . . . 0.0 110.377 177.603 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' C' C ' 121' ' ' ASN . . . . . . . . . . . . . 7.8 t-20 -113.84 -44.1 3.21 Favored 'General case' 0 C--N 1.332 -0.157 0 CA-C-N 116.457 -0.338 . . . . 0.0 110.944 -176.208 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' C' C ' 122' ' ' LYS . . . . . . . . . . . . . 61.8 mtpt -140.23 146.17 38.32 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-O 121.079 0.466 . . . . 0.0 111.518 -177.682 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' C' C ' 123' ' ' VAL . . . . . . . . . . . . . 47.7 t -124.16 126.88 72.93 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.319 0 CA-C-N 115.816 -0.629 . . . . 0.0 109.582 175.557 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' C' C ' 124' ' ' LEU . . . . . . . . . . . . . 50.9 mt -114.5 127.75 55.97 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.141 -0.481 . . . . 0.0 110.126 -179.331 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' C' C ' 125' ' ' VAL . . . . . . . . . . . . . 41.4 t -135.6 121.93 32.3 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.33 0 CA-C-O 120.765 0.317 . . . . 0.0 110.259 179.478 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' C' C ' 126' ' ' ARG . . . . . . . . . . . . . 79.0 mtt85 -151.39 136.15 17.19 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 116.094 -0.503 . . . . 0.0 109.696 175.831 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' C' C ' 127' ' ' ASN . . . . . . . . . . . . . 75.6 m-20 56.13 -152.1 0.38 Allowed 'General case' 0 CA--C 1.539 0.532 0 N-CA-C 109.702 -0.481 . . . . 0.0 109.702 -178.202 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' C' C ' 128' ' ' ASP . . . . . . . . . . . . . 20.2 p-10 -88.08 21.54 2.72 Favored 'General case' 0 CA--C 1.534 0.346 0 CA-C-N 118.596 0.635 . . . . 0.0 112.377 176.806 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' C' C ' 129' ' ' LEU . . . . . 0.478 HD11 ' NE2' ' D' ' 107' ' ' GLN . 1.4 tt -115.43 134.67 54.87 Favored 'General case' 0 C--O 1.235 0.312 0 O-C-N 122.039 -0.413 . . . . 0.0 109.963 -179.338 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' C' C ' 130' ' ' VAL . . . . . . . . . . . . . 41.6 t -123.06 139.88 48.45 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.313 0 CA-C-O 121.017 0.437 . . . . 0.0 110.579 -175.788 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' C' C ' 131' ' ' VAL . . . . . 0.465 HG22 HD12 ' C' ' 140' ' ' LEU . 41.4 t -135.99 135.8 50.14 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.278 0 CA-C-N 116.097 -0.501 . . . . 0.0 110.266 178.209 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' C' C ' 132' ' ' ILE . . . . . 0.403 HD13 ' HE2' ' C' ' 117' ' ' PHE . 71.8 mt -117.44 131.53 69.88 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.314 0 N-CA-C 109.502 -0.555 . . . . 0.0 109.502 179.297 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' C' C ' 133' ' ' ILE . . . . . . . . . . . . . 35.7 mm -115.6 119.62 62.36 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.25 0 CA-C-O 120.803 0.335 . . . . 0.0 110.86 -176.387 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' C' C ' 134' ' ' ASP . . . . . . . . . . . . . 5.9 p-10 -129.71 148.81 51.63 Favored 'General case' 0 C--N 1.332 -0.193 0 CA-C-N 116.016 -0.538 . . . . 0.0 109.734 176.502 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' C' C ' 135' ' ' GLU . . . . . . . . . . . . . 75.2 tt0 -50.29 -27.55 6.31 Favored 'General case' 0 C--N 1.328 -0.333 0 N-CA-C 113.096 0.776 . . . . 0.0 113.096 -170.884 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' C' C ' 136' ' ' GLN . . . . . . . . . . . . . 13.9 pt20 -101.94 -14.65 17.11 Favored 'General case' 0 CA--C 1.535 0.378 0 N-CA-C 113.514 0.931 . . . . 0.0 113.514 -172.237 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' C' C ' 137' ' ' LYS . . . . . . . . . . . . . 13.3 ptpt -168.52 168.2 11.17 Favored 'General case' 0 N--CA 1.462 0.175 0 CA-C-O 121.622 0.725 . . . . 0.0 112.228 178.743 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' C' C ' 138' ' ' LEU . . . . . . . . . . . . . 5.8 tt -119.39 129.57 54.87 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 114.957 -1.019 . . . . 0.0 109.737 179.395 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' C' C ' 139' ' ' THR . . . . . . . . . . . . . 38.6 m -110.29 130.04 55.62 Favored 'General case' 0 C--N 1.331 -0.214 0 CA-C-N 116.449 -0.341 . . . . 0.0 110.488 -179.218 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' C' C ' 140' ' ' LEU . . . . . 0.465 HD12 HG22 ' C' ' 131' ' ' VAL . 15.2 tp -115.71 125.29 52.62 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 115.688 -0.687 . . . . 0.0 109.41 -178.661 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' C' C ' 141' ' ' ILE . . . . . . . . . . . . . 19.2 mt -122.73 117.4 51.77 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.24 0 CA-C-O 120.861 0.362 . . . . 0.0 110.032 -175.33 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' C' C ' 142' ' ' ARG . . . . . . . . . . . . . 81.3 mtm180 . . . . . 0 C--N 1.331 -0.196 0 CA-C-N 115.499 -0.773 . . . . 0.0 109.939 179.917 . . . . . . . . 0 0 . 1 . 013 nuclear nobuild core ' D' D ' 2' ' ' SER . . . . . . . . . . . . . 2.5 p . . . . . 0 C--O 1.231 0.096 0 CA-C-O 120.897 0.379 . . . . 0.0 110.36 . . . . . . . . . 0 0 . 1 . 013 nuclear nobuild core ' D' D ' 3' ' ' GLU . . . . . . . . . . . . . 83.7 tt0 -141.54 142.26 33.54 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-N 115.931 -0.577 . . . . 0.0 111.056 -177.123 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' D' D ' 4' ' ' LEU . . . . . . . . . . . . . 21.6 tp -124.81 129.77 51.08 Favored 'General case' 0 C--N 1.331 -0.213 0 CA-C-N 116.109 -0.496 . . . . 0.0 110.192 175.803 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' D' D ' 5' ' ' LYS . . . . . . . . . . . . . 68.7 mttm -104.7 120.08 40.51 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-N 116.25 -0.432 . . . . 0.0 110.542 178.635 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' D' D ' 6' ' ' LEU . . . . . . . . . . . . . 45.5 mt -115.22 146.76 41.12 Favored 'General case' 0 C--N 1.331 -0.223 0 CA-C-N 115.389 -0.823 . . . . 0.0 110.236 -179.872 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' D' D ' 7' ' ' LYS . . . . . . . . . . . . . 85.5 tttt -132.71 131.76 22.26 Favored Pre-proline 0 CA--C 1.537 0.453 0 CA-C-O 118.67 -0.681 . . . . 0.0 110.2 176.465 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' D' D ' 8' ' ' PRO . . . . . . . . . . . . . 95.1 Cg_endo -87.37 140.78 5.55 Favored 'Trans proline' 0 N--CA 1.491 1.362 0 C-N-CA 121.508 1.472 . . . . 0.0 111.632 175.776 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' D' D ' 9' ' ' LEU . . . . . . . . . . . . . 37.2 mt -79.98 -49.21 1.3 Allowed Pre-proline 0 CA--C 1.535 0.376 0 CA-C-O 118.566 -0.731 . . . . 0.0 112.494 -177.927 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' D' D ' 10' ' ' PRO . . . . . . . . . . . . . 85.6 Cg_endo -77.5 154.32 31.29 Favored 'Trans proline' 0 N--CA 1.498 1.752 0 C-N-CA 121.183 1.255 . . . . 0.0 112.27 179.808 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' D' D ' 11' ' ' LYS . . . . . . . . . . . . . 80.8 tttt -88.1 100.18 12.75 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 116.236 -0.438 . . . . 0.0 110.382 178.438 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' D' D ' 12' ' ' VAL . . . . . . . . . . . . . 12.3 p -143.94 147.89 19.31 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.273 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.667 -178.985 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' D' D ' 13' ' ' GLU . . . . . . . . . . . . . 70.7 mm-40 -81.55 123.14 28.4 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.229 -0.441 . . . . 0.0 109.999 177.13 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' D' D ' 14' ' ' LEU . . . . . . . . . . . . . 18.2 mt -98.12 147.02 32.51 Favored Pre-proline 0 CA--C 1.532 0.285 0 CA-C-O 119.158 -0.448 . . . . 0.0 110.444 -179.203 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' D' D ' 15' ' ' PRO . . . . . . . . . . . . . 27.1 Cg_exo -61.8 156.0 51.02 Favored 'Trans proline' 0 N--CA 1.499 1.807 0 C-N-CA 121.316 1.344 . . . . 0.0 112.004 177.489 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' D' D ' 16' ' ' PRO . . . . . . . . . . . . . 32.1 Cg_exo -59.85 -37.2 87.77 Favored 'Trans proline' 0 N--CA 1.497 1.689 0 C-N-CA 121.398 1.399 . . . . 0.0 112.55 178.962 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' D' D ' 17' ' ' ASP . . . . . . . . . . . . . 8.8 p-10 -87.53 15.77 6.29 Favored 'General case' 0 CA--C 1.536 0.419 0 N-CA-C 112.869 0.692 . . . . 0.0 112.869 -177.529 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' D' D ' 18' ' ' PHE . . . . . . . . . . . . . 35.7 t80 -56.38 -47.34 79.13 Favored 'General case' 0 C--N 1.334 -0.089 0 O-C-N 122.031 -0.418 . . . . 0.0 110.536 -178.283 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' D' D ' 19' ' ' VAL . . . . . . . . . . . . . 48.5 t -55.05 -40.89 56.28 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.259 0 C-N-CA 121.139 -0.224 . . . . 0.0 110.915 -177.337 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' D' D ' 20' ' ' ASP . . . . . . . . . . . . . 70.0 m-20 -60.06 -45.01 94.29 Favored 'General case' 0 C--N 1.331 -0.233 0 C-N-CA 120.864 -0.335 . . . . 0.0 110.959 -178.143 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' D' D ' 21' ' ' VAL . . . . . . . . . . . . . 47.5 t -65.52 -46.27 90.26 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.336 0 C-N-CA 120.631 -0.428 . . . . 0.0 110.585 -178.316 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' D' D ' 22' ' ' ILE . . . . . 0.497 HG22 HD12 ' D' ' 26' ' ' LEU . 49.4 mm -55.61 -58.67 4.01 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.295 0 C-N-CA 121.074 -0.25 . . . . 0.0 111.038 -178.101 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' D' D ' 23' ' ' ARG . . . . . . . . . . . . . 12.2 ptm180 -55.83 -42.78 76.25 Favored 'General case' 0 C--N 1.332 -0.183 0 C-N-CA 120.71 -0.396 . . . . 0.0 111.747 -174.662 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' D' D ' 24' ' ' ILE . . . . . . . . . . . . . 74.4 mt -59.78 -42.66 89.59 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.321 0 C-N-CA 120.871 -0.331 . . . . 0.0 111.314 -177.502 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' D' D ' 25' ' ' LYS . . . . . . . . . . . . . 97.5 mttt -69.08 -42.02 76.76 Favored 'General case' 0 C--N 1.329 -0.298 0 N-CA-C 112.457 0.54 . . . . 0.0 112.457 -179.808 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' D' D ' 26' ' ' LEU . . . . . 0.497 HD12 HG22 ' D' ' 22' ' ' ILE . 86.9 mt -78.87 -30.9 45.32 Favored 'General case' 0 C--N 1.329 -0.3 0 N-CA-C 113.708 1.003 . . . . 0.0 113.708 -169.851 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' D' D ' 27' ' ' GLN . . . . . . . . . . . . . 10.7 pt20 -47.45 141.4 4.98 Favored 'General case' 0 N--CA 1.469 0.497 0 N-CA-C 112.679 0.622 . . . . 0.0 112.679 -175.223 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' D' D ' 28' ' ' GLY . . . . . . . . . . . . . . . 100.07 -22.38 40.43 Favored Glycine 0 CA--C 1.533 1.158 0 CA-C-N 115.709 -0.678 . . . . 0.0 112.495 -177.109 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' D' D ' 29' ' ' LYS . . . . . . . . . . . . . 74.2 mmtt -96.59 155.02 16.95 Favored 'General case' 0 C--O 1.232 0.137 0 CA-C-N 117.588 0.694 . . . . 0.0 110.721 177.901 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' D' D ' 30' ' ' THR . . . . . . . . . . . . . 32.3 m -106.6 136.76 45.83 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.154 -0.475 . . . . 0.0 109.885 176.225 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' D' D ' 31' ' ' VAL . . . . . . . . . . . . . 34.8 m -129.47 156.27 41.8 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.203 0 CA-C-O 120.907 0.384 . . . . 0.0 110.864 -178.289 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' D' D ' 32' ' ' ARG . . . . . . . . . . . . . 54.0 ttp180 -133.99 150.82 51.28 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 115.857 -0.611 . . . . 0.0 110.384 178.652 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' D' D ' 33' ' ' THR . . . . . . . . . . . . . 27.4 m -53.06 139.99 26.66 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.419 -0.355 . . . . 0.0 111.339 -179.37 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' D' D ' 34' ' ' GLY . . . . . . . . . . . . . . . 99.74 -17.18 57.81 Favored Glycine 0 CA--C 1.533 1.181 0 CA-C-O 119.762 -0.466 . . . . 0.0 113.218 179.909 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' D' D ' 35' ' ' ASP . . . . . . . . . . . . . 73.4 m-20 -66.89 149.21 50.92 Favored 'General case' 0 C--O 1.231 0.122 0 CA-C-N 118.019 0.909 . . . . 0.0 111.3 178.609 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' D' D ' 36' ' ' VAL . . . . . . . . . . . . . 45.9 t -122.24 129.46 75.31 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.286 0 CA-C-N 115.815 -0.63 . . . . 0.0 109.692 177.463 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' D' D ' 37' ' ' ILE . . . . . . . . . . . . . 66.6 mt -119.9 138.08 51.65 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.264 0 CA-C-N 116.367 -0.379 . . . . 0.0 110.042 -178.942 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' D' D ' 38' ' ' GLY . . . . . . . . . . . . . . . -112.3 128.79 8.69 Favored Glycine 0 CA--C 1.524 0.653 0 N-CA-C 111.009 -0.836 . . . . 0.0 111.009 179.487 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' D' D ' 39' ' ' ILE . . . . . . . . . . . . . 72.1 mt -122.91 132.58 71.1 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.184 0 N-CA-C 110.039 -0.356 . . . . 0.0 110.039 179.319 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' D' D ' 40' ' ' SER . . . . . . . . . . . . . 13.6 t -92.51 119.41 31.97 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.474 -0.33 . . . . 0.0 110.647 176.153 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' D' D ' 41' ' ' ILE . . . . . . . . . . . . . 73.0 mt -131.1 115.99 31.74 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.208 0 CA-C-O 120.987 0.422 . . . . 0.0 110.691 179.51 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' D' D ' 42' ' ' LEU . . . . . 0.519 HD23 ' O ' ' D' ' 42' ' ' LEU . 1.4 tt 52.58 48.17 23.12 Favored 'General case' 0 CA--C 1.532 0.288 0 CA-C-N 115.738 -0.665 . . . . 0.0 110.989 175.9 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' D' D ' 43' ' ' GLY . . . . . . . . . . . . . . . 70.19 16.44 73.13 Favored Glycine 0 CA--C 1.534 1.266 0 C-N-CA 121.064 -0.589 . . . . 0.0 113.089 174.75 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' D' D ' 44' ' ' LYS . . . . . . . . . . . . . 53.3 mtmt -128.38 130.01 47.07 Favored 'General case' 0 C--N 1.333 -0.133 0 CA-C-N 117.788 0.794 . . . . 0.0 110.304 179.629 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' D' D ' 45' ' ' GLU . . . . . . . . . . . . . 81.4 tt0 -84.84 124.51 31.67 Favored 'General case' 0 C--N 1.327 -0.406 0 CA-C-N 116.451 -0.341 . . . . 0.0 110.737 -179.858 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' D' D ' 46' ' ' VAL . . . . . . . . . . . . . 7.3 p -122.26 127.06 75.07 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.235 0 N-CA-C 109.651 -0.5 . . . . 0.0 109.651 176.498 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' D' D ' 47' ' ' LYS . . . . . . . . . . . . . 99.3 mttt -101.03 130.66 47.07 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.008 -0.542 . . . . 0.0 111.481 178.171 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' D' D ' 48' ' ' PHE . . . . . . . . . . . . . 92.1 m-85 -113.86 131.95 56.08 Favored 'General case' 0 C--N 1.329 -0.303 0 N-CA-C 109.559 -0.534 . . . . 0.0 109.559 174.592 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' D' D ' 49' ' ' LYS . . . . . . . . . . . . . 80.6 tttt -107.99 137.44 45.98 Favored 'General case' 0 C--N 1.329 -0.309 0 N-CA-C 110.284 -0.265 . . . . 0.0 110.284 178.8 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' D' D ' 50' ' ' VAL . . . . . . . . . . . . . 45.6 t -81.69 109.2 15.61 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.252 0 N-CA-C 109.236 -0.653 . . . . 0.0 109.236 176.889 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' D' D ' 51' ' ' VAL . . . . . . . . . . . . . 48.8 t -74.35 -47.07 41.96 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.278 0 CA-C-N 115.902 -0.59 . . . . 0.0 110.213 -173.809 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' D' D ' 52' ' ' GLN . . . . . . . . . . . . . 31.2 tt0 -163.88 142.49 7.63 Favored 'General case' 0 C--N 1.332 -0.19 0 C-N-CA 120.26 -0.576 . . . . 0.0 111.789 -178.432 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' D' D ' 53' ' ' ALA . . . . . . . . . . . . . . . -118.55 132.33 56.21 Favored 'General case' 0 C--N 1.332 -0.184 0 CA-C-N 115.812 -0.631 . . . . 0.0 110.194 177.207 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' D' D ' 54' ' ' TYR . . . . . . . . . . . . . 55.0 t80 -128.98 107.92 18.14 Favored Pre-proline 0 CA--C 1.534 0.362 0 CA-C-O 118.252 -0.88 . . . . 0.0 110.557 -179.849 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' D' D ' 55' ' ' PRO . . . . . . . . . . . . . 73.8 Cg_endo -77.27 170.08 72.37 Favored 'Cis proline' 0 N--CA 1.501 1.914 0 CA-C-N 121.89 1.711 . . . . 0.0 112.274 -5.67 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' D' D ' 56' ' ' SER . . . . . . . . . . . . . 32.8 m -116.46 133.57 22.97 Favored Pre-proline 0 CA--C 1.539 0.547 0 CA-C-O 118.418 -0.801 . . . . 0.0 109.408 174.447 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' D' D ' 57' ' ' PRO . . . . . . . . . . . . . 41.9 Cg_endo -67.8 166.33 66.7 Favored 'Cis proline' 0 N--CA 1.499 1.8 0 CA-C-N 121.874 1.705 . . . . 0.0 111.524 -1.446 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' D' D ' 58' ' ' LEU . . . . . . . . . . . . . 38.5 tp -129.27 138.03 51.41 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.239 -0.437 . . . . 0.0 110.173 179.657 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' D' D ' 59' ' ' ARG . . . . . . . . . . . . . 72.7 ttt-85 -101.95 129.32 48.19 Favored 'General case' 0 C--N 1.329 -0.306 0 N-CA-C 109.405 -0.591 . . . . 0.0 109.405 178.013 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' D' D ' 60' ' ' VAL . . . . . . . . . . . . . 41.5 t -78.5 113.77 18.23 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.299 0 C-N-CA 120.782 -0.367 . . . . 0.0 110.255 -176.165 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' D' D ' 61' ' ' GLU . . . . . . . . . . . . . 82.8 tt0 -131.24 151.57 51.35 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 115.913 -0.585 . . . . 0.0 109.66 175.998 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' D' D ' 62' ' ' ASP . . . . . . . . . . . . . 50.6 m-20 -49.58 -32.08 11.92 Favored 'General case' 0 C--N 1.327 -0.396 0 N-CA-C 112.129 0.418 . . . . 0.0 112.129 179.394 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' D' D ' 63' ' ' ARG . . . . . . . . . . . . . 35.0 mtp180 -75.0 -21.75 58.95 Favored 'General case' 0 CA--C 1.533 0.32 0 N-CA-C 113.1 0.778 . . . . 0.0 113.1 -174.859 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' D' D ' 64' ' ' THR . . . . . . . . . . . . . 23.1 m -70.23 146.72 50.48 Favored 'General case' 0 C--N 1.331 -0.222 0 CA-C-O 120.726 0.298 . . . . 0.0 110.995 -175.536 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' D' D ' 65' ' ' LYS . . . . . . . . . . . . . 40.2 ttpt -88.28 121.64 30.9 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-O 121.068 0.461 . . . . 0.0 110.306 179.64 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' D' D ' 66' ' ' ILE . . . . . . . . . . . . . 69.1 mt -113.75 125.22 70.99 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.271 0 N-CA-C 109.556 -0.535 . . . . 0.0 109.556 -178.24 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' D' D ' 67' ' ' THR . . . . . . . . . . . . . 10.8 m -123.92 141.73 51.78 Favored 'General case' 0 C--N 1.331 -0.216 0 CA-C-O 121.062 0.458 . . . . 0.0 111.295 -174.57 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' D' D ' 68' ' ' LEU . . . . . 0.409 ' C ' HD23 ' D' ' 68' ' ' LEU . 5.7 tt . . . . . 0 C--N 1.329 -0.3 0 CA-C-N 115.746 -0.661 . . . . 0.0 109.735 177.132 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' D' D ' 73' ' ' VAL . . . . . . . . . . . . . 34.5 m . . . . . 0 N--CA 1.461 0.078 0 CA-C-O 120.512 0.196 . . . . 0.0 110.534 . . . . . . . . . 0 0 . 1 . 013 nuclear nobuild core ' D' D ' 74' ' ' ASP . . . . . . . . . . . . . 15.6 t0 -100.85 116.48 32.82 Favored 'General case' 0 C--N 1.332 -0.162 0 N-CA-C 109.965 -0.383 . . . . 0.0 109.965 -178.795 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' D' D ' 75' ' ' VAL . . . . . . . . . . . . . 45.2 t -113.77 124.08 70.07 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.196 0 CA-C-O 121.057 0.456 . . . . 0.0 110.304 -177.992 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' D' D ' 76' ' ' LEU . . . . . . . . . . . . . 19.2 mt -127.85 145.51 50.91 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 115.726 -0.67 . . . . 0.0 109.872 179.014 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' D' D ' 77' ' ' GLU . . . . . . . . . . . . . 97.0 mt-10 -134.03 138.62 45.48 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-O 121.092 0.472 . . . . 0.0 111.359 -178.526 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' D' D ' 78' ' ' ALA . . . . . . . . . . . . . . . -125.2 138.83 54.13 Favored 'General case' 0 C--N 1.331 -0.226 0 CA-C-N 115.743 -0.662 . . . . 0.0 109.708 176.301 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' D' D ' 79' ' ' LYS . . . . . 0.516 ' O ' HD13 ' D' ' 80' ' ' ILE . 69.2 mttm -75.12 122.8 24.15 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-O 120.913 0.387 . . . . 0.0 110.797 -177.865 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' D' D ' 80' ' ' ILE . . . . . 0.516 HD13 ' O ' ' D' ' 79' ' ' LYS . 24.5 mm -139.11 114.42 8.54 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.263 0 N-CA-C 109.29 -0.633 . . . . 0.0 109.29 -177.09 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' D' D ' 81' ' ' LYS . . . . . . . . . . . . . 61.7 mttp -113.42 123.24 49.61 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-O 120.866 0.365 . . . . 0.0 111.493 -175.722 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' D' D ' 82' ' ' GLY . . . . . . . . . . . . . . . 89.04 42.08 5.72 Favored Glycine 0 CA--C 1.525 0.715 0 C-N-CA 121.004 -0.617 . . . . 0.0 112.006 174.201 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' D' D ' 83' ' ' ILE . . . . . . . . . . . . . 68.9 mt -68.74 137.39 24.48 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.269 0 N-CA-C 109.992 -0.373 . . . . 0.0 109.992 178.668 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' D' D ' 84' ' ' LYS . . . . . . . . . . . . . 25.6 ttpt -105.94 -47.27 3.9 Favored 'General case' 0 C--N 1.331 -0.217 0 CA-C-N 116.455 -0.339 . . . . 0.0 110.165 177.91 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' D' D ' 85' ' ' ASP . . . . . . . . . . . . . 12.0 t70 -150.34 151.04 32.27 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.043 -0.526 . . . . 0.0 110.441 -179.272 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' D' D ' 86' ' ' VAL . . . . . . . . . . . . . 40.5 t -138.13 137.01 44.7 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.235 0 CA-C-O 121.029 0.443 . . . . 0.0 110.764 -179.266 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' D' D ' 87' ' ' ILE . . . . . . . . . . . . . 46.2 mm -122.16 130.65 74.38 Favored 'Isoleucine or valine' 0 C--O 1.233 0.192 0 CA-C-N 115.781 -0.645 . . . . 0.0 109.793 177.159 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' D' D ' 88' ' ' LEU . . . . . . . . . . . . . 18.8 tp -116.85 132.16 56.77 Favored 'General case' 0 C--N 1.331 -0.201 0 CA-C-O 121.021 0.439 . . . . 0.0 111.161 -177.623 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' D' D ' 89' ' ' ASP . . . . . . . . . . . . . 5.5 t70 -130.66 156.29 45.15 Favored 'General case' 0 C--N 1.331 -0.204 0 CA-C-N 115.835 -0.621 . . . . 0.0 109.668 175.483 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' D' D ' 90' ' ' GLU . . . . . . . . . . . . . 83.9 tt0 -47.04 -39.49 12.9 Favored 'General case' 0 C--N 1.331 -0.201 0 N-CA-C 112.97 0.73 . . . . 0.0 112.97 -172.359 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' D' D ' 91' ' ' ASN . . . . . . . . . . . . . 21.6 p-10 -131.99 36.03 3.7 Favored 'General case' 0 C--O 1.233 0.22 0 N-CA-C 111.767 0.284 . . . . 0.0 111.767 -176.215 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' D' D ' 92' ' ' LEU . . . . . . . . . . . . . 16.0 tp -165.86 138.73 4.17 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-O 120.754 0.312 . . . . 0.0 110.605 -179.821 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' D' D ' 93' ' ' ILE . . . . . . . . . . . . . 73.2 mt -124.27 123.11 65.74 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.204 0 N-CA-C 109.431 -0.581 . . . . 0.0 109.431 179.55 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' D' D ' 94' ' ' VAL . . . . . . . . . . . . . 46.0 t -124.03 128.2 73.94 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.299 0 N-CA-C 109.897 -0.409 . . . . 0.0 109.897 -178.783 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' D' D ' 95' ' ' VAL . . . . . . . . . . . . . 40.7 t -123.78 135.28 63.99 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.346 0 CA-C-N 116.133 -0.485 . . . . 0.0 109.965 -178.611 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' D' D ' 96' ' ' ILE . . . . . . . . . . . . . 66.2 mt -117.13 128.47 74.49 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.237 0 N-CA-C 109.394 -0.595 . . . . 0.0 109.394 178.661 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' D' D ' 97' ' ' THR . . . . . . . . . . . . . 71.2 p -104.35 157.06 17.41 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-O 121.388 0.613 . . . . 0.0 111.502 -176.56 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' D' D ' 98' ' ' GLU . . . . . . . . . . . . . 12.8 pt-20 -54.85 -24.49 23.33 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 115.73 -0.668 . . . . 0.0 112.492 -179.444 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' D' D ' 99' ' ' GLU . . . . . . . . . . . . . 14.8 mm-40 -80.2 16.8 1.16 Allowed 'General case' 0 CA--C 1.536 0.441 0 N-CA-C 112.959 0.725 . . . . 0.0 112.959 -178.578 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' D' D ' 100' ' ' ASN . . . . . . . . . . . . . 4.2 m-20 62.47 37.84 13.13 Favored 'General case' 0 C--O 1.233 0.198 0 CA-C-O 121.019 0.437 . . . . 0.0 110.976 178.344 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' D' D ' 101' ' ' GLU . . . . . . . . . . . . . 84.4 tt0 -114.99 140.84 48.71 Favored 'General case' 0 C--N 1.331 -0.213 0 CA-C-N 116.127 -0.488 . . . . 0.0 109.912 177.364 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' D' D ' 102' ' ' VAL . . . . . . . . . . . . . 44.7 t -114.83 124.77 71.81 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.287 0 N-CA-C 109.656 -0.498 . . . . 0.0 109.656 179.282 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' D' D ' 103' ' ' LEU . . . . . . . . . . . . . 22.0 mt -116.6 133.6 55.82 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 115.805 -0.634 . . . . 0.0 110.155 179.055 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' D' D ' 104' ' ' ILE . . . . . . . . . . . . . 69.1 mt -121.73 121.92 65.59 Favored 'Isoleucine or valine' 0 C--O 1.234 0.239 0 CA-C-N 116.577 -0.283 . . . . 0.0 110.323 -178.35 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' D' D ' 105' ' ' PHE . . . . . . . . . . . . . 74.1 m-85 -123.81 165.81 16.68 Favored 'General case' 0 C--N 1.333 -0.141 0 O-C-N 123.994 0.808 . . . . 0.0 109.937 179.933 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' D' D ' 106' ' ' ASN . . . . . . . . . . . . . 49.8 p-10 -100.54 -174.03 2.55 Favored 'General case' 0 C--N 1.331 -0.209 0 N-CA-C 109.816 -0.438 . . . . 0.0 109.816 171.422 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' D' D ' 107' ' ' GLN . . . . . 0.478 ' NE2' HD11 ' C' ' 129' ' ' LEU . 34.7 tp60 -59.21 -25.37 63.92 Favored 'General case' 0 CA--C 1.533 0.313 0 N-CA-C 112.331 0.493 . . . . 0.0 112.331 -178.016 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' D' D ' 108' ' ' ASN . . . . . . . . . . . . . 9.7 t30 -91.45 14.17 15.52 Favored 'General case' 0 CA--C 1.534 0.365 0 N-CA-C 112.9 0.704 . . . . 0.0 112.9 -176.553 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' D' D ' 109' ' ' LEU . . . . . . . . . . . . . 76.8 mt 58.77 33.57 23.15 Favored 'General case' 0 CA--C 1.529 0.172 0 CA-C-O 120.789 0.328 . . . . 0.0 111.864 179.162 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' D' D ' 110' ' ' GLU . . . . . . . . . . . . . 70.5 mm-40 -100.21 134.82 42.58 Favored 'General case' 0 C--N 1.329 -0.284 0 N-CA-C 108.932 -0.766 . . . . 0.0 108.932 173.85 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' D' D ' 111' ' ' GLU . . . . . . . . . . . . . 45.2 tt0 -82.18 121.79 27.06 Favored 'General case' 0 C--N 1.328 -0.355 0 C-N-CA 120.643 -0.423 . . . . 0.0 110.519 -174.566 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' D' D ' 112' ' ' LEU . . . . . . . . . . . . . 34.2 mt -97.85 -45.99 6.11 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 115.851 -0.613 . . . . 0.0 110.552 179.282 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' D' D ' 113' ' ' TYR . . . . . . . . . . . . . 58.6 t80 -140.84 144.7 35.49 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.072 -0.513 . . . . 0.0 111.1 -177.854 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' D' D ' 114' ' ' ARG . . . . . . . . . . . . . 33.4 ptt180 -145.89 125.11 12.95 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 115.825 -0.625 . . . . 0.0 110.21 173.617 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' D' D ' 115' ' ' GLY . . . . . . . . . . . . . . . -149.98 143.14 10.38 Favored Glycine 0 CA--C 1.523 0.536 0 N-CA-C 110.82 -0.912 . . . . 0.0 110.82 -179.706 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' D' D ' 116' ' ' LYS . . . . . . . . . . . . . 31.4 ttmt -115.86 132.53 56.62 Favored 'General case' 0 C--N 1.329 -0.318 0 N-CA-C 109.974 -0.38 . . . . 0.0 109.974 179.184 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' D' D ' 117' ' ' PHE . . . . . . . . . . . . . 52.0 m-85 -123.52 116.27 22.91 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.123 -0.49 . . . . 0.0 110.087 -177.085 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' D' D ' 118' ' ' GLU . . . . . . . . . . . . . 84.1 tt0 -53.69 -48.47 69.48 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.576 -0.284 . . . . 0.0 111.355 -176.63 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' D' D ' 119' ' ' ASN . . . . . . . . . . . . . 87.0 m-20 -95.25 31.05 2.02 Favored 'General case' 0 C--N 1.33 -0.27 0 N-CA-C 112.203 0.446 . . . . 0.0 112.203 -174.964 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' D' D ' 120' ' ' LEU . . . . . . . . . . . . . 14.6 tp -55.34 120.32 6.92 Favored 'General case' 0 C--N 1.331 -0.202 0 CA-C-O 120.714 0.292 . . . . 0.0 110.525 178.298 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' D' D ' 121' ' ' ASN . . . . . . . . . . . . . 60.3 m-80 -113.99 -44.1 3.19 Favored 'General case' 0 C--O 1.231 0.109 0 CA-C-N 116.522 -0.308 . . . . 0.0 111.332 -176.795 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' D' D ' 122' ' ' LYS . . . . . . . . . . . . . 53.3 mttm -140.86 145.7 36.54 Favored 'General case' 0 C--N 1.331 -0.219 0 CA-C-O 120.965 0.412 . . . . 0.0 111.665 -177.647 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' D' D ' 123' ' ' VAL . . . . . . . . . . . . . 45.5 t -131.58 127.51 59.48 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.258 0 CA-C-N 116.014 -0.539 . . . . 0.0 109.696 175.319 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' D' D ' 124' ' ' LEU . . . . . . . . . . . . . 14.2 tp -131.29 133.47 45.41 Favored 'General case' 0 C--N 1.33 -0.251 0 N-CA-C 110.108 -0.33 . . . . 0.0 110.108 179.13 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' D' D ' 125' ' ' VAL . . . . . 0.559 HG12 HG13 ' D' ' 130' ' ' VAL . 32.8 m -141.24 138.5 33.39 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 CA-C-O 120.883 0.373 . . . . 0.0 111.074 -178.89 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' D' D ' 126' ' ' ARG . . . . . . . . . . . . . 98.5 mtt180 -144.04 131.05 20.5 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 115.933 -0.576 . . . . 0.0 110.249 178.64 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' D' D ' 127' ' ' ASN . . . . . . . . . . . . . 56.5 t30 52.84 -113.46 0.77 Allowed 'General case' 0 CA--C 1.546 0.813 0 CA-C-O 118.626 -0.702 . . . . 0.0 110.849 179.366 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' D' D ' 128' ' ' ASP . . . . . . . . . . . . . 12.9 p-10 -114.03 12.65 18.01 Favored 'General case' 0 CA--C 1.536 0.416 0 CA-C-N 120.126 1.33 . . . . 0.0 113.144 179.929 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' D' D ' 129' ' ' LEU . . . . . . . . . . . . . 15.8 tp -107.0 131.92 53.52 Favored 'General case' 0 C--O 1.232 0.171 0 N-CA-C 110.002 -0.37 . . . . 0.0 110.002 179.095 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' D' D ' 130' ' ' VAL . . . . . 0.559 HG13 HG12 ' D' ' 125' ' ' VAL . 46.5 t -122.7 133.76 67.88 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.246 0 CA-C-O 120.773 0.321 . . . . 0.0 110.353 -177.0 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' D' D ' 131' ' ' VAL . . . . . 0.535 HG22 HD12 ' D' ' 140' ' ' LEU . 42.8 t -135.52 133.55 52.03 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.191 0 CA-C-O 121.093 0.473 . . . . 0.0 110.204 176.441 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' D' D ' 132' ' ' ILE . . . . . . . . . . . . . 72.5 mt -122.15 134.0 66.73 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.25 0 CA-C-N 115.743 -0.662 . . . . 0.0 109.606 -178.728 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' D' D ' 133' ' ' ILE . . . . . . . . . . . . . 40.3 mm -114.98 124.39 71.6 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.251 0 CA-C-O 120.693 0.282 . . . . 0.0 110.92 -175.298 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' D' D ' 134' ' ' ASP . . . . . . . . . . . . . 9.6 p-10 -134.63 147.83 50.27 Favored 'General case' 0 C--N 1.332 -0.179 0 N-CA-C 109.721 -0.474 . . . . 0.0 109.721 174.804 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' D' D ' 135' ' ' GLU . . . . . . . . . . . . . 43.2 tp10 -50.49 -29.48 10.56 Favored 'General case' 0 C--N 1.329 -0.296 0 N-CA-C 112.845 0.683 . . . . 0.0 112.845 -171.43 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' D' D ' 136' ' ' GLN . . . . . . . . . . . . . 98.7 mt-30 -81.17 -32.71 33.48 Favored 'General case' 0 C--N 1.331 -0.197 0 N-CA-C 112.63 0.604 . . . . 0.0 112.63 -176.016 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' D' D ' 137' ' ' LYS . . . . . . . . . . . . . 37.7 pttt -167.67 172.87 8.93 Favored 'General case' 0 C--N 1.331 -0.223 0 CA-C-O 121.625 0.726 . . . . 0.0 112.261 -172.234 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' D' D ' 138' ' ' LEU . . . . . . . . . . . . . 5.5 tt -115.06 127.64 55.75 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 115.029 -0.987 . . . . 0.0 109.828 179.158 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' D' D ' 139' ' ' THR . . . . . . . . . . . . . 28.1 m -106.2 124.86 50.24 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.143 -0.481 . . . . 0.0 110.145 -179.675 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' D' D ' 140' ' ' LEU . . . . . 0.535 HD12 HG22 ' D' ' 131' ' ' VAL . 11.6 tp -115.67 121.65 43.17 Favored 'General case' 0 C--N 1.327 -0.376 0 N-CA-C 109.311 -0.626 . . . . 0.0 109.311 -178.54 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' D' D ' 141' ' ' ILE . . . . . . . . . . . . . 19.5 mt -119.13 116.75 51.95 Favored 'Isoleucine or valine' 0 C--O 1.234 0.274 0 CA-C-O 120.924 0.392 . . . . 0.0 109.966 -174.847 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' D' D ' 142' ' ' ARG . . . . . . . . . . . . . 81.7 mtp180 -106.87 131.23 54.2 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-N 115.27 -0.877 . . . . 0.0 110.626 -177.751 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' D' D ' 143' ' ' THR . . . . . . . . . . . . . 33.6 p . . . . . 0 C--O 1.221 -0.441 0 CA-C-O 117.907 -1.045 . . . . 0.0 110.893 179.624 . . . . . . . . 0 0 . 1 . 013 nuclear nobuild core ' E' E ' 2' ' ' SER . . . . . . . . . . . . . 11.1 p . . . . . 0 C--O 1.233 0.19 0 CA-C-O 120.896 0.379 . . . . 0.0 110.646 . . . . . . . . . 0 0 . 1 . 013 nuclear nobuild core ' E' E ' 3' ' ' GLU . . . . . . . . . . . . . 77.6 tt0 -141.0 140.7 34.37 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.773 179.787 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' E' E ' 4' ' ' LEU . . . . . . . . . . . . . 5.2 tt -125.82 128.28 47.42 Favored 'General case' 0 C--N 1.331 -0.215 0 CA-C-N 116.087 -0.506 . . . . 0.0 110.124 177.79 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' E' E ' 5' ' ' LYS . . . . . . . . . . . . . 68.9 mttm -105.04 122.59 46.19 Favored 'General case' 0 C--O 1.235 0.291 0 CA-C-N 116.428 -0.351 . . . . 0.0 110.868 -179.307 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' E' E ' 6' ' ' LEU . . . . . . . . . . . . . 64.6 mt -114.61 148.99 37.3 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-N 115.633 -0.712 . . . . 0.0 110.899 -179.153 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' E' E ' 7' ' ' LYS . . . . . . . . . . . . . 79.6 tttt -138.61 134.38 17.29 Favored Pre-proline 0 CA--C 1.535 0.387 0 CA-C-O 118.893 -0.575 . . . . 0.0 109.909 174.676 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' E' E ' 8' ' ' PRO . . . . . . . . . . . . . 88.8 Cg_endo -88.63 142.29 4.9 Favored 'Trans proline' 0 N--CA 1.492 1.42 0 C-N-CA 121.536 1.49 . . . . 0.0 111.624 177.497 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' E' E ' 9' ' ' LEU . . . . . . . . . . . . . 73.7 mt -76.03 -47.27 3.71 Favored Pre-proline 0 CA--C 1.534 0.341 0 CA-C-O 118.792 -0.623 . . . . 0.0 112.058 -178.432 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' E' E ' 10' ' ' PRO . . . . . . . . . . . . . 97.7 Cg_endo -82.34 149.1 14.91 Favored 'Trans proline' 0 N--CA 1.495 1.603 0 C-N-CA 121.276 1.318 . . . . 0.0 111.712 174.463 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' E' E ' 11' ' ' LYS . . . . . . . . . . . . . 59.8 mttp -88.47 97.6 11.16 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-O 120.886 0.374 . . . . 0.0 110.558 178.648 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' E' E ' 12' ' ' VAL . . . . . . . . . . . . . 11.9 p -139.54 148.28 23.45 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.274 0 CA-C-N 115.946 -0.57 . . . . 0.0 110.216 179.79 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' E' E ' 13' ' ' GLU . . . . . . . . . . . . . 81.1 tt0 -81.95 121.72 26.86 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.35 -0.386 . . . . 0.0 109.974 179.085 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' E' E ' 14' ' ' LEU . . . . . . . . . . . . . 31.2 mt -95.89 150.48 37.38 Favored Pre-proline 0 CA--C 1.532 0.271 0 CA-C-N 116.355 -0.384 . . . . 0.0 110.466 -178.581 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' E' E ' 15' ' ' PRO . . . . . . . . . . . . . 33.1 Cg_exo -60.09 158.91 27.98 Favored 'Trans proline' 0 N--CA 1.497 1.728 0 C-N-CA 121.182 1.254 . . . . 0.0 112.024 178.9 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' E' E ' 16' ' ' PRO . . . . . . . . . . . . . 26.8 Cg_exo -60.69 -44.05 28.59 Favored 'Trans proline' 0 N--CA 1.497 1.708 0 C-N-CA 121.453 1.435 . . . . 0.0 112.962 -178.106 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' E' E ' 17' ' ' ASP . . . . . . . . . . . . . 14.3 p-10 -82.69 9.83 8.81 Favored 'General case' 0 C--N 1.327 -0.388 0 N-CA-C 113.259 0.837 . . . . 0.0 113.259 -176.772 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' E' E ' 18' ' ' PHE . . . . . . . . . . . . . 48.0 t80 -57.45 -42.95 83.49 Favored 'General case' 0 N--CA 1.457 -0.089 0 O-C-N 121.896 -0.502 . . . . 0.0 110.243 -178.539 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' E' E ' 19' ' ' VAL . . . . . . . . . . . . . 47.7 t -56.88 -44.63 82.56 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.362 0 CA-C-N 116.384 -0.371 . . . . 0.0 110.473 -177.945 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' E' E ' 20' ' ' ASP . . . . . . . . . . . . . 72.3 m-20 -59.61 -41.31 90.07 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-O 120.773 0.32 . . . . 0.0 110.78 -177.824 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' E' E ' 21' ' ' VAL . . . . . . . . . . . . . 46.4 t -64.24 -46.36 93.6 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.323 0 C-N-CA 120.725 -0.39 . . . . 0.0 110.476 -178.239 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' E' E ' 22' ' ' ILE . . . . . 0.594 HG22 HD12 ' E' ' 26' ' ' LEU . 48.6 mm -61.6 -35.58 68.03 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.266 0 C-N-CA 121.034 -0.267 . . . . 0.0 111.058 -179.852 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' E' E ' 23' ' ' ARG . . . . . . . . . . . . . 58.1 ttp180 -57.38 -47.79 80.74 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-O 120.965 0.412 . . . . 0.0 110.355 176.971 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' E' E ' 24' ' ' ILE . . . . . . . . . . . . . 76.0 mt -61.83 -46.67 96.0 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.238 0 CA-C-N 115.928 -0.578 . . . . 0.0 112.02 -178.037 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' E' E ' 25' ' ' LYS . . . . . . . . . . . . . 12.6 ptmm? -68.45 -35.17 77.21 Favored 'General case' 0 CA--C 1.532 0.283 0 C-N-CA 120.632 -0.427 . . . . 0.0 111.824 -174.05 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' E' E ' 26' ' ' LEU . . . . . 0.594 HD12 HG22 ' E' ' 22' ' ' ILE . 63.3 mt -79.19 -46.45 17.88 Favored 'General case' 0 C--N 1.331 -0.219 0 N-CA-C 112.963 0.727 . . . . 0.0 112.963 -174.918 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' E' E ' 27' ' ' GLN . . . . . . . . . . . . . 11.1 pt20 -46.52 140.84 4.05 Favored 'General case' 0 N--CA 1.468 0.466 0 N-CA-C 112.937 0.717 . . . . 0.0 112.937 -173.786 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' E' E ' 28' ' ' GLY . . . . . . . . . . . . . . . 100.72 -29.93 11.37 Favored Glycine 0 CA--C 1.53 1.01 0 CA-C-N 115.382 -0.827 . . . . 0.0 112.0 -176.776 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' E' E ' 29' ' ' LYS . . . . . . . . . . . . . 98.4 mttt -99.52 155.3 17.64 Favored 'General case' 0 C--O 1.234 0.273 0 CA-C-N 117.137 0.469 . . . . 0.0 111.58 179.435 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' E' E ' 30' ' ' THR . . . . . . . . . . . . . 32.2 m -97.12 140.03 32.23 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 115.93 -0.577 . . . . 0.0 110.266 176.203 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' E' E ' 31' ' ' VAL . . . . . . . . . . . . . 35.1 m -131.13 153.7 39.52 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.238 0 CA-C-N 116.234 -0.439 . . . . 0.0 110.711 -179.616 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' E' E ' 32' ' ' ARG . . . . . . . . . . . . . 75.9 mtt180 -132.7 150.1 52.2 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.04 -0.527 . . . . 0.0 110.489 178.476 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' E' E ' 33' ' ' THR . . . . . . . . . . . . . 26.6 m -53.17 140.56 25.71 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 116.241 -0.436 . . . . 0.0 111.416 -178.016 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' E' E ' 34' ' ' GLY . . . . . . . . . . . . . . . 99.62 -17.22 57.86 Favored Glycine 0 CA--C 1.531 1.082 0 C-N-CA 121.208 -0.52 . . . . 0.0 113.259 179.447 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' E' E ' 35' ' ' ASP . . . . . . . . . . . . . 75.9 m-20 -66.11 148.89 51.14 Favored 'General case' 0 C--N 1.334 -0.098 0 CA-C-N 118.092 0.946 . . . . 0.0 110.908 178.272 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' E' E ' 36' ' ' VAL . . . . . . . . . . . . . 44.1 t -123.76 132.52 71.24 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.214 0 CA-C-N 116.096 -0.502 . . . . 0.0 109.918 178.166 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' E' E ' 37' ' ' ILE . . . . . . . . . . . . . 66.8 mt -118.43 138.79 47.99 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.317 0 CA-C-N 116.12 -0.491 . . . . 0.0 109.766 -179.648 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' E' E ' 38' ' ' GLY . . . . . . . . . . . . . . . -110.87 128.77 8.91 Favored Glycine 0 CA--C 1.526 0.751 0 N-CA-C 111.171 -0.771 . . . . 0.0 111.171 -179.337 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' E' E ' 39' ' ' ILE . . . . . . . . . . . . . 77.0 mt -123.84 136.05 61.5 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.199 0 CA-C-O 120.791 0.329 . . . . 0.0 110.123 179.018 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' E' E ' 40' ' ' SER . . . . . . . . . . . . . 78.0 p -93.64 124.07 37.38 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.705 174.8 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' E' E ' 41' ' ' ILE . . . . . . . . . . . . . 70.7 mt -127.82 118.62 49.4 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.2 0 CA-C-O 120.919 0.39 . . . . 0.0 110.373 177.785 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' E' E ' 42' ' ' LEU . . . . . . . . . . . . . 44.4 mt 51.37 34.32 11.64 Favored 'General case' 0 CA--C 1.531 0.213 0 CA-C-N 116.202 -0.454 . . . . 0.0 111.952 177.621 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' E' E ' 43' ' ' GLY . . . . . . . . . . . . . . . 74.65 32.4 57.41 Favored Glycine 0 CA--C 1.528 0.898 0 C-N-CA 121.138 -0.553 . . . . 0.0 112.095 178.303 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' E' E ' 44' ' ' LYS . . . . . . . . . . . . . 47.8 tptt -137.14 131.32 32.43 Favored 'General case' 0 C--N 1.33 -0.253 0 N-CA-C 109.549 -0.537 . . . . 0.0 109.549 177.776 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' E' E ' 45' ' ' GLU . . . . . . . . . . . . . 69.0 tt0 -85.13 123.3 30.49 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 116.538 -0.301 . . . . 0.0 111.415 -174.666 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' E' E ' 46' ' ' VAL . . . . . . . . . . . . . 7.1 p -124.99 128.7 73.27 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.21 0 CA-C-O 120.904 0.383 . . . . 0.0 110.056 176.412 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' E' E ' 47' ' ' LYS . . . . . . . . . . . . . 34.9 mmtp -101.77 132.81 47.3 Favored 'General case' 0 C--N 1.331 -0.21 0 CA-C-N 115.934 -0.575 . . . . 0.0 111.653 177.604 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' E' E ' 48' ' ' PHE . . . . . . . . . . . . . 89.6 m-85 -114.73 131.9 56.62 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-N 115.922 -0.581 . . . . 0.0 109.734 174.258 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' E' E ' 49' ' ' LYS . . . . . . . . . . . . . 57.6 tttm -106.67 139.8 40.54 Favored 'General case' 0 C--O 1.233 0.23 0 CA-C-N 116.69 -0.232 . . . . 0.0 110.586 179.426 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' E' E ' 50' ' ' VAL . . . . . . . . . . . . . 47.2 t -80.88 108.14 13.92 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.282 0 N-CA-C 109.155 -0.683 . . . . 0.0 109.155 176.026 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' E' E ' 51' ' ' VAL . . . . . . . . . . . . . 47.8 t -71.31 -47.88 57.27 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.309 0 CA-C-N 116.158 -0.474 . . . . 0.0 110.125 -174.266 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' E' E ' 52' ' ' GLN . . . . . . . . . . . . . 48.3 tt0 -164.86 141.58 5.95 Favored 'General case' 0 C--N 1.332 -0.169 0 C-N-CA 120.128 -0.629 . . . . 0.0 111.693 -178.338 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' E' E ' 53' ' ' ALA . . . . . 0.418 ' HB3' ' OG ' ' E' ' 56' ' ' SER . . . -115.0 133.11 56.32 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 115.764 -0.653 . . . . 0.0 110.001 176.5 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' E' E ' 54' ' ' TYR . . . . . . . . . . . . . 13.7 t80 -129.19 110.89 18.14 Favored Pre-proline 0 CA--C 1.534 0.364 0 CA-C-O 118.198 -0.906 . . . . 0.0 110.358 178.556 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' E' E ' 55' ' ' PRO . . . . . . . . . . . . . 72.3 Cg_endo -77.28 170.13 72.23 Favored 'Cis proline' 0 N--CA 1.5 1.862 0 CA-C-N 122.062 1.772 . . . . 0.0 112.075 -6.444 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' E' E ' 56' ' ' SER . . . . . 0.418 ' OG ' ' HB3' ' E' ' 53' ' ' ALA . 48.8 m -123.18 139.09 30.97 Favored Pre-proline 0 CA--C 1.538 0.485 0 CA-C-O 118.501 -0.761 . . . . 0.0 109.505 174.758 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' E' E ' 57' ' ' PRO . . . . . . . . . . . . . 36.7 Cg_endo -67.07 144.29 69.51 Favored 'Cis proline' 0 N--CA 1.499 1.849 0 CA-C-N 121.764 1.666 . . . . 0.0 111.489 -3.54 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' E' E ' 58' ' ' LEU . . . . . . . . . . . . . 19.6 tp -108.37 136.33 48.18 Favored 'General case' 0 C--N 1.331 -0.239 0 CA-C-N 116.313 -0.403 . . . . 0.0 111.024 -176.905 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' E' E ' 59' ' ' ARG . . . . . . . . . . . . . 74.5 ttt180 -103.63 123.78 47.62 Favored 'General case' 0 C--N 1.329 -0.32 0 N-CA-C 108.823 -0.806 . . . . 0.0 108.823 173.04 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' E' E ' 60' ' ' VAL . . . . . . . . . . . . . 43.9 t -81.67 123.02 37.51 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.258 0 C-N-CA 120.475 -0.49 . . . . 0.0 110.58 -173.367 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' E' E ' 61' ' ' GLU . . . . . . . . . . . . . 70.6 mm-40 -131.09 165.06 24.09 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 115.824 -0.625 . . . . 0.0 109.727 176.471 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' E' E ' 62' ' ' ASP . . . . . . . . . . . . . 11.7 t0 -52.62 -30.83 33.49 Favored 'General case' 0 C--N 1.328 -0.338 0 N-CA-C 111.983 0.364 . . . . 0.0 111.983 -179.822 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' E' E ' 63' ' ' ARG . . . . . . . . . . . . . 90.8 mtt-85 -71.78 -22.01 61.64 Favored 'General case' 0 CA--C 1.533 0.302 0 N-CA-C 112.829 0.677 . . . . 0.0 112.829 -176.309 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' E' E ' 64' ' ' THR . . . . . . . . . . . . . 27.3 m -73.03 136.82 45.08 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-O 120.844 0.354 . . . . 0.0 111.203 -174.246 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' E' E ' 65' ' ' LYS . . . . . . . . . . . . . 57.2 mtmt -90.08 132.61 35.32 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 115.956 -0.566 . . . . 0.0 110.454 177.946 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' E' E ' 66' ' ' ILE . . . . . . . . . . . . . 66.4 mt -112.62 128.2 69.43 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.283 0 N-CA-C 109.571 -0.529 . . . . 0.0 109.571 178.837 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' E' E ' 67' ' ' THR . . . . . . . . . . . . . 21.9 m -122.85 144.67 49.05 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-O 121.219 0.533 . . . . 0.0 111.317 -175.425 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' E' E ' 68' ' ' LEU . . . . . 0.452 ' C ' HD23 ' E' ' 68' ' ' LEU . 6.2 tt . . . . . 0 C--N 1.33 -0.281 0 CA-C-N 115.601 -0.727 . . . . 0.0 109.96 178.698 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' E' E ' 73' ' ' VAL . . . . . . . . . . . . . 27.0 m . . . . . 0 N--CA 1.461 0.112 0 CA-C-O 121.078 0.466 . . . . 0.0 110.564 . . . . . . . . . 0 0 . 1 . 013 nuclear nobuild core ' E' E ' 74' ' ' ASP . . . . . . . . . . . . . 19.2 t0 -98.88 117.77 34.14 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 115.729 -0.669 . . . . 0.0 109.514 178.306 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' E' E ' 75' ' ' VAL . . . . . . . . . . . . . 43.3 t -109.0 119.34 58.38 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.251 0 CA-C-O 121.034 0.445 . . . . 0.0 110.279 -178.235 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' E' E ' 76' ' ' LEU . . . . . . . . . . . . . 28.7 mt -119.77 143.24 47.93 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 115.653 -0.703 . . . . 0.0 109.731 178.254 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' E' E ' 77' ' ' GLU . . . . . . . . . . . . . 97.2 mt-10 -134.86 129.38 34.35 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-O 121.071 0.463 . . . . 0.0 111.011 -178.294 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' E' E ' 78' ' ' ALA . . . . . . . . . . . . . . . -115.1 127.11 55.39 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 115.707 -0.679 . . . . 0.0 109.531 177.121 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' E' E ' 79' ' ' LYS . . . . . 0.545 ' O ' HD13 ' E' ' 80' ' ' ILE . 95.4 mttt -75.18 117.7 17.3 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-O 121.014 0.435 . . . . 0.0 110.747 -177.793 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' E' E ' 80' ' ' ILE . . . . . 0.545 HD13 ' O ' ' E' ' 79' ' ' LYS . 25.2 mm -139.27 111.23 5.33 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.378 0 N-CA-C 108.918 -0.771 . . . . 0.0 108.918 -178.601 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' E' E ' 81' ' ' LYS . . . . . . . . . . . . . 20.4 pttp -101.55 128.48 47.79 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-O 121.179 0.514 . . . . 0.0 111.402 -176.883 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' E' E ' 82' ' ' GLY . . . . . . . . . . . . . . . 89.19 42.14 5.66 Favored Glycine 0 CA--C 1.527 0.789 0 CA-C-N 115.697 -0.683 . . . . 0.0 111.858 175.6 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' E' E ' 83' ' ' ILE . . . . . . . . . . . . . 68.6 mt -69.37 137.37 24.36 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.337 0 N-CA-C 109.675 -0.491 . . . . 0.0 109.675 176.737 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' E' E ' 84' ' ' LYS . . . . . . . . . . . . . 23.4 ttpp -104.72 -51.73 3.01 Favored 'General case' 0 C--N 1.331 -0.212 0 CA-C-O 120.935 0.398 . . . . 0.0 110.252 179.968 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' E' E ' 85' ' ' ASP . . . . . . . . . . . . . 11.3 t70 -147.88 148.73 31.16 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 115.988 -0.551 . . . . 0.0 110.525 -178.865 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' E' E ' 86' ' ' VAL . . . . . . . . . . . . . 43.3 t -130.37 133.58 63.67 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.212 0 CA-C-O 120.984 0.421 . . . . 0.0 110.621 -179.498 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' E' E ' 87' ' ' ILE . . . . . . . . . . . . . 43.3 mm -119.31 122.87 70.16 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 CA-C-N 115.769 -0.651 . . . . 0.0 109.374 176.532 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' E' E ' 88' ' ' LEU . . . . . . . . . . . . . 60.4 mt -113.4 133.06 55.37 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-O 120.962 0.41 . . . . 0.0 111.312 -176.86 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' E' E ' 89' ' ' ASP . . . . . . . . . . . . . 6.5 t0 -134.2 157.56 45.93 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 115.821 -0.627 . . . . 0.0 109.72 176.627 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' E' E ' 90' ' ' GLU . . . . . . . . . . . . . 82.6 tt0 -46.41 -39.08 9.9 Favored 'General case' 0 C--N 1.329 -0.287 0 N-CA-C 113.295 0.85 . . . . 0.0 113.295 -170.588 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' E' E ' 91' ' ' ASN . . . . . . . . . . . . . 44.2 t30 -124.54 11.64 8.6 Favored 'General case' 0 N--CA 1.469 0.499 0 N-CA-C 113.528 0.936 . . . . 0.0 113.528 -174.231 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' E' E ' 92' ' ' LEU . . . . . . . . . . . . . 18.5 mt -148.22 143.48 27.04 Favored 'General case' 0 C--N 1.333 -0.141 0 CA-C-N 117.941 0.337 . . . . 0.0 110.36 -176.322 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' E' E ' 93' ' ' ILE . . . . . . . . . . . . . 70.1 mt -123.98 117.37 50.73 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.294 0 N-CA-C 109.222 -0.658 . . . . 0.0 109.222 176.724 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' E' E ' 94' ' ' VAL . . . . . . . . . . . . . 44.5 t -116.59 125.99 73.83 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.281 0 N-CA-C 109.791 -0.448 . . . . 0.0 109.791 -179.44 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' E' E ' 95' ' ' VAL . . . . . . . . . . . . . 43.4 t -118.81 133.45 65.61 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.34 0 CA-C-N 115.987 -0.552 . . . . 0.0 109.83 -179.601 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' E' E ' 96' ' ' ILE . . . . . 0.434 HD11 ' HB ' ' E' ' 123' ' ' VAL . 68.7 mt -114.17 127.11 71.74 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.305 0 N-CA-C 109.255 -0.646 . . . . 0.0 109.255 178.085 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' E' E ' 97' ' ' THR . . . . . . . . . . . . . 76.4 p -99.59 158.94 15.4 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-O 121.207 0.527 . . . . 0.0 111.117 -177.242 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' E' E ' 98' ' ' GLU . . . . . . . . . . . . . 96.8 mt-10 -53.82 -25.69 20.65 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.079 -0.509 . . . . 0.0 112.181 179.296 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' E' E ' 99' ' ' GLU . . . . . . . . . . . . . 34.7 tt0 -79.34 15.29 1.27 Allowed 'General case' 0 CA--C 1.539 0.533 0 N-CA-C 112.623 0.601 . . . . 0.0 112.623 -177.277 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' E' E ' 100' ' ' ASN . . . . . . . . . . . . . 2.8 m-20 61.16 37.94 17.21 Favored 'General case' 0 CA--C 1.53 0.186 0 O-C-N 121.815 -0.553 . . . . 0.0 110.936 178.752 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' E' E ' 101' ' ' GLU . . . . . . . . . . . . . 84.0 tt0 -115.27 145.11 42.78 Favored 'General case' 0 C--N 1.332 -0.182 0 CA-C-N 116.023 -0.535 . . . . 0.0 109.8 176.89 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' E' E ' 102' ' ' VAL . . . . . . . . . . . . . 45.5 t -115.02 124.22 71.46 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.331 0 CA-C-N 116.121 -0.491 . . . . 0.0 109.867 -178.251 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' E' E ' 103' ' ' LEU . . . . . . . . . . . . . 22.3 mt -118.48 128.16 54.32 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 115.8 -0.636 . . . . 0.0 110.144 176.667 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' E' E ' 104' ' ' ILE . . . . . . . . . . . . . 71.5 mt -118.42 122.28 69.14 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.257 0 N-CA-C 110.284 -0.265 . . . . 0.0 110.284 -179.652 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' E' E ' 105' ' ' PHE . . . . . . . . . . . . . 71.3 m-85 -120.79 165.84 14.58 Favored 'General case' 0 C--N 1.332 -0.161 0 O-C-N 124.035 0.835 . . . . 0.0 110.265 -179.985 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' E' E ' 106' ' ' ASN . . . . . . . . . . . . . 53.4 p-10 -99.35 -169.98 1.84 Allowed 'General case' 0 C--N 1.331 -0.236 0 N-CA-C 109.826 -0.435 . . . . 0.0 109.826 172.731 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' E' E ' 107' ' ' GLN . . . . . . . . . . . . . 38.7 tp60 -57.45 -27.77 62.75 Favored 'General case' 0 CA--C 1.534 0.334 0 N-CA-C 112.193 0.442 . . . . 0.0 112.193 -177.889 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' E' E ' 108' ' ' ASN . . . . . . . . . . . . . 9.1 t-20 -93.68 14.34 19.38 Favored 'General case' 0 CA--C 1.534 0.351 0 N-CA-C 113.136 0.791 . . . . 0.0 113.136 -175.453 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' E' E ' 109' ' ' LEU . . . . . . . . . . . . . 72.5 mt 58.72 35.81 24.57 Favored 'General case' 0 CA--C 1.53 0.176 0 CA-C-O 120.881 0.372 . . . . 0.0 111.55 179.494 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' E' E ' 110' ' ' GLU . . . . . . . . . . . . . 95.9 mt-10 -99.26 148.19 24.39 Favored 'General case' 0 C--N 1.33 -0.282 0 N-CA-C 109.774 -0.454 . . . . 0.0 109.774 175.894 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' E' E ' 111' ' ' GLU . . . . . . . . . . . . . 57.1 tt0 -79.9 122.86 27.2 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.399 -0.364 . . . . 0.0 111.016 -176.273 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' E' E ' 112' ' ' LEU . . . . . . . . . . . . . 17.0 mt -109.89 -45.98 3.55 Favored 'General case' 0 C--N 1.331 -0.202 0 CA-C-N 116.207 -0.451 . . . . 0.0 110.616 177.584 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' E' E ' 113' ' ' TYR . . . . . . . . . . . . . 53.2 t80 -138.47 135.5 35.23 Favored 'General case' 0 C--N 1.331 -0.238 0 C-N-CA 120.837 -0.345 . . . . 0.0 111.079 -179.318 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' E' E ' 114' ' ' ARG . . . . . . . . . . . . . 61.3 ttp180 -136.19 123.45 21.83 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-N 116.228 -0.442 . . . . 0.0 110.373 178.047 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' E' E ' 115' ' ' GLY . . . . . . . . . . . . . . . -150.14 158.91 27.88 Favored Glycine 0 CA--C 1.526 0.726 0 N-CA-C 111.181 -0.768 . . . . 0.0 111.181 177.956 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' E' E ' 116' ' ' LYS . . . . . . . . . . . . . 39.5 ttpt -127.75 137.46 52.44 Favored 'General case' 0 C--N 1.331 -0.238 0 N-CA-C 109.497 -0.557 . . . . 0.0 109.497 175.105 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' E' E ' 117' ' ' PHE . . . . . . . . . . . . . 37.1 m-85 -139.75 113.89 8.95 Favored 'General case' 0 C--N 1.331 -0.209 0 C-N-CA 120.697 -0.401 . . . . 0.0 110.214 -177.094 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' E' E ' 118' ' ' GLU . . . . . . . . . . . . . 96.1 mt-10 -56.86 -43.92 81.66 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.398 -0.364 . . . . 0.0 110.891 -176.67 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' E' E ' 119' ' ' ASN . . . . . . . . . . . . . 79.0 m-20 -93.87 28.66 2.32 Favored 'General case' 0 C--N 1.329 -0.299 0 N-CA-C 112.312 0.486 . . . . 0.0 112.312 -174.943 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' E' E ' 120' ' ' LEU . . . . . . . . . . . . . 18.6 tp -59.3 123.46 16.79 Favored 'General case' 0 C--N 1.333 -0.122 0 N-CA-C 109.945 -0.391 . . . . 0.0 109.945 177.645 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' E' E ' 121' ' ' ASN . . . . . . . . . . . . . 67.3 m-80 -114.13 -43.92 3.19 Favored 'General case' 0 C--N 1.332 -0.19 0 CA-C-N 116.509 -0.314 . . . . 0.0 110.953 -177.526 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' E' E ' 122' ' ' LYS . . . . . . . . . . . . . 98.6 mttt -144.03 148.05 34.69 Favored 'General case' 0 C--N 1.332 -0.195 0 CA-C-O 121.089 0.471 . . . . 0.0 111.714 -177.109 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' E' E ' 123' ' ' VAL . . . . . 0.434 ' HB ' HD11 ' E' ' 96' ' ' ILE . 45.8 t -127.95 129.97 69.82 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.341 0 N-CA-C 109.183 -0.673 . . . . 0.0 109.183 173.528 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' E' E ' 124' ' ' LEU . . . . . . . . . . . . . 28.2 mt -129.31 137.74 51.19 Favored 'General case' 0 N--CA 1.463 0.206 0 CA-C-O 121.047 0.451 . . . . 0.0 111.036 -176.147 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' E' E ' 125' ' ' VAL . . . . . . . . . . . . . 41.4 t -124.71 129.46 73.63 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.225 0 CA-C-N 115.77 -0.65 . . . . 0.0 109.922 179.725 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' E' E ' 126' ' ' ARG . . . . . . . . . . . . . 43.4 mmm-85 -140.61 115.32 9.56 Favored 'General case' 0 C--N 1.329 -0.298 0 N-CA-C 109.416 -0.587 . . . . 0.0 109.416 177.869 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' E' E ' 127' ' ' ASN . . . . . . . . . . . . . 78.5 m-20 56.02 -149.84 0.45 Allowed 'General case' 0 CA--C 1.541 0.629 0 N-CA-C 109.838 -0.43 . . . . 0.0 109.838 -179.93 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' E' E ' 128' ' ' ASP . . . . . . . . . . . . . 38.4 p30 -80.01 14.19 1.93 Allowed 'General case' 0 CA--C 1.535 0.39 0 N-CA-C 112.932 0.716 . . . . 0.0 112.932 179.136 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' E' E ' 129' ' ' LEU . . . . . . . . . . . . . 14.3 tp -111.93 136.46 51.22 Favored 'General case' 0 C--O 1.232 0.141 0 N-CA-C 109.688 -0.486 . . . . 0.0 109.688 177.289 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' E' E ' 130' ' ' VAL . . . . . 0.52 HG13 ' HB ' ' E' ' 141' ' ' ILE . 11.3 p -129.09 140.75 48.4 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.254 0 CA-C-O 120.934 0.397 . . . . 0.0 110.341 -177.924 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' E' E ' 131' ' ' VAL . . . . . . . . . . . . . 35.1 m -136.05 145.1 31.56 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.252 0 CA-C-O 121.237 0.541 . . . . 0.0 111.292 -179.096 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' E' E ' 132' ' ' ILE . . . . . . . . . . . . . 72.5 mt -118.94 133.69 64.98 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.32 0 CA-C-N 115.269 -0.878 . . . . 0.0 109.243 179.986 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' E' E ' 133' ' ' ILE . . . . . . . . . . . . . 39.5 mm -115.37 119.84 62.96 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.274 0 CA-C-O 120.722 0.296 . . . . 0.0 110.885 -175.399 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' E' E ' 134' ' ' ASP . . . . . . . . . . . . . 9.5 p-10 -131.79 148.26 52.55 Favored 'General case' 0 C--N 1.332 -0.173 0 N-CA-C 109.542 -0.54 . . . . 0.0 109.542 175.221 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' E' E ' 135' ' ' GLU . . . . . . . . . . . . . 84.8 tt0 -49.87 -27.61 5.4 Favored 'General case' 0 C--N 1.326 -0.422 0 N-CA-C 112.796 0.665 . . . . 0.0 112.796 -172.567 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' E' E ' 136' ' ' GLN . . . . . . . . . . . . . 98.4 mt-30 -81.85 -34.45 30.11 Favored 'General case' 0 C--N 1.33 -0.249 0 N-CA-C 112.746 0.647 . . . . 0.0 112.746 -176.192 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' E' E ' 137' ' ' LYS . . . . . . . . . . . . . 54.1 pttt -167.93 171.53 9.71 Favored 'General case' 0 C--N 1.332 -0.196 0 CA-C-O 121.66 0.743 . . . . 0.0 112.573 -171.131 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' E' E ' 138' ' ' LEU . . . . . 0.582 HD23 ' N ' ' E' ' 139' ' ' THR . 3.4 tt -114.05 127.91 56.15 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 114.73 -1.123 . . . . 0.0 109.679 -179.958 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' E' E ' 139' ' ' THR . . . . . 0.582 ' N ' HD23 ' E' ' 138' ' ' LEU . 30.5 m -108.86 128.02 54.55 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-O 120.715 0.293 . . . . 0.0 110.401 179.219 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' E' E ' 140' ' ' LEU . . . . . 0.48 ' C ' HD23 ' E' ' 140' ' ' LEU . 8.0 tt -117.57 124.34 48.44 Favored 'General case' 0 C--N 1.329 -0.285 0 N-CA-C 109.359 -0.608 . . . . 0.0 109.359 -178.594 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' E' E ' 141' ' ' ILE . . . . . 0.52 ' HB ' HG13 ' E' ' 130' ' ' VAL . 19.5 mt -120.94 121.73 65.87 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.305 0 N-CA-C 109.714 -0.476 . . . . 0.0 109.714 -175.431 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' E' E ' 142' ' ' ARG . . . . . . . . . . . . . 73.7 ttt180 -112.7 130.21 56.13 Favored 'General case' 0 C--N 1.331 -0.208 0 CA-C-N 115.709 -0.678 . . . . 0.0 110.407 -176.89 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' E' E ' 143' ' ' THR . . . . . . . . . . . . . 50.8 p . . . . . 0 C--O 1.22 -0.475 0 CA-C-O 117.997 -1.001 . . . . 0.0 110.603 -179.81 . . . . . . . . 0 0 . 1 . 013 nuclear nobuild core ' F' F ' 1' ' ' MET . . . . . . . . . . . . . 25.6 ptp . . . . . 0 CA--C 1.527 0.06 0 CA-C-O 120.766 0.317 . . . . 0.0 110.615 . . . . . . . . . 0 0 . 1 . 013 nuclear nobuild core ' F' F ' 2' ' ' SER . . . . . . . . . . . . . 3.0 p -110.51 127.54 55.22 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-O 121.134 0.492 . . . . 0.0 110.449 178.916 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' F' F ' 3' ' ' GLU . . . . . . . . . . . . . 84.2 tt0 -140.17 139.14 35.66 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 115.69 -0.687 . . . . 0.0 110.771 -178.827 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' F' F ' 4' ' ' LEU . . . . . . . . . . . . . 19.1 tp -122.13 124.75 44.62 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 115.985 -0.552 . . . . 0.0 110.376 178.497 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' F' F ' 5' ' ' LYS . . . . . . . . . . . . . 97.9 mttt -101.92 118.84 37.75 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.146 -0.479 . . . . 0.0 110.28 177.261 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' F' F ' 6' ' ' LEU . . . . . . . . . . . . . 31.0 mt -114.99 148.28 38.99 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 115.486 -0.779 . . . . 0.0 110.242 -179.07 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' F' F ' 7' ' ' LYS . . . . . . . . . . . . . 52.3 tttp -137.2 140.71 31.84 Favored Pre-proline 0 CA--C 1.534 0.34 0 CA-C-O 119.124 -0.465 . . . . 0.0 110.047 175.433 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' F' F ' 8' ' ' PRO . . . . . . . . . . . . . 89.3 Cg_endo -91.85 139.37 2.17 Favored 'Trans proline' 0 N--CA 1.49 1.293 0 C-N-CA 121.736 1.624 . . . . 0.0 111.745 177.898 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' F' F ' 9' ' ' LEU . . . . . . . . . . . . . 46.1 mt -77.68 -47.66 2.34 Favored Pre-proline 0 CA--C 1.534 0.35 0 CA-C-O 118.682 -0.675 . . . . 0.0 112.237 -179.663 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' F' F ' 10' ' ' PRO . . . . . . . . . . . . . 86.2 Cg_endo -80.6 152.93 20.18 Favored 'Trans proline' 0 N--CA 1.495 1.616 0 C-N-CA 121.185 1.257 . . . . 0.0 111.89 176.064 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' F' F ' 11' ' ' LYS . . . . . . . . . . . . . 60.7 tttm -88.8 93.66 9.66 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-O 120.818 0.342 . . . . 0.0 110.456 179.038 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' F' F ' 12' ' ' VAL . . . . . . . . . . . . . 13.0 p -141.38 143.34 27.86 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.231 0 CA-C-N 116.318 -0.401 . . . . 0.0 110.701 -179.525 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' F' F ' 13' ' ' GLU . . . . . . . . . . . . . 45.9 mp0 -77.67 132.83 38.38 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.29 -0.414 . . . . 0.0 110.255 178.065 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' F' F ' 14' ' ' LEU . . . . . . . . . . . . . 31.0 mt -98.37 147.74 33.55 Favored Pre-proline 0 CA--C 1.533 0.307 0 CA-C-O 119.185 -0.436 . . . . 0.0 110.233 -179.738 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' F' F ' 15' ' ' PRO . . . . . . . . . . . . . 25.8 Cg_exo -62.17 158.95 36.94 Favored 'Trans proline' 0 N--CA 1.498 1.741 0 C-N-CA 121.335 1.356 . . . . 0.0 111.876 176.793 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' F' F ' 16' ' ' PRO . . . . . . . . . . . . . 38.7 Cg_exo -58.56 -41.17 67.31 Favored 'Trans proline' 0 N--CA 1.498 1.785 0 C-N-CA 121.497 1.465 . . . . 0.0 112.808 -177.72 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' F' F ' 17' ' ' ASP . . . . . . . . . . . . . 19.2 p-10 -85.71 9.02 17.55 Favored 'General case' 0 C--N 1.326 -0.414 0 N-CA-C 113.23 0.826 . . . . 0.0 113.23 -177.609 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' F' F ' 18' ' ' PHE . . . . . . . . . . . . . 36.7 t80 -58.34 -45.43 88.14 Favored 'General case' 0 C--N 1.333 -0.114 0 O-C-N 121.998 -0.439 . . . . 0.0 110.152 -177.594 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' F' F ' 19' ' ' VAL . . . . . 0.413 HG13 ' N ' ' F' ' 20' ' ' ASP . 13.6 p -56.69 -41.51 74.63 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.329 0 CA-C-N 116.25 -0.432 . . . . 0.0 110.954 -178.738 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' F' F ' 20' ' ' ASP . . . . . 0.413 ' N ' HG13 ' F' ' 19' ' ' VAL . 30.0 m-20 -60.53 -43.5 97.07 Favored 'General case' 0 C--N 1.331 -0.198 0 C-N-CA 120.937 -0.305 . . . . 0.0 111.12 -178.087 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' F' F ' 21' ' ' VAL . . . . . . . . . . . . . 47.0 t -64.58 -46.11 93.52 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.255 0 C-N-CA 120.834 -0.346 . . . . 0.0 110.519 -177.498 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' F' F ' 22' ' ' ILE . . . . . 0.53 HG22 HD12 ' F' ' 26' ' ' LEU . 51.5 mm -57.46 -41.05 77.93 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.288 0 C-N-CA 121.089 -0.244 . . . . 0.0 110.628 179.418 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' F' F ' 23' ' ' ARG . . . . . . . . . . . . . 32.0 ttp180 -56.14 -48.29 76.55 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-O 120.945 0.402 . . . . 0.0 110.718 178.04 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' F' F ' 24' ' ' ILE . . . . . . . . . . . . . 73.0 mt -61.66 -42.48 94.38 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.306 0 CA-C-N 116.014 -0.539 . . . . 0.0 111.941 -177.969 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' F' F ' 25' ' ' LYS . . . . . . . . . . . . . 16.4 pttp -73.58 -35.07 65.4 Favored 'General case' 0 CA--C 1.533 0.314 0 C-N-CA 120.537 -0.465 . . . . 0.0 111.801 -173.326 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' F' F ' 26' ' ' LEU . . . . . 0.53 HD12 HG22 ' F' ' 22' ' ' ILE . 64.5 mt -79.07 -43.06 24.94 Favored 'General case' 0 C--N 1.33 -0.258 0 N-CA-C 112.971 0.73 . . . . 0.0 112.971 -174.528 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' F' F ' 27' ' ' GLN . . . . . . . . . . . . . 10.6 pt20 -46.73 139.67 5.12 Favored 'General case' 0 N--CA 1.469 0.505 0 N-CA-C 112.884 0.698 . . . . 0.0 112.884 -174.54 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' F' F ' 28' ' ' GLY . . . . . . . . . . . . . . . 100.31 -29.99 11.1 Favored Glycine 0 CA--C 1.529 0.948 0 CA-C-N 115.471 -0.786 . . . . 0.0 111.971 -177.915 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' F' F ' 29' ' ' LYS . . . . . . . . . . . . . 98.1 mttt -98.09 155.2 17.25 Favored 'General case' 0 C--O 1.233 0.19 0 CA-C-O 121.061 0.458 . . . . 0.0 111.035 177.988 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' F' F ' 30' ' ' THR . . . . . . . . . . . . . 23.9 m -103.91 139.43 39.09 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.019 -0.537 . . . . 0.0 109.994 175.816 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' F' F ' 31' ' ' VAL . . . . . . . . . . . . . 34.9 m -127.34 157.61 38.93 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.288 0 CA-C-N 116.254 -0.43 . . . . 0.0 110.514 -179.125 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' F' F ' 32' ' ' ARG . . . . . . . . . . . . . 56.3 ttp180 -133.77 151.92 51.73 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-O 121.178 0.514 . . . . 0.0 110.612 179.569 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' F' F ' 33' ' ' THR . . . . . . . . . . . . . 20.7 m -53.09 138.43 31.06 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 116.221 -0.445 . . . . 0.0 111.406 -178.489 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' F' F ' 34' ' ' GLY . . . . . . . . . . . . . . . 100.84 -17.08 56.9 Favored Glycine 0 CA--C 1.534 1.223 0 CA-C-O 119.584 -0.565 . . . . 0.0 113.262 179.16 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' F' F ' 35' ' ' ASP . . . . . . . . . . . . . 63.2 m-20 -65.13 149.45 49.88 Favored 'General case' 0 N--CA 1.461 0.096 0 CA-C-N 118.006 0.903 . . . . 0.0 111.308 179.602 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' F' F ' 36' ' ' VAL . . . . . . . . . . . . . 45.8 t -125.15 129.63 73.2 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.196 0 CA-C-N 115.686 -0.688 . . . . 0.0 109.71 178.399 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' F' F ' 37' ' ' ILE . . . . . . . . . . . . . 68.4 mt -122.29 138.92 50.85 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.265 0 N-CA-C 109.839 -0.43 . . . . 0.0 109.839 -179.948 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' F' F ' 38' ' ' GLY . . . . . . . . . . . . . . . -111.07 128.87 8.93 Favored Glycine 0 CA--C 1.524 0.654 0 N-CA-C 111.191 -0.764 . . . . 0.0 111.191 -179.372 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' F' F ' 39' ' ' ILE . . . . . . . . . . . . . 72.4 mt -122.57 136.47 59.28 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.215 0 N-CA-C 109.902 -0.407 . . . . 0.0 109.902 179.014 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' F' F ' 40' ' ' SER . . . . . 0.518 ' O ' HD13 ' F' ' 41' ' ' ILE . 21.8 t -92.74 118.32 30.95 Favored 'General case' 0 C--N 1.33 -0.25 0 C-N-CA 120.956 -0.298 . . . . 0.0 110.802 176.26 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' F' F ' 41' ' ' ILE . . . . . 0.518 HD13 ' O ' ' F' ' 40' ' ' SER . 47.8 mm -128.77 115.77 38.38 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.207 0 CA-C-O 120.811 0.339 . . . . 0.0 110.273 178.331 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' F' F ' 42' ' ' LEU . . . . . . . . . . . . . 11.4 tp 57.14 37.16 28.34 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 116.137 -0.483 . . . . 0.0 111.386 178.428 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' F' F ' 43' ' ' GLY . . . . . . . . . . . . . . . 77.67 -10.09 26.21 Favored Glycine 0 CA--C 1.534 1.268 0 C-N-CA 121.316 -0.469 . . . . 0.0 113.5 177.074 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' F' F ' 44' ' ' LYS . . . . . . . . . . . . . 38.7 mmtm -97.52 135.5 39.27 Favored 'General case' 0 C--N 1.332 -0.193 0 CA-C-N 117.966 0.883 . . . . 0.0 110.17 177.277 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' F' F ' 45' ' ' GLU . . . . . . . . . . . . . 82.7 tt0 -84.65 125.99 32.96 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.358 -0.383 . . . . 0.0 110.819 179.873 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' F' F ' 46' ' ' VAL . . . . . . . . . . . . . 7.3 p -119.34 126.44 75.34 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.159 0 N-CA-C 109.437 -0.579 . . . . 0.0 109.437 176.135 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' F' F ' 47' ' ' LYS . . . . . . . . . . . . . 60.4 mttp -100.1 127.46 46.33 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 115.865 -0.607 . . . . 0.0 111.007 178.806 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' F' F ' 48' ' ' PHE . . . . . . . . . . . . . 93.9 m-85 -109.89 131.91 54.64 Favored 'General case' 0 C--N 1.33 -0.262 0 N-CA-C 109.817 -0.438 . . . . 0.0 109.817 175.925 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' F' F ' 49' ' ' LYS . . . . . . . . . . . . . 53.7 tttp -108.44 138.83 44.09 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.406 -0.361 . . . . 0.0 110.349 179.128 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' F' F ' 50' ' ' VAL . . . . . . . . . . . . . 45.2 t -81.77 108.69 15.13 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.257 0 N-CA-C 109.384 -0.598 . . . . 0.0 109.384 176.226 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' F' F ' 51' ' ' VAL . . . . . . . . . . . . . 48.5 t -74.89 -48.06 34.66 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.276 0 CA-C-N 115.988 -0.551 . . . . 0.0 110.068 -174.015 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' F' F ' 52' ' ' GLN . . . . . . . . . . . . . 62.6 tt0 -158.7 133.94 8.52 Favored 'General case' 0 C--N 1.331 -0.23 0 C-N-CA 120.241 -0.584 . . . . 0.0 111.811 -177.518 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' F' F ' 53' ' ' ALA . . . . . 0.481 ' HB1' ' HB2' ' F' ' 58' ' ' LEU . . . -108.22 127.29 53.71 Favored 'General case' 0 C--N 1.332 -0.185 0 CA-C-N 115.667 -0.697 . . . . 0.0 109.644 174.395 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' F' F ' 54' ' ' TYR . . . . . . . . . . . . . 56.5 t80 -123.38 107.45 32.24 Favored Pre-proline 0 CA--C 1.534 0.346 0 CA-C-O 118.304 -0.855 . . . . 0.0 110.643 -178.606 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' F' F ' 55' ' ' PRO . . . . . . . . . . . . . 74.0 Cg_endo -76.96 169.86 73.28 Favored 'Cis proline' 0 N--CA 1.5 1.887 0 CA-C-N 121.725 1.652 . . . . 0.0 112.434 -5.681 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' F' F ' 56' ' ' SER . . . . . . . . . . . . . 25.1 m -108.52 124.55 34.1 Favored Pre-proline 0 CA--C 1.538 0.51 0 CA-C-O 118.372 -0.823 . . . . 0.0 109.561 175.819 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' F' F ' 57' ' ' PRO . . . . . . . . . . . . . 48.1 Cg_endo -70.19 166.66 74.6 Favored 'Cis proline' 0 N--CA 1.498 1.771 0 CA-C-N 122.106 1.788 . . . . 0.0 111.824 0.391 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' F' F ' 58' ' ' LEU . . . . . 0.481 ' HB2' ' HB1' ' F' ' 53' ' ' ALA . 24.2 tp -129.09 135.37 48.81 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.137 -0.483 . . . . 0.0 110.296 -179.926 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' F' F ' 59' ' ' ARG . . . . . . . . . . . . . 52.1 ttp180 -104.56 131.87 51.46 Favored 'General case' 0 C--N 1.327 -0.4 0 N-CA-C 109.68 -0.489 . . . . 0.0 109.68 178.749 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' F' F ' 60' ' ' VAL . . . . . . . . . . . . . 45.3 t -86.2 123.22 39.45 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.214 0 C-N-CA 120.671 -0.411 . . . . 0.0 110.404 -175.469 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' F' F ' 61' ' ' GLU . . . . . . . . . . . . . 95.3 mt-10 -131.06 166.26 21.43 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 115.942 -0.572 . . . . 0.0 110.14 177.806 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' F' F ' 62' ' ' ASP . . . . . . . . . . . . . 64.0 m-20 -54.92 -32.75 61.5 Favored 'General case' 0 C--N 1.327 -0.382 0 C-N-CA 121.096 -0.242 . . . . 0.0 111.604 179.536 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' F' F ' 63' ' ' ARG . . . . . . . . . . . . . 10.3 ptm180 -87.78 6.91 32.88 Favored 'General case' 0 CA--C 1.537 0.446 0 N-CA-C 113.59 0.959 . . . . 0.0 113.59 -176.73 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' F' F ' 64' ' ' THR . . . . . . . . . . . . . 11.8 m -82.41 139.98 33.72 Favored 'General case' 0 C--N 1.333 -0.137 0 CA-C-N 118.051 0.387 . . . . 0.0 110.655 -177.967 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' F' F ' 65' ' ' LYS . . . . . . . . . . . . . 97.9 mttt -89.15 125.05 34.89 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.085 179.21 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' F' F ' 66' ' ' ILE . . . . . . . . . . . . . 59.4 mt -116.36 127.93 73.83 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.262 0 N-CA-C 109.679 -0.489 . . . . 0.0 109.679 179.0 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' F' F ' 67' ' ' THR . . . . . . . . . . . . . 25.1 m -129.13 145.63 51.25 Favored 'General case' 0 C--N 1.331 -0.214 0 CA-C-O 121.112 0.482 . . . . 0.0 111.42 -176.658 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' F' F ' 68' ' ' LEU . . . . . . . . . . . . . 15.5 tp . . . . . 0 C--N 1.33 -0.243 0 CA-C-N 115.79 -0.641 . . . . 0.0 109.527 175.899 . . . . . . . . 0 0 . 1 . 013 nuclear nobuild core ' F' F ' 73' ' ' VAL . . . . . . . . . . . . . 35.8 m . . . . . 0 C--O 1.232 0.137 0 N-CA-C 109.694 -0.484 . . . . 0.0 109.694 . . . . . . . . . 0 0 . 1 . 013 nuclear nobuild core ' F' F ' 74' ' ' ASP . . . . . . . . . . . . . 7.2 t70 -90.64 115.17 27.54 Favored 'General case' 0 C--N 1.331 -0.226 0 C-N-CA 120.645 -0.422 . . . . 0.0 110.31 -173.593 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' F' F ' 75' ' ' VAL . . . . . . . . . . . . . 44.5 t -114.89 120.45 64.55 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.228 0 CA-C-O 121.038 0.447 . . . . 0.0 110.085 -179.272 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' F' F ' 76' ' ' LEU . . . . . . . . . . . . . 20.6 mt -124.47 144.29 50.17 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 115.662 -0.699 . . . . 0.0 109.717 179.34 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' F' F ' 77' ' ' GLU . . . . . . . . . . . . . 46.6 mt-10 -134.11 135.86 43.48 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-O 121.073 0.463 . . . . 0.0 111.286 -177.761 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' F' F ' 78' ' ' ALA . . . . . . . . . . . . . . . -122.64 127.71 49.7 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 115.483 -0.78 . . . . 0.0 109.457 175.712 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' F' F ' 79' ' ' LYS . . . . . 0.651 ' O ' HD13 ' F' ' 80' ' ' ILE . 37.7 tttp -79.79 120.29 23.86 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-O 120.993 0.425 . . . . 0.0 110.828 -175.785 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' F' F ' 80' ' ' ILE . . . . . 0.651 HD13 ' O ' ' F' ' 79' ' ' LYS . 37.5 mm -139.3 108.85 3.84 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.291 0 N-CA-C 108.983 -0.747 . . . . 0.0 108.983 -179.289 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' F' F ' 81' ' ' LYS . . . . . . . . . . . . . 39.7 ttpt -99.26 123.69 43.74 Favored 'General case' 0 C--N 1.329 -0.298 0 C-N-CA 120.862 -0.335 . . . . 0.0 110.97 -176.236 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' F' F ' 82' ' ' GLY . . . . . . . . . . . . . . . 89.21 42.18 5.64 Favored Glycine 0 CA--C 1.525 0.708 0 C-N-CA 120.7 -0.762 . . . . 0.0 111.677 176.368 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' F' F ' 83' ' ' ILE . . . . . . . . . . . . . 75.3 mt -67.2 140.31 19.57 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.338 0 N-CA-C 109.875 -0.417 . . . . 0.0 109.875 177.603 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' F' F ' 84' ' ' LYS . . . . . . . . . . . . . 47.0 tttp -100.82 -53.94 2.94 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.029 -0.532 . . . . 0.0 110.654 -178.644 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' F' F ' 85' ' ' ASP . . . . . . . . . . . . . 13.5 t70 -146.22 149.43 33.9 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 115.916 -0.584 . . . . 0.0 110.705 -178.095 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' F' F ' 86' ' ' VAL . . . . . . . . . . . . . 41.3 t -128.51 127.56 67.09 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.221 0 CA-C-O 120.815 0.341 . . . . 0.0 110.364 -179.782 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' F' F ' 87' ' ' ILE . . . . . . . . . . . . . 44.4 mm -120.84 130.39 74.67 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.223 0 CA-C-N 116.071 -0.513 . . . . 0.0 109.923 178.674 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' F' F ' 88' ' ' LEU . . . . . . . . . . . . . 27.1 mt -115.47 137.4 52.09 Favored 'General case' 0 C--N 1.332 -0.182 0 CA-C-O 120.951 0.405 . . . . 0.0 111.069 -178.946 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' F' F ' 89' ' ' ASP . . . . . . . . . . . . . 7.4 t70 -135.31 162.19 33.28 Favored 'General case' 0 C--N 1.331 -0.239 0 CA-C-N 115.999 -0.546 . . . . 0.0 110.084 177.335 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' F' F ' 90' ' ' GLU . . . . . . . . . . . . . 96.4 mt-10 -45.15 -48.14 12.27 Favored 'General case' 0 N--CA 1.465 0.307 0 N-CA-C 113.149 0.796 . . . . 0.0 113.149 -171.263 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' F' F ' 91' ' ' ASN . . . . . . . . . . . . . 21.0 t-20 -132.04 39.91 3.39 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-O 120.974 0.416 . . . . 0.0 110.861 -177.606 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' F' F ' 92' ' ' LEU . . . . . . . . . . . . . 10.7 tp -163.45 138.01 6.14 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.355 -0.384 . . . . 0.0 110.89 -177.539 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' F' F ' 93' ' ' ILE . . . . . . . . . . . . . 69.0 mt -122.3 124.81 71.79 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.311 0 N-CA-C 109.226 -0.657 . . . . 0.0 109.226 177.29 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' F' F ' 94' ' ' VAL . . . . . . . . . . . . . 45.8 t -123.54 128.62 74.68 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.258 0 CA-C-O 120.983 0.42 . . . . 0.0 110.069 -178.931 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' F' F ' 95' ' ' VAL . . . . . . . . . . . . . 44.4 t -121.58 134.76 63.89 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.314 0 CA-C-N 115.921 -0.581 . . . . 0.0 109.724 178.958 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' F' F ' 96' ' ' ILE . . . . . . . . . . . . . 61.6 mt -114.47 127.71 71.83 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.354 0 N-CA-C 109.146 -0.687 . . . . 0.0 109.146 178.493 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' F' F ' 97' ' ' THR . . . . . . . . . . . . . 58.3 p -98.5 159.5 14.91 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-O 121.102 0.477 . . . . 0.0 111.177 -177.498 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' F' F ' 98' ' ' GLU . . . . . . . . . . . . . 80.4 tt0 -53.88 -28.16 34.55 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.171 -0.468 . . . . 0.0 112.092 -179.622 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' F' F ' 99' ' ' GLU . . . . . . . . . . . . . 95.6 mt-10 -79.96 16.5 1.17 Allowed 'General case' 0 CA--C 1.535 0.392 0 N-CA-C 113.043 0.757 . . . . 0.0 113.043 -177.263 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' F' F ' 100' ' ' ASN . . . . . . . . . . . . . 4.2 m-20 62.48 38.04 12.95 Favored 'General case' 0 CA--C 1.53 0.198 0 CA-C-O 121.009 0.433 . . . . 0.0 111.072 177.757 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' F' F ' 101' ' ' GLU . . . . . . . . . . . . . 83.6 tt0 -111.8 144.05 41.74 Favored 'General case' 0 C--N 1.332 -0.186 0 CA-C-N 116.004 -0.544 . . . . 0.0 109.775 175.891 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' F' F ' 102' ' ' VAL . . . . . . . . . . . . . 42.7 t -115.02 125.09 72.24 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.293 0 N-CA-C 109.798 -0.445 . . . . 0.0 109.798 -178.67 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' F' F ' 103' ' ' LEU . . . . . . . . . . . . . 44.1 mt -118.3 131.63 56.33 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 115.725 -0.67 . . . . 0.0 110.046 178.395 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' F' F ' 104' ' ' ILE . . . . . 0.614 HD13 HG11 ' F' ' 130' ' ' VAL . 67.3 mt -121.09 123.09 69.25 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.245 0 CA-C-O 120.66 0.266 . . . . 0.0 110.374 -179.787 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' F' F ' 105' ' ' PHE . . . . . . . . . . . . . 48.7 m-85 -123.95 167.42 14.17 Favored 'General case' 0 C--N 1.333 -0.122 0 CA-C-N 115.358 -0.837 . . . . 0.0 109.885 178.931 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' F' F ' 106' ' ' ASN . . . . . . . . . . . . . 36.8 p-10 -98.74 -169.97 1.86 Allowed 'General case' 0 C--N 1.331 -0.207 0 N-CA-C 109.866 -0.42 . . . . 0.0 109.866 172.919 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' F' F ' 107' ' ' GLN . . . . . . . . . . . . . 49.2 tt0 -58.6 -30.08 66.94 Favored 'General case' 0 C--N 1.329 -0.31 0 N-CA-C 112.048 0.388 . . . . 0.0 112.048 -179.339 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' F' F ' 108' ' ' ASN . . . . . . . . . . . . . 5.7 t30 -91.33 14.01 15.77 Favored 'General case' 0 CA--C 1.535 0.394 0 N-CA-C 113.153 0.797 . . . . 0.0 113.153 -176.631 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' F' F ' 109' ' ' LEU . . . . . . . . . . . . . 30.7 mt 59.25 34.61 23.12 Favored 'General case' 0 C--N 1.332 -0.167 0 N-CA-C 111.992 0.367 . . . . 0.0 111.992 177.019 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' F' F ' 110' ' ' GLU . . . . . . . . . . . . . 95.9 mt-10 -98.64 136.37 38.81 Favored 'General case' 0 C--N 1.328 -0.338 0 N-CA-C 109.049 -0.723 . . . . 0.0 109.049 173.187 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' F' F ' 111' ' ' GLU . . . . . . . . . . . . . 56.1 tt0 -78.64 121.9 25.27 Favored 'General case' 0 C--N 1.327 -0.401 0 CA-C-O 120.898 0.38 . . . . 0.0 110.743 -173.727 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' F' F ' 112' ' ' LEU . . . . . . . . . . . . . 15.3 mt -103.73 -45.97 4.65 Favored 'General case' 0 C--N 1.331 -0.204 0 CA-C-N 115.868 -0.606 . . . . 0.0 110.703 179.574 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' F' F ' 113' ' ' TYR . . . . . . . . . . . . . 44.5 t80 -136.26 141.88 43.93 Favored 'General case' 0 C--N 1.331 -0.239 0 CA-C-N 116.193 -0.458 . . . . 0.0 111.181 -177.174 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' F' F ' 114' ' ' ARG . . . . . . . . . . . . . 32.3 ptt180 -147.06 123.25 10.86 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.107 -0.497 . . . . 0.0 110.826 176.893 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' F' F ' 115' ' ' GLY . . . . . . . . . . . . . . . -150.09 163.02 29.37 Favored Glycine 0 CA--C 1.523 0.554 0 N-CA-C 110.789 -0.924 . . . . 0.0 110.789 179.472 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' F' F ' 116' ' ' LYS . . . . . . . . . . . . . 38.3 ttpt -130.17 135.77 48.54 Favored 'General case' 0 C--N 1.329 -0.295 0 O-C-N 122.627 -0.337 . . . . 0.0 110.123 179.066 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' F' F ' 117' ' ' PHE . . . . . . . . . . . . . 48.6 m-85 -133.58 114.85 14.01 Favored 'General case' 0 C--N 1.331 -0.206 0 CA-C-O 120.967 0.413 . . . . 0.0 110.176 -176.95 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' F' F ' 118' ' ' GLU . . . . . . . . . . . . . 70.6 mm-40 -54.54 -41.1 69.34 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 116.412 -0.358 . . . . 0.0 111.371 -176.319 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' F' F ' 119' ' ' ASN . . . . . . . . . . . . . 85.6 m-20 -100.73 31.04 3.68 Favored 'General case' 0 C--N 1.33 -0.276 0 N-CA-C 112.176 0.435 . . . . 0.0 112.176 -173.919 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' F' F ' 120' ' ' LEU . . . . . . . . . . . . . 15.0 tp -56.59 119.92 6.91 Favored 'General case' 0 C--N 1.332 -0.19 0 CA-C-O 120.707 0.289 . . . . 0.0 110.379 178.254 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' F' F ' 121' ' ' ASN . . . . . . . . . . . . . 72.9 m-20 -114.15 -44.13 3.16 Favored 'General case' 0 C--N 1.333 -0.141 0 CA-C-N 116.368 -0.378 . . . . 0.0 111.282 -177.647 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' F' F ' 122' ' ' LYS . . . . . . . . . . . . . 53.4 mtmt -145.3 151.27 38.08 Favored 'General case' 0 C--N 1.331 -0.239 0 CA-C-O 121.042 0.449 . . . . 0.0 111.749 -176.234 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' F' F ' 123' ' ' VAL . . . . . . . . . . . . . 46.7 t -130.8 127.97 62.3 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.235 0 CA-C-N 116.01 -0.541 . . . . 0.0 109.545 174.697 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' F' F ' 124' ' ' LEU . . . . . . . . . . . . . 41.2 mt -115.99 136.99 52.52 Favored 'General case' 0 C--N 1.331 -0.196 0 CA-C-N 116.307 -0.406 . . . . 0.0 110.709 -178.736 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' F' F ' 125' ' ' VAL . . . . . . . . . . . . . 35.1 m -128.43 138.16 55.4 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.209 0 CA-C-N 116.265 -0.425 . . . . 0.0 110.817 -179.359 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' F' F ' 126' ' ' ARG . . . . . . . . . . . . . 96.3 mtt-85 -143.9 111.44 5.98 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.102 -0.499 . . . . 0.0 110.38 177.155 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' F' F ' 127' ' ' ASN . . . . . . . . . . . . . 79.1 m-20 53.13 -104.95 0.22 Allowed 'General case' 0 CA--C 1.544 0.722 0 CA-C-O 119.122 -0.466 . . . . 0.0 111.057 -179.847 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' F' F ' 128' ' ' ASP . . . . . . . . . . . . . 12.3 p-10 -113.98 0.17 14.28 Favored 'General case' 0 CA--C 1.536 0.434 0 CA-C-N 119.509 1.049 . . . . 0.0 113.386 -177.531 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' F' F ' 129' ' ' LEU . . . . . 0.458 HD12 ' N ' ' F' ' 129' ' ' LEU . 9.9 mp -105.0 147.84 27.38 Favored 'General case' 0 CA--C 1.523 -0.096 0 N-CA-C 109.669 -0.493 . . . . 0.0 109.669 177.842 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' F' F ' 130' ' ' VAL . . . . . 0.614 HG11 HD13 ' F' ' 104' ' ' ILE . 13.1 p -137.37 145.19 29.88 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.245 0 CA-C-O 121.23 0.538 . . . . 0.0 110.87 -176.757 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' F' F ' 131' ' ' VAL . . . . . . . . . . . . . 44.1 t -134.61 136.97 51.97 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.294 0 CA-C-N 115.722 -0.672 . . . . 0.0 109.869 178.079 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' F' F ' 132' ' ' ILE . . . . . . . . . . . . . 71.1 mt -114.18 132.2 63.92 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.335 0 N-CA-C 109.452 -0.573 . . . . 0.0 109.452 -178.825 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' F' F ' 133' ' ' ILE . . . . . . . . . . . . . 43.0 mm -117.77 121.8 68.28 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.27 0 CA-C-O 120.791 0.329 . . . . 0.0 110.621 -176.041 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' F' F ' 134' ' ' ASP . . . . . . . . . . . . . 7.1 p-10 -132.38 148.56 52.42 Favored 'General case' 0 C--N 1.33 -0.249 0 N-CA-C 109.578 -0.527 . . . . 0.0 109.578 174.934 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' F' F ' 135' ' ' GLU . . . . . . . . . . . . . 32.3 tp10 -49.9 -24.4 2.48 Favored 'General case' 0 C--N 1.328 -0.328 0 N-CA-C 112.943 0.72 . . . . 0.0 112.943 -169.775 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' F' F ' 136' ' ' GLN . . . . . . . . . . . . . 60.7 tt0 -105.02 -26.42 12.15 Favored 'General case' 0 N--CA 1.466 0.327 0 N-CA-C 112.748 0.647 . . . . 0.0 112.748 -174.637 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' F' F ' 137' ' ' LYS . . . . . . . . . . . . . 77.3 mttt -141.7 154.0 45.02 Favored 'General case' 0 C--N 1.331 -0.198 0 CA-C-O 121.252 0.549 . . . . 0.0 111.798 -171.731 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' F' F ' 138' ' ' LEU . . . . . 0.41 HD23 ' C ' ' F' ' 138' ' ' LEU . 6.1 tt -120.29 124.97 46.9 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 115.616 -0.72 . . . . 0.0 109.299 173.765 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' F' F ' 139' ' ' THR . . . . . . . . . . . . . 31.1 m -114.21 129.83 56.63 Favored 'General case' 0 C--N 1.332 -0.191 0 CA-C-N 116.385 -0.37 . . . . 0.0 110.757 -177.362 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' F' F ' 140' ' ' LEU . . . . . 0.475 HD23 ' C ' ' F' ' 140' ' ' LEU . 7.4 tt -116.87 121.53 41.75 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 115.686 -0.688 . . . . 0.0 109.387 -179.119 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' F' F ' 141' ' ' ILE . . . . . 0.424 ' HB ' HG13 ' F' ' 130' ' ' VAL . 19.0 mt -121.37 118.5 56.2 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.253 0 N-CA-C 109.778 -0.453 . . . . 0.0 109.778 -176.764 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' F' F ' 142' ' ' ARG . . . . . . . . . . . . . 61.7 ttt180 -110.87 127.77 55.55 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 115.5 -0.773 . . . . 0.0 110.403 -176.86 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' F' F ' 143' ' ' THR . . . . . . . . . . . . . 42.3 p . . . . . 0 C--O 1.22 -0.458 0 CA-C-O 117.989 -1.005 . . . . 0.0 110.66 -179.706 . . . . . . . . 0 0 . 1 . 014 nuclear nobuild core ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 41.1 p . . . . . 0 N--CA 1.461 0.108 0 CA-C-O 120.915 0.388 . . . . 0.0 110.485 . . . . . . . . . 0 0 . 1 . 014 nuclear nobuild core ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 95.2 mt-10 -140.54 142.71 35.16 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.174 -0.466 . . . . 0.0 111.243 -178.162 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 4' ' ' LEU . . . . . 0.648 HD21 HD23 ' A' ' 58' ' ' LEU . 56.0 mt -119.73 130.1 54.83 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 115.819 -0.628 . . . . 0.0 110.317 175.319 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 5' ' ' LYS . . . . . . . . . . . . . 67.1 mttm -107.38 120.57 42.52 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.306 -0.406 . . . . 0.0 110.436 177.242 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 73.9 mt -116.82 150.81 37.74 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 115.532 -0.758 . . . . 0.0 110.378 -179.238 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 74.8 tttt -140.69 139.11 19.33 Favored Pre-proline 0 CA--C 1.534 0.335 0 CA-C-O 119.167 -0.444 . . . . 0.0 110.092 175.594 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 8' ' ' PRO . . . . . . . . . . . . . 86.4 Cg_endo -91.76 140.99 2.52 Favored 'Trans proline' 0 N--CA 1.49 1.267 0 C-N-CA 121.733 1.622 . . . . 0.0 111.672 176.971 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 68.8 mt -74.05 -47.93 6.22 Favored Pre-proline 0 C--N 1.328 -0.348 0 CA-C-O 118.622 -0.704 . . . . 0.0 112.243 -178.473 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 89.0 Cg_endo -80.76 146.36 16.58 Favored 'Trans proline' 0 N--CA 1.495 1.614 0 C-N-CA 121.211 1.274 . . . . 0.0 111.931 176.419 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 63.3 mttm -85.8 95.82 9.55 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-O 120.943 0.401 . . . . 0.0 110.416 178.234 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 11.7 p -139.87 149.23 22.34 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.277 0 CA-C-N 115.894 -0.594 . . . . 0.0 110.348 -179.465 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 45.5 tp10 -87.25 122.21 30.73 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 116.337 -0.392 . . . . 0.0 110.322 178.966 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 14' ' ' LEU . . . . . . . . . . . . . 44.7 mt -97.91 157.65 34.23 Favored Pre-proline 0 C--N 1.329 -0.296 0 CA-C-N 116.163 -0.471 . . . . 0.0 110.861 -179.188 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 15' ' ' PRO . . . . . . . . . . . . . 36.9 Cg_exo -59.56 158.31 28.26 Favored 'Trans proline' 0 N--CA 1.496 1.663 0 C-N-CA 121.413 1.408 . . . . 0.0 111.875 178.719 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 16' ' ' PRO . . . . . . . . . . . . . 33.4 Cg_exo -59.2 -42.65 48.27 Favored 'Trans proline' 0 N--CA 1.496 1.649 0 C-N-CA 121.516 1.478 . . . . 0.0 112.84 -177.606 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 17' ' ' ASP . . . . . . . . . . . . . 7.9 p-10 -87.43 13.42 10.01 Favored 'General case' 0 CA--C 1.536 0.414 0 N-CA-C 113.072 0.767 . . . . 0.0 113.072 -177.06 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 18' ' ' PHE . . . . . . . . . . . . . 42.0 t80 -57.16 -45.45 83.61 Favored 'General case' 0 C--N 1.334 -0.088 0 O-C-N 122.041 -0.412 . . . . 0.0 110.238 -178.994 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 19' ' ' VAL . . . . . . . . . . . . . 47.0 t -57.43 -43.37 82.53 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.262 0 CA-C-N 116.154 -0.475 . . . . 0.0 110.378 -178.451 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 32.0 m-20 -59.1 -41.96 89.37 Favored 'General case' 0 C--N 1.331 -0.224 0 C-N-CA 120.916 -0.314 . . . . 0.0 111.082 -177.634 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 46.9 t -64.55 -44.46 96.83 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.264 0 C-N-CA 120.709 -0.396 . . . . 0.0 110.427 -178.372 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 22' ' ' ILE . . . . . 0.582 HG22 HD12 ' A' ' 26' ' ' LEU . 50.9 mm -56.94 -40.14 70.11 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 C-N-CA 120.987 -0.285 . . . . 0.0 110.567 178.709 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 23' ' ' ARG . . . . . . . . . . . . . 53.4 ttp180 -57.13 -48.88 77.58 Favored 'General case' 0 C--N 1.331 -0.214 0 CA-C-O 121.018 0.437 . . . . 0.0 110.468 177.136 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 24' ' ' ILE . . . . . . . . . . . . . 72.7 mt -61.15 -39.5 82.63 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.324 0 CA-C-N 115.839 -0.619 . . . . 0.0 111.944 -177.089 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 16.6 pttp -77.35 -36.07 54.1 Favored 'General case' 0 CA--C 1.535 0.389 0 C-N-CA 120.537 -0.465 . . . . 0.0 111.806 -174.218 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 26' ' ' LEU . . . . . 0.582 HD12 HG22 ' A' ' 22' ' ' ILE . 83.4 mt -77.89 -38.55 45.57 Favored 'General case' 0 C--N 1.33 -0.275 0 N-CA-C 112.979 0.733 . . . . 0.0 112.979 -173.304 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 27' ' ' GLN . . . . . . . . . . . . . 10.1 pt20 -46.92 139.84 5.23 Favored 'General case' 0 N--CA 1.469 0.48 0 N-CA-C 112.867 0.691 . . . . 0.0 112.867 -175.265 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 100.77 -27.76 19.06 Favored Glycine 0 CA--C 1.532 1.122 0 CA-C-N 115.573 -0.739 . . . . 0.0 112.166 -177.544 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 38.0 mmtm -97.84 155.12 17.2 Favored 'General case' 0 C--O 1.232 0.169 0 CA-C-N 117.202 0.501 . . . . 0.0 111.095 178.159 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 30' ' ' THR . . . . . . . . . . . . . 32.3 m -98.92 137.0 38.11 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.107 -0.497 . . . . 0.0 109.884 175.55 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 34.7 m -126.44 151.73 33.27 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.222 0 CA-C-O 120.826 0.346 . . . . 0.0 110.655 -179.296 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 32' ' ' ARG . . . . . . . . . . . . . 76.2 ttt-85 -136.09 149.12 48.58 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.089 -0.505 . . . . 0.0 110.448 178.59 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 33' ' ' THR . . . . . . . . . . . . . 32.1 m -52.92 139.81 26.4 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.386 -0.37 . . . . 0.0 111.301 -178.448 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 100.87 -17.17 56.74 Favored Glycine 0 CA--C 1.533 1.172 0 CA-C-O 119.744 -0.476 . . . . 0.0 113.218 179.644 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 76.7 m-20 -66.69 147.94 52.59 Favored 'General case' 0 N--CA 1.461 0.099 0 CA-C-N 118.028 0.914 . . . . 0.0 111.149 178.728 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 44.6 t -124.25 130.15 73.78 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.197 0 CA-C-N 115.882 -0.599 . . . . 0.0 109.8 178.02 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 37' ' ' ILE . . . . . . . . . . . . . 66.7 mt -122.37 139.65 48.66 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.234 0 CA-C-N 116.266 -0.425 . . . . 0.0 110.126 -179.019 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . -110.18 128.78 9.02 Favored Glycine 0 CA--C 1.526 0.74 0 N-CA-C 111.053 -0.819 . . . . 0.0 111.053 179.586 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 39' ' ' ILE . . . . . . . . . . . . . 73.7 mt -123.87 135.09 64.65 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.171 0 N-CA-C 110.247 -0.279 . . . . 0.0 110.247 179.585 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 40' ' ' SER . . . . . 0.511 ' O ' HD13 ' A' ' 41' ' ' ILE . 96.6 p -92.97 120.94 33.81 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.398 -0.365 . . . . 0.0 110.984 176.07 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 41' ' ' ILE . . . . . 0.511 HD13 ' O ' ' A' ' 40' ' ' SER . 48.1 mm -128.62 115.06 35.92 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.187 0 CA-C-O 120.834 0.35 . . . . 0.0 110.371 177.698 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 42' ' ' LEU . . . . . 0.549 ' O ' HD23 ' A' ' 42' ' ' LEU . 1.3 tt 54.52 44.47 28.71 Favored 'General case' 0 CA--C 1.532 0.251 0 CA-C-O 121.392 0.615 . . . . 0.0 110.546 177.636 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . 70.64 16.28 73.96 Favored Glycine 0 CA--C 1.534 1.278 0 C-N-CA 121.093 -0.575 . . . . 0.0 113.12 175.469 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 44' ' ' LYS . . . . . . . . . . . . . 58.5 mtpt -124.05 132.61 53.7 Favored 'General case' 0 C--N 1.332 -0.17 0 CA-C-N 117.765 0.783 . . . . 0.0 109.902 179.413 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 84.8 tt0 -84.46 123.28 30.07 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 116.444 -0.344 . . . . 0.0 111.115 -179.156 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 46' ' ' VAL . . . . . . . . . . . . . 7.3 p -121.64 128.49 75.8 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.244 0 N-CA-C 109.333 -0.617 . . . . 0.0 109.333 175.731 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 66.6 mttm -100.77 128.58 46.76 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.099 -0.5 . . . . 0.0 111.259 178.602 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 48' ' ' PHE . . . . . . . . . . . . . 93.1 m-85 -110.81 131.79 54.75 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-N 116.129 -0.487 . . . . 0.0 109.811 175.603 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 78.5 tttt -108.61 137.41 46.6 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 116.314 -0.403 . . . . 0.0 110.382 179.342 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 50' ' ' VAL . . . . . . . . . . . . . 45.8 t -79.95 109.72 14.79 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.366 0 N-CA-C 109.275 -0.639 . . . . 0.0 109.275 176.326 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 51' ' ' VAL . . . . . . . . . . . . . 55.9 t -71.47 -47.31 59.39 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.324 0 CA-C-N 116.055 -0.521 . . . . 0.0 109.895 -173.795 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 52' ' ' GLN . . . . . . . . . . . . . 61.6 tt0 -171.14 142.14 1.74 Allowed 'General case' 0 C--N 1.33 -0.244 0 C-N-CA 120.145 -0.622 . . . . 0.0 111.557 -178.657 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -114.38 136.08 53.38 Favored 'General case' 0 C--N 1.331 -0.239 0 CA-C-N 115.711 -0.677 . . . . 0.0 109.99 176.135 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 54' ' ' TYR . . . . . . . . . . . . . 30.5 t80 -129.07 108.33 18.04 Favored Pre-proline 0 CA--C 1.536 0.433 0 CA-C-O 118.21 -0.9 . . . . 0.0 110.393 179.616 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 55' ' ' PRO . . . . . . . . . . . . . 73.8 Cg_endo -77.17 169.99 72.71 Favored 'Cis proline' 0 N--CA 1.5 1.873 0 CA-C-N 121.824 1.687 . . . . 0.0 112.318 -5.371 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 56' ' ' SER . . . . . . . . . . . . . 66.6 m -117.45 136.51 23.55 Favored Pre-proline 0 CA--C 1.538 0.514 0 CA-C-O 118.482 -0.771 . . . . 0.0 109.885 175.688 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 57' ' ' PRO . . . . . . . . . . . . . 50.5 Cg_endo -71.24 163.09 86.6 Favored 'Cis proline' 0 N--CA 1.497 1.706 0 CA-C-N 121.791 1.675 . . . . 0.0 111.291 -5.867 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 58' ' ' LEU . . . . . 0.648 HD23 HD21 ' A' ' 4' ' ' LEU . 39.4 tp -129.69 138.69 51.3 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-O 121.042 0.449 . . . . 0.0 110.67 -179.205 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 59' ' ' ARG . . . . . . . . . . . . . 41.6 ttm180 -95.58 125.5 40.22 Favored 'General case' 0 C--N 1.326 -0.449 0 CA-C-N 115.717 -0.674 . . . . 0.0 109.219 174.177 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 39.9 t -77.18 116.57 20.73 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.241 0 C-N-CA 120.678 -0.409 . . . . 0.0 110.332 -175.082 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 70.6 mm-40 -131.22 161.77 31.48 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.018 -0.537 . . . . 0.0 109.756 175.977 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 62' ' ' ASP . . . . . . . . . . . . . 81.4 m-20 -52.32 -28.0 17.53 Favored 'General case' 0 C--N 1.328 -0.335 0 N-CA-C 112.034 0.383 . . . . 0.0 112.034 177.816 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 63' ' ' ARG . . . . . . . . . . . . . 77.6 mtp85 -70.77 -22.01 62.44 Favored 'General case' 0 CA--C 1.534 0.331 0 N-CA-C 112.879 0.696 . . . . 0.0 112.879 -176.444 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 29.6 m -80.63 142.05 34.38 Favored 'General case' 0 C--N 1.331 -0.227 0 CA-C-O 121.041 0.448 . . . . 0.0 111.119 -175.239 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 65' ' ' LYS . . . . . . . . . . . . . 96.8 mttt -90.11 138.18 31.73 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 115.902 -0.59 . . . . 0.0 110.066 179.176 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 66' ' ' ILE . . . . . . . . . . . . . 63.9 mt -117.55 129.75 73.52 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.212 0 N-CA-C 110.03 -0.359 . . . . 0.0 110.03 179.329 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 67' ' ' THR . . . . . . . . . . . . . 33.4 m -127.19 142.34 51.51 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-O 121.091 0.472 . . . . 0.0 110.861 -178.855 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 68' ' ' LEU . . . . . . . . . . . . . 15.4 tp . . . . . 0 C--N 1.33 -0.275 0 CA-C-N 116.081 -0.509 . . . . 0.0 110.187 178.057 . . . . . . . . 0 0 . 1 . 014 nuclear nobuild core ' A' A ' 74' ' ' ASP . . . . . . . . . . . . . 10.5 t0 . . . . . 0 CA--C 1.523 -0.084 0 N-CA-C 109.903 -0.406 . . . . 0.0 109.903 . . . . . . . . . 0 0 . 1 . 014 nuclear nobuild core ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 43.9 t -111.63 120.67 62.62 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.254 0 CA-C-O 121.249 0.547 . . . . 0.0 110.329 -178.635 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 76' ' ' LEU . . . . . . . . . . . . . 18.3 mt -121.38 139.44 53.44 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 115.463 -0.79 . . . . 0.0 109.035 176.787 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 77' ' ' GLU . . . . . . . . . . . . . 26.0 tt0 -135.71 141.62 44.94 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-O 120.986 0.422 . . . . 0.0 111.361 -174.476 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 78' ' ' ALA . . . . . 0.58 ' HB2' HD21 ' A' ' 109' ' ' LEU . . . -132.14 135.26 46.26 Favored 'General case' 0 C--N 1.331 -0.201 0 CA-C-N 115.821 -0.627 . . . . 0.0 110.073 176.572 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 79' ' ' LYS . . . . . 0.651 ' O ' HD13 ' A' ' 80' ' ' ILE . 62.3 mtpt -77.95 123.28 26.6 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-O 120.868 0.366 . . . . 0.0 110.43 -179.616 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 80' ' ' ILE . . . . . 0.651 HD13 ' O ' ' A' ' 79' ' ' LYS . 38.1 mm -139.19 108.81 3.92 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.257 0 N-CA-C 109.018 -0.734 . . . . 0.0 109.018 -176.87 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 81' ' ' LYS . . . . . . . . . . . . . 95.0 mttt -102.48 125.63 49.27 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-O 120.897 0.379 . . . . 0.0 111.148 -176.12 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . 89.06 42.05 5.72 Favored Glycine 0 CA--C 1.524 0.618 0 C-N-CA 120.818 -0.706 . . . . 0.0 111.547 174.644 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 83' ' ' ILE . . . . . . . . . . . . . 73.5 mt -68.12 135.7 27.95 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.339 0 N-CA-C 109.674 -0.491 . . . . 0.0 109.674 177.939 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 84' ' ' LYS . . . . . . . . . . . . . 82.9 tttt -96.84 -53.51 3.51 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.025 -0.534 . . . . 0.0 110.18 -179.136 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 85' ' ' ASP . . . . . . . . . . . . . 8.7 t70 -154.52 151.74 29.26 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 115.627 -0.715 . . . . 0.0 110.327 -179.916 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 86' ' ' VAL . . . . . . . . . . . . . 44.1 t -130.15 132.22 65.37 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.298 0 CA-C-O 121.049 0.452 . . . . 0.0 110.383 179.774 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 87' ' ' ILE . . . . . 0.496 HD12 ' N ' ' A' ' 87' ' ' ILE . 5.1 mp -117.78 124.09 72.59 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.242 0 N-CA-C 108.975 -0.75 . . . . 0.0 108.975 176.255 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 88' ' ' LEU . . . . . . . . . . . . . 14.4 tp -112.39 128.45 56.31 Favored 'General case' 0 C--N 1.331 -0.226 0 CA-C-O 121.073 0.463 . . . . 0.0 111.309 -175.497 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 89' ' ' ASP . . . . . . . . . . . . . 5.9 t70 -120.65 155.47 33.75 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 115.831 -0.622 . . . . 0.0 109.415 175.833 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 44.4 mp0 -51.02 -36.35 39.07 Favored 'General case' 0 C--N 1.328 -0.33 0 N-CA-C 112.464 0.542 . . . . 0.0 112.464 -171.448 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 91' ' ' ASN . . . . . . . . . . . . . 84.8 m-20 -132.05 33.07 3.95 Favored 'General case' 0 N--CA 1.465 0.309 0 N-CA-C 111.963 0.357 . . . . 0.0 111.963 -176.729 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 92' ' ' LEU . . . . . . . . . . . . . 10.4 tp -166.09 146.63 6.48 Favored 'General case' 0 C--N 1.331 -0.217 0 C-N-CA 120.997 -0.281 . . . . 0.0 110.593 179.525 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 93' ' ' ILE . . . . . . . . . . . . . 63.8 mt -127.09 125.81 67.03 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.238 0 N-CA-C 109.724 -0.473 . . . . 0.0 109.724 -179.611 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 94' ' ' VAL . . . . . . . . . . . . . 45.1 t -122.21 126.04 73.76 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.197 0 N-CA-C 109.742 -0.466 . . . . 0.0 109.742 177.874 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 95' ' ' VAL . . . . . . . . . . . . . 43.5 t -122.61 134.95 64.27 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.235 0 N-CA-C 110.055 -0.35 . . . . 0.0 110.055 -179.047 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 96' ' ' ILE . . . . . . . . . . . . . 61.6 mt -114.43 129.86 69.76 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.322 0 N-CA-C 109.341 -0.614 . . . . 0.0 109.341 178.632 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 97' ' ' THR . . . . . . . . . . . . . 63.4 p -100.26 156.74 17.05 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-O 121.01 0.434 . . . . 0.0 110.814 -179.706 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 98' ' ' GLU . . . . . . . . . . . . . 45.6 tp10 -54.01 -28.1 36.02 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.304 -0.407 . . . . 0.0 112.071 -178.233 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 99' ' ' GLU . . . . . . . . . . . . . 96.0 mt-10 -79.78 16.89 1.02 Allowed 'General case' 0 CA--C 1.534 0.363 0 N-CA-C 113.218 0.821 . . . . 0.0 113.218 -175.465 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 100' ' ' ASN . . . . . . . . . . . . . 3.7 m-20 62.93 37.91 11.61 Favored 'General case' 0 N--CA 1.464 0.232 0 CA-C-O 121.159 0.504 . . . . 0.0 111.021 177.973 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 101' ' ' GLU . . . . . . . . . . . . . 84.5 tt0 -116.8 144.03 44.97 Favored 'General case' 0 C--N 1.332 -0.169 0 N-CA-C 109.583 -0.525 . . . . 0.0 109.583 175.262 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 102' ' ' VAL . . . . . . . . . . . . . 41.1 t -116.4 128.55 73.7 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.283 0 CA-C-O 120.923 0.392 . . . . 0.0 110.187 -176.035 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 103' ' ' LEU . . . . . . . . . . . . . 27.0 mt -118.21 130.29 55.99 Favored 'General case' 0 C--N 1.331 -0.239 0 CA-C-N 115.643 -0.708 . . . . 0.0 110.053 176.215 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 104' ' ' ILE . . . . . 0.424 HD12 ' HB3' ' A' ' 113' ' ' TYR . 70.3 mt -117.85 122.67 70.3 Favored 'Isoleucine or valine' 0 C--O 1.234 0.259 0 N-CA-C 110.136 -0.32 . . . . 0.0 110.136 179.822 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 105' ' ' PHE . . . . . . . . . . . . . 80.7 m-85 -122.11 164.19 18.17 Favored 'General case' 0 C--N 1.331 -0.208 0 O-C-N 124.037 0.836 . . . . 0.0 110.143 -178.353 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 106' ' ' ASN . . . . . 0.415 ' HB3' HD11 ' A' ' 112' ' ' LEU . 44.3 p-10 -100.54 -170.05 1.81 Allowed 'General case' 0 C--N 1.331 -0.198 0 N-CA-C 109.884 -0.413 . . . . 0.0 109.884 172.35 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 107' ' ' GLN . . . . . . . . . . . . . 30.2 tt0 -59.16 -29.99 67.84 Favored 'General case' 0 C--N 1.328 -0.329 0 N-CA-C 112.008 0.374 . . . . 0.0 112.008 -179.508 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 108' ' ' ASN . . . . . . . . . . . . . 3.0 t-20 -84.67 8.31 17.38 Favored 'General case' 0 CA--C 1.536 0.413 0 N-CA-C 113.271 0.841 . . . . 0.0 113.271 -176.751 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 109' ' ' LEU . . . . . 0.58 HD21 ' HB2' ' A' ' 78' ' ' ALA . 11.3 tp 61.6 36.51 16.74 Favored 'General case' 0 C--O 1.233 0.185 0 CA-C-O 120.89 0.376 . . . . 0.0 111.309 178.823 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 110' ' ' GLU . . . . . . . . . . . . . 16.1 mm-40 -103.35 155.46 18.46 Favored 'General case' 0 C--N 1.33 -0.282 0 N-CA-C 109.847 -0.427 . . . . 0.0 109.847 176.056 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 111' ' ' GLU . . . . . . . . . . . . . 44.6 tp10 -84.83 121.96 28.47 Favored 'General case' 0 C--N 1.331 -0.231 0 C-N-CA 120.807 -0.357 . . . . 0.0 110.791 -178.092 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 112' ' ' LEU . . . . . 0.415 HD11 ' HB3' ' A' ' 106' ' ' ASN . 49.7 mt -107.0 -46.05 4.01 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.091 -0.504 . . . . 0.0 110.397 177.735 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 113' ' ' TYR . . . . . 0.424 ' HB3' HD12 ' A' ' 104' ' ' ILE . 60.0 t80 -136.35 135.45 38.85 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.22 -0.446 . . . . 0.0 110.863 179.68 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 114' ' ' ARG . . . . . . . . . . . . . 61.5 ttp85 -135.66 119.09 16.84 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 116.086 -0.506 . . . . 0.0 110.028 178.624 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 115' ' ' GLY . . . . . . . . . . . . . . . -150.04 159.56 28.15 Favored Glycine 0 CA--C 1.523 0.586 0 C-N-CA 120.693 -0.765 . . . . 0.0 111.441 179.855 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 116' ' ' LYS . . . . . . . . . . . . . 39.3 ttpt -130.04 138.26 50.67 Favored 'General case' 0 C--N 1.33 -0.282 0 N-CA-C 109.858 -0.423 . . . . 0.0 109.858 176.47 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 117' ' ' PHE . . . . . . . . . . . . . 38.6 m-85 -137.38 114.04 10.38 Favored 'General case' 0 C--N 1.329 -0.319 0 N-CA-C 110.121 -0.325 . . . . 0.0 110.121 -176.453 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 118' ' ' GLU . . . . . . . . . . . . . 21.7 pt-20 -55.54 -39.71 70.92 Favored 'General case' 0 C--N 1.33 -0.276 0 C-N-CA 120.942 -0.303 . . . . 0.0 111.08 -176.615 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 119' ' ' ASN . . . . . . . . . . . . . 92.8 m-20 -100.01 29.98 3.97 Favored 'General case' 0 C--N 1.33 -0.251 0 N-CA-C 112.252 0.464 . . . . 0.0 112.252 -175.182 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 120' ' ' LEU . . . . . . . . . . . . . 13.8 tp -59.72 120.36 9.35 Favored 'General case' 0 C--N 1.331 -0.209 0 N-CA-C 109.775 -0.454 . . . . 0.0 109.775 177.751 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 121' ' ' ASN . . . . . . . . . . . . . 83.3 m-20 -113.31 -43.99 3.29 Favored 'General case' 0 C--N 1.332 -0.188 0 CA-C-N 116.578 -0.283 . . . . 0.0 111.027 -176.819 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 122' ' ' LYS . . . . . . . . . . . . . 93.4 mttt -144.2 146.93 33.01 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-O 121.054 0.454 . . . . 0.0 111.672 -178.354 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 123' ' ' VAL . . . . . 0.429 ' C ' HD12 ' A' ' 124' ' ' LEU . 44.2 t -123.22 123.45 67.77 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.334 0 N-CA-C 109.375 -0.602 . . . . 0.0 109.375 174.474 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 124' ' ' LEU . . . . . 0.483 HD12 ' N ' ' A' ' 124' ' ' LEU . 7.3 mp -114.03 127.23 55.85 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.308 -0.405 . . . . 0.0 110.209 -179.064 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 125' ' ' VAL . . . . . . . . . . . . . 11.4 p -135.31 134.08 52.56 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.328 0 CA-C-N 116.504 -0.316 . . . . 0.0 110.326 -179.602 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 126' ' ' ARG . . . . . . . . . . . . . 44.8 ttt180 -146.4 119.67 8.94 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.471 178.903 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 127' ' ' ASN . . . . . . . . . . . . . 19.1 t-20 51.26 -104.88 0.18 Allowed 'General case' 0 CA--C 1.544 0.72 0 CA-C-O 119.121 -0.466 . . . . 0.0 111.42 179.309 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 128' ' ' ASP . . . . . . . . . . . . . 20.1 p-10 -112.12 0.35 15.87 Favored 'General case' 0 N--CA 1.468 0.45 0 CA-C-N 119.448 1.022 . . . . 0.0 113.653 -174.444 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 129' ' ' LEU . . . . . . . . . . . . . 76.3 mt -107.63 138.85 43.1 Favored 'General case' 0 C--O 1.231 0.117 0 CA-C-N 118.33 0.514 . . . . 0.0 110.358 179.676 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 130' ' ' VAL . . . . . . . . . . . . . 44.0 t -127.7 135.63 62.6 Favored 'Isoleucine or valine' 0 N--CA 1.462 0.156 0 CA-C-O 120.925 0.393 . . . . 0.0 110.248 -178.932 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 131' ' ' VAL . . . . . 0.516 ' CG1' HD21 ' A' ' 138' ' ' LEU . 40.9 t -134.01 134.16 55.78 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.283 0 CA-C-N 116.083 -0.508 . . . . 0.0 110.006 178.144 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 132' ' ' ILE . . . . . . . . . . . . . 72.2 mt -111.25 129.78 65.95 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.317 0 N-CA-C 109.363 -0.606 . . . . 0.0 109.363 179.653 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 133' ' ' ILE . . . . . . . . . . . . . 41.9 mm -113.67 118.8 59.26 Favored 'Isoleucine or valine' 0 C--O 1.234 0.265 0 CA-C-O 120.92 0.39 . . . . 0.0 110.865 -175.426 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 134' ' ' ASP . . . . . . . . . . . . . 8.6 p-10 -131.03 147.03 52.58 Favored 'General case' 0 C--N 1.331 -0.218 0 N-CA-C 109.303 -0.629 . . . . 0.0 109.303 174.823 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 135' ' ' GLU . . . . . . . . . . . . . 39.0 tp10 -49.89 -28.15 6.2 Favored 'General case' 0 C--N 1.326 -0.417 0 N-CA-C 112.662 0.616 . . . . 0.0 112.662 -172.564 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 136' ' ' GLN . . . . . . . . . . . . . 97.8 mt-30 -82.59 -33.71 27.92 Favored 'General case' 0 C--N 1.331 -0.226 0 N-CA-C 112.806 0.669 . . . . 0.0 112.806 -176.073 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 137' ' ' LYS . . . . . . . . . . . . . 53.7 pttt -166.33 172.98 10.48 Favored 'General case' 0 C--O 1.232 0.165 0 CA-C-O 121.72 0.772 . . . . 0.0 112.746 -172.458 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 138' ' ' LEU . . . . . 0.516 HD21 ' CG1' ' A' ' 131' ' ' VAL . 4.2 tt -117.83 128.88 55.28 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-N 114.767 -1.106 . . . . 0.0 109.798 179.479 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 139' ' ' THR . . . . . 0.485 ' N ' HD23 ' A' ' 138' ' ' LEU . 29.2 m -108.9 127.27 53.9 Favored 'General case' 0 C--N 1.331 -0.23 0 CA-C-N 116.422 -0.354 . . . . 0.0 110.241 178.611 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 140' ' ' LEU . . . . . 0.482 HD23 ' C ' ' A' ' 140' ' ' LEU . 7.4 tt -111.48 121.77 46.08 Favored 'General case' 0 C--N 1.327 -0.382 0 N-CA-C 109.347 -0.612 . . . . 0.0 109.347 -178.594 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 141' ' ' ILE . . . . . . . . . . . . . 19.3 mt -121.08 120.62 62.73 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 CA-C-O 120.955 0.407 . . . . 0.0 110.181 -175.275 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 142' ' ' ARG . . . . . . . . . . . . . 76.4 mtp180 -106.87 122.11 45.75 Favored 'General case' 0 C--N 1.33 -0.239 0 CA-C-N 115.258 -0.883 . . . . 0.0 109.758 179.527 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 143' ' ' THR . . . . . . . . . . . . . 27.6 p . . . . . 0 C--O 1.22 -0.468 0 CA-C-O 117.996 -1.002 . . . . 0.0 110.523 179.907 . . . . . . . . 0 0 . 1 . 014 nuclear nobuild core ' B' B ' 2' ' ' SER . . . . . . . . . . . . . 2.8 p . . . . . 0 C--O 1.23 0.055 0 CA-C-O 120.642 0.258 . . . . 0.0 110.425 . . . . . . . . . 0 0 . 1 . 014 nuclear nobuild core ' B' B ' 3' ' ' GLU . . . . . . . . . . . . . 84.5 tt0 -139.95 139.1 36.04 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-O 120.996 0.426 . . . . 0.0 111.114 -179.248 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' B' B ' 4' ' ' LEU . . . . . . . . . . . . . 4.7 tt -123.24 125.32 44.86 Favored 'General case' 0 C--N 1.331 -0.22 0 CA-C-N 115.689 -0.687 . . . . 0.0 109.752 177.868 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' B' B ' 5' ' ' LYS . . . . . . . . . . . . . 62.7 mttp -106.07 122.57 46.45 Favored 'General case' 0 C--O 1.234 0.269 0 CA-C-O 120.841 0.353 . . . . 0.0 110.877 -179.551 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' B' B ' 6' ' ' LEU . . . . . . . . . . . . . 79.2 mt -114.08 154.43 27.75 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 115.367 -0.833 . . . . 0.0 110.787 -179.179 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' B' B ' 7' ' ' LYS . . . . . . . . . . . . . 62.9 tttm -143.23 140.54 17.89 Favored Pre-proline 0 CA--C 1.533 0.326 0 CA-C-O 119.152 -0.452 . . . . 0.0 110.057 174.007 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' B' B ' 8' ' ' PRO . . . . . . . . . . . . . 71.8 Cg_endo -90.27 139.56 3.01 Favored 'Trans proline' 0 N--CA 1.49 1.282 0 C-N-CA 121.723 1.615 . . . . 0.0 111.407 176.959 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' B' B ' 9' ' ' LEU . . . . . . . . . . . . . 53.6 mt -77.68 -46.69 2.43 Favored Pre-proline 0 C--N 1.329 -0.308 0 CA-C-O 118.811 -0.614 . . . . 0.0 112.102 -177.486 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' B' B ' 10' ' ' PRO . . . . . . . . . . . . . 76.8 Cg_endo -84.08 157.72 13.3 Favored 'Trans proline' 0 N--CA 1.495 1.609 0 C-N-CA 121.353 1.369 . . . . 0.0 111.686 173.771 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' B' B ' 11' ' ' LYS . . . . . . . . . . . . . 24.5 pttm -86.91 114.64 23.71 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-O 121.527 0.68 . . . . 0.0 110.544 177.417 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' B' B ' 12' ' ' VAL . . . . . . . . . . . . . 12.4 p -151.01 148.67 14.79 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.289 0 CA-C-N 115.659 -0.7 . . . . 0.0 110.447 -179.886 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' B' B ' 13' ' ' GLU . . . . . . . . . . . . . 84.5 tt0 -89.06 119.58 29.7 Favored 'General case' 0 C--N 1.329 -0.326 0 N-CA-C 109.877 -0.416 . . . . 0.0 109.877 176.494 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' B' B ' 14' ' ' LEU . . . . . . . . . . . . . 21.4 mt -93.92 147.54 33.68 Favored Pre-proline 0 C--N 1.329 -0.317 0 CA-C-O 119.102 -0.475 . . . . 0.0 110.479 -176.91 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' B' B ' 15' ' ' PRO . . . . . . . . . . . . . 25.3 Cg_exo -62.65 160.41 32.58 Favored 'Trans proline' 0 N--CA 1.497 1.733 0 C-N-CA 121.284 1.322 . . . . 0.0 112.001 177.714 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' B' B ' 16' ' ' PRO . . . . . . . . . . . . . 39.0 Cg_exo -58.88 -44.13 38.07 Favored 'Trans proline' 0 N--CA 1.498 1.781 0 C-N-CA 121.365 1.377 . . . . 0.0 112.892 -178.716 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' B' B ' 17' ' ' ASP . . . . . . . . . . . . . 11.1 p-10 -83.77 10.33 9.74 Favored 'General case' 0 C--N 1.327 -0.404 0 N-CA-C 113.169 0.803 . . . . 0.0 113.169 -177.03 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' B' B ' 18' ' ' PHE . . . . . . . . . . . . . 36.1 t80 -57.91 -43.03 85.91 Favored 'General case' 0 C--N 1.334 -0.084 0 O-C-N 121.975 -0.453 . . . . 0.0 110.088 -178.746 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' B' B ' 19' ' ' VAL . . . . . . . . . . . . . 48.3 t -57.4 -43.39 82.47 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.352 0 CA-C-N 116.247 -0.433 . . . . 0.0 110.403 -179.514 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' B' B ' 20' ' ' ASP . . . . . . . . . . . . . 53.6 m-20 -59.97 -42.57 94.44 Favored 'General case' 0 C--N 1.331 -0.204 0 C-N-CA 120.979 -0.288 . . . . 0.0 110.996 -177.299 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' B' B ' 21' ' ' VAL . . . . . . . . . . . . . 48.3 t -64.53 -45.53 95.34 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.319 0 C-N-CA 120.728 -0.389 . . . . 0.0 110.433 -178.089 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' B' B ' 22' ' ' ILE . . . . . 0.556 HG22 HD12 ' B' ' 26' ' ' LEU . 50.0 mm -58.73 -40.63 80.14 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.318 0 C-N-CA 121.081 -0.247 . . . . 0.0 110.681 179.227 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' B' B ' 23' ' ' ARG . . . . . . . . . . . . . 46.2 ttp180 -56.15 -48.29 76.56 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-O 120.984 0.421 . . . . 0.0 110.585 178.503 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' B' B ' 24' ' ' ILE . . . . . . . . . . . . . 72.5 mt -61.5 -45.19 99.15 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.274 0 CA-C-N 115.94 -0.573 . . . . 0.0 111.769 -177.966 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' B' B ' 25' ' ' LYS . . . . . . . . . . . . . 15.6 pttp -71.22 -37.35 72.05 Favored 'General case' 0 CA--C 1.534 0.36 0 C-N-CA 120.615 -0.434 . . . . 0.0 111.838 -172.545 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' B' B ' 26' ' ' LEU . . . . . 0.556 HD12 HG22 ' B' ' 22' ' ' ILE . 23.7 mt -80.5 -42.23 22.86 Favored 'General case' 0 C--N 1.33 -0.245 0 N-CA-C 113.096 0.776 . . . . 0.0 113.096 -174.674 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' B' B ' 27' ' ' GLN . . . . . . . . . . . . . 10.5 pt20 -47.0 139.98 5.21 Favored 'General case' 0 N--CA 1.469 0.487 0 N-CA-C 112.751 0.649 . . . . 0.0 112.751 -174.875 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' B' B ' 28' ' ' GLY . . . . . . . . . . . . . . . 99.92 -24.51 31.85 Favored Glycine 0 CA--C 1.533 1.187 0 CA-C-N 115.525 -0.762 . . . . 0.0 112.274 -175.539 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' B' B ' 29' ' ' LYS . . . . . . . . . . . . . 65.2 mttm -98.79 155.09 17.53 Favored 'General case' 0 C--O 1.233 0.187 0 CA-C-N 117.288 0.544 . . . . 0.0 111.009 179.525 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' B' B ' 30' ' ' THR . . . . . . . . . . . . . 31.8 m -100.21 135.26 41.92 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.196 -0.457 . . . . 0.0 109.885 175.436 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' B' B ' 31' ' ' VAL . . . . . . . . . . . . . 35.0 m -127.84 154.46 38.4 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.245 0 CA-C-O 120.897 0.379 . . . . 0.0 110.967 -178.379 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' B' B ' 32' ' ' ARG . . . . . . . . . . . . . 85.6 mtm180 -133.32 151.03 51.85 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 115.823 -0.626 . . . . 0.0 110.396 178.259 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' B' B ' 33' ' ' THR . . . . . . . . . . . . . 23.7 m -53.29 138.51 32.23 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.338 -0.392 . . . . 0.0 111.362 -178.336 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' B' B ' 34' ' ' GLY . . . . . . . . . . . . . . . 101.11 -17.05 56.62 Favored Glycine 0 CA--C 1.531 1.084 0 CA-C-O 119.658 -0.523 . . . . 0.0 113.269 178.978 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' B' B ' 35' ' ' ASP . . . . . . . . . . . . . 69.2 m-20 -64.55 148.93 49.75 Favored 'General case' 0 N--CA 1.461 0.107 0 CA-C-N 118.123 0.962 . . . . 0.0 111.018 179.098 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' B' B ' 36' ' ' VAL . . . . . . . . . . . . . 45.3 t -125.47 132.02 71.49 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.217 0 CA-C-N 115.825 -0.625 . . . . 0.0 109.869 179.157 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' B' B ' 37' ' ' ILE . . . . . . . . . . . . . 68.5 mt -120.22 138.07 51.97 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.234 0 CA-C-N 116.141 -0.482 . . . . 0.0 109.853 179.624 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' B' B ' 38' ' ' GLY . . . . . . . . . . . . . . . -108.05 128.74 9.27 Favored Glycine 0 CA--C 1.524 0.61 0 N-CA-C 110.872 -0.891 . . . . 0.0 110.872 179.848 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' B' B ' 39' ' ' ILE . . . . . . . . . . . . . 75.5 mt -125.63 137.12 58.69 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.259 0 N-CA-C 110.186 -0.302 . . . . 0.0 110.186 179.994 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' B' B ' 40' ' ' SER . . . . . 0.528 ' O ' HD13 ' B' ' 41' ' ' ILE . 42.2 p -92.8 119.17 31.88 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.378 -0.374 . . . . 0.0 110.924 176.227 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' B' B ' 41' ' ' ILE . . . . . 0.528 HD13 ' O ' ' B' ' 40' ' ' SER . 47.6 mm -129.59 117.91 43.66 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.189 0 CA-C-O 120.716 0.293 . . . . 0.0 110.325 178.69 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' B' B ' 42' ' ' LEU . . . . . . . . . . . . . 51.0 mt 57.88 34.32 24.21 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.317 -0.401 . . . . 0.0 111.819 177.7 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' B' B ' 43' ' ' GLY . . . . . . . . . . . . . . . 78.74 -10.1 33.45 Favored Glycine 0 CA--C 1.534 1.236 0 C-N-CA 121.215 -0.517 . . . . 0.0 113.438 177.539 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' B' B ' 44' ' ' LYS . . . . . . . . . . . . . 72.9 mmtt -97.82 138.63 34.88 Favored 'General case' 0 C--N 1.333 -0.132 0 CA-C-N 117.854 0.827 . . . . 0.0 109.946 176.912 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' B' B ' 45' ' ' GLU . . . . . . . . . . . . . 84.8 tt0 -84.07 125.16 31.85 Favored 'General case' 0 C--N 1.328 -0.35 0 C-N-CA 120.874 -0.33 . . . . 0.0 110.76 179.447 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' B' B ' 46' ' ' VAL . . . . . . . . . . . . . 7.4 p -121.77 127.8 75.57 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.182 0 N-CA-C 109.627 -0.509 . . . . 0.0 109.627 177.603 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' B' B ' 47' ' ' LYS . . . . . . . . . . . . . 64.0 mttp -100.45 130.43 46.53 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 115.91 -0.586 . . . . 0.0 111.16 178.911 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' B' B ' 48' ' ' PHE . . . . . . . . . . . . . 93.6 m-85 -112.73 131.84 55.49 Favored 'General case' 0 C--N 1.33 -0.258 0 N-CA-C 109.889 -0.411 . . . . 0.0 109.889 175.748 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' B' B ' 49' ' ' LYS . . . . . . . . . . . . . 85.6 tttt -108.82 139.73 43.24 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.279 -0.418 . . . . 0.0 110.846 -178.499 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' B' B ' 50' ' ' VAL . . . . . . . . . . . . . 46.2 t -83.13 108.0 15.39 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.346 0 N-CA-C 109.301 -0.629 . . . . 0.0 109.301 174.852 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' B' B ' 51' ' ' VAL . . . . . . . . . . . . . 47.7 t -72.7 -48.11 47.43 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.306 0 CA-C-N 116.118 -0.492 . . . . 0.0 110.001 -173.06 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' B' B ' 52' ' ' GLN . . . . . . . . . . . . . 60.4 tt0 -165.25 146.97 7.63 Favored 'General case' 0 C--N 1.33 -0.246 0 C-N-CA 120.266 -0.574 . . . . 0.0 111.863 -177.972 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' B' B ' 53' ' ' ALA . . . . . . . . . . . . . . . -123.23 134.54 54.11 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 115.677 -0.692 . . . . 0.0 109.929 176.48 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' B' B ' 54' ' ' TYR . . . . . . . . . . . . . 33.4 t80 -129.14 112.16 18.35 Favored Pre-proline 0 CA--C 1.535 0.403 0 CA-C-O 118.184 -0.912 . . . . 0.0 110.289 178.726 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' B' B ' 55' ' ' PRO . . . . . . . . . . . . . 73.5 Cg_endo -77.11 169.22 74.86 Favored 'Cis proline' 0 N--CA 1.5 1.904 0 CA-C-N 121.99 1.747 . . . . 0.0 112.212 -6.698 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' B' B ' 56' ' ' SER . . . . . . . . . . . . . 13.8 m -117.25 137.19 23.76 Favored Pre-proline 0 CA--C 1.537 0.467 0 CA-C-O 118.537 -0.744 . . . . 0.0 109.802 175.296 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' B' B ' 57' ' ' PRO . . . . . . . . . . . . . 32.4 Cg_endo -65.71 162.94 67.82 Favored 'Cis proline' 0 N--CA 1.498 1.757 0 CA-C-N 121.761 1.665 . . . . 0.0 111.309 -4.724 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' B' B ' 58' ' ' LEU . . . . . . . . . . . . . 31.7 tp -129.18 137.52 51.2 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-O 120.945 0.402 . . . . 0.0 110.511 -178.651 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' B' B ' 59' ' ' ARG . . . . . . . . . . . . . 27.0 ttm180 -101.49 127.43 48.18 Favored 'General case' 0 C--N 1.327 -0.392 0 N-CA-C 109.301 -0.629 . . . . 0.0 109.301 176.151 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' B' B ' 60' ' ' VAL . . . . . . . . . . . . . 46.9 t -79.57 117.73 25.82 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.33 0 C-N-CA 120.677 -0.409 . . . . 0.0 110.095 -175.967 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' B' B ' 61' ' ' GLU . . . . . . . . . . . . . 70.8 mm-40 -131.06 161.83 31.17 Favored 'General case' 0 C--N 1.331 -0.208 0 CA-C-N 116.047 -0.524 . . . . 0.0 110.284 178.846 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' B' B ' 62' ' ' ASP . . . . . . . . . . . . . 67.4 m-20 -54.53 -32.45 58.22 Favored 'General case' 0 C--N 1.327 -0.396 0 CA-C-N 116.463 -0.335 . . . . 0.0 111.748 -179.901 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' B' B ' 63' ' ' ARG . . . . . . . . . . . . . 13.8 ptp180 -84.24 10.09 11.29 Favored 'General case' 0 CA--C 1.535 0.398 0 N-CA-C 113.471 0.915 . . . . 0.0 113.471 -175.854 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' B' B ' 64' ' ' THR . . . . . . . . . . . . . 32.3 m -94.92 143.0 26.82 Favored 'General case' 0 C--O 1.231 0.128 0 CA-C-N 118.02 0.373 . . . . 0.0 110.632 -179.73 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' B' B ' 65' ' ' LYS . . . . . . . . . . . . . 92.3 mttt -88.52 129.0 35.56 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.155 -0.475 . . . . 0.0 110.267 179.633 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' B' B ' 66' ' ' ILE . . . . . . . . . . . . . 59.5 mt -115.08 130.21 69.99 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.196 0 N-CA-C 109.707 -0.479 . . . . 0.0 109.707 179.479 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' B' B ' 67' ' ' THR . . . . . . . . . . . . . 28.0 m -132.49 144.68 50.61 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-O 121.111 0.482 . . . . 0.0 111.3 -177.923 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' B' B ' 68' ' ' LEU . . . . . 0.464 HD12 ' N ' ' B' ' 68' ' ' LEU . 7.3 mp . . . . . 0 C--N 1.329 -0.296 0 CA-C-N 115.96 -0.564 . . . . 0.0 109.94 174.79 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' B' B ' 73' ' ' VAL . . . . . . . . . . . . . 34.6 m . . . . . 0 C--O 1.232 0.14 0 CA-C-O 120.793 0.33 . . . . 0.0 110.603 . . . . . . . . . 0 0 . 1 . 014 nuclear nobuild core ' B' B ' 74' ' ' ASP . . . . . . . . . . . . . 36.1 t0 -94.66 117.57 30.34 Favored 'General case' 0 C--N 1.329 -0.309 0 N-CA-C 109.669 -0.493 . . . . 0.0 109.669 -179.443 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' B' B ' 75' ' ' VAL . . . . . . . . . . . . . 44.0 t -117.9 124.66 73.4 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.287 0 CA-C-O 121.123 0.487 . . . . 0.0 110.771 -176.382 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' B' B ' 76' ' ' LEU . . . . . . . . . . . . . 5.3 mp -122.55 148.45 45.18 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 115.539 -0.755 . . . . 0.0 109.47 174.964 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' B' B ' 77' ' ' GLU . . . . . . . . . . . . . 45.8 mt-10 -135.05 139.52 44.85 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-O 120.999 0.428 . . . . 0.0 111.471 -177.645 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' B' B ' 78' ' ' ALA . . . . . 0.618 ' HB2' HD21 ' B' ' 109' ' ' LEU . . . -128.39 132.29 48.52 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 115.701 -0.681 . . . . 0.0 109.642 175.585 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' B' B ' 79' ' ' LYS . . . . . 0.565 ' O ' HD13 ' B' ' 80' ' ' ILE . 84.5 mttt -76.72 121.45 23.31 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-O 121.077 0.465 . . . . 0.0 110.851 -178.072 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' B' B ' 80' ' ' ILE . . . . . 0.565 HD13 ' O ' ' B' ' 79' ' ' LYS . 43.5 mm -139.19 109.36 4.23 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.27 0 N-CA-C 108.963 -0.754 . . . . 0.0 108.963 -177.854 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' B' B ' 81' ' ' LYS . . . . . . . . . . . . . 93.5 mttt -101.98 124.38 47.5 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-O 120.916 0.388 . . . . 0.0 111.346 -176.244 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' B' B ' 82' ' ' GLY . . . . . . . . . . . . . . . 89.07 42.16 5.69 Favored Glycine 0 CA--C 1.526 0.72 0 C-N-CA 120.956 -0.64 . . . . 0.0 111.841 174.666 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' B' B ' 83' ' ' ILE . . . . . . . . . . . . . 69.0 mt -67.39 136.86 25.85 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.28 0 N-CA-C 109.632 -0.507 . . . . 0.0 109.632 177.116 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' B' B ' 84' ' ' LYS . . . . . . . . . . . . . 38.6 ttpt -101.56 -52.4 3.23 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-O 121.022 0.439 . . . . 0.0 110.422 -178.673 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' B' B ' 85' ' ' ASP . . . . . . . . . . . . . 10.7 t70 -145.46 147.77 32.55 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 115.943 -0.571 . . . . 0.0 110.458 -178.644 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' B' B ' 86' ' ' VAL . . . . . . . . . . . . . 42.2 t -129.68 130.85 67.0 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.26 0 CA-C-O 120.905 0.383 . . . . 0.0 110.373 -179.617 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' B' B ' 87' ' ' ILE . . . . . 0.488 ' N ' HD12 ' B' ' 87' ' ' ILE . 5.0 mp -119.74 123.74 71.54 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.214 0 N-CA-C 109.313 -0.625 . . . . 0.0 109.313 176.105 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' B' B ' 88' ' ' LEU . . . . . . . . . . . . . 17.9 tp -111.01 127.77 55.64 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-O 121.038 0.447 . . . . 0.0 110.972 -177.774 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' B' B ' 89' ' ' ASP . . . . . . . . . . . . . 8.2 t70 -121.61 152.12 39.64 Favored 'General case' 0 C--N 1.331 -0.201 0 CA-C-N 115.797 -0.638 . . . . 0.0 109.6 177.005 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' B' B ' 90' ' ' GLU . . . . . . . . . . . . . 96.4 mt-10 -48.84 -36.24 16.43 Favored 'General case' 0 C--N 1.328 -0.337 0 N-CA-C 112.642 0.608 . . . . 0.0 112.642 -173.04 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' B' B ' 91' ' ' ASN . . . . . . . . . . . . . 30.5 m120 -132.21 32.87 3.93 Favored 'General case' 0 N--CA 1.466 0.336 0 N-CA-C 111.909 0.337 . . . . 0.0 111.909 -177.001 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' B' B ' 92' ' ' LEU . . . . . . . . . . . . . 15.5 tp -166.13 144.42 5.66 Favored 'General case' 0 C--N 1.331 -0.206 0 C-N-CA 121.028 -0.269 . . . . 0.0 110.574 179.722 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' B' B ' 93' ' ' ILE . . . . . . . . . . . . . 70.1 mt -123.36 122.38 65.09 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.279 0 N-CA-C 109.594 -0.521 . . . . 0.0 109.594 178.741 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' B' B ' 94' ' ' VAL . . . . . . . . . . . . . 47.3 t -120.65 125.03 73.63 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 N-CA-C 109.776 -0.453 . . . . 0.0 109.776 179.281 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' B' B ' 95' ' ' VAL . . . . . . . . . . . . . 43.5 t -124.04 134.6 66.11 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.325 0 CA-C-N 116.286 -0.415 . . . . 0.0 109.976 -178.726 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' B' B ' 96' ' ' ILE . . . . . . . . . . . . . 58.3 mt -117.6 126.96 75.04 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.255 0 N-CA-C 109.367 -0.605 . . . . 0.0 109.367 179.343 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' B' B ' 97' ' ' THR . . . . . . . . . . . . . 77.1 p -98.32 157.72 16.01 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-O 121.188 0.518 . . . . 0.0 111.137 -178.086 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' B' B ' 98' ' ' GLU . . . . . . . . . . . . . 80.2 tt0 -53.92 -29.23 41.26 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 116.1 -0.5 . . . . 0.0 112.059 -178.675 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' B' B ' 99' ' ' GLU . . . . . . . . . . . . . 39.3 tt0 -80.01 15.89 1.35 Allowed 'General case' 0 CA--C 1.541 0.61 0 N-CA-C 112.599 0.592 . . . . 0.0 112.599 -176.074 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' B' B ' 100' ' ' ASN . . . . . . . . . . . . . 4.8 m-20 63.8 33.18 12.98 Favored 'General case' 0 CA--C 1.532 0.271 0 O-C-N 121.873 -0.517 . . . . 0.0 111.703 177.859 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' B' B ' 101' ' ' GLU . . . . . . . . . . . . . 84.7 tt0 -106.47 141.94 36.95 Favored 'General case' 0 C--N 1.331 -0.215 0 N-CA-C 109.506 -0.553 . . . . 0.0 109.506 172.179 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' B' B ' 102' ' ' VAL . . . . . . . . . . . . . 45.2 t -116.89 128.18 74.35 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.299 0 N-CA-C 109.805 -0.443 . . . . 0.0 109.805 -177.813 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' B' B ' 103' ' ' LEU . . . . . . . . . . . . . 26.8 mt -118.8 131.2 56.09 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 115.839 -0.619 . . . . 0.0 110.611 178.185 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' B' B ' 104' ' ' ILE . . . . . 0.432 HD12 ' HB3' ' B' ' 113' ' ' TYR . 69.7 mt -116.17 120.12 63.93 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.245 0 N-CA-C 109.72 -0.474 . . . . 0.0 109.72 178.076 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' B' B ' 105' ' ' PHE . . . . . . . . . . . . . 70.7 m-85 -123.13 163.87 19.74 Favored 'General case' 0 C--N 1.331 -0.207 0 O-C-N 123.81 0.694 . . . . 0.0 109.722 179.867 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' B' B ' 106' ' ' ASN . . . . . . . . . . . . . 48.1 p-10 -98.87 -170.75 1.98 Allowed 'General case' 0 C--N 1.329 -0.298 0 N-CA-C 109.754 -0.461 . . . . 0.0 109.754 172.742 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' B' B ' 107' ' ' GLN . . . . . . . . . . . . . 44.7 tt0 -61.04 -30.05 70.08 Favored 'General case' 0 C--N 1.328 -0.369 0 N-CA-C 111.851 0.315 . . . . 0.0 111.851 -179.159 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' B' B ' 108' ' ' ASN . . . . . . . . . . . . . 13.7 t-20 -82.77 6.4 18.27 Favored 'General case' 0 CA--C 1.537 0.469 0 N-CA-C 113.215 0.821 . . . . 0.0 113.215 -178.421 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' B' B ' 109' ' ' LEU . . . . . 0.618 HD21 ' HB2' ' B' ' 78' ' ' ALA . 10.7 tp 61.95 39.34 13.59 Favored 'General case' 0 C--O 1.233 0.209 0 CA-C-O 121.246 0.546 . . . . 0.0 111.197 178.267 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' B' B ' 110' ' ' GLU . . . . . . . . . . . . . 70.8 mm-40 -105.77 157.83 17.17 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.105 176.419 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' B' B ' 111' ' ' GLU . . . . . . . . . . . . . 84.6 tt0 -83.17 121.99 27.8 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-O 120.901 0.381 . . . . 0.0 111.064 -176.613 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' B' B ' 112' ' ' LEU . . . . . . . . . . . . . 34.0 mt -108.29 -46.09 3.79 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-N 115.959 -0.564 . . . . 0.0 110.133 176.462 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' B' B ' 113' ' ' TYR . . . . . 0.432 ' HB3' HD12 ' B' ' 104' ' ' ILE . 63.0 t80 -143.39 135.94 27.32 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.091 -0.504 . . . . 0.0 111.182 179.141 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' B' B ' 114' ' ' ARG . . . . . . . . . . . . . 26.3 ttm180 -133.16 122.7 24.41 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.235 -0.439 . . . . 0.0 109.88 175.669 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' B' B ' 115' ' ' GLY . . . . . . . . . . . . . . . -150.08 152.34 24.27 Favored Glycine 0 CA--C 1.523 0.556 0 N-CA-C 110.69 -0.964 . . . . 0.0 110.69 179.293 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' B' B ' 116' ' ' LYS . . . . . . . . . . . . . 60.8 tttm -129.2 127.46 41.36 Favored 'General case' 0 C--N 1.328 -0.343 0 N-CA-C 109.697 -0.482 . . . . 0.0 109.697 178.351 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' B' B ' 117' ' ' PHE . . . . . 0.442 ' HE2' HD13 ' B' ' 132' ' ' ILE . 49.8 m-85 -123.27 114.06 19.72 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.258 -0.428 . . . . 0.0 110.257 -174.917 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' B' B ' 118' ' ' GLU . . . . . . . . . . . . . 84.7 tt0 -53.99 -43.29 69.86 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 116.363 -0.381 . . . . 0.0 111.357 -176.716 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' B' B ' 119' ' ' ASN . . . . . . . . . . . . . 17.7 m-80 -99.26 31.01 3.23 Favored 'General case' 0 C--N 1.33 -0.257 0 N-CA-C 112.275 0.472 . . . . 0.0 112.275 -174.203 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' B' B ' 120' ' ' LEU . . . . . . . . . . . . . 21.3 tp -56.4 120.26 7.37 Favored 'General case' 0 C--O 1.232 0.148 0 C-N-CA 121.014 -0.274 . . . . 0.0 110.445 177.877 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' B' B ' 121' ' ' ASN . . . . . . . . . . . . . 72.2 m-20 -114.16 -43.99 3.17 Favored 'General case' 0 C--O 1.232 0.181 0 CA-C-N 116.574 -0.284 . . . . 0.0 111.162 -177.283 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' B' B ' 122' ' ' LYS . . . . . . . . . . . . . 95.1 mttt -145.55 150.43 36.4 Favored 'General case' 0 C--N 1.329 -0.283 0 C-N-CA 120.69 -0.404 . . . . 0.0 111.489 -177.17 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' B' B ' 123' ' ' VAL . . . . . . . . . . . . . 43.8 t -132.77 133.26 59.36 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.235 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.107 177.896 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' B' B ' 124' ' ' LEU . . . . . . . . . . . . . 77.8 mt -120.76 130.53 54.07 Favored 'General case' 0 C--O 1.233 0.202 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.596 178.745 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' B' B ' 125' ' ' VAL . . . . . . . . . . . . . 44.8 t -128.21 128.04 68.16 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.281 0 N-CA-C 109.861 -0.422 . . . . 0.0 109.861 179.054 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' B' B ' 126' ' ' ARG . . . . . . . . . . . . . 73.3 mtp85 -140.4 115.06 9.49 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-O 120.812 0.339 . . . . 0.0 110.792 179.468 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' B' B ' 127' ' ' ASN . . . . . . . . . . . . . 21.0 t-20 51.39 -104.91 0.18 Allowed 'General case' 0 CA--C 1.544 0.718 0 CA-C-O 119.131 -0.461 . . . . 0.0 111.382 178.367 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' B' B ' 128' ' ' ASP . . . . . . . . . . . . . 18.3 p-10 -114.0 2.51 15.01 Favored 'General case' 0 N--CA 1.468 0.436 0 CA-C-N 119.562 1.074 . . . . 0.0 113.432 -177.14 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' B' B ' 129' ' ' LEU . . . . . . . . . . . . . 13.3 tp -106.45 136.89 45.41 Favored 'General case' 0 C--N 1.331 -0.218 0 CA-C-N 118.146 0.43 . . . . 0.0 109.909 178.835 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' B' B ' 130' ' ' VAL . . . . . . . . . . . . . 42.5 t -124.7 136.18 61.52 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.242 0 CA-C-O 120.881 0.372 . . . . 0.0 110.314 -177.358 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' B' B ' 131' ' ' VAL . . . . . 0.46 HG22 HD12 ' B' ' 140' ' ' LEU . 46.4 t -134.81 133.83 53.94 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.214 0 CA-C-N 116.264 -0.425 . . . . 0.0 110.187 177.984 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' B' B ' 132' ' ' ILE . . . . . 0.442 HD13 ' HE2' ' B' ' 117' ' ' PHE . 75.7 mt -117.59 133.73 63.43 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.343 0 N-CA-C 109.64 -0.504 . . . . 0.0 109.64 -179.688 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' B' B ' 133' ' ' ILE . . . . . . . . . . . . . 35.6 mm -115.76 123.25 70.93 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.242 0 CA-C-O 120.748 0.309 . . . . 0.0 111.064 -175.448 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' B' B ' 134' ' ' ASP . . . . . . . . . . . . . 9.8 p-10 -134.09 149.77 51.13 Favored 'General case' 0 C--N 1.331 -0.22 0 N-CA-C 109.621 -0.511 . . . . 0.0 109.621 174.755 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' B' B ' 135' ' ' GLU . . . . . . . . . . . . . 40.8 tp10 -50.05 -30.05 10.04 Favored 'General case' 0 C--N 1.328 -0.338 0 N-CA-C 112.651 0.612 . . . . 0.0 112.651 -170.896 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' B' B ' 136' ' ' GLN . . . . . . . . . . . . . 98.2 mt-30 -81.41 -36.4 29.54 Favored 'General case' 0 C--N 1.329 -0.3 0 N-CA-C 112.687 0.625 . . . . 0.0 112.687 -175.981 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' B' B ' 137' ' ' LYS . . . . . . . . . . . . . 20.4 pttm -163.07 172.52 14.82 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-O 121.626 0.727 . . . . 0.0 112.391 -169.706 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' B' B ' 138' ' ' LEU . . . . . . . . . . . . . 6.7 tt -118.53 129.16 55.19 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 114.94 -1.027 . . . . 0.0 109.842 178.27 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' B' B ' 139' ' ' THR . . . . . . . . . . . . . 31.5 m -108.23 128.16 54.47 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.207 -0.452 . . . . 0.0 110.328 -179.857 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' B' B ' 140' ' ' LEU . . . . . 0.46 HD12 HG22 ' B' ' 131' ' ' VAL . 9.4 tp -114.02 122.56 47.28 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 115.763 -0.653 . . . . 0.0 109.567 -178.058 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' B' B ' 141' ' ' ILE . . . . . . . . . . . . . 19.6 mt -121.37 119.71 59.85 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.34 0 N-CA-C 109.949 -0.389 . . . . 0.0 109.949 -175.322 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' B' B ' 142' ' ' ARG . . . . . . . . . . . . . 45.2 ttp180 -114.05 127.9 56.15 Favored 'General case' 0 C--N 1.331 -0.229 0 CA-C-N 115.517 -0.765 . . . . 0.0 110.314 -177.216 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' B' B ' 143' ' ' THR . . . . . . . . . . . . . 20.3 p . . . . . 0 C--O 1.22 -0.489 0 CA-C-O 118.09 -0.957 . . . . 0.0 110.625 -179.661 . . . . . . . . 0 0 . 1 . 014 nuclear nobuild core ' C' C ' 2' ' ' SER . . . . . . . . . . . . . 5.5 p . . . . . 0 N--CA 1.461 0.123 0 CA-C-O 121.119 0.485 . . . . 0.0 110.954 . . . . . . . . . 0 0 . 1 . 014 nuclear nobuild core ' C' C ' 3' ' ' GLU . . . . . . . . . . . . . 45.9 mp0 -139.45 142.19 37.41 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 115.785 -0.643 . . . . 0.0 110.707 179.232 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' C' C ' 4' ' ' LEU . . . . . 0.457 HD21 HD21 ' C' ' 6' ' ' LEU . 14.3 tp -124.52 127.42 47.4 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 116.085 -0.507 . . . . 0.0 110.214 176.593 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' C' C ' 5' ' ' LYS . . . . . . . . . . . . . 60.7 mttp -104.41 121.1 42.71 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.404 -0.362 . . . . 0.0 110.538 177.926 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' C' C ' 6' ' ' LEU . . . . . 0.457 HD21 HD21 ' C' ' 4' ' ' LEU . 54.8 mt -116.8 149.94 39.14 Favored 'General case' 0 C--N 1.331 -0.225 0 CA-C-N 115.603 -0.726 . . . . 0.0 110.927 -178.155 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' C' C ' 7' ' ' LYS . . . . . . . . . . . . . 59.7 tttm -138.07 142.91 37.39 Favored Pre-proline 0 CA--C 1.534 0.341 0 CA-C-N 116.28 -0.418 . . . . 0.0 109.958 175.448 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' C' C ' 8' ' ' PRO . . . . . . . . . . . . . 96.7 Cg_endo -91.46 143.39 3.02 Favored 'Trans proline' 0 N--CA 1.49 1.317 0 C-N-CA 121.763 1.642 . . . . 0.0 112.01 179.04 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' C' C ' 9' ' ' LEU . . . . . . . . . . . . . 50.5 mt -85.57 -48.19 0.58 Allowed Pre-proline 0 CA--C 1.534 0.363 0 CA-C-O 118.661 -0.685 . . . . 0.0 112.393 -179.544 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' C' C ' 10' ' ' PRO . . . . . . . . . . . . . 90.8 Cg_endo -79.97 157.97 23.93 Favored 'Trans proline' 0 N--CA 1.497 1.677 0 C-N-CA 121.17 1.247 . . . . 0.0 111.99 176.976 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' C' C ' 11' ' ' LYS . . . . . . . . . . . . . 1.9 ttmp? -88.35 95.35 10.16 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 116.333 -0.394 . . . . 0.0 110.548 179.358 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' C' C ' 12' ' ' VAL . . . . . . . . . . . . . 12.7 p -144.78 147.34 19.18 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.284 0 CA-C-N 116.296 -0.411 . . . . 0.0 110.669 -179.596 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' C' C ' 13' ' ' GLU . . . . . . . . . . . . . 84.7 tt0 -94.09 129.54 40.59 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.348 -0.387 . . . . 0.0 110.145 177.685 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' C' C ' 14' ' ' LEU . . . . . . . . . . . . . 18.3 mt -97.47 153.05 38.5 Favored Pre-proline 0 C--N 1.329 -0.304 0 CA-C-N 116.458 -0.337 . . . . 0.0 110.9 -176.575 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' C' C ' 15' ' ' PRO . . . . . . . . . . . . . 25.6 Cg_exo -62.48 162.19 25.08 Favored 'Trans proline' 0 N--CA 1.498 1.753 0 C-N-CA 121.242 1.295 . . . . 0.0 111.939 176.905 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' C' C ' 16' ' ' PRO . . . . . . . . . . . . . 25.6 Cg_exo -61.32 -36.58 78.32 Favored 'Trans proline' 0 N--CA 1.499 1.811 0 C-N-CA 121.423 1.415 . . . . 0.0 112.611 -178.488 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' C' C ' 17' ' ' ASP . . . . . . . . . . . . . 19.4 p-10 -89.5 9.72 25.51 Favored 'General case' 0 CA--C 1.535 0.4 0 N-CA-C 113.35 0.87 . . . . 0.0 113.35 -176.882 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' C' C ' 18' ' ' PHE . . . . . . . . . . . . . 47.3 t80 -58.07 -43.24 86.86 Favored 'General case' 0 C--O 1.227 -0.101 0 O-C-N 122.051 -0.406 . . . . 0.0 110.078 -178.281 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' C' C ' 19' ' ' VAL . . . . . . . . . . . . . 54.6 t -57.04 -42.17 78.85 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.321 0 CA-C-N 116.415 -0.357 . . . . 0.0 110.458 -178.751 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' C' C ' 20' ' ' ASP . . . . . . . . . . . . . 38.7 t0 -59.59 -43.52 93.66 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-O 120.874 0.369 . . . . 0.0 110.814 -178.153 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' C' C ' 21' ' ' VAL . . . . . . . . . . . . . 48.2 t -64.81 -46.01 93.3 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.326 0 CA-C-N 116.34 -0.391 . . . . 0.0 110.511 -178.23 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' C' C ' 22' ' ' ILE . . . . . 0.52 HG22 HD12 ' C' ' 26' ' ' LEU . 50.5 mm -59.77 -37.84 73.21 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.311 0 C-N-CA 120.946 -0.302 . . . . 0.0 110.779 -179.353 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' C' C ' 23' ' ' ARG . . . . . . . . . . . . . 36.7 ttp180 -57.75 -49.15 77.53 Favored 'General case' 0 C--N 1.33 -0.263 0 C-N-CA 120.689 -0.404 . . . . 0.0 110.457 178.187 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' C' C ' 24' ' ' ILE . . . . . . . . . . . . . 74.1 mt -61.45 -44.55 98.74 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.295 0 CA-C-N 116.1 -0.5 . . . . 0.0 111.952 -177.225 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' C' C ' 25' ' ' LYS . . . . . 0.472 ' HE3' HD13 ' C' ' 22' ' ' ILE . 0.7 OUTLIER -70.06 -34.52 73.31 Favored 'General case' 0 CA--C 1.534 0.361 0 C-N-CA 120.834 -0.346 . . . . 0.0 111.815 -174.676 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' C' C ' 26' ' ' LEU . . . . . 0.52 HD12 HG22 ' C' ' 22' ' ' ILE . 89.4 mt -78.78 -45.03 21.89 Favored 'General case' 0 C--N 1.331 -0.22 0 N-CA-C 113.085 0.772 . . . . 0.0 113.085 -174.18 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' C' C ' 27' ' ' GLN . . . . . . . . . . . . . 11.3 pt20 -47.29 139.78 6.03 Favored 'General case' 0 N--CA 1.469 0.517 0 N-CA-C 112.674 0.62 . . . . 0.0 112.674 -174.542 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' C' C ' 28' ' ' GLY . . . . . . . . . . . . . . . 99.75 -25.42 28.33 Favored Glycine 0 CA--C 1.535 1.286 0 CA-C-N 115.497 -0.774 . . . . 0.0 112.235 -176.535 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' C' C ' 29' ' ' LYS . . . . . . . . . . . . . 90.2 mttt -97.95 155.17 17.21 Favored 'General case' 0 C--O 1.232 0.169 0 CA-C-N 117.285 0.543 . . . . 0.0 110.963 178.755 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' C' C ' 30' ' ' THR . . . . . . . . . . . . . 24.8 m -106.65 136.63 46.13 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.034 -0.53 . . . . 0.0 109.977 175.515 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' C' C ' 31' ' ' VAL . . . . . . . . . . . . . 34.8 m -132.11 158.05 43.22 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.219 0 CA-C-O 120.889 0.375 . . . . 0.0 111.211 -177.378 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' C' C ' 32' ' ' ARG . . . . . . . . . . . . . 75.2 mtp180 -134.24 153.22 51.98 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-O 121.299 0.571 . . . . 0.0 110.809 178.656 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' C' C ' 33' ' ' THR . . . . . . . . . . . . . 28.0 m -53.52 139.74 30.39 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 116.066 -0.515 . . . . 0.0 111.317 -179.047 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' C' C ' 34' ' ' GLY . . . . . . . . . . . . . . . 99.78 -17.23 57.69 Favored Glycine 0 CA--C 1.533 1.173 0 CA-C-O 119.67 -0.517 . . . . 0.0 113.289 178.21 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' C' C ' 35' ' ' ASP . . . . . . . . . . . . . 79.2 m-20 -66.6 147.9 52.64 Favored 'General case' 0 C--O 1.232 0.172 0 CA-C-N 118.072 0.936 . . . . 0.0 111.166 178.901 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' C' C ' 36' ' ' VAL . . . . . . . . . . . . . 43.1 t -121.79 129.8 75.15 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.239 0 CA-C-N 116.039 -0.528 . . . . 0.0 109.696 177.282 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' C' C ' 37' ' ' ILE . . . . . . . . . . . . . 68.0 mt -120.84 139.57 47.69 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.322 0 CA-C-N 116.343 -0.39 . . . . 0.0 110.052 -178.726 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' C' C ' 38' ' ' GLY . . . . . . . . . . . . . . . -110.62 128.76 8.94 Favored Glycine 0 CA--C 1.526 0.728 0 N-CA-C 111.208 -0.757 . . . . 0.0 111.208 -179.953 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' C' C ' 39' ' ' ILE . . . . . . . . . . . . . 72.8 mt -123.52 137.94 55.04 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.255 0 N-CA-C 109.965 -0.383 . . . . 0.0 109.965 178.999 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' C' C ' 40' ' ' SER . . . . . . . . . . . . . 46.7 t -92.2 113.93 26.33 Favored 'General case' 0 C--N 1.329 -0.296 0 C-N-CA 120.896 -0.321 . . . . 0.0 110.742 176.479 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' C' C ' 41' ' ' ILE . . . . . . . . . . . . . 45.2 mm -122.54 114.91 44.33 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.214 0 N-CA-C 110.026 -0.361 . . . . 0.0 110.026 179.093 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' C' C ' 42' ' ' LEU . . . . . . . . . . . . . 79.5 mt 57.33 35.11 25.66 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.456 -0.338 . . . . 0.0 111.686 178.806 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' C' C ' 43' ' ' GLY . . . . . . . . . . . . . . . 77.98 -10.14 28.05 Favored Glycine 0 CA--C 1.534 1.249 0 C-N-CA 121.311 -0.471 . . . . 0.0 113.575 177.903 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' C' C ' 44' ' ' LYS . . . . . . . . . . . . . 61.9 tttm -96.1 134.2 39.44 Favored 'General case' 0 C--N 1.333 -0.111 0 CA-C-N 117.742 0.771 . . . . 0.0 109.762 176.445 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' C' C ' 45' ' ' GLU . . . . . . . . . . . . . 84.5 tt0 -83.04 123.63 29.66 Favored 'General case' 0 C--N 1.328 -0.335 0 C-N-CA 120.789 -0.365 . . . . 0.0 110.629 -179.73 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' C' C ' 46' ' ' VAL . . . . . . . . . . . . . 7.3 p -117.71 127.26 75.08 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.257 0 N-CA-C 109.448 -0.575 . . . . 0.0 109.448 177.235 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' C' C ' 47' ' ' LYS . . . . . . . . . . . . . 54.8 mtpt -99.51 127.99 45.6 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 115.848 -0.614 . . . . 0.0 110.89 178.858 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' C' C ' 48' ' ' PHE . . . . . . . . . . . . . 92.2 m-85 -110.98 131.97 54.6 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.272 -0.422 . . . . 0.0 110.017 176.153 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' C' C ' 49' ' ' LYS . . . . . . . . . . . . . 78.7 tttt -107.64 135.66 48.7 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.409 -0.36 . . . . 0.0 110.207 179.479 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' C' C ' 50' ' ' VAL . . . . . . . . . . . . . 43.9 t -81.16 109.57 15.64 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.272 0 N-CA-C 109.408 -0.59 . . . . 0.0 109.408 176.833 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' C' C ' 51' ' ' VAL . . . . . . . . . . . . . 48.8 t -70.12 -47.91 65.1 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.292 0 N-CA-C 109.785 -0.45 . . . . 0.0 109.785 -174.923 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' C' C ' 52' ' ' GLN . . . . . . . . . . . . . 46.1 tt0 -168.11 139.95 2.92 Favored 'General case' 0 C--N 1.33 -0.267 0 C-N-CA 120.278 -0.569 . . . . 0.0 111.638 -179.217 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' C' C ' 53' ' ' ALA . . . . . 0.44 ' HB1' ' HB2' ' C' ' 58' ' ' LEU . . . -110.59 133.45 53.3 Favored 'General case' 0 C--N 1.33 -0.239 0 CA-C-N 115.673 -0.694 . . . . 0.0 109.904 176.059 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' C' C ' 54' ' ' TYR . . . . . . . . . . . . . 30.3 t80 -129.08 112.12 18.42 Favored Pre-proline 0 CA--C 1.536 0.44 0 CA-C-O 118.247 -0.882 . . . . 0.0 110.551 179.396 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' C' C ' 55' ' ' PRO . . . . . . . . . . . . . 72.6 Cg_endo -77.07 165.79 84.0 Favored 'Cis proline' 0 N--CA 1.499 1.826 0 CA-C-N 121.953 1.733 . . . . 0.0 112.205 -7.299 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' C' C ' 56' ' ' SER . . . . . . . . . . . . . 41.8 m -113.82 130.8 23.49 Favored Pre-proline 0 CA--C 1.538 0.492 0 CA-C-O 118.529 -0.748 . . . . 0.0 109.337 175.072 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' C' C ' 57' ' ' PRO . . . . . . . . . . . . . 50.0 Cg_endo -69.55 145.47 79.04 Favored 'Cis proline' 0 N--CA 1.498 1.738 0 CA-C-N 121.885 1.709 . . . . 0.0 111.626 0.711 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' C' C ' 58' ' ' LEU . . . . . 0.44 ' HB2' ' HB1' ' C' ' 53' ' ' ALA . 21.8 tp -108.16 134.53 50.89 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.291 -0.413 . . . . 0.0 110.761 -178.784 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' C' C ' 59' ' ' ARG . . . . . . . . . . . . . 31.5 ttm180 -100.78 128.55 46.78 Favored 'General case' 0 C--N 1.328 -0.361 0 N-CA-C 109.325 -0.62 . . . . 0.0 109.325 175.227 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' C' C ' 60' ' ' VAL . . . . . . . . . . . . . 44.2 t -84.35 116.94 28.93 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.266 0 C-N-CA 120.613 -0.435 . . . . 0.0 110.411 -177.522 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' C' C ' 61' ' ' GLU . . . . . . . . . . . . . 65.2 mm-40 -126.14 163.68 22.59 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-N 115.744 -0.662 . . . . 0.0 109.774 176.862 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' C' C ' 62' ' ' ASP . . . . . . . . . . . . . 62.7 m-20 -52.72 -32.38 42.62 Favored 'General case' 0 C--N 1.329 -0.32 0 N-CA-C 111.794 0.294 . . . . 0.0 111.794 178.921 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' C' C ' 63' ' ' ARG . . . . . . . . . . . . . 92.6 mtt-85 -73.69 -22.08 60.04 Favored 'General case' 0 CA--C 1.533 0.312 0 N-CA-C 112.922 0.712 . . . . 0.0 112.922 -177.163 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' C' C ' 64' ' ' THR . . . . . . . . . . . . . 35.7 m -67.82 136.83 54.74 Favored 'General case' 0 C--N 1.332 -0.187 0 CA-C-O 120.982 0.42 . . . . 0.0 110.999 -173.631 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' C' C ' 65' ' ' LYS . . . . . . . . . . . . . 55.2 mtmt -90.56 132.11 35.9 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 115.807 -0.633 . . . . 0.0 110.578 178.484 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' C' C ' 66' ' ' ILE . . . . . . . . . . . . . 64.8 mt -113.65 128.55 70.48 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.258 0 N-CA-C 109.645 -0.502 . . . . 0.0 109.645 178.909 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' C' C ' 67' ' ' THR . . . . . . . . . . . . . 18.0 m -127.27 142.67 51.41 Favored 'General case' 0 C--O 1.233 0.218 0 CA-C-O 121.047 0.451 . . . . 0.0 111.11 -177.147 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' C' C ' 68' ' ' LEU . . . . . . . . . . . . . 13.7 tp . . . . . 0 C--N 1.328 -0.343 0 CA-C-N 115.912 -0.586 . . . . 0.0 109.832 176.975 . . . . . . . . 0 0 . 1 . 014 nuclear nobuild core ' C' C ' 73' ' ' VAL . . . . . . . . . . . . . 35.9 m . . . . . 0 C--O 1.232 0.143 0 N-CA-C 110.043 -0.355 . . . . 0.0 110.043 . . . . . . . . . 0 0 . 1 . 014 nuclear nobuild core ' C' C ' 74' ' ' ASP . . . . . . . . . . . . . 21.4 t0 -99.06 122.9 42.9 Favored 'General case' 0 C--N 1.329 -0.291 0 C-N-CA 120.896 -0.322 . . . . 0.0 110.24 -177.552 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' C' C ' 75' ' ' VAL . . . . . . . . . . . . . 41.5 t -119.96 123.33 70.6 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.2 0 CA-C-O 121.044 0.449 . . . . 0.0 110.527 -179.225 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' C' C ' 76' ' ' LEU . . . . . . . . . . . . . 5.3 mp -119.49 147.63 44.2 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 115.671 -0.695 . . . . 0.0 109.788 176.285 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' C' C ' 77' ' ' GLU . . . . . . . . . . . . . 97.8 mt-10 -136.06 134.37 38.36 Favored 'General case' 0 C--N 1.331 -0.211 0 CA-C-O 121.074 0.464 . . . . 0.0 111.327 -179.303 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' C' C ' 78' ' ' ALA . . . . . 0.743 ' HB2' HD21 ' C' ' 109' ' ' LEU . . . -124.22 133.45 53.52 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 115.696 -0.684 . . . . 0.0 109.603 176.083 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' C' C ' 79' ' ' LYS . . . . . 0.563 ' O ' HD13 ' C' ' 80' ' ' ILE . 50.0 mtpt -81.52 119.07 23.29 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-O 120.975 0.417 . . . . 0.0 110.697 -178.273 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' C' C ' 80' ' ' ILE . . . . . 0.563 HD13 ' O ' ' C' ' 79' ' ' LYS . 44.1 mm -139.18 103.09 1.83 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.338 0 N-CA-C 109.009 -0.737 . . . . 0.0 109.009 -177.1 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' C' C ' 81' ' ' LYS . . . . . . . . . . . . . 73.2 mttt -92.2 127.9 37.85 Favored 'General case' 0 C--N 1.328 -0.359 0 C-N-CA 120.644 -0.422 . . . . 0.0 111.037 -176.776 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' C' C ' 82' ' ' GLY . . . . . . . . . . . . . . . 88.98 42.18 5.71 Favored Glycine 0 CA--C 1.523 0.591 0 C-N-CA 120.889 -0.672 . . . . 0.0 112.204 173.978 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' C' C ' 83' ' ' ILE . . . . . . . . . . . . . 67.9 mt -71.26 131.89 33.96 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.217 0 N-CA-C 109.306 -0.627 . . . . 0.0 109.306 176.206 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' C' C ' 84' ' ' LYS . . . . . . . . . . . . . 28.0 ttpp -101.47 -45.73 5.21 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-O 120.724 0.297 . . . . 0.0 110.741 -176.375 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' C' C ' 85' ' ' ASP . . . . . . . . . . . . . 9.1 t70 -148.25 147.08 28.97 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.324 -0.398 . . . . 0.0 110.674 179.897 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' C' C ' 86' ' ' VAL . . . . . . . . . . . . . 44.2 t -131.74 132.41 61.96 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.229 0 CA-C-O 120.967 0.413 . . . . 0.0 110.683 -178.827 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' C' C ' 87' ' ' ILE . . . . . 0.497 ' N ' HD12 ' C' ' 87' ' ' ILE . 5.1 mp -122.9 130.42 74.48 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.256 0 CA-C-N 115.79 -0.641 . . . . 0.0 109.439 175.814 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' C' C ' 88' ' ' LEU . . . . . . . . . . . . . 23.9 tp -115.49 132.53 56.59 Favored 'General case' 0 N--CA 1.463 0.22 0 CA-C-O 120.991 0.424 . . . . 0.0 111.484 -177.086 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' C' C ' 89' ' ' ASP . . . . . . . . . . . . . 13.8 t70 -120.63 156.62 31.29 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 115.709 -0.678 . . . . 0.0 109.477 175.747 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' C' C ' 90' ' ' GLU . . . . . . . . . . . . . 70.9 mm-40 -48.05 -42.32 28.17 Favored 'General case' 0 N--CA 1.465 0.29 0 N-CA-C 112.723 0.638 . . . . 0.0 112.723 -171.629 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' C' C ' 91' ' ' ASN . . . . . . . . . . . . . 6.3 p30 -132.07 38.49 3.5 Favored 'General case' 0 C--O 1.233 0.223 0 CA-C-O 120.692 0.282 . . . . 0.0 111.488 -178.316 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' C' C ' 92' ' ' LEU . . . . . . . . . . . . . 9.9 tp -165.7 145.19 6.4 Favored 'General case' 0 C--N 1.332 -0.191 0 C-N-CA 120.754 -0.378 . . . . 0.0 110.6 -178.966 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' C' C ' 93' ' ' ILE . . . . . . . . . . . . . 55.9 mt -123.53 125.76 71.99 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.226 0 N-CA-C 109.814 -0.439 . . . . 0.0 109.814 -177.715 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' C' C ' 94' ' ' VAL . . . . . . . . . . . . . 45.8 t -124.01 126.41 72.4 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.221 0 N-CA-C 109.872 -0.418 . . . . 0.0 109.872 178.781 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' C' C ' 95' ' ' VAL . . . . . . . . . . . . . 42.4 t -126.63 137.76 56.82 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.229 0 CA-C-N 116.285 -0.416 . . . . 0.0 110.374 -178.203 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' C' C ' 96' ' ' ILE . . . . . . . . . . . . . 54.8 mt -116.65 129.44 73.14 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.28 0 N-CA-C 109.276 -0.638 . . . . 0.0 109.276 178.505 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' C' C ' 97' ' ' THR . . . . . . . . . . . . . 64.6 p -106.08 157.73 17.33 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-O 121.334 0.588 . . . . 0.0 111.628 -175.955 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' C' C ' 98' ' ' GLU . . . . . . . . . . . . . 12.8 pt-20 -53.87 -23.7 13.46 Favored 'General case' 0 CA--C 1.535 0.375 0 CA-C-N 115.818 -0.628 . . . . 0.0 112.491 179.013 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' C' C ' 99' ' ' GLU . . . . . . . . . . . . . 96.5 mt-10 -77.76 13.31 1.37 Allowed 'General case' 0 CA--C 1.536 0.433 0 N-CA-C 113.074 0.768 . . . . 0.0 113.074 -178.321 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' C' C ' 100' ' ' ASN . . . . . . . . . . . . . 1.9 m-20 61.78 37.53 15.54 Favored 'General case' 0 N--CA 1.463 0.18 0 CA-C-O 120.995 0.426 . . . . 0.0 110.759 179.599 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' C' C ' 101' ' ' GLU . . . . . . . . . . . . . 84.4 tt0 -118.92 145.21 45.94 Favored 'General case' 0 C--O 1.232 0.184 0 CA-C-N 116.058 -0.519 . . . . 0.0 109.919 179.221 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' C' C ' 102' ' ' VAL . . . . . . . . . . . . . 46.8 t -114.98 125.32 72.27 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 N-CA-C 109.646 -0.501 . . . . 0.0 109.646 -179.096 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' C' C ' 103' ' ' LEU . . . . . . . . . . . . . 37.5 mt -116.14 131.77 56.85 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-N 115.707 -0.678 . . . . 0.0 110.423 178.567 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' C' C ' 104' ' ' ILE . . . . . 0.4 HD12 ' HB3' ' C' ' 113' ' ' TYR . 66.3 mt -118.46 121.34 66.83 Favored 'Isoleucine or valine' 0 C--O 1.234 0.277 0 CA-C-N 116.332 -0.395 . . . . 0.0 110.003 177.892 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' C' C ' 105' ' ' PHE . . . . . . . . . . . . . 80.0 m-85 -120.65 162.76 19.13 Favored 'General case' 0 C--N 1.331 -0.219 0 O-C-N 123.994 0.809 . . . . 0.0 109.905 -179.749 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' C' C ' 106' ' ' ASN . . . . . . . . . . . . . 46.4 p-10 -101.09 -170.59 1.86 Allowed 'General case' 0 C--N 1.329 -0.296 0 N-CA-C 110.013 -0.366 . . . . 0.0 110.013 173.76 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' C' C ' 107' ' ' GLN . . . . . . . . . . . . . 46.2 tt0 -58.67 -29.87 66.92 Favored 'General case' 0 C--N 1.329 -0.293 0 N-CA-C 111.942 0.349 . . . . 0.0 111.942 -179.999 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' C' C ' 108' ' ' ASN . . . . . . . . . . . . . 9.7 t30 -85.12 9.98 13.39 Favored 'General case' 0 CA--C 1.535 0.381 0 N-CA-C 113.137 0.791 . . . . 0.0 113.137 -177.177 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' C' C ' 109' ' ' LEU . . . . . 0.743 HD21 ' HB2' ' C' ' 78' ' ' ALA . 8.7 tp 59.18 36.25 23.83 Favored 'General case' 0 C--O 1.232 0.159 0 O-C-N 122.159 -0.338 . . . . 0.0 111.406 178.441 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' C' C ' 110' ' ' GLU . . . . . . . . . . . . . 95.6 mt-10 -105.17 159.81 15.57 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-O 120.758 0.313 . . . . 0.0 110.35 177.766 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' C' C ' 111' ' ' GLU . . . . . . . . . . . . . 84.6 tt0 -84.67 121.98 28.42 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.309 -0.405 . . . . 0.0 110.851 -178.402 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' C' C ' 112' ' ' LEU . . . . . . . . . . . . . 14.7 mt -109.93 -46.07 3.53 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-N 116.081 -0.509 . . . . 0.0 110.158 177.211 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' C' C ' 113' ' ' TYR . . . . . 0.4 ' HB3' HD12 ' C' ' 104' ' ' ILE . 53.2 t80 -139.33 136.94 35.34 Favored 'General case' 0 C--N 1.331 -0.224 0 CA-C-N 116.254 -0.43 . . . . 0.0 111.082 179.854 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' C' C ' 114' ' ' ARG . . . . . . . . . . . . . 71.3 ttp85 -139.09 121.11 15.63 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.054 -0.521 . . . . 0.0 110.18 177.785 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' C' C ' 115' ' ' GLY . . . . . . . . . . . . . . . -150.06 159.85 28.28 Favored Glycine 0 CA--C 1.524 0.634 0 N-CA-C 110.908 -0.877 . . . . 0.0 110.908 178.316 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' C' C ' 116' ' ' LYS . . . . . . . . . . . . . 1.4 ttmp? -131.73 142.64 49.85 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-O 120.822 0.344 . . . . 0.0 110.288 178.491 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' C' C ' 117' ' ' PHE . . . . . . . . . . . . . 31.0 m-85 -138.92 115.46 10.56 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.182 -0.463 . . . . 0.0 109.948 -177.183 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' C' C ' 118' ' ' GLU . . . . . . . . . . . . . 82.9 tt0 -52.9 -48.81 66.93 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.528 -0.305 . . . . 0.0 111.662 -176.005 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' C' C ' 119' ' ' ASN . . . . . . . . . . . . . 4.0 p30 -97.25 31.13 2.55 Favored 'General case' 0 C--N 1.33 -0.259 0 N-CA-C 112.101 0.408 . . . . 0.0 112.101 -175.349 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' C' C ' 120' ' ' LEU . . . . . . . . . . . . . 15.1 tp -52.96 126.55 20.82 Favored 'General case' 0 N--CA 1.463 0.212 0 CA-C-O 120.45 0.167 . . . . 0.0 110.862 177.813 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' C' C ' 121' ' ' ASN . . . . . . . . . . . . . 51.3 t30 -113.76 -44.2 3.21 Favored 'General case' 0 C--N 1.33 -0.258 0 C-N-CA 121.165 -0.214 . . . . 0.0 111.258 -176.133 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' C' C ' 122' ' ' LYS . . . . . . . . . . . . . 88.2 mttt -148.08 151.91 36.46 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-O 121.016 0.436 . . . . 0.0 111.81 -177.267 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' C' C ' 123' ' ' VAL . . . . . . . . . . . . . 42.9 t -131.12 128.92 62.67 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 CA-C-N 115.949 -0.569 . . . . 0.0 109.503 173.865 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' C' C ' 124' ' ' LEU . . . . . . . . . . . . . 62.0 mt -122.35 136.79 54.96 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.43 -0.35 . . . . 0.0 110.308 -178.814 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' C' C ' 125' ' ' VAL . . . . . 0.436 HG23 HG22 ' C' ' 130' ' ' VAL . 12.9 p -133.16 134.59 57.52 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.219 0 CA-C-O 120.997 0.427 . . . . 0.0 110.768 -179.463 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' C' C ' 126' ' ' ARG . . . . . . . . . . . . . 88.8 mtt180 -151.67 135.24 16.2 Favored 'General case' 0 C--N 1.327 -0.37 0 N-CA-C 109.094 -0.706 . . . . 0.0 109.094 176.123 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' C' C ' 127' ' ' ASN . . . . . . . . . . . . . 9.7 p30 48.88 -150.37 0.17 Allowed 'General case' 0 CA--C 1.541 0.62 0 CA-C-O 119.431 -0.318 . . . . 0.0 110.932 179.078 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' C' C ' 128' ' ' ASP . . . . . . . . . . . . . 10.2 p-10 -81.83 18.05 1.38 Allowed 'General case' 0 CA--C 1.535 0.4 0 N-CA-C 112.723 0.638 . . . . 0.0 112.723 179.393 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' C' C ' 129' ' ' LEU . . . . . . . . . . . . . 73.0 mt -117.6 137.66 52.46 Favored 'General case' 0 C--O 1.233 0.184 0 O-C-N 122.083 -0.386 . . . . 0.0 110.416 179.477 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' C' C ' 130' ' ' VAL . . . . . 0.436 HG22 HG23 ' C' ' 125' ' ' VAL . 43.8 t -128.72 140.45 49.21 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.212 0 CA-C-N 116.254 -0.43 . . . . 0.0 110.091 -179.151 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' C' C ' 131' ' ' VAL . . . . . 0.438 ' CG1' HD21 ' C' ' 138' ' ' LEU . 41.4 t -135.46 135.27 51.83 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.226 0 CA-C-O 121.033 0.445 . . . . 0.0 110.273 178.504 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' C' C ' 132' ' ' ILE . . . . . . . . . . . . . 70.6 mt -114.51 133.31 61.0 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.352 0 CA-C-N 115.741 -0.663 . . . . 0.0 109.399 179.263 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' C' C ' 133' ' ' ILE . . . . . . . . . . . . . 39.5 mm -114.8 122.77 69.59 Favored 'Isoleucine or valine' 0 C--O 1.234 0.237 0 CA-C-O 120.714 0.292 . . . . 0.0 110.817 -175.389 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' C' C ' 134' ' ' ASP . . . . . . . . . . . . . 8.2 p-10 -131.92 150.61 52.1 Favored 'General case' 0 C--N 1.331 -0.2 0 N-CA-C 109.855 -0.424 . . . . 0.0 109.855 176.091 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' C' C ' 135' ' ' GLU . . . . . . . . . . . . . 84.7 tt0 -49.89 -26.97 4.58 Favored 'General case' 0 C--N 1.327 -0.39 0 N-CA-C 112.902 0.704 . . . . 0.0 112.902 -172.117 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' C' C ' 136' ' ' GLN . . . . . . . . . . . . . 94.0 mt-30 -93.35 -24.71 18.01 Favored 'General case' 0 C--N 1.33 -0.281 0 N-CA-C 113.088 0.774 . . . . 0.0 113.088 -172.626 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' C' C ' 137' ' ' LYS . . . . . . . . . . . . . 55.6 pttt -170.0 173.72 5.87 Favored 'General case' 0 C--O 1.232 0.163 0 CA-C-O 121.583 0.706 . . . . 0.0 112.553 -173.432 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' C' C ' 138' ' ' LEU . . . . . 0.49 HD23 ' N ' ' C' ' 139' ' ' THR . 4.4 tt -118.51 129.75 55.54 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 114.967 -1.015 . . . . 0.0 109.937 179.592 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' C' C ' 139' ' ' THR . . . . . 0.49 ' N ' HD23 ' C' ' 138' ' ' LEU . 25.9 m -109.83 124.75 51.87 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.406 -0.361 . . . . 0.0 110.319 178.834 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' C' C ' 140' ' ' LEU . . . . . 0.484 ' C ' HD23 ' C' ' 140' ' ' LEU . 7.9 tt -111.52 125.18 53.63 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 115.705 -0.679 . . . . 0.0 109.381 -178.665 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' C' C ' 141' ' ' ILE . . . . . . . . . . . . . 19.3 mt -125.08 120.16 57.66 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.251 0 CA-C-O 120.993 0.425 . . . . 0.0 110.058 -176.011 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' C' C ' 142' ' ' ARG . . . . . . . . . . . . . 59.3 ttp180 . . . . . 0 C--N 1.331 -0.21 0 CA-C-N 115.574 -0.739 . . . . 0.0 110.19 179.352 . . . . . . . . 0 0 . 1 . 014 nuclear nobuild core ' D' D ' 2' ' ' SER . . . . . . . . . . . . . 2.8 p . . . . . 0 N--CA 1.462 0.131 0 CA-C-O 120.801 0.334 . . . . 0.0 110.521 . . . . . . . . . 0 0 . 1 . 014 nuclear nobuild core ' D' D ' 3' ' ' GLU . . . . . . . . . . . . . 95.8 mt-10 -141.3 140.51 33.85 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.168 -0.469 . . . . 0.0 111.166 -179.217 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' D' D ' 4' ' ' LEU . . . . . 0.4 HD21 HD21 ' D' ' 6' ' ' LEU . 17.8 tp -125.34 131.57 52.98 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 115.928 -0.578 . . . . 0.0 110.062 176.139 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' D' D ' 5' ' ' LYS . . . . . . . . . . . . . 95.2 mttt -109.8 119.93 40.88 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.424 -0.353 . . . . 0.0 110.577 179.514 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' D' D ' 6' ' ' LEU . . . . . 0.4 HD21 HD21 ' D' ' 4' ' ' LEU . 51.5 mt -115.07 145.77 41.98 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 115.365 -0.834 . . . . 0.0 110.555 -177.821 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' D' D ' 7' ' ' LYS . . . . . . . . . . . . . 61.8 tttp -132.65 134.36 24.6 Favored Pre-proline 0 CA--C 1.537 0.458 0 CA-C-O 118.7 -0.667 . . . . 0.0 109.966 177.153 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' D' D ' 8' ' ' PRO . . . . . . . . . . . . . 90.5 Cg_endo -89.54 139.39 3.39 Favored 'Trans proline' 0 N--CA 1.491 1.336 0 C-N-CA 121.437 1.425 . . . . 0.0 111.634 176.531 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' D' D ' 9' ' ' LEU . . . . . . . . . . . . . 55.0 mt -78.02 -47.8 2.15 Favored Pre-proline 0 CA--C 1.533 0.301 0 CA-C-O 118.65 -0.69 . . . . 0.0 112.417 -178.356 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' D' D ' 10' ' ' PRO . . . . . . . . . . . . . 84.2 Cg_endo -80.33 152.53 20.79 Favored 'Trans proline' 0 N--CA 1.497 1.711 0 C-N-CA 121.232 1.288 . . . . 0.0 111.83 176.725 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' D' D ' 11' ' ' LYS . . . . . . . . . . . . . 53.5 tttp -87.97 98.37 11.47 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-O 120.924 0.392 . . . . 0.0 110.373 178.767 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' D' D ' 12' ' ' VAL . . . . . . . . . . . . . 11.9 p -141.12 147.07 22.83 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.262 0 CA-C-N 116.037 -0.529 . . . . 0.0 110.432 -179.538 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' D' D ' 13' ' ' GLU . . . . . . . . . . . . . 96.1 mt-10 -84.87 124.01 31.13 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.347 -0.388 . . . . 0.0 110.371 179.06 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' D' D ' 14' ' ' LEU . . . . . . . . . . . . . 39.8 mt -98.88 144.82 28.87 Favored Pre-proline 0 CA--C 1.534 0.356 0 CA-C-O 119.005 -0.522 . . . . 0.0 110.186 -179.511 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' D' D ' 15' ' ' PRO . . . . . . . . . . . . . 25.2 Cg_exo -62.38 159.32 36.26 Favored 'Trans proline' 0 N--CA 1.497 1.728 0 C-N-CA 121.247 1.298 . . . . 0.0 111.964 177.091 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' D' D ' 16' ' ' PRO . . . . . . . . . . . . . 38.2 Cg_exo -58.32 -41.25 68.13 Favored 'Trans proline' 0 N--CA 1.498 1.758 0 C-N-CA 121.463 1.442 . . . . 0.0 112.948 -178.467 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' D' D ' 17' ' ' ASP . . . . . . . . . . . . . 14.5 p-10 -81.9 5.99 17.22 Favored 'General case' 0 C--N 1.326 -0.432 0 N-CA-C 113.208 0.818 . . . . 0.0 113.208 -177.599 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' D' D ' 18' ' ' PHE . . . . . . . . . . . . . 55.1 t80 -57.59 -42.33 82.97 Favored 'General case' 0 N--CA 1.457 -0.075 0 O-C-N 121.937 -0.477 . . . . 0.0 110.228 -179.514 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' D' D ' 19' ' ' VAL . . . . . . . . . . . . . 47.7 t -56.63 -43.26 78.45 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.263 0 CA-C-N 116.301 -0.409 . . . . 0.0 110.371 -179.358 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' D' D ' 20' ' ' ASP . . . . . . . . . . . . . 81.4 m-20 -60.48 -41.95 95.26 Favored 'General case' 0 C--N 1.33 -0.26 0 C-N-CA 120.981 -0.288 . . . . 0.0 110.895 -178.085 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' D' D ' 21' ' ' VAL . . . . . . . . . . . . . 47.2 t -64.18 -47.93 87.87 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.27 0 C-N-CA 120.742 -0.383 . . . . 0.0 110.35 -177.821 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' D' D ' 22' ' ' ILE . . . . . 0.5 HG22 HD12 ' D' ' 26' ' ' LEU . 50.7 mm -56.11 -46.36 80.96 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.25 0 CA-C-O 120.762 0.315 . . . . 0.0 110.604 179.205 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' D' D ' 23' ' ' ARG . . . . . . . . . . . . . 52.8 ttp180 -54.9 -50.53 68.53 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 116.535 -0.302 . . . . 0.0 111.518 -178.064 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' D' D ' 24' ' ' ILE . . . . . . . . . . . . . 74.9 mt -60.16 -42.17 89.23 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 C-N-CA 121.056 -0.258 . . . . 0.0 111.351 -176.397 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' D' D ' 25' ' ' LYS . . . . . . . . . . . . . 43.6 mtmt -66.85 -39.81 87.7 Favored 'General case' 0 C--N 1.329 -0.316 0 N-CA-C 112.386 0.513 . . . . 0.0 112.386 -178.72 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' D' D ' 26' ' ' LEU . . . . . 0.5 HD12 HG22 ' D' ' 22' ' ' ILE . 92.2 mt -78.48 -40.92 34.04 Favored 'General case' 0 C--N 1.331 -0.23 0 N-CA-C 112.881 0.697 . . . . 0.0 112.881 -173.096 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' D' D ' 27' ' ' GLN . . . . . . . . . . . . . 9.1 pt20 -46.61 140.39 4.46 Favored 'General case' 0 N--CA 1.469 0.496 0 N-CA-C 112.691 0.626 . . . . 0.0 112.691 -176.082 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' D' D ' 28' ' ' GLY . . . . . . . . . . . . . . . 99.51 -26.51 24.08 Favored Glycine 0 CA--C 1.532 1.126 0 CA-C-N 115.511 -0.768 . . . . 0.0 112.144 -176.394 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' D' D ' 29' ' ' LYS . . . . . . . . . . . . . 98.7 mttt -97.86 155.2 17.17 Favored 'General case' 0 C--O 1.234 0.269 0 CA-C-N 117.267 0.534 . . . . 0.0 111.134 178.59 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' D' D ' 30' ' ' THR . . . . . . . . . . . . . 18.5 m -105.8 135.58 46.96 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.002 -0.544 . . . . 0.0 109.695 174.922 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' D' D ' 31' ' ' VAL . . . . . . . . . . . . . 35.1 m -128.35 159.68 39.43 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.245 0 CA-C-N 116.382 -0.372 . . . . 0.0 110.681 -177.916 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' D' D ' 32' ' ' ARG . . . . . . . . . . . . . 57.8 ttp180 -132.75 149.8 52.24 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-O 121.22 0.533 . . . . 0.0 110.507 179.561 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' D' D ' 33' ' ' THR . . . . . . . . . . . . . 22.4 m -53.1 139.58 28.07 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 116.333 -0.394 . . . . 0.0 111.326 -178.412 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' D' D ' 34' ' ' GLY . . . . . . . . . . . . . . . 101.26 -17.05 56.36 Favored Glycine 0 CA--C 1.532 1.155 0 CA-C-O 119.645 -0.53 . . . . 0.0 113.251 179.703 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' D' D ' 35' ' ' ASP . . . . . . . . . . . . . 62.8 m-20 -64.09 148.59 49.49 Favored 'General case' 0 C--O 1.231 0.1 0 CA-C-N 118.037 0.918 . . . . 0.0 111.222 179.102 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' D' D ' 36' ' ' VAL . . . . . . . . . . . . . 45.7 t -124.71 128.82 73.62 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.234 0 CA-C-N 115.577 -0.738 . . . . 0.0 109.541 178.185 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' D' D ' 37' ' ' ILE . . . . . . . . . . . . . 66.0 mt -121.21 138.32 52.0 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.256 0 CA-C-N 116.273 -0.421 . . . . 0.0 110.02 -179.293 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' D' D ' 38' ' ' GLY . . . . . . . . . . . . . . . -108.38 128.53 9.14 Favored Glycine 0 CA--C 1.524 0.646 0 N-CA-C 110.754 -0.938 . . . . 0.0 110.754 178.408 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' D' D ' 39' ' ' ILE . . . . . . . . . . . . . 71.9 mt -123.23 138.16 54.13 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.265 0 N-CA-C 109.934 -0.395 . . . . 0.0 109.934 179.803 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' D' D ' 40' ' ' SER . . . . . 0.513 ' O ' HD13 ' D' ' 41' ' ' ILE . 79.2 p -90.32 118.47 29.84 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.316 -0.402 . . . . 0.0 110.55 176.654 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' D' D ' 41' ' ' ILE . . . . . 0.513 HD13 ' O ' ' D' ' 40' ' ' SER . 48.5 mm -129.5 116.11 37.6 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.266 0 CA-C-N 116.453 -0.339 . . . . 0.0 110.177 179.269 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' D' D ' 42' ' ' LEU . . . . . . . . . . . . . 78.1 mt 57.46 35.77 26.27 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.217 -0.447 . . . . 0.0 111.568 177.991 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' D' D ' 43' ' ' GLY . . . . . . . . . . . . . . . 77.79 -10.1 26.99 Favored Glycine 0 CA--C 1.534 1.237 0 C-N-CA 121.303 -0.475 . . . . 0.0 113.537 177.141 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' D' D ' 44' ' ' LYS . . . . . . . . . . . . . 48.5 tttp -101.52 139.8 36.68 Favored 'General case' 0 C--N 1.333 -0.128 0 CA-C-N 117.838 0.819 . . . . 0.0 109.831 177.123 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' D' D ' 45' ' ' GLU . . . . . . . . . . . . . 84.5 tt0 -83.54 127.81 34.02 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-O 120.957 0.408 . . . . 0.0 110.931 -179.201 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' D' D ' 46' ' ' VAL . . . . . . . . . . . . . 7.4 p -121.15 126.9 75.66 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.169 0 N-CA-C 109.339 -0.615 . . . . 0.0 109.339 176.294 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' D' D ' 47' ' ' LYS . . . . . . . . . . . . . 66.3 mttm -100.31 130.12 46.38 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.166 -0.47 . . . . 0.0 111.415 179.063 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' D' D ' 48' ' ' PHE . . . . . . . . . . . . . 95.4 m-85 -112.96 131.99 55.53 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 115.97 -0.559 . . . . 0.0 109.769 176.192 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' D' D ' 49' ' ' LYS . . . . . . . . . . . . . 81.6 tttt -108.31 137.81 45.65 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.297 -0.41 . . . . 0.0 110.497 179.644 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' D' D ' 50' ' ' VAL . . . . . . . . . . . . . 46.2 t -82.41 107.05 13.94 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.287 0 N-CA-C 109.169 -0.678 . . . . 0.0 109.169 175.785 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' D' D ' 51' ' ' VAL . . . . . . . . . . . . . 46.2 t -72.15 -52.38 24.85 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.318 0 CA-C-N 116.041 -0.527 . . . . 0.0 109.683 -174.442 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' D' D ' 52' ' ' GLN . . . . . . . . . . . . . 91.6 mt-30 -152.43 151.57 30.94 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-O 121.291 0.567 . . . . 0.0 111.595 -178.011 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' D' D ' 53' ' ' ALA . . . . . . . . . . . . . . . -127.01 130.66 50.45 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 115.012 -0.995 . . . . 0.0 109.871 176.658 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' D' D ' 54' ' ' TYR . . . . . . . . . . . . . 68.2 t80 -128.66 106.78 18.74 Favored Pre-proline 0 C--N 1.327 -0.384 0 CA-C-O 118.355 -0.831 . . . . 0.0 110.248 -179.776 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' D' D ' 55' ' ' PRO . . . . . . . . . . . . . 73.3 Cg_endo -77.13 170.07 72.56 Favored 'Cis proline' 0 N--CA 1.501 1.919 0 CA-C-N 121.786 1.674 . . . . 0.0 112.631 -3.156 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' D' D ' 56' ' ' SER . . . . . . . . . . . . . 13.6 m -112.15 121.35 39.55 Favored Pre-proline 0 CA--C 1.539 0.522 0 CA-C-O 118.258 -0.877 . . . . 0.0 109.447 175.584 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' D' D ' 57' ' ' PRO . . . . . . . . . . . . . 54.3 Cg_endo -70.6 170.99 59.53 Favored 'Cis proline' 0 N--CA 1.497 1.704 0 CA-C-N 122.11 1.789 . . . . 0.0 112.109 1.35 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' D' D ' 58' ' ' LEU . . . . . . . . . . . . . 19.3 tp -130.15 137.6 50.21 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 115.885 -0.598 . . . . 0.0 110.246 -179.285 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' D' D ' 59' ' ' ARG . . . . . . . . . . . . . 32.6 ttp180 -106.77 126.74 52.69 Favored 'General case' 0 C--N 1.328 -0.338 0 N-CA-C 109.367 -0.605 . . . . 0.0 109.367 176.169 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' D' D ' 60' ' ' VAL . . . . . . . . . . . . . 47.8 t -83.35 122.4 37.51 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.239 0 C-N-CA 120.667 -0.413 . . . . 0.0 110.384 -174.544 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' D' D ' 61' ' ' GLU . . . . . . . . . . . . . 93.8 mt-10 -131.09 166.94 19.97 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-N 115.794 -0.639 . . . . 0.0 110.081 179.656 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' D' D ' 62' ' ' ASP . . . . . . . . . . . . . 81.9 m-20 -55.41 -32.91 63.05 Favored 'General case' 0 C--N 1.328 -0.363 0 C-N-CA 120.951 -0.3 . . . . 0.0 111.49 179.085 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' D' D ' 63' ' ' ARG . . . . . . . . . . . . . 7.4 ptp180 -89.49 10.13 23.92 Favored 'General case' 0 CA--C 1.535 0.389 0 N-CA-C 113.408 0.892 . . . . 0.0 113.408 -176.225 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' D' D ' 64' ' ' THR . . . . . . . . . . . . . 28.6 m -90.91 137.36 32.42 Favored 'General case' 0 C--O 1.232 0.147 0 CA-C-N 118.126 0.421 . . . . 0.0 110.24 -179.732 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' D' D ' 65' ' ' LYS . . . . . . . . . . . . . 2.2 mptp? -88.52 129.25 35.51 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 116.228 -0.442 . . . . 0.0 110.303 -178.317 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' D' D ' 66' ' ' ILE . . . . . . . . . . . . . 63.6 mt -114.68 129.93 69.95 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.298 0 N-CA-C 109.713 -0.477 . . . . 0.0 109.713 178.594 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' D' D ' 67' ' ' THR . . . . . . . . . . . . . 26.7 m -121.73 136.68 54.94 Favored 'General case' 0 C--N 1.33 -0.239 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.536 -179.22 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' D' D ' 68' ' ' LEU . . . . . . . . . . . . . 19.1 tp . . . . . 0 C--N 1.33 -0.283 0 CA-C-N 115.936 -0.574 . . . . 0.0 110.218 178.819 . . . . . . . . 0 0 . 1 . 014 nuclear nobuild core ' D' D ' 73' ' ' VAL . . . . . . . . . . . . . 30.2 m . . . . . 0 C--O 1.232 0.155 0 N-CA-C 109.566 -0.531 . . . . 0.0 109.566 . . . . . . . . . 0 0 . 1 . 014 nuclear nobuild core ' D' D ' 74' ' ' ASP . . . . . . . . . . . . . 33.2 t0 -96.06 115.04 26.83 Favored 'General case' 0 C--N 1.329 -0.314 0 N-CA-C 109.82 -0.437 . . . . 0.0 109.82 179.384 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' D' D ' 75' ' ' VAL . . . . . . . . . . . . . 40.0 t -113.42 123.76 69.39 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.206 0 CA-C-O 121.069 0.461 . . . . 0.0 110.24 -178.721 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' D' D ' 76' ' ' LEU . . . . . . . . . . . . . 22.0 mt -126.26 140.42 52.54 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 115.706 -0.679 . . . . 0.0 109.782 179.05 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' D' D ' 77' ' ' GLU . . . . . . . . . . . . . 97.2 mt-10 -133.21 134.39 44.0 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-O 121.018 0.437 . . . . 0.0 111.242 -178.635 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' D' D ' 78' ' ' ALA . . . . . 0.502 ' HB2' HD21 ' D' ' 109' ' ' LEU . . . -124.63 132.82 53.4 Favored 'General case' 0 C--N 1.331 -0.202 0 CA-C-N 115.766 -0.652 . . . . 0.0 109.936 177.026 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' D' D ' 79' ' ' LYS . . . . . 0.597 ' O ' HD13 ' D' ' 80' ' ' ILE . 98.3 mttt -77.85 119.01 20.73 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-O 120.948 0.404 . . . . 0.0 110.924 -177.673 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' D' D ' 80' ' ' ILE . . . . . 0.597 HD13 ' O ' ' D' ' 79' ' ' LYS . 41.3 mm -139.17 110.56 4.99 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.271 0 N-CA-C 109.034 -0.728 . . . . 0.0 109.034 -177.839 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' D' D ' 81' ' ' LYS . . . . . . . . . . . . . 84.3 mttt -104.16 127.0 51.73 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-O 120.765 0.316 . . . . 0.0 111.213 -177.023 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' D' D ' 82' ' ' GLY . . . . . . . . . . . . . . . 88.21 42.2 5.98 Favored Glycine 0 CA--C 1.525 0.667 0 C-N-CA 120.621 -0.8 . . . . 0.0 111.857 173.807 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' D' D ' 83' ' ' ILE . . . . . . . . . . . . . 73.1 mt -71.01 134.27 30.31 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.323 0 N-CA-C 109.858 -0.423 . . . . 0.0 109.858 178.093 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' D' D ' 84' ' ' LYS . . . . . . . . . . . . . 53.3 tttp -89.18 -53.43 4.57 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.09 -0.505 . . . . 0.0 110.063 -179.504 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' D' D ' 85' ' ' ASP . . . . . . . . . . . . . 13.2 t70 -151.52 149.52 29.31 Favored 'General case' 0 C--N 1.327 -0.396 0 CA-C-N 115.671 -0.695 . . . . 0.0 110.529 -179.033 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' D' D ' 86' ' ' VAL . . . . . . . . . . . . . 41.0 t -127.48 128.32 69.72 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.242 0 CA-C-O 120.848 0.356 . . . . 0.0 110.069 178.971 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' D' D ' 87' ' ' ILE . . . . . . . . . . . . . 44.5 mm -116.73 126.38 74.15 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.253 0 N-CA-C 109.582 -0.525 . . . . 0.0 109.582 177.452 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' D' D ' 88' ' ' LEU . . . . . . . . . . . . . 13.0 tp -111.89 133.27 54.19 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-O 121.099 0.476 . . . . 0.0 111.108 -176.864 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' D' D ' 89' ' ' ASP . . . . . . . . . . . . . 12.3 t70 -127.34 158.15 38.03 Favored 'General case' 0 C--N 1.331 -0.23 0 CA-C-N 115.705 -0.679 . . . . 0.0 109.424 176.021 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' D' D ' 90' ' ' GLU . . . . . . . . . . . . . 96.4 mt-10 -46.94 -39.46 12.38 Favored 'General case' 0 C--N 1.33 -0.261 0 N-CA-C 113.066 0.765 . . . . 0.0 113.066 -171.342 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' D' D ' 91' ' ' ASN . . . . . . . . . . . . . 87.1 m-20 -132.04 26.05 4.58 Favored 'General case' 0 N--CA 1.467 0.424 0 N-CA-C 112.631 0.604 . . . . 0.0 112.631 -177.742 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' D' D ' 92' ' ' LEU . . . . . . . . . . . . . 10.2 mt -151.37 144.26 24.49 Favored 'General case' 0 C--N 1.329 -0.285 0 N-CA-C 109.962 -0.384 . . . . 0.0 109.962 -177.706 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' D' D ' 93' ' ' ILE . . . . . . . . . . . . . 70.9 mt -126.92 117.72 48.53 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 N-CA-C 109.241 -0.652 . . . . 0.0 109.241 178.133 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' D' D ' 94' ' ' VAL . . . . . . . . . . . . . 44.3 t -118.99 125.71 74.73 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.271 0 N-CA-C 109.77 -0.455 . . . . 0.0 109.77 -178.832 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' D' D ' 95' ' ' VAL . . . . . . . . . . . . . 45.3 t -121.04 132.8 69.59 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.294 0 CA-C-N 115.949 -0.568 . . . . 0.0 109.79 -179.411 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' D' D ' 96' ' ' ILE . . . . . 0.464 HD11 ' HB ' ' D' ' 123' ' ' VAL . 63.2 mt -113.35 125.12 70.57 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.325 0 N-CA-C 109.114 -0.698 . . . . 0.0 109.114 178.72 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' D' D ' 97' ' ' THR . . . . . . . . . . . . . 69.2 p -99.49 157.34 16.5 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-O 121.315 0.579 . . . . 0.0 111.312 -176.471 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' D' D ' 98' ' ' GLU . . . . . . . . . . . . . 78.2 tt0 -53.89 -24.37 15.82 Favored 'General case' 0 CA--C 1.534 0.364 0 CA-C-N 115.953 -0.567 . . . . 0.0 112.245 178.846 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' D' D ' 99' ' ' GLU . . . . . . . . . . . . . 36.1 tt0 -78.4 13.7 1.47 Allowed 'General case' 0 CA--C 1.54 0.586 0 N-CA-C 112.684 0.624 . . . . 0.0 112.684 -177.438 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' D' D ' 100' ' ' ASN . . . . . . . . . . . . . 3.2 m-20 61.32 38.02 16.65 Favored 'General case' 0 CA--C 1.53 0.175 0 O-C-N 121.871 -0.518 . . . . 0.0 110.974 179.651 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' D' D ' 101' ' ' GLU . . . . . . . . . . . . . 84.4 tt0 -118.79 143.94 46.61 Favored 'General case' 0 C--N 1.331 -0.2 0 CA-C-N 115.947 -0.57 . . . . 0.0 109.72 176.932 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' D' D ' 102' ' ' VAL . . . . . . . . . . . . . 47.4 t -115.0 124.65 71.87 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.323 0 CA-C-N 116.251 -0.432 . . . . 0.0 109.863 -178.537 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' D' D ' 103' ' ' LEU . . . . . . . . . . . . . 69.5 mt -114.13 129.89 56.61 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 115.842 -0.617 . . . . 0.0 109.971 176.823 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' D' D ' 104' ' ' ILE . . . . . 0.587 HD13 HG11 ' D' ' 130' ' ' VAL . 66.7 mt -120.0 119.47 60.25 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.225 0 N-CA-C 110.087 -0.338 . . . . 0.0 110.087 -178.028 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' D' D ' 105' ' ' PHE . . . . . . . . . . . . . 54.2 m-85 -121.42 162.77 19.85 Favored 'General case' 0 C--N 1.331 -0.219 0 O-C-N 123.998 0.811 . . . . 0.0 109.661 179.959 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' D' D ' 106' ' ' ASN . . . . . . . . . . . . . 41.1 p-10 -95.52 -169.99 2.07 Favored 'General case' 0 C--N 1.33 -0.272 0 N-CA-C 109.782 -0.451 . . . . 0.0 109.782 173.2 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' D' D ' 107' ' ' GLN . . . . . . . . . . . . . 45.1 tt0 -58.64 -30.04 66.99 Favored 'General case' 0 C--N 1.329 -0.313 0 N-CA-C 111.847 0.314 . . . . 0.0 111.847 178.951 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' D' D ' 108' ' ' ASN . . . . . . . . . . . . . 21.1 t-20 -84.17 6.61 21.85 Favored 'General case' 0 CA--C 1.536 0.425 0 N-CA-C 113.339 0.866 . . . . 0.0 113.339 -176.68 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' D' D ' 109' ' ' LEU . . . . . 0.502 HD21 ' HB2' ' D' ' 78' ' ' ALA . 11.6 tp 62.23 37.71 13.98 Favored 'General case' 0 CA--C 1.531 0.219 0 CA-C-O 121.013 0.435 . . . . 0.0 111.196 178.456 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' D' D ' 110' ' ' GLU . . . . . . . . . . . . . 42.9 mt-10 -107.26 151.49 25.39 Favored 'General case' 0 C--N 1.33 -0.273 0 N-CA-C 109.859 -0.423 . . . . 0.0 109.859 176.016 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' D' D ' 111' ' ' GLU . . . . . . . . . . . . . 97.7 mt-10 -79.02 121.94 25.56 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-O 121.008 0.432 . . . . 0.0 111.136 -178.575 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' D' D ' 112' ' ' LEU . . . . . . . . . . . . . 29.9 mt -106.92 -45.9 4.06 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 115.888 -0.596 . . . . 0.0 109.811 175.468 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' D' D ' 113' ' ' TYR . . . . . 0.412 ' HB3' HD12 ' D' ' 104' ' ' ILE . 53.4 t80 -141.23 142.92 33.92 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 115.858 -0.61 . . . . 0.0 110.381 179.485 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' D' D ' 114' ' ' ARG . . . . . . . . . . . . . 35.6 ptt-85 -150.58 124.06 9.01 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-O 121.128 0.49 . . . . 0.0 110.841 177.316 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' D' D ' 115' ' ' GLY . . . . . . . . . . . . . . . -150.19 163.0 29.39 Favored Glycine 0 CA--C 1.525 0.673 0 N-CA-C 111.076 -0.81 . . . . 0.0 111.076 -179.417 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' D' D ' 116' ' ' LYS . . . . . . . . . . . . . 34.0 ttpt -131.03 134.55 46.78 Favored 'General case' 0 C--N 1.33 -0.265 0 N-CA-C 109.846 -0.428 . . . . 0.0 109.846 177.717 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' D' D ' 117' ' ' PHE . . . . . . . . . . . . . 26.3 m-85 -133.07 120.44 21.31 Favored 'General case' 0 C--N 1.331 -0.218 0 CA-C-O 120.894 0.378 . . . . 0.0 110.232 -174.915 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' D' D ' 118' ' ' GLU . . . . . . . . . . . . . 46.4 tp10 -51.52 -52.08 49.84 Favored 'General case' 0 C--N 1.328 -0.351 0 N-CA-C 112.01 0.374 . . . . 0.0 112.01 -174.757 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' D' D ' 119' ' ' ASN . . . . . . . . . . . . . 3.3 p30 -100.06 31.28 3.38 Favored 'General case' 0 C--N 1.33 -0.265 0 N-CA-C 112.173 0.434 . . . . 0.0 112.173 -173.735 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' D' D ' 120' ' ' LEU . . . . . . . . . . . . . 14.1 tp -52.92 125.95 18.76 Favored 'General case' 0 N--CA 1.464 0.229 0 O-C-N 122.343 -0.223 . . . . 0.0 110.985 178.263 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' D' D ' 121' ' ' ASN . . . . . . . . . . . . . 4.3 t-20 -113.96 -44.15 3.19 Favored 'General case' 0 C--N 1.331 -0.229 0 C-N-CA 121.129 -0.229 . . . . 0.0 111.218 -176.839 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' D' D ' 122' ' ' LYS . . . . . . . . . . . . . 49.3 mttm -141.98 146.91 36.14 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-O 120.983 0.42 . . . . 0.0 111.908 -177.309 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' D' D ' 123' ' ' VAL . . . . . 0.464 ' HB ' HD11 ' D' ' 96' ' ' ILE . 43.7 t -130.44 123.28 55.01 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.261 0 N-CA-C 109.22 -0.659 . . . . 0.0 109.22 173.106 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' D' D ' 124' ' ' LEU . . . . . 0.409 HD12 ' C ' ' D' ' 123' ' ' VAL . 6.2 mp -122.97 139.31 54.21 Favored 'General case' 0 C--N 1.332 -0.173 0 CA-C-O 120.93 0.395 . . . . 0.0 111.222 -175.763 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' D' D ' 125' ' ' VAL . . . . . . . . . . . . . 11.0 p -133.15 131.99 58.52 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.194 0 CA-C-N 115.921 -0.581 . . . . 0.0 110.239 178.182 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' D' D ' 126' ' ' ARG . . . . . . . . . . . . . 55.9 mtp180 -144.49 120.91 10.98 Favored 'General case' 0 C--N 1.331 -0.23 0 CA-C-N 116.482 -0.326 . . . . 0.0 110.947 179.012 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' D' D ' 127' ' ' ASN . . . . . . . . . . . . . 30.8 m120 49.96 -105.97 0.2 Allowed 'General case' 0 CA--C 1.543 0.696 0 CA-C-O 119.043 -0.503 . . . . 0.0 111.546 178.537 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' D' D ' 128' ' ' ASP . . . . . . . . . . . . . 12.0 p-10 -114.06 4.76 15.79 Favored 'General case' 0 N--CA 1.468 0.456 0 CA-C-N 119.684 1.129 . . . . 0.0 113.372 -178.455 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' D' D ' 129' ' ' LEU . . . . . . . . . . . . . 11.4 tp -106.01 131.27 53.5 Favored 'General case' 0 C--N 1.332 -0.19 0 N-CA-C 109.867 -0.42 . . . . 0.0 109.867 178.845 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' D' D ' 130' ' ' VAL . . . . . 0.587 HG11 HD13 ' D' ' 104' ' ' ILE . 44.1 t -119.23 134.06 64.06 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.283 0 N-CA-C 109.603 -0.517 . . . . 0.0 109.603 178.77 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' D' D ' 131' ' ' VAL . . . . . . . . . . . . . 40.4 t -136.06 135.22 50.38 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.246 0 CA-C-O 121.054 0.454 . . . . 0.0 110.504 -178.948 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' D' D ' 132' ' ' ILE . . . . . . . . . . . . . 68.4 mt -115.69 133.39 62.22 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.271 0 CA-C-N 115.75 -0.659 . . . . 0.0 109.24 177.317 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' D' D ' 133' ' ' ILE . . . . . . . . . . . . . 36.9 mm -116.67 120.69 65.76 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.308 0 CA-C-N 116.356 -0.384 . . . . 0.0 110.743 -174.093 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' D' D ' 134' ' ' ASP . . . . . . . . . . . . . 18.9 p-10 -138.93 150.87 46.4 Favored 'General case' 0 C--N 1.331 -0.202 0 N-CA-C 109.821 -0.437 . . . . 0.0 109.821 173.682 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' D' D ' 135' ' ' GLU . . . . . . . . . . . . . 39.8 tp10 -50.07 -25.92 3.91 Favored 'General case' 0 C--N 1.328 -0.356 0 N-CA-C 113.389 0.885 . . . . 0.0 113.389 -168.375 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' D' D ' 136' ' ' GLN . . . . . . . . . . . . . 20.5 pt20 -99.02 -18.15 17.91 Favored 'General case' 0 N--CA 1.464 0.262 0 N-CA-C 113.566 0.95 . . . . 0.0 113.566 -172.356 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' D' D ' 137' ' ' LYS . . . . . . . . . . . . . 54.6 pttt -161.61 166.73 26.44 Favored 'General case' 0 C--O 1.233 0.193 0 CA-C-O 121.999 0.904 . . . . 0.0 113.344 -175.146 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' D' D ' 138' ' ' LEU . . . . . . . . . . . . . 12.2 tp -117.1 125.73 51.73 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 114.143 -1.389 . . . . 0.0 109.345 176.043 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' D' D ' 139' ' ' THR . . . . . . . . . . . . . 19.4 m -108.41 123.19 48.47 Favored 'General case' 0 C--N 1.331 -0.209 0 CA-C-O 120.705 0.288 . . . . 0.0 110.485 179.289 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' D' D ' 140' ' ' LEU . . . . . 0.477 ' C ' HD23 ' D' ' 140' ' ' LEU . 7.6 tt -112.81 120.74 42.51 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 115.568 -0.742 . . . . 0.0 109.136 -179.09 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' D' D ' 141' ' ' ILE . . . . . . . . . . . . . 19.3 mt -120.91 120.24 61.76 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.367 0 CA-C-O 121.007 0.432 . . . . 0.0 109.953 -176.152 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' D' D ' 142' ' ' ARG . . . . . . . . . . . . . 71.5 ttt180 -106.89 120.28 41.61 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 115.332 -0.849 . . . . 0.0 110.188 -179.778 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' D' D ' 143' ' ' THR . . . . . . . . . . . . . 73.2 p . . . . . 0 C--O 1.22 -0.469 0 CA-C-O 118.011 -0.995 . . . . 0.0 110.63 -179.295 . . . . . . . . 0 0 . 1 . 014 nuclear nobuild core ' E' E ' 2' ' ' SER . . . . . . . . . . . . . 6.4 p . . . . . 0 C--O 1.232 0.158 0 CA-C-O 121.038 0.447 . . . . 0.0 110.961 . . . . . . . . . 0 0 . 1 . 014 nuclear nobuild core ' E' E ' 3' ' ' GLU . . . . . . . . . . . . . 83.5 tt0 -141.27 142.18 33.91 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 115.804 -0.634 . . . . 0.0 110.893 179.946 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' E' E ' 4' ' ' LEU . . . . . 0.518 HD23 ' N ' ' E' ' 5' ' ' LYS . 3.6 tt -123.44 123.32 40.4 Favored 'General case' 0 C--N 1.33 -0.251 0 N-CA-C 109.702 -0.481 . . . . 0.0 109.702 177.978 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' E' E ' 5' ' ' LYS . . . . . 0.518 ' N ' HD23 ' E' ' 4' ' ' LEU . 49.1 mtmt -103.31 119.62 39.21 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.205 -0.452 . . . . 0.0 111.035 -179.263 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' E' E ' 6' ' ' LEU . . . . . . . . . . . . . 15.1 mt -116.01 153.36 31.8 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 115.731 -0.668 . . . . 0.0 110.585 178.768 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' E' E ' 7' ' ' LYS . . . . . . . . . . . . . 59.5 tttp -135.02 136.89 25.86 Favored Pre-proline 0 CA--C 1.534 0.35 0 CA-C-O 119.047 -0.502 . . . . 0.0 109.987 174.609 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' E' E ' 8' ' ' PRO . . . . . . . . . . . . . 88.5 Cg_endo -91.4 137.58 2.07 Favored 'Trans proline' 0 N--CA 1.49 1.287 0 C-N-CA 121.76 1.64 . . . . 0.0 111.366 178.119 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' E' E ' 9' ' ' LEU . . . . . . . . . . . . . 27.0 mt -83.03 -47.66 0.81 Allowed Pre-proline 0 CA--C 1.533 0.309 0 CA-C-O 118.743 -0.646 . . . . 0.0 112.429 -177.133 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' E' E ' 10' ' ' PRO . . . . . . . . . . . . . 62.8 Cg_endo -83.75 156.22 13.73 Favored 'Trans proline' 0 N--CA 1.495 1.609 0 C-N-CA 121.39 1.393 . . . . 0.0 112.151 177.115 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' E' E ' 11' ' ' LYS . . . . . . . . . . . . . 20.2 pttp -78.93 116.59 19.34 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-O 121.286 0.565 . . . . 0.0 110.286 175.523 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' E' E ' 12' ' ' VAL . . . . . . . . . . . . . 12.6 p -150.65 151.99 11.95 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.28 0 CA-C-N 115.779 -0.646 . . . . 0.0 110.756 -177.192 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' E' E ' 13' ' ' GLU . . . . . . . . . . . . . 13.0 pt-20 -91.88 130.95 37.54 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.555 178.394 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' E' E ' 14' ' ' LEU . . . . . . . . . . . . . 31.4 mt -99.87 130.69 25.89 Favored Pre-proline 0 CA--C 1.536 0.437 0 CA-C-O 118.715 -0.66 . . . . 0.0 110.621 -178.341 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' E' E ' 15' ' ' PRO . . . . . . . . . . . . . 23.0 Cg_exo -65.1 161.16 38.35 Favored 'Trans proline' 0 N--CA 1.499 1.842 0 C-N-CA 121.301 1.334 . . . . 0.0 111.893 175.826 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' E' E ' 16' ' ' PRO . . . . . . . . . . . . . 30.4 Cg_exo -59.96 -32.94 95.79 Favored 'Trans proline' 0 N--CA 1.496 1.627 0 C-N-CA 121.442 1.428 . . . . 0.0 112.635 -179.096 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' E' E ' 17' ' ' ASP . . . . . . . . . . . . . 11.3 p-10 -91.13 14.44 14.16 Favored 'General case' 0 CA--C 1.535 0.38 0 N-CA-C 112.989 0.737 . . . . 0.0 112.989 -178.412 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' E' E ' 18' ' ' PHE . . . . . . . . . . . . . 47.8 t80 -55.82 -49.13 74.11 Favored 'General case' 0 C--N 1.334 -0.076 0 O-C-N 121.977 -0.452 . . . . 0.0 110.7 -177.839 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' E' E ' 19' ' ' VAL . . . . . . . . . . . . . 47.5 t -55.77 -42.33 69.6 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.304 0 CA-C-N 116.578 -0.283 . . . . 0.0 110.723 -176.703 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' E' E ' 20' ' ' ASP . . . . . . . . . . . . . 60.5 m-20 -60.12 -43.03 95.95 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-O 120.849 0.357 . . . . 0.0 110.922 -177.85 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' E' E ' 21' ' ' VAL . . . . . . . . . . . . . 44.9 t -64.98 -47.54 87.69 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.306 0 C-N-CA 120.718 -0.393 . . . . 0.0 110.415 -178.036 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' E' E ' 22' ' ' ILE . . . . . 0.565 HG22 HD12 ' E' ' 26' ' ' LEU . 50.2 mm -55.71 -58.72 3.92 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.263 0 C-N-CA 120.92 -0.312 . . . . 0.0 111.108 -178.3 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' E' E ' 23' ' ' ARG . . . . . . . . . . . . . 7.5 ptm180 -56.48 -43.44 79.63 Favored 'General case' 0 C--N 1.332 -0.177 0 C-N-CA 120.618 -0.433 . . . . 0.0 111.859 -173.783 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' E' E ' 24' ' ' ILE . . . . . . . . . . . . . 78.0 mt -60.79 -43.68 95.88 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.293 0 C-N-CA 120.996 -0.281 . . . . 0.0 111.588 -176.682 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' E' E ' 25' ' ' LYS . . . . . . . . . . . . . 98.3 mttt -71.07 -40.73 71.42 Favored 'General case' 0 C--N 1.329 -0.299 0 N-CA-C 112.421 0.526 . . . . 0.0 112.421 -178.365 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' E' E ' 26' ' ' LEU . . . . . 0.565 HD12 HG22 ' E' ' 22' ' ' ILE . 77.1 mt -80.31 -32.59 37.98 Favored 'General case' 0 C--N 1.329 -0.289 0 N-CA-C 113.708 1.003 . . . . 0.0 113.708 -170.859 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' E' E ' 27' ' ' GLN . . . . . . . . . . . . . 9.8 pt20 -47.41 142.13 4.38 Favored 'General case' 0 N--CA 1.469 0.516 0 N-CA-C 112.602 0.593 . . . . 0.0 112.602 -175.61 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' E' E ' 28' ' ' GLY . . . . . . . . . . . . . . . 99.02 -22.17 42.27 Favored Glycine 0 CA--C 1.532 1.149 0 CA-C-N 115.63 -0.714 . . . . 0.0 112.561 -177.494 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' E' E ' 29' ' ' LYS . . . . . . . . . . . . . 28.5 mmtp -96.5 154.97 16.97 Favored 'General case' 0 C--O 1.231 0.122 0 CA-C-N 117.734 0.767 . . . . 0.0 110.846 178.424 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' E' E ' 30' ' ' THR . . . . . . . . . . . . . 41.2 m -110.13 138.64 46.22 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-N 115.803 -0.635 . . . . 0.0 110.307 178.446 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' E' E ' 31' ' ' VAL . . . . . . . . . . . . . 34.7 m -133.4 159.33 42.9 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.247 0 CA-C-N 116.233 -0.44 . . . . 0.0 111.026 -179.159 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' E' E ' 32' ' ' ARG . . . . . . . . . . . . . 77.8 mtp180 -131.98 153.34 50.43 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 115.874 -0.603 . . . . 0.0 110.424 176.408 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' E' E ' 33' ' ' THR . . . . . . . . . . . . . 30.6 m -53.1 139.68 27.8 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.37 -0.377 . . . . 0.0 111.395 -177.915 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' E' E ' 34' ' ' GLY . . . . . . . . . . . . . . . 99.39 -17.14 58.2 Favored Glycine 0 CA--C 1.532 1.153 0 CA-C-O 119.601 -0.555 . . . . 0.0 113.274 178.157 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' E' E ' 35' ' ' ASP . . . . . . . . . . . . . 74.2 m-20 -65.37 148.08 52.33 Favored 'General case' 0 N--CA 1.461 0.112 0 CA-C-N 118.043 0.921 . . . . 0.0 111.211 179.318 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' E' E ' 36' ' ' VAL . . . . . . . . . . . . . 44.4 t -119.61 129.59 75.15 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 CA-C-N 115.649 -0.705 . . . . 0.0 109.705 178.875 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' E' E ' 37' ' ' ILE . . . . . . . . . . . . . 68.9 mt -121.17 139.03 49.62 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.29 0 CA-C-N 116.272 -0.422 . . . . 0.0 109.971 -179.374 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' E' E ' 38' ' ' GLY . . . . . . . . . . . . . . . -112.19 128.7 8.67 Favored Glycine 0 CA--C 1.525 0.701 0 N-CA-C 110.502 -1.039 . . . . 0.0 110.502 177.698 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' E' E ' 39' ' ' ILE . . . . . . . . . . . . . 72.1 mt -123.1 133.42 69.14 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.279 0 N-CA-C 109.944 -0.391 . . . . 0.0 109.944 -179.522 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' E' E ' 40' ' ' SER . . . . . . . . . . . . . 43.2 t -93.44 120.62 33.93 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.444 -0.344 . . . . 0.0 110.949 176.281 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' E' E ' 41' ' ' ILE . . . . . . . . . . . . . 73.6 mt -122.47 114.79 43.89 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.195 0 CA-C-O 120.955 0.407 . . . . 0.0 110.104 177.856 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' E' E ' 42' ' ' LEU . . . . . 0.542 ' O ' HD23 ' E' ' 42' ' ' LEU . 1.3 tt 51.01 44.18 28.68 Favored 'General case' 0 CA--C 1.532 0.274 0 CA-C-O 121.479 0.656 . . . . 0.0 110.829 177.866 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' E' E ' 43' ' ' GLY . . . . . . . . . . . . . . . 71.26 27.8 71.07 Favored Glycine 0 CA--C 1.531 1.084 0 C-N-CA 121.113 -0.565 . . . . 0.0 112.392 176.095 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' E' E ' 44' ' ' LYS . . . . . . . . . . . . . 61.2 tttm -133.9 129.88 36.99 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-N 117.188 0.494 . . . . 0.0 109.952 178.8 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' E' E ' 45' ' ' GLU . . . . . . . . . . . . . 82.6 tt0 -83.35 122.92 29.11 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-O 120.873 0.368 . . . . 0.0 111.274 -177.008 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' E' E ' 46' ' ' VAL . . . . . . . . . . . . . 7.4 p -122.53 128.41 75.36 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.228 0 N-CA-C 109.441 -0.577 . . . . 0.0 109.441 175.213 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' E' E ' 47' ' ' LYS . . . . . . . . . . . . . 62.5 mtpt -100.56 133.14 45.43 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 115.992 -0.549 . . . . 0.0 111.262 179.943 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' E' E ' 48' ' ' PHE . . . . . . . . . . . . . 96.0 m-85 -120.47 132.06 55.04 Favored 'General case' 0 C--N 1.331 -0.219 0 CA-C-N 116.102 -0.499 . . . . 0.0 110.075 176.897 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' E' E ' 49' ' ' LYS . . . . . . . . . . . . . 60.6 tttm -106.32 137.73 43.76 Favored 'General case' 0 C--O 1.233 0.202 0 CA-C-N 116.504 -0.316 . . . . 0.0 110.418 178.076 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' E' E ' 50' ' ' VAL . . . . . . . . . . . . . 44.0 t -80.45 105.22 9.9 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.279 0 N-CA-C 109.133 -0.692 . . . . 0.0 109.133 175.101 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' E' E ' 51' ' ' VAL . . . . . . . . . . . . . 48.0 t -70.18 -49.32 55.87 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.35 0 CA-C-N 115.956 -0.566 . . . . 0.0 109.968 -174.057 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' E' E ' 52' ' ' GLN . . . . . . . . . . . . . 60.0 tt0 -163.31 140.09 7.25 Favored 'General case' 0 C--N 1.332 -0.183 0 C-N-CA 120.179 -0.608 . . . . 0.0 111.681 -179.185 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' E' E ' 53' ' ' ALA . . . . . . . . . . . . . . . -113.64 130.96 56.31 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 115.821 -0.627 . . . . 0.0 109.907 176.238 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' E' E ' 54' ' ' TYR . . . . . . . . . . . . . 65.1 t80 -129.08 109.98 18.19 Favored Pre-proline 0 CA--C 1.535 0.385 0 CA-C-O 118.274 -0.869 . . . . 0.0 110.207 179.588 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' E' E ' 55' ' ' PRO . . . . . . . . . . . . . 73.4 Cg_endo -77.18 170.1 72.43 Favored 'Cis proline' 0 N--CA 1.499 1.838 0 CA-C-N 121.948 1.731 . . . . 0.0 112.541 -3.918 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' E' E ' 56' ' ' SER . . . . . . . . . . . . . 13.4 m -115.12 128.97 25.46 Favored Pre-proline 0 CA--C 1.539 0.546 0 CA-C-O 118.356 -0.83 . . . . 0.0 109.315 175.412 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' E' E ' 57' ' ' PRO . . . . . . . . . . . . . 44.3 Cg_endo -68.27 166.56 68.16 Favored 'Cis proline' 0 N--CA 1.497 1.722 0 CA-C-N 122.037 1.763 . . . . 0.0 111.576 0.407 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' E' E ' 58' ' ' LEU . . . . . 0.485 HD23 HD12 ' E' ' 4' ' ' LEU . 23.3 tp -129.84 138.57 51.06 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-O 121.022 0.439 . . . . 0.0 110.417 -179.148 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' E' E ' 59' ' ' ARG . . . . . . . . . . . . . 55.3 ttp180 -107.1 130.16 54.72 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 115.632 -0.713 . . . . 0.0 109.51 176.969 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' E' E ' 60' ' ' VAL . . . . . . . . . . . . . 43.7 t -77.74 119.9 27.35 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.252 0 C-N-CA 120.74 -0.384 . . . . 0.0 110.266 -177.079 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' E' E ' 61' ' ' GLU . . . . . . . . . . . . . 43.0 mt-10 -130.95 155.06 47.43 Favored 'General case' 0 C--N 1.331 -0.213 0 CA-C-N 115.944 -0.571 . . . . 0.0 110.528 179.148 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' E' E ' 62' ' ' ASP . . . . . . . . . . . . . 28.6 m-20 -54.61 -32.99 59.73 Favored 'General case' 0 C--N 1.326 -0.429 0 CA-C-N 116.491 -0.322 . . . . 0.0 111.777 179.683 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' E' E ' 63' ' ' ARG . . . . . . . . . . . . . 9.3 ptm180 -88.96 7.66 33.5 Favored 'General case' 0 CA--C 1.536 0.441 0 N-CA-C 113.652 0.982 . . . . 0.0 113.652 -175.082 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' E' E ' 64' ' ' THR . . . . . . . . . . . . . 23.3 m -89.51 146.15 24.81 Favored 'General case' 0 C--N 1.331 -0.196 0 CA-C-N 118.066 0.394 . . . . 0.0 110.319 179.648 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' E' E ' 65' ' ' LYS . . . . . . . . . . . . . 94.7 mttt -84.74 121.82 28.22 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-O 120.841 0.353 . . . . 0.0 110.211 179.914 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' E' E ' 66' ' ' ILE . . . . . . . . . . . . . 58.1 mt -112.52 122.53 66.91 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.263 0 N-CA-C 109.237 -0.653 . . . . 0.0 109.237 179.648 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' E' E ' 67' ' ' THR . . . . . . . . . . . . . 9.6 m -129.95 143.41 50.78 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-O 121.127 0.489 . . . . 0.0 111.679 -172.911 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' E' E ' 68' ' ' LEU . . . . . 0.479 HD12 ' N ' ' E' ' 68' ' ' LEU . 7.9 mp . . . . . 0 C--N 1.331 -0.239 0 CA-C-N 115.799 -0.637 . . . . 0.0 109.631 173.859 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' E' E ' 73' ' ' VAL . . . . . . . . . . . . . 32.9 m . . . . . 0 C--O 1.231 0.131 0 CA-C-O 121.0 0.428 . . . . 0.0 111.226 . . . . . . . . . 0 0 . 1 . 014 nuclear nobuild core ' E' E ' 74' ' ' ASP . . . . . . . . . . . . . 10.6 t0 -101.07 124.11 46.28 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 115.777 -0.647 . . . . 0.0 109.882 178.366 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' E' E ' 75' ' ' VAL . . . . . . . . . . . . . 41.7 t -111.53 125.02 68.82 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.224 0 CA-C-O 121.133 0.492 . . . . 0.0 110.622 -178.111 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' E' E ' 76' ' ' LEU . . . . . . . . . . . . . 42.5 mt -121.28 143.45 49.16 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 115.593 -0.731 . . . . 0.0 109.6 177.22 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' E' E ' 77' ' ' GLU . . . . . . . . . . . . . 97.9 mt-10 -136.47 134.66 37.88 Favored 'General case' 0 C--N 1.331 -0.201 0 CA-C-O 120.996 0.427 . . . . 0.0 111.462 -178.662 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' E' E ' 78' ' ' ALA . . . . . 0.408 ' HB2' HD21 ' E' ' 109' ' ' LEU . . . -121.86 137.11 54.91 Favored 'General case' 0 C--N 1.331 -0.206 0 CA-C-N 115.728 -0.669 . . . . 0.0 109.751 175.738 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' E' E ' 79' ' ' LYS . . . . . 0.582 ' O ' HD13 ' E' ' 80' ' ' ILE . 61.5 mtpt -84.49 120.73 26.66 Favored 'General case' 0 C--N 1.331 -0.219 0 CA-C-O 120.884 0.373 . . . . 0.0 110.831 -178.166 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' E' E ' 80' ' ' ILE . . . . . 0.582 HD13 ' O ' ' E' ' 79' ' ' LYS . 22.6 mm -139.16 124.84 22.38 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.231 0 CA-C-N 115.937 -0.574 . . . . 0.0 109.688 -177.235 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' E' E ' 81' ' ' LYS . . . . . . . . . . . . . 64.8 mmtt -110.22 123.85 50.54 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-O 120.837 0.351 . . . . 0.0 111.419 -179.169 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' E' E ' 82' ' ' GLY . . . . . . . . . . . . . . . 89.06 42.15 5.69 Favored Glycine 0 CA--C 1.524 0.638 0 C-N-CA 120.698 -0.763 . . . . 0.0 112.044 171.664 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' E' E ' 83' ' ' ILE . . . . . . . . . . . . . 71.9 mt -61.66 135.92 25.73 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.335 0 CA-C-O 120.958 0.408 . . . . 0.0 109.957 178.691 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' E' E ' 84' ' ' LYS . . . . . . . . . . . . . 72.7 tttt -96.54 -50.8 4.58 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 115.739 -0.664 . . . . 0.0 110.021 -179.001 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' E' E ' 85' ' ' ASP . . . . . . . . . . . . . 6.1 t0 -156.12 150.11 25.25 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 115.54 -0.755 . . . . 0.0 110.075 179.261 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' E' E ' 86' ' ' VAL . . . . . . . . . . . . . 45.7 t -129.1 129.29 67.77 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.268 0 CA-C-O 120.92 0.391 . . . . 0.0 110.315 -179.26 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' E' E ' 87' ' ' ILE . . . . . 0.473 HG21 HG21 ' E' ' 125' ' ' VAL . 43.1 mm -118.39 125.18 74.13 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.285 0 CA-C-N 115.99 -0.55 . . . . 0.0 109.767 176.489 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' E' E ' 88' ' ' LEU . . . . . . . . . . . . . 52.1 mt -111.04 136.03 50.67 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-O 121.078 0.466 . . . . 0.0 111.437 -178.14 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' E' E ' 89' ' ' ASP . . . . . . . . . . . . . 13.8 t70 -131.42 153.56 49.58 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 115.537 -0.756 . . . . 0.0 109.319 175.384 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' E' E ' 90' ' ' GLU . . . . . . . . . . . . . 46.2 tp10 -47.28 -39.2 14.03 Favored 'General case' 0 N--CA 1.464 0.264 0 N-CA-C 112.817 0.673 . . . . 0.0 112.817 -172.872 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' E' E ' 91' ' ' ASN . . . . . . . . . . . . . 30.2 m120 -132.11 35.51 3.71 Favored 'General case' 0 N--CA 1.464 0.258 0 C-N-CA 120.974 -0.29 . . . . 0.0 111.743 -177.336 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' E' E ' 92' ' ' LEU . . . . . . . . . . . . . 11.3 tp -166.1 145.82 6.19 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-O 120.781 0.324 . . . . 0.0 110.775 -179.835 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' E' E ' 93' ' ' ILE . . . . . . . . . . . . . 72.1 mt -130.63 125.64 59.16 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.24 0 N-CA-C 109.716 -0.475 . . . . 0.0 109.716 -179.736 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' E' E ' 94' ' ' VAL . . . . . 0.462 HG21 HG11 ' E' ' 125' ' ' VAL . 44.3 t -122.89 126.39 73.73 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.292 0 N-CA-C 109.722 -0.473 . . . . 0.0 109.722 178.986 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' E' E ' 95' ' ' VAL . . . . . . . . . . . . . 45.5 t -123.71 132.73 70.89 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.207 0 N-CA-C 109.915 -0.402 . . . . 0.0 109.915 -178.863 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' E' E ' 96' ' ' ILE . . . . . . . . . . . . . 56.0 mt -118.1 134.64 61.08 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.308 0 N-CA-C 109.125 -0.694 . . . . 0.0 109.125 179.51 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' E' E ' 97' ' ' THR . . . . . . . . . . . . . 58.0 p -109.86 157.29 19.36 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-O 121.357 0.599 . . . . 0.0 111.452 -177.174 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' E' E ' 98' ' ' GLU . . . . . . . . . . . . . 96.4 mt-10 -55.13 -22.1 15.56 Favored 'General case' 0 C--N 1.329 -0.306 0 N-CA-C 112.531 0.567 . . . . 0.0 112.531 179.204 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' E' E ' 99' ' ' GLU . . . . . . . . . . . . . 38.4 tt0 -78.75 14.93 1.16 Allowed 'General case' 0 CA--C 1.54 0.57 0 N-CA-C 112.52 0.563 . . . . 0.0 112.52 -178.614 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' E' E ' 100' ' ' ASN . . . . . . . . . . . . . 2.8 m-20 61.96 37.88 14.7 Favored 'General case' 0 CA--C 1.529 0.167 0 O-C-N 121.763 -0.585 . . . . 0.0 110.857 178.537 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' E' E ' 101' ' ' GLU . . . . . . . . . . . . . 84.5 tt0 -120.57 143.57 48.55 Favored 'General case' 0 C--N 1.333 -0.134 0 CA-C-N 116.051 -0.522 . . . . 0.0 109.73 177.821 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' E' E ' 102' ' ' VAL . . . . . . . . . . . . . 41.1 t -120.94 130.85 74.22 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.267 0 CA-C-N 116.313 -0.403 . . . . 0.0 110.049 -178.247 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' E' E ' 103' ' ' LEU . . . . . . . . . . . . . 5.2 mp -121.33 136.8 54.92 Favored 'General case' 0 C--N 1.331 -0.203 0 CA-C-N 115.938 -0.574 . . . . 0.0 110.486 176.456 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' E' E ' 104' ' ' ILE . . . . . . . . . . . . . 68.2 mt -117.56 122.46 69.89 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.297 0 CA-C-N 115.639 -0.71 . . . . 0.0 109.688 -179.551 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' E' E ' 105' ' ' PHE . . . . . . . . . . . . . 55.5 m-85 -123.26 165.76 16.4 Favored 'General case' 0 C--N 1.331 -0.207 0 O-C-N 123.961 0.788 . . . . 0.0 109.455 179.421 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' E' E ' 106' ' ' ASN . . . . . . . . . . . . . 44.0 p-10 -101.65 -171.84 2.05 Favored 'General case' 0 C--N 1.331 -0.225 0 N-CA-C 109.891 -0.411 . . . . 0.0 109.891 173.746 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' E' E ' 107' ' ' GLN . . . . . . . . . . . . . 43.2 tt0 -60.27 -29.88 69.09 Favored 'General case' 0 C--N 1.328 -0.347 0 N-CA-C 111.912 0.338 . . . . 0.0 111.912 179.886 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' E' E ' 108' ' ' ASN . . . . . . . . . . . . . 60.5 t30 -81.9 6.51 15.61 Favored 'General case' 0 CA--C 1.536 0.405 0 N-CA-C 113.278 0.844 . . . . 0.0 113.278 -177.944 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' E' E ' 109' ' ' LEU . . . . . 0.408 HD21 ' HB2' ' E' ' 78' ' ' ALA . 8.8 tp 62.1 36.45 15.23 Favored 'General case' 0 C--O 1.232 0.163 0 CA-C-O 120.966 0.412 . . . . 0.0 111.533 177.905 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' E' E ' 110' ' ' GLU . . . . . . . . . . . . . 70.9 mm-40 -104.26 148.63 26.12 Favored 'General case' 0 C--N 1.329 -0.315 0 N-CA-C 109.807 -0.442 . . . . 0.0 109.807 175.796 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' E' E ' 111' ' ' GLU . . . . . . . . . . . . . 77.3 tt0 -80.22 122.03 26.35 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.429 -0.351 . . . . 0.0 110.971 -176.528 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' E' E ' 112' ' ' LEU . . . . . . . . . . . . . 26.7 mt -105.02 -46.18 4.34 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 116.29 -0.414 . . . . 0.0 110.725 178.596 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' E' E ' 113' ' ' TYR . . . . . . . . . . . . . 64.5 t80 -143.75 139.8 29.61 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.353 -0.385 . . . . 0.0 111.376 -178.875 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' E' E ' 114' ' ' ARG . . . . . . . . . . . . . 60.8 ttp180 -141.07 120.89 13.49 Favored 'General case' 0 C--N 1.33 -0.239 0 CA-C-N 116.274 -0.421 . . . . 0.0 110.165 176.008 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' E' E ' 115' ' ' GLY . . . . . . . . . . . . . . . -150.01 161.7 28.96 Favored Glycine 0 CA--C 1.524 0.652 0 N-CA-C 110.898 -0.881 . . . . 0.0 110.898 178.557 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' E' E ' 116' ' ' LYS . . . . . . . . . . . . . 32.8 ttmt -128.72 139.56 52.16 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-O 120.777 0.322 . . . . 0.0 110.411 179.462 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' E' E ' 117' ' ' PHE . . . . . . . . . . . . . 43.5 m-85 -131.6 115.48 16.14 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.233 -0.44 . . . . 0.0 110.187 -176.949 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' E' E ' 118' ' ' GLU . . . . . . . . . . . . . 96.3 mt-10 -54.64 -46.5 73.95 Favored 'General case' 0 C--N 1.329 -0.299 0 C-N-CA 121.003 -0.279 . . . . 0.0 111.408 -176.004 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' E' E ' 119' ' ' ASN . . . . . . . . . . . . . 28.6 m120 -97.4 31.04 2.63 Favored 'General case' 0 C--N 1.33 -0.269 0 N-CA-C 112.318 0.488 . . . . 0.0 112.318 -174.22 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' E' E ' 120' ' ' LEU . . . . . . . . . . . . . 19.0 tp -55.43 120.82 7.73 Favored 'General case' 0 C--O 1.232 0.175 0 C-N-CA 121.197 -0.201 . . . . 0.0 110.688 178.125 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' E' E ' 121' ' ' ASN . . . . . . . . . . . . . 31.4 m120 -114.04 -44.15 3.18 Favored 'General case' 0 C--N 1.332 -0.195 0 CA-C-N 116.689 -0.232 . . . . 0.0 111.361 -177.321 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' E' E ' 122' ' ' LYS . . . . . . . . . . . . . 93.5 mttt -146.95 154.09 40.85 Favored 'General case' 0 C--N 1.331 -0.222 0 CA-C-O 121.064 0.459 . . . . 0.0 111.895 -176.313 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' E' E ' 123' ' ' VAL . . . . . . . . . . . . . 43.3 t -132.69 133.8 59.07 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.27 0 CA-C-N 115.971 -0.559 . . . . 0.0 110.089 177.142 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' E' E ' 124' ' ' LEU . . . . . . . . . . . . . 54.4 mt -124.17 134.97 53.18 Favored 'General case' 0 C--N 1.33 -0.239 0 CA-C-N 116.591 -0.277 . . . . 0.0 110.545 179.846 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' E' E ' 125' ' ' VAL . . . . . 0.473 HG21 HG21 ' E' ' 87' ' ' ILE . 35.4 m -134.75 135.67 53.07 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.255 0 CA-C-N 116.454 -0.339 . . . . 0.0 110.836 -179.685 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' E' E ' 126' ' ' ARG . . . . . . . . . . . . . 29.9 mtp180 -148.87 124.79 10.61 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-O 121.01 0.433 . . . . 0.0 110.974 175.925 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' E' E ' 127' ' ' ASN . . . . . . . . . . . . . 23.0 t-20 49.92 -106.52 0.22 Allowed 'General case' 0 CA--C 1.543 0.708 0 CA-C-N 116.094 -0.503 . . . . 0.0 111.544 179.066 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' E' E ' 128' ' ' ASP . . . . . . . . . . . . . 23.7 p-10 -114.01 3.26 15.26 Favored 'General case' 0 N--CA 1.467 0.413 0 CA-C-N 119.63 1.105 . . . . 0.0 113.469 -177.014 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' E' E ' 129' ' ' LEU . . . . . . . . . . . . . 15.1 tp -105.23 134.94 47.51 Favored 'General case' 0 C--N 1.334 -0.106 0 N-CA-C 109.876 -0.416 . . . . 0.0 109.876 179.182 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' E' E ' 130' ' ' VAL . . . . . . . . . . . . . 44.6 t -124.29 135.58 63.26 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.246 0 N-CA-C 109.925 -0.398 . . . . 0.0 109.925 -179.532 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' E' E ' 131' ' ' VAL . . . . . 0.446 HG22 HD12 ' E' ' 140' ' ' LEU . 43.4 t -134.01 133.94 55.88 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.262 0 CA-C-O 121.037 0.446 . . . . 0.0 110.094 179.004 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' E' E ' 132' ' ' ILE . . . . . . . . . . . . . 71.0 mt -114.71 132.36 64.12 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.322 0 CA-C-N 115.808 -0.633 . . . . 0.0 109.306 179.36 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' E' E ' 133' ' ' ILE . . . . . . . . . . . . . 39.3 mm -114.93 120.0 63.32 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.231 0 CA-C-O 120.892 0.377 . . . . 0.0 110.954 -174.909 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' E' E ' 134' ' ' ASP . . . . . . . . . . . . . 9.2 p-10 -132.91 145.3 50.8 Favored 'General case' 0 C--N 1.33 -0.25 0 N-CA-C 109.35 -0.611 . . . . 0.0 109.35 174.516 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' E' E ' 135' ' ' GLU . . . . . . . . . . . . . 76.9 tt0 -49.92 -25.72 3.5 Favored 'General case' 0 C--N 1.327 -0.397 0 N-CA-C 112.859 0.688 . . . . 0.0 112.859 -171.304 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' E' E ' 136' ' ' GLN . . . . . . . . . . . . . 44.2 tt0 -82.69 -38.1 23.86 Favored 'General case' 0 C--O 1.233 0.226 0 N-CA-C 112.136 0.421 . . . . 0.0 112.136 -176.172 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' E' E ' 137' ' ' LYS . . . . . . . . . . . . . 18.2 pttp -160.74 169.25 23.14 Favored 'General case' 0 C--O 1.233 0.207 0 CA-C-O 121.451 0.643 . . . . 0.0 112.126 -173.351 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' E' E ' 138' ' ' LEU . . . . . . . . . . . . . 5.9 tt -114.6 127.4 55.76 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 115.221 -0.899 . . . . 0.0 109.63 177.446 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' E' E ' 139' ' ' THR . . . . . . . . . . . . . 23.4 m -105.21 124.03 48.84 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.275 -179.37 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' E' E ' 140' ' ' LEU . . . . . 0.446 HD12 HG22 ' E' ' 131' ' ' VAL . 35.4 tp -110.79 119.94 40.76 Favored 'General case' 0 C--N 1.327 -0.384 0 N-CA-C 109.287 -0.635 . . . . 0.0 109.287 -179.153 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' E' E ' 141' ' ' ILE . . . . . . . . . . . . . 19.3 mt -121.26 117.11 51.73 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.353 0 CA-C-O 121.002 0.43 . . . . 0.0 109.863 -176.211 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' E' E ' 142' ' ' ARG . . . . . . . . . . . . . 73.9 mtp180 -103.76 129.08 51.11 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 115.433 -0.803 . . . . 0.0 110.417 179.653 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' E' E ' 143' ' ' THR . . . . . . . . . . . . . 11.9 p . . . . . 0 C--O 1.219 -0.506 0 CA-C-O 117.997 -1.001 . . . . 0.0 110.531 179.999 . . . . . . . . 0 0 . 1 . 014 nuclear nobuild core ' F' F ' 1' ' ' MET . . . . . . . . . . . . . 22.4 ptm . . . . . 0 N--CA 1.456 -0.152 0 CA-C-O 120.647 0.261 . . . . 0.0 110.81 . . . . . . . . . 0 0 . 1 . 014 nuclear nobuild core ' F' F ' 2' ' ' SER . . . . . . . . . . . . . 3.5 p -121.95 129.07 52.2 Favored 'General case' 0 C--N 1.331 -0.217 0 CA-C-O 120.904 0.383 . . . . 0.0 110.624 178.75 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' F' F ' 3' ' ' GLU . . . . . . . . . . . . . 95.0 mt-10 -140.16 141.43 36.03 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.025 -0.534 . . . . 0.0 111.141 -177.573 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' F' F ' 4' ' ' LEU . . . . . . . . . . . . . 15.5 tp -125.49 126.99 45.76 Favored 'General case' 0 C--N 1.331 -0.225 0 CA-C-N 115.832 -0.622 . . . . 0.0 110.198 176.828 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' F' F ' 5' ' ' LYS . . . . . . . . . . . . . 95.4 mttt -105.35 120.97 42.92 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.412 -0.358 . . . . 0.0 110.812 178.886 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' F' F ' 6' ' ' LEU . . . . . . . . . . . . . 77.6 mt -116.09 150.27 37.61 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-N 115.495 -0.775 . . . . 0.0 110.371 -179.885 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' F' F ' 7' ' ' LYS . . . . . . . . . . . . . 58.3 tttp -140.96 137.87 17.47 Favored Pre-proline 0 CA--C 1.535 0.369 0 CA-C-O 119.025 -0.512 . . . . 0.0 110.26 176.52 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' F' F ' 8' ' ' PRO . . . . . . . . . . . . . 80.9 Cg_endo -91.73 143.76 2.93 Favored 'Trans proline' 0 N--CA 1.491 1.333 0 C-N-CA 121.69 1.593 . . . . 0.0 111.65 177.065 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' F' F ' 9' ' ' LEU . . . . . . . . . . . . . 64.7 mt -76.69 -48.67 2.86 Favored Pre-proline 0 CA--C 1.534 0.33 0 CA-C-O 118.606 -0.712 . . . . 0.0 112.529 -177.796 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' F' F ' 10' ' ' PRO . . . . . . . . . . . . . 83.7 Cg_endo -79.62 147.71 19.92 Favored 'Trans proline' 0 N--CA 1.497 1.729 0 C-N-CA 121.166 1.244 . . . . 0.0 111.627 178.033 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' F' F ' 11' ' ' LYS . . . . . . . . . . . . . 53.5 pttt -79.36 108.85 13.19 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-O 121.778 0.799 . . . . 0.0 110.315 177.563 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' F' F ' 12' ' ' VAL . . . . . . . . . . . . . 11.7 p -148.37 145.25 18.53 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.291 0 CA-C-N 115.425 -0.807 . . . . 0.0 110.12 -179.134 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' F' F ' 13' ' ' GLU . . . . . . . . . . . . . 41.0 tp10 -87.78 123.18 32.31 Favored 'General case' 0 C--N 1.329 -0.312 0 N-CA-C 109.884 -0.413 . . . . 0.0 109.884 179.165 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' F' F ' 14' ' ' LEU . . . . . . . . . . . . . 33.5 mt -98.09 149.08 35.36 Favored Pre-proline 0 CA--C 1.532 0.288 0 CA-C-N 116.404 -0.362 . . . . 0.0 110.644 -177.258 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' F' F ' 15' ' ' PRO . . . . . . . . . . . . . 25.4 Cg_exo -62.62 159.54 36.36 Favored 'Trans proline' 0 N--CA 1.498 1.791 0 C-N-CA 121.25 1.3 . . . . 0.0 111.978 176.86 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' F' F ' 16' ' ' PRO . . . . . . . . . . . . . 27.9 Cg_exo -60.47 -34.83 92.51 Favored 'Trans proline' 0 N--CA 1.496 1.639 0 C-N-CA 121.414 1.409 . . . . 0.0 112.494 -179.659 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' F' F ' 17' ' ' ASP . . . . . . . . . . . . . 22.2 p-10 -88.04 10.79 17.89 Favored 'General case' 0 CA--C 1.535 0.393 0 N-CA-C 113.024 0.75 . . . . 0.0 113.024 -178.431 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' F' F ' 18' ' ' PHE . . . . . . . . . . . . . 30.1 t80 -58.01 -42.01 84.32 Favored 'General case' 0 N--CA 1.457 -0.115 0 O-C-N 121.932 -0.48 . . . . 0.0 110.158 -178.507 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' F' F ' 19' ' ' VAL . . . . . . . . . . . . . 49.1 t -56.35 -42.86 75.61 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.282 0 CA-C-N 116.469 -0.332 . . . . 0.0 110.41 -179.676 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' F' F ' 20' ' ' ASP . . . . . . . . . . . . . 81.7 m-20 -60.15 -43.0 96.08 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.428 -0.351 . . . . 0.0 110.884 -178.049 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' F' F ' 21' ' ' VAL . . . . . . . . . . . . . 48.7 t -64.18 -48.11 87.08 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.309 0 C-N-CA 120.832 -0.347 . . . . 0.0 110.548 -177.39 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' F' F ' 22' ' ' ILE . . . . . 0.572 HG22 HD12 ' F' ' 26' ' ' LEU . 50.1 mm -55.9 -47.44 79.83 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.312 0 C-N-CA 121.036 -0.266 . . . . 0.0 110.74 -179.978 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' F' F ' 23' ' ' ARG . . . . . . . . . . . . . 54.6 ttp180 -55.38 -48.8 73.76 Favored 'General case' 0 C--N 1.33 -0.276 0 C-N-CA 121.038 -0.265 . . . . 0.0 111.337 -178.291 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' F' F ' 24' ' ' ILE . . . . . . . . . . . . . 73.9 mt -58.48 -41.98 83.18 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.281 0 CA-C-O 120.706 0.288 . . . . 0.0 110.799 -177.378 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' F' F ' 25' ' ' LYS . . . . . . . . . . . . . 51.7 mtpt -65.55 -43.66 89.21 Favored 'General case' 0 C--N 1.327 -0.382 0 N-CA-C 112.319 0.489 . . . . 0.0 112.319 -178.697 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' F' F ' 26' ' ' LEU . . . . . 0.572 HD12 HG22 ' F' ' 22' ' ' ILE . 79.5 mt -79.74 -33.2 40.97 Favored 'General case' 0 C--N 1.331 -0.201 0 N-CA-C 113.874 1.064 . . . . 0.0 113.874 -169.549 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' F' F ' 27' ' ' GLN . . . . . . . . . . . . . 10.8 pt20 -46.76 139.42 5.35 Favored 'General case' 0 N--CA 1.469 0.507 0 N-CA-C 113.027 0.751 . . . . 0.0 113.027 -173.497 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' F' F ' 28' ' ' GLY . . . . . . . . . . . . . . . 99.35 -23.61 35.58 Favored Glycine 0 CA--C 1.535 1.292 0 CA-C-N 115.442 -0.799 . . . . 0.0 112.451 -178.962 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' F' F ' 29' ' ' LYS . . . . . . . . . . . . . 61.1 mttp -97.89 155.15 17.2 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 117.527 0.664 . . . . 0.0 111.136 179.682 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' F' F ' 30' ' ' THR . . . . . . . . . . . . . 36.3 m -104.61 137.01 43.09 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 115.931 -0.577 . . . . 0.0 109.852 175.586 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' F' F ' 31' ' ' VAL . . . . . . . . . . . . . 34.9 m -129.64 153.54 38.94 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.21 0 CA-C-O 121.003 0.43 . . . . 0.0 110.953 -178.379 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' F' F ' 32' ' ' ARG . . . . . . . . . . . . . 38.9 ttm180 -133.66 149.41 51.55 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 115.991 -0.549 . . . . 0.0 110.454 -179.991 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' F' F ' 33' ' ' THR . . . . . . . . . . . . . 21.4 m -52.17 138.7 25.27 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.307 -0.406 . . . . 0.0 111.563 -176.17 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' F' F ' 34' ' ' GLY . . . . . . . . . . . . . . . 100.48 -17.1 57.21 Favored Glycine 0 CA--C 1.533 1.209 0 CA-C-O 119.64 -0.533 . . . . 0.0 113.326 178.536 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' F' F ' 35' ' ' ASP . . . . . . . . . . . . . 80.2 m-20 -66.2 147.37 53.42 Favored 'General case' 0 C--N 1.332 -0.155 0 CA-C-N 118.014 0.907 . . . . 0.0 110.953 178.856 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' F' F ' 36' ' ' VAL . . . . . . . . . . . . . 46.3 t -122.32 129.99 74.88 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.197 0 CA-C-N 115.965 -0.561 . . . . 0.0 109.849 178.225 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' F' F ' 37' ' ' ILE . . . . . . . . . . . . . 69.3 mt -121.83 139.93 47.38 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.247 0 CA-C-N 116.194 -0.457 . . . . 0.0 109.955 -179.138 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' F' F ' 38' ' ' GLY . . . . . . . . . . . . . . . -113.64 128.74 8.46 Favored Glycine 0 CA--C 1.526 0.743 0 N-CA-C 111.282 -0.727 . . . . 0.0 111.282 -179.928 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' F' F ' 39' ' ' ILE . . . . . . . . . . . . . 70.0 mt -121.03 134.94 62.8 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.171 0 N-CA-C 109.959 -0.386 . . . . 0.0 109.959 178.269 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' F' F ' 40' ' ' SER . . . . . . . . . . . . . 87.4 p -92.16 120.68 32.97 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 116.422 -0.353 . . . . 0.0 110.62 175.537 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' F' F ' 41' ' ' ILE . . . . . . . . . . . . . 72.2 mt -132.36 117.56 32.45 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.207 0 CA-C-O 120.757 0.313 . . . . 0.0 110.157 178.554 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' F' F ' 42' ' ' LEU . . . . . . . . . . . . . 8.4 tp 57.95 35.85 25.67 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.176 -0.466 . . . . 0.0 111.363 178.515 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' F' F ' 43' ' ' GLY . . . . . . . . . . . . . . . 77.41 -10.08 24.43 Favored Glycine 0 CA--C 1.535 1.326 0 C-N-CA 121.26 -0.495 . . . . 0.0 113.381 177.431 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' F' F ' 44' ' ' LYS . . . . . . . . . . . . . 59.2 tttm -98.28 134.29 41.51 Favored 'General case' 0 C--N 1.333 -0.126 0 CA-C-N 117.996 0.898 . . . . 0.0 109.897 177.905 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' F' F ' 45' ' ' GLU . . . . . . . . . . . . . 82.3 tt0 -84.53 128.14 34.43 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.325 -0.398 . . . . 0.0 110.903 -179.423 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' F' F ' 46' ' ' VAL . . . . . . . . . . . . . 7.3 p -121.87 126.84 75.1 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.211 0 N-CA-C 109.632 -0.507 . . . . 0.0 109.632 175.936 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' F' F ' 47' ' ' LYS . . . . . . . . . . . . . 59.5 mtpt -100.58 128.85 46.5 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 115.895 -0.593 . . . . 0.0 111.24 179.573 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' F' F ' 48' ' ' PHE . . . . . . . . . . . . . 95.8 m-85 -113.28 131.88 55.76 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.279 -0.419 . . . . 0.0 110.064 176.361 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' F' F ' 49' ' ' LYS . . . . . . . . . . . . . 57.0 tttm -108.66 139.69 43.09 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.47 -0.332 . . . . 0.0 110.471 178.326 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' F' F ' 50' ' ' VAL . . . . . . . . . . . . . 45.2 t -82.22 109.18 15.96 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.308 0 N-CA-C 109.137 -0.69 . . . . 0.0 109.137 175.66 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' F' F ' 51' ' ' VAL . . . . . . . . . . . . . 47.0 t -73.5 -48.4 41.48 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.294 0 CA-C-N 116.015 -0.539 . . . . 0.0 110.032 -173.81 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' F' F ' 52' ' ' GLN . . . . . . . . . . . . . 61.4 tt0 -163.82 139.48 6.38 Favored 'General case' 0 C--N 1.33 -0.239 0 C-N-CA 120.264 -0.574 . . . . 0.0 111.817 -177.604 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' F' F ' 53' ' ' ALA . . . . . . . . . . . . . . . -116.63 131.45 56.95 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 115.832 -0.622 . . . . 0.0 110.108 175.839 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' F' F ' 54' ' ' TYR . . . . . . . . . . . . . 69.0 t80 -129.12 110.63 18.22 Favored Pre-proline 0 CA--C 1.534 0.352 0 CA-C-O 118.343 -0.837 . . . . 0.0 110.393 178.959 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' F' F ' 55' ' ' PRO . . . . . . . . . . . . . 73.9 Cg_endo -77.1 170.1 72.53 Favored 'Cis proline' 0 N--CA 1.499 1.831 0 CA-C-N 121.977 1.742 . . . . 0.0 112.292 -5.93 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' F' F ' 56' ' ' SER . . . . . . . . . . . . . 14.3 m -116.16 135.55 22.83 Favored Pre-proline 0 CA--C 1.54 0.571 0 CA-C-O 118.425 -0.798 . . . . 0.0 109.678 176.155 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' F' F ' 57' ' ' PRO . . . . . . . . . . . . . 56.8 Cg_endo -72.47 148.94 92.67 Favored 'Cis proline' 0 N--CA 1.496 1.651 0 CA-C-N 121.694 1.641 . . . . 0.0 111.339 -3.024 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' F' F ' 58' ' ' LEU . . . . . . . . . . . . . 37.7 tp -107.43 137.78 44.85 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-O 120.929 0.395 . . . . 0.0 110.688 -177.096 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' F' F ' 59' ' ' ARG . . . . . . . . . . . . . 61.0 ttt180 -98.92 125.81 44.44 Favored 'General case' 0 C--N 1.325 -0.457 0 CA-C-N 115.783 -0.644 . . . . 0.0 109.292 176.527 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' F' F ' 60' ' ' VAL . . . . . . . . . . . . . 42.0 t -84.34 114.87 25.45 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.246 0 C-N-CA 120.642 -0.423 . . . . 0.0 110.352 -174.975 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' F' F ' 61' ' ' GLU . . . . . . . . . . . . . 41.0 mt-10 -131.16 160.94 33.29 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 115.931 -0.577 . . . . 0.0 109.827 177.329 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' F' F ' 62' ' ' ASP . . . . . . . . . . . . . 74.4 m-20 -53.24 -32.49 48.58 Favored 'General case' 0 C--N 1.329 -0.283 0 N-CA-C 111.858 0.318 . . . . 0.0 111.858 -179.789 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' F' F ' 63' ' ' ARG . . . . . . . . . . . . . 83.1 mtp180 -72.87 -22.03 60.84 Favored 'General case' 0 CA--C 1.533 0.306 0 N-CA-C 112.913 0.708 . . . . 0.0 112.913 -177.048 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' F' F ' 64' ' ' THR . . . . . . . . . . . . . 32.5 m -69.55 142.67 53.57 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-O 120.82 0.343 . . . . 0.0 110.815 -175.455 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' F' F ' 65' ' ' LYS . . . . . . . . . . . . . 97.7 mttt -88.73 123.22 32.95 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.066 -0.515 . . . . 0.0 110.065 179.698 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' F' F ' 66' ' ' ILE . . . . . . . . . . . . . 63.0 mt -113.58 129.35 69.54 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.295 0 N-CA-C 109.702 -0.481 . . . . 0.0 109.702 -179.916 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' F' F ' 67' ' ' THR . . . . . . . . . . . . . 28.1 m -128.26 142.65 51.09 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.144 -0.48 . . . . 0.0 111.082 -177.473 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' F' F ' 68' ' ' LEU . . . . . . . . . . . . . 4.8 tt . . . . . 0 C--N 1.33 -0.272 0 CA-C-N 115.876 -0.602 . . . . 0.0 109.484 177.135 . . . . . . . . 0 0 . 1 . 014 nuclear nobuild core ' F' F ' 73' ' ' VAL . . . . . . . . . . . . . 29.6 m . . . . . 0 N--CA 1.461 0.077 0 CA-C-O 121.203 0.525 . . . . 0.0 111.471 . . . . . . . . . 0 0 . 1 . 014 nuclear nobuild core ' F' F ' 74' ' ' ASP . . . . . . . . . . . . . 10.0 t70 -102.96 119.32 38.64 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 115.441 -0.8 . . . . 0.0 109.503 175.898 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' F' F ' 75' ' ' VAL . . . . . . . . . . . . . 44.9 t -111.13 123.89 67.43 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.217 0 CA-C-O 121.15 0.5 . . . . 0.0 110.556 -177.347 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' F' F ' 76' ' ' LEU . . . . . . . . . . . . . 25.9 mt -125.93 147.37 49.51 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 115.561 -0.745 . . . . 0.0 109.615 178.546 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' F' F ' 77' ' ' GLU . . . . . . . . . . . . . 98.4 mt-10 -136.24 135.6 39.18 Favored 'General case' 0 C--N 1.331 -0.204 0 CA-C-O 121.134 0.493 . . . . 0.0 111.457 -177.318 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' F' F ' 78' ' ' ALA . . . . . 0.658 ' HB2' HD21 ' F' ' 109' ' ' LEU . . . -123.34 129.2 50.98 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 115.493 -0.776 . . . . 0.0 109.699 176.14 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' F' F ' 79' ' ' LYS . . . . . 0.566 ' O ' HD13 ' F' ' 80' ' ' ILE . 96.8 mttt -76.88 119.23 20.36 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-O 120.915 0.388 . . . . 0.0 110.836 -178.585 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' F' F ' 80' ' ' ILE . . . . . 0.566 HD13 ' O ' ' F' ' 79' ' ' LYS . 42.6 mm -139.09 116.68 11.64 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.326 0 N-CA-C 108.781 -0.822 . . . . 0.0 108.781 -178.186 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' F' F ' 81' ' ' LYS . . . . . . . . . . . . . 17.6 ptpt -105.96 127.72 53.34 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-O 121.303 0.573 . . . . 0.0 111.323 -175.696 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' F' F ' 82' ' ' GLY . . . . . . . . . . . . . . . 88.75 42.17 5.8 Favored Glycine 0 CA--C 1.525 0.684 0 CA-C-N 115.725 -0.67 . . . . 0.0 111.838 173.795 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' F' F ' 83' ' ' ILE . . . . . . . . . . . . . 74.6 mt -69.88 140.91 17.86 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.292 0 CA-C-O 121.043 0.449 . . . . 0.0 110.053 179.021 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' F' F ' 84' ' ' LYS . . . . . . . . . . . . . 67.5 tttt -99.75 -53.98 3.04 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 115.868 -0.605 . . . . 0.0 110.204 -178.869 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' F' F ' 85' ' ' ASP . . . . . . . . . . . . . 5.6 t70 -155.38 155.78 34.23 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 115.817 -0.629 . . . . 0.0 110.134 -179.021 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' F' F ' 86' ' ' VAL . . . . . . . . . . . . . 44.3 t -135.6 135.66 51.18 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.238 0 CA-C-O 121.038 0.447 . . . . 0.0 110.806 -178.135 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' F' F ' 87' ' ' ILE . . . . . . . . . . . . . 44.2 mm -119.38 128.5 75.85 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.199 0 CA-C-N 115.708 -0.678 . . . . 0.0 109.466 176.139 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' F' F ' 88' ' ' LEU . . . . . 0.406 HD13 HG21 ' E' ' 131' ' ' VAL . 24.0 tp -111.98 131.51 55.35 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-O 120.89 0.376 . . . . 0.0 110.996 -177.803 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' F' F ' 89' ' ' ASP . . . . . . . . . . . . . 10.0 t70 -126.09 154.05 43.63 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 116.036 -0.529 . . . . 0.0 109.597 176.39 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' F' F ' 90' ' ' GLU . . . . . . . . . . . . . 46.5 tp10 -47.29 -38.36 12.43 Favored 'General case' 0 C--N 1.33 -0.253 0 N-CA-C 112.794 0.665 . . . . 0.0 112.794 -172.394 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' F' F ' 91' ' ' ASN . . . . . . . . . . . . . 15.0 t-20 -132.06 33.34 3.92 Favored 'General case' 0 N--CA 1.466 0.353 0 C-N-CA 120.883 -0.327 . . . . 0.0 111.855 -175.889 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' F' F ' 92' ' ' LEU . . . . . . . . . . . . . 10.1 tp -166.12 148.31 7.01 Favored 'General case' 0 C--N 1.332 -0.169 0 C-N-CA 120.705 -0.398 . . . . 0.0 111.043 179.205 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' F' F ' 93' ' ' ILE . . . . . . . . . . . . . 67.4 mt -125.55 124.49 66.9 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.211 0 N-CA-C 109.588 -0.523 . . . . 0.0 109.588 -179.883 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' F' F ' 94' ' ' VAL . . . . . . . . . . . . . 43.7 t -122.27 126.57 74.45 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.186 0 N-CA-C 109.91 -0.404 . . . . 0.0 109.91 179.466 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' F' F ' 95' ' ' VAL . . . . . . . . . . . . . 46.3 t -123.59 135.0 64.81 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.175 0 CA-C-N 116.338 -0.392 . . . . 0.0 110.103 -179.175 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' F' F ' 96' ' ' ILE . . . . . . . . . . . . . 65.1 mt -116.48 130.64 70.95 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.265 0 N-CA-C 109.38 -0.6 . . . . 0.0 109.38 178.606 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' F' F ' 97' ' ' THR . . . . . . . . . . . . . 81.5 p -101.3 159.86 14.9 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-O 121.039 0.447 . . . . 0.0 111.19 -179.154 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' F' F ' 98' ' ' GLU . . . . . . . . . . . . . 45.1 mt-10 -54.35 -26.32 29.31 Favored 'General case' 0 C--N 1.328 -0.359 0 N-CA-C 112.257 0.465 . . . . 0.0 112.257 -179.497 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' F' F ' 99' ' ' GLU . . . . . . . . . . . . . 14.3 mm-40 -78.53 14.86 1.14 Allowed 'General case' 0 CA--C 1.535 0.366 0 N-CA-C 113.183 0.808 . . . . 0.0 113.183 -178.012 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' F' F ' 100' ' ' ASN . . . . . . . . . . . . . 7.6 m-20 60.13 37.46 20.85 Favored 'General case' 0 CA--C 1.529 0.138 0 CA-C-O 121.019 0.437 . . . . 0.0 111.091 -179.845 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' F' F ' 101' ' ' GLU . . . . . . . . . . . . . 84.7 tt0 -112.04 141.03 46.22 Favored 'General case' 0 C--N 1.331 -0.223 0 CA-C-N 116.023 -0.535 . . . . 0.0 109.659 174.09 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' F' F ' 102' ' ' VAL . . . . . . . . . . . . . 42.8 t -114.98 127.8 72.39 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.293 0 N-CA-C 109.9 -0.408 . . . . 0.0 109.9 -178.848 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' F' F ' 103' ' ' LEU . . . . . 0.488 HD12 ' N ' ' F' ' 103' ' ' LEU . 6.4 mp -117.6 134.48 54.83 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 115.668 -0.696 . . . . 0.0 110.164 176.739 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' F' F ' 104' ' ' ILE . . . . . . . . . . . . . 66.2 mt -117.37 123.87 72.32 Favored 'Isoleucine or valine' 0 C--O 1.233 0.211 0 CA-C-N 116.267 -0.424 . . . . 0.0 109.957 -179.601 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' F' F ' 105' ' ' PHE . . . . . . . . . . . . . 92.3 m-85 -123.25 161.36 24.72 Favored 'General case' 0 C--N 1.332 -0.184 0 O-C-N 123.992 0.808 . . . . 0.0 109.97 -179.548 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' F' F ' 106' ' ' ASN . . . . . . . . . . . . . 44.3 p-10 -99.42 -171.74 2.13 Favored 'General case' 0 C--N 1.33 -0.277 0 N-CA-C 110.209 -0.293 . . . . 0.0 110.209 175.266 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' F' F ' 107' ' ' GLN . . . . . . . . . . . . . 50.7 tt0 -58.87 -28.21 65.92 Favored 'General case' 0 C--N 1.329 -0.316 0 N-CA-C 112.176 0.436 . . . . 0.0 112.176 179.7 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' F' F ' 108' ' ' ASN . . . . . . . . . . . . . 2.7 t-20 -85.63 7.75 22.11 Favored 'General case' 0 CA--C 1.538 0.486 0 N-CA-C 113.252 0.834 . . . . 0.0 113.252 -176.857 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' F' F ' 109' ' ' LEU . . . . . 0.658 HD21 ' HB2' ' F' ' 78' ' ' ALA . 11.7 tp 59.94 38.13 21.15 Favored 'General case' 0 CA--C 1.53 0.181 0 CA-C-O 121.086 0.47 . . . . 0.0 111.166 178.984 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' F' F ' 110' ' ' GLU . . . . . . . . . . . . . 95.7 mt-10 -108.22 148.76 29.5 Favored 'General case' 0 C--N 1.33 -0.267 0 N-CA-C 109.73 -0.47 . . . . 0.0 109.73 175.274 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' F' F ' 111' ' ' GLU . . . . . . . . . . . . . 60.0 tt0 -83.51 121.88 27.8 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-O 120.774 0.321 . . . . 0.0 110.725 -175.763 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' F' F ' 112' ' ' LEU . . . . . . . . . . . . . 27.7 mt -106.92 -46.05 4.03 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.1 -0.5 . . . . 0.0 110.814 179.673 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' F' F ' 113' ' ' TYR . . . . . . . . . . . . . 60.1 t80 -134.86 141.88 46.47 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 116.437 -0.347 . . . . 0.0 111.229 -178.227 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' F' F ' 114' ' ' ARG . . . . . . . . . . . . . 36.9 ptt180 -146.61 121.05 9.66 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.738 178.12 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' F' F ' 115' ' ' GLY . . . . . . . . . . . . . . . -150.12 149.75 21.69 Favored Glycine 0 CA--C 1.526 0.744 0 N-CA-C 111.203 -0.759 . . . . 0.0 111.203 178.332 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' F' F ' 116' ' ' LYS . . . . . . . . . . . . . 35.1 ttmt -115.35 136.77 52.75 Favored 'General case' 0 C--N 1.331 -0.233 0 N-CA-C 110.133 -0.321 . . . . 0.0 110.133 176.678 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' F' F ' 117' ' ' PHE . . . . . . . . . . . . . 44.1 m-85 -132.35 114.52 14.48 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-O 120.974 0.416 . . . . 0.0 110.137 -177.344 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' F' F ' 118' ' ' GLU . . . . . . . . . . . . . 96.2 mt-10 -53.97 -46.94 71.8 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.336 -0.393 . . . . 0.0 111.427 -175.775 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' F' F ' 119' ' ' ASN . . . . . . . . . . . . . 28.6 m120 -94.43 31.06 1.81 Allowed 'General case' 0 C--N 1.328 -0.342 0 N-CA-C 112.165 0.432 . . . . 0.0 112.165 -174.334 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' F' F ' 120' ' ' LEU . . . . . . . . . . . . . 16.0 tp -57.35 119.98 7.39 Favored 'General case' 0 C--N 1.332 -0.169 0 N-CA-C 110.175 -0.305 . . . . 0.0 110.175 177.657 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' F' F ' 121' ' ' ASN . . . . . . . . . . . . . 81.2 m-20 -114.1 -44.08 3.17 Favored 'General case' 0 C--O 1.233 0.223 0 CA-C-N 116.365 -0.379 . . . . 0.0 111.026 -178.419 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' F' F ' 122' ' ' LYS . . . . . . . . . . . . . 98.4 mttt -145.77 149.55 34.57 Favored 'General case' 0 C--N 1.333 -0.128 0 CA-C-O 121.092 0.472 . . . . 0.0 111.856 -178.319 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' F' F ' 123' ' ' VAL . . . . . . . . . . . . . 46.8 t -124.92 126.66 71.64 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.211 0 CA-C-N 115.694 -0.684 . . . . 0.0 109.497 175.043 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' F' F ' 124' ' ' LEU . . . . . 0.42 HD12 ' N ' ' F' ' 124' ' ' LEU . 6.2 mp -117.88 133.94 55.43 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.473 -0.331 . . . . 0.0 110.434 -179.314 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' F' F ' 125' ' ' VAL . . . . . . . . . . . . . 12.0 p -133.77 135.91 54.74 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.285 0 CA-C-N 116.233 -0.44 . . . . 0.0 110.522 -179.875 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' F' F ' 126' ' ' ARG . . . . . . . . . . . . . 95.9 mtt-85 -143.31 116.88 9.17 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.115 -0.493 . . . . 0.0 110.267 177.716 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' F' F ' 127' ' ' ASN . . . . . . . . . . . . . 64.3 t30 52.56 -104.98 0.21 Allowed 'General case' 0 CA--C 1.544 0.744 0 CA-C-O 118.986 -0.53 . . . . 0.0 111.357 179.74 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' F' F ' 128' ' ' ASP . . . . . . . . . . . . . 8.6 p-10 -114.08 4.43 15.64 Favored 'General case' 0 CA--C 1.537 0.463 0 CA-C-N 119.526 1.057 . . . . 0.0 113.547 -176.623 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' F' F ' 129' ' ' LEU . . . . . . . . . . . . . 14.6 tp -107.37 139.0 42.53 Favored 'General case' 0 C--N 1.332 -0.173 0 CA-C-N 118.207 0.458 . . . . 0.0 110.292 179.693 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' F' F ' 130' ' ' VAL . . . . . . . . . . . . . 41.3 t -126.71 137.14 58.73 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.233 0 CA-C-O 120.942 0.401 . . . . 0.0 110.424 -178.339 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' F' F ' 131' ' ' VAL . . . . . . . . . . . . . 43.0 t -136.02 136.46 49.63 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.271 0 CA-C-N 116.239 -0.437 . . . . 0.0 110.198 176.916 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' F' F ' 132' ' ' ILE . . . . . . . . . . . . . 77.5 mt -116.57 133.16 64.07 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.257 0 CA-C-N 115.908 -0.587 . . . . 0.0 109.605 -179.071 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' F' F ' 133' ' ' ILE . . . . . . . . . . . . . 41.2 mm -116.53 125.26 73.44 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.249 0 CA-C-N 116.377 -0.374 . . . . 0.0 111.112 -174.66 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' F' F ' 134' ' ' ASP . . . . . . . . . . . . . 11.7 p-10 -139.02 151.6 46.94 Favored 'General case' 0 C--N 1.333 -0.135 0 CA-C-N 116.198 -0.455 . . . . 0.0 109.912 174.037 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' F' F ' 135' ' ' GLU . . . . . . . . . . . . . 84.8 tt0 -50.82 -27.94 8.39 Favored 'General case' 0 C--N 1.33 -0.267 0 N-CA-C 112.862 0.69 . . . . 0.0 112.862 -172.513 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' F' F ' 136' ' ' GLN . . . . . . . . . . . . . 96.9 mt-30 -84.9 -30.02 24.73 Favored 'General case' 0 C--N 1.329 -0.291 0 N-CA-C 112.63 0.604 . . . . 0.0 112.63 -174.663 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' F' F ' 137' ' ' LYS . . . . . . . . . . . . . 56.7 pttt -169.08 173.16 7.01 Favored 'General case' 0 C--O 1.233 0.212 0 CA-C-O 121.683 0.754 . . . . 0.0 112.672 -170.267 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' F' F ' 138' ' ' LEU . . . . . 0.46 HD23 ' N ' ' F' ' 139' ' ' THR . 4.7 tt -121.73 128.9 52.29 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 114.77 -1.105 . . . . 0.0 109.673 178.862 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' F' F ' 139' ' ' THR . . . . . 0.46 ' N ' HD23 ' F' ' 138' ' ' LEU . 42.1 m -111.71 126.09 54.67 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.443 -0.344 . . . . 0.0 110.146 179.402 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' F' F ' 140' ' ' LEU . . . . . 0.471 HD23 ' C ' ' F' ' 140' ' ' LEU . 6.3 tt -113.0 124.14 51.94 Favored 'General case' 0 C--N 1.329 -0.291 0 N-CA-C 109.579 -0.526 . . . . 0.0 109.579 -178.625 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' F' F ' 141' ' ' ILE . . . . . 0.433 ' N ' HD23 ' F' ' 140' ' ' LEU . 19.4 mt -122.55 120.42 60.91 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.309 0 CA-C-O 121.014 0.435 . . . . 0.0 110.049 -175.128 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' F' F ' 142' ' ' ARG . . . . . . . . . . . . . 67.7 ttt180 -111.4 126.97 55.5 Favored 'General case' 0 C--N 1.332 -0.17 0 CA-C-N 115.376 -0.829 . . . . 0.0 110.492 -177.114 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' F' F ' 143' ' ' THR . . . . . . . . . . . . . 56.0 p . . . . . 0 C--O 1.219 -0.52 0 CA-C-O 118.12 -0.943 . . . . 0.0 110.623 179.921 . . . . . . . . 0 0 . 1 . 015 nuclear nobuild core ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 40.9 p . . . . . 0 C--O 1.232 0.165 0 CA-C-O 120.84 0.352 . . . . 0.0 110.384 . . . . . . . . . 0 0 . 1 . 015 nuclear nobuild core ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 95.2 mt-10 -141.32 140.56 33.83 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.194 -0.457 . . . . 0.0 111.355 -177.861 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 4' ' ' LEU . . . . . . . . . . . . . 75.9 mt -121.82 128.38 51.6 Favored 'General case' 0 C--O 1.233 0.226 0 CA-C-N 115.951 -0.568 . . . . 0.0 110.17 174.884 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 5' ' ' LYS . . . . . . . . . . . . . 68.5 mttm -107.55 122.15 46.09 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.451 -0.341 . . . . 0.0 110.259 177.769 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 6' ' ' LEU . . . . . 0.422 HD23 ' HA ' ' A' ' 50' ' ' VAL . 70.5 mt -118.14 144.29 45.8 Favored 'General case' 0 C--N 1.331 -0.224 0 CA-C-N 115.769 -0.65 . . . . 0.0 110.287 -179.105 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 59.3 tttm -121.64 135.13 24.89 Favored Pre-proline 0 CA--C 1.534 0.363 0 CA-C-O 118.675 -0.679 . . . . 0.0 109.603 175.475 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 8' ' ' PRO . . . . . . . . . . . . . 84.9 Cg_endo -90.04 131.79 1.86 Allowed 'Trans proline' 0 N--CA 1.488 1.176 0 C-N-CA 121.605 1.537 . . . . 0.0 111.735 178.054 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 28.2 mt -73.65 -47.4 7.06 Favored Pre-proline 0 CA--C 1.535 0.384 0 CA-C-O 118.604 -0.712 . . . . 0.0 111.972 -179.072 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 95.5 Cg_endo -79.76 151.04 21.66 Favored 'Trans proline' 0 N--CA 1.497 1.697 0 C-N-CA 121.056 1.171 . . . . 0.0 111.873 176.049 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 19.2 ttpp -85.65 107.06 17.37 Favored 'General case' 0 C--N 1.33 -0.27 0 C-N-CA 120.885 -0.326 . . . . 0.0 110.31 178.895 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 12.0 p -149.22 147.68 16.34 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.323 0 CA-C-N 116.352 -0.385 . . . . 0.0 110.805 -179.153 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 94.7 mt-10 -95.75 110.05 22.26 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.087 -0.506 . . . . 0.0 109.668 175.843 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 14' ' ' LEU . . . . . . . . . . . . . 51.2 mt -86.54 148.78 47.39 Favored Pre-proline 0 CA--C 1.533 0.307 0 CA-C-O 119.303 -0.379 . . . . 0.0 110.481 -176.793 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 15' ' ' PRO . . . . . . . . . . . . . 28.6 Cg_exo -61.03 159.57 29.28 Favored 'Trans proline' 0 N--CA 1.497 1.685 0 C-N-CA 121.269 1.313 . . . . 0.0 111.738 177.263 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 16' ' ' PRO . . . . . . . . . . . . . 32.7 Cg_exo -59.75 -35.89 93.14 Favored 'Trans proline' 0 N--CA 1.498 1.74 0 C-N-CA 121.374 1.383 . . . . 0.0 112.692 -178.736 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 17' ' ' ASP . . . . . . . . . . . . . 8.5 p-10 -84.03 4.85 28.14 Favored 'General case' 0 CA--C 1.536 0.423 0 N-CA-C 113.26 0.837 . . . . 0.0 113.26 -177.959 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 18' ' ' PHE . . . . . . . . . . . . . 40.2 t80 -58.47 -46.03 87.43 Favored 'General case' 0 N--CA 1.456 -0.145 0 O-C-N 121.912 -0.493 . . . . 0.0 109.978 -178.699 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 19' ' ' VAL . . . . . . . . . . . . . 47.9 t -57.12 -41.22 77.3 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.368 0 CA-C-N 116.236 -0.438 . . . . 0.0 110.479 -177.743 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 74.9 m-20 -60.34 -45.16 94.43 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-O 120.756 0.313 . . . . 0.0 111.043 -177.356 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 46.5 t -64.98 -46.46 91.52 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.276 0 C-N-CA 120.692 -0.403 . . . . 0.0 110.436 -177.761 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 22' ' ' ILE . . . . . . . . . . . . . 51.6 mm -57.32 -42.36 80.16 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.218 0 CA-C-O 120.899 0.38 . . . . 0.0 110.362 178.389 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 23' ' ' ARG . . . . . . . . . . . . . 59.7 ttp180 -53.71 -49.17 68.67 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-O 120.794 0.33 . . . . 0.0 111.278 -179.223 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 24' ' ' ILE . . . . . . . . . . . . . 70.2 mt -60.67 -41.48 88.33 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.255 0 CA-C-N 116.497 -0.32 . . . . 0.0 110.935 -179.488 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 52.9 mmtt -63.15 -37.4 87.07 Favored 'General case' 0 C--N 1.329 -0.314 0 N-CA-C 112.073 0.397 . . . . 0.0 112.073 179.239 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 58.9 mt -79.06 -42.4 26.51 Favored 'General case' 0 C--N 1.329 -0.297 0 N-CA-C 113.347 0.869 . . . . 0.0 113.347 -172.125 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 27' ' ' GLN . . . . . . . . . . . . . 10.3 pt20 -47.37 140.68 5.42 Favored 'General case' 0 N--CA 1.47 0.545 0 N-CA-C 112.716 0.636 . . . . 0.0 112.716 -174.735 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 98.09 -25.21 28.55 Favored Glycine 0 CA--C 1.532 1.147 0 CA-C-N 115.541 -0.754 . . . . 0.0 112.398 -178.627 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 69.1 mttm -97.73 155.11 17.17 Favored 'General case' 0 C--N 1.332 -0.181 0 CA-C-N 117.397 0.598 . . . . 0.0 110.81 179.375 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 30' ' ' THR . . . . . . . . . . . . . 33.1 m -102.96 137.53 41.03 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.242 -0.435 . . . . 0.0 110.076 177.297 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 35.0 m -126.67 151.4 33.28 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.251 0 CA-C-N 116.325 -0.398 . . . . 0.0 110.97 -178.998 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 32' ' ' ARG . . . . . . . . . . . . . 62.0 mtt85 -133.26 148.71 51.97 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 115.665 -0.698 . . . . 0.0 110.202 176.645 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 33' ' ' THR . . . . . . . . . . . . . 21.5 m -53.4 138.24 33.59 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-O 120.86 0.362 . . . . 0.0 111.372 -177.644 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 101.0 -17.05 56.79 Favored Glycine 0 CA--C 1.533 1.165 0 CA-C-O 119.656 -0.525 . . . . 0.0 113.359 178.587 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 80.3 m-20 -66.5 150.03 49.57 Favored 'General case' 0 N--CA 1.463 0.202 0 CA-C-N 118.043 0.922 . . . . 0.0 111.359 179.592 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 46.2 t -122.58 129.59 75.11 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.236 0 CA-C-N 116.029 -0.532 . . . . 0.0 109.852 177.524 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 37' ' ' ILE . . . . . . . . . . . . . 62.1 mt -122.08 139.83 47.87 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.235 0 CA-C-N 116.228 -0.442 . . . . 0.0 109.962 -178.495 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . -117.01 128.3 7.82 Favored Glycine 0 CA--C 1.524 0.605 0 N-CA-C 110.89 -0.884 . . . . 0.0 110.89 178.284 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 39' ' ' ILE . . . . . . . . . . . . . 75.6 mt -127.25 132.46 69.58 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.29 0 CA-C-O 120.765 0.317 . . . . 0.0 110.199 179.754 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 40' ' ' SER . . . . . . . . . . . . . 13.0 t -93.04 122.18 35.14 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.304 -0.407 . . . . 0.0 110.923 176.419 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 41' ' ' ILE . . . . . 0.492 HD12 ' N ' ' A' ' 41' ' ' ILE . 5.1 mp -128.72 120.83 53.37 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.232 0 N-CA-C 109.902 -0.407 . . . . 0.0 109.902 176.728 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 6.8 mp 56.62 35.42 26.07 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-O 121.088 0.47 . . . . 0.0 111.203 -179.704 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . 80.14 -10.14 43.27 Favored Glycine 0 CA--C 1.533 1.198 0 C-N-CA 121.255 -0.498 . . . . 0.0 113.538 176.169 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 44' ' ' LYS . . . . . . . . . . . . . 61.7 mttp -99.68 131.25 45.79 Favored 'General case' 0 C--O 1.23 0.049 0 CA-C-N 117.891 0.846 . . . . 0.0 110.207 178.419 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 83.0 tt0 -85.57 131.06 34.43 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.371 -0.377 . . . . 0.0 111.301 -178.989 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 46' ' ' VAL . . . . . 0.405 ' O ' HG13 ' A' ' 46' ' ' VAL . 10.0 p -123.09 125.06 71.51 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.167 0 N-CA-C 109.565 -0.531 . . . . 0.0 109.565 173.786 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 66.6 mttm -99.28 127.07 45.23 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.133 -0.485 . . . . 0.0 111.042 177.856 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 48' ' ' PHE . . . . . . . . . . . . . 39.4 m-85 -112.68 131.81 55.47 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 115.918 -0.583 . . . . 0.0 110.004 178.656 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 77.8 tttt -106.4 132.36 52.52 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.471 -0.331 . . . . 0.0 110.231 178.204 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 50' ' ' VAL . . . . . 0.422 ' HA ' HD23 ' A' ' 6' ' ' LEU . 45.3 t -75.63 105.16 4.34 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.244 0 N-CA-C 109.401 -0.592 . . . . 0.0 109.401 178.002 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 51' ' ' VAL . . . . . . . . . . . . . 48.5 t -69.73 -49.64 56.29 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 N-CA-C 109.751 -0.463 . . . . 0.0 109.751 -175.035 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 52' ' ' GLN . . . . . . . . . . . . . 62.7 tt0 -167.01 147.42 5.61 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 115.971 -0.559 . . . . 0.0 111.498 -178.718 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -123.11 134.99 54.19 Favored 'General case' 0 C--N 1.332 -0.19 0 CA-C-N 116.035 -0.53 . . . . 0.0 109.972 176.884 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 54' ' ' TYR . . . . . . . . . . . . . 64.0 t80 -129.11 113.88 18.58 Favored Pre-proline 0 CA--C 1.535 0.375 0 CA-C-O 118.103 -0.951 . . . . 0.0 110.246 178.443 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 55' ' ' PRO . . . . . . . . . . . . . 72.8 Cg_endo -77.16 170.15 72.31 Favored 'Cis proline' 0 N--CA 1.501 1.956 0 CA-C-N 122.154 1.805 . . . . 0.0 111.842 -8.476 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 56' ' ' SER . . . . . . . . . . . . . 14.7 m -123.67 141.91 37.8 Favored Pre-proline 0 CA--C 1.538 0.51 0 CA-C-O 118.755 -0.641 . . . . 0.0 109.81 175.483 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 57' ' ' PRO . . . . . . . . . . . . . 37.1 Cg_endo -67.27 158.39 82.78 Favored 'Cis proline' 0 N--CA 1.5 1.892 0 CA-C-N 121.466 1.559 . . . . 0.0 111.179 -5.023 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 58' ' ' LEU . . . . . . . . . . . . . 27.9 tp -128.44 137.19 51.71 Favored 'General case' 0 C--N 1.331 -0.223 0 CA-C-O 120.833 0.349 . . . . 0.0 110.808 -178.201 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 59' ' ' ARG . . . . . . . . . . . . . 57.2 ttp180 -100.34 122.92 43.88 Favored 'General case' 0 C--N 1.328 -0.357 0 N-CA-C 108.919 -0.771 . . . . 0.0 108.919 173.613 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 40.1 t -70.25 124.62 26.74 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.327 0 C-N-CA 120.718 -0.393 . . . . 0.0 110.396 -174.21 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 42.9 mt-10 -131.04 160.69 33.88 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 115.851 -0.613 . . . . 0.0 109.907 176.798 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 62' ' ' ASP . . . . . . . . . . . . . 70.6 m-20 -52.36 -31.72 35.0 Favored 'General case' 0 CA--C 1.533 0.314 0 N-CA-C 111.957 0.355 . . . . 0.0 111.957 179.137 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 63' ' ' ARG . . . . . . . . . . . . . 79.3 mtp180 -71.41 -21.74 61.95 Favored 'General case' 0 CA--C 1.532 0.281 0 N-CA-C 113.026 0.75 . . . . 0.0 113.026 -175.5 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 19.4 m -70.81 140.56 51.25 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-O 120.948 0.404 . . . . 0.0 111.288 -173.786 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 65' ' ' LYS . . . . . . . . . . . . . 97.8 mttt -89.24 136.7 32.88 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-N 115.936 -0.575 . . . . 0.0 109.972 177.407 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 66' ' ' ILE . . . . . . . . . . . . . 65.4 mt -123.02 128.8 75.27 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.264 0 N-CA-C 110.009 -0.367 . . . . 0.0 110.009 -178.575 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 67' ' ' THR . . . . . . . . . . . . . 9.3 m -124.04 144.24 49.96 Favored 'General case' 0 N--CA 1.463 0.213 0 CA-C-O 120.951 0.405 . . . . 0.0 111.421 -176.224 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 68' ' ' LEU . . . . . 0.458 HD23 ' C ' ' A' ' 68' ' ' LEU . 5.9 tt . . . . . 0 C--N 1.332 -0.158 0 CA-C-N 116.041 -0.527 . . . . 0.0 110.283 178.83 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 74' ' ' ASP . . . . . . . . . . . . . 17.9 t0 . . . . . 0 N--CA 1.457 -0.097 0 N-CA-C 109.744 -0.465 . . . . 0.0 109.744 . . . . . . . . . 0 0 . 1 . 015 nuclear nobuild core ' A' A ' 75' ' ' VAL . . . . . 0.408 ' C ' HD12 ' A' ' 76' ' ' LEU . 40.6 t -115.75 124.48 72.21 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.311 0 CA-C-O 121.061 0.458 . . . . 0.0 110.682 -176.163 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 76' ' ' LEU . . . . . 0.408 HD12 ' C ' ' A' ' 75' ' ' VAL . 6.4 mp -122.43 142.72 50.25 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-N 115.848 -0.615 . . . . 0.0 110.007 176.358 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 77' ' ' GLU . . . . . . . . . . . . . 96.8 mt-10 -134.38 143.12 47.44 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-O 121.097 0.475 . . . . 0.0 111.242 179.739 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 78' ' ' ALA . . . . . . . . . . . . . . . -129.83 145.17 51.59 Favored 'General case' 0 C--N 1.332 -0.185 0 CA-C-N 115.712 -0.676 . . . . 0.0 109.997 176.492 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 79' ' ' LYS . . . . . 0.676 ' O ' HD13 ' A' ' 80' ' ' ILE . 33.8 mmtm -77.39 116.7 18.2 Favored 'General case' 0 C--N 1.331 -0.219 0 CA-C-N 116.374 -0.375 . . . . 0.0 110.405 179.538 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 80' ' ' ILE . . . . . 0.676 HD13 ' O ' ' A' ' 79' ' ' LYS . 35.3 mm -139.11 106.78 3.04 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.251 0 N-CA-C 109.26 -0.644 . . . . 0.0 109.26 -178.243 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 81' ' ' LYS . . . . . . . . . . . . . 38.7 tttp -109.77 130.93 55.47 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-O 120.971 0.415 . . . . 0.0 111.104 -177.135 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . 88.99 42.07 5.73 Favored Glycine 0 CA--C 1.525 0.689 0 C-N-CA 121.03 -0.605 . . . . 0.0 111.66 175.336 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 83' ' ' ILE . . . . . . . . . . . . . 67.9 mt -74.02 137.1 23.9 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.265 0 N-CA-C 110.007 -0.368 . . . . 0.0 110.007 179.307 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 84' ' ' LYS . . . . . . . . . . . . . 58.0 tttp -96.26 -52.88 3.82 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-N 116.007 -0.542 . . . . 0.0 109.875 179.035 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 85' ' ' ASP . . . . . . . . . . . . . 4.0 t70 -155.67 157.26 36.37 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 115.871 -0.604 . . . . 0.0 110.593 -179.101 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 86' ' ' VAL . . . . . . . . . . . . . 45.2 t -132.37 135.89 57.16 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.204 0 CA-C-O 120.994 0.426 . . . . 0.0 110.408 179.856 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 87' ' ' ILE . . . . . . . . . . . . . 42.3 mm -116.16 123.14 71.03 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.356 0 N-CA-C 109.161 -0.681 . . . . 0.0 109.161 176.968 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 88' ' ' LEU . . . . . . . . . . . . . 14.0 tp -109.61 130.47 55.51 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-O 121.075 0.464 . . . . 0.0 110.956 -176.597 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 89' ' ' ASP . . . . . . . . . . . . . 10.9 t70 -128.95 154.86 46.16 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-N 115.87 -0.604 . . . . 0.0 109.489 177.162 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 76.2 tt0 -48.22 -35.58 12.17 Favored 'General case' 0 C--N 1.329 -0.307 0 N-CA-C 112.808 0.669 . . . . 0.0 112.808 -172.444 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 91' ' ' ASN . . . . . . . . . . . . . 94.5 m-20 -128.43 18.3 6.4 Favored 'General case' 0 N--CA 1.469 0.487 0 N-CA-C 113.127 0.788 . . . . 0.0 113.127 -176.519 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 92' ' ' LEU . . . . . . . . . . . . . 28.5 mt -149.66 147.48 28.15 Favored 'General case' 0 C--N 1.331 -0.226 0 CA-C-O 121.0 0.429 . . . . 0.0 110.752 -177.637 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 93' ' ' ILE . . . . . . . . . . . . . 65.7 mt -127.0 113.48 32.86 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.315 0 N-CA-C 108.892 -0.781 . . . . 0.0 108.892 177.284 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 94' ' ' VAL . . . . . . . . . . . . . 45.4 t -116.08 129.42 72.5 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.241 0 N-CA-C 110.044 -0.354 . . . . 0.0 110.044 -177.93 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 95' ' ' VAL . . . . . . . . . . . . . 41.4 t -122.74 135.17 63.69 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.388 0 CA-C-N 116.111 -0.495 . . . . 0.0 110.078 -178.338 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 96' ' ' ILE . . . . . . . . . . . . . 66.0 mt -115.62 128.61 72.8 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.271 0 N-CA-C 109.364 -0.606 . . . . 0.0 109.364 178.278 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 97' ' ' THR . . . . . . . . . . . . . 79.0 p -102.43 159.51 15.36 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-O 121.132 0.492 . . . . 0.0 111.386 -177.675 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 98' ' ' GLU . . . . . . . . . . . . . 45.6 mt-10 -54.06 -25.88 23.86 Favored 'General case' 0 CA--C 1.532 0.264 0 N-CA-C 112.335 0.494 . . . . 0.0 112.335 179.736 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 99' ' ' GLU . . . . . . . . . . . . . 95.8 mt-10 -77.84 13.48 1.35 Allowed 'General case' 0 CA--C 1.535 0.37 0 N-CA-C 113.167 0.803 . . . . 0.0 113.167 -178.048 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 100' ' ' ASN . . . . . . . . . . . . . 3.3 m-20 60.87 36.59 18.93 Favored 'General case' 0 CA--C 1.529 0.173 0 CA-C-O 120.956 0.408 . . . . 0.0 110.998 -179.833 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 101' ' ' GLU . . . . . . . . . . . . . 82.9 tt0 -113.59 143.22 44.92 Favored 'General case' 0 C--N 1.332 -0.178 0 N-CA-C 109.381 -0.6 . . . . 0.0 109.381 176.348 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 102' ' ' VAL . . . . . . . . . . . . . 43.1 t -115.29 125.74 72.64 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.356 0 CA-C-O 120.909 0.385 . . . . 0.0 109.996 -177.625 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 103' ' ' LEU . . . . . . . . . . . . . 23.4 mt -114.15 130.92 56.59 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 115.518 -0.764 . . . . 0.0 109.966 176.667 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 104' ' ' ILE . . . . . 0.521 HD12 ' HB3' ' A' ' 113' ' ' TYR . 67.8 mt -119.37 118.84 58.77 Favored 'Isoleucine or valine' 0 C--O 1.234 0.27 0 N-CA-C 110.118 -0.327 . . . . 0.0 110.118 -179.846 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 105' ' ' PHE . . . . . . . . . . . . . 79.7 m-85 -117.98 164.07 15.64 Favored 'General case' 0 C--N 1.332 -0.182 0 O-C-N 123.979 0.799 . . . . 0.0 109.604 178.04 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 106' ' ' ASN . . . . . . . . . . . . . 44.2 p-10 -101.11 -170.49 1.85 Allowed 'General case' 0 C--N 1.331 -0.22 0 N-CA-C 109.992 -0.373 . . . . 0.0 109.992 173.652 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 107' ' ' GLN . . . . . . . . . . . . . 57.9 tt0 -57.43 -29.99 64.61 Favored 'General case' 0 CA--C 1.534 0.36 0 N-CA-C 111.839 0.311 . . . . 0.0 111.839 178.673 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 108' ' ' ASN . . . . . . . . . . . . . 60.3 t30 -83.94 7.42 18.37 Favored 'General case' 0 CA--C 1.536 0.434 0 N-CA-C 113.373 0.879 . . . . 0.0 113.373 -176.515 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 109' ' ' LEU . . . . . . . . . . . . . 11.2 tp 60.32 37.38 20.3 Favored 'General case' 0 CA--C 1.53 0.194 0 CA-C-O 120.955 0.407 . . . . 0.0 111.208 179.434 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 110' ' ' GLU . . . . . . . . . . . . . 70.8 mm-40 -106.88 160.95 15.13 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 116.466 -0.334 . . . . 0.0 110.169 177.85 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 111' ' ' GLU . . . . . . . . . . . . . 83.0 tt0 -85.31 122.75 29.92 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.312 -0.404 . . . . 0.0 110.801 -178.15 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 112' ' ' LEU . . . . . . . . . . . . . 17.0 mt -111.19 -46.11 3.35 Favored 'General case' 0 C--N 1.332 -0.189 0 CA-C-N 116.223 -0.444 . . . . 0.0 110.566 177.176 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 113' ' ' TYR . . . . . 0.521 ' HB3' HD12 ' A' ' 104' ' ' ILE . 46.8 t80 -141.67 139.71 33.05 Favored 'General case' 0 C--N 1.332 -0.195 0 CA-C-N 116.371 -0.377 . . . . 0.0 110.97 179.895 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 114' ' ' ARG . . . . . . . . . . . . . 58.7 ttp180 -143.09 116.02 8.81 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.068 -0.515 . . . . 0.0 110.125 178.921 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 115' ' ' GLY . . . . . . . . . . . . . . . -150.26 163.05 29.43 Favored Glycine 0 CA--C 1.525 0.678 0 N-CA-C 111.0 -0.84 . . . . 0.0 111.0 -179.506 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 116' ' ' LYS . . . . . . . . . . . . . 34.5 ttmt -128.38 137.54 51.94 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-O 120.723 0.297 . . . . 0.0 110.27 177.229 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 117' ' ' PHE . . . . . . . . . . . . . 54.4 m-85 -131.47 114.95 15.54 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.324 -0.398 . . . . 0.0 110.286 -177.007 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 118' ' ' GLU . . . . . . . . . . . . . 46.4 tp10 -53.76 -47.81 70.35 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.554 -0.294 . . . . 0.0 111.491 -176.067 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 119' ' ' ASN . . . . . . . . . . . . . 6.4 m120 -97.14 31.02 2.55 Favored 'General case' 0 C--N 1.329 -0.302 0 N-CA-C 112.088 0.403 . . . . 0.0 112.088 -174.126 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 120' ' ' LEU . . . . . 0.411 HD11 HG23 ' A' ' 132' ' ' ILE . 12.3 tp -56.63 122.22 11.55 Favored 'General case' 0 C--N 1.331 -0.224 0 C-N-CA 121.026 -0.27 . . . . 0.0 110.496 179.08 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 121' ' ' ASN . . . . . . . . . . . . . 29.2 m120 -112.78 -44.01 3.37 Favored 'General case' 0 C--O 1.232 0.157 0 CA-C-N 116.564 -0.289 . . . . 0.0 111.115 -177.299 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 122' ' ' LYS . . . . . . . . . . . . . 96.1 mttt -146.42 149.17 33.2 Favored 'General case' 0 C--N 1.331 -0.218 0 CA-C-O 120.996 0.427 . . . . 0.0 111.725 -179.544 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 123' ' ' VAL . . . . . . . . . . . . . 44.5 t -126.87 123.48 62.77 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.327 0 N-CA-C 108.971 -0.752 . . . . 0.0 108.971 171.628 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 124' ' ' LEU . . . . . . . . . . . . . 13.6 tp -120.54 137.31 54.45 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.395 -0.366 . . . . 0.0 110.537 -175.703 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 125' ' ' VAL . . . . . . . . . . . . . 43.9 t -125.36 132.76 70.67 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.243 0 CA-C-N 116.101 -0.499 . . . . 0.0 110.27 -179.412 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 126' ' ' ARG . . . . . . . . . . . . . 40.3 mmt180 -131.77 108.06 9.19 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 115.96 -0.563 . . . . 0.0 109.933 176.686 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 127' ' ' ASN . . . . . . . . . . . . . 7.8 m120 54.12 -104.83 0.23 Allowed 'General case' 0 CA--C 1.543 0.688 0 CA-C-O 119.037 -0.506 . . . . 0.0 110.935 179.85 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 128' ' ' ASP . . . . . . . . . . . . . 7.5 p-10 -113.31 4.17 16.28 Favored 'General case' 0 N--CA 1.468 0.458 0 CA-C-N 119.575 1.08 . . . . 0.0 113.387 -176.886 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 129' ' ' LEU . . . . . . . . . . . . . 76.3 mt -104.97 139.51 39.57 Favored 'General case' 0 C--N 1.332 -0.162 0 CA-C-N 118.17 0.441 . . . . 0.0 110.051 177.412 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 130' ' ' VAL . . . . . . . . . . . . . 44.8 t -120.5 135.45 60.68 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.223 0 CA-C-N 116.271 -0.422 . . . . 0.0 110.004 -177.485 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 131' ' ' VAL . . . . . 0.428 HG22 HD12 ' A' ' 140' ' ' LEU . 42.7 t -132.6 132.53 59.94 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.29 0 CA-C-O 120.985 0.421 . . . . 0.0 109.993 177.562 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 132' ' ' ILE . . . . . 0.411 HG23 HD11 ' A' ' 120' ' ' LEU . 70.8 mt -115.3 130.76 69.31 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 N-CA-C 109.251 -0.648 . . . . 0.0 109.251 178.903 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 133' ' ' ILE . . . . . . . . . . . . . 43.1 mm -115.97 121.11 66.72 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.287 0 CA-C-N 116.305 -0.407 . . . . 0.0 110.531 -175.651 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 134' ' ' ASP . . . . . . . . . . . . . 7.1 p-10 -133.0 149.98 52.19 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.045 -0.525 . . . . 0.0 109.626 175.8 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 135' ' ' GLU . . . . . . . . . . . . . 78.7 tt0 -49.79 -25.99 3.54 Favored 'General case' 0 C--N 1.327 -0.391 0 N-CA-C 113.005 0.743 . . . . 0.0 113.005 -169.244 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 136' ' ' GLN . . . . . . . . . . . . . 87.7 mt-30 -103.95 -27.43 12.17 Favored 'General case' 0 N--CA 1.465 0.32 0 N-CA-C 112.955 0.724 . . . . 0.0 112.955 -174.745 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 137' ' ' LYS . . . . . . . . . . . . . 60.5 mtpt -140.48 152.54 45.7 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-O 121.333 0.587 . . . . 0.0 111.775 -170.227 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 138' ' ' LEU . . . . . 0.4 ' C ' HD23 ' A' ' 138' ' ' LEU . 5.1 tt -117.7 121.69 41.53 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 115.504 -0.771 . . . . 0.0 109.145 172.684 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 139' ' ' THR . . . . . . . . . . . . . 26.5 m -108.5 126.63 53.13 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.425 -0.352 . . . . 0.0 110.604 -177.242 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 140' ' ' LEU . . . . . 0.428 HD12 HG22 ' A' ' 131' ' ' VAL . 12.9 tp -113.63 119.07 36.19 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 115.651 -0.704 . . . . 0.0 109.156 -179.73 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 141' ' ' ILE . . . . . . . . . . . . . 19.4 mt -119.02 120.73 64.88 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.328 0 N-CA-C 109.851 -0.426 . . . . 0.0 109.851 -174.734 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 142' ' ' ARG . . . . . . . . . . . . . 81.1 mtm180 -110.7 125.46 53.5 Favored 'General case' 0 C--N 1.331 -0.218 0 CA-C-N 115.677 -0.692 . . . . 0.0 110.203 -178.493 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 143' ' ' THR . . . . . . . . . . . . . 82.3 p . . . . . 0 C--O 1.22 -0.483 0 CA-C-O 118.04 -0.981 . . . . 0.0 110.589 -179.199 . . . . . . . . 0 0 . 1 . 015 nuclear nobuild core ' B' B ' 2' ' ' SER . . . . . . . . . . . . . 7.0 p . . . . . 0 C--O 1.231 0.13 0 CA-C-O 120.994 0.425 . . . . 0.0 110.59 . . . . . . . . . 0 0 . 1 . 015 nuclear nobuild core ' B' B ' 3' ' ' GLU . . . . . . . . . . . . . 92.4 mt-10 -141.74 142.02 33.26 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 115.977 -0.556 . . . . 0.0 110.821 -179.299 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' B' B ' 4' ' ' LEU . . . . . . . . . . . . . 18.6 tp -127.41 130.95 50.26 Favored 'General case' 0 C--N 1.331 -0.23 0 CA-C-N 116.37 -0.377 . . . . 0.0 110.219 176.179 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' B' B ' 5' ' ' LYS . . . . . . . . . . . . . 68.5 mttm -110.64 120.46 42.49 Favored 'General case' 0 C--N 1.331 -0.215 0 CA-C-N 116.347 -0.388 . . . . 0.0 110.581 179.393 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' B' B ' 6' ' ' LEU . . . . . . . . . . . . . 65.5 mt -114.82 147.94 39.15 Favored 'General case' 0 C--N 1.331 -0.225 0 CA-C-N 115.303 -0.862 . . . . 0.0 110.687 -178.492 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' B' B ' 7' ' ' LYS . . . . . . . . . . . . . 74.7 tttt -133.55 135.06 24.42 Favored Pre-proline 0 CA--C 1.535 0.366 0 CA-C-O 118.848 -0.596 . . . . 0.0 109.933 176.174 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' B' B ' 8' ' ' PRO . . . . . . . . . . . . . 93.9 Cg_endo -90.79 142.26 3.25 Favored 'Trans proline' 0 N--CA 1.489 1.263 0 C-N-CA 121.666 1.577 . . . . 0.0 111.721 177.579 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' B' B ' 9' ' ' LEU . . . . . . . . . . . . . 47.0 mt -81.13 -47.22 1.13 Allowed Pre-proline 0 CA--C 1.533 0.323 0 CA-C-O 118.714 -0.66 . . . . 0.0 112.258 -178.544 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' B' B ' 10' ' ' PRO . . . . . . . . . . . . . 86.5 Cg_endo -80.69 150.46 18.85 Favored 'Trans proline' 0 N--CA 1.497 1.722 0 C-N-CA 121.179 1.253 . . . . 0.0 111.879 175.17 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' B' B ' 11' ' ' LYS . . . . . . . . . . . . . 33.9 ttmt -85.65 100.04 11.7 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-O 120.879 0.371 . . . . 0.0 110.57 178.463 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' B' B ' 12' ' ' VAL . . . . . . . . . . . . . 12.1 p -143.66 138.82 25.7 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.273 0 CA-C-N 116.125 -0.489 . . . . 0.0 110.493 179.22 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' B' B ' 13' ' ' GLU . . . . . . . . . . . . . 15.0 mm-40 -74.93 129.49 37.74 Favored 'General case' 0 C--N 1.329 -0.316 0 N-CA-C 109.955 -0.387 . . . . 0.0 109.955 177.098 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' B' B ' 14' ' ' LEU . . . . . . . . . . . . . 33.2 mt -97.86 146.32 31.26 Favored Pre-proline 0 CA--C 1.533 0.304 0 CA-C-O 119.142 -0.456 . . . . 0.0 110.265 -179.379 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' B' B ' 15' ' ' PRO . . . . . . . . . . . . . 26.2 Cg_exo -61.96 160.04 31.36 Favored 'Trans proline' 0 N--CA 1.498 1.768 0 C-N-CA 121.251 1.3 . . . . 0.0 112.001 177.818 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' B' B ' 16' ' ' PRO . . . . . . . . . . . . . 27.5 Cg_exo -60.37 -35.04 92.69 Favored 'Trans proline' 0 N--CA 1.496 1.634 0 C-N-CA 121.452 1.435 . . . . 0.0 112.659 -179.446 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' B' B ' 17' ' ' ASP . . . . . . . . . . . . . 10.3 p-10 -87.61 9.49 21.07 Favored 'General case' 0 CA--C 1.535 0.399 0 N-CA-C 113.168 0.803 . . . . 0.0 113.168 -178.073 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' B' B ' 18' ' ' PHE . . . . . . . . . . . . . 28.8 t80 -57.25 -41.38 79.51 Favored 'General case' 0 CA--C 1.527 0.073 0 O-C-N 121.939 -0.476 . . . . 0.0 110.296 -178.971 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' B' B ' 19' ' ' VAL . . . . . . . . . . . . . 50.0 t -56.94 -42.73 79.28 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 CA-C-N 116.399 -0.364 . . . . 0.0 110.396 -179.983 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' B' B ' 20' ' ' ASP . . . . . 0.557 ' OD1' HD11 ' B' ' 24' ' ' ILE . 4.9 t70 -60.28 -39.68 87.76 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-O 120.849 0.357 . . . . 0.0 110.747 -178.603 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' B' B ' 21' ' ' VAL . . . . . . . . . . . . . 46.2 t -64.28 -47.99 87.37 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.314 0 C-N-CA 120.755 -0.378 . . . . 0.0 110.24 -179.316 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' B' B ' 22' ' ' ILE . . . . . 0.404 HG22 HD12 ' B' ' 26' ' ' LEU . 51.7 mm -55.59 -58.04 5.93 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.237 0 C-N-CA 120.954 -0.298 . . . . 0.0 111.171 -178.38 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' B' B ' 23' ' ' ARG . . . . . . . . . . . . . 12.0 ptm180 -55.85 -42.97 76.59 Favored 'General case' 0 CA--C 1.531 0.223 0 C-N-CA 120.527 -0.469 . . . . 0.0 111.792 -173.797 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' B' B ' 24' ' ' ILE . . . . . 0.557 HD11 ' OD1' ' B' ' 20' ' ' ASP . 75.5 mt -60.81 -44.17 96.98 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.264 0 C-N-CA 120.815 -0.354 . . . . 0.0 111.421 -177.958 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' B' B ' 25' ' ' LYS . . . . . . . . . . . . . 68.6 mttm -67.71 -42.66 81.64 Favored 'General case' 0 C--N 1.329 -0.311 0 N-CA-C 112.558 0.577 . . . . 0.0 112.558 -178.306 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' B' B ' 26' ' ' LEU . . . . . 0.404 HD12 HG22 ' B' ' 22' ' ' ILE . 29.3 mt -79.45 -35.83 39.77 Favored 'General case' 0 C--N 1.33 -0.265 0 N-CA-C 113.522 0.934 . . . . 0.0 113.522 -170.782 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' B' B ' 27' ' ' GLN . . . . . . . . . . . . . 9.4 pt20 -47.13 138.62 6.69 Favored 'General case' 0 N--CA 1.47 0.556 0 N-CA-C 112.742 0.645 . . . . 0.0 112.742 -175.502 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' B' B ' 28' ' ' GLY . . . . . . . . . . . . . . . 98.4 -23.19 37.24 Favored Glycine 0 CA--C 1.534 1.279 0 CA-C-N 115.636 -0.711 . . . . 0.0 112.386 -177.298 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' B' B ' 29' ' ' LYS . . . . . . . . . . . . . 64.6 mttp -97.64 155.1 17.14 Favored 'General case' 0 C--O 1.233 0.229 0 CA-C-N 117.382 0.591 . . . . 0.0 111.084 179.297 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' B' B ' 30' ' ' THR . . . . . . . . . . . . . 27.4 m -102.95 135.87 43.82 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.119 -0.491 . . . . 0.0 109.87 175.565 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' B' B ' 31' ' ' VAL . . . . . . . . . . . . . 34.9 m -128.48 153.85 38.51 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.212 0 CA-C-O 120.928 0.394 . . . . 0.0 110.706 -178.161 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' B' B ' 32' ' ' ARG . . . . . . . . . . . . . 91.8 mtm-85 -132.68 147.71 52.33 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-O 121.283 0.563 . . . . 0.0 110.883 179.868 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' B' B ' 33' ' ' THR . . . . . . . . . . . . . 26.4 m -53.23 140.18 27.19 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.127 -0.488 . . . . 0.0 111.344 -177.971 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' B' B ' 34' ' ' GLY . . . . . . . . . . . . . . . 100.15 -17.09 57.55 Favored Glycine 0 CA--C 1.533 1.166 0 CA-C-O 119.608 -0.551 . . . . 0.0 113.22 179.574 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' B' B ' 35' ' ' ASP . . . . . . . . . . . . . 76.9 m-20 -65.19 148.92 50.82 Favored 'General case' 0 C--N 1.333 -0.109 0 CA-C-N 118.037 0.918 . . . . 0.0 111.08 178.924 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' B' B ' 36' ' ' VAL . . . . . . . . . . . . . 46.8 t -120.53 129.95 75.02 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.275 0 CA-C-N 115.83 -0.623 . . . . 0.0 109.625 177.337 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' B' B ' 37' ' ' ILE . . . . . . . . . . . . . 70.0 mt -118.8 138.93 47.91 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.274 0 CA-C-N 116.137 -0.483 . . . . 0.0 109.867 -178.242 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' B' B ' 38' ' ' GLY . . . . . . . . . . . . . . . -115.36 128.88 8.28 Favored Glycine 0 CA--C 1.525 0.707 0 N-CA-C 110.915 -0.874 . . . . 0.0 110.915 179.596 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' B' B ' 39' ' ' ILE . . . . . . . . . . . . . 76.2 mt -125.09 137.0 59.07 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.28 0 N-CA-C 110.195 -0.298 . . . . 0.0 110.195 -179.839 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' B' B ' 40' ' ' SER . . . . . . . . . . . . . 32.0 t -93.12 122.94 36.02 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.346 -0.388 . . . . 0.0 110.726 175.181 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' B' B ' 41' ' ' ILE . . . . . . . . . . . . . 71.4 mt -129.19 118.33 45.98 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.226 0 CA-C-O 120.929 0.395 . . . . 0.0 110.344 178.367 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' B' B ' 42' ' ' LEU . . . . . 0.541 ' O ' HD23 ' B' ' 42' ' ' LEU . 1.3 tt 50.68 45.27 27.16 Favored 'General case' 0 N--CA 1.465 0.288 0 CA-C-O 121.421 0.629 . . . . 0.0 111.047 176.621 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' B' B ' 43' ' ' GLY . . . . . . . . . . . . . . . 70.43 24.7 76.56 Favored Glycine 0 CA--C 1.531 1.064 0 C-N-CA 121.093 -0.575 . . . . 0.0 112.585 175.433 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' B' B ' 44' ' ' LYS . . . . . . . . . . . . . 35.5 ttpt -136.57 133.43 36.38 Favored 'General case' 0 C--N 1.333 -0.145 0 CA-C-N 117.438 0.619 . . . . 0.0 110.213 179.672 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' B' B ' 45' ' ' GLU . . . . . . . . . . . . . 68.0 tt0 -84.08 127.8 34.14 Favored 'General case' 0 C--N 1.326 -0.419 0 CA-C-N 116.437 -0.347 . . . . 0.0 111.203 -177.096 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' B' B ' 46' ' ' VAL . . . . . . . . . . . . . 7.5 p -125.51 128.38 72.42 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.2 0 CA-C-O 121.138 0.494 . . . . 0.0 109.837 175.88 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' B' B ' 47' ' ' LYS . . . . . . . . . . . . . 34.0 mmtp -100.29 131.78 46.03 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 115.789 -0.641 . . . . 0.0 111.457 178.417 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' B' B ' 48' ' ' PHE . . . . . . . . . . . . . 96.3 m-85 -118.04 131.98 56.41 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 115.976 -0.556 . . . . 0.0 109.812 175.313 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' B' B ' 49' ' ' LYS . . . . . . . . . . . . . 83.4 tttt -106.95 138.68 42.66 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.757 -0.202 . . . . 0.0 110.468 178.984 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' B' B ' 50' ' ' VAL . . . . . . . . . . . . . 43.4 t -84.14 108.57 16.57 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.298 0 N-CA-C 109.423 -0.584 . . . . 0.0 109.423 176.768 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' B' B ' 51' ' ' VAL . . . . . . . . . . . . . 47.1 t -73.51 -51.79 23.9 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.277 0 CA-C-N 116.022 -0.536 . . . . 0.0 109.842 -174.603 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' B' B ' 52' ' ' GLN . . . . . . . . . . . . . 88.0 mt-30 -153.89 151.45 29.48 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-N 116.06 -0.518 . . . . 0.0 111.769 -177.912 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' B' B ' 53' ' ' ALA . . . . . . . . . . . . . . . -130.85 134.61 46.96 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 115.371 -0.832 . . . . 0.0 109.651 174.468 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' B' B ' 54' ' ' TYR . . . . . . . . . . . . . 35.8 t80 -129.09 114.2 18.65 Favored Pre-proline 0 CA--C 1.535 0.366 0 CA-C-O 118.062 -0.97 . . . . 0.0 110.407 178.669 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' B' B ' 55' ' ' PRO . . . . . . . . . . . . . 74.1 Cg_endo -77.2 166.19 82.81 Favored 'Cis proline' 0 N--CA 1.5 1.875 0 CA-C-N 122.181 1.815 . . . . 0.0 112.081 -7.468 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' B' B ' 56' ' ' SER . . . . . . . . . . . . . 13.7 m -115.79 127.38 26.83 Favored Pre-proline 0 CA--C 1.538 0.502 0 CA-C-O 118.436 -0.793 . . . . 0.0 109.048 175.297 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' B' B ' 57' ' ' PRO . . . . . . . . . . . . . 44.3 Cg_endo -68.09 146.95 79.3 Favored 'Cis proline' 0 N--CA 1.498 1.75 0 CA-C-N 121.981 1.743 . . . . 0.0 111.855 2.007 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' B' B ' 58' ' ' LEU . . . . . . . . . . . . . 22.7 tp -108.31 137.1 46.85 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.158 -0.473 . . . . 0.0 110.556 -179.381 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' B' B ' 59' ' ' ARG . . . . . . . . . . . . . 23.6 ttm180 -100.91 124.85 47.22 Favored 'General case' 0 C--N 1.326 -0.434 0 N-CA-C 109.341 -0.614 . . . . 0.0 109.341 176.281 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' B' B ' 60' ' ' VAL . . . . . . . . . . . . . 40.9 t -82.68 120.16 33.56 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.281 0 C-N-CA 120.739 -0.385 . . . . 0.0 110.684 -174.374 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' B' B ' 61' ' ' GLU . . . . . . . . . . . . . 71.0 mm-40 -131.17 155.98 46.1 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 115.926 -0.579 . . . . 0.0 109.845 175.138 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' B' B ' 62' ' ' ASP . . . . . . . . . . . . . 21.6 m-20 -52.25 -33.86 43.45 Favored 'General case' 0 C--N 1.328 -0.33 0 N-CA-C 111.842 0.312 . . . . 0.0 111.842 -179.998 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' B' B ' 63' ' ' ARG . . . . . . . . . . . . . 94.6 mtt180 -73.17 -21.89 60.6 Favored 'General case' 0 CA--C 1.532 0.273 0 N-CA-C 113.05 0.759 . . . . 0.0 113.05 -176.559 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' B' B ' 64' ' ' THR . . . . . . . . . . . . . 27.1 m -62.61 143.42 57.31 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-O 120.731 0.3 . . . . 0.0 110.514 -176.983 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' B' B ' 65' ' ' LYS . . . . . . . . . . . . . 54.6 mttm -85.18 124.17 31.53 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.283 -0.417 . . . . 0.0 110.097 179.38 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' B' B ' 66' ' ' ILE . . . . . . . . . . . . . 58.2 mt -115.22 124.06 71.44 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.307 0 N-CA-C 109.646 -0.502 . . . . 0.0 109.646 -179.42 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' B' B ' 67' ' ' THR . . . . . . . . . . . . . 14.4 m -127.64 144.58 51.06 Favored 'General case' 0 C--N 1.333 -0.151 0 CA-C-O 121.01 0.433 . . . . 0.0 111.118 -176.617 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' B' B ' 68' ' ' LEU . . . . . 0.451 HD12 ' N ' ' B' ' 68' ' ' LEU . 6.5 mp . . . . . 0 C--N 1.33 -0.28 0 CA-C-N 116.132 -0.485 . . . . 0.0 110.901 178.538 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' B' B ' 73' ' ' VAL . . . . . . . . . . . . . 34.7 m . . . . . 0 C--O 1.232 0.17 0 CA-C-O 120.676 0.274 . . . . 0.0 110.83 . . . . . . . . . 0 0 . 1 . 015 nuclear nobuild core ' B' B ' 74' ' ' ASP . . . . . . . . . . . . . 19.3 t0 -104.62 123.61 47.87 Favored 'General case' 0 C--N 1.331 -0.225 0 CA-C-N 116.389 -0.368 . . . . 0.0 110.087 -179.699 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' B' B ' 75' ' ' VAL . . . . . . . . . . . . . 42.6 t -117.44 121.72 68.24 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.221 0 CA-C-O 120.993 0.425 . . . . 0.0 110.538 -178.381 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' B' B ' 76' ' ' LEU . . . . . . . . . . . . . 5.7 mp -120.99 142.09 50.11 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 115.846 -0.615 . . . . 0.0 109.904 176.012 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' B' B ' 77' ' ' GLU . . . . . . . . . . . . . 97.5 mt-10 -133.59 134.89 43.85 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-O 121.01 0.433 . . . . 0.0 110.962 -178.991 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' B' B ' 78' ' ' ALA . . . . . 0.552 ' HB2' HD21 ' B' ' 109' ' ' LEU . . . -122.82 140.88 52.45 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 115.896 -0.593 . . . . 0.0 109.977 177.26 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' B' B ' 79' ' ' LYS . . . . . 0.687 ' O ' HD13 ' B' ' 80' ' ' ILE . 70.4 mmtt -75.0 115.86 15.09 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-O 120.972 0.415 . . . . 0.0 110.442 179.905 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' B' B ' 80' ' ' ILE . . . . . 0.687 HD13 ' O ' ' B' ' 79' ' ' LYS . 35.2 mm -139.04 105.87 2.74 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.328 0 N-CA-C 109.022 -0.733 . . . . 0.0 109.022 -178.302 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' B' B ' 81' ' ' LYS . . . . . . . . . . . . . 54.6 pttt -115.44 132.29 56.67 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-O 121.1 0.476 . . . . 0.0 111.195 -177.313 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' B' B ' 82' ' ' GLY . . . . . . . . . . . . . . . 89.07 42.09 5.71 Favored Glycine 0 CA--C 1.526 0.731 0 N-CA-C 111.135 -0.786 . . . . 0.0 111.135 179.239 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' B' B ' 83' ' ' ILE . . . . . . . . . . . . . 72.6 mt -71.55 139.27 20.1 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.293 0 CA-C-O 120.827 0.346 . . . . 0.0 110.162 -179.813 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' B' B ' 84' ' ' LYS . . . . . . . . . . . . . 15.2 ttmm -96.55 -54.07 3.37 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-O 121.179 0.514 . . . . 0.0 109.939 178.2 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' B' B ' 85' ' ' ASP . . . . . . . . . . . . . 8.9 t70 -155.44 146.41 22.45 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 115.508 -0.769 . . . . 0.0 110.125 -179.425 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' B' B ' 86' ' ' VAL . . . . . . . . . . . . . 43.6 t -124.2 129.2 74.16 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.256 0 CA-C-O 120.93 0.395 . . . . 0.0 110.249 179.888 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' B' B ' 87' ' ' ILE . . . . . . . . . . . . . 44.2 mm -118.34 124.76 73.61 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.262 0 CA-C-N 115.887 -0.597 . . . . 0.0 109.496 177.297 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' B' B ' 88' ' ' LEU . . . . . . . . . . . . . 15.3 tp -114.26 124.36 51.84 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-O 121.088 0.471 . . . . 0.0 111.238 -176.898 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' B' B ' 89' ' ' ASP . . . . . . . . . . . . . 5.7 t70 -112.44 159.61 18.58 Favored 'General case' 0 C--N 1.33 -0.24 0 N-CA-C 108.99 -0.744 . . . . 0.0 108.99 175.419 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' B' B ' 90' ' ' GLU . . . . . . . . . . . . . 94.5 mt-10 -48.28 -42.61 31.3 Favored 'General case' 0 N--CA 1.465 0.291 0 N-CA-C 112.689 0.626 . . . . 0.0 112.689 -171.479 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' B' B ' 91' ' ' ASN . . . . . . . . . . . . . 33.8 p-10 -132.2 37.06 3.58 Favored 'General case' 0 N--CA 1.464 0.251 0 N-CA-C 111.753 0.279 . . . . 0.0 111.753 -178.691 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' B' B ' 92' ' ' LEU . . . . . . . . . . . . . 15.9 tp -160.6 140.1 10.82 Favored 'General case' 0 C--N 1.331 -0.237 0 C-N-CA 120.826 -0.35 . . . . 0.0 110.667 -177.877 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' B' B ' 93' ' ' ILE . . . . . . . . . . . . . 68.2 mt -122.7 123.12 67.61 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.198 0 N-CA-C 109.679 -0.489 . . . . 0.0 109.679 -178.663 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' B' B ' 94' ' ' VAL . . . . . . . . . . . . . 46.8 t -124.46 125.77 70.8 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.243 0 N-CA-C 109.718 -0.475 . . . . 0.0 109.718 177.629 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' B' B ' 95' ' ' VAL . . . . . . . . . . . . . 44.4 t -122.3 133.44 68.56 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.341 0 CA-C-N 116.022 -0.536 . . . . 0.0 109.789 -179.178 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' B' B ' 96' ' ' ILE . . . . . 0.405 HD11 ' HB ' ' B' ' 123' ' ' VAL . 51.7 mt -114.07 127.33 71.53 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.329 0 N-CA-C 108.782 -0.822 . . . . 0.0 108.782 178.301 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' B' B ' 97' ' ' THR . . . . . . . . . . . . . 82.7 p -99.0 153.76 18.61 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-O 121.292 0.568 . . . . 0.0 111.279 -176.85 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' B' B ' 98' ' ' GLU . . . . . . . . . . . . . 73.0 tt0 -53.97 -24.02 15.21 Favored 'General case' 0 C--N 1.325 -0.471 0 CA-C-N 115.811 -0.631 . . . . 0.0 112.166 179.322 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' B' B ' 99' ' ' GLU . . . . . . . . . . . . . 91.1 mt-10 -82.07 16.09 2.07 Favored 'General case' 0 CA--C 1.535 0.389 0 N-CA-C 113.082 0.771 . . . . 0.0 113.082 -176.981 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' B' B ' 100' ' ' ASN . . . . . . . . . . . . . 2.7 m-20 64.78 36.97 7.66 Favored 'General case' 0 CA--C 1.53 0.201 0 CA-C-O 121.001 0.429 . . . . 0.0 111.343 177.218 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' B' B ' 101' ' ' GLU . . . . . . . . . . . . . 82.7 tt0 -118.1 145.05 45.15 Favored 'General case' 0 C--N 1.331 -0.199 0 CA-C-N 116.147 -0.479 . . . . 0.0 110.031 175.294 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' B' B ' 102' ' ' VAL . . . . . . . . . . . . . 44.4 t -118.13 128.5 75.18 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.295 0 N-CA-C 110.137 -0.32 . . . . 0.0 110.137 -179.286 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' B' B ' 103' ' ' LEU . . . . . . . . . . . . . 6.1 mp -120.95 135.37 55.22 Favored 'General case' 0 C--N 1.331 -0.224 0 CA-C-N 115.94 -0.573 . . . . 0.0 110.489 177.642 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' B' B ' 104' ' ' ILE . . . . . . . . . . . . . 70.0 mt -121.82 124.74 72.11 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.276 0 CA-C-N 116.509 -0.314 . . . . 0.0 110.454 -179.848 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' B' B ' 105' ' ' PHE . . . . . . . . . . . . . 62.8 m-85 -123.23 166.0 15.98 Favored 'General case' 0 C--O 1.232 0.134 0 O-C-N 124.033 0.833 . . . . 0.0 109.873 -179.534 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' B' B ' 106' ' ' ASN . . . . . . . . . . . . . 43.7 p-10 -102.52 -170.66 1.84 Allowed 'General case' 0 CA--C 1.53 0.197 0 N-CA-C 110.164 -0.309 . . . . 0.0 110.164 173.894 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' B' B ' 107' ' ' GLN . . . . . . . . . . . . . 40.4 tt0 -59.05 -30.09 67.79 Favored 'General case' 0 C--N 1.33 -0.267 0 N-CA-C 112.085 0.402 . . . . 0.0 112.085 -179.265 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' B' B ' 108' ' ' ASN . . . . . . . . . . . . . 5.3 t30 -85.53 11.03 11.42 Favored 'General case' 0 CA--C 1.536 0.412 0 N-CA-C 113.052 0.76 . . . . 0.0 113.052 -176.915 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' B' B ' 109' ' ' LEU . . . . . 0.552 HD21 ' HB2' ' B' ' 78' ' ' ALA . 9.0 tp 60.59 34.81 20.15 Favored 'General case' 0 C--N 1.331 -0.215 0 CA-C-O 120.758 0.313 . . . . 0.0 111.558 178.905 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' B' B ' 110' ' ' GLU . . . . . . . . . . . . . 95.7 mt-10 -103.01 147.02 27.47 Favored 'General case' 0 C--N 1.33 -0.258 0 N-CA-C 109.68 -0.489 . . . . 0.0 109.68 176.205 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' B' B ' 111' ' ' GLU . . . . . . . . . . . . . 55.5 tt0 -85.49 121.88 28.83 Favored 'General case' 0 C--N 1.328 -0.362 0 C-N-CA 120.831 -0.348 . . . . 0.0 110.68 -177.273 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' B' B ' 112' ' ' LEU . . . . . . . . . . . . . 37.3 mt -104.39 -46.03 4.5 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.122 -0.49 . . . . 0.0 110.88 179.151 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' B' B ' 113' ' ' TYR . . . . . 0.418 ' CE1' HG21 ' C' ' 75' ' ' VAL . 66.3 t80 -136.5 144.9 44.55 Favored 'General case' 0 N--CA 1.464 0.23 0 CA-C-O 120.969 0.414 . . . . 0.0 111.132 -179.053 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' B' B ' 114' ' ' ARG . . . . . . . . . . . . . 14.3 ptt180 -146.55 124.39 11.94 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 115.621 -0.718 . . . . 0.0 110.365 178.765 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' B' B ' 115' ' ' GLY . . . . . . . . . . . . . . . -150.16 155.26 26.14 Favored Glycine 0 CA--C 1.523 0.539 0 N-CA-C 110.908 -0.877 . . . . 0.0 110.908 -179.948 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' B' B ' 116' ' ' LYS . . . . . . . . . . . . . 19.8 ttmt -126.66 140.46 52.4 Favored 'General case' 0 C--N 1.331 -0.228 0 N-CA-C 109.638 -0.504 . . . . 0.0 109.638 178.667 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' B' B ' 117' ' ' PHE . . . . . . . . . . . . . 32.2 m-85 -138.51 114.02 9.68 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-O 120.935 0.398 . . . . 0.0 110.258 -176.35 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' B' B ' 118' ' ' GLU . . . . . . . . . . . . . 75.1 tt0 -53.42 -49.73 66.7 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 116.528 -0.306 . . . . 0.0 111.432 -176.638 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' B' B ' 119' ' ' ASN . . . . . . . . . . . . . 33.7 m120 -91.45 30.47 1.3 Allowed 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.081 -0.508 . . . . 0.0 112.213 -174.324 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' B' B ' 120' ' ' LEU . . . . . . . . . . . . . 14.2 tp -56.73 122.14 11.42 Favored 'General case' 0 C--N 1.332 -0.154 0 CA-C-O 120.666 0.27 . . . . 0.0 110.459 178.579 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' B' B ' 121' ' ' ASN . . . . . . . . . . . . . 44.8 m-20 -114.01 -44.08 3.19 Favored 'General case' 0 C--N 1.332 -0.174 0 CA-C-N 116.485 -0.325 . . . . 0.0 110.956 -176.844 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' B' B ' 122' ' ' LYS . . . . . . . . . . . . . 99.1 mttt -143.76 148.64 35.91 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-O 121.027 0.441 . . . . 0.0 111.448 -177.765 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' B' B ' 123' ' ' VAL . . . . . 0.405 ' HB ' HD11 ' B' ' 96' ' ' ILE . 45.2 t -125.0 125.85 70.21 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.292 0 CA-C-N 115.885 -0.598 . . . . 0.0 109.572 175.605 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' B' B ' 124' ' ' LEU . . . . . . . . . . . . . 28.2 mt -112.08 125.44 54.1 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 116.239 -0.437 . . . . 0.0 110.333 -179.448 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' B' B ' 125' ' ' VAL . . . . . . . . . . . . . 44.2 t -133.54 126.4 51.71 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.276 0 CA-C-N 116.495 -0.32 . . . . 0.0 110.365 -179.124 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' B' B ' 126' ' ' ARG . . . . . . . . . . . . . 69.2 ttt-85 -162.61 141.67 9.0 Favored 'General case' 0 C--N 1.329 -0.32 0 N-CA-C 109.611 -0.515 . . . . 0.0 109.611 175.094 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' B' B ' 127' ' ' ASN . . . . . . . . . . . . . 10.1 p30 48.88 -151.99 0.13 Allowed 'General case' 0 CA--C 1.54 0.563 0 CA-C-O 119.373 -0.346 . . . . 0.0 111.001 178.988 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' B' B ' 128' ' ' ASP . . . . . . . . . . . . . 13.7 p-10 -83.55 21.54 1.19 Allowed 'General case' 0 CA--C 1.533 0.307 0 CA-C-N 118.512 0.596 . . . . 0.0 112.517 179.271 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' B' B ' 129' ' ' LEU . . . . . . . . . . . . . 17.1 tp -119.66 135.23 54.9 Favored 'General case' 0 C--O 1.233 0.235 0 CA-C-O 120.969 0.414 . . . . 0.0 110.327 179.541 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' B' B ' 130' ' ' VAL . . . . . . . . . . . . . 44.6 t -128.58 135.65 61.88 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.233 0 CA-C-N 115.961 -0.563 . . . . 0.0 109.802 179.322 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' B' B ' 131' ' ' VAL . . . . . 0.44 HG22 HD12 ' B' ' 140' ' ' LEU . 43.1 t -133.82 135.59 55.05 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.285 0 CA-C-O 120.924 0.392 . . . . 0.0 110.16 179.705 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' B' B ' 132' ' ' ILE . . . . . . . . . . . . . 72.8 mt -116.22 129.76 72.1 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.327 0 N-CA-C 109.341 -0.614 . . . . 0.0 109.341 -179.958 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' B' B ' 133' ' ' ILE . . . . . . . . . . . . . 41.9 mm -116.72 120.51 65.22 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.21 0 CA-C-O 120.807 0.337 . . . . 0.0 110.859 -175.779 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' B' B ' 134' ' ' ASP . . . . . . . . . . . . . 7.7 p-10 -134.22 145.59 49.31 Favored 'General case' 0 C--N 1.33 -0.265 0 N-CA-C 109.601 -0.518 . . . . 0.0 109.601 175.11 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' B' B ' 135' ' ' GLU . . . . . . . . . . . . . 73.9 tt0 -49.96 -25.45 3.3 Favored 'General case' 0 C--N 1.329 -0.309 0 N-CA-C 112.975 0.731 . . . . 0.0 112.975 -170.578 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' B' B ' 136' ' ' GLN . . . . . . . . . . . . . 97.1 mt-30 -96.81 -31.83 12.42 Favored 'General case' 0 C--O 1.234 0.276 0 N-CA-C 112.256 0.465 . . . . 0.0 112.256 -176.291 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' B' B ' 137' ' ' LYS . . . . . . . . . . . . . 92.5 mttt -139.53 152.87 47.27 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-O 121.172 0.511 . . . . 0.0 111.48 -170.408 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' B' B ' 138' ' ' LEU . . . . . 0.469 ' C ' HD23 ' B' ' 138' ' ' LEU . 6.2 tt -119.34 119.55 34.33 Favored 'General case' 0 C--N 1.327 -0.4 0 N-CA-C 108.977 -0.749 . . . . 0.0 108.977 172.682 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' B' B ' 139' ' ' THR . . . . . . . . . . . . . 28.3 m -111.16 130.32 55.67 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-O 120.655 0.264 . . . . 0.0 110.803 -175.899 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' B' B ' 140' ' ' LEU . . . . . 0.44 HD12 HG22 ' B' ' 131' ' ' VAL . 10.6 tp -115.28 120.62 40.28 Favored 'General case' 0 C--N 1.328 -0.353 0 N-CA-C 109.299 -0.63 . . . . 0.0 109.299 -179.526 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' B' B ' 141' ' ' ILE . . . . . . . . . . . . . 19.5 mt -119.88 124.92 73.69 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.242 0 CA-C-O 121.077 0.465 . . . . 0.0 110.158 -175.044 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' B' B ' 142' ' ' ARG . . . . . . . . . . . . . 82.1 mtp180 -108.35 121.66 45.38 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 115.404 -0.816 . . . . 0.0 110.004 179.472 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' B' B ' 143' ' ' THR . . . . . . . . . . . . . 81.2 p . . . . . 0 C--O 1.219 -0.516 0 CA-C-O 117.932 -1.032 . . . . 0.0 110.747 -178.885 . . . . . . . . 0 0 . 1 . 015 nuclear nobuild core ' C' C ' 2' ' ' SER . . . . . . . . . . . . . 8.0 p . . . . . 0 C--O 1.232 0.179 0 CA-C-O 121.094 0.473 . . . . 0.0 111.146 . . . . . . . . . 0 0 . 1 . 015 nuclear nobuild core ' C' C ' 3' ' ' GLU . . . . . . . . . . . . . 47.7 mp0 -137.72 140.44 40.71 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 115.81 -0.632 . . . . 0.0 110.578 179.789 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' C' C ' 4' ' ' LEU . . . . . . . . . . . . . 13.4 tp -123.19 128.66 50.34 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 115.813 -0.63 . . . . 0.0 109.923 178.259 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' C' C ' 5' ' ' LYS . . . . . . . . . . . . . 61.3 mttp -108.89 119.61 40.07 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.538 -0.301 . . . . 0.0 110.922 -179.801 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' C' C ' 6' ' ' LEU . . . . . . . . . . . . . 38.8 mt -114.04 147.68 38.28 Favored 'General case' 0 C--N 1.331 -0.227 0 CA-C-N 115.279 -0.873 . . . . 0.0 110.232 179.286 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' C' C ' 7' ' ' LYS . . . . . . . . . . . . . 75.1 tttt -136.87 137.15 22.48 Favored Pre-proline 0 CA--C 1.534 0.33 0 CA-C-O 118.999 -0.524 . . . . 0.0 110.113 176.763 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' C' C ' 8' ' ' PRO . . . . . . . . . . . . . 98.5 Cg_endo -90.86 139.67 2.7 Favored 'Trans proline' 0 N--CA 1.491 1.328 0 C-N-CA 121.646 1.564 . . . . 0.0 111.813 177.839 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' C' C ' 9' ' ' LEU . . . . . . . . . . . . . 37.9 mt -76.3 -48.09 3.31 Favored Pre-proline 0 CA--C 1.533 0.307 0 CA-C-O 118.649 -0.691 . . . . 0.0 112.288 -179.242 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' C' C ' 10' ' ' PRO . . . . . . . . . . . . . 81.4 Cg_endo -78.26 147.36 23.11 Favored 'Trans proline' 0 N--CA 1.496 1.666 0 C-N-CA 121.003 1.135 . . . . 0.0 111.648 176.714 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' C' C ' 11' ' ' LYS . . . . . . . . . . . . . 7.3 ttpm? -86.56 87.69 7.5 Favored 'General case' 0 C--N 1.33 -0.273 0 C-N-CA 120.846 -0.342 . . . . 0.0 110.428 -179.652 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' C' C ' 12' ' ' VAL . . . . . . . . . . . . . 11.6 p -136.32 143.45 35.68 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.271 0 CA-C-N 116.03 -0.532 . . . . 0.0 110.324 179.776 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' C' C ' 13' ' ' GLU . . . . . . . . . . . . . 94.8 mt-10 -79.03 131.03 36.14 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.349 -0.387 . . . . 0.0 110.581 -179.664 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' C' C ' 14' ' ' LEU . . . . . . . . . . . . . 21.2 mt -99.42 152.52 37.83 Favored Pre-proline 0 CA--C 1.532 0.276 0 CA-C-N 116.275 -0.421 . . . . 0.0 110.787 179.236 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' C' C ' 15' ' ' PRO . . . . . . . . . . . . . 26.6 Cg_exo -61.91 157.28 44.26 Favored 'Trans proline' 0 N--CA 1.498 1.738 0 C-N-CA 121.312 1.341 . . . . 0.0 111.793 175.961 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' C' C ' 16' ' ' PRO . . . . . . . . . . . . . 33.1 Cg_exo -57.47 -41.62 70.01 Favored 'Trans proline' 0 N--CA 1.497 1.694 0 C-N-CA 121.418 1.412 . . . . 0.0 112.901 -178.478 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' C' C ' 17' ' ' ASP . . . . . . . . . . . . . 19.8 p-10 -86.35 11.93 11.21 Favored 'General case' 0 CA--C 1.536 0.433 0 N-CA-C 113.105 0.78 . . . . 0.0 113.105 -177.64 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' C' C ' 18' ' ' PHE . . . . . . . . . . . . . 51.7 t80 -57.59 -43.33 84.53 Favored 'General case' 0 C--N 1.334 -0.08 0 O-C-N 121.986 -0.446 . . . . 0.0 110.171 -178.431 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' C' C ' 19' ' ' VAL . . . . . 0.402 HG13 ' N ' ' C' ' 20' ' ' ASP . 14.9 p -56.59 -41.94 74.89 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.243 0 CA-C-N 116.29 -0.414 . . . . 0.0 110.919 -178.732 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' C' C ' 20' ' ' ASP . . . . . 0.402 ' N ' HG13 ' C' ' 19' ' ' VAL . 34.7 m-20 -60.44 -41.59 94.36 Favored 'General case' 0 C--N 1.331 -0.222 0 CA-C-O 120.831 0.348 . . . . 0.0 110.9 -178.758 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' C' C ' 21' ' ' VAL . . . . . . . . . . . . . 48.6 t -63.69 -46.96 93.23 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.287 0 CA-C-N 116.343 -0.389 . . . . 0.0 110.261 -178.828 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' C' C ' 22' ' ' ILE . . . . . 0.402 HG22 HD12 ' C' ' 26' ' ' LEU . 50.3 mm -56.68 -45.31 82.64 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.243 0 CA-C-O 120.822 0.344 . . . . 0.0 110.577 178.851 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' C' C ' 23' ' ' ARG . . . . . . . . . . . . . 49.1 ttp180 -54.22 -49.0 70.45 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.649 -0.25 . . . . 0.0 111.374 -178.018 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' C' C ' 24' ' ' ILE . . . . . . . . . . . . . 73.2 mt -59.49 -43.8 91.48 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.321 0 CA-C-O 120.864 0.364 . . . . 0.0 110.842 -178.751 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' C' C ' 25' ' ' LYS . . . . . . . . . . . . . 60.6 mtpt -62.61 -40.52 97.19 Favored 'General case' 0 C--N 1.327 -0.409 0 N-CA-C 112.113 0.412 . . . . 0.0 112.113 -178.298 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' C' C ' 26' ' ' LEU . . . . . 0.402 HD12 HG22 ' C' ' 22' ' ' ILE . 89.8 mt -79.86 -43.43 22.32 Favored 'General case' 0 C--N 1.33 -0.246 0 N-CA-C 113.352 0.871 . . . . 0.0 113.352 -171.759 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' C' C ' 27' ' ' GLN . . . . . . . . . . . . . 10.3 pt20 -46.78 138.62 6.05 Favored 'General case' 0 N--CA 1.468 0.468 0 N-CA-C 112.822 0.675 . . . . 0.0 112.822 -173.813 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' C' C ' 28' ' ' GLY . . . . . . . . . . . . . . . 100.22 -25.87 26.66 Favored Glycine 0 CA--C 1.533 1.174 0 CA-C-N 115.402 -0.817 . . . . 0.0 112.359 -177.338 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' C' C ' 29' ' ' LYS . . . . . . . . . . . . . 63.0 mttp -98.71 155.09 17.51 Favored 'General case' 0 C--N 1.332 -0.194 0 CA-C-N 117.396 0.598 . . . . 0.0 111.367 179.779 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' C' C ' 30' ' ' THR . . . . . . . . . . . . . 28.6 m -96.87 136.4 37.48 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 115.985 -0.552 . . . . 0.0 110.012 175.445 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' C' C ' 31' ' ' VAL . . . . . . . . . . . . . 34.9 m -128.94 148.76 33.26 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.316 0 CA-C-N 116.282 -0.417 . . . . 0.0 110.654 -179.368 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' C' C ' 32' ' ' ARG . . . . . . . . . . . . . 53.9 ttp180 -131.34 147.78 52.61 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-O 121.191 0.52 . . . . 0.0 110.332 178.661 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' C' C ' 33' ' ' THR . . . . . . . . . . . . . 17.5 m -52.99 138.82 29.47 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.383 -0.371 . . . . 0.0 111.46 -177.4 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' C' C ' 34' ' ' GLY . . . . . . . . . . . . . . . 101.51 -17.2 55.68 Favored Glycine 0 CA--C 1.533 1.214 0 CA-C-O 119.66 -0.522 . . . . 0.0 113.135 -179.782 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' C' C ' 35' ' ' ASP . . . . . . . . . . . . . 67.2 m-20 -65.14 149.84 49.2 Favored 'General case' 0 C--O 1.231 0.127 0 CA-C-N 118.046 0.923 . . . . 0.0 111.249 179.127 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' C' C ' 36' ' ' VAL . . . . . . . . . . . . . 46.0 t -123.3 131.46 73.13 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.239 0 CA-C-N 115.788 -0.642 . . . . 0.0 109.835 177.784 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' C' C ' 37' ' ' ILE . . . . . . . . . . . . . 69.7 mt -120.57 139.36 48.08 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.234 0 CA-C-N 116.254 -0.43 . . . . 0.0 109.984 -179.115 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' C' C ' 38' ' ' GLY . . . . . . . . . . . . . . . -113.83 128.84 8.48 Favored Glycine 0 CA--C 1.526 0.721 0 N-CA-C 111.095 -0.802 . . . . 0.0 111.095 -179.972 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' C' C ' 39' ' ' ILE . . . . . . . . . . . . . 72.8 mt -123.18 133.44 69.09 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.265 0 N-CA-C 110.026 -0.361 . . . . 0.0 110.026 179.116 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' C' C ' 40' ' ' SER . . . . . . . . . . . . . 85.8 p -92.11 122.64 34.8 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.454 -0.339 . . . . 0.0 110.684 176.222 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' C' C ' 41' ' ' ILE . . . . . . . . . . . . . 73.3 mt -135.39 118.13 22.65 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.176 0 CA-C-O 120.95 0.405 . . . . 0.0 110.467 178.738 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' C' C ' 42' ' ' LEU . . . . . 0.533 ' O ' HD23 ' C' ' 42' ' ' LEU . 1.4 tt 55.17 45.48 25.87 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-O 121.496 0.665 . . . . 0.0 110.424 177.79 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' C' C ' 43' ' ' GLY . . . . . . . . . . . . . . . 74.99 -10.01 10.4 Favored Glycine 0 CA--C 1.535 1.31 0 C-N-CA 121.239 -0.505 . . . . 0.0 113.761 174.679 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' C' C ' 44' ' ' LYS . . . . . . . . . . . . . 93.1 mttt -104.79 137.61 42.32 Favored 'General case' 0 C--N 1.334 -0.103 0 CA-C-N 118.116 0.958 . . . . 0.0 110.6 -179.464 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' C' C ' 45' ' ' GLU . . . . . . . . . . . . . 79.5 tt0 -85.58 130.0 34.68 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.247 -0.433 . . . . 0.0 111.002 179.453 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' C' C ' 46' ' ' VAL . . . . . . . . . . . . . 7.4 p -123.24 127.96 74.69 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.247 0 N-CA-C 109.587 -0.523 . . . . 0.0 109.587 175.369 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' C' C ' 47' ' ' LYS . . . . . . . . . . . . . 57.3 mtmt -101.47 129.71 47.58 Favored 'General case' 0 C--N 1.331 -0.201 0 CA-C-N 115.888 -0.596 . . . . 0.0 111.626 179.824 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' C' C ' 48' ' ' PHE . . . . . . . . . . . . . 93.1 m-85 -113.85 132.07 56.03 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.079 -0.509 . . . . 0.0 110.154 176.861 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' C' C ' 49' ' ' LYS . . . . . . . . . . . . . 77.8 tttt -106.18 139.56 40.5 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.558 -0.292 . . . . 0.0 110.635 178.978 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' C' C ' 50' ' ' VAL . . . . . . . . . . . . . 44.9 t -83.64 105.61 13.38 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.252 0 N-CA-C 109.194 -0.669 . . . . 0.0 109.194 174.64 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' C' C ' 51' ' ' VAL . . . . . . . . . . . . . 48.7 t -69.65 -54.89 17.13 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.39 0 CA-C-N 115.791 -0.64 . . . . 0.0 109.513 -175.041 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' C' C ' 52' ' ' GLN . . . . . . . . . . . . . 88.5 mt-30 -155.26 154.36 32.04 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 115.882 -0.599 . . . . 0.0 111.906 -177.561 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' C' C ' 53' ' ' ALA . . . . . 0.639 ' HB3' ' OG ' ' C' ' 56' ' ' SER . . . -131.6 132.49 44.11 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 115.334 -0.848 . . . . 0.0 109.782 174.1 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' C' C ' 54' ' ' TYR . . . . . . . . . . . . . 19.8 t80 -129.11 110.45 18.21 Favored Pre-proline 0 CA--C 1.533 0.32 0 CA-C-O 118.142 -0.932 . . . . 0.0 110.092 177.224 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' C' C ' 55' ' ' PRO . . . . . . . . . . . . . 72.7 Cg_endo -77.1 170.1 72.51 Favored 'Cis proline' 0 N--CA 1.5 1.869 0 CA-C-N 121.983 1.744 . . . . 0.0 112.326 -4.973 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' C' C ' 56' ' ' SER . . . . . 0.639 ' OG ' ' HB3' ' C' ' 53' ' ' ALA . 67.2 m -128.19 138.9 33.98 Favored Pre-proline 0 CA--C 1.536 0.429 0 CA-C-O 118.585 -0.721 . . . . 0.0 109.32 174.039 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' C' C ' 57' ' ' PRO . . . . . . . . . . . . . 40.4 Cg_endo -68.53 143.12 70.03 Favored 'Cis proline' 0 N--CA 1.498 1.789 0 CA-C-N 121.662 1.629 . . . . 0.0 111.678 -1.093 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' C' C ' 58' ' ' LEU . . . . . . . . . . . . . 27.8 tp -107.58 138.03 44.54 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.055 -0.52 . . . . 0.0 110.764 -176.085 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' C' C ' 59' ' ' ARG . . . . . . . . . . . . . 43.1 ttp180 -101.44 119.31 38.57 Favored 'General case' 0 C--N 1.328 -0.354 0 N-CA-C 108.894 -0.78 . . . . 0.0 108.894 173.698 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' C' C ' 60' ' ' VAL . . . . . . . . . . . . . 45.0 t -72.25 120.04 19.97 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.258 0 C-N-CA 120.644 -0.423 . . . . 0.0 110.3 -173.677 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' C' C ' 61' ' ' GLU . . . . . . . . . . . . . 42.8 mt-10 -131.04 162.61 29.42 Favored 'General case' 0 C--N 1.331 -0.23 0 CA-C-N 116.03 -0.532 . . . . 0.0 110.284 178.411 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' C' C ' 62' ' ' ASP . . . . . . . . . . . . . 7.7 p-10 -56.19 -32.54 64.46 Favored 'General case' 0 C--N 1.329 -0.304 0 N-CA-C 111.922 0.342 . . . . 0.0 111.922 -178.412 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' C' C ' 63' ' ' ARG . . . . . . . . . . . . . 40.4 ptt180 -81.4 3.83 23.05 Favored 'General case' 0 CA--C 1.537 0.452 0 N-CA-C 113.746 1.017 . . . . 0.0 113.746 -175.582 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' C' C ' 64' ' ' THR . . . . . . . . . . . . . 26.4 m -87.99 138.75 31.17 Favored 'General case' 0 C--N 1.332 -0.166 0 CA-C-N 118.103 0.41 . . . . 0.0 110.48 -179.061 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' C' C ' 65' ' ' LYS . . . . . . . . . . . . . 95.4 mttt -87.93 128.31 35.37 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.373 -0.376 . . . . 0.0 110.127 -179.755 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' C' C ' 66' ' ' ILE . . . . . . . . . . . . . 59.1 mt -115.64 131.62 67.48 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.215 0 N-CA-C 109.936 -0.394 . . . . 0.0 109.936 -179.329 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' C' C ' 67' ' ' THR . . . . . . . . . . . . . 26.3 m -124.69 138.21 54.31 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-N 116.151 -0.477 . . . . 0.0 110.723 -179.689 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' C' C ' 68' ' ' LEU . . . . . . . . . . . . . 48.2 mt . . . . . 0 C--N 1.33 -0.248 0 CA-C-N 115.902 -0.59 . . . . 0.0 110.297 177.367 . . . . . . . . 0 0 . 1 . 015 nuclear nobuild core ' C' C ' 73' ' ' VAL . . . . . . . . . . . . . 30.4 m . . . . . 0 C--O 1.231 0.125 0 N-CA-C 110.138 -0.319 . . . . 0.0 110.138 . . . . . . . . . 0 0 . 1 . 015 nuclear nobuild core ' C' C ' 74' ' ' ASP . . . . . 0.407 ' OD1' HD11 ' C' ' 76' ' ' LEU . 13.6 t0 -96.38 119.04 34.15 Favored 'General case' 0 C--N 1.33 -0.253 0 N-CA-C 109.919 -0.401 . . . . 0.0 109.919 -177.498 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' C' C ' 75' ' ' VAL . . . . . 0.418 HG21 ' CE1' ' B' ' 113' ' ' TYR . 43.2 t -119.44 122.95 70.25 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.208 0 CA-C-O 121.125 0.488 . . . . 0.0 110.811 -176.954 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' C' C ' 76' ' ' LEU . . . . . 0.48 ' N ' HD12 ' C' ' 76' ' ' LEU . 5.8 mp -121.05 141.48 50.72 Favored 'General case' 0 C--N 1.331 -0.205 0 CA-C-N 115.647 -0.706 . . . . 0.0 109.12 174.112 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' C' C ' 77' ' ' GLU . . . . . . . . . . . . . 31.3 tt0 -132.08 132.13 43.02 Favored 'General case' 0 C--N 1.331 -0.209 0 CA-C-O 120.841 0.353 . . . . 0.0 110.902 -176.161 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' C' C ' 78' ' ' ALA . . . . . . . . . . . . . . . -119.1 142.44 47.9 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 116.002 -0.545 . . . . 0.0 109.869 177.454 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' C' C ' 79' ' ' LYS . . . . . 0.565 ' O ' HD13 ' C' ' 80' ' ' ILE . 81.3 tttt -84.45 119.73 25.47 Favored 'General case' 0 C--N 1.328 -0.332 0 C-N-CA 120.934 -0.307 . . . . 0.0 110.58 -178.69 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' C' C ' 80' ' ' ILE . . . . . 0.565 HD13 ' O ' ' C' ' 79' ' ' LYS . 44.8 mm -138.26 117.94 14.96 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.27 0 N-CA-C 109.533 -0.543 . . . . 0.0 109.533 -177.486 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' C' C ' 81' ' ' LYS . . . . . . . . . . . . . 59.4 mtmt -112.83 125.69 54.62 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.407 -0.361 . . . . 0.0 111.37 -176.298 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' C' C ' 82' ' ' GLY . . . . . . . . . . . . . . . 89.13 42.11 5.68 Favored Glycine 0 CA--C 1.524 0.595 0 C-N-CA 120.865 -0.683 . . . . 0.0 111.458 175.485 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' C' C ' 83' ' ' ILE . . . . . . . . . . . . . 70.1 mt -67.59 132.77 32.34 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.291 0 N-CA-C 109.835 -0.431 . . . . 0.0 109.835 178.909 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' C' C ' 84' ' ' LYS . . . . . . . . . . . . . 59.4 tttp -93.5 -49.25 6.0 Favored 'General case' 0 C--N 1.327 -0.407 0 CA-C-N 116.011 -0.54 . . . . 0.0 109.837 179.967 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' C' C ' 85' ' ' ASP . . . . . . . . . . . . . 5.1 t0 -159.84 153.14 22.15 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 115.71 -0.677 . . . . 0.0 110.28 179.031 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' C' C ' 86' ' ' VAL . . . . . . . . . . . . . 42.6 t -125.92 131.75 71.46 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.274 0 CA-C-O 120.868 0.366 . . . . 0.0 110.199 -179.939 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' C' C ' 87' ' ' ILE . . . . . . . . . . . . . 44.2 mm -120.13 129.27 75.68 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.264 0 CA-C-N 116.027 -0.533 . . . . 0.0 109.632 178.981 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' C' C ' 88' ' ' LEU . . . . . . . . . . . . . 12.4 tp -112.31 130.77 55.84 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-O 120.985 0.421 . . . . 0.0 111.296 -175.857 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' C' C ' 89' ' ' ASP . . . . . . . . . . . . . 13.1 t70 -125.27 152.01 45.2 Favored 'General case' 0 C--N 1.33 -0.249 0 N-CA-C 109.272 -0.64 . . . . 0.0 109.272 175.016 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' C' C ' 90' ' ' GLU . . . . . . . . . . . . . 95.4 mt-10 -48.92 -37.8 20.93 Favored 'General case' 0 C--N 1.329 -0.324 0 N-CA-C 112.754 0.649 . . . . 0.0 112.754 -171.804 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' C' C ' 91' ' ' ASN . . . . . . . . . . . . . 14.7 m-80 -125.49 16.7 8.23 Favored 'General case' 0 N--CA 1.468 0.474 0 N-CA-C 113.21 0.819 . . . . 0.0 113.21 -177.352 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' C' C ' 92' ' ' LEU . . . . . . . . . . . . . 12.5 mt -148.86 143.26 26.15 Favored 'General case' 0 C--N 1.333 -0.114 0 N-CA-C 110.112 -0.329 . . . . 0.0 110.112 -176.605 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' C' C ' 93' ' ' ILE . . . . . . . . . . . . . 73.7 mt -121.23 119.27 58.7 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.353 0 N-CA-C 109.157 -0.683 . . . . 0.0 109.157 177.55 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' C' C ' 94' ' ' VAL . . . . . . . . . . . . . 45.3 t -118.73 127.16 75.68 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.201 0 CA-C-O 121.023 0.439 . . . . 0.0 110.061 -178.314 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' C' C ' 95' ' ' VAL . . . . . . . . . . . . . 44.9 t -118.97 132.91 67.5 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.357 0 CA-C-N 115.784 -0.644 . . . . 0.0 109.519 178.681 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' C' C ' 96' ' ' ILE . . . . . . . . . . . . . 68.3 mt -112.67 126.06 70.01 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.346 0 N-CA-C 109.214 -0.662 . . . . 0.0 109.214 178.775 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' C' C ' 97' ' ' THR . . . . . . . . . . . . . 60.6 p -99.76 158.27 15.91 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-O 121.313 0.578 . . . . 0.0 111.386 -176.904 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' C' C ' 98' ' ' GLU . . . . . . . . . . . . . 83.8 tt0 -53.88 -26.71 26.17 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.049 -0.523 . . . . 0.0 112.23 179.73 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' C' C ' 99' ' ' GLU . . . . . . . . . . . . . 71.0 mm-40 -78.87 15.35 1.1 Allowed 'General case' 0 CA--C 1.534 0.353 0 N-CA-C 113.185 0.809 . . . . 0.0 113.185 -177.691 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' C' C ' 100' ' ' ASN . . . . . . . . . . . . . 4.1 m-20 60.88 38.16 17.97 Favored 'General case' 0 C--O 1.232 0.146 0 CA-C-O 121.101 0.477 . . . . 0.0 110.823 179.833 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' C' C ' 101' ' ' GLU . . . . . . . . . . . . . 83.7 tt0 -114.83 144.36 43.65 Favored 'General case' 0 C--N 1.332 -0.16 0 CA-C-N 116.001 -0.545 . . . . 0.0 109.64 177.016 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' C' C ' 102' ' ' VAL . . . . . . . . . . . . . 44.4 t -114.93 124.84 71.98 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.306 0 N-CA-C 109.919 -0.401 . . . . 0.0 109.919 -178.156 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' C' C ' 103' ' ' LEU . . . . . . . . . . . . . 28.7 mt -113.64 131.28 56.2 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 115.717 -0.674 . . . . 0.0 110.198 176.6 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' C' C ' 104' ' ' ILE . . . . . . . . . . . . . 73.5 mt -120.36 119.06 58.76 Favored 'Isoleucine or valine' 0 C--O 1.235 0.325 0 N-CA-C 110.295 -0.261 . . . . 0.0 110.295 -179.79 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' C' C ' 105' ' ' PHE . . . . . . . . . . . . . 79.7 m-85 -120.19 167.37 12.32 Favored 'General case' 0 C--N 1.331 -0.217 0 O-C-N 124.205 0.941 . . . . 0.0 109.766 178.956 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' C' C ' 106' ' ' ASN . . . . . . . . . . . . . 39.7 p-10 -103.77 -169.91 1.7 Allowed 'General case' 0 CA--C 1.53 0.181 0 N-CA-C 109.703 -0.48 . . . . 0.0 109.703 171.394 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' C' C ' 107' ' ' GLN . . . . . . . . . . . . . 50.0 tt0 -58.69 -30.12 67.15 Favored 'General case' 0 C--N 1.329 -0.302 0 N-CA-C 111.862 0.319 . . . . 0.0 111.862 179.361 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' C' C ' 108' ' ' ASN . . . . . . . . . . . . . 45.7 t30 -89.21 12.88 14.66 Favored 'General case' 0 CA--C 1.535 0.393 0 N-CA-C 113.048 0.759 . . . . 0.0 113.048 -176.855 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' C' C ' 109' ' ' LEU . . . . . . . . . . . . . 63.3 mt 58.28 35.72 25.12 Favored 'General case' 0 C--N 1.332 -0.182 0 CA-C-O 120.755 0.312 . . . . 0.0 111.767 175.934 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' C' C ' 110' ' ' GLU . . . . . . . . . . . . . 70.3 mm-40 -103.91 135.28 45.74 Favored 'General case' 0 C--N 1.33 -0.264 0 N-CA-C 110.014 -0.365 . . . . 0.0 110.014 175.238 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' C' C ' 111' ' ' GLU . . . . . . . . . . . . . 98.1 mt-10 -67.14 123.62 20.78 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-O 121.044 0.45 . . . . 0.0 111.071 -178.39 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' C' C ' 112' ' ' LEU . . . . . . . . . . . . . 13.9 mt -105.99 -43.88 4.74 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-N 115.793 -0.64 . . . . 0.0 109.946 175.78 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' C' C ' 113' ' ' TYR . . . . . . . . . . . . . 65.0 t80 -143.86 140.76 29.96 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.236 -0.438 . . . . 0.0 111.637 -179.315 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' C' C ' 114' ' ' ARG . . . . . . . . . . . . . 37.2 ttm180 -136.31 128.1 29.16 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 115.797 -0.638 . . . . 0.0 109.96 174.026 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' C' C ' 115' ' ' GLY . . . . . . . . . . . . . . . -150.04 159.41 28.09 Favored Glycine 0 CA--C 1.526 0.774 0 N-CA-C 111.169 -0.772 . . . . 0.0 111.169 177.441 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' C' C ' 116' ' ' LYS . . . . . . . . . . . . . 33.7 ttpt -130.81 136.6 48.85 Favored 'General case' 0 C--N 1.33 -0.244 0 N-CA-C 109.974 -0.38 . . . . 0.0 109.974 177.555 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' C' C ' 117' ' ' PHE . . . . . . . . . . . . . 40.8 m-85 -135.14 117.14 15.3 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-O 120.703 0.287 . . . . 0.0 110.39 -176.672 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' C' C ' 118' ' ' GLU . . . . . . . . . . . . . 70.6 mm-40 -54.65 -46.32 73.96 Favored 'General case' 0 C--N 1.329 -0.29 0 C-N-CA 120.996 -0.282 . . . . 0.0 111.38 -177.014 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' C' C ' 119' ' ' ASN . . . . . . . . . . . . . 6.0 m120 -95.99 30.99 2.24 Favored 'General case' 0 C--N 1.329 -0.322 0 N-CA-C 112.046 0.387 . . . . 0.0 112.046 -175.457 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' C' C ' 120' ' ' LEU . . . . . . . . . . . . . 14.0 tp -57.82 120.93 9.3 Favored 'General case' 0 C--O 1.232 0.154 0 CA-C-O 120.679 0.276 . . . . 0.0 110.39 179.008 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' C' C ' 121' ' ' ASN . . . . . . . . . . . . . 93.9 m-20 -114.16 -43.96 3.18 Favored 'General case' 0 C--N 1.331 -0.217 0 CA-C-N 116.38 -0.373 . . . . 0.0 111.311 -178.304 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' C' C ' 122' ' ' LYS . . . . . . . . . . . . . 97.2 mttt -144.28 151.11 38.93 Favored 'General case' 0 C--N 1.331 -0.215 0 C-N-CA 120.647 -0.421 . . . . 0.0 111.848 -175.993 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' C' C ' 123' ' ' VAL . . . . . . . . . . . . . 46.1 t -132.08 128.59 59.4 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.311 0 N-CA-C 109.259 -0.645 . . . . 0.0 109.259 172.159 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' C' C ' 124' ' ' LEU . . . . . . . . . . . . . 8.7 tp -128.31 143.27 51.0 Favored 'General case' 0 N--CA 1.464 0.245 0 CA-C-O 120.726 0.298 . . . . 0.0 110.91 -175.845 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' C' C ' 125' ' ' VAL . . . . . 0.474 HG12 HG23 ' C' ' 130' ' ' VAL . 35.0 m -130.19 143.84 39.78 Favored 'Isoleucine or valine' 0 C--O 1.232 0.177 0 CA-C-N 116.35 -0.386 . . . . 0.0 111.254 -178.637 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' C' C ' 126' ' ' ARG . . . . . . . . . . . . . 96.0 mtt-85 -149.73 124.9 10.08 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 116.246 -0.434 . . . . 0.0 110.781 175.634 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' C' C ' 127' ' ' ASN . . . . . . . . . . . . . 24.8 m120 49.63 -109.18 0.35 Allowed 'General case' 0 CA--C 1.545 0.764 0 CA-C-O 118.828 -0.606 . . . . 0.0 111.649 178.938 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' C' C ' 128' ' ' ASP . . . . . . . . . . . . . 19.5 p-10 -114.09 7.3 16.68 Favored 'General case' 0 N--CA 1.469 0.482 0 CA-C-N 119.891 1.223 . . . . 0.0 113.371 -177.442 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' C' C ' 129' ' ' LEU . . . . . . . . . . . . . 42.1 mt -113.7 147.88 37.4 Favored 'General case' 0 C--O 1.232 0.14 0 N-CA-C 109.795 -0.446 . . . . 0.0 109.795 178.723 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' C' C ' 130' ' ' VAL . . . . . 0.49 HG13 ' HB ' ' C' ' 141' ' ' ILE . 12.9 p -133.62 143.18 39.55 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.222 0 CA-C-O 121.166 0.508 . . . . 0.0 110.511 -179.758 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' C' C ' 131' ' ' VAL . . . . . 0.476 HG22 HD12 ' C' ' 140' ' ' LEU . 41.1 t -132.92 138.4 51.82 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.248 0 CA-C-N 115.848 -0.614 . . . . 0.0 110.234 -178.068 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' C' C ' 132' ' ' ILE . . . . . . . . . . . . . 72.2 mt -116.8 133.86 62.15 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.331 0 N-CA-C 109.308 -0.627 . . . . 0.0 109.308 179.471 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' C' C ' 133' ' ' ILE . . . . . . . . . . . . . 40.1 mm -117.02 122.89 71.08 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.245 0 CA-C-N 116.673 -0.239 . . . . 0.0 110.81 -174.756 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' C' C ' 134' ' ' ASP . . . . . . . . . . . . . 7.2 p-10 -135.59 150.28 49.63 Favored 'General case' 0 C--N 1.331 -0.225 0 N-CA-C 110.003 -0.369 . . . . 0.0 110.003 175.55 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' C' C ' 135' ' ' GLU . . . . . . . . . . . . . 44.8 tp10 -50.67 -28.08 8.26 Favored 'General case' 0 C--N 1.328 -0.361 0 N-CA-C 112.756 0.65 . . . . 0.0 112.756 -173.218 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' C' C ' 136' ' ' GLN . . . . . . . . . . . . . 96.9 mt-30 -86.17 -29.22 23.41 Favored 'General case' 0 C--N 1.33 -0.253 0 N-CA-C 112.805 0.669 . . . . 0.0 112.805 -174.98 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' C' C ' 137' ' ' LYS . . . . . . . . . . . . . 43.1 pttt -170.14 173.67 5.77 Favored 'General case' 0 C--N 1.332 -0.189 0 CA-C-O 121.53 0.681 . . . . 0.0 112.503 -172.544 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' C' C ' 138' ' ' LEU . . . . . 0.42 HD23 ' N ' ' C' ' 139' ' ' THR . 5.5 tt -118.55 128.62 54.74 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 114.967 -1.015 . . . . 0.0 109.766 179.168 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' C' C ' 139' ' ' THR . . . . . 0.42 ' N ' HD23 ' C' ' 138' ' ' LEU . 31.9 m -107.09 128.16 54.13 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.43 -0.35 . . . . 0.0 110.281 179.798 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' C' C ' 140' ' ' LEU . . . . . 0.476 HD12 HG22 ' C' ' 131' ' ' VAL . 11.0 tp -114.6 121.42 43.38 Favored 'General case' 0 C--N 1.328 -0.339 0 N-CA-C 109.23 -0.655 . . . . 0.0 109.23 -178.718 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' C' C ' 141' ' ' ILE . . . . . 0.49 ' HB ' HG13 ' C' ' 130' ' ' VAL . 20.1 mt -119.28 121.6 66.97 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 CA-C-O 121.032 0.444 . . . . 0.0 110.04 -175.803 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' C' C ' 142' ' ' ARG . . . . . . . . . . . . . 69.5 mtt180 . . . . . 0 C--N 1.329 -0.312 0 CA-C-N 114.989 -1.005 . . . . 0.0 109.849 -175.263 . . . . . . . . 0 0 . 1 . 015 nuclear nobuild core ' D' D ' 2' ' ' SER . . . . . . . . . . . . . 25.2 p . . . . . 0 N--CA 1.461 0.082 0 CA-C-O 120.913 0.387 . . . . 0.0 110.574 . . . . . . . . . 0 0 . 1 . 015 nuclear nobuild core ' D' D ' 3' ' ' GLU . . . . . . . . . . . . . 95.3 mt-10 -141.13 138.78 33.72 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.1 -0.5 . . . . 0.0 111.489 -177.498 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' D' D ' 4' ' ' LEU . . . . . . . . . . . . . 70.1 mt -118.96 127.74 53.75 Favored 'General case' 0 C--N 1.331 -0.214 0 CA-C-N 115.953 -0.567 . . . . 0.0 110.079 174.392 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' D' D ' 5' ' ' LYS . . . . . . . . . . . . . 98.7 mttt -109.67 122.4 47.38 Favored 'General case' 0 C--O 1.235 0.311 0 CA-C-O 120.673 0.273 . . . . 0.0 110.659 177.225 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' D' D ' 6' ' ' LEU . . . . . . . . . . . . . 46.8 mt -113.94 146.55 39.93 Favored 'General case' 0 C--N 1.331 -0.219 0 CA-C-N 115.435 -0.802 . . . . 0.0 109.919 179.786 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' D' D ' 7' ' ' LYS . . . . . . . . . . . . . 76.4 tttt -131.28 137.63 31.01 Favored Pre-proline 0 CA--C 1.533 0.318 0 CA-C-O 118.935 -0.555 . . . . 0.0 109.732 175.74 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' D' D ' 8' ' ' PRO . . . . . . . . . . . . . 85.9 Cg_endo -90.96 135.18 1.86 Allowed 'Trans proline' 0 N--CA 1.489 1.225 0 C-N-CA 121.705 1.603 . . . . 0.0 111.825 179.316 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' D' D ' 9' ' ' LEU . . . . . . . . . . . . . 38.0 mt -73.3 -45.13 7.86 Favored Pre-proline 0 CA--C 1.533 0.311 0 CA-C-O 119.019 -0.515 . . . . 0.0 111.036 179.79 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' D' D ' 10' ' ' PRO . . . . . . . . . . . . . 64.5 Cg_endo -86.11 152.82 9.6 Favored 'Trans proline' 0 N--CA 1.492 1.425 0 C-N-CA 121.241 1.294 . . . . 0.0 111.066 169.041 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' D' D ' 11' ' ' LYS . . . . . . . . . . . . . 25.5 pttm -86.1 119.86 26.86 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-O 121.291 0.567 . . . . 0.0 110.461 177.084 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' D' D ' 12' ' ' VAL . . . . . . . . . . . . . 13.1 p -150.47 143.29 17.22 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.327 0 CA-C-N 115.928 -0.578 . . . . 0.0 110.523 -179.966 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' D' D ' 13' ' ' GLU . . . . . . . . . . . . . 43.3 mt-10 -90.36 110.47 21.55 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.296 -0.411 . . . . 0.0 110.04 177.808 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' D' D ' 14' ' ' LEU . . . . . . . . . . . . . 15.8 mt -88.08 153.05 51.47 Favored Pre-proline 0 C--N 1.33 -0.281 0 CA-C-N 116.345 -0.389 . . . . 0.0 110.646 -178.154 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' D' D ' 15' ' ' PRO . . . . . . . . . . . . . 25.4 Cg_exo -62.58 155.16 60.19 Favored 'Trans proline' 0 N--CA 1.497 1.679 0 C-N-CA 121.267 1.311 . . . . 0.0 111.35 175.17 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' D' D ' 16' ' ' PRO . . . . . . . . . . . . . 36.5 Cg_exo -58.02 -35.64 98.61 Favored 'Trans proline' 0 N--CA 1.497 1.723 0 C-N-CA 121.318 1.345 . . . . 0.0 112.923 -178.68 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' D' D ' 17' ' ' ASP . . . . . . . . . . . . . 10.8 p-10 -85.48 5.96 28.99 Favored 'General case' 0 CA--C 1.536 0.411 0 N-CA-C 113.336 0.865 . . . . 0.0 113.336 -176.508 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' D' D ' 18' ' ' PHE . . . . . . . . . . . . . 42.3 t80 -58.37 -44.49 88.9 Favored 'General case' 0 C--N 1.334 -0.101 0 O-C-N 121.939 -0.475 . . . . 0.0 109.892 -179.251 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' D' D ' 19' ' ' VAL . . . . . . . . . . . . . 47.6 t -56.76 -42.6 77.79 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.284 0 CA-C-N 116.243 -0.435 . . . . 0.0 110.316 -179.423 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' D' D ' 20' ' ' ASP . . . . . . . . . . . . . 9.6 t70 -59.47 -42.59 92.39 Favored 'General case' 0 C--N 1.33 -0.278 0 C-N-CA 120.853 -0.339 . . . . 0.0 110.72 -177.522 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' D' D ' 21' ' ' VAL . . . . . . . . . . . . . 47.3 t -64.42 -46.37 93.12 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 C-N-CA 120.754 -0.378 . . . . 0.0 110.646 -177.611 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' D' D ' 22' ' ' ILE . . . . . 0.551 HG22 HD12 ' D' ' 26' ' ' LEU . 45.4 mm -58.57 -40.27 78.38 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.267 0 C-N-CA 121.05 -0.26 . . . . 0.0 110.758 -179.449 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' D' D ' 23' ' ' ARG . . . . . . . . . . . . . 35.4 ttp180 -57.73 -49.64 75.88 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-O 121.148 0.499 . . . . 0.0 110.32 177.285 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' D' D ' 24' ' ' ILE . . . . . . . . . . . . . 66.0 mt -60.96 -38.41 79.32 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.304 0 CA-C-N 115.737 -0.665 . . . . 0.0 111.841 -176.781 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' D' D ' 25' ' ' LYS . . . . . . . . . . . . . 35.5 pttt -77.21 -37.57 53.14 Favored 'General case' 0 CA--C 1.534 0.341 0 C-N-CA 120.396 -0.521 . . . . 0.0 111.864 -174.952 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' D' D ' 26' ' ' LEU . . . . . 0.551 HD12 HG22 ' D' ' 22' ' ' ILE . 72.0 mt -77.7 -32.42 52.99 Favored 'General case' 0 C--N 1.331 -0.238 0 N-CA-C 113.237 0.828 . . . . 0.0 113.237 -172.354 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' D' D ' 27' ' ' GLN . . . . . . . . . . . . . 5.8 pt20 -45.71 135.71 6.58 Favored 'General case' 0 N--CA 1.469 0.517 0 N-CA-C 112.951 0.723 . . . . 0.0 112.951 -175.49 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' D' D ' 28' ' ' GLY . . . . . . . . . . . . . . . 99.37 -24.76 30.93 Favored Glycine 0 CA--C 1.534 1.223 0 CA-C-N 115.62 -0.718 . . . . 0.0 112.441 -177.713 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' D' D ' 29' ' ' LYS . . . . . . . . . . . . . 69.0 mttm -98.05 155.17 17.25 Favored 'General case' 0 C--N 1.333 -0.12 0 CA-C-N 117.29 0.545 . . . . 0.0 111.002 179.599 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' D' D ' 30' ' ' THR . . . . . . . . . . . . . 21.6 m -101.1 140.19 35.74 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.36 -0.382 . . . . 0.0 110.465 178.206 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' D' D ' 31' ' ' VAL . . . . . . . . . . . . . 34.9 m -130.14 150.4 34.58 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.232 0 CA-C-N 116.232 -0.44 . . . . 0.0 110.992 -179.418 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' D' D ' 32' ' ' ARG . . . . . . . . . . . . . 82.0 mtm180 -135.42 151.09 50.1 Favored 'General case' 0 C--N 1.331 -0.23 0 CA-C-O 121.258 0.551 . . . . 0.0 110.672 178.275 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' D' D ' 33' ' ' THR . . . . . . . . . . . . . 29.3 m -53.65 139.93 30.6 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.273 -0.421 . . . . 0.0 111.193 -179.49 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' D' D ' 34' ' ' GLY . . . . . . . . . . . . . . . 101.01 -17.02 56.82 Favored Glycine 0 CA--C 1.532 1.131 0 CA-C-O 119.703 -0.498 . . . . 0.0 113.244 179.609 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' D' D ' 35' ' ' ASP . . . . . . . . . . . . . 67.5 m-20 -65.15 148.63 51.33 Favored 'General case' 0 C--O 1.232 0.133 0 CA-C-N 118.103 0.951 . . . . 0.0 110.999 178.739 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' D' D ' 36' ' ' VAL . . . . . . . . . . . . . 45.4 t -126.75 131.76 70.79 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.232 0 CA-C-N 116.044 -0.525 . . . . 0.0 109.935 179.444 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' D' D ' 37' ' ' ILE . . . . . . . . . . . . . 63.0 mt -124.89 139.78 50.01 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.215 0 CA-C-N 116.226 -0.443 . . . . 0.0 110.173 -179.09 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' D' D ' 38' ' ' GLY . . . . . . . . . . . . . . . -113.83 128.41 8.28 Favored Glycine 0 CA--C 1.526 0.724 0 N-CA-C 110.741 -0.944 . . . . 0.0 110.741 177.73 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' D' D ' 39' ' ' ILE . . . . . . . . . . . . . 70.6 mt -126.92 137.72 57.0 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.282 0 CA-C-O 120.654 0.264 . . . . 0.0 110.297 -179.758 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' D' D ' 40' ' ' SER . . . . . . . . . . . . . 42.9 t -92.11 120.8 33.06 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.307 -0.406 . . . . 0.0 110.755 176.058 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' D' D ' 41' ' ' ILE . . . . . . . . . . . . . 67.7 mt -126.57 117.51 48.4 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.193 0 CA-C-O 120.707 0.289 . . . . 0.0 110.268 178.672 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' D' D ' 42' ' ' LEU . . . . . . . . . . . . . 8.2 mp 50.94 39.13 22.05 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-O 121.094 0.474 . . . . 0.0 111.729 177.262 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' D' D ' 43' ' ' GLY . . . . . . . . . . . . . . . 75.36 26.57 65.55 Favored Glycine 0 CA--C 1.531 1.077 0 C-N-CA 121.218 -0.515 . . . . 0.0 112.669 175.742 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' D' D ' 44' ' ' LYS . . . . . . . . . . . . . 98.8 mttt -136.56 129.35 30.76 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 117.142 0.471 . . . . 0.0 109.798 176.606 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' D' D ' 45' ' ' GLU . . . . . . . . . . . . . 73.0 tt0 -84.16 123.38 30.02 Favored 'General case' 0 C--N 1.329 -0.314 0 C-N-CA 120.788 -0.365 . . . . 0.0 110.8 -178.102 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' D' D ' 46' ' ' VAL . . . . . . . . . . . . . 11.3 p -117.22 127.29 74.79 Favored 'Isoleucine or valine' 0 C--O 1.233 0.196 0 N-CA-C 109.832 -0.433 . . . . 0.0 109.832 176.368 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' D' D ' 47' ' ' LYS . . . . . . . . . . . . . 34.3 mmtp -98.23 122.91 41.96 Favored 'General case' 0 C--N 1.327 -0.404 0 CA-C-N 115.927 -0.578 . . . . 0.0 110.659 177.165 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' D' D ' 48' ' ' PHE . . . . . . . . . . . . . 30.6 m-85 -108.32 131.79 54.37 Favored 'General case' 0 C--N 1.33 -0.276 0 N-CA-C 109.668 -0.493 . . . . 0.0 109.668 175.693 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' D' D ' 49' ' ' LYS . . . . . . . . . . . . . 60.1 tttm -108.82 136.12 48.9 Favored 'General case' 0 C--N 1.329 -0.316 0 N-CA-C 110.04 -0.355 . . . . 0.0 110.04 175.858 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' D' D ' 50' ' ' VAL . . . . . . . . . . . . . 45.3 t -77.63 107.05 8.71 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.343 0 N-CA-C 109.176 -0.675 . . . . 0.0 109.176 176.487 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' D' D ' 51' ' ' VAL . . . . . . . . . . . . . 45.0 t -70.96 -48.75 54.27 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.315 0 CA-C-N 116.132 -0.486 . . . . 0.0 109.781 -174.221 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' D' D ' 52' ' ' GLN . . . . . . . . . . . . . 62.2 tt0 -164.66 139.8 5.55 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 115.983 -0.553 . . . . 0.0 111.187 -176.614 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' D' D ' 53' ' ' ALA . . . . . . . . . . . . . . . -120.37 135.87 54.89 Favored 'General case' 0 C--N 1.332 -0.191 0 CA-C-N 116.009 -0.541 . . . . 0.0 109.868 174.342 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' D' D ' 54' ' ' TYR . . . . . . . . . . . . . 43.7 t80 -129.11 116.58 18.9 Favored Pre-proline 0 CA--C 1.536 0.413 0 CA-C-O 118.091 -0.957 . . . . 0.0 110.338 178.226 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' D' D ' 55' ' ' PRO . . . . . . . . . . . . . 73.8 Cg_endo -77.13 170.07 72.57 Favored 'Cis proline' 0 N--CA 1.501 1.94 0 CA-C-N 122.015 1.756 . . . . 0.0 111.56 -9.836 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' D' D ' 56' ' ' SER . . . . . . . . . . . . . 13.7 m -128.03 141.72 42.15 Favored Pre-proline 0 CA--C 1.536 0.41 0 CA-C-O 118.625 -0.702 . . . . 0.0 109.575 174.777 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' D' D ' 57' ' ' PRO . . . . . . . . . . . . . 49.8 Cg_endo -69.94 141.71 67.49 Favored 'Cis proline' 0 N--CA 1.5 1.859 0 CA-C-N 121.489 1.567 . . . . 0.0 111.689 -1.082 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' D' D ' 58' ' ' LEU . . . . . . . . . . . . . 28.1 tp -108.53 138.74 44.34 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-N 116.381 -0.372 . . . . 0.0 110.881 -177.989 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' D' D ' 59' ' ' ARG . . . . . . . . . . . . . 66.9 ttp85 -99.67 124.14 44.61 Favored 'General case' 0 C--N 1.328 -0.332 0 N-CA-C 109.099 -0.704 . . . . 0.0 109.099 173.323 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' D' D ' 60' ' ' VAL . . . . . . . . . . . . . 41.1 t -72.78 120.28 21.12 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.254 0 CA-C-O 120.964 0.411 . . . . 0.0 110.51 -175.066 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' D' D ' 61' ' ' GLU . . . . . . . . . . . . . 74.7 tt0 -131.09 156.79 44.62 Favored 'General case' 0 C--N 1.328 -0.331 0 N-CA-C 108.874 -0.787 . . . . 0.0 108.874 175.991 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' D' D ' 62' ' ' ASP . . . . . . . . . . . . . 53.1 m-20 -49.6 -30.37 8.67 Favored 'General case' 0 CA--C 1.534 0.336 0 N-CA-C 112.378 0.51 . . . . 0.0 112.378 -179.169 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' D' D ' 63' ' ' ARG . . . . . . . . . . . . . 94.2 mtt180 -72.5 -21.96 61.12 Favored 'General case' 0 CA--C 1.533 0.3 0 N-CA-C 113.118 0.784 . . . . 0.0 113.118 -175.217 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' D' D ' 64' ' ' THR . . . . . . . . . . . . . 34.2 m -66.57 139.78 57.93 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-O 120.871 0.367 . . . . 0.0 110.913 -176.257 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' D' D ' 65' ' ' LYS . . . . . . . . . . . . . 99.4 mttt -89.09 130.69 35.49 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.093 -0.503 . . . . 0.0 109.906 176.971 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' D' D ' 66' ' ' ILE . . . . . . . . . . . . . 4.0 mp -112.39 124.14 68.79 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.229 0 N-CA-C 109.518 -0.549 . . . . 0.0 109.518 178.517 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' D' D ' 67' ' ' THR . . . . . . . . . . . . . 24.4 m -119.94 137.34 54.11 Favored 'General case' 0 C--N 1.331 -0.208 0 CA-C-O 121.102 0.477 . . . . 0.0 110.877 -176.985 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' D' D ' 68' ' ' LEU . . . . . . . . . . . . . 17.3 tp . . . . . 0 C--N 1.328 -0.326 0 CA-C-N 115.831 -0.622 . . . . 0.0 109.99 178.084 . . . . . . . . 0 0 . 1 . 015 nuclear nobuild core ' D' D ' 73' ' ' VAL . . . . . . . . . . . . . 35.2 m . . . . . 0 C--O 1.231 0.103 0 CA-C-O 120.684 0.278 . . . . 0.0 110.254 . . . . . . . . . 0 0 . 1 . 015 nuclear nobuild core ' D' D ' 74' ' ' ASP . . . . . . . . . . . . . 17.9 t0 -99.85 123.73 44.4 Favored 'General case' 0 C--N 1.331 -0.233 0 N-CA-C 110.04 -0.356 . . . . 0.0 110.04 -178.242 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' D' D ' 75' ' ' VAL . . . . . 0.55 ' C ' HD12 ' D' ' 76' ' ' LEU . 43.3 t -117.96 122.82 70.62 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.197 0 CA-C-O 120.922 0.391 . . . . 0.0 110.494 -177.862 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' D' D ' 76' ' ' LEU . . . . . 0.55 HD12 ' C ' ' D' ' 75' ' ' VAL . 8.0 mp -124.42 149.33 46.87 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 115.848 -0.615 . . . . 0.0 109.737 176.25 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' D' D ' 77' ' ' GLU . . . . . . . . . . . . . 97.2 mt-10 -136.3 136.6 39.9 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-O 121.049 0.452 . . . . 0.0 111.138 -178.476 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' D' D ' 78' ' ' ALA . . . . . . . . . . . . . . . -119.23 128.75 54.49 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 115.707 -0.679 . . . . 0.0 109.803 176.511 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' D' D ' 79' ' ' LYS . . . . . 0.652 ' O ' HD13 ' D' ' 80' ' ' ILE . 32.9 ttmt -79.46 118.05 20.98 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-O 120.963 0.411 . . . . 0.0 110.986 -176.348 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' D' D ' 80' ' ' ILE . . . . . 0.652 HD13 ' O ' ' D' ' 79' ' ' LYS . 37.1 mm -139.2 104.37 2.16 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.272 0 N-CA-C 109.067 -0.716 . . . . 0.0 109.067 -178.848 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' D' D ' 81' ' ' LYS . . . . . . . . . . . . . 84.5 tttt -95.0 125.56 39.75 Favored 'General case' 0 C--N 1.329 -0.287 0 C-N-CA 120.758 -0.377 . . . . 0.0 110.944 -177.277 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' D' D ' 82' ' ' GLY . . . . . . . . . . . . . . . 89.03 42.2 5.69 Favored Glycine 0 CA--C 1.524 0.594 0 N-CA-C 111.237 -0.745 . . . . 0.0 111.237 176.401 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' D' D ' 83' ' ' ILE . . . . . . . . . . . . . 71.1 mt -65.4 131.51 31.18 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.273 0 N-CA-C 109.68 -0.489 . . . . 0.0 109.68 177.521 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' D' D ' 84' ' ' LYS . . . . . . . . . . . . . 48.6 tttp -89.97 -50.54 5.96 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.025 -0.534 . . . . 0.0 109.947 -179.117 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' D' D ' 85' ' ' ASP . . . . . . . . . . . . . 10.0 t70 -159.85 153.12 22.1 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 115.653 -0.703 . . . . 0.0 110.173 178.366 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' D' D ' 86' ' ' VAL . . . . . . . . . . . . . 41.3 t -127.4 132.63 69.23 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.244 0 CA-C-O 120.965 0.412 . . . . 0.0 110.48 -179.328 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' D' D ' 87' ' ' ILE . . . . . 0.492 HD12 ' N ' ' D' ' 87' ' ' ILE . 5.0 mp -119.95 122.83 69.55 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.238 0 N-CA-C 109.329 -0.619 . . . . 0.0 109.329 176.471 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' D' D ' 88' ' ' LEU . . . . . . . . . . . . . 86.1 mt -109.49 137.18 47.72 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-O 121.157 0.503 . . . . 0.0 111.307 -177.73 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' D' D ' 89' ' ' ASP . . . . . . . . . . . . . 8.6 t70 -131.48 156.47 45.6 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 115.598 -0.728 . . . . 0.0 109.29 176.499 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' D' D ' 90' ' ' GLU . . . . . . . . . . . . . 48.1 mp0 -50.85 -29.07 10.85 Favored 'General case' 0 C--N 1.327 -0.387 0 N-CA-C 112.544 0.572 . . . . 0.0 112.544 -171.177 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' D' D ' 91' ' ' ASN . . . . . . . . . . . . . 54.0 t30 -131.61 13.74 4.94 Favored 'General case' 0 N--CA 1.468 0.464 0 N-CA-C 113.307 0.854 . . . . 0.0 113.307 -176.228 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' D' D ' 92' ' ' LEU . . . . . . . . . . . . . 41.8 mt -147.82 148.72 31.2 Favored 'General case' 0 C--N 1.331 -0.204 0 CA-C-N 118.04 0.382 . . . . 0.0 110.55 -176.85 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' D' D ' 93' ' ' ILE . . . . . . . . . . . . . 72.3 mt -126.09 114.08 37.03 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.357 0 N-CA-C 109.063 -0.717 . . . . 0.0 109.063 175.845 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' D' D ' 94' ' ' VAL . . . . . . . . . . . . . 42.3 t -115.29 125.49 72.56 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.24 0 N-CA-C 109.816 -0.438 . . . . 0.0 109.816 -178.945 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' D' D ' 95' ' ' VAL . . . . . . . . . . . . . 44.6 t -119.29 133.24 66.77 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.283 0 CA-C-N 116.056 -0.52 . . . . 0.0 109.813 -179.83 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' D' D ' 96' ' ' ILE . . . . . . . . . . . . . 64.2 mt -111.7 126.0 69.05 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.358 0 N-CA-C 108.804 -0.813 . . . . 0.0 108.804 177.239 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' D' D ' 97' ' ' THR . . . . . . . . . . . . . 60.3 p -99.82 159.89 14.72 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-O 121.215 0.531 . . . . 0.0 111.388 -176.315 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' D' D ' 98' ' ' GLU . . . . . . . . . . . . . 81.0 tt0 -53.89 -26.28 24.23 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.043 -0.526 . . . . 0.0 112.12 179.254 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' D' D ' 99' ' ' GLU . . . . . . . . . . . . . 95.6 mt-10 -78.01 13.07 1.53 Allowed 'General case' 0 CA--C 1.536 0.432 0 N-CA-C 113.146 0.795 . . . . 0.0 113.146 -177.794 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' D' D ' 100' ' ' ASN . . . . . . . . . . . . . 3.0 m-20 60.47 37.74 19.61 Favored 'General case' 0 CA--C 1.529 0.167 0 CA-C-O 121.126 0.489 . . . . 0.0 110.961 -179.443 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' D' D ' 101' ' ' GLU . . . . . . . . . . . . . 83.4 tt0 -113.74 145.5 41.28 Favored 'General case' 0 C--N 1.332 -0.169 0 N-CA-C 109.45 -0.574 . . . . 0.0 109.45 176.097 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' D' D ' 102' ' ' VAL . . . . . . . . . . . . . 46.3 t -114.82 121.44 66.91 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.319 0 N-CA-C 109.615 -0.513 . . . . 0.0 109.615 -178.817 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' D' D ' 103' ' ' LEU . . . . . . . . . . . . . 39.0 mt -115.31 127.59 55.54 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 115.705 -0.68 . . . . 0.0 109.925 177.593 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' D' D ' 104' ' ' ILE . . . . . 0.417 HD13 HG11 ' D' ' 130' ' ' VAL . 68.4 mt -118.87 120.5 64.24 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.271 0 N-CA-C 110.164 -0.31 . . . . 0.0 110.164 -178.627 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' D' D ' 105' ' ' PHE . . . . . . . . . . . . . 54.8 m-85 -119.72 165.91 13.9 Favored 'General case' 0 C--N 1.331 -0.202 0 O-C-N 123.978 0.798 . . . . 0.0 109.542 179.268 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' D' D ' 106' ' ' ASN . . . . . . . . . . . . . 39.2 p-10 -97.32 -173.0 2.54 Favored 'General case' 0 C--N 1.329 -0.294 0 N-CA-C 109.683 -0.488 . . . . 0.0 109.683 172.597 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' D' D ' 107' ' ' GLN . . . . . . . . . . . . . 43.3 tp60 -58.77 -27.68 65.2 Favored 'General case' 0 CA--C 1.534 0.355 0 N-CA-C 111.78 0.289 . . . . 0.0 111.78 178.382 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' D' D ' 108' ' ' ASN . . . . . . . . . . . . . 9.2 t30 -84.54 9.6 13.15 Favored 'General case' 0 CA--C 1.536 0.415 0 N-CA-C 113.147 0.795 . . . . 0.0 113.147 -177.17 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' D' D ' 109' ' ' LEU . . . . . . . . . . . . . 18.8 mt 58.89 34.34 23.6 Favored 'General case' 0 CA--C 1.53 0.21 0 CA-C-O 120.942 0.401 . . . . 0.0 111.804 178.777 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' D' D ' 110' ' ' GLU . . . . . . . . . . . . . 70.7 mm-40 -107.25 141.52 38.44 Favored 'General case' 0 C--N 1.33 -0.275 0 N-CA-C 108.998 -0.742 . . . . 0.0 108.998 173.14 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' D' D ' 111' ' ' GLU . . . . . . . . . . . . . 52.1 tt0 -85.04 123.38 30.51 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-O 121.186 0.517 . . . . 0.0 111.07 -173.369 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' D' D ' 112' ' ' LEU . . . . . . . . . . . . . 30.4 mt -101.35 -43.23 6.02 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 115.625 -0.716 . . . . 0.0 110.89 178.852 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' D' D ' 113' ' ' TYR . . . . . . . . . . . . . 43.9 t80 -133.01 135.98 45.76 Favored 'General case' 0 C--N 1.332 -0.164 0 CA-C-O 120.784 0.326 . . . . 0.0 111.548 -176.367 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' D' D ' 114' ' ' ARG . . . . . . . . . . . . . 32.3 ttm180 -134.19 120.26 19.84 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-N 115.892 -0.594 . . . . 0.0 110.067 176.664 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' D' D ' 115' ' ' GLY . . . . . . . . . . . . . . . -150.01 159.73 28.22 Favored Glycine 0 CA--C 1.523 0.555 0 N-CA-C 110.825 -0.91 . . . . 0.0 110.825 178.659 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' D' D ' 116' ' ' LYS . . . . . . . . . . . . . 32.9 ttmt -136.05 139.7 43.27 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-O 120.817 0.341 . . . . 0.0 110.288 178.067 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' D' D ' 117' ' ' PHE . . . . . . . . . . . . . 20.4 m-85 -138.19 119.97 15.25 Favored 'General case' 0 C--N 1.331 -0.236 0 N-CA-C 109.911 -0.404 . . . . 0.0 109.911 -177.427 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' D' D ' 118' ' ' GLU . . . . . . . . . . . . . 96.1 mt-10 -55.51 -40.17 71.42 Favored 'General case' 0 C--N 1.329 -0.326 0 C-N-CA 120.916 -0.313 . . . . 0.0 110.915 -178.224 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' D' D ' 119' ' ' ASN . . . . . . . . . . . . . 78.3 m-20 -97.23 28.94 3.38 Favored 'General case' 0 C--N 1.331 -0.218 0 N-CA-C 112.35 0.5 . . . . 0.0 112.35 -174.795 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' D' D ' 120' ' ' LEU . . . . . . . . . . . . . 16.7 tp -58.18 119.97 7.81 Favored 'General case' 0 C--N 1.333 -0.131 0 N-CA-C 110.125 -0.324 . . . . 0.0 110.125 178.237 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' D' D ' 121' ' ' ASN . . . . . . . . . . . . . 66.2 t30 -114.01 -44.22 3.17 Favored 'General case' 0 C--N 1.331 -0.227 0 CA-C-N 116.511 -0.313 . . . . 0.0 111.273 -177.053 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' D' D ' 122' ' ' LYS . . . . . . . . . . . . . 59.8 mttm -146.7 154.5 41.5 Favored 'General case' 0 C--N 1.33 -0.241 0 C-N-CA 120.653 -0.419 . . . . 0.0 111.739 -176.434 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' D' D ' 123' ' ' VAL . . . . . . . . . . . . . 43.8 t -131.71 129.95 61.66 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.243 0 CA-C-N 115.971 -0.559 . . . . 0.0 109.731 175.221 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' D' D ' 124' ' ' LEU . . . . . . . . . . . . . 30.3 mt -118.92 133.7 55.66 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-N 116.31 -0.405 . . . . 0.0 110.623 -179.164 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' D' D ' 125' ' ' VAL . . . . . 0.426 HG22 HG23 ' D' ' 130' ' ' VAL . 45.3 t -129.01 124.41 60.81 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 N-CA-C 109.895 -0.409 . . . . 0.0 109.895 178.153 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' D' D ' 126' ' ' ARG . . . . . . . . . . . . . 44.1 mtp180 -148.87 130.92 15.33 Favored 'General case' 0 C--N 1.329 -0.296 0 N-CA-C 109.69 -0.485 . . . . 0.0 109.69 179.189 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' D' D ' 127' ' ' ASN . . . . . . . . . . . . . 37.2 t30 56.32 -152.54 0.38 Allowed 'General case' 0 CA--C 1.539 0.527 0 N-CA-C 109.742 -0.466 . . . . 0.0 109.742 -179.943 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' D' D ' 128' ' ' ASP . . . . . . . . . . . . . 12.3 p-10 -84.05 18.67 2.01 Favored 'General case' 0 CA--C 1.536 0.428 0 CA-C-N 118.506 0.594 . . . . 0.0 112.602 177.936 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' D' D ' 129' ' ' LEU . . . . . . . . . . . . . 15.3 tp -117.82 138.83 51.82 Favored 'General case' 0 C--O 1.232 0.181 0 O-C-N 122.172 -0.33 . . . . 0.0 110.164 179.632 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' D' D ' 130' ' ' VAL . . . . . 0.487 HG13 ' HB ' ' D' ' 141' ' ' ILE . 12.5 p -129.11 141.18 47.27 Favored 'Isoleucine or valine' 0 N--CA 1.462 0.171 0 CA-C-O 121.133 0.492 . . . . 0.0 110.248 179.891 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' D' D ' 131' ' ' VAL . . . . . . . . . . . . . 58.8 t -136.06 137.56 48.47 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.276 0 CA-C-N 115.85 -0.614 . . . . 0.0 110.555 -177.197 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' D' D ' 132' ' ' ILE . . . . . . . . . . . . . 74.4 mt -114.14 133.94 58.59 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.243 0 CA-C-N 115.881 -0.599 . . . . 0.0 109.441 179.296 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' D' D ' 133' ' ' ILE . . . . . . . . . . . . . 42.9 mm -116.29 122.23 69.27 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.243 0 CA-C-O 120.822 0.344 . . . . 0.0 110.8 -175.323 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' D' D ' 134' ' ' ASP . . . . . . . . . . . . . 7.2 p-10 -136.03 146.04 46.69 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.148 -0.478 . . . . 0.0 109.838 175.248 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' D' D ' 135' ' ' GLU . . . . . . . . . . . . . 80.6 tt0 -49.85 -22.97 1.65 Allowed 'General case' 0 C--N 1.328 -0.344 0 N-CA-C 113.076 0.769 . . . . 0.0 113.076 -171.464 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' D' D ' 136' ' ' GLN . . . . . . . . . . . . . 13.3 pt20 -100.9 -30.44 11.66 Favored 'General case' 0 N--CA 1.464 0.249 0 N-CA-C 112.674 0.62 . . . . 0.0 112.674 -175.587 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' D' D ' 137' ' ' LYS . . . . . . . . . . . . . 87.3 mttt -142.6 158.05 44.07 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-O 121.407 0.622 . . . . 0.0 112.129 -173.019 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' D' D ' 138' ' ' LEU . . . . . . . . . . . . . 4.6 tt -118.48 122.13 41.96 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-N 115.174 -0.921 . . . . 0.0 108.883 171.459 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' D' D ' 139' ' ' THR . . . . . . . . . . . . . 28.0 m -111.16 125.06 53.39 Favored 'General case' 0 C--N 1.332 -0.162 0 CA-C-O 120.644 0.259 . . . . 0.0 110.899 -176.71 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' D' D ' 140' ' ' LEU . . . . . 0.479 ' C ' HD23 ' D' ' 140' ' ' LEU . 7.7 tt -114.03 125.68 54.27 Favored 'General case' 0 C--N 1.327 -0.388 0 N-CA-C 109.294 -0.632 . . . . 0.0 109.294 -179.265 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' D' D ' 141' ' ' ILE . . . . . 0.487 ' HB ' HG13 ' D' ' 130' ' ' VAL . 19.7 mt -123.28 120.37 60.08 Favored 'Isoleucine or valine' 0 C--O 1.235 0.311 0 N-CA-C 109.715 -0.476 . . . . 0.0 109.715 -176.146 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' D' D ' 142' ' ' ARG . . . . . . . . . . . . . 61.2 ttt180 -114.51 127.24 55.7 Favored 'General case' 0 C--N 1.332 -0.177 0 CA-C-N 115.448 -0.796 . . . . 0.0 110.327 -176.347 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' D' D ' 143' ' ' THR . . . . . . . . . . . . . 28.7 p . . . . . 0 C--O 1.219 -0.516 0 CA-C-O 118.018 -0.992 . . . . 0.0 110.597 -179.68 . . . . . . . . 0 0 . 1 . 015 nuclear nobuild core ' E' E ' 2' ' ' SER . . . . . . . . . . . . . 4.9 p . . . . . 0 N--CA 1.462 0.164 0 CA-C-O 121.103 0.478 . . . . 0.0 110.67 . . . . . . . . . 0 0 . 1 . 015 nuclear nobuild core ' E' E ' 3' ' ' GLU . . . . . . . . . . . . . 79.8 tt0 -145.83 143.06 29.4 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 115.884 -0.598 . . . . 0.0 111.021 -178.003 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' E' E ' 4' ' ' LEU . . . . . 0.509 HD21 HD21 ' E' ' 6' ' ' LEU . 15.1 tp -123.59 135.37 53.93 Favored 'General case' 0 C--N 1.331 -0.217 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.281 177.359 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' E' E ' 5' ' ' LYS . . . . . . . . . . . . . 90.3 mttt -109.09 120.04 41.34 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.23 -0.441 . . . . 0.0 110.38 178.87 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' E' E ' 6' ' ' LEU . . . . . 0.509 HD21 HD21 ' E' ' 4' ' ' LEU . 59.4 mt -116.58 142.89 46.3 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 115.63 -0.713 . . . . 0.0 111.096 -177.815 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' E' E ' 7' ' ' LYS . . . . . . . . . . . . . 60.3 tttm -133.89 140.6 36.92 Favored Pre-proline 0 CA--C 1.534 0.338 0 CA-C-O 119.015 -0.517 . . . . 0.0 110.033 176.522 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' E' E ' 8' ' ' PRO . . . . . . . . . . . . . 98.1 Cg_endo -90.78 143.73 3.5 Favored 'Trans proline' 0 N--CA 1.49 1.314 0 C-N-CA 121.804 1.669 . . . . 0.0 111.866 178.247 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' E' E ' 9' ' ' LEU . . . . . . . . . . . . . 43.6 mt -84.08 -48.26 0.7 Allowed Pre-proline 0 CA--C 1.534 0.342 0 CA-C-O 118.683 -0.675 . . . . 0.0 112.389 -179.205 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' E' E ' 10' ' ' PRO . . . . . . . . . . . . . 88.1 Cg_endo -79.91 158.02 24.13 Favored 'Trans proline' 0 N--CA 1.496 1.642 0 C-N-CA 121.258 1.305 . . . . 0.0 111.845 177.408 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' E' E ' 11' ' ' LYS . . . . . . . . . . . . . 39.3 ttpt -88.0 94.84 9.91 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-O 120.863 0.363 . . . . 0.0 110.422 179.47 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' E' E ' 12' ' ' VAL . . . . . . . . . . . . . 12.4 p -143.15 143.47 24.86 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.286 0 CA-C-N 116.23 -0.441 . . . . 0.0 110.583 179.099 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' E' E ' 13' ' ' GLU . . . . . . . . . . . . . 70.6 mm-40 -84.4 132.62 34.56 Favored 'General case' 0 C--N 1.33 -0.254 0 N-CA-C 109.951 -0.388 . . . . 0.0 109.951 177.263 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' E' E ' 14' ' ' LEU . . . . . . . . . . . . . 48.8 mt -97.97 147.7 33.43 Favored Pre-proline 0 CA--C 1.532 0.278 0 CA-C-O 119.309 -0.376 . . . . 0.0 110.381 -178.151 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' E' E ' 15' ' ' PRO . . . . . . . . . . . . . 24.9 Cg_exo -62.69 161.72 27.49 Favored 'Trans proline' 0 N--CA 1.498 1.749 0 C-N-CA 121.25 1.3 . . . . 0.0 111.825 175.98 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' E' E ' 16' ' ' PRO . . . . . . . . . . . . . 31.2 Cg_exo -59.38 -39.51 76.21 Favored 'Trans proline' 0 N--CA 1.497 1.691 0 C-N-CA 121.422 1.414 . . . . 0.0 112.661 -178.219 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' E' E ' 17' ' ' ASP . . . . . . . . . . . . . 22.8 p-10 -88.71 11.28 18.03 Favored 'General case' 0 CA--C 1.535 0.387 0 N-CA-C 113.172 0.805 . . . . 0.0 113.172 -177.646 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' E' E ' 18' ' ' PHE . . . . . . . . . . . . . 43.5 t80 -57.82 -44.53 86.46 Favored 'General case' 0 C--N 1.335 -0.056 0 O-C-N 122.014 -0.429 . . . . 0.0 110.121 -178.059 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' E' E ' 19' ' ' VAL . . . . . . . . . . . . . 47.6 t -58.16 -41.52 80.99 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.336 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.309 -179.069 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' E' E ' 20' ' ' ASP . . . . . . . . . . . . . 76.2 m-20 -59.72 -42.35 92.89 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-O 120.851 0.358 . . . . 0.0 110.805 -177.655 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' E' E ' 21' ' ' VAL . . . . . . . . . . . . . 47.0 t -64.6 -47.87 87.2 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.294 0 CA-C-N 116.36 -0.382 . . . . 0.0 110.42 -178.194 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' E' E ' 22' ' ' ILE . . . . . 0.581 HG22 HD12 ' E' ' 26' ' ' LEU . 49.6 mm -56.05 -45.03 80.32 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.256 0 CA-C-O 120.727 0.299 . . . . 0.0 110.662 179.102 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' E' E ' 23' ' ' ARG . . . . . . . . . . . . . 59.4 ttp180 -54.09 -49.94 67.94 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-O 120.694 0.283 . . . . 0.0 111.388 -178.313 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' E' E ' 24' ' ' ILE . . . . . . . . . . . . . 71.2 mt -60.06 -44.59 95.25 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.271 0 CA-C-N 116.626 -0.261 . . . . 0.0 111.105 -178.044 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' E' E ' 25' ' ' LYS . . . . . . . . . . . . . 83.4 mttt -64.84 -37.91 89.21 Favored 'General case' 0 C--N 1.329 -0.308 0 N-CA-C 112.394 0.516 . . . . 0.0 112.394 -177.694 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' E' E ' 26' ' ' LEU . . . . . 0.581 HD12 HG22 ' E' ' 22' ' ' ILE . 50.0 mt -79.27 -42.19 26.42 Favored 'General case' 0 C--N 1.331 -0.221 0 N-CA-C 113.53 0.937 . . . . 0.0 113.53 -172.046 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' E' E ' 27' ' ' GLN . . . . . . . . . . . . . 11.1 pt20 -46.83 141.88 3.71 Favored 'General case' 0 N--CA 1.469 0.491 0 N-CA-C 112.905 0.705 . . . . 0.0 112.905 -173.772 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' E' E ' 28' ' ' GLY . . . . . . . . . . . . . . . 97.75 -26.26 23.96 Favored Glycine 0 CA--C 1.531 1.086 0 CA-C-N 115.418 -0.81 . . . . 0.0 112.184 -177.818 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' E' E ' 29' ' ' LYS . . . . . . . . . . . . . 69.5 mttm -97.77 155.12 17.18 Favored 'General case' 0 C--N 1.331 -0.222 0 CA-C-N 117.365 0.583 . . . . 0.0 110.976 178.249 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' E' E ' 30' ' ' THR . . . . . . . . . . . . . 19.2 m -106.79 137.12 45.42 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 115.931 -0.577 . . . . 0.0 109.727 175.149 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' E' E ' 31' ' ' VAL . . . . . . . . . . . . . 35.0 m -128.17 154.97 39.5 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.253 0 CA-C-O 120.973 0.416 . . . . 0.0 110.862 -177.691 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' E' E ' 32' ' ' ARG . . . . . . . . . . . . . 59.1 ttm-85 -127.24 146.1 50.54 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.04 -0.527 . . . . 0.0 110.327 -179.972 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' E' E ' 33' ' ' THR . . . . . . . . . . . . . 18.6 m -53.08 139.26 28.91 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.469 -0.332 . . . . 0.0 111.355 -177.861 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' E' E ' 34' ' ' GLY . . . . . . . . . . . . . . . 101.13 -17.13 56.44 Favored Glycine 0 CA--C 1.532 1.156 0 CA-C-O 119.674 -0.514 . . . . 0.0 113.243 -179.826 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' E' E ' 35' ' ' ASP . . . . . . . . . . . . . 78.8 m-20 -66.51 149.03 51.05 Favored 'General case' 0 C--O 1.23 0.071 0 CA-C-N 118.018 0.909 . . . . 0.0 111.198 178.542 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' E' E ' 36' ' ' VAL . . . . . . . . . . . . . 44.0 t -123.38 131.95 72.25 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.18 0 CA-C-N 115.865 -0.607 . . . . 0.0 109.786 177.985 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' E' E ' 37' ' ' ILE . . . . . . . . . . . . . 67.8 mt -121.91 140.65 45.21 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.21 0 CA-C-N 116.256 -0.429 . . . . 0.0 109.952 -178.936 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' E' E ' 38' ' ' GLY . . . . . . . . . . . . . . . -110.71 128.81 8.95 Favored Glycine 0 CA--C 1.527 0.802 0 N-CA-C 111.348 -0.701 . . . . 0.0 111.348 -179.528 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' E' E ' 39' ' ' ILE . . . . . . . . . . . . . 72.8 mt -123.83 134.25 67.0 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.207 0 N-CA-C 110.135 -0.32 . . . . 0.0 110.135 179.134 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' E' E ' 40' ' ' SER . . . . . . . . . . . . . 19.5 p -93.57 114.19 26.47 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.508 -0.314 . . . . 0.0 110.993 176.214 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' E' E ' 41' ' ' ILE . . . . . . . . . . . . . 44.7 mm -121.58 124.46 71.75 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.269 0 CA-C-O 120.789 0.328 . . . . 0.0 110.334 179.074 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' E' E ' 42' ' ' LEU . . . . . . . . . . . . . 57.7 mt 52.0 33.06 11.11 Favored 'General case' 0 C--N 1.331 -0.23 0 CA-C-N 116.254 -0.43 . . . . 0.0 111.933 177.359 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' E' E ' 43' ' ' GLY . . . . . . . . . . . . . . . 72.4 33.65 61.22 Favored Glycine 0 CA--C 1.529 0.932 0 C-N-CA 121.091 -0.576 . . . . 0.0 111.749 178.747 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' E' E ' 44' ' ' LYS . . . . . . . . . . . . . 21.1 tptm -138.86 131.23 28.54 Favored 'General case' 0 C--N 1.329 -0.3 0 N-CA-C 109.463 -0.569 . . . . 0.0 109.463 179.539 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' E' E ' 45' ' ' GLU . . . . . . . . . . . . . 80.9 tt0 -82.52 119.25 23.99 Favored 'General case' 0 C--N 1.328 -0.359 0 C-N-CA 120.795 -0.362 . . . . 0.0 110.941 -177.267 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' E' E ' 46' ' ' VAL . . . . . . . . . . . . . 7.4 p -119.97 126.44 75.29 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.18 0 N-CA-C 109.451 -0.574 . . . . 0.0 109.451 176.26 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' E' E ' 47' ' ' LYS . . . . . . . . . . . . . 63.2 mttp -99.97 129.53 46.05 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 115.898 -0.592 . . . . 0.0 111.206 178.916 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' E' E ' 48' ' ' PHE . . . . . . . . . . . . . 87.4 m-85 -112.01 131.8 55.18 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.062 -0.517 . . . . 0.0 110.191 177.162 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' E' E ' 49' ' ' LYS . . . . . . . . . . . . . 79.0 tttt -107.71 135.71 48.68 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.343 -0.39 . . . . 0.0 110.63 -179.666 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' E' E ' 50' ' ' VAL . . . . . . . . . . . . . 45.9 t -81.41 107.55 13.72 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.242 0 N-CA-C 109.123 -0.695 . . . . 0.0 109.123 175.406 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' E' E ' 51' ' ' VAL . . . . . . . . . . . . . 42.9 t -73.14 -50.85 29.01 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.346 0 CA-C-N 115.994 -0.548 . . . . 0.0 109.791 -174.399 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' E' E ' 52' ' ' GLN . . . . . . . . . . . . . 70.2 mt-30 -154.92 155.1 33.69 Favored 'General case' 0 C--N 1.331 -0.218 0 CA-C-O 121.135 0.493 . . . . 0.0 111.699 -179.332 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' E' E ' 53' ' ' ALA . . . . . 0.501 ' HB1' ' HB2' ' E' ' 58' ' ' LEU . . . -131.68 133.78 45.24 Favored 'General case' 0 C--N 1.33 -0.283 0 CA-C-N 115.364 -0.835 . . . . 0.0 109.886 175.629 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' E' E ' 54' ' ' TYR . . . . . . . . . . . . . 57.7 t80 -129.13 109.08 18.03 Favored Pre-proline 0 CA--C 1.534 0.344 0 CA-C-O 118.284 -0.865 . . . . 0.0 110.439 179.399 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' E' E ' 55' ' ' PRO . . . . . . . . . . . . . 72.8 Cg_endo -77.1 169.8 73.32 Favored 'Cis proline' 0 N--CA 1.498 1.746 0 CA-C-N 121.911 1.718 . . . . 0.0 112.356 -5.457 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' E' E ' 56' ' ' SER . . . . . . . . . . . . . 30.7 m -116.6 129.03 25.57 Favored Pre-proline 0 CA--C 1.538 0.516 0 CA-C-O 118.368 -0.825 . . . . 0.0 109.404 175.244 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' E' E ' 57' ' ' PRO . . . . . . . . . . . . . 42.6 Cg_endo -68.97 148.93 85.87 Favored 'Cis proline' 0 N--CA 1.498 1.771 0 CA-C-N 122.052 1.768 . . . . 0.0 111.815 -0.586 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' E' E ' 58' ' ' LEU . . . . . 0.501 ' HB2' ' HB1' ' E' ' 53' ' ' ALA . 23.5 tp -108.2 138.53 44.32 Favored 'General case' 0 C--N 1.331 -0.222 0 CA-C-N 116.101 -0.499 . . . . 0.0 110.667 -178.304 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' E' E ' 59' ' ' ARG . . . . . . . . . . . . . 60.6 ttt180 -103.44 131.33 50.63 Favored 'General case' 0 C--N 1.328 -0.346 0 N-CA-C 109.404 -0.591 . . . . 0.0 109.404 175.872 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' E' E ' 60' ' ' VAL . . . . . . . . . . . . . 42.1 t -89.71 119.0 36.1 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.287 0 C-N-CA 120.669 -0.412 . . . . 0.0 110.516 -176.483 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' E' E ' 61' ' ' GLU . . . . . . . . . . . . . 95.1 mt-10 -131.18 167.46 19.12 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.104 -0.498 . . . . 0.0 110.002 176.525 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' E' E ' 62' ' ' ASP . . . . . . . . . . . . . 80.5 m-20 -54.4 -32.71 57.77 Favored 'General case' 0 C--N 1.328 -0.365 0 N-CA-C 111.678 0.251 . . . . 0.0 111.678 -179.712 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' E' E ' 63' ' ' ARG . . . . . . . . . . . . . 11.1 ptm180 -85.7 6.41 27.81 Favored 'General case' 0 CA--C 1.536 0.423 0 N-CA-C 113.551 0.945 . . . . 0.0 113.551 -175.505 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' E' E ' 64' ' ' THR . . . . . . . . . . . . . 23.8 m -85.66 138.68 31.98 Favored 'General case' 0 C--N 1.332 -0.155 0 CA-C-N 118.237 0.472 . . . . 0.0 110.591 -179.09 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' E' E ' 65' ' ' LYS . . . . . . . . . . . . . 48.7 mtmt -87.68 129.78 35.02 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-O 120.949 0.404 . . . . 0.0 110.322 178.565 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' E' E ' 66' ' ' ILE . . . . . . . . . . . . . 58.8 mt -113.11 124.87 70.18 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.316 0 N-CA-C 109.504 -0.554 . . . . 0.0 109.504 179.73 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' E' E ' 67' ' ' THR . . . . . . . . . . . . . 17.8 m -115.48 137.78 51.7 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-O 121.077 0.465 . . . . 0.0 110.663 -177.582 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' E' E ' 68' ' ' LEU . . . . . . . . . . . . . 15.8 tp . . . . . 0 C--N 1.329 -0.319 0 CA-C-N 115.817 -0.628 . . . . 0.0 110.772 -178.333 . . . . . . . . 0 0 . 1 . 015 nuclear nobuild core ' E' E ' 73' ' ' VAL . . . . . . . . . . . . . 30.1 m . . . . . 0 C--O 1.231 0.13 0 CA-C-O 120.905 0.383 . . . . 0.0 111.143 . . . . . . . . . 0 0 . 1 . 015 nuclear nobuild core ' E' E ' 74' ' ' ASP . . . . . . . . . . . . . 12.3 t70 -91.28 122.78 34.19 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 115.882 -0.599 . . . . 0.0 110.48 -174.048 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' E' E ' 75' ' ' VAL . . . . . . . . . . . . . 44.3 t -116.99 120.71 65.92 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.248 0 CA-C-O 121.14 0.495 . . . . 0.0 110.134 178.98 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' E' E ' 76' ' ' LEU . . . . . . . . . . . . . 16.5 mt -122.31 143.23 49.75 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 115.603 -0.726 . . . . 0.0 109.75 178.098 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' E' E ' 77' ' ' GLU . . . . . . . . . . . . . 96.0 mt-10 -136.89 135.51 37.88 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-O 121.048 0.451 . . . . 0.0 111.112 -177.804 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' E' E ' 78' ' ' ALA . . . . . . . . . . . . . . . -119.93 139.69 52.05 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 115.643 -0.708 . . . . 0.0 109.795 176.678 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' E' E ' 79' ' ' LYS . . . . . 0.707 ' O ' HD13 ' E' ' 80' ' ' ILE . 54.7 mttp -87.94 114.5 24.62 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.412 -0.358 . . . . 0.0 110.774 -177.058 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' E' E ' 80' ' ' ILE . . . . . 0.707 HD13 ' O ' ' E' ' 79' ' ' LYS . 33.4 mm -139.05 103.7 2.04 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.325 0 N-CA-C 109.252 -0.647 . . . . 0.0 109.252 -178.703 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' E' E ' 81' ' ' LYS . . . . . . . . . . . . . 37.9 ttpt -98.12 130.51 44.89 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-O 120.93 0.395 . . . . 0.0 110.547 -178.5 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' E' E ' 82' ' ' GLY . . . . . . . . . . . . . . . 89.15 42.13 5.67 Favored Glycine 0 CA--C 1.523 0.563 0 N-CA-C 111.142 -0.783 . . . . 0.0 111.142 178.053 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' E' E ' 83' ' ' ILE . . . . . . . . . . . . . 71.8 mt -72.43 135.38 27.91 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.291 0 N-CA-C 109.323 -0.621 . . . . 0.0 109.323 176.459 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' E' E ' 84' ' ' LYS . . . . . . . . . . . . . 31.4 ttpt -100.0 -50.67 3.92 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-O 120.888 0.375 . . . . 0.0 110.528 -177.062 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' E' E ' 85' ' ' ASP . . . . . . . . . . . . . 8.1 t70 -147.24 150.17 34.32 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.109 -0.496 . . . . 0.0 110.655 -178.783 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' E' E ' 86' ' ' VAL . . . . . . . . . . . . . 42.5 t -131.28 130.71 63.33 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.202 0 CA-C-O 120.993 0.425 . . . . 0.0 110.527 -179.333 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' E' E ' 87' ' ' ILE . . . . . . . . . . . . . 43.6 mm -118.59 125.59 74.5 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.189 0 N-CA-C 109.444 -0.576 . . . . 0.0 109.444 175.843 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' E' E ' 88' ' ' LEU . . . . . . . . . . . . . 17.2 tp -112.98 128.83 56.6 Favored 'General case' 0 C--N 1.331 -0.201 0 CA-C-O 120.924 0.392 . . . . 0.0 111.135 -176.949 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' E' E ' 89' ' ' ASP . . . . . . . . . . . . . 6.7 t70 -125.95 156.28 40.03 Favored 'General case' 0 C--N 1.331 -0.22 0 CA-C-N 115.988 -0.551 . . . . 0.0 109.927 177.172 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' E' E ' 90' ' ' GLU . . . . . . . . . . . . . 64.0 tt0 -45.73 -46.19 14.88 Favored 'General case' 0 N--CA 1.464 0.238 0 N-CA-C 112.988 0.736 . . . . 0.0 112.988 -172.166 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' E' E ' 91' ' ' ASN . . . . . . . . . . . . . 41.0 t30 -132.17 39.98 3.37 Favored 'General case' 0 C--N 1.332 -0.173 0 CA-C-O 121.124 0.488 . . . . 0.0 110.882 -177.647 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' E' E ' 92' ' ' LEU . . . . . . . . . . . . . 11.9 tp -165.39 138.14 4.36 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.243 -0.435 . . . . 0.0 110.168 -178.453 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' E' E ' 93' ' ' ILE . . . . . . . . . . . . . 70.8 mt -126.08 125.17 67.47 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.29 0 N-CA-C 109.905 -0.406 . . . . 0.0 109.905 -178.531 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' E' E ' 94' ' ' VAL . . . . . 0.631 HG21 HG21 ' E' ' 125' ' ' VAL . 43.7 t -122.87 126.61 74.06 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.187 0 N-CA-C 109.938 -0.393 . . . . 0.0 109.938 179.369 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' E' E ' 95' ' ' VAL . . . . . . . . . . . . . 43.7 t -121.43 133.79 66.83 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.317 0 CA-C-N 116.1 -0.5 . . . . 0.0 109.699 179.555 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' E' E ' 96' ' ' ILE . . . . . . . . . . . . . 68.4 mt -117.36 129.63 73.54 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.283 0 N-CA-C 109.348 -0.612 . . . . 0.0 109.348 -179.778 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' E' E ' 97' ' ' THR . . . . . . . . . . . . . 61.6 p -105.31 162.42 13.44 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-O 121.549 0.69 . . . . 0.0 111.896 -174.53 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' E' E ' 98' ' ' GLU . . . . . . . . . . . . . 13.1 mm-40 -53.8 -28.91 38.0 Favored 'General case' 0 CA--C 1.531 0.241 0 CA-C-N 115.727 -0.669 . . . . 0.0 112.121 179.254 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' E' E ' 99' ' ' GLU . . . . . . . . . . . . . 95.2 mt-10 -79.53 16.92 0.95 Allowed 'General case' 0 CA--C 1.535 0.402 0 N-CA-C 113.164 0.801 . . . . 0.0 113.164 -175.032 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' E' E ' 100' ' ' ASN . . . . . . . . . . . . . 4.0 m-20 62.11 38.12 14.07 Favored 'General case' 0 N--CA 1.463 0.208 0 CA-C-O 121.094 0.473 . . . . 0.0 110.84 177.935 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' E' E ' 101' ' ' GLU . . . . . . . . . . . . . 83.3 tt0 -120.41 143.04 48.67 Favored 'General case' 0 C--N 1.331 -0.203 0 CA-C-N 116.184 -0.462 . . . . 0.0 109.979 178.242 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' E' E ' 102' ' ' VAL . . . . . . . . . . . . . 43.1 t -115.03 127.71 72.48 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.282 0 CA-C-N 116.262 -0.426 . . . . 0.0 109.938 179.135 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' E' E ' 103' ' ' LEU . . . . . 0.507 HD12 ' N ' ' E' ' 103' ' ' LEU . 6.3 mp -116.34 131.53 56.92 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-N 115.676 -0.693 . . . . 0.0 109.786 175.954 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' E' E ' 104' ' ' ILE . . . . . . . . . . . . . 69.7 mt -118.74 123.69 71.94 Favored 'Isoleucine or valine' 0 C--O 1.234 0.269 0 N-CA-C 110.118 -0.327 . . . . 0.0 110.118 -179.004 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' E' E ' 105' ' ' PHE . . . . . . . . . . . . . 57.5 m-85 -124.6 164.28 20.17 Favored 'General case' 0 C--N 1.332 -0.191 0 O-C-N 124.07 0.856 . . . . 0.0 109.774 -179.725 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' E' E ' 106' ' ' ASN . . . . . . . . . . . . . 44.1 p-10 -96.71 -169.87 1.96 Allowed 'General case' 0 C--N 1.331 -0.199 0 N-CA-C 110.114 -0.328 . . . . 0.0 110.114 173.749 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' E' E ' 107' ' ' GLN . . . . . . . . . . . . . 46.5 tt0 -58.2 -30.04 66.15 Favored 'General case' 0 C--N 1.33 -0.279 0 N-CA-C 111.927 0.344 . . . . 0.0 111.927 -179.897 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' E' E ' 108' ' ' ASN . . . . . . . . . . . . . 11.9 t-20 -88.58 13.29 12.43 Favored 'General case' 0 CA--C 1.535 0.389 0 N-CA-C 113.037 0.754 . . . . 0.0 113.037 -176.578 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' E' E ' 109' ' ' LEU . . . . . . . . . . . . . 21.2 mt 57.06 33.81 23.92 Favored 'General case' 0 CA--C 1.53 0.196 0 N-CA-C 111.812 0.301 . . . . 0.0 111.812 179.01 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' E' E ' 110' ' ' GLU . . . . . . . . . . . . . 96.0 mt-10 -100.19 132.7 45.41 Favored 'General case' 0 C--N 1.329 -0.311 0 N-CA-C 109.171 -0.677 . . . . 0.0 109.171 174.688 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' E' E ' 111' ' ' GLU . . . . . . . . . . . . . 52.6 tt0 -74.79 121.84 22.39 Favored 'General case' 0 C--N 1.327 -0.385 0 CA-C-O 121.017 0.437 . . . . 0.0 110.875 -173.606 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' E' E ' 112' ' ' LEU . . . . . . . . . . . . . 73.4 mt -100.64 -46.12 5.28 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 115.872 -0.603 . . . . 0.0 110.61 179.519 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' E' E ' 113' ' ' TYR . . . . . . . . . . . . . 64.2 t80 -140.89 143.66 34.8 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.121 -0.491 . . . . 0.0 111.277 -177.237 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' E' E ' 114' ' ' ARG . . . . . . . . . . . . . 47.0 ptt85 -144.25 126.14 15.32 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.09 -0.504 . . . . 0.0 110.603 176.417 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' E' E ' 115' ' ' GLY . . . . . . . . . . . . . . . -150.03 147.52 17.83 Favored Glycine 0 CA--C 1.524 0.646 0 N-CA-C 111.11 -0.796 . . . . 0.0 111.11 179.203 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' E' E ' 116' ' ' LYS . . . . . . . . . . . . . 37.1 ttpt -118.72 135.53 54.44 Favored 'General case' 0 C--N 1.33 -0.264 0 N-CA-C 109.92 -0.4 . . . . 0.0 109.92 177.64 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' E' E ' 117' ' ' PHE . . . . . . . . . . . . . 43.0 m-85 -127.25 115.42 19.03 Favored 'General case' 0 C--N 1.331 -0.211 0 CA-C-N 116.215 -0.448 . . . . 0.0 109.914 -177.2 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' E' E ' 118' ' ' GLU . . . . . . . . . . . . . 96.1 mt-10 -53.99 -48.26 70.58 Favored 'General case' 0 C--N 1.33 -0.282 0 C-N-CA 121.005 -0.278 . . . . 0.0 111.344 -176.364 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' E' E ' 119' ' ' ASN . . . . . . . . . . . . . 65.7 m-80 -95.69 31.13 2.12 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 115.964 -0.562 . . . . 0.0 112.074 -174.828 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' E' E ' 120' ' ' LEU . . . . . . . . . . . . . 17.5 tp -53.23 119.92 5.34 Favored 'General case' 0 N--CA 1.463 0.215 0 CA-C-O 120.795 0.331 . . . . 0.0 110.909 179.421 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' E' E ' 121' ' ' ASN . . . . . . . . . . . . . 43.2 m-80 -114.13 -44.13 3.17 Favored 'General case' 0 C--N 1.333 -0.15 0 CA-C-N 116.273 -0.421 . . . . 0.0 111.102 -177.581 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' E' E ' 122' ' ' LYS . . . . . . . . . . . . . 18.7 mtpp -139.79 142.5 36.7 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.33 -0.395 . . . . 0.0 111.706 -174.876 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' E' E ' 123' ' ' VAL . . . . . . . . . . . . . 46.4 t -132.81 126.16 53.7 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.377 0 N-CA-C 109.339 -0.615 . . . . 0.0 109.339 172.953 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' E' E ' 124' ' ' LEU . . . . . . . . . . . . . 7.4 tp -129.09 130.94 47.13 Favored 'General case' 0 C--O 1.232 0.179 0 CA-C-O 120.939 0.4 . . . . 0.0 110.538 -178.114 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' E' E ' 125' ' ' VAL . . . . . 0.631 HG21 HG21 ' E' ' 94' ' ' VAL . 41.5 t -124.75 133.17 70.12 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.218 0 CA-C-N 116.014 -0.539 . . . . 0.0 109.884 179.345 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' E' E ' 126' ' ' ARG . . . . . . . . . . . . . 34.7 ttm180 -155.68 124.04 5.88 Favored 'General case' 0 C--N 1.328 -0.327 0 N-CA-C 109.619 -0.512 . . . . 0.0 109.619 179.06 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' E' E ' 127' ' ' ASN . . . . . . . . . . . . . 32.1 t30 57.97 -154.44 0.36 Allowed 'General case' 0 CA--C 1.538 0.487 0 N-CA-C 109.296 -0.631 . . . . 0.0 109.296 -175.936 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' E' E ' 128' ' ' ASP . . . . . . . . . . . . . 9.0 p-10 -80.94 16.5 1.45 Allowed 'General case' 0 CA--C 1.536 0.424 0 N-CA-C 112.51 0.559 . . . . 0.0 112.51 176.635 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' E' E ' 129' ' ' LEU . . . . . . . . . . . . . 26.3 tp -107.7 131.28 54.59 Favored 'General case' 0 C--O 1.232 0.155 0 O-C-N 122.019 -0.426 . . . . 0.0 110.014 177.865 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' E' E ' 130' ' ' VAL . . . . . . . . . . . . . 44.6 t -125.3 134.93 65.58 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.27 0 N-CA-C 109.843 -0.428 . . . . 0.0 109.843 -179.352 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' E' E ' 131' ' ' VAL . . . . . 0.437 HG22 HD12 ' E' ' 140' ' ' LEU . 43.4 t -134.05 133.42 56.01 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.252 0 CA-C-O 121.137 0.494 . . . . 0.0 110.252 178.388 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' E' E ' 132' ' ' ILE . . . . . . . . . . . . . 73.1 mt -119.63 132.96 67.95 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.252 0 CA-C-N 115.601 -0.727 . . . . 0.0 109.411 179.648 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' E' E ' 133' ' ' ILE . . . . . . . . . . . . . 42.8 mm -118.03 123.27 71.41 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.277 0 CA-C-O 120.886 0.374 . . . . 0.0 111.2 -174.029 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' E' E ' 134' ' ' ASP . . . . . . . . . . . . . 5.3 p-10 -127.38 151.6 48.58 Favored 'General case' 0 C--N 1.331 -0.227 0 CA-C-N 115.843 -0.617 . . . . 0.0 109.6 173.397 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' E' E ' 135' ' ' GLU . . . . . . . . . . . . . 43.2 tp10 -49.73 -26.38 3.76 Favored 'General case' 0 C--N 1.329 -0.314 0 N-CA-C 112.86 0.689 . . . . 0.0 112.86 -169.859 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' E' E ' 136' ' ' GLN . . . . . . . . . . . . . 97.3 mt-30 -102.9 -31.12 10.41 Favored 'General case' 0 N--CA 1.464 0.228 0 N-CA-C 112.851 0.686 . . . . 0.0 112.851 -174.345 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' E' E ' 137' ' ' LYS . . . . . . . . . . . . . 27.7 ttpp -144.17 153.91 42.59 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-O 121.223 0.535 . . . . 0.0 111.673 -166.689 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' E' E ' 138' ' ' LEU . . . . . 0.41 ' C ' HD23 ' E' ' 138' ' ' LEU . 6.8 tt -118.73 126.31 51.61 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 115.616 -0.72 . . . . 0.0 110.056 178.388 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' E' E ' 139' ' ' THR . . . . . . . . . . . . . 33.4 m -107.45 125.44 51.25 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.095 -179.901 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' E' E ' 140' ' ' LEU . . . . . 0.437 HD12 HG22 ' E' ' 131' ' ' VAL . 7.5 tp -113.91 120.25 40.06 Favored 'General case' 0 C--N 1.329 -0.299 0 N-CA-C 109.065 -0.717 . . . . 0.0 109.065 -179.948 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' E' E ' 141' ' ' ILE . . . . . . . . . . . . . 18.3 mt -120.99 126.09 74.8 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.268 0 CA-C-O 120.894 0.378 . . . . 0.0 110.459 -172.779 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' E' E ' 142' ' ' ARG . . . . . . . . . . . . . 77.9 mtp180 -109.12 130.65 55.48 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 115.651 -0.704 . . . . 0.0 109.977 176.571 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' E' E ' 143' ' ' THR . . . . . . . . . . . . . 58.9 p . . . . . 0 C--O 1.22 -0.453 0 CA-C-O 118.025 -0.988 . . . . 0.0 110.452 -179.937 . . . . . . . . 0 0 . 1 . 015 nuclear nobuild core ' F' F ' 1' ' ' MET . . . . . . . . . . . . . 26.1 ptt? . . . . . 0 C--O 1.232 0.14 0 CA-C-O 120.914 0.388 . . . . 0.0 111.126 . . . . . . . . . 0 0 . 1 . 015 nuclear nobuild core ' F' F ' 2' ' ' SER . . . . . . . . . . . . . 7.6 p -111.57 139.94 46.6 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.028 -0.533 . . . . 0.0 110.31 178.26 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' F' F ' 3' ' ' GLU . . . . . . . . . . . . . 81.1 tt0 -143.79 143.89 31.55 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.333 -0.394 . . . . 0.0 111.356 -176.836 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' F' F ' 4' ' ' LEU . . . . . . . . . . . . . 24.1 tp -124.52 129.87 51.42 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 115.872 -0.604 . . . . 0.0 109.87 175.305 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' F' F ' 5' ' ' LYS . . . . . . . . . . . . . 99.3 mttt -110.58 122.08 46.88 Favored 'General case' 0 C--O 1.234 0.26 0 CA-C-N 116.395 -0.366 . . . . 0.0 110.901 -179.513 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' F' F ' 6' ' ' LEU . . . . . . . . . . . . . 32.8 mt -114.52 146.69 40.42 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 115.342 -0.845 . . . . 0.0 110.263 -179.264 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' F' F ' 7' ' ' LYS . . . . . . . . . . . . . 36.7 ttmt -132.92 137.76 30.35 Favored Pre-proline 0 CA--C 1.534 0.338 0 CA-C-O 118.974 -0.536 . . . . 0.0 109.805 174.758 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' F' F ' 8' ' ' PRO . . . . . . . . . . . . . 83.6 Cg_endo -91.52 141.65 2.74 Favored 'Trans proline' 0 N--CA 1.49 1.305 0 C-N-CA 121.773 1.649 . . . . 0.0 112.014 179.359 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' F' F ' 9' ' ' LEU . . . . . . . . . . . . . 37.6 mt -78.44 -46.59 2.01 Favored Pre-proline 0 CA--C 1.534 0.328 0 CA-C-O 118.765 -0.636 . . . . 0.0 111.735 179.056 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' F' F ' 10' ' ' PRO . . . . . . . . . . . . . 91.1 Cg_endo -83.08 145.96 12.54 Favored 'Trans proline' 0 N--CA 1.494 1.54 0 C-N-CA 121.218 1.279 . . . . 0.0 111.52 173.452 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' F' F ' 11' ' ' LYS . . . . . . . . . . . . . 19.8 pttp -84.01 116.78 23.0 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-O 121.324 0.583 . . . . 0.0 110.545 177.988 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' F' F ' 12' ' ' VAL . . . . . . . . . . . . . 11.9 p -151.06 143.88 16.71 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.306 0 CA-C-N 115.662 -0.699 . . . . 0.0 110.274 -179.662 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' F' F ' 13' ' ' GLU . . . . . . . . . . . . . 43.3 mt-10 -83.13 117.16 22.69 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.517 -0.311 . . . . 0.0 110.26 178.53 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' F' F ' 14' ' ' LEU . . . . . . . . . . . . . 34.7 mt -98.41 142.31 24.38 Favored Pre-proline 0 CA--C 1.534 0.358 0 CA-C-O 118.997 -0.525 . . . . 0.0 109.853 -179.695 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' F' F ' 15' ' ' PRO . . . . . . . . . . . . . 26.4 Cg_exo -61.22 160.93 24.79 Favored 'Trans proline' 0 N--CA 1.497 1.724 0 C-N-CA 121.202 1.268 . . . . 0.0 111.828 178.282 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' F' F ' 16' ' ' PRO . . . . . . . . . . . . . 32.7 Cg_exo -59.55 -37.52 88.23 Favored 'Trans proline' 0 N--CA 1.497 1.684 0 C-N-CA 121.508 1.472 . . . . 0.0 112.633 -178.303 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' F' F ' 17' ' ' ASP . . . . . . . . . . . . . 13.6 p-10 -86.44 7.94 23.83 Favored 'General case' 0 CA--C 1.536 0.423 0 N-CA-C 113.132 0.79 . . . . 0.0 113.132 -177.989 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' F' F ' 18' ' ' PHE . . . . . . . . . . . . . 52.0 t80 -58.26 -43.8 88.05 Favored 'General case' 0 N--CA 1.457 -0.102 0 O-C-N 121.985 -0.447 . . . . 0.0 109.991 -179.55 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' F' F ' 19' ' ' VAL . . . . . . . . . . . . . 47.1 t -57.33 -40.86 76.65 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.324 0 CA-C-N 116.112 -0.494 . . . . 0.0 110.322 -179.626 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' F' F ' 20' ' ' ASP . . . . . . . . . . . . . 36.6 t0 -60.37 -43.56 96.46 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-O 120.769 0.319 . . . . 0.0 110.974 -178.258 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' F' F ' 21' ' ' VAL . . . . . . . . . . . . . 47.3 t -64.35 -45.94 94.53 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.279 0 C-N-CA 120.821 -0.352 . . . . 0.0 110.361 -178.382 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' F' F ' 22' ' ' ILE . . . . . 0.669 HG22 HD12 ' F' ' 26' ' ' LEU . 50.9 mm -56.21 -43.36 76.15 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.271 0 CA-C-O 120.768 0.318 . . . . 0.0 110.49 177.957 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' F' F ' 23' ' ' ARG . . . . . . . . . . . . . 58.8 ttp180 -55.26 -49.09 72.94 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-O 120.723 0.296 . . . . 0.0 111.182 179.693 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' F' F ' 24' ' ' ILE . . . . . . . . . . . . . 73.7 mt -59.32 -41.34 83.88 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.293 0 CA-C-N 116.447 -0.342 . . . . 0.0 111.042 -177.608 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' F' F ' 25' ' ' LYS . . . . . . . . . . . . . 48.0 mttm -69.04 -42.53 76.2 Favored 'General case' 0 C--N 1.328 -0.344 0 N-CA-C 112.696 0.628 . . . . 0.0 112.696 -178.056 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' F' F ' 26' ' ' LEU . . . . . 0.669 HD12 HG22 ' F' ' 22' ' ' ILE . 53.6 mt -79.47 -34.58 41.34 Favored 'General case' 0 C--N 1.331 -0.225 0 N-CA-C 113.72 1.007 . . . . 0.0 113.72 -170.451 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' F' F ' 27' ' ' GLN . . . . . . . . . . . . . 8.3 pt20 -46.67 138.37 6.1 Favored 'General case' 0 N--CA 1.469 0.486 0 N-CA-C 112.998 0.74 . . . . 0.0 112.998 -174.18 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' F' F ' 28' ' ' GLY . . . . . . . . . . . . . . . 100.23 -24.58 31.55 Favored Glycine 0 CA--C 1.533 1.163 0 CA-C-N 115.528 -0.76 . . . . 0.0 112.525 -177.963 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' F' F ' 29' ' ' LYS . . . . . . . . . . . . . 68.7 mttm -98.04 155.08 17.28 Favored 'General case' 0 C--O 1.232 0.177 0 CA-C-N 117.387 0.594 . . . . 0.0 111.337 179.637 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' F' F ' 30' ' ' THR . . . . . . . . . . . . . 29.5 m -105.92 139.43 40.49 Favored 'General case' 0 C--N 1.331 -0.218 0 CA-C-N 115.928 -0.578 . . . . 0.0 110.345 177.989 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' F' F ' 31' ' ' VAL . . . . . . . . . . . . . 34.4 m -129.9 156.71 42.33 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.271 0 CA-C-N 116.357 -0.383 . . . . 0.0 110.616 179.918 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' F' F ' 32' ' ' ARG . . . . . . . . . . . . . 68.1 mtm180 -131.68 152.41 50.89 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-O 121.099 0.476 . . . . 0.0 110.853 177.55 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' F' F ' 33' ' ' THR . . . . . . . . . . . . . 19.8 m -53.39 138.69 32.46 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.304 -0.407 . . . . 0.0 111.175 -179.534 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' F' F ' 34' ' ' GLY . . . . . . . . . . . . . . . 99.59 -17.21 57.91 Favored Glycine 0 CA--C 1.532 1.151 0 C-N-CA 121.211 -0.519 . . . . 0.0 113.268 178.869 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' F' F ' 35' ' ' ASP . . . . . . . . . . . . . 74.3 m-20 -66.83 149.87 49.95 Favored 'General case' 0 N--CA 1.462 0.145 0 CA-C-N 118.076 0.938 . . . . 0.0 111.191 178.98 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' F' F ' 36' ' ' VAL . . . . . . . . . . . . . 43.9 t -121.83 130.0 74.97 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.209 0 N-CA-C 109.607 -0.516 . . . . 0.0 109.607 177.018 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' F' F ' 37' ' ' ILE . . . . . . . . . . . . . 66.2 mt -121.29 138.48 51.52 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.245 0 CA-C-N 116.186 -0.461 . . . . 0.0 109.978 -178.627 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' F' F ' 38' ' ' GLY . . . . . . . . . . . . . . . -113.61 128.02 8.12 Favored Glycine 0 CA--C 1.524 0.652 0 N-CA-C 110.936 -0.866 . . . . 0.0 110.936 179.219 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' F' F ' 39' ' ' ILE . . . . . . . . . . . . . 78.4 mt -127.9 140.49 49.02 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.186 0 CA-C-O 120.789 0.328 . . . . 0.0 110.265 179.2 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' F' F ' 40' ' ' SER . . . . . . . . . . . . . 42.7 t -91.26 115.5 28.07 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.226 -0.443 . . . . 0.0 110.649 176.392 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' F' F ' 41' ' ' ILE . . . . . . . . . . . . . 44.8 mm -119.62 113.22 40.24 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.231 0 N-CA-C 109.961 -0.385 . . . . 0.0 109.961 178.439 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' F' F ' 42' ' ' LEU . . . . . . . . . . . . . 69.1 mt 57.62 36.1 26.39 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.415 -0.357 . . . . 0.0 111.498 179.5 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' F' F ' 43' ' ' GLY . . . . . . . . . . . . . . . 80.34 -10.2 44.35 Favored Glycine 0 CA--C 1.533 1.197 0 C-N-CA 121.289 -0.482 . . . . 0.0 113.517 177.306 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' F' F ' 44' ' ' LYS . . . . . . . . . . . . . 42.8 tttp -99.6 134.68 42.14 Favored 'General case' 0 C--N 1.333 -0.132 0 CA-C-N 117.831 0.816 . . . . 0.0 110.007 177.339 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' F' F ' 45' ' ' GLU . . . . . . . . . . . . . 83.8 tt0 -82.61 127.99 33.89 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-O 120.797 0.332 . . . . 0.0 110.838 -179.014 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' F' F ' 46' ' ' VAL . . . . . . . . . . . . . 10.7 p -121.63 126.11 74.32 Favored 'Isoleucine or valine' 0 C--N 1.333 -0.15 0 N-CA-C 109.639 -0.504 . . . . 0.0 109.639 175.759 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' F' F ' 47' ' ' LYS . . . . . . . . . . . . . 97.7 mttt -99.23 124.82 44.6 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.044 -0.525 . . . . 0.0 110.807 178.235 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' F' F ' 48' ' ' PHE . . . . . . . . . . . . . 32.6 m-85 -108.84 131.89 54.54 Favored 'General case' 0 C--N 1.33 -0.277 0 N-CA-C 109.798 -0.445 . . . . 0.0 109.798 176.548 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' F' F ' 49' ' ' LYS . . . . . . . . . . . . . 34.6 tttp -106.86 135.51 48.29 Favored 'General case' 0 C--N 1.328 -0.355 0 N-CA-C 109.849 -0.426 . . . . 0.0 109.849 177.518 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' F' F ' 50' ' ' VAL . . . . . . . . . . . . . 45.2 t -76.99 106.82 7.37 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.308 0 N-CA-C 109.438 -0.579 . . . . 0.0 109.438 178.027 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' F' F ' 51' ' ' VAL . . . . . . . . . . . . . 47.0 t -73.91 -47.87 41.19 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.324 0 CA-C-N 116.22 -0.446 . . . . 0.0 109.982 -175.009 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' F' F ' 52' ' ' GLN . . . . . . . . . . . . . 63.0 tt0 -159.75 143.85 14.7 Favored 'General case' 0 C--N 1.33 -0.275 0 C-N-CA 120.422 -0.511 . . . . 0.0 111.447 -177.874 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' F' F ' 53' ' ' ALA . . . . . . . . . . . . . . . -123.64 132.9 53.97 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 115.747 -0.66 . . . . 0.0 109.778 175.004 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' F' F ' 54' ' ' TYR . . . . . . . . . . . . . 25.9 t80 -129.2 111.59 18.21 Favored Pre-proline 0 CA--C 1.536 0.416 0 CA-C-O 118.13 -0.938 . . . . 0.0 110.386 178.931 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' F' F ' 55' ' ' PRO . . . . . . . . . . . . . 73.6 Cg_endo -77.26 161.25 93.12 Favored 'Cis proline' 0 N--CA 1.499 1.821 0 CA-C-N 121.943 1.729 . . . . 0.0 112.407 -6.835 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' F' F ' 56' ' ' SER . . . . . . . . . . . . . 60.8 m -108.76 130.78 22.32 Favored Pre-proline 0 CA--C 1.539 0.557 0 CA-C-O 118.434 -0.793 . . . . 0.0 109.487 175.304 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' F' F ' 57' ' ' PRO . . . . . . . . . . . . . 36.5 Cg_endo -66.31 163.13 70.1 Favored 'Cis proline' 0 N--CA 1.498 1.78 0 CA-C-N 121.972 1.74 . . . . 0.0 111.601 -1.3 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' F' F ' 58' ' ' LEU . . . . . . . . . . . . . 15.7 tp -129.37 138.98 51.84 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-O 121.026 0.441 . . . . 0.0 110.405 -178.131 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' F' F ' 59' ' ' ARG . . . . . . . . . . . . . 74.2 ttt180 -104.68 136.31 44.44 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 115.836 -0.62 . . . . 0.0 109.683 176.244 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' F' F ' 60' ' ' VAL . . . . . . . . . . . . . 43.3 t -85.35 116.72 29.14 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.262 0 C-N-CA 120.662 -0.415 . . . . 0.0 110.234 -178.345 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' F' F ' 61' ' ' GLU . . . . . . . . . . . . . 39.1 tp10 -131.06 155.54 46.72 Favored 'General case' 0 C--N 1.328 -0.362 0 N-CA-C 109.005 -0.739 . . . . 0.0 109.005 176.856 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' F' F ' 62' ' ' ASP . . . . . . . . . . . . . 13.9 t70 -51.04 -32.37 21.55 Favored 'General case' 0 C--N 1.327 -0.391 0 N-CA-C 112.011 0.374 . . . . 0.0 112.011 -178.868 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' F' F ' 63' ' ' ARG . . . . . . . . . . . . . 87.6 mtt180 -73.21 -22.06 60.52 Favored 'General case' 0 CA--C 1.534 0.335 0 N-CA-C 112.908 0.707 . . . . 0.0 112.908 -176.801 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' F' F ' 64' ' ' THR . . . . . . . . . . . . . 18.9 m -71.8 143.02 49.65 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-O 120.929 0.395 . . . . 0.0 110.88 -175.3 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' F' F ' 65' ' ' LYS . . . . . . . . . . . . . 91.4 mttt -87.71 129.91 34.99 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 115.973 -0.558 . . . . 0.0 110.049 178.809 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' F' F ' 66' ' ' ILE . . . . . . . . . . . . . 58.2 mt -115.9 125.57 73.08 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.226 0 N-CA-C 109.579 -0.526 . . . . 0.0 109.579 178.32 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' F' F ' 67' ' ' THR . . . . . . . . . . . . . 24.6 m -121.79 142.3 50.35 Favored 'General case' 0 C--N 1.331 -0.227 0 CA-C-O 121.008 0.432 . . . . 0.0 111.215 -176.246 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' F' F ' 68' ' ' LEU . . . . . . . . . . . . . 4.9 tt . . . . . 0 C--N 1.328 -0.346 0 CA-C-N 115.743 -0.662 . . . . 0.0 109.85 178.173 . . . . . . . . 0 0 . 1 . 015 nuclear nobuild core ' F' F ' 73' ' ' VAL . . . . . . . . . . . . . 35.6 m . . . . . 0 N--CA 1.461 0.115 0 CA-C-O 120.902 0.382 . . . . 0.0 110.702 . . . . . . . . . 0 0 . 1 . 015 nuclear nobuild core ' F' F ' 74' ' ' ASP . . . . . . . . . . . . . 14.4 t0 -104.47 118.42 36.57 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.017 -0.538 . . . . 0.0 109.784 179.341 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' F' F ' 75' ' ' VAL . . . . . 0.568 ' C ' HD12 ' F' ' 76' ' ' LEU . 42.9 t -115.55 124.17 71.76 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.301 0 CA-C-O 120.965 0.412 . . . . 0.0 110.658 -177.466 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' F' F ' 76' ' ' LEU . . . . . 0.568 HD12 ' C ' ' F' ' 75' ' ' VAL . 8.7 mp -122.61 150.73 42.25 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-N 115.74 -0.664 . . . . 0.0 109.687 175.945 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' F' F ' 77' ' ' GLU . . . . . . . . . . . . . 98.9 mt-10 -135.59 141.47 45.14 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-O 121.183 0.516 . . . . 0.0 111.816 -175.984 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' F' F ' 78' ' ' ALA . . . . . . . . . . . . . . . -127.81 143.83 51.11 Favored 'General case' 0 C--N 1.331 -0.204 0 CA-C-N 115.518 -0.764 . . . . 0.0 109.82 175.868 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' F' F ' 79' ' ' LYS . . . . . 0.625 ' O ' HD13 ' F' ' 80' ' ' ILE . 37.8 mtmt -95.26 112.33 24.05 Favored 'General case' 0 C--N 1.33 -0.239 0 CA-C-O 120.738 0.304 . . . . 0.0 111.074 -176.89 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' F' F ' 80' ' ' ILE . . . . . 0.625 HD13 ' O ' ' F' ' 79' ' ' LYS . 39.3 mm -139.23 112.67 6.5 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.238 0 N-CA-C 109.404 -0.591 . . . . 0.0 109.404 -179.265 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' F' F ' 81' ' ' LYS . . . . . . . . . . . . . 56.3 pttt -106.67 131.48 53.76 Favored 'General case' 0 N--CA 1.464 0.242 0 CA-C-O 120.961 0.41 . . . . 0.0 111.389 -178.223 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' F' F ' 82' ' ' GLY . . . . . . . . . . . . . . . 89.13 41.95 5.72 Favored Glycine 0 CA--C 1.527 0.804 0 C-N-CA 121.018 -0.61 . . . . 0.0 111.813 176.154 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' F' F ' 83' ' ' ILE . . . . . . . . . . . . . 74.5 mt -77.13 137.9 21.55 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 N-CA-C 109.351 -0.611 . . . . 0.0 109.351 176.329 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' F' F ' 84' ' ' LYS . . . . . . . . . . . . . 19.3 ttpt -101.47 -46.85 4.86 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.431 -0.35 . . . . 0.0 110.527 -176.897 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' F' F ' 85' ' ' ASP . . . . . . . . . . . . . 13.7 t70 -143.72 146.6 33.29 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.448 -0.342 . . . . 0.0 110.479 -179.176 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' F' F ' 86' ' ' VAL . . . . . . . . . . . . . 44.7 t -128.96 128.86 67.81 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.215 0 CA-C-O 120.91 0.386 . . . . 0.0 110.405 -178.847 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' F' F ' 87' ' ' ILE . . . . . . . . . . . . . 44.7 mm -121.35 128.36 75.91 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.235 0 N-CA-C 109.359 -0.608 . . . . 0.0 109.359 177.903 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' F' F ' 88' ' ' LEU . . . . . . . . . . . . . 62.1 mt -120.21 139.26 52.92 Favored 'General case' 0 C--N 1.332 -0.194 0 CA-C-O 121.207 0.527 . . . . 0.0 111.882 -175.277 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' F' F ' 89' ' ' ASP . . . . . . . . . . . . . 13.4 t70 -133.61 154.92 50.52 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 115.423 -0.808 . . . . 0.0 109.436 175.394 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' F' F ' 90' ' ' GLU . . . . . . . . . . . . . 44.2 mt-10 -49.46 -36.78 23.7 Favored 'General case' 0 C--N 1.329 -0.294 0 N-CA-C 112.832 0.678 . . . . 0.0 112.832 -171.805 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' F' F ' 91' ' ' ASN . . . . . . . . . . . . . 9.1 m120 -127.1 22.11 6.69 Favored 'General case' 0 N--CA 1.468 0.449 0 N-CA-C 112.869 0.692 . . . . 0.0 112.869 -176.651 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' F' F ' 92' ' ' LEU . . . . . . . . . . . . . 5.8 mt -153.49 144.4 22.79 Favored 'General case' 0 C--N 1.331 -0.199 0 N-CA-C 109.573 -0.528 . . . . 0.0 109.573 -177.894 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' F' F ' 93' ' ' ILE . . . . . . . . . . . . . 71.2 mt -127.28 122.25 59.34 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.288 0 N-CA-C 109.407 -0.59 . . . . 0.0 109.407 178.41 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' F' F ' 94' ' ' VAL . . . . . . . . . . . . . 43.5 t -121.95 126.97 75.22 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.242 0 CA-C-O 120.911 0.386 . . . . 0.0 110.014 -179.821 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' F' F ' 95' ' ' VAL . . . . . . . . . . . . . 44.0 t -120.47 133.25 67.78 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.384 0 CA-C-N 115.963 -0.562 . . . . 0.0 109.662 179.671 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' F' F ' 96' ' ' ILE . . . . . . . . . . . . . 66.9 mt -114.99 124.54 71.75 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.231 0 N-CA-C 109.121 -0.696 . . . . 0.0 109.121 178.726 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' F' F ' 97' ' ' THR . . . . . . . . . . . . . 45.3 p -98.28 156.75 16.56 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-O 121.114 0.483 . . . . 0.0 111.474 -176.139 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' F' F ' 98' ' ' GLU . . . . . . . . . . . . . 96.7 mt-10 -54.09 -26.35 26.68 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 116.037 -0.529 . . . . 0.0 112.027 178.307 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' F' F ' 99' ' ' GLU . . . . . . . . . . . . . 34.6 tt0 -79.33 17.03 0.88 Allowed 'General case' 0 CA--C 1.538 0.51 0 N-CA-C 112.582 0.586 . . . . 0.0 112.582 -176.83 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' F' F ' 100' ' ' ASN . . . . . . . . . . . . . 2.0 m120 64.18 36.2 9.68 Favored 'General case' 0 CA--C 1.531 0.224 0 O-C-N 121.84 -0.538 . . . . 0.0 110.984 176.002 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' F' F ' 101' ' ' GLU . . . . . . . . . . . . . 79.1 tt0 -117.15 142.88 46.46 Favored 'General case' 0 C--O 1.231 0.099 0 N-CA-C 109.917 -0.401 . . . . 0.0 109.917 178.248 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' F' F ' 102' ' ' VAL . . . . . . . . . . . . . 43.4 t -115.56 125.16 72.66 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.312 0 N-CA-C 109.728 -0.471 . . . . 0.0 109.728 -179.848 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' F' F ' 103' ' ' LEU . . . . . . . . . . . . . 40.0 mt -117.08 131.06 57.01 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 115.972 -0.558 . . . . 0.0 110.606 178.256 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' F' F ' 104' ' ' ILE . . . . . 0.468 HD12 ' HB3' ' F' ' 113' ' ' TYR . 67.0 mt -117.19 120.08 63.87 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.221 0 CA-C-N 116.405 -0.361 . . . . 0.0 110.314 -179.477 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' F' F ' 105' ' ' PHE . . . . . . . . . . . . . 76.1 m-85 -121.58 167.4 12.93 Favored 'General case' 0 C--O 1.231 0.128 0 O-C-N 124.092 0.87 . . . . 0.0 109.688 178.238 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' F' F ' 106' ' ' ASN . . . . . . . . . . . . . 43.0 p-10 -104.09 -170.99 1.85 Allowed 'General case' 0 C--N 1.332 -0.172 0 N-CA-C 109.657 -0.497 . . . . 0.0 109.657 170.653 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' F' F ' 107' ' ' GLN . . . . . . . . . . . . . 50.3 tt0 -58.41 -29.98 66.51 Favored 'General case' 0 C--N 1.328 -0.338 0 N-CA-C 111.925 0.343 . . . . 0.0 111.925 179.735 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' F' F ' 108' ' ' ASN . . . . . . . . . . . . . 47.1 t30 -88.22 13.7 10.89 Favored 'General case' 0 CA--C 1.534 0.359 0 N-CA-C 112.91 0.707 . . . . 0.0 112.91 -176.484 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' F' F ' 109' ' ' LEU . . . . . . . . . . . . . 82.1 mt 57.2 33.6 23.55 Favored 'General case' 0 CA--C 1.529 0.173 0 N-CA-C 111.823 0.305 . . . . 0.0 111.823 176.875 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' F' F ' 110' ' ' GLU . . . . . . . . . . . . . 95.8 mt-10 -100.0 138.61 36.84 Favored 'General case' 0 C--N 1.331 -0.239 0 N-CA-C 109.339 -0.615 . . . . 0.0 109.339 175.616 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' F' F ' 111' ' ' GLU . . . . . . . . . . . . . 56.7 tt0 -75.49 121.9 23.05 Favored 'General case' 0 C--N 1.328 -0.338 0 C-N-CA 120.64 -0.424 . . . . 0.0 110.532 -175.727 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' F' F ' 112' ' ' LEU . . . . . . . . . . . . . 32.4 mt -104.36 -46.02 4.51 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.065 -0.516 . . . . 0.0 110.657 179.715 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' F' F ' 113' ' ' TYR . . . . . 0.468 ' HB3' HD12 ' F' ' 104' ' ' ILE . 58.8 t80 -143.16 141.06 31.06 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 116.247 -0.433 . . . . 0.0 111.295 -179.35 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' F' F ' 114' ' ' ARG . . . . . . . . . . . . . 39.0 ptt180 -137.81 123.76 20.16 Favored 'General case' 0 C--N 1.331 -0.203 0 CA-C-N 115.837 -0.619 . . . . 0.0 110.252 178.124 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' F' F ' 115' ' ' GLY . . . . . . . . . . . . . . . -150.08 160.94 28.74 Favored Glycine 0 CA--C 1.523 0.582 0 C-N-CA 120.565 -0.826 . . . . 0.0 111.472 -179.289 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' F' F ' 116' ' ' LYS . . . . . . . . . . . . . 32.5 ttpt -127.18 141.4 51.75 Favored 'General case' 0 C--N 1.33 -0.249 0 N-CA-C 109.838 -0.431 . . . . 0.0 109.838 176.487 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' F' F ' 117' ' ' PHE . . . . . . . . . . . . . 43.0 m-85 -141.17 113.82 8.28 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.408 -0.36 . . . . 0.0 110.061 -179.545 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' F' F ' 118' ' ' GLU . . . . . . . . . . . . . 95.9 mt-10 -55.6 -44.13 76.7 Favored 'General case' 0 C--N 1.329 -0.321 0 C-N-CA 120.867 -0.333 . . . . 0.0 111.093 -176.252 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' F' F ' 119' ' ' ASN . . . . . . . . . . . . . 3.5 m120 -98.72 31.11 3.03 Favored 'General case' 0 C--N 1.33 -0.246 0 N-CA-C 112.216 0.45 . . . . 0.0 112.216 -174.387 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' F' F ' 120' ' ' LEU . . . . . . . . . . . . . 17.5 tp -57.04 121.03 9.04 Favored 'General case' 0 N--CA 1.463 0.206 0 N-CA-C 110.092 -0.336 . . . . 0.0 110.092 177.475 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' F' F ' 121' ' ' ASN . . . . . . . . . . . . . 5.3 t30 -114.08 -44.11 3.18 Favored 'General case' 0 C--N 1.332 -0.182 0 C-N-CA 121.208 -0.197 . . . . 0.0 111.25 -176.75 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' F' F ' 122' ' ' LYS . . . . . . . . . . . . . 86.3 mttt -142.97 147.87 35.9 Favored 'General case' 0 C--N 1.332 -0.19 0 CA-C-O 121.164 0.507 . . . . 0.0 111.788 -178.986 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' F' F ' 123' ' ' VAL . . . . . . . . . . . . . 42.9 t -128.74 129.56 68.49 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.186 0 CA-C-N 115.729 -0.668 . . . . 0.0 109.553 174.823 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' F' F ' 124' ' ' LEU . . . . . . . . . . . . . 21.7 mt -123.81 135.32 53.71 Favored 'General case' 0 C--N 1.331 -0.212 0 CA-C-O 120.81 0.338 . . . . 0.0 110.679 -178.841 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' F' F ' 125' ' ' VAL . . . . . 0.439 ' O ' HG13 ' F' ' 125' ' ' VAL . 11.7 p -136.86 123.95 30.91 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.273 0 CA-C-N 116.233 -0.44 . . . . 0.0 110.214 178.0 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' F' F ' 126' ' ' ARG . . . . . . . . . . . . . 89.6 mtt180 -152.94 132.92 13.33 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.053 -0.521 . . . . 0.0 109.873 178.938 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' F' F ' 127' ' ' ASN . . . . . . . . . . . . . 3.9 m120 55.58 -151.76 0.38 Allowed 'General case' 0 CA--C 1.541 0.602 0 N-CA-C 109.898 -0.408 . . . . 0.0 109.898 179.38 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' F' F ' 128' ' ' ASP . . . . . . . . . . . . . 19.7 p-10 -81.35 15.3 2.05 Favored 'General case' 0 CA--C 1.536 0.417 0 CA-C-N 118.643 0.656 . . . . 0.0 112.764 178.675 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' F' F ' 129' ' ' LEU . . . . . . . . . . . . . 31.7 mt -111.05 131.14 55.31 Favored 'General case' 0 C--O 1.233 0.213 0 O-C-N 121.936 -0.477 . . . . 0.0 110.651 179.588 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' F' F ' 130' ' ' VAL . . . . . . . . . . . . . 41.2 t -122.15 133.64 67.85 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.223 0 N-CA-C 109.115 -0.698 . . . . 0.0 109.115 176.839 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' F' F ' 131' ' ' VAL . . . . . 0.417 HG22 HD12 ' F' ' 140' ' ' LEU . 42.6 t -135.73 137.4 49.3 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.213 0 CA-C-O 121.049 0.452 . . . . 0.0 110.694 -176.852 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' F' F ' 132' ' ' ILE . . . . . . . . . . . . . 67.7 mt -120.55 133.42 67.29 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.242 0 CA-C-N 115.748 -0.66 . . . . 0.0 109.604 179.732 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' F' F ' 133' ' ' ILE . . . . . . . . . . . . . 40.5 mm -119.8 120.6 63.79 Favored 'Isoleucine or valine' 0 C--O 1.234 0.269 0 CA-C-O 120.876 0.37 . . . . 0.0 110.949 -177.294 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' F' F ' 134' ' ' ASP . . . . . . . . . . . . . 7.2 p-10 -134.16 146.9 50.62 Favored 'General case' 0 C--N 1.329 -0.285 0 N-CA-C 109.497 -0.556 . . . . 0.0 109.497 174.562 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' F' F ' 135' ' ' GLU . . . . . . . . . . . . . 52.6 tt0 -49.86 -25.96 3.62 Favored 'General case' 0 C--N 1.328 -0.358 0 N-CA-C 112.948 0.722 . . . . 0.0 112.948 -170.145 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' F' F ' 136' ' ' GLN . . . . . . . . . . . . . 60.8 tp60 -99.2 -31.2 11.85 Favored 'General case' 0 C--N 1.332 -0.183 0 N-CA-C 112.384 0.512 . . . . 0.0 112.384 -174.767 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' F' F ' 137' ' ' LYS . . . . . . . . . . . . . 89.4 mttt -139.85 153.9 47.16 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-O 121.214 0.53 . . . . 0.0 111.532 -170.515 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' F' F ' 138' ' ' LEU . . . . . . . . . . . . . 4.3 tt -121.37 126.85 50.43 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 115.625 -0.716 . . . . 0.0 109.32 174.171 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' F' F ' 139' ' ' THR . . . . . . . . . . . . . 31.8 m -116.67 134.21 55.09 Favored 'General case' 0 N--CA 1.462 0.144 0 CA-C-O 120.891 0.377 . . . . 0.0 111.385 -176.338 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' F' F ' 140' ' ' LEU . . . . . 0.417 HD12 HG22 ' F' ' 131' ' ' VAL . 24.0 tp -120.99 122.65 40.6 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 115.387 -0.824 . . . . 0.0 109.167 179.721 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' F' F ' 141' ' ' ILE . . . . . . . . . . . . . 19.2 mt -119.87 125.24 74.09 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.323 0 CA-C-O 120.974 0.416 . . . . 0.0 110.278 -175.638 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' F' F ' 142' ' ' ARG . . . . . . . . . . . . . 43.1 mtm180 -107.59 124.67 50.29 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 115.205 -0.907 . . . . 0.0 110.134 178.948 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' F' F ' 143' ' ' THR . . . . . . . . . . . . . 21.5 p . . . . . 0 C--O 1.221 -0.443 0 CA-C-O 117.991 -1.004 . . . . 0.0 110.584 179.852 . . . . . . . . 0 0 . 1 . 016 nuclear nobuild core ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 5.0 p . . . . . 0 C--O 1.231 0.08 0 CA-C-O 120.932 0.396 . . . . 0.0 110.362 . . . . . . . . . 0 0 . 1 . 016 nuclear nobuild core ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 95.5 mt-10 -141.85 142.42 33.12 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.115 -0.493 . . . . 0.0 111.242 -178.061 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 4' ' ' LEU . . . . . . . . . . . . . 18.1 tp -124.32 124.45 42.41 Favored 'General case' 0 C--N 1.331 -0.218 0 CA-C-N 115.757 -0.656 . . . . 0.0 109.848 175.718 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 5' ' ' LYS . . . . . . . . . . . . . 98.0 mttt -105.09 120.55 41.79 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.65 -179.7 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 37.8 mt -115.37 148.81 38.86 Favored 'General case' 0 C--N 1.332 -0.183 0 CA-C-N 115.624 -0.716 . . . . 0.0 110.237 -178.414 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 21.3 ttpt -129.83 135.53 27.64 Favored Pre-proline 0 CA--C 1.534 0.339 0 CA-C-O 118.851 -0.595 . . . . 0.0 109.443 174.276 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 8' ' ' PRO . . . . . . . . . . . . . 76.8 Cg_endo -91.54 135.54 1.72 Allowed 'Trans proline' 0 N--CA 1.489 1.239 0 C-N-CA 121.694 1.596 . . . . 0.0 111.683 177.52 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 48.6 mt -72.15 -47.24 10.99 Favored Pre-proline 0 CA--C 1.533 0.309 0 CA-C-O 118.594 -0.717 . . . . 0.0 112.171 -178.988 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 83.4 Cg_endo -80.8 148.65 17.75 Favored 'Trans proline' 0 N--CA 1.496 1.666 0 C-N-CA 121.217 1.278 . . . . 0.0 111.753 175.905 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 51.2 tptt -85.2 96.05 9.36 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.466 -0.334 . . . . 0.0 110.275 179.234 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 12.5 p -142.52 149.65 18.98 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.243 0 CA-C-N 116.25 -0.432 . . . . 0.0 110.692 -178.326 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 83.1 tt0 -89.92 129.48 36.27 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-N 116.163 -0.471 . . . . 0.0 110.551 179.378 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 14' ' ' LEU . . . . . . . . . . . . . 48.3 mt -98.44 153.06 38.16 Favored Pre-proline 0 CA--C 1.532 0.282 0 CA-C-N 116.425 -0.352 . . . . 0.0 110.888 -178.872 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 15' ' ' PRO . . . . . . . . . . . . . 30.1 Cg_exo -61.19 159.88 28.78 Favored 'Trans proline' 0 N--CA 1.497 1.705 0 C-N-CA 121.356 1.371 . . . . 0.0 111.963 176.627 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 16' ' ' PRO . . . . . . . . . . . . . 31.6 Cg_exo -59.72 -42.17 48.8 Favored 'Trans proline' 0 N--CA 1.495 1.613 0 C-N-CA 121.475 1.45 . . . . 0.0 112.648 -179.068 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 17' ' ' ASP . . . . . . . . . . . . . 13.1 p-10 -84.13 11.65 7.72 Favored 'General case' 0 CA--C 1.535 0.383 0 N-CA-C 113.129 0.789 . . . . 0.0 113.129 -177.676 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 18' ' ' PHE . . . . . 0.466 ' HE1' HD13 ' A' ' 41' ' ' ILE . 31.2 t80 -57.12 -45.04 83.81 Favored 'General case' 0 N--CA 1.458 -0.074 0 O-C-N 121.917 -0.489 . . . . 0.0 110.433 -178.408 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 19' ' ' VAL . . . . . . . . . . . . . 48.0 t -57.06 -41.06 76.85 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.245 0 CA-C-N 116.371 -0.377 . . . . 0.0 110.534 -178.711 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 68.8 m-20 -59.79 -43.38 94.43 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-O 120.899 0.381 . . . . 0.0 110.703 -178.342 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 45.4 t -64.34 -46.56 92.77 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.321 0 CA-C-N 116.281 -0.418 . . . . 0.0 110.56 -178.231 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 22' ' ' ILE . . . . . 0.63 HG22 HD12 ' A' ' 26' ' ' LEU . 50.6 mm -55.11 -47.07 77.63 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.222 0 C-N-CA 120.99 -0.284 . . . . 0.0 110.828 179.272 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 23' ' ' ARG . . . . . . . . . . . . . 56.5 ttp180 -54.12 -50.03 67.82 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-O 120.697 0.284 . . . . 0.0 111.329 -179.021 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 24' ' ' ILE . . . . . . . . . . . . . 74.0 mt -58.91 -42.31 85.52 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.239 0 CA-C-N 116.432 -0.349 . . . . 0.0 111.25 -178.157 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 61.9 mtpt -67.76 -41.77 82.8 Favored 'General case' 0 C--N 1.328 -0.354 0 N-CA-C 112.404 0.52 . . . . 0.0 112.404 -177.405 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 26' ' ' LEU . . . . . 0.63 HD12 HG22 ' A' ' 22' ' ' ILE . 49.2 mt -79.43 -37.38 37.21 Favored 'General case' 0 C--N 1.33 -0.28 0 N-CA-C 113.368 0.877 . . . . 0.0 113.368 -169.495 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 27' ' ' GLN . . . . . . . . . . . . . 9.9 pt20 -46.84 136.19 8.39 Favored 'General case' 0 N--CA 1.47 0.553 0 N-CA-C 112.728 0.64 . . . . 0.0 112.728 -176.09 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 99.72 -23.99 33.94 Favored Glycine 0 CA--C 1.534 1.252 0 CA-C-N 115.624 -0.716 . . . . 0.0 112.448 -176.633 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 28.8 mtpp -97.91 155.17 17.2 Favored 'General case' 0 C--O 1.233 0.209 0 CA-C-N 117.344 0.572 . . . . 0.0 111.005 179.983 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 30' ' ' THR . . . . . . . . . . . . . 33.8 m -105.53 138.03 42.39 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.143 -0.481 . . . . 0.0 110.118 176.848 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 35.2 m -129.95 149.48 33.65 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.271 0 CA-C-O 121.018 0.437 . . . . 0.0 110.933 -179.27 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 32' ' ' ARG . . . . . . . . . . . . . 29.5 ttm105 -130.05 148.01 51.86 Favored 'General case' 0 C--N 1.331 -0.239 0 CA-C-N 115.905 -0.589 . . . . 0.0 110.233 178.9 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 33' ' ' THR . . . . . . . . . . . . . 25.4 m -52.24 138.07 27.08 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.397 -0.365 . . . . 0.0 111.496 -177.58 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 100.28 -17.1 57.41 Favored Glycine 0 CA--C 1.533 1.161 0 CA-C-O 119.649 -0.528 . . . . 0.0 113.288 178.862 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 72.6 m-20 -65.85 149.85 49.52 Favored 'General case' 0 C--O 1.231 0.128 0 CA-C-N 118.053 0.927 . . . . 0.0 111.199 -179.965 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 45.6 t -119.8 129.3 75.57 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.275 0 CA-C-N 115.904 -0.589 . . . . 0.0 109.701 177.548 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 37' ' ' ILE . . . . . . . . . . . . . 63.8 mt -120.0 137.24 54.49 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.266 0 CA-C-N 116.162 -0.472 . . . . 0.0 109.797 -179.647 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . -116.45 128.86 8.14 Favored Glycine 0 CA--C 1.525 0.672 0 N-CA-C 110.848 -0.901 . . . . 0.0 110.848 179.948 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 39' ' ' ILE . . . . . . . . . . . . . 68.3 mt -126.66 129.94 71.62 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.169 0 N-CA-C 110.056 -0.349 . . . . 0.0 110.056 179.238 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 40' ' ' SER . . . . . . . . . . . . . 16.8 p -91.31 119.0 30.98 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.1 -0.5 . . . . 0.0 110.4 175.49 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 41' ' ' ILE . . . . . 0.466 HD13 ' HE1' ' A' ' 18' ' ' PHE . 70.2 mt -127.26 113.74 33.5 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.197 0 N-CA-C 110.113 -0.329 . . . . 0.0 110.113 -179.546 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 7.8 mp 56.62 39.25 29.89 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-O 121.247 0.546 . . . . 0.0 110.913 179.184 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . 79.38 -10.23 37.33 Favored Glycine 0 CA--C 1.533 1.172 0 C-N-CA 121.252 -0.499 . . . . 0.0 113.653 175.952 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 44' ' ' LYS . . . . . . . . . . . . . 78.7 tttt -98.27 126.49 43.78 Favored 'General case' 0 C--N 1.333 -0.11 0 CA-C-N 117.913 0.856 . . . . 0.0 110.094 177.882 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 77.3 tt0 -84.9 127.45 34.16 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.372 -0.376 . . . . 0.0 111.081 -179.427 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 46' ' ' VAL . . . . . . . . . . . . . 10.9 p -123.07 125.18 71.73 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.187 0 N-CA-C 110.085 -0.339 . . . . 0.0 110.085 175.874 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 99.1 mttt -99.34 127.88 45.41 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.057 -0.52 . . . . 0.0 111.024 177.248 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 48' ' ' PHE . . . . . . . . . . . . . 34.2 m-85 -112.49 131.91 55.34 Favored 'General case' 0 C--N 1.33 -0.279 0 N-CA-C 109.605 -0.517 . . . . 0.0 109.605 176.913 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 85.9 tttt -105.07 134.36 48.29 Favored 'General case' 0 C--N 1.328 -0.363 0 N-CA-C 110.084 -0.339 . . . . 0.0 110.084 177.562 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 50' ' ' VAL . . . . . . . . . . . . . 43.2 t -77.84 105.09 6.41 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.371 0 N-CA-C 109.491 -0.559 . . . . 0.0 109.491 177.908 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 51' ' ' VAL . . . . . . . . . . . . . 46.9 t -72.88 -47.99 46.81 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.335 0 CA-C-N 116.018 -0.537 . . . . 0.0 110.075 -174.145 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 52' ' ' GLN . . . . . . . . . . . . . 44.4 tt0 -158.44 135.53 9.91 Favored 'General case' 0 C--N 1.33 -0.27 0 C-N-CA 120.274 -0.571 . . . . 0.0 111.796 -177.954 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 53' ' ' ALA . . . . . 0.613 ' HB3' ' OG ' ' A' ' 56' ' ' SER . . . -110.23 129.44 55.72 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 115.839 -0.619 . . . . 0.0 109.649 175.032 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 54' ' ' TYR . . . . . . . . . . . . . 60.2 t80 -129.03 106.64 18.02 Favored Pre-proline 0 CA--C 1.535 0.378 0 CA-C-O 118.373 -0.823 . . . . 0.0 110.546 -178.437 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 55' ' ' PRO . . . . . . . . . . . . . 73.0 Cg_endo -77.13 168.94 75.59 Favored 'Cis proline' 0 N--CA 1.499 1.81 0 CA-C-N 121.67 1.632 . . . . 0.0 112.458 -5.766 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 56' ' ' SER . . . . . 0.613 ' OG ' ' HB3' ' A' ' 53' ' ' ALA . 74.3 m -118.01 134.42 23.31 Favored Pre-proline 0 CA--C 1.539 0.556 0 CA-C-O 118.486 -0.769 . . . . 0.0 109.473 174.494 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 57' ' ' PRO . . . . . . . . . . . . . 51.7 Cg_endo -70.78 146.98 85.78 Favored 'Cis proline' 0 N--CA 1.497 1.699 0 CA-C-N 121.88 1.707 . . . . 0.0 111.347 -1.911 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 58' ' ' LEU . . . . . . . . . . . . . 20.6 tp -108.0 136.3 47.93 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 116.39 -0.368 . . . . 0.0 110.86 -177.944 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 59' ' ' ARG . . . . . . . . . . . . . 55.8 ttp180 -104.31 117.94 35.42 Favored 'General case' 0 C--N 1.327 -0.389 0 N-CA-C 109.052 -0.721 . . . . 0.0 109.052 174.018 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 42.4 t -71.55 122.13 23.08 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.353 0 CA-C-N 116.353 -0.385 . . . . 0.0 110.698 -173.114 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 95.4 mt-10 -131.07 165.32 23.51 Favored 'General case' 0 C--N 1.331 -0.225 0 CA-C-N 115.795 -0.639 . . . . 0.0 110.033 177.28 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 62' ' ' ASP . . . . . . . . . . . . . 14.9 m-20 -55.19 -32.68 62.39 Favored 'General case' 0 C--N 1.329 -0.315 0 N-CA-C 111.758 0.281 . . . . 0.0 111.758 -179.252 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 63' ' ' ARG . . . . . . . . . . . . . 17.6 ptm180 -81.35 6.56 13.99 Favored 'General case' 0 CA--C 1.535 0.399 0 N-CA-C 113.524 0.935 . . . . 0.0 113.524 -176.512 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 34.4 m -91.41 136.16 33.31 Favored 'General case' 0 C--O 1.232 0.147 0 CA-C-N 118.26 0.482 . . . . 0.0 110.751 -179.754 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 65' ' ' LYS . . . . . . . . . . . . . 68.7 mttm -89.51 135.42 33.61 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.005 -0.543 . . . . 0.0 110.319 179.473 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 66' ' ' ILE . . . . . 0.475 HD12 ' N ' ' A' ' 66' ' ' ILE . 4.3 mp -116.45 127.42 74.06 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.282 0 N-CA-C 109.552 -0.536 . . . . 0.0 109.552 178.76 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 67' ' ' THR . . . . . . . . . . . . . 25.0 m -131.38 148.66 52.68 Favored 'General case' 0 N--CA 1.464 0.237 0 CA-C-O 121.137 0.494 . . . . 0.0 111.944 -175.376 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 68' ' ' LEU . . . . . 0.425 ' N ' HD12 ' A' ' 68' ' ' LEU . 8.5 mp . . . . . 0 C--N 1.331 -0.219 0 CA-C-N 115.629 -0.714 . . . . 0.0 109.909 175.356 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 74' ' ' ASP . . . . . . . . . . . . . 13.3 t70 . . . . . 0 N--CA 1.458 -0.07 0 N-CA-C 110.432 -0.21 . . . . 0.0 110.432 . . . . . . . . . 0 0 . 1 . 016 nuclear nobuild core ' A' A ' 75' ' ' VAL . . . . . 0.417 ' C ' HD12 ' A' ' 76' ' ' LEU . 41.4 t -124.91 124.11 67.08 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.206 0 CA-C-O 121.141 0.496 . . . . 0.0 110.691 -176.481 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 76' ' ' LEU . . . . . 0.417 HD12 ' C ' ' A' ' 75' ' ' VAL . 6.4 mp -122.1 150.14 42.58 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 115.586 -0.734 . . . . 0.0 109.22 173.841 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 77' ' ' GLU . . . . . . . . . . . . . 97.0 mt-10 -137.86 137.07 37.74 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-O 121.126 0.489 . . . . 0.0 111.237 -178.073 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 78' ' ' ALA . . . . . 0.485 ' HB2' HD21 ' A' ' 109' ' ' LEU . . . -125.06 129.61 50.6 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 115.708 -0.678 . . . . 0.0 109.532 175.803 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 79' ' ' LYS . . . . . 0.695 ' O ' HD13 ' A' ' 80' ' ' ILE . 39.2 ttpt -73.69 120.15 18.89 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-O 120.795 0.331 . . . . 0.0 110.575 -177.848 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 80' ' ' ILE . . . . . 0.695 HD13 ' O ' ' A' ' 79' ' ' LYS . 25.9 mm -139.34 98.48 1.15 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.326 0 N-CA-C 109.268 -0.642 . . . . 0.0 109.268 -178.238 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 81' ' ' LYS . . . . . . . . . . . . . 56.2 mtmt -95.75 127.22 41.59 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-O 120.982 0.42 . . . . 0.0 110.97 -177.896 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . 89.18 42.08 5.67 Favored Glycine 0 CA--C 1.525 0.675 0 N-CA-C 111.566 -0.614 . . . . 0.0 111.566 176.43 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 83' ' ' ILE . . . . . . . . . . . . . 69.0 mt -67.26 137.86 23.94 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.289 0 N-CA-C 109.657 -0.497 . . . . 0.0 109.657 176.871 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 84' ' ' LYS . . . . . . . . . . . . . 54.5 tttp -95.46 -49.91 5.22 Favored 'General case' 0 C--N 1.327 -0.395 0 CA-C-N 116.15 -0.477 . . . . 0.0 109.868 -179.031 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 85' ' ' ASP . . . . . . . . . . . . . 10.4 t70 -159.16 149.95 19.77 Favored 'General case' 0 C--N 1.327 -0.401 0 CA-C-N 115.589 -0.732 . . . . 0.0 110.239 178.605 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 86' ' ' VAL . . . . . . . . . . . . . 42.1 t -130.12 131.32 65.94 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.275 0 CA-C-O 120.898 0.38 . . . . 0.0 110.237 179.241 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 87' ' ' ILE . . . . . 0.49 HD12 ' N ' ' A' ' 87' ' ' ILE . 5.1 mp -119.07 129.01 75.77 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.281 0 CA-C-N 115.89 -0.596 . . . . 0.0 109.395 178.383 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 88' ' ' LEU . . . . . . . . . . . . . 13.3 tp -118.58 133.24 56.01 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-O 121.069 0.461 . . . . 0.0 111.302 -176.078 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 89' ' ' ASP . . . . . . . . . . . . . 12.8 t70 -130.92 159.03 38.63 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 115.637 -0.71 . . . . 0.0 109.38 175.109 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 95.8 mt-10 -47.41 -37.69 11.92 Favored 'General case' 0 C--N 1.33 -0.241 0 N-CA-C 113.029 0.751 . . . . 0.0 113.029 -172.362 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 91' ' ' ASN . . . . . . . . . . . . . 69.7 m-80 -132.11 36.38 3.65 Favored 'General case' 0 N--CA 1.464 0.235 0 N-CA-C 111.877 0.325 . . . . 0.0 111.877 -175.443 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 92' ' ' LEU . . . . . . . . . . . . . 19.3 tp -166.07 139.68 4.26 Favored 'General case' 0 C--N 1.332 -0.181 0 C-N-CA 120.836 -0.346 . . . . 0.0 110.99 -179.288 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 93' ' ' ILE . . . . . . . . . . . . . 68.9 mt -126.27 118.03 50.22 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.164 0 N-CA-C 109.089 -0.708 . . . . 0.0 109.089 177.625 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 94' ' ' VAL . . . . . . . . . . . . . 42.9 t -120.25 127.0 75.87 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.289 0 N-CA-C 109.903 -0.406 . . . . 0.0 109.903 -179.004 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 95' ' ' VAL . . . . . . . . . . . . . 42.7 t -120.89 134.04 65.6 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.311 0 CA-C-N 116.131 -0.486 . . . . 0.0 109.983 -179.435 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 96' ' ' ILE . . . . . . . . . . . . . 57.5 mt -115.42 127.62 72.92 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.324 0 N-CA-C 109.155 -0.683 . . . . 0.0 109.155 178.105 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 97' ' ' THR . . . . . . . . . . . . . 59.4 p -101.95 153.31 19.98 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-O 121.015 0.436 . . . . 0.0 110.955 -177.752 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 98' ' ' GLU . . . . . . . . . . . . . 96.4 mt-10 -53.9 -23.4 12.62 Favored 'General case' 0 CA--C 1.534 0.36 0 N-CA-C 112.297 0.481 . . . . 0.0 112.297 179.426 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 99' ' ' GLU . . . . . . . . . . . . . 95.0 mt-10 -78.79 15.27 1.1 Allowed 'General case' 0 CA--C 1.536 0.419 0 N-CA-C 113.121 0.785 . . . . 0.0 113.121 -177.536 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 100' ' ' ASN . . . . . . . . . . . . . 3.6 m-20 64.01 38.07 8.86 Favored 'General case' 0 N--CA 1.463 0.188 0 CA-C-O 120.972 0.415 . . . . 0.0 110.965 177.435 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 101' ' ' GLU . . . . . . . . . . . . . 83.4 tt0 -119.22 142.82 47.68 Favored 'General case' 0 C--N 1.332 -0.165 0 CA-C-N 116.177 -0.465 . . . . 0.0 109.876 176.551 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 102' ' ' VAL . . . . . . . . . . . . . 45.5 t -115.77 126.46 73.31 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.283 0 CA-C-N 116.117 -0.492 . . . . 0.0 109.759 -178.845 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 103' ' ' LEU . . . . . . . . . . . . . 46.6 mt -120.48 132.41 55.19 Favored 'General case' 0 C--N 1.331 -0.202 0 CA-C-N 115.992 -0.549 . . . . 0.0 110.517 178.313 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 104' ' ' ILE . . . . . . . . . . . . . 67.7 mt -118.95 122.43 69.33 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.256 0 CA-C-N 116.332 -0.395 . . . . 0.0 110.324 -178.48 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 105' ' ' PHE . . . . . . . . . . . . . 85.8 m-85 -123.99 165.06 18.1 Favored 'General case' 0 C--O 1.232 0.17 0 O-C-N 123.895 0.747 . . . . 0.0 109.892 -179.527 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 106' ' ' ASN . . . . . . . . . . . . . 46.8 p-10 -100.63 -171.36 2.0 Favored 'General case' 0 C--N 1.331 -0.21 0 N-CA-C 109.742 -0.466 . . . . 0.0 109.742 172.665 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 107' ' ' GLN . . . . . . . . . . . . . 29.4 tt0 -61.09 -29.85 70.0 Favored 'General case' 0 C--N 1.329 -0.285 0 N-CA-C 111.974 0.361 . . . . 0.0 111.974 -178.642 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 108' ' ' ASN . . . . . . . . . . . . . 3.8 t-20 -83.54 10.69 8.44 Favored 'General case' 0 CA--C 1.537 0.457 0 N-CA-C 113.014 0.746 . . . . 0.0 113.014 -178.303 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 109' ' ' LEU . . . . . 0.485 HD21 ' HB2' ' A' ' 78' ' ' ALA . 7.6 tp 57.72 37.72 27.32 Favored 'General case' 0 CA--C 1.529 0.172 0 CA-C-O 121.206 0.527 . . . . 0.0 111.341 179.277 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 110' ' ' GLU . . . . . . . . . . . . . 70.8 mm-40 -103.93 142.7 33.97 Favored 'General case' 0 C--N 1.33 -0.266 0 N-CA-C 109.33 -0.619 . . . . 0.0 109.33 174.071 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 111' ' ' GLU . . . . . . . . . . . . . 48.6 tt0 -79.14 121.94 25.63 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-N 116.454 -0.339 . . . . 0.0 110.893 -176.062 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 112' ' ' LEU . . . . . . . . . . . . . 44.1 mt -102.93 -46.12 4.76 Favored 'General case' 0 C--N 1.33 -0.239 0 CA-C-N 116.128 -0.487 . . . . 0.0 110.515 179.589 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 113' ' ' TYR . . . . . . . . . . . . . 63.9 t80 -140.59 145.02 36.17 Favored 'General case' 0 C--N 1.332 -0.182 0 CA-C-N 116.397 -0.365 . . . . 0.0 111.061 -179.682 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 114' ' ' ARG . . . . . . . . . . . . . 39.0 ptt180 -144.59 126.7 15.58 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.085 -0.507 . . . . 0.0 110.462 178.807 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 115' ' ' GLY . . . . . . . . . . . . . . . -150.05 150.75 22.85 Favored Glycine 0 CA--C 1.524 0.602 0 C-N-CA 120.682 -0.77 . . . . 0.0 111.192 179.654 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 116' ' ' LYS . . . . . . . . . . . . . 27.5 ttpp -123.45 135.77 54.26 Favored 'General case' 0 C--N 1.33 -0.274 0 N-CA-C 109.687 -0.486 . . . . 0.0 109.687 177.27 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 117' ' ' PHE . . . . . . . . . . . . . 36.2 m-85 -134.07 113.92 12.62 Favored 'General case' 0 C--N 1.33 -0.262 0 N-CA-C 110.037 -0.357 . . . . 0.0 110.037 -177.291 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 118' ' ' GLU . . . . . . . . . . . . . 83.5 tt0 -55.09 -44.72 75.16 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.383 -0.371 . . . . 0.0 111.185 -177.123 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 119' ' ' ASN . . . . . . . . . . . . . 85.2 m-20 -95.48 30.99 2.1 Favored 'General case' 0 C--N 1.33 -0.264 0 N-CA-C 112.214 0.45 . . . . 0.0 112.214 -175.649 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 120' ' ' LEU . . . . . . . . . . . . . 24.8 tp -57.63 122.16 12.08 Favored 'General case' 0 C--N 1.333 -0.132 0 N-CA-C 110.141 -0.318 . . . . 0.0 110.141 176.656 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 121' ' ' ASN . . . . . . . . . . . . . 61.5 m-20 -114.05 -43.99 3.19 Favored 'General case' 0 C--N 1.332 -0.187 0 CA-C-N 116.647 -0.251 . . . . 0.0 110.998 -176.773 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 122' ' ' LYS . . . . . . . . . . . . . 98.1 mttt -145.91 150.87 36.91 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-O 121.061 0.457 . . . . 0.0 111.505 -177.596 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 123' ' ' VAL . . . . . . . . . . . . . 43.5 t -128.75 131.16 68.72 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.253 0 CA-C-N 115.955 -0.566 . . . . 0.0 109.695 176.516 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 124' ' ' LEU . . . . . . . . . . . . . 34.0 mt -121.76 128.75 52.1 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.277 -0.419 . . . . 0.0 110.16 -179.547 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 125' ' ' VAL . . . . . 0.459 ' CG2' HG21 ' A' ' 87' ' ' ILE . 35.6 m -140.07 141.45 33.71 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 CA-C-O 120.862 0.363 . . . . 0.0 110.81 179.688 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 126' ' ' ARG . . . . . . . . . . . . . 51.0 ttp180 -161.29 129.66 4.4 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.07 -0.514 . . . . 0.0 110.622 177.502 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 127' ' ' ASN . . . . . . . . . . . . . 6.1 m120 52.77 -111.24 0.58 Allowed 'General case' 0 CA--C 1.544 0.741 0 CA-C-O 118.871 -0.585 . . . . 0.0 111.024 179.347 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 128' ' ' ASP . . . . . . . . . . . . . 11.9 p-10 -114.04 12.21 17.89 Favored 'General case' 0 N--CA 1.466 0.337 0 CA-C-N 119.892 1.224 . . . . 0.0 113.244 -177.747 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 129' ' ' LEU . . . . . . . . . . . . . 30.5 mt -107.7 134.11 51.15 Favored 'General case' 0 C--N 1.333 -0.147 0 O-C-N 121.968 -0.457 . . . . 0.0 110.136 178.013 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 130' ' ' VAL . . . . . . . . . . . . . 45.5 t -125.08 131.02 73.03 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.229 0 N-CA-C 109.58 -0.526 . . . . 0.0 109.58 178.759 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 131' ' ' VAL . . . . . 0.523 HG22 HD12 ' A' ' 140' ' ' LEU . 42.2 t -135.61 133.81 51.75 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.307 0 CA-C-O 120.999 0.428 . . . . 0.0 110.192 178.514 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 132' ' ' ILE . . . . . . . . . . . . . 74.6 mt -114.48 130.63 68.47 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.378 0 CA-C-N 115.81 -0.632 . . . . 0.0 109.308 179.44 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 133' ' ' ILE . . . . . . . . . . . . . 42.9 mm -114.56 119.24 60.96 Favored 'Isoleucine or valine' 0 C--O 1.234 0.263 0 CA-C-O 120.874 0.368 . . . . 0.0 110.748 -175.353 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 134' ' ' ASP . . . . . . . . . . . . . 9.6 p-10 -133.94 147.95 51.12 Favored 'General case' 0 C--N 1.331 -0.225 0 N-CA-C 109.678 -0.489 . . . . 0.0 109.678 176.282 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 135' ' ' GLU . . . . . . . . . . . . . 78.8 tt0 -49.9 -27.84 5.81 Favored 'General case' 0 C--N 1.328 -0.368 0 N-CA-C 112.833 0.679 . . . . 0.0 112.833 -173.698 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 136' ' ' GLN . . . . . . . . . . . . . 48.2 tt0 -79.05 -37.39 39.11 Favored 'General case' 0 C--O 1.233 0.229 0 N-CA-C 111.973 0.361 . . . . 0.0 111.973 -176.064 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 137' ' ' LYS . . . . . . . . . . . . . 51.8 pttt -166.32 175.46 8.22 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-O 121.689 0.756 . . . . 0.0 112.197 -171.129 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 138' ' ' LEU . . . . . 0.41 HD23 ' N ' ' A' ' 139' ' ' THR . 4.8 tt -119.46 128.45 54.02 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 114.877 -1.056 . . . . 0.0 109.757 178.7 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 139' ' ' THR . . . . . 0.41 ' N ' HD23 ' A' ' 138' ' ' LEU . 19.5 m -109.12 124.08 50.23 Favored 'General case' 0 C--N 1.331 -0.205 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.598 -179.496 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 140' ' ' LEU . . . . . 0.523 HD12 HG22 ' A' ' 131' ' ' VAL . 48.0 tp -112.09 120.43 41.82 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 115.982 -0.554 . . . . 0.0 109.574 -179.166 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 141' ' ' ILE . . . . . . . . . . . . . 19.1 mt -122.95 120.65 61.18 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.278 0 CA-C-O 120.993 0.425 . . . . 0.0 110.088 -176.198 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 142' ' ' ARG . . . . . . . . . . . . . 22.3 mtp-105 -97.59 121.23 39.25 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 115.463 -0.79 . . . . 0.0 109.976 176.49 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 143' ' ' THR . . . . . . . . . . . . . 48.2 p . . . . . 0 C--O 1.22 -0.459 0 CA-C-O 118.051 -0.976 . . . . 0.0 110.423 179.339 . . . . . . . . 0 0 . 1 . 016 nuclear nobuild core ' B' B ' 2' ' ' SER . . . . . . . . . . . . . 2.3 p . . . . . 0 C--O 1.23 0.066 0 N-CA-C 110.017 -0.364 . . . . 0.0 110.017 . . . . . . . . . 0 0 . 1 . 016 nuclear nobuild core ' B' B ' 3' ' ' GLU . . . . . . . . . . . . . 81.3 tt0 -140.94 142.46 34.36 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-N 116.172 -0.467 . . . . 0.0 111.158 -176.266 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' B' B ' 4' ' ' LEU . . . . . . . . . . . . . 11.4 tp -123.6 130.95 53.43 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 115.946 -0.57 . . . . 0.0 109.744 176.298 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' B' B ' 5' ' ' LYS . . . . . . . . . . . . . 91.5 mttt -110.87 121.43 45.33 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 116.31 -0.405 . . . . 0.0 110.729 -178.307 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' B' B ' 6' ' ' LEU . . . . . . . . . . . . . 55.9 mt -116.54 151.27 36.51 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 115.569 -0.741 . . . . 0.0 110.653 -178.856 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' B' B ' 7' ' ' LYS . . . . . . . . . . . . . 59.1 tttt -139.04 135.42 17.46 Favored Pre-proline 0 CA--C 1.535 0.396 0 CA-C-O 118.966 -0.54 . . . . 0.0 110.152 175.936 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' B' B ' 8' ' ' PRO . . . . . . . . . . . . . 94.7 Cg_endo -92.04 144.79 2.89 Favored 'Trans proline' 0 N--CA 1.49 1.274 0 C-N-CA 121.814 1.676 . . . . 0.0 111.632 177.359 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' B' B ' 9' ' ' LEU . . . . . . . . . . . . . 47.3 mt -86.54 -47.91 0.52 Allowed Pre-proline 0 CA--C 1.534 0.345 0 CA-C-O 118.701 -0.666 . . . . 0.0 112.646 -177.981 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' B' B ' 10' ' ' PRO . . . . . . . . . . . . . 97.3 Cg_endo -81.91 160.77 18.54 Favored 'Trans proline' 0 N--CA 1.495 1.616 0 C-N-CA 121.421 1.414 . . . . 0.0 112.063 177.802 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' B' B ' 11' ' ' LYS . . . . . . . . . . . . . 52.5 pttt -85.67 121.67 28.67 Favored 'General case' 0 C--N 1.331 -0.196 0 CA-C-O 120.953 0.406 . . . . 0.0 110.377 178.145 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' B' B ' 12' ' ' VAL . . . . . . . . . . . . . 12.5 p -151.09 144.81 16.7 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.251 0 CA-C-N 116.226 -0.443 . . . . 0.0 110.705 -179.971 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' B' B ' 13' ' ' GLU . . . . . . . . . . . . . 81.4 tt0 -91.88 108.98 20.32 Favored 'General case' 0 C--N 1.329 -0.325 0 N-CA-C 109.718 -0.475 . . . . 0.0 109.718 176.263 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' B' B ' 14' ' ' LEU . . . . . . . . . . . . . 81.2 mt -84.44 143.41 41.56 Favored Pre-proline 0 CA--C 1.534 0.343 0 CA-C-O 119.168 -0.444 . . . . 0.0 110.666 -175.923 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' B' B ' 15' ' ' PRO . . . . . . . . . . . . . 24.8 Cg_exo -63.06 163.33 22.97 Favored 'Trans proline' 0 N--CA 1.497 1.703 0 C-N-CA 121.301 1.334 . . . . 0.0 111.879 175.608 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' B' B ' 16' ' ' PRO . . . . . . . . . . . . . 29.6 Cg_exo -60.17 -39.17 71.28 Favored 'Trans proline' 0 N--CA 1.496 1.671 0 C-N-CA 121.478 1.452 . . . . 0.0 112.846 -178.105 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' B' B ' 17' ' ' ASP . . . . . . . . . . . . . 20.1 p-10 -90.74 12.5 18.96 Favored 'General case' 0 CA--C 1.536 0.423 0 N-CA-C 113.161 0.8 . . . . 0.0 113.161 -176.814 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' B' B ' 18' ' ' PHE . . . . . . . . . . . . . 33.9 t80 -56.21 -46.0 79.66 Favored 'General case' 0 C--N 1.334 -0.104 0 O-C-N 121.937 -0.477 . . . . 0.0 110.671 -178.364 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' B' B ' 19' ' ' VAL . . . . . . . . . . . . . 46.6 t -55.48 -43.54 72.64 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.277 0 CA-C-N 116.61 -0.268 . . . . 0.0 110.858 -177.931 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' B' B ' 20' ' ' ASP . . . . . . . . . . . . . 50.7 m-20 -60.01 -43.79 94.99 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-O 120.988 0.423 . . . . 0.0 111.017 -177.682 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' B' B ' 21' ' ' VAL . . . . . . . . . . . . . 45.1 t -64.38 -46.6 92.54 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.259 0 CA-C-N 116.401 -0.363 . . . . 0.0 110.573 -177.554 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' B' B ' 22' ' ' ILE . . . . . 0.45 HG22 HD12 ' B' ' 26' ' ' LEU . 50.7 mm -56.27 -44.5 79.7 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.206 0 C-N-CA 120.926 -0.31 . . . . 0.0 110.564 178.678 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' B' B ' 23' ' ' ARG . . . . . . . . . . . . . 55.7 ttp180 -53.36 -48.08 68.85 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-O 120.722 0.296 . . . . 0.0 111.396 -179.76 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' B' B ' 24' ' ' ILE . . . . . . . . . . . . . 71.4 mt -58.97 -44.53 91.27 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.251 0 CA-C-N 116.496 -0.32 . . . . 0.0 110.938 -179.228 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' B' B ' 25' ' ' LYS . . . . . . . . . . . . . 53.0 mttm -65.59 -35.27 80.33 Favored 'General case' 0 C--N 1.327 -0.404 0 N-CA-C 112.3 0.482 . . . . 0.0 112.3 -178.051 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' B' B ' 26' ' ' LEU . . . . . 0.45 HD12 HG22 ' B' ' 22' ' ' ILE . 56.1 mt -80.01 -46.02 17.36 Favored 'General case' 0 C--N 1.329 -0.31 0 N-CA-C 112.943 0.72 . . . . 0.0 112.943 -172.896 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' B' B ' 27' ' ' GLN . . . . . . . . . . . . . 11.2 pt20 -46.56 138.74 5.63 Favored 'General case' 0 N--CA 1.468 0.464 0 N-CA-C 112.677 0.621 . . . . 0.0 112.677 -174.909 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' B' B ' 28' ' ' GLY . . . . . . . . . . . . . . . 100.09 -24.92 30.24 Favored Glycine 0 CA--C 1.533 1.195 0 CA-C-N 115.599 -0.728 . . . . 0.0 112.412 -177.869 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' B' B ' 29' ' ' LYS . . . . . . . . . . . . . 67.9 mttm -97.72 155.08 17.18 Favored 'General case' 0 C--N 1.331 -0.198 0 CA-C-N 117.402 0.601 . . . . 0.0 111.145 179.656 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' B' B ' 30' ' ' THR . . . . . . . . . . . . . 28.9 m -106.04 133.34 50.9 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 115.861 -0.609 . . . . 0.0 109.778 175.008 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' B' B ' 31' ' ' VAL . . . . . . . . . . . . . 35.2 m -128.63 156.1 40.86 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.214 0 CA-C-N 116.437 -0.347 . . . . 0.0 110.693 -178.619 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' B' B ' 32' ' ' ARG . . . . . . . . . . . . . 72.2 ttt180 -132.73 148.03 52.33 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.036 -0.529 . . . . 0.0 110.351 178.929 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' B' B ' 33' ' ' THR . . . . . . . . . . . . . 19.6 m -52.64 138.09 29.27 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-O 120.858 0.361 . . . . 0.0 111.396 -178.25 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' B' B ' 34' ' ' GLY . . . . . . . . . . . . . . . 102.13 -17.24 54.51 Favored Glycine 0 CA--C 1.534 1.23 0 CA-C-N 116.074 -0.512 . . . . 0.0 113.235 179.286 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' B' B ' 35' ' ' ASP . . . . . . . . . . . . . 78.6 m-20 -66.91 151.17 48.09 Favored 'General case' 0 N--CA 1.462 0.158 0 CA-C-N 117.972 0.886 . . . . 0.0 111.052 178.715 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' B' B ' 36' ' ' VAL . . . . . . . . . . . . . 44.4 t -124.25 132.73 70.91 Favored 'Isoleucine or valine' 0 C--N 1.333 -0.145 0 CA-C-N 115.959 -0.564 . . . . 0.0 109.902 178.234 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' B' B ' 37' ' ' ILE . . . . . . . . . . . . . 68.5 mt -119.66 140.16 44.58 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.189 0 CA-C-N 116.063 -0.517 . . . . 0.0 109.96 -179.258 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' B' B ' 38' ' ' GLY . . . . . . . . . . . . . . . -116.95 128.84 8.07 Favored Glycine 0 CA--C 1.525 0.714 0 N-CA-C 111.043 -0.823 . . . . 0.0 111.043 179.598 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' B' B ' 39' ' ' ILE . . . . . . . . . . . . . 76.9 mt -128.89 139.68 51.26 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.248 0 N-CA-C 110.147 -0.316 . . . . 0.0 110.147 179.245 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' B' B ' 40' ' ' SER . . . . . . . . . . . . . 53.7 p -93.22 126.01 38.12 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.263 -0.426 . . . . 0.0 110.863 175.26 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' B' B ' 41' ' ' ILE . . . . . . . . . . . . . 68.6 mt -134.99 113.94 16.62 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.247 0 CA-C-O 120.826 0.346 . . . . 0.0 110.534 177.702 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' B' B ' 42' ' ' LEU . . . . . 0.516 ' O ' HD23 ' B' ' 42' ' ' LEU . 1.5 tt 56.33 47.84 18.3 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-O 121.52 0.676 . . . . 0.0 110.358 177.604 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' B' B ' 43' ' ' GLY . . . . . . . . . . . . . . . 72.2 -5.49 14.05 Favored Glycine 0 CA--C 1.536 1.351 0 C-N-CA 121.162 -0.542 . . . . 0.0 113.724 175.118 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' B' B ' 44' ' ' LYS . . . . . . . . . . . . . 80.6 tttt -108.85 135.04 50.71 Favored 'General case' 0 C--N 1.332 -0.181 0 CA-C-N 118.049 0.924 . . . . 0.0 110.19 -179.212 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' B' B ' 45' ' ' GLU . . . . . . . . . . . . . 84.1 tt0 -83.73 130.65 34.95 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-N 116.458 -0.337 . . . . 0.0 111.079 -179.075 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' B' B ' 46' ' ' VAL . . . . . . . . . . . . . 7.3 p -124.04 125.06 70.25 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.189 0 CA-C-O 121.002 0.43 . . . . 0.0 109.875 175.616 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' B' B ' 47' ' ' LYS . . . . . . . . . . . . . 91.9 mttt -100.08 131.46 46.02 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 115.951 -0.568 . . . . 0.0 111.031 176.529 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' B' B ' 48' ' ' PHE . . . . . . . . . . . . . 94.6 m-85 -113.08 131.88 55.64 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.057 -0.52 . . . . 0.0 109.644 175.341 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' B' B ' 49' ' ' LYS . . . . . . . . . . . . . 76.1 tttt -107.22 135.46 48.71 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.605 -0.27 . . . . 0.0 110.302 178.094 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' B' B ' 50' ' ' VAL . . . . . . . . . . . . . 43.9 t -81.16 107.48 13.48 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.315 0 N-CA-C 109.219 -0.66 . . . . 0.0 109.219 176.268 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' B' B ' 51' ' ' VAL . . . . . . . . . . . . . 40.4 t -74.88 -49.65 28.29 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.337 0 CA-C-N 115.982 -0.554 . . . . 0.0 110.14 -172.716 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' B' B ' 52' ' ' GLN . . . . . . . . . . . . . 85.8 mt-30 -154.34 152.98 30.87 Favored 'General case' 0 C--N 1.331 -0.199 0 C-N-CA 120.449 -0.5 . . . . 0.0 111.797 -177.304 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' B' B ' 53' ' ' ALA . . . . . 0.413 ' HB3' ' OG ' ' B' ' 56' ' ' SER . . . -130.35 130.5 44.51 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 115.339 -0.846 . . . . 0.0 109.643 175.016 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' B' B ' 54' ' ' TYR . . . . . . . . . . . . . 19.1 t80 -129.13 105.91 17.95 Favored Pre-proline 0 CA--C 1.534 0.357 0 CA-C-O 118.357 -0.83 . . . . 0.0 110.464 -179.572 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' B' B ' 55' ' ' PRO . . . . . . . . . . . . . 73.8 Cg_endo -77.2 170.06 72.49 Favored 'Cis proline' 0 N--CA 1.5 1.912 0 CA-C-N 121.673 1.633 . . . . 0.0 112.474 -5.98 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' B' B ' 56' ' ' SER . . . . . 0.413 ' OG ' ' HB3' ' B' ' 53' ' ' ALA . 36.0 m -116.42 134.16 22.89 Favored Pre-proline 0 CA--C 1.539 0.524 0 CA-C-O 118.461 -0.781 . . . . 0.0 109.606 175.17 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' B' B ' 57' ' ' PRO . . . . . . . . . . . . . 36.2 Cg_endo -67.07 166.53 62.35 Favored 'Cis proline' 0 N--CA 1.497 1.732 0 CA-C-N 121.856 1.698 . . . . 0.0 111.349 -3.727 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' B' B ' 58' ' ' LEU . . . . . . . . . . . . . 31.4 tp -130.77 138.04 49.75 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.239 -0.437 . . . . 0.0 110.512 -179.324 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' B' B ' 59' ' ' ARG . . . . . . . . . . . . . 59.8 ttm-85 -105.47 127.34 52.95 Favored 'General case' 0 C--N 1.327 -0.37 0 N-CA-C 109.148 -0.686 . . . . 0.0 109.148 175.0 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' B' B ' 60' ' ' VAL . . . . . . . . . . . . . 40.1 t -81.2 123.99 38.33 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.338 0 C-N-CA 120.651 -0.42 . . . . 0.0 110.872 -173.788 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' B' B ' 61' ' ' GLU . . . . . . . . . . . . . 95.7 mt-10 -131.0 162.55 29.52 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 115.691 -0.686 . . . . 0.0 109.666 176.251 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' B' B ' 62' ' ' ASP . . . . . . . . . . . . . 78.7 m-20 -54.85 -33.96 62.35 Favored 'General case' 0 C--N 1.328 -0.329 0 C-N-CA 121.015 -0.274 . . . . 0.0 111.646 -178.86 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' B' B ' 63' ' ' ARG . . . . . . . . . . . . . 7.3 mmm180 -76.18 -10.3 59.3 Favored 'General case' 0 CA--C 1.537 0.446 0 N-CA-C 113.186 0.81 . . . . 0.0 113.186 -176.74 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' B' B ' 64' ' ' THR . . . . . . . . . . . . . 30.0 m -72.27 145.32 47.98 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-O 121.004 0.43 . . . . 0.0 111.246 -175.915 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' B' B ' 65' ' ' LYS . . . . . . . . . . . . . 23.9 mtpp -89.58 127.52 35.9 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 115.878 -0.601 . . . . 0.0 110.265 178.491 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' B' B ' 66' ' ' ILE . . . . . . . . . . . . . 55.7 mt -114.77 129.93 70.07 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.245 0 N-CA-C 109.779 -0.452 . . . . 0.0 109.779 179.59 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' B' B ' 67' ' ' THR . . . . . . . . . . . . . 25.9 m -127.76 143.63 51.12 Favored 'General case' 0 C--N 1.332 -0.176 0 CA-C-O 121.171 0.51 . . . . 0.0 111.586 -176.842 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' B' B ' 68' ' ' LEU . . . . . . . . . . . . . 16.0 tp . . . . . 0 C--N 1.33 -0.255 0 CA-C-N 115.59 -0.732 . . . . 0.0 109.622 175.666 . . . . . . . . 0 0 . 1 . 016 nuclear nobuild core ' B' B ' 73' ' ' VAL . . . . . . . . . . . . . 35.4 m . . . . . 0 C--O 1.232 0.146 0 CA-C-O 120.854 0.359 . . . . 0.0 110.697 . . . . . . . . . 0 0 . 1 . 016 nuclear nobuild core ' B' B ' 74' ' ' ASP . . . . . . . . . . . . . 18.6 t0 -104.09 115.43 30.42 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.001 -0.545 . . . . 0.0 109.893 179.245 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' B' B ' 75' ' ' VAL . . . . . . . . . . . . . 40.8 t -116.69 123.58 71.82 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.291 0 CA-C-O 121.086 0.47 . . . . 0.0 110.738 -176.271 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' B' B ' 76' ' ' LEU . . . . . . . . . . . . . 4.9 mp -125.19 146.63 49.42 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 115.635 -0.712 . . . . 0.0 109.516 176.273 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' B' B ' 77' ' ' GLU . . . . . . . . . . . . . 46.4 mt-10 -134.22 141.11 46.91 Favored 'General case' 0 C--N 1.331 -0.227 0 CA-C-O 120.944 0.402 . . . . 0.0 111.119 -178.513 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' B' B ' 78' ' ' ALA . . . . . 0.788 ' HB2' HD21 ' B' ' 109' ' ' LEU . . . -129.81 135.34 48.3 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 115.879 -0.601 . . . . 0.0 109.925 176.289 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' B' B ' 79' ' ' LYS . . . . . 0.553 ' O ' HD13 ' B' ' 80' ' ' ILE . 43.3 pttt -80.36 121.59 25.88 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-O 121.123 0.487 . . . . 0.0 111.18 -176.951 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' B' B ' 80' ' ' ILE . . . . . 0.553 HD13 ' O ' ' B' ' 79' ' ' LYS . 23.7 mm -139.45 112.26 5.87 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.327 0 N-CA-C 109.119 -0.697 . . . . 0.0 109.119 -179.018 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' B' B ' 81' ' ' LYS . . . . . . . . . . . . . 36.2 ttpt -100.45 123.08 44.2 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-O 120.911 0.386 . . . . 0.0 111.148 -178.363 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' B' B ' 82' ' ' GLY . . . . . . . . . . . . . . . 89.17 42.07 5.68 Favored Glycine 0 CA--C 1.527 0.792 0 C-N-CA 120.859 -0.686 . . . . 0.0 112.225 173.732 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' B' B ' 83' ' ' ILE . . . . . . . . . . . . . 69.2 mt -67.46 136.1 27.26 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.321 0 N-CA-C 109.689 -0.486 . . . . 0.0 109.689 175.993 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' B' B ' 84' ' ' LYS . . . . . . . . . . . . . 38.6 ttpt -104.48 -48.21 3.88 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-O 120.873 0.368 . . . . 0.0 110.584 -178.266 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' B' B ' 85' ' ' ASP . . . . . . . . . . . . . 13.8 t70 -143.37 146.64 33.68 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.06 -0.518 . . . . 0.0 110.631 -178.594 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' B' B ' 86' ' ' VAL . . . . . . . . . . . . . 44.7 t -131.08 132.69 63.42 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.268 0 CA-C-O 120.863 0.363 . . . . 0.0 110.389 -179.285 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' B' B ' 87' ' ' ILE . . . . . 0.496 ' N ' HD12 ' B' ' 87' ' ' ILE . 5.2 mp -123.97 128.09 73.95 Favored 'Isoleucine or valine' 0 C--O 1.233 0.187 0 CA-C-N 115.945 -0.571 . . . . 0.0 109.762 177.527 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' B' B ' 88' ' ' LEU . . . . . . . . . . . . . 18.8 tp -113.62 133.14 55.46 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.284 -0.416 . . . . 0.0 110.953 -177.901 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' B' B ' 89' ' ' ASP . . . . . . . . . . . . . 6.4 t0 -132.33 160.5 36.1 Favored 'General case' 0 C--N 1.331 -0.199 0 CA-C-N 116.171 -0.468 . . . . 0.0 109.848 177.955 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' B' B ' 90' ' ' GLU . . . . . . . . . . . . . 95.7 mt-10 -44.95 -47.29 11.38 Favored 'General case' 0 N--CA 1.465 0.28 0 N-CA-C 113.328 0.862 . . . . 0.0 113.328 -171.785 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' B' B ' 91' ' ' ASN . . . . . . . . . . . . . 77.7 m-20 -124.26 21.48 8.76 Favored 'General case' 0 N--CA 1.468 0.428 0 N-CA-C 112.809 0.67 . . . . 0.0 112.809 -176.237 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' B' B ' 92' ' ' LEU . . . . . . . . . . . . . 26.6 mt -148.23 145.96 28.46 Favored 'General case' 0 C--N 1.331 -0.208 0 CA-C-O 120.757 0.313 . . . . 0.0 110.872 -174.861 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' B' B ' 93' ' ' ILE . . . . . . . . . . . . . 71.7 mt -125.58 115.93 44.86 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.319 0 N-CA-C 108.898 -0.779 . . . . 0.0 108.898 176.683 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' B' B ' 94' ' ' VAL . . . . . . . . . . . . . 43.6 t -116.45 127.06 74.16 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.322 0 N-CA-C 109.95 -0.389 . . . . 0.0 109.95 -177.283 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' B' B ' 95' ' ' VAL . . . . . . . . . . . . . 43.7 t -122.56 134.4 65.86 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.265 0 CA-C-N 116.099 -0.5 . . . . 0.0 109.91 -179.318 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' B' B ' 96' ' ' ILE . . . . . . . . . . . . . 68.8 mt -118.07 126.75 75.15 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.287 0 N-CA-C 109.349 -0.611 . . . . 0.0 109.349 178.981 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' B' B ' 97' ' ' THR . . . . . . . . . . . . . 69.6 p -99.39 157.08 16.66 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-O 121.274 0.559 . . . . 0.0 111.495 -176.029 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' B' B ' 98' ' ' GLU . . . . . . . . . . . . . 12.1 pt-20 -53.82 -25.23 18.45 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 115.966 -0.561 . . . . 0.0 112.489 -179.275 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' B' B ' 99' ' ' GLU . . . . . . . . . . . . . 95.6 mt-10 -81.97 17.85 1.47 Allowed 'General case' 0 CA--C 1.535 0.366 0 N-CA-C 113.021 0.748 . . . . 0.0 113.021 -177.529 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' B' B ' 100' ' ' ASN . . . . . . . . . . . . . 3.2 m-20 61.75 37.96 15.34 Favored 'General case' 0 C--O 1.232 0.175 0 CA-C-O 120.955 0.407 . . . . 0.0 110.98 177.86 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' B' B ' 101' ' ' GLU . . . . . . . . . . . . . 83.9 tt0 -115.2 142.97 45.94 Favored 'General case' 0 C--N 1.331 -0.208 0 N-CA-C 109.709 -0.478 . . . . 0.0 109.709 176.35 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' B' B ' 102' ' ' VAL . . . . . . . . . . . . . 44.4 t -116.04 127.06 73.75 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.34 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.037 -177.247 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' B' B ' 103' ' ' LEU . . . . . . . . . . . . . 45.3 mt -120.44 131.12 54.63 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 115.828 -0.624 . . . . 0.0 110.243 177.081 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' B' B ' 104' ' ' ILE . . . . . 0.663 HD13 HG21 ' B' ' 130' ' ' VAL . 67.5 mt -119.68 121.47 66.3 Favored 'Isoleucine or valine' 0 C--O 1.234 0.285 0 CA-C-N 116.471 -0.331 . . . . 0.0 110.182 -178.791 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' B' B ' 105' ' ' PHE . . . . . . . . . . . . . 51.2 m-85 -123.38 163.95 19.81 Favored 'General case' 0 C--N 1.334 -0.089 0 O-C-N 123.838 0.711 . . . . 0.0 109.769 178.7 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' B' B ' 106' ' ' ASN . . . . . . . . . . . . . 43.3 p-10 -97.06 -169.95 1.95 Allowed 'General case' 0 C--N 1.331 -0.221 0 N-CA-C 110.096 -0.335 . . . . 0.0 110.096 174.845 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' B' B ' 107' ' ' GLN . . . . . . . . . . . . . 50.7 tt0 -59.55 -30.0 68.31 Favored 'General case' 0 C--N 1.328 -0.327 0 N-CA-C 111.886 0.328 . . . . 0.0 111.886 179.029 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' B' B ' 108' ' ' ASN . . . . . . . . . . . . . 65.9 t30 -82.56 7.09 15.52 Favored 'General case' 0 CA--C 1.536 0.421 0 N-CA-C 113.283 0.846 . . . . 0.0 113.283 -177.864 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' B' B ' 109' ' ' LEU . . . . . 0.788 HD21 ' HB2' ' B' ' 78' ' ' ALA . 11.9 tp 60.21 37.49 20.57 Favored 'General case' 0 C--N 1.331 -0.2 0 CA-C-O 121.112 0.482 . . . . 0.0 111.218 179.464 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' B' B ' 110' ' ' GLU . . . . . . . . . . . . . 70.9 mm-40 -103.61 148.43 26.01 Favored 'General case' 0 C--N 1.33 -0.264 0 N-CA-C 109.639 -0.504 . . . . 0.0 109.639 175.199 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' B' B ' 111' ' ' GLU . . . . . . . . . . . . . 62.6 tt0 -84.97 122.04 28.64 Favored 'General case' 0 C--N 1.327 -0.396 0 CA-C-O 120.893 0.377 . . . . 0.0 110.586 -176.75 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' B' B ' 112' ' ' LEU . . . . . . . . . . . . . 45.5 mt -109.57 -45.99 3.6 Favored 'General case' 0 C--N 1.332 -0.171 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.722 179.963 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' B' B ' 113' ' ' TYR . . . . . . . . . . . . . 55.5 t80 -133.33 139.12 46.68 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.328 -0.396 . . . . 0.0 110.872 -178.861 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' B' B ' 114' ' ' ARG . . . . . . . . . . . . . 34.7 ptt-85 -145.12 121.01 10.63 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.235 -0.438 . . . . 0.0 110.726 179.624 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' B' B ' 115' ' ' GLY . . . . . . . . . . . . . . . -150.24 159.2 28.01 Favored Glycine 0 CA--C 1.524 0.646 0 C-N-CA 120.871 -0.681 . . . . 0.0 111.439 178.88 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' B' B ' 116' ' ' LYS . . . . . . . . . . . . . 38.6 ttpt -125.59 130.71 52.2 Favored 'General case' 0 C--N 1.33 -0.251 0 N-CA-C 109.525 -0.546 . . . . 0.0 109.525 175.524 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' B' B ' 117' ' ' PHE . . . . . . . . . . . . . 44.5 m-85 -132.43 116.31 16.64 Favored 'General case' 0 C--N 1.331 -0.224 0 CA-C-O 120.934 0.397 . . . . 0.0 110.481 -174.535 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' B' B ' 118' ' ' GLU . . . . . . . . . . . . . 95.8 mt-10 -53.46 -45.03 69.37 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.374 -0.376 . . . . 0.0 111.503 -177.228 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' B' B ' 119' ' ' ASN . . . . . . . . . . . . . 4.6 m120 -97.12 29.72 3.03 Favored 'General case' 0 C--N 1.33 -0.249 0 N-CA-C 112.403 0.52 . . . . 0.0 112.403 -173.958 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' B' B ' 120' ' ' LEU . . . . . . . . . . . . . 17.8 tp -59.07 119.89 8.13 Favored 'General case' 0 C--N 1.331 -0.205 0 N-CA-C 110.067 -0.346 . . . . 0.0 110.067 177.647 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' B' B ' 121' ' ' ASN . . . . . . . . . . . . . 72.8 m-20 -114.07 -44.03 3.18 Favored 'General case' 0 C--N 1.332 -0.167 0 CA-C-N 116.493 -0.321 . . . . 0.0 111.162 -177.521 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' B' B ' 122' ' ' LYS . . . . . . . . . . . . . 97.8 mttt -143.77 151.37 39.9 Favored 'General case' 0 C--N 1.332 -0.162 0 CA-C-O 121.184 0.516 . . . . 0.0 111.748 -176.353 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' B' B ' 123' ' ' VAL . . . . . . . . . . . . . 45.1 t -128.38 126.71 66.19 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.22 0 CA-C-N 115.83 -0.623 . . . . 0.0 109.515 175.225 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' B' B ' 124' ' ' LEU . . . . . 0.425 ' N ' HD12 ' B' ' 124' ' ' LEU . 7.0 mp -114.36 131.61 56.49 Favored 'General case' 0 C--N 1.332 -0.186 0 CA-C-N 116.373 -0.376 . . . . 0.0 110.772 -178.179 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' B' B ' 125' ' ' VAL . . . . . . . . . . . . . 9.2 p -131.94 131.33 61.68 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.215 0 CA-C-N 116.151 -0.477 . . . . 0.0 109.855 178.024 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' B' B ' 126' ' ' ARG . . . . . . . . . . . . . 48.2 ttt180 -151.44 128.77 11.28 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-O 120.951 0.405 . . . . 0.0 110.772 178.74 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' B' B ' 127' ' ' ASN . . . . . . . . . . . . . 6.9 m120 52.1 -112.73 0.69 Allowed 'General case' 0 CA--C 1.545 0.756 0 CA-C-O 118.837 -0.601 . . . . 0.0 111.029 179.242 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' B' B ' 128' ' ' ASP . . . . . . . . . . . . . 10.9 p-10 -114.17 10.16 17.27 Favored 'General case' 0 N--CA 1.468 0.447 0 CA-C-N 119.934 1.243 . . . . 0.0 113.216 -177.288 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' B' B ' 129' ' ' LEU . . . . . . . . . . . . . 77.9 mt -118.43 149.81 40.62 Favored 'General case' 0 C--O 1.233 0.235 0 CA-C-N 118.212 0.46 . . . . 0.0 110.445 -178.605 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' B' B ' 130' ' ' VAL . . . . . 0.663 HG21 HD13 ' B' ' 104' ' ' ILE . 32.9 m -135.43 144.6 33.57 Favored 'Isoleucine or valine' 0 C--O 1.232 0.182 0 CA-C-O 121.326 0.584 . . . . 0.0 111.042 -179.876 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' B' B ' 131' ' ' VAL . . . . . 0.557 HG22 HD12 ' B' ' 140' ' ' LEU . 45.7 t -136.03 137.88 48.11 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.324 0 CA-C-N 115.595 -0.73 . . . . 0.0 109.901 179.013 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' B' B ' 132' ' ' ILE . . . . . . . . . . . . . 71.6 mt -112.32 130.35 66.19 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.337 0 N-CA-C 109.317 -0.623 . . . . 0.0 109.317 179.452 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' B' B ' 133' ' ' ILE . . . . . . . . . . . . . 38.9 mm -114.48 120.09 63.22 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.255 0 CA-C-O 120.752 0.31 . . . . 0.0 111.007 -174.513 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' B' B ' 134' ' ' ASP . . . . . . . . . . . . . 6.9 p-10 -130.93 146.3 52.3 Favored 'General case' 0 C--N 1.332 -0.194 0 N-CA-C 109.465 -0.568 . . . . 0.0 109.465 175.048 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' B' B ' 135' ' ' GLU . . . . . . . . . . . . . 33.6 tt0 -49.95 -27.49 5.41 Favored 'General case' 0 C--N 1.329 -0.323 0 N-CA-C 112.731 0.641 . . . . 0.0 112.731 -173.262 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' B' B ' 136' ' ' GLN . . . . . . . . . . . . . 98.7 mt-30 -79.4 -36.2 39.51 Favored 'General case' 0 C--N 1.331 -0.202 0 N-CA-C 112.175 0.435 . . . . 0.0 112.175 -176.86 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' B' B ' 137' ' ' LYS . . . . . . . . . . . . . 45.6 pttt -169.45 175.39 5.51 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-O 121.448 0.642 . . . . 0.0 112.148 -172.137 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' B' B ' 138' ' ' LEU . . . . . 0.429 ' C ' HD23 ' B' ' 138' ' ' LEU . 7.7 tt -118.18 129.5 55.55 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 115.266 -0.879 . . . . 0.0 110.355 -179.459 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' B' B ' 139' ' ' THR . . . . . . . . . . . . . 32.7 m -107.35 126.45 52.48 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 115.923 -0.58 . . . . 0.0 110.238 178.191 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' B' B ' 140' ' ' LEU . . . . . 0.557 HD12 HG22 ' B' ' 131' ' ' VAL . 12.3 tp -111.63 119.11 37.59 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 115.904 -0.589 . . . . 0.0 109.652 -176.602 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' B' B ' 141' ' ' ILE . . . . . 0.529 ' HB ' HG23 ' B' ' 130' ' ' VAL . 27.2 mt -121.71 121.47 64.47 Favored 'Isoleucine or valine' 0 C--O 1.234 0.245 0 CA-C-O 121.351 0.596 . . . . 0.0 110.525 -173.969 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' B' B ' 142' ' ' ARG . . . . . . . . . . . . . 0.5 OUTLIER -108.25 123.99 49.62 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 114.903 -1.044 . . . . 0.0 110.068 -179.794 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' B' B ' 143' ' ' THR . . . . . . . . . . . . . 40.3 p . . . . . 0 C--O 1.219 -0.516 0 CA-C-O 118.002 -0.999 . . . . 0.0 110.574 179.443 . . . . . . . . 0 0 . 1 . 016 nuclear nobuild core ' C' C ' 2' ' ' SER . . . . . . . . . . . . . 2.9 p . . . . . 0 C--O 1.231 0.094 0 CA-C-O 120.937 0.399 . . . . 0.0 110.691 . . . . . . . . . 0 0 . 1 . 016 nuclear nobuild core ' C' C ' 3' ' ' GLU . . . . . . . . . . . . . 45.0 mt-10 -140.12 143.1 36.05 Favored 'General case' 0 C--N 1.331 -0.227 0 CA-C-N 116.027 -0.533 . . . . 0.0 110.981 -179.656 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' C' C ' 4' ' ' LEU . . . . . 0.595 HD12 HD23 ' C' ' 58' ' ' LEU . 2.4 tt -124.57 124.35 42.05 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 115.65 -0.705 . . . . 0.0 109.535 177.075 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' C' C ' 5' ' ' LYS . . . . . . . . . . . . . 78.6 mttt -103.87 118.77 37.48 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.721 -178.564 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' C' C ' 6' ' ' LEU . . . . . . . . . . . . . 27.3 mt -116.79 147.96 41.61 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 115.566 -0.743 . . . . 0.0 110.317 -179.172 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' C' C ' 7' ' ' LYS . . . . . . . . . . . . . 81.2 tttt -134.87 139.87 33.49 Favored Pre-proline 0 CA--C 1.533 0.308 0 CA-C-O 119.124 -0.465 . . . . 0.0 109.957 175.643 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' C' C ' 8' ' ' PRO . . . . . . . . . . . . . 88.4 Cg_endo -91.34 137.74 2.12 Favored 'Trans proline' 0 N--CA 1.489 1.236 0 C-N-CA 121.722 1.615 . . . . 0.0 111.555 177.813 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' C' C ' 9' ' ' LEU . . . . . . . . . . . . . 68.0 mt -77.73 -47.79 2.3 Favored Pre-proline 0 CA--C 1.535 0.396 0 CA-C-O 118.634 -0.698 . . . . 0.0 112.444 -178.25 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' C' C ' 10' ' ' PRO . . . . . . . . . . . . . 88.9 Cg_endo -80.28 152.84 21.08 Favored 'Trans proline' 0 N--CA 1.497 1.678 0 C-N-CA 121.135 1.223 . . . . 0.0 112.03 177.006 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' C' C ' 11' ' ' LYS . . . . . . . . . . . . . 33.9 mmtp -85.65 97.57 10.19 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.354 -0.384 . . . . 0.0 110.396 177.851 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' C' C ' 12' ' ' VAL . . . . . . . . . . . . . 11.8 p -140.03 145.17 26.76 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.288 0 CA-C-N 116.107 -0.497 . . . . 0.0 110.308 179.778 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' C' C ' 13' ' ' GLU . . . . . . . . . . . . . 70.5 tt0 -84.27 116.16 22.83 Favored 'General case' 0 C--N 1.328 -0.333 0 N-CA-C 109.756 -0.461 . . . . 0.0 109.756 178.179 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' C' C ' 14' ' ' LEU . . . . . . . . . . . . . 19.0 mt -87.21 152.24 52.55 Favored Pre-proline 0 C--N 1.328 -0.33 0 CA-C-N 116.421 -0.354 . . . . 0.0 111.079 -175.131 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' C' C ' 15' ' ' PRO . . . . . . . . . . . . . 26.8 Cg_exo -61.95 161.61 25.2 Favored 'Trans proline' 0 N--CA 1.496 1.65 0 C-N-CA 121.443 1.428 . . . . 0.0 111.698 176.451 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' C' C ' 16' ' ' PRO . . . . . . . . . . . . . 24.0 Cg_exo -62.81 -38.14 50.74 Favored 'Trans proline' 0 N--CA 1.497 1.729 0 C-N-CA 121.485 1.457 . . . . 0.0 112.75 -179.248 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' C' C ' 17' ' ' ASP . . . . . . . . . . . . . 9.4 p-10 -93.88 15.84 15.7 Favored 'General case' 0 C--N 1.327 -0.388 0 N-CA-C 113.154 0.798 . . . . 0.0 113.154 -175.688 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' C' C ' 18' ' ' PHE . . . . . . . . . . . . . 38.2 t80 -57.06 -47.03 81.97 Favored 'General case' 0 C--N 1.334 -0.076 0 O-C-N 122.06 -0.4 . . . . 0.0 110.595 -176.998 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' C' C ' 19' ' ' VAL . . . . . . . . . . . . . 46.3 t -56.33 -46.28 81.69 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.323 0 CA-C-N 116.464 -0.335 . . . . 0.0 110.852 -176.261 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' C' C ' 20' ' ' ASP . . . . . . . . . . . . . 77.2 m-20 -60.08 -41.55 92.7 Favored 'General case' 0 C--N 1.329 -0.298 0 C-N-CA 120.939 -0.304 . . . . 0.0 111.159 -177.066 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' C' C ' 21' ' ' VAL . . . . . . . . . . . . . 44.5 t -64.04 -46.75 92.95 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.29 0 C-N-CA 120.759 -0.376 . . . . 0.0 110.383 -177.968 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' C' C ' 22' ' ' ILE . . . . . 0.597 HG22 HD12 ' C' ' 26' ' ' LEU . 51.5 mm -56.36 -46.32 81.8 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.218 0 C-N-CA 120.951 -0.3 . . . . 0.0 110.567 178.352 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' C' C ' 23' ' ' ARG . . . . . . . . . . . . . 56.4 ttp180 -52.88 -49.05 66.64 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-O 120.652 0.263 . . . . 0.0 111.558 -178.798 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' C' C ' 24' ' ' ILE . . . . . . . . . . . . . 71.3 mt -58.32 -47.75 86.84 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.341 0 CA-C-N 116.661 -0.245 . . . . 0.0 110.802 -178.187 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' C' C ' 25' ' ' LYS . . . . . . . . . . . . . 40.4 mmtt -60.76 -43.96 97.34 Favored 'General case' 0 C--N 1.329 -0.315 0 N-CA-C 112.129 0.418 . . . . 0.0 112.129 -177.959 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' C' C ' 26' ' ' LEU . . . . . 0.597 HD12 HG22 ' C' ' 22' ' ' ILE . 81.8 mt -80.88 -29.21 35.75 Favored 'General case' 0 C--N 1.33 -0.273 0 N-CA-C 113.392 0.886 . . . . 0.0 113.392 -170.721 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' C' C ' 27' ' ' GLN . . . . . . . . . . . . . 4.4 pt20 -45.87 134.53 7.78 Favored 'General case' 0 N--CA 1.467 0.423 0 N-CA-C 112.856 0.687 . . . . 0.0 112.856 -174.931 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' C' C ' 28' ' ' GLY . . . . . . . . . . . . . . . 101.11 -20.21 48.45 Favored Glycine 0 CA--C 1.533 1.191 0 CA-C-N 115.948 -0.569 . . . . 0.0 112.863 -179.038 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' C' C ' 29' ' ' LYS . . . . . . . . . . . . . 59.9 mtpt -97.53 155.08 17.11 Favored 'General case' 0 C--N 1.332 -0.17 0 CA-C-N 117.78 0.79 . . . . 0.0 111.153 179.84 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' C' C ' 30' ' ' THR . . . . . . . . . . . . . 42.6 m -107.38 138.41 43.63 Favored 'General case' 0 C--N 1.332 -0.164 0 CA-C-N 116.157 -0.474 . . . . 0.0 110.038 176.262 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' C' C ' 31' ' ' VAL . . . . . . . . . . . . . 35.0 m -131.33 160.61 42.19 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.252 0 CA-C-N 116.38 -0.373 . . . . 0.0 110.771 -178.928 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' C' C ' 32' ' ' ARG . . . . . . . . . . . . . 21.1 mtp-105 -132.99 153.3 51.6 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-O 121.37 0.605 . . . . 0.0 110.552 178.236 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' C' C ' 33' ' ' THR . . . . . . . . . . . . . 17.9 m -52.98 139.72 26.97 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.022 -0.536 . . . . 0.0 111.457 -177.817 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' C' C ' 34' ' ' GLY . . . . . . . . . . . . . . . 99.85 -17.06 57.87 Favored Glycine 0 CA--C 1.532 1.108 0 CA-C-O 119.623 -0.543 . . . . 0.0 113.447 177.678 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' C' C ' 35' ' ' ASP . . . . . . . . . . . . . 70.9 m-20 -64.23 148.85 49.19 Favored 'General case' 0 C--O 1.232 0.167 0 CA-C-N 118.004 0.902 . . . . 0.0 111.17 -179.833 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' C' C ' 36' ' ' VAL . . . . . . . . . . . . . 45.9 t -122.63 129.69 75.03 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.241 0 CA-C-N 115.794 -0.639 . . . . 0.0 109.629 178.117 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' C' C ' 37' ' ' ILE . . . . . . . . . . . . . 67.7 mt -121.82 140.23 46.44 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.278 0 CA-C-N 116.396 -0.365 . . . . 0.0 110.129 -178.146 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' C' C ' 38' ' ' GLY . . . . . . . . . . . . . . . -113.2 128.96 8.62 Favored Glycine 0 CA--C 1.526 0.745 0 N-CA-C 111.082 -0.807 . . . . 0.0 111.082 -179.845 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' C' C ' 39' ' ' ILE . . . . . . . . . . . . . 76.2 mt -124.24 142.64 40.35 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.205 0 N-CA-C 110.025 -0.361 . . . . 0.0 110.025 179.564 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' C' C ' 40' ' ' SER . . . . . 0.536 ' O ' HD13 ' C' ' 41' ' ' ILE . 89.7 p -91.3 120.47 32.22 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.361 -0.381 . . . . 0.0 111.067 177.888 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' C' C ' 41' ' ' ILE . . . . . 0.536 HD13 ' O ' ' C' ' 40' ' ' SER . 46.3 mm -130.16 114.96 30.9 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.242 0 CA-C-N 116.435 -0.348 . . . . 0.0 110.098 177.904 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' C' C ' 42' ' ' LEU . . . . . . . . . . . . . 49.0 mt 58.03 35.16 24.97 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.391 -0.368 . . . . 0.0 111.566 178.248 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' C' C ' 43' ' ' GLY . . . . . . . . . . . . . . . 77.89 -10.08 27.74 Favored Glycine 0 CA--C 1.533 1.203 0 C-N-CA 121.316 -0.469 . . . . 0.0 113.499 177.81 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' C' C ' 44' ' ' LYS . . . . . . . . . . . . . 68.4 mmtt -98.04 139.47 33.81 Favored 'General case' 0 C--N 1.333 -0.11 0 CA-C-N 117.96 0.88 . . . . 0.0 109.869 176.057 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' C' C ' 45' ' ' GLU . . . . . . . . . . . . . 82.2 tt0 -83.3 123.81 29.99 Favored 'General case' 0 C--N 1.329 -0.315 0 C-N-CA 120.936 -0.306 . . . . 0.0 110.713 179.536 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' C' C ' 46' ' ' VAL . . . . . . . . . . . . . 7.7 p -115.5 128.37 72.74 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.167 0 N-CA-C 109.511 -0.552 . . . . 0.0 109.511 177.441 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' C' C ' 47' ' ' LYS . . . . . . . . . . . . . 67.4 mttm -100.24 130.74 46.4 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 115.97 -0.559 . . . . 0.0 111.56 -179.927 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' C' C ' 48' ' ' PHE . . . . . . . . . . . . . 91.1 m-85 -115.31 131.91 56.78 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.079 -0.509 . . . . 0.0 109.714 175.813 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' C' C ' 49' ' ' LYS . . . . . . . . . . . . . 82.8 tttt -107.92 137.18 46.37 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.498 -0.319 . . . . 0.0 110.716 -179.478 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' C' C ' 50' ' ' VAL . . . . . . . . . . . . . 44.3 t -82.29 105.64 12.36 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.262 0 N-CA-C 109.543 -0.54 . . . . 0.0 109.543 176.288 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' C' C ' 51' ' ' VAL . . . . . . . . . . . . . 46.4 t -71.0 -52.89 24.08 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.333 0 CA-C-N 115.926 -0.579 . . . . 0.0 109.75 -174.914 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' C' C ' 52' ' ' GLN . . . . . . . . . . . . . 81.9 mt-30 -154.57 149.92 27.19 Favored 'General case' 0 C--N 1.331 -0.198 0 C-N-CA 120.41 -0.516 . . . . 0.0 111.58 -177.418 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' C' C ' 53' ' ' ALA . . . . . . . . . . . . . . . -122.89 130.69 53.17 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 115.41 -0.813 . . . . 0.0 109.43 174.833 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' C' C ' 54' ' ' TYR . . . . . . . . . . . . . 67.9 t80 -129.0 107.41 18.08 Favored Pre-proline 0 CA--C 1.533 0.318 0 CA-C-O 118.215 -0.898 . . . . 0.0 110.493 -179.416 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' C' C ' 55' ' ' PRO . . . . . . . . . . . . . 73.1 Cg_endo -77.09 170.05 72.67 Favored 'Cis proline' 0 N--CA 1.5 1.907 0 CA-C-N 121.726 1.652 . . . . 0.0 112.583 -5.07 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' C' C ' 56' ' ' SER . . . . . . . . . . . . . 32.5 m -115.71 132.12 23.33 Favored Pre-proline 0 CA--C 1.538 0.516 0 CA-C-O 118.429 -0.796 . . . . 0.0 109.515 175.428 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' C' C ' 57' ' ' PRO . . . . . . . . . . . . . 33.5 Cg_endo -65.76 166.26 55.41 Favored 'Cis proline' 0 N--CA 1.498 1.785 0 CA-C-N 121.971 1.74 . . . . 0.0 111.378 -2.583 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' C' C ' 58' ' ' LEU . . . . . 0.595 HD23 HD12 ' C' ' 4' ' ' LEU . 19.4 tp -130.5 138.58 50.31 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-O 121.018 0.437 . . . . 0.0 110.662 -179.919 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' C' C ' 59' ' ' ARG . . . . . . . . . . . . . 78.6 ttt-85 -103.61 128.4 50.9 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 115.579 -0.737 . . . . 0.0 109.47 175.767 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' C' C ' 60' ' ' VAL . . . . . . . . . . . . . 43.2 t -78.86 112.93 17.48 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.344 0 CA-C-O 120.817 0.342 . . . . 0.0 110.378 -177.114 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' C' C ' 61' ' ' GLU . . . . . . . . . . . . . 72.9 tt0 -130.95 157.01 44.11 Favored 'General case' 0 C--N 1.329 -0.314 0 N-CA-C 109.359 -0.608 . . . . 0.0 109.359 177.936 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' C' C ' 62' ' ' ASP . . . . . . . . . . . . . 9.5 t0 -51.7 -30.79 23.51 Favored 'General case' 0 C--N 1.326 -0.414 0 N-CA-C 112.213 0.449 . . . . 0.0 112.213 -177.479 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' C' C ' 63' ' ' ARG . . . . . . . . . . . . . 73.8 mtp180 -72.66 -22.06 60.99 Favored 'General case' 0 CA--C 1.532 0.288 0 N-CA-C 112.966 0.728 . . . . 0.0 112.966 -175.38 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' C' C ' 64' ' ' THR . . . . . . . . . . . . . 32.3 m -73.69 140.58 46.14 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-O 120.895 0.379 . . . . 0.0 110.829 -176.226 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' C' C ' 65' ' ' LYS . . . . . . . . . . . . . 42.1 mtmt -89.22 127.79 35.78 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.099 -0.501 . . . . 0.0 110.12 177.868 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' C' C ' 66' ' ' ILE . . . . . . . . . . . . . 64.8 mt -109.48 125.73 66.62 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.32 0 N-CA-C 109.427 -0.583 . . . . 0.0 109.427 179.152 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' C' C ' 67' ' ' THR . . . . . . . . . . . . . 23.1 m -124.81 142.29 51.53 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-O 121.277 0.56 . . . . 0.0 111.358 -174.9 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' C' C ' 68' ' ' LEU . . . . . . . . . . . . . 43.8 mt . . . . . 0 C--N 1.33 -0.25 0 CA-C-N 115.59 -0.732 . . . . 0.0 109.894 176.123 . . . . . . . . 0 0 . 1 . 016 nuclear nobuild core ' C' C ' 73' ' ' VAL . . . . . . . . . . . . . 34.8 m . . . . . 0 N--CA 1.462 0.146 0 CA-C-O 120.717 0.294 . . . . 0.0 110.799 . . . . . . . . . 0 0 . 1 . 016 nuclear nobuild core ' C' C ' 74' ' ' ASP . . . . . . . . . . . . . 35.6 t0 -102.83 118.06 36.0 Favored 'General case' 0 C--N 1.331 -0.199 0 N-CA-C 109.455 -0.572 . . . . 0.0 109.455 177.835 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' C' C ' 75' ' ' VAL . . . . . . . . . . . . . 39.9 t -118.63 123.88 72.25 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.245 0 CA-C-O 121.141 0.496 . . . . 0.0 110.795 -176.634 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' C' C ' 76' ' ' LEU . . . . . . . . . . . . . 6.7 mp -117.62 150.39 39.11 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 115.503 -0.771 . . . . 0.0 109.613 176.184 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' C' C ' 77' ' ' GLU . . . . . . . . . . . . . 47.2 mt-10 -134.62 132.32 38.85 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-O 120.963 0.411 . . . . 0.0 111.019 179.916 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' C' C ' 78' ' ' ALA . . . . . 0.776 ' HB2' HD21 ' C' ' 109' ' ' LEU . . . -124.66 127.76 47.8 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 115.838 -0.619 . . . . 0.0 109.919 177.05 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' C' C ' 79' ' ' LYS . . . . . 0.559 ' O ' HD13 ' C' ' 80' ' ' ILE . 14.4 ptpt -72.81 119.29 16.85 Favored 'General case' 0 C--N 1.331 -0.239 0 CA-C-O 121.239 0.543 . . . . 0.0 110.589 -178.772 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' C' C ' 80' ' ' ILE . . . . . 0.559 HD13 ' O ' ' C' ' 79' ' ' LYS . 24.1 mm -139.44 105.59 2.43 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.285 0 N-CA-C 109.213 -0.662 . . . . 0.0 109.213 -177.781 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' C' C ' 81' ' ' LYS . . . . . . . . . . . . . 55.9 pttt -98.91 126.83 44.68 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-O 121.032 0.444 . . . . 0.0 111.26 -177.205 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' C' C ' 82' ' ' GLY . . . . . . . . . . . . . . . 89.16 42.03 5.69 Favored Glycine 0 CA--C 1.526 0.754 0 CA-C-N 115.838 -0.619 . . . . 0.0 111.834 175.05 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' C' C ' 83' ' ' ILE . . . . . . . . . . . . . 67.3 mt -71.99 139.35 19.88 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.391 0 N-CA-C 109.551 -0.537 . . . . 0.0 109.551 176.57 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' C' C ' 84' ' ' LYS . . . . . . . . . . . . . 20.2 ttpp -102.28 -50.21 3.68 Favored 'General case' 0 C--N 1.331 -0.215 0 CA-C-O 120.895 0.378 . . . . 0.0 110.317 -178.857 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' C' C ' 85' ' ' ASP . . . . . . . . . . . . . 11.1 t70 -150.95 150.0 30.29 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.034 -0.53 . . . . 0.0 110.641 -179.184 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' C' C ' 86' ' ' VAL . . . . . . . . . . . . . 44.7 t -132.93 131.12 59.06 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.275 0 CA-C-O 120.89 0.376 . . . . 0.0 110.3 179.779 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' C' C ' 87' ' ' ILE . . . . . . . . . . . . . 40.3 mm -119.5 127.08 75.86 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.233 0 N-CA-C 109.359 -0.608 . . . . 0.0 109.359 177.457 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' C' C ' 88' ' ' LEU . . . . . . . . . . . . . 20.4 tp -113.03 132.15 55.5 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-O 120.973 0.416 . . . . 0.0 111.119 -177.209 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' C' C ' 89' ' ' ASP . . . . . . . . . . . . . 8.6 t70 -125.1 156.5 38.19 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 115.77 -0.65 . . . . 0.0 109.587 176.272 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' C' C ' 90' ' ' GLU . . . . . . . . . . . . . 95.4 mt-10 -47.02 -39.28 12.34 Favored 'General case' 0 C--N 1.329 -0.301 0 N-CA-C 113.007 0.743 . . . . 0.0 113.007 -172.167 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' C' C ' 91' ' ' ASN . . . . . . . . . . . . . 3.7 t-20 -132.09 34.8 3.77 Favored 'General case' 0 N--CA 1.464 0.251 0 N-CA-C 111.832 0.308 . . . . 0.0 111.832 -175.862 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' C' C ' 92' ' ' LEU . . . . . . . . . . . . . 11.4 tp -166.09 146.03 6.27 Favored 'General case' 0 C--N 1.332 -0.187 0 C-N-CA 120.755 -0.378 . . . . 0.0 111.058 -179.335 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' C' C ' 93' ' ' ILE . . . . . . . . . . . . . 64.4 mt -125.3 123.42 65.05 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.18 0 N-CA-C 109.575 -0.528 . . . . 0.0 109.575 178.622 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' C' C ' 94' ' ' VAL . . . . . 0.452 HG21 HG11 ' C' ' 125' ' ' VAL . 47.0 t -122.64 125.02 71.92 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.218 0 N-CA-C 109.887 -0.412 . . . . 0.0 109.887 178.806 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' C' C ' 95' ' ' VAL . . . . . . . . . . . . . 44.3 t -121.61 135.8 60.6 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.273 0 CA-C-N 116.068 -0.515 . . . . 0.0 110.049 -178.38 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' C' C ' 96' ' ' ILE . . . . . . . . . . . . . 64.9 mt -117.87 127.31 75.17 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.307 0 N-CA-C 109.647 -0.501 . . . . 0.0 109.647 -179.949 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' C' C ' 97' ' ' THR . . . . . . . . . . . . . 81.2 p -98.94 156.41 16.91 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-O 121.021 0.439 . . . . 0.0 110.984 -178.965 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' C' C ' 98' ' ' GLU . . . . . . . . . . . . . 14.2 pt-20 -55.58 -22.18 20.83 Favored 'General case' 0 CA--C 1.534 0.343 0 N-CA-C 112.603 0.594 . . . . 0.0 112.603 -178.736 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' C' C ' 99' ' ' GLU . . . . . . . . . . . . . 51.0 mp0 -81.22 15.49 1.92 Allowed 'General case' 0 CA--C 1.535 0.399 0 N-CA-C 112.95 0.722 . . . . 0.0 112.95 -178.881 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' C' C ' 100' ' ' ASN . . . . . . . . . . . . . 22.3 m-20 59.66 37.37 22.42 Favored 'General case' 0 C--N 1.332 -0.153 0 CA-C-O 121.026 0.441 . . . . 0.0 111.159 -179.428 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' C' C ' 101' ' ' GLU . . . . . . . . . . . . . 84.4 tt0 -111.91 142.35 44.41 Favored 'General case' 0 C--N 1.333 -0.132 0 N-CA-C 109.575 -0.528 . . . . 0.0 109.575 173.198 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' C' C ' 102' ' ' VAL . . . . . . . . . . . . . 44.3 t -114.95 127.93 72.31 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.249 0 CA-C-N 116.27 -0.423 . . . . 0.0 109.998 -177.025 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' C' C ' 103' ' ' LEU . . . . . . . . . . . . . 39.8 mt -117.01 131.56 56.92 Favored 'General case' 0 C--N 1.331 -0.216 0 CA-C-N 115.604 -0.726 . . . . 0.0 110.224 177.087 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' C' C ' 104' ' ' ILE . . . . . 0.5 HD12 ' HB3' ' C' ' 113' ' ' TYR . 66.8 mt -118.44 122.9 70.66 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.255 0 CA-C-N 116.491 -0.322 . . . . 0.0 110.155 -179.865 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' C' C ' 105' ' ' PHE . . . . . . . . . . . . . 89.7 m-85 -124.85 162.66 23.88 Favored 'General case' 0 N--CA 1.462 0.135 0 O-C-N 123.983 0.802 . . . . 0.0 110.3 -178.3 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' C' C ' 106' ' ' ASN . . . . . . . . . . . . . 41.3 p-10 -100.27 -169.95 1.8 Allowed 'General case' 0 C--N 1.331 -0.21 0 CA-C-N 116.309 -0.405 . . . . 0.0 109.934 174.018 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' C' C ' 107' ' ' GLN . . . . . . . . . . . . . 32.3 tt0 -58.49 -30.01 66.68 Favored 'General case' 0 CA--C 1.532 0.252 0 N-CA-C 111.998 0.37 . . . . 0.0 111.998 179.553 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' C' C ' 108' ' ' ASN . . . . . . . . . . . . . 10.7 t-20 -84.24 9.62 12.46 Favored 'General case' 0 CA--C 1.536 0.407 0 N-CA-C 113.114 0.783 . . . . 0.0 113.114 -176.787 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' C' C ' 109' ' ' LEU . . . . . 0.776 HD21 ' HB2' ' C' ' 78' ' ' ALA . 11.1 tp 56.13 35.85 26.39 Favored 'General case' 0 CA--C 1.531 0.225 0 CA-C-O 120.898 0.38 . . . . 0.0 111.266 -179.97 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' C' C ' 110' ' ' GLU . . . . . . . . . . . . . 42.8 mt-10 -103.17 147.62 26.79 Favored 'General case' 0 C--N 1.331 -0.22 0 N-CA-C 109.522 -0.547 . . . . 0.0 109.522 175.613 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' C' C ' 111' ' ' GLU . . . . . . . . . . . . . 50.9 tt0 -79.68 121.9 25.88 Favored 'General case' 0 C--N 1.327 -0.396 0 CA-C-O 120.822 0.344 . . . . 0.0 110.877 -175.838 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' C' C ' 112' ' ' LEU . . . . . . . . . . . . . 22.9 mt -106.03 -45.89 4.23 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-N 116.029 -0.532 . . . . 0.0 110.42 178.805 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' C' C ' 113' ' ' TYR . . . . . 0.5 ' HB3' HD12 ' C' ' 104' ' ' ILE . 53.4 t80 -136.26 138.79 42.17 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-O 120.905 0.383 . . . . 0.0 111.294 -178.849 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' C' C ' 114' ' ' ARG . . . . . . . . . . . . . 58.8 ttp180 -137.08 121.62 18.37 Favored 'General case' 0 C--N 1.331 -0.197 0 CA-C-N 115.775 -0.648 . . . . 0.0 110.221 178.164 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' C' C ' 115' ' ' GLY . . . . . . . . . . . . . . . -150.0 151.13 23.25 Favored Glycine 0 CA--C 1.523 0.584 0 N-CA-C 111.094 -0.802 . . . . 0.0 111.094 178.033 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' C' C ' 116' ' ' LYS . . . . . . . . . . . . . 72.6 tttt -130.01 133.19 46.6 Favored 'General case' 0 C--N 1.33 -0.261 0 N-CA-C 109.793 -0.447 . . . . 0.0 109.793 178.013 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' C' C ' 117' ' ' PHE . . . . . . . . . . . . . 23.1 m-85 -133.5 113.94 13.04 Favored 'General case' 0 C--N 1.331 -0.226 0 CA-C-O 120.884 0.373 . . . . 0.0 110.339 -174.136 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' C' C ' 118' ' ' GLU . . . . . . . . . . . . . 95.7 mt-10 -54.15 -50.43 66.98 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.396 -0.365 . . . . 0.0 111.179 -177.736 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' C' C ' 119' ' ' ASN . . . . . . . . . . . . . 35.6 m120 -89.67 29.64 1.13 Allowed 'General case' 0 C--N 1.33 -0.278 0 N-CA-C 112.261 0.467 . . . . 0.0 112.261 -174.922 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' C' C ' 120' ' ' LEU . . . . . . . . . . . . . 30.6 tp -57.95 121.22 10.05 Favored 'General case' 0 C--N 1.332 -0.162 0 N-CA-C 110.161 -0.311 . . . . 0.0 110.161 177.313 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' C' C ' 121' ' ' ASN . . . . . . . . . . . . . 32.1 m120 -114.11 -43.41 3.24 Favored 'General case' 0 C--N 1.331 -0.209 0 CA-C-N 116.326 -0.397 . . . . 0.0 111.017 -177.155 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' C' C ' 122' ' ' LYS . . . . . . . . . . . . . 67.9 mttm -138.68 144.34 39.57 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-O 121.152 0.501 . . . . 0.0 111.614 -175.909 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' C' C ' 123' ' ' VAL . . . . . . . . . . . . . 45.7 t -124.55 126.23 71.41 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.21 0 CA-C-N 115.715 -0.675 . . . . 0.0 109.448 176.146 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' C' C ' 124' ' ' LEU . . . . . . . . . . . . . 27.3 mt -123.18 131.0 53.52 Favored 'General case' 0 C--N 1.332 -0.166 0 CA-C-O 120.642 0.258 . . . . 0.0 110.683 -178.212 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' C' C ' 125' ' ' VAL . . . . . 0.452 HG11 HG21 ' C' ' 94' ' ' VAL . 35.1 m -136.31 134.41 49.84 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.288 0 CA-C-N 116.321 -0.4 . . . . 0.0 110.752 179.896 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' C' C ' 126' ' ' ARG . . . . . . . . . . . . . 95.7 mtt-85 -146.28 118.17 8.19 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.325 -0.398 . . . . 0.0 110.671 178.053 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' C' C ' 127' ' ' ASN . . . . . . . . . . . . . 34.8 m120 49.84 -104.97 0.16 Allowed 'General case' 0 CA--C 1.544 0.718 0 CA-C-O 119.202 -0.428 . . . . 0.0 111.78 177.599 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' C' C ' 128' ' ' ASP . . . . . . . . . . . . . 13.0 p-10 -114.23 13.5 17.94 Favored 'General case' 0 N--CA 1.467 0.408 0 CA-C-N 119.406 1.003 . . . . 0.0 113.263 -175.112 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' C' C ' 129' ' ' LEU . . . . . . . . . . . . . 24.4 tp -118.32 136.83 53.48 Favored 'General case' 0 C--N 1.332 -0.161 0 O-C-N 122.029 -0.42 . . . . 0.0 110.046 177.592 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' C' C ' 130' ' ' VAL . . . . . . . . . . . . . 42.4 t -125.09 136.56 60.47 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.196 0 CA-C-O 120.926 0.393 . . . . 0.0 110.025 -179.347 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' C' C ' 131' ' ' VAL . . . . . 0.485 HG22 HD12 ' C' ' 140' ' ' LEU . 41.8 t -136.02 135.26 50.46 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.291 0 CA-C-O 121.131 0.491 . . . . 0.0 110.167 178.022 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' C' C ' 132' ' ' ILE . . . . . . . . . . . . . 73.1 mt -117.08 129.85 72.95 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.323 0 CA-C-N 115.717 -0.674 . . . . 0.0 109.388 -179.295 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' C' C ' 133' ' ' ILE . . . . . . . . . . . . . 37.6 mm -115.46 120.3 64.31 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.301 0 CA-C-O 120.608 0.242 . . . . 0.0 111.047 -174.494 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' C' C ' 134' ' ' ASP . . . . . . . . . . . . . 7.5 p-10 -130.42 149.87 51.9 Favored 'General case' 0 C--N 1.333 -0.138 0 N-CA-C 109.944 -0.391 . . . . 0.0 109.944 174.655 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' C' C ' 135' ' ' GLU . . . . . . . . . . . . . 58.0 tt0 -49.92 -25.93 3.69 Favored 'General case' 0 C--N 1.327 -0.375 0 N-CA-C 113.088 0.773 . . . . 0.0 113.088 -170.889 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' C' C ' 136' ' ' GLN . . . . . . . . . . . . . 30.1 tt0 -95.38 -26.87 15.71 Favored 'General case' 0 CA--C 1.531 0.221 0 N-CA-C 112.765 0.654 . . . . 0.0 112.765 -172.472 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' C' C ' 137' ' ' LYS . . . . . . . . . . . . . 58.3 pttt -163.86 167.46 20.72 Favored 'General case' 0 C--O 1.233 0.193 0 CA-C-O 121.576 0.703 . . . . 0.0 112.162 -175.114 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' C' C ' 138' ' ' LEU . . . . . 0.413 HD23 ' C ' ' C' ' 138' ' ' LEU . 6.3 tt -117.12 128.43 55.12 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 115.029 -0.987 . . . . 0.0 109.928 179.712 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' C' C ' 139' ' ' THR . . . . . . . . . . . . . 27.7 m -108.24 124.83 50.9 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.156 -0.474 . . . . 0.0 110.402 179.236 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' C' C ' 140' ' ' LEU . . . . . 0.485 HD12 HG22 ' C' ' 131' ' ' VAL . 10.5 tp -111.21 120.47 42.38 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 115.853 -0.612 . . . . 0.0 109.355 -178.977 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' C' C ' 141' ' ' ILE . . . . . . . . . . . . . 18.9 mt -123.21 118.28 54.18 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.269 0 CA-C-O 121.118 0.485 . . . . 0.0 110.081 -174.862 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' C' C ' 142' ' ' ARG . . . . . . . . . . . . . 72.1 mtp180 . . . . . 0 C--N 1.328 -0.349 0 CA-C-N 115.435 -0.802 . . . . 0.0 110.176 176.736 . . . . . . . . 0 0 . 1 . 016 nuclear nobuild core ' D' D ' 2' ' ' SER . . . . . . . . . . . . . 3.9 p . . . . . 0 N--CA 1.462 0.168 0 CA-C-O 120.951 0.405 . . . . 0.0 110.613 . . . . . . . . . 0 0 . 1 . 016 nuclear nobuild core ' D' D ' 3' ' ' GLU . . . . . . . . . . . . . 80.7 tt0 -146.6 142.93 28.45 Favored 'General case' 0 C--N 1.327 -0.396 0 CA-C-N 115.987 -0.551 . . . . 0.0 111.019 -178.658 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' D' D ' 4' ' ' LEU . . . . . . . . . . . . . 17.2 tp -124.3 132.27 53.56 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.01 -0.541 . . . . 0.0 110.056 177.171 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' D' D ' 5' ' ' LYS . . . . . . . . . . . . . 66.4 mttm -111.13 121.76 46.14 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 116.331 -0.395 . . . . 0.0 110.513 -179.176 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' D' D ' 6' ' ' LEU . . . . . . . . . . . . . 71.1 mt -117.2 151.43 36.9 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 115.668 -0.696 . . . . 0.0 110.94 -177.384 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' D' D ' 7' ' ' LYS . . . . . . . . . . . . . 74.9 tttt -142.5 141.72 21.47 Favored Pre-proline 0 CA--C 1.532 0.278 0 CA-C-N 116.18 -0.464 . . . . 0.0 109.952 174.005 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' D' D ' 8' ' ' PRO . . . . . . . . . . . . . 84.1 Cg_endo -90.76 144.8 3.7 Favored 'Trans proline' 0 N--CA 1.491 1.325 0 C-N-CA 121.74 1.627 . . . . 0.0 112.081 179.039 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' D' D ' 9' ' ' LEU . . . . . . . . . . . . . 40.9 mt -81.07 -47.18 1.14 Allowed Pre-proline 0 CA--C 1.533 0.292 0 CA-C-O 118.71 -0.662 . . . . 0.0 112.048 179.784 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' D' D ' 10' ' ' PRO . . . . . . . . . . . . . 88.1 Cg_endo -81.34 154.3 18.68 Favored 'Trans proline' 0 N--CA 1.497 1.711 0 C-N-CA 121.149 1.233 . . . . 0.0 111.643 175.223 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' D' D ' 11' ' ' LYS . . . . . . . . . . . . . 61.6 tttm -88.71 100.41 13.1 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.473 -0.331 . . . . 0.0 110.513 179.392 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' D' D ' 12' ' ' VAL . . . . . . . . . . . . . 12.3 p -144.92 146.44 19.98 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.233 0 CA-C-N 116.22 -0.446 . . . . 0.0 110.679 -179.516 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' D' D ' 13' ' ' GLU . . . . . . . . . . . . . 95.1 mt-10 -82.57 130.56 35.14 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 116.28 -0.418 . . . . 0.0 109.97 176.782 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' D' D ' 14' ' ' LEU . . . . . . . . . . . . . 16.8 mt -97.52 146.93 32.25 Favored Pre-proline 0 CA--C 1.533 0.303 0 CA-C-O 119.223 -0.418 . . . . 0.0 110.238 -178.476 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' D' D ' 15' ' ' PRO . . . . . . . . . . . . . 30.5 Cg_exo -60.43 159.36 27.68 Favored 'Trans proline' 0 N--CA 1.497 1.721 0 C-N-CA 121.328 1.352 . . . . 0.0 111.783 177.176 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' D' D ' 16' ' ' PRO . . . . . . . . . . . . . 39.4 Cg_exo -58.4 -41.04 69.67 Favored 'Trans proline' 0 N--CA 1.497 1.683 0 C-N-CA 121.472 1.448 . . . . 0.0 112.676 -178.261 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' D' D ' 17' ' ' ASP . . . . . . . . . . . . . 12.6 p-10 -87.82 13.01 11.55 Favored 'General case' 0 CA--C 1.535 0.404 0 N-CA-C 113.086 0.772 . . . . 0.0 113.086 -178.084 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' D' D ' 18' ' ' PHE . . . . . . . . . . . . . 46.6 t80 -58.26 -45.01 88.61 Favored 'General case' 0 C--N 1.334 -0.079 0 CA-C-O 120.935 0.398 . . . . 0.0 110.078 -178.542 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' D' D ' 19' ' ' VAL . . . . . . . . . . . . . 47.7 t -56.87 -41.2 75.64 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.249 0 CA-C-N 116.142 -0.481 . . . . 0.0 110.438 -178.805 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' D' D ' 20' ' ' ASP . . . . . . . . . . . . . 71.1 m-20 -60.39 -44.0 96.1 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-O 120.811 0.339 . . . . 0.0 111.071 -178.074 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' D' D ' 21' ' ' VAL . . . . . . . . . . . . . 46.1 t -64.22 -48.6 84.89 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 CA-C-N 116.353 -0.385 . . . . 0.0 110.484 -177.844 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' D' D ' 22' ' ' ILE . . . . . 0.666 HG22 HD12 ' D' ' 26' ' ' LEU . 50.6 mm -55.09 -47.92 76.62 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.241 0 CA-C-O 120.687 0.279 . . . . 0.0 110.829 179.356 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' D' D ' 23' ' ' ARG . . . . . . . . . . . . . 3.7 tmm_? -53.5 -53.38 52.33 Favored 'General case' 0 C--N 1.329 -0.313 0 N-CA-C 111.605 0.224 . . . . 0.0 111.605 -177.719 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' D' D ' 24' ' ' ILE . . . . . . . . . . . . . 72.2 mt -60.31 -41.86 88.64 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.28 0 N-CA-C 111.659 0.244 . . . . 0.0 111.659 -175.711 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' D' D ' 25' ' ' LYS . . . . . . . . . . . . . 53.0 mttm -67.79 -36.95 81.37 Favored 'General case' 0 C--N 1.328 -0.334 0 N-CA-C 112.147 0.425 . . . . 0.0 112.147 -177.707 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' D' D ' 26' ' ' LEU . . . . . 0.666 HD12 HG22 ' D' ' 22' ' ' ILE . 26.5 mt -79.46 -41.94 26.41 Favored 'General case' 0 C--N 1.33 -0.275 0 N-CA-C 112.798 0.666 . . . . 0.0 112.798 -173.617 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' D' D ' 27' ' ' GLN . . . . . . . . . . . . . 8.9 pt20 -46.0 138.57 4.99 Favored 'General case' 0 N--CA 1.47 0.554 0 N-CA-C 112.686 0.625 . . . . 0.0 112.686 -175.669 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' D' D ' 28' ' ' GLY . . . . . . . . . . . . . . . 100.79 -27.86 18.59 Favored Glycine 0 CA--C 1.53 1.02 0 CA-C-N 115.334 -0.848 . . . . 0.0 112.073 -176.086 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' D' D ' 29' ' ' LYS . . . . . . . . . . . . . 94.4 mttt -97.91 155.14 17.22 Favored 'General case' 0 C--O 1.232 0.164 0 CA-C-N 117.186 0.493 . . . . 0.0 111.01 178.796 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' D' D ' 30' ' ' THR . . . . . . . . . . . . . 25.2 m -103.96 139.39 39.18 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.167 -0.47 . . . . 0.0 110.33 176.935 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' D' D ' 31' ' ' VAL . . . . . . . . . . . . . 35.1 m -128.76 151.05 35.0 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.278 0 CA-C-O 121.047 0.451 . . . . 0.0 110.91 -178.922 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' D' D ' 32' ' ' ARG . . . . . . . . . . . . . 26.3 ttm180 -129.05 146.25 51.06 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 115.971 -0.559 . . . . 0.0 110.212 178.895 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' D' D ' 33' ' ' THR . . . . . . . . . . . . . 16.9 m -52.5 139.07 26.2 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.455 -0.339 . . . . 0.0 111.488 -177.301 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' D' D ' 34' ' ' GLY . . . . . . . . . . . . . . . 101.1 -17.21 56.38 Favored Glycine 0 CA--C 1.532 1.151 0 CA-C-O 119.702 -0.499 . . . . 0.0 113.242 179.962 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' D' D ' 35' ' ' ASP . . . . . . . . . . . . . 74.3 m-20 -66.08 149.65 49.94 Favored 'General case' 0 N--CA 1.461 0.095 0 CA-C-N 118.033 0.916 . . . . 0.0 111.15 179.176 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' D' D ' 36' ' ' VAL . . . . . . . . . . . . . 45.9 t -122.12 130.74 74.31 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.193 0 CA-C-N 115.838 -0.619 . . . . 0.0 109.776 177.947 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' D' D ' 37' ' ' ILE . . . . . . . . . . . . . 71.9 mt -121.13 140.13 46.2 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.218 0 CA-C-N 116.299 -0.409 . . . . 0.0 109.994 -179.149 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' D' D ' 38' ' ' GLY . . . . . . . . . . . . . . . -114.26 128.91 8.44 Favored Glycine 0 CA--C 1.526 0.767 0 N-CA-C 111.297 -0.721 . . . . 0.0 111.297 -178.685 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' D' D ' 39' ' ' ILE . . . . . . . . . . . . . 72.2 mt -123.51 135.63 62.69 Favored 'Isoleucine or valine' 0 C--N 1.333 -0.135 0 N-CA-C 109.963 -0.384 . . . . 0.0 109.963 178.268 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' D' D ' 40' ' ' SER . . . . . . . . . . . . . 23.1 t -92.71 123.12 35.76 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-N 116.521 -0.309 . . . . 0.0 111.018 176.786 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' D' D ' 41' ' ' ILE . . . . . . . . . . . . . 73.2 mt -132.21 112.9 20.49 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.167 0 CA-C-O 120.844 0.355 . . . . 0.0 110.315 177.511 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' D' D ' 42' ' ' LEU . . . . . 0.527 HD23 ' O ' ' D' ' 42' ' ' LEU . 1.4 tt 54.5 47.35 22.97 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-O 121.53 0.681 . . . . 0.0 110.647 178.237 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' D' D ' 43' ' ' GLY . . . . . . . . . . . . . . . 75.23 -10.1 11.51 Favored Glycine 0 CA--C 1.535 1.289 0 CA-C-O 119.692 -0.504 . . . . 0.0 113.796 175.274 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' D' D ' 44' ' ' LYS . . . . . . . . . . . . . 35.8 mmtm -99.79 132.65 45.01 Favored 'General case' 0 C--N 1.332 -0.165 0 CA-C-N 118.066 0.933 . . . . 0.0 110.378 -179.981 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' D' D ' 45' ' ' GLU . . . . . . . . . . . . . 80.3 tt0 -84.45 122.83 29.52 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.22 -0.446 . . . . 0.0 110.806 178.635 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' D' D ' 46' ' ' VAL . . . . . . . . . . . . . 7.7 p -117.19 124.27 72.81 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.199 0 N-CA-C 109.542 -0.54 . . . . 0.0 109.542 176.09 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' D' D ' 47' ' ' LYS . . . . . . . . . . . . . 57.7 mtmt -99.94 129.58 46.03 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 115.812 -0.631 . . . . 0.0 111.18 179.515 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' D' D ' 48' ' ' PHE . . . . . . . . . . . . . 91.3 m-85 -112.34 132.36 55.03 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-N 116.166 -0.47 . . . . 0.0 109.982 177.277 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' D' D ' 49' ' ' LYS . . . . . . . . . . . . . 76.1 tttt -105.84 135.54 47.09 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.348 -0.387 . . . . 0.0 110.41 179.581 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' D' D ' 50' ' ' VAL . . . . . . . . . . . . . 44.1 t -79.47 107.2 11.64 Favored 'Isoleucine or valine' 0 C--O 1.232 0.177 0 N-CA-C 109.324 -0.621 . . . . 0.0 109.324 175.717 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' D' D ' 51' ' ' VAL . . . . . . . . . . . . . 48.2 t -71.21 -51.69 32.54 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.344 0 CA-C-N 115.998 -0.547 . . . . 0.0 109.787 -174.376 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' D' D ' 52' ' ' GLN . . . . . . . . . . . . . 45.1 mt-30 -155.53 150.73 26.83 Favored 'General case' 0 C--N 1.331 -0.221 0 CA-C-O 121.18 0.514 . . . . 0.0 111.74 -177.467 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' D' D ' 53' ' ' ALA . . . . . . . . . . . . . . . -125.19 127.27 46.53 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 115.216 -0.902 . . . . 0.0 109.604 175.907 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' D' D ' 54' ' ' TYR . . . . . . . . . . . . . 62.6 t80 -126.37 107.32 24.02 Favored Pre-proline 0 CA--C 1.535 0.392 0 CA-C-O 118.321 -0.847 . . . . 0.0 110.689 -178.242 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' D' D ' 55' ' ' PRO . . . . . . . . . . . . . 74.1 Cg_endo -77.12 170.02 72.71 Favored 'Cis proline' 0 N--CA 1.499 1.836 0 CA-C-N 121.697 1.642 . . . . 0.0 112.355 -6.022 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' D' D ' 56' ' ' SER . . . . . . . . . . . . . 14.5 m -110.59 128.69 24.93 Favored Pre-proline 0 CA--C 1.539 0.526 0 CA-C-O 118.407 -0.806 . . . . 0.0 109.384 175.739 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' D' D ' 57' ' ' PRO . . . . . . . . . . . . . 61.2 Cg_endo -74.84 149.09 93.3 Favored 'Cis proline' 0 N--CA 1.496 1.639 0 CA-C-N 121.96 1.736 . . . . 0.0 111.716 -0.714 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' D' D ' 58' ' ' LEU . . . . . . . . . . . . . 27.9 tp -108.19 137.52 46.02 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.227 -0.442 . . . . 0.0 110.454 -179.04 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' D' D ' 59' ' ' ARG . . . . . . . . . . . . . 25.5 ttm180 -103.82 126.59 51.06 Favored 'General case' 0 C--N 1.327 -0.383 0 N-CA-C 109.394 -0.595 . . . . 0.0 109.394 176.029 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' D' D ' 60' ' ' VAL . . . . . . . . . . . . . 45.6 t -78.8 116.63 22.96 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.231 0 C-N-CA 120.684 -0.407 . . . . 0.0 110.409 -174.833 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' D' D ' 61' ' ' GLU . . . . . . . . . . . . . 94.7 mt-10 -131.06 163.1 28.36 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 116.0 -0.545 . . . . 0.0 109.849 177.795 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' D' D ' 62' ' ' ASP . . . . . . . . . . . . . 14.2 t0 -52.81 -32.99 47.06 Favored 'General case' 0 C--N 1.329 -0.296 0 N-CA-C 111.864 0.32 . . . . 0.0 111.864 -178.67 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' D' D ' 63' ' ' ARG . . . . . . . . . . . . . 77.2 mtt85 -73.64 -21.97 60.13 Favored 'General case' 0 C--N 1.33 -0.258 0 N-CA-C 113.076 0.769 . . . . 0.0 113.076 -176.061 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' D' D ' 64' ' ' THR . . . . . . . . . . . . . 31.4 m -66.14 138.39 57.69 Favored 'General case' 0 C--N 1.331 -0.211 0 CA-C-O 120.955 0.407 . . . . 0.0 111.14 -175.14 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' D' D ' 65' ' ' LYS . . . . . . . . . . . . . 93.2 mttt -89.01 136.62 32.92 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 115.763 -0.653 . . . . 0.0 109.827 176.969 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' D' D ' 66' ' ' ILE . . . . . . . . . . . . . 58.1 mt -115.8 127.21 73.46 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.294 0 N-CA-C 109.852 -0.425 . . . . 0.0 109.852 -179.181 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' D' D ' 67' ' ' THR . . . . . . . . . . . . . 26.5 m -126.45 147.57 49.78 Favored 'General case' 0 N--CA 1.463 0.215 0 CA-C-O 121.148 0.499 . . . . 0.0 111.362 -175.928 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' D' D ' 68' ' ' LEU . . . . . 0.473 ' N ' HD12 ' D' ' 68' ' ' LEU . 8.9 mp . . . . . 0 C--N 1.329 -0.292 0 CA-C-N 115.869 -0.605 . . . . 0.0 110.454 177.389 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' D' D ' 73' ' ' VAL . . . . . . . . . . . . . 3.5 m . . . . . 0 CA--C 1.522 -0.128 0 CA-C-O 121.138 0.494 . . . . 0.0 110.992 . . . . . . . . . 0 0 . 1 . 016 nuclear nobuild core ' D' D ' 74' ' ' ASP . . . . . . . . . . . . . 6.0 t70 -93.1 118.77 31.59 Favored 'General case' 0 C--N 1.327 -0.409 0 N-CA-C 108.691 -0.855 . . . . 0.0 108.691 173.136 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' D' D ' 75' ' ' VAL . . . . . 0.427 ' C ' HD12 ' D' ' 76' ' ' LEU . 36.6 t -111.44 126.8 68.86 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.313 0 CA-C-O 121.241 0.543 . . . . 0.0 111.312 -171.754 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' D' D ' 76' ' ' LEU . . . . . 0.427 HD12 ' C ' ' D' ' 75' ' ' VAL . 5.9 mp -125.97 145.53 50.25 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 115.363 -0.835 . . . . 0.0 109.531 174.672 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' D' D ' 77' ' ' GLU . . . . . . . . . . . . . 97.7 mt-10 -135.26 137.81 42.91 Favored 'General case' 0 N--CA 1.463 0.202 0 CA-C-O 120.982 0.42 . . . . 0.0 111.183 -179.468 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' D' D ' 78' ' ' ALA . . . . . 0.528 ' HB2' HD21 ' D' ' 109' ' ' LEU . . . -131.41 142.12 49.97 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 115.885 -0.598 . . . . 0.0 110.199 177.492 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' D' D ' 79' ' ' LYS . . . . . 0.558 ' O ' HD13 ' D' ' 80' ' ' ILE . 71.2 mmtt -82.05 122.2 27.52 Favored 'General case' 0 C--N 1.331 -0.239 0 CA-C-O 121.058 0.456 . . . . 0.0 111.276 -178.031 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' D' D ' 80' ' ' ILE . . . . . 0.558 HD13 ' O ' ' D' ' 79' ' ' LYS . 41.6 mm -139.17 118.94 13.97 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.304 0 N-CA-C 108.926 -0.768 . . . . 0.0 108.926 179.889 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' D' D ' 81' ' ' LYS . . . . . . . . . . . . . 47.5 pttt -112.28 125.56 54.29 Favored 'General case' 0 N--CA 1.464 0.269 0 CA-C-O 121.051 0.453 . . . . 0.0 111.381 -177.051 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' D' D ' 82' ' ' GLY . . . . . . . . . . . . . . . 88.52 42.22 5.86 Favored Glycine 0 CA--C 1.525 0.677 0 C-N-CA 120.825 -0.702 . . . . 0.0 111.689 173.659 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' D' D ' 83' ' ' ILE . . . . . . . . . . . . . 70.1 mt -63.55 138.64 22.63 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.33 0 CA-C-O 121.017 0.437 . . . . 0.0 110.206 179.343 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' D' D ' 84' ' ' LYS . . . . . . . . . . . . . 83.7 tttt -96.96 -50.3 4.68 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 115.792 -0.64 . . . . 0.0 109.718 179.306 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' D' D ' 85' ' ' ASP . . . . . . . . . . . . . 9.8 t70 -158.63 152.52 23.57 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 115.636 -0.711 . . . . 0.0 110.182 179.214 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' D' D ' 86' ' ' VAL . . . . . . . . . . . . . 43.4 t -130.48 130.13 64.93 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.297 0 CA-C-O 120.863 0.364 . . . . 0.0 110.429 -178.991 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' D' D ' 87' ' ' ILE . . . . . 0.493 HD12 ' N ' ' D' ' 87' ' ' ILE . 5.0 mp -119.6 126.13 75.02 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.261 0 N-CA-C 109.43 -0.582 . . . . 0.0 109.43 176.696 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' D' D ' 88' ' ' LEU . . . . . 0.452 ' CD1' HG21 ' C' ' 131' ' ' VAL . 12.9 tp -113.45 126.19 55.06 Favored 'General case' 0 C--N 1.331 -0.23 0 CA-C-O 120.987 0.422 . . . . 0.0 111.29 -176.636 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' D' D ' 89' ' ' ASP . . . . . . . . . . . . . 9.3 t0 -118.52 151.42 37.88 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 115.871 -0.604 . . . . 0.0 109.524 175.77 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' D' D ' 90' ' ' GLU . . . . . . . . . . . . . 95.4 mt-10 -48.63 -36.85 16.72 Favored 'General case' 0 C--N 1.33 -0.263 0 N-CA-C 112.782 0.66 . . . . 0.0 112.782 -173.054 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' D' D ' 91' ' ' ASN . . . . . . . . . . . . . 36.2 m120 -130.95 31.58 4.45 Favored 'General case' 0 N--CA 1.465 0.307 0 N-CA-C 112.022 0.378 . . . . 0.0 112.022 -176.711 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' D' D ' 92' ' ' LEU . . . . . . . . . . . . . 13.1 tp -166.14 139.38 4.12 Favored 'General case' 0 C--N 1.33 -0.274 0 N-CA-C 110.06 -0.348 . . . . 0.0 110.06 -179.818 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' D' D ' 93' ' ' ILE . . . . . . . . . . . . . 66.2 mt -125.01 124.15 67.02 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.255 0 N-CA-C 109.698 -0.482 . . . . 0.0 109.698 -178.435 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' D' D ' 94' ' ' VAL . . . . . 0.422 HG21 HG11 ' D' ' 125' ' ' VAL . 43.0 t -125.72 127.15 71.2 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.256 0 CA-C-O 121.023 0.44 . . . . 0.0 110.169 -179.367 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' D' D ' 95' ' ' VAL . . . . . . . . . . . . . 43.7 t -122.17 135.4 62.39 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.262 0 CA-C-N 115.893 -0.594 . . . . 0.0 109.856 179.845 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' D' D ' 96' ' ' ILE . . . . . . . . . . . . . 58.5 mt -115.43 129.29 71.95 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.323 0 N-CA-C 109.24 -0.652 . . . . 0.0 109.24 179.631 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' D' D ' 97' ' ' THR . . . . . . . . . . . . . 69.7 p -103.92 157.71 16.91 Favored 'General case' 0 C--N 1.331 -0.211 0 CA-C-O 121.381 0.61 . . . . 0.0 111.631 -176.522 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' D' D ' 98' ' ' GLU . . . . . . . . . . . . . 44.6 tp10 -53.77 -29.05 38.31 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 115.832 -0.622 . . . . 0.0 112.16 -178.871 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' D' D ' 99' ' ' GLU . . . . . . . . . . . . . 12.9 pt-20 -80.1 18.07 0.91 Allowed 'General case' 0 CA--C 1.534 0.359 0 N-CA-C 113.12 0.785 . . . . 0.0 113.12 -176.419 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' D' D ' 100' ' ' ASN . . . . . . . . . . . . . 4.6 m-20 62.91 38.13 11.53 Favored 'General case' 0 CA--C 1.529 0.151 0 CA-C-O 121.039 0.447 . . . . 0.0 110.897 177.773 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' D' D ' 101' ' ' GLU . . . . . . . . . . . . . 82.8 tt0 -114.71 142.07 46.99 Favored 'General case' 0 C--N 1.332 -0.173 0 CA-C-N 116.111 -0.495 . . . . 0.0 109.743 176.707 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' D' D ' 102' ' ' VAL . . . . . . . . . . . . . 44.8 t -115.84 125.97 73.18 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.312 0 N-CA-C 109.754 -0.462 . . . . 0.0 109.754 -179.49 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' D' D ' 103' ' ' LEU . . . . . . . . . . . . . 47.7 mt -117.15 130.31 56.53 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 115.746 -0.661 . . . . 0.0 110.295 177.777 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' D' D ' 104' ' ' ILE . . . . . 0.4 HD13 HG21 ' D' ' 130' ' ' VAL . 68.9 mt -120.06 121.35 65.64 Favored 'Isoleucine or valine' 0 C--O 1.235 0.316 0 N-CA-C 110.095 -0.335 . . . . 0.0 110.095 -179.139 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' D' D ' 105' ' ' PHE . . . . . . . . . . . . . 62.5 m-85 -122.69 162.65 21.57 Favored 'General case' 0 C--N 1.332 -0.159 0 O-C-N 123.924 0.765 . . . . 0.0 110.099 -178.902 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' D' D ' 106' ' ' ASN . . . . . 0.401 ' HB3' HD11 ' D' ' 112' ' ' LEU . 43.5 p30 -96.03 -171.63 2.37 Favored 'General case' 0 C--N 1.328 -0.348 0 N-CA-C 109.368 -0.604 . . . . 0.0 109.368 172.174 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' D' D ' 107' ' ' GLN . . . . . . . . . . . . . 45.8 tt0 -60.97 -29.9 69.94 Favored 'General case' 0 C--N 1.329 -0.325 0 N-CA-C 112.027 0.38 . . . . 0.0 112.027 -178.634 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' D' D ' 108' ' ' ASN . . . . . . . . . . . . . 6.7 t-20 -82.58 8.59 11.42 Favored 'General case' 0 CA--C 1.537 0.463 0 N-CA-C 113.15 0.796 . . . . 0.0 113.15 -178.069 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' D' D ' 109' ' ' LEU . . . . . 0.528 HD21 ' HB2' ' D' ' 78' ' ' ALA . 11.7 tp 61.67 37.92 15.61 Favored 'General case' 0 CA--C 1.53 0.182 0 CA-C-O 121.089 0.471 . . . . 0.0 111.324 178.122 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' D' D ' 110' ' ' GLU . . . . . . . . . . . . . 70.7 mm-40 -105.72 154.5 20.38 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.272 -0.422 . . . . 0.0 110.058 175.98 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' D' D ' 111' ' ' GLU . . . . . . . . . . . . . 44.4 mt-10 -83.61 122.19 28.25 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-O 120.852 0.358 . . . . 0.0 111.336 -177.88 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' D' D ' 112' ' ' LEU . . . . . 0.401 HD11 ' HB3' ' D' ' 106' ' ' ASN . 95.0 mt -106.25 -45.92 4.18 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.054 -0.521 . . . . 0.0 109.903 175.516 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' D' D ' 113' ' ' TYR . . . . . . . . . . . . . 59.9 t80 -140.0 139.95 36.14 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-N 116.26 -0.427 . . . . 0.0 110.808 179.602 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' D' D ' 114' ' ' ARG . . . . . . . . . . . . . 34.2 ptt180 -145.31 123.01 11.84 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.222 -0.445 . . . . 0.0 110.536 178.579 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' D' D ' 115' ' ' GLY . . . . . . . . . . . . . . . -150.12 156.91 26.97 Favored Glycine 0 CA--C 1.525 0.717 0 C-N-CA 120.694 -0.765 . . . . 0.0 111.641 179.516 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' D' D ' 116' ' ' LYS . . . . . . . . . . . . . 27.1 ttpp -128.44 133.13 48.48 Favored 'General case' 0 C--N 1.33 -0.259 0 N-CA-C 109.826 -0.435 . . . . 0.0 109.826 176.849 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' D' D ' 117' ' ' PHE . . . . . 0.439 ' HE2' HD13 ' D' ' 132' ' ' ILE . 31.4 m-85 -130.41 113.94 14.95 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-O 120.85 0.357 . . . . 0.0 110.237 -175.896 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' D' D ' 118' ' ' GLU . . . . . . . . . . . . . 95.9 mt-10 -52.97 -47.88 67.84 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.477 -0.328 . . . . 0.0 111.491 -176.981 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' D' D ' 119' ' ' ASN . . . . . . . . . . . . . 3.6 m-20 -94.96 31.01 1.95 Allowed 'General case' 0 C--N 1.329 -0.326 0 N-CA-C 112.338 0.496 . . . . 0.0 112.338 -174.131 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' D' D ' 120' ' ' LEU . . . . . . . . . . . . . 18.6 tp -55.96 124.5 17.91 Favored 'General case' 0 C--N 1.333 -0.146 0 CA-C-O 120.565 0.222 . . . . 0.0 110.507 176.86 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' D' D ' 121' ' ' ASN . . . . . . . . . . . . . 35.1 m120 -111.94 -44.0 3.51 Favored 'General case' 0 C--N 1.331 -0.222 0 CA-C-N 116.596 -0.275 . . . . 0.0 110.959 -177.605 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' D' D ' 122' ' ' LYS . . . . . . . . . . . . . 97.9 mttt -144.73 146.1 32.02 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-O 121.001 0.429 . . . . 0.0 111.621 -178.112 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' D' D ' 123' ' ' VAL . . . . . . . . . . . . . 45.6 t -125.69 125.28 68.25 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.26 0 N-CA-C 109.446 -0.575 . . . . 0.0 109.446 175.162 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' D' D ' 124' ' ' LEU . . . . . . . . . . . . . 49.3 mt -124.07 131.05 53.51 Favored 'General case' 0 C--N 1.331 -0.227 0 CA-C-O 120.676 0.274 . . . . 0.0 110.737 -178.169 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' D' D ' 125' ' ' VAL . . . . . 0.449 ' CG2' HG21 ' D' ' 87' ' ' ILE . 34.8 m -132.09 131.48 61.26 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.294 0 CA-C-N 116.274 -0.421 . . . . 0.0 110.389 179.285 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' D' D ' 126' ' ' ARG . . . . . . . . . . . . . 94.3 mtt180 -144.13 125.44 14.71 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-O 121.068 0.461 . . . . 0.0 111.12 -179.555 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' D' D ' 127' ' ' ASN . . . . . . . . . . . . . 6.7 m120 49.98 -109.53 0.38 Allowed 'General case' 0 CA--C 1.545 0.772 0 CA-C-O 118.972 -0.537 . . . . 0.0 111.685 177.334 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' D' D ' 128' ' ' ASP . . . . . . . . . . . . . 11.3 p-10 -114.15 8.72 17.01 Favored 'General case' 0 N--CA 1.469 0.479 0 CA-C-N 119.71 1.141 . . . . 0.0 113.224 -176.194 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' D' D ' 129' ' ' LEU . . . . . . . . . . . . . 58.4 mt -121.98 143.63 49.36 Favored 'General case' 0 C--N 1.333 -0.145 0 N-CA-C 109.483 -0.562 . . . . 0.0 109.483 177.357 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' D' D ' 130' ' ' VAL . . . . . 0.4 HG21 HD13 ' D' ' 104' ' ' ILE . 34.9 m -134.8 146.04 31.38 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.288 0 CA-C-O 121.229 0.537 . . . . 0.0 110.644 179.848 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' D' D ' 131' ' ' VAL . . . . . . . . . . . . . 43.1 t -136.03 139.84 45.09 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.396 0 CA-C-N 115.758 -0.655 . . . . 0.0 110.112 -179.789 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' D' D ' 132' ' ' ILE . . . . . 0.439 HD13 ' HE2' ' D' ' 117' ' ' PHE . 71.6 mt -114.59 130.95 68.08 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.322 0 N-CA-C 109.209 -0.663 . . . . 0.0 109.209 178.89 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' D' D ' 133' ' ' ILE . . . . . . . . . . . . . 40.3 mm -112.45 118.94 59.09 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.263 0 CA-C-N 116.438 -0.346 . . . . 0.0 110.763 -174.767 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' D' D ' 134' ' ' ASP . . . . . . . . . . . . . 6.6 p-10 -129.0 145.27 51.29 Favored 'General case' 0 C--N 1.331 -0.214 0 N-CA-C 109.396 -0.594 . . . . 0.0 109.396 175.984 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' D' D ' 135' ' ' GLU . . . . . . . . . . . . . 39.7 tp10 -49.95 -27.32 5.19 Favored 'General case' 0 C--O 1.235 0.315 0 N-CA-C 112.63 0.604 . . . . 0.0 112.63 -174.155 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' D' D ' 136' ' ' GLN . . . . . . . . . . . . . 95.4 mt-30 -76.88 -39.5 50.81 Favored 'General case' 0 C--O 1.235 0.319 0 CA-C-O 120.814 0.34 . . . . 0.0 111.893 -177.884 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' D' D ' 137' ' ' LYS . . . . . . . . . . . . . 55.0 pttt -170.01 176.91 4.51 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-O 121.475 0.655 . . . . 0.0 112.328 -171.825 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' D' D ' 138' ' ' LEU . . . . . 0.411 ' C ' HD23 ' D' ' 138' ' ' LEU . 6.8 tt -117.23 129.3 55.84 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 115.065 -0.97 . . . . 0.0 110.317 -178.515 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' D' D ' 139' ' ' THR . . . . . . . . . . . . . 35.6 m -109.08 124.88 51.47 Favored 'General case' 0 C--N 1.331 -0.219 0 CA-C-N 116.024 -0.535 . . . . 0.0 110.179 178.577 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' D' D ' 140' ' ' LEU . . . . . 0.457 ' C ' HD23 ' D' ' 140' ' ' LEU . 5.8 tt -111.29 122.14 47.08 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 115.781 -0.645 . . . . 0.0 109.308 -178.145 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' D' D ' 141' ' ' ILE . . . . . 0.43 ' N ' HD23 ' D' ' 140' ' ' LEU . 19.6 mt -122.79 118.55 55.37 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.221 0 CA-C-O 121.177 0.513 . . . . 0.0 110.201 -175.993 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' D' D ' 142' ' ' ARG . . . . . . . . . . . . . 92.6 mtt180 -92.77 120.45 33.16 Favored 'General case' 0 C--O 1.234 0.24 0 CA-C-N 115.223 -0.899 . . . . 0.0 109.823 176.865 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' D' D ' 143' ' ' THR . . . . . . . . . . . . . 67.1 p . . . . . 0 C--O 1.221 -0.428 0 CA-C-O 118.006 -0.997 . . . . 0.0 110.464 179.724 . . . . . . . . 0 0 . 1 . 016 nuclear nobuild core ' E' E ' 2' ' ' SER . . . . . . . . . . . . . 13.1 p . . . . . 0 N--CA 1.462 0.136 0 CA-C-O 121.087 0.47 . . . . 0.0 110.809 . . . . . . . . . 0 0 . 1 . 016 nuclear nobuild core ' E' E ' 3' ' ' GLU . . . . . . . . . . . . . 46.8 tt0 -152.46 145.63 24.65 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 116.059 -0.519 . . . . 0.0 111.152 -177.227 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' E' E ' 4' ' ' LEU . . . . . . . . . . . . . 18.4 tp -124.04 129.4 50.84 Favored 'General case' 0 C--N 1.331 -0.198 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.281 177.397 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' E' E ' 5' ' ' LYS . . . . . . . . . . . . . 67.6 mttm -108.24 123.1 48.26 Favored 'General case' 0 C--N 1.331 -0.215 0 CA-C-N 116.339 -0.391 . . . . 0.0 110.888 179.047 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' E' E ' 6' ' ' LEU . . . . . . . . . . . . . 33.7 mt -115.83 146.3 42.1 Favored 'General case' 0 N--CA 1.464 0.227 0 CA-C-N 115.641 -0.709 . . . . 0.0 110.155 179.132 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' E' E ' 7' ' ' LYS . . . . . . . . . . . . . 31.2 ttmt -128.32 136.76 29.57 Favored Pre-proline 0 CA--C 1.534 0.329 0 CA-C-O 118.88 -0.581 . . . . 0.0 109.585 174.912 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' E' E ' 8' ' ' PRO . . . . . . . . . . . . . 83.1 Cg_endo -92.0 141.51 2.47 Favored 'Trans proline' 0 N--CA 1.49 1.271 0 C-N-CA 121.719 1.613 . . . . 0.0 112.126 178.53 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' E' E ' 9' ' ' LEU . . . . . . . . . . . . . 20.3 mt -78.95 -46.91 1.72 Allowed Pre-proline 0 CA--C 1.534 0.359 0 CA-C-O 118.628 -0.701 . . . . 0.0 111.712 178.419 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' E' E ' 10' ' ' PRO . . . . . . . . . . . . . 91.5 Cg_endo -81.79 150.79 16.54 Favored 'Trans proline' 0 N--CA 1.495 1.615 0 C-N-CA 121.156 1.237 . . . . 0.0 111.539 174.645 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' E' E ' 11' ' ' LYS . . . . . . . . . . . . . 25.1 pttm -86.91 115.84 24.58 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-O 121.389 0.614 . . . . 0.0 110.742 179.423 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' E' E ' 12' ' ' VAL . . . . . . . . . . . . . 12.4 p -151.16 144.77 16.64 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.295 0 CA-C-N 115.822 -0.627 . . . . 0.0 110.341 177.496 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' E' E ' 13' ' ' GLU . . . . . . . . . . . . . 81.5 tt0 -92.83 114.18 26.67 Favored 'General case' 0 C--N 1.329 -0.32 0 N-CA-C 109.749 -0.463 . . . . 0.0 109.749 176.13 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' E' E ' 14' ' ' LEU . . . . . . . . . . . . . 27.9 mt -86.29 144.22 37.96 Favored Pre-proline 0 CA--C 1.533 0.301 0 CA-C-O 119.075 -0.488 . . . . 0.0 110.238 -176.508 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' E' E ' 15' ' ' PRO . . . . . . . . . . . . . 29.4 Cg_exo -60.34 162.62 16.83 Favored 'Trans proline' 0 N--CA 1.498 1.758 0 C-N-CA 121.271 1.314 . . . . 0.0 111.667 178.221 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' E' E ' 16' ' ' PRO . . . . . . . . . . . . . 33.0 Cg_exo -59.09 -38.86 84.7 Favored 'Trans proline' 0 N--CA 1.497 1.711 0 C-N-CA 121.511 1.474 . . . . 0.0 112.904 -176.892 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' E' E ' 17' ' ' ASP . . . . . . . . . . . . . 14.8 p-10 -83.94 1.67 42.41 Favored 'General case' 0 C--N 1.327 -0.383 0 N-CA-C 113.326 0.861 . . . . 0.0 113.326 -177.376 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' E' E ' 18' ' ' PHE . . . . . 0.405 ' CZ ' HD11 ' E' ' 22' ' ' ILE . 61.5 t80 -58.15 -46.4 85.73 Favored 'General case' 0 N--CA 1.457 -0.088 0 O-C-N 121.899 -0.5 . . . . 0.0 110.255 -178.048 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' E' E ' 19' ' ' VAL . . . . . . . . . . . . . 46.6 t -55.45 -43.02 70.39 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.264 0 CA-C-N 116.269 -0.423 . . . . 0.0 110.639 -178.082 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' E' E ' 20' ' ' ASP . . . . . . . . . . . . . 9.5 t0 -60.31 -43.15 96.61 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-O 120.803 0.335 . . . . 0.0 110.844 -178.588 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' E' E ' 21' ' ' VAL . . . . . . . . . . . . . 47.5 t -64.19 -45.88 95.06 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.299 0 C-N-CA 120.882 -0.327 . . . . 0.0 110.603 -177.851 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' E' E ' 22' ' ' ILE . . . . . 0.608 HG22 HD12 ' E' ' 26' ' ' LEU . 51.5 mm -55.53 -46.27 78.89 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.251 0 CA-C-O 120.822 0.344 . . . . 0.0 110.521 178.372 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' E' E ' 23' ' ' ARG . . . . . . . . . . . . . 60.0 ttp180 -53.31 -50.88 64.01 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.65 -0.25 . . . . 0.0 111.509 179.744 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' E' E ' 24' ' ' ILE . . . . . . . . . . . . . 73.7 mt -58.81 -42.9 86.87 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.27 0 CA-C-N 116.546 -0.297 . . . . 0.0 111.332 -176.737 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' E' E ' 25' ' ' LYS . . . . . . . . . . . . . 93.1 mttt -68.88 -38.59 79.79 Favored 'General case' 0 C--N 1.328 -0.332 0 N-CA-C 112.379 0.511 . . . . 0.0 112.379 -177.639 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' E' E ' 26' ' ' LEU . . . . . 0.608 HD12 HG22 ' E' ' 22' ' ' ILE . 78.3 mt -79.85 -38.81 31.96 Favored 'General case' 0 C--N 1.331 -0.236 0 N-CA-C 113.311 0.856 . . . . 0.0 113.311 -170.947 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' E' E ' 27' ' ' GLN . . . . . . . . . . . . . 10.3 pt20 -46.79 140.03 4.93 Favored 'General case' 0 N--CA 1.47 0.559 0 N-CA-C 112.643 0.609 . . . . 0.0 112.643 -175.376 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' E' E ' 28' ' ' GLY . . . . . . . . . . . . . . . 101.4 -26.02 26.06 Favored Glycine 0 CA--C 1.533 1.201 0 CA-C-N 115.57 -0.741 . . . . 0.0 112.174 -175.811 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' E' E ' 29' ' ' LYS . . . . . . . . . . . . . 88.0 mttt -97.51 155.06 17.11 Favored 'General case' 0 C--O 1.232 0.178 0 CA-C-N 117.374 0.587 . . . . 0.0 111.147 178.713 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' E' E ' 30' ' ' THR . . . . . . . . . . . . . 20.8 m -102.57 140.72 36.48 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 115.947 -0.57 . . . . 0.0 110.28 176.735 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' E' E ' 31' ' ' VAL . . . . . . . . . . . . . 34.9 m -128.4 147.48 32.94 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.25 0 CA-C-O 120.901 0.381 . . . . 0.0 110.64 -179.566 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' E' E ' 32' ' ' ARG . . . . . . . . . . . . . 68.8 ttt-85 -130.12 147.16 51.82 Favored 'General case' 0 C--N 1.331 -0.21 0 CA-C-N 116.07 -0.514 . . . . 0.0 110.415 179.541 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' E' E ' 33' ' ' THR . . . . . . . . . . . . . 22.9 m -52.46 139.36 25.28 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 116.458 -0.337 . . . . 0.0 111.594 -177.958 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' E' E ' 34' ' ' GLY . . . . . . . . . . . . . . . 97.48 -17.13 59.52 Favored Glycine 0 CA--C 1.533 1.179 0 C-N-CA 121.176 -0.535 . . . . 0.0 113.322 178.837 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' E' E ' 35' ' ' ASP . . . . . . . . . . . . . 77.1 m-20 -66.16 151.17 47.53 Favored 'General case' 0 C--O 1.231 0.087 0 CA-C-N 118.032 0.916 . . . . 0.0 111.057 179.838 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' E' E ' 36' ' ' VAL . . . . . . . . . . . . . 44.1 t -123.95 128.05 73.95 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.236 0 N-CA-C 109.678 -0.49 . . . . 0.0 109.678 177.038 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' E' E ' 37' ' ' ILE . . . . . . . . . . . . . 60.7 mt -120.78 137.5 54.31 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.26 0 CA-C-N 116.023 -0.535 . . . . 0.0 109.87 -179.473 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' E' E ' 38' ' ' GLY . . . . . . . . . . . . . . . -113.91 127.35 7.77 Favored Glycine 0 CA--C 1.526 0.748 0 N-CA-C 110.854 -0.898 . . . . 0.0 110.854 178.867 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' E' E ' 39' ' ' ILE . . . . . . . . . . . . . 72.7 mt -126.23 126.53 69.57 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.237 0 N-CA-C 110.005 -0.368 . . . . 0.0 110.005 179.451 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' E' E ' 40' ' ' SER . . . . . . . . . . . . . 80.2 p -93.33 123.1 36.38 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.398 -0.364 . . . . 0.0 111.052 176.423 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' E' E ' 41' ' ' ILE . . . . . . . . . . . . . 71.4 mt -137.3 127.97 39.38 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.215 0 CA-C-O 120.943 0.401 . . . . 0.0 110.21 177.11 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' E' E ' 42' ' ' LEU . . . . . . . . . . . . . 8.7 tp 58.47 35.15 24.5 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.045 -0.525 . . . . 0.0 111.522 179.257 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' E' E ' 43' ' ' GLY . . . . . . . . . . . . . . . 72.48 14.61 77.37 Favored Glycine 0 CA--C 1.535 1.285 0 C-N-CA 121.246 -0.502 . . . . 0.0 113.222 176.933 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' E' E ' 44' ' ' LYS . . . . . . . . . . . . . 72.0 mmtt -124.45 130.28 52.18 Favored 'General case' 0 N--CA 1.462 0.172 0 CA-C-N 117.89 0.845 . . . . 0.0 110.203 178.129 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' E' E ' 45' ' ' GLU . . . . . . . . . . . . . 79.1 tt0 -85.34 122.78 30.0 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 115.954 -0.567 . . . . 0.0 111.11 -179.812 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' E' E ' 46' ' ' VAL . . . . . 0.406 ' O ' HG13 ' E' ' 46' ' ' VAL . 10.9 p -118.82 123.0 70.79 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.197 0 N-CA-C 109.555 -0.535 . . . . 0.0 109.555 174.376 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' E' E ' 47' ' ' LYS . . . . . . . . . . . . . 68.1 mttm -99.33 126.93 45.28 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 115.984 -0.553 . . . . 0.0 111.014 179.114 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' E' E ' 48' ' ' PHE . . . . . . . . . . . . . 29.1 m-85 -111.09 131.82 54.77 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.116 -0.493 . . . . 0.0 109.944 177.446 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' E' E ' 49' ' ' LYS . . . . . . . . . . . . . 80.9 tttt -107.11 137.19 45.64 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.374 -0.376 . . . . 0.0 110.284 177.557 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' E' E ' 50' ' ' VAL . . . . . . . . . . . . . 42.9 t -74.15 106.72 4.19 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.345 0 N-CA-C 109.812 -0.44 . . . . 0.0 109.812 178.682 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' E' E ' 51' ' ' VAL . . . . . . . . . . . . . 46.1 t -70.75 -50.34 44.73 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.277 0 O-C-N 123.65 0.594 . . . . 0.0 109.704 -176.104 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' E' E ' 52' ' ' GLN . . . . . . . . . . . . . 56.3 tt0 -168.02 138.19 2.66 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 115.908 -0.587 . . . . 0.0 111.145 -179.19 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' E' E ' 53' ' ' ALA . . . . . . . . . . . . . . . -112.15 132.4 54.9 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 115.873 -0.603 . . . . 0.0 110.135 177.04 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' E' E ' 54' ' ' TYR . . . . . . . . . . . . . 22.9 t80 -127.97 107.22 20.1 Favored Pre-proline 0 CA--C 1.534 0.345 0 CA-C-O 118.285 -0.864 . . . . 0.0 110.364 179.778 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' E' E ' 55' ' ' PRO . . . . . . . . . . . . . 73.3 Cg_endo -77.06 170.05 72.7 Favored 'Cis proline' 0 N--CA 1.5 1.888 0 CA-C-N 121.682 1.637 . . . . 0.0 112.488 -5.286 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' E' E ' 56' ' ' SER . . . . . . . . . . . . . 70.5 m -115.54 129.93 24.73 Favored Pre-proline 0 CA--C 1.539 0.538 0 CA-C-O 118.427 -0.796 . . . . 0.0 109.35 175.391 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' E' E ' 57' ' ' PRO . . . . . . . . . . . . . 60.8 Cg_endo -74.34 150.61 95.81 Favored 'Cis proline' 0 N--CA 1.497 1.684 0 CA-C-N 121.952 1.733 . . . . 0.0 111.722 -0.31 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' E' E ' 58' ' ' LEU . . . . . . . . . . . . . 21.4 tp -109.02 138.11 45.88 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 116.299 -0.409 . . . . 0.0 110.85 -177.84 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' E' E ' 59' ' ' ARG . . . . . . . . . . . . . 78.0 ttt180 -101.75 125.88 48.5 Favored 'General case' 0 C--N 1.328 -0.339 0 N-CA-C 109.244 -0.65 . . . . 0.0 109.244 173.537 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' E' E ' 60' ' ' VAL . . . . . . . . . . . . . 46.8 t -77.81 114.64 18.6 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.308 0 C-N-CA 120.72 -0.392 . . . . 0.0 110.378 -176.88 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' E' E ' 61' ' ' GLU . . . . . . . . . . . . . 44.2 mt-10 -131.01 161.19 32.51 Favored 'General case' 0 C--N 1.332 -0.167 0 CA-C-N 115.933 -0.576 . . . . 0.0 110.012 177.663 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' E' E ' 62' ' ' ASP . . . . . . . . . . . . . 77.9 m-20 -54.4 -33.71 59.86 Favored 'General case' 0 C--N 1.328 -0.352 0 N-CA-C 112.088 0.403 . . . . 0.0 112.088 -175.798 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' E' E ' 63' ' ' ARG . . . . . . . . . . . . . 25.0 mmm180 -74.87 -17.21 60.62 Favored 'General case' 0 CA--C 1.535 0.391 0 N-CA-C 113.125 0.787 . . . . 0.0 113.125 -175.427 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' E' E ' 64' ' ' THR . . . . . . . . . . . . . 11.4 m -75.77 142.93 42.24 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-O 120.852 0.358 . . . . 0.0 110.865 -176.131 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' E' E ' 65' ' ' LYS . . . . . . . . . . . . . 95.6 mttt -89.63 139.76 30.23 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.111 -0.495 . . . . 0.0 110.531 179.938 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' E' E ' 66' ' ' ILE . . . . . . . . . . . . . 55.3 mt -113.81 133.37 59.99 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.287 0 N-CA-C 109.837 -0.431 . . . . 0.0 109.837 178.256 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' E' E ' 67' ' ' THR . . . . . . . . . . . . . 25.3 m -128.34 139.14 52.56 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-O 121.056 0.455 . . . . 0.0 111.166 -178.191 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' E' E ' 68' ' ' LEU . . . . . 0.489 HD12 ' N ' ' E' ' 68' ' ' LEU . 7.2 mp . . . . . 0 C--N 1.328 -0.336 0 CA-C-N 115.826 -0.625 . . . . 0.0 109.853 176.411 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' E' E ' 73' ' ' VAL . . . . . . . . . . . . . 34.7 m . . . . . 0 N--CA 1.462 0.138 0 CA-C-O 120.98 0.419 . . . . 0.0 110.616 . . . . . . . . . 0 0 . 1 . 016 nuclear nobuild core ' E' E ' 74' ' ' ASP . . . . . . . . . . . . . 9.7 t0 -104.33 120.39 41.09 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.025 -0.534 . . . . 0.0 109.822 179.104 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' E' E ' 75' ' ' VAL . . . . . . . . . . . . . 40.5 t -114.39 123.05 69.68 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.18 0 CA-C-O 121.055 0.455 . . . . 0.0 110.955 -175.4 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' E' E ' 76' ' ' LEU . . . . . . . . . . . . . 6.0 mp -123.34 146.71 47.72 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 115.657 -0.701 . . . . 0.0 109.591 175.632 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' E' E ' 77' ' ' GLU . . . . . . . . . . . . . 97.1 mt-10 -134.03 140.84 46.95 Favored 'General case' 0 N--CA 1.463 0.207 0 CA-C-O 121.167 0.508 . . . . 0.0 111.383 -178.418 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' E' E ' 78' ' ' ALA . . . . . . . . . . . . . . . -130.51 129.51 42.98 Favored 'General case' 0 C--N 1.332 -0.193 0 CA-C-N 115.684 -0.689 . . . . 0.0 109.751 175.849 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' E' E ' 79' ' ' LYS . . . . . 0.714 ' O ' HD13 ' E' ' 80' ' ' ILE . 37.3 mmtm -71.74 119.54 16.04 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-O 120.886 0.374 . . . . 0.0 110.981 -178.234 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' E' E ' 80' ' ' ILE . . . . . 0.714 HD13 ' O ' ' E' ' 79' ' ' LYS . 32.1 mm -139.31 99.91 1.32 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.259 0 N-CA-C 109.089 -0.708 . . . . 0.0 109.089 -178.213 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' E' E ' 81' ' ' LYS . . . . . . . . . . . . . 53.0 pttt -101.51 128.13 47.89 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-O 121.103 0.478 . . . . 0.0 111.31 -176.639 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' E' E ' 82' ' ' GLY . . . . . . . . . . . . . . . 89.21 41.95 5.7 Favored Glycine 0 CA--C 1.526 0.777 0 CA-C-N 115.799 -0.637 . . . . 0.0 111.66 177.2 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' E' E ' 83' ' ' ILE . . . . . . . . . . . . . 73.7 mt -68.94 144.66 13.95 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 CA-C-O 121.034 0.445 . . . . 0.0 110.234 179.078 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' E' E ' 84' ' ' LYS . . . . . . . . . . . . . 87.6 tttt -100.99 -51.77 3.46 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 115.792 -0.64 . . . . 0.0 109.993 -179.905 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' E' E ' 85' ' ' ASP . . . . . . . . . . . . . 7.9 t70 -160.44 154.69 23.33 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 115.597 -0.729 . . . . 0.0 110.057 179.459 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' E' E ' 86' ' ' VAL . . . . . . . . . . . . . 40.6 t -132.95 131.61 59.04 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.212 0 CA-C-O 121.06 0.457 . . . . 0.0 110.576 -178.588 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' E' E ' 87' ' ' ILE . . . . . . . . . . . . . 44.9 mm -119.45 128.23 75.86 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.208 0 CA-C-N 115.804 -0.634 . . . . 0.0 109.556 176.515 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' E' E ' 88' ' ' LEU . . . . . . . . . . . . . 84.2 mt -110.29 137.82 47.5 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-O 121.111 0.481 . . . . 0.0 111.499 -177.363 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' E' E ' 89' ' ' ASP . . . . . . . . . . . . . 10.9 t70 -127.07 153.23 46.24 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 115.502 -0.772 . . . . 0.0 109.074 174.436 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' E' E ' 90' ' ' GLU . . . . . . . . . . . . . 95.8 mt-10 -48.06 -36.91 13.9 Favored 'General case' 0 C--N 1.33 -0.244 0 N-CA-C 112.903 0.705 . . . . 0.0 112.903 -172.605 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' E' E ' 91' ' ' ASN . . . . . . . . . . . . . 27.6 m120 -132.06 32.03 4.08 Favored 'General case' 0 N--CA 1.465 0.277 0 N-CA-C 112.102 0.408 . . . . 0.0 112.102 -176.848 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' E' E ' 92' ' ' LEU . . . . . . . . . . . . . 8.1 tp -166.09 152.94 9.59 Favored 'General case' 0 C--N 1.33 -0.247 0 C-N-CA 120.897 -0.321 . . . . 0.0 110.81 -179.44 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' E' E ' 93' ' ' ILE . . . . . . . . . . . . . 73.0 mt -130.37 129.91 65.08 Favored 'Isoleucine or valine' 0 N--CA 1.462 0.166 0 N-CA-C 109.971 -0.381 . . . . 0.0 109.971 179.171 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' E' E ' 94' ' ' VAL . . . . . . . . . . . . . 44.7 t -122.56 125.0 71.97 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.246 0 N-CA-C 109.597 -0.52 . . . . 0.0 109.597 176.942 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' E' E ' 95' ' ' VAL . . . . . . . . . . . . . 43.5 t -120.66 134.52 63.82 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.295 0 CA-C-N 116.285 -0.416 . . . . 0.0 110.145 -177.929 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' E' E ' 96' ' ' ILE . . . . . . . . . . . . . 66.9 mt -115.83 129.4 72.25 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 N-CA-C 109.361 -0.607 . . . . 0.0 109.361 178.985 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' E' E ' 97' ' ' THR . . . . . . . . . . . . . 77.8 p -101.28 155.89 17.76 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-O 121.033 0.444 . . . . 0.0 111.111 -178.028 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' E' E ' 98' ' ' GLU . . . . . . . . . . . . . 12.8 pt-20 -54.05 -22.14 10.07 Favored 'General case' 0 CA--C 1.535 0.393 0 N-CA-C 112.613 0.598 . . . . 0.0 112.613 -179.256 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' E' E ' 99' ' ' GLU . . . . . . . . . . . . . 31.2 tt0 -83.38 18.15 1.9 Allowed 'General case' 0 CA--C 1.536 0.417 0 N-CA-C 112.79 0.663 . . . . 0.0 112.79 -177.333 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' E' E ' 100' ' ' ASN . . . . . . . . . . . . . 2.6 m-20 62.16 37.98 14.03 Favored 'General case' 0 CA--C 1.53 0.198 0 CA-C-O 121.011 0.434 . . . . 0.0 110.828 177.961 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' E' E ' 101' ' ' GLU . . . . . . . . . . . . . 81.4 tt0 -119.75 141.55 49.35 Favored 'General case' 0 C--N 1.332 -0.195 0 N-CA-C 109.765 -0.457 . . . . 0.0 109.765 177.684 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' E' E ' 102' ' ' VAL . . . . . . . . . . . . . 41.0 t -115.12 128.69 72.2 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.271 0 N-CA-C 110.216 -0.29 . . . . 0.0 110.216 -178.238 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' E' E ' 103' ' ' LEU . . . . . . . . . . . . . 7.0 mp -116.5 136.69 52.77 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 115.559 -0.746 . . . . 0.0 109.93 176.864 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' E' E ' 104' ' ' ILE . . . . . 0.498 HD12 ' HB3' ' E' ' 113' ' ' TYR . 68.2 mt -116.02 121.82 68.26 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.259 0 N-CA-C 109.766 -0.457 . . . . 0.0 109.766 179.742 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' E' E ' 105' ' ' PHE . . . . . . . . . . . . . 93.0 m-85 -123.33 165.76 16.44 Favored 'General case' 0 C--N 1.332 -0.163 0 O-C-N 124.281 0.988 . . . . 0.0 109.997 -177.713 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' E' E ' 106' ' ' ASN . . . . . . . . . . . . . 46.0 p-10 -104.0 -171.61 1.96 Allowed 'General case' 0 C--N 1.331 -0.197 0 N-CA-C 109.61 -0.515 . . . . 0.0 109.61 171.205 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' E' E ' 107' ' ' GLN . . . . . . . . . . . . . 20.7 tt0 -60.55 -24.37 65.35 Favored 'General case' 0 CA--C 1.534 0.35 0 N-CA-C 112.221 0.452 . . . . 0.0 112.221 179.831 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' E' E ' 108' ' ' ASN . . . . . . . . . . . . . 26.1 t30 -90.19 13.66 14.57 Favored 'General case' 0 CA--C 1.534 0.356 0 N-CA-C 112.978 0.733 . . . . 0.0 112.978 -178.609 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' E' E ' 109' ' ' LEU . . . . . . . . . . . . . 46.0 mt 56.73 35.24 25.91 Favored 'General case' 0 CA--C 1.53 0.206 0 CA-C-N 117.866 0.303 . . . . 0.0 111.557 177.511 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' E' E ' 110' ' ' GLU . . . . . . . . . . . . . 71.0 mm-40 -102.38 146.8 27.53 Favored 'General case' 0 C--N 1.33 -0.269 0 N-CA-C 109.906 -0.405 . . . . 0.0 109.906 176.926 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' E' E ' 111' ' ' GLU . . . . . . . . . . . . . 79.6 tt0 -82.29 124.73 30.23 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-O 120.953 0.406 . . . . 0.0 111.254 -175.993 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' E' E ' 112' ' ' LEU . . . . . . . . . . . . . 15.4 mt -108.38 -46.05 3.78 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 115.915 -0.584 . . . . 0.0 110.061 176.569 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' E' E ' 113' ' ' TYR . . . . . 0.498 ' HB3' HD12 ' E' ' 104' ' ' ILE . 48.3 t80 -142.55 145.06 33.22 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.169 -0.469 . . . . 0.0 111.317 -178.915 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' E' E ' 114' ' ' ARG . . . . . . . . . . . . . 55.1 ttp180 -151.02 125.26 9.38 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-O 121.065 0.459 . . . . 0.0 110.448 174.798 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' E' E ' 115' ' ' GLY . . . . . . . . . . . . . . . -150.13 155.65 26.34 Favored Glycine 0 CA--C 1.524 0.64 0 N-CA-C 110.67 -0.972 . . . . 0.0 110.67 178.374 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' E' E ' 116' ' ' LYS . . . . . . . . . . . . . 38.8 ttpt -114.9 140.29 49.1 Favored 'General case' 0 C--N 1.331 -0.197 0 O-C-N 122.593 -0.357 . . . . 0.0 110.338 179.14 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' E' E ' 117' ' ' PHE . . . . . . . . . . . . . 41.4 m-85 -133.95 114.59 13.43 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.2 -0.455 . . . . 0.0 110.17 -177.778 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' E' E ' 118' ' ' GLU . . . . . . . . . . . . . 70.8 mm-40 -51.28 -53.16 38.34 Favored 'General case' 0 C--N 1.33 -0.27 0 N-CA-C 111.837 0.31 . . . . 0.0 111.837 -175.925 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' E' E ' 119' ' ' ASN . . . . . . . . . . . . . 25.2 m120 -94.22 31.07 1.76 Allowed 'General case' 0 C--N 1.328 -0.334 0 N-CA-C 112.176 0.436 . . . . 0.0 112.176 -174.128 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' E' E ' 120' ' ' LEU . . . . . . . . . . . . . 12.9 tp -54.33 119.82 5.7 Favored 'General case' 0 N--CA 1.464 0.257 0 CA-C-O 120.749 0.309 . . . . 0.0 110.854 179.156 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' E' E ' 121' ' ' ASN . . . . . . . . . . . . . 88.8 m-20 -114.1 -44.03 3.18 Favored 'General case' 0 C--N 1.332 -0.176 0 CA-C-N 116.356 -0.384 . . . . 0.0 111.141 -178.036 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' E' E ' 122' ' ' LYS . . . . . . . . . . . . . 63.2 mtpt -140.63 148.61 41.14 Favored 'General case' 0 C--N 1.331 -0.211 0 CA-C-O 121.137 0.494 . . . . 0.0 111.682 -175.754 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' E' E ' 123' ' ' VAL . . . . . . . . . . . . . 43.5 t -131.27 126.45 58.81 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.261 0 CA-C-N 115.79 -0.641 . . . . 0.0 109.359 174.052 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' E' E ' 124' ' ' LEU . . . . . . . . . . . . . 41.1 mt -121.61 135.61 54.98 Favored 'General case' 0 C--N 1.331 -0.22 0 CA-C-N 116.496 -0.32 . . . . 0.0 110.565 -177.898 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' E' E ' 125' ' ' VAL . . . . . . . . . . . . . 11.6 p -134.0 129.26 54.11 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.277 0 CA-C-N 116.257 -0.429 . . . . 0.0 110.249 179.151 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' E' E ' 126' ' ' ARG . . . . . . . . . . . . . 52.1 mmm-85 -137.33 116.16 12.27 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.348 179.32 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' E' E ' 127' ' ' ASN . . . . . . . . . . . . . 7.1 m-80 52.65 -104.85 0.21 Allowed 'General case' 0 CA--C 1.543 0.689 0 CA-C-O 119.205 -0.426 . . . . 0.0 111.273 178.956 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' E' E ' 128' ' ' ASP . . . . . . . . . . . . . 10.9 p-10 -114.1 2.25 14.86 Favored 'General case' 0 N--CA 1.468 0.468 0 CA-C-N 119.48 1.036 . . . . 0.0 113.464 -176.458 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' E' E ' 129' ' ' LEU . . . . . . . . . . . . . 14.5 tp -105.36 135.1 47.36 Favored 'General case' 0 C--N 1.333 -0.146 0 CA-C-N 118.233 0.469 . . . . 0.0 110.012 179.018 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' E' E ' 130' ' ' VAL . . . . . . . . . . . . . 43.1 t -121.32 135.58 61.03 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.192 0 CA-C-O 120.897 0.379 . . . . 0.0 110.003 -178.288 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' E' E ' 131' ' ' VAL . . . . . . . . . . . . . 43.5 t -135.64 134.14 51.65 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.202 0 CA-C-O 120.991 0.424 . . . . 0.0 110.176 178.541 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' E' E ' 132' ' ' ILE . . . . . . . . . . . . . 71.5 mt -116.86 132.32 66.94 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.352 0 CA-C-N 115.713 -0.676 . . . . 0.0 109.357 179.748 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' E' E ' 133' ' ' ILE . . . . . . . . . . . . . 39.9 mm -116.0 119.26 61.37 Favored 'Isoleucine or valine' 0 C--O 1.234 0.25 0 CA-C-O 120.79 0.329 . . . . 0.0 111.029 -173.862 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' E' E ' 134' ' ' ASP . . . . . . . . . . . . . 10.4 p-10 -131.11 144.98 51.81 Favored 'General case' 0 C--N 1.332 -0.18 0 N-CA-C 109.454 -0.573 . . . . 0.0 109.454 174.584 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' E' E ' 135' ' ' GLU . . . . . . . . . . . . . 80.0 tt0 -49.8 -26.07 3.62 Favored 'General case' 0 C--N 1.328 -0.334 0 N-CA-C 112.95 0.722 . . . . 0.0 112.95 -171.656 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' E' E ' 136' ' ' GLN . . . . . . . . . . . . . 35.0 tt0 -80.9 -38.33 28.15 Favored 'General case' 0 C--O 1.234 0.256 0 N-CA-C 111.887 0.328 . . . . 0.0 111.887 -176.417 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' E' E ' 137' ' ' LYS . . . . . . . . . . . . . 15.3 pttp -162.02 171.56 17.37 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-O 121.602 0.715 . . . . 0.0 112.119 -172.423 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' E' E ' 138' ' ' LEU . . . . . 0.484 HD23 ' N ' ' E' ' 139' ' ' THR . 3.6 tt -114.07 126.51 55.19 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 114.864 -1.062 . . . . 0.0 109.744 179.171 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' E' E ' 139' ' ' THR . . . . . 0.484 ' N ' HD23 ' E' ' 138' ' ' LEU . 26.2 m -105.32 123.39 47.78 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.338 -0.392 . . . . 0.0 110.529 -179.858 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' E' E ' 140' ' ' LEU . . . . . 0.472 ' C ' HD23 ' E' ' 140' ' ' LEU . 7.6 tt -110.67 122.28 47.41 Favored 'General case' 0 C--N 1.327 -0.401 0 N-CA-C 109.251 -0.648 . . . . 0.0 109.251 -179.35 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' E' E ' 141' ' ' ILE . . . . . . . . . . . . . 19.7 mt -122.46 113.89 40.28 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.264 0 N-CA-C 109.786 -0.45 . . . . 0.0 109.786 -176.45 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' E' E ' 142' ' ' ARG . . . . . . . . . . . . . 67.8 ttp85 -103.05 129.7 49.94 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 115.416 -0.811 . . . . 0.0 110.831 -177.934 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' E' E ' 143' ' ' THR . . . . . . . . . . . . . 81.3 p . . . . . 0 C--O 1.22 -0.47 0 CA-C-O 117.873 -1.06 . . . . 0.0 110.834 179.463 . . . . . . . . 0 0 . 1 . 016 nuclear nobuild core ' F' F ' 1' ' ' MET . . . . . . . . . . . . . 23.5 ptp . . . . . 0 C--O 1.232 0.169 0 CA-C-O 120.733 0.301 . . . . 0.0 110.685 . . . . . . . . . 0 0 . 1 . 016 nuclear nobuild core ' F' F ' 2' ' ' SER . . . . . . . . . . . . . 6.8 p -114.45 132.55 56.22 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.252 -0.431 . . . . 0.0 110.723 -179.566 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' F' F ' 3' ' ' GLU . . . . . . . . . . . . . 81.8 tt0 -141.35 141.06 33.87 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 115.963 -0.562 . . . . 0.0 111.032 -179.07 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' F' F ' 4' ' ' LEU . . . . . . . . . . . . . 15.2 tp -125.58 132.02 52.61 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.049 -0.523 . . . . 0.0 110.01 176.618 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' F' F ' 5' ' ' LYS . . . . . . . . . . . . . 65.1 mttm -111.61 120.18 41.21 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.249 -0.432 . . . . 0.0 110.606 -179.673 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' F' F ' 6' ' ' LEU . . . . . . . . . . . . . 67.1 mt -114.35 150.34 34.72 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 115.477 -0.783 . . . . 0.0 110.279 -178.609 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' F' F ' 7' ' ' LYS . . . . . . . . . . . . . 40.9 tttp -137.65 139.72 27.8 Favored Pre-proline 0 CA--C 1.534 0.353 0 CA-C-O 119.048 -0.501 . . . . 0.0 110.145 176.758 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' F' F ' 8' ' ' PRO . . . . . . . . . . . . . 94.0 Cg_endo -90.21 139.92 3.13 Favored 'Trans proline' 0 N--CA 1.489 1.263 0 C-N-CA 121.746 1.63 . . . . 0.0 111.662 177.575 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' F' F ' 9' ' ' LEU . . . . . . . . . . . . . 46.8 mt -78.7 -47.64 1.81 Allowed Pre-proline 0 CA--C 1.533 0.3 0 CA-C-O 118.652 -0.689 . . . . 0.0 112.181 -178.963 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' F' F ' 10' ' ' PRO . . . . . . . . . . . . . 92.1 Cg_endo -79.47 150.18 21.9 Favored 'Trans proline' 0 N--CA 1.496 1.647 0 C-N-CA 121.139 1.226 . . . . 0.0 111.766 175.95 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' F' F ' 11' ' ' LYS . . . . . . . . . . . . . 82.9 tttt -86.31 101.43 13.07 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.295 -0.411 . . . . 0.0 110.371 179.256 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' F' F ' 12' ' ' VAL . . . . . . . . . . . . . 12.5 p -146.64 149.84 15.55 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.255 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.76 -178.526 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' F' F ' 13' ' ' GLU . . . . . . . . . . . . . 70.7 mm-40 -79.87 126.64 31.25 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.152 -0.477 . . . . 0.0 110.098 177.112 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' F' F ' 14' ' ' LEU . . . . . . . . . . . . . 37.8 mt -97.53 144.48 28.03 Favored Pre-proline 0 CA--C 1.533 0.291 0 CA-C-O 119.012 -0.518 . . . . 0.0 110.038 179.464 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' F' F ' 15' ' ' PRO . . . . . . . . . . . . . 25.7 Cg_exo -62.01 153.97 65.23 Favored 'Trans proline' 0 N--CA 1.497 1.72 0 C-N-CA 121.204 1.27 . . . . 0.0 111.442 177.133 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' F' F ' 16' ' ' PRO . . . . . . . . . . . . . 31.2 Cg_exo -57.2 -38.84 94.14 Favored 'Trans proline' 0 N--CA 1.497 1.715 0 C-N-CA 121.412 1.408 . . . . 0.0 112.856 -179.244 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' F' F ' 17' ' ' ASP . . . . . . . . . . . . . 21.7 p-10 -85.98 9.63 16.45 Favored 'General case' 0 CA--C 1.537 0.444 0 N-CA-C 113.319 0.859 . . . . 0.0 113.319 -177.138 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' F' F ' 18' ' ' PHE . . . . . . . . . . . . . 43.3 t80 -58.47 -48.51 80.51 Favored 'General case' 0 N--CA 1.457 -0.109 0 O-C-N 121.971 -0.455 . . . . 0.0 110.153 -177.239 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' F' F ' 19' ' ' VAL . . . . . . . . . . . . . 14.0 p -54.46 -41.36 53.58 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.256 0 CA-C-N 116.378 -0.374 . . . . 0.0 111.284 -177.611 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' F' F ' 20' ' ' ASP . . . . . . . . . . . . . 73.3 m-20 -60.87 -45.95 92.52 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-O 120.823 0.344 . . . . 0.0 111.039 -177.806 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' F' F ' 21' ' ' VAL . . . . . . . . . . . . . 46.4 t -64.34 -46.92 91.71 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 C-N-CA 120.76 -0.376 . . . . 0.0 110.573 -177.103 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' F' F ' 22' ' ' ILE . . . . . 0.488 HG22 HD12 ' F' ' 26' ' ' LEU . 49.1 mm -56.21 -46.72 81.39 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.221 0 C-N-CA 120.917 -0.313 . . . . 0.0 110.647 179.347 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' F' F ' 23' ' ' ARG . . . . . . . . . . . . . 50.9 ttp180 -53.51 -48.42 69.02 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-O 120.639 0.257 . . . . 0.0 111.468 -178.477 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' F' F ' 24' ' ' ILE . . . . . . . . . . . . . 73.1 mt -59.58 -43.38 90.84 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.337 0 C-N-CA 121.072 -0.251 . . . . 0.0 111.05 -178.984 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' F' F ' 25' ' ' LYS . . . . . . . . . . . . . 53.5 mtmt -64.61 -39.1 93.11 Favored 'General case' 0 C--N 1.329 -0.307 0 N-CA-C 112.255 0.465 . . . . 0.0 112.255 -178.409 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' F' F ' 26' ' ' LEU . . . . . 0.488 HD12 HG22 ' F' ' 22' ' ' ILE . 63.3 mt -79.8 -40.59 28.27 Favored 'General case' 0 C--N 1.329 -0.298 0 N-CA-C 113.501 0.926 . . . . 0.0 113.501 -170.591 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' F' F ' 27' ' ' GLN . . . . . . . . . . . . . 10.6 pt20 -46.38 138.4 5.66 Favored 'General case' 0 N--CA 1.469 0.506 0 N-CA-C 112.995 0.739 . . . . 0.0 112.995 -173.821 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' F' F ' 28' ' ' GLY . . . . . . . . . . . . . . . 100.92 -26.88 23.05 Favored Glycine 0 CA--C 1.533 1.201 0 CA-C-N 115.611 -0.722 . . . . 0.0 112.185 -177.379 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' F' F ' 29' ' ' LYS . . . . . . . . . . . . . 83.1 mttt -97.98 155.12 17.25 Favored 'General case' 0 C--O 1.233 0.187 0 CA-C-N 117.329 0.564 . . . . 0.0 111.227 179.6 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' F' F ' 30' ' ' THR . . . . . . . . . . . . . 40.9 m -101.19 140.54 35.34 Favored 'General case' 0 C--N 1.33 -0.239 0 CA-C-N 116.01 -0.541 . . . . 0.0 110.375 177.755 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' F' F ' 31' ' ' VAL . . . . . . . . . . . . . 35.4 m -129.79 152.97 38.14 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.164 0 CA-C-N 116.313 -0.403 . . . . 0.0 110.327 178.673 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' F' F ' 32' ' ' ARG . . . . . . . . . . . . . 50.1 ttt180 -132.04 149.08 52.51 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-O 121.185 0.517 . . . . 0.0 110.277 178.529 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' F' F ' 33' ' ' THR . . . . . . . . . . . . . 19.5 m -52.46 137.63 29.34 Favored 'General case' 0 C--N 1.331 -0.212 0 CA-C-N 116.369 -0.378 . . . . 0.0 111.44 -178.218 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' F' F ' 34' ' ' GLY . . . . . . . . . . . . . . . 100.51 -17.15 57.11 Favored Glycine 0 CA--C 1.534 1.238 0 C-N-CA 121.172 -0.537 . . . . 0.0 113.188 179.532 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' F' F ' 35' ' ' ASP . . . . . . . . . . . . . 52.2 m-20 -64.54 151.04 45.59 Favored 'General case' 0 C--N 1.333 -0.115 0 CA-C-N 118.034 0.917 . . . . 0.0 111.19 -179.817 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' F' F ' 36' ' ' VAL . . . . . . . . . . . . . 44.7 t -127.85 130.92 70.12 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.199 0 CA-C-N 115.815 -0.629 . . . . 0.0 109.858 178.685 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' F' F ' 37' ' ' ILE . . . . . . . . . . . . . 66.0 mt -124.37 142.76 40.1 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.231 0 CA-C-N 116.282 -0.417 . . . . 0.0 110.033 -178.73 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' F' F ' 38' ' ' GLY . . . . . . . . . . . . . . . -111.98 128.84 8.77 Favored Glycine 0 CA--C 1.526 0.75 0 N-CA-C 111.036 -0.826 . . . . 0.0 111.036 179.133 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' F' F ' 39' ' ' ILE . . . . . . . . . . . . . 76.2 mt -125.14 135.68 63.26 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.224 0 N-CA-C 110.107 -0.331 . . . . 0.0 110.107 179.469 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' F' F ' 40' ' ' SER . . . . . . . . . . . . . 60.0 p -92.86 116.41 29.01 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.307 -0.406 . . . . 0.0 111.046 176.431 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' F' F ' 41' ' ' ILE . . . . . . . . . . . . . 44.5 mm -121.54 121.52 64.76 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.205 0 CA-C-O 120.86 0.362 . . . . 0.0 110.235 178.865 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' F' F ' 42' ' ' LEU . . . . . . . . . . . . . 60.3 mt 52.28 34.69 15.24 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.166 -0.47 . . . . 0.0 111.819 176.961 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' F' F ' 43' ' ' GLY . . . . . . . . . . . . . . . 72.98 32.56 60.61 Favored Glycine 0 CA--C 1.529 0.939 0 C-N-CA 121.047 -0.597 . . . . 0.0 112.064 177.869 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' F' F ' 44' ' ' LYS . . . . . . . . . . . . . 28.0 ttpp -139.92 132.96 29.51 Favored 'General case' 0 C--N 1.329 -0.322 0 N-CA-C 109.635 -0.506 . . . . 0.0 109.635 177.657 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' F' F ' 45' ' ' GLU . . . . . . . . . . . . . 79.5 tt0 -82.25 121.11 26.23 Favored 'General case' 0 C--N 1.328 -0.326 0 C-N-CA 120.928 -0.309 . . . . 0.0 111.134 -177.025 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' F' F ' 46' ' ' VAL . . . . . . . . . . . . . 7.5 p -120.88 127.03 75.89 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.254 0 N-CA-C 109.454 -0.572 . . . . 0.0 109.454 175.384 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' F' F ' 47' ' ' LYS . . . . . . . . . . . . . 69.0 mttm -100.02 129.93 46.13 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 115.96 -0.564 . . . . 0.0 111.159 179.338 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' F' F ' 48' ' ' PHE . . . . . . . . . . . . . 92.0 m-85 -113.18 131.81 55.73 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.233 -0.439 . . . . 0.0 110.002 177.489 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' F' F ' 49' ' ' LYS . . . . . . . . . . . . . 76.5 tttt -109.52 139.33 44.64 Favored 'General case' 0 C--N 1.331 -0.205 0 CA-C-N 116.409 -0.359 . . . . 0.0 110.581 178.839 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' F' F ' 50' ' ' VAL . . . . . . . . . . . . . 43.6 t -82.59 108.85 15.87 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.212 0 N-CA-C 109.528 -0.545 . . . . 0.0 109.528 176.251 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' F' F ' 51' ' ' VAL . . . . . . . . . . . . . 46.9 t -71.64 -53.68 19.74 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.338 0 CA-C-N 115.91 -0.586 . . . . 0.0 109.536 -175.316 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' F' F ' 52' ' ' GLN . . . . . . . . . . . . . 85.2 mt-30 -154.63 152.55 30.12 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-O 121.114 0.483 . . . . 0.0 111.481 -177.31 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' F' F ' 53' ' ' ALA . . . . . . . . . . . . . . . -129.79 133.3 46.89 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 115.496 -0.774 . . . . 0.0 109.858 175.156 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' F' F ' 54' ' ' TYR . . . . . . . . . . . . . 29.7 t80 -129.08 107.91 18.0 Favored Pre-proline 0 C--N 1.328 -0.331 0 CA-C-O 118.27 -0.871 . . . . 0.0 110.211 179.218 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' F' F ' 55' ' ' PRO . . . . . . . . . . . . . 73.9 Cg_endo -77.2 170.07 72.48 Favored 'Cis proline' 0 N--CA 1.501 1.916 0 CA-C-N 121.881 1.707 . . . . 0.0 112.549 -4.245 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' F' F ' 56' ' ' SER . . . . . . . . . . . . . 60.6 m -117.2 130.74 24.42 Favored Pre-proline 0 CA--C 1.538 0.495 0 CA-C-O 118.413 -0.803 . . . . 0.0 109.602 175.494 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' F' F ' 57' ' ' PRO . . . . . . . . . . . . . 31.3 Cg_endo -65.06 167.32 46.71 Favored 'Cis proline' 0 N--CA 1.498 1.749 0 CA-C-N 121.953 1.733 . . . . 0.0 111.542 -2.848 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' F' F ' 58' ' ' LEU . . . . . . . . . . . . . 18.2 tp -130.77 139.06 50.21 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.081 -0.509 . . . . 0.0 110.203 -179.81 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' F' F ' 59' ' ' ARG . . . . . . . . . . . . . 41.4 ttm180 -101.77 134.35 45.08 Favored 'General case' 0 C--N 1.326 -0.445 0 N-CA-C 109.276 -0.638 . . . . 0.0 109.276 174.523 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' F' F ' 60' ' ' VAL . . . . . . . . . . . . . 42.2 t -84.53 119.29 33.21 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.299 0 C-N-CA 120.569 -0.452 . . . . 0.0 110.161 -178.631 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' F' F ' 61' ' ' GLU . . . . . . . . . . . . . 70.5 tt0 -131.14 155.57 46.77 Favored 'General case' 0 C--N 1.327 -0.373 0 N-CA-C 109.094 -0.706 . . . . 0.0 109.094 176.276 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' F' F ' 62' ' ' ASP . . . . . . . . . . . . . 10.4 p-10 -52.49 -29.78 26.68 Favored 'General case' 0 C--N 1.326 -0.438 0 N-CA-C 112.064 0.394 . . . . 0.0 112.064 -177.72 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' F' F ' 63' ' ' ARG . . . . . . . . . . . . . 84.5 mtt-85 -75.5 -21.97 57.57 Favored 'General case' 0 CA--C 1.532 0.26 0 N-CA-C 113.092 0.775 . . . . 0.0 113.092 -175.902 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' F' F ' 64' ' ' THR . . . . . . . . . . . . . 31.5 m -67.07 146.47 54.28 Favored 'General case' 0 C--N 1.331 -0.227 0 CA-C-O 120.903 0.382 . . . . 0.0 111.195 -174.148 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' F' F ' 65' ' ' LYS . . . . . . . . . . . . . 68.3 mttm -88.63 127.65 35.57 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 115.954 -0.566 . . . . 0.0 110.036 177.691 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' F' F ' 66' ' ' ILE . . . . . . . . . . . . . 60.6 mt -115.02 127.43 72.58 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.322 0 N-CA-C 109.637 -0.505 . . . . 0.0 109.637 179.343 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' F' F ' 67' ' ' THR . . . . . . . . . . . . . 26.0 m -124.73 143.54 50.71 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-O 121.166 0.508 . . . . 0.0 111.357 -176.435 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' F' F ' 68' ' ' LEU . . . . . 0.474 HD23 ' C ' ' F' ' 68' ' ' LEU . 6.3 tt . . . . . 0 C--N 1.328 -0.333 0 CA-C-N 115.557 -0.747 . . . . 0.0 109.525 175.473 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' F' F ' 73' ' ' VAL . . . . . . . . . . . . . 33.5 m . . . . . 0 C--O 1.232 0.138 0 CA-C-O 121.044 0.449 . . . . 0.0 110.929 . . . . . . . . . 0 0 . 1 . 016 nuclear nobuild core ' F' F ' 74' ' ' ASP . . . . . . . . . . . . . 12.9 t70 -98.75 118.35 35.29 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 115.697 -0.683 . . . . 0.0 109.463 176.505 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' F' F ' 75' ' ' VAL . . . . . . . . . . . . . 38.5 t -111.5 125.44 68.81 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.298 0 CA-C-O 121.083 0.468 . . . . 0.0 110.619 -176.351 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' F' F ' 76' ' ' LEU . . . . . . . . . . . . . 21.1 mt -129.5 147.98 51.36 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 115.575 -0.739 . . . . 0.0 109.765 178.793 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' F' F ' 77' ' ' GLU . . . . . . . . . . . . . 43.9 mp0 -135.57 136.49 41.16 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-O 120.981 0.419 . . . . 0.0 111.01 -179.301 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' F' F ' 78' ' ' ALA . . . . . 0.722 ' HB2' HD21 ' F' ' 109' ' ' LEU . . . -123.12 135.25 54.28 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 115.701 -0.681 . . . . 0.0 109.935 176.903 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' F' F ' 79' ' ' LYS . . . . . 0.724 ' O ' HD13 ' F' ' 80' ' ' ILE . 99.0 mttt -74.93 120.25 20.22 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-O 120.85 0.357 . . . . 0.0 110.801 -177.565 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' F' F ' 80' ' ' ILE . . . . . 0.724 HD13 ' O ' ' F' ' 79' ' ' LYS . 31.6 mm -139.19 104.6 2.23 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.241 0 N-CA-C 108.956 -0.757 . . . . 0.0 108.956 -178.635 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' F' F ' 81' ' ' LYS . . . . . . . . . . . . . 60.4 tttm -99.11 121.55 41.15 Favored 'General case' 0 C--N 1.327 -0.403 0 CA-C-O 120.881 0.372 . . . . 0.0 111.318 -175.47 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' F' F ' 82' ' ' GLY . . . . . . . . . . . . . . . 89.17 42.17 5.65 Favored Glycine 0 CA--C 1.525 0.681 0 C-N-CA 121.026 -0.607 . . . . 0.0 111.99 174.705 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' F' F ' 83' ' ' ILE . . . . . . . . . . . . . 71.7 mt -66.3 137.38 24.99 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.314 0 N-CA-C 109.65 -0.5 . . . . 0.0 109.65 175.909 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' F' F ' 84' ' ' LYS . . . . . . . . . . . . . 24.1 ttpp -102.38 -50.6 3.56 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-O 120.863 0.363 . . . . 0.0 110.464 -179.758 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' F' F ' 85' ' ' ASP . . . . . . . . . . . . . 8.6 t70 -149.41 151.33 33.86 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 115.976 -0.556 . . . . 0.0 110.648 -179.59 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' F' F ' 86' ' ' VAL . . . . . . . . . . . . . 44.0 t -131.34 132.84 62.76 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.248 0 CA-C-O 120.895 0.379 . . . . 0.0 110.547 -178.645 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' F' F ' 87' ' ' ILE . . . . . 0.497 HD12 ' N ' ' F' ' 87' ' ' ILE . 5.1 mp -121.94 129.93 75.01 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.289 0 N-CA-C 109.364 -0.606 . . . . 0.0 109.364 176.315 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' F' F ' 88' ' ' LEU . . . . . . . . . . . . . 13.9 tp -115.29 134.58 55.0 Favored 'General case' 0 C--N 1.332 -0.182 0 CA-C-O 121.182 0.515 . . . . 0.0 111.693 -175.366 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' F' F ' 89' ' ' ASP . . . . . . . . . . . . . 7.4 t0 -126.53 148.9 49.66 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 115.465 -0.788 . . . . 0.0 109.0 174.067 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' F' F ' 90' ' ' GLU . . . . . . . . . . . . . 93.5 mt-10 -49.38 -34.08 15.28 Favored 'General case' 0 C--N 1.329 -0.286 0 N-CA-C 112.625 0.602 . . . . 0.0 112.625 -173.769 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' F' F ' 91' ' ' ASN . . . . . . . . . . . . . 21.9 m120 -128.05 30.32 5.26 Favored 'General case' 0 N--CA 1.465 0.323 0 N-CA-C 112.187 0.44 . . . . 0.0 112.187 -176.974 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' F' F ' 92' ' ' LEU . . . . . . . . . . . . . 13.4 tp -166.19 147.57 6.68 Favored 'General case' 0 C--N 1.332 -0.179 0 CA-C-O 120.609 0.242 . . . . 0.0 110.52 -179.993 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' F' F ' 93' ' ' ILE . . . . . . . . . . . . . 70.4 mt -128.83 123.39 59.02 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.254 0 N-CA-C 109.541 -0.54 . . . . 0.0 109.541 179.416 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' F' F ' 94' ' ' VAL . . . . . 0.541 HG21 HG11 ' F' ' 125' ' ' VAL . 44.0 t -122.05 129.21 75.57 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.253 0 CA-C-O 120.884 0.373 . . . . 0.0 110.137 -179.424 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' F' F ' 95' ' ' VAL . . . . . . . . . . . . . 43.9 t -124.63 136.1 61.76 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.275 0 CA-C-N 116.04 -0.527 . . . . 0.0 110.054 -179.452 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' F' F ' 96' ' ' ILE . . . . . . . . . . . . . 59.6 mt -116.05 128.48 73.33 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.274 0 N-CA-C 109.255 -0.646 . . . . 0.0 109.255 178.783 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' F' F ' 97' ' ' THR . . . . . . . . . . . . . 82.6 p -102.89 156.63 17.53 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-O 121.156 0.503 . . . . 0.0 111.559 -175.845 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' F' F ' 98' ' ' GLU . . . . . . . . . . . . . 45.0 mt-10 -53.93 -26.04 23.39 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 116.099 -0.5 . . . . 0.0 112.179 179.395 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' F' F ' 99' ' ' GLU . . . . . . . . . . . . . 71.2 mm-40 -79.36 16.32 1.04 Allowed 'General case' 0 CA--C 1.535 0.377 0 N-CA-C 113.158 0.799 . . . . 0.0 113.158 -176.973 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' F' F ' 100' ' ' ASN . . . . . . . . . . . . . 2.1 m-20 62.11 32.78 17.35 Favored 'General case' 0 CA--C 1.531 0.232 0 CA-C-N 117.996 0.362 . . . . 0.0 111.555 178.412 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' F' F ' 101' ' ' GLU . . . . . . . . . . . . . 84.1 tt0 -112.56 144.71 41.59 Favored 'General case' 0 C--O 1.232 0.164 0 N-CA-C 109.735 -0.469 . . . . 0.0 109.735 175.412 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' F' F ' 102' ' ' VAL . . . . . . . . . . . . . 46.5 t -117.21 127.19 74.8 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.367 0 N-CA-C 109.67 -0.493 . . . . 0.0 109.67 -179.087 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' F' F ' 103' ' ' LEU . . . . . . . . . . . . . 27.9 mt -118.99 133.69 55.66 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 115.919 -0.582 . . . . 0.0 110.275 179.561 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' F' F ' 104' ' ' ILE . . . . . . . . . . . . . 70.5 mt -120.2 121.94 67.04 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.205 0 CA-C-N 116.469 -0.332 . . . . 0.0 110.295 -179.791 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' F' F ' 105' ' ' PHE . . . . . . . . . . . . . 81.4 m-85 -120.17 164.03 16.84 Favored 'General case' 0 C--N 1.332 -0.194 0 O-C-N 124.043 0.84 . . . . 0.0 109.681 179.504 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' F' F ' 106' ' ' ASN . . . . . . . . . . . . . 38.8 p-10 -97.41 -171.75 2.27 Favored 'General case' 0 C--N 1.331 -0.216 0 N-CA-C 109.957 -0.386 . . . . 0.0 109.957 174.091 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' F' F ' 107' ' ' GLN . . . . . . . . . . . . . 29.5 tt0 -60.01 -30.07 68.9 Favored 'General case' 0 C--N 1.33 -0.263 0 N-CA-C 111.986 0.365 . . . . 0.0 111.986 179.73 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' F' F ' 108' ' ' ASN . . . . . . . . . . . . . 44.6 t30 -82.71 6.04 19.3 Favored 'General case' 0 CA--C 1.536 0.433 0 N-CA-C 113.246 0.832 . . . . 0.0 113.246 -177.354 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' F' F ' 109' ' ' LEU . . . . . 0.722 HD21 ' HB2' ' F' ' 78' ' ' ALA . 12.6 tp 63.13 40.84 8.61 Favored 'General case' 0 C--O 1.233 0.189 0 CA-C-O 121.229 0.537 . . . . 0.0 111.091 178.107 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' F' F ' 110' ' ' GLU . . . . . . . . . . . . . 43.8 mt-10 -111.67 150.68 29.82 Favored 'General case' 0 C--N 1.33 -0.271 0 N-CA-C 109.814 -0.439 . . . . 0.0 109.814 174.639 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' F' F ' 111' ' ' GLU . . . . . . . . . . . . . 62.8 tt0 -84.75 121.98 28.46 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.389 -0.369 . . . . 0.0 110.956 -176.292 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' F' F ' 112' ' ' LEU . . . . . . . . . . . . . 57.7 mt -109.83 -46.02 3.55 Favored 'General case' 0 C--N 1.333 -0.144 0 CA-C-N 116.277 -0.419 . . . . 0.0 110.796 179.771 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' F' F ' 113' ' ' TYR . . . . . 0.415 ' HE2' HG21 ' A' ' 75' ' ' VAL . 61.0 t80 -132.99 140.56 47.83 Favored 'General case' 0 N--CA 1.464 0.271 0 CA-C-O 120.852 0.358 . . . . 0.0 110.745 -179.551 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' F' F ' 114' ' ' ARG . . . . . . . . . . . . . 36.0 ptt180 -143.99 123.46 13.17 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 115.848 -0.615 . . . . 0.0 110.347 178.384 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' F' F ' 115' ' ' GLY . . . . . . . . . . . . . . . -150.13 160.82 28.69 Favored Glycine 0 CA--C 1.525 0.661 0 N-CA-C 111.196 -0.762 . . . . 0.0 111.196 179.58 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' F' F ' 116' ' ' LYS . . . . . . . . . . . . . 76.8 tttt -130.5 140.6 50.51 Favored 'General case' 0 C--N 1.329 -0.287 0 N-CA-C 109.846 -0.428 . . . . 0.0 109.846 177.597 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' F' F ' 117' ' ' PHE . . . . . . . . . . . . . 30.8 m-85 -139.28 114.02 9.26 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.11 -0.495 . . . . 0.0 109.975 -177.222 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' F' F ' 118' ' ' GLU . . . . . . . . . . . . . 44.9 tp10 -52.05 -45.81 64.86 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.534 -0.303 . . . . 0.0 111.565 -176.927 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' F' F ' 119' ' ' ASN . . . . . . . . . . . . . 86.4 m-20 -98.52 31.14 2.96 Favored 'General case' 0 C--N 1.329 -0.299 0 N-CA-C 112.185 0.439 . . . . 0.0 112.185 -174.608 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' F' F ' 120' ' ' LEU . . . . . . . . . . . . . 17.5 tp -55.33 120.12 6.61 Favored 'General case' 0 N--CA 1.462 0.146 0 O-C-N 122.266 -0.271 . . . . 0.0 110.608 178.067 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' F' F ' 121' ' ' ASN . . . . . . . . . . . . . 89.1 m-20 -112.49 -44.09 3.41 Favored 'General case' 0 C--O 1.232 0.167 0 CA-C-N 116.579 -0.282 . . . . 0.0 111.219 -176.491 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' F' F ' 122' ' ' LYS . . . . . . . . . . . . . 92.4 mttt -146.68 150.24 35.02 Favored 'General case' 0 C--N 1.333 -0.138 0 C-N-CA 120.389 -0.524 . . . . 0.0 111.978 -177.862 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' F' F ' 123' ' ' VAL . . . . . . . . . . . . . 46.1 t -125.62 126.05 69.63 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.224 0 CA-C-N 115.726 -0.67 . . . . 0.0 109.53 175.471 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' F' F ' 124' ' ' LEU . . . . . . . . . . . . . 48.3 mt -115.97 132.99 56.49 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.399 -0.364 . . . . 0.0 110.363 -178.685 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' F' F ' 125' ' ' VAL . . . . . 0.541 HG11 HG21 ' F' ' 94' ' ' VAL . 34.9 m -131.73 137.1 55.83 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.211 0 CA-C-O 120.868 0.366 . . . . 0.0 111.074 -177.902 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' F' F ' 126' ' ' ARG . . . . . . . . . . . . . 96.7 mtt-85 -145.43 111.37 5.55 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.151 -0.477 . . . . 0.0 110.575 176.179 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' F' F ' 127' ' ' ASN . . . . . . . . . . . . . 6.2 m120 53.29 -104.91 0.22 Allowed 'General case' 0 CA--C 1.542 0.651 0 CA-C-O 119.07 -0.49 . . . . 0.0 111.193 178.869 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' F' F ' 128' ' ' ASP . . . . . . . . . . . . . 13.3 p-10 -113.66 3.22 15.53 Favored 'General case' 0 N--CA 1.469 0.495 0 CA-C-N 119.454 1.025 . . . . 0.0 113.378 -176.239 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' F' F ' 129' ' ' LEU . . . . . . . . . . . . . 17.2 tp -106.82 139.66 40.89 Favored 'General case' 0 C--N 1.334 -0.104 0 N-CA-C 109.787 -0.449 . . . . 0.0 109.787 177.853 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' F' F ' 130' ' ' VAL . . . . . . . . . . . . . 41.8 t -129.36 139.79 50.85 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.231 0 CA-C-O 121.064 0.459 . . . . 0.0 110.339 -177.565 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' F' F ' 131' ' ' VAL . . . . . . . . . . . . . 44.6 t -136.1 135.61 50.01 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.319 0 CA-C-N 116.015 -0.539 . . . . 0.0 109.838 176.915 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' F' F ' 132' ' ' ILE . . . . . . . . . . . . . 71.3 mt -117.57 134.05 62.4 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.292 0 CA-C-N 116.141 -0.481 . . . . 0.0 109.709 -178.681 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' F' F ' 133' ' ' ILE . . . . . . . . . . . . . 43.0 mm -115.3 123.24 70.67 Favored 'Isoleucine or valine' 0 C--O 1.233 0.217 0 CA-C-N 116.277 -0.42 . . . . 0.0 111.003 -175.054 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' F' F ' 134' ' ' ASP . . . . . . . . . . . . . 8.1 p-10 -134.87 145.48 48.32 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 115.892 -0.595 . . . . 0.0 109.505 173.952 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' F' F ' 135' ' ' GLU . . . . . . . . . . . . . 40.1 tp10 -49.9 -24.83 2.72 Favored 'General case' 0 CA--C 1.534 0.346 0 N-CA-C 112.737 0.643 . . . . 0.0 112.737 -173.901 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' F' F ' 136' ' ' GLN . . . . . . . . . . . . . 60.1 tt0 -81.91 -36.76 27.74 Favored 'General case' 0 C--O 1.234 0.243 0 N-CA-C 111.859 0.318 . . . . 0.0 111.859 -176.533 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' F' F ' 137' ' ' LYS . . . . . . . . . . . . . 20.0 pttp -168.18 175.36 6.59 Favored 'General case' 0 C--N 1.331 -0.201 0 CA-C-O 121.503 0.668 . . . . 0.0 111.984 -173.0 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' F' F ' 138' ' ' LEU . . . . . 0.418 HD23 ' C ' ' F' ' 138' ' ' LEU . 7.3 tt -118.94 129.79 55.36 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 115.107 -0.951 . . . . 0.0 110.15 179.563 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' F' F ' 139' ' ' THR . . . . . . . . . . . . . 37.7 m -110.39 130.02 55.64 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.104 -0.498 . . . . 0.0 110.508 -179.984 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' F' F ' 140' ' ' LEU . . . . . 0.446 HD23 ' N ' ' F' ' 141' ' ' ILE . 5.2 tt -115.38 123.98 50.04 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 115.855 -0.611 . . . . 0.0 109.755 -178.091 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' F' F ' 141' ' ' ILE . . . . . 0.446 ' N ' HD23 ' F' ' 140' ' ' LEU . 18.8 mt -123.4 124.69 70.32 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.184 0 N-CA-C 110.015 -0.365 . . . . 0.0 110.015 -174.379 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' F' F ' 142' ' ' ARG . . . . . . . . . . . . . 77.1 ttt180 -120.91 134.57 55.3 Favored 'General case' 0 C--O 1.234 0.259 0 CA-C-N 116.106 -0.497 . . . . 0.0 110.297 -178.823 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' F' F ' 143' ' ' THR . . . . . . . . . . . . . 21.5 p . . . . . 0 C--O 1.219 -0.533 0 CA-C-O 117.99 -1.005 . . . . 0.0 110.567 -179.607 . . . . . . . . 0 0 . 1 . 017 nuclear nobuild core ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 7.1 p . . . . . 0 C--O 1.232 0.154 0 CA-C-O 121.084 0.469 . . . . 0.0 110.598 . . . . . . . . . 0 0 . 1 . 017 nuclear nobuild core ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 95.6 mt-10 -141.23 141.41 34.03 Favored 'General case' 0 C--N 1.327 -0.406 0 CA-C-N 115.861 -0.609 . . . . 0.0 110.876 -179.096 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 4' ' ' LEU . . . . . 0.488 HD23 ' N ' ' A' ' 5' ' ' LYS . 3.7 tt -128.19 124.95 38.04 Favored 'General case' 0 C--N 1.33 -0.268 0 N-CA-C 109.679 -0.489 . . . . 0.0 109.679 176.887 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 5' ' ' LYS . . . . . 0.488 ' N ' HD23 ' A' ' 4' ' ' LEU . 63.0 mttp -107.7 122.61 47.08 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-O 120.625 0.25 . . . . 0.0 111.087 -179.189 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 25.2 mt -114.0 144.51 42.97 Favored 'General case' 0 C--O 1.232 0.145 0 CA-C-N 115.542 -0.754 . . . . 0.0 110.525 179.419 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 24.8 ttmt -126.52 139.38 34.56 Favored Pre-proline 0 CA--C 1.531 0.247 0 N-CA-C 109.537 -0.542 . . . . 0.0 109.537 173.224 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 8' ' ' PRO . . . . . . . . . . . . . 98.3 Cg_endo -91.5 141.76 2.76 Favored 'Trans proline' 0 N--CA 1.491 1.335 0 C-N-CA 121.715 1.61 . . . . 0.0 112.156 -179.674 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 56.3 mt -80.07 -47.22 1.39 Allowed Pre-proline 0 CA--C 1.534 0.364 0 CA-C-O 118.64 -0.695 . . . . 0.0 112.222 178.799 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 89.8 Cg_endo -80.98 153.79 19.36 Favored 'Trans proline' 0 N--CA 1.496 1.644 0 C-N-CA 121.168 1.245 . . . . 0.0 111.749 176.142 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 19.4 tptp -88.23 99.09 11.95 Favored 'General case' 0 C--N 1.33 -0.274 0 N-CA-C 110.005 -0.369 . . . . 0.0 110.005 179.303 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 12.7 p -142.34 148.54 20.09 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.258 0 CA-C-N 116.326 -0.397 . . . . 0.0 110.928 -177.766 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 84.2 tt0 -93.69 121.1 34.78 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.05 -0.523 . . . . 0.0 110.04 176.628 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 14' ' ' LEU . . . . . . . . . . . . . 46.6 mt -98.58 152.3 37.84 Favored Pre-proline 0 CA--C 1.533 0.29 0 CA-C-N 116.468 -0.333 . . . . 0.0 110.843 -178.309 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 15' ' ' PRO . . . . . . . . . . . . . 28.6 Cg_exo -61.03 158.65 33.24 Favored 'Trans proline' 0 N--CA 1.498 1.74 0 C-N-CA 121.3 1.333 . . . . 0.0 112.013 177.706 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 16' ' ' PRO . . . . . . . . . . . . . 29.5 Cg_exo -59.99 -36.08 91.04 Favored 'Trans proline' 0 N--CA 1.497 1.677 0 C-N-CA 121.443 1.429 . . . . 0.0 112.689 -179.919 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 17' ' ' ASP . . . . . . . . . . . . . 21.7 p-10 -85.84 8.72 19.02 Favored 'General case' 0 CA--C 1.536 0.406 0 N-CA-C 113.295 0.85 . . . . 0.0 113.295 -177.172 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 18' ' ' PHE . . . . . . . . . . . . . 41.9 t80 -58.09 -44.01 87.36 Favored 'General case' 0 N--CA 1.457 -0.087 0 O-C-N 122.03 -0.419 . . . . 0.0 110.102 -178.713 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 19' ' ' VAL . . . . . . . . . . . . . 48.5 t -56.15 -42.66 73.64 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.291 0 CA-C-N 116.275 -0.42 . . . . 0.0 110.457 -178.81 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 73.0 m-20 -59.89 -43.68 94.67 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-O 120.791 0.329 . . . . 0.0 110.885 -177.907 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 45.8 t -64.35 -45.57 95.61 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.292 0 C-N-CA 120.715 -0.394 . . . . 0.0 110.574 -177.466 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 22' ' ' ILE . . . . . 0.687 HG22 HD12 ' A' ' 26' ' ' LEU . 51.1 mm -55.36 -47.61 77.83 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.254 0 C-N-CA 120.921 -0.312 . . . . 0.0 110.73 179.26 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 23' ' ' ARG . . . . . . . . . . . . . 55.6 ttp180 -55.44 -49.1 73.34 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-O 120.704 0.288 . . . . 0.0 111.207 -178.48 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 24' ' ' ILE . . . . . . . . . . . . . 71.6 mt -58.99 -41.72 84.06 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.258 0 CA-C-N 116.529 -0.305 . . . . 0.0 111.351 -176.419 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 83.6 mttt -71.75 -41.1 68.86 Favored 'General case' 0 C--N 1.328 -0.346 0 N-CA-C 112.714 0.635 . . . . 0.0 112.714 -178.02 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 26' ' ' LEU . . . . . 0.687 HD12 HG22 ' A' ' 22' ' ' ILE . 34.2 mt -78.53 -32.58 48.03 Favored 'General case' 0 C--N 1.328 -0.343 0 N-CA-C 113.697 0.999 . . . . 0.0 113.697 -170.332 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 27' ' ' GLN . . . . . . . . . . . . . 10.2 pt20 -47.11 140.76 4.81 Favored 'General case' 0 N--CA 1.468 0.463 0 N-CA-C 112.771 0.656 . . . . 0.0 112.771 -175.873 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 99.62 -24.11 33.49 Favored Glycine 0 CA--C 1.534 1.222 0 CA-C-N 115.696 -0.684 . . . . 0.0 112.399 -178.047 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 57.2 mtpt -97.62 155.06 17.15 Favored 'General case' 0 C--N 1.333 -0.13 0 CA-C-N 117.531 0.666 . . . . 0.0 111.125 179.312 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 30' ' ' THR . . . . . . . . . . . . . 41.0 m -105.18 137.32 43.14 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 115.89 -0.595 . . . . 0.0 110.036 176.273 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 31' ' ' VAL . . . . . 0.429 HG21 HD11 ' A' ' 4' ' ' LEU . 34.7 m -129.08 152.27 36.96 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.213 0 CA-C-O 120.932 0.396 . . . . 0.0 110.932 -178.402 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 32' ' ' ARG . . . . . . . . . . . . . 68.3 ttp85 -130.28 148.51 52.12 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 115.94 -0.573 . . . . 0.0 110.477 179.924 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 33' ' ' THR . . . . . . . . . . . . . 25.0 m -52.99 139.3 28.17 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.308 -0.405 . . . . 0.0 111.435 -178.024 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 100.16 -17.12 57.49 Favored Glycine 0 CA--C 1.532 1.137 0 CA-C-O 119.698 -0.501 . . . . 0.0 113.342 179.437 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 77.8 m-20 -66.43 149.58 50.2 Favored 'General case' 0 C--N 1.334 -0.102 0 CA-C-N 118.055 0.927 . . . . 0.0 111.228 179.122 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 47.4 t -122.35 130.55 74.44 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.199 0 CA-C-N 115.881 -0.6 . . . . 0.0 109.729 177.922 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 37' ' ' ILE . . . . . . . . . . . . . 65.4 mt -122.56 140.24 46.98 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.282 0 CA-C-N 116.063 -0.517 . . . . 0.0 109.998 -178.196 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . -113.89 128.45 8.28 Favored Glycine 0 CA--C 1.525 0.71 0 N-CA-C 110.983 -0.847 . . . . 0.0 110.983 178.343 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 39' ' ' ILE . . . . . . . . . . . . . 73.9 mt -127.95 136.63 59.77 Favored 'Isoleucine or valine' 0 N--CA 1.462 0.175 0 N-CA-C 110.069 -0.345 . . . . 0.0 110.069 178.928 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 40' ' ' SER . . . . . . . . . . . . . 88.3 p -92.69 118.99 31.64 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.481 -0.327 . . . . 0.0 111.15 177.014 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 41' ' ' ILE . . . . . . . . . . . . . 45.2 mm -121.66 121.99 65.84 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.214 0 CA-C-N 116.438 -0.346 . . . . 0.0 110.232 178.327 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 38.1 mt 53.25 34.25 17.27 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.265 -0.425 . . . . 0.0 111.918 176.602 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . 75.72 27.51 62.81 Favored Glycine 0 CA--C 1.53 1.016 0 C-N-CA 121.077 -0.583 . . . . 0.0 112.594 176.646 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 44' ' ' LYS . . . . . . . . . . . . . 24.7 ttpp -140.33 133.44 29.51 Favored 'General case' 0 C--N 1.33 -0.25 0 N-CA-C 109.427 -0.583 . . . . 0.0 109.427 176.582 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 84.3 tt0 -82.85 126.12 32.09 Favored 'General case' 0 C--N 1.329 -0.318 0 C-N-CA 120.796 -0.361 . . . . 0.0 111.327 -176.325 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 46' ' ' VAL . . . . . . . . . . . . . 9.2 p -120.29 125.67 74.44 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.199 0 N-CA-C 109.166 -0.679 . . . . 0.0 109.166 173.975 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 95.5 mttt -99.2 127.67 45.21 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.085 -0.507 . . . . 0.0 110.807 179.076 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 48' ' ' PHE . . . . . . . . . . . . . 37.7 m-85 -111.39 131.89 54.85 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.075 -0.511 . . . . 0.0 109.998 178.486 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 80.4 tttt -106.61 134.86 49.09 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.45 -0.341 . . . . 0.0 110.164 177.469 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 50' ' ' VAL . . . . . . . . . . . . . 44.4 t -78.16 106.14 8.29 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.285 0 N-CA-C 109.559 -0.534 . . . . 0.0 109.559 177.949 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 51' ' ' VAL . . . . . . . . . . . . . 48.7 t -71.25 -49.96 44.61 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.303 0 CA-C-N 115.946 -0.57 . . . . 0.0 109.83 -175.457 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 52' ' ' GLN . . . . . . . . . . . . . 62.0 tt0 -158.55 139.63 13.09 Favored 'General case' 0 C--N 1.33 -0.28 0 C-N-CA 120.278 -0.569 . . . . 0.0 111.764 -177.82 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -115.5 131.52 56.91 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 115.569 -0.741 . . . . 0.0 109.739 174.976 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 54' ' ' TYR . . . . . . . . . . . . . 43.6 t80 -129.03 110.21 18.29 Favored Pre-proline 0 CA--C 1.535 0.397 0 CA-C-O 118.208 -0.901 . . . . 0.0 110.52 -179.334 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 55' ' ' PRO . . . . . . . . . . . . . 72.9 Cg_endo -77.1 169.95 72.9 Favored 'Cis proline' 0 N--CA 1.498 1.781 0 CA-C-N 121.913 1.719 . . . . 0.0 112.228 -5.067 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 56' ' ' SER . . . . . . . . . . . . . 15.0 m -113.64 127.88 26.34 Favored Pre-proline 0 CA--C 1.539 0.529 0 CA-C-O 118.446 -0.788 . . . . 0.0 109.633 176.616 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 57' ' ' PRO . . . . . . . . . . . . . 60.4 Cg_endo -74.11 149.55 94.17 Favored 'Cis proline' 0 N--CA 1.498 1.739 0 CA-C-N 122.002 1.751 . . . . 0.0 111.685 0.063 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 58' ' ' LEU . . . . . . . . . . . . . 32.0 tp -108.16 137.09 46.74 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.229 -0.441 . . . . 0.0 110.606 -178.253 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 59' ' ' ARG . . . . . . . . . . . . . 52.8 ttp180 -104.4 127.94 52.17 Favored 'General case' 0 C--N 1.328 -0.338 0 N-CA-C 109.24 -0.652 . . . . 0.0 109.24 175.345 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 42.2 t -83.5 121.26 36.01 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.259 0 C-N-CA 120.731 -0.388 . . . . 0.0 110.771 -173.758 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 95.8 mt-10 -131.12 165.02 24.18 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 115.667 -0.697 . . . . 0.0 109.627 175.749 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 62' ' ' ASP . . . . . . . . . . . . . 19.0 p-10 -53.78 -32.49 52.69 Favored 'General case' 0 C--N 1.329 -0.322 0 C-N-CA 121.035 -0.266 . . . . 0.0 111.663 179.428 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 63' ' ' ARG . . . . . . . . . . . . . 67.7 mtp180 -72.52 -22.08 61.09 Favored 'General case' 0 CA--C 1.532 0.282 0 N-CA-C 112.963 0.727 . . . . 0.0 112.963 -176.814 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 25.8 m -69.18 138.97 54.54 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-O 120.981 0.42 . . . . 0.0 110.876 -174.982 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 65' ' ' LYS . . . . . . . . . . . . . 90.8 mttt -88.56 127.78 35.55 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 115.964 -0.562 . . . . 0.0 109.854 178.673 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 66' ' ' ILE . . . . . . . . . . . . . 63.4 mt -112.47 129.01 68.79 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.189 0 N-CA-C 109.62 -0.511 . . . . 0.0 109.62 178.718 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 67' ' ' THR . . . . . . . . . . . . . 19.4 m -121.03 136.29 55.02 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.09 -0.504 . . . . 0.0 110.689 -177.311 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 68' ' ' LEU . . . . . . . . . . . . . 17.7 tp . . . . . 0 C--N 1.33 -0.261 0 CA-C-N 115.938 -0.574 . . . . 0.0 110.342 178.753 . . . . . . . . 0 0 . 1 . 017 nuclear nobuild core ' A' A ' 74' ' ' ASP . . . . . . . . . . . . . 7.2 t70 . . . . . 0 C--O 1.231 0.096 0 N-CA-C 109.71 -0.478 . . . . 0.0 109.71 . . . . . . . . . 0 0 . 1 . 017 nuclear nobuild core ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 42.7 t -119.19 128.84 75.81 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.322 0 CA-C-O 121.188 0.518 . . . . 0.0 110.899 -176.342 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 76' ' ' LEU . . . . . . . . . . . . . 5.0 mp -124.56 145.63 49.48 Favored 'General case' 0 C--N 1.332 -0.161 0 CA-C-N 115.643 -0.708 . . . . 0.0 109.818 174.679 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 77' ' ' GLU . . . . . . . . . . . . . 97.5 mt-10 -136.15 133.04 36.78 Favored 'General case' 0 C--N 1.331 -0.226 0 CA-C-O 120.927 0.394 . . . . 0.0 111.3 -179.935 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 78' ' ' ALA . . . . . . . . . . . . . . . -121.53 139.62 53.26 Favored 'General case' 0 C--N 1.331 -0.197 0 CA-C-N 115.82 -0.627 . . . . 0.0 109.698 176.105 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 79' ' ' LYS . . . . . 0.622 ' O ' HD13 ' A' ' 80' ' ' ILE . 32.8 ttpt -76.96 119.85 21.27 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-O 120.889 0.376 . . . . 0.0 110.247 -179.919 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 80' ' ' ILE . . . . . 0.622 HD13 ' O ' ' A' ' 79' ' ' LYS . 22.9 mm -139.24 111.86 5.86 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.327 0 N-CA-C 109.007 -0.738 . . . . 0.0 109.007 -178.544 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 81' ' ' LYS . . . . . . . . . . . . . 79.0 tttt -115.77 129.09 56.31 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-O 120.902 0.382 . . . . 0.0 110.657 -177.138 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . 89.11 41.98 5.72 Favored Glycine 0 CA--C 1.525 0.704 0 N-CA-C 111.342 -0.703 . . . . 0.0 111.342 178.085 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 83' ' ' ILE . . . . . . . . . . . . . 75.9 mt -67.33 140.21 19.7 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.309 0 CA-C-O 120.902 0.382 . . . . 0.0 109.993 178.593 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 84' ' ' LYS . . . . . . . . . . . . . 71.6 tttt -99.71 -52.03 3.57 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.043 -0.526 . . . . 0.0 110.074 -179.901 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 85' ' ' ASP . . . . . . . . . . . . . 5.0 t70 -159.86 156.73 27.86 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 115.758 -0.656 . . . . 0.0 110.365 179.809 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 86' ' ' VAL . . . . . . . . . . . . . 40.7 t -131.13 132.87 63.22 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.228 0 CA-C-O 120.983 0.42 . . . . 0.0 110.744 -178.94 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 87' ' ' ILE . . . . . . . . . . . . . 43.9 mm -120.07 126.82 75.68 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.268 0 CA-C-N 115.771 -0.649 . . . . 0.0 109.361 177.08 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 88' ' ' LEU . . . . . . . . . . . . . 19.1 tp -114.84 134.33 55.22 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-O 120.944 0.402 . . . . 0.0 111.423 -176.8 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 89' ' ' ASP . . . . . . . . . . . . . 13.5 t70 -129.38 157.17 42.67 Favored 'General case' 0 C--N 1.331 -0.226 0 CA-C-N 115.787 -0.642 . . . . 0.0 109.606 176.719 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 60.2 mp0 -48.51 -35.96 14.24 Favored 'General case' 0 C--N 1.332 -0.192 0 N-CA-C 113.06 0.763 . . . . 0.0 113.06 -171.154 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 91' ' ' ASN . . . . . . . . . . . . . 27.6 t30 -130.65 18.35 5.21 Favored 'General case' 0 N--CA 1.47 0.534 0 N-CA-C 113.15 0.796 . . . . 0.0 113.15 -177.238 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 92' ' ' LEU . . . . . . . . . . . . . 22.6 mt -146.99 142.52 27.59 Favored 'General case' 0 C--N 1.331 -0.216 0 N-CA-C 110.221 -0.288 . . . . 0.0 110.221 -177.595 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 93' ' ' ILE . . . . . . . . . . . . . 71.9 mt -123.21 117.86 52.89 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.354 0 N-CA-C 109.312 -0.625 . . . . 0.0 109.312 177.695 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 94' ' ' VAL . . . . . . . . . . . . . 41.9 t -120.24 128.75 76.0 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.25 0 CA-C-O 120.959 0.409 . . . . 0.0 110.102 -178.987 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 95' ' ' VAL . . . . . . . . . . . . . 42.5 t -123.24 135.56 62.79 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.367 0 CA-C-N 115.933 -0.576 . . . . 0.0 109.77 179.616 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 96' ' ' ILE . . . . . . . . . . . . . 66.9 mt -114.17 130.94 67.53 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.36 0 N-CA-C 109.425 -0.583 . . . . 0.0 109.425 179.259 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 97' ' ' THR . . . . . . . . . . . . . 60.4 p -104.65 158.09 16.73 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-O 121.04 0.447 . . . . 0.0 111.267 -177.825 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 98' ' ' GLU . . . . . . . . . . . . . 97.3 mt-10 -53.98 -26.03 23.89 Favored 'General case' 0 C--N 1.328 -0.355 0 N-CA-C 112.371 0.508 . . . . 0.0 112.371 -179.763 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 99' ' ' GLU . . . . . . . . . . . . . 95.6 mt-10 -78.56 14.62 1.22 Allowed 'General case' 0 CA--C 1.536 0.417 0 N-CA-C 113.171 0.804 . . . . 0.0 113.171 -177.343 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 100' ' ' ASN . . . . . . . . . . . . . 3.6 m-20 62.17 37.94 14.02 Favored 'General case' 0 N--CA 1.462 0.172 0 CA-C-O 121.125 0.488 . . . . 0.0 110.894 178.818 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 101' ' ' GLU . . . . . . . . . . . . . 84.6 tt0 -115.36 144.24 44.07 Favored 'General case' 0 C--O 1.233 0.2 0 CA-C-N 116.047 -0.524 . . . . 0.0 109.807 176.584 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 102' ' ' VAL . . . . . . . . . . . . . 45.1 t -115.03 124.69 71.93 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.338 0 CA-C-N 116.067 -0.515 . . . . 0.0 109.94 -178.339 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 103' ' ' LEU . . . . . . . . . . . . . 23.2 mt -115.13 126.82 55.09 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 115.753 -0.658 . . . . 0.0 110.168 176.449 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 104' ' ' ILE . . . . . . . . . . . . . 72.6 mt -118.21 120.42 64.37 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.232 0 N-CA-C 109.983 -0.377 . . . . 0.0 109.983 179.438 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 105' ' ' PHE . . . . . . . . . . . . . 53.5 m-85 -120.32 162.33 19.63 Favored 'General case' 0 C--N 1.332 -0.178 0 CA-C-N 115.5 -0.773 . . . . 0.0 110.052 179.955 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 106' ' ' ASN . . . . . . . . . . . . . 43.1 p-10 -93.8 -169.83 2.19 Favored 'General case' 0 C--N 1.329 -0.311 0 N-CA-C 109.785 -0.45 . . . . 0.0 109.785 173.375 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 107' ' ' GLN . . . . . . . . . . . . . 48.6 tt0 -57.64 -30.03 65.06 Favored 'General case' 0 CA--C 1.532 0.268 0 N-CA-C 112.061 0.393 . . . . 0.0 112.061 179.37 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 108' ' ' ASN . . . . . . . . . . . . . 49.4 t30 -84.72 9.48 13.87 Favored 'General case' 0 CA--C 1.536 0.412 0 N-CA-C 113.251 0.834 . . . . 0.0 113.251 -177.131 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 109' ' ' LEU . . . . . . . . . . . . . 10.9 tp 58.28 37.03 26.03 Favored 'General case' 0 C--N 1.331 -0.23 0 CA-C-O 120.983 0.421 . . . . 0.0 111.28 179.167 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 110' ' ' GLU . . . . . . . . . . . . . 95.7 mt-10 -106.64 159.48 16.16 Favored 'General case' 0 C--N 1.332 -0.174 0 CA-C-O 120.811 0.338 . . . . 0.0 110.166 176.846 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 111' ' ' GLU . . . . . . . . . . . . . 80.4 tt0 -81.58 121.92 26.93 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.282 -0.417 . . . . 0.0 111.213 -175.646 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 112' ' ' LEU . . . . . . . . . . . . . 15.3 mt -110.29 -46.08 3.48 Favored 'General case' 0 C--N 1.331 -0.227 0 CA-C-N 116.064 -0.516 . . . . 0.0 109.829 175.238 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 113' ' ' TYR . . . . . 0.423 ' CE2' HG21 ' B' ' 75' ' ' VAL . 58.7 t80 -139.24 136.6 35.13 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.145 -0.48 . . . . 0.0 110.931 178.849 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 114' ' ' ARG . . . . . . . . . . . . . 63.3 ttt180 -140.3 122.06 15.4 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 116.095 -0.502 . . . . 0.0 110.187 178.117 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 115' ' ' GLY . . . . . . . . . . . . . . . -150.08 161.66 28.96 Favored Glycine 0 CA--C 1.525 0.703 0 C-N-CA 120.732 -0.747 . . . . 0.0 111.391 179.676 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 116' ' ' LYS . . . . . . . . . . . . . 39.8 ttpt -128.88 136.17 50.07 Favored 'General case' 0 C--N 1.33 -0.27 0 N-CA-C 109.869 -0.419 . . . . 0.0 109.869 177.179 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 117' ' ' PHE . . . . . . . . . . . . . 39.3 m-85 -134.55 113.88 12.23 Favored 'General case' 0 C--N 1.329 -0.285 0 N-CA-C 109.878 -0.416 . . . . 0.0 109.878 -178.012 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 118' ' ' GLU . . . . . . . . . . . . . 12.9 pt-20 -57.06 -39.29 74.64 Favored 'General case' 0 C--N 1.329 -0.313 0 C-N-CA 120.726 -0.39 . . . . 0.0 111.084 -176.415 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 119' ' ' ASN . . . . . . . . . . . . . 32.7 m120 -94.81 26.0 3.79 Favored 'General case' 0 C--N 1.331 -0.207 0 N-CA-C 112.644 0.609 . . . . 0.0 112.644 -174.558 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 120' ' ' LEU . . . . . . . . . . . . . 17.5 tp -58.55 125.01 21.58 Favored 'General case' 0 C--N 1.333 -0.139 0 CA-C-O 120.816 0.341 . . . . 0.0 110.227 178.973 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 121' ' ' ASN . . . . . . . . . . . . . 4.2 m120 -113.96 -44.16 3.19 Favored 'General case' 0 C--N 1.332 -0.186 0 CA-C-N 116.262 -0.426 . . . . 0.0 110.581 -179.141 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 122' ' ' LYS . . . . . . . . . . . . . 56.6 pttt -159.71 157.93 30.41 Favored 'General case' 0 C--N 1.332 -0.186 0 C-N-CA 120.525 -0.47 . . . . 0.0 111.671 -179.624 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 123' ' ' VAL . . . . . . . . . . . . . 43.7 t -129.99 136.78 58.11 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.229 0 CA-C-N 116.022 -0.535 . . . . 0.0 110.09 179.956 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 124' ' ' LEU . . . . . . . . . . . . . 78.4 mt -119.82 133.96 55.41 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.152 -0.476 . . . . 0.0 110.81 -178.93 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 125' ' ' VAL . . . . . . . . . . . . . 48.3 t -126.91 127.25 69.67 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.218 0 N-CA-C 109.482 -0.562 . . . . 0.0 109.482 176.671 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 126' ' ' ARG . . . . . . . . . . . . . 41.7 ttt180 -144.01 124.4 13.89 Favored 'General case' 0 C--N 1.33 -0.242 0 C-N-CA 120.763 -0.375 . . . . 0.0 110.834 -179.192 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 127' ' ' ASN . . . . . . . . . . . . . 3.5 m120 51.2 -106.63 0.26 Allowed 'General case' 0 CA--C 1.544 0.726 0 CA-C-O 118.934 -0.555 . . . . 0.0 111.311 179.916 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 128' ' ' ASP . . . . . . . . . . . . . 10.9 p-10 -114.09 0.4 14.28 Favored 'General case' 0 N--CA 1.467 0.407 0 CA-C-N 119.754 1.161 . . . . 0.0 113.463 -177.883 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 129' ' ' LEU . . . . . . . . . . . . . 30.6 mt -104.91 141.73 36.02 Favored 'General case' 0 C--O 1.232 0.161 0 CA-C-N 118.249 0.477 . . . . 0.0 110.668 -178.429 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 130' ' ' VAL . . . . . . . . . . . . . 46.2 t -123.42 133.59 68.73 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.274 0 CA-C-N 115.973 -0.558 . . . . 0.0 109.574 178.422 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 131' ' ' VAL . . . . . 0.445 HG22 HD12 ' A' ' 140' ' ' LEU . 44.4 t -133.86 135.8 54.69 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.27 0 CA-C-O 121.119 0.485 . . . . 0.0 110.162 179.451 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 132' ' ' ILE . . . . . . . . . . . . . 73.8 mt -113.41 130.94 66.5 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.289 0 CA-C-N 115.668 -0.696 . . . . 0.0 109.249 179.423 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 133' ' ' ILE . . . . . . . . . . . . . 42.1 mm -114.2 120.33 63.66 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.277 0 CA-C-O 120.888 0.375 . . . . 0.0 110.727 -176.356 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 134' ' ' ASP . . . . . . . . . . . . . 7.1 p-10 -132.36 145.96 51.62 Favored 'General case' 0 C--N 1.33 -0.255 0 N-CA-C 109.104 -0.702 . . . . 0.0 109.104 174.003 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 135' ' ' GLU . . . . . . . . . . . . . 41.8 tp10 -49.69 -24.66 2.39 Favored 'General case' 0 C--N 1.328 -0.34 0 N-CA-C 112.881 0.697 . . . . 0.0 112.881 -170.961 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 136' ' ' GLN . . . . . . . . . . . . . 54.1 tp60 -96.53 -34.08 11.59 Favored 'General case' 0 CA--C 1.53 0.18 0 N-CA-C 112.223 0.453 . . . . 0.0 112.223 -175.871 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 137' ' ' LYS . . . . . . . . . . . . . 65.3 mttt -141.22 156.57 45.89 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-O 121.31 0.576 . . . . 0.0 111.905 -169.551 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 138' ' ' LEU . . . . . 0.497 HD23 ' N ' ' A' ' 139' ' ' THR . 5.1 tt -119.41 122.9 42.81 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 115.392 -0.822 . . . . 0.0 109.042 172.028 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 139' ' ' THR . . . . . 0.497 ' N ' HD23 ' A' ' 138' ' ' LEU . 24.8 m -107.06 128.11 54.08 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.552 -0.295 . . . . 0.0 110.548 -178.107 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 140' ' ' LEU . . . . . 0.445 HD12 HG22 ' A' ' 131' ' ' VAL . 44.4 tp -113.32 119.73 38.69 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 115.74 -0.664 . . . . 0.0 109.417 -179.08 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 141' ' ' ILE . . . . . . . . . . . . . 19.3 mt -119.89 118.11 55.96 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.264 0 CA-C-O 121.006 0.431 . . . . 0.0 109.88 -176.713 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 142' ' ' ARG . . . . . . . . . . . . . 78.1 mtm180 -104.47 129.7 52.45 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 115.285 -0.871 . . . . 0.0 110.549 -178.693 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 143' ' ' THR . . . . . . . . . . . . . 77.1 p . . . . . 0 C--O 1.22 -0.466 0 CA-C-O 117.944 -1.027 . . . . 0.0 110.482 179.501 . . . . . . . . 0 0 . 1 . 017 nuclear nobuild core ' B' B ' 2' ' ' SER . . . . . . . . . . . . . 12.5 p . . . . . 0 C--O 1.231 0.083 0 CA-C-O 121.009 0.433 . . . . 0.0 110.37 . . . . . . . . . 0 0 . 1 . 017 nuclear nobuild core ' B' B ' 3' ' ' GLU . . . . . . . . . . . . . 43.6 mt-10 -140.52 145.02 36.28 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-N 115.751 -0.658 . . . . 0.0 110.999 -176.989 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' B' B ' 4' ' ' LEU . . . . . . . . . . . . . 23.1 tp -124.28 128.25 48.87 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.063 -0.517 . . . . 0.0 110.131 174.747 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' B' B ' 5' ' ' LYS . . . . . . . . . . . . . 63.8 mmtt -105.45 113.8 27.58 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 115.988 -0.551 . . . . 0.0 111.121 -179.202 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' B' B ' 6' ' ' LEU . . . . . . . . . . . . . 28.7 mt -113.71 137.48 51.55 Favored 'General case' 0 C--N 1.333 -0.147 0 O-C-N 124.034 0.834 . . . . 0.0 109.659 178.214 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' B' B ' 7' ' ' LYS . . . . . . . . . . . . . 57.7 tttp -123.2 137.95 29.14 Favored Pre-proline 0 CA--C 1.533 0.32 0 CA-C-O 118.853 -0.594 . . . . 0.0 109.862 177.333 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' B' B ' 8' ' ' PRO . . . . . . . . . . . . . 85.0 Cg_endo -90.41 137.2 2.44 Favored 'Trans proline' 0 N--CA 1.491 1.377 0 C-N-CA 121.625 1.55 . . . . 0.0 111.872 179.062 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' B' B ' 9' ' ' LEU . . . . . . . . . . . . . 39.5 mt -80.43 -48.57 1.23 Allowed Pre-proline 0 CA--C 1.535 0.374 0 CA-C-O 118.555 -0.736 . . . . 0.0 112.441 -179.69 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' B' B ' 10' ' ' PRO . . . . . . . . . . . . . 90.0 Cg_endo -78.88 156.21 27.0 Favored 'Trans proline' 0 N--CA 1.497 1.694 0 C-N-CA 121.183 1.256 . . . . 0.0 112.051 178.727 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' B' B ' 11' ' ' LYS . . . . . . . . . . . . . 60.6 mttp -82.71 93.13 7.32 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.353 -0.385 . . . . 0.0 110.333 178.476 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' B' B ' 12' ' ' VAL . . . . . . . . . . . . . 12.7 p -140.16 146.91 24.05 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.303 0 CA-C-N 116.296 -0.411 . . . . 0.0 110.718 -179.262 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' B' B ' 13' ' ' GLU . . . . . . . . . . . . . 84.7 tt0 -97.66 129.04 44.77 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.345 -0.389 . . . . 0.0 110.057 177.823 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' B' B ' 14' ' ' LEU . . . . . . . . . . . . . 27.3 mt -98.37 149.91 36.2 Favored Pre-proline 0 CA--C 1.532 0.282 0 CA-C-O 119.298 -0.382 . . . . 0.0 110.65 -177.12 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' B' B ' 15' ' ' PRO . . . . . . . . . . . . . 24.2 Cg_exo -63.68 160.57 35.87 Favored 'Trans proline' 0 N--CA 1.498 1.737 0 C-N-CA 121.366 1.377 . . . . 0.0 111.733 175.36 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' B' B ' 16' ' ' PRO . . . . . . . . . . . . . 30.4 Cg_exo -59.84 -35.81 92.86 Favored 'Trans proline' 0 N--CA 1.498 1.737 0 C-N-CA 121.47 1.447 . . . . 0.0 112.688 -178.589 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' B' B ' 17' ' ' ASP . . . . . . . . . . . . . 38.1 p30 -90.2 9.6 27.87 Favored 'General case' 0 CA--C 1.535 0.391 0 N-CA-C 113.367 0.877 . . . . 0.0 113.367 -177.553 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' B' B ' 18' ' ' PHE . . . . . . . . . . . . . 37.4 t80 -58.43 -46.38 86.61 Favored 'General case' 0 N--CA 1.458 -0.059 0 O-C-N 121.965 -0.459 . . . . 0.0 110.017 -177.598 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' B' B ' 19' ' ' VAL . . . . . . . . . . . . . 48.5 t -56.86 -41.72 76.63 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.399 0 CA-C-N 116.228 -0.442 . . . . 0.0 110.392 -178.176 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' B' B ' 20' ' ' ASP . . . . . . . . . . . . . 78.3 m-20 -60.14 -44.0 95.29 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-O 120.784 0.326 . . . . 0.0 111.0 -177.399 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' B' B ' 21' ' ' VAL . . . . . . . . . . . . . 48.0 t -64.5 -46.13 93.65 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.294 0 C-N-CA 120.765 -0.374 . . . . 0.0 110.468 -177.648 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' B' B ' 22' ' ' ILE . . . . . 0.536 HG22 HD12 ' B' ' 26' ' ' LEU . 50.1 mm -56.31 -44.73 80.48 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.25 0 C-N-CA 120.857 -0.337 . . . . 0.0 110.582 179.083 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' B' B ' 23' ' ' ARG . . . . . . . . . . . . . 59.6 ttp180 -54.49 -48.81 71.4 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-O 120.763 0.316 . . . . 0.0 111.17 -179.549 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' B' B ' 24' ' ' ILE . . . . . . . . . . . . . 74.2 mt -59.52 -41.1 83.69 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.247 0 CA-C-N 116.336 -0.393 . . . . 0.0 111.424 -176.66 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' B' B ' 25' ' ' LYS . . . . . . . . . . . . . 97.7 mttt -70.07 -43.33 71.38 Favored 'General case' 0 C--N 1.33 -0.273 0 N-CA-C 112.719 0.637 . . . . 0.0 112.719 -178.625 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' B' B ' 26' ' ' LEU . . . . . 0.536 HD12 HG22 ' B' ' 22' ' ' ILE . 92.2 mt -78.11 -34.23 50.12 Favored 'General case' 0 C--N 1.33 -0.26 0 N-CA-C 113.444 0.905 . . . . 0.0 113.444 -170.336 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' B' B ' 27' ' ' GLN . . . . . . . . . . . . . 6.6 pt20 -46.98 139.38 5.66 Favored 'General case' 0 N--CA 1.468 0.47 0 N-CA-C 112.755 0.65 . . . . 0.0 112.755 -175.95 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' B' B ' 28' ' ' GLY . . . . . . . . . . . . . . . 100.8 -23.95 33.79 Favored Glycine 0 CA--C 1.535 1.283 0 CA-C-N 115.671 -0.695 . . . . 0.0 112.384 -176.232 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' B' B ' 29' ' ' LYS . . . . . . . . . . . . . 45.4 mtmt -97.99 155.16 17.23 Favored 'General case' 0 C--O 1.231 0.1 0 CA-C-N 117.396 0.598 . . . . 0.0 111.037 178.804 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' B' B ' 30' ' ' THR . . . . . . . . . . . . . 32.0 m -105.05 137.7 42.39 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 116.043 -0.526 . . . . 0.0 110.236 177.978 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' B' B ' 31' ' ' VAL . . . . . . . . . . . . . 35.2 m -131.35 158.26 43.29 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.22 0 CA-C-O 120.865 0.364 . . . . 0.0 110.898 -179.153 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' B' B ' 32' ' ' ARG . . . . . . . . . . . . . 98.1 mtt180 -135.63 153.15 51.74 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-O 121.284 0.564 . . . . 0.0 110.77 178.245 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' B' B ' 33' ' ' THR . . . . . . . . . . . . . 19.8 m -53.6 140.67 28.05 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.153 -0.476 . . . . 0.0 111.441 -178.478 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' B' B ' 34' ' ' GLY . . . . . . . . . . . . . . . 99.29 -17.11 58.34 Favored Glycine 0 CA--C 1.532 1.109 0 CA-C-N 116.09 -0.505 . . . . 0.0 113.309 178.996 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' B' B ' 35' ' ' ASP . . . . . . . . . . . . . 78.2 m-20 -67.02 149.14 51.03 Favored 'General case' 0 N--CA 1.462 0.13 0 CA-C-N 118.036 0.918 . . . . 0.0 111.194 178.946 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' B' B ' 36' ' ' VAL . . . . . . . . . . . . . 45.7 t -119.48 129.84 74.8 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.197 0 CA-C-N 115.895 -0.593 . . . . 0.0 109.668 176.768 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' B' B ' 37' ' ' ILE . . . . . . . . . . . . . 65.1 mt -119.08 137.71 52.17 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.275 0 CA-C-N 116.125 -0.489 . . . . 0.0 109.968 -178.93 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' B' B ' 38' ' ' GLY . . . . . . . . . . . . . . . -113.34 127.77 8.04 Favored Glycine 0 CA--C 1.526 0.725 0 N-CA-C 110.873 -0.891 . . . . 0.0 110.873 179.43 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' B' B ' 39' ' ' ILE . . . . . . . . . . . . . 72.2 mt -125.6 131.55 71.94 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.27 0 N-CA-C 110.127 -0.323 . . . . 0.0 110.127 179.254 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' B' B ' 40' ' ' SER . . . . . . . . . . . . . 26.7 p -92.15 114.68 27.28 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.418 -0.356 . . . . 0.0 110.997 176.875 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' B' B ' 41' ' ' ILE . . . . . 0.443 HG22 HD13 ' B' ' 42' ' ' LEU . 44.1 mm -121.44 123.43 69.62 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.236 0 CA-C-N 116.483 -0.326 . . . . 0.0 110.33 179.714 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' B' B ' 42' ' ' LEU . . . . . 0.443 HD13 HG22 ' B' ' 41' ' ' ILE . 6.7 mp 52.94 34.53 17.02 Favored 'General case' 0 CA--C 1.533 0.29 0 CA-C-N 116.292 -0.413 . . . . 0.0 111.505 177.92 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' B' B ' 43' ' ' GLY . . . . . . . . . . . . . . . 72.67 30.48 63.96 Favored Glycine 0 CA--C 1.53 0.999 0 C-N-CA 121.199 -0.524 . . . . 0.0 112.211 177.888 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' B' B ' 44' ' ' LYS . . . . . . . . . . . . . 61.5 tttm -138.21 128.94 26.69 Favored 'General case' 0 C--N 1.329 -0.288 0 N-CA-C 109.585 -0.524 . . . . 0.0 109.585 178.132 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' B' B ' 45' ' ' GLU . . . . . . . . . . . . . 84.7 tt0 -83.28 122.0 27.85 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-O 120.817 0.342 . . . . 0.0 111.019 -177.153 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' B' B ' 46' ' ' VAL . . . . . . . . . . . . . 10.6 p -119.98 125.03 73.85 Favored 'Isoleucine or valine' 0 C--O 1.232 0.147 0 N-CA-C 109.444 -0.576 . . . . 0.0 109.444 174.651 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' B' B ' 47' ' ' LYS . . . . . . . . . . . . . 99.3 mttt -99.91 128.31 46.01 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.145 -0.479 . . . . 0.0 111.025 179.094 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' B' B ' 48' ' ' PHE . . . . . . . . . . . . . 26.7 m-85 -110.74 131.84 54.7 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 115.946 -0.57 . . . . 0.0 109.588 175.489 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' B' B ' 49' ' ' LYS . . . . . . . . . . . . . 60.8 tttm -105.62 135.42 47.05 Favored 'General case' 0 C--N 1.327 -0.37 0 N-CA-C 109.867 -0.42 . . . . 0.0 109.867 177.047 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' B' B ' 50' ' ' VAL . . . . . . . . . . . . . 47.3 t -79.99 104.99 8.93 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.326 0 N-CA-C 109.563 -0.532 . . . . 0.0 109.563 178.509 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' B' B ' 51' ' ' VAL . . . . . . . . . . . . . 46.4 t -69.88 -51.86 36.49 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.335 0 CA-C-N 115.945 -0.57 . . . . 0.0 109.8 -176.721 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' B' B ' 52' ' ' GLN . . . . . . . . . . . . . 92.4 mt-30 -151.88 151.36 31.18 Favored 'General case' 0 C--N 1.334 -0.105 0 C-N-CA 120.244 -0.582 . . . . 0.0 111.957 -179.456 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' B' B ' 53' ' ' ALA . . . . . . . . . . . . . . . -126.8 131.11 51.34 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 115.092 -0.958 . . . . 0.0 109.555 174.402 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' B' B ' 54' ' ' TYR . . . . . . . . . . . . . 30.2 t80 -129.12 109.67 18.1 Favored Pre-proline 0 C--N 1.328 -0.351 0 CA-C-O 118.201 -0.904 . . . . 0.0 110.31 178.902 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' B' B ' 55' ' ' PRO . . . . . . . . . . . . . 73.7 Cg_endo -77.28 168.3 77.18 Favored 'Cis proline' 0 N--CA 1.5 1.911 0 CA-C-N 121.985 1.745 . . . . 0.0 112.634 -3.558 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' B' B ' 56' ' ' SER . . . . . . . . . . . . . 13.5 m -114.63 125.84 28.64 Favored Pre-proline 0 CA--C 1.538 0.516 0 CA-C-O 118.368 -0.825 . . . . 0.0 109.241 174.907 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' B' B ' 57' ' ' PRO . . . . . . . . . . . . . 44.8 Cg_endo -68.67 168.38 63.03 Favored 'Cis proline' 0 N--CA 1.496 1.66 0 CA-C-N 122.041 1.764 . . . . 0.0 111.573 1.325 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' B' B ' 58' ' ' LEU . . . . . . . . . . . . . 26.9 tp -129.23 135.64 49.07 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.137 179.28 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' B' B ' 59' ' ' ARG . . . . . . . . . . . . . 69.8 ttt180 -104.16 124.27 48.8 Favored 'General case' 0 C--N 1.327 -0.388 0 N-CA-C 109.277 -0.638 . . . . 0.0 109.277 177.413 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' B' B ' 60' ' ' VAL . . . . . . . . . . . . . 46.5 t -73.2 115.45 14.1 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.234 0 C-N-CA 120.61 -0.436 . . . . 0.0 110.078 -175.488 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' B' B ' 61' ' ' GLU . . . . . . . . . . . . . 75.0 tt0 -131.02 155.08 47.46 Favored 'General case' 0 C--N 1.329 -0.314 0 N-CA-C 109.152 -0.685 . . . . 0.0 109.152 177.897 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' B' B ' 62' ' ' ASP . . . . . . . . . . . . . 13.6 t70 -52.0 -32.79 35.37 Favored 'General case' 0 C--N 1.327 -0.405 0 N-CA-C 111.946 0.351 . . . . 0.0 111.946 -177.732 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' B' B ' 63' ' ' ARG . . . . . . . . . . . . . 98.6 mtt180 -74.16 -22.14 59.56 Favored 'General case' 0 C--N 1.33 -0.272 0 N-CA-C 113.04 0.756 . . . . 0.0 113.04 -177.185 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' B' B ' 64' ' ' THR . . . . . . . . . . . . . 31.0 m -64.84 136.85 57.34 Favored 'General case' 0 C--N 1.331 -0.226 0 CA-C-O 120.725 0.298 . . . . 0.0 110.57 -176.843 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' B' B ' 65' ' ' LYS . . . . . . . . . . . . . 40.3 ttpt -88.66 124.6 34.24 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-O 121.079 0.466 . . . . 0.0 110.176 -179.976 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' B' B ' 66' ' ' ILE . . . . . . . . . . . . . 69.9 mt -108.09 126.59 64.66 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.298 0 N-CA-C 109.815 -0.439 . . . . 0.0 109.815 -177.906 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' B' B ' 67' ' ' THR . . . . . . . . . . . . . 42.1 m -120.69 139.93 52.34 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.039 -0.528 . . . . 0.0 110.769 -176.422 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' B' B ' 68' ' ' LEU . . . . . . . . . . . . . 19.8 tp . . . . . 0 C--N 1.329 -0.303 0 CA-C-N 115.796 -0.638 . . . . 0.0 110.463 179.749 . . . . . . . . 0 0 . 1 . 017 nuclear nobuild core ' B' B ' 73' ' ' VAL . . . . . . . . . . . . . 17.2 m . . . . . 0 C--O 1.231 0.081 0 CA-C-O 121.171 0.51 . . . . 0.0 110.78 . . . . . . . . . 0 0 . 1 . 017 nuclear nobuild core ' B' B ' 74' ' ' ASP . . . . . . . . . . . . . 18.1 t0 -103.43 121.42 42.76 Favored 'General case' 0 C--N 1.328 -0.36 0 N-CA-C 108.955 -0.757 . . . . 0.0 108.955 175.441 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' B' B ' 75' ' ' VAL . . . . . 0.423 HG21 ' CE2' ' A' ' 113' ' ' TYR . 41.8 t -114.86 124.99 72.05 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.225 0 CA-C-O 121.135 0.493 . . . . 0.0 110.954 -175.017 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' B' B ' 76' ' ' LEU . . . . . . . . . . . . . 5.6 mp -125.13 147.37 49.05 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 115.394 -0.821 . . . . 0.0 109.492 175.069 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' B' B ' 77' ' ' GLU . . . . . . . . . . . . . 97.6 mt-10 -133.35 131.23 39.85 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-O 121.053 0.454 . . . . 0.0 111.165 -178.444 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' B' B ' 78' ' ' ALA . . . . . . . . . . . . . . . -117.67 139.08 51.5 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 115.67 -0.696 . . . . 0.0 109.662 176.822 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' B' B ' 79' ' ' LYS . . . . . 0.515 ' O ' HD13 ' B' ' 80' ' ' ILE . 9.4 mtpm? -87.34 117.88 26.41 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-O 120.948 0.404 . . . . 0.0 110.707 -178.501 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' B' B ' 80' ' ' ILE . . . . . 0.515 HD13 ' O ' ' B' ' 79' ' ' LYS . 25.2 mm -139.08 114.29 8.45 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.268 0 N-CA-C 108.979 -0.749 . . . . 0.0 108.979 -177.958 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' B' B ' 81' ' ' LYS . . . . . . . . . . . . . 53.8 tttp -103.92 127.3 51.45 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-O 120.812 0.339 . . . . 0.0 111.402 -175.718 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' B' B ' 82' ' ' GLY . . . . . . . . . . . . . . . 89.19 41.98 5.7 Favored Glycine 0 CA--C 1.527 0.843 0 C-N-CA 120.839 -0.696 . . . . 0.0 112.258 173.271 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' B' B ' 83' ' ' ILE . . . . . . . . . . . . . 69.7 mt -73.57 138.91 20.31 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.347 0 N-CA-C 109.571 -0.529 . . . . 0.0 109.571 176.961 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' B' B ' 84' ' ' LYS . . . . . . . . . . . . . 38.5 ttpt -103.52 -49.08 3.78 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-N 116.294 -0.412 . . . . 0.0 110.606 -177.828 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' B' B ' 85' ' ' ASP . . . . . . . . . . . . . 12.2 t70 -144.49 148.51 34.62 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.091 -0.504 . . . . 0.0 110.603 -178.532 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' B' B ' 86' ' ' VAL . . . . . . . . . . . . . 46.4 t -130.38 133.12 64.33 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.247 0 CA-C-O 120.87 0.367 . . . . 0.0 110.428 -179.189 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' B' B ' 87' ' ' ILE . . . . . 0.489 ' N ' HD12 ' B' ' 87' ' ' ILE . 5.0 mp -122.64 124.38 70.52 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.195 0 CA-C-N 115.935 -0.575 . . . . 0.0 109.522 176.617 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' B' B ' 88' ' ' LEU . . . . . . . . . . . . . 16.0 tp -109.74 129.61 55.6 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-O 120.866 0.365 . . . . 0.0 110.709 -178.629 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' B' B ' 89' ' ' ASP . . . . . . . . . . . . . 13.4 t70 -128.23 155.68 44.16 Favored 'General case' 0 C--N 1.331 -0.215 0 CA-C-N 116.12 -0.491 . . . . 0.0 110.031 178.122 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' B' B ' 90' ' ' GLU . . . . . . . . . . . . . 96.2 mt-10 -47.5 -36.84 10.84 Favored 'General case' 0 C--N 1.328 -0.357 0 N-CA-C 113.055 0.761 . . . . 0.0 113.055 -171.457 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' B' B ' 91' ' ' ASN . . . . . . . . . . . . . 66.0 m-80 -129.01 16.54 6.22 Favored 'General case' 0 N--CA 1.469 0.502 0 N-CA-C 113.285 0.846 . . . . 0.0 113.285 -176.435 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' B' B ' 92' ' ' LEU . . . . . . . . . . . . . 11.4 mt -148.73 144.89 27.37 Favored 'General case' 0 C--N 1.331 -0.198 0 CA-C-O 120.818 0.342 . . . . 0.0 110.248 -176.265 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' B' B ' 93' ' ' ILE . . . . . . . . . . . . . 72.3 mt -121.59 116.43 49.48 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.224 0 N-CA-C 108.838 -0.801 . . . . 0.0 108.838 174.946 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' B' B ' 94' ' ' VAL . . . . . . . . . . . . . 43.9 t -115.7 125.8 73.0 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.294 0 N-CA-C 109.68 -0.489 . . . . 0.0 109.68 -178.084 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' B' B ' 95' ' ' VAL . . . . . . . . . . . . . 41.9 t -120.8 132.74 69.55 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.315 0 CA-C-N 116.065 -0.516 . . . . 0.0 109.681 -179.636 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' B' B ' 96' ' ' ILE . . . . . . . . . . . . . 70.7 mt -114.31 125.27 71.57 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.353 0 N-CA-C 109.228 -0.656 . . . . 0.0 109.228 178.577 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' B' B ' 97' ' ' THR . . . . . . . . . . . . . 54.6 p -96.2 155.29 16.82 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-O 121.164 0.506 . . . . 0.0 111.115 -177.583 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' B' B ' 98' ' ' GLU . . . . . . . . . . . . . 12.6 pt-20 -55.4 -20.67 12.82 Favored 'General case' 0 C--N 1.328 -0.338 0 N-CA-C 112.707 0.632 . . . . 0.0 112.707 -179.396 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' B' B ' 99' ' ' GLU . . . . . . . . . . . . . 12.8 pt-20 -84.56 17.61 2.62 Favored 'General case' 0 CA--C 1.535 0.377 0 N-CA-C 113.117 0.784 . . . . 0.0 113.117 -178.7 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' B' B ' 100' ' ' ASN . . . . . . . . . . . . . 3.1 m-20 62.86 37.95 11.8 Favored 'General case' 0 N--CA 1.462 0.171 0 CA-C-O 121.084 0.468 . . . . 0.0 111.129 177.29 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' B' B ' 101' ' ' GLU . . . . . . . . . . . . . 84.6 tt0 -117.72 141.01 48.88 Favored 'General case' 0 C--N 1.332 -0.158 0 N-CA-C 109.77 -0.456 . . . . 0.0 109.77 175.358 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' B' B ' 102' ' ' VAL . . . . . . . . . . . . . 45.2 t -114.96 127.67 72.42 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.329 0 N-CA-C 109.991 -0.374 . . . . 0.0 109.991 -178.134 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' B' B ' 103' ' ' LEU . . . . . . . . . . . . . 29.4 mt -119.27 133.99 55.45 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 115.762 -0.653 . . . . 0.0 110.19 177.599 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' B' B ' 104' ' ' ILE . . . . . 0.409 ' CD1' HG11 ' B' ' 130' ' ' VAL . 69.8 mt -118.73 121.48 67.05 Favored 'Isoleucine or valine' 0 C--O 1.233 0.215 0 CA-C-N 116.52 -0.309 . . . . 0.0 110.272 -179.449 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' B' B ' 105' ' ' PHE . . . . . . . . . . . . . 90.1 m-85 -118.57 163.31 16.98 Favored 'General case' 0 C--O 1.232 0.143 0 O-C-N 124.116 0.885 . . . . 0.0 109.692 178.442 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' B' B ' 106' ' ' ASN . . . . . . . . . . . . . 44.6 p-10 -101.21 -170.64 1.87 Allowed 'General case' 0 C--N 1.33 -0.276 0 N-CA-C 110.185 -0.302 . . . . 0.0 110.185 174.1 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' B' B ' 107' ' ' GLN . . . . . . . . . . . . . 42.4 tt0 -57.49 -26.89 61.98 Favored 'General case' 0 C--N 1.328 -0.331 0 N-CA-C 112.325 0.491 . . . . 0.0 112.325 179.526 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' B' B ' 108' ' ' ASN . . . . . . . . . . . . . 21.4 t-20 -92.41 13.53 19.26 Favored 'General case' 0 CA--C 1.535 0.396 0 N-CA-C 113.144 0.794 . . . . 0.0 113.144 -176.43 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' B' B ' 109' ' ' LEU . . . . . 0.4 HD11 ' HB3' ' A' ' 140' ' ' LEU . 38.9 mt 57.26 32.92 22.54 Favored 'General case' 0 C--O 1.233 0.22 0 N-CA-C 112.013 0.375 . . . . 0.0 112.013 178.332 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' B' B ' 110' ' ' GLU . . . . . . . . . . . . . 70.7 mm-40 -103.21 140.19 37.69 Favored 'General case' 0 C--N 1.329 -0.303 0 N-CA-C 109.497 -0.557 . . . . 0.0 109.497 175.203 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' B' B ' 111' ' ' GLU . . . . . . . . . . . . . 52.7 tt0 -76.95 121.72 23.87 Favored 'General case' 0 C--N 1.326 -0.418 0 CA-C-N 116.426 -0.352 . . . . 0.0 110.512 -175.698 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' B' B ' 112' ' ' LEU . . . . . . . . . . . . . 85.6 mt -103.09 -45.77 4.83 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.13 -0.487 . . . . 0.0 110.522 178.841 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' B' B ' 113' ' ' TYR . . . . . . . . . . . . . 65.0 t80 -137.87 144.06 41.21 Favored 'General case' 0 C--N 1.331 -0.2 0 CA-C-N 116.188 -0.46 . . . . 0.0 111.29 -178.105 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' B' B ' 114' ' ' ARG . . . . . . . . . . . . . 37.3 ptt180 -145.59 125.47 13.52 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 115.994 -0.548 . . . . 0.0 110.513 177.429 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' B' B ' 115' ' ' GLY . . . . . . . . . . . . . . . -150.22 149.22 21.07 Favored Glycine 0 CA--C 1.525 0.668 0 N-CA-C 111.12 -0.792 . . . . 0.0 111.12 179.467 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' B' B ' 116' ' ' LYS . . . . . . . . . . . . . 7.4 ttpm? -114.49 137.6 51.65 Favored 'General case' 0 C--N 1.33 -0.265 0 N-CA-C 109.661 -0.496 . . . . 0.0 109.661 176.288 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' B' B ' 117' ' ' PHE . . . . . . . . . . . . . 39.0 m-85 -137.02 113.79 10.37 Favored 'General case' 0 C--N 1.329 -0.305 0 N-CA-C 109.962 -0.384 . . . . 0.0 109.962 -179.036 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' B' B ' 118' ' ' GLU . . . . . . . . . . . . . 96.3 mt-10 -57.91 -42.42 84.69 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.332 -0.395 . . . . 0.0 110.742 -176.371 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' B' B ' 119' ' ' ASN . . . . . . . . . . . . . 69.1 m-80 -97.22 31.1 2.55 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.207 -0.451 . . . . 0.0 112.094 -174.707 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' B' B ' 120' ' ' LEU . . . . . . . . . . . . . 24.2 tp -57.1 121.23 9.54 Favored 'General case' 0 C--N 1.333 -0.136 0 C-N-CA 120.944 -0.302 . . . . 0.0 110.429 177.969 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' B' B ' 121' ' ' ASN . . . . . . . . . . . . . 27.2 m-80 -103.43 -43.56 5.38 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.356 -0.384 . . . . 0.0 110.287 -179.556 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' B' B ' 122' ' ' LYS . . . . . . . . . . . . . 53.6 pttt -165.95 152.98 9.87 Favored 'General case' 0 C--N 1.331 -0.222 0 CA-C-O 121.186 0.517 . . . . 0.0 111.892 179.047 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' B' B ' 123' ' ' VAL . . . . . . . . . . . . . 45.1 t -119.71 132.46 69.39 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.261 0 CA-C-N 115.852 -0.613 . . . . 0.0 109.538 177.911 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' B' B ' 124' ' ' LEU . . . . . . . . . . . . . 6.5 mp -119.36 136.42 54.28 Favored 'General case' 0 C--N 1.332 -0.193 0 CA-C-N 116.156 -0.474 . . . . 0.0 110.673 -177.757 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' B' B ' 125' ' ' VAL . . . . . . . . . . . . . 46.0 t -119.2 131.89 70.62 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.273 0 CA-C-N 116.002 -0.545 . . . . 0.0 109.833 178.36 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' B' B ' 126' ' ' ARG . . . . . . . . . . . . . 40.7 mmt180 -133.27 99.14 4.44 Favored 'General case' 0 C--N 1.331 -0.21 0 CA-C-N 116.25 -0.432 . . . . 0.0 110.278 179.12 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' B' B ' 127' ' ' ASN . . . . . . . . . . . . . 34.3 t-20 53.42 -104.89 0.22 Allowed 'General case' 0 CA--C 1.542 0.65 0 CA-C-O 119.02 -0.514 . . . . 0.0 111.157 178.793 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' B' B ' 128' ' ' ASP . . . . . . . . . . . . . 19.5 p-10 -105.86 -3.09 22.3 Favored 'General case' 0 CA--C 1.537 0.468 0 CA-C-N 119.562 1.074 . . . . 0.0 113.684 -175.971 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' B' B ' 129' ' ' LEU . . . . . . . . . . . . . 60.2 mt -105.09 142.84 34.16 Favored 'General case' 0 C--N 1.332 -0.157 0 O-C-N 122.102 -0.374 . . . . 0.0 110.116 178.571 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' B' B ' 130' ' ' VAL . . . . . 0.409 HG11 ' CD1' ' B' ' 104' ' ' ILE . 42.9 t -121.27 135.88 60.02 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.213 0 N-CA-C 110.016 -0.365 . . . . 0.0 110.016 -178.582 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' B' B ' 131' ' ' VAL . . . . . . . . . . . . . 39.6 t -133.13 133.34 58.47 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.278 0 CA-C-O 120.932 0.396 . . . . 0.0 110.275 179.479 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' B' B ' 132' ' ' ILE . . . . . . . . . . . . . 73.1 mt -114.06 130.17 68.73 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.363 0 N-CA-C 109.263 -0.643 . . . . 0.0 109.263 178.604 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' B' B ' 133' ' ' ILE . . . . . . . . . . . . . 42.3 mm -111.98 119.61 60.46 Favored 'Isoleucine or valine' 0 C--O 1.234 0.247 0 CA-C-O 120.877 0.37 . . . . 0.0 110.878 -176.095 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' B' B ' 134' ' ' ASP . . . . . . . . . . . . . 7.4 p-10 -132.88 143.56 49.59 Favored 'General case' 0 C--N 1.33 -0.246 0 N-CA-C 109.312 -0.625 . . . . 0.0 109.312 175.449 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' B' B ' 135' ' ' GLU . . . . . . . . . . . . . 77.7 tt0 -49.99 -25.77 3.64 Favored 'General case' 0 C--N 1.327 -0.389 0 N-CA-C 112.697 0.629 . . . . 0.0 112.697 -174.599 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' B' B ' 136' ' ' GLN . . . . . . . . . . . . . 47.7 tt0 -85.54 -31.42 22.71 Favored 'General case' 0 C--O 1.233 0.192 0 N-CA-C 112.386 0.513 . . . . 0.0 112.386 -175.388 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' B' B ' 137' ' ' LYS . . . . . . . . . . . . . 18.2 ptpt -164.7 174.06 11.17 Favored 'General case' 0 C--O 1.233 0.205 0 CA-C-O 121.64 0.733 . . . . 0.0 112.193 -175.359 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' B' B ' 138' ' ' LEU . . . . . 0.409 HD23 ' N ' ' B' ' 139' ' ' THR . 6.5 tt -119.5 128.87 54.37 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 114.938 -1.028 . . . . 0.0 109.504 176.418 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' B' B ' 139' ' ' THR . . . . . 0.409 ' N ' HD23 ' B' ' 138' ' ' LEU . 25.4 m -108.1 126.0 52.24 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.315 -0.402 . . . . 0.0 110.467 -179.933 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' B' B ' 140' ' ' LEU . . . . . . . . . . . . . 17.2 tp -112.95 119.9 39.55 Favored 'General case' 0 C--N 1.331 -0.209 0 CA-C-N 115.791 -0.64 . . . . 0.0 109.304 -178.926 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' B' B ' 141' ' ' ILE . . . . . . . . . . . . . 19.2 mt -119.16 123.19 70.93 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.289 0 CA-C-O 120.884 0.373 . . . . 0.0 110.118 -173.845 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' B' B ' 142' ' ' ARG . . . . . . . . . . . . . 72.7 mtt180 -108.79 127.58 54.14 Favored 'General case' 0 C--N 1.331 -0.239 0 CA-C-N 115.439 -0.801 . . . . 0.0 110.027 -176.301 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' B' B ' 143' ' ' THR . . . . . . . . . . . . . 52.9 p . . . . . 0 C--O 1.221 -0.442 0 CA-C-O 117.992 -1.004 . . . . 0.0 110.576 179.804 . . . . . . . . 0 0 . 1 . 017 nuclear nobuild core ' C' C ' 2' ' ' SER . . . . . . . . . . . . . 55.2 p . . . . . 0 N--CA 1.461 0.112 0 CA-C-O 120.888 0.375 . . . . 0.0 110.554 . . . . . . . . . 0 0 . 1 . 017 nuclear nobuild core ' C' C ' 3' ' ' GLU . . . . . . . . . . . . . 42.7 mt-10 -140.37 141.07 35.64 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.039 -0.528 . . . . 0.0 111.013 -178.458 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' C' C ' 4' ' ' LEU . . . . . . . . . . . . . 19.0 tp -124.27 128.28 48.92 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 115.808 -0.633 . . . . 0.0 109.976 176.19 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' C' C ' 5' ' ' LYS . . . . . . . . . . . . . 99.1 mttt -110.36 123.43 49.83 Favored 'General case' 0 C--O 1.234 0.254 0 CA-C-O 120.672 0.272 . . . . 0.0 110.929 179.877 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' C' C ' 6' ' ' LEU . . . . . . . . . . . . . 52.4 mt -114.61 145.62 41.77 Favored 'General case' 0 C--N 1.332 -0.185 0 CA-C-N 115.559 -0.746 . . . . 0.0 110.146 178.586 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' C' C ' 7' ' ' LYS . . . . . . . . . . . . . 35.7 ttpt -127.36 141.41 40.78 Favored Pre-proline 0 CA--C 1.533 0.319 0 CA-C-O 119.071 -0.49 . . . . 0.0 109.711 175.286 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' C' C ' 8' ' ' PRO . . . . . . . . . . . . . 91.7 Cg_endo -91.69 138.56 2.1 Favored 'Trans proline' 0 N--CA 1.489 1.211 0 C-N-CA 121.718 1.612 . . . . 0.0 112.129 179.255 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' C' C ' 9' ' ' LEU . . . . . . . . . . . . . 67.8 mt -78.19 -47.16 2.12 Favored Pre-proline 0 C--N 1.329 -0.312 0 CA-C-O 118.714 -0.66 . . . . 0.0 111.826 178.189 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' C' C ' 10' ' ' PRO . . . . . . . . . . . . . 85.5 Cg_endo -81.14 151.61 18.19 Favored 'Trans proline' 0 N--CA 1.495 1.613 0 C-N-CA 121.14 1.226 . . . . 0.0 111.536 174.58 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' C' C ' 11' ' ' LYS . . . . . . . . . . . . . 66.7 tttt -88.33 98.85 11.82 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-O 120.836 0.351 . . . . 0.0 110.194 178.712 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' C' C ' 12' ' ' VAL . . . . . . . . . . . . . 13.2 p -140.03 147.14 23.93 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.285 0 CA-C-N 116.29 -0.414 . . . . 0.0 110.727 -178.463 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' C' C ' 13' ' ' GLU . . . . . . . . . . . . . 84.1 tt0 -88.96 123.82 33.66 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.21 -0.45 . . . . 0.0 109.908 176.978 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' C' C ' 14' ' ' LEU . . . . . . . . . . . . . 22.2 mt -98.14 152.29 37.94 Favored Pre-proline 0 C--N 1.329 -0.299 0 CA-C-N 116.402 -0.363 . . . . 0.0 110.84 -177.189 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' C' C ' 15' ' ' PRO . . . . . . . . . . . . . 25.6 Cg_exo -62.31 157.02 47.6 Favored 'Trans proline' 0 N--CA 1.498 1.761 0 C-N-CA 121.261 1.308 . . . . 0.0 111.713 176.116 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' C' C ' 16' ' ' PRO . . . . . . . . . . . . . 39.5 Cg_exo -58.72 -36.47 97.08 Favored 'Trans proline' 0 N--CA 1.498 1.776 0 C-N-CA 121.389 1.393 . . . . 0.0 112.65 -179.533 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' C' C ' 17' ' ' ASP . . . . . . . . . . . . . 16.6 p-10 -85.66 7.94 21.46 Favored 'General case' 0 CA--C 1.535 0.393 0 N-CA-C 113.23 0.826 . . . . 0.0 113.23 -177.641 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' C' C ' 18' ' ' PHE . . . . . . . . . . . . . 43.9 t80 -58.09 -46.8 84.89 Favored 'General case' 0 N--CA 1.456 -0.126 0 O-C-N 121.983 -0.448 . . . . 0.0 110.285 -176.876 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' C' C ' 19' ' ' VAL . . . . . 0.4 HG13 ' N ' ' C' ' 20' ' ' ASP . 14.7 p -55.48 -41.76 64.72 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.288 0 CA-C-N 116.523 -0.308 . . . . 0.0 111.029 -178.019 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' C' C ' 20' ' ' ASP . . . . . 0.4 ' N ' HG13 ' C' ' 19' ' ' VAL . 78.3 m-20 -61.4 -44.44 97.14 Favored 'General case' 0 C--N 1.329 -0.286 0 C-N-CA 120.935 -0.306 . . . . 0.0 111.231 -178.198 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' C' C ' 21' ' ' VAL . . . . . . . . . . . . . 47.6 t -64.11 -45.22 97.12 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.287 0 C-N-CA 120.715 -0.394 . . . . 0.0 110.447 -176.953 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' C' C ' 22' ' ' ILE . . . . . 0.41 HG22 HD12 ' C' ' 26' ' ' LEU . 51.0 mm -56.5 -46.25 82.27 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.227 0 C-N-CA 120.872 -0.331 . . . . 0.0 110.55 178.614 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' C' C ' 23' ' ' ARG . . . . . . . . . . . . . 56.1 ttp180 -54.89 -46.75 74.84 Favored 'General case' 0 C--N 1.329 -0.302 0 C-N-CA 121.057 -0.257 . . . . 0.0 111.384 -179.269 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' C' C ' 24' ' ' ILE . . . . . . . . . . . . . 79.7 mt -59.58 -43.87 91.97 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.303 0 C-N-CA 121.075 -0.25 . . . . 0.0 111.246 -177.987 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' C' C ' 25' ' ' LYS . . . . . . . . . . . . . 97.4 mttt -66.01 -42.1 90.12 Favored 'General case' 0 C--N 1.328 -0.361 0 N-CA-C 112.504 0.557 . . . . 0.0 112.504 -178.878 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' C' C ' 26' ' ' LEU . . . . . 0.41 HD12 HG22 ' C' ' 22' ' ' ILE . 93.0 mt -77.91 -38.79 44.88 Favored 'General case' 0 C--N 1.33 -0.254 0 N-CA-C 113.216 0.821 . . . . 0.0 113.216 -170.833 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' C' C ' 27' ' ' GLN . . . . . . . . . . . . . 9.9 pt20 -47.19 139.94 5.66 Favored 'General case' 0 N--CA 1.469 0.521 0 N-CA-C 112.709 0.633 . . . . 0.0 112.709 -176.137 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' C' C ' 28' ' ' GLY . . . . . . . . . . . . . . . 100.61 -26.15 25.69 Favored Glycine 0 CA--C 1.534 1.269 0 CA-C-N 115.598 -0.728 . . . . 0.0 112.14 -176.3 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' C' C ' 29' ' ' LYS . . . . . . . . . . . . . 37.9 mtmm -98.79 155.02 17.57 Favored 'General case' 0 C--N 1.332 -0.181 0 CA-C-N 117.295 0.547 . . . . 0.0 111.292 179.115 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' C' C ' 30' ' ' THR . . . . . . . . . . . . . 50.1 m -107.84 136.45 47.55 Favored 'General case' 0 C--N 1.332 -0.19 0 CA-C-N 116.147 -0.479 . . . . 0.0 109.991 176.349 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' C' C ' 31' ' ' VAL . . . . . . . . . . . . . 34.9 m -132.2 162.16 40.16 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.247 0 CA-C-N 116.302 -0.408 . . . . 0.0 111.036 -178.347 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' C' C ' 32' ' ' ARG . . . . . . . . . . . . . 81.6 mtt180 -132.29 152.43 51.38 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 115.989 -0.551 . . . . 0.0 110.591 178.654 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' C' C ' 33' ' ' THR . . . . . . . . . . . . . 28.8 m -53.61 140.18 29.63 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.299 -0.41 . . . . 0.0 111.237 -179.313 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' C' C ' 34' ' ' GLY . . . . . . . . . . . . . . . 100.49 -17.16 57.12 Favored Glycine 0 CA--C 1.532 1.139 0 CA-C-O 119.589 -0.562 . . . . 0.0 113.17 179.755 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' C' C ' 35' ' ' ASP . . . . . . . . . . . . . 72.1 m-20 -65.98 149.69 49.83 Favored 'General case' 0 N--CA 1.461 0.123 0 CA-C-N 118.127 0.963 . . . . 0.0 111.151 178.79 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' C' C ' 36' ' ' VAL . . . . . . . . . . . . . 43.5 t -122.6 130.82 74.23 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.213 0 CA-C-N 115.968 -0.56 . . . . 0.0 109.934 178.9 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' C' C ' 37' ' ' ILE . . . . . . . . . . . . . 69.3 mt -122.53 140.55 45.99 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.205 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.093 -178.928 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' C' C ' 38' ' ' GLY . . . . . . . . . . . . . . . -115.7 128.73 8.17 Favored Glycine 0 CA--C 1.525 0.708 0 N-CA-C 111.177 -0.769 . . . . 0.0 111.177 179.42 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' C' C ' 39' ' ' ILE . . . . . . . . . . . . . 72.9 mt -125.9 135.69 63.12 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.306 0 N-CA-C 110.136 -0.32 . . . . 0.0 110.136 179.245 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' C' C ' 40' ' ' SER . . . . . . . . . . . . . 9.7 t -93.32 114.08 26.43 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.343 -0.389 . . . . 0.0 111.132 177.268 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' C' C ' 41' ' ' ILE . . . . . . . . . . . . . 45.8 mm -122.58 119.55 58.46 Favored 'Isoleucine or valine' 0 CA--C 1.529 0.153 0 N-CA-C 110.07 -0.344 . . . . 0.0 110.07 178.758 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' C' C ' 42' ' ' LEU . . . . . . . . . . . . . 41.3 mt 57.39 34.06 24.15 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.394 -0.366 . . . . 0.0 111.916 177.479 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' C' C ' 43' ' ' GLY . . . . . . . . . . . . . . . 79.32 -10.13 37.37 Favored Glycine 0 CA--C 1.535 1.325 0 C-N-CA 121.271 -0.49 . . . . 0.0 113.485 177.312 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' C' C ' 44' ' ' LYS . . . . . . . . . . . . . 64.0 mmtt -100.46 134.72 42.99 Favored 'General case' 0 C--N 1.332 -0.156 0 CA-C-N 117.887 0.844 . . . . 0.0 110.079 175.878 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' C' C ' 45' ' ' GLU . . . . . . . . . . . . . 84.0 tt0 -85.18 131.57 34.41 Favored 'General case' 0 C--N 1.326 -0.425 0 CA-C-N 116.455 -0.339 . . . . 0.0 111.159 -179.279 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' C' C ' 46' ' ' VAL . . . . . . . . . . . . . 9.5 p -120.97 125.77 74.41 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.189 0 N-CA-C 109.585 -0.524 . . . . 0.0 109.585 174.428 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' C' C ' 47' ' ' LYS . . . . . . . . . . . . . 82.8 mttt -98.8 125.96 44.31 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 115.993 -0.549 . . . . 0.0 110.524 177.83 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' C' C ' 48' ' ' PHE . . . . . . . . . . . . . 31.0 m-85 -110.53 131.91 54.64 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.359 -0.382 . . . . 0.0 110.175 178.293 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' C' C ' 49' ' ' LYS . . . . . . . . . . . . . 58.5 tttt -105.92 132.42 52.05 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.251 -0.431 . . . . 0.0 109.97 177.677 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' C' C ' 50' ' ' VAL . . . . . . . . . . . . . 46.0 t -75.74 104.98 4.29 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.247 0 N-CA-C 109.14 -0.689 . . . . 0.0 109.14 176.552 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' C' C ' 51' ' ' VAL . . . . . . . . . . . . . 47.3 t -69.17 -48.51 68.43 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.324 0 CA-C-N 116.085 -0.507 . . . . 0.0 109.925 -173.418 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' C' C ' 52' ' ' GLN . . . . . . . . . . . . . 46.9 tt0 -168.33 146.83 4.34 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 115.95 -0.568 . . . . 0.0 111.381 -178.706 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' C' C ' 53' ' ' ALA . . . . . . . . . . . . . . . -122.61 136.54 54.91 Favored 'General case' 0 C--N 1.331 -0.209 0 CA-C-N 115.842 -0.617 . . . . 0.0 110.109 177.032 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' C' C ' 54' ' ' TYR . . . . . . . . . . . . . 58.3 t80 -129.12 112.11 18.37 Favored Pre-proline 0 CA--C 1.534 0.329 0 CA-C-O 118.081 -0.961 . . . . 0.0 110.202 177.55 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' C' C ' 55' ' ' PRO . . . . . . . . . . . . . 72.8 Cg_endo -77.31 170.14 72.16 Favored 'Cis proline' 0 N--CA 1.499 1.829 0 CA-C-N 122.015 1.755 . . . . 0.0 112.337 -6.283 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' C' C ' 56' ' ' SER . . . . . . . . . . . . . 25.5 m -122.25 135.65 25.67 Favored Pre-proline 0 CA--C 1.538 0.491 0 CA-C-O 118.513 -0.756 . . . . 0.0 109.537 175.049 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' C' C ' 57' ' ' PRO . . . . . . . . . . . . . 34.9 Cg_endo -66.29 160.85 75.13 Favored 'Cis proline' 0 N--CA 1.499 1.799 0 CA-C-N 121.864 1.701 . . . . 0.0 111.525 -2.839 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' C' C ' 58' ' ' LEU . . . . . . . . . . . . . 30.3 tp -127.57 136.4 51.64 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-O 121.118 0.485 . . . . 0.0 110.713 -178.101 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' C' C ' 59' ' ' ARG . . . . . . . . . . . . . 20.7 ttm180 -103.01 122.52 44.78 Favored 'General case' 0 C--N 1.327 -0.411 0 N-CA-C 108.919 -0.771 . . . . 0.0 108.919 173.936 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' C' C ' 60' ' ' VAL . . . . . . . . . . . . . 39.9 t -77.72 120.81 29.09 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.323 0 C-N-CA 120.561 -0.456 . . . . 0.0 110.349 -173.647 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' C' C ' 61' ' ' GLU . . . . . . . . . . . . . 96.3 mt-10 -131.13 165.5 23.15 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 115.679 -0.691 . . . . 0.0 109.567 176.807 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' C' C ' 62' ' ' ASP . . . . . . . . . . . . . 7.8 p-10 -53.09 -31.25 40.9 Favored 'General case' 0 C--N 1.329 -0.325 0 N-CA-C 111.912 0.338 . . . . 0.0 111.912 179.816 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' C' C ' 63' ' ' ARG . . . . . . . . . . . . . 87.6 mtt180 -71.77 -22.1 61.64 Favored 'General case' 0 CA--C 1.533 0.293 0 N-CA-C 112.962 0.727 . . . . 0.0 112.962 -176.307 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' C' C ' 64' ' ' THR . . . . . . . . . . . . . 32.9 m -74.48 136.6 42.26 Favored 'General case' 0 C--N 1.332 -0.192 0 CA-C-O 120.918 0.389 . . . . 0.0 110.832 -175.956 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' C' C ' 65' ' ' LYS . . . . . . . . . . . . . 96.0 mttt -89.36 133.88 34.31 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.023 -0.535 . . . . 0.0 109.977 179.013 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' C' C ' 66' ' ' ILE . . . . . . . . . . . . . 65.3 mt -115.48 130.56 69.87 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.266 0 N-CA-C 109.976 -0.379 . . . . 0.0 109.976 179.739 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' C' C ' 67' ' ' THR . . . . . . . . . . . . . 23.8 m -122.54 138.42 54.58 Favored 'General case' 0 C--N 1.331 -0.214 0 CA-C-N 115.929 -0.578 . . . . 0.0 110.516 -179.071 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' C' C ' 68' ' ' LEU . . . . . 0.437 HD23 ' C ' ' C' ' 68' ' ' LEU . 5.8 tt . . . . . 0 C--N 1.33 -0.267 0 CA-C-N 115.959 -0.564 . . . . 0.0 110.173 178.795 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' C' C ' 73' ' ' VAL . . . . . . . . . . . . . 34.0 m . . . . . 0 C--O 1.231 0.094 0 CA-C-O 120.894 0.378 . . . . 0.0 110.871 . . . . . . . . . 0 0 . 1 . 017 nuclear nobuild core ' C' C ' 74' ' ' ASP . . . . . . . . . . . . . 8.0 t70 -103.84 126.03 50.68 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.105 -0.498 . . . . 0.0 109.737 179.993 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' C' C ' 75' ' ' VAL . . . . . . . . . . . . . 40.5 t -121.13 127.95 75.95 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.345 0 CA-C-O 121.169 0.509 . . . . 0.0 110.957 -176.633 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' C' C ' 76' ' ' LEU . . . . . . . . . . . . . 5.2 mp -121.47 144.67 48.56 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 115.488 -0.778 . . . . 0.0 109.523 174.244 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' C' C ' 77' ' ' GLU . . . . . . . . . . . . . 47.1 mt-10 -133.92 137.84 45.15 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-O 121.033 0.444 . . . . 0.0 111.127 -177.629 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' C' C ' 78' ' ' ALA . . . . . 0.643 ' HB2' HD21 ' C' ' 109' ' ' LEU . . . -125.79 128.61 47.96 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 115.78 -0.646 . . . . 0.0 109.707 176.477 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' C' C ' 79' ' ' LYS . . . . . 0.622 ' O ' HD13 ' C' ' 80' ' ' ILE . 54.1 mtmt -77.45 122.72 25.59 Favored 'General case' 0 C--N 1.331 -0.214 0 CA-C-O 121.044 0.449 . . . . 0.0 110.667 -178.327 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' C' C ' 80' ' ' ILE . . . . . 0.622 HD13 ' O ' ' C' ' 79' ' ' LYS . 39.4 mm -139.05 114.16 8.36 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.356 0 N-CA-C 109.178 -0.675 . . . . 0.0 109.178 -177.779 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' C' C ' 81' ' ' LYS . . . . . . . . . . . . . 31.8 ttpt -101.4 121.99 42.92 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-O 120.821 0.343 . . . . 0.0 111.002 -177.461 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' C' C ' 82' ' ' GLY . . . . . . . . . . . . . . . 89.12 42.23 5.65 Favored Glycine 0 CA--C 1.527 0.786 0 C-N-CA 120.683 -0.77 . . . . 0.0 111.91 174.246 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' C' C ' 83' ' ' ILE . . . . . . . . . . . . . 73.4 mt -67.74 131.91 32.87 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.341 0 N-CA-C 109.468 -0.567 . . . . 0.0 109.468 175.944 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' C' C ' 84' ' ' LYS . . . . . . . . . . . . . 72.8 tttt -88.84 -53.26 4.69 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-O 121.046 0.451 . . . . 0.0 110.181 -178.22 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' C' C ' 85' ' ' ASP . . . . . . . . . . . . . 11.5 t70 -155.85 152.96 29.0 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 115.626 -0.715 . . . . 0.0 110.146 179.201 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' C' C ' 86' ' ' VAL . . . . . . . . . . . . . 46.6 t -128.65 130.59 68.9 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.252 0 CA-C-O 120.961 0.41 . . . . 0.0 110.564 -178.475 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' C' C ' 87' ' ' ILE . . . . . . . . . . . . . 45.0 mm -119.58 126.54 75.42 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.303 0 CA-C-N 115.781 -0.645 . . . . 0.0 109.612 177.453 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' C' C ' 88' ' ' LEU . . . . . . . . . . . . . 86.5 mt -111.15 139.34 46.61 Favored 'General case' 0 C--N 1.331 -0.214 0 CA-C-O 121.152 0.501 . . . . 0.0 111.286 -178.151 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' C' C ' 89' ' ' ASP . . . . . . . . . . . . . 46.8 t0 -130.57 162.94 28.18 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 115.462 -0.79 . . . . 0.0 109.457 176.864 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' C' C ' 90' ' ' GLU . . . . . . . . . . . . . 45.5 tp10 -44.99 -44.51 9.96 Favored 'General case' 0 N--CA 1.465 0.293 0 N-CA-C 113.222 0.823 . . . . 0.0 113.222 -170.874 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' C' C ' 91' ' ' ASN . . . . . . . . . . . . . 31.0 m120 -132.12 26.41 4.55 Favored 'General case' 0 N--CA 1.467 0.381 0 N-CA-C 112.473 0.546 . . . . 0.0 112.473 -178.478 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' C' C ' 92' ' ' LEU . . . . . . . . . . . . . 36.5 mt -146.58 144.87 29.86 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-O 120.736 0.303 . . . . 0.0 110.51 -176.931 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' C' C ' 93' ' ' ILE . . . . . . . . . . . . . 65.3 mt -124.18 115.07 43.75 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.311 0 N-CA-C 109.104 -0.702 . . . . 0.0 109.104 177.505 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' C' C ' 94' ' ' VAL . . . . . 0.516 HG11 HG11 ' C' ' 123' ' ' VAL . 46.6 t -115.89 126.4 73.39 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.218 0 N-CA-C 109.763 -0.458 . . . . 0.0 109.763 -179.382 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' C' C ' 95' ' ' VAL . . . . . . . . . . . . . 43.2 t -121.18 133.72 66.86 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.372 0 CA-C-N 116.047 -0.524 . . . . 0.0 109.935 -178.893 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' C' C ' 96' ' ' ILE . . . . . . . . . . . . . 67.8 mt -110.14 124.52 66.95 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.317 0 N-CA-C 108.939 -0.763 . . . . 0.0 108.939 177.637 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' C' C ' 97' ' ' THR . . . . . . . . . . . . . 82.7 p -97.8 155.01 17.23 Favored 'General case' 0 C--N 1.327 -0.395 0 CA-C-O 121.059 0.457 . . . . 0.0 111.025 -177.176 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' C' C ' 98' ' ' GLU . . . . . . . . . . . . . 84.2 tt0 -53.79 -23.22 11.36 Favored 'General case' 0 C--N 1.327 -0.399 0 N-CA-C 112.379 0.511 . . . . 0.0 112.379 -179.835 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' C' C ' 99' ' ' GLU . . . . . . . . . . . . . 68.9 mm-40 -82.26 15.05 2.58 Favored 'General case' 0 CA--C 1.536 0.412 0 N-CA-C 113.2 0.815 . . . . 0.0 113.2 -176.569 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' C' C ' 100' ' ' ASN . . . . . . . . . . . . . 3.0 m-20 62.83 33.5 15.18 Favored 'General case' 0 N--CA 1.465 0.276 0 CA-C-O 120.914 0.387 . . . . 0.0 111.535 179.336 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' C' C ' 101' ' ' GLU . . . . . . . . . . . . . 84.9 tt0 -113.12 145.88 40.17 Favored 'General case' 0 C--N 1.331 -0.225 0 N-CA-C 109.639 -0.504 . . . . 0.0 109.639 174.144 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' C' C ' 102' ' ' VAL . . . . . . . . . . . . . 44.9 t -114.87 123.56 70.68 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.316 0 N-CA-C 109.717 -0.475 . . . . 0.0 109.717 -178.484 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' C' C ' 103' ' ' LEU . . . . . . . . . . . . . 35.5 mt -115.29 132.74 56.52 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 115.804 -0.634 . . . . 0.0 109.82 178.888 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' C' C ' 104' ' ' ILE . . . . . . . . . . . . . 64.6 mt -123.86 121.56 62.54 Favored 'Isoleucine or valine' 0 C--O 1.234 0.248 0 N-CA-C 110.432 -0.21 . . . . 0.0 110.432 -179.241 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' C' C ' 105' ' ' PHE . . . . . . . . . . . . . 61.8 m-85 -118.91 165.29 14.25 Favored 'General case' 0 C--N 1.33 -0.254 0 O-C-N 124.104 0.878 . . . . 0.0 109.617 178.561 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' C' C ' 106' ' ' ASN . . . . . . . . . . . . . 40.9 p-10 -101.21 -169.9 1.76 Allowed 'General case' 0 C--N 1.33 -0.25 0 N-CA-C 109.857 -0.423 . . . . 0.0 109.857 173.627 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' C' C ' 107' ' ' GLN . . . . . . . . . . . . . 49.2 tt0 -56.42 -29.69 61.89 Favored 'General case' 0 CA--C 1.534 0.332 0 N-CA-C 111.823 0.305 . . . . 0.0 111.823 176.744 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' C' C ' 108' ' ' ASN . . . . . . . . . . . . . 8.0 t-20 -84.35 9.57 12.81 Favored 'General case' 0 CA--C 1.536 0.43 0 N-CA-C 113.205 0.816 . . . . 0.0 113.205 -176.684 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' C' C ' 109' ' ' LEU . . . . . 0.643 HD21 ' HB2' ' C' ' 78' ' ' ALA . 8.0 tp 56.05 36.55 27.59 Favored 'General case' 0 C--N 1.332 -0.167 0 CA-C-O 120.923 0.392 . . . . 0.0 111.339 179.442 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' C' C ' 110' ' ' GLU . . . . . . . . . . . . . 70.5 mm-40 -107.79 150.29 27.17 Favored 'General case' 0 C--N 1.333 -0.141 0 N-CA-C 110.07 -0.344 . . . . 0.0 110.07 176.876 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' C' C ' 111' ' ' GLU . . . . . . . . . . . . . 98.0 mt-10 -77.16 122.29 24.8 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-O 120.876 0.37 . . . . 0.0 111.051 -178.296 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' C' C ' 112' ' ' LEU . . . . . . . . . . . . . 17.9 mt -108.62 -46.0 3.75 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 115.988 -0.551 . . . . 0.0 110.388 177.08 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' C' C ' 113' ' ' TYR . . . . . . . . . . . . . 59.6 t80 -136.75 137.68 40.13 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.359 -0.382 . . . . 0.0 111.048 179.943 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' C' C ' 114' ' ' ARG . . . . . . . . . . . . . 72.4 mtm180 -141.44 122.08 14.25 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 115.998 -0.546 . . . . 0.0 110.482 178.111 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' C' C ' 115' ' ' GLY . . . . . . . . . . . . . . . -150.11 160.91 28.73 Favored Glycine 0 CA--C 1.525 0.708 0 N-CA-C 111.03 -0.828 . . . . 0.0 111.03 178.572 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' C' C ' 116' ' ' LYS . . . . . . . . . . . . . 72.5 tttt -134.27 133.43 40.79 Favored 'General case' 0 C--N 1.33 -0.266 0 N-CA-C 110.021 -0.363 . . . . 0.0 110.021 179.27 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' C' C ' 117' ' ' PHE . . . . . . . . . . . . . 31.2 m-85 -133.06 123.15 25.25 Favored 'General case' 0 C--N 1.331 -0.202 0 CA-C-O 120.932 0.396 . . . . 0.0 110.363 -174.457 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' C' C ' 118' ' ' GLU . . . . . . . . . . . . . 43.4 mt-10 -53.77 -48.54 69.65 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.459 -0.337 . . . . 0.0 111.4 -176.49 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' C' C ' 119' ' ' ASN . . . . . . . . . . . . . 67.5 m-80 -98.57 31.03 3.01 Favored 'General case' 0 C--N 1.329 -0.321 0 N-CA-C 112.255 0.465 . . . . 0.0 112.255 -174.098 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' C' C ' 120' ' ' LEU . . . . . . . . . . . . . 18.4 tp -56.6 120.27 7.49 Favored 'General case' 0 N--CA 1.462 0.15 0 C-N-CA 121.04 -0.264 . . . . 0.0 110.325 177.888 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' C' C ' 121' ' ' ASN . . . . . . . . . . . . . 9.8 t-20 -109.42 -44.03 3.98 Favored 'General case' 0 C--N 1.331 -0.219 0 CA-C-N 116.58 -0.282 . . . . 0.0 111.192 -175.646 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' C' C ' 122' ' ' LYS . . . . . . . . . . . . . 15.9 ptpt -154.77 153.54 31.39 Favored 'General case' 0 C--N 1.332 -0.187 0 CA-C-O 121.286 0.565 . . . . 0.0 112.019 -178.291 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' C' C ' 123' ' ' VAL . . . . . 0.516 HG11 HG11 ' C' ' 94' ' ' VAL . 45.6 t -121.68 130.89 74.2 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.224 0 CA-C-N 115.698 -0.683 . . . . 0.0 109.474 176.223 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' C' C ' 124' ' ' LEU . . . . . 0.429 HD12 ' N ' ' C' ' 124' ' ' LEU . 6.2 mp -121.4 140.02 52.69 Favored 'General case' 0 C--N 1.331 -0.215 0 CA-C-N 116.319 -0.401 . . . . 0.0 110.635 -178.05 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' C' C ' 125' ' ' VAL . . . . . 0.436 HG11 HG21 ' C' ' 94' ' ' VAL . 35.2 m -134.78 140.12 46.16 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.258 0 CA-C-N 116.334 -0.394 . . . . 0.0 110.453 178.237 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' C' C ' 126' ' ' ARG . . . . . . . . . . . . . 52.5 ttt85 -149.13 118.69 6.95 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-O 120.907 0.384 . . . . 0.0 110.615 178.322 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' C' C ' 127' ' ' ASN . . . . . . . . . . . . . 35.7 t30 50.83 -104.95 0.18 Allowed 'General case' 0 CA--C 1.542 0.668 0 CA-C-N 116.144 -0.48 . . . . 0.0 111.572 179.862 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' C' C ' 128' ' ' ASP . . . . . . . . . . . . . 11.8 p-10 -110.61 -0.17 17.34 Favored 'General case' 0 CA--C 1.536 0.413 0 CA-C-N 119.501 1.046 . . . . 0.0 113.658 -175.043 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' C' C ' 129' ' ' LEU . . . . . . . . . . . . . 88.0 mt -106.35 142.73 35.54 Favored 'General case' 0 C--O 1.232 0.138 0 CA-C-N 118.186 0.448 . . . . 0.0 110.838 -179.451 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' C' C ' 130' ' ' VAL . . . . . . . . . . . . . 47.0 t -122.04 135.91 60.63 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.302 0 N-CA-C 109.619 -0.511 . . . . 0.0 109.619 178.625 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' C' C ' 131' ' ' VAL . . . . . . . . . . . . . 42.9 t -133.48 137.1 53.64 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.269 0 CA-C-O 121.018 0.437 . . . . 0.0 110.624 -178.726 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' C' C ' 132' ' ' ILE . . . . . . . . . . . . . 74.3 mt -115.61 130.46 70.21 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.304 0 CA-C-N 115.642 -0.708 . . . . 0.0 109.262 178.762 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' C' C ' 133' ' ' ILE . . . . . . . . . . . . . 43.7 mm -116.62 121.32 67.4 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.215 0 CA-C-O 120.774 0.321 . . . . 0.0 111.04 -175.447 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' C' C ' 134' ' ' ASP . . . . . . . . . . . . . 8.2 p-10 -136.11 144.3 45.03 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 115.878 -0.601 . . . . 0.0 109.443 173.756 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' C' C ' 135' ' ' GLU . . . . . . . . . . . . . 42.2 tp10 -49.81 -23.85 2.08 Favored 'General case' 0 C--N 1.327 -0.395 0 N-CA-C 112.724 0.639 . . . . 0.0 112.724 -172.226 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' C' C ' 136' ' ' GLN . . . . . . . . . . . . . 50.5 tt0 -93.13 -36.77 12.48 Favored 'General case' 0 C--O 1.233 0.2 0 N-CA-C 112.082 0.401 . . . . 0.0 112.082 -176.468 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' C' C ' 137' ' ' LYS . . . . . . . . . . . . . 89.9 mttt -140.12 155.06 47.15 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-O 121.251 0.548 . . . . 0.0 111.648 -171.185 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' C' C ' 138' ' ' LEU . . . . . . . . . . . . . 5.2 tt -117.8 123.54 46.22 Favored 'General case' 0 C--N 1.329 -0.321 0 N-CA-C 108.881 -0.785 . . . . 0.0 108.881 171.544 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' C' C ' 139' ' ' THR . . . . . . . . . . . . . 31.2 m -113.35 131.11 56.09 Favored 'General case' 0 C--N 1.331 -0.215 0 CA-C-O 120.875 0.369 . . . . 0.0 111.05 -176.353 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' C' C ' 140' ' ' LEU . . . . . 0.476 ' C ' HD23 ' C' ' 140' ' ' LEU . 6.8 tt -116.61 122.67 45.3 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 115.333 -0.849 . . . . 0.0 108.914 -179.407 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' C' C ' 141' ' ' ILE . . . . . . . . . . . . . 19.5 mt -119.81 120.41 63.21 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.276 0 CA-C-O 120.929 0.395 . . . . 0.0 110.02 -176.239 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' C' C ' 142' ' ' ARG . . . . . . . . . . . . . 57.6 mtp180 . . . . . 0 C--N 1.331 -0.212 0 CA-C-N 115.431 -0.804 . . . . 0.0 110.014 179.319 . . . . . . . . 0 0 . 1 . 017 nuclear nobuild core ' D' D ' 2' ' ' SER . . . . . . . . . . . . . 2.9 p . . . . . 0 C--O 1.232 0.137 0 CA-C-O 120.833 0.349 . . . . 0.0 110.616 . . . . . . . . . 0 0 . 1 . 017 nuclear nobuild core ' D' D ' 3' ' ' GLU . . . . . . . . . . . . . 94.3 mt-10 -141.19 139.82 33.91 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.12 -0.491 . . . . 0.0 111.158 -178.798 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' D' D ' 4' ' ' LEU . . . . . . . . . . . . . 21.7 tp -123.27 128.96 50.69 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 115.869 -0.605 . . . . 0.0 109.763 174.799 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' D' D ' 5' ' ' LYS . . . . . . . . . . . . . 94.8 mttt -112.75 121.6 45.2 Favored 'General case' 0 C--O 1.235 0.302 0 CA-C-O 120.897 0.38 . . . . 0.0 111.014 -177.95 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' D' D ' 6' ' ' LEU . . . . . 0.454 HD23 ' HA ' ' D' ' 50' ' ' VAL . 61.9 mt -114.94 142.17 46.97 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-N 115.225 -0.898 . . . . 0.0 110.274 -179.185 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' D' D ' 7' ' ' LYS . . . . . . . . . . . . . 44.7 tttm -122.35 140.48 32.72 Favored Pre-proline 0 CA--C 1.533 0.291 0 CA-C-O 119.017 -0.516 . . . . 0.0 109.993 176.056 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' D' D ' 8' ' ' PRO . . . . . . . . . . . . . 96.9 Cg_endo -91.72 137.76 1.97 Allowed 'Trans proline' 0 N--CA 1.49 1.316 0 C-N-CA 121.83 1.687 . . . . 0.0 111.964 179.45 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' D' D ' 9' ' ' LEU . . . . . . . . . . . . . 26.3 mt -77.54 -48.28 2.34 Favored Pre-proline 0 CA--C 1.535 0.371 0 CA-C-O 118.675 -0.678 . . . . 0.0 112.341 -179.991 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' D' D ' 10' ' ' PRO . . . . . . . . . . . . . 87.0 Cg_endo -80.23 159.35 23.29 Favored 'Trans proline' 0 N--CA 1.497 1.685 0 C-N-CA 121.308 1.339 . . . . 0.0 112.219 177.961 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' D' D ' 11' ' ' LYS . . . . . . . . . . . . . 82.5 mttt -86.54 95.69 9.82 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.51 -0.314 . . . . 0.0 110.318 177.543 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' D' D ' 12' ' ' VAL . . . . . . . . . . . . . 12.4 p -142.2 147.55 21.26 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.324 0 CA-C-N 116.238 -0.437 . . . . 0.0 110.443 179.928 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' D' D ' 13' ' ' GLU . . . . . . . . . . . . . 45.5 tp10 -92.09 121.83 34.01 Favored 'General case' 0 C--N 1.328 -0.336 0 N-CA-C 109.985 -0.376 . . . . 0.0 109.985 177.797 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' D' D ' 14' ' ' LEU . . . . . . . . . . . . . 41.0 mt -93.02 138.15 23.41 Favored Pre-proline 0 C--N 1.329 -0.305 0 CA-C-O 118.88 -0.581 . . . . 0.0 110.073 -178.666 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' D' D ' 15' ' ' PRO . . . . . . . . . . . . . 28.7 Cg_exo -60.47 158.55 31.25 Favored 'Trans proline' 0 N--CA 1.498 1.782 0 C-N-CA 121.268 1.312 . . . . 0.0 111.953 178.995 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' D' D ' 16' ' ' PRO . . . . . . . . . . . . . 39.3 Cg_exo -58.91 -35.52 98.47 Favored 'Trans proline' 0 N--CA 1.498 1.766 0 C-N-CA 121.527 1.485 . . . . 0.0 112.894 -179.469 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' D' D ' 17' ' ' ASP . . . . . . . . . . . . . 15.8 p-10 -82.18 2.65 30.62 Favored 'General case' 0 CA--C 1.537 0.454 0 N-CA-C 113.296 0.85 . . . . 0.0 113.296 -177.682 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' D' D ' 18' ' ' PHE . . . . . . . . . . . . . 36.7 t80 -58.15 -47.08 84.45 Favored 'General case' 0 C--N 1.333 -0.115 0 O-C-N 121.933 -0.48 . . . . 0.0 110.019 -178.242 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' D' D ' 19' ' ' VAL . . . . . 0.425 HG13 ' N ' ' D' ' 20' ' ' ASP . 12.7 p -55.19 -41.73 62.03 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 CA-C-N 116.353 -0.385 . . . . 0.0 111.197 -178.094 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' D' D ' 20' ' ' ASP . . . . . 0.425 ' N ' HG13 ' D' ' 19' ' ' VAL . 7.7 t0 -60.91 -44.31 97.36 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-O 120.9 0.381 . . . . 0.0 110.827 -177.811 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' D' D ' 21' ' ' VAL . . . . . . . . . . . . . 45.5 t -64.62 -45.71 94.61 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.324 0 CA-C-N 116.326 -0.397 . . . . 0.0 110.41 -177.486 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' D' D ' 22' ' ' ILE . . . . . 0.671 HG22 HD12 ' D' ' 26' ' ' LEU . 49.5 mm -55.55 -47.73 78.31 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.264 0 C-N-CA 121.096 -0.242 . . . . 0.0 110.672 179.533 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' D' D ' 23' ' ' ARG . . . . . . . . . . . . . 47.0 ttp180 -55.15 -49.05 72.8 Favored 'General case' 0 C--N 1.331 -0.219 0 C-N-CA 121.042 -0.263 . . . . 0.0 111.155 -178.33 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' D' D ' 24' ' ' ILE . . . . . . . . . . . . . 71.4 mt -58.93 -43.97 89.85 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.281 0 C-N-CA 121.05 -0.26 . . . . 0.0 111.251 -176.308 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' D' D ' 25' ' ' LYS . . . . . . . . . . . . . 49.2 mttm -68.18 -41.05 82.05 Favored 'General case' 0 C--N 1.328 -0.332 0 N-CA-C 112.582 0.586 . . . . 0.0 112.582 -177.86 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' D' D ' 26' ' ' LEU . . . . . 0.671 HD12 HG22 ' D' ' 22' ' ' ILE . 36.1 mt -79.46 -33.49 42.32 Favored 'General case' 0 C--N 1.329 -0.311 0 N-CA-C 113.837 1.051 . . . . 0.0 113.837 -170.421 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' D' D ' 27' ' ' GLN . . . . . . . . . . . . . 10.6 pt20 -46.84 140.76 4.43 Favored 'General case' 0 N--CA 1.469 0.514 0 N-CA-C 112.956 0.725 . . . . 0.0 112.956 -174.247 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' D' D ' 28' ' ' GLY . . . . . . . . . . . . . . . 98.14 -24.15 33.05 Favored Glycine 0 CA--C 1.532 1.141 0 CA-C-N 115.571 -0.74 . . . . 0.0 112.427 -178.355 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' D' D ' 29' ' ' LYS . . . . . . . . . . . . . 48.9 mtpt -97.45 155.11 17.07 Favored 'General case' 0 C--N 1.333 -0.126 0 CA-C-N 117.425 0.612 . . . . 0.0 110.783 179.101 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' D' D ' 30' ' ' THR . . . . . . . . . . . . . 23.5 m -104.51 139.84 38.83 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.196 -0.456 . . . . 0.0 110.338 178.876 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' D' D ' 31' ' ' VAL . . . . . . . . . . . . . 34.4 m -130.98 150.28 34.44 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.303 0 CA-C-N 116.101 -0.5 . . . . 0.0 110.783 -179.176 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' D' D ' 32' ' ' ARG . . . . . . . . . . . . . 83.0 mtm180 -128.67 150.34 50.29 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 115.913 -0.585 . . . . 0.0 110.475 178.324 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' D' D ' 33' ' ' THR . . . . . . . . . . . . . 15.0 m -53.64 138.53 34.51 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.305 -0.407 . . . . 0.0 111.385 -178.036 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' D' D ' 34' ' ' GLY . . . . . . . . . . . . . . . 100.43 -17.23 57.07 Favored Glycine 0 CA--C 1.532 1.145 0 CA-C-O 119.67 -0.517 . . . . 0.0 113.192 179.589 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' D' D ' 35' ' ' ASP . . . . . . . . . . . . . 75.1 m-20 -66.35 149.8 49.84 Favored 'General case' 0 N--CA 1.461 0.085 0 CA-C-N 118.015 0.907 . . . . 0.0 111.087 178.838 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' D' D ' 36' ' ' VAL . . . . . . . . . . . . . 44.2 t -118.77 130.75 73.17 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.244 0 CA-C-N 115.908 -0.587 . . . . 0.0 109.839 178.08 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' D' D ' 37' ' ' ILE . . . . . . . . . . . . . 64.7 mt -119.72 138.12 51.38 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.233 0 N-CA-C 109.854 -0.425 . . . . 0.0 109.854 -179.723 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' D' D ' 38' ' ' GLY . . . . . . . . . . . . . . . -113.54 127.89 8.07 Favored Glycine 0 CA--C 1.525 0.661 0 N-CA-C 110.782 -0.927 . . . . 0.0 110.782 179.064 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' D' D ' 39' ' ' ILE . . . . . . . . . . . . . 78.0 mt -128.25 137.46 57.39 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.237 0 CA-C-O 120.814 0.34 . . . . 0.0 110.313 179.626 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' D' D ' 40' ' ' SER . . . . . . . . . . . . . 32.4 t -91.54 116.53 28.94 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.248 -0.433 . . . . 0.0 110.598 175.285 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' D' D ' 41' ' ' ILE . . . . . . . . . . . . . 44.0 mm -119.83 114.34 43.86 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.216 0 CA-C-O 120.886 0.374 . . . . 0.0 110.177 178.823 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' D' D ' 42' ' ' LEU . . . . . 0.545 HD23 ' O ' ' D' ' 42' ' ' LEU . 1.3 tt 52.27 46.23 27.02 Favored 'General case' 0 CA--C 1.532 0.262 0 CA-C-O 121.399 0.618 . . . . 0.0 111.036 177.527 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' D' D ' 43' ' ' GLY . . . . . . . . . . . . . . . 70.9 25.79 75.14 Favored Glycine 0 CA--C 1.532 1.109 0 C-N-CA 121.1 -0.571 . . . . 0.0 112.532 175.398 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' D' D ' 44' ' ' LYS . . . . . . . . . . . . . 85.9 tttt -136.01 129.65 32.35 Favored 'General case' 0 C--N 1.331 -0.221 0 CA-C-N 117.274 0.537 . . . . 0.0 109.975 179.323 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' D' D ' 45' ' ' GLU . . . . . . . . . . . . . 84.7 tt0 -82.47 119.33 24.07 Favored 'General case' 0 C--N 1.328 -0.355 0 C-N-CA 120.816 -0.354 . . . . 0.0 110.842 -179.275 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' D' D ' 46' ' ' VAL . . . . . . . . . . . . . 10.0 p -118.57 125.17 74.16 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.179 0 N-CA-C 109.425 -0.583 . . . . 0.0 109.425 175.391 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' D' D ' 47' ' ' LYS . . . . . . . . . . . . . 39.6 mtmt -98.73 126.77 44.45 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 115.953 -0.567 . . . . 0.0 110.729 177.809 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' D' D ' 48' ' ' PHE . . . . . . . . . . . . . 45.9 m-85 -111.2 131.95 54.71 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 115.747 -0.66 . . . . 0.0 109.928 178.532 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' D' D ' 49' ' ' LYS . . . . . . . . . . . . . 38.2 tttp -104.48 131.78 51.46 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.334 -0.394 . . . . 0.0 110.09 178.531 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' D' D ' 50' ' ' VAL . . . . . 0.454 ' HA ' HD23 ' D' ' 6' ' ' LEU . 45.7 t -77.04 105.33 5.79 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.33 0 N-CA-C 109.204 -0.665 . . . . 0.0 109.204 177.623 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' D' D ' 51' ' ' VAL . . . . . . . . . . . . . 48.8 t -71.27 -52.5 26.37 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.317 0 CA-C-N 116.064 -0.516 . . . . 0.0 109.683 -174.93 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' D' D ' 52' ' ' GLN . . . . . . . . . . . . . 89.4 mt-30 -153.7 151.17 29.33 Favored 'General case' 0 C--N 1.331 -0.239 0 CA-C-N 115.995 -0.548 . . . . 0.0 111.845 -178.308 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' D' D ' 53' ' ' ALA . . . . . . . . . . . . . . . -129.74 133.24 46.91 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 115.145 -0.934 . . . . 0.0 109.561 174.057 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' D' D ' 54' ' ' TYR . . . . . . . . . . . . . 44.0 t80 -129.08 112.04 18.42 Favored Pre-proline 0 CA--C 1.536 0.419 0 CA-C-O 118.107 -0.949 . . . . 0.0 110.124 178.122 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' D' D ' 55' ' ' PRO . . . . . . . . . . . . . 73.3 Cg_endo -77.19 167.56 79.31 Favored 'Cis proline' 0 N--CA 1.5 1.857 0 CA-C-N 121.907 1.717 . . . . 0.0 112.585 -5.875 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' D' D ' 56' ' ' SER . . . . . . . . . . . . . 13.6 m -117.34 134.09 23.14 Favored Pre-proline 0 CA--C 1.539 0.549 0 CA-C-O 118.483 -0.77 . . . . 0.0 109.292 174.204 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' D' D ' 57' ' ' PRO . . . . . . . . . . . . . 56.0 Cg_endo -70.68 147.7 87.16 Favored 'Cis proline' 0 N--CA 1.498 1.785 0 CA-C-N 121.844 1.694 . . . . 0.0 111.415 -1.608 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' D' D ' 58' ' ' LEU . . . . . . . . . . . . . 24.2 tp -107.84 138.14 44.62 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-O 120.896 0.379 . . . . 0.0 110.495 -179.139 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' D' D ' 59' ' ' ARG . . . . . . . . . . . . . 61.2 ttt180 -103.04 120.25 40.32 Favored 'General case' 0 C--N 1.327 -0.397 0 N-CA-C 108.981 -0.748 . . . . 0.0 108.981 174.812 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' D' D ' 60' ' ' VAL . . . . . . . . . . . . . 42.4 t -71.93 119.7 18.93 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.277 0 C-N-CA 120.615 -0.434 . . . . 0.0 110.198 -174.276 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' D' D ' 61' ' ' GLU . . . . . . . . . . . . . 81.3 tt0 -131.14 152.15 50.72 Favored 'General case' 0 C--N 1.328 -0.33 0 N-CA-C 109.268 -0.641 . . . . 0.0 109.268 178.166 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' D' D ' 62' ' ' ASP . . . . . . . . . . . . . 19.3 p-10 -54.48 -31.97 56.89 Favored 'General case' 0 N--CA 1.465 0.301 0 C-N-CA 120.751 -0.38 . . . . 0.0 111.835 -176.405 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' D' D ' 63' ' ' ARG . . . . . . . . . . . . . 77.6 mtp180 -72.32 -21.24 61.36 Favored 'General case' 0 CA--C 1.535 0.38 0 N-CA-C 112.816 0.673 . . . . 0.0 112.816 -177.514 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' D' D ' 64' ' ' THR . . . . . . . . . . . . . 33.1 m -72.26 146.91 46.92 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-O 120.926 0.393 . . . . 0.0 110.905 -176.238 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' D' D ' 65' ' ' LYS . . . . . . . . . . . . . 68.8 mttm -90.14 131.67 35.86 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.018 -0.537 . . . . 0.0 110.819 -179.229 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' D' D ' 66' ' ' ILE . . . . . . . . . . . . . 68.3 mt -118.2 130.52 72.94 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.24 0 N-CA-C 109.655 -0.498 . . . . 0.0 109.655 178.391 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' D' D ' 67' ' ' THR . . . . . . . . . . . . . 29.5 m -126.48 139.65 53.07 Favored 'General case' 0 C--N 1.332 -0.194 0 CA-C-O 121.169 0.509 . . . . 0.0 111.253 -177.537 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' D' D ' 68' ' ' LEU . . . . . . . . . . . . . 51.0 mt . . . . . 0 C--N 1.33 -0.253 0 CA-C-N 115.733 -0.667 . . . . 0.0 110.121 176.62 . . . . . . . . 0 0 . 1 . 017 nuclear nobuild core ' D' D ' 73' ' ' VAL . . . . . . . . . . . . . 34.8 m . . . . . 0 C--O 1.232 0.176 0 CA-C-O 120.819 0.343 . . . . 0.0 110.716 . . . . . . . . . 0 0 . 1 . 017 nuclear nobuild core ' D' D ' 74' ' ' ASP . . . . . . . . . . . . . 39.7 t0 -101.77 119.03 38.14 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.309 -0.405 . . . . 0.0 110.126 -179.836 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' D' D ' 75' ' ' VAL . . . . . . . . . . . . . 44.3 t -114.0 123.04 69.27 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.25 0 CA-C-O 121.131 0.491 . . . . 0.0 110.268 -179.451 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' D' D ' 76' ' ' LEU . . . . . . . . . . . . . 33.9 mt -123.4 141.58 51.85 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 115.616 -0.72 . . . . 0.0 109.511 178.535 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' D' D ' 77' ' ' GLU . . . . . . . . . . . . . 96.7 mt-10 -134.75 138.6 44.47 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-O 121.211 0.529 . . . . 0.0 111.375 -177.849 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' D' D ' 78' ' ' ALA . . . . . . . . . . . . . . . -125.11 137.31 54.18 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 115.556 -0.747 . . . . 0.0 109.581 175.809 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' D' D ' 79' ' ' LYS . . . . . 0.616 ' O ' HD13 ' D' ' 80' ' ' ILE . 65.0 mttp -80.17 117.91 21.39 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-O 120.864 0.364 . . . . 0.0 110.65 -179.017 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' D' D ' 80' ' ' ILE . . . . . 0.616 HD13 ' O ' ' D' ' 79' ' ' LYS . 40.7 mm -138.96 102.82 1.84 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.32 0 N-CA-C 109.135 -0.691 . . . . 0.0 109.135 -178.052 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' D' D ' 81' ' ' LYS . . . . . . . . . . . . . 78.1 tttt -99.49 128.37 45.6 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-O 120.889 0.376 . . . . 0.0 110.92 -176.195 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' D' D ' 82' ' ' GLY . . . . . . . . . . . . . . . 89.07 42.21 5.67 Favored Glycine 0 CA--C 1.526 0.743 0 C-N-CA 120.987 -0.625 . . . . 0.0 111.862 175.791 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' D' D ' 83' ' ' ILE . . . . . . . . . . . . . 70.1 mt -70.17 137.77 23.36 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.311 0 N-CA-C 109.358 -0.608 . . . . 0.0 109.358 175.874 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' D' D ' 84' ' ' LYS . . . . . . . . . . . . . 38.5 ttpt -99.57 -46.59 5.4 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.343 -0.39 . . . . 0.0 110.243 -178.541 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' D' D ' 85' ' ' ASP . . . . . . . . . . . . . 8.0 t70 -155.11 152.66 29.76 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.072 -0.513 . . . . 0.0 110.663 179.21 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' D' D ' 86' ' ' VAL . . . . . . . . . . . . . 44.0 t -128.57 134.82 63.87 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.19 0 CA-C-O 120.91 0.386 . . . . 0.0 110.347 179.843 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' D' D ' 87' ' ' ILE . . . . . . . . . . . . . 43.7 mm -119.73 125.34 74.23 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.228 0 CA-C-N 115.909 -0.587 . . . . 0.0 109.719 178.152 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' D' D ' 88' ' ' LEU . . . . . . . . . . . . . 14.7 tp -111.05 131.46 55.04 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-O 120.835 0.35 . . . . 0.0 110.96 -177.622 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' D' D ' 89' ' ' ASP . . . . . . . . . . . . . 13.6 t70 -133.1 157.44 45.28 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 116.151 -0.477 . . . . 0.0 110.039 177.737 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' D' D ' 90' ' ' GLU . . . . . . . . . . . . . 82.6 tt0 -46.18 -39.11 9.19 Favored 'General case' 0 C--N 1.331 -0.23 0 N-CA-C 113.127 0.788 . . . . 0.0 113.127 -172.146 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' D' D ' 91' ' ' ASN . . . . . . . . . . . . . 82.8 m-20 -130.75 22.76 5.01 Favored 'General case' 0 N--CA 1.469 0.488 0 N-CA-C 112.762 0.653 . . . . 0.0 112.762 -176.785 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' D' D ' 92' ' ' LEU . . . . . . . . . . . . . 37.6 mt -149.05 141.22 23.97 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-O 120.826 0.346 . . . . 0.0 110.581 -176.931 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' D' D ' 93' ' ' ILE . . . . . . . . . . . . . 69.5 mt -122.08 113.11 37.52 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.255 0 N-CA-C 108.638 -0.875 . . . . 0.0 108.638 174.895 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' D' D ' 94' ' ' VAL . . . . . 0.453 HG21 HG11 ' D' ' 125' ' ' VAL . 41.4 t -116.57 128.93 73.79 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.291 0 CA-C-O 120.949 0.404 . . . . 0.0 110.013 -176.955 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' D' D ' 95' ' ' VAL . . . . . . . . . . . . . 46.1 t -121.65 132.58 70.46 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.282 0 CA-C-N 116.021 -0.536 . . . . 0.0 109.808 -179.826 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' D' D ' 96' ' ' ILE . . . . . . . . . . . . . 62.8 mt -113.29 126.41 70.71 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.322 0 N-CA-C 109.074 -0.713 . . . . 0.0 109.074 178.482 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' D' D ' 97' ' ' THR . . . . . . . . . . . . . 81.0 p -101.79 156.91 17.22 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-O 121.085 0.469 . . . . 0.0 111.44 -175.262 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' D' D ' 98' ' ' GLU . . . . . . . . . . . . . 46.1 mt-10 -55.62 -25.35 38.29 Favored 'General case' 0 CA--C 1.533 0.298 0 N-CA-C 112.324 0.49 . . . . 0.0 112.324 178.783 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' D' D ' 99' ' ' GLU . . . . . . . . . . . . . 14.1 mm-40 -76.12 11.92 1.33 Allowed 'General case' 0 CA--C 1.537 0.467 0 N-CA-C 113.161 0.8 . . . . 0.0 113.161 -179.708 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' D' D ' 100' ' ' ASN . . . . . . . . . . . . . 3.2 m-20 62.72 38.0 12.22 Favored 'General case' 0 CA--C 1.529 0.147 0 CA-C-O 121.039 0.447 . . . . 0.0 110.949 179.113 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' D' D ' 101' ' ' GLU . . . . . . . . . . . . . 84.8 tt0 -117.69 145.29 44.51 Favored 'General case' 0 C--N 1.332 -0.155 0 N-CA-C 109.505 -0.554 . . . . 0.0 109.505 176.658 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' D' D ' 102' ' ' VAL . . . . . . . . . . . . . 42.2 t -115.8 124.45 72.22 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.337 0 CA-C-N 116.272 -0.422 . . . . 0.0 109.98 -178.406 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' D' D ' 103' ' ' LEU . . . . . . . . . . . . . 19.3 mt -115.17 127.85 55.8 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 115.69 -0.686 . . . . 0.0 110.129 176.87 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' D' D ' 104' ' ' ILE . . . . . 0.433 HD12 ' HB3' ' D' ' 113' ' ' TYR . 65.6 mt -119.95 120.32 62.83 Favored 'Isoleucine or valine' 0 C--O 1.233 0.223 0 N-CA-C 110.136 -0.32 . . . . 0.0 110.136 -179.496 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' D' D ' 105' ' ' PHE . . . . . . . . . . . . . 46.3 m-85 -120.44 164.2 16.75 Favored 'General case' 0 C--N 1.334 -0.109 0 O-C-N 123.885 0.741 . . . . 0.0 109.977 179.61 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' D' D ' 106' ' ' ASN . . . . . . . . . . . . . 43.4 p-10 -99.24 -169.79 1.81 Allowed 'General case' 0 C--N 1.332 -0.192 0 N-CA-C 110.1 -0.333 . . . . 0.0 110.1 174.883 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' D' D ' 107' ' ' GLN . . . . . . . . . . . . . 62.3 tt0 -57.37 -30.16 64.64 Favored 'General case' 0 C--N 1.33 -0.243 0 N-CA-C 112.121 0.415 . . . . 0.0 112.121 -179.581 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' D' D ' 108' ' ' ASN . . . . . . . . . . . . . 5.4 t30 -88.43 11.24 17.48 Favored 'General case' 0 CA--C 1.536 0.424 0 N-CA-C 113.304 0.853 . . . . 0.0 113.304 -176.405 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' D' D ' 109' ' ' LEU . . . . . . . . . . . . . 9.5 tp 60.63 36.07 19.76 Favored 'General case' 0 CA--C 1.531 0.213 0 O-C-N 122.141 -0.349 . . . . 0.0 111.446 178.452 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' D' D ' 110' ' ' GLU . . . . . . . . . . . . . 95.5 mt-10 -107.84 152.22 24.69 Favored 'General case' 0 C--N 1.331 -0.237 0 N-CA-C 109.836 -0.431 . . . . 0.0 109.836 176.495 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' D' D ' 111' ' ' GLU . . . . . . . . . . . . . 97.3 mt-10 -78.48 126.87 31.36 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-O 121.102 0.477 . . . . 0.0 111.661 -176.359 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' D' D ' 112' ' ' LEU . . . . . . . . . . . . . 30.9 mt -108.93 -46.03 3.69 Favored 'General case' 0 C--N 1.332 -0.181 0 CA-C-N 115.573 -0.74 . . . . 0.0 109.952 174.736 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' D' D ' 113' ' ' TYR . . . . . 0.433 ' HB3' HD12 ' D' ' 104' ' ' ILE . 50.8 t80 -140.45 137.45 33.92 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.095 -0.502 . . . . 0.0 110.91 -179.813 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' D' D ' 114' ' ' ARG . . . . . . . . . . . . . 60.2 ttp180 -142.15 119.09 11.24 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.262 -0.426 . . . . 0.0 110.416 178.701 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' D' D ' 115' ' ' GLY . . . . . . . . . . . . . . . -150.19 162.59 29.27 Favored Glycine 0 CA--C 1.525 0.687 0 N-CA-C 111.021 -0.832 . . . . 0.0 111.021 179.3 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' D' D ' 116' ' ' LYS . . . . . . . . . . . . . 35.0 ttmt -131.66 135.44 46.9 Favored 'General case' 0 C--N 1.33 -0.251 0 N-CA-C 110.024 -0.362 . . . . 0.0 110.024 177.221 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' D' D ' 117' ' ' PHE . . . . . . . . . . . . . 39.8 m-85 -132.2 120.78 22.69 Favored 'General case' 0 C--N 1.331 -0.211 0 CA-C-O 120.86 0.362 . . . . 0.0 110.46 -174.532 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' D' D ' 118' ' ' GLU . . . . . . . . . . . . . 95.9 mt-10 -53.97 -48.53 70.25 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.413 -0.358 . . . . 0.0 111.571 -175.438 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' D' D ' 119' ' ' ASN . . . . . . . . . . . . . 9.4 m120 -99.28 31.11 3.2 Favored 'General case' 0 C--N 1.329 -0.288 0 N-CA-C 112.201 0.445 . . . . 0.0 112.201 -173.771 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' D' D ' 120' ' ' LEU . . . . . . . . . . . . . 23.7 tp -54.88 127.7 29.83 Favored 'General case' 0 C--N 1.332 -0.169 0 CA-C-O 120.805 0.336 . . . . 0.0 110.8 179.544 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' D' D ' 121' ' ' ASN . . . . . . . . . . . . . 95.1 m-20 -111.11 -44.05 3.65 Favored 'General case' 0 C--O 1.233 0.211 0 CA-C-N 116.287 -0.415 . . . . 0.0 111.109 -177.496 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' D' D ' 122' ' ' LYS . . . . . . . . . . . . . 19.0 ptpt -164.34 166.99 20.28 Favored 'General case' 0 N--CA 1.463 0.176 0 CA-C-O 121.277 0.56 . . . . 0.0 112.149 -178.285 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' D' D ' 123' ' ' VAL . . . . . . . . . . . . . 45.5 t -131.49 139.36 50.89 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.207 0 CA-C-N 115.584 -0.735 . . . . 0.0 110.121 179.749 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' D' D ' 124' ' ' LEU . . . . . . . . . . . . . 37.2 mt -121.55 138.9 54.11 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-N 116.313 -0.403 . . . . 0.0 110.737 -179.151 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' D' D ' 125' ' ' VAL . . . . . 0.453 HG11 HG21 ' D' ' 94' ' ' VAL . 35.6 m -135.06 134.12 53.23 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.211 0 CA-C-N 116.585 -0.28 . . . . 0.0 110.939 178.922 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' D' D ' 126' ' ' ARG . . . . . . . . . . . . . 22.3 mtp-105 -148.87 118.31 6.92 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 116.523 -0.308 . . . . 0.0 111.048 177.0 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' D' D ' 127' ' ' ASN . . . . . . . . . . . . . 34.6 m120 48.97 -104.89 0.14 Allowed 'General case' 0 CA--C 1.545 0.76 0 CA-C-O 119.193 -0.432 . . . . 0.0 111.976 175.604 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' D' D ' 128' ' ' ASP . . . . . . . . . . . . . 19.2 p-10 -114.05 14.61 18.38 Favored 'General case' 0 N--CA 1.468 0.463 0 CA-C-N 119.407 1.003 . . . . 0.0 113.28 -174.968 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' D' D ' 129' ' ' LEU . . . . . . . . . . . . . 19.1 tp -123.62 139.22 54.22 Favored 'General case' 0 C--N 1.331 -0.233 0 N-CA-C 109.736 -0.468 . . . . 0.0 109.736 177.458 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' D' D ' 130' ' ' VAL . . . . . 0.549 HG13 ' HB ' ' D' ' 141' ' ' ILE . 13.4 p -131.91 140.54 47.78 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.202 0 CA-C-O 121.173 0.511 . . . . 0.0 110.317 179.523 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' D' D ' 131' ' ' VAL . . . . . . . . . . . . . 40.7 t -135.99 140.46 43.98 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.241 0 CA-C-N 115.864 -0.607 . . . . 0.0 110.493 -177.013 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' D' D ' 132' ' ' ILE . . . . . . . . . . . . . 73.4 mt -115.8 131.33 68.52 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.283 0 N-CA-C 109.188 -0.671 . . . . 0.0 109.188 177.501 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' D' D ' 133' ' ' ILE . . . . . . . . . . . . . 43.6 mm -115.12 119.63 62.32 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.191 0 CA-C-O 120.716 0.293 . . . . 0.0 110.752 -175.904 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' D' D ' 134' ' ' ASP . . . . . . . . . . . . . 8.0 p-10 -133.01 144.25 49.96 Favored 'General case' 0 C--N 1.331 -0.233 0 N-CA-C 109.425 -0.583 . . . . 0.0 109.425 175.896 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' D' D ' 135' ' ' GLU . . . . . . . . . . . . . 83.4 tt0 -49.93 -26.86 4.55 Favored 'General case' 0 C--N 1.327 -0.391 0 N-CA-C 112.779 0.659 . . . . 0.0 112.779 -173.63 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' D' D ' 136' ' ' GLN . . . . . . . . . . . . . 97.3 mt-30 -79.01 -36.89 40.44 Favored 'General case' 0 C--O 1.233 0.225 0 N-CA-C 112.448 0.536 . . . . 0.0 112.448 -178.122 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' D' D ' 137' ' ' LYS . . . . . . . . . . . . . 1.2 ptpm? -164.39 174.11 11.41 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-O 121.671 0.748 . . . . 0.0 112.223 -173.206 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' D' D ' 138' ' ' LEU . . . . . 0.413 HD23 ' N ' ' D' ' 139' ' ' THR . 5.7 tt -117.89 127.3 53.72 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 114.905 -1.043 . . . . 0.0 109.553 177.637 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' D' D ' 139' ' ' THR . . . . . 0.413 ' N ' HD23 ' D' ' 138' ' ' LEU . 42.4 m -106.42 123.61 48.34 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.354 -0.385 . . . . 0.0 110.152 179.301 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' D' D ' 140' ' ' LEU . . . . . . . . . . . . . 14.1 tp -110.61 118.41 36.13 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-N 115.723 -0.672 . . . . 0.0 109.33 -177.901 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' D' D ' 141' ' ' ILE . . . . . 0.549 ' HB ' HG13 ' D' ' 130' ' ' VAL . 19.4 mt -120.11 118.25 56.27 Favored 'Isoleucine or valine' 0 C--O 1.234 0.279 0 CA-C-O 121.045 0.45 . . . . 0.0 110.042 -176.632 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' D' D ' 142' ' ' ARG . . . . . . . . . . . . . 81.3 mtp180 -92.03 128.98 38.08 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 115.433 -0.803 . . . . 0.0 110.009 177.459 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' D' D ' 143' ' ' THR . . . . . 0.58 HG22 HG12 ' E' ' 73' ' ' VAL . 63.6 p . . . . . 0 C--O 1.221 -0.431 0 CA-C-O 117.965 -1.017 . . . . 0.0 110.424 -179.701 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' E' E ' 2' ' ' SER . . . . . . . . . . . . . 2.7 p . . . . . 0 N--CA 1.462 0.155 0 CA-C-O 121.138 0.494 . . . . 0.0 110.856 . . . . . . . . . 0 0 . 1 . 017 nuclear nobuild core ' E' E ' 3' ' ' GLU . . . . . . . . . . . . . 84.2 tt0 -141.53 138.23 32.58 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 115.699 -0.682 . . . . 0.0 110.882 -179.911 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' E' E ' 4' ' ' LEU . . . . . . . . . . . . . 13.6 tp -123.47 127.13 47.95 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.113 -0.494 . . . . 0.0 109.983 176.78 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' E' E ' 5' ' ' LYS . . . . . . . . . . . . . 91.5 mttt -107.2 121.24 44.14 Favored 'General case' 0 C--N 1.331 -0.23 0 CA-C-N 116.442 -0.345 . . . . 0.0 110.627 178.844 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' E' E ' 6' ' ' LEU . . . . . . . . . . . . . 30.6 mt -115.97 147.05 41.59 Favored 'General case' 0 C--N 1.331 -0.222 0 CA-C-N 115.529 -0.76 . . . . 0.0 110.385 -179.147 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' E' E ' 7' ' ' LYS . . . . . . . . . . . . . 36.9 ttmt -133.18 137.93 30.48 Favored Pre-proline 0 CA--C 1.535 0.384 0 CA-C-O 119.028 -0.51 . . . . 0.0 109.928 176.246 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' E' E ' 8' ' ' PRO . . . . . . . . . . . . . 85.9 Cg_endo -90.63 143.97 3.67 Favored 'Trans proline' 0 N--CA 1.49 1.314 0 C-N-CA 121.798 1.665 . . . . 0.0 111.84 178.805 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' E' E ' 9' ' ' LEU . . . . . . . . . . . . . 57.8 mt -81.15 -48.47 1.07 Allowed Pre-proline 0 CA--C 1.534 0.335 0 CA-C-O 118.669 -0.682 . . . . 0.0 112.385 -178.915 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' E' E ' 10' ' ' PRO . . . . . . . . . . . . . 86.0 Cg_endo -80.41 154.24 21.27 Favored 'Trans proline' 0 N--CA 1.496 1.637 0 C-N-CA 121.281 1.321 . . . . 0.0 111.934 177.169 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' E' E ' 11' ' ' LYS . . . . . . . . . . . . . 46.8 pttt -85.06 111.01 19.35 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-O 121.543 0.687 . . . . 0.0 110.426 177.415 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' E' E ' 12' ' ' VAL . . . . . . . . . . . . . 12.7 p -151.09 151.0 12.86 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.276 0 CA-C-N 115.769 -0.65 . . . . 0.0 110.858 -179.196 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' E' E ' 13' ' ' GLU . . . . . . . . . . . . . 95.2 mt-10 -94.26 120.93 35.22 Favored 'General case' 0 C--N 1.329 -0.32 0 N-CA-C 109.827 -0.434 . . . . 0.0 109.827 175.842 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' E' E ' 14' ' ' LEU . . . . . . . . . . . . . 27.4 mt -97.35 150.96 37.37 Favored Pre-proline 0 CA--C 1.532 0.265 0 CA-C-O 119.333 -0.365 . . . . 0.0 110.735 -177.916 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' E' E ' 15' ' ' PRO . . . . . . . . . . . . . 28.0 Cg_exo -60.86 159.5 28.9 Favored 'Trans proline' 0 N--CA 1.497 1.735 0 C-N-CA 121.339 1.359 . . . . 0.0 111.977 178.055 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' E' E ' 16' ' ' PRO . . . . . . . . . . . . . 27.5 Cg_exo -60.14 -37.22 85.2 Favored 'Trans proline' 0 N--CA 1.496 1.661 0 C-N-CA 121.464 1.443 . . . . 0.0 112.497 -179.006 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' E' E ' 17' ' ' ASP . . . . . . . . . . . . . 19.6 p-10 -86.84 10.26 16.61 Favored 'General case' 0 CA--C 1.537 0.455 0 N-CA-C 113.144 0.794 . . . . 0.0 113.144 -177.89 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' E' E ' 18' ' ' PHE . . . . . . . . . . . . . 59.7 t80 -57.56 -45.66 84.89 Favored 'General case' 0 N--CA 1.458 -0.059 0 O-C-N 122.059 -0.401 . . . . 0.0 110.275 -178.075 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' E' E ' 19' ' ' VAL . . . . . . . . . . . . . 14.4 p -56.35 -41.46 71.4 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.307 0 CA-C-N 116.499 -0.318 . . . . 0.0 110.858 -178.832 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' E' E ' 20' ' ' ASP . . . . . . . . . . . . . 67.0 m-20 -60.78 -41.17 94.99 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-O 120.762 0.315 . . . . 0.0 110.7 -179.54 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' E' E ' 21' ' ' VAL . . . . . . . . . . . . . 50.0 t -64.02 -43.91 97.69 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.323 0 CA-C-N 116.346 -0.388 . . . . 0.0 110.148 -178.359 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' E' E ' 22' ' ' ILE . . . . . 0.641 HG22 HD12 ' E' ' 26' ' ' LEU . 46.2 mm -55.8 -49.15 76.45 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.227 0 C-N-CA 120.889 -0.324 . . . . 0.0 110.705 178.373 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' E' E ' 23' ' ' ARG . . . . . . . . . . . . . 30.7 ttp180 -54.86 -50.28 69.04 Favored 'General case' 0 C--N 1.33 -0.261 0 C-N-CA 121.013 -0.275 . . . . 0.0 111.466 -178.452 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' E' E ' 24' ' ' ILE . . . . . . . . . . . . . 75.0 mt -58.77 -46.43 90.79 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.293 0 C-N-CA 120.988 -0.285 . . . . 0.0 111.132 -176.308 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' E' E ' 25' ' ' LYS . . . . . . . . . . . . . 8.5 mtpm? -67.17 -42.31 84.5 Favored 'General case' 0 C--N 1.328 -0.366 0 N-CA-C 112.283 0.475 . . . . 0.0 112.283 -176.607 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' E' E ' 26' ' ' LEU . . . . . 0.641 HD12 HG22 ' E' ' 22' ' ' ILE . 42.3 mt -80.11 -29.72 39.0 Favored 'General case' 0 C--N 1.33 -0.252 0 N-CA-C 113.326 0.861 . . . . 0.0 113.326 -171.957 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' E' E ' 27' ' ' GLN . . . . . . . . . . . . . 6.0 pt20 -45.99 134.49 8.06 Favored 'General case' 0 N--CA 1.467 0.406 0 N-CA-C 112.78 0.659 . . . . 0.0 112.78 -174.38 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' E' E ' 28' ' ' GLY . . . . . . . . . . . . . . . 99.78 -21.94 42.67 Favored Glycine 0 CA--C 1.535 1.325 0 CA-C-N 115.815 -0.629 . . . . 0.0 112.477 -177.428 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' E' E ' 29' ' ' LYS . . . . . . . . . . . . . 9.1 mtpm? -97.39 155.16 17.03 Favored 'General case' 0 C--N 1.331 -0.2 0 CA-C-N 117.542 0.671 . . . . 0.0 110.875 179.63 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' E' E ' 30' ' ' THR . . . . . . . . . . . . . 37.8 m -102.42 139.03 38.57 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 115.929 -0.578 . . . . 0.0 110.424 177.997 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' E' E ' 31' ' ' VAL . . . . . . . . . . . . . 35.4 m -126.26 150.3 31.76 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.266 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.127 179.028 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' E' E ' 32' ' ' ARG . . . . . . . . . . . . . 66.9 ttt-85 -136.04 148.4 48.34 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-O 121.06 0.457 . . . . 0.0 110.332 179.377 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' E' E ' 33' ' ' THR . . . . . . . . . . . . . 28.0 m -52.84 138.27 29.95 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.35 -0.386 . . . . 0.0 111.515 -177.195 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' E' E ' 34' ' ' GLY . . . . . . . . . . . . . . . 98.44 -17.04 59.06 Favored Glycine 0 CA--C 1.533 1.189 0 CA-C-N 116.141 -0.482 . . . . 0.0 113.316 178.536 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' E' E ' 35' ' ' ASP . . . . . . . . . . . . . 81.2 m-20 -66.66 149.31 50.7 Favored 'General case' 0 C--O 1.231 0.131 0 CA-C-N 117.976 0.888 . . . . 0.0 111.312 179.85 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' E' E ' 36' ' ' VAL . . . . . . . . . . . . . 47.0 t -118.79 129.41 75.04 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.233 0 CA-C-N 115.745 -0.661 . . . . 0.0 109.674 176.679 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' E' E ' 37' ' ' ILE . . . . . . . . . . . . . 70.3 mt -120.17 138.46 50.64 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.26 0 N-CA-C 109.82 -0.437 . . . . 0.0 109.82 179.909 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' E' E ' 38' ' ' GLY . . . . . . . . . . . . . . . -111.9 128.57 8.65 Favored Glycine 0 CA--C 1.525 0.689 0 N-CA-C 111.055 -0.818 . . . . 0.0 111.055 179.384 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' E' E ' 39' ' ' ILE . . . . . . . . . . . . . 73.8 mt -127.59 135.98 61.72 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.189 0 CA-C-O 120.731 0.3 . . . . 0.0 110.267 179.186 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' E' E ' 40' ' ' SER . . . . . . . . . . . . . 91.0 p -92.99 116.24 28.87 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.278 -0.419 . . . . 0.0 110.733 174.429 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' E' E ' 41' ' ' ILE . . . . . . . . . . . . . 44.0 mm -121.1 123.17 69.43 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.216 0 CA-C-N 116.552 -0.294 . . . . 0.0 110.431 179.588 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' E' E ' 42' ' ' LEU . . . . . . . . . . . . . 47.0 mt 52.27 33.27 12.29 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.303 -0.408 . . . . 0.0 111.951 176.919 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' E' E ' 43' ' ' GLY . . . . . . . . . . . . . . . 74.15 31.69 59.27 Favored Glycine 0 CA--C 1.528 0.88 0 C-N-CA 121.135 -0.555 . . . . 0.0 112.159 177.711 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' E' E ' 44' ' ' LYS . . . . . . . . . . . . . 67.6 tttt -139.58 135.54 33.48 Favored 'General case' 0 C--N 1.329 -0.308 0 N-CA-C 109.674 -0.491 . . . . 0.0 109.674 177.747 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' E' E ' 45' ' ' GLU . . . . . . . . . . . . . 83.6 tt0 -82.16 120.92 25.95 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-O 120.861 0.362 . . . . 0.0 110.971 -177.098 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' E' E ' 46' ' ' VAL . . . . . . . . . . . . . 7.6 p -124.58 125.04 69.46 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.179 0 N-CA-C 109.41 -0.589 . . . . 0.0 109.41 176.277 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' E' E ' 47' ' ' LYS . . . . . . . . . . . . . 96.1 mttt -101.08 134.5 43.99 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.019 -0.537 . . . . 0.0 111.31 177.768 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' E' E ' 48' ' ' PHE . . . . . . . . . . . . . 88.5 m-85 -115.19 132.89 56.46 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 115.88 -0.6 . . . . 0.0 109.965 176.553 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' E' E ' 49' ' ' LYS . . . . . . . . . . . . . 83.3 tttt -105.33 136.91 43.99 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 116.347 -0.388 . . . . 0.0 109.987 177.303 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' E' E ' 50' ' ' VAL . . . . . . . . . . . . . 43.1 t -80.42 109.92 15.42 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.277 0 N-CA-C 109.353 -0.61 . . . . 0.0 109.353 176.821 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' E' E ' 51' ' ' VAL . . . . . . . . . . . . . 53.4 t -68.91 -47.33 76.46 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.24 0 CA-C-N 115.898 -0.592 . . . . 0.0 109.889 -174.777 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' E' E ' 52' ' ' GLN . . . . . . . . . . . . . 48.7 tt0 -167.85 141.77 3.46 Favored 'General case' 0 C--N 1.331 -0.219 0 C-N-CA 120.342 -0.543 . . . . 0.0 111.672 -179.688 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' E' E ' 53' ' ' ALA . . . . . . . . . . . . . . . -111.58 131.49 55.22 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 115.55 -0.75 . . . . 0.0 109.675 175.742 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' E' E ' 54' ' ' TYR . . . . . . . . . . . . . 50.6 t80 -127.67 106.48 20.8 Favored Pre-proline 0 CA--C 1.536 0.418 0 CA-C-O 118.319 -0.848 . . . . 0.0 110.438 -179.61 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' E' E ' 55' ' ' PRO . . . . . . . . . . . . . 73.4 Cg_endo -77.02 170.02 72.83 Favored 'Cis proline' 0 N--CA 1.499 1.836 0 CA-C-N 121.696 1.641 . . . . 0.0 112.607 -2.91 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' E' E ' 56' ' ' SER . . . . . . . . . . . . . 13.6 m -109.49 121.19 43.1 Favored Pre-proline 0 CA--C 1.539 0.537 0 CA-C-O 118.381 -0.819 . . . . 0.0 109.563 177.22 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' E' E ' 57' ' ' PRO . . . . . . . . . . . . . 61.1 Cg_endo -74.36 169.3 74.38 Favored 'Cis proline' 0 N--CA 1.497 1.686 0 CA-C-N 122.049 1.767 . . . . 0.0 112.073 0.97 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' E' E ' 58' ' ' LEU . . . . . . . . . . . . . 26.3 tp -128.13 136.16 50.78 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 115.999 -0.546 . . . . 0.0 110.014 179.755 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' E' E ' 59' ' ' ARG . . . . . . . . . . . . . 39.4 ttm180 -101.2 124.99 47.77 Favored 'General case' 0 C--N 1.326 -0.425 0 CA-C-N 115.89 -0.595 . . . . 0.0 109.467 178.512 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' E' E ' 60' ' ' VAL . . . . . . . . . . . . . 42.9 t -80.04 116.56 24.36 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.207 0 C-N-CA 120.57 -0.452 . . . . 0.0 110.353 -175.691 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' E' E ' 61' ' ' GLU . . . . . . . . . . . . . 95.6 mt-10 -131.04 166.07 21.85 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 115.792 -0.64 . . . . 0.0 110.045 178.765 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' E' E ' 62' ' ' ASP . . . . . . . . . . . . . 81.1 m-20 -54.94 -32.6 61.46 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.505 -0.316 . . . . 0.0 111.763 -179.991 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' E' E ' 63' ' ' ARG . . . . . . . . . . . . . 16.8 ptp180 -85.5 7.71 21.88 Favored 'General case' 0 CA--C 1.535 0.402 0 N-CA-C 113.536 0.939 . . . . 0.0 113.536 -175.751 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' E' E ' 64' ' ' THR . . . . . . . . . . . . . 34.0 m -94.35 141.79 28.16 Favored 'General case' 0 C--N 1.332 -0.166 0 CA-C-N 118.156 0.435 . . . . 0.0 110.587 -177.969 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' E' E ' 65' ' ' LYS . . . . . . . . . . . . . 98.3 mttt -88.87 126.8 35.54 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.09 -0.504 . . . . 0.0 110.195 179.234 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' E' E ' 66' ' ' ILE . . . . . . . . . . . . . 59.4 mt -114.23 126.45 71.75 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.292 0 N-CA-C 109.542 -0.54 . . . . 0.0 109.542 178.23 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' E' E ' 67' ' ' THR . . . . . . . . . . . . . 20.6 m -119.46 134.83 55.03 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-O 120.944 0.402 . . . . 0.0 110.481 -178.497 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' E' E ' 68' ' ' LEU . . . . . 0.481 ' C ' HD23 ' E' ' 68' ' ' LEU . 6.4 tt . . . . . 0 C--N 1.328 -0.345 0 CA-C-N 115.886 -0.597 . . . . 0.0 110.113 179.247 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' E' E ' 73' ' ' VAL . . . . . 0.58 HG12 HG22 ' D' ' 143' ' ' THR . 26.7 m . . . . . 0 C--O 1.232 0.136 0 CA-C-O 121.06 0.457 . . . . 0.0 110.968 . . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' E' E ' 74' ' ' ASP . . . . . . . . . . . . . 19.6 t0 -112.33 119.13 37.23 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 115.738 -0.665 . . . . 0.0 109.521 177.646 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' E' E ' 75' ' ' VAL . . . . . . . . . . . . . 43.8 t -110.63 126.53 67.96 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.258 0 CA-C-O 121.141 0.496 . . . . 0.0 111.0 -174.983 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' E' E ' 76' ' ' LEU . . . . . . . . . . . . . 23.0 mt -128.76 144.52 51.19 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 115.456 -0.793 . . . . 0.0 109.475 176.379 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' E' E ' 77' ' ' GLU . . . . . . . . . . . . . 98.0 mt-10 -131.72 139.33 48.97 Favored 'General case' 0 C--N 1.332 -0.163 0 CA-C-O 121.117 0.484 . . . . 0.0 111.622 -177.07 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' E' E ' 78' ' ' ALA . . . . . . . . . . . . . . . -126.68 129.41 48.39 Favored 'General case' 0 C--N 1.331 -0.196 0 CA-C-N 115.573 -0.74 . . . . 0.0 109.685 175.693 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' E' E ' 79' ' ' LYS . . . . . 0.602 ' O ' HD13 ' E' ' 80' ' ' ILE . 51.8 pttt -75.85 121.09 22.11 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-O 121.471 0.653 . . . . 0.0 110.997 -177.996 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' E' E ' 80' ' ' ILE . . . . . 0.602 HD13 ' O ' ' E' ' 79' ' ' LYS . 41.2 mm -139.28 107.52 3.26 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.224 0 CA-C-N 115.531 -0.759 . . . . 0.0 109.111 -177.131 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' E' E ' 81' ' ' LYS . . . . . . . . . . . . . 31.7 ttpt -103.61 126.94 51.06 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-O 120.838 0.351 . . . . 0.0 111.111 -177.199 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' E' E ' 82' ' ' GLY . . . . . . . . . . . . . . . 89.03 42.01 5.74 Favored Glycine 0 CA--C 1.526 0.722 0 C-N-CA 120.8 -0.714 . . . . 0.0 111.716 174.977 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' E' E ' 83' ' ' ILE . . . . . . . . . . . . . 70.8 mt -65.48 138.97 22.11 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.356 0 CA-C-O 120.931 0.396 . . . . 0.0 110.033 179.194 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' E' E ' 84' ' ' LYS . . . . . . . . . . . . . 57.0 tttp -98.72 -50.27 4.3 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 115.964 -0.562 . . . . 0.0 109.893 179.043 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' E' E ' 85' ' ' ASP . . . . . . . . . . . . . 5.3 t70 -157.92 153.4 26.16 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 115.647 -0.706 . . . . 0.0 110.228 178.696 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' E' E ' 86' ' ' VAL . . . . . . . . . . . . . 44.6 t -128.39 131.77 68.7 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.208 0 CA-C-O 121.014 0.435 . . . . 0.0 110.559 -178.838 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' E' E ' 87' ' ' ILE . . . . . . . . . . . . . 4.9 mp -117.99 123.3 71.46 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.253 0 CA-C-N 115.743 -0.662 . . . . 0.0 109.245 175.149 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' E' E ' 88' ' ' LEU . . . . . . . . . . . . . 13.0 tp -111.08 130.98 55.44 Favored 'General case' 0 C--N 1.331 -0.198 0 CA-C-O 120.99 0.424 . . . . 0.0 111.032 -177.328 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' E' E ' 89' ' ' ASP . . . . . . . . . . . . . 13.2 t70 -126.65 153.12 45.81 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 115.867 -0.606 . . . . 0.0 109.451 176.51 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' E' E ' 90' ' ' GLU . . . . . . . . . . . . . 80.4 tt0 -47.81 -33.42 7.25 Favored 'General case' 0 C--N 1.331 -0.23 0 N-CA-C 112.866 0.691 . . . . 0.0 112.866 -172.271 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' E' E ' 91' ' ' ASN . . . . . . . . . . . . . 3.8 p30 -129.14 14.55 6.22 Favored 'General case' 0 N--CA 1.469 0.509 0 N-CA-C 113.349 0.87 . . . . 0.0 113.349 -175.905 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' E' E ' 92' ' ' LEU . . . . . . . . . . . . . 34.9 mt -149.42 147.17 27.95 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-O 120.796 0.331 . . . . 0.0 110.508 -176.355 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' E' E ' 93' ' ' ILE . . . . . . . . . . . . . 71.7 mt -125.07 117.17 49.25 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.274 0 N-CA-C 109.319 -0.623 . . . . 0.0 109.319 177.696 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' E' E ' 94' ' ' VAL . . . . . . . . . . . . . 46.6 t -116.39 125.85 73.6 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.273 0 N-CA-C 109.753 -0.462 . . . . 0.0 109.753 -179.897 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' E' E ' 95' ' ' VAL . . . . . . . . . . . . . 38.7 t -122.74 132.93 70.32 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.293 0 CA-C-N 116.113 -0.494 . . . . 0.0 109.838 -179.097 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' E' E ' 96' ' ' ILE . . . . . . . . . . . . . 59.4 mt -114.53 129.57 70.37 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.327 0 N-CA-C 109.224 -0.658 . . . . 0.0 109.224 178.451 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' E' E ' 97' ' ' THR . . . . . . . . . . . . . 68.1 p -101.51 157.79 16.56 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-O 121.001 0.429 . . . . 0.0 110.968 -177.762 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' E' E ' 98' ' ' GLU . . . . . . . . . . . . . 44.6 mt-10 -53.81 -25.01 17.34 Favored 'General case' 0 C--N 1.329 -0.298 0 N-CA-C 112.489 0.551 . . . . 0.0 112.489 179.982 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' E' E ' 99' ' ' GLU . . . . . . . . . . . . . 96.4 mt-10 -78.1 14.69 1.08 Allowed 'General case' 0 CA--C 1.536 0.42 0 N-CA-C 113.331 0.863 . . . . 0.0 113.331 -177.052 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' E' E ' 100' ' ' ASN . . . . . . . . . . . . . 2.2 m-20 63.06 34.43 13.82 Favored 'General case' 0 N--CA 1.464 0.264 0 CA-C-N 117.909 0.322 . . . . 0.0 111.352 178.032 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' E' E ' 101' ' ' GLU . . . . . . . . . . . . . 81.4 tt0 -116.49 144.23 44.59 Favored 'General case' 0 C--N 1.332 -0.189 0 N-CA-C 109.582 -0.525 . . . . 0.0 109.582 175.195 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' E' E ' 102' ' ' VAL . . . . . . . . . . . . . 46.2 t -118.94 127.47 75.79 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.257 0 N-CA-C 109.864 -0.421 . . . . 0.0 109.864 -178.269 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' E' E ' 103' ' ' LEU . . . . . 0.506 HD12 ' N ' ' E' ' 103' ' ' LEU . 6.1 mp -118.39 135.8 54.12 Favored 'General case' 0 C--N 1.332 -0.188 0 CA-C-N 115.829 -0.623 . . . . 0.0 110.112 177.26 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' E' E ' 104' ' ' ILE . . . . . 0.408 HD13 HG21 ' E' ' 130' ' ' VAL . 66.2 mt -119.46 122.0 67.84 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.265 0 N-CA-C 110.147 -0.316 . . . . 0.0 110.147 -179.723 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' E' E ' 105' ' ' PHE . . . . . . . . . . . . . 73.7 m-85 -118.84 163.67 16.55 Favored 'General case' 0 C--N 1.33 -0.245 0 O-C-N 123.991 0.807 . . . . 0.0 109.405 179.353 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' E' E ' 106' ' ' ASN . . . . . . . . . . . . . 47.6 p-10 -96.64 -170.93 2.15 Favored 'General case' 0 C--N 1.331 -0.201 0 N-CA-C 109.803 -0.443 . . . . 0.0 109.803 172.714 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' E' E ' 107' ' ' GLN . . . . . . . . . . . . . 42.1 tt0 -59.73 -27.62 66.64 Favored 'General case' 0 C--N 1.327 -0.373 0 N-CA-C 112.104 0.409 . . . . 0.0 112.104 -179.963 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' E' E ' 108' ' ' ASN . . . . . . . . . . . . . 6.9 t-20 -88.14 13.9 10.33 Favored 'General case' 0 CA--C 1.536 0.418 0 N-CA-C 112.874 0.694 . . . . 0.0 112.874 -178.161 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' E' E ' 109' ' ' LEU . . . . . . . . . . . . . 42.0 mt 57.25 32.3 21.51 Favored 'General case' 0 CA--C 1.529 0.172 0 N-CA-C 112.013 0.375 . . . . 0.0 112.013 178.697 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' E' E ' 110' ' ' GLU . . . . . . . . . . . . . 95.1 mt-10 -101.18 140.02 36.05 Favored 'General case' 0 C--N 1.33 -0.261 0 N-CA-C 109.125 -0.694 . . . . 0.0 109.125 174.269 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' E' E ' 111' ' ' GLU . . . . . . . . . . . . . 44.7 tt0 -82.43 121.91 27.34 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-O 120.948 0.404 . . . . 0.0 110.69 -174.605 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' E' E ' 112' ' ' LEU . . . . . . . . . . . . . 14.0 mt -102.12 -45.18 5.23 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 115.909 -0.587 . . . . 0.0 110.547 179.338 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' E' E ' 113' ' ' TYR . . . . . . . . . . . . . 57.4 t80 -134.8 143.51 47.12 Favored 'General case' 0 C--N 1.331 -0.218 0 CA-C-N 116.387 -0.37 . . . . 0.0 111.078 -177.536 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' E' E ' 114' ' ' ARG . . . . . . . . . . . . . 35.1 ptt180 -147.06 125.49 12.36 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.18 -0.463 . . . . 0.0 110.727 177.863 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' E' E ' 115' ' ' GLY . . . . . . . . . . . . . . . -150.15 162.97 29.38 Favored Glycine 0 CA--C 1.523 0.572 0 N-CA-C 110.834 -0.907 . . . . 0.0 110.834 -179.927 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' E' E ' 116' ' ' LYS . . . . . . . . . . . . . 30.7 ttmt -132.06 138.97 48.37 Favored 'General case' 0 C--N 1.329 -0.305 0 O-C-N 122.59 -0.359 . . . . 0.0 110.051 177.922 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' E' E ' 117' ' ' PHE . . . . . . . . . . . . . 28.0 m-85 -137.09 114.78 11.22 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-O 120.875 0.369 . . . . 0.0 110.038 -175.938 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' E' E ' 118' ' ' GLU . . . . . . . . . . . . . 96.8 mt-10 -54.27 -43.03 70.64 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.458 -0.337 . . . . 0.0 111.333 -176.679 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' E' E ' 119' ' ' ASN . . . . . . . . . . . . . 59.2 m-80 -98.9 31.06 3.1 Favored 'General case' 0 C--N 1.331 -0.215 0 CA-C-N 116.222 -0.444 . . . . 0.0 112.159 -174.257 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' E' E ' 120' ' ' LEU . . . . . . . . . . . . . 25.1 tp -57.03 119.82 6.96 Favored 'General case' 0 C--N 1.333 -0.127 0 C-N-CA 121.028 -0.269 . . . . 0.0 110.322 177.937 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' E' E ' 121' ' ' ASN . . . . . . . . . . . . . 9.9 t-20 -114.14 -44.14 3.16 Favored 'General case' 0 C--N 1.332 -0.182 0 CA-C-N 116.545 -0.298 . . . . 0.0 111.192 -177.28 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' E' E ' 122' ' ' LYS . . . . . . . . . . . . . 61.8 mtpt -144.29 152.59 41.0 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-O 121.048 0.451 . . . . 0.0 111.561 -176.814 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' E' E ' 123' ' ' VAL . . . . . . . . . . . . . 43.5 t -132.32 131.89 60.64 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.238 0 CA-C-N 116.01 -0.541 . . . . 0.0 109.808 175.983 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' E' E ' 124' ' ' LEU . . . . . . . . . . . . . 52.6 mt -120.15 133.12 55.58 Favored 'General case' 0 C--N 1.331 -0.213 0 CA-C-N 116.275 -0.421 . . . . 0.0 110.624 -179.339 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' E' E ' 125' ' ' VAL . . . . . . . . . . . . . 43.3 t -127.83 120.34 53.8 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.188 0 N-CA-C 109.788 -0.449 . . . . 0.0 109.788 177.818 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' E' E ' 126' ' ' ARG . . . . . . . . . . . . . 51.2 mtp180 -148.87 138.86 22.16 Favored 'General case' 0 C--N 1.329 -0.323 0 N-CA-C 109.661 -0.496 . . . . 0.0 109.661 179.615 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' E' E ' 127' ' ' ASN . . . . . . . . . . . . . 4.9 p-10 48.67 -151.13 0.14 Allowed 'General case' 0 CA--C 1.54 0.585 0 CA-C-O 119.434 -0.317 . . . . 0.0 111.024 177.353 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' E' E ' 128' ' ' ASP . . . . . . . . . . . . . 13.3 p-10 -84.14 22.84 1.14 Allowed 'General case' 0 CA--C 1.534 0.332 0 CA-C-N 118.541 0.61 . . . . 0.0 112.416 178.653 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' E' E ' 129' ' ' LEU . . . . . . . . . . . . . 15.0 tp -127.08 140.4 52.31 Favored 'General case' 0 C--O 1.233 0.2 0 O-C-N 122.072 -0.393 . . . . 0.0 110.354 -179.398 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' E' E ' 130' ' ' VAL . . . . . 0.495 HG23 ' HB ' ' E' ' 141' ' ' ILE . 30.9 m -129.5 142.81 42.98 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.218 0 CA-C-O 121.001 0.429 . . . . 0.0 110.468 179.297 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' E' E ' 131' ' ' VAL . . . . . 0.525 HG22 HD12 ' E' ' 140' ' ' LEU . 39.8 t -136.1 138.92 46.65 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.234 0 CA-C-N 116.118 -0.492 . . . . 0.0 110.545 -177.77 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' E' E ' 132' ' ' ILE . . . . . . . . . . . . . 73.8 mt -117.18 132.22 67.61 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.289 0 N-CA-C 109.347 -0.612 . . . . 0.0 109.347 177.761 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' E' E ' 133' ' ' ILE . . . . . . . . . . . . . 35.2 mm -115.65 122.39 69.32 Favored 'Isoleucine or valine' 0 C--O 1.234 0.278 0 CA-C-O 120.656 0.265 . . . . 0.0 111.06 -174.766 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' E' E ' 134' ' ' ASP . . . . . . . . . . . . . 7.5 p-10 -135.15 146.44 48.78 Favored 'General case' 0 C--N 1.329 -0.31 0 N-CA-C 109.374 -0.602 . . . . 0.0 109.374 174.812 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' E' E ' 135' ' ' GLU . . . . . . . . . . . . . 84.4 tt0 -49.91 -26.37 4.06 Favored 'General case' 0 CA--C 1.532 0.285 0 N-CA-C 112.721 0.637 . . . . 0.0 112.721 -174.242 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' E' E ' 136' ' ' GLN . . . . . . . . . . . . . 24.9 tt0 -77.64 -38.56 47.63 Favored 'General case' 0 C--O 1.234 0.28 0 CA-C-O 120.896 0.379 . . . . 0.0 111.933 -177.01 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' E' E ' 137' ' ' LYS . . . . . . . . . . . . . 17.4 ptpt -166.83 176.47 7.05 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-O 121.496 0.665 . . . . 0.0 111.621 -173.364 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' E' E ' 138' ' ' LEU . . . . . 0.425 ' C ' HD23 ' E' ' 138' ' ' LEU . 7.4 tt -119.62 128.07 53.53 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 115.243 -0.89 . . . . 0.0 109.954 177.83 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' E' E ' 139' ' ' THR . . . . . . . . . . . . . 36.9 m -105.94 125.85 51.49 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.245 -0.434 . . . . 0.0 110.372 179.869 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' E' E ' 140' ' ' LEU . . . . . 0.525 HD12 HG22 ' E' ' 131' ' ' VAL . 21.3 tp -113.08 119.52 38.12 Favored 'General case' 0 C--N 1.329 -0.306 0 N-CA-C 109.018 -0.734 . . . . 0.0 109.018 -179.137 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' E' E ' 141' ' ' ILE . . . . . 0.495 ' HB ' HG23 ' E' ' 130' ' ' VAL . 19.5 mt -119.17 121.64 67.18 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.309 0 CA-C-O 121.042 0.449 . . . . 0.0 110.012 -175.944 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' E' E ' 142' ' ' ARG . . . . . . . . . . . . . 78.9 mtp180 -109.97 115.76 30.38 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 115.126 -0.943 . . . . 0.0 109.901 -177.748 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' E' E ' 143' ' ' THR . . . . . . . . . . . . . 34.9 p . . . . . 0 C--O 1.219 -0.51 0 CA-C-O 118.037 -0.983 . . . . 0.0 110.649 -178.24 . . . . . . . . 0 0 . 1 . 017 nuclear nobuild core ' F' F ' 1' ' ' MET . . . . . . . . . . . . . 24.6 ptp . . . . . 0 C--O 1.232 0.147 0 CA-C-O 120.686 0.279 . . . . 0.0 110.683 . . . . . . . . . 0 0 . 1 . 017 nuclear nobuild core ' F' F ' 2' ' ' SER . . . . . . . . . . . . . 50.6 p -123.7 141.06 52.37 Favored 'General case' 0 C--N 1.332 -0.184 0 CA-C-O 120.986 0.422 . . . . 0.0 110.534 178.968 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' F' F ' 3' ' ' GLU . . . . . . . . . . . . . 84.7 tt0 -142.01 140.45 32.67 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.041 -0.527 . . . . 0.0 111.376 -178.777 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' F' F ' 4' ' ' LEU . . . . . . . . . . . . . 67.9 mt -120.16 134.0 55.36 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.042 -0.526 . . . . 0.0 110.2 176.253 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' F' F ' 5' ' ' LYS . . . . . . . . . . . . . 68.1 mttm -109.97 119.85 40.6 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.303 -0.408 . . . . 0.0 110.275 178.194 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' F' F ' 6' ' ' LEU . . . . . . . . . . . . . 57.1 mt -114.51 147.51 39.28 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 115.382 -0.826 . . . . 0.0 110.472 -178.109 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' F' F ' 7' ' ' LYS . . . . . . . . . . . . . 56.4 tttm -136.84 137.14 22.52 Favored Pre-proline 0 CA--C 1.534 0.34 0 CA-C-O 118.901 -0.571 . . . . 0.0 109.962 176.78 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' F' F ' 8' ' ' PRO . . . . . . . . . . . . . 97.3 Cg_endo -91.97 141.98 2.55 Favored 'Trans proline' 0 N--CA 1.488 1.2 0 C-N-CA 121.688 1.592 . . . . 0.0 111.776 177.397 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' F' F ' 9' ' ' LEU . . . . . . . . . . . . . 21.9 mt -79.79 -47.3 1.46 Allowed Pre-proline 0 CA--C 1.532 0.274 0 CA-C-O 118.697 -0.668 . . . . 0.0 111.92 -178.94 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' F' F ' 10' ' ' PRO . . . . . . . . . . . . . 96.0 Cg_endo -81.66 140.61 11.83 Favored 'Trans proline' 0 N--CA 1.494 1.55 0 C-N-CA 121.188 1.258 . . . . 0.0 111.509 175.254 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' F' F ' 11' ' ' LYS . . . . . . . . . . . . . 46.3 tptt -79.94 98.09 7.01 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-O 120.863 0.363 . . . . 0.0 110.184 179.726 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' F' F ' 12' ' ' VAL . . . . . . . . . . . . . 12.7 p -138.16 145.81 27.98 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.245 0 CA-C-N 116.132 -0.485 . . . . 0.0 110.542 -179.357 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' F' F ' 13' ' ' GLU . . . . . . . . . . . . . 84.6 tt0 -83.56 126.13 32.49 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.353 -0.385 . . . . 0.0 110.403 179.515 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' F' F ' 14' ' ' LEU . . . . . . . . . . . . . 15.5 mt -98.13 149.86 36.15 Favored Pre-proline 0 CA--C 1.532 0.284 0 CA-C-N 116.338 -0.392 . . . . 0.0 110.352 -178.593 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' F' F ' 15' ' ' PRO . . . . . . . . . . . . . 25.8 Cg_exo -62.51 164.11 19.03 Favored 'Trans proline' 0 N--CA 1.496 1.628 0 C-N-CA 121.277 1.318 . . . . 0.0 111.916 176.001 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' F' F ' 16' ' ' PRO . . . . . . . . . . . . . 27.6 Cg_exo -60.32 -41.84 46.86 Favored 'Trans proline' 0 N--CA 1.498 1.748 0 C-N-CA 121.439 1.426 . . . . 0.0 112.842 -177.974 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' F' F ' 17' ' ' ASP . . . . . . . . . . . . . 7.9 p-10 -88.67 11.09 18.45 Favored 'General case' 0 C--N 1.327 -0.376 0 N-CA-C 113.249 0.833 . . . . 0.0 113.249 -176.679 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' F' F ' 18' ' ' PHE . . . . . . . . . . . . . 49.2 t80 -57.18 -42.72 81.69 Favored 'General case' 0 C--N 1.334 -0.07 0 O-C-N 121.922 -0.486 . . . . 0.0 110.25 -178.816 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' F' F ' 19' ' ' VAL . . . . . . . . . . . . . 47.7 t -57.52 -43.05 82.3 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.321 0 CA-C-N 116.144 -0.48 . . . . 0.0 110.36 -179.092 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' F' F ' 20' ' ' ASP . . . . . . . . . . . . . 8.6 t70 -59.85 -41.13 90.74 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-O 120.873 0.368 . . . . 0.0 110.726 -178.217 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' F' F ' 21' ' ' VAL . . . . . . . . . . . . . 51.1 t -64.36 -47.2 90.58 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.332 0 CA-C-N 116.323 -0.398 . . . . 0.0 110.392 -178.2 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' F' F ' 22' ' ' ILE . . . . . 0.446 HG22 HD12 ' F' ' 26' ' ' LEU . 50.5 mm -55.93 -45.37 80.0 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.202 0 C-N-CA 120.928 -0.309 . . . . 0.0 110.662 179.201 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' F' F ' 23' ' ' ARG . . . . . . . . . . . . . 36.1 ttp180 -53.83 -50.7 65.62 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-O 120.675 0.274 . . . . 0.0 111.428 -178.999 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' F' F ' 24' ' ' ILE . . . . . . . . . . . . . 71.5 mt -60.31 -41.36 86.83 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.264 0 CA-C-N 116.514 -0.312 . . . . 0.0 111.314 -177.18 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' F' F ' 25' ' ' LYS . . . . . . . . . . . . . 82.3 mttt -66.39 -39.02 88.81 Favored 'General case' 0 C--N 1.33 -0.265 0 N-CA-C 112.354 0.502 . . . . 0.0 112.354 -178.674 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' F' F ' 26' ' ' LEU . . . . . 0.446 HD12 HG22 ' F' ' 22' ' ' ILE . 75.7 mt -78.42 -41.9 31.64 Favored 'General case' 0 C--N 1.33 -0.278 0 N-CA-C 113.005 0.742 . . . . 0.0 113.005 -173.39 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' F' F ' 27' ' ' GLN . . . . . . . . . . . . . 9.1 pt20 -46.91 142.1 3.66 Favored 'General case' 0 N--CA 1.47 0.538 0 N-CA-C 112.694 0.627 . . . . 0.0 112.694 -175.377 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' F' F ' 28' ' ' GLY . . . . . . . . . . . . . . . 98.94 -29.77 11.09 Favored Glycine 0 CA--C 1.531 1.087 0 CA-C-N 115.514 -0.766 . . . . 0.0 111.96 -177.477 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' F' F ' 29' ' ' LYS . . . . . . . . . . . . . 8.7 mtpm? -98.66 155.14 17.47 Favored 'General case' 0 C--O 1.232 0.167 0 CA-C-O 121.013 0.435 . . . . 0.0 110.955 179.264 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' F' F ' 30' ' ' THR . . . . . . . . . . . . . 29.7 m -97.28 138.4 34.82 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.151 -0.477 . . . . 0.0 109.947 175.682 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' F' F ' 31' ' ' VAL . . . . . . . . . . . . . 35.3 m -124.94 151.45 30.56 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.257 0 CA-C-N 116.289 -0.414 . . . . 0.0 110.82 -178.47 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' F' F ' 32' ' ' ARG . . . . . . . . . . . . . 61.5 mtp180 -135.3 152.19 51.26 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-O 121.398 0.618 . . . . 0.0 110.717 176.82 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' F' F ' 33' ' ' THR . . . . . . . . . . . . . 8.4 m -54.0 138.3 37.48 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 115.973 -0.558 . . . . 0.0 111.18 -179.085 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' F' F ' 34' ' ' GLY . . . . . . . . . . . . . . . 101.57 -17.08 55.79 Favored Glycine 0 CA--C 1.532 1.139 0 CA-C-O 119.539 -0.59 . . . . 0.0 113.293 178.768 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' F' F ' 35' ' ' ASP . . . . . . . . . . . . . 74.2 m-20 -65.27 148.81 51.04 Favored 'General case' 0 N--CA 1.461 0.113 0 CA-C-N 118.134 0.967 . . . . 0.0 111.25 179.869 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' F' F ' 36' ' ' VAL . . . . . . . . . . . . . 44.8 t -122.48 129.84 74.96 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.16 0 CA-C-N 115.741 -0.663 . . . . 0.0 109.793 178.308 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' F' F ' 37' ' ' ILE . . . . . . . . . . . . . 70.4 mt -122.71 140.18 47.28 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.185 0 CA-C-N 116.233 -0.439 . . . . 0.0 109.96 -179.813 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' F' F ' 38' ' ' GLY . . . . . . . . . . . . . . . -114.0 128.78 8.42 Favored Glycine 0 CA--C 1.525 0.679 0 N-CA-C 111.211 -0.756 . . . . 0.0 111.211 -179.973 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' F' F ' 39' ' ' ILE . . . . . . . . . . . . . 72.4 mt -126.25 130.27 72.03 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.214 0 N-CA-C 109.746 -0.465 . . . . 0.0 109.746 178.539 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' F' F ' 40' ' ' SER . . . . . 0.558 ' O ' HD13 ' F' ' 41' ' ' ILE . 83.7 p -93.45 121.62 35.04 Favored 'General case' 0 C--N 1.331 -0.227 0 C-N-CA 120.945 -0.302 . . . . 0.0 111.456 178.826 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' F' F ' 41' ' ' ILE . . . . . 0.558 HD13 ' O ' ' F' ' 40' ' ' SER . 44.5 mm -133.4 129.13 55.99 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.181 0 CA-C-N 116.427 -0.351 . . . . 0.0 110.163 177.813 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' F' F ' 42' ' ' LEU . . . . . 0.481 ' HG ' HG22 ' F' ' 41' ' ' ILE . 70.3 mt 57.6 32.99 22.67 Favored 'General case' 0 C--N 1.33 -0.249 0 N-CA-C 112.023 0.379 . . . . 0.0 112.023 176.93 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' F' F ' 43' ' ' GLY . . . . . . . . . . . . . . . 77.46 -10.12 24.6 Favored Glycine 0 CA--C 1.533 1.205 0 C-N-CA 121.108 -0.568 . . . . 0.0 113.553 177.502 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' F' F ' 44' ' ' LYS . . . . . . . . . . . . . 37.6 mmtm -103.25 136.31 43.26 Favored 'General case' 0 C--O 1.232 0.173 0 CA-C-N 117.988 0.894 . . . . 0.0 110.051 176.638 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' F' F ' 45' ' ' GLU . . . . . . . . . . . . . 35.1 tp10 -84.58 127.56 34.13 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.344 -0.389 . . . . 0.0 110.628 -179.805 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' F' F ' 46' ' ' VAL . . . . . . . . . . . . . 5.8 p -115.22 126.67 72.85 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.223 0 N-CA-C 109.212 -0.662 . . . . 0.0 109.212 176.23 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' F' F ' 47' ' ' LYS . . . . . . . . . . . . . 63.4 mttm -100.14 128.99 46.12 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 115.791 -0.641 . . . . 0.0 110.924 -179.482 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' F' F ' 48' ' ' PHE . . . . . . . . . . . . . 95.6 m-85 -113.73 131.83 56.04 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.358 -0.383 . . . . 0.0 110.324 177.884 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' F' F ' 49' ' ' LYS . . . . . . . . . . . . . 80.0 tttt -108.06 139.01 43.34 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.357 -0.383 . . . . 0.0 110.633 178.214 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' F' F ' 50' ' ' VAL . . . . . . . . . . . . . 45.0 t -82.11 107.33 14.0 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.343 0 N-CA-C 109.224 -0.658 . . . . 0.0 109.224 175.011 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' F' F ' 51' ' ' VAL . . . . . . . . . . . . . 50.3 t -72.25 -51.87 27.42 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.258 0 CA-C-N 116.103 -0.499 . . . . 0.0 109.757 -174.753 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' F' F ' 52' ' ' GLN . . . . . . . . . . . . . 90.7 mt-30 -153.84 153.23 31.73 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-O 121.296 0.57 . . . . 0.0 111.722 -178.564 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' F' F ' 53' ' ' ALA . . . . . . . . . . . . . . . -129.98 132.64 46.37 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 115.252 -0.885 . . . . 0.0 109.635 173.825 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' F' F ' 54' ' ' TYR . . . . . . . . . . . . . 41.1 t80 -129.09 110.58 18.24 Favored Pre-proline 0 CA--C 1.536 0.406 0 CA-C-O 118.231 -0.89 . . . . 0.0 110.555 179.974 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' F' F ' 55' ' ' PRO . . . . . . . . . . . . . 74.4 Cg_endo -77.21 169.37 74.35 Favored 'Cis proline' 0 N--CA 1.5 1.869 0 CA-C-N 121.823 1.687 . . . . 0.0 112.165 -7.971 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' F' F ' 56' ' ' SER . . . . . . . . . . . . . 13.6 m -117.84 135.03 23.22 Favored Pre-proline 0 CA--C 1.538 0.487 0 CA-C-O 118.515 -0.755 . . . . 0.0 109.599 174.809 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' F' F ' 57' ' ' PRO . . . . . . . . . . . . . 58.8 Cg_endo -73.18 162.01 92.69 Favored 'Cis proline' 0 N--CA 1.498 1.736 0 CA-C-N 121.898 1.714 . . . . 0.0 111.412 -2.656 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' F' F ' 58' ' ' LEU . . . . . . . . . . . . . 23.9 tp -130.88 139.64 50.13 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-O 121.003 0.43 . . . . 0.0 110.936 -179.673 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' F' F ' 59' ' ' ARG . . . . . . . . . . . . . 35.7 ttm180 -97.84 125.22 42.59 Favored 'General case' 0 C--N 1.327 -0.399 0 N-CA-C 109.087 -0.708 . . . . 0.0 109.087 173.052 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' F' F ' 60' ' ' VAL . . . . . . . . . . . . . 43.4 t -79.44 119.86 29.59 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.262 0 C-N-CA 120.599 -0.44 . . . . 0.0 110.426 -175.144 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' F' F ' 61' ' ' GLU . . . . . . . . . . . . . 95.2 mt-10 -131.08 169.93 15.21 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 115.792 -0.64 . . . . 0.0 109.742 176.592 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' F' F ' 62' ' ' ASP . . . . . . . . . . . . . 80.1 m-20 -52.8 -32.37 43.66 Favored 'General case' 0 C--N 1.329 -0.305 0 N-CA-C 111.948 0.351 . . . . 0.0 111.948 -178.417 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' F' F ' 63' ' ' ARG . . . . . . . . . . . . . 85.4 mtt180 -72.29 -22.06 61.26 Favored 'General case' 0 CA--C 1.533 0.308 0 N-CA-C 113.019 0.748 . . . . 0.0 113.019 -175.661 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' F' F ' 64' ' ' THR . . . . . . . . . . . . . 33.1 m -68.72 135.43 51.29 Favored 'General case' 0 C--N 1.331 -0.229 0 CA-C-O 120.995 0.426 . . . . 0.0 111.049 -175.099 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' F' F ' 65' ' ' LYS . . . . . . . . . . . . . 63.3 mttm -89.95 136.47 33.02 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 115.912 -0.585 . . . . 0.0 110.064 177.922 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' F' F ' 66' ' ' ILE . . . . . . . . . . . . . 60.1 mt -118.29 129.95 73.86 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.185 0 N-CA-C 109.851 -0.426 . . . . 0.0 109.851 179.06 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' F' F ' 67' ' ' THR . . . . . . . . . . . . . 24.2 m -124.88 142.26 51.57 Favored 'General case' 0 C--N 1.332 -0.186 0 CA-C-O 121.103 0.477 . . . . 0.0 110.9 -178.878 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' F' F ' 68' ' ' LEU . . . . . 0.478 HD23 ' C ' ' F' ' 68' ' ' LEU . 7.1 tt . . . . . 0 C--N 1.33 -0.24 0 CA-C-N 115.944 -0.571 . . . . 0.0 109.822 177.396 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' F' F ' 73' ' ' VAL . . . . . . . . . . . . . 33.1 m . . . . . 0 C--O 1.23 0.066 0 N-CA-C 110.112 -0.329 . . . . 0.0 110.112 . . . . . . . . . 0 0 . 1 . 017 nuclear nobuild core ' F' F ' 74' ' ' ASP . . . . . . . . . . . . . 14.4 t0 -92.85 117.49 30.08 Favored 'General case' 0 C--N 1.331 -0.227 0 C-N-CA 120.735 -0.386 . . . . 0.0 110.3 -173.729 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' F' F ' 75' ' ' VAL . . . . . . . . . . . . . 41.8 t -113.72 120.43 63.56 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.287 0 CA-C-O 121.101 0.477 . . . . 0.0 110.075 -179.785 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' F' F ' 76' ' ' LEU . . . . . . . . . . . . . 15.4 mt -125.17 144.17 50.58 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 115.728 -0.669 . . . . 0.0 109.686 178.129 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' F' F ' 77' ' ' GLU . . . . . . . . . . . . . 97.4 mt-10 -134.6 132.69 39.35 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-O 121.151 0.501 . . . . 0.0 110.981 -176.855 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' F' F ' 78' ' ' ALA . . . . . . . . . . . . . . . -116.33 127.29 54.56 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 115.658 -0.701 . . . . 0.0 109.719 177.309 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' F' F ' 79' ' ' LYS . . . . . 0.623 ' O ' HD13 ' F' ' 80' ' ' ILE . 52.5 mtmt -78.39 116.31 18.71 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-O 120.85 0.357 . . . . 0.0 110.691 -177.586 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' F' F ' 80' ' ' ILE . . . . . 0.623 HD13 ' O ' ' F' ' 79' ' ' LYS . 40.1 mm -139.14 106.25 2.83 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.295 0 N-CA-C 109.003 -0.74 . . . . 0.0 109.003 -177.313 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' F' F ' 81' ' ' LYS . . . . . . . . . . . . . 44.3 tptt -98.05 124.17 42.42 Favored 'General case' 0 C--N 1.328 -0.355 0 C-N-CA 120.788 -0.365 . . . . 0.0 110.806 -175.95 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' F' F ' 82' ' ' GLY . . . . . . . . . . . . . . . 89.09 42.24 5.66 Favored Glycine 0 CA--C 1.524 0.648 0 C-N-CA 120.756 -0.735 . . . . 0.0 111.798 175.423 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' F' F ' 83' ' ' ILE . . . . . . . . . . . . . 75.7 mt -66.45 141.09 18.45 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.286 0 N-CA-C 109.815 -0.439 . . . . 0.0 109.815 177.122 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' F' F ' 84' ' ' LYS . . . . . . . . . . . . . 41.6 tttp -95.4 -53.42 3.77 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 115.93 -0.577 . . . . 0.0 110.361 -178.775 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' F' F ' 85' ' ' ASP . . . . . . . . . . . . . 12.9 t70 -153.21 151.98 30.69 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 115.714 -0.675 . . . . 0.0 110.419 -179.711 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' F' F ' 86' ' ' VAL . . . . . . . . . . . . . 44.6 t -127.22 130.68 71.01 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.266 0 CA-C-O 120.951 0.405 . . . . 0.0 110.406 -179.113 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' F' F ' 87' ' ' ILE . . . . . 0.498 HD12 ' N ' ' F' ' 87' ' ' ILE . 5.0 mp -122.03 129.02 75.74 Favored 'Isoleucine or valine' 0 C--O 1.233 0.206 0 CA-C-N 115.932 -0.576 . . . . 0.0 109.604 176.954 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' F' F ' 88' ' ' LEU . . . . . . . . . . . . . 18.5 tp -112.32 128.36 56.26 Favored 'General case' 0 C--N 1.332 -0.183 0 CA-C-O 121.03 0.443 . . . . 0.0 110.983 -179.0 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' F' F ' 89' ' ' ASP . . . . . . . . . . . . . 6.5 t0 -117.28 152.1 35.56 Favored 'General case' 0 C--N 1.329 -0.3 0 N-CA-C 109.093 -0.706 . . . . 0.0 109.093 175.63 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' F' F ' 90' ' ' GLU . . . . . . . . . . . . . 84.3 tt0 -48.86 -30.57 5.96 Favored 'General case' 0 C--N 1.329 -0.299 0 N-CA-C 112.83 0.678 . . . . 0.0 112.83 -172.534 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' F' F ' 91' ' ' ASN . . . . . . . . . . . . . 7.3 m120 -130.55 15.78 5.43 Favored 'General case' 0 N--CA 1.468 0.468 0 N-CA-C 113.308 0.855 . . . . 0.0 113.308 -177.051 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' F' F ' 92' ' ' LEU . . . . . . . . . . . . . 55.7 mt -149.96 149.59 30.62 Favored 'General case' 0 C--N 1.332 -0.195 0 CA-C-N 117.964 0.347 . . . . 0.0 110.764 -176.396 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' F' F ' 93' ' ' ILE . . . . . . . . . . . . . 68.2 mt -122.16 119.63 59.01 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.244 0 N-CA-C 108.985 -0.746 . . . . 0.0 108.985 176.631 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' F' F ' 94' ' ' VAL . . . . . 0.452 HG21 HG21 ' F' ' 125' ' ' VAL . 47.6 t -120.67 127.31 75.91 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.254 0 CA-C-O 121.008 0.432 . . . . 0.0 110.016 -178.785 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' F' F ' 95' ' ' VAL . . . . . . . . . . . . . 40.4 t -122.87 134.84 64.84 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.342 0 CA-C-N 115.809 -0.632 . . . . 0.0 109.876 -179.754 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' F' F ' 96' ' ' ILE . . . . . 0.528 HD11 ' HB ' ' F' ' 123' ' ' VAL . 59.1 mt -114.48 125.65 71.83 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.379 0 N-CA-C 108.947 -0.76 . . . . 0.0 108.947 178.266 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' F' F ' 97' ' ' THR . . . . . . . . . . . . . 73.9 p -98.91 155.23 17.51 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-O 121.221 0.534 . . . . 0.0 111.438 -175.585 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' F' F ' 98' ' ' GLU . . . . . . . . . . . . . 22.1 pt-20 -54.26 -21.76 10.01 Favored 'General case' 0 CA--C 1.534 0.353 0 N-CA-C 112.568 0.581 . . . . 0.0 112.568 179.339 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' F' F ' 99' ' ' GLU . . . . . . . . . . . . . 34.7 tt0 -83.74 18.11 2.07 Favored 'General case' 0 CA--C 1.539 0.542 0 N-CA-C 112.394 0.516 . . . . 0.0 112.394 -177.548 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' F' F ' 100' ' ' ASN . . . . . . . . . . . . . 3.6 m-20 62.04 37.98 14.37 Favored 'General case' 0 C--O 1.232 0.183 0 CA-C-O 121.161 0.505 . . . . 0.0 111.029 177.247 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' F' F ' 101' ' ' GLU . . . . . . . . . . . . . 84.2 tt0 -118.13 143.36 46.55 Favored 'General case' 0 C--N 1.331 -0.219 0 CA-C-N 116.147 -0.479 . . . . 0.0 109.998 176.836 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' F' F ' 102' ' ' VAL . . . . . . . . . . . . . 44.8 t -114.9 125.54 72.25 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.345 0 N-CA-C 109.822 -0.436 . . . . 0.0 109.822 -179.268 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' F' F ' 103' ' ' LEU . . . . . . . . . . . . . 21.2 mt -118.79 129.45 55.25 Favored 'General case' 0 C--N 1.331 -0.223 0 CA-C-N 115.791 -0.64 . . . . 0.0 110.28 178.116 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' F' F ' 104' ' ' ILE . . . . . . . . . . . . . 67.4 mt -118.63 121.56 67.3 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.251 0 N-CA-C 109.974 -0.38 . . . . 0.0 109.974 178.575 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' F' F ' 105' ' ' PHE . . . . . . . . . . . . . 52.7 m-85 -120.74 163.59 17.88 Favored 'General case' 0 C--N 1.332 -0.176 0 O-C-N 123.978 0.799 . . . . 0.0 109.623 179.647 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' F' F ' 106' ' ' ASN . . . . . . . . . . . . . 48.7 p-10 -97.67 -173.45 2.63 Favored 'General case' 0 C--N 1.328 -0.34 0 N-CA-C 109.618 -0.512 . . . . 0.0 109.618 171.887 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' F' F ' 107' ' ' GLN . . . . . . . . . . . . . 47.2 tt0 -58.57 -26.56 63.72 Favored 'General case' 0 C--N 1.329 -0.317 0 N-CA-C 112.349 0.5 . . . . 0.0 112.349 -178.543 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' F' F ' 108' ' ' ASN . . . . . . . . . . . . . 8.3 t-20 -89.63 14.07 12.55 Favored 'General case' 0 CA--C 1.535 0.379 0 N-CA-C 112.96 0.726 . . . . 0.0 112.96 -176.725 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' F' F ' 109' ' ' LEU . . . . . . . . . . . . . 48.9 mt 57.56 38.98 28.08 Favored 'General case' 0 C--N 1.332 -0.154 0 CA-C-O 121.163 0.506 . . . . 0.0 111.504 178.01 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' F' F ' 110' ' ' GLU . . . . . . . . . . . . . 95.9 mt-10 -104.05 161.03 14.34 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.076 -0.511 . . . . 0.0 109.958 176.466 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' F' F ' 111' ' ' GLU . . . . . . . . . . . . . 84.6 tt0 -89.64 122.33 32.67 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-O 120.905 0.383 . . . . 0.0 110.922 -177.869 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' F' F ' 112' ' ' LEU . . . . . . . . . . . . . 14.0 mt -112.1 -46.04 3.24 Favored 'General case' 0 C--N 1.332 -0.195 0 CA-C-N 116.071 -0.513 . . . . 0.0 110.419 178.029 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' F' F ' 113' ' ' TYR . . . . . . . . . . . . . 54.3 t80 -140.84 134.61 30.37 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.286 -0.416 . . . . 0.0 110.921 179.85 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' F' F ' 114' ' ' ARG . . . . . . . . . . . . . 43.4 ttp180 -141.71 122.49 14.37 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.489 -0.323 . . . . 0.0 110.479 177.782 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' F' F ' 115' ' ' GLY . . . . . . . . . . . . . . . -150.16 146.94 16.6 Favored Glycine 0 CA--C 1.526 0.72 0 N-CA-C 111.193 -0.763 . . . . 0.0 111.193 178.998 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' F' F ' 116' ' ' LYS . . . . . . . . . . . . . 33.2 ttpt -115.2 133.76 55.75 Favored 'General case' 0 C--N 1.33 -0.24 0 N-CA-C 109.776 -0.453 . . . . 0.0 109.776 176.228 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' F' F ' 117' ' ' PHE . . . . . . . . . . . . . 52.3 m-85 -131.77 114.59 14.92 Favored 'General case' 0 C--N 1.332 -0.184 0 CA-C-O 120.924 0.392 . . . . 0.0 110.279 -176.298 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' F' F ' 118' ' ' GLU . . . . . . . . . . . . . 84.4 tt0 -54.26 -45.39 72.4 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.443 -0.344 . . . . 0.0 111.539 -176.015 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' F' F ' 119' ' ' ASN . . . . . . . . . . . . . 9.2 m120 -97.54 30.94 2.7 Favored 'General case' 0 C--N 1.33 -0.281 0 N-CA-C 112.178 0.436 . . . . 0.0 112.178 -174.934 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' F' F ' 120' ' ' LEU . . . . . . . . . . . . . 23.9 tp -58.01 126.95 29.68 Favored 'General case' 0 C--N 1.333 -0.148 0 CA-C-O 120.76 0.314 . . . . 0.0 110.304 178.411 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' F' F ' 121' ' ' ASN . . . . . . . . . . . . . 20.8 t-20 -109.77 -44.0 3.92 Favored 'General case' 0 C--N 1.332 -0.181 0 CA-C-N 116.376 -0.374 . . . . 0.0 110.946 -177.987 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' F' F ' 122' ' ' LYS . . . . . . . . . . . . . 18.8 ptpt -161.29 159.72 28.91 Favored 'General case' 0 C--N 1.333 -0.136 0 CA-C-O 121.141 0.496 . . . . 0.0 111.82 -179.33 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' F' F ' 123' ' ' VAL . . . . . 0.528 ' HB ' HD11 ' F' ' 96' ' ' ILE . 45.8 t -127.27 135.59 63.02 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.199 0 CA-C-N 115.867 -0.606 . . . . 0.0 109.749 177.15 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' F' F ' 124' ' ' LEU . . . . . . . . . . . . . 6.5 mp -118.53 130.41 55.9 Favored 'General case' 0 C--N 1.331 -0.22 0 CA-C-N 116.37 -0.377 . . . . 0.0 110.636 -179.22 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' F' F ' 125' ' ' VAL . . . . . 0.568 HG22 HG23 ' F' ' 130' ' ' VAL . 44.6 t -131.69 127.71 59.4 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.236 0 CA-C-N 116.331 -0.395 . . . . 0.0 110.17 179.371 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' F' F ' 126' ' ' ARG . . . . . . . . . . . . . 78.7 mtt180 -149.98 133.63 16.72 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-O 120.95 0.405 . . . . 0.0 110.889 177.154 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' F' F ' 127' ' ' ASN . . . . . . . . . . . . . 9.4 m120 52.48 -118.28 1.29 Allowed 'General case' 0 CA--C 1.545 0.77 0 CA-C-O 118.657 -0.687 . . . . 0.0 110.798 178.826 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' F' F ' 128' ' ' ASP . . . . . . . . . . . . . 8.2 p-10 -113.26 13.55 19.17 Favored 'General case' 0 N--CA 1.469 0.477 0 CA-C-N 120.107 1.321 . . . . 0.0 112.838 -179.624 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' F' F ' 129' ' ' LEU . . . . . . . . . . . . . 13.5 tp -116.26 139.2 50.62 Favored 'General case' 0 C--O 1.233 0.187 0 N-CA-C 109.832 -0.433 . . . . 0.0 109.832 179.121 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' F' F ' 130' ' ' VAL . . . . . 0.568 HG23 HG22 ' F' ' 125' ' ' VAL . 13.0 p -134.06 141.22 44.44 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.196 0 CA-C-O 121.1 0.476 . . . . 0.0 110.554 -179.326 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' F' F ' 131' ' ' VAL . . . . . . . . . . . . . 35.3 m -136.06 147.45 28.16 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.362 0 CA-C-N 115.963 -0.562 . . . . 0.0 110.801 179.212 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' F' F ' 132' ' ' ILE . . . . . . . . . . . . . 71.0 mt -118.43 131.05 72.33 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.373 0 CA-C-N 115.736 -0.665 . . . . 0.0 109.285 -179.873 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' F' F ' 133' ' ' ILE . . . . . . . . . . . . . 43.4 mm -115.6 121.81 68.08 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.241 0 CA-C-O 120.753 0.311 . . . . 0.0 110.708 -175.979 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' F' F ' 134' ' ' ASP . . . . . . . . . . . . . 7.6 p-10 -133.88 149.15 51.32 Favored 'General case' 0 C--N 1.331 -0.212 0 N-CA-C 109.586 -0.524 . . . . 0.0 109.586 174.562 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' F' F ' 135' ' ' GLU . . . . . . . . . . . . . 84.9 tt0 -49.84 -24.33 2.38 Favored 'General case' 0 C--N 1.326 -0.423 0 N-CA-C 112.949 0.722 . . . . 0.0 112.949 -170.869 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' F' F ' 136' ' ' GLN . . . . . . . . . . . . . 48.5 tt0 -104.68 -25.57 12.65 Favored 'General case' 0 N--CA 1.465 0.297 0 N-CA-C 112.846 0.684 . . . . 0.0 112.846 -174.484 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' F' F ' 137' ' ' LYS . . . . . . . . . . . . . 88.5 mttt -141.62 151.72 43.36 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-O 121.169 0.509 . . . . 0.0 111.777 -171.23 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' F' F ' 138' ' ' LEU . . . . . . . . . . . . . 5.0 tt -120.04 120.27 35.81 Favored 'General case' 0 C--N 1.329 -0.29 0 N-CA-C 109.151 -0.685 . . . . 0.0 109.151 172.502 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' F' F ' 139' ' ' THR . . . . . . . . . . . . . 40.6 m -110.92 131.15 55.29 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.416 -0.356 . . . . 0.0 110.792 -176.956 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' F' F ' 140' ' ' LEU . . . . . 0.485 HD23 ' C ' ' F' ' 140' ' ' LEU . 8.0 tt -116.26 123.77 48.53 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 115.769 -0.651 . . . . 0.0 109.309 -179.671 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' F' F ' 141' ' ' ILE . . . . . 0.566 ' HB ' HG13 ' F' ' 130' ' ' VAL . 19.2 mt -122.54 121.1 62.77 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.295 0 CA-C-O 121.08 0.467 . . . . 0.0 110.072 -175.811 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' F' F ' 142' ' ' ARG . . . . . . . . . . . . . 65.8 ttt180 -109.98 129.23 55.7 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 115.318 -0.855 . . . . 0.0 110.364 -178.992 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' F' F ' 143' ' ' THR . . . . . . . . . . . . . 81.3 p . . . . . 0 C--O 1.219 -0.505 0 CA-C-O 117.915 -1.04 . . . . 0.0 110.484 178.927 . . . . . . . . 0 0 . 1 . 018 nuclear nobuild core ' A' A ' 2' ' ' SER . . . . . 0.415 ' HB2' HD11 ' A' ' 58' ' ' LEU . 79.0 p . . . . . 0 N--CA 1.462 0.126 0 CA-C-O 120.936 0.398 . . . . 0.0 110.625 . . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 44.5 mp0 -138.2 141.26 40.01 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.098 -0.501 . . . . 0.0 110.882 -178.523 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 4' ' ' LEU . . . . . . . . . . . . . 15.1 tp -126.77 131.05 51.38 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 115.939 -0.573 . . . . 0.0 110.077 177.274 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 5' ' ' LYS . . . . . . . . . . . . . 68.9 mttm -114.04 121.52 44.12 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-O 120.901 0.381 . . . . 0.0 110.923 -179.164 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 6' ' ' LEU . . . . . 0.433 HD23 ' HA ' ' A' ' 50' ' ' VAL . 63.7 mt -115.45 141.05 48.57 Favored 'General case' 0 C--N 1.331 -0.227 0 CA-C-N 115.237 -0.892 . . . . 0.0 110.046 179.686 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 86.3 tttt -121.0 136.87 25.95 Favored Pre-proline 0 CA--C 1.533 0.308 0 CA-C-O 118.867 -0.587 . . . . 0.0 109.751 177.032 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 8' ' ' PRO . . . . . . . . . . . . . 93.0 Cg_endo -89.03 131.91 2.25 Favored 'Trans proline' 0 N--CA 1.491 1.327 0 C-N-CA 121.699 1.599 . . . . 0.0 111.921 179.088 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 57.1 mt -70.95 -47.91 14.57 Favored Pre-proline 0 CA--C 1.533 0.321 0 CA-C-O 118.575 -0.726 . . . . 0.0 112.211 -179.985 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 71.5 Cg_endo -77.77 153.13 29.5 Favored 'Trans proline' 0 N--CA 1.496 1.626 0 C-N-CA 121.14 1.227 . . . . 0.0 111.913 176.528 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 58.7 tttm -87.18 89.71 8.09 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-O 120.842 0.353 . . . . 0.0 110.266 179.634 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 12.1 p -139.34 148.01 23.93 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.245 0 CA-C-N 116.231 -0.441 . . . . 0.0 110.707 -178.072 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 95.6 mt-10 -90.89 128.53 36.79 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.141 -0.481 . . . . 0.0 110.026 177.248 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 14' ' ' LEU . . . . . . . . . . . . . 24.0 mt -98.0 152.55 38.11 Favored Pre-proline 0 CA--C 1.532 0.267 0 CA-C-O 119.512 -0.28 . . . . 0.0 110.801 -178.586 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 15' ' ' PRO . . . . . . . . . . . . . 25.5 Cg_exo -62.09 159.06 36.07 Favored 'Trans proline' 0 N--CA 1.497 1.727 0 C-N-CA 121.281 1.321 . . . . 0.0 112.165 177.513 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 16' ' ' PRO . . . . . . . . . . . . . 37.5 Cg_exo -58.35 -45.02 33.37 Favored 'Trans proline' 0 N--CA 1.498 1.792 0 C-N-CA 121.437 1.425 . . . . 0.0 112.866 -178.863 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 17' ' ' ASP . . . . . . . . . . . . . 19.8 p-10 -85.32 12.9 7.28 Favored 'General case' 0 C--N 1.326 -0.435 0 N-CA-C 113.14 0.793 . . . . 0.0 113.14 -177.016 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 18' ' ' PHE . . . . . . . . . . . . . 42.6 t80 -58.36 -46.79 85.61 Favored 'General case' 0 CA--C 1.523 -0.078 0 O-C-N 122.096 -0.378 . . . . 0.0 110.162 -177.963 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 19' ' ' VAL . . . . . . . . . . . . . 14.0 p -55.92 -40.23 61.43 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.347 0 CA-C-N 116.227 -0.442 . . . . 0.0 111.104 -178.345 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 78.3 m-20 -61.15 -45.18 95.69 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-O 120.783 0.325 . . . . 0.0 111.093 -177.977 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 60.7 t -64.66 -47.02 90.6 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 C-N-CA 120.781 -0.368 . . . . 0.0 110.591 -177.919 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 22' ' ' ILE . . . . . 0.53 HG22 HD12 ' A' ' 26' ' ' LEU . 50.5 mm -56.89 -43.35 80.18 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.189 0 C-N-CA 120.829 -0.348 . . . . 0.0 110.483 179.142 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 23' ' ' ARG . . . . . . . . . . . . . 43.2 ttp180 -54.71 -49.38 70.86 Favored 'General case' 0 C--N 1.33 -0.257 0 C-N-CA 121.143 -0.223 . . . . 0.0 111.309 -178.727 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 24' ' ' ILE . . . . . . . . . . . . . 73.2 mt -59.25 -39.84 79.78 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.244 0 C-N-CA 120.869 -0.332 . . . . 0.0 110.751 -178.699 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 8.3 mtpm? -66.05 -41.82 90.33 Favored 'General case' 0 C--N 1.327 -0.385 0 N-CA-C 112.276 0.473 . . . . 0.0 112.276 -179.253 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 26' ' ' LEU . . . . . 0.53 HD12 HG22 ' A' ' 22' ' ' ILE . 67.0 mt -80.75 -36.07 32.46 Favored 'General case' 0 C--N 1.331 -0.228 0 N-CA-C 113.881 1.067 . . . . 0.0 113.881 -171.134 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 27' ' ' GLN . . . . . . . . . . . . . 8.9 pt20 -46.85 141.49 3.97 Favored 'General case' 0 N--CA 1.47 0.527 0 N-CA-C 112.81 0.67 . . . . 0.0 112.81 -175.17 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 98.64 -24.21 33.07 Favored Glycine 0 CA--C 1.533 1.201 0 CA-C-N 115.673 -0.694 . . . . 0.0 112.354 -176.886 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 60.5 mttp -98.07 155.22 17.23 Favored 'General case' 0 C--O 1.232 0.16 0 CA-C-N 117.45 0.625 . . . . 0.0 110.901 179.167 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 30' ' ' THR . . . . . . . . . . . . . 30.9 m -104.51 136.71 43.56 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.161 -0.472 . . . . 0.0 109.88 176.25 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 33.9 m -129.27 152.51 37.35 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.194 0 CA-C-O 120.987 0.423 . . . . 0.0 110.975 -178.683 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 32' ' ' ARG . . . . . . . . . . . . . 94.2 mtt180 -129.34 152.3 49.05 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-O 121.32 0.581 . . . . 0.0 110.614 179.943 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 33' ' ' THR . . . . . . . . . . . . . 21.4 m -53.63 139.75 31.01 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-N 116.162 -0.472 . . . . 0.0 111.202 -179.297 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 98.62 -17.09 58.88 Favored Glycine 0 CA--C 1.534 1.263 0 C-N-CA 121.106 -0.569 . . . . 0.0 113.269 178.844 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 58.7 m-20 -64.14 149.7 47.18 Favored 'General case' 0 C--O 1.231 0.11 0 CA-C-N 117.997 0.898 . . . . 0.0 111.369 -179.609 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 45.6 t -119.46 126.55 75.44 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.288 0 CA-C-N 115.458 -0.792 . . . . 0.0 109.538 177.896 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 37' ' ' ILE . . . . . . . . . . . . . 69.4 mt -120.71 138.34 51.52 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.226 0 CA-C-N 116.397 -0.365 . . . . 0.0 110.05 -179.072 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . -118.67 128.77 7.84 Favored Glycine 0 CA--C 1.525 0.66 0 N-CA-C 110.98 -0.848 . . . . 0.0 110.98 179.467 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 39' ' ' ILE . . . . . . . . . . . . . 70.8 mt -123.21 134.58 65.8 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.184 0 N-CA-C 109.938 -0.393 . . . . 0.0 109.938 178.228 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 40' ' ' SER . . . . . . . . . . . . . 23.2 t -91.49 120.54 32.4 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 116.272 -0.422 . . . . 0.0 111.04 178.72 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 41' ' ' ILE . . . . . . . . . . . . . 71.4 mt -127.5 116.38 43.39 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.234 0 CA-C-N 116.41 -0.359 . . . . 0.0 110.16 177.392 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 42' ' ' LEU . . . . . 0.532 ' O ' HD23 ' A' ' 42' ' ' LEU . 1.3 tt 49.58 47.65 22.41 Favored 'General case' 0 CA--C 1.533 0.311 0 CA-C-O 121.468 0.652 . . . . 0.0 111.43 177.166 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . 71.24 21.73 78.51 Favored Glycine 0 CA--C 1.532 1.094 0 C-N-CA 121.102 -0.571 . . . . 0.0 112.862 174.632 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 44' ' ' LYS . . . . . . . . . . . . . 85.3 tttt -135.14 126.43 28.3 Favored 'General case' 0 C--N 1.331 -0.222 0 CA-C-N 117.636 0.718 . . . . 0.0 109.881 178.959 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 84.9 tt0 -84.72 125.82 32.86 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.485 -0.325 . . . . 0.0 111.176 -178.682 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 46' ' ' VAL . . . . . 0.425 HG13 ' O ' ' A' ' 46' ' ' VAL . 10.3 p -113.34 123.25 68.8 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.252 0 N-CA-C 109.144 -0.687 . . . . 0.0 109.144 174.072 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 88.6 mttt -98.98 122.94 42.9 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 115.92 -0.582 . . . . 0.0 110.857 179.726 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 48' ' ' PHE . . . . . . . . . . . . . 31.0 m-85 -108.76 131.87 54.53 Favored 'General case' 0 C--N 1.329 -0.3 0 N-CA-C 109.71 -0.478 . . . . 0.0 109.71 176.924 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 76.6 tttt -106.57 130.62 54.3 Favored 'General case' 0 C--N 1.328 -0.33 0 N-CA-C 109.964 -0.384 . . . . 0.0 109.964 178.239 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 50' ' ' VAL . . . . . 0.433 ' HA ' HD23 ' A' ' 6' ' ' LEU . 45.5 t -74.82 105.29 3.75 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.305 0 N-CA-C 109.366 -0.605 . . . . 0.0 109.366 178.433 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 51' ' ' VAL . . . . . . . . . . . . . 48.2 t -70.35 -54.01 20.42 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.303 0 N-CA-C 109.475 -0.565 . . . . 0.0 109.475 -175.916 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 52' ' ' GLN . . . . . . . . . . . . . 89.9 mt-30 -153.73 150.15 28.23 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 115.856 -0.611 . . . . 0.0 111.79 -178.129 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -127.21 131.57 50.61 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 115.041 -0.981 . . . . 0.0 109.524 173.5 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 54' ' ' TYR . . . . . . . . . . . . . 14.5 t80 -129.06 110.24 18.25 Favored Pre-proline 0 C--N 1.329 -0.304 0 CA-C-O 118.198 -0.906 . . . . 0.0 110.234 177.453 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 55' ' ' PRO . . . . . . . . . . . . . 75.4 Cg_endo -77.31 170.22 71.94 Favored 'Cis proline' 0 N--CA 1.5 1.861 0 CA-C-N 121.958 1.735 . . . . 0.0 112.492 -5.927 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 56' ' ' SER . . . . . . . . . . . . . 14.1 m -123.91 138.9 31.34 Favored Pre-proline 0 CA--C 1.537 0.462 0 CA-C-O 118.499 -0.762 . . . . 0.0 109.401 173.532 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 57' ' ' PRO . . . . . . . . . . . . . 39.3 Cg_endo -67.67 144.28 71.07 Favored 'Cis proline' 0 N--CA 1.499 1.797 0 CA-C-N 121.695 1.641 . . . . 0.0 111.61 -2.627 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 58' ' ' LEU . . . . . 0.415 HD11 ' HB2' ' A' ' 2' ' ' SER . 15.7 tp -107.16 136.92 46.17 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-O 120.934 0.397 . . . . 0.0 110.629 -176.841 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 59' ' ' ARG . . . . . . . . . . . . . 56.5 ttp180 -103.73 124.9 49.73 Favored 'General case' 0 C--N 1.327 -0.378 0 N-CA-C 109.272 -0.64 . . . . 0.0 109.272 176.229 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 43.9 t -77.87 116.42 21.39 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 C-N-CA 120.73 -0.388 . . . . 0.0 110.745 -173.306 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 95.2 mt-10 -131.02 161.1 32.72 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 115.699 -0.682 . . . . 0.0 109.531 175.028 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 62' ' ' ASP . . . . . . . . . . . . . 70.0 m-20 -52.36 -31.67 34.77 Favored 'General case' 0 C--N 1.328 -0.349 0 N-CA-C 112.179 0.437 . . . . 0.0 112.179 -178.001 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 63' ' ' ARG . . . . . . . . . . . . . 87.5 mtt180 -70.92 -22.07 62.29 Favored 'General case' 0 CA--C 1.533 0.301 0 N-CA-C 113.038 0.755 . . . . 0.0 113.038 -174.942 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 27.8 m -68.43 137.16 54.28 Favored 'General case' 0 C--N 1.332 -0.188 0 CA-C-O 120.925 0.393 . . . . 0.0 111.061 -175.482 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 65' ' ' LYS . . . . . . . . . . . . . 90.5 mttt -88.92 127.62 35.66 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 115.984 -0.553 . . . . 0.0 109.772 177.832 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 66' ' ' ILE . . . . . . . . . . . . . 65.4 mt -118.06 130.24 73.22 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.278 0 CA-C-O 120.773 0.32 . . . . 0.0 110.236 -177.502 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 67' ' ' THR . . . . . . . . . . . . . 31.4 m -125.55 139.82 53.27 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-O 121.064 0.459 . . . . 0.0 110.967 -178.844 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 68' ' ' LEU . . . . . 0.499 ' N ' HD12 ' A' ' 68' ' ' LEU . 7.1 mp . . . . . 0 C--N 1.331 -0.211 0 CA-C-N 115.941 -0.572 . . . . 0.0 110.442 177.264 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 74' ' ' ASP . . . . . . . . . . . . . 31.6 t0 . . . . . 0 C--O 1.23 0.058 0 N-CA-C 109.717 -0.475 . . . . 0.0 109.717 . . . . . . . . . 0 0 . 1 . 018 nuclear nobuild core ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 40.9 t -114.74 123.87 70.84 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.249 0 CA-C-O 121.083 0.468 . . . . 0.0 110.776 -177.253 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 76' ' ' LEU . . . . . . . . . . . . . 5.5 mp -120.96 144.35 48.53 Favored 'General case' 0 C--N 1.331 -0.226 0 CA-C-N 115.667 -0.697 . . . . 0.0 109.59 175.185 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 77' ' ' GLU . . . . . . . . . . . . . 97.8 mt-10 -133.96 138.01 45.19 Favored 'General case' 0 C--N 1.331 -0.213 0 CA-C-O 121.112 0.482 . . . . 0.0 111.445 -178.95 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 78' ' ' ALA . . . . . . . . . . . . . . . -127.12 142.05 51.61 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 115.579 -0.737 . . . . 0.0 109.745 177.314 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 79' ' ' LYS . . . . . 0.645 ' O ' HD13 ' A' ' 80' ' ' ILE . 47.3 pttt -85.79 120.78 27.58 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-O 121.23 0.538 . . . . 0.0 110.967 -178.218 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 80' ' ' ILE . . . . . 0.645 HD13 ' O ' ' A' ' 79' ' ' LYS . 37.0 mm -139.2 114.9 8.9 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.312 0 CA-C-N 115.768 -0.651 . . . . 0.0 109.411 -179.159 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 81' ' ' LYS . . . . . . . . . . . . . 97.7 mttt -107.4 126.96 53.14 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-O 120.804 0.335 . . . . 0.0 111.011 -179.178 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . 89.05 42.17 5.69 Favored Glycine 0 CA--C 1.525 0.683 0 C-N-CA 120.845 -0.693 . . . . 0.0 111.65 175.526 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 83' ' ' ILE . . . . . . . . . . . . . 69.7 mt -69.91 138.2 22.56 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.309 0 CA-C-O 120.901 0.381 . . . . 0.0 110.042 178.514 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 84' ' ' LYS . . . . . . . . . . . . . 63.4 tttm -94.5 -54.05 3.67 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-N 115.945 -0.57 . . . . 0.0 110.07 -179.104 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 85' ' ' ASP . . . . . . . . . . . . . 7.2 t70 -158.01 154.95 28.52 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 115.652 -0.704 . . . . 0.0 110.412 -179.969 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 86' ' ' VAL . . . . . . . . . . . . . 40.0 t -131.94 132.32 61.5 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.259 0 CA-C-O 120.914 0.388 . . . . 0.0 110.576 179.473 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 87' ' ' ILE . . . . . 0.493 HD12 ' N ' ' A' ' 87' ' ' ILE . 5.1 mp -118.9 128.37 75.73 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.281 0 CA-C-N 115.816 -0.629 . . . . 0.0 109.414 176.044 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 88' ' ' LEU . . . . . . . . . . . . . 16.9 tp -110.95 134.6 52.45 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-O 121.138 0.494 . . . . 0.0 111.414 -176.234 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 89' ' ' ASP . . . . . . . . . . . . . 12.9 t70 -127.14 149.75 49.81 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 115.602 -0.727 . . . . 0.0 109.36 175.129 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 83.6 tt0 -48.89 -32.57 9.15 Favored 'General case' 0 C--N 1.33 -0.264 0 N-CA-C 112.606 0.595 . . . . 0.0 112.606 -173.357 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 91' ' ' ASN . . . . . . . . . . . . . 79.2 m-20 -131.18 29.67 4.62 Favored 'General case' 0 N--CA 1.465 0.316 0 N-CA-C 112.216 0.45 . . . . 0.0 112.216 -176.368 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 92' ' ' LEU . . . . . . . . . . . . . 8.1 tp -166.21 148.83 7.07 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-O 120.784 0.326 . . . . 0.0 110.602 179.299 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 93' ' ' ILE . . . . . . . . . . . . . 69.9 mt -126.74 122.99 61.92 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.277 0 N-CA-C 109.487 -0.56 . . . . 0.0 109.487 178.931 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 94' ' ' VAL . . . . . . . . . . . . . 42.8 t -121.27 127.6 75.81 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.265 0 N-CA-C 110.084 -0.339 . . . . 0.0 110.084 -179.442 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 95' ' ' VAL . . . . . . . . . . . . . 43.4 t -125.66 136.0 62.19 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.239 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.228 -179.294 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 96' ' ' ILE . . . . . . . . . . . . . 51.6 mt -115.86 129.42 72.25 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 N-CA-C 109.112 -0.699 . . . . 0.0 109.112 178.495 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 97' ' ' THR . . . . . . . . . . . . . 81.7 p -101.21 159.06 15.57 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-O 121.105 0.479 . . . . 0.0 111.16 -178.024 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 98' ' ' GLU . . . . . . . . . . . . . 84.8 tt0 -53.85 -28.37 35.47 Favored 'General case' 0 CA--C 1.533 0.312 0 CA-C-N 116.208 -0.451 . . . . 0.0 112.152 -178.797 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 99' ' ' GLU . . . . . . . . . . . . . 96.0 mt-10 -79.04 14.61 1.35 Allowed 'General case' 0 CA--C 1.535 0.375 0 N-CA-C 113.22 0.822 . . . . 0.0 113.22 -176.316 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 100' ' ' ASN . . . . . . . . . . . . . 3.3 m-20 61.54 33.23 18.51 Favored 'General case' 0 N--CA 1.464 0.24 0 CA-C-N 118.067 0.394 . . . . 0.0 111.639 -179.833 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 101' ' ' GLU . . . . . . . . . . . . . 84.9 tt0 -107.61 144.2 34.99 Favored 'General case' 0 C--O 1.232 0.143 0 N-CA-C 109.607 -0.516 . . . . 0.0 109.607 173.08 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 102' ' ' VAL . . . . . . . . . . . . . 42.7 t -114.93 126.07 72.41 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.304 0 CA-C-N 116.294 -0.412 . . . . 0.0 110.009 -177.627 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 103' ' ' LEU . . . . . . . . . . . . . 21.2 mt -115.72 129.7 56.57 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 115.79 -0.641 . . . . 0.0 109.889 177.324 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 104' ' ' ILE . . . . . 0.612 HD13 HG11 ' A' ' 130' ' ' VAL . 68.3 mt -118.49 121.51 67.24 Favored 'Isoleucine or valine' 0 C--O 1.235 0.297 0 N-CA-C 110.13 -0.322 . . . . 0.0 110.13 179.274 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 105' ' ' PHE . . . . . . . . . . . . . 78.3 m-85 -118.92 164.47 15.4 Favored 'General case' 0 C--N 1.333 -0.126 0 O-C-N 124.129 0.893 . . . . 0.0 109.757 -179.499 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 106' ' ' ASN . . . . . . . . . . . . . 42.3 p-10 -101.66 -170.83 1.88 Allowed 'General case' 0 C--N 1.331 -0.221 0 N-CA-C 110.039 -0.356 . . . . 0.0 110.039 173.54 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 107' ' ' GLN . . . . . . . . . . . . . 59.4 tt0 -57.67 -28.69 64.0 Favored 'General case' 0 CA--C 1.534 0.341 0 N-CA-C 111.894 0.331 . . . . 0.0 111.894 177.243 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 108' ' ' ASN . . . . . . . . . . . . . 50.1 t30 -82.94 3.28 30.61 Favored 'General case' 0 CA--C 1.536 0.415 0 N-CA-C 113.353 0.872 . . . . 0.0 113.353 -176.447 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 109' ' ' LEU . . . . . . . . . . . . . 11.5 tp 62.66 39.6 11.09 Favored 'General case' 0 CA--C 1.529 0.172 0 CA-C-O 121.115 0.483 . . . . 0.0 111.051 178.378 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 110' ' ' GLU . . . . . . . . . . . . . 95.5 mt-10 -114.28 150.32 34.61 Favored 'General case' 0 C--N 1.331 -0.198 0 CA-C-N 116.366 -0.379 . . . . 0.0 110.278 176.31 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 111' ' ' GLU . . . . . . . . . . . . . 45.6 mt-10 -76.07 123.62 26.08 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 116.359 -0.382 . . . . 0.0 110.894 -179.739 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 112' ' ' LEU . . . . . . . . . . . . . 16.3 mt -110.04 -46.05 3.52 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.142 -0.481 . . . . 0.0 110.178 176.665 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 113' ' ' TYR . . . . . . . . . . . . . 41.0 t80 -134.79 136.73 42.77 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.235 -0.439 . . . . 0.0 110.659 -179.682 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 114' ' ' ARG . . . . . . . . . . . . . 65.8 ttp85 -141.37 123.25 15.36 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.406 -0.361 . . . . 0.0 110.569 178.014 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 115' ' ' GLY . . . . . . . . . . . . . . . -150.14 163.04 29.39 Favored Glycine 0 CA--C 1.523 0.556 0 N-CA-C 111.054 -0.819 . . . . 0.0 111.054 -179.192 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 116' ' ' LYS . . . . . . . . . . . . . 57.1 tttm -131.56 136.63 47.98 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-O 120.781 0.324 . . . . 0.0 110.188 178.656 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 117' ' ' PHE . . . . . . . . . . . . . 36.2 m-85 -136.34 115.58 12.55 Favored 'General case' 0 C--N 1.331 -0.209 0 CA-C-N 116.245 -0.434 . . . . 0.0 110.283 -176.062 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 118' ' ' GLU . . . . . . . . . . . . . 45.4 mp0 -56.48 -44.46 80.64 Favored 'General case' 0 C--N 1.327 -0.381 0 C-N-CA 120.781 -0.368 . . . . 0.0 111.098 -175.194 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 119' ' ' ASN . . . . . . . . . . . . . 11.4 m120 -98.01 30.97 2.85 Favored 'General case' 0 C--N 1.33 -0.259 0 N-CA-C 112.194 0.442 . . . . 0.0 112.194 -174.011 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 120' ' ' LEU . . . . . . . . . . . . . 21.9 tp -57.64 123.29 15.11 Favored 'General case' 0 C--N 1.332 -0.163 0 C-N-CA 120.854 -0.338 . . . . 0.0 110.379 177.941 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 121' ' ' ASN . . . . . . . . . . . . . 34.6 m120 -114.09 -44.08 3.18 Favored 'General case' 0 C--O 1.233 0.191 0 CA-C-N 116.548 -0.296 . . . . 0.0 111.002 -177.561 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 122' ' ' LYS . . . . . . . . . . . . . 98.3 mttt -144.49 149.16 35.49 Favored 'General case' 0 C--N 1.331 -0.198 0 CA-C-O 121.152 0.501 . . . . 0.0 111.621 -176.365 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 123' ' ' VAL . . . . . . . . . . . . . 47.3 t -129.67 128.55 65.77 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.276 0 CA-C-N 115.733 -0.667 . . . . 0.0 109.538 175.952 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 124' ' ' LEU . . . . . . . . . . . . . 75.0 mt -119.72 134.83 55.08 Favored 'General case' 0 C--N 1.331 -0.219 0 CA-C-N 116.48 -0.327 . . . . 0.0 110.443 -178.213 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 125' ' ' VAL . . . . . . . . . . . . . 12.4 p -140.13 130.93 30.6 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.223 0 CA-C-O 120.878 0.37 . . . . 0.0 110.97 -179.76 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 126' ' ' ARG . . . . . . . . . . . . . 72.8 mtt180 -152.55 134.1 14.53 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 115.822 -0.626 . . . . 0.0 109.674 175.848 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 127' ' ' ASN . . . . . . . . . . . . . 31.5 m120 55.74 -147.77 0.51 Allowed 'General case' 0 CA--C 1.542 0.647 0 N-CA-C 109.729 -0.471 . . . . 0.0 109.729 -178.855 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 128' ' ' ASP . . . . . . . . . . . . . 9.3 p-10 -87.23 14.62 7.45 Favored 'General case' 0 CA--C 1.536 0.409 0 CA-C-N 118.809 0.732 . . . . 0.0 112.934 178.641 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 129' ' ' LEU . . . . . . . . . . . . . 80.5 mt -110.89 138.21 47.57 Favored 'General case' 0 C--O 1.233 0.216 0 O-C-N 121.974 -0.454 . . . . 0.0 110.273 179.575 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 130' ' ' VAL . . . . . 0.612 HG11 HD13 ' A' ' 104' ' ' ILE . 14.4 p -134.03 142.14 41.97 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.176 0 CA-C-O 121.177 0.513 . . . . 0.0 110.847 -178.937 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 131' ' ' VAL . . . . . 0.558 HG22 HD12 ' A' ' 140' ' ' LEU . 44.5 t -135.76 138.51 47.7 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.228 0 CA-C-N 115.876 -0.602 . . . . 0.0 110.243 -178.923 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 132' ' ' ILE . . . . . . . . . . . . . 72.6 mt -115.87 132.39 65.48 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.298 0 CA-C-N 115.948 -0.569 . . . . 0.0 109.488 -179.856 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 133' ' ' ILE . . . . . . . . . . . . . 39.0 mm -116.9 117.37 55.18 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.21 0 CA-C-N 116.5 -0.318 . . . . 0.0 110.624 -176.333 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 134' ' ' ASP . . . . . . . . . . . . . 7.2 p-10 -128.63 151.43 49.5 Favored 'General case' 0 C--N 1.331 -0.204 0 N-CA-C 109.629 -0.508 . . . . 0.0 109.629 175.252 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 135' ' ' GLU . . . . . . . . . . . . . 45.8 tp10 -49.92 -28.16 6.31 Favored 'General case' 0 C--N 1.327 -0.398 0 N-CA-C 112.748 0.647 . . . . 0.0 112.748 -171.056 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 136' ' ' GLN . . . . . . . . . . . . . 76.9 mt-30 -103.45 -22.95 13.58 Favored 'General case' 0 N--CA 1.464 0.254 0 N-CA-C 113.144 0.794 . . . . 0.0 113.144 -173.874 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 137' ' ' LYS . . . . . . . . . . . . . 94.9 mttt -141.93 147.19 36.65 Favored 'General case' 0 C--N 1.331 -0.224 0 CA-C-O 121.376 0.608 . . . . 0.0 112.007 -168.695 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 138' ' ' LEU . . . . . . . . . . . . . 10.5 tp -111.66 118.3 35.29 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 115.193 -0.912 . . . . 0.0 108.863 172.326 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 139' ' ' THR . . . . . . . . . . . . . 24.9 m -111.98 125.61 54.25 Favored 'General case' 0 N--CA 1.463 0.21 0 CA-C-O 120.695 0.283 . . . . 0.0 110.882 -176.819 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 140' ' ' LEU . . . . . 0.558 HD12 HG22 ' A' ' 131' ' ' VAL . 11.6 tp -114.03 122.96 48.51 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 115.664 -0.698 . . . . 0.0 109.23 179.534 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 141' ' ' ILE . . . . . 0.515 ' HB ' HG13 ' A' ' 130' ' ' VAL . 20.3 mt -123.15 122.66 66.01 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.243 0 CA-C-O 120.997 0.427 . . . . 0.0 110.3 -175.778 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 142' ' ' ARG . . . . . . . . . . . . . 84.2 mtp180 -106.91 123.22 47.86 Favored 'General case' 0 C--N 1.331 -0.22 0 CA-C-N 115.264 -0.88 . . . . 0.0 110.068 179.252 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 143' ' ' THR . . . . . . . . . . . . . 26.6 p . . . . . 0 C--O 1.221 -0.428 0 CA-C-O 117.939 -1.029 . . . . 0.0 110.58 179.742 . . . . . . . . 0 0 . 1 . 018 nuclear nobuild core ' B' B ' 2' ' ' SER . . . . . . . . . . . . . 2.8 p . . . . . 0 N--CA 1.462 0.152 0 CA-C-O 120.901 0.382 . . . . 0.0 110.606 . . . . . . . . . 0 0 . 1 . 018 nuclear nobuild core ' B' B ' 3' ' ' GLU . . . . . . . . . . . . . 84.6 tt0 -142.64 142.55 32.1 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 115.981 -0.554 . . . . 0.0 111.193 -178.297 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' B' B ' 4' ' ' LEU . . . . . . . . . . . . . 13.4 tp -123.05 131.01 53.52 Favored 'General case' 0 C--N 1.331 -0.209 0 CA-C-N 115.757 -0.656 . . . . 0.0 110.143 177.109 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' B' B ' 5' ' ' LYS . . . . . . . . . . . . . 94.6 mttt -107.72 121.8 45.44 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.232 -0.44 . . . . 0.0 110.433 178.727 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' B' B ' 6' ' ' LEU . . . . . . . . . . . . . 44.4 mt -115.88 148.18 40.25 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 115.554 -0.748 . . . . 0.0 110.195 -179.283 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' B' B ' 7' ' ' LYS . . . . . . . . . . . . . 83.4 tttt -135.35 140.31 34.02 Favored Pre-proline 0 CA--C 1.535 0.388 0 CA-C-O 119.092 -0.48 . . . . 0.0 110.118 176.335 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' B' B ' 8' ' ' PRO . . . . . . . . . . . . . 88.8 Cg_endo -92.04 143.71 2.74 Favored 'Trans proline' 0 N--CA 1.491 1.345 0 C-N-CA 121.718 1.612 . . . . 0.0 111.653 177.689 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' B' B ' 9' ' ' LEU . . . . . . . . . . . . . 75.3 mt -81.8 -47.67 1.0 Allowed Pre-proline 0 CA--C 1.535 0.384 0 CA-C-O 118.611 -0.709 . . . . 0.0 112.303 -179.321 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' B' B ' 10' ' ' PRO . . . . . . . . . . . . . 95.1 Cg_endo -79.61 154.48 23.84 Favored 'Trans proline' 0 N--CA 1.496 1.662 0 C-N-CA 121.125 1.217 . . . . 0.0 111.869 176.412 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' B' B ' 11' ' ' LYS . . . . . . . . . . . . . 62.2 tttm -88.46 102.79 15.25 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-N 116.378 -0.374 . . . . 0.0 110.439 179.058 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' B' B ' 12' ' ' VAL . . . . . . . . . . . . . 12.8 p -149.67 144.29 17.82 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.319 0 CA-C-N 116.294 -0.412 . . . . 0.0 110.875 179.945 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' B' B ' 13' ' ' GLU . . . . . . . . . . . . . 95.8 mt-10 -79.62 131.99 36.14 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.14 -0.482 . . . . 0.0 110.062 177.468 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' B' B ' 14' ' ' LEU . . . . . . . . . . . . . 26.6 mt -98.67 147.97 33.91 Favored Pre-proline 0 CA--C 1.534 0.337 0 CA-C-O 119.252 -0.404 . . . . 0.0 110.623 -177.955 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' B' B ' 15' ' ' PRO . . . . . . . . . . . . . 24.7 Cg_exo -62.88 158.26 43.88 Favored 'Trans proline' 0 N--CA 1.498 1.772 0 C-N-CA 121.328 1.352 . . . . 0.0 111.779 176.828 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' B' B ' 16' ' ' PRO . . . . . . . . . . . . . 33.6 Cg_exo -59.2 -39.31 79.87 Favored 'Trans proline' 0 N--CA 1.498 1.748 0 C-N-CA 121.508 1.472 . . . . 0.0 112.714 -177.581 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' B' B ' 17' ' ' ASP . . . . . . . . . . . . . 24.1 p-10 -89.12 11.9 17.25 Favored 'General case' 0 C--N 1.328 -0.358 0 N-CA-C 113.154 0.798 . . . . 0.0 113.154 -177.411 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' B' B ' 18' ' ' PHE . . . . . . . . . . . . . 44.2 t80 -58.09 -45.82 86.53 Favored 'General case' 0 C--N 1.335 -0.056 0 O-C-N 121.993 -0.442 . . . . 0.0 110.081 -178.458 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' B' B ' 19' ' ' VAL . . . . . . . . . . . . . 13.7 p -56.57 -40.52 69.23 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.297 0 CA-C-N 116.15 -0.477 . . . . 0.0 110.878 -179.219 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' B' B ' 20' ' ' ASP . . . . . . . . . . . . . 9.8 t70 -60.53 -44.78 95.71 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-O 120.768 0.318 . . . . 0.0 111.032 -177.766 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' B' B ' 21' ' ' VAL . . . . . . . . . . . . . 46.9 t -64.3 -47.83 88.04 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.282 0 C-N-CA 120.676 -0.41 . . . . 0.0 110.377 -177.891 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' B' B ' 22' ' ' ILE . . . . . 0.468 HG22 HD12 ' B' ' 26' ' ' LEU . 51.1 mm -55.92 -46.16 80.23 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.261 0 CA-C-O 120.672 0.273 . . . . 0.0 110.589 179.813 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' B' B ' 23' ' ' ARG . . . . . . . . . . . . . 60.4 ttp180 -54.38 -50.88 66.48 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.779 -0.191 . . . . 0.0 111.39 -178.281 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' B' B ' 24' ' ' ILE . . . . . . . . . . . . . 75.6 mt -59.8 -42.47 89.05 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.298 0 C-N-CA 121.036 -0.266 . . . . 0.0 110.939 -177.686 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' B' B ' 25' ' ' LYS . . . . . . . . . . . . . 60.3 mtpt -64.6 -39.38 93.62 Favored 'General case' 0 C--N 1.328 -0.333 0 N-CA-C 112.232 0.456 . . . . 0.0 112.232 -177.898 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' B' B ' 26' ' ' LEU . . . . . 0.468 HD12 HG22 ' B' ' 22' ' ' ILE . 55.7 mt -79.0 -43.5 24.23 Favored 'General case' 0 C--N 1.33 -0.268 0 N-CA-C 113.089 0.774 . . . . 0.0 113.089 -172.454 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' B' B ' 27' ' ' GLN . . . . . . . . . . . . . 10.3 pt20 -46.55 139.31 5.17 Favored 'General case' 0 N--CA 1.469 0.475 0 N-CA-C 112.841 0.682 . . . . 0.0 112.841 -174.084 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' B' B ' 28' ' ' GLY . . . . . . . . . . . . . . . 100.23 -28.06 17.47 Favored Glycine 0 CA--C 1.533 1.192 0 CA-C-N 115.43 -0.805 . . . . 0.0 112.083 -176.215 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' B' B ' 29' ' ' LYS . . . . . . . . . . . . . 55.5 mtmt -98.88 155.16 17.53 Favored 'General case' 0 C--O 1.233 0.226 0 CA-C-N 117.085 0.442 . . . . 0.0 111.248 178.494 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' B' B ' 30' ' ' THR . . . . . . . . . . . . . 35.2 m -104.35 140.39 37.96 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.13 -0.486 . . . . 0.0 110.115 176.305 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' B' B ' 31' ' ' VAL . . . . . . . . . . . . . 35.2 m -129.08 156.61 41.78 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.274 0 CA-C-N 116.321 -0.399 . . . . 0.0 110.627 -179.575 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' B' B ' 32' ' ' ARG . . . . . . . . . . . . . 62.7 ttt180 -133.37 148.64 51.85 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.066 -0.516 . . . . 0.0 110.143 179.076 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' B' B ' 33' ' ' THR . . . . . . . . . . . . . 18.0 m -53.05 139.11 29.14 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.43 -0.35 . . . . 0.0 111.414 -177.248 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' B' B ' 34' ' ' GLY . . . . . . . . . . . . . . . 100.94 -17.19 56.64 Favored Glycine 0 CA--C 1.532 1.142 0 CA-C-O 119.571 -0.572 . . . . 0.0 113.281 179.085 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' B' B ' 35' ' ' ASP . . . . . . . . . . . . . 79.4 m-20 -66.28 149.3 50.56 Favored 'General case' 0 C--N 1.334 -0.09 0 CA-C-N 118.119 0.959 . . . . 0.0 111.077 179.04 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' B' B ' 36' ' ' VAL . . . . . . . . . . . . . 44.3 t -121.71 129.88 75.1 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.204 0 CA-C-N 115.92 -0.582 . . . . 0.0 109.826 178.523 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' B' B ' 37' ' ' ILE . . . . . . . . . . . . . 65.8 mt -120.8 138.69 50.43 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.254 0 N-CA-C 109.982 -0.377 . . . . 0.0 109.982 -179.534 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' B' B ' 38' ' ' GLY . . . . . . . . . . . . . . . -111.61 128.87 8.84 Favored Glycine 0 CA--C 1.526 0.723 0 N-CA-C 111.07 -0.812 . . . . 0.0 111.07 -179.94 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' B' B ' 39' ' ' ILE . . . . . . . . . . . . . 72.3 mt -123.11 138.52 52.82 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.188 0 N-CA-C 110.165 -0.309 . . . . 0.0 110.165 179.161 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' B' B ' 40' ' ' SER . . . . . 0.465 ' O ' HD13 ' B' ' 41' ' ' ILE . 32.9 t -93.22 117.13 29.71 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.481 -0.327 . . . . 0.0 110.981 175.636 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' B' B ' 41' ' ' ILE . . . . . 0.465 HD13 ' O ' ' B' ' 40' ' ' SER . 47.7 mm -125.68 122.96 63.49 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.262 0 CA-C-O 120.844 0.354 . . . . 0.0 110.586 178.694 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' B' B ' 42' ' ' LEU . . . . . . . . . . . . . 65.3 mt 52.61 33.63 14.06 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.185 -0.462 . . . . 0.0 111.881 177.368 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' B' B ' 43' ' ' GLY . . . . . . . . . . . . . . . 73.19 31.19 61.79 Favored Glycine 0 CA--C 1.529 0.963 0 C-N-CA 121.09 -0.576 . . . . 0.0 112.194 177.951 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' B' B ' 44' ' ' LYS . . . . . . . . . . . . . 40.3 ttpt -138.57 133.72 32.91 Favored 'General case' 0 C--N 1.329 -0.303 0 N-CA-C 109.663 -0.495 . . . . 0.0 109.663 178.098 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' B' B ' 45' ' ' GLU . . . . . . . . . . . . . 78.0 tt0 -83.2 118.55 23.68 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-O 120.918 0.39 . . . . 0.0 110.814 -177.598 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' B' B ' 46' ' ' VAL . . . . . . . . . . . . . 7.4 p -117.18 128.08 74.6 Favored 'Isoleucine or valine' 0 N--CA 1.462 0.159 0 N-CA-C 109.611 -0.514 . . . . 0.0 109.611 177.917 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' B' B ' 47' ' ' LYS . . . . . . . . . . . . . 32.3 mmtp -98.93 129.5 45.26 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 115.96 -0.564 . . . . 0.0 111.357 178.721 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' B' B ' 48' ' ' PHE . . . . . . . . . . . . . 90.5 m-85 -114.08 131.83 56.25 Favored 'General case' 0 C--N 1.329 -0.296 0 N-CA-C 109.378 -0.601 . . . . 0.0 109.378 173.966 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' B' B ' 49' ' ' LYS . . . . . . . . . . . . . 59.5 tttm -108.28 138.54 44.39 Favored 'General case' 0 C--N 1.329 -0.308 0 N-CA-C 110.315 -0.254 . . . . 0.0 110.315 179.359 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' B' B ' 50' ' ' VAL . . . . . . . . . . . . . 44.8 t -78.99 107.88 11.96 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.299 0 N-CA-C 109.226 -0.657 . . . . 0.0 109.226 176.529 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' B' B ' 51' ' ' VAL . . . . . . . . . . . . . 52.9 t -73.04 -48.17 45.14 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.271 0 CA-C-N 115.938 -0.574 . . . . 0.0 110.225 -173.573 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' B' B ' 52' ' ' GLN . . . . . . . . . . . . . 45.3 tt0 -162.62 145.17 10.87 Favored 'General case' 0 C--N 1.332 -0.192 0 C-N-CA 120.303 -0.559 . . . . 0.0 111.554 -177.711 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' B' B ' 53' ' ' ALA . . . . . . . . . . . . . . . -121.1 133.89 55.23 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 115.821 -0.627 . . . . 0.0 110.044 176.76 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' B' B ' 54' ' ' TYR . . . . . . . . . . . . . 33.9 t80 -129.01 106.97 18.02 Favored Pre-proline 0 CA--C 1.534 0.342 0 CA-C-O 118.303 -0.856 . . . . 0.0 110.355 179.435 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' B' B ' 55' ' ' PRO . . . . . . . . . . . . . 73.8 Cg_endo -77.13 169.27 74.69 Favored 'Cis proline' 0 N--CA 1.5 1.858 0 CA-C-N 121.812 1.683 . . . . 0.0 112.503 -4.478 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' B' B ' 56' ' ' SER . . . . . . . . . . . . . 67.4 m -115.3 128.07 26.26 Favored Pre-proline 0 CA--C 1.539 0.543 0 CA-C-O 118.454 -0.784 . . . . 0.0 109.466 175.891 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' B' B ' 57' ' ' PRO . . . . . . . . . . . . . 40.0 Cg_endo -67.84 167.38 62.69 Favored 'Cis proline' 0 N--CA 1.496 1.666 0 CA-C-N 121.984 1.744 . . . . 0.0 111.648 -0.845 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' B' B ' 58' ' ' LEU . . . . . . . . . . . . . 31.4 tp -129.85 136.71 49.87 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.187 -0.46 . . . . 0.0 110.334 179.674 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' B' B ' 59' ' ' ARG . . . . . . . . . . . . . 53.6 ttp180 -103.06 128.3 49.98 Favored 'General case' 0 C--N 1.326 -0.417 0 N-CA-C 109.16 -0.682 . . . . 0.0 109.16 176.898 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' B' B ' 60' ' ' VAL . . . . . . . . . . . . . 42.1 t -84.05 127.64 39.6 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.185 0 C-N-CA 120.533 -0.467 . . . . 0.0 110.622 -174.139 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' B' B ' 61' ' ' GLU . . . . . . . . . . . . . 96.0 mt-10 -129.9 159.13 37.55 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 115.558 -0.747 . . . . 0.0 109.611 176.969 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' B' B ' 62' ' ' ASP . . . . . . . . . . . . . 6.8 t0 -53.5 -32.47 50.49 Favored 'General case' 0 C--N 1.328 -0.363 0 N-CA-C 111.88 0.326 . . . . 0.0 111.88 -178.58 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' B' B ' 63' ' ' ARG . . . . . . . . . . . . . 28.7 ptt180 -90.04 6.23 43.24 Favored 'General case' 0 CA--C 1.537 0.476 0 N-CA-C 113.878 1.066 . . . . 0.0 113.878 -175.633 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' B' B ' 64' ' ' THR . . . . . . . . . . . . . 25.7 m -75.11 147.23 40.74 Favored 'General case' 0 C--N 1.331 -0.206 0 CA-C-O 121.006 0.432 . . . . 0.0 111.069 -177.854 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' B' B ' 65' ' ' LYS . . . . . . . . . . . . . 25.2 mtpp -84.94 126.71 33.74 Favored 'General case' 0 C--N 1.331 -0.227 0 CA-C-N 115.893 -0.594 . . . . 0.0 110.208 179.453 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' B' B ' 66' ' ' ILE . . . . . . . . . . . . . 60.4 mt -121.94 132.17 71.51 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.235 0 N-CA-C 110.151 -0.314 . . . . 0.0 110.151 -179.426 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' B' B ' 67' ' ' THR . . . . . . . . . . . . . 29.6 m -130.11 141.55 50.68 Favored 'General case' 0 C--N 1.332 -0.154 0 CA-C-O 121.02 0.438 . . . . 0.0 111.184 -179.458 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' B' B ' 68' ' ' LEU . . . . . 0.488 HD12 ' N ' ' B' ' 68' ' ' LEU . 7.0 mp . . . . . 0 C--N 1.332 -0.195 0 CA-C-N 115.942 -0.572 . . . . 0.0 110.427 177.013 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' B' B ' 73' ' ' VAL . . . . . . . . . . . . . 27.1 m . . . . . 0 C--O 1.232 0.135 0 CA-C-O 120.754 0.312 . . . . 0.0 110.365 . . . . . . . . . 0 0 . 1 . 018 nuclear nobuild core ' B' B ' 74' ' ' ASP . . . . . . . . . . . . . 36.3 t0 -97.78 116.26 29.65 Favored 'General case' 0 C--N 1.329 -0.289 0 N-CA-C 109.732 -0.47 . . . . 0.0 109.732 -179.28 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' B' B ' 75' ' ' VAL . . . . . . . . . . . . . 42.0 t -112.38 122.15 66.07 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.171 0 CA-C-O 121.112 0.482 . . . . 0.0 110.388 -177.97 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' B' B ' 76' ' ' LEU . . . . . . . . . . . . . 14.7 mt -124.82 133.7 53.02 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 115.537 -0.756 . . . . 0.0 109.2 177.422 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' B' B ' 77' ' ' GLU . . . . . . . . . . . . . 35.9 tt0 -131.91 136.89 47.73 Favored 'General case' 0 C--N 1.331 -0.222 0 CA-C-O 121.013 0.435 . . . . 0.0 110.98 -176.25 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' B' B ' 78' ' ' ALA . . . . . . . . . . . . . . . -123.87 139.81 53.6 Favored 'General case' 0 C--N 1.331 -0.219 0 CA-C-N 115.947 -0.57 . . . . 0.0 110.214 178.08 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' B' B ' 79' ' ' LYS . . . . . 0.626 ' O ' HD13 ' B' ' 80' ' ' ILE . 50.0 pttt -73.37 118.15 15.98 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-O 121.292 0.567 . . . . 0.0 110.453 179.402 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' B' B ' 80' ' ' ILE . . . . . 0.626 HD13 ' O ' ' B' ' 79' ' ' LYS . 38.0 mm -139.22 109.68 4.4 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.346 0 CA-C-N 115.906 -0.588 . . . . 0.0 109.718 -177.734 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' B' B ' 81' ' ' LYS . . . . . . . . . . . . . 67.6 mttm -110.76 130.6 55.53 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-O 120.948 0.404 . . . . 0.0 110.927 -179.67 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' B' B ' 82' ' ' GLY . . . . . . . . . . . . . . . 89.05 42.22 5.68 Favored Glycine 0 CA--C 1.525 0.698 0 C-N-CA 120.971 -0.633 . . . . 0.0 111.655 175.527 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' B' B ' 83' ' ' ILE . . . . . . . . . . . . . 71.9 mt -66.91 132.35 32.27 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.317 0 N-CA-C 109.672 -0.492 . . . . 0.0 109.672 177.688 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' B' B ' 84' ' ' LYS . . . . . . . . . . . . . 44.9 tttp -96.37 -52.72 3.87 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-O 121.091 0.472 . . . . 0.0 110.227 -178.742 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' B' B ' 85' ' ' ASP . . . . . . . . . . . . . 7.3 t70 -150.98 149.41 29.56 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 115.647 -0.706 . . . . 0.0 110.118 179.422 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' B' B ' 86' ' ' VAL . . . . . . . . . . . . . 43.2 t -128.6 128.77 68.31 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.292 0 CA-C-O 120.887 0.375 . . . . 0.0 110.529 -178.307 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' B' B ' 87' ' ' ILE . . . . . . . . . . . . . 43.7 mm -120.3 125.2 73.93 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.224 0 CA-C-N 116.002 -0.545 . . . . 0.0 109.968 176.251 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' B' B ' 88' ' ' LEU . . . . . . . . . . . . . 19.2 tp -109.64 130.04 55.54 Favored 'General case' 0 C--N 1.331 -0.225 0 CA-C-O 120.967 0.413 . . . . 0.0 111.141 -178.086 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' B' B ' 89' ' ' ASP . . . . . . . . . . . . . 12.7 t70 -123.12 151.6 41.91 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 115.827 -0.624 . . . . 0.0 109.583 176.0 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' B' B ' 90' ' ' GLU . . . . . . . . . . . . . 96.8 mt-10 -47.08 -36.56 8.32 Favored 'General case' 0 C--N 1.33 -0.253 0 N-CA-C 112.993 0.738 . . . . 0.0 112.993 -173.061 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' B' B ' 91' ' ' ASN . . . . . . . . . . . . . 3.4 p-10 -130.47 19.69 5.23 Favored 'General case' 0 N--CA 1.467 0.421 0 N-CA-C 113.051 0.76 . . . . 0.0 113.051 -177.668 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' B' B ' 92' ' ' LEU . . . . . . . . . . . . . 16.5 mt -148.89 143.16 26.05 Favored 'General case' 0 C--N 1.332 -0.169 0 N-CA-C 109.982 -0.377 . . . . 0.0 109.982 -177.336 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' B' B ' 93' ' ' ILE . . . . . . . . . . . . . 70.7 mt -120.09 118.03 55.55 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.328 0 N-CA-C 109.314 -0.624 . . . . 0.0 109.314 178.003 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' B' B ' 94' ' ' VAL . . . . . . . . . . . . . 48.4 t -119.22 123.5 71.44 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.207 0 N-CA-C 109.901 -0.407 . . . . 0.0 109.901 -179.304 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' B' B ' 95' ' ' VAL . . . . . . . . . . . . . 44.3 t -122.4 132.83 70.32 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.397 0 CA-C-N 115.916 -0.584 . . . . 0.0 109.876 -179.439 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' B' B ' 96' ' ' ILE . . . . . . . . . . . . . 67.0 mt -112.78 126.77 70.22 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.287 0 N-CA-C 109.12 -0.696 . . . . 0.0 109.12 178.265 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' B' B ' 97' ' ' THR . . . . . . . . . . . . . 68.2 p -99.6 152.72 19.72 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-O 120.877 0.37 . . . . 0.0 110.929 -178.543 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' B' B ' 98' ' ' GLU . . . . . . . . . . . . . 45.0 mt-10 -53.87 -24.23 15.19 Favored 'General case' 0 CA--C 1.533 0.324 0 N-CA-C 112.346 0.498 . . . . 0.0 112.346 179.927 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' B' B ' 99' ' ' GLU . . . . . . . . . . . . . 31.1 tt0 -79.27 15.54 1.19 Allowed 'General case' 0 CA--C 1.539 0.549 0 N-CA-C 112.697 0.629 . . . . 0.0 112.697 -177.306 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' B' B ' 100' ' ' ASN . . . . . . . . . . . . . 3.8 m-20 63.56 38.0 9.99 Favored 'General case' 0 CA--C 1.531 0.213 0 CA-C-O 121.006 0.432 . . . . 0.0 111.107 177.366 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' B' B ' 101' ' ' GLU . . . . . . . . . . . . . 85.0 tt0 -118.95 143.26 47.13 Favored 'General case' 0 C--N 1.331 -0.202 0 CA-C-N 116.042 -0.526 . . . . 0.0 109.909 176.014 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' B' B ' 102' ' ' VAL . . . . . . . . . . . . . 45.0 t -114.99 126.29 72.53 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.273 0 CA-C-N 116.262 -0.427 . . . . 0.0 109.946 -177.534 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' B' B ' 103' ' ' LEU . . . . . . . . . . . . . 21.2 mt -116.0 129.38 56.35 Favored 'General case' 0 C--N 1.331 -0.201 0 CA-C-N 115.848 -0.614 . . . . 0.0 110.555 178.263 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' B' B ' 104' ' ' ILE . . . . . . . . . . . . . 66.9 mt -118.82 119.55 61.37 Favored 'Isoleucine or valine' 0 C--O 1.233 0.215 0 CA-C-N 116.443 -0.344 . . . . 0.0 110.109 179.216 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' B' B ' 105' ' ' PHE . . . . . . . . . . . . . 66.8 m-85 -120.72 164.69 16.17 Favored 'General case' 0 C--N 1.331 -0.212 0 O-C-N 123.972 0.795 . . . . 0.0 109.878 178.741 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' B' B ' 106' ' ' ASN . . . . . . . . . . . . . 46.0 p-10 -101.08 -171.49 2.01 Favored 'General case' 0 N--CA 1.463 0.215 0 N-CA-C 110.267 -0.272 . . . . 0.0 110.267 174.605 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' B' B ' 107' ' ' GLN . . . . . . . . . . . . . 60.3 tt0 -59.47 -29.37 67.77 Favored 'General case' 0 CA--C 1.531 0.225 0 N-CA-C 112.021 0.378 . . . . 0.0 112.021 -179.347 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' B' B ' 108' ' ' ASN . . . . . . . . . . . . . 17.9 t30 -86.59 10.01 16.78 Favored 'General case' 0 CA--C 1.536 0.426 0 N-CA-C 113.189 0.811 . . . . 0.0 113.189 -177.115 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' B' B ' 109' ' ' LEU . . . . . . . . . . . . . 12.9 tp 59.68 41.65 18.24 Favored 'General case' 0 C--N 1.331 -0.198 0 CA-C-O 121.25 0.548 . . . . 0.0 110.897 178.318 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' B' B ' 110' ' ' GLU . . . . . . . . . . . . . 70.9 mm-40 -108.07 156.79 18.88 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.138 -0.483 . . . . 0.0 109.866 176.133 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' B' B ' 111' ' ' GLU . . . . . . . . . . . . . 84.9 tt0 -84.39 121.96 28.28 Favored 'General case' 0 C--N 1.329 -0.298 0 C-N-CA 120.845 -0.342 . . . . 0.0 110.79 -178.566 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' B' B ' 112' ' ' LEU . . . . . . . . . . . . . 28.4 mt -110.58 -46.18 3.42 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 116.16 -0.473 . . . . 0.0 110.547 178.169 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' B' B ' 113' ' ' TYR . . . . . . . . . . . . . 54.0 t80 -142.17 134.24 27.44 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.357 -0.383 . . . . 0.0 111.249 -179.941 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' B' B ' 114' ' ' ARG . . . . . . . . . . . . . 29.9 ttm180 -135.28 124.27 24.21 Favored 'General case' 0 C--N 1.329 -0.292 0 N-CA-C 109.839 -0.43 . . . . 0.0 109.839 175.44 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' B' B ' 115' ' ' GLY . . . . . . . . . . . . . . . -150.03 151.64 23.67 Favored Glycine 0 CA--C 1.523 0.569 0 C-N-CA 120.754 -0.736 . . . . 0.0 111.325 179.213 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' B' B ' 116' ' ' LYS . . . . . . . . . . . . . 39.1 ttpt -121.94 136.43 54.92 Favored 'General case' 0 C--N 1.328 -0.333 0 N-CA-C 109.662 -0.495 . . . . 0.0 109.662 177.744 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' B' B ' 117' ' ' PHE . . . . . . . . . . . . . 40.6 m-85 -135.2 113.76 11.66 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-O 121.082 0.468 . . . . 0.0 110.074 -176.861 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' B' B ' 118' ' ' GLU . . . . . . . . . . . . . 97.0 mt-10 -53.86 -43.78 69.82 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.073 -0.512 . . . . 0.0 111.662 -174.256 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' B' B ' 119' ' ' ASN . . . . . . . . . . . . . 5.6 p30 -104.63 31.13 4.91 Favored 'General case' 0 C--N 1.33 -0.257 0 N-CA-C 112.244 0.461 . . . . 0.0 112.244 -173.942 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' B' B ' 120' ' ' LEU . . . . . . . . . . . . . 13.7 tp -53.48 126.05 20.14 Favored 'General case' 0 N--CA 1.464 0.238 0 CA-C-O 120.469 0.176 . . . . 0.0 110.8 177.72 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' B' B ' 121' ' ' ASN . . . . . . . . . . . . . 77.3 m-20 -114.1 -44.12 3.17 Favored 'General case' 0 N--CA 1.462 0.173 0 C-N-CA 121.195 -0.202 . . . . 0.0 111.283 -176.843 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' B' B ' 122' ' ' LYS . . . . . . . . . . . . . 62.2 mtpt -142.1 145.69 34.57 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-O 121.121 0.486 . . . . 0.0 111.727 -176.775 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' B' B ' 123' ' ' VAL . . . . . . . . . . . . . 44.0 t -127.24 127.52 69.35 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.264 0 N-CA-C 109.21 -0.663 . . . . 0.0 109.21 174.909 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' B' B ' 124' ' ' LEU . . . . . . . . . . . . . 51.1 mt -128.03 136.38 51.18 Favored 'General case' 0 C--N 1.331 -0.196 0 CA-C-O 120.853 0.358 . . . . 0.0 111.097 -177.216 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' B' B ' 125' ' ' VAL . . . . . . . . . . . . . 11.1 p -133.97 133.65 56.11 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.249 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.027 177.304 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' B' B ' 126' ' ' ARG . . . . . . . . . . . . . 77.0 mtp85 -146.64 126.47 13.52 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-O 120.86 0.362 . . . . 0.0 111.073 -179.275 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' B' B ' 127' ' ' ASN . . . . . . . . . . . . . 7.6 m-80 49.23 -105.21 0.15 Allowed 'General case' 0 CA--C 1.545 0.76 0 CA-C-O 119.036 -0.507 . . . . 0.0 111.784 178.162 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' B' B ' 128' ' ' ASP . . . . . . . . . . . . . 15.9 p-10 -114.09 3.02 15.11 Favored 'General case' 0 CA--C 1.535 0.396 0 CA-C-N 119.552 1.069 . . . . 0.0 113.546 -176.36 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' B' B ' 129' ' ' LEU . . . . . . . . . . . . . 52.8 mt -111.48 140.85 45.73 Favored 'General case' 0 C--N 1.333 -0.114 0 O-C-N 121.972 -0.455 . . . . 0.0 110.522 -179.078 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' B' B ' 130' ' ' VAL . . . . . . . . . . . . . 46.5 t -122.98 134.85 64.9 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.326 0 N-CA-C 109.401 -0.592 . . . . 0.0 109.401 177.839 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' B' B ' 131' ' ' VAL . . . . . . . . . . . . . 39.3 t -134.36 138.06 50.53 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.223 0 CA-C-O 121.187 0.518 . . . . 0.0 110.45 -179.002 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' B' B ' 132' ' ' ILE . . . . . . . . . . . . . 70.7 mt -116.76 130.19 72.04 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.339 0 CA-C-N 115.556 -0.747 . . . . 0.0 109.388 179.508 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' B' B ' 133' ' ' ILE . . . . . . . . . . . . . 40.4 mm -112.2 119.25 59.72 Favored 'Isoleucine or valine' 0 C--O 1.233 0.221 0 CA-C-O 120.855 0.36 . . . . 0.0 110.67 -177.241 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' B' B ' 134' ' ' ASP . . . . . . . . . . . . . 7.2 p-10 -134.13 148.78 51.01 Favored 'General case' 0 C--N 1.331 -0.206 0 CA-C-N 116.103 -0.499 . . . . 0.0 109.76 177.156 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' B' B ' 135' ' ' GLU . . . . . . . . . . . . . 42.8 tp10 -49.9 -30.0 9.33 Favored 'General case' 0 C--N 1.328 -0.36 0 N-CA-C 112.576 0.584 . . . . 0.0 112.576 -173.523 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' B' B ' 136' ' ' GLN . . . . . . . . . . . . . 43.2 tp60 -80.18 -34.91 37.13 Favored 'General case' 0 C--N 1.33 -0.251 0 N-CA-C 112.282 0.475 . . . . 0.0 112.282 -175.046 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' B' B ' 137' ' ' LYS . . . . . . . . . . . . . 40.0 pttt -170.0 174.2 5.64 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-O 121.452 0.644 . . . . 0.0 112.179 -170.512 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' B' B ' 138' ' ' LEU . . . . . . . . . . . . . 6.1 tt -118.0 128.21 54.56 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 115.186 -0.915 . . . . 0.0 109.9 178.969 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' B' B ' 139' ' ' THR . . . . . . . . . . . . . 34.0 m -106.27 127.76 53.48 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.261 -0.427 . . . . 0.0 110.396 -179.87 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' B' B ' 140' ' ' LEU . . . . . 0.461 ' C ' HD23 ' B' ' 140' ' ' LEU . 5.5 tt -113.88 121.02 42.71 Favored 'General case' 0 C--N 1.328 -0.351 0 N-CA-C 109.149 -0.686 . . . . 0.0 109.149 -178.922 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' B' B ' 141' ' ' ILE . . . . . 0.416 ' N ' HD23 ' B' ' 140' ' ' LEU . 19.1 mt -119.88 116.81 51.65 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.303 0 N-CA-C 109.814 -0.439 . . . . 0.0 109.814 -176.604 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' B' B ' 142' ' ' ARG . . . . . . . . . . . . . 68.5 ttt180 -108.18 131.97 54.11 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 115.417 -0.81 . . . . 0.0 110.463 -177.092 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' B' B ' 143' ' ' THR . . . . . . . . . . . . . 35.2 p . . . . . 0 C--O 1.22 -0.45 0 CA-C-O 117.936 -1.03 . . . . 0.0 110.522 179.092 . . . . . . . . 0 0 . 1 . 018 nuclear nobuild core ' C' C ' 2' ' ' SER . . . . . . . . . . . . . 12.6 p . . . . . 0 N--CA 1.463 0.181 0 CA-C-O 121.024 0.44 . . . . 0.0 110.906 . . . . . . . . . 0 0 . 1 . 018 nuclear nobuild core ' C' C ' 3' ' ' GLU . . . . . . . . . . . . . 95.8 mt-10 -141.0 142.44 34.26 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 115.863 -0.608 . . . . 0.0 110.961 -178.356 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' C' C ' 4' ' ' LEU . . . . . . . . . . . . . 16.2 tp -122.73 127.05 48.7 Favored 'General case' 0 C--N 1.331 -0.207 0 CA-C-N 116.103 -0.499 . . . . 0.0 109.719 175.402 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' C' C ' 5' ' ' LYS . . . . . . . . . . . . . 52.5 mttp -108.07 122.12 46.23 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-O 120.763 0.315 . . . . 0.0 110.995 -179.109 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' C' C ' 6' ' ' LEU . . . . . . . . . . . . . 27.6 mt -116.21 151.81 34.98 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 115.543 -0.753 . . . . 0.0 110.522 179.863 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' C' C ' 7' ' ' LYS . . . . . . . . . . . . . 74.2 tttt -144.02 139.56 16.11 Favored Pre-proline 0 CA--C 1.534 0.331 0 CA-C-O 119.124 -0.465 . . . . 0.0 109.949 173.569 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' C' C ' 8' ' ' PRO . . . . . . . . . . . . . 80.3 Cg_endo -90.65 141.54 3.23 Favored 'Trans proline' 0 N--CA 1.491 1.364 0 C-N-CA 121.66 1.573 . . . . 0.0 111.72 176.764 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' C' C ' 9' ' ' LEU . . . . . . . . . . . . . 54.6 mt -73.78 -47.97 6.66 Favored Pre-proline 0 CA--C 1.535 0.392 0 CA-C-O 118.665 -0.683 . . . . 0.0 112.472 -178.519 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' C' C ' 10' ' ' PRO . . . . . . . . . . . . . 88.1 Cg_endo -80.66 152.3 19.73 Favored 'Trans proline' 0 N--CA 1.497 1.677 0 C-N-CA 121.313 1.342 . . . . 0.0 111.99 177.422 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' C' C ' 11' ' ' LYS . . . . . . . . . . . . . 73.8 mmtt -82.49 102.0 11.06 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-O 120.929 0.395 . . . . 0.0 110.222 177.524 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' C' C ' 12' ' ' VAL . . . . . . . . . . . . . 12.9 p -141.31 146.4 23.53 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 CA-C-N 116.136 -0.483 . . . . 0.0 110.466 -179.225 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' C' C ' 13' ' ' GLU . . . . . . . . . . . . . 85.0 tt0 -85.19 124.44 31.84 Favored 'General case' 0 C--N 1.329 -0.306 0 N-CA-C 109.93 -0.396 . . . . 0.0 109.93 177.429 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' C' C ' 14' ' ' LEU . . . . . . . . . . . . . 48.8 mt -93.12 142.8 25.81 Favored Pre-proline 0 CA--C 1.533 0.314 0 CA-C-O 119.072 -0.49 . . . . 0.0 110.379 -177.453 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' C' C ' 15' ' ' PRO . . . . . . . . . . . . . 35.6 Cg_exo -60.22 162.1 17.94 Favored 'Trans proline' 0 N--CA 1.496 1.665 0 C-N-CA 121.353 1.369 . . . . 0.0 112.034 176.887 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' C' C ' 16' ' ' PRO . . . . . . . . . . . . . 38.3 Cg_exo -58.2 -42.33 57.87 Favored 'Trans proline' 0 N--CA 1.496 1.632 0 C-N-CA 121.507 1.472 . . . . 0.0 112.897 -176.399 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' C' C ' 17' ' ' ASP . . . . . . . . . . . . . 15.2 p-10 -92.87 13.03 21.68 Favored 'General case' 0 C--N 1.327 -0.383 0 N-CA-C 113.239 0.829 . . . . 0.0 113.239 -175.966 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' C' C ' 18' ' ' PHE . . . . . . . . . . . . . 41.8 t80 -57.71 -43.98 85.59 Favored 'General case' 0 C--O 1.231 0.1 0 CA-C-O 121.073 0.463 . . . . 0.0 110.08 -178.188 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' C' C ' 19' ' ' VAL . . . . . . . . . . . . . 44.9 t -59.47 -42.39 87.66 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.346 0 CA-C-N 116.122 -0.49 . . . . 0.0 110.21 -179.259 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' C' C ' 20' ' ' ASP . . . . . . . . . . . . . 78.5 m-20 -59.69 -42.66 93.46 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-O 120.732 0.301 . . . . 0.0 110.951 -177.361 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' C' C ' 21' ' ' VAL . . . . . . . . . . . . . 43.7 t -64.58 -46.8 91.46 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.318 0 C-N-CA 120.79 -0.364 . . . . 0.0 110.315 -177.755 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' C' C ' 22' ' ' ILE . . . . . 0.488 HG22 HD12 ' C' ' 26' ' ' LEU . 24.5 mm -59.32 -40.1 80.58 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.276 0 C-N-CA 120.869 -0.332 . . . . 0.0 110.362 -179.017 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' C' C ' 23' ' ' ARG . . . . . . . . . . . . . 55.8 ttp180 -55.36 -50.04 70.72 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-O 121.038 0.447 . . . . 0.0 110.736 178.335 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' C' C ' 24' ' ' ILE . . . . . . . . . . . . . 78.0 mt -60.21 -46.06 95.2 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.327 0 CA-C-N 116.005 -0.543 . . . . 0.0 111.595 -177.379 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' C' C ' 25' ' ' LYS . . . . . . . . . . . . . 17.7 ptpt -67.47 -39.15 85.28 Favored 'General case' 0 CA--C 1.534 0.358 0 C-N-CA 120.584 -0.446 . . . . 0.0 111.94 -173.71 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' C' C ' 26' ' ' LEU . . . . . 0.488 HD12 HG22 ' C' ' 22' ' ' ILE . 21.8 mt -79.49 -31.66 42.33 Favored 'General case' 0 C--N 1.33 -0.255 0 N-CA-C 113.045 0.757 . . . . 0.0 113.045 -174.765 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' C' C ' 27' ' ' GLN . . . . . . . . . . . . . 4.5 pt20 -45.9 135.48 7.14 Favored 'General case' 0 CA--C 1.536 0.436 0 N-CA-C 112.78 0.659 . . . . 0.0 112.78 -175.083 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' C' C ' 28' ' ' GLY . . . . . . . . . . . . . . . 97.06 -21.14 47.83 Favored Glycine 0 CA--C 1.534 1.264 0 CA-C-N 115.985 -0.552 . . . . 0.0 112.683 -177.822 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' C' C ' 29' ' ' LYS . . . . . . . . . . . . . 61.7 mttp -97.53 155.14 17.08 Favored 'General case' 0 C--N 1.331 -0.213 0 CA-C-N 117.522 0.661 . . . . 0.0 110.963 -178.984 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' C' C ' 30' ' ' THR . . . . . . . . . . . . . 13.9 m -104.02 139.72 38.74 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.337 177.989 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' C' C ' 31' ' ' VAL . . . . . . . . . . . . . 34.0 m -131.61 157.35 43.15 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.206 0 CA-C-N 116.234 -0.439 . . . . 0.0 110.856 -179.151 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' C' C ' 32' ' ' ARG . . . . . . . . . . . . . 81.7 mtt85 -133.65 150.7 51.57 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-N 115.957 -0.565 . . . . 0.0 110.744 176.828 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' C' C ' 33' ' ' THR . . . . . . . . . . . . . 33.5 m -53.41 139.98 28.95 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.206 -0.452 . . . . 0.0 111.282 -178.944 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' C' C ' 34' ' ' GLY . . . . . . . . . . . . . . . 98.65 -16.98 59.02 Favored Glycine 0 CA--C 1.532 1.125 0 CA-C-O 119.638 -0.535 . . . . 0.0 113.329 178.332 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' C' C ' 35' ' ' ASP . . . . . . . . . . . . . 76.9 m-20 -64.3 149.08 48.86 Favored 'General case' 0 C--O 1.231 0.125 0 CA-C-N 118.054 0.927 . . . . 0.0 111.225 -179.865 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' C' C ' 36' ' ' VAL . . . . . . . . . . . . . 46.2 t -121.07 129.66 75.46 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.211 0 CA-C-N 115.777 -0.647 . . . . 0.0 109.816 178.644 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' C' C ' 37' ' ' ILE . . . . . . . . . . . . . 72.1 mt -123.23 139.98 48.27 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.276 0 CA-C-N 116.182 -0.463 . . . . 0.0 109.994 -179.77 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' C' C ' 38' ' ' GLY . . . . . . . . . . . . . . . -108.91 128.67 9.15 Favored Glycine 0 CA--C 1.526 0.736 0 N-CA-C 111.317 -0.713 . . . . 0.0 111.317 -179.302 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' C' C ' 39' ' ' ILE . . . . . . . . . . . . . 77.7 mt -128.34 135.36 62.82 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.187 0 CA-C-O 120.757 0.313 . . . . 0.0 110.185 178.535 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' C' C ' 40' ' ' SER . . . . . . . . . . . . . 32.6 p -92.78 117.03 29.57 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.324 -0.398 . . . . 0.0 110.822 175.377 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' C' C ' 41' ' ' ILE . . . . . . . . . . . . . 45.7 mm -121.12 112.91 37.66 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.21 0 CA-C-O 120.794 0.331 . . . . 0.0 110.186 178.686 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' C' C ' 42' ' ' LEU . . . . . 0.424 ' O ' HD23 ' C' ' 42' ' ' LEU . 2.0 tt 55.58 48.56 18.4 Favored 'General case' 0 CA--C 1.533 0.307 0 CA-C-O 121.538 0.685 . . . . 0.0 110.098 178.643 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' C' C ' 43' ' ' GLY . . . . . . . . . . . . . . . 71.77 -5.48 11.92 Favored Glycine 0 CA--C 1.536 1.359 0 C-N-CA 121.125 -0.559 . . . . 0.0 113.766 175.642 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' C' C ' 44' ' ' LYS . . . . . . . . . . . . . 25.6 tptp -103.34 132.97 49.17 Favored 'General case' 0 C--O 1.231 0.126 0 CA-C-N 117.975 0.888 . . . . 0.0 110.031 -178.716 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' C' C ' 45' ' ' GLU . . . . . . . . . . . . . 82.5 tt0 -82.34 119.7 24.48 Favored 'General case' 0 C--N 1.329 -0.32 0 C-N-CA 120.808 -0.357 . . . . 0.0 110.78 -178.476 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' C' C ' 46' ' ' VAL . . . . . . . . . . . . . 7.2 p -122.8 124.52 70.65 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.21 0 N-CA-C 109.42 -0.585 . . . . 0.0 109.42 177.283 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' C' C ' 47' ' ' LYS . . . . . . . . . . . . . 53.7 mtmt -100.88 132.0 46.49 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.073 -0.512 . . . . 0.0 111.124 177.201 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' C' C ' 48' ' ' PHE . . . . . . . . . . . . . 84.3 m-85 -109.42 134.17 52.17 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 115.87 -0.605 . . . . 0.0 110.417 179.741 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' C' C ' 49' ' ' LYS . . . . . . . . . . . . . 87.5 tttt -105.3 134.36 48.54 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 115.844 -0.616 . . . . 0.0 110.05 178.589 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' C' C ' 50' ' ' VAL . . . . . . . . . . . . . 44.6 t -77.87 106.69 8.62 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.243 0 N-CA-C 109.147 -0.686 . . . . 0.0 109.147 174.873 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' C' C ' 51' ' ' VAL . . . . . . . . . . . . . 45.8 t -68.71 -46.63 79.37 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.308 0 CA-C-N 116.107 -0.497 . . . . 0.0 110.018 -172.59 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' C' C ' 52' ' ' GLN . . . . . . . . . . . . . 45.0 tt0 -171.39 145.25 2.09 Favored 'General case' 0 C--N 1.331 -0.207 0 C-N-CA 120.229 -0.588 . . . . 0.0 111.662 -179.361 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' C' C ' 53' ' ' ALA . . . . . . . . . . . . . . . -116.63 132.1 56.77 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 115.766 -0.652 . . . . 0.0 110.013 176.459 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' C' C ' 54' ' ' TYR . . . . . . . . . . . . . 48.2 t80 -129.11 108.87 18.03 Favored Pre-proline 0 CA--C 1.535 0.39 0 CA-C-O 118.264 -0.874 . . . . 0.0 110.242 177.983 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' C' C ' 55' ' ' PRO . . . . . . . . . . . . . 72.4 Cg_endo -77.11 168.5 76.83 Favored 'Cis proline' 0 N--CA 1.498 1.774 0 CA-C-N 121.865 1.702 . . . . 0.0 112.504 -3.823 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' C' C ' 56' ' ' SER . . . . . . . . . . . . . 50.2 m -115.71 130.49 24.31 Favored Pre-proline 0 CA--C 1.538 0.501 0 CA-C-O 118.456 -0.783 . . . . 0.0 109.373 174.446 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' C' C ' 57' ' ' PRO . . . . . . . . . . . . . 54.8 Cg_endo -70.0 165.3 77.7 Favored 'Cis proline' 0 N--CA 1.497 1.732 0 CA-C-N 121.918 1.721 . . . . 0.0 111.432 0.606 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' C' C ' 58' ' ' LEU . . . . . . . . . . . . . 29.3 tp -129.73 137.51 50.61 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-O 120.908 0.385 . . . . 0.0 110.419 -179.957 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' C' C ' 59' ' ' ARG . . . . . . . . . . . . . 64.7 ttp85 -106.98 125.72 51.38 Favored 'General case' 0 C--N 1.328 -0.332 0 N-CA-C 109.328 -0.619 . . . . 0.0 109.328 176.917 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' C' C ' 60' ' ' VAL . . . . . . . . . . . . . 45.0 t -75.48 115.97 17.66 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.288 0 CA-C-O 120.878 0.37 . . . . 0.0 110.656 -173.884 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' C' C ' 61' ' ' GLU . . . . . . . . . . . . . 39.1 tp10 -131.05 154.76 47.89 Favored 'General case' 0 C--N 1.33 -0.263 0 N-CA-C 109.062 -0.718 . . . . 0.0 109.062 176.77 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' C' C ' 62' ' ' ASP . . . . . . . . . . . . . 83.4 m-20 -50.86 -32.33 20.01 Favored 'General case' 0 C--N 1.326 -0.444 0 N-CA-C 112.162 0.43 . . . . 0.0 112.162 -176.612 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' C' C ' 63' ' ' ARG . . . . . . . . . . . . . 75.4 mtt85 -72.37 -22.19 61.18 Favored 'General case' 0 C--N 1.33 -0.261 0 N-CA-C 113.154 0.798 . . . . 0.0 113.154 -175.627 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' C' C ' 64' ' ' THR . . . . . . . . . . . . . 33.3 m -68.81 140.36 55.26 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-O 120.86 0.362 . . . . 0.0 110.697 -176.778 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' C' C ' 65' ' ' LYS . . . . . . . . . . . . . 97.2 mttt -88.08 134.64 33.71 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.045 -0.525 . . . . 0.0 109.989 179.159 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' C' C ' 66' ' ' ILE . . . . . . . . . . . . . 53.7 mt -111.09 129.84 65.64 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.238 0 N-CA-C 109.607 -0.516 . . . . 0.0 109.607 -178.248 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' C' C ' 67' ' ' THR . . . . . . . . . . . . . 34.6 m -123.69 140.24 53.19 Favored 'General case' 0 C--N 1.331 -0.223 0 CA-C-O 121.079 0.466 . . . . 0.0 111.295 -175.724 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' C' C ' 68' ' ' LEU . . . . . 0.465 HD12 ' N ' ' C' ' 68' ' ' LEU . 8.2 mp . . . . . 0 C--N 1.328 -0.353 0 CA-C-N 115.667 -0.697 . . . . 0.0 110.1 176.077 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' C' C ' 73' ' ' VAL . . . . . . . . . . . . . 21.1 m . . . . . 0 C--O 1.232 0.134 0 CA-C-O 121.137 0.494 . . . . 0.0 111.038 . . . . . . . . . 0 0 . 1 . 018 nuclear nobuild core ' C' C ' 74' ' ' ASP . . . . . . . . . . . . . 7.0 t0 -107.95 122.92 47.81 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 115.572 -0.74 . . . . 0.0 109.371 175.251 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' C' C ' 75' ' ' VAL . . . . . . . . . . . . . 40.1 t -112.52 121.32 64.63 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.231 0 CA-C-O 121.128 0.49 . . . . 0.0 110.676 -177.69 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' C' C ' 76' ' ' LEU . . . . . 0.469 ' N ' HD12 ' C' ' 76' ' ' LEU . 6.4 mp -119.57 148.48 43.26 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 115.573 -0.74 . . . . 0.0 109.621 176.309 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' C' C ' 77' ' ' GLU . . . . . . . . . . . . . 98.0 mt-10 -137.84 133.58 34.1 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-O 121.108 0.48 . . . . 0.0 111.129 -177.988 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' C' C ' 78' ' ' ALA . . . . . 0.663 ' HB2' HD21 ' C' ' 109' ' ' LEU . . . -118.74 128.0 54.08 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 115.674 -0.693 . . . . 0.0 109.672 176.724 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' C' C ' 79' ' ' LYS . . . . . 0.563 ' O ' HD13 ' C' ' 80' ' ' ILE . 61.7 mttp -83.87 114.94 22.01 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-O 121.05 0.452 . . . . 0.0 110.897 -176.072 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' C' C ' 80' ' ' ILE . . . . . 0.563 HD13 ' O ' ' C' ' 79' ' ' LYS . 43.7 mm -139.26 107.33 3.19 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.28 0 N-CA-C 109.025 -0.731 . . . . 0.0 109.025 -178.023 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' C' C ' 81' ' ' LYS . . . . . . . . . . . . . 77.4 tttt -95.34 127.41 41.37 Favored 'General case' 0 C--N 1.328 -0.369 0 C-N-CA 120.676 -0.409 . . . . 0.0 110.687 -177.837 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' C' C ' 82' ' ' GLY . . . . . . . . . . . . . . . 89.29 42.03 5.65 Favored Glycine 0 CA--C 1.524 0.645 0 C-N-CA 120.749 -0.738 . . . . 0.0 111.744 176.426 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' C' C ' 83' ' ' ILE . . . . . . . . . . . . . 67.9 mt -68.39 139.28 20.92 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.324 0 N-CA-C 109.47 -0.567 . . . . 0.0 109.47 176.586 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' C' C ' 84' ' ' LYS . . . . . . . . . . . . . 68.5 tttt -98.42 -54.14 3.13 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.112 -0.495 . . . . 0.0 110.704 -176.009 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' C' C ' 85' ' ' ASP . . . . . . . . . . . . . 6.9 t70 -152.14 155.31 37.6 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 115.885 -0.598 . . . . 0.0 110.353 -177.883 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' C' C ' 86' ' ' VAL . . . . . . . . . . . . . 40.3 t -133.17 132.23 58.48 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.254 0 CA-C-O 121.017 0.437 . . . . 0.0 110.729 -178.485 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' C' C ' 87' ' ' ILE . . . . . . . . . . . . . 45.1 mm -117.63 122.28 69.47 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.276 0 CA-C-N 115.776 -0.647 . . . . 0.0 109.325 174.431 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' C' C ' 88' ' ' LEU . . . . . . . . . . . . . 13.4 tp -113.04 130.75 56.04 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-O 120.992 0.425 . . . . 0.0 110.998 -176.219 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' C' C ' 89' ' ' ASP . . . . . . . . . . . . . 11.7 t70 -128.65 160.24 33.06 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 115.888 -0.597 . . . . 0.0 109.863 178.38 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' C' C ' 90' ' ' GLU . . . . . . . . . . . . . 83.3 tt0 -46.23 -41.13 12.45 Favored 'General case' 0 CA--C 1.532 0.282 0 N-CA-C 113.073 0.768 . . . . 0.0 113.073 -172.041 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' C' C ' 91' ' ' ASN . . . . . . . . . . . . . 25.6 m120 -132.05 27.55 4.53 Favored 'General case' 0 N--CA 1.467 0.409 0 N-CA-C 112.44 0.533 . . . . 0.0 112.44 -177.451 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' C' C ' 92' ' ' LEU . . . . . . . . . . . . . 12.2 mt -149.98 141.17 23.11 Favored 'General case' 0 C--N 1.33 -0.265 0 N-CA-C 110.221 -0.288 . . . . 0.0 110.221 -177.43 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' C' C ' 93' ' ' ILE . . . . . . . . . . . . . 73.0 mt -124.5 113.63 37.22 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.284 0 N-CA-C 109.075 -0.713 . . . . 0.0 109.075 176.887 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' C' C ' 94' ' ' VAL . . . . . . . . . . . . . 45.0 t -116.6 126.49 74.08 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.247 0 N-CA-C 109.806 -0.442 . . . . 0.0 109.806 -179.388 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' C' C ' 95' ' ' VAL . . . . . . . . . . . . . 40.2 t -124.38 136.63 59.89 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.325 0 CA-C-N 116.28 -0.418 . . . . 0.0 110.056 -178.687 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' C' C ' 96' ' ' ILE . . . . . . . . . . . . . 61.4 mt -116.55 130.55 71.19 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.361 0 N-CA-C 109.221 -0.659 . . . . 0.0 109.221 179.112 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' C' C ' 97' ' ' THR . . . . . . . . . . . . . 71.4 p -98.37 159.99 14.58 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-O 120.908 0.385 . . . . 0.0 110.619 -178.346 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' C' C ' 98' ' ' GLU . . . . . . . . . . . . . 12.8 pt-20 -53.99 -19.27 4.45 Favored 'General case' 0 CA--C 1.535 0.367 0 N-CA-C 112.801 0.667 . . . . 0.0 112.801 -179.266 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' C' C ' 99' ' ' GLU . . . . . . . . . . . . . 37.1 tt0 -85.67 16.34 4.02 Favored 'General case' 0 CA--C 1.539 0.545 0 N-CA-C 112.567 0.58 . . . . 0.0 112.567 -177.259 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' C' C ' 100' ' ' ASN . . . . . . . . . . . . . 3.4 m-20 61.14 38.06 17.18 Favored 'General case' 0 CA--C 1.529 0.17 0 O-C-N 121.818 -0.551 . . . . 0.0 110.971 178.564 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' C' C ' 101' ' ' GLU . . . . . . . . . . . . . 82.0 tt0 -116.12 143.24 45.74 Favored 'General case' 0 C--N 1.331 -0.207 0 N-CA-C 109.444 -0.576 . . . . 0.0 109.444 175.831 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' C' C ' 102' ' ' VAL . . . . . . . . . . . . . 44.4 t -117.66 128.41 74.87 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.263 0 CA-C-O 120.972 0.415 . . . . 0.0 110.098 -177.609 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' C' C ' 103' ' ' LEU . . . . . . . . . . . . . 25.0 mt -118.38 136.35 53.8 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 115.564 -0.743 . . . . 0.0 109.752 176.164 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' C' C ' 104' ' ' ILE . . . . . . . . . . . . . 69.2 mt -118.19 121.34 66.99 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.244 0 N-CA-C 109.844 -0.428 . . . . 0.0 109.844 179.725 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' C' C ' 105' ' ' PHE . . . . . . . . . . . . . 53.9 m-85 -118.11 161.31 20.06 Favored 'General case' 0 C--N 1.333 -0.139 0 O-C-N 124.183 0.927 . . . . 0.0 109.836 -179.328 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' C' C ' 106' ' ' ASN . . . . . . . . . . . . . 44.7 p-10 -98.82 -171.04 2.03 Favored 'General case' 0 C--N 1.33 -0.246 0 N-CA-C 110.049 -0.352 . . . . 0.0 110.049 175.427 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' C' C ' 107' ' ' GLN . . . . . . . . . . . . . 41.0 tt0 -58.29 -30.13 66.39 Favored 'General case' 0 C--N 1.329 -0.284 0 N-CA-C 111.968 0.358 . . . . 0.0 111.968 -179.459 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' C' C ' 108' ' ' ASN . . . . . . . . . . . . . 12.9 t30 -86.17 8.78 19.68 Favored 'General case' 0 CA--C 1.535 0.398 0 N-CA-C 113.475 0.917 . . . . 0.0 113.475 -175.954 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' C' C ' 109' ' ' LEU . . . . . 0.663 HD21 ' HB2' ' C' ' 78' ' ' ALA . 11.9 tp 62.96 38.55 11.06 Favored 'General case' 0 CA--C 1.53 0.185 0 CA-C-O 121.073 0.464 . . . . 0.0 111.301 177.752 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' C' C ' 110' ' ' GLU . . . . . . . . . . . . . 70.7 mm-40 -109.16 157.43 18.78 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 116.37 -0.377 . . . . 0.0 110.114 176.211 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' C' C ' 111' ' ' GLU . . . . . . . . . . . . . 98.5 mt-10 -86.35 124.24 32.48 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-O 120.806 0.336 . . . . 0.0 111.263 -178.401 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' C' C ' 112' ' ' LEU . . . . . . . . . . . . . 13.5 mt -111.14 -45.99 3.37 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 115.982 -0.554 . . . . 0.0 110.711 178.479 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' C' C ' 113' ' ' TYR . . . . . . . . . . . . . 61.6 t80 -135.85 142.45 44.79 Favored 'General case' 0 N--CA 1.464 0.256 0 C-N-CA 120.749 -0.381 . . . . 0.0 111.532 -178.224 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' C' C ' 114' ' ' ARG . . . . . . . . . . . . . 51.3 mtt85 -135.75 125.88 26.2 Favored 'General case' 0 C--N 1.331 -0.21 0 CA-C-N 115.996 -0.547 . . . . 0.0 109.937 179.684 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' C' C ' 115' ' ' GLY . . . . . . . . . . . . . . . -150.13 155.06 26.04 Favored Glycine 0 CA--C 1.524 0.65 0 C-N-CA 120.643 -0.789 . . . . 0.0 111.296 177.886 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' C' C ' 116' ' ' LYS . . . . . . . . . . . . . 36.1 ttpt -129.98 136.07 49.02 Favored 'General case' 0 C--N 1.331 -0.224 0 N-CA-C 109.64 -0.504 . . . . 0.0 109.64 175.875 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' C' C ' 117' ' ' PHE . . . . . . . . . . . . . 40.0 m-85 -137.7 113.92 10.08 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-O 120.927 0.394 . . . . 0.0 110.313 -176.033 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' C' C ' 118' ' ' GLU . . . . . . . . . . . . . 95.7 mt-10 -56.0 -46.4 78.74 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.388 -0.369 . . . . 0.0 110.976 -176.321 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' C' C ' 119' ' ' ASN . . . . . . . . . . . . . 71.0 m-80 -95.86 31.03 2.19 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.102 -0.499 . . . . 0.0 112.002 -174.99 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' C' C ' 120' ' ' LEU . . . . . . . . . . . . . 12.2 tp -56.7 119.96 7.02 Favored 'General case' 0 C--N 1.333 -0.144 0 C-N-CA 120.993 -0.283 . . . . 0.0 110.278 178.284 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' C' C ' 121' ' ' ASN . . . . . . . . . . . . . 56.3 m-20 -114.08 -44.2 3.17 Favored 'General case' 0 C--N 1.331 -0.226 0 CA-C-N 116.491 -0.322 . . . . 0.0 110.983 -176.883 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' C' C ' 122' ' ' LYS . . . . . . . . . . . . . 92.5 mttt -143.26 145.21 32.54 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-O 121.126 0.489 . . . . 0.0 111.688 -178.133 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' C' C ' 123' ' ' VAL . . . . . . . . . . . . . 43.8 t -124.75 126.2 71.11 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.262 0 CA-C-N 115.735 -0.666 . . . . 0.0 109.325 174.997 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' C' C ' 124' ' ' LEU . . . . . . . . . . . . . 74.4 mt -115.13 129.45 56.67 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.507 -0.315 . . . . 0.0 110.379 -177.122 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' C' C ' 125' ' ' VAL . . . . . . . . . . . . . 43.6 t -127.9 122.6 58.99 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.225 0 CA-C-N 116.282 -0.417 . . . . 0.0 109.898 178.851 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' C' C ' 126' ' ' ARG . . . . . . . . . . . . . 80.9 mtt85 -151.99 135.6 16.18 Favored 'General case' 0 C--N 1.33 -0.255 0 N-CA-C 109.748 -0.464 . . . . 0.0 109.748 178.267 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' C' C ' 127' ' ' ASN . . . . . . . . . . . . . 3.1 m120 55.99 -154.99 0.3 Allowed 'General case' 0 CA--C 1.539 0.549 0 N-CA-C 109.644 -0.502 . . . . 0.0 109.644 -179.282 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' C' C ' 128' ' ' ASP . . . . . . . . . . . . . 9.3 p-10 -84.88 21.47 1.58 Allowed 'General case' 0 CA--C 1.535 0.384 0 CA-C-N 118.432 0.56 . . . . 0.0 112.199 175.831 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' C' C ' 129' ' ' LEU . . . . . . . . . . . . . 12.8 tp -116.42 137.76 51.9 Favored 'General case' 0 C--O 1.234 0.254 0 CA-C-O 120.91 0.386 . . . . 0.0 110.381 -179.676 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' C' C ' 130' ' ' VAL . . . . . . . . . . . . . 42.8 t -124.33 136.8 59.32 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.204 0 CA-C-N 116.079 -0.509 . . . . 0.0 110.049 -178.864 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' C' C ' 131' ' ' VAL . . . . . . . . . . . . . 44.6 t -136.02 137.79 48.24 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.292 0 CA-C-O 120.946 0.403 . . . . 0.0 110.329 179.181 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' C' C ' 132' ' ' ILE . . . . . . . . . . . . . 72.4 mt -121.26 134.09 65.74 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.247 0 CA-C-N 116.064 -0.516 . . . . 0.0 109.795 -179.027 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' C' C ' 133' ' ' ILE . . . . . . . . . . . . . 42.9 mm -117.2 121.56 67.97 Favored 'Isoleucine or valine' 0 C--O 1.233 0.228 0 CA-C-O 120.834 0.349 . . . . 0.0 111.156 -176.275 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' C' C ' 134' ' ' ASP . . . . . . . . . . . . . 6.9 p-10 -133.47 147.12 51.65 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 115.78 -0.645 . . . . 0.0 109.52 174.003 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' C' C ' 135' ' ' GLU . . . . . . . . . . . . . 83.3 tt0 -50.05 -25.05 3.05 Favored 'General case' 0 C--N 1.327 -0.373 0 N-CA-C 112.96 0.726 . . . . 0.0 112.96 -171.247 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' C' C ' 136' ' ' GLN . . . . . . . . . . . . . 95.6 mm-40 -93.46 -35.03 13.17 Favored 'General case' 0 C--N 1.33 -0.267 0 N-CA-C 112.633 0.605 . . . . 0.0 112.633 -176.379 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' C' C ' 137' ' ' LYS . . . . . . . . . . . . . 50.0 mtmt -146.2 154.74 42.1 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-O 121.303 0.573 . . . . 0.0 112.056 -169.13 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' C' C ' 138' ' ' LEU . . . . . 0.423 HD23 ' C ' ' C' ' 138' ' ' LEU . 5.5 tt -116.81 123.45 47.15 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 115.349 -0.841 . . . . 0.0 109.16 175.151 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' C' C ' 139' ' ' THR . . . . . . . . . . . . . 30.7 m -111.57 129.71 55.98 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 116.483 -0.326 . . . . 0.0 110.97 -175.939 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' C' C ' 140' ' ' LEU . . . . . 0.473 ' C ' HD23 ' C' ' 140' ' ' LEU . 7.4 tt -117.77 124.36 48.24 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 115.747 -0.66 . . . . 0.0 109.449 -179.624 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' C' C ' 141' ' ' ILE . . . . . . . . . . . . . 19.0 mt -122.43 120.54 61.35 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.277 0 N-CA-C 109.909 -0.404 . . . . 0.0 109.909 -175.972 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' C' C ' 142' ' ' ARG . . . . . . . . . . . . . 78.3 ttt-85 . . . . . 0 C--N 1.33 -0.248 0 CA-C-N 115.84 -0.618 . . . . 0.0 110.099 -178.086 . . . . . . . . 0 0 . 1 . 018 nuclear nobuild core ' D' D ' 2' ' ' SER . . . . . . . . . . . . . 79.5 p . . . . . 0 C--O 1.232 0.183 0 CA-C-O 120.92 0.39 . . . . 0.0 110.522 . . . . . . . . . 0 0 . 1 . 018 nuclear nobuild core ' D' D ' 3' ' ' GLU . . . . . . . . . . . . . 84.9 tt0 -140.22 138.4 35.06 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.063 -0.517 . . . . 0.0 110.987 -178.647 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' D' D ' 4' ' ' LEU . . . . . 0.491 HD21 HG13 ' D' ' 50' ' ' VAL . 4.9 tt -124.25 130.23 52.15 Favored 'General case' 0 C--N 1.332 -0.187 0 CA-C-N 115.96 -0.564 . . . . 0.0 110.137 178.309 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' D' D ' 5' ' ' LYS . . . . . 0.415 ' N ' HD23 ' D' ' 4' ' ' LEU . 67.6 mttm -109.65 122.58 47.78 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.455 -0.339 . . . . 0.0 111.017 -178.739 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' D' D ' 6' ' ' LEU . . . . . 0.453 HD23 ' HA ' ' D' ' 50' ' ' VAL . 79.6 mt -115.38 149.78 37.41 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 115.369 -0.832 . . . . 0.0 110.331 179.793 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' D' D ' 7' ' ' LYS . . . . . . . . . . . . . 64.1 tttm -137.45 137.07 21.29 Favored Pre-proline 0 CA--C 1.534 0.338 0 CA-C-O 119.014 -0.517 . . . . 0.0 110.087 176.587 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' D' D ' 8' ' ' PRO . . . . . . . . . . . . . 93.1 Cg_endo -92.01 141.73 2.49 Favored 'Trans proline' 0 N--CA 1.49 1.3 0 C-N-CA 121.823 1.682 . . . . 0.0 111.491 176.701 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' D' D ' 9' ' ' LEU . . . . . . . . . . . . . 66.7 mt -75.86 -47.48 3.84 Favored Pre-proline 0 CA--C 1.533 0.292 0 CA-C-O 118.74 -0.648 . . . . 0.0 112.219 -178.439 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' D' D ' 10' ' ' PRO . . . . . . . . . . . . . 98.6 Cg_endo -81.74 149.04 16.04 Favored 'Trans proline' 0 N--CA 1.495 1.612 0 C-N-CA 121.184 1.256 . . . . 0.0 111.852 175.542 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' D' D ' 11' ' ' LYS . . . . . . . . . . . . . 24.3 tptp -88.86 100.53 13.24 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-O 120.764 0.316 . . . . 0.0 110.399 179.539 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' D' D ' 12' ' ' VAL . . . . . . . . . . . . . 11.4 p -139.62 142.23 33.19 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.233 0 CA-C-N 116.358 -0.383 . . . . 0.0 110.548 -179.206 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' D' D ' 13' ' ' GLU . . . . . . . . . . . . . 43.1 mp0 -78.17 122.44 25.65 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 116.3 -0.409 . . . . 0.0 110.165 178.041 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' D' D ' 14' ' ' LEU . . . . . . . . . . . . . 35.8 mt -98.4 153.44 38.02 Favored Pre-proline 0 CA--C 1.532 0.285 0 CA-C-N 116.462 -0.336 . . . . 0.0 110.51 -179.283 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' D' D ' 15' ' ' PRO . . . . . . . . . . . . . 33.5 Cg_exo -60.56 157.41 36.92 Favored 'Trans proline' 0 N--CA 1.496 1.653 0 C-N-CA 121.256 1.304 . . . . 0.0 111.792 176.801 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' D' D ' 16' ' ' PRO . . . . . . . . . . . . . 36.2 Cg_exo -58.83 -37.39 94.05 Favored 'Trans proline' 0 N--CA 1.498 1.737 0 C-N-CA 121.376 1.384 . . . . 0.0 112.654 -178.177 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' D' D ' 17' ' ' ASP . . . . . . . . . . . . . 7.1 p-10 -88.46 9.94 21.9 Favored 'General case' 0 CA--C 1.534 0.355 0 N-CA-C 113.284 0.846 . . . . 0.0 113.284 -176.832 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' D' D ' 18' ' ' PHE . . . . . . . . . . . . . 19.8 t80 -57.72 -45.06 86.25 Favored 'General case' 0 C--N 1.334 -0.091 0 O-C-N 121.916 -0.49 . . . . 0.0 110.041 -177.653 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' D' D ' 19' ' ' VAL . . . . . . . . . . . . . 48.0 t -57.61 -43.15 82.82 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.286 0 CA-C-N 116.273 -0.421 . . . . 0.0 110.548 -178.521 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' D' D ' 20' ' ' ASP . . . . . . . . . . . . . 82.5 m-20 -60.15 -42.56 95.15 Favored 'General case' 0 C--N 1.33 -0.258 0 C-N-CA 120.837 -0.345 . . . . 0.0 111.112 -176.789 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' D' D ' 21' ' ' VAL . . . . . . . . . . . . . 45.6 t -64.73 -46.28 92.67 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.33 0 C-N-CA 120.807 -0.357 . . . . 0.0 110.347 -177.863 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' D' D ' 22' ' ' ILE . . . . . . . . . . . . . 50.5 mm -56.91 -42.98 79.61 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.229 0 C-N-CA 120.815 -0.354 . . . . 0.0 110.441 178.379 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' D' D ' 23' ' ' ARG . . . . . . . . . . . . . 54.7 ttp180 -53.5 -47.39 69.9 Favored 'General case' 0 C--N 1.33 -0.266 0 O-C-N 122.32 -0.237 . . . . 0.0 111.339 -179.208 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' D' D ' 24' ' ' ILE . . . . . . . . . . . . . 71.7 mt -60.02 -43.41 92.52 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.342 0 C-N-CA 120.933 -0.307 . . . . 0.0 110.698 179.541 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' D' D ' 25' ' ' LYS . . . . . . . . . . . . . 89.0 mttt -61.73 -38.09 86.62 Favored 'General case' 0 C--N 1.328 -0.343 0 N-CA-C 112.379 0.511 . . . . 0.0 112.379 -179.564 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' D' D ' 26' ' ' LEU . . . . . . . . . . . . . 86.3 mt -77.99 -46.63 20.52 Favored 'General case' 0 C--N 1.329 -0.32 0 N-CA-C 112.702 0.63 . . . . 0.0 112.702 -171.719 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' D' D ' 27' ' ' GLN . . . . . . . . . . . . . 11.2 pt20 -47.03 137.76 7.25 Favored 'General case' 0 N--CA 1.47 0.556 0 N-CA-C 112.75 0.648 . . . . 0.0 112.75 -175.839 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' D' D ' 28' ' ' GLY . . . . . . . . . . . . . . . 101.14 -26.86 23.1 Favored Glycine 0 CA--C 1.531 1.092 0 CA-C-N 115.591 -0.731 . . . . 0.0 112.312 -178.454 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' D' D ' 29' ' ' LYS . . . . . . . . . . . . . 87.4 mttt -99.67 155.14 17.77 Favored 'General case' 0 C--N 1.332 -0.182 0 CA-C-N 117.398 0.599 . . . . 0.0 111.385 179.707 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' D' D ' 30' ' ' THR . . . . . . . . . . . . . 22.2 m -101.07 135.38 42.63 Favored 'General case' 0 C--N 1.33 -0.239 0 CA-C-N 116.099 -0.501 . . . . 0.0 109.662 174.119 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' D' D ' 31' ' ' VAL . . . . . . . . . . . . . 34.3 m -127.48 156.33 39.12 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.226 0 CA-C-O 120.866 0.365 . . . . 0.0 111.14 -177.644 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' D' D ' 32' ' ' ARG . . . . . . . . . . . . . 72.8 mtt85 -132.93 149.35 52.25 Favored 'General case' 0 C--O 1.233 0.186 0 CA-C-N 115.724 -0.671 . . . . 0.0 110.838 178.864 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' D' D ' 33' ' ' THR . . . . . 0.432 HG23 ' HA ' ' D' ' 52' ' ' GLN . 23.7 m -53.8 140.46 29.97 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.07 -0.514 . . . . 0.0 111.146 -179.784 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' D' D ' 34' ' ' GLY . . . . . . . . . . . . . . . 99.7 -17.08 57.99 Favored Glycine 0 CA--C 1.531 1.047 0 C-N-CA 121.105 -0.569 . . . . 0.0 113.31 178.753 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' D' D ' 35' ' ' ASP . . . . . . . . . . . . . 75.8 m-20 -62.15 147.63 47.03 Favored 'General case' 0 N--CA 1.461 0.125 0 CA-C-N 118.054 0.927 . . . . 0.0 111.156 179.683 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' D' D ' 36' ' ' VAL . . . . . . . . . . . . . 46.5 t -124.63 129.12 73.79 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.234 0 CA-C-N 115.659 -0.7 . . . . 0.0 109.721 178.883 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' D' D ' 37' ' ' ILE . . . . . . . . . . . . . 68.0 mt -120.74 137.6 53.95 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.229 0 N-CA-C 109.857 -0.423 . . . . 0.0 109.857 -179.706 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' D' D ' 38' ' ' GLY . . . . . . . . . . . . . . . -111.5 128.74 8.8 Favored Glycine 0 CA--C 1.525 0.666 0 N-CA-C 111.018 -0.833 . . . . 0.0 111.018 179.606 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' D' D ' 39' ' ' ILE . . . . . . . . . . . . . 69.6 mt -125.44 126.64 70.89 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.228 0 N-CA-C 109.849 -0.426 . . . . 0.0 109.849 178.782 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' D' D ' 40' ' ' SER . . . . . . . . . . . . . 46.6 t -93.4 120.45 33.69 Favored 'General case' 0 C--N 1.33 -0.262 0 C-N-CA 120.825 -0.35 . . . . 0.0 110.88 176.158 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' D' D ' 41' ' ' ILE . . . . . . . . . . . . . 71.1 mt -132.88 125.47 52.32 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.186 0 CA-C-O 120.749 0.309 . . . . 0.0 110.316 178.589 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' D' D ' 42' ' ' LEU . . . . . . . . . . . . . 61.4 mt 57.5 34.39 24.54 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.098 -0.501 . . . . 0.0 111.891 177.296 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' D' D ' 43' ' ' GLY . . . . . . . . . . . . . . . 78.52 -10.11 31.88 Favored Glycine 0 CA--C 1.535 1.295 0 C-N-CA 121.192 -0.528 . . . . 0.0 113.463 176.975 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' D' D ' 44' ' ' LYS . . . . . . . . . . . . . 52.7 mtmt -101.76 130.25 48.13 Favored 'General case' 0 C--N 1.333 -0.14 0 CA-C-N 117.884 0.842 . . . . 0.0 110.066 176.65 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' D' D ' 45' ' ' GLU . . . . . . . . . . . . . 38.9 tp10 -85.53 130.33 34.6 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.4 -0.364 . . . . 0.0 110.777 -179.924 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' D' D ' 46' ' ' VAL . . . . . . . . . . . . . 7.2 p -121.61 129.46 75.5 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.235 0 N-CA-C 109.631 -0.507 . . . . 0.0 109.631 176.298 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' D' D ' 47' ' ' LYS . . . . . . . . . . . . . 98.5 mttt -101.03 130.44 47.03 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 115.892 -0.595 . . . . 0.0 111.119 178.387 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' D' D ' 48' ' ' PHE . . . . . . . . . . . . . 95.3 m-85 -113.41 131.83 55.85 Favored 'General case' 0 C--N 1.33 -0.244 0 N-CA-C 109.831 -0.433 . . . . 0.0 109.831 176.211 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' D' D ' 49' ' ' LYS . . . . . . . . . . . . . 81.8 tttt -110.5 139.11 46.05 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.402 -0.363 . . . . 0.0 110.63 179.454 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' D' D ' 50' ' ' VAL . . . . . 0.491 HG13 HD21 ' D' ' 4' ' ' LEU . 42.5 t -83.53 108.13 15.76 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.276 0 N-CA-C 109.4 -0.593 . . . . 0.0 109.4 175.59 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' D' D ' 51' ' ' VAL . . . . . . . . . . . . . 48.8 t -70.37 -48.26 61.36 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.314 0 CA-C-N 116.039 -0.528 . . . . 0.0 109.851 -173.816 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' D' D ' 52' ' ' GLN . . . . . 0.432 ' HA ' HG23 ' D' ' 33' ' ' THR . 14.0 pt20 -167.79 157.6 10.24 Favored 'General case' 0 C--N 1.331 -0.201 0 C-N-CA 120.115 -0.634 . . . . 0.0 112.017 -179.864 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' D' D ' 53' ' ' ALA . . . . . 0.656 ' HB3' ' OG ' ' D' ' 56' ' ' SER . . . -133.85 135.28 43.62 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 115.314 -0.857 . . . . 0.0 109.97 177.317 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' D' D ' 54' ' ' TYR . . . . . . . . . . . . . 13.8 t80 -129.01 111.69 18.47 Favored Pre-proline 0 CA--C 1.535 0.39 0 CA-C-O 118.24 -0.886 . . . . 0.0 110.133 179.163 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' D' D ' 55' ' ' PRO . . . . . . . . . . . . . 73.4 Cg_endo -77.12 170.21 72.21 Favored 'Cis proline' 0 N--CA 1.501 1.93 0 CA-C-N 121.899 1.714 . . . . 0.0 112.127 -7.587 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' D' D ' 56' ' ' SER . . . . . 0.656 ' OG ' ' HB3' ' D' ' 53' ' ' ALA . 66.0 m -129.71 140.64 39.23 Favored Pre-proline 0 CA--C 1.538 0.499 0 CA-C-O 118.71 -0.662 . . . . 0.0 109.489 174.52 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' D' D ' 57' ' ' PRO . . . . . . . . . . . . . 38.3 Cg_endo -68.05 156.31 87.46 Favored 'Cis proline' 0 N--CA 1.499 1.836 0 CA-C-N 121.559 1.592 . . . . 0.0 111.723 -2.018 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' D' D ' 58' ' ' LEU . . . . . . . . . . . . . 32.4 tp -128.75 138.86 52.34 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.252 -0.431 . . . . 0.0 110.778 -176.664 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' D' D ' 59' ' ' ARG . . . . . . . . . . . . . 60.1 ttt180 -100.48 120.36 39.88 Favored 'General case' 0 C--N 1.327 -0.4 0 N-CA-C 108.904 -0.776 . . . . 0.0 108.904 173.413 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' D' D ' 60' ' ' VAL . . . . . . . . . . . . . 43.3 t -72.63 126.38 33.12 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.252 0 C-N-CA 120.67 -0.412 . . . . 0.0 110.279 -174.084 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' D' D ' 61' ' ' GLU . . . . . . . . . . . . . 95.5 mt-10 -130.39 162.88 28.12 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 115.85 -0.613 . . . . 0.0 109.687 178.567 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' D' D ' 62' ' ' ASP . . . . . . . . . . . . . 5.2 t70 -53.34 -32.08 47.44 Favored 'General case' 0 C--N 1.328 -0.353 0 N-CA-C 111.782 0.29 . . . . 0.0 111.782 -179.638 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' D' D ' 63' ' ' ARG . . . . . . . . . . . . . 34.4 ptt180 -84.07 4.26 30.98 Favored 'General case' 0 CA--C 1.537 0.456 0 N-CA-C 113.779 1.029 . . . . 0.0 113.779 -174.926 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' D' D ' 64' ' ' THR . . . . . . . . . . . . . 35.4 m -86.93 139.61 30.45 Favored 'General case' 0 C--N 1.332 -0.186 0 CA-C-N 118.211 0.46 . . . . 0.0 110.713 -178.659 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' D' D ' 65' ' ' LYS . . . . . . . . . . . . . 67.5 mttm -90.14 134.05 34.51 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.252 -0.431 . . . . 0.0 110.581 -179.443 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' D' D ' 66' ' ' ILE . . . . . . . . . . . . . 58.8 mt -116.35 134.32 60.15 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.201 0 CA-C-O 120.897 0.379 . . . . 0.0 110.002 -179.719 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' D' D ' 67' ' ' THR . . . . . . . . . . . . . 34.6 m -125.31 141.46 52.07 Favored 'General case' 0 C--N 1.332 -0.17 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.92 -178.344 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' D' D ' 68' ' ' LEU . . . . . 0.426 ' C ' HD23 ' D' ' 68' ' ' LEU . 5.3 tt . . . . . 0 C--N 1.33 -0.257 0 CA-C-N 116.002 -0.544 . . . . 0.0 110.128 178.468 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' D' D ' 73' ' ' VAL . . . . . . . . . . . . . 27.7 m . . . . . 0 C--O 1.232 0.134 0 CA-C-O 120.628 0.251 . . . . 0.0 110.468 . . . . . . . . . 0 0 . 1 . 018 nuclear nobuild core ' D' D ' 74' ' ' ASP . . . . . . . . . . . . . 10.3 t0 -103.68 117.98 35.66 Favored 'General case' 0 C--N 1.33 -0.242 0 N-CA-C 109.796 -0.446 . . . . 0.0 109.796 179.821 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' D' D ' 75' ' ' VAL . . . . . . . . . . . . . 45.4 t -113.52 122.86 68.46 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.227 0 CA-C-O 121.173 0.511 . . . . 0.0 110.474 -178.756 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' D' D ' 76' ' ' LEU . . . . . . . . . . . . . 24.5 mt -122.71 138.04 54.73 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 115.398 -0.819 . . . . 0.0 109.035 176.451 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' D' D ' 77' ' ' GLU . . . . . . . . . . . . . 58.6 tt0 -136.84 135.34 37.83 Favored 'General case' 0 C--N 1.331 -0.197 0 CA-C-O 121.027 0.441 . . . . 0.0 110.995 -177.133 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' D' D ' 78' ' ' ALA . . . . . 0.576 ' HB2' HD21 ' D' ' 109' ' ' LEU . . . -122.47 137.67 54.8 Favored 'General case' 0 C--N 1.331 -0.203 0 CA-C-N 115.862 -0.608 . . . . 0.0 109.926 178.517 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' D' D ' 79' ' ' LYS . . . . . 0.59 ' O ' HD13 ' D' ' 80' ' ' ILE . 54.2 mtmt -81.97 120.41 25.21 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-O 120.884 0.374 . . . . 0.0 110.483 179.831 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' D' D ' 80' ' ' ILE . . . . . 0.59 HD13 ' O ' ' D' ' 79' ' ' LYS . 42.6 mm -138.99 112.55 6.76 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.344 0 N-CA-C 109.254 -0.647 . . . . 0.0 109.254 -177.423 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' D' D ' 81' ' ' LYS . . . . . . . . . . . . . 9.3 mtmp? -103.33 126.88 50.72 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-O 120.91 0.386 . . . . 0.0 111.259 -177.158 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' D' D ' 82' ' ' GLY . . . . . . . . . . . . . . . 89.18 42.06 5.68 Favored Glycine 0 CA--C 1.525 0.712 0 C-N-CA 120.989 -0.624 . . . . 0.0 111.645 174.795 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' D' D ' 83' ' ' ILE . . . . . . . . . . . . . 72.5 mt -69.92 134.71 29.65 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.331 0 N-CA-C 109.501 -0.555 . . . . 0.0 109.501 176.347 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' D' D ' 84' ' ' LYS . . . . . . . . . . . . . 35.7 ttpt -98.65 -54.11 3.12 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-O 121.057 0.456 . . . . 0.0 110.423 -178.811 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' D' D ' 85' ' ' ASP . . . . . . . . . . . . . 10.6 t70 -148.53 149.94 32.5 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 115.758 -0.656 . . . . 0.0 110.387 -178.168 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' D' D ' 86' ' ' VAL . . . . . . . . . . . . . 40.7 t -127.41 129.51 70.58 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.252 0 CA-C-O 120.813 0.339 . . . . 0.0 110.474 -178.906 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' D' D ' 87' ' ' ILE . . . . . . . . . . . . . 43.7 mm -119.49 130.87 73.48 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.255 0 CA-C-N 115.98 -0.554 . . . . 0.0 109.61 177.305 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' D' D ' 88' ' ' LEU . . . . . . . . . . . . . 19.3 tp -115.42 135.79 53.75 Favored 'General case' 0 C--N 1.331 -0.205 0 CA-C-O 120.952 0.406 . . . . 0.0 111.544 -175.797 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' D' D ' 89' ' ' ASP . . . . . . . . . . . . . 13.3 t70 -128.67 156.97 42.6 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-N 115.755 -0.657 . . . . 0.0 109.537 176.091 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' D' D ' 90' ' ' GLU . . . . . . . . . . . . . 70.8 mm-40 -46.96 -38.53 10.79 Favored 'General case' 0 N--CA 1.465 0.305 0 N-CA-C 113.035 0.754 . . . . 0.0 113.035 -171.102 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' D' D ' 91' ' ' ASN . . . . . . . . . . . . . 59.7 m-80 -131.97 20.0 4.54 Favored 'General case' 0 N--CA 1.467 0.413 0 N-CA-C 112.968 0.729 . . . . 0.0 112.968 -177.421 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' D' D ' 92' ' ' LEU . . . . . 0.408 HD21 HG21 ' D' ' 143' ' ' THR . 15.8 mt -147.04 143.93 28.73 Favored 'General case' 0 C--N 1.331 -0.213 0 N-CA-C 110.141 -0.318 . . . . 0.0 110.141 -176.654 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' D' D ' 93' ' ' ILE . . . . . . . . . . . . . 75.2 mt -123.55 119.5 57.44 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.285 0 N-CA-C 109.294 -0.632 . . . . 0.0 109.294 179.035 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' D' D ' 94' ' ' VAL . . . . . 0.475 HG21 HG11 ' D' ' 125' ' ' VAL . 46.5 t -118.35 125.09 74.04 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.208 0 CA-C-O 120.988 0.423 . . . . 0.0 109.912 -178.57 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' D' D ' 95' ' ' VAL . . . . . . . . . . . . . 47.0 t -118.72 131.98 69.91 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.344 0 CA-C-N 115.862 -0.608 . . . . 0.0 109.643 -179.564 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' D' D ' 96' ' ' ILE . . . . . . . . . . . . . 68.7 mt -112.61 126.79 70.04 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.328 0 N-CA-C 109.184 -0.672 . . . . 0.0 109.184 178.354 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' D' D ' 97' ' ' THR . . . . . . . . . . . . . 78.4 p -97.63 159.64 14.8 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-O 121.28 0.562 . . . . 0.0 111.214 -176.678 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' D' D ' 98' ' ' GLU . . . . . . . . . . . . . 85.4 tt0 -53.96 -27.48 31.5 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 115.906 -0.588 . . . . 0.0 112.202 -179.061 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' D' D ' 99' ' ' GLU . . . . . . . . . . . . . 95.2 mt-10 -82.32 15.4 2.47 Favored 'General case' 0 CA--C 1.535 0.403 0 N-CA-C 113.14 0.793 . . . . 0.0 113.14 -176.581 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' D' D ' 100' ' ' ASN . . . . . . . . . . . . . 4.1 m-20 62.2 35.63 15.41 Favored 'General case' 0 C--N 1.331 -0.212 0 CA-C-O 120.949 0.404 . . . . 0.0 111.441 179.675 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' D' D ' 101' ' ' GLU . . . . . . . . . . . . . 84.2 tt0 -109.04 143.83 37.84 Favored 'General case' 0 C--N 1.331 -0.203 0 N-CA-C 109.595 -0.521 . . . . 0.0 109.595 173.227 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' D' D ' 102' ' ' VAL . . . . . . . . . . . . . 43.0 t -114.94 125.24 72.21 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.292 0 CA-C-N 116.206 -0.452 . . . . 0.0 109.944 -177.399 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' D' D ' 103' ' ' LEU . . . . . . . . . . . . . 16.8 mt -116.13 130.18 56.68 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 115.877 -0.601 . . . . 0.0 110.256 177.532 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' D' D ' 104' ' ' ILE . . . . . . . . . . . . . 70.9 mt -116.98 121.94 68.92 Favored 'Isoleucine or valine' 0 C--O 1.235 0.299 0 N-CA-C 110.286 -0.265 . . . . 0.0 110.286 179.83 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' D' D ' 105' ' ' PHE . . . . . . . . . . . . . 86.7 m-85 -121.67 163.47 18.95 Favored 'General case' 0 CA--C 1.528 0.134 0 O-C-N 124.052 0.845 . . . . 0.0 109.885 179.0 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' D' D ' 106' ' ' ASN . . . . . . . . . . . . . 40.6 p-10 -96.72 -169.94 1.97 Allowed 'General case' 0 C--N 1.33 -0.274 0 N-CA-C 109.913 -0.403 . . . . 0.0 109.913 173.075 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' D' D ' 107' ' ' GLN . . . . . . . . . . . . . 34.3 tt0 -60.59 -30.09 69.6 Favored 'General case' 0 CA--C 1.532 0.269 0 C-N-CA 121.014 -0.275 . . . . 0.0 111.628 179.565 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' D' D ' 108' ' ' ASN . . . . . . . . . . . . . 4.0 t-20 -82.67 4.79 23.5 Favored 'General case' 0 CA--C 1.536 0.421 0 N-CA-C 113.355 0.872 . . . . 0.0 113.355 -178.454 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' D' D ' 109' ' ' LEU . . . . . 0.576 HD21 ' HB2' ' D' ' 78' ' ' ALA . 7.4 tp 63.87 36.69 10.13 Favored 'General case' 0 CA--C 1.53 0.185 0 O-C-N 122.13 -0.356 . . . . 0.0 111.467 177.492 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' D' D ' 110' ' ' GLU . . . . . . . . . . . . . 95.5 mt-10 -105.13 154.49 20.11 Favored 'General case' 0 C--N 1.331 -0.222 0 N-CA-C 109.887 -0.412 . . . . 0.0 109.887 176.401 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' D' D ' 111' ' ' GLU . . . . . . . . . . . . . 83.6 tt0 -80.46 124.87 29.29 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-O 120.952 0.406 . . . . 0.0 110.928 -176.506 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' D' D ' 112' ' ' LEU . . . . . . . . . . . . . 31.8 mt -111.89 -46.08 3.27 Favored 'General case' 0 C--N 1.331 -0.216 0 CA-C-N 115.995 -0.548 . . . . 0.0 110.511 178.355 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' D' D ' 113' ' ' TYR . . . . . . . . . . . . . 58.1 t80 -142.21 140.35 32.3 Favored 'General case' 0 C--N 1.328 -0.331 0 C-N-CA 120.792 -0.363 . . . . 0.0 111.242 -179.644 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' D' D ' 114' ' ' ARG . . . . . . . . . . . . . 33.6 ttp180 -136.82 126.48 25.4 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.202 -0.454 . . . . 0.0 110.419 176.975 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' D' D ' 115' ' ' GLY . . . . . . . . . . . . . . . -150.05 158.93 27.89 Favored Glycine 0 CA--C 1.524 0.636 0 N-CA-C 110.78 -0.928 . . . . 0.0 110.78 178.164 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' D' D ' 116' ' ' LYS . . . . . . . . . . . . . 79.3 tttt -136.02 131.75 35.38 Favored 'General case' 0 C--N 1.328 -0.331 0 N-CA-C 109.925 -0.398 . . . . 0.0 109.925 178.879 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' D' D ' 117' ' ' PHE . . . . . . . . . . . . . 32.4 m-85 -132.72 117.56 18.0 Favored 'General case' 0 N--CA 1.463 0.214 0 CA-C-O 120.929 0.395 . . . . 0.0 110.599 -173.72 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' D' D ' 118' ' ' GLU . . . . . . . . . . . . . 46.5 tp10 -52.88 -50.96 62.79 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.296 -0.411 . . . . 0.0 111.393 -177.577 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' D' D ' 119' ' ' ASN . . . . . . . . . . . . . 79.4 m-20 -93.61 31.07 1.62 Allowed 'General case' 0 C--N 1.33 -0.27 0 N-CA-C 112.202 0.445 . . . . 0.0 112.202 -173.783 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' D' D ' 120' ' ' LEU . . . . . . . . . . . . . 20.2 tp -58.36 124.58 20.01 Favored 'General case' 0 C--N 1.332 -0.195 0 N-CA-C 110.075 -0.343 . . . . 0.0 110.075 177.474 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' D' D ' 121' ' ' ASN . . . . . . . . . . . . . 4.4 m-20 -114.03 -44.09 3.18 Favored 'General case' 0 C--N 1.331 -0.213 0 CA-C-N 116.56 -0.291 . . . . 0.0 110.963 -178.143 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' D' D ' 122' ' ' LYS . . . . . . . . . . . . . 85.1 mttt -146.45 149.98 34.74 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-O 121.156 0.503 . . . . 0.0 111.902 -176.414 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' D' D ' 123' ' ' VAL . . . . . 0.433 ' C ' HD12 ' D' ' 124' ' ' LEU . 44.1 t -124.91 128.88 73.47 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.299 0 N-CA-C 109.211 -0.663 . . . . 0.0 109.211 172.873 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' D' D ' 124' ' ' LEU . . . . . 0.433 HD12 ' C ' ' D' ' 123' ' ' VAL . 6.6 mp -121.89 135.96 54.91 Favored 'General case' 0 C--N 1.332 -0.176 0 CA-C-N 116.609 -0.269 . . . . 0.0 110.732 -176.273 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' D' D ' 125' ' ' VAL . . . . . 0.475 HG11 HG21 ' D' ' 94' ' ' VAL . 35.5 m -136.72 130.21 45.96 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.193 0 CA-C-O 120.955 0.407 . . . . 0.0 110.983 178.734 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' D' D ' 126' ' ' ARG . . . . . . . . . . . . . 95.2 mtt180 -151.69 130.19 12.19 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 115.911 -0.586 . . . . 0.0 109.802 176.901 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' D' D ' 127' ' ' ASN . . . . . . . . . . . . . 4.1 m120 56.6 -152.38 0.39 Allowed 'General case' 0 CA--C 1.539 0.536 0 N-CA-C 109.764 -0.458 . . . . 0.0 109.764 179.68 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' D' D ' 128' ' ' ASP . . . . . . . . . . . . . 15.4 p-10 -80.47 14.59 1.96 Allowed 'General case' 0 CA--C 1.536 0.423 0 N-CA-C 112.876 0.695 . . . . 0.0 112.876 178.662 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' D' D ' 129' ' ' LEU . . . . . 0.541 HD13 ' NE ' ' D' ' 142' ' ' ARG . 11.6 tp -114.17 132.63 56.02 Favored 'General case' 0 N--CA 1.46 0.045 0 CA-C-N 118.09 0.404 . . . . 0.0 109.911 179.049 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' D' D ' 130' ' ' VAL . . . . . 0.404 HG23 ' HB ' ' D' ' 141' ' ' ILE . 34.5 m -132.07 142.39 42.97 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.193 0 CA-C-O 121.086 0.469 . . . . 0.0 110.157 176.763 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' D' D ' 131' ' ' VAL . . . . . . . . . . . . . 34.4 m -136.14 148.79 27.41 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 CA-C-O 121.191 0.519 . . . . 0.0 111.21 -179.255 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' D' D ' 132' ' ' ILE . . . . . . . . . . . . . 75.2 mt -115.44 130.66 69.65 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.383 0 CA-C-N 115.4 -0.818 . . . . 0.0 109.024 178.307 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' D' D ' 133' ' ' ILE . . . . . . . . . . . . . 42.3 mm -115.27 115.2 48.66 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.197 0 CA-C-O 120.884 0.373 . . . . 0.0 110.753 -175.993 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' D' D ' 134' ' ' ASP . . . . . . . . . . . . . 6.1 p-10 -125.88 145.51 50.22 Favored 'General case' 0 C--N 1.333 -0.12 0 N-CA-C 109.371 -0.603 . . . . 0.0 109.371 174.95 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' D' D ' 135' ' ' GLU . . . . . . . . . . . . . 46.2 tp10 -49.75 -26.58 3.98 Favored 'General case' 0 C--N 1.327 -0.388 0 N-CA-C 112.761 0.652 . . . . 0.0 112.761 -169.318 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' D' D ' 136' ' ' GLN . . . . . . . . . . . . . 99.1 mm-40 -92.95 -39.74 10.97 Favored 'General case' 0 C--N 1.332 -0.179 0 N-CA-C 112.293 0.479 . . . . 0.0 112.293 -177.126 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' D' D ' 137' ' ' LYS . . . . . . . . . . . . . 28.0 mtpp -137.99 155.02 49.28 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-O 121.277 0.56 . . . . 0.0 111.698 -170.015 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' D' D ' 138' ' ' LEU . . . . . . . . . . . . . 5.3 tt -116.06 125.34 52.29 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 115.547 -0.752 . . . . 0.0 109.286 174.407 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' D' D ' 139' ' ' THR . . . . . . . . . . . . . 39.9 m -110.67 129.65 55.77 Favored 'General case' 0 C--N 1.332 -0.183 0 CA-C-N 116.406 -0.361 . . . . 0.0 110.993 -177.6 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' D' D ' 140' ' ' LEU . . . . . 0.469 ' C ' HD23 ' D' ' 140' ' ' LEU . 6.5 tt -111.17 123.59 50.5 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 115.499 -0.773 . . . . 0.0 109.322 -179.502 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' D' D ' 141' ' ' ILE . . . . . 0.415 ' N ' HD23 ' D' ' 140' ' ' LEU . 18.8 mt -125.36 118.38 52.4 Favored 'Isoleucine or valine' 0 C--O 1.234 0.255 0 CA-C-O 120.964 0.411 . . . . 0.0 110.404 -177.199 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' D' D ' 142' ' ' ARG . . . . . 0.541 ' NE ' HD13 ' D' ' 129' ' ' LEU . 15.9 mmt180 -102.91 122.75 45.19 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 115.425 -0.807 . . . . 0.0 109.777 175.079 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' D' D ' 143' ' ' THR . . . . . 0.408 HG21 HD21 ' D' ' 92' ' ' LEU . 2.5 p . . . . . 0 C--O 1.22 -0.487 0 CA-C-O 117.983 -1.008 . . . . 0.0 110.568 179.898 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' E' E ' 2' ' ' SER . . . . . . . . . . . . . 3.9 p . . . . . 0 C--O 1.23 0.06 0 CA-C-O 120.744 0.307 . . . . 0.0 110.287 . . . . . . . . . 0 0 . 1 . 018 nuclear nobuild core ' E' E ' 3' ' ' GLU . . . . . . . . . . . . . 30.4 tp10 -139.14 139.75 37.71 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.244 -0.435 . . . . 0.0 110.79 -176.215 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' E' E ' 4' ' ' LEU . . . . . . . . . . . . . 18.1 tp -126.01 130.79 51.88 Favored 'General case' 0 C--N 1.332 -0.184 0 N-CA-C 109.881 -0.415 . . . . 0.0 109.881 174.809 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' E' E ' 5' ' ' LYS . . . . . . . . . . . . . 99.3 mttt -116.33 123.98 48.99 Favored 'General case' 0 C--O 1.235 0.297 0 CA-C-O 120.734 0.302 . . . . 0.0 111.192 -178.236 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' E' E ' 6' ' ' LEU . . . . . 0.404 HD23 ' HA ' ' E' ' 50' ' ' VAL . 50.8 mt -113.98 147.11 39.14 Favored 'General case' 0 N--CA 1.461 0.117 0 CA-C-N 115.437 -0.801 . . . . 0.0 110.272 178.837 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' E' E ' 7' ' ' LYS . . . . . . . . . . . . . 82.2 tttt -129.37 141.02 40.36 Favored Pre-proline 0 CA--C 1.533 0.302 0 CA-C-O 119.137 -0.459 . . . . 0.0 109.883 175.031 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' E' E ' 8' ' ' PRO . . . . . . . . . . . . . 90.0 Cg_endo -91.84 146.17 3.13 Favored 'Trans proline' 0 N--CA 1.49 1.272 0 C-N-CA 121.916 1.744 . . . . 0.0 112.163 179.392 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' E' E ' 9' ' ' LEU . . . . . . . . . . . . . 37.1 mt -86.79 -49.23 0.48 Allowed Pre-proline 0 CA--C 1.535 0.376 0 CA-C-O 118.682 -0.675 . . . . 0.0 112.562 178.818 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' E' E ' 10' ' ' PRO . . . . . . . . . . . . . 97.2 Cg_endo -77.93 161.65 29.87 Favored 'Trans proline' 0 N--CA 1.497 1.725 0 C-N-CA 121.256 1.304 . . . . 0.0 112.444 -179.665 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' E' E ' 11' ' ' LYS . . . . . . . . . . . . . 25.1 tptp -86.93 95.44 9.9 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-N 116.231 -0.441 . . . . 0.0 110.085 177.536 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' E' E ' 12' ' ' VAL . . . . . . . . . . . . . 12.5 p -142.18 147.63 21.2 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 CA-C-N 116.313 -0.403 . . . . 0.0 110.838 -179.008 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' E' E ' 13' ' ' GLU . . . . . . . . . . . . . 95.9 mt-10 -93.81 122.6 36.45 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.029 -0.532 . . . . 0.0 110.128 177.507 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' E' E ' 14' ' ' LEU . . . . . . . . . . . . . 22.3 mt -97.65 151.26 37.51 Favored Pre-proline 0 CA--C 1.533 0.301 0 CA-C-O 119.329 -0.367 . . . . 0.0 110.464 -178.714 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' E' E ' 15' ' ' PRO . . . . . . . . . . . . . 37.8 Cg_exo -59.46 156.06 38.25 Favored 'Trans proline' 0 N--CA 1.498 1.775 0 C-N-CA 121.241 1.294 . . . . 0.0 111.835 178.391 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' E' E ' 16' ' ' PRO . . . . . . . . . . . . . 31.4 Cg_exo -56.83 -38.99 94.57 Favored 'Trans proline' 0 N--CA 1.497 1.711 0 C-N-CA 121.333 1.355 . . . . 0.0 112.475 -179.856 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' E' E ' 17' ' ' ASP . . . . . . . . . . . . . 23.1 p-10 -93.48 20.18 7.56 Favored 'General case' 0 C--N 1.329 -0.324 0 N-CA-C 112.665 0.617 . . . . 0.0 112.665 -178.242 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' E' E ' 18' ' ' PHE . . . . . 0.53 ' CZ ' HD11 ' E' ' 22' ' ' ILE . 62.5 t80 -57.11 -41.6 79.28 Favored 'General case' 0 C--O 1.227 -0.101 0 O-C-N 122.051 -0.405 . . . . 0.0 110.308 -178.329 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' E' E ' 19' ' ' VAL . . . . . . . . . . . . . 52.2 t -54.91 -45.82 75.84 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.289 0 CA-C-N 116.396 -0.365 . . . . 0.0 110.815 -178.912 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' E' E ' 20' ' ' ASP . . . . . . . . . . . . . 80.8 m-20 -60.28 -41.4 93.25 Favored 'General case' 0 C--N 1.331 -0.222 0 C-N-CA 120.905 -0.318 . . . . 0.0 110.886 -178.165 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' E' E ' 21' ' ' VAL . . . . . . . . . . . . . 47.9 t -63.92 -47.15 91.89 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.306 0 C-N-CA 120.736 -0.386 . . . . 0.0 110.398 -177.931 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' E' E ' 22' ' ' ILE . . . . . 0.615 HG22 HD12 ' E' ' 26' ' ' LEU . 51.3 mm -57.18 -43.83 82.4 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.197 0 C-N-CA 120.856 -0.338 . . . . 0.0 110.529 179.158 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' E' E ' 23' ' ' ARG . . . . . . . . . . . . . 28.7 ttp180 -54.56 -48.24 72.3 Favored 'General case' 0 C--N 1.331 -0.201 0 C-N-CA 121.082 -0.247 . . . . 0.0 111.286 -179.472 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' E' E ' 24' ' ' ILE . . . . . . . . . . . . . 72.9 mt -58.52 -44.44 89.18 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.377 0 C-N-CA 120.959 -0.297 . . . . 0.0 110.708 -177.92 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' E' E ' 25' ' ' LYS . . . . . . . . . . . . . 24.5 mtpp -64.68 -44.01 91.71 Favored 'General case' 0 C--N 1.329 -0.291 0 N-CA-C 112.456 0.539 . . . . 0.0 112.456 -178.046 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' E' E ' 26' ' ' LEU . . . . . 0.615 HD12 HG22 ' E' ' 22' ' ' ILE . 79.1 mt -84.03 -25.29 30.02 Favored 'General case' 0 C--N 1.329 -0.289 0 N-CA-C 113.388 0.884 . . . . 0.0 113.388 -171.667 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' E' E ' 27' ' ' GLN . . . . . . . . . . . . . 6.1 pt20 -46.13 135.84 7.32 Favored 'General case' 0 N--CA 1.467 0.416 0 N-CA-C 112.757 0.651 . . . . 0.0 112.757 -174.41 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' E' E ' 28' ' ' GLY . . . . . . . . . . . . . . . 98.86 -22.3 41.67 Favored Glycine 0 CA--C 1.535 1.291 0 CA-C-N 115.792 -0.64 . . . . 0.0 112.516 -177.474 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' E' E ' 29' ' ' LYS . . . . . . . . . . . . . 8.2 mtpm? -97.53 155.08 17.11 Favored 'General case' 0 C--N 1.331 -0.2 0 CA-C-N 117.474 0.637 . . . . 0.0 110.925 179.523 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' E' E ' 30' ' ' THR . . . . . . . . . . . . . 22.3 m -109.77 139.27 45.02 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.337 177.115 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' E' E ' 31' ' ' VAL . . . . . . . . . . . . . 35.1 m -128.35 157.7 40.67 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.266 0 CA-C-N 116.254 -0.43 . . . . 0.0 110.505 -179.528 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' E' E ' 32' ' ' ARG . . . . . . . . . . . . . 53.0 ttp180 -132.21 150.92 52.04 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-O 121.198 0.523 . . . . 0.0 110.579 179.139 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' E' E ' 33' ' ' THR . . . . . . . . . . . . . 27.6 m -52.81 138.88 28.37 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.264 -0.425 . . . . 0.0 111.471 -177.812 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' E' E ' 34' ' ' GLY . . . . . . . . . . . . . . . 99.36 -17.23 58.1 Favored Glycine 0 CA--C 1.532 1.142 0 CA-C-N 116.151 -0.477 . . . . 0.0 113.2 179.087 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' E' E ' 35' ' ' ASP . . . . . . . . . . . . . 78.7 m-20 -67.46 149.39 50.27 Favored 'General case' 0 C--N 1.334 -0.085 0 CA-C-N 118.059 0.929 . . . . 0.0 111.204 178.539 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' E' E ' 36' ' ' VAL . . . . . . . . . . . . . 43.4 t -119.27 129.1 75.69 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.216 0 CA-C-N 115.945 -0.57 . . . . 0.0 109.582 176.785 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' E' E ' 37' ' ' ILE . . . . . . . . . . . . . 64.3 mt -118.19 138.35 49.19 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 CA-C-N 116.178 -0.464 . . . . 0.0 109.76 -178.967 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' E' E ' 38' ' ' GLY . . . . . . . . . . . . . . . -116.51 127.64 7.57 Favored Glycine 0 CA--C 1.523 0.567 0 N-CA-C 110.88 -0.888 . . . . 0.0 110.88 179.097 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' E' E ' 39' ' ' ILE . . . . . . . . . . . . . 72.0 mt -127.22 126.78 68.49 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.214 0 N-CA-C 110.136 -0.32 . . . . 0.0 110.136 179.135 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' E' E ' 40' ' ' SER . . . . . . . . . . . . . 53.8 p -92.52 122.41 34.93 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.374 -0.375 . . . . 0.0 110.826 176.632 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' E' E ' 41' ' ' ILE . . . . . . . . . . . . . 70.6 mt -132.22 130.55 60.64 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.228 0 CA-C-O 120.808 0.337 . . . . 0.0 110.22 177.502 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' E' E ' 42' ' ' LEU . . . . . . . . . . . . . 64.7 mt 56.87 32.94 22.32 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 116.144 -0.48 . . . . 0.0 111.959 178.176 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' E' E ' 43' ' ' GLY . . . . . . . . . . . . . . . 72.95 23.69 77.39 Favored Glycine 0 CA--C 1.531 1.039 0 C-N-CA 121.067 -0.587 . . . . 0.0 112.71 177.717 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' E' E ' 44' ' ' LYS . . . . . . . . . . . . . 99.4 mttt -138.66 128.65 25.34 Favored 'General case' 0 C--N 1.331 -0.206 0 CA-C-N 117.404 0.602 . . . . 0.0 109.861 178.051 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' E' E ' 45' ' ' GLU . . . . . . . . . . . . . 44.0 tp10 -85.55 132.36 34.2 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.42 -0.354 . . . . 0.0 111.539 -176.835 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' E' E ' 46' ' ' VAL . . . . . . . . . . . . . 8.8 p -121.92 127.93 75.52 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.186 0 N-CA-C 109.343 -0.614 . . . . 0.0 109.343 172.81 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' E' E ' 47' ' ' LYS . . . . . . . . . . . . . 55.4 mtmt -98.42 127.21 44.25 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.142 -0.481 . . . . 0.0 110.833 177.781 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' E' E ' 48' ' ' PHE . . . . . . . . . . . . . 43.0 m-85 -114.21 131.9 56.3 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 115.925 -0.58 . . . . 0.0 109.683 177.333 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' E' E ' 49' ' ' LYS . . . . . . . . . . . . . 75.8 tttt -105.81 134.81 48.33 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 116.417 -0.356 . . . . 0.0 110.102 178.483 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' E' E ' 50' ' ' VAL . . . . . 0.404 ' HA ' HD23 ' E' ' 6' ' ' LEU . 45.8 t -78.7 107.15 10.64 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.339 0 N-CA-C 109.245 -0.65 . . . . 0.0 109.245 177.752 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' E' E ' 51' ' ' VAL . . . . . . . . . . . . . 48.4 t -73.56 -51.11 26.43 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.316 0 CA-C-N 116.152 -0.476 . . . . 0.0 109.769 -174.567 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' E' E ' 52' ' ' GLN . . . . . . . . . . . . . 90.4 mt-30 -152.77 149.61 28.53 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-O 121.249 0.547 . . . . 0.0 111.963 -177.803 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' E' E ' 53' ' ' ALA . . . . . . . . . . . . . . . -130.46 130.63 44.48 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 114.978 -1.01 . . . . 0.0 109.243 173.143 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' E' E ' 54' ' ' TYR . . . . . . . . . . . . . 6.9 t80 -129.14 109.33 18.03 Favored Pre-proline 0 CA--C 1.534 0.361 0 CA-C-O 118.203 -0.903 . . . . 0.0 110.138 179.011 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' E' E ' 55' ' ' PRO . . . . . . . . . . . . . 74.1 Cg_endo -77.07 170.08 72.61 Favored 'Cis proline' 0 N--CA 1.5 1.895 0 CA-C-N 122.012 1.754 . . . . 0.0 112.593 -4.795 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' E' E ' 56' ' ' SER . . . . . . . . . . . . . 13.6 m -116.39 132.67 23.2 Favored Pre-proline 0 CA--C 1.539 0.546 0 CA-C-O 118.359 -0.829 . . . . 0.0 109.579 176.058 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' E' E ' 57' ' ' PRO . . . . . . . . . . . . . 48.3 Cg_endo -70.57 165.34 79.21 Favored 'Cis proline' 0 N--CA 1.496 1.663 0 CA-C-N 121.975 1.741 . . . . 0.0 111.536 -2.572 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' E' E ' 58' ' ' LEU . . . . . . . . . . . . . 22.5 tp -129.9 138.19 50.79 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.2 -0.455 . . . . 0.0 110.273 -179.563 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' E' E ' 59' ' ' ARG . . . . . . . . . . . . . 53.9 ttp180 -105.83 136.24 45.83 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-N 115.924 -0.58 . . . . 0.0 109.463 176.684 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' E' E ' 60' ' ' VAL . . . . . . . . . . . . . 39.9 t -89.62 116.34 30.88 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.264 0 CA-C-O 121.04 0.448 . . . . 0.0 110.638 -175.172 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' E' E ' 61' ' ' GLU . . . . . . . . . . . . . 95.6 mt-10 -131.05 173.28 11.16 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 115.552 -0.749 . . . . 0.0 109.455 175.501 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' E' E ' 62' ' ' ASP . . . . . . . . . . . . . 58.8 m-20 -53.72 -33.96 57.33 Favored 'General case' 0 C--N 1.328 -0.347 0 N-CA-C 111.778 0.288 . . . . 0.0 111.778 -178.821 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' E' E ' 63' ' ' ARG . . . . . . . . . . . . . 26.2 mmm180 -76.57 -17.81 59.01 Favored 'General case' 0 CA--C 1.533 0.317 0 N-CA-C 113.224 0.824 . . . . 0.0 113.224 -176.28 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' E' E ' 64' ' ' THR . . . . . . . . . . . . . 19.0 m -68.95 136.16 52.11 Favored 'General case' 0 C--N 1.331 -0.208 0 CA-C-O 120.896 0.379 . . . . 0.0 110.707 -174.919 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' E' E ' 65' ' ' LYS . . . . . . . . . . . . . 43.4 mtpt -90.06 122.33 32.95 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.098 -0.501 . . . . 0.0 109.9 179.946 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' E' E ' 66' ' ' ILE . . . . . . . . . . . . . 62.3 mt -113.83 131.95 64.23 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.234 0 CA-C-O 120.896 0.379 . . . . 0.0 110.35 -176.975 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' E' E ' 67' ' ' THR . . . . . . . . . . . . . 41.4 m -126.84 139.42 53.1 Favored 'General case' 0 C--O 1.234 0.24 0 CA-C-N 115.923 -0.58 . . . . 0.0 110.59 179.137 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' E' E ' 68' ' ' LEU . . . . . 0.429 ' C ' HD23 ' E' ' 68' ' ' LEU . 5.4 tt . . . . . 0 C--N 1.327 -0.397 0 CA-C-N 115.787 -0.642 . . . . 0.0 109.894 177.461 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' E' E ' 73' ' ' VAL . . . . . . . . . . . . . 35.1 m . . . . . 0 C--O 1.231 0.125 0 N-CA-C 109.882 -0.414 . . . . 0.0 109.882 . . . . . . . . . 0 0 . 1 . 018 nuclear nobuild core ' E' E ' 74' ' ' ASP . . . . . . . . . . . . . 19.5 t0 -95.41 115.05 26.89 Favored 'General case' 0 C--N 1.332 -0.191 0 N-CA-C 109.764 -0.458 . . . . 0.0 109.764 -178.493 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' E' E ' 75' ' ' VAL . . . . . 0.452 ' C ' HD12 ' E' ' 76' ' ' LEU . 38.4 t -118.6 126.39 75.14 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.218 0 CA-C-O 121.0 0.428 . . . . 0.0 110.655 -176.547 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' E' E ' 76' ' ' LEU . . . . . 0.452 HD12 ' C ' ' E' ' 75' ' ' VAL . 5.8 mp -127.32 147.48 50.25 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 115.646 -0.707 . . . . 0.0 109.863 177.125 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' E' E ' 77' ' ' GLU . . . . . . . . . . . . . 96.3 mt-10 -134.21 133.33 40.77 Favored 'General case' 0 C--N 1.332 -0.19 0 CA-C-O 121.078 0.466 . . . . 0.0 111.27 -178.748 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' E' E ' 78' ' ' ALA . . . . . 0.441 ' HB2' HD21 ' E' ' 109' ' ' LEU . . . -122.3 141.29 51.68 Favored 'General case' 0 C--N 1.331 -0.221 0 CA-C-N 115.7 -0.682 . . . . 0.0 109.739 176.347 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' E' E ' 79' ' ' LYS . . . . . 0.588 ' O ' HD13 ' E' ' 80' ' ' ILE . 82.3 tttt -84.5 117.51 23.73 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-O 120.889 0.376 . . . . 0.0 110.641 -178.262 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' E' E ' 80' ' ' ILE . . . . . 0.588 HD13 ' O ' ' E' ' 79' ' ' LYS . 42.9 mm -137.95 110.74 7.15 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.381 0 N-CA-C 108.953 -0.758 . . . . 0.0 108.953 -178.858 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' E' E ' 81' ' ' LYS . . . . . . . . . . . . . 55.3 pttt -100.18 125.91 46.38 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-O 120.895 0.378 . . . . 0.0 111.336 -176.589 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' E' E ' 82' ' ' GLY . . . . . . . . . . . . . . . 87.85 42.17 6.11 Favored Glycine 0 CA--C 1.525 0.683 0 C-N-CA 120.825 -0.702 . . . . 0.0 111.714 175.072 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' E' E ' 83' ' ' ILE . . . . . . . . . . . . . 73.4 mt -66.77 127.35 28.07 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.271 0 N-CA-C 109.508 -0.552 . . . . 0.0 109.508 177.548 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' E' E ' 84' ' ' LYS . . . . . . . . . . . . . 59.8 tttt -82.58 -48.44 10.97 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 115.928 -0.578 . . . . 0.0 110.145 -178.25 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' E' E ' 85' ' ' ASP . . . . . . . . . . . . . 33.2 t0 -163.94 159.03 20.4 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 115.851 -0.613 . . . . 0.0 110.653 179.022 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' E' E ' 86' ' ' VAL . . . . . 0.446 ' O ' HD13 ' E' ' 87' ' ' ILE . 43.2 t -129.33 136.25 59.86 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.27 0 CA-C-O 121.031 0.443 . . . . 0.0 110.55 -179.606 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' E' E ' 87' ' ' ILE . . . . . 0.446 HD13 ' O ' ' E' ' 86' ' ' VAL . 44.0 mm -123.18 128.55 75.01 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.227 0 CA-C-N 115.821 -0.627 . . . . 0.0 109.685 176.605 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' E' E ' 88' ' ' LEU . . . . . . . . . . . . . 17.4 tp -111.89 133.84 53.83 Favored 'General case' 0 N--CA 1.464 0.227 0 CA-C-O 121.052 0.453 . . . . 0.0 111.43 -175.539 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' E' E ' 89' ' ' ASP . . . . . . . . . . . . . 13.8 t70 -125.66 157.49 37.13 Favored 'General case' 0 C--N 1.331 -0.222 0 CA-C-N 115.688 -0.687 . . . . 0.0 109.679 176.252 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' E' E ' 90' ' ' GLU . . . . . . . . . . . . . 84.1 tt0 -45.56 -42.71 11.31 Favored 'General case' 0 N--CA 1.465 0.314 0 N-CA-C 113.087 0.773 . . . . 0.0 113.087 -171.632 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' E' E ' 91' ' ' ASN . . . . . . . . . . . . . 3.3 t-20 -132.16 25.78 4.55 Favored 'General case' 0 N--CA 1.468 0.446 0 N-CA-C 112.464 0.542 . . . . 0.0 112.464 -178.703 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' E' E ' 92' ' ' LEU . . . . . . . . . . . . . 28.5 mt -149.34 145.22 26.9 Favored 'General case' 0 C--N 1.331 -0.213 0 CA-C-O 120.721 0.296 . . . . 0.0 110.202 -177.376 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' E' E ' 93' ' ' ILE . . . . . . . . . . . . . 66.0 mt -123.71 121.12 61.64 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.292 0 N-CA-C 109.327 -0.62 . . . . 0.0 109.327 178.798 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' E' E ' 94' ' ' VAL . . . . . . . . . . . . . 46.8 t -117.52 126.67 74.82 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.282 0 N-CA-C 109.655 -0.498 . . . . 0.0 109.655 179.956 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' E' E ' 95' ' ' VAL . . . . . . . . . . . . . 38.8 t -121.47 134.15 65.73 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.331 0 CA-C-N 116.102 -0.499 . . . . 0.0 109.731 -178.872 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' E' E ' 96' ' ' ILE . . . . . 0.581 HD11 ' HB ' ' E' ' 123' ' ' VAL . 65.3 mt -113.81 127.07 71.36 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.33 0 N-CA-C 109.267 -0.642 . . . . 0.0 109.267 178.674 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' E' E ' 97' ' ' THR . . . . . . . . . . . . . 68.5 p -98.09 152.38 19.38 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-O 121.108 0.48 . . . . 0.0 111.102 -178.311 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' E' E ' 98' ' ' GLU . . . . . . . . . . . . . 85.0 tt0 -53.95 -23.44 13.08 Favored 'General case' 0 CA--C 1.535 0.377 0 N-CA-C 112.313 0.486 . . . . 0.0 112.313 179.738 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' E' E ' 99' ' ' GLU . . . . . . . . . . . . . 36.6 tt0 -80.94 18.08 1.08 Allowed 'General case' 0 CA--C 1.54 0.571 0 N-CA-C 112.5 0.556 . . . . 0.0 112.5 -177.012 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' E' E ' 100' ' ' ASN . . . . . . . . . . . . . 2.5 m-20 61.54 37.92 16.02 Favored 'General case' 0 CA--C 1.53 0.206 0 O-C-N 121.869 -0.519 . . . . 0.0 110.997 178.365 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' E' E ' 101' ' ' GLU . . . . . . . . . . . . . 85.1 tt0 -119.71 140.71 50.25 Favored 'General case' 0 C--N 1.332 -0.19 0 CA-C-N 116.099 -0.5 . . . . 0.0 109.66 176.703 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' E' E ' 102' ' ' VAL . . . . . . . . . . . . . 41.7 t -115.58 127.86 73.01 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.257 0 N-CA-C 109.732 -0.47 . . . . 0.0 109.732 -177.581 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' E' E ' 103' ' ' LEU . . . . . . . . . . . . . 5.0 mp -124.1 137.94 54.5 Favored 'General case' 0 C--N 1.331 -0.216 0 CA-C-N 116.33 -0.396 . . . . 0.0 110.607 177.506 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' E' E ' 104' ' ' ILE . . . . . . . . . . . . . 64.3 mt -117.63 126.3 74.63 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.274 0 CA-C-N 115.892 -0.594 . . . . 0.0 109.927 -178.893 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' E' E ' 105' ' ' PHE . . . . . . . . . . . . . 98.9 m-85 -120.86 161.35 21.69 Favored 'General case' 0 C--N 1.332 -0.18 0 O-C-N 124.046 0.841 . . . . 0.0 110.275 -179.008 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' E' E ' 106' ' ' ASN . . . . . . . . . . . . . 43.6 p-10 -99.0 -169.8 1.83 Allowed 'General case' 0 CA--C 1.532 0.284 0 CA-C-N 116.351 -0.386 . . . . 0.0 110.123 175.128 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' E' E ' 107' ' ' GLN . . . . . . . . . . . . . 20.4 tt0 -56.33 -30.05 62.1 Favored 'General case' 0 C--N 1.329 -0.303 0 N-CA-C 111.811 0.3 . . . . 0.0 111.811 179.732 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' E' E ' 108' ' ' ASN . . . . . . . . . . . . . 13.1 t30 -90.72 14.1 14.36 Favored 'General case' 0 CA--C 1.535 0.396 0 N-CA-C 113.197 0.814 . . . . 0.0 113.197 -175.889 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' E' E ' 109' ' ' LEU . . . . . 0.441 HD21 ' HB2' ' E' ' 78' ' ' ALA . 11.0 tp 54.88 36.0 25.64 Favored 'General case' 0 C--N 1.332 -0.191 0 CA-C-O 120.829 0.347 . . . . 0.0 111.506 178.501 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' E' E ' 110' ' ' GLU . . . . . . . . . . . . . 70.6 mm-40 -101.29 151.33 22.02 Favored 'General case' 0 C--N 1.33 -0.271 0 N-CA-C 109.808 -0.442 . . . . 0.0 109.808 176.514 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' E' E ' 111' ' ' GLU . . . . . . . . . . . . . 44.0 tp10 -78.52 122.03 25.35 Favored 'General case' 0 C--N 1.329 -0.296 0 C-N-CA 120.698 -0.401 . . . . 0.0 110.825 -176.901 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' E' E ' 112' ' ' LEU . . . . . . . . . . . . . 15.3 mt -110.58 -45.97 3.45 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.115 -0.493 . . . . 0.0 110.428 177.837 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' E' E ' 113' ' ' TYR . . . . . . . . . . . . . 55.7 t80 -137.27 137.22 38.8 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 116.402 -0.363 . . . . 0.0 110.862 -179.585 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' E' E ' 114' ' ' ARG . . . . . . . . . . . . . 56.0 ttp180 -143.45 119.71 10.85 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.422 -0.354 . . . . 0.0 110.413 179.03 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' E' E ' 115' ' ' GLY . . . . . . . . . . . . . . . -150.16 153.75 25.26 Favored Glycine 0 CA--C 1.525 0.704 0 N-CA-C 111.075 -0.81 . . . . 0.0 111.075 178.376 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' E' E ' 116' ' ' LYS . . . . . . . . . . . . . 27.5 ttpp -116.97 143.7 45.42 Favored 'General case' 0 C--N 1.33 -0.262 0 N-CA-C 109.955 -0.387 . . . . 0.0 109.955 177.662 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' E' E ' 117' ' ' PHE . . . . . . . . . . . . . 51.2 m-85 -139.19 114.63 9.78 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-O 120.935 0.397 . . . . 0.0 110.204 -178.24 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' E' E ' 118' ' ' GLU . . . . . . . . . . . . . 95.6 mt-10 -53.61 -50.15 66.28 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.472 -0.331 . . . . 0.0 111.411 -175.558 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' E' E ' 119' ' ' ASN . . . . . . . . . . . . . 2.6 m120 -93.63 31.02 1.63 Allowed 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.192 -0.458 . . . . 0.0 112.158 -175.222 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' E' E ' 120' ' ' LEU . . . . . . . . . . . . . 16.2 tp -57.11 122.89 13.46 Favored 'General case' 0 C--N 1.333 -0.14 0 CA-C-O 120.721 0.296 . . . . 0.0 110.277 178.563 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' E' E ' 121' ' ' ASN . . . . . . . . . . . . . 13.7 m120 -112.13 -44.17 3.45 Favored 'General case' 0 C--N 1.332 -0.185 0 CA-C-N 116.395 -0.366 . . . . 0.0 110.991 -177.183 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' E' E ' 122' ' ' LYS . . . . . . . . . . . . . 80.2 mttt -146.2 145.7 30.53 Favored 'General case' 0 C--N 1.332 -0.194 0 C-N-CA 120.575 -0.45 . . . . 0.0 111.832 -177.282 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' E' E ' 123' ' ' VAL . . . . . 0.581 ' HB ' HD11 ' E' ' 96' ' ' ILE . 46.9 t -127.89 123.83 61.66 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.291 0 N-CA-C 108.883 -0.784 . . . . 0.0 108.883 171.96 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' E' E ' 124' ' ' LEU . . . . . . . . . . . . . 69.0 mt -132.66 145.9 51.44 Favored 'General case' 0 C--N 1.331 -0.2 0 CA-C-O 121.048 0.451 . . . . 0.0 111.492 -175.036 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' E' E ' 125' ' ' VAL . . . . . 0.565 HG23 HG22 ' E' ' 130' ' ' VAL . 11.9 p -135.17 137.41 50.33 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.238 0 CA-C-N 115.834 -0.621 . . . . 0.0 110.395 178.915 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' E' E ' 126' ' ' ARG . . . . . . . . . . . . . 25.3 mmt180 -140.35 124.64 17.73 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 115.976 -0.556 . . . . 0.0 110.206 178.605 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' E' E ' 127' ' ' ASN . . . . . . . . . . . . . 14.9 m-80 51.4 -106.67 0.27 Allowed 'General case' 0 CA--C 1.543 0.695 0 CA-C-O 118.976 -0.535 . . . . 0.0 111.36 179.739 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' E' E ' 128' ' ' ASP . . . . . . . . . . . . . 14.8 p-10 -114.07 5.93 16.21 Favored 'General case' 0 N--CA 1.468 0.43 0 CA-C-N 119.723 1.147 . . . . 0.0 113.468 -176.948 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' E' E ' 129' ' ' LEU . . . . . . . . . . . . . 15.8 tp -111.56 134.5 53.09 Favored 'General case' 0 C--N 1.333 -0.138 0 CA-C-N 118.261 0.482 . . . . 0.0 110.472 -179.492 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' E' E ' 130' ' ' VAL . . . . . 0.565 HG22 HG23 ' E' ' 125' ' ' VAL . 45.0 t -118.66 134.84 60.99 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.183 0 N-CA-C 109.523 -0.547 . . . . 0.0 109.523 178.657 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' E' E ' 131' ' ' VAL . . . . . . . . . . . . . 39.4 t -136.05 141.01 42.87 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.258 0 CA-C-O 121.119 0.485 . . . . 0.0 110.704 -178.525 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' E' E ' 132' ' ' ILE . . . . . . . . . . . . . 71.5 mt -117.96 132.54 67.5 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.279 0 CA-C-N 115.457 -0.792 . . . . 0.0 109.413 178.669 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' E' E ' 133' ' ' ILE . . . . . . . . . . . . . 44.0 mm -115.8 121.97 68.5 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.246 0 CA-C-O 120.747 0.308 . . . . 0.0 110.675 -176.769 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' E' E ' 134' ' ' ASP . . . . . . . . . . . . . 7.3 p-10 -134.37 149.68 50.84 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.02 -0.536 . . . . 0.0 109.795 175.47 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' E' E ' 135' ' ' GLU . . . . . . . . . . . . . 42.9 tp10 -49.78 -26.71 4.13 Favored 'General case' 0 C--N 1.327 -0.383 0 N-CA-C 112.85 0.685 . . . . 0.0 112.85 -170.442 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' E' E ' 136' ' ' GLN . . . . . . . . . . . . . 55.3 mt-30 -102.78 -25.67 13.43 Favored 'General case' 0 N--CA 1.466 0.367 0 N-CA-C 112.888 0.699 . . . . 0.0 112.888 -174.532 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' E' E ' 137' ' ' LYS . . . . . . . . . . . . . 82.7 mttt -143.21 153.31 42.7 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-O 121.23 0.538 . . . . 0.0 111.714 -170.239 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' E' E ' 138' ' ' LEU . . . . . 0.426 ' C ' HD23 ' E' ' 138' ' ' LEU . 5.8 tt -118.29 121.15 39.7 Favored 'General case' 0 C--N 1.328 -0.352 0 N-CA-C 108.744 -0.836 . . . . 0.0 108.744 171.667 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' E' E ' 139' ' ' THR . . . . . . . . . . . . . 23.8 m -109.27 128.19 54.88 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.452 -0.34 . . . . 0.0 110.54 -176.344 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' E' E ' 140' ' ' LEU . . . . . 0.478 ' C ' HD23 ' E' ' 140' ' ' LEU . 7.1 tt -114.37 122.12 45.69 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 115.724 -0.671 . . . . 0.0 109.494 -178.835 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' E' E ' 141' ' ' ILE . . . . . . . . . . . . . 19.1 mt -122.84 116.81 49.9 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.288 0 N-CA-C 109.601 -0.518 . . . . 0.0 109.601 -176.897 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' E' E ' 142' ' ' ARG . . . . . . . . . . . . . 71.5 ttt180 -101.52 120.67 40.67 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 115.671 -0.695 . . . . 0.0 110.458 -179.107 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' E' E ' 143' ' ' THR . . . . . 0.497 HG22 HG12 ' F' ' 73' ' ' VAL . 16.4 p . . . . . 0 C--O 1.22 -0.472 0 CA-C-O 118.009 -0.996 . . . . 0.0 110.469 179.678 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' F' F ' 1' ' ' MET . . . . . . . . . . . . . 25.5 ptp . . . . . 0 CA--C 1.529 0.149 0 CA-C-O 120.644 0.259 . . . . 0.0 110.371 . . . . . . . . . 0 0 . 1 . 018 nuclear nobuild core ' F' F ' 2' ' ' SER . . . . . . . . . . . . . 4.9 p -124.28 132.8 53.59 Favored 'General case' 0 C--N 1.332 -0.188 0 CA-C-O 120.908 0.385 . . . . 0.0 110.803 179.754 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' F' F ' 3' ' ' GLU . . . . . . . . . . . . . 85.2 tt0 -142.61 140.38 31.64 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.155 -0.475 . . . . 0.0 111.225 -179.119 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' F' F ' 4' ' ' LEU . . . . . 0.446 HD21 HD21 ' F' ' 6' ' ' LEU . 14.9 tp -125.55 135.09 51.88 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.03 -0.532 . . . . 0.0 110.049 177.163 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' F' F ' 5' ' ' LYS . . . . . . . . . . . . . 69.0 mttm -112.43 120.73 42.65 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.237 -0.438 . . . . 0.0 110.58 178.764 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' F' F ' 6' ' ' LEU . . . . . 0.446 HD21 HD21 ' F' ' 4' ' ' LEU . 73.4 mt -114.93 146.06 41.56 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 115.294 -0.866 . . . . 0.0 110.043 -179.968 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' F' F ' 7' ' ' LYS . . . . . . . . . . . . . 53.4 tttm -133.88 140.2 35.71 Favored Pre-proline 0 CA--C 1.534 0.334 0 CA-C-O 119.115 -0.469 . . . . 0.0 110.245 177.576 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' F' F ' 8' ' ' PRO . . . . . . . . . . . . . 94.4 Cg_endo -91.95 139.07 2.07 Favored 'Trans proline' 0 N--CA 1.489 1.22 0 C-N-CA 121.668 1.578 . . . . 0.0 111.537 176.798 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' F' F ' 9' ' ' LEU . . . . . . . . . . . . . 56.5 mt -71.57 -47.9 12.46 Favored Pre-proline 0 C--N 1.329 -0.315 0 CA-C-O 118.613 -0.708 . . . . 0.0 112.176 -178.889 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' F' F ' 10' ' ' PRO . . . . . . . . . . . . . 97.4 Cg_endo -79.46 157.9 25.55 Favored 'Trans proline' 0 N--CA 1.495 1.616 0 C-N-CA 121.197 1.264 . . . . 0.0 112.291 177.061 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' F' F ' 11' ' ' LYS . . . . . . . . . . . . . 6.6 tmtm? -87.21 97.28 10.68 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.256 178.756 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' F' F ' 12' ' ' VAL . . . . . . . . . . . . . 13.0 p -143.63 146.62 20.93 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.23 0 CA-C-N 116.301 -0.408 . . . . 0.0 110.778 179.607 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' F' F ' 13' ' ' GLU . . . . . . . . . . . . . 94.5 mt-10 -82.71 135.12 35.1 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.079 -0.509 . . . . 0.0 110.256 178.23 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' F' F ' 14' ' ' LEU . . . . . . . . . . . . . 15.2 mt -98.18 141.59 23.21 Favored Pre-proline 0 CA--C 1.534 0.328 0 CA-C-O 118.887 -0.578 . . . . 0.0 110.099 179.536 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' F' F ' 15' ' ' PRO . . . . . . . . . . . . . 26.0 Cg_exo -62.24 159.92 33.09 Favored 'Trans proline' 0 N--CA 1.496 1.658 0 C-N-CA 121.297 1.331 . . . . 0.0 111.711 176.113 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' F' F ' 16' ' ' PRO . . . . . . . . . . . . . 39.6 Cg_exo -58.42 -41.23 67.64 Favored 'Trans proline' 0 N--CA 1.496 1.657 0 C-N-CA 121.499 1.466 . . . . 0.0 112.907 -177.313 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' F' F ' 17' ' ' ASP . . . . . . . . . . . . . 24.2 p-10 -84.71 6.99 22.06 Favored 'General case' 0 CA--C 1.538 0.498 0 N-CA-C 113.261 0.837 . . . . 0.0 113.261 -177.38 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' F' F ' 18' ' ' PHE . . . . . . . . . . . . . 41.2 t80 -57.83 -45.72 85.78 Favored 'General case' 0 C--N 1.334 -0.099 0 O-C-N 122.012 -0.43 . . . . 0.0 110.161 -177.798 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' F' F ' 19' ' ' VAL . . . . . . . . . . . . . 48.7 t -56.71 -44.37 81.28 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.304 0 CA-C-N 116.298 -0.41 . . . . 0.0 110.559 -178.101 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' F' F ' 20' ' ' ASP . . . . . . . . . . . . . 29.2 m-20 -59.67 -42.06 92.01 Favored 'General case' 0 C--N 1.329 -0.296 0 C-N-CA 120.896 -0.322 . . . . 0.0 111.089 -177.711 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' F' F ' 21' ' ' VAL . . . . . . . . . . . . . 46.9 t -63.48 -45.63 97.34 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.285 0 C-N-CA 120.824 -0.35 . . . . 0.0 110.17 -177.738 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' F' F ' 22' ' ' ILE . . . . . 0.611 HG22 HD12 ' F' ' 26' ' ' LEU . 51.7 mm -55.56 -48.2 77.73 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 C-N-CA 121.085 -0.246 . . . . 0.0 110.679 178.568 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' F' F ' 23' ' ' ARG . . . . . . . . . . . . . 41.5 ttp180 -54.97 -47.46 74.53 Favored 'General case' 0 C--N 1.328 -0.339 0 C-N-CA 121.074 -0.25 . . . . 0.0 111.395 -177.937 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' F' F ' 24' ' ' ILE . . . . . . . . . . . . . 82.5 mt -58.8 -45.72 91.25 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.29 0 C-N-CA 121.144 -0.222 . . . . 0.0 111.341 -177.442 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' F' F ' 25' ' ' LYS . . . . . . . . . . . . . 93.0 mttt -67.78 -42.68 81.3 Favored 'General case' 0 C--N 1.328 -0.333 0 N-CA-C 112.538 0.57 . . . . 0.0 112.538 -177.56 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' F' F ' 26' ' ' LEU . . . . . 0.611 HD12 HG22 ' F' ' 22' ' ' ILE . 94.6 mt -77.68 -37.76 49.0 Favored 'General case' 0 C--N 1.329 -0.287 0 N-CA-C 113.288 0.848 . . . . 0.0 113.288 -170.128 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' F' F ' 27' ' ' GLN . . . . . . . . . . . . . 10.3 pt20 -47.19 137.95 7.49 Favored 'General case' 0 N--CA 1.468 0.451 0 N-CA-C 112.698 0.629 . . . . 0.0 112.698 -174.917 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' F' F ' 28' ' ' GLY . . . . . . . . . . . . . . . 100.77 -26.21 25.47 Favored Glycine 0 CA--C 1.533 1.184 0 CA-C-N 115.533 -0.758 . . . . 0.0 112.26 -177.435 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' F' F ' 29' ' ' LYS . . . . . . . . . . . . . 91.4 mttt -97.79 155.06 17.21 Favored 'General case' 0 C--N 1.332 -0.167 0 CA-C-N 117.375 0.588 . . . . 0.0 110.946 178.101 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' F' F ' 30' ' ' THR . . . . . . . . . . . . . 26.2 m -106.06 138.44 42.25 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.006 -0.543 . . . . 0.0 110.152 177.244 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' F' F ' 31' ' ' VAL . . . . . . . . . . . . . 34.1 m -128.64 157.1 41.34 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.267 0 CA-C-N 116.343 -0.39 . . . . 0.0 110.722 -178.792 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' F' F ' 32' ' ' ARG . . . . . . . . . . . . . 98.6 mtt180 -130.15 150.28 51.48 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-O 121.243 0.544 . . . . 0.0 110.654 177.824 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' F' F ' 33' ' ' THR . . . . . . . . . . . . . 15.2 m -53.66 138.34 35.09 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.217 -0.447 . . . . 0.0 111.187 -178.787 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' F' F ' 34' ' ' GLY . . . . . . . . . . . . . . . 100.88 -17.05 56.91 Favored Glycine 0 CA--C 1.532 1.15 0 CA-C-O 119.614 -0.548 . . . . 0.0 113.287 179.381 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' F' F ' 35' ' ' ASP . . . . . . . . . . . . . 73.5 m-20 -65.25 149.43 49.95 Favored 'General case' 0 C--O 1.231 0.13 0 CA-C-N 118.049 0.924 . . . . 0.0 111.264 179.49 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' F' F ' 36' ' ' VAL . . . . . . . . . . . . . 46.6 t -123.13 131.91 72.36 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.171 0 CA-C-N 115.88 -0.6 . . . . 0.0 110.038 178.884 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' F' F ' 37' ' ' ILE . . . . . . . . . . . . . 67.5 mt -123.67 142.66 39.58 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.28 0 CA-C-N 116.156 -0.475 . . . . 0.0 109.811 -179.959 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' F' F ' 38' ' ' GLY . . . . . . . . . . . . . . . -113.09 128.78 8.56 Favored Glycine 0 CA--C 1.527 0.791 0 N-CA-C 111.335 -0.706 . . . . 0.0 111.335 -179.574 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' F' F ' 39' ' ' ILE . . . . . . . . . . . . . 72.0 mt -126.61 127.3 70.1 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.18 0 N-CA-C 109.829 -0.434 . . . . 0.0 109.829 177.862 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' F' F ' 40' ' ' SER . . . . . . . . . . . . . 42.3 t -93.42 116.43 28.97 Favored 'General case' 0 C--N 1.329 -0.29 0 C-N-CA 120.918 -0.313 . . . . 0.0 110.836 175.815 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' F' F ' 41' ' ' ILE . . . . . . . . . . . . . 44.2 mm -122.78 121.91 64.55 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.188 0 CA-C-O 120.934 0.397 . . . . 0.0 110.362 179.853 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' F' F ' 42' ' ' LEU . . . . . 0.541 ' O ' HD23 ' F' ' 42' ' ' LEU . 1.3 tt 54.94 46.44 24.37 Favored 'General case' 0 C--N 1.331 -0.211 0 CA-C-O 121.366 0.603 . . . . 0.0 110.686 177.118 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' F' F ' 43' ' ' GLY . . . . . . . . . . . . . . . 70.5 10.05 65.99 Favored Glycine 0 CA--C 1.534 1.259 0 C-N-CA 121.232 -0.509 . . . . 0.0 113.32 174.522 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' F' F ' 44' ' ' LYS . . . . . . . . . . . . . 43.1 tptt -124.83 127.18 46.76 Favored 'General case' 0 C--N 1.333 -0.146 0 CA-C-N 117.986 0.893 . . . . 0.0 109.767 -178.715 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' F' F ' 45' ' ' GLU . . . . . . . . . . . . . 36.9 tp10 -83.43 127.43 33.68 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-O 120.875 0.369 . . . . 0.0 110.943 -177.148 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' F' F ' 46' ' ' VAL . . . . . . . . . . . . . 7.5 p -124.32 130.59 73.59 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.194 0 N-CA-C 109.491 -0.559 . . . . 0.0 109.491 176.191 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' F' F ' 47' ' ' LYS . . . . . . . . . . . . . 30.0 mtpp -100.7 131.21 46.71 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.054 -0.521 . . . . 0.0 111.221 178.292 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' F' F ' 48' ' ' PHE . . . . . . . . . . . . . 89.1 m-85 -113.26 131.91 55.73 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.242 -0.435 . . . . 0.0 110.367 178.118 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' F' F ' 49' ' ' LYS . . . . . . . . . . . . . 82.1 tttt -107.31 137.21 45.78 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.169 -0.469 . . . . 0.0 110.412 178.492 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' F' F ' 50' ' ' VAL . . . . . 0.404 ' HA ' HD23 ' F' ' 6' ' ' LEU . 47.6 t -80.32 106.89 12.08 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.316 0 N-CA-C 109.138 -0.689 . . . . 0.0 109.138 175.061 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' F' F ' 51' ' ' VAL . . . . . . . . . . . . . 55.2 t -70.51 -48.22 60.58 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.286 0 CA-C-N 116.114 -0.494 . . . . 0.0 109.932 -173.373 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' F' F ' 52' ' ' GLN . . . . . . . . . . . . . 21.4 pt20 -164.64 158.92 18.42 Favored 'General case' 0 C--N 1.331 -0.229 0 C-N-CA 120.156 -0.618 . . . . 0.0 111.859 -179.505 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' F' F ' 53' ' ' ALA . . . . . . . . . . . . . . . -135.46 135.86 40.85 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 115.361 -0.836 . . . . 0.0 110.495 179.347 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' F' F ' 54' ' ' TYR . . . . . . . . . . . . . 59.6 t80 -128.98 110.52 18.4 Favored Pre-proline 0 CA--C 1.534 0.345 0 CA-C-O 118.225 -0.893 . . . . 0.0 110.211 177.232 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' F' F ' 55' ' ' PRO . . . . . . . . . . . . . 72.6 Cg_endo -77.15 166.27 82.72 Favored 'Cis proline' 0 N--CA 1.5 1.859 0 CA-C-N 121.988 1.746 . . . . 0.0 112.322 -6.0 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' F' F ' 56' ' ' SER . . . . . . . . . . . . . 43.5 m -116.03 130.09 24.69 Favored Pre-proline 0 CA--C 1.538 0.488 0 CA-C-O 118.387 -0.816 . . . . 0.0 109.293 174.059 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' F' F ' 57' ' ' PRO . . . . . . . . . . . . . 37.6 Cg_endo -66.72 163.64 70.72 Favored 'Cis proline' 0 N--CA 1.498 1.788 0 CA-C-N 122.054 1.769 . . . . 0.0 111.701 -0.172 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' F' F ' 58' ' ' LEU . . . . . . . . . . . . . 24.7 tp -129.37 137.38 50.92 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.349 -179.025 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' F' F ' 59' ' ' ARG . . . . . . . . . . . . . 74.8 ttt180 -105.18 128.59 53.47 Favored 'General case' 0 C--N 1.327 -0.391 0 N-CA-C 109.272 -0.64 . . . . 0.0 109.272 175.657 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' F' F ' 60' ' ' VAL . . . . . . . . . . . . . 45.5 t -79.01 123.09 35.52 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.306 0 C-N-CA 120.686 -0.405 . . . . 0.0 110.347 -175.432 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' F' F ' 61' ' ' GLU . . . . . . . . . . . . . 95.4 mt-10 -131.09 162.75 29.17 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 115.732 -0.667 . . . . 0.0 109.949 177.894 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' F' F ' 62' ' ' ASP . . . . . . . . . . . . . 16.7 p-10 -56.8 -32.84 66.08 Favored 'General case' 0 C--N 1.328 -0.342 0 C-N-CA 120.941 -0.304 . . . . 0.0 111.522 179.329 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' F' F ' 63' ' ' ARG . . . . . . . . . . . . . 17.0 ptm180 -82.9 5.4 21.98 Favored 'General case' 0 CA--C 1.537 0.462 0 N-CA-C 113.558 0.947 . . . . 0.0 113.558 -176.602 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' F' F ' 64' ' ' THR . . . . . . . . . . . . . 19.4 m -88.53 141.97 28.09 Favored 'General case' 0 C--O 1.231 0.126 0 CA-C-N 118.235 0.471 . . . . 0.0 110.753 -177.66 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' F' F ' 65' ' ' LYS . . . . . . . . . . . . . 97.7 mttt -87.4 125.64 34.39 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.264 -0.425 . . . . 0.0 109.918 178.514 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' F' F ' 66' ' ' ILE . . . . . . . . . . . . . 59.0 mt -116.36 124.92 73.11 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.336 0 N-CA-C 109.712 -0.477 . . . . 0.0 109.712 179.708 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' F' F ' 67' ' ' THR . . . . . . . . . . . . . 19.6 m -123.8 146.03 48.64 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-O 121.043 0.449 . . . . 0.0 111.247 -176.231 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' F' F ' 68' ' ' LEU . . . . . . . . . . . . . 49.8 mt . . . . . 0 C--N 1.329 -0.317 0 CA-C-N 115.77 -0.65 . . . . 0.0 110.486 177.637 . . . . . . . . 0 0 . 1 . 018 nuclear nobuild core ' F' F ' 73' ' ' VAL . . . . . 0.497 HG12 HG22 ' E' ' 143' ' ' THR . 31.0 m . . . . . 0 C--O 1.231 0.122 0 CA-C-O 121.096 0.474 . . . . 0.0 111.213 . . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' F' F ' 74' ' ' ASP . . . . . . . . . . . . . 9.6 t0 -101.9 120.86 41.07 Favored 'General case' 0 C--N 1.327 -0.383 0 N-CA-C 109.042 -0.725 . . . . 0.0 109.042 174.724 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' F' F ' 75' ' ' VAL . . . . . . . . . . . . . 40.5 t -109.39 123.16 65.06 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.288 0 CA-C-O 121.207 0.527 . . . . 0.0 110.779 -175.939 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' F' F ' 76' ' ' LEU . . . . . . . . . . . . . 15.4 mt -129.55 144.25 51.19 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 115.477 -0.783 . . . . 0.0 109.127 177.101 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' F' F ' 77' ' ' GLU . . . . . . . . . . . . . 56.2 tt0 -138.86 139.99 38.31 Favored 'General case' 0 C--N 1.332 -0.184 0 C-N-CA 120.671 -0.411 . . . . 0.0 111.269 -175.148 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' F' F ' 78' ' ' ALA . . . . . 0.481 ' HB2' HD21 ' F' ' 109' ' ' LEU . . . -124.4 140.02 53.35 Favored 'General case' 0 C--N 1.331 -0.229 0 CA-C-N 115.947 -0.57 . . . . 0.0 110.308 178.217 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' F' F ' 79' ' ' LYS . . . . . 0.624 ' O ' HD13 ' F' ' 80' ' ' ILE . 3.9 mptp? -82.75 116.36 22.07 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-N 116.427 -0.351 . . . . 0.0 110.685 -178.529 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' F' F ' 80' ' ' ILE . . . . . 0.624 HD13 ' O ' ' F' ' 79' ' ' LYS . 40.0 mm -139.2 107.04 3.08 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.279 0 N-CA-C 109.391 -0.596 . . . . 0.0 109.391 -178.855 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' F' F ' 81' ' ' LYS . . . . . . . . . . . . . 99.3 mttt -105.19 133.61 49.68 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-O 120.902 0.382 . . . . 0.0 110.975 -179.037 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' F' F ' 82' ' ' GLY . . . . . . . . . . . . . . . 88.9 42.23 5.73 Favored Glycine 0 CA--C 1.524 0.63 0 N-CA-C 111.228 -0.749 . . . . 0.0 111.228 176.549 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' F' F ' 83' ' ' ILE . . . . . . . . . . . . . 72.8 mt -72.56 135.91 26.74 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.336 0 N-CA-C 109.964 -0.384 . . . . 0.0 109.964 179.382 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' F' F ' 84' ' ' LYS . . . . . . . . . . . . . 54.7 tttp -98.4 -53.96 3.19 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 115.971 -0.559 . . . . 0.0 110.329 -178.535 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' F' F ' 85' ' ' ASP . . . . . . . . . . . . . 7.4 t0 -149.6 148.31 29.18 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 115.85 -0.613 . . . . 0.0 110.327 -178.808 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' F' F ' 86' ' ' VAL . . . . . . . . . . . . . 42.3 t -129.79 129.39 66.18 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.274 0 CA-C-O 120.906 0.384 . . . . 0.0 110.456 -179.527 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' F' F ' 87' ' ' ILE . . . . . . . . . . . . . 45.6 mm -118.66 125.96 74.82 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.268 0 CA-C-N 116.006 -0.543 . . . . 0.0 109.734 175.809 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' F' F ' 88' ' ' LEU . . . . . . . . . . . . . 38.5 mt -113.02 136.82 52.27 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-O 121.12 0.486 . . . . 0.0 111.303 -177.973 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' F' F ' 89' ' ' ASP . . . . . . . . . . . . . 7.6 t70 -134.85 155.29 50.92 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 115.687 -0.688 . . . . 0.0 109.618 175.538 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' F' F ' 90' ' ' GLU . . . . . . . . . . . . . 95.7 mt-10 -48.78 -33.15 9.82 Favored 'General case' 0 C--N 1.329 -0.324 0 N-CA-C 112.927 0.714 . . . . 0.0 112.927 -172.542 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' F' F ' 91' ' ' ASN . . . . . . . . . . . . . 27.9 t30 -130.44 18.86 5.29 Favored 'General case' 0 N--CA 1.469 0.493 0 N-CA-C 113.063 0.764 . . . . 0.0 113.063 -176.056 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' F' F ' 92' ' ' LEU . . . . . . . . . . . . . 12.0 mt -151.66 143.63 23.83 Favored 'General case' 0 C--N 1.333 -0.151 0 N-CA-C 109.976 -0.379 . . . . 0.0 109.976 -177.225 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' F' F ' 93' ' ' ILE . . . . . . . . . . . . . 71.9 mt -128.82 118.11 46.24 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 N-CA-C 109.278 -0.638 . . . . 0.0 109.278 176.086 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' F' F ' 94' ' ' VAL . . . . . . . . . . . . . 44.5 t -120.84 127.02 75.89 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.344 0 N-CA-C 109.998 -0.371 . . . . 0.0 109.998 -178.538 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' F' F ' 95' ' ' VAL . . . . . . . . . . . . . 44.0 t -123.14 134.11 67.16 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.33 0 CA-C-N 116.064 -0.516 . . . . 0.0 109.95 -179.593 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' F' F ' 96' ' ' ILE . . . . . . . . . . . . . 52.8 mt -113.61 127.54 70.9 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.345 0 N-CA-C 109.006 -0.738 . . . . 0.0 109.006 178.391 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' F' F ' 97' ' ' THR . . . . . . . . . . . . . 66.1 p -99.42 157.15 16.62 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-O 121.204 0.526 . . . . 0.0 111.069 -177.142 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' F' F ' 98' ' ' GLU . . . . . . . . . . . . . 81.9 tt0 -53.98 -27.87 34.22 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 116.127 -0.488 . . . . 0.0 112.056 179.909 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' F' F ' 99' ' ' GLU . . . . . . . . . . . . . 95.9 mt-10 -76.92 12.54 1.32 Allowed 'General case' 0 CA--C 1.536 0.404 0 N-CA-C 113.329 0.863 . . . . 0.0 113.329 -176.737 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' F' F ' 100' ' ' ASN . . . . . . . . . . . . . 3.9 m-20 63.57 34.61 12.37 Favored 'General case' 0 CA--C 1.531 0.248 0 CA-C-O 120.964 0.412 . . . . 0.0 111.369 179.328 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' F' F ' 101' ' ' GLU . . . . . . . . . . . . . 84.0 tt0 -113.96 145.6 41.29 Favored 'General case' 0 C--N 1.333 -0.133 0 N-CA-C 109.52 -0.548 . . . . 0.0 109.52 173.607 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' F' F ' 102' ' ' VAL . . . . . . . . . . . . . 43.9 t -118.12 128.93 75.13 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.253 0 CA-C-O 120.849 0.356 . . . . 0.0 110.096 -177.802 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' F' F ' 103' ' ' LEU . . . . . . . . . . . . . 48.4 mt -115.84 130.43 56.83 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 115.479 -0.782 . . . . 0.0 109.823 178.372 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' F' F ' 104' ' ' ILE . . . . . . . . . . . . . 62.5 mt -119.87 121.59 66.43 Favored 'Isoleucine or valine' 0 C--O 1.233 0.23 0 N-CA-C 110.152 -0.314 . . . . 0.0 110.152 179.597 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' F' F ' 105' ' ' PHE . . . . . . . . . . . . . 30.8 m-85 -124.25 165.78 17.03 Favored 'General case' 0 C--N 1.333 -0.149 0 O-C-N 123.936 0.773 . . . . 0.0 109.521 178.152 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' F' F ' 106' ' ' ASN . . . . . . . . . . . . . 44.1 p-10 -96.99 -170.0 1.96 Allowed 'General case' 0 C--N 1.329 -0.29 0 N-CA-C 109.861 -0.422 . . . . 0.0 109.861 172.858 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' F' F ' 107' ' ' GLN . . . . . . . . . . . . . 47.8 tt0 -60.1 -30.14 69.05 Favored 'General case' 0 CA--C 1.532 0.286 0 N-CA-C 111.873 0.323 . . . . 0.0 111.873 179.532 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' F' F ' 108' ' ' ASN . . . . . . . . . . . . . 7.1 t-20 -82.5 8.19 12.34 Favored 'General case' 0 CA--C 1.537 0.457 0 N-CA-C 113.219 0.822 . . . . 0.0 113.219 -178.31 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' F' F ' 109' ' ' LEU . . . . . 0.481 HD21 ' HB2' ' F' ' 78' ' ' ALA . 11.0 tp 59.76 37.45 22.07 Favored 'General case' 0 CA--C 1.529 0.17 0 CA-C-O 120.977 0.418 . . . . 0.0 111.294 178.255 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' F' F ' 110' ' ' GLU . . . . . . . . . . . . . 70.7 mm-40 -104.04 163.68 12.22 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.416 -0.356 . . . . 0.0 110.109 177.228 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' F' F ' 111' ' ' GLU . . . . . . . . . . . . . 83.6 tt0 -84.86 124.18 31.31 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-N 116.328 -0.397 . . . . 0.0 111.053 -177.215 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' F' F ' 112' ' ' LEU . . . . . . . . . . . . . 15.3 mt -112.64 -46.06 3.18 Favored 'General case' 0 C--N 1.331 -0.197 0 CA-C-N 116.051 -0.522 . . . . 0.0 110.014 175.163 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' F' F ' 113' ' ' TYR . . . . . . . . . . . . . 57.7 t80 -148.25 137.91 22.28 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.228 -0.442 . . . . 0.0 111.036 179.775 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' F' F ' 114' ' ' ARG . . . . . . . . . . . . . 31.1 mtp180 -137.13 123.77 21.05 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.346 -0.388 . . . . 0.0 109.995 174.713 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' F' F ' 115' ' ' GLY . . . . . . . . . . . . . . . -149.46 160.15 28.34 Favored Glycine 0 CA--C 1.523 0.544 0 N-CA-C 110.832 -0.907 . . . . 0.0 110.832 -179.658 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' F' F ' 116' ' ' LYS . . . . . . . . . . . . . 72.5 tttt -133.32 133.64 42.79 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-O 120.844 0.354 . . . . 0.0 110.184 179.622 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' F' F ' 117' ' ' PHE . . . . . . . . . . . . . 23.6 m-85 -132.1 115.64 16.01 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.192 -0.458 . . . . 0.0 109.843 -175.459 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' F' F ' 118' ' ' GLU . . . . . . . . . . . . . 85.2 tt0 -55.4 -40.09 70.99 Favored 'General case' 0 C--N 1.329 -0.324 0 C-N-CA 120.902 -0.319 . . . . 0.0 111.213 -177.152 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' F' F ' 119' ' ' ASN . . . . . . . . . . . . . 4.5 m-80 -97.8 30.99 2.77 Favored 'General case' 0 C--N 1.33 -0.282 0 N-CA-C 112.173 0.434 . . . . 0.0 112.173 -176.084 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' F' F ' 120' ' ' LEU . . . . . . . . . . . . . 11.7 tp -56.54 122.31 11.7 Favored 'General case' 0 C--N 1.333 -0.146 0 C-N-CA 121.065 -0.254 . . . . 0.0 110.641 178.991 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' F' F ' 121' ' ' ASN . . . . . . . . . . . . . 10.5 t-20 -108.16 -44.14 4.22 Favored 'General case' 0 C--O 1.233 0.192 0 CA-C-N 116.578 -0.283 . . . . 0.0 111.05 -177.859 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' F' F ' 122' ' ' LYS . . . . . . . . . . . . . 55.7 pttt -165.94 161.73 17.73 Favored 'General case' 0 C--N 1.332 -0.17 0 C-N-CA 120.398 -0.521 . . . . 0.0 112.218 -179.223 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' F' F ' 123' ' ' VAL . . . . . . . . . . . . . 44.1 t -131.36 137.38 55.61 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.202 0 CA-C-N 115.809 -0.632 . . . . 0.0 109.956 178.959 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' F' F ' 124' ' ' LEU . . . . . . . . . . . . . 88.4 mt -122.38 136.8 54.97 Favored 'General case' 0 C--N 1.331 -0.223 0 CA-C-N 116.498 -0.319 . . . . 0.0 110.944 -179.47 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' F' F ' 125' ' ' VAL . . . . . . . . . . . . . 44.3 t -126.12 129.27 72.19 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.217 0 CA-C-N 116.096 -0.502 . . . . 0.0 109.849 178.576 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' F' F ' 126' ' ' ARG . . . . . . . . . . . . . 27.3 mmt85 -139.85 118.12 12.03 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.408 -0.36 . . . . 0.0 110.701 179.122 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' F' F ' 127' ' ' ASN . . . . . . . . . . . . . 4.9 m-20 49.66 -105.0 0.16 Allowed 'General case' 0 CA--C 1.545 0.759 0 CA-C-O 119.052 -0.499 . . . . 0.0 111.678 178.438 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' F' F ' 128' ' ' ASP . . . . . . . . . . . . . 17.5 p-10 -114.0 1.21 14.6 Favored 'General case' 0 N--CA 1.468 0.429 0 CA-C-N 119.571 1.078 . . . . 0.0 113.401 -178.046 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' F' F ' 129' ' ' LEU . . . . . . . . . . . . . 62.1 mt -107.32 142.86 36.44 Favored 'General case' 0 C--N 1.333 -0.131 0 N-CA-C 109.782 -0.451 . . . . 0.0 109.782 179.508 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' F' F ' 130' ' ' VAL . . . . . . . . . . . . . 41.9 t -129.5 140.31 49.43 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.287 0 CA-C-O 120.911 0.386 . . . . 0.0 110.066 -179.12 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' F' F ' 131' ' ' VAL . . . . . 0.426 HG12 HD12 ' F' ' 140' ' ' LEU . 34.8 m -135.93 142.0 40.23 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.267 0 CA-C-O 121.151 0.5 . . . . 0.0 110.838 178.882 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' F' F ' 132' ' ' ILE . . . . . . . . . . . . . 73.7 mt -118.61 134.0 63.64 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.259 0 CA-C-N 115.649 -0.705 . . . . 0.0 109.37 -179.78 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' F' F ' 133' ' ' ILE . . . . . . . . . . . . . 38.7 mm -116.79 122.51 70.11 Favored 'Isoleucine or valine' 0 C--O 1.234 0.278 0 CA-C-O 120.828 0.347 . . . . 0.0 111.077 -175.161 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' F' F ' 134' ' ' ASP . . . . . . . . . . . . . 6.1 p-10 -134.2 147.24 50.7 Favored 'General case' 0 C--N 1.332 -0.183 0 CA-C-N 115.87 -0.605 . . . . 0.0 109.577 172.693 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' F' F ' 135' ' ' GLU . . . . . . . . . . . . . 81.9 tt0 -49.94 -23.91 2.25 Favored 'General case' 0 C--N 1.328 -0.369 0 N-CA-C 113.088 0.773 . . . . 0.0 113.088 -170.147 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' F' F ' 136' ' ' GLN . . . . . . . . . . . . . 47.6 tt0 -104.69 -26.27 12.37 Favored 'General case' 0 CA--C 1.531 0.238 0 N-CA-C 112.748 0.648 . . . . 0.0 112.748 -174.625 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' F' F ' 137' ' ' LYS . . . . . . . . . . . . . 7.2 ttpm? -143.87 150.14 37.99 Favored 'General case' 0 C--N 1.332 -0.167 0 CA-C-O 121.36 0.6 . . . . 0.0 111.781 -170.5 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' F' F ' 138' ' ' LEU . . . . . . . . . . . . . 5.7 tt -116.87 126.62 53.29 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 115.466 -0.788 . . . . 0.0 109.241 175.183 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' F' F ' 139' ' ' THR . . . . . . . . . . . . . 26.4 m -112.44 128.27 56.27 Favored 'General case' 0 C--N 1.331 -0.208 0 CA-C-N 116.592 -0.276 . . . . 0.0 110.82 -178.106 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' F' F ' 140' ' ' LEU . . . . . 0.426 HD12 HG12 ' F' ' 131' ' ' VAL . 36.5 tp -112.71 120.24 40.85 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 115.573 -0.739 . . . . 0.0 109.263 179.783 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' F' F ' 141' ' ' ILE . . . . . . . . . . . . . 19.3 mt -119.83 119.73 61.17 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.28 0 N-CA-C 109.863 -0.421 . . . . 0.0 109.863 -175.009 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' F' F ' 142' ' ' ARG . . . . . . . . . . . . . 78.9 mtp180 -108.9 130.11 55.43 Favored 'General case' 0 C--N 1.331 -0.23 0 CA-C-N 115.556 -0.747 . . . . 0.0 110.624 -177.948 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' F' F ' 143' ' ' THR . . . . . . . . . . . . . 26.5 p . . . . . 0 C--O 1.22 -0.485 0 CA-C-O 118.106 -0.95 . . . . 0.0 110.532 -179.238 . . . . . . . . 0 0 . 1 . 019 nuclear nobuild core ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 3.9 p . . . . . 0 N--CA 1.462 0.152 0 CA-C-O 121.149 0.5 . . . . 0.0 110.692 . . . . . . . . . 0 0 . 1 . 019 nuclear nobuild core ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 95.7 mt-10 -141.26 144.36 34.63 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 115.593 -0.731 . . . . 0.0 110.996 -176.55 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 4' ' ' LEU . . . . . . . . . . . . . 21.8 tp -122.46 125.6 46.15 Favored 'General case' 0 C--N 1.331 -0.206 0 CA-C-N 115.919 -0.582 . . . . 0.0 109.758 174.431 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 5' ' ' LYS . . . . . . . . . . . . . 90.5 mttt -104.64 120.95 42.52 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.341 -0.391 . . . . 0.0 110.685 -179.51 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 65.9 mt -117.82 147.27 43.19 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 115.575 -0.739 . . . . 0.0 110.7 -178.08 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 56.6 tttt -140.31 139.37 20.66 Favored Pre-proline 0 CA--C 1.533 0.314 0 CA-C-O 119.066 -0.492 . . . . 0.0 109.953 175.103 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 8' ' ' PRO . . . . . . . . . . . . . 94.1 Cg_endo -91.81 146.63 3.18 Favored 'Trans proline' 0 N--CA 1.49 1.319 0 C-N-CA 121.623 1.549 . . . . 0.0 111.834 178.119 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 59.1 mt -78.64 -47.18 1.87 Allowed Pre-proline 0 CA--C 1.534 0.359 0 CA-C-O 118.724 -0.655 . . . . 0.0 112.029 179.96 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 87.8 Cg_endo -81.34 151.37 17.68 Favored 'Trans proline' 0 N--CA 1.495 1.609 0 C-N-CA 121.195 1.264 . . . . 0.0 111.939 175.774 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 34.4 mmtp -84.26 100.43 11.21 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.445 -0.343 . . . . 0.0 110.347 177.703 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 12.5 p -140.28 143.73 29.02 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.275 0 CA-C-N 116.233 -0.439 . . . . 0.0 110.545 -179.794 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 15.0 pt-20 -89.62 130.84 35.86 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.198 -0.455 . . . . 0.0 110.224 177.72 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 14' ' ' LEU . . . . . . . . . . . . . 35.0 mt -98.24 153.72 37.95 Favored Pre-proline 0 C--O 1.234 0.241 0 CA-C-N 116.377 -0.374 . . . . 0.0 111.16 -176.5 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 15' ' ' PRO . . . . . . . . . . . . . 24.8 Cg_exo -63.0 165.44 16.59 Favored 'Trans proline' 0 N--CA 1.496 1.667 0 C-N-CA 121.37 1.38 . . . . 0.0 111.806 174.657 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 16' ' ' PRO . . . . . . . . . . . . . 26.5 Cg_exo -60.71 -46.32 17.36 Favored 'Trans proline' 0 N--CA 1.498 1.763 0 C-N-CA 121.48 1.454 . . . . 0.0 112.912 -177.649 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 17' ' ' ASP . . . . . . . . . . . . . 22.4 p-10 -86.06 11.31 11.96 Favored 'General case' 0 C--N 1.327 -0.412 0 N-CA-C 113.207 0.817 . . . . 0.0 113.207 -176.508 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 18' ' ' PHE . . . . . . . . . . . . . 37.5 t80 -57.03 -40.5 76.86 Favored 'General case' 0 C--N 1.334 -0.091 0 O-C-N 121.877 -0.514 . . . . 0.0 110.461 -179.215 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 19' ' ' VAL . . . . . . . . . . . . . 47.7 t -56.91 -44.06 81.63 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.285 0 CA-C-N 116.344 -0.389 . . . . 0.0 110.412 -179.683 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 18.1 t70 -59.79 -41.55 91.42 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-O 120.892 0.377 . . . . 0.0 110.702 -178.031 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 47.5 t -63.76 -47.74 89.63 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.308 0 CA-C-N 116.422 -0.353 . . . . 0.0 110.487 -178.021 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 22' ' ' ILE . . . . . 0.53 HG22 HD12 ' A' ' 26' ' ' LEU . 50.6 mm -56.16 -44.61 79.58 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.201 0 C-N-CA 120.863 -0.335 . . . . 0.0 110.656 179.07 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 23' ' ' ARG . . . . . . . . . . . . . 51.2 ttp180 -53.62 -49.1 68.59 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-O 120.715 0.293 . . . . 0.0 111.462 -179.393 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 24' ' ' ILE . . . . . . . . . . . . . 71.8 mt -59.24 -44.63 92.45 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.268 0 CA-C-N 116.441 -0.345 . . . . 0.0 111.157 -178.329 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 79.3 mttt -64.06 -41.38 97.37 Favored 'General case' 0 C--N 1.329 -0.318 0 N-CA-C 112.377 0.51 . . . . 0.0 112.377 -177.554 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 26' ' ' LEU . . . . . 0.53 HD12 HG22 ' A' ' 22' ' ' ILE . 65.2 mt -79.48 -42.34 25.51 Favored 'General case' 0 C--N 1.329 -0.307 0 N-CA-C 113.147 0.795 . . . . 0.0 113.147 -171.108 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 27' ' ' GLN . . . . . . . . . . . . . 10.2 pt20 -46.58 138.43 5.91 Favored 'General case' 0 N--CA 1.469 0.491 0 N-CA-C 112.816 0.673 . . . . 0.0 112.816 -175.533 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 100.77 -25.65 27.56 Favored Glycine 0 CA--C 1.531 1.086 0 CA-C-N 115.498 -0.774 . . . . 0.0 112.387 -178.515 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 85.6 mttt -98.68 155.22 17.43 Favored 'General case' 0 C--O 1.233 0.197 0 CA-C-N 117.428 0.614 . . . . 0.0 111.467 179.47 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 30' ' ' THR . . . . . . . . . . . . . 29.9 m -100.79 137.14 39.57 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 115.836 -0.62 . . . . 0.0 109.748 175.125 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 34.0 m -128.81 151.77 36.04 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.24 0 CA-C-O 120.829 0.347 . . . . 0.0 111.076 -177.602 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 32' ' ' ARG . . . . . . . . . . . . . 75.5 mtp180 -131.08 150.23 52.24 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-O 121.294 0.569 . . . . 0.0 110.541 177.241 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 33' ' ' THR . . . . . . . . . . . . . 17.6 m -53.17 138.2 32.2 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.163 -0.471 . . . . 0.0 111.471 -178.611 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 102.07 -17.23 54.63 Favored Glycine 0 CA--C 1.531 1.06 0 CA-C-O 119.67 -0.517 . . . . 0.0 113.333 178.06 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 79.7 m-20 -65.82 146.07 55.2 Favored 'General case' 0 C--O 1.231 0.107 0 CA-C-N 118.075 0.938 . . . . 0.0 110.98 179.268 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 46.9 t -121.19 129.19 75.9 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.197 0 CA-C-N 115.943 -0.571 . . . . 0.0 109.806 178.603 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 37' ' ' ILE . . . . . . . . . . . . . 67.7 mt -119.62 138.23 50.92 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.228 0 CA-C-N 116.211 -0.45 . . . . 0.0 109.835 -179.522 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . -112.15 128.68 8.66 Favored Glycine 0 CA--C 1.525 0.682 0 N-CA-C 111.034 -0.826 . . . . 0.0 111.034 179.963 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 39' ' ' ILE . . . . . . . . . . . . . 72.3 mt -127.41 127.18 68.72 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.206 0 N-CA-C 109.848 -0.427 . . . . 0.0 109.848 178.453 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 40' ' ' SER . . . . . . . . . . . . . 45.7 t -92.72 124.88 37.05 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.476 -0.329 . . . . 0.0 110.79 177.0 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 41' ' ' ILE . . . . . . . . . . . . . 73.9 mt -128.67 116.41 41.22 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.158 0 CA-C-O 120.92 0.391 . . . . 0.0 110.186 178.261 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 42' ' ' LEU . . . . . 0.538 ' O ' HD23 ' A' ' 42' ' ' LEU . 1.3 tt 54.91 46.71 23.83 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-O 121.441 0.639 . . . . 0.0 110.616 177.835 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . 75.97 -10.05 15.87 Favored Glycine 0 CA--C 1.533 1.194 0 CA-C-N 116.042 -0.526 . . . . 0.0 113.667 174.35 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 44' ' ' LYS . . . . . . . . . . . . . 46.6 mtmt -104.41 126.92 51.94 Favored 'General case' 0 C--N 1.332 -0.175 0 CA-C-N 118.178 0.989 . . . . 0.0 110.328 179.224 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 39.5 tp10 -84.83 134.25 34.3 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-O 120.96 0.409 . . . . 0.0 111.34 -177.699 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 46' ' ' VAL . . . . . . . . . . . . . 7.4 p -127.81 130.65 70.14 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.175 0 CA-C-N 116.085 -0.507 . . . . 0.0 109.851 176.075 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 97.7 mttt -100.89 131.54 46.72 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.146 -0.479 . . . . 0.0 111.452 177.59 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 48' ' ' PHE . . . . . . . . . . . . . 90.4 m-85 -113.9 131.77 56.17 Favored 'General case' 0 C--N 1.33 -0.278 0 N-CA-C 109.535 -0.542 . . . . 0.0 109.535 175.246 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 45.3 tttp -108.07 137.23 46.41 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-O 120.715 0.293 . . . . 0.0 110.736 179.405 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 50' ' ' VAL . . . . . . . . . . . . . 45.0 t -78.91 107.04 10.87 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.236 0 N-CA-C 109.157 -0.683 . . . . 0.0 109.157 175.163 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 51' ' ' VAL . . . . . . . . . . . . . 47.5 t -73.23 -47.68 45.94 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.356 0 CA-C-N 116.263 -0.426 . . . . 0.0 110.053 -173.555 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 52' ' ' GLN . . . . . . . . . . . . . 62.0 tt0 -162.69 141.96 9.04 Favored 'General case' 0 C--N 1.331 -0.201 0 C-N-CA 120.158 -0.617 . . . . 0.0 111.838 -178.129 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -114.92 130.7 56.96 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 115.65 -0.705 . . . . 0.0 109.9 176.057 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 54' ' ' TYR . . . . . . . . . . . . . 37.9 t80 -129.15 107.44 17.85 Favored Pre-proline 0 CA--C 1.534 0.338 0 CA-C-O 118.292 -0.861 . . . . 0.0 110.52 -179.726 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 55' ' ' PRO . . . . . . . . . . . . . 72.4 Cg_endo -77.2 169.98 72.71 Favored 'Cis proline' 0 N--CA 1.499 1.85 0 CA-C-N 121.778 1.671 . . . . 0.0 112.562 -5.145 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 56' ' ' SER . . . . . . . . . . . . . 16.1 m -115.34 133.21 22.76 Favored Pre-proline 0 CA--C 1.538 0.506 0 CA-C-O 118.457 -0.782 . . . . 0.0 109.494 174.764 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 57' ' ' PRO . . . . . . . . . . . . . 56.0 Cg_endo -71.62 147.98 89.3 Favored 'Cis proline' 0 N--CA 1.497 1.71 0 CA-C-N 121.851 1.697 . . . . 0.0 111.502 -2.171 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 58' ' ' LEU . . . . . . . . . . . . . 22.2 tp -108.05 137.11 46.61 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-O 120.926 0.393 . . . . 0.0 110.74 -177.952 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 59' ' ' ARG . . . . . . . . . . . . . 77.2 ttt180 -102.89 122.05 43.76 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-N 115.882 -0.599 . . . . 0.0 109.401 175.714 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 43.3 t -79.31 119.81 29.33 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.254 0 C-N-CA 120.633 -0.427 . . . . 0.0 110.331 -176.3 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 75.3 tt0 -130.88 158.72 39.45 Favored 'General case' 0 C--N 1.328 -0.33 0 N-CA-C 109.059 -0.719 . . . . 0.0 109.059 177.435 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 62' ' ' ASP . . . . . . . . . . . . . 68.4 m-20 -50.98 -31.11 16.93 Favored 'General case' 0 C--N 1.327 -0.381 0 N-CA-C 112.211 0.448 . . . . 0.0 112.211 -178.65 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 63' ' ' ARG . . . . . . . . . . . . . 7.1 ptp180 -86.25 4.63 38.01 Favored 'General case' 0 CA--C 1.535 0.383 0 N-CA-C 113.728 1.01 . . . . 0.0 113.728 -175.579 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 17.9 m -86.65 141.85 28.65 Favored 'General case' 0 C--N 1.332 -0.162 0 CA-C-N 118.188 0.449 . . . . 0.0 110.371 -178.667 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 65' ' ' LYS . . . . . . . . . . . . . 37.3 ttpt -89.08 130.74 35.48 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-O 121.0 0.428 . . . . 0.0 110.607 -177.94 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 66' ' ' ILE . . . . . . . . . . . . . 64.7 mt -111.78 131.52 62.93 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.288 0 N-CA-C 109.857 -0.423 . . . . 0.0 109.857 -179.104 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 67' ' ' THR . . . . . . . . . . . . . 28.5 m -125.7 138.25 53.87 Favored 'General case' 0 C--N 1.332 -0.166 0 CA-C-O 121.059 0.457 . . . . 0.0 110.865 -177.928 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 68' ' ' LEU . . . . . 0.496 ' N ' HD12 ' A' ' 68' ' ' LEU . 6.8 mp . . . . . 0 C--N 1.33 -0.239 0 CA-C-N 115.889 -0.596 . . . . 0.0 110.332 178.132 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 74' ' ' ASP . . . . . . . . . . . . . 23.9 t0 . . . . . 0 C--O 1.23 0.064 0 N-CA-C 109.839 -0.43 . . . . 0.0 109.839 . . . . . . . . . 0 0 . 1 . 019 nuclear nobuild core ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 42.3 t -115.78 124.54 72.29 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.204 0 CA-C-O 121.073 0.463 . . . . 0.0 110.906 -175.712 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 76' ' ' LEU . . . . . . . . . . . . . 5.0 mp -121.08 137.17 54.78 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 115.625 -0.716 . . . . 0.0 109.336 174.162 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 77' ' ' GLU . . . . . 0.442 ' HG2' HG23 ' F' ' 139' ' ' THR . 96.9 mt-10 -131.75 133.11 44.42 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-O 120.967 0.413 . . . . 0.0 111.141 -178.568 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 78' ' ' ALA . . . . . . . . . . . . . . . -122.39 137.74 54.76 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 115.813 -0.631 . . . . 0.0 109.923 176.971 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 79' ' ' LYS . . . . . 0.577 ' O ' HD13 ' A' ' 80' ' ' ILE . 99.2 mttt -75.92 117.25 17.45 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-O 120.983 0.421 . . . . 0.0 110.285 179.541 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 80' ' ' ILE . . . . . 0.577 HD13 ' O ' ' A' ' 79' ' ' LYS . 42.8 mm -139.1 102.6 1.76 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.394 0 N-CA-C 109.382 -0.599 . . . . 0.0 109.382 -176.888 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 81' ' ' LYS . . . . . . . . . . . . . 97.1 mttt -99.7 131.35 45.74 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-O 120.981 0.42 . . . . 0.0 111.198 -177.704 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . 89.02 42.1 5.72 Favored Glycine 0 CA--C 1.526 0.742 0 CA-C-N 115.893 -0.594 . . . . 0.0 111.779 174.866 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 83' ' ' ILE . . . . . . . . . . . . . 70.5 mt -69.3 136.62 25.89 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.354 0 N-CA-C 109.833 -0.432 . . . . 0.0 109.833 178.068 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 84' ' ' LYS . . . . . . . . . . . . . 59.5 tttt -99.11 -53.7 3.18 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.115 -0.493 . . . . 0.0 110.285 -178.395 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 85' ' ' ASP . . . . . . . . . . . . . 8.6 t70 -155.12 154.65 32.69 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 115.857 -0.611 . . . . 0.0 110.4 179.841 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 86' ' ' VAL . . . . . . . . . . . . . 42.2 t -129.41 132.0 66.9 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.225 0 CA-C-O 120.942 0.401 . . . . 0.0 110.642 -178.756 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 87' ' ' ILE . . . . . 0.496 HD12 ' N ' ' A' ' 87' ' ' ILE . 5.0 mp -119.62 126.81 75.68 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.219 0 CA-C-N 115.975 -0.557 . . . . 0.0 109.566 176.81 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 88' ' ' LEU . . . . . . . . . . . . . 66.8 mt -107.02 135.29 48.83 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-O 121.075 0.464 . . . . 0.0 111.322 -177.949 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 89' ' ' ASP . . . . . . . . . . . . . 13.1 t70 -127.89 152.15 48.2 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 115.758 -0.655 . . . . 0.0 109.536 175.532 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 83.3 tt0 -47.28 -39.68 15.06 Favored 'General case' 0 C--N 1.33 -0.266 0 N-CA-C 112.792 0.664 . . . . 0.0 112.792 -172.978 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 91' ' ' ASN . . . . . . . . . . . . . 29.0 p30 -132.03 34.95 3.77 Favored 'General case' 0 N--CA 1.464 0.245 0 N-CA-C 111.695 0.257 . . . . 0.0 111.695 -177.673 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 92' ' ' LEU . . . . . . . . . . . . . 8.0 tp -166.11 147.0 6.59 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-O 120.73 0.3 . . . . 0.0 110.533 -178.718 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 93' ' ' ILE . . . . . . . . . . . . . 74.6 mt -129.72 122.92 55.99 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.267 0 N-CA-C 109.545 -0.539 . . . . 0.0 109.545 179.881 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 94' ' ' VAL . . . . . . . . . . . . . 40.3 t -121.06 128.06 76.0 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.271 0 CA-C-O 120.854 0.359 . . . . 0.0 110.051 -179.519 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 95' ' ' VAL . . . . . . . . . . . . . 42.0 t -120.12 134.29 64.12 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.314 0 CA-C-N 116.031 -0.531 . . . . 0.0 109.804 179.695 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 96' ' ' ILE . . . . . . . . . . . . . 63.3 mt -111.18 128.77 67.42 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.409 0 N-CA-C 109.166 -0.679 . . . . 0.0 109.166 178.856 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 97' ' ' THR . . . . . . . . . . . . . 75.8 p -100.82 157.63 16.57 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-O 121.343 0.592 . . . . 0.0 111.283 -177.412 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 98' ' ' GLU . . . . . . . . . . . . . 84.7 tt0 -53.92 -28.16 35.12 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.001 -0.545 . . . . 0.0 112.066 -179.478 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 99' ' ' GLU . . . . . . . . . . . . . 44.9 mp0 -80.58 17.73 1.07 Allowed 'General case' 0 CA--C 1.534 0.34 0 N-CA-C 112.984 0.735 . . . . 0.0 112.984 -176.339 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 100' ' ' ASN . . . . . . . . . . . . . 4.1 m-20 61.51 37.97 16.08 Favored 'General case' 0 CA--C 1.529 0.157 0 CA-C-O 121.063 0.459 . . . . 0.0 110.938 178.459 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 101' ' ' GLU . . . . . . . . . . . . . 84.9 tt0 -117.83 144.72 45.13 Favored 'General case' 0 C--N 1.331 -0.232 0 N-CA-C 109.671 -0.492 . . . . 0.0 109.671 176.307 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 102' ' ' VAL . . . . . . . . . . . . . 45.6 t -114.98 126.2 72.51 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.257 0 CA-C-O 120.887 0.375 . . . . 0.0 110.152 -177.483 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 103' ' ' LEU . . . . . . . . . . . . . 42.5 mt -114.3 130.98 56.67 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-N 115.592 -0.731 . . . . 0.0 109.822 176.614 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 104' ' ' ILE . . . . . 0.675 HD13 HG11 ' A' ' 130' ' ' VAL . 67.7 mt -122.37 120.96 62.55 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.236 0 N-CA-C 110.436 -0.209 . . . . 0.0 110.436 -177.312 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 105' ' ' PHE . . . . . . . . . . . . . 43.8 m-85 -123.83 166.63 15.28 Favored 'General case' 0 C--N 1.332 -0.193 0 O-C-N 124.041 0.838 . . . . 0.0 109.798 179.64 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 106' ' ' ASN . . . . . . . . . . . . . 41.2 p-10 -96.21 -169.91 2.0 Favored 'General case' 0 C--N 1.329 -0.302 0 N-CA-C 109.377 -0.601 . . . . 0.0 109.377 171.545 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 107' ' ' GLN . . . . . . . . . . . . . 48.0 tt0 -59.61 -30.04 68.42 Favored 'General case' 0 CA--C 1.532 0.256 0 C-N-CA 120.74 -0.384 . . . . 0.0 111.644 177.688 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 108' ' ' ASN . . . . . . . . . . . . . 13.9 t30 -81.89 6.32 16.18 Favored 'General case' 0 CA--C 1.537 0.476 0 N-CA-C 113.178 0.807 . . . . 0.0 113.178 -178.145 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 109' ' ' LEU . . . . . . . . . . . . . 8.9 tp 61.88 36.94 15.65 Favored 'General case' 0 C--O 1.232 0.155 0 O-C-N 122.123 -0.36 . . . . 0.0 111.526 176.567 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 110' ' ' GLU . . . . . . . . . . . . . 96.0 mt-10 -104.99 149.61 25.62 Favored 'General case' 0 C--N 1.33 -0.267 0 N-CA-C 110.032 -0.358 . . . . 0.0 110.032 176.018 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 111' ' ' GLU . . . . . . . . . . . . . 98.8 mt-10 -76.61 122.62 24.9 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-O 120.99 0.424 . . . . 0.0 111.222 -178.101 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 112' ' ' LEU . . . . . . . . . . . . . 16.1 mt -110.78 -45.94 3.42 Favored 'General case' 0 C--N 1.332 -0.177 0 CA-C-N 115.953 -0.567 . . . . 0.0 110.188 176.986 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 113' ' ' TYR . . . . . 0.412 ' HB3' HD12 ' A' ' 104' ' ' ILE . 34.5 t80 -138.65 140.69 38.96 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.859 179.381 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 114' ' ' ARG . . . . . . . . . . . . . 78.3 mtp180 -143.05 122.4 13.07 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.078 -0.51 . . . . 0.0 110.355 179.074 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 115' ' ' GLY . . . . . . . . . . . . . . . -150.12 153.79 25.29 Favored Glycine 0 CA--C 1.525 0.67 0 N-CA-C 111.22 -0.752 . . . . 0.0 111.22 179.73 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 116' ' ' LYS . . . . . . . . . . . . . 40.3 ttpt -126.47 129.46 48.73 Favored 'General case' 0 C--N 1.331 -0.226 0 N-CA-C 109.72 -0.474 . . . . 0.0 109.72 178.778 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 117' ' ' PHE . . . . . 0.412 ' HE2' HD13 ' A' ' 132' ' ' ILE . 41.6 m-85 -130.56 114.96 16.11 Favored 'General case' 0 C--N 1.333 -0.15 0 CA-C-O 120.851 0.358 . . . . 0.0 110.631 -174.155 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 118' ' ' GLU . . . . . . . . . . . . . 84.7 tt0 -53.93 -46.69 71.6 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.418 -0.355 . . . . 0.0 111.379 -177.875 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 119' ' ' ASN . . . . . . . . . . . . . 33.0 m120 -94.77 30.44 2.06 Favored 'General case' 0 C--N 1.329 -0.299 0 N-CA-C 112.241 0.46 . . . . 0.0 112.241 -175.197 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 120' ' ' LEU . . . . . . . . . . . . . 17.1 tp -58.47 123.4 16.06 Favored 'General case' 0 C--N 1.332 -0.153 0 N-CA-C 110.204 -0.295 . . . . 0.0 110.204 177.575 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 121' ' ' ASN . . . . . . . . . . . . . 14.7 m120 -113.77 -44.19 3.21 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-N 116.678 -0.237 . . . . 0.0 110.989 -178.399 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 122' ' ' LYS . . . . . . . . . . . . . 97.3 mttt -148.28 150.31 33.42 Favored 'General case' 0 C--N 1.331 -0.236 0 C-N-CA 120.549 -0.46 . . . . 0.0 111.523 -178.04 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 123' ' ' VAL . . . . . . . . . . . . . 43.9 t -130.13 132.23 65.4 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.185 0 CA-C-N 115.967 -0.561 . . . . 0.0 109.55 175.825 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 124' ' ' LEU . . . . . . . . . . . . . 17.6 tp -127.62 136.9 52.27 Favored 'General case' 0 C--N 1.332 -0.162 0 CA-C-O 120.808 0.337 . . . . 0.0 110.621 -178.188 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 125' ' ' VAL . . . . . . . . . . . . . 11.4 p -125.59 128.05 72.07 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.22 0 CA-C-N 116.112 -0.495 . . . . 0.0 110.252 178.978 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 126' ' ' ARG . . . . . . . . . . . . . 51.8 mmm-85 -140.84 123.9 16.46 Favored 'General case' 0 C--N 1.33 -0.269 0 N-CA-C 109.19 -0.67 . . . . 0.0 109.19 178.909 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 127' ' ' ASN . . . . . . . . . . . . . 37.1 t30 57.25 -150.99 0.43 Allowed 'General case' 0 CA--C 1.539 0.546 0 N-CA-C 109.56 -0.533 . . . . 0.0 109.56 -179.074 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 128' ' ' ASP . . . . . . . . . . . . . 19.5 p-10 -83.57 14.75 3.54 Favored 'General case' 0 CA--C 1.537 0.46 0 CA-C-N 118.637 0.653 . . . . 0.0 112.694 177.024 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 129' ' ' LEU . . . . . . . . . . . . . 40.2 mt -114.1 145.09 42.1 Favored 'General case' 0 C--O 1.231 0.119 0 O-C-N 121.975 -0.453 . . . . 0.0 109.83 179.06 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 130' ' ' VAL . . . . . 0.675 HG11 HD13 ' A' ' 104' ' ' ILE . 12.3 p -133.73 144.98 34.24 Favored 'Isoleucine or valine' 0 C--O 1.233 0.206 0 CA-C-O 121.248 0.547 . . . . 0.0 110.756 -176.914 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 131' ' ' VAL . . . . . 0.548 HG22 HD12 ' A' ' 140' ' ' LEU . 45.3 t -134.36 137.35 51.74 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.303 0 CA-C-N 115.707 -0.679 . . . . 0.0 110.063 179.695 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 132' ' ' ILE . . . . . 0.412 HD13 ' HE2' ' A' ' 117' ' ' PHE . 72.1 mt -116.53 132.82 65.05 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.367 0 CA-C-N 115.757 -0.656 . . . . 0.0 109.336 179.47 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 133' ' ' ILE . . . . . . . . . . . . . 42.6 mm -114.55 120.18 63.52 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.259 0 CA-C-O 120.693 0.282 . . . . 0.0 110.879 -175.356 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 134' ' ' ASP . . . . . . . . . . . . . 8.4 p-10 -130.62 143.25 50.62 Favored 'General case' 0 C--N 1.33 -0.244 0 N-CA-C 109.351 -0.611 . . . . 0.0 109.351 174.732 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 135' ' ' GLU . . . . . . . . . . . . . 39.6 tp10 -50.0 -26.32 4.18 Favored 'General case' 0 C--N 1.328 -0.328 0 N-CA-C 112.89 0.7 . . . . 0.0 112.89 -171.939 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 136' ' ' GLN . . . . . . . . . . . . . 97.0 mt-30 -80.43 -35.1 35.52 Favored 'General case' 0 C--N 1.331 -0.218 0 N-CA-C 112.022 0.378 . . . . 0.0 112.022 -176.962 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 137' ' ' LYS . . . . . . . . . . . . . 49.7 pttt -167.64 172.61 9.19 Favored 'General case' 0 C--N 1.331 -0.219 0 CA-C-O 121.478 0.656 . . . . 0.0 112.052 -173.828 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 138' ' ' LEU . . . . . 0.411 HD23 ' N ' ' A' ' 139' ' ' THR . 6.1 tt -113.99 129.81 56.58 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 115.164 -0.925 . . . . 0.0 110.114 -179.48 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 139' ' ' THR . . . . . 0.411 ' N ' HD23 ' A' ' 138' ' ' LEU . 24.8 m -108.63 126.41 52.93 Favored 'General case' 0 C--N 1.332 -0.179 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.568 179.964 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 140' ' ' LEU . . . . . 0.548 HD12 HG22 ' A' ' 131' ' ' VAL . 11.1 tp -114.26 122.89 48.14 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-N 115.753 -0.658 . . . . 0.0 109.404 -178.846 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 141' ' ' ILE . . . . . 0.473 ' HB ' HG13 ' A' ' 130' ' ' VAL . 19.9 mt -121.48 120.38 61.69 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.273 0 CA-C-O 120.954 0.407 . . . . 0.0 109.94 -176.41 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 142' ' ' ARG . . . . . . . . . . . . . 72.0 mtp180 -110.61 118.03 35.12 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 115.327 -0.851 . . . . 0.0 110.64 -177.405 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 143' ' ' THR . . . . . . . . . . . . . 33.7 p . . . . . 0 C--O 1.219 -0.502 0 CA-C-O 117.891 -1.052 . . . . 0.0 110.533 179.929 . . . . . . . . 0 0 . 1 . 019 nuclear nobuild core ' B' B ' 2' ' ' SER . . . . . . . . . . . . . 7.3 p . . . . . 0 C--O 1.23 0.074 0 CA-C-O 120.818 0.342 . . . . 0.0 110.358 . . . . . . . . . 0 0 . 1 . 019 nuclear nobuild core ' B' B ' 3' ' ' GLU . . . . . . . . . . . . . 94.5 mt-10 -140.71 142.96 34.79 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.112 -0.495 . . . . 0.0 111.022 -177.943 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' B' B ' 4' ' ' LEU . . . . . . . . . . . . . 17.7 tp -127.85 127.86 44.2 Favored 'General case' 0 C--N 1.331 -0.205 0 CA-C-N 116.087 -0.506 . . . . 0.0 109.865 175.538 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' B' B ' 5' ' ' LYS . . . . . . . . . . . . . 98.6 mttt -109.02 122.74 47.89 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-O 120.487 0.184 . . . . 0.0 110.87 -179.673 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' B' B ' 6' ' ' LEU . . . . . . . . . . . . . 53.6 mt -114.94 143.89 44.44 Favored 'General case' 0 N--CA 1.463 0.215 0 O-C-N 123.8 0.688 . . . . 0.0 110.946 179.679 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' B' B ' 7' ' ' LYS . . . . . . . . . . . . . 84.3 tttt -129.88 135.47 27.55 Favored Pre-proline 0 CA--C 1.535 0.366 0 CA-C-O 118.811 -0.614 . . . . 0.0 109.643 175.226 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' B' B ' 8' ' ' PRO . . . . . . . . . . . . . 71.8 Cg_endo -90.48 142.85 3.59 Favored 'Trans proline' 0 N--CA 1.492 1.396 0 C-N-CA 121.578 1.519 . . . . 0.0 112.421 179.726 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' B' B ' 9' ' ' LEU . . . . . . . . . . . . . 19.5 mt -87.08 -49.64 0.46 Allowed Pre-proline 0 CA--C 1.535 0.386 0 CA-C-O 118.669 -0.682 . . . . 0.0 112.477 -179.399 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' B' B ' 10' ' ' PRO . . . . . . . . . . . . . 95.7 Cg_endo -79.12 163.03 25.64 Favored 'Trans proline' 0 N--CA 1.496 1.657 0 C-N-CA 121.317 1.344 . . . . 0.0 112.315 -178.995 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' B' B ' 11' ' ' LYS . . . . . . . . . . . . . 26.5 tptp -87.09 104.06 15.98 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.404 178.604 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' B' B ' 12' ' ' VAL . . . . . . . . . . . . . 12.5 p -147.83 147.09 17.57 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.231 0 CA-C-N 116.31 -0.404 . . . . 0.0 110.684 -179.661 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' B' B ' 13' ' ' GLU . . . . . . . . . . . . . 84.7 tt0 -100.34 124.57 45.99 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.158 -0.474 . . . . 0.0 110.079 177.447 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' B' B ' 14' ' ' LEU . . . . . 0.404 HD13 ' CD2' ' B' ' 18' ' ' PHE . 30.3 mt -98.93 151.46 37.4 Favored Pre-proline 0 CA--C 1.533 0.291 0 CA-C-O 119.311 -0.376 . . . . 0.0 111.228 -176.329 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' B' B ' 15' ' ' PRO . . . . . . . . . . . . . 24.2 Cg_exo -63.84 162.25 29.46 Favored 'Trans proline' 0 N--CA 1.498 1.792 0 C-N-CA 121.372 1.382 . . . . 0.0 111.97 175.625 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' B' B ' 16' ' ' PRO . . . . . . . . . . . . . 24.7 Cg_exo -62.41 -37.91 56.82 Favored 'Trans proline' 0 N--CA 1.497 1.694 0 C-N-CA 121.409 1.406 . . . . 0.0 112.469 179.235 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' B' B ' 17' ' ' ASP . . . . . . . . . . . . . 10.0 p-10 -85.25 12.33 8.28 Favored 'General case' 0 CA--C 1.536 0.423 0 N-CA-C 113.012 0.745 . . . . 0.0 113.012 -178.303 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' B' B ' 18' ' ' PHE . . . . . 0.404 ' CD2' HD13 ' B' ' 14' ' ' LEU . 18.7 t80 -56.8 -41.55 77.94 Favored 'General case' 0 C--N 1.334 -0.095 0 O-C-N 121.899 -0.5 . . . . 0.0 110.358 -179.183 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' B' B ' 19' ' ' VAL . . . . . . . . . . . . . 46.8 t -55.63 -41.08 62.99 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.205 0 CA-C-N 116.5 -0.318 . . . . 0.0 110.577 -179.45 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' B' B ' 20' ' ' ASP . . . . . . . . . . . . . 74.6 m-20 -59.33 -41.49 89.26 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-O 121.015 0.436 . . . . 0.0 110.427 179.942 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' B' B ' 21' ' ' VAL . . . . . . . . . . . . . 47.9 t -64.11 -46.0 94.92 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.306 0 CA-C-N 116.136 -0.484 . . . . 0.0 110.386 179.936 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' B' B ' 22' ' ' ILE . . . . . 0.468 HG22 HD12 ' B' ' 26' ' ' LEU . 51.2 mm -53.98 -60.02 1.66 Allowed 'Isoleucine or valine' 0 CA--C 1.53 0.191 0 C-N-CA 120.959 -0.296 . . . . 0.0 111.42 -178.324 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' B' B ' 23' ' ' ARG . . . . . . . . . . . . . 6.0 ptm180 -54.84 -44.75 74.2 Favored 'General case' 0 CA--C 1.53 0.184 0 C-N-CA 120.513 -0.475 . . . . 0.0 111.853 -174.244 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' B' B ' 24' ' ' ILE . . . . . . . . . . . . . 81.0 mt -61.03 -45.12 99.18 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.268 0 C-N-CA 120.836 -0.346 . . . . 0.0 111.663 -176.67 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' B' B ' 25' ' ' LYS . . . . . . . . . . . . . 72.1 mmtt -68.78 -42.56 77.22 Favored 'General case' 0 C--N 1.33 -0.267 0 N-CA-C 112.355 0.502 . . . . 0.0 112.355 -177.186 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' B' B ' 26' ' ' LEU . . . . . 0.468 HD12 HG22 ' B' ' 22' ' ' ILE . 83.0 mt -79.4 -33.97 42.26 Favored 'General case' 0 C--N 1.33 -0.275 0 N-CA-C 113.679 0.992 . . . . 0.0 113.679 -168.571 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' B' B ' 27' ' ' GLN . . . . . . . . . . . . . 10.6 pt20 -46.7 141.27 3.95 Favored 'General case' 0 N--CA 1.469 0.504 0 N-CA-C 112.785 0.661 . . . . 0.0 112.785 -175.577 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' B' B ' 28' ' ' GLY . . . . . . . . . . . . . . . 101.59 -27.16 21.73 Favored Glycine 0 CA--C 1.531 1.077 0 CA-C-N 115.612 -0.722 . . . . 0.0 112.205 -177.389 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' B' B ' 29' ' ' LYS . . . . . . . . . . . . . 68.0 mttm -97.48 155.09 17.09 Favored 'General case' 0 C--O 1.232 0.155 0 CA-C-N 117.451 0.625 . . . . 0.0 111.07 178.051 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' B' B ' 30' ' ' THR . . . . . . . . . . . . . 29.8 m -107.38 139.63 41.57 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.032 -0.531 . . . . 0.0 110.294 177.719 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' B' B ' 31' ' ' VAL . . . . . . . . . . . . . 34.5 m -129.25 152.97 38.0 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.212 0 CA-C-N 116.211 -0.45 . . . . 0.0 110.658 -179.256 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' B' B ' 32' ' ' ARG . . . . . . . . . . . . . 57.8 ttt180 -130.78 151.11 51.58 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-O 121.119 0.485 . . . . 0.0 110.243 178.798 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' B' B ' 33' ' ' THR . . . . . . . . . . . . . 21.6 m -52.12 137.16 28.39 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.366 -0.379 . . . . 0.0 111.676 -176.705 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' B' B ' 34' ' ' GLY . . . . . . . . . . . . . . . 100.61 -17.21 56.92 Favored Glycine 0 CA--C 1.532 1.154 0 CA-C-N 116.042 -0.526 . . . . 0.0 113.39 178.283 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' B' B ' 35' ' ' ASP . . . . . . . . . . . . . 78.3 m-20 -67.4 151.22 47.8 Favored 'General case' 0 C--O 1.231 0.129 0 CA-C-N 118.002 0.901 . . . . 0.0 111.244 179.141 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' B' B ' 36' ' ' VAL . . . . . . . . . . . . . 45.8 t -120.66 130.12 74.88 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.252 0 CA-C-N 115.996 -0.547 . . . . 0.0 109.806 177.429 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' B' B ' 37' ' ' ILE . . . . . . . . . . . . . 63.0 mt -119.53 138.24 50.81 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.256 0 CA-C-N 116.16 -0.473 . . . . 0.0 109.743 -179.132 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' B' B ' 38' ' ' GLY . . . . . . . . . . . . . . . -116.02 128.72 8.13 Favored Glycine 0 CA--C 1.526 0.724 0 N-CA-C 111.096 -0.802 . . . . 0.0 111.096 -179.765 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' B' B ' 39' ' ' ILE . . . . . . . . . . . . . 74.8 mt -130.58 131.0 65.16 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.237 0 N-CA-C 110.134 -0.321 . . . . 0.0 110.134 178.878 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' B' B ' 40' ' ' SER . . . . . . . . . . . . . 68.2 p -92.79 115.22 27.91 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 116.418 -0.355 . . . . 0.0 110.911 176.47 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' B' B ' 41' ' ' ILE . . . . . . . . . . . . . 44.0 mm -122.07 128.86 75.7 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.232 0 CA-C-N 116.476 -0.329 . . . . 0.0 110.276 -179.934 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' B' B ' 42' ' ' LEU . . . . . . . . . . . . . 49.9 mt 55.32 33.52 20.91 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.24 -0.436 . . . . 0.0 111.825 177.263 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' B' B ' 43' ' ' GLY . . . . . . . . . . . . . . . 72.56 27.62 69.09 Favored Glycine 0 CA--C 1.531 1.052 0 C-N-CA 121.203 -0.522 . . . . 0.0 112.393 177.646 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' B' B ' 44' ' ' LYS . . . . . . . . . . . . . 49.4 tptt -141.9 128.32 20.05 Favored 'General case' 0 C--N 1.331 -0.227 0 N-CA-C 109.65 -0.5 . . . . 0.0 109.65 177.832 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' B' B ' 45' ' ' GLU . . . . . . . . . . . . . 44.1 tp10 -82.93 128.06 34.1 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-O 120.891 0.377 . . . . 0.0 111.323 -176.147 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' B' B ' 46' ' ' VAL . . . . . . . . . . . . . 8.5 p -121.86 128.08 75.59 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.255 0 N-CA-C 109.5 -0.556 . . . . 0.0 109.5 174.765 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' B' B ' 47' ' ' LYS . . . . . . . . . . . . . 52.0 mtpt -98.86 127.26 44.74 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.011 -0.54 . . . . 0.0 110.616 177.41 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' B' B ' 48' ' ' PHE . . . . . . . . . . . . . 46.1 m-85 -111.05 131.84 54.74 Favored 'General case' 0 C--N 1.329 -0.309 0 N-CA-C 109.667 -0.494 . . . . 0.0 109.667 177.082 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' B' B ' 49' ' ' LYS . . . . . . . . . . . . . 77.5 tttt -104.71 133.32 49.75 Favored 'General case' 0 C--N 1.328 -0.327 0 N-CA-C 109.926 -0.398 . . . . 0.0 109.926 178.225 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' B' B ' 50' ' ' VAL . . . . . . . . . . . . . 42.3 t -77.76 105.45 6.8 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.28 0 N-CA-C 109.38 -0.6 . . . . 0.0 109.38 178.169 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' B' B ' 51' ' ' VAL . . . . . . . . . . . . . 49.8 t -73.02 -47.28 48.7 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.372 0 CA-C-N 116.061 -0.518 . . . . 0.0 109.879 -174.693 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' B' B ' 52' ' ' GLN . . . . . . . . . . . . . 62.1 tt0 -158.97 138.43 11.59 Favored 'General case' 0 C--N 1.33 -0.274 0 C-N-CA 120.417 -0.513 . . . . 0.0 111.486 -178.241 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' B' B ' 53' ' ' ALA . . . . . . . . . . . . . . . -117.13 130.7 56.8 Favored 'General case' 0 C--N 1.332 -0.193 0 CA-C-N 115.687 -0.688 . . . . 0.0 109.632 172.058 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' B' B ' 54' ' ' TYR . . . . . . . . . . . . . 57.9 t80 -129.18 112.17 18.29 Favored Pre-proline 0 CA--C 1.536 0.432 0 CA-C-O 118.189 -0.91 . . . . 0.0 110.359 178.933 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' B' B ' 55' ' ' PRO . . . . . . . . . . . . . 74.3 Cg_endo -77.11 168.89 75.76 Favored 'Cis proline' 0 N--CA 1.5 1.9 0 CA-C-N 121.973 1.74 . . . . 0.0 112.156 -6.002 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' B' B ' 56' ' ' SER . . . . . . . . . . . . . 13.5 m -116.6 134.88 22.84 Favored Pre-proline 0 CA--C 1.538 0.492 0 CA-C-O 118.478 -0.772 . . . . 0.0 109.456 175.881 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' B' B ' 57' ' ' PRO . . . . . . . . . . . . . 56.0 Cg_endo -72.11 146.73 86.87 Favored 'Cis proline' 0 N--CA 1.497 1.728 0 CA-C-N 121.842 1.694 . . . . 0.0 111.496 -2.229 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' B' B ' 58' ' ' LEU . . . . . . . . . . . . . 25.0 tp -108.35 136.81 47.36 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.378 -0.374 . . . . 0.0 110.832 -177.667 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' B' B ' 59' ' ' ARG . . . . . . . . . . . . . 29.0 ttm180 -100.51 125.9 46.89 Favored 'General case' 0 C--N 1.328 -0.34 0 N-CA-C 109.371 -0.603 . . . . 0.0 109.371 175.521 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' B' B ' 60' ' ' VAL . . . . . . . . . . . . . 40.8 t -78.04 121.73 31.44 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.247 0 C-N-CA 120.828 -0.349 . . . . 0.0 110.848 -174.798 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' B' B ' 61' ' ' GLU . . . . . . . . . . . . . 42.9 mt-10 -130.96 154.05 48.55 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 115.744 -0.662 . . . . 0.0 109.822 175.308 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' B' B ' 62' ' ' ASP . . . . . . . . . . . . . 19.8 p-10 -53.72 -33.64 56.26 Favored 'General case' 0 C--N 1.327 -0.397 0 N-CA-C 111.843 0.312 . . . . 0.0 111.843 -177.792 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' B' B ' 63' ' ' ARG . . . . . . . . . . . . . 36.5 mmt180 -75.66 -18.61 59.59 Favored 'General case' 0 CA--C 1.535 0.371 0 N-CA-C 113.099 0.778 . . . . 0.0 113.099 -175.969 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' B' B ' 64' ' ' THR . . . . . . . . . . . . . 24.0 m -67.2 147.91 52.46 Favored 'General case' 0 C--N 1.332 -0.172 0 CA-C-N 117.724 0.238 . . . . 0.0 110.48 -177.06 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' B' B ' 65' ' ' LYS . . . . . . . . . . . . . 98.4 mttt -87.61 122.95 31.95 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-O 120.937 0.398 . . . . 0.0 110.116 -179.648 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' B' B ' 66' ' ' ILE . . . . . . . . . . . . . 63.4 mt -108.57 120.27 59.64 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.26 0 N-CA-C 109.581 -0.526 . . . . 0.0 109.581 179.183 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' B' B ' 67' ' ' THR . . . . . . . . . . . . . 4.6 m -109.36 140.69 42.73 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-O 121.338 0.59 . . . . 0.0 111.132 -173.511 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' B' B ' 68' ' ' LEU . . . . . . . . . . . . . 7.0 tt . . . . . 0 C--N 1.329 -0.283 0 CA-C-N 115.202 -0.908 . . . . 0.0 110.121 -178.926 . . . . . . . . 0 0 . 1 . 019 nuclear nobuild core ' B' B ' 73' ' ' VAL . . . . . . . . . . . . . 34.2 m . . . . . 0 CA--C 1.527 0.065 0 CA-C-O 120.755 0.312 . . . . 0.0 110.377 . . . . . . . . . 0 0 . 1 . 019 nuclear nobuild core ' B' B ' 74' ' ' ASP . . . . . . . . . . . . . 26.4 t0 -78.85 123.89 27.68 Favored 'General case' 0 C--N 1.331 -0.205 0 CA-C-N 116.259 -0.428 . . . . 0.0 111.156 -165.058 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' B' B ' 75' ' ' VAL . . . . . . . . . . . . . 47.0 t -119.7 118.83 58.5 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.218 0 CA-C-N 116.138 -0.483 . . . . 0.0 110.098 -179.571 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' B' B ' 76' ' ' LEU . . . . . . . . . . . . . 23.8 mt -124.33 145.37 49.46 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 115.63 -0.714 . . . . 0.0 109.688 -179.966 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' B' B ' 77' ' ' GLU . . . . . . . . . . . . . 96.0 mt-10 -136.42 134.94 38.28 Favored 'General case' 0 C--N 1.331 -0.227 0 CA-C-O 121.056 0.455 . . . . 0.0 111.184 -178.606 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' B' B ' 78' ' ' ALA . . . . . . . . . . . . . . . -123.57 131.23 53.57 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 115.611 -0.722 . . . . 0.0 109.701 176.462 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' B' B ' 79' ' ' LYS . . . . . 0.608 ' O ' HD13 ' B' ' 80' ' ' ILE . 97.3 mttt -77.32 120.33 22.19 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-O 121.043 0.449 . . . . 0.0 111.266 -175.389 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' B' B ' 80' ' ' ILE . . . . . 0.608 HD13 ' O ' ' B' ' 79' ' ' LYS . 25.9 mm -139.27 101.14 1.49 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.256 0 N-CA-C 109.015 -0.735 . . . . 0.0 109.015 179.11 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' B' B ' 81' ' ' LYS . . . . . . . . . . . . . 68.6 tttt -93.06 124.6 37.15 Favored 'General case' 0 C--N 1.328 -0.332 0 C-N-CA 120.776 -0.37 . . . . 0.0 110.993 -177.01 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' B' B ' 82' ' ' GLY . . . . . . . . . . . . . . . 89.2 42.14 5.65 Favored Glycine 0 CA--C 1.524 0.641 0 C-N-CA 120.738 -0.744 . . . . 0.0 111.416 176.288 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' B' B ' 83' ' ' ILE . . . . . . . . . . . . . 72.1 mt -64.45 137.76 24.31 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.352 0 N-CA-C 109.91 -0.404 . . . . 0.0 109.91 177.884 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' B' B ' 84' ' ' LYS . . . . . . . . . . . . . 80.2 tttt -93.51 -51.38 4.98 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 115.932 -0.576 . . . . 0.0 110.001 -179.426 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' B' B ' 85' ' ' ASP . . . . . . . . . . . . . 9.9 t70 -159.87 153.59 22.78 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 115.514 -0.766 . . . . 0.0 110.062 179.558 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' B' B ' 86' ' ' VAL . . . . . . . . . . . . . 43.9 t -129.94 132.15 65.8 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.212 0 CA-C-O 121.021 0.438 . . . . 0.0 110.479 -179.166 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' B' B ' 87' ' ' ILE . . . . . . . . . . . . . 43.5 mm -120.12 125.38 74.17 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.265 0 CA-C-N 115.665 -0.698 . . . . 0.0 109.221 177.132 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' B' B ' 88' ' ' LEU . . . . . . . . . . . . . 12.0 tp -114.51 127.92 56.06 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-O 121.021 0.439 . . . . 0.0 111.254 -176.788 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' B' B ' 89' ' ' ASP . . . . . . . . . . . . . 11.2 t70 -117.81 153.66 33.1 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 115.702 -0.681 . . . . 0.0 109.407 175.931 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' B' B ' 90' ' ' GLU . . . . . . . . . . . . . 84.6 tt0 -47.78 -35.5 10.12 Favored 'General case' 0 C--N 1.33 -0.282 0 N-CA-C 112.869 0.692 . . . . 0.0 112.869 -172.836 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' B' B ' 91' ' ' ASN . . . . . . . . . . . . . 18.3 p-10 -132.06 31.36 4.16 Favored 'General case' 0 N--CA 1.466 0.326 0 N-CA-C 112.256 0.465 . . . . 0.0 112.256 -175.808 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' B' B ' 92' ' ' LEU . . . . . . . . . . . . . 6.7 tp -166.13 145.1 5.9 Favored 'General case' 0 C--N 1.331 -0.213 0 C-N-CA 120.934 -0.307 . . . . 0.0 110.54 -179.619 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' B' B ' 93' ' ' ILE . . . . . . . . . . . . . 68.8 mt -123.14 123.36 67.67 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.264 0 N-CA-C 109.704 -0.48 . . . . 0.0 109.704 -179.413 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' B' B ' 94' ' ' VAL . . . . . . . . . . . . . 43.5 t -121.38 124.96 73.04 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.239 0 CA-C-O 120.967 0.413 . . . . 0.0 110.024 179.689 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' B' B ' 95' ' ' VAL . . . . . . . . . . . . . 45.9 t -119.68 133.4 66.58 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.283 0 CA-C-N 115.917 -0.583 . . . . 0.0 109.928 -179.071 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' B' B ' 96' ' ' ILE . . . . . 0.666 HD11 ' HB ' ' B' ' 123' ' ' VAL . 61.8 mt -114.59 126.38 72.12 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.366 0 N-CA-C 109.467 -0.568 . . . . 0.0 109.467 178.988 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' B' B ' 97' ' ' THR . . . . . . . . . . . . . 67.4 p -95.94 156.21 16.43 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-O 120.99 0.424 . . . . 0.0 110.812 -179.267 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' B' B ' 98' ' ' GLU . . . . . . . . . . . . . 40.1 tp10 -53.92 -28.66 38.19 Favored 'General case' 0 C--N 1.329 -0.287 0 N-CA-C 112.144 0.424 . . . . 0.0 112.144 -178.401 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' B' B ' 99' ' ' GLU . . . . . . . . . . . . . 14.7 pt-20 -81.54 17.25 1.45 Allowed 'General case' 0 CA--C 1.535 0.373 0 N-CA-C 113.326 0.862 . . . . 0.0 113.326 -176.19 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' B' B ' 100' ' ' ASN . . . . . . . . . . . . . 4.9 m-20 64.89 34.65 9.0 Favored 'General case' 0 N--CA 1.463 0.216 0 CA-C-O 120.793 0.33 . . . . 0.0 111.678 176.959 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' B' B ' 101' ' ' GLU . . . . . . . . . . . . . 84.5 tt0 -108.84 141.78 40.38 Favored 'General case' 0 C--N 1.331 -0.2 0 N-CA-C 109.642 -0.503 . . . . 0.0 109.642 172.226 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' B' B ' 102' ' ' VAL . . . . . . . . . . . . . 46.3 t -114.96 125.9 72.41 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.308 0 N-CA-C 109.967 -0.382 . . . . 0.0 109.967 -177.846 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' B' B ' 103' ' ' LEU . . . . . . . . . . . . . 57.4 mt -117.26 129.79 56.14 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 115.845 -0.616 . . . . 0.0 110.13 177.944 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' B' B ' 104' ' ' ILE . . . . . 0.57 HD13 HG11 ' B' ' 130' ' ' VAL . 67.8 mt -118.31 120.84 65.6 Favored 'Isoleucine or valine' 0 C--O 1.234 0.289 0 N-CA-C 110.161 -0.311 . . . . 0.0 110.161 -178.976 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' B' B ' 105' ' ' PHE . . . . . . . . . . . . . 74.6 m-85 -123.53 165.16 17.6 Favored 'General case' 0 C--N 1.333 -0.15 0 O-C-N 123.92 0.763 . . . . 0.0 109.836 -179.252 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' B' B ' 106' ' ' ASN . . . . . . . . . . . . . 46.7 p-10 -99.51 -170.77 1.95 Allowed 'General case' 0 C--N 1.33 -0.274 0 N-CA-C 109.788 -0.449 . . . . 0.0 109.788 171.832 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' B' B ' 107' ' ' GLN . . . . . . . . . . . . . 51.0 tt0 -57.58 -27.64 62.87 Favored 'General case' 0 C--N 1.327 -0.373 0 N-CA-C 112.305 0.483 . . . . 0.0 112.305 -178.944 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' B' B ' 108' ' ' ASN . . . . . . . . . . . . . 14.4 t30 -93.5 14.31 19.11 Favored 'General case' 0 CA--C 1.535 0.379 0 N-CA-C 113.0 0.741 . . . . 0.0 113.0 -175.43 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' B' B ' 109' ' ' LEU . . . . . . . . . . . . . 71.1 mt 59.12 37.7 24.04 Favored 'General case' 0 C--N 1.332 -0.189 0 CA-C-O 121.067 0.461 . . . . 0.0 111.377 177.596 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' B' B ' 110' ' ' GLU . . . . . . . . . . . . . 43.4 mt-10 -103.46 163.43 12.29 Favored 'General case' 0 C--N 1.331 -0.225 0 CA-C-N 116.388 -0.369 . . . . 0.0 110.223 177.331 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' B' B ' 111' ' ' GLU . . . . . . . . . . . . . 82.6 tt0 -84.58 124.9 31.94 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-O 120.94 0.4 . . . . 0.0 111.243 -177.22 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' B' B ' 112' ' ' LEU . . . . . . . . . . . . . 20.0 mt -113.02 -45.99 3.14 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 115.905 -0.589 . . . . 0.0 109.6 172.84 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' B' B ' 113' ' ' TYR . . . . . 0.487 ' HB3' HD12 ' B' ' 104' ' ' ILE . 34.9 t80 -150.64 137.04 18.72 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.02 -0.536 . . . . 0.0 110.821 179.097 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' B' B ' 114' ' ' ARG . . . . . . . . . . . . . 57.0 mtm180 -140.39 124.4 17.46 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-O 120.733 0.302 . . . . 0.0 110.306 175.242 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' B' B ' 115' ' ' GLY . . . . . . . . . . . . . . . -150.15 162.9 29.36 Favored Glycine 0 CA--C 1.523 0.566 0 N-CA-C 110.632 -0.987 . . . . 0.0 110.632 -179.555 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' B' B ' 116' ' ' LYS . . . . . . . . . . . . . 82.7 tttt -133.37 130.83 39.32 Favored 'General case' 0 C--N 1.33 -0.278 0 N-CA-C 109.918 -0.401 . . . . 0.0 109.918 178.553 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' B' B ' 117' ' ' PHE . . . . . . . . . . . . . 46.5 m-85 -125.79 118.43 25.51 Favored 'General case' 0 C--N 1.331 -0.227 0 CA-C-O 121.015 0.436 . . . . 0.0 110.49 -174.862 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' B' B ' 118' ' ' GLU . . . . . . . . . . . . . 44.5 tp10 -52.83 -49.38 65.82 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.397 -0.365 . . . . 0.0 111.572 -176.979 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' B' B ' 119' ' ' ASN . . . . . . . . . . . . . 20.4 m120 -95.76 31.21 2.12 Favored 'General case' 0 C--N 1.33 -0.253 0 N-CA-C 112.11 0.411 . . . . 0.0 112.11 -174.803 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' B' B ' 120' ' ' LEU . . . . . . . . . . . . . 13.7 tp -55.04 123.38 13.4 Favored 'General case' 0 N--CA 1.462 0.134 0 CA-C-O 120.711 0.291 . . . . 0.0 110.769 178.282 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' B' B ' 121' ' ' ASN . . . . . . . . . . . . . 60.5 t30 -113.58 -44.01 3.25 Favored 'General case' 0 C--N 1.332 -0.184 0 CA-C-N 116.337 -0.392 . . . . 0.0 110.822 -177.742 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' B' B ' 122' ' ' LYS . . . . . . . . . . . . . 97.8 mttt -148.53 150.72 33.87 Favored 'General case' 0 C--N 1.331 -0.229 0 CA-C-O 121.119 0.485 . . . . 0.0 111.562 -178.434 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' B' B ' 123' ' ' VAL . . . . . 0.666 ' HB ' HD11 ' B' ' 96' ' ' ILE . 47.4 t -131.74 129.35 61.19 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.224 0 N-CA-C 109.325 -0.62 . . . . 0.0 109.325 174.812 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' B' B ' 124' ' ' LEU . . . . . . . . . . . . . 67.3 mt -130.87 142.65 50.39 Favored 'General case' 0 C--N 1.331 -0.203 0 CA-C-O 120.959 0.409 . . . . 0.0 110.769 -177.438 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' B' B ' 125' ' ' VAL . . . . . . . . . . . . . 12.1 p -135.7 138.32 48.07 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.255 0 CA-C-N 116.005 -0.543 . . . . 0.0 110.555 179.946 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' B' B ' 126' ' ' ARG . . . . . . . . . . . . . 75.3 mtt180 -148.08 121.95 9.35 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 115.838 -0.619 . . . . 0.0 109.393 178.04 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' B' B ' 127' ' ' ASN . . . . . . . . . . . . . 71.6 m-80 57.04 -147.44 0.52 Allowed 'General case' 0 CA--C 1.541 0.614 0 N-CA-C 109.602 -0.518 . . . . 0.0 109.602 -178.278 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' B' B ' 128' ' ' ASP . . . . . . . . . . . . . 23.1 p-10 -83.44 12.62 5.3 Favored 'General case' 0 CA--C 1.537 0.464 0 CA-C-N 118.845 0.748 . . . . 0.0 112.989 179.199 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' B' B ' 129' ' ' LEU . . . . . . . . . . . . . 19.6 tp -109.03 136.45 48.53 Favored 'General case' 0 C--O 1.231 0.084 0 N-CA-C 109.747 -0.464 . . . . 0.0 109.747 178.32 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' B' B ' 130' ' ' VAL . . . . . 0.57 HG11 HD13 ' B' ' 104' ' ' ILE . 12.3 p -131.3 141.76 45.12 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.213 0 CA-C-O 120.982 0.42 . . . . 0.0 110.637 -178.806 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' B' B ' 131' ' ' VAL . . . . . 0.553 HG22 HD12 ' B' ' 140' ' ' LEU . 41.5 t -136.14 138.37 47.3 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 CA-C-N 116.021 -0.536 . . . . 0.0 110.495 -178.741 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' B' B ' 132' ' ' ILE . . . . . . . . . . . . . 73.1 mt -116.79 133.64 62.82 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.323 0 CA-C-N 115.591 -0.731 . . . . 0.0 109.244 178.448 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' B' B ' 133' ' ' ILE . . . . . . . . . . . . . 41.1 mm -115.94 120.81 65.9 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.268 0 CA-C-O 120.714 0.293 . . . . 0.0 111.018 -175.521 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' B' B ' 134' ' ' ASP . . . . . . . . . . . . . 7.5 p-10 -131.98 144.98 51.19 Favored 'General case' 0 C--N 1.33 -0.262 0 N-CA-C 109.433 -0.58 . . . . 0.0 109.433 175.124 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' B' B ' 135' ' ' GLU . . . . . . . . . . . . . 83.7 tt0 -50.06 -26.23 4.2 Favored 'General case' 0 C--N 1.328 -0.348 0 N-CA-C 112.861 0.689 . . . . 0.0 112.861 -173.682 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' B' B ' 136' ' ' GLN . . . . . . . . . . . . . 97.1 mt-30 -78.51 -35.8 45.81 Favored 'General case' 0 C--O 1.234 0.245 0 N-CA-C 112.058 0.392 . . . . 0.0 112.058 -177.465 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' B' B ' 137' ' ' LYS . . . . . . . . . . . . . 56.2 pttt -170.0 173.66 5.89 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-O 121.426 0.631 . . . . 0.0 111.907 -172.613 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' B' B ' 138' ' ' LEU . . . . . 0.422 ' C ' HD23 ' B' ' 138' ' ' LEU . 8.2 tt -116.31 130.14 56.63 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 115.415 -0.811 . . . . 0.0 110.136 179.557 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' B' B ' 139' ' ' THR . . . . . . . . . . . . . 25.8 m -108.07 124.35 50.07 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.069 -0.514 . . . . 0.0 110.501 179.995 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' B' B ' 140' ' ' LEU . . . . . 0.553 HD12 HG22 ' B' ' 131' ' ' VAL . 49.7 tp -113.08 121.07 43.48 Favored 'General case' 0 C--N 1.328 -0.351 0 N-CA-C 109.094 -0.706 . . . . 0.0 109.094 -179.241 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' B' B ' 141' ' ' ILE . . . . . 0.494 ' HB ' HG13 ' B' ' 130' ' ' VAL . 19.0 mt -121.23 121.1 63.95 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.309 0 CA-C-O 120.985 0.422 . . . . 0.0 110.189 -175.261 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' B' B ' 142' ' ' ARG . . . . . . . . . . . . . 61.4 mtp180 -105.21 120.81 42.45 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 115.15 -0.932 . . . . 0.0 109.985 179.363 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' B' B ' 143' ' ' THR . . . . . . . . . . . . . 35.9 p . . . . . 0 C--O 1.22 -0.486 0 CA-C-O 118.065 -0.969 . . . . 0.0 110.604 -179.697 . . . . . . . . 0 0 . 1 . 019 nuclear nobuild core ' C' C ' 2' ' ' SER . . . . . . . . . . . . . 3.1 p . . . . . 0 C--O 1.232 0.149 0 CA-C-O 121.043 0.449 . . . . 0.0 110.351 . . . . . . . . . 0 0 . 1 . 019 nuclear nobuild core ' C' C ' 3' ' ' GLU . . . . . . . . . . . . . 84.8 tt0 -141.24 141.61 33.99 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 115.89 -0.595 . . . . 0.0 110.954 -178.891 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' C' C ' 4' ' ' LEU . . . . . . . . . . . . . 19.2 tp -126.14 129.08 48.35 Favored 'General case' 0 C--N 1.331 -0.216 0 CA-C-N 115.866 -0.606 . . . . 0.0 110.257 177.73 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' C' C ' 5' ' ' LYS . . . . . . . . . . . . . 66.9 mttm -105.35 120.96 42.88 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.255 -0.429 . . . . 0.0 110.543 178.728 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' C' C ' 6' ' ' LEU . . . . . . . . . . . . . 55.1 mt -116.56 146.53 42.57 Favored 'General case' 0 C--N 1.331 -0.23 0 O-C-N 123.831 0.707 . . . . 0.0 110.109 -179.703 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' C' C ' 7' ' ' LYS . . . . . . . . . . . . . 49.8 tttp -126.83 137.67 30.99 Favored Pre-proline 0 CA--C 1.534 0.329 0 CA-C-O 118.901 -0.571 . . . . 0.0 109.912 175.664 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' C' C ' 8' ' ' PRO . . . . . . . . . . . . . 89.8 Cg_endo -92.1 131.72 1.17 Allowed 'Trans proline' 0 N--CA 1.489 1.257 0 C-N-CA 121.661 1.574 . . . . 0.0 111.673 178.016 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' C' C ' 9' ' ' LEU . . . . . . . . . . . . . 64.8 mt -70.98 -46.59 15.0 Favored Pre-proline 0 CA--C 1.533 0.303 0 CA-C-O 118.808 -0.615 . . . . 0.0 112.191 -179.053 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' C' C ' 10' ' ' PRO . . . . . . . . . . . . . 85.8 Cg_endo -81.79 147.89 15.47 Favored 'Trans proline' 0 N--CA 1.495 1.617 0 C-N-CA 121.237 1.291 . . . . 0.0 111.574 174.26 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' C' C ' 11' ' ' LYS . . . . . . . . . . . . . 60.7 tttm -88.14 96.54 10.57 Favored 'General case' 0 C--N 1.33 -0.254 0 C-N-CA 120.862 -0.335 . . . . 0.0 110.455 179.145 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' C' C ' 12' ' ' VAL . . . . . . . . . . . . . 12.5 p -140.06 146.78 24.35 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.321 0 CA-C-N 116.241 -0.436 . . . . 0.0 110.512 -179.79 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' C' C ' 13' ' ' GLU . . . . . . . . . . . . . 81.4 tt0 -85.86 125.8 33.57 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.243 -0.435 . . . . 0.0 110.008 177.949 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' C' C ' 14' ' ' LEU . . . . . . . . . . . . . 17.6 mt -96.94 149.63 35.94 Favored Pre-proline 0 CA--C 1.532 0.263 0 CA-C-O 119.262 -0.399 . . . . 0.0 110.366 -178.708 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' C' C ' 15' ' ' PRO . . . . . . . . . . . . . 26.1 Cg_exo -61.76 160.65 28.01 Favored 'Trans proline' 0 N--CA 1.497 1.732 0 C-N-CA 121.23 1.287 . . . . 0.0 111.852 177.496 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' C' C ' 16' ' ' PRO . . . . . . . . . . . . . 34.0 Cg_exo -59.5 -34.01 97.07 Favored 'Trans proline' 0 N--CA 1.498 1.754 0 C-N-CA 121.437 1.425 . . . . 0.0 112.714 -178.127 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' C' C ' 17' ' ' ASP . . . . . . . . . . . . . 18.5 p-10 -87.88 3.58 47.91 Favored 'General case' 0 CA--C 1.536 0.435 0 N-CA-C 113.409 0.892 . . . . 0.0 113.409 -177.042 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' C' C ' 18' ' ' PHE . . . . . . . . . . . . . 43.3 t80 -58.18 -46.5 85.64 Favored 'General case' 0 C--N 1.334 -0.091 0 O-C-N 122.046 -0.409 . . . . 0.0 110.098 -177.689 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' C' C ' 19' ' ' VAL . . . . . . . . . . . . . 47.8 t -56.75 -43.0 78.59 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.372 0 CA-C-N 116.27 -0.423 . . . . 0.0 110.608 -177.895 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' C' C ' 20' ' ' ASP . . . . . . . . . . . . . 67.7 m-20 -59.66 -43.0 94.11 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-O 120.786 0.327 . . . . 0.0 110.813 -177.549 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' C' C ' 21' ' ' VAL . . . . . . . . . . . . . 46.2 t -64.01 -45.41 96.78 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.32 0 C-N-CA 120.818 -0.353 . . . . 0.0 110.425 -177.848 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' C' C ' 22' ' ' ILE . . . . . 0.547 HG22 HD12 ' C' ' 26' ' ' LEU . 51.8 mm -54.96 -48.44 75.26 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.276 0 C-N-CA 120.993 -0.283 . . . . 0.0 110.743 179.032 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' C' C ' 23' ' ' ARG . . . . . . . . . . . . . 54.3 ttp180 -54.65 -47.93 72.93 Favored 'General case' 0 C--N 1.33 -0.258 0 C-N-CA 121.022 -0.271 . . . . 0.0 111.355 -178.328 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' C' C ' 24' ' ' ILE . . . . . . . . . . . . . 74.2 mt -59.11 -42.89 87.98 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.34 0 C-N-CA 121.184 -0.206 . . . . 0.0 111.208 -177.901 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' C' C ' 25' ' ' LYS . . . . . . . . . . . . . 73.9 mmtt -66.68 -41.37 88.21 Favored 'General case' 0 C--N 1.328 -0.335 0 N-CA-C 112.253 0.464 . . . . 0.0 112.253 -178.428 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' C' C ' 26' ' ' LEU . . . . . 0.547 HD12 HG22 ' C' ' 22' ' ' ILE . 83.1 mt -79.22 -38.76 34.9 Favored 'General case' 0 C--N 1.328 -0.332 0 N-CA-C 113.283 0.845 . . . . 0.0 113.283 -169.872 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' C' C ' 27' ' ' GLN . . . . . . . . . . . . . 10.4 pt20 -47.06 140.05 5.28 Favored 'General case' 0 N--CA 1.468 0.444 0 N-CA-C 112.78 0.659 . . . . 0.0 112.78 -175.831 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' C' C ' 28' ' ' GLY . . . . . . . . . . . . . . . 99.15 -25.7 27.21 Favored Glycine 0 CA--C 1.533 1.159 0 CA-C-N 115.687 -0.688 . . . . 0.0 112.297 -177.013 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' C' C ' 29' ' ' LYS . . . . . . . . . . . . . 87.5 mttt -97.89 155.11 17.22 Favored 'General case' 0 C--N 1.331 -0.199 0 CA-C-N 117.357 0.579 . . . . 0.0 111.053 179.362 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' C' C ' 30' ' ' THR . . . . . . . . . . . . . 26.2 m -103.79 138.3 40.59 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.133 -0.485 . . . . 0.0 110.1 176.696 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' C' C ' 31' ' ' VAL . . . . . . . . . . . . . 34.4 m -129.85 151.14 35.39 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.201 0 CA-C-O 120.868 0.366 . . . . 0.0 110.986 -178.429 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' C' C ' 32' ' ' ARG . . . . . . . . . . . . . 71.3 mtt85 -127.91 149.19 50.42 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 115.971 -0.558 . . . . 0.0 110.489 178.743 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' C' C ' 33' ' ' THR . . . . . . . . . . . . . 30.3 m -53.18 138.76 30.85 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.43 -0.35 . . . . 0.0 111.375 -179.175 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' C' C ' 34' ' ' GLY . . . . . . . . . . . . . . . 100.23 -17.2 57.32 Favored Glycine 0 CA--C 1.533 1.159 0 C-N-CA 121.307 -0.473 . . . . 0.0 113.223 179.266 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' C' C ' 35' ' ' ASP . . . . . . . . . . . . . 76.2 m-20 -66.63 149.3 50.69 Favored 'General case' 0 N--CA 1.462 0.151 0 CA-C-N 117.967 0.883 . . . . 0.0 111.155 179.361 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' C' C ' 36' ' ' VAL . . . . . . . . . . . . . 44.6 t -119.3 128.99 75.83 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.26 0 CA-C-N 115.845 -0.616 . . . . 0.0 109.674 177.929 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' C' C ' 37' ' ' ILE . . . . . . . . . . . . . 65.6 mt -119.83 138.28 50.95 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.271 0 CA-C-N 116.151 -0.477 . . . . 0.0 109.804 -179.466 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' C' C ' 38' ' ' GLY . . . . . . . . . . . . . . . -116.9 128.71 8.02 Favored Glycine 0 CA--C 1.525 0.667 0 N-CA-C 111.121 -0.792 . . . . 0.0 111.121 -179.653 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' C' C ' 39' ' ' ILE . . . . . . . . . . . . . 70.7 mt -127.0 127.05 69.35 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.256 0 N-CA-C 109.961 -0.385 . . . . 0.0 109.961 178.268 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' C' C ' 40' ' ' SER . . . . . . . . . . . . . 59.6 p -91.41 113.94 26.34 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.561 -0.29 . . . . 0.0 110.988 177.773 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' C' C ' 41' ' ' ILE . . . . . . . . . . . . . 45.5 mm -123.3 128.14 74.69 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.248 0 CA-C-N 116.408 -0.36 . . . . 0.0 110.063 179.694 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' C' C ' 42' ' ' LEU . . . . . . . . . . . . . 69.8 mt 58.02 33.86 23.63 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 116.194 -0.457 . . . . 0.0 111.779 176.934 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' C' C ' 43' ' ' GLY . . . . . . . . . . . . . . . 73.11 21.81 79.5 Favored Glycine 0 CA--C 1.533 1.195 0 C-N-CA 121.227 -0.511 . . . . 0.0 112.89 177.623 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' C' C ' 44' ' ' LYS . . . . . . . . . . . . . 67.6 mttm -138.25 130.54 28.88 Favored 'General case' 0 C--N 1.332 -0.16 0 CA-C-N 117.41 0.605 . . . . 0.0 109.919 177.548 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' C' C ' 45' ' ' GLU . . . . . . . . . . . . . 43.5 tp10 -84.06 127.26 33.78 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.367 -0.379 . . . . 0.0 111.413 -177.545 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' C' C ' 46' ' ' VAL . . . . . . . . . . . . . 8.9 p -116.06 127.3 73.7 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.282 0 N-CA-C 109.249 -0.648 . . . . 0.0 109.249 173.312 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' C' C ' 47' ' ' LYS . . . . . . . . . . . . . 64.8 mttp -98.07 126.16 43.38 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 116.104 -0.498 . . . . 0.0 110.787 178.715 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' C' C ' 48' ' ' PHE . . . . . . . . . . . . . 34.2 m-85 -110.82 131.88 54.67 Favored 'General case' 0 C--N 1.328 -0.345 0 N-CA-C 109.453 -0.573 . . . . 0.0 109.453 177.159 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' C' C ' 49' ' ' LYS . . . . . . . . . . . . . 45.2 tttp -105.65 133.27 50.67 Favored 'General case' 0 C--N 1.328 -0.354 0 N-CA-C 110.085 -0.339 . . . . 0.0 110.085 178.831 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' C' C ' 50' ' ' VAL . . . . . . . . . . . . . 46.2 t -75.79 102.4 2.83 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.324 0 N-CA-C 109.189 -0.671 . . . . 0.0 109.189 176.669 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' C' C ' 51' ' ' VAL . . . . . . . . . . . . . 47.0 t -70.03 -48.18 64.22 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.279 0 CA-C-N 116.005 -0.543 . . . . 0.0 109.895 -174.293 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' C' C ' 52' ' ' GLN . . . . . . . . . . . . . 62.0 tt0 -160.14 138.92 10.54 Favored 'General case' 0 C--N 1.33 -0.252 0 C-N-CA 120.382 -0.527 . . . . 0.0 111.631 -178.8 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' C' C ' 53' ' ' ALA . . . . . 0.447 ' HB3' ' OG ' ' C' ' 56' ' ' SER . . . -111.55 130.97 55.57 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 115.665 -0.698 . . . . 0.0 109.806 176.012 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' C' C ' 54' ' ' TYR . . . . . . . . . . . . . 45.7 t80 -128.93 107.32 18.19 Favored Pre-proline 0 CA--C 1.535 0.395 0 CA-C-O 118.335 -0.841 . . . . 0.0 110.54 -179.04 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' C' C ' 55' ' ' PRO . . . . . . . . . . . . . 73.7 Cg_endo -77.12 170.04 72.65 Favored 'Cis proline' 0 N--CA 1.499 1.81 0 CA-C-N 121.784 1.673 . . . . 0.0 112.355 -6.158 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' C' C ' 56' ' ' SER . . . . . 0.447 ' OG ' ' HB3' ' C' ' 53' ' ' ALA . 69.8 m -117.06 132.33 23.52 Favored Pre-proline 0 CA--C 1.539 0.544 0 CA-C-O 118.492 -0.766 . . . . 0.0 109.476 175.371 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' C' C ' 57' ' ' PRO . . . . . . . . . . . . . 44.2 Cg_endo -69.35 147.4 83.72 Favored 'Cis proline' 0 N--CA 1.498 1.767 0 CA-C-N 121.909 1.718 . . . . 0.0 111.335 -1.46 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' C' C ' 58' ' ' LEU . . . . . . . . . . . . . 27.0 tp -107.06 136.63 46.59 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.372 -0.377 . . . . 0.0 110.68 -178.017 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' C' C ' 59' ' ' ARG . . . . . . . . . . . . . 75.4 ttt180 -102.12 120.79 41.02 Favored 'General case' 0 C--N 1.325 -0.482 0 N-CA-C 109.364 -0.606 . . . . 0.0 109.364 176.27 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' C' C ' 60' ' ' VAL . . . . . . . . . . . . . 40.8 t -74.31 122.09 26.9 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.268 0 C-N-CA 120.633 -0.427 . . . . 0.0 110.09 -176.021 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' C' C ' 61' ' ' GLU . . . . . . . . . . . . . 32.4 tp10 -130.72 157.78 41.87 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 115.994 -0.548 . . . . 0.0 109.759 -178.409 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' C' C ' 62' ' ' ASP . . . . . . . . . . . . . 35.7 m-20 -53.22 -32.5 48.51 Favored 'General case' 0 C--N 1.326 -0.417 0 N-CA-C 111.762 0.282 . . . . 0.0 111.762 179.947 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' C' C ' 63' ' ' ARG . . . . . . . . . . . . . 9.5 ptm180 -86.25 6.56 29.07 Favored 'General case' 0 CA--C 1.535 0.397 0 N-CA-C 113.551 0.945 . . . . 0.0 113.551 -177.522 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' C' C ' 64' ' ' THR . . . . . . . . . . . . . 37.6 m -83.58 137.87 33.64 Favored 'General case' 0 C--N 1.332 -0.166 0 CA-C-N 118.095 0.407 . . . . 0.0 110.569 -178.144 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' C' C ' 65' ' ' LYS . . . . . . . . . . . . . 53.4 mtmt -89.67 127.27 35.9 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 116.016 -0.538 . . . . 0.0 110.279 178.232 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' C' C ' 66' ' ' ILE . . . . . . . . . . . . . 64.1 mt -113.52 125.72 70.84 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.288 0 N-CA-C 109.413 -0.588 . . . . 0.0 109.413 178.957 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' C' C ' 67' ' ' THR . . . . . . . . . . . . . 20.9 m -125.21 143.67 50.83 Favored 'General case' 0 C--N 1.331 -0.208 0 CA-C-O 121.139 0.495 . . . . 0.0 111.221 -175.858 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' C' C ' 68' ' ' LEU . . . . . 0.433 HD12 ' N ' ' C' ' 68' ' ' LEU . 7.8 mp . . . . . 0 C--N 1.329 -0.295 0 CA-C-N 115.738 -0.665 . . . . 0.0 110.129 176.471 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' C' C ' 73' ' ' VAL . . . . . . . . . . . . . 35.8 m . . . . . 0 C--O 1.231 0.088 0 CA-C-O 120.828 0.347 . . . . 0.0 110.354 . . . . . . . . . 0 0 . 1 . 019 nuclear nobuild core ' C' C ' 74' ' ' ASP . . . . . . . . . . . . . 29.4 t0 -101.06 117.53 35.2 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.253 -0.43 . . . . 0.0 110.071 -178.802 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' C' C ' 75' ' ' VAL . . . . . . . . . . . . . 43.5 t -111.48 120.95 63.13 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.241 0 CA-C-O 120.992 0.425 . . . . 0.0 110.315 -179.266 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' C' C ' 76' ' ' LEU . . . . . . . . . . . . . 29.5 mt -123.42 145.41 48.81 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 115.869 -0.605 . . . . 0.0 109.604 179.212 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' C' C ' 77' ' ' GLU . . . . . . . . . . . . . 45.4 mt-10 -136.83 135.47 37.96 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-O 121.035 0.445 . . . . 0.0 111.149 -177.25 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' C' C ' 78' ' ' ALA . . . . . 0.573 ' HB2' HD21 ' C' ' 109' ' ' LEU . . . -122.17 125.84 47.0 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 115.615 -0.721 . . . . 0.0 109.465 176.862 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' C' C ' 79' ' ' LYS . . . . . 0.58 ' O ' HD13 ' C' ' 80' ' ' ILE . 47.4 pttt -78.63 119.86 22.49 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-O 121.437 0.637 . . . . 0.0 111.208 -175.781 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' C' C ' 80' ' ' ILE . . . . . 0.58 HD13 ' O ' ' C' ' 79' ' ' LYS . 38.8 mm -139.39 110.25 4.57 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.246 0 CA-C-N 115.478 -0.783 . . . . 0.0 108.993 -179.832 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' C' C ' 81' ' ' LYS . . . . . . . . . . . . . 25.1 mtpp -97.77 123.99 41.94 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-O 120.894 0.378 . . . . 0.0 111.097 -177.977 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' C' C ' 82' ' ' GLY . . . . . . . . . . . . . . . 89.19 42.22 5.63 Favored Glycine 0 CA--C 1.527 0.839 0 C-N-CA 120.85 -0.691 . . . . 0.0 111.604 175.8 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' C' C ' 83' ' ' ILE . . . . . . . . . . . . . 69.2 mt -65.24 136.58 26.45 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.35 0 N-CA-C 109.732 -0.469 . . . . 0.0 109.732 177.477 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' C' C ' 84' ' ' LYS . . . . . . . . . . . . . 26.9 ttmt -88.64 -48.74 7.33 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.136 -0.484 . . . . 0.0 110.114 -179.508 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' C' C ' 85' ' ' ASP . . . . . . . . . . . . . 4.6 t70 -162.97 157.69 21.34 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 115.799 -0.637 . . . . 0.0 110.537 179.311 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' C' C ' 86' ' ' VAL . . . . . . . . . . . . . 41.1 t -130.22 133.81 63.56 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.277 0 CA-C-O 120.984 0.421 . . . . 0.0 110.469 -178.535 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' C' C ' 87' ' ' ILE . . . . . 0.498 ' N ' HD12 ' C' ' 87' ' ' ILE . 5.0 mp -119.36 125.97 74.91 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.257 0 CA-C-N 115.848 -0.615 . . . . 0.0 109.474 176.993 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' C' C ' 88' ' ' LEU . . . . . . . . . . . . . 54.5 mt -110.52 135.6 50.94 Favored 'General case' 0 C--N 1.332 -0.187 0 CA-C-O 120.998 0.427 . . . . 0.0 111.495 -176.776 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' C' C ' 89' ' ' ASP . . . . . . . . . . . . . 9.0 t70 -131.46 153.16 50.04 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 115.777 -0.647 . . . . 0.0 109.554 174.802 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' C' C ' 90' ' ' GLU . . . . . . . . . . . . . 95.4 mt-10 -48.33 -38.58 19.46 Favored 'General case' 0 C--N 1.33 -0.274 0 N-CA-C 112.666 0.617 . . . . 0.0 112.666 -172.858 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' C' C ' 91' ' ' ASN . . . . . . . . . . . . . 19.0 p30 -132.02 36.82 3.64 Favored 'General case' 0 N--CA 1.463 0.221 0 CA-C-O 120.807 0.336 . . . . 0.0 111.404 -177.294 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' C' C ' 92' ' ' LEU . . . . . . . . . . . . . 13.1 tp -166.07 142.85 5.18 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.578 -0.283 . . . . 0.0 110.626 -179.155 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' C' C ' 93' ' ' ILE . . . . . . . . . . . . . 67.0 mt -127.47 122.16 58.79 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.262 0 N-CA-C 109.461 -0.57 . . . . 0.0 109.461 178.741 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' C' C ' 94' ' ' VAL . . . . . 0.423 HG21 HG21 ' C' ' 125' ' ' VAL . 44.9 t -120.8 125.47 74.1 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.228 0 N-CA-C 109.757 -0.46 . . . . 0.0 109.757 179.252 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' C' C ' 95' ' ' VAL . . . . . . . . . . . . . 45.1 t -119.87 132.61 69.13 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.264 0 CA-C-N 116.015 -0.538 . . . . 0.0 109.77 -179.642 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' C' C ' 96' ' ' ILE . . . . . . . . . . . . . 65.9 mt -113.48 125.19 70.71 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.34 0 N-CA-C 109.106 -0.702 . . . . 0.0 109.106 179.025 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' C' C ' 97' ' ' THR . . . . . . . . . . . . . 73.0 p -99.74 151.43 21.24 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-O 121.118 0.485 . . . . 0.0 111.183 -177.185 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' C' C ' 98' ' ' GLU . . . . . . . . . . . . . 85.6 tt0 -53.87 -24.98 17.69 Favored 'General case' 0 C--N 1.33 -0.265 0 N-CA-C 112.343 0.497 . . . . 0.0 112.343 -179.603 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' C' C ' 99' ' ' GLU . . . . . . . . . . . . . 71.1 mm-40 -79.31 16.35 1.02 Allowed 'General case' 0 CA--C 1.534 0.356 0 N-CA-C 113.033 0.753 . . . . 0.0 113.033 -178.102 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' C' C ' 100' ' ' ASN . . . . . . . . . . . . . 4.5 m-20 64.19 37.95 8.49 Favored 'General case' 0 C--O 1.233 0.222 0 CA-C-O 121.0 0.428 . . . . 0.0 111.076 177.326 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' C' C ' 101' ' ' GLU . . . . . . . . . . . . . 84.2 tt0 -118.29 143.65 46.43 Favored 'General case' 0 C--N 1.333 -0.145 0 CA-C-N 116.1 -0.5 . . . . 0.0 109.795 176.711 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' C' C ' 102' ' ' VAL . . . . . . . . . . . . . 42.8 t -115.04 126.11 72.54 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.335 0 CA-C-N 116.434 -0.348 . . . . 0.0 110.063 -178.689 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' C' C ' 103' ' ' LEU . . . . . 0.434 HD23 ' HG3' ' C' ' 114' ' ' ARG . 15.1 mt -115.57 126.87 54.76 Favored 'General case' 0 C--N 1.331 -0.205 0 CA-C-N 115.484 -0.78 . . . . 0.0 110.028 176.873 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' C' C ' 104' ' ' ILE . . . . . . . . . . . . . 68.4 mt -119.22 121.11 65.8 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.275 0 N-CA-C 110.293 -0.262 . . . . 0.0 110.293 -179.973 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' C' C ' 105' ' ' PHE . . . . . . . . . . . . . 35.7 m-85 -125.35 167.05 15.47 Favored 'General case' 0 C--N 1.334 -0.105 0 O-C-N 123.838 0.711 . . . . 0.0 110.166 179.788 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' C' C ' 106' ' ' ASN . . . . . . . . . . . . . 41.3 p-10 -99.95 -169.79 1.79 Allowed 'General case' 0 C--N 1.33 -0.254 0 N-CA-C 110.01 -0.367 . . . . 0.0 110.01 174.399 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' C' C ' 107' ' ' GLN . . . . . . . . . . . . . 46.5 tt0 -58.36 -29.46 66.01 Favored 'General case' 0 C--N 1.329 -0.318 0 N-CA-C 112.006 0.373 . . . . 0.0 112.006 179.421 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' C' C ' 108' ' ' ASN . . . . . . . . . . . . . 10.3 t30 -86.75 13.01 9.51 Favored 'General case' 0 CA--C 1.536 0.435 0 N-CA-C 113.051 0.76 . . . . 0.0 113.051 -177.977 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' C' C ' 109' ' ' LEU . . . . . 0.573 HD21 ' HB2' ' C' ' 78' ' ' ALA . 7.9 tp 55.67 37.83 29.37 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-O 120.947 0.403 . . . . 0.0 111.36 178.277 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' C' C ' 110' ' ' GLU . . . . . . . . . . . . . 96.0 mt-10 -103.04 156.85 17.39 Favored 'General case' 0 C--N 1.33 -0.255 0 N-CA-C 109.832 -0.433 . . . . 0.0 109.832 175.947 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' C' C ' 111' ' ' GLU . . . . . . . . . . . . . 84.6 tt0 -84.31 121.99 28.29 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-O 120.952 0.406 . . . . 0.0 111.127 -176.852 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' C' C ' 112' ' ' LEU . . . . . . . . . . . . . 27.2 mt -105.72 -46.11 4.23 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-N 115.979 -0.555 . . . . 0.0 110.057 176.586 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' C' C ' 113' ' ' TYR . . . . . . . . . . . . . 59.6 t80 -145.49 138.88 26.42 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.048 -0.523 . . . . 0.0 110.856 -179.689 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' C' C ' 114' ' ' ARG . . . . . 0.434 ' HG3' HD23 ' C' ' 103' ' ' LEU . 27.1 ttm180 -141.88 126.29 17.7 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.32 -0.4 . . . . 0.0 110.266 176.965 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' C' C ' 115' ' ' GLY . . . . . . . . . . . . . . . -150.21 160.82 28.7 Favored Glycine 0 CA--C 1.524 0.597 0 N-CA-C 111.101 -0.799 . . . . 0.0 111.101 179.333 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' C' C ' 116' ' ' LYS . . . . . . . . . . . . . 38.9 ttpt -130.39 134.18 46.95 Favored 'General case' 0 C--N 1.33 -0.253 0 N-CA-C 110.035 -0.357 . . . . 0.0 110.035 177.24 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' C' C ' 117' ' ' PHE . . . . . 0.414 ' HE2' HD13 ' C' ' 132' ' ' ILE . 47.5 m-85 -126.99 118.64 24.9 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.333 -0.394 . . . . 0.0 110.464 -176.337 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' C' C ' 118' ' ' GLU . . . . . . . . . . . . . 95.9 mt-10 -51.86 -51.61 55.48 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.39 -0.368 . . . . 0.0 111.697 -175.629 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' C' C ' 119' ' ' ASN . . . . . . . . . . . . . 70.5 m-80 -98.03 31.01 2.84 Favored 'General case' 0 C--N 1.329 -0.294 0 N-CA-C 112.19 0.441 . . . . 0.0 112.19 -173.485 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' C' C ' 120' ' ' LEU . . . . . 0.477 HD23 ' C ' ' C' ' 120' ' ' LEU . 6.5 tt -56.27 121.3 9.2 Favored 'General case' 0 C--N 1.333 -0.129 0 CA-C-O 120.727 0.299 . . . . 0.0 110.562 178.751 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' C' C ' 121' ' ' ASN . . . . . . . . . . . . . 74.5 m-20 -114.03 -44.12 3.18 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 116.364 -0.38 . . . . 0.0 111.159 -176.44 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' C' C ' 122' ' ' LYS . . . . . . . . . . . . . 55.2 mtmt -142.87 150.73 40.24 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-O 121.149 0.499 . . . . 0.0 111.513 -176.379 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' C' C ' 123' ' ' VAL . . . . . . . . . . . . . 45.8 t -130.38 133.46 63.84 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.228 0 CA-C-N 115.863 -0.608 . . . . 0.0 109.653 177.812 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' C' C ' 124' ' ' LEU . . . . . . . . . . . . . 30.1 mt -125.14 127.78 47.38 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.468 -0.333 . . . . 0.0 110.416 -179.852 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' C' C ' 125' ' ' VAL . . . . . 0.423 HG21 HG21 ' C' ' 94' ' ' VAL . 43.0 t -132.57 131.09 60.04 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.262 0 CA-C-N 116.183 -0.462 . . . . 0.0 109.97 -179.829 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' C' C ' 126' ' ' ARG . . . . . . . . . . . . . 78.1 mtt180 -145.95 119.77 9.28 Favored 'General case' 0 C--N 1.331 -0.22 0 CA-C-N 116.348 -0.387 . . . . 0.0 110.79 178.88 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' C' C ' 127' ' ' ASN . . . . . . . . . . . . . 64.1 t30 51.12 -105.75 0.22 Allowed 'General case' 0 CA--C 1.543 0.696 0 CA-C-O 119.023 -0.513 . . . . 0.0 111.476 179.188 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' C' C ' 128' ' ' ASP . . . . . . . . . . . . . 16.1 p-10 -114.08 5.27 15.96 Favored 'General case' 0 N--CA 1.469 0.483 0 CA-C-N 119.602 1.092 . . . . 0.0 113.442 -177.084 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' C' C ' 129' ' ' LEU . . . . . 0.47 HD22 ' NH1' ' C' ' 142' ' ' ARG . 26.1 mt -105.01 133.22 50.17 Favored 'General case' 0 C--N 1.332 -0.184 0 N-CA-C 109.555 -0.535 . . . . 0.0 109.555 177.703 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' C' C ' 130' ' ' VAL . . . . . . . . . . . . . 46.3 t -128.11 132.02 68.85 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.287 0 CA-C-O 120.881 0.372 . . . . 0.0 110.218 -178.508 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' C' C ' 131' ' ' VAL . . . . . 0.472 HG12 HD12 ' C' ' 140' ' ' LEU . 35.2 m -136.15 138.69 46.86 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.228 0 CA-C-O 121.15 0.5 . . . . 0.0 111.059 177.246 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' C' C ' 132' ' ' ILE . . . . . 0.414 HD13 ' HE2' ' C' ' 117' ' ' PHE . 71.4 mt -116.4 131.55 68.62 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.303 0 CA-C-N 115.67 -0.695 . . . . 0.0 109.26 179.189 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' C' C ' 133' ' ' ILE . . . . . . . . . . . . . 33.3 mm -115.09 120.66 65.24 Favored 'Isoleucine or valine' 0 C--O 1.234 0.255 0 CA-C-O 120.762 0.315 . . . . 0.0 111.316 -173.958 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' C' C ' 134' ' ' ASP . . . . . . . . . . . . . 10.0 p-10 -132.94 148.43 52.28 Favored 'General case' 0 C--N 1.33 -0.255 0 N-CA-C 109.538 -0.542 . . . . 0.0 109.538 175.066 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' C' C ' 135' ' ' GLU . . . . . . . . . . . . . 85.3 tt0 -49.94 -25.37 3.21 Favored 'General case' 0 C--N 1.328 -0.355 0 N-CA-C 112.864 0.691 . . . . 0.0 112.864 -172.281 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' C' C ' 136' ' ' GLN . . . . . . . . . . . . . 97.5 mt-30 -84.16 -37.83 21.43 Favored 'General case' 0 C--O 1.234 0.245 0 N-CA-C 112.305 0.483 . . . . 0.0 112.305 -176.588 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' C' C ' 137' ' ' LYS . . . . . . . . . . . . . 22.7 pttm -162.16 174.71 12.55 Favored 'General case' 0 C--N 1.331 -0.224 0 CA-C-O 121.507 0.67 . . . . 0.0 112.402 -170.634 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' C' C ' 138' ' ' LEU . . . . . . . . . . . . . 7.0 tt -122.6 128.1 50.25 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 114.903 -1.044 . . . . 0.0 109.918 178.558 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' C' C ' 139' ' ' THR . . . . . . . . . . . . . 30.1 m -104.15 124.05 48.39 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.121 -0.491 . . . . 0.0 110.236 179.012 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' C' C ' 140' ' ' LEU . . . . . 0.476 HD11 ' NH2' ' C' ' 142' ' ' ARG . 19.4 tp -109.25 119.56 39.87 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 115.719 -0.673 . . . . 0.0 109.674 -177.808 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' C' C ' 141' ' ' ILE . . . . . . . . . . . . . 19.0 mt -121.15 120.93 63.55 Favored 'Isoleucine or valine' 0 C--O 1.235 0.297 0 CA-C-O 120.986 0.422 . . . . 0.0 110.235 -175.093 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' C' C ' 142' ' ' ARG . . . . . 0.476 ' NH2' HD11 ' C' ' 140' ' ' LEU . 1.1 mpt_? . . . . . 0 C--N 1.33 -0.272 0 CA-C-N 115.312 -0.858 . . . . 0.0 110.08 -179.296 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' D' D ' 2' ' ' SER . . . . . . . . . . . . . 7.6 p . . . . . 0 C--O 1.232 0.16 0 CA-C-O 121.124 0.488 . . . . 0.0 110.917 . . . . . . . . . 0 0 . 1 . 019 nuclear nobuild core ' D' D ' 3' ' ' GLU . . . . . . . . . . . . . 43.6 mp0 -137.85 142.19 40.75 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 115.619 -0.719 . . . . 0.0 110.571 -178.991 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' D' D ' 4' ' ' LEU . . . . . . . . . . . . . 4.2 tt -123.9 123.13 39.74 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 115.753 -0.658 . . . . 0.0 109.78 177.24 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' D' D ' 5' ' ' LYS . . . . . . . . . . . . . 63.6 mttp -102.63 121.51 42.54 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-O 120.77 0.319 . . . . 0.0 110.825 -179.984 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' D' D ' 6' ' ' LEU . . . . . . . . . . . . . 64.7 mt -114.37 148.3 37.84 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 115.553 -0.748 . . . . 0.0 110.614 179.836 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' D' D ' 7' ' ' LYS . . . . . . . . . . . . . 22.7 ttmm -139.82 141.32 27.17 Favored Pre-proline 0 CA--C 1.534 0.339 0 N-CA-C 109.811 -0.44 . . . . 0.0 109.811 174.826 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' D' D ' 8' ' ' PRO . . . . . . . . . . . . . 96.4 Cg_endo -91.22 139.16 2.41 Favored 'Trans proline' 0 N--CA 1.49 1.316 0 C-N-CA 121.694 1.596 . . . . 0.0 111.663 177.988 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' D' D ' 9' ' ' LEU . . . . . . . . . . . . . 49.2 mt -78.28 -45.84 2.13 Favored Pre-proline 0 CA--C 1.533 0.313 0 CA-C-O 118.838 -0.601 . . . . 0.0 111.788 -179.655 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' D' D ' 10' ' ' PRO . . . . . . . . . . . . . 74.7 Cg_endo -84.63 150.75 11.51 Favored 'Trans proline' 0 N--CA 1.495 1.604 0 C-N-CA 121.224 1.283 . . . . 0.0 111.364 171.804 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' D' D ' 11' ' ' LYS . . . . . . . . . . . . . 19.8 pttp -83.47 117.28 22.98 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-O 121.385 0.612 . . . . 0.0 110.423 178.4 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' D' D ' 12' ' ' VAL . . . . . . . . . . . . . 12.3 p -151.05 148.58 14.84 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.271 0 CA-C-N 115.837 -0.62 . . . . 0.0 110.625 -179.965 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' D' D ' 13' ' ' GLU . . . . . . . . . . . . . 44.7 mp0 -91.07 121.59 33.0 Favored 'General case' 0 C--N 1.328 -0.346 0 N-CA-C 109.866 -0.42 . . . . 0.0 109.866 176.663 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' D' D ' 14' ' ' LEU . . . . . 0.42 HD22 ' CD1' ' D' ' 18' ' ' PHE . 15.7 mt -98.09 147.8 33.6 Favored Pre-proline 0 CA--C 1.533 0.3 0 CA-C-O 119.23 -0.414 . . . . 0.0 110.627 -177.801 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' D' D ' 15' ' ' PRO . . . . . . . . . . . . . 24.4 Cg_exo -63.33 162.41 27.11 Favored 'Trans proline' 0 N--CA 1.497 1.685 0 C-N-CA 121.39 1.393 . . . . 0.0 111.813 175.877 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' D' D ' 16' ' ' PRO . . . . . . . . . . . . . 27.8 Cg_exo -60.27 -33.94 94.21 Favored 'Trans proline' 0 N--CA 1.497 1.723 0 C-N-CA 121.495 1.463 . . . . 0.0 112.687 -178.724 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' D' D ' 17' ' ' ASP . . . . . . . . . . . . . 23.1 p-10 -90.07 6.73 41.11 Favored 'General case' 0 CA--C 1.536 0.421 0 N-CA-C 113.447 0.906 . . . . 0.0 113.447 -176.936 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' D' D ' 18' ' ' PHE . . . . . 0.42 ' CD1' HD22 ' D' ' 14' ' ' LEU . 53.4 t80 -58.04 -42.87 86.31 Favored 'General case' 0 C--N 1.335 -0.036 0 O-C-N 122.045 -0.409 . . . . 0.0 110.171 -178.777 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' D' D ' 19' ' ' VAL . . . . . . . . . . . . . 47.3 t -56.6 -43.46 78.74 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 CA-C-N 116.236 -0.438 . . . . 0.0 110.514 -179.27 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' D' D ' 20' ' ' ASP . . . . . . . . . . . . . 79.3 m-20 -60.26 -42.02 94.48 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-O 120.696 0.284 . . . . 0.0 110.923 -178.276 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' D' D ' 21' ' ' VAL . . . . . . . . . . . . . 46.3 t -64.12 -48.38 86.04 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.294 0 C-N-CA 120.854 -0.339 . . . . 0.0 110.517 -177.871 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' D' D ' 22' ' ' ILE . . . . . 0.502 HG22 HD12 ' D' ' 26' ' ' LEU . 50.3 mm -55.97 -45.45 80.15 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.218 0 CA-C-O 120.867 0.365 . . . . 0.0 110.577 179.087 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' D' D ' 23' ' ' ARG . . . . . . . . . . . . . 53.7 ttp180 -54.13 -49.93 68.07 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.602 -0.272 . . . . 0.0 111.427 -178.86 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' D' D ' 24' ' ' ILE . . . . . . . . . . . . . 77.5 mt -59.78 -41.5 85.73 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.267 0 C-N-CA 121.172 -0.211 . . . . 0.0 111.253 -178.065 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' D' D ' 25' ' ' LYS . . . . . . . . . . . . . 73.2 mmtt -63.51 -42.56 98.48 Favored 'General case' 0 C--N 1.328 -0.346 0 N-CA-C 112.015 0.376 . . . . 0.0 112.015 -179.695 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' D' D ' 26' ' ' LEU . . . . . 0.502 HD12 HG22 ' D' ' 22' ' ' ILE . 74.5 mt -79.87 -40.19 28.88 Favored 'General case' 0 C--N 1.329 -0.311 0 N-CA-C 113.344 0.868 . . . . 0.0 113.344 -170.856 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' D' D ' 27' ' ' GLN . . . . . . . . . . . . . 8.6 pt20 -46.67 140.94 4.12 Favored 'General case' 0 N--CA 1.47 0.526 0 N-CA-C 112.785 0.661 . . . . 0.0 112.785 -174.923 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' D' D ' 28' ' ' GLY . . . . . . . . . . . . . . . 98.57 -27.6 18.84 Favored Glycine 0 CA--C 1.533 1.186 0 CA-C-N 115.527 -0.761 . . . . 0.0 112.123 -177.87 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' D' D ' 29' ' ' LYS . . . . . . . . . . . . . 67.3 mttm -98.39 155.14 17.38 Favored 'General case' 0 C--O 1.232 0.181 0 CA-C-N 117.229 0.515 . . . . 0.0 111.044 179.636 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' D' D ' 30' ' ' THR . . . . . . . . . . . . . 37.9 m -100.7 137.65 38.81 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.075 -0.511 . . . . 0.0 110.062 176.095 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' D' D ' 31' ' ' VAL . . . . . . . . . . . . . 34.6 m -128.4 157.31 40.88 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.282 0 CA-C-O 120.992 0.425 . . . . 0.0 110.716 -178.953 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' D' D ' 32' ' ' ARG . . . . . . . . . . . . . 94.2 mtt180 -133.72 151.26 51.57 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 115.74 -0.664 . . . . 0.0 110.446 177.832 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' D' D ' 33' ' ' THR . . . . . . . . . . . . . 30.0 m -53.12 138.52 31.03 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.496 -0.32 . . . . 0.0 111.317 -179.339 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' D' D ' 34' ' ' GLY . . . . . . . . . . . . . . . 101.28 -17.13 56.19 Favored Glycine 0 CA--C 1.533 1.17 0 CA-C-O 119.593 -0.559 . . . . 0.0 113.305 179.124 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' D' D ' 35' ' ' ASP . . . . . . . . . . . . . 67.9 m-20 -65.26 148.95 50.79 Favored 'General case' 0 N--CA 1.461 0.122 0 CA-C-N 118.039 0.92 . . . . 0.0 110.987 179.332 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' D' D ' 36' ' ' VAL . . . . . . . . . . . . . 44.7 t -124.23 130.86 73.54 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.25 0 CA-C-N 115.858 -0.61 . . . . 0.0 109.916 179.49 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' D' D ' 37' ' ' ILE . . . . . . . . . . . . . 65.4 mt -119.7 138.19 51.12 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.267 0 CA-C-N 116.195 -0.457 . . . . 0.0 109.787 179.396 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' D' D ' 38' ' ' GLY . . . . . . . . . . . . . . . -114.33 128.72 8.34 Favored Glycine 0 CA--C 1.524 0.637 0 N-CA-C 111.096 -0.801 . . . . 0.0 111.096 -179.699 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' D' D ' 39' ' ' ILE . . . . . . . . . . . . . 72.7 mt -127.34 131.03 70.84 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.282 0 N-CA-C 109.863 -0.421 . . . . 0.0 109.863 178.373 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' D' D ' 40' ' ' SER . . . . . . . . . . . . . 51.8 p -91.92 121.1 33.2 Favored 'General case' 0 C--N 1.329 -0.292 0 C-N-CA 120.894 -0.322 . . . . 0.0 110.81 176.348 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' D' D ' 41' ' ' ILE . . . . . . . . . . . . . 71.9 mt -130.02 119.29 46.68 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.201 0 CA-C-O 120.833 0.349 . . . . 0.0 110.295 179.918 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' D' D ' 42' ' ' LEU . . . . . . . . . . . . . 83.5 mt 58.15 33.41 23.14 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.073 -0.512 . . . . 0.0 111.874 177.551 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' D' D ' 43' ' ' GLY . . . . . . . . . . . . . . . 82.57 -10.1 56.8 Favored Glycine 0 CA--C 1.533 1.216 0 C-N-CA 121.22 -0.514 . . . . 0.0 113.468 176.746 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' D' D ' 44' ' ' LYS . . . . . . . . . . . . . 68.2 tttt -103.34 129.51 50.39 Favored 'General case' 0 C--N 1.332 -0.167 0 CA-C-N 117.948 0.874 . . . . 0.0 109.851 176.885 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' D' D ' 45' ' ' GLU . . . . . . . . . . . . . 39.9 tp10 -84.22 131.14 34.78 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-O 120.816 0.341 . . . . 0.0 110.99 -179.47 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' D' D ' 46' ' ' VAL . . . . . . . . . . . . . 7.3 p -120.99 129.03 76.13 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.191 0 N-CA-C 109.69 -0.485 . . . . 0.0 109.69 176.793 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' D' D ' 47' ' ' LYS . . . . . . . . . . . . . 65.2 mmtt -99.59 126.6 45.61 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 115.87 -0.605 . . . . 0.0 110.931 177.075 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' D' D ' 48' ' ' PHE . . . . . . . . . . . . . 95.8 m-85 -108.78 131.74 54.66 Favored 'General case' 0 C--N 1.328 -0.328 0 N-CA-C 109.399 -0.593 . . . . 0.0 109.399 175.193 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' D' D ' 49' ' ' LYS . . . . . . . . . . . . . 74.3 tttt -109.01 135.48 50.11 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.467 -0.333 . . . . 0.0 110.501 179.934 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' D' D ' 50' ' ' VAL . . . . . . . . . . . . . 43.7 t -78.72 106.05 8.95 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.293 0 N-CA-C 109.187 -0.671 . . . . 0.0 109.187 175.73 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' D' D ' 51' ' ' VAL . . . . . . . . . . . . . 52.9 t -68.8 -47.63 75.23 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.315 0 CA-C-N 116.077 -0.511 . . . . 0.0 109.992 -173.251 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' D' D ' 52' ' ' GLN . . . . . . . . . . . . . 62.8 tt0 -170.18 144.2 2.57 Favored 'General case' 0 C--N 1.33 -0.271 0 C-N-CA 120.262 -0.575 . . . . 0.0 111.839 -178.996 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' D' D ' 53' ' ' ALA . . . . . . . . . . . . . . . -116.46 134.32 55.0 Favored 'General case' 0 C--N 1.331 -0.213 0 CA-C-N 115.641 -0.709 . . . . 0.0 109.831 175.948 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' D' D ' 54' ' ' TYR . . . . . . . . . . . . . 48.7 t80 -129.06 112.82 18.52 Favored Pre-proline 0 CA--C 1.534 0.343 0 CA-C-O 118.194 -0.908 . . . . 0.0 110.442 178.578 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' D' D ' 55' ' ' PRO . . . . . . . . . . . . . 74.0 Cg_endo -77.18 167.86 78.5 Favored 'Cis proline' 0 N--CA 1.499 1.84 0 CA-C-N 122.002 1.751 . . . . 0.0 112.14 -7.727 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' D' D ' 56' ' ' SER . . . . . . . . . . . . . 13.6 m -117.11 140.64 27.34 Favored Pre-proline 0 CA--C 1.537 0.454 0 CA-C-O 118.674 -0.679 . . . . 0.0 109.741 174.802 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' D' D ' 57' ' ' PRO . . . . . . . . . . . . . 38.2 Cg_endo -68.0 159.95 82.92 Favored 'Cis proline' 0 N--CA 1.498 1.786 0 CA-C-N 121.596 1.606 . . . . 0.0 111.139 -3.544 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' D' D ' 58' ' ' LEU . . . . . . . . . . . . . 20.7 tp -129.6 137.16 50.55 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-O 120.995 0.426 . . . . 0.0 110.473 -178.136 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' D' D ' 59' ' ' ARG . . . . . . . . . . . . . 41.7 ttp180 -104.57 126.6 51.81 Favored 'General case' 0 C--N 1.327 -0.379 0 N-CA-C 109.24 -0.652 . . . . 0.0 109.24 175.342 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' D' D ' 60' ' ' VAL . . . . . . . . . . . . . 41.4 t -80.06 123.45 36.87 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.291 0 C-N-CA 120.676 -0.409 . . . . 0.0 110.649 -173.411 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' D' D ' 61' ' ' GLU . . . . . . . . . . . . . 95.9 mt-10 -131.05 164.19 25.97 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 115.782 -0.645 . . . . 0.0 109.78 177.34 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' D' D ' 62' ' ' ASP . . . . . . . . . . . . . 76.4 m-20 -53.19 -32.5 48.29 Favored 'General case' 0 C--N 1.328 -0.345 0 N-CA-C 111.81 0.3 . . . . 0.0 111.81 -179.981 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' D' D ' 63' ' ' ARG . . . . . . . . . . . . . 95.7 mtt180 -74.48 -21.99 59.3 Favored 'General case' 0 CA--C 1.533 0.294 0 N-CA-C 112.945 0.72 . . . . 0.0 112.945 -176.986 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' D' D ' 64' ' ' THR . . . . . . . . . . . . . 26.8 m -64.84 137.17 57.61 Favored 'General case' 0 C--N 1.331 -0.223 0 CA-C-O 120.965 0.412 . . . . 0.0 110.572 -175.599 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' D' D ' 65' ' ' LYS . . . . . . . . . . . . . 39.8 ttpt -89.14 123.78 33.72 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 115.903 -0.589 . . . . 0.0 110.317 -179.721 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' D' D ' 66' ' ' ILE . . . . . . . . . . . . . 62.7 mt -111.48 130.2 65.46 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.261 0 N-CA-C 109.94 -0.393 . . . . 0.0 109.94 -178.564 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' D' D ' 67' ' ' THR . . . . . . . . . . . . . 8.1 m -130.1 146.97 51.79 Favored 'General case' 0 C--N 1.332 -0.192 0 CA-C-O 121.068 0.461 . . . . 0.0 111.231 -176.663 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' D' D ' 68' ' ' LEU . . . . . . . . . . . . . 54.0 mt . . . . . 0 C--N 1.33 -0.247 0 CA-C-N 115.836 -0.62 . . . . 0.0 110.266 177.47 . . . . . . . . 0 0 . 1 . 019 nuclear nobuild core ' D' D ' 73' ' ' VAL . . . . . . . . . . . . . 34.6 m . . . . . 0 C--O 1.231 0.1 0 CA-C-O 120.795 0.331 . . . . 0.0 110.874 . . . . . . . . . 0 0 . 1 . 019 nuclear nobuild core ' D' D ' 74' ' ' ASP . . . . . . . . . . . . . 23.6 t0 -96.84 124.66 40.88 Favored 'General case' 0 C--N 1.33 -0.264 0 N-CA-C 109.548 -0.538 . . . . 0.0 109.548 178.516 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' D' D ' 75' ' ' VAL . . . . . . . . . . . . . 40.6 t -114.31 122.88 69.31 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.258 0 CA-C-O 121.064 0.459 . . . . 0.0 110.7 -177.524 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' D' D ' 76' ' ' LEU . . . . . . . . . . . . . 5.5 mp -124.76 152.41 43.86 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 115.653 -0.703 . . . . 0.0 109.608 175.951 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' D' D ' 77' ' ' GLU . . . . . . . . . . . . . 98.4 mt-10 -137.35 139.66 40.95 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-O 121.068 0.461 . . . . 0.0 111.34 -177.669 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' D' D ' 78' ' ' ALA . . . . . 0.723 ' HB2' HD21 ' D' ' 109' ' ' LEU . . . -125.58 137.99 53.92 Favored 'General case' 0 C--N 1.331 -0.217 0 CA-C-N 115.711 -0.677 . . . . 0.0 109.841 176.778 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' D' D ' 79' ' ' LYS . . . . . 0.652 ' O ' HD13 ' D' ' 80' ' ' ILE . 68.8 mttm -88.94 115.82 26.77 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.39 -0.368 . . . . 0.0 110.848 -177.747 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' D' D ' 80' ' ' ILE . . . . . 0.652 HD13 ' O ' ' D' ' 79' ' ' LYS . 36.2 mm -139.18 111.7 5.8 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.267 0 N-CA-C 109.153 -0.684 . . . . 0.0 109.153 -177.863 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' D' D ' 81' ' ' LYS . . . . . . . . . . . . . 39.7 ttpt -100.7 126.85 47.27 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-O 120.928 0.394 . . . . 0.0 111.279 -176.558 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' D' D ' 82' ' ' GLY . . . . . . . . . . . . . . . 89.18 42.15 5.65 Favored Glycine 0 CA--C 1.526 0.746 0 N-CA-C 111.534 -0.626 . . . . 0.0 111.534 175.548 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' D' D ' 83' ' ' ILE . . . . . . . . . . . . . 67.8 mt -68.26 139.4 20.77 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.348 0 CA-C-O 120.849 0.357 . . . . 0.0 110.111 179.008 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' D' D ' 84' ' ' LYS . . . . . . . . . . . . . 30.3 ttmt -96.66 -53.64 3.49 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.041 -0.527 . . . . 0.0 109.949 179.467 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' D' D ' 85' ' ' ASP . . . . . . . . . . . . . 7.1 t70 -155.41 152.63 29.27 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 115.507 -0.77 . . . . 0.0 110.117 -179.53 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' D' D ' 86' ' ' VAL . . . . . . . . . . . . . 41.6 t -130.13 132.52 65.22 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.215 0 CA-C-O 120.879 0.371 . . . . 0.0 110.533 -179.476 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' D' D ' 87' ' ' ILE . . . . . . . . . . . . . 45.0 mm -119.37 127.61 75.85 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.263 0 CA-C-N 115.902 -0.59 . . . . 0.0 109.643 177.271 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' D' D ' 88' ' ' LEU . . . . . . . . . . . . . 14.7 tp -110.45 131.3 55.17 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.377 -0.374 . . . . 0.0 110.967 -178.16 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' D' D ' 89' ' ' ASP . . . . . . . . . . . . . 13.3 t70 -124.82 152.2 44.22 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.033 -0.531 . . . . 0.0 109.821 177.611 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' D' D ' 90' ' ' GLU . . . . . . . . . . . . . 96.2 mt-10 -48.56 -34.65 11.82 Favored 'General case' 0 C--N 1.328 -0.368 0 N-CA-C 112.605 0.595 . . . . 0.0 112.605 -173.878 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' D' D ' 91' ' ' ASN . . . . . . . . . . . . . 33.6 m120 -132.05 30.99 4.21 Favored 'General case' 0 CA--C 1.531 0.219 0 N-CA-C 112.167 0.432 . . . . 0.0 112.167 -176.179 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' D' D ' 92' ' ' LEU . . . . . . . . . . . . . 10.8 tp -166.06 149.35 7.49 Favored 'General case' 0 C--N 1.331 -0.215 0 CA-C-O 120.795 0.331 . . . . 0.0 111.089 -179.749 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' D' D ' 93' ' ' ILE . . . . . . . . . . . . . 72.6 mt -126.25 120.23 56.13 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.22 0 N-CA-C 109.298 -0.63 . . . . 0.0 109.298 177.426 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' D' D ' 94' ' ' VAL . . . . . 0.711 HG21 HG11 ' D' ' 125' ' ' VAL . 45.1 t -120.39 127.19 75.89 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.233 0 CA-C-O 120.818 0.342 . . . . 0.0 110.092 -178.637 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' D' D ' 95' ' ' VAL . . . . . . . . . . . . . 43.9 t -122.91 134.22 66.7 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.341 0 CA-C-N 116.123 -0.489 . . . . 0.0 109.98 -179.062 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' D' D ' 96' ' ' ILE . . . . . . . . . . . . . 60.9 mt -115.97 128.15 73.34 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.317 0 N-CA-C 109.478 -0.564 . . . . 0.0 109.478 179.143 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' D' D ' 97' ' ' THR . . . . . . . . . . . . . 66.9 p -100.98 154.01 19.05 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-O 121.138 0.494 . . . . 0.0 111.011 -178.171 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' D' D ' 98' ' ' GLU . . . . . . . . . . . . . 96.4 mt-10 -56.94 -23.86 48.5 Favored 'General case' 0 CA--C 1.533 0.325 0 N-CA-C 112.469 0.544 . . . . 0.0 112.469 -178.736 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' D' D ' 99' ' ' GLU . . . . . . . . . . . . . 71.1 mm-40 -80.5 18.08 0.99 Allowed 'General case' 0 CA--C 1.533 0.324 0 N-CA-C 112.961 0.726 . . . . 0.0 112.961 -178.699 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' D' D ' 100' ' ' ASN . . . . . . . . . . . . . 3.8 m-20 64.09 38.12 8.62 Favored 'General case' 0 N--CA 1.463 0.191 0 CA-C-O 121.063 0.459 . . . . 0.0 111.049 176.899 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' D' D ' 101' ' ' GLU . . . . . . . . . . . . . 84.5 tt0 -116.68 143.07 46.08 Favored 'General case' 0 C--N 1.332 -0.162 0 CA-C-N 116.068 -0.515 . . . . 0.0 109.884 177.125 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' D' D ' 102' ' ' VAL . . . . . . . . . . . . . 43.5 t -114.99 126.93 72.71 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.287 0 CA-C-N 116.275 -0.42 . . . . 0.0 109.891 -178.801 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' D' D ' 103' ' ' LEU . . . . . . . . . . . . . 44.9 mt -118.16 134.28 55.14 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 115.668 -0.696 . . . . 0.0 109.632 179.532 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' D' D ' 104' ' ' ILE . . . . . . . . . . . . . 73.2 mt -126.11 122.81 62.48 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.266 0 C-N-CA 121.213 -0.195 . . . . 0.0 110.562 -176.819 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' D' D ' 105' ' ' PHE . . . . . . . . . . . . . 49.7 m-85 -127.36 165.94 18.79 Favored 'General case' 0 C--N 1.333 -0.112 0 O-C-N 123.993 0.808 . . . . 0.0 110.075 -179.781 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' D' D ' 106' ' ' ASN . . . . . . . . . . . . . 45.7 p-10 -101.85 -170.01 1.76 Allowed 'General case' 0 C--N 1.331 -0.227 0 N-CA-C 109.94 -0.392 . . . . 0.0 109.94 174.379 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' D' D ' 107' ' ' GLN . . . . . . . . . . . . . 39.0 tt0 -58.72 -30.1 67.19 Favored 'General case' 0 C--N 1.33 -0.269 0 N-CA-C 111.996 0.369 . . . . 0.0 111.996 179.73 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' D' D ' 108' ' ' ASN . . . . . . . . . . . . . 11.3 t-20 -83.55 7.99 15.5 Favored 'General case' 0 CA--C 1.534 0.357 0 N-CA-C 113.238 0.829 . . . . 0.0 113.238 -176.836 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' D' D ' 109' ' ' LEU . . . . . 0.723 HD21 ' HB2' ' D' ' 78' ' ' ALA . 12.8 tp 61.29 38.55 16.35 Favored 'General case' 0 CA--C 1.529 0.154 0 CA-C-O 120.999 0.428 . . . . 0.0 111.028 178.388 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' D' D ' 110' ' ' GLU . . . . . . . . . . . . . 95.5 mt-10 -108.21 152.81 24.09 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 116.396 -0.365 . . . . 0.0 110.373 177.937 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' D' D ' 111' ' ' GLU . . . . . . . . . . . . . 94.9 mt-10 -77.69 125.31 29.14 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-O 120.913 0.387 . . . . 0.0 111.123 -179.543 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' D' D ' 112' ' ' LEU . . . . . . . . . . . . . 83.4 mt -107.99 -45.36 3.99 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 115.975 -0.557 . . . . 0.0 109.664 173.297 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' D' D ' 113' ' ' TYR . . . . . . . . . . . . . 64.6 t80 -147.31 141.55 26.21 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.133 -0.485 . . . . 0.0 111.555 -179.252 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' D' D ' 114' ' ' ARG . . . . . . . . . . . . . 65.3 mtt180 -139.36 124.65 19.07 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 115.874 -0.603 . . . . 0.0 110.3 173.69 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' D' D ' 115' ' ' GLY . . . . . . . . . . . . . . . -150.06 157.43 27.21 Favored Glycine 0 CA--C 1.525 0.683 0 N-CA-C 110.862 -0.895 . . . . 0.0 110.862 178.69 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' D' D ' 116' ' ' LYS . . . . . . . . . . . . . 39.7 ttpt -129.12 139.04 52.12 Favored 'General case' 0 C--N 1.329 -0.322 0 N-CA-C 110.103 -0.332 . . . . 0.0 110.103 178.195 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' D' D ' 117' ' ' PHE . . . . . . . . . . . . . 47.9 m-85 -132.15 116.01 16.46 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.283 -0.417 . . . . 0.0 110.489 -176.196 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' D' D ' 118' ' ' GLU . . . . . . . . . . . . . 84.7 tt0 -51.95 -52.93 46.88 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.407 -0.36 . . . . 0.0 111.659 -176.853 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' D' D ' 119' ' ' ASN . . . . . . . . . . . . . 96.3 m-20 -93.65 31.14 1.62 Allowed 'General case' 0 C--N 1.329 -0.29 0 N-CA-C 112.227 0.454 . . . . 0.0 112.227 -174.525 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' D' D ' 120' ' ' LEU . . . . . . . . . . . . . 15.8 tp -54.08 122.1 9.48 Favored 'General case' 0 N--CA 1.464 0.231 0 O-C-N 122.289 -0.257 . . . . 0.0 110.671 177.562 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' D' D ' 121' ' ' ASN . . . . . . . . . . . . . 26.7 m120 -114.09 -44.02 3.18 Favored 'General case' 0 C--O 1.232 0.166 0 CA-C-N 116.595 -0.275 . . . . 0.0 111.188 -175.977 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' D' D ' 122' ' ' LYS . . . . . . . . . . . . . 44.4 mtmt -145.68 146.52 31.32 Favored 'General case' 0 C--N 1.331 -0.215 0 C-N-CA 120.538 -0.465 . . . . 0.0 111.665 -176.471 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' D' D ' 123' ' ' VAL . . . . . . . . . . . . . 44.0 t -129.02 130.5 68.31 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.275 0 CA-C-N 115.849 -0.614 . . . . 0.0 109.53 176.096 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' D' D ' 124' ' ' LEU . . . . . . . . . . . . . 14.9 tp -128.34 135.34 49.45 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-O 120.78 0.324 . . . . 0.0 110.612 -178.555 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' D' D ' 125' ' ' VAL . . . . . 0.711 HG11 HG21 ' D' ' 94' ' ' VAL . 34.9 m -133.61 141.0 45.44 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.195 0 CA-C-N 116.328 -0.396 . . . . 0.0 111.031 -178.719 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' D' D ' 126' ' ' ARG . . . . . . . . . . . . . 78.2 mtt180 -149.41 125.19 10.49 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.554 176.267 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' D' D ' 127' ' ' ASN . . . . . . . . . . . . . 18.8 t-20 52.51 -111.37 0.58 Allowed 'General case' 0 CA--C 1.545 0.755 0 CA-C-O 118.734 -0.65 . . . . 0.0 111.046 178.849 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' D' D ' 128' ' ' ASP . . . . . . . . . . . . . 21.5 p-10 -114.15 10.7 17.4 Favored 'General case' 0 N--CA 1.468 0.454 0 CA-C-N 120.044 1.293 . . . . 0.0 113.081 -179.747 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' D' D ' 129' ' ' LEU . . . . . . . . . . . . . 13.1 tp -107.29 135.77 48.25 Favored 'General case' 0 C--N 1.332 -0.165 0 N-CA-C 109.877 -0.416 . . . . 0.0 109.877 178.914 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' D' D ' 130' ' ' VAL . . . . . . . . . . . . . 44.3 t -123.79 136.16 61.12 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.239 0 CA-C-O 120.869 0.366 . . . . 0.0 110.023 -178.127 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' D' D ' 131' ' ' VAL . . . . . . . . . . . . . 43.4 t -133.87 133.71 56.35 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.258 0 CA-C-O 121.027 0.441 . . . . 0.0 110.059 177.561 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' D' D ' 132' ' ' ILE . . . . . . . . . . . . . 71.6 mt -118.01 131.51 70.55 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.335 0 CA-C-N 115.724 -0.671 . . . . 0.0 109.604 -179.273 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' D' D ' 133' ' ' ILE . . . . . . . . . . . . . 36.8 mm -116.19 124.33 72.35 Favored 'Isoleucine or valine' 0 C--O 1.233 0.197 0 CA-C-O 120.804 0.335 . . . . 0.0 111.106 -175.062 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' D' D ' 134' ' ' ASP . . . . . . . . . . . . . 11.6 p-10 -135.22 151.33 50.52 Favored 'General case' 0 C--N 1.332 -0.18 0 CA-C-N 116.104 -0.498 . . . . 0.0 109.916 174.603 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' D' D ' 135' ' ' GLU . . . . . . . . . . . . . 84.6 tt0 -49.95 -26.24 4.01 Favored 'General case' 0 C--O 1.236 0.354 0 N-CA-C 113.571 0.952 . . . . 0.0 113.571 -168.493 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' D' D ' 136' ' ' GLN . . . . . . . . . . . . . 14.3 pt20 -100.15 -19.55 16.39 Favored 'General case' 0 N--CA 1.466 0.352 0 N-CA-C 113.314 0.857 . . . . 0.0 113.314 -172.491 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' D' D ' 137' ' ' LYS . . . . . . . . . . . . . 56.8 pttt -165.88 170.54 13.69 Favored 'General case' 0 C--O 1.232 0.139 0 CA-C-O 121.645 0.736 . . . . 0.0 112.344 -176.693 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' D' D ' 138' ' ' LEU . . . . . . . . . . . . . 7.2 tt -121.23 127.67 51.67 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 114.919 -1.037 . . . . 0.0 109.827 178.938 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' D' D ' 139' ' ' THR . . . . . . . . . . . . . 42.1 m -106.18 126.71 52.55 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.089 -0.505 . . . . 0.0 110.331 179.895 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' D' D ' 140' ' ' LEU . . . . . 0.464 ' C ' HD23 ' D' ' 140' ' ' LEU . 5.7 tt -110.74 122.49 47.94 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 115.748 -0.66 . . . . 0.0 109.27 -179.203 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' D' D ' 141' ' ' ILE . . . . . 0.438 ' N ' HD23 ' D' ' 140' ' ' LEU . 19.1 mt -122.21 116.16 48.32 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.294 0 N-CA-C 109.867 -0.42 . . . . 0.0 109.867 -175.176 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' D' D ' 142' ' ' ARG . . . . . . . . . . . . . 58.9 ttp180 -108.75 129.29 55.37 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 115.64 -0.709 . . . . 0.0 110.507 -178.784 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' D' D ' 143' ' ' THR . . . . . . . . . . . . . 70.2 p . . . . . 0 C--O 1.22 -0.475 0 CA-C-O 118.223 -0.894 . . . . 0.0 110.894 179.695 . . . . . . . . 0 0 . 1 . 019 nuclear nobuild core ' E' E ' 2' ' ' SER . . . . . . . . . . . . . 2.1 p . . . . . 0 C--O 1.231 0.08 0 N-CA-C 110.026 -0.361 . . . . 0.0 110.026 . . . . . . . . . 0 0 . 1 . 019 nuclear nobuild core ' E' E ' 3' ' ' GLU . . . . . . . . . . . . . 89.2 mt-10 -139.29 140.75 37.71 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.016 -0.538 . . . . 0.0 111.103 -175.374 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' E' E ' 4' ' ' LEU . . . . . . . . . . . . . 16.0 tp -122.89 124.93 44.35 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 115.785 -0.643 . . . . 0.0 109.506 173.979 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' E' E ' 5' ' ' LYS . . . . . . . . . . . . . 60.7 mttp -108.83 120.26 41.98 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 116.397 -0.365 . . . . 0.0 110.573 -179.265 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' E' E ' 6' ' ' LEU . . . . . . . . . . . . . 54.1 mt -113.91 143.43 44.71 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 115.402 -0.817 . . . . 0.0 110.041 -178.796 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' E' E ' 7' ' ' LYS . . . . . . . . . . . . . 78.4 tttt -122.71 135.77 26.04 Favored Pre-proline 0 CA--C 1.535 0.388 0 CA-C-O 118.84 -0.6 . . . . 0.0 109.542 176.087 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' E' E ' 8' ' ' PRO . . . . . . . . . . . . . 72.4 Cg_endo -88.9 131.54 2.27 Favored 'Trans proline' 0 N--CA 1.49 1.309 0 C-N-CA 121.566 1.511 . . . . 0.0 111.814 178.938 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' E' E ' 9' ' ' LEU . . . . . . . . . . . . . 73.9 mt -70.36 -51.22 13.55 Favored Pre-proline 0 C--N 1.329 -0.313 0 CA-C-O 118.694 -0.67 . . . . 0.0 111.817 -178.703 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' E' E ' 10' ' ' PRO . . . . . . . . . . . . . 70.3 Cg_endo -74.66 151.24 41.08 Favored 'Trans proline' 0 N--CA 1.497 1.713 0 C-N-CA 121.076 1.184 . . . . 0.0 111.891 175.226 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' E' E ' 11' ' ' LYS . . . . . . . . . . . . . 70.6 mmtt -83.92 89.11 7.16 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-O 120.879 0.371 . . . . 0.0 110.42 178.511 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' E' E ' 12' ' ' VAL . . . . . . . . . . . . . 12.2 p -140.06 144.81 27.32 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.276 0 CA-C-N 116.024 -0.535 . . . . 0.0 110.359 179.877 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' E' E ' 13' ' ' GLU . . . . . . . . . . . . . 84.9 tt0 -91.79 130.62 37.53 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.275 -0.42 . . . . 0.0 110.241 178.626 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' E' E ' 14' ' ' LEU . . . . . . . . . . . . . 19.9 mt -97.65 152.98 38.45 Favored Pre-proline 0 C--N 1.33 -0.251 0 CA-C-N 116.258 -0.428 . . . . 0.0 110.796 -177.509 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' E' E ' 15' ' ' PRO . . . . . . . . . . . . . 27.9 Cg_exo -60.81 159.28 29.51 Favored 'Trans proline' 0 N--CA 1.497 1.692 0 C-N-CA 121.334 1.356 . . . . 0.0 111.795 176.833 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' E' E ' 16' ' ' PRO . . . . . . . . . . . . . 38.6 Cg_exo -58.48 -37.04 96.58 Favored 'Trans proline' 0 N--CA 1.497 1.727 0 C-N-CA 121.362 1.374 . . . . 0.0 112.704 -178.211 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' E' E ' 17' ' ' ASP . . . . . . . . . . . . . 10.5 p-10 -94.47 15.43 17.83 Favored 'General case' 0 C--N 1.328 -0.345 0 N-CA-C 113.063 0.764 . . . . 0.0 113.063 -177.088 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' E' E ' 18' ' ' PHE . . . . . . . . . . . . . 51.9 t80 -58.03 -44.34 87.28 Favored 'General case' 0 N--CA 1.46 0.06 0 O-C-N 122.0 -0.437 . . . . 0.0 110.085 -178.788 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' E' E ' 19' ' ' VAL . . . . . . . . . . . . . 47.4 t -56.61 -40.83 71.52 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.344 0 CA-C-N 116.255 -0.43 . . . . 0.0 110.35 -179.764 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' E' E ' 20' ' ' ASP . . . . . . . . . . . . . 70.1 m-20 -60.07 -42.69 95.09 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-O 120.801 0.334 . . . . 0.0 110.85 -178.274 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' E' E ' 21' ' ' VAL . . . . . . . . . . . . . 47.5 t -65.38 -52.02 57.0 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.278 0 C-N-CA 120.828 -0.349 . . . . 0.0 110.613 -178.334 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' E' E ' 22' ' ' ILE . . . . . . . . . . . . . 48.7 mm -54.32 -54.57 20.49 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.231 0 CA-C-O 120.743 0.306 . . . . 0.0 111.24 -177.493 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' E' E ' 23' ' ' ARG . . . . . . . . . . . . . 14.4 ptm180 -61.34 -45.29 95.04 Favored 'General case' 0 CA--C 1.532 0.275 0 N-CA-C 112.166 0.432 . . . . 0.0 112.166 -173.656 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' E' E ' 24' ' ' ILE . . . . . . . . . . . . . 73.0 mt -61.85 -38.53 80.78 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.209 0 O-C-N 122.138 -0.352 . . . . 0.0 111.224 -175.474 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' E' E ' 25' ' ' LYS . . . . . . . . . . . . . 66.6 mttm -72.33 -43.81 63.56 Favored 'General case' 0 C--N 1.331 -0.237 0 N-CA-C 112.077 0.399 . . . . 0.0 112.077 -178.971 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' E' E ' 26' ' ' LEU . . . . . . . . . . . . . 56.4 mt -87.03 -8.19 57.38 Favored 'General case' 0 CA--C 1.533 0.303 0 N-CA-C 113.835 1.05 . . . . 0.0 113.835 -173.627 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' E' E ' 27' ' ' GLN . . . . . . . . . . . . . 3.4 pt20 -46.59 143.13 2.82 Favored 'General case' 0 N--CA 1.467 0.412 0 O-C-N 121.592 -0.692 . . . . 0.0 112.451 -179.706 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' E' E ' 28' ' ' GLY . . . . . . . . . . . . . . . 100.07 -22.49 39.92 Favored Glycine 0 CA--C 1.533 1.212 0 CA-C-N 115.885 -0.598 . . . . 0.0 112.467 -177.953 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' E' E ' 29' ' ' LYS . . . . . . . . . . . . . 34.8 mmtp -89.6 154.98 19.55 Favored 'General case' 0 C--O 1.233 0.186 0 CA-C-N 117.599 0.699 . . . . 0.0 110.632 177.994 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' E' E ' 30' ' ' THR . . . . . . . . . . . . . 9.1 m -107.95 139.77 42.07 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.093 -0.503 . . . . 0.0 110.17 178.269 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' E' E ' 31' ' ' VAL . . . . . . . . . . . . . 35.0 m -127.91 152.87 36.55 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.263 0 CA-C-O 120.929 0.395 . . . . 0.0 110.755 -178.963 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' E' E ' 32' ' ' ARG . . . . . . . . . . . . . 83.5 mtt180 -131.68 150.31 52.19 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.025 -0.534 . . . . 0.0 110.366 177.565 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' E' E ' 33' ' ' THR . . . . . . . . . . . . . 22.0 m -52.8 138.64 28.88 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.366 -0.379 . . . . 0.0 111.457 -178.383 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' E' E ' 34' ' ' GLY . . . . . . . . . . . . . . . 100.16 -17.13 57.47 Favored Glycine 0 CA--C 1.532 1.101 0 CA-C-N 116.18 -0.464 . . . . 0.0 113.28 179.485 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' E' E ' 35' ' ' ASP . . . . . . . . . . . . . 77.0 m-20 -67.97 149.51 49.65 Favored 'General case' 0 N--CA 1.462 0.125 0 CA-C-N 117.989 0.894 . . . . 0.0 111.183 178.683 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' E' E ' 36' ' ' VAL . . . . . . . . . . . . . 44.6 t -120.95 128.81 76.13 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.219 0 CA-C-N 116.063 -0.517 . . . . 0.0 109.688 176.775 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' E' E ' 37' ' ' ILE . . . . . . . . . . . . . 62.9 mt -119.08 138.4 49.93 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 CA-C-N 116.089 -0.505 . . . . 0.0 109.923 -178.539 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' E' E ' 38' ' ' GLY . . . . . . . . . . . . . . . -116.42 128.14 7.81 Favored Glycine 0 CA--C 1.526 0.757 0 N-CA-C 110.937 -0.865 . . . . 0.0 110.937 179.285 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' E' E ' 39' ' ' ILE . . . . . . . . . . . . . 73.5 mt -128.82 131.07 68.7 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.216 0 N-CA-C 110.066 -0.346 . . . . 0.0 110.066 178.893 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' E' E ' 40' ' ' SER . . . . . . . . . . . . . 46.8 t -91.79 113.94 26.34 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.392 -0.367 . . . . 0.0 110.965 177.908 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' E' E ' 41' ' ' ILE . . . . . . . . . . . . . 45.9 mm -123.24 123.45 67.76 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.22 0 N-CA-C 109.835 -0.431 . . . . 0.0 109.835 179.467 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' E' E ' 42' ' ' LEU . . . . . . . . . . . . . 68.7 mt 57.85 34.85 24.84 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.307 -0.406 . . . . 0.0 111.683 177.94 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' E' E ' 43' ' ' GLY . . . . . . . . . . . . . . . 78.94 -10.22 34.22 Favored Glycine 0 CA--C 1.534 1.219 0 C-N-CA 121.248 -0.501 . . . . 0.0 113.43 177.094 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' E' E ' 44' ' ' LYS . . . . . . . . . . . . . 30.4 ttmt -102.83 129.36 49.48 Favored 'General case' 0 N--CA 1.461 0.078 0 CA-C-N 117.982 0.891 . . . . 0.0 110.157 177.103 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' E' E ' 45' ' ' GLU . . . . . . . . . . . . . 39.9 tp10 -84.18 127.54 34.0 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 116.283 -0.417 . . . . 0.0 110.93 -179.662 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' E' E ' 46' ' ' VAL . . . . . . . . . . . . . 9.2 p -119.27 125.9 74.86 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.22 0 N-CA-C 109.675 -0.491 . . . . 0.0 109.675 176.468 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' E' E ' 47' ' ' LYS . . . . . . . . . . . . . 62.8 mttp -99.23 126.81 45.12 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.023 -0.535 . . . . 0.0 110.889 177.266 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' E' E ' 48' ' ' PHE . . . . . . . . . . . . . 41.1 m-85 -110.55 131.87 54.68 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.035 -0.529 . . . . 0.0 109.805 177.138 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' E' E ' 49' ' ' LYS . . . . . . . . . . . . . 78.9 tttt -105.95 132.24 52.29 Favored 'General case' 0 C--N 1.328 -0.351 0 N-CA-C 110.074 -0.343 . . . . 0.0 110.074 177.887 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' E' E ' 50' ' ' VAL . . . . . . . . . . . . . 46.6 t -77.1 107.55 8.68 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.331 0 N-CA-C 109.449 -0.574 . . . . 0.0 109.449 178.023 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' E' E ' 51' ' ' VAL . . . . . . . . . . . . . 46.6 t -71.55 -52.71 24.22 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.339 0 N-CA-C 109.545 -0.539 . . . . 0.0 109.545 -175.943 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' E' E ' 52' ' ' GLN . . . . . . . . . . . . . 83.3 mt-30 -154.74 152.5 29.96 Favored 'General case' 0 C--N 1.331 -0.207 0 CA-C-O 121.252 0.549 . . . . 0.0 111.66 -178.105 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' E' E ' 53' ' ' ALA . . . . . . . . . . . . . . . -130.2 131.96 45.8 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 115.313 -0.858 . . . . 0.0 109.545 174.141 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' E' E ' 54' ' ' TYR . . . . . . . . . . . . . 59.8 t80 -129.04 110.29 18.28 Favored Pre-proline 0 CA--C 1.535 0.374 0 CA-C-O 118.205 -0.902 . . . . 0.0 110.32 179.457 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' E' E ' 55' ' ' PRO . . . . . . . . . . . . . 73.9 Cg_endo -77.16 169.82 73.18 Favored 'Cis proline' 0 N--CA 1.5 1.865 0 CA-C-N 121.987 1.745 . . . . 0.0 112.153 -5.638 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' E' E ' 56' ' ' SER . . . . . . . . . . . . . 13.7 m -115.89 132.44 23.2 Favored Pre-proline 0 CA--C 1.538 0.488 0 CA-C-O 118.458 -0.782 . . . . 0.0 109.155 175.416 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' E' E ' 57' ' ' PRO . . . . . . . . . . . . . 50.9 Cg_endo -69.75 164.12 80.01 Favored 'Cis proline' 0 N--CA 1.498 1.753 0 CA-C-N 121.928 1.724 . . . . 0.0 111.684 0.166 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' E' E ' 58' ' ' LEU . . . . . . . . . . . . . 36.8 tp -129.82 139.4 51.24 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.079 179.821 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' E' E ' 59' ' ' ARG . . . . . . . . . . . . . 26.6 ttm180 -103.83 139.11 39.47 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.246 -0.434 . . . . 0.0 110.05 178.983 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' E' E ' 60' ' ' VAL . . . . . . . . . . . . . 42.9 t -86.64 111.22 21.18 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.196 0 CA-C-O 120.84 0.352 . . . . 0.0 110.34 -177.991 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' E' E ' 61' ' ' GLU . . . . . . . . . . . . . 81.3 tt0 -131.17 154.44 48.37 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 115.845 -0.616 . . . . 0.0 109.58 177.407 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' E' E ' 62' ' ' ASP . . . . . . . . . . . . . 9.4 p-10 -52.82 -23.74 7.55 Favored 'General case' 0 C--N 1.326 -0.433 0 N-CA-C 112.467 0.543 . . . . 0.0 112.467 -179.579 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' E' E ' 63' ' ' ARG . . . . . . . . . . . . . 23.8 mmm180 -84.72 -14.22 49.03 Favored 'General case' 0 CA--C 1.534 0.349 0 N-CA-C 113.443 0.905 . . . . 0.0 113.443 -177.066 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' E' E ' 64' ' ' THR . . . . . . . . . . . . . 14.0 m -76.58 151.84 36.15 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-O 120.937 0.399 . . . . 0.0 111.05 -176.066 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' E' E ' 65' ' ' LYS . . . . . . . . . . . . . 45.7 mtpt -90.49 118.7 30.16 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.134 179.063 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' E' E ' 66' ' ' ILE . . . . . . . . . . . . . 72.0 mt -117.62 124.67 73.37 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.219 0 N-CA-C 109.741 -0.466 . . . . 0.0 109.741 -178.344 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' E' E ' 67' ' ' THR . . . . . . . . . . . . . 27.4 m -132.1 151.06 51.98 Favored 'General case' 0 C--N 1.332 -0.182 0 CA-C-O 121.269 0.557 . . . . 0.0 111.876 -173.437 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' E' E ' 68' ' ' LEU . . . . . . . . . . . . . 78.9 mt . . . . . 0 C--N 1.331 -0.237 0 CA-C-N 115.548 -0.751 . . . . 0.0 110.126 175.474 . . . . . . . . 0 0 . 1 . 019 nuclear nobuild core ' E' E ' 73' ' ' VAL . . . . . . . . . . . . . 31.5 m . . . . . 0 C--O 1.233 0.213 0 CA-C-O 121.174 0.511 . . . . 0.0 111.097 . . . . . . . . . 0 0 . 1 . 019 nuclear nobuild core ' E' E ' 74' ' ' ASP . . . . . . . . . . . . . 16.6 t0 -106.94 122.55 46.64 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 115.496 -0.775 . . . . 0.0 109.232 174.273 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' E' E ' 75' ' ' VAL . . . . . 0.492 ' C ' HD12 ' E' ' 76' ' ' LEU . 41.2 t -117.83 125.68 74.31 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.294 0 CA-C-O 121.112 0.482 . . . . 0.0 110.809 -176.916 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' E' E ' 76' ' ' LEU . . . . . 0.492 HD12 ' C ' ' E' ' 75' ' ' VAL . 6.1 mp -127.37 151.11 49.21 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-N 115.566 -0.743 . . . . 0.0 109.62 176.437 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' E' E ' 77' ' ' GLU . . . . . . . . . . . . . 97.0 mt-10 -136.48 136.03 39.1 Favored 'General case' 0 C--N 1.332 -0.171 0 CA-C-O 121.068 0.461 . . . . 0.0 111.26 -177.4 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' E' E ' 78' ' ' ALA . . . . . . . . . . . . . . . -121.05 138.85 53.98 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-N 115.737 -0.665 . . . . 0.0 109.819 176.838 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' E' E ' 79' ' ' LYS . . . . . 0.576 ' O ' HD13 ' E' ' 80' ' ' ILE . 99.7 mttt -83.59 118.85 24.09 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-O 120.951 0.405 . . . . 0.0 111.0 -176.982 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' E' E ' 80' ' ' ILE . . . . . 0.576 HD13 ' O ' ' E' ' 79' ' ' LYS . 42.0 mm -139.25 115.43 9.5 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.2 0 N-CA-C 109.346 -0.613 . . . . 0.0 109.346 -178.229 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' E' E ' 81' ' ' LYS . . . . . . . . . . . . . 64.7 mttm -109.44 125.51 52.51 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-O 120.854 0.359 . . . . 0.0 111.09 -177.705 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' E' E ' 82' ' ' GLY . . . . . . . . . . . . . . . 89.09 42.12 5.69 Favored Glycine 0 CA--C 1.523 0.582 0 C-N-CA 120.774 -0.727 . . . . 0.0 111.419 175.994 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' E' E ' 83' ' ' ILE . . . . . . . . . . . . . 72.9 mt -66.06 133.31 31.14 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.297 0 CA-C-O 120.942 0.401 . . . . 0.0 110.01 178.181 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' E' E ' 84' ' ' LYS . . . . . . . . . . . . . 85.9 tttt -91.67 -53.14 4.42 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-N 115.936 -0.574 . . . . 0.0 109.97 -179.633 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' E' E ' 85' ' ' ASP . . . . . . . . . . . . . 13.3 t70 -156.24 151.02 26.03 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 115.553 -0.749 . . . . 0.0 110.059 179.402 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' E' E ' 86' ' ' VAL . . . . . . . . . . . . . 43.3 t -125.87 129.63 72.44 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.287 0 CA-C-O 120.937 0.399 . . . . 0.0 110.439 -178.986 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' E' E ' 87' ' ' ILE . . . . . . . . . . . . . 44.5 mm -118.28 126.15 74.82 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.208 0 CA-C-N 115.979 -0.555 . . . . 0.0 109.714 177.008 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' E' E ' 88' ' ' LEU . . . . . . . . . . . . . 14.2 tp -108.8 131.08 55.32 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-O 120.972 0.415 . . . . 0.0 111.004 -177.591 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' E' E ' 89' ' ' ASP . . . . . . . . . . . . . 7.7 t70 -119.61 154.07 34.52 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 115.787 -0.642 . . . . 0.0 109.5 176.781 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' E' E ' 90' ' ' GLU . . . . . . . . . . . . . 82.4 tt0 -46.28 -43.57 15.8 Favored 'General case' 0 N--CA 1.464 0.263 0 N-CA-C 112.871 0.693 . . . . 0.0 112.871 -173.106 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' E' E ' 91' ' ' ASN . . . . . . . . . . . . . 16.0 t-20 -132.15 39.11 3.44 Favored 'General case' 0 C--N 1.331 -0.217 0 CA-C-O 120.907 0.384 . . . . 0.0 111.195 -178.815 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' E' E ' 92' ' ' LEU . . . . . . . . . . . . . 10.5 tp -166.08 147.26 6.72 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 116.526 -0.307 . . . . 0.0 110.386 -178.708 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' E' E ' 93' ' ' ILE . . . . . . . . . . . . . 65.8 mt -128.78 123.49 59.31 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.214 0 N-CA-C 109.483 -0.562 . . . . 0.0 109.483 -178.972 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' E' E ' 94' ' ' VAL . . . . . 0.647 HG21 HG11 ' E' ' 125' ' ' VAL . 44.1 t -124.24 129.36 74.07 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.216 0 CA-C-O 121.021 0.438 . . . . 0.0 110.035 -179.841 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' E' E ' 95' ' ' VAL . . . . . . . . . . . . . 42.5 t -122.04 135.83 60.89 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.328 0 CA-C-N 115.881 -0.599 . . . . 0.0 109.926 -178.906 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' E' E ' 96' ' ' ILE . . . . . . . . . . . . . 62.0 mt -111.92 126.7 69.33 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.355 0 N-CA-C 109.215 -0.661 . . . . 0.0 109.215 178.068 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' E' E ' 97' ' ' THR . . . . . . . . . . . . . 68.3 p -97.16 155.91 16.63 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-O 121.168 0.509 . . . . 0.0 111.134 -178.176 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' E' E ' 98' ' ' GLU . . . . . . . . . . . . . 82.6 tt0 -53.86 -25.88 21.89 Favored 'General case' 0 C--N 1.327 -0.372 0 N-CA-C 112.304 0.483 . . . . 0.0 112.304 -178.941 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' E' E ' 99' ' ' GLU . . . . . . . . . . . . . 71.2 mm-40 -81.56 16.16 1.83 Allowed 'General case' 0 CA--C 1.536 0.413 0 N-CA-C 113.137 0.791 . . . . 0.0 113.137 -176.74 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' E' E ' 100' ' ' ASN . . . . . . . . . . . . . 3.5 m-20 62.89 34.33 14.37 Favored 'General case' 0 CA--C 1.531 0.227 0 CA-C-O 120.909 0.385 . . . . 0.0 111.519 178.644 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' E' E ' 101' ' ' GLU . . . . . . . . . . . . . 84.6 tt0 -112.65 143.63 43.52 Favored 'General case' 0 C--N 1.334 -0.093 0 N-CA-C 109.69 -0.485 . . . . 0.0 109.69 173.422 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' E' E ' 102' ' ' VAL . . . . . . . . . . . . . 45.6 t -115.21 129.43 71.47 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.322 0 CA-C-N 116.49 -0.323 . . . . 0.0 110.297 -177.414 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' E' E ' 103' ' ' LEU . . . . . . . . . . . . . 51.1 mt -117.85 130.75 56.45 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-N 115.7 -0.682 . . . . 0.0 110.415 177.31 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' E' E ' 104' ' ' ILE . . . . . . . . . . . . . 70.7 mt -117.45 122.86 70.88 Favored 'Isoleucine or valine' 0 C--O 1.233 0.226 0 N-CA-C 110.154 -0.313 . . . . 0.0 110.154 178.373 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' E' E ' 105' ' ' PHE . . . . . . . . . . . . . 74.3 m-85 -123.6 164.36 19.19 Favored 'General case' 0 C--O 1.232 0.132 0 O-C-N 123.905 0.753 . . . . 0.0 109.876 -179.781 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' E' E ' 106' ' ' ASN . . . . . 0.415 ' HB3' HD11 ' E' ' 112' ' ' LEU . 43.5 p-10 -99.07 -170.02 1.86 Allowed 'General case' 0 C--N 1.33 -0.254 0 N-CA-C 109.738 -0.467 . . . . 0.0 109.738 172.381 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' E' E ' 107' ' ' GLN . . . . . . . . . . . . . 48.8 tt0 -57.91 -29.8 65.4 Favored 'General case' 0 C--N 1.329 -0.298 0 N-CA-C 112.025 0.38 . . . . 0.0 112.025 179.982 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' E' E ' 108' ' ' ASN . . . . . . . . . . . . . 22.5 t30 -88.69 13.14 12.99 Favored 'General case' 0 CA--C 1.535 0.388 0 N-CA-C 113.094 0.776 . . . . 0.0 113.094 -176.024 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' E' E ' 109' ' ' LEU . . . . . . . . . . . . . 38.4 mt 57.43 36.18 26.77 Favored 'General case' 0 C--N 1.333 -0.149 0 CA-C-O 120.941 0.4 . . . . 0.0 111.566 177.811 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' E' E ' 110' ' ' GLU . . . . . . . . . . . . . 95.6 mt-10 -100.56 155.26 17.95 Favored 'General case' 0 C--N 1.33 -0.258 0 N-CA-C 109.72 -0.474 . . . . 0.0 109.72 176.191 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' E' E ' 111' ' ' GLU . . . . . . . . . . . . . 84.4 tt0 -82.26 121.91 27.25 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-O 120.883 0.373 . . . . 0.0 110.92 -177.707 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' E' E ' 112' ' ' LEU . . . . . 0.415 HD11 ' HB3' ' E' ' 106' ' ' ASN . 75.2 mt -107.9 -45.99 3.87 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.017 -0.538 . . . . 0.0 110.047 176.416 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' E' E ' 113' ' ' TYR . . . . . . . . . . . . . 63.3 t80 -143.28 135.76 27.32 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.153 -0.476 . . . . 0.0 111.52 -179.395 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' E' E ' 114' ' ' ARG . . . . . . . . . . . . . 21.4 ttm180 -131.13 123.88 29.52 Favored 'General case' 0 C--N 1.331 -0.201 0 CA-C-N 115.775 -0.648 . . . . 0.0 109.623 173.529 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' E' E ' 115' ' ' GLY . . . . . . . . . . . . . . . -150.0 156.41 26.73 Favored Glycine 0 CA--C 1.523 0.539 0 N-CA-C 110.85 -0.9 . . . . 0.0 110.85 178.531 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' E' E ' 116' ' ' LYS . . . . . . . . . . . . . 55.6 tttt -132.68 140.31 48.08 Favored 'General case' 0 C--N 1.329 -0.309 0 O-C-N 122.646 -0.326 . . . . 0.0 110.16 179.245 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' E' E ' 117' ' ' PHE . . . . . . . . . . . . . 18.2 m-85 -139.63 113.82 8.95 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-O 120.887 0.375 . . . . 0.0 110.091 -176.194 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' E' E ' 118' ' ' GLU . . . . . . . . . . . . . 83.2 tt0 -53.3 -47.43 69.22 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.453 -0.339 . . . . 0.0 111.573 -175.84 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' E' E ' 119' ' ' ASN . . . . . . . . . . . . . 74.4 m-20 -95.15 31.12 1.98 Allowed 'General case' 0 C--N 1.332 -0.196 0 N-CA-C 112.265 0.468 . . . . 0.0 112.265 -174.45 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' E' E ' 120' ' ' LEU . . . . . . . . . . . . . 22.1 tp -55.85 122.95 12.66 Favored 'General case' 0 C--N 1.333 -0.136 0 CA-C-O 120.724 0.297 . . . . 0.0 110.52 177.146 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' E' E ' 121' ' ' ASN . . . . . . . . . . . . . 62.7 t30 -112.2 -44.08 3.46 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-N 116.362 -0.381 . . . . 0.0 110.718 -177.977 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' E' E ' 122' ' ' LYS . . . . . . . . . . . . . 98.0 mttt -143.45 144.76 32.15 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-O 120.96 0.409 . . . . 0.0 111.661 -177.476 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' E' E ' 123' ' ' VAL . . . . . . . . . . . . . 46.7 t -123.61 122.37 64.77 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.284 0 N-CA-C 109.136 -0.69 . . . . 0.0 109.136 173.826 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' E' E ' 124' ' ' LEU . . . . . 0.512 HD12 ' N ' ' E' ' 124' ' ' LEU . 5.6 mp -120.59 132.3 55.08 Favored 'General case' 0 C--N 1.331 -0.203 0 CA-C-N 116.483 -0.326 . . . . 0.0 110.389 -177.155 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' E' E ' 125' ' ' VAL . . . . . 0.647 HG11 HG21 ' E' ' 94' ' ' VAL . 35.1 m -135.56 138.74 47.7 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.314 0 CA-C-N 116.379 -0.373 . . . . 0.0 110.736 179.279 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' E' E ' 126' ' ' ARG . . . . . . . . . . . . . 32.8 ptt-85 -150.19 125.23 9.95 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 116.088 -0.506 . . . . 0.0 110.178 177.926 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' E' E ' 127' ' ' ASN . . . . . . . . . . . . . 85.5 m-20 55.07 -123.38 2.03 Favored 'General case' 0 CA--C 1.546 0.804 0 CA-C-O 118.529 -0.748 . . . . 0.0 110.209 -178.191 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' E' E ' 128' ' ' ASP . . . . . . . . . . . . . 23.3 p-10 -106.07 12.29 30.51 Favored 'General case' 0 CA--C 1.536 0.431 0 CA-C-N 120.235 1.379 . . . . 0.0 113.088 179.349 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' E' E ' 129' ' ' LEU . . . . . 0.442 HD23 ' N ' ' E' ' 130' ' ' VAL . 5.0 tt -106.14 132.63 51.98 Favored 'General case' 0 C--O 1.231 0.121 0 N-CA-C 109.653 -0.499 . . . . 0.0 109.653 179.079 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' E' E ' 130' ' ' VAL . . . . . 0.478 HG13 HG12 ' E' ' 125' ' ' VAL . 46.4 t -122.05 136.32 59.3 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.248 0 CA-C-O 120.894 0.378 . . . . 0.0 110.185 -177.926 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' E' E ' 131' ' ' VAL . . . . . 0.515 HG22 HD12 ' E' ' 140' ' ' LEU . 42.1 t -135.11 135.5 52.46 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.19 0 CA-C-O 121.128 0.49 . . . . 0.0 110.076 177.668 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' E' E ' 132' ' ' ILE . . . . . . . . . . . . . 74.7 mt -118.1 132.34 68.21 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.338 0 CA-C-N 115.746 -0.661 . . . . 0.0 109.532 -178.86 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' E' E ' 133' ' ' ILE . . . . . . . . . . . . . 37.5 mm -116.88 121.9 68.78 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.205 0 CA-C-O 120.78 0.324 . . . . 0.0 111.075 -174.694 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' E' E ' 134' ' ' ASP . . . . . . . . . . . . . 10.2 p-10 -135.23 149.84 49.96 Favored 'General case' 0 C--N 1.331 -0.221 0 CA-C-N 116.03 -0.532 . . . . 0.0 109.767 175.225 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' E' E ' 135' ' ' GLU . . . . . . . . . . . . . 85.1 tt0 -49.92 -26.67 4.36 Favored 'General case' 0 C--N 1.329 -0.318 0 N-CA-C 113.019 0.748 . . . . 0.0 113.019 -172.159 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' E' E ' 136' ' ' GLN . . . . . . . . . . . . . 99.7 mm-40 -85.55 -32.11 22.33 Favored 'General case' 0 C--O 1.235 0.299 0 N-CA-C 112.401 0.519 . . . . 0.0 112.401 -174.935 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' E' E ' 137' ' ' LYS . . . . . . . . . . . . . 55.7 pttt -168.54 174.07 7.04 Favored 'General case' 0 C--N 1.332 -0.186 0 CA-C-O 121.5 0.667 . . . . 0.0 112.257 -171.008 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' E' E ' 138' ' ' LEU . . . . . 0.438 ' C ' HD23 ' E' ' 138' ' ' LEU . 8.7 tt -121.88 130.1 53.09 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 115.032 -0.985 . . . . 0.0 110.264 179.8 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' E' E ' 139' ' ' THR . . . . . . . . . . . . . 38.0 m -108.3 130.27 55.19 Favored 'General case' 0 C--N 1.331 -0.23 0 CA-C-N 116.163 -0.471 . . . . 0.0 110.653 -179.546 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' E' E ' 140' ' ' LEU . . . . . 0.515 HD12 HG22 ' E' ' 131' ' ' VAL . 12.3 tp -116.34 121.8 43.02 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 115.724 -0.671 . . . . 0.0 109.332 -179.271 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' E' E ' 141' ' ' ILE . . . . . . . . . . . . . 18.9 mt -120.57 121.65 65.98 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.288 0 CA-C-O 120.976 0.417 . . . . 0.0 110.296 -175.152 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' E' E ' 142' ' ' ARG . . . . . . . . . . . . . 66.4 mtp180 -108.93 130.86 55.46 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 115.264 -0.88 . . . . 0.0 110.438 179.906 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' E' E ' 143' ' ' THR . . . . . . . . . . . . . 19.1 p . . . . . 0 C--O 1.221 -0.417 0 CA-C-O 117.988 -1.006 . . . . 0.0 110.492 178.782 . . . . . . . . 0 0 . 1 . 019 nuclear nobuild core ' F' F ' 1' ' ' MET . . . . . . . . . . . . . 16.0 ptm . . . . . 0 CA--C 1.528 0.128 0 CA-C-O 120.679 0.276 . . . . 0.0 110.594 . . . . . . . . . 0 0 . 1 . 019 nuclear nobuild core ' F' F ' 2' ' ' SER . . . . . . . . . . . . . 11.7 p -118.77 132.77 56.15 Favored 'General case' 0 C--N 1.332 -0.182 0 CA-C-O 121.006 0.431 . . . . 0.0 110.824 -179.335 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' F' F ' 3' ' ' GLU . . . . . . . . . . . . . 95.6 mt-10 -141.3 141.08 33.94 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 115.779 -0.646 . . . . 0.0 110.823 -179.284 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' F' F ' 4' ' ' LEU . . . . . . . . . . . . . 12.5 tp -129.38 131.05 46.74 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.235 -0.439 . . . . 0.0 110.267 177.115 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' F' F ' 5' ' ' LYS . . . . . . . . . . . . . 98.7 mttt -113.77 121.62 44.62 Favored 'General case' 0 C--O 1.234 0.247 0 CA-C-N 116.505 -0.316 . . . . 0.0 110.825 -179.708 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' F' F ' 6' ' ' LEU . . . . . 0.442 HD23 ' HA ' ' F' ' 50' ' ' VAL . 66.7 mt -114.05 145.08 42.08 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-N 115.478 -0.783 . . . . 0.0 110.007 179.372 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' F' F ' 7' ' ' LYS . . . . . . . . . . . . . 27.2 ttpp -126.72 141.22 39.7 Favored Pre-proline 0 CA--C 1.534 0.329 0 CA-C-O 119.059 -0.496 . . . . 0.0 109.804 176.134 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' F' F ' 8' ' ' PRO . . . . . . . . . . . . . 97.8 Cg_endo -92.07 137.2 1.76 Allowed 'Trans proline' 0 N--CA 1.49 1.295 0 C-N-CA 121.799 1.666 . . . . 0.0 111.897 178.801 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' F' F ' 9' ' ' LEU . . . . . . . . . . . . . 63.0 mt -75.64 -46.93 4.15 Favored Pre-proline 0 CA--C 1.535 0.384 0 CA-C-O 118.764 -0.636 . . . . 0.0 112.076 179.255 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' F' F ' 10' ' ' PRO . . . . . . . . . . . . . 71.1 Cg_endo -83.44 158.29 14.64 Favored 'Trans proline' 0 N--CA 1.497 1.691 0 C-N-CA 121.294 1.329 . . . . 0.0 112.179 175.583 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' F' F ' 11' ' ' LYS . . . . . . . . . . . . . 37.0 mmtm -79.19 105.33 10.44 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.396 -0.365 . . . . 0.0 110.167 176.044 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' F' F ' 12' ' ' VAL . . . . . . . . . . . . . 12.7 p -145.58 141.18 22.22 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.312 0 CA-C-O 120.833 0.349 . . . . 0.0 110.863 -179.602 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' F' F ' 13' ' ' GLU . . . . . . . . . . . . . 15.2 mm-40 -95.45 124.82 39.67 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.202 -0.454 . . . . 0.0 109.874 175.378 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' F' F ' 14' ' ' LEU . . . . . . . . . . . . . 44.6 mt -96.79 151.49 37.88 Favored Pre-proline 0 C--N 1.328 -0.332 0 CA-C-N 116.411 -0.359 . . . . 0.0 110.497 -177.131 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' F' F ' 15' ' ' PRO . . . . . . . . . . . . . 35.4 Cg_exo -59.3 158.49 26.37 Favored 'Trans proline' 0 N--CA 1.497 1.716 0 C-N-CA 121.27 1.313 . . . . 0.0 111.795 178.715 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' F' F ' 16' ' ' PRO . . . . . . . . . . . . . 37.1 Cg_exo -59.03 -37.75 91.42 Favored 'Trans proline' 0 N--CA 1.497 1.677 0 C-N-CA 121.472 1.448 . . . . 0.0 112.516 -179.485 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' F' F ' 17' ' ' ASP . . . . . . . . . . . . . 18.2 p-10 -89.04 14.02 11.63 Favored 'General case' 0 CA--C 1.536 0.406 0 N-CA-C 112.984 0.735 . . . . 0.0 112.984 -178.77 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' F' F ' 18' ' ' PHE . . . . . 0.502 ' CZ ' HD11 ' F' ' 22' ' ' ILE . 53.0 t80 -58.4 -45.25 88.74 Favored 'General case' 0 N--CA 1.457 -0.082 0 O-C-N 121.975 -0.453 . . . . 0.0 110.122 -177.487 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' F' F ' 19' ' ' VAL . . . . . 0.402 HG13 ' N ' ' F' ' 20' ' ' ASP . 14.6 p -55.15 -41.39 59.89 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.243 0 CA-C-N 116.512 -0.313 . . . . 0.0 111.066 -177.96 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' F' F ' 20' ' ' ASP . . . . . 0.402 ' N ' HG13 ' F' ' 19' ' ' VAL . 68.5 m-20 -60.5 -44.47 95.95 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-O 120.83 0.348 . . . . 0.0 110.852 -179.19 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' F' F ' 21' ' ' VAL . . . . . . . . . . . . . 50.4 t -64.07 -48.37 86.2 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.308 0 CA-C-N 116.43 -0.35 . . . . 0.0 110.568 -177.478 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' F' F ' 22' ' ' ILE . . . . . 0.72 HG22 HD12 ' F' ' 26' ' ' LEU . 49.0 mm -58.01 -43.55 85.21 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.288 0 C-N-CA 120.926 -0.309 . . . . 0.0 110.754 -178.885 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' F' F ' 23' ' ' ARG . . . . . . . . . . . . . 55.7 ttp180 -55.92 -47.56 77.29 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-O 120.654 0.264 . . . . 0.0 110.832 -179.98 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' F' F ' 24' ' ' ILE . . . . . . . . . . . . . 69.0 mt -60.49 -41.03 86.17 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.29 0 CA-C-N 116.578 -0.283 . . . . 0.0 111.643 -178.473 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' F' F ' 25' ' ' LYS . . . . . 0.621 ' HE3' HD13 ' F' ' 22' ' ' ILE . 14.9 ptpt -74.13 -35.14 64.08 Favored 'General case' 0 CA--C 1.534 0.327 0 N-CA-C 112.317 0.488 . . . . 0.0 112.317 -175.063 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' F' F ' 26' ' ' LEU . . . . . 0.72 HD12 HG22 ' F' ' 22' ' ' ILE . 22.7 mt -80.66 -38.89 28.27 Favored 'General case' 0 C--N 1.327 -0.378 0 N-CA-C 113.31 0.855 . . . . 0.0 113.31 -173.662 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' F' F ' 27' ' ' GLN . . . . . . . . . . . . . 10.0 pt20 -46.47 141.23 3.74 Favored 'General case' 0 N--CA 1.47 0.528 0 N-CA-C 112.784 0.661 . . . . 0.0 112.784 -174.411 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' F' F ' 28' ' ' GLY . . . . . . . . . . . . . . . 101.14 -25.92 26.52 Favored Glycine 0 CA--C 1.532 1.122 0 CA-C-N 115.464 -0.789 . . . . 0.0 112.262 -176.477 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' F' F ' 29' ' ' LYS . . . . . . . . . . . . . 55.5 mtpt -98.04 155.04 17.31 Favored 'General case' 0 C--N 1.332 -0.161 0 CA-C-N 117.483 0.642 . . . . 0.0 111.183 178.827 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' F' F ' 30' ' ' THR . . . . . . . . . . . . . 29.9 m -103.63 138.97 39.56 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 115.988 -0.551 . . . . 0.0 109.964 176.127 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' F' F ' 31' ' ' VAL . . . . . . . . . . . . . 35.0 m -129.46 156.25 41.78 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.235 0 CA-C-N 116.382 -0.372 . . . . 0.0 110.972 -178.26 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' F' F ' 32' ' ' ARG . . . . . . . . . . . . . 93.6 mtm-85 -133.31 148.41 51.9 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 115.731 -0.668 . . . . 0.0 110.248 177.439 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' F' F ' 33' ' ' THR . . . . . . . . . . . . . 19.0 m -53.03 140.03 26.35 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.411 -0.359 . . . . 0.0 111.372 -178.442 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' F' F ' 34' ' ' GLY . . . . . . . . . . . . . . . 100.33 -17.14 57.3 Favored Glycine 0 CA--C 1.532 1.144 0 CA-C-O 119.609 -0.55 . . . . 0.0 113.251 179.765 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' F' F ' 35' ' ' ASP . . . . . . . . . . . . . 73.3 m-20 -65.66 149.28 50.36 Favored 'General case' 0 N--CA 1.462 0.151 0 CA-C-N 118.04 0.92 . . . . 0.0 111.094 179.435 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' F' F ' 36' ' ' VAL . . . . . . . . . . . . . 45.6 t -124.83 131.31 72.8 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.174 0 CA-C-N 115.963 -0.562 . . . . 0.0 109.801 178.335 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' F' F ' 37' ' ' ILE . . . . . . . . . . . . . 65.1 mt -122.09 140.0 47.35 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.224 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.027 -178.678 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' F' F ' 38' ' ' GLY . . . . . . . . . . . . . . . -113.76 128.63 8.39 Favored Glycine 0 CA--C 1.524 0.639 0 N-CA-C 110.888 -0.885 . . . . 0.0 110.888 178.329 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' F' F ' 39' ' ' ILE . . . . . . . . . . . . . 71.8 mt -127.52 133.97 66.64 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.197 0 N-CA-C 110.093 -0.336 . . . . 0.0 110.093 179.439 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' F' F ' 40' ' ' SER . . . . . . . . . . . . . 20.4 t -92.35 124.26 36.28 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.376 -0.375 . . . . 0.0 111.298 178.381 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' F' F ' 41' ' ' ILE . . . . . . . . . . . . . 68.9 mt -134.35 121.9 38.46 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.236 0 N-CA-C 110.058 -0.349 . . . . 0.0 110.058 176.436 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' F' F ' 42' ' ' LEU . . . . . . . . . . . . . 45.0 mt 58.84 35.13 24.11 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.087 -0.506 . . . . 0.0 111.694 177.942 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' F' F ' 43' ' ' GLY . . . . . . . . . . . . . . . 74.35 13.13 81.78 Favored Glycine 0 CA--C 1.534 1.231 0 C-N-CA 121.135 -0.555 . . . . 0.0 113.371 176.964 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' F' F ' 44' ' ' LYS . . . . . . . . . . . . . 94.9 mttt -126.21 130.98 52.03 Favored 'General case' 0 C--N 1.332 -0.155 0 CA-C-N 117.847 0.824 . . . . 0.0 109.785 177.191 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' F' F ' 45' ' ' GLU . . . . . . . . . . . . . 83.9 tt0 -84.81 130.5 34.66 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-O 120.887 0.375 . . . . 0.0 111.39 -178.391 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' F' F ' 46' ' ' VAL . . . . . . . . . . . . . 9.8 p -117.96 128.26 75.09 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.236 0 N-CA-C 109.566 -0.531 . . . . 0.0 109.566 174.508 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' F' F ' 47' ' ' LYS . . . . . . . . . . . . . 92.3 mttt -98.13 124.29 42.61 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.157 -0.474 . . . . 0.0 110.693 177.846 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' F' F ' 48' ' ' PHE . . . . . . . . . . . . . 33.5 m-85 -108.43 131.79 54.43 Favored 'General case' 0 C--N 1.329 -0.32 0 N-CA-C 109.571 -0.529 . . . . 0.0 109.571 175.866 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' F' F ' 49' ' ' LYS . . . . . . . . . . . . . 46.6 tttm -108.58 134.2 51.67 Favored 'General case' 0 C--N 1.331 -0.227 0 CA-C-N 116.342 -0.39 . . . . 0.0 110.202 177.678 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' F' F ' 50' ' ' VAL . . . . . 0.442 ' HA ' HD23 ' F' ' 6' ' ' LEU . 45.0 t -78.74 105.68 8.38 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.342 0 N-CA-C 109.368 -0.604 . . . . 0.0 109.368 177.227 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' F' F ' 51' ' ' VAL . . . . . . . . . . . . . 47.8 t -69.68 -52.78 28.65 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.276 0 N-CA-C 109.534 -0.543 . . . . 0.0 109.534 -175.903 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' F' F ' 52' ' ' GLN . . . . . . . . . . . . . 87.8 mt-30 -153.54 151.12 29.42 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 115.889 -0.596 . . . . 0.0 111.544 -178.634 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' F' F ' 53' ' ' ALA . . . . . . . . . . . . . . . -128.82 134.17 48.25 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 115.021 -0.99 . . . . 0.0 109.493 175.089 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' F' F ' 54' ' ' TYR . . . . . . . . . . . . . 84.3 t80 -129.12 111.47 18.31 Favored Pre-proline 0 CA--C 1.535 0.401 0 CA-C-O 118.15 -0.929 . . . . 0.0 110.387 -179.862 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' F' F ' 55' ' ' PRO . . . . . . . . . . . . . 73.4 Cg_endo -77.07 169.18 75.01 Favored 'Cis proline' 0 N--CA 1.5 1.879 0 CA-C-N 121.94 1.729 . . . . 0.0 112.303 -5.952 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' F' F ' 56' ' ' SER . . . . . . . . . . . . . 13.7 m -116.76 128.16 26.21 Favored Pre-proline 0 CA--C 1.538 0.509 0 CA-C-O 118.366 -0.826 . . . . 0.0 109.274 174.686 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' F' F ' 57' ' ' PRO . . . . . . . . . . . . . 37.2 Cg_endo -66.68 165.44 64.93 Favored 'Cis proline' 0 N--CA 1.496 1.647 0 CA-C-N 122.023 1.758 . . . . 0.0 111.78 0.259 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' F' F ' 58' ' ' LEU . . . . . . . . . . . . . 26.6 tp -130.08 135.85 48.69 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.155 -0.475 . . . . 0.0 110.276 179.296 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' F' F ' 59' ' ' ARG . . . . . . . . . . . . . 58.2 ttt-85 -103.82 125.02 49.97 Favored 'General case' 0 C--N 1.327 -0.406 0 N-CA-C 109.278 -0.638 . . . . 0.0 109.278 175.39 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' F' F ' 60' ' ' VAL . . . . . . . . . . . . . 47.6 t -76.86 117.81 22.36 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.318 0 C-N-CA 120.756 -0.378 . . . . 0.0 110.362 -175.127 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' F' F ' 61' ' ' GLU . . . . . . . . . . . . . 95.6 mt-10 -130.95 166.44 20.95 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 115.728 -0.669 . . . . 0.0 109.661 177.917 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' F' F ' 62' ' ' ASP . . . . . . . . . . . . . 82.0 m-20 -53.97 -32.58 54.41 Favored 'General case' 0 C--N 1.329 -0.312 0 C-N-CA 121.012 -0.275 . . . . 0.0 111.688 179.651 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' F' F ' 63' ' ' ARG . . . . . . . . . . . . . 49.8 ptt85 -78.41 -1.0 31.38 Favored 'General case' 0 CA--C 1.537 0.46 0 N-CA-C 113.781 1.03 . . . . 0.0 113.781 -175.838 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' F' F ' 64' ' ' THR . . . . . . . . . . . . . 34.3 m -86.6 134.75 33.61 Favored 'General case' 0 C--O 1.232 0.161 0 CA-C-N 118.164 0.438 . . . . 0.0 110.808 -177.158 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' F' F ' 65' ' ' LYS . . . . . . . . . . . . . 90.9 mttt -90.01 128.11 36.2 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.01 -0.541 . . . . 0.0 110.211 178.208 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' F' F ' 66' ' ' ILE . . . . . . . . . . . . . 63.3 mt -114.04 130.93 67.38 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.252 0 N-CA-C 109.886 -0.412 . . . . 0.0 109.886 -179.682 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' F' F ' 67' ' ' THR . . . . . . . . . . . . . 30.5 m -125.5 143.57 50.94 Favored 'General case' 0 C--N 1.331 -0.227 0 CA-C-N 116.013 -0.54 . . . . 0.0 111.113 -177.977 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' F' F ' 68' ' ' LEU . . . . . . . . . . . . . 20.6 tp . . . . . 0 C--N 1.33 -0.269 0 CA-C-N 115.687 -0.688 . . . . 0.0 110.118 177.431 . . . . . . . . 0 0 . 1 . 019 nuclear nobuild core ' F' F ' 73' ' ' VAL . . . . . . . . . . . . . 34.3 m . . . . . 0 N--CA 1.462 0.164 0 CA-C-O 120.893 0.378 . . . . 0.0 111.002 . . . . . . . . . 0 0 . 1 . 019 nuclear nobuild core ' F' F ' 74' ' ' ASP . . . . . . . . . . . . . 33.0 t0 -100.79 124.08 45.92 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 115.842 -0.617 . . . . 0.0 110.233 -178.923 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' F' F ' 75' ' ' VAL . . . . . . . . . . . . . 42.5 t -118.1 123.17 71.25 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.24 0 CA-C-O 121.027 0.441 . . . . 0.0 110.594 -178.294 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' F' F ' 76' ' ' LEU . . . . . 0.516 HD12 ' N ' ' F' ' 76' ' ' LEU . 5.5 mp -121.94 147.89 45.47 Favored 'General case' 0 C--N 1.331 -0.217 0 CA-C-N 115.744 -0.662 . . . . 0.0 109.686 175.661 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' F' F ' 77' ' ' GLU . . . . . . . . . . . . . 96.4 mt-10 -137.63 132.17 32.61 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-O 121.005 0.431 . . . . 0.0 111.165 -178.712 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' F' F ' 78' ' ' ALA . . . . . . . . . . . . . . . -115.33 131.01 57.07 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 115.744 -0.662 . . . . 0.0 109.859 177.17 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' F' F ' 79' ' ' LYS . . . . . 0.623 ' O ' HD13 ' F' ' 80' ' ' ILE . 34.3 tptt -85.75 117.42 24.62 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-O 120.798 0.332 . . . . 0.0 110.955 -176.71 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' F' F ' 80' ' ' ILE . . . . . 0.623 HD13 ' O ' ' F' ' 79' ' ' LYS . 39.1 mm -139.23 107.46 3.26 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.272 0 N-CA-C 109.227 -0.657 . . . . 0.0 109.227 -179.314 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' F' F ' 81' ' ' LYS . . . . . . . . . . . . . 38.8 ttpt -89.08 121.47 31.45 Favored 'General case' 0 C--N 1.328 -0.334 0 C-N-CA 120.865 -0.334 . . . . 0.0 111.084 -177.207 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' F' F ' 82' ' ' GLY . . . . . . . . . . . . . . . 89.21 42.19 5.64 Favored Glycine 0 CA--C 1.525 0.698 0 C-N-CA 120.561 -0.828 . . . . 0.0 111.651 174.239 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' F' F ' 83' ' ' ILE . . . . . . . . . . . . . 73.9 mt -65.45 139.79 20.75 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.306 0 N-CA-C 109.623 -0.51 . . . . 0.0 109.623 176.997 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' F' F ' 84' ' ' LYS . . . . . . . . . . . . . 84.3 tttt -94.72 -53.27 3.93 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.028 -0.533 . . . . 0.0 110.49 -176.773 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' F' F ' 85' ' ' ASP . . . . . . . . . . . . . 9.3 t70 -154.12 153.1 31.25 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 115.787 -0.642 . . . . 0.0 110.313 -179.39 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' F' F ' 86' ' ' VAL . . . . . . . . . . . . . 44.4 t -130.79 131.12 64.66 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.247 0 CA-C-O 120.846 0.355 . . . . 0.0 110.616 -179.009 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' F' F ' 87' ' ' ILE . . . . . 0.497 HD12 ' N ' ' F' ' 87' ' ' ILE . 5.1 mp -123.13 126.57 73.76 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.249 0 CA-C-N 115.992 -0.549 . . . . 0.0 109.566 176.892 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' F' F ' 88' ' ' LEU . . . . . . . . . . . . . 53.7 mt -113.18 137.76 50.98 Favored 'General case' 0 C--N 1.331 -0.224 0 CA-C-O 121.12 0.486 . . . . 0.0 111.649 -175.963 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' F' F ' 89' ' ' ASP . . . . . . . . . . . . . 12.3 t0 -133.23 150.76 51.93 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 115.592 -0.731 . . . . 0.0 109.279 174.973 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' F' F ' 90' ' ' GLU . . . . . . . . . . . . . 82.9 tt0 -48.18 -38.01 17.15 Favored 'General case' 0 C--N 1.33 -0.258 0 N-CA-C 112.827 0.677 . . . . 0.0 112.827 -173.385 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' F' F ' 91' ' ' ASN . . . . . . . . . . . . . 26.5 m120 -128.44 32.93 4.77 Favored 'General case' 0 N--CA 1.466 0.361 0 N-CA-C 111.794 0.294 . . . . 0.0 111.794 -177.077 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' F' F ' 92' ' ' LEU . . . . . . . . . . . . . 19.3 tp -166.13 138.9 4.01 Favored 'General case' 0 C--N 1.33 -0.259 0 N-CA-C 110.2 -0.296 . . . . 0.0 110.2 -179.438 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' F' F ' 93' ' ' ILE . . . . . . . . . . . . . 71.0 mt -126.36 122.46 61.3 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.279 0 N-CA-C 109.666 -0.494 . . . . 0.0 109.666 178.368 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' F' F ' 94' ' ' VAL . . . . . 0.558 HG21 HG11 ' F' ' 125' ' ' VAL . 43.8 t -120.78 126.25 75.01 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.265 0 N-CA-C 109.887 -0.412 . . . . 0.0 109.887 179.995 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' F' F ' 95' ' ' VAL . . . . . . . . . . . . . 42.7 t -121.45 133.77 66.92 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.282 0 CA-C-N 115.939 -0.573 . . . . 0.0 109.665 179.849 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' F' F ' 96' ' ' ILE . . . . . . . . . . . . . 60.9 mt -115.5 126.66 73.12 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.323 0 N-CA-C 109.363 -0.606 . . . . 0.0 109.363 179.039 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' F' F ' 97' ' ' THR . . . . . . . . . . . . . 80.8 p -96.5 156.52 16.31 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-O 120.863 0.363 . . . . 0.0 110.765 -179.191 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' F' F ' 98' ' ' GLU . . . . . . . . . . . . . 40.8 tp10 -53.82 -25.54 19.97 Favored 'General case' 0 CA--C 1.533 0.317 0 N-CA-C 112.111 0.411 . . . . 0.0 112.111 -179.461 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' F' F ' 99' ' ' GLU . . . . . . . . . . . . . 18.1 tp10 -80.05 17.42 1.0 Allowed 'General case' 0 CA--C 1.538 0.503 0 N-CA-C 112.858 0.688 . . . . 0.0 112.858 -177.732 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' F' F ' 100' ' ' ASN . . . . . . . . . . . . . 3.6 m-20 63.1 35.59 12.83 Favored 'General case' 0 CA--C 1.531 0.233 0 CA-C-O 120.882 0.372 . . . . 0.0 111.435 176.39 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' F' F ' 101' ' ' GLU . . . . . . . . . . . . . 83.9 tt0 -113.19 142.06 46.23 Favored 'General case' 0 C--N 1.332 -0.173 0 N-CA-C 109.866 -0.42 . . . . 0.0 109.866 175.355 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' F' F ' 102' ' ' VAL . . . . . . . . . . . . . 45.8 t -115.01 126.17 72.53 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.266 0 N-CA-C 109.896 -0.409 . . . . 0.0 109.896 -178.537 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' F' F ' 103' ' ' LEU . . . . . . . . . . . . . 58.2 mt -116.1 133.85 55.57 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 115.685 -0.689 . . . . 0.0 109.796 177.798 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' F' F ' 104' ' ' ILE . . . . . . . . . . . . . 73.8 mt -121.53 119.41 58.87 Favored 'Isoleucine or valine' 0 C--O 1.233 0.23 0 N-CA-C 110.211 -0.292 . . . . 0.0 110.211 -178.939 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' F' F ' 105' ' ' PHE . . . . . . . . . . . . . 35.5 m-85 -121.79 168.2 12.11 Favored 'General case' 0 C--N 1.332 -0.153 0 O-C-N 124.222 0.951 . . . . 0.0 109.907 -179.968 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' F' F ' 106' ' ' ASN . . . . . . . . . . . . . 45.5 p-10 -102.56 -170.03 1.75 Allowed 'General case' 0 C--N 1.33 -0.273 0 N-CA-C 109.509 -0.552 . . . . 0.0 109.509 171.917 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' F' F ' 107' ' ' GLN . . . . . . . . . . . . . 57.1 tt0 -58.21 -26.1 62.4 Favored 'General case' 0 CA--C 1.534 0.337 0 N-CA-C 112.162 0.43 . . . . 0.0 112.162 179.024 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' F' F ' 108' ' ' ASN . . . . . . . . . . . . . 5.6 t-20 -91.16 13.29 17.43 Favored 'General case' 0 CA--C 1.536 0.426 0 N-CA-C 112.974 0.731 . . . . 0.0 112.974 -176.729 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' F' F ' 109' ' ' LEU . . . . . . . . . . . . . 67.7 mt 57.17 35.44 26.24 Favored 'General case' 0 CA--C 1.53 0.178 0 CA-C-O 120.714 0.292 . . . . 0.0 111.543 177.795 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' F' F ' 110' ' ' GLU . . . . . . . . . . . . . 70.8 mm-40 -102.75 149.27 24.63 Favored 'General case' 0 C--N 1.33 -0.282 0 N-CA-C 109.897 -0.409 . . . . 0.0 109.897 176.249 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' F' F ' 111' ' ' GLU . . . . . . . . . . . . . 98.6 mt-10 -81.47 121.97 26.94 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-O 120.997 0.427 . . . . 0.0 111.38 -176.644 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' F' F ' 112' ' ' LEU . . . . . . . . . . . . . 44.7 mt -105.52 -45.69 4.38 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 115.852 -0.613 . . . . 0.0 109.905 175.94 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' F' F ' 113' ' ' TYR . . . . . . . . . . . . . 61.5 t80 -141.92 140.86 32.91 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 115.976 -0.556 . . . . 0.0 110.761 179.928 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' F' F ' 114' ' ' ARG . . . . . . . . . . . . . 71.7 mtm180 -145.17 121.0 10.59 Favored 'General case' 0 C--N 1.331 -0.226 0 CA-C-N 116.358 -0.383 . . . . 0.0 110.557 177.65 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' F' F ' 115' ' ' GLY . . . . . . . . . . . . . . . -150.13 162.67 29.28 Favored Glycine 0 CA--C 1.525 0.677 0 N-CA-C 110.908 -0.877 . . . . 0.0 110.908 -179.603 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' F' F ' 116' ' ' LYS . . . . . . . . . . . . . 1.9 ttmp? -126.43 136.0 52.1 Favored 'General case' 0 C--N 1.33 -0.267 0 N-CA-C 109.933 -0.395 . . . . 0.0 109.933 176.47 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' F' F ' 117' ' ' PHE . . . . . . . . . . . . . 60.6 m-85 -128.91 115.13 17.38 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.237 -0.438 . . . . 0.0 110.264 -176.519 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' F' F ' 118' ' ' GLU . . . . . . . . . . . . . 84.5 tt0 -51.83 -49.16 63.38 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 116.431 -0.349 . . . . 0.0 111.742 -175.718 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' F' F ' 119' ' ' ASN . . . . . . . . . . . . . 5.2 m120 -98.8 31.08 3.06 Favored 'General case' 0 C--N 1.33 -0.249 0 N-CA-C 112.126 0.417 . . . . 0.0 112.126 -174.053 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' F' F ' 120' ' ' LEU . . . . . . . . . . . . . 19.1 tp -54.5 121.29 8.07 Favored 'General case' 0 N--CA 1.462 0.157 0 CA-C-O 120.671 0.272 . . . . 0.0 110.959 179.056 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' F' F ' 121' ' ' ASN . . . . . . . . . . . . . 6.6 t-20 -113.97 -44.08 3.19 Favored 'General case' 0 C--N 1.333 -0.113 0 CA-C-N 116.536 -0.302 . . . . 0.0 111.008 -177.352 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' F' F ' 122' ' ' LYS . . . . . . . . . . . . . 95.8 mttt -146.9 151.36 36.93 Favored 'General case' 0 C--N 1.331 -0.209 0 CA-C-O 121.064 0.459 . . . . 0.0 111.734 -178.416 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' F' F ' 123' ' ' VAL . . . . . . . . . . . . . 46.1 t -129.52 124.41 59.54 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.325 0 N-CA-C 109.181 -0.674 . . . . 0.0 109.181 173.058 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' F' F ' 124' ' ' LEU . . . . . 0.5 HD12 ' N ' ' F' ' 124' ' ' LEU . 6.1 mp -117.1 138.79 51.4 Favored 'General case' 0 C--N 1.331 -0.215 0 CA-C-O 120.818 0.342 . . . . 0.0 110.492 -176.699 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' F' F ' 125' ' ' VAL . . . . . 0.652 HG12 HG23 ' F' ' 130' ' ' VAL . 35.2 m -135.16 140.06 45.84 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.238 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.996 -179.514 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' F' F ' 126' ' ' ARG . . . . . . . . . . . . . 6.7 ptm85 -139.86 118.98 12.69 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 115.938 -0.574 . . . . 0.0 109.966 176.052 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' F' F ' 127' ' ' ASN . . . . . . . . . . . . . 29.9 m120 52.55 -107.65 0.35 Allowed 'General case' 0 CA--C 1.544 0.747 0 CA-C-O 118.968 -0.539 . . . . 0.0 111.053 -178.221 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' F' F ' 128' ' ' ASP . . . . . . . . . . . . . 9.5 p-10 -114.17 3.9 15.36 Favored 'General case' 0 N--CA 1.467 0.4 0 CA-C-N 119.746 1.157 . . . . 0.0 113.476 -178.378 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' F' F ' 129' ' ' LEU . . . . . . . . . . . . . 10.4 tp -105.04 141.81 35.94 Favored 'General case' 0 C--O 1.232 0.142 0 N-CA-C 109.619 -0.512 . . . . 0.0 109.619 179.413 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' F' F ' 130' ' ' VAL . . . . . 0.652 HG23 HG12 ' F' ' 125' ' ' VAL . 14.5 p -133.12 143.4 39.44 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.249 0 CA-C-O 121.312 0.577 . . . . 0.0 111.5 -175.538 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' F' F ' 131' ' ' VAL . . . . . . . . . . . . . 43.8 t -136.06 137.58 48.45 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.232 0 CA-C-N 115.591 -0.732 . . . . 0.0 109.949 177.882 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' F' F ' 132' ' ' ILE . . . . . . . . . . . . . 69.6 mt -114.21 134.08 58.23 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.257 0 CA-C-N 116.075 -0.511 . . . . 0.0 109.628 -179.215 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' F' F ' 133' ' ' ILE . . . . . . . . . . . . . 43.2 mm -117.92 119.53 61.79 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.238 0 CA-C-O 121.007 0.432 . . . . 0.0 110.819 -176.549 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' F' F ' 134' ' ' ASP . . . . . . . . . . . . . 7.3 p-10 -132.84 144.68 50.37 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 115.77 -0.65 . . . . 0.0 109.329 174.834 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' F' F ' 135' ' ' GLU . . . . . . . . . . . . . 85.5 tt0 -49.86 -25.04 2.8 Favored 'General case' 0 C--N 1.328 -0.332 0 N-CA-C 112.942 0.719 . . . . 0.0 112.942 -170.745 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' F' F ' 136' ' ' GLN . . . . . . . . . . . . . 97.4 mt-30 -94.09 -34.47 12.97 Favored 'General case' 0 C--N 1.331 -0.221 0 N-CA-C 112.112 0.412 . . . . 0.0 112.112 -176.953 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' F' F ' 137' ' ' LYS . . . . . . . . . . . . . 78.6 mttt -139.91 153.21 46.91 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-O 121.247 0.546 . . . . 0.0 111.702 -170.149 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' F' F ' 138' ' ' LEU . . . . . 0.441 HD23 ' C ' ' F' ' 138' ' ' LEU . 6.6 tt -117.56 123.07 45.35 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 115.53 -0.759 . . . . 0.0 108.973 170.94 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' F' F ' 139' ' ' THR . . . . . 0.442 HG23 ' HG2' ' A' ' 77' ' ' GLU . 31.3 m -114.55 128.58 56.4 Favored 'General case' 0 C--N 1.331 -0.218 0 CA-C-N 116.327 -0.397 . . . . 0.0 111.053 -175.537 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' F' F ' 140' ' ' LEU . . . . . 0.479 HD23 ' C ' ' F' ' 140' ' ' LEU . 7.3 tt -114.18 125.08 53.53 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 115.619 -0.719 . . . . 0.0 109.308 179.634 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' F' F ' 141' ' ' ILE . . . . . 0.49 ' HB ' HG13 ' F' ' 130' ' ' VAL . 19.0 mt -124.72 119.78 57.07 Favored 'Isoleucine or valine' 0 C--O 1.235 0.31 0 CA-C-O 121.005 0.431 . . . . 0.0 110.52 -175.301 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' F' F ' 142' ' ' ARG . . . . . . . . . . . . . 94.1 mtt180 -94.69 125.25 39.22 Favored 'General case' 0 C--N 1.332 -0.182 0 CA-C-N 115.249 -0.887 . . . . 0.0 109.387 174.527 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' F' F ' 143' ' ' THR . . . . . . . . . . . . . 45.1 p . . . . . 0 C--O 1.221 -0.437 0 CA-C-O 117.982 -1.009 . . . . 0.0 110.61 179.58 . . . . . . . . 0 0 . 1 . 020 nuclear nobuild core ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 59.9 p . . . . . 0 C--O 1.231 0.103 0 N-CA-C 110.063 -0.347 . . . . 0.0 110.063 . . . . . . . . . 0 0 . 1 . 020 nuclear nobuild core ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 95.6 mt-10 -139.95 142.75 36.36 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-O 121.08 0.467 . . . . 0.0 111.385 -177.423 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 4' ' ' LEU . . . . . 0.423 HD21 HD23 ' A' ' 58' ' ' LEU . 39.0 mt -120.86 127.52 51.96 Favored 'General case' 0 C--N 1.331 -0.215 0 CA-C-N 115.603 -0.726 . . . . 0.0 110.043 174.978 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 5' ' ' LYS . . . . . . . . . . . . . 88.8 mttt -108.9 119.43 39.54 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-O 120.862 0.363 . . . . 0.0 110.498 176.364 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 45.6 mt -115.55 146.73 41.47 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 115.297 -0.865 . . . . 0.0 110.234 -179.199 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 75.4 tttt -135.91 136.25 22.93 Favored Pre-proline 0 CA--C 1.534 0.328 0 CA-C-O 118.981 -0.533 . . . . 0.0 110.247 176.125 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 8' ' ' PRO . . . . . . . . . . . . . 89.1 Cg_endo -90.81 141.86 3.17 Favored 'Trans proline' 0 N--CA 1.491 1.361 0 C-N-CA 121.553 1.502 . . . . 0.0 111.526 176.281 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 65.1 mt -73.4 -47.42 7.5 Favored Pre-proline 0 CA--C 1.533 0.313 0 CA-C-O 118.711 -0.661 . . . . 0.0 112.235 -178.266 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 83.2 Cg_endo -80.95 153.11 19.21 Favored 'Trans proline' 0 N--CA 1.495 1.608 0 C-N-CA 121.268 1.312 . . . . 0.0 111.767 175.558 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 24.7 ttpp -86.99 102.57 14.52 Favored 'General case' 0 C--N 1.329 -0.295 0 C-N-CA 120.772 -0.371 . . . . 0.0 110.174 178.588 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 11.8 p -141.33 144.05 26.86 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.291 0 CA-C-N 116.275 -0.42 . . . . 0.0 110.368 -179.412 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 95.3 mt-10 -84.5 129.84 34.81 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.062 178.635 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 14' ' ' LEU . . . . . . . . . . . . . 34.7 mt -98.66 148.54 34.69 Favored Pre-proline 0 CA--C 1.533 0.327 0 CA-C-O 119.229 -0.415 . . . . 0.0 110.629 -177.938 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 15' ' ' PRO . . . . . . . . . . . . . 24.5 Cg_exo -63.51 163.64 23.34 Favored 'Trans proline' 0 N--CA 1.498 1.758 0 C-N-CA 121.382 1.388 . . . . 0.0 111.978 175.992 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 16' ' ' PRO . . . . . . . . . . . . . 25.6 Cg_exo -61.29 -39.91 53.79 Favored 'Trans proline' 0 N--CA 1.496 1.651 0 C-N-CA 121.544 1.496 . . . . 0.0 112.836 -178.511 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 17' ' ' ASP . . . . . . . . . . . . . 7.9 p-10 -83.64 4.57 27.88 Favored 'General case' 0 CA--C 1.535 0.394 0 N-CA-C 113.344 0.868 . . . . 0.0 113.344 -176.973 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 18' ' ' PHE . . . . . . . . . . . . . 39.7 t80 -57.28 -46.66 82.89 Favored 'General case' 0 N--CA 1.457 -0.098 0 O-C-N 121.943 -0.473 . . . . 0.0 110.471 -176.494 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 19' ' ' VAL . . . . . . . . . . . . . 45.9 t -56.05 -47.15 80.71 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.362 0 CA-C-N 116.477 -0.328 . . . . 0.0 110.831 -176.527 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 49.3 m-20 -60.13 -41.09 91.95 Favored 'General case' 0 C--N 1.329 -0.302 0 C-N-CA 120.921 -0.312 . . . . 0.0 111.158 -176.954 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 56.1 t -64.74 -45.3 95.56 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.255 0 C-N-CA 120.746 -0.382 . . . . 0.0 110.504 -177.78 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 22' ' ' ILE . . . . . 0.583 HG22 HD12 ' A' ' 26' ' ' LEU . 51.2 mm -56.49 -45.05 81.89 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.235 0 C-N-CA 121.031 -0.268 . . . . 0.0 110.385 178.027 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 23' ' ' ARG . . . . . . . . . . . . . 45.3 ttp180 -53.99 -48.8 70.02 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-O 120.611 0.243 . . . . 0.0 111.375 -179.629 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 24' ' ' ILE . . . . . . . . . . . . . 70.7 mt -60.55 -43.26 94.09 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.349 0 CA-C-O 120.634 0.254 . . . . 0.0 111.025 -178.217 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 74.5 mttt -64.97 -36.48 84.52 Favored 'General case' 0 C--N 1.328 -0.367 0 N-CA-C 112.069 0.396 . . . . 0.0 112.069 -178.804 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 26' ' ' LEU . . . . . 0.583 HD12 HG22 ' A' ' 22' ' ' ILE . 42.6 mt -79.72 -44.19 21.23 Favored 'General case' 0 C--N 1.33 -0.269 0 N-CA-C 113.413 0.894 . . . . 0.0 113.413 -173.396 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 27' ' ' GLN . . . . . . . . . . . . . 11.3 pt20 -46.95 140.08 5.08 Favored 'General case' 0 N--CA 1.469 0.48 0 N-CA-C 112.833 0.679 . . . . 0.0 112.833 -173.619 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 97.55 -26.65 22.18 Favored Glycine 0 CA--C 1.534 1.24 0 CA-C-N 115.525 -0.761 . . . . 0.0 112.169 -176.062 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 65.5 mttm -97.58 155.17 17.09 Favored 'General case' 0 C--O 1.233 0.214 0 CA-C-N 117.108 0.454 . . . . 0.0 110.939 179.009 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 30' ' ' THR . . . . . . . . . . . . . 29.0 m -95.58 136.3 36.15 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.06 -0.518 . . . . 0.0 110.293 176.669 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 35.5 m -121.24 138.87 50.21 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.239 0 CA-C-N 116.352 -0.386 . . . . 0.0 110.612 -179.79 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 32' ' ' ARG . . . . . . . . . . . . . 48.0 tpt85 -134.08 139.11 45.75 Favored 'General case' 0 C--N 1.326 -0.428 0 CA-C-N 115.878 -0.601 . . . . 0.0 110.086 -178.822 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 33' ' ' THR . . . . . . . . . . . . . 19.7 m -51.67 140.58 18.42 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-O 120.922 0.391 . . . . 0.0 111.642 -175.475 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 99.13 -17.34 58.17 Favored Glycine 0 CA--C 1.533 1.181 0 CA-C-N 116.006 -0.543 . . . . 0.0 113.024 -179.372 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 82.0 m-20 -64.95 147.97 52.41 Favored 'General case' 0 C--O 1.231 0.096 0 CA-C-N 118.02 0.91 . . . . 0.0 111.088 179.079 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 46.0 t -120.39 128.18 75.97 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.166 0 CA-C-N 115.712 -0.676 . . . . 0.0 109.66 177.835 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 37' ' ' ILE . . . . . . . . . . . . . 66.9 mt -120.74 138.47 51.09 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.273 0 N-CA-C 109.782 -0.451 . . . . 0.0 109.782 -179.572 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . -114.29 128.68 8.33 Favored Glycine 0 CA--C 1.526 0.762 0 N-CA-C 110.935 -0.866 . . . . 0.0 110.935 179.53 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 39' ' ' ILE . . . . . . . . . . . . . 73.3 mt -126.62 127.01 69.83 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.246 0 N-CA-C 109.936 -0.394 . . . . 0.0 109.936 179.05 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 40' ' ' SER . . . . . . . . . . . . . 45.8 t -93.12 123.24 36.25 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.558 -0.292 . . . . 0.0 110.996 177.31 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 41' ' ' ILE . . . . . . . . . . . . . 73.0 mt -131.16 123.01 52.67 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.21 0 CA-C-O 120.92 0.391 . . . . 0.0 110.059 177.715 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 10.9 tp 56.35 36.8 28.1 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.072 -0.513 . . . . 0.0 111.339 178.847 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . 79.01 -10.08 35.39 Favored Glycine 0 CA--C 1.534 1.227 0 C-N-CA 121.21 -0.519 . . . . 0.0 113.641 175.963 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 44' ' ' LYS . . . . . . . . . . . . . 83.4 tttt -101.15 128.3 47.3 Favored 'General case' 0 C--N 1.334 -0.091 0 CA-C-N 117.968 0.884 . . . . 0.0 109.975 177.699 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 41.2 tp10 -84.94 130.63 34.61 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.373 -0.376 . . . . 0.0 110.921 -178.995 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 46' ' ' VAL . . . . . . . . . . . . . 7.4 p -121.82 132.07 71.69 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.199 0 N-CA-C 109.651 -0.5 . . . . 0.0 109.651 176.419 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 94.1 mttt -100.88 131.1 46.92 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.083 -0.508 . . . . 0.0 111.281 178.982 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 48' ' ' PHE . . . . . . . . . . . . . 92.1 m-85 -115.5 131.88 56.8 Favored 'General case' 0 C--N 1.33 -0.244 0 N-CA-C 109.759 -0.46 . . . . 0.0 109.759 175.598 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 54.4 tttm -108.32 139.32 43.19 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.693 -0.23 . . . . 0.0 110.425 178.022 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 50' ' ' VAL . . . . . . . . . . . . . 44.9 t -79.04 107.84 11.96 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.355 0 N-CA-C 109.262 -0.644 . . . . 0.0 109.262 175.909 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 51' ' ' VAL . . . . . . . . . . . . . 49.2 t -72.06 -48.62 48.82 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.324 0 CA-C-N 116.023 -0.535 . . . . 0.0 109.909 -174.324 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 52' ' ' GLN . . . . . . . . . . . . . 61.8 tt0 -162.95 144.45 9.95 Favored 'General case' 0 C--N 1.331 -0.238 0 C-N-CA 120.345 -0.542 . . . . 0.0 111.917 -178.52 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -121.66 132.61 54.75 Favored 'General case' 0 C--N 1.331 -0.196 0 CA-C-N 115.717 -0.674 . . . . 0.0 109.827 175.913 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 54' ' ' TYR . . . . . . . . . . . . . 22.5 t80 -129.16 110.94 18.2 Favored Pre-proline 0 CA--C 1.535 0.396 0 CA-C-O 118.101 -0.952 . . . . 0.0 110.656 177.787 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 55' ' ' PRO . . . . . . . . . . . . . 71.1 Cg_endo -75.94 170.04 72.86 Favored 'Cis proline' 0 N--CA 1.501 1.929 0 CA-C-N 121.898 1.714 . . . . 0.0 112.578 -7.908 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 56' ' ' SER . . . . . . . . . . . . . 66.3 m -118.36 132.53 23.75 Favored Pre-proline 0 CA--C 1.54 0.58 0 CA-C-O 118.439 -0.791 . . . . 0.0 110.079 178.257 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 57' ' ' PRO . . . . . . . . . . . . . 75.9 Cg_endo -79.22 149.73 84.03 Favored 'Cis proline' 0 N--CA 1.495 1.601 0 CA-C-N 121.932 1.726 . . . . 0.0 111.535 -4.922 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 58' ' ' LEU . . . . . 0.423 HD23 HD21 ' A' ' 4' ' ' LEU . 30.6 tp -108.84 140.89 41.66 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.303 -0.408 . . . . 0.0 110.929 -177.817 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 59' ' ' ARG . . . . . . . . . . . . . 78.2 ttt180 -94.06 119.02 32.34 Favored 'General case' 0 C--N 1.328 -0.331 0 N-CA-C 108.809 -0.812 . . . . 0.0 108.809 170.862 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 45.8 t -72.87 120.3 21.28 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.322 0 C-N-CA 120.55 -0.46 . . . . 0.0 110.667 -173.462 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 95.3 mt-10 -131.14 162.68 29.36 Favored 'General case' 0 C--N 1.331 -0.239 0 CA-C-N 115.63 -0.714 . . . . 0.0 109.78 176.945 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 62' ' ' ASP . . . . . . . . . . . . . 12.6 p-10 -54.28 -31.4 53.69 Favored 'General case' 0 C--N 1.329 -0.315 0 N-CA-C 112.185 0.439 . . . . 0.0 112.185 -177.693 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 63' ' ' ARG . . . . . . . . . . . . . 15.2 mmm180 -71.01 -21.81 62.24 Favored 'General case' 0 C--N 1.329 -0.285 0 N-CA-C 113.02 0.748 . . . . 0.0 113.02 -175.787 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 30.3 m -69.76 140.36 53.41 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-O 120.788 0.327 . . . . 0.0 110.997 -175.679 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 65' ' ' LYS . . . . . . . . . . . . . 12.1 mptt -88.91 134.7 33.87 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.154 -0.475 . . . . 0.0 109.836 179.731 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 66' ' ' ILE . . . . . . . . . . . . . 61.1 mt -117.91 131.81 69.57 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.302 0 CA-C-O 120.844 0.354 . . . . 0.0 110.321 -179.067 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 67' ' ' THR . . . . . . . . . . . . . 19.1 m -128.01 135.5 49.98 Favored 'General case' 0 C--N 1.331 -0.23 0 CA-C-N 116.112 -0.495 . . . . 0.0 110.507 178.517 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 68' ' ' LEU . . . . . 0.484 ' N ' HD12 ' A' ' 68' ' ' LEU . 8.5 mp . . . . . 0 C--N 1.329 -0.293 0 CA-C-N 115.939 -0.573 . . . . 0.0 110.296 177.731 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 74' ' ' ASP . . . . . . . . . . . . . 36.1 t0 . . . . . 0 N--CA 1.46 0.028 0 N-CA-C 109.998 -0.371 . . . . 0.0 109.998 . . . . . . . . . 0 0 . 1 . 020 nuclear nobuild core ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 40.2 t -118.26 122.64 70.08 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.262 0 CA-C-O 120.922 0.392 . . . . 0.0 110.791 -176.745 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 76' ' ' LEU . . . . . . . . . . . . . 5.6 mp -122.54 146.43 47.42 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 115.869 -0.605 . . . . 0.0 109.832 175.572 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 77' ' ' GLU . . . . . . . . . . . . . 97.9 mt-10 -134.94 141.59 46.31 Favored 'General case' 0 C--N 1.331 -0.218 0 CA-C-O 121.04 0.448 . . . . 0.0 111.419 -179.241 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 78' ' ' ALA . . . . . . . . . . . . . . . -130.62 140.27 50.41 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-N 115.682 -0.69 . . . . 0.0 109.858 175.581 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 79' ' ' LYS . . . . . 0.589 ' O ' HD13 ' A' ' 80' ' ' ILE . 53.0 mttm -87.49 122.77 31.64 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-O 120.994 0.426 . . . . 0.0 111.239 -177.606 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 80' ' ' ILE . . . . . 0.589 HD13 ' O ' ' A' ' 79' ' ' LYS . 39.8 mm -139.2 109.26 4.16 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.298 0 N-CA-C 108.994 -0.743 . . . . 0.0 108.994 179.37 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 81' ' ' LYS . . . . . . . . . . . . . 78.2 tttt -97.8 123.37 41.73 Favored 'General case' 0 C--N 1.329 -0.3 0 C-N-CA 120.788 -0.365 . . . . 0.0 110.935 -176.949 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . 89.17 42.21 5.64 Favored Glycine 0 CA--C 1.526 0.741 0 C-N-CA 120.759 -0.734 . . . . 0.0 111.705 175.292 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 83' ' ' ILE . . . . . . . . . . . . . 71.1 mt -66.12 138.52 22.86 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.218 0 N-CA-C 109.736 -0.468 . . . . 0.0 109.736 177.178 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 84' ' ' LYS . . . . . . . . . . . . . 78.5 tttt -96.17 -52.9 3.83 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.031 -0.531 . . . . 0.0 110.405 -179.192 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 85' ' ' ASP . . . . . . . . . . . . . 7.1 t70 -154.19 153.7 32.23 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 115.906 -0.588 . . . . 0.0 110.567 -178.977 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 86' ' ' VAL . . . . . . . . . . . . . 42.6 t -131.77 131.32 62.13 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.242 0 CA-C-O 120.984 0.421 . . . . 0.0 110.468 -179.821 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 87' ' ' ILE . . . . . 0.498 HD12 ' N ' ' A' ' 87' ' ' ILE . 5.0 mp -119.06 127.91 75.82 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.224 0 N-CA-C 109.301 -0.629 . . . . 0.0 109.301 176.25 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 88' ' ' LEU . . . . . . . . . . . . . 84.8 mt -117.32 138.82 51.52 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-O 121.149 0.499 . . . . 0.0 111.857 -177.071 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 89' ' ' ASP . . . . . . . . . . . . . 13.7 t70 -134.13 157.75 45.4 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-N 115.375 -0.829 . . . . 0.0 109.19 175.014 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 74.0 tt0 -47.5 -38.13 13.28 Favored 'General case' 0 C--N 1.33 -0.244 0 N-CA-C 112.772 0.656 . . . . 0.0 112.772 -172.785 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 91' ' ' ASN . . . . . . . . . . . . . 13.5 p-10 -132.09 35.97 3.68 Favored 'General case' 0 C--N 1.331 -0.207 0 N-CA-C 111.866 0.321 . . . . 0.0 111.866 -176.604 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 92' ' ' LEU . . . . . . . . . . . . . 13.1 tp -163.73 141.72 7.49 Favored 'General case' 0 C--N 1.332 -0.168 0 C-N-CA 120.85 -0.34 . . . . 0.0 110.934 -179.051 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 93' ' ' ILE . . . . . . . . . . . . . 74.8 mt -126.59 120.83 57.19 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.245 0 N-CA-C 109.461 -0.57 . . . . 0.0 109.461 178.268 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 94' ' ' VAL . . . . . 0.48 HG21 HG11 ' A' ' 125' ' ' VAL . 43.7 t -120.96 127.17 75.91 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.271 0 N-CA-C 109.873 -0.418 . . . . 0.0 109.873 179.306 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 95' ' ' VAL . . . . . . . . . . . . . 44.4 t -123.42 134.79 65.29 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.283 0 CA-C-N 116.137 -0.483 . . . . 0.0 109.92 -178.908 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 96' ' ' ILE . . . . . . . . . . . . . 65.3 mt -116.51 128.69 73.79 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.294 0 N-CA-C 109.286 -0.635 . . . . 0.0 109.286 179.157 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 97' ' ' THR . . . . . . . . . . . . . 74.1 p -100.7 156.07 17.54 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-O 121.206 0.527 . . . . 0.0 111.177 -177.606 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 98' ' ' GLU . . . . . . . . . . . . . 79.8 tt0 -54.02 -26.26 25.47 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.166 -0.47 . . . . 0.0 112.129 -178.808 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 99' ' ' GLU . . . . . . . . . . . . . 95.4 mt-10 -81.83 16.62 1.76 Allowed 'General case' 0 CA--C 1.535 0.374 0 N-CA-C 113.232 0.826 . . . . 0.0 113.232 -175.814 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 100' ' ' ASN . . . . . . . . . . . . . 3.7 m-20 62.97 36.03 12.87 Favored 'General case' 0 N--CA 1.464 0.243 0 CA-C-O 120.906 0.384 . . . . 0.0 111.345 178.548 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 101' ' ' GLU . . . . . . . . . . . . . 84.2 tt0 -112.33 144.4 41.82 Favored 'General case' 0 C--N 1.332 -0.188 0 CA-C-N 116.126 -0.488 . . . . 0.0 109.858 173.549 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 102' ' ' VAL . . . . . . . . . . . . . 48.1 t -116.19 128.05 73.61 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.283 0 CA-C-N 116.325 -0.398 . . . . 0.0 110.128 -178.324 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 103' ' ' LEU . . . . . . . . . . . . . 21.3 mt -118.97 131.86 56.04 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 115.693 -0.685 . . . . 0.0 110.094 177.475 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 104' ' ' ILE . . . . . 0.494 ' CD1' HG11 ' A' ' 130' ' ' VAL . 70.1 mt -120.76 123.39 70.17 Favored 'Isoleucine or valine' 0 C--O 1.234 0.248 0 N-CA-C 110.398 -0.223 . . . . 0.0 110.398 -179.735 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 105' ' ' PHE . . . . . . . . . . . . . 66.5 m-85 -122.92 166.15 15.52 Favored 'General case' 0 C--O 1.232 0.162 0 O-C-N 123.915 0.759 . . . . 0.0 109.942 -179.486 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 106' ' ' ASN . . . . . . . . . . . . . 38.0 p-10 -103.71 -171.08 1.88 Allowed 'General case' 0 C--N 1.331 -0.235 0 N-CA-C 109.951 -0.389 . . . . 0.0 109.951 172.662 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 107' ' ' GLN . . . . . . . . . . . . . 62.0 tt0 -59.85 -24.83 64.54 Favored 'General case' 0 CA--C 1.533 0.324 0 N-CA-C 112.156 0.428 . . . . 0.0 112.156 177.199 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 108' ' ' ASN . . . . . . . . . . . . . 28.5 t30 -84.51 4.16 33.18 Favored 'General case' 0 CA--C 1.538 0.498 0 N-CA-C 113.16 0.8 . . . . 0.0 113.16 -178.022 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 109' ' ' LEU . . . . . . . . . . . . . 12.0 tp 60.88 37.68 18.28 Favored 'General case' 0 CA--C 1.531 0.232 0 CA-C-O 120.943 0.401 . . . . 0.0 111.209 179.669 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 110' ' ' GLU . . . . . . . . . . . . . 15.1 mm-40 -106.55 150.14 26.44 Favored 'General case' 0 C--N 1.329 -0.294 0 N-CA-C 109.958 -0.386 . . . . 0.0 109.958 176.598 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 111' ' ' GLU . . . . . . . . . . . . . 43.3 tp10 -80.16 121.91 26.16 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-O 120.889 0.376 . . . . 0.0 110.043 179.776 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 112' ' ' LEU . . . . . . . . . . . . . 14.8 mt -108.34 -45.62 3.87 Favored 'General case' 0 C--N 1.331 -0.201 0 CA-C-N 116.07 -0.514 . . . . 0.0 110.142 178.511 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 113' ' ' TYR . . . . . . . . . . . . . 64.0 t80 -137.29 139.36 40.87 Favored 'General case' 0 C--N 1.331 -0.211 0 CA-C-N 116.248 -0.433 . . . . 0.0 111.221 -179.805 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 114' ' ' ARG . . . . . . . . . . . . . 32.4 ttm180 -140.95 124.26 16.61 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 115.888 -0.596 . . . . 0.0 110.275 177.509 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 115' ' ' GLY . . . . . . . . . . . . . . . -149.98 158.39 27.64 Favored Glycine 0 CA--C 1.524 0.61 0 N-CA-C 110.938 -0.865 . . . . 0.0 110.938 178.967 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 116' ' ' LYS . . . . . . . . . . . . . 77.5 tttt -136.65 133.61 36.42 Favored 'General case' 0 C--N 1.329 -0.311 0 N-CA-C 110.097 -0.335 . . . . 0.0 110.097 178.636 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 117' ' ' PHE . . . . . . . . . . . . . 9.7 m-85 -138.08 118.98 14.23 Favored 'General case' 0 C--N 1.33 -0.25 0 C-N-CA 120.754 -0.379 . . . . 0.0 110.103 -174.208 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 118' ' ' GLU . . . . . . . . . . . . . 70.6 mm-40 -55.18 -43.65 74.53 Favored 'General case' 0 C--N 1.33 -0.279 0 C-N-CA 120.847 -0.341 . . . . 0.0 111.027 -177.935 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 119' ' ' ASN . . . . . . . . . . . . . 65.7 m-80 -93.71 28.41 2.36 Favored 'General case' 0 C--N 1.329 -0.288 0 N-CA-C 112.414 0.524 . . . . 0.0 112.414 -174.248 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 120' ' ' LEU . . . . . . . . . . . . . 19.2 tp -58.65 120.25 8.57 Favored 'General case' 0 C--N 1.333 -0.128 0 N-CA-C 110.028 -0.36 . . . . 0.0 110.028 177.263 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 121' ' ' ASN . . . . . . . . . . . . . 10.4 t-20 -112.46 -44.13 3.41 Favored 'General case' 0 C--O 1.232 0.148 0 CA-C-N 116.655 -0.248 . . . . 0.0 111.058 -176.274 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 122' ' ' LYS . . . . . . . . . . . . . 82.8 mttt -144.52 147.46 33.26 Favored 'General case' 0 C--N 1.332 -0.162 0 CA-C-O 121.177 0.513 . . . . 0.0 111.793 -177.928 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 123' ' ' VAL . . . . . . . . . . . . . 45.8 t -123.24 128.64 74.98 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.193 0 CA-C-N 115.759 -0.655 . . . . 0.0 109.459 175.139 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 124' ' ' LEU . . . . . . . . . . . . . 52.5 mt -123.6 141.09 52.35 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-O 120.798 0.332 . . . . 0.0 110.854 -177.063 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 125' ' ' VAL . . . . . 0.48 HG11 HG21 ' A' ' 94' ' ' VAL . 34.8 m -135.11 140.93 44.2 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.259 0 CA-C-N 116.287 -0.415 . . . . 0.0 110.992 179.446 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 126' ' ' ARG . . . . . . . . . . . . . 77.6 mtp85 -144.91 111.01 5.5 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 115.975 -0.557 . . . . 0.0 110.396 176.47 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 127' ' ' ASN . . . . . . . . . . . . . 55.8 t30 52.3 -108.54 0.4 Allowed 'General case' 0 CA--C 1.545 0.765 0 CA-C-O 118.83 -0.605 . . . . 0.0 111.344 179.691 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 128' ' ' ASP . . . . . . . . . . . . . 22.9 p-10 -108.09 5.8 26.34 Favored 'General case' 0 N--CA 1.468 0.464 0 CA-C-N 119.876 1.216 . . . . 0.0 113.485 -177.79 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 129' ' ' LEU . . . . . . . . . . . . . 12.1 tp -104.99 138.33 41.37 Favored 'General case' 0 C--N 1.332 -0.175 0 N-CA-C 109.883 -0.414 . . . . 0.0 109.883 178.692 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 130' ' ' VAL . . . . . 0.494 HG11 ' CD1' ' A' ' 104' ' ' ILE . 41.5 t -121.76 137.99 53.53 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.23 0 N-CA-C 110.081 -0.34 . . . . 0.0 110.081 -178.584 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 131' ' ' VAL . . . . . 0.5 HG22 HD12 ' A' ' 140' ' ' LEU . 40.0 t -134.71 136.23 52.58 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.248 0 CA-C-O 121.036 0.446 . . . . 0.0 110.45 -179.476 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 132' ' ' ILE . . . . . . . . . . . . . 75.0 mt -118.21 130.69 72.69 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.273 0 CA-C-N 115.738 -0.665 . . . . 0.0 109.49 179.436 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 133' ' ' ILE . . . . . . . . . . . . . 43.0 mm -117.75 123.33 71.55 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.261 0 CA-C-O 120.985 0.422 . . . . 0.0 111.063 -175.907 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 134' ' ' ASP . . . . . . . . . . . . . 7.7 p-10 -135.01 148.18 49.88 Favored 'General case' 0 C--N 1.331 -0.223 0 CA-C-N 115.849 -0.614 . . . . 0.0 109.517 173.92 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 135' ' ' GLU . . . . . . . . . . . . . 43.6 tp10 -49.89 -24.71 2.64 Favored 'General case' 0 C--N 1.326 -0.416 0 N-CA-C 112.797 0.665 . . . . 0.0 112.797 -172.01 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 136' ' ' GLN . . . . . . . . . . . . . 59.7 tp60 -101.11 -27.49 13.22 Favored 'General case' 0 CA--C 1.53 0.211 0 N-CA-C 112.668 0.618 . . . . 0.0 112.668 -174.863 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 137' ' ' LYS . . . . . . . . . . . . . 81.5 mttt -142.36 152.99 43.43 Favored 'General case' 0 C--N 1.332 -0.188 0 CA-C-O 121.17 0.51 . . . . 0.0 111.685 -171.661 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 138' ' ' LEU . . . . . . . . . . . . . 4.7 tt -120.22 122.27 40.56 Favored 'General case' 0 C--N 1.328 -0.346 0 N-CA-C 109.011 -0.737 . . . . 0.0 109.011 171.675 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 139' ' ' THR . . . . . . . . . . . . . 32.8 m -112.62 128.6 56.42 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 116.376 -0.374 . . . . 0.0 110.787 -176.835 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 140' ' ' LEU . . . . . 0.5 HD12 HG22 ' A' ' 131' ' ' VAL . 15.0 tp -115.85 121.63 42.96 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 115.522 -0.763 . . . . 0.0 109.264 -179.292 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 141' ' ' ILE . . . . . . . . . . . . . 19.3 mt -119.29 120.15 62.87 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.266 0 CA-C-O 120.888 0.375 . . . . 0.0 110.354 -174.613 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 142' ' ' ARG . . . . . . . . . . . . . 73.1 mtm180 -106.48 127.51 53.36 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-N 115.498 -0.774 . . . . 0.0 110.166 179.629 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 143' ' ' THR . . . . . . . . . . . . . 77.3 p . . . . . 0 C--O 1.221 -0.398 0 CA-C-O 117.922 -1.037 . . . . 0.0 110.577 -179.419 . . . . . . . . 0 0 . 1 . 020 nuclear nobuild core ' B' B ' 2' ' ' SER . . . . . . . . . . . . . 36.4 p . . . . . 0 C--O 1.231 0.125 0 CA-C-O 120.896 0.379 . . . . 0.0 110.687 . . . . . . . . . 0 0 . 1 . 020 nuclear nobuild core ' B' B ' 3' ' ' GLU . . . . . . . . . . . . . 95.2 mt-10 -140.52 145.96 37.52 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-O 121.026 0.441 . . . . 0.0 111.484 -177.106 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' B' B ' 4' ' ' LEU . . . . . . . . . . . . . 17.2 tp -125.47 131.03 52.93 Favored 'General case' 0 C--N 1.332 -0.191 0 CA-C-N 115.82 -0.627 . . . . 0.0 109.859 175.264 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' B' B ' 5' ' ' LYS . . . . . . . . . . . . . 98.6 mttt -108.55 120.86 43.67 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.42 -0.354 . . . . 0.0 110.837 -179.256 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' B' B ' 6' ' ' LEU . . . . . . . . . . . . . 55.2 mt -114.64 148.71 37.76 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 115.35 -0.841 . . . . 0.0 110.225 -179.728 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' B' B ' 7' ' ' LYS . . . . . . . . . . . . . 58.9 tttp -138.47 140.86 29.38 Favored Pre-proline 0 CA--C 1.535 0.379 0 CA-C-O 119.132 -0.461 . . . . 0.0 110.015 175.139 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' B' B ' 8' ' ' PRO . . . . . . . . . . . . . 90.1 Cg_endo -91.98 142.27 2.58 Favored 'Trans proline' 0 N--CA 1.489 1.247 0 C-N-CA 121.76 1.64 . . . . 0.0 111.922 178.229 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' B' B ' 9' ' ' LEU . . . . . . . . . . . . . 68.8 mt -74.22 -47.35 6.09 Favored Pre-proline 0 CA--C 1.533 0.316 0 CA-C-O 118.64 -0.695 . . . . 0.0 112.105 179.244 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' B' B ' 10' ' ' PRO . . . . . . . . . . . . . 84.0 Cg_endo -80.77 150.39 18.61 Favored 'Trans proline' 0 N--CA 1.495 1.6 0 C-N-CA 121.242 1.295 . . . . 0.0 111.816 175.49 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' B' B ' 11' ' ' LYS . . . . . . . . . . . . . 62.3 mtpt -86.67 97.46 10.58 Favored 'General case' 0 C--N 1.331 -0.229 0 CA-C-O 120.82 0.343 . . . . 0.0 110.362 178.74 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' B' B ' 12' ' ' VAL . . . . . . . . . . . . . 12.6 p -142.67 148.91 19.36 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.259 0 CA-C-N 116.102 -0.499 . . . . 0.0 110.568 -179.186 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' B' B ' 13' ' ' GLU . . . . . . . . . . . . . 82.3 tt0 -87.29 131.5 34.22 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 116.307 -0.406 . . . . 0.0 110.09 178.144 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' B' B ' 14' ' ' LEU . . . . . . . . . . . . . 28.0 mt -96.23 150.9 37.76 Favored Pre-proline 0 CA--C 1.532 0.263 0 CA-C-O 119.376 -0.345 . . . . 0.0 110.62 -178.225 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' B' B ' 15' ' ' PRO . . . . . . . . . . . . . 28.4 Cg_exo -60.75 159.43 28.71 Favored 'Trans proline' 0 N--CA 1.497 1.702 0 C-N-CA 121.307 1.338 . . . . 0.0 111.832 177.228 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' B' B ' 16' ' ' PRO . . . . . . . . . . . . . 38.5 Cg_exo -57.94 -45.0 35.2 Favored 'Trans proline' 0 N--CA 1.498 1.776 0 C-N-CA 121.452 1.435 . . . . 0.0 113.061 -176.73 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' B' B ' 17' ' ' ASP . . . . . . . . . . . . . 22.7 p-10 -87.64 12.47 12.54 Favored 'General case' 0 CA--C 1.536 0.413 0 N-CA-C 113.138 0.792 . . . . 0.0 113.138 -177.303 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' B' B ' 18' ' ' PHE . . . . . . . . . . . . . 48.2 t80 -58.26 -42.69 86.99 Favored 'General case' 0 N--CA 1.457 -0.092 0 O-C-N 122.054 -0.404 . . . . 0.0 110.178 -178.297 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' B' B ' 19' ' ' VAL . . . . . . . . . . . . . 46.3 t -56.94 -43.83 81.33 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 CA-C-N 116.308 -0.405 . . . . 0.0 110.533 -178.384 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' B' B ' 20' ' ' ASP . . . . . . . . . . . . . 36.8 m-20 -59.94 -41.95 92.94 Favored 'General case' 0 C--N 1.33 -0.276 0 C-N-CA 120.924 -0.31 . . . . 0.0 110.908 -177.964 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' B' B ' 21' ' ' VAL . . . . . . . . . . . . . 48.9 t -64.29 -46.65 92.63 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.27 0 C-N-CA 120.661 -0.416 . . . . 0.0 110.376 -177.78 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' B' B ' 22' ' ' ILE . . . . . 0.511 HG22 HD12 ' B' ' 26' ' ' LEU . 51.3 mm -56.32 -45.28 81.37 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.275 0 C-N-CA 120.955 -0.298 . . . . 0.0 110.577 179.036 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' B' B ' 23' ' ' ARG . . . . . . . . . . . . . 51.7 ttp180 -54.65 -48.58 72.14 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-O 120.584 0.23 . . . . 0.0 111.224 -178.472 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' B' B ' 24' ' ' ILE . . . . . . . . . . . . . 72.0 mt -59.96 -44.38 94.43 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.268 0 CA-C-N 116.599 -0.273 . . . . 0.0 111.293 -177.675 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' B' B ' 25' ' ' LYS . . . . . . . . . . . . . 35.9 mttm -63.99 -42.16 97.27 Favored 'General case' 0 C--N 1.33 -0.277 0 N-CA-C 112.341 0.496 . . . . 0.0 112.341 -178.82 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' B' B ' 26' ' ' LEU . . . . . 0.511 HD12 HG22 ' B' ' 22' ' ' ILE . 92.0 mt -78.42 -42.2 30.82 Favored 'General case' 0 C--N 1.328 -0.35 0 N-CA-C 113.162 0.801 . . . . 0.0 113.162 -170.911 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' B' B ' 27' ' ' GLN . . . . . . . . . . . . . 4.1 pt20 -47.51 140.93 5.45 Favored 'General case' 0 N--CA 1.468 0.459 0 N-CA-C 112.708 0.633 . . . . 0.0 112.708 -174.726 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' B' B ' 28' ' ' GLY . . . . . . . . . . . . . . . 100.7 -26.93 22.8 Favored Glycine 0 CA--C 1.533 1.168 0 CA-C-N 115.564 -0.744 . . . . 0.0 112.205 -177.521 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' B' B ' 29' ' ' LYS . . . . . . . . . . . . . 99.5 mttt -98.71 155.08 17.51 Favored 'General case' 0 C--N 1.332 -0.168 0 CA-C-N 117.379 0.59 . . . . 0.0 111.269 179.32 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' B' B ' 30' ' ' THR . . . . . . . . . . . . . 34.6 m -103.57 135.65 44.77 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 115.75 -0.659 . . . . 0.0 109.763 174.925 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' B' B ' 31' ' ' VAL . . . . . . . . . . . . . 35.4 m -130.86 161.21 41.25 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.245 0 CA-C-N 116.379 -0.373 . . . . 0.0 110.775 -178.805 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' B' B ' 32' ' ' ARG . . . . . . . . . . . . . 70.5 mtm180 -133.75 151.98 51.75 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 115.848 -0.615 . . . . 0.0 110.981 179.748 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' B' B ' 33' ' ' THR . . . . . . . . . . . . . 20.7 m -53.5 139.53 30.87 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.199 -0.455 . . . . 0.0 111.29 -178.758 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' B' B ' 34' ' ' GLY . . . . . . . . . . . . . . . 100.5 -17.01 57.34 Favored Glycine 0 CA--C 1.531 1.086 0 CA-C-O 119.584 -0.565 . . . . 0.0 113.224 178.9 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' B' B ' 35' ' ' ASP . . . . . . . . . . . . . 71.9 m-20 -64.78 148.29 51.5 Favored 'General case' 0 C--O 1.232 0.147 0 CA-C-N 118.183 0.992 . . . . 0.0 111.251 179.639 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' B' B ' 36' ' ' VAL . . . . . . . . . . . . . 46.3 t -117.92 128.41 75.05 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.22 0 CA-C-N 115.527 -0.76 . . . . 0.0 109.739 178.52 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' B' B ' 37' ' ' ILE . . . . . . . . . . . . . 69.8 mt -121.91 138.99 50.32 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.26 0 CA-C-N 116.259 -0.428 . . . . 0.0 109.977 -179.306 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' B' B ' 38' ' ' GLY . . . . . . . . . . . . . . . -114.22 128.97 8.48 Favored Glycine 0 CA--C 1.526 0.742 0 N-CA-C 111.176 -0.769 . . . . 0.0 111.176 -179.203 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' B' B ' 39' ' ' ILE . . . . . . . . . . . . . 75.6 mt -124.06 134.54 66.29 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.253 0 CA-C-O 120.765 0.317 . . . . 0.0 110.164 179.077 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' B' B ' 40' ' ' SER . . . . . . . . . . . . . 53.3 p -92.88 115.95 28.59 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 116.39 -0.368 . . . . 0.0 111.052 176.345 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' B' B ' 41' ' ' ILE . . . . . . . . . . . . . 44.7 mm -121.42 120.78 62.91 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.257 0 CA-C-O 120.775 0.321 . . . . 0.0 110.305 178.461 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' B' B ' 42' ' ' LEU . . . . . . . . . . . . . 62.6 mt 51.75 35.39 15.13 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-N 116.252 -0.431 . . . . 0.0 111.799 176.688 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' B' B ' 43' ' ' GLY . . . . . . . . . . . . . . . 73.88 31.79 59.7 Favored Glycine 0 CA--C 1.528 0.872 0 C-N-CA 121.073 -0.584 . . . . 0.0 112.141 177.706 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' B' B ' 44' ' ' LYS . . . . . . . . . . . . . 23.6 tptm -136.85 128.0 27.9 Favored 'General case' 0 C--N 1.329 -0.293 0 N-CA-C 109.397 -0.594 . . . . 0.0 109.397 177.736 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' B' B ' 45' ' ' GLU . . . . . . . . . . . . . 81.8 tt0 -82.73 117.42 22.64 Favored 'General case' 0 C--N 1.327 -0.373 0 C-N-CA 120.917 -0.313 . . . . 0.0 110.702 -178.356 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' B' B ' 46' ' ' VAL . . . . . . . . . . . . . 7.3 p -115.84 128.58 73.06 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.192 0 N-CA-C 109.412 -0.588 . . . . 0.0 109.412 176.284 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' B' B ' 47' ' ' LYS . . . . . . . . . . . . . 68.6 mttm -99.55 126.93 45.6 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 115.788 -0.642 . . . . 0.0 110.991 179.451 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' B' B ' 48' ' ' PHE . . . . . . . . . . . . . 91.1 m-85 -111.3 131.93 54.77 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-N 116.078 -0.51 . . . . 0.0 109.816 176.996 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' B' B ' 49' ' ' LYS . . . . . . . . . . . . . 83.5 tttt -106.56 134.97 48.88 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-N 116.365 -0.379 . . . . 0.0 110.269 178.6 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' B' B ' 50' ' ' VAL . . . . . . . . . . . . . 45.3 t -78.92 105.59 8.45 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.329 0 N-CA-C 108.993 -0.743 . . . . 0.0 108.993 175.328 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' B' B ' 51' ' ' VAL . . . . . . . . . . . . . 49.0 t -70.1 -53.42 23.58 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.387 0 N-CA-C 109.479 -0.563 . . . . 0.0 109.479 -174.208 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' B' B ' 52' ' ' GLN . . . . . . . . . . . . . 91.7 mt-30 -153.88 152.51 30.72 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 115.947 -0.57 . . . . 0.0 111.695 -177.617 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' B' B ' 53' ' ' ALA . . . . . . . . . . . . . . . -128.2 132.93 48.81 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 115.313 -0.858 . . . . 0.0 109.62 174.87 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' B' B ' 54' ' ' TYR . . . . . . . . . . . . . 58.2 t80 -129.05 107.61 18.01 Favored Pre-proline 0 CA--C 1.534 0.33 0 CA-C-O 118.219 -0.896 . . . . 0.0 110.354 179.767 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' B' B ' 55' ' ' PRO . . . . . . . . . . . . . 73.8 Cg_endo -77.22 169.75 73.32 Favored 'Cis proline' 0 N--CA 1.501 1.926 0 CA-C-N 121.839 1.692 . . . . 0.0 112.863 -4.419 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' B' B ' 56' ' ' SER . . . . . . . . . . . . . 50.6 m -117.59 132.0 23.81 Favored Pre-proline 0 CA--C 1.539 0.537 0 CA-C-O 118.352 -0.832 . . . . 0.0 109.548 174.361 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' B' B ' 57' ' ' PRO . . . . . . . . . . . . . 32.4 Cg_endo -65.21 164.99 57.4 Favored 'Cis proline' 0 N--CA 1.498 1.769 0 CA-C-N 122.027 1.76 . . . . 0.0 111.554 -2.615 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' B' B ' 58' ' ' LEU . . . . . . . . . . . . . 25.0 tp -129.4 137.51 50.96 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-O 120.997 0.427 . . . . 0.0 110.518 -178.284 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' B' B ' 59' ' ' ARG . . . . . . . . . . . . . 75.0 ttt180 -103.4 127.71 50.7 Favored 'General case' 0 C--N 1.326 -0.443 0 CA-C-N 115.731 -0.668 . . . . 0.0 109.225 175.169 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' B' B ' 60' ' ' VAL . . . . . . . . . . . . . 45.6 t -82.07 116.77 26.9 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.232 0 C-N-CA 120.553 -0.459 . . . . 0.0 110.39 -175.928 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' B' B ' 61' ' ' GLU . . . . . . . . . . . . . 70.6 mm-40 -131.14 162.14 30.57 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 115.905 -0.589 . . . . 0.0 109.877 176.618 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' B' B ' 62' ' ' ASP . . . . . . . . . . . . . 43.7 m-20 -53.15 -32.36 47.22 Favored 'General case' 0 C--N 1.328 -0.331 0 N-CA-C 111.807 0.299 . . . . 0.0 111.807 -179.694 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' B' B ' 63' ' ' ARG . . . . . . . . . . . . . 23.7 mmt180 -71.14 -21.94 62.13 Favored 'General case' 0 CA--C 1.532 0.282 0 N-CA-C 112.858 0.688 . . . . 0.0 112.858 -175.99 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' B' B ' 64' ' ' THR . . . . . . . . . . . . . 26.1 m -77.4 140.95 40.01 Favored 'General case' 0 C--N 1.331 -0.226 0 CA-C-O 121.0 0.429 . . . . 0.0 110.877 -175.315 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' B' B ' 65' ' ' LYS . . . . . . . . . . . . . 3.0 mptp? -89.75 134.67 34.05 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 115.976 -0.556 . . . . 0.0 110.233 179.753 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' B' B ' 66' ' ' ILE . . . . . . . . . . . . . 58.9 mt -114.28 129.0 71.04 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.229 0 N-CA-C 109.649 -0.5 . . . . 0.0 109.649 178.083 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' B' B ' 67' ' ' THR . . . . . . . . . . . . . 32.6 m -124.79 139.65 53.65 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-O 121.001 0.429 . . . . 0.0 111.014 -177.128 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' B' B ' 68' ' ' LEU . . . . . . . . . . . . . 6.8 mp . . . . . 0 C--N 1.329 -0.285 0 CA-C-N 115.886 -0.597 . . . . 0.0 110.171 176.196 . . . . . . . . 0 0 . 1 . 020 nuclear nobuild core ' B' B ' 73' ' ' VAL . . . . . . . . . . . . . 30.4 m . . . . . 0 C--O 1.231 0.112 0 N-CA-C 110.06 -0.348 . . . . 0.0 110.06 . . . . . . . . . 0 0 . 1 . 020 nuclear nobuild core ' B' B ' 74' ' ' ASP . . . . . . . . . . . . . 25.2 t0 -103.44 116.42 32.36 Favored 'General case' 0 C--N 1.33 -0.273 0 N-CA-C 109.819 -0.438 . . . . 0.0 109.819 -178.691 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' B' B ' 75' ' ' VAL . . . . . . . . . . . . . 41.7 t -111.34 122.23 65.39 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.243 0 CA-C-O 121.042 0.448 . . . . 0.0 110.355 -178.354 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' B' B ' 76' ' ' LEU . . . . . . . . . . . . . 35.8 mt -119.09 138.69 52.7 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 115.665 -0.698 . . . . 0.0 109.39 177.341 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' B' B ' 77' ' ' GLU . . . . . . . . . . . . . 46.3 mt-10 -134.32 136.37 43.43 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-O 121.14 0.495 . . . . 0.0 111.265 -176.914 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' B' B ' 78' ' ' ALA . . . . . . . . . . . . . . . -125.87 137.55 53.75 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 115.602 -0.726 . . . . 0.0 109.768 176.258 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' B' B ' 79' ' ' LYS . . . . . . . . . . . . . 93.5 mttt -81.73 119.1 23.43 Favored 'General case' 0 C--N 1.329 -0.311 0 C-N-CA 120.811 -0.356 . . . . 0.0 110.438 -179.16 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' B' B ' 80' ' ' ILE . . . . . . . . . . . . . 29.5 mm -134.65 118.46 26.04 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.292 0 CA-C-N 115.721 -0.672 . . . . 0.0 109.234 -176.652 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' B' B ' 81' ' ' LYS . . . . . . . . . . . . . 17.8 ttpt -108.67 123.92 49.73 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-O 120.818 0.342 . . . . 0.0 111.13 -177.073 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' B' B ' 82' ' ' GLY . . . . . . . . . . . . . . . 89.08 42.19 5.68 Favored Glycine 0 CA--C 1.526 0.779 0 C-N-CA 120.838 -0.696 . . . . 0.0 111.816 173.88 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' B' B ' 83' ' ' ILE . . . . . . . . . . . . . 69.9 mt -67.55 138.41 22.78 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.369 0 N-CA-C 109.883 -0.414 . . . . 0.0 109.883 177.969 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' B' B ' 84' ' ' LYS . . . . . . . . . . . . . 39.8 ttpt -100.39 -52.09 3.46 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-O 121.103 0.477 . . . . 0.0 110.046 179.643 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' B' B ' 85' ' ' ASP . . . . . . . . . . . . . 6.5 t70 -153.04 152.35 31.26 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 115.69 -0.687 . . . . 0.0 110.393 -179.955 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' B' B ' 86' ' ' VAL . . . . . . . . . . . . . 41.2 t -129.07 131.73 67.75 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.207 0 CA-C-O 120.871 0.367 . . . . 0.0 110.426 -179.61 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' B' B ' 87' ' ' ILE . . . . . . . . . . . . . 44.3 mm -119.28 126.37 75.28 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.238 0 N-CA-C 109.301 -0.629 . . . . 0.0 109.301 176.251 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' B' B ' 88' ' ' LEU . . . . . 0.434 HD13 HG21 ' A' ' 131' ' ' VAL . 81.3 mt -120.95 137.22 54.72 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-O 121.236 0.541 . . . . 0.0 111.706 -176.23 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' B' B ' 89' ' ' ASP . . . . . . . . . . . . . 5.2 t0 -133.09 154.83 50.2 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 115.452 -0.795 . . . . 0.0 109.054 174.823 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' B' B ' 90' ' ' GLU . . . . . . . . . . . . . 84.2 tt0 -48.84 -30.92 6.33 Favored 'General case' 0 C--N 1.33 -0.273 0 N-CA-C 112.804 0.668 . . . . 0.0 112.804 -172.891 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' B' B ' 91' ' ' ASN . . . . . . . . . . . . . 78.2 m-20 -131.54 28.78 4.6 Favored 'General case' 0 N--CA 1.466 0.343 0 N-CA-C 112.521 0.563 . . . . 0.0 112.521 -174.46 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' B' B ' 92' ' ' LEU . . . . . . . . . . . . . 16.9 tp -166.11 143.07 5.22 Favored 'General case' 0 C--N 1.331 -0.217 0 C-N-CA 120.765 -0.374 . . . . 0.0 110.923 179.794 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' B' B ' 93' ' ' ILE . . . . . . . . . . . . . 72.3 mt -125.13 123.83 66.17 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.242 0 N-CA-C 109.633 -0.506 . . . . 0.0 109.633 178.548 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' B' B ' 94' ' ' VAL . . . . . 0.591 HG21 HG11 ' B' ' 125' ' ' VAL . 44.1 t -125.41 127.54 71.92 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.238 0 CA-C-O 121.016 0.436 . . . . 0.0 109.996 178.126 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' B' B ' 95' ' ' VAL . . . . . . . . . . . . . 46.1 t -120.7 134.87 62.76 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.312 0 CA-C-N 115.944 -0.571 . . . . 0.0 109.765 179.872 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' B' B ' 96' ' ' ILE . . . . . . . . . . . . . 67.9 mt -115.46 128.46 72.67 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.273 0 N-CA-C 109.416 -0.587 . . . . 0.0 109.416 178.898 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' B' B ' 97' ' ' THR . . . . . . . . . . . . . 74.5 p -102.7 159.11 15.75 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-O 121.283 0.563 . . . . 0.0 111.308 -177.103 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' B' B ' 98' ' ' GLU . . . . . . . . . . . . . 45.0 mt-10 -53.95 -25.01 18.53 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.049 -0.523 . . . . 0.0 112.276 179.736 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' B' B ' 99' ' ' GLU . . . . . . . . . . . . . 33.7 tt0 -80.69 17.37 1.15 Allowed 'General case' 0 CA--C 1.538 0.494 0 N-CA-C 112.519 0.563 . . . . 0.0 112.519 -176.485 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' B' B ' 100' ' ' ASN . . . . . . . . . . . . . 2.4 m-20 60.72 37.97 18.61 Favored 'General case' 0 N--CA 1.463 0.181 0 O-C-N 121.801 -0.562 . . . . 0.0 110.883 179.392 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' B' B ' 101' ' ' GLU . . . . . . . . . . . . . 84.7 tt0 -116.19 144.13 44.59 Favored 'General case' 0 C--N 1.332 -0.169 0 CA-C-N 116.215 -0.448 . . . . 0.0 109.895 178.133 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' B' B ' 102' ' ' VAL . . . . . . . . . . . . . 44.8 t -116.51 127.07 74.22 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.234 0 CA-C-O 120.963 0.411 . . . . 0.0 109.907 -178.724 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' B' B ' 103' ' ' LEU . . . . . . . . . . . . . 51.1 mt -113.33 129.95 56.4 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 115.431 -0.804 . . . . 0.0 110.063 178.2 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' B' B ' 104' ' ' ILE . . . . . 0.41 HD12 ' HB3' ' B' ' 113' ' ' TYR . 67.7 mt -118.82 120.08 62.99 Favored 'Isoleucine or valine' 0 C--O 1.234 0.249 0 N-CA-C 110.213 -0.291 . . . . 0.0 110.213 -179.418 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' B' B ' 105' ' ' PHE . . . . . . . . . . . . . 38.6 m-85 -124.04 163.69 20.91 Favored 'General case' 0 C--N 1.332 -0.168 0 CA-C-N 115.537 -0.756 . . . . 0.0 109.55 178.404 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' B' B ' 106' ' ' ASN . . . . . . . . . . . . . 41.5 p-10 -95.92 -171.68 2.4 Favored 'General case' 0 C--N 1.33 -0.262 0 N-CA-C 109.955 -0.387 . . . . 0.0 109.955 173.949 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' B' B ' 107' ' ' GLN . . . . . . . . . . . . . 39.3 tt0 -59.86 -30.05 68.71 Favored 'General case' 0 C--N 1.328 -0.341 0 N-CA-C 111.806 0.299 . . . . 0.0 111.806 179.782 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' B' B ' 108' ' ' ASN . . . . . . . . . . . . . 3.7 t-20 -83.66 7.54 17.15 Favored 'General case' 0 CA--C 1.535 0.398 0 N-CA-C 113.275 0.843 . . . . 0.0 113.275 -177.366 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' B' B ' 109' ' ' LEU . . . . . . . . . . . . . 12.2 tp 63.01 39.88 9.75 Favored 'General case' 0 C--O 1.232 0.179 0 CA-C-O 121.116 0.484 . . . . 0.0 111.371 176.971 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' B' B ' 110' ' ' GLU . . . . . . . . . . . . . 95.9 mt-10 -108.88 163.44 13.28 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.28 -0.418 . . . . 0.0 110.381 177.064 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' B' B ' 111' ' ' GLU . . . . . . . . . . . . . 82.6 tt0 -84.65 123.63 30.57 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.193 -0.458 . . . . 0.0 111.037 -178.552 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' B' B ' 112' ' ' LEU . . . . . . . . . . . . . 22.7 mt -113.08 -46.02 3.13 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.094 -0.503 . . . . 0.0 110.257 174.374 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' B' B ' 113' ' ' TYR . . . . . 0.41 ' HB3' HD12 ' B' ' 104' ' ' ILE . 53.7 t80 -146.72 140.22 25.74 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.333 -0.394 . . . . 0.0 111.199 -179.998 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' B' B ' 114' ' ' ARG . . . . . . . . . . . . . 33.6 mtp180 -141.7 123.25 15.03 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.381 -0.372 . . . . 0.0 110.276 175.483 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' B' B ' 115' ' ' GLY . . . . . . . . . . . . . . . -150.08 161.08 28.79 Favored Glycine 0 CA--C 1.523 0.576 0 C-N-CA 120.7 -0.762 . . . . 0.0 111.364 179.922 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' B' B ' 116' ' ' LYS . . . . . . . . . . . . . 38.6 ttpt -126.9 138.08 53.25 Favored 'General case' 0 C--N 1.33 -0.25 0 N-CA-C 109.929 -0.397 . . . . 0.0 109.929 177.661 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' B' B ' 117' ' ' PHE . . . . . . . . . . . . . 35.7 m-85 -136.35 113.81 10.86 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-O 120.752 0.311 . . . . 0.0 110.347 -176.556 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' B' B ' 118' ' ' GLU . . . . . . . . . . . . . 44.2 mt-10 -54.83 -45.63 74.49 Favored 'General case' 0 C--N 1.329 -0.29 0 C-N-CA 120.942 -0.303 . . . . 0.0 111.27 -176.986 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' B' B ' 119' ' ' ASN . . . . . . . . . . . . . 34.7 m120 -93.78 28.78 2.25 Favored 'General case' 0 C--N 1.329 -0.287 0 O-C-N 123.554 0.534 . . . . 0.0 112.381 -173.688 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' B' B ' 120' ' ' LEU . . . . . . . . . . . . . 17.9 tp -57.37 119.9 7.26 Favored 'General case' 0 C--N 1.333 -0.141 0 C-N-CA 120.957 -0.297 . . . . 0.0 110.317 177.82 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' B' B ' 121' ' ' ASN . . . . . . . . . . . . . 45.8 t-20 -113.32 -44.06 3.28 Favored 'General case' 0 C--N 1.332 -0.19 0 CA-C-N 116.651 -0.25 . . . . 0.0 111.191 -177.164 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' B' B ' 122' ' ' LYS . . . . . . . . . . . . . 98.7 mttt -143.89 146.37 32.95 Favored 'General case' 0 C--N 1.332 -0.182 0 CA-C-O 121.087 0.47 . . . . 0.0 111.698 -178.351 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' B' B ' 123' ' ' VAL . . . . . . . . . . . . . 47.4 t -127.85 126.08 66.1 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.234 0 CA-C-N 115.756 -0.657 . . . . 0.0 109.375 175.075 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' B' B ' 124' ' ' LEU . . . . . . . . . . . . . 31.2 mt -125.6 134.7 51.83 Favored 'General case' 0 C--N 1.331 -0.212 0 CA-C-O 120.799 0.333 . . . . 0.0 110.675 -178.604 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' B' B ' 125' ' ' VAL . . . . . 0.721 HG12 HG23 ' B' ' 130' ' ' VAL . 35.1 m -132.15 144.22 37.74 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.244 0 CA-C-N 116.075 -0.511 . . . . 0.0 110.801 -179.213 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' B' B ' 126' ' ' ARG . . . . . 0.583 ' NH2' HD23 ' B' ' 129' ' ' LEU . 34.3 ptt-85 -152.51 120.49 6.18 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-O 121.328 0.585 . . . . 0.0 111.147 176.0 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' B' B ' 127' ' ' ASN . . . . . . . . . . . . . 82.3 m-20 52.82 -106.24 0.28 Allowed 'General case' 0 CA--C 1.542 0.637 0 CA-C-N 115.457 -0.792 . . . . 0.0 111.284 -179.439 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' B' B ' 128' ' ' ASP . . . . . . . . . . . . . 16.3 p-10 -114.1 0.87 14.42 Favored 'General case' 0 N--CA 1.468 0.445 0 CA-C-N 119.585 1.084 . . . . 0.0 113.372 -176.239 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' B' B ' 129' ' ' LEU . . . . . 0.583 HD23 ' NH2' ' B' ' 126' ' ' ARG . 18.0 tp -109.71 139.8 44.32 Favored 'General case' 0 C--N 1.332 -0.159 0 N-CA-C 109.699 -0.482 . . . . 0.0 109.699 -179.513 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' B' B ' 130' ' ' VAL . . . . . 0.721 HG23 HG12 ' B' ' 125' ' ' VAL . 13.2 p -134.39 143.1 38.94 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.2 0 CA-C-O 121.229 0.537 . . . . 0.0 110.9 -177.958 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' B' B ' 131' ' ' VAL . . . . . . . . . . . . . 42.9 t -135.97 139.79 45.27 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.246 0 CA-C-N 115.753 -0.658 . . . . 0.0 110.319 179.024 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' B' B ' 132' ' ' ILE . . . . . . . . . . . . . 72.9 mt -117.29 133.85 62.74 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.264 0 CA-C-N 115.599 -0.728 . . . . 0.0 109.481 179.7 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' B' B ' 133' ' ' ILE . . . . . . . . . . . . . 37.3 mm -115.47 124.21 71.74 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.224 0 CA-C-O 120.681 0.277 . . . . 0.0 110.965 -175.877 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' B' B ' 134' ' ' ASP . . . . . . . . . . . . . 9.6 p-10 -136.13 150.68 49.18 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-N 115.996 -0.547 . . . . 0.0 109.837 174.975 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' B' B ' 135' ' ' GLU . . . . . . . . . . . . . 46.7 tp10 -49.88 -28.95 7.26 Favored 'General case' 0 C--N 1.327 -0.393 0 N-CA-C 112.675 0.62 . . . . 0.0 112.675 -172.111 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' B' B ' 136' ' ' GLN . . . . . . . . . . . . . 58.7 tt0 -86.74 -31.55 20.89 Favored 'General case' 0 C--N 1.331 -0.233 0 N-CA-C 112.562 0.579 . . . . 0.0 112.562 -173.394 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' B' B ' 137' ' ' LYS . . . . . . . . . . . . . 56.9 pttt -166.09 174.66 9.12 Favored 'General case' 0 C--O 1.232 0.143 0 CA-C-O 121.545 0.688 . . . . 0.0 112.498 -172.649 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' B' B ' 138' ' ' LEU . . . . . 0.416 HD23 ' N ' ' B' ' 139' ' ' THR . 5.9 tt -120.54 129.84 53.98 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 114.932 -1.031 . . . . 0.0 109.811 179.048 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' B' B ' 139' ' ' THR . . . . . 0.416 ' N ' HD23 ' B' ' 138' ' ' LEU . 28.2 m -108.51 125.85 52.27 Favored 'General case' 0 C--N 1.331 -0.22 0 CA-C-N 116.272 -0.422 . . . . 0.0 110.357 179.446 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' B' B ' 140' ' ' LEU . . . . . 0.482 ' C ' HD23 ' B' ' 140' ' ' LEU . 8.0 tt -113.94 121.7 44.72 Favored 'General case' 0 C--N 1.329 -0.315 0 N-CA-C 109.156 -0.683 . . . . 0.0 109.156 -179.171 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' B' B ' 141' ' ' ILE . . . . . 0.421 ' HB ' HG13 ' B' ' 130' ' ' VAL . 19.0 mt -121.64 119.66 59.5 Favored 'Isoleucine or valine' 0 C--O 1.234 0.26 0 CA-C-O 120.949 0.404 . . . . 0.0 110.074 -176.193 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' B' B ' 142' ' ' ARG . . . . . . . . . . . . . 46.2 ttp180 -107.48 129.79 54.91 Favored 'General case' 0 C--N 1.332 -0.163 0 CA-C-N 115.198 -0.91 . . . . 0.0 110.772 -178.779 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' B' B ' 143' ' ' THR . . . . . . . . . . . . . 38.1 p . . . . . 0 C--O 1.22 -0.468 0 CA-C-O 118.044 -0.979 . . . . 0.0 110.516 178.969 . . . . . . . . 0 0 . 1 . 020 nuclear nobuild core ' C' C ' 2' ' ' SER . . . . . . . . . . . . . 16.6 p . . . . . 0 N--CA 1.461 0.089 0 CA-C-O 121.014 0.435 . . . . 0.0 110.52 . . . . . . . . . 0 0 . 1 . 020 nuclear nobuild core ' C' C ' 3' ' ' GLU . . . . . . . . . . . . . 95.5 mt-10 -141.48 141.29 33.65 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 115.978 -0.555 . . . . 0.0 111.089 -179.078 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' C' C ' 4' ' ' LEU . . . . . . . . . . . . . 15.3 tp -126.0 127.53 46.04 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 115.931 -0.577 . . . . 0.0 110.032 176.892 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' C' C ' 5' ' ' LYS . . . . . . . . . . . . . 86.8 mttt -106.5 120.57 42.26 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 116.438 -0.347 . . . . 0.0 110.776 178.162 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' C' C ' 6' ' ' LEU . . . . . 0.437 HD23 ' HA ' ' C' ' 50' ' ' VAL . 27.9 mt -115.05 148.82 38.4 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-N 115.295 -0.866 . . . . 0.0 110.381 179.772 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' C' C ' 7' ' ' LYS . . . . . . . . . . . . . 25.7 ttpp -134.62 133.18 21.13 Favored Pre-proline 0 CA--C 1.534 0.331 0 CA-C-O 118.791 -0.623 . . . . 0.0 110.04 176.875 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' C' C ' 8' ' ' PRO . . . . . . . . . . . . . 59.1 Cg_endo -89.7 135.81 2.53 Favored 'Trans proline' 0 N--CA 1.489 1.229 0 C-N-CA 121.69 1.593 . . . . 0.0 111.586 176.656 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' C' C ' 9' ' ' LEU . . . . . . . . . . . . . 34.2 mt -75.36 -47.47 4.33 Favored Pre-proline 0 CA--C 1.534 0.345 0 CA-C-O 118.581 -0.724 . . . . 0.0 112.085 -177.234 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' C' C ' 10' ' ' PRO . . . . . . . . . . . . . 71.8 Cg_endo -78.65 146.82 21.58 Favored 'Trans proline' 0 N--CA 1.495 1.609 0 C-N-CA 121.052 1.168 . . . . 0.0 111.684 175.143 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' C' C ' 11' ' ' LYS . . . . . . . . . . . . . 21.3 tptm -85.92 99.62 11.54 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-O 120.84 0.352 . . . . 0.0 110.349 -178.625 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' C' C ' 12' ' ' VAL . . . . . . . . . . . . . 12.6 p -143.65 150.12 17.5 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.264 0 CA-C-N 116.207 -0.451 . . . . 0.0 110.665 -179.172 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' C' C ' 13' ' ' GLU . . . . . . . . . . . . . 81.2 tt0 -84.55 127.67 34.18 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.281 -0.418 . . . . 0.0 110.13 178.582 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' C' C ' 14' ' ' LEU . . . . . . . . . . . . . 43.7 mt -96.63 150.03 36.51 Favored Pre-proline 0 CA--C 1.532 0.284 0 CA-C-O 119.368 -0.349 . . . . 0.0 110.627 -178.136 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' C' C ' 15' ' ' PRO . . . . . . . . . . . . . 28.0 Cg_exo -61.23 158.95 32.7 Favored 'Trans proline' 0 N--CA 1.497 1.701 0 C-N-CA 121.26 1.307 . . . . 0.0 111.97 177.754 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' C' C ' 16' ' ' PRO . . . . . . . . . . . . . 26.4 Cg_exo -60.79 -39.34 63.47 Favored 'Trans proline' 0 N--CA 1.496 1.671 0 C-N-CA 121.433 1.422 . . . . 0.0 112.732 -179.128 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' C' C ' 17' ' ' ASP . . . . . . . . . . . . . 19.3 p-10 -87.84 12.76 12.22 Favored 'General case' 0 CA--C 1.535 0.385 0 N-CA-C 113.171 0.804 . . . . 0.0 113.171 -177.006 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' C' C ' 18' ' ' PHE . . . . . . . . . . . . . 42.7 t80 -58.29 -45.39 88.05 Favored 'General case' 0 C--N 1.333 -0.117 0 O-C-N 122.135 -0.353 . . . . 0.0 110.089 -177.754 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' C' C ' 19' ' ' VAL . . . . . . . . . . . . . 47.8 t -55.87 -43.25 73.84 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.355 0 CA-C-N 116.523 -0.308 . . . . 0.0 110.779 -177.356 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' C' C ' 20' ' ' ASP . . . . . . . . . . . . . 7.5 t70 -60.09 -47.29 86.5 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-O 120.799 0.333 . . . . 0.0 111.009 -176.676 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' C' C ' 21' ' ' VAL . . . . . . . . . . . . . 46.4 t -64.4 -43.06 96.99 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.259 0 C-N-CA 120.663 -0.415 . . . . 0.0 110.408 -177.1 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' C' C ' 22' ' ' ILE . . . . . . . . . . . . . 43.9 mm -55.76 -48.31 78.2 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.346 0 N-CA-C 110.438 -0.208 . . . . 0.0 110.438 178.488 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' C' C ' 23' ' ' ARG . . . . . . . . . . . . . 53.8 ttp180 -54.97 -44.48 74.43 Favored 'General case' 0 C--N 1.332 -0.175 0 C-N-CA 120.911 -0.316 . . . . 0.0 111.221 -177.988 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' C' C ' 24' ' ' ILE . . . . . . . . . . . . . 75.0 mt -59.23 -46.9 91.89 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.253 0 CA-C-O 120.721 0.296 . . . . 0.0 110.938 -179.658 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' C' C ' 25' ' ' LYS . . . . . . . . . . . . . 44.2 mtmt -64.63 -38.62 91.63 Favored 'General case' 0 C--N 1.328 -0.331 0 N-CA-C 112.483 0.549 . . . . 0.0 112.483 -177.61 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' C' C ' 26' ' ' LEU . . . . . . . . . . . . . 81.1 mt -79.02 -44.74 21.62 Favored 'General case' 0 C--N 1.33 -0.259 0 N-CA-C 113.268 0.84 . . . . 0.0 113.268 -172.282 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' C' C ' 27' ' ' GLN . . . . . . . . . . . . . 11.6 pt20 -47.01 140.39 4.92 Favored 'General case' 0 N--CA 1.467 0.423 0 N-CA-C 112.812 0.671 . . . . 0.0 112.812 -173.548 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' C' C ' 28' ' ' GLY . . . . . . . . . . . . . . . 98.21 -27.09 20.91 Favored Glycine 0 CA--C 1.533 1.199 0 CA-C-N 115.513 -0.767 . . . . 0.0 112.103 -176.774 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' C' C ' 29' ' ' LYS . . . . . . . . . . . . . 29.2 mtpp -98.0 155.18 17.22 Favored 'General case' 0 C--O 1.232 0.154 0 CA-C-N 117.149 0.474 . . . . 0.0 111.072 179.246 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' C' C ' 30' ' ' THR . . . . . . . . . . . . . 28.7 m -100.37 139.59 35.82 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 115.991 -0.55 . . . . 0.0 110.361 177.307 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' C' C ' 31' ' ' VAL . . . . . . . . . . . . . 35.0 m -130.41 149.84 33.99 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.285 0 CA-C-N 116.319 -0.401 . . . . 0.0 110.759 -179.619 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' C' C ' 32' ' ' ARG . . . . . . . . . . . . . 72.2 mtp180 -132.68 154.09 50.48 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-O 121.198 0.523 . . . . 0.0 110.821 177.07 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' C' C ' 33' ' ' THR . . . . . 0.437 HG23 ' HA ' ' C' ' 52' ' ' GLN . 15.3 m -53.5 136.96 37.32 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-N 116.022 -0.536 . . . . 0.0 111.239 -179.026 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' C' C ' 34' ' ' GLY . . . . . . . . . . . . . . . 101.15 -16.99 56.63 Favored Glycine 0 CA--C 1.532 1.142 0 CA-C-O 119.641 -0.533 . . . . 0.0 113.346 178.24 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' C' C ' 35' ' ' ASP . . . . . . . . . . . . . 61.5 m-20 -64.53 149.61 48.35 Favored 'General case' 0 N--CA 1.461 0.116 0 CA-C-N 118.081 0.941 . . . . 0.0 111.1 179.599 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' C' C ' 36' ' ' VAL . . . . . . . . . . . . . 46.0 t -126.34 130.69 71.93 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.277 0 CA-C-N 115.82 -0.627 . . . . 0.0 109.812 178.682 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' C' C ' 37' ' ' ILE . . . . . . . . . . . . . 68.3 mt -122.2 139.39 49.3 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.259 0 CA-C-N 116.137 -0.483 . . . . 0.0 109.952 -179.458 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' C' C ' 38' ' ' GLY . . . . . . . . . . . . . . . -113.34 128.84 8.55 Favored Glycine 0 CA--C 1.527 0.782 0 N-CA-C 110.908 -0.877 . . . . 0.0 110.908 179.294 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' C' C ' 39' ' ' ILE . . . . . . . . . . . . . 72.7 mt -125.07 129.56 73.3 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.212 0 N-CA-C 109.828 -0.434 . . . . 0.0 109.828 179.091 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' C' C ' 40' ' ' SER . . . . . . . . . . . . . 85.7 p -92.97 121.13 33.99 Favored 'General case' 0 C--N 1.329 -0.294 0 C-N-CA 120.915 -0.314 . . . . 0.0 110.946 176.803 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' C' C ' 41' ' ' ILE . . . . . . . . . . . . . 74.5 mt -131.78 122.47 49.73 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.19 0 CA-C-O 120.756 0.312 . . . . 0.0 110.179 178.363 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' C' C ' 42' ' ' LEU . . . . . . . . . . . . . 82.2 mt 57.5 34.18 24.25 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.146 -0.479 . . . . 0.0 111.756 178.59 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' C' C ' 43' ' ' GLY . . . . . . . . . . . . . . . 80.39 -10.14 45.11 Favored Glycine 0 CA--C 1.534 1.264 0 C-N-CA 121.262 -0.494 . . . . 0.0 113.447 176.879 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' C' C ' 44' ' ' LYS . . . . . . . . . . . . . 96.6 mttt -99.19 129.16 45.41 Favored 'General case' 0 C--N 1.333 -0.127 0 CA-C-N 117.917 0.858 . . . . 0.0 110.052 177.327 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' C' C ' 45' ' ' GLU . . . . . . . . . . . . . 37.7 tp10 -85.18 126.92 34.04 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.414 -0.357 . . . . 0.0 110.481 179.321 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' C' C ' 46' ' ' VAL . . . . . . . . . . . . . 7.4 p -119.23 130.69 73.59 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.227 0 CA-C-O 121.203 0.525 . . . . 0.0 109.824 177.484 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' C' C ' 47' ' ' LYS . . . . . . . . . . . . . 44.6 mmtm -99.09 128.4 45.22 Favored 'General case' 0 C--N 1.331 -0.23 0 CA-C-N 115.719 -0.673 . . . . 0.0 111.281 177.746 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' C' C ' 48' ' ' PHE . . . . . . . . . . . . . 95.5 m-85 -112.3 131.8 55.31 Favored 'General case' 0 C--N 1.33 -0.251 0 N-CA-C 109.634 -0.506 . . . . 0.0 109.634 174.676 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' C' C ' 49' ' ' LYS . . . . . . . . . . . . . 79.7 tttt -107.94 137.53 45.77 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.417 -0.356 . . . . 0.0 110.222 179.103 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' C' C ' 50' ' ' VAL . . . . . 0.437 ' HA ' HD23 ' C' ' 6' ' ' LEU . 44.8 t -82.04 107.72 14.35 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.289 0 N-CA-C 109.389 -0.597 . . . . 0.0 109.389 177.065 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' C' C ' 51' ' ' VAL . . . . . . . . . . . . . 51.8 t -69.58 -47.45 71.51 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.335 0 CA-C-N 116.029 -0.532 . . . . 0.0 109.893 -174.335 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' C' C ' 52' ' ' GLN . . . . . 0.437 ' HA ' HG23 ' C' ' 33' ' ' THR . 61.3 tt0 -169.74 144.43 2.86 Favored 'General case' 0 C--N 1.331 -0.217 0 C-N-CA 120.288 -0.565 . . . . 0.0 111.648 -179.978 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' C' C ' 53' ' ' ALA . . . . . . . . . . . . . . . -114.51 134.85 54.71 Favored 'General case' 0 C--N 1.331 -0.227 0 CA-C-N 115.627 -0.715 . . . . 0.0 110.117 176.429 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' C' C ' 54' ' ' TYR . . . . . . . . . . . . . 51.0 t80 -128.99 112.08 18.55 Favored Pre-proline 0 CA--C 1.536 0.408 0 CA-C-O 118.189 -0.91 . . . . 0.0 110.453 178.809 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' C' C ' 55' ' ' PRO . . . . . . . . . . . . . 72.7 Cg_endo -77.15 169.36 74.43 Favored 'Cis proline' 0 N--CA 1.5 1.9 0 CA-C-N 122.053 1.769 . . . . 0.0 112.2 -6.336 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' C' C ' 56' ' ' SER . . . . . . . . . . . . . 14.7 m -117.23 135.87 23.25 Favored Pre-proline 0 CA--C 1.538 0.509 0 CA-C-O 118.591 -0.718 . . . . 0.0 109.605 175.272 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' C' C ' 57' ' ' PRO . . . . . . . . . . . . . 49.1 Cg_endo -70.17 146.76 83.92 Favored 'Cis proline' 0 N--CA 1.496 1.653 0 CA-C-N 121.724 1.651 . . . . 0.0 111.355 -3.484 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' C' C ' 58' ' ' LEU . . . . . . . . . . . . . 17.2 tp -107.81 135.87 48.49 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-O 120.847 0.356 . . . . 0.0 110.798 -177.329 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' C' C ' 59' ' ' ARG . . . . . . . . . . . . . 42.4 ttp180 -102.44 119.85 39.51 Favored 'General case' 0 C--N 1.328 -0.349 0 N-CA-C 108.971 -0.752 . . . . 0.0 108.971 174.418 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' C' C ' 60' ' ' VAL . . . . . . . . . . . . . 41.2 t -76.2 122.73 30.97 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.238 0 C-N-CA 120.661 -0.415 . . . . 0.0 110.674 -173.289 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' C' C ' 61' ' ' GLU . . . . . . . . . . . . . 88.3 mt-10 -131.09 163.13 28.32 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 115.938 -0.573 . . . . 0.0 109.749 175.962 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' C' C ' 62' ' ' ASP . . . . . . . . . . . . . 11.4 p-10 -53.87 -30.4 45.59 Favored 'General case' 0 C--N 1.328 -0.339 0 N-CA-C 111.85 0.315 . . . . 0.0 111.85 178.751 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' C' C ' 63' ' ' ARG . . . . . . . . . . . . . 77.8 mtp180 -71.58 -22.08 61.78 Favored 'General case' 0 CA--C 1.533 0.308 0 N-CA-C 112.952 0.723 . . . . 0.0 112.952 -175.958 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' C' C ' 64' ' ' THR . . . . . . . . . . . . . 31.0 m -71.46 141.79 50.22 Favored 'General case' 0 C--N 1.331 -0.213 0 CA-C-O 120.859 0.362 . . . . 0.0 111.381 -174.173 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' C' C ' 65' ' ' LYS . . . . . . . . . . . . . 2.4 mptp? -88.96 129.66 35.59 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 115.925 -0.579 . . . . 0.0 109.849 177.416 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' C' C ' 66' ' ' ILE . . . . . . . . . . . . . 66.8 mt -116.68 127.84 74.2 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.268 0 N-CA-C 109.913 -0.402 . . . . 0.0 109.913 179.615 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' C' C ' 67' ' ' THR . . . . . . . . . . . . . 32.2 m -127.89 143.69 51.1 Favored 'General case' 0 C--N 1.332 -0.164 0 CA-C-N 116.16 -0.473 . . . . 0.0 111.0 -177.25 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' C' C ' 68' ' ' LEU . . . . . . . . . . . . . 28.2 mt . . . . . 0 C--N 1.33 -0.246 0 CA-C-N 115.877 -0.602 . . . . 0.0 110.404 177.435 . . . . . . . . 0 0 . 1 . 020 nuclear nobuild core ' C' C ' 73' ' ' VAL . . . . . . . . . . . . . 31.5 m . . . . . 0 C--O 1.231 0.127 0 CA-C-O 121.069 0.462 . . . . 0.0 110.741 . . . . . . . . . 0 0 . 1 . 020 nuclear nobuild core ' C' C ' 74' ' ' ASP . . . . . . . . . . . . . 13.7 t0 -97.46 119.64 36.37 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 115.58 -0.736 . . . . 0.0 109.437 178.436 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' C' C ' 75' ' ' VAL . . . . . . . . . . . . . 43.0 t -109.75 122.52 64.49 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.221 0 CA-C-O 121.036 0.446 . . . . 0.0 110.402 -177.906 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' C' C ' 76' ' ' LEU . . . . . . . . . . . . . 28.7 mt -123.1 140.53 52.93 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 115.612 -0.722 . . . . 0.0 109.678 178.568 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' C' C ' 77' ' ' GLU . . . . . . . . . . . . . 97.2 mt-10 -132.83 135.67 45.78 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-O 121.082 0.468 . . . . 0.0 111.12 -179.267 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' C' C ' 78' ' ' ALA . . . . . . . . . . . . . . . -124.55 133.92 53.15 Favored 'General case' 0 C--O 1.233 0.221 0 CA-C-N 115.807 -0.633 . . . . 0.0 109.903 177.013 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' C' C ' 79' ' ' LYS . . . . . 0.683 ' O ' HD13 ' C' ' 80' ' ' ILE . 61.3 mtpt -79.15 118.31 20.98 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-O 120.874 0.369 . . . . 0.0 110.747 -178.068 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' C' C ' 80' ' ' ILE . . . . . 0.683 HD13 ' O ' ' C' ' 79' ' ' LYS . 34.7 mm -139.18 105.98 2.7 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.285 0 N-CA-C 108.886 -0.783 . . . . 0.0 108.886 -178.462 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' C' C ' 81' ' ' LYS . . . . . . . . . . . . . 23.2 tptm -98.99 126.52 44.71 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-O 120.849 0.357 . . . . 0.0 111.137 -175.715 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' C' C ' 82' ' ' GLY . . . . . . . . . . . . . . . 89.17 42.07 5.68 Favored Glycine 0 CA--C 1.526 0.758 0 C-N-CA 120.755 -0.736 . . . . 0.0 111.798 174.816 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' C' C ' 83' ' ' ILE . . . . . . . . . . . . . 72.5 mt -69.73 136.22 26.62 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.338 0 N-CA-C 109.648 -0.501 . . . . 0.0 109.648 177.182 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' C' C ' 84' ' ' LYS . . . . . . . . . . . . . 22.9 ttmt -94.7 -54.1 3.62 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-O 121.123 0.487 . . . . 0.0 110.121 -179.759 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' C' C ' 85' ' ' ASP . . . . . . . . . . . . . 7.6 t70 -152.31 148.09 27.11 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 115.604 -0.725 . . . . 0.0 110.352 -179.005 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' C' C ' 86' ' ' VAL . . . . . . . . . . . . . 45.3 t -126.9 129.32 71.34 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.275 0 CA-C-O 120.976 0.417 . . . . 0.0 110.225 179.999 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' C' C ' 87' ' ' ILE . . . . . 0.498 ' N ' HD12 ' C' ' 87' ' ' ILE . 5.1 mp -118.32 129.41 74.67 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.239 0 CA-C-N 115.898 -0.592 . . . . 0.0 109.524 177.403 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' C' C ' 88' ' ' LEU . . . . . . . . . . . . . 26.9 mt -111.14 140.15 45.92 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-O 120.96 0.409 . . . . 0.0 111.312 -177.277 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' C' C ' 89' ' ' ASP . . . . . . . . . . . . . 36.0 t0 -132.16 157.39 44.4 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 115.811 -0.631 . . . . 0.0 109.542 177.314 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' C' C ' 90' ' ' GLU . . . . . . . . . . . . . 40.5 mp0 -49.66 -34.09 17.45 Favored 'General case' 0 C--N 1.331 -0.222 0 N-CA-C 112.914 0.709 . . . . 0.0 112.914 -171.448 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' C' C ' 91' ' ' ASN . . . . . . . . . . . . . 26.2 m120 -130.23 16.22 5.58 Favored 'General case' 0 N--CA 1.469 0.492 0 N-CA-C 113.256 0.836 . . . . 0.0 113.256 -177.225 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' C' C ' 92' ' ' LEU . . . . . . . . . . . . . 28.9 mt -148.12 149.76 32.61 Favored 'General case' 0 C--N 1.332 -0.188 0 CA-C-O 120.798 0.332 . . . . 0.0 110.763 -175.568 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' C' C ' 93' ' ' ILE . . . . . . . . . . . . . 68.1 mt -126.01 118.25 51.18 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.292 0 N-CA-C 109.041 -0.725 . . . . 0.0 109.041 175.648 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' C' C ' 94' ' ' VAL . . . . . 0.542 HG21 HG11 ' C' ' 125' ' ' VAL . 44.5 t -117.61 125.54 74.15 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.255 0 CA-C-O 121.034 0.445 . . . . 0.0 109.956 -178.727 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' C' C ' 95' ' ' VAL . . . . . . . . . . . . . 42.3 t -120.1 134.64 62.93 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.307 0 CA-C-N 115.859 -0.61 . . . . 0.0 109.852 -178.94 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' C' C ' 96' ' ' ILE . . . . . . . . . . . . . 64.9 mt -114.17 126.03 71.59 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.279 0 N-CA-C 109.016 -0.735 . . . . 0.0 109.016 177.432 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' C' C ' 97' ' ' THR . . . . . . . . . . . . . 76.2 p -100.87 157.49 16.68 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-O 120.908 0.385 . . . . 0.0 111.093 -176.317 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' C' C ' 98' ' ' GLU . . . . . . . . . . . . . 13.0 pt-20 -53.96 -22.57 10.61 Favored 'General case' 0 CA--C 1.535 0.366 0 N-CA-C 112.279 0.474 . . . . 0.0 112.279 178.019 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' C' C ' 99' ' ' GLU . . . . . . . . . . . . . 95.3 mt-10 -78.18 12.51 1.83 Allowed 'General case' 0 CA--C 1.536 0.434 0 N-CA-C 113.022 0.749 . . . . 0.0 113.022 179.605 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' C' C ' 100' ' ' ASN . . . . . . . . . . . . . 2.1 m-20 61.87 38.07 14.86 Favored 'General case' 0 CA--C 1.53 0.207 0 CA-C-O 121.028 0.442 . . . . 0.0 110.923 179.48 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' C' C ' 101' ' ' GLU . . . . . . . . . . . . . 42.0 mt-10 -111.17 148.71 32.17 Favored 'General case' 0 CA--C 1.521 -0.17 0 CA-C-N 115.988 -0.551 . . . . 0.0 110.494 176.019 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' C' C ' 102' ' ' VAL . . . . . . . . . . . . . 46.6 t -114.85 120.9 65.76 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.293 0 CA-C-N 115.487 -0.779 . . . . 0.0 109.126 177.114 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' C' C ' 103' ' ' LEU . . . . . . . . . . . . . 22.1 mt -111.56 126.12 54.65 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 115.68 -0.691 . . . . 0.0 109.994 177.851 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' C' C ' 104' ' ' ILE . . . . . 0.543 HD12 ' HB3' ' C' ' 113' ' ' TYR . 68.4 mt -111.94 114.21 46.39 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.325 0 N-CA-C 109.58 -0.526 . . . . 0.0 109.58 179.318 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' C' C ' 105' ' ' PHE . . . . . . . . . . . . . 95.6 m-85 -117.23 163.12 16.78 Favored 'General case' 0 C--N 1.332 -0.169 0 O-C-N 124.056 0.847 . . . . 0.0 109.956 -179.796 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' C' C ' 106' ' ' ASN . . . . . . . . . . . . . 51.1 p-10 -104.05 -170.73 1.82 Allowed 'General case' 0 C--N 1.328 -0.362 0 N-CA-C 109.661 -0.496 . . . . 0.0 109.661 171.805 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' C' C ' 107' ' ' GLN . . . . . . . . . . . . . 45.4 tt0 -58.39 -28.9 65.6 Favored 'General case' 0 C--N 1.328 -0.35 0 N-CA-C 112.071 0.397 . . . . 0.0 112.071 178.513 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' C' C ' 108' ' ' ASN . . . . . . . . . . . . . 48.6 t30 -89.49 6.86 39.01 Favored 'General case' 0 CA--C 1.536 0.427 0 N-CA-C 113.202 0.815 . . . . 0.0 113.202 -175.857 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' C' C ' 109' ' ' LEU . . . . . . . . . . . . . 89.0 mt 59.09 31.94 21.74 Favored 'General case' 0 C--N 1.332 -0.157 0 N-CA-C 112.034 0.383 . . . . 0.0 112.034 175.968 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' C' C ' 110' ' ' GLU . . . . . . . . . . . . . 14.0 pt-20 -106.09 144.22 33.11 Favored 'General case' 0 C--N 1.332 -0.165 0 N-CA-C 109.616 -0.513 . . . . 0.0 109.616 173.867 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' C' C ' 111' ' ' GLU . . . . . . . . . . . . . 54.5 tt0 -66.79 121.95 16.59 Favored 'General case' 0 C--N 1.327 -0.412 0 CA-C-N 116.12 -0.491 . . . . 0.0 111.528 -172.281 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' C' C ' 112' ' ' LEU . . . . . . . . . . . . . 10.7 mt -101.41 -46.16 5.09 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.039 -0.528 . . . . 0.0 109.653 174.009 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' C' C ' 113' ' ' TYR . . . . . 0.543 ' HB3' HD12 ' C' ' 104' ' ' ILE . 64.0 t80 -148.48 140.55 23.98 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.059 -0.519 . . . . 0.0 111.133 178.023 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' C' C ' 114' ' ' ARG . . . . . . . . . . . . . 29.6 ttm180 -137.61 126.12 23.54 Favored 'General case' 0 C--N 1.329 -0.289 0 N-CA-C 109.819 -0.438 . . . . 0.0 109.819 175.803 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' C' C ' 115' ' ' GLY . . . . . . . . . . . . . . . -150.12 161.56 28.94 Favored Glycine 0 CA--C 1.522 0.505 0 N-CA-C 110.753 -0.939 . . . . 0.0 110.753 -179.089 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' C' C ' 116' ' ' LYS . . . . . . . . . . . . . 26.4 ttpp -127.84 134.35 49.42 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-O 120.755 0.312 . . . . 0.0 110.363 -179.614 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' C' C ' 117' ' ' PHE . . . . . . . . . . . . . 59.2 m-85 -134.37 113.91 12.39 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.249 -0.432 . . . . 0.0 109.982 -178.932 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' C' C ' 118' ' ' GLU . . . . . . . . . . . . . 44.4 mp0 -58.06 -39.47 78.56 Favored 'General case' 0 C--N 1.328 -0.332 0 C-N-CA 120.629 -0.429 . . . . 0.0 110.745 -175.649 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' C' C ' 119' ' ' ASN . . . . . . . . . . . . . 3.5 m120 -100.06 30.73 3.62 Favored 'General case' 0 C--N 1.329 -0.286 0 N-CA-C 112.169 0.433 . . . . 0.0 112.169 -175.341 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' C' C ' 120' ' ' LEU . . . . . . . . . . . . . 18.5 tp -58.85 119.85 7.94 Favored 'General case' 0 C--N 1.332 -0.157 0 N-CA-C 110.029 -0.36 . . . . 0.0 110.029 178.279 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' C' C ' 121' ' ' ASN . . . . . . . . . . . . . 87.0 m-20 -114.16 -44.16 3.16 Favored 'General case' 0 C--N 1.333 -0.137 0 CA-C-N 116.493 -0.322 . . . . 0.0 111.302 -178.272 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' C' C ' 122' ' ' LYS . . . . . . . . . . . . . 62.1 mtpt -143.51 151.27 40.07 Favored 'General case' 0 C--N 1.33 -0.239 0 CA-C-O 120.973 0.416 . . . . 0.0 111.532 -175.258 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' C' C ' 123' ' ' VAL . . . . . . . . . . . . . 43.6 t -135.2 135.16 52.55 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.245 0 CA-C-N 116.143 -0.48 . . . . 0.0 109.866 176.059 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' C' C ' 124' ' ' LEU . . . . . . . . . . . . . 55.8 mt -126.0 141.88 51.77 Favored 'General case' 0 C--N 1.331 -0.221 0 CA-C-O 120.897 0.38 . . . . 0.0 110.839 -177.962 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' C' C ' 125' ' ' VAL . . . . . 0.542 HG11 HG21 ' C' ' 94' ' ' VAL . 34.9 m -135.93 138.72 47.17 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.201 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.74 179.039 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' C' C ' 126' ' ' ARG . . . . . . . . . . . . . 46.6 ptt85 -152.53 131.08 12.23 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-O 120.849 0.357 . . . . 0.0 110.774 175.873 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' C' C ' 127' ' ' ASN . . . . . . . . . . . . . 89.7 m-20 50.71 -115.43 0.86 Allowed 'General case' 0 CA--C 1.546 0.797 0 CA-C-O 118.67 -0.681 . . . . 0.0 111.177 -179.77 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' C' C ' 128' ' ' ASP . . . . . . . . . . . . . 8.7 p-10 -114.11 16.06 18.19 Favored 'General case' 0 CA--C 1.536 0.433 0 CA-C-N 120.17 1.35 . . . . 0.0 112.848 -179.884 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' C' C ' 129' ' ' LEU . . . . . . . . . . . . . 5.7 tt -111.96 136.75 50.89 Favored 'General case' 0 C--O 1.234 0.252 0 N-CA-C 110.024 -0.361 . . . . 0.0 110.024 -179.617 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' C' C ' 130' ' ' VAL . . . . . . . . . . . . . 43.2 t -117.99 135.88 56.97 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.185 0 CA-C-N 116.39 -0.368 . . . . 0.0 110.109 -177.442 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' C' C ' 131' ' ' VAL . . . . . . . . . . . . . 43.4 t -133.79 133.78 56.51 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.214 0 CA-C-O 120.938 0.399 . . . . 0.0 110.289 178.513 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' C' C ' 132' ' ' ILE . . . . . . . . . . . . . 70.6 mt -119.82 133.31 66.99 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.233 0 N-CA-C 109.513 -0.551 . . . . 0.0 109.513 -179.567 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' C' C ' 133' ' ' ILE . . . . . . . . . . . . . 40.9 mm -117.77 120.78 65.7 Favored 'Isoleucine or valine' 0 C--O 1.234 0.266 0 CA-C-O 120.801 0.334 . . . . 0.0 111.102 -175.301 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' C' C ' 134' ' ' ASP . . . . . . . . . . . . . 6.9 p-10 -132.43 148.0 52.39 Favored 'General case' 0 C--N 1.33 -0.251 0 N-CA-C 109.708 -0.478 . . . . 0.0 109.708 176.322 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' C' C ' 135' ' ' GLU . . . . . . . . . . . . . 41.6 tp10 -49.98 -29.42 8.5 Favored 'General case' 0 C--N 1.327 -0.387 0 N-CA-C 112.648 0.61 . . . . 0.0 112.648 -173.667 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' C' C ' 136' ' ' GLN . . . . . . . . . . . . . 93.9 mt-30 -79.96 -33.32 39.63 Favored 'General case' 0 C--O 1.234 0.268 0 N-CA-C 112.321 0.489 . . . . 0.0 112.321 -175.302 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' C' C ' 137' ' ' LYS . . . . . . . . . . . . . 46.8 pttt -169.93 174.65 5.49 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-O 121.403 0.621 . . . . 0.0 112.31 -172.451 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' C' C ' 138' ' ' LEU . . . . . 0.411 HD23 ' N ' ' C' ' 139' ' ' THR . 5.2 tt -116.12 129.88 56.54 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 115.116 -0.947 . . . . 0.0 109.951 179.499 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' C' C ' 139' ' ' THR . . . . . 0.411 ' N ' HD23 ' C' ' 138' ' ' LEU . 27.0 m -108.39 126.61 53.07 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-N 116.318 -0.401 . . . . 0.0 110.366 179.855 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' C' C ' 140' ' ' LEU . . . . . . . . . . . . . 14.3 tp -114.44 121.37 43.33 Favored 'General case' 0 C--N 1.33 -0.273 0 N-CA-C 109.048 -0.723 . . . . 0.0 109.048 -179.463 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' C' C ' 141' ' ' ILE . . . . . . . . . . . . . 19.5 mt -119.91 115.6 47.91 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.279 0 CA-C-O 120.978 0.418 . . . . 0.0 109.906 -175.888 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' C' C ' 142' ' ' ARG . . . . . . . . . . . . . 84.2 mtm180 . . . . . 0 C--N 1.33 -0.25 0 CA-C-N 115.243 -0.889 . . . . 0.0 110.841 -175.933 . . . . . . . . 0 0 . 1 . 020 nuclear nobuild core ' D' D ' 2' ' ' SER . . . . . . . . . . . . . 6.8 p . . . . . 0 C--O 1.231 0.119 0 CA-C-O 120.859 0.362 . . . . 0.0 110.718 . . . . . . . . . 0 0 . 1 . 020 nuclear nobuild core ' D' D ' 3' ' ' GLU . . . . . . . . . . . . . 95.6 mt-10 -140.22 138.23 34.92 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.03 -0.532 . . . . 0.0 110.897 179.236 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' D' D ' 4' ' ' LEU . . . . . 0.414 HD21 HD21 ' D' ' 6' ' ' LEU . 17.2 tp -122.86 128.33 50.21 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 115.911 -0.586 . . . . 0.0 110.249 178.095 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' D' D ' 5' ' ' LYS . . . . . . . . . . . . . 67.6 mttm -105.54 121.4 43.88 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.382 -0.372 . . . . 0.0 110.468 178.219 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' D' D ' 6' ' ' LEU . . . . . 0.414 HD21 HD21 ' D' ' 4' ' ' LEU . 73.8 mt -117.65 149.46 40.68 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 115.622 -0.717 . . . . 0.0 110.778 -178.78 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' D' D ' 7' ' ' LYS . . . . . . . . . . . . . 35.5 ttpt -139.55 139.41 22.29 Favored Pre-proline 0 CA--C 1.535 0.376 0 CA-C-O 119.136 -0.459 . . . . 0.0 110.135 175.704 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' D' D ' 8' ' ' PRO . . . . . . . . . . . . . 94.0 Cg_endo -92.09 144.06 2.76 Favored 'Trans proline' 0 N--CA 1.49 1.267 0 C-N-CA 121.778 1.652 . . . . 0.0 111.659 177.053 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' D' D ' 9' ' ' LEU . . . . . . . . . . . . . 45.1 mt -80.25 -48.23 1.29 Allowed Pre-proline 0 CA--C 1.534 0.349 0 CA-C-O 118.665 -0.683 . . . . 0.0 112.445 -178.602 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' D' D ' 10' ' ' PRO . . . . . . . . . . . . . 86.1 Cg_endo -79.75 152.61 22.52 Favored 'Trans proline' 0 N--CA 1.496 1.632 0 C-N-CA 121.213 1.276 . . . . 0.0 112.055 177.318 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' D' D ' 11' ' ' LYS . . . . . . . . . . . . . 90.2 mttt -85.38 97.85 10.22 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.483 -0.326 . . . . 0.0 110.534 178.374 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' D' D ' 12' ' ' VAL . . . . . . . . . . . . . 12.1 p -144.32 143.12 23.57 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.288 0 CA-C-N 116.222 -0.445 . . . . 0.0 110.524 179.743 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' D' D ' 13' ' ' GLU . . . . . . . . . . . . . 45.8 mp0 -81.89 127.01 32.57 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.342 -0.39 . . . . 0.0 110.037 176.956 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' D' D ' 14' ' ' LEU . . . . . . . . . . . . . 22.5 mt -97.28 144.79 28.53 Favored Pre-proline 0 CA--C 1.533 0.311 0 CA-C-O 119.019 -0.515 . . . . 0.0 110.11 -179.688 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' D' D ' 15' ' ' PRO . . . . . . . . . . . . . 29.8 Cg_exo -59.95 160.32 22.38 Favored 'Trans proline' 0 N--CA 1.497 1.709 0 C-N-CA 121.241 1.294 . . . . 0.0 112.085 179.079 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' D' D ' 16' ' ' PRO . . . . . . . . . . . . . 31.6 Cg_exo -59.3 -37.83 88.56 Favored 'Trans proline' 0 N--CA 1.497 1.691 0 C-N-CA 121.452 1.434 . . . . 0.0 112.905 -177.424 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' D' D ' 17' ' ' ASP . . . . . . . . . . . . . 13.7 p-10 -85.33 4.17 36.34 Favored 'General case' 0 CA--C 1.537 0.46 0 N-CA-C 113.301 0.852 . . . . 0.0 113.301 -177.204 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' D' D ' 18' ' ' PHE . . . . . . . . . . . . . 48.2 t80 -58.29 -47.17 84.52 Favored 'General case' 0 C--N 1.334 -0.102 0 O-C-N 122.03 -0.419 . . . . 0.0 110.151 -177.275 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' D' D ' 19' ' ' VAL . . . . . . . . . . . . . 47.5 t -56.72 -42.94 78.26 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.356 0 CA-C-N 116.335 -0.393 . . . . 0.0 110.504 -177.789 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' D' D ' 20' ' ' ASP . . . . . . . . . . . . . 53.4 m-20 -59.82 -41.79 92.07 Favored 'General case' 0 C--N 1.328 -0.333 0 C-N-CA 120.913 -0.315 . . . . 0.0 110.896 -177.851 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' D' D ' 21' ' ' VAL . . . . . . . . . . . . . 47.7 t -64.63 -46.26 92.97 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.275 0 C-N-CA 120.811 -0.356 . . . . 0.0 110.491 -178.06 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' D' D ' 22' ' ' ILE . . . . . 0.45 HG22 HD12 ' D' ' 26' ' ' LEU . 46.8 mm -57.75 -40.44 75.69 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.317 0 C-N-CA 120.745 -0.382 . . . . 0.0 110.615 179.726 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' D' D ' 23' ' ' ARG . . . . . . . . . . . . . 59.1 ttp180 -55.69 -49.97 71.55 Favored 'General case' 0 C--N 1.331 -0.219 0 CA-C-O 120.969 0.414 . . . . 0.0 110.843 178.11 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' D' D ' 24' ' ' ILE . . . . . . . . . . . . . 74.1 mt -61.36 -40.26 85.57 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.324 0 CA-C-N 115.918 -0.583 . . . . 0.0 111.925 -176.666 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' D' D ' 25' ' ' LYS . . . . . . . . . . . . . 7.7 ptmm? -72.19 -36.46 69.23 Favored 'General case' 0 CA--C 1.531 0.239 0 C-N-CA 120.534 -0.466 . . . . 0.0 111.882 -176.145 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' D' D ' 26' ' ' LEU . . . . . 0.45 HD12 HG22 ' D' ' 22' ' ' ILE . 77.0 mt -77.7 -40.25 41.96 Favored 'General case' 0 C--N 1.33 -0.243 0 N-CA-C 113.194 0.813 . . . . 0.0 113.194 -173.23 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' D' D ' 27' ' ' GLN . . . . . . . . . . . . . 10.5 pt20 -47.53 137.12 9.26 Favored 'General case' 0 N--CA 1.471 0.58 0 N-CA-C 112.661 0.615 . . . . 0.0 112.661 -175.901 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' D' D ' 28' ' ' GLY . . . . . . . . . . . . . . . 99.63 -24.84 30.58 Favored Glycine 0 CA--C 1.533 1.21 0 CA-C-N 115.545 -0.752 . . . . 0.0 112.304 -176.345 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' D' D ' 29' ' ' LYS . . . . . . . . . . . . . 72.9 mmtt -98.11 155.18 17.26 Favored 'General case' 0 C--N 1.331 -0.218 0 CA-C-N 117.318 0.559 . . . . 0.0 111.232 179.352 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' D' D ' 30' ' ' THR . . . . . . . . . . . . . 24.4 m -105.79 135.85 46.47 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 115.784 -0.643 . . . . 0.0 109.859 175.342 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' D' D ' 31' ' ' VAL . . . . . . . . . . . . . 34.8 m -130.83 155.52 41.96 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.276 0 CA-C-O 120.994 0.426 . . . . 0.0 110.926 -178.225 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' D' D ' 32' ' ' ARG . . . . . . . . . . . . . 84.8 mtm180 -131.65 150.78 52.03 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.012 -0.54 . . . . 0.0 110.863 179.143 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' D' D ' 33' ' ' THR . . . . . . . . . . . . . 20.8 m -53.5 140.37 28.36 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.111 -0.495 . . . . 0.0 111.293 -179.09 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' D' D ' 34' ' ' GLY . . . . . . . . . . . . . . . 98.99 -17.17 58.55 Favored Glycine 0 CA--C 1.533 1.189 0 C-N-CA 121.103 -0.57 . . . . 0.0 113.207 179.699 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' D' D ' 35' ' ' ASP . . . . . . . . . . . . . 69.1 m-20 -65.47 148.87 50.99 Favored 'General case' 0 C--O 1.232 0.138 0 CA-C-N 118.013 0.907 . . . . 0.0 111.122 178.99 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' D' D ' 36' ' ' VAL . . . . . . . . . . . . . 45.7 t -122.97 130.03 74.72 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.251 0 CA-C-N 115.774 -0.648 . . . . 0.0 109.704 178.594 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' D' D ' 37' ' ' ILE . . . . . . . . . . . . . 69.7 mt -120.12 137.93 52.33 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.276 0 N-CA-C 109.767 -0.457 . . . . 0.0 109.767 179.442 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' D' D ' 38' ' ' GLY . . . . . . . . . . . . . . . -112.52 128.79 8.65 Favored Glycine 0 CA--C 1.526 0.724 0 N-CA-C 111.11 -0.796 . . . . 0.0 111.11 -179.078 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' D' D ' 39' ' ' ILE . . . . . . . . . . . . . 75.8 mt -124.23 135.55 63.33 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.261 0 CA-C-O 120.795 0.331 . . . . 0.0 110.164 178.999 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' D' D ' 40' ' ' SER . . . . . . . . . . . . . 23.0 t -92.71 120.74 33.41 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.321 -0.399 . . . . 0.0 110.723 176.142 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' D' D ' 41' ' ' ILE . . . . . . . . . . . . . 70.3 mt -132.09 118.16 35.89 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.23 0 N-CA-C 110.107 -0.331 . . . . 0.0 110.107 178.272 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' D' D ' 42' ' ' LEU . . . . . . . . . . . . . 5.4 mp 56.11 36.96 28.32 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.179 -0.464 . . . . 0.0 111.326 179.315 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' D' D ' 43' ' ' GLY . . . . . . . . . . . . . . . 77.48 -10.07 24.99 Favored Glycine 0 CA--C 1.533 1.209 0 C-N-CA 121.279 -0.486 . . . . 0.0 113.531 176.54 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' D' D ' 44' ' ' LYS . . . . . . . . . . . . . 61.9 mttp -97.19 135.96 38.39 Favored 'General case' 0 C--N 1.333 -0.123 0 CA-C-N 117.993 0.897 . . . . 0.0 110.151 177.398 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' D' D ' 45' ' ' GLU . . . . . . . . . . . . . 80.8 tt0 -85.2 126.9 34.03 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.282 -0.417 . . . . 0.0 110.758 179.817 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' D' D ' 46' ' ' VAL . . . . . . . . . . . . . 7.1 p -121.15 127.13 75.81 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.224 0 N-CA-C 109.597 -0.52 . . . . 0.0 109.597 175.895 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' D' D ' 47' ' ' LYS . . . . . . . . . . . . . 58.4 mttm -100.63 129.48 46.56 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 115.862 -0.608 . . . . 0.0 111.139 178.051 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' D' D ' 48' ' ' PHE . . . . . . . . . . . . . 92.5 m-85 -111.12 131.75 54.84 Favored 'General case' 0 C--N 1.329 -0.319 0 N-CA-C 109.61 -0.515 . . . . 0.0 109.61 174.807 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' D' D ' 49' ' ' LYS . . . . . . . . . . . . . 83.3 tttt -108.82 138.15 45.62 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.414 -0.357 . . . . 0.0 110.486 179.76 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' D' D ' 50' ' ' VAL . . . . . . . . . . . . . 44.9 t -80.3 109.56 14.93 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.285 0 N-CA-C 109.292 -0.632 . . . . 0.0 109.292 176.141 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' D' D ' 51' ' ' VAL . . . . . . . . . . . . . 51.2 t -71.81 -47.14 57.94 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.273 0 CA-C-N 115.988 -0.551 . . . . 0.0 109.97 -174.084 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' D' D ' 52' ' ' GLN . . . . . . . . . . . . . 47.6 tt0 -170.93 145.09 2.29 Favored 'General case' 0 C--N 1.33 -0.28 0 C-N-CA 120.433 -0.507 . . . . 0.0 111.439 -179.8 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' D' D ' 53' ' ' ALA . . . . . . . . . . . . . . . -121.14 136.18 55.02 Favored 'General case' 0 C--N 1.331 -0.227 0 CA-C-N 115.903 -0.589 . . . . 0.0 110.474 178.499 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' D' D ' 54' ' ' TYR . . . . . . . . . . . . . 35.6 t80 -129.16 113.59 18.49 Favored Pre-proline 0 CA--C 1.536 0.406 0 CA-C-O 118.24 -0.886 . . . . 0.0 110.117 176.142 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' D' D ' 55' ' ' PRO . . . . . . . . . . . . . 72.8 Cg_endo -77.29 170.08 72.35 Favored 'Cis proline' 0 N--CA 1.499 1.825 0 CA-C-N 122.037 1.763 . . . . 0.0 112.057 -6.089 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' D' D ' 56' ' ' SER . . . . . . . . . . . . . 17.5 m -122.51 134.1 24.74 Favored Pre-proline 0 CA--C 1.538 0.508 0 CA-C-O 118.519 -0.753 . . . . 0.0 109.496 175.204 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' D' D ' 57' ' ' PRO . . . . . . . . . . . . . 38.4 Cg_endo -67.2 145.54 73.63 Favored 'Cis proline' 0 N--CA 1.498 1.777 0 CA-C-N 121.834 1.691 . . . . 0.0 111.562 -1.67 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' D' D ' 58' ' ' LEU . . . . . . . . . . . . . 23.7 tp -106.25 136.05 46.65 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.263 -0.426 . . . . 0.0 110.736 -177.626 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' D' D ' 59' ' ' ARG . . . . . . . . . . . . . 42.1 ttm180 -103.28 127.83 50.5 Favored 'General case' 0 C--N 1.328 -0.367 0 N-CA-C 109.247 -0.649 . . . . 0.0 109.247 174.945 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' D' D ' 60' ' ' VAL . . . . . . . . . . . . . 45.5 t -84.18 120.28 34.73 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.242 0 C-N-CA 120.689 -0.404 . . . . 0.0 110.37 -175.916 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' D' D ' 61' ' ' GLU . . . . . . . . . . . . . 43.9 mt-10 -131.11 167.19 19.53 Favored 'General case' 0 C--N 1.331 -0.214 0 CA-C-N 115.735 -0.666 . . . . 0.0 109.858 177.391 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' D' D ' 62' ' ' ASP . . . . . . . . . . . . . 13.3 t70 -53.81 -32.57 53.19 Favored 'General case' 0 C--N 1.327 -0.377 0 N-CA-C 111.776 0.287 . . . . 0.0 111.776 -179.879 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' D' D ' 63' ' ' ARG . . . . . . . . . . . . . 26.5 ptt180 -82.99 3.79 28.65 Favored 'General case' 0 CA--C 1.536 0.434 0 N-CA-C 113.793 1.034 . . . . 0.0 113.793 -175.629 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' D' D ' 64' ' ' THR . . . . . . . . . . . . . 38.0 m -86.98 135.12 33.4 Favored 'General case' 0 C--N 1.333 -0.148 0 CA-C-N 118.117 0.417 . . . . 0.0 110.584 -178.343 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' D' D ' 65' ' ' LYS . . . . . . . . . . . . . 93.4 mttt -90.24 129.54 36.48 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.066 -0.515 . . . . 0.0 110.237 178.917 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' D' D ' 66' ' ' ILE . . . . . . . . . . . . . 63.4 mt -112.67 129.52 68.12 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.314 0 N-CA-C 109.725 -0.472 . . . . 0.0 109.725 179.641 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' D' D ' 67' ' ' THR . . . . . . . . . . . . . 29.3 m -124.02 138.11 54.5 Favored 'General case' 0 C--N 1.331 -0.204 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.807 -178.267 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' D' D ' 68' ' ' LEU . . . . . 0.496 ' N ' HD12 ' D' ' 68' ' ' LEU . 7.8 mp . . . . . 0 C--N 1.327 -0.386 0 CA-C-N 115.845 -0.616 . . . . 0.0 110.219 178.2 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' D' D ' 73' ' ' VAL . . . . . . . . . . . . . 30.7 m . . . . . 0 C--O 1.231 0.088 0 CA-C-O 121.067 0.46 . . . . 0.0 111.253 . . . . . . . . . 0 0 . 1 . 020 nuclear nobuild core ' D' D ' 74' ' ' ASP . . . . . . . . . . . . . 8.3 t0 -101.54 118.42 36.91 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 115.696 -0.684 . . . . 0.0 109.598 178.539 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' D' D ' 75' ' ' VAL . . . . . . . . . . . . . 40.8 t -110.2 123.71 66.33 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.244 0 CA-C-O 120.99 0.424 . . . . 0.0 110.481 -177.179 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' D' D ' 76' ' ' LEU . . . . . . . . . . . . . 30.0 mt -128.49 147.41 50.68 Favored 'General case' 0 C--N 1.331 -0.22 0 CA-C-N 115.794 -0.639 . . . . 0.0 110.066 178.854 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' D' D ' 77' ' ' GLU . . . . . . . . . . . . . 97.1 mt-10 -136.75 140.65 42.73 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-O 120.98 0.419 . . . . 0.0 110.99 -177.95 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' D' D ' 78' ' ' ALA . . . . . 0.674 ' HB2' HD21 ' D' ' 109' ' ' LEU . . . -125.67 127.39 46.19 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 115.799 -0.637 . . . . 0.0 109.748 176.878 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' D' D ' 79' ' ' LYS . . . . . 0.581 ' O ' HD13 ' D' ' 80' ' ' ILE . 48.8 mmtm -71.59 119.37 15.66 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-O 120.849 0.357 . . . . 0.0 110.848 -178.096 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' D' D ' 80' ' ' ILE . . . . . 0.581 HD13 ' O ' ' D' ' 79' ' ' LYS . 41.3 mm -139.09 112.73 6.75 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.289 0 N-CA-C 108.885 -0.783 . . . . 0.0 108.885 -179.298 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' D' D ' 81' ' ' LYS . . . . . . . . . . . . . 83.2 tttt -102.65 123.67 46.79 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-O 120.833 0.349 . . . . 0.0 111.205 -174.534 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' D' D ' 82' ' ' GLY . . . . . . . . . . . . . . . 89.22 41.99 5.68 Favored Glycine 0 CA--C 1.526 0.747 0 C-N-CA 120.824 -0.703 . . . . 0.0 112.064 173.702 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' D' D ' 83' ' ' ILE . . . . . . . . . . . . . 67.6 mt -68.25 139.63 20.39 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.311 0 N-CA-C 109.802 -0.444 . . . . 0.0 109.802 177.249 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' D' D ' 84' ' ' LYS . . . . . . . . . . . . . 39.7 ttpt -102.62 -47.9 4.29 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.165 -0.47 . . . . 0.0 110.295 -179.081 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' D' D ' 85' ' ' ASP . . . . . . . . . . . . . 7.5 t70 -152.31 151.04 30.4 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.068 -0.515 . . . . 0.0 110.552 179.903 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' D' D ' 86' ' ' VAL . . . . . . . . . . . . . 42.0 t -129.04 131.5 68.02 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.241 0 CA-C-O 120.917 0.389 . . . . 0.0 110.394 179.513 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' D' D ' 87' ' ' ILE . . . . . 0.499 HD12 ' N ' ' D' ' 87' ' ' ILE . 5.1 mp -118.64 127.35 75.62 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.245 0 N-CA-C 109.472 -0.566 . . . . 0.0 109.472 177.506 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' D' D ' 88' ' ' LEU . . . . . . . . . . . . . 20.6 tp -111.66 123.45 50.26 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.382 -0.372 . . . . 0.0 110.691 -176.963 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' D' D ' 89' ' ' ASP . . . . . . . . . . . . . 12.8 t70 -121.23 156.14 33.1 Favored 'General case' 0 C--N 1.332 -0.184 0 CA-C-N 116.419 -0.355 . . . . 0.0 110.235 -179.983 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' D' D ' 90' ' ' GLU . . . . . . . . . . . . . 68.1 tt0 -46.04 -45.7 16.22 Favored 'General case' 0 N--CA 1.465 0.291 0 N-CA-C 112.972 0.73 . . . . 0.0 112.972 -171.832 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' D' D ' 91' ' ' ASN . . . . . . . . . . . . . 8.4 t-20 -129.59 34.76 4.29 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-O 120.709 0.29 . . . . 0.0 111.665 -176.039 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' D' D ' 92' ' ' LEU . . . . . . . . . . . . . 7.0 tp -166.14 146.38 6.33 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-O 120.944 0.402 . . . . 0.0 110.554 179.68 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' D' D ' 93' ' ' ILE . . . . . . . . . . . . . 66.7 mt -122.26 123.0 67.8 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.366 0 N-CA-C 109.13 -0.693 . . . . 0.0 109.13 179.146 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' D' D ' 94' ' ' VAL . . . . . . . . . . . . . 43.1 t -119.33 128.19 75.84 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.246 0 CA-C-O 120.839 0.352 . . . . 0.0 110.053 -178.122 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' D' D ' 95' ' ' VAL . . . . . . . . . . . . . 42.4 t -123.12 132.59 71.11 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.302 0 CA-C-N 116.043 -0.526 . . . . 0.0 109.882 179.474 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' D' D ' 96' ' ' ILE . . . . . . . . . . . . . 67.5 mt -116.2 127.87 73.67 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.312 0 N-CA-C 109.268 -0.642 . . . . 0.0 109.268 179.077 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' D' D ' 97' ' ' THR . . . . . . . . . . . . . 70.0 p -99.76 158.27 15.91 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-O 121.029 0.442 . . . . 0.0 111.026 -177.664 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' D' D ' 98' ' ' GLU . . . . . . . . . . . . . 44.8 tp10 -54.03 -26.13 24.89 Favored 'General case' 0 CA--C 1.534 0.34 0 CA-C-N 116.224 -0.444 . . . . 0.0 111.916 179.058 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' D' D ' 99' ' ' GLU . . . . . . . . . . . . . 34.5 tt0 -76.3 11.47 1.54 Allowed 'General case' 0 CA--C 1.539 0.533 0 N-CA-C 112.765 0.654 . . . . 0.0 112.765 -177.512 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' D' D ' 100' ' ' ASN . . . . . . . . . . . . . 2.1 m-20 62.81 32.15 16.07 Favored 'General case' 0 CA--C 1.532 0.277 0 O-C-N 121.705 -0.622 . . . . 0.0 111.555 178.983 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' D' D ' 101' ' ' GLU . . . . . . . . . . . . . 78.5 tt0 -109.75 144.66 37.85 Favored 'General case' 0 C--O 1.234 0.241 0 N-CA-C 109.631 -0.507 . . . . 0.0 109.631 172.887 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' D' D ' 102' ' ' VAL . . . . . . . . . . . . . 44.6 t -116.13 128.2 73.5 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.248 0 CA-C-N 116.432 -0.349 . . . . 0.0 110.134 -178.592 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' D' D ' 103' ' ' LEU . . . . . . . . . . . . . 21.1 mt -116.2 130.52 56.83 Favored 'General case' 0 C--N 1.331 -0.208 0 CA-C-N 115.717 -0.674 . . . . 0.0 110.163 176.973 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' D' D ' 104' ' ' ILE . . . . . 0.58 HD13 HG21 ' D' ' 130' ' ' VAL . 66.9 mt -116.82 120.5 65.22 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.299 0 N-CA-C 110.018 -0.364 . . . . 0.0 110.018 179.621 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' D' D ' 105' ' ' PHE . . . . . . . . . . . . . 62.8 m-85 -120.8 165.12 15.59 Favored 'General case' 0 C--N 1.333 -0.123 0 O-C-N 123.893 0.746 . . . . 0.0 109.807 178.777 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' D' D ' 106' ' ' ASN . . . . . . . . . . . . . 42.9 p-10 -98.94 -170.05 1.87 Allowed 'General case' 0 C--N 1.331 -0.229 0 N-CA-C 109.936 -0.394 . . . . 0.0 109.936 173.549 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' D' D ' 107' ' ' GLN . . . . . . . . . . . . . 48.7 tt0 -60.5 -30.03 69.46 Favored 'General case' 0 C--N 1.329 -0.289 0 N-CA-C 111.955 0.354 . . . . 0.0 111.955 179.946 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' D' D ' 108' ' ' ASN . . . . . . . . . . . . . 6.6 t-20 -83.27 6.78 18.46 Favored 'General case' 0 CA--C 1.536 0.425 0 N-CA-C 113.223 0.824 . . . . 0.0 113.223 -178.371 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' D' D ' 109' ' ' LEU . . . . . 0.674 HD21 ' HB2' ' D' ' 78' ' ' ALA . 10.2 tp 62.41 37.69 13.41 Favored 'General case' 0 CA--C 1.529 0.167 0 O-C-N 122.087 -0.383 . . . . 0.0 111.377 178.244 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' D' D ' 110' ' ' GLU . . . . . . . . . . . . . 70.7 mm-40 -105.89 162.24 13.75 Favored 'General case' 0 C--N 1.33 -0.255 0 N-CA-C 109.765 -0.457 . . . . 0.0 109.765 176.014 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' D' D ' 111' ' ' GLU . . . . . . . . . . . . . 83.9 tt0 -86.67 127.45 34.95 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-O 120.938 0.399 . . . . 0.0 111.208 -176.357 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' D' D ' 112' ' ' LEU . . . . . . . . . . . . . 15.6 mt -113.03 -46.09 3.13 Favored 'General case' 0 C--N 1.331 -0.197 0 CA-C-N 115.953 -0.567 . . . . 0.0 110.418 176.579 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' D' D ' 113' ' ' TYR . . . . . 0.563 ' HB3' HD12 ' D' ' 104' ' ' ILE . 38.2 t80 -143.06 138.73 30.13 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.269 -0.423 . . . . 0.0 111.26 -179.295 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' D' D ' 114' ' ' ARG . . . . . . . . . . . . . 27.4 ttm180 -137.42 122.61 19.24 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.338 -0.392 . . . . 0.0 109.968 174.908 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' D' D ' 115' ' ' GLY . . . . . . . . . . . . . . . -150.07 163.1 29.38 Favored Glycine 0 CA--C 1.526 0.775 0 N-CA-C 111.115 -0.794 . . . . 0.0 111.115 179.031 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' D' D ' 116' ' ' LYS . . . . . . . . . . . . . 88.2 tttt -131.69 138.19 48.59 Favored 'General case' 0 C--N 1.33 -0.241 0 N-CA-C 110.046 -0.353 . . . . 0.0 110.046 178.628 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' D' D ' 117' ' ' PHE . . . . . 0.423 ' HE2' HD13 ' D' ' 132' ' ' ILE . 27.6 m-85 -139.05 113.96 9.32 Favored 'General case' 0 C--N 1.331 -0.205 0 CA-C-N 116.26 -0.427 . . . . 0.0 109.963 -176.657 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' D' D ' 118' ' ' GLU . . . . . . . . . . . . . 70.7 mm-40 -54.5 -47.78 72.65 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.564 -0.289 . . . . 0.0 111.542 -174.982 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' D' D ' 119' ' ' ASN . . . . . . . . . . . . . 29.5 m120 -93.59 31.06 1.61 Allowed 'General case' 0 C--N 1.329 -0.315 0 N-CA-C 112.15 0.426 . . . . 0.0 112.15 -174.319 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' D' D ' 120' ' ' LEU . . . . . . . . . . . . . 10.3 tp -56.06 120.69 7.89 Favored 'General case' 0 C--N 1.333 -0.139 0 C-N-CA 121.078 -0.249 . . . . 0.0 110.584 177.864 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' D' D ' 121' ' ' ASN . . . . . . . . . . . . . 36.2 m120 -113.78 -44.05 3.22 Favored 'General case' 0 C--O 1.233 0.204 0 CA-C-N 116.575 -0.284 . . . . 0.0 111.178 -177.582 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' D' D ' 122' ' ' LYS . . . . . . . . . . . . . 98.3 mttt -145.72 150.11 35.65 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-O 121.081 0.467 . . . . 0.0 111.945 -177.978 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' D' D ' 123' ' ' VAL . . . . . . . . . . . . . 44.0 t -127.67 127.56 68.6 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.166 0 CA-C-N 115.811 -0.631 . . . . 0.0 109.485 175.292 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' D' D ' 124' ' ' LEU . . . . . 0.429 HD13 ' HB2' ' E' ' 88' ' ' LEU . 35.6 mt -118.02 136.59 53.44 Favored 'General case' 0 C--N 1.332 -0.161 0 CA-C-N 116.426 -0.352 . . . . 0.0 110.606 -179.231 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' D' D ' 125' ' ' VAL . . . . . . . . . . . . . 34.9 m -121.82 141.95 40.16 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.223 0 CA-C-N 116.128 -0.487 . . . . 0.0 110.608 -179.293 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' D' D ' 126' ' ' ARG . . . . . . . . . . . . . 36.5 ptt180 -148.05 114.78 6.04 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-O 121.292 0.567 . . . . 0.0 110.462 177.725 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' D' D ' 127' ' ' ASN . . . . . . . . . . . . . 60.6 t30 49.48 -107.74 0.26 Allowed 'General case' 0 CA--C 1.546 0.823 0 CA-C-O 118.967 -0.539 . . . . 0.0 111.432 -178.516 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' D' D ' 128' ' ' ASP . . . . . . . . . . . . . 20.4 p-10 -114.08 4.98 15.85 Favored 'General case' 0 N--CA 1.469 0.482 0 CA-C-N 119.813 1.188 . . . . 0.0 113.264 179.726 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' D' D ' 129' ' ' LEU . . . . . . . . . . . . . 25.1 mt -108.82 152.75 24.46 Favored 'General case' 0 C--O 1.233 0.222 0 N-CA-C 109.349 -0.612 . . . . 0.0 109.349 178.332 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' D' D ' 130' ' ' VAL . . . . . 0.58 HG21 HD13 ' D' ' 104' ' ' ILE . 33.3 m -139.34 150.17 22.84 Favored 'Isoleucine or valine' 0 N--CA 1.462 0.153 0 CA-C-O 121.462 0.649 . . . . 0.0 111.804 -177.756 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' D' D ' 131' ' ' VAL . . . . . 0.753 HG22 HD12 ' D' ' 140' ' ' LEU . 43.4 t -136.09 138.49 47.21 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.267 0 CA-C-N 115.321 -0.854 . . . . 0.0 109.891 177.277 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' D' D ' 132' ' ' ILE . . . . . 0.423 HD13 ' HE2' ' D' ' 117' ' ' PHE . 70.6 mt -118.03 133.97 63.14 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.305 0 CA-C-N 116.086 -0.506 . . . . 0.0 109.702 -178.538 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' D' D ' 133' ' ' ILE . . . . . . . . . . . . . 42.9 mm -115.07 124.06 71.34 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.287 0 CA-C-N 116.399 -0.364 . . . . 0.0 110.846 -175.643 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' D' D ' 134' ' ' ASP . . . . . . . . . . . . . 8.9 p-10 -136.6 146.58 46.23 Favored 'General case' 0 C--N 1.332 -0.166 0 N-CA-C 109.651 -0.5 . . . . 0.0 109.651 174.227 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' D' D ' 135' ' ' GLU . . . . . . . . . . . . . 45.7 tp10 -49.9 -28.4 6.58 Favored 'General case' 0 C--N 1.328 -0.346 0 N-CA-C 112.874 0.694 . . . . 0.0 112.874 -172.05 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' D' D ' 136' ' ' GLN . . . . . . . . . . . . . 36.5 tt0 -80.48 -35.6 34.56 Favored 'General case' 0 C--N 1.331 -0.21 0 N-CA-C 112.236 0.458 . . . . 0.0 112.236 -176.048 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' D' D ' 137' ' ' LYS . . . . . . . . . . . . . 58.5 pttt -167.05 172.59 9.98 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-O 121.61 0.719 . . . . 0.0 112.193 -171.994 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' D' D ' 138' ' ' LEU . . . . . . . . . . . . . 5.0 tt -115.8 128.39 55.8 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 115.046 -0.979 . . . . 0.0 109.847 179.749 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' D' D ' 139' ' ' THR . . . . . . . . . . . . . 38.5 m -109.62 130.25 55.53 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.303 -0.408 . . . . 0.0 110.377 -179.459 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' D' D ' 140' ' ' LEU . . . . . 0.753 HD12 HG22 ' D' ' 131' ' ' VAL . 10.0 tp -118.46 127.54 53.75 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.025 -0.534 . . . . 0.0 109.914 -178.26 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' D' D ' 141' ' ' ILE . . . . . 0.475 ' HB ' HG23 ' D' ' 130' ' ' VAL . 19.0 mt -125.71 121.64 60.41 Favored 'Isoleucine or valine' 0 C--O 1.234 0.28 0 N-CA-C 109.898 -0.408 . . . . 0.0 109.898 -176.043 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' D' D ' 142' ' ' ARG . . . . . . . . . . . . . 73.9 mtm180 -115.42 123.48 48.73 Favored 'General case' 0 N--CA 1.463 0.179 0 CA-C-N 116.132 -0.485 . . . . 0.0 109.872 -179.463 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' D' D ' 143' ' ' THR . . . . . . . . . . . . . 25.2 p . . . . . 0 C--O 1.219 -0.526 0 CA-C-O 118.047 -0.977 . . . . 0.0 110.57 -179.263 . . . . . . . . 0 0 . 1 . 020 nuclear nobuild core ' E' E ' 2' ' ' SER . . . . . 0.432 ' OG ' HG23 ' E' ' 64' ' ' THR . 87.3 p . . . . . 0 N--CA 1.463 0.2 0 CA-C-O 121.042 0.449 . . . . 0.0 111.173 . . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' E' E ' 3' ' ' GLU . . . . . . . . . . . . . 47.6 mp0 -138.74 144.7 39.6 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 115.855 -0.611 . . . . 0.0 110.986 -178.468 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' E' E ' 4' ' ' LEU . . . . . . . . . . . . . 16.8 tp -125.02 125.13 43.38 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 115.809 -0.632 . . . . 0.0 109.931 176.298 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' E' E ' 5' ' ' LYS . . . . . . . . . . . . . 69.2 mttm -106.39 121.71 44.79 Favored 'General case' 0 C--N 1.331 -0.224 0 CA-C-N 116.362 -0.381 . . . . 0.0 110.634 179.078 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' E' E ' 6' ' ' LEU . . . . . . . . . . . . . 77.1 mt -118.65 147.87 43.32 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 115.492 -0.776 . . . . 0.0 110.522 179.768 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' E' E ' 7' ' ' LYS . . . . . . . . . . . . . 84.9 tttt -140.25 142.46 29.93 Favored Pre-proline 0 C--N 1.329 -0.316 0 N-CA-C 109.666 -0.494 . . . . 0.0 109.666 175.687 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' E' E ' 8' ' ' PRO . . . . . . . . . . . . . 85.1 Cg_endo -90.86 147.45 3.87 Favored 'Trans proline' 0 N--CA 1.492 1.391 0 C-N-CA 121.779 1.653 . . . . 0.0 112.081 179.584 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' E' E ' 9' ' ' LEU . . . . . . . . . . . . . 37.4 mt -84.03 -47.69 0.72 Allowed Pre-proline 0 C--N 1.329 -0.301 0 CA-C-O 118.598 -0.715 . . . . 0.0 112.012 178.929 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' E' E ' 10' ' ' PRO . . . . . . . . . . . . . 97.3 Cg_endo -80.76 154.42 20.27 Favored 'Trans proline' 0 N--CA 1.495 1.602 0 C-N-CA 121.124 1.216 . . . . 0.0 111.667 176.052 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' E' E ' 11' ' ' LYS . . . . . . . . . . . . . 58.2 mtpt -88.71 100.99 13.56 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-O 120.804 0.335 . . . . 0.0 110.471 -179.969 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' E' E ' 12' ' ' VAL . . . . . . . . . . . . . 12.3 p -139.6 143.94 29.67 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.224 0 CA-C-N 116.18 -0.464 . . . . 0.0 110.62 -179.225 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' E' E ' 13' ' ' GLU . . . . . . . . . . . . . 45.5 mp0 -90.98 117.41 29.55 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.31 -0.405 . . . . 0.0 110.018 177.254 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' E' E ' 14' ' ' LEU . . . . . 0.46 HD22 ' CE1' ' E' ' 18' ' ' PHE . 25.3 mt -97.93 155.3 37.23 Favored Pre-proline 0 C--N 1.329 -0.283 0 CA-C-N 116.334 -0.394 . . . . 0.0 111.03 -176.832 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' E' E ' 15' ' ' PRO . . . . . . . . . . . . . 32.9 Cg_exo -60.46 161.27 21.0 Favored 'Trans proline' 0 N--CA 1.496 1.676 0 C-N-CA 121.316 1.344 . . . . 0.0 112.048 177.067 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' E' E ' 16' ' ' PRO . . . . . . . . . . . . . 24.6 Cg_exo -61.82 -34.88 81.45 Favored 'Trans proline' 0 N--CA 1.497 1.725 0 C-N-CA 121.472 1.448 . . . . 0.0 112.753 -178.954 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' E' E ' 17' ' ' ASP . . . . . . . . . . . . . 15.7 p-10 -88.38 11.65 16.27 Favored 'General case' 0 CA--C 1.534 0.336 0 N-CA-C 113.24 0.829 . . . . 0.0 113.24 -176.408 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' E' E ' 18' ' ' PHE . . . . . 0.46 ' CE1' HD22 ' E' ' 14' ' ' LEU . 37.3 t80 -56.91 -45.53 82.57 Favored 'General case' 0 C--O 1.231 0.118 0 O-C-N 122.024 -0.423 . . . . 0.0 110.334 -178.377 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' E' E ' 19' ' ' VAL . . . . . 0.408 HG13 ' N ' ' E' ' 20' ' ' ASP . 13.2 p -56.55 -41.57 73.58 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.317 0 CA-C-N 116.544 -0.298 . . . . 0.0 110.898 -179.013 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' E' E ' 20' ' ' ASP . . . . . 0.408 ' N ' HG13 ' E' ' 19' ' ' VAL . 78.1 m-20 -61.05 -43.12 99.37 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-O 120.837 0.351 . . . . 0.0 110.889 -178.545 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' E' E ' 21' ' ' VAL . . . . . . . . . . . . . 48.8 t -64.3 -44.86 97.34 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.319 0 C-N-CA 120.797 -0.361 . . . . 0.0 110.448 -176.952 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' E' E ' 22' ' ' ILE . . . . . 0.609 HG22 HD12 ' E' ' 26' ' ' LEU . 49.8 mm -55.2 -50.62 62.74 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.247 0 C-N-CA 121.151 -0.22 . . . . 0.0 110.716 178.72 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' E' E ' 23' ' ' ARG . . . . . . . . . . . . . 37.8 ttp180 -55.21 -48.65 73.57 Favored 'General case' 0 C--N 1.329 -0.311 0 C-N-CA 120.949 -0.3 . . . . 0.0 111.567 -177.778 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' E' E ' 24' ' ' ILE . . . . . . . . . . . . . 75.4 mt -58.91 -43.72 89.21 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 C-N-CA 121.054 -0.258 . . . . 0.0 111.368 -176.126 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' E' E ' 25' ' ' LYS . . . . . . . . . . . . . 93.1 mttt -69.34 -39.62 78.04 Favored 'General case' 0 C--N 1.33 -0.268 0 N-CA-C 112.556 0.576 . . . . 0.0 112.556 -178.302 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' E' E ' 26' ' ' LEU . . . . . 0.609 HD12 HG22 ' E' ' 22' ' ' ILE . 79.2 mt -78.98 -33.49 45.07 Favored 'General case' 0 C--N 1.331 -0.219 0 N-CA-C 113.673 0.99 . . . . 0.0 113.673 -170.745 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' E' E ' 27' ' ' GLN . . . . . . . . . . . . . 6.3 pt20 -46.4 137.42 6.5 Favored 'General case' 0 N--CA 1.469 0.5 0 N-CA-C 112.861 0.689 . . . . 0.0 112.861 -174.406 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' E' E ' 28' ' ' GLY . . . . . . . . . . . . . . . 99.99 -23.73 34.89 Favored Glycine 0 CA--C 1.533 1.198 0 CA-C-N 115.68 -0.691 . . . . 0.0 112.53 -177.448 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' E' E ' 29' ' ' LYS . . . . . . . . . . . . . 97.7 mttt -97.59 155.13 17.11 Favored 'General case' 0 C--O 1.233 0.235 0 CA-C-N 117.459 0.63 . . . . 0.0 111.132 179.512 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' E' E ' 30' ' ' THR . . . . . . . . . . . . . 27.0 m -103.28 138.52 39.95 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.085 -0.507 . . . . 0.0 110.272 177.545 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' E' E ' 31' ' ' VAL . . . . . . . . . . . . . 34.9 m -130.23 156.73 42.54 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.239 0 CA-C-N 116.385 -0.371 . . . . 0.0 110.879 -178.923 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' E' E ' 32' ' ' ARG . . . . . . . . . . . . . 79.0 mtm180 -136.1 150.4 49.1 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-O 121.32 0.581 . . . . 0.0 110.819 178.112 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' E' E ' 33' ' ' THR . . . . . . . . . . . . . 17.6 m -53.55 141.43 25.54 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.128 -0.487 . . . . 0.0 111.27 -178.625 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' E' E ' 34' ' ' GLY . . . . . . . . . . . . . . . 99.64 -17.08 58.06 Favored Glycine 0 CA--C 1.532 1.149 0 CA-C-O 119.699 -0.501 . . . . 0.0 113.275 179.609 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' E' E ' 35' ' ' ASP . . . . . . . . . . . . . 76.6 m-20 -66.03 147.69 52.95 Favored 'General case' 0 C--O 1.23 0.071 0 CA-C-N 118.054 0.927 . . . . 0.0 111.152 179.054 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' E' E ' 36' ' ' VAL . . . . . . . . . . . . . 46.4 t -122.54 127.97 75.2 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.204 0 CA-C-N 115.83 -0.623 . . . . 0.0 109.649 177.803 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' E' E ' 37' ' ' ILE . . . . . . . . . . . . . 68.2 mt -119.31 138.66 49.28 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.239 0 CA-C-N 116.247 -0.433 . . . . 0.0 109.928 -179.499 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' E' E ' 38' ' ' GLY . . . . . . . . . . . . . . . -110.34 128.58 8.9 Favored Glycine 0 CA--C 1.525 0.7 0 N-CA-C 111.025 -0.83 . . . . 0.0 111.025 179.891 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' E' E ' 39' ' ' ILE . . . . . . . . . . . . . 75.4 mt -126.13 139.34 51.83 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.2 0 N-CA-C 110.027 -0.36 . . . . 0.0 110.027 178.835 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' E' E ' 40' ' ' SER . . . . . 0.432 ' O ' HD13 ' E' ' 41' ' ' ILE . 31.0 t -92.28 116.66 29.16 Favored 'General case' 0 C--N 1.329 -0.297 0 C-N-CA 120.935 -0.306 . . . . 0.0 110.936 176.107 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' E' E ' 41' ' ' ILE . . . . . 0.432 HD13 ' O ' ' E' ' 40' ' ' SER . 46.0 mm -124.59 115.96 46.06 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.157 0 N-CA-C 110.112 -0.329 . . . . 0.0 110.112 178.584 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' E' E ' 42' ' ' LEU . . . . . . . . . . . . . 70.4 mt 57.58 33.43 23.24 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-N 116.196 -0.457 . . . . 0.0 111.793 179.437 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' E' E ' 43' ' ' GLY . . . . . . . . . . . . . . . 81.78 -10.05 53.44 Favored Glycine 0 CA--C 1.534 1.261 0 C-N-CA 121.26 -0.495 . . . . 0.0 113.435 177.043 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' E' E ' 44' ' ' LYS . . . . . . . . . . . . . 53.1 mtpt -100.45 140.45 34.68 Favored 'General case' 0 C--N 1.333 -0.134 0 CA-C-N 117.892 0.846 . . . . 0.0 110.198 178.321 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' E' E ' 45' ' ' GLU . . . . . . . . . . . . . 80.7 tt0 -83.98 126.05 32.65 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.464 -0.334 . . . . 0.0 110.985 -178.752 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' E' E ' 46' ' ' VAL . . . . . . . . . . . . . 7.6 p -120.68 124.37 72.27 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.224 0 N-CA-C 109.409 -0.589 . . . . 0.0 109.409 175.836 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' E' E ' 47' ' ' LYS . . . . . . . . . . . . . 93.1 mttt -100.51 128.5 46.55 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.011 -0.54 . . . . 0.0 111.132 178.027 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' E' E ' 48' ' ' PHE . . . . . . . . . . . . . 93.5 m-85 -109.56 131.96 54.58 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.249 -0.432 . . . . 0.0 110.015 176.499 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' E' E ' 49' ' ' LYS . . . . . . . . . . . . . 80.0 tttt -107.49 134.59 50.3 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.312 -0.403 . . . . 0.0 110.293 179.53 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' E' E ' 50' ' ' VAL . . . . . . . . . . . . . 46.2 t -77.13 110.01 12.31 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.304 0 N-CA-C 109.287 -0.635 . . . . 0.0 109.287 176.393 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' E' E ' 51' ' ' VAL . . . . . . . . . . . . . 48.4 t -74.28 -47.08 42.29 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.278 0 CA-C-N 116.073 -0.512 . . . . 0.0 110.233 -173.852 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' E' E ' 52' ' ' GLN . . . . . . . . . . . . . 61.9 tt0 -168.01 140.08 3.0 Favored 'General case' 0 C--N 1.331 -0.228 0 C-N-CA 120.409 -0.516 . . . . 0.0 111.351 -177.942 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' E' E ' 53' ' ' ALA . . . . . . . . . . . . . . . -117.18 134.46 54.75 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 115.798 -0.637 . . . . 0.0 110.179 175.62 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' E' E ' 54' ' ' TYR . . . . . . . . . . . . . 55.5 t80 -129.05 112.69 18.53 Favored Pre-proline 0 CA--C 1.535 0.375 0 CA-C-O 118.146 -0.93 . . . . 0.0 110.378 177.877 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' E' E ' 55' ' ' PRO . . . . . . . . . . . . . 74.0 Cg_endo -77.09 168.13 77.89 Favored 'Cis proline' 0 N--CA 1.5 1.902 0 CA-C-N 122.14 1.8 . . . . 0.0 112.273 -6.925 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' E' E ' 56' ' ' SER . . . . . . . . . . . . . 15.5 m -116.89 133.79 23.04 Favored Pre-proline 0 CA--C 1.538 0.506 0 CA-C-O 118.414 -0.803 . . . . 0.0 109.572 175.198 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' E' E ' 57' ' ' PRO . . . . . . . . . . . . . 39.4 Cg_endo -67.54 161.11 79.13 Favored 'Cis proline' 0 N--CA 1.497 1.716 0 CA-C-N 121.864 1.701 . . . . 0.0 111.29 -1.695 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' E' E ' 58' ' ' LEU . . . . . . . . . . . . . 21.3 tp -125.99 138.39 53.74 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-O 120.969 0.414 . . . . 0.0 110.46 -178.967 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' E' E ' 59' ' ' ARG . . . . . . . . . . . . . 74.6 ttt180 -103.25 127.0 50.7 Favored 'General case' 0 C--N 1.327 -0.4 0 CA-C-N 115.737 -0.665 . . . . 0.0 109.355 176.249 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' E' E ' 60' ' ' VAL . . . . . . . . . . . . . 41.8 t -77.35 116.74 21.21 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.26 0 C-N-CA 120.672 -0.411 . . . . 0.0 110.156 -176.441 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' E' E ' 61' ' ' GLU . . . . . . . . . . . . . 95.7 mt-10 -131.15 162.17 30.5 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 115.907 -0.588 . . . . 0.0 110.145 178.423 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' E' E ' 62' ' ' ASP . . . . . . . . . . . . . 79.3 m-20 -54.79 -32.67 60.5 Favored 'General case' 0 C--N 1.328 -0.346 0 C-N-CA 121.065 -0.254 . . . . 0.0 111.667 -179.851 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' E' E ' 63' ' ' ARG . . . . . . . . . . . . . 10.8 ptm180 -82.6 6.82 16.47 Favored 'General case' 0 CA--C 1.534 0.354 0 N-CA-C 113.744 1.016 . . . . 0.0 113.744 -175.887 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' E' E ' 64' ' ' THR . . . . . 0.432 HG23 ' OG ' ' E' ' 2' ' ' SER . 27.6 m -93.43 140.14 29.91 Favored 'General case' 0 C--O 1.232 0.133 0 CA-C-N 118.16 0.436 . . . . 0.0 110.486 -179.62 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' E' E ' 65' ' ' LYS . . . . . . . . . . . . . 68.3 mttm -88.62 124.2 33.83 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.277 -0.42 . . . . 0.0 110.008 179.558 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' E' E ' 66' ' ' ILE . . . . . . . . . . . . . 56.5 mt -113.58 129.8 68.74 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.253 0 N-CA-C 109.815 -0.439 . . . . 0.0 109.815 -179.814 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' E' E ' 67' ' ' THR . . . . . . . . . . . . . 19.0 m -127.21 133.97 50.18 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-O 121.245 0.545 . . . . 0.0 110.767 179.949 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' E' E ' 68' ' ' LEU . . . . . . . . . . . . . 21.7 tp . . . . . 0 C--N 1.33 -0.269 0 CA-C-N 115.737 -0.665 . . . . 0.0 109.72 176.55 . . . . . . . . 0 0 . 1 . 020 nuclear nobuild core ' E' E ' 73' ' ' VAL . . . . . . . . . . . . . 34.3 m . . . . . 0 C--O 1.232 0.132 0 N-CA-C 110.293 -0.262 . . . . 0.0 110.293 . . . . . . . . . 0 0 . 1 . 020 nuclear nobuild core ' E' E ' 74' ' ' ASP . . . . . . . . . . . . . 13.9 t70 -77.35 114.98 16.73 Favored 'General case' 0 C--N 1.328 -0.338 0 C-N-CA 120.362 -0.535 . . . . 0.0 110.274 -168.414 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' E' E ' 75' ' ' VAL . . . . . . . . . . . . . 46.8 t -119.38 117.91 55.63 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.273 0 CA-C-O 121.16 0.505 . . . . 0.0 109.733 -179.654 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' E' E ' 76' ' ' LEU . . . . . . . . . . . . . 15.2 mt -124.59 148.57 47.78 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 115.459 -0.791 . . . . 0.0 109.613 -178.329 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' E' E ' 77' ' ' GLU . . . . . . . . . . . . . 45.3 mt-10 -138.77 135.46 34.7 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-O 121.15 0.5 . . . . 0.0 111.266 -177.604 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' E' E ' 78' ' ' ALA . . . . . 0.569 ' HB2' HD21 ' E' ' 109' ' ' LEU . . . -121.78 129.24 52.52 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 115.562 -0.745 . . . . 0.0 109.622 175.708 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' E' E ' 79' ' ' LYS . . . . . 0.652 ' O ' HD13 ' E' ' 80' ' ' ILE . 48.7 mttm -75.83 117.84 18.0 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-O 121.008 0.433 . . . . 0.0 110.875 -178.55 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' E' E ' 80' ' ' ILE . . . . . 0.652 HD13 ' O ' ' E' ' 79' ' ' LYS . 38.4 mm -139.14 102.5 1.73 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.261 0 N-CA-C 108.908 -0.775 . . . . 0.0 108.908 -177.95 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' E' E ' 81' ' ' LYS . . . . . . . . . . . . . 53.5 mttp -96.31 127.82 42.66 Favored 'General case' 0 C--N 1.327 -0.397 0 C-N-CA 120.783 -0.367 . . . . 0.0 111.305 -176.489 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' E' E ' 82' ' ' GLY . . . . . . . . . . . . . . . 89.14 42.18 5.66 Favored Glycine 0 CA--C 1.525 0.703 0 C-N-CA 120.714 -0.755 . . . . 0.0 111.867 173.588 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' E' E ' 83' ' ' ILE . . . . . . . . . . . . . 70.7 mt -70.95 135.0 28.98 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.358 0 N-CA-C 109.477 -0.564 . . . . 0.0 109.477 177.186 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' E' E ' 84' ' ' LYS . . . . . . . . . . . . . 31.1 ttpt -94.34 -51.64 4.7 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-O 121.023 0.44 . . . . 0.0 110.212 -177.521 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' E' E ' 85' ' ' ASP . . . . . . . . . . . . . 8.9 t70 -149.49 149.31 30.57 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 115.696 -0.684 . . . . 0.0 110.068 -179.383 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' E' E ' 86' ' ' VAL . . . . . . . . . . . . . 39.6 t -132.3 133.65 59.99 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.244 0 CA-C-O 120.959 0.409 . . . . 0.0 110.502 -179.671 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' E' E ' 87' ' ' ILE . . . . . 0.5 ' N ' HD12 ' E' ' 87' ' ' ILE . 5.0 mp -118.94 123.48 71.56 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 N-CA-C 109.206 -0.665 . . . . 0.0 109.206 176.717 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' E' E ' 88' ' ' LEU . . . . . 0.429 ' HB2' HD13 ' D' ' 124' ' ' LEU . 14.0 tp -109.43 119.52 39.72 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.401 -0.363 . . . . 0.0 110.475 -179.068 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' E' E ' 89' ' ' ASP . . . . . . . . . . . . . 6.6 t70 -112.28 153.92 26.43 Favored 'General case' 0 C--N 1.33 -0.28 0 N-CA-C 109.628 -0.508 . . . . 0.0 109.628 178.249 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' E' E ' 90' ' ' GLU . . . . . . . . . . . . . 82.0 tt0 -47.76 -36.86 12.22 Favored 'General case' 0 C--N 1.329 -0.296 0 N-CA-C 112.685 0.624 . . . . 0.0 112.685 -173.364 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' E' E ' 91' ' ' ASN . . . . . . . . . . . . . 13.2 p30 -131.97 32.19 4.08 Favored 'General case' 0 N--CA 1.465 0.285 0 N-CA-C 112.29 0.478 . . . . 0.0 112.29 -175.79 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' E' E ' 92' ' ' LEU . . . . . . . . . . . . . 6.4 tp -166.02 144.68 5.87 Favored 'General case' 0 C--N 1.332 -0.183 0 C-N-CA 120.686 -0.406 . . . . 0.0 111.016 -179.656 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' E' E ' 93' ' ' ILE . . . . . . . . . . . . . 62.3 mt -119.82 119.87 61.59 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.24 0 N-CA-C 109.346 -0.613 . . . . 0.0 109.346 -179.787 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' E' E ' 94' ' ' VAL . . . . . . . . . . . . . 45.5 t -122.22 126.44 74.3 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.293 0 CA-C-O 120.849 0.357 . . . . 0.0 110.212 -178.984 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' E' E ' 95' ' ' VAL . . . . . . . . . . . . . 42.9 t -123.65 134.23 66.99 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.209 0 CA-C-N 116.109 -0.496 . . . . 0.0 110.093 -179.356 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' E' E ' 96' ' ' ILE . . . . . . . . . . . . . 66.6 mt -117.13 127.54 74.69 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.257 0 N-CA-C 109.509 -0.552 . . . . 0.0 109.509 178.634 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' E' E ' 97' ' ' THR . . . . . . . . . . . . . 82.0 p -99.28 157.33 16.46 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-O 121.13 0.491 . . . . 0.0 111.282 -177.433 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' E' E ' 98' ' ' GLU . . . . . . . . . . . . . 96.7 mt-10 -54.62 -26.45 32.89 Favored 'General case' 0 C--N 1.328 -0.328 0 N-CA-C 112.236 0.458 . . . . 0.0 112.236 -179.829 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' E' E ' 99' ' ' GLU . . . . . . . . . . . . . 95.7 mt-10 -78.22 14.7 1.11 Allowed 'General case' 0 CA--C 1.536 0.43 0 N-CA-C 113.1 0.778 . . . . 0.0 113.1 -177.425 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' E' E ' 100' ' ' ASN . . . . . . . . . . . . . 4.5 m-20 63.47 38.03 10.19 Favored 'General case' 0 C--O 1.232 0.149 0 CA-C-O 121.055 0.455 . . . . 0.0 110.951 178.11 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' E' E ' 101' ' ' GLU . . . . . . . . . . . . . 83.3 tt0 -119.24 141.31 49.03 Favored 'General case' 0 C--N 1.332 -0.192 0 N-CA-C 109.601 -0.518 . . . . 0.0 109.601 176.178 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' E' E ' 102' ' ' VAL . . . . . . . . . . . . . 41.8 t -115.03 130.9 68.76 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.271 0 CA-C-O 120.812 0.339 . . . . 0.0 110.407 -177.527 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' E' E ' 103' ' ' LEU . . . . . . . . . . . . . 27.1 mt -119.29 130.89 55.64 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 115.454 -0.794 . . . . 0.0 109.992 176.725 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' E' E ' 104' ' ' ILE . . . . . 0.456 HD11 HG11 ' E' ' 130' ' ' VAL . 72.4 mt -119.65 123.56 71.26 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.252 0 N-CA-C 110.096 -0.335 . . . . 0.0 110.096 179.506 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' E' E ' 105' ' ' PHE . . . . . . . . . . . . . 66.9 m-85 -124.86 162.99 23.16 Favored 'General case' 0 C--N 1.332 -0.159 0 O-C-N 123.735 0.647 . . . . 0.0 110.482 -177.792 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' E' E ' 106' ' ' ASN . . . . . . . . . . . . . 40.6 p-10 -100.7 -169.98 1.79 Allowed 'General case' 0 CA--C 1.531 0.218 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.263 175.592 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' E' E ' 107' ' ' GLN . . . . . . . . . . . . . 47.2 tt0 -59.09 -29.97 67.74 Favored 'General case' 0 CA--C 1.531 0.232 0 N-CA-C 112.017 0.377 . . . . 0.0 112.017 179.917 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' E' E ' 108' ' ' ASN . . . . . . . . . . . . . 12.2 t-20 -86.01 9.62 16.57 Favored 'General case' 0 CA--C 1.534 0.348 0 N-CA-C 113.275 0.842 . . . . 0.0 113.275 -177.087 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' E' E ' 109' ' ' LEU . . . . . 0.569 HD21 ' HB2' ' E' ' 78' ' ' ALA . 12.1 tp 57.76 40.11 26.55 Favored 'General case' 0 CA--C 1.529 0.169 0 CA-C-O 121.206 0.527 . . . . 0.0 111.012 178.33 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' E' E ' 110' ' ' GLU . . . . . . . . . . . . . 95.5 mt-10 -108.32 156.93 18.83 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.202 -0.454 . . . . 0.0 109.99 175.953 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' E' E ' 111' ' ' GLU . . . . . . . . . . . . . 35.5 tt0 -81.61 122.08 27.15 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-O 120.892 0.377 . . . . 0.0 110.744 -177.304 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' E' E ' 112' ' ' LEU . . . . . . . . . . . . . 16.8 mt -107.74 -45.94 3.91 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 115.991 -0.549 . . . . 0.0 110.219 175.996 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' E' E ' 113' ' ' TYR . . . . . . . . . . . . . 63.2 t80 -139.5 135.08 33.13 Favored 'General case' 0 C--N 1.332 -0.19 0 C-N-CA 120.814 -0.355 . . . . 0.0 111.456 179.624 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' E' E ' 114' ' ' ARG . . . . . . . . . . . . . 19.4 ttm180 -133.76 123.85 25.61 Favored 'General case' 0 C--N 1.331 -0.224 0 CA-C-N 115.811 -0.631 . . . . 0.0 109.72 175.58 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' E' E ' 115' ' ' GLY . . . . . . . . . . . . . . . -150.11 141.36 8.72 Favored Glycine 0 CA--C 1.524 0.655 0 N-CA-C 111.272 -0.731 . . . . 0.0 111.272 178.906 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' E' E ' 116' ' ' LYS . . . . . . . . . . . . . 17.1 ttpp -116.57 130.72 56.9 Favored 'General case' 0 C--N 1.332 -0.194 0 N-CA-C 109.748 -0.464 . . . . 0.0 109.748 177.443 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' E' E ' 117' ' ' PHE . . . . . . . . . . . . . 38.6 m-85 -130.58 114.04 14.96 Favored 'General case' 0 C--N 1.331 -0.213 0 CA-C-O 120.782 0.325 . . . . 0.0 110.211 -175.696 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' E' E ' 118' ' ' GLU . . . . . . . . . . . . . 96.0 mt-10 -55.54 -41.49 73.29 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.406 -0.361 . . . . 0.0 111.102 -176.695 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' E' E ' 119' ' ' ASN . . . . . . . . . . . . . 34.7 m-80 -99.57 30.96 3.36 Favored 'General case' 0 C--N 1.33 -0.268 0 N-CA-C 112.121 0.415 . . . . 0.0 112.121 -174.123 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' E' E ' 120' ' ' LEU . . . . . . . . . . . . . 13.7 tp -55.33 121.3 8.61 Favored 'General case' 0 C--N 1.333 -0.115 0 CA-C-O 120.747 0.308 . . . . 0.0 110.736 178.382 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' E' E ' 121' ' ' ASN . . . . . . . . . . . . . 72.0 m-80 -112.51 -44.13 3.4 Favored 'General case' 0 C--N 1.332 -0.175 0 CA-C-N 116.316 -0.402 . . . . 0.0 110.841 -178.145 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' E' E ' 122' ' ' LYS . . . . . . . . . . . . . 35.4 mtmm -147.47 147.05 29.78 Favored 'General case' 0 C--N 1.331 -0.231 0 C-N-CA 120.6 -0.44 . . . . 0.0 111.783 -177.985 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' E' E ' 123' ' ' VAL . . . . . . . . . . . . . 45.5 t -123.94 127.27 73.54 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.233 0 CA-C-N 115.88 -0.6 . . . . 0.0 109.562 176.133 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' E' E ' 124' ' ' LEU . . . . . . . . . . . . . 51.5 mt -119.73 136.36 54.46 Favored 'General case' 0 C--N 1.331 -0.23 0 CA-C-N 116.355 -0.384 . . . . 0.0 110.673 -177.743 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' E' E ' 125' ' ' VAL . . . . . . . . . . . . . 12.1 p -133.31 135.25 56.58 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.265 0 CA-C-O 120.749 0.309 . . . . 0.0 110.392 178.505 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' E' E ' 126' ' ' ARG . . . . . . . . . . . . . 95.8 mtt-85 -144.5 120.9 10.97 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-N 116.093 -0.503 . . . . 0.0 110.566 179.139 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' E' E ' 127' ' ' ASN . . . . . . . . . . . . . 94.9 m-20 50.4 -108.02 0.31 Allowed 'General case' 0 CA--C 1.544 0.721 0 CA-C-O 118.854 -0.593 . . . . 0.0 111.428 179.662 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' E' E ' 128' ' ' ASP . . . . . . . . . . . . . 11.0 p-10 -114.08 6.85 16.54 Favored 'General case' 0 CA--C 1.536 0.436 0 CA-C-N 119.796 1.18 . . . . 0.0 113.417 -177.776 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' E' E ' 129' ' ' LEU . . . . . . . . . . . . . 6.1 mp -110.75 150.04 29.66 Favored 'General case' 0 C--O 1.233 0.189 0 CA-C-N 118.206 0.457 . . . . 0.0 110.435 178.666 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' E' E ' 130' ' ' VAL . . . . . 0.456 HG11 HD11 ' E' ' 104' ' ' ILE . 40.6 t -130.86 140.98 47.35 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.237 0 CA-C-N 116.271 -0.422 . . . . 0.0 110.406 -178.213 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' E' E ' 131' ' ' VAL . . . . . . . . . . . . . 41.3 t -134.92 135.88 52.51 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 CA-C-N 116.096 -0.502 . . . . 0.0 109.806 177.835 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' E' E ' 132' ' ' ILE . . . . . . . . . . . . . 71.3 mt -119.29 133.68 65.32 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.25 0 N-CA-C 109.737 -0.468 . . . . 0.0 109.737 -179.842 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' E' E ' 133' ' ' ILE . . . . . . . . . . . . . 41.8 mm -115.9 123.58 71.35 Favored 'Isoleucine or valine' 0 C--O 1.233 0.223 0 CA-C-N 116.39 -0.368 . . . . 0.0 110.663 -176.867 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' E' E ' 134' ' ' ASP . . . . . . . . . . . . . 10.1 p-10 -134.88 150.14 50.4 Favored 'General case' 0 C--N 1.331 -0.237 0 N-CA-C 109.75 -0.463 . . . . 0.0 109.75 175.332 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' E' E ' 135' ' ' GLU . . . . . . . . . . . . . 40.6 tp10 -49.95 -27.29 5.14 Favored 'General case' 0 C--N 1.328 -0.347 0 N-CA-C 112.809 0.67 . . . . 0.0 112.809 -171.581 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' E' E ' 136' ' ' GLN . . . . . . . . . . . . . 43.4 tt0 -89.99 -29.97 18.09 Favored 'General case' 0 C--O 1.234 0.266 0 N-CA-C 112.619 0.6 . . . . 0.0 112.619 -173.388 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' E' E ' 137' ' ' LYS . . . . . . . . . . . . . 52.2 pttt -163.86 173.02 13.23 Favored 'General case' 0 C--N 1.332 -0.179 0 CA-C-O 121.528 0.68 . . . . 0.0 112.448 -173.238 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' E' E ' 138' ' ' LEU . . . . . . . . . . . . . 6.4 tt -121.15 129.94 53.49 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 115.03 -0.986 . . . . 0.0 109.928 178.579 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' E' E ' 139' ' ' THR . . . . . . . . . . . . . 27.9 m -111.78 129.49 56.11 Favored 'General case' 0 C--N 1.331 -0.211 0 CA-C-N 116.315 -0.402 . . . . 0.0 110.676 -178.856 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' E' E ' 140' ' ' LEU . . . . . . . . . . . . . 8.7 tp -117.14 120.7 39.1 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 115.748 -0.66 . . . . 0.0 109.363 -177.989 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' E' E ' 141' ' ' ILE . . . . . . . . . . . . . 19.4 mt -119.49 121.42 66.33 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.239 0 CA-C-O 120.818 0.342 . . . . 0.0 110.219 -175.701 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' E' E ' 142' ' ' ARG . . . . . . . . . . . . . 75.1 mtp180 -111.85 130.4 55.83 Favored 'General case' 0 C--N 1.331 -0.222 0 CA-C-N 115.556 -0.747 . . . . 0.0 110.185 -178.666 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' E' E ' 143' ' ' THR . . . . . . . . . . . . . 39.9 p . . . . . 0 C--O 1.219 -0.506 0 CA-C-O 118.011 -0.995 . . . . 0.0 110.598 179.953 . . . . . . . . 0 0 . 1 . 020 nuclear nobuild core ' F' F ' 1' ' ' MET . . . . . . . . . . . . . 26.1 ptt? . . . . . 0 CA--C 1.527 0.094 0 CA-C-O 120.849 0.356 . . . . 0.0 110.441 . . . . . . . . . 0 0 . 1 . 020 nuclear nobuild core ' F' F ' 2' ' ' SER . . . . . . . . . . . . . 6.2 p -108.34 139.38 43.13 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-N 116.1 -0.5 . . . . 0.0 110.805 -178.536 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' F' F ' 3' ' ' GLU . . . . . . . . . . . . . 33.1 tp10 -139.18 133.58 31.6 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 115.723 -0.671 . . . . 0.0 110.194 -178.102 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' F' F ' 4' ' ' LEU . . . . . . . . . . . . . 19.7 tp -125.15 127.59 47.08 Favored 'General case' 0 C--N 1.331 -0.196 0 N-CA-C 110.071 -0.344 . . . . 0.0 110.071 175.23 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' F' F ' 5' ' ' LYS . . . . . . . . . . . . . 98.7 mttt -111.14 121.39 45.18 Favored 'General case' 0 C--O 1.235 0.302 0 CA-C-O 120.831 0.348 . . . . 0.0 110.827 179.378 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' F' F ' 6' ' ' LEU . . . . . . . . . . . . . 60.4 mt -114.46 143.31 45.15 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 115.369 -0.832 . . . . 0.0 109.898 179.549 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' F' F ' 7' ' ' LYS . . . . . . . . . . . . . 80.6 tttt -123.43 134.23 25.08 Favored Pre-proline 0 CA--C 1.534 0.339 0 CA-C-O 118.893 -0.575 . . . . 0.0 109.812 175.96 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' F' F ' 8' ' ' PRO . . . . . . . . . . . . . 94.4 Cg_endo -92.03 136.57 1.69 Allowed 'Trans proline' 0 N--CA 1.489 1.261 0 C-N-CA 121.607 1.538 . . . . 0.0 111.703 177.722 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' F' F ' 9' ' ' LEU . . . . . . . . . . . . . 63.0 mt -79.32 -47.53 1.57 Allowed Pre-proline 0 CA--C 1.533 0.301 0 CA-C-O 118.61 -0.71 . . . . 0.0 112.1 -179.486 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' F' F ' 10' ' ' PRO . . . . . . . . . . . . . 90.1 Cg_endo -80.9 149.82 18.04 Favored 'Trans proline' 0 N--CA 1.496 1.63 0 C-N-CA 121.207 1.271 . . . . 0.0 111.87 176.502 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' F' F ' 11' ' ' LYS . . . . . . . . . . . . . 45.3 tttp -88.25 111.2 21.39 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-O 120.753 0.311 . . . . 0.0 110.371 178.99 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' F' F ' 12' ' ' VAL . . . . . . . . . . . . . 12.4 p -145.52 146.78 19.24 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.299 0 CA-C-O 120.898 0.38 . . . . 0.0 110.801 -178.645 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' F' F ' 13' ' ' GLU . . . . . . . . . . . . . 70.3 mm-40 -88.22 108.95 19.55 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.084 -0.507 . . . . 0.0 110.382 175.384 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' F' F ' 14' ' ' LEU . . . . . . . . . . . . . 38.9 mt -91.75 147.04 34.23 Favored Pre-proline 0 C--N 1.328 -0.361 0 CA-C-N 116.125 -0.489 . . . . 0.0 110.012 -179.439 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' F' F ' 15' ' ' PRO . . . . . . . . . . . . . 36.3 Cg_exo -58.37 157.42 26.51 Favored 'Trans proline' 0 N--CA 1.497 1.705 0 C-N-CA 121.237 1.291 . . . . 0.0 111.823 179.024 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' F' F ' 16' ' ' PRO . . . . . . . . . . . . . 36.9 Cg_exo -58.22 -36.79 97.45 Favored 'Trans proline' 0 N--CA 1.497 1.73 0 C-N-CA 121.384 1.389 . . . . 0.0 112.876 -178.505 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' F' F ' 17' ' ' ASP . . . . . . . . . . . . . 8.7 p-10 -83.51 12.19 5.98 Favored 'General case' 0 CA--C 1.536 0.412 0 N-CA-C 113.146 0.795 . . . . 0.0 113.146 -177.803 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' F' F ' 18' ' ' PHE . . . . . . . . . . . . . 45.6 t80 -56.78 -45.86 81.88 Favored 'General case' 0 N--CA 1.457 -0.096 0 O-C-N 122.007 -0.433 . . . . 0.0 110.424 -178.566 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' F' F ' 19' ' ' VAL . . . . . . . . . . . . . 15.0 p -54.85 -41.04 55.24 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.273 0 CA-C-N 116.549 -0.296 . . . . 0.0 111.175 -178.176 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' F' F ' 20' ' ' ASP . . . . . . . . . . . . . 73.7 m-20 -60.72 -45.25 94.99 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-O 120.814 0.34 . . . . 0.0 111.075 -178.429 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' F' F ' 21' ' ' VAL . . . . . . . . . . . . . 47.6 t -64.64 -46.97 90.83 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.328 0 C-N-CA 120.65 -0.42 . . . . 0.0 110.574 -177.273 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' F' F ' 22' ' ' ILE . . . . . 0.622 HG22 HD12 ' F' ' 26' ' ' LEU . 50.8 mm -56.46 -45.73 81.97 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.271 0 CA-C-O 120.875 0.369 . . . . 0.0 110.462 179.443 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' F' F ' 23' ' ' ARG . . . . . . . . . . . . . 32.3 ttp180 -53.64 -49.03 68.78 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.655 -0.248 . . . . 0.0 111.369 -179.076 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' F' F ' 24' ' ' ILE . . . . . . . . . . . . . 67.8 mt -59.27 -48.27 87.55 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.336 0 C-N-CA 121.039 -0.265 . . . . 0.0 111.193 -177.361 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' F' F ' 25' ' ' LYS . . . . . . . . . . . . . 98.8 mttt -64.35 -36.23 83.45 Favored 'General case' 0 C--N 1.329 -0.286 0 N-CA-C 112.538 0.57 . . . . 0.0 112.538 -177.029 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' F' F ' 26' ' ' LEU . . . . . 0.622 HD12 HG22 ' F' ' 22' ' ' ILE . 53.4 mt -77.47 -43.77 31.19 Favored 'General case' 0 C--N 1.33 -0.259 0 N-CA-C 112.869 0.692 . . . . 0.0 112.869 -173.169 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' F' F ' 27' ' ' GLN . . . . . . . . . . . . . 10.9 pt20 -47.4 137.91 8.1 Favored 'General case' 0 N--CA 1.468 0.439 0 N-CA-C 112.714 0.635 . . . . 0.0 112.714 -175.424 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' F' F ' 28' ' ' GLY . . . . . . . . . . . . . . . 101.02 -26.45 24.63 Favored Glycine 0 CA--C 1.533 1.165 0 CA-C-N 115.587 -0.733 . . . . 0.0 112.235 -176.998 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' F' F ' 29' ' ' LYS . . . . . . . . . . . . . 66.7 mmtt -98.14 155.1 17.31 Favored 'General case' 0 C--O 1.233 0.217 0 CA-C-N 117.311 0.556 . . . . 0.0 111.26 178.792 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' F' F ' 30' ' ' THR . . . . . . . . . . . . . 26.9 m -107.95 139.8 42.04 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 115.882 -0.599 . . . . 0.0 110.152 176.741 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' F' F ' 31' ' ' VAL . . . . . . . . . . . . . 34.7 m -129.5 157.67 42.19 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.267 0 CA-C-N 116.373 -0.376 . . . . 0.0 111.08 -178.121 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' F' F ' 32' ' ' ARG . . . . . . . . . . . . . 88.7 mtt180 -131.03 149.02 52.8 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 115.7 -0.682 . . . . 0.0 110.34 177.01 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' F' F ' 33' ' ' THR . . . . . . . . . . . . . 14.1 m -53.5 138.47 33.72 Favored 'General case' 0 C--N 1.332 -0.189 0 CA-C-N 116.489 -0.323 . . . . 0.0 111.271 -177.949 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' F' F ' 34' ' ' GLY . . . . . . . . . . . . . . . 100.72 -17.04 57.06 Favored Glycine 0 CA--C 1.532 1.139 0 CA-C-O 119.632 -0.538 . . . . 0.0 113.298 179.326 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' F' F ' 35' ' ' ASP . . . . . . . . . . . . . 54.1 m-20 -63.0 150.63 41.93 Favored 'General case' 0 C--O 1.233 0.206 0 CA-C-N 118.121 0.961 . . . . 0.0 111.316 -179.926 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' F' F ' 36' ' ' VAL . . . . . . . . . . . . . 45.3 t -123.33 129.48 74.79 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.232 0 CA-C-N 115.76 -0.655 . . . . 0.0 109.822 178.582 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' F' F ' 37' ' ' ILE . . . . . . . . . . . . . 67.5 mt -124.84 140.41 48.08 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.257 0 CA-C-N 116.304 -0.407 . . . . 0.0 110.183 -179.096 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' F' F ' 38' ' ' GLY . . . . . . . . . . . . . . . -118.65 128.71 7.81 Favored Glycine 0 CA--C 1.525 0.689 0 N-CA-C 111.181 -0.768 . . . . 0.0 111.181 179.322 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' F' F ' 39' ' ' ILE . . . . . . . . . . . . . 77.4 mt -127.36 141.25 46.83 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.276 0 N-CA-C 110.234 -0.284 . . . . 0.0 110.234 179.218 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' F' F ' 40' ' ' SER . . . . . . . . . . . . . 76.8 p -92.48 119.11 31.66 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.445 -0.343 . . . . 0.0 110.995 176.068 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' F' F ' 41' ' ' ILE . . . . . . . . . . . . . 43.8 mm -121.05 118.74 57.22 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.195 0 CA-C-N 116.463 -0.335 . . . . 0.0 110.141 178.125 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' F' F ' 42' ' ' LEU . . . . . . . . . . . . . 64.5 mt 52.05 34.42 13.97 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.308 -0.405 . . . . 0.0 111.907 177.194 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' F' F ' 43' ' ' GLY . . . . . . . . . . . . . . . 76.74 28.8 58.52 Favored Glycine 0 CA--C 1.53 1.028 0 C-N-CA 121.185 -0.531 . . . . 0.0 112.523 176.693 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' F' F ' 44' ' ' LYS . . . . . . . . . . . . . 7.8 ttpm? -140.52 131.28 25.79 Favored 'General case' 0 C--N 1.33 -0.242 0 N-CA-C 109.289 -0.634 . . . . 0.0 109.289 176.316 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' F' F ' 45' ' ' GLU . . . . . . . . . . . . . 81.3 tt0 -82.4 126.71 32.5 Favored 'General case' 0 C--N 1.328 -0.332 0 C-N-CA 120.865 -0.334 . . . . 0.0 111.263 -175.806 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' F' F ' 46' ' ' VAL . . . . . . . . . . . . . 10.4 p -118.2 124.96 73.88 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.2 0 N-CA-C 109.532 -0.544 . . . . 0.0 109.532 175.091 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' F' F ' 47' ' ' LYS . . . . . . . . . . . . . 62.0 mttp -99.14 125.53 44.71 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 115.866 -0.606 . . . . 0.0 110.942 178.105 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' F' F ' 48' ' ' PHE . . . . . . . . . . . . . 33.7 m-85 -110.26 131.91 54.64 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.037 -0.529 . . . . 0.0 109.921 177.384 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' F' F ' 49' ' ' LYS . . . . . . . . . . . . . 43.0 tttp -107.67 132.99 52.74 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 116.31 -0.404 . . . . 0.0 109.975 176.402 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' F' F ' 50' ' ' VAL . . . . . . . . . . . . . 44.0 t -76.81 107.82 8.71 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.312 0 N-CA-C 109.483 -0.562 . . . . 0.0 109.483 178.701 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' F' F ' 51' ' ' VAL . . . . . . . . . . . . . 44.7 t -72.43 -50.42 35.31 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.289 0 CA-C-N 116.022 -0.535 . . . . 0.0 109.825 -174.747 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' F' F ' 52' ' ' GLN . . . . . . . . . . . . . 62.8 tt0 -159.06 144.61 16.25 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 115.836 -0.62 . . . . 0.0 111.501 -176.908 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' F' F ' 53' ' ' ALA . . . . . . . . . . . . . . . -123.25 132.43 54.02 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 115.524 -0.762 . . . . 0.0 109.931 175.971 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' F' F ' 54' ' ' TYR . . . . . . . . . . . . . 67.7 t80 -129.13 112.81 18.43 Favored Pre-proline 0 CA--C 1.536 0.407 0 CA-C-O 118.154 -0.927 . . . . 0.0 110.261 177.351 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' F' F ' 55' ' ' PRO . . . . . . . . . . . . . 74.4 Cg_endo -77.05 166.97 81.17 Favored 'Cis proline' 0 N--CA 1.501 1.919 0 CA-C-N 122.09 1.782 . . . . 0.0 112.467 -5.4 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' F' F ' 56' ' ' SER . . . . . . . . . . . . . 13.7 m -114.05 124.99 29.96 Favored Pre-proline 0 CA--C 1.539 0.535 0 CA-C-O 118.369 -0.824 . . . . 0.0 109.381 176.506 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' F' F ' 57' ' ' PRO . . . . . . . . . . . . . 39.5 Cg_endo -67.16 166.24 64.07 Favored 'Cis proline' 0 N--CA 1.498 1.751 0 CA-C-N 122.065 1.773 . . . . 0.0 111.556 0.939 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' F' F ' 58' ' ' LEU . . . . . . . . . . . . . 24.0 tp -127.46 135.0 49.81 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.227 -0.442 . . . . 0.0 110.365 179.958 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' F' F ' 59' ' ' ARG . . . . . . . . . . . . . 57.4 ttp180 -106.63 123.1 47.61 Favored 'General case' 0 C--N 1.328 -0.358 0 N-CA-C 109.244 -0.65 . . . . 0.0 109.244 177.129 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' F' F ' 60' ' ' VAL . . . . . . . . . . . . . 44.5 t -78.12 122.22 32.57 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.347 0 C-N-CA 120.753 -0.379 . . . . 0.0 110.546 -174.049 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' F' F ' 61' ' ' GLU . . . . . . . . . . . . . 95.5 mt-10 -131.06 164.92 24.36 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-N 115.804 -0.635 . . . . 0.0 109.784 176.293 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' F' F ' 62' ' ' ASP . . . . . . . . . . . . . 80.5 m-20 -53.94 -32.66 54.4 Favored 'General case' 0 C--N 1.328 -0.342 0 C-N-CA 121.027 -0.269 . . . . 0.0 111.646 -179.663 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' F' F ' 63' ' ' ARG . . . . . . . . . . . . . 24.4 mmt180 -73.07 -21.39 60.79 Favored 'General case' 0 CA--C 1.533 0.32 0 N-CA-C 113.034 0.753 . . . . 0.0 113.034 -177.519 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' F' F ' 64' ' ' THR . . . . . . . . . . . . . 30.9 m -68.08 137.35 54.91 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-O 120.882 0.373 . . . . 0.0 111.009 -174.201 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' F' F ' 65' ' ' LYS . . . . . . . . . . . . . 97.9 mttt -90.36 132.17 35.73 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.038 -0.528 . . . . 0.0 109.992 178.525 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' F' F ' 66' ' ' ILE . . . . . . . . . . . . . 64.2 mt -119.51 131.39 72.25 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.264 0 CA-C-O 120.934 0.397 . . . . 0.0 110.071 -179.822 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' F' F ' 67' ' ' THR . . . . . . . . . . . . . 22.9 m -123.39 139.03 54.45 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 115.96 -0.563 . . . . 0.0 110.651 -179.412 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' F' F ' 68' ' ' LEU . . . . . 0.478 HD23 ' C ' ' F' ' 68' ' ' LEU . 6.3 tt . . . . . 0 C--N 1.331 -0.225 0 CA-C-N 116.108 -0.496 . . . . 0.0 110.506 179.673 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' F' F ' 73' ' ' VAL . . . . . . . . . . . . . 35.6 m . . . . . 0 N--CA 1.462 0.15 0 N-CA-C 109.747 -0.464 . . . . 0.0 109.747 . . . . . . . . . 0 0 . 1 . 020 nuclear nobuild core ' F' F ' 74' ' ' ASP . . . . . . . . . . . . . 12.0 t0 -96.43 117.19 30.37 Favored 'General case' 0 C--N 1.332 -0.192 0 C-N-CA 120.743 -0.383 . . . . 0.0 110.065 -176.284 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' F' F ' 75' ' ' VAL . . . . . . . . . . . . . 41.9 t -116.99 122.21 69.54 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.253 0 CA-C-O 120.985 0.421 . . . . 0.0 110.522 -178.043 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' F' F ' 76' ' ' LEU . . . . . . . . . . . . . 6.2 mp -119.85 144.96 47.08 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 115.675 -0.693 . . . . 0.0 109.782 176.51 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' F' F ' 77' ' ' GLU . . . . . . . . . . . . . 46.3 mt-10 -136.11 136.75 40.38 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-O 121.082 0.468 . . . . 0.0 111.351 -179.278 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' F' F ' 78' ' ' ALA . . . . . . . . . . . . . . . -123.97 132.27 53.68 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-N 115.68 -0.691 . . . . 0.0 109.7 175.873 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' F' F ' 79' ' ' LYS . . . . . 0.618 ' O ' HD13 ' F' ' 80' ' ' ILE . 62.1 mttp -81.17 117.37 21.66 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-O 120.925 0.393 . . . . 0.0 110.669 -178.814 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' F' F ' 80' ' ' ILE . . . . . 0.618 HD13 ' O ' ' F' ' 79' ' ' LYS . 40.3 mm -139.04 112.25 6.44 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.37 0 N-CA-C 109.13 -0.693 . . . . 0.0 109.13 -177.002 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' F' F ' 81' ' ' LYS . . . . . . . . . . . . . 79.0 tttt -102.08 127.49 48.96 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-O 120.852 0.358 . . . . 0.0 111.071 -177.668 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' F' F ' 82' ' ' GLY . . . . . . . . . . . . . . . 89.07 42.15 5.69 Favored Glycine 0 CA--C 1.525 0.691 0 C-N-CA 120.872 -0.68 . . . . 0.0 112.037 174.481 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' F' F ' 83' ' ' ILE . . . . . . . . . . . . . 68.7 mt -71.6 136.93 24.73 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.351 0 N-CA-C 109.281 -0.637 . . . . 0.0 109.281 175.684 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' F' F ' 84' ' ' LYS . . . . . . . . . . . . . 27.7 ttpp -94.94 -48.92 5.79 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-O 121.03 0.443 . . . . 0.0 110.047 -178.717 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' F' F ' 85' ' ' ASP . . . . . . . . . . . . . 10.0 t70 -154.57 153.38 31.32 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 115.756 -0.656 . . . . 0.0 110.562 -179.682 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' F' F ' 86' ' ' VAL . . . . . . . . . . . . . 41.9 t -128.98 133.47 66.01 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.202 0 CA-C-O 121.043 0.449 . . . . 0.0 110.243 179.201 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' F' F ' 87' ' ' ILE . . . . . . . . . . . . . 43.9 mm -117.77 123.69 72.04 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.263 0 CA-C-N 115.777 -0.647 . . . . 0.0 109.277 177.21 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' F' F ' 88' ' ' LEU . . . . . . . . . . . . . 14.7 tp -115.02 125.28 53.4 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-O 121.147 0.498 . . . . 0.0 111.44 -175.701 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' F' F ' 89' ' ' ASP . . . . . . . . . . . . . 13.2 t70 -118.4 154.78 31.86 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 115.525 -0.761 . . . . 0.0 109.147 174.185 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' F' F ' 90' ' ' GLU . . . . . . . . . . . . . 96.0 mt-10 -48.7 -39.92 26.35 Favored 'General case' 0 C--N 1.329 -0.302 0 N-CA-C 112.717 0.636 . . . . 0.0 112.717 -172.187 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' F' F ' 91' ' ' ASN . . . . . . . . . . . . . 21.8 p30 -132.15 38.09 3.52 Favored 'General case' 0 N--CA 1.464 0.259 0 CA-C-O 120.815 0.341 . . . . 0.0 111.477 -178.291 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' F' F ' 92' ' ' LEU . . . . . . . . . . . . . 18.4 tp -165.64 137.99 4.15 Favored 'General case' 0 C--N 1.329 -0.298 0 N-CA-C 110.25 -0.278 . . . . 0.0 110.25 -179.996 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' F' F ' 93' ' ' ILE . . . . . . . . . . . . . 71.5 mt -125.02 126.49 71.24 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.23 0 N-CA-C 109.91 -0.404 . . . . 0.0 109.91 -176.956 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' F' F ' 94' ' ' VAL . . . . . 0.472 HG21 HG11 ' F' ' 125' ' ' VAL . 44.0 t -125.05 128.47 73.04 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.207 0 N-CA-C 109.915 -0.402 . . . . 0.0 109.915 178.212 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' F' F ' 95' ' ' VAL . . . . . . . . . . . . . 44.0 t -120.14 133.4 67.0 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.302 0 CA-C-N 116.096 -0.502 . . . . 0.0 109.749 179.001 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' F' F ' 96' ' ' ILE . . . . . . . . . . . . . 64.3 mt -115.66 128.11 73.02 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.293 0 N-CA-C 109.462 -0.57 . . . . 0.0 109.462 179.545 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' F' F ' 97' ' ' THR . . . . . . . . . . . . . 72.7 p -103.74 157.76 16.85 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-O 121.331 0.586 . . . . 0.0 111.516 -176.392 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' F' F ' 98' ' ' GLU . . . . . . . . . . . . . 70.8 mm-40 -53.9 -26.02 23.04 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 115.994 -0.548 . . . . 0.0 112.397 179.709 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' F' F ' 99' ' ' GLU . . . . . . . . . . . . . 36.1 tt0 -79.99 16.99 1.05 Allowed 'General case' 0 CA--C 1.538 0.51 0 N-CA-C 112.588 0.588 . . . . 0.0 112.588 -176.441 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' F' F ' 100' ' ' ASN . . . . . . . . . . . . . 2.6 m-20 60.85 37.76 18.34 Favored 'General case' 0 C--O 1.232 0.165 0 O-C-N 121.761 -0.587 . . . . 0.0 110.95 178.454 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' F' F ' 101' ' ' GLU . . . . . . . . . . . . . 84.2 tt0 -116.37 144.38 44.34 Favored 'General case' 0 C--N 1.331 -0.225 0 CA-C-N 115.99 -0.55 . . . . 0.0 109.679 176.852 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' F' F ' 102' ' ' VAL . . . . . . . . . . . . . 44.6 t -117.63 126.37 74.68 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.357 0 CA-C-N 116.24 -0.436 . . . . 0.0 109.839 -178.257 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' F' F ' 103' ' ' LEU . . . . . . . . . . . . . 40.7 mt -116.39 129.22 56.13 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 115.717 -0.674 . . . . 0.0 110.121 176.692 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' F' F ' 104' ' ' ILE . . . . . . . . . . . . . 72.2 mt -116.62 122.08 69.09 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.257 0 N-CA-C 110.136 -0.32 . . . . 0.0 110.136 -179.596 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' F' F ' 105' ' ' PHE . . . . . . . . . . . . . 58.6 m-85 -121.21 166.38 14.07 Favored 'General case' 0 C--N 1.332 -0.162 0 O-C-N 124.087 0.867 . . . . 0.0 109.837 -178.968 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' F' F ' 106' ' ' ASN . . . . . . . . . . . . . 42.1 p-10 -102.79 -170.83 1.85 Allowed 'General case' 0 C--N 1.331 -0.231 0 N-CA-C 110.011 -0.366 . . . . 0.0 110.011 172.501 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' F' F ' 107' ' ' GLN . . . . . . . . . . . . . 45.4 tt0 -59.58 -30.16 68.46 Favored 'General case' 0 C--N 1.328 -0.358 0 N-CA-C 111.903 0.335 . . . . 0.0 111.903 179.106 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' F' F ' 108' ' ' ASN . . . . . . . . . . . . . 12.3 t-20 -81.84 6.19 16.45 Favored 'General case' 0 CA--C 1.537 0.467 0 N-CA-C 113.221 0.822 . . . . 0.0 113.221 -177.768 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' F' F ' 109' ' ' LEU . . . . . . . . . . . . . 9.7 tp 61.6 36.82 16.59 Favored 'General case' 0 CA--C 1.53 0.178 0 CA-C-O 120.905 0.383 . . . . 0.0 111.369 178.816 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' F' F ' 110' ' ' GLU . . . . . . . . . . . . . 43.0 mt-10 -106.36 158.44 16.88 Favored 'General case' 0 C--N 1.33 -0.264 0 N-CA-C 109.623 -0.51 . . . . 0.0 109.623 175.805 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' F' F ' 111' ' ' GLU . . . . . . . . . . . . . 44.1 mp0 -87.07 121.97 30.26 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-O 121.106 0.479 . . . . 0.0 111.212 -177.985 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' F' F ' 112' ' ' LEU . . . . . . . . . . . . . 42.9 mt -101.19 -45.95 5.2 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 115.611 -0.722 . . . . 0.0 110.095 175.768 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' F' F ' 113' ' ' TYR . . . . . . . . . . . . . 64.3 t80 -141.79 137.28 31.44 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.049 -0.523 . . . . 0.0 111.613 -178.054 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' F' F ' 114' ' ' ARG . . . . . . . . . . . . . 92.3 mtt180 -129.06 123.65 32.84 Favored 'General case' 0 C--N 1.331 -0.23 0 N-CA-C 109.3 -0.63 . . . . 0.0 109.3 175.245 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' F' F ' 115' ' ' GLY . . . . . . . . . . . . . . . -150.06 157.68 27.33 Favored Glycine 0 CA--C 1.525 0.661 0 C-N-CA 120.447 -0.882 . . . . 0.0 111.807 -179.835 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' F' F ' 116' ' ' LYS . . . . . . . . . . . . . 39.7 ttpt -128.72 140.7 51.61 Favored 'General case' 0 C--N 1.33 -0.263 0 N-CA-C 109.848 -0.427 . . . . 0.0 109.848 176.695 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' F' F ' 117' ' ' PHE . . . . . . . . . . . . . 47.2 m-85 -139.56 114.28 9.33 Favored 'General case' 0 C--N 1.329 -0.283 0 C-N-CA 120.836 -0.346 . . . . 0.0 110.334 -178.257 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' F' F ' 118' ' ' GLU . . . . . . . . . . . . . 84.4 tt0 -53.58 -45.87 70.13 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.523 -0.308 . . . . 0.0 111.405 -176.489 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' F' F ' 119' ' ' ASN . . . . . . . . . . . . . 85.4 m-20 -97.51 31.03 2.66 Favored 'General case' 0 C--N 1.331 -0.22 0 N-CA-C 112.182 0.438 . . . . 0.0 112.182 -174.86 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' F' F ' 120' ' ' LEU . . . . . . . . . . . . . 22.8 tp -57.51 120.44 8.28 Favored 'General case' 0 C--N 1.332 -0.174 0 CA-C-O 120.638 0.256 . . . . 0.0 110.326 178.146 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' F' F ' 121' ' ' ASN . . . . . . . . . . . . . 35.1 m120 -114.13 -44.13 3.17 Favored 'General case' 0 C--N 1.332 -0.188 0 CA-C-N 116.62 -0.263 . . . . 0.0 111.159 -177.521 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' F' F ' 122' ' ' LYS . . . . . . . . . . . . . 92.8 mttt -144.43 150.16 37.23 Favored 'General case' 0 C--N 1.332 -0.189 0 C-N-CA 120.598 -0.441 . . . . 0.0 111.646 -177.448 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' F' F ' 123' ' ' VAL . . . . . . . . . . . . . 42.5 t -132.91 129.32 57.76 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.267 0 N-CA-C 109.526 -0.546 . . . . 0.0 109.526 174.044 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' F' F ' 124' ' ' LEU . . . . . . . . . . . . . 80.4 mt -127.92 144.28 51.1 Favored 'General case' 0 C--N 1.331 -0.209 0 CA-C-O 120.754 0.311 . . . . 0.0 111.23 -176.87 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' F' F ' 125' ' ' VAL . . . . . 0.63 HG12 HG23 ' F' ' 130' ' ' VAL . 34.6 m -132.49 143.95 38.3 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.182 0 CA-C-N 116.173 -0.467 . . . . 0.0 111.18 -179.584 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' F' F ' 126' ' ' ARG . . . . . . . . . . . . . 76.7 mtp85 -145.58 116.49 7.78 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 116.006 -0.543 . . . . 0.0 110.408 176.406 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' F' F ' 127' ' ' ASN . . . . . . . . . . . . . 88.2 m-20 51.52 -104.84 0.19 Allowed 'General case' 0 CA--C 1.544 0.729 0 CA-C-O 119.087 -0.483 . . . . 0.0 111.283 179.824 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' F' F ' 128' ' ' ASP . . . . . . . . . . . . . 11.7 p-10 -114.03 0.19 14.25 Favored 'General case' 0 N--CA 1.468 0.463 0 CA-C-N 119.619 1.1 . . . . 0.0 113.318 -178.079 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' F' F ' 129' ' ' LEU . . . . . . . . . . . . . 17.2 tp -104.93 140.32 38.34 Favored 'General case' 0 C--N 1.332 -0.187 0 N-CA-C 109.565 -0.531 . . . . 0.0 109.565 178.463 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' F' F ' 130' ' ' VAL . . . . . 0.63 HG23 HG12 ' F' ' 125' ' ' VAL . 13.1 p -133.71 143.37 38.91 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.236 0 CA-C-O 121.257 0.551 . . . . 0.0 110.663 -179.357 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' F' F ' 131' ' ' VAL . . . . . 0.498 HG22 HD12 ' F' ' 140' ' ' LEU . 43.4 t -134.67 138.86 48.76 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.259 0 CA-C-N 115.766 -0.652 . . . . 0.0 110.162 -179.372 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' F' F ' 132' ' ' ILE . . . . . . . . . . . . . 69.5 mt -115.26 133.02 62.83 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.345 0 CA-C-N 115.625 -0.716 . . . . 0.0 109.078 179.003 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' F' F ' 133' ' ' ILE . . . . . . . . . . . . . 41.5 mm -117.13 123.55 71.95 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.211 0 CA-C-O 120.727 0.299 . . . . 0.0 110.949 -174.664 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' F' F ' 134' ' ' ASP . . . . . . . . . . . . . 8.1 p-10 -136.68 147.24 46.71 Favored 'General case' 0 C--N 1.331 -0.202 0 N-CA-C 109.654 -0.498 . . . . 0.0 109.654 174.13 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' F' F ' 135' ' ' GLU . . . . . . . . . . . . . 38.6 tp10 -49.89 -26.42 4.08 Favored 'General case' 0 C--N 1.328 -0.334 0 N-CA-C 112.709 0.633 . . . . 0.0 112.709 -172.348 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' F' F ' 136' ' ' GLN . . . . . . . . . . . . . 65.5 tp60 -81.9 -39.07 24.36 Favored 'General case' 0 C--O 1.233 0.21 0 N-CA-C 112.077 0.399 . . . . 0.0 112.077 -176.764 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' F' F ' 137' ' ' LYS . . . . . . . . . . . . . 50.4 pttt -161.48 172.24 16.78 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-O 121.484 0.659 . . . . 0.0 112.2 -171.303 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' F' F ' 138' ' ' LEU . . . . . 0.4 ' C ' HD23 ' F' ' 138' ' ' LEU . 7.2 tt -119.58 129.82 54.83 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 115.111 -0.949 . . . . 0.0 109.664 178.584 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' F' F ' 139' ' ' THR . . . . . . . . . . . . . 21.6 m -109.34 126.64 53.6 Favored 'General case' 0 C--N 1.331 -0.21 0 CA-C-N 116.24 -0.436 . . . . 0.0 110.4 -179.677 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' F' F ' 140' ' ' LEU . . . . . 0.498 HD12 HG22 ' F' ' 131' ' ' VAL . 25.6 tp -112.09 120.06 40.56 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 115.73 -0.668 . . . . 0.0 109.417 -178.665 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' F' F ' 141' ' ' ILE . . . . . 0.499 ' HB ' HG13 ' F' ' 130' ' ' VAL . 19.5 mt -120.91 122.95 69.11 Favored 'Isoleucine or valine' 0 C--O 1.235 0.307 0 CA-C-O 121.022 0.439 . . . . 0.0 110.108 -175.591 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' F' F ' 142' ' ' ARG . . . . . . . . . . . . . 76.9 mtt180 -113.24 131.96 55.7 Favored 'General case' 0 C--O 1.233 0.206 0 CA-C-N 115.302 -0.863 . . . . 0.0 109.961 -175.969 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' F' F ' 143' ' ' THR . . . . . . . . . . . . . 52.0 p . . . . . 0 C--O 1.221 -0.418 0 CA-C-O 118.024 -0.989 . . . . 0.0 110.408 178.275 . . . . . . . . 0 0 . 1 . 001 nuclear nobuild full ' A' A ' -3' ' ' GLU . . . . . . . . . . . . . 48.2 mt-10 . . . . . 0 N--CA 1.491 1.581 0 N-CA-C 109.567 -0.531 . . . . 32.38 109.567 . . . . . . . . . 0 0 . 1 . 001 nuclear nobuild full ' A' A ' -2' ' ' GLY . . . . . . . . . . . . . . . -69.3 141.34 35.4 Favored Glycine 0 CA--C 1.525 0.671 0 N-CA-C 110.484 -1.046 . . . . 28.94 110.484 177.692 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' -1' ' ' VAL . . . . . . . . . . . . . 43.2 t -96.01 136.32 27.3 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.315 0 CA-C-O 120.815 0.341 . . . . 26.21 110.246 -178.457 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 0' ' ' ILE . . . . . . . . . . . . . 75.1 mt -107.64 130.62 59.65 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.266 0 CA-C-N 116.141 -0.481 . . . . 24.64 109.751 178.537 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 26.1 ptt? -79.17 169.78 17.64 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.25 -0.432 . . . . 20.97 111.111 -177.219 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 1.9 p -120.37 125.95 49.26 Favored 'General case' 0 C--N 1.331 -0.22 0 CA-C-N 115.963 -0.562 . . . . 18.2 110.564 178.464 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 84.7 tt0 -143.85 141.64 30.43 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 116.023 -0.535 . . . . 15.68 111.114 -179.308 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 4' ' ' LEU . . . . . . . . . . . . . 19.0 tp -122.62 127.84 49.89 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-N 116.019 -0.537 . . . . 13.41 110.087 177.485 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 5' ' ' LYS . . . . . . . . . . . . . 72.6 mttt -109.81 121.44 45.23 Favored 'General case' 0 C--O 1.234 0.246 0 CA-C-O 120.916 0.389 . . . . 11.98 110.709 178.94 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 31.1 mt -114.33 149.18 36.41 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 115.205 -0.907 . . . . 10.99 110.371 -178.719 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 19.5 ttmm -133.85 139.41 33.35 Favored Pre-proline 0 CA--C 1.536 0.418 0 CA-C-O 119.095 -0.479 . . . . 9.31 109.799 175.17 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 8' ' ' PRO . . . . . . . . . . . . . 90.3 Cg_endo -91.82 134.47 1.49 Allowed 'Trans proline' 0 N--CA 1.49 1.293 0 C-N-CA 121.718 1.612 . . . . 9.35 111.649 177.427 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 59.0 mt -71.78 -46.54 12.3 Favored Pre-proline 0 C--N 1.329 -0.295 0 CA-C-O 118.723 -0.656 . . . . 13.42 111.838 -179.703 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 92.4 Cg_endo -80.47 146.85 17.5 Favored 'Trans proline' 0 N--CA 1.494 1.556 0 C-N-CA 121.077 1.185 . . . . 13.21 111.582 173.071 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 93.4 mttt -87.09 92.21 8.97 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-O 120.872 0.367 . . . . 12.71 110.561 -179.942 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 12.4 p -138.63 143.74 31.6 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.292 0 CA-C-N 116.111 -0.495 . . . . 13.83 110.414 179.672 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 94.8 mt-10 -82.24 131.35 35.23 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.298 -0.41 . . . . 13.84 110.126 178.055 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 14' ' ' LEU . . . . . . . . . . . . . 30.8 mt -93.92 150.32 38.38 Favored Pre-proline 0 C--N 1.328 -0.328 0 CA-C-N 116.358 -0.383 . . . . 13.0 110.164 -179.483 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 15' ' ' PRO . . . . . . . . . . . . . 39.2 Cg_exo -57.9 159.92 16.59 Favored 'Trans proline' 0 N--CA 1.497 1.684 0 C-N-CA 121.213 1.275 . . . . 15.42 111.624 179.515 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 16' ' ' PRO . . . . . . . . . . . . . 39.7 Cg_exo -58.54 -39.78 80.12 Favored 'Trans proline' 0 N--CA 1.497 1.698 0 C-N-CA 121.479 1.453 . . . . 16.07 112.866 -177.39 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 17' ' ' ASP . . . . . . . . . . . . . 19.5 p-10 -88.4 9.11 24.61 Favored 'General case' 0 C--N 1.326 -0.415 0 N-CA-C 113.22 0.822 . . . . 16.69 113.22 -178.168 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 18' ' ' PHE . . . . . . . . . . . . . 50.3 t80 -58.27 -48.05 81.68 Favored 'General case' 0 N--CA 1.457 -0.103 0 O-C-N 121.91 -0.494 . . . . 13.52 110.19 -176.316 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 19' ' ' VAL . . . . . . . . . . . . . 46.4 t -54.8 -47.95 73.93 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.345 0 CA-C-N 116.446 -0.343 . . . . 12.65 111.167 -175.077 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 2.6 p30 -62.71 -38.24 89.65 Favored 'General case' 0 C--N 1.332 -0.175 0 C-N-CA 120.572 -0.451 . . . . 15.76 111.336 -176.245 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 54.7 t -64.34 -46.79 92.09 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.181 0 C-N-CA 120.582 -0.447 . . . . 15.45 110.213 -179.775 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 22' ' ' ILE . . . . . 0.615 HG22 HD12 ' A' ' 26' ' ' LEU . 51.6 mm -56.71 -45.26 82.72 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.248 0 C-N-CA 121.036 -0.266 . . . . 13.87 110.454 178.96 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 23' ' ' ARG . . . . . . . . . . . . . 59.5 ttp180 -53.98 -48.43 70.36 Favored 'General case' 0 C--N 1.329 -0.295 0 C-N-CA 121.179 -0.208 . . . . 16.33 111.32 -179.273 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 24' ' ' ILE . . . . . . . . . . . . . 76.1 mt -58.97 -46.58 91.47 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.339 0 C-N-CA 120.877 -0.329 . . . . 17.1 110.86 -177.965 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 99.6 mttt -64.25 -38.08 89.77 Favored 'General case' 0 C--N 1.329 -0.324 0 N-CA-C 112.546 0.572 . . . . 16.69 112.546 -177.948 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 26' ' ' LEU . . . . . 0.615 HD12 HG22 ' A' ' 22' ' ' ILE . 49.7 mt -77.89 -41.6 36.09 Favored 'General case' 0 C--N 1.33 -0.247 0 N-CA-C 113.093 0.775 . . . . 16.62 113.093 -172.015 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 27' ' ' GLN . . . . . . . . . . . . . 14.3 pt20 -47.69 139.35 7.33 Favored 'General case' 0 N--CA 1.468 0.462 0 N-CA-C 112.77 0.656 . . . . 18.08 112.77 -174.426 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 100.29 -24.11 33.35 Favored Glycine 0 CA--C 1.535 1.287 0 CA-C-N 115.532 -0.758 . . . . 19.92 112.259 -175.698 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 98.0 mttt -97.78 155.19 17.14 Favored 'General case' 0 C--O 1.233 0.228 0 CA-C-N 117.369 0.585 . . . . 19.41 110.993 178.568 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 30' ' ' THR . . . . . . . . . . . . . 29.5 m -104.01 139.2 39.46 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 115.907 -0.588 . . . . 20.61 110.034 176.141 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 34.8 m -126.34 150.58 32.06 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.221 0 CA-C-N 116.408 -0.36 . . . . 17.93 110.719 -178.997 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 32' ' ' ARG . . . . . . . . . . . . . 32.4 ttm105 -134.94 147.33 49.75 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-O 121.16 0.505 . . . . 23.02 110.31 177.519 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 33' ' ' THR . . . . . . . . . . . . . 15.9 m -52.18 137.93 27.07 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.214 -0.448 . . . . 17.9 111.534 -177.355 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 100.71 -17.0 57.13 Favored Glycine 0 CA--C 1.532 1.147 0 CA-C-O 119.663 -0.52 . . . . 17.01 113.301 178.819 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 78.6 m-20 -65.8 147.8 52.8 Favored 'General case' 0 N--CA 1.462 0.146 0 CA-C-N 118.022 0.911 . . . . 18.86 111.125 179.135 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 44.8 t -123.25 129.76 74.7 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.173 0 CA-C-N 115.927 -0.579 . . . . 17.24 109.852 177.888 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 37' ' ' ILE . . . . . . . . . . . . . 65.0 mt -122.57 139.02 50.74 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.279 0 CA-C-N 116.345 -0.389 . . . . 15.76 109.961 -179.749 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . -112.9 128.79 8.59 Favored Glycine 0 CA--C 1.527 0.787 0 N-CA-C 111.013 -0.835 . . . . 17.43 111.013 179.281 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 39' ' ' ILE . . . . . . . . . . . . . 76.7 mt -123.9 136.25 60.89 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.22 0 N-CA-C 109.994 -0.373 . . . . 17.07 109.994 179.046 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 40' ' ' SER . . . . . . . . . . . . . 34.5 t -91.91 118.16 30.48 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-O 120.696 0.284 . . . . 20.45 111.09 178.181 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 41' ' ' ILE . . . . . . . . . . . . . 45.2 mm -120.93 116.71 50.67 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.237 0 CA-C-N 116.283 -0.417 . . . . 18.94 110.23 178.881 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 7.5 mp 50.92 35.62 12.95 Favored 'General case' 0 N--CA 1.464 0.228 0 CA-C-N 116.345 -0.389 . . . . 21.68 111.751 177.708 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . 76.05 31.13 56.2 Favored Glycine 0 CA--C 1.529 0.946 0 C-N-CA 121.082 -0.58 . . . . 22.22 112.274 177.57 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 44' ' ' LYS . . . . . . . . . . . . . 59.6 tttp -136.64 129.11 30.22 Favored 'General case' 0 C--N 1.33 -0.262 0 N-CA-C 109.484 -0.561 . . . . 20.38 109.484 176.862 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 82.1 tt0 -81.73 115.08 20.8 Favored 'General case' 0 C--N 1.329 -0.324 0 C-N-CA 120.75 -0.38 . . . . 20.21 110.663 -178.22 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 46' ' ' VAL . . . . . . . . . . . . . 6.8 p -110.86 125.17 68.16 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.24 0 N-CA-C 109.061 -0.718 . . . . 16.13 109.061 175.967 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 9.5 mtmp? -99.9 125.61 45.91 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 115.702 -0.681 . . . . 18.68 111.282 -178.568 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 48' ' ' PHE . . . . . . . . . . . . . 96.0 m-85 -111.26 131.9 54.78 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-N 116.188 -0.46 . . . . 13.1 109.899 177.268 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 49.1 tttm -108.31 139.07 43.55 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.357 -0.383 . . . . 14.45 110.513 178.941 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 50' ' ' VAL . . . . . . . . . . . . . 44.2 t -82.46 111.47 18.9 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.298 0 N-CA-C 109.505 -0.554 . . . . 13.58 109.505 176.683 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 51' ' ' VAL . . . . . . . . . . . . . 45.9 t -77.74 -46.54 26.98 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.321 0 CA-C-N 116.129 -0.487 . . . . 13.24 110.27 -174.014 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 52' ' ' GLN . . . . . . . . . . . . . 59.9 tt0 -157.82 135.35 10.43 Favored 'General case' 0 C--N 1.33 -0.276 0 C-N-CA 120.413 -0.515 . . . . 15.29 111.526 -177.0 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -113.2 118.78 35.63 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 115.401 -0.818 . . . . 16.95 109.596 173.497 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 54' ' ' TYR . . . . . . . . . . . . . 16.9 t80 -116.91 107.14 46.53 Favored Pre-proline 0 CA--C 1.534 0.351 0 CA-C-O 118.246 -0.883 . . . . 21.06 110.613 -177.757 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 55' ' ' PRO . . . . . . . . . . . . . 73.0 Cg_endo -76.98 169.98 72.96 Favored 'Cis proline' 0 N--CA 1.499 1.828 0 CA-C-N 121.758 1.664 . . . . 20.7 112.605 -3.775 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 56' ' ' SER . . . . . . . . . . . . . 13.6 m -105.2 117.73 57.7 Favored Pre-proline 0 CA--C 1.538 0.513 0 CA-C-O 118.41 -0.805 . . . . 21.83 109.546 176.92 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 57' ' ' PRO . . . . . . . . . . . . . 72.1 Cg_endo -77.84 171.05 68.85 Favored 'Cis proline' 0 N--CA 1.495 1.604 0 CA-C-N 121.968 1.738 . . . . 22.39 112.422 2.164 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 58' ' ' LEU . . . . . . . . . . . . . 25.6 tp -128.18 138.14 52.35 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 115.789 -0.641 . . . . 18.81 110.348 -178.735 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 59' ' ' ARG . . . . . . . . . . . . . 59.9 ttt85 -101.12 129.74 47.06 Favored 'General case' 0 C--N 1.326 -0.419 0 CA-C-N 115.949 -0.569 . . . . 22.37 109.549 176.441 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 42.1 t -88.79 116.7 30.86 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.229 0 C-N-CA 120.572 -0.451 . . . . 17.4 110.496 -176.631 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 94.8 mt-10 -131.14 168.76 16.9 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 115.967 -0.56 . . . . 20.44 109.581 174.953 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 62' ' ' ASP . . . . . . . . . . . . . 2.1 m-20 -53.91 -34.34 59.25 Favored 'General case' 0 C--N 1.329 -0.312 0 C-N-CA 121.046 -0.262 . . . . 18.68 111.693 -177.783 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 63' ' ' ARG . . . . . . . . . . . . . 28.2 mmm180 -73.87 -17.65 61.02 Favored 'General case' 0 CA--C 1.533 0.313 0 N-CA-C 113.234 0.827 . . . . 22.37 113.234 -176.169 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 18.0 m -69.94 141.72 53.02 Favored 'General case' 0 C--N 1.332 -0.191 0 CA-C-O 120.838 0.351 . . . . 16.58 111.014 -174.887 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 65' ' ' LYS . . . . . . . . . . . . . 93.8 mttt -88.5 132.66 34.41 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.098 -0.501 . . . . 17.07 109.988 178.732 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 66' ' ' ILE . . . . . . . . . . . . . 53.7 mt -117.56 131.91 68.9 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.233 0 N-CA-C 110.012 -0.366 . . . . 12.48 110.012 179.921 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 67' ' ' THR . . . . . . . . . . . . . 18.8 m -130.96 135.86 48.03 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-O 121.011 0.434 . . . . 10.9 110.788 178.796 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 68' ' ' LEU . . . . . 0.497 ' N ' HD12 ' A' ' 68' ' ' LEU . 6.7 mp -108.0 129.58 55.11 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.124 -0.489 . . . . 8.22 110.43 176.685 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 69' ' ' VAL . . . . . . . . . . . . . 43.2 t -102.22 131.77 49.6 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.312 0 CA-C-N 116.225 -0.443 . . . . 7.13 110.37 -179.046 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 70' ' ' THR . . . . . . . . . . . . . 3.4 m -99.09 -55.1 2.79 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.107 -0.497 . . . . 5.72 110.552 178.101 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 71' ' ' HIS . . . . . . . . . . . . . 62.2 m80 -140.02 155.78 70.65 Favored Pre-proline 0 C--N 1.331 -0.221 0 CA-C-N 116.213 -0.449 . . . . 6.72 110.763 -179.6 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 72' ' ' PRO . . . . . . . . . . . . . 91.0 Cg_endo -85.01 -29.3 0.7 Allowed 'Trans proline' 0 N--CA 1.493 1.446 0 C-N-CA 121.649 1.566 . . . . 3.4 112.644 178.843 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 73' ' ' VAL . . . . . . . . . . . . . 35.3 m -127.17 166.32 24.12 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.202 0 CA-C-N 116.474 -0.33 . . . . 1.24 110.303 -179.837 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 74' ' ' ASP . . . . . . . . . . . . . 29.6 t70 -99.33 119.52 38.07 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.471 -0.332 . . . . 0.96 110.217 -177.849 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 44.7 t -112.72 122.7 67.39 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.228 0 CA-C-O 121.148 0.499 . . . . 0.71 110.243 -179.551 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 76' ' ' LEU . . . . . . . . . . . . . 36.0 mt -124.12 139.24 54.13 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 115.56 -0.745 . . . . 1.13 109.403 177.802 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 77' ' ' GLU . . . . . . . . . . . . . 96.8 mt-10 -129.99 142.24 50.66 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-O 121.136 0.493 . . . . 1.42 111.142 -177.224 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 78' ' ' ALA . . . . . . . . . . . . . . . -131.64 136.56 47.83 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 115.479 -0.782 . . . . 0.57 109.937 177.334 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 79' ' ' LYS . . . . . 0.58 ' O ' HD13 ' A' ' 80' ' ' ILE . 38.0 tttp -81.23 119.57 23.79 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-O 120.91 0.386 . . . . 2.96 110.939 -176.537 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 80' ' ' ILE . . . . . 0.58 HD13 ' O ' ' A' ' 79' ' ' LYS . 42.0 mm -139.13 108.45 3.8 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.324 0 N-CA-C 109.089 -0.708 . . . . 0.56 109.089 -178.347 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 81' ' ' LYS . . . . . . . . . . . . . 37.9 tttp -102.78 125.44 49.52 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-O 120.95 0.405 . . . . 2.85 111.114 -176.818 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . 89.01 42.13 5.71 Favored Glycine 0 CA--C 1.526 0.757 0 C-N-CA 121.057 -0.592 . . . . 0.57 111.93 174.993 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 83' ' ' ILE . . . . . . . . . . . . . 72.2 mt -68.14 136.35 26.68 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 N-CA-C 109.641 -0.503 . . . . 0.55 109.641 177.01 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 84' ' ' LYS . . . . . . . . . . . . . 40.2 ttpt -104.93 -46.94 4.15 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.35 -0.387 . . . . 1.44 110.306 -178.432 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 85' ' ' ASP . . . . . . . . . . . . . 20.7 t70 -149.49 148.48 29.46 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.068 -0.514 . . . . 0.79 110.455 179.319 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 86' ' ' VAL . . . . . . . . . . . . . 43.2 t -130.89 133.31 63.24 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.227 0 CA-C-O 120.955 0.407 . . . . 0.54 110.375 -179.887 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 87' ' ' ILE . . . . . . . . . . . . . 45.1 mm -120.55 127.74 75.95 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.231 0 CA-C-N 115.821 -0.627 . . . . 1.41 109.781 178.537 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 88' ' ' LEU . . . . . . . . . . . . . 54.5 mt -107.82 135.49 49.14 Favored 'General case' 0 C--N 1.331 -0.221 0 CA-C-N 116.276 -0.42 . . . . 1.56 110.974 -179.659 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 89' ' ' ASP . . . . . . . . . . . . . 12.2 t70 -130.78 155.48 46.6 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.005 -0.543 . . . . 0.97 109.655 176.988 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 96.8 mt-10 -48.69 -36.35 15.95 Favored 'General case' 0 C--N 1.329 -0.3 0 N-CA-C 112.818 0.673 . . . . 2.49 112.818 -171.478 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 91' ' ' ASN . . . . . . . . . . . . . 12.6 t-20 -131.99 22.2 4.54 Favored 'General case' 0 N--CA 1.468 0.452 0 N-CA-C 112.781 0.659 . . . . 2.35 112.781 -177.572 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 92' ' ' LEU . . . . . . . . . . . . . 23.1 mt -150.06 147.1 27.4 Favored 'General case' 0 C--N 1.332 -0.153 0 CA-C-O 120.799 0.333 . . . . 1.35 110.395 -177.348 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 93' ' ' ILE . . . . . . . . . . . . . 70.6 mt -124.24 117.94 52.24 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.272 0 N-CA-C 109.104 -0.702 . . . . 0.52 109.104 175.964 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 94' ' ' VAL . . . . . . . . . . . . . 46.4 t -118.96 127.08 75.82 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.268 0 CA-C-O 120.91 0.386 . . . . 0.46 110.028 -178.427 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 95' ' ' VAL . . . . . . . . . . . . . 43.7 t -120.88 132.7 69.72 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.308 0 CA-C-N 115.945 -0.571 . . . . 0.42 109.733 179.912 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 96' ' ' ILE . . . . . . . . . . . . . 67.5 mt -114.21 126.94 71.83 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.24 0 N-CA-C 109.215 -0.661 . . . . 0.51 109.215 178.859 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 97' ' ' THR . . . . . . . . . . . . . 69.6 p -102.6 155.64 18.15 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-O 121.241 0.543 . . . . 0.53 111.228 -176.41 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 98' ' ' GLU . . . . . . . . . . . . . 48.6 mt-10 -54.27 -23.54 15.32 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.017 -0.538 . . . . 2.42 112.275 178.279 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 99' ' ' GLU . . . . . . . . . . . . . 95.0 mt-10 -76.82 13.28 1.07 Allowed 'General case' 0 CA--C 1.536 0.406 0 N-CA-C 113.24 0.829 . . . . 2.34 113.24 -178.278 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 100' ' ' ASN . . . . . . . . . . . . . 1.7 m120 64.35 36.28 9.2 Favored 'General case' 0 CA--C 1.53 0.19 0 CA-C-O 120.944 0.402 . . . . 0.6 110.922 177.545 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 101' ' ' GLU . . . . . . . . . . . . . 84.3 tt0 -122.43 143.93 49.37 Favored 'General case' 0 C--N 1.333 -0.139 0 CA-C-N 116.239 -0.437 . . . . 0.54 109.916 178.586 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 102' ' ' VAL . . . . . . . . . . . . . 45.4 t -115.09 126.79 72.77 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.231 0 N-CA-C 109.811 -0.441 . . . . 0.41 109.811 -179.713 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 103' ' ' LEU . . . . . . . . . . . . . 27.6 mt -114.69 130.11 56.77 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 115.723 -0.671 . . . . 0.77 110.051 177.308 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 104' ' ' ILE . . . . . . . . . . . . . 72.4 mt -116.63 121.44 67.67 Favored 'Isoleucine or valine' 0 C--O 1.234 0.279 0 CA-C-N 116.552 -0.295 . . . . 0.43 110.321 -179.193 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 105' ' ' PHE . . . . . . . . . . . . . 88.3 m-85 -120.9 161.26 21.86 Favored 'General case' 0 C--N 1.333 -0.134 0 O-C-N 123.953 0.783 . . . . 0.48 109.884 -179.856 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 106' ' ' ASN . . . . . . . . . . . . . 39.0 p30 -95.87 -173.19 2.77 Favored 'General case' 0 C--N 1.33 -0.276 0 N-CA-C 110.065 -0.346 . . . . 0.63 110.065 175.314 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 107' ' ' GLN . . . . . . . . . . . . . 61.1 tt0 -60.17 -30.06 69.09 Favored 'General case' 0 C--N 1.329 -0.29 0 N-CA-C 111.936 0.347 . . . . 1.47 111.936 -179.98 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 108' ' ' ASN . . . . . . . . . . . . . 50.7 t30 -82.33 8.66 10.71 Favored 'General case' 0 CA--C 1.537 0.446 0 N-CA-C 113.043 0.757 . . . . 1.35 113.043 -177.831 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 109' ' ' LEU . . . . . . . . . . . . . 13.0 tp 61.47 39.83 14.53 Favored 'General case' 0 C--O 1.233 0.193 0 CA-C-O 121.324 0.583 . . . . 1.14 110.975 179.229 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 110' ' ' GLU . . . . . . . . . . . . . 95.2 mt-10 -109.97 152.2 26.17 Favored 'General case' 0 C--N 1.33 -0.244 0 N-CA-C 109.532 -0.544 . . . . 1.92 109.532 175.535 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 111' ' ' GLU . . . . . . . . . . . . . 81.2 tt0 -88.02 122.3 31.45 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-O 120.828 0.347 . . . . 1.78 110.941 -175.555 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 112' ' ' LEU . . . . . . . . . . . . . 51.8 mt -106.09 -46.1 4.17 Favored 'General case' 0 C--N 1.332 -0.186 0 CA-C-N 116.14 -0.482 . . . . 0.56 111.139 179.539 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 113' ' ' TYR . . . . . . . . . . . . . 61.4 t80 -136.76 138.23 40.71 Favored 'General case' 0 C--N 1.331 -0.213 0 CA-C-O 120.912 0.386 . . . . 0.5 111.545 -176.148 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 114' ' ' ARG . . . . . . . . . . . . . 38.9 ttm180 -132.54 122.89 25.52 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 115.878 -0.601 . . . . 2.76 109.773 175.612 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 115' ' ' GLY . . . . . . . . . . . . . . . -150.1 138.62 6.84 Favored Glycine 0 CA--C 1.523 0.543 0 N-CA-C 111.07 -0.812 . . . . 0.43 111.07 178.779 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 116' ' ' LYS . . . . . . . . . . . . . 34.0 ttmt -114.95 140.22 49.19 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-O 120.818 0.342 . . . . 1.57 110.079 177.256 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 117' ' ' PHE . . . . . . . . . . . . . 32.4 m-85 -136.89 114.93 11.49 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.147 -0.479 . . . . 0.49 109.892 -176.724 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 118' ' ' GLU . . . . . . . . . . . . . 84.2 tt0 -51.39 -49.4 61.61 Favored 'General case' 0 C--N 1.328 -0.358 0 N-CA-C 111.869 0.322 . . . . 2.77 111.869 -176.221 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 119' ' ' ASN . . . . . . . . . . . . . 97.7 m-20 -98.07 31.29 2.77 Favored 'General case' 0 C--N 1.328 -0.335 0 N-CA-C 112.221 0.452 . . . . 1.35 112.221 -174.321 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 120' ' ' LEU . . . . . . . . . . . . . 21.8 tp -54.57 120.74 7.12 Favored 'General case' 0 N--CA 1.463 0.19 0 O-C-N 122.243 -0.286 . . . . 0.56 110.71 178.727 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 121' ' ' ASN . . . . . . . . . . . . . 85.9 m-20 -113.81 -44.0 3.22 Favored 'General case' 0 C--N 1.332 -0.181 0 CA-C-N 116.459 -0.337 . . . . 1.74 111.07 -176.465 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 122' ' ' LYS . . . . . . . . . . . . . 84.9 mttt -142.93 145.3 32.9 Favored 'General case' 0 C--N 1.331 -0.227 0 CA-C-O 121.148 0.499 . . . . 1.94 111.705 -178.129 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 123' ' ' VAL . . . . . . . . . . . . . 46.4 t -121.8 122.57 67.21 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.249 0 N-CA-C 108.978 -0.749 . . . . 0.55 108.978 173.363 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 124' ' ' LEU . . . . . 0.511 HD12 ' N ' ' A' ' 124' ' ' LEU . 6.8 mp -108.9 122.97 48.32 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 116.272 -0.422 . . . . 1.63 110.349 -177.301 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 125' ' ' VAL . . . . . . . . . . . . . 44.2 t -126.16 125.37 67.69 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.307 0 N-CA-C 109.608 -0.516 . . . . 1.58 109.608 178.825 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 126' ' ' ARG . . . . . . . . . . . . . 81.2 mtt-85 -143.94 123.84 13.5 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-O 121.045 0.45 . . . . 3.09 110.774 -179.535 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 127' ' ' ASN . . . . . . . . . . . . . 18.9 t-20 50.91 -105.23 0.19 Allowed 'General case' 0 CA--C 1.543 0.709 0 CA-C-O 118.965 -0.54 . . . . 2.33 111.398 179.764 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 128' ' ' ASP . . . . . . . . . . . . . 9.1 p-10 -114.16 -1.51 13.65 Favored 'General case' 0 CA--C 1.537 0.452 0 CA-C-N 119.697 1.135 . . . . 1.17 113.522 -177.425 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 129' ' ' LEU . . . . . . . . . . . . . 79.3 mt -105.58 144.24 32.62 Favored 'General case' 0 C--O 1.232 0.162 0 CA-C-N 118.207 0.458 . . . . 1.96 110.876 -177.398 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 130' ' ' VAL . . . . . . . . . . . . . 45.1 t -127.35 134.99 64.6 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.169 0 CA-C-O 121.075 0.464 . . . . 1.37 110.251 -179.354 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 131' ' ' VAL . . . . . 0.455 HG22 HD12 ' A' ' 140' ' ' LEU . 45.5 t -133.02 135.35 57.04 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.287 0 CA-C-N 116.088 -0.505 . . . . 1.07 109.906 177.517 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 132' ' ' ILE . . . . . . . . . . . . . 68.5 mt -113.46 131.17 65.97 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.304 0 N-CA-C 109.381 -0.6 . . . . 0.42 109.381 -179.976 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 133' ' ' ILE . . . . . . . . . . . . . 41.9 mm -118.55 120.77 65.26 Favored 'Isoleucine or valine' 0 C--O 1.233 0.22 0 CA-C-O 120.954 0.407 . . . . 0.5 111.111 -175.384 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 134' ' ' ASP . . . . . . . . . . . . . 3.6 p30 -135.59 146.73 48.26 Favored 'General case' 0 C--N 1.332 -0.196 0 N-CA-C 109.362 -0.607 . . . . 0.55 109.362 173.19 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 135' ' ' GLU . . . . . . . . . . . . . 85.9 tt0 -49.88 -23.76 2.1 Favored 'General case' 0 C--N 1.326 -0.454 0 N-CA-C 112.85 0.685 . . . . 2.04 112.85 -172.658 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 136' ' ' GLN . . . . . . . . . . . . . 52.0 mt-30 -87.57 -36.27 17.65 Favored 'General case' 0 C--O 1.234 0.251 0 N-CA-C 112.586 0.587 . . . . 2.11 112.586 -176.203 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 137' ' ' LYS . . . . . . . . . . . . . 40.7 pttt -157.44 167.45 30.18 Favored 'General case' 0 C--N 1.331 -0.197 0 CA-C-O 121.514 0.673 . . . . 1.56 112.277 -172.87 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 138' ' ' LEU . . . . . 0.415 HD23 ' N ' ' A' ' 139' ' ' THR . 6.1 tt -121.31 128.74 52.62 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 115.084 -0.962 . . . . 0.97 109.701 178.006 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 139' ' ' THR . . . . . 0.415 ' N ' HD23 ' A' ' 138' ' ' LEU . 28.6 m -111.78 129.9 55.98 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.41 -0.359 . . . . 0.44 110.46 -179.411 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 140' ' ' LEU . . . . . 0.455 HD12 HG22 ' A' ' 131' ' ' VAL . 21.6 tp -111.75 118.82 36.64 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 115.679 -0.691 . . . . 1.03 109.165 179.734 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 141' ' ' ILE . . . . . . . . . . . . . 19.5 mt -119.09 118.02 56.22 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.314 0 N-CA-C 109.569 -0.53 . . . . 0.5 109.569 -176.794 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 142' ' ' ARG . . . . . . . . . . . . . 49.5 ttp180 -110.84 124.81 52.78 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 115.354 -0.839 . . . . 2.87 110.174 -176.6 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 143' ' ' THR . . . . . . . . . . . . . 27.6 p . . . . . 0 C--O 1.219 -0.525 0 CA-C-O 117.977 -1.011 . . . . 1.48 110.6 -179.242 . . . . . . . . 0 0 . 1 . 001 nuclear nobuild full ' B' B ' -3' ' ' GLU . . . . . . . . . . . . . 47.3 mt-10 . . . . . 0 N--CA 1.491 1.587 0 N-CA-C 109.31 -0.626 . . . . 33.38 109.31 . . . . . . . . . 0 0 . 1 . 001 nuclear nobuild full ' B' B ' -2' ' ' GLY . . . . . . . . . . . . . . . -65.61 138.63 38.22 Favored Glycine 0 CA--C 1.525 0.676 0 N-CA-C 110.874 -0.89 . . . . 29.16 110.874 179.9 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' -1' ' ' VAL . . . . . 0.444 ' O ' HD13 ' B' ' 0' ' ' ILE . 42.9 t -96.96 126.5 49.69 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.294 0 N-CA-C 110.081 -0.34 . . . . 26.67 110.081 -179.857 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 0' ' ' ILE . . . . . 0.444 HD13 ' O ' ' B' ' -1' ' ' VAL . 44.8 mm -124.53 118.7 54.28 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.235 0 CA-C-N 116.354 -0.385 . . . . 24.73 110.117 179.489 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 1' ' ' MET . . . . . . . . . . . . . 24.6 ptt? -95.94 156.39 16.35 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.12 -0.491 . . . . 21.58 110.57 179.57 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 2' ' ' SER . . . . . . . . . . . . . 2.0 p -114.68 123.14 48.53 Favored 'General case' 0 C--O 1.232 0.183 0 CA-C-O 121.125 0.488 . . . . 19.08 110.598 178.492 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 3' ' ' GLU . . . . . . . . . . . . . 93.2 mt-10 -140.71 141.86 34.9 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-N 115.781 -0.645 . . . . 16.48 110.956 -178.157 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 4' ' ' LEU . . . . . 0.503 HD21 HD21 ' B' ' 6' ' ' LEU . 12.7 tp -125.6 130.05 50.87 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 115.986 -0.552 . . . . 14.28 109.874 176.336 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 5' ' ' LYS . . . . . . . . . . . . . 94.8 mttt -106.73 119.77 40.22 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.37 -0.377 . . . . 12.15 110.285 179.839 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 6' ' ' LEU . . . . . 0.503 HD21 HD21 ' B' ' 4' ' ' LEU . 75.7 mt -117.13 148.68 41.34 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 115.477 -0.783 . . . . 11.97 110.257 -176.982 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 7' ' ' LYS . . . . . . . . . . . . . 34.1 ttmt -132.76 134.83 25.08 Favored Pre-proline 0 CA--C 1.535 0.385 0 CA-C-O 118.853 -0.594 . . . . 9.81 110.118 177.578 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 8' ' ' PRO . . . . . . . . . . . . . 74.3 Cg_endo -91.61 131.87 1.33 Allowed 'Trans proline' 0 N--CA 1.491 1.329 0 C-N-CA 121.668 1.578 . . . . 9.83 111.606 176.537 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 9' ' ' LEU . . . . . . . . . . . . . 72.8 mt -70.95 -52.12 10.1 Favored Pre-proline 0 CA--C 1.533 0.295 0 CA-C-O 118.591 -0.718 . . . . 13.18 112.106 -177.526 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 10' ' ' PRO . . . . . . . . . . . . . 38.4 Cg_endo -68.59 141.8 51.45 Favored 'Trans proline' 0 N--CA 1.498 1.78 0 CA-C-N 120.287 1.138 . . . . 13.3 111.613 175.072 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 11' ' ' LYS . . . . . . . . . . . . . 69.1 mttm -87.04 97.38 10.69 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.408 -0.36 . . . . 12.9 110.645 -179.921 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 12' ' ' VAL . . . . . . . . . . . . . 11.8 p -139.38 142.08 34.05 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.325 0 CA-C-N 116.021 -0.536 . . . . 14.63 110.385 -179.902 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 13' ' ' GLU . . . . . . . . . . . . . 47.7 mt-10 -73.48 120.44 19.08 Favored 'General case' 0 C--N 1.329 -0.317 0 N-CA-C 110.007 -0.368 . . . . 14.92 110.007 177.64 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 14' ' ' LEU . . . . . . . . . . . . . 26.3 mt -95.84 143.16 25.65 Favored Pre-proline 0 CA--C 1.533 0.303 0 CA-C-O 118.928 -0.558 . . . . 14.87 109.752 179.953 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 15' ' ' PRO . . . . . . . . . . . . . 29.6 Cg_exo -59.82 159.82 23.63 Favored 'Trans proline' 0 N--CA 1.497 1.682 0 C-N-CA 121.253 1.302 . . . . 17.71 111.545 178.764 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 16' ' ' PRO . . . . . . . . . . . . . 37.4 Cg_exo -58.88 -40.11 75.04 Favored 'Trans proline' 0 N--CA 1.498 1.791 0 C-N-CA 121.429 1.419 . . . . 18.26 112.799 -177.813 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 17' ' ' ASP . . . . . . . . . . . . . 3.1 p30 -87.5 10.88 16.26 Favored 'General case' 0 CA--C 1.536 0.409 0 N-CA-C 113.05 0.759 . . . . 19.81 113.05 -178.61 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 18' ' ' PHE . . . . . . . . . . . . . 50.2 t80 -58.62 -44.97 90.13 Favored 'General case' 0 CA--C 1.523 -0.095 0 O-C-N 121.902 -0.499 . . . . 16.3 109.883 -178.348 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 19' ' ' VAL . . . . . . . . . . . . . 13.7 p -56.0 -39.04 55.58 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.283 0 CA-C-N 116.121 -0.491 . . . . 15.53 110.827 179.838 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 20' ' ' ASP . . . . . . . . . . . . . 31.0 t0 -60.11 -44.91 94.51 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-O 120.767 0.318 . . . . 19.22 110.717 -179.032 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 21' ' ' VAL . . . . . . . . . . . . . 47.7 t -64.24 -45.82 95.14 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.293 0 C-N-CA 120.757 -0.377 . . . . 18.61 110.43 -177.813 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 22' ' ' ILE . . . . . 0.659 HG22 HD12 ' B' ' 26' ' ' LEU . 51.0 mm -55.82 -47.3 79.75 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.224 0 C-N-CA 121.002 -0.279 . . . . 16.42 110.651 179.525 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 23' ' ' ARG . . . . . . . . . . . . . 43.7 ttp180 -55.25 -48.11 74.46 Favored 'General case' 0 C--N 1.329 -0.291 0 C-N-CA 121.064 -0.254 . . . . 19.83 111.346 -178.354 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 24' ' ' ILE . . . . . . . . . . . . . 72.9 mt -59.26 -41.28 83.52 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.297 0 C-N-CA 121.076 -0.25 . . . . 20.56 110.96 -177.964 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 25' ' ' LYS . . . . . . . . . . . . . 8.3 mtpm? -69.45 -38.91 78.01 Favored 'General case' 0 C--N 1.328 -0.356 0 N-CA-C 112.274 0.472 . . . . 19.42 112.274 -178.122 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 26' ' ' LEU . . . . . 0.659 HD12 HG22 ' B' ' 22' ' ' ILE . 37.9 mt -79.35 -38.08 35.94 Favored 'General case' 0 C--N 1.329 -0.291 0 N-CA-C 113.587 0.958 . . . . 18.5 113.587 -171.457 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 27' ' ' GLN . . . . . . . . . . . . . 9.7 pt20 -46.77 141.08 4.13 Favored 'General case' 0 N--CA 1.47 0.554 0 N-CA-C 112.747 0.647 . . . . 21.33 112.747 -175.189 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 28' ' ' GLY . . . . . . . . . . . . . . . 100.26 -23.68 34.97 Favored Glycine 0 CA--C 1.533 1.17 0 CA-C-N 115.481 -0.781 . . . . 21.4 112.289 -176.152 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 29' ' ' LYS . . . . . . . . . . . . . 68.5 mttm -98.06 155.11 17.27 Favored 'General case' 0 C--O 1.233 0.194 0 CA-C-N 117.559 0.679 . . . . 20.58 111.212 178.986 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 30' ' ' THR . . . . . . . . . . . . . 30.7 m -104.93 139.46 39.62 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 115.953 -0.567 . . . . 21.06 109.936 176.303 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 31' ' ' VAL . . . . . . . . . . . . . 34.8 m -129.78 149.09 33.28 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.252 0 CA-C-O 120.954 0.407 . . . . 18.25 111.167 -177.957 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 32' ' ' ARG . . . . . . . . . . . . . 75.2 mtt85 -124.69 149.15 47.52 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 115.823 -0.626 . . . . 22.16 110.166 177.427 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 33' ' ' THR . . . . . . . . . . . . . 23.6 m -53.83 136.7 39.94 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.369 -0.378 . . . . 17.28 111.356 -179.053 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 34' ' ' GLY . . . . . . . . . . . . . . . 100.0 -17.11 57.65 Favored Glycine 0 CA--C 1.531 1.053 0 CA-C-O 119.585 -0.564 . . . . 16.47 113.386 177.457 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 35' ' ' ASP . . . . . . . . . . . . . 81.8 m-20 -66.0 146.93 54.11 Favored 'General case' 0 C--O 1.231 0.117 0 CA-C-N 118.111 0.956 . . . . 18.38 111.17 -179.366 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 36' ' ' VAL . . . . . . . . . . . . . 44.5 t -121.17 128.83 76.07 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.235 0 CA-C-N 115.999 -0.546 . . . . 17.19 109.698 176.982 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 37' ' ' ILE . . . . . . . . . . . . . 64.6 mt -120.57 138.81 49.84 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.305 0 CA-C-N 116.238 -0.437 . . . . 16.42 110.019 -178.138 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 38' ' ' GLY . . . . . . . . . . . . . . . -106.63 127.24 8.79 Favored Glycine 0 CA--C 1.524 0.615 0 N-CA-C 110.927 -0.869 . . . . 18.22 110.927 178.424 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 39' ' ' ILE . . . . . . . . . . . . . 76.8 mt -127.72 141.48 46.29 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.264 0 N-CA-C 110.048 -0.353 . . . . 18.12 110.048 179.583 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 40' ' ' SER . . . . . 0.427 ' O ' HD13 ' B' ' 41' ' ' ILE . 40.6 t -91.8 118.83 31.06 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-O 120.813 0.34 . . . . 21.59 110.96 177.189 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 41' ' ' ILE . . . . . 0.438 HG22 HD13 ' B' ' 42' ' ' LEU . 47.3 mm -124.7 120.0 57.65 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.213 0 CA-C-N 116.149 -0.478 . . . . 20.26 110.487 178.989 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 42' ' ' LEU . . . . . 0.438 HD13 HG22 ' B' ' 41' ' ' ILE . 7.8 mp 52.06 35.87 17.37 Favored 'General case' 0 C--N 1.331 -0.2 0 CA-C-N 116.301 -0.409 . . . . 22.74 111.638 177.848 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 43' ' ' GLY . . . . . . . . . . . . . . . 72.8 31.5 62.31 Favored Glycine 0 CA--C 1.529 0.956 0 C-N-CA 121.131 -0.557 . . . . 23.04 112.101 178.375 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 44' ' ' LYS . . . . . . . . . . . . . 85.1 tttt -137.71 131.46 31.39 Favored 'General case' 0 C--N 1.329 -0.311 0 N-CA-C 109.57 -0.53 . . . . 21.05 109.57 178.416 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 45' ' ' GLU . . . . . . . . . . . . . 81.7 tt0 -80.17 111.0 16.12 Favored 'General case' 0 C--N 1.328 -0.337 0 C-N-CA 120.657 -0.417 . . . . 20.06 110.238 -179.222 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 46' ' ' VAL . . . . . . . . . . . . . 7.0 p -109.86 128.2 66.16 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.188 0 N-CA-C 109.332 -0.618 . . . . 16.65 109.332 178.954 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 47' ' ' LYS . . . . . . . . . . . . . 44.0 mttm -98.54 124.28 43.2 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 115.781 -0.645 . . . . 18.21 110.666 178.409 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 48' ' ' PHE . . . . . . . . . . . . . 96.4 m-85 -108.99 131.79 54.73 Favored 'General case' 0 C--N 1.328 -0.351 0 N-CA-C 109.679 -0.489 . . . . 13.38 109.679 176.013 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 49' ' ' LYS . . . . . . . . . . . . . 42.6 tttp -109.18 137.97 46.26 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.484 -0.326 . . . . 14.08 110.593 178.246 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 50' ' ' VAL . . . . . 0.433 ' HA ' HD23 ' B' ' 6' ' ' LEU . 48.1 t -82.41 106.85 13.73 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.369 0 N-CA-C 109.156 -0.683 . . . . 13.85 109.156 175.527 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 51' ' ' VAL . . . . . . . . . . . . . 48.2 t -69.92 -52.35 31.85 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.354 0 N-CA-C 109.476 -0.564 . . . . 12.96 109.476 -176.113 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 52' ' ' GLN . . . . . . . . . . . . . 46.6 mt-30 -155.14 152.72 29.8 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 115.914 -0.584 . . . . 14.9 111.61 -179.401 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 53' ' ' ALA . . . . . . . . . . . . . . . -127.27 131.31 50.56 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 115.327 -0.851 . . . . 16.72 109.847 176.473 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 54' ' ' TYR . . . . . . . . . . . . . 9.8 t80 -129.1 107.5 17.93 Favored Pre-proline 0 CA--C 1.535 0.367 0 CA-C-O 118.337 -0.839 . . . . 20.83 110.496 -179.829 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 55' ' ' PRO . . . . . . . . . . . . . 73.2 Cg_endo -77.11 170.0 72.77 Favored 'Cis proline' 0 N--CA 1.5 1.882 0 CA-C-N 121.781 1.672 . . . . 20.51 112.397 -5.952 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 56' ' ' SER . . . . . . . . . . . . . 18.7 m -116.54 133.21 23.03 Favored Pre-proline 0 CA--C 1.538 0.494 0 CA-C-O 118.445 -0.788 . . . . 21.17 109.433 174.37 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 57' ' ' PRO . . . . . . . . . . . . . 55.4 Cg_endo -71.72 149.04 91.86 Favored 'Cis proline' 0 N--CA 1.497 1.728 0 CA-C-N 121.967 1.738 . . . . 21.75 111.566 -1.057 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 58' ' ' LEU . . . . . . . . . . . . . 26.7 tp -107.63 136.24 47.73 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.438 -0.347 . . . . 18.89 110.467 -178.873 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 59' ' ' ARG . . . . . . . . . . . . . 71.3 ttt-85 -106.64 119.23 38.74 Favored 'General case' 0 C--N 1.327 -0.371 0 N-CA-C 109.131 -0.692 . . . . 23.48 109.131 177.239 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 60' ' ' VAL . . . . . . . . . . . . . 44.7 t -78.05 122.27 32.6 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.286 0 C-N-CA 120.753 -0.379 . . . . 19.33 110.428 -173.96 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 61' ' ' GLU . . . . . . . . . . . . . 46.9 mt-10 -131.0 174.31 10.13 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.065 -0.516 . . . . 21.74 109.882 176.923 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 62' ' ' ASP . . . . . . . . . . . . . 10.9 t70 -54.29 -32.71 57.06 Favored 'General case' 0 C--N 1.327 -0.381 0 C-N-CA 121.037 -0.265 . . . . 21.65 111.668 -178.812 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 63' ' ' ARG . . . . . . . . . . . . . 39.9 ptt180 -89.49 5.14 46.75 Favored 'General case' 0 CA--C 1.537 0.452 0 N-CA-C 113.715 1.006 . . . . 24.12 113.715 -176.152 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 64' ' ' THR . . . . . . . . . . . . . 38.7 m -81.1 130.7 35.14 Favored 'General case' 0 C--N 1.331 -0.2 0 CA-C-N 118.134 0.425 . . . . 18.66 110.386 -179.717 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 65' ' ' LYS . . . . . . . . . . . . . 91.0 mttt -90.47 130.37 36.54 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.353 -0.385 . . . . 18.71 110.469 -179.715 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 66' ' ' ILE . . . . . . . . . . . . . 65.1 mt -116.48 132.35 66.37 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.232 0 CA-C-O 120.923 0.392 . . . . 14.83 110.006 179.456 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 67' ' ' THR . . . . . . . . . . . . . 30.4 m -120.4 139.37 52.91 Favored 'General case' 0 C--N 1.331 -0.22 0 CA-C-N 116.04 -0.527 . . . . 12.49 110.637 -178.938 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 68' ' ' LEU . . . . . . . . . . . . . 6.8 mp -101.24 116.32 32.53 Favored 'General case' 0 C--N 1.332 -0.193 0 CA-C-N 116.209 -0.45 . . . . 10.14 110.781 179.692 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 69' ' ' VAL . . . . . . . . . . . . . 44.1 t -103.57 139.29 24.92 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.322 0 CA-C-N 115.926 -0.579 . . . . 7.78 109.933 178.5 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 70' ' ' THR . . . . . . . . . . . . . 3.2 p -136.88 45.46 2.27 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-O 121.325 0.583 . . . . 6.56 110.619 179.983 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 71' ' ' HIS . . . . . . . . . . . . . 18.5 t60 -125.71 80.62 66.38 Favored Pre-proline 0 CA--C 1.535 0.371 0 CA-C-N 116.063 -0.517 . . . . 6.6 110.595 -179.372 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 72' ' ' PRO . . . . . . . . . . . . . 16.8 Cg_exo -65.0 -30.04 56.94 Favored 'Trans proline' 0 N--CA 1.496 1.656 0 C-N-CA 121.429 1.42 . . . . 2.94 112.443 -179.436 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 73' ' ' VAL . . . . . . . . . . . . . 34.5 m -147.93 172.12 2.5 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.36 0 CA-C-N 116.515 -0.311 . . . . 1.07 110.53 -179.831 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 74' ' ' ASP . . . . . . . . . . . . . 29.8 t0 -94.01 120.23 33.98 Favored 'General case' 0 C--N 1.331 -0.229 0 CA-C-N 116.446 -0.343 . . . . 0.93 110.159 -179.631 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 75' ' ' VAL . . . . . . . . . . . . . 43.4 t -118.76 121.77 67.75 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.212 0 CA-C-O 121.046 0.45 . . . . 0.66 110.688 -177.86 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 76' ' ' LEU . . . . . . . . . . . . . 6.0 mp -123.66 146.49 48.18 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-N 115.82 -0.627 . . . . 1.16 109.672 175.284 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 77' ' ' GLU . . . . . . . . . . . . . 98.1 mt-10 -135.54 139.74 44.18 Favored 'General case' 0 N--CA 1.462 0.161 0 CA-C-O 121.015 0.436 . . . . 1.33 111.582 -177.642 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 78' ' ' ALA . . . . . . . . . . . . . . . -127.73 137.79 52.56 Favored 'General case' 0 C--N 1.331 -0.223 0 CA-C-N 115.639 -0.71 . . . . 0.63 109.69 175.474 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 79' ' ' LYS . . . . . 0.605 ' O ' HD13 ' B' ' 80' ' ' ILE . 49.8 pttt -84.64 123.15 30.03 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-O 121.073 0.464 . . . . 3.1 110.937 -179.019 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 80' ' ' ILE . . . . . 0.605 HD13 ' O ' ' B' ' 79' ' ' LYS . 40.0 mm -139.16 117.54 12.51 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.28 0 N-CA-C 109.421 -0.585 . . . . 0.65 109.421 -177.659 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 81' ' ' LYS . . . . . . . . . . . . . 85.4 tttt -104.14 121.79 43.97 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-O 120.795 0.331 . . . . 2.96 111.122 -177.292 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 82' ' ' GLY . . . . . . . . . . . . . . . 89.11 42.2 5.67 Favored Glycine 0 CA--C 1.526 0.733 0 C-N-CA 120.648 -0.786 . . . . 0.68 112.069 173.618 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 83' ' ' ILE . . . . . . . . . . . . . 69.3 mt -67.43 137.92 23.78 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.282 0 N-CA-C 109.669 -0.493 . . . . 0.62 109.669 176.625 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 84' ' ' LYS . . . . . . . . . . . . . 80.5 tttt -93.46 -54.07 3.82 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.078 -0.51 . . . . 1.62 110.379 -178.388 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 85' ' ' ASP . . . . . . . . . . . . . 19.5 t70 -156.43 152.92 28.07 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 115.63 -0.714 . . . . 0.7 110.138 -179.085 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 86' ' ' VAL . . . . . . . . . . . . . 45.1 t -127.5 131.07 70.57 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.25 0 CA-C-O 121.096 0.474 . . . . 0.48 110.543 -179.092 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 87' ' ' ILE . . . . . 0.491 ' N ' HD12 ' B' ' 87' ' ' ILE . 5.1 mp -118.94 125.13 74.23 Favored 'Isoleucine or valine' 0 C--O 1.233 0.23 0 CA-C-N 115.668 -0.696 . . . . 1.38 109.276 176.64 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 88' ' ' LEU . . . . . . . . . . . . . 16.6 tp -110.05 127.28 54.75 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-O 120.926 0.393 . . . . 1.67 110.958 -177.415 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 89' ' ' ASP . . . . . . . . . . . . . 14.6 t70 -118.89 158.17 26.21 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 115.813 -0.631 . . . . 0.85 109.408 177.09 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 90' ' ' GLU . . . . . . . . . . . . . 95.1 mt-10 -47.31 -40.35 16.83 Favored 'General case' 0 C--N 1.33 -0.265 0 N-CA-C 113.0 0.741 . . . . 2.51 113.0 -171.33 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 91' ' ' ASN . . . . . . . . . . . . . 69.9 m-80 -132.09 26.51 4.56 Favored 'General case' 0 N--CA 1.466 0.373 0 N-CA-C 112.469 0.544 . . . . 2.35 112.469 -178.023 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 92' ' ' LEU . . . . . . . . . . . . . 84.9 mt -150.51 143.22 24.57 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-O 120.748 0.308 . . . . 1.45 110.448 -178.731 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 93' ' ' ILE . . . . . . . . . . . . . 74.5 mt -118.53 113.37 41.63 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.346 0 N-CA-C 109.257 -0.646 . . . . 0.54 109.257 178.181 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 94' ' ' VAL . . . . . . . . . . . . . 46.1 t -115.35 124.95 72.41 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.201 0 CA-C-O 120.939 0.4 . . . . 0.45 109.99 -178.43 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 95' ' ' VAL . . . . . . . . . . . . . 42.7 t -121.91 134.34 65.49 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.285 0 CA-C-N 116.07 -0.514 . . . . 0.43 109.881 -179.122 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 96' ' ' ILE . . . . . . . . . . . . . 64.6 mt -112.89 128.71 69.48 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.365 0 N-CA-C 109.075 -0.713 . . . . 0.5 109.075 177.831 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 97' ' ' THR . . . . . . . . . . . . . 69.6 p -98.37 158.72 15.4 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-O 121.153 0.501 . . . . 0.56 111.082 -178.043 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 98' ' ' GLU . . . . . . . . . . . . . 83.6 tt0 -53.93 -27.66 32.18 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.148 -0.478 . . . . 3.05 112.081 -179.819 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 99' ' ' GLU . . . . . . . . . . . . . 95.5 mt-10 -81.31 16.78 1.49 Allowed 'General case' 0 CA--C 1.534 0.363 0 N-CA-C 113.152 0.797 . . . . 2.29 113.152 -176.588 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 100' ' ' ASN . . . . . . . . . . . . . 4.3 m-20 62.89 38.05 11.65 Favored 'General case' 0 N--CA 1.462 0.158 0 CA-C-O 121.073 0.464 . . . . 0.66 111.158 177.265 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 101' ' ' GLU . . . . . . . . . . . . . 84.6 tt0 -115.18 144.46 43.65 Favored 'General case' 0 C--N 1.333 -0.132 0 CA-C-N 116.1 -0.5 . . . . 0.69 109.738 174.937 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 102' ' ' VAL . . . . . . . . . . . . . 45.0 t -115.5 126.23 72.98 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 CA-C-N 116.257 -0.429 . . . . 0.48 110.083 -177.812 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 103' ' ' LEU . . . . . . . . . . . . . 55.6 mt -119.23 132.48 55.93 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 115.789 -0.641 . . . . 1.28 110.014 177.15 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 104' ' ' ILE . . . . . . . . . . . . . 66.7 mt -121.34 121.61 65.18 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.236 0 N-CA-C 110.369 -0.234 . . . . 0.51 110.369 179.047 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 105' ' ' PHE . . . . . . . . . . . . . 76.0 m-85 -115.81 166.32 12.09 Favored 'General case' 0 C--N 1.332 -0.175 0 O-C-N 124.205 0.941 . . . . 0.55 109.643 177.911 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 106' ' ' ASN . . . . . . . . . . . . . 52.0 p-10 -100.08 -171.57 2.07 Favored 'General case' 0 C--N 1.331 -0.213 0 N-CA-C 110.086 -0.338 . . . . 0.71 110.086 173.546 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 107' ' ' GLN . . . . . . . . . . . . . 50.2 tt0 -58.37 -30.15 66.56 Favored 'General case' 0 CA--C 1.532 0.286 0 N-CA-C 111.901 0.334 . . . . 1.83 111.901 178.574 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 108' ' ' ASN . . . . . . . . . . . . . 63.6 t30 -83.03 8.16 13.63 Favored 'General case' 0 CA--C 1.535 0.388 0 N-CA-C 113.212 0.819 . . . . 1.5 113.212 -177.147 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 109' ' ' LEU . . . . . . . . . . . . . 11.9 tp 60.92 37.43 18.33 Favored 'General case' 0 CA--C 1.53 0.186 0 CA-C-O 120.99 0.424 . . . . 1.18 111.197 179.028 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 110' ' ' GLU . . . . . . . . . . . . . 47.6 mt-10 -110.09 153.09 25.16 Favored 'General case' 0 C--N 1.33 -0.24 0 N-CA-C 109.751 -0.463 . . . . 1.97 109.751 176.436 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 111' ' ' GLU . . . . . . . . . . . . . 73.7 tt0 -86.76 123.17 31.61 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-O 120.855 0.359 . . . . 1.84 110.926 -174.931 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 112' ' ' LEU . . . . . . . . . . . . . 32.9 mt -108.9 -46.06 3.69 Favored 'General case' 0 C--N 1.332 -0.186 0 CA-C-N 116.198 -0.455 . . . . 0.75 111.27 -179.55 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 113' ' ' TYR . . . . . . . . . . . . . 71.6 t80 -136.83 142.3 42.87 Favored 'General case' 0 N--CA 1.464 0.244 0 CA-C-O 120.778 0.323 . . . . 0.68 111.064 -178.202 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 114' ' ' ARG . . . . . . . . . . . . . 25.0 ptt180 -144.52 127.25 16.21 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.05 -0.523 . . . . 3.02 110.927 -179.989 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 115' ' ' GLY . . . . . . . . . . . . . . . -150.19 160.46 28.55 Favored Glycine 0 CA--C 1.525 0.659 0 N-CA-C 111.242 -0.743 . . . . 0.53 111.242 178.614 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 116' ' ' LYS . . . . . . . . . . . . . 7.9 ttpm? -129.65 134.45 47.69 Favored 'General case' 0 C--N 1.33 -0.267 0 N-CA-C 109.782 -0.451 . . . . 1.72 109.782 175.911 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 117' ' ' PHE . . . . . . . . . . . . . 38.3 m-85 -134.46 113.97 12.39 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-O 120.815 0.34 . . . . 0.56 110.258 -176.939 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 118' ' ' GLU . . . . . . . . . . . . . 95.9 mt-10 -55.29 -40.94 71.66 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.424 -0.353 . . . . 2.56 111.129 -176.371 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 119' ' ' ASN . . . . . . . . . . . . . 7.2 m120 -102.84 31.12 4.33 Favored 'General case' 0 C--N 1.331 -0.227 0 CA-C-N 116.272 -0.422 . . . . 1.35 112.136 -174.431 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 120' ' ' LEU . . . . . . . . . . . . . 18.8 tp -56.23 120.46 7.6 Favored 'General case' 0 N--CA 1.462 0.156 0 C-N-CA 120.971 -0.292 . . . . 0.57 110.403 178.418 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 121' ' ' ASN . . . . . . . . . . . . . 64.2 t30 -114.08 -44.1 3.18 Favored 'General case' 0 C--O 1.233 0.186 0 CA-C-N 116.504 -0.316 . . . . 1.95 111.239 -175.891 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 122' ' ' LYS . . . . . . . . . . . . . 91.0 mttt -146.22 150.32 35.61 Favored 'General case' 0 C--N 1.331 -0.197 0 CA-C-O 121.192 0.52 . . . . 1.8 111.981 -176.339 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 123' ' ' VAL . . . . . . . . . . . . . 45.4 t -124.73 128.86 73.64 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.245 0 CA-C-N 115.651 -0.704 . . . . 0.57 109.391 174.723 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 124' ' ' LEU . . . . . . . . . . . . . 72.5 mt -120.8 132.43 55.02 Favored 'General case' 0 C--N 1.33 -0.273 0 N-CA-C 110.181 -0.303 . . . . 1.68 110.181 -178.194 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 125' ' ' VAL . . . . . . . . . . . . . 35.1 m -138.43 132.44 41.61 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.25 0 CA-C-O 120.971 0.415 . . . . 1.73 111.085 -179.754 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 126' ' ' ARG . . . . . . . . . . . . . 89.3 mtt-85 -151.58 132.92 14.57 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 115.777 -0.647 . . . . 2.53 109.714 176.605 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 127' ' ' ASN . . . . . . . . . . . . . 32.0 t30 56.67 -147.82 0.51 Allowed 'General case' 0 CA--C 1.541 0.623 0 N-CA-C 109.686 -0.487 . . . . 2.3 109.686 -179.415 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 128' ' ' ASP . . . . . . . . . . . . . 4.5 p30 -88.04 16.89 5.46 Favored 'General case' 0 CA--C 1.536 0.433 0 CA-C-N 118.75 0.705 . . . . 1.02 112.725 178.446 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 129' ' ' LEU . . . . . . . . . . . . . 15.0 tp -115.37 136.08 53.46 Favored 'General case' 0 C--O 1.232 0.167 0 O-C-N 122.118 -0.364 . . . . 1.86 110.073 179.389 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 130' ' ' VAL . . . . . 0.496 HG23 ' HB ' ' B' ' 141' ' ' ILE . 32.6 m -131.53 144.0 38.81 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.27 0 CA-C-O 120.995 0.426 . . . . 1.48 111.0 -178.546 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 131' ' ' VAL . . . . . 0.43 HG13 ' O ' ' B' ' 139' ' ' THR . 42.8 t -136.04 140.07 44.65 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 CA-C-N 116.022 -0.536 . . . . 0.7 110.34 179.796 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 132' ' ' ILE . . . . . . . . . . . . . 72.4 mt -112.95 133.88 57.37 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.323 0 N-CA-C 109.422 -0.584 . . . . 0.45 109.422 178.256 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 133' ' ' ILE . . . . . . . . . . . . . 38.5 mm -114.68 116.97 54.18 Favored 'Isoleucine or valine' 0 C--O 1.233 0.232 0 CA-C-N 116.534 -0.303 . . . . 0.54 110.767 -176.118 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 134' ' ' ASP . . . . . . . . . . . . . 7.6 p-10 -129.61 149.79 51.22 Favored 'General case' 0 C--N 1.331 -0.215 0 N-CA-C 109.594 -0.521 . . . . 0.56 109.594 174.963 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 135' ' ' GLU . . . . . . . . . . . . . 85.0 tt0 -49.9 -25.94 3.65 Favored 'General case' 0 C--N 1.327 -0.372 0 N-CA-C 112.719 0.637 . . . . 1.64 112.719 -172.113 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 136' ' ' GLN . . . . . . . . . . . . . 53.0 mt-30 -101.82 -25.68 13.73 Favored 'General case' 0 C--O 1.233 0.218 0 N-CA-C 112.892 0.701 . . . . 2.0 112.892 -173.939 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 137' ' ' LYS . . . . . . . . . . . . . 86.5 mttt -144.84 150.67 37.52 Favored 'General case' 0 C--N 1.331 -0.227 0 CA-C-O 121.482 0.658 . . . . 1.9 112.559 -168.503 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 138' ' ' LEU . . . . . . . . . . . . . 12.5 tp -112.65 117.6 32.71 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 114.888 -1.051 . . . . 0.74 108.78 172.64 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 139' ' ' THR . . . . . 0.43 ' O ' HG13 ' B' ' 131' ' ' VAL . 22.1 m -110.54 124.97 52.83 Favored 'General case' 0 C--N 1.332 -0.182 0 CA-C-O 120.596 0.236 . . . . 0.47 110.753 -177.266 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 140' ' ' LEU . . . . . 0.464 ' C ' HD23 ' B' ' 140' ' ' LEU . 6.5 tt -116.1 122.73 45.99 Favored 'General case' 0 C--N 1.33 -0.249 0 N-CA-C 109.484 -0.561 . . . . 0.86 109.484 -178.261 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 141' ' ' ILE . . . . . 0.496 ' HB ' HG23 ' B' ' 130' ' ' VAL . 19.8 mt -120.71 122.95 69.26 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.298 0 CA-C-O 120.949 0.404 . . . . 0.56 110.015 -175.397 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 142' ' ' ARG . . . . . . . . . . . . . 67.5 mtm180 -104.4 126.38 51.45 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 115.281 -0.872 . . . . 3.56 109.938 179.78 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 143' ' ' THR . . . . . . . . . . . . . 23.0 p . . . . . 0 C--O 1.22 -0.497 0 CA-C-O 117.963 -1.018 . . . . 1.46 110.645 -179.576 . . . . . . . . 0 0 . 1 . 001 nuclear nobuild full ' C' C ' -3' ' ' GLU . . . . . . . . . . . . . 21.9 pt-20 . . . . . 0 N--CA 1.492 1.643 0 N-CA-C 110.322 -0.251 . . . . 36.63 110.322 . . . . . . . . . 0 0 . 1 . 001 nuclear nobuild full ' C' C ' -2' ' ' GLY . . . . . . . . . . . . . . . -73.3 94.0 0.71 Allowed Glycine 0 CA--C 1.524 0.603 0 N-CA-C 111.245 -0.742 . . . . 32.08 111.245 -178.441 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' C' C ' -1' ' ' VAL . . . . . . . . . . . . . 45.1 t -93.84 126.69 46.23 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.337 0 N-CA-C 109.018 -0.734 . . . . 29.13 109.018 175.43 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' C' C ' 0' ' ' ILE . . . . . . . . . . . . . 44.6 mm -99.44 117.86 45.2 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.316 0 CA-C-O 120.944 0.402 . . . . 27.62 110.588 -175.998 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' C' C ' 1' ' ' MET . . . . . . . . . . . . . 24.9 ptm -90.72 141.11 29.13 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-N 115.815 -0.63 . . . . 23.77 110.079 178.21 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' C' C ' 2' ' ' SER . . . . . . . . . . . . . 51.0 p -104.93 140.09 38.68 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-O 120.996 0.427 . . . . 21.19 110.875 -178.159 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' C' C ' 3' ' ' GLU . . . . . . . . . . . . . 95.2 mt-10 -140.02 142.57 36.22 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 115.832 -0.622 . . . . 18.63 110.711 -179.463 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' C' C ' 4' ' ' LEU . . . . . 0.409 HD12 HD23 ' C' ' 58' ' ' LEU . 4.0 tt -123.78 124.02 41.78 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.083 -0.508 . . . . 16.59 109.788 176.63 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' C' C ' 5' ' ' LYS . . . . . . . . . . . . . 57.3 mttm -100.12 121.7 41.81 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.298 -0.41 . . . . 14.18 110.866 -179.314 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' C' C ' 6' ' ' LEU . . . . . . . . . . . . . 60.6 mt -117.59 146.3 43.72 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 115.557 -0.747 . . . . 13.76 110.67 -179.437 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' C' C ' 7' ' ' LYS . . . . . . . . . . . . . 38.5 ttmt -138.89 139.14 22.8 Favored Pre-proline 0 CA--C 1.533 0.318 0 CA-C-O 119.115 -0.469 . . . . 11.14 109.998 174.779 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' C' C ' 8' ' ' PRO . . . . . . . . . . . . . 94.1 Cg_endo -91.95 146.12 3.05 Favored 'Trans proline' 0 N--CA 1.489 1.258 0 C-N-CA 121.82 1.68 . . . . 10.45 112.098 178.817 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' C' C ' 9' ' ' LEU . . . . . . . . . . . . . 70.2 mt -75.89 -46.34 3.93 Favored Pre-proline 0 CA--C 1.533 0.31 0 CA-C-O 118.742 -0.647 . . . . 14.46 111.596 178.035 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' C' C ' 10' ' ' PRO . . . . . . . . . . . . . 84.6 Cg_endo -81.76 142.68 12.85 Favored 'Trans proline' 0 N--CA 1.495 1.574 0 C-N-CA 121.024 1.15 . . . . 13.28 111.227 172.308 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' C' C ' 11' ' ' LYS . . . . . . . . . . . . . 53.7 tttm -86.33 109.94 19.33 Favored 'General case' 0 C--N 1.331 -0.223 0 C-N-CA 120.68 -0.408 . . . . 12.2 110.524 -179.254 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' C' C ' 12' ' ' VAL . . . . . . . . . . . . . 11.6 p -147.38 145.62 18.95 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.299 0 CA-C-N 116.003 -0.544 . . . . 13.43 110.402 -179.294 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' C' C ' 13' ' ' GLU . . . . . . . . . . . . . 46.1 mt-10 -81.15 130.28 34.95 Favored 'General case' 0 C--N 1.329 -0.286 0 N-CA-C 110.096 -0.335 . . . . 13.26 110.096 177.91 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' C' C ' 14' ' ' LEU . . . . . . . . . . . . . 17.3 mt -98.78 143.94 27.27 Favored Pre-proline 0 CA--C 1.533 0.326 0 CA-C-O 118.987 -0.53 . . . . 13.07 110.336 -178.215 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' C' C ' 15' ' ' PRO . . . . . . . . . . . . . 23.2 Cg_exo -64.49 161.09 36.49 Favored 'Trans proline' 0 N--CA 1.498 1.754 0 C-N-CA 121.36 1.373 . . . . 15.43 111.733 176.333 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' C' C ' 16' ' ' PRO . . . . . . . . . . . . . 35.7 Cg_exo -59.12 -35.32 98.18 Favored 'Trans proline' 0 N--CA 1.498 1.748 0 C-N-CA 121.508 1.472 . . . . 15.95 112.979 -178.545 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' C' C ' 17' ' ' ASP . . . . . . . . . . . . . 11.6 p-10 -83.3 -0.71 50.9 Favored 'General case' 0 CA--C 1.537 0.452 0 N-CA-C 113.35 0.87 . . . . 17.37 113.35 -177.397 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' C' C ' 18' ' ' PHE . . . . . . . . . . . . . 29.2 t80 -58.34 -44.26 88.65 Favored 'General case' 0 C--N 1.334 -0.107 0 O-C-N 121.972 -0.455 . . . . 14.54 110.082 -177.343 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' C' C ' 19' ' ' VAL . . . . . . . . . . . . . 49.7 t -57.14 -43.96 82.47 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.288 0 CA-C-N 116.132 -0.485 . . . . 15.03 110.423 -177.737 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' C' C ' 20' ' ' ASP . . . . . . . . . . . . . 2.0 m-20 -60.07 -43.31 95.54 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.551 -0.295 . . . . 17.45 111.029 -177.653 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' C' C ' 21' ' ' VAL . . . . . . . . . . . . . 46.4 t -63.84 -45.49 96.94 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.289 0 C-N-CA 120.707 -0.397 . . . . 17.27 110.545 -176.94 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' C' C ' 22' ' ' ILE . . . . . 0.599 HG22 HD12 ' C' ' 26' ' ' LEU . 50.6 mm -55.9 -48.58 78.25 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.226 0 C-N-CA 121.038 -0.265 . . . . 16.84 110.71 179.014 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' C' C ' 23' ' ' ARG . . . . . . . . . . . . . 49.3 ttp180 -54.84 -45.76 74.55 Favored 'General case' 0 C--N 1.331 -0.234 0 C-N-CA 120.92 -0.312 . . . . 19.12 111.347 -178.245 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' C' C ' 24' ' ' ILE . . . . . . . . . . . . . 75.5 mt -58.94 -45.33 92.03 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.253 0 C-N-CA 121.013 -0.275 . . . . 20.12 111.073 -178.696 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' C' C ' 25' ' ' LYS . . . . . . . . . . . . . 53.6 mttm -65.81 -38.1 88.04 Favored 'General case' 0 C--N 1.328 -0.349 0 N-CA-C 112.418 0.525 . . . . 20.06 112.418 -178.325 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' C' C ' 26' ' ' LEU . . . . . 0.599 HD12 HG22 ' C' ' 22' ' ' ILE . 62.8 mt -78.51 -39.82 36.99 Favored 'General case' 0 C--N 1.33 -0.25 0 N-CA-C 113.697 0.999 . . . . 20.37 113.697 -170.443 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' C' C ' 27' ' ' GLN . . . . . . . . . . . . . 12.1 pt20 -47.39 138.66 7.29 Favored 'General case' 0 N--CA 1.469 0.478 0 N-CA-C 112.827 0.677 . . . . 21.9 112.827 -174.772 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' C' C ' 28' ' ' GLY . . . . . . . . . . . . . . . 98.62 -22.05 42.86 Favored Glycine 0 CA--C 1.534 1.234 0 CA-C-N 115.772 -0.649 . . . . 24.11 112.683 -177.737 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' C' C ' 29' ' ' LYS . . . . . . . . . . . . . 63.3 mttp -98.26 155.07 17.37 Favored 'General case' 0 C--N 1.333 -0.129 0 CA-C-N 117.521 0.661 . . . . 22.95 111.02 -179.964 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' C' C ' 30' ' ' THR . . . . . . . . . . . . . 41.7 m -105.73 135.25 47.49 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.165 -0.47 . . . . 24.58 109.826 175.33 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' C' C ' 31' ' ' VAL . . . . . . . . . . . . . 34.9 m -130.56 150.5 34.68 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.289 0 CA-C-O 120.979 0.419 . . . . 21.44 111.171 -177.815 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' C' C ' 32' ' ' ARG . . . . . . . . . . . . . 56.0 ttp180 -131.71 151.0 51.97 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 115.772 -0.649 . . . . 25.8 110.182 177.674 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' C' C ' 33' ' ' THR . . . . . . . . . . . . . 23.5 m -52.92 138.82 29.09 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.423 -0.353 . . . . 20.32 111.436 -177.761 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' C' C ' 34' ' ' GLY . . . . . . . . . . . . . . . 101.25 -17.23 56.08 Favored Glycine 0 CA--C 1.533 1.177 0 CA-C-O 119.695 -0.503 . . . . 19.11 113.276 179.24 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' C' C ' 35' ' ' ASP . . . . . . . . . . . . . 75.1 m-20 -67.0 152.48 45.7 Favored 'General case' 0 N--CA 1.461 0.103 0 CA-C-N 118.046 0.923 . . . . 21.47 111.417 178.984 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' C' C ' 36' ' ' VAL . . . . . . . . . . . . . 44.9 t -121.03 130.98 74.12 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.227 0 CA-C-N 115.969 -0.56 . . . . 19.32 109.99 178.423 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' C' C ' 37' ' ' ILE . . . . . . . . . . . . . 71.9 mt -123.61 140.87 45.83 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.23 0 CA-C-N 116.158 -0.474 . . . . 17.81 109.858 179.972 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' C' C ' 38' ' ' GLY . . . . . . . . . . . . . . . -113.42 128.93 8.58 Favored Glycine 0 CA--C 1.528 0.851 0 N-CA-C 111.272 -0.731 . . . . 18.91 111.272 -179.548 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' C' C ' 39' ' ' ILE . . . . . . . . . . . . . 68.7 mt -124.83 132.37 71.41 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.199 0 N-CA-C 109.911 -0.403 . . . . 17.92 109.911 178.395 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' C' C ' 40' ' ' SER . . . . . 0.52 ' O ' HD13 ' C' ' 41' ' ' ILE . 15.7 t -92.78 117.92 30.53 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-N 116.546 -0.297 . . . . 20.9 111.009 177.093 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' C' C ' 41' ' ' ILE . . . . . 0.52 HD13 ' O ' ' C' ' 40' ' ' SER . 47.4 mm -130.89 128.2 62.36 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.217 0 CA-C-O 120.711 0.291 . . . . 18.73 110.223 178.847 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' C' C ' 42' ' ' LEU . . . . . . . . . . . . . 23.1 mt 57.33 33.53 23.42 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.196 -0.456 . . . . 20.86 111.873 177.985 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' C' C ' 43' ' ' GLY . . . . . . . . . . . . . . . 77.64 -10.1 25.89 Favored Glycine 0 CA--C 1.535 1.311 0 C-N-CA 121.188 -0.529 . . . . 21.69 113.421 177.341 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' C' C ' 44' ' ' LYS . . . . . . . . . . . . . 65.6 tttt -104.87 135.46 46.19 Favored 'General case' 0 C--N 1.332 -0.162 0 CA-C-N 117.938 0.869 . . . . 19.99 110.105 177.58 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' C' C ' 45' ' ' GLU . . . . . . . . . . . . . 84.6 tt0 -83.72 131.14 34.95 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.36 -0.382 . . . . 20.5 110.91 -179.734 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' C' C ' 46' ' ' VAL . . . . . . . . . . . . . 7.3 p -120.76 130.64 74.36 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.229 0 N-CA-C 109.369 -0.604 . . . . 16.54 109.369 175.99 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' C' C ' 47' ' ' LYS . . . . . . . . . . . . . 66.8 mttm -99.26 126.89 45.17 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 115.877 -0.601 . . . . 19.31 110.709 178.949 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' C' C ' 48' ' ' PHE . . . . . . . . . . . . . 85.2 m-85 -111.27 131.96 54.74 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.366 -0.379 . . . . 15.05 110.085 177.921 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' C' C ' 49' ' ' LYS . . . . . . . . . . . . . 78.9 tttt -105.16 136.09 45.3 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.228 -0.442 . . . . 16.18 109.913 178.156 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' C' C ' 50' ' ' VAL . . . . . . . . . . . . . 46.6 t -78.22 107.85 10.81 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.312 0 N-CA-C 109.161 -0.681 . . . . 16.26 109.161 177.174 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' C' C ' 51' ' ' VAL . . . . . . . . . . . . . 48.9 t -70.22 -47.87 64.71 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.304 0 CA-C-N 115.964 -0.562 . . . . 15.45 109.956 -174.298 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' C' C ' 52' ' ' GLN . . . . . . . . . . . . . 48.4 tt0 -168.99 140.1 2.43 Favored 'General case' 0 C--N 1.33 -0.255 0 C-N-CA 120.389 -0.524 . . . . 17.03 111.581 -179.004 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' C' C ' 53' ' ' ALA . . . . . . . . . . . . . . . -109.65 133.3 53.28 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 115.85 -0.614 . . . . 19.6 109.799 174.922 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' C' C ' 54' ' ' TYR . . . . . . . . . . . . . 10.0 t80 -129.03 107.39 18.03 Favored Pre-proline 0 CA--C 1.534 0.35 0 CA-C-O 118.27 -0.871 . . . . 23.17 110.389 -179.942 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' C' C ' 55' ' ' PRO . . . . . . . . . . . . . 72.7 Cg_endo -77.21 170.03 72.59 Favored 'Cis proline' 0 N--CA 1.501 1.932 0 CA-C-N 121.798 1.678 . . . . 23.64 112.558 -6.009 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' C' C ' 56' ' ' SER . . . . . . . . . . . . . 20.0 m -116.59 140.21 26.44 Favored Pre-proline 0 CA--C 1.539 0.524 0 CA-C-O 118.616 -0.707 . . . . 24.73 109.737 174.763 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' C' C ' 57' ' ' PRO . . . . . . . . . . . . . 57.0 Cg_endo -73.36 148.01 91.04 Favored 'Cis proline' 0 N--CA 1.499 1.809 0 CA-C-N 121.621 1.615 . . . . 25.61 111.161 -6.123 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' C' C ' 58' ' ' LEU . . . . . 0.409 HD23 HD12 ' C' ' 4' ' ' LEU . 25.1 tp -107.47 139.3 42.18 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-O 120.986 0.422 . . . . 22.18 110.759 -177.487 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' C' C ' 59' ' ' ARG . . . . . . . . . . . . . 54.3 ttp180 -103.91 119.42 38.89 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 115.543 -0.753 . . . . 26.61 109.016 174.598 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' C' C ' 60' ' ' VAL . . . . . . . . . . . . . 40.9 t -72.58 120.18 20.67 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.286 0 C-N-CA 120.872 -0.331 . . . . 21.45 110.726 -173.092 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' C' C ' 61' ' ' GLU . . . . . . . . . . . . . 94.8 mt-10 -131.03 164.9 24.39 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 115.774 -0.648 . . . . 24.7 109.764 175.979 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' C' C ' 62' ' ' ASP . . . . . . . . . . . . . 39.4 m-20 -53.87 -32.49 53.32 Favored 'General case' 0 C--N 1.328 -0.349 0 C-N-CA 120.982 -0.287 . . . . 22.78 111.763 -179.865 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' C' C ' 63' ' ' ARG . . . . . . . . . . . . . 28.5 ptt180 -78.77 0.23 27.73 Favored 'General case' 0 CA--C 1.537 0.468 0 N-CA-C 113.799 1.037 . . . . 25.71 113.799 -175.445 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' C' C ' 64' ' ' THR . . . . . . . . . . . . . 32.5 m -86.28 136.4 33.17 Favored 'General case' 0 C--N 1.333 -0.148 0 CA-C-N 118.146 0.43 . . . . 20.03 110.797 -177.926 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' C' C ' 65' ' ' LYS . . . . . . . . . . . . . 62.8 mttm -89.67 131.08 35.83 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.166 -0.47 . . . . 19.19 110.192 178.924 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' C' C ' 66' ' ' ILE . . . . . . . . . . . . . 58.2 mt -112.2 130.18 66.35 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.254 0 N-CA-C 109.631 -0.507 . . . . 15.6 109.631 -179.808 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' C' C ' 67' ' ' THR . . . . . . . . . . . . . 26.5 m -124.78 137.34 54.33 Favored 'General case' 0 C--N 1.332 -0.167 0 CA-C-O 121.01 0.433 . . . . 13.36 111.022 -177.307 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' C' C ' 68' ' ' LEU . . . . . . . . . . . . . 53.9 mt -105.02 127.45 52.88 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 115.859 -0.61 . . . . 10.54 110.209 177.806 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' C' C ' 69' ' ' VAL . . . . . . . . . . . . . 44.1 t -102.4 117.25 47.47 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.275 0 CA-C-O 120.836 0.35 . . . . 9.48 110.245 179.434 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' C' C ' 70' ' ' THR . . . . . . . . . . . . . 27.3 p -150.07 161.68 41.89 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.045 -0.525 . . . . 6.72 110.425 178.391 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' C' C ' 71' ' ' HIS . . . . . . . . . . . . . 15.8 t60 -135.81 68.33 65.05 Favored Pre-proline 0 CA--C 1.535 0.396 0 CA-C-N 116.352 -0.386 . . . . 7.9 110.38 177.924 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' C' C ' 72' ' ' PRO . . . . . . . . . . . . . 93.8 Cg_endo -90.89 160.04 4.03 Favored 'Trans proline' 0 N--CA 1.489 1.211 0 C-N-CA 121.936 1.758 . . . . 3.33 112.222 179.049 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' C' C ' 73' ' ' VAL . . . . . . . . . . . . . 33.8 m -111.61 154.59 13.14 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.214 0 CA-C-O 120.87 0.367 . . . . 1.13 110.48 179.322 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' C' C ' 74' ' ' ASP . . . . . 0.408 ' OD2' HD11 ' C' ' 76' ' ' LEU . 6.7 t70 -103.36 128.33 50.48 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 115.978 -0.555 . . . . 0.81 109.778 -179.514 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' C' C ' 75' ' ' VAL . . . . . 0.422 ' C ' HD12 ' C' ' 76' ' ' LEU . 41.0 t -114.63 122.9 69.67 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.209 0 CA-C-O 121.063 0.458 . . . . 0.61 110.745 -176.878 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' C' C ' 76' ' ' LEU . . . . . 0.433 ' N ' HD12 ' C' ' 76' ' ' LEU . 6.8 mp -119.88 139.56 52.2 Favored 'General case' 0 C--N 1.33 -0.277 0 N-CA-C 108.875 -0.787 . . . . 1.07 108.875 173.831 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' C' C ' 77' ' ' GLU . . . . . . . . . . . . . 59.6 tt0 -137.29 136.25 37.86 Favored 'General case' 0 C--N 1.333 -0.14 0 C-N-CA 120.496 -0.482 . . . . 1.18 111.416 -174.237 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' C' C ' 78' ' ' ALA . . . . . 0.516 ' HB2' HD21 ' C' ' 109' ' ' LEU . . . -124.07 137.43 54.57 Favored 'General case' 0 C--N 1.331 -0.199 0 CA-C-N 115.771 -0.65 . . . . 0.56 109.835 177.45 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' C' C ' 79' ' ' LYS . . . . . 0.58 ' O ' HD13 ' C' ' 80' ' ' ILE . 68.1 mttm -79.84 120.27 23.85 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-O 120.976 0.417 . . . . 3.18 110.621 -179.542 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' C' C ' 80' ' ' ILE . . . . . 0.58 HD13 ' O ' ' C' ' 79' ' ' LYS . 43.4 mm -139.11 114.05 8.13 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.311 0 N-CA-C 109.13 -0.693 . . . . 0.53 109.13 -176.95 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' C' C ' 81' ' ' LYS . . . . . . . . . . . . . 41.6 tttp -110.22 130.42 55.55 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-O 120.974 0.416 . . . . 2.98 111.247 -176.362 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' C' C ' 82' ' ' GLY . . . . . . . . . . . . . . . 89.13 42.08 5.69 Favored Glycine 0 CA--C 1.526 0.722 0 CA-C-N 115.857 -0.61 . . . . 0.52 111.692 175.694 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' C' C ' 83' ' ' ILE . . . . . . . . . . . . . 67.7 mt -69.95 138.34 22.26 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.279 0 N-CA-C 109.833 -0.432 . . . . 0.54 109.833 178.54 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' C' C ' 84' ' ' LYS . . . . . . . . . . . . . 35.3 tttp -101.01 -54.03 2.9 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.068 -0.515 . . . . 1.68 110.366 -178.658 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' C' C ' 85' ' ' ASP . . . . . . . . . . . . . 13.3 t70 -151.97 151.33 31.06 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 115.862 -0.608 . . . . 0.76 110.353 -179.7 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' C' C ' 86' ' ' VAL . . . . . . . . . . . . . 44.6 t -131.06 130.43 63.77 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.235 0 CA-C-O 120.93 0.395 . . . . 0.54 110.596 -178.657 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' C' C ' 87' ' ' ILE . . . . . . . . . . . . . 46.1 mm -119.88 127.29 75.88 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.221 0 CA-C-N 115.883 -0.599 . . . . 1.38 109.71 176.297 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' C' C ' 88' ' ' LEU . . . . . . . . . . . . . 14.1 tp -110.02 131.5 55.0 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-O 120.869 0.366 . . . . 1.66 110.969 -178.228 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' C' C ' 89' ' ' ASP . . . . . . . . . . . . . 21.8 t70 -123.42 156.68 35.01 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-N 116.087 -0.506 . . . . 0.95 109.939 178.389 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' C' C ' 90' ' ' GLU . . . . . . . . . . . . . 81.2 tt0 -46.33 -40.17 11.38 Favored 'General case' 0 C--N 1.33 -0.255 0 N-CA-C 113.048 0.758 . . . . 2.43 113.048 -171.738 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' C' C ' 91' ' ' ASN . . . . . . . . . . . . . 6.3 p-10 -132.1 23.03 4.51 Favored 'General case' 0 N--CA 1.468 0.434 0 N-CA-C 112.779 0.659 . . . . 2.22 112.779 -178.546 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' C' C ' 92' ' ' LEU . . . . . . . . . . . . . 15.1 mt -149.26 148.79 29.98 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-O 120.734 0.302 . . . . 1.45 110.262 -176.504 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' C' C ' 93' ' ' ILE . . . . . . . . . . . . . 75.7 mt -125.84 120.23 56.75 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.262 0 N-CA-C 109.41 -0.589 . . . . 0.48 109.41 177.005 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' C' C ' 94' ' ' VAL . . . . . 0.679 HG21 HG21 ' C' ' 125' ' ' VAL . 46.4 t -118.65 124.97 74.01 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.244 0 N-CA-C 109.765 -0.457 . . . . 0.47 109.765 -179.603 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' C' C ' 95' ' ' VAL . . . . . . . . . . . . . 41.6 t -122.02 134.49 65.13 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.328 0 CA-C-N 116.038 -0.528 . . . . 0.41 109.946 -178.226 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' C' C ' 96' ' ' ILE . . . . . . . . . . . . . 62.6 mt -115.85 127.73 73.35 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.341 0 N-CA-C 109.004 -0.739 . . . . 0.46 109.004 178.039 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' C' C ' 97' ' ' THR . . . . . . . . . . . . . 81.4 p -99.56 157.45 16.44 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-O 121.199 0.523 . . . . 0.43 111.1 -178.262 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' C' C ' 98' ' ' GLU . . . . . . . . . . . . . 85.0 tt0 -54.01 -27.82 34.23 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.065 -0.516 . . . . 2.33 112.043 179.771 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' C' C ' 99' ' ' GLU . . . . . . . . . . . . . 94.6 mt-10 -77.49 12.14 1.71 Allowed 'General case' 0 CA--C 1.537 0.458 0 N-CA-C 113.162 0.801 . . . . 2.1 113.162 -177.676 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' C' C ' 100' ' ' ASN . . . . . . . . . . . . . 3.4 m-20 63.57 33.59 13.22 Favored 'General case' 0 CA--C 1.532 0.262 0 CA-C-O 120.904 0.383 . . . . 0.51 111.565 179.174 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' C' C ' 101' ' ' GLU . . . . . . . . . . . . . 85.1 tt0 -107.71 144.74 34.4 Favored 'General case' 0 C--N 1.333 -0.15 0 N-CA-C 109.715 -0.476 . . . . 0.45 109.715 172.833 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' C' C ' 102' ' ' VAL . . . . . . . . . . . . . 45.7 t -115.35 127.08 73.05 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.317 0 CA-C-N 116.255 -0.429 . . . . 0.41 109.851 -177.876 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' C' C ' 103' ' ' LEU . . . . . . . . . . . . . 27.0 mt -117.78 131.41 56.59 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-N 115.883 -0.599 . . . . 0.59 110.407 178.526 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' C' C ' 104' ' ' ILE . . . . . . . . . . . . . 68.9 mt -117.34 119.79 62.92 Favored 'Isoleucine or valine' 0 C--O 1.233 0.219 0 N-CA-C 110.132 -0.321 . . . . 0.45 110.132 178.308 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' C' C ' 105' ' ' PHE . . . . . . . . . . . . . 95.8 m-85 -120.65 166.9 13.04 Favored 'General case' 0 C--N 1.332 -0.158 0 O-C-N 124.136 0.897 . . . . 0.46 110.038 179.676 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' C' C ' 106' ' ' ASN . . . . . . . . . . . . . 35.5 p30 -101.11 -171.94 2.08 Favored 'General case' 0 C--N 1.33 -0.265 0 N-CA-C 110.17 -0.307 . . . . 0.56 110.17 173.073 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' C' C ' 107' ' ' GLN . . . . . . . . . . . . . 63.0 tt0 -60.56 -30.29 69.7 Favored 'General case' 0 CA--C 1.531 0.236 0 N-CA-C 111.803 0.298 . . . . 1.49 111.803 179.633 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' C' C ' 108' ' ' ASN . . . . . . . . . . . . . 6.6 t30 -82.94 9.28 10.39 Favored 'General case' 0 CA--C 1.536 0.426 0 N-CA-C 112.976 0.732 . . . . 1.39 112.976 -178.375 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' C' C ' 109' ' ' LEU . . . . . 0.516 HD21 ' HB2' ' C' ' 78' ' ' ALA . 7.6 tp 61.24 32.99 19.33 Favored 'General case' 0 CA--C 1.53 0.193 0 O-C-N 122.228 -0.295 . . . . 0.96 111.741 179.14 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' C' C ' 110' ' ' GLU . . . . . . . . . . . . . 94.9 mt-10 -100.89 142.3 32.55 Favored 'General case' 0 C--N 1.33 -0.265 0 N-CA-C 109.319 -0.623 . . . . 1.9 109.319 174.724 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' C' C ' 111' ' ' GLU . . . . . . . . . . . . . 60.6 tt0 -85.05 121.99 28.61 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-O 120.893 0.378 . . . . 1.86 110.807 -175.14 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' C' C ' 112' ' ' LEU . . . . . . . . . . . . . 60.3 mt -99.71 -46.13 5.52 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 115.94 -0.573 . . . . 0.63 110.877 179.256 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' C' C ' 113' ' ' TYR . . . . . . . . . . . . . 85.5 t80 -137.15 140.0 41.55 Favored 'General case' 0 N--CA 1.464 0.242 0 CA-C-O 121.078 0.466 . . . . 0.53 111.59 -178.1 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' C' C ' 114' ' ' ARG . . . . . . . . . . . . . 41.1 ttm180 -130.5 124.57 32.24 Favored 'General case' 0 C--N 1.331 -0.23 0 CA-C-N 115.361 -0.836 . . . . 2.7 109.862 175.993 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' C' C ' 115' ' ' GLY . . . . . . . . . . . . . . . -147.18 159.02 27.91 Favored Glycine 0 CA--C 1.523 0.572 0 N-CA-C 110.56 -1.016 . . . . 0.45 110.56 178.474 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' C' C ' 116' ' ' LYS . . . . . . . . . . . . . 77.3 tttt -137.49 133.12 34.25 Favored 'General case' 0 C--N 1.329 -0.305 0 N-CA-C 109.996 -0.372 . . . . 1.58 109.996 179.385 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' C' C ' 117' ' ' PHE . . . . . . . . . . . . . 35.6 m-85 -134.18 115.75 14.56 Favored 'General case' 0 C--N 1.331 -0.223 0 CA-C-N 116.386 -0.37 . . . . 0.56 110.226 -174.82 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' C' C ' 118' ' ' GLU . . . . . . . . . . . . . 95.2 mt-10 -54.64 -40.88 69.43 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.472 -0.331 . . . . 2.11 111.498 -175.623 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' C' C ' 119' ' ' ASN . . . . . . . . . . . . . 30.6 m120 -100.53 31.16 3.58 Favored 'General case' 0 C--N 1.33 -0.244 0 N-CA-C 112.266 0.469 . . . . 1.52 112.266 -173.187 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' C' C ' 120' ' ' LEU . . . . . . . . . . . . . 14.2 tp -53.79 120.03 5.73 Favored 'General case' 0 N--CA 1.464 0.267 0 CA-C-O 120.676 0.274 . . . . 0.49 110.907 178.048 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' C' C ' 121' ' ' ASN . . . . . . . . . . . . . 59.9 m-80 -113.92 -44.15 3.19 Favored 'General case' 0 C--N 1.331 -0.2 0 CA-C-N 116.441 -0.345 . . . . 1.98 110.992 -177.699 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' C' C ' 122' ' ' LYS . . . . . . . . . . . . . 97.9 mttt -146.44 150.31 35.38 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-O 121.059 0.457 . . . . 1.85 111.644 -178.022 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' C' C ' 123' ' ' VAL . . . . . . . . . . . . . 44.7 t -129.78 127.58 64.31 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.303 0 N-CA-C 109.383 -0.599 . . . . 0.62 109.383 174.536 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' C' C ' 124' ' ' LEU . . . . . . . . . . . . . 71.0 mt -117.18 132.34 56.67 Favored 'General case' 0 N--CA 1.463 0.223 0 CA-C-N 116.547 -0.297 . . . . 1.7 110.663 -178.066 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' C' C ' 125' ' ' VAL . . . . . 0.679 HG21 HG21 ' C' ' 94' ' ' VAL . 43.7 t -132.63 121.8 45.81 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.206 0 CA-C-N 116.234 -0.439 . . . . 1.65 110.283 -179.411 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' C' C ' 126' ' ' ARG . . . . . . . . . . . . . 80.5 mtt85 -152.69 137.31 16.89 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.287 -0.415 . . . . 3.27 110.152 176.647 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' C' C ' 127' ' ' ASN . . . . . . . . . . . . . 20.1 m120 54.82 -154.44 0.28 Allowed 'General case' 0 CA--C 1.539 0.53 0 N-CA-C 110.102 -0.332 . . . . 2.28 110.102 178.562 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' C' C ' 128' ' ' ASP . . . . . . . . . . . . . 4.2 p30 -82.9 19.71 1.32 Allowed 'General case' 0 CA--C 1.534 0.332 0 N-CA-C 112.483 0.549 . . . . 1.11 112.483 178.543 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' C' C ' 129' ' ' LEU . . . . . . . . . . . . . 15.5 tp -122.75 137.09 55.02 Favored 'General case' 0 C--O 1.233 0.193 0 O-C-N 122.019 -0.426 . . . . 2.08 110.381 179.935 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' C' C ' 130' ' ' VAL . . . . . 0.553 HG23 ' HB ' ' C' ' 141' ' ' ILE . 32.1 m -132.8 143.68 38.89 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.215 0 CA-C-O 120.957 0.408 . . . . 1.44 110.379 178.527 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' C' C ' 131' ' ' VAL . . . . . 0.503 HG12 HD22 ' D' ' 88' ' ' LEU . 14.1 p -136.05 141.15 42.48 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.283 0 CA-C-N 116.349 -0.387 . . . . 0.91 110.683 179.9 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' C' C ' 132' ' ' ILE . . . . . . . . . . . . . 74.1 mt -114.64 131.84 65.57 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.354 0 N-CA-C 109.196 -0.668 . . . . 0.49 109.196 178.751 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' C' C ' 133' ' ' ILE . . . . . . . . . . . . . 42.7 mm -117.37 120.14 63.98 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.232 0 CA-C-O 120.946 0.403 . . . . 0.47 110.901 -175.659 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' C' C ' 134' ' ' ASP . . . . . . . . . . . . . 7.2 p-10 -130.79 144.29 51.34 Favored 'General case' 0 C--N 1.33 -0.257 0 N-CA-C 109.072 -0.714 . . . . 0.53 109.072 173.689 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' C' C ' 135' ' ' GLU . . . . . . . . . . . . . 84.4 tt0 -49.78 -25.35 2.97 Favored 'General case' 0 C--N 1.327 -0.379 0 N-CA-C 112.852 0.686 . . . . 2.0 112.852 -170.559 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' C' C ' 136' ' ' GLN . . . . . . . . . . . . . 94.7 mt-30 -92.78 -36.97 12.59 Favored 'General case' 0 C--N 1.332 -0.183 0 N-CA-C 112.105 0.409 . . . . 2.24 112.105 -177.499 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' C' C ' 137' ' ' LYS . . . . . . . . . . . . . 41.6 mttp -136.83 151.53 49.24 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-O 121.03 0.443 . . . . 1.48 111.1 -168.453 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' C' C ' 138' ' ' LEU . . . . . . . . . . . . . 5.2 tt -118.91 121.47 40.05 Favored 'General case' 0 C--N 1.332 -0.19 0 N-CA-C 109.047 -0.723 . . . . 0.81 109.047 173.133 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' C' C ' 139' ' ' THR . . . . . 0.454 ' O ' HG23 ' C' ' 131' ' ' VAL . 33.1 m -114.19 127.38 55.87 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-O 120.711 0.291 . . . . 0.54 111.066 -176.565 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' C' C ' 140' ' ' LEU . . . . . . . . . . . . . 21.6 tp -111.03 123.84 50.98 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 115.599 -0.728 . . . . 1.11 109.158 179.922 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' C' C ' 141' ' ' ILE . . . . . 0.553 ' HB ' HG23 ' C' ' 130' ' ' VAL . 19.5 mt -122.19 121.61 64.38 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.298 0 CA-C-O 120.981 0.419 . . . . 0.65 110.073 -173.906 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' C' C ' 142' ' ' ARG . . . . . . . . . . . . . 59.3 mtp180 -100.88 122.29 43.19 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 115.419 -0.809 . . . . 4.0 110.001 178.762 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' C' C ' 143' ' ' THR . . . . . . . . . . . . . 37.4 p . . . . . 0 C--O 1.219 -0.505 0 CA-C-O 117.871 -1.061 . . . . 1.67 110.599 -179.28 . . . . . . . . 0 0 . 1 . 001 nuclear nobuild full ' D' D ' -3' ' ' GLU . . . . . . . . . . . . . 95.2 mt-10 . . . . . 0 N--CA 1.49 1.544 0 N-CA-C 109.439 -0.578 . . . . 32.38 109.439 . . . . . . . . . 0 0 . 1 . 001 nuclear nobuild full ' D' D ' -2' ' ' GLY . . . . . . . . . . . . . . . -111.62 128.36 8.59 Favored Glycine 0 CA--C 1.526 0.721 0 N-CA-C 111.015 -0.834 . . . . 30.2 111.015 179.987 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' D' D ' -1' ' ' VAL . . . . . . . . . . . . . 44.2 t -97.2 134.12 36.22 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.323 0 CA-C-O 120.767 0.318 . . . . 27.44 110.148 179.313 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' D' D ' 0' ' ' ILE . . . . . . . . . . . . . 68.7 mt -115.45 143.98 24.08 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.26 0 CA-C-N 116.18 -0.464 . . . . 25.56 109.959 -179.462 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' D' D ' 1' ' ' MET . . . . . . . . . . . . . 25.6 ptm -143.16 149.93 38.72 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.196 -0.456 . . . . 22.18 110.903 -179.53 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' D' D ' 2' ' ' SER . . . . . . . . . . . . . 3.6 p -125.02 134.76 52.44 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 116.153 -0.476 . . . . 19.86 110.477 178.286 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' D' D ' 3' ' ' GLU . . . . . . . . . . . . . 84.7 tt0 -139.71 139.57 36.6 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.137 -0.483 . . . . 17.06 110.807 -179.434 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' D' D ' 4' ' ' LEU . . . . . 0.426 HD21 HD21 ' D' ' 6' ' ' LEU . 15.3 tp -124.42 126.09 45.36 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 115.912 -0.585 . . . . 14.92 110.117 177.695 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' D' D ' 5' ' ' LYS . . . . . . . . . . . . . 46.5 mttm -102.49 120.48 40.59 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.328 -0.396 . . . . 12.31 110.389 177.795 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' D' D ' 6' ' ' LEU . . . . . 0.426 HD21 HD21 ' D' ' 4' ' ' LEU . 78.4 mt -117.63 149.25 41.01 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 115.564 -0.744 . . . . 12.66 110.663 -179.145 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' D' D ' 7' ' ' LYS . . . . . . . . . . . . . 77.5 tttt -136.77 135.68 20.54 Favored Pre-proline 0 CA--C 1.534 0.359 0 CA-C-O 118.764 -0.636 . . . . 10.07 109.792 176.266 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' D' D ' 8' ' ' PRO . . . . . . . . . . . . . 86.9 Cg_endo -87.83 143.91 6.17 Favored 'Trans proline' 0 N--CA 1.492 1.395 0 C-N-CA 121.546 1.497 . . . . 10.15 111.635 178.43 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' D' D ' 9' ' ' LEU . . . . . . . . . . . . . 21.7 mt -79.86 -46.99 1.46 Allowed Pre-proline 0 CA--C 1.533 0.305 0 CA-C-O 118.746 -0.645 . . . . 13.43 111.91 -178.884 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' D' D ' 10' ' ' PRO . . . . . . . . . . . . . 92.3 Cg_endo -80.69 148.9 18.14 Favored 'Trans proline' 0 N--CA 1.495 1.603 0 C-N-CA 121.194 1.263 . . . . 13.55 111.646 174.127 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' D' D ' 11' ' ' LYS . . . . . . . . . . . . . 96.0 mttt -88.71 102.1 14.65 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-O 120.886 0.374 . . . . 13.05 110.767 179.961 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' D' D ' 12' ' ' VAL . . . . . . . . . . . . . 12.2 p -141.03 143.85 27.61 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 CA-C-N 116.108 -0.496 . . . . 14.73 110.391 179.145 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' D' D ' 13' ' ' GLU . . . . . . . . . . . . . 45.9 mt-10 -79.72 124.65 28.78 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.408 -0.36 . . . . 15.06 110.38 179.245 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' D' D ' 14' ' ' LEU . . . . . . . . . . . . . 22.7 mt -99.52 147.78 33.81 Favored Pre-proline 0 CA--C 1.534 0.332 0 CA-C-O 119.185 -0.436 . . . . 15.04 110.534 -178.139 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' D' D ' 15' ' ' PRO . . . . . . . . . . . . . 23.8 Cg_exo -64.1 160.82 36.28 Favored 'Trans proline' 0 N--CA 1.499 1.821 0 C-N-CA 121.298 1.332 . . . . 17.83 111.816 175.018 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' D' D ' 16' ' ' PRO . . . . . . . . . . . . . 28.1 Cg_exo -60.02 -36.76 88.53 Favored 'Trans proline' 0 N--CA 1.496 1.64 0 C-N-CA 121.486 1.457 . . . . 18.35 112.795 -178.408 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' D' D ' 17' ' ' ASP . . . . . . . . . . . . . 2.9 p30 -88.27 9.22 23.85 Favored 'General case' 0 CA--C 1.535 0.402 0 N-CA-C 113.189 0.811 . . . . 20.13 113.189 -177.775 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' D' D ' 18' ' ' PHE . . . . . . . . . . . . . 61.8 t80 -57.53 -42.44 82.87 Favored 'General case' 0 N--CA 1.46 0.042 0 O-C-N 121.983 -0.448 . . . . 16.67 110.172 -179.443 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' D' D ' 19' ' ' VAL . . . . . . . . . . . . . 48.0 t -56.91 -42.53 78.67 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.321 0 CA-C-N 116.264 -0.426 . . . . 16.27 110.428 -179.353 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' D' D ' 20' ' ' ASP . . . . . . . . . . . . . 18.4 t70 -59.98 -42.16 93.57 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-O 120.8 0.333 . . . . 19.6 110.89 -178.12 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' D' D ' 21' ' ' VAL . . . . . . . . . . . . . 46.2 t -64.26 -46.61 92.82 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.269 0 C-N-CA 120.793 -0.363 . . . . 19.26 110.452 -177.938 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' D' D ' 22' ' ' ILE . . . . . 0.503 HG22 HD12 ' D' ' 26' ' ' LEU . 49.0 mm -56.23 -44.41 79.25 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.211 0 C-N-CA 120.962 -0.295 . . . . 17.48 110.565 178.651 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' D' D ' 23' ' ' ARG . . . . . . . . . . . . . 55.9 ttp180 -54.15 -49.38 69.39 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-O 120.673 0.273 . . . . 20.79 111.444 -179.689 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' D' D ' 24' ' ' ILE . . . . . . . . . . . . . 76.9 mt -58.88 -43.01 87.45 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.308 0 CA-C-N 116.48 -0.327 . . . . 21.9 111.135 -177.474 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' D' D ' 25' ' ' LYS . . . . . . . . . . . . . 63.4 mttm -66.39 -43.25 86.36 Favored 'General case' 0 C--N 1.328 -0.355 0 N-CA-C 112.619 0.6 . . . . 20.64 112.619 -178.438 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' D' D ' 26' ' ' LEU . . . . . 0.503 HD12 HG22 ' D' ' 22' ' ' ILE . 92.8 mt -78.71 -37.54 41.29 Favored 'General case' 0 C--N 1.331 -0.228 0 N-CA-C 113.55 0.944 . . . . 19.88 113.55 -170.385 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' D' D ' 27' ' ' GLN . . . . . . . . . . . . . 9.7 pt20 -46.75 138.99 5.67 Favored 'General case' 0 N--CA 1.469 0.488 0 N-CA-C 112.765 0.654 . . . . 22.91 112.765 -175.305 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' D' D ' 28' ' ' GLY . . . . . . . . . . . . . . . 100.3 -23.42 35.94 Favored Glycine 0 CA--C 1.534 1.263 0 CA-C-N 115.606 -0.725 . . . . 23.12 112.393 -176.572 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' D' D ' 29' ' ' LYS . . . . . . . . . . . . . 68.8 mttm -98.44 155.11 17.41 Favored 'General case' 0 C--O 1.233 0.2 0 CA-C-N 117.441 0.621 . . . . 21.77 111.253 179.436 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' D' D ' 30' ' ' THR . . . . . . . . . . . . . 40.8 m -102.98 137.88 40.58 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.034 -0.53 . . . . 22.51 109.938 175.362 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' D' D ' 31' ' ' VAL . . . . . . . . . . . . . 34.8 m -128.19 154.38 38.79 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.249 0 CA-C-O 120.911 0.386 . . . . 19.36 110.854 -178.708 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' D' D ' 32' ' ' ARG . . . . . . . . . . . . . 43.6 mtm180 -133.46 151.53 51.8 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 115.742 -0.663 . . . . 23.0 110.307 177.908 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' D' D ' 33' ' ' THR . . . . . . . . . . . . . 31.9 m -53.2 137.77 33.47 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.498 -0.319 . . . . 17.54 111.458 -178.155 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' D' D ' 34' ' ' GLY . . . . . . . . . . . . . . . 98.91 -17.02 58.8 Favored Glycine 0 CA--C 1.532 1.147 0 CA-C-O 119.65 -0.528 . . . . 16.71 113.365 177.927 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' D' D ' 35' ' ' ASP . . . . . . . . . . . . . 75.2 m-20 -65.72 149.69 49.72 Favored 'General case' 0 C--O 1.231 0.108 0 CA-C-N 118.012 0.906 . . . . 19.02 111.198 179.96 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' D' D ' 36' ' ' VAL . . . . . . . . . . . . . 46.3 t -118.66 130.11 73.96 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.251 0 CA-C-N 115.847 -0.615 . . . . 17.79 109.682 177.304 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' D' D ' 37' ' ' ILE . . . . . . . . . . . . . 64.1 mt -115.55 136.98 50.62 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.298 0 CA-C-N 116.11 -0.496 . . . . 17.21 109.764 179.912 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' D' D ' 38' ' ' GLY . . . . . . . . . . . . . . . -109.53 127.61 8.55 Favored Glycine 0 CA--C 1.524 0.635 0 N-CA-C 110.73 -0.948 . . . . 18.84 110.73 178.945 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' D' D ' 39' ' ' ILE . . . . . . . . . . . . . 72.2 mt -121.19 130.73 74.37 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.206 0 N-CA-C 109.911 -0.403 . . . . 18.53 109.911 179.222 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' D' D ' 40' ' ' SER . . . . . . . . . . . . . 78.0 p -92.24 119.18 31.6 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.233 -0.44 . . . . 21.82 110.74 176.506 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' D' D ' 41' ' ' ILE . . . . . . . . . . . . . 72.6 mt -129.59 116.91 40.53 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.244 0 N-CA-C 109.954 -0.387 . . . . 20.47 109.954 177.938 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' D' D ' 42' ' ' LEU . . . . . . . . . . . . . 69.8 mt 58.08 33.23 22.96 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.269 -0.423 . . . . 22.9 111.698 179.173 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' D' D ' 43' ' ' GLY . . . . . . . . . . . . . . . 80.9 -10.13 48.82 Favored Glycine 0 CA--C 1.535 1.293 0 C-N-CA 121.188 -0.53 . . . . 23.16 113.433 177.303 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' D' D ' 44' ' ' LYS . . . . . . . . . . . . . 94.6 mttt -99.05 137.33 37.73 Favored 'General case' 0 C--N 1.332 -0.173 0 CA-C-N 117.966 0.883 . . . . 21.23 110.285 178.622 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' D' D ' 45' ' ' GLU . . . . . . . . . . . . . 84.7 tt0 -85.21 130.61 34.57 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.257 -0.429 . . . . 20.64 111.474 -178.686 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' D' D ' 46' ' ' VAL . . . . . . . . . . . . . 7.4 p -125.37 126.2 70.26 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.22 0 N-CA-C 109.275 -0.639 . . . . 16.96 109.275 173.333 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' D' D ' 47' ' ' LYS . . . . . . . . . . . . . 9.7 mtmp? -101.46 131.27 47.67 Favored 'General case' 0 C--N 1.331 -0.23 0 CA-C-N 116.165 -0.47 . . . . 18.29 111.688 179.204 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' D' D ' 48' ' ' PHE . . . . . . . . . . . . . 92.2 m-85 -114.58 133.63 55.67 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 115.893 -0.594 . . . . 13.84 109.985 176.32 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' D' D ' 49' ' ' LYS . . . . . . . . . . . . . 60.7 tttm -105.33 137.61 42.86 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.743 -0.208 . . . . 13.73 110.559 179.065 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' D' D ' 50' ' ' VAL . . . . . . . . . . . . . 44.2 t -81.04 108.35 14.28 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.268 0 N-CA-C 109.275 -0.639 . . . . 14.42 109.275 175.862 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' D' D ' 51' ' ' VAL . . . . . . . . . . . . . 48.4 t -73.23 -47.35 47.23 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.351 0 CA-C-N 116.224 -0.443 . . . . 12.84 110.107 -173.821 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' D' D ' 52' ' ' GLN . . . . . . . . . . . . . 48.4 tt0 -162.54 136.82 6.5 Favored 'General case' 0 C--N 1.331 -0.234 0 C-N-CA 120.354 -0.538 . . . . 14.45 111.648 -178.378 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' D' D ' 53' ' ' ALA . . . . . . . . . . . . . . . -110.06 131.3 55.18 Favored 'General case' 0 C--N 1.332 -0.19 0 CA-C-N 115.852 -0.613 . . . . 16.93 109.891 175.482 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' D' D ' 54' ' ' TYR . . . . . . . . . . . . . 8.9 t80 -129.02 108.34 18.12 Favored Pre-proline 0 CA--C 1.534 0.361 0 CA-C-O 118.333 -0.842 . . . . 20.68 110.47 179.8 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' D' D ' 55' ' ' PRO . . . . . . . . . . . . . 74.2 Cg_endo -77.14 170.05 72.6 Favored 'Cis proline' 0 N--CA 1.5 1.858 0 CA-C-N 121.831 1.689 . . . . 21.15 112.481 -5.288 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' D' D ' 56' ' ' SER . . . . . . . . . . . . . 50.1 m -117.29 133.62 23.17 Favored Pre-proline 0 CA--C 1.538 0.515 0 CA-C-O 118.511 -0.757 . . . . 21.68 109.714 175.307 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' D' D ' 57' ' ' PRO . . . . . . . . . . . . . 38.0 Cg_endo -68.09 165.15 72.06 Favored 'Cis proline' 0 N--CA 1.496 1.666 0 CA-C-N 121.828 1.689 . . . . 22.71 111.217 -3.535 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' D' D ' 58' ' ' LEU . . . . . . . . . . . . . 25.0 tp -130.2 136.29 49.08 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-O 120.937 0.399 . . . . 19.85 110.891 -179.001 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' D' D ' 59' ' ' ARG . . . . . . . . . . . . . 55.8 ttp180 -101.73 124.39 47.3 Favored 'General case' 0 C--N 1.327 -0.377 0 N-CA-C 109.08 -0.711 . . . . 25.3 109.08 174.383 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' D' D ' 60' ' ' VAL . . . . . . . . . . . . . 41.3 t -82.12 122.49 36.96 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.304 0 C-N-CA 120.677 -0.409 . . . . 20.84 110.491 -174.538 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' D' D ' 61' ' ' GLU . . . . . . . . . . . . . 45.2 mt-10 -131.13 169.72 15.51 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 115.972 -0.558 . . . . 23.88 109.74 177.415 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' D' D ' 62' ' ' ASP . . . . . . . . . . . . . 6.9 p-10 -55.3 -32.32 62.34 Favored 'General case' 0 C--N 1.328 -0.366 0 N-CA-C 111.743 0.275 . . . . 23.34 111.743 -179.123 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' D' D ' 63' ' ' ARG . . . . . . . . . . . . . 40.2 ptt180 -77.63 -8.44 57.88 Favored 'General case' 0 CA--C 1.537 0.451 0 N-CA-C 113.669 0.988 . . . . 25.78 113.669 -176.415 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' D' D ' 64' ' ' THR . . . . . . . . . . . . . 36.9 m -77.29 136.68 38.51 Favored 'General case' 0 C--N 1.333 -0.116 0 CA-C-O 120.902 0.382 . . . . 19.75 110.73 -176.149 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' D' D ' 65' ' ' LYS . . . . . . . . . . . . . 61.2 mttm -89.51 127.6 35.88 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.026 -0.534 . . . . 18.76 110.031 178.043 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' D' D ' 66' ' ' ILE . . . . . . . . . . . . . 62.5 mt -113.31 127.78 70.44 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.284 0 N-CA-C 109.66 -0.496 . . . . 15.71 109.66 179.376 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' D' D ' 67' ' ' THR . . . . . . . . . . . . . 18.3 m -124.37 141.74 51.83 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.226 -0.443 . . . . 12.72 110.825 -176.925 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' D' D ' 68' ' ' LEU . . . . . . . . . . . . . 16.6 tp -102.08 130.16 48.6 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 115.938 -0.574 . . . . 10.78 110.038 178.545 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' D' D ' 69' ' ' VAL . . . . . . . . . . . . . 40.9 t -96.3 136.51 26.93 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.317 0 CA-C-N 116.321 -0.399 . . . . 7.93 110.507 -177.822 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' D' D ' 70' ' ' THR . . . . . . . . . . . . . 29.6 p -139.23 -47.89 0.48 Allowed 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 115.93 -0.577 . . . . 7.09 110.558 179.299 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' D' D ' 71' ' ' HIS . . . . . . . . . . . . . 32.3 m-70 -127.05 99.08 29.15 Favored Pre-proline 0 CA--C 1.533 0.305 0 CA-C-N 116.044 -0.526 . . . . 7.29 110.324 -178.833 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' D' D ' 72' ' ' PRO . . . . . . . . . . . . . 19.3 Cg_exo -64.93 -29.93 57.7 Favored 'Trans proline' 0 N--CA 1.497 1.691 0 C-N-CA 121.277 1.318 . . . . 2.9 112.328 -177.689 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' D' D ' 73' ' ' VAL . . . . . . . . . . . . . 34.9 m -136.38 158.56 38.05 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.232 0 CA-C-O 120.841 0.353 . . . . 1.1 110.578 177.377 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' D' D ' 74' ' ' ASP . . . . . . . . . . . . . 21.5 t70 -100.57 118.49 36.85 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.088 -0.506 . . . . 0.93 109.947 179.648 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' D' D ' 75' ' ' VAL . . . . . . . . . . . . . 43.9 t -113.97 122.38 67.97 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.213 0 CA-C-O 121.118 0.485 . . . . 0.71 110.555 -177.654 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' D' D ' 76' ' ' LEU . . . . . . . . . . . . . 14.1 mt -125.92 138.26 53.76 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 115.52 -0.764 . . . . 1.2 109.059 175.77 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' D' D ' 77' ' ' GLU . . . . . . . . . . . . . 73.3 tt0 -136.43 141.93 43.62 Favored 'General case' 0 C--N 1.332 -0.17 0 CA-C-O 121.118 0.485 . . . . 1.29 111.591 -173.762 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' D' D ' 78' ' ' ALA . . . . . . . . . . . . . . . -127.88 145.12 51.05 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 115.52 -0.764 . . . . 0.68 109.94 177.476 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' D' D ' 79' ' ' LYS . . . . . 0.563 ' O ' HD13 ' D' ' 80' ' ' ILE . 45.8 mttm -81.48 123.86 28.97 Favored 'General case' 0 C--N 1.331 -0.234 0 C-N-CA 120.753 -0.379 . . . . 3.12 110.688 178.913 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' D' D ' 80' ' ' ILE . . . . . 0.563 HD13 ' O ' ' D' ' 79' ' ' LYS . 42.8 mm -138.46 113.7 9.23 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.343 0 N-CA-C 109.212 -0.662 . . . . 0.59 109.212 -179.15 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' D' D ' 81' ' ' LYS . . . . . . . . . . . . . 58.6 mttp -102.04 121.94 43.14 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-O 120.784 0.326 . . . . 3.19 111.243 -176.536 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' D' D ' 82' ' ' GLY . . . . . . . . . . . . . . . 89.07 42.14 5.69 Favored Glycine 0 CA--C 1.525 0.702 0 C-N-CA 120.935 -0.65 . . . . 0.48 112.006 173.702 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' D' D ' 83' ' ' ILE . . . . . . . . . . . . . 76.3 mt -65.69 136.93 25.88 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.257 0 N-CA-C 109.765 -0.457 . . . . 0.52 109.765 177.113 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' D' D ' 84' ' ' LYS . . . . . . . . . . . . . 55.2 tttp -98.66 -53.63 3.25 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.21 -0.45 . . . . 1.6 110.275 -178.757 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' D' D ' 85' ' ' ASP . . . . . . . . . . . . . 20.9 t0 -152.86 149.72 28.57 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 115.755 -0.657 . . . . 0.83 110.28 -179.756 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' D' D ' 86' ' ' VAL . . . . . . . . . . . . . 40.5 t -133.79 131.16 56.42 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.286 0 CA-C-O 120.973 0.416 . . . . 0.47 110.56 -179.702 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' D' D ' 87' ' ' ILE . . . . . . . . . . . . . 45.3 mm -119.85 129.54 75.27 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.243 0 CA-C-N 115.795 -0.639 . . . . 1.31 109.695 176.857 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' D' D ' 88' ' ' LEU . . . . . 0.503 HD22 HG12 ' C' ' 131' ' ' VAL . 17.0 tp -112.6 135.75 52.96 Favored 'General case' 0 C--N 1.331 -0.203 0 CA-C-O 121.083 0.468 . . . . 1.72 111.289 -177.354 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' D' D ' 89' ' ' ASP . . . . . . . . . . . . . 20.6 t70 -128.62 155.11 45.48 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 115.545 -0.752 . . . . 0.88 109.253 174.587 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' D' D ' 90' ' ' GLU . . . . . . . . . . . . . 82.6 tt0 -46.97 -39.95 13.43 Favored 'General case' 0 C--N 1.33 -0.243 0 N-CA-C 112.964 0.727 . . . . 2.54 112.964 -171.887 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' D' D ' 91' ' ' ASN . . . . . . . . . . . . . 7.4 t-20 -132.07 37.85 3.55 Favored 'General case' 0 N--CA 1.463 0.189 0 CA-C-O 120.836 0.351 . . . . 2.21 111.437 -177.223 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' D' D ' 92' ' ' LEU . . . . . . . . . . . . . 11.7 tp -166.09 140.37 4.43 Favored 'General case' 0 C--N 1.33 -0.246 0 C-N-CA 121.01 -0.276 . . . . 1.41 110.602 -179.038 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' D' D ' 93' ' ' ILE . . . . . . . . . . . . . 71.3 mt -124.14 122.62 64.75 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.188 0 N-CA-C 109.653 -0.499 . . . . 0.47 109.653 178.679 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' D' D ' 94' ' ' VAL . . . . . 0.706 HG21 HG11 ' D' ' 125' ' ' VAL . 42.9 t -120.77 125.07 73.64 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.214 0 N-CA-C 109.901 -0.407 . . . . 0.44 109.901 179.52 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' D' D ' 95' ' ' VAL . . . . . . . . . . . . . 42.9 t -123.88 135.16 64.42 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.25 0 CA-C-N 116.097 -0.502 . . . . 0.38 110.109 -178.448 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' D' D ' 96' ' ' ILE . . . . . . . . . . . . . 58.3 mt -116.59 128.49 73.94 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.28 0 N-CA-C 109.256 -0.646 . . . . 0.51 109.256 178.37 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' D' D ' 97' ' ' THR . . . . . . . . . . . . . 81.2 p -103.7 155.79 18.3 Favored 'General case' 0 C--N 1.331 -0.222 0 CA-C-O 121.356 0.598 . . . . 0.48 111.561 -176.74 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' D' D ' 98' ' ' GLU . . . . . . . . . . . . . 84.8 tt0 -54.0 -27.26 30.6 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 115.836 -0.62 . . . . 2.67 112.191 179.504 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' D' D ' 99' ' ' GLU . . . . . . . . . . . . . 46.0 mp0 -78.93 16.2 0.94 Allowed 'General case' 0 CA--C 1.536 0.406 0 N-CA-C 113.123 0.786 . . . . 2.3 113.123 -177.474 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' D' D ' 100' ' ' ASN . . . . . . . . . . . . . 1.8 m-20 63.59 37.34 10.37 Favored 'General case' 0 CA--C 1.529 0.147 0 CA-C-O 121.007 0.432 . . . . 0.62 110.945 176.757 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' D' D ' 101' ' ' GLU . . . . . . . . . . . . . 84.9 tt0 -116.52 144.69 44.03 Favored 'General case' 0 C--N 1.332 -0.157 0 CA-C-N 116.187 -0.461 . . . . 1.1 109.892 176.88 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' D' D ' 102' ' ' VAL . . . . . . . . . . . . . 46.7 t -114.98 125.36 72.28 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.32 0 CA-C-N 116.116 -0.493 . . . . 0.43 109.815 -179.206 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' D' D ' 103' ' ' LEU . . . . . 0.408 HD23 ' HG3' ' D' ' 114' ' ' ARG . 19.2 mt -117.36 128.93 55.52 Favored 'General case' 0 C--N 1.331 -0.219 0 CA-C-N 115.789 -0.642 . . . . 0.97 110.19 178.08 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' D' D ' 104' ' ' ILE . . . . . . . . . . . . . 71.9 mt -119.09 120.69 64.68 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.278 0 N-CA-C 110.042 -0.355 . . . . 0.39 110.042 177.807 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' D' D ' 105' ' ' PHE . . . . . . . . . . . . . 97.4 m-85 -118.47 161.23 20.34 Favored 'General case' 0 C--N 1.332 -0.187 0 O-C-N 124.084 0.865 . . . . 0.42 110.129 -178.627 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' D' D ' 106' ' ' ASN . . . . . . . . . . . . . 18.4 p-10 -93.26 -170.63 2.44 Favored 'General case' 0 C--N 1.329 -0.315 0 N-CA-C 109.805 -0.443 . . . . 0.53 109.805 172.278 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' D' D ' 107' ' ' GLN . . . . . . . . . . . . . 48.8 tt0 -59.63 -30.2 68.54 Favored 'General case' 0 C--N 1.328 -0.336 0 N-CA-C 112.0 0.37 . . . . 1.77 112.0 -179.849 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' D' D ' 108' ' ' ASN . . . . . . . . . . . . . 13.1 t30 -85.55 8.29 19.86 Favored 'General case' 0 CA--C 1.536 0.428 0 N-CA-C 113.293 0.849 . . . . 1.37 113.293 -177.292 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' D' D ' 109' ' ' LEU . . . . . . . . . . . . . 13.6 tp 61.97 43.76 8.84 Favored 'General case' 0 C--N 1.332 -0.18 0 CA-C-O 121.377 0.608 . . . . 1.37 110.854 178.797 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' D' D ' 110' ' ' GLU . . . . . . . . . . . . . 77.7 mm-40 -114.23 143.66 44.48 Favored 'General case' 0 C--N 1.331 -0.224 0 CA-C-N 116.035 -0.53 . . . . 2.08 109.998 176.557 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' D' D ' 111' ' ' GLU . . . . . . . . . . . . . 96.3 mt-10 -72.03 123.02 21.9 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-O 120.908 0.385 . . . . 1.92 111.197 -177.392 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' D' D ' 112' ' ' LEU . . . . . . . . . . . . . 12.3 mt -108.09 -44.89 4.06 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 115.932 -0.576 . . . . 0.62 109.795 175.0 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' D' D ' 113' ' ' TYR . . . . . . . . . . . . . 71.9 t80 -136.62 132.32 34.9 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 115.969 -0.56 . . . . 0.58 110.549 178.785 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' D' D ' 114' ' ' ARG . . . . . 0.408 ' HG3' HD23 ' D' ' 103' ' ' LEU . 56.3 ttp180 -139.74 121.75 15.66 Favored 'General case' 0 C--N 1.331 -0.225 0 CA-C-O 120.823 0.344 . . . . 3.47 110.498 178.662 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' D' D ' 115' ' ' GLY . . . . . . . . . . . . . . . -150.12 163.07 29.39 Favored Glycine 0 CA--C 1.524 0.604 0 N-CA-C 110.949 -0.86 . . . . 0.52 110.949 179.779 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' D' D ' 116' ' ' LYS . . . . . . . . . . . . . 40.2 ttpt -128.84 138.1 51.86 Favored 'General case' 0 C--N 1.331 -0.237 0 N-CA-C 110.098 -0.334 . . . . 1.54 110.098 177.84 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' D' D ' 117' ' ' PHE . . . . . . . . . . . . . 42.6 m-85 -135.81 113.89 11.34 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-N 116.334 -0.394 . . . . 0.55 110.148 -177.757 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' D' D ' 118' ' ' GLU . . . . . . . . . . . . . 96.9 mt-10 -56.97 -43.74 81.93 Favored 'General case' 0 C--N 1.328 -0.338 0 C-N-CA 120.883 -0.327 . . . . 2.59 110.832 -177.0 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' D' D ' 119' ' ' ASN . . . . . . . . . . . . . 10.1 m120 -96.44 30.98 2.36 Favored 'General case' 0 C--N 1.328 -0.349 0 N-CA-C 112.116 0.413 . . . . 1.6 112.116 -174.765 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' D' D ' 120' ' ' LEU . . . . . . . . . . . . . 20.2 tp -57.7 120.0 7.61 Favored 'General case' 0 N--CA 1.461 0.104 0 N-CA-C 110.009 -0.367 . . . . 0.63 110.009 176.854 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' D' D ' 121' ' ' ASN . . . . . . . . . . . . . 8.4 t-20 -111.95 -44.1 3.5 Favored 'General case' 0 C--N 1.332 -0.156 0 CA-C-N 116.597 -0.274 . . . . 2.02 111.132 -175.423 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' D' D ' 122' ' ' LYS . . . . . . . . . . . . . 98.4 mttt -143.82 145.17 32.15 Favored 'General case' 0 C--N 1.33 -0.274 0 C-N-CA 120.691 -0.404 . . . . 1.81 111.728 -177.316 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' D' D ' 123' ' ' VAL . . . . . . . . . . . . . 45.0 t -127.92 128.73 69.41 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.295 0 N-CA-C 109.383 -0.599 . . . . 0.62 109.383 175.318 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' D' D ' 124' ' ' LEU . . . . . . . . . . . . . 8.2 tp -130.81 134.73 47.09 Favored 'General case' 0 C--N 1.332 -0.179 0 CA-C-O 120.932 0.396 . . . . 1.62 110.367 -178.292 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' D' D ' 125' ' ' VAL . . . . . 0.706 HG11 HG21 ' D' ' 94' ' ' VAL . 35.1 m -130.66 137.53 55.87 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.208 0 CA-C-N 116.251 -0.431 . . . . 1.73 110.991 -178.551 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' D' D ' 126' ' ' ARG . . . . . . . . . . . . . 96.7 mtt-85 -148.71 119.21 7.4 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 115.947 -0.57 . . . . 3.32 109.934 176.097 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' D' D ' 127' ' ' ASN . . . . . . . . . . . . . 2.0 t30 56.29 -149.06 0.47 Allowed 'General case' 0 CA--C 1.541 0.632 0 N-CA-C 109.723 -0.473 . . . . 2.38 109.723 179.669 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' D' D ' 128' ' ' ASP . . . . . . . . . . . . . 11.8 p-10 -80.43 13.06 2.61 Favored 'General case' 0 CA--C 1.537 0.444 0 CA-C-N 118.78 0.718 . . . . 1.18 112.93 -179.993 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' D' D ' 129' ' ' LEU . . . . . . . . . . . . . 15.7 tp -110.02 133.15 53.5 Favored 'General case' 0 C--O 1.232 0.175 0 CA-C-N 118.217 0.462 . . . . 1.83 110.085 178.423 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' D' D ' 130' ' ' VAL . . . . . . . . . . . . . 41.4 t -122.65 139.81 48.37 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.308 0 CA-C-N 116.578 -0.283 . . . . 1.36 110.498 -176.987 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' D' D ' 131' ' ' VAL . . . . . 0.413 HG22 HD12 ' D' ' 140' ' ' LEU . 40.7 t -133.93 134.86 55.62 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.192 0 CA-C-O 121.087 0.47 . . . . 0.64 110.484 177.536 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' D' D ' 132' ' ' ILE . . . . . . . . . . . . . 72.3 mt -117.95 134.07 62.74 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.269 0 CA-C-N 115.61 -0.723 . . . . 0.49 109.424 179.294 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' D' D ' 133' ' ' ILE . . . . . . . . . . . . . 29.7 mm -115.35 120.57 65.06 Favored 'Isoleucine or valine' 0 C--O 1.234 0.262 0 CA-C-N 116.5 -0.318 . . . . 0.52 110.763 -175.254 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' D' D ' 134' ' ' ASP . . . . . . . . . . . . . 5.6 p-10 -136.41 148.14 47.63 Favored 'General case' 0 C--N 1.331 -0.203 0 CA-C-N 116.327 -0.397 . . . . 0.59 109.946 176.331 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' D' D ' 135' ' ' GLU . . . . . . . . . . . . . 84.6 tt0 -49.85 -28.46 6.51 Favored 'General case' 0 C--O 1.236 0.352 0 N-CA-C 112.582 0.586 . . . . 1.68 112.582 -175.277 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' D' D ' 136' ' ' GLN . . . . . . . . . . . . . 94.8 mt-30 -78.26 -36.12 47.29 Favored 'General case' 0 C--N 1.331 -0.223 0 N-CA-C 112.414 0.524 . . . . 2.43 112.414 -176.458 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' D' D ' 137' ' ' LYS . . . . . . . . . . . . . 35.3 pttt -170.06 177.0 4.44 Favored 'General case' 0 C--O 1.233 0.217 0 CA-C-O 121.827 0.822 . . . . 1.39 113.117 -170.821 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' D' D ' 138' ' ' LEU . . . . . . . . . . . . . 9.5 tp -113.18 129.2 56.59 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 114.233 -1.348 . . . . 0.76 109.797 178.311 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' D' D ' 139' ' ' THR . . . . . . . . . . . . . 36.9 m -112.09 126.02 54.73 Favored 'General case' 0 C--N 1.331 -0.22 0 CA-C-O 120.673 0.273 . . . . 0.47 110.616 179.197 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' D' D ' 140' ' ' LEU . . . . . 0.413 HD12 HG22 ' D' ' 131' ' ' VAL . 17.1 tp -115.01 124.28 51.23 Favored 'General case' 0 C--N 1.329 -0.299 0 N-CA-C 108.905 -0.776 . . . . 1.08 108.905 179.261 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' D' D ' 141' ' ' ILE . . . . . . . . . . . . . 20.0 mt -119.91 118.54 57.37 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.375 0 N-CA-C 109.808 -0.441 . . . . 0.53 109.808 -175.796 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' D' D ' 142' ' ' ARG . . . . . . . . . . . . . 74.3 ttt180 -109.75 124.02 50.53 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-N 115.141 -0.936 . . . . 2.96 110.453 -175.472 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' D' D ' 143' ' ' THR . . . . . . . . . . . . . 22.6 p . . . . . 0 C--O 1.22 -0.485 0 CA-C-O 118.015 -0.993 . . . . 1.86 110.601 -179.75 . . . . . . . . 0 0 . 1 . 001 nuclear nobuild full ' E' E ' -3' ' ' GLU . . . . . . . . . . . . . 95.1 mt-10 . . . . . 0 N--CA 1.491 1.592 0 N-CA-C 109.16 -0.682 . . . . 32.09 109.16 . . . . . . . . . 0 0 . 1 . 001 nuclear nobuild full ' E' E ' -2' ' ' GLY . . . . . . . . . . . . . . . -72.83 133.67 19.28 Favored Glycine 0 CA--C 1.523 0.58 0 N-CA-C 110.641 -0.984 . . . . 28.09 110.641 178.247 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' E' E ' -1' ' ' VAL . . . . . . . . . . . . . 46.3 t -90.46 130.88 38.98 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.363 0 CA-C-O 120.916 0.389 . . . . 25.41 110.088 -178.953 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' E' E ' 0' ' ' ILE . . . . . . . . . . . . . 72.7 mt -115.85 127.19 73.53 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.278 0 CA-C-N 115.959 -0.564 . . . . 24.25 109.511 178.588 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' E' E ' 1' ' ' MET . . . . . . . . . . . . . 16.3 ptt? -84.01 153.5 23.82 Favored 'General case' 0 C--N 1.329 -0.305 0 C-N-CA 120.818 -0.353 . . . . 20.31 110.586 -178.3 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' E' E ' 2' ' ' SER . . . . . . . . . . . . . 2.0 p -113.04 122.96 49.17 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-O 121.075 0.464 . . . . 17.92 110.299 177.715 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' E' E ' 3' ' ' GLU . . . . . . . . . . . . . 85.0 tt0 -140.33 139.14 35.37 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-N 115.711 -0.677 . . . . 15.6 110.869 -178.485 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' E' E ' 4' ' ' LEU . . . . . 0.428 HD21 HD21 ' E' ' 6' ' ' LEU . 18.8 tp -122.56 126.34 47.55 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 115.987 -0.551 . . . . 14.43 110.154 177.248 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' E' E ' 5' ' ' LYS . . . . . . . . . . . . . 91.4 mttt -103.43 120.31 40.58 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.238 -0.437 . . . . 11.5 110.319 178.028 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' E' E ' 6' ' ' LEU . . . . . 0.43 HD23 ' HA ' ' E' ' 50' ' ' VAL . 69.6 mt -118.32 149.9 40.4 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 115.565 -0.743 . . . . 12.06 110.437 -178.68 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' E' E ' 7' ' ' LYS . . . . . . . . . . . . . 59.8 tttm -135.67 141.69 38.06 Favored Pre-proline 0 CA--C 1.534 0.351 0 CA-C-O 119.192 -0.432 . . . . 10.04 110.039 176.976 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' E' E ' 8' ' ' PRO . . . . . . . . . . . . . 75.1 Cg_endo -88.52 136.97 3.39 Favored 'Trans proline' 0 N--CA 1.49 1.295 0 C-N-CA 121.643 1.562 . . . . 9.88 111.568 178.924 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' E' E ' 9' ' ' LEU . . . . . . . . . . . . . 81.8 mt -77.72 -52.17 1.7 Allowed Pre-proline 0 C--N 1.33 -0.258 0 CA-C-O 119.057 -0.497 . . . . 13.89 111.587 -177.95 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' E' E ' 10' ' ' PRO . . . . . . . . . . . . . 57.2 Cg_endo -73.19 148.3 43.9 Favored 'Trans proline' 0 N--CA 1.496 1.67 0 C-N-CA 121.049 1.166 . . . . 13.57 111.439 172.399 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' E' E ' 11' ' ' LYS . . . . . . . . . . . . . 63.9 mttp -82.91 97.34 8.63 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-O 120.84 0.352 . . . . 12.82 110.853 -179.124 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' E' E ' 12' ' ' VAL . . . . . . . . . . . . . 12.3 p -142.72 144.25 24.6 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.334 0 CA-C-N 116.09 -0.505 . . . . 14.34 110.422 178.802 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' E' E ' 13' ' ' GLU . . . . . . . . . . . . . 85.0 tt0 -87.0 129.39 34.9 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.312 -0.403 . . . . 14.37 109.947 177.539 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' E' E ' 14' ' ' LEU . . . . . . . . . . . . . 21.3 mt -91.36 148.19 37.07 Favored Pre-proline 0 CA--C 1.533 0.309 0 C-N-CA 120.804 -0.358 . . . . 13.43 110.51 -176.701 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' E' E ' 15' ' ' PRO . . . . . . . . . . . . . 26.5 Cg_exo -62.22 161.2 27.62 Favored 'Trans proline' 0 N--CA 1.496 1.632 0 C-N-CA 121.321 1.348 . . . . 15.98 111.84 175.497 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' E' E ' 16' ' ' PRO . . . . . . . . . . . . . 35.7 Cg_exo -59.08 -31.88 96.38 Favored 'Trans proline' 0 N--CA 1.496 1.673 0 C-N-CA 121.45 1.433 . . . . 15.78 112.704 -178.779 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' E' E ' 17' ' ' ASP . . . . . . . . . . . . . 3.0 p30 -93.58 8.5 40.54 Favored 'General case' 0 CA--C 1.535 0.403 0 N-CA-C 113.302 0.853 . . . . 17.13 113.302 -176.847 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' E' E ' 18' ' ' PHE . . . . . . . . . . . . . 47.4 t80 -57.93 -44.47 86.93 Favored 'General case' 0 C--N 1.334 -0.105 0 CA-C-N 118.098 0.408 . . . . 14.38 110.184 -178.074 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' E' E ' 19' ' ' VAL . . . . . . . . . . . . . 47.8 t -57.35 -42.95 81.44 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 CA-C-N 116.311 -0.404 . . . . 13.57 110.345 -178.624 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' E' E ' 20' ' ' ASP . . . . . . . . . . . . . 8.5 m-20 -59.2 -41.98 89.86 Favored 'General case' 0 C--N 1.329 -0.32 0 C-N-CA 120.85 -0.34 . . . . 15.68 110.554 -178.268 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' E' E ' 21' ' ' VAL . . . . . . . . . . . . . 47.1 t -64.78 -46.78 91.03 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.347 0 C-N-CA 120.829 -0.348 . . . . 17.06 110.612 -178.079 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' E' E ' 22' ' ' ILE . . . . . 0.655 HG22 HD12 ' E' ' 26' ' ' LEU . 48.3 mm -61.22 -34.65 61.48 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 C-N-CA 120.981 -0.287 . . . . 15.74 111.253 -178.303 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' E' E ' 23' ' ' ARG . . . . . . . . . . . . . 58.3 ttp180 -60.52 -51.58 68.82 Favored 'General case' 0 C--N 1.331 -0.235 0 C-N-CA 120.537 -0.465 . . . . 16.75 110.164 176.135 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' E' E ' 24' ' ' ILE . . . . . . . . . . . . . 78.5 mt -60.76 -39.3 81.3 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.323 0 CA-C-N 115.968 -0.56 . . . . 18.88 111.985 -176.467 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' E' E ' 25' ' ' LYS . . . . . . . . . . . . . 11.7 ptmm? -76.67 -39.39 52.28 Favored 'General case' 0 CA--C 1.535 0.37 0 N-CA-C 112.003 0.371 . . . . 19.21 112.003 -174.615 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' E' E ' 26' ' ' LEU . . . . . 0.655 HD12 HG22 ' E' ' 22' ' ' ILE . 30.6 mt -78.82 -32.34 46.19 Favored 'General case' 0 C--N 1.332 -0.183 0 N-CA-C 113.51 0.93 . . . . 18.9 113.51 -172.267 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' E' E ' 27' ' ' GLN . . . . . . . . . . . . . 10.6 pt20 -46.69 139.02 5.57 Favored 'General case' 0 N--CA 1.471 0.593 0 N-CA-C 112.862 0.689 . . . . 20.23 112.862 -175.481 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' E' E ' 28' ' ' GLY . . . . . . . . . . . . . . . 97.17 -22.17 42.2 Favored Glycine 0 CA--C 1.534 1.245 0 CA-C-N 115.554 -0.748 . . . . 22.39 112.554 -177.284 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' E' E ' 29' ' ' LYS . . . . . . . . . . . . . 93.1 mttt -98.29 155.14 17.34 Favored 'General case' 0 C--O 1.232 0.176 0 CA-C-N 117.419 0.609 . . . . 22.36 111.136 -179.469 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' E' E ' 30' ' ' THR . . . . . . . . . . . . . 30.5 m -105.68 139.33 40.44 Favored 'General case' 0 C--N 1.332 -0.191 0 CA-C-N 116.029 -0.532 . . . . 22.55 110.341 177.659 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' E' E ' 31' ' ' VAL . . . . . . . . . . . . . 34.8 m -131.15 154.11 40.15 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.21 0 CA-C-N 116.33 -0.395 . . . . 19.56 110.821 -179.766 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' E' E ' 32' ' ' ARG . . . . . . . . . . . . . 22.2 ttp180 -136.15 151.32 49.63 Favored 'General case' 0 C--N 1.331 -0.219 0 CA-C-O 121.225 0.535 . . . . 24.48 110.439 177.004 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' E' E ' 33' ' ' THR . . . . . . . . . . . . . 41.9 m -52.78 138.64 28.75 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 116.258 -0.428 . . . . 18.58 111.417 -179.228 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' E' E ' 34' ' ' GLY . . . . . . . . . . . . . . . 98.68 -17.1 58.84 Favored Glycine 0 CA--C 1.531 1.092 0 CA-C-N 116.048 -0.524 . . . . 17.78 113.369 177.312 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' E' E ' 35' ' ' ASP . . . . . . . . . . . . . 80.9 m-20 -66.6 147.39 53.34 Favored 'General case' 0 C--O 1.231 0.129 0 CA-C-N 118.015 0.907 . . . . 20.26 111.232 179.488 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' E' E ' 36' ' ' VAL . . . . . . . . . . . . . 44.1 t -121.13 128.2 75.99 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.264 0 N-CA-C 109.443 -0.577 . . . . 18.85 109.443 175.96 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' E' E ' 37' ' ' ILE . . . . . . . . . . . . . 66.4 mt -120.32 139.72 46.71 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.271 0 CA-C-N 116.328 -0.396 . . . . 17.65 110.156 -177.96 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' E' E ' 38' ' ' GLY . . . . . . . . . . . . . . . -108.22 128.57 9.18 Favored Glycine 0 CA--C 1.524 0.653 0 N-CA-C 110.884 -0.887 . . . . 19.38 110.884 177.739 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' E' E ' 39' ' ' ILE . . . . . . . . . . . . . 74.4 mt -124.48 135.31 64.22 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.193 0 N-CA-C 110.085 -0.339 . . . . 18.73 110.085 179.479 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' E' E ' 40' ' ' SER . . . . . 0.51 ' O ' HD13 ' E' ' 41' ' ' ILE . 34.6 t -92.56 116.96 29.46 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.433 -0.349 . . . . 22.11 110.86 176.241 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' E' E ' 41' ' ' ILE . . . . . 0.51 HD13 ' O ' ' E' ' 40' ' ' SER . 48.5 mm -128.94 128.16 67.03 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.19 0 CA-C-O 120.778 0.323 . . . . 20.19 110.407 179.37 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' E' E ' 42' ' ' LEU . . . . . . . . . . . . . 56.7 mt 54.59 33.03 18.24 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.194 -0.457 . . . . 22.67 111.856 177.824 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' E' E ' 43' ' ' GLY . . . . . . . . . . . . . . . 71.16 28.74 69.68 Favored Glycine 0 CA--C 1.532 1.106 0 C-N-CA 121.109 -0.567 . . . . 23.39 112.176 177.872 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' E' E ' 44' ' ' LYS . . . . . . . . . . . . . 45.9 tttp -141.75 137.7 31.81 Favored 'General case' 0 C--N 1.33 -0.263 0 N-CA-C 109.773 -0.454 . . . . 21.45 109.773 179.464 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' E' E ' 45' ' ' GLU . . . . . . . . . . . . . 83.7 tt0 -82.36 126.64 32.4 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-O 120.934 0.397 . . . . 21.32 111.18 -176.993 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' E' E ' 46' ' ' VAL . . . . . . . . . . . . . 7.6 p -124.32 129.83 73.84 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.222 0 N-CA-C 109.367 -0.605 . . . . 17.3 109.367 175.822 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' E' E ' 47' ' ' LYS . . . . . . . . . . . . . 98.7 mttt -101.07 132.61 46.43 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.087 -0.506 . . . . 19.29 111.364 179.799 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' E' E ' 48' ' ' PHE . . . . . . . . . . . . . 92.3 m-85 -117.01 132.02 56.8 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.267 -0.424 . . . . 14.33 110.364 176.952 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' E' E ' 49' ' ' LYS . . . . . . . . . . . . . 84.6 tttt -106.78 137.28 45.11 Favored 'General case' 0 C--N 1.331 -0.23 0 CA-C-N 116.503 -0.317 . . . . 14.41 110.45 178.045 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' E' E ' 50' ' ' VAL . . . . . 0.43 ' HA ' HD23 ' E' ' 6' ' ' LEU . 44.7 t -84.29 111.13 19.68 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.258 0 N-CA-C 109.245 -0.65 . . . . 14.75 109.245 175.701 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' E' E ' 51' ' ' VAL . . . . . . . . . . . . . 46.8 t -72.66 -46.72 53.37 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.317 0 CA-C-N 116.265 -0.425 . . . . 13.28 110.053 -174.269 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' E' E ' 52' ' ' GLN . . . . . . . . . . . . . 46.9 tt0 -169.04 142.6 2.87 Favored 'General case' 0 C--N 1.331 -0.205 0 C-N-CA 120.295 -0.562 . . . . 14.71 111.776 -178.922 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' E' E ' 53' ' ' ALA . . . . . . . . . . . . . . . -116.13 135.41 53.95 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-N 115.714 -0.675 . . . . 17.09 110.106 176.589 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' E' E ' 54' ' ' TYR . . . . . . . . . . . . . 62.5 t80 -128.94 109.23 18.34 Favored Pre-proline 0 CA--C 1.536 0.427 0 CA-C-O 118.26 -0.876 . . . . 20.27 110.181 178.688 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' E' E ' 55' ' ' PRO . . . . . . . . . . . . . 74.0 Cg_endo -77.09 170.06 72.65 Favored 'Cis proline' 0 N--CA 1.499 1.826 0 CA-C-N 121.81 1.682 . . . . 20.84 112.445 -4.544 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' E' E ' 56' ' ' SER . . . . . . . . . . . . . 13.6 m -113.99 126.96 27.34 Favored Pre-proline 0 CA--C 1.538 0.498 0 CA-C-O 118.405 -0.807 . . . . 22.33 109.476 176.28 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' E' E ' 57' ' ' PRO . . . . . . . . . . . . . 56.9 Cg_endo -72.64 169.04 73.39 Favored 'Cis proline' 0 N--CA 1.497 1.704 0 CA-C-N 122.083 1.78 . . . . 23.32 111.848 -0.096 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' E' E ' 58' ' ' LEU . . . . . . . . . . . . . 28.9 tp -130.0 137.7 50.42 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.139 -0.482 . . . . 19.78 110.294 179.95 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' E' E ' 59' ' ' ARG . . . . . . . . . . . . . 52.2 ttp180 -105.19 128.75 53.55 Favored 'General case' 0 C--N 1.328 -0.35 0 N-CA-C 109.239 -0.652 . . . . 24.23 109.239 176.106 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' E' E ' 60' ' ' VAL . . . . . . . . . . . . . 41.9 t -85.39 119.08 33.38 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.272 0 C-N-CA 120.607 -0.437 . . . . 18.94 110.919 -173.992 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' E' E ' 61' ' ' GLU . . . . . . . . . . . . . 47.2 mt-10 -131.03 170.11 14.94 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 115.703 -0.68 . . . . 21.28 109.492 174.29 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' E' E ' 62' ' ' ASP . . . . . . . . . . . . . 4.5 m-20 -53.23 -32.67 49.46 Favored 'General case' 0 C--N 1.329 -0.308 0 N-CA-C 111.925 0.343 . . . . 19.55 111.925 -177.609 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' E' E ' 63' ' ' ARG . . . . . . . . . . . . . 98.2 mtt180 -73.13 -22.0 60.62 Favored 'General case' 0 CA--C 1.533 0.289 0 N-CA-C 113.038 0.755 . . . . 21.98 113.038 -176.188 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' E' E ' 64' ' ' THR . . . . . . . . . . . . . 26.7 m -66.42 137.24 56.71 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-O 120.983 0.42 . . . . 17.14 111.061 -174.692 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' E' E ' 65' ' ' LYS . . . . . . . . . . . . . 67.5 mttm -89.71 129.79 36.08 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 115.927 -0.579 . . . . 16.15 109.967 177.207 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' E' E ' 66' ' ' ILE . . . . . . . . . . . . . 63.2 mt -118.83 129.57 74.86 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.287 0 N-CA-C 109.849 -0.426 . . . . 13.46 109.849 -179.775 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' E' E ' 67' ' ' THR . . . . . . . . . . . . . 25.9 m -127.38 139.82 52.59 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-O 120.95 0.405 . . . . 10.58 110.994 -178.165 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' E' E ' 68' ' ' LEU . . . . . . . . . . . . . 65.4 mt -104.95 131.32 52.6 Favored 'General case' 0 C--N 1.331 -0.226 0 CA-C-N 116.056 -0.52 . . . . 8.76 110.528 177.912 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' E' E ' 69' ' ' VAL . . . . . . . . . . . . . 42.0 t -102.83 125.64 57.16 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.334 0 CA-C-N 116.33 -0.396 . . . . 7.11 110.205 179.024 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' E' E ' 70' ' ' THR . . . . . . . . . . . . . 10.2 t -150.05 149.78 30.81 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.042 -0.527 . . . . 5.99 110.319 177.711 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' E' E ' 71' ' ' HIS . . . . . . . . . . . . . 83.1 t60 -141.88 69.79 24.22 Favored Pre-proline 0 CA--C 1.535 0.4 0 C-N-CA 120.858 -0.337 . . . . 6.64 111.135 -179.447 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' E' E ' 72' ' ' PRO . . . . . . . . . . . . . 64.8 Cg_endo -91.38 160.04 3.68 Favored 'Trans proline' 0 N--CA 1.488 1.194 0 C-N-CA 121.861 1.707 . . . . 2.87 111.606 174.16 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' E' E ' 73' ' ' VAL . . . . . . . . . . . . . 26.9 m -105.0 154.59 6.43 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.163 0 CA-C-O 120.972 0.415 . . . . 1.03 110.452 179.161 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' E' E ' 74' ' ' ASP . . . . . . . . . . . . . 21.6 t0 -96.08 119.91 35.42 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 115.907 -0.588 . . . . 0.96 109.544 179.853 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' E' E ' 75' ' ' VAL . . . . . . . . . . . . . 41.8 t -107.54 119.32 56.93 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.268 0 CA-C-O 121.071 0.462 . . . . 0.72 110.233 -178.973 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' E' E ' 76' ' ' LEU . . . . . . . . . . . . . 34.8 mt -115.11 137.86 51.54 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 115.592 -0.731 . . . . 1.25 109.435 177.232 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' E' E ' 77' ' ' GLU . . . . . . . . . . . . . 98.0 mt-10 -134.06 131.45 38.84 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-O 121.064 0.459 . . . . 1.17 111.061 -177.769 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' E' E ' 78' ' ' ALA . . . . . . . . . . . . . . . -119.1 124.07 45.99 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 115.654 -0.703 . . . . 0.61 109.625 176.419 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' E' E ' 79' ' ' LYS . . . . . 0.606 ' O ' HD13 ' E' ' 80' ' ' ILE . 7.8 ttpm? -74.58 122.82 23.73 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-O 120.876 0.369 . . . . 2.97 110.615 -177.162 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' E' E ' 80' ' ' ILE . . . . . 0.606 HD13 ' O ' ' E' ' 79' ' ' LYS . 39.6 mm -139.06 113.72 7.84 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.298 0 N-CA-C 109.009 -0.737 . . . . 0.63 109.009 -178.443 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' E' E ' 81' ' ' LYS . . . . . . . . . . . . . 29.2 tttp -98.94 118.12 35.0 Favored 'General case' 0 C--N 1.327 -0.397 0 CA-C-N 116.524 -0.307 . . . . 2.98 110.646 -175.381 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' E' E ' 82' ' ' GLY . . . . . . . . . . . . . . . 89.16 42.32 5.62 Favored Glycine 0 CA--C 1.527 0.818 0 C-N-CA 120.421 -0.895 . . . . 0.62 112.058 175.282 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' E' E ' 83' ' ' ILE . . . . . . . . . . . . . 77.1 mt -61.67 142.37 16.37 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.293 0 N-CA-C 109.704 -0.48 . . . . 0.62 109.704 175.994 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' E' E ' 84' ' ' LYS . . . . . . . . . . . . . 84.9 tttt -98.68 -54.02 3.14 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.11 -0.495 . . . . 1.64 110.536 -178.293 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' E' E ' 85' ' ' ASP . . . . . . . . . . . . . 11.6 t70 -156.37 155.67 32.58 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 115.769 -0.651 . . . . 0.83 110.254 -178.912 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' E' E ' 86' ' ' VAL . . . . . . . . . . . . . 43.5 t -129.28 130.86 67.86 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.268 0 CA-C-O 121.048 0.451 . . . . 0.58 110.622 -178.308 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' E' E ' 87' ' ' ILE . . . . . . . . . . . . . 44.1 mm -118.74 122.81 70.34 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.281 0 CA-C-N 115.651 -0.704 . . . . 1.46 109.249 175.653 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' E' E ' 88' ' ' LEU . . . . . . . . . . . . . 14.4 tp -115.03 131.7 56.84 Favored 'General case' 0 C--N 1.331 -0.217 0 CA-C-O 121.014 0.435 . . . . 1.69 111.256 -176.072 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' E' E ' 89' ' ' ASP . . . . . . . . . . . . . 21.3 t70 -125.5 154.41 42.12 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 115.788 -0.642 . . . . 0.91 109.472 175.427 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' E' E ' 90' ' ' GLU . . . . . . . . . . . . . 48.1 mt-10 -49.46 -34.43 16.79 Favored 'General case' 0 C--N 1.328 -0.336 0 N-CA-C 112.845 0.683 . . . . 2.25 112.845 -171.653 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' E' E ' 91' ' ' ASN . . . . . . . . . . . . . 37.6 p-10 -132.0 32.2 4.07 Favored 'General case' 0 N--CA 1.466 0.33 0 N-CA-C 112.17 0.433 . . . . 2.37 112.17 -176.096 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' E' E ' 92' ' ' LEU . . . . . . . . . . . . . 16.0 tp -166.04 141.75 4.87 Favored 'General case' 0 C--N 1.329 -0.292 0 C-N-CA 120.886 -0.326 . . . . 1.45 110.668 179.56 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' E' E ' 93' ' ' ILE . . . . . . . . . . . . . 69.1 mt -121.45 121.75 65.43 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.217 0 N-CA-C 109.722 -0.473 . . . . 0.57 109.722 -179.583 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' E' E ' 94' ' ' VAL . . . . . . . . . . . . . 45.1 t -122.74 126.64 74.21 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.202 0 N-CA-C 109.969 -0.382 . . . . 0.53 109.969 179.212 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' E' E ' 95' ' ' VAL . . . . . . . . . . . . . 42.2 t -124.0 135.88 62.15 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.307 0 CA-C-N 116.276 -0.42 . . . . 0.75 110.01 -179.377 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' E' E ' 96' ' ' ILE . . . . . . . . . . . . . 59.2 mt -115.38 132.46 64.66 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.248 0 N-CA-C 109.429 -0.582 . . . . 0.54 109.429 179.408 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' E' E ' 97' ' ' THR . . . . . . . . . . . . . 68.9 p -103.56 158.92 16.03 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-O 120.906 0.384 . . . . 0.59 110.782 -179.579 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' E' E ' 98' ' ' GLU . . . . . . . . . . . . . 96.9 mt-10 -53.85 -24.21 15.04 Favored 'General case' 0 CA--C 1.533 0.327 0 N-CA-C 112.413 0.523 . . . . 2.63 112.413 -179.983 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' E' E ' 99' ' ' GLU . . . . . . . . . . . . . 95.3 mt-10 -78.43 14.36 1.27 Allowed 'General case' 0 CA--C 1.535 0.385 0 N-CA-C 113.218 0.821 . . . . 2.62 113.218 -176.7 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' E' E ' 100' ' ' ASN . . . . . . . . . . . . . 2.7 m-20 61.8 38.03 15.11 Favored 'General case' 0 N--CA 1.463 0.193 0 CA-C-O 121.148 0.499 . . . . 0.76 110.922 179.221 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' E' E ' 101' ' ' GLU . . . . . . . . . . . . . 61.2 tt0 -119.98 142.35 48.86 Favored 'General case' 0 C--N 1.331 -0.217 0 CA-C-N 116.093 -0.503 . . . . 0.85 109.673 176.404 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' E' E ' 102' ' ' VAL . . . . . . . . . . . . . 46.3 t -115.25 130.19 70.22 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.291 0 CA-C-N 116.227 -0.442 . . . . 0.49 110.162 -178.521 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' E' E ' 103' ' ' LEU . . . . . . . . . . . . . 20.0 mt -117.35 133.93 55.41 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 115.502 -0.772 . . . . 1.1 110.066 176.221 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' E' E ' 104' ' ' ILE . . . . . 0.604 HD13 HG11 ' E' ' 130' ' ' VAL . 67.0 mt -119.48 124.91 73.81 Favored 'Isoleucine or valine' 0 C--O 1.234 0.284 0 N-CA-C 110.192 -0.299 . . . . 0.49 110.192 179.912 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' E' E ' 105' ' ' PHE . . . . . . . . . . . . . 67.4 m-85 -123.92 163.4 21.39 Favored 'General case' 0 C--O 1.232 0.151 0 O-C-N 124.013 0.821 . . . . 0.56 110.182 -179.444 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' E' E ' 106' ' ' ASN . . . . . . . . . . . . . 40.1 p30 -98.39 -171.94 2.23 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.421 -0.354 . . . . 0.71 110.327 175.651 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' E' E ' 107' ' ' GLN . . . . . . . . . . . . . 59.5 tt0 -58.37 -29.53 66.08 Favored 'General case' 0 CA--C 1.534 0.329 0 N-CA-C 111.858 0.318 . . . . 1.69 111.858 178.774 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' E' E ' 108' ' ' ASN . . . . . . . . . . . . . 7.5 t-20 -83.24 10.95 7.29 Favored 'General case' 0 CA--C 1.536 0.422 0 N-CA-C 112.933 0.716 . . . . 1.39 112.933 -177.729 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' E' E ' 109' ' ' LEU . . . . . . . . . . . . . 12.5 tp 54.82 37.66 28.91 Favored 'General case' 0 C--N 1.332 -0.169 0 CA-C-O 121.023 0.44 . . . . 1.41 111.08 -179.509 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' E' E ' 110' ' ' GLU . . . . . . . . . . . . . 95.4 mt-10 -104.78 145.91 29.7 Favored 'General case' 0 C--N 1.331 -0.224 0 N-CA-C 109.704 -0.48 . . . . 1.89 109.704 175.275 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' E' E ' 111' ' ' GLU . . . . . . . . . . . . . 80.2 tt0 -83.69 122.15 28.24 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.401 -0.363 . . . . 1.32 110.747 -175.783 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' E' E ' 112' ' ' LEU . . . . . . . . . . . . . 49.4 mt -109.14 -45.26 3.79 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-N 116.095 -0.502 . . . . 0.64 111.128 -179.275 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' E' E ' 113' ' ' TYR . . . . . . . . . . . . . 58.0 t80 -132.96 137.58 46.62 Favored 'General case' 0 N--CA 1.464 0.238 0 CA-C-O 120.839 0.352 . . . . 0.47 111.36 -176.828 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' E' E ' 114' ' ' ARG . . . . . . . . . . . . . 47.5 ttp180 -138.73 123.66 18.88 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 115.831 -0.622 . . . . 2.83 110.123 177.361 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' E' E ' 115' ' ' GLY . . . . . . . . . . . . . . . -150.14 140.09 7.78 Favored Glycine 0 CA--C 1.526 0.719 0 C-N-CA 120.737 -0.744 . . . . 0.48 111.356 178.732 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' E' E ' 116' ' ' LYS . . . . . . . . . . . . . 27.5 ttpp -110.37 134.59 52.15 Favored 'General case' 0 C--N 1.33 -0.24 0 N-CA-C 109.748 -0.464 . . . . 1.84 109.748 176.618 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' E' E ' 117' ' ' PHE . . . . . . . . . . . . . 31.7 m-85 -135.57 113.9 11.52 Favored 'General case' 0 C--N 1.332 -0.191 0 C-N-CA 120.871 -0.331 . . . . 0.59 110.158 -176.817 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' E' E ' 118' ' ' GLU . . . . . . . . . . . . . 96.3 mt-10 -55.59 -45.71 77.36 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.519 -0.31 . . . . 2.45 111.176 -176.191 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' E' E ' 119' ' ' ASN . . . . . . . . . . . . . 68.3 m-80 -95.99 30.0 2.56 Favored 'General case' 0 C--N 1.329 -0.287 0 N-CA-C 112.22 0.452 . . . . 1.54 112.22 -174.172 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' E' E ' 120' ' ' LEU . . . . . . . . . . . . . 22.0 tp -58.39 122.13 12.54 Favored 'General case' 0 C--N 1.333 -0.149 0 N-CA-C 110.027 -0.36 . . . . 0.64 110.027 177.509 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' E' E ' 121' ' ' ASN . . . . . . . . . . . . . 68.2 m-20 -113.99 -44.07 3.19 Favored 'General case' 0 C--O 1.232 0.147 0 CA-C-N 116.534 -0.303 . . . . 1.89 111.094 -178.081 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' E' E ' 122' ' ' LYS . . . . . . . . . . . . . 60.7 mttm -145.1 149.51 35.16 Favored 'General case' 0 C--N 1.332 -0.18 0 CA-C-O 121.28 0.562 . . . . 1.81 112.064 -177.028 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' E' E ' 123' ' ' VAL . . . . . . . . . . . . . 47.3 t -126.68 129.66 71.59 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.239 0 CA-C-N 115.627 -0.715 . . . . 0.54 109.461 175.536 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' E' E ' 124' ' ' LEU . . . . . . . . . . . . . 57.6 mt -121.98 139.56 53.53 Favored 'General case' 0 N--CA 1.463 0.212 0 CA-C-N 116.551 -0.295 . . . . 1.39 110.792 -178.114 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' E' E ' 125' ' ' VAL . . . . . 0.585 HG12 HG23 ' E' ' 130' ' ' VAL . 34.3 m -137.23 139.87 43.25 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.239 0 CA-C-O 121.042 0.448 . . . . 1.56 111.603 -178.723 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' E' E ' 126' ' ' ARG . . . . . . . . . . . . . 93.4 mtt-85 -147.77 115.57 6.41 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 115.687 -0.688 . . . . 3.5 110.19 174.207 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' E' E ' 127' ' ' ASN . . . . . . . . . . . . . 93.4 m-20 53.79 -129.92 2.21 Favored 'General case' 0 CA--C 1.545 0.786 0 CA-C-O 118.557 -0.735 . . . . 2.24 110.552 179.578 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' E' E ' 128' ' ' ASP . . . . . . . . . . . . . 5.1 p30 -91.82 5.78 48.6 Favored 'General case' 0 CA--C 1.536 0.42 0 CA-C-N 120.078 1.308 . . . . 1.0 113.457 -178.216 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' E' E ' 129' ' ' LEU . . . . . . . . . . . . . 15.3 tp -105.41 134.51 48.41 Favored 'General case' 0 C--N 1.333 -0.115 0 CA-C-N 118.17 0.441 . . . . 1.81 109.834 178.555 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' E' E ' 130' ' ' VAL . . . . . 0.604 HG11 HD13 ' E' ' 104' ' ' ILE . 12.4 p -132.17 143.32 40.37 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.165 0 CA-C-O 121.019 0.438 . . . . 1.29 110.705 -177.943 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' E' E ' 131' ' ' VAL . . . . . 0.581 HG22 HD12 ' E' ' 140' ' ' LEU . 38.9 t -136.0 140.09 44.66 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.278 0 CA-C-N 116.034 -0.53 . . . . 0.91 110.437 -179.086 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' E' E ' 132' ' ' ILE . . . . . . . . . . . . . 76.3 mt -114.98 133.88 59.78 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.288 0 CA-C-N 115.67 -0.695 . . . . 0.53 109.472 179.515 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' E' E ' 133' ' ' ILE . . . . . . . . . . . . . 38.0 mm -116.57 119.16 61.14 Favored 'Isoleucine or valine' 0 C--O 1.236 0.345 0 CA-C-N 116.537 -0.301 . . . . 0.46 110.989 -175.58 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' E' E ' 134' ' ' ASP . . . . . . . . . . . . . 5.8 p-10 -135.21 148.5 49.65 Favored 'General case' 0 C--N 1.332 -0.167 0 N-CA-C 109.809 -0.441 . . . . 0.56 109.809 174.753 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' E' E ' 135' ' ' GLU . . . . . . . . . . . . . 44.6 tp10 -50.01 -28.06 6.41 Favored 'General case' 0 C--N 1.329 -0.323 0 N-CA-C 112.702 0.63 . . . . 2.01 112.702 -172.222 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' E' E ' 136' ' ' GLN . . . . . . . . . . . . . 95.9 mt-30 -81.98 -37.63 26.33 Favored 'General case' 0 C--O 1.234 0.272 0 N-CA-C 112.683 0.623 . . . . 2.44 112.683 -175.694 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' E' E ' 137' ' ' LYS . . . . . . . . . . . . . 20.3 pttp -160.47 169.52 22.85 Favored 'General case' 0 C--O 1.234 0.251 0 CA-C-O 121.825 0.821 . . . . 1.77 113.192 -169.801 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' E' E ' 138' ' ' LEU . . . . . . . . . . . . . 7.7 tp -111.96 127.83 55.98 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 114.085 -1.416 . . . . 0.51 109.459 177.859 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' E' E ' 139' ' ' THR . . . . . . . . . . . . . 27.3 m -113.59 123.59 50.33 Favored 'General case' 0 C--N 1.331 -0.221 0 CA-C-O 120.614 0.245 . . . . 0.42 110.39 178.699 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' E' E ' 140' ' ' LEU . . . . . 0.581 HD12 HG22 ' E' ' 131' ' ' VAL . 8.1 tp -113.36 121.39 44.21 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 115.884 -0.598 . . . . 1.01 109.44 -179.439 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' E' E ' 141' ' ' ILE . . . . . 0.514 ' HB ' HG13 ' E' ' 130' ' ' VAL . 19.4 mt -121.14 122.79 68.46 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.307 0 CA-C-O 121.053 0.454 . . . . 0.49 109.791 -176.218 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' E' E ' 142' ' ' ARG . . . . . . . . . . . . . 50.6 ttp180 -117.35 129.46 55.89 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 115.382 -0.826 . . . . 3.09 110.587 -175.51 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' E' E ' 143' ' ' THR . . . . . . . . . . . . . 11.6 p . . . . . 0 C--O 1.22 -0.458 0 CA-C-O 117.938 -1.03 . . . . 1.57 110.603 179.642 . . . . . . . . 0 0 . 1 . 001 nuclear nobuild full ' F' F ' -3' ' ' GLU . . . . . . . . . . . . . 13.8 pt-20 . . . . . 0 N--CA 1.49 1.543 0 N-CA-C 109.502 -0.555 . . . . 33.38 109.502 . . . . . . . . . 0 0 . 1 . 001 nuclear nobuild full ' F' F ' -2' ' ' GLY . . . . . . . . . . . . . . . -99.3 135.17 11.99 Favored Glycine 0 CA--C 1.525 0.669 0 N-CA-C 110.715 -0.954 . . . . 31.12 110.715 178.438 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' F' F ' -1' ' ' VAL . . . . . . . . . . . . . 44.1 t -96.07 132.83 39.32 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.333 0 CA-C-O 120.868 0.366 . . . . 28.28 110.117 -179.099 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' F' F ' 0' ' ' ILE . . . . . . . . . . . . . 73.8 mt -117.61 136.65 54.08 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.215 0 CA-C-N 116.076 -0.511 . . . . 26.64 109.941 -179.942 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' F' F ' 1' ' ' MET . . . . . . . . . . . . . 26.2 ptt? -80.82 137.41 36.2 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.083 -0.508 . . . . 22.8 111.283 -177.55 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' F' F ' 2' ' ' SER . . . . . . . . . . . . . 4.4 p -121.85 135.71 54.91 Favored 'General case' 0 C--N 1.332 -0.187 0 CA-C-N 116.001 -0.545 . . . . 20.13 110.4 177.243 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' F' F ' 3' ' ' GLU . . . . . . . . . . . . . 46.0 mt-10 -141.25 142.74 33.9 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.218 -0.446 . . . . 17.46 111.133 -178.055 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' F' F ' 4' ' ' LEU . . . . . . . . . . . . . 13.5 tp -127.24 133.25 50.24 Favored 'General case' 0 C--N 1.331 -0.202 0 CA-C-N 115.886 -0.597 . . . . 15.24 109.989 176.813 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' F' F ' 5' ' ' LYS . . . . . . . . . . . . . 92.6 mttt -112.99 120.68 42.22 Favored 'General case' 0 C--O 1.234 0.273 0 CA-C-N 116.409 -0.359 . . . . 13.01 110.952 -179.573 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' F' F ' 6' ' ' LEU . . . . . . . . . . . . . 35.6 mt -113.91 149.06 35.73 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 115.289 -0.869 . . . . 12.6 110.23 179.713 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' F' F ' 7' ' ' LYS . . . . . . . . . . . . . 42.6 tttt -139.71 142.01 29.9 Favored Pre-proline 0 CA--C 1.533 0.307 0 CA-C-O 119.176 -0.44 . . . . 10.04 110.248 174.553 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' F' F ' 8' ' ' PRO . . . . . . . . . . . . . 85.5 Cg_endo -91.62 139.58 2.32 Favored 'Trans proline' 0 N--CA 1.489 1.241 0 C-N-CA 121.838 1.692 . . . . 9.67 111.782 177.997 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' F' F ' 9' ' ' LEU . . . . . . . . . . . . . 83.6 mt -70.1 -47.57 21.38 Favored Pre-proline 0 CA--C 1.533 0.293 0 CA-C-O 118.656 -0.688 . . . . 13.6 111.975 179.612 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' F' F ' 10' ' ' PRO . . . . . . . . . . . . . 84.4 Cg_endo -80.52 151.52 19.79 Favored 'Trans proline' 0 N--CA 1.495 1.586 0 C-N-CA 121.172 1.248 . . . . 13.17 111.859 175.615 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' F' F ' 11' ' ' LYS . . . . . . . . . . . . . 28.0 ttpt -83.69 103.75 13.25 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-O 120.81 0.338 . . . . 12.33 110.183 178.286 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' F' F ' 12' ' ' VAL . . . . . . . . . . . . . 12.7 p -141.02 147.41 22.59 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.258 0 CA-C-N 116.164 -0.471 . . . . 14.09 110.574 -178.589 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' F' F ' 13' ' ' GLU . . . . . . . . . . . . . 95.2 mt-10 -85.92 124.89 32.89 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 116.349 -0.387 . . . . 14.23 110.376 179.152 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' F' F ' 14' ' ' LEU . . . . . . . . . . . . . 30.9 mt -99.48 147.37 33.25 Favored Pre-proline 0 CA--C 1.532 0.284 0 CA-C-O 119.163 -0.446 . . . . 14.0 110.471 -179.186 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' F' F ' 15' ' ' PRO . . . . . . . . . . . . . 24.0 Cg_exo -63.85 154.65 68.55 Favored 'Trans proline' 0 N--CA 1.499 1.836 0 C-N-CA 121.354 1.369 . . . . 16.72 112.07 176.964 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' F' F ' 16' ' ' PRO . . . . . . . . . . . . . 39.8 Cg_exo -59.45 -35.58 95.78 Favored 'Trans proline' 0 N--CA 1.498 1.738 0 C-N-CA 121.368 1.379 . . . . 17.12 112.381 177.836 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' F' F ' 17' ' ' ASP . . . . . . . . . . . . . 6.1 p-10 -82.92 11.87 5.59 Favored 'General case' 0 C--N 1.327 -0.398 0 N-CA-C 112.95 0.722 . . . . 18.76 112.95 -179.341 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' F' F ' 18' ' ' PHE . . . . . . . . . . . . . 36.7 t80 -57.34 -44.17 84.05 Favored 'General case' 0 C--O 1.227 -0.11 0 O-C-N 121.914 -0.491 . . . . 15.4 110.196 -178.523 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' F' F ' 19' ' ' VAL . . . . . . . . . . . . . 47.4 t -55.55 -42.1 66.84 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.29 0 CA-C-N 116.417 -0.356 . . . . 15.15 110.786 -177.825 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' F' F ' 20' ' ' ASP . . . . . . . . . . . . . 5.2 t70 -60.14 -44.1 95.2 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-O 120.9 0.381 . . . . 18.08 110.969 -177.498 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' F' F ' 21' ' ' VAL . . . . . . . . . . . . . 47.5 t -65.6 -47.91 84.58 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.307 0 C-N-CA 120.576 -0.449 . . . . 18.15 110.593 -178.625 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' F' F ' 22' ' ' ILE . . . . . 0.456 ' CG2' HD12 ' F' ' 26' ' ' LEU . 49.1 mm -55.45 -58.46 4.53 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.315 0 C-N-CA 121.119 -0.232 . . . . 16.72 111.151 -177.976 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' F' F ' 23' ' ' ARG . . . . . . . . . . . . . 6.1 ptm180 -54.99 -44.0 74.06 Favored 'General case' 0 CA--C 1.53 0.189 0 C-N-CA 120.54 -0.464 . . . . 19.2 111.632 -173.696 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' F' F ' 24' ' ' ILE . . . . . . . . . . . . . 85.0 mt -60.06 -43.46 92.76 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.223 0 C-N-CA 120.796 -0.361 . . . . 20.65 111.404 -177.362 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' F' F ' 25' ' ' LYS . . . . . . . . . . . . . 93.3 mttt -71.55 -43.85 65.63 Favored 'General case' 0 C--N 1.33 -0.281 0 N-CA-C 112.823 0.675 . . . . 19.9 112.823 -177.933 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' F' F ' 26' ' ' LEU . . . . . 0.456 HD12 ' CG2' ' F' ' 22' ' ' ILE . 79.0 mt -79.04 -27.36 43.16 Favored 'General case' 0 C--N 1.329 -0.289 0 N-CA-C 113.777 1.029 . . . . 19.69 113.777 -169.301 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' F' F ' 27' ' ' GLN . . . . . . . . . . . . . 10.4 pt20 -46.78 139.83 5.07 Favored 'General case' 0 N--CA 1.469 0.523 0 N-CA-C 112.894 0.702 . . . . 21.81 112.894 -175.741 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' F' F ' 28' ' ' GLY . . . . . . . . . . . . . . . 100.66 -20.41 48.28 Favored Glycine 0 CA--C 1.534 1.221 0 CA-C-N 115.501 -0.772 . . . . 23.21 112.744 -179.0 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' F' F ' 29' ' ' LYS . . . . . . . . . . . . . 62.0 mttp -96.34 155.08 16.91 Favored 'General case' 0 C--O 1.231 0.101 0 CA-C-N 117.843 0.821 . . . . 22.44 110.99 177.726 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' F' F ' 30' ' ' THR . . . . . . . . . . . . . 30.1 m -107.02 138.97 42.17 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 115.96 -0.564 . . . . 23.24 109.948 177.584 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' F' F ' 31' ' ' VAL . . . . . . . . . . . . . 35.1 m -128.33 152.61 36.68 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.172 0 CA-C-N 116.352 -0.386 . . . . 20.1 110.779 -179.045 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' F' F ' 32' ' ' ARG . . . . . . . . . . . . . 2.8 mpt_? -131.37 150.72 52.04 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.009 -0.541 . . . . 24.75 109.976 177.195 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' F' F ' 33' ' ' THR . . . . . . . . . . . . . 14.6 m -53.68 137.39 37.53 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.426 -0.352 . . . . 18.77 111.394 -177.953 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' F' F ' 34' ' ' GLY . . . . . . . . . . . . . . . 99.88 -17.08 57.81 Favored Glycine 0 CA--C 1.533 1.198 0 C-N-CA 121.186 -0.531 . . . . 17.72 113.348 178.869 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' F' F ' 35' ' ' ASP . . . . . . . . . . . . . 60.1 m-20 -64.92 150.71 47.37 Favored 'General case' 0 C--O 1.231 0.091 0 CA-C-N 117.977 0.888 . . . . 20.13 111.487 -179.253 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' F' F ' 36' ' ' VAL . . . . . . . . . . . . . 47.7 t -121.91 129.14 75.68 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.205 0 CA-C-N 115.641 -0.709 . . . . 18.53 109.844 178.037 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' F' F ' 37' ' ' ILE . . . . . . . . . . . . . 73.9 mt -122.09 140.48 45.89 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.245 0 CA-C-N 116.299 -0.41 . . . . 17.49 110.068 -179.731 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' F' F ' 38' ' ' GLY . . . . . . . . . . . . . . . -110.52 128.68 8.92 Favored Glycine 0 CA--C 1.526 0.761 0 N-CA-C 111.092 -0.803 . . . . 19.07 111.092 179.476 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' F' F ' 39' ' ' ILE . . . . . . . . . . . . . 74.7 mt -123.47 133.35 69.43 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.262 0 N-CA-C 110.087 -0.338 . . . . 18.48 110.087 178.845 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' F' F ' 40' ' ' SER . . . . . . . . . . . . . 25.0 t -93.46 123.03 36.49 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.509 -0.314 . . . . 21.9 111.352 177.584 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' F' F ' 41' ' ' ILE . . . . . . . . . . . . . 73.2 mt -123.79 116.41 48.03 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.214 0 CA-C-N 116.348 -0.387 . . . . 20.06 110.136 176.667 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' F' F ' 42' ' ' LEU . . . . . . . . . . . . . 8.7 mp 51.06 37.08 16.98 Favored 'General case' 0 N--CA 1.465 0.313 0 CA-C-O 121.174 0.511 . . . . 22.47 111.507 178.694 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' F' F ' 43' ' ' GLY . . . . . . . . . . . . . . . 74.06 32.21 58.82 Favored Glycine 0 CA--C 1.529 0.948 0 C-N-CA 121.163 -0.541 . . . . 23.1 112.016 178.95 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' F' F ' 44' ' ' LYS . . . . . . . . . . . . . 87.6 tttt -130.62 125.9 35.27 Favored 'General case' 0 C--N 1.331 -0.232 0 N-CA-C 109.535 -0.543 . . . . 21.12 109.535 177.227 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' F' F ' 45' ' ' GLU . . . . . . . . . . . . . 82.1 tt0 -84.39 115.6 22.61 Favored 'General case' 0 C--N 1.328 -0.369 0 C-N-CA 120.811 -0.356 . . . . 20.71 110.966 -178.891 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' F' F ' 46' ' ' VAL . . . . . . . . . . . . . 7.3 p -115.25 130.36 69.93 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.243 0 N-CA-C 109.191 -0.67 . . . . 16.87 109.191 175.38 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' F' F ' 47' ' ' LYS . . . . . . . . . . . . . 63.5 mttp -99.48 125.81 45.3 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 115.97 -0.559 . . . . 18.86 111.119 179.089 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' F' F ' 48' ' ' PHE . . . . . . . . . . . . . 87.6 m-85 -108.9 131.95 54.53 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.078 -0.51 . . . . 14.18 109.899 176.735 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' F' F ' 49' ' ' LYS . . . . . . . . . . . . . 46.8 tttm -106.31 137.34 44.44 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.222 -0.445 . . . . 14.73 110.326 179.483 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' F' F ' 50' ' ' VAL . . . . . . . . . . . . . 47.6 t -81.04 107.09 13.0 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.333 0 N-CA-C 109.324 -0.621 . . . . 14.98 109.324 175.769 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' F' F ' 51' ' ' VAL . . . . . . . . . . . . . 56.6 t -70.57 -53.49 22.22 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.312 0 CA-C-N 115.864 -0.607 . . . . 13.92 109.452 -175.282 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' F' F ' 52' ' ' GLN . . . . . . . . . . . . . 88.1 mt-30 -154.34 151.96 29.68 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 115.99 -0.55 . . . . 15.71 111.822 -178.31 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' F' F ' 53' ' ' ALA . . . . . . . . . . . . . . . -129.68 130.79 45.98 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 115.21 -0.905 . . . . 18.15 109.552 174.06 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' F' F ' 54' ' ' TYR . . . . . . . . . . . . . 8.3 t80 -129.18 110.55 18.12 Favored Pre-proline 0 CA--C 1.535 0.383 0 CA-C-O 118.214 -0.898 . . . . 22.12 110.038 177.652 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' F' F ' 55' ' ' PRO . . . . . . . . . . . . . 74.0 Cg_endo -77.16 169.75 73.37 Favored 'Cis proline' 0 N--CA 1.5 1.857 0 CA-C-N 121.999 1.75 . . . . 22.21 112.666 -2.796 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' F' F ' 56' ' ' SER . . . . . . . . . . . . . 13.6 m -116.82 127.95 26.37 Favored Pre-proline 0 CA--C 1.539 0.554 0 CA-C-O 118.383 -0.818 . . . . 23.18 109.474 176.643 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' F' F ' 57' ' ' PRO . . . . . . . . . . . . . 37.6 Cg_endo -66.95 167.94 55.24 Favored 'Cis proline' 0 N--CA 1.497 1.726 0 CA-C-N 121.994 1.748 . . . . 24.03 111.466 -1.103 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' F' F ' 58' ' ' LEU . . . . . . . . . . . . . 33.5 tp -129.43 135.82 49.15 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-O 120.935 0.398 . . . . 20.69 110.507 -179.834 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' F' F ' 59' ' ' ARG . . . . . . . . . . . . . 52.5 ttt85 -97.56 127.23 43.35 Favored 'General case' 0 C--N 1.326 -0.417 0 N-CA-C 109.259 -0.645 . . . . 25.29 109.259 177.237 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' F' F ' 60' ' ' VAL . . . . . . . . . . . . . 42.6 t -82.52 114.68 23.77 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.208 0 C-N-CA 120.564 -0.454 . . . . 20.51 110.2 -176.169 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' F' F ' 61' ' ' GLU . . . . . . . . . . . . . 95.7 mt-10 -131.14 158.15 41.24 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 115.806 -0.634 . . . . 23.66 110.117 177.844 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' F' F ' 62' ' ' ASP . . . . . . . . . . . . . 4.6 p-10 -55.51 -32.46 62.91 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-N 116.511 -0.313 . . . . 21.75 111.513 177.951 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' F' F ' 63' ' ' ARG . . . . . . . . . . . . . 14.4 ptp180 -75.59 -4.94 42.84 Favored 'General case' 0 CA--C 1.535 0.389 0 N-CA-C 113.578 0.955 . . . . 25.02 113.578 -177.177 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' F' F ' 64' ' ' THR . . . . . . . . . . . . . 30.5 m -91.76 145.97 24.14 Favored 'General case' 0 C--N 1.332 -0.156 0 CA-C-N 118.271 0.487 . . . . 19.14 110.376 -178.036 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' F' F ' 65' ' ' LYS . . . . . . . . . . . . . 51.9 mtmt -87.55 124.9 33.97 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-O 121.109 0.481 . . . . 19.04 110.328 179.998 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' F' F ' 66' ' ' ILE . . . . . . . . . . . . . 71.5 mt -116.29 124.38 72.46 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.289 0 N-CA-C 109.704 -0.48 . . . . 15.12 109.704 -179.555 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' F' F ' 67' ' ' THR . . . . . . . . . . . . . 25.3 m -123.59 146.27 48.28 Favored 'General case' 0 C--N 1.331 -0.223 0 CA-C-O 121.054 0.455 . . . . 12.47 111.201 -175.776 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' F' F ' 68' ' ' LEU . . . . . 0.49 HD12 ' N ' ' F' ' 68' ' ' LEU . 8.2 mp -106.46 130.29 54.28 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 115.902 -0.59 . . . . 9.77 110.664 178.796 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' F' F ' 69' ' ' VAL . . . . . . . . . . . . . 45.8 t -101.75 138.26 26.6 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.287 0 CA-C-N 115.977 -0.556 . . . . 8.23 109.896 178.574 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' F' F ' 70' ' ' THR . . . . . . . . . . . . . 21.7 p -131.69 -46.3 0.96 Allowed 'General case' 0 C--N 1.331 -0.231 0 CA-C-N 116.503 -0.317 . . . . 6.29 110.966 -178.272 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' F' F ' 71' ' ' HIS . . . . . . . . . . . . . 51.3 m-70 -134.42 154.65 79.92 Favored Pre-proline 0 C--N 1.33 -0.258 0 CA-C-N 116.686 -0.234 . . . . 7.28 110.802 -179.157 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' F' F ' 72' ' ' PRO . . . . . . . . . . . . . 59.5 Cg_endo -74.99 -29.97 7.66 Favored 'Trans proline' 0 N--CA 1.495 1.577 0 C-N-CA 121.356 1.371 . . . . 3.42 112.608 -179.888 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' F' F ' 73' ' ' VAL . . . . . . . . . . . . . 33.4 m -132.99 168.62 23.82 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.192 0 CA-C-O 120.88 0.371 . . . . 1.16 110.737 179.815 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' F' F ' 74' ' ' ASP . . . . . 0.431 ' OD1' HD11 ' F' ' 76' ' ' LEU . 2.5 t70 -101.35 127.96 47.74 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 115.954 -0.567 . . . . 1.06 109.947 179.825 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' F' F ' 75' ' ' VAL . . . . . . . . . . . . . 42.2 t -119.59 124.31 72.68 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.277 0 CA-C-O 120.935 0.398 . . . . 0.62 110.607 -178.273 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' F' F ' 76' ' ' LEU . . . . . 0.431 HD11 ' OD1' ' F' ' 74' ' ' ASP . 5.8 mp -122.48 140.72 52.42 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 115.825 -0.625 . . . . 1.06 109.79 175.689 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' F' F ' 77' ' ' GLU . . . . . . . . . . . . . 98.2 mt-10 -133.69 140.75 47.23 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-O 121.075 0.464 . . . . 1.24 111.324 -178.442 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' F' F ' 78' ' ' ALA . . . . . . . . . . . . . . . -130.9 130.2 43.21 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 115.8 -0.636 . . . . 0.61 109.971 176.326 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' F' F ' 79' ' ' LYS . . . . . 0.584 ' O ' HD13 ' F' ' 80' ' ' ILE . 35.5 mmtt -76.55 119.43 20.37 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-O 121.05 0.452 . . . . 2.99 110.847 179.334 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' F' F ' 80' ' ' ILE . . . . . 0.584 HD13 ' O ' ' F' ' 79' ' ' LYS . 41.1 mm -139.26 100.86 1.45 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.285 0 N-CA-C 108.814 -0.81 . . . . 0.65 108.814 -179.093 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' F' F ' 81' ' ' LYS . . . . . . . . . . . . . 81.3 tttt -91.41 127.5 36.88 Favored 'General case' 0 C--N 1.327 -0.388 0 C-N-CA 120.804 -0.358 . . . . 3.19 111.085 -174.967 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' F' F ' 82' ' ' GLY . . . . . . . . . . . . . . . 89.16 42.16 5.66 Favored Glycine 0 CA--C 1.525 0.715 0 C-N-CA 120.772 -0.728 . . . . 0.65 111.974 174.961 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' F' F ' 83' ' ' ILE . . . . . . . . . . . . . 70.4 mt -72.78 138.02 22.28 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.241 0 N-CA-C 109.611 -0.514 . . . . 0.6 109.611 175.802 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' F' F ' 84' ' ' LYS . . . . . . . . . . . . . 55.7 tttp -97.89 -53.99 3.23 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.13 -0.486 . . . . 1.54 110.377 -178.325 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' F' F ' 85' ' ' ASP . . . . . . . . . . . . . 22.5 t70 -148.88 148.5 29.93 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 115.92 -0.582 . . . . 0.75 110.54 -177.381 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' F' F ' 86' ' ' VAL . . . . . . . . . . . . . 43.8 t -129.77 130.25 66.58 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.259 0 CA-C-O 120.924 0.393 . . . . 0.48 110.49 -179.518 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' F' F ' 87' ' ' ILE . . . . . 0.496 HD12 ' N ' ' F' ' 87' ' ' ILE . 5.1 mp -115.59 125.66 72.86 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.283 0 CA-C-N 115.8 -0.636 . . . . 1.33 109.352 176.51 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' F' F ' 88' ' ' LEU . . . . . . . . . . . . . 18.1 tp -111.49 131.2 55.39 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-O 121.056 0.455 . . . . 1.67 111.297 -176.465 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' F' F ' 89' ' ' ASP . . . . . . . . . . . . . 31.4 t0 -130.99 153.97 48.66 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 115.718 -0.674 . . . . 0.83 109.546 176.225 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' F' F ' 90' ' ' GLU . . . . . . . . . . . . . 95.9 mt-10 -49.34 -37.98 26.49 Favored 'General case' 0 C--N 1.328 -0.331 0 N-CA-C 112.749 0.648 . . . . 2.21 112.749 -171.959 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' F' F ' 91' ' ' ASN . . . . . . . . . . . . . 25.6 m120 -122.57 14.54 10.23 Favored 'General case' 0 N--CA 1.469 0.5 0 N-CA-C 113.193 0.812 . . . . 2.27 113.193 -176.84 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' F' F ' 92' ' ' LEU . . . . . . . . . . . . . 49.0 mt -148.74 141.52 24.6 Favored 'General case' 0 C--N 1.332 -0.195 0 CA-C-O 120.838 0.351 . . . . 1.42 110.516 -175.919 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' F' F ' 93' ' ' ILE . . . . . . . . . . . . . 73.2 mt -124.65 116.17 46.63 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.37 0 N-CA-C 109.063 -0.717 . . . . 0.46 109.063 176.256 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' F' F ' 94' ' ' VAL . . . . . 0.558 HG11 HG11 ' F' ' 123' ' ' VAL . 45.0 t -117.36 125.16 73.84 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.249 0 N-CA-C 109.907 -0.405 . . . . 0.46 109.907 -178.439 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' F' F ' 95' ' ' VAL . . . . . . . . . . . . . 42.2 t -120.84 133.41 67.6 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.344 0 CA-C-N 116.055 -0.52 . . . . 0.42 109.766 -179.739 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' F' F ' 96' ' ' ILE . . . . . . . . . . . . . 59.1 mt -114.01 128.11 71.12 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.297 0 N-CA-C 109.124 -0.695 . . . . 0.46 109.124 178.353 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' F' F ' 97' ' ' THR . . . . . . . . . . . . . 62.7 p -101.1 161.37 13.65 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-O 121.034 0.445 . . . . 0.5 110.999 -177.65 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' F' F ' 98' ' ' GLU . . . . . . . . . . . . . 97.3 mt-10 -54.03 -26.09 24.71 Favored 'General case' 0 CA--C 1.532 0.284 0 N-CA-C 112.345 0.498 . . . . 2.47 112.345 179.958 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' F' F ' 99' ' ' GLU . . . . . . . . . . . . . 95.1 mt-10 -77.69 13.08 1.4 Allowed 'General case' 0 CA--C 1.535 0.384 0 N-CA-C 113.24 0.829 . . . . 2.06 113.24 -177.748 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' F' F ' 100' ' ' ASN . . . . . . . . . . . . . 2.9 m-20 61.23 37.61 17.22 Favored 'General case' 0 CA--C 1.529 0.169 0 CA-C-O 121.106 0.479 . . . . 0.74 110.955 179.442 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' F' F ' 101' ' ' GLU . . . . . . . . . . . . . 84.0 tt0 -115.93 144.72 43.67 Favored 'General case' 0 C--N 1.334 -0.108 0 CA-C-N 116.062 -0.517 . . . . 0.54 109.606 176.182 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' F' F ' 102' ' ' VAL . . . . . . . . . . . . . 45.5 t -114.97 125.35 72.27 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.261 0 CA-C-N 116.291 -0.413 . . . . 0.44 109.963 -178.092 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' F' F ' 103' ' ' LEU . . . . . . . . . . . . . 26.4 mt -113.44 128.84 56.59 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 115.621 -0.718 . . . . 0.86 109.909 175.883 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' F' F ' 104' ' ' ILE . . . . . . . . . . . . . 65.3 mt -118.42 119.16 60.37 Favored 'Isoleucine or valine' 0 C--O 1.233 0.229 0 N-CA-C 110.308 -0.256 . . . . 0.45 110.308 -179.25 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' F' F ' 105' ' ' PHE . . . . . . . . . . . . . 49.0 m-85 -118.99 169.45 9.89 Favored 'General case' 0 C--N 1.332 -0.157 0 CA-C-N 115.423 -0.808 . . . . 0.49 109.71 177.152 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' F' F ' 106' ' ' ASN . . . . . . . . . . . . . 51.2 p-10 -102.03 -170.15 1.78 Allowed 'General case' 0 C--N 1.33 -0.277 0 N-CA-C 109.886 -0.413 . . . . 0.62 109.886 172.987 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' F' F ' 107' ' ' GLN . . . . . 0.423 ' O ' HD21 ' E' ' 140' ' ' LEU . 48.5 tt0 -59.79 -29.96 68.58 Favored 'General case' 0 C--N 1.33 -0.264 0 N-CA-C 111.766 0.284 . . . . 1.17 111.766 178.535 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' F' F ' 108' ' ' ASN . . . . . . . . . . . . . 3.6 t-20 -81.9 9.88 7.39 Favored 'General case' 0 CA--C 1.537 0.459 0 N-CA-C 112.976 0.732 . . . . 1.23 112.976 -178.496 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' F' F ' 109' ' ' LEU . . . . . . . . . . . . . 8.1 tp 58.12 36.38 25.85 Favored 'General case' 0 CA--C 1.529 0.164 0 CA-C-O 120.874 0.369 . . . . 1.33 111.461 177.9 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' F' F ' 110' ' ' GLU . . . . . . . . . . . . . 47.2 mt-10 -105.1 151.22 24.28 Favored 'General case' 0 C--N 1.33 -0.241 0 N-CA-C 109.781 -0.451 . . . . 1.71 109.781 176.67 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' F' F ' 111' ' ' GLU . . . . . . . . . . . . . 83.1 tt0 -83.92 121.92 28.03 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-O 120.858 0.361 . . . . 1.71 110.73 -176.634 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' F' F ' 112' ' ' LEU . . . . . . . . . . . . . 37.4 mt -107.77 -46.2 3.85 Favored 'General case' 0 C--N 1.332 -0.181 0 CA-C-N 116.112 -0.494 . . . . 0.69 110.809 179.241 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' F' F ' 113' ' ' TYR . . . . . . . . . . . . . 42.9 t80 -138.82 139.66 38.27 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-N 116.385 -0.37 . . . . 0.57 111.377 -178.249 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' F' F ' 114' ' ' ARG . . . . . . . . . . . . . 23.7 ttp-105 -136.15 123.75 22.29 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 115.913 -0.585 . . . . 2.6 110.167 176.234 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' F' F ' 115' ' ' GLY . . . . . . . . . . . . . . . -150.06 155.4 26.22 Favored Glycine 0 CA--C 1.521 0.446 0 N-CA-C 110.855 -0.898 . . . . 0.53 110.855 178.677 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' F' F ' 116' ' ' LYS . . . . . . . . . . . . . 33.9 ttmt -127.44 137.78 52.8 Favored 'General case' 0 C--N 1.329 -0.284 0 N-CA-C 109.925 -0.398 . . . . 1.66 109.925 177.009 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' F' F ' 117' ' ' PHE . . . . . . . . . . . . . 31.9 m-85 -137.42 114.51 10.77 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.254 -0.43 . . . . 0.53 109.932 -176.002 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' F' F ' 118' ' ' GLU . . . . . . . . . . . . . 84.4 tt0 -53.77 -42.36 68.16 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.557 -0.292 . . . . 2.71 111.349 -177.134 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' F' F ' 119' ' ' ASN . . . . . . . . . . . . . 30.8 m-80 -99.51 31.14 3.26 Favored 'General case' 0 C--N 1.33 -0.272 0 N-CA-C 112.075 0.398 . . . . 1.32 112.075 -175.062 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' F' F ' 120' ' ' LEU . . . . . . . . . . . . . 25.8 tp -58.53 119.94 7.94 Favored 'General case' 0 C--N 1.332 -0.171 0 N-CA-C 110.033 -0.358 . . . . 0.48 110.033 178.34 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' F' F ' 121' ' ' ASN . . . . . . . . . . . . . 48.3 t30 -114.16 -43.98 3.18 Favored 'General case' 0 C--N 1.332 -0.173 0 CA-C-N 116.372 -0.376 . . . . 1.85 110.909 -178.146 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' F' F ' 122' ' ' LYS . . . . . . . . . . . . . 57.1 mttm -141.62 146.81 36.66 Favored 'General case' 0 C--N 1.331 -0.227 0 CA-C-O 121.111 0.481 . . . . 1.96 111.577 -176.011 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' F' F ' 123' ' ' VAL . . . . . 0.558 HG11 HG11 ' F' ' 94' ' ' VAL . 46.7 t -130.12 129.53 65.47 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.307 0 N-CA-C 109.177 -0.675 . . . . 0.49 109.177 173.82 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' F' F ' 124' ' ' LEU . . . . . . . . . . . . . 81.8 mt -130.95 139.81 50.09 Favored 'General case' 0 C--N 1.332 -0.192 0 CA-C-O 121.086 0.469 . . . . 1.57 111.322 -175.613 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' F' F ' 125' ' ' VAL . . . . . 0.619 HG12 HG23 ' F' ' 130' ' ' VAL . 35.8 m -128.0 131.54 69.43 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.216 0 CA-C-N 115.696 -0.683 . . . . 1.64 110.213 177.689 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' F' F ' 126' ' ' ARG . . . . . . . . . . . . . 77.6 mtt180 -147.39 124.29 11.3 Favored 'General case' 0 C--N 1.327 -0.372 0 N-CA-C 109.656 -0.498 . . . . 3.24 109.656 178.639 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' F' F ' 127' ' ' ASN . . . . . . . . . . . . . 18.4 t30 56.85 -152.3 0.39 Allowed 'General case' 0 CA--C 1.54 0.565 0 N-CA-C 109.57 -0.53 . . . . 2.21 109.57 -178.828 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' F' F ' 128' ' ' ASP . . . . . . . . . . . . . 20.7 p-10 -81.13 14.65 2.22 Favored 'General case' 0 CA--C 1.537 0.46 0 N-CA-C 112.772 0.656 . . . . 1.07 112.772 178.235 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' F' F ' 129' ' ' LEU . . . . . . . . . . . . . 16.5 tp -114.33 137.24 52.06 Favored 'General case' 0 C--O 1.232 0.166 0 O-C-N 122.027 -0.42 . . . . 1.85 109.953 179.315 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' F' F ' 130' ' ' VAL . . . . . 0.619 HG23 HG12 ' F' ' 125' ' ' VAL . 12.3 p -130.22 141.81 45.39 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.268 0 CA-C-O 120.842 0.353 . . . . 1.29 110.528 -178.18 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' F' F ' 131' ' ' VAL . . . . . 0.401 ' CG2' HD21 ' F' ' 138' ' ' LEU . 14.7 p -136.17 143.01 37.1 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.207 0 CA-C-O 121.063 0.458 . . . . 0.89 111.386 -179.584 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' F' F ' 132' ' ' ILE . . . . . . . . . . . . . 70.2 mt -116.15 132.68 64.97 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.32 0 CA-C-N 115.577 -0.738 . . . . 0.41 109.044 176.188 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' F' F ' 133' ' ' ILE . . . . . . . . . . . . . 37.3 mm -116.05 121.75 68.12 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.296 0 CA-C-O 120.785 0.326 . . . . 0.39 111.386 -173.601 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' F' F ' 134' ' ' ASP . . . . . . . . . . . . . 2.8 p30 -130.68 148.64 52.49 Favored 'General case' 0 C--N 1.331 -0.219 0 N-CA-C 109.534 -0.543 . . . . 0.51 109.534 174.294 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' F' F ' 135' ' ' GLU . . . . . . . . . . . . . 84.4 tt0 -50.96 -27.53 7.86 Favored 'General case' 0 C--N 1.326 -0.424 0 N-CA-C 112.955 0.724 . . . . 1.83 112.955 -171.939 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' F' F ' 136' ' ' GLN . . . . . . . . . . . . . 98.1 mt-30 -86.18 -27.82 24.31 Favored 'General case' 0 C--O 1.234 0.24 0 N-CA-C 112.845 0.683 . . . . 1.86 112.845 -175.251 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' F' F ' 137' ' ' LYS . . . . . . . . . . . . . 33.2 pttt -170.01 172.72 6.35 Favored 'General case' 0 C--N 1.331 -0.208 0 CA-C-O 121.588 0.708 . . . . 1.76 112.378 -173.178 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' F' F ' 138' ' ' LEU . . . . . 0.401 HD21 ' CG2' ' F' ' 131' ' ' VAL . 7.1 tt -120.06 130.17 54.56 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 114.998 -1.001 . . . . 0.78 110.048 -179.428 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' F' F ' 139' ' ' THR . . . . . . . . . . . . . 46.5 m -108.51 120.59 42.88 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 116.207 -0.451 . . . . 0.45 109.92 177.786 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' F' F ' 140' ' ' LEU . . . . . . . . . . . . . 17.6 tp -109.71 125.85 53.08 Favored 'General case' 0 C--N 1.329 -0.291 0 N-CA-C 109.31 -0.626 . . . . 1.13 109.31 -178.015 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' F' F ' 141' ' ' ILE . . . . . 0.538 ' HB ' HG13 ' F' ' 130' ' ' VAL . 19.4 mt -123.46 122.76 65.89 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.275 0 CA-C-O 120.843 0.354 . . . . 0.53 110.19 -172.918 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' F' F ' 142' ' ' ARG . . . . . . . . . . . . . 80.6 mtp180 -108.04 126.64 52.97 Favored 'General case' 0 C--N 1.331 -0.219 0 CA-C-N 115.491 -0.777 . . . . 3.85 110.269 -179.466 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' F' F ' 143' ' ' THR . . . . . . . . . . . . . 66.5 p . . . . . 0 C--O 1.22 -0.472 0 CA-C-O 118.09 -0.957 . . . . 1.61 110.493 179.749 . . . . . . . . 0 0 . 1 . 002 nuclear nobuild full ' A' A ' -3' ' ' GLU . . . . . . . . . . . . . 84.8 tt0 . . . . . 0 N--CA 1.49 1.551 0 N-CA-C 109.297 -0.631 . . . . 0.0 109.297 . . . . . . . . . 0 0 . 1 . 002 nuclear nobuild full ' A' A ' -2' ' ' GLY . . . . . . . . . . . . . . . -81.47 135.23 14.13 Favored Glycine 0 CA--C 1.525 0.664 0 N-CA-C 111.102 -0.799 . . . . 0.0 111.102 -179.437 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' -1' ' ' VAL . . . . . . . . . . . . . 46.7 t -96.01 129.43 46.1 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.285 0 N-CA-C 109.898 -0.408 . . . . 0.0 109.898 178.938 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 0' ' ' ILE . . . . . . . . . . . . . 73.7 mt -114.28 128.17 71.41 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.243 0 CA-C-N 116.241 -0.436 . . . . 0.0 109.995 -179.137 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 25.5 ptp -85.36 140.3 30.88 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.142 -0.481 . . . . 0.0 110.924 -178.679 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 2.8 p -117.6 139.24 51.24 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-N 116.047 -0.524 . . . . 0.0 110.479 179.359 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 84.4 tt0 -140.17 143.36 36.08 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.187 -0.46 . . . . 0.0 110.988 -178.721 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 4' ' ' LEU . . . . . 0.437 HD12 HD23 ' A' ' 58' ' ' LEU . 4.9 tt -127.88 127.24 43.06 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 115.864 -0.607 . . . . 0.0 109.997 177.964 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 5' ' ' LYS . . . . . 0.418 ' N ' HD23 ' A' ' 4' ' ' LEU . 98.0 mttt -108.7 122.8 47.87 Favored 'General case' 0 C--O 1.234 0.249 0 CA-C-O 120.771 0.32 . . . . 0.0 110.909 -179.586 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 22.4 mt -113.99 150.06 34.4 Favored 'General case' 0 C--N 1.332 -0.177 0 CA-C-N 115.393 -0.821 . . . . 0.0 110.065 179.552 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 61.0 tttt -137.95 137.2 20.8 Favored Pre-proline 0 CA--C 1.535 0.377 0 CA-C-O 118.942 -0.552 . . . . 0.0 110.007 175.852 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 8' ' ' PRO . . . . . . . . . . . . . 85.9 Cg_endo -87.61 141.7 5.66 Favored 'Trans proline' 0 N--CA 1.492 1.386 0 C-N-CA 121.541 1.494 . . . . 0.0 111.792 177.575 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 46.7 mt -78.23 -47.07 2.11 Favored Pre-proline 0 CA--C 1.533 0.305 0 CA-C-O 118.745 -0.645 . . . . 0.0 112.275 -179.118 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 92.4 Cg_endo -81.98 153.9 17.05 Favored 'Trans proline' 0 N--CA 1.496 1.655 0 C-N-CA 121.269 1.313 . . . . 0.0 111.901 175.353 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 59.8 mttp -89.38 99.93 12.83 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.458 -0.337 . . . . 0.0 110.82 179.513 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 12.0 p -145.76 143.08 21.78 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.268 0 CA-C-N 116.236 -0.438 . . . . 0.0 110.493 179.198 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 43.9 mp0 -79.88 125.87 30.27 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.379 -0.373 . . . . 0.0 110.148 177.687 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 14' ' ' LEU . . . . . . . . . . . . . 29.5 mt -97.89 154.59 37.75 Favored Pre-proline 0 C--N 1.329 -0.284 0 CA-C-N 116.487 -0.324 . . . . 0.0 111.02 -177.651 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 15' ' ' PRO . . . . . . . . . . . . . 35.4 Cg_exo -59.88 160.6 21.17 Favored 'Trans proline' 0 N--CA 1.497 1.686 0 C-N-CA 121.364 1.376 . . . . 0.0 111.872 177.957 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 16' ' ' PRO . . . . . . . . . . . . . 25.7 Cg_exo -61.33 -43.19 29.74 Favored 'Trans proline' 0 N--CA 1.497 1.686 0 C-N-CA 121.571 1.514 . . . . 0.0 112.571 -179.031 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 17' ' ' ASP . . . . . . . . . . . . . 17.9 p-10 -88.34 17.0 5.57 Favored 'General case' 0 CA--C 1.535 0.371 0 N-CA-C 112.953 0.723 . . . . 0.0 112.953 -177.219 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 18' ' ' PHE . . . . . . . . . . . . . 42.7 t80 -58.27 -45.87 87.07 Favored 'General case' 0 C--N 1.334 -0.087 0 O-C-N 122.142 -0.349 . . . . 0.0 110.081 -178.489 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 19' ' ' VAL . . . . . . . . . . . . . 13.3 p -55.59 -39.69 55.72 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 CA-C-N 116.423 -0.353 . . . . 0.0 110.937 -179.532 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 77.5 m-20 -60.42 -46.65 89.27 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-O 120.926 0.393 . . . . 0.0 110.876 -178.378 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 46.4 t -64.27 -47.25 90.59 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.347 0 CA-C-N 116.365 -0.38 . . . . 0.0 110.561 -177.229 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 22' ' ' ILE . . . . . 0.506 HG22 HD12 ' A' ' 26' ' ' LEU . 50.9 mm -56.36 -45.33 81.5 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.218 0 C-N-CA 120.947 -0.301 . . . . 0.0 110.58 179.335 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 23' ' ' ARG . . . . . . . . . . . . . 59.2 ttp180 -54.24 -46.5 72.57 Favored 'General case' 0 C--N 1.33 -0.27 0 C-N-CA 121.164 -0.215 . . . . 0.0 111.366 -179.062 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 24' ' ' ILE . . . . . . . . . . . . . 74.7 mt -58.91 -45.09 92.03 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 C-N-CA 121.137 -0.225 . . . . 0.0 111.057 -179.467 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 93.8 mttt -65.22 -40.66 94.39 Favored 'General case' 0 C--N 1.329 -0.302 0 N-CA-C 112.352 0.501 . . . . 0.0 112.352 -177.89 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 26' ' ' LEU . . . . . 0.506 HD12 HG22 ' A' ' 22' ' ' ILE . 80.1 mt -79.64 -42.19 25.37 Favored 'General case' 0 C--N 1.33 -0.274 0 N-CA-C 112.898 0.703 . . . . 0.0 112.898 -171.575 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 27' ' ' GLN . . . . . . . . . . . . . 9.8 pt20 -46.05 139.51 4.41 Favored 'General case' 0 N--CA 1.469 0.49 0 N-CA-C 112.79 0.663 . . . . 0.0 112.79 -175.292 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 101.33 -28.61 15.21 Favored Glycine 0 CA--C 1.531 1.058 0 CA-C-N 115.483 -0.781 . . . . 0.0 111.973 -176.779 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 90.4 mttt -98.16 155.23 17.26 Favored 'General case' 0 C--O 1.233 0.203 0 CA-C-N 117.267 0.533 . . . . 0.0 111.055 178.452 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 30' ' ' THR . . . . . . . . . . . . . 38.0 m -101.6 138.36 38.69 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.235 -0.438 . . . . 0.0 109.831 175.026 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 34.5 m -126.31 156.45 36.8 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.191 0 CA-C-N 116.45 -0.341 . . . . 0.0 110.675 -178.822 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 32' ' ' ARG . . . . . . . . . . . . . 90.4 mtt180 -132.93 150.39 52.16 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.0 -0.545 . . . . 0.0 110.683 178.858 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 33' ' ' THR . . . . . . . . . . . . . 24.5 m -52.5 139.07 26.24 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.177 -0.465 . . . . 0.0 111.453 -178.643 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 99.47 -17.14 58.13 Favored Glycine 0 CA--C 1.533 1.175 0 CA-C-O 119.631 -0.538 . . . . 0.0 113.29 178.598 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 74.7 m-20 -65.6 148.72 51.27 Favored 'General case' 0 C--N 1.334 -0.073 0 CA-C-N 118.081 0.941 . . . . 0.0 110.954 179.463 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 46.9 t -123.13 130.1 74.58 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.249 0 CA-C-N 115.87 -0.605 . . . . 0.0 109.797 178.241 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 37' ' ' ILE . . . . . . . . . . . . . 63.3 mt -117.57 137.97 49.76 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.275 0 N-CA-C 109.844 -0.428 . . . . 0.0 109.844 -179.742 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . -108.3 128.75 9.25 Favored Glycine 0 CA--C 1.525 0.701 0 N-CA-C 110.957 -0.857 . . . . 0.0 110.957 179.885 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 39' ' ' ILE . . . . . . . . . . . . . 75.8 mt -127.02 135.51 63.41 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.244 0 N-CA-C 110.12 -0.326 . . . . 0.0 110.12 179.4 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 40' ' ' SER . . . . . . . . . . . . . 11.1 p -92.04 115.15 27.82 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.218 -0.447 . . . . 0.0 110.751 176.085 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 41' ' ' ILE . . . . . . . . . . . . . 43.7 mm -120.82 116.78 50.98 Favored 'Isoleucine or valine' 0 N--CA 1.462 0.171 0 CA-C-O 120.772 0.32 . . . . 0.0 110.498 -179.81 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 6.8 mp 50.9 37.12 16.51 Favored 'General case' 0 C--N 1.331 -0.219 0 CA-C-O 121.081 0.467 . . . . 0.0 111.656 177.301 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . 75.16 30.71 58.52 Favored Glycine 0 CA--C 1.528 0.886 0 C-N-CA 121.072 -0.585 . . . . 0.0 112.345 176.67 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 44' ' ' LYS . . . . . . . . . . . . . 16.5 ttmm -136.04 132.69 36.56 Favored 'General case' 0 C--N 1.33 -0.274 0 N-CA-C 109.861 -0.422 . . . . 0.0 109.861 176.652 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 79.0 tt0 -81.79 113.34 19.68 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.408 -0.36 . . . . 0.0 110.747 -178.844 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 46' ' ' VAL . . . . . . . . . . . . . 7.3 p -116.01 125.92 73.31 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.195 0 N-CA-C 109.628 -0.508 . . . . 0.0 109.628 177.936 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 97.1 mttt -100.48 130.0 46.5 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 115.965 -0.561 . . . . 0.0 111.287 178.445 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 48' ' ' PHE . . . . . . . . . . . . . 80.7 m-85 -111.2 131.95 54.71 Favored 'General case' 0 C--N 1.329 -0.296 0 N-CA-C 109.749 -0.463 . . . . 0.0 109.749 175.902 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 85.5 tttt -107.04 137.01 45.92 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.288 -0.415 . . . . 0.0 110.674 -179.172 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 50' ' ' VAL . . . . . . . . . . . . . 42.9 t -81.26 108.78 14.86 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.262 0 N-CA-C 109.462 -0.57 . . . . 0.0 109.462 176.094 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 51' ' ' VAL . . . . . . . . . . . . . 45.2 t -70.2 -49.29 55.97 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.288 0 CA-C-N 115.971 -0.559 . . . . 0.0 109.924 -174.116 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 52' ' ' GLN . . . . . . . . . . . . . 46.6 tt0 -168.13 142.5 3.45 Favored 'General case' 0 C--N 1.33 -0.273 0 C-N-CA 120.082 -0.647 . . . . 0.0 112.009 -177.378 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 53' ' ' ALA . . . . . 0.453 ' HB3' ' OG ' ' A' ' 56' ' ' SER . . . -113.08 133.39 55.02 Favored 'General case' 0 C--N 1.331 -0.215 0 CA-C-N 115.395 -0.82 . . . . 0.0 109.81 175.496 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 54' ' ' TYR . . . . . . . . . . . . . 50.5 t80 -129.03 107.29 18.02 Favored Pre-proline 0 CA--C 1.534 0.351 0 CA-C-O 118.314 -0.85 . . . . 0.0 110.41 179.709 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 55' ' ' PRO . . . . . . . . . . . . . 72.6 Cg_endo -77.14 169.19 74.92 Favored 'Cis proline' 0 N--CA 1.5 1.884 0 CA-C-N 121.764 1.666 . . . . 0.0 112.291 -4.827 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 56' ' ' SER . . . . . 0.453 ' OG ' ' HB3' ' A' ' 53' ' ' ALA . 74.7 m -117.3 137.31 23.9 Favored Pre-proline 0 CA--C 1.538 0.49 0 CA-C-O 118.494 -0.765 . . . . 0.0 109.691 175.114 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 57' ' ' PRO . . . . . . . . . . . . . 36.5 Cg_endo -66.72 161.66 75.03 Favored 'Cis proline' 0 N--CA 1.499 1.797 0 CA-C-N 121.746 1.659 . . . . 0.0 111.388 -3.385 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 58' ' ' LEU . . . . . 0.437 HD23 HD12 ' A' ' 4' ' ' LEU . 28.8 tp -130.03 137.29 50.18 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-O 120.945 0.403 . . . . 0.0 110.676 -178.785 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 59' ' ' ARG . . . . . . . . . . . . . 73.8 ttt180 -99.11 135.4 40.56 Favored 'General case' 0 C--N 1.327 -0.394 0 N-CA-C 109.513 -0.551 . . . . 0.0 109.513 175.395 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 40.3 t -84.93 116.33 28.28 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.287 0 C-N-CA 120.652 -0.419 . . . . 0.0 110.453 -177.398 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 34.6 tp10 -131.03 155.49 46.78 Favored 'General case' 0 C--N 1.329 -0.288 0 N-CA-C 109.088 -0.708 . . . . 0.0 109.088 177.138 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 62' ' ' ASP . . . . . . . . . . . . . 77.4 m-20 -51.68 -32.26 29.15 Favored 'General case' 0 C--N 1.326 -0.438 0 N-CA-C 112.134 0.42 . . . . 0.0 112.134 -175.787 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 63' ' ' ARG . . . . . . . . . . . . . 34.5 mmt180 -74.48 -21.61 59.49 Favored 'General case' 0 C--N 1.33 -0.281 0 N-CA-C 113.022 0.749 . . . . 0.0 113.022 -175.447 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 20.8 m -63.29 141.44 58.76 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-O 120.849 0.357 . . . . 0.0 110.824 -176.148 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 65' ' ' LYS . . . . . . . . . . . . . 94.4 mttt -84.06 123.96 30.59 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.191 -0.459 . . . . 0.0 109.796 178.013 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 66' ' ' ILE . . . . . . . . . . . . . 54.9 mt -113.83 129.7 69.25 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.247 0 N-CA-C 109.994 -0.373 . . . . 0.0 109.994 -178.803 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 67' ' ' THR . . . . . . . . . . . . . 12.0 m -125.16 136.63 53.78 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-N 116.234 -0.439 . . . . 0.0 110.736 -179.058 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 68' ' ' LEU . . . . . 0.433 ' N ' HD12 ' A' ' 68' ' ' LEU . 7.4 mp -108.27 123.1 48.27 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-N 116.04 -0.527 . . . . 0.0 110.906 179.397 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 69' ' ' VAL . . . . . . . . . . . . . 45.5 t -101.67 139.06 23.79 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.344 0 N-CA-C 109.394 -0.595 . . . . 0.0 109.394 176.959 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 70' ' ' THR . . . . . 0.486 HG23 ' N ' ' A' ' 71' ' ' HIS . 4.5 t -133.4 -53.24 0.89 Allowed 'General case' 0 N--CA 1.463 0.213 0 N-CA-C 112.062 0.393 . . . . 0.0 112.062 -176.248 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 71' ' ' HIS . . . . . 0.486 ' N ' HG23 ' A' ' 70' ' ' THR . 32.0 m80 -150.03 93.39 3.92 Favored Pre-proline 0 CA--C 1.531 0.244 0 C-N-CA 120.562 -0.455 . . . . 0.0 111.993 -174.571 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 72' ' ' PRO . . . . . . . . . . . . . 57.1 Cg_endo -75.19 -30.06 7.29 Favored 'Trans proline' 0 N--CA 1.495 1.583 0 C-N-CA 121.154 1.236 . . . . 0.0 111.869 170.039 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 73' ' ' VAL . . . . . . . . . . . . . 32.0 m -144.36 179.7 1.31 Allowed 'Isoleucine or valine' 0 C--N 1.332 -0.182 0 N-CA-C 109.322 -0.621 . . . . 0.0 109.322 174.483 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 74' ' ' ASP . . . . . . . . . . . . . 15.9 t0 -99.08 115.34 28.78 Favored 'General case' 0 C--N 1.331 -0.215 0 N-CA-C 109.93 -0.396 . . . . 0.0 109.93 179.929 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 40.9 t -112.98 122.52 67.28 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.271 0 CA-C-O 121.164 0.507 . . . . 0.0 110.432 -178.877 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 76' ' ' LEU . . . . . . . . . . . . . 23.4 mt -119.77 140.52 50.61 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 115.507 -0.77 . . . . 0.0 109.242 178.44 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 77' ' ' GLU . . . . . . . . . . . . . 98.4 mt-10 -136.18 136.96 40.42 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-O 121.102 0.477 . . . . 0.0 111.492 -177.204 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 78' ' ' ALA . . . . . 0.571 ' HB2' HD21 ' A' ' 109' ' ' LEU . . . -125.76 136.15 52.84 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 115.554 -0.748 . . . . 0.0 109.947 176.842 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 79' ' ' LYS . . . . . 0.601 ' O ' HD13 ' A' ' 80' ' ' ILE . 43.3 mmtm -81.52 113.62 19.69 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.405 -0.361 . . . . 0.0 110.562 -179.48 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 80' ' ' ILE . . . . . 0.601 HD13 ' O ' ' A' ' 79' ' ' LYS . 28.5 mm -139.22 104.12 2.09 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.355 0 N-CA-C 109.26 -0.644 . . . . 0.0 109.26 -179.633 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 81' ' ' LYS . . . . . . . . . . . . . 60.4 mtpt -99.71 131.42 45.71 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-O 120.851 0.357 . . . . 0.0 110.81 -177.307 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . 89.2 42.07 5.67 Favored Glycine 0 CA--C 1.525 0.707 0 N-CA-C 111.194 -0.762 . . . . 0.0 111.194 178.34 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 83' ' ' ILE . . . . . . . . . . . . . 70.1 mt -71.08 137.54 23.59 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.308 0 N-CA-C 109.486 -0.561 . . . . 0.0 109.486 176.801 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 84' ' ' LYS . . . . . . . . . . . . . 38.1 ttpt -98.91 -52.62 3.51 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-O 120.843 0.354 . . . . 0.0 110.379 -178.687 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 85' ' ' ASP . . . . . . . . . . . . . 12.6 t70 -151.76 153.16 33.77 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.039 -0.528 . . . . 0.0 110.692 -179.167 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 86' ' ' VAL . . . . . . . . . . . . . 41.9 t -131.4 132.97 62.59 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.248 0 CA-C-O 120.964 0.412 . . . . 0.0 110.421 -178.763 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 87' ' ' ILE . . . . . 0.494 HD12 ' N ' ' A' ' 87' ' ' ILE . 5.1 mp -122.31 129.66 75.13 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.225 0 CA-C-N 115.819 -0.628 . . . . 0.0 109.358 177.351 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 88' ' ' LEU . . . . . . . . . . . . . 25.5 tp -116.28 132.52 56.64 Favored 'General case' 0 C--N 1.331 -0.219 0 CA-C-O 120.995 0.426 . . . . 0.0 111.433 -176.4 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 89' ' ' ASP . . . . . . . . . . . . . 13.4 t70 -127.04 154.84 44.14 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 115.764 -0.653 . . . . 0.0 109.511 175.668 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 96.1 mt-10 -46.72 -39.36 11.42 Favored 'General case' 0 C--N 1.329 -0.288 0 N-CA-C 113.222 0.823 . . . . 0.0 113.222 -171.735 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 91' ' ' ASN . . . . . . . . . . . . . 12.8 m120 -129.56 22.25 5.52 Favored 'General case' 0 N--CA 1.469 0.496 0 N-CA-C 112.802 0.667 . . . . 0.0 112.802 -177.409 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 92' ' ' LEU . . . . . . . . . . . . . 10.1 mt -150.09 141.91 23.74 Favored 'General case' 0 C--N 1.331 -0.209 0 N-CA-C 109.564 -0.532 . . . . 0.0 109.564 -178.094 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 93' ' ' ILE . . . . . . . . . . . . . 72.2 mt -123.99 121.28 61.73 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 N-CA-C 109.412 -0.588 . . . . 0.0 109.412 178.382 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 94' ' ' VAL . . . . . . . . . . . . . 46.3 t -120.3 126.86 75.72 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.264 0 CA-C-O 120.853 0.359 . . . . 0.0 110.145 -178.215 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 95' ' ' VAL . . . . . . . . . . . . . 41.5 t -122.48 134.3 66.1 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.316 0 CA-C-N 116.001 -0.545 . . . . 0.0 109.801 -179.731 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 96' ' ' ILE . . . . . . . . . . . . . 64.4 mt -115.9 126.73 73.53 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.255 0 N-CA-C 109.405 -0.591 . . . . 0.0 109.405 179.221 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 97' ' ' THR . . . . . . . . . . . . . 70.9 p -103.26 157.34 17.08 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-O 121.356 0.598 . . . . 0.0 111.639 -175.505 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 98' ' ' GLU . . . . . . . . . . . . . 81.5 tt0 -53.96 -26.83 27.63 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 115.893 -0.594 . . . . 0.0 112.303 -178.832 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 99' ' ' GLU . . . . . . . . . . . . . 43.2 mt-10 -80.33 17.62 1.03 Allowed 'General case' 0 CA--C 1.533 0.317 0 N-CA-C 113.069 0.766 . . . . 0.0 113.069 -177.096 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 100' ' ' ASN . . . . . . . . . . . . . 3.2 m-20 61.65 37.37 16.08 Favored 'General case' 0 CA--C 1.53 0.174 0 CA-C-O 121.09 0.472 . . . . 0.0 111.014 178.292 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 101' ' ' GLU . . . . . . . . . . . . . 84.2 tt0 -113.12 143.5 44.25 Favored 'General case' 0 C--O 1.232 0.139 0 CA-C-N 116.083 -0.508 . . . . 0.0 109.966 176.52 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 102' ' ' VAL . . . . . . . . . . . . . 46.2 t -114.98 123.8 71.03 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.27 0 N-CA-C 109.658 -0.497 . . . . 0.0 109.658 -179.653 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 103' ' ' LEU . . . . . . . . . . . . . 22.4 mt -115.98 129.51 56.41 Favored 'General case' 0 C--N 1.331 -0.199 0 CA-C-N 115.696 -0.684 . . . . 0.0 110.355 178.36 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 104' ' ' ILE . . . . . 0.519 HD13 HG21 ' A' ' 130' ' ' VAL . 70.5 mt -118.29 120.27 63.87 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.246 0 CA-C-N 116.446 -0.343 . . . . 0.0 110.189 179.081 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 105' ' ' PHE . . . . . . . . . . . . . 57.9 m-85 -121.3 165.4 15.55 Favored 'General case' 0 C--N 1.332 -0.168 0 O-C-N 123.932 0.77 . . . . 0.0 110.155 179.478 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 106' ' ' ASN . . . . . . . . . . . . . 40.9 p-10 -96.88 -169.93 1.96 Allowed 'General case' 0 C--N 1.331 -0.205 0 N-CA-C 109.913 -0.403 . . . . 0.0 109.913 173.636 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 107' ' ' GLN . . . . . . . . . . . . . 63.3 tt0 -58.96 -30.1 67.66 Favored 'General case' 0 C--N 1.329 -0.306 0 N-CA-C 111.781 0.289 . . . . 0.0 111.781 178.38 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 108' ' ' ASN . . . . . . . . . . . . . 52.2 t30 -83.47 7.22 17.59 Favored 'General case' 0 CA--C 1.536 0.437 0 N-CA-C 113.304 0.853 . . . . 0.0 113.304 -177.698 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 109' ' ' LEU . . . . . 0.571 HD21 ' HB2' ' A' ' 78' ' ' ALA . 11.4 tp 59.6 37.24 22.65 Favored 'General case' 0 C--N 1.332 -0.165 0 CA-C-O 121.017 0.437 . . . . 0.0 111.349 178.409 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 110' ' ' GLU . . . . . . . . . . . . . 70.7 mm-40 -103.55 152.12 22.09 Favored 'General case' 0 C--N 1.331 -0.216 0 N-CA-C 109.886 -0.413 . . . . 0.0 109.886 176.019 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 111' ' ' GLU . . . . . . . . . . . . . 83.4 tt0 -79.35 121.98 25.8 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-O 120.944 0.402 . . . . 0.0 110.73 -177.598 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 112' ' ' LEU . . . . . . . . . . . . . 28.8 mt -111.32 -46.04 3.34 Favored 'General case' 0 C--N 1.331 -0.229 0 CA-C-N 116.063 -0.517 . . . . 0.0 110.145 178.1 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 113' ' ' TYR . . . . . . . . . . . . . 59.8 t80 -138.99 133.43 31.73 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-N 116.115 -0.493 . . . . 0.0 111.009 179.59 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 114' ' ' ARG . . . . . . . . . . . . . 60.1 ttp180 -137.19 122.91 19.9 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.167 -0.469 . . . . 0.0 110.179 176.692 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 115' ' ' GLY . . . . . . . . . . . . . . . -150.07 146.66 16.06 Favored Glycine 0 CA--C 1.524 0.618 0 N-CA-C 110.91 -0.876 . . . . 0.0 110.91 178.974 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 116' ' ' LYS . . . . . . . . . . . . . 14.1 ttmm -116.42 134.93 54.3 Favored 'General case' 0 C--N 1.33 -0.271 0 N-CA-C 109.932 -0.396 . . . . 0.0 109.932 178.663 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 117' ' ' PHE . . . . . . . . . . . . . 48.8 m-85 -132.55 116.92 17.32 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-O 121.01 0.433 . . . . 0.0 110.331 -176.123 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 118' ' ' GLU . . . . . . . . . . . . . 43.8 mp0 -55.22 -45.06 75.96 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 116.246 -0.434 . . . . 0.0 111.133 -175.529 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 119' ' ' ASN . . . . . . . . . . . . . 35.1 m120 -98.71 31.0 3.06 Favored 'General case' 0 C--N 1.33 -0.24 0 N-CA-C 112.208 0.447 . . . . 0.0 112.208 -174.331 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 120' ' ' LEU . . . . . . . . . . . . . 31.5 tp -56.79 121.4 9.76 Favored 'General case' 0 C--N 1.333 -0.14 0 CA-C-O 120.752 0.31 . . . . 0.0 110.471 178.028 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 121' ' ' ASN . . . . . . . . . . . . . 20.3 m120 -114.05 -44.12 3.18 Favored 'General case' 0 C--N 1.333 -0.146 0 CA-C-N 116.414 -0.357 . . . . 0.0 111.204 -177.328 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 122' ' ' LYS . . . . . . . . . . . . . 96.1 mttt -144.1 149.85 37.2 Favored 'General case' 0 C--N 1.331 -0.205 0 CA-C-O 121.01 0.433 . . . . 0.0 111.72 -175.609 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 123' ' ' VAL . . . . . . . . . . . . . 47.1 t -129.69 130.4 66.81 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.27 0 N-CA-C 109.399 -0.593 . . . . 0.0 109.399 174.658 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 124' ' ' LEU . . . . . . . . . . . . . 69.9 mt -125.07 140.04 53.25 Favored 'General case' 0 N--CA 1.464 0.267 0 CA-C-O 120.782 0.325 . . . . 0.0 111.094 -177.237 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 125' ' ' VAL . . . . . . . . . . . . . 10.4 p -132.22 131.21 60.97 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.19 0 CA-C-N 116.009 -0.541 . . . . 0.0 110.332 -179.928 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 126' ' ' ARG . . . . . . . . . . . . . 35.3 mmt180 -142.3 118.03 10.45 Favored 'General case' 0 C--N 1.332 -0.192 0 CA-C-O 120.841 0.353 . . . . 0.0 110.733 178.44 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 127' ' ' ASN . . . . . . . . . . . . . 18.3 t-20 50.07 -104.89 0.16 Allowed 'General case' 0 CA--C 1.543 0.702 0 CA-C-O 119.098 -0.477 . . . . 0.0 111.664 178.017 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 128' ' ' ASP . . . . . . . . . . . . . 22.6 p-10 -114.08 3.8 15.41 Favored 'General case' 0 CA--C 1.537 0.478 0 CA-C-N 119.562 1.074 . . . . 0.0 113.451 -176.689 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 129' ' ' LEU . . . . . . . . . . . . . 14.4 tp -110.91 139.76 45.96 Favored 'General case' 0 C--N 1.332 -0.191 0 N-CA-C 109.673 -0.491 . . . . 0.0 109.673 178.374 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 130' ' ' VAL . . . . . 0.519 HG21 HD13 ' A' ' 104' ' ' ILE . 30.1 m -128.64 140.75 48.4 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.226 0 CA-C-O 120.892 0.377 . . . . 0.0 110.176 178.792 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 131' ' ' VAL . . . . . . . . . . . . . 43.8 t -136.06 140.52 43.78 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 CA-C-O 121.257 0.551 . . . . 0.0 110.458 -178.754 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 132' ' ' ILE . . . . . . . . . . . . . 71.8 mt -114.87 132.17 64.88 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.336 0 CA-C-N 115.415 -0.811 . . . . 0.0 109.302 179.28 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 133' ' ' ILE . . . . . . . . . . . . . 39.0 mm -114.25 118.76 59.44 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.236 0 CA-C-N 116.53 -0.304 . . . . 0.0 110.74 -175.604 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 134' ' ' ASP . . . . . . . . . . . . . 8.1 p-10 -133.63 146.31 50.79 Favored 'General case' 0 C--N 1.33 -0.254 0 N-CA-C 109.587 -0.523 . . . . 0.0 109.587 174.95 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 135' ' ' GLU . . . . . . . . . . . . . 80.1 tt0 -49.85 -24.21 2.32 Favored 'General case' 0 C--N 1.328 -0.359 0 N-CA-C 112.782 0.66 . . . . 0.0 112.782 -172.644 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 136' ' ' GLN . . . . . . . . . . . . . 98.7 mt-30 -93.73 -35.35 12.83 Favored 'General case' 0 C--N 1.333 -0.126 0 N-CA-C 112.294 0.479 . . . . 0.0 112.294 -176.243 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 137' ' ' LYS . . . . . . . . . . . . . 88.6 mttt -142.32 153.62 44.02 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-O 121.59 0.709 . . . . 0.0 112.622 -167.788 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 138' ' ' LEU . . . . . . . . . . . . . 14.3 tp -110.7 116.87 32.06 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 114.725 -1.125 . . . . 0.0 108.76 170.725 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 139' ' ' THR . . . . . . . . . . . . . 31.7 m -107.68 121.14 44.09 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-O 120.558 0.218 . . . . 0.0 110.775 -178.165 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 140' ' ' LEU . . . . . 0.475 HD23 ' C ' ' A' ' 140' ' ' LEU . 7.4 tt -112.85 122.83 48.82 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 115.885 -0.598 . . . . 0.0 109.426 -179.372 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 141' ' ' ILE . . . . . 0.514 ' HB ' HG23 ' A' ' 130' ' ' VAL . 18.9 mt -124.09 122.57 64.7 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.254 0 CA-C-O 121.007 0.432 . . . . 0.0 109.891 -175.863 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 142' ' ' ARG . . . . . . . . . . . . . 71.4 ttt180 -108.86 125.24 51.78 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 115.443 -0.799 . . . . 0.0 110.468 -179.196 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 143' ' ' THR . . . . . . . . . . . . . 5.6 p . . . . . 0 C--O 1.219 -0.536 0 CA-C-O 118.028 -0.986 . . . . 0.0 110.457 179.799 . . . . . . . . 0 0 . 1 . 002 nuclear nobuild full ' B' B ' -3' ' ' GLU . . . . . . . . . . . . . 84.8 tt0 . . . . . 0 N--CA 1.49 1.574 0 N-CA-C 109.362 -0.606 . . . . 0.0 109.362 . . . . . . . . . 0 0 . 1 . 002 nuclear nobuild full ' B' B ' -2' ' ' GLY . . . . . . . . . . . . . . . -71.21 144.26 37.34 Favored Glycine 0 CA--C 1.526 0.722 0 N-CA-C 111.031 -0.828 . . . . 0.0 111.031 -179.975 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' -1' ' ' VAL . . . . . . . . . . . . . 43.3 t -96.5 138.79 20.78 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.332 0 CA-C-O 120.789 0.328 . . . . 0.0 110.272 179.922 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 0' ' ' ILE . . . . . . . . . . . . . 72.3 mt -110.04 131.15 61.82 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.236 0 CA-C-N 116.214 -0.448 . . . . 0.0 109.941 179.074 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 1' ' ' MET . . . . . . . . . . . . . 25.6 ptm -80.81 136.22 36.08 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.229 -0.442 . . . . 0.0 110.626 179.62 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 2' ' ' SER . . . . . . . . . . . . . 90.2 p -126.56 153.72 44.84 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 116.155 -0.475 . . . . 0.0 110.269 179.341 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 3' ' ' GLU . . . . . . . . . . . . . 95.2 mt-10 -140.41 143.74 35.8 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.274 -0.421 . . . . 0.0 111.147 -177.712 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 4' ' ' LEU . . . . . . . . . . . . . 38.9 mt -121.32 127.01 50.88 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 115.811 -0.631 . . . . 0.0 110.037 175.939 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 5' ' ' LYS . . . . . . . . . . . . . 91.8 mttt -104.64 120.46 41.37 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.29 -0.414 . . . . 0.0 110.468 178.843 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 6' ' ' LEU . . . . . . . . . . . . . 57.8 mt -115.46 148.03 39.91 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 115.564 -0.744 . . . . 0.0 110.406 -179.171 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 7' ' ' LYS . . . . . . . . . . . . . 82.2 tttt -139.95 137.85 18.84 Favored Pre-proline 0 CA--C 1.534 0.357 0 CA-C-O 119.046 -0.502 . . . . 0.0 109.976 176.86 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 8' ' ' PRO . . . . . . . . . . . . . 98.0 Cg_endo -91.44 142.48 2.9 Favored 'Trans proline' 0 N--CA 1.49 1.295 0 C-N-CA 121.734 1.623 . . . . 0.0 111.718 177.719 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 9' ' ' LEU . . . . . . . . . . . . . 52.8 mt -79.23 -46.71 1.64 Allowed Pre-proline 0 CA--C 1.532 0.278 0 CA-C-O 118.847 -0.597 . . . . 0.0 112.105 -179.055 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 10' ' ' PRO . . . . . 0.443 ' HG2' HG23 ' B' ' 46' ' ' VAL . 65.7 Cg_endo -84.36 156.57 12.63 Favored 'Trans proline' 0 N--CA 1.496 1.663 0 C-N-CA 121.309 1.339 . . . . 0.0 111.631 174.488 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' B' B ' 11' ' ' LYS . . . . . . . . . . . . . 20.0 pttm -86.16 120.85 27.97 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-O 120.998 0.428 . . . . 0.0 110.045 176.494 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 12' ' ' VAL . . . . . . . . . . . . . 12.0 p -151.02 148.79 14.7 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.327 0 CA-C-N 116.081 -0.509 . . . . 0.0 110.637 -178.26 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 13' ' ' GLU . . . . . . . . . . . . . 84.7 tt0 -91.62 116.58 28.99 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.279 -0.419 . . . . 0.0 110.132 177.464 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 14' ' ' LEU . . . . . . . . . . . . . 29.5 mt -98.15 146.52 31.66 Favored Pre-proline 0 CA--C 1.532 0.287 0 CA-C-O 119.171 -0.442 . . . . 0.0 110.425 -177.491 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 15' ' ' PRO . . . . . . . . . . . . . 24.0 Cg_exo -64.01 162.18 30.3 Favored 'Trans proline' 0 N--CA 1.498 1.769 0 C-N-CA 121.335 1.357 . . . . 0.0 111.86 176.409 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 16' ' ' PRO . . . . . . . . . . . . . 27.0 Cg_exo -61.14 -35.34 86.64 Favored 'Trans proline' 0 N--CA 1.497 1.699 0 C-N-CA 121.484 1.456 . . . . 0.0 112.511 -179.585 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 17' ' ' ASP . . . . . . . . . . . . . 7.1 p-10 -85.86 6.27 28.98 Favored 'General case' 0 CA--C 1.535 0.388 0 N-CA-C 113.302 0.852 . . . . 0.0 113.302 -177.226 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 18' ' ' PHE . . . . . . . . . . . . . 51.5 t80 -57.48 -43.41 84.07 Favored 'General case' 0 C--N 1.334 -0.105 0 O-C-N 121.891 -0.506 . . . . 0.0 110.152 -179.038 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 19' ' ' VAL . . . . . 0.412 HG13 ' N ' ' B' ' 20' ' ' ASP . 12.3 p -56.85 -41.76 76.62 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.345 0 CA-C-N 116.304 -0.407 . . . . 0.0 110.763 -179.509 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' B' B ' 20' ' ' ASP . . . . . 0.412 ' N ' HG13 ' B' ' 19' ' ' VAL . 71.5 m-20 -60.68 -42.04 96.32 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-O 120.893 0.378 . . . . 0.0 110.881 -178.203 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' B' B ' 21' ' ' VAL . . . . . . . . . . . . . 50.6 t -64.42 -47.17 90.56 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.332 0 CA-C-N 116.314 -0.403 . . . . 0.0 110.512 -178.488 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 22' ' ' ILE . . . . . 0.586 HG22 HD12 ' B' ' 26' ' ' LEU . 50.5 mm -57.5 -40.21 73.43 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.281 0 C-N-CA 120.916 -0.313 . . . . 0.0 110.675 179.95 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' B' B ' 23' ' ' ARG . . . . . . . . . . . . . 46.4 ttp180 -55.95 -50.75 69.92 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-O 120.927 0.394 . . . . 0.0 110.774 177.571 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 24' ' ' ILE . . . . . . . . . . . . . 67.7 mt -62.17 -41.23 90.52 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.278 0 CA-C-N 116.047 -0.524 . . . . 0.0 112.078 -176.667 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 25' ' ' LYS . . . . . 0.469 ' HE2' HD11 ' B' ' 39' ' ' ILE . 14.9 pttp -73.32 -34.88 65.93 Favored 'General case' 0 CA--C 1.533 0.324 0 C-N-CA 120.687 -0.405 . . . . 0.0 111.79 -174.125 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' B' B ' 26' ' ' LEU . . . . . 0.586 HD12 HG22 ' B' ' 22' ' ' ILE . 75.6 mt -79.86 -43.09 22.94 Favored 'General case' 0 C--N 1.33 -0.255 0 N-CA-C 112.426 0.528 . . . . 0.0 112.426 -174.912 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' B' B ' 27' ' ' GLN . . . . . . . . . . . . . 9.6 pt20 -46.36 139.21 5.0 Favored 'General case' 0 N--CA 1.469 0.478 0 N-CA-C 112.838 0.681 . . . . 0.0 112.838 -175.554 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 28' ' ' GLY . . . . . . . . . . . . . . . 101.35 -29.53 12.32 Favored Glycine 0 CA--C 1.531 1.078 0 CA-C-N 115.355 -0.838 . . . . 0.0 112.031 -177.289 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 29' ' ' LYS . . . . . . . . . . . . . 73.7 mmtt -98.16 155.17 17.29 Favored 'General case' 0 C--N 1.332 -0.196 0 CA-C-N 117.194 0.497 . . . . 0.0 110.964 178.466 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 30' ' ' THR . . . . . . . . . . . . . 27.9 m -92.2 135.43 34.01 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.081 -0.509 . . . . 0.0 109.906 175.107 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 31' ' ' VAL . . . . . . . . . . . . . 34.9 m -122.51 145.09 29.84 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.227 0 CA-C-O 120.896 0.379 . . . . 0.0 110.57 -179.152 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 32' ' ' ARG . . . . . . . . . . . . . 73.1 ttt-85 -136.0 148.86 48.61 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 115.863 -0.608 . . . . 0.0 110.383 178.436 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 33' ' ' THR . . . . . . . . . . . . . 26.8 m -52.62 140.7 22.5 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.357 -0.383 . . . . 0.0 111.493 -178.543 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 34' ' ' GLY . . . . . . . . . . . . . . . 100.17 -17.3 57.23 Favored Glycine 0 CA--C 1.533 1.187 0 CA-C-O 119.675 -0.514 . . . . 0.0 113.159 179.678 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 35' ' ' ASP . . . . . . . . . . . . . 75.5 m-20 -65.96 148.87 51.12 Favored 'General case' 0 C--O 1.231 0.092 0 CA-C-N 118.091 0.946 . . . . 0.0 111.054 178.648 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 36' ' ' VAL . . . . . . . . . . . . . 43.4 t -126.44 130.92 71.85 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.2 0 CA-C-N 116.199 -0.455 . . . . 0.0 109.91 178.414 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 37' ' ' ILE . . . . . . . . . . . . . 65.5 mt -122.73 139.69 48.79 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.237 0 CA-C-N 116.174 -0.466 . . . . 0.0 109.984 -179.758 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 38' ' ' GLY . . . . . . . . . . . . . . . -109.31 128.76 9.13 Favored Glycine 0 CA--C 1.526 0.738 0 N-CA-C 111.086 -0.805 . . . . 0.0 111.086 179.518 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 39' ' ' ILE . . . . . 0.469 HD11 ' HE2' ' B' ' 25' ' ' LYS . 65.5 mt -125.69 126.82 70.82 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.249 0 N-CA-C 109.802 -0.444 . . . . 0.0 109.802 178.621 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' B' B ' 40' ' ' SER . . . . . 0.55 ' O ' HD13 ' B' ' 41' ' ' ILE . 41.2 t -92.44 117.32 29.81 Favored 'General case' 0 C--N 1.329 -0.307 0 C-N-CA 120.961 -0.296 . . . . 0.0 110.914 177.075 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' B' B ' 41' ' ' ILE . . . . . 0.55 HD13 ' O ' ' B' ' 40' ' ' SER . 45.3 mm -130.32 124.64 58.08 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.227 0 CA-C-O 120.722 0.296 . . . . 0.0 110.288 179.45 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' B' B ' 42' ' ' LEU . . . . . . . . . . . . . 77.9 mt 58.54 35.1 24.4 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.19 -0.459 . . . . 0.0 111.678 177.307 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 43' ' ' GLY . . . . . . . . . . . . . . . 77.54 -10.12 25.09 Favored Glycine 0 CA--C 1.534 1.261 0 C-N-CA 121.212 -0.518 . . . . 0.0 113.479 177.586 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 44' ' ' LYS . . . . . . . . . . . . . 60.3 mttp -102.49 130.13 49.21 Favored 'General case' 0 C--O 1.232 0.154 0 CA-C-N 117.977 0.888 . . . . 0.0 110.175 177.505 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 45' ' ' GLU . . . . . . . . . . . . . 38.1 tp10 -84.48 128.14 34.42 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-O 120.797 0.332 . . . . 0.0 110.887 179.552 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 46' ' ' VAL . . . . . 0.443 HG23 ' HG2' ' B' ' 10' ' ' PRO . 7.3 p -119.56 129.44 75.32 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.235 0 N-CA-C 109.617 -0.512 . . . . 0.0 109.617 176.741 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' B' B ' 47' ' ' LYS . . . . . . . . . . . . . 35.0 mmtp -99.78 126.91 45.93 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.074 -0.512 . . . . 0.0 110.885 177.833 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 48' ' ' PHE . . . . . . . . . . . . . 91.2 m-85 -108.68 131.81 54.54 Favored 'General case' 0 C--N 1.33 -0.247 0 N-CA-C 109.824 -0.435 . . . . 0.0 109.824 176.461 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 49' ' ' LYS . . . . . . . . . . . . . 85.0 tttt -108.29 136.83 47.29 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.274 -0.421 . . . . 0.0 110.276 178.698 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 50' ' ' VAL . . . . . . . . . . . . . 44.2 t -78.37 108.47 11.83 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.368 0 N-CA-C 109.318 -0.623 . . . . 0.0 109.318 176.304 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 51' ' ' VAL . . . . . . . . . . . . . 48.0 t -69.68 -48.32 65.9 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.298 0 CA-C-N 116.044 -0.525 . . . . 0.0 109.898 -174.27 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 52' ' ' GLN . . . . . . . . . . . . . 47.5 tt0 -169.2 142.56 2.78 Favored 'General case' 0 C--N 1.33 -0.266 0 C-N-CA 120.256 -0.578 . . . . 0.0 111.774 -178.551 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 53' ' ' ALA . . . . . . . . . . . . . . . -111.83 134.17 53.57 Favored 'General case' 0 C--N 1.332 -0.191 0 CA-C-N 115.594 -0.73 . . . . 0.0 109.867 175.572 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 54' ' ' TYR . . . . . . . . . . . . . 41.8 t80 -129.04 108.01 18.07 Favored Pre-proline 0 CA--C 1.534 0.36 0 CA-C-O 118.279 -0.867 . . . . 0.0 110.387 179.823 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 55' ' ' PRO . . . . . . . . . . . . . 73.7 Cg_endo -77.16 170.11 72.4 Favored 'Cis proline' 0 N--CA 1.5 1.863 0 CA-C-N 121.826 1.688 . . . . 0.0 112.396 -6.059 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 56' ' ' SER . . . . . . . . . . . . . 20.9 m -116.1 135.19 22.74 Favored Pre-proline 0 CA--C 1.539 0.544 0 CA-C-O 118.489 -0.767 . . . . 0.0 109.709 175.874 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 57' ' ' PRO . . . . . . . . . . . . . 60.8 Cg_endo -75.15 161.62 94.38 Favored 'Cis proline' 0 N--CA 1.497 1.714 0 CA-C-N 121.792 1.676 . . . . 0.0 111.346 -4.982 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 58' ' ' LEU . . . . . . . . . . . . . 40.4 tp -129.98 138.54 50.88 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-O 120.922 0.392 . . . . 0.0 110.335 -179.791 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 59' ' ' ARG . . . . . . . . . . . . . 74.3 ttt180 -95.52 125.99 40.5 Favored 'General case' 0 C--N 1.326 -0.456 0 N-CA-C 109.229 -0.656 . . . . 0.0 109.229 175.235 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 60' ' ' VAL . . . . . . . . . . . . . 49.9 t -74.76 114.49 14.76 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.331 0 C-N-CA 120.709 -0.396 . . . . 0.0 110.392 -174.587 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 61' ' ' GLU . . . . . . . . . . . . . 70.9 mm-40 -131.1 164.53 25.26 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 115.901 -0.59 . . . . 0.0 110.021 176.542 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 62' ' ' ASP . . . . . . . . . . . . . 13.4 t70 -52.34 -30.32 27.97 Favored 'General case' 0 C--N 1.328 -0.345 0 N-CA-C 112.149 0.426 . . . . 0.0 112.149 -179.408 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 63' ' ' ARG . . . . . . . . . . . . . 39.9 mmt180 -72.05 -20.8 61.62 Favored 'General case' 0 CA--C 1.533 0.301 0 N-CA-C 112.968 0.729 . . . . 0.0 112.968 -174.837 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 64' ' ' THR . . . . . . . . . . . . . 32.9 m -75.66 139.44 41.98 Favored 'General case' 0 C--N 1.331 -0.207 0 CA-C-O 120.947 0.403 . . . . 0.0 111.0 -175.896 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 65' ' ' LYS . . . . . . . . . . . . . 2.3 mptm? -89.4 137.56 32.22 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 115.882 -0.599 . . . . 0.0 109.994 177.457 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 66' ' ' ILE . . . . . . . . . . . . . 60.3 mt -116.51 130.88 70.59 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.29 0 N-CA-C 110.047 -0.353 . . . . 0.0 110.047 179.602 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 67' ' ' THR . . . . . . . . . . . . . 25.5 m -125.06 137.76 54.2 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 116.241 -0.436 . . . . 0.0 110.932 -178.631 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 68' ' ' LEU . . . . . 0.417 HD12 ' N ' ' B' ' 68' ' ' LEU . 8.4 mp -103.65 121.16 42.37 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 115.99 -0.55 . . . . 0.0 110.588 178.835 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' B' B ' 69' ' ' VAL . . . . . . . . . . . . . 44.8 t -102.28 129.16 54.17 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.323 0 CA-C-N 116.146 -0.479 . . . . 0.0 109.878 178.007 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 70' ' ' THR . . . . . . . . . . . . . 8.5 t -139.37 135.12 33.36 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-O 120.849 0.357 . . . . 0.0 110.597 179.448 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 71' ' ' HIS . . . . . . . . . . . . . 94.6 m-70 -147.71 80.73 8.82 Favored Pre-proline 0 C--N 1.329 -0.318 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.456 179.72 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 72' ' ' PRO . . . . . . . . . . . . . 72.9 Cg_endo -86.69 150.14 8.67 Favored 'Trans proline' 0 N--CA 1.489 1.248 0 C-N-CA 121.665 1.577 . . . . 0.0 112.272 179.721 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 73' ' ' VAL . . . . . . . . . . . . . 28.9 m -103.19 171.4 1.6 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.262 0 CA-C-N 116.166 -0.47 . . . . 0.0 109.909 177.445 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 74' ' ' ASP . . . . . . . . . . . . . 8.8 t70 -97.28 115.01 26.86 Favored 'General case' 0 C--N 1.329 -0.292 0 N-CA-C 109.803 -0.443 . . . . 0.0 109.803 -178.924 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 75' ' ' VAL . . . . . . . . . . . . . 46.3 t -113.08 120.29 62.71 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.242 0 CA-C-O 121.059 0.457 . . . . 0.0 110.223 -178.164 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 76' ' ' LEU . . . . . . . . . . . . . 26.9 mt -123.45 139.74 53.72 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 115.586 -0.734 . . . . 0.0 109.588 178.739 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 77' ' ' GLU . . . . . . . . . . . . . 97.5 mt-10 -134.61 130.97 37.25 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-O 121.101 0.477 . . . . 0.0 111.18 -178.134 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 78' ' ' ALA . . . . . 0.588 ' HB2' HD21 ' B' ' 109' ' ' LEU . . . -120.97 130.46 53.83 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 115.582 -0.736 . . . . 0.0 109.702 177.005 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' B' B ' 79' ' ' LYS . . . . . 0.646 ' O ' HD13 ' B' ' 80' ' ' ILE . 9.1 ptpp? -73.7 120.97 20.04 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-O 121.201 0.524 . . . . 0.0 110.381 -179.306 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' B' B ' 80' ' ' ILE . . . . . 0.646 HD13 ' O ' ' B' ' 79' ' ' LYS . 36.8 mm -139.12 108.66 3.9 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.288 0 N-CA-C 109.133 -0.691 . . . . 0.0 109.133 -177.648 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' B' B ' 81' ' ' LYS . . . . . . . . . . . . . 45.6 tttm -107.52 125.93 51.89 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-O 120.877 0.37 . . . . 0.0 111.205 -175.827 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 82' ' ' GLY . . . . . . . . . . . . . . . 89.18 42.0 5.69 Favored Glycine 0 CA--C 1.525 0.665 0 C-N-CA 120.773 -0.727 . . . . 0.0 111.811 175.005 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 83' ' ' ILE . . . . . . . . . . . . . 69.7 mt -69.15 139.94 19.64 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.315 0 N-CA-C 109.936 -0.394 . . . . 0.0 109.936 178.206 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 84' ' ' LYS . . . . . . . . . . . . . 53.1 tttp -96.74 -51.98 4.09 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.158 -0.474 . . . . 0.0 110.221 -179.199 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 85' ' ' ASP . . . . . . . . . . . . . 3.8 t70 -155.62 155.13 32.73 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 115.784 -0.644 . . . . 0.0 110.386 -179.902 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 86' ' ' VAL . . . . . . . . . . . . . 44.2 t -133.51 132.33 57.53 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.198 0 CA-C-O 121.05 0.452 . . . . 0.0 110.715 -177.957 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 87' ' ' ILE . . . . . . . . . . . . . 46.5 mm -121.26 128.12 75.91 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.194 0 CA-C-N 115.693 -0.685 . . . . 0.0 109.439 175.361 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 88' ' ' LEU . . . . . . . . . . . . . 12.8 tp -113.84 133.17 55.58 Favored 'General case' 0 C--N 1.331 -0.212 0 CA-C-O 120.997 0.427 . . . . 0.0 111.298 -176.793 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 89' ' ' ASP . . . . . . . . . . . . . 6.8 t70 -124.96 157.88 34.99 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-N 115.863 -0.608 . . . . 0.0 109.684 176.375 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 90' ' ' GLU . . . . . . . . . . . . . 44.3 mt-10 -44.99 -45.87 10.83 Favored 'General case' 0 N--CA 1.465 0.285 0 N-CA-C 113.272 0.841 . . . . 0.0 113.272 -172.025 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 91' ' ' ASN . . . . . . . . . . . . . 7.7 p-10 -131.97 37.7 3.58 Favored 'General case' 0 N--CA 1.463 0.22 0 CA-C-O 120.801 0.334 . . . . 0.0 111.373 -176.836 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 92' ' ' LEU . . . . . . . . . . . . . 4.3 tp -166.0 144.09 5.68 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-O 120.812 0.339 . . . . 0.0 110.33 179.916 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 93' ' ' ILE . . . . . . . . . . . . . 62.9 mt -125.42 124.74 67.65 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.279 0 N-CA-C 109.709 -0.478 . . . . 0.0 109.709 -177.658 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 94' ' ' VAL . . . . . . . . . . . . . 46.5 t -122.4 125.92 73.43 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.242 0 N-CA-C 109.917 -0.401 . . . . 0.0 109.917 179.527 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 95' ' ' VAL . . . . . . . . . . . . . 45.4 t -124.01 138.09 54.84 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.32 0 CA-C-N 116.131 -0.486 . . . . 0.0 110.113 -178.749 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 96' ' ' ILE . . . . . . . . . . . . . 61.8 mt -116.44 128.51 73.76 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.315 0 N-CA-C 109.255 -0.646 . . . . 0.0 109.255 178.556 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 97' ' ' THR . . . . . . . . . . . . . 71.8 p -102.9 159.61 15.34 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-O 121.265 0.555 . . . . 0.0 111.436 -175.888 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 98' ' ' GLU . . . . . . . . . . . . . 84.9 tt0 -53.91 -25.73 21.64 Favored 'General case' 0 CA--C 1.532 0.272 0 CA-C-N 116.083 -0.508 . . . . 0.0 112.161 179.327 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 99' ' ' GLU . . . . . . . . . . . . . 41.2 mt-10 -78.66 14.93 1.14 Allowed 'General case' 0 CA--C 1.535 0.39 0 N-CA-C 113.097 0.777 . . . . 0.0 113.097 -177.773 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 100' ' ' ASN . . . . . . . . . . . . . 2.4 m-20 60.63 38.01 18.89 Favored 'General case' 0 CA--C 1.529 0.167 0 CA-C-O 121.018 0.437 . . . . 0.0 110.713 179.481 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 101' ' ' GLU . . . . . . . . . . . . . 84.9 tt0 -117.29 146.31 43.41 Favored 'General case' 0 C--N 1.332 -0.173 0 CA-C-N 116.078 -0.51 . . . . 0.0 109.795 178.189 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 102' ' ' VAL . . . . . . . . . . . . . 44.9 t -114.95 124.74 71.91 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.275 0 CA-C-N 116.258 -0.428 . . . . 0.0 109.85 -178.158 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 103' ' ' LEU . . . . . . . . . . . . . 50.9 mt -115.15 132.69 56.52 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 115.715 -0.675 . . . . 0.0 109.996 178.594 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 104' ' ' ILE . . . . . 0.449 HD12 ' HB3' ' B' ' 113' ' ' TYR . 66.6 mt -123.22 119.59 58.02 Favored 'Isoleucine or valine' 0 C--O 1.233 0.2 0 N-CA-C 110.375 -0.231 . . . . 0.0 110.375 -178.334 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' B' B ' 105' ' ' PHE . . . . . . . . . . . . . 47.1 m-85 -121.17 164.61 16.62 Favored 'General case' 0 C--N 1.331 -0.211 0 CA-C-N 115.471 -0.786 . . . . 0.0 109.809 178.841 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 106' ' ' ASN . . . . . . . . . . . . . 47.4 p-10 -97.67 -169.98 1.92 Allowed 'General case' 0 C--N 1.33 -0.282 0 N-CA-C 109.652 -0.499 . . . . 0.0 109.652 172.851 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 107' ' ' GLN . . . . . . . . . . . . . 62.6 tt0 -59.67 -30.07 68.5 Favored 'General case' 0 C--N 1.33 -0.27 0 N-CA-C 111.879 0.325 . . . . 0.0 111.879 179.81 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 108' ' ' ASN . . . . . . . . . . . . . 7.0 t30 -83.24 8.76 12.39 Favored 'General case' 0 CA--C 1.536 0.432 0 N-CA-C 113.148 0.796 . . . . 0.0 113.148 -177.535 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 109' ' ' LEU . . . . . 0.588 HD21 ' HB2' ' B' ' 78' ' ' ALA . 11.1 tp 60.99 36.21 18.71 Favored 'General case' 0 CA--C 1.53 0.198 0 CA-C-O 120.838 0.351 . . . . 0.0 111.434 178.845 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' B' B ' 110' ' ' GLU . . . . . . . . . . . . . 95.3 mt-10 -105.9 151.2 24.86 Favored 'General case' 0 C--N 1.33 -0.264 0 N-CA-C 109.898 -0.408 . . . . 0.0 109.898 176.884 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 111' ' ' GLU . . . . . . . . . . . . . 99.4 mt-10 -79.77 121.97 26.03 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-O 120.961 0.41 . . . . 0.0 111.34 -177.107 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 112' ' ' LEU . . . . . . . . . . . . . 16.3 mt -106.6 -45.74 4.16 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 115.894 -0.593 . . . . 0.0 110.086 176.418 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 113' ' ' TYR . . . . . 0.449 ' HB3' HD12 ' B' ' 104' ' ' ILE . 61.1 t80 -141.16 142.92 34.0 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 116.104 -0.498 . . . . 0.0 111.006 -179.488 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' B' B ' 114' ' ' ARG . . . . . . . . . . . . . 83.7 mtp180 -144.86 122.12 11.55 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.097 -0.502 . . . . 0.0 110.285 177.388 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 115' ' ' GLY . . . . . . . . . . . . . . . -150.05 162.59 29.23 Favored Glycine 0 CA--C 1.524 0.646 0 N-CA-C 111.006 -0.837 . . . . 0.0 111.006 179.881 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 116' ' ' LYS . . . . . . . . . . . . . 21.6 ttpt -129.1 140.8 51.42 Favored 'General case' 0 C--N 1.33 -0.267 0 N-CA-C 110.204 -0.295 . . . . 0.0 110.204 179.376 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 117' ' ' PHE . . . . . . . . . . . . . 29.1 m-85 -140.8 113.91 8.48 Favored 'General case' 0 C--N 1.331 -0.215 0 N-CA-C 109.927 -0.397 . . . . 0.0 109.927 -178.919 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 118' ' ' GLU . . . . . . . . . . . . . 70.8 mm-40 -56.19 -40.1 73.44 Favored 'General case' 0 C--N 1.329 -0.304 0 C-N-CA 120.912 -0.315 . . . . 0.0 110.944 -177.164 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 119' ' ' ASN . . . . . . . . . . . . . 80.7 m-20 -98.02 30.73 2.95 Favored 'General case' 0 C--N 1.33 -0.261 0 N-CA-C 112.168 0.432 . . . . 0.0 112.168 -175.502 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 120' ' ' LEU . . . . . . . . . . . . . 15.3 tp -58.29 123.69 16.92 Favored 'General case' 0 C--N 1.332 -0.184 0 N-CA-C 110.177 -0.305 . . . . 0.0 110.177 177.051 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 121' ' ' ASN . . . . . . . . . . . . . 77.7 m-20 -114.09 -44.08 3.18 Favored 'General case' 0 C--N 1.332 -0.195 0 CA-C-N 116.545 -0.298 . . . . 0.0 110.866 -178.475 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 122' ' ' LYS . . . . . . . . . . . . . 97.2 mttt -148.58 153.69 38.71 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-O 121.052 0.453 . . . . 0.0 111.569 -178.288 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 123' ' ' VAL . . . . . . . . . . . . . 46.1 t -133.91 130.87 55.9 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.228 0 CA-C-N 115.95 -0.568 . . . . 0.0 109.658 175.13 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 124' ' ' LEU . . . . . . . . . . . . . 64.5 mt -120.56 138.67 53.74 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.176 -0.465 . . . . 0.0 110.476 -178.206 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 125' ' ' VAL . . . . . . . . . . . . . 11.9 p -133.19 127.35 54.36 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.254 0 CA-C-N 116.463 -0.335 . . . . 0.0 110.266 178.413 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 126' ' ' ARG . . . . . . . . . . . . . 40.8 mmt180 -136.84 116.11 12.61 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.3 -0.409 . . . . 0.0 110.339 -179.707 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 127' ' ' ASN . . . . . . . . . . . . . 47.8 t30 52.67 -106.27 0.28 Allowed 'General case' 0 CA--C 1.543 0.71 0 CA-C-O 119.039 -0.505 . . . . 0.0 111.058 -179.986 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 128' ' ' ASP . . . . . . . . . . . . . 19.0 p-10 -114.09 2.92 15.07 Favored 'General case' 0 CA--C 1.536 0.426 0 CA-C-N 119.665 1.12 . . . . 0.0 113.422 -178.449 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 129' ' ' LEU . . . . . 0.547 HD23 ' N ' ' B' ' 130' ' ' VAL . 2.5 tt -104.86 135.72 45.7 Favored 'General case' 0 C--N 1.332 -0.17 0 N-CA-C 109.583 -0.525 . . . . 0.0 109.583 179.324 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' B' B ' 130' ' ' VAL . . . . . 0.547 ' N ' HD23 ' B' ' 129' ' ' LEU . 42.0 t -123.13 139.64 49.25 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.298 0 CA-C-O 120.799 0.333 . . . . 0.0 110.176 -177.678 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' B' B ' 131' ' ' VAL . . . . . . . . . . . . . 39.9 t -135.8 135.17 51.07 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.284 0 CA-C-N 116.235 -0.438 . . . . 0.0 110.162 179.561 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 132' ' ' ILE . . . . . . . . . . . . . 71.1 mt -117.52 132.45 67.3 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 N-CA-C 109.37 -0.604 . . . . 0.0 109.37 178.493 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 133' ' ' ILE . . . . . . . . . . . . . 37.7 mm -117.79 122.31 69.46 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.268 0 CA-C-O 120.617 0.246 . . . . 0.0 111.09 -174.272 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 134' ' ' ASP . . . . . . . . . . . . . 9.1 p-10 -137.38 147.82 45.76 Favored 'General case' 0 C--N 1.331 -0.207 0 CA-C-N 116.179 -0.464 . . . . 0.0 109.794 174.862 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 135' ' ' GLU . . . . . . . . . . . . . 85.5 tt0 -49.78 -24.67 2.5 Favored 'General case' 0 C--N 1.328 -0.333 0 N-CA-C 112.875 0.695 . . . . 0.0 112.875 -173.239 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 136' ' ' GLN . . . . . . . . . . . . . 56.1 tp60 -83.91 -37.64 22.11 Favored 'General case' 0 C--O 1.235 0.316 0 N-CA-C 111.959 0.355 . . . . 0.0 111.959 -175.762 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 137' ' ' LYS . . . . . . . . . . . . . 54.0 pttt -161.28 171.92 17.53 Favored 'General case' 0 C--N 1.331 -0.239 0 CA-C-O 121.558 0.694 . . . . 0.0 112.072 -172.394 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 138' ' ' LEU . . . . . . . . . . . . . 4.7 tt -118.36 126.21 51.62 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 114.962 -1.017 . . . . 0.0 109.649 177.425 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 139' ' ' THR . . . . . . . . . . . . . 16.9 m -106.88 126.19 51.99 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-N 116.24 -0.436 . . . . 0.0 110.616 -178.735 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 140' ' ' LEU . . . . . . . . . . . . . 30.8 tp -114.98 122.51 46.46 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 115.655 -0.702 . . . . 0.0 109.456 -178.405 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 141' ' ' ILE . . . . . . . . . . . . . 19.3 mt -121.86 119.79 59.71 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.282 0 N-CA-C 110.142 -0.318 . . . . 0.0 110.142 -175.039 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 142' ' ' ARG . . . . . . . . . . . . . 82.0 mtm180 -110.18 127.45 54.94 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 115.661 -0.699 . . . . 0.0 110.286 -179.585 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 143' ' ' THR . . . . . . . . . . . . . 41.6 p . . . . . 0 C--O 1.22 -0.467 0 CA-C-O 118.037 -0.982 . . . . 0.0 110.68 -179.436 . . . . . . . . 0 0 . 1 . 002 nuclear nobuild full ' C' C ' -3' ' ' GLU . . . . . . . . . . . . . 95.7 mt-10 . . . . . 0 N--CA 1.49 1.557 0 N-CA-C 109.441 -0.577 . . . . 0.0 109.441 . . . . . . . . . 0 0 . 1 . 002 nuclear nobuild full ' C' C ' -2' ' ' GLY . . . . . . . . . . . . . . . -72.98 113.2 4.23 Favored Glycine 0 CA--C 1.526 0.771 0 N-CA-C 110.783 -0.927 . . . . 0.0 110.783 178.899 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' C' C ' -1' ' ' VAL . . . . . . . . . . . . . 43.1 t -95.68 139.82 18.23 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 CA-C-O 120.822 0.344 . . . . 0.0 110.11 -179.322 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' C' C ' 0' ' ' ILE . . . . . . . . . . . . . 43.9 mm -100.92 139.32 22.52 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.293 0 CA-C-N 116.15 -0.477 . . . . 0.0 110.205 -179.59 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' C' C ' 1' ' ' MET . . . . . . . . . . . . . 21.5 ptm -77.69 136.84 38.24 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.088 -0.506 . . . . 0.0 110.661 179.939 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' C' C ' 2' ' ' SER . . . . . . . . . . . . . 2.6 p -123.44 127.07 47.89 Favored 'General case' 0 C--N 1.331 -0.239 0 CA-C-N 116.123 -0.489 . . . . 0.0 110.336 178.778 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' C' C ' 3' ' ' GLU . . . . . . . . . . . . . 95.5 mt-10 -140.99 140.34 34.33 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 116.049 -0.523 . . . . 0.0 111.063 -177.9 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' C' C ' 4' ' ' LEU . . . . . . . . . . . . . 16.1 tp -126.62 128.52 46.91 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 115.996 -0.547 . . . . 0.0 110.098 176.508 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' C' C ' 5' ' ' LYS . . . . . . . . . . . . . 97.4 mttt -109.27 121.5 45.31 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.4 -0.363 . . . . 0.0 110.478 179.531 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' C' C ' 6' ' ' LEU . . . . . . . . . . . . . 62.1 mt -116.21 148.8 40.05 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 115.616 -0.72 . . . . 0.0 110.293 -178.398 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' C' C ' 7' ' ' LYS . . . . . . . . . . . . . 75.6 tttt -136.4 138.54 27.16 Favored Pre-proline 0 CA--C 1.535 0.374 0 CA-C-O 118.996 -0.526 . . . . 0.0 110.2 176.774 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' C' C ' 8' ' ' PRO . . . . . . . . . . . . . 94.2 Cg_endo -91.81 142.76 2.74 Favored 'Trans proline' 0 N--CA 1.489 1.263 0 C-N-CA 121.725 1.617 . . . . 0.0 111.664 176.959 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' C' C ' 9' ' ' LEU . . . . . . . . . . . . . 36.9 mt -82.52 -47.83 0.88 Allowed Pre-proline 0 CA--C 1.534 0.343 0 CA-C-O 118.74 -0.647 . . . . 0.0 112.495 -177.681 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' C' C ' 10' ' ' PRO . . . . . . . . . . . . . 94.5 Cg_endo -81.65 161.13 19.2 Favored 'Trans proline' 0 N--CA 1.497 1.694 0 C-N-CA 121.24 1.293 . . . . 0.0 111.969 177.101 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' C' C ' 11' ' ' LYS . . . . . . . . . . . . . 91.0 mttt -86.52 103.11 14.73 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.389 -0.368 . . . . 0.0 110.38 177.825 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' C' C ' 12' ' ' VAL . . . . . . . . . . . . . 11.9 p -141.71 143.61 26.93 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.276 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.371 179.847 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' C' C ' 13' ' ' GLU . . . . . . . . . . . . . 82.5 tt0 -90.82 122.81 33.86 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 116.323 -0.399 . . . . 0.0 109.987 177.967 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' C' C ' 14' ' ' LEU . . . . . . . . . . . . . 25.3 mt -96.9 152.38 38.36 Favored Pre-proline 0 C--N 1.329 -0.311 0 CA-C-N 116.458 -0.337 . . . . 0.0 111.03 -175.973 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' C' C ' 15' ' ' PRO . . . . . . . . . . . . . 26.6 Cg_exo -61.72 163.11 19.48 Favored 'Trans proline' 0 N--CA 1.497 1.711 0 C-N-CA 121.255 1.303 . . . . 0.0 111.892 176.634 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' C' C ' 16' ' ' PRO . . . . . . . . . . . . . 25.2 Cg_exo -61.64 -44.44 21.77 Favored 'Trans proline' 0 N--CA 1.497 1.713 0 C-N-CA 121.516 1.478 . . . . 0.0 112.668 -178.472 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' C' C ' 17' ' ' ASP . . . . . . . . . . . . . 22.3 p-10 -88.72 16.23 7.07 Favored 'General case' 0 C--N 1.327 -0.385 0 N-CA-C 112.994 0.738 . . . . 0.0 112.994 -177.13 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' C' C ' 18' ' ' PHE . . . . . 0.522 ' CZ ' HD11 ' C' ' 22' ' ' ILE . 63.4 t80 -57.6 -41.53 81.43 Favored 'General case' 0 C--N 1.335 -0.064 0 O-C-N 122.053 -0.404 . . . . 0.0 110.315 -178.59 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' C' C ' 19' ' ' VAL . . . . . . . . . . . . . 44.3 t -56.26 -45.56 81.22 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.338 0 CA-C-N 116.47 -0.332 . . . . 0.0 110.624 -178.173 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' C' C ' 20' ' ' ASP . . . . . . . . . . . . . 51.4 m-20 -60.6 -40.43 91.77 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-O 120.763 0.316 . . . . 0.0 111.021 -178.295 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' C' C ' 21' ' ' VAL . . . . . . . . . . . . . 48.2 t -64.0 -48.46 85.91 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.328 0 C-N-CA 120.769 -0.373 . . . . 0.0 110.421 -178.373 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' C' C ' 22' ' ' ILE . . . . . 0.542 HG22 HD12 ' C' ' 26' ' ' LEU . 51.5 mm -55.61 -44.37 76.41 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.299 0 CA-C-O 120.895 0.379 . . . . 0.0 110.461 178.29 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' C' C ' 23' ' ' ARG . . . . . . . . . . . . . 56.6 ttp180 -52.51 -52.26 55.44 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-O 120.717 0.294 . . . . 0.0 111.609 -179.955 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' C' C ' 24' ' ' ILE . . . . . . . . . . . . . 71.1 mt -59.4 -40.63 82.12 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.294 0 CA-C-N 116.407 -0.361 . . . . 0.0 111.389 -176.338 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' C' C ' 25' ' ' LYS . . . . . . . . . . . . . 91.3 mttt -67.2 -37.83 84.31 Favored 'General case' 0 C--N 1.329 -0.288 0 N-CA-C 112.179 0.437 . . . . 0.0 112.179 -179.53 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' C' C ' 26' ' ' LEU . . . . . 0.542 HD12 HG22 ' C' ' 22' ' ' ILE . 68.2 mt -79.13 -41.18 29.15 Favored 'General case' 0 C--N 1.329 -0.295 0 N-CA-C 113.125 0.787 . . . . 0.0 113.125 -171.297 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' C' C ' 27' ' ' GLN . . . . . . . . . . . . . 9.9 pt20 -46.68 139.0 5.57 Favored 'General case' 0 N--CA 1.47 0.558 0 N-CA-C 112.659 0.614 . . . . 0.0 112.659 -176.151 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' C' C ' 28' ' ' GLY . . . . . . . . . . . . . . . 101.13 -26.87 23.07 Favored Glycine 0 CA--C 1.532 1.114 0 CA-C-N 115.536 -0.756 . . . . 0.0 112.213 -177.441 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' C' C ' 29' ' ' LYS . . . . . . . . . . . . . 61.7 mtpt -98.22 155.2 17.29 Favored 'General case' 0 C--N 1.333 -0.138 0 CA-C-N 117.32 0.56 . . . . 0.0 111.2 179.595 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' C' C ' 30' ' ' THR . . . . . . . . . . . . . 36.0 m -105.91 135.63 47.0 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 115.962 -0.563 . . . . 0.0 109.939 175.705 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' C' C ' 31' ' ' VAL . . . . . . . . . . . . . 34.5 m -132.87 158.32 43.24 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.271 0 CA-C-O 120.947 0.403 . . . . 0.0 111.019 -177.587 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' C' C ' 32' ' ' ARG . . . . . . . . . . . . . 50.7 mtp180 -134.89 152.71 51.97 Favored 'General case' 0 C--N 1.331 -0.219 0 CA-C-O 121.353 0.597 . . . . 0.0 110.706 178.736 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' C' C ' 33' ' ' THR . . . . . . . . . . . . . 22.1 m -52.57 140.17 23.68 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 115.997 -0.547 . . . . 0.0 111.509 -178.347 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' C' C ' 34' ' ' GLY . . . . . . . . . . . . . . . 100.0 -17.22 57.51 Favored Glycine 0 CA--C 1.532 1.117 0 CA-C-O 119.553 -0.582 . . . . 0.0 113.258 178.092 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' C' C ' 35' ' ' ASP . . . . . . . . . . . . . 77.5 m-20 -66.06 148.08 52.36 Favored 'General case' 0 N--CA 1.461 0.109 0 CA-C-N 118.148 0.974 . . . . 0.0 110.897 178.836 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' C' C ' 36' ' ' VAL . . . . . . . . . . . . . 44.2 t -124.92 132.8 70.85 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.238 0 CA-C-N 116.169 -0.468 . . . . 0.0 109.955 178.648 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' C' C ' 37' ' ' ILE . . . . . . . . . . . . . 67.8 mt -123.43 141.64 42.97 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.286 0 CA-C-N 116.072 -0.513 . . . . 0.0 110.04 -178.714 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' C' C ' 38' ' ' GLY . . . . . . . . . . . . . . . -111.56 129.0 8.91 Favored Glycine 0 CA--C 1.525 0.673 0 N-CA-C 111.021 -0.832 . . . . 0.0 111.021 179.667 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' C' C ' 39' ' ' ILE . . . . . . . . . . . . . 76.3 mt -125.39 137.34 57.96 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.193 0 CA-C-O 120.731 0.3 . . . . 0.0 110.205 179.805 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' C' C ' 40' ' ' SER . . . . . . . . . . . . . 35.8 t -93.4 124.6 37.5 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.273 -0.421 . . . . 0.0 110.903 175.643 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' C' C ' 41' ' ' ILE . . . . . 0.432 HD12 HG11 ' C' ' 46' ' ' VAL . 73.1 mt -130.56 119.59 46.21 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.181 0 CA-C-O 120.845 0.355 . . . . 0.0 110.336 177.757 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' C' C ' 42' ' ' LEU . . . . . . . . . . . . . 7.3 mp 51.71 37.24 19.66 Favored 'General case' 0 C--N 1.331 -0.221 0 CA-C-N 116.06 -0.518 . . . . 0.0 111.489 177.306 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' C' C ' 43' ' ' GLY . . . . . . . . . . . . . . . 72.58 30.88 63.58 Favored Glycine 0 CA--C 1.528 0.892 0 C-N-CA 121.07 -0.586 . . . . 0.0 112.309 176.837 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' C' C ' 44' ' ' LYS . . . . . . . . . . . . . 82.4 tttt -137.75 131.62 31.56 Favored 'General case' 0 C--N 1.33 -0.265 0 N-CA-C 109.692 -0.484 . . . . 0.0 109.692 177.085 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' C' C ' 45' ' ' GLU . . . . . . . . . . . . . 81.2 tt0 -82.91 123.08 29.07 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-O 120.725 0.298 . . . . 0.0 111.179 -177.345 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' C' C ' 46' ' ' VAL . . . . . 0.432 HG11 HD12 ' C' ' 41' ' ' ILE . 7.3 p -121.58 128.24 75.77 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.223 0 N-CA-C 109.624 -0.51 . . . . 0.0 109.624 176.212 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' C' C ' 47' ' ' LYS . . . . . . . . . . . . . 66.8 mttm -99.45 129.99 45.68 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.008 -0.542 . . . . 0.0 111.138 178.668 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' C' C ' 48' ' ' PHE . . . . . . . . . . . . . 91.6 m-85 -113.82 131.86 56.09 Favored 'General case' 0 C--N 1.33 -0.269 0 N-CA-C 109.873 -0.418 . . . . 0.0 109.873 176.255 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' C' C ' 49' ' ' LYS . . . . . . . . . . . . . 63.6 tttm -109.28 139.23 44.48 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.528 -0.305 . . . . 0.0 110.7 178.323 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' C' C ' 50' ' ' VAL . . . . . . . . . . . . . 45.7 t -81.17 108.54 14.56 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.352 0 N-CA-C 109.327 -0.62 . . . . 0.0 109.327 175.614 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' C' C ' 51' ' ' VAL . . . . . . . . . . . . . 46.7 t -70.04 -48.66 61.37 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.316 0 CA-C-N 116.131 -0.486 . . . . 0.0 109.8 -174.494 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' C' C ' 52' ' ' GLN . . . . . . . . . . . . . 61.6 tt0 -165.72 148.21 7.51 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.063 -0.517 . . . . 0.0 111.691 -178.964 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' C' C ' 53' ' ' ALA . . . . . . . . . . . . . . . -123.35 133.55 54.11 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 115.655 -0.702 . . . . 0.0 110.01 177.928 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' C' C ' 54' ' ' TYR . . . . . . . . . . . . . 10.3 t80 -129.02 111.98 18.5 Favored Pre-proline 0 CA--C 1.536 0.409 0 CA-C-O 118.179 -0.915 . . . . 0.0 110.483 178.977 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' C' C ' 55' ' ' PRO . . . . . . . . . . . . . 73.2 Cg_endo -77.23 168.27 77.32 Favored 'Cis proline' 0 N--CA 1.501 1.918 0 CA-C-N 122.028 1.76 . . . . 0.0 112.278 -6.782 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' C' C ' 56' ' ' SER . . . . . . . . . . . . . 13.5 m -117.35 132.33 23.59 Favored Pre-proline 0 CA--C 1.539 0.533 0 CA-C-O 118.453 -0.784 . . . . 0.0 109.292 174.21 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' C' C ' 57' ' ' PRO . . . . . . . . . . . . . 54.2 Cg_endo -70.08 147.15 84.72 Favored 'Cis proline' 0 N--CA 1.497 1.735 0 CA-C-N 121.834 1.691 . . . . 0.0 111.573 -0.109 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' C' C ' 58' ' ' LEU . . . . . . . . . . . . . 24.6 tp -108.51 136.51 48.0 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.409 -0.359 . . . . 0.0 110.843 -178.427 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' C' C ' 59' ' ' ARG . . . . . . . . . . . . . 59.2 ttt85 -102.95 121.11 41.86 Favored 'General case' 0 C--N 1.326 -0.421 0 N-CA-C 109.288 -0.634 . . . . 0.0 109.288 175.15 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' C' C ' 60' ' ' VAL . . . . . . . . . . . . . 42.5 t -76.42 118.42 22.78 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.28 0 C-N-CA 120.728 -0.389 . . . . 0.0 110.559 -174.881 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' C' C ' 61' ' ' GLU . . . . . . . . . . . . . 71.0 mm-40 -130.99 162.7 29.18 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 115.984 -0.553 . . . . 0.0 109.779 176.377 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' C' C ' 62' ' ' ASP . . . . . . . . . . . . . 80.3 m-20 -52.41 -30.5 29.66 Favored 'General case' 0 C--N 1.329 -0.302 0 N-CA-C 112.05 0.389 . . . . 0.0 112.05 179.758 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' C' C ' 63' ' ' ARG . . . . . . . . . . . . . 77.1 mtp85 -72.61 -21.85 61.05 Favored 'General case' 0 CA--C 1.533 0.294 0 N-CA-C 112.894 0.702 . . . . 0.0 112.894 -175.956 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' C' C ' 64' ' ' THR . . . . . . . . . . . . . 26.4 m -69.52 137.7 52.72 Favored 'General case' 0 C--N 1.331 -0.215 0 CA-C-O 120.993 0.425 . . . . 0.0 111.292 -174.683 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' C' C ' 65' ' ' LYS . . . . . . . . . . . . . 98.7 mttt -90.08 135.61 33.55 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 115.832 -0.622 . . . . 0.0 110.111 177.561 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' C' C ' 66' ' ' ILE . . . . . . . . . . . . . 64.4 mt -117.66 132.89 66.14 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.224 0 CA-C-O 120.868 0.366 . . . . 0.0 110.166 -179.787 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' C' C ' 67' ' ' THR . . . . . . . . . . . . . 30.1 m -122.39 139.61 53.64 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 115.988 -0.551 . . . . 0.0 110.813 -179.188 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' C' C ' 68' ' ' LEU . . . . . . . . . . . . . 4.1 tt -103.63 121.74 43.56 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 115.982 -0.554 . . . . 0.0 110.29 178.971 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' C' C ' 69' ' ' VAL . . . . . . . . . . . . . 42.0 t -101.63 129.13 53.29 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.257 0 CA-C-N 116.363 -0.381 . . . . 0.0 110.581 -178.031 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' C' C ' 70' ' ' THR . . . . . . . . . . . . . 12.0 m -144.76 132.7 21.35 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 115.992 -0.549 . . . . 0.0 110.128 177.114 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' C' C ' 71' ' ' HIS . . . . . . . . . . . . . 61.0 m-70 -129.4 84.79 60.97 Favored Pre-proline 0 CA--C 1.533 0.31 0 CA-C-N 116.5 -0.318 . . . . 0.0 110.577 -178.585 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' C' C ' 72' ' ' PRO . . . . . . . . . . . . . 74.1 Cg_endo -81.88 160.05 18.58 Favored 'Trans proline' 0 N--CA 1.493 1.465 0 C-N-CA 121.474 1.45 . . . . 0.0 112.429 -179.551 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' C' C ' 73' ' ' VAL . . . . . . . . . . . . . 30.2 m -116.53 171.22 5.48 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.229 0 CA-C-N 115.981 -0.554 . . . . 0.0 110.382 -179.973 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' C' C ' 74' ' ' ASP . . . . . . . . . . . . . 25.8 t0 -98.59 119.91 38.13 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.463 -0.335 . . . . 0.0 110.243 -177.552 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' C' C ' 75' ' ' VAL . . . . . . . . . . . . . 44.2 t -114.84 121.79 67.64 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.222 0 CA-C-O 121.176 0.513 . . . . 0.0 110.379 -179.277 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' C' C ' 76' ' ' LEU . . . . . . . . . . . . . 24.3 mt -118.92 146.58 44.83 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 115.553 -0.749 . . . . 0.0 109.628 178.119 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' C' C ' 77' ' ' GLU . . . . . . . . . . . . . 97.6 mt-10 -138.62 129.35 26.39 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-O 121.051 0.453 . . . . 0.0 111.204 -179.214 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' C' C ' 78' ' ' ALA . . . . . 0.746 ' HB2' HD21 ' C' ' 109' ' ' LEU . . . -116.94 136.5 52.9 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 115.797 -0.638 . . . . 0.0 109.787 177.345 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' C' C ' 79' ' ' LYS . . . . . 0.627 ' O ' HD13 ' C' ' 80' ' ' ILE . 52.2 pttt -84.79 119.4 25.26 Favored 'General case' 0 C--N 1.331 -0.218 0 CA-C-O 121.237 0.541 . . . . 0.0 111.006 -177.247 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' C' C ' 80' ' ' ILE . . . . . 0.627 HD13 ' O ' ' C' ' 79' ' ' LYS . 36.0 mm -139.43 117.98 12.26 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.212 0 N-CA-C 109.277 -0.638 . . . . 0.0 109.277 179.946 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' C' C ' 81' ' ' LYS . . . . . . . . . . . . . 57.2 tttm -103.36 122.54 45.05 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-O 120.777 0.322 . . . . 0.0 111.031 -178.037 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' C' C ' 82' ' ' GLY . . . . . . . . . . . . . . . 89.24 42.13 5.64 Favored Glycine 0 CA--C 1.526 0.719 0 C-N-CA 120.819 -0.705 . . . . 0.0 111.831 175.044 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' C' C ' 83' ' ' ILE . . . . . . . . . . . . . 75.3 mt -66.97 137.42 24.87 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.312 0 N-CA-C 109.858 -0.423 . . . . 0.0 109.858 177.318 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' C' C ' 84' ' ' LYS . . . . . . . . . . . . . 80.0 tttt -96.74 -54.02 3.36 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 115.971 -0.558 . . . . 0.0 110.326 -177.727 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' C' C ' 85' ' ' ASP . . . . . . . . . . . . . 8.1 t70 -151.14 150.01 30.15 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 115.748 -0.66 . . . . 0.0 110.407 -177.648 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' C' C ' 86' ' ' VAL . . . . . . . . . . . . . 44.6 t -129.04 129.18 67.87 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.266 0 CA-C-O 120.896 0.379 . . . . 0.0 110.435 -179.483 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' C' C ' 87' ' ' ILE . . . . . 0.497 ' N ' HD12 ' C' ' 87' ' ' ILE . 5.0 mp -117.45 125.56 74.11 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.288 0 CA-C-N 115.909 -0.587 . . . . 0.0 109.481 176.872 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' C' C ' 88' ' ' LEU . . . . . . . . . . . . . 16.7 tp -110.5 129.68 55.73 Favored 'General case' 0 C--N 1.331 -0.221 0 CA-C-N 116.373 -0.376 . . . . 0.0 110.719 -179.025 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' C' C ' 89' ' ' ASP . . . . . . . . . . . . . 11.9 t70 -126.63 154.75 43.58 Favored 'General case' 0 C--N 1.331 -0.222 0 CA-C-N 116.119 -0.491 . . . . 0.0 109.945 178.0 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' C' C ' 90' ' ' GLU . . . . . . . . . . . . . 77.8 tt0 -45.73 -35.14 4.04 Favored 'General case' 0 C--N 1.329 -0.299 0 N-CA-C 113.332 0.864 . . . . 0.0 113.332 -172.218 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' C' C ' 91' ' ' ASN . . . . . . . . . . . . . 56.7 m-80 -130.87 15.27 5.28 Favored 'General case' 0 N--CA 1.469 0.488 0 N-CA-C 113.309 0.855 . . . . 0.0 113.309 -175.587 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' C' C ' 92' ' ' LEU . . . . . . . . . . . . . 8.5 mt -150.34 151.97 33.71 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 118.131 0.423 . . . . 0.0 110.33 -176.414 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' C' C ' 93' ' ' ILE . . . . . . . . . . . . . 70.1 mt -129.15 119.29 48.63 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.316 0 N-CA-C 109.172 -0.677 . . . . 0.0 109.172 177.342 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' C' C ' 94' ' ' VAL . . . . . 0.56 HG21 HG11 ' C' ' 125' ' ' VAL . 45.7 t -119.91 127.98 75.91 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.252 0 CA-C-O 120.875 0.369 . . . . 0.0 110.08 -178.364 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' C' C ' 95' ' ' VAL . . . . . . . . . . . . . 42.5 t -122.46 134.02 66.93 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.25 0 CA-C-N 116.045 -0.525 . . . . 0.0 109.899 -179.984 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' C' C ' 96' ' ' ILE . . . . . . . . . . . . . 64.9 mt -114.54 127.65 71.93 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.386 0 N-CA-C 109.384 -0.599 . . . . 0.0 109.384 179.435 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' C' C ' 97' ' ' THR . . . . . . . . . . . . . 68.1 p -97.8 156.46 16.57 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-O 120.92 0.391 . . . . 0.0 110.732 -179.495 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' C' C ' 98' ' ' GLU . . . . . . . . . . . . . 45.6 tp10 -53.82 -26.5 24.44 Favored 'General case' 0 CA--C 1.534 0.336 0 N-CA-C 112.1 0.407 . . . . 0.0 112.1 -179.531 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' C' C ' 99' ' ' GLU . . . . . . . . . . . . . 28.3 tt0 -79.74 17.26 0.95 Allowed 'General case' 0 CA--C 1.536 0.417 0 N-CA-C 113.004 0.742 . . . . 0.0 113.004 -176.467 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' C' C ' 100' ' ' ASN . . . . . . . . . . . . . 3.0 m-20 62.74 31.39 16.6 Favored 'General case' 0 CA--C 1.532 0.272 0 O-C-N 122.11 -0.369 . . . . 0.0 111.908 176.765 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' C' C ' 101' ' ' GLU . . . . . . . . . . . . . 84.8 tt0 -111.92 142.55 44.18 Favored 'General case' 0 C--N 1.332 -0.165 0 N-CA-C 109.594 -0.521 . . . . 0.0 109.594 173.762 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' C' C ' 102' ' ' VAL . . . . . . . . . . . . . 43.3 t -115.42 129.33 71.87 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.306 0 CA-C-N 116.368 -0.378 . . . . 0.0 110.213 -177.449 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' C' C ' 103' ' ' LEU . . . . . . . . . . . . . 39.9 mt -115.96 129.7 56.5 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 115.601 -0.727 . . . . 0.0 109.822 176.9 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' C' C ' 104' ' ' ILE . . . . . . . . . . . . . 67.4 mt -117.97 121.19 66.73 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.228 0 N-CA-C 110.343 -0.243 . . . . 0.0 110.343 -178.784 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' C' C ' 105' ' ' PHE . . . . . . . . . . . . . 52.7 m-85 -122.66 166.95 14.06 Favored 'General case' 0 C--N 1.333 -0.139 0 O-C-N 123.872 0.732 . . . . 0.0 109.948 179.625 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' C' C ' 106' ' ' ASN . . . . . . . . . . . . . 43.9 p-10 -102.23 -169.97 1.75 Allowed 'General case' 0 C--N 1.33 -0.245 0 N-CA-C 109.972 -0.381 . . . . 0.0 109.972 174.883 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' C' C ' 107' ' ' GLN . . . . . . . . . . . . . 43.2 tt0 -57.19 -29.52 63.75 Favored 'General case' 0 C--N 1.33 -0.274 0 N-CA-C 111.915 0.339 . . . . 0.0 111.915 178.19 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' C' C ' 108' ' ' ASN . . . . . . . . . . . . . 4.0 t-20 -84.67 11.5 8.85 Favored 'General case' 0 CA--C 1.535 0.384 0 N-CA-C 113.009 0.744 . . . . 0.0 113.009 -176.96 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' C' C ' 109' ' ' LEU . . . . . 0.746 HD21 ' HB2' ' C' ' 78' ' ' ALA . 9.7 tp 53.65 37.23 25.56 Favored 'General case' 0 C--O 1.233 0.19 0 CA-C-O 121.064 0.459 . . . . 0.0 111.254 -179.809 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' C' C ' 110' ' ' GLU . . . . . . . . . . . . . 95.8 mt-10 -104.8 145.36 30.48 Favored 'General case' 0 C--N 1.33 -0.25 0 N-CA-C 109.566 -0.531 . . . . 0.0 109.566 175.499 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' C' C ' 111' ' ' GLU . . . . . . . . . . . . . 71.0 tt0 -80.01 121.93 26.1 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-O 120.893 0.377 . . . . 0.0 110.576 -176.738 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' C' C ' 112' ' ' LEU . . . . . . . . . . . . . 10.8 mt -107.66 -46.05 3.9 Favored 'General case' 0 C--N 1.331 -0.218 0 CA-C-N 116.066 -0.515 . . . . 0.0 110.386 -179.54 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' C' C ' 113' ' ' TYR . . . . . . . . . . . . . 55.6 t80 -136.79 142.2 42.94 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-N 116.336 -0.393 . . . . 0.0 111.085 -178.784 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' C' C ' 114' ' ' ARG . . . . . . . . . . . . . 35.9 ptt-85 -142.52 124.59 15.34 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.063 -0.517 . . . . 0.0 110.363 177.507 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' C' C ' 115' ' ' GLY . . . . . . . . . . . . . . . -150.11 162.6 29.25 Favored Glycine 0 CA--C 1.524 0.629 0 N-CA-C 111.123 -0.791 . . . . 0.0 111.123 -179.765 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' C' C ' 116' ' ' LYS . . . . . . . . . . . . . 69.2 tttt -132.09 136.73 47.38 Favored 'General case' 0 C--N 1.329 -0.319 0 N-CA-C 109.797 -0.445 . . . . 0.0 109.797 177.266 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' C' C ' 117' ' ' PHE . . . . . . . . . . . . . 38.2 m-85 -133.67 114.8 13.88 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-O 120.905 0.383 . . . . 0.0 110.179 -175.595 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' C' C ' 118' ' ' GLU . . . . . . . . . . . . . 71.0 mm-40 -51.07 -52.42 43.59 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.454 -0.339 . . . . 0.0 111.792 -176.042 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' C' C ' 119' ' ' ASN . . . . . . . . . . . . . 1.8 m-80 -95.63 31.18 2.09 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.274 -0.421 . . . . 0.0 112.024 -174.193 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' C' C ' 120' ' ' LEU . . . . . . . . . . . . . 18.3 tp -53.57 121.24 7.36 Favored 'General case' 0 N--CA 1.463 0.22 0 O-C-N 122.234 -0.291 . . . . 0.0 110.929 178.704 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' C' C ' 121' ' ' ASN . . . . . . . . . . . . . 69.2 m-20 -113.75 -43.85 3.25 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.341 -0.391 . . . . 0.0 110.929 -177.096 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' C' C ' 122' ' ' LYS . . . . . . . . . . . . . 97.1 mttt -144.69 147.47 33.05 Favored 'General case' 0 C--N 1.332 -0.177 0 CA-C-O 121.154 0.502 . . . . 0.0 111.946 -176.993 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' C' C ' 123' ' ' VAL . . . . . . . . . . . . . 45.6 t -125.82 125.43 68.31 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.259 0 N-CA-C 109.079 -0.711 . . . . 0.0 109.079 173.351 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' C' C ' 124' ' ' LEU . . . . . . . . . . . . . 59.9 mt -123.9 138.76 54.43 Favored 'General case' 0 C--N 1.331 -0.216 0 CA-C-O 120.877 0.37 . . . . 0.0 110.99 -176.232 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' C' C ' 125' ' ' VAL . . . . . 0.56 HG11 HG21 ' C' ' 94' ' ' VAL . 35.7 m -133.97 140.51 46.16 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.28 0 CA-C-N 116.018 -0.537 . . . . 0.0 110.365 178.399 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' C' C ' 126' ' ' ARG . . . . . . . . . . . . . 38.9 ttt180 -151.09 122.66 7.95 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-O 120.98 0.419 . . . . 0.0 110.67 177.634 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' C' C ' 127' ' ' ASN . . . . . . . . . . . . . 20.3 t-20 52.08 -107.29 0.32 Allowed 'General case' 0 CA--C 1.543 0.687 0 CA-C-O 118.968 -0.539 . . . . 0.0 111.177 -179.048 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' C' C ' 128' ' ' ASP . . . . . . . . . . . . . 17.7 p-10 -114.17 5.07 15.78 Favored 'General case' 0 N--CA 1.467 0.413 0 CA-C-N 119.654 1.116 . . . . 0.0 113.468 -177.223 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' C' C ' 129' ' ' LEU . . . . . . . . . . . . . 18.3 tp -106.66 138.62 42.49 Favored 'General case' 0 C--O 1.232 0.147 0 O-C-N 122.008 -0.432 . . . . 0.0 110.362 -179.419 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' C' C ' 130' ' ' VAL . . . . . . . . . . . . . 40.4 t -121.33 135.36 61.75 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.227 0 N-CA-C 109.724 -0.472 . . . . 0.0 109.724 179.938 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' C' C ' 131' ' ' VAL . . . . . 0.436 HG22 HD12 ' C' ' 140' ' ' LEU . 43.0 t -136.01 136.82 49.42 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.24 0 CA-C-O 120.997 0.427 . . . . 0.0 110.419 179.985 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' C' C ' 132' ' ' ILE . . . . . . . . . . . . . 68.5 mt -118.42 133.87 63.86 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.314 0 CA-C-N 115.853 -0.612 . . . . 0.0 109.491 179.058 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' C' C ' 133' ' ' ILE . . . . . . . . . . . . . 37.6 mm -116.78 119.31 61.62 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.231 0 CA-C-N 116.52 -0.309 . . . . 0.0 110.941 -175.361 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' C' C ' 134' ' ' ASP . . . . . . . . . . . . . 7.4 p-10 -130.13 148.95 52.03 Favored 'General case' 0 C--N 1.332 -0.182 0 N-CA-C 109.727 -0.471 . . . . 0.0 109.727 174.258 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' C' C ' 135' ' ' GLU . . . . . . . . . . . . . 39.2 tp10 -49.95 -24.57 2.63 Favored 'General case' 0 C--N 1.329 -0.302 0 N-CA-C 112.996 0.739 . . . . 0.0 112.996 -170.471 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' C' C ' 136' ' ' GLN . . . . . . . . . . . . . 52.8 mt-30 -104.76 -26.63 12.19 Favored 'General case' 0 N--CA 1.464 0.248 0 N-CA-C 112.773 0.657 . . . . 0.0 112.773 -174.113 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' C' C ' 137' ' ' LYS . . . . . . . . . . . . . 56.6 mtpt -141.15 150.0 42.23 Favored 'General case' 0 C--N 1.332 -0.194 0 CA-C-O 121.404 0.621 . . . . 0.0 112.099 -169.038 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' C' C ' 138' ' ' LEU . . . . . . . . . . . . . 18.1 tp -111.12 120.6 42.86 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 115.054 -0.975 . . . . 0.0 109.045 173.259 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' C' C ' 139' ' ' THR . . . . . . . . . . . . . 27.0 m -109.82 126.02 53.36 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-O 120.82 0.343 . . . . 0.0 110.973 -178.23 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' C' C ' 140' ' ' LEU . . . . . 0.436 HD12 HG22 ' C' ' 131' ' ' VAL . 17.7 tp -115.61 122.71 46.42 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 115.471 -0.786 . . . . 0.0 109.309 -179.361 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' C' C ' 141' ' ' ILE . . . . . . . . . . . . . 19.5 mt -121.76 119.42 58.74 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 N-CA-C 109.763 -0.458 . . . . 0.0 109.763 -176.37 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' C' C ' 142' ' ' ARG . . . . . . . . . . . . . 82.6 mtm180 -111.92 122.93 49.14 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 115.691 -0.686 . . . . 0.0 110.721 -177.769 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' C' C ' 143' ' ' THR . . . . . . . . . . . . . 41.1 p . . . . . 0 C--O 1.22 -0.477 0 CA-C-O 118.06 -0.971 . . . . 0.0 110.606 -179.52 . . . . . . . . 0 0 . 1 . 002 nuclear nobuild full ' D' D ' -3' ' ' GLU . . . . . . . . . . . . . 44.3 mp0 . . . . . 0 N--CA 1.489 1.524 0 N-CA-C 109.317 -0.623 . . . . 0.0 109.317 . . . . . . . . . 0 0 . 1 . 002 nuclear nobuild full ' D' D ' -2' ' ' GLY . . . . . . . . . . . . . . . -69.92 140.14 32.44 Favored Glycine 0 CA--C 1.525 0.692 0 N-CA-C 111.123 -0.791 . . . . 0.0 111.123 -179.54 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' D' D ' -1' ' ' VAL . . . . . . . . . . . . . 46.9 t -141.47 131.61 25.57 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.348 0 N-CA-C 109.607 -0.516 . . . . 0.0 109.607 178.451 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' D' D ' 0' ' ' ILE . . . . . . . . . . . . . 69.9 mt -111.77 126.92 69.2 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.266 0 CA-C-N 116.249 -0.432 . . . . 0.0 110.227 -178.173 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' D' D ' 1' ' ' MET . . . . . . . . . . . . . 18.2 ptp -80.39 119.82 23.6 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.049 -0.523 . . . . 0.0 110.134 177.655 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' D' D ' 2' ' ' SER . . . . . . . . . . . . . 92.7 p -113.95 154.55 27.39 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-O 121.01 0.433 . . . . 0.0 110.742 -177.836 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' D' D ' 3' ' ' GLU . . . . . . . . . . . . . 47.1 mp0 -139.41 144.58 38.17 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 115.933 -0.576 . . . . 0.0 111.227 -176.669 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' D' D ' 4' ' ' LEU . . . . . . . . . . . . . 16.4 tp -123.32 126.8 47.54 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 115.777 -0.647 . . . . 0.0 109.685 175.187 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' D' D ' 5' ' ' LYS . . . . . . . . . . . . . 88.3 mttt -109.02 121.0 44.21 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.384 -0.371 . . . . 0.0 110.642 -178.542 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' D' D ' 6' ' ' LEU . . . . . . . . . . . . . 47.8 mt -115.48 144.5 43.75 Favored 'General case' 0 C--N 1.331 -0.21 0 CA-C-N 115.87 -0.605 . . . . 0.0 110.256 -179.844 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' D' D ' 7' ' ' LYS . . . . . . . . . . . . . 45.4 tttp -127.37 136.89 29.59 Favored Pre-proline 0 CA--C 1.532 0.278 0 CA-C-O 118.886 -0.578 . . . . 0.0 109.465 175.17 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' D' D ' 8' ' ' PRO . . . . . . . . . . . . . 71.9 Cg_endo -90.41 132.99 1.82 Allowed 'Trans proline' 0 N--CA 1.49 1.319 0 C-N-CA 121.619 1.546 . . . . 0.0 111.858 178.548 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' D' D ' 9' ' ' LEU . . . . . . . . . . . . . 43.0 mt -72.26 -46.99 10.77 Favored Pre-proline 0 C--N 1.329 -0.313 0 CA-C-O 118.69 -0.671 . . . . 0.0 111.963 -179.956 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' D' D ' 10' ' ' PRO . . . . . . . . . . . . . 93.2 Cg_endo -82.37 146.63 13.94 Favored 'Trans proline' 0 N--CA 1.496 1.62 0 C-N-CA 121.178 1.252 . . . . 0.0 111.635 174.978 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' D' D ' 11' ' ' LYS . . . . . . . . . . . . . 25.1 pttm -71.67 119.2 15.49 Favored 'General case' 0 C--N 1.331 -0.203 0 N-CA-C 109.692 -0.484 . . . . 0.0 109.692 177.19 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' D' D ' 12' ' ' VAL . . . . . . . . . . . . . 12.2 p -151.17 149.51 14.07 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.288 0 CA-C-N 116.094 -0.503 . . . . 0.0 111.127 -176.414 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' D' D ' 13' ' ' GLU . . . . . . . . . . . . . 42.5 mt-10 -108.46 109.98 21.38 Favored 'General case' 0 C--N 1.331 -0.227 0 CA-C-N 115.985 -0.552 . . . . 0.0 109.81 175.466 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' D' D ' 14' ' ' LEU . . . . . . . . . . . . . 16.1 mt -97.6 152.1 37.98 Favored Pre-proline 0 CA--C 1.532 0.282 0 CA-C-O 119.398 -0.334 . . . . 0.0 110.915 -176.724 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' D' D ' 15' ' ' PRO . . . . . . . . . . . . . 25.5 Cg_exo -62.36 160.41 31.39 Favored 'Trans proline' 0 N--CA 1.498 1.769 0 C-N-CA 121.337 1.358 . . . . 0.0 111.894 176.999 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' D' D ' 16' ' ' PRO . . . . . . . . . . . . . 27.2 Cg_exo -60.98 -37.79 73.91 Favored 'Trans proline' 0 N--CA 1.498 1.758 0 C-N-CA 121.479 1.453 . . . . 0.0 112.643 -179.7 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' D' D ' 17' ' ' ASP . . . . . . . . . . . . . 11.1 p-10 -81.63 4.9 19.93 Favored 'General case' 0 CA--C 1.536 0.429 0 N-CA-C 113.303 0.853 . . . . 0.0 113.303 -177.501 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' D' D ' 18' ' ' PHE . . . . . . . . . . . . . 52.4 t80 -57.5 -44.26 84.85 Favored 'General case' 0 C--N 1.335 -0.059 0 O-C-N 121.929 -0.482 . . . . 0.0 110.272 -178.286 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' D' D ' 19' ' ' VAL . . . . . . . . . . . . . 44.0 t -55.52 -44.16 75.17 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.289 0 CA-C-N 116.396 -0.365 . . . . 0.0 110.804 -178.144 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' D' D ' 20' ' ' ASP . . . . . . . . . . . . . 13.4 t70 -59.8 -42.2 92.93 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-O 120.888 0.375 . . . . 0.0 110.809 -177.761 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' D' D ' 21' ' ' VAL . . . . . . . . . . . . . 45.2 t -64.31 -46.48 93.08 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.28 0 C-N-CA 120.742 -0.383 . . . . 0.0 110.534 -178.3 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' D' D ' 22' ' ' ILE . . . . . 0.604 HG22 HD12 ' D' ' 26' ' ' LEU . 51.4 mm -55.12 -47.38 77.32 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.232 0 C-N-CA 121.087 -0.245 . . . . 0.0 110.662 178.931 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' D' D ' 23' ' ' ARG . . . . . . . . . . . . . 52.6 ttp180 -53.74 -51.92 61.81 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-O 120.659 0.266 . . . . 0.0 111.418 -178.792 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' D' D ' 24' ' ' ILE . . . . . . . . . . . . . 71.2 mt -58.54 -43.15 86.45 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.344 0 C-N-CA 121.034 -0.266 . . . . 0.0 111.451 -175.705 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' D' D ' 25' ' ' LYS . . . . . . . . . . . . . 60.1 mttm -66.67 -43.68 83.82 Favored 'General case' 0 C--N 1.33 -0.269 0 N-CA-C 112.183 0.438 . . . . 0.0 112.183 -177.768 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' D' D ' 26' ' ' LEU . . . . . 0.604 HD12 HG22 ' D' ' 22' ' ' ILE . 27.1 mt -81.73 -25.95 34.98 Favored 'General case' 0 C--N 1.329 -0.298 0 N-CA-C 113.1 0.778 . . . . 0.0 113.1 -172.825 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' D' D ' 27' ' ' GLN . . . . . . . . . . . . . 5.8 pt20 -45.76 139.28 4.19 Favored 'General case' 0 N--CA 1.467 0.412 0 N-CA-C 112.819 0.674 . . . . 0.0 112.819 -174.666 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' D' D ' 28' ' ' GLY . . . . . . . . . . . . . . . 100.43 -26.95 22.63 Favored Glycine 0 CA--C 1.532 1.14 0 CA-C-N 115.755 -0.657 . . . . 0.0 112.116 -177.671 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' D' D ' 29' ' ' LYS . . . . . . . . . . . . . 64.0 mttp -96.72 155.09 16.92 Favored 'General case' 0 C--N 1.332 -0.175 0 CA-C-N 117.376 0.588 . . . . 0.0 110.788 178.525 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' D' D ' 30' ' ' THR . . . . . . . . . . . . . 35.3 m -108.11 141.24 40.11 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.196 -0.456 . . . . 0.0 110.489 178.993 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' D' D ' 31' ' ' VAL . . . . . . . . . . . . . 35.4 m -127.96 156.5 39.99 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.234 0 CA-C-N 116.097 -0.501 . . . . 0.0 110.32 179.147 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' D' D ' 32' ' ' ARG . . . . . . . . . . . . . 72.9 ttt-85 -130.17 150.28 51.49 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-O 121.116 0.484 . . . . 0.0 110.456 179.703 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' D' D ' 33' ' ' THR . . . . . . . . . . . . . 14.9 m -52.39 137.15 30.03 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.376 -0.375 . . . . 0.0 111.478 -178.148 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' D' D ' 34' ' ' GLY . . . . . . . . . . . . . . . 100.84 -17.17 56.77 Favored Glycine 0 CA--C 1.533 1.175 0 CA-C-O 119.691 -0.505 . . . . 0.0 113.241 179.021 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' D' D ' 35' ' ' ASP . . . . . . . . . . . . . 73.4 m-20 -66.58 150.96 48.24 Favored 'General case' 0 C--O 1.231 0.124 0 CA-C-N 118.083 0.941 . . . . 0.0 111.364 179.992 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' D' D ' 36' ' ' VAL . . . . . . . . . . . . . 41.9 t -122.01 127.81 75.44 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.228 0 CA-C-N 115.934 -0.575 . . . . 0.0 109.684 177.652 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' D' D ' 37' ' ' ILE . . . . . . . . . . . . . 61.8 mt -121.33 138.53 51.39 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.256 0 N-CA-C 109.882 -0.414 . . . . 0.0 109.882 -179.253 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' D' D ' 38' ' ' GLY . . . . . . . . . . . . . . . -117.52 128.85 8.01 Favored Glycine 0 CA--C 1.526 0.764 0 N-CA-C 111.123 -0.791 . . . . 0.0 111.123 -179.892 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' D' D ' 39' ' ' ILE . . . . . . . . . . . . . 74.5 mt -126.21 136.62 60.29 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.176 0 CA-C-O 120.785 0.326 . . . . 0.0 110.179 178.903 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' D' D ' 40' ' ' SER . . . . . . . . . . . . . 63.7 p -91.59 122.44 34.16 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.219 -0.446 . . . . 0.0 110.816 176.216 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' D' D ' 41' ' ' ILE . . . . . . . . . . . . . 68.3 mt -130.46 117.55 39.78 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.231 0 CA-C-O 120.89 0.376 . . . . 0.0 110.244 178.262 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' D' D ' 42' ' ' LEU . . . . . 0.555 HD23 ' O ' ' D' ' 42' ' ' LEU . 1.3 tt 54.62 43.73 29.75 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-O 121.419 0.628 . . . . 0.0 110.401 177.603 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' D' D ' 43' ' ' GLY . . . . . . . . . . . . . . . 71.12 19.0 76.96 Favored Glycine 0 CA--C 1.533 1.157 0 C-N-CA 121.211 -0.519 . . . . 0.0 113.089 175.411 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' D' D ' 44' ' ' LYS . . . . . . . . . . . . . 53.1 mttm -131.05 130.5 43.33 Favored 'General case' 0 C--N 1.333 -0.137 0 CA-C-N 117.774 0.787 . . . . 0.0 110.342 178.836 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' D' D ' 45' ' ' GLU . . . . . . . . . . . . . 84.8 tt0 -84.1 124.93 31.63 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 116.499 -0.319 . . . . 0.0 111.258 -178.917 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' D' D ' 46' ' ' VAL . . . . . 0.412 HG13 ' O ' ' D' ' 46' ' ' VAL . 10.1 p -117.84 124.71 73.46 Favored 'Isoleucine or valine' 0 N--CA 1.462 0.172 0 N-CA-C 109.577 -0.527 . . . . 0.0 109.577 174.549 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' D' D ' 47' ' ' LYS . . . . . . . . . . . . . 64.7 mttp -98.52 124.11 43.07 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.076 -0.511 . . . . 0.0 110.859 178.529 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' D' D ' 48' ' ' PHE . . . . . . . . . . . . . 34.3 m-85 -108.49 131.87 54.39 Favored 'General case' 0 C--N 1.329 -0.324 0 N-CA-C 109.563 -0.532 . . . . 0.0 109.563 176.545 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' D' D ' 49' ' ' LYS . . . . . . . . . . . . . 46.6 tttp -107.48 133.65 51.66 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.367 -0.379 . . . . 0.0 110.137 178.202 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' D' D ' 50' ' ' VAL . . . . . . . . . . . . . 44.1 t -76.63 104.4 4.64 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.325 0 N-CA-C 109.414 -0.587 . . . . 0.0 109.414 177.802 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' D' D ' 51' ' ' VAL . . . . . . . . . . . . . 52.5 t -69.83 -53.38 24.38 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.324 0 CA-C-N 115.985 -0.552 . . . . 0.0 109.646 -175.732 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' D' D ' 52' ' ' GLN . . . . . . . . . . . . . 87.9 mt-30 -153.73 152.2 30.49 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 115.949 -0.569 . . . . 0.0 111.377 -177.752 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' D' D ' 53' ' ' ALA . . . . . . . . . . . . . . . -131.04 129.9 42.58 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 115.231 -0.895 . . . . 0.0 109.55 175.198 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' D' D ' 54' ' ' TYR . . . . . . . . . . . . . 54.3 t80 -128.35 108.01 19.36 Favored Pre-proline 0 CA--C 1.534 0.339 0 CA-C-O 118.179 -0.915 . . . . 0.0 110.276 -179.536 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' D' D ' 55' ' ' PRO . . . . . . . . . . . . . 74.0 Cg_endo -77.09 170.08 72.59 Favored 'Cis proline' 0 N--CA 1.5 1.859 0 CA-C-N 121.754 1.662 . . . . 0.0 112.608 -3.981 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' D' D ' 56' ' ' SER . . . . . . . . . . . . . 13.6 m -112.88 131.72 22.64 Favored Pre-proline 0 CA--C 1.539 0.53 0 CA-C-O 118.438 -0.791 . . . . 0.0 109.666 176.17 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' D' D ' 57' ' ' PRO . . . . . . . . . . . . . 42.2 Cg_endo -69.42 168.17 67.25 Favored 'Cis proline' 0 N--CA 1.496 1.66 0 CA-C-N 121.929 1.725 . . . . 0.0 111.374 -3.732 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' D' D ' 58' ' ' LEU . . . . . . . . . . . . . 44.9 tp -130.24 137.67 50.15 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-O 120.955 0.407 . . . . 0.0 110.256 -179.804 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' D' D ' 59' ' ' ARG . . . . . . . . . . . . . 74.0 ttt180 -104.2 134.47 47.38 Favored 'General case' 0 C--N 1.327 -0.396 0 CA-C-N 115.918 -0.583 . . . . 0.0 109.767 178.033 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' D' D ' 60' ' ' VAL . . . . . . . . . . . . . 42.6 t -76.98 112.91 15.43 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.316 0 C-N-CA 120.821 -0.351 . . . . 0.0 110.183 -177.545 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' D' D ' 61' ' ' GLU . . . . . . . . . . . . . 96.0 mt-10 -131.08 162.05 30.69 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.001 -0.545 . . . . 0.0 110.077 178.944 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' D' D ' 62' ' ' ASP . . . . . . . . . . . . . 6.4 t70 -53.63 -31.86 48.98 Favored 'General case' 0 C--N 1.327 -0.375 0 N-CA-C 111.862 0.319 . . . . 0.0 111.862 -179.092 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' D' D ' 63' ' ' ARG . . . . . . . . . . . . . 39.4 ptt180 -84.66 3.91 34.9 Favored 'General case' 0 CA--C 1.537 0.449 0 N-CA-C 113.774 1.027 . . . . 0.0 113.774 -174.555 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' D' D ' 64' ' ' THR . . . . . . . . . . . . . 25.7 m -92.02 138.84 31.21 Favored 'General case' 0 C--N 1.333 -0.152 0 CA-C-N 118.155 0.434 . . . . 0.0 110.854 -177.805 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' D' D ' 65' ' ' LYS . . . . . . . . . . . . . 68.0 mttm -88.62 127.84 35.57 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.069 -0.514 . . . . 0.0 109.894 177.834 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' D' D ' 66' ' ' ILE . . . . . . . . . . . . . 59.8 mt -115.65 126.43 73.18 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.228 0 N-CA-C 109.684 -0.487 . . . . 0.0 109.684 179.314 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' D' D ' 67' ' ' THR . . . . . . . . . . . . . 28.4 m -126.8 145.04 50.78 Favored 'General case' 0 C--O 1.233 0.216 0 CA-C-O 121.271 0.558 . . . . 0.0 111.637 -175.448 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' D' D ' 68' ' ' LEU . . . . . 0.464 ' C ' HD23 ' D' ' 68' ' ' LEU . 6.1 tt -97.18 124.07 41.14 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 115.435 -0.802 . . . . 0.0 109.528 175.366 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' D' D ' 69' ' ' VAL . . . . . 0.421 ' N ' HD23 ' D' ' 68' ' ' LEU . 44.7 t -100.14 137.22 28.33 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.315 0 CA-C-O 121.102 0.477 . . . . 0.0 110.902 -175.008 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' D' D ' 70' ' ' THR . . . . . . . . . . . . . 3.6 t -137.27 63.0 1.57 Allowed 'General case' 0 C--N 1.33 -0.244 0 CA-C-O 121.625 0.726 . . . . 0.0 110.129 178.134 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' D' D ' 71' ' ' HIS . . . . . . . . . . . . . 6.1 m-70 -109.82 175.34 1.97 Allowed Pre-proline 0 CA--C 1.534 0.362 0 CA-C-N 115.688 -0.687 . . . . 0.0 110.476 -176.705 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' D' D ' 72' ' ' PRO . . . . . . . . . . . . . 21.7 Cg_exo -64.92 160.03 43.22 Favored 'Trans proline' 0 N--CA 1.496 1.63 0 C-N-CA 121.569 1.512 . . . . 0.0 112.148 179.836 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' D' D ' 73' ' ' VAL . . . . . . . . . . . . . 35.1 m -69.82 172.32 0.89 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.298 0 CA-C-N 115.881 -0.6 . . . . 0.0 111.18 -174.557 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' D' D ' 74' ' ' ASP . . . . . . . . . . . . . 12.5 t0 -94.89 123.24 38.24 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 115.893 -0.594 . . . . 0.0 110.294 -176.873 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' D' D ' 75' ' ' VAL . . . . . . . . . . . . . 47.1 t -116.33 121.9 68.57 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.209 0 CA-C-O 121.143 0.496 . . . . 0.0 110.204 -179.323 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' D' D ' 76' ' ' LEU . . . . . . . . . . . . . 36.8 mt -123.67 144.6 49.54 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 115.547 -0.751 . . . . 0.0 109.68 -179.54 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' D' D ' 77' ' ' GLU . . . . . . . . . . . . . 97.2 mt-10 -137.74 131.29 31.09 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-O 121.096 0.474 . . . . 0.0 111.274 -178.946 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' D' D ' 78' ' ' ALA . . . . . . . . . . . . . . . -118.94 139.82 51.02 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 115.693 -0.685 . . . . 0.0 109.974 177.183 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' D' D ' 79' ' ' LYS . . . . . 0.603 ' O ' HD13 ' D' ' 80' ' ' ILE . 35.2 tptt -80.47 116.43 20.51 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.513 -0.312 . . . . 0.0 110.818 -177.586 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' D' D ' 80' ' ' ILE . . . . . 0.603 HD13 ' O ' ' D' ' 79' ' ' LYS . 40.7 mm -139.11 108.18 3.69 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.237 0 CA-C-N 116.325 -0.398 . . . . 0.0 109.971 -176.542 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' D' D ' 81' ' ' LYS . . . . . . . . . . . . . 51.1 mttm -103.56 129.09 50.71 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-O 120.761 0.315 . . . . 0.0 111.18 -179.088 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' D' D ' 82' ' ' GLY . . . . . . . . . . . . . . . 89.05 42.16 5.69 Favored Glycine 0 CA--C 1.524 0.656 0 C-N-CA 120.828 -0.701 . . . . 0.0 111.545 173.64 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' D' D ' 83' ' ' ILE . . . . . . . . . . . . . 72.7 mt -67.15 131.1 32.93 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.365 0 N-CA-C 109.915 -0.402 . . . . 0.0 109.915 178.646 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' D' D ' 84' ' ' LYS . . . . . . . . . . . . . 76.3 tttt -91.15 -50.45 5.83 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-O 121.198 0.523 . . . . 0.0 109.665 179.619 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' D' D ' 85' ' ' ASP . . . . . . . . . . . . . 5.1 t70 -160.43 155.3 24.25 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 115.448 -0.796 . . . . 0.0 110.193 178.939 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' D' D ' 86' ' ' VAL . . . . . . . . . . . . . 40.1 t -131.54 133.31 61.91 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.285 0 CA-C-O 121.039 0.447 . . . . 0.0 110.175 179.699 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' D' D ' 87' ' ' ILE . . . . . . . . . . . . . 44.7 mm -119.05 128.46 75.8 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.294 0 CA-C-N 115.79 -0.641 . . . . 0.0 109.584 178.659 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' D' D ' 88' ' ' LEU . . . . . . . . . . . . . 21.8 tp -108.53 130.14 55.29 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-N 116.282 -0.417 . . . . 0.0 111.117 -177.638 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' D' D ' 89' ' ' ASP . . . . . . . . . . . . . 13.6 t70 -121.68 150.89 41.1 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 115.846 -0.616 . . . . 0.0 109.352 175.691 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' D' D ' 90' ' ' GLU . . . . . . . . . . . . . 43.8 tp10 -47.29 -36.34 9.07 Favored 'General case' 0 C--N 1.331 -0.206 0 N-CA-C 112.868 0.692 . . . . 0.0 112.868 -173.327 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' D' D ' 91' ' ' ASN . . . . . . . . . . . . . 86.9 m-20 -132.14 32.4 4.01 Favored 'General case' 0 N--CA 1.463 0.209 0 N-CA-C 112.097 0.406 . . . . 0.0 112.097 -176.332 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' D' D ' 92' ' ' LEU . . . . . . . . . . . . . 9.0 tp -166.15 151.23 8.32 Favored 'General case' 0 C--N 1.331 -0.223 0 C-N-CA 120.871 -0.332 . . . . 0.0 111.016 179.929 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' D' D ' 93' ' ' ILE . . . . . . . . . . . . . 71.2 mt -125.84 122.7 62.64 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.234 0 N-CA-C 109.429 -0.582 . . . . 0.0 109.429 179.707 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' D' D ' 94' ' ' VAL . . . . . . . . . . . . . 41.9 t -120.1 127.59 75.9 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.186 0 N-CA-C 110.09 -0.337 . . . . 0.0 110.09 -179.201 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' D' D ' 95' ' ' VAL . . . . . . . . . . . . . 44.4 t -123.27 133.47 69.02 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.275 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.042 -179.797 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' D' D ' 96' ' ' ILE . . . . . . . . . . . . . 65.5 mt -115.61 127.52 73.16 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.225 0 N-CA-C 109.559 -0.534 . . . . 0.0 109.559 179.231 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' D' D ' 97' ' ' THR . . . . . . . . . . . . . 66.4 p -100.47 153.58 19.24 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-O 121.081 0.467 . . . . 0.0 110.882 -178.656 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' D' D ' 98' ' ' GLU . . . . . . . . . . . . . 12.7 pt-20 -53.96 -21.71 8.65 Favored 'General case' 0 CA--C 1.534 0.362 0 N-CA-C 112.532 0.567 . . . . 0.0 112.532 -179.409 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' D' D ' 99' ' ' GLU . . . . . . . . . . . . . 96.2 mt-10 -81.34 14.99 2.16 Favored 'General case' 0 CA--C 1.534 0.364 0 N-CA-C 113.077 0.769 . . . . 0.0 113.077 -177.071 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' D' D ' 100' ' ' ASN . . . . . . . . . . . . . 4.7 m-20 62.18 34.86 15.91 Favored 'General case' 0 CA--C 1.53 0.203 0 CA-C-N 118.085 0.402 . . . . 0.0 111.182 -179.904 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' D' D ' 101' ' ' GLU . . . . . . . . . . . . . 83.5 tt0 -112.37 142.04 45.38 Favored 'General case' 0 C--N 1.333 -0.148 0 N-CA-C 109.534 -0.543 . . . . 0.0 109.534 174.552 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' D' D ' 102' ' ' VAL . . . . . . . . . . . . . 46.7 t -115.0 126.57 72.62 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.277 0 N-CA-C 109.847 -0.427 . . . . 0.0 109.847 -178.239 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' D' D ' 103' ' ' LEU . . . . . . . . . . . . . 26.0 mt -116.64 127.87 54.84 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 115.658 -0.701 . . . . 0.0 110.022 177.703 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' D' D ' 104' ' ' ILE . . . . . . . . . . . . . 67.9 mt -117.61 122.68 70.39 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.262 0 CA-C-N 116.408 -0.36 . . . . 0.0 110.219 -179.336 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' D' D ' 105' ' ' PHE . . . . . . . . . . . . . 66.2 m-85 -124.5 163.16 22.45 Favored 'General case' 0 C--N 1.331 -0.202 0 O-C-N 123.804 0.69 . . . . 0.0 109.757 179.521 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' D' D ' 106' ' ' ASN . . . . . . . . . . . . . 45.8 p-10 -96.83 -173.11 2.62 Favored 'General case' 0 C--N 1.329 -0.308 0 N-CA-C 109.59 -0.522 . . . . 0.0 109.59 173.889 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' D' D ' 107' ' ' GLN . . . . . . . . . . . . . 28.6 tt0 -60.85 -23.99 65.55 Favored 'General case' 0 CA--C 1.534 0.337 0 N-CA-C 112.312 0.486 . . . . 0.0 112.312 179.862 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' D' D ' 108' ' ' ASN . . . . . . . . . . . . . 60.6 t30 -86.53 10.22 16.0 Favored 'General case' 0 CA--C 1.536 0.43 0 N-CA-C 113.037 0.754 . . . . 0.0 113.037 -178.737 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' D' D ' 109' ' ' LEU . . . . . . . . . . . . . 12.3 tp 57.04 38.94 29.54 Favored 'General case' 0 C--N 1.332 -0.194 0 CA-C-O 121.152 0.501 . . . . 0.0 111.206 178.885 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' D' D ' 110' ' ' GLU . . . . . . . . . . . . . 70.9 mm-40 -107.1 148.82 28.32 Favored 'General case' 0 C--N 1.33 -0.265 0 N-CA-C 109.832 -0.432 . . . . 0.0 109.832 175.566 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' D' D ' 111' ' ' GLU . . . . . . . . . . . . . 83.1 tt0 -78.16 121.89 24.92 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.27 -0.423 . . . . 0.0 110.821 -177.683 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' D' D ' 112' ' ' LEU . . . . . . . . . . . . . 31.4 mt -109.6 -46.05 3.58 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-N 116.256 -0.429 . . . . 0.0 110.686 179.564 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' D' D ' 113' ' ' TYR . . . . . . . . . . . . . 58.0 t80 -140.71 135.31 31.45 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 116.264 -0.425 . . . . 0.0 110.927 -179.2 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' D' D ' 114' ' ' ARG . . . . . . . . . . . . . 69.6 ttp85 -136.42 122.03 19.65 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.138 -0.483 . . . . 0.0 110.117 178.035 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' D' D ' 115' ' ' GLY . . . . . . . . . . . . . . . -150.03 153.14 24.91 Favored Glycine 0 CA--C 1.524 0.652 0 N-CA-C 110.996 -0.842 . . . . 0.0 110.996 179.015 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' D' D ' 116' ' ' LYS . . . . . . . . . . . . . 63.4 tttt -129.5 132.13 46.82 Favored 'General case' 0 C--N 1.329 -0.321 0 N-CA-C 109.825 -0.435 . . . . 0.0 109.825 177.941 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' D' D ' 117' ' ' PHE . . . . . . . . . . . . . 37.3 m-85 -128.13 117.25 21.27 Favored 'General case' 0 C--N 1.332 -0.187 0 CA-C-O 120.963 0.411 . . . . 0.0 110.232 -175.11 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' D' D ' 118' ' ' GLU . . . . . . . . . . . . . 44.9 tp10 -51.67 -51.21 57.68 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.403 -0.362 . . . . 0.0 111.61 -177.078 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' D' D ' 119' ' ' ASN . . . . . . . . . . . . . 3.6 m120 -94.48 30.95 1.85 Allowed 'General case' 0 C--N 1.329 -0.287 0 N-CA-C 112.249 0.463 . . . . 0.0 112.249 -174.927 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' D' D ' 120' ' ' LEU . . . . . . . . . . . . . 15.6 tp -56.7 121.09 8.97 Favored 'General case' 0 C--N 1.332 -0.167 0 CA-C-O 120.597 0.237 . . . . 0.0 110.41 178.032 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' D' D ' 121' ' ' ASN . . . . . . . . . . . . . 33.1 m120 -114.08 -44.0 3.19 Favored 'General case' 0 C--O 1.232 0.171 0 CA-C-N 116.723 -0.217 . . . . 0.0 111.147 -176.649 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' D' D ' 122' ' ' LYS . . . . . . . . . . . . . 61.4 mtpt -139.13 138.58 37.13 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-O 120.92 0.391 . . . . 0.0 111.314 -176.674 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' D' D ' 123' ' ' VAL . . . . . . . . . . . . . 45.1 t -126.93 126.2 67.98 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.326 0 N-CA-C 109.375 -0.602 . . . . 0.0 109.375 175.26 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' D' D ' 124' ' ' LEU . . . . . . . . . . . . . 59.5 mt -131.21 136.43 48.24 Favored 'General case' 0 C--N 1.332 -0.194 0 CA-C-O 120.95 0.405 . . . . 0.0 110.781 -177.444 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' D' D ' 125' ' ' VAL . . . . . 0.413 HG23 HG22 ' D' ' 130' ' ' VAL . 11.6 p -133.95 138.57 50.17 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.284 0 CA-C-N 116.113 -0.494 . . . . 0.0 110.355 178.863 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' D' D ' 126' ' ' ARG . . . . . . . . . . . . . 96.7 mtt180 -149.1 126.82 11.74 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 115.769 -0.65 . . . . 0.0 109.425 177.778 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' D' D ' 127' ' ' ASN . . . . . . . . . . . . . 1.8 t-20 57.63 -147.47 0.51 Allowed 'General case' 0 CA--C 1.541 0.62 0 N-CA-C 109.418 -0.586 . . . . 0.0 109.418 -178.352 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' D' D ' 128' ' ' ASP . . . . . . . . . . . . . 8.7 p-10 -87.32 17.38 4.44 Favored 'General case' 0 CA--C 1.534 0.36 0 CA-C-N 118.892 0.769 . . . . 0.0 112.657 178.03 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' D' D ' 129' ' ' LEU . . . . . . . . . . . . . 13.3 tp -112.5 136.16 52.35 Favored 'General case' 0 C--O 1.231 0.098 0 O-C-N 122.003 -0.435 . . . . 0.0 109.988 179.001 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' D' D ' 130' ' ' VAL . . . . . 0.413 HG22 HG23 ' D' ' 125' ' ' VAL . 39.0 t -124.89 140.05 49.19 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.338 0 CA-C-O 120.768 0.318 . . . . 0.0 110.354 -176.646 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' D' D ' 131' ' ' VAL . . . . . . . . . . . . . 44.2 t -136.07 136.48 49.52 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.206 0 CA-C-O 121.144 0.497 . . . . 0.0 110.309 177.459 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' D' D ' 132' ' ' ILE . . . . . . . . . . . . . 71.3 mt -120.41 134.16 64.78 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.229 0 CA-C-N 115.69 -0.686 . . . . 0.0 109.645 -179.105 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' D' D ' 133' ' ' ILE . . . . . . . . . . . . . 43.5 mm -117.44 120.96 66.44 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.215 0 CA-C-O 121.142 0.496 . . . . 0.0 111.045 -175.915 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' D' D ' 134' ' ' ASP . . . . . . . . . . . . . 6.7 p-10 -131.71 145.82 51.84 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 115.671 -0.695 . . . . 0.0 109.449 174.216 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' D' D ' 135' ' ' GLU . . . . . . . . . . . . . 41.2 tp10 -49.74 -24.63 2.43 Favored 'General case' 0 C--N 1.328 -0.361 0 N-CA-C 112.872 0.693 . . . . 0.0 112.872 -171.584 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' D' D ' 136' ' ' GLN . . . . . . . . . . . . . 96.9 mt-30 -94.25 -33.23 13.33 Favored 'General case' 0 C--O 1.232 0.166 0 N-CA-C 112.356 0.502 . . . . 0.0 112.356 -175.932 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' D' D ' 137' ' ' LYS . . . . . . . . . . . . . 54.4 mtmt -148.17 158.11 43.89 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-O 121.388 0.613 . . . . 0.0 112.114 -170.445 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' D' D ' 138' ' ' LEU . . . . . 0.412 ' C ' HD23 ' D' ' 138' ' ' LEU . 5.6 tt -116.6 124.77 50.62 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 115.219 -0.9 . . . . 0.0 109.323 174.783 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' D' D ' 139' ' ' THR . . . . . . . . . . . . . 34.5 m -110.12 131.1 55.36 Favored 'General case' 0 C--N 1.331 -0.208 0 CA-C-N 116.366 -0.379 . . . . 0.0 110.863 -176.735 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' D' D ' 140' ' ' LEU . . . . . 0.472 ' C ' HD23 ' D' ' 140' ' ' LEU . 6.1 tt -119.79 124.02 45.12 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 115.543 -0.753 . . . . 0.0 109.303 -178.735 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' D' D ' 141' ' ' ILE . . . . . 0.437 ' N ' HD23 ' D' ' 140' ' ' LEU . 19.1 mt -121.28 120.25 61.49 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.314 0 CA-C-O 120.779 0.323 . . . . 0.0 110.131 -174.723 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' D' D ' 142' ' ' ARG . . . . . . . . . . . . . 82.8 mtp180 -110.32 127.66 55.15 Favored 'General case' 0 C--N 1.331 -0.226 0 CA-C-N 115.613 -0.722 . . . . 0.0 110.426 -179.039 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' D' D ' 143' ' ' THR . . . . . . . . . . . . . 59.8 p . . . . . 0 C--O 1.22 -0.463 0 CA-C-O 117.942 -1.028 . . . . 0.0 110.575 179.73 . . . . . . . . 0 0 . 1 . 002 nuclear nobuild full ' E' E ' -3' ' ' GLU . . . . . . . . . . . . . 95.6 mt-10 . . . . . 0 N--CA 1.489 1.525 0 N-CA-C 109.281 -0.637 . . . . 0.0 109.281 . . . . . . . . . 0 0 . 1 . 002 nuclear nobuild full ' E' E ' -2' ' ' GLY . . . . . . . . . . . . . . . -76.79 149.61 36.67 Favored Glycine 0 CA--C 1.525 0.702 0 N-CA-C 110.958 -0.857 . . . . 0.0 110.958 179.828 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' E' E ' -1' ' ' VAL . . . . . . . . . . . . . 46.5 t -95.71 133.1 38.03 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.368 0 N-CA-C 109.992 -0.373 . . . . 0.0 109.992 179.505 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' E' E ' 0' ' ' ILE . . . . . . . . . . . . . 70.0 mt -119.32 134.18 63.76 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.191 0 CA-C-N 116.207 -0.451 . . . . 0.0 110.105 -179.204 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' E' E ' 1' ' ' MET . . . . . . . . . . . . . 25.6 ptm -78.08 132.83 37.89 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.078 -0.51 . . . . 0.0 110.464 178.398 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' E' E ' 2' ' ' SER . . . . . . . . . . . . . 3.6 p -129.11 127.13 40.83 Favored 'General case' 0 C--N 1.331 -0.218 0 CA-C-O 120.955 0.407 . . . . 0.0 110.46 -179.617 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' E' E ' 3' ' ' GLU . . . . . . . . . . . . . 28.6 tp10 -139.44 137.55 35.71 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 115.745 -0.661 . . . . 0.0 110.503 -176.511 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' E' E ' 4' ' ' LEU . . . . . . . . . . . . . 17.8 tp -124.12 126.15 45.71 Favored 'General case' 0 C--N 1.33 -0.244 0 N-CA-C 109.564 -0.532 . . . . 0.0 109.564 174.525 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' E' E ' 5' ' ' LYS . . . . . . . . . . . . . 66.4 mttm -112.85 122.13 46.75 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-O 120.948 0.404 . . . . 0.0 110.87 -177.668 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' E' E ' 6' ' ' LEU . . . . . 0.461 HD23 ' HA ' ' E' ' 50' ' ' VAL . 59.2 mt -113.89 143.87 43.97 Favored 'General case' 0 C--N 1.331 -0.23 0 CA-C-N 115.199 -0.909 . . . . 0.0 110.161 -179.421 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' E' E ' 7' ' ' LYS . . . . . . . . . . . . . 84.8 tttt -121.05 135.22 24.68 Favored Pre-proline 0 CA--C 1.535 0.398 0 CA-C-O 118.858 -0.591 . . . . 0.0 109.529 176.167 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' E' E ' 8' ' ' PRO . . . . . . . . . . . . . 97.6 Cg_endo -91.19 132.65 1.5 Allowed 'Trans proline' 0 N--CA 1.49 1.275 0 C-N-CA 121.683 1.589 . . . . 0.0 111.765 178.484 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' E' E ' 9' ' ' LEU . . . . . . . . . . . . . 46.9 mt -74.31 -47.02 6.02 Favored Pre-proline 0 CA--C 1.533 0.32 0 CA-C-O 118.709 -0.662 . . . . 0.0 112.176 -177.55 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' E' E ' 10' ' ' PRO . . . . . . . . . . . . . 84.4 Cg_endo -81.41 153.37 18.2 Favored 'Trans proline' 0 N--CA 1.496 1.671 0 C-N-CA 121.158 1.239 . . . . 0.0 111.726 174.95 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' E' E ' 11' ' ' LYS . . . . . . . . . . . . . 57.1 tttm -86.77 99.44 11.8 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.418 -0.356 . . . . 0.0 110.3 178.747 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' E' E ' 12' ' ' VAL . . . . . . . . . . . . . 12.0 p -141.5 147.54 21.98 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.254 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.571 -178.59 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' E' E ' 13' ' ' GLU . . . . . . . . . . . . . 43.1 tp10 -93.76 122.36 36.15 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.059 -0.519 . . . . 0.0 110.045 177.61 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' E' E ' 14' ' ' LEU . . . . . . . . . . . . . 20.7 mt -95.94 148.94 35.33 Favored Pre-proline 0 C--N 1.329 -0.292 0 CA-C-O 119.328 -0.368 . . . . 0.0 110.465 -178.161 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' E' E ' 15' ' ' PRO . . . . . . . . . . . . . 24.8 Cg_exo -62.46 160.25 32.54 Favored 'Trans proline' 0 N--CA 1.497 1.731 0 C-N-CA 121.214 1.276 . . . . 0.0 111.722 177.404 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' E' E ' 16' ' ' PRO . . . . . . . . . . . . . 29.9 Cg_exo -60.06 -32.37 94.7 Favored 'Trans proline' 0 N--CA 1.497 1.685 0 C-N-CA 121.385 1.39 . . . . 0.0 112.718 -178.659 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' E' E ' 17' ' ' ASP . . . . . . . . . . . . . 18.1 p-10 -88.39 4.73 45.25 Favored 'General case' 0 CA--C 1.536 0.422 0 N-CA-C 113.326 0.861 . . . . 0.0 113.326 -177.414 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' E' E ' 18' ' ' PHE . . . . . . . . . . . . . 52.4 t80 -58.23 -43.2 87.64 Favored 'General case' 0 C--N 1.334 -0.077 0 O-C-N 121.998 -0.439 . . . . 0.0 110.042 -178.606 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' E' E ' 19' ' ' VAL . . . . . . . . . . . . . 47.2 t -55.54 -42.81 69.99 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.28 0 CA-C-N 116.33 -0.395 . . . . 0.0 110.585 -179.425 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' E' E ' 20' ' ' ASP . . . . . . . . . . . . . 76.7 m-20 -60.57 -42.99 97.76 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-O 120.801 0.334 . . . . 0.0 110.926 -178.485 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' E' E ' 21' ' ' VAL . . . . . . . . . . . . . 45.7 t -64.01 -46.32 94.24 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.265 0 C-N-CA 120.792 -0.363 . . . . 0.0 110.463 -177.757 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' E' E ' 22' ' ' ILE . . . . . 0.68 HG22 HD12 ' E' ' 26' ' ' LEU . 51.5 mm -55.67 -46.29 79.4 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.234 0 CA-C-O 120.788 0.328 . . . . 0.0 110.548 178.45 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' E' E ' 23' ' ' ARG . . . . . . . . . . . . . 54.6 ttp180 -53.1 -50.97 63.35 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-O 120.669 0.271 . . . . 0.0 111.569 -179.887 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' E' E ' 24' ' ' ILE . . . . . . . . . . . . . 74.6 mt -58.35 -47.28 88.22 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.312 0 CA-C-N 116.505 -0.316 . . . . 0.0 111.452 -176.3 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' E' E ' 25' ' ' LYS . . . . . . . . . . . . . 76.0 mttt -65.49 -40.59 93.26 Favored 'General case' 0 C--N 1.329 -0.298 0 N-CA-C 112.428 0.529 . . . . 0.0 112.428 -176.613 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' E' E ' 26' ' ' LEU . . . . . 0.68 HD12 HG22 ' E' ' 22' ' ' ILE . 40.6 mt -79.65 -38.6 33.35 Favored 'General case' 0 C--N 1.33 -0.245 0 N-CA-C 113.19 0.811 . . . . 0.0 113.19 -171.143 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' E' E ' 27' ' ' GLN . . . . . . . . . . . . . 13.1 pt20 -46.88 139.46 5.47 Favored 'General case' 0 N--CA 1.468 0.443 0 N-CA-C 112.785 0.661 . . . . 0.0 112.785 -174.976 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' E' E ' 28' ' ' GLY . . . . . . . . . . . . . . . 99.61 -25.54 27.86 Favored Glycine 0 CA--C 1.534 1.229 0 CA-C-N 115.559 -0.746 . . . . 0.0 112.178 -176.209 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' E' E ' 29' ' ' LYS . . . . . . . . . . . . . 95.6 mttt -97.21 155.19 16.95 Favored 'General case' 0 C--O 1.233 0.186 0 CA-C-N 117.324 0.562 . . . . 0.0 110.918 178.935 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' E' E ' 30' ' ' THR . . . . . . . . . . . . . 23.6 m -104.68 137.66 42.16 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 115.922 -0.581 . . . . 0.0 110.035 175.83 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' E' E ' 31' ' ' VAL . . . . . . . . . . . . . 35.2 m -127.82 155.69 39.36 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.235 0 CA-C-N 116.381 -0.372 . . . . 0.0 110.685 -179.235 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' E' E ' 32' ' ' ARG . . . . . . . . . . . . . 78.2 mtt85 -132.6 150.49 52.15 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.079 -0.51 . . . . 0.0 110.402 177.821 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' E' E ' 33' ' ' THR . . . . . . . . . . . . . 22.3 m -52.8 139.1 27.71 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.302 -0.408 . . . . 0.0 111.419 -179.194 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' E' E ' 34' ' ' GLY . . . . . . . . . . . . . . . 101.03 -17.21 56.49 Favored Glycine 0 CA--C 1.532 1.141 0 CA-C-O 119.69 -0.505 . . . . 0.0 113.165 179.751 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' E' E ' 35' ' ' ASP . . . . . . . . . . . . . 73.5 m-20 -66.95 149.64 50.33 Favored 'General case' 0 C--O 1.231 0.104 0 CA-C-N 118.08 0.94 . . . . 0.0 111.147 178.859 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' E' E ' 36' ' ' VAL . . . . . . . . . . . . . 43.1 t -121.83 130.89 74.19 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.24 0 CA-C-N 116.107 -0.497 . . . . 0.0 109.843 178.188 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' E' E ' 37' ' ' ILE . . . . . . . . . . . . . 65.1 mt -121.32 139.18 49.28 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.194 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.0 -178.971 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' E' E ' 38' ' ' GLY . . . . . . . . . . . . . . . -116.66 129.0 8.18 Favored Glycine 0 CA--C 1.525 0.676 0 N-CA-C 111.137 -0.785 . . . . 0.0 111.137 -179.873 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' E' E ' 39' ' ' ILE . . . . . . . . . . . . . 76.5 mt -127.26 139.96 50.44 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.224 0 CA-C-O 120.755 0.312 . . . . 0.0 110.243 179.351 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' E' E ' 40' ' ' SER . . . . . . . . . . . . . 13.3 t -92.6 126.02 37.5 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.288 -0.414 . . . . 0.0 111.059 177.0 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' E' E ' 41' ' ' ILE . . . . . . . . . . . . . 65.5 mt -129.53 117.0 41.12 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.193 0 CA-C-O 120.863 0.363 . . . . 0.0 110.126 177.088 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' E' E ' 42' ' ' LEU . . . . . . . . . . . . . 7.2 mp 51.78 38.18 22.44 Favored 'General case' 0 CA--C 1.53 0.195 0 CA-C-N 116.101 -0.499 . . . . 0.0 111.598 176.747 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' E' E ' 43' ' ' GLY . . . . . . . . . . . . . . . 74.17 29.1 62.96 Favored Glycine 0 CA--C 1.529 0.969 0 C-N-CA 121.156 -0.545 . . . . 0.0 112.51 176.663 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' E' E ' 44' ' ' LYS . . . . . . . . . . . . . 30.0 ttpt -139.13 128.39 24.07 Favored 'General case' 0 C--N 1.33 -0.281 0 N-CA-C 109.523 -0.547 . . . . 0.0 109.523 176.578 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' E' E ' 45' ' ' GLU . . . . . . . . . . . . . 84.3 tt0 -83.1 125.66 31.73 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-O 120.799 0.333 . . . . 0.0 111.305 -177.111 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' E' E ' 46' ' ' VAL . . . . . 0.402 HG13 ' O ' ' E' ' 46' ' ' VAL . 9.2 p -117.38 124.96 73.7 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.183 0 N-CA-C 109.558 -0.534 . . . . 0.0 109.558 174.852 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' E' E ' 47' ' ' LYS . . . . . . . . . . . . . 62.5 mttp -98.16 126.46 43.64 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.06 -0.518 . . . . 0.0 110.904 177.973 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' E' E ' 48' ' ' PHE . . . . . . . . . . . . . 33.0 m-85 -110.13 131.86 54.68 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.025 -0.534 . . . . 0.0 109.679 176.568 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' E' E ' 49' ' ' LYS . . . . . . . . . . . . . 70.2 tttt -106.53 130.55 54.29 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.378 -0.373 . . . . 0.0 110.159 178.581 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' E' E ' 50' ' ' VAL . . . . . 0.461 ' HA ' HD23 ' E' ' 6' ' ' LEU . 46.4 t -74.73 103.16 2.52 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.258 0 N-CA-C 109.151 -0.685 . . . . 0.0 109.151 176.821 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' E' E ' 51' ' ' VAL . . . . . . . . . . . . . 47.3 t -69.58 -52.97 27.12 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.289 0 N-CA-C 109.478 -0.564 . . . . 0.0 109.478 -174.687 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' E' E ' 52' ' ' GLN . . . . . . . . . . . . . 81.3 mt-30 -154.49 149.93 27.27 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 115.986 -0.552 . . . . 0.0 111.624 -178.101 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' E' E ' 53' ' ' ALA . . . . . . . . . . . . . . . -128.26 133.21 48.75 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 115.305 -0.861 . . . . 0.0 109.542 175.046 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' E' E ' 54' ' ' TYR . . . . . . . . . . . . . 58.8 t80 -129.03 110.44 18.32 Favored Pre-proline 0 C--N 1.327 -0.372 0 CA-C-O 118.202 -0.904 . . . . 0.0 110.191 179.123 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' E' E ' 55' ' ' PRO . . . . . . . . . . . . . 73.7 Cg_endo -77.21 168.36 77.08 Favored 'Cis proline' 0 N--CA 1.5 1.865 0 CA-C-N 121.828 1.689 . . . . 0.0 112.511 -5.453 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' E' E ' 56' ' ' SER . . . . . . . . . . . . . 17.7 m -116.76 131.36 23.96 Favored Pre-proline 0 CA--C 1.537 0.479 0 CA-C-O 118.392 -0.813 . . . . 0.0 109.361 174.104 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' E' E ' 57' ' ' PRO . . . . . . . . . . . . . 38.6 Cg_endo -67.13 164.98 69.45 Favored 'Cis proline' 0 N--CA 1.497 1.72 0 CA-C-N 121.96 1.736 . . . . 0.0 111.522 -0.919 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' E' E ' 58' ' ' LEU . . . . . . . . . . . . . 27.0 tp -130.44 137.0 49.59 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.218 -0.447 . . . . 0.0 110.316 -179.535 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' E' E ' 59' ' ' ARG . . . . . . . . . . . . . 41.1 ttm180 -103.05 132.67 49.14 Favored 'General case' 0 C--N 1.327 -0.373 0 N-CA-C 109.525 -0.546 . . . . 0.0 109.525 176.65 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' E' E ' 60' ' ' VAL . . . . . . . . . . . . . 45.8 t -83.24 115.44 25.65 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.284 0 C-N-CA 120.751 -0.379 . . . . 0.0 110.532 -176.9 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' E' E ' 61' ' ' GLU . . . . . . . . . . . . . 15.6 mm-40 -131.06 163.54 27.41 Favored 'General case' 0 C--N 1.331 -0.23 0 CA-C-N 115.75 -0.659 . . . . 0.0 109.714 175.165 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' E' E ' 62' ' ' ASP . . . . . . . . . . . . . 78.4 m-20 -53.13 -32.35 47.1 Favored 'General case' 0 C--N 1.328 -0.35 0 N-CA-C 111.917 0.34 . . . . 0.0 111.917 -178.95 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' E' E ' 63' ' ' ARG . . . . . . . . . . . . . 84.0 mtt180 -74.03 -22.02 59.72 Favored 'General case' 0 C--N 1.33 -0.26 0 N-CA-C 112.992 0.738 . . . . 0.0 112.992 -176.619 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' E' E ' 64' ' ' THR . . . . . . . . . . . . . 37.8 m -64.78 140.07 58.83 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-O 120.913 0.387 . . . . 0.0 110.835 -175.947 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' E' E ' 65' ' ' LYS . . . . . . . . . . . . . 25.0 mtpp -90.05 123.17 33.7 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.061 -0.518 . . . . 0.0 109.995 179.567 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' E' E ' 66' ' ' ILE . . . . . . . . . . . . . 57.3 mt -113.79 131.13 66.53 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.241 0 CA-C-O 120.85 0.357 . . . . 0.0 110.351 -177.623 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' E' E ' 67' ' ' THR . . . . . . . . . . . . . 30.9 m -132.49 139.84 48.12 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.127 -0.488 . . . . 0.0 111.012 -179.122 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' E' E ' 68' ' ' LEU . . . . . 0.446 HD12 ' N ' ' E' ' 68' ' ' LEU . 8.1 mp -107.36 135.48 48.78 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.039 -0.528 . . . . 0.0 110.203 176.836 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' E' E ' 69' ' ' VAL . . . . . . . . . . . . . 43.8 t -98.32 132.62 43.0 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.346 0 CA-C-N 116.064 -0.516 . . . . 0.0 110.197 -179.036 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' E' E ' 70' ' ' THR . . . . . . . . . . . . . 19.8 m -135.0 -50.89 0.77 Allowed 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.491 -179.916 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' E' E ' 71' ' ' HIS . . . . . . . . . . . . . 81.2 m-70 -108.53 153.17 42.28 Favored Pre-proline 0 CA--C 1.532 0.279 0 CA-C-N 116.282 -0.417 . . . . 0.0 110.419 -179.913 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' E' E ' 72' ' ' PRO . . . . . . . . . . . . . 97.7 Cg_endo -85.01 -21.34 3.17 Favored 'Trans proline' 0 N--CA 1.493 1.475 0 C-N-CA 121.589 1.526 . . . . 0.0 113.238 179.744 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' E' E ' 73' ' ' VAL . . . . . . . . . . . . . 34.6 m -126.11 167.48 20.52 Favored 'Isoleucine or valine' 0 C--O 1.232 0.155 0 CA-C-O 120.804 0.335 . . . . 0.0 110.663 -178.464 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' E' E ' 74' ' ' ASP . . . . . . . . . . . . . 26.4 t0 -99.33 120.57 39.78 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.222 -0.445 . . . . 0.0 109.998 -178.901 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' E' E ' 75' ' ' VAL . . . . . . . . . . . . . 46.8 t -112.61 121.3 64.66 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.19 0 CA-C-O 121.031 0.443 . . . . 0.0 110.358 -178.477 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' E' E ' 76' ' ' LEU . . . . . . . . . . . . . 41.2 mt -118.42 144.75 45.72 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 115.626 -0.716 . . . . 0.0 109.737 178.713 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' E' E ' 77' ' ' GLU . . . . . . . . . . . . . 97.3 mt-10 -139.43 130.2 26.07 Favored 'General case' 0 C--N 1.331 -0.205 0 CA-C-O 120.999 0.428 . . . . 0.0 111.327 -179.416 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' E' E ' 78' ' ' ALA . . . . . 0.557 ' HB2' HD21 ' E' ' 109' ' ' LEU . . . -119.16 135.28 54.74 Favored 'General case' 0 C--N 1.331 -0.212 0 CA-C-N 115.797 -0.638 . . . . 0.0 109.775 176.689 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' E' E ' 79' ' ' LYS . . . . . 0.591 ' O ' HD13 ' E' ' 80' ' ' ILE . 91.0 mttt -77.13 118.62 19.85 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-O 120.882 0.373 . . . . 0.0 110.711 -179.452 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' E' E ' 80' ' ' ILE . . . . . 0.591 HD13 ' O ' ' E' ' 79' ' ' LYS . 41.1 mm -139.13 106.04 2.75 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.39 0 N-CA-C 109.138 -0.69 . . . . 0.0 109.138 -178.077 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' E' E ' 81' ' ' LYS . . . . . . . . . . . . . 76.0 tttt -105.24 127.34 52.88 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-O 120.895 0.379 . . . . 0.0 111.164 -176.0 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' E' E ' 82' ' ' GLY . . . . . . . . . . . . . . . 89.13 42.09 5.69 Favored Glycine 0 CA--C 1.524 0.638 0 N-CA-C 111.615 -0.594 . . . . 0.0 111.615 176.346 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' E' E ' 83' ' ' ILE . . . . . . . . . . . . . 72.4 mt -69.64 140.18 19.1 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.294 0 N-CA-C 109.836 -0.431 . . . . 0.0 109.836 177.446 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' E' E ' 84' ' ' LYS . . . . . . . . . . . . . 49.4 tttp -98.17 -51.06 4.14 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 115.9 -0.591 . . . . 0.0 110.263 -178.733 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' E' E ' 85' ' ' ASP . . . . . . . . . . . . . 6.5 t70 -155.27 151.72 28.39 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 115.764 -0.653 . . . . 0.0 110.316 179.67 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' E' E ' 86' ' ' VAL . . . . . . . . . . . . . 44.2 t -130.44 131.41 65.24 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.221 0 CA-C-O 120.931 0.395 . . . . 0.0 110.553 -178.719 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' E' E ' 87' ' ' ILE . . . . . 0.49 ' N ' HD12 ' E' ' 87' ' ' ILE . 5.0 mp -120.6 126.65 75.49 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.22 0 CA-C-N 115.889 -0.596 . . . . 0.0 109.494 176.382 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' E' E ' 88' ' ' LEU . . . . . . . . . . . . . 47.2 mt -116.0 137.76 51.82 Favored 'General case' 0 N--CA 1.462 0.167 0 CA-C-O 121.045 0.45 . . . . 0.0 111.468 -176.88 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' E' E ' 89' ' ' ASP . . . . . . . . . . . . . 8.7 t70 -136.14 156.73 48.27 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 115.655 -0.702 . . . . 0.0 109.584 175.202 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' E' E ' 90' ' ' GLU . . . . . . . . . . . . . 40.8 mp0 -51.23 -34.01 30.45 Favored 'General case' 0 C--N 1.328 -0.326 0 N-CA-C 112.507 0.558 . . . . 0.0 112.507 -171.919 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' E' E ' 91' ' ' ASN . . . . . . . . . . . . . 7.8 m120 -130.28 32.01 4.54 Favored 'General case' 0 N--CA 1.465 0.313 0 N-CA-C 112.062 0.393 . . . . 0.0 112.062 -175.897 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' E' E ' 92' ' ' LEU . . . . . . . . . . . . . 13.8 tp -166.11 141.77 4.82 Favored 'General case' 0 C--N 1.331 -0.239 0 C-N-CA 120.945 -0.302 . . . . 0.0 110.526 179.242 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' E' E ' 93' ' ' ILE . . . . . . . . . . . . . 71.9 mt -128.73 119.48 49.94 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.207 0 N-CA-C 109.121 -0.696 . . . . 0.0 109.121 176.686 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' E' E ' 94' ' ' VAL . . . . . . . . . . . . . 47.6 t -123.53 128.27 74.52 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.286 0 CA-C-O 121.037 0.446 . . . . 0.0 110.019 -178.898 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' E' E ' 95' ' ' VAL . . . . . . . . . . . . . 41.6 t -121.04 135.5 61.02 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.347 0 CA-C-N 115.807 -0.633 . . . . 0.0 109.821 -179.831 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' E' E ' 96' ' ' ILE . . . . . . . . . . . . . 49.9 mt -111.18 126.31 68.56 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.36 0 N-CA-C 108.959 -0.756 . . . . 0.0 108.959 178.041 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' E' E ' 97' ' ' THR . . . . . . . . . . . . . 74.7 p -96.27 155.73 16.64 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-O 121.114 0.483 . . . . 0.0 111.005 -177.747 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' E' E ' 98' ' ' GLU . . . . . . . . . . . . . 79.2 tt0 -53.84 -27.37 29.29 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.153 -0.476 . . . . 0.0 112.1 -179.143 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' E' E ' 99' ' ' GLU . . . . . . . . . . . . . 12.7 pt-20 -81.08 18.01 1.14 Allowed 'General case' 0 CA--C 1.535 0.374 0 N-CA-C 113.181 0.808 . . . . 0.0 113.181 -176.946 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' E' E ' 100' ' ' ASN . . . . . . . . . . . . . 3.4 m-20 63.52 37.43 10.49 Favored 'General case' 0 N--CA 1.463 0.179 0 CA-C-O 121.063 0.459 . . . . 0.0 111.204 176.831 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' E' E ' 101' ' ' GLU . . . . . . . . . . . . . 84.6 tt0 -116.22 146.02 42.67 Favored 'General case' 0 C--N 1.333 -0.131 0 CA-C-N 116.202 -0.454 . . . . 0.0 109.982 175.981 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' E' E ' 102' ' ' VAL . . . . . . . . . . . . . 46.8 t -115.08 126.1 72.57 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.346 0 CA-C-N 116.34 -0.391 . . . . 0.0 110.144 -177.668 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' E' E ' 103' ' ' LEU . . . . . . . . . . . . . 35.1 mt -117.82 128.54 54.95 Favored 'General case' 0 C--N 1.332 -0.169 0 CA-C-N 115.777 -0.647 . . . . 0.0 110.083 176.832 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' E' E ' 104' ' ' ILE . . . . . 0.599 HD13 HG11 ' E' ' 130' ' ' VAL . 68.9 mt -119.13 122.71 69.9 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.225 0 CA-C-N 116.722 -0.217 . . . . 0.0 110.422 -179.072 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' E' E ' 105' ' ' PHE . . . . . . . . . . . . . 55.5 m-85 -122.8 166.8 14.39 Favored 'General case' 0 C--O 1.232 0.137 0 O-C-N 123.917 0.76 . . . . 0.0 109.753 179.494 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' E' E ' 106' ' ' ASN . . . . . . . . . . . . . 45.9 p-10 -99.11 -170.04 1.86 Allowed 'General case' 0 C--N 1.33 -0.276 0 N-CA-C 109.758 -0.46 . . . . 0.0 109.758 173.079 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' E' E ' 107' ' ' GLN . . . . . . . . . . . . . 46.9 tt0 -60.61 -30.0 69.57 Favored 'General case' 0 C--N 1.329 -0.289 0 N-CA-C 111.932 0.345 . . . . 0.0 111.932 -179.675 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' E' E ' 108' ' ' ASN . . . . . . . . . . . . . 5.3 t30 -81.96 7.84 12.05 Favored 'General case' 0 CA--C 1.536 0.416 0 N-CA-C 113.108 0.781 . . . . 0.0 113.108 -177.891 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' E' E ' 109' ' ' LEU . . . . . 0.557 HD21 ' HB2' ' E' ' 78' ' ' ALA . 11.4 tp 61.42 35.97 17.53 Favored 'General case' 0 CA--C 1.53 0.19 0 O-C-N 122.106 -0.371 . . . . 0.0 111.442 178.724 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' E' E ' 110' ' ' GLU . . . . . . . . . . . . . 42.8 mt-10 -104.9 143.15 33.55 Favored 'General case' 0 C--N 1.33 -0.256 0 N-CA-C 109.586 -0.524 . . . . 0.0 109.586 175.288 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' E' E ' 111' ' ' GLU . . . . . . . . . . . . . 61.0 tt0 -79.72 121.98 26.01 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-O 120.877 0.37 . . . . 0.0 110.727 -176.661 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' E' E ' 112' ' ' LEU . . . . . . . . . . . . . 20.3 mt -105.98 -46.13 4.18 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 116.123 -0.489 . . . . 0.0 110.665 179.864 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' E' E ' 113' ' ' TYR . . . . . . . . . . . . . 57.1 t80 -134.31 138.26 44.83 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-O 120.901 0.382 . . . . 0.0 111.26 -178.077 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' E' E ' 114' ' ' ARG . . . . . . . . . . . . . 52.7 ttp180 -136.09 123.49 22.0 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 115.842 -0.617 . . . . 0.0 110.325 177.494 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' E' E ' 115' ' ' GLY . . . . . . . . . . . . . . . -150.0 157.98 27.46 Favored Glycine 0 CA--C 1.524 0.601 0 N-CA-C 110.915 -0.874 . . . . 0.0 110.915 179.0 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' E' E ' 116' ' ' LYS . . . . . . . . . . . . . 31.9 ttmt -131.83 138.95 48.7 Favored 'General case' 0 C--N 1.329 -0.303 0 N-CA-C 109.886 -0.413 . . . . 0.0 109.886 177.317 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' E' E ' 117' ' ' PHE . . . . . . . . . . . . . 39.1 m-85 -137.74 114.61 10.65 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-O 120.867 0.365 . . . . 0.0 110.208 -175.769 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' E' E ' 118' ' ' GLU . . . . . . . . . . . . . 81.2 tt0 -52.81 -44.51 66.7 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.493 -0.321 . . . . 0.0 111.503 -177.078 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' E' E ' 119' ' ' ASN . . . . . . . . . . . . . 36.5 m120 -95.77 30.69 2.27 Favored 'General case' 0 C--N 1.33 -0.248 0 N-CA-C 112.262 0.467 . . . . 0.0 112.262 -174.938 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' E' E ' 120' ' ' LEU . . . . . . . . . . . . . 13.9 tp -57.35 121.02 9.19 Favored 'General case' 0 C--N 1.332 -0.169 0 CA-C-O 120.631 0.253 . . . . 0.0 110.385 178.068 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' E' E ' 121' ' ' ASN . . . . . . . . . . . . . 66.7 m-20 -114.09 -44.12 3.17 Favored 'General case' 0 C--N 1.332 -0.188 0 CA-C-N 116.471 -0.331 . . . . 0.0 111.101 -178.794 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' E' E ' 122' ' ' LYS . . . . . . . . . . . . . 63.2 mtpt -145.5 152.12 39.27 Favored 'General case' 0 C--N 1.332 -0.171 0 CA-C-O 121.041 0.448 . . . . 0.0 111.714 -176.447 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' E' E ' 123' ' ' VAL . . . . . . . . . . . . . 47.2 t -130.85 131.95 64.19 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.252 0 CA-C-N 115.943 -0.571 . . . . 0.0 109.482 174.461 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' E' E ' 124' ' ' LEU . . . . . . . . . . . . . 83.0 mt -125.72 140.48 52.66 Favored 'General case' 0 C--N 1.332 -0.181 0 CA-C-O 120.827 0.346 . . . . 0.0 110.911 -177.549 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' E' E ' 125' ' ' VAL . . . . . . . . . . . . . 34.5 m -132.89 142.79 41.37 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.182 0 CA-C-N 116.127 -0.488 . . . . 0.0 110.764 179.878 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' E' E ' 126' ' ' ARG . . . . . . . . . . . . . 96.2 mtt-85 -148.05 112.15 5.18 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.443 177.105 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' E' E ' 127' ' ' ASN . . . . . . . . . . . . . 17.1 m120 53.85 -104.93 0.23 Allowed 'General case' 0 CA--C 1.543 0.699 0 CA-C-O 119.078 -0.487 . . . . 0.0 111.017 179.542 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' E' E ' 128' ' ' ASP . . . . . . . . . . . . . 18.7 p-10 -113.98 3.5 15.38 Favored 'General case' 0 N--CA 1.468 0.453 0 CA-C-N 119.508 1.049 . . . . 0.0 113.473 -177.487 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' E' E ' 129' ' ' LEU . . . . . . . . . . . . . 12.4 tp -104.92 140.47 38.1 Favored 'General case' 0 C--N 1.331 -0.215 0 N-CA-C 109.609 -0.515 . . . . 0.0 109.609 178.034 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' E' E ' 130' ' ' VAL . . . . . 0.599 HG11 HD13 ' E' ' 104' ' ' ILE . 13.4 p -132.92 139.2 50.14 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.184 0 CA-C-O 121.132 0.491 . . . . 0.0 110.742 -178.28 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' E' E ' 131' ' ' VAL . . . . . 0.589 HG22 HD12 ' E' ' 140' ' ' LEU . 38.4 t -136.11 140.85 43.11 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.267 0 CA-C-N 115.96 -0.564 . . . . 0.0 110.565 -179.792 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' E' E ' 132' ' ' ILE . . . . . . . . . . . . . 70.0 mt -116.17 133.08 63.8 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.27 0 CA-C-N 115.747 -0.66 . . . . 0.0 109.433 178.957 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' E' E ' 133' ' ' ILE . . . . . . . . . . . . . 39.0 mm -116.1 123.26 71.13 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.228 0 CA-C-O 120.678 0.275 . . . . 0.0 111.1 -174.898 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' E' E ' 134' ' ' ASP . . . . . . . . . . . . . 9.3 p-10 -136.18 149.73 48.72 Favored 'General case' 0 C--N 1.331 -0.226 0 CA-C-N 116.253 -0.431 . . . . 0.0 110.101 175.428 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' E' E ' 135' ' ' GLU . . . . . . . . . . . . . 81.5 tt0 -49.96 -27.33 5.22 Favored 'General case' 0 C--N 1.329 -0.299 0 N-CA-C 112.878 0.696 . . . . 0.0 112.878 -173.753 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' E' E ' 136' ' ' GLN . . . . . . . . . . . . . 94.8 mt-30 -83.24 -34.48 25.83 Favored 'General case' 0 C--O 1.233 0.232 0 N-CA-C 112.304 0.483 . . . . 0.0 112.304 -175.621 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' E' E ' 137' ' ' LYS . . . . . . . . . . . . . 15.2 pttp -167.51 174.23 8.04 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-O 121.597 0.713 . . . . 0.0 112.194 -170.941 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' E' E ' 138' ' ' LEU . . . . . 0.427 ' C ' HD23 ' E' ' 138' ' ' LEU . 6.3 tt -119.42 126.65 51.86 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 114.951 -1.022 . . . . 0.0 109.923 178.652 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' E' E ' 139' ' ' THR . . . . . . . . . . . . . 25.9 m -105.82 122.91 47.06 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.139 -0.482 . . . . 0.0 110.217 179.367 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' E' E ' 140' ' ' LEU . . . . . 0.589 HD12 HG22 ' E' ' 131' ' ' VAL . 10.6 tp -111.91 121.48 45.14 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 115.94 -0.573 . . . . 0.0 109.619 -177.428 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' E' E ' 141' ' ' ILE . . . . . 0.522 ' HB ' HG13 ' E' ' 130' ' ' VAL . 19.4 mt -122.0 118.68 56.31 Favored 'Isoleucine or valine' 0 C--O 1.234 0.265 0 CA-C-O 121.168 0.509 . . . . 0.0 110.121 -176.799 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' E' E ' 142' ' ' ARG . . . . . . . . . . . . . 78.6 mtp180 -102.75 110.13 21.96 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 115.058 -0.973 . . . . 0.0 110.114 178.985 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' E' E ' 143' ' ' THR . . . . . . . . . . . . . 69.6 p . . . . . 0 C--O 1.219 -0.538 0 CA-C-O 118.041 -0.98 . . . . 0.0 110.558 -178.561 . . . . . . . . 0 0 . 1 . 002 nuclear nobuild full ' F' F ' -3' ' ' GLU . . . . . . . . . . . . . 95.9 mt-10 . . . . . 0 N--CA 1.49 1.528 0 N-CA-C 109.458 -0.571 . . . . 0.0 109.458 . . . . . . . . . 0 0 . 1 . 002 nuclear nobuild full ' F' F ' -2' ' ' GLY . . . . . . . . . . . . . . . -75.58 150.0 39.31 Favored Glycine 0 CA--C 1.525 0.676 0 N-CA-C 110.906 -0.878 . . . . 0.0 110.906 179.86 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' F' F ' -1' ' ' VAL . . . . . . . . . . . . . 44.4 t -90.68 131.43 37.87 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.261 0 CA-C-O 120.842 0.353 . . . . 0.0 110.055 179.98 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' F' F ' 0' ' ' ILE . . . . . . . . . . . . . 44.1 mm -116.65 130.59 71.23 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.224 0 CA-C-N 116.121 -0.49 . . . . 0.0 109.996 179.224 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' F' F ' 1' ' ' MET . . . . . . . . . . . . . 25.3 ptp -83.05 134.8 35.01 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.246 -0.434 . . . . 0.0 110.778 -179.509 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' F' F ' 2' ' ' SER . . . . . . . . . . . . . 10.1 p -112.22 134.47 53.75 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.562 179.319 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' F' F ' 3' ' ' GLU . . . . . . . . . . . . . 40.6 mt-10 -139.61 141.6 37.11 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 115.991 -0.55 . . . . 0.0 110.653 -179.544 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' F' F ' 4' ' ' LEU . . . . . 0.427 HD12 HD23 ' F' ' 58' ' ' LEU . 3.1 tt -128.01 125.63 39.77 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-N 115.896 -0.593 . . . . 0.0 109.945 179.11 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' F' F ' 5' ' ' LYS . . . . . . . . . . . . . 97.9 mttt -106.28 120.05 40.84 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.297 -0.411 . . . . 0.0 110.655 -179.811 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' F' F ' 6' ' ' LEU . . . . . . . . . . . . . 64.1 mt -114.01 150.06 34.46 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 115.538 -0.756 . . . . 0.0 110.485 -178.88 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' F' F ' 7' ' ' LYS . . . . . . . . . . . . . 82.3 tttt -137.15 134.74 19.03 Favored Pre-proline 0 CA--C 1.534 0.365 0 CA-C-O 118.806 -0.616 . . . . 0.0 109.676 175.021 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' F' F ' 8' ' ' PRO . . . . . . . . . . . . . 71.8 Cg_endo -89.6 135.97 2.61 Favored 'Trans proline' 0 N--CA 1.49 1.319 0 C-N-CA 121.615 1.544 . . . . 0.0 111.483 177.838 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' F' F ' 9' ' ' LEU . . . . . . . . . . . . . 37.9 mt -72.93 -47.1 8.54 Favored Pre-proline 0 CA--C 1.533 0.325 0 CA-C-O 118.689 -0.672 . . . . 0.0 112.318 -177.538 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' F' F ' 10' ' ' PRO . . . . . . . . . . . . . 92.5 Cg_endo -80.68 149.87 18.61 Favored 'Trans proline' 0 N--CA 1.495 1.576 0 C-N-CA 121.104 1.203 . . . . 0.0 111.757 175.586 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' F' F ' 11' ' ' LYS . . . . . . . . . . . . . 83.6 tttt -84.1 96.9 9.06 Favored 'General case' 0 C--N 1.33 -0.275 0 C-N-CA 120.836 -0.346 . . . . 0.0 110.49 179.358 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' F' F ' 12' ' ' VAL . . . . . . . . . . . . . 12.1 p -142.77 144.39 24.36 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.364 0 CA-C-N 116.123 -0.49 . . . . 0.0 110.434 179.678 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' F' F ' 13' ' ' GLU . . . . . . . . . . . . . 43.7 mp0 -85.67 125.37 33.12 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.224 -0.444 . . . . 0.0 110.045 177.666 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' F' F ' 14' ' ' LEU . . . . . . . . . . . . . 45.7 mt -95.15 153.52 39.73 Favored Pre-proline 0 C--N 1.329 -0.303 0 CA-C-N 116.444 -0.344 . . . . 0.0 110.81 -177.8 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' F' F ' 15' ' ' PRO . . . . . . . . . . . . . 36.8 Cg_exo -59.33 160.14 20.67 Favored 'Trans proline' 0 N--CA 1.497 1.7 0 C-N-CA 121.296 1.331 . . . . 0.0 111.704 177.743 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' F' F ' 16' ' ' PRO . . . . . . . . . . . . . 27.5 Cg_exo -60.25 -43.13 36.98 Favored 'Trans proline' 0 N--CA 1.498 1.737 0 C-N-CA 121.381 1.388 . . . . 0.0 112.802 -177.628 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' F' F ' 17' ' ' ASP . . . . . . . . . . . . . 16.3 p-10 -87.72 12.5 12.65 Favored 'General case' 0 C--N 1.326 -0.422 0 N-CA-C 113.182 0.808 . . . . 0.0 113.182 -176.377 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' F' F ' 18' ' ' PHE . . . . . . . . . . . . . 48.1 t80 -58.0 -44.64 87.33 Favored 'General case' 0 C--N 1.334 -0.074 0 O-C-N 122.04 -0.413 . . . . 0.0 110.151 -178.241 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' F' F ' 19' ' ' VAL . . . . . 0.41 HG13 ' N ' ' F' ' 20' ' ' ASP . 14.6 p -56.46 -42.08 74.18 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.333 0 CA-C-N 116.36 -0.382 . . . . 0.0 110.941 -178.474 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' F' F ' 20' ' ' ASP . . . . . 0.41 ' N ' HG13 ' F' ' 19' ' ' VAL . 79.9 m-20 -60.98 -42.12 97.77 Favored 'General case' 0 C--O 1.233 0.234 0 CA-C-O 120.884 0.373 . . . . 0.0 110.957 -178.051 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' F' F ' 21' ' ' VAL . . . . . . . . . . . . . 46.9 t -64.0 -47.37 90.74 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 CA-C-N 116.343 -0.39 . . . . 0.0 110.406 -178.395 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' F' F ' 22' ' ' ILE . . . . . 0.51 HG22 HD12 ' F' ' 26' ' ' LEU . 50.1 mm -55.96 -43.96 76.67 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.182 0 CA-C-O 120.774 0.321 . . . . 0.0 110.66 178.769 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' F' F ' 23' ' ' ARG . . . . . . . . . . . . . 56.0 ttp180 -52.86 -52.36 57.57 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-O 120.709 0.29 . . . . 0.0 111.519 179.986 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' F' F ' 24' ' ' ILE . . . . . . . . . . . . . 69.3 mt -59.63 -40.62 82.68 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.268 0 CA-C-N 116.414 -0.357 . . . . 0.0 111.273 -177.051 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' F' F ' 25' ' ' LYS . . . . . . . . . . . . . 46.4 mttm -65.46 -42.06 92.7 Favored 'General case' 0 C--N 1.327 -0.377 0 N-CA-C 112.192 0.442 . . . . 0.0 112.192 -178.626 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' F' F ' 26' ' ' LEU . . . . . 0.51 HD12 HG22 ' F' ' 22' ' ' ILE . 74.4 mt -80.58 -38.03 30.21 Favored 'General case' 0 C--N 1.33 -0.261 0 N-CA-C 113.39 0.885 . . . . 0.0 113.39 -170.841 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' F' F ' 27' ' ' GLN . . . . . . . . . . . . . 8.6 pt20 -46.48 139.78 4.74 Favored 'General case' 0 N--CA 1.469 0.479 0 N-CA-C 112.871 0.693 . . . . 0.0 112.871 -174.946 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' F' F ' 28' ' ' GLY . . . . . . . . . . . . . . . 99.29 -25.4 28.37 Favored Glycine 0 CA--C 1.533 1.193 0 CA-C-N 115.507 -0.77 . . . . 0.0 112.264 -177.035 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' F' F ' 29' ' ' LYS . . . . . . . . . . . . . 33.5 mmtp -97.61 155.15 17.1 Favored 'General case' 0 C--O 1.233 0.198 0 CA-C-N 117.335 0.568 . . . . 0.0 110.771 178.982 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' F' F ' 30' ' ' THR . . . . . . . . . . . . . 25.2 m -107.21 136.65 46.68 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 115.928 -0.578 . . . . 0.0 109.827 175.428 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' F' F ' 31' ' ' VAL . . . . . . . . . . . . . 35.0 m -129.78 161.15 39.94 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.267 0 CA-C-N 116.473 -0.33 . . . . 0.0 110.814 -177.959 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' F' F ' 32' ' ' ARG . . . . . . . . . . . . . 92.7 mtt180 -132.56 151.22 52.0 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-O 121.307 0.575 . . . . 0.0 110.595 178.88 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' F' F ' 33' ' ' THR . . . . . . . . . . . . . 24.1 m -52.45 140.54 22.18 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.112 -0.494 . . . . 0.0 111.396 -178.467 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' F' F ' 34' ' ' GLY . . . . . . . . . . . . . . . 99.28 -17.09 58.39 Favored Glycine 0 CA--C 1.532 1.135 0 CA-C-O 119.596 -0.558 . . . . 0.0 113.218 178.977 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' F' F ' 35' ' ' ASP . . . . . . . . . . . . . 54.3 m-20 -63.3 150.48 43.18 Favored 'General case' 0 C--O 1.232 0.142 0 CA-C-N 118.09 0.945 . . . . 0.0 111.0 179.365 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' F' F ' 36' ' ' VAL . . . . . . . . . . . . . 42.4 t -125.72 130.44 72.53 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.293 0 CA-C-N 115.801 -0.636 . . . . 0.0 109.706 178.763 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' F' F ' 37' ' ' ILE . . . . . . . . . . . . . 65.2 mt -120.66 138.92 49.57 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.294 0 CA-C-N 116.336 -0.393 . . . . 0.0 110.098 -178.921 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' F' F ' 38' ' ' GLY . . . . . . . . . . . . . . . -109.13 128.86 9.21 Favored Glycine 0 CA--C 1.525 0.689 0 N-CA-C 110.872 -0.891 . . . . 0.0 110.872 179.02 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' F' F ' 39' ' ' ILE . . . . . . . . . . . . . 74.4 mt -123.57 134.91 65.03 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.256 0 N-CA-C 110.176 -0.305 . . . . 0.0 110.176 179.828 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' F' F ' 40' ' ' SER . . . . . . . . . . . . . 88.0 p -92.65 118.63 31.24 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.895 176.383 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' F' F ' 41' ' ' ILE . . . . . . . . . . . . . 44.5 mm -120.48 113.01 38.68 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.263 0 CA-C-O 120.751 0.31 . . . . 0.0 110.247 178.799 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' F' F ' 42' ' ' LEU . . . . . 0.409 HD12 ' N ' ' F' ' 42' ' ' LEU . 7.9 mp 51.21 37.4 18.37 Favored 'General case' 0 C--N 1.331 -0.223 0 CA-C-N 116.151 -0.477 . . . . 0.0 111.748 177.006 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' F' F ' 43' ' ' GLY . . . . . . . . . . . . . . . 75.95 29.84 58.4 Favored Glycine 0 CA--C 1.53 1.03 0 C-N-CA 121.151 -0.547 . . . . 0.0 112.33 177.606 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' F' F ' 44' ' ' LYS . . . . . . . . . . . . . 60.0 mtpt -135.29 127.88 30.76 Favored 'General case' 0 C--N 1.329 -0.295 0 N-CA-C 109.65 -0.5 . . . . 0.0 109.65 177.062 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' F' F ' 45' ' ' GLU . . . . . . . . . . . . . 84.2 tt0 -82.73 123.42 29.29 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-O 120.822 0.344 . . . . 0.0 111.322 -176.738 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' F' F ' 46' ' ' VAL . . . . . . . . . . . . . 7.1 p -123.23 128.4 74.89 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.202 0 N-CA-C 109.592 -0.521 . . . . 0.0 109.592 175.386 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' F' F ' 47' ' ' LYS . . . . . . . . . . . . . 63.6 mttp -99.53 128.79 45.65 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.125 -0.489 . . . . 0.0 111.229 178.099 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' F' F ' 48' ' ' PHE . . . . . . . . . . . . . 91.5 m-85 -111.64 131.9 54.96 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.023 -0.535 . . . . 0.0 109.746 176.196 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' F' F ' 49' ' ' LYS . . . . . . . . . . . . . 71.9 tttt -106.6 136.18 46.83 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.4 -0.364 . . . . 0.0 110.455 -179.654 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' F' F ' 50' ' ' VAL . . . . . . . . . . . . . 45.4 t -81.11 105.62 11.25 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.292 0 N-CA-C 109.53 -0.544 . . . . 0.0 109.53 176.691 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' F' F ' 51' ' ' VAL . . . . . . . . . . . . . 47.6 t -70.21 -51.96 34.34 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.33 0 CA-C-N 115.879 -0.6 . . . . 0.0 109.73 -174.387 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' F' F ' 52' ' ' GLN . . . . . . . . . . . . . 77.8 mt-30 -154.62 147.67 24.68 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-O 121.175 0.512 . . . . 0.0 111.756 -177.261 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' F' F ' 53' ' ' ALA . . . . . 0.456 ' HB1' ' HB2' ' F' ' 58' ' ' LEU . . . -122.39 128.84 51.46 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 115.19 -0.914 . . . . 0.0 109.317 175.282 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' F' F ' 54' ' ' TYR . . . . . . . . . . . . . 45.7 t80 -126.77 109.53 22.51 Favored Pre-proline 0 CA--C 1.534 0.335 0 CA-C-O 118.383 -0.817 . . . . 0.0 110.443 -178.479 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' F' F ' 55' ' ' PRO . . . . . . . . . . . . . 74.4 Cg_endo -77.09 170.04 72.69 Favored 'Cis proline' 0 N--CA 1.5 1.902 0 CA-C-N 121.768 1.667 . . . . 0.0 112.536 -5.091 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' F' F ' 56' ' ' SER . . . . . . . . . . . . . 13.7 m -112.27 126.91 27.6 Favored Pre-proline 0 CA--C 1.539 0.542 0 CA-C-O 118.409 -0.805 . . . . 0.0 109.642 176.52 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' F' F ' 57' ' ' PRO . . . . . . . . . . . . . 33.7 Cg_endo -65.27 169.15 41.16 Favored 'Cis proline' 0 N--CA 1.498 1.791 0 CA-C-N 122.083 1.78 . . . . 0.0 111.475 -1.543 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' F' F ' 58' ' ' LEU . . . . . 0.456 ' HB2' ' HB1' ' F' ' 53' ' ' ALA . 34.0 tp -130.61 137.05 49.45 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-O 120.971 0.415 . . . . 0.0 110.574 -179.313 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' F' F ' 59' ' ' ARG . . . . . . . . . . . . . 71.1 ttt180 -104.68 129.24 52.88 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 115.773 -0.648 . . . . 0.0 109.575 177.695 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' F' F ' 60' ' ' VAL . . . . . . . . . . . . . 42.3 t -86.74 119.17 34.23 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.272 0 C-N-CA 120.744 -0.382 . . . . 0.0 110.353 -176.131 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' F' F ' 61' ' ' GLU . . . . . . . . . . . . . 95.3 mt-10 -131.08 168.04 18.07 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.329 178.28 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' F' F ' 62' ' ' ASP . . . . . . . . . . . . . 55.8 m-20 -54.01 -32.51 54.43 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.641 -0.254 . . . . 0.0 111.641 179.259 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' F' F ' 63' ' ' ARG . . . . . . . . . . . . . 6.8 ptp180 -85.5 9.08 16.85 Favored 'General case' 0 CA--C 1.537 0.447 0 N-CA-C 113.508 0.929 . . . . 0.0 113.508 -175.892 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' F' F ' 64' ' ' THR . . . . . . . . . . . . . 30.1 m -85.43 134.81 34.05 Favored 'General case' 0 C--N 1.333 -0.124 0 CA-C-N 118.085 0.402 . . . . 0.0 110.813 -178.749 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' F' F ' 65' ' ' LYS . . . . . . . . . . . . . 52.4 mtmt -88.74 124.6 34.28 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.234 -0.439 . . . . 0.0 109.932 177.426 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' F' F ' 66' ' ' ILE . . . . . . . . . . . . . 62.3 mt -112.51 128.54 69.12 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.325 0 N-CA-C 109.835 -0.431 . . . . 0.0 109.835 -178.572 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' F' F ' 67' ' ' THR . . . . . . . . . . . . . 28.5 m -126.15 141.82 51.78 Favored 'General case' 0 C--N 1.331 -0.222 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.972 -177.05 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' F' F ' 68' ' ' LEU . . . . . 0.476 HD12 ' N ' ' F' ' 68' ' ' LEU . 8.5 mp -104.46 122.95 46.59 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 115.966 -0.561 . . . . 0.0 110.104 178.061 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' F' F ' 69' ' ' VAL . . . . . . . . . . . . . 46.8 t -101.12 102.84 14.02 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.262 0 CA-C-O 120.852 0.358 . . . . 0.0 110.206 -179.119 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' F' F ' 70' ' ' THR . . . . . . . . . . . . . 10.0 t -150.07 157.62 43.32 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.129 -0.487 . . . . 0.0 110.513 177.511 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' F' F ' 71' ' ' HIS . . . . . . . . . . . . . 83.3 m-70 -137.92 65.76 45.91 Favored Pre-proline 0 CA--C 1.536 0.426 0 C-N-CA 121.048 -0.261 . . . . 0.0 110.626 176.4 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' F' F ' 72' ' ' PRO . . . . . . . . . . . . . 69.5 Cg_endo -95.0 158.58 1.73 Allowed 'Trans proline' 0 N--CA 1.489 1.253 0 C-N-CA 121.989 1.793 . . . . 0.0 111.996 177.781 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' F' F ' 73' ' ' VAL . . . . . . . . . . . . . 35.6 m -96.19 145.19 8.97 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.305 0 N-CA-C 109.681 -0.489 . . . . 0.0 109.681 174.812 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' F' F ' 74' ' ' ASP . . . . . . . . . . . . . 39.7 t0 -88.85 114.91 25.98 Favored 'General case' 0 C--N 1.328 -0.343 0 N-CA-C 109.982 -0.377 . . . . 0.0 109.982 -177.596 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' F' F ' 75' ' ' VAL . . . . . . . . . . . . . 41.4 t -111.05 120.79 62.47 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.287 0 CA-C-O 121.07 0.462 . . . . 0.0 110.242 -178.784 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' F' F ' 76' ' ' LEU . . . . . . . . . . . . . 15.3 mt -128.55 143.81 51.03 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 115.732 -0.667 . . . . 0.0 109.692 179.097 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' F' F ' 77' ' ' GLU . . . . . . . . . . . . . 97.3 mt-10 -131.94 131.26 42.5 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-O 120.989 0.424 . . . . 0.0 111.093 -177.153 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' F' F ' 78' ' ' ALA . . . . . . . . . . . . . . . -117.94 128.38 54.75 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 115.747 -0.661 . . . . 0.0 109.621 177.148 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' F' F ' 79' ' ' LYS . . . . . 0.595 ' O ' HD13 ' F' ' 80' ' ' ILE . 95.2 mttt -79.93 120.63 24.41 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-O 120.904 0.383 . . . . 0.0 110.857 -177.085 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' F' F ' 80' ' ' ILE . . . . . 0.595 HD13 ' O ' ' F' ' 79' ' ' LYS . 41.4 mm -139.1 108.68 3.93 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.309 0 N-CA-C 109.072 -0.714 . . . . 0.0 109.072 -177.322 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' F' F ' 81' ' ' LYS . . . . . . . . . . . . . 82.7 tttt -97.53 123.79 41.54 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-O 120.868 0.366 . . . . 0.0 111.239 -175.913 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' F' F ' 82' ' ' GLY . . . . . . . . . . . . . . . 89.22 42.02 5.68 Favored Glycine 0 CA--C 1.526 0.724 0 C-N-CA 120.884 -0.674 . . . . 0.0 111.907 174.647 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' F' F ' 83' ' ' ILE . . . . . . . . . . . . . 71.4 mt -68.7 136.71 25.85 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.304 0 N-CA-C 109.661 -0.496 . . . . 0.0 109.661 176.571 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' F' F ' 84' ' ' LYS . . . . . . . . . . . . . 36.7 ttpt -101.36 -51.31 3.52 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-O 120.868 0.366 . . . . 0.0 110.262 -178.908 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' F' F ' 85' ' ' ASP . . . . . . . . . . . . . 11.9 t70 -148.22 148.65 30.74 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 115.874 -0.603 . . . . 0.0 110.385 -179.752 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' F' F ' 86' ' ' VAL . . . . . . . . . . . . . 46.3 t -133.56 132.95 57.52 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.269 0 CA-C-O 121.0 0.429 . . . . 0.0 110.494 -178.98 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' F' F ' 87' ' ' ILE . . . . . 0.498 HD12 ' N ' ' F' ' 87' ' ' ILE . 5.0 mp -119.82 127.25 75.87 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.202 0 CA-C-N 115.859 -0.61 . . . . 0.0 109.474 175.901 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' F' F ' 88' ' ' LEU . . . . . . . . . . . . . 12.8 tp -112.6 129.94 56.2 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.3 -0.409 . . . . 0.0 111.022 -177.453 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' F' F ' 89' ' ' ASP . . . . . . . . . . . . . 6.2 t70 -123.94 156.36 36.49 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 115.868 -0.606 . . . . 0.0 109.747 176.794 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' F' F ' 90' ' ' GLU . . . . . . . . . . . . . 96.3 mt-10 -46.15 -41.93 13.21 Favored 'General case' 0 C--N 1.332 -0.192 0 N-CA-C 113.15 0.796 . . . . 0.0 113.15 -172.58 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' F' F ' 91' ' ' ASN . . . . . . . . . . . . . 54.0 m-80 -132.09 36.6 3.64 Favored 'General case' 0 N--CA 1.464 0.259 0 CA-C-O 120.732 0.301 . . . . 0.0 111.569 -176.575 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' F' F ' 92' ' ' LEU . . . . . . . . . . . . . 12.6 tp -166.07 144.98 5.91 Favored 'General case' 0 C--N 1.331 -0.232 0 C-N-CA 120.927 -0.309 . . . . 0.0 110.746 -179.752 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' F' F ' 93' ' ' ILE . . . . . . . . . . . . . 68.7 mt -127.3 123.63 62.31 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.253 0 N-CA-C 109.584 -0.524 . . . . 0.0 109.584 179.795 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' F' F ' 94' ' ' VAL . . . . . 0.446 HG21 HG11 ' F' ' 125' ' ' VAL . 47.2 t -123.09 125.4 72.02 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.27 0 N-CA-C 109.907 -0.405 . . . . 0.0 109.907 -179.92 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' F' F ' 95' ' ' VAL . . . . . . . . . . . . . 43.4 t -121.16 135.81 60.13 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.325 0 CA-C-N 115.902 -0.59 . . . . 0.0 109.97 -177.877 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' F' F ' 96' ' ' ILE . . . . . . . . . . . . . 60.3 mt -117.62 126.51 74.76 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.286 0 N-CA-C 109.258 -0.645 . . . . 0.0 109.258 178.58 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' F' F ' 97' ' ' THR . . . . . . . . . . . . . 64.0 p -102.6 157.61 16.81 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-O 121.081 0.467 . . . . 0.0 111.36 -176.432 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' F' F ' 98' ' ' GLU . . . . . . . . . . . . . 12.5 pt-20 -53.88 -22.17 9.33 Favored 'General case' 0 CA--C 1.534 0.345 0 N-CA-C 112.51 0.559 . . . . 0.0 112.51 -179.936 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' F' F ' 99' ' ' GLU . . . . . . . . . . . . . 16.9 tt0 -78.94 14.56 1.34 Allowed 'General case' 0 CA--C 1.537 0.444 0 N-CA-C 112.855 0.687 . . . . 0.0 112.855 -178.061 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' F' F ' 100' ' ' ASN . . . . . . . . . . . . . 3.6 m-20 59.92 38.09 21.23 Favored 'General case' 0 CA--C 1.531 0.214 0 CA-C-O 121.027 0.441 . . . . 0.0 110.599 -179.536 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' F' F ' 101' ' ' GLU . . . . . . . . . . . . . 84.7 tt0 -118.24 143.49 46.51 Favored 'General case' 0 C--N 1.332 -0.163 0 CA-C-N 116.014 -0.539 . . . . 0.0 109.776 178.429 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' F' F ' 102' ' ' VAL . . . . . . . . . . . . . 43.6 t -114.95 126.75 72.61 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.269 0 CA-C-N 116.182 -0.463 . . . . 0.0 109.946 -177.862 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' F' F ' 103' ' ' LEU . . . . . . . . . . . . . 27.0 mt -116.53 130.78 56.94 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 115.665 -0.698 . . . . 0.0 110.267 177.704 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' F' F ' 104' ' ' ILE . . . . . . . . . . . . . 66.5 mt -118.38 120.75 65.28 Favored 'Isoleucine or valine' 0 C--O 1.234 0.25 0 N-CA-C 110.053 -0.351 . . . . 0.0 110.053 179.669 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' F' F ' 105' ' ' PHE . . . . . . . . . . . . . 84.3 m-85 -123.47 164.87 18.08 Favored 'General case' 0 C--N 1.333 -0.15 0 O-C-N 123.928 0.768 . . . . 0.0 109.91 179.742 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' F' F ' 106' ' ' ASN . . . . . . . . . . . . . 45.4 p-10 -100.07 -171.31 2.02 Favored 'General case' 0 C--N 1.331 -0.229 0 N-CA-C 109.88 -0.415 . . . . 0.0 109.88 172.934 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' F' F ' 107' ' ' GLN . . . . . . . . . . . . . 48.7 tt0 -58.67 -28.23 65.54 Favored 'General case' 0 C--N 1.328 -0.365 0 N-CA-C 112.278 0.473 . . . . 0.0 112.278 -178.693 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' F' F ' 108' ' ' ASN . . . . . . . . . . . . . 14.0 t30 -91.4 14.11 15.59 Favored 'General case' 0 CA--C 1.534 0.359 0 N-CA-C 113.177 0.806 . . . . 0.0 113.177 -176.336 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' F' F ' 109' ' ' LEU . . . . . . . . . . . . . 28.2 mt 59.15 37.2 24.09 Favored 'General case' 0 CA--C 1.529 0.144 0 CA-C-O 121.03 0.443 . . . . 0.0 111.551 177.122 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' F' F ' 110' ' ' GLU . . . . . . . . . . . . . 95.7 mt-10 -100.6 150.15 23.01 Favored 'General case' 0 C--N 1.329 -0.285 0 N-CA-C 109.818 -0.438 . . . . 0.0 109.818 176.058 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' F' F ' 111' ' ' GLU . . . . . . . . . . . . . 84.9 tt0 -82.38 122.01 27.45 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-O 120.918 0.389 . . . . 0.0 110.713 -178.255 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' F' F ' 112' ' ' LEU . . . . . . . . . . . . . 60.6 mt -110.91 -46.02 3.39 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.029 -0.532 . . . . 0.0 110.334 178.872 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' F' F ' 113' ' ' TYR . . . . . . . . . . . . . 52.6 t80 -140.96 138.58 33.87 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-O 120.874 0.368 . . . . 0.0 111.393 -179.791 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' F' F ' 114' ' ' ARG . . . . . . . . . . . . . 31.4 ttp180 -138.61 123.02 18.34 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 115.863 -0.608 . . . . 0.0 109.955 176.29 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' F' F ' 115' ' ' GLY . . . . . . . . . . . . . . . -150.08 157.78 27.37 Favored Glycine 0 CA--C 1.523 0.581 0 C-N-CA 120.794 -0.717 . . . . 0.0 111.35 179.002 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' F' F ' 116' ' ' LYS . . . . . . . . . . . . . 39.8 ttpt -127.7 140.74 51.88 Favored 'General case' 0 C--N 1.331 -0.228 0 N-CA-C 110.139 -0.319 . . . . 0.0 110.139 178.446 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' F' F ' 117' ' ' PHE . . . . . 0.472 ' HE2' HD13 ' F' ' 132' ' ' ILE . 44.2 m-85 -136.16 115.01 12.13 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-O 120.865 0.364 . . . . 0.0 110.292 -178.331 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' F' F ' 118' ' ' GLU . . . . . . . . . . . . . 84.9 tt0 -52.23 -46.9 65.89 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.43 -0.35 . . . . 0.0 111.561 -177.515 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' F' F ' 119' ' ' ASN . . . . . . . . . . . . . 18.0 m120 -97.01 31.02 2.51 Favored 'General case' 0 C--N 1.329 -0.285 0 N-CA-C 112.105 0.409 . . . . 0.0 112.105 -175.213 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' F' F ' 120' ' ' LEU . . . . . . . . . . . . . 15.5 tp -56.29 120.11 7.07 Favored 'General case' 0 C--N 1.331 -0.202 0 CA-C-O 120.694 0.283 . . . . 0.0 110.543 178.392 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' F' F ' 121' ' ' ASN . . . . . . . . . . . . . 12.5 m120 -114.06 -44.02 3.19 Favored 'General case' 0 C--N 1.332 -0.181 0 CA-C-N 116.499 -0.319 . . . . 0.0 111.225 -177.53 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' F' F ' 122' ' ' LYS . . . . . . . . . . . . . 88.4 mttt -144.7 153.84 42.14 Favored 'General case' 0 C--N 1.332 -0.195 0 CA-C-O 121.096 0.474 . . . . 0.0 111.912 -176.104 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' F' F ' 123' ' ' VAL . . . . . . . . . . . . . 44.3 t -129.29 129.04 67.23 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.261 0 CA-C-N 115.735 -0.666 . . . . 0.0 109.621 175.428 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' F' F ' 124' ' ' LEU . . . . . . . . . . . . . 34.0 mt -116.69 133.25 56.24 Favored 'General case' 0 C--N 1.331 -0.208 0 CA-C-N 116.305 -0.407 . . . . 0.0 110.275 -179.251 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' F' F ' 125' ' ' VAL . . . . . 0.446 HG11 HG21 ' F' ' 94' ' ' VAL . 34.3 m -136.21 139.03 46.33 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.298 0 CA-C-N 116.506 -0.315 . . . . 0.0 110.831 -179.032 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' F' F ' 126' ' ' ARG . . . . . . . . . . . . . 19.2 ttm180 -157.63 127.46 6.11 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-O 120.974 0.416 . . . . 0.0 110.88 175.913 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' F' F ' 127' ' ' ASN . . . . . . . . . . . . . 78.8 m-20 52.9 -113.09 0.74 Allowed 'General case' 0 CA--C 1.544 0.73 0 CA-C-O 118.748 -0.644 . . . . 0.0 110.858 -179.77 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' F' F ' 128' ' ' ASP . . . . . . . . . . . . . 18.9 p-10 -114.17 9.84 17.21 Favored 'General case' 0 CA--C 1.536 0.42 0 CA-C-N 119.978 1.263 . . . . 0.0 113.074 -178.233 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' F' F ' 129' ' ' LEU . . . . . . . . . . . . . 15.1 tp -109.02 138.69 44.97 Favored 'General case' 0 C--O 1.233 0.211 0 O-C-N 122.056 -0.403 . . . . 0.0 109.93 179.123 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' F' F ' 130' ' ' VAL . . . . . . . . . . . . . 43.0 t -125.36 139.49 51.1 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.24 0 CA-C-N 116.311 -0.404 . . . . 0.0 110.002 -178.968 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' F' F ' 131' ' ' VAL . . . . . . . . . . . . . 43.6 t -135.62 135.62 51.14 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.338 0 CA-C-N 116.239 -0.437 . . . . 0.0 109.959 178.287 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' F' F ' 132' ' ' ILE . . . . . 0.472 HD13 ' HE2' ' F' ' 117' ' ' PHE . 69.3 mt -114.41 134.13 58.31 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.323 0 N-CA-C 109.41 -0.589 . . . . 0.0 109.41 -179.926 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' F' F ' 133' ' ' ILE . . . . . . . . . . . . . 39.2 mm -116.22 117.88 56.97 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.211 0 CA-C-N 116.295 -0.411 . . . . 0.0 111.006 -174.594 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' F' F ' 134' ' ' ASP . . . . . . . . . . . . . 7.0 p-10 -129.81 149.64 51.47 Favored 'General case' 0 C--N 1.332 -0.177 0 N-CA-C 109.582 -0.525 . . . . 0.0 109.582 174.085 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' F' F ' 135' ' ' GLU . . . . . . . . . . . . . 39.7 tp10 -49.87 -26.17 3.83 Favored 'General case' 0 C--N 1.327 -0.39 0 N-CA-C 112.988 0.736 . . . . 0.0 112.988 -169.676 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' F' F ' 136' ' ' GLN . . . . . . . . . . . . . 96.9 mt-30 -105.09 -24.27 12.8 Favored 'General case' 0 N--CA 1.466 0.353 0 N-CA-C 113.178 0.807 . . . . 0.0 113.178 -174.654 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' F' F ' 137' ' ' LYS . . . . . . . . . . . . . 38.6 ttpt -140.86 147.75 39.44 Favored 'General case' 0 C--N 1.331 -0.21 0 CA-C-O 121.515 0.674 . . . . 0.0 112.35 -168.32 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' F' F ' 138' ' ' LEU . . . . . . . . . . . . . 16.3 tp -111.67 121.19 44.46 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 114.863 -1.062 . . . . 0.0 109.069 173.567 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' F' F ' 139' ' ' THR . . . . . . . . . . . . . 21.7 m -110.88 126.39 54.64 Favored 'General case' 0 C--N 1.332 -0.179 0 CA-C-O 120.689 0.28 . . . . 0.0 110.963 -178.328 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' F' F ' 140' ' ' LEU . . . . . 0.479 HD23 ' C ' ' F' ' 140' ' ' LEU . 7.8 tt -114.56 123.45 49.38 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 115.592 -0.731 . . . . 0.0 109.247 179.701 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' F' F ' 141' ' ' ILE . . . . . . . . . . . . . 19.5 mt -122.09 121.42 63.99 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.326 0 CA-C-O 120.988 0.423 . . . . 0.0 109.929 -175.545 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' F' F ' 142' ' ' ARG . . . . . . . . . . . . . 72.3 ttt-85 -113.91 131.43 56.3 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 115.268 -0.878 . . . . 0.0 110.452 -176.917 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' F' F ' 143' ' ' THR . . . . . . . . . . . . . 20.1 p . . . . . 0 C--O 1.221 -0.422 0 CA-C-O 117.991 -1.005 . . . . 0.0 110.522 179.458 . . . . . . . . 0 0 . 1 . 003 nuclear nobuild full ' A' A ' -3' ' ' GLU . . . . . . . . . . . . . 95.7 mt-10 . . . . . 0 N--CA 1.49 1.539 0 N-CA-C 109.281 -0.637 . . . . 0.0 109.281 . . . . . . . . . 0 0 . 1 . 003 nuclear nobuild full ' A' A ' -2' ' ' GLY . . . . . . . . . . . . . . . -61.18 150.01 44.44 Favored Glycine 0 CA--C 1.525 0.66 0 N-CA-C 110.764 -0.934 . . . . 0.0 110.764 179.694 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' -1' ' ' VAL . . . . . . . . . . . . . 45.6 t -95.22 125.23 47.94 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.273 0 CA-C-O 120.939 0.4 . . . . 0.0 110.108 -179.546 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 0' ' ' ILE . . . . . . . . . . . . . 74.2 mt -124.03 131.15 73.36 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.235 0 CA-C-N 116.037 -0.529 . . . . 0.0 109.675 178.844 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 24.6 ptp -90.57 131.86 36.05 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.241 -0.436 . . . . 0.0 110.604 -178.905 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 6.7 p -112.07 135.3 52.9 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.287 -0.415 . . . . 0.0 110.96 -179.254 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 53.7 mp0 -140.96 141.48 34.45 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.065 -0.516 . . . . 0.0 111.005 179.04 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 4' ' ' LEU . . . . . . . . . . . . . 15.8 tp -128.22 130.44 47.97 Favored 'General case' 0 C--N 1.331 -0.206 0 CA-C-N 116.067 -0.515 . . . . 0.0 110.106 175.833 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 5' ' ' LYS . . . . . . . . . . . . . 66.8 mttm -113.71 121.58 44.54 Favored 'General case' 0 C--O 1.235 0.308 0 CA-C-N 116.356 -0.384 . . . . 0.0 110.845 -179.765 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 45.1 mt -114.17 145.46 41.64 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 115.413 -0.812 . . . . 0.0 110.3 -179.271 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 78.6 tttt -131.75 136.96 29.27 Favored Pre-proline 0 CA--C 1.535 0.374 0 CA-C-O 119.011 -0.519 . . . . 0.0 109.934 176.573 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 8' ' ' PRO . . . . . . . . . . . . . 85.5 Cg_endo -91.9 143.32 2.77 Favored 'Trans proline' 0 N--CA 1.491 1.358 0 C-N-CA 121.786 1.657 . . . . 0.0 111.864 178.623 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 43.4 mt -77.94 -47.79 2.19 Favored Pre-proline 0 CA--C 1.534 0.349 0 CA-C-O 118.657 -0.687 . . . . 0.0 112.22 179.787 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 95.0 Cg_endo -81.19 156.21 19.66 Favored 'Trans proline' 0 N--CA 1.496 1.649 0 C-N-CA 121.253 1.302 . . . . 0.0 112.128 177.075 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 62.9 tttm -88.96 107.33 18.96 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.358 -0.383 . . . . 0.0 110.435 177.908 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 12.7 p -147.83 146.29 18.16 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.336 0 CA-C-O 120.814 0.34 . . . . 0.0 110.763 -179.855 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 70.7 mm-40 -84.47 130.28 34.78 Favored 'General case' 0 C--N 1.33 -0.275 0 N-CA-C 109.874 -0.417 . . . . 0.0 109.874 177.033 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 14' ' ' LEU . . . . . . . . . . . . . 32.9 mt -98.56 145.04 29.21 Favored Pre-proline 0 CA--C 1.534 0.357 0 CA-C-O 119.042 -0.504 . . . . 0.0 110.472 -178.653 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 15' ' ' PRO . . . . . . . . . . . . . 24.7 Cg_exo -62.85 160.37 33.61 Favored 'Trans proline' 0 N--CA 1.497 1.722 0 C-N-CA 121.359 1.373 . . . . 0.0 112.053 176.749 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 16' ' ' PRO . . . . . . . . . . . . . 27.8 Cg_exo -60.4 -33.04 94.58 Favored 'Trans proline' 0 N--CA 1.497 1.7 0 C-N-CA 121.556 1.504 . . . . 0.0 112.693 -179.637 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 17' ' ' ASP . . . . . . . . . . . . . 11.0 p-10 -86.16 4.42 38.54 Favored 'General case' 0 CA--C 1.536 0.42 0 N-CA-C 113.264 0.839 . . . . 0.0 113.264 -177.583 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 18' ' ' PHE . . . . . . . . . . . . . 23.0 t80 -57.45 -44.79 85.05 Favored 'General case' 0 N--CA 1.457 -0.093 0 O-C-N 121.878 -0.514 . . . . 0.0 110.252 -177.374 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 19' ' ' VAL . . . . . . . . . . . . . 48.4 t -55.9 -46.07 80.12 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.36 0 CA-C-N 116.449 -0.342 . . . . 0.0 110.823 -177.532 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 79.8 m-20 -59.59 -42.01 91.57 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-O 120.771 0.319 . . . . 0.0 110.951 -176.855 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 48.0 t -64.13 -47.48 89.93 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.25 0 C-N-CA 120.645 -0.422 . . . . 0.0 110.495 -177.701 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 22' ' ' ILE . . . . . 0.528 HG22 HD12 ' A' ' 26' ' ' LEU . 51.6 mm -55.82 -47.05 80.1 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.237 0 C-N-CA 120.978 -0.289 . . . . 0.0 110.684 179.631 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 23' ' ' ARG . . . . . . . . . . . . . 50.9 ttp180 -54.35 -49.39 69.89 Favored 'General case' 0 C--N 1.329 -0.286 0 C-N-CA 121.005 -0.278 . . . . 0.0 111.419 -177.626 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 24' ' ' ILE . . . . . . . . . . . . . 74.0 mt -60.32 -45.12 96.87 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.235 0 C-N-CA 121.117 -0.233 . . . . 0.0 111.26 -177.197 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 56.2 mmtt -64.67 -38.7 91.91 Favored 'General case' 0 C--N 1.328 -0.334 0 N-CA-C 112.259 0.466 . . . . 0.0 112.259 -177.571 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 26' ' ' LEU . . . . . 0.528 HD12 HG22 ' A' ' 22' ' ' ILE . 91.2 mt -78.33 -44.8 24.25 Favored 'General case' 0 C--N 1.33 -0.273 0 N-CA-C 112.983 0.734 . . . . 0.0 112.983 -172.27 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 27' ' ' GLN . . . . . . . . . . . . . 11.1 pt20 -47.23 139.41 6.2 Favored 'General case' 0 N--CA 1.469 0.492 0 N-CA-C 112.714 0.635 . . . . 0.0 112.714 -175.495 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 99.37 -26.34 24.74 Favored Glycine 0 CA--C 1.533 1.17 0 CA-C-N 115.613 -0.721 . . . . 0.0 112.245 -177.744 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 89.9 mttt -98.5 155.1 17.43 Favored 'General case' 0 C--O 1.233 0.191 0 CA-C-N 117.248 0.524 . . . . 0.0 111.439 179.756 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 30' ' ' THR . . . . . . . . . . . . . 24.2 m -105.78 135.17 47.68 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 115.717 -0.674 . . . . 0.0 109.774 174.906 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 34.8 m -131.73 157.13 43.1 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.276 0 CA-C-N 116.353 -0.385 . . . . 0.0 111.006 -177.739 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 32' ' ' ARG . . . . . . . . . . . . . 91.6 mtm-85 -130.61 150.42 51.82 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-O 121.289 0.566 . . . . 0.0 110.902 179.43 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 33' ' ' THR . . . . . . . . . . . . . 20.3 m -53.47 140.63 27.43 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.076 -0.511 . . . . 0.0 111.299 -178.634 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 99.63 -17.08 58.06 Favored Glycine 0 CA--C 1.534 1.278 0 C-N-CA 121.116 -0.564 . . . . 0.0 113.155 179.252 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 73.0 m-20 -64.68 148.46 50.96 Favored 'General case' 0 C--O 1.232 0.136 0 CA-C-N 118.081 0.941 . . . . 0.0 111.127 179.278 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 46.5 t -118.94 129.43 75.14 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.208 0 CA-C-N 115.721 -0.672 . . . . 0.0 109.686 178.529 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 37' ' ' ILE . . . . . . . . . . . . . 69.0 mt -121.22 138.73 50.63 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.265 0 CA-C-N 116.14 -0.482 . . . . 0.0 109.907 -179.158 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . -113.53 128.94 8.57 Favored Glycine 0 CA--C 1.526 0.758 0 N-CA-C 110.989 -0.844 . . . . 0.0 110.989 -179.976 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 39' ' ' ILE . . . . . . . . . . . . . 70.7 mt -123.43 136.99 58.22 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.218 0 N-CA-C 110.041 -0.355 . . . . 0.0 110.041 179.478 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 40' ' ' SER . . . . . . . . . . . . . 13.4 p -92.83 121.68 34.45 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.344 -0.389 . . . . 0.0 110.961 176.406 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 41' ' ' ILE . . . . . 0.413 HG22 HD13 ' A' ' 42' ' ' LEU . 70.6 mt -129.42 114.1 30.19 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.218 0 N-CA-C 109.756 -0.461 . . . . 0.0 109.756 177.136 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 42' ' ' LEU . . . . . 0.413 HD13 HG22 ' A' ' 41' ' ' ILE . 8.6 mp 57.22 35.29 25.98 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-O 120.954 0.407 . . . . 0.0 111.337 -178.973 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . 77.79 -10.13 26.77 Favored Glycine 0 CA--C 1.536 1.359 0 C-N-CA 121.275 -0.488 . . . . 0.0 113.414 178.218 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 44' ' ' LYS . . . . . . . . . . . . . 25.5 ttpt -91.77 129.97 37.64 Favored 'General case' 0 C--N 1.331 -0.226 0 CA-C-N 117.915 0.858 . . . . 0.0 109.811 176.693 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 84.4 tt0 -84.05 125.97 32.61 Favored 'General case' 0 C--N 1.327 -0.392 0 C-N-CA 120.874 -0.33 . . . . 0.0 110.805 -179.731 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 46' ' ' VAL . . . . . . . . . . . . . 7.5 p -119.4 129.25 75.52 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.187 0 N-CA-C 109.553 -0.536 . . . . 0.0 109.553 176.147 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 59.0 mtpt -100.34 126.39 46.68 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 115.704 -0.68 . . . . 0.0 111.059 179.238 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 48' ' ' PHE . . . . . . . . . . . . . 94.0 m-85 -111.33 131.9 54.81 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.198 -0.456 . . . . 0.0 109.918 176.361 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 78.4 tttt -107.28 135.61 48.5 Favored 'General case' 0 C--N 1.329 -0.322 0 N-CA-C 110.155 -0.313 . . . . 0.0 110.155 178.265 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 50' ' ' VAL . . . . . . . . . . . . . 45.0 t -79.7 109.56 14.41 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.285 0 N-CA-C 109.333 -0.617 . . . . 0.0 109.333 177.047 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 51' ' ' VAL . . . . . . . . . . . . . 49.1 t -72.4 -52.37 24.18 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.321 0 CA-C-N 115.993 -0.548 . . . . 0.0 109.626 -174.885 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 52' ' ' GLN . . . . . . . . . . . . . 90.8 mt-30 -153.42 150.27 28.64 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.061 -0.518 . . . . 0.0 111.769 -177.821 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -130.16 132.81 46.22 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 115.208 -0.905 . . . . 0.0 109.611 174.725 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 54' ' ' TYR . . . . . . . . . . . . . 37.4 t80 -129.07 113.02 18.53 Favored Pre-proline 0 CA--C 1.535 0.392 0 CA-C-O 118.144 -0.931 . . . . 0.0 110.496 179.092 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 55' ' ' PRO . . . . . . . . . . . . . 74.4 Cg_endo -77.11 167.37 79.96 Favored 'Cis proline' 0 N--CA 1.5 1.854 0 CA-C-N 121.97 1.739 . . . . 0.0 112.475 -6.872 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 56' ' ' SER . . . . . . . . . . . . . 13.6 m -116.09 127.02 27.09 Favored Pre-proline 0 CA--C 1.538 0.502 0 CA-C-O 118.427 -0.797 . . . . 0.0 109.239 175.859 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 57' ' ' PRO . . . . . . . . . . . . . 46.7 Cg_endo -69.7 148.65 87.03 Favored 'Cis proline' 0 N--CA 1.498 1.741 0 CA-C-N 122.067 1.774 . . . . 0.0 111.862 0.497 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 58' ' ' LEU . . . . . . . . . . . . . 23.2 tp -107.52 137.18 46.02 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.014 -0.539 . . . . 0.0 110.742 -178.898 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 59' ' ' ARG . . . . . . . . . . . . . 56.9 ttp180 -104.04 120.12 40.39 Favored 'General case' 0 C--N 1.327 -0.383 0 N-CA-C 109.205 -0.665 . . . . 0.0 109.205 174.513 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 40.3 t -81.37 122.35 36.28 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.232 0 C-N-CA 120.626 -0.429 . . . . 0.0 110.74 -173.453 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 91.1 mt-10 -131.07 164.15 26.06 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 115.96 -0.564 . . . . 0.0 109.675 176.567 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 62' ' ' ASP . . . . . . . . . . . . . 44.5 m-20 -53.04 -32.8 48.79 Favored 'General case' 0 C--N 1.328 -0.347 0 N-CA-C 111.852 0.316 . . . . 0.0 111.852 -179.739 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 63' ' ' ARG . . . . . . . . . . . . . 68.4 mtp180 -72.47 -21.79 61.16 Favored 'General case' 0 CA--C 1.534 0.335 0 N-CA-C 112.907 0.706 . . . . 0.0 112.907 -176.354 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 31.1 m -68.77 140.14 55.32 Favored 'General case' 0 C--N 1.331 -0.2 0 CA-C-O 120.86 0.362 . . . . 0.0 111.057 -175.675 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 65' ' ' LYS . . . . . . . . . . . . . 50.3 mtmt -89.5 134.24 34.2 Favored 'General case' 0 C--N 1.331 -0.23 0 CA-C-N 116.11 -0.496 . . . . 0.0 110.444 178.316 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 66' ' ' ILE . . . . . . . . . . . . . 61.0 mt -118.27 132.59 67.67 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.254 0 N-CA-C 109.98 -0.378 . . . . 0.0 109.98 179.917 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 67' ' ' THR . . . . . . . . . . . . . 20.5 m -124.18 136.81 54.46 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-O 121.028 0.442 . . . . 0.0 110.918 -179.362 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 68' ' ' LEU . . . . . . . . . . . . . 30.6 mt -106.16 123.02 47.37 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 115.881 -0.599 . . . . 0.0 110.431 177.498 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 69' ' ' VAL . . . . . . . . . . . . . 46.3 t -102.68 130.64 52.37 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.245 0 CA-C-N 116.159 -0.473 . . . . 0.0 109.928 178.337 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 70' ' ' THR . . . . . . . . . . . . . 24.1 m -145.28 -57.74 0.33 Allowed 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.308 -0.405 . . . . 0.0 110.466 179.685 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 71' ' ' HIS . . . . . . . . . . . . . 32.4 m80 -110.12 153.79 43.08 Favored Pre-proline 0 C--N 1.329 -0.302 0 CA-C-N 116.259 -0.428 . . . . 0.0 110.366 179.623 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 72' ' ' PRO . . . . . . . . . . . . . 38.0 Cg_endo -66.17 -15.78 49.61 Favored 'Trans proline' 0 N--CA 1.499 1.821 0 C-N-CA 121.298 1.332 . . . . 0.0 113.218 178.379 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 73' ' ' VAL . . . . . . . . . . . . . 35.6 m -120.25 161.5 19.76 Favored 'Isoleucine or valine' 0 N--CA 1.462 0.133 0 CA-C-O 120.913 0.387 . . . . 0.0 110.545 -178.802 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 74' ' ' ASP . . . . . 0.509 ' OD1' HD11 ' A' ' 76' ' ' LEU . 4.9 t70 -98.57 124.07 43.11 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.082 -0.508 . . . . 0.0 110.275 -178.243 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 42.8 t -117.8 123.65 71.98 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.26 0 CA-C-O 120.931 0.396 . . . . 0.0 110.646 -177.937 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 76' ' ' LEU . . . . . 0.509 HD11 ' OD1' ' A' ' 74' ' ' ASP . 5.8 mp -121.81 148.48 44.63 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 115.848 -0.615 . . . . 0.0 109.679 175.537 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 77' ' ' GLU . . . . . . . . . . . . . 96.6 mt-10 -137.68 134.93 35.99 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-O 120.991 0.424 . . . . 0.0 111.354 -178.308 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 78' ' ' ALA . . . . . . . . . . . . . . . -119.95 135.44 54.9 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 115.718 -0.674 . . . . 0.0 109.679 176.266 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 79' ' ' LYS . . . . . 0.612 ' O ' HD13 ' A' ' 80' ' ' ILE . 62.0 mttp -84.78 115.56 22.79 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-O 120.816 0.341 . . . . 0.0 111.078 -176.578 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 80' ' ' ILE . . . . . 0.612 HD13 ' O ' ' A' ' 79' ' ' LYS . 39.6 mm -139.3 108.56 3.71 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.27 0 N-CA-C 109.301 -0.629 . . . . 0.0 109.301 -178.082 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 81' ' ' LYS . . . . . . . . . . . . . 63.6 mttp -94.53 126.25 39.69 Favored 'General case' 0 C--N 1.33 -0.249 0 C-N-CA 120.629 -0.428 . . . . 0.0 111.175 -179.734 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . 89.08 42.1 5.7 Favored Glycine 0 CA--C 1.527 0.821 0 C-N-CA 120.679 -0.772 . . . . 0.0 112.119 173.798 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 83' ' ' ILE . . . . . . . . . . . . . 72.9 mt -68.84 137.91 23.42 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.291 0 N-CA-C 109.597 -0.52 . . . . 0.0 109.597 176.19 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 84' ' ' LYS . . . . . . . . . . . . . 14.2 ttmm -93.08 -54.05 3.88 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-O 121.104 0.478 . . . . 0.0 110.216 -178.029 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 85' ' ' ASP . . . . . . . . . . . . . 13.1 t70 -151.22 151.41 31.83 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 115.611 -0.722 . . . . 0.0 110.55 -178.725 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 86' ' ' VAL . . . . . . . . . . . . . 44.1 t -128.58 129.43 68.72 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.255 0 CA-C-O 121.016 0.436 . . . . 0.0 110.083 178.914 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 87' ' ' ILE . . . . . 0.493 HD12 ' N ' ' A' ' 87' ' ' ILE . 5.1 mp -119.33 124.04 72.31 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.207 0 N-CA-C 109.229 -0.656 . . . . 0.0 109.229 178.22 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 88' ' ' LEU . . . . . . . . . . . . . 15.9 tp -113.79 126.74 55.54 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-O 121.077 0.465 . . . . 0.0 111.259 -175.758 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 89' ' ' ASP . . . . . . . . . . . . . 13.0 t70 -121.87 152.45 39.57 Favored 'General case' 0 C--N 1.331 -0.223 0 N-CA-C 109.232 -0.655 . . . . 0.0 109.232 174.994 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 44.4 mt-10 -49.83 -35.18 22.08 Favored 'General case' 0 C--N 1.328 -0.348 0 N-CA-C 112.812 0.671 . . . . 0.0 112.812 -172.179 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 91' ' ' ASN . . . . . . . . . . . . . 87.9 m-20 -126.87 26.77 6.11 Favored 'General case' 0 N--CA 1.467 0.391 0 N-CA-C 112.596 0.591 . . . . 0.0 112.596 -175.272 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 92' ' ' LEU . . . . . . . . . . . . . 7.2 tp -166.2 141.39 4.61 Favored 'General case' 0 C--N 1.33 -0.239 0 CA-C-O 120.728 0.299 . . . . 0.0 110.387 178.233 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 93' ' ' ILE . . . . . . . . . . . . . 68.1 mt -120.61 122.4 67.9 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.267 0 N-CA-C 109.407 -0.59 . . . . 0.0 109.407 179.327 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 94' ' ' VAL . . . . . . . . . . . . . 48.0 t -120.92 125.81 74.47 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.267 0 CA-C-O 120.981 0.419 . . . . 0.0 109.993 -179.864 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 95' ' ' VAL . . . . . . . . . . . . . 44.9 t -119.81 132.25 70.04 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.249 0 CA-C-N 115.867 -0.606 . . . . 0.0 109.543 178.872 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 96' ' ' ILE . . . . . . . . . . . . . 63.3 mt -114.0 125.56 71.31 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.293 0 N-CA-C 109.077 -0.712 . . . . 0.0 109.077 179.069 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 97' ' ' THR . . . . . . . . . . . . . 80.3 p -97.66 156.46 16.53 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-O 121.011 0.434 . . . . 0.0 110.864 -177.78 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 98' ' ' GLU . . . . . . . . . . . . . 84.4 tt0 -53.88 -24.32 15.61 Favored 'General case' 0 CA--C 1.534 0.343 0 N-CA-C 112.163 0.431 . . . . 0.0 112.163 179.348 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 99' ' ' GLU . . . . . . . . . . . . . 96.0 mt-10 -76.4 11.69 1.49 Allowed 'General case' 0 CA--C 1.537 0.451 0 N-CA-C 113.227 0.825 . . . . 0.0 113.227 -178.597 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 100' ' ' ASN . . . . . . . . . . . . . 2.1 m-20 63.2 37.16 11.45 Favored 'General case' 0 CA--C 1.53 0.203 0 CA-C-O 121.005 0.431 . . . . 0.0 111.093 178.601 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 101' ' ' GLU . . . . . . . . . . . . . 68.5 tt0 -117.08 145.41 43.76 Favored 'General case' 0 C--N 1.332 -0.173 0 N-CA-C 109.386 -0.598 . . . . 0.0 109.386 175.654 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 102' ' ' VAL . . . . . . . . . . . . . 43.6 t -117.19 126.2 74.38 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.249 0 N-CA-C 109.869 -0.419 . . . . 0.0 109.869 -178.308 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 103' ' ' LEU . . . . . . . . . . . . . 28.7 mt -115.68 130.53 56.89 Favored 'General case' 0 C--N 1.331 -0.225 0 CA-C-N 115.552 -0.749 . . . . 0.0 110.157 176.409 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 104' ' ' ILE . . . . . 0.418 HD13 HG11 ' A' ' 130' ' ' VAL . 67.2 mt -116.78 120.45 65.08 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.294 0 N-CA-C 109.972 -0.381 . . . . 0.0 109.972 179.606 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 105' ' ' PHE . . . . . . . . . . . . . 66.3 m-85 -120.03 166.34 13.51 Favored 'General case' 0 C--N 1.333 -0.143 0 CA-C-N 115.323 -0.853 . . . . 0.0 109.622 179.754 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 106' ' ' ASN . . . . . . . . . . . . . 51.9 p-10 -101.49 -170.96 1.9 Allowed 'General case' 0 C--N 1.33 -0.257 0 N-CA-C 109.976 -0.379 . . . . 0.0 109.976 174.159 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 107' ' ' GLN . . . . . . . . . . . . . 50.4 tt0 -59.6 -28.02 66.81 Favored 'General case' 0 CA--C 1.533 0.301 0 N-CA-C 112.131 0.419 . . . . 0.0 112.131 179.997 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 108' ' ' ASN . . . . . . . . . . . . . 6.0 t-20 -85.22 13.37 6.46 Favored 'General case' 0 CA--C 1.536 0.418 0 N-CA-C 112.81 0.671 . . . . 0.0 112.81 -178.891 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 109' ' ' LEU . . . . . . . . . . . . . 7.1 tp 54.64 37.03 27.42 Favored 'General case' 0 CA--C 1.529 0.161 0 CA-C-O 120.935 0.398 . . . . 0.0 111.385 179.212 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 110' ' ' GLU . . . . . . . . . . . . . 95.6 mt-10 -104.33 148.6 26.2 Favored 'General case' 0 C--N 1.331 -0.216 0 N-CA-C 109.742 -0.466 . . . . 0.0 109.742 175.717 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 111' ' ' GLU . . . . . . . . . . . . . 61.3 tt0 -85.06 121.86 28.45 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-O 120.798 0.332 . . . . 0.0 110.611 -176.434 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 112' ' ' LEU . . . . . . . . . . . . . 15.0 mt -107.48 -46.13 3.91 Favored 'General case' 0 C--N 1.331 -0.225 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.699 179.886 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 113' ' ' TYR . . . . . . . . . . . . . 57.5 t80 -133.05 139.28 47.1 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.399 -0.364 . . . . 0.0 110.802 -178.101 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 114' ' ' ARG . . . . . . . . . . . . . 26.4 ptt180 -141.36 123.07 15.21 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.769 -179.923 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 115' ' ' GLY . . . . . . . . . . . . . . . -150.13 158.81 27.84 Favored Glycine 0 CA--C 1.522 0.471 0 N-CA-C 110.931 -0.868 . . . . 0.0 110.931 179.892 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 116' ' ' LYS . . . . . . . . . . . . . 33.0 ttmt -131.44 135.85 47.48 Favored 'General case' 0 C--N 1.327 -0.379 0 N-CA-C 109.868 -0.419 . . . . 0.0 109.868 177.464 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 117' ' ' PHE . . . . . . . . . . . . . 25.2 m-85 -137.91 113.86 9.9 Favored 'General case' 0 C--N 1.329 -0.319 0 N-CA-C 109.8 -0.444 . . . . 0.0 109.8 -175.805 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 118' ' ' GLU . . . . . . . . . . . . . 84.7 tt0 -56.31 -40.5 74.47 Favored 'General case' 0 C--N 1.33 -0.272 0 C-N-CA 120.787 -0.365 . . . . 0.0 110.959 -177.362 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 119' ' ' ASN . . . . . . . . . . . . . 5.4 m120 -97.5 30.62 2.82 Favored 'General case' 0 C--N 1.33 -0.263 0 N-CA-C 112.251 0.463 . . . . 0.0 112.251 -175.034 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 120' ' ' LEU . . . . . . . . . . . . . 23.9 tp -59.21 120.26 8.89 Favored 'General case' 0 C--N 1.332 -0.167 0 N-CA-C 109.859 -0.422 . . . . 0.0 109.859 176.545 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 121' ' ' ASN . . . . . . . . . . . . . 31.8 m120 -113.49 -44.18 3.24 Favored 'General case' 0 C--N 1.331 -0.223 0 CA-C-N 116.609 -0.268 . . . . 0.0 111.032 -177.162 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 122' ' ' LYS . . . . . . . . . . . . . 60.6 mtpt -143.52 144.42 31.96 Favored 'General case' 0 C--N 1.331 -0.22 0 CA-C-O 121.015 0.435 . . . . 0.0 111.383 -178.46 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 123' ' ' VAL . . . . . . . . . . . . . 47.7 t -128.9 127.53 66.35 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.297 0 N-CA-C 109.298 -0.63 . . . . 0.0 109.298 174.897 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 124' ' ' LEU . . . . . . . . . . . . . 51.8 mt -126.23 132.58 51.71 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-O 120.791 0.329 . . . . 0.0 110.654 -178.636 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 125' ' ' VAL . . . . . . . . . . . . . 11.6 p -134.45 136.0 53.3 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.34 0 CA-C-N 116.111 -0.495 . . . . 0.0 110.375 179.32 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 126' ' ' ARG . . . . . . . . . . . . . 76.2 mtt180 -143.91 127.79 17.35 Favored 'General case' 0 C--N 1.327 -0.395 0 CA-C-N 115.846 -0.615 . . . . 0.0 109.365 178.158 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 127' ' ' ASN . . . . . . . . . . . . . 79.9 m-20 56.83 -134.72 1.24 Allowed 'General case' 0 CA--C 1.544 0.743 0 CA-C-O 118.679 -0.677 . . . . 0.0 109.65 -178.285 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 128' ' ' ASP . . . . . . . . . . . . . 8.4 p-10 -99.06 15.81 24.64 Favored 'General case' 0 CA--C 1.535 0.389 0 CA-C-N 119.923 1.238 . . . . 0.0 113.057 178.641 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 129' ' ' LEU . . . . . 0.512 HD12 ' N ' ' A' ' 129' ' ' LEU . 7.0 mp -114.27 141.23 47.84 Favored 'General case' 0 N--CA 1.463 0.224 0 N-CA-C 109.874 -0.417 . . . . 0.0 109.874 178.346 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 130' ' ' VAL . . . . . 0.479 HG13 ' HB ' ' A' ' 141' ' ' ILE . 14.6 p -140.06 146.47 24.81 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.234 0 CA-C-O 121.312 0.577 . . . . 0.0 111.682 -176.432 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 131' ' ' VAL . . . . . 0.463 HG22 HD12 ' A' ' 140' ' ' LEU . 44.2 t -136.02 139.52 45.7 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.264 0 CA-C-N 115.712 -0.677 . . . . 0.0 110.196 177.105 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 132' ' ' ILE . . . . . . . . . . . . . 70.9 mt -115.58 132.68 64.25 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.335 0 CA-C-N 115.998 -0.547 . . . . 0.0 109.673 -179.82 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 133' ' ' ILE . . . . . . . . . . . . . 41.1 mm -116.94 123.43 71.79 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.241 0 CA-C-O 120.781 0.324 . . . . 0.0 111.078 -175.127 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 134' ' ' ASP . . . . . . . . . . . . . 10.3 p-10 -136.61 149.4 48.0 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-N 116.227 -0.442 . . . . 0.0 109.981 175.255 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 135' ' ' GLU . . . . . . . . . . . . . 41.8 tp10 -49.95 -28.36 6.66 Favored 'General case' 0 C--N 1.327 -0.385 0 N-CA-C 112.673 0.62 . . . . 0.0 112.673 -171.986 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 136' ' ' GLN . . . . . . . . . . . . . 97.6 mt-30 -83.47 -34.96 25.27 Favored 'General case' 0 C--O 1.234 0.242 0 N-CA-C 112.707 0.632 . . . . 0.0 112.707 -175.96 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 137' ' ' LYS . . . . . . . . . . . . . 56.3 pttt -164.08 174.51 11.24 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-O 121.6 0.714 . . . . 0.0 112.529 -171.055 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 138' ' ' LEU . . . . . 0.409 ' C ' HD23 ' A' ' 138' ' ' LEU . 6.9 tt -121.33 128.43 52.28 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 114.889 -1.05 . . . . 0.0 109.881 177.716 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 139' ' ' THR . . . . . . . . . . . . . 47.0 m -109.26 127.98 54.7 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-N 116.117 -0.492 . . . . 0.0 109.882 178.282 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 140' ' ' LEU . . . . . 0.463 HD12 HG22 ' A' ' 131' ' ' VAL . 6.9 tp -114.56 121.36 43.24 Favored 'General case' 0 C--N 1.327 -0.395 0 CA-C-N 115.983 -0.553 . . . . 0.0 109.608 -176.574 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 141' ' ' ILE . . . . . 0.479 ' HB ' HG13 ' A' ' 130' ' ' VAL . 18.9 mt -121.75 118.49 55.91 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.245 0 N-CA-C 109.885 -0.413 . . . . 0.0 109.885 -175.817 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 142' ' ' ARG . . . . . . . . . . . . . 34.4 mmt180 -116.21 134.81 54.51 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 115.557 -0.747 . . . . 0.0 110.054 -178.248 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 143' ' ' THR . . . . . . . . . . . . . 48.8 p . . . . . 0 C--O 1.221 -0.444 0 CA-C-O 118.041 -0.98 . . . . 0.0 110.775 179.363 . . . . . . . . 0 0 . 1 . 003 nuclear nobuild full ' B' B ' -3' ' ' GLU . . . . . . . . . . . . . 95.6 mt-10 . . . . . 0 N--CA 1.49 1.55 0 N-CA-C 109.3 -0.629 . . . . 0.0 109.3 . . . . . . . . . 0 0 . 1 . 003 nuclear nobuild full ' B' B ' -2' ' ' GLY . . . . . . . . . . . . . . . -60.4 146.17 46.42 Favored Glycine 0 CA--C 1.524 0.617 0 N-CA-C 110.771 -0.931 . . . . 0.0 110.771 179.635 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' -1' ' ' VAL . . . . . . . . . . . . . 42.7 t -95.56 133.92 34.87 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.349 0 CA-C-O 120.829 0.347 . . . . 0.0 110.149 -179.908 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 0' ' ' ILE . . . . . . . . . . . . . 42.9 mm -113.47 143.31 23.43 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.249 0 CA-C-N 116.118 -0.492 . . . . 0.0 109.916 -179.977 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 1' ' ' MET . . . . . . . . . . . . . 24.0 ptm -141.94 138.98 32.35 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.233 -0.44 . . . . 0.0 110.523 -178.748 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 2' ' ' SER . . . . . . . . . . . . . 96.8 p -129.27 151.18 50.21 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.238 -0.437 . . . . 0.0 110.627 -179.089 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 3' ' ' GLU . . . . . . . . . . . . . 95.3 mt-10 -139.4 141.27 37.54 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 115.879 -0.6 . . . . 0.0 110.804 -179.223 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 4' ' ' LEU . . . . . . . . . . . . . 5.2 tt -126.14 128.01 46.64 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.131 -0.486 . . . . 0.0 109.803 177.342 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 5' ' ' LYS . . . . . . . . . . . . . 92.5 mttt -110.19 122.28 47.27 Favored 'General case' 0 C--O 1.235 0.315 0 CA-C-O 120.873 0.368 . . . . 0.0 111.034 -178.313 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 6' ' ' LEU . . . . . . . . . . . . . 48.9 mt -114.02 148.42 37.02 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 115.296 -0.866 . . . . 0.0 110.536 -179.5 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 7' ' ' LYS . . . . . . . . . . . . . 35.8 ttpt -134.63 139.5 32.7 Favored Pre-proline 0 CA--C 1.534 0.356 0 CA-C-O 119.023 -0.513 . . . . 0.0 110.022 175.683 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 8' ' ' PRO . . . . . . . . . . . . . 84.9 Cg_endo -91.76 141.72 2.62 Favored 'Trans proline' 0 N--CA 1.489 1.257 0 C-N-CA 121.754 1.636 . . . . 0.0 111.61 177.731 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 9' ' ' LEU . . . . . . . . . . . . . 24.1 mt -79.35 -47.62 1.56 Allowed Pre-proline 0 CA--C 1.534 0.343 0 CA-C-O 118.696 -0.669 . . . . 0.0 112.203 -178.397 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 10' ' ' PRO . . . . . . . . . . . . . 89.6 Cg_endo -81.22 155.53 19.37 Favored 'Trans proline' 0 N--CA 1.495 1.581 0 C-N-CA 121.213 1.275 . . . . 0.0 111.95 176.059 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 11' ' ' LYS . . . . . . . . . . . . . 85.5 tttt -83.71 96.02 8.58 Favored 'General case' 0 C--N 1.33 -0.282 0 C-N-CA 120.832 -0.347 . . . . 0.0 110.099 177.465 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 12' ' ' VAL . . . . . . . . . . . . . 12.1 p -136.28 145.64 30.39 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.276 0 CA-C-N 116.1 -0.5 . . . . 0.0 110.411 -178.64 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 13' ' ' GLU . . . . . . . . . . . . . 81.9 tt0 -91.72 126.32 36.76 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.152 -0.476 . . . . 0.0 110.109 178.562 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 14' ' ' LEU . . . . . . . . . . . . . 27.5 mt -98.1 145.25 29.47 Favored Pre-proline 0 CA--C 1.532 0.281 0 CA-C-O 119.167 -0.444 . . . . 0.0 110.365 -177.932 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 15' ' ' PRO . . . . . . . . . . . . . 24.0 Cg_exo -63.71 160.0 38.68 Favored 'Trans proline' 0 N--CA 1.497 1.695 0 C-N-CA 121.331 1.354 . . . . 0.0 111.694 176.144 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 16' ' ' PRO . . . . . . . . . . . . . 37.5 Cg_exo -59.22 -31.6 95.53 Favored 'Trans proline' 0 N--CA 1.495 1.613 0 C-N-CA 121.474 1.45 . . . . 0.0 112.737 -179.747 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 17' ' ' ASP . . . . . . . . . . . . . 10.0 p-10 -88.1 3.97 47.11 Favored 'General case' 0 CA--C 1.536 0.404 0 N-CA-C 113.319 0.859 . . . . 0.0 113.319 -177.323 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 18' ' ' PHE . . . . . . . . . . . . . 39.2 t80 -58.26 -47.03 84.86 Favored 'General case' 0 C--N 1.334 -0.107 0 O-C-N 121.931 -0.481 . . . . 0.0 110.121 -177.64 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 19' ' ' VAL . . . . . . . . . . . . . 47.3 t -56.6 -40.83 71.5 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 CA-C-N 116.249 -0.432 . . . . 0.0 110.54 -178.236 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 20' ' ' ASP . . . . . . . . . . . . . 74.3 m-20 -59.63 -44.79 93.35 Favored 'General case' 0 C--N 1.33 -0.269 0 C-N-CA 120.919 -0.312 . . . . 0.0 110.797 -177.398 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 21' ' ' VAL . . . . . . . . . . . . . 46.9 t -64.69 -45.48 95.14 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.255 0 C-N-CA 120.702 -0.399 . . . . 0.0 110.522 -177.61 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 22' ' ' ILE . . . . . 0.588 HG22 HD12 ' B' ' 26' ' ' LEU . 50.7 mm -58.71 -40.59 79.96 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.299 0 C-N-CA 120.98 -0.288 . . . . 0.0 110.826 -179.803 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' B' B ' 23' ' ' ARG . . . . . . . . . . . . . 52.2 ttp180 -56.73 -47.07 80.82 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-O 120.891 0.377 . . . . 0.0 110.515 178.713 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 24' ' ' ILE . . . . . . . . . . . . . 77.3 mt -60.87 -44.8 98.51 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.261 0 CA-C-N 115.979 -0.555 . . . . 0.0 111.822 -178.852 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 25' ' ' LYS . . . . . . . . . . . . . 12.5 pttp -71.69 -36.56 70.63 Favored 'General case' 0 CA--C 1.533 0.309 0 C-N-CA 120.372 -0.531 . . . . 0.0 111.851 -173.042 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 26' ' ' LEU . . . . . 0.588 HD12 HG22 ' B' ' 22' ' ' ILE . 24.8 mt -78.94 -42.68 26.33 Favored 'General case' 0 C--N 1.331 -0.228 0 N-CA-C 113.186 0.81 . . . . 0.0 113.186 -173.435 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' B' B ' 27' ' ' GLN . . . . . . . . . . . . . 11.2 pt20 -47.17 138.24 7.16 Favored 'General case' 0 N--CA 1.47 0.553 0 N-CA-C 112.696 0.628 . . . . 0.0 112.696 -175.356 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 28' ' ' GLY . . . . . . . . . . . . . . . 101.5 -25.95 26.26 Favored Glycine 0 CA--C 1.532 1.122 0 CA-C-N 115.669 -0.696 . . . . 0.0 112.295 -176.391 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 29' ' ' LYS . . . . . . . . . . . . . 63.8 mttp -98.14 155.15 17.28 Favored 'General case' 0 C--O 1.232 0.175 0 CA-C-N 117.5 0.65 . . . . 0.0 111.256 178.219 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 30' ' ' THR . . . . . . . . . . . . . 41.3 m -100.49 136.23 40.68 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.015 -0.539 . . . . 0.0 109.83 175.157 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 31' ' ' VAL . . . . . . . . . . . . . 35.2 m -125.78 153.72 33.98 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.314 0 CA-C-O 120.902 0.382 . . . . 0.0 110.622 -178.738 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 32' ' ' ARG . . . . . . . . . . . . . 34.2 ttp180 -132.39 147.55 52.39 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 115.897 -0.592 . . . . 0.0 110.242 178.118 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 33' ' ' THR . . . . . . . . . . . . . 17.0 m -53.42 139.37 30.8 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.394 -0.366 . . . . 0.0 111.355 -178.342 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 34' ' ' GLY . . . . . . . . . . . . . . . 101.1 -17.18 56.42 Favored Glycine 0 CA--C 1.534 1.219 0 CA-C-O 119.69 -0.505 . . . . 0.0 113.274 179.842 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 35' ' ' ASP . . . . . . . . . . . . . 70.5 m-20 -64.46 149.34 48.71 Favored 'General case' 0 C--O 1.232 0.148 0 CA-C-N 118.017 0.908 . . . . 0.0 111.478 179.506 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 36' ' ' VAL . . . . . . . . . . . . . 44.9 t -121.4 130.25 74.82 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.216 0 CA-C-N 115.752 -0.658 . . . . 0.0 109.791 178.148 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 37' ' ' ILE . . . . . . . . . . . . . 69.7 mt -121.7 139.59 48.3 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.267 0 CA-C-N 116.294 -0.412 . . . . 0.0 110.095 -179.548 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 38' ' ' GLY . . . . . . . . . . . . . . . -111.52 128.85 8.85 Favored Glycine 0 CA--C 1.525 0.712 0 N-CA-C 111.017 -0.833 . . . . 0.0 111.017 179.634 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 39' ' ' ILE . . . . . . . . . . . . . 73.9 mt -123.3 137.12 57.71 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.201 0 N-CA-C 110.072 -0.344 . . . . 0.0 110.072 179.521 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 40' ' ' SER . . . . . . . . . . . . . 59.6 p -91.78 115.91 28.45 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.559 -0.291 . . . . 0.0 111.117 177.612 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 41' ' ' ILE . . . . . . . . . . . . . 44.7 mm -121.39 114.2 42.27 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.231 0 N-CA-C 109.772 -0.455 . . . . 0.0 109.772 178.159 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 42' ' ' LEU . . . . . . . . . . . . . 6.4 mp 56.9 35.5 26.44 Favored 'General case' 0 CA--C 1.532 0.26 0 CA-C-O 120.973 0.416 . . . . 0.0 111.342 -179.378 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 43' ' ' GLY . . . . . . . . . . . . . . . 77.91 -10.06 27.93 Favored Glycine 0 CA--C 1.534 1.276 0 C-N-CA 121.249 -0.5 . . . . 0.0 113.472 177.725 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 44' ' ' LYS . . . . . . . . . . . . . 61.1 tttm -96.32 134.33 39.6 Favored 'General case' 0 C--N 1.331 -0.197 0 CA-C-N 117.901 0.851 . . . . 0.0 109.819 176.651 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 45' ' ' GLU . . . . . . . . . . . . . 82.9 tt0 -83.5 127.94 34.11 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-O 120.867 0.365 . . . . 0.0 111.084 -177.863 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 46' ' ' VAL . . . . . . . . . . . . . 7.3 p -120.53 130.07 74.89 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.265 0 N-CA-C 109.315 -0.624 . . . . 0.0 109.315 175.541 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 47' ' ' LYS . . . . . . . . . . . . . 79.8 mttt -100.4 128.64 46.41 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.076 -0.511 . . . . 0.0 111.366 179.317 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 48' ' ' PHE . . . . . . . . . . . . . 92.1 m-85 -112.89 131.91 55.53 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 115.88 -0.6 . . . . 0.0 109.78 176.705 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 49' ' ' LYS . . . . . . . . . . . . . 66.8 tttt -107.19 137.45 45.22 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.48 -0.327 . . . . 0.0 110.64 179.68 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 50' ' ' VAL . . . . . . . . . . . . . 45.0 t -80.71 107.22 12.82 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.241 0 N-CA-C 109.17 -0.678 . . . . 0.0 109.17 175.613 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 51' ' ' VAL . . . . . . . . . . . . . 49.4 t -71.47 -54.14 18.29 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.292 0 N-CA-C 109.493 -0.558 . . . . 0.0 109.493 -174.516 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 52' ' ' GLN . . . . . . . . . . . . . 90.8 mt-30 -154.7 154.07 32.31 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 115.93 -0.577 . . . . 0.0 112.097 -176.74 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 53' ' ' ALA . . . . . 0.518 ' HB3' ' OG ' ' B' ' 56' ' ' SER . . . -132.6 134.37 44.83 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 115.191 -0.913 . . . . 0.0 109.784 174.421 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' B' B ' 54' ' ' TYR . . . . . . . . . . . . . 58.6 t80 -129.21 111.31 18.16 Favored Pre-proline 0 CA--C 1.533 0.309 0 CA-C-O 118.147 -0.93 . . . . 0.0 110.344 178.007 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 55' ' ' PRO . . . . . . . . . . . . . 74.4 Cg_endo -77.14 170.15 72.34 Favored 'Cis proline' 0 N--CA 1.5 1.907 0 CA-C-N 121.996 1.749 . . . . 0.0 111.957 -6.859 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 56' ' ' SER . . . . . 0.518 ' OG ' ' HB3' ' B' ' 53' ' ' ALA . 68.8 m -125.02 136.24 27.85 Favored Pre-proline 0 CA--C 1.538 0.491 0 CA-C-O 118.556 -0.735 . . . . 0.0 109.457 175.969 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' B' B ' 57' ' ' PRO . . . . . . . . . . . . . 37.2 Cg_endo -67.32 160.67 79.1 Favored 'Cis proline' 0 N--CA 1.499 1.852 0 CA-C-N 121.771 1.668 . . . . 0.0 111.689 -2.129 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 58' ' ' LEU . . . . . . . . . . . . . 29.4 tp -129.27 138.07 51.42 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-O 120.993 0.425 . . . . 0.0 110.593 -178.558 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 59' ' ' ARG . . . . . . . . . . . . . 57.2 ttp180 -101.02 121.22 41.39 Favored 'General case' 0 C--N 1.327 -0.38 0 N-CA-C 109.12 -0.696 . . . . 0.0 109.12 174.325 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 60' ' ' VAL . . . . . . . . . . . . . 47.4 t -72.14 122.07 23.77 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.361 0 C-N-CA 120.848 -0.341 . . . . 0.0 110.365 -173.969 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 61' ' ' GLU . . . . . . . . . . . . . 95.4 mt-10 -131.04 165.73 22.57 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.0 -0.546 . . . . 0.0 110.206 179.213 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 62' ' ' ASP . . . . . . . . . . . . . 48.2 m-20 -55.01 -32.61 61.94 Favored 'General case' 0 C--N 1.329 -0.324 0 N-CA-C 111.766 0.284 . . . . 0.0 111.766 -179.25 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 63' ' ' ARG . . . . . . . . . . . . . 32.5 ptt180 -83.35 3.36 31.95 Favored 'General case' 0 CA--C 1.538 0.487 0 N-CA-C 113.583 0.957 . . . . 0.0 113.583 -175.36 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 64' ' ' THR . . . . . . . . . . . . . 40.1 m -85.01 135.29 34.08 Favored 'General case' 0 C--N 1.331 -0.217 0 CA-C-N 118.137 0.426 . . . . 0.0 110.258 -178.997 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 65' ' ' LYS . . . . . . . . . . . . . 99.1 mttt -88.97 127.36 35.66 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.012 179.245 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 66' ' ' ILE . . . . . . . . . . . . . 58.4 mt -112.74 129.48 68.27 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.328 0 N-CA-C 109.859 -0.422 . . . . 0.0 109.859 -178.531 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 67' ' ' THR . . . . . . . . . . . . . 23.9 m -124.46 138.7 54.33 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-O 121.045 0.45 . . . . 0.0 110.801 -177.527 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 68' ' ' LEU . . . . . 0.415 HD12 ' N ' ' B' ' 68' ' ' LEU . 7.6 mp -107.28 131.15 54.52 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 115.972 -0.558 . . . . 0.0 110.242 177.025 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' B' B ' 69' ' ' VAL . . . . . . . . . . . . . 43.2 t -87.37 130.53 37.03 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.294 0 CA-C-N 116.424 -0.353 . . . . 0.0 110.067 179.132 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 70' ' ' THR . . . . . . . . . . . . . 5.7 p -99.52 -60.02 1.61 Allowed 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 116.11 -0.495 . . . . 0.0 111.092 -178.253 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 71' ' ' HIS . . . . . . . . . . . . . 83.3 m-70 -69.57 131.4 89.85 Favored Pre-proline 0 CA--C 1.536 0.412 0 CA-C-O 118.563 -0.732 . . . . 0.0 110.237 -177.768 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 72' ' ' PRO . . . . . . . . . . . . . 13.2 Cg_exo -66.37 -30.0 45.17 Favored 'Trans proline' 0 N--CA 1.498 1.759 0 C-N-CA 121.161 1.241 . . . . 0.0 112.252 177.785 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 73' ' ' VAL . . . . . . . . . . . . . 33.1 m -137.25 169.88 18.78 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.218 0 CA-C-O 121.018 0.437 . . . . 0.0 110.983 -177.711 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 74' ' ' ASP . . . . . . . . . . . . . 4.8 t0 -98.93 125.59 44.39 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 115.828 -0.623 . . . . 0.0 110.101 -179.601 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 75' ' ' VAL . . . . . . . . . . . . . 42.9 t -119.14 123.35 71.23 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.286 0 CA-C-O 121.084 0.468 . . . . 0.0 110.509 -179.402 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 76' ' ' LEU . . . . . . . . . . . . . 6.6 mp -120.39 148.38 43.84 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-N 115.691 -0.686 . . . . 0.0 109.741 176.043 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 77' ' ' GLU . . . . . . . . . . . . . 98.5 mt-10 -137.86 138.3 38.97 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-O 121.015 0.436 . . . . 0.0 111.577 -179.024 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 78' ' ' ALA . . . . . 0.613 ' HB2' HD21 ' B' ' 109' ' ' LEU . . . -130.47 134.29 46.97 Favored 'General case' 0 C--N 1.331 -0.227 0 CA-C-N 115.755 -0.657 . . . . 0.0 109.728 175.541 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' B' B ' 79' ' ' LYS . . . . . 0.603 ' O ' HD13 ' B' ' 80' ' ' ILE . 30.0 ttmt -81.2 119.53 23.72 Favored 'General case' 0 C--N 1.331 -0.204 0 CA-C-O 120.925 0.393 . . . . 0.0 110.603 -179.38 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' B' B ' 80' ' ' ILE . . . . . 0.603 HD13 ' O ' ' B' ' 79' ' ' LYS . 41.7 mm -139.15 108.43 3.77 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.367 0 N-CA-C 109.201 -0.666 . . . . 0.0 109.201 -177.439 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' B' B ' 81' ' ' LYS . . . . . . . . . . . . . 55.6 mtpt -100.49 129.16 46.4 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-O 120.941 0.4 . . . . 0.0 111.257 -176.642 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 82' ' ' GLY . . . . . . . . . . . . . . . 89.16 42.11 5.67 Favored Glycine 0 CA--C 1.526 0.725 0 C-N-CA 120.956 -0.64 . . . . 0.0 111.726 174.344 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 83' ' ' ILE . . . . . . . . . . . . . 68.2 mt -69.13 136.02 27.16 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.407 0 N-CA-C 109.563 -0.532 . . . . 0.0 109.563 177.625 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 84' ' ' LYS . . . . . . . . . . . . . 25.2 ttpp -100.5 -51.66 3.56 Favored 'General case' 0 C--N 1.332 -0.195 0 CA-C-O 121.002 0.429 . . . . 0.0 110.082 179.938 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 85' ' ' ASP . . . . . . . . . . . . . 13.4 t70 -149.16 147.16 28.11 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 115.812 -0.631 . . . . 0.0 110.358 179.754 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 86' ' ' VAL . . . . . . . . . . . . . 42.7 t -129.34 130.29 67.53 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.24 0 CA-C-O 120.969 0.414 . . . . 0.0 110.251 179.427 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 87' ' ' ILE . . . . . . . . . . . . . 44.6 mm -118.25 125.04 73.99 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.28 0 CA-C-N 115.847 -0.615 . . . . 0.0 109.555 177.347 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 88' ' ' LEU . . . . . . . . . . . . . 44.5 mt -116.84 135.56 53.64 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-O 121.292 0.568 . . . . 0.0 111.688 -177.025 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 89' ' ' ASP . . . . . . . . . . . . . 7.3 t0 -128.58 155.96 44.1 Favored 'General case' 0 C--N 1.327 -0.403 0 CA-C-N 115.156 -0.929 . . . . 0.0 108.642 174.78 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 90' ' ' GLU . . . . . . . . . . . . . 76.9 tt0 -48.67 -36.09 15.27 Favored 'General case' 0 C--N 1.329 -0.285 0 N-CA-C 112.562 0.578 . . . . 0.0 112.562 -172.749 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 91' ' ' ASN . . . . . . . . . . . . . 26.3 m120 -132.07 37.23 3.6 Favored 'General case' 0 CA--C 1.531 0.248 0 N-CA-C 111.757 0.281 . . . . 0.0 111.757 -176.953 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 92' ' ' LEU . . . . . 0.41 HD21 ' CG2' ' B' ' 130' ' ' VAL . 26.3 tp -166.06 139.72 4.28 Favored 'General case' 0 C--N 1.33 -0.265 0 C-N-CA 121.005 -0.278 . . . . 0.0 110.801 -179.377 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' B' B ' 93' ' ' ILE . . . . . . . . . . . . . 72.3 mt -126.39 122.48 61.31 Favored 'Isoleucine or valine' 0 N--CA 1.462 0.157 0 N-CA-C 109.648 -0.501 . . . . 0.0 109.648 178.605 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 94' ' ' VAL . . . . . 0.428 HG21 HG11 ' B' ' 125' ' ' VAL . 43.8 t -124.61 126.19 71.28 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.239 0 N-CA-C 109.774 -0.454 . . . . 0.0 109.774 177.994 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' B' B ' 95' ' ' VAL . . . . . . . . . . . . . 44.6 t -120.73 133.59 66.9 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.336 0 CA-C-N 116.009 -0.541 . . . . 0.0 109.806 -179.165 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 96' ' ' ILE . . . . . . . . . . . . . 61.1 mt -115.4 128.29 72.66 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.25 0 N-CA-C 109.257 -0.646 . . . . 0.0 109.257 178.788 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 97' ' ' THR . . . . . . . . . . . . . 82.1 p -102.96 155.62 18.23 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-O 121.279 0.561 . . . . 0.0 111.343 -176.368 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 98' ' ' GLU . . . . . . . . . . . . . 13.2 pt-20 -55.08 -17.02 3.43 Favored 'General case' 0 CA--C 1.535 0.382 0 N-CA-C 112.814 0.672 . . . . 0.0 112.814 179.277 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 99' ' ' GLU . . . . . . . . . . . . . 41.7 mt-10 -85.36 16.29 3.81 Favored 'General case' 0 CA--C 1.535 0.402 0 N-CA-C 112.952 0.723 . . . . 0.0 112.952 -178.674 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 100' ' ' ASN . . . . . . . . . . . . . 3.6 m-20 62.36 38.02 13.34 Favored 'General case' 0 CA--C 1.529 0.166 0 CA-C-O 121.046 0.451 . . . . 0.0 110.869 178.505 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 101' ' ' GLU . . . . . . . . . . . . . 84.3 tt0 -121.26 143.63 49.05 Favored 'General case' 0 C--N 1.332 -0.187 0 CA-C-N 116.2 -0.455 . . . . 0.0 110.045 177.955 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 102' ' ' VAL . . . . . . . . . . . . . 43.9 t -116.73 127.59 74.31 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.28 0 CA-C-N 116.341 -0.39 . . . . 0.0 110.102 -178.671 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 103' ' ' LEU . . . . . 0.511 ' N ' HD12 ' B' ' 103' ' ' LEU . 6.2 mp -116.86 134.31 54.93 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 115.747 -0.66 . . . . 0.0 110.285 176.745 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' B' B ' 104' ' ' ILE . . . . . . . . . . . . . 71.3 mt -120.87 123.24 69.78 Favored 'Isoleucine or valine' 0 C--O 1.234 0.285 0 CA-C-N 116.612 -0.267 . . . . 0.0 110.56 -178.885 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 105' ' ' PHE . . . . . . . . . . . . . 60.0 m-85 -124.98 167.24 14.99 Favored 'General case' 0 C--O 1.232 0.178 0 O-C-N 124.07 0.856 . . . . 0.0 109.736 -179.665 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 106' ' ' ASN . . . . . . . . . . . . . 44.8 p-10 -104.11 -170.23 1.74 Allowed 'General case' 0 C--N 1.331 -0.237 0 N-CA-C 110.15 -0.315 . . . . 0.0 110.15 174.218 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 107' ' ' GLN . . . . . . . . . . . . . 37.9 tt0 -58.64 -30.11 67.04 Favored 'General case' 0 C--N 1.33 -0.278 0 N-CA-C 112.047 0.388 . . . . 0.0 112.047 -179.603 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 108' ' ' ASN . . . . . . . . . . . . . 5.4 t30 -86.02 10.6 13.74 Favored 'General case' 0 CA--C 1.536 0.43 0 N-CA-C 113.116 0.784 . . . . 0.0 113.116 -176.699 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 109' ' ' LEU . . . . . 0.613 HD21 ' HB2' ' B' ' 78' ' ' ALA . 8.5 tp 59.38 37.63 23.21 Favored 'General case' 0 C--N 1.332 -0.173 0 CA-C-O 121.034 0.445 . . . . 0.0 111.315 178.69 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' B' B ' 110' ' ' GLU . . . . . . . . . . . . . 94.9 mt-10 -105.18 138.5 41.28 Favored 'General case' 0 C--N 1.329 -0.3 0 N-CA-C 109.222 -0.659 . . . . 0.0 109.222 173.718 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 111' ' ' GLU . . . . . . . . . . . . . 47.8 tt0 -85.54 121.77 28.7 Favored 'General case' 0 C--N 1.329 -0.308 0 C-N-CA 120.708 -0.397 . . . . 0.0 110.249 -176.492 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 112' ' ' LEU . . . . . . . . . . . . . 58.2 mt -103.06 -42.89 5.65 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.074 -0.512 . . . . 0.0 110.527 179.687 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 113' ' ' TYR . . . . . . . . . . . . . 64.3 t80 -133.02 141.23 48.16 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.297 -0.411 . . . . 0.0 111.254 -177.1 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 114' ' ' ARG . . . . . . . . . . . . . 36.5 ptt180 -149.27 124.09 9.91 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.092 -0.504 . . . . 0.0 110.541 177.407 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 115' ' ' GLY . . . . . . . . . . . . . . . -150.02 158.9 27.87 Favored Glycine 0 CA--C 1.524 0.601 0 N-CA-C 111.254 -0.739 . . . . 0.0 111.254 179.933 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 116' ' ' LYS . . . . . . . . . . . . . 34.4 ttpt -125.07 134.92 52.32 Favored 'General case' 0 C--N 1.33 -0.257 0 N-CA-C 110.02 -0.363 . . . . 0.0 110.02 178.491 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 117' ' ' PHE . . . . . . . . . . . . . 51.5 m-85 -129.08 115.21 17.38 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-O 120.97 0.414 . . . . 0.0 110.155 -177.064 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 118' ' ' GLU . . . . . . . . . . . . . 95.8 mt-10 -53.6 -49.79 67.03 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.387 -0.37 . . . . 0.0 111.526 -175.633 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 119' ' ' ASN . . . . . . . . . . . . . 87.2 m-20 -96.7 31.13 2.4 Favored 'General case' 0 C--N 1.328 -0.342 0 N-CA-C 112.207 0.447 . . . . 0.0 112.207 -174.169 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 120' ' ' LEU . . . . . . . . . . . . . 17.1 tp -53.44 121.84 8.48 Favored 'General case' 0 N--CA 1.464 0.271 0 CA-C-O 120.599 0.238 . . . . 0.0 110.88 178.062 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 121' ' ' ASN . . . . . . . . . . . . . 34.4 m120 -114.07 -44.17 3.17 Favored 'General case' 0 N--CA 1.463 0.203 0 CA-C-N 116.547 -0.297 . . . . 0.0 111.213 -176.289 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 122' ' ' LYS . . . . . . . . . . . . . 97.2 mttt -144.61 150.7 37.88 Favored 'General case' 0 C--N 1.331 -0.206 0 CA-C-O 120.982 0.42 . . . . 0.0 111.591 -177.386 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 123' ' ' VAL . . . . . . . . . . . . . 45.9 t -130.44 127.94 63.13 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.298 0 N-CA-C 109.437 -0.579 . . . . 0.0 109.437 174.929 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 124' ' ' LEU . . . . . . . . . . . . . 52.7 mt -127.35 138.09 52.94 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-O 120.871 0.367 . . . . 0.0 110.633 -178.067 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 125' ' ' VAL . . . . . 0.428 HG11 HG21 ' B' ' 94' ' ' VAL . 34.7 m -135.73 140.09 45.01 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.24 0 CA-C-N 116.221 -0.445 . . . . 0.0 110.885 -179.53 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' B' B ' 126' ' ' ARG . . . . . . . . . . . . . 90.5 mtt-85 -140.69 112.12 7.36 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 115.889 -0.596 . . . . 0.0 110.199 177.117 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 127' ' ' ASN . . . . . . . . . . . . . 26.2 m-20 48.96 -105.01 0.14 Allowed 'General case' 0 CA--C 1.541 0.618 0 CA-C-O 119.299 -0.381 . . . . 0.0 111.79 -179.964 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 128' ' ' ASP . . . . . . . . . . . . . 13.0 p-10 -106.08 1.02 26.01 Favored 'General case' 0 CA--C 1.536 0.414 0 N-CA-C 113.692 0.997 . . . . 0.0 113.692 -174.957 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 129' ' ' LEU . . . . . . . . . . . . . 14.5 tp -104.94 131.82 51.96 Favored 'General case' 0 C--N 1.332 -0.188 0 CA-C-N 118.125 0.421 . . . . 0.0 109.996 178.479 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 130' ' ' VAL . . . . . 0.41 ' CG2' HD21 ' B' ' 92' ' ' LEU . 46.8 t -118.95 132.97 67.3 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.252 0 N-CA-C 109.828 -0.434 . . . . 0.0 109.828 -179.618 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' B' B ' 131' ' ' VAL . . . . . . . . . . . . . 42.1 t -134.96 134.37 53.44 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.196 0 CA-C-O 121.042 0.449 . . . . 0.0 110.416 179.396 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 132' ' ' ILE . . . . . . . . . . . . . 74.0 mt -117.25 133.78 62.91 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 CA-C-N 115.773 -0.649 . . . . 0.0 109.294 -179.799 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 133' ' ' ILE . . . . . . . . . . . . . 43.0 mm -117.62 123.86 72.29 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.224 0 CA-C-O 121.031 0.443 . . . . 0.0 111.086 -173.931 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 134' ' ' ASP . . . . . . . . . . . . . 9.1 p-10 -135.03 144.67 47.43 Favored 'General case' 0 C--N 1.33 -0.242 0 N-CA-C 109.228 -0.656 . . . . 0.0 109.228 173.777 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 135' ' ' GLU . . . . . . . . . . . . . 38.0 tp10 -49.93 -25.56 3.36 Favored 'General case' 0 C--N 1.326 -0.439 0 N-CA-C 112.719 0.637 . . . . 0.0 112.719 -174.553 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 136' ' ' GLN . . . . . . . . . . . . . 47.6 tt0 -80.43 -33.77 36.62 Favored 'General case' 0 C--O 1.233 0.212 0 N-CA-C 112.364 0.505 . . . . 0.0 112.364 -176.705 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 137' ' ' LYS . . . . . . . . . . . . . 57.7 pttt -169.98 175.3 5.16 Favored 'General case' 0 C--N 1.332 -0.182 0 CA-C-O 121.461 0.648 . . . . 0.0 112.182 -174.901 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 138' ' ' LEU . . . . . . . . . . . . . 6.1 tt -120.28 129.47 54.04 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-N 115.221 -0.9 . . . . 0.0 110.188 -179.96 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 139' ' ' THR . . . . . . . . . . . . . 36.2 m -110.19 128.21 55.36 Favored 'General case' 0 C--N 1.332 -0.181 0 CA-C-N 116.341 -0.391 . . . . 0.0 110.656 179.995 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 140' ' ' LEU . . . . . 0.477 ' C ' HD23 ' B' ' 140' ' ' LEU . 7.4 tt -112.27 124.36 52.29 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 115.656 -0.702 . . . . 0.0 109.2 -179.428 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' B' B ' 141' ' ' ILE . . . . . . . . . . . . . 19.5 mt -124.08 117.46 50.92 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.36 0 CA-C-O 121.053 0.454 . . . . 0.0 109.959 -176.439 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 142' ' ' ARG . . . . . . . . . . . . . 60.0 ttt-85 -107.54 126.51 52.62 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 115.594 -0.73 . . . . 0.0 110.698 -179.195 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 143' ' ' THR . . . . . . . . . . . . . 25.3 p . . . . . 0 C--O 1.221 -0.409 0 CA-C-O 118.248 -0.882 . . . . 0.0 110.938 179.138 . . . . . . . . 0 0 . 1 . 003 nuclear nobuild full ' C' C ' -3' ' ' GLU . . . . . . . . . . . . . 83.6 tt0 . . . . . 0 N--CA 1.491 1.596 0 N-CA-C 109.25 -0.648 . . . . 0.0 109.25 . . . . . . . . . 0 0 . 1 . 003 nuclear nobuild full ' C' C ' -2' ' ' GLY . . . . . . . . . . . . . . . -71.58 150.04 46.03 Favored Glycine 0 CA--C 1.525 0.659 0 N-CA-C 111.019 -0.832 . . . . 0.0 111.019 179.627 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' C' C ' -1' ' ' VAL . . . . . . . . . . . . . 44.0 t -94.28 140.95 15.69 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.359 0 N-CA-C 110.086 -0.338 . . . . 0.0 110.086 179.883 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' C' C ' 0' ' ' ILE . . . . . . . . . . . . . 43.8 mm -98.57 141.87 15.63 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.38 0 CA-C-N 116.228 -0.442 . . . . 0.0 110.256 -178.272 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' C' C ' 1' ' ' MET . . . . . . . . . . . . . 24.8 ptp -83.59 142.16 31.04 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.067 -0.515 . . . . 0.0 110.789 -179.684 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' C' C ' 2' ' ' SER . . . . . . . . . . . . . 6.9 p -116.61 132.96 56.55 Favored 'General case' 0 C--N 1.331 -0.211 0 CA-C-N 116.128 -0.487 . . . . 0.0 110.054 176.88 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' C' C ' 3' ' ' GLU . . . . . . . . . . . . . 95.6 mt-10 -140.77 141.14 34.85 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.107 -0.497 . . . . 0.0 111.134 -177.388 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' C' C ' 4' ' ' LEU . . . . . . . . . . . . . 19.7 tp -125.38 130.38 51.8 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 115.713 -0.676 . . . . 0.0 110.122 176.799 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' C' C ' 5' ' ' LYS . . . . . . . . . . . . . 61.4 mttp -108.4 120.16 41.6 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.483 -0.326 . . . . 0.0 110.66 179.534 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' C' C ' 6' ' ' LEU . . . . . . . . . . . . . 46.6 mt -114.36 147.17 39.57 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 115.499 -0.773 . . . . 0.0 110.459 -178.642 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' C' C ' 7' ' ' LYS . . . . . . . . . . . . . 83.2 tttt -135.15 135.97 23.82 Favored Pre-proline 0 CA--C 1.535 0.402 0 CA-C-O 118.87 -0.586 . . . . 0.0 109.88 175.901 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' C' C ' 8' ' ' PRO . . . . . . . . . . . . . 79.1 Cg_endo -90.5 143.25 3.65 Favored 'Trans proline' 0 N--CA 1.49 1.313 0 C-N-CA 121.745 1.63 . . . . 0.0 111.794 178.255 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' C' C ' 9' ' ' LEU . . . . . . . . . . . . . 41.2 mt -81.59 -48.75 0.99 Allowed Pre-proline 0 CA--C 1.534 0.359 0 CA-C-O 118.706 -0.664 . . . . 0.0 112.527 -178.601 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' C' C ' 10' ' ' PRO . . . . . . . . . . . . . 91.5 Cg_endo -78.97 154.68 25.96 Favored 'Trans proline' 0 N--CA 1.498 1.755 0 C-N-CA 121.113 1.209 . . . . 0.0 111.983 178.161 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' C' C ' 11' ' ' LYS . . . . . . . . . . . . . 72.4 tttt -88.46 94.26 9.81 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-N 116.345 -0.389 . . . . 0.0 110.499 179.47 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' C' C ' 12' ' ' VAL . . . . . . . . . . . . . 13.0 p -141.96 147.99 21.05 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.282 0 CA-C-N 116.236 -0.438 . . . . 0.0 110.533 -179.989 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' C' C ' 13' ' ' GLU . . . . . . . . . . . . . 84.3 tt0 -87.98 128.76 35.39 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.246 -0.434 . . . . 0.0 110.403 179.151 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' C' C ' 14' ' ' LEU . . . . . . . . . . . . . 19.2 mt -98.5 151.39 37.45 Favored Pre-proline 0 CA--C 1.533 0.296 0 CA-C-N 116.467 -0.333 . . . . 0.0 110.677 -178.438 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' C' C ' 15' ' ' PRO . . . . . . . . . . . . . 27.4 Cg_exo -61.84 161.25 26.02 Favored 'Trans proline' 0 N--CA 1.497 1.714 0 C-N-CA 121.395 1.397 . . . . 0.0 112.042 177.298 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' C' C ' 16' ' ' PRO . . . . . . . . . . . . . 26.0 Cg_exo -61.51 -38.55 62.13 Favored 'Trans proline' 0 N--CA 1.497 1.705 0 C-N-CA 121.412 1.408 . . . . 0.0 112.699 179.97 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' C' C ' 17' ' ' ASP . . . . . . . . . . . . . 21.3 p-10 -84.84 9.26 14.71 Favored 'General case' 0 CA--C 1.535 0.403 0 N-CA-C 113.232 0.827 . . . . 0.0 113.232 -176.951 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' C' C ' 18' ' ' PHE . . . . . . . . . . . . . 45.1 t80 -56.83 -48.06 78.89 Favored 'General case' 0 N--CA 1.456 -0.14 0 O-C-N 121.978 -0.451 . . . . 0.0 110.662 -177.287 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' C' C ' 19' ' ' VAL . . . . . 0.416 HG13 ' N ' ' C' ' 20' ' ' ASP . 14.9 p -54.82 -43.15 66.19 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.259 0 C-N-CA 121.007 -0.277 . . . . 0.0 111.441 -176.404 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' C' C ' 20' ' ' ASP . . . . . 0.416 ' N ' HG13 ' C' ' 19' ' ' VAL . 42.1 m-20 -62.37 -43.28 99.19 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-O 120.759 0.314 . . . . 0.0 111.217 -177.637 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' C' C ' 21' ' ' VAL . . . . . . . . . . . . . 47.9 t -64.63 -44.38 96.7 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.288 0 C-N-CA 120.637 -0.425 . . . . 0.0 110.534 -177.199 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' C' C ' 22' ' ' ILE . . . . . 0.684 HG22 HD12 ' C' ' 26' ' ' LEU . 50.8 mm -56.16 -46.7 81.23 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.21 0 C-N-CA 121.029 -0.268 . . . . 0.0 110.477 178.313 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' C' C ' 23' ' ' ARG . . . . . . . . . . . . . 55.3 ttp180 -54.21 -48.45 71.02 Favored 'General case' 0 C--N 1.33 -0.28 0 C-N-CA 121.06 -0.256 . . . . 0.0 111.336 -178.754 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' C' C ' 24' ' ' ILE . . . . . . . . . . . . . 73.8 mt -59.89 -43.93 93.21 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.331 0 CA-C-N 116.685 -0.234 . . . . 0.0 111.249 -177.815 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' C' C ' 25' ' ' LYS . . . . . . . . . . . . . 80.6 mttt -67.66 -40.43 84.49 Favored 'General case' 0 C--N 1.328 -0.352 0 N-CA-C 112.666 0.617 . . . . 0.0 112.666 -177.164 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' C' C ' 26' ' ' LEU . . . . . 0.684 HD12 HG22 ' C' ' 22' ' ' ILE . 36.8 mt -79.19 -39.43 33.38 Favored 'General case' 0 C--N 1.33 -0.274 0 N-CA-C 113.303 0.853 . . . . 0.0 113.303 -171.849 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' C' C ' 27' ' ' GLN . . . . . . . . . . . . . 9.8 pt20 -46.62 140.76 4.2 Favored 'General case' 0 N--CA 1.47 0.533 0 N-CA-C 112.732 0.641 . . . . 0.0 112.732 -175.088 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' C' C ' 28' ' ' GLY . . . . . . . . . . . . . . . 100.97 -24.82 30.61 Favored Glycine 0 CA--C 1.532 1.136 0 CA-C-N 115.388 -0.824 . . . . 0.0 112.31 -177.2 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' C' C ' 29' ' ' LYS . . . . . . . . . . . . . 69.0 mttm -97.42 155.07 17.08 Favored 'General case' 0 C--N 1.331 -0.202 0 CA-C-N 117.609 0.705 . . . . 0.0 110.904 177.317 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' C' C ' 30' ' ' THR . . . . . . . . . . . . . 13.8 m -106.6 133.69 50.9 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.07 -0.514 . . . . 0.0 109.624 175.257 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' C' C ' 31' ' ' VAL . . . . . . . . . . . . . 34.4 m -130.2 156.63 42.45 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.278 0 CA-C-O 120.982 0.42 . . . . 0.0 110.94 -176.823 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' C' C ' 32' ' ' ARG . . . . . . . . . . . . . 36.0 mtp180 -129.77 153.59 48.07 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-O 121.433 0.635 . . . . 0.0 110.84 179.476 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' C' C ' 33' ' ' THR . . . . . . . . . . . . . 24.5 m -53.84 138.85 35.09 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-N 115.907 -0.588 . . . . 0.0 111.231 -179.664 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' C' C ' 34' ' ' GLY . . . . . . . . . . . . . . . 100.95 -17.04 56.85 Favored Glycine 0 CA--C 1.532 1.136 0 CA-C-O 119.678 -0.512 . . . . 0.0 113.307 179.411 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' C' C ' 35' ' ' ASP . . . . . . . . . . . . . 62.7 m-20 -65.58 149.9 49.32 Favored 'General case' 0 C--O 1.232 0.155 0 CA-C-N 118.036 0.918 . . . . 0.0 111.315 179.496 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' C' C ' 36' ' ' VAL . . . . . . . . . . . . . 46.3 t -119.01 128.97 75.78 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.232 0 CA-C-N 115.779 -0.646 . . . . 0.0 109.686 177.836 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' C' C ' 37' ' ' ILE . . . . . . . . . . . . . 70.1 mt -120.35 139.42 47.7 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.255 0 CA-C-N 116.274 -0.421 . . . . 0.0 109.939 -178.568 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' C' C ' 38' ' ' GLY . . . . . . . . . . . . . . . -113.03 128.88 8.61 Favored Glycine 0 CA--C 1.526 0.763 0 N-CA-C 110.977 -0.849 . . . . 0.0 110.977 -179.924 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' C' C ' 39' ' ' ILE . . . . . . . . . . . . . 75.1 mt -123.24 136.97 58.18 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.243 0 N-CA-C 110.085 -0.339 . . . . 0.0 110.085 179.16 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' C' C ' 40' ' ' SER . . . . . . . . . . . . . 84.0 p -93.13 124.24 36.97 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.359 -0.382 . . . . 0.0 110.95 175.883 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' C' C ' 41' ' ' ILE . . . . . . . . . . . . . 72.7 mt -127.5 113.1 30.25 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.225 0 CA-C-O 120.925 0.393 . . . . 0.0 110.213 177.262 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' C' C ' 42' ' ' LEU . . . . . 0.535 ' O ' HD23 ' C' ' 42' ' ' LEU . 1.3 tt 49.4 47.46 22.38 Favored 'General case' 0 CA--C 1.533 0.318 0 CA-C-O 121.529 0.68 . . . . 0.0 111.357 177.73 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' C' C ' 43' ' ' GLY . . . . . . . . . . . . . . . 70.68 24.16 77.16 Favored Glycine 0 CA--C 1.53 1.01 0 C-N-CA 121.116 -0.564 . . . . 0.0 112.563 175.946 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' C' C ' 44' ' ' LYS . . . . . . . . . . . . . 17.0 ttmm -132.14 129.5 39.93 Favored 'General case' 0 C--N 1.331 -0.215 0 CA-C-N 117.515 0.658 . . . . 0.0 109.956 179.049 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' C' C ' 45' ' ' GLU . . . . . . . . . . . . . 81.6 tt0 -84.07 125.79 32.45 Favored 'General case' 0 C--N 1.327 -0.381 0 C-N-CA 120.856 -0.338 . . . . 0.0 111.148 -177.787 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' C' C ' 46' ' ' VAL . . . . . . . . . . . . . 7.4 p -123.22 129.68 74.76 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.19 0 N-CA-C 109.614 -0.513 . . . . 0.0 109.614 174.773 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' C' C ' 47' ' ' LYS . . . . . . . . . . . . . 64.1 mttp -99.67 129.98 45.85 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.117 -0.492 . . . . 0.0 111.157 177.757 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' C' C ' 48' ' ' PHE . . . . . . . . . . . . . 92.8 m-85 -113.04 132.05 55.55 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 115.792 -0.64 . . . . 0.0 109.769 175.276 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' C' C ' 49' ' ' LYS . . . . . . . . . . . . . 84.1 tttt -106.13 135.43 47.61 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.412 -0.358 . . . . 0.0 110.142 179.359 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' C' C ' 50' ' ' VAL . . . . . . . . . . . . . 44.9 t -81.41 108.13 14.31 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.321 0 N-CA-C 109.304 -0.628 . . . . 0.0 109.304 176.749 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' C' C ' 51' ' ' VAL . . . . . . . . . . . . . 44.0 t -73.31 -51.23 26.6 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.333 0 CA-C-N 116.079 -0.51 . . . . 0.0 109.843 -174.302 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' C' C ' 52' ' ' GLN . . . . . . . . . . . . . 91.3 mt-30 -152.9 151.84 30.83 Favored 'General case' 0 C--N 1.333 -0.148 0 CA-C-O 121.095 0.474 . . . . 0.0 111.743 -178.104 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' C' C ' 53' ' ' ALA . . . . . . . . . . . . . . . -130.05 131.95 46.0 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 115.374 -0.83 . . . . 0.0 109.841 174.525 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' C' C ' 54' ' ' TYR . . . . . . . . . . . . . 15.5 t80 -129.16 111.34 18.24 Favored Pre-proline 0 CA--C 1.536 0.41 0 CA-C-O 118.159 -0.924 . . . . 0.0 110.33 177.423 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' C' C ' 55' ' ' PRO . . . . . . . . . . . . . 73.4 Cg_endo -77.26 167.0 80.73 Favored 'Cis proline' 0 N--CA 1.501 1.92 0 CA-C-N 122.03 1.761 . . . . 0.0 112.356 -6.056 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' C' C ' 56' ' ' SER . . . . . . . . . . . . . 13.6 m -116.89 130.73 24.37 Favored Pre-proline 0 CA--C 1.538 0.503 0 CA-C-O 118.384 -0.817 . . . . 0.0 109.158 174.086 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' C' C ' 57' ' ' PRO . . . . . . . . . . . . . 42.7 Cg_endo -68.42 146.99 80.38 Favored 'Cis proline' 0 N--CA 1.497 1.706 0 CA-C-N 122.011 1.754 . . . . 0.0 111.527 -0.353 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' C' C ' 58' ' ' LEU . . . . . . . . . . . . . 22.7 tp -107.36 135.44 48.84 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.145 -0.479 . . . . 0.0 110.403 -178.876 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' C' C ' 59' ' ' ARG . . . . . . . . . . . . . 48.6 ttt180 -102.08 122.92 45.05 Favored 'General case' 0 C--N 1.326 -0.433 0 N-CA-C 109.134 -0.691 . . . . 0.0 109.134 176.707 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' C' C ' 60' ' ' VAL . . . . . . . . . . . . . 43.8 t -78.26 117.53 23.77 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.207 0 C-N-CA 120.633 -0.427 . . . . 0.0 110.084 -175.565 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' C' C ' 61' ' ' GLU . . . . . . . . . . . . . 95.8 mt-10 -131.06 162.92 28.77 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.025 -0.534 . . . . 0.0 109.992 178.355 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' C' C ' 62' ' ' ASP . . . . . . . . . . . . . 10.0 t0 -53.55 -32.16 49.58 Favored 'General case' 0 C--N 1.327 -0.402 0 N-CA-C 111.834 0.309 . . . . 0.0 111.834 -179.117 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' C' C ' 63' ' ' ARG . . . . . . . . . . . . . 33.6 ptt180 -84.11 3.43 34.81 Favored 'General case' 0 CA--C 1.536 0.424 0 N-CA-C 113.762 1.023 . . . . 0.0 113.762 -174.972 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' C' C ' 64' ' ' THR . . . . . . . . . . . . . 34.8 m -86.53 139.26 31.03 Favored 'General case' 0 C--O 1.232 0.144 0 CA-C-N 118.171 0.442 . . . . 0.0 110.742 -178.003 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' C' C ' 65' ' ' LYS . . . . . . . . . . . . . 98.7 mttt -89.35 127.67 35.83 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.157 -0.474 . . . . 0.0 110.205 178.918 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' C' C ' 66' ' ' ILE . . . . . . . . . . . . . 63.8 mt -114.06 127.46 71.46 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.269 0 N-CA-C 109.638 -0.505 . . . . 0.0 109.638 179.995 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' C' C ' 67' ' ' THR . . . . . . . . . . . . . 22.6 m -123.5 139.24 54.22 Favored 'General case' 0 C--N 1.331 -0.216 0 CA-C-N 116.223 -0.444 . . . . 0.0 110.818 -177.459 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' C' C ' 68' ' ' LEU . . . . . . . . . . . . . 30.4 mt -102.22 126.68 49.27 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 115.881 -0.6 . . . . 0.0 110.124 178.126 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' C' C ' 69' ' ' VAL . . . . . . . . . . . . . 43.8 t -101.27 104.11 15.82 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.334 0 N-CA-C 109.765 -0.458 . . . . 0.0 109.765 179.253 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' C' C ' 70' ' ' THR . . . . . 0.442 HG23 ' O ' ' C' ' 70' ' ' THR . 9.9 t -149.98 123.86 9.3 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 116.055 -0.52 . . . . 0.0 110.586 179.402 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' C' C ' 71' ' ' HIS . . . . . . . . . . . . . 91.0 m-70 -147.21 67.17 10.65 Favored Pre-proline 0 C--N 1.328 -0.348 0 C-N-CA 120.848 -0.341 . . . . 0.0 110.855 178.164 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' C' C ' 72' ' ' PRO . . . . . . . . . . . . . 82.0 Cg_endo -93.46 156.91 2.47 Favored 'Trans proline' 0 N--CA 1.487 1.116 0 C-N-CA 121.955 1.77 . . . . 0.0 111.731 176.751 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' C' C ' 73' ' ' VAL . . . . . . . . . . . . . 27.6 m -80.73 140.25 16.93 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.258 0 CA-C-O 121.118 0.485 . . . . 0.0 110.348 178.577 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' C' C ' 74' ' ' ASP . . . . . . . . . . . . . 13.6 t70 -89.76 119.85 30.51 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 115.743 -0.662 . . . . 0.0 109.717 179.854 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' C' C ' 75' ' ' VAL . . . . . . . . . . . . . 45.1 t -110.43 121.15 62.72 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.203 0 CA-C-O 121.204 0.526 . . . . 0.0 110.327 -178.56 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' C' C ' 76' ' ' LEU . . . . . . . . . . . . . 18.6 mt -121.08 141.69 50.54 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 115.377 -0.829 . . . . 0.0 109.192 177.468 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' C' C ' 77' ' ' GLU . . . . . . . . . . . . . 97.9 mt-10 -134.14 134.02 41.71 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-O 121.204 0.526 . . . . 0.0 111.338 -177.425 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' C' C ' 78' ' ' ALA . . . . . 0.517 ' HB2' HD21 ' C' ' 109' ' ' LEU . . . -122.9 129.51 51.7 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 115.455 -0.793 . . . . 0.0 109.654 176.593 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' C' C ' 79' ' ' LYS . . . . . 0.676 ' O ' HD13 ' C' ' 80' ' ' ILE . 80.6 tttt -73.98 119.7 18.55 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.477 -0.328 . . . . 0.0 110.241 -179.013 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' C' C ' 80' ' ' ILE . . . . . 0.676 HD13 ' O ' ' C' ' 79' ' ' LYS . 35.7 mm -139.13 116.21 10.86 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.304 0 N-CA-C 109.403 -0.591 . . . . 0.0 109.403 -176.279 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' C' C ' 81' ' ' LYS . . . . . . . . . . . . . 21.1 pttp -110.73 124.18 51.47 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-O 121.246 0.546 . . . . 0.0 111.284 -177.033 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' C' C ' 82' ' ' GLY . . . . . . . . . . . . . . . 89.2 42.09 5.67 Favored Glycine 0 CA--C 1.528 0.854 0 CA-C-N 115.675 -0.693 . . . . 0.0 112.053 175.677 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' C' C ' 83' ' ' ILE . . . . . . . . . . . . . 68.2 mt -69.56 137.09 24.87 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.248 0 N-CA-C 109.487 -0.56 . . . . 0.0 109.487 176.498 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' C' C ' 84' ' ' LYS . . . . . . . . . . . . . 28.1 ttpp -103.68 -52.13 3.04 Favored 'General case' 0 C--N 1.331 -0.201 0 CA-C-O 120.852 0.358 . . . . 0.0 110.524 -179.104 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' C' C ' 85' ' ' ASP . . . . . . . . . . . . . 13.3 t70 -143.54 145.31 32.44 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.077 -0.511 . . . . 0.0 110.653 -178.597 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' C' C ' 86' ' ' VAL . . . . . . . . . . . . . 44.4 t -127.66 129.2 70.15 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.234 0 CA-C-O 120.871 0.367 . . . . 0.0 110.382 179.89 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' C' C ' 87' ' ' ILE . . . . . . . . . . . . . 43.9 mm -118.5 123.98 72.41 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.26 0 CA-C-N 116.041 -0.527 . . . . 0.0 109.604 176.598 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' C' C ' 88' ' ' LEU . . . . . . . . . . . . . 68.2 mt -113.66 137.22 51.91 Favored 'General case' 0 C--N 1.331 -0.201 0 CA-C-O 121.081 0.467 . . . . 0.0 111.687 -176.347 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' C' C ' 89' ' ' ASP . . . . . . . . . . . . . 10.2 t70 -132.62 156.35 47.08 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 115.631 -0.713 . . . . 0.0 109.204 174.352 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' C' C ' 90' ' ' GLU . . . . . . . . . . . . . 82.0 tt0 -47.4 -41.62 20.35 Favored 'General case' 0 N--CA 1.464 0.228 0 N-CA-C 112.95 0.722 . . . . 0.0 112.95 -171.633 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' C' C ' 91' ' ' ASN . . . . . . . . . . . . . 15.7 p-10 -132.14 38.49 3.49 Favored 'General case' 0 N--CA 1.465 0.298 0 CA-C-O 120.821 0.343 . . . . 0.0 111.345 -177.934 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' C' C ' 92' ' ' LEU . . . . . . . . . . . . . 20.7 tp -164.74 139.88 5.5 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.59 -0.277 . . . . 0.0 110.258 -178.872 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' C' C ' 93' ' ' ILE . . . . . . . . . . . . . 66.3 mt -130.18 124.2 57.53 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.221 0 N-CA-C 109.576 -0.527 . . . . 0.0 109.576 -177.886 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' C' C ' 94' ' ' VAL . . . . . 0.579 HG21 HG11 ' C' ' 125' ' ' VAL . 46.7 t -125.81 127.91 71.69 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.265 0 N-CA-C 109.848 -0.427 . . . . 0.0 109.848 178.551 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' C' C ' 95' ' ' VAL . . . . . . . . . . . . . 42.4 t -122.08 136.09 60.06 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.283 0 CA-C-N 115.979 -0.555 . . . . 0.0 109.852 -179.089 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' C' C ' 96' ' ' ILE . . . . . . . . . . . . . 60.4 mt -116.12 127.61 73.66 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.328 0 N-CA-C 109.348 -0.612 . . . . 0.0 109.348 179.51 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' C' C ' 97' ' ' THR . . . . . . . . . . . . . 80.6 p -99.3 157.7 16.22 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-O 120.983 0.42 . . . . 0.0 110.952 -177.81 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' C' C ' 98' ' ' GLU . . . . . . . . . . . . . 96.2 mt-10 -53.98 -25.54 21.41 Favored 'General case' 0 CA--C 1.534 0.336 0 N-CA-C 112.306 0.484 . . . . 0.0 112.306 -179.03 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' C' C ' 99' ' ' GLU . . . . . . . . . . . . . 95.7 mt-10 -79.39 15.79 1.17 Allowed 'General case' 0 CA--C 1.535 0.379 0 N-CA-C 113.197 0.814 . . . . 0.0 113.197 -177.541 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' C' C ' 100' ' ' ASN . . . . . . . . . . . . . 2.6 m-20 62.05 37.27 14.87 Favored 'General case' 0 C--O 1.233 0.216 0 CA-C-O 121.076 0.465 . . . . 0.0 111.064 178.948 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' C' C ' 101' ' ' GLU . . . . . . . . . . . . . 83.6 tt0 -111.96 143.04 43.6 Favored 'General case' 0 C--N 1.333 -0.147 0 N-CA-C 109.611 -0.514 . . . . 0.0 109.611 176.436 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' C' C ' 102' ' ' VAL . . . . . . . . . . . . . 43.7 t -114.97 123.76 70.97 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.275 0 CA-C-N 116.123 -0.489 . . . . 0.0 109.833 -178.753 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' C' C ' 103' ' ' LEU . . . . . . . . . . . . . 69.1 mt -116.58 127.53 54.58 Favored 'General case' 0 C--N 1.331 -0.207 0 CA-C-N 115.76 -0.654 . . . . 0.0 109.902 176.086 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' C' C ' 104' ' ' ILE . . . . . . . . . . . . . 65.2 mt -114.84 123.41 70.49 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.289 0 N-CA-C 109.855 -0.424 . . . . 0.0 109.855 -179.665 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' C' C ' 105' ' ' PHE . . . . . . . . . . . . . 81.9 m-85 -123.53 162.1 23.58 Favored 'General case' 0 C--N 1.331 -0.226 0 O-C-N 123.864 0.728 . . . . 0.0 109.788 -178.333 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' C' C ' 106' ' ' ASN . . . . . . . . . . . . . 38.9 p30 -98.03 -173.98 2.74 Favored 'General case' 0 C--N 1.328 -0.334 0 N-CA-C 109.553 -0.536 . . . . 0.0 109.553 173.942 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' C' C ' 107' ' ' GLN . . . . . . . . . . . . . 45.7 tt0 -59.37 -29.06 67.42 Favored 'General case' 0 CA--C 1.532 0.264 0 N-CA-C 112.004 0.372 . . . . 0.0 112.004 -179.836 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' C' C ' 108' ' ' ASN . . . . . . . . . . . . . 52.9 t30 -81.94 8.59 10.07 Favored 'General case' 0 CA--C 1.537 0.472 0 N-CA-C 113.14 0.792 . . . . 0.0 113.14 -177.485 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' C' C ' 109' ' ' LEU . . . . . 0.517 HD21 ' HB2' ' C' ' 78' ' ' ALA . 13.2 tp 58.9 40.45 22.63 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-O 121.293 0.568 . . . . 0.0 110.981 178.425 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' C' C ' 110' ' ' GLU . . . . . . . . . . . . . 95.9 mt-10 -110.26 147.39 33.92 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.05 -0.523 . . . . 0.0 109.711 174.089 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' C' C ' 111' ' ' GLU . . . . . . . . . . . . . 55.5 tt0 -82.58 121.96 27.48 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.402 -0.363 . . . . 0.0 110.497 -176.043 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' C' C ' 112' ' ' LEU . . . . . . . . . . . . . 24.3 mt -105.37 -46.09 4.3 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.079 -0.51 . . . . 0.0 110.892 -179.549 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' C' C ' 113' ' ' TYR . . . . . . . . . . . . . 55.3 t80 -135.54 140.45 44.73 Favored 'General case' 0 C--N 1.331 -0.239 0 CA-C-N 116.221 -0.445 . . . . 0.0 110.805 -178.881 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' C' C ' 114' ' ' ARG . . . . . . . . . . . . . 36.1 ptt180 -143.61 120.88 11.56 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-O 121.183 0.516 . . . . 0.0 110.902 178.327 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' C' C ' 115' ' ' GLY . . . . . . . . . . . . . . . -150.19 163.04 29.4 Favored Glycine 0 CA--C 1.524 0.631 0 N-CA-C 110.866 -0.894 . . . . 0.0 110.866 -179.328 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' C' C ' 116' ' ' LYS . . . . . . . . . . . . . 40.0 ttpt -128.75 136.13 50.15 Favored 'General case' 0 C--N 1.33 -0.266 0 O-C-N 122.616 -0.343 . . . . 0.0 110.082 177.439 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' C' C ' 117' ' ' PHE . . . . . . . . . . . . . 61.9 m-85 -132.2 114.24 14.24 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-O 120.902 0.382 . . . . 0.0 110.448 -176.263 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' C' C ' 118' ' ' GLU . . . . . . . . . . . . . 70.8 mm-40 -53.47 -50.88 64.38 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.447 -0.342 . . . . 0.0 111.499 -176.205 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' C' C ' 119' ' ' ASN . . . . . . . . . . . . . 83.1 m-20 -94.73 31.06 1.88 Allowed 'General case' 0 C--N 1.329 -0.31 0 N-CA-C 112.187 0.44 . . . . 0.0 112.187 -174.083 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' C' C ' 120' ' ' LEU . . . . . . . . . . . . . 16.7 tp -56.46 124.71 19.1 Favored 'General case' 0 C--O 1.232 0.161 0 CA-C-O 120.659 0.266 . . . . 0.0 110.556 178.484 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' C' C ' 121' ' ' ASN . . . . . . . . . . . . . 35.5 m120 -114.03 -43.97 3.2 Favored 'General case' 0 C--N 1.332 -0.167 0 CA-C-N 116.483 -0.326 . . . . 0.0 111.044 -177.871 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' C' C ' 122' ' ' LYS . . . . . . . . . . . . . 55.5 mttm -145.3 148.09 33.06 Favored 'General case' 0 C--N 1.33 -0.239 0 CA-C-O 121.071 0.463 . . . . 0.0 111.815 -176.937 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' C' C ' 123' ' ' VAL . . . . . . . . . . . . . 45.4 t -128.0 124.23 62.29 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 N-CA-C 108.909 -0.774 . . . . 0.0 108.909 171.965 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' C' C ' 124' ' ' LEU . . . . . . . . . . . . . 11.3 tp -123.29 135.66 54.33 Favored 'General case' 0 C--N 1.332 -0.185 0 CA-C-O 120.765 0.317 . . . . 0.0 110.914 -174.941 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' C' C ' 125' ' ' VAL . . . . . 0.773 HG12 HG23 ' C' ' 130' ' ' VAL . 35.7 m -131.34 139.18 51.46 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.229 0 CA-C-N 116.225 -0.443 . . . . 0.0 110.886 -179.507 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' C' C ' 126' ' ' ARG . . . . . . . . . . . . . 89.0 mtt180 -146.6 125.07 12.37 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.167 -0.469 . . . . 0.0 110.51 175.83 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' C' C ' 127' ' ' ASN . . . . . . . . . . . . . 13.4 t-20 51.62 -109.31 0.43 Allowed 'General case' 0 CA--C 1.545 0.753 0 CA-C-O 118.824 -0.608 . . . . 0.0 111.199 -179.989 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' C' C ' 128' ' ' ASP . . . . . . . . . . . . . 14.3 p-10 -114.01 5.76 16.22 Favored 'General case' 0 N--CA 1.468 0.438 0 CA-C-N 119.818 1.19 . . . . 0.0 113.413 -177.918 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' C' C ' 129' ' ' LEU . . . . . . . . . . . . . 13.2 tp -109.89 136.6 48.93 Favored 'General case' 0 C--N 1.334 -0.108 0 N-CA-C 109.718 -0.475 . . . . 0.0 109.718 179.445 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' C' C ' 130' ' ' VAL . . . . . 0.773 HG23 HG12 ' C' ' 125' ' ' VAL . 12.9 p -129.54 140.7 48.42 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.205 0 CA-C-O 121.047 0.451 . . . . 0.0 110.46 -179.521 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' C' C ' 131' ' ' VAL . . . . . . . . . . . . . 43.0 t -135.72 138.29 48.07 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.314 0 CA-C-O 121.125 0.488 . . . . 0.0 110.18 179.689 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' C' C ' 132' ' ' ILE . . . . . . . . . . . . . 69.2 mt -110.64 131.23 62.34 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.328 0 CA-C-N 115.527 -0.76 . . . . 0.0 109.11 179.335 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' C' C ' 133' ' ' ILE . . . . . . . . . . . . . 42.4 mm -115.22 119.75 62.69 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.222 0 CA-C-O 120.859 0.361 . . . . 0.0 110.893 -174.716 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' C' C ' 134' ' ' ASP . . . . . . . . . . . . . 8.0 p-10 -132.17 144.24 50.53 Favored 'General case' 0 C--N 1.33 -0.253 0 N-CA-C 109.271 -0.64 . . . . 0.0 109.271 174.7 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' C' C ' 135' ' ' GLU . . . . . . . . . . . . . 84.2 tt0 -49.97 -26.41 4.2 Favored 'General case' 0 C--N 1.327 -0.395 0 N-CA-C 112.774 0.657 . . . . 0.0 112.774 -173.643 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' C' C ' 136' ' ' GLN . . . . . . . . . . . . . 62.8 tt0 -78.95 -36.59 41.39 Favored 'General case' 0 CA--C 1.531 0.217 0 N-CA-C 112.196 0.443 . . . . 0.0 112.196 -177.237 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' C' C ' 137' ' ' LYS . . . . . . . . . . . . . 34.5 pttt -167.27 172.29 9.96 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-O 121.482 0.658 . . . . 0.0 112.025 -173.258 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' C' C ' 138' ' ' LEU . . . . . 0.433 HD23 ' C ' ' C' ' 138' ' ' LEU . 7.1 tt -117.01 128.78 55.52 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 115.223 -0.899 . . . . 0.0 109.953 179.213 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' C' C ' 139' ' ' THR . . . . . . . . . . . . . 32.7 m -110.46 123.47 49.97 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.164 178.885 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' C' C ' 140' ' ' LEU . . . . . 0.479 ' C ' HD23 ' C' ' 140' ' ' LEU . 7.0 tt -107.95 123.11 48.13 Favored 'General case' 0 C--N 1.327 -0.408 0 N-CA-C 108.947 -0.76 . . . . 0.0 108.947 -179.49 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' C' C ' 141' ' ' ILE . . . . . 0.456 ' HB ' HG13 ' C' ' 130' ' ' VAL . 20.0 mt -124.96 118.64 53.71 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.248 0 CA-C-O 121.205 0.526 . . . . 0.0 109.944 -176.448 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' C' C ' 142' ' ' ARG . . . . . . . . . . . . . 67.1 ttt-85 -103.7 118.46 36.77 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 115.221 -0.9 . . . . 0.0 109.929 178.919 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' C' C ' 143' ' ' THR . . . . . . . . . . . . . 70.7 p . . . . . 0 C--O 1.22 -0.493 0 CA-C-O 117.975 -1.012 . . . . 0.0 110.565 -179.19 . . . . . . . . 0 0 . 1 . 003 nuclear nobuild full ' D' D ' -3' ' ' GLU . . . . . . . . . . . . . 84.7 tt0 . . . . . 0 N--CA 1.49 1.571 0 N-CA-C 109.35 -0.611 . . . . 0.0 109.35 . . . . . . . . . 0 0 . 1 . 003 nuclear nobuild full ' D' D ' -2' ' ' GLY . . . . . . . . . . . . . . . -67.21 134.92 31.49 Favored Glycine 0 CA--C 1.525 0.716 0 N-CA-C 110.999 -0.841 . . . . 0.0 110.999 -179.935 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' D' D ' -1' ' ' VAL . . . . . . . . . . . . . 42.8 t -96.82 139.79 18.77 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.358 0 N-CA-C 110.063 -0.347 . . . . 0.0 110.063 179.556 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' D' D ' 0' ' ' ILE . . . . . . . . . . . . . 45.0 mm -103.17 133.34 47.27 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.251 0 CA-C-N 116.334 -0.394 . . . . 0.0 110.197 -179.817 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' D' D ' 1' ' ' MET . . . . . . . . . . . . . 25.4 ptm -94.89 156.35 16.39 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.055 -0.52 . . . . 0.0 110.747 -178.922 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' D' D ' 2' ' ' SER . . . . . . . . . . . . . 2.3 p -130.13 124.46 32.74 Favored 'General case' 0 C--N 1.331 -0.22 0 CA-C-N 116.124 -0.489 . . . . 0.0 110.271 178.217 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' D' D ' 3' ' ' GLU . . . . . . . . . . . . . 84.3 tt0 -140.03 141.24 36.3 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 115.778 -0.646 . . . . 0.0 110.983 -176.666 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' D' D ' 4' ' ' LEU . . . . . . . . . . . . . 12.6 tp -125.38 127.64 46.9 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-N 115.927 -0.579 . . . . 0.0 110.18 176.568 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' D' D ' 5' ' ' LYS . . . . . . . . . . . . . 98.8 mttt -108.8 121.58 45.38 Favored 'General case' 0 C--O 1.235 0.322 0 CA-C-N 116.532 -0.304 . . . . 0.0 110.905 179.931 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' D' D ' 6' ' ' LEU . . . . . . . . . . . . . 40.5 mt -114.02 148.32 37.19 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-N 115.352 -0.84 . . . . 0.0 110.289 179.989 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' D' D ' 7' ' ' LYS . . . . . . . . . . . . . 57.8 tttm -128.72 137.04 30.1 Favored Pre-proline 0 CA--C 1.535 0.383 0 CA-C-O 118.831 -0.604 . . . . 0.0 109.703 173.62 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' D' D ' 8' ' ' PRO . . . . . . . . . . . . . 90.8 Cg_endo -90.84 134.05 1.77 Allowed 'Trans proline' 0 N--CA 1.491 1.344 0 C-N-CA 121.7 1.6 . . . . 0.0 111.694 178.081 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' D' D ' 9' ' ' LEU . . . . . . . . . . . . . 35.5 mt -73.38 -46.98 7.69 Favored Pre-proline 0 CA--C 1.532 0.277 0 CA-C-O 118.701 -0.666 . . . . 0.0 112.056 -178.845 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' D' D ' 10' ' ' PRO . . . . . . . . . . . . . 91.7 Cg_endo -81.78 150.38 16.42 Favored 'Trans proline' 0 N--CA 1.495 1.614 0 C-N-CA 121.267 1.311 . . . . 0.0 111.64 174.61 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' D' D ' 11' ' ' LYS . . . . . . . . . . . . . 49.9 pttt -85.38 111.29 19.79 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-O 121.626 0.727 . . . . 0.0 110.606 178.367 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' D' D ' 12' ' ' VAL . . . . . . . . . . . . . 12.3 p -151.12 148.28 15.01 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.309 0 CA-C-N 115.57 -0.741 . . . . 0.0 110.348 179.339 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' D' D ' 13' ' ' GLU . . . . . . . . . . . . . 45.5 tp10 -94.0 122.16 36.23 Favored 'General case' 0 C--N 1.33 -0.282 0 N-CA-C 110.002 -0.37 . . . . 0.0 110.002 177.584 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' D' D ' 14' ' ' LEU . . . . . . . . . . . . . 46.4 mt -98.02 152.44 38.05 Favored Pre-proline 0 CA--C 1.532 0.272 0 CA-C-O 119.439 -0.315 . . . . 0.0 110.758 -177.558 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' D' D ' 15' ' ' PRO . . . . . . . . . . . . . 27.8 Cg_exo -61.13 159.84 28.69 Favored 'Trans proline' 0 N--CA 1.497 1.684 0 C-N-CA 121.315 1.343 . . . . 0.0 111.977 177.499 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' D' D ' 16' ' ' PRO . . . . . . . . . . . . . 29.8 Cg_exo -59.96 -36.36 90.31 Favored 'Trans proline' 0 N--CA 1.497 1.692 0 C-N-CA 121.434 1.423 . . . . 0.0 112.742 -178.536 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' D' D ' 17' ' ' ASP . . . . . . . . . . . . . 8.2 p-10 -88.18 8.88 24.95 Favored 'General case' 0 CA--C 1.536 0.404 0 N-CA-C 113.24 0.829 . . . . 0.0 113.24 -177.388 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' D' D ' 18' ' ' PHE . . . . . . . . . . . . . 43.6 t80 -58.16 -46.13 86.22 Favored 'General case' 0 CA--C 1.524 -0.031 0 O-C-N 121.887 -0.508 . . . . 0.0 109.973 -178.391 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' D' D ' 19' ' ' VAL . . . . . . . . . . . . . 13.8 p -57.47 -40.6 75.58 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.34 0 CA-C-N 116.121 -0.49 . . . . 0.0 110.723 -179.519 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' D' D ' 20' ' ' ASP . . . . . . . . . . . . . 22.2 m-20 -59.49 -43.14 93.39 Favored 'General case' 0 C--N 1.331 -0.228 0 C-N-CA 120.88 -0.328 . . . . 0.0 110.846 -178.143 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' D' D ' 21' ' ' VAL . . . . . . . . . . . . . 47.7 t -64.92 -46.3 92.14 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.246 0 C-N-CA 120.717 -0.393 . . . . 0.0 110.472 -178.192 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' D' D ' 22' ' ' ILE . . . . . 0.51 HG22 HD12 ' D' ' 26' ' ' LEU . 45.2 mm -59.33 -35.82 60.4 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.256 0 C-N-CA 120.843 -0.343 . . . . 0.0 110.98 -179.872 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' D' D ' 23' ' ' ARG . . . . . . . . . . . . . 33.1 ttp180 -59.45 -49.74 76.63 Favored 'General case' 0 C--N 1.33 -0.242 0 C-N-CA 120.621 -0.432 . . . . 0.0 110.19 176.789 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' D' D ' 24' ' ' ILE . . . . . . . . . . . . . 75.6 mt -61.34 -39.8 83.94 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.322 0 CA-C-N 116.155 -0.475 . . . . 0.0 112.085 -177.034 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' D' D ' 25' ' ' LYS . . . . . . . . . . . . . 10.2 ptmt -75.06 -40.43 60.29 Favored 'General case' 0 CA--C 1.535 0.38 0 C-N-CA 120.537 -0.465 . . . . 0.0 111.98 -175.144 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' D' D ' 26' ' ' LEU . . . . . 0.51 HD12 HG22 ' D' ' 22' ' ' ILE . 24.2 mt -79.04 -33.92 44.32 Favored 'General case' 0 C--N 1.331 -0.225 0 N-CA-C 113.337 0.866 . . . . 0.0 113.337 -172.978 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' D' D ' 27' ' ' GLN . . . . . . . . . . . . . 8.7 pt20 -46.55 139.66 4.91 Favored 'General case' 0 N--CA 1.47 0.527 0 N-CA-C 112.726 0.639 . . . . 0.0 112.726 -176.3 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' D' D ' 28' ' ' GLY . . . . . . . . . . . . . . . 100.24 -24.59 31.53 Favored Glycine 0 CA--C 1.534 1.231 0 CA-C-N 115.688 -0.687 . . . . 0.0 112.134 -174.287 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' D' D ' 29' ' ' LYS . . . . . . . . . . . . . 99.4 mttt -97.83 155.22 17.15 Favored 'General case' 0 C--N 1.333 -0.113 0 CA-C-N 117.334 0.567 . . . . 0.0 110.985 178.791 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' D' D ' 30' ' ' THR . . . . . . . . . . . . . 17.8 m -105.56 140.52 38.52 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 115.949 -0.569 . . . . 0.0 110.179 176.447 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' D' D ' 31' ' ' VAL . . . . . . . . . . . . . 35.1 m -126.66 149.51 31.73 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.224 0 CA-C-N 116.398 -0.365 . . . . 0.0 110.793 -179.393 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' D' D ' 32' ' ' ARG . . . . . . . . . . . . . 93.1 mtt180 -129.91 149.18 51.75 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-O 121.29 0.567 . . . . 0.0 110.431 179.348 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' D' D ' 33' ' ' THR . . . . . . . . . . . . . 21.2 m -53.24 137.49 34.37 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.169 -0.468 . . . . 0.0 111.546 -176.671 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' D' D ' 34' ' ' GLY . . . . . . . . . . . . . . . 99.31 -16.98 58.5 Favored Glycine 0 CA--C 1.531 1.067 0 C-N-CA 121.243 -0.503 . . . . 0.0 113.358 177.278 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' D' D ' 35' ' ' ASP . . . . . . . . . . . . . 81.3 m-20 -65.89 147.98 52.51 Favored 'General case' 0 C--O 1.231 0.117 0 CA-C-N 118.045 0.923 . . . . 0.0 111.127 -179.879 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' D' D ' 36' ' ' VAL . . . . . . . . . . . . . 46.4 t -119.95 129.5 75.36 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.266 0 CA-C-N 115.971 -0.559 . . . . 0.0 109.646 176.891 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' D' D ' 37' ' ' ILE . . . . . . . . . . . . . 63.0 mt -119.33 138.02 51.38 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.267 0 N-CA-C 109.864 -0.421 . . . . 0.0 109.864 -178.306 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' D' D ' 38' ' ' GLY . . . . . . . . . . . . . . . -115.77 128.2 7.92 Favored Glycine 0 CA--C 1.526 0.763 0 N-CA-C 110.881 -0.888 . . . . 0.0 110.881 179.04 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' D' D ' 39' ' ' ILE . . . . . . . . . . . . . 68.7 mt -126.15 127.42 70.85 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.223 0 N-CA-C 110.011 -0.366 . . . . 0.0 110.011 179.036 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' D' D ' 40' ' ' SER . . . . . . . . . . . . . 42.5 t -93.12 119.92 32.85 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.509 -0.314 . . . . 0.0 111.03 176.935 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' D' D ' 41' ' ' ILE . . . . . . . . . . . . . 71.6 mt -132.93 129.96 58.21 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.206 0 CA-C-O 120.795 0.331 . . . . 0.0 110.441 178.144 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' D' D ' 42' ' ' LEU . . . . . . . . . . . . . 74.0 mt 56.74 33.01 22.24 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.204 -0.453 . . . . 0.0 111.853 177.401 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' D' D ' 43' ' ' GLY . . . . . . . . . . . . . . . 72.85 24.81 75.34 Favored Glycine 0 CA--C 1.532 1.129 0 C-N-CA 121.149 -0.548 . . . . 0.0 112.55 177.712 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' D' D ' 44' ' ' LYS . . . . . . . . . . . . . 67.3 mttm -136.85 127.01 26.2 Favored 'General case' 0 C--N 1.331 -0.214 0 CA-C-N 117.162 0.481 . . . . 0.0 109.899 178.001 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' D' D ' 45' ' ' GLU . . . . . . . . . . . . . 39.2 tp10 -85.53 126.29 33.74 Favored 'General case' 0 C--N 1.328 -0.349 0 C-N-CA 120.776 -0.369 . . . . 0.0 110.968 -178.979 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' D' D ' 46' ' ' VAL . . . . . . . . . . . . . 9.0 p -118.14 126.43 74.96 Favored 'Isoleucine or valine' 0 C--O 1.233 0.224 0 N-CA-C 109.417 -0.586 . . . . 0.0 109.417 174.778 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' D' D ' 47' ' ' LYS . . . . . . . . . . . . . 62.0 mttp -98.89 125.62 44.35 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 116.111 -0.495 . . . . 0.0 110.886 177.762 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' D' D ' 48' ' ' PHE . . . . . . . . . . . . . 38.4 m-85 -111.22 131.86 54.79 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 115.79 -0.641 . . . . 0.0 109.458 177.166 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' D' D ' 49' ' ' LYS . . . . . . . . . . . . . 46.0 tttp -105.44 133.33 50.37 Favored 'General case' 0 C--N 1.328 -0.355 0 N-CA-C 110.174 -0.306 . . . . 0.0 110.174 178.823 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' D' D ' 50' ' ' VAL . . . . . . . . . . . . . 44.0 t -77.94 103.44 5.01 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.299 0 N-CA-C 109.243 -0.651 . . . . 0.0 109.243 177.894 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' D' D ' 51' ' ' VAL . . . . . . . . . . . . . 48.1 t -72.21 -48.36 49.19 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.324 0 CA-C-N 116.105 -0.498 . . . . 0.0 110.068 -173.664 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' D' D ' 52' ' ' GLN . . . . . . . . . . . . . 62.6 tt0 -159.13 141.44 13.86 Favored 'General case' 0 C--N 1.33 -0.27 0 C-N-CA 120.298 -0.561 . . . . 0.0 111.749 -178.542 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' D' D ' 53' ' ' ALA . . . . . . . . . . . . . . . -120.66 132.41 55.09 Favored 'General case' 0 C--N 1.331 -0.2 0 CA-C-N 115.96 -0.564 . . . . 0.0 109.889 175.172 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' D' D ' 54' ' ' TYR . . . . . . . . . . . . . 71.5 t80 -129.05 111.17 18.37 Favored Pre-proline 0 CA--C 1.534 0.355 0 CA-C-O 118.231 -0.89 . . . . 0.0 110.522 179.522 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' D' D ' 55' ' ' PRO . . . . . . . . . . . . . 72.7 Cg_endo -77.24 169.9 72.89 Favored 'Cis proline' 0 N--CA 1.5 1.872 0 CA-C-N 121.945 1.73 . . . . 0.0 112.086 -7.417 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' D' D ' 56' ' ' SER . . . . . . . . . . . . . 13.7 m -119.27 134.32 23.73 Favored Pre-proline 0 CA--C 1.538 0.507 0 CA-C-O 118.51 -0.757 . . . . 0.0 109.403 174.219 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' D' D ' 57' ' ' PRO . . . . . . . . . . . . . 48.7 Cg_endo -69.85 144.7 77.56 Favored 'Cis proline' 0 N--CA 1.498 1.745 0 CA-C-N 121.857 1.699 . . . . 0.0 111.496 -0.695 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' D' D ' 58' ' ' LEU . . . . . . . . . . . . . 19.6 tp -106.75 134.55 49.72 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.369 -0.378 . . . . 0.0 110.57 -178.756 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' D' D ' 59' ' ' ARG . . . . . . . . . . . . . 19.9 ttm180 -103.59 125.52 50.17 Favored 'General case' 0 C--N 1.327 -0.395 0 N-CA-C 109.158 -0.682 . . . . 0.0 109.158 175.823 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' D' D ' 60' ' ' VAL . . . . . . . . . . . . . 43.1 t -82.23 123.51 38.29 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.25 0 C-N-CA 120.557 -0.457 . . . . 0.0 110.491 -175.659 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' D' D ' 61' ' ' GLU . . . . . . . . . . . . . 95.3 mt-10 -129.71 172.3 11.77 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 115.721 -0.672 . . . . 0.0 109.36 176.689 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' D' D ' 62' ' ' ASP . . . . . . . . . . . . . 69.2 m-20 -53.89 -32.37 53.11 Favored 'General case' 0 C--N 1.328 -0.332 0 C-N-CA 121.068 -0.253 . . . . 0.0 111.636 178.595 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' D' D ' 63' ' ' ARG . . . . . . . . . . . . . 40.7 ptt180 -83.86 -0.38 50.97 Favored 'General case' 0 CA--C 1.537 0.475 0 N-CA-C 113.754 1.02 . . . . 0.0 113.754 -176.037 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' D' D ' 64' ' ' THR . . . . . . . . . . . . . 25.3 m -76.31 132.11 39.61 Favored 'General case' 0 C--N 1.333 -0.127 0 CA-C-N 118.158 0.435 . . . . 0.0 110.733 -176.234 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' D' D ' 65' ' ' LYS . . . . . . . . . . . . . 36.5 ttpt -89.78 122.62 33.03 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.191 -0.459 . . . . 0.0 110.136 179.249 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' D' D ' 66' ' ' ILE . . . . . . . . . . . . . 61.9 mt -112.8 131.98 62.85 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.268 0 N-CA-C 109.918 -0.401 . . . . 0.0 109.918 -178.229 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' D' D ' 67' ' ' THR . . . . . . . . . . . . . 24.4 m -130.05 143.82 51.0 Favored 'General case' 0 C--O 1.234 0.268 0 CA-C-O 121.172 0.51 . . . . 0.0 111.496 -177.835 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' D' D ' 68' ' ' LEU . . . . . 0.475 ' C ' HD23 ' D' ' 68' ' ' LEU . 8.2 tt -101.09 127.02 47.82 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 115.656 -0.702 . . . . 0.0 109.553 175.908 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' D' D ' 69' ' ' VAL . . . . . . . . . . . . . 41.5 t -89.05 116.71 31.05 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.294 0 CA-C-O 121.124 0.488 . . . . 0.0 110.639 -177.036 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' D' D ' 70' ' ' THR . . . . . . . . . . . . . 10.0 t -150.1 143.83 25.34 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 115.643 -0.708 . . . . 0.0 109.833 175.565 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' D' D ' 71' ' ' HIS . . . . . . . . . . . . . 68.1 m-70 -144.44 73.22 15.76 Favored Pre-proline 0 CA--C 1.535 0.391 0 C-N-CA 120.85 -0.34 . . . . 0.0 111.132 -178.326 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' D' D ' 72' ' ' PRO . . . . . . . . . . . . . 91.2 Cg_endo -88.21 146.93 6.48 Favored 'Trans proline' 0 N--CA 1.491 1.367 0 C-N-CA 121.635 1.557 . . . . 0.0 111.625 175.575 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' D' D ' 73' ' ' VAL . . . . . . . . . . . . . 27.4 m -69.92 147.6 11.64 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.209 0 CA-C-O 120.85 0.357 . . . . 0.0 110.41 179.278 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' D' D ' 74' ' ' ASP . . . . . . . . . . . . . 42.6 t0 -90.87 115.08 27.64 Favored 'General case' 0 C--N 1.326 -0.44 0 CA-C-N 115.981 -0.554 . . . . 0.0 109.719 179.471 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' D' D ' 75' ' ' VAL . . . . . . . . . . . . . 46.0 t -112.27 120.11 61.77 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.264 0 CA-C-O 121.238 0.542 . . . . 0.0 110.279 -178.943 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' D' D ' 76' ' ' LEU . . . . . . . . . . . . . 23.4 mt -122.67 144.33 49.21 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 115.408 -0.815 . . . . 0.0 109.446 179.53 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' D' D ' 77' ' ' GLU . . . . . . . . . . . . . 45.9 mt-10 -135.64 137.31 41.74 Favored 'General case' 0 N--CA 1.463 0.212 0 CA-C-O 121.219 0.533 . . . . 0.0 111.688 -176.914 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' D' D ' 78' ' ' ALA . . . . . 0.606 ' HB2' HD21 ' D' ' 109' ' ' LEU . . . -126.52 131.6 51.56 Favored 'General case' 0 C--N 1.332 -0.184 0 CA-C-N 115.507 -0.77 . . . . 0.0 109.725 175.558 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' D' D ' 79' ' ' LYS . . . . . 0.522 ' O ' HD13 ' D' ' 80' ' ' ILE . 64.7 mttp -81.32 118.46 22.66 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-O 120.832 0.349 . . . . 0.0 110.718 -177.913 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' D' D ' 80' ' ' ILE . . . . . 0.522 HD13 ' O ' ' D' ' 79' ' ' LYS . 24.8 mm -139.26 114.71 8.57 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.306 0 N-CA-C 109.57 -0.53 . . . . 0.0 109.57 -177.91 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' D' D ' 81' ' ' LYS . . . . . . . . . . . . . 97.9 mttt -98.64 123.71 43.0 Favored 'General case' 0 C--N 1.33 -0.28 0 C-N-CA 120.907 -0.317 . . . . 0.0 110.993 -179.938 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' D' D ' 82' ' ' GLY . . . . . . . . . . . . . . . 89.21 42.18 5.64 Favored Glycine 0 CA--C 1.524 0.654 0 C-N-CA 120.676 -0.773 . . . . 0.0 112.168 173.057 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' D' D ' 83' ' ' ILE . . . . . . . . . . . . . 73.5 mt -65.4 133.23 30.85 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.279 0 N-CA-C 109.314 -0.625 . . . . 0.0 109.314 175.194 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' D' D ' 84' ' ' LYS . . . . . . . . . . . . . 28.2 ttpp -97.71 -53.14 3.51 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-O 120.981 0.42 . . . . 0.0 110.51 -176.734 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' D' D ' 85' ' ' ASP . . . . . . . . . . . . . 13.9 t70 -147.54 146.67 29.53 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 115.868 -0.606 . . . . 0.0 110.396 -179.475 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' D' D ' 86' ' ' VAL . . . . . . . . . . . . . 45.0 t -128.91 129.39 68.17 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.299 0 CA-C-O 121.01 0.433 . . . . 0.0 110.545 -179.53 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' D' D ' 87' ' ' ILE . . . . . . . . . . . . . 43.6 mm -116.46 121.87 68.55 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.274 0 N-CA-C 109.087 -0.709 . . . . 0.0 109.087 175.451 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' D' D ' 88' ' ' LEU . . . . . . . . . . . . . 10.0 tp -114.93 131.58 56.84 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-O 121.047 0.451 . . . . 0.0 111.327 -174.907 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' D' D ' 89' ' ' ASP . . . . . . . . . . . . . 12.8 t70 -129.62 152.28 49.3 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 115.697 -0.683 . . . . 0.0 109.358 175.359 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' D' D ' 90' ' ' GLU . . . . . . . . . . . . . 95.9 mt-10 -50.65 -31.61 16.72 Favored 'General case' 0 C--N 1.328 -0.366 0 N-CA-C 112.477 0.547 . . . . 0.0 112.477 -173.115 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' D' D ' 91' ' ' ASN . . . . . . . . . . . . . 23.6 p30 -128.54 27.69 5.51 Favored 'General case' 0 N--CA 1.465 0.32 0 N-CA-C 112.607 0.595 . . . . 0.0 112.607 -175.779 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' D' D ' 92' ' ' LEU . . . . . . . . . . . . . 15.1 tp -166.11 143.11 5.24 Favored 'General case' 0 C--N 1.331 -0.196 0 C-N-CA 121.074 -0.25 . . . . 0.0 110.662 179.445 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' D' D ' 93' ' ' ILE . . . . . . . . . . . . . 75.6 mt -126.17 119.66 54.78 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.263 0 N-CA-C 109.552 -0.536 . . . . 0.0 109.552 178.082 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' D' D ' 94' ' ' VAL . . . . . . . . . . . . . 43.8 t -118.3 124.16 72.69 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.255 0 N-CA-C 109.627 -0.509 . . . . 0.0 109.627 178.954 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' D' D ' 95' ' ' VAL . . . . . . . . . . . . . 44.7 t -121.38 132.65 70.15 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.275 0 CA-C-N 116.233 -0.44 . . . . 0.0 109.934 -178.586 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' D' D ' 96' ' ' ILE . . . . . . . . . . . . . 67.7 mt -115.58 127.36 73.18 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 N-CA-C 109.244 -0.65 . . . . 0.0 109.244 179.128 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' D' D ' 97' ' ' THR . . . . . . . . . . . . . 80.5 p -101.47 159.68 15.08 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-O 121.364 0.602 . . . . 0.0 111.48 -176.18 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' D' D ' 98' ' ' GLU . . . . . . . . . . . . . 84.4 tt0 -53.95 -26.46 25.75 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 115.836 -0.62 . . . . 0.0 112.264 179.965 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' D' D ' 99' ' ' GLU . . . . . . . . . . . . . 43.3 mt-10 -79.49 15.64 1.24 Allowed 'General case' 0 CA--C 1.534 0.35 0 N-CA-C 113.115 0.783 . . . . 0.0 113.115 -177.169 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' D' D ' 100' ' ' ASN . . . . . . . . . . . . . 3.2 m-20 61.3 38.02 16.7 Favored 'General case' 0 N--CA 1.463 0.183 0 CA-C-O 121.16 0.505 . . . . 0.0 110.962 178.948 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' D' D ' 101' ' ' GLU . . . . . . . . . . . . . 84.1 tt0 -117.47 142.1 47.55 Favored 'General case' 0 C--N 1.333 -0.14 0 N-CA-C 109.636 -0.505 . . . . 0.0 109.636 176.308 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' D' D ' 102' ' ' VAL . . . . . . . . . . . . . 43.0 t -114.94 126.15 72.44 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.351 0 N-CA-C 109.947 -0.39 . . . . 0.0 109.947 -179.149 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' D' D ' 103' ' ' LEU . . . . . . . . . . . . . 45.7 mt -115.95 133.34 56.13 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 115.728 -0.669 . . . . 0.0 109.948 177.179 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' D' D ' 104' ' ' ILE . . . . . 0.641 HD13 HG11 ' D' ' 130' ' ' VAL . 68.2 mt -118.35 120.71 65.18 Favored 'Isoleucine or valine' 0 C--O 1.233 0.221 0 N-CA-C 110.112 -0.329 . . . . 0.0 110.112 -179.475 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' D' D ' 105' ' ' PHE . . . . . . . . . . . . . 55.8 m-85 -122.8 167.35 13.62 Favored 'General case' 0 C--N 1.332 -0.158 0 O-C-N 124.011 0.82 . . . . 0.0 109.933 -179.694 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' D' D ' 106' ' ' ASN . . . . . . . . . . . . . 41.2 p-10 -101.48 -170.84 1.89 Allowed 'General case' 0 C--N 1.331 -0.205 0 N-CA-C 109.95 -0.389 . . . . 0.0 109.95 172.922 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' D' D ' 107' ' ' GLN . . . . . . . . . . . . . 47.4 tt0 -60.57 -29.99 69.51 Favored 'General case' 0 C--N 1.33 -0.273 0 N-CA-C 111.904 0.335 . . . . 0.0 111.904 179.754 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' D' D ' 108' ' ' ASN . . . . . . . . . . . . . 10.8 t30 -82.18 7.41 13.7 Favored 'General case' 0 CA--C 1.537 0.443 0 N-CA-C 113.143 0.794 . . . . 0.0 113.143 -178.026 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' D' D ' 109' ' ' LEU . . . . . 0.606 HD21 ' HB2' ' D' ' 78' ' ' ALA . 10.0 tp 62.31 36.67 14.45 Favored 'General case' 0 CA--C 1.53 0.204 0 CA-C-O 120.881 0.372 . . . . 0.0 111.393 178.082 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' D' D ' 110' ' ' GLU . . . . . . . . . . . . . 70.7 mm-40 -104.57 155.55 18.73 Favored 'General case' 0 C--N 1.33 -0.243 0 N-CA-C 109.503 -0.554 . . . . 0.0 109.503 175.348 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' D' D ' 111' ' ' GLU . . . . . . . . . . . . . 66.2 tt0 -91.07 124.68 35.48 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-O 120.982 0.42 . . . . 0.0 111.0 -176.003 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' D' D ' 112' ' ' LEU . . . . . . . . . . . . . 23.8 mt -108.77 -45.93 3.73 Favored 'General case' 0 C--N 1.331 -0.204 0 CA-C-N 116.097 -0.501 . . . . 0.0 110.861 179.264 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' D' D ' 113' ' ' TYR . . . . . 0.463 ' HB3' HD12 ' D' ' 104' ' ' ILE . 51.1 t80 -138.32 143.18 39.83 Favored 'General case' 0 N--CA 1.462 0.174 0 C-N-CA 120.835 -0.346 . . . . 0.0 111.074 -178.027 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' D' D ' 114' ' ' ARG . . . . . . . . . . . . . 36.2 ptt-85 -142.57 127.8 18.7 Favored 'General case' 0 C--N 1.331 -0.217 0 CA-C-N 116.274 -0.421 . . . . 0.0 110.85 177.094 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' D' D ' 115' ' ' GLY . . . . . . . . . . . . . . . -150.15 141.72 9.04 Favored Glycine 0 CA--C 1.524 0.621 0 N-CA-C 111.439 -0.665 . . . . 0.0 111.439 178.559 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' D' D ' 116' ' ' LYS . . . . . . . . . . . . . 39.5 ttpt -111.74 134.38 53.34 Favored 'General case' 0 C--N 1.331 -0.198 0 N-CA-C 109.485 -0.561 . . . . 0.0 109.485 175.101 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' D' D ' 117' ' ' PHE . . . . . . . . . . . . . 42.1 m-85 -135.79 113.95 11.4 Favored 'General case' 0 C--N 1.331 -0.225 0 CA-C-O 120.967 0.413 . . . . 0.0 110.394 -175.912 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' D' D ' 118' ' ' GLU . . . . . . . . . . . . . 70.7 mm-40 -55.13 -48.76 73.2 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.313 -0.403 . . . . 0.0 111.257 -175.811 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' D' D ' 119' ' ' ASN . . . . . . . . . . . . . 11.7 m-80 -96.01 31.05 2.23 Favored 'General case' 0 C--N 1.328 -0.344 0 N-CA-C 112.149 0.426 . . . . 0.0 112.149 -174.04 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' D' D ' 120' ' ' LEU . . . . . . . . . . . . . 15.7 tp -56.48 122.23 11.48 Favored 'General case' 0 C--N 1.332 -0.175 0 CA-C-O 120.686 0.279 . . . . 0.0 110.391 177.538 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' D' D ' 121' ' ' ASN . . . . . . . . . . . . . 12.5 t-20 -112.17 -44.12 3.46 Favored 'General case' 0 C--N 1.332 -0.18 0 CA-C-N 116.488 -0.323 . . . . 0.0 110.846 -176.027 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' D' D ' 122' ' ' LYS . . . . . . . . . . . . . 98.3 mttt -146.37 149.61 34.1 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-O 121.112 0.482 . . . . 0.0 111.51 -178.489 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' D' D ' 123' ' ' VAL . . . . . . . . . . . . . 46.4 t -130.31 126.33 61.14 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.289 0 N-CA-C 109.25 -0.648 . . . . 0.0 109.25 172.928 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' D' D ' 124' ' ' LEU . . . . . 0.453 HD22 HD12 ' E' ' 88' ' ' LEU . 6.2 mp -114.71 137.09 52.34 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-O 120.824 0.345 . . . . 0.0 111.0 -176.52 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' D' D ' 125' ' ' VAL . . . . . . . . . . . . . 44.3 t -122.83 132.15 71.88 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.179 0 CA-C-N 115.911 -0.586 . . . . 0.0 109.939 179.861 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' D' D ' 126' ' ' ARG . . . . . . . . . . . . . 25.7 mmt180 -134.86 104.66 6.08 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 116.124 -0.489 . . . . 0.0 110.215 178.021 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' D' D ' 127' ' ' ASN . . . . . . . . . . . . . 35.0 m120 53.98 -104.98 0.23 Allowed 'General case' 0 CA--C 1.544 0.733 0 CA-C-O 119.053 -0.499 . . . . 0.0 110.922 179.75 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' D' D ' 128' ' ' ASP . . . . . . . . . . . . . 13.8 p-10 -112.33 2.65 16.6 Favored 'General case' 0 CA--C 1.536 0.431 0 CA-C-N 119.579 1.081 . . . . 0.0 113.498 -177.574 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' D' D ' 129' ' ' LEU . . . . . . . . . . . . . 26.1 mt -105.01 148.66 26.51 Favored 'General case' 0 C--O 1.231 0.124 0 N-CA-C 109.726 -0.472 . . . . 0.0 109.726 177.263 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' D' D ' 130' ' ' VAL . . . . . 0.641 HG11 HD13 ' D' ' 104' ' ' ILE . 12.7 p -133.04 141.03 45.87 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.233 0 CA-C-O 121.301 0.572 . . . . 0.0 110.784 -177.682 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' D' D ' 131' ' ' VAL . . . . . 0.571 HG22 HD12 ' D' ' 140' ' ' LEU . 38.9 t -134.43 135.96 53.4 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 CA-C-N 115.716 -0.675 . . . . 0.0 109.924 178.909 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' D' D ' 132' ' ' ILE . . . . . . . . . . . . . 70.6 mt -113.87 132.21 63.53 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.366 0 N-CA-C 109.394 -0.595 . . . . 0.0 109.394 -178.717 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' D' D ' 133' ' ' ILE . . . . . . . . . . . . . 35.4 mm -117.31 120.39 64.78 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.261 0 CA-C-O 120.837 0.351 . . . . 0.0 110.78 -176.06 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' D' D ' 134' ' ' ASP . . . . . . . . . . . . . 9.3 p-10 -129.89 148.95 51.81 Favored 'General case' 0 C--N 1.329 -0.284 0 N-CA-C 109.419 -0.586 . . . . 0.0 109.419 175.179 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' D' D ' 135' ' ' GLU . . . . . . . . . . . . . 54.6 tt0 -50.03 -25.43 3.38 Favored 'General case' 0 C--N 1.327 -0.39 0 N-CA-C 112.746 0.647 . . . . 0.0 112.746 -172.414 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' D' D ' 136' ' ' GLN . . . . . . . . . . . . . 43.0 tt0 -89.86 -31.1 17.49 Favored 'General case' 0 C--O 1.233 0.208 0 N-CA-C 112.542 0.571 . . . . 0.0 112.542 -174.058 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' D' D ' 137' ' ' LYS . . . . . . . . . . . . . 25.1 pttm -164.07 174.09 11.74 Favored 'General case' 0 C--O 1.232 0.176 0 CA-C-O 121.434 0.635 . . . . 0.0 112.57 -174.373 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' D' D ' 138' ' ' LEU . . . . . 0.401 ' C ' HD23 ' D' ' 138' ' ' LEU . 7.4 tt -122.44 130.33 52.98 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 115.197 -0.91 . . . . 0.0 110.109 179.564 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' D' D ' 139' ' ' THR . . . . . 0.407 HG23 ' HG2' ' E' ' 77' ' ' GLU . 34.9 m -112.68 129.77 56.28 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-N 116.341 -0.39 . . . . 0.0 110.677 179.914 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' D' D ' 140' ' ' LEU . . . . . 0.571 HD12 HG22 ' D' ' 131' ' ' VAL . 19.5 tp -113.98 120.41 40.55 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 115.567 -0.742 . . . . 0.0 109.462 -178.241 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' D' D ' 141' ' ' ILE . . . . . 0.482 ' HB ' HG13 ' D' ' 130' ' ' VAL . 20.1 mt -120.3 119.49 60.07 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.281 0 CA-C-O 121.193 0.52 . . . . 0.0 109.93 -177.589 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' D' D ' 142' ' ' ARG . . . . . . . . . . . . . 84.6 mtm180 -111.17 133.29 53.64 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 114.941 -1.027 . . . . 0.0 110.689 -174.699 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' D' D ' 143' ' ' THR . . . . . . . . . . . . . 48.7 p . . . . . 0 C--O 1.22 -0.465 0 CA-C-O 118.03 -0.986 . . . . 0.0 110.371 179.588 . . . . . . . . 0 0 . 1 . 003 nuclear nobuild full ' E' E ' -3' ' ' GLU . . . . . . . . . . . . . 84.5 tt0 . . . . . 0 N--CA 1.49 1.538 0 N-CA-C 109.515 -0.55 . . . . 0.0 109.515 . . . . . . . . . 0 0 . 1 . 003 nuclear nobuild full ' E' E ' -2' ' ' GLY . . . . . . . . . . . . . . . -76.4 121.68 6.19 Favored Glycine 0 CA--C 1.525 0.712 0 N-CA-C 111.117 -0.793 . . . . 0.0 111.117 -179.432 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' E' E ' -1' ' ' VAL . . . . . . . . . . . . . 45.1 t -97.07 134.78 33.53 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.283 0 N-CA-C 110.053 -0.351 . . . . 0.0 110.053 178.684 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' E' E ' 0' ' ' ILE . . . . . . . . . . . . . 73.4 mt -115.14 132.44 64.4 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.203 0 CA-C-N 116.244 -0.435 . . . . 0.0 109.998 -179.683 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' E' E ' 1' ' ' MET . . . . . . . . . . . . . 25.6 ptt? -81.13 150.68 28.61 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.433 179.277 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' E' E ' 2' ' ' SER . . . . . . . . . . . . . 15.9 p -130.33 148.87 52.2 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.338 -0.392 . . . . 0.0 110.949 -178.997 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' E' E ' 3' ' ' GLU . . . . . . . . . . . . . 95.7 mt-10 -140.61 139.33 34.88 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 115.992 -0.549 . . . . 0.0 110.927 -179.864 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' E' E ' 4' ' ' LEU . . . . . . . . . . . . . 17.4 tp -122.94 126.76 47.84 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-N 116.071 -0.513 . . . . 0.0 110.155 176.533 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' E' E ' 5' ' ' LYS . . . . . . . . . . . . . 86.4 mttt -106.96 121.6 44.76 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.3 -0.409 . . . . 0.0 110.711 179.024 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' E' E ' 6' ' ' LEU . . . . . . . . . . . . . 75.9 mt -116.78 151.3 36.74 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 115.46 -0.791 . . . . 0.0 110.58 -179.394 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' E' E ' 7' ' ' LYS . . . . . . . . . . . . . 33.9 ttpt -140.32 142.14 28.58 Favored Pre-proline 0 CA--C 1.534 0.338 0 N-CA-C 109.764 -0.458 . . . . 0.0 109.764 175.088 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' E' E ' 8' ' ' PRO . . . . . . . . . . . . . 92.2 Cg_endo -89.03 147.91 5.6 Favored 'Trans proline' 0 N--CA 1.491 1.372 0 C-N-CA 121.654 1.569 . . . . 0.0 112.024 -179.896 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' E' E ' 9' ' ' LEU . . . . . . . . . . . . . 84.3 mt -84.23 -52.07 0.56 Allowed Pre-proline 0 C--N 1.329 -0.284 0 CA-C-O 118.855 -0.593 . . . . 0.0 111.551 -179.94 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' E' E ' 10' ' ' PRO . . . . . . . . . . . . . 61.6 Cg_endo -73.43 155.66 50.56 Favored 'Trans proline' 0 N--CA 1.498 1.762 0 C-N-CA 121.093 1.196 . . . . 0.0 111.898 173.469 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' E' E ' 11' ' ' LYS . . . . . . . . . . . . . 62.1 mtpt -89.07 98.93 12.04 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.433 -0.349 . . . . 0.0 110.749 179.207 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' E' E ' 12' ' ' VAL . . . . . . . . . . . . . 12.6 p -142.68 142.58 26.5 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.288 0 CA-C-N 116.335 -0.393 . . . . 0.0 110.667 179.809 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' E' E ' 13' ' ' GLU . . . . . . . . . . . . . 45.1 mp0 -84.74 128.28 34.53 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 116.267 -0.424 . . . . 0.0 109.86 176.754 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' E' E ' 14' ' ' LEU . . . . . . . . . . . . . 32.3 mt -98.5 148.99 35.29 Favored Pre-proline 0 CA--C 1.533 0.293 0 CA-C-O 119.197 -0.43 . . . . 0.0 110.499 -177.585 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' E' E ' 15' ' ' PRO . . . . . . . . . . . . . 26.3 Cg_exo -62.37 159.96 33.44 Favored 'Trans proline' 0 N--CA 1.497 1.71 0 C-N-CA 121.245 1.296 . . . . 0.0 111.478 174.869 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' E' E ' 16' ' ' PRO . . . . . . . . . . . . . 38.6 Cg_exo -58.68 -34.34 98.86 Favored 'Trans proline' 0 N--CA 1.496 1.666 0 C-N-CA 121.413 1.409 . . . . 0.0 112.899 -178.32 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' E' E ' 17' ' ' ASP . . . . . . . . . . . . . 22.9 p-10 -91.4 8.43 36.3 Favored 'General case' 0 CA--C 1.534 0.362 0 N-CA-C 113.341 0.867 . . . . 0.0 113.341 -177.193 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' E' E ' 18' ' ' PHE . . . . . . . . . . . . . 52.3 t80 -58.19 -43.85 87.77 Favored 'General case' 0 N--CA 1.457 -0.093 0 O-C-N 121.944 -0.472 . . . . 0.0 110.058 -178.162 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' E' E ' 19' ' ' VAL . . . . . . . . . . . . . 48.7 t -58.17 -42.52 83.51 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.304 0 CA-C-N 116.207 -0.452 . . . . 0.0 110.234 -178.909 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' E' E ' 20' ' ' ASP . . . . . . . . . . . . . 7.5 t70 -59.92 -42.09 93.15 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-O 120.833 0.349 . . . . 0.0 110.83 -177.92 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' E' E ' 21' ' ' VAL . . . . . . . . . . . . . 48.3 t -64.73 -46.18 92.94 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.332 0 CA-C-N 116.405 -0.361 . . . . 0.0 110.483 -177.723 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' E' E ' 22' ' ' ILE . . . . . 0.627 HG22 HD12 ' E' ' 26' ' ' LEU . 29.3 mm -57.0 -45.13 83.74 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.257 0 N-CA-C 110.172 -0.307 . . . . 0.0 110.172 179.266 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' E' E ' 23' ' ' ARG . . . . . . . . . . . . . 2.3 tmm_? -54.39 -48.77 71.18 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-O 120.573 0.225 . . . . 0.0 111.246 -178.935 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' E' E ' 24' ' ' ILE . . . . . . . . . . . . . 72.8 mt -59.02 -42.98 87.91 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.316 0 C-N-CA 120.943 -0.303 . . . . 0.0 110.963 -177.828 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' E' E ' 25' ' ' LYS . . . . . . . . . . . . . 96.2 mttt -66.34 -41.7 89.21 Favored 'General case' 0 C--N 1.329 -0.293 0 N-CA-C 112.759 0.652 . . . . 0.0 112.759 -178.874 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' E' E ' 26' ' ' LEU . . . . . 0.627 HD12 HG22 ' E' ' 22' ' ' ILE . 48.6 mt -78.48 -37.31 43.65 Favored 'General case' 0 C--N 1.327 -0.372 0 N-CA-C 113.689 0.996 . . . . 0.0 113.689 -169.812 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' E' E ' 27' ' ' GLN . . . . . . . . . . . . . 10.4 pt20 -47.23 138.85 6.7 Favored 'General case' 0 N--CA 1.467 0.422 0 N-CA-C 112.765 0.654 . . . . 0.0 112.765 -175.261 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' E' E ' 28' ' ' GLY . . . . . . . . . . . . . . . 101.17 -24.53 31.52 Favored Glycine 0 CA--C 1.532 1.139 0 CA-C-N 115.552 -0.749 . . . . 0.0 112.405 -177.182 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' E' E ' 29' ' ' LYS . . . . . . . . . . . . . 86.5 mttt -98.4 155.06 17.42 Favored 'General case' 0 C--O 1.233 0.198 0 CA-C-N 117.594 0.697 . . . . 0.0 111.381 179.376 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' E' E ' 30' ' ' THR . . . . . . . . . . . . . 30.5 m -104.39 136.7 43.49 Favored 'General case' 0 C--N 1.331 -0.226 0 CA-C-N 116.011 -0.54 . . . . 0.0 110.268 177.42 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' E' E ' 31' ' ' VAL . . . . . . . . . . . . . 35.0 m -132.29 157.06 43.0 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.329 0 CA-C-N 116.327 -0.397 . . . . 0.0 110.831 -179.123 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' E' E ' 32' ' ' ARG . . . . . . . . . . . . . 96.9 mtt180 -132.12 154.84 49.08 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 115.954 -0.566 . . . . 0.0 110.44 176.673 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' E' E ' 33' ' ' THR . . . . . . . . . . . . . 29.1 m -53.53 138.13 34.71 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.307 -0.406 . . . . 0.0 111.279 -178.978 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' E' E ' 34' ' ' GLY . . . . . . . . . . . . . . . 100.16 -17.11 57.51 Favored Glycine 0 CA--C 1.532 1.107 0 CA-C-O 119.616 -0.547 . . . . 0.0 113.295 178.744 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' E' E ' 35' ' ' ASP . . . . . . . . . . . . . 54.1 m-20 -65.37 150.18 48.73 Favored 'General case' 0 C--N 1.334 -0.077 0 CA-C-N 118.019 0.909 . . . . 0.0 111.137 179.818 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' E' E ' 36' ' ' VAL . . . . . . . . . . . . . 44.6 t -121.56 130.0 75.02 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.233 0 CA-C-N 115.67 -0.696 . . . . 0.0 109.76 178.536 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' E' E ' 37' ' ' ILE . . . . . . . . . . . . . 69.7 mt -119.31 138.66 49.27 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.29 0 CA-C-N 116.275 -0.421 . . . . 0.0 109.923 -179.636 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' E' E ' 38' ' ' GLY . . . . . . . . . . . . . . . -112.27 128.95 8.77 Favored Glycine 0 CA--C 1.526 0.77 0 N-CA-C 111.086 -0.806 . . . . 0.0 111.086 -179.505 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' E' E ' 39' ' ' ILE . . . . . . . . . . . . . 71.1 mt -122.03 134.14 66.21 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.275 0 N-CA-C 109.899 -0.408 . . . . 0.0 109.899 178.895 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' E' E ' 40' ' ' SER . . . . . . . . . . . . . 53.8 p -93.39 122.71 36.08 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.323 -0.398 . . . . 0.0 110.857 175.509 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' E' E ' 41' ' ' ILE . . . . . . . . . . . . . 71.4 mt -131.85 114.37 24.57 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.225 0 N-CA-C 110.021 -0.363 . . . . 0.0 110.021 177.678 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' E' E ' 42' ' ' LEU . . . . . . . . . . . . . 7.9 mp 56.6 37.57 28.92 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-O 121.086 0.47 . . . . 0.0 111.074 -179.707 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' E' E ' 43' ' ' GLY . . . . . . . . . . . . . . . 77.42 -10.08 24.53 Favored Glycine 0 CA--C 1.534 1.219 0 C-N-CA 121.296 -0.478 . . . . 0.0 113.473 177.043 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' E' E ' 44' ' ' LYS . . . . . . . . . . . . . 68.7 mttm -93.99 132.97 37.93 Favored 'General case' 0 C--N 1.333 -0.121 0 CA-C-N 118.005 0.903 . . . . 0.0 110.069 178.093 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' E' E ' 45' ' ' GLU . . . . . . . . . . . . . 69.3 tt0 -86.46 127.28 34.83 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.172 -0.467 . . . . 0.0 111.04 -177.816 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' E' E ' 46' ' ' VAL . . . . . . . . . . . . . 7.2 p -124.84 128.13 73.04 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.198 0 CA-C-O 120.943 0.401 . . . . 0.0 109.98 176.627 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' E' E ' 47' ' ' LYS . . . . . . . . . . . . . 72.6 mmtt -100.08 133.91 43.78 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-N 115.972 -0.558 . . . . 0.0 111.525 177.631 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' E' E ' 48' ' ' PHE . . . . . . . . . . . . . 91.1 m-85 -116.34 131.98 56.79 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 115.907 -0.588 . . . . 0.0 109.782 174.046 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' E' E ' 49' ' ' LYS . . . . . . . . . . . . . 82.4 tttt -105.73 136.34 45.53 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.488 -0.324 . . . . 0.0 110.527 -179.927 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' E' E ' 50' ' ' VAL . . . . . . . . . . . . . 45.0 t -80.53 108.67 14.16 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.331 0 N-CA-C 109.196 -0.668 . . . . 0.0 109.196 176.089 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' E' E ' 51' ' ' VAL . . . . . . . . . . . . . 47.5 t -74.63 -47.21 39.75 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.289 0 CA-C-N 116.139 -0.482 . . . . 0.0 110.174 -172.968 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' E' E ' 52' ' ' GLN . . . . . . . . . . . . . 48.2 tt0 -164.85 138.49 4.9 Favored 'General case' 0 C--N 1.331 -0.236 0 C-N-CA 120.155 -0.618 . . . . 0.0 111.749 -177.954 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' E' E ' 53' ' ' ALA . . . . . . . . . . . . . . . -116.46 133.6 55.82 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 115.9 -0.591 . . . . 0.0 110.169 176.835 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' E' E ' 54' ' ' TYR . . . . . . . . . . . . . 38.5 t80 -129.13 112.47 18.4 Favored Pre-proline 0 CA--C 1.535 0.398 0 CA-C-O 118.154 -0.927 . . . . 0.0 110.171 177.607 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' E' E ' 55' ' ' PRO . . . . . . . . . . . . . 72.2 Cg_endo -77.09 168.72 76.23 Favored 'Cis proline' 0 N--CA 1.5 1.904 0 CA-C-N 122.082 1.779 . . . . 0.0 112.426 -5.346 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' E' E ' 56' ' ' SER . . . . . . . . . . . . . 13.6 m -117.57 134.08 23.21 Favored Pre-proline 0 CA--C 1.54 0.562 0 CA-C-O 118.455 -0.783 . . . . 0.0 109.595 174.764 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' E' E ' 57' ' ' PRO . . . . . . . . . . . . . 36.0 Cg_endo -66.36 164.7 65.68 Favored 'Cis proline' 0 N--CA 1.498 1.751 0 CA-C-N 121.862 1.701 . . . . 0.0 111.299 -3.177 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' E' E ' 58' ' ' LEU . . . . . . . . . . . . . 23.4 tp -129.96 138.82 51.06 Favored 'General case' 0 C--N 1.331 -0.222 0 CA-C-O 121.081 0.467 . . . . 0.0 110.584 179.61 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' E' E ' 59' ' ' ARG . . . . . . . . . . . . . 75.1 ttt180 -106.06 123.31 47.8 Favored 'General case' 0 C--N 1.329 -0.295 0 N-CA-C 109.084 -0.71 . . . . 0.0 109.084 174.115 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' E' E ' 60' ' ' VAL . . . . . . . . . . . . . 44.3 t -73.52 118.95 19.69 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.351 0 C-N-CA 120.735 -0.386 . . . . 0.0 110.166 -175.198 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' E' E ' 61' ' ' GLU . . . . . . . . . . . . . 95.0 mt-10 -131.05 162.43 29.84 Favored 'General case' 0 C--N 1.331 -0.222 0 CA-C-N 116.107 -0.497 . . . . 0.0 110.109 178.455 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' E' E ' 62' ' ' ASP . . . . . . . . . . . . . 65.2 m-20 -53.57 -32.84 52.58 Favored 'General case' 0 C--N 1.326 -0.427 0 N-CA-C 111.751 0.278 . . . . 0.0 111.751 -178.898 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' E' E ' 63' ' ' ARG . . . . . . . . . . . . . 27.6 mmm180 -72.69 -21.35 61.07 Favored 'General case' 0 C--N 1.33 -0.267 0 N-CA-C 113.054 0.761 . . . . 0.0 113.054 -176.159 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' E' E ' 64' ' ' THR . . . . . . . . . . . . . 29.6 m -72.56 139.37 47.47 Favored 'General case' 0 C--N 1.331 -0.21 0 CA-C-O 120.869 0.366 . . . . 0.0 111.183 -174.409 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' E' E ' 65' ' ' LYS . . . . . . . . . . . . . 13.1 mptt -89.04 134.34 34.03 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.009 -0.541 . . . . 0.0 109.982 178.68 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' E' E ' 66' ' ' ILE . . . . . . . . . . . . . 64.4 mt -116.96 131.75 68.72 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.326 0 CA-C-O 120.885 0.374 . . . . 0.0 110.076 -179.772 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' E' E ' 67' ' ' THR . . . . . . . . . . . . . 32.5 m -127.6 140.44 52.1 Favored 'General case' 0 C--N 1.332 -0.19 0 CA-C-N 116.047 -0.524 . . . . 0.0 110.821 -178.559 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' E' E ' 68' ' ' LEU . . . . . 0.428 ' C ' HD23 ' E' ' 68' ' ' LEU . 5.0 tt -102.85 120.97 41.54 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 115.994 -0.548 . . . . 0.0 109.649 177.044 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' E' E ' 69' ' ' VAL . . . . . . . . . . . . . 42.3 t -102.0 135.14 40.24 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.29 0 CA-C-O 120.982 0.42 . . . . 0.0 110.635 -176.091 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' E' E ' 70' ' ' THR . . . . . . . . . . . . . 11.4 m -147.18 92.42 2.11 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 115.857 -0.61 . . . . 0.0 109.976 177.934 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' E' E ' 71' ' ' HIS . . . . . . . . . . . . . 86.1 m-70 -145.8 153.0 49.78 Favored Pre-proline 0 CA--C 1.534 0.327 0 C-N-CA 120.746 -0.382 . . . . 0.0 111.029 -178.268 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' E' E ' 72' ' ' PRO . . . . . . . . . . . . . 93.8 Cg_endo -93.03 160.12 2.64 Favored 'Trans proline' 0 N--CA 1.488 1.187 0 C-N-CA 121.988 1.792 . . . . 0.0 111.511 173.483 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' E' E ' 73' ' ' VAL . . . . . . . . . . . . . 33.9 m -69.87 154.05 8.36 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.224 0 C-N-CA 120.739 -0.384 . . . . 0.0 110.41 -179.477 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' E' E ' 74' ' ' ASP . . . . . . . . . . . . . 7.3 t0 -95.34 126.44 40.65 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.009 -0.542 . . . . 0.0 110.228 -176.924 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' E' E ' 75' ' ' VAL . . . . . 0.444 ' C ' HD12 ' E' ' 76' ' ' LEU . 40.4 t -119.17 123.79 71.96 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.205 0 CA-C-O 121.025 0.44 . . . . 0.0 110.583 -178.514 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' E' E ' 76' ' ' LEU . . . . . 0.444 HD12 ' C ' ' E' ' 75' ' ' VAL . 6.3 mp -123.94 146.24 48.6 Favored 'General case' 0 C--N 1.331 -0.224 0 CA-C-N 115.828 -0.624 . . . . 0.0 109.908 176.195 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' E' E ' 77' ' ' GLU . . . . . 0.407 ' HG2' HG23 ' D' ' 139' ' ' THR . 45.9 mt-10 -135.69 136.86 41.22 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-O 121.011 0.434 . . . . 0.0 111.22 -178.883 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' E' E ' 78' ' ' ALA . . . . . 0.424 ' HB2' HD21 ' E' ' 109' ' ' LEU . . . -125.95 133.44 51.83 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 115.816 -0.629 . . . . 0.0 109.674 176.145 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' E' E ' 79' ' ' LYS . . . . . 0.565 ' O ' HD13 ' E' ' 80' ' ' ILE . 84.0 mttt -80.51 120.3 24.31 Favored 'General case' 0 C--N 1.331 -0.215 0 CA-C-O 121.091 0.472 . . . . 0.0 110.754 -178.199 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' E' E ' 80' ' ' ILE . . . . . 0.565 HD13 ' O ' ' E' ' 79' ' ' LYS . 43.1 mm -139.18 108.68 3.86 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.335 0 N-CA-C 108.961 -0.755 . . . . 0.0 108.961 -176.991 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' E' E ' 81' ' ' LYS . . . . . . . . . . . . . 68.8 mttm -97.84 126.73 43.36 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-O 120.877 0.37 . . . . 0.0 111.199 -176.265 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' E' E ' 82' ' ' GLY . . . . . . . . . . . . . . . 89.08 42.14 5.69 Favored Glycine 0 CA--C 1.527 0.791 0 C-N-CA 120.911 -0.662 . . . . 0.0 111.725 174.992 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' E' E ' 83' ' ' ILE . . . . . . . . . . . . . 75.5 mt -66.83 138.52 22.75 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.314 0 CA-C-O 120.945 0.402 . . . . 0.0 109.94 178.34 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' E' E ' 84' ' ' LYS . . . . . . . . . . . . . 83.8 tttt -99.22 -53.97 3.09 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 115.989 -0.55 . . . . 0.0 110.34 -178.815 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' E' E ' 85' ' ' ASP . . . . . . . . . . . . . 5.9 t0 -154.69 151.4 28.71 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-N 115.746 -0.661 . . . . 0.0 110.044 -178.943 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' E' E ' 86' ' ' VAL . . . . . . . . . . . . . 42.8 t -131.9 130.77 61.7 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.233 0 CA-C-O 120.961 0.41 . . . . 0.0 110.537 -179.181 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' E' E ' 87' ' ' ILE . . . . . . . . . . . . . 44.5 mm -119.04 128.89 75.78 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.221 0 CA-C-N 115.863 -0.608 . . . . 0.0 109.705 177.011 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' E' E ' 88' ' ' LEU . . . . . 0.453 HD12 HD22 ' D' ' 124' ' ' LEU . 27.5 mt -114.54 139.33 49.67 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-O 121.151 0.501 . . . . 0.0 111.463 -177.635 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' E' E ' 89' ' ' ASP . . . . . . . . . . . . . 11.6 t70 -132.96 156.83 46.56 Favored 'General case' 0 C--N 1.331 -0.23 0 CA-C-N 115.517 -0.765 . . . . 0.0 109.388 175.39 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' E' E ' 90' ' ' GLU . . . . . . . . . . . . . 96.0 mt-10 -48.44 -38.52 20.0 Favored 'General case' 0 C--N 1.327 -0.371 0 N-CA-C 112.796 0.665 . . . . 0.0 112.796 -171.507 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' E' E ' 91' ' ' ASN . . . . . . . . . . . . . 33.5 m120 -132.11 34.73 3.77 Favored 'General case' 0 N--CA 1.465 0.278 0 C-N-CA 120.961 -0.296 . . . . 0.0 111.703 -176.494 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' E' E ' 92' ' ' LEU . . . . . . . . . . . . . 9.7 tp -166.16 145.55 6.02 Favored 'General case' 0 C--N 1.33 -0.258 0 C-N-CA 120.885 -0.326 . . . . 0.0 110.717 -179.66 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' E' E ' 93' ' ' ILE . . . . . . . . . . . . . 67.7 mt -127.79 125.96 65.98 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.222 0 N-CA-C 109.711 -0.477 . . . . 0.0 109.711 178.989 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' E' E ' 94' ' ' VAL . . . . . . . . . . . . . 47.1 t -122.99 127.14 74.62 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.267 0 N-CA-C 109.797 -0.446 . . . . 0.0 109.797 178.868 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' E' E ' 95' ' ' VAL . . . . . . . . . . . . . 44.2 t -122.93 135.38 63.18 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.294 0 CA-C-N 116.328 -0.396 . . . . 0.0 110.061 -179.252 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' E' E ' 96' ' ' ILE . . . . . . . . . . . . . 61.9 mt -116.31 128.75 73.54 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.326 0 N-CA-C 109.304 -0.628 . . . . 0.0 109.304 179.341 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' E' E ' 97' ' ' THR . . . . . . . . . . . . . 75.7 p -101.67 157.09 17.08 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-O 121.191 0.52 . . . . 0.0 111.371 -177.353 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' E' E ' 98' ' ' GLU . . . . . . . . . . . . . 84.6 tt0 -53.99 -26.66 27.14 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-N 116.008 -0.542 . . . . 0.0 112.133 -179.793 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' E' E ' 99' ' ' GLU . . . . . . . . . . . . . 45.7 mp0 -79.14 16.25 0.99 Allowed 'General case' 0 CA--C 1.536 0.426 0 N-CA-C 113.013 0.746 . . . . 0.0 113.013 -177.931 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' E' E ' 100' ' ' ASN . . . . . . . . . . . . . 3.8 m-20 62.95 38.08 11.44 Favored 'General case' 0 C--O 1.233 0.186 0 CA-C-O 120.952 0.406 . . . . 0.0 110.939 177.397 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' E' E ' 101' ' ' GLU . . . . . . . . . . . . . 84.5 tt0 -116.49 142.5 46.78 Favored 'General case' 0 C--N 1.331 -0.221 0 CA-C-N 116.078 -0.51 . . . . 0.0 109.801 177.124 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' E' E ' 102' ' ' VAL . . . . . . . . . . . . . 46.4 t -115.12 126.46 72.71 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.22 0 N-CA-C 109.87 -0.419 . . . . 0.0 109.87 -178.615 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' E' E ' 103' ' ' LEU . . . . . . . . . . . . . 42.5 mt -118.29 133.43 55.9 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-N 115.692 -0.685 . . . . 0.0 110.249 177.098 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' E' E ' 104' ' ' ILE . . . . . . . . . . . . . 68.5 mt -118.1 123.36 71.53 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.316 0 N-CA-C 109.986 -0.375 . . . . 0.0 109.986 179.632 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' E' E ' 105' ' ' PHE . . . . . . . . . . . . . 75.4 m-85 -122.43 165.69 15.94 Favored 'General case' 0 C--N 1.332 -0.157 0 O-C-N 124.047 0.842 . . . . 0.0 109.607 -179.964 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' E' E ' 106' ' ' ASN . . . . . . . . . . . . . 50.5 p-10 -101.54 -171.23 1.95 Allowed 'General case' 0 C--N 1.331 -0.204 0 N-CA-C 110.002 -0.37 . . . . 0.0 110.002 174.996 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' E' E ' 107' ' ' GLN . . . . . . . . . . . . . 45.8 tt0 -59.13 -29.3 67.29 Favored 'General case' 0 C--N 1.329 -0.3 0 N-CA-C 112.003 0.372 . . . . 0.0 112.003 -179.733 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' E' E ' 108' ' ' ASN . . . . . . . . . . . . . 14.4 t-20 -84.55 10.48 10.89 Favored 'General case' 0 CA--C 1.536 0.42 0 N-CA-C 113.035 0.754 . . . . 0.0 113.035 -177.508 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' E' E ' 109' ' ' LEU . . . . . 0.424 HD21 ' HB2' ' E' ' 78' ' ' ALA . 8.7 tp 58.33 36.77 25.79 Favored 'General case' 0 CA--C 1.531 0.226 0 CA-C-O 121.046 0.45 . . . . 0.0 111.373 179.711 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' E' E ' 110' ' ' GLU . . . . . . . . . . . . . 43.4 mt-10 -103.65 152.84 21.31 Favored 'General case' 0 C--N 1.33 -0.244 0 N-CA-C 109.662 -0.496 . . . . 0.0 109.662 175.676 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' E' E ' 111' ' ' GLU . . . . . . . . . . . . . 58.9 tt0 -87.29 121.91 30.36 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-O 120.914 0.387 . . . . 0.0 110.763 -176.315 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' E' E ' 112' ' ' LEU . . . . . . . . . . . . . 13.8 mt -105.18 -46.06 4.34 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 115.978 -0.556 . . . . 0.0 110.834 -179.895 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' E' E ' 113' ' ' TYR . . . . . 0.413 ' CE1' HG21 ' F' ' 75' ' ' VAL . 65.3 t80 -139.91 143.75 36.79 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.299 -0.41 . . . . 0.0 111.221 -178.431 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' E' E ' 114' ' ' ARG . . . . . . . . . . . . . 38.8 ptt180 -144.55 123.28 12.59 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.096 -0.502 . . . . 0.0 110.796 178.128 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' E' E ' 115' ' ' GLY . . . . . . . . . . . . . . . -150.13 158.81 27.84 Favored Glycine 0 CA--C 1.525 0.703 0 N-CA-C 110.934 -0.866 . . . . 0.0 110.934 178.205 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' E' E ' 116' ' ' LYS . . . . . . . . . . . . . 37.4 ttpt -127.87 139.01 52.88 Favored 'General case' 0 C--N 1.331 -0.224 0 O-C-N 122.634 -0.333 . . . . 0.0 110.29 178.118 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' E' E ' 117' ' ' PHE . . . . . . . . . . . . . 39.8 m-85 -133.75 114.96 13.99 Favored 'General case' 0 C--N 1.329 -0.296 0 N-CA-C 110.0 -0.37 . . . . 0.0 110.0 -178.153 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' E' E ' 118' ' ' GLU . . . . . . . . . . . . . 84.3 tt0 -53.57 -43.2 68.33 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.64 -0.255 . . . . 0.0 111.542 -175.97 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' E' E ' 119' ' ' ASN . . . . . . . . . . . . . 82.3 m-20 -100.17 31.0 3.53 Favored 'General case' 0 C--N 1.33 -0.24 0 N-CA-C 112.154 0.428 . . . . 0.0 112.154 -174.185 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' E' E ' 120' ' ' LEU . . . . . 0.421 HD11 HG23 ' E' ' 132' ' ' ILE . 13.9 tp -54.97 121.04 7.82 Favored 'General case' 0 C--N 1.331 -0.207 0 CA-C-O 120.663 0.268 . . . . 0.0 110.745 178.716 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' E' E ' 121' ' ' ASN . . . . . . . . . . . . . 46.1 t30 -114.03 -43.93 3.2 Favored 'General case' 0 C--O 1.232 0.167 0 CA-C-N 116.598 -0.273 . . . . 0.0 111.516 -176.184 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' E' E ' 122' ' ' LYS . . . . . . . . . . . . . 57.9 mtpt -140.08 144.55 36.88 Favored 'General case' 0 C--N 1.332 -0.159 0 CA-C-O 120.938 0.399 . . . . 0.0 111.741 -176.084 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' E' E ' 123' ' ' VAL . . . . . . . . . . . . . 46.7 t -127.1 124.9 65.34 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 N-CA-C 109.381 -0.6 . . . . 0.0 109.381 174.078 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' E' E ' 124' ' ' LEU . . . . . . . . . . . . . 51.6 mt -126.73 139.32 53.23 Favored 'General case' 0 C--N 1.331 -0.201 0 CA-C-O 120.95 0.405 . . . . 0.0 110.967 -177.186 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' E' E ' 125' ' ' VAL . . . . . . . . . . . . . 34.9 m -132.01 139.03 51.28 Favored 'Isoleucine or valine' 0 C--N 1.333 -0.145 0 CA-C-N 116.017 -0.538 . . . . 0.0 110.911 -179.871 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' E' E ' 126' ' ' ARG . . . . . . . . . . . . . 77.1 mtp85 -140.52 109.41 6.04 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 115.958 -0.565 . . . . 0.0 110.29 175.422 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' E' E ' 127' ' ' ASN . . . . . . . . . . . . . 94.5 m-20 53.32 -104.9 0.22 Allowed 'General case' 0 CA--C 1.542 0.663 0 CA-C-O 119.067 -0.492 . . . . 0.0 111.136 -179.897 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' E' E ' 128' ' ' ASP . . . . . . . . . . . . . 14.6 p-10 -113.69 5.41 16.44 Favored 'General case' 0 CA--C 1.537 0.447 0 CA-C-N 119.496 1.044 . . . . 0.0 113.393 -177.334 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' E' E ' 129' ' ' LEU . . . . . . . . . . . . . 3.9 tt -105.11 131.51 52.51 Favored 'General case' 0 C--N 1.332 -0.154 0 N-CA-C 109.367 -0.605 . . . . 0.0 109.367 177.809 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' E' E ' 130' ' ' VAL . . . . . . . . . . . . . 44.2 t -120.6 137.05 55.64 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.218 0 CA-C-O 120.765 0.317 . . . . 0.0 110.165 -177.236 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' E' E ' 131' ' ' VAL . . . . . . . . . . . . . 41.8 t -135.95 138.07 48.0 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.249 0 CA-C-O 121.203 0.525 . . . . 0.0 110.459 178.926 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' E' E ' 132' ' ' ILE . . . . . 0.421 HG23 HD11 ' E' ' 120' ' ' LEU . 76.4 mt -119.93 134.0 64.87 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.324 0 CA-C-N 115.513 -0.767 . . . . 0.0 109.51 -179.739 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' E' E ' 133' ' ' ILE . . . . . . . . . . . . . 42.8 mm -117.21 125.32 73.89 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.23 0 CA-C-O 120.798 0.332 . . . . 0.0 110.865 -176.142 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' E' E ' 134' ' ' ASP . . . . . . . . . . . . . 7.7 p-10 -137.03 148.72 47.0 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.0 -0.545 . . . . 0.0 109.568 174.187 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' E' E ' 135' ' ' GLU . . . . . . . . . . . . . 43.5 tp10 -49.81 -25.88 3.48 Favored 'General case' 0 C--N 1.327 -0.377 0 N-CA-C 112.792 0.664 . . . . 0.0 112.792 -171.585 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' E' E ' 136' ' ' GLN . . . . . . . . . . . . . 97.3 mt-30 -96.5 -33.06 11.98 Favored 'General case' 0 CA--C 1.53 0.178 0 N-CA-C 112.476 0.547 . . . . 0.0 112.476 -175.995 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' E' E ' 137' ' ' LYS . . . . . . . . . . . . . 84.5 mttt -141.37 154.56 45.72 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-O 121.233 0.54 . . . . 0.0 111.697 -168.427 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' E' E ' 138' ' ' LEU . . . . . 0.407 ' C ' HD23 ' E' ' 138' ' ' LEU . 4.5 tt -117.56 119.68 35.74 Favored 'General case' 0 C--N 1.33 -0.246 0 N-CA-C 108.965 -0.754 . . . . 0.0 108.965 171.071 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' E' E ' 139' ' ' THR . . . . . . . . . . . . . 25.3 m -106.05 128.8 54.1 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.454 -0.339 . . . . 0.0 110.712 -176.53 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' E' E ' 140' ' ' LEU . . . . . 0.468 HD23 ' N ' ' E' ' 141' ' ' ILE . 5.4 tt -116.56 122.85 45.88 Favored 'General case' 0 C--N 1.329 -0.322 0 N-CA-C 109.068 -0.716 . . . . 0.0 109.068 -179.221 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' E' E ' 141' ' ' ILE . . . . . 0.468 ' N ' HD23 ' E' ' 140' ' ' LEU . 18.9 mt -121.99 118.79 56.69 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.288 0 CA-C-O 121.025 0.44 . . . . 0.0 109.981 -176.757 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' E' E ' 142' ' ' ARG . . . . . . . . . . . . . 84.4 mtp180 -103.7 125.27 50.08 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 115.285 -0.871 . . . . 0.0 110.341 -179.576 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' E' E ' 143' ' ' THR . . . . . . . . . . . . . 43.2 p . . . . . 0 C--O 1.22 -0.472 0 CA-C-O 118.015 -0.993 . . . . 0.0 110.527 -179.781 . . . . . . . . 0 0 . 1 . 003 nuclear nobuild full ' F' F ' -3' ' ' GLU . . . . . . . . . . . . . 95.6 mt-10 . . . . . 0 N--CA 1.49 1.554 0 N-CA-C 109.466 -0.568 . . . . 0.0 109.466 . . . . . . . . . 0 0 . 1 . 003 nuclear nobuild full ' F' F ' -2' ' ' GLY . . . . . . . . . . . . . . . -105.79 149.29 16.67 Favored Glycine 0 CA--C 1.525 0.659 0 N-CA-C 110.641 -0.984 . . . . 0.0 110.641 178.279 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' F' F ' -1' ' ' VAL . . . . . . . . . . . . . 46.6 t -95.1 134.16 33.45 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.347 0 N-CA-C 109.776 -0.453 . . . . 0.0 109.776 179.289 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' F' F ' 0' ' ' ILE . . . . . . . . . . . . . 70.7 mt -101.85 130.91 50.8 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.286 0 CA-C-N 116.211 -0.45 . . . . 0.0 110.073 -178.03 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' F' F ' 1' ' ' MET . . . . . . . . . . . . . 27.3 ptm -81.86 133.87 35.36 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 115.872 -0.604 . . . . 0.0 110.564 178.876 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' F' F ' 2' ' ' SER . . . . . . . . . . . . . 4.5 p -117.78 130.1 56.09 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.135 177.686 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' F' F ' 3' ' ' GLU . . . . . . . . . . . . . 83.3 tt0 -142.08 137.74 31.23 Favored 'General case' 0 C--N 1.327 -0.4 0 CA-C-N 115.988 -0.551 . . . . 0.0 111.062 -177.928 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' F' F ' 4' ' ' LEU . . . . . . . . . . . . . 17.1 tp -124.54 131.1 53.49 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.059 176.816 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' F' F ' 5' ' ' LYS . . . . . . . . . . . . . 69.0 mttm -110.28 122.29 47.3 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.305 -0.407 . . . . 0.0 110.602 179.962 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' F' F ' 6' ' ' LEU . . . . . . . . . . . . . 30.3 mt -113.88 149.44 35.12 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 115.234 -0.893 . . . . 0.0 109.954 -178.895 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' F' F ' 7' ' ' LYS . . . . . . . . . . . . . 52.4 tttp -137.11 137.15 22.03 Favored Pre-proline 0 CA--C 1.534 0.34 0 CA-C-O 118.857 -0.592 . . . . 0.0 109.994 175.569 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' F' F ' 8' ' ' PRO . . . . . . . . . . . . . 74.3 Cg_endo -91.45 138.41 2.18 Favored 'Trans proline' 0 N--CA 1.49 1.276 0 C-N-CA 121.675 1.583 . . . . 0.0 111.708 177.259 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' F' F ' 9' ' ' LEU . . . . . . . . . . . . . 58.1 mt -74.78 -48.18 4.92 Favored Pre-proline 0 CA--C 1.534 0.336 0 CA-C-O 118.629 -0.7 . . . . 0.0 112.277 -178.881 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' F' F ' 10' ' ' PRO . . . . . . . . . . . . . 95.3 Cg_endo -78.79 156.8 27.6 Favored 'Trans proline' 0 N--CA 1.496 1.653 0 C-N-CA 121.081 1.187 . . . . 0.0 112.008 177.381 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' F' F ' 11' ' ' LYS . . . . . . . . . . . . . 81.8 tttt -87.92 101.76 14.06 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.396 -0.365 . . . . 0.0 110.266 179.32 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' F' F ' 12' ' ' VAL . . . . . . . . . . . . . 12.3 p -143.57 149.3 18.2 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.295 0 CA-C-N 116.2 -0.454 . . . . 0.0 110.744 -178.313 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' F' F ' 13' ' ' GLU . . . . . . . . . . . . . 84.0 tt0 -91.43 127.6 36.94 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.302 -0.408 . . . . 0.0 109.989 177.598 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' F' F ' 14' ' ' LEU . . . . . . . . . . . . . 29.9 mt -98.83 146.04 30.97 Favored Pre-proline 0 CA--C 1.534 0.333 0 CA-C-O 119.183 -0.437 . . . . 0.0 110.632 -177.711 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' F' F ' 15' ' ' PRO . . . . . . . . . . . . . 23.8 Cg_exo -64.44 158.61 48.44 Favored 'Trans proline' 0 N--CA 1.497 1.707 0 C-N-CA 121.401 1.4 . . . . 0.0 111.777 174.309 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' F' F ' 16' ' ' PRO . . . . . . . . . . . . . 37.8 Cg_exo -57.98 -43.51 47.93 Favored 'Trans proline' 0 N--CA 1.496 1.648 0 C-N-CA 121.477 1.451 . . . . 0.0 112.97 -177.834 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' F' F ' 17' ' ' ASP . . . . . . . . . . . . . 23.2 p-10 -82.42 7.73 13.41 Favored 'General case' 0 CA--C 1.536 0.429 0 N-CA-C 113.252 0.834 . . . . 0.0 113.252 -177.615 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' F' F ' 18' ' ' PHE . . . . . . . . . . . . . 45.7 t80 -58.05 -45.11 87.57 Favored 'General case' 0 N--CA 1.458 -0.069 0 O-C-N 121.996 -0.44 . . . . 0.0 110.183 -178.179 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' F' F ' 19' ' ' VAL . . . . . 0.407 HG13 ' N ' ' F' ' 20' ' ' ASP . 14.4 p -56.98 -41.96 78.12 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.35 0 CA-C-N 116.34 -0.391 . . . . 0.0 110.935 -178.585 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' F' F ' 20' ' ' ASP . . . . . 0.407 ' N ' HG13 ' F' ' 19' ' ' VAL . 67.6 m-20 -60.85 -42.13 97.23 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-O 120.884 0.373 . . . . 0.0 110.9 -178.125 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' F' F ' 21' ' ' VAL . . . . . . . . . . . . . 52.9 t -64.36 -47.37 89.84 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.32 0 CA-C-N 116.374 -0.376 . . . . 0.0 110.353 -178.107 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' F' F ' 22' ' ' ILE . . . . . . . . . . . . . 51.0 mm -56.72 -43.49 79.47 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.283 0 CA-C-O 120.773 0.32 . . . . 0.0 110.479 178.764 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' F' F ' 23' ' ' ARG . . . . . . . . . . . . . 42.2 ttp180 -54.4 -49.12 70.66 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.632 -0.258 . . . . 0.0 111.432 -179.003 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' F' F ' 24' ' ' ILE . . . . . . . . . . . . . 73.4 mt -59.37 -43.72 90.88 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.284 0 C-N-CA 121.072 -0.251 . . . . 0.0 111.019 -178.071 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' F' F ' 25' ' ' LYS . . . . . . . . . . . . . 99.0 mttt -63.79 -41.8 97.87 Favored 'General case' 0 C--N 1.327 -0.382 0 N-CA-C 112.526 0.565 . . . . 0.0 112.526 -178.255 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' F' F ' 26' ' ' LEU . . . . . . . . . . . . . 93.3 mt -79.49 -41.64 26.98 Favored 'General case' 0 C--N 1.329 -0.318 0 N-CA-C 113.14 0.793 . . . . 0.0 113.14 -172.511 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' F' F ' 27' ' ' GLN . . . . . . . . . . . . . 9.5 pt20 -46.41 142.16 3.19 Favored 'General case' 0 N--CA 1.469 0.482 0 N-CA-C 112.9 0.704 . . . . 0.0 112.9 -173.581 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' F' F ' 28' ' ' GLY . . . . . . . . . . . . . . . 101.26 -29.85 11.64 Favored Glycine 0 CA--C 1.529 0.953 0 CA-C-N 115.15 -0.932 . . . . 0.0 111.941 -177.182 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' F' F ' 29' ' ' LYS . . . . . . . . . . . . . 93.3 mttt -98.62 155.18 17.43 Favored 'General case' 0 C--N 1.332 -0.173 0 CA-C-N 117.329 0.564 . . . . 0.0 111.129 177.981 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' F' F ' 30' ' ' THR . . . . . . . . . . . . . 34.8 m -102.58 138.91 38.86 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.163 -0.471 . . . . 0.0 110.063 176.657 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' F' F ' 31' ' ' VAL . . . . . . . . . . . . . 34.9 m -128.91 158.6 41.47 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.186 0 CA-C-N 116.413 -0.358 . . . . 0.0 110.808 -178.8 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' F' F ' 32' ' ' ARG . . . . . . . . . . . . . 96.9 mtt180 -130.79 151.74 50.89 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 115.922 -0.581 . . . . 0.0 110.5 178.735 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' F' F ' 33' ' ' THR . . . . . . . . . . . . . 18.4 m -53.97 138.78 36.13 Favored 'General case' 0 C--N 1.331 -0.239 0 CA-C-N 116.19 -0.459 . . . . 0.0 111.153 -179.519 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' F' F ' 34' ' ' GLY . . . . . . . . . . . . . . . 101.82 -17.12 55.29 Favored Glycine 0 CA--C 1.534 1.225 0 CA-C-O 119.618 -0.546 . . . . 0.0 113.191 -179.915 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' F' F ' 35' ' ' ASP . . . . . . . . . . . . . 56.7 m-20 -64.71 149.57 48.89 Favored 'General case' 0 C--O 1.232 0.14 0 CA-C-N 118.146 0.973 . . . . 0.0 111.29 179.434 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' F' F ' 36' ' ' VAL . . . . . . . . . . . . . 46.3 t -124.32 130.07 73.76 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.303 0 CA-C-N 115.698 -0.683 . . . . 0.0 109.845 179.565 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' F' F ' 37' ' ' ILE . . . . . . . . . . . . . 69.1 mt -121.97 139.42 49.05 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.219 0 CA-C-N 116.216 -0.447 . . . . 0.0 109.835 179.95 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' F' F ' 38' ' ' GLY . . . . . . . . . . . . . . . -114.41 128.88 8.41 Favored Glycine 0 CA--C 1.526 0.75 0 N-CA-C 110.943 -0.863 . . . . 0.0 110.943 -179.974 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' F' F ' 39' ' ' ILE . . . . . . . . . . . . . 70.8 mt -119.37 129.89 74.69 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.245 0 N-CA-C 109.929 -0.397 . . . . 0.0 109.929 179.059 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' F' F ' 40' ' ' SER . . . . . . . . . . . . . 22.8 t -93.74 118.9 32.03 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.437 -0.347 . . . . 0.0 110.788 175.732 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' F' F ' 41' ' ' ILE . . . . . . . . . . . . . 71.4 mt -124.76 117.06 49.2 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.269 0 CA-C-O 120.787 0.327 . . . . 0.0 110.315 178.808 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' F' F ' 42' ' ' LEU . . . . . . . . . . . . . 6.9 mp 51.04 36.93 16.52 Favored 'General case' 0 N--CA 1.463 0.21 0 CA-C-O 121.143 0.497 . . . . 0.0 111.548 178.17 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' F' F ' 43' ' ' GLY . . . . . . . . . . . . . . . 73.88 30.79 60.95 Favored Glycine 0 CA--C 1.529 0.941 0 C-N-CA 121.184 -0.531 . . . . 0.0 112.324 177.636 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' F' F ' 44' ' ' LYS . . . . . . . . . . . . . 64.1 mttp -132.5 127.21 34.71 Favored 'General case' 0 C--N 1.331 -0.233 0 N-CA-C 109.679 -0.489 . . . . 0.0 109.679 177.231 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' F' F ' 45' ' ' GLU . . . . . . . . . . . . . 80.2 tt0 -84.79 122.77 29.61 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-O 120.843 0.354 . . . . 0.0 111.215 -177.535 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' F' F ' 46' ' ' VAL . . . . . . . . . . . . . 7.6 p -122.2 126.45 74.34 Favored 'Isoleucine or valine' 0 C--O 1.233 0.186 0 N-CA-C 109.329 -0.619 . . . . 0.0 109.329 174.625 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' F' F ' 47' ' ' LYS . . . . . . . . . . . . . 93.7 mttt -100.33 130.48 46.44 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.123 -0.49 . . . . 0.0 111.342 179.871 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' F' F ' 48' ' ' PHE . . . . . . . . . . . . . 91.7 m-85 -114.21 131.79 56.34 Favored 'General case' 0 C--N 1.33 -0.267 0 N-CA-C 109.637 -0.505 . . . . 0.0 109.637 175.095 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' F' F ' 49' ' ' LYS . . . . . . . . . . . . . 37.2 tttp -109.38 139.9 43.76 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.452 -0.34 . . . . 0.0 110.542 179.846 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' F' F ' 50' ' ' VAL . . . . . . . . . . . . . 43.4 t -82.96 108.22 15.5 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.225 0 N-CA-C 109.267 -0.642 . . . . 0.0 109.267 175.513 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' F' F ' 51' ' ' VAL . . . . . . . . . . . . . 48.0 t -73.08 -53.08 19.48 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.32 0 CA-C-N 115.926 -0.579 . . . . 0.0 109.615 -174.404 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' F' F ' 52' ' ' GLN . . . . . . . . . . . . . 88.7 mt-30 -154.09 151.44 29.29 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.022 -0.535 . . . . 0.0 111.972 -177.493 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' F' F ' 53' ' ' ALA . . . . . . . . . . . . . . . -128.18 132.96 48.84 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 115.214 -0.903 . . . . 0.0 109.683 174.975 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' F' F ' 54' ' ' TYR . . . . . . . . . . . . . 25.7 t80 -129.07 108.41 18.06 Favored Pre-proline 0 CA--C 1.535 0.4 0 CA-C-O 118.327 -0.844 . . . . 0.0 110.256 179.07 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' F' F ' 55' ' ' PRO . . . . . . . . . . . . . 73.2 Cg_endo -77.16 169.0 75.4 Favored 'Cis proline' 0 N--CA 1.501 1.919 0 CA-C-N 121.853 1.698 . . . . 0.0 112.453 -5.205 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' F' F ' 56' ' ' SER . . . . . . . . . . . . . 54.3 m -116.72 130.42 24.56 Favored Pre-proline 0 CA--C 1.539 0.536 0 CA-C-O 118.413 -0.803 . . . . 0.0 109.229 174.819 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' F' F ' 57' ' ' PRO . . . . . . . . . . . . . 38.1 Cg_endo -67.15 164.65 70.31 Favored 'Cis proline' 0 N--CA 1.498 1.741 0 CA-C-N 121.991 1.747 . . . . 0.0 111.584 -0.282 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' F' F ' 58' ' ' LEU . . . . . . . . . . . . . 29.7 tp -129.75 136.2 49.35 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-N 116.26 -0.427 . . . . 0.0 110.297 179.702 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' F' F ' 59' ' ' ARG . . . . . . . . . . . . . 70.5 ttt180 -100.42 128.57 46.44 Favored 'General case' 0 C--N 1.326 -0.423 0 N-CA-C 109.188 -0.671 . . . . 0.0 109.188 176.244 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' F' F ' 60' ' ' VAL . . . . . . . . . . . . . 46.9 t -80.65 115.01 22.45 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.254 0 C-N-CA 120.588 -0.445 . . . . 0.0 110.096 -175.075 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' F' F ' 61' ' ' GLU . . . . . . . . . . . . . 95.3 mt-10 -130.99 160.53 34.29 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 115.841 -0.618 . . . . 0.0 109.758 178.221 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' F' F ' 62' ' ' ASP . . . . . . . . . . . . . 15.0 p-10 -53.25 -31.45 43.56 Favored 'General case' 0 C--N 1.327 -0.387 0 N-CA-C 111.925 0.343 . . . . 0.0 111.925 179.944 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' F' F ' 63' ' ' ARG . . . . . . . . . . . . . 39.7 mtp180 -71.86 -22.11 61.57 Favored 'General case' 0 CA--C 1.532 0.27 0 N-CA-C 112.894 0.701 . . . . 0.0 112.894 -176.095 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' F' F ' 64' ' ' THR . . . . . . . . . . . . . 34.2 m -72.73 141.13 48.16 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-O 121.013 0.435 . . . . 0.0 111.013 -175.612 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' F' F ' 65' ' ' LYS . . . . . . . . . . . . . 97.5 mttt -89.18 131.2 35.42 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 115.851 -0.613 . . . . 0.0 109.84 177.635 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' F' F ' 66' ' ' ILE . . . . . . . . . . . . . 59.9 mt -116.01 129.03 73.06 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.228 0 N-CA-C 109.798 -0.445 . . . . 0.0 109.798 179.37 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' F' F ' 67' ' ' THR . . . . . . . . . . . . . 23.8 m -127.05 142.63 51.49 Favored 'General case' 0 C--N 1.331 -0.227 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.892 -178.148 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' F' F ' 68' ' ' LEU . . . . . . . . . . . . . 6.7 mp -102.3 125.72 49.09 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.023 -0.535 . . . . 0.0 110.321 176.948 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' F' F ' 69' ' ' VAL . . . . . . . . . . . . . 44.2 t -102.07 123.73 55.48 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 CA-C-N 116.11 -0.496 . . . . 0.0 110.111 -179.889 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' F' F ' 70' ' ' THR . . . . . . . . . . . . . 78.0 p -150.07 120.34 7.32 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 115.944 -0.571 . . . . 0.0 110.088 178.401 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' F' F ' 71' ' ' HIS . . . . . . . . . . . . . 54.6 m-70 -132.43 60.04 47.88 Favored Pre-proline 0 CA--C 1.538 0.517 0 C-N-CA 120.945 -0.302 . . . . 0.0 111.449 179.711 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' F' F ' 72' ' ' PRO . . . . . . . . . . . . . 77.9 Cg_endo -88.36 144.93 5.92 Favored 'Trans proline' 0 N--CA 1.491 1.379 0 C-N-CA 121.569 1.513 . . . . 0.0 110.839 170.363 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' F' F ' 73' ' ' VAL . . . . . . . . . . . . . 24.5 m -83.51 130.55 35.62 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.231 0 CA-C-O 121.356 0.598 . . . . 0.0 110.933 -179.323 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' F' F ' 74' ' ' ASP . . . . . . . . . . . . . 12.3 t0 -99.41 124.1 44.25 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 115.404 -0.816 . . . . 0.0 108.981 176.053 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' F' F ' 75' ' ' VAL . . . . . 0.413 HG21 ' CE1' ' E' ' 113' ' ' TYR . 41.8 t -112.83 124.08 69.13 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.245 0 CA-C-O 121.072 0.463 . . . . 0.0 110.839 -174.35 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' F' F ' 76' ' ' LEU . . . . . . . . . . . . . 5.8 mp -125.76 146.87 49.59 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 115.549 -0.75 . . . . 0.0 109.638 175.394 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' F' F ' 77' ' ' GLU . . . . . . . . . . . . . 97.7 mt-10 -134.22 130.88 37.84 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-O 120.977 0.418 . . . . 0.0 110.889 -178.075 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' F' F ' 78' ' ' ALA . . . . . . . . . . . . . . . -114.47 134.21 55.18 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 115.709 -0.678 . . . . 0.0 109.502 176.806 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' F' F ' 79' ' ' LYS . . . . . 0.648 ' O ' HD13 ' F' ' 80' ' ' ILE . 25.7 pttm -77.55 119.31 20.95 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-O 121.472 0.653 . . . . 0.0 110.792 -178.644 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' F' F ' 80' ' ' ILE . . . . . 0.648 HD13 ' O ' ' F' ' 79' ' ' LYS . 36.6 mm -139.26 113.87 7.66 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.282 0 CA-C-N 115.546 -0.752 . . . . 0.0 109.103 -178.795 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' F' F ' 81' ' ' LYS . . . . . . . . . . . . . 24.5 pttm -114.32 128.01 56.14 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-O 120.991 0.424 . . . . 0.0 111.269 -177.252 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' F' F ' 82' ' ' GLY . . . . . . . . . . . . . . . 88.89 42.21 5.73 Favored Glycine 0 CA--C 1.527 0.794 0 N-CA-C 111.483 -0.647 . . . . 0.0 111.483 177.078 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' F' F ' 83' ' ' ILE . . . . . . . . . . . . . 72.9 mt -69.88 140.95 17.79 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 CA-C-O 120.871 0.367 . . . . 0.0 110.197 179.633 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' F' F ' 84' ' ' LYS . . . . . . . . . . . . . 54.7 tttp -101.6 -50.88 3.59 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-N 115.951 -0.568 . . . . 0.0 109.984 178.746 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' F' F ' 85' ' ' ASP . . . . . . . . . . . . . 6.5 t0 -153.71 149.26 27.31 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 115.792 -0.64 . . . . 0.0 110.402 -179.543 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' F' F ' 86' ' ' VAL . . . . . . . . . . . . . 42.1 t -132.2 129.73 60.13 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.185 0 CA-C-O 120.882 0.372 . . . . 0.0 110.319 -179.852 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' F' F ' 87' ' ' ILE . . . . . 0.494 HD12 ' N ' ' F' ' 87' ' ' ILE . 4.9 mp -120.1 126.65 75.5 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.245 0 N-CA-C 109.548 -0.538 . . . . 0.0 109.548 176.321 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' F' F ' 88' ' ' LEU . . . . . . . . . . . . . 59.0 mt -111.59 136.9 50.17 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-O 121.103 0.478 . . . . 0.0 111.263 -177.798 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' F' F ' 89' ' ' ASP . . . . . . . . . . . . . 12.6 t70 -129.49 153.66 47.77 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 115.646 -0.706 . . . . 0.0 109.285 175.742 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' F' F ' 90' ' ' GLU . . . . . . . . . . . . . 43.6 tp10 -48.47 -33.99 10.33 Favored 'General case' 0 C--N 1.329 -0.326 0 N-CA-C 112.918 0.71 . . . . 0.0 112.918 -172.011 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' F' F ' 91' ' ' ASN . . . . . . . . . . . . . 83.3 m-20 -131.25 27.54 4.79 Favored 'General case' 0 N--CA 1.466 0.343 0 N-CA-C 112.514 0.561 . . . . 0.0 112.514 -175.381 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' F' F ' 92' ' ' LEU . . . . . . . . . . . . . 6.6 tp -166.13 150.46 7.94 Favored 'General case' 0 C--N 1.331 -0.199 0 C-N-CA 120.83 -0.348 . . . . 0.0 110.752 -179.981 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' F' F ' 93' ' ' ILE . . . . . . . . . . . . . 71.8 mt -129.03 126.14 63.95 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.216 0 N-CA-C 109.693 -0.484 . . . . 0.0 109.693 178.927 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' F' F ' 94' ' ' VAL . . . . . . . . . . . . . 44.8 t -121.8 127.16 75.39 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.258 0 N-CA-C 109.735 -0.468 . . . . 0.0 109.735 178.8 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' F' F ' 95' ' ' VAL . . . . . . . . . . . . . 42.4 t -124.16 136.3 60.86 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.25 0 CA-C-N 116.091 -0.504 . . . . 0.0 110.054 -178.361 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' F' F ' 96' ' ' ILE . . . . . 0.559 HD11 ' HB ' ' F' ' 123' ' ' VAL . 47.3 mt -118.27 130.93 72.41 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.235 0 N-CA-C 109.37 -0.604 . . . . 0.0 109.37 179.306 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' F' F ' 97' ' ' THR . . . . . . . . . . . . . 67.3 p -103.16 157.21 17.16 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-O 121.1 0.476 . . . . 0.0 111.101 -178.586 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' F' F ' 98' ' ' GLU . . . . . . . . . . . . . 96.5 mt-10 -53.84 -26.01 22.35 Favored 'General case' 0 C--N 1.328 -0.354 0 N-CA-C 112.424 0.527 . . . . 0.0 112.424 -178.79 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' F' F ' 99' ' ' GLU . . . . . . . . . . . . . 95.7 mt-10 -79.62 16.8 1.0 Allowed 'General case' 0 CA--C 1.534 0.352 0 N-CA-C 113.213 0.82 . . . . 0.0 113.213 -176.126 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' F' F ' 100' ' ' ASN . . . . . . . . . . . . . 3.6 m-20 62.72 37.4 12.68 Favored 'General case' 0 C--O 1.234 0.24 0 CA-C-O 121.212 0.53 . . . . 0.0 111.038 178.136 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' F' F ' 101' ' ' GLU . . . . . . . . . . . . . 84.5 tt0 -117.65 139.85 50.44 Favored 'General case' 0 C--N 1.333 -0.142 0 N-CA-C 109.378 -0.601 . . . . 0.0 109.378 176.217 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' F' F ' 102' ' ' VAL . . . . . . . . . . . . . 45.0 t -117.57 129.89 73.32 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 N-CA-C 109.847 -0.427 . . . . 0.0 109.847 -177.377 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' F' F ' 103' ' ' LEU . . . . . . . . . . . . . 4.7 mp -123.09 137.99 54.78 Favored 'General case' 0 C--N 1.331 -0.219 0 CA-C-N 116.144 -0.48 . . . . 0.0 110.715 178.288 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' F' F ' 104' ' ' ILE . . . . . . . . . . . . . 65.5 mt -117.8 124.7 73.44 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.255 0 CA-C-N 115.802 -0.635 . . . . 0.0 109.882 179.989 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' F' F ' 105' ' ' PHE . . . . . . . . . . . . . 89.9 m-85 -122.43 161.47 23.45 Favored 'General case' 0 C--N 1.332 -0.187 0 O-C-N 123.969 0.793 . . . . 0.0 109.817 179.458 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' F' F ' 106' ' ' ASN . . . . . . . . . . . . . 47.2 p-10 -97.5 -171.35 2.17 Favored 'General case' 0 C--N 1.331 -0.209 0 N-CA-C 109.932 -0.396 . . . . 0.0 109.932 173.132 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' F' F ' 107' ' ' GLN . . . . . . . . . . . . . 48.4 tt0 -57.3 -30.12 64.47 Favored 'General case' 0 C--N 1.328 -0.348 0 N-CA-C 112.043 0.386 . . . . 0.0 112.043 -179.188 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' F' F ' 108' ' ' ASN . . . . . . . . . . . . . 13.0 t-20 -88.73 14.02 11.09 Favored 'General case' 0 CA--C 1.534 0.349 0 N-CA-C 112.973 0.731 . . . . 0.0 112.973 -175.612 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' F' F ' 109' ' ' LEU . . . . . . . . . . . . . 33.5 mt 57.97 33.4 23.15 Favored 'General case' 0 C--O 1.233 0.19 0 N-CA-C 111.756 0.28 . . . . 0.0 111.756 179.247 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' F' F ' 110' ' ' GLU . . . . . . . . . . . . . 43.3 mt-10 -98.05 145.24 26.73 Favored 'General case' 0 C--N 1.33 -0.277 0 N-CA-C 109.594 -0.521 . . . . 0.0 109.594 175.924 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' F' F ' 111' ' ' GLU . . . . . . . . . . . . . 53.7 tt0 -81.24 122.02 26.89 Favored 'General case' 0 C--N 1.328 -0.351 0 C-N-CA 120.725 -0.39 . . . . 0.0 110.487 -176.992 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' F' F ' 112' ' ' LEU . . . . . . . . . . . . . 58.2 mt -106.53 -46.09 4.09 Favored 'General case' 0 C--N 1.331 -0.226 0 CA-C-N 116.135 -0.484 . . . . 0.0 110.42 178.178 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' F' F ' 113' ' ' TYR . . . . . . . . . . . . . 64.6 t80 -138.36 137.08 36.98 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.134 -0.485 . . . . 0.0 111.169 -179.017 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' F' F ' 114' ' ' ARG . . . . . . . . . . . . . 56.1 ttp180 -141.45 121.29 13.55 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.277 -0.419 . . . . 0.0 109.949 174.848 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' F' F ' 115' ' ' GLY . . . . . . . . . . . . . . . -148.52 160.96 28.54 Favored Glycine 0 CA--C 1.524 0.595 0 N-CA-C 111.069 -0.812 . . . . 0.0 111.069 179.826 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' F' F ' 116' ' ' LYS . . . . . . . . . . . . . 40.2 ttpt -124.36 141.93 51.69 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-O 120.64 0.257 . . . . 0.0 110.385 -179.901 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' F' F ' 117' ' ' PHE . . . . . . . . . . . . . 47.4 m-85 -135.24 113.9 11.76 Favored 'General case' 0 C--N 1.332 -0.184 0 CA-C-O 120.907 0.384 . . . . 0.0 110.019 179.459 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' F' F ' 118' ' ' GLU . . . . . . . . . . . . . 82.1 tt0 -53.95 -51.69 63.03 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.457 -0.338 . . . . 0.0 111.376 -176.348 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' F' F ' 119' ' ' ASN . . . . . . . . . . . . . 87.6 m-20 -93.84 31.19 1.65 Allowed 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.052 -0.522 . . . . 0.0 112.19 -174.712 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' F' F ' 120' ' ' LEU . . . . . . . . . . . . . 12.9 tp -54.2 124.08 14.69 Favored 'General case' 0 N--CA 1.462 0.153 0 CA-C-O 120.624 0.249 . . . . 0.0 110.738 178.348 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' F' F ' 121' ' ' ASN . . . . . . . . . . . . . 12.4 m120 -112.15 -44.06 3.47 Favored 'General case' 0 C--O 1.232 0.137 0 CA-C-N 116.62 -0.264 . . . . 0.0 110.944 -176.679 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' F' F ' 122' ' ' LYS . . . . . . . . . . . . . 98.2 mttt -146.66 143.16 28.57 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-O 120.917 0.389 . . . . 0.0 111.387 -178.875 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' F' F ' 123' ' ' VAL . . . . . 0.559 ' HB ' HD11 ' F' ' 96' ' ' ILE . 46.5 t -126.77 127.43 70.01 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.314 0 N-CA-C 109.19 -0.67 . . . . 0.0 109.19 175.049 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' F' F ' 124' ' ' LEU . . . . . . . . . . . . . 13.9 tp -134.05 140.05 46.41 Favored 'General case' 0 C--N 1.331 -0.227 0 CA-C-O 120.947 0.403 . . . . 0.0 110.805 -176.797 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' F' F ' 125' ' ' VAL . . . . . . . . . . . . . 12.2 p -131.51 140.03 49.26 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.215 0 CA-C-N 116.239 -0.437 . . . . 0.0 110.335 178.492 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' F' F ' 126' ' ' ARG . . . . . . . . . . . . . 96.6 mtt-85 -136.97 124.24 21.85 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.064 -0.516 . . . . 0.0 110.402 179.297 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' F' F ' 127' ' ' ASN . . . . . . . . . . . . . 67.7 m-80 52.02 -106.46 0.27 Allowed 'General case' 0 CA--C 1.544 0.73 0 CA-C-O 119.044 -0.503 . . . . 0.0 111.104 179.997 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' F' F ' 128' ' ' ASP . . . . . . . . . . . . . 8.1 p-10 -114.09 1.67 14.68 Favored 'General case' 0 CA--C 1.536 0.414 0 CA-C-N 119.629 1.104 . . . . 0.0 113.459 -177.86 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' F' F ' 129' ' ' LEU . . . . . . . . . . . . . 29.3 mt -107.35 145.12 33.26 Favored 'General case' 0 C--N 1.333 -0.11 0 O-C-N 121.962 -0.461 . . . . 0.0 110.383 -178.571 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' F' F ' 130' ' ' VAL . . . . . . . . . . . . . 43.3 t -122.18 136.31 59.44 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.231 0 CA-C-O 120.909 0.385 . . . . 0.0 110.072 -178.109 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' F' F ' 131' ' ' VAL . . . . . . . . . . . . . 42.4 t -131.69 133.61 61.27 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.247 0 CA-C-N 116.209 -0.451 . . . . 0.0 109.812 177.651 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' F' F ' 132' ' ' ILE . . . . . . . . . . . . . 71.0 mt -119.68 132.14 70.25 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.317 0 CA-C-N 115.966 -0.561 . . . . 0.0 109.536 -179.143 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' F' F ' 133' ' ' ILE . . . . . . . . . . . . . 37.4 mm -116.84 123.39 71.69 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.331 0 CA-C-O 120.916 0.388 . . . . 0.0 110.855 -175.274 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' F' F ' 134' ' ' ASP . . . . . . . . . . . . . 9.3 p-10 -134.07 149.12 51.12 Favored 'General case' 0 C--N 1.329 -0.298 0 N-CA-C 109.606 -0.516 . . . . 0.0 109.606 174.661 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' F' F ' 135' ' ' GLU . . . . . . . . . . . . . 84.3 tt0 -49.87 -26.58 4.19 Favored 'General case' 0 C--N 1.327 -0.386 0 N-CA-C 112.71 0.633 . . . . 0.0 112.71 -173.283 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' F' F ' 136' ' ' GLN . . . . . . . . . . . . . 36.3 tt0 -84.72 -36.47 21.8 Favored 'General case' 0 C--O 1.234 0.289 0 N-CA-C 112.19 0.441 . . . . 0.0 112.19 -174.729 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' F' F ' 137' ' ' LYS . . . . . . . . . . . . . 20.4 pttp -163.08 171.7 16.02 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-O 121.539 0.685 . . . . 0.0 112.375 -171.32 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' F' F ' 138' ' ' LEU . . . . . 0.513 HD23 ' N ' ' F' ' 139' ' ' THR . 3.9 tt -116.33 127.64 54.86 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 114.995 -1.002 . . . . 0.0 109.661 178.808 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' F' F ' 139' ' ' THR . . . . . 0.513 ' N ' HD23 ' F' ' 138' ' ' LEU . 28.4 m -108.46 127.82 54.25 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-O 120.772 0.32 . . . . 0.0 110.676 -179.88 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' F' F ' 140' ' ' LEU . . . . . . . . . . . . . 10.0 tp -113.57 120.48 41.11 Favored 'General case' 0 C--N 1.328 -0.339 0 N-CA-C 109.175 -0.676 . . . . 0.0 109.175 -179.367 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' F' F ' 141' ' ' ILE . . . . . . . . . . . . . 18.9 mt -120.56 118.36 56.29 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.299 0 CA-C-O 120.986 0.422 . . . . 0.0 109.966 -174.76 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' F' F ' 142' ' ' ARG . . . . . . . . . . . . . 83.9 mtm180 -108.86 128.18 54.69 Favored 'General case' 0 C--N 1.332 -0.19 0 CA-C-N 115.543 -0.753 . . . . 0.0 110.318 -179.255 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' F' F ' 143' ' ' THR . . . . . . . . . . . . . 22.6 p . . . . . 0 C--O 1.22 -0.462 0 CA-C-O 117.94 -1.028 . . . . 0.0 110.669 -179.42 . . . . . . . . 0 0 . 1 . 004 nuclear nobuild full ' A' A ' -3' ' ' GLU . . . . . . . . . . . . . 42.4 mp0 . . . . . 0 N--CA 1.489 1.52 0 N-CA-C 109.361 -0.607 . . . . 0.0 109.361 . . . . . . . . . 0 0 . 1 . 004 nuclear nobuild full ' A' A ' -2' ' ' GLY . . . . . . . . . . . . . . . -97.81 142.01 15.91 Favored Glycine 0 CA--C 1.525 0.715 0 N-CA-C 111.099 -0.801 . . . . 0.0 111.099 -179.616 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' -1' ' ' VAL . . . . . . . . . . . . . 42.7 t -142.32 147.8 20.88 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.4 0 N-CA-C 109.929 -0.397 . . . . 0.0 109.929 179.652 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 0' ' ' ILE . . . . . . . . . . . . . 42.9 mm -96.67 131.93 42.27 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.284 0 CA-C-N 116.256 -0.429 . . . . 0.0 110.282 -179.604 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 24.9 ptp -80.27 146.85 31.44 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.136 -0.484 . . . . 0.0 110.636 -179.953 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 3.8 p -122.93 130.14 52.46 Favored 'General case' 0 N--CA 1.463 0.206 0 CA-C-O 121.065 0.459 . . . . 0.0 110.875 -179.202 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 95.6 mt-10 -140.32 139.57 35.46 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 115.737 -0.665 . . . . 0.0 110.904 -179.974 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 4' ' ' LEU . . . . . . . . . . . . . 18.6 tp -125.91 129.54 49.52 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 115.922 -0.581 . . . . 0.0 110.19 177.641 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 5' ' ' LYS . . . . . . . . . . . . . 64.0 mttp -111.65 121.12 44.29 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.393 -0.367 . . . . 0.0 110.784 179.892 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 18.8 mt -114.09 148.17 37.55 Favored 'General case' 0 C--N 1.332 -0.193 0 CA-C-N 115.52 -0.764 . . . . 0.0 109.771 179.449 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 48.4 tttp -126.09 137.88 31.06 Favored Pre-proline 0 CA--C 1.533 0.3 0 CA-C-O 118.863 -0.589 . . . . 0.0 109.842 174.954 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 8' ' ' PRO . . . . . . . . . . . . . 91.6 Cg_endo -90.51 134.93 2.02 Favored 'Trans proline' 0 N--CA 1.489 1.219 0 C-N-CA 121.729 1.619 . . . . 0.0 111.791 179.182 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 22.1 mt -80.16 -47.92 1.33 Allowed Pre-proline 0 CA--C 1.533 0.307 0 CA-C-O 118.654 -0.688 . . . . 0.0 112.238 -178.844 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 90.8 Cg_endo -79.53 152.26 22.98 Favored 'Trans proline' 0 N--CA 1.497 1.677 0 C-N-CA 121.065 1.176 . . . . 0.0 111.914 176.977 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 22.9 tptm -84.35 92.38 8.01 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.39 -0.368 . . . . 0.0 110.312 178.841 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 12.0 p -139.97 144.11 28.77 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.339 0 CA-C-N 116.151 -0.477 . . . . 0.0 110.441 179.957 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 95.5 mt-10 -89.18 122.23 32.26 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.339 -0.391 . . . . 0.0 110.194 178.063 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 14' ' ' LEU . . . . . . . . . . . . . 28.5 mt -93.91 144.77 28.67 Favored Pre-proline 0 C--N 1.329 -0.29 0 CA-C-O 118.971 -0.538 . . . . 0.0 109.99 -179.354 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 15' ' ' PRO . . . . . . . . . . . . . 31.0 Cg_exo -59.53 159.92 22.19 Favored 'Trans proline' 0 N--CA 1.498 1.757 0 C-N-CA 121.256 1.304 . . . . 0.0 111.713 179.095 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 16' ' ' PRO . . . . . . . . . . . . . 37.0 Cg_exo -58.59 -41.21 66.64 Favored 'Trans proline' 0 N--CA 1.496 1.648 0 C-N-CA 121.477 1.451 . . . . 0.0 112.757 -178.226 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 17' ' ' ASP . . . . . . . . . . . . . 19.1 p-10 -82.34 6.14 18.0 Favored 'General case' 0 CA--C 1.536 0.434 0 N-CA-C 113.274 0.842 . . . . 0.0 113.274 -178.008 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 18' ' ' PHE . . . . . . . . . . . . . 58.1 t80 -57.99 -45.18 87.22 Favored 'General case' 0 C--N 1.334 -0.084 0 O-C-N 121.938 -0.476 . . . . 0.0 110.119 -178.389 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 19' ' ' VAL . . . . . . . . . . . . . 48.3 t -56.33 -43.77 77.98 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.297 0 CA-C-N 116.291 -0.413 . . . . 0.0 110.628 -177.959 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 80.6 m-20 -60.31 -42.61 95.93 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.497 -0.32 . . . . 0.0 110.964 -178.068 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 45.6 t -64.01 -46.48 93.79 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.282 0 C-N-CA 120.846 -0.342 . . . . 0.0 110.56 -177.711 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 22' ' ' ILE . . . . . 0.517 HG22 HD12 ' A' ' 26' ' ' LEU . 50.8 mm -55.54 -46.02 78.85 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.241 0 CA-C-O 120.727 0.299 . . . . 0.0 110.549 178.649 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 23' ' ' ARG . . . . . . . . . . . . . 53.7 ttp180 -53.36 -49.15 67.74 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-O 120.711 0.291 . . . . 0.0 111.412 179.959 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 24' ' ' ILE . . . . . . . . . . . . . 73.9 mt -58.81 -40.54 80.18 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.306 0 CA-C-N 116.483 -0.326 . . . . 0.0 111.133 -178.345 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 51.4 mttm -70.91 -37.54 72.94 Favored 'General case' 0 C--N 1.329 -0.308 0 N-CA-C 112.511 0.56 . . . . 0.0 112.511 -178.272 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 26' ' ' LEU . . . . . 0.517 HD12 HG22 ' A' ' 22' ' ' ILE . 67.6 mt -78.73 -35.85 44.14 Favored 'General case' 0 C--N 1.33 -0.265 0 N-CA-C 113.199 0.814 . . . . 0.0 113.199 -170.062 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 27' ' ' GLN . . . . . . . . . . . . . 7.3 pt20 -46.57 135.98 8.07 Favored 'General case' 0 N--CA 1.468 0.426 0 N-CA-C 112.822 0.675 . . . . 0.0 112.822 -176.319 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 101.15 -20.69 46.35 Favored Glycine 0 CA--C 1.535 1.294 0 CA-C-N 115.759 -0.655 . . . . 0.0 112.644 -177.84 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 56.5 mtpt -97.12 155.11 16.96 Favored 'General case' 0 C--O 1.233 0.196 0 CA-C-N 117.695 0.747 . . . . 0.0 111.061 178.84 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 30' ' ' THR . . . . . . . . . . . . . 44.5 m -106.96 133.76 51.13 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 115.95 -0.568 . . . . 0.0 109.613 174.356 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 34.7 m -128.81 153.19 38.02 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.241 0 CA-C-O 121.017 0.437 . . . . 0.0 110.961 -177.43 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 32' ' ' ARG . . . . . . . . . . . . . 96.9 mtt180 -132.81 150.92 52.11 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 115.897 -0.592 . . . . 0.0 110.623 179.365 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 33' ' ' THR . . . . . . . . . . . . . 12.5 m -53.03 139.01 29.23 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.232 -0.44 . . . . 0.0 111.295 -178.638 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 100.65 -17.14 56.99 Favored Glycine 0 CA--C 1.532 1.109 0 C-N-CA 121.205 -0.521 . . . . 0.0 113.232 179.275 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 54.4 m-20 -64.48 151.07 45.3 Favored 'General case' 0 C--O 1.232 0.136 0 CA-C-N 118.099 0.949 . . . . 0.0 111.308 -179.621 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 47.5 t -125.04 128.33 72.96 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.258 0 CA-C-N 115.767 -0.651 . . . . 0.0 109.621 178.223 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 37' ' ' ILE . . . . . . . . . . . . . 64.1 mt -123.41 140.43 47.03 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.173 0 CA-C-N 116.29 -0.414 . . . . 0.0 110.039 -178.656 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . -115.07 128.77 8.26 Favored Glycine 0 CA--C 1.526 0.752 0 N-CA-C 110.815 -0.914 . . . . 0.0 110.815 178.179 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 39' ' ' ILE . . . . . . . . . . . . . 74.5 mt -126.42 138.08 55.79 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.221 0 CA-C-O 120.75 0.31 . . . . 0.0 110.205 -179.907 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 40' ' ' SER . . . . . . . . . . . . . 35.1 t -91.51 113.94 26.34 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.616 175.491 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 41' ' ' ILE . . . . . . . . . . . . . 45.3 mm -119.66 119.99 62.08 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.214 0 CA-C-O 120.76 0.314 . . . . 0.0 110.415 -179.852 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 37.3 mt 52.74 35.08 17.62 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.192 -0.458 . . . . 0.0 111.744 177.007 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . 73.25 31.0 61.91 Favored Glycine 0 CA--C 1.529 0.947 0 C-N-CA 121.106 -0.569 . . . . 0.0 112.264 177.976 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 44' ' ' LYS . . . . . . . . . . . . . 21.0 tptp -141.36 130.8 23.79 Favored 'General case' 0 C--N 1.329 -0.315 0 N-CA-C 109.548 -0.538 . . . . 0.0 109.548 178.142 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 82.7 tt0 -81.53 121.62 26.53 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-O 120.883 0.373 . . . . 0.0 111.277 -176.397 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 46' ' ' VAL . . . . . . . . . . . . . 9.0 p -119.61 124.5 73.02 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.175 0 N-CA-C 109.564 -0.532 . . . . 0.0 109.564 175.754 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 97.7 mttt -98.83 128.71 45.11 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 116.09 -0.505 . . . . 0.0 110.843 178.326 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 48' ' ' PHE . . . . . . . . . . . . . 30.1 m-85 -113.63 131.81 55.99 Favored 'General case' 0 C--N 1.33 -0.267 0 N-CA-C 109.86 -0.422 . . . . 0.0 109.86 177.862 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 83.1 tttt -107.24 135.79 48.16 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 116.39 -0.368 . . . . 0.0 110.193 177.629 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 50' ' ' VAL . . . . . . . . . . . . . 43.9 t -79.52 107.64 12.17 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.33 0 N-CA-C 109.682 -0.488 . . . . 0.0 109.682 178.228 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 51' ' ' VAL . . . . . . . . . . . . . 47.5 t -72.51 -51.95 26.07 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.354 0 CA-C-N 115.872 -0.604 . . . . 0.0 109.619 -176.046 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 52' ' ' GLN . . . . . . . . . . . . . 63.0 mt-30 -155.59 147.62 23.44 Favored 'General case' 0 C--N 1.331 -0.225 0 C-N-CA 120.346 -0.541 . . . . 0.0 111.698 -177.672 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -124.38 132.08 53.52 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 115.231 -0.895 . . . . 0.0 109.419 174.512 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 54' ' ' TYR . . . . . . . . . . . . . 38.3 t80 -129.03 110.69 18.34 Favored Pre-proline 0 CA--C 1.535 0.368 0 CA-C-O 118.181 -0.914 . . . . 0.0 110.353 179.836 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 55' ' ' PRO . . . . . . . . . . . . . 73.8 Cg_endo -77.15 170.01 72.71 Favored 'Cis proline' 0 N--CA 1.501 1.914 0 CA-C-N 121.947 1.731 . . . . 0.0 112.335 -6.405 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 56' ' ' SER . . . . . . . . . . . . . 13.6 m -117.48 132.73 23.43 Favored Pre-proline 0 CA--C 1.539 0.555 0 CA-C-O 118.476 -0.773 . . . . 0.0 109.487 175.185 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 57' ' ' PRO . . . . . . . . . . . . . 43.5 Cg_endo -69.53 148.59 86.52 Favored 'Cis proline' 0 N--CA 1.498 1.785 0 CA-C-N 121.823 1.687 . . . . 0.0 111.348 -2.082 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 58' ' ' LEU . . . . . . . . . . . . . 19.0 tp -107.65 135.83 48.44 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.327 -0.397 . . . . 0.0 110.591 -178.168 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 59' ' ' ARG . . . . . . . . . . . . . 23.0 ttm180 -102.83 123.54 46.68 Favored 'General case' 0 C--N 1.327 -0.4 0 N-CA-C 109.293 -0.632 . . . . 0.0 109.293 175.751 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 40.5 t -82.14 119.8 32.38 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.359 0 CA-C-O 120.933 0.396 . . . . 0.0 110.807 -174.067 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 95.6 mt-10 -130.98 165.33 23.41 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 115.817 -0.629 . . . . 0.0 109.417 175.12 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 62' ' ' ASP . . . . . . . . . . . . . 64.1 m-20 -52.37 -32.01 36.44 Favored 'General case' 0 C--N 1.328 -0.332 0 N-CA-C 111.948 0.351 . . . . 0.0 111.948 -178.548 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 63' ' ' ARG . . . . . . . . . . . . . 74.4 mtt180 -73.41 -21.96 60.35 Favored 'General case' 0 CA--C 1.533 0.291 0 N-CA-C 112.84 0.682 . . . . 0.0 112.84 -175.719 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 30.6 m -69.52 134.58 49.04 Favored 'General case' 0 C--N 1.331 -0.208 0 CA-C-O 120.787 0.327 . . . . 0.0 110.952 -175.823 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 65' ' ' LYS . . . . . . . . . . . . . 57.6 mtmt -90.55 133.77 34.85 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.52 179.206 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 66' ' ' ILE . . . . . . . . . . . . . 65.4 mt -117.12 131.14 70.7 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.234 0 N-CA-C 109.995 -0.372 . . . . 0.0 109.995 -179.84 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 67' ' ' THR . . . . . . . . . . . . . 31.6 m -127.19 143.55 51.23 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.876 -178.645 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 68' ' ' LEU . . . . . . . . . . . . . 15.4 tp -105.71 131.36 53.16 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 116.119 -0.491 . . . . 0.0 110.127 177.596 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 69' ' ' VAL . . . . . . . . . . . . . 42.3 t -86.01 135.18 25.56 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.364 0 CA-C-N 116.128 -0.487 . . . . 0.0 110.488 -178.109 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 70' ' ' THR . . . . . 0.466 HG22 ' H ' ' A' ' 71' ' ' HIS . 4.0 m -87.86 167.42 13.8 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 115.833 -0.621 . . . . 0.0 109.943 177.316 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 71' ' ' HIS . . . . . 0.466 ' H ' HG22 ' A' ' 70' ' ' THR . 44.3 m80 -64.93 145.63 98.98 Favored Pre-proline 0 CA--C 1.534 0.328 0 N-CA-C 109.814 -0.439 . . . . 0.0 109.814 -179.959 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 72' ' ' PRO . . . . . . . . . . . . . 72.9 Cg_endo -77.39 -27.63 6.27 Favored 'Trans proline' 0 N--CA 1.493 1.498 0 C-N-CA 121.326 1.35 . . . . 0.0 112.707 -178.644 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 73' ' ' VAL . . . . . . . . . . . . . 35.7 m -130.27 162.89 37.27 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.184 0 CA-C-O 121.046 0.45 . . . . 0.0 110.887 -178.68 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 74' ' ' ASP . . . . . . . . . . . . . 7.1 t70 -101.64 125.87 48.38 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 115.741 -0.663 . . . . 0.0 109.806 178.939 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 42.7 t -113.94 125.04 71.15 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.268 0 CA-C-O 121.154 0.502 . . . . 0.0 110.508 -177.424 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 76' ' ' LEU . . . . . . . . . . . . . 37.7 mt -125.77 140.08 52.98 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 115.578 -0.737 . . . . 0.0 109.73 177.787 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 77' ' ' GLU . . . . . . . . . . . . . 45.9 mt-10 -132.75 136.41 46.34 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-O 120.983 0.42 . . . . 0.0 111.193 -178.751 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 78' ' ' ALA . . . . . . . . . . . . . . . -124.92 136.96 54.25 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-N 115.76 -0.654 . . . . 0.0 110.01 177.128 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 79' ' ' LYS . . . . . 0.511 ' O ' HD13 ' A' ' 80' ' ' ILE . 74.6 mmtt -78.86 119.55 22.22 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-O 120.808 0.337 . . . . 0.0 110.516 -178.54 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 80' ' ' ILE . . . . . 0.511 HD13 ' O ' ' A' ' 79' ' ' LYS . 24.2 mm -139.27 113.33 7.05 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.267 0 N-CA-C 109.303 -0.629 . . . . 0.0 109.303 -177.237 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 81' ' ' LYS . . . . . . . . . . . . . 38.5 ttpt -105.86 124.24 49.26 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-O 120.855 0.36 . . . . 0.0 111.226 -177.809 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . 89.12 42.16 5.67 Favored Glycine 0 CA--C 1.525 0.663 0 C-N-CA 120.758 -0.734 . . . . 0.0 111.886 173.655 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 83' ' ' ILE . . . . . . . . . . . . . 72.1 mt -65.64 132.79 31.26 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 CA-C-O 120.973 0.416 . . . . 0.0 110.019 178.185 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 84' ' ' LYS . . . . . . . . . . . . . 30.3 ttmt -91.87 -50.67 5.6 Favored 'General case' 0 C--N 1.331 -0.204 0 CA-C-N 116.067 -0.515 . . . . 0.0 109.883 179.493 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 85' ' ' ASP . . . . . . . . . . . . . 5.7 t70 -159.75 157.0 28.6 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 115.715 -0.675 . . . . 0.0 110.474 179.73 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 86' ' ' VAL . . . . . . . . . . . . . 42.1 t -127.86 132.46 68.78 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.221 0 CA-C-O 121.049 0.452 . . . . 0.0 110.457 -179.038 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 87' ' ' ILE . . . . . . . . . . . . . 43.2 mm -119.64 124.4 72.82 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.216 0 CA-C-N 115.863 -0.608 . . . . 0.0 109.731 177.463 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 88' ' ' LEU . . . . . . . . . . . . . 50.5 mt -108.42 136.68 47.64 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-O 120.986 0.422 . . . . 0.0 111.286 -178.521 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 89' ' ' ASP . . . . . . . . . . . . . 6.5 t70 -130.41 155.36 46.53 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 115.72 -0.673 . . . . 0.0 109.546 176.177 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 96.2 mt-10 -47.29 -36.66 9.51 Favored 'General case' 0 C--N 1.33 -0.253 0 N-CA-C 113.099 0.777 . . . . 0.0 113.099 -172.148 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 91' ' ' ASN . . . . . . . . . . . . . 35.9 t30 -132.1 21.24 4.48 Favored 'General case' 0 N--CA 1.467 0.417 0 N-CA-C 112.95 0.722 . . . . 0.0 112.95 -177.429 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 92' ' ' LEU . . . . . . . . . . . . . 20.2 mt -151.25 150.43 30.56 Favored 'General case' 0 C--N 1.333 -0.152 0 N-CA-C 110.138 -0.319 . . . . 0.0 110.138 -176.597 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 93' ' ' ILE . . . . . . . . . . . . . 76.2 mt -129.09 120.41 51.57 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.186 0 N-CA-C 109.325 -0.62 . . . . 0.0 109.325 176.159 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 94' ' ' VAL . . . . . . . . . . . . . 43.2 t -118.02 127.01 75.3 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.282 0 N-CA-C 109.68 -0.489 . . . . 0.0 109.68 -179.863 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 95' ' ' VAL . . . . . . . . . . . . . 42.8 t -120.78 135.08 62.11 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.36 0 CA-C-N 116.171 -0.468 . . . . 0.0 109.819 -179.258 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 96' ' ' ILE . . . . . . . . . . . . . 58.6 mt -113.99 128.23 71.03 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.338 0 N-CA-C 109.258 -0.645 . . . . 0.0 109.258 179.594 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 97' ' ' THR . . . . . . . . . . . . . 70.6 p -99.67 154.12 18.54 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-O 120.856 0.36 . . . . 0.0 110.686 -179.09 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 98' ' ' GLU . . . . . . . . . . . . . 96.0 mt-10 -54.76 -23.21 16.86 Favored 'General case' 0 CA--C 1.533 0.319 0 N-CA-C 112.451 0.537 . . . . 0.0 112.451 -179.701 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 99' ' ' GLU . . . . . . . . . . . . . 43.0 mt-10 -79.6 16.14 1.16 Allowed 'General case' 0 CA--C 1.535 0.379 0 N-CA-C 113.05 0.759 . . . . 0.0 113.05 -179.458 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 100' ' ' ASN . . . . . . . . . . . . . 3.6 m-20 63.57 37.97 9.97 Favored 'General case' 0 CA--C 1.529 0.144 0 CA-C-O 121.05 0.452 . . . . 0.0 110.967 177.694 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 101' ' ' GLU . . . . . . . . . . . . . 83.0 tt0 -114.38 142.36 46.45 Favored 'General case' 0 C--N 1.332 -0.162 0 CA-C-N 116.118 -0.492 . . . . 0.0 109.731 176.618 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 102' ' ' VAL . . . . . . . . . . . . . 43.6 t -115.14 123.72 71.04 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 N-CA-C 109.693 -0.484 . . . . 0.0 109.693 -179.731 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 103' ' ' LEU . . . . . . . . . . . . . 36.4 mt -116.57 130.6 56.84 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 115.877 -0.601 . . . . 0.0 110.05 178.294 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 104' ' ' ILE . . . . . 0.595 HD13 HG11 ' A' ' 130' ' ' VAL . 65.5 mt -115.35 118.95 60.41 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.324 0 N-CA-C 109.934 -0.395 . . . . 0.0 109.934 -179.591 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 105' ' ' PHE . . . . . . . . . . . . . 96.9 m-85 -118.29 162.86 17.57 Favored 'General case' 0 C--O 1.233 0.192 0 O-C-N 124.061 0.851 . . . . 0.0 110.079 -178.643 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 106' ' ' ASN . . . . . . . . . . . . . 53.2 p-10 -96.36 -169.95 2.0 Favored 'General case' 0 C--N 1.329 -0.285 0 N-CA-C 109.297 -0.631 . . . . 0.0 109.297 170.664 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 107' ' ' GLN . . . . . . . . . . . . . 44.1 tt0 -57.82 -27.53 63.25 Favored 'General case' 0 C--N 1.328 -0.335 0 N-CA-C 112.405 0.52 . . . . 0.0 112.405 -178.067 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 108' ' ' ASN . . . . . . . . . . . . . 19.6 t30 -94.63 14.25 21.65 Favored 'General case' 0 CA--C 1.534 0.333 0 N-CA-C 113.033 0.753 . . . . 0.0 113.033 -175.149 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 109' ' ' LEU . . . . . . . . . . . . . 91.4 mt 60.4 34.65 20.6 Favored 'General case' 0 CA--C 1.529 0.162 0 CA-C-O 120.756 0.312 . . . . 0.0 111.679 178.169 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 110' ' ' GLU . . . . . . . . . . . . . 96.2 mt-10 -101.47 141.16 34.75 Favored 'General case' 0 C--N 1.33 -0.265 0 N-CA-C 109.717 -0.475 . . . . 0.0 109.717 175.973 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 111' ' ' GLU . . . . . . . . . . . . . 96.4 mt-10 -73.13 121.86 20.91 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-O 120.945 0.402 . . . . 0.0 111.242 -176.719 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 112' ' ' LEU . . . . . . . . . . . . . 17.3 mt -103.43 -45.04 4.98 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 115.861 -0.608 . . . . 0.0 109.737 173.718 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 113' ' ' TYR . . . . . 0.432 ' HB3' HD12 ' A' ' 104' ' ' ILE . 61.8 t80 -142.03 142.48 32.89 Favored 'General case' 0 C--N 1.331 -0.224 0 CA-C-N 115.8 -0.636 . . . . 0.0 110.158 178.251 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 114' ' ' ARG . . . . . . . . . . . . . 33.6 ptt180 -150.65 123.59 8.71 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-O 120.957 0.408 . . . . 0.0 110.966 178.699 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 115' ' ' GLY . . . . . . . . . . . . . . . -150.2 163.03 29.4 Favored Glycine 0 CA--C 1.524 0.624 0 N-CA-C 110.664 -0.974 . . . . 0.0 110.664 -179.385 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 116' ' ' LYS . . . . . . . . . . . . . 29.8 ttmt -127.51 136.23 51.46 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-O 120.883 0.373 . . . . 0.0 110.185 178.604 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 117' ' ' PHE . . . . . . . . . . . . . 43.0 m-85 -131.44 115.15 15.81 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.12 -0.491 . . . . 0.0 110.161 -177.051 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 118' ' ' GLU . . . . . . . . . . . . . 96.2 mt-10 -54.0 -42.08 68.65 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.564 -0.289 . . . . 0.0 111.356 -176.895 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 119' ' ' ASN . . . . . . . . . . . . . 33.6 m120 -99.75 31.02 3.38 Favored 'General case' 0 CA--C 1.531 0.215 0 N-CA-C 112.132 0.419 . . . . 0.0 112.132 -174.809 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 120' ' ' LEU . . . . . . . . . . . . . 13.4 tp -56.83 121.19 9.28 Favored 'General case' 0 C--N 1.332 -0.177 0 CA-C-O 120.756 0.312 . . . . 0.0 110.562 178.41 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 121' ' ' ASN . . . . . . . . . . . . . 6.2 m120 -113.97 -44.01 3.2 Favored 'General case' 0 C--N 1.331 -0.204 0 CA-C-N 116.324 -0.398 . . . . 0.0 110.876 -178.981 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 122' ' ' LYS . . . . . . . . . . . . . 63.9 mtpt -139.68 144.54 37.64 Favored 'General case' 0 C--N 1.331 -0.211 0 CA-C-O 120.972 0.415 . . . . 0.0 111.631 -175.989 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 123' ' ' VAL . . . . . . . . . . . . . 45.2 t -131.36 122.52 51.02 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.305 0 N-CA-C 109.126 -0.694 . . . . 0.0 109.126 172.788 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 124' ' ' LEU . . . . . . . . . . . . . 14.3 tp -127.87 136.04 50.85 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-O 120.82 0.343 . . . . 0.0 110.813 -176.057 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 125' ' ' VAL . . . . . . . . . . . . . 12.6 p -134.03 137.01 52.88 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.205 0 CA-C-N 116.288 -0.414 . . . . 0.0 110.412 178.938 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 126' ' ' ARG . . . . . . . . . . . . . 26.3 mmt180 -141.77 124.99 16.39 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.118 -0.492 . . . . 0.0 110.368 179.43 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 127' ' ' ASN . . . . . . . . . . . . . 81.8 m-20 51.87 -105.02 0.2 Allowed 'General case' 0 CA--C 1.543 0.691 0 CA-C-N 115.982 -0.554 . . . . 0.0 111.356 178.949 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 128' ' ' ASP . . . . . . . . . . . . . 10.3 p-10 -114.21 0.45 14.22 Favored 'General case' 0 N--CA 1.466 0.368 0 CA-C-N 119.506 1.048 . . . . 0.0 113.656 -175.77 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 129' ' ' LEU . . . . . . . . . . . . . 47.4 mt -111.85 145.71 38.99 Favored 'General case' 0 C--O 1.231 0.117 0 CA-C-N 118.166 0.439 . . . . 0.0 110.344 -179.417 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 130' ' ' VAL . . . . . 0.595 HG11 HD13 ' A' ' 104' ' ' ILE . 12.5 p -134.16 141.21 44.38 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.217 0 CA-C-O 121.15 0.5 . . . . 0.0 110.559 -179.843 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 131' ' ' VAL . . . . . . . . . . . . . 44.3 t -135.84 139.6 45.78 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.271 0 CA-C-N 115.985 -0.552 . . . . 0.0 110.109 -179.784 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 132' ' ' ILE . . . . . . . . . . . . . 74.4 mt -118.65 133.42 65.54 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.268 0 CA-C-N 115.708 -0.678 . . . . 0.0 109.49 179.883 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 133' ' ' ILE . . . . . . . . . . . . . 38.1 mm -116.2 121.37 67.35 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.256 0 CA-C-N 116.39 -0.368 . . . . 0.0 110.78 -175.156 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 134' ' ' ASP . . . . . . . . . . . . . 8.4 p-10 -131.94 147.93 52.49 Favored 'General case' 0 C--N 1.332 -0.183 0 N-CA-C 109.871 -0.418 . . . . 0.0 109.871 175.33 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 135' ' ' GLU . . . . . . . . . . . . . 78.8 tt0 -49.86 -26.64 4.22 Favored 'General case' 0 C--N 1.328 -0.336 0 N-CA-C 113.02 0.748 . . . . 0.0 113.02 -172.742 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 136' ' ' GLN . . . . . . . . . . . . . 98.5 mt-30 -85.43 -32.04 22.54 Favored 'General case' 0 C--O 1.234 0.243 0 N-CA-C 112.425 0.528 . . . . 0.0 112.425 -175.428 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 137' ' ' LYS . . . . . . . . . . . . . 48.3 pttt -168.31 173.24 7.86 Favored 'General case' 0 C--N 1.332 -0.161 0 CA-C-O 121.646 0.736 . . . . 0.0 112.417 -173.226 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 138' ' ' LEU . . . . . 0.459 HD23 ' N ' ' A' ' 139' ' ' THR . 3.6 tt -115.7 129.11 56.35 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 114.831 -1.077 . . . . 0.0 109.996 -179.572 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 139' ' ' THR . . . . . 0.459 ' N ' HD23 ' A' ' 138' ' ' LEU . 39.0 m -110.67 123.51 50.16 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 116.221 -0.445 . . . . 0.0 110.223 179.358 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 140' ' ' LEU . . . . . 0.477 HD23 ' C ' ' A' ' 140' ' ' LEU . 6.1 tt -113.28 122.33 47.09 Favored 'General case' 0 C--N 1.328 -0.351 0 N-CA-C 109.567 -0.531 . . . . 0.0 109.567 -178.961 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 141' ' ' ILE . . . . . 0.542 ' HB ' HG13 ' A' ' 130' ' ' VAL . 19.6 mt -121.67 118.5 55.98 Favored 'Isoleucine or valine' 0 C--O 1.235 0.303 0 CA-C-O 121.104 0.478 . . . . 0.0 109.899 -175.938 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 142' ' ' ARG . . . . . . . . . . . . . 58.9 ttt180 -108.31 132.28 53.87 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 115.298 -0.864 . . . . 0.0 110.734 -177.198 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 143' ' ' THR . . . . . . . . . . . . . 56.0 p . . . . . 0 C--O 1.22 -0.483 0 CA-C-O 118.026 -0.988 . . . . 0.0 110.601 178.934 . . . . . . . . 0 0 . 1 . 004 nuclear nobuild full ' B' B ' -3' ' ' GLU . . . . . . . . . . . . . 95.8 mt-10 . . . . . 0 N--CA 1.491 1.606 0 N-CA-C 109.385 -0.598 . . . . 0.0 109.385 . . . . . . . . . 0 0 . 1 . 004 nuclear nobuild full ' B' B ' -2' ' ' GLY . . . . . . . . . . . . . . . -66.62 140.26 38.43 Favored Glycine 0 CA--C 1.525 0.714 0 N-CA-C 111.062 -0.815 . . . . 0.0 111.062 -179.901 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' -1' ' ' VAL . . . . . . . . . . . . . 44.5 t -96.1 132.28 40.75 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.372 0 CA-C-O 120.845 0.355 . . . . 0.0 110.07 179.454 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 0' ' ' ILE . . . . . . . . . . . . . 70.6 mt -117.68 134.48 61.13 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.178 0 CA-C-N 116.301 -0.409 . . . . 0.0 110.129 -179.759 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 1' ' ' MET . . . . . . . . . . . . . 26.6 ptt? -91.59 139.64 30.5 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.032 -0.531 . . . . 0.0 110.315 178.222 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 2' ' ' SER . . . . . . . . . . . . . 6.7 p -114.32 131.72 56.43 Favored 'General case' 0 C--N 1.331 -0.23 0 CA-C-O 121.072 0.463 . . . . 0.0 110.88 -178.519 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 3' ' ' GLU . . . . . . . . . . . . . 95.5 mt-10 -141.15 141.56 34.14 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 115.79 -0.641 . . . . 0.0 110.897 -179.226 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 4' ' ' LEU . . . . . . . . . . . . . 18.8 tp -127.15 128.33 45.99 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 115.955 -0.566 . . . . 0.0 110.12 177.056 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 5' ' ' LYS . . . . . . . . . . . . . 83.1 mttt -104.93 119.62 39.45 Favored 'General case' 0 C--O 1.234 0.267 0 CA-C-N 116.084 -0.507 . . . . 0.0 110.462 178.828 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 6' ' ' LEU . . . . . . . . . . . . . 45.1 mt -116.57 144.38 44.44 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 115.458 -0.792 . . . . 0.0 110.313 -178.967 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 7' ' ' LYS . . . . . . . . . . . . . 82.9 tttt -133.05 138.36 31.59 Favored Pre-proline 0 CA--C 1.534 0.328 0 CA-C-O 119.007 -0.521 . . . . 0.0 109.988 177.247 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 8' ' ' PRO . . . . . . . . . . . . . 89.7 Cg_endo -92.09 144.19 2.78 Favored 'Trans proline' 0 N--CA 1.489 1.223 0 C-N-CA 121.717 1.611 . . . . 0.0 111.97 178.155 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 9' ' ' LEU . . . . . . . . . . . . . 62.4 mt -81.09 -47.65 1.11 Allowed Pre-proline 0 CA--C 1.534 0.36 0 CA-C-O 118.637 -0.697 . . . . 0.0 112.319 -179.946 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 10' ' ' PRO . . . . . . . . . . . . . 86.8 Cg_endo -80.3 151.43 20.36 Favored 'Trans proline' 0 N--CA 1.496 1.656 0 C-N-CA 121.125 1.217 . . . . 0.0 111.888 176.999 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 11' ' ' LYS . . . . . . . . . . . . . 96.5 mttt -87.47 96.98 10.58 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.432 -0.349 . . . . 0.0 110.492 178.79 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 12' ' ' VAL . . . . . . . . . . . . . 12.6 p -142.06 147.07 21.9 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.328 0 CA-C-N 116.237 -0.438 . . . . 0.0 110.5 -179.932 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 13' ' ' GLU . . . . . . . . . . . . . 84.4 tt0 -84.92 127.9 34.37 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.253 -0.43 . . . . 0.0 110.055 178.069 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 14' ' ' LEU . . . . . . . . . . . . . 36.5 mt -96.41 149.96 36.51 Favored Pre-proline 0 CA--C 1.533 0.309 0 CA-C-O 119.311 -0.376 . . . . 0.0 110.713 -177.154 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 15' ' ' PRO . . . . . . . . . . . . . 27.8 Cg_exo -60.99 158.39 34.27 Favored 'Trans proline' 0 N--CA 1.499 1.797 0 C-N-CA 121.269 1.313 . . . . 0.0 111.964 178.272 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 16' ' ' PRO . . . . . . . . . . . . . 35.7 Cg_exo -59.09 -41.02 64.85 Favored 'Trans proline' 0 N--CA 1.497 1.692 0 C-N-CA 121.439 1.426 . . . . 0.0 112.714 -179.218 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 17' ' ' ASP . . . . . . . . . . . . . 15.8 p-10 -84.73 11.59 8.79 Favored 'General case' 0 CA--C 1.535 0.388 0 N-CA-C 113.155 0.798 . . . . 0.0 113.155 -178.183 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 18' ' ' PHE . . . . . . . . . . . . . 44.9 t80 -57.6 -45.73 84.94 Favored 'General case' 0 C--N 1.335 -0.064 0 O-C-N 121.949 -0.47 . . . . 0.0 110.305 -177.833 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 19' ' ' VAL . . . . . 0.413 HG13 ' N ' ' B' ' 20' ' ' ASP . 15.0 p -55.88 -42.21 69.98 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.326 0 CA-C-N 116.475 -0.329 . . . . 0.0 111.075 -177.599 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' B' B ' 20' ' ' ASP . . . . . 0.413 ' N ' HG13 ' B' ' 19' ' ' VAL . 32.8 m-20 -60.76 -42.85 98.27 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-O 120.9 0.381 . . . . 0.0 110.923 -178.397 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' B' B ' 21' ' ' VAL . . . . . . . . . . . . . 46.9 t -63.8 -45.41 97.25 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.264 0 C-N-CA 120.735 -0.386 . . . . 0.0 110.4 -178.52 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 22' ' ' ILE . . . . . 0.566 HG22 HD12 ' B' ' 26' ' ' LEU . 50.7 mm -55.7 -47.13 79.57 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.262 0 C-N-CA 121.001 -0.28 . . . . 0.0 110.592 178.366 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' B' B ' 23' ' ' ARG . . . . . . . . . . . . . 47.0 ttp180 -53.41 -51.66 61.87 Favored 'General case' 0 C--N 1.329 -0.292 0 C-N-CA 121.13 -0.228 . . . . 0.0 111.534 -178.615 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 24' ' ' ILE . . . . . . . . . . . . . 71.9 mt -59.52 -44.24 92.56 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.319 0 C-N-CA 121.112 -0.235 . . . . 0.0 111.163 -177.293 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 25' ' ' LYS . . . . . . . . . . . . . 8.7 mtpm? -64.94 -40.1 94.51 Favored 'General case' 0 C--N 1.328 -0.357 0 N-CA-C 112.178 0.436 . . . . 0.0 112.178 -176.946 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 26' ' ' LEU . . . . . 0.566 HD12 HG22 ' B' ' 22' ' ' ILE . 74.6 mt -80.09 -43.41 21.8 Favored 'General case' 0 C--N 1.33 -0.276 0 N-CA-C 112.945 0.72 . . . . 0.0 112.945 -172.106 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' B' B ' 27' ' ' GLN . . . . . . . . . . . . . 10.3 pt20 -46.39 137.67 6.27 Favored 'General case' 0 N--CA 1.469 0.487 0 N-CA-C 112.81 0.67 . . . . 0.0 112.81 -174.996 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 28' ' ' GLY . . . . . . . . . . . . . . . 100.85 -26.31 25.11 Favored Glycine 0 CA--C 1.533 1.196 0 CA-C-N 115.518 -0.765 . . . . 0.0 112.216 -176.575 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 29' ' ' LYS . . . . . . . . . . . . . 35.2 mmtp -97.79 155.08 17.2 Favored 'General case' 0 C--N 1.332 -0.159 0 CA-C-N 117.251 0.526 . . . . 0.0 111.012 179.28 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 30' ' ' THR . . . . . . . . . . . . . 43.5 m -108.01 134.4 50.97 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 115.934 -0.576 . . . . 0.0 109.869 175.202 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 31' ' ' VAL . . . . . . . . . . . . . 34.5 m -129.39 155.56 41.31 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.251 0 CA-C-O 120.9 0.381 . . . . 0.0 111.049 -177.363 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 32' ' ' ARG . . . . . . . . . . . . . 92.5 mtt180 -129.9 152.9 48.87 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-O 121.291 0.567 . . . . 0.0 110.604 179.16 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 33' ' ' THR . . . . . . . . . . . . . 18.2 m -52.82 139.02 28.03 Favored 'General case' 0 C--N 1.331 -0.225 0 CA-C-N 116.228 -0.442 . . . . 0.0 111.39 -179.001 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 34' ' ' GLY . . . . . . . . . . . . . . . 100.31 -17.12 57.34 Favored Glycine 0 CA--C 1.533 1.172 0 C-N-CA 121.219 -0.515 . . . . 0.0 113.224 179.346 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 35' ' ' ASP . . . . . . . . . . . . . 56.1 m-20 -66.04 150.5 48.59 Favored 'General case' 0 C--O 1.23 0.041 0 CA-C-N 118.043 0.922 . . . . 0.0 111.055 179.443 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 36' ' ' VAL . . . . . . . . . . . . . 46.5 t -123.06 129.72 74.86 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.207 0 CA-C-N 115.748 -0.66 . . . . 0.0 109.677 178.39 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 37' ' ' ILE . . . . . . . . . . . . . 64.8 mt -120.1 138.34 50.98 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.297 0 N-CA-C 109.755 -0.461 . . . . 0.0 109.755 179.816 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 38' ' ' GLY . . . . . . . . . . . . . . . -112.36 128.86 8.71 Favored Glycine 0 CA--C 1.525 0.716 0 N-CA-C 110.731 -0.948 . . . . 0.0 110.731 179.552 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 39' ' ' ILE . . . . . . . . . . . . . 73.4 mt -121.12 136.18 58.91 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.277 0 N-CA-C 110.043 -0.354 . . . . 0.0 110.043 179.831 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 40' ' ' SER . . . . . 0.527 ' O ' HD13 ' B' ' 41' ' ' ILE . 74.6 p -91.65 116.16 28.64 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.246 -0.434 . . . . 0.0 110.78 176.185 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' B' B ' 41' ' ' ILE . . . . . 0.527 HD13 ' O ' ' B' ' 40' ' ' SER . 48.1 mm -128.74 118.13 46.42 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.165 0 N-CA-C 110.063 -0.347 . . . . 0.0 110.063 178.711 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' B' B ' 42' ' ' LEU . . . . . . . . . . . . . 38.7 mt 58.1 34.53 24.29 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.212 -0.449 . . . . 0.0 111.52 179.325 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 43' ' ' GLY . . . . . . . . . . . . . . . 77.47 -10.14 24.54 Favored Glycine 0 CA--C 1.535 1.286 0 C-N-CA 121.315 -0.469 . . . . 0.0 113.424 178.047 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 44' ' ' LYS . . . . . . . . . . . . . 47.7 mtmt -98.85 137.47 37.38 Favored 'General case' 0 C--N 1.333 -0.144 0 CA-C-N 117.897 0.848 . . . . 0.0 110.198 177.965 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 45' ' ' GLU . . . . . . . . . . . . . 83.8 tt0 -84.46 128.18 34.44 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.293 -0.412 . . . . 0.0 111.287 -179.409 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 46' ' ' VAL . . . . . . . . . . . . . 7.2 p -120.61 129.14 75.93 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.197 0 N-CA-C 109.508 -0.553 . . . . 0.0 109.508 175.465 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 47' ' ' LYS . . . . . . . . . . . . . 98.8 mttt -99.4 128.32 45.51 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.009 -0.541 . . . . 0.0 111.007 179.001 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 48' ' ' PHE . . . . . . . . . . . . . 93.2 m-85 -113.08 131.85 55.65 Favored 'General case' 0 C--N 1.331 -0.232 0 N-CA-C 109.67 -0.493 . . . . 0.0 109.67 175.041 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 49' ' ' LYS . . . . . . . . . . . . . 79.2 tttt -106.98 136.14 47.35 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.304 -0.407 . . . . 0.0 110.426 -179.777 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 50' ' ' VAL . . . . . . . . . . . . . 42.2 t -80.08 106.99 11.99 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 N-CA-C 109.433 -0.58 . . . . 0.0 109.433 176.799 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 51' ' ' VAL . . . . . . . . . . . . . 46.7 t -75.15 -48.21 32.83 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.286 0 CA-C-N 116.064 -0.516 . . . . 0.0 110.077 -174.044 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 52' ' ' GLN . . . . . . . . . . . . . 62.6 tt0 -159.46 137.05 9.96 Favored 'General case' 0 C--N 1.33 -0.251 0 C-N-CA 120.475 -0.49 . . . . 0.0 111.397 -177.692 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 53' ' ' ALA . . . . . 0.484 ' HB1' ' HB2' ' B' ' 58' ' ' LEU . . . -114.23 130.76 56.63 Favored 'General case' 0 C--N 1.331 -0.23 0 CA-C-N 115.783 -0.644 . . . . 0.0 109.755 174.561 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' B' B ' 54' ' ' TYR . . . . . . . . . . . . . 30.2 t80 -129.08 110.76 18.29 Favored Pre-proline 0 CA--C 1.535 0.399 0 CA-C-O 118.334 -0.841 . . . . 0.0 110.329 179.495 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 55' ' ' PRO . . . . . . . . . . . . . 73.9 Cg_endo -77.11 170.08 72.56 Favored 'Cis proline' 0 N--CA 1.499 1.823 0 CA-C-N 121.918 1.721 . . . . 0.0 112.44 -4.554 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 56' ' ' SER . . . . . . . . . . . . . 13.7 m -116.18 129.46 25.2 Favored Pre-proline 0 CA--C 1.539 0.548 0 CA-C-O 118.347 -0.835 . . . . 0.0 109.37 175.96 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 57' ' ' PRO . . . . . . . . . . . . . 50.8 Cg_endo -69.99 148.18 86.7 Favored 'Cis proline' 0 N--CA 1.497 1.735 0 CA-C-N 122.053 1.769 . . . . 0.0 111.561 -0.771 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 58' ' ' LEU . . . . . 0.484 ' HB2' ' HB1' ' B' ' 53' ' ' ALA . 22.4 tp -106.48 135.44 47.97 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-O 120.851 0.357 . . . . 0.0 110.454 -178.994 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' B' B ' 59' ' ' ARG . . . . . . . . . . . . . 52.9 ttp180 -105.82 121.85 44.9 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-N 115.873 -0.603 . . . . 0.0 109.377 177.307 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 60' ' ' VAL . . . . . . . . . . . . . 42.6 t -79.09 122.92 35.31 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.287 0 C-N-CA 120.807 -0.357 . . . . 0.0 110.591 -173.848 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 61' ' ' GLU . . . . . . . . . . . . . 95.5 mt-10 -131.03 165.62 22.8 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.021 -0.536 . . . . 0.0 110.149 178.195 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 62' ' ' ASP . . . . . . . . . . . . . 14.9 p-10 -55.87 -32.59 63.8 Favored 'General case' 0 C--N 1.329 -0.324 0 N-CA-C 111.781 0.289 . . . . 0.0 111.781 -179.147 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 63' ' ' ARG . . . . . . . . . . . . . 11.0 ptm180 -86.41 4.58 38.87 Favored 'General case' 0 CA--C 1.537 0.47 0 N-CA-C 113.527 0.936 . . . . 0.0 113.527 -176.15 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 64' ' ' THR . . . . . . . . . . . . . 31.5 m -83.54 137.86 33.66 Favored 'General case' 0 C--N 1.332 -0.166 0 CA-C-N 118.231 0.469 . . . . 0.0 110.443 -178.22 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 65' ' ' LYS . . . . . . . . . . . . . 67.7 mttm -88.24 123.72 33.15 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.219 -179.911 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 66' ' ' ILE . . . . . . . . . . . . . 62.6 mt -111.94 126.59 69.35 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.283 0 N-CA-C 109.574 -0.528 . . . . 0.0 109.574 179.63 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 67' ' ' THR . . . . . . . . . . . . . 18.4 m -122.08 139.32 53.86 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 116.176 -0.465 . . . . 0.0 110.908 -177.119 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 68' ' ' LEU . . . . . . . . . . . . . 15.7 tp -103.77 129.9 51.23 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 115.841 -0.618 . . . . 0.0 110.236 178.624 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 69' ' ' VAL . . . . . . . . . . . . . 43.0 t -96.25 135.06 31.59 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.286 0 CA-C-N 116.252 -0.431 . . . . 0.0 110.45 -179.101 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 70' ' ' THR . . . . . . . . . . . . . 74.9 p -107.25 -174.33 2.51 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.117 -0.492 . . . . 0.0 110.597 -179.932 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 71' ' ' HIS . . . . . . . . . . . . . 48.7 m-70 -112.03 87.51 8.88 Favored Pre-proline 0 CA--C 1.533 0.304 0 CA-C-N 116.276 -0.42 . . . . 0.0 110.911 -178.557 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 72' ' ' PRO . . . . . . . . . . . . . 90.5 Cg_endo -85.28 159.98 11.26 Favored 'Trans proline' 0 N--CA 1.492 1.435 0 C-N-CA 121.566 1.511 . . . . 0.0 112.105 178.072 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 73' ' ' VAL . . . . . . . . . . . . . 34.2 m -87.19 164.45 2.32 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.335 0 CA-C-N 116.303 -0.408 . . . . 0.0 110.703 179.741 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 74' ' ' ASP . . . . . . . . . . . . . 13.8 t0 -99.53 123.52 43.87 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.152 -0.476 . . . . 0.0 110.051 -179.444 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 75' ' ' VAL . . . . . . . . . . . . . 41.5 t -115.24 123.89 71.28 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.261 0 CA-C-O 120.905 0.383 . . . . 0.0 110.617 -177.788 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 76' ' ' LEU . . . . . . . . . . . . . 4.4 mp -124.84 144.99 50.01 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 115.934 -0.576 . . . . 0.0 109.697 176.261 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 77' ' ' GLU . . . . . . . . . . . . . 97.4 mt-10 -134.96 138.53 44.13 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-O 121.0 0.429 . . . . 0.0 111.243 -178.068 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 78' ' ' ALA . . . . . . . . . . . . . . . -125.76 130.5 51.61 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 115.697 -0.683 . . . . 0.0 109.674 176.229 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 79' ' ' LYS . . . . . 0.597 ' O ' HD13 ' B' ' 80' ' ' ILE . 62.1 mtpt -79.02 119.44 22.17 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-O 120.865 0.364 . . . . 0.0 110.898 -177.481 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' B' B ' 80' ' ' ILE . . . . . 0.597 HD13 ' O ' ' B' ' 79' ' ' LYS . 41.6 mm -139.19 109.31 4.2 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.311 0 N-CA-C 109.138 -0.69 . . . . 0.0 109.138 -177.721 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' B' B ' 81' ' ' LYS . . . . . . . . . . . . . 60.6 tttm -101.81 126.55 48.71 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-O 120.842 0.353 . . . . 0.0 111.223 -176.642 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 82' ' ' GLY . . . . . . . . . . . . . . . 89.2 42.11 5.66 Favored Glycine 0 CA--C 1.527 0.784 0 C-N-CA 120.885 -0.674 . . . . 0.0 112.017 174.193 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 83' ' ' ILE . . . . . . . . . . . . . 72.5 mt -70.13 136.34 26.29 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.269 0 N-CA-C 109.676 -0.49 . . . . 0.0 109.676 176.407 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 84' ' ' LYS . . . . . . . . . . . . . 19.7 ttpp -101.0 -50.14 3.9 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-O 120.9 0.381 . . . . 0.0 110.461 -178.176 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 85' ' ' ASP . . . . . . . . . . . . . 10.8 t70 -147.1 148.13 31.29 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 115.987 -0.551 . . . . 0.0 110.348 -179.729 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 86' ' ' VAL . . . . . . . . . . . . . 42.2 t -130.71 132.62 64.12 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.232 0 CA-C-O 121.05 0.452 . . . . 0.0 110.578 -178.365 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 87' ' ' ILE . . . . . 0.5 ' N ' HD12 ' B' ' 87' ' ' ILE . 5.1 mp -122.62 123.02 67.47 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.217 0 N-CA-C 109.208 -0.664 . . . . 0.0 109.208 176.102 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' B' B ' 88' ' ' LEU . . . . . . . . . . . . . 33.8 mt -111.66 136.29 51.08 Favored 'General case' 0 C--N 1.332 -0.182 0 CA-C-O 121.223 0.535 . . . . 0.0 111.352 -176.129 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 89' ' ' ASP . . . . . . . . . . . . . 11.3 t70 -129.19 146.25 51.15 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 115.511 -0.768 . . . . 0.0 109.296 175.333 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 90' ' ' GLU . . . . . . . . . . . . . 12.8 pt-20 -51.09 -28.8 11.42 Favored 'General case' 0 C--N 1.328 -0.347 0 N-CA-C 112.522 0.564 . . . . 0.0 112.522 -174.017 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 91' ' ' ASN . . . . . . . . . . . . . 92.1 m-20 -127.26 22.67 6.54 Favored 'General case' 0 N--CA 1.469 0.486 0 N-CA-C 112.8 0.667 . . . . 0.0 112.8 -176.558 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 92' ' ' LEU . . . . . . . . . . . . . 7.4 tp -166.24 148.54 6.94 Favored 'General case' 0 C--N 1.331 -0.237 0 N-CA-C 110.302 -0.258 . . . . 0.0 110.302 179.471 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 93' ' ' ILE . . . . . . . . . . . . . 71.0 mt -128.18 123.97 61.42 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.285 0 N-CA-C 109.848 -0.427 . . . . 0.0 109.848 179.145 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 94' ' ' VAL . . . . . . . . . . . . . 40.8 t -122.13 125.88 73.61 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.182 0 N-CA-C 109.98 -0.378 . . . . 0.0 109.98 179.038 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 95' ' ' VAL . . . . . . . . . . . . . 41.8 t -120.82 134.66 63.54 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.329 0 CA-C-N 116.026 -0.533 . . . . 0.0 109.815 -179.959 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 96' ' ' ILE . . . . . 0.418 HD11 ' HB ' ' B' ' 123' ' ' VAL . 67.4 mt -115.76 126.15 73.18 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.209 0 N-CA-C 109.381 -0.6 . . . . 0.0 109.381 179.071 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' B' B ' 97' ' ' THR . . . . . . . . . . . . . 73.5 p -99.89 158.36 15.86 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-O 121.307 0.575 . . . . 0.0 111.326 -176.404 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 98' ' ' GLU . . . . . . . . . . . . . 43.7 tp10 -53.83 -26.62 25.21 Favored 'General case' 0 CA--C 1.533 0.311 0 CA-C-N 116.052 -0.522 . . . . 0.0 112.267 -179.174 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 99' ' ' GLU . . . . . . . . . . . . . 95.7 mt-10 -79.91 17.6 0.94 Allowed 'General case' 0 CA--C 1.535 0.377 0 N-CA-C 113.151 0.797 . . . . 0.0 113.151 -176.212 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 100' ' ' ASN . . . . . . . . . . . . . 4.2 m-20 62.42 38.1 13.1 Favored 'General case' 0 N--CA 1.463 0.175 0 CA-C-O 121.115 0.484 . . . . 0.0 110.894 177.954 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 101' ' ' GLU . . . . . . . . . . . . . 84.4 tt0 -119.04 141.86 48.34 Favored 'General case' 0 C--N 1.332 -0.184 0 CA-C-N 116.208 -0.451 . . . . 0.0 109.869 177.562 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 102' ' ' VAL . . . . . . . . . . . . . 46.2 t -115.08 127.54 72.6 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.264 0 N-CA-C 109.895 -0.409 . . . . 0.0 109.895 -178.915 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 103' ' ' LEU . . . . . . . . . . . . . 28.8 mt -118.58 131.9 56.2 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-N 115.78 -0.646 . . . . 0.0 110.306 177.845 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 104' ' ' ILE . . . . . . . . . . . . . 71.4 mt -119.52 121.85 67.39 Favored 'Isoleucine or valine' 0 C--O 1.234 0.283 0 CA-C-N 116.606 -0.27 . . . . 0.0 110.426 -179.106 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 105' ' ' PHE . . . . . . . . . . . . . 53.2 m-85 -123.18 168.44 12.42 Favored 'General case' 0 C--N 1.333 -0.122 0 O-C-N 124.115 0.885 . . . . 0.0 109.901 179.499 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 106' ' ' ASN . . . . . . . . . . . . . 44.0 p-10 -100.38 -170.61 1.89 Allowed 'General case' 0 CA--C 1.531 0.217 0 N-CA-C 109.789 -0.448 . . . . 0.0 109.789 171.754 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 107' ' ' GLN . . . . . . . . . . . . . 63.3 tt0 -58.55 -30.06 66.83 Favored 'General case' 0 C--N 1.328 -0.339 0 N-CA-C 111.858 0.318 . . . . 0.0 111.858 179.567 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 108' ' ' ASN . . . . . . . . . . . . . 59.8 t30 -86.85 14.06 7.88 Favored 'General case' 0 CA--C 1.534 0.343 0 N-CA-C 112.923 0.712 . . . . 0.0 112.923 -176.757 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 109' ' ' LEU . . . . . . . . . . . . . 34.5 mt 58.35 33.19 22.91 Favored 'General case' 0 C--N 1.332 -0.188 0 N-CA-C 111.877 0.325 . . . . 0.0 111.877 177.262 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 110' ' ' GLU . . . . . . . . . . . . . 70.5 mm-40 -98.97 138.82 35.52 Favored 'General case' 0 C--N 1.331 -0.226 0 N-CA-C 109.21 -0.663 . . . . 0.0 109.21 174.426 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 111' ' ' GLU . . . . . . . . . . . . . 42.2 tt0 -85.72 121.81 28.91 Favored 'General case' 0 C--N 1.327 -0.408 0 CA-C-O 120.942 0.401 . . . . 0.0 110.574 -176.243 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 112' ' ' LEU . . . . . . . . . . . . . 38.6 mt -105.73 -42.4 5.18 Favored 'General case' 0 C--N 1.331 -0.227 0 CA-C-N 116.007 -0.542 . . . . 0.0 110.466 179.745 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 113' ' ' TYR . . . . . . . . . . . . . 63.9 t80 -132.89 138.7 47.07 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-N 116.274 -0.421 . . . . 0.0 110.883 -178.452 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 114' ' ' ARG . . . . . . . . . . . . . 24.6 ptt180 -147.89 122.22 9.65 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.3 -0.409 . . . . 0.0 110.619 179.126 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 115' ' ' GLY . . . . . . . . . . . . . . . -150.13 148.15 19.1 Favored Glycine 0 CA--C 1.525 0.701 0 C-N-CA 120.682 -0.77 . . . . 0.0 111.451 179.761 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 116' ' ' LYS . . . . . . . . . . . . . 21.3 ttpp -116.44 131.93 56.81 Favored 'General case' 0 C--N 1.33 -0.26 0 N-CA-C 109.717 -0.475 . . . . 0.0 109.717 176.517 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 117' ' ' PHE . . . . . 0.477 ' HE2' HD13 ' B' ' 132' ' ' ILE . 47.5 m-85 -127.12 116.85 21.29 Favored 'General case' 0 C--N 1.331 -0.216 0 CA-C-O 120.945 0.403 . . . . 0.0 110.243 -176.47 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' B' B ' 118' ' ' GLU . . . . . . . . . . . . . 95.8 mt-10 -52.97 -47.03 68.47 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.309 -0.405 . . . . 0.0 111.476 -176.293 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 119' ' ' ASN . . . . . . . . . . . . . 82.6 m-20 -98.16 31.02 2.88 Favored 'General case' 0 C--N 1.33 -0.256 0 N-CA-C 112.173 0.435 . . . . 0.0 112.173 -173.805 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 120' ' ' LEU . . . . . . . . . . . . . 21.4 tp -56.72 121.82 10.69 Favored 'General case' 0 C--N 1.332 -0.184 0 CA-C-O 120.677 0.275 . . . . 0.0 110.466 177.778 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 121' ' ' ASN . . . . . . . . . . . . . 31.4 m120 -113.98 -44.14 3.19 Favored 'General case' 0 N--CA 1.462 0.155 0 CA-C-N 116.554 -0.294 . . . . 0.0 111.323 -176.684 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 122' ' ' LYS . . . . . . . . . . . . . 55.4 mtmt -147.67 152.7 38.28 Favored 'General case' 0 C--N 1.332 -0.172 0 C-N-CA 120.651 -0.42 . . . . 0.0 111.62 -177.701 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 123' ' ' VAL . . . . . 0.418 ' HB ' HD11 ' B' ' 96' ' ' ILE . 46.2 t -132.77 132.18 59.52 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.243 0 CA-C-N 115.919 -0.582 . . . . 0.0 109.862 177.715 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' B' B ' 124' ' ' LEU . . . . . . . . . . . . . 23.9 mt -121.15 136.13 55.03 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.231 -0.44 . . . . 0.0 110.548 -179.059 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 125' ' ' VAL . . . . . . . . . . . . . 43.5 t -130.46 130.73 65.28 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.262 0 CA-C-N 116.335 -0.393 . . . . 0.0 110.019 179.078 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 126' ' ' ARG . . . . . . . . . . . . . 89.8 mtt-85 -142.05 121.14 12.93 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-O 120.935 0.398 . . . . 0.0 110.642 178.578 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 127' ' ' ASN . . . . . . . . . . . . . 58.4 m-80 51.46 -107.75 0.33 Allowed 'General case' 0 CA--C 1.545 0.761 0 CA-C-O 118.881 -0.581 . . . . 0.0 111.146 179.404 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 128' ' ' ASP . . . . . . . . . . . . . 14.7 p-10 -114.19 4.26 15.47 Favored 'General case' 0 CA--C 1.537 0.445 0 CA-C-N 119.802 1.183 . . . . 0.0 113.257 -178.111 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 129' ' ' LEU . . . . . . . . . . . . . 72.6 mt -107.75 144.93 34.21 Favored 'General case' 0 C--O 1.231 0.109 0 CA-C-N 118.142 0.428 . . . . 0.0 110.09 -179.916 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 130' ' ' VAL . . . . . . . . . . . . . 41.4 t -127.67 140.22 49.73 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.185 0 CA-C-O 120.98 0.419 . . . . 0.0 110.156 -177.739 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 131' ' ' VAL . . . . . 0.505 HG22 HD12 ' B' ' 140' ' ' LEU . 41.0 t -135.01 134.84 53.23 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.277 0 CA-C-N 116.15 -0.477 . . . . 0.0 110.025 178.317 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' B' B ' 132' ' ' ILE . . . . . 0.477 HD13 ' HE2' ' B' ' 117' ' ' PHE . 69.9 mt -118.07 132.84 66.72 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.274 0 CA-C-N 115.984 -0.553 . . . . 0.0 109.606 -179.468 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' B' B ' 133' ' ' ILE . . . . . . . . . . . . . 34.0 mm -116.0 123.49 71.32 Favored 'Isoleucine or valine' 0 C--O 1.234 0.262 0 CA-C-N 116.511 -0.313 . . . . 0.0 110.894 -175.598 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 134' ' ' ASP . . . . . . . . . . . . . 7.9 p-10 -132.61 155.11 49.31 Favored 'General case' 0 C--N 1.332 -0.196 0 CA-C-N 116.434 -0.348 . . . . 0.0 110.089 174.371 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 135' ' ' GLU . . . . . . . . . . . . . 80.7 tt0 -49.83 -28.66 6.71 Favored 'General case' 0 C--N 1.328 -0.364 0 N-CA-C 113.17 0.804 . . . . 0.0 113.17 -169.951 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 136' ' ' GLN . . . . . . . . . . . . . 97.5 mt-30 -99.22 -24.78 14.73 Favored 'General case' 0 C--O 1.233 0.227 0 N-CA-C 113.096 0.776 . . . . 0.0 113.096 -171.761 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 137' ' ' LYS . . . . . . . . . . . . . 57.0 pttt -161.01 168.25 24.89 Favored 'General case' 0 C--O 1.232 0.163 0 CA-C-O 121.619 0.723 . . . . 0.0 112.56 -173.23 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 138' ' ' LEU . . . . . 0.413 ' C ' HD23 ' B' ' 138' ' ' LEU . 6.9 tt -120.07 128.36 53.41 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 114.848 -1.069 . . . . 0.0 110.009 178.219 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' B' B ' 139' ' ' THR . . . . . . . . . . . . . 43.1 m -106.49 127.82 53.6 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.068 -0.515 . . . . 0.0 110.28 179.562 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 140' ' ' LEU . . . . . 0.505 HD12 HG22 ' B' ' 131' ' ' VAL . 19.3 tp -114.92 119.26 35.95 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 115.795 -0.639 . . . . 0.0 109.674 -177.969 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' B' B ' 141' ' ' ILE . . . . . . . . . . . . . 19.3 mt -119.35 119.91 62.07 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.221 0 CA-C-O 120.95 0.405 . . . . 0.0 110.015 -174.516 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 142' ' ' ARG . . . . . . . . . . . . . 76.2 mtm180 -113.77 126.21 54.96 Favored 'General case' 0 C--N 1.332 -0.166 0 CA-C-N 115.44 -0.8 . . . . 0.0 110.369 -177.97 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 143' ' ' THR . . . . . . . . . . . . . 52.0 p . . . . . 0 C--O 1.22 -0.493 0 CA-C-O 118.123 -0.942 . . . . 0.0 110.527 -179.564 . . . . . . . . 0 0 . 1 . 004 nuclear nobuild full ' C' C ' -3' ' ' GLU . . . . . . . . . . . . . 96.0 mt-10 . . . . . 0 N--CA 1.49 1.54 0 N-CA-C 109.437 -0.579 . . . . 0.0 109.437 . . . . . . . . . 0 0 . 1 . 004 nuclear nobuild full ' C' C ' -2' ' ' GLY . . . . . . . . . . . . . . . -71.11 131.54 20.5 Favored Glycine 0 CA--C 1.524 0.638 0 N-CA-C 110.676 -0.969 . . . . 0.0 110.676 178.7 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' C' C ' -1' ' ' VAL . . . . . . . . . . . . . 43.7 t -95.51 139.38 19.01 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.323 0 CA-C-O 120.948 0.404 . . . . 0.0 110.14 -179.04 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' C' C ' 0' ' ' ILE . . . . . . . . . . . . . 69.4 mt -103.52 131.76 51.34 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.208 0 CA-C-N 116.051 -0.522 . . . . 0.0 110.127 -179.108 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' C' C ' 1' ' ' MET . . . . . . . . . . . . . 25.2 ptp -82.88 141.05 32.51 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.309 -0.405 . . . . 0.0 110.608 179.82 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' C' C ' 2' ' ' SER . . . . . 0.435 ' HB2' HD11 ' C' ' 58' ' ' LEU . 3.9 p -124.14 133.53 53.56 Favored 'General case' 0 C--N 1.331 -0.212 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.597 179.925 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' C' C ' 3' ' ' GLU . . . . . . . . . . . . . 93.6 mt-10 -141.04 140.9 34.33 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 115.974 -0.557 . . . . 0.0 110.879 -179.292 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' C' C ' 4' ' ' LEU . . . . . . . . . . . . . 15.5 tp -125.21 130.29 51.8 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 116.151 -0.477 . . . . 0.0 110.01 175.629 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' C' C ' 5' ' ' LYS . . . . . . . . . . . . . 96.5 mttt -111.77 121.85 46.21 Favored 'General case' 0 C--N 1.332 -0.192 0 CA-C-N 116.686 -0.234 . . . . 0.0 110.939 -178.512 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' C' C ' 6' ' ' LEU . . . . . . . . . . . . . 27.7 mt -114.3 140.91 48.23 Favored 'General case' 0 C--O 1.234 0.27 0 CA-C-N 115.504 -0.771 . . . . 0.0 110.591 -179.506 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' C' C ' 7' ' ' LYS . . . . . . . . . . . . . 41.1 tttp -121.54 137.88 27.6 Favored Pre-proline 0 CA--C 1.534 0.351 0 CA-C-O 118.935 -0.555 . . . . 0.0 109.592 174.934 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' C' C ' 8' ' ' PRO . . . . . . . . . . . . . 86.9 Cg_endo -91.93 134.68 1.49 Allowed 'Trans proline' 0 N--CA 1.488 1.193 0 C-N-CA 121.682 1.588 . . . . 0.0 111.831 178.858 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' C' C ' 9' ' ' LEU . . . . . . . . . . . . . 49.0 mt -76.66 -46.26 3.15 Favored Pre-proline 0 CA--C 1.533 0.319 0 CA-C-O 118.791 -0.623 . . . . 0.0 111.764 -179.908 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' C' C ' 10' ' ' PRO . . . . . . . . . . . . . 79.2 Cg_endo -83.78 140.46 9.19 Favored 'Trans proline' 0 N--CA 1.495 1.575 0 C-N-CA 121.288 1.325 . . . . 0.0 111.408 173.259 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' C' C ' 11' ' ' LYS . . . . . . . . . . . . . 48.8 pttt -78.96 111.34 15.05 Favored 'General case' 0 C--N 1.331 -0.214 0 CA-C-O 121.449 0.642 . . . . 0.0 110.174 178.414 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' C' C ' 12' ' ' VAL . . . . . . . . . . . . . 11.6 p -151.1 151.99 11.79 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.373 0 CA-C-N 115.711 -0.677 . . . . 0.0 110.589 -178.553 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' C' C ' 13' ' ' GLU . . . . . . . . . . . . . 80.6 tt0 -91.04 124.51 35.33 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.303 -0.408 . . . . 0.0 110.082 177.241 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' C' C ' 14' ' ' LEU . . . . . . . . . . . . . 23.8 mt -95.16 150.87 38.29 Favored Pre-proline 0 C--N 1.329 -0.284 0 CA-C-O 119.332 -0.366 . . . . 0.0 110.511 -179.141 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' C' C ' 15' ' ' PRO . . . . . . . . . . . . . 28.2 Cg_exo -60.51 157.86 34.56 Favored 'Trans proline' 0 N--CA 1.496 1.673 0 C-N-CA 121.257 1.305 . . . . 0.0 111.65 177.623 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' C' C ' 16' ' ' PRO . . . . . . . . . . . . . 38.4 Cg_exo -58.27 -39.79 81.52 Favored 'Trans proline' 0 N--CA 1.497 1.722 0 C-N-CA 121.428 1.419 . . . . 0.0 112.634 -178.718 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' C' C ' 17' ' ' ASP . . . . . . . . . . . . . 19.5 p-10 -87.79 12.76 12.13 Favored 'General case' 0 CA--C 1.536 0.421 0 N-CA-C 113.027 0.751 . . . . 0.0 113.027 -177.896 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' C' C ' 18' ' ' PHE . . . . . . . . . . . . . 45.9 t80 -57.85 -41.29 82.05 Favored 'General case' 0 C--O 1.228 -0.046 0 O-C-N 122.008 -0.432 . . . . 0.0 110.271 -178.664 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' C' C ' 19' ' ' VAL . . . . . . . . . . . . . 48.5 t -56.49 -43.83 79.0 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.271 0 CA-C-N 116.529 -0.305 . . . . 0.0 110.429 -179.484 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' C' C ' 20' ' ' ASP . . . . . . . . . . . . . 35.3 m-20 -60.31 -41.18 92.95 Favored 'General case' 0 C--N 1.33 -0.282 0 C-N-CA 120.872 -0.331 . . . . 0.0 110.719 -178.935 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' C' C ' 21' ' ' VAL . . . . . . . . . . . . . 47.9 t -63.33 -49.23 83.77 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 C-N-CA 120.836 -0.346 . . . . 0.0 110.344 -178.232 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' C' C ' 22' ' ' ILE . . . . . 0.478 HG22 HD12 ' C' ' 26' ' ' LEU . 50.6 mm -55.63 -47.57 78.79 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.268 0 CA-C-O 120.696 0.284 . . . . 0.0 110.828 179.482 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' C' C ' 23' ' ' ARG . . . . . . . . . . . . . 50.8 ttp180 -53.97 -50.65 66.06 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-O 120.619 0.247 . . . . 0.0 111.444 -177.832 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' C' C ' 24' ' ' ILE . . . . . . . . . . . . . 75.5 mt -58.66 -43.0 86.58 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.286 0 CA-C-N 116.688 -0.233 . . . . 0.0 111.139 -177.454 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' C' C ' 25' ' ' LYS . . . . . . . . . . . . . 42.8 mttm -65.37 -40.88 94.08 Favored 'General case' 0 C--N 1.328 -0.348 0 N-CA-C 112.223 0.453 . . . . 0.0 112.223 -178.264 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' C' C ' 26' ' ' LEU . . . . . 0.478 HD12 HG22 ' C' ' 22' ' ' ILE . 91.9 mt -79.98 -39.4 30.16 Favored 'General case' 0 C--N 1.33 -0.253 0 N-CA-C 113.546 0.943 . . . . 0.0 113.546 -170.061 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' C' C ' 27' ' ' GLN . . . . . . . . . . . . . 10.4 pt20 -46.35 138.71 5.36 Favored 'General case' 0 N--CA 1.47 0.527 0 N-CA-C 112.922 0.712 . . . . 0.0 112.922 -174.162 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' C' C ' 28' ' ' GLY . . . . . . . . . . . . . . . 99.95 -27.27 21.06 Favored Glycine 0 CA--C 1.534 1.263 0 CA-C-N 115.47 -0.786 . . . . 0.0 112.175 -177.074 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' C' C ' 29' ' ' LYS . . . . . . . . . . . . . 99.0 mttt -97.83 155.15 17.18 Favored 'General case' 0 C--O 1.234 0.272 0 CA-C-O 121.107 0.48 . . . . 0.0 111.26 179.457 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' C' C ' 30' ' ' THR . . . . . . . . . . . . . 36.2 m -104.82 138.93 40.33 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 115.903 -0.59 . . . . 0.0 110.057 176.14 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' C' C ' 31' ' ' VAL . . . . . . . . . . . . . 35.3 m -126.76 149.94 32.2 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.197 0 CA-C-O 120.878 0.37 . . . . 0.0 110.814 -178.702 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' C' C ' 32' ' ' ARG . . . . . . . . . . . . . 73.8 mtt85 -128.28 148.1 50.63 Favored 'General case' 0 C--N 1.331 -0.239 0 CA-C-N 116.041 -0.527 . . . . 0.0 110.481 178.788 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' C' C ' 33' ' ' THR . . . . . . . . . . . . . 11.2 m -52.68 137.89 29.96 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.292 -0.413 . . . . 0.0 111.497 -177.763 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' C' C ' 34' ' ' GLY . . . . . . . . . . . . . . . 101.31 -17.16 56.09 Favored Glycine 0 CA--C 1.532 1.134 0 CA-C-O 119.643 -0.532 . . . . 0.0 113.241 179.221 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' C' C ' 35' ' ' ASP . . . . . . . . . . . . . 77.9 m-20 -66.47 150.49 48.87 Favored 'General case' 0 N--CA 1.462 0.168 0 CA-C-N 118.062 0.931 . . . . 0.0 110.912 178.917 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' C' C ' 36' ' ' VAL . . . . . . . . . . . . . 43.9 t -124.49 132.57 71.15 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.264 0 CA-C-N 116.107 -0.497 . . . . 0.0 109.908 178.503 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' C' C ' 37' ' ' ILE . . . . . . . . . . . . . 64.3 mt -120.82 139.21 48.79 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.187 0 CA-C-N 116.065 -0.516 . . . . 0.0 109.863 -179.53 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' C' C ' 38' ' ' GLY . . . . . . . . . . . . . . . -116.16 128.7 8.1 Favored Glycine 0 CA--C 1.526 0.752 0 N-CA-C 110.922 -0.871 . . . . 0.0 110.922 178.826 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' C' C ' 39' ' ' ILE . . . . . . . . . . . . . 71.2 mt -124.53 135.27 64.4 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.215 0 CA-C-O 120.733 0.302 . . . . 0.0 110.209 179.806 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' C' C ' 40' ' ' SER . . . . . . . . . . . . . 78.9 p -92.05 121.99 34.12 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.2 -0.455 . . . . 0.0 110.885 176.942 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' C' C ' 41' ' ' ILE . . . . . . . . . . . . . 71.0 mt -130.68 120.69 48.62 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.166 0 CA-C-O 120.772 0.32 . . . . 0.0 110.461 178.07 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' C' C ' 42' ' ' LEU . . . . . . . . . . . . . 76.4 mt 53.21 35.32 19.66 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.141 -0.481 . . . . 0.0 111.703 177.349 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' C' C ' 43' ' ' GLY . . . . . . . . . . . . . . . 72.47 30.44 64.49 Favored Glycine 0 CA--C 1.53 0.994 0 C-N-CA 121.051 -0.595 . . . . 0.0 112.173 178.015 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' C' C ' 44' ' ' LYS . . . . . . . . . . . . . 29.5 ttmt -138.78 128.7 25.16 Favored 'General case' 0 C--N 1.33 -0.258 0 N-CA-C 109.616 -0.513 . . . . 0.0 109.616 178.195 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' C' C ' 45' ' ' GLU . . . . . . . . . . . . . 83.1 tt0 -83.8 124.25 30.73 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-O 120.705 0.288 . . . . 0.0 111.41 -177.566 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' C' C ' 46' ' ' VAL . . . . . 0.417 ' O ' HG13 ' C' ' 46' ' ' VAL . 10.2 p -115.89 123.1 70.84 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.245 0 N-CA-C 109.485 -0.561 . . . . 0.0 109.485 173.618 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' C' C ' 47' ' ' LYS . . . . . . . . . . . . . 61.9 mtpt -98.3 124.35 42.88 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.03 -0.532 . . . . 0.0 110.76 179.016 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' C' C ' 48' ' ' PHE . . . . . . . . . . . . . 32.7 m-85 -110.78 131.84 54.71 Favored 'General case' 0 C--N 1.33 -0.247 0 N-CA-C 109.659 -0.497 . . . . 0.0 109.659 177.178 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' C' C ' 49' ' ' LYS . . . . . . . . . . . . . 82.8 tttt -106.51 132.36 52.61 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.224 179.068 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' C' C ' 50' ' ' VAL . . . . . . . . . . . . . 42.7 t -75.92 103.54 3.52 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.335 0 N-CA-C 109.432 -0.581 . . . . 0.0 109.432 178.021 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' C' C ' 51' ' ' VAL . . . . . . . . . . . . . 44.9 t -69.47 -54.07 21.56 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 CA-C-N 115.898 -0.592 . . . . 0.0 109.449 -175.437 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' C' C ' 52' ' ' GLN . . . . . . . . . . . . . 89.1 mt-30 -153.27 150.73 29.26 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.007 -0.542 . . . . 0.0 111.531 -177.961 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' C' C ' 53' ' ' ALA . . . . . . . . . . . . . . . -126.92 131.65 51.06 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 115.157 -0.929 . . . . 0.0 109.478 174.637 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' C' C ' 54' ' ' TYR . . . . . . . . . . . . . 78.0 t80 -129.1 109.62 18.13 Favored Pre-proline 0 CA--C 1.534 0.359 0 CA-C-O 118.281 -0.866 . . . . 0.0 110.464 -179.17 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' C' C ' 55' ' ' PRO . . . . . . . . . . . . . 73.6 Cg_endo -77.15 170.02 72.68 Favored 'Cis proline' 0 N--CA 1.501 1.936 0 CA-C-N 121.895 1.713 . . . . 0.0 112.269 -6.057 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' C' C ' 56' ' ' SER . . . . . . . . . . . . . 13.6 m -116.28 131.15 23.96 Favored Pre-proline 0 CA--C 1.538 0.487 0 CA-C-O 118.46 -0.781 . . . . 0.0 109.36 174.972 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' C' C ' 57' ' ' PRO . . . . . . . . . . . . . 55.3 Cg_endo -71.38 146.83 86.3 Favored 'Cis proline' 0 N--CA 1.497 1.73 0 CA-C-N 121.996 1.749 . . . . 0.0 111.531 -1.055 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' C' C ' 58' ' ' LEU . . . . . 0.435 HD11 ' HB2' ' C' ' 2' ' ' SER . 14.4 tp -105.97 136.59 45.36 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.286 -0.416 . . . . 0.0 110.651 -178.422 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' C' C ' 59' ' ' ARG . . . . . . . . . . . . . 78.6 ttt180 -103.58 122.46 45.02 Favored 'General case' 0 C--N 1.327 -0.394 0 N-CA-C 109.308 -0.627 . . . . 0.0 109.308 175.788 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' C' C ' 60' ' ' VAL . . . . . . . . . . . . . 42.2 t -80.09 123.71 37.21 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.315 0 C-N-CA 120.704 -0.398 . . . . 0.0 110.48 -175.346 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' C' C ' 61' ' ' GLU . . . . . . . . . . . . . 95.6 mt-10 -130.84 164.25 25.62 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 115.705 -0.679 . . . . 0.0 109.745 177.645 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' C' C ' 62' ' ' ASP . . . . . . . . . . . . . 48.1 m-20 -53.37 -32.1 47.76 Favored 'General case' 0 C--N 1.327 -0.371 0 N-CA-C 111.895 0.331 . . . . 0.0 111.895 -179.178 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' C' C ' 63' ' ' ARG . . . . . . . . . . . . . 35.9 ptt180 -88.5 5.17 43.86 Favored 'General case' 0 CA--C 1.537 0.46 0 N-CA-C 113.676 0.991 . . . . 0.0 113.676 -174.929 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' C' C ' 64' ' ' THR . . . . . . . . . . . . . 26.0 m -84.59 141.66 30.52 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-N 118.19 0.45 . . . . 0.0 110.653 -178.7 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' C' C ' 65' ' ' LYS . . . . . . . . . . . . . 98.8 mttt -89.52 133.53 34.54 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-O 121.092 0.473 . . . . 0.0 110.646 -179.195 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' C' C ' 66' ' ' ILE . . . . . . . . . . . . . 60.4 mt -114.15 127.26 71.66 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.237 0 N-CA-C 109.579 -0.526 . . . . 0.0 109.579 179.482 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' C' C ' 67' ' ' THR . . . . . . . . . . . . . 15.1 m -120.5 142.66 49.1 Favored 'General case' 0 C--N 1.331 -0.214 0 CA-C-O 121.176 0.512 . . . . 0.0 111.149 -175.597 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' C' C ' 68' ' ' LEU . . . . . . . . . . . . . 34.2 mt -104.82 145.75 29.94 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 115.761 -0.654 . . . . 0.0 110.534 179.605 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' C' C ' 69' ' ' VAL . . . . . . . . . . . . . 46.9 t -82.97 155.02 3.84 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.351 0 N-CA-C 109.757 -0.46 . . . . 0.0 109.757 176.394 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' C' C ' 70' ' ' THR . . . . . . . . . . . . . 66.1 p -83.16 171.0 14.14 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-O 121.226 0.536 . . . . 0.0 111.701 -172.502 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' C' C ' 71' ' ' HIS . . . . . . . . . . . . . 69.5 m80 -69.57 161.14 76.21 Favored Pre-proline 0 CA--C 1.533 0.308 0 CA-C-N 115.343 -0.844 . . . . 0.0 111.561 -176.464 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' C' C ' 72' ' ' PRO . . . . . . . . . . . . . 28.6 Cg_endo -64.98 160.23 42.46 Favored 'Trans proline' 0 N--CA 1.495 1.601 0 C-N-CA 121.537 1.492 . . . . 0.0 111.97 175.909 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' C' C ' 73' ' ' VAL . . . . . . . . . . . . . 34.6 m -69.91 -178.72 0.26 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.25 0 CA-C-N 116.174 -0.466 . . . . 0.0 110.618 -176.128 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' C' C ' 74' ' ' ASP . . . . . . . . . . . . . 15.7 t0 -96.06 122.75 39.22 Favored 'General case' 0 C--N 1.333 -0.147 0 C-N-CA 120.753 -0.379 . . . . 0.0 110.489 -174.094 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' C' C ' 75' ' ' VAL . . . . . . . . . . . . . 41.2 t -121.07 121.17 64.28 Favored 'Isoleucine or valine' 0 N--CA 1.462 0.166 0 CA-C-O 121.119 0.485 . . . . 0.0 110.498 -179.364 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' C' C ' 76' ' ' LEU . . . . . . . . . . . . . 5.4 mp -118.01 150.78 38.71 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 115.651 -0.704 . . . . 0.0 109.501 175.833 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' C' C ' 77' ' ' GLU . . . . . . . . . . . . . 97.7 mt-10 -136.87 136.59 38.84 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-O 121.042 0.449 . . . . 0.0 111.214 -177.769 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' C' C ' 78' ' ' ALA . . . . . 0.618 ' HB2' HD21 ' C' ' 109' ' ' LEU . . . -124.77 135.91 53.39 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 115.669 -0.696 . . . . 0.0 109.712 176.353 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' C' C ' 79' ' ' LYS . . . . . 0.664 ' O ' HD13 ' C' ' 80' ' ' ILE . 99.0 mttt -81.73 119.04 23.35 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-O 120.913 0.387 . . . . 0.0 110.757 -178.498 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' C' C ' 80' ' ' ILE . . . . . 0.664 HD13 ' O ' ' C' ' 79' ' ' LYS . 35.5 mm -139.1 105.6 2.61 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.334 0 N-CA-C 109.22 -0.659 . . . . 0.0 109.22 -178.013 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' C' C ' 81' ' ' LYS . . . . . . . . . . . . . 53.4 mtmt -98.12 125.24 43.04 Favored 'General case' 0 C--N 1.329 -0.314 0 C-N-CA 120.95 -0.3 . . . . 0.0 111.167 -176.934 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' C' C ' 82' ' ' GLY . . . . . . . . . . . . . . . 89.17 42.04 5.69 Favored Glycine 0 CA--C 1.526 0.728 0 C-N-CA 120.786 -0.721 . . . . 0.0 112.048 174.816 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' C' C ' 83' ' ' ILE . . . . . . . . . . . . . 76.5 mt -69.8 138.3 22.38 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.336 0 N-CA-C 109.676 -0.491 . . . . 0.0 109.676 176.749 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' C' C ' 84' ' ' LYS . . . . . . . . . . . . . 38.0 ttpt -101.58 -50.56 3.69 Favored 'General case' 0 C--N 1.331 -0.23 0 CA-C-O 120.942 0.401 . . . . 0.0 110.381 -178.77 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' C' C ' 85' ' ' ASP . . . . . . . . . . . . . 6.6 t0 -149.65 147.51 28.19 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 115.938 -0.574 . . . . 0.0 110.509 -178.572 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' C' C ' 86' ' ' VAL . . . . . . . . . . . . . 43.7 t -129.35 133.64 65.12 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.215 0 CA-C-O 120.925 0.393 . . . . 0.0 110.414 -179.043 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' C' C ' 87' ' ' ILE . . . . . 0.502 ' N ' HD12 ' C' ' 87' ' ' ILE . 4.9 mp -121.94 127.6 75.42 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.215 0 CA-C-N 115.854 -0.612 . . . . 0.0 109.449 176.62 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' C' C ' 88' ' ' LEU . . . . . . . . . . . . . 22.3 tp -118.07 131.52 56.44 Favored 'General case' 0 C--N 1.331 -0.221 0 CA-C-O 121.078 0.466 . . . . 0.0 111.339 -177.279 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' C' C ' 89' ' ' ASP . . . . . . . . . . . . . 14.0 t70 -130.84 152.02 50.63 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 115.616 -0.72 . . . . 0.0 109.293 174.987 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' C' C ' 90' ' ' GLU . . . . . . . . . . . . . 84.9 tt0 -47.81 -35.73 10.62 Favored 'General case' 0 C--N 1.329 -0.286 0 N-CA-C 113.079 0.77 . . . . 0.0 113.079 -172.299 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' C' C ' 91' ' ' ASN . . . . . . . . . . . . . 35.9 m120 -115.4 2.88 14.03 Favored 'General case' 0 N--CA 1.468 0.462 0 N-CA-C 113.734 1.012 . . . . 0.0 113.734 -174.664 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' C' C ' 92' ' ' LEU . . . . . . . . . . . . . 40.7 mt -148.77 147.31 28.66 Favored 'General case' 0 C--N 1.332 -0.196 0 CA-C-N 118.305 0.502 . . . . 0.0 110.972 -175.228 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' C' C ' 93' ' ' ILE . . . . . . . . . . . . . 69.4 mt -125.18 122.05 62.16 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.278 0 N-CA-C 109.383 -0.599 . . . . 0.0 109.383 176.998 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' C' C ' 94' ' ' VAL . . . . . 0.433 HG21 HG21 ' C' ' 125' ' ' VAL . 42.9 t -121.87 127.12 75.34 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.267 0 CA-C-O 120.802 0.334 . . . . 0.0 110.155 -179.448 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' C' C ' 95' ' ' VAL . . . . . . . . . . . . . 45.8 t -122.7 132.64 70.86 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.249 0 CA-C-N 116.094 -0.503 . . . . 0.0 109.786 179.151 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' C' C ' 96' ' ' ILE . . . . . . . . . . . . . 62.7 mt -115.77 128.37 73.05 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.247 0 N-CA-C 109.433 -0.581 . . . . 0.0 109.433 179.75 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' C' C ' 97' ' ' THR . . . . . . . . . . . . . 64.9 p -105.3 163.16 12.82 Favored 'General case' 0 N--CA 1.464 0.233 0 CA-C-O 121.244 0.545 . . . . 0.0 111.68 -174.636 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' C' C ' 98' ' ' GLU . . . . . . . . . . . . . 14.9 mm-40 -53.78 -27.29 28.11 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 115.933 -0.576 . . . . 0.0 112.203 177.676 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' C' C ' 99' ' ' GLU . . . . . . . . . . . . . 71.1 mm-40 -75.26 9.74 1.93 Allowed 'General case' 0 CA--C 1.535 0.395 0 N-CA-C 113.284 0.846 . . . . 0.0 113.284 -177.681 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' C' C ' 100' ' ' ASN . . . . . . . . . . . . . 3.1 m-20 61.03 31.63 19.86 Favored 'General case' 0 CA--C 1.534 0.342 0 CA-C-N 118.268 0.485 . . . . 0.0 111.302 -178.611 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' C' C ' 101' ' ' GLU . . . . . . . . . . . . . 84.5 tt0 -109.63 145.14 36.95 Favored 'General case' 0 C--O 1.233 0.199 0 N-CA-C 109.729 -0.471 . . . . 0.0 109.729 174.569 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' C' C ' 102' ' ' VAL . . . . . . . . . . . . . 45.2 t -114.99 124.12 71.34 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.302 0 CA-C-N 116.137 -0.483 . . . . 0.0 109.783 -179.834 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' C' C ' 103' ' ' LEU . . . . . . . . . . . . . 21.5 mt -112.26 127.69 56.05 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 115.845 -0.616 . . . . 0.0 109.982 176.902 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' C' C ' 104' ' ' ILE . . . . . . . . . . . . . 66.3 mt -116.88 119.74 62.92 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.261 0 N-CA-C 110.268 -0.271 . . . . 0.0 110.268 -179.728 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' C' C ' 105' ' ' PHE . . . . . . . . . . . . . 44.7 m-85 -119.83 168.87 10.66 Favored 'General case' 0 C--N 1.332 -0.158 0 CA-C-N 115.421 -0.809 . . . . 0.0 110.078 179.183 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' C' C ' 106' ' ' ASN . . . . . . . . . . . . . 46.9 p-10 -103.02 -170.48 1.8 Allowed 'General case' 0 CA--C 1.53 0.187 0 N-CA-C 110.018 -0.364 . . . . 0.0 110.018 174.46 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' C' C ' 107' ' ' GLN . . . . . . . . . . . . . 57.0 tt0 -60.94 -23.2 65.12 Favored 'General case' 0 CA--C 1.532 0.272 0 N-CA-C 112.52 0.563 . . . . 0.0 112.52 -179.803 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' C' C ' 108' ' ' ASN . . . . . . . . . . . . . 37.5 t30 -89.88 14.02 13.12 Favored 'General case' 0 CA--C 1.536 0.406 0 N-CA-C 112.89 0.7 . . . . 0.0 112.89 -179.413 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' C' C ' 109' ' ' LEU . . . . . 0.618 HD21 ' HB2' ' C' ' 78' ' ' ALA . 10.4 tp 54.96 37.95 29.68 Favored 'General case' 0 C--O 1.232 0.144 0 CA-C-O 121.036 0.446 . . . . 0.0 111.225 178.732 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' C' C ' 110' ' ' GLU . . . . . . . . . . . . . 70.7 mm-40 -107.98 155.93 19.79 Favored 'General case' 0 C--N 1.331 -0.237 0 N-CA-C 109.921 -0.4 . . . . 0.0 109.921 175.423 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' C' C ' 111' ' ' GLU . . . . . . . . . . . . . 65.8 tt0 -84.56 122.02 28.43 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-N 116.278 -0.419 . . . . 0.0 111.053 -176.245 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' C' C ' 112' ' ' LEU . . . . . . . . . . . . . 36.2 mt -105.44 -46.04 4.3 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.343 -0.39 . . . . 0.0 110.376 177.58 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' C' C ' 113' ' ' TYR . . . . . . . . . . . . . 56.8 t80 -143.68 141.35 30.5 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.301 -0.409 . . . . 0.0 110.966 -179.487 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' C' C ' 114' ' ' ARG . . . . . . . . . . . . . 58.2 ttp180 -139.45 125.27 19.6 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.248 -0.433 . . . . 0.0 110.332 177.642 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' C' C ' 115' ' ' GLY . . . . . . . . . . . . . . . -149.97 151.11 23.23 Favored Glycine 0 CA--C 1.524 0.624 0 N-CA-C 110.905 -0.878 . . . . 0.0 110.905 -179.963 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' C' C ' 116' ' ' LYS . . . . . . . . . . . . . 53.3 tttt -122.09 134.85 54.76 Favored 'General case' 0 C--N 1.328 -0.355 0 N-CA-C 110.021 -0.363 . . . . 0.0 110.021 179.03 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' C' C ' 117' ' ' PHE . . . . . . . . . . . . . 40.9 m-85 -132.31 114.95 15.01 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-N 116.256 -0.429 . . . . 0.0 110.2 -175.921 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' C' C ' 118' ' ' GLU . . . . . . . . . . . . . 43.2 mt-10 -53.32 -44.95 68.8 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.478 -0.328 . . . . 0.0 111.599 -176.625 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' C' C ' 119' ' ' ASN . . . . . . . . . . . . . 30.4 m120 -100.06 31.07 3.46 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.238 -0.437 . . . . 0.0 112.098 -174.271 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' C' C ' 120' ' ' LEU . . . . . . . . . . . . . 13.2 tp -55.39 119.83 6.19 Favored 'General case' 0 N--CA 1.462 0.174 0 C-N-CA 120.984 -0.286 . . . . 0.0 110.696 178.456 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' C' C ' 121' ' ' ASN . . . . . . . . . . . . . 8.2 t-20 -113.98 -44.07 3.19 Favored 'General case' 0 C--N 1.331 -0.209 0 CA-C-N 116.477 -0.329 . . . . 0.0 111.257 -175.884 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' C' C ' 122' ' ' LYS . . . . . . . . . . . . . 95.1 mttt -142.13 148.74 38.8 Favored 'General case' 0 C--N 1.331 -0.216 0 CA-C-O 121.055 0.455 . . . . 0.0 111.602 -176.255 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' C' C ' 123' ' ' VAL . . . . . . . . . . . . . 47.1 t -132.04 124.58 53.21 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.267 0 CA-C-N 115.846 -0.616 . . . . 0.0 109.418 174.222 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' C' C ' 124' ' ' LEU . . . . . . . . . . . . . 6.3 mp -119.71 134.72 55.12 Favored 'General case' 0 N--CA 1.463 0.191 0 CA-C-N 116.453 -0.34 . . . . 0.0 110.711 -178.118 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' C' C ' 125' ' ' VAL . . . . . 0.519 HG22 HG23 ' C' ' 130' ' ' VAL . 43.5 t -132.58 124.23 50.95 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.254 0 CA-C-N 116.144 -0.48 . . . . 0.0 110.183 -179.82 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' C' C ' 126' ' ' ARG . . . . . . . . . . . . . 59.9 mtm180 -151.86 135.74 16.42 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.32 -0.4 . . . . 0.0 109.95 176.7 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' C' C ' 127' ' ' ASN . . . . . . . . . . . . . 5.5 m120 55.0 -154.22 0.3 Allowed 'General case' 0 CA--C 1.54 0.559 0 N-CA-C 110.073 -0.343 . . . . 0.0 110.073 177.852 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' C' C ' 128' ' ' ASP . . . . . . . . . . . . . 15.1 p-10 -83.05 20.74 1.16 Allowed 'General case' 0 CA--C 1.533 0.309 0 N-CA-C 112.509 0.559 . . . . 0.0 112.509 178.13 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' C' C ' 129' ' ' LEU . . . . . . . . . . . . . 14.5 tp -123.15 137.1 54.99 Favored 'General case' 0 C--O 1.234 0.269 0 O-C-N 122.052 -0.405 . . . . 0.0 110.311 179.091 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' C' C ' 130' ' ' VAL . . . . . 0.519 HG23 HG22 ' C' ' 125' ' ' VAL . 12.3 p -132.74 143.29 40.07 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.255 0 CA-C-O 120.999 0.428 . . . . 0.0 110.2 179.412 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' C' C ' 131' ' ' VAL . . . . . . . . . . . . . 41.5 t -136.04 138.93 46.72 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.37 0 CA-C-N 116.032 -0.531 . . . . 0.0 110.339 -178.436 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' C' C ' 132' ' ' ILE . . . . . . . . . . . . . 71.3 mt -116.09 132.45 65.59 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.323 0 CA-C-N 115.614 -0.721 . . . . 0.0 109.141 177.683 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' C' C ' 133' ' ' ILE . . . . . . . . . . . . . 41.4 mm -116.8 121.61 68.12 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.237 0 CA-C-O 120.753 0.311 . . . . 0.0 110.927 -174.464 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' C' C ' 134' ' ' ASP . . . . . . . . . . . . . 8.1 p-10 -135.42 146.48 48.31 Favored 'General case' 0 C--N 1.332 -0.18 0 CA-C-N 116.006 -0.543 . . . . 0.0 109.589 175.316 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' C' C ' 135' ' ' GLU . . . . . . . . . . . . . 83.2 tt0 -50.53 -27.67 7.09 Favored 'General case' 0 C--N 1.329 -0.321 0 N-CA-C 112.827 0.677 . . . . 0.0 112.827 -172.967 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' C' C ' 136' ' ' GLN . . . . . . . . . . . . . 98.4 mt-30 -79.7 -33.24 41.19 Favored 'General case' 0 C--N 1.331 -0.203 0 N-CA-C 112.263 0.468 . . . . 0.0 112.263 -176.226 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' C' C ' 137' ' ' LYS . . . . . . . . . . . . . 56.1 pttt -169.74 174.7 5.61 Favored 'General case' 0 C--N 1.331 -0.21 0 CA-C-O 121.524 0.678 . . . . 0.0 112.257 -172.894 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' C' C ' 138' ' ' LEU . . . . . 0.41 HD23 ' N ' ' C' ' 139' ' ' THR . 6.0 tt -119.14 130.38 55.51 Favored 'General case' 0 C--N 1.331 -0.226 0 CA-C-N 114.973 -1.012 . . . . 0.0 110.236 -179.109 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' C' C ' 139' ' ' THR . . . . . 0.41 ' N ' HD23 ' C' ' 138' ' ' LEU . 21.7 m -108.52 121.76 45.65 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.141 -0.482 . . . . 0.0 110.755 179.551 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' C' C ' 140' ' ' LEU . . . . . . . . . . . . . 33.3 tp -109.59 118.9 37.8 Favored 'General case' 0 C--N 1.329 -0.283 0 N-CA-C 109.058 -0.719 . . . . 0.0 109.058 -179.975 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' C' C ' 141' ' ' ILE . . . . . 0.516 ' HB ' HG13 ' C' ' 130' ' ' VAL . 22.1 mt -121.82 121.61 64.72 Favored 'Isoleucine or valine' 0 C--O 1.234 0.259 0 CA-C-O 121.089 0.471 . . . . 0.0 110.225 -175.627 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' C' C ' 142' ' ' ARG . . . . . . . . . . . . . 80.6 mtp180 -103.6 116.56 32.58 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 115.273 -0.876 . . . . 0.0 110.111 178.265 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' C' C ' 143' ' ' THR . . . . . . . . . . . . . 71.4 p . . . . . 0 C--O 1.219 -0.519 0 CA-C-O 117.992 -1.004 . . . . 0.0 110.528 -179.453 . . . . . . . . 0 0 . 1 . 004 nuclear nobuild full ' D' D ' -3' ' ' GLU . . . . . . . . . . . . . 96.0 mt-10 . . . . . 0 N--CA 1.489 1.524 0 N-CA-C 109.446 -0.576 . . . . 0.0 109.446 . . . . . . . . . 0 0 . 1 . 004 nuclear nobuild full ' D' D ' -2' ' ' GLY . . . . . . . . . . . . . . . -97.81 121.76 7.23 Favored Glycine 0 CA--C 1.526 0.767 0 N-CA-C 110.733 -0.947 . . . . 0.0 110.733 179.271 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' D' D ' -1' ' ' VAL . . . . . . . . . . . . . 43.7 t -95.85 134.33 33.74 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.317 0 CA-C-O 120.78 0.324 . . . . 0.0 110.163 -179.642 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' D' D ' 0' ' ' ILE . . . . . . . . . . . . . 43.9 mm -113.66 138.19 44.22 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.237 0 CA-C-N 116.265 -0.425 . . . . 0.0 110.15 -179.529 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' D' D ' 1' ' ' MET . . . . . . . . . . . . . 24.9 ptp -84.04 132.24 34.74 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.701 179.974 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' D' D ' 2' ' ' SER . . . . . . . . . . . . . 18.2 p -125.83 136.97 53.7 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.125 -0.489 . . . . 0.0 110.274 178.582 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' D' D ' 3' ' ' GLU . . . . . . . . . . . . . 75.4 tt0 -148.0 139.23 23.46 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.235 -0.439 . . . . 0.0 111.305 -176.816 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' D' D ' 4' ' ' LEU . . . . . . . . . . . . . 16.1 tp -124.01 130.2 52.18 Favored 'General case' 0 C--N 1.331 -0.214 0 CA-C-N 116.051 -0.522 . . . . 0.0 110.031 176.477 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' D' D ' 5' ' ' LYS . . . . . . . . . . . . . 65.3 mttm -112.66 123.22 49.81 Favored 'General case' 0 C--O 1.233 0.215 0 CA-C-N 116.516 -0.311 . . . . 0.0 110.944 -179.734 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' D' D ' 6' ' ' LEU . . . . . . . . . . . . . 55.0 mt -115.72 143.19 45.72 Favored 'General case' 0 N--CA 1.463 0.206 0 CA-C-N 115.609 -0.723 . . . . 0.0 110.63 -179.299 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' D' D ' 7' ' ' LYS . . . . . . . . . . . . . 52.1 tttm -124.36 139.37 32.77 Favored Pre-proline 0 CA--C 1.536 0.409 0 CA-C-O 118.88 -0.581 . . . . 0.0 109.434 175.474 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' D' D ' 8' ' ' PRO . . . . . . . . . . . . . 86.4 Cg_endo -91.72 143.07 2.84 Favored 'Trans proline' 0 N--CA 1.491 1.363 0 C-N-CA 121.707 1.605 . . . . 0.0 112.026 179.647 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' D' D ' 9' ' ' LEU . . . . . . . . . . . . . 48.9 mt -81.98 -46.59 1.01 Allowed Pre-proline 0 CA--C 1.533 0.302 0 CA-C-O 118.757 -0.64 . . . . 0.0 112.113 178.595 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' D' D ' 10' ' ' PRO . . . . . . . . . . . . . 83.6 Cg_endo -83.46 151.5 13.43 Favored 'Trans proline' 0 N--CA 1.495 1.57 0 C-N-CA 121.316 1.344 . . . . 0.0 111.693 174.928 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' D' D ' 11' ' ' LYS . . . . . . . . . . . . . 53.4 pttt -84.98 116.68 23.51 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-O 121.234 0.54 . . . . 0.0 110.144 177.41 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' D' D ' 12' ' ' VAL . . . . . . . . . . . . . 12.1 p -151.06 149.63 14.01 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.223 0 CA-C-N 116.023 -0.535 . . . . 0.0 110.777 -178.457 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' D' D ' 13' ' ' GLU . . . . . . . . . . . . . 84.7 tt0 -99.16 111.69 24.02 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.262 -0.426 . . . . 0.0 110.225 177.164 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' D' D ' 14' ' ' LEU . . . . . . . . . . . . . 20.0 mt -98.37 158.05 33.32 Favored Pre-proline 0 C--N 1.33 -0.274 0 CA-C-N 116.513 -0.312 . . . . 0.0 111.27 -177.469 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' D' D ' 15' ' ' PRO . . . . . . . . . . . . . 23.1 Cg_exo -64.72 161.53 35.48 Favored 'Trans proline' 0 N--CA 1.496 1.671 0 C-N-CA 121.424 1.416 . . . . 0.0 111.876 176.973 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' D' D ' 16' ' ' PRO . . . . . . . . . . . . . 24.6 Cg_exo -62.2 -39.8 45.81 Favored 'Trans proline' 0 N--CA 1.496 1.667 0 C-N-CA 121.53 1.487 . . . . 0.0 112.622 -179.182 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' D' D ' 17' ' ' ASP . . . . . . . . . . . . . 16.2 p-10 -84.66 9.58 13.46 Favored 'General case' 0 CA--C 1.537 0.446 0 N-CA-C 113.175 0.805 . . . . 0.0 113.175 -177.109 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' D' D ' 18' ' ' PHE . . . . . 0.434 ' HE1' HD13 ' D' ' 41' ' ' ILE . 48.0 t80 -56.64 -46.47 81.0 Favored 'General case' 0 C--N 1.334 -0.097 0 O-C-N 121.983 -0.448 . . . . 0.0 110.465 -178.397 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' D' D ' 19' ' ' VAL . . . . . . . . . . . . . 48.0 t -56.65 -42.7 77.22 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.338 0 CA-C-N 116.354 -0.385 . . . . 0.0 110.595 -178.006 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' D' D ' 20' ' ' ASP . . . . . . . . . . . . . 9.9 t0 -59.63 -42.46 92.76 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-O 120.79 0.329 . . . . 0.0 110.839 -177.82 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' D' D ' 21' ' ' VAL . . . . . . . . . . . . . 46.5 t -64.02 -45.96 95.21 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.257 0 C-N-CA 120.806 -0.358 . . . . 0.0 110.479 -178.524 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' D' D ' 22' ' ' ILE . . . . . 0.446 HG22 HD12 ' D' ' 26' ' ' LEU . 51.4 mm -54.33 -48.49 67.86 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.258 0 O-C-N 122.289 -0.257 . . . . 0.0 110.812 178.812 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' D' D ' 23' ' ' ARG . . . . . . . . . . . . . 54.1 ttp180 -54.24 -52.12 62.35 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-O 120.793 0.33 . . . . 0.0 111.43 -178.905 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' D' D ' 24' ' ' ILE . . . . . . . . . . . . . 71.4 mt -56.85 -44.2 81.58 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.315 0 CA-C-N 116.541 -0.299 . . . . 0.0 111.271 -174.703 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' D' D ' 25' ' ' LYS . . . . . . . . . . . . . 80.9 mttt -69.34 -43.95 72.64 Favored 'General case' 0 C--N 1.329 -0.311 0 N-CA-C 112.428 0.529 . . . . 0.0 112.428 -177.466 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' D' D ' 26' ' ' LEU . . . . . 0.446 HD12 HG22 ' D' ' 22' ' ' ILE . 59.3 mt -83.35 -16.15 47.17 Favored 'General case' 0 C--N 1.329 -0.307 0 N-CA-C 113.786 1.032 . . . . 0.0 113.786 -170.12 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' D' D ' 27' ' ' GLN . . . . . . . . . . . . . 11.0 pt20 -46.65 151.44 0.58 Allowed 'General case' 0 N--CA 1.468 0.439 0 N-CA-C 112.837 0.68 . . . . 0.0 112.837 -177.013 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' D' D ' 28' ' ' GLY . . . . . . . . . . . . . . . 84.74 -18.18 27.07 Favored Glycine 0 CA--C 1.537 1.438 0 CA-C-N 114.937 -1.029 . . . . 0.0 113.055 -173.636 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' D' D ' 29' ' ' LYS . . . . . . . . . . . . . 51.7 mttm -86.5 134.81 33.64 Favored 'General case' 0 CA--C 1.535 0.371 0 CA-C-N 118.273 1.037 . . . . 0.0 112.596 179.343 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' D' D ' 30' ' ' THR . . . . . . . . . . . . . 26.7 m -88.73 132.77 34.46 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 115.531 -0.759 . . . . 0.0 109.593 175.791 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' D' D ' 31' ' ' VAL . . . . . . . . . . . . . 35.0 m -126.46 148.8 31.14 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.29 0 CA-C-O 120.767 0.318 . . . . 0.0 111.066 -177.532 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' D' D ' 32' ' ' ARG . . . . . . . . . . . . . 75.6 mtt180 -131.29 151.07 51.85 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 116.056 -0.52 . . . . 0.0 110.381 177.764 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' D' D ' 33' ' ' THR . . . . . . . . . . . . . 12.6 m -52.93 137.63 32.02 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.243 -0.435 . . . . 0.0 111.43 -178.49 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' D' D ' 34' ' ' GLY . . . . . . . . . . . . . . . 100.74 -17.1 56.97 Favored Glycine 0 CA--C 1.533 1.177 0 CA-C-O 119.642 -0.532 . . . . 0.0 113.228 178.779 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' D' D ' 35' ' ' ASP . . . . . . . . . . . . . 62.1 m-20 -65.34 150.32 48.48 Favored 'General case' 0 C--O 1.232 0.156 0 CA-C-N 118.038 0.919 . . . . 0.0 111.224 -179.733 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' D' D ' 36' ' ' VAL . . . . . . . . . . . . . 46.8 t -121.22 128.27 75.95 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.272 0 CA-C-N 115.776 -0.647 . . . . 0.0 109.682 178.031 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' D' D ' 37' ' ' ILE . . . . . . . . . . . . . 65.2 mt -122.25 139.24 49.8 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.243 0 CA-C-N 116.159 -0.473 . . . . 0.0 109.807 -179.29 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' D' D ' 38' ' ' GLY . . . . . . . . . . . . . . . -118.47 128.9 7.92 Favored Glycine 0 CA--C 1.526 0.721 0 N-CA-C 111.2 -0.76 . . . . 0.0 111.2 -179.613 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' D' D ' 39' ' ' ILE . . . . . . . . . . . . . 70.3 mt -124.7 130.51 73.39 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.179 0 N-CA-C 109.881 -0.414 . . . . 0.0 109.881 178.196 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' D' D ' 40' ' ' SER . . . . . . . . . . . . . 18.4 m -92.47 124.83 36.8 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.301 -0.409 . . . . 0.0 111.116 177.634 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' D' D ' 41' ' ' ILE . . . . . 0.434 HD13 ' HE1' ' D' ' 18' ' ' PHE . 66.8 mt -135.65 122.84 34.97 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.204 0 N-CA-C 110.02 -0.363 . . . . 0.0 110.02 177.749 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' D' D ' 42' ' ' LEU . . . . . . . . . . . . . 68.2 mt 58.2 35.2 24.83 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.176 -0.465 . . . . 0.0 111.522 178.124 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' D' D ' 43' ' ' GLY . . . . . . . . . . . . . . . 77.88 -10.19 27.05 Favored Glycine 0 CA--C 1.534 1.261 0 C-N-CA 121.235 -0.507 . . . . 0.0 113.418 177.278 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' D' D ' 44' ' ' LYS . . . . . . . . . . . . . 57.7 tttm -102.91 131.52 49.78 Favored 'General case' 0 C--N 1.334 -0.071 0 CA-C-N 118.007 0.903 . . . . 0.0 110.144 177.857 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' D' D ' 45' ' ' GLU . . . . . . . . . . . . . 83.6 tt0 -85.77 133.23 34.01 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.328 -0.396 . . . . 0.0 111.539 -179.318 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' D' D ' 46' ' ' VAL . . . . . . . . . . . . . 9.6 p -120.24 123.96 71.67 Favored 'Isoleucine or valine' 0 C--O 1.233 0.208 0 N-CA-C 109.42 -0.585 . . . . 0.0 109.42 173.206 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' D' D ' 47' ' ' LYS . . . . . . . . . . . . . 98.2 mttt -98.72 127.73 44.74 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.092 -0.504 . . . . 0.0 110.79 178.594 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' D' D ' 48' ' ' PHE . . . . . . . . . . . . . 35.9 m-85 -112.17 131.92 55.19 Favored 'General case' 0 C--N 1.33 -0.263 0 N-CA-C 109.714 -0.476 . . . . 0.0 109.714 177.362 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' D' D ' 49' ' ' LYS . . . . . . . . . . . . . 79.5 tttt -107.07 133.04 52.29 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.325 -0.398 . . . . 0.0 109.967 177.531 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' D' D ' 50' ' ' VAL . . . . . . . . . . . . . 43.2 t -76.71 109.83 11.49 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.339 0 N-CA-C 109.631 -0.507 . . . . 0.0 109.631 179.001 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' D' D ' 51' ' ' VAL . . . . . . . . . . . . . 47.3 t -74.17 -48.37 37.65 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.35 0 CA-C-N 116.057 -0.52 . . . . 0.0 109.918 -175.179 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' D' D ' 52' ' ' GLN . . . . . . . . . . . . . 48.4 tt0 -160.72 137.75 9.03 Favored 'General case' 0 C--N 1.33 -0.266 0 C-N-CA 120.299 -0.56 . . . . 0.0 111.595 -178.121 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' D' D ' 53' ' ' ALA . . . . . . . . . . . . . . . -116.64 132.12 56.77 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 115.975 -0.557 . . . . 0.0 109.744 174.619 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' D' D ' 54' ' ' TYR . . . . . . . . . . . . . 50.7 t80 -129.01 112.02 18.51 Favored Pre-proline 0 CA--C 1.535 0.385 0 CA-C-O 118.166 -0.921 . . . . 0.0 110.346 179.12 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' D' D ' 55' ' ' PRO . . . . . . . . . . . . . 73.8 Cg_endo -77.18 168.73 76.1 Favored 'Cis proline' 0 N--CA 1.499 1.822 0 CA-C-N 122.061 1.772 . . . . 0.0 112.368 -6.223 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' D' D ' 56' ' ' SER . . . . . . . . . . . . . 13.5 m -117.11 126.57 27.34 Favored Pre-proline 0 CA--C 1.538 0.505 0 CA-C-O 118.347 -0.835 . . . . 0.0 109.108 174.732 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' D' D ' 57' ' ' PRO . . . . . . . . . . . . . 49.6 Cg_endo -69.55 146.66 82.37 Favored 'Cis proline' 0 N--CA 1.497 1.683 0 CA-C-N 122.063 1.772 . . . . 0.0 112.044 1.934 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' D' D ' 58' ' ' LEU . . . . . . . . . . . . . 17.5 tp -106.28 135.09 48.38 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 115.99 -0.55 . . . . 0.0 110.641 179.745 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' D' D ' 59' ' ' ARG . . . . . . . . . . . . . 1.5 tpm_? -104.58 107.59 18.6 Favored 'General case' 0 C--N 1.327 -0.401 0 N-CA-C 109.01 -0.737 . . . . 0.0 109.01 178.473 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' D' D ' 60' ' ' VAL . . . . . . . . . . . . . 43.1 t -72.69 108.72 4.25 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.378 0 CA-C-O 121.449 0.642 . . . . 0.0 112.005 -174.643 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' D' D ' 61' ' ' GLU . . . . . . . . . . . . . 95.7 mt-10 -125.16 167.21 15.13 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.269 -0.423 . . . . 0.0 109.892 175.624 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' D' D ' 62' ' ' ASP . . . . . . . . . . . . . 7.6 t0 -52.85 -32.36 44.12 Favored 'General case' 0 C--N 1.328 -0.36 0 N-CA-C 112.066 0.395 . . . . 0.0 112.066 -177.035 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' D' D ' 63' ' ' ARG . . . . . . . . . . . . . 34.5 ptt180 -73.66 -17.32 61.16 Favored 'General case' 0 CA--C 1.535 0.38 0 N-CA-C 113.282 0.845 . . . . 0.0 113.282 -175.743 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' D' D ' 64' ' ' THR . . . . . . . . . . . . . 32.6 m -77.54 143.75 38.16 Favored 'General case' 0 C--N 1.331 -0.229 0 CA-C-O 120.872 0.368 . . . . 0.0 111.048 -175.511 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' D' D ' 65' ' ' LYS . . . . . . . . . . . . . 99.1 mttt -89.17 134.62 33.95 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 115.977 -0.556 . . . . 0.0 110.313 178.591 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' D' D ' 66' ' ' ILE . . . . . . . . . . . . . 69.2 mt -118.7 127.66 75.64 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.228 0 N-CA-C 109.733 -0.469 . . . . 0.0 109.733 178.625 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' D' D ' 67' ' ' THR . . . . . . . . . . . . . 20.2 m -116.02 135.87 53.56 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.113 -0.494 . . . . 0.0 110.948 -176.72 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' D' D ' 68' ' ' LEU . . . . . . . . . . . . . 16.7 tp -106.33 121.53 44.42 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 115.726 -0.67 . . . . 0.0 110.319 178.553 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' D' D ' 69' ' ' VAL . . . . . . . . . . . . . 44.1 t -100.24 135.14 37.36 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.321 0 N-CA-C 109.904 -0.406 . . . . 0.0 109.904 179.334 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' D' D ' 70' ' ' THR . . . . . . . . . . . . . 19.9 m -132.32 107.12 8.33 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-N 116.281 -0.418 . . . . 0.0 110.601 -178.668 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' D' D ' 71' ' ' HIS . . . . . . . . . . . . . 31.7 m80 -150.01 65.56 7.52 Favored Pre-proline 0 CA--C 1.536 0.436 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.549 177.89 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' D' D ' 72' ' ' PRO . . . . . . . . . . . . . 98.5 Cg_endo -89.92 159.05 4.98 Favored 'Trans proline' 0 N--CA 1.49 1.269 0 C-N-CA 121.896 1.73 . . . . 0.0 112.052 178.106 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' D' D ' 73' ' ' VAL . . . . . . . . . . . . . 36.0 m -102.7 151.34 6.09 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.241 0 CA-C-O 120.743 0.306 . . . . 0.0 110.182 177.686 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' D' D ' 74' ' ' ASP . . . . . . . . . . . . . 18.5 t0 -95.21 116.66 29.04 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.152 -0.477 . . . . 0.0 109.831 -178.45 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' D' D ' 75' ' ' VAL . . . . . . . . . . . . . 44.6 t -111.68 121.95 65.15 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.227 0 CA-C-O 121.164 0.507 . . . . 0.0 110.547 -177.02 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' D' D ' 76' ' ' LEU . . . . . . . . . . . . . 21.7 mt -122.13 140.47 52.5 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 115.563 -0.744 . . . . 0.0 109.514 177.543 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' D' D ' 77' ' ' GLU . . . . . . . . . . . . . 46.7 mt-10 -133.77 135.88 44.19 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-O 120.92 0.39 . . . . 0.0 111.126 -178.136 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' D' D ' 78' ' ' ALA . . . . . 0.403 ' HB2' HD21 ' D' ' 109' ' ' LEU . . . -124.59 127.18 46.98 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 115.729 -0.669 . . . . 0.0 109.998 177.771 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' D' D ' 79' ' ' LYS . . . . . 0.619 ' O ' HD13 ' D' ' 80' ' ' ILE . 37.0 tptt -75.9 115.72 15.88 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-O 120.864 0.364 . . . . 0.0 110.535 -177.89 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' D' D ' 80' ' ' ILE . . . . . 0.619 HD13 ' O ' ' D' ' 79' ' ' LYS . 40.4 mm -139.26 111.59 5.62 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.287 0 N-CA-C 109.493 -0.558 . . . . 0.0 109.493 -176.355 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' D' D ' 81' ' ' LYS . . . . . . . . . . . . . 99.1 mttt -101.14 123.82 45.89 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-O 120.855 0.36 . . . . 0.0 110.96 -178.091 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' D' D ' 82' ' ' GLY . . . . . . . . . . . . . . . 89.0 42.35 5.66 Favored Glycine 0 CA--C 1.524 0.647 0 C-N-CA 120.791 -0.718 . . . . 0.0 111.826 175.05 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' D' D ' 83' ' ' ILE . . . . . . . . . . . . . 71.8 mt -63.77 136.73 25.89 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.33 0 N-CA-C 109.607 -0.516 . . . . 0.0 109.607 176.338 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' D' D ' 84' ' ' LYS . . . . . . . . . . . . . 76.7 tttt -95.78 -53.95 3.52 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.107 -0.497 . . . . 0.0 110.412 -177.567 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' D' D ' 85' ' ' ASP . . . . . . . . . . . . . 12.9 t70 -151.43 148.87 28.62 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 115.878 -0.601 . . . . 0.0 110.379 -179.21 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' D' D ' 86' ' ' VAL . . . . . . . . . . . . . 42.2 t -127.84 128.17 68.96 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.28 0 CA-C-O 120.886 0.374 . . . . 0.0 110.379 -179.078 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' D' D ' 87' ' ' ILE . . . . . 0.493 HD12 ' N ' ' D' ' 87' ' ' ILE . 4.9 mp -122.36 127.39 75.11 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.153 0 CA-C-N 115.994 -0.548 . . . . 0.0 109.634 176.993 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' D' D ' 88' ' ' LEU . . . . . . . . . . . . . 58.5 mt -110.22 134.96 51.7 Favored 'General case' 0 C--N 1.331 -0.204 0 CA-C-O 121.025 0.441 . . . . 0.0 110.802 -179.784 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' D' D ' 89' ' ' ASP . . . . . . . . . . . . . 4.4 t70 -123.82 163.12 21.85 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 115.775 -0.648 . . . . 0.0 109.526 178.265 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' D' D ' 90' ' ' GLU . . . . . . . . . . . . . 43.6 tp10 -44.92 -46.02 10.72 Favored 'General case' 0 N--CA 1.464 0.255 0 N-CA-C 113.158 0.799 . . . . 0.0 113.158 -171.495 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' D' D ' 91' ' ' ASN . . . . . . . . . . . . . 25.5 p30 -132.1 26.93 4.55 Favored 'General case' 0 N--CA 1.465 0.276 0 N-CA-C 112.408 0.521 . . . . 0.0 112.408 -178.837 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' D' D ' 92' ' ' LEU . . . . . . . . . . . . . 15.3 mt -147.72 150.44 34.32 Favored 'General case' 0 C--N 1.332 -0.164 0 CA-C-O 120.738 0.304 . . . . 0.0 110.493 -176.352 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' D' D ' 93' ' ' ILE . . . . . . . . . . . . . 69.0 mt -126.38 119.55 54.2 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.272 0 N-CA-C 109.363 -0.606 . . . . 0.0 109.363 177.785 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' D' D ' 94' ' ' VAL . . . . . 0.468 HG21 HG11 ' D' ' 125' ' ' VAL . 45.2 t -119.69 126.28 75.16 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.282 0 CA-C-O 120.99 0.424 . . . . 0.0 109.892 -179.743 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' D' D ' 95' ' ' VAL . . . . . . . . . . . . . 45.6 t -124.15 136.22 61.1 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.265 0 CA-C-N 116.003 -0.544 . . . . 0.0 110.046 -179.392 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' D' D ' 96' ' ' ILE . . . . . . . . . . . . . 54.4 mt -114.75 128.52 71.82 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.343 0 N-CA-C 108.979 -0.749 . . . . 0.0 108.979 178.539 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' D' D ' 97' ' ' THR . . . . . . . . . . . . . 55.1 p -101.11 160.53 14.31 Favored 'General case' 0 C--N 1.331 -0.216 0 CA-C-O 121.115 0.484 . . . . 0.0 111.416 -175.824 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' D' D ' 98' ' ' GLU . . . . . . . . . . . . . 84.2 tt0 -53.86 -26.97 27.12 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.192 -0.458 . . . . 0.0 112.094 178.399 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' D' D ' 99' ' ' GLU . . . . . . . . . . . . . 43.6 mt-10 -77.83 14.34 1.11 Allowed 'General case' 0 CA--C 1.536 0.409 0 N-CA-C 113.01 0.744 . . . . 0.0 113.01 -178.921 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' D' D ' 100' ' ' ASN . . . . . . . . . . . . . 1.9 m120 63.58 37.87 10.03 Favored 'General case' 0 CA--C 1.529 0.155 0 CA-C-N 118.103 0.411 . . . . 0.0 110.731 177.288 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' D' D ' 101' ' ' GLU . . . . . . . . . . . . . 96.7 mt-10 -113.12 148.21 35.76 Favored 'General case' 0 C--O 1.232 0.152 0 CA-C-N 116.268 -0.424 . . . . 0.0 110.377 177.356 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' D' D ' 102' ' ' VAL . . . . . . . . . . . . . 45.5 t -114.88 121.73 67.55 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.367 0 CA-C-N 115.662 -0.699 . . . . 0.0 109.412 177.811 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' D' D ' 103' ' ' LEU . . . . . . . . . . . . . 21.1 mt -115.0 125.66 53.85 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 115.811 -0.631 . . . . 0.0 109.889 177.531 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' D' D ' 104' ' ' ILE . . . . . 0.401 HD12 ' HB3' ' D' ' 113' ' ' TYR . 69.5 mt -114.77 118.77 59.7 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 N-CA-C 110.038 -0.356 . . . . 0.0 110.038 -179.648 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' D' D ' 105' ' ' PHE . . . . . . . . . . . . . 27.9 m-85 -119.88 166.1 13.74 Favored 'General case' 0 C--N 1.331 -0.216 0 O-C-N 123.972 0.795 . . . . 0.0 109.929 178.513 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' D' D ' 106' ' ' ASN . . . . . . . . . . . . . 41.3 p-10 -98.27 -170.33 1.95 Allowed 'General case' 0 C--N 1.329 -0.313 0 N-CA-C 109.791 -0.448 . . . . 0.0 109.791 174.614 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' D' D ' 107' ' ' GLN . . . . . . . . . . . . . 58.1 tt0 -59.77 -29.79 68.42 Favored 'General case' 0 CA--C 1.532 0.285 0 N-CA-C 111.827 0.306 . . . . 0.0 111.827 178.675 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' D' D ' 108' ' ' ASN . . . . . . . . . . . . . 5.1 t-20 -81.99 3.19 27.49 Favored 'General case' 0 CA--C 1.536 0.442 0 N-CA-C 113.283 0.846 . . . . 0.0 113.283 -177.443 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' D' D ' 109' ' ' LEU . . . . . 0.403 HD21 ' HB2' ' D' ' 78' ' ' ALA . 9.5 tp 64.48 40.94 5.91 Favored 'General case' 0 CA--C 1.53 0.182 0 CA-C-O 121.13 0.491 . . . . 0.0 111.364 177.543 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' D' D ' 110' ' ' GLU . . . . . . . . . . . . . 70.7 mm-40 -111.11 160.97 16.4 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-N 116.226 -0.443 . . . . 0.0 109.954 175.243 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' D' D ' 111' ' ' GLU . . . . . . . . . . . . . 45.1 tp10 -84.55 127.14 33.89 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-O 120.881 0.372 . . . . 0.0 111.065 -177.113 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' D' D ' 112' ' ' LEU . . . . . . . . . . . . . 18.9 mt -113.05 -46.11 3.12 Favored 'General case' 0 C--O 1.233 0.213 0 CA-C-N 116.017 -0.538 . . . . 0.0 110.388 176.825 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' D' D ' 113' ' ' TYR . . . . . 0.401 ' HB3' HD12 ' D' ' 104' ' ' ILE . 59.3 t80 -141.13 140.32 34.1 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.303 -0.408 . . . . 0.0 111.003 -179.939 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' D' D ' 114' ' ' ARG . . . . . . . . . . . . . 36.5 ttp180 -141.83 125.1 16.46 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 116.443 -0.344 . . . . 0.0 110.543 177.95 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' D' D ' 115' ' ' GLY . . . . . . . . . . . . . . . -150.1 160.95 28.75 Favored Glycine 0 CA--C 1.523 0.56 0 N-CA-C 111.124 -0.79 . . . . 0.0 111.124 178.867 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' D' D ' 116' ' ' LYS . . . . . . . . . . . . . 39.4 ttpt -127.25 134.34 50.09 Favored 'General case' 0 C--N 1.33 -0.281 0 N-CA-C 110.119 -0.326 . . . . 0.0 110.119 177.287 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' D' D ' 117' ' ' PHE . . . . . . . . . . . . . 31.5 m-85 -138.32 113.89 9.69 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.241 -0.436 . . . . 0.0 110.059 -176.739 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' D' D ' 118' ' ' GLU . . . . . . . . . . . . . 41.6 mp0 -55.18 -49.22 72.43 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-N 116.45 -0.341 . . . . 0.0 111.436 -174.504 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' D' D ' 119' ' ' ASN . . . . . . . . . . . . . 2.7 p30 -94.5 31.16 1.81 Allowed 'General case' 0 C--N 1.331 -0.216 0 N-CA-C 112.168 0.433 . . . . 0.0 112.168 -175.337 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' D' D ' 120' ' ' LEU . . . . . . . . . . . . . 26.8 tp -55.7 119.91 6.46 Favored 'General case' 0 C--N 1.332 -0.175 0 N-CA-C 110.344 -0.243 . . . . 0.0 110.344 175.831 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' D' D ' 121' ' ' ASN . . . . . . . . . . . . . 86.6 m-20 -114.19 -44.0 3.17 Favored 'General case' 0 N--CA 1.463 0.202 0 N-CA-C 111.569 0.211 . . . . 0.0 111.569 -175.37 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' D' D ' 122' ' ' LYS . . . . . . . . . . . . . 53.4 mtpt -138.59 149.02 44.83 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-O 121.11 0.481 . . . . 0.0 111.534 -175.419 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' D' D ' 123' ' ' VAL . . . . . 0.431 ' C ' HD12 ' D' ' 124' ' ' LEU . 46.4 t -133.92 126.49 50.55 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.268 0 CA-C-N 116.0 -0.545 . . . . 0.0 109.588 174.108 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' D' D ' 124' ' ' LEU . . . . . 0.431 HD12 ' C ' ' D' ' 123' ' ' VAL . 7.2 mp -116.99 134.44 54.73 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.311 -0.404 . . . . 0.0 110.571 -177.48 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' D' D ' 125' ' ' VAL . . . . . 0.468 HG11 HG21 ' D' ' 94' ' ' VAL . 34.8 m -131.32 125.85 57.65 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.283 0 CA-C-N 116.389 -0.368 . . . . 0.0 110.36 178.492 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' D' D ' 126' ' ' ARG . . . . . . . . . . . . . 91.2 mtt-85 -150.42 126.44 10.51 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.258 -0.428 . . . . 0.0 110.003 179.468 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' D' D ' 127' ' ' ASN . . . . . . . . . . . . . 10.9 t30 55.57 -148.94 0.47 Allowed 'General case' 0 CA--C 1.54 0.575 0 N-CA-C 110.001 -0.37 . . . . 0.0 110.001 179.502 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' D' D ' 128' ' ' ASP . . . . . . . . . . . . . 17.3 p-10 -82.84 15.35 2.73 Favored 'General case' 0 CA--C 1.535 0.388 0 CA-C-N 118.782 0.719 . . . . 0.0 112.931 179.459 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' D' D ' 129' ' ' LEU . . . . . . . . . . . . . 58.6 mt -112.49 138.2 49.59 Favored 'General case' 0 C--O 1.233 0.216 0 CA-C-N 118.171 0.441 . . . . 0.0 110.7 -179.991 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' D' D ' 130' ' ' VAL . . . . . . . . . . . . . 44.7 t -124.16 136.18 61.25 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.217 0 CA-C-N 115.924 -0.58 . . . . 0.0 109.744 179.638 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' D' D ' 131' ' ' VAL . . . . . 0.43 HG22 HD12 ' D' ' 140' ' ' LEU . 42.6 t -134.71 134.21 54.09 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.215 0 CA-C-O 120.964 0.411 . . . . 0.0 110.339 179.645 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' D' D ' 132' ' ' ILE . . . . . . . . . . . . . 73.6 mt -115.86 132.83 64.15 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.321 0 CA-C-N 115.963 -0.562 . . . . 0.0 109.509 -179.805 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' D' D ' 133' ' ' ILE . . . . . . . . . . . . . 35.7 mm -118.46 120.04 63.05 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.247 0 CA-C-O 120.847 0.356 . . . . 0.0 110.943 -174.043 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' D' D ' 134' ' ' ASP . . . . . . . . . . . . . 8.1 p-10 -133.11 147.95 52.14 Favored 'General case' 0 C--N 1.332 -0.185 0 N-CA-C 109.801 -0.444 . . . . 0.0 109.801 174.789 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' D' D ' 135' ' ' GLU . . . . . . . . . . . . . 84.1 tt0 -49.76 -23.86 2.04 Favored 'General case' 0 C--N 1.329 -0.32 0 N-CA-C 113.049 0.759 . . . . 0.0 113.049 -170.962 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' D' D ' 136' ' ' GLN . . . . . . . . . . . . . 39.3 tp60 -89.4 -37.68 14.66 Favored 'General case' 0 C--N 1.33 -0.241 0 N-CA-C 112.146 0.425 . . . . 0.0 112.146 -175.366 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' D' D ' 137' ' ' LYS . . . . . . . . . . . . . 57.0 pttt -156.41 166.0 34.69 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-O 121.525 0.679 . . . . 0.0 112.077 -171.185 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' D' D ' 138' ' ' LEU . . . . . 0.455 HD23 ' N ' ' D' ' 139' ' ' THR . 4.8 tt -117.7 128.4 54.86 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 115.065 -0.97 . . . . 0.0 109.793 178.115 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' D' D ' 139' ' ' THR . . . . . 0.455 ' N ' HD23 ' D' ' 138' ' ' LEU . 29.8 m -110.43 127.4 55.1 Favored 'General case' 0 C--N 1.331 -0.224 0 CA-C-N 116.421 -0.354 . . . . 0.0 110.809 -179.59 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' D' D ' 140' ' ' LEU . . . . . 0.43 HD12 HG22 ' D' ' 131' ' ' VAL . 9.9 tp -112.61 120.12 40.47 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 115.567 -0.742 . . . . 0.0 109.056 -179.912 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' D' D ' 141' ' ' ILE . . . . . . . . . . . . . 19.6 mt -119.66 117.12 52.77 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.283 0 CA-C-O 121.077 0.465 . . . . 0.0 109.933 -175.823 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' D' D ' 142' ' ' ARG . . . . . . . . . . . . . 58.8 ttp180 -108.85 119.1 38.55 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 115.28 -0.873 . . . . 0.0 110.13 -178.344 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' D' D ' 143' ' ' THR . . . . . . . . . . . . . 54.6 p . . . . . 0 C--O 1.22 -0.465 0 CA-C-O 117.983 -1.008 . . . . 0.0 110.749 -178.596 . . . . . . . . 0 0 . 1 . 004 nuclear nobuild full ' E' E ' -3' ' ' GLU . . . . . . . . . . . . . 96.0 mt-10 . . . . . 0 N--CA 1.49 1.57 0 N-CA-C 109.387 -0.597 . . . . 0.0 109.387 . . . . . . . . . 0 0 . 1 . 004 nuclear nobuild full ' E' E ' -2' ' ' GLY . . . . . . . . . . . . . . . -63.12 145.04 49.93 Favored Glycine 0 CA--C 1.525 0.681 0 N-CA-C 111.139 -0.785 . . . . 0.0 111.139 -179.305 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' E' E ' -1' ' ' VAL . . . . . . . . . . . . . 45.0 t -96.41 136.72 26.34 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.269 0 N-CA-C 110.1 -0.333 . . . . 0.0 110.1 179.703 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' E' E ' 0' ' ' ILE . . . . . . . . . . . . . 70.2 mt -112.27 135.52 51.35 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.202 0 CA-C-N 116.294 -0.412 . . . . 0.0 109.994 179.935 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' E' E ' 1' ' ' MET . . . . . . . . . . . . . 25.0 ptm -78.44 144.12 36.11 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 115.956 -0.565 . . . . 0.0 111.129 -178.519 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' E' E ' 2' ' ' SER . . . . . . . . . . . . . 3.0 p -126.79 129.01 47.49 Favored 'General case' 0 C--N 1.331 -0.207 0 CA-C-N 116.249 -0.432 . . . . 0.0 110.629 178.933 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' E' E ' 3' ' ' GLU . . . . . . . . . . . . . 83.4 tt0 -142.27 142.35 32.57 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.034 -0.53 . . . . 0.0 111.203 -178.579 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' E' E ' 4' ' ' LEU . . . . . . . . . . . . . 14.4 tp -123.24 128.58 50.19 Favored 'General case' 0 C--N 1.332 -0.187 0 CA-C-N 115.958 -0.565 . . . . 0.0 110.281 176.85 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' E' E ' 5' ' ' LYS . . . . . . . . . . . . . 75.1 mttt -105.86 121.4 44.0 Favored 'General case' 0 C--O 1.235 0.293 0 CA-C-N 116.306 -0.406 . . . . 0.0 110.57 178.065 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' E' E ' 6' ' ' LEU . . . . . . . . . . . . . 29.3 mt -115.3 149.82 37.22 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 115.531 -0.759 . . . . 0.0 110.251 -179.735 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' E' E ' 7' ' ' LYS . . . . . . . . . . . . . 58.4 tttm -139.6 138.08 19.66 Favored Pre-proline 0 CA--C 1.533 0.305 0 CA-C-O 119.031 -0.509 . . . . 0.0 110.086 175.088 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' E' E ' 8' ' ' PRO . . . . . . . . . . . . . 98.7 Cg_endo -91.44 139.28 2.34 Favored 'Trans proline' 0 N--CA 1.489 1.258 0 C-N-CA 121.716 1.611 . . . . 0.0 111.728 177.396 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' E' E ' 9' ' ' LEU . . . . . . . . . . . . . 57.5 mt -71.46 -46.65 13.36 Favored Pre-proline 0 CA--C 1.533 0.312 0 CA-C-O 118.644 -0.693 . . . . 0.0 112.033 -179.026 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' E' E ' 10' ' ' PRO . . . . . . . . . . . . . 89.9 Cg_endo -82.31 147.36 14.35 Favored 'Trans proline' 0 N--CA 1.495 1.596 0 C-N-CA 121.147 1.231 . . . . 0.0 111.509 174.419 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' E' E ' 11' ' ' LYS . . . . . . . . . . . . . 50.3 pttt -86.51 115.06 23.76 Favored 'General case' 0 C--N 1.331 -0.222 0 CA-C-O 121.383 0.611 . . . . 0.0 110.217 178.122 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' E' E ' 12' ' ' VAL . . . . . . . . . . . . . 11.6 p -151.11 146.59 16.06 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 CA-C-N 115.879 -0.6 . . . . 0.0 110.544 -178.89 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' E' E ' 13' ' ' GLU . . . . . . . . . . . . . 95.8 mt-10 -83.23 118.03 23.35 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.347 -0.388 . . . . 0.0 110.042 177.126 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' E' E ' 14' ' ' LEU . . . . . . . . . . . . . 48.6 mt -96.53 148.8 35.01 Favored Pre-proline 0 C--N 1.33 -0.265 0 CA-C-O 119.282 -0.39 . . . . 0.0 110.665 -177.881 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' E' E ' 15' ' ' PRO . . . . . . . . . . . . . 27.9 Cg_exo -61.31 163.61 16.98 Favored 'Trans proline' 0 N--CA 1.497 1.704 0 C-N-CA 121.339 1.36 . . . . 0.0 112.093 177.015 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' E' E ' 16' ' ' PRO . . . . . . . . . . . . . 24.4 Cg_exo -62.25 -39.58 46.82 Favored 'Trans proline' 0 N--CA 1.497 1.69 0 C-N-CA 121.561 1.508 . . . . 0.0 112.987 -178.296 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' E' E ' 17' ' ' ASP . . . . . . . . . . . . . 22.1 p-10 -85.39 8.42 18.94 Favored 'General case' 0 CA--C 1.535 0.396 0 N-CA-C 113.302 0.853 . . . . 0.0 113.302 -176.304 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' E' E ' 18' ' ' PHE . . . . . . . . . . . . . 32.4 t80 -55.97 -47.87 76.86 Favored 'General case' 0 C--N 1.334 -0.107 0 O-C-N 121.904 -0.498 . . . . 0.0 110.506 -179.359 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' E' E ' 19' ' ' VAL . . . . . . . . . . . . . 14.0 p -56.3 -40.77 68.13 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.272 0 CA-C-N 116.227 -0.442 . . . . 0.0 111.037 -178.985 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' E' E ' 20' ' ' ASP . . . . . . . . . . . . . 20.2 t0 -60.54 -43.78 96.81 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-O 120.793 0.33 . . . . 0.0 111.15 -177.312 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' E' E ' 21' ' ' VAL . . . . . . . . . . . . . 49.1 t -63.67 -46.33 95.0 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.332 0 C-N-CA 120.834 -0.346 . . . . 0.0 110.296 -178.488 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' E' E ' 22' ' ' ILE . . . . . 0.677 HG22 HD12 ' E' ' 26' ' ' LEU . 49.3 mm -55.54 -45.79 78.77 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.227 0 C-N-CA 120.956 -0.298 . . . . 0.0 110.707 178.377 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' E' E ' 23' ' ' ARG . . . . . . . . . . . . . 54.7 ttp180 -53.33 -51.0 63.79 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-O 120.584 0.23 . . . . 0.0 111.538 -178.544 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' E' E ' 24' ' ' ILE . . . . . . . . . . . . . 68.5 mt -59.64 -43.71 91.82 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.287 0 C-N-CA 121.138 -0.225 . . . . 0.0 111.349 -177.221 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' E' E ' 25' ' ' LYS . . . . . . . . . . . . . 97.9 mttt -64.85 -38.45 91.02 Favored 'General case' 0 C--N 1.329 -0.314 0 N-CA-C 112.208 0.447 . . . . 0.0 112.208 -178.247 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' E' E ' 26' ' ' LEU . . . . . 0.677 HD12 HG22 ' E' ' 22' ' ' ILE . 37.5 mt -80.47 -41.77 23.79 Favored 'General case' 0 C--N 1.329 -0.302 0 N-CA-C 113.258 0.836 . . . . 0.0 113.258 -171.675 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' E' E ' 27' ' ' GLN . . . . . . . . . . . . . 11.0 pt20 -46.42 142.68 2.91 Favored 'General case' 0 N--CA 1.469 0.486 0 N-CA-C 112.869 0.692 . . . . 0.0 112.869 -174.325 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' E' E ' 28' ' ' GLY . . . . . . . . . . . . . . . 98.75 -28.68 13.98 Favored Glycine 0 CA--C 1.531 1.066 0 CA-C-N 115.479 -0.782 . . . . 0.0 112.02 -177.467 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' E' E ' 29' ' ' LYS . . . . . . . . . . . . . 87.7 mttt -98.07 155.08 17.29 Favored 'General case' 0 C--N 1.331 -0.224 0 CA-C-N 117.235 0.517 . . . . 0.0 111.08 178.808 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' E' E ' 30' ' ' THR . . . . . . . . . . . . . 40.1 m -102.4 137.39 40.71 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.002 -0.544 . . . . 0.0 109.949 175.679 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' E' E ' 31' ' ' VAL . . . . . . . . . . . . . 34.6 m -127.92 152.81 36.48 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.256 0 CA-C-O 120.939 0.4 . . . . 0.0 110.729 -178.23 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' E' E ' 32' ' ' ARG . . . . . . . . . . . . . 61.1 ttt180 -131.09 147.82 52.66 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-O 121.215 0.531 . . . . 0.0 110.628 -179.527 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' E' E ' 33' ' ' THR . . . . . . . . . . . . . 31.4 m -52.56 140.7 22.25 Favored 'General case' 0 C--N 1.331 -0.23 0 CA-C-N 116.293 -0.412 . . . . 0.0 111.453 -178.552 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' E' E ' 34' ' ' GLY . . . . . . . . . . . . . . . 99.51 -17.2 58.01 Favored Glycine 0 CA--C 1.531 1.087 0 CA-C-O 119.681 -0.511 . . . . 0.0 113.247 179.502 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' E' E ' 35' ' ' ASP . . . . . . . . . . . . . 80.0 m-20 -66.88 147.52 53.13 Favored 'General case' 0 C--O 1.232 0.138 0 CA-C-N 118.013 0.906 . . . . 0.0 111.028 178.531 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' E' E ' 36' ' ' VAL . . . . . . . . . . . . . 44.2 t -120.9 129.31 75.81 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.208 0 CA-C-N 116.082 -0.508 . . . . 0.0 109.713 177.527 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' E' E ' 37' ' ' ILE . . . . . . . . . . . . . 67.2 mt -121.01 138.83 50.16 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.289 0 CA-C-N 116.246 -0.434 . . . . 0.0 109.937 -178.951 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' E' E ' 38' ' ' GLY . . . . . . . . . . . . . . . -109.78 128.86 9.11 Favored Glycine 0 CA--C 1.524 0.656 0 N-CA-C 111.159 -0.776 . . . . 0.0 111.159 -179.64 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' E' E ' 39' ' ' ILE . . . . . . . . . . . . . 74.4 mt -123.61 133.73 68.38 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.203 0 N-CA-C 109.976 -0.379 . . . . 0.0 109.976 179.017 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' E' E ' 40' ' ' SER . . . . . . . . . . . . . 59.7 p -92.87 117.4 30.0 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.284 -0.417 . . . . 0.0 110.797 175.465 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' E' E ' 41' ' ' ILE . . . . . . . . . . . . . 43.8 mm -121.05 118.0 54.76 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.224 0 CA-C-O 120.802 0.334 . . . . 0.0 110.379 -179.864 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' E' E ' 42' ' ' LEU . . . . . . . . . . . . . 61.1 mt 52.65 36.3 20.51 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 116.194 -0.457 . . . . 0.0 111.604 176.646 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' E' E ' 43' ' ' GLY . . . . . . . . . . . . . . . 73.04 30.51 63.08 Favored Glycine 0 CA--C 1.529 0.911 0 C-N-CA 121.135 -0.555 . . . . 0.0 112.275 177.816 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' E' E ' 44' ' ' LYS . . . . . . . . . . . . . 68.7 mttm -138.31 134.27 34.08 Favored 'General case' 0 C--N 1.331 -0.234 0 N-CA-C 109.759 -0.46 . . . . 0.0 109.759 177.757 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' E' E ' 45' ' ' GLU . . . . . . . . . . . . . 80.6 tt0 -83.02 124.46 30.44 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-O 120.839 0.352 . . . . 0.0 111.6 -176.192 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' E' E ' 46' ' ' VAL . . . . . . . . . . . . . 7.2 p -124.61 126.44 71.68 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.19 0 N-CA-C 109.478 -0.564 . . . . 0.0 109.478 173.863 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' E' E ' 47' ' ' LYS . . . . . . . . . . . . . 98.9 mttt -99.91 129.66 46.01 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.064 -0.516 . . . . 0.0 111.081 178.994 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' E' E ' 48' ' ' PHE . . . . . . . . . . . . . 91.1 m-85 -112.69 131.9 55.44 Favored 'General case' 0 C--N 1.33 -0.271 0 N-CA-C 109.872 -0.418 . . . . 0.0 109.872 177.035 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' E' E ' 49' ' ' LYS . . . . . . . . . . . . . 80.0 tttt -106.96 135.99 47.57 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.294 -0.412 . . . . 0.0 110.279 179.067 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' E' E ' 50' ' ' VAL . . . . . . . . . . . . . 46.0 t -77.14 105.02 5.56 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.218 0 N-CA-C 109.192 -0.67 . . . . 0.0 109.192 175.585 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' E' E ' 51' ' ' VAL . . . . . . . . . . . . . 48.6 t -68.71 -47.97 73.75 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.362 0 O-C-N 123.563 0.539 . . . . 0.0 109.744 -173.179 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' E' E ' 52' ' ' GLN . . . . . . . . . . . . . 43.2 tt0 -171.03 142.12 1.78 Allowed 'General case' 0 C--N 1.329 -0.318 0 C-N-CA 120.313 -0.555 . . . . 0.0 111.423 -179.709 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' E' E ' 53' ' ' ALA . . . . . . . . . . . . . . . -114.41 136.03 53.45 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 115.697 -0.683 . . . . 0.0 110.14 177.517 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' E' E ' 54' ' ' TYR . . . . . . . . . . . . . 37.0 t80 -128.99 108.6 18.18 Favored Pre-proline 0 CA--C 1.535 0.374 0 CA-C-O 118.245 -0.883 . . . . 0.0 110.206 178.558 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' E' E ' 55' ' ' PRO . . . . . . . . . . . . . 73.4 Cg_endo -77.15 170.01 72.71 Favored 'Cis proline' 0 N--CA 1.499 1.841 0 CA-C-N 121.769 1.667 . . . . 0.0 112.486 -5.025 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' E' E ' 56' ' ' SER . . . . . . . . . . . . . 41.2 m -117.21 131.39 24.03 Favored Pre-proline 0 CA--C 1.539 0.524 0 CA-C-O 118.399 -0.81 . . . . 0.0 109.509 174.768 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' E' E ' 57' ' ' PRO . . . . . . . . . . . . . 57.0 Cg_endo -72.36 148.26 90.9 Favored 'Cis proline' 0 N--CA 1.497 1.719 0 CA-C-N 121.917 1.72 . . . . 0.0 111.54 -1.173 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' E' E ' 58' ' ' LEU . . . . . . . . . . . . . 23.8 tp -108.26 137.11 46.79 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.561 -178.622 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' E' E ' 59' ' ' ARG . . . . . . . . . . . . . 54.0 ttp180 -99.92 126.06 46.01 Favored 'General case' 0 C--N 1.328 -0.341 0 N-CA-C 109.334 -0.617 . . . . 0.0 109.334 174.92 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' E' E ' 60' ' ' VAL . . . . . . . . . . . . . 40.5 t -83.03 120.43 34.36 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.269 0 C-N-CA 120.599 -0.44 . . . . 0.0 110.578 -174.955 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' E' E ' 61' ' ' GLU . . . . . . . . . . . . . 74.7 tt0 -130.8 156.01 45.72 Favored 'General case' 0 C--N 1.329 -0.326 0 N-CA-C 108.989 -0.745 . . . . 0.0 108.989 176.252 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' E' E ' 62' ' ' ASP . . . . . . . . . . . . . 9.8 p-10 -51.01 -30.62 15.78 Favored 'General case' 0 C--N 1.327 -0.385 0 N-CA-C 112.369 0.507 . . . . 0.0 112.369 -175.312 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' E' E ' 63' ' ' ARG . . . . . . . . . . . . . 76.0 mtt180 -77.89 -22.07 50.3 Favored 'General case' 0 CA--C 1.533 0.322 0 N-CA-C 113.149 0.796 . . . . 0.0 113.149 -174.987 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' E' E ' 64' ' ' THR . . . . . . . . . . . . . 28.3 m -63.37 146.16 54.1 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-O 120.872 0.367 . . . . 0.0 110.964 -175.841 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' E' E ' 65' ' ' LYS . . . . . . . . . . . . . 67.5 mttm -89.2 134.37 34.06 Favored 'General case' 0 C--N 1.331 -0.212 0 CA-C-N 116.121 -0.49 . . . . 0.0 110.662 -179.733 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' E' E ' 66' ' ' ILE . . . . . . . . . . . . . 62.4 mt -120.9 130.97 74.08 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.238 0 N-CA-C 109.993 -0.373 . . . . 0.0 109.993 179.224 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' E' E ' 67' ' ' THR . . . . . . . . . . . . . 19.1 m -129.72 142.82 50.64 Favored 'General case' 0 C--N 1.332 -0.175 0 CA-C-O 120.979 0.418 . . . . 0.0 111.042 -178.403 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' E' E ' 68' ' ' LEU . . . . . 0.506 HD12 ' N ' ' E' ' 68' ' ' LEU . 6.7 mp -105.98 128.69 53.99 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 116.106 -0.497 . . . . 0.0 110.601 177.702 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' E' E ' 69' ' ' VAL . . . . . . . . . . . . . 43.7 t -102.39 137.44 30.37 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.314 0 CA-C-N 116.163 -0.471 . . . . 0.0 110.09 179.306 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' E' E ' 70' ' ' THR . . . . . . . . . . . . . 28.8 m -134.23 114.95 13.59 Favored 'General case' 0 C--N 1.331 -0.213 0 CA-C-O 120.87 0.367 . . . . 0.0 110.875 179.598 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' E' E ' 71' ' ' HIS . . . . . . . . . . . . . 64.5 t60 -150.03 79.46 7.65 Favored Pre-proline 0 C--N 1.328 -0.347 0 CA-C-N 116.077 -0.51 . . . . 0.0 110.156 177.167 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' E' E ' 72' ' ' PRO . . . . . . . . . . . . . 55.5 Cg_endo -89.17 160.01 5.73 Favored 'Trans proline' 0 N--CA 1.489 1.213 0 C-N-CA 121.769 1.646 . . . . 0.0 112.42 -177.733 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' E' E ' 73' ' ' VAL . . . . . . . . . . . . . 36.0 m -116.32 168.87 7.39 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.216 0 CA-C-N 115.855 -0.611 . . . . 0.0 110.008 178.355 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' E' E ' 74' ' ' ASP . . . . . . . . . . . . . 18.9 t0 -93.85 118.78 31.91 Favored 'General case' 0 C--N 1.328 -0.331 0 N-CA-C 109.978 -0.378 . . . . 0.0 109.978 -177.84 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' E' E ' 75' ' ' VAL . . . . . 0.419 ' C ' HD12 ' E' ' 76' ' ' LEU . 42.2 t -116.57 121.0 66.66 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.224 0 CA-C-O 121.055 0.455 . . . . 0.0 110.468 -178.445 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' E' E ' 76' ' ' LEU . . . . . 0.419 HD12 ' C ' ' E' ' 75' ' ' VAL . 7.0 mp -119.01 149.06 42.28 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 115.778 -0.646 . . . . 0.0 109.788 176.961 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' E' E ' 77' ' ' GLU . . . . . . . . . . . . . 96.3 mt-10 -136.97 134.63 36.89 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-O 121.006 0.432 . . . . 0.0 111.333 -178.975 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' E' E ' 78' ' ' ALA . . . . . . . . . . . . . . . -121.28 136.63 54.94 Favored 'General case' 0 C--N 1.331 -0.225 0 CA-C-N 115.671 -0.695 . . . . 0.0 109.85 176.959 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' E' E ' 79' ' ' LYS . . . . . 0.452 ' O ' HD13 ' E' ' 80' ' ' ILE . 46.3 mmtm -78.48 119.25 21.51 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-O 120.798 0.332 . . . . 0.0 110.611 179.859 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' E' E ' 80' ' ' ILE . . . . . 0.452 HD13 ' O ' ' E' ' 79' ' ' LYS . 26.4 mm -139.25 110.45 4.85 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.28 0 N-CA-C 108.967 -0.753 . . . . 0.0 108.967 -179.351 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' E' E ' 81' ' ' LYS . . . . . . . . . . . . . 54.8 pttt -103.24 124.56 48.85 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-O 120.948 0.404 . . . . 0.0 111.194 -176.753 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' E' E ' 82' ' ' GLY . . . . . . . . . . . . . . . 88.94 42.2 5.72 Favored Glycine 0 CA--C 1.525 0.695 0 C-N-CA 120.713 -0.756 . . . . 0.0 111.616 174.622 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' E' E ' 83' ' ' ILE . . . . . . . . . . . . . 68.2 mt -66.35 139.7 20.74 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.362 0 N-CA-C 109.779 -0.452 . . . . 0.0 109.779 178.247 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' E' E ' 84' ' ' LYS . . . . . . . . . . . . . 87.6 tttt -101.05 -53.96 2.91 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-N 116.011 -0.54 . . . . 0.0 110.311 -178.217 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' E' E ' 85' ' ' ASP . . . . . . . . . . . . . 9.6 t70 -149.97 146.98 27.33 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 115.754 -0.657 . . . . 0.0 110.187 -178.373 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' E' E ' 86' ' ' VAL . . . . . . . . . . . . . 43.0 t -131.69 129.78 61.61 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.228 0 CA-C-O 121.006 0.431 . . . . 0.0 110.476 -178.495 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' E' E ' 87' ' ' ILE . . . . . 0.495 ' N ' HD12 ' E' ' 87' ' ' ILE . 4.9 mp -119.94 125.05 73.88 Favored 'Isoleucine or valine' 0 C--O 1.233 0.198 0 CA-C-N 115.943 -0.571 . . . . 0.0 109.481 176.2 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' E' E ' 88' ' ' LEU . . . . . . . . . . . . . 16.8 tp -110.54 129.19 55.85 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-O 120.911 0.386 . . . . 0.0 110.737 -179.185 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' E' E ' 89' ' ' ASP . . . . . . . . . . . . . 9.5 t70 -123.79 154.18 39.92 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-N 116.01 -0.541 . . . . 0.0 109.815 178.709 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' E' E ' 90' ' ' GLU . . . . . . . . . . . . . 43.1 mt-10 -47.82 -38.43 15.89 Favored 'General case' 0 C--N 1.33 -0.241 0 N-CA-C 112.71 0.633 . . . . 0.0 112.71 -172.643 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' E' E ' 91' ' ' ASN . . . . . . . . . . . . . 6.6 t-20 -132.1 34.58 3.79 Favored 'General case' 0 N--CA 1.463 0.217 0 N-CA-C 111.738 0.273 . . . . 0.0 111.738 -176.455 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' E' E ' 92' ' ' LEU . . . . . . . . . . . . . 12.5 tp -166.16 148.76 7.11 Favored 'General case' 0 C--N 1.329 -0.286 0 C-N-CA 120.937 -0.305 . . . . 0.0 110.906 -178.991 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' E' E ' 93' ' ' ILE . . . . . . . . . . . . . 72.9 mt -128.18 123.28 59.98 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.178 0 N-CA-C 109.491 -0.559 . . . . 0.0 109.491 178.222 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' E' E ' 94' ' ' VAL . . . . . . . . . . . . . 44.8 t -123.96 126.12 72.0 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.277 0 CA-C-O 120.875 0.369 . . . . 0.0 110.035 -179.66 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' E' E ' 95' ' ' VAL . . . . . . . . . . . . . 41.8 t -123.77 134.73 65.64 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.252 0 CA-C-N 116.104 -0.498 . . . . 0.0 110.21 -178.419 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' E' E ' 96' ' ' ILE . . . . . . . . . . . . . 58.1 mt -115.51 130.06 70.75 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 N-CA-C 109.287 -0.634 . . . . 0.0 109.287 178.359 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' E' E ' 97' ' ' THR . . . . . . . . . . . . . 80.3 p -102.09 158.44 16.16 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-O 121.257 0.551 . . . . 0.0 111.324 -177.034 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' E' E ' 98' ' ' GLU . . . . . . . . . . . . . 83.5 tt0 -53.86 -27.05 27.61 Favored 'General case' 0 CA--C 1.533 0.313 0 N-CA-C 112.3 0.481 . . . . 0.0 112.3 -179.529 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' E' E ' 99' ' ' GLU . . . . . . . . . . . . . 34.7 tt0 -80.77 18.06 1.05 Allowed 'General case' 0 CA--C 1.536 0.418 0 N-CA-C 112.728 0.64 . . . . 0.0 112.728 -176.619 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' E' E ' 100' ' ' ASN . . . . . . . . . . . . . 3.2 m-20 61.06 37.96 17.52 Favored 'General case' 0 N--CA 1.463 0.176 0 O-C-N 121.955 -0.466 . . . . 0.0 110.819 178.366 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' E' E ' 101' ' ' GLU . . . . . . . . . . . . . 84.2 tt0 -116.74 143.11 46.05 Favored 'General case' 0 C--N 1.331 -0.203 0 CA-C-N 116.159 -0.473 . . . . 0.0 109.75 177.379 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' E' E ' 102' ' ' VAL . . . . . . . . . . . . . 44.0 t -115.52 127.55 73.05 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.367 0 CA-C-N 116.419 -0.355 . . . . 0.0 110.132 -177.804 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' E' E ' 103' ' ' LEU . . . . . . . . . . . . . 28.9 mt -117.96 131.14 56.53 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-N 115.677 -0.692 . . . . 0.0 109.889 177.123 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' E' E ' 104' ' ' ILE . . . . . . . . . . . . . 67.4 mt -117.66 122.17 69.19 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.26 0 N-CA-C 110.107 -0.331 . . . . 0.0 110.107 -178.336 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' E' E ' 105' ' ' PHE . . . . . . . . . . . . . 91.5 m-85 -124.11 166.4 15.86 Favored 'General case' 0 C--O 1.232 0.151 0 O-C-N 123.985 0.803 . . . . 0.0 110.131 -178.52 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' E' E ' 106' ' ' ASN . . . . . . . . . . . . . 45.6 p-10 -104.04 -172.51 2.12 Favored 'General case' 0 C--N 1.332 -0.172 0 N-CA-C 109.755 -0.461 . . . . 0.0 109.755 171.131 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' E' E ' 107' ' ' GLN . . . . . . . . . . . . . 49.4 tt0 -58.76 -29.99 67.18 Favored 'General case' 0 CA--C 1.532 0.255 0 N-CA-C 112.065 0.394 . . . . 0.0 112.065 -179.72 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' E' E ' 108' ' ' ASN . . . . . . . . . . . . . 48.4 t30 -86.72 12.7 10.15 Favored 'General case' 0 CA--C 1.534 0.34 0 N-CA-C 113.001 0.741 . . . . 0.0 113.001 -176.384 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' E' E ' 109' ' ' LEU . . . . . . . . . . . . . 34.4 mt 58.2 33.34 23.06 Favored 'General case' 0 C--O 1.232 0.168 0 N-CA-C 111.998 0.37 . . . . 0.0 111.998 176.912 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' E' E ' 110' ' ' GLU . . . . . . . . . . . . . 95.5 mt-10 -101.86 129.94 48.21 Favored 'General case' 0 C--N 1.33 -0.25 0 N-CA-C 109.182 -0.673 . . . . 0.0 109.182 174.582 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' E' E ' 111' ' ' GLU . . . . . . . . . . . . . 45.5 tt0 -74.11 121.99 22.02 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-O 121.073 0.463 . . . . 0.0 110.352 -176.108 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' E' E ' 112' ' ' LEU . . . . . . . . . . . . . 35.4 mt -99.62 -46.07 5.57 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 115.795 -0.639 . . . . 0.0 110.461 -179.612 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' E' E ' 113' ' ' TYR . . . . . . . . . . . . . 57.8 t80 -139.22 145.66 39.53 Favored 'General case' 0 C--N 1.331 -0.208 0 CA-C-N 116.317 -0.402 . . . . 0.0 111.197 -178.166 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' E' E ' 114' ' ' ARG . . . . . . . . . . . . . 45.3 ptt85 -147.35 125.27 11.98 Favored 'General case' 0 C--N 1.33 -0.239 0 CA-C-N 116.07 -0.514 . . . . 0.0 110.663 179.062 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' E' E ' 115' ' ' GLY . . . . . . . . . . . . . . . -150.07 159.11 27.96 Favored Glycine 0 CA--C 1.523 0.538 0 N-CA-C 111.105 -0.798 . . . . 0.0 111.105 178.96 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' E' E ' 116' ' ' LYS . . . . . . . . . . . . . 38.4 ttpt -127.07 132.46 50.66 Favored 'General case' 0 C--N 1.33 -0.268 0 N-CA-C 109.809 -0.441 . . . . 0.0 109.809 178.077 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' E' E ' 117' ' ' PHE . . . . . . . . . . . . . 36.6 m-85 -132.14 113.82 13.77 Favored 'General case' 0 C--N 1.331 -0.213 0 CA-C-O 121.014 0.435 . . . . 0.0 110.376 -175.582 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' E' E ' 118' ' ' GLU . . . . . . . . . . . . . 96.3 mt-10 -54.77 -46.93 74.45 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 116.268 -0.424 . . . . 0.0 111.254 -176.728 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' E' E ' 119' ' ' ASN . . . . . . . . . . . . . 24.4 m120 -95.62 31.01 2.13 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.165 -0.471 . . . . 0.0 112.139 -173.523 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' E' E ' 120' ' ' LEU . . . . . . . . . . . . . 14.7 tp -54.92 119.94 6.14 Favored 'General case' 0 N--CA 1.463 0.191 0 C-N-CA 121.019 -0.272 . . . . 0.0 110.752 177.449 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' E' E ' 121' ' ' ASN . . . . . . . . . . . . . 33.3 t-20 -114.09 -43.97 3.19 Favored 'General case' 0 C--N 1.331 -0.22 0 CA-C-N 116.599 -0.273 . . . . 0.0 111.359 -175.181 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' E' E ' 122' ' ' LYS . . . . . . . . . . . . . 36.5 mtmm -143.3 145.22 32.53 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-O 121.121 0.486 . . . . 0.0 111.63 -176.628 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' E' E ' 123' ' ' VAL . . . . . . . . . . . . . 46.8 t -126.67 127.54 70.25 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.22 0 CA-C-N 115.873 -0.603 . . . . 0.0 109.63 176.525 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' E' E ' 124' ' ' LEU . . . . . . . . . . . . . 50.2 mt -130.33 123.56 30.27 Favored 'General case' 0 C--N 1.331 -0.222 0 CA-C-N 116.441 -0.345 . . . . 0.0 110.186 179.751 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' E' E ' 125' ' ' VAL . . . . . 0.486 HG12 HG13 ' E' ' 130' ' ' VAL . 33.0 m -143.14 136.43 25.58 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.305 0 CA-C-O 120.816 0.341 . . . . 0.0 111.125 -178.937 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' E' E ' 126' ' ' ARG . . . . . . . . . . . . . 63.3 mtm180 -151.02 131.15 13.49 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-O 121.152 0.501 . . . . 0.0 110.876 177.82 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' E' E ' 127' ' ' ASN . . . . . . . . . . . . . 3.7 m120 52.01 -105.05 0.2 Allowed 'General case' 0 CA--C 1.543 0.677 0 CA-C-N 115.827 -0.624 . . . . 0.0 111.489 178.629 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' E' E ' 128' ' ' ASP . . . . . . . . . . . . . 22.8 p-10 -114.13 1.45 14.59 Favored 'General case' 0 N--CA 1.467 0.409 0 CA-C-N 119.345 0.975 . . . . 0.0 113.461 -174.895 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' E' E ' 129' ' ' LEU . . . . . . . . . . . . . 68.7 mt -105.55 128.91 53.86 Favored 'General case' 0 C--N 1.333 -0.126 0 CA-C-N 118.28 0.491 . . . . 0.0 110.301 179.215 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' E' E ' 130' ' ' VAL . . . . . 0.486 HG13 HG12 ' E' ' 125' ' ' VAL . 60.3 t -122.06 128.75 75.67 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.273 0 CA-C-N 115.95 -0.568 . . . . 0.0 109.544 -179.571 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' E' E ' 131' ' ' VAL . . . . . . . . . . . . . 41.8 t -136.03 132.38 50.13 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.227 0 CA-C-O 121.186 0.517 . . . . 0.0 110.288 177.493 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' E' E ' 132' ' ' ILE . . . . . . . . . . . . . 73.5 mt -117.25 131.78 68.96 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.316 0 CA-C-N 115.625 -0.716 . . . . 0.0 109.393 179.784 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' E' E ' 133' ' ' ILE . . . . . . . . . . . . . 36.9 mm -113.04 121.07 64.56 Favored 'Isoleucine or valine' 0 C--O 1.233 0.206 0 CA-C-O 120.741 0.305 . . . . 0.0 111.009 -174.935 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' E' E ' 134' ' ' ASP . . . . . . . . . . . . . 9.7 p-10 -131.73 148.23 52.56 Favored 'General case' 0 C--N 1.332 -0.18 0 N-CA-C 109.727 -0.472 . . . . 0.0 109.727 175.2 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' E' E ' 135' ' ' GLU . . . . . . . . . . . . . 78.2 tt0 -49.9 -26.61 4.27 Favored 'General case' 0 C--N 1.328 -0.331 0 N-CA-C 113.019 0.748 . . . . 0.0 113.019 -171.515 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' E' E ' 136' ' ' GLN . . . . . . . . . . . . . 99.4 mm-40 -86.26 -32.07 21.32 Favored 'General case' 0 C--N 1.331 -0.234 0 N-CA-C 112.411 0.522 . . . . 0.0 112.411 -174.932 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' E' E ' 137' ' ' LYS . . . . . . . . . . . . . 23.8 pttm -167.21 174.04 8.51 Favored 'General case' 0 C--O 1.233 0.191 0 CA-C-O 121.472 0.653 . . . . 0.0 112.429 -172.488 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' E' E ' 138' ' ' LEU . . . . . 0.401 ' C ' HD23 ' E' ' 138' ' ' LEU . 5.6 tt -118.52 127.32 53.51 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 114.925 -1.034 . . . . 0.0 110.033 179.867 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' E' E ' 139' ' ' THR . . . . . . . . . . . . . 28.4 m -104.51 120.39 41.15 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.042 -0.526 . . . . 0.0 110.257 179.439 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' E' E ' 140' ' ' LEU . . . . . 0.473 ' C ' HD23 ' E' ' 140' ' ' LEU . 7.7 tt -108.65 120.65 43.08 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 115.824 -0.626 . . . . 0.0 109.427 -179.974 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' E' E ' 141' ' ' ILE . . . . . . . . . . . . . 18.4 mt -123.84 121.2 61.69 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.265 0 CA-C-O 121.012 0.434 . . . . 0.0 109.833 -175.041 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' E' E ' 142' ' ' ARG . . . . . . . . . . . . . 64.5 ttt180 -109.11 124.12 50.29 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 115.689 -0.687 . . . . 0.0 110.22 179.218 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' E' E ' 143' ' ' THR . . . . . . . . . . . . . 55.9 p . . . . . 0 C--O 1.22 -0.467 0 CA-C-O 118.19 -0.909 . . . . 0.0 110.822 -179.542 . . . . . . . . 0 0 . 1 . 004 nuclear nobuild full ' F' F ' -3' ' ' GLU . . . . . . . . . . . . . 82.8 tt0 . . . . . 0 N--CA 1.491 1.61 0 N-CA-C 109.252 -0.647 . . . . 0.0 109.252 . . . . . . . . . 0 0 . 1 . 004 nuclear nobuild full ' F' F ' -2' ' ' GLY . . . . . . . . . . . . . . . -71.33 136.55 25.12 Favored Glycine 0 CA--C 1.526 0.767 0 N-CA-C 111.281 -0.728 . . . . 0.0 111.281 -178.178 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' F' F ' -1' ' ' VAL . . . . . . . . . . . . . 43.5 t -142.38 138.3 29.32 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.292 0 N-CA-C 110.03 -0.359 . . . . 0.0 110.03 178.94 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' F' F ' 0' ' ' ILE . . . . . . . . . . . . . 72.3 mt -112.27 135.73 50.71 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.273 0 CA-C-N 116.209 -0.45 . . . . 0.0 109.884 179.69 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' F' F ' 1' ' ' MET . . . . . . . . . . . . . 27.6 ptm -92.11 147.73 22.72 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.084 -0.507 . . . . 0.0 110.638 -179.31 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' F' F ' 2' ' ' SER . . . . . . . . . . . . . 2.5 p -129.32 128.1 42.45 Favored 'General case' 0 C--N 1.331 -0.198 0 CA-C-N 116.113 -0.494 . . . . 0.0 110.596 179.59 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' F' F ' 3' ' ' GLU . . . . . . . . . . . . . 83.8 tt0 -142.29 141.24 32.41 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.151 -0.477 . . . . 0.0 111.293 -179.984 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' F' F ' 4' ' ' LEU . . . . . . . . . . . . . 17.5 tp -127.31 133.23 50.14 Favored 'General case' 0 C--N 1.331 -0.201 0 CA-C-N 116.04 -0.527 . . . . 0.0 110.272 177.782 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' F' F ' 5' ' ' LYS . . . . . . . . . . . . . 98.5 mttt -112.06 121.32 44.66 Favored 'General case' 0 C--N 1.331 -0.212 0 CA-C-N 116.241 -0.436 . . . . 0.0 110.638 179.829 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' F' F ' 6' ' ' LEU . . . . . . . . . . . . . 69.8 mt -115.02 145.86 41.85 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 115.446 -0.797 . . . . 0.0 110.058 179.948 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' F' F ' 7' ' ' LYS . . . . . . . . . . . . . 40.2 ttmt -128.45 138.58 33.36 Favored Pre-proline 0 CA--C 1.533 0.295 0 CA-C-O 119.052 -0.499 . . . . 0.0 109.879 176.166 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' F' F ' 8' ' ' PRO . . . . . . . . . . . . . 94.4 Cg_endo -92.03 139.38 2.09 Favored 'Trans proline' 0 N--CA 1.488 1.197 0 C-N-CA 121.786 1.658 . . . . 0.0 111.963 178.694 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' F' F ' 9' ' ' LEU . . . . . . . . . . . . . 66.3 mt -74.46 -46.6 5.77 Favored Pre-proline 0 CA--C 1.533 0.314 0 CA-C-O 118.691 -0.671 . . . . 0.0 111.967 178.942 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' F' F ' 10' ' ' PRO . . . . . . . . . . . . . 90.0 Cg_endo -81.04 142.29 13.6 Favored 'Trans proline' 0 N--CA 1.496 1.635 0 C-N-CA 121.076 1.184 . . . . 0.0 111.561 174.035 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' F' F ' 11' ' ' LYS . . . . . . . . . . . . . 80.6 tttt -80.98 101.95 9.84 Favored 'General case' 0 C--N 1.329 -0.295 0 C-N-CA 120.802 -0.359 . . . . 0.0 110.441 179.317 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' F' F ' 12' ' ' VAL . . . . . . . . . . . . . 11.9 p -145.35 147.57 18.55 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.291 0 CA-C-N 116.233 -0.439 . . . . 0.0 110.715 -178.592 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' F' F ' 13' ' ' GLU . . . . . . . . . . . . . 70.7 mm-40 -92.9 123.74 36.38 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.033 176.687 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' F' F ' 14' ' ' LEU . . . . . . . . . . . . . 26.1 mt -96.81 154.48 38.32 Favored Pre-proline 0 C--N 1.329 -0.322 0 CA-C-N 116.426 -0.352 . . . . 0.0 110.69 -178.689 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' F' F ' 15' ' ' PRO . . . . . . . . . . . . . 31.3 Cg_exo -57.04 156.2 25.33 Favored 'Trans proline' 0 N--CA 1.496 1.659 0 C-N-CA 121.335 1.356 . . . . 0.0 111.777 179.636 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' F' F ' 16' ' ' PRO . . . . . . . . . . . . . 35.0 Cg_exo -57.81 -37.76 95.24 Favored 'Trans proline' 0 N--CA 1.497 1.677 0 C-N-CA 121.46 1.44 . . . . 0.0 112.802 -178.627 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' F' F ' 17' ' ' ASP . . . . . . . . . . . . . 19.1 p-10 -90.29 13.36 15.54 Favored 'General case' 0 CA--C 1.537 0.445 0 N-CA-C 113.116 0.784 . . . . 0.0 113.116 -177.38 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' F' F ' 18' ' ' PHE . . . . . . . . . . . . . 46.1 t80 -58.11 -45.32 87.46 Favored 'General case' 0 C--N 1.333 -0.126 0 CA-C-O 120.876 0.37 . . . . 0.0 110.089 -178.512 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' F' F ' 19' ' ' VAL . . . . . . . . . . . . . 48.4 t -57.18 -39.67 68.54 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.322 0 CA-C-N 116.25 -0.432 . . . . 0.0 110.505 -178.131 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' F' F ' 20' ' ' ASP . . . . . . . . . . . . . 10.2 t70 -59.85 -46.46 89.2 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-O 121.095 0.474 . . . . 0.0 110.875 -178.315 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' F' F ' 21' ' ' VAL . . . . . . . . . . . . . 49.5 t -64.19 -48.74 84.34 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.305 0 CA-C-N 116.207 -0.451 . . . . 0.0 110.624 -177.925 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' F' F ' 22' ' ' ILE . . . . . 0.565 HG22 HD12 ' F' ' 26' ' ' LEU . 51.0 mm -56.36 -43.45 77.35 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.297 0 CA-C-O 120.888 0.375 . . . . 0.0 110.51 179.135 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' F' F ' 23' ' ' ARG . . . . . . . . . . . . . 41.0 ttp180 -54.2 -47.52 72.0 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.545 -0.298 . . . . 0.0 111.337 -178.535 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' F' F ' 24' ' ' ILE . . . . . . . . . . . . . 73.8 mt -58.68 -44.17 89.26 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.307 0 CA-C-N 116.578 -0.283 . . . . 0.0 111.082 -179.068 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' F' F ' 25' ' ' LYS . . . . . . . . . . . . . 55.8 mttp -64.81 -39.33 93.41 Favored 'General case' 0 N--CA 1.464 0.24 0 N-CA-C 112.461 0.541 . . . . 0.0 112.461 -179.632 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' F' F ' 26' ' ' LEU . . . . . 0.565 HD12 HG22 ' F' ' 22' ' ' ILE . 49.7 mt -78.9 -41.72 29.0 Favored 'General case' 0 C--N 1.33 -0.28 0 N-CA-C 113.299 0.851 . . . . 0.0 113.299 -170.114 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' F' F ' 27' ' ' GLN . . . . . . . . . . . . . 10.9 pt20 -46.66 139.65 5.05 Favored 'General case' 0 N--CA 1.469 0.508 0 N-CA-C 112.817 0.673 . . . . 0.0 112.817 -175.11 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' F' F ' 28' ' ' GLY . . . . . . . . . . . . . . . 100.63 -27.97 18.04 Favored Glycine 0 CA--C 1.53 0.995 0 CA-C-N 115.494 -0.775 . . . . 0.0 112.218 -177.382 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' F' F ' 29' ' ' LYS . . . . . . . . . . . . . 98.2 mttt -97.9 155.07 17.24 Favored 'General case' 0 C--O 1.232 0.18 0 CA-C-N 117.33 0.565 . . . . 0.0 111.247 179.056 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' F' F ' 30' ' ' THR . . . . . . . . . . . . . 42.0 m -103.67 140.28 37.8 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 115.892 -0.594 . . . . 0.0 110.162 176.839 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' F' F ' 31' ' ' VAL . . . . . . . . . . . . . 35.5 m -127.48 155.06 38.53 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.303 0 CA-C-N 116.272 -0.422 . . . . 0.0 110.374 179.429 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' F' F ' 32' ' ' ARG . . . . . . . . . . . . . 35.9 ttp180 -134.03 149.31 51.17 Favored 'General case' 0 C--N 1.331 -0.207 0 CA-C-O 121.305 0.574 . . . . 0.0 110.603 178.678 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' F' F ' 33' ' ' THR . . . . . 0.417 HG23 ' HA ' ' F' ' 52' ' ' GLN . 16.3 m -52.51 139.61 24.85 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-N 116.073 -0.512 . . . . 0.0 111.544 -177.939 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' F' F ' 34' ' ' GLY . . . . . . . . . . . . . . . 98.75 -17.23 58.61 Favored Glycine 0 CA--C 1.533 1.175 0 C-N-CA 121.236 -0.507 . . . . 0.0 113.366 178.947 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' F' F ' 35' ' ' ASP . . . . . . . . . . . . . 76.3 m-20 -65.79 150.17 48.97 Favored 'General case' 0 N--CA 1.462 0.161 0 CA-C-N 117.942 0.871 . . . . 0.0 111.291 -179.891 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' F' F ' 36' ' ' VAL . . . . . . . . . . . . . 44.3 t -119.73 128.93 75.91 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.222 0 CA-C-N 115.798 -0.637 . . . . 0.0 109.725 177.882 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' F' F ' 37' ' ' ILE . . . . . . . . . . . . . 68.8 mt -122.22 139.19 49.94 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.248 0 CA-C-N 116.261 -0.427 . . . . 0.0 109.928 -179.275 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' F' F ' 38' ' ' GLY . . . . . . . . . . . . . . . -115.3 128.35 8.04 Favored Glycine 0 CA--C 1.525 0.693 0 N-CA-C 110.859 -0.896 . . . . 0.0 110.859 178.853 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' F' F ' 39' ' ' ILE . . . . . . . . . . . . . 76.3 mt -127.44 138.6 54.29 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.217 0 CA-C-O 120.74 0.305 . . . . 0.0 110.197 179.921 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' F' F ' 40' ' ' SER . . . . . . . . . . . . . 42.6 t -91.96 114.05 26.48 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.274 -0.421 . . . . 0.0 110.981 176.849 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' F' F ' 41' ' ' ILE . . . . . . . . . . . . . 44.3 mm -122.94 121.06 62.3 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.234 0 N-CA-C 109.665 -0.494 . . . . 0.0 109.665 178.645 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' F' F ' 42' ' ' LEU . . . . . . . . . . . . . 84.2 mt 57.71 33.67 23.51 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 116.454 -0.339 . . . . 0.0 111.662 179.606 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' F' F ' 43' ' ' GLY . . . . . . . . . . . . . . . 77.64 -10.2 25.37 Favored Glycine 0 CA--C 1.535 1.288 0 C-N-CA 121.311 -0.471 . . . . 0.0 113.47 178.114 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' F' F ' 44' ' ' LYS . . . . . . . . . . . . . 98.3 mttt -101.05 138.76 37.66 Favored 'General case' 0 C--N 1.334 -0.108 0 CA-C-N 117.898 0.849 . . . . 0.0 110.05 177.436 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' F' F ' 45' ' ' GLU . . . . . . . . . . . . . 80.9 tt0 -83.75 130.08 34.95 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.431 -0.35 . . . . 0.0 111.263 -178.945 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' F' F ' 46' ' ' VAL . . . . . . . . . . . . . 10.4 p -120.55 125.87 74.61 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.209 0 N-CA-C 109.653 -0.499 . . . . 0.0 109.653 174.512 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' F' F ' 47' ' ' LYS . . . . . . . . . . . . . 29.2 mtpp -98.0 124.98 42.74 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 115.984 -0.553 . . . . 0.0 110.622 177.979 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' F' F ' 48' ' ' PHE . . . . . . . . . . . . . 40.8 m-85 -110.15 131.89 54.65 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.251 -0.431 . . . . 0.0 109.893 177.534 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' F' F ' 49' ' ' LYS . . . . . . . . . . . . . 85.6 tttt -106.34 131.39 53.61 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.209 -0.451 . . . . 0.0 109.811 177.158 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' F' F ' 50' ' ' VAL . . . . . . . . . . . . . 43.8 t -75.59 105.92 4.95 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.335 0 N-CA-C 109.384 -0.598 . . . . 0.0 109.384 177.911 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' F' F ' 51' ' ' VAL . . . . . . . . . . . . . 48.1 t -69.17 -48.01 71.23 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.27 0 CA-C-N 116.062 -0.517 . . . . 0.0 109.761 -174.354 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' F' F ' 52' ' ' GLN . . . . . 0.417 ' HA ' HG23 ' F' ' 33' ' ' THR . 21.4 pt20 -167.01 158.56 12.47 Favored 'General case' 0 C--N 1.331 -0.199 0 C-N-CA 120.249 -0.58 . . . . 0.0 111.79 179.167 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' F' F ' 53' ' ' ALA . . . . . . . . . . . . . . . -133.5 137.04 45.44 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 115.485 -0.779 . . . . 0.0 110.243 179.07 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' F' F ' 54' ' ' TYR . . . . . . . . . . . . . 38.4 t80 -128.98 109.43 18.29 Favored Pre-proline 0 CA--C 1.535 0.372 0 CA-C-O 118.274 -0.87 . . . . 0.0 110.359 -179.425 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' F' F ' 55' ' ' PRO . . . . . . . . . . . . . 74.0 Cg_endo -77.17 169.97 72.77 Favored 'Cis proline' 0 N--CA 1.502 2.002 0 CA-C-N 121.855 1.698 . . . . 0.0 112.145 -7.375 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' F' F ' 56' ' ' SER . . . . . . . . . . . . . 49.0 m -117.82 132.8 23.48 Favored Pre-proline 0 CA--C 1.538 0.483 0 CA-C-O 118.492 -0.766 . . . . 0.0 109.616 175.057 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' F' F ' 57' ' ' PRO . . . . . . . . . . . . . 40.4 Cg_endo -68.56 165.45 72.8 Favored 'Cis proline' 0 N--CA 1.497 1.731 0 CA-C-N 121.88 1.707 . . . . 0.0 111.328 -1.657 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' F' F ' 58' ' ' LEU . . . . . . . . . . . . . 23.4 tp -130.62 137.45 49.63 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-O 120.871 0.367 . . . . 0.0 110.691 -178.049 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' F' F ' 59' ' ' ARG . . . . . . . . . . . . . 57.6 ttt85 -104.05 128.4 51.65 Favored 'General case' 0 C--N 1.328 -0.35 0 N-CA-C 109.464 -0.569 . . . . 0.0 109.464 176.35 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' F' F ' 60' ' ' VAL . . . . . . . . . . . . . 41.1 t -81.48 122.61 36.77 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.267 0 C-N-CA 120.769 -0.372 . . . . 0.0 110.69 -175.159 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' F' F ' 61' ' ' GLU . . . . . . . . . . . . . 44.3 mt-10 -131.12 168.0 18.18 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 115.842 -0.617 . . . . 0.0 109.77 176.892 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' F' F ' 62' ' ' ASP . . . . . . . . . . . . . 10.0 p-10 -55.91 -32.67 63.97 Favored 'General case' 0 C--N 1.329 -0.316 0 N-CA-C 111.803 0.297 . . . . 0.0 111.803 -178.484 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' F' F ' 63' ' ' ARG . . . . . . . . . . . . . 24.5 mmt180 -78.77 -9.33 59.4 Favored 'General case' 0 N--CA 1.467 0.383 0 N-CA-C 113.347 0.869 . . . . 0.0 113.347 -176.772 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' F' F ' 64' ' ' THR . . . . . . . . . . . . . 31.4 m -70.85 138.93 50.67 Favored 'General case' 0 C--N 1.332 -0.165 0 CA-C-O 121.007 0.432 . . . . 0.0 111.148 -175.356 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' F' F ' 65' ' ' LYS . . . . . . . . . . . . . 62.2 mttm -88.95 123.12 32.99 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 115.862 -0.608 . . . . 0.0 109.881 176.425 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' F' F ' 66' ' ' ILE . . . . . . . . . . . . . 61.7 mt -115.2 126.61 72.82 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 N-CA-C 109.779 -0.452 . . . . 0.0 109.779 179.758 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' F' F ' 67' ' ' THR . . . . . . . . . . . . . 28.4 m -125.38 138.76 54.04 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-O 121.126 0.488 . . . . 0.0 111.175 -177.351 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' F' F ' 68' ' ' LEU . . . . . . . . . . . . . 46.3 mt -103.24 127.89 50.42 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 115.753 -0.658 . . . . 0.0 109.959 176.161 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' F' F ' 69' ' ' VAL . . . . . . . . . . . . . 42.8 t -100.59 133.49 43.57 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.345 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.189 -178.69 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' F' F ' 70' ' ' THR . . . . . . . . . . . . . 21.6 p -103.69 152.22 22.06 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.488 179.616 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' F' F ' 71' ' ' HIS . . . . . . . . . . . . . 6.8 t60 -94.79 145.22 29.2 Favored Pre-proline 0 CA--C 1.534 0.353 0 CA-C-O 119.075 -0.488 . . . . 0.0 109.846 -179.904 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' F' F ' 72' ' ' PRO . . . . . . . . . . . . . 59.2 Cg_endo -75.24 -23.95 12.92 Favored 'Trans proline' 0 N--CA 1.495 1.606 0 C-N-CA 121.284 1.323 . . . . 0.0 112.867 -179.85 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' F' F ' 73' ' ' VAL . . . . . . . . . . . . . 35.9 m -130.95 167.85 25.12 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.161 0 CA-C-O 121.027 0.441 . . . . 0.0 110.814 -179.862 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' F' F ' 74' ' ' ASP . . . . . . . . . . . . . 13.5 t0 -105.11 117.9 35.18 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 115.849 -0.614 . . . . 0.0 109.741 177.748 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' F' F ' 75' ' ' VAL . . . . . 0.429 ' C ' HD12 ' F' ' 76' ' ' LEU . 40.1 t -118.06 125.61 74.34 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.267 0 CA-C-O 121.048 0.451 . . . . 0.0 110.61 -178.08 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' F' F ' 76' ' ' LEU . . . . . 0.429 HD12 ' C ' ' F' ' 75' ' ' VAL . 5.7 mp -126.3 145.42 50.43 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 115.672 -0.695 . . . . 0.0 109.559 176.206 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' F' F ' 77' ' ' GLU . . . . . . . . . . . . . 96.7 mt-10 -132.04 129.11 39.62 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-O 121.02 0.438 . . . . 0.0 110.715 -178.064 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' F' F ' 78' ' ' ALA . . . . . . . . . . . . . . . -115.4 132.62 56.56 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 115.75 -0.659 . . . . 0.0 109.999 178.869 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' F' F ' 79' ' ' LYS . . . . . 0.584 ' O ' HD13 ' F' ' 80' ' ' ILE . 20.2 tptm -76.91 116.38 17.52 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-O 120.916 0.389 . . . . 0.0 110.791 -177.424 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' F' F ' 80' ' ' ILE . . . . . 0.584 HD13 ' O ' ' F' ' 79' ' ' LYS . 42.3 mm -139.28 98.45 1.16 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.282 0 N-CA-C 109.152 -0.684 . . . . 0.0 109.152 -176.938 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' F' F ' 81' ' ' LYS . . . . . . . . . . . . . 17.8 pttp -98.4 131.26 44.82 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-O 120.956 0.408 . . . . 0.0 111.454 -175.72 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' F' F ' 82' ' ' GLY . . . . . . . . . . . . . . . 89.12 41.98 5.72 Favored Glycine 0 CA--C 1.524 0.643 0 CA-C-N 115.82 -0.627 . . . . 0.0 111.57 176.076 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' F' F ' 83' ' ' ILE . . . . . . . . . . . . . 65.8 mt -74.59 135.5 27.24 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 N-CA-C 109.453 -0.573 . . . . 0.0 109.453 176.719 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' F' F ' 84' ' ' LYS . . . . . . . . . . . . . 38.0 ttpt -106.94 -42.48 4.91 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-O 120.782 0.325 . . . . 0.0 110.634 -177.805 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' F' F ' 85' ' ' ASP . . . . . . . . . . . . . 9.2 t70 -149.23 149.83 31.6 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.311 -0.404 . . . . 0.0 110.433 179.336 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' F' F ' 86' ' ' VAL . . . . . . . . . . . . . 41.9 t -137.64 136.76 45.9 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.231 0 CA-C-O 120.936 0.398 . . . . 0.0 110.74 -178.915 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' F' F ' 87' ' ' ILE . . . . . . . . . . . . . 4.9 mp -123.83 126.86 73.32 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.251 0 CA-C-N 115.828 -0.624 . . . . 0.0 109.522 176.171 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' F' F ' 88' ' ' LEU . . . . . . . . . . . . . 19.2 tp -114.89 130.26 56.86 Favored 'General case' 0 N--CA 1.463 0.184 0 CA-C-O 121.088 0.47 . . . . 0.0 111.187 -177.525 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' F' F ' 89' ' ' ASP . . . . . . . . . . . . . 4.2 t0 -125.42 156.58 38.6 Favored 'General case' 0 C--N 1.331 -0.207 0 CA-C-N 115.638 -0.71 . . . . 0.0 109.388 175.399 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' F' F ' 90' ' ' GLU . . . . . . . . . . . . . 81.9 tt0 -46.53 -40.89 13.39 Favored 'General case' 0 N--CA 1.463 0.211 0 N-CA-C 113.11 0.781 . . . . 0.0 113.11 -172.445 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' F' F ' 91' ' ' ASN . . . . . . . . . . . . . 71.1 m-80 -132.14 37.75 3.55 Favored 'General case' 0 N--CA 1.465 0.28 0 CA-C-O 120.785 0.326 . . . . 0.0 111.554 -176.479 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' F' F ' 92' ' ' LEU . . . . . . . . . . . . . 17.3 tp -166.08 138.85 4.04 Favored 'General case' 0 C--N 1.33 -0.281 0 C-N-CA 120.931 -0.308 . . . . 0.0 110.589 -179.563 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' F' F ' 93' ' ' ILE . . . . . . . . . . . . . 67.0 mt -124.02 122.42 64.42 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.187 0 N-CA-C 109.769 -0.456 . . . . 0.0 109.769 179.724 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' F' F ' 94' ' ' VAL . . . . . . . . . . . . . 44.8 t -120.92 125.18 73.73 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.222 0 N-CA-C 109.789 -0.448 . . . . 0.0 109.789 178.59 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' F' F ' 95' ' ' VAL . . . . . . . . . . . . . 43.1 t -120.11 134.04 64.88 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.379 0 CA-C-N 116.071 -0.513 . . . . 0.0 109.746 -179.422 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' F' F ' 96' ' ' ILE . . . . . 0.432 HD11 HG21 ' F' ' 123' ' ' VAL . 68.4 mt -116.6 127.88 74.1 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.232 0 N-CA-C 109.458 -0.571 . . . . 0.0 109.458 179.31 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' F' F ' 97' ' ' THR . . . . . . . . . . . . . 77.8 p -101.92 162.23 13.06 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-O 121.5 0.667 . . . . 0.0 111.704 -175.362 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' F' F ' 98' ' ' GLU . . . . . . . . . . . . . 82.1 tt0 -53.82 -28.51 35.92 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 115.442 -0.799 . . . . 0.0 112.361 -178.947 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' F' F ' 99' ' ' GLU . . . . . . . . . . . . . 96.0 mt-10 -81.97 18.04 1.42 Allowed 'General case' 0 CA--C 1.534 0.354 0 N-CA-C 113.116 0.784 . . . . 0.0 113.116 -176.356 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' F' F ' 100' ' ' ASN . . . . . . . . . . . . . 2.7 m-20 62.22 37.65 14.07 Favored 'General case' 0 CA--C 1.53 0.185 0 CA-C-O 121.036 0.446 . . . . 0.0 111.047 177.591 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' F' F ' 101' ' ' GLU . . . . . . . . . . . . . 84.7 tt0 -117.1 144.61 44.48 Favored 'General case' 0 C--N 1.332 -0.193 0 N-CA-C 109.719 -0.475 . . . . 0.0 109.719 177.342 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' F' F ' 102' ' ' VAL . . . . . . . . . . . . . 42.4 t -117.47 127.29 74.94 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.23 0 N-CA-C 109.962 -0.385 . . . . 0.0 109.962 -178.446 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' F' F ' 103' ' ' LEU . . . . . . . . . . . . . 31.5 mt -116.33 132.07 56.77 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 115.572 -0.74 . . . . 0.0 110.036 176.699 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' F' F ' 104' ' ' ILE . . . . . 0.528 HD13 HG11 ' F' ' 130' ' ' VAL . 66.4 mt -117.73 122.21 69.26 Favored 'Isoleucine or valine' 0 C--O 1.234 0.265 0 N-CA-C 110.238 -0.282 . . . . 0.0 110.238 -178.939 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' F' F ' 105' ' ' PHE . . . . . . . . . . . . . 86.5 m-85 -123.48 164.27 19.27 Favored 'General case' 0 C--N 1.332 -0.165 0 O-C-N 123.936 0.773 . . . . 0.0 110.3 -178.857 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' F' F ' 106' ' ' ASN . . . . . . . . . . . . . 46.0 p-10 -99.73 -169.92 1.82 Allowed 'General case' 0 CA--C 1.53 0.2 0 N-CA-C 109.655 -0.498 . . . . 0.0 109.655 171.849 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' F' F ' 107' ' ' GLN . . . . . . . . . . . . . 41.4 tt0 -57.86 -30.06 65.49 Favored 'General case' 0 C--N 1.327 -0.379 0 N-CA-C 112.117 0.414 . . . . 0.0 112.117 -178.767 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' F' F ' 108' ' ' ASN . . . . . . . . . . . . . 8.8 t30 -91.24 14.11 15.29 Favored 'General case' 0 CA--C 1.535 0.398 0 N-CA-C 113.106 0.78 . . . . 0.0 113.106 -175.558 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' F' F ' 109' ' ' LEU . . . . . . . . . . . . . 40.8 mt 58.12 34.01 23.75 Favored 'General case' 0 CA--C 1.53 0.204 0 CA-C-O 120.718 0.294 . . . . 0.0 111.723 177.914 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' F' F ' 110' ' ' GLU . . . . . . . . . . . . . 96.0 mt-10 -98.92 134.75 41.33 Favored 'General case' 0 C--N 1.329 -0.288 0 N-CA-C 109.408 -0.59 . . . . 0.0 109.408 175.434 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' F' F ' 111' ' ' GLU . . . . . . . . . . . . . 48.4 tt0 -71.7 121.97 19.8 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-O 121.009 0.433 . . . . 0.0 110.729 -175.751 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' F' F ' 112' ' ' LEU . . . . . . . . . . . . . 25.6 mt -105.87 -46.04 4.22 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-N 115.898 -0.592 . . . . 0.0 110.327 178.994 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' F' F ' 113' ' ' TYR . . . . . 0.405 ' HB3' HD12 ' F' ' 104' ' ' ILE . 31.2 t80 -137.95 141.54 40.53 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.11 -0.495 . . . . 0.0 111.05 -179.036 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' F' F ' 114' ' ' ARG . . . . . . . . . . . . . 32.7 ptt180 -141.69 123.58 15.31 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.247 -0.433 . . . . 0.0 110.392 177.206 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' F' F ' 115' ' ' GLY . . . . . . . . . . . . . . . -150.14 160.08 28.38 Favored Glycine 0 CA--C 1.524 0.601 0 N-CA-C 111.16 -0.776 . . . . 0.0 111.16 179.821 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' F' F ' 116' ' ' LYS . . . . . . . . . . . . . 33.4 ttpt -128.96 136.91 50.99 Favored 'General case' 0 C--N 1.33 -0.276 0 N-CA-C 109.908 -0.405 . . . . 0.0 109.908 177.333 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' F' F ' 117' ' ' PHE . . . . . . . . . . . . . 43.4 m-85 -134.1 113.79 12.45 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-O 120.971 0.415 . . . . 0.0 110.238 -177.124 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' F' F ' 118' ' ' GLU . . . . . . . . . . . . . 45.7 tp10 -54.69 -48.88 71.89 Favored 'General case' 0 C--N 1.326 -0.449 0 CA-C-N 116.289 -0.414 . . . . 0.0 111.277 -176.188 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' F' F ' 119' ' ' ASN . . . . . . . . . . . . . 73.3 m-20 -95.17 31.1 1.99 Allowed 'General case' 0 C--N 1.33 -0.275 0 N-CA-C 112.155 0.428 . . . . 0.0 112.155 -173.836 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' F' F ' 120' ' ' LEU . . . . . . . . . . . . . 20.0 tp -54.18 119.91 5.76 Favored 'General case' 0 N--CA 1.464 0.233 0 O-C-N 122.207 -0.308 . . . . 0.0 110.738 177.29 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' F' F ' 121' ' ' ASN . . . . . . . . . . . . . 13.6 t-20 -114.11 -44.03 3.18 Favored 'General case' 0 C--N 1.331 -0.214 0 CA-C-N 116.455 -0.339 . . . . 0.0 110.962 -177.009 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' F' F ' 122' ' ' LYS . . . . . . . . . . . . . 61.9 mtpt -142.0 147.29 36.67 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-O 121.168 0.509 . . . . 0.0 111.233 -177.059 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' F' F ' 123' ' ' VAL . . . . . 0.432 HG21 HD11 ' F' ' 96' ' ' ILE . 44.2 t -128.66 125.98 64.39 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.191 0 N-CA-C 109.312 -0.625 . . . . 0.0 109.312 174.679 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' F' F ' 124' ' ' LEU . . . . . 0.517 HD12 ' N ' ' F' ' 124' ' ' LEU . 6.0 mp -118.17 132.82 56.3 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-O 120.766 0.317 . . . . 0.0 110.696 -177.019 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' F' F ' 125' ' ' VAL . . . . . . . . . . . . . 43.9 t -125.57 127.51 71.69 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.241 0 CA-C-N 116.051 -0.522 . . . . 0.0 110.178 179.918 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' F' F ' 126' ' ' ARG . . . . . . . . . . . . . 40.8 mmt180 -145.22 119.88 9.8 Favored 'General case' 0 C--N 1.328 -0.336 0 N-CA-C 109.478 -0.564 . . . . 0.0 109.478 177.193 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' F' F ' 127' ' ' ASN . . . . . . . . . . . . . 13.8 m120 56.38 -152.73 0.37 Allowed 'General case' 0 CA--C 1.54 0.564 0 N-CA-C 109.737 -0.468 . . . . 0.0 109.737 -179.164 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' F' F ' 128' ' ' ASP . . . . . . . . . . . . . 23.3 p-10 -79.95 14.29 1.87 Allowed 'General case' 0 CA--C 1.537 0.448 0 N-CA-C 112.759 0.652 . . . . 0.0 112.759 177.799 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' F' F ' 129' ' ' LEU . . . . . . . . . . . . . 60.9 mt -109.37 139.75 43.93 Favored 'General case' 0 C--O 1.232 0.181 0 O-C-N 121.955 -0.465 . . . . 0.0 109.747 178.254 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' F' F ' 130' ' ' VAL . . . . . 0.528 HG11 HD13 ' F' ' 104' ' ' ILE . 12.1 p -132.34 141.75 44.45 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.235 0 CA-C-O 121.202 0.525 . . . . 0.0 110.562 -177.746 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' F' F ' 131' ' ' VAL . . . . . . . . . . . . . 42.8 t -135.99 135.2 50.58 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.299 0 CA-C-N 115.794 -0.639 . . . . 0.0 110.035 178.63 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' F' F ' 132' ' ' ILE . . . . . . . . . . . . . 69.0 mt -113.52 130.76 66.98 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.332 0 CA-C-N 115.815 -0.629 . . . . 0.0 109.348 -179.784 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' F' F ' 133' ' ' ILE . . . . . . . . . . . . . 36.8 mm -114.59 120.41 64.19 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.216 0 CA-C-O 120.989 0.423 . . . . 0.0 110.914 -175.044 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' F' F ' 134' ' ' ASP . . . . . . . . . . . . . 6.9 p-10 -132.56 147.45 52.35 Favored 'General case' 0 C--N 1.332 -0.181 0 N-CA-C 109.519 -0.549 . . . . 0.0 109.519 176.007 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' F' F ' 135' ' ' GLU . . . . . . . . . . . . . 84.5 tt0 -49.94 -27.57 5.51 Favored 'General case' 0 C--N 1.329 -0.298 0 N-CA-C 112.703 0.631 . . . . 0.0 112.703 -173.008 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' F' F ' 136' ' ' GLN . . . . . . . . . . . . . 98.5 mt-30 -81.36 -34.48 31.71 Favored 'General case' 0 C--O 1.232 0.183 0 N-CA-C 112.181 0.438 . . . . 0.0 112.181 -176.158 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' F' F ' 137' ' ' LYS . . . . . . . . . . . . . 56.3 pttt -168.01 175.04 6.92 Favored 'General case' 0 C--N 1.332 -0.188 0 CA-C-O 121.506 0.669 . . . . 0.0 112.14 -172.482 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' F' F ' 138' ' ' LEU . . . . . 0.462 HD23 ' C ' ' F' ' 138' ' ' LEU . 8.5 tt -120.13 128.59 53.58 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 115.174 -0.921 . . . . 0.0 110.135 179.205 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' F' F ' 139' ' ' THR . . . . . . . . . . . . . 33.2 m -107.64 122.41 46.65 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-N 116.116 -0.493 . . . . 0.0 110.239 178.906 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' F' F ' 140' ' ' LEU . . . . . 0.463 HD23 ' C ' ' F' ' 140' ' ' LEU . 6.2 tt -111.03 122.27 47.47 Favored 'General case' 0 C--N 1.329 -0.326 0 N-CA-C 109.189 -0.671 . . . . 0.0 109.189 -179.432 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' F' F ' 141' ' ' ILE . . . . . 0.456 ' HB ' HG13 ' F' ' 130' ' ' VAL . 19.8 mt -121.63 116.36 49.25 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.275 0 CA-C-O 121.086 0.47 . . . . 0.0 109.927 -176.113 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' F' F ' 142' ' ' ARG . . . . . . . . . . . . . 61.6 ttt180 -106.07 127.46 53.2 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 114.921 -1.036 . . . . 0.0 110.619 -176.259 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' F' F ' 143' ' ' THR . . . . . . . . . . . . . 75.8 p . . . . . 0 C--O 1.22 -0.46 0 CA-C-O 118.001 -1.0 . . . . 0.0 110.589 179.192 . . . . . . . . 0 0 . 1 . 005 nuclear nobuild full ' A' A ' -3' ' ' GLU . . . . . . . . . . . . . 11.8 pt-20 . . . . . 0 N--CA 1.49 1.557 0 N-CA-C 109.501 -0.555 . . . . 0.0 109.501 . . . . . . . . . 0 0 . 1 . 005 nuclear nobuild full ' A' A ' -2' ' ' GLY . . . . . . . . . . . . . . . -62.93 115.13 7.63 Favored Glycine 0 CA--C 1.525 0.695 0 N-CA-C 110.843 -0.903 . . . . 0.0 110.843 -179.86 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' -1' ' ' VAL . . . . . . . . . . . . . 41.0 t -97.35 128.64 48.43 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 CA-C-O 120.83 0.348 . . . . 0.0 110.233 -179.518 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 0' ' ' ILE . . . . . . . . . . . . . 74.8 mt -122.58 133.51 68.54 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.234 0 N-CA-C 109.741 -0.466 . . . . 0.0 109.741 177.773 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 26.8 ptm -143.66 166.83 23.75 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.264 -0.426 . . . . 0.0 110.909 -178.52 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 13.7 p -114.74 135.41 54.2 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.01 -0.541 . . . . 0.0 110.618 177.934 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 84.9 tt0 -140.02 138.94 35.84 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-N 115.724 -0.671 . . . . 0.0 110.676 179.64 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 4' ' ' LEU . . . . . 0.49 HD23 ' N ' ' A' ' 5' ' ' LYS . 3.0 tt -125.7 126.51 44.76 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 115.734 -0.666 . . . . 0.0 109.698 178.579 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 5' ' ' LYS . . . . . 0.49 ' N ' HD23 ' A' ' 4' ' ' LEU . 87.8 mttt -108.99 124.34 50.56 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-O 120.655 0.265 . . . . 0.0 110.864 -179.119 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 6' ' ' LEU . . . . . 0.475 HD23 ' HA ' ' A' ' 50' ' ' VAL . 18.3 mt -122.01 150.29 42.28 Favored 'General case' 0 C--O 1.232 0.163 0 CA-C-N 115.811 -0.631 . . . . 0.0 111.254 -178.879 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 49.3 tttm -138.27 143.47 39.1 Favored Pre-proline 0 C--N 1.329 -0.304 0 CA-C-N 115.757 -0.656 . . . . 0.0 109.792 175.199 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 8' ' ' PRO . . . . . . . . . . . . . 97.5 Cg_endo -89.8 136.72 2.65 Favored 'Trans proline' 0 N--CA 1.489 1.234 0 C-N-CA 121.741 1.628 . . . . 0.0 111.766 178.537 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 40.9 mt -75.9 -45.68 3.93 Favored Pre-proline 0 CA--C 1.532 0.285 0 CA-C-O 119.064 -0.493 . . . . 0.0 111.524 -179.253 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 71.1 Cg_endo -85.1 152.12 10.93 Favored 'Trans proline' 0 N--CA 1.494 1.519 0 C-N-CA 121.234 1.289 . . . . 0.0 111.31 170.534 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 27.5 ttpp -86.23 109.78 19.16 Favored 'General case' 0 C--N 1.33 -0.271 0 C-N-CA 120.702 -0.399 . . . . 0.0 110.235 178.692 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 11.8 p -142.77 145.09 23.55 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.291 0 CA-C-N 116.092 -0.504 . . . . 0.0 110.62 -178.576 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 84.8 tt0 -88.47 121.32 30.72 Favored 'General case' 0 C--N 1.328 -0.344 0 N-CA-C 109.913 -0.403 . . . . 0.0 109.913 176.886 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 14' ' ' LEU . . . . . . . . . . . . . 29.6 mt -98.01 151.56 37.61 Favored Pre-proline 0 C--N 1.33 -0.268 0 CA-C-N 116.354 -0.384 . . . . 0.0 110.976 -176.277 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 15' ' ' PRO . . . . . . . . . . . . . 24.5 Cg_exo -63.31 161.13 31.95 Favored 'Trans proline' 0 N--CA 1.497 1.723 0 C-N-CA 121.322 1.348 . . . . 0.0 111.666 175.436 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 16' ' ' PRO . . . . . . . . . . . . . 26.6 Cg_exo -60.73 -34.0 92.39 Favored 'Trans proline' 0 N--CA 1.496 1.646 0 C-N-CA 121.478 1.452 . . . . 0.0 112.966 -177.722 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 17' ' ' ASP . . . . . . . . . . . . . 18.8 p-10 -90.62 6.6 43.17 Favored 'General case' 0 CA--C 1.537 0.465 0 N-CA-C 113.402 0.89 . . . . 0.0 113.402 -176.833 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 18' ' ' PHE . . . . . . . . . . . . . 49.6 t80 -57.59 -42.93 84.18 Favored 'General case' 0 C--N 1.334 -0.105 0 CA-C-O 120.952 0.406 . . . . 0.0 110.291 -178.021 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 19' ' ' VAL . . . . . . . . . . . . . 47.8 t -57.16 -43.57 81.84 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.346 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.358 -178.827 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 4.2 m-20 -60.15 -41.33 92.54 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.525 -0.307 . . . . 0.0 110.882 -178.381 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 47.0 t -63.58 -46.17 95.66 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 C-N-CA 120.85 -0.34 . . . . 0.0 110.296 -177.385 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 22' ' ' ILE . . . . . 0.564 HG22 HD12 ' A' ' 26' ' ' LEU . 51.0 mm -55.54 -48.63 77.13 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.237 0 CA-C-O 120.81 0.338 . . . . 0.0 110.714 178.778 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 23' ' ' ARG . . . . . . . . . . . . . 55.9 ttp180 -54.31 -48.77 70.93 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.629 -0.26 . . . . 0.0 111.568 -178.057 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 24' ' ' ILE . . . . . . . . . . . . . 78.5 mt -60.11 -42.7 90.92 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.269 0 C-N-CA 121.052 -0.259 . . . . 0.0 111.54 -176.791 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 51.1 mttm -65.13 -40.49 94.52 Favored 'General case' 0 C--N 1.328 -0.327 0 N-CA-C 112.21 0.448 . . . . 0.0 112.21 -179.12 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 26' ' ' LEU . . . . . 0.564 HD12 HG22 ' A' ' 22' ' ' ILE . 37.6 mt -78.96 -40.06 32.83 Favored 'General case' 0 C--N 1.33 -0.271 0 N-CA-C 113.526 0.935 . . . . 0.0 113.526 -171.366 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 27' ' ' GLN . . . . . . . . . . . . . 9.8 pt20 -46.88 141.91 3.75 Favored 'General case' 0 N--CA 1.47 0.545 0 N-CA-C 112.82 0.674 . . . . 0.0 112.82 -175.207 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 97.72 -30.0 10.06 Favored Glycine 0 CA--C 1.531 1.044 0 CA-C-N 115.652 -0.703 . . . . 0.0 111.984 -177.529 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 48.8 mtmt -99.3 155.3 17.58 Favored 'General case' 0 C--O 1.233 0.227 0 CA-C-O 120.993 0.425 . . . . 0.0 111.324 179.304 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 30' ' ' THR . . . . . . . . . . . . . 20.8 m -105.57 140.55 38.49 Favored 'General case' 0 C--N 1.331 -0.212 0 CA-C-N 115.91 -0.586 . . . . 0.0 110.166 176.657 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 35.5 m -129.54 161.43 39.08 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.187 0 CA-C-N 116.41 -0.359 . . . . 0.0 110.848 -179.138 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 32' ' ' ARG . . . . . . . . . . . . . 79.7 mtt85 -127.28 147.37 50.23 Favored 'General case' 0 C--N 1.331 -0.212 0 CA-C-O 121.291 0.567 . . . . 0.0 110.776 179.093 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 33' ' ' THR . . . . . . . . . . . . . 29.2 m -53.91 140.69 29.98 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.248 -0.433 . . . . 0.0 111.146 -179.879 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 98.83 -17.13 58.69 Favored Glycine 0 CA--C 1.532 1.144 0 C-N-CA 121.131 -0.557 . . . . 0.0 113.232 179.33 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 76.1 m-20 -64.63 150.26 47.37 Favored 'General case' 0 C--O 1.232 0.147 0 CA-C-N 118.096 0.948 . . . . 0.0 111.241 179.813 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 45.0 t -119.07 129.65 74.91 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.247 0 CA-C-N 115.713 -0.676 . . . . 0.0 109.81 178.85 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 37' ' ' ILE . . . . . . . . . . . . . 69.2 mt -119.94 138.28 51.03 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.273 0 CA-C-N 116.171 -0.468 . . . . 0.0 109.759 179.414 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . -113.74 128.98 8.56 Favored Glycine 0 CA--C 1.525 0.707 0 N-CA-C 111.029 -0.828 . . . . 0.0 111.029 -179.255 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 39' ' ' ILE . . . . . . . . . . . . . 72.4 mt -123.55 133.97 67.69 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.231 0 N-CA-C 110.188 -0.301 . . . . 0.0 110.188 179.079 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 40' ' ' SER . . . . . . . . . . . . . 45.2 t -93.0 113.93 26.34 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.455 -0.338 . . . . 0.0 110.776 175.597 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 41' ' ' ILE . . . . . . . . . . . . . 44.9 mm -121.51 123.44 69.59 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.265 0 CA-C-O 120.778 0.323 . . . . 0.0 110.45 179.997 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 34.5 mt 52.57 34.09 14.91 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.235 -0.438 . . . . 0.0 111.791 177.292 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . 72.52 32.16 62.28 Favored Glycine 0 CA--C 1.53 0.988 0 C-N-CA 121.113 -0.565 . . . . 0.0 111.889 178.747 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 44' ' ' LYS . . . . . . . . . . . . . 33.7 ttmt -139.21 130.48 26.82 Favored 'General case' 0 C--N 1.329 -0.314 0 N-CA-C 109.767 -0.457 . . . . 0.0 109.767 179.188 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 84.0 tt0 -82.62 122.38 28.03 Favored 'General case' 0 C--N 1.329 -0.29 0 C-N-CA 120.755 -0.378 . . . . 0.0 111.003 -177.848 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 46' ' ' VAL . . . . . . . . . . . . . 7.1 p -120.64 129.1 75.98 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.227 0 N-CA-C 109.338 -0.616 . . . . 0.0 109.338 174.682 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 59.7 mtpt -100.32 127.05 46.71 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 115.748 -0.66 . . . . 0.0 110.858 179.624 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 48' ' ' PHE . . . . . . . . . . . . . 89.5 m-85 -110.44 131.87 54.68 Favored 'General case' 0 C--N 1.33 -0.275 0 N-CA-C 110.017 -0.364 . . . . 0.0 110.017 176.919 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 86.2 tttt -106.33 133.94 50.24 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.258 -0.428 . . . . 0.0 110.415 179.892 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 50' ' ' VAL . . . . . 0.475 ' HA ' HD23 ' A' ' 6' ' ' LEU . 42.1 t -77.76 105.38 6.7 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.236 0 N-CA-C 109.165 -0.68 . . . . 0.0 109.165 176.177 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 51' ' ' VAL . . . . . . . . . . . . . 48.9 t -69.79 -48.52 63.97 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.295 0 CA-C-N 116.022 -0.535 . . . . 0.0 110.146 -173.16 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 52' ' ' GLN . . . . . . . . . . . . . 61.8 tt0 -163.96 144.62 8.51 Favored 'General case' 0 C--N 1.329 -0.296 0 C-N-CA 120.288 -0.565 . . . . 0.0 111.811 -177.911 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 53' ' ' ALA . . . . . 0.442 ' HB1' ' HB2' ' A' ' 58' ' ' LEU . . . -115.18 133.04 56.39 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 115.559 -0.746 . . . . 0.0 109.79 176.016 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 54' ' ' TYR . . . . . . . . . . . . . 9.5 t80 -129.04 108.41 18.09 Favored Pre-proline 0 CA--C 1.535 0.379 0 CA-C-O 118.182 -0.914 . . . . 0.0 110.464 178.499 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 55' ' ' PRO . . . . . . . . . . . . . 72.0 Cg_endo -76.96 168.89 75.87 Favored 'Cis proline' 0 N--CA 1.501 1.952 0 CA-C-N 121.941 1.729 . . . . 0.0 112.408 -4.945 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 56' ' ' SER . . . . . . . . . . . . . 14.4 m -112.33 128.0 26.1 Favored Pre-proline 0 CA--C 1.539 0.535 0 CA-C-O 118.366 -0.826 . . . . 0.0 109.673 176.961 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 57' ' ' PRO . . . . . . . . . . . . . 35.2 Cg_endo -65.72 168.86 44.6 Favored 'Cis proline' 0 N--CA 1.497 1.715 0 CA-C-N 122.029 1.76 . . . . 0.0 111.45 -2.862 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 58' ' ' LEU . . . . . 0.442 ' HB2' ' HB1' ' A' ' 53' ' ' ALA . 30.0 tp -129.95 135.71 48.63 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-O 120.887 0.375 . . . . 0.0 110.707 -179.41 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 59' ' ' ARG . . . . . . . . . . . . . 52.9 ttt180 -106.99 129.12 54.83 Favored 'General case' 0 C--N 1.328 -0.335 0 N-CA-C 108.688 -0.856 . . . . 0.0 108.688 176.521 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 40.6 t -89.85 126.23 42.75 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.183 0 C-N-CA 120.385 -0.526 . . . . 0.0 111.36 -172.607 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 49.8 mp0 -131.07 168.55 17.21 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 115.58 -0.737 . . . . 0.0 109.077 171.917 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 62' ' ' ASP . . . . . . . . . . . . . 18.2 p-10 -53.87 -32.6 53.72 Favored 'General case' 0 C--N 1.329 -0.323 0 C-N-CA 120.931 -0.308 . . . . 0.0 111.815 -178.449 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 63' ' ' ARG . . . . . . . . . . . . . 98.4 mtt180 -71.97 -22.14 61.49 Favored 'General case' 0 CA--C 1.532 0.273 0 N-CA-C 112.896 0.702 . . . . 0.0 112.896 -177.299 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 50.9 m -67.37 130.24 42.43 Favored 'General case' 0 C--N 1.332 -0.193 0 N-CA-C 110.125 -0.324 . . . . 0.0 110.125 -178.275 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 65' ' ' LYS . . . . . . . . . . . . . 50.3 mtmt -89.23 135.79 33.38 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.222 -0.445 . . . . 0.0 110.538 179.825 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 66' ' ' ILE . . . . . . . . . . . . . 65.1 mt -114.8 130.95 68.36 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.229 0 N-CA-C 109.736 -0.468 . . . . 0.0 109.736 -178.408 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 67' ' ' THR . . . . . . . . . . . . . 23.4 m -117.63 134.73 54.57 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.123 -0.49 . . . . 0.0 110.608 -178.524 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 68' ' ' LEU . . . . . . . . . . . . . 15.4 tp -108.4 127.72 54.14 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 115.891 -0.595 . . . . 0.0 110.472 179.585 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 69' ' ' VAL . . . . . . . . . . . . . 43.0 t -97.61 136.2 29.31 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.272 0 CA-C-O 120.877 0.37 . . . . 0.0 110.284 178.318 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 70' ' ' THR . . . . . . . . . . . . . 69.7 p -92.2 173.65 7.71 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.031 -0.531 . . . . 0.0 110.748 179.927 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 71' ' ' HIS . . . . . . . . . . . . . 14.4 t60 -65.07 141.14 98.25 Favored Pre-proline 0 CA--C 1.533 0.321 0 CA-C-N 116.239 -0.437 . . . . 0.0 110.365 -178.462 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 72' ' ' PRO . . . . . . . . . . . . . 64.1 Cg_endo -94.49 159.91 1.95 Allowed 'Trans proline' 0 N--CA 1.491 1.362 0 C-N-CA 121.891 1.727 . . . . 0.0 112.903 179.771 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 73' ' ' VAL . . . . . . . . . . . . . 35.4 m -79.68 -170.26 0.11 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.271 0 CA-C-N 115.934 -0.575 . . . . 0.0 109.773 175.255 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 74' ' ' ASP . . . . . . . . . . . . . 13.6 t70 -86.18 114.97 23.45 Favored 'General case' 0 C--N 1.33 -0.247 0 N-CA-C 109.557 -0.535 . . . . 0.0 109.557 -179.088 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 41.4 t -122.59 124.26 70.28 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.203 0 CA-C-O 121.077 0.465 . . . . 0.0 110.909 -175.203 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 76' ' ' LEU . . . . . . . . . . . . . 5.1 mp -126.38 147.05 49.83 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 115.664 -0.698 . . . . 0.0 109.603 174.852 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 77' ' ' GLU . . . . . . . . . . . . . 45.9 mt-10 -135.1 140.52 45.55 Favored 'General case' 0 C--N 1.331 -0.207 0 CA-C-O 121.015 0.436 . . . . 0.0 111.425 -178.443 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 78' ' ' ALA . . . . . 0.42 ' HB2' HD21 ' A' ' 109' ' ' LEU . . . -129.92 131.33 45.96 Favored 'General case' 0 C--N 1.331 -0.22 0 CA-C-N 115.774 -0.648 . . . . 0.0 109.842 176.513 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 79' ' ' LYS . . . . . 0.583 ' O ' HD13 ' A' ' 80' ' ' ILE . 16.3 ptpt -74.94 122.57 23.65 Favored 'General case' 0 C--N 1.331 -0.222 0 CA-C-O 121.281 0.562 . . . . 0.0 111.087 -176.801 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 80' ' ' ILE . . . . . 0.583 HD13 ' O ' ' A' ' 79' ' ' LYS . 41.2 mm -139.22 110.57 4.95 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.318 0 CA-C-N 115.779 -0.646 . . . . 0.0 109.289 -177.875 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 81' ' ' LYS . . . . . . . . . . . . . 60.6 mttp -101.37 125.56 48.03 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-O 120.914 0.388 . . . . 0.0 111.293 -178.234 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . 89.15 42.07 5.69 Favored Glycine 0 CA--C 1.525 0.702 0 C-N-CA 121.105 -0.569 . . . . 0.0 111.894 174.254 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 83' ' ' ILE . . . . . . . . . . . . . 71.4 mt -69.55 133.3 32.09 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.33 0 N-CA-C 109.489 -0.56 . . . . 0.0 109.489 175.999 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 84' ' ' LYS . . . . . . . . . . . . . 35.7 ttpt -101.58 -49.58 3.97 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-O 120.742 0.306 . . . . 0.0 110.398 -177.881 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 85' ' ' ASP . . . . . . . . . . . . . 5.6 t70 -150.87 151.26 31.97 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.242 -0.435 . . . . 0.0 110.483 -179.972 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 86' ' ' VAL . . . . . . . . . . . . . 41.0 t -133.89 137.62 52.0 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.261 0 CA-C-O 121.014 0.435 . . . . 0.0 110.537 -179.061 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 87' ' ' ILE . . . . . 0.497 HD12 ' N ' ' A' ' 87' ' ' ILE . 5.0 mp -121.0 130.69 74.42 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.21 0 CA-C-N 115.701 -0.681 . . . . 0.0 109.699 178.134 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 88' ' ' LEU . . . . . . . . . . . . . 15.9 tp -111.79 132.83 54.4 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-O 120.858 0.361 . . . . 0.0 110.743 -178.893 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 89' ' ' ASP . . . . . . . . . . . . . 46.4 t0 -130.6 160.31 34.58 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.161 178.584 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 84.6 tt0 -45.77 -43.1 12.83 Favored 'General case' 0 CA--C 1.532 0.257 0 N-CA-C 113.06 0.763 . . . . 0.0 113.06 -171.392 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 91' ' ' ASN . . . . . . . . . . . . . 3.0 m120 -131.96 26.49 4.6 Favored 'General case' 0 N--CA 1.467 0.394 0 N-CA-C 112.471 0.545 . . . . 0.0 112.471 -178.286 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 92' ' ' LEU . . . . . . . . . . . . . 18.6 mt -148.58 144.47 27.28 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-O 120.759 0.314 . . . . 0.0 110.508 -176.693 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 93' ' ' ILE . . . . . . . . . . . . . 69.3 mt -125.23 116.69 47.65 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.306 0 N-CA-C 108.822 -0.807 . . . . 0.0 108.822 175.694 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 94' ' ' VAL . . . . . . . . . . . . . 44.3 t -117.62 127.85 74.93 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.286 0 N-CA-C 109.904 -0.406 . . . . 0.0 109.904 -177.807 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 95' ' ' VAL . . . . . . . . . . . . . 43.1 t -121.38 133.94 66.31 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.339 0 CA-C-N 116.027 -0.533 . . . . 0.0 109.813 -179.822 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 96' ' ' ILE . . . . . 0.52 HD11 ' HB ' ' A' ' 123' ' ' VAL . 66.8 mt -114.57 125.17 71.82 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.355 0 N-CA-C 109.254 -0.647 . . . . 0.0 109.254 178.63 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 97' ' ' THR . . . . . . . . . . . . . 74.7 p -97.37 156.29 16.52 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-O 121.401 0.62 . . . . 0.0 111.091 -177.388 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 98' ' ' GLU . . . . . . . . . . . . . 84.9 tt0 -53.86 -27.25 28.84 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 115.831 -0.622 . . . . 0.0 112.242 -179.163 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 99' ' ' GLU . . . . . . . . . . . . . 18.8 tp10 -80.8 16.71 1.34 Allowed 'General case' 0 CA--C 1.538 0.491 0 N-CA-C 112.741 0.645 . . . . 0.0 112.741 -176.538 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 100' ' ' ASN . . . . . . . . . . . . . 4.5 m-20 63.43 33.33 13.79 Favored 'General case' 0 C--O 1.233 0.233 0 O-C-N 122.013 -0.43 . . . . 0.0 111.694 177.478 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 101' ' ' GLU . . . . . . . . . . . . . 84.6 tt0 -111.3 142.72 43.16 Favored 'General case' 0 C--N 1.333 -0.147 0 N-CA-C 109.654 -0.498 . . . . 0.0 109.654 173.754 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 102' ' ' VAL . . . . . . . . . . . . . 46.7 t -115.06 127.3 72.67 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.294 0 CA-C-N 116.167 -0.47 . . . . 0.0 109.942 -177.711 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 103' ' ' LEU . . . . . . . . . . . . . 30.5 mt -117.8 129.55 55.74 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 115.809 -0.632 . . . . 0.0 110.279 177.267 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 104' ' ' ILE . . . . . . . . . . . . . 70.9 mt -118.35 120.86 65.65 Favored 'Isoleucine or valine' 0 C--O 1.234 0.244 0 N-CA-C 110.198 -0.297 . . . . 0.0 110.198 179.927 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 105' ' ' PHE . . . . . . . . . . . . . 54.3 m-85 -121.99 164.8 17.03 Favored 'General case' 0 C--N 1.333 -0.15 0 O-C-N 123.87 0.731 . . . . 0.0 109.781 179.377 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 106' ' ' ASN . . . . . 0.414 ' HB3' HD11 ' A' ' 112' ' ' LEU . 45.9 p-10 -99.04 -169.95 1.85 Allowed 'General case' 0 C--N 1.331 -0.219 0 N-CA-C 110.021 -0.363 . . . . 0.0 110.021 174.563 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 107' ' ' GLN . . . . . . . . . . . . . 40.0 tt0 -59.73 -30.1 68.59 Favored 'General case' 0 C--N 1.33 -0.268 0 N-CA-C 111.988 0.366 . . . . 0.0 111.988 -179.744 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 108' ' ' ASN . . . . . . . . . . . . . 51.7 t30 -82.85 8.83 11.29 Favored 'General case' 0 CA--C 1.536 0.425 0 N-CA-C 113.19 0.811 . . . . 0.0 113.19 -178.0 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 109' ' ' LEU . . . . . 0.42 HD21 ' HB2' ' A' ' 78' ' ' ALA . 12.2 tp 58.98 39.02 24.06 Favored 'General case' 0 C--N 1.332 -0.184 0 CA-C-O 121.162 0.506 . . . . 0.0 111.009 178.966 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 110' ' ' GLU . . . . . . . . . . . . . 70.7 mm-40 -106.91 155.41 19.79 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 116.299 -0.41 . . . . 0.0 109.998 176.595 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 111' ' ' GLU . . . . . . . . . . . . . 84.4 tt0 -83.54 121.92 27.87 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-O 120.835 0.35 . . . . 0.0 110.787 -177.364 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 112' ' ' LEU . . . . . 0.414 HD11 ' HB3' ' A' ' 106' ' ' ASN . 38.5 mt -109.02 -46.0 3.68 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 116.178 -0.465 . . . . 0.0 110.495 177.949 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 113' ' ' TYR . . . . . . . . . . . . . 63.0 t80 -140.29 138.01 34.63 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-O 120.804 0.335 . . . . 0.0 111.388 -179.383 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 114' ' ' ARG . . . . . . . . . . . . . 68.9 ttp85 -136.37 124.82 23.46 Favored 'General case' 0 C--N 1.331 -0.239 0 CA-C-N 115.946 -0.57 . . . . 0.0 110.274 177.535 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 115' ' ' GLY . . . . . . . . . . . . . . . -150.03 157.12 27.08 Favored Glycine 0 CA--C 1.522 0.524 0 N-CA-C 110.784 -0.926 . . . . 0.0 110.784 179.099 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 116' ' ' LYS . . . . . . . . . . . . . 69.8 tttt -134.68 132.23 38.65 Favored 'General case' 0 C--N 1.329 -0.305 0 N-CA-C 109.958 -0.386 . . . . 0.0 109.958 177.641 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 117' ' ' PHE . . . . . . . . . . . . . 39.9 m-85 -127.41 120.6 28.8 Favored 'General case' 0 N--CA 1.463 0.2 0 CA-C-N 116.308 -0.406 . . . . 0.0 110.073 -174.761 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 118' ' ' GLU . . . . . . . . . . . . . 95.6 mt-10 -54.35 -45.89 72.82 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 116.421 -0.354 . . . . 0.0 111.314 -175.851 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 119' ' ' ASN . . . . . . . . . . . . . 88.3 m-20 -101.31 31.11 3.84 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.137 -0.483 . . . . 0.0 112.076 -174.285 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 120' ' ' LEU . . . . . . . . . . . . . 15.0 tp -54.98 119.97 6.21 Favored 'General case' 0 N--CA 1.463 0.214 0 O-C-N 122.264 -0.272 . . . . 0.0 110.615 179.724 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 121' ' ' ASN . . . . . . . . . . . . . 23.9 t-20 -114.18 -44.07 3.17 Favored 'General case' 0 C--O 1.232 0.143 0 CA-C-N 116.487 -0.324 . . . . 0.0 111.151 -177.072 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 122' ' ' LYS . . . . . . . . . . . . . 63.6 mtpt -139.26 142.16 37.78 Favored 'General case' 0 C--N 1.331 -0.225 0 CA-C-O 120.99 0.424 . . . . 0.0 111.594 -175.59 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 123' ' ' VAL . . . . . 0.52 ' HB ' HD11 ' A' ' 96' ' ' ILE . 48.0 t -126.17 125.75 68.32 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 N-CA-C 109.01 -0.737 . . . . 0.0 109.01 173.001 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 124' ' ' LEU . . . . . . . . . . . . . 78.5 mt -121.42 131.13 53.99 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-O 120.843 0.354 . . . . 0.0 110.77 -175.853 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 125' ' ' VAL . . . . . . . . . . . . . 44.5 t -126.15 126.29 69.27 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.239 0 CA-C-N 115.98 -0.555 . . . . 0.0 109.742 178.52 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 126' ' ' ARG . . . . . 0.494 HH11 HD23 ' B' ' 88' ' ' LEU . 82.4 mtt85 -150.9 129.24 12.03 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.299 -0.41 . . . . 0.0 110.045 177.729 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 127' ' ' ASN . . . . . . . . . . . . . 8.8 t-20 56.21 -152.42 0.38 Allowed 'General case' 0 CA--C 1.54 0.581 0 N-CA-C 109.736 -0.468 . . . . 0.0 109.736 179.755 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 128' ' ' ASP . . . . . . . . . . . . . 23.4 p-10 -83.06 18.13 1.76 Allowed 'General case' 0 CA--C 1.536 0.414 0 N-CA-C 112.628 0.603 . . . . 0.0 112.628 178.303 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 129' ' ' LEU . . . . . . . . . . . . . 11.7 tp -117.35 137.2 52.61 Favored 'General case' 0 C--O 1.234 0.241 0 O-C-N 122.079 -0.388 . . . . 0.0 110.472 179.765 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 130' ' ' VAL . . . . . . . . . . . . . 42.0 t -125.84 138.73 53.59 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.188 0 CA-C-N 116.276 -0.42 . . . . 0.0 109.963 -179.424 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 131' ' ' VAL . . . . . . . . . . . . . 35.1 m -136.1 143.98 34.49 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.282 0 CA-C-O 121.152 0.501 . . . . 0.0 111.163 178.143 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 132' ' ' ILE . . . . . . . . . . . . . 69.9 mt -120.9 134.03 65.63 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 CA-C-N 115.657 -0.702 . . . . 0.0 109.606 179.966 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 133' ' ' ILE . . . . . . . . . . . . . 40.8 mm -116.68 117.83 56.75 Favored 'Isoleucine or valine' 0 C--O 1.233 0.224 0 CA-C-O 120.965 0.412 . . . . 0.0 110.711 -176.684 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 134' ' ' ASP . . . . . . . . . . . . . 8.0 p-10 -131.49 148.47 52.64 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 115.844 -0.616 . . . . 0.0 109.408 174.717 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 135' ' ' GLU . . . . . . . . . . . . . 84.8 tt0 -49.76 -24.44 2.35 Favored 'General case' 0 C--N 1.327 -0.399 0 N-CA-C 112.835 0.68 . . . . 0.0 112.835 -171.947 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 136' ' ' GLN . . . . . . . . . . . . . 51.2 tt0 -101.67 -27.72 12.9 Favored 'General case' 0 C--O 1.233 0.212 0 N-CA-C 112.58 0.585 . . . . 0.0 112.58 -173.789 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 137' ' ' LYS . . . . . . . . . . . . . 49.6 mttm -142.13 149.23 39.53 Favored 'General case' 0 C--N 1.332 -0.17 0 N-CA-C 112.766 0.654 . . . . 0.0 112.766 -170.51 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 138' ' ' LEU . . . . . . . . . . . . . 9.9 tp -110.4 118.66 36.87 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 114.891 -1.049 . . . . 0.0 108.732 170.973 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 139' ' ' THR . . . . . . . . . . . . . 31.5 m -111.05 127.47 55.55 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-O 120.67 0.271 . . . . 0.0 110.86 -177.283 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 140' ' ' LEU . . . . . 0.48 HD23 ' C ' ' A' ' 140' ' ' LEU . 7.3 tt -116.05 122.66 45.84 Favored 'General case' 0 C--N 1.329 -0.292 0 N-CA-C 109.251 -0.648 . . . . 0.0 109.251 179.913 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 141' ' ' ILE . . . . . . . . . . . . . 19.0 mt -120.6 123.45 70.41 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.273 0 CA-C-O 120.87 0.367 . . . . 0.0 110.112 -174.378 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 142' ' ' ARG . . . . . . . . . . . . . 76.4 mtp180 -110.94 127.61 55.54 Favored 'General case' 0 C--N 1.331 -0.229 0 CA-C-N 115.521 -0.763 . . . . 0.0 110.164 -178.507 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 143' ' ' THR . . . . . . . . . . . . . 42.0 p . . . . . 0 C--O 1.219 -0.505 0 CA-C-O 118.024 -0.988 . . . . 0.0 110.593 -179.524 . . . . . . . . 0 0 . 1 . 005 nuclear nobuild full ' B' B ' -3' ' ' GLU . . . . . . . . . . . . . 70.3 mm-40 . . . . . 0 N--CA 1.489 1.518 0 N-CA-C 109.32 -0.622 . . . . 0.0 109.32 . . . . . . . . . 0 0 . 1 . 005 nuclear nobuild full ' B' B ' -2' ' ' GLY . . . . . . . . . . . . . . . -109.36 125.42 7.66 Favored Glycine 0 CA--C 1.526 0.76 0 N-CA-C 110.889 -0.885 . . . . 0.0 110.889 -179.886 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' -1' ' ' VAL . . . . . . . . . . . . . 44.4 t -141.21 135.28 31.99 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.299 0 N-CA-C 109.988 -0.375 . . . . 0.0 109.988 179.696 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 0' ' ' ILE . . . . . . . . . . . . . 69.3 mt -113.5 133.64 58.77 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.21 0 CA-C-N 116.395 -0.366 . . . . 0.0 110.026 179.622 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 1' ' ' MET . . . . . . . . . . . . . 25.9 ptt? -78.55 137.98 38.16 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.092 -0.504 . . . . 0.0 110.677 -179.611 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 2' ' ' SER . . . . . . . . . . . . . 5.2 p -111.78 139.87 46.9 Favored 'General case' 0 C--O 1.233 0.191 0 CA-C-N 116.187 -0.46 . . . . 0.0 111.03 -178.769 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 3' ' ' GLU . . . . . . . . . . . . . 33.8 tp10 -139.55 136.4 34.43 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 115.786 -0.643 . . . . 0.0 110.402 -178.52 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 4' ' ' LEU . . . . . . . . . . . . . 21.3 tp -124.49 128.77 49.48 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-O 120.714 0.292 . . . . 0.0 110.355 176.028 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 5' ' ' LYS . . . . . . . . . . . . . 98.3 mttt -105.5 120.94 42.89 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.344 -0.389 . . . . 0.0 110.539 179.074 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 6' ' ' LEU . . . . . . . . . . . . . 79.8 mt -118.21 147.62 43.2 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 115.587 -0.733 . . . . 0.0 110.549 -179.474 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 7' ' ' LYS . . . . . . . . . . . . . 73.5 tttt -134.79 140.11 34.3 Favored Pre-proline 0 CA--C 1.534 0.332 0 CA-C-O 118.985 -0.531 . . . . 0.0 110.038 176.193 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 8' ' ' PRO . . . . . . . . . . . . . 88.1 Cg_endo -91.79 137.17 1.86 Allowed 'Trans proline' 0 N--CA 1.489 1.25 0 C-N-CA 121.649 1.566 . . . . 0.0 111.559 177.804 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 9' ' ' LEU . . . . . . . . . . . . . 68.3 mt -72.32 -46.21 10.55 Favored Pre-proline 0 CA--C 1.533 0.32 0 CA-C-O 118.937 -0.554 . . . . 0.0 111.905 -178.682 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 10' ' ' PRO . . . . . . . . . . . . . 78.1 Cg_endo -84.37 152.09 12.08 Favored 'Trans proline' 0 N--CA 1.495 1.575 0 C-N-CA 121.318 1.345 . . . . 0.0 111.734 172.597 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 11' ' ' LYS . . . . . . . . . . . . . 67.5 mttm -88.91 99.9 12.76 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-O 120.81 0.338 . . . . 0.0 110.614 178.104 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 12' ' ' VAL . . . . . . . . . . . . . 12.6 p -140.91 142.42 30.09 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.28 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.362 179.239 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 13' ' ' GLU . . . . . . . . . . . . . 96.1 mt-10 -78.62 129.26 34.56 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.365 -0.379 . . . . 0.0 110.168 178.166 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 14' ' ' LEU . . . . . . . . . . . . . 29.9 mt -98.03 148.66 34.8 Favored Pre-proline 0 C--N 1.329 -0.301 0 CA-C-O 119.223 -0.417 . . . . 0.0 110.282 -179.016 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 15' ' ' PRO . . . . . . . . . . . . . 30.0 Cg_exo -60.67 160.46 24.55 Favored 'Trans proline' 0 N--CA 1.497 1.681 0 C-N-CA 121.322 1.348 . . . . 0.0 111.492 176.117 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 16' ' ' PRO . . . . . . . . . . . . . 38.8 Cg_exo -58.72 -33.81 98.57 Favored 'Trans proline' 0 N--CA 1.497 1.704 0 C-N-CA 121.375 1.384 . . . . 0.0 112.795 -177.993 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 17' ' ' ASP . . . . . . . . . . . . . 11.6 p-10 -93.76 9.83 35.5 Favored 'General case' 0 CA--C 1.535 0.381 0 N-CA-C 113.287 0.847 . . . . 0.0 113.287 -177.147 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 18' ' ' PHE . . . . . . . . . . . . . 44.4 t80 -58.49 -47.21 84.82 Favored 'General case' 0 C--N 1.334 -0.082 0 CA-C-O 120.963 0.411 . . . . 0.0 110.084 -177.961 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 19' ' ' VAL . . . . . . . . . . . . . 49.0 t -57.41 -40.65 75.66 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.339 0 CA-C-N 116.277 -0.42 . . . . 0.0 110.361 -178.737 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 20' ' ' ASP . . . . . . . . . . . . . 79.8 m-20 -60.4 -43.73 96.38 Favored 'General case' 0 C--N 1.331 -0.205 0 C-N-CA 120.936 -0.306 . . . . 0.0 110.968 -178.272 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 21' ' ' VAL . . . . . . . . . . . . . 49.1 t -64.4 -47.35 89.88 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.262 0 C-N-CA 120.753 -0.379 . . . . 0.0 110.359 -177.448 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 22' ' ' ILE . . . . . . . . . . . . . 48.9 mm -56.29 -46.53 81.61 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.258 0 CA-C-O 120.813 0.34 . . . . 0.0 110.598 179.501 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 23' ' ' ARG . . . . . . . . . . . . . 47.9 ttp180 -54.64 -50.61 67.74 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.532 -0.304 . . . . 0.0 111.391 -178.6 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 24' ' ' ILE . . . . . . . . . . . . . 76.1 mt -60.06 -40.5 83.43 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.268 0 C-N-CA 121.073 -0.251 . . . . 0.0 111.432 -176.78 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 25' ' ' LYS . . . . . . . . . . . . . 52.2 mtmt -66.9 -38.93 87.17 Favored 'General case' 0 C--N 1.328 -0.329 0 N-CA-C 112.114 0.413 . . . . 0.0 112.114 -179.833 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 26' ' ' LEU . . . . . . . . . . . . . 93.3 mt -78.49 -40.49 35.22 Favored 'General case' 0 C--N 1.331 -0.21 0 N-CA-C 113.175 0.806 . . . . 0.0 113.175 -172.441 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 27' ' ' GLN . . . . . . . . . . . . . 9.5 pt20 -46.83 139.06 5.71 Favored 'General case' 0 N--CA 1.471 0.591 0 N-CA-C 112.635 0.605 . . . . 0.0 112.635 -175.467 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 28' ' ' GLY . . . . . . . . . . . . . . . 97.68 -23.08 37.48 Favored Glycine 0 CA--C 1.535 1.283 0 CA-C-N 115.573 -0.74 . . . . 0.0 112.319 -175.931 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 29' ' ' LYS . . . . . . . . . . . . . 96.3 mttt -98.41 155.08 17.41 Favored 'General case' 0 C--O 1.233 0.234 0 CA-C-N 117.486 0.643 . . . . 0.0 111.143 179.135 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 30' ' ' THR . . . . . . . . . . . . . 38.6 m -98.38 137.88 36.44 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-N 116.073 -0.512 . . . . 0.0 110.07 176.091 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 31' ' ' VAL . . . . . . . . . . . . . 34.7 m -128.04 148.48 32.6 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.267 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.902 -178.349 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 32' ' ' ARG . . . . . . . . . . . . . 80.3 mtt180 -133.4 150.72 51.79 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-O 121.326 0.584 . . . . 0.0 110.627 177.83 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 33' ' ' THR . . . . . . . . . . . . . 23.1 m -53.39 138.57 32.77 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.034 -0.53 . . . . 0.0 111.279 -178.369 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 34' ' ' GLY . . . . . . . . . . . . . . . 100.35 -17.22 57.17 Favored Glycine 0 CA--C 1.533 1.178 0 CA-C-O 119.537 -0.591 . . . . 0.0 113.243 178.252 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 35' ' ' ASP . . . . . . . . . . . . . 77.7 m-20 -65.33 148.26 52.0 Favored 'General case' 0 C--N 1.333 -0.132 0 CA-C-N 118.131 0.965 . . . . 0.0 111.043 179.808 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 36' ' ' VAL . . . . . . . . . . . . . 44.5 t -121.06 129.72 75.41 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.228 0 CA-C-N 115.852 -0.613 . . . . 0.0 109.842 178.387 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 37' ' ' ILE . . . . . . . . . . . . . 65.3 mt -117.82 137.84 50.44 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.261 0 CA-C-N 116.19 -0.459 . . . . 0.0 109.843 -179.83 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 38' ' ' GLY . . . . . . . . . . . . . . . -110.6 128.58 8.86 Favored Glycine 0 CA--C 1.526 0.764 0 N-CA-C 110.986 -0.845 . . . . 0.0 110.986 179.561 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 39' ' ' ILE . . . . . . . . . . . . . 73.6 mt -124.34 134.66 66.06 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.178 0 N-CA-C 110.015 -0.365 . . . . 0.0 110.015 179.039 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 40' ' ' SER . . . . . . . . . . . . . 43.0 t -92.62 117.56 30.1 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.535 -0.302 . . . . 0.0 110.873 176.201 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 41' ' ' ILE . . . . . . . . . . . . . 45.3 mm -122.75 114.38 42.06 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.159 0 CA-C-O 120.897 0.38 . . . . 0.0 110.546 179.261 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 42' ' ' LEU . . . . . . . . . . . . . 9.2 tp 53.58 37.84 26.82 Favored 'General case' 0 C--N 1.331 -0.216 0 CA-C-N 116.094 -0.503 . . . . 0.0 111.399 176.862 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 43' ' ' GLY . . . . . . . . . . . . . . . 74.62 25.28 70.38 Favored Glycine 0 CA--C 1.531 1.075 0 C-N-CA 121.126 -0.559 . . . . 0.0 112.725 177.563 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 44' ' ' LYS . . . . . . . . . . . . . 34.6 mmtp -130.18 129.31 43.28 Favored 'General case' 0 C--N 1.331 -0.207 0 N-CA-C 109.546 -0.538 . . . . 0.0 109.546 177.682 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 45' ' ' GLU . . . . . . . . . . . . . 81.1 tt0 -83.1 118.98 23.93 Favored 'General case' 0 C--N 1.329 -0.295 0 C-N-CA 120.762 -0.375 . . . . 0.0 110.762 -179.173 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 46' ' ' VAL . . . . . . . . . . . . . 7.4 p -118.6 126.75 75.42 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.216 0 N-CA-C 109.288 -0.634 . . . . 0.0 109.288 176.489 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 47' ' ' LYS . . . . . . . . . . . . . 56.3 mtmt -100.67 128.73 46.61 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 115.84 -0.618 . . . . 0.0 111.304 178.85 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 48' ' ' PHE . . . . . . . . . . . . . 94.3 m-85 -110.73 131.87 54.68 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 115.999 -0.546 . . . . 0.0 109.774 176.089 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 49' ' ' LYS . . . . . . . . . . . . . 36.1 tttp -106.58 135.64 47.75 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.407 -0.36 . . . . 0.0 110.407 -179.498 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 50' ' ' VAL . . . . . . . . . . . . . 43.7 t -80.18 108.76 13.96 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.207 0 N-CA-C 109.257 -0.646 . . . . 0.0 109.257 176.488 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 51' ' ' VAL . . . . . . . . . . . . . 46.0 t -73.39 -47.94 43.93 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.273 0 CA-C-N 116.141 -0.481 . . . . 0.0 110.11 -174.125 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 52' ' ' GLN . . . . . . . . . . . . . 59.8 tt0 -162.6 140.84 8.57 Favored 'General case' 0 C--N 1.33 -0.262 0 C-N-CA 120.401 -0.52 . . . . 0.0 111.343 -177.37 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 53' ' ' ALA . . . . . . . . . . . . . . . -114.82 131.67 56.74 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 115.45 -0.795 . . . . 0.0 109.971 175.56 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 54' ' ' TYR . . . . . . . . . . . . . 30.9 t80 -129.12 111.54 18.31 Favored Pre-proline 0 CA--C 1.535 0.386 0 CA-C-O 118.302 -0.856 . . . . 0.0 110.232 177.598 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 55' ' ' PRO . . . . . . . . . . . . . 73.5 Cg_endo -77.18 167.94 78.3 Favored 'Cis proline' 0 N--CA 1.499 1.835 0 CA-C-N 121.985 1.745 . . . . 0.0 112.373 -5.955 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 56' ' ' SER . . . . . . . . . . . . . 13.6 m -117.34 134.87 23.06 Favored Pre-proline 0 CA--C 1.538 0.51 0 CA-C-O 118.574 -0.727 . . . . 0.0 109.493 174.049 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 57' ' ' PRO . . . . . . . . . . . . . 39.8 Cg_endo -68.11 146.66 78.64 Favored 'Cis proline' 0 N--CA 1.498 1.744 0 CA-C-N 121.87 1.704 . . . . 0.0 111.329 -3.06 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 58' ' ' LEU . . . . . . . . . . . . . 16.3 tp -107.2 136.8 46.41 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.282 -0.417 . . . . 0.0 110.584 -177.599 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 59' ' ' ARG . . . . . . . . . . . . . 51.2 ttp180 -104.64 119.9 40.07 Favored 'General case' 0 C--N 1.328 -0.342 0 N-CA-C 109.315 -0.624 . . . . 0.0 109.315 175.975 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 60' ' ' VAL . . . . . . . . . . . . . 48.7 t -73.37 122.53 26.47 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.252 0 C-N-CA 120.662 -0.415 . . . . 0.0 110.154 -175.214 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 61' ' ' GLU . . . . . . . . . . . . . 95.8 mt-10 -131.05 163.39 27.71 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 115.934 -0.575 . . . . 0.0 110.422 -179.21 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 62' ' ' ASP . . . . . . . . . . . . . 12.5 t70 -55.15 -32.73 62.34 Favored 'General case' 0 C--N 1.327 -0.401 0 CA-C-N 116.426 -0.352 . . . . 0.0 111.523 178.59 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 63' ' ' ARG . . . . . . . . . . . . . 13.1 ptp180 -89.84 9.6 26.86 Favored 'General case' 0 CA--C 1.534 0.337 0 N-CA-C 113.522 0.934 . . . . 0.0 113.522 -176.016 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 64' ' ' THR . . . . . . . . . . . . . 39.4 m -91.41 133.41 35.49 Favored 'General case' 0 C--N 1.332 -0.16 0 CA-C-N 118.198 0.454 . . . . 0.0 110.087 179.667 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 65' ' ' LYS . . . . . . . . . . . . . 57.6 mtmt -90.0 132.55 35.3 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-O 120.987 0.422 . . . . 0.0 110.648 -177.664 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 66' ' ' ILE . . . . . . . . . . . . . 60.7 mt -114.84 127.84 72.21 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.358 0 N-CA-C 109.755 -0.461 . . . . 0.0 109.755 -179.269 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 67' ' ' THR . . . . . . . . . . . . . 30.6 m -119.12 138.84 52.63 Favored 'General case' 0 C--N 1.332 -0.186 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.941 -176.91 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 68' ' ' LEU . . . . . . . . . . . . . 14.8 tp -103.14 125.57 49.9 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 115.913 -0.585 . . . . 0.0 110.065 178.223 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 69' ' ' VAL . . . . . . . . . . . . . 44.1 t -96.82 117.94 42.27 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.344 0 CA-C-O 120.968 0.413 . . . . 0.0 110.324 -178.774 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 70' ' ' THR . . . . . . . . . . . . . 17.4 p -150.04 75.22 1.24 Allowed 'General case' 0 C--N 1.331 -0.238 0 CA-C-N 116.007 -0.542 . . . . 0.0 110.496 178.317 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 71' ' ' HIS . . . . . . . . . . . . . 81.5 m-70 -135.71 84.41 33.09 Favored Pre-proline 0 CA--C 1.534 0.332 0 CA-C-N 116.335 -0.393 . . . . 0.0 110.59 -179.203 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 72' ' ' PRO . . . . . . . . . . . . . 61.8 Cg_endo -74.97 -26.35 11.07 Favored 'Trans proline' 0 N--CA 1.496 1.637 0 C-N-CA 121.472 1.448 . . . . 0.0 113.075 -178.069 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 73' ' ' VAL . . . . . . . . . . . . . 35.1 m -130.5 168.65 22.94 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.214 0 CA-C-O 120.859 0.361 . . . . 0.0 111.091 -176.893 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 74' ' ' ASP . . . . . . . . . . . . . 38.7 t0 -99.11 122.95 43.02 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 115.963 -0.562 . . . . 0.0 109.94 -178.975 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 75' ' ' VAL . . . . . . . . . . . . . 40.0 t -119.9 124.13 72.18 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.264 0 CA-C-O 121.063 0.459 . . . . 0.0 110.802 -177.609 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 76' ' ' LEU . . . . . . . . . . . . . 5.7 mp -119.65 142.12 48.74 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 115.687 -0.688 . . . . 0.0 109.426 174.696 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 77' ' ' GLU . . . . . . . . . . . . . 97.4 mt-10 -135.6 130.75 34.93 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-O 121.117 0.484 . . . . 0.0 111.011 -177.789 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 78' ' ' ALA . . . . . . . . . . . . . . . -117.46 134.93 54.29 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 115.619 -0.718 . . . . 0.0 109.725 177.007 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 79' ' ' LYS . . . . . 0.568 ' O ' HD13 ' B' ' 80' ' ' ILE . 90.0 mttt -75.49 115.87 15.61 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-O 120.903 0.382 . . . . 0.0 110.236 -179.041 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' B' B ' 80' ' ' ILE . . . . . 0.568 HD13 ' O ' ' B' ' 79' ' ' LYS . 44.0 mm -139.09 119.35 14.69 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.328 0 N-CA-C 109.346 -0.613 . . . . 0.0 109.346 -176.836 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' B' B ' 81' ' ' LYS . . . . . . . . . . . . . 60.0 tttm -117.92 129.67 55.76 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-O 120.924 0.392 . . . . 0.0 111.088 -176.964 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 82' ' ' GLY . . . . . . . . . . . . . . . 88.96 42.13 5.73 Favored Glycine 0 CA--C 1.524 0.651 0 CA-C-N 115.883 -0.599 . . . . 0.0 112.089 175.687 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 83' ' ' ILE . . . . . . . . . . . . . 73.9 mt -73.72 133.01 32.52 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.249 0 N-CA-C 109.229 -0.656 . . . . 0.0 109.229 175.398 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 84' ' ' LYS . . . . . . . . . . . . . 38.4 ttpt -102.47 -45.1 5.17 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.567 -0.288 . . . . 0.0 110.567 -176.94 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 85' ' ' ASP . . . . . . . . . . . . . 9.1 t70 -147.68 149.44 32.46 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.293 -0.412 . . . . 0.0 110.518 -179.914 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 86' ' ' VAL . . . . . . . . . . . . . 40.3 t -130.79 134.55 61.71 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.251 0 CA-C-O 121.002 0.429 . . . . 0.0 110.485 -179.208 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 87' ' ' ILE . . . . . 0.494 ' N ' HD12 ' B' ' 87' ' ' ILE . 5.0 mp -121.8 125.89 73.89 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.214 0 CA-C-N 115.841 -0.618 . . . . 0.0 109.385 176.51 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' B' B ' 88' ' ' LEU . . . . . 0.494 HD23 HH11 ' A' ' 126' ' ' ARG . 8.3 tp -117.91 134.19 55.18 Favored 'General case' 0 C--N 1.331 -0.224 0 CA-C-O 120.9 0.381 . . . . 0.0 111.088 -176.058 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' B' B ' 89' ' ' ASP . . . . . . . . . . . . . 12.4 t70 -134.84 160.12 39.24 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 115.948 -0.569 . . . . 0.0 109.859 177.943 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 90' ' ' GLU . . . . . . . . . . . . . 95.6 mt-10 -48.14 -37.75 16.25 Favored 'General case' 0 C--N 1.331 -0.226 0 N-CA-C 112.991 0.737 . . . . 0.0 112.991 -171.637 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 91' ' ' ASN . . . . . . . . . . . . . 12.2 m120 -130.01 22.35 5.33 Favored 'General case' 0 N--CA 1.468 0.468 0 N-CA-C 112.813 0.672 . . . . 0.0 112.813 -176.621 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 92' ' ' LEU . . . . . . . . . . . . . 51.0 mt -148.45 141.23 24.63 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-O 120.773 0.32 . . . . 0.0 110.599 -178.237 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 93' ' ' ILE . . . . . . . . . . . . . 73.2 mt -124.42 112.78 33.65 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.322 0 N-CA-C 108.858 -0.793 . . . . 0.0 108.858 176.195 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 94' ' ' VAL . . . . . 0.432 HG21 HG21 ' B' ' 125' ' ' VAL . 46.1 t -116.58 127.85 74.09 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.284 0 CA-C-O 120.923 0.392 . . . . 0.0 110.038 -177.681 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' B' B ' 95' ' ' VAL . . . . . . . . . . . . . 42.3 t -121.08 132.7 69.86 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.388 0 CA-C-N 115.885 -0.598 . . . . 0.0 109.595 -179.556 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 96' ' ' ILE . . . . . . . . . . . . . 72.4 mt -115.11 125.16 72.33 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.251 0 N-CA-C 109.192 -0.67 . . . . 0.0 109.192 178.259 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 97' ' ' THR . . . . . . . . . . . . . 80.7 p -98.67 160.42 14.29 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-O 121.33 0.586 . . . . 0.0 111.302 -175.868 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 98' ' ' GLU . . . . . . . . . . . . . 84.3 tt0 -53.84 -26.72 25.77 Favored 'General case' 0 C--N 1.327 -0.385 0 CA-C-N 115.683 -0.69 . . . . 0.0 112.249 179.843 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 99' ' ' GLU . . . . . . . . . . . . . 69.4 mm-40 -79.04 11.59 2.67 Favored 'General case' 0 CA--C 1.536 0.432 0 N-CA-C 113.227 0.825 . . . . 0.0 113.227 -177.36 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 100' ' ' ASN . . . . . . . . . . . . . 3.3 m-20 62.71 32.31 16.2 Favored 'General case' 0 CA--C 1.533 0.29 0 CA-C-N 118.233 0.469 . . . . 0.0 111.756 -179.796 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 101' ' ' GLU . . . . . . . . . . . . . 84.2 tt0 -107.79 144.18 35.31 Favored 'General case' 0 C--N 1.332 -0.187 0 N-CA-C 109.714 -0.476 . . . . 0.0 109.714 171.559 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 102' ' ' VAL . . . . . . . . . . . . . 44.5 t -116.28 126.49 73.78 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.246 0 N-CA-C 110.055 -0.35 . . . . 0.0 110.055 -178.957 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 103' ' ' LEU . . . . . . . . . . . . . 63.7 mt -114.48 131.77 56.51 Favored 'General case' 0 C--N 1.331 -0.23 0 CA-C-N 115.641 -0.709 . . . . 0.0 109.58 178.112 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 104' ' ' ILE . . . . . 0.476 HD12 ' HB3' ' B' ' 113' ' ' TYR . 62.3 mt -122.17 118.64 56.07 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.242 0 N-CA-C 110.293 -0.262 . . . . 0.0 110.293 -178.857 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' B' B ' 105' ' ' PHE . . . . . . . . . . . . . 41.3 m-85 -119.84 165.31 14.76 Favored 'General case' 0 C--N 1.331 -0.196 0 O-C-N 123.986 0.804 . . . . 0.0 109.717 178.032 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 106' ' ' ASN . . . . . . . . . . . . . 46.8 p-10 -98.07 -169.89 1.89 Allowed 'General case' 0 C--N 1.329 -0.313 0 N-CA-C 109.664 -0.495 . . . . 0.0 109.664 172.591 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 107' ' ' GLN . . . . . . . . . . . . . 28.0 tt0 -59.83 -30.21 68.78 Favored 'General case' 0 C--N 1.329 -0.29 0 N-CA-C 111.938 0.347 . . . . 0.0 111.938 -179.905 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 108' ' ' ASN . . . . . . . . . . . . . 14.8 t-20 -83.59 9.32 11.74 Favored 'General case' 0 CA--C 1.538 0.515 0 N-CA-C 113.09 0.774 . . . . 0.0 113.09 -178.354 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 109' ' ' LEU . . . . . . . . . . . . . 9.2 tp 60.38 36.32 20.41 Favored 'General case' 0 C--N 1.332 -0.179 0 CA-C-O 120.918 0.39 . . . . 0.0 111.495 178.921 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 110' ' ' GLU . . . . . . . . . . . . . 70.7 mm-40 -105.65 149.82 26.0 Favored 'General case' 0 C--N 1.33 -0.24 0 N-CA-C 109.978 -0.378 . . . . 0.0 109.978 177.094 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 111' ' ' GLU . . . . . . . . . . . . . 47.2 mp0 -76.86 126.41 30.93 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-O 121.035 0.445 . . . . 0.0 111.357 -177.249 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 112' ' ' LEU . . . . . . . . . . . . . 39.5 mt -110.07 -46.05 3.51 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 115.821 -0.627 . . . . 0.0 109.967 174.974 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 113' ' ' TYR . . . . . 0.476 ' HB3' HD12 ' B' ' 104' ' ' ILE . 65.5 t80 -143.62 140.52 30.17 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 115.975 -0.557 . . . . 0.0 111.134 179.752 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' B' B ' 114' ' ' ARG . . . . . . . . . . . . . 93.2 mtt180 -139.51 125.66 19.98 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.54 173.665 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 115' ' ' GLY . . . . . . . . . . . . . . . -150.16 162.92 29.36 Favored Glycine 0 CA--C 1.524 0.623 0 N-CA-C 111.083 -0.807 . . . . 0.0 111.083 179.491 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 116' ' ' LYS . . . . . . . . . . . . . 87.6 tttt -131.22 135.14 47.12 Favored 'General case' 0 C--N 1.33 -0.277 0 N-CA-C 109.832 -0.432 . . . . 0.0 109.832 177.412 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 117' ' ' PHE . . . . . . . . . . . . . 33.4 m-85 -136.46 114.16 11.12 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.327 -0.397 . . . . 0.0 110.393 -174.789 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 118' ' ' GLU . . . . . . . . . . . . . 83.4 tt0 -52.3 -47.68 65.8 Favored 'General case' 0 C--N 1.327 -0.408 0 CA-C-N 116.475 -0.33 . . . . 0.0 111.618 -176.999 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 119' ' ' ASN . . . . . . . . . . . . . 50.3 m-80 -97.4 30.94 2.66 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.192 -0.458 . . . . 0.0 112.175 -173.826 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 120' ' ' LEU . . . . . . . . . . . . . 12.8 tp -57.15 122.31 12.11 Favored 'General case' 0 C--N 1.332 -0.19 0 C-N-CA 120.987 -0.285 . . . . 0.0 110.318 177.98 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 121' ' ' ASN . . . . . . . . . . . . . 26.3 m120 -113.29 -44.2 3.27 Favored 'General case' 0 C--O 1.232 0.162 0 CA-C-N 116.652 -0.249 . . . . 0.0 111.101 -176.965 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 122' ' ' LYS . . . . . . . . . . . . . 97.1 mttt -148.22 150.65 34.11 Favored 'General case' 0 C--N 1.331 -0.208 0 CA-C-O 121.061 0.458 . . . . 0.0 111.701 -178.684 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 123' ' ' VAL . . . . . . . . . . . . . 43.9 t -127.38 129.09 70.58 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.233 0 N-CA-C 109.447 -0.575 . . . . 0.0 109.447 174.716 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 124' ' ' LEU . . . . . 0.403 ' N ' HD12 ' B' ' 124' ' ' LEU . 6.1 mp -122.06 134.57 54.78 Favored 'General case' 0 C--N 1.332 -0.184 0 CA-C-O 120.863 0.363 . . . . 0.0 110.757 -178.538 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' B' B ' 125' ' ' VAL . . . . . 0.432 HG21 HG21 ' B' ' 94' ' ' VAL . 43.2 t -125.28 128.23 72.59 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.283 0 CA-C-N 115.933 -0.576 . . . . 0.0 109.765 178.21 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' B' B ' 126' ' ' ARG . . . . . . . . . . . . . 30.5 ttm180 -149.15 122.01 8.74 Favored 'General case' 0 C--N 1.33 -0.276 0 N-CA-C 109.809 -0.441 . . . . 0.0 109.809 178.368 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 127' ' ' ASN . . . . . . . . . . . . . 76.9 m-20 56.37 -151.55 0.4 Allowed 'General case' 0 CA--C 1.541 0.609 0 N-CA-C 109.771 -0.455 . . . . 0.0 109.771 179.742 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 128' ' ' ASP . . . . . . . . . . . . . 19.7 p-10 -80.18 15.43 1.54 Allowed 'General case' 0 CA--C 1.535 0.383 0 N-CA-C 112.861 0.689 . . . . 0.0 112.861 178.797 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 129' ' ' LEU . . . . . . . . . . . . . 15.6 tp -111.84 133.66 53.9 Favored 'General case' 0 C--O 1.232 0.133 0 O-C-N 122.0 -0.438 . . . . 0.0 110.287 179.158 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 130' ' ' VAL . . . . . . . . . . . . . 47.7 t -121.91 135.3 62.47 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.222 0 N-CA-C 109.759 -0.46 . . . . 0.0 109.759 -179.953 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 131' ' ' VAL . . . . . . . . . . . . . 42.8 t -134.83 135.62 52.95 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.253 0 CA-C-O 121.029 0.442 . . . . 0.0 110.594 -179.533 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 132' ' ' ILE . . . . . . . . . . . . . 73.1 mt -117.51 132.69 66.57 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.26 0 CA-C-N 115.676 -0.693 . . . . 0.0 109.392 178.84 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 133' ' ' ILE . . . . . . . . . . . . . 44.6 mm -116.34 122.32 69.49 Favored 'Isoleucine or valine' 0 C--O 1.234 0.251 0 CA-C-N 116.55 -0.296 . . . . 0.0 110.931 -176.014 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 134' ' ' ASP . . . . . . . . . . . . . 7.2 p-10 -133.0 146.7 52.01 Favored 'General case' 0 C--N 1.33 -0.258 0 N-CA-C 109.714 -0.476 . . . . 0.0 109.714 174.628 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 135' ' ' GLU . . . . . . . . . . . . . 84.7 tt0 -49.87 -26.27 3.91 Favored 'General case' 0 C--N 1.326 -0.445 0 N-CA-C 112.916 0.71 . . . . 0.0 112.916 -173.321 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 136' ' ' GLN . . . . . . . . . . . . . 61.4 tt0 -84.55 -32.4 23.86 Favored 'General case' 0 C--N 1.331 -0.231 0 N-CA-C 112.42 0.526 . . . . 0.0 112.42 -175.488 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 137' ' ' LYS . . . . . . . . . . . . . 18.1 pttp -168.64 172.74 7.81 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-O 121.436 0.636 . . . . 0.0 112.245 -172.536 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 138' ' ' LEU . . . . . 0.426 HD23 ' N ' ' B' ' 139' ' ' THR . 5.3 tt -117.72 130.1 56.11 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 115.113 -0.948 . . . . 0.0 110.025 -179.217 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' B' B ' 139' ' ' THR . . . . . 0.426 ' N ' HD23 ' B' ' 138' ' ' LEU . 42.2 m -111.53 126.74 55.3 Favored 'General case' 0 C--N 1.331 -0.223 0 CA-C-N 116.147 -0.479 . . . . 0.0 110.384 179.833 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' B' B ' 140' ' ' LEU . . . . . 0.473 HD23 ' N ' ' B' ' 141' ' ' ILE . 5.6 tt -114.18 124.02 51.03 Favored 'General case' 0 C--N 1.329 -0.322 0 N-CA-C 109.261 -0.644 . . . . 0.0 109.261 -179.65 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' B' B ' 141' ' ' ILE . . . . . 0.473 ' N ' HD23 ' B' ' 140' ' ' LEU . 19.1 mt -121.94 125.71 73.53 Favored 'Isoleucine or valine' 0 C--O 1.234 0.266 0 CA-C-O 120.818 0.342 . . . . 0.0 110.15 -173.783 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' B' B ' 142' ' ' ARG . . . . . . . . . . . . . 72.0 mtm180 -114.23 133.94 55.27 Favored 'General case' 0 C--O 1.233 0.233 0 CA-C-N 115.66 -0.7 . . . . 0.0 109.82 -179.267 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 143' ' ' THR . . . . . . . . . . . . . 60.6 p . . . . . 0 C--O 1.219 -0.514 0 CA-C-O 117.957 -1.02 . . . . 0.0 110.449 179.207 . . . . . . . . 0 0 . 1 . 005 nuclear nobuild full ' C' C ' -3' ' ' GLU . . . . . . . . . . . . . 95.7 mt-10 . . . . . 0 N--CA 1.49 1.568 0 N-CA-C 109.376 -0.602 . . . . 0.0 109.376 . . . . . . . . . 0 0 . 1 . 005 nuclear nobuild full ' C' C ' -2' ' ' GLY . . . . . . . . . . . . . . . -61.7 149.74 46.1 Favored Glycine 0 CA--C 1.524 0.627 0 N-CA-C 110.871 -0.891 . . . . 0.0 110.871 179.75 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' C' C ' -1' ' ' VAL . . . . . . . . . . . . . 43.5 t -95.88 137.8 23.0 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.317 0 N-CA-C 110.022 -0.362 . . . . 0.0 110.022 -179.895 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' C' C ' 0' ' ' ILE . . . . . . . . . . . . . 43.4 mm -107.63 129.02 62.31 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.27 0 CA-C-N 116.258 -0.428 . . . . 0.0 110.166 -178.93 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' C' C ' 1' ' ' MET . . . . . . . . . . . . . 25.0 ptp -79.85 142.87 34.85 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.072 -0.513 . . . . 0.0 110.413 178.956 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' C' C ' 2' ' ' SER . . . . . . . . . . . . . 2.9 p -127.61 126.53 42.23 Favored 'General case' 0 C--N 1.331 -0.203 0 CA-C-N 116.356 -0.384 . . . . 0.0 110.329 -179.71 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' C' C ' 3' ' ' GLU . . . . . . . . . . . . . 94.2 mt-10 -138.51 141.54 39.36 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 115.902 -0.59 . . . . 0.0 110.721 -176.769 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' C' C ' 4' ' ' LEU . . . . . . . . . . . . . 25.2 tp -126.37 126.73 44.36 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.054 -0.521 . . . . 0.0 110.039 176.198 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' C' C ' 5' ' ' LYS . . . . . . . . . . . . . 62.7 mttp -103.83 120.96 42.07 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.508 -0.315 . . . . 0.0 110.647 179.354 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' C' C ' 6' ' ' LEU . . . . . . . . . . . . . 43.1 mt -116.79 143.03 46.16 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 115.536 -0.756 . . . . 0.0 110.556 -178.598 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' C' C ' 7' ' ' LYS . . . . . . . . . . . . . 54.8 tttm -134.3 139.58 33.31 Favored Pre-proline 0 CA--C 1.534 0.349 0 CA-C-O 119.117 -0.468 . . . . 0.0 109.997 176.164 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' C' C ' 8' ' ' PRO . . . . . . . . . . . . . 88.7 Cg_endo -91.94 143.79 2.81 Favored 'Trans proline' 0 N--CA 1.491 1.35 0 C-N-CA 121.721 1.614 . . . . 0.0 111.888 177.812 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' C' C ' 9' ' ' LEU . . . . . . . . . . . . . 63.9 mt -79.2 -48.28 1.55 Allowed Pre-proline 0 CA--C 1.535 0.385 0 CA-C-O 118.638 -0.696 . . . . 0.0 112.242 -179.93 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' C' C ' 10' ' ' PRO . . . . . . . . . . . . . 94.0 Cg_endo -79.51 153.78 23.82 Favored 'Trans proline' 0 N--CA 1.497 1.697 0 C-N-CA 121.149 1.232 . . . . 0.0 111.819 176.949 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' C' C ' 11' ' ' LYS . . . . . . . . . . . . . 51.6 tptt -87.19 96.64 10.39 Favored 'General case' 0 C--N 1.331 -0.226 0 CA-C-N 116.373 -0.376 . . . . 0.0 110.315 178.861 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' C' C ' 12' ' ' VAL . . . . . . . . . . . . . 12.0 p -143.86 143.44 23.93 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.284 0 CA-C-N 116.219 -0.446 . . . . 0.0 110.462 179.019 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' C' C ' 13' ' ' GLU . . . . . . . . . . . . . 12.8 pt-20 -88.09 128.15 35.42 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.351 -0.386 . . . . 0.0 110.296 177.751 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' C' C ' 14' ' ' LEU . . . . . . . . . . . . . 24.4 mt -98.22 153.01 38.26 Favored Pre-proline 0 C--N 1.329 -0.291 0 CA-C-N 116.232 -0.44 . . . . 0.0 110.369 -178.473 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' C' C ' 15' ' ' PRO . . . . . . . . . . . . . 33.6 Cg_exo -59.66 159.97 22.52 Favored 'Trans proline' 0 N--CA 1.495 1.616 0 C-N-CA 121.31 1.34 . . . . 0.0 111.621 178.082 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' C' C ' 16' ' ' PRO . . . . . . . . . . . . . 32.2 Cg_exo -59.42 -32.56 96.68 Favored 'Trans proline' 0 N--CA 1.498 1.743 0 C-N-CA 121.435 1.423 . . . . 0.0 112.714 -177.855 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' C' C ' 17' ' ' ASP . . . . . . . . . . . . . 9.5 p-10 -94.13 9.96 35.7 Favored 'General case' 0 CA--C 1.535 0.388 0 N-CA-C 113.211 0.819 . . . . 0.0 113.211 -177.301 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' C' C ' 18' ' ' PHE . . . . . . . . . . . . . 48.9 t80 -58.13 -42.67 86.33 Favored 'General case' 0 C--O 1.231 0.091 0 O-C-N 121.987 -0.446 . . . . 0.0 110.111 -178.511 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' C' C ' 19' ' ' VAL . . . . . . . . . . . . . 48.7 t -57.7 -42.13 80.96 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.352 0 CA-C-N 116.332 -0.395 . . . . 0.0 110.311 -179.311 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' C' C ' 20' ' ' ASP . . . . . . . . . . . . . 13.6 t70 -60.64 -42.09 96.22 Favored 'General case' 0 C--N 1.329 -0.304 0 C-N-CA 120.988 -0.285 . . . . 0.0 110.99 -178.642 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' C' C ' 21' ' ' VAL . . . . . . . . . . . . . 47.5 t -64.04 -47.56 89.8 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.284 0 C-N-CA 120.713 -0.395 . . . . 0.0 110.38 -177.973 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' C' C ' 22' ' ' ILE . . . . . 0.507 HG22 HD12 ' C' ' 26' ' ' LEU . 51.0 mm -56.67 -43.99 80.28 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.279 0 CA-C-O 120.668 0.27 . . . . 0.0 110.456 178.689 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' C' C ' 23' ' ' ARG . . . . . . . . . . . . . 60.3 ttp180 -54.11 -49.03 70.08 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-O 120.627 0.251 . . . . 0.0 111.419 -179.373 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' C' C ' 24' ' ' ILE . . . . . . . . . . . . . 75.7 mt -59.96 -42.35 89.2 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.295 0 CA-C-N 116.592 -0.276 . . . . 0.0 111.003 -178.348 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' C' C ' 25' ' ' LYS . . . . . . . . . . . . . 54.9 mtmt -67.2 -36.49 81.85 Favored 'General case' 0 C--N 1.328 -0.355 0 N-CA-C 112.299 0.481 . . . . 0.0 112.299 -179.088 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' C' C ' 26' ' ' LEU . . . . . 0.507 HD12 HG22 ' C' ' 22' ' ' ILE . 46.9 mt -77.74 -43.62 30.33 Favored 'General case' 0 C--N 1.33 -0.26 0 N-CA-C 112.899 0.703 . . . . 0.0 112.899 -172.373 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' C' C ' 27' ' ' GLN . . . . . . . . . . . . . 10.6 pt20 -46.91 138.13 6.68 Favored 'General case' 0 N--CA 1.47 0.539 0 N-CA-C 112.564 0.579 . . . . 0.0 112.564 -175.673 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' C' C ' 28' ' ' GLY . . . . . . . . . . . . . . . 100.6 -26.12 25.79 Favored Glycine 0 CA--C 1.533 1.172 0 CA-C-N 115.645 -0.707 . . . . 0.0 112.174 -176.652 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' C' C ' 29' ' ' LYS . . . . . . . . . . . . . 60.3 mmtt -98.06 155.17 17.25 Favored 'General case' 0 C--O 1.232 0.145 0 CA-C-N 117.257 0.529 . . . . 0.0 111.174 178.327 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' C' C ' 30' ' ' THR . . . . . . . . . . . . . 37.7 m -105.94 136.4 45.66 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 115.807 -0.633 . . . . 0.0 109.561 174.26 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' C' C ' 31' ' ' VAL . . . . . . . . . . . . . 34.9 m -127.4 153.75 36.97 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.234 0 CA-C-O 121.172 0.51 . . . . 0.0 111.169 -176.442 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' C' C ' 32' ' ' ARG . . . . . . . . . . . . . 78.2 mtm180 -130.53 150.07 51.91 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 115.537 -0.756 . . . . 0.0 110.26 178.663 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' C' C ' 33' ' ' THR . . . . . . . . . . . . . 24.3 m -53.68 138.95 33.74 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-N 116.453 -0.34 . . . . 0.0 111.285 -178.863 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' C' C ' 34' ' ' GLY . . . . . . . . . . . . . . . 101.0 -17.14 56.66 Favored Glycine 0 CA--C 1.532 1.154 0 CA-C-O 119.621 -0.544 . . . . 0.0 113.306 179.209 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' C' C ' 35' ' ' ASP . . . . . . . . . . . . . 72.5 m-20 -65.25 148.41 51.73 Favored 'General case' 0 C--O 1.232 0.166 0 CA-C-N 118.054 0.927 . . . . 0.0 111.069 179.421 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' C' C ' 36' ' ' VAL . . . . . . . . . . . . . 43.8 t -122.42 131.68 72.69 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.237 0 CA-C-N 115.933 -0.576 . . . . 0.0 109.871 179.111 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' C' C ' 37' ' ' ILE . . . . . . . . . . . . . 67.1 mt -121.06 138.16 52.4 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 CA-C-N 116.114 -0.494 . . . . 0.0 109.902 179.794 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' C' C ' 38' ' ' GLY . . . . . . . . . . . . . . . -112.42 128.63 8.59 Favored Glycine 0 CA--C 1.525 0.692 0 N-CA-C 111.071 -0.812 . . . . 0.0 111.071 179.562 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' C' C ' 39' ' ' ILE . . . . . . . . . . . . . 74.7 mt -124.85 137.13 58.53 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.184 0 N-CA-C 110.128 -0.323 . . . . 0.0 110.128 179.449 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' C' C ' 40' ' ' SER . . . . . . . . . . . . . 41.4 t -92.44 114.06 26.51 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 116.445 -0.343 . . . . 0.0 110.755 176.213 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' C' C ' 41' ' ' ILE . . . . . . . . . . . . . 42.7 mm -119.99 120.67 63.84 Favored 'Isoleucine or valine' 0 N--CA 1.462 0.167 0 CA-C-O 120.737 0.304 . . . . 0.0 110.59 179.879 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' C' C ' 42' ' ' LEU . . . . . . . . . . . . . 47.3 mt 51.85 34.84 14.17 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-N 116.308 -0.405 . . . . 0.0 111.856 176.435 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' C' C ' 43' ' ' GLY . . . . . . . . . . . . . . . 72.88 33.24 60.17 Favored Glycine 0 CA--C 1.529 0.907 0 C-N-CA 121.017 -0.611 . . . . 0.0 111.961 178.665 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' C' C ' 44' ' ' LYS . . . . . . . . . . . . . 55.6 tptt -140.7 129.61 23.2 Favored 'General case' 0 C--N 1.33 -0.268 0 N-CA-C 109.4 -0.593 . . . . 0.0 109.4 178.622 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' C' C ' 45' ' ' GLU . . . . . . . . . . . . . 83.6 tt0 -81.71 119.39 23.78 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-O 120.928 0.394 . . . . 0.0 110.658 -177.782 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' C' C ' 46' ' ' VAL . . . . . . . . . . . . . 7.4 p -117.56 127.06 75.03 Favored 'Isoleucine or valine' 0 C--N 1.333 -0.12 0 N-CA-C 109.303 -0.629 . . . . 0.0 109.303 176.765 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' C' C ' 47' ' ' LYS . . . . . . . . . . . . . 68.0 mttm -100.37 127.36 46.7 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 115.827 -0.624 . . . . 0.0 111.001 179.312 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' C' C ' 48' ' ' PHE . . . . . . . . . . . . . 93.8 m-85 -109.94 131.92 54.62 Favored 'General case' 0 C--N 1.328 -0.347 0 N-CA-C 109.81 -0.441 . . . . 0.0 109.81 175.632 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' C' C ' 49' ' ' LYS . . . . . . . . . . . . . 85.6 tttt -107.75 135.63 48.84 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.437 -0.347 . . . . 0.0 110.385 178.857 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' C' C ' 50' ' ' VAL . . . . . . . . . . . . . 44.6 t -79.76 107.25 11.97 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 N-CA-C 109.198 -0.668 . . . . 0.0 109.198 176.261 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' C' C ' 51' ' ' VAL . . . . . . . . . . . . . 48.4 t -70.36 -46.96 68.97 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.316 0 N-CA-C 109.856 -0.424 . . . . 0.0 109.856 -174.339 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' C' C ' 52' ' ' GLN . . . . . . . . . . . . . 37.4 tt0 -167.14 142.44 4.09 Favored 'General case' 0 C--N 1.33 -0.241 0 C-N-CA 120.314 -0.554 . . . . 0.0 111.711 -179.887 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' C' C ' 53' ' ' ALA . . . . . . . . . . . . . . . -114.69 133.79 55.6 Favored 'General case' 0 C--N 1.331 -0.227 0 CA-C-N 115.761 -0.654 . . . . 0.0 109.745 175.113 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' C' C ' 54' ' ' TYR . . . . . . . . . . . . . 64.2 t80 -129.08 112.81 18.5 Favored Pre-proline 0 CA--C 1.534 0.348 0 CA-C-O 118.259 -0.877 . . . . 0.0 110.52 -179.963 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' C' C ' 55' ' ' PRO . . . . . . . . . . . . . 73.4 Cg_endo -77.18 168.19 77.58 Favored 'Cis proline' 0 N--CA 1.501 1.964 0 CA-C-N 122.05 1.768 . . . . 0.0 112.083 -7.607 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' C' C ' 56' ' ' SER . . . . . . . . . . . . . 14.0 m -117.22 140.42 27.16 Favored Pre-proline 0 CA--C 1.539 0.52 0 CA-C-O 118.599 -0.715 . . . . 0.0 109.828 174.518 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' C' C ' 57' ' ' PRO . . . . . . . . . . . . . 51.5 Cg_endo -70.82 144.2 78.18 Favored 'Cis proline' 0 N--CA 1.498 1.742 0 CA-C-N 121.575 1.598 . . . . 0.0 111.2 -3.742 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' C' C ' 58' ' ' LEU . . . . . . . . . . . . . 16.9 tp -107.49 135.88 48.22 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-O 120.796 0.331 . . . . 0.0 110.981 -176.199 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' C' C ' 59' ' ' ARG . . . . . . . . . . . . . 55.7 ttt180 -101.68 126.06 48.45 Favored 'General case' 0 C--N 1.327 -0.405 0 N-CA-C 109.15 -0.685 . . . . 0.0 109.15 174.254 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' C' C ' 60' ' ' VAL . . . . . . . . . . . . . 42.5 t -83.65 124.48 39.69 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.264 0 C-N-CA 120.64 -0.424 . . . . 0.0 110.549 -175.426 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' C' C ' 61' ' ' GLU . . . . . . . . . . . . . 95.6 mt-10 -129.02 170.74 13.1 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 115.68 -0.691 . . . . 0.0 109.881 177.238 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' C' C ' 62' ' ' ASP . . . . . . . . . . . . . 81.6 m-20 -54.81 -32.51 60.45 Favored 'General case' 0 C--N 1.327 -0.372 0 C-N-CA 121.048 -0.261 . . . . 0.0 111.695 -178.877 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' C' C ' 63' ' ' ARG . . . . . . . . . . . . . 9.2 ptm180 -86.73 6.21 32.47 Favored 'General case' 0 CA--C 1.536 0.415 0 N-CA-C 113.623 0.972 . . . . 0.0 113.623 -175.474 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' C' C ' 64' ' ' THR . . . . . . . . . . . . . 19.8 m -73.36 135.91 44.34 Favored 'General case' 0 C--N 1.332 -0.186 0 CA-C-N 118.138 0.427 . . . . 0.0 110.799 -177.814 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' C' C ' 65' ' ' LYS . . . . . . . . . . . . . 25.3 mtpp -89.94 119.21 30.11 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.098 -0.501 . . . . 0.0 110.001 178.062 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' C' C ' 66' ' ' ILE . . . . . . . . . . . . . 65.6 mt -114.56 131.18 67.41 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.277 0 CA-C-O 120.83 0.348 . . . . 0.0 110.07 -178.681 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' C' C ' 67' ' ' THR . . . . . . . . . . . . . 21.3 m -123.01 134.65 54.3 Favored 'General case' 0 C--N 1.331 -0.224 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.478 -179.253 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' C' C ' 68' ' ' LEU . . . . . . . . . . . . . 21.5 tp -108.63 130.48 55.32 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 115.876 -0.602 . . . . 0.0 110.802 -179.809 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' C' C ' 69' ' ' VAL . . . . . . . . . . . . . 45.8 t -89.45 133.41 31.6 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.292 0 N-CA-C 109.768 -0.456 . . . . 0.0 109.768 177.476 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' C' C ' 70' ' ' THR . . . . . . . . . . . . . 3.3 m -144.44 32.28 1.19 Allowed 'General case' 0 C--N 1.331 -0.236 0 N-CA-C 111.95 0.352 . . . . 0.0 111.95 -177.944 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' C' C ' 71' ' ' HIS . . . . . . . . . . . . . 27.2 t-80 -134.18 81.8 49.45 Favored Pre-proline 0 C--O 1.234 0.238 0 N-CA-C 110.364 -0.236 . . . . 0.0 110.364 178.458 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' C' C ' 72' ' ' PRO . . . . . . . . . . . . . 90.2 Cg_endo -90.17 154.64 4.7 Favored 'Trans proline' 0 N--CA 1.49 1.274 0 C-N-CA 121.837 1.691 . . . . 0.0 113.254 -176.657 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' C' C ' 73' ' ' VAL . . . . . . . . . . . . . 33.0 m -120.52 -171.37 0.62 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 CA-C-N 115.365 -0.834 . . . . 0.0 109.243 174.896 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' C' C ' 74' ' ' ASP . . . . . . . . . . . . . 7.4 t0 -89.13 114.88 26.2 Favored 'General case' 0 C--N 1.331 -0.211 0 N-CA-C 109.09 -0.707 . . . . 0.0 109.09 -178.753 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' C' C ' 75' ' ' VAL . . . . . . . . . . . . . 42.3 t -124.52 122.0 62.85 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.266 0 CA-C-O 121.054 0.454 . . . . 0.0 110.652 -175.109 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' C' C ' 76' ' ' LEU . . . . . 0.455 ' N ' HD12 ' C' ' 76' ' ' LEU . 6.4 mp -118.92 144.54 46.37 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 115.584 -0.735 . . . . 0.0 109.378 175.332 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' C' C ' 77' ' ' GLU . . . . . . . . . . . . . 96.3 mt-10 -134.07 137.49 44.68 Favored 'General case' 0 C--N 1.331 -0.219 0 CA-C-O 120.998 0.428 . . . . 0.0 111.081 -177.653 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' C' C ' 78' ' ' ALA . . . . . 0.579 ' HB2' HD21 ' C' ' 109' ' ' LEU . . . -125.1 135.69 52.93 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 115.738 -0.665 . . . . 0.0 109.79 176.568 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' C' C ' 79' ' ' LYS . . . . . 0.598 ' O ' HD13 ' C' ' 80' ' ' ILE . 61.6 mmtt -78.0 118.5 20.35 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-O 121.002 0.43 . . . . 0.0 110.949 -177.815 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' C' C ' 80' ' ' ILE . . . . . 0.598 HD13 ' O ' ' C' ' 79' ' ' LYS . 41.5 mm -139.1 106.55 2.96 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.327 0 N-CA-C 109.107 -0.701 . . . . 0.0 109.107 -178.951 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' C' C ' 81' ' ' LYS . . . . . . . . . . . . . 99.4 mttt -100.2 127.34 46.48 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-O 120.928 0.394 . . . . 0.0 110.949 -178.145 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' C' C ' 82' ' ' GLY . . . . . . . . . . . . . . . 89.04 42.1 5.71 Favored Glycine 0 CA--C 1.524 0.634 0 C-N-CA 120.968 -0.634 . . . . 0.0 111.722 176.057 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' C' C ' 83' ' ' ILE . . . . . . . . . . . . . 72.5 mt -66.47 137.26 25.21 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.321 0 N-CA-C 109.634 -0.506 . . . . 0.0 109.634 176.339 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' C' C ' 84' ' ' LYS . . . . . . . . . . . . . 39.6 ttpt -101.02 -50.66 3.74 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-O 120.894 0.378 . . . . 0.0 110.389 -179.066 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' C' C ' 85' ' ' ASP . . . . . . . . . . . . . 12.7 t70 -152.44 151.1 30.37 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.078 -0.51 . . . . 0.0 110.783 -179.894 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' C' C ' 86' ' ' VAL . . . . . . . . . . . . . 42.4 t -128.15 131.19 69.54 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.222 0 CA-C-O 120.895 0.379 . . . . 0.0 110.261 179.362 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' C' C ' 87' ' ' ILE . . . . . 0.5 ' N ' HD12 ' C' ' 87' ' ' ILE . 5.0 mp -122.98 131.58 73.01 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.251 0 CA-C-N 116.178 -0.464 . . . . 0.0 109.781 178.884 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' C' C ' 88' ' ' LEU . . . . . . . . . . . . . 80.8 mt -109.31 139.61 44.04 Favored 'General case' 0 C--N 1.331 -0.212 0 CA-C-O 121.03 0.443 . . . . 0.0 111.181 -179.354 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' C' C ' 89' ' ' ASP . . . . . . . . . . . . . 13.6 t70 -129.23 156.25 44.26 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 115.667 -0.697 . . . . 0.0 109.624 177.562 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' C' C ' 90' ' ' GLU . . . . . . . . . . . . . 85.3 tt0 -45.93 -38.77 7.93 Favored 'General case' 0 CA--C 1.532 0.265 0 N-CA-C 113.101 0.778 . . . . 0.0 113.101 -172.151 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' C' C ' 91' ' ' ASN . . . . . . . . . . . . . 78.9 m-20 -132.07 21.48 4.49 Favored 'General case' 0 N--CA 1.469 0.485 0 N-CA-C 112.799 0.666 . . . . 0.0 112.799 -178.035 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' C' C ' 92' ' ' LEU . . . . . . . . . . . . . 40.4 mt -150.59 152.26 33.81 Favored 'General case' 0 C--N 1.331 -0.217 0 CA-C-O 120.997 0.427 . . . . 0.0 110.678 -176.423 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' C' C ' 93' ' ' ILE . . . . . . . . . . . . . 69.8 mt -125.35 123.33 64.79 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.335 0 N-CA-C 109.141 -0.689 . . . . 0.0 109.141 175.727 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' C' C ' 94' ' ' VAL . . . . . . . . . . . . . 42.3 t -119.74 128.78 75.91 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.284 0 CA-C-O 120.964 0.411 . . . . 0.0 110.079 -179.192 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' C' C ' 95' ' ' VAL . . . . . . . . . . . . . 45.5 t -120.48 134.18 64.78 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.322 0 CA-C-N 115.94 -0.573 . . . . 0.0 109.655 179.89 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' C' C ' 96' ' ' ILE . . . . . . . . . . . . . 66.9 mt -115.59 127.05 73.3 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.309 0 N-CA-C 109.283 -0.636 . . . . 0.0 109.283 178.845 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' C' C ' 97' ' ' THR . . . . . . . . . . . . . 68.6 p -100.87 158.22 16.14 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-O 121.139 0.495 . . . . 0.0 111.115 -176.819 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' C' C ' 98' ' ' GLU . . . . . . . . . . . . . 84.6 tt0 -53.85 -26.31 23.87 Favored 'General case' 0 CA--C 1.534 0.335 0 CA-C-N 116.22 -0.445 . . . . 0.0 112.172 179.861 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' C' C ' 99' ' ' GLU . . . . . . . . . . . . . 18.2 tp10 -76.8 9.97 2.52 Favored 'General case' 0 CA--C 1.538 0.517 0 N-CA-C 113.007 0.743 . . . . 0.0 113.007 -177.929 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' C' C ' 100' ' ' ASN . . . . . . . . . . . . . 3.6 m-20 63.32 33.48 13.96 Favored 'General case' 0 N--CA 1.464 0.258 0 O-C-N 121.984 -0.447 . . . . 0.0 111.57 -179.812 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' C' C ' 101' ' ' GLU . . . . . . . . . . . . . 84.7 tt0 -108.64 143.99 36.97 Favored 'General case' 0 C--N 1.332 -0.167 0 N-CA-C 109.666 -0.494 . . . . 0.0 109.666 172.038 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' C' C ' 102' ' ' VAL . . . . . . . . . . . . . 46.9 t -115.61 126.1 73.03 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.27 0 N-CA-C 109.72 -0.474 . . . . 0.0 109.72 -177.958 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' C' C ' 103' ' ' LEU . . . . . . . . . . . . . 30.9 mt -117.3 130.77 56.76 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-N 115.856 -0.611 . . . . 0.0 110.334 177.845 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' C' C ' 104' ' ' ILE . . . . . 0.449 HD13 HG21 ' C' ' 130' ' ' VAL . 64.0 mt -118.28 121.29 66.82 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.207 0 N-CA-C 110.07 -0.345 . . . . 0.0 110.07 179.383 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' C' C ' 105' ' ' PHE . . . . . . . . . . . . . 45.4 m-85 -121.63 167.55 12.78 Favored 'General case' 0 C--N 1.332 -0.182 0 O-C-N 123.851 0.719 . . . . 0.0 109.883 177.993 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' C' C ' 106' ' ' ASN . . . . . . . . . . . . . 45.2 p-10 -97.29 -169.93 1.93 Allowed 'General case' 0 C--N 1.331 -0.209 0 N-CA-C 109.879 -0.415 . . . . 0.0 109.879 173.677 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' C' C ' 107' ' ' GLN . . . . . . . . . . . . . 48.9 tt0 -59.57 -30.13 68.43 Favored 'General case' 0 CA--C 1.532 0.251 0 N-CA-C 111.9 0.333 . . . . 0.0 111.9 179.84 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' C' C ' 108' ' ' ASN . . . . . . . . . . . . . 51.6 t30 -83.78 9.85 10.91 Favored 'General case' 0 CA--C 1.536 0.424 0 N-CA-C 113.062 0.764 . . . . 0.0 113.062 -178.195 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' C' C ' 109' ' ' LEU . . . . . 0.579 HD21 ' HB2' ' C' ' 78' ' ' ALA . 8.0 tp 59.85 36.29 21.93 Favored 'General case' 0 C--N 1.331 -0.223 0 CA-C-O 120.853 0.359 . . . . 0.0 111.366 179.085 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' C' C ' 110' ' ' GLU . . . . . . . . . . . . . 96.0 mt-10 -103.38 150.1 24.13 Favored 'General case' 0 C--N 1.33 -0.26 0 N-CA-C 109.957 -0.386 . . . . 0.0 109.957 176.06 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' C' C ' 111' ' ' GLU . . . . . . . . . . . . . 71.6 tt0 -81.98 121.99 27.21 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-O 120.886 0.374 . . . . 0.0 111.111 -174.713 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' C' C ' 112' ' ' LEU . . . . . . . . . . . . . 34.1 mt -107.08 -46.09 3.99 Favored 'General case' 0 C--N 1.331 -0.21 0 CA-C-N 116.16 -0.473 . . . . 0.0 110.76 178.049 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' C' C ' 113' ' ' TYR . . . . . . . . . . . . . 60.7 t80 -139.34 139.72 37.33 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.201 -0.454 . . . . 0.0 111.14 -178.047 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' C' C ' 114' ' ' ARG . . . . . . . . . . . . . 59.1 ttp180 -137.6 125.53 22.69 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 115.956 -0.565 . . . . 0.0 110.224 177.321 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' C' C ' 115' ' ' GLY . . . . . . . . . . . . . . . -149.98 153.25 24.98 Favored Glycine 0 CA--C 1.523 0.573 0 N-CA-C 110.262 -1.135 . . . . 0.0 110.262 178.505 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' C' C ' 116' ' ' LYS . . . . . . . . . . . . . 59.0 tttm -131.5 128.98 40.48 Favored 'General case' 0 C--N 1.329 -0.325 0 N-CA-C 109.65 -0.5 . . . . 0.0 109.65 179.388 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' C' C ' 117' ' ' PHE . . . . . . . . . . . . . 26.1 m-85 -132.91 117.64 17.94 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.329 -0.396 . . . . 0.0 110.029 -173.153 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' C' C ' 118' ' ' GLU . . . . . . . . . . . . . 95.8 mt-10 -55.18 -39.46 69.58 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.521 -0.308 . . . . 0.0 111.043 -177.774 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' C' C ' 119' ' ' ASN . . . . . . . . . . . . . 29.5 m120 -100.7 30.98 3.7 Favored 'General case' 0 C--N 1.33 -0.271 0 N-CA-C 112.229 0.455 . . . . 0.0 112.229 -173.896 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' C' C ' 120' ' ' LEU . . . . . . . . . . . . . 17.1 tp -57.76 122.56 13.14 Favored 'General case' 0 N--CA 1.462 0.16 0 C-N-CA 120.845 -0.342 . . . . 0.0 110.121 177.462 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' C' C ' 121' ' ' ASN . . . . . . . . . . . . . 21.9 t-20 -112.79 -44.03 3.36 Favored 'General case' 0 C--N 1.332 -0.183 0 CA-C-N 116.554 -0.294 . . . . 0.0 111.41 -175.968 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' C' C ' 122' ' ' LYS . . . . . . . . . . . . . 31.4 ttmt -158.57 151.04 21.84 Favored 'General case' 0 C--N 1.332 -0.188 0 C-N-CA 120.546 -0.462 . . . . 0.0 111.156 -176.721 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' C' C ' 123' ' ' VAL . . . . . 0.439 ' C ' HD12 ' C' ' 124' ' ' LEU . 41.9 t -122.42 131.91 72.22 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.218 0 CA-C-N 116.19 -0.459 . . . . 0.0 109.957 177.687 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' C' C ' 124' ' ' LEU . . . . . 0.463 HD12 ' N ' ' C' ' 124' ' ' LEU . 7.2 mp -116.76 133.67 55.74 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-N 116.147 -0.479 . . . . 0.0 109.999 179.28 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' C' C ' 125' ' ' VAL . . . . . . . . . . . . . 35.2 m -135.25 139.68 46.46 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.289 0 CA-C-O 120.843 0.354 . . . . 0.0 110.922 -179.479 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' C' C ' 126' ' ' ARG . . . . . . . . . . . . . 38.8 ttt180 -163.32 133.63 4.44 Favored 'General case' 0 C--N 1.329 -0.298 0 N-CA-C 109.525 -0.546 . . . . 0.0 109.525 177.015 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' C' C ' 127' ' ' ASN . . . . . . . . . . . . . 33.4 m120 56.85 -155.13 0.32 Allowed 'General case' 0 CA--C 1.538 0.503 0 N-CA-C 109.627 -0.508 . . . . 0.0 109.627 -177.843 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' C' C ' 128' ' ' ASP . . . . . . . . . . . . . 11.6 p-10 -82.31 16.92 1.84 Allowed 'General case' 0 CA--C 1.536 0.421 0 N-CA-C 112.642 0.608 . . . . 0.0 112.642 177.705 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' C' C ' 129' ' ' LEU . . . . . . . . . . . . . 49.3 mt -115.74 142.45 46.73 Favored 'General case' 0 C--O 1.231 0.116 0 O-C-N 122.077 -0.39 . . . . 0.0 110.279 179.723 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' C' C ' 130' ' ' VAL . . . . . 0.498 HG23 ' HB ' ' C' ' 141' ' ' ILE . 32.5 m -134.77 146.8 30.12 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.249 0 CA-C-O 120.986 0.422 . . . . 0.0 110.947 -179.333 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' C' C ' 131' ' ' VAL . . . . . 0.401 ' CG1' HD21 ' C' ' 138' ' ' LEU . 39.1 t -135.99 137.86 48.2 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.299 0 CA-C-N 116.087 -0.506 . . . . 0.0 110.157 178.43 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' C' C ' 132' ' ' ILE . . . . . . . . . . . . . 70.2 mt -112.96 131.75 63.68 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.357 0 N-CA-C 109.341 -0.614 . . . . 0.0 109.341 179.933 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' C' C ' 133' ' ' ILE . . . . . . . . . . . . . 36.6 mm -113.64 122.33 67.57 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.256 0 CA-C-O 120.837 0.351 . . . . 0.0 110.79 -176.15 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' C' C ' 134' ' ' ASP . . . . . . . . . . . . . 9.4 p-10 -132.97 150.06 52.19 Favored 'General case' 0 C--N 1.331 -0.222 0 CA-C-N 116.107 -0.497 . . . . 0.0 109.66 174.741 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' C' C ' 135' ' ' GLU . . . . . . . . . . . . . 40.3 tp10 -50.0 -29.02 7.79 Favored 'General case' 0 C--N 1.327 -0.398 0 N-CA-C 112.715 0.635 . . . . 0.0 112.715 -171.873 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' C' C ' 136' ' ' GLN . . . . . . . . . . . . . 99.6 mm-40 -85.87 -29.52 23.62 Favored 'General case' 0 C--N 1.33 -0.247 0 N-CA-C 112.896 0.702 . . . . 0.0 112.896 -174.086 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' C' C ' 137' ' ' LYS . . . . . . . . . . . . . 21.0 pttm -168.97 173.16 7.12 Favored 'General case' 0 C--O 1.234 0.242 0 CA-C-O 121.496 0.665 . . . . 0.0 112.477 -171.975 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' C' C ' 138' ' ' LEU . . . . . 0.431 HD23 ' C ' ' C' ' 138' ' ' LEU . 7.3 tt -120.71 129.38 53.63 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 115.088 -0.96 . . . . 0.0 109.869 179.594 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' C' C ' 139' ' ' THR . . . . . . . . . . . . . 38.0 m -109.76 128.5 55.33 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 116.112 -0.495 . . . . 0.0 110.444 179.703 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' C' C ' 140' ' ' LEU . . . . . 0.464 ' C ' HD23 ' C' ' 140' ' ' LEU . 5.9 tt -112.01 122.64 48.33 Favored 'General case' 0 C--N 1.329 -0.305 0 N-CA-C 109.039 -0.726 . . . . 0.0 109.039 -179.39 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' C' C ' 141' ' ' ILE . . . . . 0.498 ' HB ' HG23 ' C' ' 130' ' ' VAL . 19.5 mt -121.86 121.39 64.13 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.333 0 CA-C-O 120.98 0.419 . . . . 0.0 109.93 -176.298 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' C' C ' 142' ' ' ARG . . . . . . . . . . . . . 78.9 mtm180 -111.14 125.13 53.46 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 115.463 -0.79 . . . . 0.0 110.169 -178.379 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' C' C ' 143' ' ' THR . . . . . . . . . . . . . 41.9 p . . . . . 0 C--O 1.221 -0.447 0 CA-C-O 117.905 -1.045 . . . . 0.0 110.618 -179.436 . . . . . . . . 0 0 . 1 . 005 nuclear nobuild full ' D' D ' -3' ' ' GLU . . . . . . . . . . . . . 95.6 mt-10 . . . . . 0 N--CA 1.489 1.52 0 N-CA-C 109.34 -0.615 . . . . 0.0 109.34 . . . . . . . . . 0 0 . 1 . 005 nuclear nobuild full ' D' D ' -2' ' ' GLY . . . . . . . . . . . . . . . -91.56 115.57 4.77 Favored Glycine 0 CA--C 1.525 0.697 0 N-CA-C 111.065 -0.814 . . . . 0.0 111.065 -179.804 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' D' D ' -1' ' ' VAL . . . . . . . . . . . . . 41.5 t -140.98 140.48 32.66 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.351 0 N-CA-C 110.138 -0.319 . . . . 0.0 110.138 179.483 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' D' D ' 0' ' ' ILE . . . . . . . . . . . . . 73.3 mt -105.58 136.38 39.94 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.223 0 CA-C-N 116.25 -0.432 . . . . 0.0 109.977 -179.849 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' D' D ' 1' ' ' MET . . . . . . . . . . . . . 26.3 ptt? -88.2 151.78 22.44 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 115.982 -0.554 . . . . 0.0 110.796 -179.059 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' D' D ' 2' ' ' SER . . . . . . . . . . . . . 6.5 p -121.1 134.0 55.24 Favored 'General case' 0 C--N 1.332 -0.187 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.752 179.703 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' D' D ' 3' ' ' GLU . . . . . . . . . . . . . 94.9 mt-10 -140.54 140.14 35.15 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.14 -0.482 . . . . 0.0 110.986 -179.044 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' D' D ' 4' ' ' LEU . . . . . . . . . . . . . 21.0 tp -126.31 128.01 46.46 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 116.129 -0.487 . . . . 0.0 110.223 176.912 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' D' D ' 5' ' ' LYS . . . . . . . . . . . . . 64.1 mttp -107.39 122.19 46.11 Favored 'General case' 0 C--O 1.234 0.274 0 CA-C-N 116.456 -0.338 . . . . 0.0 110.696 178.726 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' D' D ' 6' ' ' LEU . . . . . . . . . . . . . 73.3 mt -118.32 144.12 46.1 Favored 'General case' 0 C--N 1.331 -0.223 0 CA-C-N 115.683 -0.69 . . . . 0.0 110.778 -178.947 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' D' D ' 7' ' ' LYS . . . . . . . . . . . . . 59.3 tttm -133.95 141.76 40.91 Favored Pre-proline 0 CA--C 1.535 0.382 0 CA-C-O 119.12 -0.466 . . . . 0.0 110.158 176.727 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' D' D ' 8' ' ' PRO . . . . . . . . . . . . . 87.5 Cg_endo -91.52 140.64 2.57 Favored 'Trans proline' 0 N--CA 1.49 1.273 0 C-N-CA 121.748 1.632 . . . . 0.0 111.711 177.759 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' D' D ' 9' ' ' LEU . . . . . . . . . . . . . 53.5 mt -77.08 -48.06 2.6 Favored Pre-proline 0 CA--C 1.533 0.301 0 CA-C-O 118.799 -0.619 . . . . 0.0 112.464 -178.707 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' D' D ' 10' ' ' PRO . . . . . 0.42 ' CG ' HG23 ' D' ' 46' ' ' VAL . 85.2 Cg_endo -80.3 160.54 23.03 Favored 'Trans proline' 0 N--CA 1.495 1.605 0 C-N-CA 121.187 1.258 . . . . 0.0 112.071 176.92 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' D' D ' 11' ' ' LYS . . . . . . . . . . . . . 52.6 mttm -88.69 100.62 13.26 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.317 -0.402 . . . . 0.0 110.151 178.241 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' D' D ' 12' ' ' VAL . . . . . . . . . . . . . 12.9 p -145.77 147.34 18.53 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.263 0 CA-C-N 116.363 -0.38 . . . . 0.0 110.882 -178.888 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' D' D ' 13' ' ' GLU . . . . . . . . . . . . . 70.7 mm-40 -92.12 124.0 35.88 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.069 177.526 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' D' D ' 14' ' ' LEU . . . . . . . . . . . . . 36.4 mt -98.02 154.73 37.63 Favored Pre-proline 0 C--N 1.33 -0.258 0 CA-C-N 116.426 -0.352 . . . . 0.0 110.958 -177.88 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' D' D ' 15' ' ' PRO . . . . . . . . . . . . . 28.7 Cg_exo -60.6 154.82 51.74 Favored 'Trans proline' 0 N--CA 1.496 1.661 0 C-N-CA 121.405 1.403 . . . . 0.0 111.857 177.941 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' D' D ' 16' ' ' PRO . . . . . . . . . . . . . 36.4 Cg_exo -58.21 -37.13 96.72 Favored 'Trans proline' 0 N--CA 1.496 1.65 0 C-N-CA 121.4 1.4 . . . . 0.0 112.703 179.749 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' D' D ' 17' ' ' ASP . . . . . . . . . . . . . 15.0 p-10 -87.38 13.46 9.84 Favored 'General case' 0 CA--C 1.536 0.414 0 N-CA-C 112.981 0.734 . . . . 0.0 112.981 -178.384 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' D' D ' 18' ' ' PHE . . . . . . . . . . . . . 48.3 t80 -58.24 -45.09 88.39 Favored 'General case' 0 C--N 1.334 -0.104 0 O-C-N 122.145 -0.347 . . . . 0.0 110.14 -177.997 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' D' D ' 19' ' ' VAL . . . . . 0.402 HG13 ' N ' ' D' ' 20' ' ' ASP . 14.6 p -55.7 -41.38 64.99 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.305 0 CA-C-N 116.478 -0.328 . . . . 0.0 111.073 -178.364 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' D' D ' 20' ' ' ASP . . . . . 0.402 ' N ' HG13 ' D' ' 19' ' ' VAL . 71.5 m-20 -61.09 -43.76 98.4 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-O 120.818 0.342 . . . . 0.0 111.06 -178.329 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' D' D ' 21' ' ' VAL . . . . . . . . . . . . . 46.8 t -65.04 -46.78 90.36 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.318 0 C-N-CA 120.71 -0.396 . . . . 0.0 110.565 -177.285 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' D' D ' 22' ' ' ILE . . . . . 0.686 HG22 HD12 ' D' ' 26' ' ' LEU . 50.1 mm -56.7 -43.69 79.77 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.207 0 C-N-CA 120.959 -0.297 . . . . 0.0 110.493 179.378 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' D' D ' 23' ' ' ARG . . . . . . . . . . . . . 26.8 ttm-85 -52.93 -53.96 41.84 Favored 'General case' 0 C--N 1.331 -0.213 0 CA-C-O 121.413 0.625 . . . . 0.0 111.393 179.293 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' D' D ' 24' ' ' ILE . . . . . . . . . . . . . 78.8 mt -59.34 -41.06 83.06 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.356 0 CA-C-N 115.282 -0.872 . . . . 0.0 111.368 -173.524 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' D' D ' 25' ' ' LYS . . . . . . . . . . . . . 68.0 mttm -69.55 -41.63 75.66 Favored 'General case' 0 C--N 1.33 -0.278 0 N-CA-C 112.651 0.611 . . . . 0.0 112.651 -179.434 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' D' D ' 26' ' ' LEU . . . . . 0.686 HD12 HG22 ' D' ' 22' ' ' ILE . 60.4 mt -78.62 -33.86 47.05 Favored 'General case' 0 C--N 1.33 -0.262 0 N-CA-C 113.674 0.99 . . . . 0.0 113.674 -170.323 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' D' D ' 27' ' ' GLN . . . . . . . . . . . . . 10.4 pt20 -46.74 139.95 4.93 Favored 'General case' 0 N--CA 1.469 0.505 0 N-CA-C 112.863 0.69 . . . . 0.0 112.863 -174.884 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' D' D ' 28' ' ' GLY . . . . . . . . . . . . . . . 96.82 -21.39 46.27 Favored Glycine 0 CA--C 1.534 1.239 0 CA-C-N 115.728 -0.669 . . . . 0.0 112.531 -177.458 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' D' D ' 29' ' ' LYS . . . . . . . . . . . . . 35.1 mmtp -97.34 155.07 17.05 Favored 'General case' 0 C--O 1.232 0.16 0 CA-C-N 117.605 0.703 . . . . 0.0 110.783 179.407 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' D' D ' 30' ' ' THR . . . . . . . . . . . . . 32.0 m -106.0 137.1 44.49 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.043 -0.526 . . . . 0.0 109.868 176.165 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' D' D ' 31' ' ' VAL . . . . . . . . . . . . . 35.1 m -128.5 152.78 37.11 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.243 0 CA-C-O 121.026 0.441 . . . . 0.0 111.057 -178.088 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' D' D ' 32' ' ' ARG . . . . . . . . . . . . . 76.5 mtm180 -130.6 149.37 52.29 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 115.767 -0.652 . . . . 0.0 110.44 178.084 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' D' D ' 33' ' ' THR . . . . . . . . . . . . . 19.4 m -53.44 139.16 31.53 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.449 -0.342 . . . . 0.0 111.392 -178.238 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' D' D ' 34' ' ' GLY . . . . . . . . . . . . . . . 99.58 -17.02 58.2 Favored Glycine 0 CA--C 1.531 1.084 0 CA-C-O 119.684 -0.509 . . . . 0.0 113.296 179.378 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' D' D ' 35' ' ' ASP . . . . . . . . . . . . . 76.7 m-20 -66.17 148.74 51.38 Favored 'General case' 0 N--CA 1.461 0.107 0 CA-C-N 118.056 0.928 . . . . 0.0 111.074 179.145 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' D' D ' 36' ' ' VAL . . . . . . . . . . . . . 44.4 t -120.19 130.56 74.19 Favored 'Isoleucine or valine' 0 C--N 1.333 -0.133 0 CA-C-N 115.811 -0.631 . . . . 0.0 109.981 179.042 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' D' D ' 37' ' ' ILE . . . . . . . . . . . . . 68.3 mt -119.75 137.76 52.56 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.262 0 N-CA-C 109.721 -0.474 . . . . 0.0 109.721 179.103 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' D' D ' 38' ' ' GLY . . . . . . . . . . . . . . . -111.05 128.57 8.79 Favored Glycine 0 CA--C 1.524 0.633 0 N-CA-C 111.394 -0.682 . . . . 0.0 111.394 -178.955 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' D' D ' 39' ' ' ILE . . . . . . . . . . . . . 73.9 mt -129.99 130.47 66.18 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.217 0 N-CA-C 109.817 -0.438 . . . . 0.0 109.817 177.838 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' D' D ' 40' ' ' SER . . . . . . . . . . . . . 59.6 p -92.28 115.19 27.86 Favored 'General case' 0 C--N 1.33 -0.281 0 C-N-CA 120.912 -0.315 . . . . 0.0 110.875 176.968 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' D' D ' 41' ' ' ILE . . . . . . . . . . . . . 44.1 mm -123.39 124.48 69.85 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.223 0 N-CA-C 109.996 -0.372 . . . . 0.0 109.996 -179.754 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' D' D ' 42' ' ' LEU . . . . . . . . . . . . . 56.1 mt 57.67 34.16 24.14 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.362 -0.381 . . . . 0.0 111.729 178.274 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' D' D ' 43' ' ' GLY . . . . . . . . . . . . . . . 77.94 -10.05 28.25 Favored Glycine 0 CA--C 1.535 1.308 0 C-N-CA 121.28 -0.486 . . . . 0.0 113.407 177.713 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' D' D ' 44' ' ' LYS . . . . . . . . . . . . . 61.0 tttm -101.31 130.99 47.57 Favored 'General case' 0 C--N 1.331 -0.211 0 CA-C-N 117.914 0.857 . . . . 0.0 109.846 176.869 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' D' D ' 45' ' ' GLU . . . . . . . . . . . . . 43.3 tp10 -83.23 128.17 34.26 Favored 'General case' 0 C--N 1.329 -0.293 0 C-N-CA 120.817 -0.353 . . . . 0.0 110.727 -179.113 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' D' D ' 46' ' ' VAL . . . . . 0.42 HG23 ' CG ' ' D' ' 10' ' ' PRO . 7.3 p -121.67 131.2 73.63 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.227 0 CA-C-O 121.11 0.481 . . . . 0.0 109.704 177.363 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' D' D ' 47' ' ' LYS . . . . . . . . . . . . . 37.1 mtmm -100.47 128.06 46.64 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 115.879 -0.601 . . . . 0.0 111.069 176.349 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' D' D ' 48' ' ' PHE . . . . . . . . . . . . . 89.9 m-85 -107.97 131.96 54.0 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.077 -0.51 . . . . 0.0 109.75 176.125 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' D' D ' 49' ' ' LYS . . . . . . . . . . . . . 82.8 tttt -107.17 134.57 50.09 Favored 'General case' 0 C--N 1.327 -0.385 0 CA-C-N 116.289 -0.414 . . . . 0.0 110.379 179.856 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' D' D ' 50' ' ' VAL . . . . . . . . . . . . . 46.8 t -76.95 108.68 10.39 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.297 0 N-CA-C 109.037 -0.727 . . . . 0.0 109.037 175.709 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' D' D ' 51' ' ' VAL . . . . . . . . . . . . . 51.0 t -70.67 -47.16 65.82 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.329 0 CA-C-N 116.131 -0.486 . . . . 0.0 109.868 -174.338 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' D' D ' 52' ' ' GLN . . . . . . . . . . . . . 49.6 tt0 -167.94 142.08 3.47 Favored 'General case' 0 C--N 1.33 -0.275 0 C-N-CA 120.308 -0.557 . . . . 0.0 111.567 -179.907 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' D' D ' 53' ' ' ALA . . . . . 0.478 ' HB1' ' HB2' ' D' ' 58' ' ' LEU . . . -115.76 132.87 56.51 Favored 'General case' 0 C--N 1.331 -0.196 0 CA-C-N 115.745 -0.661 . . . . 0.0 110.024 176.255 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' D' D ' 54' ' ' TYR . . . . . . . . . . . . . 75.4 t80 -129.14 112.19 18.35 Favored Pre-proline 0 CA--C 1.536 0.413 0 CA-C-O 118.291 -0.861 . . . . 0.0 110.319 178.503 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' D' D ' 55' ' ' PRO . . . . . . . . . . . . . 73.0 Cg_endo -77.21 170.01 72.62 Favored 'Cis proline' 0 N--CA 1.499 1.836 0 CA-C-N 121.995 1.748 . . . . 0.0 112.119 -5.61 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' D' D ' 56' ' ' SER . . . . . . . . . . . . . 13.5 m -117.2 132.05 23.7 Favored Pre-proline 0 CA--C 1.538 0.502 0 CA-C-O 118.464 -0.779 . . . . 0.0 109.454 175.666 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' D' D ' 57' ' ' PRO . . . . . . . . . . . . . 45.3 Cg_endo -69.37 146.86 82.54 Favored 'Cis proline' 0 N--CA 1.496 1.667 0 CA-C-N 121.902 1.715 . . . . 0.0 111.532 -0.835 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' D' D ' 58' ' ' LEU . . . . . 0.478 ' HB2' ' HB1' ' D' ' 53' ' ' ALA . 27.2 tp -107.61 135.23 49.4 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.275 -0.421 . . . . 0.0 110.527 -179.035 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' D' D ' 59' ' ' ARG . . . . . . . . . . . . . 52.7 ttp180 -102.43 125.28 49.09 Favored 'General case' 0 C--N 1.328 -0.356 0 N-CA-C 109.482 -0.562 . . . . 0.0 109.482 177.101 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' D' D ' 60' ' ' VAL . . . . . . . . . . . . . 41.2 t -81.44 121.37 34.74 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.2 0 C-N-CA 120.745 -0.382 . . . . 0.0 110.505 -174.917 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' D' D ' 61' ' ' GLU . . . . . . . . . . . . . 96.1 mt-10 -131.13 159.92 36.25 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 115.73 -0.668 . . . . 0.0 109.929 177.213 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' D' D ' 62' ' ' ASP . . . . . . . . . . . . . 10.8 t70 -53.66 -32.3 51.02 Favored 'General case' 0 C--N 1.327 -0.376 0 N-CA-C 111.722 0.268 . . . . 0.0 111.722 179.648 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' D' D ' 63' ' ' ARG . . . . . . . . . . . . . 27.8 ptt180 -85.78 5.05 34.19 Favored 'General case' 0 CA--C 1.537 0.459 0 N-CA-C 113.771 1.026 . . . . 0.0 113.771 -175.634 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' D' D ' 64' ' ' THR . . . . . . . . . . . . . 39.9 m -86.19 143.67 27.86 Favored 'General case' 0 C--N 1.332 -0.184 0 CA-C-N 118.002 0.365 . . . . 0.0 110.411 -179.728 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' D' D ' 65' ' ' LYS . . . . . . . . . . . . . 98.7 mttt -87.21 126.08 34.58 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.438 -0.346 . . . . 0.0 110.104 179.968 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' D' D ' 66' ' ' ILE . . . . . . . . . . . . . 65.5 mt -117.71 128.33 74.91 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.295 0 N-CA-C 109.862 -0.422 . . . . 0.0 109.862 -178.969 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' D' D ' 67' ' ' THR . . . . . . . . . . . . . 25.4 m -121.86 136.8 54.94 Favored 'General case' 0 C--N 1.331 -0.202 0 CA-C-O 121.05 0.452 . . . . 0.0 110.981 -177.65 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' D' D ' 68' ' ' LEU . . . . . . . . . . . . . 19.0 tp -107.77 134.09 51.23 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-N 115.914 -0.585 . . . . 0.0 110.635 179.593 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' D' D ' 69' ' ' VAL . . . . . . . . . . . . . 43.1 t -83.77 138.02 19.95 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.29 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.238 178.326 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' D' D ' 70' ' ' THR . . . . . . . . . . . . . 9.1 t -96.4 177.87 5.55 Favored 'General case' 0 C--N 1.331 -0.2 0 CA-C-N 116.198 -0.456 . . . . 0.0 110.749 -179.424 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' D' D ' 71' ' ' HIS . . . . . . . . . . . . . 95.9 m-70 -65.1 151.13 94.34 Favored Pre-proline 0 C--N 1.331 -0.23 0 CA-C-N 116.238 -0.437 . . . . 0.0 110.882 -178.282 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' D' D ' 72' ' ' PRO . . . . . . . . . . . . . 93.2 Cg_endo -92.2 160.01 3.16 Favored 'Trans proline' 0 N--CA 1.489 1.221 0 C-N-CA 121.864 1.709 . . . . 0.0 112.38 178.774 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' D' D ' 73' ' ' VAL . . . . . . . . . . . . . 35.4 m -87.51 -176.85 0.33 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.246 0 CA-C-N 116.206 -0.452 . . . . 0.0 109.984 177.229 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' D' D ' 74' ' ' ASP . . . . . . . . . . . . . 12.8 t70 -91.47 118.56 30.67 Favored 'General case' 0 C--N 1.331 -0.217 0 N-CA-C 109.953 -0.388 . . . . 0.0 109.953 -178.832 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' D' D ' 75' ' ' VAL . . . . . . . . . . . . . 45.8 t -117.36 123.67 72.06 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.239 0 CA-C-O 121.184 0.516 . . . . 0.0 110.507 -177.328 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' D' D ' 76' ' ' LEU . . . . . . . . . . . . . 14.6 mt -125.85 144.61 50.59 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-N 115.463 -0.79 . . . . 0.0 109.347 177.726 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' D' D ' 77' ' ' GLU . . . . . . . . . . . . . 97.0 mt-10 -135.67 138.33 42.7 Favored 'General case' 0 C--N 1.332 -0.183 0 CA-C-O 121.029 0.443 . . . . 0.0 111.583 -176.739 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' D' D ' 78' ' ' ALA . . . . . 0.559 ' HB2' HD21 ' D' ' 109' ' ' LEU . . . -127.14 135.28 50.49 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 115.627 -0.715 . . . . 0.0 109.675 175.772 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' D' D ' 79' ' ' LYS . . . . . 0.568 ' O ' HD13 ' D' ' 80' ' ' ILE . 22.7 tptm -78.08 121.83 24.8 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-O 120.914 0.388 . . . . 0.0 110.647 -177.604 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' D' D ' 80' ' ' ILE . . . . . 0.568 HD13 ' O ' ' D' ' 79' ' ' LYS . 43.2 mm -139.22 113.21 7.0 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.325 0 N-CA-C 108.995 -0.743 . . . . 0.0 108.995 -178.358 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' D' D ' 81' ' ' LYS . . . . . . . . . . . . . 76.2 tttt -103.09 123.24 46.27 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-O 120.749 0.309 . . . . 0.0 111.134 -175.809 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' D' D ' 82' ' ' GLY . . . . . . . . . . . . . . . 89.15 42.19 5.65 Favored Glycine 0 CA--C 1.528 0.871 0 C-N-CA 120.925 -0.655 . . . . 0.0 112.356 173.422 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' D' D ' 83' ' ' ILE . . . . . . . . . . . . . 71.4 mt -70.84 139.43 19.99 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.245 0 N-CA-C 109.706 -0.479 . . . . 0.0 109.706 176.359 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' D' D ' 84' ' ' LYS . . . . . . . . . . . . . 38.9 ttpt -107.16 -47.28 3.71 Favored 'General case' 0 C--N 1.331 -0.197 0 CA-C-N 116.451 -0.34 . . . . 0.0 110.631 -178.316 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' D' D ' 85' ' ' ASP . . . . . . . . . . . . . 9.9 t70 -148.35 148.13 30.02 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.253 -0.43 . . . . 0.0 110.489 -179.439 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' D' D ' 86' ' ' VAL . . . . . . . . . . . . . 42.4 t -133.25 134.48 57.39 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.252 0 CA-C-O 121.032 0.444 . . . . 0.0 110.425 179.442 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' D' D ' 87' ' ' ILE . . . . . . . . . . . . . 46.0 mm -120.09 127.52 75.9 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.29 0 CA-C-N 115.799 -0.637 . . . . 0.0 109.658 178.403 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' D' D ' 88' ' ' LEU . . . . . . . . . . . . . 18.2 tp -109.66 127.06 54.3 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-O 120.937 0.398 . . . . 0.0 110.898 -178.612 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' D' D ' 89' ' ' ASP . . . . . . . . . . . . . 13.7 t70 -117.96 154.68 31.54 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 115.926 -0.579 . . . . 0.0 109.559 177.124 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' D' D ' 90' ' ' GLU . . . . . . . . . . . . . 96.3 mt-10 -49.0 -38.63 23.95 Favored 'General case' 0 C--N 1.329 -0.311 0 N-CA-C 112.748 0.648 . . . . 0.0 112.748 -172.195 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' D' D ' 91' ' ' ASN . . . . . . . . . . . . . 37.5 t30 -132.06 35.64 3.71 Favored 'General case' 0 N--CA 1.464 0.258 0 C-N-CA 120.91 -0.316 . . . . 0.0 111.654 -177.797 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' D' D ' 92' ' ' LEU . . . . . . . . . . . . . 9.2 tp -166.06 146.66 6.53 Favored 'General case' 0 C--N 1.33 -0.244 0 C-N-CA 120.8 -0.36 . . . . 0.0 110.815 -179.304 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' D' D ' 93' ' ' ILE . . . . . . . . . . . . . 71.2 mt -125.71 123.66 64.93 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.262 0 N-CA-C 109.501 -0.555 . . . . 0.0 109.501 179.975 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' D' D ' 94' ' ' VAL . . . . . 0.516 HG21 HG11 ' D' ' 125' ' ' VAL . 46.4 t -124.41 129.69 73.82 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.24 0 CA-C-O 121.011 0.434 . . . . 0.0 110.236 179.893 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' D' D ' 95' ' ' VAL . . . . . . . . . . . . . 42.8 t -121.8 135.68 61.14 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.294 0 CA-C-N 115.86 -0.609 . . . . 0.0 109.821 -179.255 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' D' D ' 96' ' ' ILE . . . . . . . . . . . . . 67.8 mt -117.93 128.03 75.11 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.239 0 N-CA-C 109.561 -0.533 . . . . 0.0 109.561 179.043 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' D' D ' 97' ' ' THR . . . . . . . . . . . . . 65.8 p -100.12 159.53 15.03 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-O 121.102 0.477 . . . . 0.0 111.067 -178.16 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' D' D ' 98' ' ' GLU . . . . . . . . . . . . . 44.4 mt-10 -54.49 -26.32 30.71 Favored 'General case' 0 C--N 1.329 -0.319 0 N-CA-C 112.296 0.48 . . . . 0.0 112.296 -179.89 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' D' D ' 99' ' ' GLU . . . . . . . . . . . . . 95.4 mt-10 -76.08 10.77 1.74 Allowed 'General case' 0 CA--C 1.536 0.427 0 N-CA-C 113.326 0.862 . . . . 0.0 113.326 -177.557 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' D' D ' 100' ' ' ASN . . . . . . . . . . . . . 4.4 m-20 64.16 34.64 10.86 Favored 'General case' 0 N--CA 1.463 0.22 0 CA-C-O 120.971 0.415 . . . . 0.0 111.418 179.836 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' D' D ' 101' ' ' GLU . . . . . . . . . . . . . 84.7 tt0 -112.38 141.8 45.67 Favored 'General case' 0 C--N 1.334 -0.102 0 N-CA-C 109.778 -0.453 . . . . 0.0 109.778 173.72 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' D' D ' 102' ' ' VAL . . . . . . . . . . . . . 44.1 t -116.62 128.95 73.85 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.336 0 N-CA-C 109.988 -0.375 . . . . 0.0 109.988 -178.643 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' D' D ' 103' ' ' LEU . . . . . . . . . . . . . 52.9 mt -117.7 134.43 54.91 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 115.747 -0.661 . . . . 0.0 110.202 177.509 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' D' D ' 104' ' ' ILE . . . . . 0.5 HD13 HG21 ' D' ' 130' ' ' VAL . 67.9 mt -119.67 123.41 70.96 Favored 'Isoleucine or valine' 0 C--O 1.234 0.288 0 N-CA-C 110.35 -0.241 . . . . 0.0 110.35 -179.39 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' D' D ' 105' ' ' PHE . . . . . . . . . . . . . 63.9 m-85 -123.69 166.56 15.32 Favored 'General case' 0 C--N 1.333 -0.133 0 O-C-N 123.913 0.758 . . . . 0.0 109.666 179.577 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' D' D ' 106' ' ' ASN . . . . . . . . . . . . . 44.7 p-10 -101.45 -169.97 1.77 Allowed 'General case' 0 C--N 1.331 -0.235 0 N-CA-C 109.82 -0.437 . . . . 0.0 109.82 174.474 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' D' D ' 107' ' ' GLN . . . . . . . . . . . . . 62.2 tt0 -59.73 -30.14 68.63 Favored 'General case' 0 C--N 1.33 -0.273 0 N-CA-C 111.887 0.329 . . . . 0.0 111.887 179.82 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' D' D ' 108' ' ' ASN . . . . . . . . . . . . . 13.1 t-20 -82.05 7.02 14.41 Favored 'General case' 0 CA--C 1.537 0.46 0 N-CA-C 113.067 0.766 . . . . 0.0 113.067 -177.723 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' D' D ' 109' ' ' LEU . . . . . 0.559 HD21 ' HB2' ' D' ' 78' ' ' ALA . 8.0 tp 60.29 36.28 20.67 Favored 'General case' 0 C--N 1.332 -0.163 0 CA-C-O 120.878 0.371 . . . . 0.0 111.488 179.246 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' D' D ' 110' ' ' GLU . . . . . . . . . . . . . 43.1 mt-10 -104.83 150.77 24.54 Favored 'General case' 0 C--N 1.332 -0.176 0 N-CA-C 109.603 -0.517 . . . . 0.0 109.603 175.424 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' D' D ' 111' ' ' GLU . . . . . . . . . . . . . 67.8 tt0 -84.68 121.87 28.28 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-O 120.907 0.384 . . . . 0.0 110.722 -175.774 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' D' D ' 112' ' ' LEU . . . . . . . . . . . . . 11.4 mt -104.29 -46.07 4.51 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.016 -0.538 . . . . 0.0 110.489 179.36 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' D' D ' 113' ' ' TYR . . . . . . . . . . . . . 64.9 t80 -140.95 145.01 35.47 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.189 -0.46 . . . . 0.0 111.319 -178.236 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' D' D ' 114' ' ' ARG . . . . . . . . . . . . . 39.0 ptt85 -142.5 127.75 18.71 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 115.994 -0.548 . . . . 0.0 110.615 177.134 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' D' D ' 115' ' ' GLY . . . . . . . . . . . . . . . -150.06 151.79 23.8 Favored Glycine 0 CA--C 1.522 0.48 0 N-CA-C 110.724 -0.95 . . . . 0.0 110.724 178.788 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' D' D ' 116' ' ' LYS . . . . . . . . . . . . . 79.1 tttt -128.37 128.82 45.24 Favored 'General case' 0 C--N 1.328 -0.335 0 N-CA-C 109.842 -0.429 . . . . 0.0 109.842 178.531 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' D' D ' 117' ' ' PHE . . . . . . . . . . . . . 33.3 m-85 -125.86 117.97 24.48 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.283 -0.417 . . . . 0.0 110.154 -174.302 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' D' D ' 118' ' ' GLU . . . . . . . . . . . . . 96.0 mt-10 -55.02 -43.01 73.3 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.558 -0.292 . . . . 0.0 111.144 -176.615 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' D' D ' 119' ' ' ASN . . . . . . . . . . . . . 26.7 m120 -99.93 30.98 3.46 Favored 'General case' 0 C--N 1.331 -0.235 0 N-CA-C 112.176 0.435 . . . . 0.0 112.176 -174.273 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' D' D ' 120' ' ' LEU . . . . . . . . . . . . . 17.3 tp -56.11 119.87 6.6 Favored 'General case' 0 C--O 1.232 0.136 0 C-N-CA 120.925 -0.31 . . . . 0.0 110.613 178.539 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' D' D ' 121' ' ' ASN . . . . . . . . . . . . . 15.8 t-20 -114.16 -44.09 3.17 Favored 'General case' 0 C--N 1.332 -0.183 0 CA-C-N 116.592 -0.276 . . . . 0.0 111.416 -177.648 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' D' D ' 122' ' ' LYS . . . . . . . . . . . . . 96.5 mttt -145.23 150.38 36.59 Favored 'General case' 0 C--N 1.332 -0.153 0 C-N-CA 120.54 -0.464 . . . . 0.0 111.828 -176.671 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' D' D ' 123' ' ' VAL . . . . . . . . . . . . . 43.8 t -130.59 130.46 64.86 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.275 0 CA-C-N 115.951 -0.568 . . . . 0.0 109.753 176.318 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' D' D ' 124' ' ' LEU . . . . . . . . . . . . . 75.5 mt -131.1 135.61 47.65 Favored 'General case' 0 C--N 1.331 -0.208 0 CA-C-N 116.628 -0.26 . . . . 0.0 110.536 -179.643 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' D' D ' 125' ' ' VAL . . . . . 0.516 HG11 HG21 ' D' ' 94' ' ' VAL . 34.2 m -141.66 151.32 19.18 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.306 0 CA-C-O 121.007 0.432 . . . . 0.0 111.337 -179.09 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' D' D ' 126' ' ' ARG . . . . . 0.499 ' NH1' HD21 ' E' ' 88' ' ' LEU . 35.8 ptt-85 -154.15 129.75 9.97 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 115.873 -0.603 . . . . 0.0 110.549 175.965 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' D' D ' 127' ' ' ASN . . . . . . . . . . . . . 6.8 m120 51.91 -109.39 0.44 Allowed 'General case' 0 CA--C 1.546 0.809 0 CA-C-O 118.925 -0.559 . . . . 0.0 111.154 -179.927 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' D' D ' 128' ' ' ASP . . . . . . . . . . . . . 18.5 p-10 -114.13 2.92 15.04 Favored 'General case' 0 N--CA 1.468 0.438 0 CA-C-N 119.755 1.161 . . . . 0.0 113.443 -177.998 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' D' D ' 129' ' ' LEU . . . . . . . . . . . . . 48.7 mt -106.82 139.26 41.52 Favored 'General case' 0 C--N 1.333 -0.115 0 N-CA-C 109.558 -0.534 . . . . 0.0 109.558 179.12 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' D' D ' 130' ' ' VAL . . . . . 0.5 HG21 HD13 ' D' ' 104' ' ' ILE . 32.7 m -137.25 144.26 32.29 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.246 0 CA-C-O 121.167 0.508 . . . . 0.0 111.263 -178.322 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' D' D ' 131' ' ' VAL . . . . . . . . . . . . . 41.7 t -136.04 139.69 45.34 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.286 0 CA-C-N 115.878 -0.601 . . . . 0.0 110.243 178.199 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' D' D ' 132' ' ' ILE . . . . . . . . . . . . . 73.7 mt -117.14 133.31 64.28 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 CA-C-N 115.496 -0.774 . . . . 0.0 109.28 179.997 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' D' D ' 133' ' ' ILE . . . . . . . . . . . . . 40.8 mm -115.73 124.27 71.98 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.236 0 CA-C-O 120.72 0.295 . . . . 0.0 110.966 -175.034 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' D' D ' 134' ' ' ASP . . . . . . . . . . . . . 9.5 p-10 -136.46 146.4 46.29 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 115.972 -0.558 . . . . 0.0 109.719 175.548 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' D' D ' 135' ' ' GLU . . . . . . . . . . . . . 86.2 tt0 -50.27 -24.63 3.03 Favored 'General case' 0 C--N 1.327 -0.379 0 N-CA-C 112.85 0.685 . . . . 0.0 112.85 -175.014 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' D' D ' 136' ' ' GLN . . . . . . . . . . . . . 53.1 mt-30 -82.89 -32.48 27.32 Favored 'General case' 0 C--O 1.234 0.241 0 N-CA-C 112.384 0.512 . . . . 0.0 112.384 -177.15 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' D' D ' 137' ' ' LYS . . . . . . . . . . . . . 52.5 pttt -170.09 175.63 4.95 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-O 121.474 0.654 . . . . 0.0 112.295 -173.567 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' D' D ' 138' ' ' LEU . . . . . 0.45 ' C ' HD23 ' D' ' 138' ' ' LEU . 7.5 tt -119.68 127.5 52.95 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 115.184 -0.916 . . . . 0.0 109.944 177.65 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' D' D ' 139' ' ' THR . . . . . . . . . . . . . 44.6 m -110.16 127.3 54.84 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 116.243 -0.435 . . . . 0.0 110.129 -179.896 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' D' D ' 140' ' ' LEU . . . . . 0.469 ' C ' HD23 ' D' ' 140' ' ' LEU . 8.1 tt -117.07 126.23 52.53 Favored 'General case' 0 C--N 1.329 -0.311 0 N-CA-C 109.498 -0.556 . . . . 0.0 109.498 -178.708 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' D' D ' 141' ' ' ILE . . . . . 0.494 ' HB ' HG23 ' D' ' 130' ' ' VAL . 19.1 mt -123.37 121.4 62.67 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.281 0 N-CA-C 109.733 -0.469 . . . . 0.0 109.733 -175.627 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' D' D ' 142' ' ' ARG . . . . . . . . . . . . . 29.5 ttp180 -115.66 128.07 55.64 Favored 'General case' 0 C--N 1.331 -0.212 0 CA-C-N 115.696 -0.683 . . . . 0.0 110.331 -177.205 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' D' D ' 143' ' ' THR . . . . . . . . . . . . . 35.4 p . . . . . 0 C--O 1.22 -0.487 0 CA-C-O 117.976 -1.011 . . . . 0.0 110.53 -179.7 . . . . . . . . 0 0 . 1 . 005 nuclear nobuild full ' E' E ' -3' ' ' GLU . . . . . . . . . . . . . 83.5 tt0 . . . . . 0 N--CA 1.491 1.599 0 N-CA-C 109.387 -0.597 . . . . 0.0 109.387 . . . . . . . . . 0 0 . 1 . 005 nuclear nobuild full ' E' E ' -2' ' ' GLY . . . . . . . . . . . . . . . -105.18 146.25 16.04 Favored Glycine 0 CA--C 1.525 0.708 0 N-CA-C 111.038 -0.825 . . . . 0.0 111.038 -179.639 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' E' E ' -1' ' ' VAL . . . . . . . . . . . . . 41.0 t -141.12 139.23 33.56 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.35 0 CA-C-O 120.854 0.359 . . . . 0.0 110.118 179.475 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' E' E ' 0' ' ' ILE . . . . . . . . . . . . . 69.4 mt -111.03 135.62 49.62 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.262 0 CA-C-N 116.09 -0.505 . . . . 0.0 109.779 -179.947 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' E' E ' 1' ' ' MET . . . . . . . . . . . . . 25.4 ptp -78.81 134.97 36.95 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-O 120.892 0.377 . . . . 0.0 110.909 -178.969 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' E' E ' 2' ' ' SER . . . . . . . . . . . . . 5.3 p -123.09 132.22 54.01 Favored 'General case' 0 C--N 1.331 -0.2 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.129 176.721 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' E' E ' 3' ' ' GLU . . . . . . . . . . . . . 84.9 tt0 -144.41 141.35 29.58 Favored 'General case' 0 C--N 1.327 -0.409 0 CA-C-N 116.198 -0.456 . . . . 0.0 111.182 -178.63 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' E' E ' 4' ' ' LEU . . . . . . . . . . . . . 20.1 tp -122.73 132.07 54.07 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-N 116.04 -0.527 . . . . 0.0 110.102 176.235 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' E' E ' 5' ' ' LYS . . . . . . . . . . . . . 50.2 mtmt -108.27 119.02 38.28 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 116.353 -0.385 . . . . 0.0 110.69 -179.604 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' E' E ' 6' ' ' LEU . . . . . . . . . . . . . 54.8 mt -114.15 142.19 46.55 Favored 'General case' 0 C--N 1.331 -0.229 0 O-C-N 123.86 0.725 . . . . 0.0 111.169 -178.165 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' E' E ' 7' ' ' LYS . . . . . . . . . . . . . 65.5 tttt -132.97 138.48 31.94 Favored Pre-proline 0 CA--C 1.534 0.356 0 CA-C-O 118.922 -0.561 . . . . 0.0 109.672 176.152 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' E' E ' 8' ' ' PRO . . . . . . . . . . . . . 78.1 Cg_endo -90.99 146.55 3.68 Favored 'Trans proline' 0 N--CA 1.49 1.317 0 C-N-CA 121.691 1.594 . . . . 0.0 112.083 178.671 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' E' E ' 9' ' ' LEU . . . . . . . . . . . . . 54.8 mt -86.0 -48.55 0.55 Allowed Pre-proline 0 CA--C 1.535 0.392 0 CA-C-O 118.518 -0.753 . . . . 0.0 112.499 -179.845 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' E' E ' 10' ' ' PRO . . . . . . . . . . . . . 95.6 Cg_endo -78.41 157.13 29.14 Favored 'Trans proline' 0 N--CA 1.496 1.645 0 C-N-CA 121.22 1.28 . . . . 0.0 112.002 178.651 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' E' E ' 11' ' ' LYS . . . . . . . . . . . . . 92.5 mttt -85.18 92.2 8.34 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.311 -0.404 . . . . 0.0 110.539 179.383 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' E' E ' 12' ' ' VAL . . . . . . . . . . . . . 12.6 p -142.5 143.42 25.93 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.281 0 CA-C-N 116.372 -0.376 . . . . 0.0 110.61 179.819 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' E' E ' 13' ' ' GLU . . . . . . . . . . . . . 41.7 mt-10 -93.28 132.49 37.42 Favored 'General case' 0 C--N 1.329 -0.307 0 N-CA-C 109.926 -0.398 . . . . 0.0 109.926 177.349 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' E' E ' 14' ' ' LEU . . . . . . . . . . . . . 21.2 mt -98.5 149.76 36.05 Favored Pre-proline 0 CA--C 1.534 0.342 0 CA-C-O 119.318 -0.373 . . . . 0.0 110.737 -176.351 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' E' E ' 15' ' ' PRO . . . . . . . . . . . . . 23.5 Cg_exo -64.26 161.21 35.16 Favored 'Trans proline' 0 N--CA 1.498 1.791 0 C-N-CA 121.291 1.328 . . . . 0.0 111.971 175.841 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' E' E ' 16' ' ' PRO . . . . . . . . . . . . . 29.7 Cg_exo -59.9 -34.81 95.16 Favored 'Trans proline' 0 N--CA 1.498 1.774 0 C-N-CA 121.451 1.434 . . . . 0.0 112.938 -178.536 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' E' E ' 17' ' ' ASP . . . . . . . . . . . . . 16.5 p-10 -83.91 0.99 45.53 Favored 'General case' 0 CA--C 1.538 0.488 0 N-CA-C 113.375 0.88 . . . . 0.0 113.375 -177.738 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' E' E ' 18' ' ' PHE . . . . . . . . . . . . . 45.9 t80 -57.92 -42.27 84.46 Favored 'General case' 0 C--N 1.333 -0.124 0 O-C-N 121.938 -0.476 . . . . 0.0 110.228 -177.426 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' E' E ' 19' ' ' VAL . . . . . . . . . . . . . 46.7 t -56.19 -45.74 81.05 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.244 0 CA-C-N 116.44 -0.346 . . . . 0.0 110.62 -178.003 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' E' E ' 20' ' ' ASP . . . . . . . . . . . . . 81.3 m-20 -60.14 -40.18 88.92 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-O 120.833 0.349 . . . . 0.0 110.936 -178.217 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' E' E ' 21' ' ' VAL . . . . . . . . . . . . . 46.2 t -63.78 -47.02 92.8 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.265 0 C-N-CA 120.675 -0.41 . . . . 0.0 110.381 -178.262 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' E' E ' 22' ' ' ILE . . . . . 0.642 HG22 HD12 ' E' ' 26' ' ' LEU . 51.7 mm -55.28 -46.74 78.22 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.274 0 C-N-CA 121.131 -0.228 . . . . 0.0 110.771 179.304 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' E' E ' 23' ' ' ARG . . . . . . . . . . . . . 34.6 ttp180 -54.42 -49.36 70.14 Favored 'General case' 0 C--N 1.33 -0.267 0 C-N-CA 121.023 -0.271 . . . . 0.0 111.454 -178.841 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' E' E ' 24' ' ' ILE . . . . . . . . . . . . . 70.3 mt -59.88 -44.13 93.6 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.257 0 CA-C-N 116.549 -0.296 . . . . 0.0 111.223 -177.172 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' E' E ' 25' ' ' LYS . . . . . . . . . . . . . 50.9 mmtt -64.46 -41.85 96.28 Favored 'General case' 0 C--N 1.328 -0.336 0 N-CA-C 112.406 0.521 . . . . 0.0 112.406 -178.027 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' E' E ' 26' ' ' LEU . . . . . 0.642 HD12 HG22 ' E' ' 22' ' ' ILE . 28.8 mt -78.54 -41.59 31.76 Favored 'General case' 0 C--N 1.33 -0.269 0 N-CA-C 113.252 0.834 . . . . 0.0 113.252 -171.181 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' E' E ' 27' ' ' GLN . . . . . . . . . . . . . 10.2 pt20 -46.58 139.03 5.4 Favored 'General case' 0 N--CA 1.469 0.502 0 N-CA-C 112.787 0.662 . . . . 0.0 112.787 -175.056 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' E' E ' 28' ' ' GLY . . . . . . . . . . . . . . . 98.77 -27.04 21.61 Favored Glycine 0 CA--C 1.533 1.174 0 CA-C-N 115.528 -0.76 . . . . 0.0 112.226 -177.247 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' E' E ' 29' ' ' LYS . . . . . . . . . . . . . 46.0 mtmt -98.12 155.16 17.28 Favored 'General case' 0 C--N 1.331 -0.203 0 CA-C-N 117.168 0.484 . . . . 0.0 111.182 179.35 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' E' E ' 30' ' ' THR . . . . . . . . . . . . . 28.8 m -104.15 137.71 41.7 Favored 'General case' 0 C--N 1.331 -0.222 0 CA-C-N 115.908 -0.587 . . . . 0.0 110.149 175.957 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' E' E ' 31' ' ' VAL . . . . . . . . . . . . . 35.2 m -130.6 153.51 39.18 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 CA-C-N 116.361 -0.381 . . . . 0.0 110.94 -178.709 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' E' E ' 32' ' ' ARG . . . . . . . . . . . . . 87.8 mtm-85 -128.1 149.21 50.51 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.138 -0.483 . . . . 0.0 110.653 179.432 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' E' E ' 33' ' ' THR . . . . . . . . . . . . . 29.9 m -53.46 139.22 31.51 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.372 -0.376 . . . . 0.0 111.376 -178.524 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' E' E ' 34' ' ' GLY . . . . . . . . . . . . . . . 99.35 -17.14 58.24 Favored Glycine 0 CA--C 1.532 1.111 0 CA-C-O 119.707 -0.496 . . . . 0.0 113.312 179.217 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' E' E ' 35' ' ' ASP . . . . . . . . . . . . . 77.8 m-20 -66.3 148.62 51.58 Favored 'General case' 0 C--O 1.231 0.129 0 CA-C-N 118.02 0.91 . . . . 0.0 111.078 179.189 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' E' E ' 36' ' ' VAL . . . . . . . . . . . . . 43.9 t -119.91 129.68 75.13 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.2 0 CA-C-N 115.78 -0.645 . . . . 0.0 109.822 178.267 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' E' E ' 37' ' ' ILE . . . . . . . . . . . . . 67.5 mt -116.88 137.51 50.53 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.272 0 N-CA-C 109.739 -0.467 . . . . 0.0 109.739 179.437 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' E' E ' 38' ' ' GLY . . . . . . . . . . . . . . . -114.72 128.67 8.26 Favored Glycine 0 CA--C 1.525 0.672 0 N-CA-C 111.143 -0.783 . . . . 0.0 111.143 -179.164 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' E' E ' 39' ' ' ILE . . . . . . . . . . . . . 77.2 mt -122.41 134.4 65.73 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.249 0 N-CA-C 109.974 -0.38 . . . . 0.0 109.974 178.787 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' E' E ' 40' ' ' SER . . . . . . . . . . . . . 59.8 p -92.74 119.04 31.72 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.441 -0.345 . . . . 0.0 110.829 175.7 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' E' E ' 41' ' ' ILE . . . . . . . . . . . . . 72.3 mt -126.37 122.23 60.76 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.215 0 CA-C-N 116.553 -0.294 . . . . 0.0 110.32 178.652 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' E' E ' 42' ' ' LEU . . . . . . . . . . . . . 44.4 mt 52.11 34.25 13.8 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.251 -0.431 . . . . 0.0 111.853 177.675 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' E' E ' 43' ' ' GLY . . . . . . . . . . . . . . . 72.23 33.2 62.05 Favored Glycine 0 CA--C 1.529 0.935 0 C-N-CA 121.053 -0.594 . . . . 0.0 111.796 179.002 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' E' E ' 44' ' ' LYS . . . . . . . . . . . . . 44.2 tttp -138.35 128.76 26.13 Favored 'General case' 0 C--N 1.328 -0.33 0 N-CA-C 109.696 -0.483 . . . . 0.0 109.696 179.711 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' E' E ' 45' ' ' GLU . . . . . . . . . . . . . 83.7 tt0 -83.03 121.78 27.46 Favored 'General case' 0 C--N 1.328 -0.347 0 C-N-CA 120.786 -0.366 . . . . 0.0 111.127 -177.639 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' E' E ' 46' ' ' VAL . . . . . . . . . . . . . 7.5 p -119.94 125.88 74.73 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.194 0 N-CA-C 109.298 -0.63 . . . . 0.0 109.298 175.087 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' E' E ' 47' ' ' LYS . . . . . . . . . . . . . 96.5 mttt -100.87 129.78 46.78 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 115.964 -0.562 . . . . 0.0 111.437 179.442 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' E' E ' 48' ' ' PHE . . . . . . . . . . . . . 91.7 m-85 -112.73 131.81 55.5 Favored 'General case' 0 C--N 1.33 -0.253 0 N-CA-C 109.612 -0.514 . . . . 0.0 109.612 174.507 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' E' E ' 49' ' ' LYS . . . . . . . . . . . . . 68.5 tttt -107.87 137.42 45.91 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.643 -0.253 . . . . 0.0 110.715 179.817 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' E' E ' 50' ' ' VAL . . . . . . . . . . . . . 46.7 t -81.04 106.57 12.37 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.281 0 N-CA-C 109.175 -0.676 . . . . 0.0 109.175 175.148 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' E' E ' 51' ' ' VAL . . . . . . . . . . . . . 48.0 t -69.68 -53.99 21.64 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.324 0 N-CA-C 109.479 -0.563 . . . . 0.0 109.479 -176.302 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' E' E ' 52' ' ' GLN . . . . . . . . . . . . . 93.7 mt-30 -152.53 154.55 35.67 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.097 -0.501 . . . . 0.0 111.714 -179.226 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' E' E ' 53' ' ' ALA . . . . . 0.41 ' HB1' ' HB2' ' E' ' 58' ' ' LEU . . . -130.49 132.33 45.59 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 115.168 -0.924 . . . . 0.0 109.764 176.056 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' E' E ' 54' ' ' TYR . . . . . . . . . . . . . 57.9 t80 -129.1 108.82 18.04 Favored Pre-proline 0 CA--C 1.534 0.351 0 CA-C-O 118.312 -0.851 . . . . 0.0 110.368 -179.767 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' E' E ' 55' ' ' PRO . . . . . . . . . . . . . 73.8 Cg_endo -77.21 170.03 72.57 Favored 'Cis proline' 0 N--CA 1.499 1.813 0 CA-C-N 121.808 1.682 . . . . 0.0 112.583 -5.154 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' E' E ' 56' ' ' SER . . . . . . . . . . . . . 13.8 m -116.12 128.97 25.57 Favored Pre-proline 0 CA--C 1.539 0.53 0 CA-C-O 118.356 -0.83 . . . . 0.0 109.139 174.425 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' E' E ' 57' ' ' PRO . . . . . . . . . . . . . 54.3 Cg_endo -70.7 149.63 91.18 Favored 'Cis proline' 0 N--CA 1.497 1.684 0 CA-C-N 121.993 1.747 . . . . 0.0 111.733 0.454 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' E' E ' 58' ' ' LEU . . . . . 0.41 ' HB2' ' HB1' ' E' ' 53' ' ' ALA . 25.3 tp -108.39 136.53 47.86 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.572 -179.426 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' E' E ' 59' ' ' ARG . . . . . . . . . . . . . 72.8 ttt180 -104.55 125.96 51.19 Favored 'General case' 0 C--N 1.326 -0.438 0 N-CA-C 109.14 -0.689 . . . . 0.0 109.14 176.0 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' E' E ' 60' ' ' VAL . . . . . . . . . . . . . 45.8 t -80.44 118.07 27.48 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.213 0 C-N-CA 120.521 -0.471 . . . . 0.0 110.48 -174.765 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' E' E ' 61' ' ' GLU . . . . . . . . . . . . . 95.0 mt-10 -131.02 162.81 28.97 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 115.786 -0.643 . . . . 0.0 109.563 176.326 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' E' E ' 62' ' ' ASP . . . . . . . . . . . . . 21.1 p-10 -56.27 -33.12 65.17 Favored 'General case' 0 C--N 1.328 -0.328 0 N-CA-C 111.854 0.316 . . . . 0.0 111.854 -177.15 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' E' E ' 63' ' ' ARG . . . . . . . . . . . . . 27.1 mmm180 -73.31 -17.36 61.32 Favored 'General case' 0 CA--C 1.533 0.317 0 N-CA-C 113.178 0.807 . . . . 0.0 113.178 -177.08 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' E' E ' 64' ' ' THR . . . . . . . . . . . . . 25.7 m -70.07 139.25 52.56 Favored 'General case' 0 C--N 1.332 -0.156 0 CA-C-O 120.865 0.364 . . . . 0.0 110.987 -175.235 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' E' E ' 65' ' ' LYS . . . . . . . . . . . . . 64.4 mttm -86.06 133.94 33.86 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.041 -0.527 . . . . 0.0 109.922 178.167 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' E' E ' 66' ' ' ILE . . . . . . . . . . . . . 64.3 mt -114.31 125.59 71.65 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.29 0 N-CA-C 109.57 -0.53 . . . . 0.0 109.57 178.839 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' E' E ' 67' ' ' THR . . . . . . . . . . . . . 29.5 m -118.12 137.53 52.89 Favored 'General case' 0 C--N 1.331 -0.213 0 CA-C-N 116.06 -0.518 . . . . 0.0 110.555 -178.013 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' E' E ' 68' ' ' LEU . . . . . . . . . . . . . 19.6 tp -107.29 143.47 35.51 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 115.79 -0.641 . . . . 0.0 110.466 -179.222 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' E' E ' 69' ' ' VAL . . . . . . . . . . . . . 48.3 t -82.77 155.15 3.88 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.359 0 N-CA-C 109.027 -0.731 . . . . 0.0 109.027 175.322 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' E' E ' 70' ' ' THR . . . . . . . . . . . . . 73.8 p -76.05 153.47 36.39 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-O 121.347 0.594 . . . . 0.0 110.909 -169.892 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' E' E ' 71' ' ' HIS . . . . . . . . . . . . . 46.9 m-70 -96.49 172.24 5.33 Favored Pre-proline 0 C--N 1.329 -0.283 0 CA-C-N 115.09 -0.959 . . . . 0.0 111.159 -174.084 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' E' E ' 72' ' ' PRO . . . . . . . . . . . . . 22.7 Cg_exo -64.85 160.16 42.31 Favored 'Trans proline' 0 N--CA 1.493 1.498 0 C-N-CA 121.543 1.495 . . . . 0.0 111.226 174.399 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' E' E ' 73' ' ' VAL . . . . . . . . . . . . . 34.2 m -69.88 -179.74 0.31 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.331 0 CA-C-N 116.316 -0.402 . . . . 0.0 110.597 -174.565 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' E' E ' 74' ' ' ASP . . . . . . . . . . . . . 33.7 t0 -86.46 117.59 25.35 Favored 'General case' 0 C--N 1.33 -0.259 0 C-N-CA 120.933 -0.307 . . . . 0.0 110.187 -173.862 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' E' E ' 75' ' ' VAL . . . . . . . . . . . . . 46.4 t -117.28 120.78 65.99 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.235 0 CA-C-O 121.126 0.489 . . . . 0.0 110.191 -178.439 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' E' E ' 76' ' ' LEU . . . . . . . . . . . . . 15.7 mt -123.32 142.22 51.17 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 115.559 -0.746 . . . . 0.0 109.502 178.688 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' E' E ' 77' ' ' GLU . . . . . . . . . . . . . 97.1 mt-10 -135.4 129.58 33.53 Favored 'General case' 0 C--N 1.331 -0.227 0 CA-C-O 121.064 0.459 . . . . 0.0 111.058 -177.221 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' E' E ' 78' ' ' ALA . . . . . 0.606 ' HB2' HD21 ' E' ' 109' ' ' LEU . . . -116.25 126.54 53.73 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 115.649 -0.705 . . . . 0.0 109.586 177.24 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' E' E ' 79' ' ' LYS . . . . . 0.436 ' O ' HD13 ' E' ' 80' ' ' ILE . 48.0 pttt -76.72 119.18 20.16 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-O 121.284 0.564 . . . . 0.0 110.962 -177.386 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' E' E ' 80' ' ' ILE . . . . . 0.436 HD13 ' O ' ' E' ' 79' ' ' LYS . 26.8 mm -139.25 106.11 2.71 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.244 0 CA-C-N 115.563 -0.744 . . . . 0.0 109.09 -178.932 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' E' E ' 81' ' ' LYS . . . . . . . . . . . . . 53.1 mtmt -99.5 129.19 45.65 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-O 120.925 0.393 . . . . 0.0 110.865 -178.678 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' E' E ' 82' ' ' GLY . . . . . . . . . . . . . . . 89.16 42.18 5.65 Favored Glycine 0 CA--C 1.525 0.666 0 C-N-CA 120.915 -0.66 . . . . 0.0 111.701 175.423 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' E' E ' 83' ' ' ILE . . . . . . . . . . . . . 75.2 mt -67.95 138.16 23.16 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.302 0 N-CA-C 109.771 -0.455 . . . . 0.0 109.771 176.48 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' E' E ' 84' ' ' LYS . . . . . . . . . . . . . 58.6 tttp -95.06 -52.76 4.08 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.122 -0.49 . . . . 0.0 109.956 -179.702 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' E' E ' 85' ' ' ASP . . . . . . . . . . . . . 6.5 t70 -155.72 153.58 30.15 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 115.792 -0.64 . . . . 0.0 110.371 -179.458 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' E' E ' 86' ' ' VAL . . . . . . . . . . . . . 43.0 t -130.29 132.67 64.86 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.258 0 CA-C-O 120.991 0.424 . . . . 0.0 110.498 -179.628 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' E' E ' 87' ' ' ILE . . . . . . . . . . . . . 45.2 mm -116.95 125.72 74.0 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.252 0 CA-C-N 115.722 -0.672 . . . . 0.0 109.55 176.745 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' E' E ' 88' ' ' LEU . . . . . 0.499 HD21 ' NH1' ' D' ' 126' ' ' ARG . 16.8 tp -110.11 129.87 55.63 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-O 120.852 0.358 . . . . 0.0 110.946 -177.436 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' E' E ' 89' ' ' ASP . . . . . . . . . . . . . 13.9 t70 -125.47 155.7 40.08 Favored 'General case' 0 C--N 1.331 -0.221 0 CA-C-N 116.085 -0.507 . . . . 0.0 109.936 177.637 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' E' E ' 90' ' ' GLU . . . . . . . . . . . . . 45.3 tp10 -45.84 -38.84 7.75 Favored 'General case' 0 C--N 1.33 -0.282 0 N-CA-C 113.132 0.79 . . . . 0.0 113.132 -172.167 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' E' E ' 91' ' ' ASN . . . . . . . . . . . . . 20.9 t30 -132.04 22.37 4.52 Favored 'General case' 0 N--CA 1.468 0.462 0 N-CA-C 112.87 0.692 . . . . 0.0 112.87 -177.147 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' E' E ' 92' ' ' LEU . . . . . 0.413 HD12 ' O ' ' E' ' 127' ' ' ASN . 10.2 mt -149.48 147.14 27.87 Favored 'General case' 0 C--N 1.332 -0.167 0 N-CA-C 110.191 -0.3 . . . . 0.0 110.191 -177.025 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' E' E ' 93' ' ' ILE . . . . . . . . . . . . . 67.6 mt -124.34 119.57 56.88 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.203 0 N-CA-C 109.199 -0.667 . . . . 0.0 109.199 176.213 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' E' E ' 94' ' ' VAL . . . . . . . . . . . . . 45.7 t -118.84 127.44 75.74 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.252 0 N-CA-C 109.849 -0.426 . . . . 0.0 109.849 -179.482 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' E' E ' 95' ' ' VAL . . . . . . . . . . . . . 44.0 t -123.99 135.8 62.38 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.324 0 CA-C-N 116.135 -0.484 . . . . 0.0 110.177 -178.404 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' E' E ' 96' ' ' ILE . . . . . . . . . . . . . 57.7 mt -117.19 129.19 74.12 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.287 0 N-CA-C 109.269 -0.641 . . . . 0.0 109.269 178.117 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' E' E ' 97' ' ' THR . . . . . . . . . . . . . 78.5 p -103.63 158.16 16.56 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-O 121.185 0.517 . . . . 0.0 111.282 -177.431 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' E' E ' 98' ' ' GLU . . . . . . . . . . . . . 70.6 mm-40 -54.23 -25.62 24.12 Favored 'General case' 0 C--N 1.33 -0.247 0 N-CA-C 112.408 0.521 . . . . 0.0 112.408 -179.754 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' E' E ' 99' ' ' GLU . . . . . . . . . . . . . 47.2 mp0 -78.19 14.33 1.21 Allowed 'General case' 0 CA--C 1.535 0.402 0 N-CA-C 113.136 0.791 . . . . 0.0 113.136 -178.032 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' E' E ' 100' ' ' ASN . . . . . . . . . . . . . 3.6 m-20 62.21 37.33 14.32 Favored 'General case' 0 CA--C 1.53 0.201 0 CA-C-O 120.994 0.426 . . . . 0.0 110.997 178.741 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' E' E ' 101' ' ' GLU . . . . . . . . . . . . . 84.7 tt0 -113.99 144.14 43.58 Favored 'General case' 0 C--N 1.331 -0.198 0 CA-C-N 116.02 -0.536 . . . . 0.0 109.735 176.244 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' E' E ' 102' ' ' VAL . . . . . . . . . . . . . 44.3 t -114.98 126.0 72.45 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.299 0 CA-C-N 116.225 -0.443 . . . . 0.0 109.914 -178.803 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' E' E ' 103' ' ' LEU . . . . . . . . . . . . . 21.5 mt -118.29 132.08 56.31 Favored 'General case' 0 C--N 1.331 -0.217 0 CA-C-N 115.662 -0.699 . . . . 0.0 110.31 178.778 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' E' E ' 104' ' ' ILE . . . . . . . . . . . . . 69.7 mt -120.14 123.57 70.96 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.266 0 N-CA-C 110.063 -0.347 . . . . 0.0 110.063 178.601 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' E' E ' 105' ' ' PHE . . . . . . . . . . . . . 70.8 m-85 -124.88 162.43 24.41 Favored 'General case' 0 C--N 1.333 -0.15 0 O-C-N 123.848 0.718 . . . . 0.0 109.89 179.336 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' E' E ' 106' ' ' ASN . . . . . . . . . . . . . 46.0 p-10 -97.22 -170.46 2.03 Favored 'General case' 0 C--N 1.33 -0.266 0 N-CA-C 109.981 -0.377 . . . . 0.0 109.981 174.143 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' E' E ' 107' ' ' GLN . . . . . . . . . . . . . 55.6 tp60 -59.71 -30.07 68.55 Favored 'General case' 0 CA--C 1.531 0.214 0 N-CA-C 111.911 0.337 . . . . 0.0 111.911 179.911 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' E' E ' 108' ' ' ASN . . . . . . . . . . . . . 52.0 t30 -81.92 8.21 11.01 Favored 'General case' 0 CA--C 1.535 0.384 0 N-CA-C 113.109 0.781 . . . . 0.0 113.109 -177.601 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' E' E ' 109' ' ' LEU . . . . . 0.606 HD21 ' HB2' ' E' ' 78' ' ' ALA . 12.7 tp 58.39 38.79 25.75 Favored 'General case' 0 C--N 1.332 -0.183 0 CA-C-O 121.105 0.479 . . . . 0.0 110.901 179.339 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' E' E ' 110' ' ' GLU . . . . . . . . . . . . . 70.8 mm-40 -105.23 149.14 26.22 Favored 'General case' 0 C--N 1.332 -0.192 0 N-CA-C 109.925 -0.398 . . . . 0.0 109.925 176.798 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' E' E ' 111' ' ' GLU . . . . . . . . . . . . . 84.5 tt0 -78.39 121.83 25.01 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 116.419 -0.355 . . . . 0.0 110.616 -177.402 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' E' E ' 112' ' ' LEU . . . . . . . . . . . . . 18.4 mt -110.17 -46.11 3.49 Favored 'General case' 0 C--N 1.331 -0.21 0 CA-C-N 116.283 -0.417 . . . . 0.0 110.697 179.174 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' E' E ' 113' ' ' TYR . . . . . . . . . . . . . 64.3 t80 -138.89 136.27 35.35 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.262 -0.426 . . . . 0.0 111.045 -179.147 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' E' E ' 114' ' ' ARG . . . . . . . . . . . . . 70.1 ttp85 -138.53 120.37 15.37 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-N 116.025 -0.534 . . . . 0.0 110.277 176.695 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' E' E ' 115' ' ' GLY . . . . . . . . . . . . . . . -150.14 145.65 13.95 Favored Glycine 0 CA--C 1.524 0.641 0 N-CA-C 110.842 -0.903 . . . . 0.0 110.842 178.118 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' E' E ' 116' ' ' LYS . . . . . . . . . . . . . 28.4 ttmt -115.26 136.59 52.95 Favored 'General case' 0 C--N 1.331 -0.23 0 O-C-N 122.565 -0.374 . . . . 0.0 110.171 177.94 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' E' E ' 117' ' ' PHE . . . . . . . . . . . . . 58.5 m-85 -131.46 117.37 18.74 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 116.15 -0.477 . . . . 0.0 110.129 -177.018 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' E' E ' 118' ' ' GLU . . . . . . . . . . . . . 96.2 mt-10 -54.43 -41.64 69.6 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.507 -0.315 . . . . 0.0 111.486 -175.31 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' E' E ' 119' ' ' ASN . . . . . . . . . . . . . 19.0 m120 -104.05 31.1 4.73 Favored 'General case' 0 C--N 1.33 -0.249 0 N-CA-C 112.129 0.418 . . . . 0.0 112.129 -173.885 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' E' E ' 120' ' ' LEU . . . . . . . . . . . . . 21.3 tp -56.65 123.29 14.36 Favored 'General case' 0 C--N 1.332 -0.16 0 C-N-CA 121.118 -0.233 . . . . 0.0 110.412 178.555 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' E' E ' 121' ' ' ASN . . . . . . . . . . . . . 27.2 m120 -114.13 -44.28 3.15 Favored 'General case' 0 N--CA 1.462 0.165 0 CA-C-N 116.759 -0.201 . . . . 0.0 111.353 -176.829 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' E' E ' 122' ' ' LYS . . . . . . . . . . . . . 94.4 mttt -147.73 151.52 36.23 Favored 'General case' 0 C--N 1.332 -0.191 0 CA-C-O 121.03 0.443 . . . . 0.0 111.715 -176.963 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' E' E ' 123' ' ' VAL . . . . . . . . . . . . . 42.7 t -132.91 133.13 59.14 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.181 0 N-CA-C 109.633 -0.506 . . . . 0.0 109.633 175.249 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' E' E ' 124' ' ' LEU . . . . . . . . . . . . . 69.9 mt -130.09 137.72 50.33 Favored 'General case' 0 C--N 1.331 -0.197 0 CA-C-N 116.452 -0.34 . . . . 0.0 110.842 -178.772 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' E' E ' 125' ' ' VAL . . . . . . . . . . . . . 11.8 p -136.95 137.17 47.24 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.262 0 CA-C-N 116.385 -0.37 . . . . 0.0 110.651 179.669 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' E' E ' 126' ' ' ARG . . . . . . . . . . . . . 83.3 mtt180 -146.06 130.28 17.54 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.679 177.226 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' E' E ' 127' ' ' ASN . . . . . 0.413 ' O ' HD12 ' E' ' 92' ' ' LEU . 36.3 t30 50.64 -112.22 0.59 Allowed 'General case' 0 CA--C 1.545 0.761 0 CA-C-O 118.64 -0.695 . . . . 0.0 111.46 178.751 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' E' E ' 128' ' ' ASP . . . . . . . . . . . . . 17.3 p-10 -112.59 8.16 19.07 Favored 'General case' 0 N--CA 1.468 0.435 0 CA-C-N 120.157 1.344 . . . . 0.0 113.317 -177.317 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' E' E ' 129' ' ' LEU . . . . . . . . . . . . . 15.5 tp -116.38 137.49 52.11 Favored 'General case' 0 C--N 1.333 -0.139 0 N-CA-C 109.745 -0.465 . . . . 0.0 109.745 178.89 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' E' E ' 130' ' ' VAL . . . . . 0.532 HG13 ' HB ' ' E' ' 141' ' ' ILE . 12.7 p -132.62 143.39 39.86 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.198 0 CA-C-O 121.143 0.497 . . . . 0.0 110.563 -179.556 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' E' E ' 131' ' ' VAL . . . . . . . . . . . . . 39.3 t -135.53 140.72 44.08 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.246 0 CA-C-N 115.969 -0.559 . . . . 0.0 110.383 -178.941 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' E' E ' 132' ' ' ILE . . . . . . . . . . . . . 70.3 mt -115.93 132.86 64.17 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.316 0 CA-C-N 115.752 -0.658 . . . . 0.0 109.355 179.292 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' E' E ' 133' ' ' ILE . . . . . . . . . . . . . 41.9 mm -116.24 124.15 72.18 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.238 0 CA-C-O 120.896 0.379 . . . . 0.0 111.064 -175.061 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' E' E ' 134' ' ' ASP . . . . . . . . . . . . . 7.8 p-10 -135.35 149.76 49.79 Favored 'General case' 0 C--N 1.331 -0.205 0 CA-C-N 116.075 -0.511 . . . . 0.0 109.677 174.574 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' E' E ' 135' ' ' GLU . . . . . . . . . . . . . 40.2 tp10 -50.76 -28.38 9.09 Favored 'General case' 0 C--N 1.327 -0.377 0 N-CA-C 112.709 0.633 . . . . 0.0 112.709 -173.088 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' E' E ' 136' ' ' GLN . . . . . . . . . . . . . 98.3 mt-30 -84.55 -29.82 25.58 Favored 'General case' 0 C--O 1.233 0.229 0 N-CA-C 112.882 0.697 . . . . 0.0 112.882 -175.432 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' E' E ' 137' ' ' LYS . . . . . . . . . . . . . 58.9 pttt -168.86 175.35 5.98 Favored 'General case' 0 C--N 1.332 -0.171 0 CA-C-O 121.609 0.719 . . . . 0.0 112.449 -172.879 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' E' E ' 138' ' ' LEU . . . . . 0.457 ' C ' HD23 ' E' ' 138' ' ' LEU . 8.6 tt -121.62 129.42 52.81 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 114.997 -1.001 . . . . 0.0 109.958 178.475 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' E' E ' 139' ' ' THR . . . . . . . . . . . . . 43.7 m -109.1 128.22 54.82 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.188 179.316 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' E' E ' 140' ' ' LEU . . . . . 0.48 ' C ' HD23 ' E' ' 140' ' ' LEU . 7.2 tt -112.81 125.25 54.14 Favored 'General case' 0 C--N 1.328 -0.35 0 N-CA-C 109.174 -0.676 . . . . 0.0 109.174 -178.828 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' E' E ' 141' ' ' ILE . . . . . 0.532 ' HB ' HG13 ' E' ' 130' ' ' VAL . 19.4 mt -123.57 119.29 56.86 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.277 0 CA-C-O 121.132 0.492 . . . . 0.0 110.09 -176.469 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' E' E ' 142' ' ' ARG . . . . . . . . . . . . . 77.6 ttt-85 -106.39 130.0 54.28 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 115.001 -1.0 . . . . 0.0 110.226 -179.882 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' E' E ' 143' ' ' THR . . . . . . . . . . . . . 44.6 p . . . . . 0 C--O 1.219 -0.514 0 CA-C-O 117.959 -1.02 . . . . 0.0 110.547 179.112 . . . . . . . . 0 0 . 1 . 005 nuclear nobuild full ' F' F ' -3' ' ' GLU . . . . . . . . . . . . . 45.8 tp10 . . . . . 0 N--CA 1.489 1.505 0 N-CA-C 109.332 -0.618 . . . . 0.0 109.332 . . . . . . . . . 0 0 . 1 . 005 nuclear nobuild full ' F' F ' -2' ' ' GLY . . . . . . . . . . . . . . . -67.57 140.2 36.52 Favored Glycine 0 CA--C 1.524 0.63 0 N-CA-C 111.223 -0.751 . . . . 0.0 111.223 -178.651 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' F' F ' -1' ' ' VAL . . . . . . . . . . . . . 44.7 t -141.57 140.34 31.16 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.292 0 N-CA-C 110.079 -0.341 . . . . 0.0 110.079 179.603 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' F' F ' 0' ' ' ILE . . . . . . . . . . . . . 43.7 mm -110.64 136.11 47.68 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.295 0 CA-C-N 116.236 -0.438 . . . . 0.0 110.186 -179.742 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' F' F ' 1' ' ' MET . . . . . . . . . . . . . 26.2 ptt? -82.39 137.12 34.82 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.276 -0.42 . . . . 0.0 110.957 -179.212 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' F' F ' 2' ' ' SER . . . . . . . . . . . . . 14.3 p -130.8 135.33 47.65 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.083 -0.508 . . . . 0.0 110.082 178.419 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' F' F ' 3' ' ' GLU . . . . . . . . . . . . . 46.8 mp0 -139.45 141.15 37.45 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.146 -0.479 . . . . 0.0 111.321 -176.615 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' F' F ' 4' ' ' LEU . . . . . . . . . . . . . 57.6 mt -118.94 124.97 48.35 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 115.606 -0.725 . . . . 0.0 109.85 173.96 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' F' F ' 5' ' ' LYS . . . . . . . . . . . . . 98.3 mttt -102.36 119.81 39.44 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.459 -0.337 . . . . 0.0 110.144 177.646 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' F' F ' 6' ' ' LEU . . . . . . . . . . . . . 70.5 mt -119.45 144.32 47.03 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 115.416 -0.811 . . . . 0.0 110.421 -177.9 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' F' F ' 7' ' ' LYS . . . . . . . . . . . . . 47.4 tttm -134.64 142.78 43.86 Favored Pre-proline 0 CA--C 1.534 0.354 0 CA-C-O 119.2 -0.428 . . . . 0.0 110.142 177.331 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' F' F ' 8' ' ' PRO . . . . . . . . . . . . . 85.0 Cg_endo -92.16 143.35 2.63 Favored 'Trans proline' 0 N--CA 1.49 1.319 0 C-N-CA 121.749 1.633 . . . . 0.0 111.714 176.997 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' F' F ' 9' ' ' LEU . . . . . . . . . . . . . 62.0 mt -76.74 -47.02 3.04 Favored Pre-proline 0 CA--C 1.535 0.367 0 CA-C-O 118.691 -0.671 . . . . 0.0 112.041 179.735 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' F' F ' 10' ' ' PRO . . . . . . . . . . . . . 85.4 Cg_endo -81.71 150.2 16.5 Favored 'Trans proline' 0 N--CA 1.495 1.59 0 C-N-CA 121.185 1.257 . . . . 0.0 111.54 174.604 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' F' F ' 11' ' ' LYS . . . . . . . . . . . . . 54.0 pttt -86.95 113.12 22.45 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-O 121.552 0.692 . . . . 0.0 110.949 179.981 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' F' F ' 12' ' ' VAL . . . . . . . . . . . . . 13.3 p -151.09 148.34 14.99 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.194 0 CA-C-N 115.736 -0.666 . . . . 0.0 110.458 178.901 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' F' F ' 13' ' ' GLU . . . . . . . . . . . . . 45.3 mt-10 -88.0 124.19 33.48 Favored 'General case' 0 C--N 1.331 -0.224 0 CA-C-O 120.759 0.314 . . . . 0.0 110.595 177.836 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' F' F ' 14' ' ' LEU . . . . . . . . . . . . . 22.8 mt -99.77 154.61 37.16 Favored Pre-proline 0 CA--C 1.532 0.285 0 CA-C-N 116.276 -0.42 . . . . 0.0 111.012 -178.282 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' F' F ' 15' ' ' PRO . . . . . . . . . . . . . 27.7 Cg_exo -62.05 162.99 20.83 Favored 'Trans proline' 0 N--CA 1.498 1.736 0 C-N-CA 121.423 1.415 . . . . 0.0 111.963 176.07 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' F' F ' 16' ' ' PRO . . . . . . . . . . . . . 21.5 Cg_exo -64.61 -37.07 39.07 Favored 'Trans proline' 0 N--CA 1.497 1.705 0 C-N-CA 121.592 1.528 . . . . 0.0 112.724 -179.512 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' F' F ' 17' ' ' ASP . . . . . . . . . . . . . 12.7 p-10 -87.09 12.11 12.25 Favored 'General case' 0 CA--C 1.535 0.391 0 N-CA-C 113.142 0.793 . . . . 0.0 113.142 -177.149 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' F' F ' 18' ' ' PHE . . . . . . . . . . . . . 41.1 t80 -56.44 -41.85 77.15 Favored 'General case' 0 CA--C 1.526 0.047 0 O-C-N 121.939 -0.476 . . . . 0.0 110.375 -179.56 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' F' F ' 19' ' ' VAL . . . . . . . . . . . . . 44.3 t -55.98 -43.51 75.28 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.285 0 CA-C-N 116.399 -0.364 . . . . 0.0 110.579 -178.627 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' F' F ' 20' ' ' ASP . . . . . . . . . . . . . 29.8 t0 -59.88 -43.09 94.95 Favored 'General case' 0 C--N 1.33 -0.274 0 C-N-CA 120.915 -0.314 . . . . 0.0 110.784 -177.811 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' F' F ' 21' ' ' VAL . . . . . . . . . . . . . 45.4 t -63.33 -46.44 95.51 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.277 0 C-N-CA 120.63 -0.428 . . . . 0.0 110.437 -177.748 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' F' F ' 22' ' ' ILE . . . . . 0.437 HG22 ' CD1' ' F' ' 26' ' ' LEU . 51.4 mm -55.98 -47.11 80.54 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.275 0 C-N-CA 120.905 -0.318 . . . . 0.0 110.808 179.793 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' F' F ' 23' ' ' ARG . . . . . . . . . . . . . 55.4 ttp180 -55.02 -47.19 75.03 Favored 'General case' 0 C--N 1.331 -0.239 0 C-N-CA 120.932 -0.307 . . . . 0.0 111.303 -178.194 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' F' F ' 24' ' ' ILE . . . . . . . . . . . . . 75.5 mt -59.17 -42.58 87.23 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.268 0 C-N-CA 120.939 -0.304 . . . . 0.0 111.212 -177.672 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' F' F ' 25' ' ' LYS . . . . . . . . . . . . . 50.3 mttm -67.74 -39.57 84.23 Favored 'General case' 0 C--N 1.33 -0.266 0 N-CA-C 112.67 0.619 . . . . 0.0 112.67 -179.51 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' F' F ' 26' ' ' LEU . . . . . 0.437 ' CD1' HG22 ' F' ' 22' ' ' ILE . 95.8 mt -77.37 -39.85 45.96 Favored 'General case' 0 C--N 1.329 -0.307 0 N-CA-C 113.17 0.804 . . . . 0.0 113.17 -170.486 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' F' F ' 27' ' ' GLN . . . . . . . . . . . . . 10.4 pt20 -46.7 139.99 4.86 Favored 'General case' 0 N--CA 1.469 0.476 0 N-CA-C 112.785 0.661 . . . . 0.0 112.785 -174.501 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' F' F ' 28' ' ' GLY . . . . . . . . . . . . . . . 100.56 -29.29 12.67 Favored Glycine 0 CA--C 1.531 1.045 0 CA-C-N 115.592 -0.731 . . . . 0.0 112.016 -177.642 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' F' F ' 29' ' ' LYS . . . . . . . . . . . . . 72.8 mttt -97.92 155.08 17.25 Favored 'General case' 0 C--O 1.233 0.199 0 CA-C-N 117.203 0.501 . . . . 0.0 111.163 178.236 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' F' F ' 30' ' ' THR . . . . . . . . . . . . . 29.6 m -100.67 139.16 36.74 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 115.899 -0.591 . . . . 0.0 109.822 175.272 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' F' F ' 31' ' ' VAL . . . . . . . . . . . . . 35.0 m -122.08 149.55 25.45 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.259 0 CA-C-O 120.926 0.393 . . . . 0.0 110.823 -178.105 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' F' F ' 32' ' ' ARG . . . . . . . . . . . . . 39.1 ttp180 -132.95 147.86 52.28 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-N 115.669 -0.696 . . . . 0.0 110.314 177.582 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' F' F ' 33' ' ' THR . . . . . . . . . . . . . 27.4 m -53.61 137.34 37.16 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.418 -0.355 . . . . 0.0 111.281 -179.348 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' F' F ' 34' ' ' GLY . . . . . . . . . . . . . . . 101.76 -17.22 55.2 Favored Glycine 0 CA--C 1.532 1.108 0 CA-C-O 119.7 -0.5 . . . . 0.0 113.348 178.813 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' F' F ' 35' ' ' ASP . . . . . . . . . . . . . 78.8 m-20 -65.79 147.73 52.91 Favored 'General case' 0 N--CA 1.462 0.147 0 CA-C-N 118.015 0.907 . . . . 0.0 111.058 179.472 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' F' F ' 36' ' ' VAL . . . . . . . . . . . . . 44.3 t -122.97 129.62 74.99 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.267 0 CA-C-N 116.115 -0.493 . . . . 0.0 109.815 178.431 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' F' F ' 37' ' ' ILE . . . . . . . . . . . . . 68.0 mt -119.62 138.64 49.58 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.184 0 CA-C-N 116.123 -0.489 . . . . 0.0 109.846 -179.972 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' F' F ' 38' ' ' GLY . . . . . . . . . . . . . . . -110.58 128.65 8.9 Favored Glycine 0 CA--C 1.525 0.683 0 N-CA-C 111.19 -0.764 . . . . 0.0 111.19 -179.653 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' F' F ' 39' ' ' ILE . . . . . . . . . . . . . 72.5 mt -127.13 128.07 70.09 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.233 0 N-CA-C 109.922 -0.399 . . . . 0.0 109.922 178.537 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' F' F ' 40' ' ' SER . . . . . . . . . . . . . 30.8 t -92.42 121.19 33.65 Favored 'General case' 0 C--N 1.329 -0.305 0 C-N-CA 120.823 -0.351 . . . . 0.0 110.677 175.967 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' F' F ' 41' ' ' ILE . . . . . . . . . . . . . 71.1 mt -127.45 123.99 62.81 Favored 'Isoleucine or valine' 0 N--CA 1.462 0.159 0 CA-C-O 120.935 0.398 . . . . 0.0 110.582 -179.226 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' F' F ' 42' ' ' LEU . . . . . . . . . . . . . 7.0 tp 52.58 37.65 23.78 Favored 'General case' 0 C--N 1.331 -0.219 0 CA-C-N 116.062 -0.517 . . . . 0.0 111.671 175.661 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' F' F ' 43' ' ' GLY . . . . . . . . . . . . . . . 73.18 28.16 66.84 Favored Glycine 0 CA--C 1.53 1.025 0 C-N-CA 121.073 -0.584 . . . . 0.0 112.567 176.569 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' F' F ' 44' ' ' LYS . . . . . . . . . . . . . 62.8 tttm -140.59 126.38 19.28 Favored 'General case' 0 C--N 1.33 -0.272 0 N-CA-C 109.474 -0.565 . . . . 0.0 109.474 177.234 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' F' F ' 45' ' ' GLU . . . . . . . . . . . . . 34.7 tp10 -82.82 124.31 30.18 Favored 'General case' 0 C--N 1.328 -0.331 0 C-N-CA 120.718 -0.393 . . . . 0.0 110.836 -176.876 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' F' F ' 46' ' ' VAL . . . . . . . . . . . . . 7.6 p -120.8 129.45 75.64 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.204 0 N-CA-C 109.561 -0.533 . . . . 0.0 109.561 177.285 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' F' F ' 47' ' ' LYS . . . . . . . . . . . . . 61.3 mmtt -100.23 130.09 46.32 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 115.935 -0.575 . . . . 0.0 111.104 178.572 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' F' F ' 48' ' ' PHE . . . . . . . . . . . . . 94.2 m-85 -112.61 131.86 55.42 Favored 'General case' 0 C--N 1.331 -0.233 0 N-CA-C 109.638 -0.504 . . . . 0.0 109.638 175.795 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' F' F ' 49' ' ' LYS . . . . . . . . . . . . . 48.9 tttp -108.7 136.71 47.83 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.314 -0.403 . . . . 0.0 110.612 179.936 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' F' F ' 50' ' ' VAL . . . . . . . . . . . . . 46.8 t -78.92 106.46 9.92 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.333 0 N-CA-C 108.91 -0.774 . . . . 0.0 108.91 175.155 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' F' F ' 51' ' ' VAL . . . . . . . . . . . . . 47.3 t -74.81 -47.43 37.8 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.327 0 CA-C-N 116.075 -0.511 . . . . 0.0 110.139 -172.957 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' F' F ' 52' ' ' GLN . . . . . . . . . . . . . 57.5 tt0 -160.72 137.84 9.1 Favored 'General case' 0 C--N 1.33 -0.281 0 C-N-CA 120.465 -0.494 . . . . 0.0 111.351 -177.466 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' F' F ' 53' ' ' ALA . . . . . . . . . . . . . . . -114.75 131.79 56.66 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 115.964 -0.562 . . . . 0.0 109.983 174.494 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' F' F ' 54' ' ' TYR . . . . . . . . . . . . . 33.7 t80 -129.01 109.16 18.2 Favored Pre-proline 0 C--N 1.328 -0.334 0 CA-C-O 118.302 -0.856 . . . . 0.0 110.492 179.271 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' F' F ' 55' ' ' PRO . . . . . . . . . . . . . 74.0 Cg_endo -77.14 168.51 76.76 Favored 'Cis proline' 0 N--CA 1.499 1.841 0 CA-C-N 121.951 1.733 . . . . 0.0 112.292 -5.819 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' F' F ' 56' ' ' SER . . . . . . . . . . . . . 69.2 m -117.5 134.78 23.12 Favored Pre-proline 0 CA--C 1.539 0.524 0 CA-C-O 118.466 -0.778 . . . . 0.0 109.704 175.126 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' F' F ' 57' ' ' PRO . . . . . . . . . . . . . 57.6 Cg_endo -73.14 162.82 90.92 Favored 'Cis proline' 0 N--CA 1.496 1.619 0 CA-C-N 121.806 1.681 . . . . 0.0 111.375 -3.501 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' F' F ' 58' ' ' LEU . . . . . . . . . . . . . 33.6 tp -130.0 137.84 50.5 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-O 120.851 0.357 . . . . 0.0 110.793 -178.658 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' F' F ' 59' ' ' ARG . . . . . . . . . . . . . 32.2 ttp180 -99.65 127.52 45.76 Favored 'General case' 0 C--N 1.327 -0.374 0 N-CA-C 109.335 -0.617 . . . . 0.0 109.335 175.459 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' F' F ' 60' ' ' VAL . . . . . . . . . . . . . 41.2 t -80.96 123.15 37.27 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.266 0 C-N-CA 120.598 -0.441 . . . . 0.0 110.506 -175.073 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' F' F ' 61' ' ' GLU . . . . . . . . . . . . . 42.9 mt-10 -131.13 171.38 13.34 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 115.608 -0.724 . . . . 0.0 109.674 176.483 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' F' F ' 62' ' ' ASP . . . . . . . . . . . . . 83.8 m-20 -54.27 -32.59 56.58 Favored 'General case' 0 C--N 1.329 -0.308 0 C-N-CA 120.968 -0.293 . . . . 0.0 111.752 -179.279 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' F' F ' 63' ' ' ARG . . . . . . . . . . . . . 25.0 ptt180 -83.9 2.25 39.46 Favored 'General case' 0 CA--C 1.537 0.455 0 N-CA-C 113.727 1.01 . . . . 0.0 113.727 -175.263 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' F' F ' 64' ' ' THR . . . . . . . . . . . . . 28.4 m -78.44 136.8 37.71 Favored 'General case' 0 C--N 1.333 -0.133 0 CA-C-N 118.119 0.418 . . . . 0.0 110.705 -177.621 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' F' F ' 65' ' ' LYS . . . . . . . . . . . . . 24.6 mtpp -90.35 127.04 36.07 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.037 -0.529 . . . . 0.0 110.218 179.275 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' F' F ' 66' ' ' ILE . . . . . . . . . . . . . 4.3 mp -113.87 131.47 65.65 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.262 0 N-CA-C 110.012 -0.366 . . . . 0.0 110.012 179.628 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' F' F ' 67' ' ' THR . . . . . . . . . . . . . 20.9 m -122.19 132.62 54.54 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-O 121.069 0.462 . . . . 0.0 110.331 178.525 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' F' F ' 68' ' ' LEU . . . . . 0.435 HD23 ' C ' ' F' ' 68' ' ' LEU . 6.2 tt -106.91 124.79 50.14 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 115.825 -0.625 . . . . 0.0 110.002 -179.982 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' F' F ' 69' ' ' VAL . . . . . . . . . . . . . 43.4 t -95.22 135.95 27.76 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.315 0 CA-C-O 121.061 0.458 . . . . 0.0 110.412 -178.008 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' F' F ' 70' ' ' THR . . . . . . . . . . . . . 9.0 t -130.91 175.14 9.31 Favored 'General case' 0 C--N 1.331 -0.219 0 CA-C-N 115.882 -0.599 . . . . 0.0 110.304 -178.999 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' F' F ' 71' ' ' HIS . . . . . . . . . . . . . 96.1 m-70 -64.95 149.68 96.25 Favored Pre-proline 0 C--N 1.329 -0.324 0 CA-C-N 116.269 -0.423 . . . . 0.0 110.396 -178.367 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' F' F ' 72' ' ' PRO . . . . . . . . . . . . . 71.8 Cg_endo -77.58 -24.38 8.98 Favored 'Trans proline' 0 N--CA 1.495 1.592 0 C-N-CA 121.375 1.383 . . . . 0.0 113.038 -177.238 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' F' F ' 73' ' ' VAL . . . . . . . . . . . . . 34.8 m -129.11 154.24 39.78 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.158 0 CA-C-O 121.109 0.481 . . . . 0.0 111.154 -178.201 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' F' F ' 74' ' ' ASP . . . . . . . . . . . . . 12.8 t70 -101.82 123.72 46.24 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 115.542 -0.754 . . . . 0.0 109.594 177.464 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' F' F ' 75' ' ' VAL . . . . . . . . . . . . . 45.1 t -111.86 123.92 68.1 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.253 0 CA-C-O 121.145 0.498 . . . . 0.0 110.527 -178.105 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' F' F ' 76' ' ' LEU . . . . . . . . . . . . . 29.1 mt -123.86 142.23 51.31 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 115.533 -0.758 . . . . 0.0 109.418 177.661 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' F' F ' 77' ' ' GLU . . . . . . . . . . . . . 97.8 mt-10 -133.92 137.98 45.24 Favored 'General case' 0 C--N 1.331 -0.227 0 CA-C-O 121.018 0.437 . . . . 0.0 111.312 -178.145 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' F' F ' 78' ' ' ALA . . . . . 0.688 ' HB2' HD21 ' F' ' 109' ' ' LEU . . . -128.11 136.36 51.06 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 115.718 -0.673 . . . . 0.0 109.722 176.35 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' F' F ' 79' ' ' LYS . . . . . 0.593 ' O ' HD13 ' F' ' 80' ' ' ILE . 19.8 pttp -79.46 123.76 27.83 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-O 121.187 0.518 . . . . 0.0 111.142 -177.893 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' F' F ' 80' ' ' ILE . . . . . 0.593 HD13 ' O ' ' F' ' 79' ' ' LYS . 40.6 mm -139.21 112.73 6.57 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.279 0 CA-C-N 115.725 -0.671 . . . . 0.0 109.278 -178.199 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' F' F ' 81' ' ' LYS . . . . . . . . . . . . . 47.0 tptt -102.1 123.43 45.96 Favored 'General case' 0 C--N 1.329 -0.287 0 C-N-CA 120.921 -0.312 . . . . 0.0 111.072 -177.474 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' F' F ' 82' ' ' GLY . . . . . . . . . . . . . . . 89.07 42.15 5.69 Favored Glycine 0 CA--C 1.525 0.657 0 C-N-CA 120.722 -0.752 . . . . 0.0 111.954 173.551 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' F' F ' 83' ' ' ILE . . . . . . . . . . . . . 72.4 mt -64.04 137.47 24.75 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.29 0 N-CA-C 109.915 -0.402 . . . . 0.0 109.915 178.139 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' F' F ' 84' ' ' LYS . . . . . . . . . . . . . 82.2 tttt -99.43 -53.8 3.12 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 115.999 -0.546 . . . . 0.0 110.42 -178.975 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' F' F ' 85' ' ' ASP . . . . . . . . . . . . . 8.6 t0 -154.96 153.01 30.39 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 115.748 -0.66 . . . . 0.0 109.972 -179.706 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' F' F ' 86' ' ' VAL . . . . . . . . . . . . . 43.2 t -128.85 131.59 68.22 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.24 0 CA-C-O 120.9 0.381 . . . . 0.0 110.767 -178.016 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' F' F ' 87' ' ' ILE . . . . . . . . . . . . . 42.4 mm -118.22 124.26 72.84 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.245 0 CA-C-N 115.782 -0.644 . . . . 0.0 109.503 175.164 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' F' F ' 88' ' ' LEU . . . . . . . . . . . . . 14.8 tp -112.96 131.9 55.56 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-O 120.938 0.399 . . . . 0.0 111.36 -176.185 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' F' F ' 89' ' ' ASP . . . . . . . . . . . . . 13.5 t70 -131.08 151.52 51.35 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 115.861 -0.609 . . . . 0.0 109.442 175.932 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' F' F ' 90' ' ' GLU . . . . . . . . . . . . . 46.6 tp10 -48.96 -35.05 14.19 Favored 'General case' 0 C--N 1.329 -0.32 0 N-CA-C 112.712 0.634 . . . . 0.0 112.712 -172.49 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' F' F ' 91' ' ' ASN . . . . . . . . . . . . . 12.7 p30 -123.36 14.58 9.64 Favored 'General case' 0 N--CA 1.47 0.534 0 N-CA-C 113.452 0.908 . . . . 0.0 113.452 -175.883 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' F' F ' 92' ' ' LEU . . . . . . . . . . . . . 8.1 mt -151.66 143.17 23.53 Favored 'General case' 0 C--N 1.332 -0.171 0 N-CA-C 109.797 -0.446 . . . . 0.0 109.797 -177.101 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' F' F ' 93' ' ' ILE . . . . . . . . . . . . . 71.0 mt -127.26 117.13 46.39 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.346 0 N-CA-C 108.892 -0.781 . . . . 0.0 108.892 176.186 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' F' F ' 94' ' ' VAL . . . . . 0.468 HG21 HG21 ' F' ' 125' ' ' VAL . 48.4 t -121.71 128.11 75.67 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.257 0 CA-C-O 121.147 0.498 . . . . 0.0 110.189 -178.174 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' F' F ' 95' ' ' VAL . . . . . . . . . . . . . 45.2 t -120.78 135.08 62.12 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.358 0 CA-C-N 115.524 -0.762 . . . . 0.0 109.644 -179.168 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' F' F ' 96' ' ' ILE . . . . . . . . . . . . . 62.0 mt -111.66 129.03 67.8 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.358 0 N-CA-C 108.789 -0.819 . . . . 0.0 108.789 178.137 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' F' F ' 97' ' ' THR . . . . . . . . . . . . . 58.1 p -103.93 157.08 17.34 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-O 121.335 0.588 . . . . 0.0 111.235 -176.77 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' F' F ' 98' ' ' GLU . . . . . . . . . . . . . 85.4 tt0 -53.93 -24.03 14.97 Favored 'General case' 0 CA--C 1.534 0.36 0 CA-C-N 115.866 -0.606 . . . . 0.0 112.314 179.581 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' F' F ' 99' ' ' GLU . . . . . . . . . . . . . 41.3 tt0 -79.74 16.69 1.06 Allowed 'General case' 0 CA--C 1.54 0.561 0 N-CA-C 112.401 0.519 . . . . 0.0 112.401 -178.354 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' F' F ' 100' ' ' ASN . . . . . . . . . . . . . 2.2 m-20 60.05 37.39 21.14 Favored 'General case' 0 CA--C 1.53 0.209 0 O-C-N 121.675 -0.64 . . . . 0.0 110.818 178.367 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' F' F ' 101' ' ' GLU . . . . . . . . . . . . . 85.1 tt0 -117.1 145.38 43.81 Favored 'General case' 0 C--N 1.332 -0.186 0 CA-C-N 116.018 -0.537 . . . . 0.0 109.876 178.075 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' F' F ' 102' ' ' VAL . . . . . . . . . . . . . 46.2 t -115.51 124.79 72.36 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.372 0 N-CA-C 109.776 -0.453 . . . . 0.0 109.776 -178.83 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' F' F ' 103' ' ' LEU . . . . . . . . . . . . . 56.3 mt -114.47 129.92 56.69 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 115.83 -0.623 . . . . 0.0 110.016 176.961 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' F' F ' 104' ' ' ILE . . . . . . . . . . . . . 68.9 mt -117.93 118.43 58.25 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.27 0 N-CA-C 109.909 -0.404 . . . . 0.0 109.909 -179.811 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' F' F ' 105' ' ' PHE . . . . . . . . . . . . . 36.0 m-85 -119.36 164.18 16.08 Favored 'General case' 0 C--N 1.332 -0.163 0 O-C-N 123.898 0.749 . . . . 0.0 109.647 179.715 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' F' F ' 106' ' ' ASN . . . . . 0.446 ' HB3' HD11 ' F' ' 112' ' ' LEU . 44.3 p-10 -100.03 -170.65 1.91 Allowed 'General case' 0 C--N 1.33 -0.259 0 N-CA-C 109.808 -0.441 . . . . 0.0 109.808 173.575 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' F' F ' 107' ' ' GLN . . . . . . . . . . . . . 27.7 tt0 -59.75 -29.88 68.47 Favored 'General case' 0 C--N 1.329 -0.29 0 N-CA-C 111.944 0.35 . . . . 0.0 111.944 179.201 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' F' F ' 108' ' ' ASN . . . . . . . . . . . . . 16.6 t-20 -81.88 6.92 14.28 Favored 'General case' 0 CA--C 1.537 0.445 0 N-CA-C 113.232 0.827 . . . . 0.0 113.232 -177.948 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' F' F ' 109' ' ' LEU . . . . . 0.688 HD21 ' HB2' ' F' ' 78' ' ' ALA . 11.1 tp 62.4 36.68 14.18 Favored 'General case' 0 C--O 1.233 0.186 0 O-C-N 122.054 -0.404 . . . . 0.0 111.436 177.248 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' F' F ' 110' ' ' GLU . . . . . . . . . . . . . 70.9 mm-40 -109.58 156.96 19.53 Favored 'General case' 0 C--N 1.331 -0.237 0 N-CA-C 110.107 -0.331 . . . . 0.0 110.107 177.127 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' F' F ' 111' ' ' GLU . . . . . . . . . . . . . 46.4 mp0 -83.69 122.03 28.07 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-O 120.941 0.401 . . . . 0.0 111.053 -178.501 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' F' F ' 112' ' ' LEU . . . . . 0.446 HD11 ' HB3' ' F' ' 106' ' ' ASN . 29.5 mt -104.87 -45.97 4.42 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 115.987 -0.552 . . . . 0.0 109.941 175.117 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' F' F ' 113' ' ' TYR . . . . . . . . . . . . . 64.5 t80 -138.6 137.42 36.93 Favored 'General case' 0 C--N 1.33 -0.239 0 CA-C-N 115.988 -0.551 . . . . 0.0 110.842 -179.7 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' F' F ' 114' ' ' ARG . . . . . . . . . . . . . 83.4 mtm180 -139.61 122.66 16.77 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.448 -0.342 . . . . 0.0 110.315 176.254 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' F' F ' 115' ' ' GLY . . . . . . . . . . . . . . . -150.05 163.0 29.36 Favored Glycine 0 CA--C 1.526 0.722 0 N-CA-C 111.211 -0.756 . . . . 0.0 111.211 -179.937 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' F' F ' 116' ' ' LYS . . . . . . . . . . . . . 8.0 ttpm? -127.47 139.76 52.6 Favored 'General case' 0 C--N 1.33 -0.248 0 N-CA-C 110.074 -0.343 . . . . 0.0 110.074 178.368 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' F' F ' 117' ' ' PHE . . . . . . . . . . . . . 51.8 m-85 -136.44 113.96 10.95 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 116.397 -0.365 . . . . 0.0 110.054 -178.679 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' F' F ' 118' ' ' GLU . . . . . . . . . . . . . 96.1 mt-10 -55.1 -42.9 73.5 Favored 'General case' 0 C--N 1.33 -0.268 0 C-N-CA 121.0 -0.28 . . . . 0.0 111.13 -176.35 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' F' F ' 119' ' ' ASN . . . . . . . . . . . . . 2.4 m120 -97.97 31.0 2.83 Favored 'General case' 0 C--N 1.33 -0.258 0 N-CA-C 112.096 0.406 . . . . 0.0 112.096 -175.107 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' F' F ' 120' ' ' LEU . . . . . . . . . . . . . 14.8 tp -57.6 119.99 7.54 Favored 'General case' 0 C--N 1.333 -0.139 0 N-CA-C 110.264 -0.273 . . . . 0.0 110.264 178.166 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' F' F ' 121' ' ' ASN . . . . . . . . . . . . . 26.5 m120 -114.0 -43.95 3.2 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-N 116.487 -0.324 . . . . 0.0 110.832 -178.376 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' F' F ' 122' ' ' LYS . . . . . . . . . . . . . 38.3 ttpt -144.76 141.5 29.27 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-O 120.87 0.367 . . . . 0.0 111.28 -176.773 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' F' F ' 123' ' ' VAL . . . . . . . . . . . . . 46.1 t -126.69 127.19 69.9 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.315 0 N-CA-C 109.21 -0.663 . . . . 0.0 109.21 173.255 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' F' F ' 124' ' ' LEU . . . . . . . . . . . . . 16.2 tp -129.08 137.67 51.4 Favored 'General case' 0 C--N 1.331 -0.225 0 CA-C-O 121.034 0.445 . . . . 0.0 111.013 -176.344 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' F' F ' 125' ' ' VAL . . . . . 0.468 HG21 HG21 ' F' ' 94' ' ' VAL . 42.3 t -125.14 131.26 72.67 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.259 0 CA-C-N 115.844 -0.616 . . . . 0.0 109.624 177.864 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' F' F ' 126' ' ' ARG . . . . . . . . . . . . . 57.9 ttt180 -147.45 126.79 13.08 Favored 'General case' 0 C--N 1.329 -0.284 0 N-CA-C 109.46 -0.571 . . . . 0.0 109.46 178.858 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' F' F ' 127' ' ' ASN . . . . . . . . . . . . . 79.7 m-20 56.49 -147.13 0.53 Allowed 'General case' 0 CA--C 1.541 0.61 0 N-CA-C 109.682 -0.488 . . . . 0.0 109.682 -178.033 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' F' F ' 128' ' ' ASP . . . . . . . . . . . . . 24.1 p-10 -87.91 18.15 4.38 Favored 'General case' 0 CA--C 1.537 0.46 0 CA-C-N 118.901 0.773 . . . . 0.0 112.605 178.639 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' F' F ' 129' ' ' LEU . . . . . . . . . . . . . 15.6 tp -113.63 137.35 51.71 Favored 'General case' 0 N--CA 1.461 0.116 0 CA-C-N 117.99 0.359 . . . . 0.0 110.315 178.65 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' F' F ' 130' ' ' VAL . . . . . . . . . . . . . 46.1 t -121.89 135.9 60.53 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.215 0 CA-C-N 116.086 -0.506 . . . . 0.0 109.732 -179.963 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' F' F ' 131' ' ' VAL . . . . . . . . . . . . . 41.4 t -134.8 136.35 52.28 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.264 0 CA-C-O 121.104 0.478 . . . . 0.0 110.697 -179.454 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' F' F ' 132' ' ' ILE . . . . . . . . . . . . . 72.2 mt -116.62 132.93 64.84 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.234 0 CA-C-N 115.667 -0.697 . . . . 0.0 109.49 178.598 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' F' F ' 133' ' ' ILE . . . . . . . . . . . . . 42.7 mm -116.83 122.01 69.02 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.242 0 CA-C-O 120.764 0.316 . . . . 0.0 110.802 -176.629 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' F' F ' 134' ' ' ASP . . . . . . . . . . . . . 7.8 p-10 -133.42 146.23 51.0 Favored 'General case' 0 C--N 1.329 -0.29 0 N-CA-C 109.297 -0.631 . . . . 0.0 109.297 174.338 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' F' F ' 135' ' ' GLU . . . . . . . . . . . . . 84.6 tt0 -50.07 -27.79 6.15 Favored 'General case' 0 C--N 1.328 -0.333 0 N-CA-C 112.645 0.609 . . . . 0.0 112.645 -174.212 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' F' F ' 136' ' ' GLN . . . . . . . . . . . . . 95.7 mt-30 -79.09 -34.65 43.39 Favored 'General case' 0 C--O 1.232 0.174 0 N-CA-C 112.35 0.5 . . . . 0.0 112.35 -176.847 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' F' F ' 137' ' ' LYS . . . . . . . . . . . . . 49.8 pttt -170.06 176.2 4.75 Favored 'General case' 0 C--N 1.331 -0.227 0 CA-C-O 121.489 0.661 . . . . 0.0 112.577 -173.143 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' F' F ' 138' ' ' LEU . . . . . . . . . . . . . 6.7 tt -119.36 130.99 55.63 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 115.107 -0.951 . . . . 0.0 110.111 179.875 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' F' F ' 139' ' ' THR . . . . . . . . . . . . . 39.7 m -111.42 129.67 55.95 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.198 -0.455 . . . . 0.0 110.359 179.412 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' F' F ' 140' ' ' LEU . . . . . 0.468 HD23 ' C ' ' F' ' 140' ' ' LEU . 8.5 tt -113.73 125.42 54.1 Favored 'General case' 0 C--N 1.328 -0.365 0 N-CA-C 109.515 -0.55 . . . . 0.0 109.515 -178.867 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' F' F ' 141' ' ' ILE . . . . . . . . . . . . . 19.0 mt -124.55 125.91 70.91 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.371 0 N-CA-C 109.873 -0.417 . . . . 0.0 109.873 -175.64 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' F' F ' 142' ' ' ARG . . . . . . . . . . . . . 23.4 tpt180 -120.37 135.42 55.03 Favored 'General case' 0 C--N 1.332 -0.193 0 CA-C-N 115.973 -0.558 . . . . 0.0 109.936 -178.458 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' F' F ' 143' ' ' THR . . . . . . . . . . . . . 23.9 p . . . . . 0 C--O 1.22 -0.49 0 CA-C-O 118.025 -0.988 . . . . 0.0 110.485 179.776 . . . . . . . . 0 0 . 1 . 006 nuclear nobuild full ' A' A ' -3' ' ' GLU . . . . . . . . . . . . . 40.5 mp0 . . . . . 0 N--CA 1.491 1.609 0 N-CA-C 109.73 -0.471 . . . . 0.0 109.73 . . . . . . . . . 0 0 . 1 . 006 nuclear nobuild full ' A' A ' -2' ' ' GLY . . . . . . . . . . . . . . . -109.24 123.54 6.93 Favored Glycine 0 CA--C 1.525 0.688 0 N-CA-C 111.318 -0.713 . . . . 0.0 111.318 -178.935 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' -1' ' ' VAL . . . . . . . . . . . . . 45.3 t -97.07 139.63 19.22 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.325 0 CA-C-O 120.789 0.328 . . . . 0.0 110.16 178.892 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 0' ' ' ILE . . . . . . . . . . . . . 69.5 mt -103.14 126.92 57.41 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.288 0 N-CA-C 109.558 -0.534 . . . . 0.0 109.558 178.111 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 26.7 ptm -78.05 157.38 29.59 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.247 -0.433 . . . . 0.0 110.763 -178.546 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 2.9 p -113.91 138.42 50.35 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 116.044 -0.526 . . . . 0.0 110.677 -179.407 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 85.4 tt0 -139.71 139.97 36.7 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.092 -0.503 . . . . 0.0 110.909 -179.333 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 4' ' ' LEU . . . . . . . . . . . . . 22.1 tp -121.74 125.7 47.18 Favored 'General case' 0 C--N 1.332 -0.185 0 CA-C-N 115.781 -0.645 . . . . 0.0 110.065 178.256 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 5' ' ' LYS . . . . . . . . . . . . . 64.7 mttp -101.73 121.24 41.7 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.437 -0.347 . . . . 0.0 110.656 178.923 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 85.8 mt -116.34 145.96 42.8 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 115.622 -0.717 . . . . 0.0 110.574 -179.76 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 82.6 tttt -139.34 135.31 17.05 Favored Pre-proline 0 CA--C 1.533 0.326 0 CA-C-O 118.905 -0.569 . . . . 0.0 109.723 177.01 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 8' ' ' PRO . . . . . . . . . . . . . 96.1 Cg_endo -89.49 142.87 4.35 Favored 'Trans proline' 0 N--CA 1.491 1.333 0 C-N-CA 121.621 1.547 . . . . 0.0 111.728 177.954 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 46.3 mt -77.07 -46.44 2.77 Favored Pre-proline 0 C--N 1.329 -0.317 0 CA-C-O 118.889 -0.577 . . . . 0.0 111.644 -179.374 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 94.8 Cg_endo -82.67 144.87 12.71 Favored 'Trans proline' 0 N--CA 1.493 1.497 0 C-N-CA 121.174 1.249 . . . . 0.0 111.361 172.159 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 64.4 mttp -86.58 100.63 12.55 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-O 121.037 0.446 . . . . 0.0 110.596 178.967 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 11.6 p -137.52 145.36 29.42 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.26 0 CA-C-N 115.762 -0.654 . . . . 0.0 110.022 179.765 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 84.1 tt0 -82.13 116.42 21.69 Favored 'General case' 0 C--N 1.329 -0.299 0 N-CA-C 109.973 -0.38 . . . . 0.0 109.973 178.938 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 14' ' ' LEU . . . . . . . . . . . . . 17.9 mt -92.82 153.18 42.12 Favored Pre-proline 0 C--N 1.33 -0.25 0 CA-C-N 116.224 -0.443 . . . . 0.0 110.864 -176.387 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 15' ' ' PRO . . . . . . . . . . . . . 31.1 Cg_exo -60.22 156.58 39.46 Favored 'Trans proline' 0 N--CA 1.495 1.578 0 C-N-CA 121.314 1.343 . . . . 0.0 111.876 177.744 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 16' ' ' PRO . . . . . . . . . . . . . 38.0 Cg_exo -58.02 -38.07 93.38 Favored 'Trans proline' 0 N--CA 1.497 1.714 0 C-N-CA 121.441 1.427 . . . . 0.0 112.777 -177.681 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 17' ' ' ASP . . . . . . . . . . . . . 18.7 p-10 -89.72 10.51 23.08 Favored 'General case' 0 CA--C 1.535 0.393 0 N-CA-C 113.313 0.857 . . . . 0.0 113.313 -176.482 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 18' ' ' PHE . . . . . . . . . . . . . 44.1 t80 -58.09 -44.58 87.68 Favored 'General case' 0 C--N 1.334 -0.068 0 O-C-N 122.047 -0.408 . . . . 0.0 110.121 -177.624 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 19' ' ' VAL . . . . . . . . . . . . . 47.2 t -57.96 -44.6 87.13 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.318 0 CA-C-N 116.251 -0.431 . . . . 0.0 110.4 -178.647 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 14.7 t70 -59.52 -40.23 86.46 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-O 120.829 0.347 . . . . 0.0 110.75 -177.462 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 47.2 t -64.53 -48.61 84.27 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.304 0 CA-C-N 116.382 -0.372 . . . . 0.0 110.251 -178.514 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 22' ' ' ILE . . . . . 0.541 HG22 HD12 ' A' ' 26' ' ' LEU . 51.5 mm -55.18 -42.26 64.69 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.242 0 CA-C-O 120.833 0.349 . . . . 0.0 110.605 179.441 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 23' ' ' ARG . . . . . . . . . . . . . 54.5 ttp180 -53.89 -53.58 50.6 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.464 -0.335 . . . . 0.0 111.49 179.577 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 24' ' ' ILE . . . . . . . . . . . . . 71.9 mt -61.24 -38.76 80.52 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.335 0 CA-C-N 116.56 -0.291 . . . . 0.0 111.508 -177.18 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 59.9 mmtt -65.88 -40.94 92.07 Favored 'General case' 0 C--N 1.329 -0.311 0 N-CA-C 112.104 0.409 . . . . 0.0 112.104 179.884 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 26' ' ' LEU . . . . . 0.541 HD12 HG22 ' A' ' 22' ' ' ILE . 75.7 mt -78.41 -38.18 42.15 Favored 'General case' 0 C--N 1.33 -0.266 0 N-CA-C 113.312 0.856 . . . . 0.0 113.312 -171.205 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 27' ' ' GLN . . . . . . . . . . . . . 9.4 pt20 -46.99 140.22 5.01 Favored 'General case' 0 N--CA 1.47 0.552 0 N-CA-C 112.732 0.641 . . . . 0.0 112.732 -175.541 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 98.22 -26.08 25.09 Favored Glycine 0 CA--C 1.533 1.18 0 CA-C-N 115.58 -0.737 . . . . 0.0 112.242 -176.194 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 58.6 mtpt -98.07 155.12 17.28 Favored 'General case' 0 C--O 1.232 0.177 0 CA-C-N 117.117 0.458 . . . . 0.0 110.764 179.358 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 30' ' ' THR . . . . . . . . . . . . . 25.9 m -103.3 138.35 40.2 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.293 -0.412 . . . . 0.0 110.021 176.63 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 34.3 m -129.19 150.9 35.06 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.215 0 CA-C-O 121.066 0.46 . . . . 0.0 111.145 -178.179 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 32' ' ' ARG . . . . . . . . . . . . . 83.7 mtt180 -132.64 152.85 51.55 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 115.589 -0.732 . . . . 0.0 110.168 177.492 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 33' ' ' THR . . . . . . . . . . . . . 20.9 m -53.35 137.23 35.73 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.3 -0.409 . . . . 0.0 111.359 -177.685 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 102.06 -16.94 55.21 Favored Glycine 0 CA--C 1.532 1.122 0 CA-C-O 119.655 -0.525 . . . . 0.0 113.386 177.619 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 72.3 m-20 -64.26 148.31 50.48 Favored 'General case' 0 N--CA 1.461 0.112 0 CA-C-N 118.125 0.963 . . . . 0.0 110.987 179.494 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 44.7 t -125.83 133.23 69.54 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.19 0 CA-C-N 116.017 -0.538 . . . . 0.0 110.001 179.52 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 37' ' ' ILE . . . . . . . . . . . . . 68.6 mt -122.43 140.18 47.07 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.255 0 CA-C-N 116.081 -0.509 . . . . 0.0 109.981 179.849 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . -113.17 128.91 8.61 Favored Glycine 0 CA--C 1.527 0.815 0 N-CA-C 110.978 -0.849 . . . . 0.0 110.978 179.485 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 39' ' ' ILE . . . . . . . . . . . . . 71.9 mt -122.97 130.14 74.65 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.2 0 N-CA-C 110.091 -0.337 . . . . 0.0 110.091 179.793 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 40' ' ' SER . . . . . . . . . . . . . 35.8 t -94.58 124.79 38.82 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.483 -0.326 . . . . 0.0 111.007 175.377 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 41' ' ' ILE . . . . . . . . . . . . . 71.9 mt -133.42 123.79 47.34 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.247 0 CA-C-O 120.907 0.384 . . . . 0.0 110.567 177.183 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 10.9 tp 52.51 35.93 19.06 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 115.994 -0.548 . . . . 0.0 111.695 177.319 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . 73.23 28.38 66.31 Favored Glycine 0 CA--C 1.53 1.007 0 C-N-CA 121.169 -0.539 . . . . 0.0 112.46 176.6 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 44' ' ' LYS . . . . . . . . . . . . . 94.5 mttt -134.9 129.98 35.19 Favored 'General case' 0 C--N 1.332 -0.189 0 CA-C-N 117.044 0.422 . . . . 0.0 110.01 177.268 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 68.0 tt0 -86.96 125.78 34.29 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 116.067 -0.515 . . . . 0.0 111.371 -175.8 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 46' ' ' VAL . . . . . . . . . . . . . 7.1 p -125.17 129.77 73.16 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.19 0 CA-C-O 120.926 0.393 . . . . 0.0 110.02 175.744 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 56.5 mmtt -100.53 130.91 46.66 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 115.865 -0.607 . . . . 0.0 111.768 177.896 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 48' ' ' PHE . . . . . . . . . . . . . 93.8 m-85 -113.86 131.89 56.1 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.071 -0.513 . . . . 0.0 109.929 175.022 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 83.1 tttt -106.62 137.76 44.03 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.382 -0.372 . . . . 0.0 110.492 179.357 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 50' ' ' VAL . . . . . . . . . . . . . 44.5 t -81.3 105.98 11.86 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.297 0 N-CA-C 108.991 -0.744 . . . . 0.0 108.991 174.735 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 51' ' ' VAL . . . . . . . . . . . . . 45.6 t -69.54 -48.13 67.95 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.349 0 CA-C-N 116.05 -0.523 . . . . 0.0 110.016 -173.075 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 52' ' ' GLN . . . . . . . . . . . . . 48.0 tt0 -167.89 139.9 3.04 Favored 'General case' 0 C--N 1.328 -0.348 0 C-N-CA 120.362 -0.535 . . . . 0.0 111.651 -177.816 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 53' ' ' ALA . . . . . 0.484 ' HB3' ' OG ' ' A' ' 56' ' ' SER . . . -110.47 131.93 54.62 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 115.839 -0.619 . . . . 0.0 109.882 174.776 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 54' ' ' TYR . . . . . . . . . . . . . 40.7 t80 -129.07 110.66 18.28 Favored Pre-proline 0 CA--C 1.535 0.381 0 CA-C-O 118.292 -0.861 . . . . 0.0 110.546 179.769 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 55' ' ' PRO . . . . . . . . . . . . . 71.7 Cg_endo -77.22 166.96 80.91 Favored 'Cis proline' 0 N--CA 1.5 1.866 0 CA-C-N 121.874 1.705 . . . . 0.0 111.978 -7.102 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 56' ' ' SER . . . . . 0.484 ' OG ' ' HB3' ' A' ' 53' ' ' ALA . 51.3 m -118.02 141.97 30.18 Favored Pre-proline 0 CA--C 1.538 0.519 0 CA-C-O 118.699 -0.667 . . . . 0.0 109.596 174.132 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 57' ' ' PRO . . . . . . . . . . . . . 43.9 Cg_endo -68.96 142.87 70.55 Favored 'Cis proline' 0 N--CA 1.499 1.807 0 CA-C-N 121.484 1.566 . . . . 0.0 111.205 -3.006 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 58' ' ' LEU . . . . . . . . . . . . . 29.7 tp -107.75 136.05 48.14 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-O 120.729 0.3 . . . . 0.0 110.877 -177.849 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 59' ' ' ARG . . . . . . . . . . . . . 66.5 ttt180 -101.79 122.2 43.51 Favored 'General case' 0 C--N 1.326 -0.426 0 N-CA-C 109.099 -0.704 . . . . 0.0 109.099 175.919 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 43.9 t -76.18 120.88 27.03 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.263 0 C-N-CA 120.68 -0.408 . . . . 0.0 110.639 -173.964 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 43.7 mt-10 -131.04 165.38 23.34 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 115.954 -0.566 . . . . 0.0 109.838 175.181 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 62' ' ' ASP . . . . . . . . . . . . . 9.5 p-10 -55.51 -32.55 62.97 Favored 'General case' 0 C--N 1.329 -0.311 0 N-CA-C 111.89 0.33 . . . . 0.0 111.89 -177.289 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 63' ' ' ARG . . . . . . . . . . . . . 24.3 ptt180 -79.76 -4.4 51.79 Favored 'General case' 0 CA--C 1.536 0.441 0 N-CA-C 113.753 1.02 . . . . 0.0 113.753 -174.945 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 24.6 m -75.08 136.07 41.18 Favored 'General case' 0 C--N 1.333 -0.118 0 CA-C-N 118.118 0.417 . . . . 0.0 110.453 -177.943 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 65' ' ' LYS . . . . . . . . . . . . . 3.0 mptp? -88.35 128.12 35.5 Favored 'General case' 0 C--N 1.328 -0.329 0 N-CA-C 109.689 -0.486 . . . . 0.0 109.689 -179.86 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 66' ' ' ILE . . . . . . . . . . . . . 59.2 mt -112.03 131.96 62.01 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.244 0 N-CA-C 109.807 -0.442 . . . . 0.0 109.807 -179.223 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 67' ' ' THR . . . . . . . . . . . . . 27.5 m -123.95 137.15 54.66 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.138 -0.483 . . . . 0.0 110.744 -179.142 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 68' ' ' LEU . . . . . . . . . . . . . 3.6 tt -103.89 120.28 40.68 Favored 'General case' 0 C--N 1.329 -0.302 0 N-CA-C 109.37 -0.604 . . . . 0.0 109.37 178.072 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 69' ' ' VAL . . . . . . . . . . . . . 41.0 t -100.13 130.83 48.71 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.273 0 CA-C-O 120.98 0.419 . . . . 0.0 111.021 -174.683 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 70' ' ' THR . . . . . . . . . . . . . 10.1 p -146.88 178.63 8.18 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 115.746 -0.661 . . . . 0.0 110.387 177.514 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 71' ' ' HIS . . . . . . . . . . . . . 91.7 m-70 -122.52 85.68 48.48 Favored Pre-proline 0 CA--C 1.532 0.274 0 CA-C-N 116.42 -0.355 . . . . 0.0 110.589 -179.741 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 72' ' ' PRO . . . . . . . . . . . . . 84.0 Cg_endo -87.35 160.09 8.23 Favored 'Trans proline' 0 N--CA 1.492 1.405 0 C-N-CA 121.762 1.642 . . . . 0.0 112.717 -179.366 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 73' ' ' VAL . . . . . . . . . . . . . 28.7 m -114.95 170.28 5.25 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.245 0 CA-C-N 116.095 -0.502 . . . . 0.0 110.101 177.469 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 74' ' ' ASP . . . . . . . . . . . . . 40.5 t0 -95.22 116.58 28.94 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 116.359 -0.382 . . . . 0.0 110.11 -178.192 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 44.8 t -112.52 121.64 65.24 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.211 0 CA-C-O 121.081 0.467 . . . . 0.0 110.259 179.961 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 76' ' ' LEU . . . . . . . . . . . . . 35.1 mt -125.42 140.59 52.66 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 115.571 -0.74 . . . . 0.0 109.539 179.381 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 77' ' ' GLU . . . . . . . . . . . . . 96.8 mt-10 -133.94 143.96 48.52 Favored 'General case' 0 C--N 1.332 -0.185 0 CA-C-O 121.153 0.501 . . . . 0.0 111.622 -177.166 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 78' ' ' ALA . . . . . . . . . . . . . . . -130.62 133.64 46.32 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 115.435 -0.802 . . . . 0.0 109.886 175.574 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 79' ' ' LYS . . . . . 0.564 ' O ' HD13 ' A' ' 80' ' ' ILE . 36.6 ttpt -82.26 117.83 22.66 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.358 -0.383 . . . . 0.0 110.634 -178.019 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 80' ' ' ILE . . . . . 0.564 HD13 ' O ' ' A' ' 79' ' ' LYS . 42.7 mm -139.06 113.07 7.1 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.285 0 N-CA-C 109.156 -0.683 . . . . 0.0 109.156 -178.142 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 81' ' ' LYS . . . . . . . . . . . . . 6.3 mtmp? -100.5 124.69 46.37 Favored 'General case' 0 C--N 1.327 -0.409 0 CA-C-O 120.913 0.387 . . . . 0.0 111.116 -176.637 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . 89.25 42.05 5.66 Favored Glycine 0 CA--C 1.525 0.691 0 C-N-CA 120.961 -0.638 . . . . 0.0 111.642 176.259 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 83' ' ' ILE . . . . . . . . . . . . . 74.9 mt -68.06 132.58 32.6 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.309 0 N-CA-C 109.575 -0.528 . . . . 0.0 109.575 176.694 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 84' ' ' LYS . . . . . . . . . . . . . 39.6 ttpt -95.05 -53.41 3.82 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-O 120.986 0.422 . . . . 0.0 110.365 -177.96 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 85' ' ' ASP . . . . . . . . . . . . . 7.9 t70 -149.69 151.87 34.39 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 115.944 -0.571 . . . . 0.0 110.696 -179.131 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 86' ' ' VAL . . . . . . . . . . . . . 44.1 t -130.67 131.65 64.66 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.267 0 CA-C-N 116.339 -0.392 . . . . 0.0 110.305 179.444 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 87' ' ' ILE . . . . . 0.499 HD12 ' N ' ' A' ' 87' ' ' ILE . 5.1 mp -118.47 126.1 74.86 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.273 0 N-CA-C 109.564 -0.532 . . . . 0.0 109.564 177.027 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 88' ' ' LEU . . . . . . . . . . . . . 15.7 tp -109.79 130.41 55.52 Favored 'General case' 0 C--N 1.332 -0.191 0 CA-C-N 116.34 -0.391 . . . . 0.0 110.687 -178.534 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 89' ' ' ASP . . . . . . . . . . . . . 9.8 t70 -125.88 156.94 38.86 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 116.107 -0.497 . . . . 0.0 109.964 179.091 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 84.8 tt0 -46.48 -38.24 8.94 Favored 'General case' 0 C--N 1.33 -0.248 0 N-CA-C 113.088 0.773 . . . . 0.0 113.088 -172.068 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 91' ' ' ASN . . . . . . . . . . . . . 2.7 t-20 -132.06 20.99 4.49 Favored 'General case' 0 N--CA 1.47 0.532 0 N-CA-C 112.925 0.713 . . . . 0.0 112.925 -177.518 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 92' ' ' LEU . . . . . . . . . . . . . 28.4 mt -149.55 147.71 28.5 Favored 'General case' 0 C--N 1.331 -0.225 0 CA-C-O 120.78 0.324 . . . . 0.0 110.617 -175.938 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 93' ' ' ILE . . . . . . . . . . . . . 70.1 mt -126.22 119.47 54.21 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.264 0 N-CA-C 109.197 -0.668 . . . . 0.0 109.197 176.538 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 94' ' ' VAL . . . . . . . . . . . . . 44.1 t -120.11 127.77 75.91 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.253 0 N-CA-C 109.957 -0.386 . . . . 0.0 109.957 -179.275 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 95' ' ' VAL . . . . . . . . . . . . . 45.9 t -123.32 134.58 65.86 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.208 0 CA-C-N 116.082 -0.508 . . . . 0.0 109.939 -179.433 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 96' ' ' ILE . . . . . . . . . . . . . 63.4 mt -116.86 128.03 74.34 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.284 0 N-CA-C 109.434 -0.58 . . . . 0.0 109.434 -179.726 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 97' ' ' THR . . . . . . . . . . . . . 75.3 p -100.36 155.57 17.73 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-O 121.214 0.531 . . . . 0.0 111.286 -177.501 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 98' ' ' GLU . . . . . . . . . . . . . 84.9 tt0 -53.94 -25.84 22.48 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-N 115.954 -0.566 . . . . 0.0 112.34 179.851 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 99' ' ' GLU . . . . . . . . . . . . . 34.4 tt0 -80.41 17.95 0.99 Allowed 'General case' 0 CA--C 1.54 0.594 0 N-CA-C 112.553 0.575 . . . . 0.0 112.553 -177.164 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 100' ' ' ASN . . . . . . . . . . . . . 3.5 m-20 63.11 36.44 12.2 Favored 'General case' 0 CA--C 1.53 0.174 0 O-C-N 121.931 -0.481 . . . . 0.0 111.221 176.077 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 101' ' ' GLU . . . . . . . . . . . . . 84.8 tt0 -116.72 142.88 46.33 Favored 'General case' 0 C--N 1.332 -0.189 0 CA-C-N 116.318 -0.401 . . . . 0.0 109.942 175.788 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 102' ' ' VAL . . . . . . . . . . . . . 45.0 t -117.11 126.55 74.53 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.262 0 CA-C-N 116.193 -0.458 . . . . 0.0 109.947 -178.06 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 103' ' ' LEU . . . . . 0.407 HD12 ' N ' ' A' ' 103' ' ' LEU . 6.3 mp -118.43 133.73 55.64 Favored 'General case' 0 C--N 1.331 -0.227 0 CA-C-N 116.045 -0.525 . . . . 0.0 110.283 176.759 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 104' ' ' ILE . . . . . . . . . . . . . 70.4 mt -121.27 122.6 67.82 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.235 0 CA-C-N 116.542 -0.299 . . . . 0.0 110.21 -179.045 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 105' ' ' PHE . . . . . . . . . . . . . 39.0 m-85 -123.41 164.52 18.72 Favored 'General case' 0 C--N 1.332 -0.173 0 O-C-N 123.839 0.712 . . . . 0.0 109.809 179.754 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 106' ' ' ASN . . . . . . . . . . . . . 41.7 p-10 -97.55 -169.9 1.92 Allowed 'General case' 0 C--N 1.33 -0.254 0 N-CA-C 109.989 -0.374 . . . . 0.0 109.989 174.315 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 107' ' ' GLN . . . . . . . . . . . . . 27.5 tt0 -60.2 -27.29 67.04 Favored 'General case' 0 CA--C 1.533 0.308 0 N-CA-C 112.002 0.371 . . . . 0.0 112.002 177.925 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 108' ' ' ASN . . . . . . . . . . . . . 10.2 t-20 -81.87 4.21 23.23 Favored 'General case' 0 CA--C 1.536 0.419 0 N-CA-C 113.232 0.827 . . . . 0.0 113.232 -178.95 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 109' ' ' LEU . . . . . . . . . . . . . 12.5 tp 61.03 38.26 17.38 Favored 'General case' 0 C--O 1.234 0.26 0 CA-C-O 120.973 0.415 . . . . 0.0 111.072 179.109 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 110' ' ' GLU . . . . . . . . . . . . . 95.2 mt-10 -111.16 149.89 30.26 Favored 'General case' 0 C--N 1.332 -0.189 0 CA-C-N 116.539 -0.3 . . . . 0.0 110.332 177.086 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 111' ' ' GLU . . . . . . . . . . . . . 98.4 mt-10 -73.12 125.04 26.78 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-O 120.977 0.418 . . . . 0.0 111.48 -178.823 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 112' ' ' LEU . . . . . . . . . . . . . 21.7 mt -109.95 -45.95 3.55 Favored 'General case' 0 C--N 1.331 -0.221 0 CA-C-N 115.819 -0.628 . . . . 0.0 109.917 174.669 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 113' ' ' TYR . . . . . . . . . . . . . 63.7 t80 -141.55 142.55 33.52 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 115.877 -0.601 . . . . 0.0 110.608 178.782 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 114' ' ' ARG . . . . . . . . . . . . . 33.8 ptt-85 -149.14 124.07 9.99 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-O 121.059 0.457 . . . . 0.0 110.789 177.325 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 115' ' ' GLY . . . . . . . . . . . . . . . -150.11 163.03 29.38 Favored Glycine 0 CA--C 1.524 0.636 0 N-CA-C 110.964 -0.854 . . . . 0.0 110.964 -179.12 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 116' ' ' LYS . . . . . . . . . . . . . 34.5 ttmt -130.07 134.98 47.74 Favored 'General case' 0 C--N 1.33 -0.244 0 N-CA-C 110.088 -0.338 . . . . 0.0 110.088 177.928 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 117' ' ' PHE . . . . . 0.425 ' HE2' HD13 ' A' ' 132' ' ' ILE . 33.4 m-85 -130.93 117.39 19.17 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.403 -0.362 . . . . 0.0 110.297 -175.711 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 118' ' ' GLU . . . . . . . . . . . . . 48.9 mp0 -56.08 -43.37 77.95 Favored 'General case' 0 C--N 1.328 -0.352 0 C-N-CA 120.759 -0.376 . . . . 0.0 111.104 -175.025 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 119' ' ' ASN . . . . . . . . . . . . . 71.1 m-80 -100.26 31.08 3.52 Favored 'General case' 0 C--N 1.329 -0.299 0 N-CA-C 112.259 0.466 . . . . 0.0 112.259 -172.737 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 120' ' ' LEU . . . . . . . . . . . . . 11.1 tp -55.82 120.76 7.86 Favored 'General case' 0 C--O 1.232 0.138 0 C-N-CA 121.078 -0.249 . . . . 0.0 110.491 177.199 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 121' ' ' ASN . . . . . . . . . . . . . 33.1 m120 -114.02 -44.06 3.19 Favored 'General case' 0 N--CA 1.463 0.205 0 CA-C-N 116.654 -0.248 . . . . 0.0 111.035 -176.793 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 122' ' ' LYS . . . . . . . . . . . . . 89.0 mttt -143.58 144.89 32.12 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-O 120.942 0.401 . . . . 0.0 111.352 -177.628 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 123' ' ' VAL . . . . . . . . . . . . . 45.7 t -130.53 131.17 65.18 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.27 0 N-CA-C 109.387 -0.597 . . . . 0.0 109.387 175.27 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 124' ' ' LEU . . . . . . . . . . . . . 10.1 tp -131.43 136.27 47.84 Favored 'General case' 0 C--N 1.331 -0.199 0 CA-C-O 120.824 0.345 . . . . 0.0 111.151 -176.857 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 125' ' ' VAL . . . . . . . . . . . . . 45.0 t -127.58 129.96 70.38 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.232 0 CA-C-N 116.059 -0.519 . . . . 0.0 109.751 177.061 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 126' ' ' ARG . . . . . . . . . . . . . 63.0 ttm-85 -141.63 124.73 16.32 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-O 120.944 0.402 . . . . 0.0 110.603 179.851 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 127' ' ' ASN . . . . . . . . . . . . . 23.1 m120 50.58 -109.79 0.42 Allowed 'General case' 0 CA--C 1.545 0.754 0 CA-C-O 118.832 -0.604 . . . . 0.0 111.293 179.738 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 128' ' ' ASP . . . . . . . . . . . . . 9.9 p-10 -114.08 8.67 17.09 Favored 'General case' 0 N--CA 1.469 0.516 0 CA-C-N 119.875 1.216 . . . . 0.0 113.158 -179.124 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 129' ' ' LEU . . . . . . . . . . . . . 18.1 tp -107.75 134.99 49.92 Favored 'General case' 0 C--N 1.332 -0.166 0 CA-C-N 117.956 0.344 . . . . 0.0 110.123 179.643 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 130' ' ' VAL . . . . . . . . . . . . . 44.0 t -116.69 132.69 65.64 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.253 0 N-CA-C 109.583 -0.525 . . . . 0.0 109.583 179.617 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 131' ' ' VAL . . . . . . . . . . . . . 40.7 t -132.89 133.99 58.55 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.253 0 CA-C-O 121.034 0.445 . . . . 0.0 110.474 -179.258 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 132' ' ' ILE . . . . . 0.425 HD13 ' HE2' ' A' ' 117' ' ' PHE . 74.6 mt -118.45 130.66 72.99 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 CA-C-N 115.72 -0.673 . . . . 0.0 109.204 177.718 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 133' ' ' ILE . . . . . . . . . . . . . 40.0 mm -116.68 123.39 71.6 Favored 'Isoleucine or valine' 0 C--O 1.234 0.262 0 CA-C-O 120.933 0.397 . . . . 0.0 111.071 -174.228 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 134' ' ' ASP . . . . . . . . . . . . . 6.8 p-10 -136.45 146.33 46.23 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-N 116.006 -0.543 . . . . 0.0 109.557 175.227 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 135' ' ' GLU . . . . . . . . . . . . . 38.9 tp10 -50.32 -27.94 7.04 Favored 'General case' 0 C--N 1.328 -0.36 0 N-CA-C 112.598 0.592 . . . . 0.0 112.598 -173.592 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 136' ' ' GLN . . . . . . . . . . . . . 97.8 mt-30 -76.04 -37.23 58.59 Favored 'General case' 0 C--O 1.234 0.246 0 N-CA-C 112.34 0.496 . . . . 0.0 112.34 -177.903 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 137' ' ' LYS . . . . . . . . . . . . . 47.5 pttt -168.02 175.0 6.93 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-O 121.607 0.718 . . . . 0.0 112.19 -171.593 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 138' ' ' LEU . . . . . 0.412 ' C ' HD23 ' A' ' 138' ' ' LEU . 6.3 tt -118.94 128.57 54.54 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 115.13 -0.941 . . . . 0.0 110.039 179.247 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 139' ' ' THR . . . . . 0.403 ' N ' HD23 ' A' ' 138' ' ' LEU . 31.5 m -108.03 126.02 52.24 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.285 -0.416 . . . . 0.0 110.291 179.885 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 140' ' ' LEU . . . . . . . . . . . . . 36.5 tp -113.04 122.95 49.13 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 115.722 -0.672 . . . . 0.0 109.305 -179.364 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 141' ' ' ILE . . . . . . . . . . . . . 19.0 mt -121.84 119.82 59.81 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 CA-C-O 120.955 0.407 . . . . 0.0 110.052 -174.411 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 142' ' ' ARG . . . . . . . . . . . . . 54.8 mtp180 -105.09 123.22 47.44 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 115.583 -0.735 . . . . 0.0 110.165 178.856 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 143' ' ' THR . . . . . . . . . . . . . 31.8 p . . . . . 0 C--O 1.221 -0.446 0 CA-C-O 117.98 -1.01 . . . . 0.0 110.515 -179.672 . . . . . . . . 0 0 . 1 . 006 nuclear nobuild full ' B' B ' -3' ' ' GLU . . . . . . . . . . . . . 70.5 mm-40 . . . . . 0 N--CA 1.49 1.526 0 N-CA-C 109.428 -0.582 . . . . 0.0 109.428 . . . . . . . . . 0 0 . 1 . 006 nuclear nobuild full ' B' B ' -2' ' ' GLY . . . . . . . . . . . . . . . -72.27 146.26 38.98 Favored Glycine 0 CA--C 1.526 0.774 0 N-CA-C 110.912 -0.875 . . . . 0.0 110.912 179.825 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' -1' ' ' VAL . . . . . . . . . . . . . 43.3 t -141.41 137.15 32.8 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.299 0 N-CA-C 110.095 -0.335 . . . . 0.0 110.095 179.381 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 0' ' ' ILE . . . . . . . . . . . . . 44.7 mm -113.92 136.25 50.99 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.273 0 CA-C-N 116.258 -0.428 . . . . 0.0 110.088 179.376 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 1' ' ' MET . . . . . . . . . . . . . 23.7 ptm -81.14 133.04 35.39 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.065 -0.516 . . . . 0.0 110.916 -178.46 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 2' ' ' SER . . . . . . . . . . . . . 13.5 p -118.97 136.26 54.19 Favored 'General case' 0 C--O 1.233 0.197 0 CA-C-N 116.308 -0.405 . . . . 0.0 110.9 -179.668 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 3' ' ' GLU . . . . . . . . . . . . . 46.9 mp0 -140.65 147.37 39.21 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.181 -0.463 . . . . 0.0 111.33 -178.746 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 4' ' ' LEU . . . . . . . . . . . . . 17.8 tp -127.02 127.71 45.19 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 115.702 -0.681 . . . . 0.0 109.947 174.718 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 5' ' ' LYS . . . . . . . . . . . . . 92.5 mttt -109.51 121.23 44.72 Favored 'General case' 0 C--O 1.234 0.27 0 CA-C-O 120.815 0.34 . . . . 0.0 110.855 178.919 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 6' ' ' LEU . . . . . . . . . . . . . 58.1 mt -115.08 147.24 40.44 Favored 'General case' 0 C--N 1.331 -0.211 0 CA-C-N 115.375 -0.83 . . . . 0.0 110.716 -179.097 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 7' ' ' LYS . . . . . . . . . . . . . 69.5 tttt -134.89 138.02 28.63 Favored Pre-proline 0 CA--C 1.534 0.355 0 CA-C-O 118.955 -0.545 . . . . 0.0 109.989 175.78 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 8' ' ' PRO . . . . . . . . . . . . . 75.1 Cg_endo -90.06 139.67 3.16 Favored 'Trans proline' 0 N--CA 1.489 1.249 0 C-N-CA 121.7 1.6 . . . . 0.0 111.574 178.213 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 9' ' ' LEU . . . . . . . . . . . . . 26.8 mt -77.27 -51.91 1.91 Allowed Pre-proline 0 CA--C 1.531 0.239 0 CA-C-O 119.138 -0.458 . . . . 0.0 111.313 -177.488 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 10' ' ' PRO . . . . . . . . . . . . . 71.7 Cg_endo -76.56 149.86 31.03 Favored 'Trans proline' 0 N--CA 1.497 1.682 0 C-N-CA 121.156 1.238 . . . . 0.0 111.399 170.671 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 11' ' ' LYS . . . . . . . . . . . . . 25.1 pttm -84.91 117.02 23.66 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-O 121.45 0.643 . . . . 0.0 110.61 178.254 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 12' ' ' VAL . . . . . . . . . . . . . 12.8 p -151.06 148.04 15.2 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 CA-C-N 115.653 -0.703 . . . . 0.0 110.493 -179.44 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 13' ' ' GLU . . . . . . . . . . . . . 84.7 tt0 -91.03 125.5 35.84 Favored 'General case' 0 C--N 1.329 -0.321 0 N-CA-C 110.034 -0.358 . . . . 0.0 110.034 177.827 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 14' ' ' LEU . . . . . . . . . . . . . 28.2 mt -97.87 149.86 36.17 Favored Pre-proline 0 CA--C 1.533 0.291 0 CA-C-N 116.357 -0.383 . . . . 0.0 110.718 -176.583 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 15' ' ' PRO . . . . . . . . . . . . . 24.0 Cg_exo -63.69 161.28 32.75 Favored 'Trans proline' 0 N--CA 1.497 1.689 0 C-N-CA 121.402 1.401 . . . . 0.0 111.866 175.648 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 16' ' ' PRO . . . . . . . . . . . . . 27.4 Cg_exo -60.35 -35.64 90.42 Favored 'Trans proline' 0 N--CA 1.498 1.745 0 C-N-CA 121.451 1.434 . . . . 0.0 112.789 -178.535 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 17' ' ' ASP . . . . . . . . . . . . . 9.4 p-10 -89.13 8.07 31.85 Favored 'General case' 0 CA--C 1.536 0.426 0 N-CA-C 113.245 0.831 . . . . 0.0 113.245 -177.428 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 18' ' ' PHE . . . . . . . . . . . . . 47.5 t80 -58.27 -44.97 88.67 Favored 'General case' 0 C--N 1.334 -0.108 0 O-C-N 122.041 -0.412 . . . . 0.0 110.031 -178.017 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 19' ' ' VAL . . . . . 0.407 HG13 ' N ' ' B' ' 20' ' ' ASP . 13.8 p -55.66 -41.27 64.19 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.36 0 CA-C-N 116.283 -0.417 . . . . 0.0 111.058 -178.984 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' B' B ' 20' ' ' ASP . . . . . 0.407 ' N ' HG13 ' B' ' 19' ' ' VAL . 75.6 m-20 -60.9 -43.49 98.44 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-O 120.951 0.405 . . . . 0.0 110.888 -178.154 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' B' B ' 21' ' ' VAL . . . . . . . . . . . . . 47.4 t -65.07 -46.39 91.46 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.281 0 CA-C-N 116.331 -0.395 . . . . 0.0 110.555 -177.556 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 22' ' ' ILE . . . . . 0.626 HG22 HD12 ' B' ' 26' ' ' LEU . 50.9 mm -55.15 -46.52 77.68 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.259 0 CA-C-O 120.817 0.341 . . . . 0.0 110.645 179.483 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' B' B ' 23' ' ' ARG . . . . . . . . . . . . . 26.8 ttm-85 -53.65 -54.08 42.87 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-O 121.16 0.505 . . . . 0.0 111.385 -179.727 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 24' ' ' ILE . . . . . . . . . . . . . 77.3 mt -60.66 -36.72 72.47 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.373 0 CA-C-N 115.61 -0.723 . . . . 0.0 111.581 -173.675 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 25' ' ' LYS . . . . . . . . . . . . . 57.5 mttm -70.71 -42.86 70.07 Favored 'General case' 0 C--N 1.33 -0.281 0 N-CA-C 112.551 0.574 . . . . 0.0 112.551 179.781 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 26' ' ' LEU . . . . . 0.626 HD12 HG22 ' B' ' 22' ' ' ILE . 34.3 mt -77.75 -35.84 51.34 Favored 'General case' 0 C--N 1.331 -0.23 0 N-CA-C 113.15 0.796 . . . . 0.0 113.15 -170.748 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' B' B ' 27' ' ' GLN . . . . . . . . . . . . . 5.3 pt20 -46.97 140.91 4.44 Favored 'General case' 0 N--CA 1.468 0.462 0 N-CA-C 112.747 0.647 . . . . 0.0 112.747 -175.808 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 28' ' ' GLY . . . . . . . . . . . . . . . 99.96 -24.79 30.76 Favored Glycine 0 CA--C 1.534 1.223 0 CA-C-N 115.624 -0.716 . . . . 0.0 112.261 -176.733 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 29' ' ' LYS . . . . . . . . . . . . . 47.2 mtmt -98.24 155.15 17.32 Favored 'General case' 0 C--N 1.332 -0.187 0 CA-C-N 117.339 0.57 . . . . 0.0 111.269 179.64 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 30' ' ' THR . . . . . . . . . . . . . 38.9 m -107.19 138.48 43.3 Favored 'General case' 0 C--N 1.331 -0.209 0 CA-C-N 115.914 -0.585 . . . . 0.0 109.901 176.62 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 31' ' ' VAL . . . . . . . . . . . . . 34.1 m -131.72 155.89 42.09 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.206 0 CA-C-O 120.99 0.424 . . . . 0.0 111.551 -176.866 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 32' ' ' ARG . . . . . . . . . . . . . 36.3 mtp180 -129.28 152.69 48.57 Favored 'General case' 0 C--O 1.233 0.236 0 CA-C-N 115.667 -0.697 . . . . 0.0 110.688 176.802 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 33' ' ' THR . . . . . . . . . . . . . 24.6 m -53.57 139.71 30.77 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.203 -0.453 . . . . 0.0 111.253 -179.075 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 34' ' ' GLY . . . . . . . . . . . . . . . 99.43 -17.13 58.18 Favored Glycine 0 CA--C 1.532 1.109 0 CA-C-O 119.486 -0.619 . . . . 0.0 113.304 177.69 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 35' ' ' ASP . . . . . . . . . . . . . 76.1 m-20 -65.09 148.25 52.0 Favored 'General case' 0 C--O 1.232 0.178 0 CA-C-N 118.116 0.958 . . . . 0.0 110.97 179.346 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 36' ' ' VAL . . . . . . . . . . . . . 45.7 t -122.52 131.52 73.05 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.241 0 CA-C-N 115.969 -0.559 . . . . 0.0 109.85 178.58 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 37' ' ' ILE . . . . . . . . . . . . . 66.7 mt -118.68 138.52 49.12 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 CA-C-N 116.128 -0.487 . . . . 0.0 109.89 -179.462 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 38' ' ' GLY . . . . . . . . . . . . . . . -109.83 128.69 9.02 Favored Glycine 0 CA--C 1.526 0.757 0 N-CA-C 110.871 -0.892 . . . . 0.0 110.871 179.5 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 39' ' ' ILE . . . . . . . . . . . . . 71.7 mt -124.62 131.46 72.67 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.246 0 N-CA-C 110.047 -0.353 . . . . 0.0 110.047 179.437 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 40' ' ' SER . . . . . . . . . . . . . 31.5 t -92.86 119.99 32.75 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.332 -0.395 . . . . 0.0 110.675 175.819 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 41' ' ' ILE . . . . . . . . . . . . . 70.4 mt -131.54 119.99 44.23 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.202 0 N-CA-C 110.223 -0.288 . . . . 0.0 110.223 178.418 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 42' ' ' LEU . . . . . . . . . . . . . 30.1 mt 56.87 33.83 23.8 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.227 -0.442 . . . . 0.0 111.84 178.729 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 43' ' ' GLY . . . . . . . . . . . . . . . 81.05 -10.13 49.78 Favored Glycine 0 CA--C 1.535 1.302 0 C-N-CA 121.24 -0.505 . . . . 0.0 113.584 176.482 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 44' ' ' LYS . . . . . . . . . . . . . 93.4 mttt -100.03 134.43 42.96 Favored 'General case' 0 C--N 1.333 -0.126 0 CA-C-N 117.821 0.81 . . . . 0.0 110.188 177.563 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 45' ' ' GLU . . . . . . . . . . . . . 85.0 tt0 -85.71 130.5 34.55 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 116.213 -0.449 . . . . 0.0 111.217 -179.815 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 46' ' ' VAL . . . . . . . . . . . . . 7.3 p -124.46 129.85 73.73 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.211 0 N-CA-C 109.605 -0.517 . . . . 0.0 109.605 175.714 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 47' ' ' LYS . . . . . . . . . . . . . 79.9 mttt -101.08 130.75 47.16 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.006 -0.543 . . . . 0.0 111.171 177.674 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 48' ' ' PHE . . . . . . . . . . . . . 93.5 m-85 -112.46 132.0 55.28 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 116.478 -0.328 . . . . 0.0 110.131 176.102 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 49' ' ' LYS . . . . . . . . . . . . . 68.5 tttt -106.04 135.54 47.3 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.352 -0.386 . . . . 0.0 110.398 179.123 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 50' ' ' VAL . . . . . . . . . . . . . 43.4 t -81.96 110.18 16.92 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.243 0 N-CA-C 109.435 -0.58 . . . . 0.0 109.435 177.001 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 51' ' ' VAL . . . . . . . . . . . . . 47.5 t -75.53 -47.04 35.63 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.295 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.092 -173.964 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 52' ' ' GLN . . . . . . . . . . . . . 62.8 tt0 -160.83 137.26 8.57 Favored 'General case' 0 C--N 1.332 -0.186 0 C-N-CA 120.165 -0.614 . . . . 0.0 112.193 -177.917 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 53' ' ' ALA . . . . . . . . . . . . . . . -112.51 130.35 56.03 Favored 'General case' 0 C--N 1.331 -0.211 0 CA-C-N 115.741 -0.663 . . . . 0.0 109.312 172.295 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 54' ' ' TYR . . . . . . . . . . . . . 47.4 t80 -129.05 110.22 18.26 Favored Pre-proline 0 C--N 1.328 -0.341 0 CA-C-O 118.22 -0.895 . . . . 0.0 110.689 -178.342 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 55' ' ' PRO . . . . . . . . . . . . . 72.8 Cg_endo -77.31 170.11 72.23 Favored 'Cis proline' 0 N--CA 1.5 1.909 0 CA-C-N 121.949 1.732 . . . . 0.0 112.22 -6.177 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 56' ' ' SER . . . . . . . . . . . . . 13.7 m -116.24 135.88 22.91 Favored Pre-proline 0 CA--C 1.539 0.536 0 CA-C-O 118.491 -0.766 . . . . 0.0 109.329 175.143 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 57' ' ' PRO . . . . . . . . . . . . . 53.1 Cg_endo -70.34 145.57 81.06 Favored 'Cis proline' 0 N--CA 1.498 1.755 0 CA-C-N 121.795 1.677 . . . . 0.0 111.452 -1.546 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 58' ' ' LEU . . . . . . . . . . . . . 29.2 tp -108.34 138.3 44.85 Favored 'General case' 0 C--N 1.331 -0.225 0 CA-C-N 116.271 -0.422 . . . . 0.0 110.866 -177.865 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 59' ' ' ARG . . . . . . . . . . . . . 55.7 ttt180 -103.52 127.05 50.99 Favored 'General case' 0 C--N 1.328 -0.333 0 N-CA-C 109.341 -0.614 . . . . 0.0 109.341 174.543 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 60' ' ' VAL . . . . . . . . . . . . . 42.2 t -82.2 117.27 27.88 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.285 0 C-N-CA 120.74 -0.384 . . . . 0.0 110.327 -176.486 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 61' ' ' GLU . . . . . . . . . . . . . 77.5 tt0 -131.2 156.83 44.68 Favored 'General case' 0 C--N 1.329 -0.302 0 N-CA-C 109.12 -0.696 . . . . 0.0 109.12 176.158 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 62' ' ' ASP . . . . . . . . . . . . . 5.6 t70 -50.11 -30.99 12.24 Favored 'General case' 0 C--N 1.328 -0.363 0 N-CA-C 112.223 0.453 . . . . 0.0 112.223 -178.987 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 63' ' ' ARG . . . . . . . . . . . . . 20.5 mtp-105 -72.12 -22.08 61.38 Favored 'General case' 0 CA--C 1.533 0.311 0 N-CA-C 113.063 0.764 . . . . 0.0 113.063 -176.398 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 64' ' ' THR . . . . . . . . . . . . . 27.1 m -69.55 144.05 53.21 Favored 'General case' 0 C--N 1.331 -0.209 0 CA-C-O 120.92 0.39 . . . . 0.0 111.122 -174.989 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 65' ' ' LYS . . . . . . . . . . . . . 85.1 mttt -89.18 130.08 35.66 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.062 -0.517 . . . . 0.0 110.126 178.739 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 66' ' ' ILE . . . . . . . . . . . . . 67.6 mt -115.53 131.94 66.4 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.223 0 N-CA-C 109.886 -0.413 . . . . 0.0 109.886 -179.762 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 67' ' ' THR . . . . . . . . . . . . . 32.7 m -127.54 140.44 52.13 Favored 'General case' 0 C--N 1.331 -0.225 0 CA-C-O 121.232 0.539 . . . . 0.0 110.999 -178.235 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 68' ' ' LEU . . . . . . . . . . . . . 41.5 mt -101.51 130.25 47.74 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 115.768 -0.651 . . . . 0.0 109.978 177.349 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 69' ' ' VAL . . . . . . . . . . . . . 43.5 t -99.42 130.54 48.26 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.319 0 CA-C-N 116.359 -0.382 . . . . 0.0 110.1 -179.829 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 70' ' ' THR . . . . . . . . . . . . . 7.1 m -134.82 118.03 16.56 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.429 178.84 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 71' ' ' HIS . . . . . . . . . . . . . 39.9 m80 -148.72 151.51 35.66 Favored Pre-proline 0 C--N 1.329 -0.3 0 CA-C-N 116.052 -0.522 . . . . 0.0 109.957 178.848 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 72' ' ' PRO . . . . . . . . . . . . . 90.0 Cg_endo -81.26 -30.03 1.73 Allowed 'Trans proline' 0 N--CA 1.493 1.492 0 C-N-CA 121.254 1.303 . . . . 0.0 112.465 -179.198 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 73' ' ' VAL . . . . . . . . . . . . . 27.7 m -151.43 161.94 3.15 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.282 0 CA-C-O 120.874 0.368 . . . . 0.0 110.488 177.923 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 74' ' ' ASP . . . . . . . . . . . . . 31.9 t0 -102.88 116.96 33.57 Favored 'General case' 0 C--N 1.33 -0.27 0 N-CA-C 109.467 -0.568 . . . . 0.0 109.467 176.867 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 75' ' ' VAL . . . . . 0.492 ' C ' HD12 ' B' ' 76' ' ' LEU . 42.1 t -114.04 124.41 70.67 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.26 0 CA-C-O 121.057 0.456 . . . . 0.0 110.704 -176.148 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' B' B ' 76' ' ' LEU . . . . . 0.492 HD12 ' C ' ' B' ' 75' ' ' VAL . 7.3 mp -122.39 144.25 49.15 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 115.71 -0.677 . . . . 0.0 109.841 175.864 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' B' B ' 77' ' ' GLU . . . . . . . . . . . . . 97.7 mt-10 -134.6 130.28 36.24 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-O 121.07 0.462 . . . . 0.0 110.837 -178.887 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 78' ' ' ALA . . . . . 0.646 ' HB2' HD21 ' B' ' 109' ' ' LEU . . . -117.68 128.24 54.72 Favored 'General case' 0 C--N 1.331 -0.221 0 CA-C-N 115.8 -0.636 . . . . 0.0 109.938 177.966 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' B' B ' 79' ' ' LYS . . . . . 0.648 ' O ' HD13 ' B' ' 80' ' ' ILE . 49.0 tptt -75.65 118.75 18.81 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.306 -0.406 . . . . 0.0 110.62 -177.37 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' B' B ' 80' ' ' ILE . . . . . 0.648 HD13 ' O ' ' B' ' 79' ' ' LYS . 38.1 mm -139.11 106.24 2.84 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.325 0 N-CA-C 109.278 -0.638 . . . . 0.0 109.278 -177.588 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' B' B ' 81' ' ' LYS . . . . . . . . . . . . . 86.1 mttt -93.56 126.85 38.94 Favored 'General case' 0 C--N 1.328 -0.368 0 C-N-CA 120.709 -0.397 . . . . 0.0 111.086 -178.636 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 82' ' ' GLY . . . . . . . . . . . . . . . 89.04 42.14 5.7 Favored Glycine 0 CA--C 1.525 0.71 0 C-N-CA 120.811 -0.709 . . . . 0.0 111.839 174.092 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 83' ' ' ILE . . . . . . . . . . . . . 71.6 mt -70.28 131.46 34.22 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.312 0 N-CA-C 109.339 -0.615 . . . . 0.0 109.339 176.128 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 84' ' ' LYS . . . . . . . . . . . . . 38.5 ttpt -99.05 -43.99 6.47 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.568 -0.287 . . . . 0.0 110.389 -178.272 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 85' ' ' ASP . . . . . . . . . . . . . 9.7 t70 -155.48 154.26 31.56 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.356 -0.384 . . . . 0.0 110.792 179.348 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 86' ' ' VAL . . . . . . . . . . . . . 44.5 t -132.93 134.36 58.2 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.183 0 CA-C-O 120.959 0.409 . . . . 0.0 110.502 -179.476 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 87' ' ' ILE . . . . . . . . . . . . . 44.3 mm -121.03 128.47 76.07 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.274 0 CA-C-N 115.798 -0.637 . . . . 0.0 109.593 178.7 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 88' ' ' LEU . . . . . . . . . . . . . 17.4 tp -115.17 133.19 56.26 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-O 120.985 0.421 . . . . 0.0 111.116 -178.04 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 89' ' ' ASP . . . . . . . . . . . . . 7.0 t70 -127.42 159.9 33.08 Favored 'General case' 0 C--N 1.332 -0.17 0 CA-C-N 115.898 -0.592 . . . . 0.0 109.574 176.822 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 90' ' ' GLU . . . . . . . . . . . . . 96.3 mt-10 -47.15 -38.07 11.04 Favored 'General case' 0 C--N 1.33 -0.272 0 N-CA-C 113.2 0.815 . . . . 0.0 113.2 -171.009 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 91' ' ' ASN . . . . . . . . . . . . . 1.2 p30 -132.04 20.69 4.5 Favored 'General case' 0 N--CA 1.468 0.442 0 N-CA-C 113.038 0.755 . . . . 0.0 113.038 -176.736 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 92' ' ' LEU . . . . . . . . . . . . . 57.5 mt -149.01 146.93 28.0 Favored 'General case' 0 C--N 1.331 -0.204 0 CA-C-O 120.767 0.318 . . . . 0.0 110.64 -177.038 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 93' ' ' ILE . . . . . . . . . . . . . 67.1 mt -123.89 119.86 58.08 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.291 0 N-CA-C 109.236 -0.653 . . . . 0.0 109.236 178.231 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 94' ' ' VAL . . . . . . . . . . . . . 44.7 t -118.76 128.28 75.64 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.257 0 N-CA-C 109.829 -0.434 . . . . 0.0 109.829 -179.076 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 95' ' ' VAL . . . . . . . . . . . . . 42.6 t -121.73 134.1 66.08 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.304 0 CA-C-N 116.138 -0.483 . . . . 0.0 109.829 -179.882 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 96' ' ' ILE . . . . . . . . . . . . . 63.7 mt -115.13 127.1 72.82 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.21 0 N-CA-C 109.411 -0.589 . . . . 0.0 109.411 179.95 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 97' ' ' THR . . . . . . . . . . . . . 66.4 p -102.6 157.71 16.75 Favored 'General case' 0 C--N 1.331 -0.222 0 CA-C-O 121.394 0.616 . . . . 0.0 111.376 -176.74 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 98' ' ' GLU . . . . . . . . . . . . . 84.0 tt0 -53.9 -25.54 20.61 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 115.867 -0.606 . . . . 0.0 112.317 179.834 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 99' ' ' GLU . . . . . . . . . . . . . 45.8 mp0 -77.69 14.37 1.06 Allowed 'General case' 0 CA--C 1.535 0.403 0 N-CA-C 113.161 0.8 . . . . 0.0 113.161 -177.206 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 100' ' ' ASN . . . . . . . . . . . . . 3.2 m-20 62.32 38.04 13.45 Favored 'General case' 0 CA--C 1.529 0.169 0 CA-C-O 121.05 0.453 . . . . 0.0 110.747 178.699 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 101' ' ' GLU . . . . . . . . . . . . . 84.7 tt0 -120.61 141.76 50.03 Favored 'General case' 0 C--N 1.332 -0.163 0 CA-C-N 116.098 -0.501 . . . . 0.0 109.75 177.214 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 102' ' ' VAL . . . . . . . . . . . . . 44.9 t -114.97 127.63 72.45 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.297 0 CA-C-N 116.331 -0.395 . . . . 0.0 109.972 -178.297 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 103' ' ' LEU . . . . . . . . . . . . . 6.7 mp -117.25 132.83 56.54 Favored 'General case' 0 C--N 1.331 -0.227 0 CA-C-N 115.763 -0.653 . . . . 0.0 110.273 176.988 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 104' ' ' ILE . . . . . 0.556 HD13 HG21 ' B' ' 130' ' ' VAL . 67.3 mt -118.24 121.69 67.79 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.24 0 CA-C-N 116.037 -0.529 . . . . 0.0 110.031 179.662 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' B' B ' 105' ' ' PHE . . . . . . . . . . . . . 56.7 m-85 -120.37 161.72 20.71 Favored 'General case' 0 C--N 1.331 -0.219 0 O-C-N 123.98 0.8 . . . . 0.0 109.651 178.64 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 106' ' ' ASN . . . . . . . . . . . . . 44.2 p-10 -93.97 -169.95 2.2 Favored 'General case' 0 C--N 1.33 -0.249 0 N-CA-C 110.053 -0.351 . . . . 0.0 110.053 175.019 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 107' ' ' GLN . . . . . . . . . . . . . 61.4 tt0 -58.91 -30.03 67.51 Favored 'General case' 0 C--N 1.33 -0.258 0 N-CA-C 111.876 0.324 . . . . 0.0 111.876 179.333 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 108' ' ' ASN . . . . . . . . . . . . . 6.8 t30 -83.66 7.94 15.96 Favored 'General case' 0 CA--C 1.536 0.406 0 N-CA-C 113.193 0.812 . . . . 0.0 113.193 -177.274 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 109' ' ' LEU . . . . . 0.646 HD21 ' HB2' ' B' ' 78' ' ' ALA . 12.0 tp 60.78 37.66 18.64 Favored 'General case' 0 C--O 1.232 0.181 0 CA-C-O 120.962 0.41 . . . . 0.0 111.211 179.074 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' B' B ' 110' ' ' GLU . . . . . . . . . . . . . 95.4 mt-10 -107.34 151.24 25.76 Favored 'General case' 0 C--N 1.331 -0.238 0 N-CA-C 109.925 -0.398 . . . . 0.0 109.925 176.174 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 111' ' ' GLU . . . . . . . . . . . . . 84.8 tt0 -82.01 123.24 28.73 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-O 120.939 0.399 . . . . 0.0 111.175 -175.626 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 112' ' ' LEU . . . . . . . . . . . . . 33.7 mt -108.36 -46.0 3.79 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 115.933 -0.576 . . . . 0.0 110.481 177.443 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 113' ' ' TYR . . . . . . . . . . . . . 60.5 t80 -140.61 137.68 33.84 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.163 -0.471 . . . . 0.0 110.921 -179.053 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 114' ' ' ARG . . . . . . . . . . . . . 56.9 ttp180 -147.0 124.98 12.0 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-O 120.991 0.424 . . . . 0.0 110.386 175.866 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 115' ' ' GLY . . . . . . . . . . . . . . . -150.15 156.53 26.78 Favored Glycine 0 CA--C 1.526 0.737 0 N-CA-C 110.95 -0.86 . . . . 0.0 110.95 179.164 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 116' ' ' LYS . . . . . . . . . . . . . 35.0 ttpt -118.69 138.45 52.62 Favored 'General case' 0 C--O 1.233 0.189 0 CA-C-O 120.73 0.3 . . . . 0.0 110.288 179.18 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 117' ' ' PHE . . . . . . . . . . . . . 24.0 m-85 -135.78 114.07 11.53 Favored 'General case' 0 C--N 1.329 -0.299 0 N-CA-C 109.733 -0.469 . . . . 0.0 109.733 -178.973 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 118' ' ' GLU . . . . . . . . . . . . . 96.3 mt-10 -54.97 -42.22 72.12 Favored 'General case' 0 C--N 1.329 -0.29 0 C-N-CA 120.874 -0.33 . . . . 0.0 111.223 -176.234 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 119' ' ' ASN . . . . . . . . . . . . . 2.5 m120 -97.32 31.13 2.58 Favored 'General case' 0 C--N 1.33 -0.257 0 N-CA-C 112.148 0.425 . . . . 0.0 112.148 -174.97 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 120' ' ' LEU . . . . . . . . . . . . . 18.7 tp -57.13 121.85 11.03 Favored 'General case' 0 C--N 1.332 -0.174 0 N-CA-C 110.278 -0.268 . . . . 0.0 110.278 177.253 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 121' ' ' ASN . . . . . . . . . . . . . 57.9 m-20 -113.98 -44.17 3.18 Favored 'General case' 0 C--N 1.332 -0.186 0 CA-C-N 116.667 -0.242 . . . . 0.0 111.309 -176.766 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 122' ' ' LYS . . . . . . . . . . . . . 98.3 mttt -146.67 149.76 34.09 Favored 'General case' 0 C--O 1.232 0.171 0 C-N-CA 120.442 -0.503 . . . . 0.0 112.008 -177.951 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 123' ' ' VAL . . . . . . . . . . . . . 48.8 t -119.41 127.78 75.85 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.218 0 CA-C-N 115.697 -0.683 . . . . 0.0 109.163 174.326 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 124' ' ' LEU . . . . . . . . . . . . . 31.6 mt -120.89 136.01 55.04 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 116.531 -0.304 . . . . 0.0 110.633 -176.255 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 125' ' ' VAL . . . . . . . . . . . . . 42.6 t -131.1 131.45 63.84 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.264 0 CA-C-N 116.306 -0.406 . . . . 0.0 110.266 179.121 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 126' ' ' ARG . . . . . . . . . . . . . 27.7 mtp180 -151.55 129.73 11.93 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.113 -0.494 . . . . 0.0 109.842 176.619 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 127' ' ' ASN . . . . . . . . . . . . . 32.5 t30 56.2 -152.45 0.38 Allowed 'General case' 0 CA--C 1.54 0.565 0 N-CA-C 109.7 -0.481 . . . . 0.0 109.7 -179.119 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 128' ' ' ASP . . . . . . . . . . . . . 15.9 p-10 -83.6 18.04 2.03 Favored 'General case' 0 CA--C 1.537 0.45 0 CA-C-N 118.526 0.603 . . . . 0.0 112.562 177.558 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 129' ' ' LEU . . . . . . . . . . . . . 41.1 mt -115.24 144.92 42.99 Favored 'General case' 0 C--O 1.232 0.179 0 CA-C-N 117.956 0.344 . . . . 0.0 110.24 179.69 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 130' ' ' VAL . . . . . 0.556 HG21 HD13 ' B' ' 104' ' ' ILE . 32.3 m -129.31 143.21 41.89 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.232 0 CA-C-O 120.93 0.395 . . . . 0.0 110.6 -178.512 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' B' B ' 131' ' ' VAL . . . . . 0.587 HG22 HD12 ' B' ' 140' ' ' LEU . 38.0 t -136.1 141.34 41.87 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.254 0 CA-C-O 121.079 0.466 . . . . 0.0 110.551 -178.844 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' B' B ' 132' ' ' ILE . . . . . . . . . . . . . 74.1 mt -118.39 131.38 71.34 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.262 0 CA-C-N 115.805 -0.634 . . . . 0.0 109.396 178.726 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 133' ' ' ILE . . . . . . . . . . . . . 41.8 mm -117.11 125.12 73.75 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.235 0 CA-C-O 120.785 0.326 . . . . 0.0 111.158 -174.035 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 134' ' ' ASP . . . . . . . . . . . . . 9.7 p-10 -136.09 148.01 48.09 Favored 'General case' 0 C--N 1.332 -0.167 0 N-CA-C 109.514 -0.55 . . . . 0.0 109.514 172.89 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 135' ' ' GLU . . . . . . . . . . . . . 44.3 tp10 -49.92 -27.26 5.02 Favored 'General case' 0 C--N 1.326 -0.45 0 N-CA-C 112.873 0.694 . . . . 0.0 112.873 -172.668 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 136' ' ' GLN . . . . . . . . . . . . . 53.8 mt-30 -85.23 -30.46 23.82 Favored 'General case' 0 C--N 1.33 -0.24 0 N-CA-C 112.694 0.627 . . . . 0.0 112.694 -175.113 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 137' ' ' LYS . . . . . . . . . . . . . 22.9 pttm -167.62 171.18 10.44 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-O 121.518 0.675 . . . . 0.0 112.483 -173.024 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 138' ' ' LEU . . . . . 0.406 HD23 ' N ' ' B' ' 139' ' ' THR . 6.4 tt -121.11 130.02 53.56 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 115.059 -0.973 . . . . 0.0 110.164 -178.521 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' B' B ' 139' ' ' THR . . . . . 0.406 ' N ' HD23 ' B' ' 138' ' ' LEU . 29.2 m -109.57 125.38 52.47 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-N 116.26 -0.427 . . . . 0.0 110.291 178.593 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' B' B ' 140' ' ' LEU . . . . . 0.587 HD12 HG22 ' B' ' 131' ' ' VAL . 15.0 tp -114.24 119.24 36.35 Favored 'General case' 0 C--N 1.328 -0.328 0 N-CA-C 109.412 -0.588 . . . . 0.0 109.412 -178.015 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' B' B ' 141' ' ' ILE . . . . . 0.518 ' HB ' HG23 ' B' ' 130' ' ' VAL . 22.1 mt -120.08 121.18 65.2 Favored 'Isoleucine or valine' 0 C--O 1.234 0.248 0 CA-C-O 121.067 0.461 . . . . 0.0 110.217 -175.731 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' B' B ' 142' ' ' ARG . . . . . . . . . . . . . 85.3 mtm180 -107.13 127.23 53.31 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 115.219 -0.9 . . . . 0.0 110.435 -178.748 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 143' ' ' THR . . . . . . . . . . . . . 76.5 p . . . . . 0 C--O 1.22 -0.472 0 CA-C-O 117.976 -1.011 . . . . 0.0 110.537 179.778 . . . . . . . . 0 0 . 1 . 006 nuclear nobuild full ' C' C ' -3' ' ' GLU . . . . . . . . . . . . . 70.5 mm-40 . . . . . 0 N--CA 1.49 1.537 0 N-CA-C 109.408 -0.59 . . . . 0.0 109.408 . . . . . . . . . 0 0 . 1 . 006 nuclear nobuild full ' C' C ' -2' ' ' GLY . . . . . . . . . . . . . . . -67.31 147.61 49.12 Favored Glycine 0 CA--C 1.524 0.654 0 N-CA-C 110.875 -0.89 . . . . 0.0 110.875 179.984 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' C' C ' -1' ' ' VAL . . . . . . . . . . . . . 44.8 t -96.43 131.85 42.2 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.248 0 CA-C-O 120.868 0.366 . . . . 0.0 110.093 -179.925 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' C' C ' 0' ' ' ILE . . . . . . . . . . . . . 70.8 mt -119.02 127.88 75.82 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.265 0 CA-C-N 116.123 -0.49 . . . . 0.0 109.892 179.379 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' C' C ' 1' ' ' MET . . . . . . . . . . . . . 26.6 ptt? -93.36 133.61 36.44 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.241 -0.436 . . . . 0.0 110.325 179.156 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' C' C ' 2' ' ' SER . . . . . . . . . . . . . 5.7 p -110.41 132.32 54.28 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-O 121.071 0.463 . . . . 0.0 110.818 -178.297 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' C' C ' 3' ' ' GLU . . . . . . . . . . . . . 85.1 tt0 -142.12 140.44 32.48 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 115.801 -0.636 . . . . 0.0 111.001 -179.832 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' C' C ' 4' ' ' LEU . . . . . 0.438 HD21 HD21 ' C' ' 6' ' ' LEU . 15.9 tp -121.89 126.53 48.9 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 115.887 -0.597 . . . . 0.0 110.093 177.171 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' C' C ' 5' ' ' LYS . . . . . . . . . . . . . 99.0 mttt -104.64 121.0 42.65 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.414 -0.357 . . . . 0.0 110.572 178.577 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' C' C ' 6' ' ' LEU . . . . . 0.438 HD21 HD21 ' C' ' 4' ' ' LEU . 75.7 mt -116.63 148.71 40.71 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 115.43 -0.804 . . . . 0.0 110.284 -178.959 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' C' C ' 7' ' ' LYS . . . . . . . . . . . . . 64.2 tttm -133.18 136.04 26.68 Favored Pre-proline 0 CA--C 1.534 0.365 0 CA-C-O 118.929 -0.558 . . . . 0.0 109.91 177.084 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' C' C ' 8' ' ' PRO . . . . . . . . . . . . . 84.7 Cg_endo -90.61 140.64 3.07 Favored 'Trans proline' 0 N--CA 1.491 1.365 0 C-N-CA 121.716 1.611 . . . . 0.0 111.571 178.063 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' C' C ' 9' ' ' LEU . . . . . . . . . . . . . 68.6 mt -75.13 -47.53 4.55 Favored Pre-proline 0 CA--C 1.534 0.345 0 CA-C-O 118.712 -0.661 . . . . 0.0 112.311 -178.689 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' C' C ' 10' ' ' PRO . . . . . . . . . . . . . 91.4 Cg_endo -81.49 152.57 17.76 Favored 'Trans proline' 0 N--CA 1.497 1.715 0 C-N-CA 121.312 1.341 . . . . 0.0 111.987 176.038 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' C' C ' 11' ' ' LYS . . . . . . . . . . . . . 50.0 tttm -89.23 102.2 14.86 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.426 -0.352 . . . . 0.0 110.373 178.282 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' C' C ' 12' ' ' VAL . . . . . . . . . . . . . 12.8 p -147.36 145.7 18.89 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.359 0 CA-C-N 116.313 -0.403 . . . . 0.0 110.802 -179.461 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' C' C ' 13' ' ' GLU . . . . . . . . . . . . . 39.6 mt-10 -83.72 122.15 28.25 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.324 -0.398 . . . . 0.0 109.99 175.613 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' C' C ' 14' ' ' LEU . . . . . . . . . . . . . 27.4 mt -94.68 153.92 40.08 Favored Pre-proline 0 C--N 1.329 -0.288 0 CA-C-N 116.456 -0.338 . . . . 0.0 110.83 -177.699 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' C' C ' 15' ' ' PRO . . . . . . . . . . . . . 36.0 Cg_exo -58.35 154.96 37.84 Favored 'Trans proline' 0 N--CA 1.495 1.588 0 C-N-CA 121.268 1.312 . . . . 0.0 111.724 178.576 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' C' C ' 16' ' ' PRO . . . . . . . . . . . . . 34.2 Cg_exo -57.85 -33.61 97.21 Favored 'Trans proline' 0 N--CA 1.497 1.701 0 C-N-CA 121.483 1.455 . . . . 0.0 112.817 -179.098 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' C' C ' 17' ' ' ASP . . . . . . . . . . . . . 20.8 p-10 -90.1 8.79 30.98 Favored 'General case' 0 CA--C 1.536 0.41 0 N-CA-C 113.45 0.907 . . . . 0.0 113.45 -176.671 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' C' C ' 18' ' ' PHE . . . . . . . . . . . . . 35.4 t80 -58.4 -45.8 87.65 Favored 'General case' 0 N--CA 1.457 -0.094 0 O-C-N 121.972 -0.455 . . . . 0.0 110.122 -177.212 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' C' C ' 19' ' ' VAL . . . . . 0.408 HG13 ' N ' ' C' ' 20' ' ' ASP . 14.2 p -56.51 -41.33 72.47 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.411 0 CA-C-N 116.269 -0.423 . . . . 0.0 110.889 -178.916 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' C' C ' 20' ' ' ASP . . . . . 0.408 ' N ' HG13 ' C' ' 19' ' ' VAL . 68.8 m-20 -60.73 -42.83 98.09 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-O 120.83 0.348 . . . . 0.0 111.076 -178.191 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' C' C ' 21' ' ' VAL . . . . . . . . . . . . . 48.7 t -64.44 -48.52 84.78 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.32 0 CA-C-N 116.311 -0.404 . . . . 0.0 110.403 -177.566 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' C' C ' 22' ' ' ILE . . . . . 0.438 HG22 HD12 ' C' ' 26' ' ' LEU . 48.8 mm -55.73 -46.37 79.64 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.221 0 CA-C-O 120.869 0.366 . . . . 0.0 110.738 -179.742 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' C' C ' 23' ' ' ARG . . . . . . . . . . . . . 59.9 ttp180 -53.48 -51.7 61.91 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-O 120.777 0.323 . . . . 0.0 111.566 -178.719 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' C' C ' 24' ' ' ILE . . . . . . . . . . . . . 74.9 mt -60.12 -41.42 86.49 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.269 0 CA-C-N 116.6 -0.273 . . . . 0.0 111.214 -176.631 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' C' C ' 25' ' ' LYS . . . . . . . . . . . . . 53.6 mmtt -63.78 -39.97 95.54 Favored 'General case' 0 C--N 1.328 -0.33 0 N-CA-C 112.107 0.41 . . . . 0.0 112.107 -179.948 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' C' C ' 26' ' ' LEU . . . . . 0.438 HD12 HG22 ' C' ' 22' ' ' ILE . 87.7 mt -78.48 -41.12 33.47 Favored 'General case' 0 C--N 1.33 -0.252 0 N-CA-C 113.539 0.94 . . . . 0.0 113.539 -170.715 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' C' C ' 27' ' ' GLN . . . . . . . . . . . . . 11.3 pt20 -47.24 139.85 5.85 Favored 'General case' 0 N--CA 1.469 0.509 0 N-CA-C 112.75 0.648 . . . . 0.0 112.75 -174.237 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' C' C ' 28' ' ' GLY . . . . . . . . . . . . . . . 99.33 -26.75 23.12 Favored Glycine 0 CA--C 1.532 1.127 0 CA-C-N 115.633 -0.712 . . . . 0.0 112.217 -177.723 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' C' C ' 29' ' ' LYS . . . . . . . . . . . . . 98.9 mttt -98.51 155.06 17.45 Favored 'General case' 0 C--O 1.232 0.181 0 CA-C-N 117.273 0.536 . . . . 0.0 111.254 179.662 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' C' C ' 30' ' ' THR . . . . . . . . . . . . . 23.5 m -103.88 137.3 42.08 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-N 115.957 -0.565 . . . . 0.0 110.092 176.392 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' C' C ' 31' ' ' VAL . . . . . . . . . . . . . 34.8 m -130.51 154.07 40.01 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.245 0 CA-C-O 120.947 0.403 . . . . 0.0 110.971 -178.523 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' C' C ' 32' ' ' ARG . . . . . . . . . . . . . 95.6 mtt180 -130.11 151.58 50.49 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 116.013 -0.539 . . . . 0.0 110.466 178.502 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' C' C ' 33' ' ' THR . . . . . . . . . . . . . 29.3 m -53.4 139.25 31.07 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-O 120.851 0.358 . . . . 0.0 111.225 -178.314 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' C' C ' 34' ' ' GLY . . . . . . . . . . . . . . . 100.63 -17.05 57.14 Favored Glycine 0 CA--C 1.532 1.136 0 CA-C-O 119.671 -0.516 . . . . 0.0 113.244 179.732 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' C' C ' 35' ' ' ASP . . . . . . . . . . . . . 64.4 m-20 -65.65 150.81 47.85 Favored 'General case' 0 C--O 1.231 0.089 0 CA-C-N 118.028 0.914 . . . . 0.0 110.891 178.461 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' C' C ' 36' ' ' VAL . . . . . . . . . . . . . 43.7 t -124.38 133.61 68.89 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.188 0 CA-C-N 116.044 -0.526 . . . . 0.0 110.027 179.056 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' C' C ' 37' ' ' ILE . . . . . . . . . . . . . 69.9 mt -119.98 139.73 46.35 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.25 0 CA-C-N 116.087 -0.506 . . . . 0.0 109.842 179.882 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' C' C ' 38' ' ' GLY . . . . . . . . . . . . . . . -114.22 128.73 8.37 Favored Glycine 0 CA--C 1.526 0.727 0 N-CA-C 111.214 -0.754 . . . . 0.0 111.214 -179.82 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' C' C ' 39' ' ' ILE . . . . . . . . . . . . . 70.8 mt -125.34 130.84 72.84 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.267 0 N-CA-C 109.791 -0.448 . . . . 0.0 109.791 178.371 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' C' C ' 40' ' ' SER . . . . . . . . . . . . . 31.3 t -93.18 113.95 26.32 Favored 'General case' 0 C--N 1.33 -0.24 0 C-N-CA 120.747 -0.381 . . . . 0.0 110.817 176.185 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' C' C ' 41' ' ' ILE . . . . . . . . . . . . . 43.9 mm -123.82 121.79 63.12 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.204 0 CA-C-N 116.484 -0.326 . . . . 0.0 110.237 -179.413 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' C' C ' 42' ' ' LEU . . . . . . . . . . . . . 72.4 mt 57.68 35.33 25.51 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-N 116.349 -0.387 . . . . 0.0 111.8 177.118 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' C' C ' 43' ' ' GLY . . . . . . . . . . . . . . . 78.3 -10.18 30.01 Favored Glycine 0 CA--C 1.533 1.169 0 C-N-CA 121.178 -0.534 . . . . 0.0 113.449 177.248 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' C' C ' 44' ' ' LYS . . . . . . . . . . . . . 68.7 mttm -100.24 131.71 46.02 Favored 'General case' 0 C--N 1.333 -0.125 0 CA-C-N 118.016 0.908 . . . . 0.0 110.078 176.51 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' C' C ' 45' ' ' GLU . . . . . . . . . . . . . 31.5 tp10 -84.37 127.02 33.75 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.396 -0.366 . . . . 0.0 110.459 -179.905 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' C' C ' 46' ' ' VAL . . . . . . . . . . . . . 7.6 p -121.09 128.15 76.0 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.243 0 CA-C-O 121.116 0.484 . . . . 0.0 109.807 178.36 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' C' C ' 47' ' ' LYS . . . . . . . . . . . . . 62.8 mttp -100.57 130.66 46.66 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 115.903 -0.59 . . . . 0.0 111.459 178.058 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' C' C ' 48' ' ' PHE . . . . . . . . . . . . . 94.9 m-85 -113.95 131.95 56.13 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 115.915 -0.584 . . . . 0.0 109.873 176.023 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' C' C ' 49' ' ' LYS . . . . . . . . . . . . . 84.4 tttt -106.53 136.53 46.14 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.471 -0.331 . . . . 0.0 110.518 179.975 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' C' C ' 50' ' ' VAL . . . . . . . . . . . . . 43.6 t -80.99 109.3 15.21 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.302 0 N-CA-C 109.311 -0.626 . . . . 0.0 109.311 177.252 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' C' C ' 51' ' ' VAL . . . . . . . . . . . . . 47.9 t -73.96 -47.55 42.24 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.39 0 CA-C-N 116.148 -0.478 . . . . 0.0 110.11 -173.781 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' C' C ' 52' ' ' GLN . . . . . . . . . . . . . 61.9 tt0 -163.86 139.43 6.31 Favored 'General case' 0 C--N 1.331 -0.222 0 C-N-CA 120.218 -0.593 . . . . 0.0 111.912 -177.724 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' C' C ' 53' ' ' ALA . . . . . 0.421 ' HB1' ' HB2' ' C' ' 58' ' ' LEU . . . -112.94 133.67 54.8 Favored 'General case' 0 C--N 1.332 -0.195 0 CA-C-N 115.66 -0.7 . . . . 0.0 109.853 175.445 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' C' C ' 54' ' ' TYR . . . . . . . . . . . . . 48.9 t80 -129.08 111.14 18.33 Favored Pre-proline 0 CA--C 1.536 0.415 0 CA-C-O 118.172 -0.918 . . . . 0.0 110.456 179.263 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' C' C ' 55' ' ' PRO . . . . . . . . . . . . . 72.5 Cg_endo -77.17 168.09 77.89 Favored 'Cis proline' 0 N--CA 1.497 1.726 0 CA-C-N 121.883 1.708 . . . . 0.0 112.213 -6.24 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' C' C ' 56' ' ' SER . . . . . . . . . . . . . 48.1 m -117.32 136.5 23.48 Favored Pre-proline 0 CA--C 1.539 0.525 0 CA-C-O 118.518 -0.754 . . . . 0.0 109.683 174.652 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' C' C ' 57' ' ' PRO . . . . . . . . . . . . . 36.8 Cg_endo -66.95 145.99 73.87 Favored 'Cis proline' 0 N--CA 1.499 1.795 0 CA-C-N 121.822 1.687 . . . . 0.0 111.383 -3.473 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' C' C ' 58' ' ' LEU . . . . . 0.421 ' HB2' ' HB1' ' C' ' 53' ' ' ALA . 20.6 tp -107.76 136.17 47.95 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.505 -0.316 . . . . 0.0 110.699 -177.796 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' C' C ' 59' ' ' ARG . . . . . . . . . . . . . 71.3 ttt180 -104.58 124.42 49.29 Favored 'General case' 0 C--N 1.328 -0.355 0 N-CA-C 109.247 -0.649 . . . . 0.0 109.247 175.462 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' C' C ' 60' ' ' VAL . . . . . . . . . . . . . 42.3 t -79.73 126.23 39.14 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.251 0 C-N-CA 120.663 -0.415 . . . . 0.0 110.492 -174.459 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' C' C ' 61' ' ' GLU . . . . . . . . . . . . . 96.4 mt-10 -131.05 160.97 33.07 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 115.712 -0.676 . . . . 0.0 109.967 178.507 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' C' C ' 62' ' ' ASP . . . . . . . . . . . . . 11.7 t70 -53.76 -32.49 52.49 Favored 'General case' 0 C--N 1.328 -0.363 0 N-CA-C 111.822 0.304 . . . . 0.0 111.822 -179.154 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' C' C ' 63' ' ' ARG . . . . . . . . . . . . . 38.0 ptt180 -88.38 6.19 38.55 Favored 'General case' 0 CA--C 1.537 0.447 0 N-CA-C 113.688 0.996 . . . . 0.0 113.688 -175.616 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' C' C ' 64' ' ' THR . . . . . . . . . . . . . 38.2 m -81.12 142.51 33.22 Favored 'General case' 0 C--N 1.331 -0.2 0 CA-C-N 118.03 0.377 . . . . 0.0 110.549 -179.404 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' C' C ' 65' ' ' LYS . . . . . . . . . . . . . 68.4 mttm -89.26 129.9 35.75 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.237 179.543 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' C' C ' 66' ' ' ILE . . . . . . . . . . . . . 64.7 mt -116.93 130.1 72.4 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.217 0 N-CA-C 109.758 -0.46 . . . . 0.0 109.758 178.86 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' C' C ' 67' ' ' THR . . . . . . . . . . . . . 36.0 m -126.47 140.23 52.63 Favored 'General case' 0 C--N 1.331 -0.22 0 CA-C-O 121.069 0.461 . . . . 0.0 111.065 -177.119 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' C' C ' 68' ' ' LEU . . . . . 0.551 ' CD2' HG23 ' C' ' 70' ' ' THR . 6.4 tt -101.72 123.03 45.02 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 115.763 -0.653 . . . . 0.0 109.446 176.562 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' C' C ' 69' ' ' VAL . . . . . . . . . . . . . 40.4 t -96.22 106.05 17.85 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.309 0 CA-C-O 121.009 0.433 . . . . 0.0 110.944 -175.365 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' C' C ' 70' ' ' THR . . . . . 0.551 HG23 ' CD2' ' C' ' 68' ' ' LEU . 5.9 p -141.55 169.61 17.29 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 115.559 -0.746 . . . . 0.0 109.63 175.806 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' C' C ' 71' ' ' HIS . . . . . . . . . . . . . 21.6 m80 -127.45 64.19 61.78 Favored Pre-proline 0 CA--C 1.537 0.472 0 CA-C-O 120.653 0.263 . . . . 0.0 111.241 179.016 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' C' C ' 72' ' ' PRO . . . . . . . . . . . . . 63.6 Cg_endo -92.74 153.97 2.82 Favored 'Trans proline' 0 N--CA 1.49 1.305 0 C-N-CA 121.875 1.716 . . . . 0.0 111.289 172.447 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' C' C ' 73' ' ' VAL . . . . . . . . . . . . . 18.7 m -92.79 132.51 36.86 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.26 0 CA-C-O 121.201 0.524 . . . . 0.0 110.541 177.706 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' C' C ' 74' ' ' ASP . . . . . . . . . . . . . 13.7 t0 -97.52 123.72 41.49 Favored 'General case' 0 C--N 1.326 -0.417 0 CA-C-N 115.508 -0.769 . . . . 0.0 109.34 178.262 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' C' C ' 75' ' ' VAL . . . . . 0.478 ' C ' HD12 ' C' ' 76' ' ' LEU . 42.1 t -112.65 121.23 64.56 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.257 0 CA-C-O 121.187 0.518 . . . . 0.0 110.621 -176.221 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' C' C ' 76' ' ' LEU . . . . . 0.478 HD12 ' C ' ' C' ' 75' ' ' VAL . 7.6 mp -119.09 141.32 48.87 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 115.58 -0.737 . . . . 0.0 109.496 175.673 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' C' C ' 77' ' ' GLU . . . . . . . . . . . . . 46.3 mt-10 -132.23 137.0 47.38 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-O 121.059 0.457 . . . . 0.0 110.994 -178.515 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' C' C ' 78' ' ' ALA . . . . . 0.584 ' HB2' HD21 ' C' ' 109' ' ' LEU . . . -127.39 135.68 50.81 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 115.727 -0.67 . . . . 0.0 109.889 177.152 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' C' C ' 79' ' ' LYS . . . . . 0.6 ' O ' HD13 ' C' ' 80' ' ' ILE . 54.9 pttt -83.85 120.87 26.58 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-O 121.31 0.576 . . . . 0.0 110.932 -178.516 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' C' C ' 80' ' ' ILE . . . . . 0.6 HD13 ' O ' ' C' ' 79' ' ' LYS . 39.6 mm -139.18 115.92 10.34 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.274 0 CA-C-N 115.738 -0.665 . . . . 0.0 109.359 -177.769 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' C' C ' 81' ' ' LYS . . . . . . . . . . . . . 99.3 mttt -101.09 125.48 47.71 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-O 120.828 0.347 . . . . 0.0 111.156 -178.172 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' C' C ' 82' ' ' GLY . . . . . . . . . . . . . . . 89.13 42.2 5.66 Favored Glycine 0 CA--C 1.524 0.624 0 C-N-CA 120.714 -0.755 . . . . 0.0 111.772 173.117 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' C' C ' 83' ' ' ILE . . . . . . . . . . . . . 74.8 mt -65.61 134.91 29.18 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.374 0 N-CA-C 109.606 -0.516 . . . . 0.0 109.606 176.841 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' C' C ' 84' ' ' LYS . . . . . . . . . . . . . 51.0 tttp -99.09 -53.96 3.11 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-O 121.061 0.458 . . . . 0.0 110.375 -179.148 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' C' C ' 85' ' ' ASP . . . . . . . . . . . . . 10.1 t70 -148.78 146.37 28.0 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 115.786 -0.643 . . . . 0.0 110.284 -179.082 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' C' C ' 86' ' ' VAL . . . . . . . . . . . . . 43.7 t -127.14 127.61 69.63 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.196 0 CA-C-O 120.783 0.325 . . . . 0.0 110.414 -179.558 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' C' C ' 87' ' ' ILE . . . . . . . . . . . . . 44.6 mm -120.53 126.71 75.55 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.27 0 CA-C-N 115.996 -0.547 . . . . 0.0 109.766 177.935 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' C' C ' 88' ' ' LEU . . . . . . . . . . . . . 74.6 mt -107.25 139.61 41.44 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-O 121.006 0.432 . . . . 0.0 111.037 -179.314 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' C' C ' 89' ' ' ASP . . . . . . . . . . . . . 6.0 t70 -130.3 154.06 48.01 Favored 'General case' 0 C--N 1.328 -0.328 0 N-CA-C 109.302 -0.629 . . . . 0.0 109.302 176.253 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' C' C ' 90' ' ' GLU . . . . . . . . . . . . . 84.9 tt0 -47.91 -34.79 9.53 Favored 'General case' 0 C--N 1.33 -0.253 0 N-CA-C 112.972 0.73 . . . . 0.0 112.972 -172.07 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' C' C ' 91' ' ' ASN . . . . . . . . . . . . . 86.9 m-20 -132.03 19.51 4.53 Favored 'General case' 0 N--CA 1.468 0.464 0 N-CA-C 113.124 0.787 . . . . 0.0 113.124 -178.437 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' C' C ' 92' ' ' LEU . . . . . . . . . . . . . 48.5 mt -148.66 148.55 30.21 Favored 'General case' 0 C--N 1.331 -0.218 0 CA-C-O 120.644 0.259 . . . . 0.0 110.35 -177.702 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' C' C ' 93' ' ' ILE . . . . . . . . . . . . . 70.5 mt -126.94 118.39 50.33 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.345 0 N-CA-C 109.148 -0.686 . . . . 0.0 109.148 176.42 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' C' C ' 94' ' ' VAL . . . . . . . . . . . . . 46.3 t -118.89 126.29 75.19 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.281 0 CA-C-O 121.028 0.442 . . . . 0.0 110.022 -179.035 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' C' C ' 95' ' ' VAL . . . . . . . . . . . . . 44.7 t -119.91 133.1 67.77 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.382 0 CA-C-N 115.788 -0.642 . . . . 0.0 109.648 179.386 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' C' C ' 96' ' ' ILE . . . . . . . . . . . . . 63.9 mt -111.77 127.74 68.76 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.349 0 N-CA-C 109.089 -0.708 . . . . 0.0 109.089 178.016 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' C' C ' 97' ' ' THR . . . . . . . . . . . . . 80.9 p -97.83 157.91 15.82 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-O 121.159 0.504 . . . . 0.0 110.979 -178.071 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' C' C ' 98' ' ' GLU . . . . . . . . . . . . . 82.1 tt0 -53.73 -25.53 19.02 Favored 'General case' 0 CA--C 1.533 0.323 0 CA-C-N 116.105 -0.498 . . . . 0.0 112.145 179.509 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' C' C ' 99' ' ' GLU . . . . . . . . . . . . . 95.4 mt-10 -80.12 15.34 1.54 Allowed 'General case' 0 CA--C 1.535 0.398 0 N-CA-C 113.191 0.811 . . . . 0.0 113.191 -176.714 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' C' C ' 100' ' ' ASN . . . . . . . . . . . . . 3.3 m-20 61.96 37.89 14.71 Favored 'General case' 0 N--CA 1.463 0.198 0 CA-C-O 121.105 0.479 . . . . 0.0 110.939 179.001 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' C' C ' 101' ' ' GLU . . . . . . . . . . . . . 84.5 tt0 -117.99 144.43 45.54 Favored 'General case' 0 C--N 1.332 -0.172 0 CA-C-N 116.074 -0.512 . . . . 0.0 109.755 176.764 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' C' C ' 102' ' ' VAL . . . . . . . . . . . . . 44.7 t -115.14 126.26 72.67 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.253 0 CA-C-N 116.284 -0.416 . . . . 0.0 110.14 -176.75 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' C' C ' 103' ' ' LEU . . . . . . . . . . . . . 29.5 mt -115.25 127.14 55.29 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-N 115.686 -0.688 . . . . 0.0 109.932 175.905 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' C' C ' 104' ' ' ILE . . . . . . . . . . . . . 66.7 mt -116.33 120.32 64.57 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.225 0 N-CA-C 110.15 -0.315 . . . . 0.0 110.15 179.737 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' C' C ' 105' ' ' PHE . . . . . . . . . . . . . 47.8 m-85 -119.8 166.41 13.3 Favored 'General case' 0 C--N 1.332 -0.178 0 CA-C-N 115.415 -0.812 . . . . 0.0 109.535 178.364 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' C' C ' 106' ' ' ASN . . . . . . . . . . . . . 43.0 p-10 -99.5 -170.07 1.85 Allowed 'General case' 0 C--N 1.33 -0.261 0 N-CA-C 109.993 -0.373 . . . . 0.0 109.993 174.988 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' C' C ' 107' ' ' GLN . . . . . . . . . . . . . 29.7 tt0 -58.51 -30.07 66.77 Favored 'General case' 0 C--N 1.329 -0.313 0 N-CA-C 111.984 0.365 . . . . 0.0 111.984 179.287 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' C' C ' 108' ' ' ASN . . . . . . . . . . . . . 13.5 t-20 -84.05 7.57 18.16 Favored 'General case' 0 CA--C 1.536 0.439 0 N-CA-C 113.204 0.816 . . . . 0.0 113.204 -176.903 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' C' C ' 109' ' ' LEU . . . . . 0.584 HD21 ' HB2' ' C' ' 78' ' ' ALA . 10.6 tp 61.39 38.39 16.15 Favored 'General case' 0 C--N 1.332 -0.189 0 CA-C-O 121.131 0.491 . . . . 0.0 111.19 179.192 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' C' C ' 110' ' ' GLU . . . . . . . . . . . . . 96.8 mt-10 -105.38 153.29 21.86 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.219 -0.446 . . . . 0.0 109.928 176.85 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' C' C ' 111' ' ' GLU . . . . . . . . . . . . . 83.2 tt0 -85.67 121.9 29.01 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-O 120.768 0.318 . . . . 0.0 110.587 -178.508 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' C' C ' 112' ' ' LEU . . . . . . . . . . . . . 61.6 mt -111.61 -46.14 3.29 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.258 -0.428 . . . . 0.0 110.741 179.623 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' C' C ' 113' ' ' TYR . . . . . . . . . . . . . 55.8 t80 -137.17 134.72 36.64 Favored 'General case' 0 C--N 1.331 -0.223 0 CA-C-N 116.434 -0.348 . . . . 0.0 110.966 -179.094 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' C' C ' 114' ' ' ARG . . . . . . . . . . . . . 31.6 ttp180 -135.62 124.03 23.39 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.34 -0.391 . . . . 0.0 110.164 176.604 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' C' C ' 115' ' ' GLY . . . . . . . . . . . . . . . -150.05 162.68 29.26 Favored Glycine 0 CA--C 1.523 0.567 0 N-CA-C 111.038 -0.825 . . . . 0.0 111.038 179.334 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' C' C ' 116' ' ' LYS . . . . . . . . . . . . . 30.0 ttpt -131.28 137.85 49.02 Favored 'General case' 0 C--N 1.33 -0.248 0 N-CA-C 109.941 -0.392 . . . . 0.0 109.941 178.42 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' C' C ' 117' ' ' PHE . . . . . . . . . . . . . 39.2 m-85 -135.11 113.93 11.89 Favored 'General case' 0 C--N 1.331 -0.23 0 N-CA-C 109.919 -0.4 . . . . 0.0 109.919 -178.55 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' C' C ' 118' ' ' GLU . . . . . . . . . . . . . 44.1 mt-10 -57.07 -42.12 80.07 Favored 'General case' 0 C--N 1.328 -0.34 0 C-N-CA 120.774 -0.37 . . . . 0.0 110.886 -176.324 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' C' C ' 119' ' ' ASN . . . . . . . . . . . . . 3.9 p30 -100.51 31.19 3.56 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.232 -0.44 . . . . 0.0 111.964 -175.674 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' C' C ' 120' ' ' LEU . . . . . . . . . . . . . 14.2 tp -54.03 125.9 20.6 Favored 'General case' 0 N--CA 1.463 0.195 0 CA-C-O 120.487 0.184 . . . . 0.0 110.776 177.996 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' C' C ' 121' ' ' ASN . . . . . . . . . . . . . 16.6 m120 -112.72 -44.14 3.36 Favored 'General case' 0 C--O 1.231 0.12 0 C-N-CA 121.125 -0.23 . . . . 0.0 111.415 -176.422 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' C' C ' 122' ' ' LYS . . . . . . . . . . . . . 97.7 mttt -148.3 149.38 31.75 Favored 'General case' 0 C--N 1.332 -0.189 0 C-N-CA 120.557 -0.457 . . . . 0.0 111.879 -177.593 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' C' C ' 123' ' ' VAL . . . . . . . . . . . . . 44.3 t -130.18 126.92 62.47 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.325 0 N-CA-C 109.117 -0.697 . . . . 0.0 109.117 172.908 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' C' C ' 124' ' ' LEU . . . . . . . . . . . . . 12.1 tp -127.97 138.38 52.6 Favored 'General case' 0 N--CA 1.463 0.208 0 CA-C-O 120.859 0.362 . . . . 0.0 111.371 -175.661 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' C' C ' 125' ' ' VAL . . . . . 0.489 HG12 HG23 ' C' ' 130' ' ' VAL . 35.6 m -126.19 133.02 69.82 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.241 0 CA-C-N 115.942 -0.572 . . . . 0.0 110.436 177.715 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' C' C ' 126' ' ' ARG . . . . . . . . . . . . . 24.4 mmt180 -139.38 116.48 11.05 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.312 -0.404 . . . . 0.0 110.537 178.367 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' C' C ' 127' ' ' ASN . . . . . . . . . . . . . 17.8 m-80 52.1 -105.03 0.2 Allowed 'General case' 0 CA--C 1.543 0.68 0 CA-C-O 119.173 -0.441 . . . . 0.0 111.255 178.578 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' C' C ' 128' ' ' ASP . . . . . . . . . . . . . 21.2 p-10 -113.95 1.19 14.63 Favored 'General case' 0 N--CA 1.469 0.487 0 CA-C-N 119.501 1.046 . . . . 0.0 113.423 -176.916 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' C' C ' 129' ' ' LEU . . . . . . . . . . . . . 12.1 tp -108.13 137.77 45.54 Favored 'General case' 0 C--N 1.332 -0.166 0 N-CA-C 109.728 -0.471 . . . . 0.0 109.728 179.155 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' C' C ' 130' ' ' VAL . . . . . 0.507 HG13 ' HB ' ' C' ' 141' ' ' ILE . 13.0 p -126.74 137.97 56.21 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.235 0 CA-C-O 121.035 0.445 . . . . 0.0 110.131 179.906 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' C' C ' 131' ' ' VAL . . . . . . . . . . . . . 42.3 t -135.73 141.14 42.9 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.274 0 CA-C-O 121.16 0.505 . . . . 0.0 110.495 -177.358 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' C' C ' 132' ' ' ILE . . . . . . . . . . . . . 73.6 mt -115.92 132.1 66.4 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.345 0 CA-C-N 115.477 -0.783 . . . . 0.0 109.051 177.838 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' C' C ' 133' ' ' ILE . . . . . . . . . . . . . 43.3 mm -113.36 122.21 67.04 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.242 0 CA-C-O 120.9 0.381 . . . . 0.0 110.494 -175.715 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' C' C ' 134' ' ' ASP . . . . . . . . . . . . . 7.4 p-10 -135.17 146.98 49.26 Favored 'General case' 0 C--N 1.331 -0.209 0 CA-C-N 116.045 -0.525 . . . . 0.0 109.892 178.063 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' C' C ' 135' ' ' GLU . . . . . . . . . . . . . 85.2 tt0 -50.01 -27.9 6.16 Favored 'General case' 0 C--N 1.326 -0.417 0 N-CA-C 112.738 0.644 . . . . 0.0 112.738 -174.536 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' C' C ' 136' ' ' GLN . . . . . . . . . . . . . 97.3 mt-30 -79.81 -34.23 39.71 Favored 'General case' 0 C--O 1.233 0.232 0 N-CA-C 112.456 0.539 . . . . 0.0 112.456 -176.818 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' C' C ' 137' ' ' LYS . . . . . . . . . . . . . 53.1 pttt -169.99 177.06 4.46 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-O 121.551 0.691 . . . . 0.0 112.31 -172.289 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' C' C ' 138' ' ' LEU . . . . . 0.418 HD23 ' N ' ' C' ' 139' ' ' THR . 5.7 tt -116.32 126.38 53.44 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 115.126 -0.943 . . . . 0.0 109.634 176.547 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' C' C ' 139' ' ' THR . . . . . 0.418 ' N ' HD23 ' C' ' 138' ' ' LEU . 28.4 m -106.65 123.24 47.82 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.305 -0.407 . . . . 0.0 110.158 -179.638 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' C' C ' 140' ' ' LEU . . . . . 0.457 ' C ' HD23 ' C' ' 140' ' ' LEU . 5.7 tt -108.78 120.77 43.46 Favored 'General case' 0 C--N 1.329 -0.321 0 N-CA-C 109.114 -0.699 . . . . 0.0 109.114 -178.311 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' C' C ' 141' ' ' ILE . . . . . 0.507 ' HB ' HG13 ' C' ' 130' ' ' VAL . 21.1 mt -123.38 118.91 55.98 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.286 0 CA-C-O 121.211 0.529 . . . . 0.0 109.833 -177.153 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' C' C ' 142' ' ' ARG . . . . . . . . . . . . . 47.0 ttt180 -101.27 120.15 39.82 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 115.207 -0.906 . . . . 0.0 110.002 179.838 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' C' C ' 143' ' ' THR . . . . . . . . . . . . . 76.5 p . . . . . 0 C--O 1.22 -0.476 0 CA-C-O 117.988 -1.006 . . . . 0.0 110.474 -179.104 . . . . . . . . 0 0 . 1 . 006 nuclear nobuild full ' D' D ' -3' ' ' GLU . . . . . . . . . . . . . 84.6 tt0 . . . . . 0 N--CA 1.49 1.543 0 N-CA-C 109.427 -0.582 . . . . 0.0 109.427 . . . . . . . . . 0 0 . 1 . 006 nuclear nobuild full ' D' D ' -2' ' ' GLY . . . . . . . . . . . . . . . -67.88 143.56 41.92 Favored Glycine 0 CA--C 1.524 0.638 0 N-CA-C 110.963 -0.855 . . . . 0.0 110.963 179.882 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' D' D ' -1' ' ' VAL . . . . . . . . . . . . . 43.7 t -96.27 136.73 26.19 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.326 0 N-CA-C 110.067 -0.346 . . . . 0.0 110.067 -179.583 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' D' D ' 0' ' ' ILE . . . . . . . . . . . . . 69.6 mt -107.29 134.97 47.43 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.318 0 CA-C-N 116.157 -0.474 . . . . 0.0 109.982 -179.401 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' D' D ' 1' ' ' MET . . . . . . . . . . . . . 25.4 ptp -86.48 147.05 26.15 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.156 -0.475 . . . . 0.0 110.63 -179.874 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' D' D ' 2' ' ' SER . . . . . . . . . . . . . 3.2 p -114.73 134.13 55.34 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-N 116.096 -0.502 . . . . 0.0 110.219 178.848 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' D' D ' 3' ' ' GLU . . . . . . . . . . . . . 95.6 mt-10 -141.02 139.67 34.17 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-O 120.971 0.415 . . . . 0.0 111.074 -178.985 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' D' D ' 4' ' ' LEU . . . . . . . . . . . . . 20.1 tp -123.55 125.21 44.46 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 115.889 -0.596 . . . . 0.0 110.108 176.402 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' D' D ' 5' ' ' LYS . . . . . . . . . . . . . 54.2 mtmt -104.22 118.06 35.72 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.156 -0.474 . . . . 0.0 110.725 179.493 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' D' D ' 6' ' ' LEU . . . . . 0.404 HD23 ' HA ' ' D' ' 50' ' ' VAL . 26.3 mt -115.15 146.0 41.81 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 115.632 -0.713 . . . . 0.0 110.087 179.877 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' D' D ' 7' ' ' LYS . . . . . . . . . . . . . 74.2 tttt -131.93 139.56 35.44 Favored Pre-proline 0 CA--C 1.534 0.347 0 CA-C-O 119.164 -0.446 . . . . 0.0 109.841 176.763 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' D' D ' 8' ' ' PRO . . . . . . . . . . . . . 84.4 Cg_endo -91.96 139.23 2.1 Favored 'Trans proline' 0 N--CA 1.49 1.306 0 C-N-CA 121.776 1.651 . . . . 0.0 111.802 177.782 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' D' D ' 9' ' ' LEU . . . . . . . . . . . . . 59.0 mt -76.14 -46.93 3.65 Favored Pre-proline 0 CA--C 1.533 0.313 0 CA-C-O 118.818 -0.611 . . . . 0.0 112.146 -179.59 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' D' D ' 10' ' ' PRO . . . . . . . . . . . . . 89.1 Cg_endo -81.88 147.06 14.98 Favored 'Trans proline' 0 N--CA 1.495 1.582 0 C-N-CA 121.269 1.313 . . . . 0.0 111.614 174.175 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' D' D ' 11' ' ' LYS . . . . . . . . . . . . . 83.9 tttt -85.07 99.81 11.28 Favored 'General case' 0 C--N 1.33 -0.263 0 C-N-CA 120.801 -0.36 . . . . 0.0 110.136 178.84 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' D' D ' 12' ' ' VAL . . . . . . . . . . . . . 12.2 p -140.84 144.38 27.03 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.257 0 CA-C-N 116.219 -0.446 . . . . 0.0 110.65 -177.788 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' D' D ' 13' ' ' GLU . . . . . . . . . . . . . 43.4 mt-10 -77.69 130.32 36.65 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.253 -0.43 . . . . 0.0 110.02 176.687 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' D' D ' 14' ' ' LEU . . . . . . . . . . . . . 27.3 mt -97.88 146.1 30.89 Favored Pre-proline 0 C--N 1.329 -0.286 0 CA-C-O 119.096 -0.478 . . . . 0.0 109.996 -179.717 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' D' D ' 15' ' ' PRO . . . . . . . . . . . . . 26.9 Cg_exo -61.83 158.69 36.73 Favored 'Trans proline' 0 N--CA 1.498 1.741 0 C-N-CA 121.261 1.307 . . . . 0.0 111.693 177.144 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' D' D ' 16' ' ' PRO . . . . . . . . . . . . . 38.7 Cg_exo -58.79 -34.06 98.79 Favored 'Trans proline' 0 N--CA 1.497 1.711 0 C-N-CA 121.516 1.477 . . . . 0.0 112.898 -178.196 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' D' D ' 17' ' ' ASP . . . . . . . . . . . . . 17.3 p-10 -92.45 9.65 33.43 Favored 'General case' 0 CA--C 1.535 0.389 0 N-CA-C 113.322 0.86 . . . . 0.0 113.322 -177.348 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' D' D ' 18' ' ' PHE . . . . . . . . . . . . . 50.7 t80 -58.15 -45.71 86.93 Favored 'General case' 0 N--CA 1.457 -0.115 0 CA-C-O 121.04 0.448 . . . . 0.0 110.219 -177.709 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' D' D ' 19' ' ' VAL . . . . . . . . . . . . . 47.3 t -56.24 -44.01 78.17 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.337 0 CA-C-N 116.085 -0.507 . . . . 0.0 110.557 -177.493 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' D' D ' 20' ' ' ASP . . . . . . . . . . . . . 44.4 t0 -59.86 -43.41 94.7 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-O 120.729 0.3 . . . . 0.0 110.95 -177.338 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' D' D ' 21' ' ' VAL . . . . . . . . . . . . . 47.5 t -63.93 -46.65 93.49 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.305 0 C-N-CA 120.702 -0.399 . . . . 0.0 110.506 -177.086 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' D' D ' 22' ' ' ILE . . . . . 0.503 HG22 HD12 ' D' ' 26' ' ' LEU . 51.4 mm -55.87 -47.95 79.01 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.275 0 C-N-CA 120.946 -0.301 . . . . 0.0 110.774 179.937 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' D' D ' 23' ' ' ARG . . . . . . . . . . . . . 60.8 ttp180 -54.93 -48.76 72.7 Favored 'General case' 0 C--N 1.331 -0.233 0 C-N-CA 121.06 -0.256 . . . . 0.0 111.347 -178.143 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' D' D ' 24' ' ' ILE . . . . . . . . . . . . . 77.0 mt -59.33 -41.96 85.85 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.357 0 C-N-CA 121.027 -0.269 . . . . 0.0 111.21 -177.126 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' D' D ' 25' ' ' LYS . . . . . . . . . . . . . 73.5 mmtt -65.49 -43.58 89.75 Favored 'General case' 0 C--N 1.329 -0.312 0 N-CA-C 112.445 0.535 . . . . 0.0 112.445 -179.54 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' D' D ' 26' ' ' LEU . . . . . 0.503 HD12 HG22 ' D' ' 22' ' ' ILE . 83.8 mt -78.26 -36.15 47.19 Favored 'General case' 0 C--N 1.329 -0.308 0 N-CA-C 113.287 0.847 . . . . 0.0 113.287 -170.181 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' D' D ' 27' ' ' GLN . . . . . . . . . . . . . 4.6 pt20 -46.3 137.08 6.61 Favored 'General case' 0 N--CA 1.467 0.391 0 N-CA-C 112.871 0.693 . . . . 0.0 112.871 -174.709 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' D' D ' 28' ' ' GLY . . . . . . . . . . . . . . . 99.43 -25.37 28.52 Favored Glycine 0 CA--C 1.533 1.186 0 CA-C-N 115.883 -0.598 . . . . 0.0 112.374 -178.383 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' D' D ' 29' ' ' LYS . . . . . . . . . . . . . 54.7 mtmt -97.88 155.2 17.18 Favored 'General case' 0 C--N 1.332 -0.187 0 CA-C-N 117.341 0.57 . . . . 0.0 111.253 179.76 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' D' D ' 30' ' ' THR . . . . . . . . . . . . . 25.0 m -106.46 138.39 42.72 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 115.908 -0.587 . . . . 0.0 109.992 176.654 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' D' D ' 31' ' ' VAL . . . . . . . . . . . . . 35.8 m -128.85 155.96 41.12 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.239 0 CA-C-N 116.303 -0.408 . . . . 0.0 110.876 -178.486 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' D' D ' 32' ' ' ARG . . . . . . . . . . . . . 77.5 mtt85 -129.46 148.09 51.34 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-N 116.06 -0.518 . . . . 0.0 110.697 178.811 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' D' D ' 33' ' ' THR . . . . . . . . . . . . . 26.7 m -53.87 140.15 31.38 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.34 -0.391 . . . . 0.0 111.27 -179.703 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' D' D ' 34' ' ' GLY . . . . . . . . . . . . . . . 100.71 -17.1 56.99 Favored Glycine 0 CA--C 1.532 1.118 0 CA-C-O 119.618 -0.545 . . . . 0.0 113.306 179.541 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' D' D ' 35' ' ' ASP . . . . . . . . . . . . . 78.7 m-20 -66.51 147.87 52.68 Favored 'General case' 0 C--O 1.232 0.167 0 CA-C-N 118.017 0.909 . . . . 0.0 111.179 178.881 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' D' D ' 36' ' ' VAL . . . . . . . . . . . . . 45.1 t -121.63 129.81 75.18 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.206 0 CA-C-N 116.003 -0.544 . . . . 0.0 109.728 177.317 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' D' D ' 37' ' ' ILE . . . . . . . . . . . . . 68.0 mt -122.64 140.14 47.35 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.264 0 CA-C-N 116.293 -0.412 . . . . 0.0 110.109 -178.332 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' D' D ' 38' ' ' GLY . . . . . . . . . . . . . . . -108.96 128.74 9.18 Favored Glycine 0 CA--C 1.526 0.719 0 N-CA-C 111.086 -0.806 . . . . 0.0 111.086 179.166 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' D' D ' 39' ' ' ILE . . . . . . . . . . . . . 74.6 mt -125.54 140.81 47.29 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.258 0 N-CA-C 110.104 -0.332 . . . . 0.0 110.104 179.445 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' D' D ' 40' ' ' SER . . . . . 0.531 ' O ' HD13 ' D' ' 41' ' ' ILE . 36.3 t -92.13 117.57 29.98 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.41 -0.359 . . . . 0.0 110.828 175.998 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' D' D ' 41' ' ' ILE . . . . . 0.531 HD13 ' O ' ' D' ' 40' ' ' SER . 48.1 mm -130.03 123.35 56.13 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.243 0 N-CA-C 110.174 -0.306 . . . . 0.0 110.174 178.852 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' D' D ' 42' ' ' LEU . . . . . . . . . . . . . 9.0 tp 58.09 33.45 23.18 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.241 -0.436 . . . . 0.0 111.68 178.674 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' D' D ' 43' ' ' GLY . . . . . . . . . . . . . . . 77.02 -10.04 21.96 Favored Glycine 0 CA--C 1.534 1.262 0 C-N-CA 121.258 -0.496 . . . . 0.0 113.517 178.152 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' D' D ' 44' ' ' LYS . . . . . . . . . . . . . 99.2 mttt -103.06 146.26 28.64 Favored 'General case' 0 C--N 1.334 -0.081 0 CA-C-N 117.884 0.842 . . . . 0.0 110.081 178.443 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' D' D ' 45' ' ' GLU . . . . . . . . . . . . . 81.8 tt0 -83.85 127.42 33.82 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.377 -0.374 . . . . 0.0 110.797 -179.51 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' D' D ' 46' ' ' VAL . . . . . . . . . . . . . 7.4 p -122.11 128.8 75.66 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.183 0 N-CA-C 109.521 -0.548 . . . . 0.0 109.521 176.393 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' D' D ' 47' ' ' LYS . . . . . . . . . . . . . 89.8 mttt -100.1 130.0 46.2 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 115.993 -0.549 . . . . 0.0 111.28 178.969 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' D' D ' 48' ' ' PHE . . . . . . . . . . . . . 92.0 m-85 -113.43 131.77 55.89 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.01 176.541 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' D' D ' 49' ' ' LYS . . . . . . . . . . . . . 80.7 tttt -108.34 137.6 46.04 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 116.309 -0.405 . . . . 0.0 110.337 178.797 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' D' D ' 50' ' ' VAL . . . . . 0.404 ' HA ' HD23 ' D' ' 6' ' ' LEU . 44.1 t -82.39 109.71 16.7 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.288 0 N-CA-C 109.521 -0.548 . . . . 0.0 109.521 176.81 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' D' D ' 51' ' ' VAL . . . . . . . . . . . . . 47.8 t -72.82 -48.79 43.91 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.326 0 CA-C-N 115.794 -0.639 . . . . 0.0 110.043 -175.228 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' D' D ' 52' ' ' GLN . . . . . . . . . . . . . 49.7 tt0 -162.96 142.09 8.7 Favored 'General case' 0 C--N 1.332 -0.168 0 C-N-CA 120.037 -0.665 . . . . 0.0 111.941 -178.663 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' D' D ' 53' ' ' ALA . . . . . 0.414 ' HB1' ' HB2' ' D' ' 58' ' ' LEU . . . -116.83 132.63 56.65 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 115.766 -0.652 . . . . 0.0 109.998 175.577 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' D' D ' 54' ' ' TYR . . . . . . . . . . . . . 67.1 t80 -129.01 111.97 18.51 Favored Pre-proline 0 CA--C 1.535 0.379 0 CA-C-O 118.204 -0.903 . . . . 0.0 110.487 179.384 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' D' D ' 55' ' ' PRO . . . . . . . . . . . . . 74.4 Cg_endo -77.2 169.32 74.5 Favored 'Cis proline' 0 N--CA 1.499 1.848 0 CA-C-N 122.027 1.76 . . . . 0.0 112.198 -5.979 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' D' D ' 56' ' ' SER . . . . . . . . . . . . . 13.6 m -115.24 128.96 25.49 Favored Pre-proline 0 CA--C 1.539 0.525 0 CA-C-O 118.388 -0.815 . . . . 0.0 109.424 176.521 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' D' D ' 57' ' ' PRO . . . . . . . . . . . . . 56.7 Cg_endo -71.77 148.13 89.82 Favored 'Cis proline' 0 N--CA 1.497 1.688 0 CA-C-N 121.958 1.735 . . . . 0.0 111.62 0.19 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' D' D ' 58' ' ' LEU . . . . . 0.414 ' HB2' ' HB1' ' D' ' 53' ' ' ALA . 14.2 tp -107.69 135.73 48.63 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 116.296 -0.411 . . . . 0.0 110.559 -178.567 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' D' D ' 59' ' ' ARG . . . . . . . . . . . . . 43.6 ttp180 -106.19 124.47 49.64 Favored 'General case' 0 C--N 1.327 -0.41 0 N-CA-C 109.324 -0.621 . . . . 0.0 109.324 175.891 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' D' D ' 60' ' ' VAL . . . . . . . . . . . . . 41.4 t -79.98 120.99 32.47 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.299 0 C-N-CA 120.741 -0.384 . . . . 0.0 110.352 -175.46 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' D' D ' 61' ' ' GLU . . . . . . . . . . . . . 42.6 mt-10 -130.97 170.22 14.77 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.066 -0.515 . . . . 0.0 110.129 178.425 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' D' D ' 62' ' ' ASP . . . . . . . . . . . . . 45.1 m-20 -54.31 -32.54 56.79 Favored 'General case' 0 C--N 1.327 -0.379 0 N-CA-C 111.847 0.314 . . . . 0.0 111.847 -178.151 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' D' D ' 63' ' ' ARG . . . . . . . . . . . . . 30.7 ptt180 -88.47 4.41 46.64 Favored 'General case' 0 CA--C 1.537 0.446 0 N-CA-C 113.751 1.019 . . . . 0.0 113.751 -175.011 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' D' D ' 64' ' ' THR . . . . . . . . . . . . . 32.3 m -85.4 136.97 33.23 Favored 'General case' 0 C--N 1.332 -0.163 0 CA-C-O 120.934 0.397 . . . . 0.0 110.628 -178.609 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' D' D ' 65' ' ' LYS . . . . . . . . . . . . . 90.5 mttt -89.61 129.79 36.01 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.096 -0.502 . . . . 0.0 110.223 179.306 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' D' D ' 66' ' ' ILE . . . . . . . . . . . . . 62.5 mt -113.55 128.6 70.33 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.26 0 N-CA-C 109.575 -0.528 . . . . 0.0 109.575 178.684 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' D' D ' 67' ' ' THR . . . . . . . . . . . . . 27.0 m -122.3 138.73 54.41 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-O 120.991 0.424 . . . . 0.0 111.118 -176.31 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' D' D ' 68' ' ' LEU . . . . . . . . . . . . . 7.3 mp -100.56 111.18 23.4 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 115.863 -0.608 . . . . 0.0 110.282 177.706 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' D' D ' 69' ' ' VAL . . . . . . . . . . . . . 43.3 t -103.06 140.2 21.94 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.364 0 CA-C-N 115.867 -0.606 . . . . 0.0 110.081 -179.145 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' D' D ' 70' ' ' THR . . . . . . . . . . . . . 23.6 m -146.11 -60.05 0.32 Allowed 'General case' 0 C--N 1.328 -0.345 0 CA-C-O 120.844 0.354 . . . . 0.0 110.363 177.287 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' D' D ' 71' ' ' HIS . . . . . . . . . . . . . 2.5 t60 -150.06 80.99 7.04 Favored Pre-proline 0 C--N 1.329 -0.302 0 CA-C-N 116.021 -0.536 . . . . 0.0 110.121 177.865 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' D' D ' 72' ' ' PRO . . . . . . . . . . . . . 59.4 Cg_endo -73.27 -30.18 10.67 Favored 'Trans proline' 0 N--CA 1.496 1.619 0 C-N-CA 121.152 1.235 . . . . 0.0 112.515 -175.96 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' D' D ' 73' ' ' VAL . . . . . . . . . . . . . 15.6 m -155.16 151.51 10.35 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.299 0 CA-C-O 120.993 0.425 . . . . 0.0 110.667 178.435 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' D' D ' 74' ' ' ASP . . . . . . . . . . . . . 5.0 t70 -108.77 118.87 37.92 Favored 'General case' 0 C--N 1.328 -0.362 0 N-CA-C 109.288 -0.634 . . . . 0.0 109.288 174.541 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' D' D ' 75' ' ' VAL . . . . . 0.407 ' C ' HD12 ' D' ' 76' ' ' LEU . 41.9 t -113.74 125.68 71.06 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.214 0 CA-C-O 121.059 0.457 . . . . 0.0 110.898 -175.854 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' D' D ' 76' ' ' LEU . . . . . 0.407 HD12 ' C ' ' D' ' 75' ' ' VAL . 5.6 mp -125.56 146.42 49.69 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 115.581 -0.736 . . . . 0.0 109.538 174.953 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' D' D ' 77' ' ' GLU . . . . . . . . . . . . . 99.2 mt-10 -134.23 131.23 38.27 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-O 121.134 0.492 . . . . 0.0 111.291 -176.95 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' D' D ' 78' ' ' ALA . . . . . . . . . . . . . . . -118.38 121.72 41.06 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 115.69 -0.686 . . . . 0.0 109.558 176.647 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' D' D ' 79' ' ' LYS . . . . . 0.644 ' O ' HD13 ' D' ' 80' ' ' ILE . 19.2 pttp -71.77 122.65 21.04 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-O 121.134 0.492 . . . . 0.0 110.96 -178.091 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' D' D ' 80' ' ' ILE . . . . . 0.644 HD13 ' O ' ' D' ' 79' ' ' LYS . 37.4 mm -139.19 108.87 3.94 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.355 0 N-CA-C 109.023 -0.732 . . . . 0.0 109.023 -178.122 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' D' D ' 81' ' ' LYS . . . . . . . . . . . . . 50.7 pttt -97.59 123.7 41.58 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-O 120.941 0.401 . . . . 0.0 111.152 -177.617 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' D' D ' 82' ' ' GLY . . . . . . . . . . . . . . . 88.97 42.26 5.69 Favored Glycine 0 CA--C 1.525 0.699 0 C-N-CA 120.718 -0.753 . . . . 0.0 111.533 174.649 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' D' D ' 83' ' ' ILE . . . . . . . . . . . . . 75.3 mt -65.91 137.17 25.41 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.332 0 N-CA-C 109.809 -0.441 . . . . 0.0 109.809 178.106 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' D' D ' 84' ' ' LYS . . . . . . . . . . . . . 50.9 tttp -98.59 -54.18 3.1 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.246 -0.434 . . . . 0.0 110.283 -179.469 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' D' D ' 85' ' ' ASP . . . . . . . . . . . . . 13.4 t70 -151.77 150.89 30.67 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 115.902 -0.59 . . . . 0.0 110.456 -179.474 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' D' D ' 86' ' ' VAL . . . . . . . . . . . . . 42.5 t -129.86 129.79 66.18 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.248 0 CA-C-O 120.974 0.416 . . . . 0.0 110.598 -179.058 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' D' D ' 87' ' ' ILE . . . . . . . . . . . . . 45.2 mm -118.83 125.79 74.75 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.286 0 CA-C-N 115.826 -0.625 . . . . 0.0 109.373 175.31 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' D' D ' 88' ' ' LEU . . . . . . . . . . . . . 30.8 mt -118.65 138.84 52.33 Favored 'General case' 0 C--N 1.332 -0.188 0 CA-C-O 121.316 0.579 . . . . 0.0 111.941 -175.427 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' D' D ' 89' ' ' ASP . . . . . . . . . . . . . 12.2 t0 -136.09 151.72 50.11 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 115.171 -0.922 . . . . 0.0 108.764 174.725 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' D' D ' 90' ' ' GLU . . . . . . . . . . . . . 83.5 tt0 -49.0 -31.8 8.13 Favored 'General case' 0 C--N 1.329 -0.32 0 N-CA-C 112.876 0.695 . . . . 0.0 112.876 -172.829 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' D' D ' 91' ' ' ASN . . . . . . . . . . . . . 12.4 p30 -117.24 3.07 12.62 Favored 'General case' 0 N--CA 1.469 0.513 0 N-CA-C 113.815 1.043 . . . . 0.0 113.815 -174.867 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' D' D ' 92' ' ' LEU . . . . . . . . . . . . . 17.7 mt -148.47 148.45 30.29 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 118.241 0.473 . . . . 0.0 110.647 -175.421 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' D' D ' 93' ' ' ILE . . . . . . . . . . . . . 75.9 mt -129.65 118.36 44.84 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.285 0 N-CA-C 109.233 -0.654 . . . . 0.0 109.233 176.949 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' D' D ' 94' ' ' VAL . . . . . . . . . . . . . 44.7 t -118.29 125.12 74.05 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.288 0 N-CA-C 109.884 -0.413 . . . . 0.0 109.884 -178.786 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' D' D ' 95' ' ' VAL . . . . . . . . . . . . . 43.5 t -120.91 134.09 65.45 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.343 0 CA-C-N 116.133 -0.485 . . . . 0.0 109.841 -179.703 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' D' D ' 96' ' ' ILE . . . . . . . . . . . . . 68.6 mt -114.42 126.71 72.01 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.339 0 N-CA-C 109.042 -0.725 . . . . 0.0 109.042 178.439 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' D' D ' 97' ' ' THR . . . . . . . . . . . . . 79.7 p -98.82 158.15 15.82 Favored 'General case' 0 C--N 1.331 -0.239 0 CA-C-O 121.176 0.512 . . . . 0.0 111.124 -176.965 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' D' D ' 98' ' ' GLU . . . . . . . . . . . . . 83.1 tt0 -53.98 -27.3 30.61 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-N 116.093 -0.503 . . . . 0.0 112.065 179.843 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' D' D ' 99' ' ' GLU . . . . . . . . . . . . . 96.6 mt-10 -78.07 13.48 1.43 Allowed 'General case' 0 CA--C 1.536 0.421 0 N-CA-C 113.294 0.85 . . . . 0.0 113.294 -176.852 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' D' D ' 100' ' ' ASN . . . . . . . . . . . . . 3.2 m-20 62.49 32.93 16.4 Favored 'General case' 0 N--CA 1.464 0.266 0 CA-C-O 120.898 0.38 . . . . 0.0 111.637 179.155 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' D' D ' 101' ' ' GLU . . . . . . . . . . . . . 84.6 tt0 -109.59 144.4 37.95 Favored 'General case' 0 C--N 1.334 -0.105 0 N-CA-C 109.709 -0.478 . . . . 0.0 109.709 173.247 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' D' D ' 102' ' ' VAL . . . . . . . . . . . . . 45.9 t -114.94 125.88 72.37 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.331 0 CA-C-N 116.113 -0.494 . . . . 0.0 109.858 -178.181 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' D' D ' 103' ' ' LEU . . . . . . . . . . . . . 53.1 mt -117.71 129.77 55.92 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 115.998 -0.546 . . . . 0.0 110.331 177.553 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' D' D ' 104' ' ' ILE . . . . . . . . . . . . . 70.3 mt -118.15 119.58 61.83 Favored 'Isoleucine or valine' 0 C--O 1.234 0.256 0 CA-C-N 116.393 -0.367 . . . . 0.0 110.173 -179.692 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' D' D ' 105' ' ' PHE . . . . . . . . . . . . . 46.6 m-85 -121.55 168.15 12.07 Favored 'General case' 0 C--N 1.332 -0.194 0 O-C-N 123.879 0.737 . . . . 0.0 109.738 179.794 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' D' D ' 106' ' ' ASN . . . . . . . . . . . . . 44.0 p-10 -99.42 -170.2 1.87 Allowed 'General case' 0 C--N 1.331 -0.217 0 N-CA-C 109.734 -0.469 . . . . 0.0 109.734 172.036 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' D' D ' 107' ' ' GLN . . . . . . . . . . . . . 59.3 tt0 -59.37 -30.03 68.12 Favored 'General case' 0 C--N 1.329 -0.31 0 N-CA-C 111.824 0.305 . . . . 0.0 111.824 -179.724 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' D' D ' 108' ' ' ASN . . . . . . . . . . . . . 11.8 t-20 -86.56 13.53 8.34 Favored 'General case' 0 CA--C 1.535 0.399 0 N-CA-C 112.904 0.705 . . . . 0.0 112.904 -177.152 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' D' D ' 109' ' ' LEU . . . . . . . . . . . . . 21.7 mt 58.51 34.03 23.58 Favored 'General case' 0 C--O 1.233 0.198 0 CA-C-O 120.73 0.3 . . . . 0.0 111.747 177.563 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' D' D ' 110' ' ' GLU . . . . . . . . . . . . . 96.1 mt-10 -99.73 138.8 36.31 Favored 'General case' 0 C--N 1.33 -0.28 0 N-CA-C 109.455 -0.572 . . . . 0.0 109.455 175.222 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' D' D ' 111' ' ' GLU . . . . . . . . . . . . . 48.3 tt0 -79.67 121.86 25.83 Favored 'General case' 0 C--N 1.327 -0.373 0 C-N-CA 120.759 -0.376 . . . . 0.0 110.293 -176.402 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' D' D ' 112' ' ' LEU . . . . . . . . . . . . . 26.6 mt -105.79 -46.01 4.24 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.019 -0.537 . . . . 0.0 110.432 179.656 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' D' D ' 113' ' ' TYR . . . . . . . . . . . . . 61.3 t80 -135.91 138.85 42.83 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.089 -0.505 . . . . 0.0 110.838 -179.041 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' D' D ' 114' ' ' ARG . . . . . . . . . . . . . 39.6 ptt180 -141.6 126.38 18.07 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-O 120.941 0.401 . . . . 0.0 110.681 176.913 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' D' D ' 115' ' ' GLY . . . . . . . . . . . . . . . -150.06 163.08 29.38 Favored Glycine 0 CA--C 1.522 0.515 0 N-CA-C 110.604 -0.999 . . . . 0.0 110.604 -179.723 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' D' D ' 116' ' ' LYS . . . . . . . . . . . . . 72.4 tttt -134.35 134.07 41.35 Favored 'General case' 0 C--N 1.33 -0.257 0 N-CA-C 110.093 -0.336 . . . . 0.0 110.093 179.192 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' D' D ' 117' ' ' PHE . . . . . . . . . . . . . 39.2 m-85 -134.03 114.01 12.74 Favored 'General case' 0 C--N 1.331 -0.209 0 CA-C-N 116.328 -0.396 . . . . 0.0 110.124 -175.18 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' D' D ' 118' ' ' GLU . . . . . . . . . . . . . 45.0 tp10 -53.49 -43.82 68.54 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.467 -0.333 . . . . 0.0 111.526 -175.665 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' D' D ' 119' ' ' ASN . . . . . . . . . . . . . 80.4 m-20 -99.69 31.04 3.36 Favored 'General case' 0 C--N 1.332 -0.175 0 N-CA-C 112.319 0.489 . . . . 0.0 112.319 -173.875 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' D' D ' 120' ' ' LEU . . . . . . . . . . . . . 15.0 tp -57.44 122.72 13.31 Favored 'General case' 0 C--N 1.331 -0.213 0 N-CA-C 110.162 -0.31 . . . . 0.0 110.162 177.386 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' D' D ' 121' ' ' ASN . . . . . . . . . . . . . 73.8 m-20 -114.02 -44.15 3.18 Favored 'General case' 0 C--O 1.232 0.153 0 CA-C-N 116.689 -0.232 . . . . 0.0 111.378 -176.883 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' D' D ' 122' ' ' LYS . . . . . . . . . . . . . 98.0 mttt -143.83 147.02 33.5 Favored 'General case' 0 C--N 1.333 -0.15 0 CA-C-O 121.072 0.463 . . . . 0.0 111.657 -178.36 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' D' D ' 123' ' ' VAL . . . . . 0.44 ' C ' HD12 ' D' ' 124' ' ' LEU . 45.4 t -127.21 124.33 63.96 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.256 0 N-CA-C 109.302 -0.629 . . . . 0.0 109.302 174.158 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' D' D ' 124' ' ' LEU . . . . . 0.485 ' N ' HD12 ' D' ' 124' ' ' LEU . 7.2 mp -115.39 131.49 56.91 Favored 'General case' 0 C--N 1.331 -0.229 0 CA-C-N 116.306 -0.406 . . . . 0.0 110.617 -177.898 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' D' D ' 125' ' ' VAL . . . . . . . . . . . . . 45.9 t -126.72 126.83 69.39 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.243 0 CA-C-N 116.128 -0.487 . . . . 0.0 109.999 179.49 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' D' D ' 126' ' ' ARG . . . . . . . . . . . . . 69.6 ttt180 -155.22 141.13 18.22 Favored 'General case' 0 C--N 1.328 -0.356 0 N-CA-C 109.527 -0.545 . . . . 0.0 109.527 177.542 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' D' D ' 127' ' ' ASN . . . . . . . . . . . . . 9.7 p30 48.73 -151.84 0.13 Allowed 'General case' 0 CA--C 1.54 0.593 0 CA-C-O 119.299 -0.381 . . . . 0.0 110.897 178.989 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' D' D ' 128' ' ' ASP . . . . . . . . . . . . . 12.7 p-10 -84.49 22.71 1.23 Allowed 'General case' 0 CA--C 1.535 0.385 0 CA-C-N 118.61 0.641 . . . . 0.0 112.264 177.705 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' D' D ' 129' ' ' LEU . . . . . . . . . . . . . 13.4 tp -120.72 137.02 54.7 Favored 'General case' 0 C--O 1.233 0.216 0 CA-C-O 121.061 0.458 . . . . 0.0 110.508 -179.605 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' D' D ' 130' ' ' VAL . . . . . . . . . . . . . 45.0 t -123.24 136.01 61.32 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.218 0 CA-C-N 115.949 -0.569 . . . . 0.0 109.61 178.26 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' D' D ' 131' ' ' VAL . . . . . . . . . . . . . 42.2 t -134.9 136.82 51.63 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.238 0 CA-C-O 121.186 0.517 . . . . 0.0 110.516 179.957 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' D' D ' 132' ' ' ILE . . . . . . . . . . . . . 72.1 mt -117.55 133.89 62.87 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.295 0 CA-C-N 115.639 -0.71 . . . . 0.0 109.63 -179.579 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' D' D ' 133' ' ' ILE . . . . . . . . . . . . . 43.1 mm -118.55 122.21 68.92 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.19 0 CA-C-O 120.961 0.41 . . . . 0.0 110.947 -176.221 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' D' D ' 134' ' ' ASP . . . . . . . . . . . . . 8.0 p-10 -135.11 148.04 49.69 Favored 'General case' 0 C--N 1.329 -0.299 0 N-CA-C 109.3 -0.63 . . . . 0.0 109.3 173.029 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' D' D ' 135' ' ' GLU . . . . . . . . . . . . . 43.5 tp10 -49.83 -24.74 2.59 Favored 'General case' 0 C--N 1.327 -0.386 0 N-CA-C 112.768 0.655 . . . . 0.0 112.768 -171.671 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' D' D ' 136' ' ' GLN . . . . . . . . . . . . . 46.5 tt0 -102.83 -24.65 13.69 Favored 'General case' 0 CA--C 1.533 0.298 0 N-CA-C 112.96 0.726 . . . . 0.0 112.96 -173.995 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' D' D ' 137' ' ' LYS . . . . . . . . . . . . . 97.3 mttt -143.65 152.77 41.77 Favored 'General case' 0 C--N 1.331 -0.201 0 CA-C-O 121.168 0.508 . . . . 0.0 111.821 -172.574 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' D' D ' 138' ' ' LEU . . . . . . . . . . . . . 4.4 tt -120.41 121.8 39.32 Favored 'General case' 0 C--N 1.33 -0.262 0 N-CA-C 109.079 -0.712 . . . . 0.0 109.079 172.434 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' D' D ' 139' ' ' THR . . . . . . . . . . . . . 34.3 m -111.23 130.4 55.66 Favored 'General case' 0 C--N 1.332 -0.193 0 CA-C-O 120.734 0.302 . . . . 0.0 111.036 -175.683 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' D' D ' 140' ' ' LEU . . . . . 0.462 ' C ' HD23 ' D' ' 140' ' ' LEU . 5.6 tt -116.98 122.54 44.53 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 115.618 -0.719 . . . . 0.0 109.238 -179.683 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' D' D ' 141' ' ' ILE . . . . . 0.455 ' N ' HD23 ' D' ' 140' ' ' LEU . 18.8 mt -121.6 122.74 67.83 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.248 0 CA-C-O 120.888 0.375 . . . . 0.0 110.085 -175.663 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' D' D ' 142' ' ' ARG . . . . . . . . . . . . . 73.4 mtp180 -110.9 125.95 54.2 Favored 'General case' 0 C--N 1.331 -0.22 0 CA-C-N 115.682 -0.69 . . . . 0.0 110.16 -179.534 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' D' D ' 143' ' ' THR . . . . . . . . . . . . . 66.6 p . . . . . 0 C--O 1.219 -0.503 0 CA-C-O 118.074 -0.965 . . . . 0.0 110.492 -179.796 . . . . . . . . 0 0 . 1 . 006 nuclear nobuild full ' E' E ' -3' ' ' GLU . . . . . . . . . . . . . 95.9 mt-10 . . . . . 0 N--CA 1.49 1.559 0 N-CA-C 109.404 -0.591 . . . . 0.0 109.404 . . . . . . . . . 0 0 . 1 . 006 nuclear nobuild full ' E' E ' -2' ' ' GLY . . . . . . . . . . . . . . . -74.65 145.73 34.53 Favored Glycine 0 CA--C 1.524 0.638 0 N-CA-C 111.261 -0.735 . . . . 0.0 111.261 -179.325 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' E' E ' -1' ' ' VAL . . . . . . . . . . . . . 44.9 t -141.05 134.38 31.43 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.278 0 N-CA-C 109.748 -0.464 . . . . 0.0 109.748 178.719 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' E' E ' 0' ' ' ILE . . . . . . . . . . . . . 74.2 mt -116.01 138.59 45.97 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.255 0 CA-C-O 120.899 0.381 . . . . 0.0 110.148 -178.677 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' E' E ' 1' ' ' MET . . . . . . . . . . . . . 22.6 ptm -91.71 140.04 30.1 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.014 -0.539 . . . . 0.0 110.876 -178.306 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' E' E ' 2' ' ' SER . . . . . . . . . . . . . 6.4 p -122.88 132.97 54.42 Favored 'General case' 0 C--N 1.331 -0.22 0 CA-C-O 121.033 0.444 . . . . 0.0 110.994 -178.973 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' E' E ' 3' ' ' GLU . . . . . . . . . . . . . 95.1 mt-10 -140.91 141.95 34.49 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 115.876 -0.602 . . . . 0.0 110.961 -179.238 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' E' E ' 4' ' ' LEU . . . . . . . . . . . . . 15.0 tp -126.77 126.16 42.95 Favored 'General case' 0 C--N 1.331 -0.206 0 CA-C-N 116.091 -0.504 . . . . 0.0 109.97 176.516 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' E' E ' 5' ' ' LYS . . . . . . . . . . . . . 68.6 mttm -106.11 122.2 45.7 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-O 120.844 0.355 . . . . 0.0 110.826 178.426 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' E' E ' 6' ' ' LEU . . . . . . . . . . . . . 74.6 mt -118.59 146.56 44.52 Favored 'General case' 0 C--N 1.331 -0.209 0 CA-C-N 115.535 -0.757 . . . . 0.0 110.311 179.765 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' E' E ' 7' ' ' LYS . . . . . . . . . . . . . 80.0 tttt -135.66 140.24 33.26 Favored Pre-proline 0 CA--C 1.534 0.335 0 CA-C-O 119.093 -0.479 . . . . 0.0 110.254 176.985 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' E' E ' 8' ' ' PRO . . . . . . . . . . . . . 88.8 Cg_endo -91.98 143.39 2.74 Favored 'Trans proline' 0 N--CA 1.49 1.311 0 C-N-CA 121.827 1.685 . . . . 0.0 111.934 177.773 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' E' E ' 9' ' ' LEU . . . . . . . . . . . . . 60.8 mt -77.37 -47.51 2.52 Favored Pre-proline 0 CA--C 1.533 0.317 0 CA-C-O 118.688 -0.673 . . . . 0.0 112.226 179.533 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' E' E ' 10' ' ' PRO . . . . . . . . . . . . . 94.8 Cg_endo -80.26 142.82 15.31 Favored 'Trans proline' 0 N--CA 1.495 1.582 0 C-N-CA 121.133 1.222 . . . . 0.0 111.518 175.905 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' E' E ' 11' ' ' LYS . . . . . . . . . . . . . 46.0 pttt -83.76 113.38 20.86 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-O 121.496 0.665 . . . . 0.0 110.879 -179.74 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' E' E ' 12' ' ' VAL . . . . . . . . . . . . . 12.2 p -151.18 148.54 14.8 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.284 0 CA-C-N 115.649 -0.705 . . . . 0.0 110.377 179.873 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' E' E ' 13' ' ' GLU . . . . . . . . . . . . . 43.0 mt-10 -83.78 116.03 22.51 Favored 'General case' 0 C--N 1.329 -0.313 0 N-CA-C 110.144 -0.317 . . . . 0.0 110.144 177.658 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' E' E ' 14' ' ' LEU . . . . . . . . . . . . . 31.1 mt -99.33 143.53 26.59 Favored Pre-proline 0 CA--C 1.533 0.309 0 CA-C-O 119.09 -0.481 . . . . 0.0 110.279 -179.439 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' E' E ' 15' ' ' PRO . . . . . . . . . . . . . 25.7 Cg_exo -62.55 157.34 47.11 Favored 'Trans proline' 0 N--CA 1.498 1.774 0 C-N-CA 121.342 1.361 . . . . 0.0 112.013 177.682 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' E' E ' 16' ' ' PRO . . . . . . . . . . . . . 31.4 Cg_exo -59.76 -34.43 95.93 Favored 'Trans proline' 0 N--CA 1.498 1.752 0 C-N-CA 121.452 1.435 . . . . 0.0 112.782 179.969 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' E' E ' 17' ' ' ASP . . . . . . . . . . . . . 9.1 p-10 -83.32 4.43 27.24 Favored 'General case' 0 CA--C 1.537 0.465 0 N-CA-C 113.26 0.837 . . . . 0.0 113.26 -177.462 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' E' E ' 18' ' ' PHE . . . . . . . . . . . . . 33.8 t80 -58.06 -44.69 87.63 Favored 'General case' 0 C--N 1.334 -0.07 0 O-C-N 121.884 -0.51 . . . . 0.0 109.898 -178.574 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' E' E ' 19' ' ' VAL . . . . . . . . . . . . . 48.5 t -58.3 -40.33 77.45 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.361 0 CA-C-N 116.037 -0.529 . . . . 0.0 110.525 -178.725 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' E' E ' 20' ' ' ASP . . . . . . . . . . . . . 11.8 t70 -58.85 -43.74 90.86 Favored 'General case' 0 C--O 1.234 0.268 0 CA-C-O 120.947 0.403 . . . . 0.0 110.772 -177.223 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' E' E ' 21' ' ' VAL . . . . . . . . . . . . . 48.4 t -65.8 -51.98 55.24 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.291 0 C-N-CA 120.662 -0.415 . . . . 0.0 110.517 -179.011 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' E' E ' 22' ' ' ILE . . . . . 0.473 HG22 HD12 ' E' ' 26' ' ' LEU . 50.4 mm -55.24 -54.09 28.29 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.295 0 C-N-CA 120.901 -0.32 . . . . 0.0 111.168 -176.665 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' E' E ' 23' ' ' ARG . . . . . . . . . . . . . 13.8 ptm180 -58.52 -44.45 89.52 Favored 'General case' 0 C--N 1.33 -0.249 0 C-N-CA 120.773 -0.371 . . . . 0.0 111.721 -172.973 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' E' E ' 24' ' ' ILE . . . . . . . . . . . . . 86.9 mt -64.18 -34.97 72.29 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.303 0 C-N-CA 120.767 -0.373 . . . . 0.0 111.355 -177.714 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' E' E ' 25' ' ' LYS . . . . . . . . . . . . . 34.4 mmtp -67.87 -44.07 77.93 Favored 'General case' 0 C--N 1.33 -0.27 0 N-CA-C 112.09 0.404 . . . . 0.0 112.09 177.365 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' E' E ' 26' ' ' LEU . . . . . 0.473 HD12 HG22 ' E' ' 22' ' ' ILE . 75.8 mt -85.49 -23.79 27.63 Favored 'General case' 0 C--N 1.329 -0.294 0 N-CA-C 114.065 1.135 . . . . 0.0 114.065 -170.266 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' E' E ' 27' ' ' GLN . . . . . . . . . . . . . 8.3 pt20 -47.63 145.66 2.58 Favored 'General case' 0 N--CA 1.47 0.535 0 N-CA-C 112.553 0.575 . . . . 0.0 112.553 -176.152 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' E' E ' 28' ' ' GLY . . . . . . . . . . . . . . . 99.77 -23.82 34.58 Favored Glycine 0 CA--C 1.532 1.121 0 CA-C-N 115.512 -0.767 . . . . 0.0 112.2 -175.28 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' E' E ' 29' ' ' LYS . . . . . . . . . . . . . 79.9 mttt -94.54 155.06 17.09 Favored 'General case' 0 C--O 1.233 0.212 0 CA-C-N 117.577 0.689 . . . . 0.0 110.518 177.153 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' E' E ' 30' ' ' THR . . . . . . . . . . . . . 26.9 m -107.48 138.5 43.57 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 116.116 -0.493 . . . . 0.0 110.128 178.056 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' E' E ' 31' ' ' VAL . . . . . . . . . . . . . 34.7 m -127.24 151.66 34.36 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.199 0 CA-C-O 121.005 0.431 . . . . 0.0 110.893 -179.161 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' E' E ' 32' ' ' ARG . . . . . . . . . . . . . 55.0 ttt180 -128.32 150.09 50.23 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 115.893 -0.594 . . . . 0.0 110.073 179.389 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' E' E ' 33' ' ' THR . . . . . . . . . . . . . 23.2 m -52.59 137.62 30.08 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-O 120.733 0.302 . . . . 0.0 111.528 -177.357 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' E' E ' 34' ' ' GLY . . . . . . . . . . . . . . . 100.03 -17.04 57.73 Favored Glycine 0 CA--C 1.533 1.183 0 CA-C-O 119.671 -0.516 . . . . 0.0 113.313 178.763 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' E' E ' 35' ' ' ASP . . . . . . . . . . . . . 76.7 m-20 -67.22 149.88 49.83 Favored 'General case' 0 N--CA 1.462 0.144 0 CA-C-N 117.983 0.891 . . . . 0.0 111.266 179.043 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' E' E ' 36' ' ' VAL . . . . . . . . . . . . . 44.8 t -121.23 130.5 74.59 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.186 0 CA-C-N 115.966 -0.561 . . . . 0.0 109.956 178.464 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' E' E ' 37' ' ' ILE . . . . . . . . . . . . . 69.9 mt -121.27 139.09 49.52 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.279 0 CA-C-N 116.139 -0.482 . . . . 0.0 109.85 179.839 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' E' E ' 38' ' ' GLY . . . . . . . . . . . . . . . -114.33 129.38 8.68 Favored Glycine 0 CA--C 1.527 0.784 0 N-CA-C 111.53 -0.628 . . . . 0.0 111.53 -177.791 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' E' E ' 39' ' ' ILE . . . . . . . . . . . . . 69.9 mt -121.85 136.76 57.71 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.189 0 N-CA-C 109.829 -0.434 . . . . 0.0 109.829 177.765 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' E' E ' 40' ' ' SER . . . . . . . . . . . . . 39.7 t -92.88 113.98 26.41 Favored 'General case' 0 C--N 1.33 -0.264 0 C-N-CA 120.935 -0.306 . . . . 0.0 110.895 176.167 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' E' E ' 41' ' ' ILE . . . . . . . . . . . . . 47.9 mm -120.87 113.2 39.01 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.167 0 N-CA-C 110.157 -0.312 . . . . 0.0 110.157 179.196 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' E' E ' 42' ' ' LEU . . . . . . . . . . . . . 7.0 mp 57.01 36.17 27.41 Favored 'General case' 0 CA--C 1.533 0.298 0 CA-C-O 120.84 0.352 . . . . 0.0 111.232 179.681 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' E' E ' 43' ' ' GLY . . . . . . . . . . . . . . . 77.74 -10.17 26.21 Favored Glycine 0 CA--C 1.535 1.29 0 C-N-CA 121.245 -0.502 . . . . 0.0 113.566 177.708 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' E' E ' 44' ' ' LYS . . . . . . . . . . . . . 49.4 tptt -94.95 132.91 39.27 Favored 'General case' 0 C--N 1.332 -0.19 0 CA-C-N 117.763 0.781 . . . . 0.0 109.695 176.821 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' E' E ' 45' ' ' GLU . . . . . . . . . . . . . 84.5 tt0 -83.49 125.82 32.14 Favored 'General case' 0 C--N 1.328 -0.359 0 C-N-CA 120.838 -0.345 . . . . 0.0 111.003 -178.796 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' E' E ' 46' ' ' VAL . . . . . . . . . . . . . 7.2 p -119.44 124.68 73.42 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.231 0 N-CA-C 109.311 -0.626 . . . . 0.0 109.311 175.268 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' E' E ' 47' ' ' LYS . . . . . . . . . . . . . 60.6 mttp -99.36 128.34 45.47 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 115.976 -0.557 . . . . 0.0 111.11 178.486 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' E' E ' 48' ' ' PHE . . . . . . . . . . . . . 95.7 m-85 -110.2 131.87 54.67 Favored 'General case' 0 C--N 1.329 -0.321 0 N-CA-C 109.687 -0.486 . . . . 0.0 109.687 175.44 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' E' E ' 49' ' ' LYS . . . . . . . . . . . . . 61.9 tttm -106.99 136.6 46.58 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.485 -0.325 . . . . 0.0 110.283 178.984 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' E' E ' 50' ' ' VAL . . . . . . . . . . . . . 45.7 t -75.4 107.29 5.98 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.34 0 N-CA-C 109.023 -0.732 . . . . 0.0 109.023 175.715 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' E' E ' 51' ' ' VAL . . . . . . . . . . . . . 47.0 t -71.34 -48.07 55.98 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.261 0 O-C-N 123.511 0.507 . . . . 0.0 109.856 -174.063 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' E' E ' 52' ' ' GLN . . . . . . . . . . . . . 48.2 tt0 -168.11 135.65 2.19 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 116.051 -0.522 . . . . 0.0 111.445 -179.142 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' E' E ' 53' ' ' ALA . . . . . . . . . . . . . . . -110.34 131.44 55.05 Favored 'General case' 0 C--N 1.331 -0.23 0 CA-C-N 115.943 -0.571 . . . . 0.0 109.865 176.114 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' E' E ' 54' ' ' TYR . . . . . . . . . . . . . 34.0 t80 -129.07 108.0 18.01 Favored Pre-proline 0 CA--C 1.535 0.389 0 CA-C-O 118.28 -0.867 . . . . 0.0 110.379 -179.735 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' E' E ' 55' ' ' PRO . . . . . . . . . . . . . 73.9 Cg_endo -77.09 170.02 72.74 Favored 'Cis proline' 0 N--CA 1.499 1.833 0 CA-C-N 121.85 1.697 . . . . 0.0 112.369 -5.351 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' E' E ' 56' ' ' SER . . . . . . . . . . . . . 48.9 m -115.9 137.12 23.1 Favored Pre-proline 0 CA--C 1.538 0.518 0 CA-C-O 118.51 -0.757 . . . . 0.0 109.565 175.547 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' E' E ' 57' ' ' PRO . . . . . . . . . . . . . 59.7 Cg_endo -73.76 146.79 87.89 Favored 'Cis proline' 0 N--CA 1.497 1.712 0 CA-C-N 121.705 1.644 . . . . 0.0 111.553 -2.481 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' E' E ' 58' ' ' LEU . . . . . . . . . . . . . 31.1 tp -108.38 138.3 44.91 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.375 -0.375 . . . . 0.0 110.762 -177.509 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' E' E ' 59' ' ' ARG . . . . . . . . . . . . . 55.8 ttp180 -102.04 128.71 48.37 Favored 'General case' 0 C--N 1.327 -0.387 0 N-CA-C 109.266 -0.642 . . . . 0.0 109.266 175.837 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' E' E ' 60' ' ' VAL . . . . . . . . . . . . . 42.3 t -84.88 116.36 28.31 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.233 0 C-N-CA 120.743 -0.383 . . . . 0.0 110.815 -173.235 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' E' E ' 61' ' ' GLU . . . . . . . . . . . . . 95.8 mt-10 -131.25 159.47 37.72 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 115.909 -0.587 . . . . 0.0 110.139 175.095 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' E' E ' 62' ' ' ASP . . . . . . . . . . . . . 81.4 m-20 -54.43 -30.79 53.75 Favored 'General case' 0 C--N 1.329 -0.319 0 N-CA-C 111.893 0.331 . . . . 0.0 111.893 179.507 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' E' E ' 63' ' ' ARG . . . . . . . . . . . . . 39.0 ptt180 -78.4 -1.18 32.2 Favored 'General case' 0 CA--C 1.538 0.487 0 N-CA-C 113.72 1.007 . . . . 0.0 113.72 -175.8 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' E' E ' 64' ' ' THR . . . . . . . . . . . . . 31.6 m -93.4 148.25 22.23 Favored 'General case' 0 C--N 1.331 -0.199 0 CA-C-N 118.168 0.44 . . . . 0.0 110.305 -179.134 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' E' E ' 65' ' ' LYS . . . . . . . . . . . . . 43.7 mtmt -86.31 122.44 30.29 Favored 'General case' 0 C--N 1.329 -0.287 0 C-N-CA 120.654 -0.419 . . . . 0.0 110.213 179.413 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' E' E ' 66' ' ' ILE . . . . . . . . . . . . . 61.0 mt -112.26 125.71 69.57 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.246 0 N-CA-C 109.393 -0.595 . . . . 0.0 109.393 179.91 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' E' E ' 67' ' ' THR . . . . . . . . . . . . . 27.8 m -119.33 138.12 53.25 Favored 'General case' 0 C--N 1.331 -0.202 0 CA-C-N 116.235 -0.439 . . . . 0.0 110.891 -175.749 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' E' E ' 68' ' ' LEU . . . . . . . . . . . . . 4.4 tt -106.21 124.39 49.52 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 115.788 -0.642 . . . . 0.0 109.725 178.191 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' E' E ' 69' ' ' VAL . . . . . . . . . . . . . 41.8 t -95.32 139.17 19.35 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.281 0 CA-C-O 120.963 0.411 . . . . 0.0 110.59 -177.002 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' E' E ' 70' ' ' THR . . . . . . . . . . . . . 23.7 p -132.16 -37.95 1.1 Allowed 'General case' 0 C--N 1.332 -0.162 0 CA-C-N 115.865 -0.607 . . . . 0.0 111.037 179.799 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' E' E ' 71' ' ' HIS . . . . . . . . . . . . . 18.2 m80 -71.11 113.45 19.19 Favored Pre-proline 0 CA--C 1.536 0.416 0 CA-C-O 118.631 -0.699 . . . . 0.0 110.574 -178.887 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' E' E ' 72' ' ' PRO . . . . . . . . . . . . . 95.6 Cg_endo -82.33 -24.35 3.78 Favored 'Trans proline' 0 N--CA 1.496 1.645 0 C-N-CA 121.407 1.405 . . . . 0.0 112.989 178.966 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' E' E ' 73' ' ' VAL . . . . . . . . . . . . . 35.9 m -126.15 166.45 22.32 Favored 'Isoleucine or valine' 0 C--O 1.233 0.187 0 CA-C-O 120.8 0.333 . . . . 0.0 110.667 -179.046 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' E' E ' 74' ' ' ASP . . . . . . . . . . . . . 6.0 t70 -103.04 122.3 44.35 Favored 'General case' 0 C--N 1.329 -0.296 0 N-CA-C 109.614 -0.513 . . . . 0.0 109.614 -178.937 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' E' E ' 75' ' ' VAL . . . . . . . . . . . . . 40.5 t -119.37 125.73 74.68 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.241 0 CA-C-O 121.095 0.474 . . . . 0.0 110.808 -176.699 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' E' E ' 76' ' ' LEU . . . . . . . . . . . . . 6.0 mp -120.51 143.37 48.59 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 115.659 -0.7 . . . . 0.0 109.586 174.701 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' E' E ' 77' ' ' GLU . . . . . . . . . . . . . 47.1 mt-10 -134.99 129.05 33.57 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-O 121.022 0.439 . . . . 0.0 110.768 -178.563 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' E' E ' 78' ' ' ALA . . . . . 0.538 ' HB2' HD21 ' E' ' 109' ' ' LEU . . . -114.47 133.6 55.63 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 115.802 -0.635 . . . . 0.0 109.865 177.854 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' E' E ' 79' ' ' LYS . . . . . 0.58 ' O ' HD13 ' E' ' 80' ' ' ILE . 83.3 tttt -78.8 114.87 18.09 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.332 -0.395 . . . . 0.0 109.981 -179.792 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' E' E ' 80' ' ' ILE . . . . . 0.58 HD13 ' O ' ' E' ' 79' ' ' LYS . 41.9 mm -138.14 121.16 19.77 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.255 0 N-CA-C 109.864 -0.421 . . . . 0.0 109.864 -175.551 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' E' E ' 81' ' ' LYS . . . . . . . . . . . . . 9.6 mtmp? -110.92 126.9 55.22 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-O 120.962 0.41 . . . . 0.0 111.02 -178.426 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' E' E ' 82' ' ' GLY . . . . . . . . . . . . . . . 89.06 42.12 5.7 Favored Glycine 0 CA--C 1.525 0.679 0 C-N-CA 121.003 -0.618 . . . . 0.0 112.025 174.403 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' E' E ' 83' ' ' ILE . . . . . . . . . . . . . 74.7 mt -67.78 133.26 31.88 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.246 0 N-CA-C 109.719 -0.474 . . . . 0.0 109.719 177.329 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' E' E ' 84' ' ' LYS . . . . . . . . . . . . . 83.0 tttt -97.21 -54.15 3.25 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 115.999 -0.546 . . . . 0.0 110.465 -176.979 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' E' E ' 85' ' ' ASP . . . . . . . . . . . . . 13.8 t70 -152.15 149.87 29.24 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 115.604 -0.726 . . . . 0.0 110.163 -179.226 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' E' E ' 86' ' ' VAL . . . . . . . . . . . . . 44.0 t -133.5 131.08 57.31 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.297 0 CA-C-O 120.97 0.414 . . . . 0.0 110.523 -179.66 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' E' E ' 87' ' ' ILE . . . . . . . . . . . . . 46.9 mm -120.07 126.53 75.38 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.254 0 CA-C-N 115.846 -0.616 . . . . 0.0 109.585 176.241 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' E' E ' 88' ' ' LEU . . . . . . . . . . . . . 53.6 mt -110.96 135.75 51.0 Favored 'General case' 0 C--N 1.331 -0.218 0 CA-C-O 121.153 0.501 . . . . 0.0 111.375 -176.243 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' E' E ' 89' ' ' ASP . . . . . . . . . . . . . 7.8 t0 -128.84 150.52 50.3 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 115.596 -0.729 . . . . 0.0 109.034 175.045 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' E' E ' 90' ' ' GLU . . . . . . . . . . . . . 44.1 mt-10 -49.12 -32.82 10.65 Favored 'General case' 0 C--N 1.329 -0.31 0 N-CA-C 112.864 0.69 . . . . 0.0 112.864 -172.339 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' E' E ' 91' ' ' ASN . . . . . . . . . . . . . 65.7 m-80 -131.86 28.68 4.51 Favored 'General case' 0 N--CA 1.467 0.388 0 N-CA-C 112.412 0.523 . . . . 0.0 112.412 -176.208 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' E' E ' 92' ' ' LEU . . . . . . . . . . . . . 9.0 tp -166.2 145.7 6.02 Favored 'General case' 0 C--N 1.33 -0.258 0 N-CA-C 110.207 -0.294 . . . . 0.0 110.207 179.623 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' E' E ' 93' ' ' ILE . . . . . 0.409 HD11 HD11 ' D' ' 140' ' ' LEU . 69.2 mt -127.72 125.17 64.72 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.202 0 N-CA-C 109.795 -0.446 . . . . 0.0 109.795 179.857 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' E' E ' 94' ' ' VAL . . . . . . . . . . . . . 45.8 t -120.88 125.91 74.6 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.22 0 N-CA-C 109.688 -0.486 . . . . 0.0 109.688 179.255 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' E' E ' 95' ' ' VAL . . . . . . . . . . . . . 43.3 t -122.52 135.18 63.44 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.236 0 CA-C-N 116.205 -0.452 . . . . 0.0 109.979 -178.471 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' E' E ' 96' ' ' ILE . . . . . . . . . . . . . 57.1 mt -116.27 130.11 71.57 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 N-CA-C 109.372 -0.603 . . . . 0.0 109.372 179.224 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' E' E ' 97' ' ' THR . . . . . . . . . . . . . 72.9 p -102.23 154.85 18.64 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-O 121.184 0.516 . . . . 0.0 111.056 -178.778 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' E' E ' 98' ' ' GLU . . . . . . . . . . . . . 96.8 mt-10 -54.23 -23.26 14.07 Favored 'General case' 0 CA--C 1.533 0.318 0 N-CA-C 112.366 0.506 . . . . 0.0 112.366 178.932 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' E' E ' 99' ' ' GLU . . . . . . . . . . . . . 32.5 tt0 -79.09 14.69 1.35 Allowed 'General case' 0 CA--C 1.539 0.523 0 N-CA-C 112.688 0.625 . . . . 0.0 112.688 -177.97 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' E' E ' 100' ' ' ASN . . . . . . . . . . . . . 4.4 m-20 62.35 38.06 13.35 Favored 'General case' 0 C--O 1.231 0.117 0 O-C-N 121.801 -0.562 . . . . 0.0 111.002 178.817 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' E' E ' 101' ' ' GLU . . . . . . . . . . . . . 84.9 tt0 -118.01 142.64 47.16 Favored 'General case' 0 C--N 1.331 -0.212 0 CA-C-N 115.996 -0.547 . . . . 0.0 109.845 176.263 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' E' E ' 102' ' ' VAL . . . . . . . . . . . . . 45.5 t -114.97 128.51 72.09 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.306 0 N-CA-C 109.811 -0.44 . . . . 0.0 109.811 -178.688 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' E' E ' 103' ' ' LEU . . . . . . . . . . . . . 51.0 mt -120.29 134.85 55.18 Favored 'General case' 0 C--N 1.331 -0.219 0 CA-C-N 115.865 -0.607 . . . . 0.0 110.382 178.222 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' E' E ' 104' ' ' ILE . . . . . . . . . . . . . 67.8 mt -118.78 124.36 73.03 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.304 0 N-CA-C 110.077 -0.342 . . . . 0.0 110.077 -179.745 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' E' E ' 105' ' ' PHE . . . . . . . . . . . . . 92.2 m-85 -124.07 162.77 22.84 Favored 'General case' 0 C--N 1.332 -0.194 0 O-C-N 123.912 0.758 . . . . 0.0 109.984 -179.981 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' E' E ' 106' ' ' ASN . . . . . . . . . . . . . 47.7 p-10 -98.59 -170.5 1.95 Allowed 'General case' 0 C--N 1.33 -0.279 0 N-CA-C 109.871 -0.418 . . . . 0.0 109.871 174.551 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' E' E ' 107' ' ' GLN . . . . . . . . . . . . . 46.0 tt0 -60.18 -30.07 69.1 Favored 'General case' 0 C--N 1.329 -0.297 0 N-CA-C 111.987 0.366 . . . . 0.0 111.987 -178.827 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' E' E ' 108' ' ' ASN . . . . . . . . . . . . . 59.9 t30 -84.86 10.16 12.34 Favored 'General case' 0 CA--C 1.536 0.439 0 N-CA-C 113.154 0.798 . . . . 0.0 113.154 -177.632 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' E' E ' 109' ' ' LEU . . . . . 0.538 HD21 ' HB2' ' E' ' 78' ' ' ALA . 8.4 tp 58.6 37.18 25.4 Favored 'General case' 0 C--N 1.331 -0.198 0 CA-C-O 121.065 0.459 . . . . 0.0 111.232 179.476 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' E' E ' 110' ' ' GLU . . . . . . . . . . . . . 70.5 mm-40 -103.4 142.16 34.71 Favored 'General case' 0 C--N 1.329 -0.303 0 N-CA-C 109.358 -0.608 . . . . 0.0 109.358 174.908 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' E' E ' 111' ' ' GLU . . . . . . . . . . . . . 71.6 tt0 -78.36 121.77 24.9 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-O 120.94 0.4 . . . . 0.0 110.387 -175.199 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' E' E ' 112' ' ' LEU . . . . . . . . . . . . . 15.3 mt -106.21 -46.02 4.16 Favored 'General case' 0 C--N 1.331 -0.196 0 CA-C-N 116.08 -0.509 . . . . 0.0 110.778 -178.913 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' E' E ' 113' ' ' TYR . . . . . . . . . . . . . 59.0 t80 -137.31 144.38 42.58 Favored 'General case' 0 C--N 1.331 -0.223 0 CA-C-N 116.204 -0.453 . . . . 0.0 111.012 -178.4 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' E' E ' 114' ' ' ARG . . . . . . . . . . . . . 48.1 ptt85 -147.12 125.75 12.53 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.271 -0.422 . . . . 0.0 111.003 179.073 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' E' E ' 115' ' ' GLY . . . . . . . . . . . . . . . -149.98 153.95 25.4 Favored Glycine 0 CA--C 1.525 0.678 0 N-CA-C 111.231 -0.748 . . . . 0.0 111.231 178.206 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' E' E ' 116' ' ' LYS . . . . . . . . . . . . . 25.9 ttpp -124.83 132.49 53.33 Favored 'General case' 0 C--N 1.331 -0.212 0 N-CA-C 109.942 -0.392 . . . . 0.0 109.942 178.352 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' E' E ' 117' ' ' PHE . . . . . . . . . . . . . 48.5 m-85 -130.68 115.9 17.32 Favored 'General case' 0 C--N 1.331 -0.206 0 CA-C-O 120.928 0.394 . . . . 0.0 110.373 -175.568 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' E' E ' 118' ' ' GLU . . . . . . . . . . . . . 46.1 tp10 -52.84 -51.11 62.2 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.36 -0.382 . . . . 0.0 111.784 -174.734 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' E' E ' 119' ' ' ASN . . . . . . . . . . . . . 3.2 p30 -98.45 31.31 2.88 Favored 'General case' 0 C--N 1.33 -0.274 0 N-CA-C 112.197 0.443 . . . . 0.0 112.197 -174.418 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' E' E ' 120' ' ' LEU . . . . . . . . . . . . . 14.5 tp -51.71 124.81 13.24 Favored 'General case' 0 N--CA 1.464 0.237 0 CA-C-O 120.535 0.207 . . . . 0.0 111.057 178.025 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' E' E ' 121' ' ' ASN . . . . . . . . . . . . . 15.6 m120 -113.55 -44.06 3.25 Favored 'General case' 0 C--O 1.232 0.183 0 CA-C-N 116.727 -0.215 . . . . 0.0 111.285 -176.495 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' E' E ' 122' ' ' LYS . . . . . . . . . . . . . 98.8 mttt -145.36 148.53 33.48 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-O 121.049 0.452 . . . . 0.0 111.826 -176.737 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' E' E ' 123' ' ' VAL . . . . . . . . . . . . . 45.6 t -129.41 130.93 67.6 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.293 0 N-CA-C 109.396 -0.594 . . . . 0.0 109.396 175.462 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' E' E ' 124' ' ' LEU . . . . . . . . . . . . . 19.7 tp -130.26 133.97 46.9 Favored 'General case' 0 C--N 1.332 -0.163 0 CA-C-O 120.791 0.329 . . . . 0.0 110.748 -177.179 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' E' E ' 125' ' ' VAL . . . . . . . . . . . . . 11.1 p -133.67 135.49 55.49 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.25 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.303 179.776 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' E' E ' 126' ' ' ARG . . . . . . . . . . . . . 20.8 ttm180 -144.39 121.86 11.71 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.307 -0.406 . . . . 0.0 110.626 178.331 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' E' E ' 127' ' ' ASN . . . . . . . . . . . . . 4.3 m120 49.41 -106.39 0.2 Allowed 'General case' 0 CA--C 1.545 0.77 0 CA-C-O 118.957 -0.544 . . . . 0.0 111.639 178.994 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' E' E ' 128' ' ' ASP . . . . . . . . . . . . . 11.6 p-10 -114.09 4.0 15.47 Favored 'General case' 0 N--CA 1.468 0.468 0 CA-C-N 119.693 1.133 . . . . 0.0 113.408 -177.21 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' E' E ' 129' ' ' LEU . . . . . . . . . . . . . 15.5 tp -107.13 132.67 52.75 Favored 'General case' 0 C--N 1.333 -0.147 0 N-CA-C 109.561 -0.533 . . . . 0.0 109.561 178.617 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' E' E ' 130' ' ' VAL . . . . . . . . . . . . . 41.5 t -122.92 136.55 59.35 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.243 0 CA-C-O 120.668 0.271 . . . . 0.0 110.349 -177.309 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' E' E ' 131' ' ' VAL . . . . . 0.521 HG12 HD12 ' E' ' 140' ' ' LEU . 27.1 m -136.07 140.81 43.23 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.236 0 CA-C-O 121.166 0.508 . . . . 0.0 111.274 177.579 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' E' E ' 132' ' ' ILE . . . . . . . . . . . . . 75.5 mt -121.22 132.4 70.67 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.384 0 CA-C-N 115.39 -0.823 . . . . 0.0 109.171 178.125 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' E' E ' 133' ' ' ILE . . . . . . . . . . . . . 33.2 mm -115.37 121.17 66.65 Favored 'Isoleucine or valine' 0 C--O 1.234 0.251 0 CA-C-O 120.898 0.38 . . . . 0.0 111.237 -173.464 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' E' E ' 134' ' ' ASP . . . . . . . . . . . . . 7.3 p-10 -133.59 146.53 51.05 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 115.904 -0.589 . . . . 0.0 109.584 175.724 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' E' E ' 135' ' ' GLU . . . . . . . . . . . . . 39.2 tp10 -49.93 -26.8 4.49 Favored 'General case' 0 C--N 1.326 -0.422 0 N-CA-C 112.815 0.672 . . . . 0.0 112.815 -173.407 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' E' E ' 136' ' ' GLN . . . . . . . . . . . . . 49.7 tt0 -81.91 -32.99 30.66 Favored 'General case' 0 C--O 1.234 0.274 0 N-CA-C 112.328 0.492 . . . . 0.0 112.328 -175.968 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' E' E ' 137' ' ' LYS . . . . . . . . . . . . . 50.7 pttt -170.06 173.04 6.14 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-O 121.451 0.643 . . . . 0.0 112.27 -172.967 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' E' E ' 138' ' ' LEU . . . . . 0.405 ' C ' HD23 ' E' ' 138' ' ' LEU . 6.6 tt -118.33 129.13 55.26 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 115.212 -0.904 . . . . 0.0 110.055 179.521 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' E' E ' 139' ' ' THR . . . . . . . . . . . . . 24.4 m -106.87 130.25 54.58 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.439 -0.346 . . . . 0.0 110.516 -179.803 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' E' E ' 140' ' ' LEU . . . . . 0.521 HD12 HG12 ' E' ' 131' ' ' VAL . 51.2 tp -118.34 127.21 53.48 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 115.784 -0.644 . . . . 0.0 109.413 -177.766 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' E' E ' 141' ' ' ILE . . . . . . . . . . . . . 19.1 mt -123.49 122.38 64.92 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 CA-C-N 116.397 -0.365 . . . . 0.0 110.143 -174.996 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' E' E ' 142' ' ' ARG . . . . . . . . . . . . . 84.4 mtp180 -108.77 129.41 55.38 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-N 115.523 -0.762 . . . . 0.0 110.455 179.46 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' E' E ' 143' ' ' THR . . . . . . . . . . . . . 40.0 p . . . . . 0 C--O 1.221 -0.442 0 CA-C-O 117.961 -1.018 . . . . 0.0 110.605 179.145 . . . . . . . . 0 0 . 1 . 006 nuclear nobuild full ' F' F ' -3' ' ' GLU . . . . . . . . . . . . . 95.7 mt-10 . . . . . 0 N--CA 1.49 1.56 0 N-CA-C 109.36 -0.607 . . . . 0.0 109.36 . . . . . . . . . 0 0 . 1 . 006 nuclear nobuild full ' F' F ' -2' ' ' GLY . . . . . . . . . . . . . . . -69.48 136.37 27.99 Favored Glycine 0 CA--C 1.524 0.655 0 N-CA-C 110.918 -0.873 . . . . 0.0 110.918 179.699 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' F' F ' -1' ' ' VAL . . . . . . . . . . . . . 42.6 t -141.0 142.07 30.42 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.27 0 N-CA-C 109.907 -0.405 . . . . 0.0 109.907 179.306 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' F' F ' 0' ' ' ILE . . . . . . . . . . . . . 43.4 mm -102.3 135.05 41.16 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.285 0 CA-C-N 116.263 -0.426 . . . . 0.0 110.157 -179.355 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' F' F ' 1' ' ' MET . . . . . . . . . . . . . 24.2 ptp -90.63 144.48 25.71 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.228 -0.442 . . . . 0.0 110.728 -178.899 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' F' F ' 2' ' ' SER . . . . . . . . . . . . . 4.5 p -115.79 131.19 57.01 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.107 -0.497 . . . . 0.0 110.098 177.249 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' F' F ' 3' ' ' GLU . . . . . . . . . . . . . 84.8 tt0 -142.75 141.07 31.67 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.054 -0.521 . . . . 0.0 111.08 -178.304 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' F' F ' 4' ' ' LEU . . . . . . . . . . . . . 18.0 tp -127.41 132.52 50.1 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 115.883 -0.599 . . . . 0.0 110.216 178.097 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' F' F ' 5' ' ' LYS . . . . . . . . . . . . . 68.6 mttm -112.03 121.06 43.95 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-N 116.338 -0.392 . . . . 0.0 110.665 179.477 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' F' F ' 6' ' ' LEU . . . . . . . . . . . . . 68.4 mt -116.61 144.76 44.0 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 115.451 -0.795 . . . . 0.0 110.158 -178.394 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' F' F ' 7' ' ' LYS . . . . . . . . . . . . . 1.7 ttmp? -130.56 135.25 27.1 Favored Pre-proline 0 CA--C 1.534 0.351 0 CA-C-O 118.848 -0.596 . . . . 0.0 110.293 177.627 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' F' F ' 8' ' ' PRO . . . . . . . . . . . . . 62.9 Cg_endo -91.03 137.91 2.26 Favored 'Trans proline' 0 N--CA 1.49 1.265 0 C-N-CA 121.715 1.61 . . . . 0.0 111.348 175.75 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' F' F ' 9' ' ' LEU . . . . . . . . . . . . . 50.6 mt -77.01 -47.45 2.72 Favored Pre-proline 0 CA--C 1.532 0.274 0 CA-C-O 118.762 -0.637 . . . . 0.0 112.241 -176.693 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' F' F ' 10' ' ' PRO . . . . . . . . . . . . . 93.0 Cg_endo -82.03 151.21 16.17 Favored 'Trans proline' 0 N--CA 1.498 1.744 0 C-N-CA 121.178 1.252 . . . . 0.0 111.607 174.956 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' F' F ' 11' ' ' LYS . . . . . . . . . . . . . 19.5 pttp -84.6 114.02 21.68 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-O 121.623 0.725 . . . . 0.0 110.682 178.166 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' F' F ' 12' ' ' VAL . . . . . . . . . . . . . 11.5 p -151.05 148.79 14.69 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.241 0 CA-C-N 115.534 -0.757 . . . . 0.0 110.059 179.918 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' F' F ' 13' ' ' GLU . . . . . . . . . . . . . 84.8 tt0 -89.58 122.87 33.15 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-O 120.822 0.344 . . . . 0.0 110.246 178.458 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' F' F ' 14' ' ' LEU . . . . . . . . . . . . . 21.1 mt -97.61 151.48 37.64 Favored Pre-proline 0 C--N 1.33 -0.266 0 CA-C-N 116.293 -0.412 . . . . 0.0 110.431 -178.342 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' F' F ' 15' ' ' PRO . . . . . . . . . . . . . 27.0 Cg_exo -61.17 156.58 44.38 Favored 'Trans proline' 0 N--CA 1.496 1.676 0 C-N-CA 121.21 1.273 . . . . 0.0 111.577 177.381 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' F' F ' 16' ' ' PRO . . . . . . . . . . . . . 39.5 Cg_exo -58.78 -35.66 98.27 Favored 'Trans proline' 0 N--CA 1.496 1.621 0 C-N-CA 121.436 1.424 . . . . 0.0 112.708 -179.62 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' F' F ' 17' ' ' ASP . . . . . . . . . . . . . 12.4 p-10 -88.24 11.17 17.2 Favored 'General case' 0 CA--C 1.536 0.427 0 N-CA-C 113.12 0.785 . . . . 0.0 113.12 -178.211 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' F' F ' 18' ' ' PHE . . . . . . . . . . . . . 61.6 t80 -58.06 -43.52 86.95 Favored 'General case' 0 C--N 1.333 -0.111 0 O-C-N 121.994 -0.441 . . . . 0.0 110.131 -178.232 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' F' F ' 19' ' ' VAL . . . . . . . . . . . . . 48.5 t -57.01 -42.06 78.54 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.308 0 CA-C-N 116.256 -0.429 . . . . 0.0 110.416 -178.568 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' F' F ' 20' ' ' ASP . . . . . . . . . . . . . 17.0 t0 -59.95 -42.59 94.36 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-O 120.872 0.368 . . . . 0.0 110.882 -178.303 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' F' F ' 21' ' ' VAL . . . . . . . . . . . . . 48.0 t -64.55 -46.23 93.23 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.285 0 C-N-CA 120.84 -0.344 . . . . 0.0 110.518 -177.988 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' F' F ' 22' ' ' ILE . . . . . 0.603 HG22 HD12 ' F' ' 26' ' ' LEU . 48.5 mm -56.34 -45.04 81.35 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.177 0 C-N-CA 120.92 -0.312 . . . . 0.0 110.583 178.968 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' F' F ' 23' ' ' ARG . . . . . . . . . . . . . 56.6 ttp180 -54.39 -48.55 71.42 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-O 120.738 0.304 . . . . 0.0 111.305 -179.27 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' F' F ' 24' ' ' ILE . . . . . . . . . . . . . 72.4 mt -59.19 -44.3 91.54 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.21 0 CA-C-N 116.493 -0.321 . . . . 0.0 110.935 -178.047 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' F' F ' 25' ' ' LYS . . . . . . . . . . . . . 44.8 mtpt -63.91 -43.31 96.33 Favored 'General case' 0 C--N 1.328 -0.347 0 N-CA-C 112.357 0.502 . . . . 0.0 112.357 -177.997 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' F' F ' 26' ' ' LEU . . . . . 0.603 HD12 HG22 ' F' ' 22' ' ' ILE . 67.7 mt -79.18 -40.95 29.55 Favored 'General case' 0 C--N 1.33 -0.273 0 N-CA-C 113.428 0.899 . . . . 0.0 113.428 -170.551 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' F' F ' 27' ' ' GLN . . . . . . . . . . . . . 9.9 pt20 -46.67 137.66 6.73 Favored 'General case' 0 N--CA 1.468 0.449 0 N-CA-C 112.871 0.693 . . . . 0.0 112.871 -174.607 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' F' F ' 28' ' ' GLY . . . . . . . . . . . . . . . 100.47 -25.85 26.76 Favored Glycine 0 CA--C 1.533 1.181 0 CA-C-N 115.571 -0.741 . . . . 0.0 112.312 -177.589 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' F' F ' 29' ' ' LYS . . . . . . . . . . . . . 55.1 mmtt -97.4 155.17 17.03 Favored 'General case' 0 C--O 1.232 0.169 0 CA-C-N 117.272 0.536 . . . . 0.0 111.304 178.253 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' F' F ' 30' ' ' THR . . . . . . . . . . . . . 26.6 m -107.09 134.28 50.45 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 115.517 -0.765 . . . . 0.0 109.577 174.802 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' F' F ' 31' ' ' VAL . . . . . . . . . . . . . 35.0 m -130.1 158.94 42.54 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.226 0 CA-C-O 120.926 0.393 . . . . 0.0 110.918 -177.086 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' F' F ' 32' ' ' ARG . . . . . . . . . . . . . 34.9 mtp180 -131.46 152.82 50.36 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-O 121.458 0.647 . . . . 0.0 110.94 179.095 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' F' F ' 33' ' ' THR . . . . . 0.41 HG23 ' O ' ' F' ' 51' ' ' VAL . 16.8 m -53.53 139.67 30.64 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 115.786 -0.643 . . . . 0.0 111.22 -179.417 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' F' F ' 34' ' ' GLY . . . . . . . . . . . . . . . 101.81 -17.05 55.45 Favored Glycine 0 CA--C 1.533 1.181 0 CA-C-O 119.635 -0.536 . . . . 0.0 113.287 179.261 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' F' F ' 35' ' ' ASP . . . . . . . . . . . . . 72.0 m-20 -64.9 148.4 51.53 Favored 'General case' 0 N--CA 1.461 0.106 0 CA-C-N 118.073 0.936 . . . . 0.0 111.19 178.98 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' F' F ' 36' ' ' VAL . . . . . . . . . . . . . 44.3 t -124.01 131.82 72.32 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.179 0 CA-C-N 115.929 -0.578 . . . . 0.0 109.906 179.844 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' F' F ' 37' ' ' ILE . . . . . . . . . . . . . 68.4 mt -122.93 139.9 48.32 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.195 0 CA-C-N 116.076 -0.511 . . . . 0.0 109.777 179.702 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' F' F ' 38' ' ' GLY . . . . . . . . . . . . . . . -115.2 128.99 8.35 Favored Glycine 0 CA--C 1.526 0.742 0 N-CA-C 110.904 -0.878 . . . . 0.0 110.904 179.508 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' F' F ' 39' ' ' ILE . . . . . . . . . . . . . 72.6 mt -123.69 136.21 60.91 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.229 0 CA-C-O 120.722 0.296 . . . . 0.0 110.359 -179.18 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' F' F ' 40' ' ' SER . . . . . . . . . . . . . 48.0 t -93.77 120.3 33.86 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.326 -0.397 . . . . 0.0 110.654 173.833 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' F' F ' 41' ' ' ILE . . . . . . . . . . . . . 72.3 mt -125.84 121.07 58.91 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.243 0 CA-C-O 120.817 0.341 . . . . 0.0 110.343 178.337 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' F' F ' 42' ' ' LEU . . . . . . . . . . . . . 7.0 mp 50.94 35.09 11.72 Favored 'General case' 0 CA--C 1.532 0.256 0 CA-C-O 121.131 0.491 . . . . 0.0 111.636 178.326 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' F' F ' 43' ' ' GLY . . . . . . . . . . . . . . . 73.03 32.84 60.18 Favored Glycine 0 CA--C 1.527 0.839 0 C-N-CA 121.132 -0.556 . . . . 0.0 112.076 177.842 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' F' F ' 44' ' ' LYS . . . . . . . . . . . . . 44.7 tttp -137.54 130.01 29.65 Favored 'General case' 0 C--N 1.329 -0.288 0 N-CA-C 109.539 -0.541 . . . . 0.0 109.539 178.318 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' F' F ' 45' ' ' GLU . . . . . . . . . . . . . 77.5 tt0 -84.15 123.59 30.25 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.529 -0.305 . . . . 0.0 111.336 -175.462 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' F' F ' 46' ' ' VAL . . . . . . . . . . . . . 7.2 p -124.7 130.31 73.44 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.207 0 CA-C-O 120.918 0.389 . . . . 0.0 109.994 176.876 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' F' F ' 47' ' ' LYS . . . . . . . . . . . . . 33.8 mmtp -99.75 132.22 45.23 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 115.906 -0.588 . . . . 0.0 111.298 177.647 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' F' F ' 48' ' ' PHE . . . . . . . . . . . . . 95.4 m-85 -115.8 131.87 56.81 Favored 'General case' 0 C--N 1.331 -0.208 0 N-CA-C 109.603 -0.517 . . . . 0.0 109.603 174.449 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' F' F ' 49' ' ' LYS . . . . . . . . . . . . . 82.4 tttt -108.92 135.88 49.38 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.338 -0.392 . . . . 0.0 110.51 179.553 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' F' F ' 50' ' ' VAL . . . . . . . . . . . . . 47.1 t -79.03 105.82 8.98 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.253 0 N-CA-C 109.127 -0.694 . . . . 0.0 109.127 176.061 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' F' F ' 51' ' ' VAL . . . . . 0.41 ' O ' HG23 ' F' ' 33' ' ' THR . 46.3 t -70.54 -53.48 22.33 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.298 0 CA-C-N 115.887 -0.597 . . . . 0.0 109.579 -174.271 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' F' F ' 52' ' ' GLN . . . . . . . . . . . . . 90.9 mt-30 -153.75 152.05 30.3 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 115.974 -0.557 . . . . 0.0 111.742 -178.114 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' F' F ' 53' ' ' ALA . . . . . 0.463 ' HB1' ' HB2' ' F' ' 58' ' ' LEU . . . -128.42 132.92 48.47 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 115.317 -0.856 . . . . 0.0 109.765 174.547 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' F' F ' 54' ' ' TYR . . . . . . . . . . . . . 82.3 t80 -129.13 111.67 18.31 Favored Pre-proline 0 CA--C 1.535 0.368 0 CA-C-O 118.298 -0.858 . . . . 0.0 110.402 179.473 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' F' F ' 55' ' ' PRO . . . . . . . . . . . . . 73.6 Cg_endo -77.05 169.6 73.93 Favored 'Cis proline' 0 N--CA 1.5 1.854 0 CA-C-N 122.023 1.758 . . . . 0.0 112.226 -6.227 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' F' F ' 56' ' ' SER . . . . . . . . . . . . . 13.6 m -116.43 124.66 29.26 Favored Pre-proline 0 CA--C 1.539 0.554 0 CA-C-O 118.37 -0.824 . . . . 0.0 109.219 176.102 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' F' F ' 57' ' ' PRO . . . . . . . . . . . . . 53.9 Cg_endo -69.55 149.32 87.88 Favored 'Cis proline' 0 N--CA 1.498 1.754 0 CA-C-N 122.063 1.773 . . . . 0.0 112.086 2.128 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' F' F ' 58' ' ' LEU . . . . . 0.463 ' HB2' ' HB1' ' F' ' 53' ' ' ALA . 21.4 tp -108.63 136.3 48.45 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.111 -0.495 . . . . 0.0 110.619 -179.569 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' F' F ' 59' ' ' ARG . . . . . . . . . . . . . 40.9 ttm180 -103.75 123.4 46.98 Favored 'General case' 0 C--N 1.329 -0.291 0 N-CA-C 109.346 -0.613 . . . . 0.0 109.346 175.867 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' F' F ' 60' ' ' VAL . . . . . . . . . . . . . 42.1 t -81.91 124.09 38.73 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.269 0 C-N-CA 120.638 -0.425 . . . . 0.0 110.362 -175.581 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' F' F ' 61' ' ' GLU . . . . . . . . . . . . . 79.3 tt0 -131.09 157.47 43.0 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 115.74 -0.664 . . . . 0.0 109.27 179.367 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' F' F ' 62' ' ' ASP . . . . . . . . . . . . . 10.5 t0 -51.56 -32.48 28.39 Favored 'General case' 0 C--N 1.328 -0.368 0 N-CA-C 112.138 0.422 . . . . 0.0 112.138 -176.692 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' F' F ' 63' ' ' ARG . . . . . . . . . . . . . 16.7 ptp180 -89.4 10.05 23.98 Favored 'General case' 0 N--CA 1.466 0.36 0 N-CA-C 113.613 0.968 . . . . 0.0 113.613 -176.157 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' F' F ' 64' ' ' THR . . . . . . . . . . . . . 22.4 m -80.15 143.34 33.95 Favored 'General case' 0 C--N 1.331 -0.21 0 CA-C-N 118.001 0.364 . . . . 0.0 110.63 -178.508 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' F' F ' 65' ' ' LYS . . . . . . . . . . . . . 95.9 mttt -87.47 126.69 35.05 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.169 -0.468 . . . . 0.0 110.008 179.372 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' F' F ' 66' ' ' ILE . . . . . . . . . . . . . 66.6 mt -118.2 129.52 74.41 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.288 0 N-CA-C 109.903 -0.406 . . . . 0.0 109.903 -179.404 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' F' F ' 67' ' ' THR . . . . . . . . . . . . . 24.4 m -121.0 138.97 53.91 Favored 'General case' 0 C--N 1.331 -0.207 0 CA-C-N 116.248 -0.433 . . . . 0.0 110.856 -178.189 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' F' F ' 68' ' ' LEU . . . . . . . . . . . . . 15.2 tp -107.42 126.18 52.16 Favored 'General case' 0 C--N 1.332 -0.172 0 CA-C-N 115.929 -0.578 . . . . 0.0 110.347 179.155 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' F' F ' 69' ' ' VAL . . . . . . . . . . . . . 44.8 t -102.86 138.81 25.69 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.26 0 CA-C-N 116.068 -0.515 . . . . 0.0 110.17 178.873 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' F' F ' 70' ' ' THR . . . . . 0.428 HG23 ' N ' ' F' ' 71' ' ' HIS . 6.6 t -132.7 -39.46 0.99 Allowed 'General case' 0 C--N 1.332 -0.181 0 CA-C-N 116.138 -0.483 . . . . 0.0 110.726 179.549 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' F' F ' 71' ' ' HIS . . . . . 0.428 ' N ' HG23 ' F' ' 70' ' ' THR . 71.5 t60 -149.82 105.65 3.23 Favored Pre-proline 0 CA--C 1.535 0.366 0 CA-C-O 118.71 -0.662 . . . . 0.0 110.267 -179.649 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' F' F ' 72' ' ' PRO . . . . . . . . . . . . . 57.2 Cg_endo -70.3 160.04 50.92 Favored 'Trans proline' 0 N--CA 1.496 1.665 0 C-N-CA 121.274 1.316 . . . . 0.0 112.247 -177.984 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' F' F ' 73' ' ' VAL . . . . . . . . . . . . . 34.6 m -110.53 154.9 12.0 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.204 0 CA-C-N 116.18 -0.463 . . . . 0.0 110.193 178.541 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' F' F ' 74' ' ' ASP . . . . . . . . . . . . . 7.5 t0 -97.6 124.77 42.0 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.138 -0.483 . . . . 0.0 110.157 -177.769 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' F' F ' 75' ' ' VAL . . . . . . . . . . . . . 42.7 t -113.42 125.93 70.77 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.247 0 CA-C-O 121.078 0.466 . . . . 0.0 110.446 -178.745 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' F' F ' 76' ' ' LEU . . . . . . . . . . . . . 27.0 mt -128.78 149.54 50.68 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 115.671 -0.695 . . . . 0.0 109.727 178.737 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' F' F ' 77' ' ' GLU . . . . . . . . . . . . . 47.2 mt-10 -136.05 140.31 43.73 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-O 121.004 0.43 . . . . 0.0 111.44 -176.526 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' F' F ' 78' ' ' ALA . . . . . . . . . . . . . . . -124.03 126.62 46.58 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 115.663 -0.698 . . . . 0.0 109.56 175.906 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' F' F ' 79' ' ' LYS . . . . . 0.587 ' O ' HD13 ' F' ' 80' ' ' ILE . 53.7 pttt -80.06 123.93 28.29 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-O 121.133 0.492 . . . . 0.0 111.341 -176.714 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' F' F ' 80' ' ' ILE . . . . . 0.587 HD13 ' O ' ' F' ' 79' ' ' LYS . 39.5 mm -139.14 118.49 13.58 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.238 0 CA-C-N 115.901 -0.591 . . . . 0.0 109.692 -178.287 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' F' F ' 81' ' ' LYS . . . . . . . . . . . . . 40.2 mmtt -96.1 118.87 33.55 Favored 'General case' 0 C--N 1.327 -0.374 0 C-N-CA 120.905 -0.318 . . . . 0.0 111.205 179.667 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' F' F ' 82' ' ' GLY . . . . . . . . . . . . . . . 89.19 42.17 5.65 Favored Glycine 0 CA--C 1.526 0.747 0 C-N-CA 120.654 -0.784 . . . . 0.0 112.027 172.202 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' F' F ' 83' ' ' ILE . . . . . . . . . . . . . 73.1 mt -64.47 134.21 29.35 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.294 0 N-CA-C 109.505 -0.554 . . . . 0.0 109.505 175.835 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' F' F ' 84' ' ' LYS . . . . . . . . . . . . . 36.5 ttpt -97.73 -53.97 3.26 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-O 120.992 0.425 . . . . 0.0 110.14 -179.346 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' F' F ' 85' ' ' ASP . . . . . . . . . . . . . 9.1 t70 -149.35 151.56 34.33 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 115.745 -0.661 . . . . 0.0 110.503 -179.472 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' F' F ' 86' ' ' VAL . . . . . . . . . . . . . 44.6 t -126.67 130.58 71.63 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.218 0 CA-C-O 120.952 0.406 . . . . 0.0 110.321 -178.986 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' F' F ' 87' ' ' ILE . . . . . . . . . . . . . 43.4 mm -119.2 126.2 75.14 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.304 0 CA-C-N 115.84 -0.618 . . . . 0.0 109.388 177.961 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' F' F ' 88' ' ' LEU . . . . . . . . . . . . . 13.0 tp -116.94 135.32 53.8 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-O 120.976 0.417 . . . . 0.0 111.394 -175.943 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' F' F ' 89' ' ' ASP . . . . . . . . . . . . . 6.1 t70 -132.17 156.31 46.65 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 115.812 -0.631 . . . . 0.0 109.457 175.228 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' F' F ' 90' ' ' GLU . . . . . . . . . . . . . 96.6 mt-10 -48.03 -36.95 13.78 Favored 'General case' 0 C--N 1.33 -0.28 0 N-CA-C 113.176 0.806 . . . . 0.0 113.176 -171.123 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' F' F ' 91' ' ' ASN . . . . . . . . . . . . . 35.3 m120 -123.44 13.14 9.45 Favored 'General case' 0 N--CA 1.468 0.466 0 N-CA-C 113.555 0.946 . . . . 0.0 113.555 -174.763 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' F' F ' 92' ' ' LEU . . . . . . . . . . . . . 44.3 mt -149.73 147.98 28.69 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-N 117.925 0.33 . . . . 0.0 110.721 -176.577 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' F' F ' 93' ' ' ILE . . . . . . . . . . . . . 74.0 mt -122.71 118.3 54.62 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.268 0 N-CA-C 109.102 -0.703 . . . . 0.0 109.102 175.736 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' F' F ' 94' ' ' VAL . . . . . . . . . . . . . 45.5 t -117.42 127.28 74.91 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.249 0 N-CA-C 109.743 -0.466 . . . . 0.0 109.743 -179.054 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' F' F ' 95' ' ' VAL . . . . . . . . . . . . . 43.0 t -123.21 134.94 64.77 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.364 0 CA-C-N 116.1 -0.5 . . . . 0.0 109.964 -178.958 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' F' F ' 96' ' ' ILE . . . . . 0.406 HD11 ' HB ' ' F' ' 123' ' ' VAL . 65.8 mt -115.45 126.28 72.95 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.308 0 N-CA-C 109.259 -0.645 . . . . 0.0 109.259 178.718 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' F' F ' 97' ' ' THR . . . . . . . . . . . . . 69.4 p -99.75 155.93 17.37 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-O 121.228 0.537 . . . . 0.0 110.957 -177.341 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' F' F ' 98' ' ' GLU . . . . . . . . . . . . . 84.9 tt0 -53.87 -24.91 17.45 Favored 'General case' 0 CA--C 1.536 0.422 0 CA-C-N 116.057 -0.519 . . . . 0.0 112.267 179.658 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' F' F ' 99' ' ' GLU . . . . . . . . . . . . . 96.8 mt-10 -77.55 12.89 1.42 Allowed 'General case' 0 CA--C 1.537 0.45 0 N-CA-C 113.301 0.852 . . . . 0.0 113.301 -177.924 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' F' F ' 100' ' ' ASN . . . . . . . . . . . . . 2.2 m-20 61.84 33.62 17.55 Favored 'General case' 0 N--CA 1.464 0.262 0 CA-C-N 118.099 0.409 . . . . 0.0 111.315 -179.74 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' F' F ' 101' ' ' GLU . . . . . . . . . . . . . 54.4 tt0 -110.27 143.69 40.07 Favored 'General case' 0 C--N 1.333 -0.137 0 N-CA-C 109.571 -0.529 . . . . 0.0 109.571 174.189 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' F' F ' 102' ' ' VAL . . . . . . . . . . . . . 46.7 t -115.39 127.16 73.06 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.295 0 N-CA-C 109.84 -0.429 . . . . 0.0 109.84 -178.39 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' F' F ' 103' ' ' LEU . . . . . . . . . . . . . 19.7 mt -118.64 132.58 56.18 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 115.864 -0.607 . . . . 0.0 110.715 178.711 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' F' F ' 104' ' ' ILE . . . . . 0.575 HD13 HG11 ' F' ' 130' ' ' VAL . 63.8 mt -116.85 120.65 65.68 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.277 0 N-CA-C 109.81 -0.441 . . . . 0.0 109.81 177.921 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' F' F ' 105' ' ' PHE . . . . . . . . . . . . . 92.3 m-85 -120.43 162.78 18.95 Favored 'General case' 0 C--N 1.332 -0.157 0 O-C-N 123.859 0.724 . . . . 0.0 109.91 -179.906 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' F' F ' 106' ' ' ASN . . . . . . . . . . . . . 45.6 p-10 -97.62 -174.09 2.81 Favored 'General case' 0 C--N 1.33 -0.268 0 N-CA-C 109.593 -0.521 . . . . 0.0 109.593 172.214 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' F' F ' 107' ' ' GLN . . . . . . . . . . . . . 21.6 tt0 -62.21 -19.24 62.95 Favored 'General case' 0 CA--C 1.536 0.429 0 N-CA-C 112.586 0.588 . . . . 0.0 112.586 -178.725 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' F' F ' 108' ' ' ASN . . . . . . . . . . . . . 17.2 t30 -95.68 14.09 24.23 Favored 'General case' 0 CA--C 1.535 0.393 0 N-CA-C 113.124 0.787 . . . . 0.0 113.124 -178.259 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' F' F ' 109' ' ' LEU . . . . . . . . . . . . . 52.5 mt 58.98 38.92 24.1 Favored 'General case' 0 C--O 1.232 0.155 0 CA-C-O 121.139 0.495 . . . . 0.0 111.395 178.095 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' F' F ' 110' ' ' GLU . . . . . . . . . . . . . 96.5 mt-10 -106.14 156.9 17.97 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.15 -0.477 . . . . 0.0 109.95 176.055 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' F' F ' 111' ' ' GLU . . . . . . . . . . . . . 84.5 tt0 -86.98 121.91 30.1 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-O 120.884 0.374 . . . . 0.0 111.107 -177.258 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' F' F ' 112' ' ' LEU . . . . . . . . . . . . . 31.4 mt -108.43 -45.95 3.79 Favored 'General case' 0 C--N 1.332 -0.189 0 CA-C-N 116.054 -0.521 . . . . 0.0 110.448 176.735 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' F' F ' 113' ' ' TYR . . . . . 0.455 ' HB3' HD12 ' F' ' 104' ' ' ILE . 55.5 t80 -141.86 138.55 32.21 Favored 'General case' 0 C--N 1.331 -0.229 0 C-N-CA 120.614 -0.434 . . . . 0.0 111.319 179.947 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' F' F ' 114' ' ' ARG . . . . . . . . . . . . . 23.7 ttm180 -138.1 124.2 20.28 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.232 -0.44 . . . . 0.0 110.195 176.539 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' F' F ' 115' ' ' GLY . . . . . . . . . . . . . . . -150.17 159.64 28.2 Favored Glycine 0 CA--C 1.525 0.676 0 N-CA-C 110.798 -0.921 . . . . 0.0 110.798 178.283 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' F' F ' 116' ' ' LYS . . . . . . . . . . . . . 55.4 tttt -132.6 135.33 45.83 Favored 'General case' 0 C--N 1.329 -0.305 0 N-CA-C 110.098 -0.334 . . . . 0.0 110.098 178.714 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' F' F ' 117' ' ' PHE . . . . . . . . . . . . . 26.3 m-85 -137.72 116.31 12.11 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-O 120.799 0.333 . . . . 0.0 110.309 -174.611 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' F' F ' 118' ' ' GLU . . . . . . . . . . . . . 46.0 tp10 -53.96 -44.58 70.85 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.594 -0.276 . . . . 0.0 111.309 -177.621 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' F' F ' 119' ' ' ASN . . . . . . . . . . . . . 11.7 m120 -97.09 31.1 2.51 Favored 'General case' 0 C--N 1.329 -0.309 0 N-CA-C 112.202 0.445 . . . . 0.0 112.202 -174.497 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' F' F ' 120' ' ' LEU . . . . . . . . . . . . . 15.5 tp -57.76 122.53 13.06 Favored 'General case' 0 C--N 1.333 -0.126 0 N-CA-C 110.225 -0.287 . . . . 0.0 110.225 177.744 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' F' F ' 121' ' ' ASN . . . . . . . . . . . . . 88.6 m-20 -113.75 -43.95 3.23 Favored 'General case' 0 C--N 1.333 -0.124 0 CA-C-N 116.66 -0.246 . . . . 0.0 111.232 -176.729 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' F' F ' 122' ' ' LYS . . . . . . . . . . . . . 51.2 mttm -143.74 144.73 31.96 Favored 'General case' 0 C--N 1.33 -0.25 0 C-N-CA 120.629 -0.428 . . . . 0.0 111.669 -177.408 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' F' F ' 123' ' ' VAL . . . . . 0.406 ' HB ' HD11 ' F' ' 96' ' ' ILE . 43.9 t -127.18 127.84 69.77 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.249 0 N-CA-C 109.328 -0.619 . . . . 0.0 109.328 174.795 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' F' F ' 124' ' ' LEU . . . . . . . . . . . . . 56.5 mt -128.78 139.2 52.3 Favored 'General case' 0 C--N 1.331 -0.211 0 CA-C-O 120.792 0.33 . . . . 0.0 110.933 -176.653 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' F' F ' 125' ' ' VAL . . . . . . . . . . . . . 12.8 p -137.88 137.72 44.63 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.249 0 CA-C-N 116.344 -0.389 . . . . 0.0 110.569 178.487 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' F' F ' 126' ' ' ARG . . . . . . . . . . . . . 55.2 ttt180 -163.87 135.31 4.68 Favored 'General case' 0 C--N 1.33 -0.243 0 N-CA-C 109.803 -0.443 . . . . 0.0 109.803 177.775 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' F' F ' 127' ' ' ASN . . . . . . . . . . . . . 77.7 m-20 55.39 -153.34 0.33 Allowed 'General case' 0 CA--C 1.541 0.607 0 N-CA-C 109.974 -0.38 . . . . 0.0 109.974 -179.791 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' F' F ' 128' ' ' ASP . . . . . . . . . . . . . 10.4 p-10 -80.76 16.06 1.54 Allowed 'General case' 0 CA--C 1.535 0.386 0 N-CA-C 112.815 0.672 . . . . 0.0 112.815 179.439 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' F' F ' 129' ' ' LEU . . . . . . . . . . . . . 38.5 mt -117.51 138.32 51.97 Favored 'General case' 0 C--O 1.231 0.106 0 CA-C-N 118.131 0.423 . . . . 0.0 110.371 179.778 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' F' F ' 130' ' ' VAL . . . . . 0.575 HG11 HD13 ' F' ' 104' ' ' ILE . 12.9 p -132.07 141.0 46.59 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.217 0 N-CA-C 109.919 -0.4 . . . . 0.0 109.919 175.983 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' F' F ' 131' ' ' VAL . . . . . 0.417 HG22 HD12 ' F' ' 140' ' ' LEU . 39.4 t -134.58 140.77 45.03 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.218 0 CA-C-O 121.13 0.491 . . . . 0.0 110.636 -175.24 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' F' F ' 132' ' ' ILE . . . . . . . . . . . . . 71.4 mt -119.28 130.75 73.53 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.316 0 CA-C-N 115.526 -0.761 . . . . 0.0 109.133 177.451 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' F' F ' 133' ' ' ILE . . . . . . . . . . . . . 41.4 mm -117.87 123.49 71.75 Favored 'Isoleucine or valine' 0 C--O 1.233 0.221 0 CA-C-O 120.773 0.321 . . . . 0.0 111.041 -175.184 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' F' F ' 134' ' ' ASP . . . . . . . . . . . . . 8.5 p-10 -135.63 146.51 47.94 Favored 'General case' 0 C--N 1.33 -0.25 0 N-CA-C 109.57 -0.53 . . . . 0.0 109.57 173.268 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' F' F ' 135' ' ' GLU . . . . . . . . . . . . . 40.6 tp10 -49.87 -25.83 3.51 Favored 'General case' 0 C--N 1.327 -0.387 0 N-CA-C 112.725 0.639 . . . . 0.0 112.725 -173.259 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' F' F ' 136' ' ' GLN . . . . . . . . . . . . . 61.7 tt0 -82.39 -35.7 27.44 Favored 'General case' 0 C--O 1.233 0.236 0 N-CA-C 112.269 0.47 . . . . 0.0 112.269 -176.333 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' F' F ' 137' ' ' LYS . . . . . . . . . . . . . 45.6 pttt -165.12 167.98 17.68 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-O 121.486 0.66 . . . . 0.0 112.12 -172.315 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' F' F ' 138' ' ' LEU . . . . . 0.412 HD23 ' C ' ' F' ' 138' ' ' LEU . 7.3 tt -118.34 130.79 56.22 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 115.169 -0.923 . . . . 0.0 109.866 -179.526 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' F' F ' 139' ' ' THR . . . . . . . . . . . . . 38.0 m -113.1 126.22 55.23 Favored 'General case' 0 C--N 1.331 -0.21 0 CA-C-N 116.328 -0.396 . . . . 0.0 110.773 179.92 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' F' F ' 140' ' ' LEU . . . . . 0.417 HD12 HG22 ' F' ' 131' ' ' VAL . 18.7 tp -109.85 122.77 48.28 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 115.526 -0.761 . . . . 0.0 108.973 178.745 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' F' F ' 141' ' ' ILE . . . . . 0.535 ' HB ' HG13 ' F' ' 130' ' ' VAL . 19.6 mt -122.04 119.48 58.69 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.32 0 N-CA-C 109.594 -0.521 . . . . 0.0 109.594 -177.158 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' F' F ' 142' ' ' ARG . . . . . . . . . . . . . 66.4 ttp85 -110.92 128.85 55.96 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 115.488 -0.778 . . . . 0.0 110.57 -176.415 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' F' F ' 143' ' ' THR . . . . . . . . . . . . . 39.4 p . . . . . 0 C--O 1.222 -0.37 0 CA-C-O 117.952 -1.023 . . . . 0.0 110.558 -179.983 . . . . . . . . 0 0 . 1 . 007 nuclear nobuild full ' A' A ' -3' ' ' GLU . . . . . . . . . . . . . 95.9 mt-10 . . . . . 0 N--CA 1.491 1.622 0 N-CA-C 109.46 -0.571 . . . . 0.0 109.46 . . . . . . . . . 0 0 . 1 . 007 nuclear nobuild full ' A' A ' -2' ' ' GLY . . . . . . . . . . . . . . . -70.5 140.22 31.69 Favored Glycine 0 CA--C 1.525 0.697 0 N-CA-C 111.035 -0.826 . . . . 0.0 111.035 -179.377 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' -1' ' ' VAL . . . . . . . . . . . . . 42.9 t -141.51 144.37 26.12 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.358 0 N-CA-C 109.895 -0.409 . . . . 0.0 109.895 179.216 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 0' ' ' ILE . . . . . . . . . . . . . 44.1 mm -102.06 134.68 41.96 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.22 0 CA-C-N 116.221 -0.445 . . . . 0.0 110.381 -178.757 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 27.6 ptm -77.92 136.57 38.04 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.076 -0.511 . . . . 0.0 110.48 178.779 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 88.8 p -131.0 160.54 34.26 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.48 179.809 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 85.2 tt0 -140.5 142.53 35.25 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-N 116.149 -0.478 . . . . 0.0 111.057 -177.527 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 4' ' ' LEU . . . . . . . . . . . . . 19.0 tp -122.99 127.57 49.0 Favored 'General case' 0 C--N 1.331 -0.198 0 CA-C-N 115.964 -0.562 . . . . 0.0 110.148 177.046 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 5' ' ' LYS . . . . . . . . . . . . . 98.8 mttt -106.71 122.88 47.24 Favored 'General case' 0 C--O 1.234 0.244 0 CA-C-N 116.543 -0.299 . . . . 0.0 110.641 179.275 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 63.5 mt -116.08 144.65 43.85 Favored 'General case' 0 N--CA 1.464 0.235 0 CA-C-N 115.859 -0.609 . . . . 0.0 110.692 -179.241 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 85.0 tttt -125.81 131.22 23.94 Favored Pre-proline 0 CA--C 1.536 0.433 0 CA-C-O 118.583 -0.722 . . . . 0.0 109.523 175.758 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 8' ' ' PRO . . . . . . . . . . . . . 96.1 Cg_endo -83.56 137.79 8.12 Favored 'Trans proline' 0 N--CA 1.494 1.529 0 C-N-CA 121.295 1.33 . . . . 0.0 112.078 177.851 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 67.4 mt -77.95 -47.87 2.18 Favored Pre-proline 0 CA--C 1.534 0.352 0 CA-C-O 118.548 -0.739 . . . . 0.0 112.084 179.165 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 72.2 Cg_endo -77.8 151.34 27.99 Favored 'Trans proline' 0 N--CA 1.497 1.679 0 CA-C-N 120.28 1.136 . . . . 0.0 111.642 176.36 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 23.2 tptm -85.67 95.15 9.27 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.421 -0.354 . . . . 0.0 110.55 -179.336 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 12.1 p -143.7 144.33 23.29 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.319 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.552 -179.92 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 45.6 mp0 -90.4 127.23 36.14 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.334 -0.393 . . . . 0.0 109.963 177.58 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 14' ' ' LEU . . . . . . . . . . . . . 37.2 mt -97.87 146.89 32.24 Favored Pre-proline 0 CA--C 1.533 0.29 0 CA-C-O 119.19 -0.433 . . . . 0.0 110.371 -177.44 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 15' ' ' PRO . . . . . . . . . . . . . 26.2 Cg_exo -61.29 162.32 20.55 Favored 'Trans proline' 0 N--CA 1.498 1.759 0 C-N-CA 121.345 1.363 . . . . 0.0 111.939 178.148 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 16' ' ' PRO . . . . . . . . . . . . . 34.8 Cg_exo -59.34 -38.64 83.42 Favored 'Trans proline' 0 N--CA 1.496 1.629 0 C-N-CA 121.541 1.494 . . . . 0.0 112.907 -177.699 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 17' ' ' ASP . . . . . . . . . . . . . 18.9 p-10 -86.52 6.34 31.09 Favored 'General case' 0 CA--C 1.537 0.443 0 N-CA-C 113.303 0.853 . . . . 0.0 113.303 -178.161 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 18' ' ' PHE . . . . . . . . . . . . . 39.2 t80 -58.33 -43.09 88.07 Favored 'General case' 0 C--N 1.334 -0.108 0 O-C-N 121.982 -0.449 . . . . 0.0 110.103 -178.212 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 19' ' ' VAL . . . . . . . . . . . . . 47.5 t -56.69 -41.14 73.79 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.282 0 CA-C-N 116.243 -0.435 . . . . 0.0 110.468 -179.405 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 5.7 t70 -59.77 -42.0 92.33 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-O 120.873 0.368 . . . . 0.0 110.534 -179.002 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 47.9 t -63.86 -46.18 94.97 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.325 0 CA-C-N 116.242 -0.435 . . . . 0.0 110.301 -178.971 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 22' ' ' ILE . . . . . 0.558 HG22 HD12 ' A' ' 26' ' ' LEU . 51.6 mm -55.03 -47.93 76.41 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.282 0 CA-C-O 120.572 0.225 . . . . 0.0 110.819 179.241 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 23' ' ' ARG . . . . . . . . . . . . . 30.8 ttp180 -54.53 -51.5 64.97 Favored 'General case' 0 C--N 1.329 -0.307 0 C-N-CA 121.121 -0.232 . . . . 0.0 111.332 -177.813 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 24' ' ' ILE . . . . . . . . . . . . . 72.9 mt -59.53 -41.3 84.37 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.277 0 C-N-CA 121.031 -0.267 . . . . 0.0 111.232 -176.881 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 60.7 mtpt -68.67 -41.9 78.64 Favored 'General case' 0 C--N 1.328 -0.333 0 N-CA-C 112.45 0.537 . . . . 0.0 112.45 -177.324 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 26' ' ' LEU . . . . . 0.558 HD12 HG22 ' A' ' 22' ' ' ILE . 95.3 mt -79.57 -37.46 36.32 Favored 'General case' 0 C--N 1.33 -0.266 0 N-CA-C 113.152 0.797 . . . . 0.0 113.152 -171.365 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 27' ' ' GLN . . . . . . . . . . . . . 9.1 pt20 -46.33 140.48 4.09 Favored 'General case' 0 N--CA 1.47 0.544 0 N-CA-C 112.802 0.667 . . . . 0.0 112.802 -175.273 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 100.97 -25.44 28.33 Favored Glycine 0 CA--C 1.532 1.14 0 CA-C-N 115.575 -0.739 . . . . 0.0 112.229 -176.089 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 96.9 mttt -98.18 155.1 17.33 Favored 'General case' 0 C--O 1.233 0.185 0 CA-C-N 117.451 0.625 . . . . 0.0 111.192 179.267 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 30' ' ' THR . . . . . . . . . . . . . 41.5 m -100.96 138.73 37.62 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.138 -0.483 . . . . 0.0 110.273 177.154 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 34.7 m -131.3 148.52 32.81 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.247 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.79 -178.971 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 32' ' ' ARG . . . . . . . . . . . . . 23.0 ttm180 -130.06 146.69 51.74 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.163 -0.471 . . . . 0.0 110.26 178.166 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 33' ' ' THR . . . . . . . . . . . . . 29.6 m -52.39 139.18 25.36 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-O 120.777 0.323 . . . . 0.0 111.469 -178.285 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 98.91 -17.25 58.48 Favored Glycine 0 CA--C 1.534 1.23 0 CA-C-O 119.737 -0.479 . . . . 0.0 113.135 -179.907 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 78.1 m-20 -67.67 149.19 50.35 Favored 'General case' 0 C--N 1.334 -0.09 0 CA-C-N 117.948 0.874 . . . . 0.0 111.346 179.065 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 46.3 t -117.01 126.45 74.44 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.179 0 CA-C-N 115.652 -0.703 . . . . 0.0 109.441 176.513 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 37' ' ' ILE . . . . . . . . . . . . . 64.0 mt -118.36 137.15 53.25 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.297 0 N-CA-C 109.866 -0.42 . . . . 0.0 109.866 -179.118 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . -114.74 128.51 8.19 Favored Glycine 0 CA--C 1.524 0.656 0 N-CA-C 110.876 -0.889 . . . . 0.0 110.876 179.304 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 39' ' ' ILE . . . . . . . . . . . . . 70.4 mt -124.45 127.36 72.99 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.224 0 N-CA-C 110.08 -0.341 . . . . 0.0 110.08 179.223 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 40' ' ' SER . . . . . . . . . . . . . 27.5 t -92.84 119.04 31.76 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.312 -0.403 . . . . 0.0 110.931 176.727 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 41' ' ' ILE . . . . . . . . . . . . . 71.7 mt -134.02 129.13 53.92 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.211 0 CA-C-O 121.017 0.436 . . . . 0.0 110.462 178.491 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 8.3 tp 54.75 33.4 19.5 Favored 'General case' 0 CA--C 1.531 0.244 0 CA-C-N 115.958 -0.565 . . . . 0.0 111.737 177.523 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . 71.52 29.02 68.48 Favored Glycine 0 CA--C 1.53 0.996 0 C-N-CA 121.046 -0.597 . . . . 0.0 112.253 177.794 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 44' ' ' LYS . . . . . . . . . . . . . 81.3 tttt -139.1 127.4 22.75 Favored 'General case' 0 C--N 1.33 -0.255 0 N-CA-C 109.739 -0.467 . . . . 0.0 109.739 178.833 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 84.8 tt0 -85.24 125.78 33.15 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-N 116.375 -0.375 . . . . 0.0 111.423 -178.395 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 46' ' ' VAL . . . . . 0.405 ' O ' HG13 ' A' ' 46' ' ' VAL . 9.6 p -118.69 124.41 73.1 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.172 0 N-CA-C 109.434 -0.58 . . . . 0.0 109.434 173.587 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 61.9 mtpt -98.49 124.27 43.12 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 116.046 -0.525 . . . . 0.0 110.523 177.726 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 48' ' ' PHE . . . . . . . . . . . . . 38.9 m-85 -111.1 131.81 54.78 Favored 'General case' 0 C--N 1.328 -0.344 0 N-CA-C 109.555 -0.535 . . . . 0.0 109.555 177.573 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 43.0 tttp -106.42 131.92 53.06 Favored 'General case' 0 C--N 1.328 -0.345 0 N-CA-C 109.936 -0.394 . . . . 0.0 109.936 178.638 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 50' ' ' VAL . . . . . . . . . . . . . 46.0 t -75.38 106.58 5.27 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.332 0 N-CA-C 109.336 -0.616 . . . . 0.0 109.336 178.068 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 51' ' ' VAL . . . . . . . . . . . . . 44.6 t -71.17 -49.65 47.12 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.288 0 CA-C-N 116.165 -0.471 . . . . 0.0 109.79 -174.789 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 52' ' ' GLN . . . . . . . . . . . . . 43.3 tt0 -162.73 136.88 6.33 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 115.88 -0.6 . . . . 0.0 111.289 -178.102 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 53' ' ' ALA . . . . . 0.412 ' HB3' ' OG ' ' A' ' 56' ' ' SER . . . -115.9 132.84 56.53 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 115.968 -0.56 . . . . 0.0 109.999 176.119 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 54' ' ' TYR . . . . . . . . . . . . . 11.6 t80 -129.06 110.64 18.3 Favored Pre-proline 0 CA--C 1.534 0.346 0 CA-C-O 118.157 -0.925 . . . . 0.0 110.192 178.466 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 55' ' ' PRO . . . . . . . . . . . . . 72.7 Cg_endo -77.22 170.13 72.29 Favored 'Cis proline' 0 N--CA 1.501 1.931 0 CA-C-N 122.024 1.758 . . . . 0.0 112.49 -6.054 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 56' ' ' SER . . . . . 0.412 ' OG ' ' HB3' ' A' ' 53' ' ' ALA . 48.9 m -124.01 137.55 29.11 Favored Pre-proline 0 CA--C 1.538 0.514 0 CA-C-O 118.532 -0.747 . . . . 0.0 109.546 174.904 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 57' ' ' PRO . . . . . . . . . . . . . 37.8 Cg_endo -67.52 145.52 74.37 Favored 'Cis proline' 0 N--CA 1.498 1.778 0 CA-C-N 121.687 1.638 . . . . 0.0 111.487 -2.894 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 58' ' ' LEU . . . . . . . . . . . . . 20.7 tp -107.99 137.95 45.09 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.256 -0.429 . . . . 0.0 110.47 -178.768 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 59' ' ' ARG . . . . . . . . . . . . . 56.7 ttp180 -103.31 120.61 41.1 Favored 'General case' 0 C--N 1.328 -0.366 0 N-CA-C 109.133 -0.691 . . . . 0.0 109.133 174.917 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 42.2 t -72.95 118.53 18.29 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.276 0 C-N-CA 120.766 -0.374 . . . . 0.0 110.647 -173.8 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 70.6 mm-40 -131.02 159.12 38.45 Favored 'General case' 0 C--N 1.331 -0.216 0 CA-C-N 115.951 -0.568 . . . . 0.0 109.734 176.909 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 62' ' ' ASP . . . . . . . . . . . . . 11.0 p-10 -53.34 -31.43 44.3 Favored 'General case' 0 C--N 1.328 -0.343 0 N-CA-C 112.034 0.383 . . . . 0.0 112.034 -178.27 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 63' ' ' ARG . . . . . . . . . . . . . 86.2 mtt-85 -72.02 -21.94 61.48 Favored 'General case' 0 CA--C 1.533 0.324 0 N-CA-C 112.888 0.699 . . . . 0.0 112.888 -175.444 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 33.3 m -70.1 143.75 52.31 Favored 'General case' 0 C--N 1.332 -0.191 0 CA-C-O 120.988 0.423 . . . . 0.0 111.209 -174.479 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 65' ' ' LYS . . . . . . . . . . . . . 1.1 mptm? -89.54 134.8 33.95 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 115.839 -0.619 . . . . 0.0 110.013 177.827 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 66' ' ' ILE . . . . . . . . . . . . . 58.9 mt -114.82 130.36 69.39 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.27 0 N-CA-C 109.771 -0.455 . . . . 0.0 109.771 178.394 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 67' ' ' THR . . . . . . . . . . . . . 30.8 m -124.47 142.1 51.58 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-O 121.247 0.546 . . . . 0.0 111.136 -177.253 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 68' ' ' LEU . . . . . 0.543 HD23 ' N ' ' A' ' 69' ' ' VAL . 2.6 tt -100.88 134.49 43.79 Favored 'General case' 0 C--N 1.331 -0.224 0 CA-C-N 115.544 -0.753 . . . . 0.0 109.68 178.485 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 69' ' ' VAL . . . . . 0.543 ' N ' HD23 ' A' ' 68' ' ' LEU . 43.3 t -82.86 148.7 4.98 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.25 0 CA-C-O 120.919 0.39 . . . . 0.0 110.196 -179.25 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 70' ' ' THR . . . . . . . . . . . . . 6.9 m -82.6 149.19 27.58 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.087 -0.506 . . . . 0.0 110.673 -175.832 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 71' ' ' HIS . . . . . . . . . . . . . 1.3 m-70 -123.91 171.91 6.41 Favored Pre-proline 0 CA--C 1.535 0.393 0 CA-C-N 115.82 -0.627 . . . . 0.0 110.581 -175.073 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 72' ' ' PRO . . . . . . . . . . . . . 19.8 Cg_endo -64.82 160.35 41.27 Favored 'Trans proline' 0 N--CA 1.496 1.67 0 C-N-CA 121.43 1.42 . . . . 0.0 111.719 175.869 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 73' ' ' VAL . . . . . . . . . . . . . 35.1 m -69.62 -176.43 0.16 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.287 0 CA-C-N 116.255 -0.43 . . . . 0.0 110.438 -171.782 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 74' ' ' ASP . . . . . . . . . . . . . 13.0 t70 -81.99 114.98 20.93 Favored 'General case' 0 C--N 1.331 -0.199 0 C-N-CA 120.388 -0.525 . . . . 0.0 110.229 -168.937 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 45.7 t -117.37 117.92 56.82 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 CA-C-O 121.192 0.52 . . . . 0.0 109.919 -179.439 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 76' ' ' LEU . . . . . . . . . . . . . 14.9 mt -120.9 142.92 49.25 Favored 'General case' 0 C--N 1.327 -0.403 0 CA-C-N 115.453 -0.794 . . . . 0.0 109.3 178.552 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 77' ' ' GLU . . . . . . . . . . . . . 96.8 mt-10 -135.31 128.91 32.66 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-O 121.16 0.505 . . . . 0.0 110.527 -177.548 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 78' ' ' ALA . . . . . 0.746 ' HB2' HD21 ' A' ' 109' ' ' LEU . . . -113.0 130.71 56.04 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 115.582 -0.735 . . . . 0.0 109.478 177.353 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 79' ' ' LYS . . . . . 0.581 ' O ' HD13 ' A' ' 80' ' ' ILE . 84.2 tttt -76.07 112.7 12.79 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-O 120.963 0.411 . . . . 0.0 110.532 -177.193 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 80' ' ' ILE . . . . . 0.581 HD13 ' O ' ' A' ' 79' ' ' LYS . 42.4 mm -139.08 109.95 4.7 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.346 0 CA-C-N 115.768 -0.651 . . . . 0.0 109.316 -177.727 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 81' ' ' LYS . . . . . . . . . . . . . 48.5 mtmt -108.64 130.76 55.32 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-O 120.875 0.369 . . . . 0.0 110.728 -178.321 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . 89.06 42.18 5.68 Favored Glycine 0 CA--C 1.525 0.708 0 C-N-CA 120.794 -0.717 . . . . 0.0 111.434 176.806 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 83' ' ' ILE . . . . . . . . . . . . . 73.5 mt -68.49 136.16 26.99 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.297 0 N-CA-C 109.872 -0.418 . . . . 0.0 109.872 177.423 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 84' ' ' LYS . . . . . . . . . . . . . 50.0 tttp -93.05 -50.45 5.52 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.213 -0.448 . . . . 0.0 110.18 -179.341 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 85' ' ' ASP . . . . . . . . . . . . . 6.6 t0 -157.22 154.97 30.05 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 115.908 -0.587 . . . . 0.0 110.517 179.734 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 86' ' ' VAL . . . . . . . . . . . . . 42.7 t -129.81 132.34 65.91 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.201 0 CA-C-O 120.974 0.416 . . . . 0.0 110.552 -178.862 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 87' ' ' ILE . . . . . 0.494 HD12 ' N ' ' A' ' 87' ' ' ILE . 5.0 mp -121.84 128.83 75.79 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.193 0 CA-C-N 115.957 -0.565 . . . . 0.0 109.629 176.887 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 88' ' ' LEU . . . . . . . . . . . . . 75.2 mt -112.6 135.96 52.7 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-O 120.997 0.427 . . . . 0.0 111.268 -177.826 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 89' ' ' ASP . . . . . . . . . . . . . 13.6 t70 -133.02 152.4 51.97 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 115.754 -0.657 . . . . 0.0 109.532 175.613 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 97.4 mt-10 -48.56 -36.27 15.14 Favored 'General case' 0 C--N 1.329 -0.319 0 N-CA-C 113.036 0.754 . . . . 0.0 113.036 -172.678 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 91' ' ' ASN . . . . . . . . . . . . . 81.8 m-20 -121.96 12.19 10.42 Favored 'General case' 0 N--CA 1.468 0.473 0 N-CA-C 113.379 0.881 . . . . 0.0 113.379 -176.268 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 92' ' ' LEU . . . . . . . . . . . . . 11.8 mt -148.68 145.3 27.64 Favored 'General case' 0 C--N 1.332 -0.185 0 CA-C-N 118.101 0.41 . . . . 0.0 110.455 -175.701 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 93' ' ' ILE . . . . . . . . . . . . . 66.8 mt -120.95 117.81 54.21 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.294 0 N-CA-C 108.942 -0.762 . . . . 0.0 108.942 174.499 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 94' ' ' VAL . . . . . 0.456 HG11 HG11 ' A' ' 123' ' ' VAL . 46.2 t -118.83 128.2 75.69 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.24 0 CA-C-O 120.82 0.343 . . . . 0.0 110.224 -177.097 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 95' ' ' VAL . . . . . . . . . . . . . 44.2 t -125.63 137.25 58.28 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.334 0 CA-C-N 116.115 -0.493 . . . . 0.0 109.916 179.977 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 96' ' ' ILE . . . . . . . . . . . . . 57.0 mt -116.6 128.45 73.95 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.325 0 N-CA-C 109.098 -0.705 . . . . 0.0 109.098 178.575 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 97' ' ' THR . . . . . . . . . . . . . 81.7 p -102.59 159.96 14.99 Favored 'General case' 0 C--N 1.331 -0.223 0 CA-C-O 121.099 0.476 . . . . 0.0 111.471 -175.202 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 98' ' ' GLU . . . . . . . . . . . . . 84.8 tt0 -53.86 -27.5 30.37 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.168 -0.469 . . . . 0.0 112.037 179.443 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 99' ' ' GLU . . . . . . . . . . . . . 42.8 mt-10 -79.62 15.83 1.24 Allowed 'General case' 0 CA--C 1.535 0.398 0 N-CA-C 113.07 0.767 . . . . 0.0 113.07 -178.393 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 100' ' ' ASN . . . . . . . . . . . . . 3.3 m-20 62.37 30.97 17.46 Favored 'General case' 0 CA--C 1.532 0.279 0 N-CA-C 111.832 0.308 . . . . 0.0 111.832 177.663 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 101' ' ' GLU . . . . . . . . . . . . . 98.5 mt-10 -101.28 150.58 22.84 Favored 'General case' 0 C--N 1.333 -0.128 0 CA-C-O 120.78 0.324 . . . . 0.0 110.851 171.687 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 102' ' ' VAL . . . . . . . . . . . . . 47.3 t -117.83 124.44 73.08 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.379 0 CA-C-N 115.469 -0.787 . . . . 0.0 109.208 176.442 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 103' ' ' LEU . . . . . . . . . . . . . 40.2 mt -116.44 130.06 56.56 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 115.925 -0.58 . . . . 0.0 110.261 178.602 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 104' ' ' ILE . . . . . 0.434 HD12 ' HB3' ' A' ' 113' ' ' TYR . 68.0 mt -118.76 117.94 56.13 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.291 0 N-CA-C 109.948 -0.39 . . . . 0.0 109.948 179.194 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 105' ' ' PHE . . . . . . . . . . . . . 40.1 m-85 -118.5 163.96 16.0 Favored 'General case' 0 C--N 1.332 -0.19 0 O-C-N 124.086 0.866 . . . . 0.0 110.255 179.282 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 106' ' ' ASN . . . . . . . . . . . . . 43.6 p-10 -98.69 -169.91 1.86 Allowed 'General case' 0 C--N 1.33 -0.263 0 N-CA-C 109.898 -0.408 . . . . 0.0 109.898 173.506 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 107' ' ' GLN . . . . . . . . . . . . . 41.2 tt0 -58.67 -29.89 66.93 Favored 'General case' 0 C--N 1.329 -0.322 0 N-CA-C 112.01 0.374 . . . . 0.0 112.01 179.242 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 108' ' ' ASN . . . . . . . . . . . . . 8.3 t-20 -83.55 6.61 19.91 Favored 'General case' 0 CA--C 1.537 0.458 0 N-CA-C 113.298 0.851 . . . . 0.0 113.298 -177.509 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 109' ' ' LEU . . . . . 0.746 HD21 ' HB2' ' A' ' 78' ' ' ALA . 9.1 tp 61.98 36.24 15.72 Favored 'General case' 0 CA--C 1.53 0.2 0 CA-C-O 120.877 0.37 . . . . 0.0 111.536 178.595 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 110' ' ' GLU . . . . . . . . . . . . . 70.8 mm-40 -105.6 152.27 23.31 Favored 'General case' 0 C--N 1.332 -0.189 0 CA-C-N 116.516 -0.311 . . . . 0.0 110.196 177.443 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 111' ' ' GLU . . . . . . . . . . . . . 98.6 mt-10 -80.9 122.06 26.76 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-O 120.878 0.371 . . . . 0.0 111.193 -178.486 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 112' ' ' LEU . . . . . . . . . . . . . 19.2 mt -108.55 -46.01 3.76 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 115.969 -0.56 . . . . 0.0 110.054 176.165 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 113' ' ' TYR . . . . . 0.434 ' HB3' HD12 ' A' ' 104' ' ' ILE . 57.7 t80 -134.74 133.06 39.52 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 116.284 -0.416 . . . . 0.0 110.735 179.184 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 114' ' ' ARG . . . . . . . . . . . . . 55.1 ttp180 -138.11 123.44 19.42 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.262 -0.426 . . . . 0.0 110.006 178.089 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 115' ' ' GLY . . . . . . . . . . . . . . . -150.12 162.84 29.33 Favored Glycine 0 CA--C 1.523 0.553 0 N-CA-C 110.902 -0.879 . . . . 0.0 110.902 -178.522 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 116' ' ' LYS . . . . . . . . . . . . . 76.3 tttt -131.9 131.02 42.36 Favored 'General case' 0 C--N 1.33 -0.278 0 N-CA-C 110.082 -0.34 . . . . 0.0 110.082 178.184 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 117' ' ' PHE . . . . . . . . . . . . . 47.9 m-85 -130.03 117.34 19.88 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 116.238 -0.437 . . . . 0.0 110.25 -177.196 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 118' ' ' GLU . . . . . . . . . . . . . 97.5 mt-10 -53.81 -43.69 69.57 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 116.433 -0.349 . . . . 0.0 111.363 -176.803 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 119' ' ' ASN . . . . . . . . . . . . . 2.8 m-20 -101.98 31.09 4.06 Favored 'General case' 0 C--N 1.331 -0.214 0 N-CA-C 112.089 0.403 . . . . 0.0 112.089 -174.786 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 120' ' ' LEU . . . . . . . . . . . . . 13.8 tp -55.04 120.07 6.38 Favored 'General case' 0 N--CA 1.462 0.169 0 CA-C-O 120.62 0.248 . . . . 0.0 110.666 178.65 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 121' ' ' ASN . . . . . . . . . . . . . 32.7 t-20 -110.77 -44.11 3.7 Favored 'General case' 0 C--N 1.332 -0.189 0 CA-C-N 116.565 -0.288 . . . . 0.0 111.137 -176.543 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 122' ' ' LYS . . . . . . . . . . . . . 90.6 mttt -148.23 152.03 36.49 Favored 'General case' 0 C--N 1.331 -0.204 0 CA-C-O 121.129 0.49 . . . . 0.0 111.955 -177.996 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 123' ' ' VAL . . . . . 0.456 HG11 HG11 ' A' ' 94' ' ' VAL . 42.2 t -129.45 124.66 60.24 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.268 0 CA-C-N 115.685 -0.689 . . . . 0.0 109.158 172.407 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 124' ' ' LEU . . . . . 0.496 HD12 ' N ' ' A' ' 124' ' ' LEU . 6.2 mp -118.1 141.67 48.23 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-O 120.765 0.316 . . . . 0.0 111.004 -175.65 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 125' ' ' VAL . . . . . 0.412 ' CG2' HG21 ' A' ' 94' ' ' VAL . 41.2 t -129.17 135.66 61.39 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.209 0 CA-C-N 116.24 -0.436 . . . . 0.0 110.427 -179.901 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 126' ' ' ARG . . . . . . . . . . . . . 26.3 mmt85 -139.48 109.92 6.6 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.081 -0.509 . . . . 0.0 110.215 176.712 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 127' ' ' ASN . . . . . . . . . . . . . 79.1 m-20 51.96 -104.83 0.19 Allowed 'General case' 0 CA--C 1.543 0.691 0 CA-C-O 119.1 -0.476 . . . . 0.0 111.341 179.521 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 128' ' ' ASP . . . . . . . . . . . . . 18.7 p-10 -110.3 -2.13 16.88 Favored 'General case' 0 CA--C 1.536 0.439 0 CA-C-N 119.513 1.051 . . . . 0.0 113.459 -176.105 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 129' ' ' LEU . . . . . . . . . . . . . 27.5 mt -104.99 143.89 32.56 Favored 'General case' 0 C--N 1.332 -0.17 0 N-CA-C 109.721 -0.474 . . . . 0.0 109.721 178.557 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 130' ' ' VAL . . . . . 0.525 HG13 ' HB ' ' A' ' 141' ' ' ILE . 12.2 p -132.23 142.06 43.72 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.212 0 CA-C-O 121.147 0.499 . . . . 0.0 110.507 -178.92 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 131' ' ' VAL . . . . . 0.576 HG22 HD12 ' A' ' 140' ' ' LEU . 40.9 t -134.39 138.09 50.43 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.252 0 CA-C-N 115.917 -0.583 . . . . 0.0 110.315 -178.236 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 132' ' ' ILE . . . . . . . . . . . . . 70.7 mt -113.98 131.52 65.67 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.341 0 N-CA-C 109.137 -0.69 . . . . 0.0 109.137 178.308 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 133' ' ' ILE . . . . . . . . . . . . . 40.2 mm -115.65 121.02 66.43 Favored 'Isoleucine or valine' 0 C--O 1.234 0.257 0 CA-C-O 120.665 0.269 . . . . 0.0 110.993 -174.501 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 134' ' ' ASP . . . . . . . . . . . . . 9.7 p-10 -134.72 146.39 49.39 Favored 'General case' 0 C--N 1.331 -0.215 0 CA-C-N 115.984 -0.553 . . . . 0.0 109.66 174.509 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 135' ' ' GLU . . . . . . . . . . . . . 85.2 tt0 -49.89 -26.49 4.13 Favored 'General case' 0 C--N 1.328 -0.33 0 N-CA-C 112.792 0.664 . . . . 0.0 112.792 -173.946 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 136' ' ' GLN . . . . . . . . . . . . . 43.2 tt0 -80.03 -35.19 37.58 Favored 'General case' 0 C--O 1.233 0.205 0 N-CA-C 112.124 0.416 . . . . 0.0 112.124 -176.644 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 137' ' ' LYS . . . . . . . . . . . . . 50.3 pttt -167.61 171.47 10.21 Favored 'General case' 0 C--N 1.331 -0.208 0 CA-C-O 121.527 0.68 . . . . 0.0 112.244 -172.5 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 138' ' ' LEU . . . . . 0.466 HD23 ' N ' ' A' ' 139' ' ' THR . 4.3 tt -114.83 127.34 55.66 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 115.053 -0.976 . . . . 0.0 109.821 178.269 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 139' ' ' THR . . . . . 0.466 ' N ' HD23 ' A' ' 138' ' ' LEU . 22.8 m -107.08 125.41 51.01 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.323 -0.399 . . . . 0.0 110.458 179.609 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 140' ' ' LEU . . . . . 0.576 HD12 HG22 ' A' ' 131' ' ' VAL . 14.9 tp -113.49 119.64 38.25 Favored 'General case' 0 C--N 1.328 -0.365 0 N-CA-C 109.252 -0.647 . . . . 0.0 109.252 -178.371 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 141' ' ' ILE . . . . . 0.525 ' HB ' HG13 ' A' ' 130' ' ' VAL . 19.4 mt -119.65 120.91 64.86 Favored 'Isoleucine or valine' 0 C--O 1.234 0.269 0 CA-C-O 120.949 0.404 . . . . 0.0 110.046 -175.977 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 142' ' ' ARG . . . . . . . . . . . . . 73.3 mtm180 -107.32 129.48 54.89 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 115.38 -0.827 . . . . 0.0 110.258 179.575 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 143' ' ' THR . . . . . . . . . . . . . 32.1 p . . . . . 0 C--O 1.22 -0.448 0 CA-C-O 118.045 -0.979 . . . . 0.0 110.618 179.691 . . . . . . . . 0 0 . 1 . 007 nuclear nobuild full ' B' B ' -3' ' ' GLU . . . . . . . . . . . . . 85.0 tt0 . . . . . 0 N--CA 1.49 1.563 0 N-CA-C 109.438 -0.579 . . . . 0.0 109.438 . . . . . . . . . 0 0 . 1 . 007 nuclear nobuild full ' B' B ' -2' ' ' GLY . . . . . . . . . . . . . . . -65.9 138.45 37.38 Favored Glycine 0 CA--C 1.525 0.673 0 N-CA-C 110.981 -0.848 . . . . 0.0 110.981 -179.939 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' -1' ' ' VAL . . . . . . . . . . . . . 44.5 t -96.65 133.19 38.96 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.283 0 CA-C-O 120.775 0.321 . . . . 0.0 110.156 179.42 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 0' ' ' ILE . . . . . . . . . . . . . 71.8 mt -115.94 129.44 72.31 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.248 0 N-CA-C 109.725 -0.472 . . . . 0.0 109.725 179.124 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 1' ' ' MET . . . . . . . . . . . . . 23.6 ptm -144.55 139.96 28.51 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.125 -0.489 . . . . 0.0 110.781 -179.222 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 2' ' ' SER . . . . . . . . . . . . . 3.6 p -121.78 129.45 52.68 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 116.319 -0.401 . . . . 0.0 110.411 178.514 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 3' ' ' GLU . . . . . . . . . . . . . 95.1 mt-10 -140.62 140.63 35.1 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-N 116.094 -0.503 . . . . 0.0 110.882 -178.445 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 4' ' ' LEU . . . . . 0.475 HD21 HD21 ' B' ' 6' ' ' LEU . 16.5 tp -126.21 127.5 45.76 Favored 'General case' 0 C--N 1.331 -0.216 0 CA-C-N 115.971 -0.559 . . . . 0.0 110.36 177.441 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' B' B ' 5' ' ' LYS . . . . . . . . . . . . . 98.1 mttt -104.37 120.95 42.37 Favored 'General case' 0 C--O 1.234 0.237 0 CA-C-N 116.287 -0.415 . . . . 0.0 110.336 177.727 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 6' ' ' LEU . . . . . 0.475 HD21 HD21 ' B' ' 4' ' ' LEU . 54.3 mt -117.14 148.0 41.94 Favored 'General case' 0 C--N 1.331 -0.227 0 CA-C-N 115.499 -0.773 . . . . 0.0 110.613 -178.501 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' B' B ' 7' ' ' LYS . . . . . . . . . . . . . 79.4 tttt -138.84 141.04 29.14 Favored Pre-proline 0 CA--C 1.534 0.344 0 CA-C-O 119.135 -0.46 . . . . 0.0 110.163 175.505 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 8' ' ' PRO . . . . . . . . . . . . . 88.0 Cg_endo -92.04 142.11 2.53 Favored 'Trans proline' 0 N--CA 1.49 1.287 0 C-N-CA 121.792 1.661 . . . . 0.0 111.723 177.438 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 9' ' ' LEU . . . . . . . . . . . . . 57.8 mt -77.36 -46.78 2.6 Favored Pre-proline 0 CA--C 1.534 0.348 0 CA-C-O 118.671 -0.68 . . . . 0.0 112.175 -179.736 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 10' ' ' PRO . . . . . . . . . . . . . 86.5 Cg_endo -81.75 150.47 16.51 Favored 'Trans proline' 0 N--CA 1.495 1.612 0 C-N-CA 121.266 1.311 . . . . 0.0 111.79 175.232 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 11' ' ' LYS . . . . . . . . . . . . . 28.2 ttpp -88.87 99.72 12.61 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-O 120.778 0.323 . . . . 0.0 110.541 179.742 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 12' ' ' VAL . . . . . . . . . . . . . 12.6 p -143.68 148.02 19.39 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.29 0 CA-C-N 116.261 -0.427 . . . . 0.0 110.559 -179.398 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 13' ' ' GLU . . . . . . . . . . . . . 44.5 mp0 -84.51 126.09 32.98 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.315 -0.402 . . . . 0.0 110.298 178.676 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 14' ' ' LEU . . . . . . . . . . . . . 47.9 mt -98.63 148.27 34.32 Favored Pre-proline 0 CA--C 1.532 0.284 0 CA-C-O 119.168 -0.444 . . . . 0.0 110.498 -179.415 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 15' ' ' PRO . . . . . . . . . . . . . 24.7 Cg_exo -63.16 159.62 38.24 Favored 'Trans proline' 0 N--CA 1.497 1.73 0 C-N-CA 121.301 1.334 . . . . 0.0 111.831 176.518 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 16' ' ' PRO . . . . . . . . . . . . . 28.8 Cg_exo -60.18 -33.69 94.73 Favored 'Trans proline' 0 N--CA 1.497 1.722 0 C-N-CA 121.52 1.48 . . . . 0.0 112.677 -178.998 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 17' ' ' ASP . . . . . . . . . . . . . 10.6 p-10 -82.79 1.07 40.86 Favored 'General case' 0 CA--C 1.537 0.458 0 N-CA-C 113.281 0.845 . . . . 0.0 113.281 -177.617 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 18' ' ' PHE . . . . . . . . . . . . . 36.2 t80 -57.61 -45.04 85.84 Favored 'General case' 0 C--N 1.334 -0.106 0 O-C-N 121.962 -0.461 . . . . 0.0 110.23 -178.182 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 19' ' ' VAL . . . . . . . . . . . . . 46.9 t -57.08 -43.99 82.24 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.349 0 CA-C-N 116.263 -0.426 . . . . 0.0 110.492 -178.407 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 20' ' ' ASP . . . . . . . . . . . . . 40.8 m-20 -59.76 -42.54 93.5 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-O 120.742 0.306 . . . . 0.0 110.948 -177.467 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 21' ' ' VAL . . . . . . . . . . . . . 46.8 t -63.85 -48.31 86.86 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.241 0 C-N-CA 120.724 -0.391 . . . . 0.0 110.515 -177.792 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 22' ' ' ILE . . . . . 0.479 HG22 HD12 ' B' ' 26' ' ' LEU . 50.4 mm -55.57 -46.92 79.25 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.258 0 C-N-CA 120.997 -0.281 . . . . 0.0 110.798 179.639 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' B' B ' 23' ' ' ARG . . . . . . . . . . . . . 57.8 ttp180 -53.8 -50.39 66.23 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-O 120.594 0.235 . . . . 0.0 111.449 -178.152 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 24' ' ' ILE . . . . . . . . . . . . . 74.8 mt -60.13 -42.96 91.89 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.317 0 CA-C-N 116.57 -0.286 . . . . 0.0 111.304 -177.462 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 25' ' ' LYS . . . . . . . . . . . . . 70.7 mmtt -65.13 -38.44 90.65 Favored 'General case' 0 C--N 1.33 -0.265 0 N-CA-C 112.127 0.417 . . . . 0.0 112.127 -178.73 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 26' ' ' LEU . . . . . 0.479 HD12 HG22 ' B' ' 22' ' ' ILE . 83.4 mt -77.9 -44.77 26.02 Favored 'General case' 0 C--N 1.329 -0.307 0 N-CA-C 112.747 0.647 . . . . 0.0 112.747 -172.119 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' B' B ' 27' ' ' GLN . . . . . . . . . . . . . 10.7 pt20 -46.98 137.88 7.01 Favored 'General case' 0 N--CA 1.469 0.489 0 N-CA-C 112.751 0.648 . . . . 0.0 112.751 -176.168 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 28' ' ' GLY . . . . . . . . . . . . . . . 100.66 -28.82 14.15 Favored Glycine 0 CA--C 1.533 1.195 0 CA-C-N 115.619 -0.718 . . . . 0.0 111.978 -177.066 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 29' ' ' LYS . . . . . . . . . . . . . 93.3 mttt -98.84 155.19 17.5 Favored 'General case' 0 C--O 1.233 0.216 0 CA-C-O 121.053 0.454 . . . . 0.0 111.133 179.285 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 30' ' ' THR . . . . . . . . . . . . . 27.3 m -104.28 137.39 42.26 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.136 -0.484 . . . . 0.0 110.065 175.884 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 31' ' ' VAL . . . . . . . . . . . . . 34.9 m -130.56 155.84 42.07 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.308 0 CA-C-N 116.375 -0.375 . . . . 0.0 110.927 -178.133 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 32' ' ' ARG . . . . . . . . . . . . . 66.2 mtp180 -132.29 152.9 51.16 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-O 121.334 0.588 . . . . 0.0 110.835 179.084 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 33' ' ' THR . . . . . . . . . . . . . 23.9 m -53.27 140.06 27.77 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 115.985 -0.552 . . . . 0.0 111.378 -178.245 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 34' ' ' GLY . . . . . . . . . . . . . . . 99.28 -17.02 58.48 Favored Glycine 0 CA--C 1.532 1.121 0 CA-C-O 119.611 -0.549 . . . . 0.0 113.279 178.273 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 35' ' ' ASP . . . . . . . . . . . . . 77.0 m-20 -66.1 147.71 52.92 Favored 'General case' 0 C--O 1.231 0.109 0 CA-C-N 118.06 0.93 . . . . 0.0 110.888 178.6 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 36' ' ' VAL . . . . . . . . . . . . . 44.3 t -124.58 131.06 73.24 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.271 0 CA-C-N 116.07 -0.514 . . . . 0.0 109.927 178.853 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 37' ' ' ILE . . . . . . . . . . . . . 64.8 mt -120.47 138.97 49.22 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.277 0 CA-C-N 116.197 -0.456 . . . . 0.0 109.951 -179.69 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 38' ' ' GLY . . . . . . . . . . . . . . . -109.22 128.7 9.12 Favored Glycine 0 CA--C 1.526 0.729 0 N-CA-C 111.171 -0.772 . . . . 0.0 111.171 179.969 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 39' ' ' ILE . . . . . . . . . . . . . 72.1 mt -124.38 130.12 73.7 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.256 0 N-CA-C 109.779 -0.452 . . . . 0.0 109.779 178.422 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 40' ' ' SER . . . . . 0.535 ' O ' HD13 ' B' ' 41' ' ' ILE . 78.6 p -91.42 117.02 29.32 Favored 'General case' 0 C--N 1.329 -0.294 0 C-N-CA 120.973 -0.291 . . . . 0.0 111.02 178.512 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' B' B ' 41' ' ' ILE . . . . . 0.535 HD13 ' O ' ' B' ' 40' ' ' SER . 47.1 mm -130.32 125.07 58.94 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.23 0 CA-C-O 120.778 0.323 . . . . 0.0 110.191 179.512 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' B' B ' 42' ' ' LEU . . . . . . . . . . . . . 52.8 mt 57.8 34.23 24.16 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.246 -0.433 . . . . 0.0 111.782 177.802 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 43' ' ' GLY . . . . . . . . . . . . . . . 77.7 -10.08 26.42 Favored Glycine 0 CA--C 1.534 1.279 0 C-N-CA 121.265 -0.493 . . . . 0.0 113.456 177.525 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 44' ' ' LYS . . . . . . . . . . . . . 39.1 mtpt -104.83 133.93 48.81 Favored 'General case' 0 C--N 1.333 -0.121 0 CA-C-N 117.952 0.876 . . . . 0.0 109.855 177.086 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 45' ' ' GLU . . . . . . . . . . . . . 36.3 tp10 -84.6 129.25 34.87 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.425 -0.352 . . . . 0.0 110.864 -179.475 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 46' ' ' VAL . . . . . . . . . . . . . 7.5 p -116.79 129.62 73.0 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.224 0 N-CA-C 109.312 -0.625 . . . . 0.0 109.312 176.599 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 47' ' ' LYS . . . . . . . . . . . . . 58.9 mtpt -99.99 126.8 46.22 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 115.912 -0.585 . . . . 0.0 111.032 179.134 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 48' ' ' PHE . . . . . . . . . . . . . 92.4 m-85 -109.86 131.88 54.66 Favored 'General case' 0 C--N 1.331 -0.213 0 CA-C-N 116.318 -0.401 . . . . 0.0 110.047 176.454 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 49' ' ' LYS . . . . . . . . . . . . . 62.4 tttm -107.64 137.42 45.7 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 116.276 -0.42 . . . . 0.0 110.509 179.2 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 50' ' ' VAL . . . . . . . . . . . . . 45.5 t -80.29 107.42 12.65 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.286 0 N-CA-C 109.135 -0.691 . . . . 0.0 109.135 174.615 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 51' ' ' VAL . . . . . . . . . . . . . 47.8 t -73.5 -47.3 45.9 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.374 0 CA-C-N 116.35 -0.386 . . . . 0.0 110.024 -173.773 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 52' ' ' GLN . . . . . . . . . . . . . 43.3 tt0 -162.17 137.07 7.02 Favored 'General case' 0 C--N 1.33 -0.279 0 C-N-CA 120.418 -0.513 . . . . 0.0 111.606 -178.964 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 53' ' ' ALA . . . . . . . . . . . . . . . -113.47 133.01 55.44 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 115.782 -0.645 . . . . 0.0 109.987 175.35 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 54' ' ' TYR . . . . . . . . . . . . . 12.5 t80 -129.11 112.65 18.44 Favored Pre-proline 0 CA--C 1.534 0.358 0 CA-C-O 118.32 -0.848 . . . . 0.0 110.469 179.208 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 55' ' ' PRO . . . . . . . . . . . . . 73.9 Cg_endo -77.07 169.61 73.87 Favored 'Cis proline' 0 N--CA 1.499 1.8 0 CA-C-N 121.934 1.726 . . . . 0.0 112.195 -6.412 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 56' ' ' SER . . . . . . . . . . . . . 13.6 m -116.83 131.02 24.15 Favored Pre-proline 0 CA--C 1.54 0.559 0 CA-C-O 118.37 -0.824 . . . . 0.0 109.474 176.097 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 57' ' ' PRO . . . . . . . . . . . . . 48.4 Cg_endo -69.99 148.2 86.74 Favored 'Cis proline' 0 N--CA 1.497 1.683 0 CA-C-N 121.937 1.728 . . . . 0.0 111.573 -1.349 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 58' ' ' LEU . . . . . . . . . . . . . 25.8 tp -107.74 135.38 49.25 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.384 -0.371 . . . . 0.0 110.744 -178.399 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 59' ' ' ARG . . . . . . . . . . . . . 55.0 ttt180 -101.96 121.15 41.6 Favored 'General case' 0 C--N 1.327 -0.382 0 N-CA-C 109.297 -0.631 . . . . 0.0 109.297 176.14 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 60' ' ' VAL . . . . . . . . . . . . . 44.4 t -78.97 123.19 35.62 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.263 0 C-N-CA 120.694 -0.402 . . . . 0.0 110.36 -174.987 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 61' ' ' GLU . . . . . . . . . . . . . 95.7 mt-10 -131.03 165.57 22.93 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.062 -0.517 . . . . 0.0 110.057 178.269 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 62' ' ' ASP . . . . . . . . . . . . . 18.0 p-10 -54.61 -32.64 59.19 Favored 'General case' 0 C--N 1.328 -0.329 0 C-N-CA 120.975 -0.29 . . . . 0.0 111.675 179.872 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 63' ' ' ARG . . . . . . . . . . . . . 10.8 ptm180 -85.21 7.29 22.52 Favored 'General case' 0 CA--C 1.537 0.452 0 N-CA-C 113.523 0.934 . . . . 0.0 113.523 -176.273 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 64' ' ' THR . . . . . . . . . . . . . 33.0 m -83.84 138.48 33.19 Favored 'General case' 0 C--N 1.332 -0.17 0 CA-C-N 118.135 0.425 . . . . 0.0 110.76 -178.319 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 65' ' ' LYS . . . . . . . . . . . . . 69.2 mttm -89.99 129.27 36.34 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.106 -0.497 . . . . 0.0 110.281 178.541 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 66' ' ' ILE . . . . . . . . . . . . . 63.0 mt -116.84 130.37 71.83 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.292 0 N-CA-C 109.935 -0.395 . . . . 0.0 109.935 179.454 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 67' ' ' THR . . . . . . . . . . . . . 25.5 m -123.3 136.69 54.81 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.596 -179.513 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 68' ' ' LEU . . . . . . . . . . . . . 17.7 tp -107.86 126.06 52.21 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.039 -0.528 . . . . 0.0 110.551 179.515 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 69' ' ' VAL . . . . . . . . . . . . . 43.2 t -101.29 146.72 9.2 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.308 0 CA-C-N 116.243 -0.435 . . . . 0.0 110.059 179.256 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 70' ' ' THR . . . . . . . . . . . . . 4.8 m -130.49 -49.33 1.07 Allowed 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 116.261 -0.427 . . . . 0.0 110.59 -178.522 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 71' ' ' HIS . . . . . . . . . . . . . 82.6 m-70 -72.49 154.08 91.73 Favored Pre-proline 0 C--N 1.329 -0.321 0 CA-C-N 116.336 -0.393 . . . . 0.0 110.601 -179.464 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 72' ' ' PRO . . . . . . . . . . . . . 87.3 Cg_endo -86.08 24.54 0.74 Allowed 'Trans proline' 0 N--CA 1.492 1.384 0 C-N-CA 121.692 1.595 . . . . 0.0 113.131 -178.188 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 73' ' ' VAL . . . . . . . . . . . . . 31.0 m -130.94 163.13 37.7 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.17 0 CA-C-O 120.902 0.382 . . . . 0.0 110.668 179.148 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 74' ' ' ASP . . . . . . . . . . . . . 7.5 t70 -102.84 120.69 41.05 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.041 -0.527 . . . . 0.0 109.731 179.695 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 75' ' ' VAL . . . . . . . . . . . . . 42.5 t -113.74 122.21 67.42 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.219 0 CA-C-O 121.087 0.47 . . . . 0.0 110.531 -177.76 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 76' ' ' LEU . . . . . . . . . . . . . 32.6 mt -119.85 145.57 46.53 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 115.575 -0.739 . . . . 0.0 109.434 177.471 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 77' ' ' GLU . . . . . . . . . . . . . 98.0 mt-10 -136.46 134.24 37.46 Favored 'General case' 0 C--N 1.332 -0.187 0 CA-C-O 121.189 0.518 . . . . 0.0 111.18 -178.095 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 78' ' ' ALA . . . . . 0.662 ' HB2' HD21 ' B' ' 109' ' ' LEU . . . -122.22 123.76 42.22 Favored 'General case' 0 C--N 1.331 -0.224 0 CA-C-N 115.62 -0.718 . . . . 0.0 109.666 176.471 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' B' B ' 79' ' ' LYS . . . . . 0.566 ' O ' HD13 ' B' ' 80' ' ' ILE . 45.9 pttt -73.6 121.04 20.03 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-O 121.295 0.569 . . . . 0.0 110.811 -177.832 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' B' B ' 80' ' ' ILE . . . . . 0.566 HD13 ' O ' ' B' ' 79' ' ' LYS . 40.4 mm -139.33 112.49 6.22 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.267 0 CA-C-N 115.658 -0.701 . . . . 0.0 109.267 -177.799 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' B' B ' 81' ' ' LYS . . . . . . . . . . . . . 28.9 mtpt -99.46 122.31 42.38 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-O 120.845 0.355 . . . . 0.0 111.113 -177.789 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 82' ' ' GLY . . . . . . . . . . . . . . . 89.22 42.2 5.63 Favored Glycine 0 CA--C 1.525 0.694 0 C-N-CA 120.738 -0.744 . . . . 0.0 111.808 174.362 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 83' ' ' ILE . . . . . . . . . . . . . 68.5 mt -61.92 135.39 26.55 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.33 0 N-CA-C 109.727 -0.472 . . . . 0.0 109.727 176.938 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 84' ' ' LYS . . . . . . . . . . . . . 75.6 tttt -94.39 -51.6 4.71 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.129 -0.487 . . . . 0.0 109.988 -179.312 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 85' ' ' ASP . . . . . . . . . . . . . 11.6 t70 -157.86 152.14 24.57 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 115.666 -0.697 . . . . 0.0 110.347 178.979 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 86' ' ' VAL . . . . . . . . . . . . . 42.6 t -127.41 129.46 70.58 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.275 0 CA-C-O 120.897 0.38 . . . . 0.0 110.313 -179.541 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 87' ' ' ILE . . . . . . . . . . . . . 44.7 mm -119.55 128.95 75.88 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.312 0 CA-C-N 115.985 -0.552 . . . . 0.0 109.755 177.984 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 88' ' ' LEU . . . . . 0.447 HD12 HD22 ' A' ' 124' ' ' LEU . 47.7 mt -111.85 138.12 48.88 Favored 'General case' 0 C--N 1.332 -0.185 0 CA-C-O 121.057 0.456 . . . . 0.0 111.791 -176.645 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' B' B ' 89' ' ' ASP . . . . . . . . . . . . . 13.4 t70 -132.87 155.34 49.2 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 115.401 -0.818 . . . . 0.0 109.226 174.876 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 90' ' ' GLU . . . . . . . . . . . . . 35.0 tt0 -47.54 -37.21 11.72 Favored 'General case' 0 N--CA 1.465 0.301 0 N-CA-C 113.005 0.743 . . . . 0.0 113.005 -171.409 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 91' ' ' ASN . . . . . . . . . . . . . 4.1 t-20 -129.59 20.3 5.63 Favored 'General case' 0 N--CA 1.469 0.507 0 N-CA-C 112.823 0.675 . . . . 0.0 112.823 -177.005 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 92' ' ' LEU . . . . . . . . . . . . . 19.6 mt -148.73 143.25 26.29 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-O 120.822 0.344 . . . . 0.0 110.288 -177.427 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 93' ' ' ILE . . . . . . . . . . . . . 71.3 mt -121.54 117.0 51.2 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.331 0 N-CA-C 108.947 -0.76 . . . . 0.0 108.947 175.755 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 94' ' ' VAL . . . . . . . . . . . . . 46.8 t -114.37 123.51 70.12 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.292 0 N-CA-C 109.728 -0.471 . . . . 0.0 109.728 -179.102 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 95' ' ' VAL . . . . . . . . . . . . . 44.1 t -119.95 132.0 70.83 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.321 0 CA-C-N 116.032 -0.531 . . . . 0.0 109.767 -179.447 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 96' ' ' ILE . . . . . . . . . . . . . 66.1 mt -114.48 127.93 71.76 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.33 0 N-CA-C 109.073 -0.714 . . . . 0.0 109.073 178.471 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 97' ' ' THR . . . . . . . . . . . . . 61.3 p -102.31 154.9 18.61 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-O 121.061 0.457 . . . . 0.0 111.094 -177.644 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 98' ' ' GLU . . . . . . . . . . . . . 98.0 mt-10 -53.96 -22.2 9.77 Favored 'General case' 0 CA--C 1.533 0.302 0 N-CA-C 112.355 0.502 . . . . 0.0 112.355 178.177 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 99' ' ' GLU . . . . . . . . . . . . . 95.9 mt-10 -76.54 11.67 1.54 Allowed 'General case' 0 CA--C 1.537 0.468 0 N-CA-C 113.149 0.796 . . . . 0.0 113.149 -178.939 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 100' ' ' ASN . . . . . . . . . . . . . 2.4 m-20 61.96 37.94 14.66 Favored 'General case' 0 CA--C 1.529 0.172 0 CA-C-O 121.077 0.465 . . . . 0.0 110.836 179.785 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 101' ' ' GLU . . . . . . . . . . . . . 84.6 tt0 -120.39 142.02 49.57 Favored 'General case' 0 C--N 1.332 -0.193 0 N-CA-C 109.564 -0.532 . . . . 0.0 109.564 176.215 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 102' ' ' VAL . . . . . . . . . . . . . 45.9 t -114.92 127.57 72.41 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.238 0 N-CA-C 109.976 -0.379 . . . . 0.0 109.976 -178.362 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 103' ' ' LEU . . . . . . . . . . . . . 55.6 mt -116.77 131.89 56.84 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 115.641 -0.709 . . . . 0.0 110.335 177.771 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 104' ' ' ILE . . . . . 0.414 HD12 ' HB3' ' B' ' 113' ' ' TYR . 66.2 mt -115.97 119.35 61.63 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.256 0 CA-C-N 116.375 -0.375 . . . . 0.0 110.03 178.511 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' B' B ' 105' ' ' PHE . . . . . . . . . . . . . 34.7 m-85 -119.59 167.1 12.33 Favored 'General case' 0 C--N 1.333 -0.142 0 O-C-N 123.995 0.809 . . . . 0.0 109.994 178.657 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 106' ' ' ASN . . . . . . . . . . . . . 44.3 p-10 -104.02 -169.98 1.71 Allowed 'General case' 0 C--N 1.331 -0.232 0 N-CA-C 110.078 -0.341 . . . . 0.0 110.078 174.631 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 107' ' ' GLN . . . . . . . . . . . . . 41.0 tt0 -59.64 -29.9 68.35 Favored 'General case' 0 CA--C 1.531 0.244 0 N-CA-C 111.963 0.357 . . . . 0.0 111.963 179.612 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 108' ' ' ASN . . . . . . . . . . . . . 4.9 t-20 -82.87 6.77 17.34 Favored 'General case' 0 CA--C 1.537 0.45 0 N-CA-C 113.171 0.804 . . . . 0.0 113.171 -177.749 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 109' ' ' LEU . . . . . 0.662 HD21 ' HB2' ' B' ' 78' ' ' ALA . 12.0 tp 61.85 37.76 15.15 Favored 'General case' 0 CA--C 1.53 0.18 0 CA-C-O 120.948 0.404 . . . . 0.0 111.294 178.188 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' B' B ' 110' ' ' GLU . . . . . . . . . . . . . 96.0 mt-10 -107.66 165.59 11.32 Favored 'General case' 0 C--N 1.331 -0.218 0 CA-C-N 116.342 -0.39 . . . . 0.0 110.123 176.9 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 111' ' ' GLU . . . . . . . . . . . . . 45.4 tp10 -89.1 125.51 35.06 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-O 120.928 0.394 . . . . 0.0 111.0 -177.452 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 112' ' ' LEU . . . . . . . . . . . . . 17.4 mt -109.62 -46.05 3.58 Favored 'General case' 0 C--N 1.332 -0.19 0 CA-C-N 115.991 -0.55 . . . . 0.0 110.404 177.201 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 113' ' ' TYR . . . . . 0.414 ' HB3' HD12 ' B' ' 104' ' ' ILE . 64.4 t80 -145.42 140.31 27.53 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.226 -0.443 . . . . 0.0 111.382 -179.398 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' B' B ' 114' ' ' ARG . . . . . . . . . . . . . 21.3 ttm180 -132.39 127.8 36.21 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-N 116.006 -0.543 . . . . 0.0 109.842 175.627 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 115' ' ' GLY . . . . . . . . . . . . . . . -150.1 131.35 3.58 Favored Glycine 0 CA--C 1.523 0.573 0 N-CA-C 111.137 -0.785 . . . . 0.0 111.137 178.334 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 116' ' ' LYS . . . . . . . . . . . . . 28.4 ttpp -106.68 133.24 51.65 Favored 'General case' 0 C--N 1.331 -0.235 0 N-CA-C 109.664 -0.495 . . . . 0.0 109.664 176.85 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 117' ' ' PHE . . . . . . . . . . . . . 39.4 m-85 -136.01 113.92 11.23 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-O 120.903 0.382 . . . . 0.0 110.246 -175.591 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 118' ' ' GLU . . . . . . . . . . . . . 97.0 mt-10 -54.34 -44.01 71.73 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.485 -0.325 . . . . 0.0 111.279 -177.628 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 119' ' ' ASN . . . . . . . . . . . . . 83.9 m-20 -96.67 31.03 2.41 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 116.182 -0.463 . . . . 0.0 112.146 -174.661 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 120' ' ' LEU . . . . . . . . . . . . . 14.9 tp -57.04 120.25 7.68 Favored 'General case' 0 C--N 1.333 -0.137 0 CA-C-O 120.641 0.258 . . . . 0.0 110.33 177.447 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 121' ' ' ASN . . . . . . . . . . . . . 61.1 m-80 -113.6 -44.0 3.25 Favored 'General case' 0 C--N 1.332 -0.156 0 CA-C-N 116.627 -0.26 . . . . 0.0 111.084 -177.357 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 122' ' ' LYS . . . . . . . . . . . . . 88.6 mttt -147.4 149.8 33.43 Favored 'General case' 0 C--N 1.331 -0.197 0 CA-C-O 121.221 0.534 . . . . 0.0 111.744 -178.035 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 123' ' ' VAL . . . . . . . . . . . . . 44.6 t -128.19 129.2 69.29 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.263 0 CA-C-N 115.71 -0.677 . . . . 0.0 109.589 175.506 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 124' ' ' LEU . . . . . . . . . . . . . 83.8 mt -123.63 131.93 53.74 Favored 'General case' 0 C--N 1.331 -0.224 0 CA-C-N 116.396 -0.366 . . . . 0.0 110.573 -179.041 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 125' ' ' VAL . . . . . 0.452 ' O ' HG13 ' B' ' 125' ' ' VAL . 11.2 p -131.12 122.86 52.46 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.232 0 CA-C-N 116.163 -0.471 . . . . 0.0 109.835 177.161 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' B' B ' 126' ' ' ARG . . . . . . . . . . . . . 88.8 mtt180 -147.45 128.82 14.86 Favored 'General case' 0 C--N 1.33 -0.252 0 N-CA-C 109.62 -0.511 . . . . 0.0 109.62 -179.802 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 127' ' ' ASN . . . . . . . . . . . . . 32.0 m120 55.95 -151.94 0.39 Allowed 'General case' 0 CA--C 1.541 0.616 0 N-CA-C 109.784 -0.451 . . . . 0.0 109.784 -178.749 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 128' ' ' ASP . . . . . . . . . . . . . 19.4 p-10 -83.69 19.73 1.59 Allowed 'General case' 0 CA--C 1.536 0.412 0 CA-C-N 118.67 0.668 . . . . 0.0 112.49 177.337 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 129' ' ' LEU . . . . . . . . . . . . . 2.0 tt -116.41 131.81 56.85 Favored 'General case' 0 C--O 1.232 0.156 0 N-CA-C 109.96 -0.385 . . . . 0.0 109.96 -179.92 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 130' ' ' VAL . . . . . . . . . . . . . 44.7 t -124.19 138.26 54.38 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.228 0 CA-C-O 120.765 0.317 . . . . 0.0 110.146 -178.826 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 131' ' ' VAL . . . . . 0.434 HG22 HD12 ' B' ' 140' ' ' LEU . 41.2 t -136.1 137.75 48.14 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.261 0 CA-C-O 121.037 0.446 . . . . 0.0 110.444 179.851 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' B' B ' 132' ' ' ILE . . . . . . . . . . . . . 73.5 mt -119.84 133.39 66.76 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.254 0 N-CA-C 109.342 -0.614 . . . . 0.0 109.342 178.68 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 133' ' ' ILE . . . . . . . . . . . . . 40.1 mm -117.44 121.71 68.22 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.29 0 CA-C-O 120.824 0.345 . . . . 0.0 111.205 -174.498 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 134' ' ' ASP . . . . . . . . . . . . . 6.8 p-10 -132.07 147.25 52.43 Favored 'General case' 0 C--N 1.332 -0.178 0 CA-C-N 115.852 -0.613 . . . . 0.0 109.521 173.831 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 135' ' ' GLU . . . . . . . . . . . . . 43.7 tp10 -49.9 -26.72 4.37 Favored 'General case' 0 C--N 1.328 -0.33 0 N-CA-C 112.904 0.705 . . . . 0.0 112.904 -170.756 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 136' ' ' GLN . . . . . . . . . . . . . 96.9 mt-30 -92.88 -34.76 13.69 Favored 'General case' 0 C--N 1.331 -0.232 0 N-CA-C 112.381 0.511 . . . . 0.0 112.381 -175.475 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 137' ' ' LYS . . . . . . . . . . . . . 55.4 mtmt -145.49 154.98 42.81 Favored 'General case' 0 C--N 1.33 -0.239 0 CA-C-O 121.474 0.654 . . . . 0.0 111.856 -170.141 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 138' ' ' LEU . . . . . 0.454 HD23 ' N ' ' B' ' 139' ' ' THR . 4.2 tt -113.31 123.05 49.22 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 115.144 -0.935 . . . . 0.0 108.981 174.403 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' B' B ' 139' ' ' THR . . . . . 0.454 ' N ' HD23 ' B' ' 138' ' ' LEU . 33.1 m -107.61 128.48 54.58 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-O 120.848 0.356 . . . . 0.0 110.852 -177.218 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' B' B ' 140' ' ' LEU . . . . . 0.434 HD12 HG22 ' B' ' 131' ' ' VAL . 18.8 tp -114.08 121.53 44.09 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 115.45 -0.796 . . . . 0.0 109.355 -179.28 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' B' B ' 141' ' ' ILE . . . . . . . . . . . . . 19.5 mt -120.86 120.13 61.5 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.342 0 N-CA-C 109.855 -0.424 . . . . 0.0 109.855 -175.733 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 142' ' ' ARG . . . . . . . . . . . . . 73.5 mtm180 -111.01 129.23 55.96 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 115.55 -0.75 . . . . 0.0 110.547 -179.401 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 143' ' ' THR . . . . . . . . . . . . . 39.9 p . . . . . 0 C--O 1.222 -0.373 0 CA-C-O 117.959 -1.02 . . . . 0.0 110.56 179.939 . . . . . . . . 0 0 . 1 . 007 nuclear nobuild full ' C' C ' -3' ' ' GLU . . . . . . . . . . . . . 84.9 tt0 . . . . . 0 N--CA 1.489 1.508 0 N-CA-C 109.345 -0.613 . . . . 0.0 109.345 . . . . . . . . . 0 0 . 1 . 007 nuclear nobuild full ' C' C ' -2' ' ' GLY . . . . . . . . . . . . . . . -84.03 110.34 3.31 Favored Glycine 0 CA--C 1.525 0.706 0 N-CA-C 110.784 -0.927 . . . . 0.0 110.784 179.599 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' C' C ' -1' ' ' VAL . . . . . . . . . . . . . 46.2 t -84.99 123.93 39.57 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.321 0 N-CA-C 109.547 -0.538 . . . . 0.0 109.547 179.112 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' C' C ' 0' ' ' ILE . . . . . . . . . . . . . 71.3 mt -120.29 137.19 54.91 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.262 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.254 -177.506 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' C' C ' 1' ' ' MET . . . . . . . . . . . . . 26.4 ptm -90.15 131.96 35.72 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.017 -0.538 . . . . 0.0 110.489 178.511 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' C' C ' 2' ' ' SER . . . . . . . . . . . . . 25.9 p -117.71 150.13 39.6 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.312 179.179 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' C' C ' 3' ' ' GLU . . . . . . . . . . . . . 95.7 mt-10 -139.42 141.8 37.48 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.191 -0.459 . . . . 0.0 111.014 -178.021 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' C' C ' 4' ' ' LEU . . . . . 0.4 HD11 HG13 ' C' ' 50' ' ' VAL . 16.9 tp -125.11 125.83 44.37 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 115.724 -0.671 . . . . 0.0 110.197 177.165 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' C' C ' 5' ' ' LYS . . . . . . . . . . . . . 60.5 mttp -105.23 121.53 44.04 Favored 'General case' 0 C--O 1.234 0.25 0 CA-C-N 116.505 -0.316 . . . . 0.0 110.282 177.632 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' C' C ' 6' ' ' LEU . . . . . . . . . . . . . 53.2 mt -114.46 145.71 41.55 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-N 115.623 -0.717 . . . . 0.0 110.917 -178.058 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' C' C ' 7' ' ' LYS . . . . . . . . . . . . . 25.9 ttpt -132.7 134.53 24.77 Favored Pre-proline 0 CA--C 1.536 0.412 0 CA-C-O 118.884 -0.579 . . . . 0.0 109.64 176.449 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' C' C ' 8' ' ' PRO . . . . . . . . . . . . . 86.5 Cg_endo -90.67 133.3 1.75 Allowed 'Trans proline' 0 N--CA 1.489 1.228 0 C-N-CA 121.624 1.55 . . . . 0.0 111.343 174.095 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' C' C ' 9' ' ' LEU . . . . . . . . . . . . . 62.1 mt -69.13 -48.21 27.59 Favored Pre-proline 0 CA--C 1.533 0.325 0 CA-C-O 118.608 -0.711 . . . . 0.0 112.48 -177.085 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' C' C ' 10' ' ' PRO . . . . . . . . . . . . . 90.0 Cg_endo -78.81 146.83 21.17 Favored 'Trans proline' 0 N--CA 1.495 1.59 0 C-N-CA 121.109 1.206 . . . . 0.0 111.817 177.367 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' C' C ' 11' ' ' LYS . . . . . . . . . . . . . 62.0 tttm -78.55 91.39 4.57 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.436 -0.347 . . . . 0.0 110.424 179.185 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' C' C ' 12' ' ' VAL . . . . . . . . . . . . . 12.4 p -139.63 146.15 25.77 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.308 0 CA-C-N 116.297 -0.41 . . . . 0.0 110.485 -179.705 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' C' C ' 13' ' ' GLU . . . . . . . . . . . . . 44.7 tp10 -90.26 129.37 36.51 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.33 -0.396 . . . . 0.0 110.298 179.351 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' C' C ' 14' ' ' LEU . . . . . . . . . . . . . 27.3 mt -97.99 152.36 38.02 Favored Pre-proline 0 CA--C 1.531 0.246 0 CA-C-N 116.33 -0.395 . . . . 0.0 110.653 -178.323 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' C' C ' 15' ' ' PRO . . . . . . . . . . . . . 27.2 Cg_exo -61.31 159.01 32.77 Favored 'Trans proline' 0 N--CA 1.499 1.795 0 C-N-CA 121.307 1.338 . . . . 0.0 111.815 177.265 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' C' C ' 16' ' ' PRO . . . . . . . . . . . . . 39.8 Cg_exo -58.63 -39.37 83.27 Favored 'Trans proline' 0 N--CA 1.498 1.74 0 C-N-CA 121.483 1.455 . . . . 0.0 112.871 -178.481 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' C' C ' 17' ' ' ASP . . . . . . . . . . . . . 12.9 p-10 -85.81 8.51 19.73 Favored 'General case' 0 CA--C 1.536 0.44 0 N-CA-C 113.176 0.806 . . . . 0.0 113.176 -177.738 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' C' C ' 18' ' ' PHE . . . . . . . . . . . . . 55.0 t80 -58.1 -45.53 87.06 Favored 'General case' 0 C--N 1.333 -0.118 0 O-C-N 122.077 -0.389 . . . . 0.0 110.178 -177.925 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' C' C ' 19' ' ' VAL . . . . . 0.414 HG13 ' N ' ' C' ' 20' ' ' ASP . 13.8 p -55.88 -41.69 67.9 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.371 0 CA-C-N 116.336 -0.393 . . . . 0.0 111.006 -178.244 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' C' C ' 20' ' ' ASP . . . . . 0.414 ' N ' HG13 ' C' ' 19' ' ' VAL . 11.3 t70 -60.82 -42.03 96.91 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-O 120.977 0.418 . . . . 0.0 110.655 -178.831 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' C' C ' 21' ' ' VAL . . . . . . . . . . . . . 47.3 t -64.04 -45.47 96.58 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.248 0 CA-C-N 116.244 -0.434 . . . . 0.0 110.442 -178.138 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' C' C ' 22' ' ' ILE . . . . . 0.45 HG22 HD12 ' C' ' 26' ' ' LEU . 51.5 mm -55.4 -47.25 78.41 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.265 0 C-N-CA 121.056 -0.258 . . . . 0.0 110.661 179.037 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' C' C ' 23' ' ' ARG . . . . . . . . . . . . . 54.0 ttp180 -54.35 -49.83 68.86 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-O 120.671 0.272 . . . . 0.0 111.411 -179.068 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' C' C ' 24' ' ' ILE . . . . . . . . . . . . . 73.1 mt -59.34 -41.76 85.26 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.314 0 CA-C-N 116.566 -0.288 . . . . 0.0 111.422 -176.889 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' C' C ' 25' ' ' LYS . . . . . . . . . . . . . 49.6 mttm -67.28 -42.64 83.46 Favored 'General case' 0 C--N 1.329 -0.32 0 N-CA-C 112.351 0.5 . . . . 0.0 112.351 -178.791 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' C' C ' 26' ' ' LEU . . . . . 0.45 HD12 HG22 ' C' ' 22' ' ' ILE . 92.6 mt -78.34 -37.91 43.38 Favored 'General case' 0 C--N 1.33 -0.272 0 N-CA-C 113.116 0.784 . . . . 0.0 113.116 -170.651 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' C' C ' 27' ' ' GLN . . . . . . . . . . . . . 9.3 pt20 -46.87 139.12 5.72 Favored 'General case' 0 N--CA 1.47 0.531 0 N-CA-C 112.918 0.71 . . . . 0.0 112.918 -175.016 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' C' C ' 28' ' ' GLY . . . . . . . . . . . . . . . 100.01 -26.69 23.51 Favored Glycine 0 CA--C 1.533 1.17 0 CA-C-N 115.493 -0.776 . . . . 0.0 112.207 -177.505 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' C' C ' 29' ' ' LYS . . . . . . . . . . . . . 60.8 mttp -98.24 155.12 17.34 Favored 'General case' 0 C--O 1.232 0.169 0 CA-C-N 117.264 0.532 . . . . 0.0 111.071 179.555 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' C' C ' 30' ' ' THR . . . . . . . . . . . . . 32.8 m -110.0 133.52 53.1 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-N 116.048 -0.523 . . . . 0.0 110.186 176.823 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' C' C ' 31' ' ' VAL . . . . . . . . . . . . . 35.0 m -133.45 164.3 35.32 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.267 0 CA-C-N 116.265 -0.425 . . . . 0.0 110.364 -179.641 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' C' C ' 32' ' ' ARG . . . . . . . . . . . . . 29.9 ttp180 -132.53 153.59 50.8 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-O 121.294 0.569 . . . . 0.0 110.605 179.232 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' C' C ' 33' ' ' THR . . . . . . . . . . . . . 28.8 m -52.41 140.35 22.46 Favored 'General case' 0 C--N 1.331 -0.227 0 CA-C-N 116.127 -0.488 . . . . 0.0 111.561 -178.327 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' C' C ' 34' ' ' GLY . . . . . . . . . . . . . . . 100.02 -17.2 57.52 Favored Glycine 0 CA--C 1.533 1.181 0 CA-C-O 119.713 -0.493 . . . . 0.0 113.199 179.875 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' C' C ' 35' ' ' ASP . . . . . . . . . . . . . 60.7 m-20 -66.77 149.73 50.12 Favored 'General case' 0 C--O 1.232 0.164 0 CA-C-N 118.074 0.937 . . . . 0.0 111.2 178.918 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' C' C ' 36' ' ' VAL . . . . . . . . . . . . . 45.2 t -123.65 130.44 74.05 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.261 0 CA-C-N 115.897 -0.592 . . . . 0.0 109.825 178.905 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' C' C ' 37' ' ' ILE . . . . . . . . . . . . . 62.1 mt -122.15 139.2 49.84 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.265 0 CA-C-N 116.259 -0.428 . . . . 0.0 109.898 -178.84 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' C' C ' 38' ' ' GLY . . . . . . . . . . . . . . . -109.83 128.74 9.05 Favored Glycine 0 CA--C 1.525 0.696 0 N-CA-C 111.192 -0.763 . . . . 0.0 111.192 179.744 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' C' C ' 39' ' ' ILE . . . . . . . . . . . . . 68.8 mt -120.76 130.96 74.02 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.19 0 N-CA-C 109.944 -0.391 . . . . 0.0 109.944 178.406 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' C' C ' 40' ' ' SER . . . . . . . . . . . . . 32.8 t -93.12 122.58 35.65 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.423 -0.353 . . . . 0.0 111.099 177.324 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' C' C ' 41' ' ' ILE . . . . . . . . . . . . . 70.3 mt -129.75 120.24 49.66 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.206 0 CA-C-O 120.881 0.372 . . . . 0.0 110.325 177.405 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' C' C ' 42' ' ' LEU . . . . . . . . . . . . . 62.6 mt 52.84 36.13 20.67 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 116.02 -0.536 . . . . 0.0 111.677 177.163 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' C' C ' 43' ' ' GLY . . . . . . . . . . . . . . . 72.64 30.0 64.74 Favored Glycine 0 CA--C 1.529 0.967 0 C-N-CA 121.108 -0.567 . . . . 0.0 112.284 177.615 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' C' C ' 44' ' ' LYS . . . . . . . . . . . . . 62.3 mtpt -134.65 129.06 34.27 Favored 'General case' 0 C--N 1.331 -0.222 0 N-CA-C 109.645 -0.502 . . . . 0.0 109.645 177.809 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' C' C ' 45' ' ' GLU . . . . . . . . . . . . . 84.5 tt0 -84.23 122.2 28.55 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-O 120.871 0.367 . . . . 0.0 111.304 -178.255 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' C' C ' 46' ' ' VAL . . . . . . . . . . . . . 7.6 p -119.03 125.6 74.64 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.168 0 N-CA-C 109.06 -0.718 . . . . 0.0 109.06 173.643 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' C' C ' 47' ' ' LYS . . . . . . . . . . . . . 97.9 mttt -99.62 126.87 45.7 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.099 -0.5 . . . . 0.0 111.151 -179.843 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' C' C ' 48' ' ' PHE . . . . . . . . . . . . . 93.6 m-85 -110.39 131.78 54.75 Favored 'General case' 0 C--N 1.329 -0.289 0 N-CA-C 109.624 -0.51 . . . . 0.0 109.624 176.76 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' C' C ' 49' ' ' LYS . . . . . . . . . . . . . 71.4 tttt -108.79 136.83 47.71 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.388 -0.369 . . . . 0.0 110.459 179.075 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' C' C ' 50' ' ' VAL . . . . . 0.4 HG13 HD11 ' C' ' 4' ' ' LEU . 48.0 t -78.87 105.36 8.0 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.278 0 N-CA-C 109.087 -0.709 . . . . 0.0 109.087 175.899 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' C' C ' 51' ' ' VAL . . . . . . . . . . . . . 46.8 t -69.19 -48.96 65.75 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.291 0 CA-C-N 116.07 -0.514 . . . . 0.0 109.843 -173.922 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' C' C ' 52' ' ' GLN . . . . . . . . . . . . . 32.3 tt0 -162.43 143.23 10.12 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-N 115.949 -0.569 . . . . 0.0 111.522 -179.1 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' C' C ' 53' ' ' ALA . . . . . . . . . . . . . . . -122.58 133.85 54.54 Favored 'General case' 0 C--N 1.331 -0.212 0 CA-C-N 115.786 -0.643 . . . . 0.0 109.718 176.714 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' C' C ' 54' ' ' TYR . . . . . . . . . . . . . 14.9 t80 -129.08 113.08 18.52 Favored Pre-proline 0 CA--C 1.535 0.397 0 CA-C-O 118.041 -0.981 . . . . 0.0 110.345 179.265 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' C' C ' 55' ' ' PRO . . . . . . . . . . . . . 73.7 Cg_endo -77.08 169.15 75.09 Favored 'Cis proline' 0 N--CA 1.501 1.967 0 CA-C-N 122.017 1.756 . . . . 0.0 112.214 -6.95 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' C' C ' 56' ' ' SER . . . . . . . . . . . . . 13.5 m -117.74 135.95 23.51 Favored Pre-proline 0 CA--C 1.539 0.533 0 CA-C-O 118.549 -0.738 . . . . 0.0 109.825 175.681 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' C' C ' 57' ' ' PRO . . . . . . . . . . . . . 36.5 Cg_endo -67.22 164.68 70.47 Favored 'Cis proline' 0 N--CA 1.496 1.665 0 CA-C-N 121.743 1.658 . . . . 0.0 111.231 -4.318 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' C' C ' 58' ' ' LEU . . . . . . . . . . . . . 42.4 tp -130.71 138.4 49.99 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-O 121.126 0.489 . . . . 0.0 110.777 -178.737 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' C' C ' 59' ' ' ARG . . . . . . . . . . . . . 51.1 ttt180 -104.1 125.81 50.72 Favored 'General case' 0 C--N 1.327 -0.395 0 N-CA-C 108.939 -0.763 . . . . 0.0 108.939 173.297 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' C' C ' 60' ' ' VAL . . . . . . . . . . . . . 44.1 t -78.94 122.46 34.2 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.319 0 CA-C-O 120.937 0.398 . . . . 0.0 110.609 -174.135 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' C' C ' 61' ' ' GLU . . . . . . . . . . . . . 43.1 mt-10 -131.03 166.04 21.89 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 115.79 -0.641 . . . . 0.0 109.697 174.739 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' C' C ' 62' ' ' ASP . . . . . . . . . . . . . 81.0 m-20 -52.87 -31.85 41.69 Favored 'General case' 0 C--N 1.328 -0.369 0 N-CA-C 111.971 0.36 . . . . 0.0 111.971 -179.883 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' C' C ' 63' ' ' ARG . . . . . . . . . . . . . 21.0 mmm180 -71.17 -21.88 62.11 Favored 'General case' 0 CA--C 1.534 0.351 0 N-CA-C 112.76 0.652 . . . . 0.0 112.76 -176.128 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' C' C ' 64' ' ' THR . . . . . . . . . . . . . 25.3 m -72.12 136.3 46.49 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-O 120.933 0.397 . . . . 0.0 110.947 -175.829 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' C' C ' 65' ' ' LYS . . . . . . . . . . . . . 96.9 mttt -89.8 131.45 35.74 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.011 -0.54 . . . . 0.0 110.144 179.221 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' C' C ' 66' ' ' ILE . . . . . . . . . . . . . 64.0 mt -116.67 130.52 71.38 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.256 0 CA-C-O 120.89 0.376 . . . . 0.0 110.121 -179.892 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' C' C ' 67' ' ' THR . . . . . . . . . . . . . 21.7 m -129.19 142.5 50.85 Favored 'General case' 0 C--N 1.332 -0.185 0 CA-C-N 116.084 -0.507 . . . . 0.0 110.787 -178.846 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' C' C ' 68' ' ' LEU . . . . . 0.5 HD12 ' N ' ' C' ' 68' ' ' LEU . 7.1 mp -105.09 138.46 41.26 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 116.081 -0.509 . . . . 0.0 110.417 178.631 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' C' C ' 69' ' ' VAL . . . . . 0.478 HG11 ' HB3' ' C' ' 72' ' ' PRO . 38.6 t -82.9 138.62 19.04 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.265 0 N-CA-C 109.869 -0.419 . . . . 0.0 109.869 178.18 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' C' C ' 70' ' ' THR . . . . . . . . . . . . . 42.9 p -86.17 -60.04 2.12 Favored 'General case' 0 C--N 1.33 -0.258 0 N-CA-C 112.247 0.462 . . . . 0.0 112.247 -172.557 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' C' C ' 71' ' ' HIS . . . . . . . . . . . . . 91.3 m-70 -129.3 67.85 79.28 Favored Pre-proline 0 CA--C 1.536 0.442 0 CA-C-O 120.662 0.268 . . . . 0.0 111.262 -174.793 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' C' C ' 72' ' ' PRO . . . . . 0.478 ' HB3' HG11 ' C' ' 69' ' ' VAL . 72.7 Cg_endo -94.94 160.13 1.74 Allowed 'Trans proline' 0 N--CA 1.488 1.156 0 C-N-CA 122.034 1.823 . . . . 0.0 112.297 175.925 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' C' C ' 73' ' ' VAL . . . . . . . . . . . . . 26.8 m -103.59 161.63 4.32 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.299 0 N-CA-C 109.802 -0.444 . . . . 0.0 109.802 175.347 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' C' C ' 74' ' ' ASP . . . . . . . . . . . . . 14.0 t70 -91.35 115.24 27.87 Favored 'General case' 0 C--N 1.328 -0.33 0 N-CA-C 109.921 -0.4 . . . . 0.0 109.921 -178.351 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' C' C ' 75' ' ' VAL . . . . . . . . . . . . . 45.6 t -113.1 120.29 62.72 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.268 0 CA-C-O 121.094 0.473 . . . . 0.0 110.216 -178.446 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' C' C ' 76' ' ' LEU . . . . . . . . . . . . . 19.8 mt -123.18 144.94 49.02 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 115.605 -0.725 . . . . 0.0 109.585 179.452 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' C' C ' 77' ' ' GLU . . . . . . . . . . . . . 46.2 mt-10 -134.31 133.5 40.78 Favored 'General case' 0 C--N 1.332 -0.188 0 CA-C-O 121.042 0.449 . . . . 0.0 111.149 -178.804 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' C' C ' 78' ' ' ALA . . . . . . . . . . . . . . . -118.94 135.75 54.43 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 115.713 -0.676 . . . . 0.0 109.808 176.461 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' C' C ' 79' ' ' LYS . . . . . 0.664 ' O ' HD13 ' C' ' 80' ' ' ILE . 62.5 mtpt -80.7 115.3 20.13 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-O 120.813 0.34 . . . . 0.0 110.869 -177.627 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' C' C ' 80' ' ' ILE . . . . . 0.664 HD13 ' O ' ' C' ' 79' ' ' LYS . 37.2 mm -139.23 104.61 2.22 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.281 0 N-CA-C 109.284 -0.636 . . . . 0.0 109.284 -178.527 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' C' C ' 81' ' ' LYS . . . . . . . . . . . . . 93.1 mttt -97.65 128.48 44.38 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-O 120.782 0.325 . . . . 0.0 110.839 -178.766 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' C' C ' 82' ' ' GLY . . . . . . . . . . . . . . . 89.08 42.25 5.66 Favored Glycine 0 CA--C 1.524 0.655 0 N-CA-C 111.176 -0.77 . . . . 0.0 111.176 176.685 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' C' C ' 83' ' ' ILE . . . . . . . . . . . . . 73.6 mt -67.37 132.3 32.5 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.306 0 N-CA-C 109.771 -0.455 . . . . 0.0 109.771 177.689 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' C' C ' 84' ' ' LYS . . . . . . . . . . . . . 76.4 tttt -95.42 -54.06 3.53 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.22 -0.445 . . . . 0.0 110.311 -178.736 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' C' C ' 85' ' ' ASP . . . . . . . . . . . . . 7.4 t0 -149.81 146.3 27.07 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 115.806 -0.634 . . . . 0.0 110.39 -178.652 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' C' C ' 86' ' ' VAL . . . . . . . . . . . . . 42.6 t -124.31 129.5 73.96 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.216 0 CA-C-O 120.858 0.361 . . . . 0.0 110.291 -179.597 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' C' C ' 87' ' ' ILE . . . . . . . . . . . . . 45.1 mm -120.18 126.15 74.97 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.268 0 CA-C-N 115.957 -0.565 . . . . 0.0 109.738 177.637 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' C' C ' 88' ' ' LEU . . . . . . . . . . . . . 19.9 tp -115.15 134.72 54.91 Favored 'General case' 0 C--N 1.332 -0.171 0 CA-C-O 120.992 0.425 . . . . 0.0 111.222 -177.736 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' C' C ' 89' ' ' ASP . . . . . . . . . . . . . 5.6 t70 -131.53 162.23 30.77 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 115.861 -0.609 . . . . 0.0 109.562 176.43 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' C' C ' 90' ' ' GLU . . . . . . . . . . . . . 43.2 mt-10 -46.94 -41.9 16.83 Favored 'General case' 0 N--CA 1.464 0.26 0 N-CA-C 113.015 0.746 . . . . 0.0 113.015 -171.224 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' C' C ' 91' ' ' ASN . . . . . . . . . . . . . 1.8 p30 -132.04 28.29 4.48 Favored 'General case' 0 N--CA 1.466 0.329 0 N-CA-C 112.301 0.482 . . . . 0.0 112.301 -177.773 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' C' C ' 92' ' ' LEU . . . . . . . . . . . . . 16.1 mt -148.62 142.33 25.57 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-O 120.689 0.281 . . . . 0.0 110.35 -177.38 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' C' C ' 93' ' ' ILE . . . . . . . . . . . . . 72.9 mt -125.25 116.58 47.27 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.286 0 N-CA-C 109.143 -0.688 . . . . 0.0 109.143 176.11 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' C' C ' 94' ' ' VAL . . . . . 0.588 HG21 HG11 ' C' ' 125' ' ' VAL . 45.2 t -118.54 127.73 75.53 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.29 0 CA-C-O 120.959 0.409 . . . . 0.0 109.939 -178.795 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' C' C ' 95' ' ' VAL . . . . . . . . . . . . . 44.0 t -122.59 132.78 70.53 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.373 0 CA-C-N 115.96 -0.564 . . . . 0.0 109.854 -179.524 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' C' C ' 96' ' ' ILE . . . . . . . . . . . . . 58.6 mt -113.12 125.58 70.4 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.327 0 N-CA-C 109.058 -0.719 . . . . 0.0 109.058 178.066 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' C' C ' 97' ' ' THR . . . . . . . . . . . . . 71.5 p -98.95 154.53 17.99 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-O 121.197 0.522 . . . . 0.0 111.108 -177.758 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' C' C ' 98' ' ' GLU . . . . . . . . . . . . . 85.1 tt0 -53.82 -25.48 19.62 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 115.959 -0.564 . . . . 0.0 112.341 179.771 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' C' C ' 99' ' ' GLU . . . . . . . . . . . . . 37.0 tt0 -81.07 17.96 1.14 Allowed 'General case' 0 CA--C 1.539 0.525 0 N-CA-C 112.625 0.602 . . . . 0.0 112.625 -177.436 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' C' C ' 100' ' ' ASN . . . . . . . . . . . . . 2.7 m-20 62.39 32.77 16.72 Favored 'General case' 0 N--CA 1.464 0.259 0 O-C-N 121.85 -0.531 . . . . 0.0 111.836 176.276 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' C' C ' 101' ' ' GLU . . . . . . . . . . . . . 84.8 tt0 -113.06 144.82 41.96 Favored 'General case' 0 C--N 1.332 -0.155 0 N-CA-C 109.812 -0.44 . . . . 0.0 109.812 174.14 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' C' C ' 102' ' ' VAL . . . . . . . . . . . . . 45.7 t -115.09 127.43 72.65 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.293 0 CA-C-N 116.244 -0.435 . . . . 0.0 109.926 -177.695 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' C' C ' 103' ' ' LEU . . . . . . . . . . . . . 50.6 mt -117.38 131.53 56.76 Favored 'General case' 0 C--N 1.331 -0.215 0 CA-C-N 115.881 -0.6 . . . . 0.0 110.132 178.531 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' C' C ' 104' ' ' ILE . . . . . . . . . . . . . 65.1 mt -122.56 122.65 66.61 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.227 0 CA-C-O 120.568 0.223 . . . . 0.0 110.46 -179.657 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' C' C ' 105' ' ' PHE . . . . . . . . . . . . . 47.7 m-85 -124.07 164.64 19.0 Favored 'General case' 0 C--N 1.331 -0.225 0 CA-C-N 115.596 -0.729 . . . . 0.0 109.843 178.432 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' C' C ' 106' ' ' ASN . . . . . . . . . . . . . 42.9 p-10 -96.29 -171.41 2.29 Favored 'General case' 0 C--N 1.331 -0.212 0 N-CA-C 109.992 -0.373 . . . . 0.0 109.992 174.929 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' C' C ' 107' ' ' GLN . . . . . . . . . . . . . 40.1 tt0 -60.23 -29.46 68.77 Favored 'General case' 0 C--N 1.329 -0.32 0 N-CA-C 111.96 0.355 . . . . 0.0 111.96 -179.659 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' C' C ' 108' ' ' ASN . . . . . . . . . . . . . 12.1 t30 -83.95 6.16 22.83 Favored 'General case' 0 CA--C 1.536 0.441 0 N-CA-C 113.277 0.843 . . . . 0.0 113.277 -177.468 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' C' C ' 109' ' ' LEU . . . . . . . . . . . . . 12.0 tp 62.09 41.67 10.64 Favored 'General case' 0 C--N 1.332 -0.164 0 CA-C-O 121.383 0.611 . . . . 0.0 110.98 178.657 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' C' C ' 110' ' ' GLU . . . . . . . . . . . . . 96.2 mt-10 -108.55 155.97 20.04 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.139 -0.482 . . . . 0.0 110.014 176.094 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' C' C ' 111' ' ' GLU . . . . . . . . . . . . . 83.7 tt0 -79.97 121.93 26.09 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.394 -0.366 . . . . 0.0 110.683 -179.121 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' C' C ' 112' ' ' LEU . . . . . . . . . . . . . 17.9 mt -112.44 -46.03 3.2 Favored 'General case' 0 C--N 1.331 -0.212 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.306 177.026 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' C' C ' 113' ' ' TYR . . . . . . . . . . . . . 62.7 t80 -147.07 137.2 23.35 Favored 'General case' 0 C--N 1.33 -0.243 0 C-N-CA 120.606 -0.438 . . . . 0.0 111.462 179.991 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' C' C ' 114' ' ' ARG . . . . . . . . . . . . . 93.2 mtt180 -137.67 127.83 26.05 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.131 -0.486 . . . . 0.0 110.096 173.876 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' C' C ' 115' ' ' GLY . . . . . . . . . . . . . . . -149.99 162.89 29.31 Favored Glycine 0 CA--C 1.524 0.596 0 N-CA-C 110.682 -0.967 . . . . 0.0 110.682 179.337 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' C' C ' 116' ' ' LYS . . . . . . . . . . . . . 75.2 tttt -132.31 138.5 47.84 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-O 120.856 0.36 . . . . 0.0 110.143 179.287 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' C' C ' 117' ' ' PHE . . . . . . . . . . . . . 33.4 m-85 -136.28 116.72 13.71 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.158 -0.474 . . . . 0.0 109.812 -177.113 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' C' C ' 118' ' ' GLU . . . . . . . . . . . . . 45.7 mp0 -56.01 -40.62 73.65 Favored 'General case' 0 C--N 1.329 -0.304 0 C-N-CA 120.803 -0.359 . . . . 0.0 110.92 -175.758 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' C' C ' 119' ' ' ASN . . . . . . . . . . . . . 30.5 m120 -100.07 31.19 3.42 Favored 'General case' 0 CA--C 1.53 0.21 0 N-CA-C 112.103 0.408 . . . . 0.0 112.103 -174.912 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' C' C ' 120' ' ' LEU . . . . . . . . . . . . . 15.0 tp -57.34 119.9 7.25 Favored 'General case' 0 C--N 1.333 -0.148 0 C-N-CA 121.005 -0.278 . . . . 0.0 110.352 178.087 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' C' C ' 121' ' ' ASN . . . . . . . . . . . . . 46.8 m-80 -114.15 -44.1 3.17 Favored 'General case' 0 C--N 1.332 -0.195 0 CA-C-N 116.571 -0.286 . . . . 0.0 111.245 -177.705 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' C' C ' 122' ' ' LYS . . . . . . . . . . . . . 75.7 mttt -143.35 149.22 37.44 Favored 'General case' 0 C--N 1.331 -0.222 0 CA-C-O 121.066 0.46 . . . . 0.0 111.834 -176.312 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' C' C ' 123' ' ' VAL . . . . . . . . . . . . . 43.1 t -128.62 130.96 69.03 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.227 0 N-CA-C 109.266 -0.642 . . . . 0.0 109.266 174.847 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' C' C ' 124' ' ' LEU . . . . . . . . . . . . . 13.3 tp -130.27 138.3 50.43 Favored 'General case' 0 C--N 1.332 -0.184 0 CA-C-O 120.837 0.351 . . . . 0.0 110.916 -177.484 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' C' C ' 125' ' ' VAL . . . . . 0.588 HG11 HG21 ' C' ' 94' ' ' VAL . 34.9 m -129.74 138.82 53.19 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.229 0 CA-C-N 116.127 -0.488 . . . . 0.0 110.603 179.939 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' C' C ' 126' ' ' ARG . . . . . . . . . . . . . 77.9 mtp85 -147.17 121.88 9.87 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-O 120.868 0.366 . . . . 0.0 110.938 178.162 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' C' C ' 127' ' ' ASN . . . . . . . . . . . . . 9.5 m120 51.02 -105.11 0.19 Allowed 'General case' 0 CA--C 1.544 0.739 0 CA-C-N 116.113 -0.494 . . . . 0.0 111.437 178.684 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' C' C ' 128' ' ' ASP . . . . . . . . . . . . . 12.6 p-10 -114.13 -0.32 14.02 Favored 'General case' 0 CA--C 1.537 0.461 0 CA-C-N 119.504 1.047 . . . . 0.0 113.372 -177.37 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' C' C ' 129' ' ' LEU . . . . . . . . . . . . . 58.3 mt -105.01 143.65 32.89 Favored 'General case' 0 C--O 1.232 0.166 0 CA-C-N 118.135 0.425 . . . . 0.0 110.373 -179.465 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' C' C ' 130' ' ' VAL . . . . . . . . . . . . . 44.9 t -124.4 136.97 58.81 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.284 0 N-CA-C 109.642 -0.503 . . . . 0.0 109.642 -179.956 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' C' C ' 131' ' ' VAL . . . . . 0.496 HG22 HD12 ' C' ' 140' ' ' LEU . 41.3 t -134.55 137.62 51.0 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.248 0 CA-C-O 121.194 0.521 . . . . 0.0 110.376 179.974 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' C' C ' 132' ' ' ILE . . . . . . . . . . . . . 73.3 mt -118.85 133.71 64.82 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.29 0 CA-C-N 115.54 -0.755 . . . . 0.0 109.366 179.565 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' C' C ' 133' ' ' ILE . . . . . . . . . . . . . 37.7 mm -117.02 121.62 68.21 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.229 0 CA-C-N 116.462 -0.336 . . . . 0.0 110.889 -175.035 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' C' C ' 134' ' ' ASP . . . . . . . . . . . . . 7.9 p-10 -133.57 145.86 50.46 Favored 'General case' 0 C--N 1.332 -0.163 0 N-CA-C 109.652 -0.499 . . . . 0.0 109.652 174.067 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' C' C ' 135' ' ' GLU . . . . . . . . . . . . . 80.4 tt0 -49.75 -23.0 1.58 Allowed 'General case' 0 C--N 1.327 -0.403 0 N-CA-C 113.055 0.761 . . . . 0.0 113.055 -171.356 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' C' C ' 136' ' ' GLN . . . . . . . . . . . . . 44.6 tt0 -105.0 -22.56 13.1 Favored 'General case' 0 N--CA 1.465 0.294 0 N-CA-C 113.075 0.769 . . . . 0.0 113.075 -174.976 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' C' C ' 137' ' ' LYS . . . . . . . . . . . . . 78.4 mttt -145.37 153.09 40.85 Favored 'General case' 0 C--N 1.333 -0.143 0 CA-C-O 121.538 0.685 . . . . 0.0 112.22 -172.342 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' C' C ' 138' ' ' LEU . . . . . . . . . . . . . 14.6 tp -115.2 122.16 45.18 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 115.064 -0.971 . . . . 0.0 109.237 173.743 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' C' C ' 139' ' ' THR . . . . . . . . . . . . . 24.4 m -111.79 126.5 55.14 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-O 120.584 0.23 . . . . 0.0 111.011 -177.817 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' C' C ' 140' ' ' LEU . . . . . 0.496 HD12 HG22 ' C' ' 131' ' ' VAL . 15.0 tp -117.84 122.5 43.54 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 115.796 -0.638 . . . . 0.0 109.387 -178.976 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' C' C ' 141' ' ' ILE . . . . . . . . . . . . . 19.1 mt -121.7 123.05 68.51 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.252 0 CA-C-O 120.853 0.359 . . . . 0.0 110.127 -176.317 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' C' C ' 142' ' ' ARG . . . . . . . . . . . . . 84.2 mtp180 -109.62 129.61 55.58 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 115.521 -0.763 . . . . 0.0 110.536 -178.696 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' C' C ' 143' ' ' THR . . . . . . . . . . . . . 61.2 p . . . . . 0 C--O 1.219 -0.5 0 CA-C-O 117.963 -1.018 . . . . 0.0 110.497 179.78 . . . . . . . . 0 0 . 1 . 007 nuclear nobuild full ' D' D ' -3' ' ' GLU . . . . . . . . . . . . . 70.4 mm-40 . . . . . 0 N--CA 1.49 1.537 0 N-CA-C 109.351 -0.611 . . . . 0.0 109.351 . . . . . . . . . 0 0 . 1 . 007 nuclear nobuild full ' D' D ' -2' ' ' GLY . . . . . . . . . . . . . . . -76.36 141.61 27.04 Favored Glycine 0 CA--C 1.524 0.654 0 N-CA-C 110.76 -0.936 . . . . 0.0 110.76 178.977 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' D' D ' -1' ' ' VAL . . . . . . . . . . . . . 43.5 t -96.39 126.87 48.94 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.334 0 CA-C-O 120.813 0.339 . . . . 0.0 110.187 -179.872 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' D' D ' 0' ' ' ILE . . . . . . . . . . . . . 71.3 mt -124.72 140.48 47.81 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.196 0 CA-C-N 116.192 -0.458 . . . . 0.0 109.924 -179.865 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' D' D ' 1' ' ' MET . . . . . . . . . . . . . 25.6 ptp -78.52 143.58 36.44 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.224 -0.444 . . . . 0.0 111.044 -178.704 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' D' D ' 2' ' ' SER . . . . . . . . . . . . . 1.8 p -131.05 121.99 25.98 Favored 'General case' 0 C--N 1.331 -0.216 0 CA-C-N 116.097 -0.501 . . . . 0.0 110.178 177.706 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' D' D ' 3' ' ' GLU . . . . . . . . . . . . . 93.3 mt-10 -139.99 143.17 36.34 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-N 116.042 -0.526 . . . . 0.0 111.403 -175.819 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' D' D ' 4' ' ' LEU . . . . . . . . . . . . . 20.9 tp -126.53 129.52 48.77 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 115.776 -0.647 . . . . 0.0 109.751 175.49 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' D' D ' 5' ' ' LYS . . . . . . . . . . . . . 99.7 mttt -113.43 122.43 47.3 Favored 'General case' 0 C--O 1.235 0.336 0 CA-C-N 116.581 -0.281 . . . . 0.0 111.069 -178.624 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' D' D ' 6' ' ' LEU . . . . . . . . . . . . . 43.7 mt -114.0 143.34 44.91 Favored 'General case' 0 C--N 1.332 -0.19 0 CA-C-N 115.49 -0.777 . . . . 0.0 110.202 -179.958 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' D' D ' 7' ' ' LYS . . . . . . . . . . . . . 31.3 ttpt -125.88 138.57 32.32 Favored Pre-proline 0 CA--C 1.534 0.346 0 CA-C-O 118.917 -0.564 . . . . 0.0 109.637 175.601 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' D' D ' 8' ' ' PRO . . . . . . . . . . . . . 85.9 Cg_endo -91.14 135.22 1.8 Allowed 'Trans proline' 0 N--CA 1.489 1.23 0 C-N-CA 121.71 1.607 . . . . 0.0 112.049 179.537 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' D' D ' 9' ' ' LEU . . . . . . . . . . . . . 35.3 mt -73.81 -46.78 6.91 Favored Pre-proline 0 C--N 1.329 -0.313 0 CA-C-O 118.715 -0.66 . . . . 0.0 111.865 179.527 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' D' D ' 10' ' ' PRO . . . . . . . . . . . . . 89.4 Cg_endo -81.77 153.17 17.32 Favored 'Trans proline' 0 N--CA 1.495 1.588 0 C-N-CA 121.179 1.253 . . . . 0.0 111.574 174.71 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' D' D ' 11' ' ' LYS . . . . . . . . . . . . . 62.7 tttm -87.6 99.08 11.78 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-O 120.893 0.378 . . . . 0.0 110.443 178.863 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' D' D ' 12' ' ' VAL . . . . . . . . . . . . . 12.2 p -140.47 145.46 25.8 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.293 0 CA-C-N 116.108 -0.496 . . . . 0.0 110.352 179.971 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' D' D ' 13' ' ' GLU . . . . . . . . . . . . . 84.6 tt0 -90.1 125.45 35.43 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.317 -0.401 . . . . 0.0 110.029 178.588 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' D' D ' 14' ' ' LEU . . . . . 0.407 HD22 ' CD1' ' D' ' 18' ' ' PHE . 21.1 mt -96.77 151.17 37.7 Favored Pre-proline 0 C--N 1.329 -0.309 0 CA-C-N 116.404 -0.362 . . . . 0.0 110.692 -177.669 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' D' D ' 15' ' ' PRO . . . . . . . . . . . . . 26.7 Cg_exo -61.61 157.38 42.29 Favored 'Trans proline' 0 N--CA 1.497 1.697 0 C-N-CA 121.225 1.283 . . . . 0.0 111.669 176.812 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' D' D ' 16' ' ' PRO . . . . . . . . . . . . . 37.2 Cg_exo -57.59 -36.21 98.63 Favored 'Trans proline' 0 N--CA 1.496 1.66 0 C-N-CA 121.461 1.441 . . . . 0.0 112.981 -177.466 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' D' D ' 17' ' ' ASP . . . . . . . . . . . . . 22.4 p-10 -92.03 9.06 34.86 Favored 'General case' 0 CA--C 1.535 0.403 0 N-CA-C 113.418 0.896 . . . . 0.0 113.418 -175.988 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' D' D ' 18' ' ' PHE . . . . . 0.407 ' CD1' HD22 ' D' ' 14' ' ' LEU . 62.4 t80 -57.09 -47.61 80.63 Favored 'General case' 0 C--N 1.333 -0.145 0 O-C-N 121.837 -0.539 . . . . 0.0 110.483 -177.585 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' D' D ' 19' ' ' VAL . . . . . . . . . . . . . 44.3 t -55.57 -51.0 62.7 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.382 0 CA-C-N 116.281 -0.418 . . . . 0.0 111.235 -174.429 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' D' D ' 20' ' ' ASP . . . . . . . . . . . . . 2.3 p-10 -59.33 -37.27 77.39 Favored 'General case' 0 N--CA 1.464 0.228 0 C-N-CA 120.381 -0.527 . . . . 0.0 111.252 -176.32 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' D' D ' 21' ' ' VAL . . . . . . . . . . . . . 59.7 t -63.0 -45.15 99.61 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.266 0 C-N-CA 120.314 -0.555 . . . . 0.0 110.191 179.885 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' D' D ' 22' ' ' ILE . . . . . 0.534 HG22 HD12 ' D' ' 26' ' ' LEU . 46.1 mm -57.39 -39.46 68.45 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.317 0 C-N-CA 120.961 -0.296 . . . . 0.0 110.475 178.36 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' D' D ' 23' ' ' ARG . . . . . . . . . . . . . 55.5 ttp180 -57.26 -49.97 74.38 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-O 121.057 0.456 . . . . 0.0 110.437 176.751 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' D' D ' 24' ' ' ILE . . . . . . . . . . . . . 76.6 mt -60.0 -38.89 78.56 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.34 0 CA-C-N 116.028 -0.533 . . . . 0.0 111.858 -176.884 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' D' D ' 25' ' ' LYS . . . . . . . . . . . . . 25.9 pttt -76.64 -40.82 47.97 Favored 'General case' 0 CA--C 1.534 0.36 0 C-N-CA 120.343 -0.543 . . . . 0.0 112.112 -174.426 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' D' D ' 26' ' ' LEU . . . . . 0.534 HD12 HG22 ' D' ' 22' ' ' ILE . 14.7 mt -79.35 -28.39 42.0 Favored 'General case' 0 CA--C 1.53 0.211 0 N-CA-C 113.172 0.804 . . . . 0.0 113.172 -171.828 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' D' D ' 27' ' ' GLN . . . . . . . . . . . . . 10.2 pt20 -46.37 141.68 3.4 Favored 'General case' 0 N--CA 1.471 0.589 0 N-CA-C 112.931 0.715 . . . . 0.0 112.931 -175.518 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' D' D ' 28' ' ' GLY . . . . . . . . . . . . . . . 100.36 -25.85 26.74 Favored Glycine 0 CA--C 1.532 1.117 0 CA-C-N 115.58 -0.736 . . . . 0.0 112.189 -176.55 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' D' D ' 29' ' ' LYS . . . . . . . . . . . . . 53.2 mttm -97.65 155.13 17.13 Favored 'General case' 0 C--N 1.332 -0.162 0 CA-C-N 117.422 0.611 . . . . 0.0 110.854 178.45 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' D' D ' 30' ' ' THR . . . . . . . . . . . . . 33.4 m -106.19 140.64 38.83 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.235 -0.438 . . . . 0.0 110.24 176.946 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' D' D ' 31' ' ' VAL . . . . . . . . . . . . . 35.0 m -127.82 155.03 39.03 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.198 0 CA-C-O 120.819 0.342 . . . . 0.0 110.875 -178.581 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' D' D ' 32' ' ' ARG . . . . . . . . . . . . . 43.6 mtp180 -133.31 152.57 51.93 Favored 'General case' 0 C--N 1.331 -0.203 0 CA-C-N 115.854 -0.612 . . . . 0.0 110.675 177.719 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' D' D ' 33' ' ' THR . . . . . . . . . . . . . 18.8 m -53.46 139.14 31.72 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.034 -0.53 . . . . 0.0 111.387 -179.256 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' D' D ' 34' ' ' GLY . . . . . . . . . . . . . . . 99.84 -17.2 57.69 Favored Glycine 0 CA--C 1.533 1.202 0 C-N-CA 121.123 -0.56 . . . . 0.0 113.284 178.13 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' D' D ' 35' ' ' ASP . . . . . . . . . . . . . 77.3 m-20 -66.12 147.79 52.8 Favored 'General case' 0 C--O 1.231 0.112 0 CA-C-N 118.053 0.927 . . . . 0.0 111.064 179.444 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' D' D ' 36' ' ' VAL . . . . . . . . . . . . . 45.0 t -122.23 129.61 75.19 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.241 0 CA-C-N 115.933 -0.576 . . . . 0.0 109.751 177.775 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' D' D ' 37' ' ' ILE . . . . . . . . . . . . . 63.9 mt -120.14 137.91 52.44 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.254 0 CA-C-N 116.289 -0.414 . . . . 0.0 110.031 -179.381 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' D' D ' 38' ' ' GLY . . . . . . . . . . . . . . . -112.65 127.72 8.12 Favored Glycine 0 CA--C 1.526 0.746 0 N-CA-C 110.828 -0.909 . . . . 0.0 110.828 178.557 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' D' D ' 39' ' ' ILE . . . . . . . . . . . . . 70.8 mt -124.76 131.0 73.24 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.282 0 N-CA-C 110.113 -0.329 . . . . 0.0 110.113 179.58 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' D' D ' 40' ' ' SER . . . . . . . . . . . . . 53.1 p -91.94 123.05 35.02 Favored 'General case' 0 C--N 1.331 -0.2 0 CA-C-N 116.292 -0.413 . . . . 0.0 110.928 177.555 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' D' D ' 41' ' ' ILE . . . . . . . . . . . . . 72.9 mt -132.34 122.43 48.03 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.229 0 CA-C-N 116.469 -0.332 . . . . 0.0 110.344 177.756 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' D' D ' 42' ' ' LEU . . . . . . . . . . . . . 52.9 mt 53.87 35.9 22.84 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.161 -0.472 . . . . 0.0 111.742 176.821 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' D' D ' 43' ' ' GLY . . . . . . . . . . . . . . . 72.85 28.03 67.75 Favored Glycine 0 CA--C 1.53 1.031 0 C-N-CA 121.171 -0.537 . . . . 0.0 112.457 177.241 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' D' D ' 44' ' ' LYS . . . . . . . . . . . . . 48.7 mtmt -138.12 128.24 25.8 Favored 'General case' 0 C--N 1.331 -0.206 0 N-CA-C 109.778 -0.453 . . . . 0.0 109.778 177.77 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' D' D ' 45' ' ' GLU . . . . . . . . . . . . . 84.5 tt0 -84.62 125.92 32.89 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.515 -0.311 . . . . 0.0 111.444 -177.939 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' D' D ' 46' ' ' VAL . . . . . 0.417 HG13 ' O ' ' D' ' 46' ' ' VAL . 8.9 p -118.58 124.39 73.06 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.23 0 N-CA-C 109.22 -0.659 . . . . 0.0 109.22 173.553 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' D' D ' 47' ' ' LYS . . . . . . . . . . . . . 91.8 mttt -98.96 124.86 44.21 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 116.087 -0.506 . . . . 0.0 110.845 178.362 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' D' D ' 48' ' ' PHE . . . . . . . . . . . . . 31.7 m-85 -108.03 131.86 54.15 Favored 'General case' 0 C--N 1.329 -0.32 0 N-CA-C 109.626 -0.509 . . . . 0.0 109.626 176.812 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' D' D ' 49' ' ' LYS . . . . . . . . . . . . . 82.2 tttt -106.79 132.08 53.17 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.246 -0.434 . . . . 0.0 110.123 178.718 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' D' D ' 50' ' ' VAL . . . . . . . . . . . . . 45.7 t -75.65 105.02 4.24 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.323 0 N-CA-C 109.257 -0.645 . . . . 0.0 109.257 177.5 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' D' D ' 51' ' ' VAL . . . . . . . . . . . . . 47.7 t -71.61 -51.43 32.7 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.273 0 CA-C-N 116.04 -0.527 . . . . 0.0 109.774 -174.687 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' D' D ' 52' ' ' GLN . . . . . . . . . . . . . 55.0 mt-30 -155.35 147.48 23.62 Favored 'General case' 0 C--N 1.33 -0.256 0 C-N-CA 120.343 -0.543 . . . . 0.0 111.789 -177.862 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' D' D ' 53' ' ' ALA . . . . . . . . . . . . . . . -124.47 130.8 53.14 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 115.291 -0.868 . . . . 0.0 109.51 173.909 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' D' D ' 54' ' ' TYR . . . . . . . . . . . . . 16.0 t80 -128.97 108.19 18.19 Favored Pre-proline 0 CA--C 1.534 0.341 0 CA-C-O 118.272 -0.871 . . . . 0.0 110.458 -179.465 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' D' D ' 55' ' ' PRO . . . . . . . . . . . . . 74.2 Cg_endo -77.16 170.0 72.71 Favored 'Cis proline' 0 N--CA 1.499 1.845 0 CA-C-N 121.86 1.7 . . . . 0.0 112.422 -5.915 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' D' D ' 56' ' ' SER . . . . . . . . . . . . . 19.6 m -116.85 133.19 23.1 Favored Pre-proline 0 CA--C 1.539 0.533 0 CA-C-O 118.465 -0.778 . . . . 0.0 109.487 174.826 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' D' D ' 57' ' ' PRO . . . . . . . . . . . . . 49.0 Cg_endo -69.91 164.18 80.32 Favored 'Cis proline' 0 N--CA 1.497 1.726 0 CA-C-N 121.848 1.696 . . . . 0.0 111.485 -1.898 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' D' D ' 58' ' ' LEU . . . . . . . . . . . . . 37.4 tp -130.23 138.05 50.35 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-O 120.886 0.374 . . . . 0.0 110.589 -179.355 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' D' D ' 59' ' ' ARG . . . . . . . . . . . . . 30.1 ttm180 -99.66 132.51 44.96 Favored 'General case' 0 C--N 1.327 -0.396 0 CA-C-N 115.85 -0.614 . . . . 0.0 109.617 176.236 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' D' D ' 60' ' ' VAL . . . . . . . . . . . . . 42.9 t -82.34 114.79 23.78 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.259 0 C-N-CA 120.787 -0.365 . . . . 0.0 110.238 -178.092 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' D' D ' 61' ' ' GLU . . . . . . . . . . . . . 96.0 mt-10 -131.19 169.43 15.93 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.079 -0.51 . . . . 0.0 109.928 176.709 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' D' D ' 62' ' ' ASP . . . . . . . . . . . . . 10.1 p-10 -55.26 -32.58 62.45 Favored 'General case' 0 C--N 1.329 -0.3 0 C-N-CA 120.904 -0.319 . . . . 0.0 111.572 178.716 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' D' D ' 63' ' ' ARG . . . . . . . . . . . . . 16.8 ptp180 -82.51 7.66 13.82 Favored 'General case' 0 CA--C 1.536 0.407 0 N-CA-C 113.504 0.927 . . . . 0.0 113.504 -176.743 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' D' D ' 64' ' ' THR . . . . . . . . . . . . . 28.5 m -91.65 134.31 34.81 Favored 'General case' 0 C--N 1.333 -0.133 0 CA-C-N 118.167 0.439 . . . . 0.0 110.618 -179.385 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' D' D ' 65' ' ' LYS . . . . . . . . . . . . . 23.0 mtpp -89.86 127.6 36.03 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.034 -0.53 . . . . 0.0 110.268 179.589 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' D' D ' 66' ' ' ILE . . . . . . . . . . . . . 65.0 mt -117.35 132.84 65.97 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.25 0 CA-C-O 120.805 0.336 . . . . 0.0 110.291 -178.327 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' D' D ' 67' ' ' THR . . . . . . . . . . . . . 23.1 m -128.7 144.19 51.1 Favored 'General case' 0 N--CA 1.463 0.217 0 CA-C-N 116.094 -0.503 . . . . 0.0 110.941 -179.139 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' D' D ' 68' ' ' LEU . . . . . . . . . . . . . 15.8 tp -107.7 134.4 50.73 Favored 'General case' 0 C--N 1.331 -0.225 0 CA-C-N 115.916 -0.584 . . . . 0.0 110.622 179.348 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' D' D ' 69' ' ' VAL . . . . . . . . . . . . . 43.6 t -99.67 140.43 18.98 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.295 0 CA-C-N 116.057 -0.52 . . . . 0.0 110.043 178.358 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' D' D ' 70' ' ' THR . . . . . . . . . . . . . 3.1 m -136.24 40.62 2.65 Favored 'General case' 0 C--N 1.331 -0.213 0 CA-C-O 121.131 0.491 . . . . 0.0 110.975 -178.263 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' D' D ' 71' ' ' HIS . . . . . . . . . . . . . 5.9 t60 -130.8 75.99 77.88 Favored Pre-proline 0 CA--C 1.535 0.382 0 CA-C-N 116.36 -0.382 . . . . 0.0 110.523 179.569 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' D' D ' 72' ' ' PRO . . . . . . . . . . . . . 90.1 Cg_endo -91.62 160.07 3.53 Favored 'Trans proline' 0 N--CA 1.491 1.364 0 C-N-CA 121.936 1.757 . . . . 0.0 112.851 -178.448 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' D' D ' 73' ' ' VAL . . . . . . . . . . . . . 34.7 m -117.31 168.29 9.22 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.205 0 CA-C-N 116.076 -0.511 . . . . 0.0 109.801 176.576 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' D' D ' 74' ' ' ASP . . . . . . . . . . . . . 13.7 t70 -97.75 116.88 30.83 Favored 'General case' 0 C--N 1.33 -0.259 0 C-N-CA 120.86 -0.336 . . . . 0.0 110.149 -177.257 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' D' D ' 75' ' ' VAL . . . . . . . . . . . . . 45.3 t -112.76 122.09 66.27 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.212 0 CA-C-O 121.086 0.469 . . . . 0.0 110.218 -178.617 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' D' D ' 76' ' ' LEU . . . . . . . . . . . . . 29.7 mt -126.78 143.2 51.32 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 115.623 -0.717 . . . . 0.0 109.433 179.28 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' D' D ' 77' ' ' GLU . . . . . . . . . . . . . 39.4 tt0 -138.44 138.97 38.67 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-O 121.052 0.453 . . . . 0.0 111.228 -177.156 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' D' D ' 78' ' ' ALA . . . . . . . . . . . . . . . -122.94 142.01 51.29 Favored 'General case' 0 C--N 1.331 -0.239 0 CA-C-N 115.881 -0.6 . . . . 0.0 110.063 177.613 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' D' D ' 79' ' ' LYS . . . . . 0.639 ' O ' HD13 ' D' ' 80' ' ' ILE . 84.4 tttt -84.7 119.2 24.98 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-O 120.743 0.306 . . . . 0.0 110.741 -178.263 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' D' D ' 80' ' ' ILE . . . . . 0.639 HD13 ' O ' ' D' ' 79' ' ' LYS . 38.2 mm -139.13 113.33 7.27 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.283 0 N-CA-C 109.763 -0.458 . . . . 0.0 109.763 -178.302 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' D' D ' 81' ' ' LYS . . . . . . . . . . . . . 39.2 tptt -105.12 125.56 51.11 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-O 120.734 0.302 . . . . 0.0 110.814 -178.275 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' D' D ' 82' ' ' GLY . . . . . . . . . . . . . . . 89.16 42.16 5.66 Favored Glycine 0 CA--C 1.526 0.726 0 C-N-CA 120.83 -0.7 . . . . 0.0 111.473 174.986 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' D' D ' 83' ' ' ILE . . . . . . . . . . . . . 71.5 mt -67.92 137.02 25.41 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.286 0 N-CA-C 109.897 -0.408 . . . . 0.0 109.897 177.78 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' D' D ' 84' ' ' LYS . . . . . . . . . . . . . 42.8 tttp -95.11 -52.31 4.26 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 116.139 -0.482 . . . . 0.0 110.075 -179.63 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' D' D ' 85' ' ' ASP . . . . . . . . . . . . . 10.9 t70 -158.48 154.32 26.6 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 115.694 -0.685 . . . . 0.0 110.252 178.632 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' D' D ' 86' ' ' VAL . . . . . . . . . . . . . 43.3 t -130.11 132.86 65.05 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.223 0 CA-C-O 120.935 0.398 . . . . 0.0 110.563 -178.939 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' D' D ' 87' ' ' ILE . . . . . 0.492 HD12 ' N ' ' D' ' 87' ' ' ILE . 5.0 mp -120.48 128.37 76.0 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.272 0 CA-C-N 115.851 -0.613 . . . . 0.0 109.516 176.752 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' D' D ' 88' ' ' LEU . . . . . . . . . . . . . 16.6 tp -114.17 134.46 54.89 Favored 'General case' 0 C--N 1.331 -0.218 0 CA-C-O 121.066 0.46 . . . . 0.0 110.949 -177.652 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' D' D ' 89' ' ' ASP . . . . . . . . . . . . . 7.6 t70 -130.49 160.93 32.62 Favored 'General case' 0 C--N 1.332 -0.187 0 CA-C-N 115.849 -0.614 . . . . 0.0 109.734 177.046 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' D' D ' 90' ' ' GLU . . . . . . . . . . . . . 71.0 mm-40 -46.63 -40.11 12.45 Favored 'General case' 0 C--N 1.329 -0.289 0 N-CA-C 113.117 0.784 . . . . 0.0 113.117 -171.517 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' D' D ' 91' ' ' ASN . . . . . . . . . . . . . 82.4 m-20 -132.04 25.44 4.59 Favored 'General case' 0 N--CA 1.467 0.403 0 N-CA-C 112.665 0.617 . . . . 0.0 112.665 -177.015 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' D' D ' 92' ' ' LEU . . . . . . . . . . . . . 18.1 mt -149.76 143.36 25.36 Favored 'General case' 0 C--N 1.331 -0.223 0 CA-C-O 120.622 0.249 . . . . 0.0 110.382 -177.361 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' D' D ' 93' ' ' ILE . . . . . . . . . . . . . 73.4 mt -126.19 115.1 41.39 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.345 0 N-CA-C 109.19 -0.67 . . . . 0.0 109.19 176.022 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' D' D ' 94' ' ' VAL . . . . . 0.623 HG21 HG11 ' D' ' 125' ' ' VAL . 45.1 t -117.82 126.4 74.79 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.267 0 CA-C-O 120.878 0.371 . . . . 0.0 110.049 -177.857 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' D' D ' 95' ' ' VAL . . . . . . . . . . . . . 43.4 t -120.63 134.01 65.46 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 CA-C-N 115.918 -0.583 . . . . 0.0 109.824 179.978 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' D' D ' 96' ' ' ILE . . . . . 0.459 HD11 ' HB ' ' D' ' 123' ' ' VAL . 63.3 mt -112.58 126.88 70.03 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 N-CA-C 108.951 -0.759 . . . . 0.0 108.951 178.466 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' D' D ' 97' ' ' THR . . . . . . . . . . . . . 81.7 p -99.34 156.95 16.73 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-O 121.21 0.529 . . . . 0.0 111.154 -177.036 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' D' D ' 98' ' ' GLU . . . . . . . . . . . . . 45.9 tp10 -53.85 -27.61 30.9 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.193 -0.458 . . . . 0.0 112.182 -179.529 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' D' D ' 99' ' ' GLU . . . . . . . . . . . . . 40.8 tt0 -79.78 16.31 1.17 Allowed 'General case' 0 CA--C 1.538 0.517 0 N-CA-C 112.666 0.617 . . . . 0.0 112.666 -176.808 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' D' D ' 100' ' ' ASN . . . . . . . . . . . . . 4.2 m-20 61.24 34.37 18.74 Favored 'General case' 0 CA--C 1.531 0.245 0 O-C-N 121.749 -0.595 . . . . 0.0 111.399 177.828 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' D' D ' 101' ' ' GLU . . . . . . . . . . . . . 84.9 tt0 -111.79 145.65 39.02 Favored 'General case' 0 C--N 1.331 -0.2 0 N-CA-C 109.594 -0.521 . . . . 0.0 109.594 173.604 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' D' D ' 102' ' ' VAL . . . . . . . . . . . . . 45.5 t -114.93 125.98 72.39 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.356 0 CA-C-N 116.275 -0.421 . . . . 0.0 110.125 -177.502 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' D' D ' 103' ' ' LEU . . . . . . . . . . . . . 29.8 mt -117.55 128.28 54.81 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 115.794 -0.639 . . . . 0.0 110.232 177.441 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' D' D ' 104' ' ' ILE . . . . . . . . . . . . . 67.3 mt -119.45 122.18 68.3 Favored 'Isoleucine or valine' 0 C--O 1.235 0.299 0 N-CA-C 110.403 -0.221 . . . . 0.0 110.403 -179.612 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' D' D ' 105' ' ' PHE . . . . . . . . . . . . . 62.4 m-85 -120.78 165.16 15.53 Favored 'General case' 0 C--O 1.232 0.147 0 O-C-N 123.95 0.781 . . . . 0.0 109.804 179.126 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' D' D ' 106' ' ' ASN . . . . . . . . . . . . . 43.3 p-10 -99.56 -170.1 1.85 Allowed 'General case' 0 C--N 1.33 -0.249 0 N-CA-C 109.78 -0.452 . . . . 0.0 109.78 172.708 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' D' D ' 107' ' ' GLN . . . . . . . . . . . . . 50.9 tt0 -57.65 -29.79 64.88 Favored 'General case' 0 C--N 1.328 -0.337 0 N-CA-C 112.033 0.383 . . . . 0.0 112.033 179.707 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' D' D ' 108' ' ' ASN . . . . . . . . . . . . . 15.1 t-20 -88.07 13.43 11.18 Favored 'General case' 0 CA--C 1.535 0.386 0 N-CA-C 112.917 0.71 . . . . 0.0 112.917 -176.215 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' D' D ' 109' ' ' LEU . . . . . . . . . . . . . 29.4 mt 57.64 34.81 24.97 Favored 'General case' 0 CA--C 1.53 0.182 0 O-C-N 122.108 -0.37 . . . . 0.0 111.661 177.98 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' D' D ' 110' ' ' GLU . . . . . . . . . . . . . 43.3 mt-10 -101.3 153.99 19.17 Favored 'General case' 0 C--N 1.331 -0.235 0 N-CA-C 109.984 -0.376 . . . . 0.0 109.984 176.991 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' D' D ' 111' ' ' GLU . . . . . . . . . . . . . 80.6 tt0 -82.7 121.96 27.54 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.383 -0.371 . . . . 0.0 110.589 -178.246 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' D' D ' 112' ' ' LEU . . . . . . . . . . . . . 25.5 mt -110.92 -46.05 3.39 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 116.293 -0.412 . . . . 0.0 110.444 178.354 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' D' D ' 113' ' ' TYR . . . . . . . . . . . . . 46.8 t80 -137.93 136.3 36.89 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-O 120.839 0.352 . . . . 0.0 111.061 -179.679 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' D' D ' 114' ' ' ARG . . . . . . . . . . . . . 60.1 ttt180 -138.01 121.45 17.17 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 115.931 -0.577 . . . . 0.0 110.257 177.034 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' D' D ' 115' ' ' GLY . . . . . . . . . . . . . . . -150.07 162.44 29.19 Favored Glycine 0 CA--C 1.525 0.677 0 N-CA-C 110.977 -0.849 . . . . 0.0 110.977 179.506 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' D' D ' 116' ' ' LYS . . . . . . . . . . . . . 70.3 tttt -136.72 137.5 40.0 Favored 'General case' 0 C--N 1.328 -0.36 0 N-CA-C 110.124 -0.324 . . . . 0.0 110.124 178.762 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' D' D ' 117' ' ' PHE . . . . . . . . . . . . . 26.3 m-85 -135.61 117.59 15.29 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 116.403 -0.362 . . . . 0.0 110.198 -176.135 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' D' D ' 118' ' ' GLU . . . . . . . . . . . . . 96.0 mt-10 -54.17 -44.96 71.94 Favored 'General case' 0 C--N 1.33 -0.27 0 C-N-CA 120.937 -0.305 . . . . 0.0 111.392 -176.316 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' D' D ' 119' ' ' ASN . . . . . . . . . . . . . 3.2 m-20 -97.78 31.04 2.75 Favored 'General case' 0 C--N 1.329 -0.317 0 N-CA-C 112.143 0.423 . . . . 0.0 112.143 -174.838 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' D' D ' 120' ' ' LEU . . . . . . . . . . . . . 20.3 tp -56.48 122.61 12.35 Favored 'General case' 0 C--O 1.233 0.197 0 CA-C-O 120.587 0.232 . . . . 0.0 110.407 178.01 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' D' D ' 121' ' ' ASN . . . . . . . . . . . . . 53.4 m-20 -114.11 -44.13 3.17 Favored 'General case' 0 C--N 1.332 -0.18 0 CA-C-N 116.707 -0.224 . . . . 0.0 111.394 -176.325 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' D' D ' 122' ' ' LYS . . . . . . . . . . . . . 26.1 ttmt -149.97 147.52 27.97 Favored 'General case' 0 C--N 1.332 -0.177 0 C-N-CA 120.417 -0.513 . . . . 0.0 111.563 -176.312 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' D' D ' 123' ' ' VAL . . . . . 0.459 ' HB ' HD11 ' D' ' 96' ' ' ILE . 43.9 t -126.73 134.35 66.45 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.181 0 CA-C-N 116.038 -0.528 . . . . 0.0 109.731 177.742 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' D' D ' 124' ' ' LEU . . . . . . . . . . . . . 65.7 mt -130.08 142.7 50.58 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-O 120.809 0.338 . . . . 0.0 110.986 -178.275 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' D' D ' 125' ' ' VAL . . . . . 0.623 HG11 HG21 ' D' ' 94' ' ' VAL . 35.1 m -132.79 140.25 47.84 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.243 0 CA-C-N 116.26 -0.427 . . . . 0.0 110.569 178.416 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' D' D ' 126' ' ' ARG . . . . . . . . . . . . . 95.3 mtt-85 -144.26 119.09 9.89 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.443 -0.344 . . . . 0.0 110.617 178.74 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' D' D ' 127' ' ' ASN . . . . . . . . . . . . . 84.9 m-20 51.36 -104.98 0.19 Allowed 'General case' 0 CA--C 1.543 0.697 0 CA-C-O 119.095 -0.479 . . . . 0.0 111.334 179.707 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' D' D ' 128' ' ' ASP . . . . . . . . . . . . . 18.9 p-10 -114.19 1.35 14.51 Favored 'General case' 0 N--CA 1.468 0.442 0 CA-C-N 119.548 1.067 . . . . 0.0 113.371 -177.794 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' D' D ' 129' ' ' LEU . . . . . . . . . . . . . 58.8 mt -104.96 144.84 31.24 Favored 'General case' 0 C--N 1.334 -0.108 0 O-C-N 121.961 -0.462 . . . . 0.0 110.246 179.881 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' D' D ' 130' ' ' VAL . . . . . . . . . . . . . 42.4 t -124.48 139.56 50.38 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.214 0 CA-C-N 116.375 -0.375 . . . . 0.0 110.009 -178.107 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' D' D ' 131' ' ' VAL . . . . . 0.516 HG22 HD12 ' D' ' 140' ' ' LEU . 42.6 t -134.55 135.37 53.8 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.24 0 CA-C-O 121.065 0.459 . . . . 0.0 110.271 179.275 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' D' D ' 132' ' ' ILE . . . . . . . . . . . . . 73.2 mt -118.47 130.82 72.77 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.282 0 CA-C-N 115.657 -0.701 . . . . 0.0 109.354 179.068 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' D' D ' 133' ' ' ILE . . . . . 0.412 HG21 HG21 ' E' ' 86' ' ' VAL . 43.1 mm -115.83 121.95 68.45 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.249 0 CA-C-O 120.975 0.417 . . . . 0.0 110.912 -175.992 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' D' D ' 134' ' ' ASP . . . . . . . . . . . . . 7.2 p-10 -133.43 146.08 50.86 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 115.826 -0.625 . . . . 0.0 109.507 174.615 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' D' D ' 135' ' ' GLU . . . . . . . . . . . . . 85.9 tt0 -49.8 -23.02 1.64 Allowed 'General case' 0 C--N 1.328 -0.36 0 N-CA-C 113.022 0.749 . . . . 0.0 113.022 -171.573 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' D' D ' 136' ' ' GLN . . . . . . . . . . . . . 50.2 tt0 -100.18 -31.57 11.33 Favored 'General case' 0 N--CA 1.462 0.175 0 N-CA-C 112.342 0.497 . . . . 0.0 112.342 -176.07 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' D' D ' 137' ' ' LYS . . . . . . . . . . . . . 88.4 mttt -140.45 153.11 46.16 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-O 121.288 0.566 . . . . 0.0 111.644 -171.057 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' D' D ' 138' ' ' LEU . . . . . 0.418 ' C ' HD23 ' D' ' 138' ' ' LEU . 5.5 tt -116.87 120.52 38.72 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 115.488 -0.778 . . . . 0.0 109.017 171.733 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' D' D ' 139' ' ' THR . . . . . . . . . . . . . 30.5 m -108.38 128.11 54.48 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 116.322 -0.399 . . . . 0.0 110.744 -176.451 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' D' D ' 140' ' ' LEU . . . . . 0.516 HD12 HG22 ' D' ' 131' ' ' VAL . 14.0 tp -117.54 122.6 44.1 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 115.619 -0.719 . . . . 0.0 109.354 -178.811 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' D' D ' 141' ' ' ILE . . . . . . . . . . . . . 19.1 mt -120.92 119.64 60.02 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.274 0 N-CA-C 109.964 -0.384 . . . . 0.0 109.964 -175.404 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' D' D ' 142' ' ' ARG . . . . . . . . . . . . . 74.3 mtm180 -106.93 131.31 54.15 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 115.782 -0.645 . . . . 0.0 110.481 -178.318 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' D' D ' 143' ' ' THR . . . . . . . . . . . . . 44.6 p . . . . . 0 C--O 1.22 -0.466 0 CA-C-O 117.984 -1.008 . . . . 0.0 110.591 179.798 . . . . . . . . 0 0 . 1 . 007 nuclear nobuild full ' E' E ' -3' ' ' GLU . . . . . . . . . . . . . 96.0 mt-10 . . . . . 0 N--CA 1.49 1.529 0 N-CA-C 109.464 -0.569 . . . . 0.0 109.464 . . . . . . . . . 0 0 . 1 . 007 nuclear nobuild full ' E' E ' -2' ' ' GLY . . . . . . . . . . . . . . . -69.58 102.29 0.94 Allowed Glycine 0 CA--C 1.524 0.649 0 N-CA-C 111.182 -0.767 . . . . 0.0 111.182 -179.337 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' E' E ' -1' ' ' VAL . . . . . . . . . . . . . 44.1 t -141.91 142.35 28.22 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.262 0 N-CA-C 109.908 -0.404 . . . . 0.0 109.908 179.198 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' E' E ' 0' ' ' ILE . . . . . . . . . . . . . 70.4 mt -88.39 142.54 12.77 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.236 0 CA-C-N 116.31 -0.405 . . . . 0.0 110.265 -178.572 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' E' E ' 1' ' ' MET . . . . . . . . . . . . . 24.8 ptp -82.4 153.27 25.8 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.077 -0.511 . . . . 0.0 110.639 179.89 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' E' E ' 2' ' ' SER . . . . . . . . . . . . . 98.5 p -124.57 152.56 43.36 Favored 'General case' 0 C--O 1.232 0.155 0 CA-C-N 116.227 -0.442 . . . . 0.0 110.664 -179.516 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' E' E ' 3' ' ' GLU . . . . . . . . . . . . . 85.0 tt0 -140.33 144.73 36.48 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.107 -0.497 . . . . 0.0 111.109 -178.025 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' E' E ' 4' ' ' LEU . . . . . . . . . . . . . 16.3 tp -127.56 134.59 49.72 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 115.852 -0.613 . . . . 0.0 110.131 177.426 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' E' E ' 5' ' ' LYS . . . . . . . . . . . . . 68.9 mttm -115.23 122.67 46.7 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.635 -0.257 . . . . 0.0 110.997 -178.808 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' E' E ' 6' ' ' LEU . . . . . 0.429 HD23 ' HA ' ' E' ' 50' ' ' VAL . 58.5 mt -114.34 142.52 46.21 Favored 'General case' 0 N--CA 1.462 0.163 0 CA-C-N 115.564 -0.744 . . . . 0.0 110.095 178.601 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' E' E ' 7' ' ' LYS . . . . . . . . . . . . . 79.3 tttt -122.49 136.19 26.33 Favored Pre-proline 0 CA--C 1.534 0.348 0 CA-C-O 118.775 -0.631 . . . . 0.0 109.781 176.634 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' E' E ' 8' ' ' PRO . . . . . . . . . . . . . 89.4 Cg_endo -91.36 131.49 1.38 Allowed 'Trans proline' 0 N--CA 1.49 1.279 0 C-N-CA 121.741 1.627 . . . . 0.0 111.705 178.089 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' E' E ' 9' ' ' LEU . . . . . 0.406 HD12 ' HB2' ' E' ' 47' ' ' LYS . 59.4 mt -72.01 -47.86 11.11 Favored Pre-proline 0 CA--C 1.534 0.335 0 CA-C-O 118.563 -0.732 . . . . 0.0 112.286 -178.642 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' E' E ' 10' ' ' PRO . . . . . . . . . . . . . 95.1 Cg_endo -79.61 152.37 22.81 Favored 'Trans proline' 0 N--CA 1.497 1.713 0 C-N-CA 121.166 1.244 . . . . 0.0 111.916 177.145 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' E' E ' 11' ' ' LYS . . . . . . . . . . . . . 97.7 mttt -83.86 91.92 7.67 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.366 -0.379 . . . . 0.0 110.262 178.34 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' E' E ' 12' ' ' VAL . . . . . . . . . . . . . 12.2 p -139.0 145.15 28.05 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.257 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.476 -178.931 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' E' E ' 13' ' ' GLU . . . . . . . . . . . . . 44.6 mp0 -91.6 125.93 36.51 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.235 -0.439 . . . . 0.0 110.179 178.671 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' E' E ' 14' ' ' LEU . . . . . . . . . . . . . 20.8 mt -97.93 149.99 36.29 Favored Pre-proline 0 CA--C 1.532 0.287 0 CA-C-O 119.331 -0.366 . . . . 0.0 110.562 -178.843 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' E' E ' 15' ' ' PRO . . . . . . . . . . . . . 27.4 Cg_exo -61.02 158.74 32.76 Favored 'Trans proline' 0 N--CA 1.496 1.675 0 C-N-CA 121.317 1.345 . . . . 0.0 111.943 177.979 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' E' E ' 16' ' ' PRO . . . . . . . . . . . . . 29.8 Cg_exo -59.68 -34.85 96.15 Favored 'Trans proline' 0 N--CA 1.496 1.675 0 C-N-CA 121.403 1.402 . . . . 0.0 112.76 -178.938 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' E' E ' 17' ' ' ASP . . . . . . . . . . . . . 8.3 p-10 -85.03 4.73 32.49 Favored 'General case' 0 C--N 1.327 -0.401 0 N-CA-C 113.322 0.86 . . . . 0.0 113.322 -177.497 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' E' E ' 18' ' ' PHE . . . . . . . . . . . . . 44.0 t80 -57.95 -44.85 87.24 Favored 'General case' 0 N--CA 1.457 -0.091 0 O-C-N 121.836 -0.54 . . . . 0.0 110.187 -178.315 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' E' E ' 19' ' ' VAL . . . . . . . . . . . . . 46.6 t -56.78 -44.99 82.88 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 CA-C-N 116.152 -0.476 . . . . 0.0 110.544 -178.304 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' E' E ' 20' ' ' ASP . . . . . . . . . . . . . 80.1 m-20 -59.54 -41.9 91.12 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-O 120.772 0.32 . . . . 0.0 110.808 -177.233 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' E' E ' 21' ' ' VAL . . . . . . . . . . . . . 46.9 t -64.55 -46.79 91.6 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.284 0 C-N-CA 120.809 -0.356 . . . . 0.0 110.621 -177.801 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' E' E ' 22' ' ' ILE . . . . . 0.662 HG22 HD12 ' E' ' 26' ' ' LEU . 51.4 mm -57.26 -39.98 70.97 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.217 0 C-N-CA 120.902 -0.319 . . . . 0.0 110.774 -179.562 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' E' E ' 23' ' ' ARG . . . . . . . . . . . . . 34.2 ttp180 -56.91 -50.28 73.02 Favored 'General case' 0 N--CA 1.464 0.255 0 CA-C-O 121.08 0.466 . . . . 0.0 110.443 177.326 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' E' E ' 24' ' ' ILE . . . . . . . . . . . . . 70.6 mt -61.16 -38.65 80.17 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.327 0 CA-C-N 115.807 -0.633 . . . . 0.0 112.072 -176.739 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' E' E ' 25' ' ' LYS . . . . . . . . . . . . . 14.7 pttp -78.34 -36.42 46.29 Favored 'General case' 0 CA--C 1.534 0.348 0 C-N-CA 120.606 -0.437 . . . . 0.0 112.007 -174.049 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' E' E ' 26' ' ' LEU . . . . . 0.662 HD12 HG22 ' E' ' 22' ' ' ILE . 47.6 mt -79.74 -35.06 39.38 Favored 'General case' 0 C--N 1.33 -0.266 0 N-CA-C 113.046 0.758 . . . . 0.0 113.046 -173.022 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' E' E ' 27' ' ' GLN . . . . . . . . . . . . . 9.6 pt20 -46.82 139.75 5.18 Favored 'General case' 0 N--CA 1.468 0.465 0 N-CA-C 112.906 0.706 . . . . 0.0 112.906 -175.49 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' E' E ' 28' ' ' GLY . . . . . . . . . . . . . . . 100.54 -25.94 26.44 Favored Glycine 0 CA--C 1.533 1.166 0 CA-C-N 115.511 -0.768 . . . . 0.0 112.304 -177.991 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' E' E ' 29' ' ' LYS . . . . . . . . . . . . . 98.9 mttt -98.3 155.12 17.36 Favored 'General case' 0 C--N 1.332 -0.167 0 CA-C-N 117.423 0.611 . . . . 0.0 111.175 179.439 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' E' E ' 30' ' ' THR . . . . . . . . . . . . . 31.2 m -102.72 137.14 41.33 Favored 'General case' 0 C--N 1.331 -0.199 0 CA-C-N 116.105 -0.498 . . . . 0.0 110.204 177.069 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' E' E ' 31' ' ' VAL . . . . . . . . . . . . . 34.9 m -128.98 154.27 39.74 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.26 0 CA-C-N 116.444 -0.344 . . . . 0.0 110.816 -179.226 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' E' E ' 32' ' ' ARG . . . . . . . . . . . . . 94.8 mtt180 -131.67 149.08 52.61 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-O 121.179 0.514 . . . . 0.0 110.611 178.332 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' E' E ' 33' ' ' THR . . . . . . . . . . . . . 22.3 m -53.44 139.74 29.84 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.22 -0.446 . . . . 0.0 111.357 -179.382 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' E' E ' 34' ' ' GLY . . . . . . . . . . . . . . . 99.69 -17.12 57.94 Favored Glycine 0 CA--C 1.532 1.126 0 CA-C-O 119.62 -0.545 . . . . 0.0 113.263 179.36 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' E' E ' 35' ' ' ASP . . . . . . . . . . . . . 78.3 m-20 -66.67 148.5 51.82 Favored 'General case' 0 C--N 1.333 -0.152 0 CA-C-N 118.041 0.921 . . . . 0.0 111.078 178.934 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' E' E ' 36' ' ' VAL . . . . . . . . . . . . . 44.3 t -120.97 129.91 75.21 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.262 0 CA-C-N 115.933 -0.576 . . . . 0.0 109.785 178.236 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' E' E ' 37' ' ' ILE . . . . . . . . . . . . . 63.8 mt -119.79 136.96 55.23 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.257 0 N-CA-C 109.751 -0.463 . . . . 0.0 109.751 -179.636 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' E' E ' 38' ' ' GLY . . . . . . . . . . . . . . . -114.97 128.72 8.25 Favored Glycine 0 CA--C 1.524 0.644 0 N-CA-C 111.006 -0.838 . . . . 0.0 111.006 -179.77 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' E' E ' 39' ' ' ILE . . . . . . . . . . . . . 72.5 mt -126.47 127.67 70.63 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.232 0 N-CA-C 110.143 -0.317 . . . . 0.0 110.143 179.142 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' E' E ' 40' ' ' SER . . . . . . . . . . . . . 7.4 m -92.7 119.35 32.01 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.295 -0.411 . . . . 0.0 110.595 175.423 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' E' E ' 41' ' ' ILE . . . . . . . . . . . . . 69.3 mt -129.73 126.57 62.98 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.175 0 CA-C-O 120.951 0.405 . . . . 0.0 110.49 179.769 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' E' E ' 42' ' ' LEU . . . . . . . . . . . . . 30.7 mt 54.1 33.8 18.57 Favored 'General case' 0 C--N 1.331 -0.223 0 CA-C-N 116.033 -0.53 . . . . 0.0 111.781 177.395 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' E' E ' 43' ' ' GLY . . . . . . . . . . . . . . . 72.36 29.54 66.04 Favored Glycine 0 CA--C 1.529 0.936 0 C-N-CA 121.127 -0.559 . . . . 0.0 112.296 177.811 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' E' E ' 44' ' ' LYS . . . . . . . . . . . . . 83.6 tttt -139.43 126.92 21.61 Favored 'General case' 0 C--N 1.331 -0.225 0 N-CA-C 109.637 -0.505 . . . . 0.0 109.637 178.217 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' E' E ' 45' ' ' GLU . . . . . . . . . . . . . 47.1 tt0 -85.65 126.59 34.05 Favored 'General case' 0 C--N 1.327 -0.397 0 CA-C-N 116.229 -0.441 . . . . 0.0 111.539 -175.483 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' E' E ' 46' ' ' VAL . . . . . . . . . . . . . 9.9 p -123.21 126.08 72.9 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.198 0 N-CA-C 109.966 -0.383 . . . . 0.0 109.966 174.457 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' E' E ' 47' ' ' LYS . . . . . 0.406 ' HB2' HD12 ' E' ' 9' ' ' LEU . 33.8 mmtp -99.48 127.44 45.54 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 115.967 -0.561 . . . . 0.0 110.877 176.223 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' E' E ' 48' ' ' PHE . . . . . . . . . . . . . 34.6 m-85 -109.78 131.7 54.82 Favored 'General case' 0 C--N 1.329 -0.289 0 N-CA-C 109.444 -0.576 . . . . 0.0 109.444 175.506 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' E' E ' 49' ' ' LYS . . . . . . . . . . . . . 46.2 tttp -107.67 132.12 53.67 Favored 'General case' 0 C--N 1.327 -0.38 0 N-CA-C 110.08 -0.341 . . . . 0.0 110.08 178.081 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' E' E ' 50' ' ' VAL . . . . . 0.429 ' HA ' HD23 ' E' ' 6' ' ' LEU . 46.7 t -76.58 104.42 4.61 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.268 0 N-CA-C 109.188 -0.671 . . . . 0.0 109.188 177.022 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' E' E ' 51' ' ' VAL . . . . . . . . . . . . . 48.3 t -69.74 -52.94 27.02 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.363 0 N-CA-C 109.609 -0.515 . . . . 0.0 109.609 -174.959 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' E' E ' 52' ' ' GLN . . . . . . . . . . . . . 91.1 mt-30 -153.64 153.69 32.79 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-O 121.253 0.549 . . . . 0.0 111.783 -178.08 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' E' E ' 53' ' ' ALA . . . . . 0.444 ' HB3' ' OG ' ' E' ' 56' ' ' SER . . . -130.57 132.69 45.68 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 115.02 -0.991 . . . . 0.0 109.621 174.978 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' E' E ' 54' ' ' TYR . . . . . . . . . . . . . 40.4 t80 -129.0 107.65 18.1 Favored Pre-proline 0 CA--C 1.535 0.397 0 CA-C-O 118.138 -0.934 . . . . 0.0 110.36 179.893 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' E' E ' 55' ' ' PRO . . . . . . . . . . . . . 72.8 Cg_endo -77.17 168.07 77.94 Favored 'Cis proline' 0 N--CA 1.5 1.891 0 CA-C-N 121.783 1.672 . . . . 0.0 112.713 -5.278 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' E' E ' 56' ' ' SER . . . . . 0.444 ' OG ' ' HB3' ' E' ' 53' ' ' ALA . 68.4 m -118.2 132.89 23.54 Favored Pre-proline 0 CA--C 1.539 0.553 0 CA-C-O 118.377 -0.821 . . . . 0.0 109.463 173.77 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' E' E ' 57' ' ' PRO . . . . . . . . . . . . . 34.4 Cg_endo -66.19 163.97 66.91 Favored 'Cis proline' 0 N--CA 1.496 1.675 0 CA-C-N 121.95 1.732 . . . . 0.0 111.66 -1.788 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' E' E ' 58' ' ' LEU . . . . . . . . . . . . . 33.5 tp -130.07 136.83 49.79 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.104 -0.498 . . . . 0.0 110.281 -179.537 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' E' E ' 59' ' ' ARG . . . . . . . . . . . . . 41.8 ttm180 -102.72 123.58 46.67 Favored 'General case' 0 C--N 1.327 -0.403 0 CA-C-N 115.791 -0.64 . . . . 0.0 109.31 176.349 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' E' E ' 60' ' ' VAL . . . . . . . . . . . . . 45.8 t -71.99 116.97 14.7 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.294 0 C-N-CA 120.803 -0.359 . . . . 0.0 110.331 -174.584 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' E' E ' 61' ' ' GLU . . . . . . . . . . . . . 95.7 mt-10 -131.05 159.5 37.36 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 115.816 -0.629 . . . . 0.0 109.761 176.475 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' E' E ' 62' ' ' ASP . . . . . . . . . . . . . 13.8 t70 -52.48 -31.94 37.57 Favored 'General case' 0 C--N 1.328 -0.357 0 N-CA-C 111.953 0.353 . . . . 0.0 111.953 -179.209 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' E' E ' 63' ' ' ARG . . . . . . . . . . . . . 37.3 mtp180 -72.22 -21.89 61.34 Favored 'General case' 0 C--N 1.33 -0.281 0 N-CA-C 112.954 0.724 . . . . 0.0 112.954 -175.935 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' E' E ' 64' ' ' THR . . . . . . . . . . . . . 28.4 m -69.33 136.77 52.25 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-O 120.93 0.395 . . . . 0.0 110.865 -175.988 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' E' E ' 65' ' ' LYS . . . . . . . . . . . . . 92.1 mttt -89.31 127.91 35.83 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-N 115.97 -0.559 . . . . 0.0 109.917 177.987 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' E' E ' 66' ' ' ILE . . . . . . . . . . . . . 64.4 mt -114.49 129.33 70.73 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 N-CA-C 110.008 -0.368 . . . . 0.0 110.008 -179.705 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' E' E ' 67' ' ' THR . . . . . . . . . . . . . 30.2 m -122.74 142.27 50.89 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-O 121.16 0.505 . . . . 0.0 111.11 -177.644 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' E' E ' 68' ' ' LEU . . . . . . . . . . . . . 17.6 tp -101.56 125.84 48.28 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 115.563 -0.744 . . . . 0.0 109.898 177.491 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' E' E ' 69' ' ' VAL . . . . . . . . . . . . . 43.3 t -101.38 127.98 54.16 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.298 0 CA-C-N 116.333 -0.394 . . . . 0.0 110.174 -179.445 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' E' E ' 70' ' ' THR . . . . . . . . . . . . . 21.6 p -101.7 -52.26 3.24 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.137 -0.483 . . . . 0.0 110.602 179.689 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' E' E ' 71' ' ' HIS . . . . . . . . . . . . . 66.2 m80 -91.09 164.93 23.27 Favored Pre-proline 0 C--N 1.33 -0.257 0 CA-C-N 116.25 -0.432 . . . . 0.0 110.712 -179.471 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' E' E ' 72' ' ' PRO . . . . . . . . . . . . . 16.9 Cg_exo -64.91 -21.81 63.65 Favored 'Trans proline' 0 N--CA 1.497 1.696 0 C-N-CA 121.521 1.481 . . . . 0.0 113.081 -179.012 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' E' E ' 73' ' ' VAL . . . . . . . . . . . . . 27.0 m -99.89 163.63 2.82 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.222 0 CA-C-O 120.893 0.378 . . . . 0.0 110.752 -179.162 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' E' E ' 74' ' ' ASP . . . . . . . . . . . . . 28.2 t0 -98.77 119.6 37.78 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.028 -0.533 . . . . 0.0 110.023 -178.762 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' E' E ' 75' ' ' VAL . . . . . . . . . . . . . 42.7 t -112.64 123.43 68.32 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.256 0 CA-C-O 120.987 0.422 . . . . 0.0 110.427 -178.263 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' E' E ' 76' ' ' LEU . . . . . . . . . . . . . 27.0 mt -125.02 142.64 51.36 Favored 'General case' 0 C--N 1.331 -0.239 0 CA-C-N 115.842 -0.617 . . . . 0.0 109.772 177.492 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' E' E ' 77' ' ' GLU . . . . . . . . . . . . . 97.6 mt-10 -135.22 131.24 36.42 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-O 121.005 0.431 . . . . 0.0 111.123 -177.747 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' E' E ' 78' ' ' ALA . . . . . . . . . . . . . . . -118.06 135.86 53.92 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 115.814 -0.63 . . . . 0.0 109.67 176.588 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' E' E ' 79' ' ' LYS . . . . . 0.594 ' O ' HD13 ' E' ' 80' ' ' ILE . 90.0 mttt -79.65 118.46 21.5 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-O 121.003 0.43 . . . . 0.0 110.677 -178.864 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' E' E ' 80' ' ' ILE . . . . . 0.594 HD13 ' O ' ' E' ' 79' ' ' LYS . 41.1 mm -139.12 114.09 8.15 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.376 0 N-CA-C 108.944 -0.761 . . . . 0.0 108.944 -178.502 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' E' E ' 81' ' ' LYS . . . . . . . . . . . . . 56.2 pttt -111.06 129.46 55.91 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-O 121.009 0.433 . . . . 0.0 111.628 -174.253 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' E' E ' 82' ' ' GLY . . . . . . . . . . . . . . . 89.13 42.04 5.7 Favored Glycine 0 CA--C 1.526 0.728 0 N-CA-C 111.524 -0.63 . . . . 0.0 111.524 175.974 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' E' E ' 83' ' ' ILE . . . . . . . . . . . . . 69.1 mt -74.23 138.62 20.76 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.342 0 N-CA-C 109.833 -0.432 . . . . 0.0 109.833 178.145 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' E' E ' 84' ' ' LYS . . . . . . . . . . . . . 39.4 ttpt -102.49 -47.4 4.47 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.302 -0.408 . . . . 0.0 110.163 -179.756 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' E' E ' 85' ' ' ASP . . . . . . . . . . . . . 45.5 t0 -148.91 147.06 28.21 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 115.987 -0.551 . . . . 0.0 110.608 179.876 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' E' E ' 86' ' ' VAL . . . . . 0.412 HG21 HG21 ' D' ' 133' ' ' ILE . 42.4 t -127.84 131.46 69.73 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.266 0 CA-C-O 120.902 0.382 . . . . 0.0 110.404 -179.208 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' E' E ' 87' ' ' ILE . . . . . . . . . . . . . 46.7 mm -121.4 125.12 73.26 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.271 0 CA-C-N 115.955 -0.566 . . . . 0.0 109.686 176.772 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' E' E ' 88' ' ' LEU . . . . . . . . . . . . . 18.3 tp -114.26 130.49 56.65 Favored 'General case' 0 C--N 1.332 -0.163 0 CA-C-O 120.924 0.392 . . . . 0.0 111.074 -177.445 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' E' E ' 89' ' ' ASP . . . . . . . . . . . . . 13.0 t70 -127.33 154.79 44.52 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 115.957 -0.565 . . . . 0.0 109.896 177.16 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' E' E ' 90' ' ' GLU . . . . . . . . . . . . . 96.8 mt-10 -48.1 -36.93 14.15 Favored 'General case' 0 C--N 1.329 -0.313 0 N-CA-C 112.923 0.712 . . . . 0.0 112.923 -172.722 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' E' E ' 91' ' ' ASN . . . . . . . . . . . . . 87.6 m-20 -132.0 33.76 3.89 Favored 'General case' 0 N--CA 1.465 0.31 0 N-CA-C 111.939 0.348 . . . . 0.0 111.939 -175.942 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' E' E ' 92' ' ' LEU . . . . . . . . . . . . . 17.3 tp -166.12 141.66 4.77 Favored 'General case' 0 C--N 1.329 -0.308 0 C-N-CA 121.027 -0.269 . . . . 0.0 110.719 179.46 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' E' E ' 93' ' ' ILE . . . . . . . . . . . . . 72.8 mt -121.86 120.42 61.48 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.27 0 N-CA-C 109.138 -0.69 . . . . 0.0 109.138 178.017 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' E' E ' 94' ' ' VAL . . . . . . . . . . . . . 47.1 t -121.4 125.74 74.03 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.261 0 CA-C-O 121.052 0.453 . . . . 0.0 109.986 -177.763 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' E' E ' 95' ' ' VAL . . . . . . . . . . . . . 43.0 t -121.27 132.81 69.7 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.245 0 CA-C-N 115.873 -0.603 . . . . 0.0 109.847 -179.257 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' E' E ' 96' ' ' ILE . . . . . . . . . . . . . 66.7 mt -115.48 124.19 71.72 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.273 0 N-CA-C 109.147 -0.686 . . . . 0.0 109.147 178.395 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' E' E ' 97' ' ' THR . . . . . . . . . . . . . 77.1 p -99.9 155.02 17.9 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-O 121.523 0.678 . . . . 0.0 111.595 -174.657 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' E' E ' 98' ' ' GLU . . . . . . . . . . . . . 84.7 tt0 -54.03 -26.72 27.87 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 115.548 -0.751 . . . . 0.0 112.141 179.726 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' E' E ' 99' ' ' GLU . . . . . . . . . . . . . 96.3 mt-10 -79.76 16.72 1.06 Allowed 'General case' 0 CA--C 1.537 0.454 0 N-CA-C 113.126 0.788 . . . . 0.0 113.126 -177.369 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' E' E ' 100' ' ' ASN . . . . . . . . . . . . . 4.2 m-20 62.81 37.38 12.39 Favored 'General case' 0 CA--C 1.53 0.198 0 CA-C-O 121.073 0.463 . . . . 0.0 111.048 178.168 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' E' E ' 101' ' ' GLU . . . . . . . . . . . . . 84.7 tt0 -116.46 143.98 44.89 Favored 'General case' 0 C--N 1.333 -0.139 0 CA-C-N 116.159 -0.473 . . . . 0.0 109.909 176.939 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' E' E ' 102' ' ' VAL . . . . . . . . . . . . . 46.4 t -115.0 125.68 72.38 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.27 0 N-CA-C 109.803 -0.443 . . . . 0.0 109.803 -179.468 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' E' E ' 103' ' ' LEU . . . . . . . . . . . . . 27.7 mt -118.94 128.69 54.65 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-N 115.732 -0.667 . . . . 0.0 110.251 177.783 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' E' E ' 104' ' ' ILE . . . . . 0.61 HD13 HG21 ' E' ' 130' ' ' VAL . 66.4 mt -117.66 122.67 70.36 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.2 0 N-CA-C 110.028 -0.36 . . . . 0.0 110.028 179.787 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' E' E ' 105' ' ' PHE . . . . . . . . . . . . . 91.6 m-85 -122.75 166.08 15.53 Favored 'General case' 0 N--CA 1.462 0.129 0 O-C-N 123.999 0.812 . . . . 0.0 110.131 -179.464 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' E' E ' 106' ' ' ASN . . . . . . . . . . . . . 48.7 p-10 -102.94 -172.59 2.14 Favored 'General case' 0 C--N 1.331 -0.196 0 N-CA-C 109.888 -0.412 . . . . 0.0 109.888 172.378 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' E' E ' 107' ' ' GLN . . . . . . . . . . . . . 53.3 tp60 -59.16 -27.9 66.1 Favored 'General case' 0 C--N 1.329 -0.294 0 N-CA-C 112.239 0.459 . . . . 0.0 112.239 -178.586 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' E' E ' 108' ' ' ASN . . . . . . . . . . . . . 8.4 t-20 -88.24 14.06 10.17 Favored 'General case' 0 CA--C 1.533 0.306 0 N-CA-C 112.92 0.711 . . . . 0.0 112.92 -176.918 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' E' E ' 109' ' ' LEU . . . . . . . . . . . . . 41.4 mt 57.99 34.53 24.36 Favored 'General case' 0 CA--C 1.531 0.224 0 CA-C-O 120.718 0.294 . . . . 0.0 111.643 178.514 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' E' E ' 110' ' ' GLU . . . . . . . . . . . . . 43.5 mt-10 -101.49 154.51 18.76 Favored 'General case' 0 C--N 1.33 -0.272 0 N-CA-C 109.28 -0.637 . . . . 0.0 109.28 174.968 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' E' E ' 111' ' ' GLU . . . . . . . . . . . . . 41.6 tt0 -90.96 121.83 33.12 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-O 121.048 0.451 . . . . 0.0 110.987 -175.444 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' E' E ' 112' ' ' LEU . . . . . . . . . . . . . 90.4 mt -101.23 -46.15 5.13 Favored 'General case' 0 C--N 1.332 -0.195 0 CA-C-N 115.803 -0.635 . . . . 0.0 110.388 178.675 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' E' E ' 113' ' ' TYR . . . . . 0.402 ' HB3' HD12 ' E' ' 104' ' ' ILE . 59.8 t80 -139.17 136.56 35.2 Favored 'General case' 0 C--N 1.331 -0.211 0 CA-C-N 116.174 -0.467 . . . . 0.0 111.355 -177.475 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' E' E ' 114' ' ' ARG . . . . . . . . . . . . . 57.3 ttp180 -135.05 120.15 18.75 Favored 'General case' 0 C--N 1.331 -0.22 0 CA-C-N 115.943 -0.572 . . . . 0.0 110.107 177.239 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' E' E ' 115' ' ' GLY . . . . . . . . . . . . . . . -150.07 149.39 21.29 Favored Glycine 0 CA--C 1.524 0.617 0 N-CA-C 111.073 -0.811 . . . . 0.0 111.073 178.281 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' E' E ' 116' ' ' LYS . . . . . . . . . . . . . 34.3 ttmt -125.8 136.45 53.13 Favored 'General case' 0 C--N 1.33 -0.266 0 N-CA-C 109.977 -0.379 . . . . 0.0 109.977 176.042 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' E' E ' 117' ' ' PHE . . . . . . . . . . . . . 40.1 m-85 -129.65 115.97 18.14 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.167 -0.47 . . . . 0.0 110.136 -176.584 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' E' E ' 118' ' ' GLU . . . . . . . . . . . . . 85.4 tt0 -53.7 -46.18 70.63 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.493 -0.322 . . . . 0.0 111.451 -177.133 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' E' E ' 119' ' ' ASN . . . . . . . . . . . . . 86.7 m-20 -96.99 31.07 2.49 Favored 'General case' 0 C--N 1.331 -0.2 0 N-CA-C 112.11 0.411 . . . . 0.0 112.11 -175.8 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' E' E ' 120' ' ' LEU . . . . . . . . . . . . . 10.4 tp -56.12 121.06 8.55 Favored 'General case' 0 C--N 1.332 -0.161 0 O-C-N 122.313 -0.242 . . . . 0.0 110.449 178.343 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' E' E ' 121' ' ' ASN . . . . . . . . . . . . . 31.1 m120 -113.82 -44.07 3.21 Favored 'General case' 0 C--N 1.331 -0.217 0 CA-C-N 116.734 -0.212 . . . . 0.0 111.245 -175.765 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' E' E ' 122' ' ' LYS . . . . . . . . . . . . . 97.9 mttt -146.5 147.3 31.04 Favored 'General case' 0 C--N 1.332 -0.194 0 C-N-CA 120.488 -0.485 . . . . 0.0 111.389 -177.705 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' E' E ' 123' ' ' VAL . . . . . 0.512 ' C ' HD12 ' E' ' 124' ' ' LEU . 44.6 t -130.61 129.11 64.11 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.252 0 CA-C-N 115.982 -0.554 . . . . 0.0 109.678 176.759 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' E' E ' 124' ' ' LEU . . . . . 0.512 HD12 ' C ' ' E' ' 123' ' ' VAL . 6.5 mp -126.49 131.06 51.71 Favored 'General case' 0 C--N 1.331 -0.205 0 N-CA-C 109.999 -0.371 . . . . 0.0 109.999 -179.513 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' E' E ' 125' ' ' VAL . . . . . . . . . . . . . 33.7 m -139.7 137.02 39.8 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.342 0 CA-C-O 120.766 0.317 . . . . 0.0 110.792 -179.071 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' E' E ' 126' ' ' ARG . . . . . . . . . . . . . 74.5 ttt-85 -143.91 127.73 17.28 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.708 -179.683 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' E' E ' 127' ' ' ASN . . . . . . . . . . . . . 4.6 m120 51.24 -106.62 0.26 Allowed 'General case' 0 CA--C 1.544 0.713 0 CA-C-O 118.982 -0.532 . . . . 0.0 111.594 179.064 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' E' E ' 128' ' ' ASP . . . . . . . . . . . . . 23.7 p-10 -114.16 1.86 14.69 Favored 'General case' 0 CA--C 1.536 0.406 0 CA-C-N 119.675 1.125 . . . . 0.0 113.582 -175.854 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' E' E ' 129' ' ' LEU . . . . . . . . . . . . . 13.5 tp -112.79 136.43 52.41 Favored 'General case' 0 C--N 1.333 -0.135 0 N-CA-C 109.771 -0.455 . . . . 0.0 109.771 179.605 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' E' E ' 130' ' ' VAL . . . . . 0.61 HG21 HD13 ' E' ' 104' ' ' ILE . 32.4 m -132.74 142.89 41.22 Favored 'Isoleucine or valine' 0 C--O 1.233 0.198 0 CA-C-O 121.115 0.484 . . . . 0.0 110.976 -179.18 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' E' E ' 131' ' ' VAL . . . . . . . . . . . . . 41.4 t -136.12 138.63 46.98 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.338 0 CA-C-N 115.986 -0.552 . . . . 0.0 109.981 178.37 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' E' E ' 132' ' ' ILE . . . . . . . . . . . . . 74.1 mt -113.57 133.75 58.52 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.312 0 CA-C-N 115.665 -0.698 . . . . 0.0 109.508 -179.568 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' E' E ' 133' ' ' ILE . . . . . . . . . . . . . 42.6 mm -116.04 122.62 69.99 Favored 'Isoleucine or valine' 0 C--O 1.233 0.225 0 CA-C-O 120.991 0.424 . . . . 0.0 110.928 -176.18 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' E' E ' 134' ' ' ASP . . . . . . . . . . . . . 10.5 p-10 -134.86 147.59 49.92 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 115.84 -0.618 . . . . 0.0 109.537 174.625 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' E' E ' 135' ' ' GLU . . . . . . . . . . . . . 84.6 tt0 -49.76 -26.64 4.04 Favored 'General case' 0 C--N 1.325 -0.463 0 N-CA-C 112.811 0.671 . . . . 0.0 112.811 -171.627 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' E' E ' 136' ' ' GLN . . . . . . . . . . . . . 96.8 mt-30 -83.6 -37.88 22.34 Favored 'General case' 0 C--O 1.234 0.243 0 N-CA-C 112.332 0.493 . . . . 0.0 112.332 -176.243 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' E' E ' 137' ' ' LYS . . . . . . . . . . . . . 19.5 pttp -159.91 174.09 14.93 Favored 'General case' 0 C--N 1.331 -0.209 0 CA-C-O 121.51 0.671 . . . . 0.0 112.296 -171.834 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' E' E ' 138' ' ' LEU . . . . . 0.424 ' C ' HD23 ' E' ' 138' ' ' LEU . 8.1 tt -121.91 130.5 53.39 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 114.926 -1.034 . . . . 0.0 109.732 177.599 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' E' E ' 139' ' ' THR . . . . . . . . . . . . . 40.8 m -113.07 125.51 54.46 Favored 'General case' 0 C--N 1.331 -0.23 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.716 -178.558 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' E' E ' 140' ' ' LEU . . . . . 0.484 ' C ' HD23 ' E' ' 140' ' ' LEU . 8.7 tt -107.65 122.57 46.98 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 115.636 -0.711 . . . . 0.0 109.288 -179.502 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' E' E ' 141' ' ' ILE . . . . . 0.509 ' HB ' HG23 ' E' ' 130' ' ' VAL . 19.2 mt -125.07 118.87 54.25 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.288 0 CA-C-O 121.066 0.46 . . . . 0.0 109.886 -177.692 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' E' E ' 142' ' ' ARG . . . . . . . . . . . . . 77.4 ttt-85 -110.94 119.3 38.62 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 115.474 -0.785 . . . . 0.0 109.822 -179.428 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' E' E ' 143' ' ' THR . . . . . . . . . . . . . 71.4 p . . . . . 0 C--O 1.221 -0.442 0 CA-C-O 117.951 -1.023 . . . . 0.0 110.623 -178.14 . . . . . . . . 0 0 . 1 . 007 nuclear nobuild full ' F' F ' -3' ' ' GLU . . . . . . . . . . . . . 70.5 mm-40 . . . . . 0 N--CA 1.49 1.531 0 N-CA-C 109.388 -0.597 . . . . 0.0 109.388 . . . . . . . . . 0 0 . 1 . 007 nuclear nobuild full ' F' F ' -2' ' ' GLY . . . . . . . . . . . . . . . -77.62 130.85 10.58 Favored Glycine 0 CA--C 1.525 0.71 0 N-CA-C 110.875 -0.89 . . . . 0.0 110.875 179.448 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' F' F ' -1' ' ' VAL . . . . . . . . . . . . . 43.0 t -96.61 129.45 46.65 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.34 0 CA-C-O 120.789 0.328 . . . . 0.0 110.335 -179.786 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' F' F ' 0' ' ' ILE . . . . . . . . . . . . . 71.3 mt -124.57 143.01 39.53 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.164 0 CA-C-N 116.302 -0.408 . . . . 0.0 109.931 -179.888 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' F' F ' 1' ' ' MET . . . . . . . . . . . . . 25.3 ptp -91.02 146.28 23.99 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.312 -0.404 . . . . 0.0 110.691 179.826 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' F' F ' 2' ' ' SER . . . . . . . . . . . . . 2.2 p -122.52 125.24 45.35 Favored 'General case' 0 C--N 1.331 -0.227 0 CA-C-O 121.096 0.474 . . . . 0.0 110.564 178.426 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' F' F ' 3' ' ' GLU . . . . . . . . . . . . . 85.1 tt0 -144.49 144.56 31.41 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-N 115.942 -0.572 . . . . 0.0 111.184 -178.973 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' F' F ' 4' ' ' LEU . . . . . 0.444 HD21 HD21 ' F' ' 6' ' ' LEU . 12.1 tp -126.11 135.32 51.57 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 115.782 -0.645 . . . . 0.0 110.292 178.092 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' F' F ' 5' ' ' LYS . . . . . . . . . . . . . 98.9 mttt -111.37 121.57 45.59 Favored 'General case' 0 C--O 1.235 0.316 0 CA-C-N 116.345 -0.389 . . . . 0.0 110.505 179.764 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' F' F ' 6' ' ' LEU . . . . . 0.444 HD21 HD21 ' F' ' 4' ' ' LEU . 78.7 mt -116.93 147.24 42.4 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 115.735 -0.666 . . . . 0.0 110.538 -178.981 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' F' F ' 7' ' ' LYS . . . . . . . . . . . . . 55.0 tttt -137.45 140.38 30.27 Favored Pre-proline 0 CA--C 1.534 0.328 0 CA-C-O 119.201 -0.428 . . . . 0.0 110.1 177.035 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' F' F ' 8' ' ' PRO . . . . . . . . . . . . . 93.5 Cg_endo -91.55 143.2 2.95 Favored 'Trans proline' 0 N--CA 1.49 1.303 0 C-N-CA 121.764 1.643 . . . . 0.0 111.717 177.781 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' F' F ' 9' ' ' LEU . . . . . . . . . . . . . 41.6 mt -79.81 -47.41 1.45 Allowed Pre-proline 0 CA--C 1.535 0.373 0 CA-C-O 118.686 -0.673 . . . . 0.0 112.42 -178.594 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' F' F ' 10' ' ' PRO . . . . . . . . . . . . . 86.1 Cg_endo -80.67 155.98 21.11 Favored 'Trans proline' 0 N--CA 1.496 1.638 0 C-N-CA 121.243 1.296 . . . . 0.0 111.951 176.252 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' F' F ' 11' ' ' LYS . . . . . . . . . . . . . 53.9 tptt -88.01 99.32 12.07 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.393 -0.367 . . . . 0.0 110.39 179.094 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' F' F ' 12' ' ' VAL . . . . . . . . . . . . . 11.9 p -145.94 143.21 21.51 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.305 0 CA-C-N 116.118 -0.492 . . . . 0.0 110.378 179.03 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' F' F ' 13' ' ' GLU . . . . . . . . . . . . . 43.8 mt-10 -85.91 124.27 32.19 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.373 -0.376 . . . . 0.0 110.219 177.677 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' F' F ' 14' ' ' LEU . . . . . . . . . . . . . 18.7 mt -94.76 152.19 39.59 Favored Pre-proline 0 C--N 1.329 -0.298 0 CA-C-N 116.315 -0.402 . . . . 0.0 110.544 -178.695 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' F' F ' 15' ' ' PRO . . . . . . . . . . . . . 39.7 Cg_exo -58.43 157.31 27.19 Favored 'Trans proline' 0 N--CA 1.498 1.752 0 C-N-CA 121.235 1.29 . . . . 0.0 111.796 179.586 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' F' F ' 16' ' ' PRO . . . . . . . . . . . . . 32.1 Cg_exo -59.5 -37.92 86.21 Favored 'Trans proline' 0 N--CA 1.497 1.729 0 C-N-CA 121.42 1.414 . . . . 0.0 112.672 -178.182 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' F' F ' 17' ' ' ASP . . . . . . . . . . . . . 15.2 p-10 -87.59 11.25 15.48 Favored 'General case' 0 CA--C 1.535 0.387 0 N-CA-C 113.074 0.768 . . . . 0.0 113.074 -178.149 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' F' F ' 18' ' ' PHE . . . . . . . . . . . . . 45.2 t80 -58.28 -43.33 87.92 Favored 'General case' 0 CA--C 1.522 -0.114 0 O-C-N 121.863 -0.523 . . . . 0.0 110.089 -178.524 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' F' F ' 19' ' ' VAL . . . . . . . . . . . . . 46.8 t -55.54 -42.77 69.81 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.323 0 CA-C-N 116.354 -0.384 . . . . 0.0 110.675 -178.583 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' F' F ' 20' ' ' ASP . . . . . . . . . . . . . 81.2 m-20 -60.2 -44.94 94.71 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-O 120.859 0.362 . . . . 0.0 110.857 -177.97 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' F' F ' 21' ' ' VAL . . . . . . . . . . . . . 48.7 t -64.13 -46.71 92.83 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.309 0 C-N-CA 120.788 -0.365 . . . . 0.0 110.547 -177.52 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' F' F ' 22' ' ' ILE . . . . . 0.461 HG22 HD12 ' F' ' 26' ' ' LEU . 49.4 mm -55.88 -46.63 80.25 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.257 0 CA-C-O 120.633 0.254 . . . . 0.0 110.597 179.375 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' F' F ' 23' ' ' ARG . . . . . . . . . . . . . 53.9 ttp180 -54.11 -47.91 71.32 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-O 120.607 0.242 . . . . 0.0 111.349 -178.502 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' F' F ' 24' ' ' ILE . . . . . . . . . . . . . 72.2 mt -59.12 -44.51 91.76 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.285 0 CA-C-N 116.677 -0.238 . . . . 0.0 111.098 -178.405 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' F' F ' 25' ' ' LYS . . . . . . . . . . . . . 67.6 mttm -65.05 -39.75 93.75 Favored 'General case' 0 C--N 1.328 -0.339 0 N-CA-C 112.429 0.529 . . . . 0.0 112.429 -177.977 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' F' F ' 26' ' ' LEU . . . . . 0.461 HD12 HG22 ' F' ' 22' ' ' ILE . 63.6 mt -78.62 -43.27 26.71 Favored 'General case' 0 C--N 1.331 -0.229 0 N-CA-C 112.882 0.697 . . . . 0.0 112.882 -171.824 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' F' F ' 27' ' ' GLN . . . . . . . . . . . . . 10.5 pt20 -46.73 139.4 5.33 Favored 'General case' 0 N--CA 1.467 0.41 0 N-CA-C 112.883 0.697 . . . . 0.0 112.883 -174.641 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' F' F ' 28' ' ' GLY . . . . . . . . . . . . . . . 99.82 -25.57 27.76 Favored Glycine 0 CA--C 1.533 1.199 0 CA-C-N 115.472 -0.786 . . . . 0.0 112.197 -176.154 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' F' F ' 29' ' ' LYS . . . . . . . . . . . . . 91.4 mttt -98.0 155.22 17.21 Favored 'General case' 0 C--O 1.233 0.197 0 CA-C-N 117.242 0.521 . . . . 0.0 110.929 178.091 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' F' F ' 30' ' ' THR . . . . . . . . . . . . . 26.0 m -107.28 134.57 50.16 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 115.894 -0.594 . . . . 0.0 109.565 173.9 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' F' F ' 31' ' ' VAL . . . . . . . . . . . . . 34.9 m -125.98 153.5 34.18 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.214 0 CA-C-O 120.924 0.393 . . . . 0.0 110.938 -176.978 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' F' F ' 32' ' ' ARG . . . . . . . . . . . . . 47.8 ttp180 -126.46 147.07 49.86 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 116.044 -0.525 . . . . 0.0 110.334 179.421 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' F' F ' 33' ' ' THR . . . . . . . . . . . . . 15.8 m -52.84 138.74 28.86 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.323 -0.399 . . . . 0.0 111.46 -177.514 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' F' F ' 34' ' ' GLY . . . . . . . . . . . . . . . 101.17 -17.22 56.23 Favored Glycine 0 CA--C 1.535 1.287 0 CA-C-O 119.662 -0.521 . . . . 0.0 113.253 179.248 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' F' F ' 35' ' ' ASP . . . . . . . . . . . . . 78.5 m-20 -66.06 149.06 50.85 Favored 'General case' 0 N--CA 1.461 0.11 0 CA-C-N 117.947 0.873 . . . . 0.0 110.938 178.645 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' F' F ' 36' ' ' VAL . . . . . . . . . . . . . 44.1 t -122.25 131.99 72.01 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.219 0 CA-C-N 116.034 -0.53 . . . . 0.0 109.967 179.178 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' F' F ' 37' ' ' ILE . . . . . . . . . . . . . 66.0 mt -120.76 139.3 48.43 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.247 0 CA-C-N 115.973 -0.558 . . . . 0.0 109.667 179.7 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' F' F ' 38' ' ' GLY . . . . . . . . . . . . . . . -114.49 128.9 8.41 Favored Glycine 0 CA--C 1.525 0.686 0 N-CA-C 111.371 -0.692 . . . . 0.0 111.371 -178.536 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' F' F ' 39' ' ' ILE . . . . . . . . . . . . . 72.1 mt -125.19 129.41 73.2 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.188 0 N-CA-C 109.896 -0.409 . . . . 0.0 109.896 178.014 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' F' F ' 40' ' ' SER . . . . . . . . . . . . . 28.8 t -92.47 121.82 34.31 Favored 'General case' 0 C--N 1.329 -0.301 0 C-N-CA 120.997 -0.281 . . . . 0.0 110.834 176.935 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' F' F ' 41' ' ' ILE . . . . . . . . . . . . . 72.9 mt -133.98 124.96 47.84 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.224 0 CA-C-O 120.774 0.321 . . . . 0.0 110.253 179.304 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' F' F ' 42' ' ' LEU . . . . . . . . . . . . . 60.6 mt 58.29 33.65 23.33 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-N 116.145 -0.48 . . . . 0.0 111.798 178.082 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' F' F ' 43' ' ' GLY . . . . . . . . . . . . . . . 77.66 -10.23 25.37 Favored Glycine 0 CA--C 1.536 1.361 0 C-N-CA 121.268 -0.492 . . . . 0.0 113.456 178.203 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' F' F ' 44' ' ' LYS . . . . . . . . . . . . . 27.1 mtpp -100.52 130.58 46.61 Favored 'General case' 0 C--N 1.332 -0.171 0 CA-C-N 117.852 0.826 . . . . 0.0 109.891 176.937 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' F' F ' 45' ' ' GLU . . . . . . . . . . . . . 38.2 tp10 -84.53 128.46 34.61 Favored 'General case' 0 C--N 1.33 -0.271 0 C-N-CA 120.884 -0.326 . . . . 0.0 110.808 179.877 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' F' F ' 46' ' ' VAL . . . . . . . . . . . . . 7.6 p -119.89 128.57 75.93 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.242 0 N-CA-C 109.702 -0.481 . . . . 0.0 109.702 177.543 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' F' F ' 47' ' ' LYS . . . . . . . . . . . . . 64.9 mttp -100.25 130.17 46.34 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 115.948 -0.569 . . . . 0.0 111.214 178.975 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' F' F ' 48' ' ' PHE . . . . . . . . . . . . . 92.2 m-85 -113.46 131.87 55.87 Favored 'General case' 0 C--N 1.33 -0.267 0 N-CA-C 109.721 -0.474 . . . . 0.0 109.721 176.024 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' F' F ' 49' ' ' LYS . . . . . . . . . . . . . 54.1 tttm -107.83 137.79 45.22 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.545 -0.298 . . . . 0.0 110.622 179.197 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' F' F ' 50' ' ' VAL . . . . . . . . . . . . . 44.5 t -79.17 107.23 11.39 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.282 0 N-CA-C 109.179 -0.674 . . . . 0.0 109.179 175.22 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' F' F ' 51' ' ' VAL . . . . . . . . . . . . . 46.0 t -70.52 -52.78 26.24 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.339 0 CA-C-N 115.934 -0.576 . . . . 0.0 109.585 -174.664 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' F' F ' 52' ' ' GLN . . . . . . . . . . . . . 46.9 mt-30 -155.73 153.6 30.18 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.058 -0.519 . . . . 0.0 111.669 -177.527 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' F' F ' 53' ' ' ALA . . . . . 0.446 ' HB1' ' HB2' ' F' ' 58' ' ' LEU . . . -128.97 132.44 47.57 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 115.292 -0.867 . . . . 0.0 109.889 175.546 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' F' F ' 54' ' ' TYR . . . . . . . . . . . . . 27.1 t80 -129.01 107.71 18.08 Favored Pre-proline 0 CA--C 1.535 0.378 0 CA-C-O 118.238 -0.887 . . . . 0.0 110.43 -179.849 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' F' F ' 55' ' ' PRO . . . . . . . . . . . . . 73.7 Cg_endo -77.1 170.1 72.53 Favored 'Cis proline' 0 N--CA 1.5 1.862 0 CA-C-N 121.787 1.674 . . . . 0.0 112.364 -5.812 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' F' F ' 56' ' ' SER . . . . . . . . . . . . . 45.5 m -115.61 131.44 23.65 Favored Pre-proline 0 CA--C 1.538 0.507 0 CA-C-O 118.499 -0.763 . . . . 0.0 109.448 175.74 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' F' F ' 57' ' ' PRO . . . . . . . . . . . . . 53.7 Cg_endo -70.88 149.04 90.61 Favored 'Cis proline' 0 N--CA 1.496 1.675 0 CA-C-N 121.955 1.734 . . . . 0.0 111.577 -1.899 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' F' F ' 58' ' ' LEU . . . . . 0.446 ' HB2' ' HB1' ' F' ' 53' ' ' ALA . 23.8 tp -108.29 136.43 47.95 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.219 -0.446 . . . . 0.0 110.725 -177.449 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' F' F ' 59' ' ' ARG . . . . . . . . . . . . . 70.7 ttt180 -103.02 126.12 50.06 Favored 'General case' 0 C--N 1.327 -0.384 0 N-CA-C 109.117 -0.697 . . . . 0.0 109.117 175.744 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' F' F ' 60' ' ' VAL . . . . . . . . . . . . . 41.2 t -91.07 123.21 43.12 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.303 0 C-N-CA 120.663 -0.415 . . . . 0.0 111.014 -174.059 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' F' F ' 61' ' ' GLU . . . . . . . . . . . . . 96.1 mt-10 -131.13 172.06 12.55 Favored 'General case' 0 C--N 1.329 -0.317 0 N-CA-C 109.407 -0.59 . . . . 0.0 109.407 173.055 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' F' F ' 62' ' ' ASP . . . . . . . . . . . . . 73.3 m-20 -54.22 -32.67 56.47 Favored 'General case' 0 C--N 1.328 -0.334 0 C-N-CA 121.029 -0.268 . . . . 0.0 111.583 179.299 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' F' F ' 63' ' ' ARG . . . . . . . . . . . . . 13.5 ptm180 -74.56 -11.91 60.33 Favored 'General case' 0 CA--C 1.535 0.394 0 N-CA-C 113.409 0.892 . . . . 0.0 113.409 -177.298 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' F' F ' 64' ' ' THR . . . . . . . . . . . . . 37.6 m -74.67 138.72 43.04 Favored 'General case' 0 C--O 1.233 0.193 0 O-C-N 122.096 -0.377 . . . . 0.0 110.75 -176.09 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' F' F ' 65' ' ' LYS . . . . . . . . . . . . . 55.5 mtmt -89.24 129.12 35.86 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.149 -0.478 . . . . 0.0 110.141 177.863 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' F' F ' 66' ' ' ILE . . . . . . . . . . . . . 65.3 mt -114.75 129.84 70.19 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.295 0 N-CA-C 109.899 -0.408 . . . . 0.0 109.899 -179.835 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' F' F ' 67' ' ' THR . . . . . . . . . . . . . 24.8 m -118.82 135.51 54.5 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-N 116.076 -0.511 . . . . 0.0 110.464 179.862 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' F' F ' 68' ' ' LEU . . . . . 0.479 HD23 ' C ' ' F' ' 68' ' ' LEU . 6.5 tt -106.75 122.97 47.44 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 115.912 -0.586 . . . . 0.0 110.01 179.062 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' F' F ' 69' ' ' VAL . . . . . . . . . . . . . 43.4 t -99.58 129.98 49.32 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.291 0 CA-C-N 116.31 -0.404 . . . . 0.0 110.043 179.83 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' F' F ' 70' ' ' THR . . . . . . . . . . . . . 74.7 p -101.31 162.48 12.86 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.246 -0.434 . . . . 0.0 110.585 -179.681 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' F' F ' 71' ' ' HIS . . . . . . . . . . . . . 20.3 m-70 -82.93 119.07 73.64 Favored Pre-proline 0 CA--C 1.535 0.372 0 CA-C-O 118.74 -0.648 . . . . 0.0 110.842 -177.328 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' F' F ' 72' ' ' PRO . . . . . . . . . . . . . 7.3 Cg_exo -70.74 -27.43 21.8 Favored 'Trans proline' 0 N--CA 1.498 1.776 0 C-N-CA 121.274 1.316 . . . . 0.0 112.18 174.448 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' F' F ' 73' ' ' VAL . . . . . . . . . . . . . 34.4 m -124.84 178.91 3.36 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.228 0 N-CA-C 110.118 -0.327 . . . . 0.0 110.118 -179.44 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' F' F ' 74' ' ' ASP . . . . . . . . . . . . . 24.1 t0 -96.37 121.9 38.67 Favored 'General case' 0 C--N 1.33 -0.263 0 C-N-CA 120.941 -0.304 . . . . 0.0 110.186 -177.302 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' F' F ' 75' ' ' VAL . . . . . 0.49 ' C ' HD12 ' F' ' 76' ' ' LEU . 41.0 t -121.29 124.68 72.52 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.214 0 CA-C-O 121.039 0.447 . . . . 0.0 110.913 -177.781 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' F' F ' 76' ' ' LEU . . . . . 0.49 HD12 ' C ' ' F' ' 75' ' ' VAL . 7.5 mp -121.57 143.73 49.13 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 115.61 -0.723 . . . . 0.0 109.512 176.473 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' F' F ' 77' ' ' GLU . . . . . . . . . . . . . 98.3 mt-10 -134.78 140.83 46.2 Favored 'General case' 0 N--CA 1.463 0.186 0 CA-C-O 121.091 0.472 . . . . 0.0 111.617 -178.16 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' F' F ' 78' ' ' ALA . . . . . 0.608 ' HB2' HD21 ' F' ' 109' ' ' LEU . . . -133.95 141.2 47.21 Favored 'General case' 0 C--N 1.331 -0.223 0 CA-C-N 115.706 -0.679 . . . . 0.0 110.229 176.248 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' F' F ' 79' ' ' LYS . . . . . 0.571 ' O ' HD13 ' F' ' 80' ' ' ILE . 10.0 mtpm? -82.19 119.96 24.74 Favored 'General case' 0 C--N 1.331 -0.225 0 CA-C-O 120.934 0.397 . . . . 0.0 110.801 -178.868 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' F' F ' 80' ' ' ILE . . . . . 0.571 HD13 ' O ' ' F' ' 79' ' ' LYS . 42.2 mm -139.23 102.09 1.65 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 N-CA-C 109.165 -0.679 . . . . 0.0 109.165 -178.705 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' F' F ' 81' ' ' LYS . . . . . . . . . . . . . 54.6 mtpt -97.21 127.71 43.42 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-O 120.957 0.408 . . . . 0.0 111.133 -176.92 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' F' F ' 82' ' ' GLY . . . . . . . . . . . . . . . 89.16 42.12 5.67 Favored Glycine 0 CA--C 1.525 0.695 0 C-N-CA 120.937 -0.649 . . . . 0.0 111.522 175.793 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' F' F ' 83' ' ' ILE . . . . . . . . . . . . . 71.9 mt -67.49 138.03 23.55 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.297 0 N-CA-C 109.89 -0.411 . . . . 0.0 109.89 178.407 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' F' F ' 84' ' ' LYS . . . . . . . . . . . . . 56.3 tttp -99.63 -51.91 3.62 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.02 -0.536 . . . . 0.0 110.173 -179.726 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' F' F ' 85' ' ' ASP . . . . . . . . . . . . . 7.9 t70 -156.85 153.31 28.02 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 115.811 -0.632 . . . . 0.0 110.293 -179.914 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' F' F ' 86' ' ' VAL . . . . . . . . . . . . . 41.9 t -133.36 134.75 56.96 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.246 0 CA-C-O 121.083 0.468 . . . . 0.0 110.548 -179.128 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' F' F ' 87' ' ' ILE . . . . . . . . . . . . . 45.1 mm -119.36 128.16 75.85 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.25 0 CA-C-N 115.666 -0.697 . . . . 0.0 109.733 176.892 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' F' F ' 88' ' ' LEU . . . . . . . . . . . . . 63.9 mt -114.54 133.62 55.65 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-O 121.078 0.466 . . . . 0.0 111.173 -178.754 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' F' F ' 89' ' ' ASP . . . . . . . . . . . . . 8.8 t70 -131.89 154.62 49.03 Favored 'General case' 0 C--N 1.327 -0.385 0 CA-C-N 115.667 -0.697 . . . . 0.0 109.425 177.094 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' F' F ' 90' ' ' GLU . . . . . . . . . . . . . 83.9 tt0 -47.49 -32.98 5.73 Favored 'General case' 0 C--N 1.328 -0.33 0 N-CA-C 113.031 0.752 . . . . 0.0 113.031 -172.483 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' F' F ' 91' ' ' ASN . . . . . . . . . . . . . 35.0 m120 -124.47 7.82 8.34 Favored 'General case' 0 N--CA 1.469 0.489 0 N-CA-C 113.613 0.968 . . . . 0.0 113.613 -175.128 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' F' F ' 92' ' ' LEU . . . . . . . . . . . . . 27.5 mt -147.15 148.57 31.69 Favored 'General case' 0 C--N 1.333 -0.14 0 CA-C-N 118.247 0.476 . . . . 0.0 110.965 -175.464 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' F' F ' 93' ' ' ILE . . . . . . . . . . . . . 74.0 mt -126.52 116.45 45.26 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.286 0 N-CA-C 109.105 -0.702 . . . . 0.0 109.105 175.846 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' F' F ' 94' ' ' VAL . . . . . 0.402 HG21 HG21 ' F' ' 125' ' ' VAL . 46.1 t -118.79 128.59 75.64 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.193 0 CA-C-O 120.827 0.346 . . . . 0.0 110.101 -177.967 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' F' F ' 95' ' ' VAL . . . . . . . . . . . . . 42.1 t -123.27 134.98 64.68 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.317 0 CA-C-N 116.079 -0.509 . . . . 0.0 109.871 -179.853 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' F' F ' 96' ' ' ILE . . . . . . . . . . . . . 59.8 mt -115.25 129.22 71.85 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.282 0 N-CA-C 109.324 -0.621 . . . . 0.0 109.324 178.822 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' F' F ' 97' ' ' THR . . . . . . . . . . . . . 82.5 p -100.72 158.83 15.66 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-O 121.298 0.571 . . . . 0.0 111.157 -177.95 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' F' F ' 98' ' ' GLU . . . . . . . . . . . . . 46.4 tp10 -53.74 -27.2 27.02 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.011 -0.541 . . . . 0.0 112.259 -179.436 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' F' F ' 99' ' ' GLU . . . . . . . . . . . . . 39.4 tt0 -80.25 17.87 0.97 Allowed 'General case' 0 CA--C 1.539 0.555 0 N-CA-C 112.679 0.622 . . . . 0.0 112.679 -176.822 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' F' F ' 100' ' ' ASN . . . . . . . . . . . . . 4.1 m-20 61.05 38.0 17.52 Favored 'General case' 0 N--CA 1.462 0.166 0 O-C-N 121.857 -0.527 . . . . 0.0 111.017 176.792 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' F' F ' 101' ' ' GLU . . . . . . . . . . . . . 84.8 tt0 -117.66 143.08 46.51 Favored 'General case' 0 C--N 1.331 -0.226 0 N-CA-C 109.574 -0.528 . . . . 0.0 109.574 175.838 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' F' F ' 102' ' ' VAL . . . . . . . . . . . . . 44.9 t -116.73 126.59 74.25 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.353 0 CA-C-N 116.319 -0.4 . . . . 0.0 110.107 -176.986 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' F' F ' 103' ' ' LEU . . . . . . . . . . . . . 6.8 mp -118.42 135.31 54.42 Favored 'General case' 0 C--N 1.331 -0.215 0 CA-C-N 115.752 -0.658 . . . . 0.0 110.01 176.446 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' F' F ' 104' ' ' ILE . . . . . . . . . . . . . 72.4 mt -123.67 122.24 64.39 Favored 'Isoleucine or valine' 0 C--O 1.234 0.246 0 CA-C-N 116.503 -0.317 . . . . 0.0 110.29 -178.525 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' F' F ' 105' ' ' PHE . . . . . . . . . . . . . 47.5 m-85 -121.16 166.5 13.85 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 115.314 -0.857 . . . . 0.0 109.92 179.778 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' F' F ' 106' ' ' ASN . . . . . . . . . . . . . 42.3 p-10 -99.7 -169.89 1.81 Allowed 'General case' 0 C--N 1.33 -0.25 0 N-CA-C 109.821 -0.437 . . . . 0.0 109.821 172.992 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' F' F ' 107' ' ' GLN . . . . . . . . . . . . . 29.5 tt0 -60.44 -30.07 69.42 Favored 'General case' 0 C--N 1.329 -0.317 0 N-CA-C 111.734 0.272 . . . . 0.0 111.734 178.857 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' F' F ' 108' ' ' ASN . . . . . . . . . . . . . 10.1 t-20 -81.96 4.93 20.79 Favored 'General case' 0 CA--C 1.537 0.458 0 N-CA-C 113.305 0.854 . . . . 0.0 113.305 -178.833 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' F' F ' 109' ' ' LEU . . . . . 0.608 HD21 ' HB2' ' F' ' 78' ' ' ALA . 6.0 tp 63.4 38.51 10.02 Favored 'General case' 0 C--O 1.232 0.167 0 CA-C-O 121.107 0.479 . . . . 0.0 111.377 177.158 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' F' F ' 110' ' ' GLU . . . . . . . . . . . . . 70.7 mm-40 -107.76 152.44 24.36 Favored 'General case' 0 C--N 1.331 -0.23 0 CA-C-N 116.256 -0.429 . . . . 0.0 110.12 176.03 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' F' F ' 111' ' ' GLU . . . . . . . . . . . . . 98.6 mt-10 -78.58 125.83 29.91 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-O 120.944 0.402 . . . . 0.0 111.188 -178.542 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' F' F ' 112' ' ' LEU . . . . . . . . . . . . . 8.4 mt -111.97 -46.04 3.26 Favored 'General case' 0 C--N 1.332 -0.159 0 CA-C-N 116.012 -0.54 . . . . 0.0 109.905 176.336 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' F' F ' 113' ' ' TYR . . . . . . . . . . . . . 49.5 t80 -139.69 140.94 36.97 Favored 'General case' 0 C--N 1.332 -0.19 0 CA-C-N 116.128 -0.487 . . . . 0.0 110.773 -179.637 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' F' F ' 114' ' ' ARG . . . . . . . . . . . . . 42.4 ptt85 -150.96 118.75 6.16 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-O 121.043 0.449 . . . . 0.0 110.959 179.731 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' F' F ' 115' ' ' GLY . . . . . . . . . . . . . . . -150.28 162.98 29.41 Favored Glycine 0 CA--C 1.527 0.786 0 N-CA-C 111.177 -0.769 . . . . 0.0 111.177 -178.846 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' F' F ' 116' ' ' LYS . . . . . . . . . . . . . 26.6 ttpp -122.41 144.84 48.79 Favored 'General case' 0 C--N 1.33 -0.245 0 O-C-N 122.644 -0.327 . . . . 0.0 110.172 176.457 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' F' F ' 117' ' ' PHE . . . . . . . . . . . . . 45.4 m-85 -138.22 113.9 9.76 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-O 121.035 0.445 . . . . 0.0 110.278 179.771 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' F' F ' 118' ' ' GLU . . . . . . . . . . . . . 84.7 tt0 -52.53 -50.17 63.39 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-N 116.385 -0.371 . . . . 0.0 111.702 -176.016 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' F' F ' 119' ' ' ASN . . . . . . . . . . . . . 72.2 m-80 -95.78 30.98 2.18 Favored 'General case' 0 C--N 1.329 -0.285 0 N-CA-C 112.246 0.462 . . . . 0.0 112.246 -174.458 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' F' F ' 120' ' ' LEU . . . . . . . . . . . . . 17.3 tp -55.29 120.75 7.54 Favored 'General case' 0 C--N 1.332 -0.163 0 CA-C-O 120.703 0.287 . . . . 0.0 110.77 178.392 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' F' F ' 121' ' ' ASN . . . . . . . . . . . . . 37.2 t30 -114.16 -44.05 3.17 Favored 'General case' 0 C--N 1.333 -0.125 0 CA-C-N 116.6 -0.273 . . . . 0.0 111.039 -177.995 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' F' F ' 122' ' ' LYS . . . . . . . . . . . . . 61.2 mtpt -140.6 148.54 41.1 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-O 121.045 0.45 . . . . 0.0 111.584 -175.461 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' F' F ' 123' ' ' VAL . . . . . . . . . . . . . 45.0 t -132.6 133.19 59.76 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.274 0 N-CA-C 109.374 -0.602 . . . . 0.0 109.374 174.761 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' F' F ' 124' ' ' LEU . . . . . . . . . . . . . 66.8 mt -131.74 136.05 47.3 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-O 120.988 0.423 . . . . 0.0 111.201 -176.415 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' F' F ' 125' ' ' VAL . . . . . 0.402 HG21 HG21 ' F' ' 94' ' ' VAL . 38.7 t -129.2 135.19 62.48 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.207 0 CA-C-N 115.73 -0.668 . . . . 0.0 110.067 -179.582 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' F' F ' 126' ' ' ARG . . . . . . . . . . . . . 17.1 ptp180 -165.18 142.78 6.02 Favored 'General case' 0 C--N 1.331 -0.202 0 CA-C-O 121.004 0.431 . . . . 0.0 110.414 176.31 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' F' F ' 127' ' ' ASN . . . . . . . . . . . . . 1.3 t-20 54.74 -155.13 0.26 Allowed 'General case' 0 CA--C 1.538 0.517 0 N-CA-C 110.104 -0.332 . . . . 0.0 110.104 -179.656 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' F' F ' 128' ' ' ASP . . . . . . . . . . . . . 23.1 p-10 -84.12 20.71 1.51 Allowed 'General case' 0 CA--C 1.534 0.35 0 CA-C-N 118.325 0.511 . . . . 0.0 112.347 176.481 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' F' F ' 129' ' ' LEU . . . . . . . . . . . . . 46.2 mt -121.09 144.47 48.54 Favored 'General case' 0 C--O 1.234 0.246 0 O-C-N 122.053 -0.405 . . . . 0.0 110.438 -179.376 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' F' F ' 130' ' ' VAL . . . . . 0.532 HG13 ' HB ' ' F' ' 141' ' ' ILE . 11.1 p -134.19 139.76 47.51 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.268 0 CA-C-N 116.286 -0.415 . . . . 0.0 110.016 178.832 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' F' F ' 131' ' ' VAL . . . . . 0.554 HG12 HD12 ' F' ' 140' ' ' LEU . 34.6 m -136.06 146.49 29.23 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.254 0 CA-C-O 121.268 0.556 . . . . 0.0 111.286 -178.265 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' F' F ' 132' ' ' ILE . . . . . . . . . . . . . 68.2 mt -121.91 133.97 66.64 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.299 0 CA-C-N 115.389 -0.823 . . . . 0.0 109.497 179.645 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' F' F ' 133' ' ' ILE . . . . . . . . . . . . . 37.3 mm -115.57 117.52 55.85 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.267 0 CA-C-N 116.463 -0.335 . . . . 0.0 110.828 -175.984 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' F' F ' 134' ' ' ASP . . . . . . . . . . . . . 8.0 p-10 -129.92 146.65 51.63 Favored 'General case' 0 C--N 1.33 -0.245 0 N-CA-C 109.649 -0.501 . . . . 0.0 109.649 175.526 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' F' F ' 135' ' ' GLU . . . . . . . . . . . . . 41.5 tp10 -49.93 -23.04 1.75 Allowed 'General case' 0 C--N 1.327 -0.371 0 N-CA-C 112.799 0.666 . . . . 0.0 112.799 -172.207 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' F' F ' 136' ' ' GLN . . . . . . . . . . . . . 48.1 tt0 -101.38 -28.73 12.43 Favored 'General case' 0 CA--C 1.531 0.215 0 N-CA-C 112.481 0.549 . . . . 0.0 112.481 -174.801 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' F' F ' 137' ' ' LYS . . . . . . . . . . . . . 76.6 mttt -141.95 151.74 42.85 Favored 'General case' 0 C--O 1.233 0.22 0 CA-C-O 121.363 0.601 . . . . 0.0 112.378 -170.714 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' F' F ' 138' ' ' LEU . . . . . . . . . . . . . 24.3 tp -109.14 119.14 38.63 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 115.011 -0.995 . . . . 0.0 108.941 170.251 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' F' F ' 139' ' ' THR . . . . . . . . . . . . . 33.0 m -108.19 123.73 49.2 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-O 120.751 0.31 . . . . 0.0 110.914 -177.263 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' F' F ' 140' ' ' LEU . . . . . 0.554 HD12 HG12 ' F' ' 131' ' ' VAL . 12.4 tp -115.82 120.61 39.81 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 115.601 -0.727 . . . . 0.0 109.503 -179.219 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' F' F ' 141' ' ' ILE . . . . . 0.532 ' HB ' HG13 ' F' ' 130' ' ' VAL . 19.7 mt -118.97 121.18 66.19 Favored 'Isoleucine or valine' 0 C--O 1.235 0.302 0 N-CA-C 109.801 -0.444 . . . . 0.0 109.801 -176.676 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' F' F ' 142' ' ' ARG . . . . . . . . . . . . . 73.8 mtm180 -111.56 126.82 55.4 Favored 'General case' 0 C--N 1.332 -0.175 0 CA-C-N 115.798 -0.637 . . . . 0.0 110.125 -178.348 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' F' F ' 143' ' ' THR . . . . . . . . . . . . . 25.8 p . . . . . 0 C--O 1.221 -0.443 0 CA-C-O 118.235 -0.888 . . . . 0.0 110.998 -179.368 . . . . . . . . 0 0 . 1 . 008 nuclear nobuild full ' A' A ' -3' ' ' GLU . . . . . . . . . . . . . 85.1 tt0 . . . . . 0 N--CA 1.49 1.556 0 N-CA-C 109.432 -0.581 . . . . 0.0 109.432 . . . . . . . . . 0 0 . 1 . 008 nuclear nobuild full ' A' A ' -2' ' ' GLY . . . . . . . . . . . . . . . -75.5 99.67 1.23 Allowed Glycine 0 CA--C 1.525 0.702 0 N-CA-C 111.066 -0.813 . . . . 0.0 111.066 179.866 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' -1' ' ' VAL . . . . . . . . . . . . . 45.3 t -141.46 139.54 32.17 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.311 0 N-CA-C 109.989 -0.374 . . . . 0.0 109.989 179.488 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 0' ' ' ILE . . . . . . . . . . . . . 44.3 mm -109.0 128.49 64.83 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.243 0 CA-C-N 116.23 -0.441 . . . . 0.0 110.138 179.925 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 25.8 ptt? -81.03 145.09 31.32 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.131 -0.486 . . . . 0.0 110.783 -179.537 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 5.0 p -119.65 137.49 53.86 Favored 'General case' 0 C--N 1.332 -0.181 0 CA-C-N 116.211 -0.45 . . . . 0.0 110.781 179.989 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 41.2 mt-10 -140.4 140.74 35.53 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 115.985 -0.552 . . . . 0.0 111.029 -179.332 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 4' ' ' LEU . . . . . 0.425 HD12 HD23 ' A' ' 58' ' ' LEU . 3.0 tt -124.2 126.3 45.89 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 115.918 -0.583 . . . . 0.0 109.707 177.338 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 5' ' ' LYS . . . . . . . . . . . . . 63.9 mttp -106.91 120.24 41.51 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-O 120.69 0.281 . . . . 0.0 110.807 -179.791 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 37.2 mt -114.66 145.64 41.79 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 115.502 -0.772 . . . . 0.0 110.742 -178.573 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 53.6 tttm -137.78 140.56 30.05 Favored Pre-proline 0 CA--C 1.534 0.35 0 CA-C-O 119.104 -0.474 . . . . 0.0 109.791 174.36 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 8' ' ' PRO . . . . . . . . . . . . . 88.4 Cg_endo -91.81 144.71 3.01 Favored 'Trans proline' 0 N--CA 1.489 1.23 0 C-N-CA 121.775 1.65 . . . . 0.0 111.83 177.931 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 62.7 mt -78.64 -46.51 1.91 Allowed Pre-proline 0 CA--C 1.532 0.277 0 CA-C-O 118.859 -0.591 . . . . 0.0 111.906 179.663 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 75.5 Cg_endo -83.93 144.98 11.11 Favored 'Trans proline' 0 N--CA 1.494 1.543 0 C-N-CA 121.219 1.28 . . . . 0.0 111.516 173.362 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 22.3 pttm -74.53 116.44 15.22 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-O 121.319 0.58 . . . . 0.0 110.437 177.639 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 12.3 p -150.41 147.32 16.04 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.359 0 CA-C-N 115.682 -0.69 . . . . 0.0 110.56 -177.966 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 84.6 tt0 -95.73 121.98 38.02 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.394 -0.366 . . . . 0.0 110.099 177.881 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 14' ' ' LEU . . . . . . . . . . . . . 21.9 mt -99.14 144.03 27.48 Favored Pre-proline 0 CA--C 1.533 0.324 0 CA-C-O 119.093 -0.48 . . . . 0.0 110.521 -176.718 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 15' ' ' PRO . . . . . . . . . . . . . 23.6 Cg_exo -64.76 161.66 35.08 Favored 'Trans proline' 0 N--CA 1.498 1.754 0 C-N-CA 121.292 1.328 . . . . 0.0 111.933 175.209 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 16' ' ' PRO . . . . . . . . . . . . . 27.1 Cg_exo -60.67 -31.97 92.67 Favored 'Trans proline' 0 N--CA 1.496 1.643 0 C-N-CA 121.538 1.492 . . . . 0.0 112.79 -178.96 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 17' ' ' ASP . . . . . . . . . . . . . 10.0 p-10 -83.16 -2.41 55.42 Favored 'General case' 0 CA--C 1.535 0.386 0 N-CA-C 113.351 0.871 . . . . 0.0 113.351 -176.556 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 18' ' ' PHE . . . . . . . . . . . . . 45.5 t80 -57.45 -43.76 84.2 Favored 'General case' 0 C--O 1.23 0.035 0 O-C-N 121.913 -0.492 . . . . 0.0 110.236 -178.478 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 19' ' ' VAL . . . . . . . . . . . . . 48.5 t -57.02 -44.1 82.18 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.314 0 CA-C-N 116.269 -0.423 . . . . 0.0 110.485 -178.497 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 18.2 t70 -59.69 -41.81 91.55 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-O 120.757 0.313 . . . . 0.0 110.902 -177.651 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 43.8 t -64.32 -47.28 90.32 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.274 0 C-N-CA 120.692 -0.403 . . . . 0.0 110.459 -177.948 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 22' ' ' ILE . . . . . 0.581 HG22 HD12 ' A' ' 26' ' ' LEU . 50.2 mm -57.3 -42.05 79.48 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.244 0 C-N-CA 120.801 -0.359 . . . . 0.0 110.591 179.942 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 23' ' ' ARG . . . . . . . . . . . . . 56.5 ttp180 -55.8 -50.31 70.85 Favored 'General case' 0 C--N 1.331 -0.211 0 CA-C-O 120.928 0.394 . . . . 0.0 110.899 179.73 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 24' ' ' ILE . . . . . . . . . . . . . 77.5 mt -60.44 -41.02 86.01 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.251 0 CA-C-N 116.09 -0.505 . . . . 0.0 111.67 -176.961 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 25' ' ' LYS . . . . . 0.574 ' HE3' HD13 ' A' ' 22' ' ' ILE . 16.5 ptpt -72.49 -37.57 68.41 Favored 'General case' 0 CA--C 1.535 0.376 0 C-N-CA 120.622 -0.431 . . . . 0.0 112.115 -175.15 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 26' ' ' LEU . . . . . 0.581 HD12 HG22 ' A' ' 22' ' ' ILE . 43.9 mt -79.84 -39.5 30.52 Favored 'General case' 0 C--N 1.331 -0.209 0 N-CA-C 113.383 0.883 . . . . 0.0 113.383 -173.406 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 27' ' ' GLN . . . . . . . . . . . . . 9.9 pt20 -46.49 141.24 3.76 Favored 'General case' 0 N--CA 1.469 0.503 0 N-CA-C 112.958 0.725 . . . . 0.0 112.958 -173.492 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 97.26 -25.97 24.82 Favored Glycine 0 CA--C 1.534 1.262 0 CA-C-N 115.553 -0.749 . . . . 0.0 112.164 -177.304 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 84.0 mttt -97.94 155.14 17.22 Favored 'General case' 0 C--O 1.233 0.21 0 CA-C-N 117.232 0.516 . . . . 0.0 110.943 179.812 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 30' ' ' THR . . . . . . . . . . . . . 29.1 m -106.86 137.62 44.57 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.142 -0.481 . . . . 0.0 110.101 177.168 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 34.8 m -130.2 159.45 42.21 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.202 0 CA-C-N 116.321 -0.4 . . . . 0.0 110.84 -178.8 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 32' ' ' ARG . . . . . . . . . . . . . 82.2 mtm180 -132.82 150.93 52.11 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-O 121.31 0.576 . . . . 0.0 110.682 178.357 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 33' ' ' THR . . . . . . . . . . . . . 22.0 m -53.4 139.82 29.34 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.074 -0.512 . . . . 0.0 111.312 -178.764 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 100.11 -17.15 57.49 Favored Glycine 0 CA--C 1.532 1.119 0 CA-C-O 119.591 -0.561 . . . . 0.0 113.226 178.881 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 76.6 m-20 -66.08 147.98 52.52 Favored 'General case' 0 C--O 1.233 0.187 0 CA-C-N 118.078 0.939 . . . . 0.0 111.155 178.857 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 44.0 t -122.79 131.53 73.08 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.224 0 CA-C-N 115.937 -0.574 . . . . 0.0 109.906 178.871 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 37' ' ' ILE . . . . . . . . . . . . . 69.0 mt -120.95 139.01 49.5 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.253 0 CA-C-N 116.167 -0.469 . . . . 0.0 110.008 -179.683 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . -109.43 128.85 9.16 Favored Glycine 0 CA--C 1.527 0.785 0 N-CA-C 110.975 -0.85 . . . . 0.0 110.975 179.663 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 39' ' ' ILE . . . . . . . . . . . . . 77.6 mt -126.06 135.9 62.46 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.229 0 CA-C-O 120.765 0.317 . . . . 0.0 110.181 179.612 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 40' ' ' SER . . . . . . . . . . . . . 36.6 t -93.87 122.28 36.19 Favored 'General case' 0 C--N 1.331 -0.239 0 CA-C-N 116.309 -0.405 . . . . 0.0 110.902 175.149 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 41' ' ' ILE . . . . . . . . . . . . . 70.6 mt -133.36 127.43 53.89 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.202 0 CA-C-O 120.841 0.353 . . . . 0.0 110.376 178.662 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 83.4 mt 53.66 33.04 15.71 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 116.203 -0.453 . . . . 0.0 111.959 177.788 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . 72.39 29.37 66.22 Favored Glycine 0 CA--C 1.529 0.952 0 C-N-CA 121.112 -0.566 . . . . 0.0 112.313 177.839 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 44' ' ' LYS . . . . . . . . . . . . . 60.3 mttm -137.36 136.5 37.98 Favored 'General case' 0 C--N 1.331 -0.215 0 N-CA-C 109.862 -0.422 . . . . 0.0 109.862 178.723 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 84.4 tt0 -83.81 122.02 28.11 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.459 -0.337 . . . . 0.0 110.899 -179.688 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 46' ' ' VAL . . . . . . . . . . . . . 7.3 p -122.07 130.06 74.87 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.212 0 N-CA-C 109.547 -0.538 . . . . 0.0 109.547 176.221 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 64.3 mttp -100.66 128.4 46.72 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.011 -0.541 . . . . 0.0 110.994 178.935 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 48' ' ' PHE . . . . . . . . . . . . . 91.0 m-85 -111.12 131.89 54.72 Favored 'General case' 0 C--N 1.33 -0.272 0 N-CA-C 109.698 -0.482 . . . . 0.0 109.698 176.035 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 84.5 tttt -109.12 136.89 47.87 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.356 -0.383 . . . . 0.0 110.729 -179.558 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 50' ' ' VAL . . . . . . . . . . . . . 44.0 t -80.49 106.22 11.33 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.317 0 N-CA-C 109.178 -0.675 . . . . 0.0 109.178 175.159 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 51' ' ' VAL . . . . . . . . . . . . . 47.0 t -70.55 -53.21 23.47 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.354 0 N-CA-C 109.493 -0.558 . . . . 0.0 109.493 -175.035 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 52' ' ' GLN . . . . . . . . . . . . . 90.5 mt-30 -153.85 153.55 32.31 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-O 121.258 0.552 . . . . 0.0 111.796 -178.575 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -129.06 132.11 47.4 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 115.072 -0.967 . . . . 0.0 109.552 175.041 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 54' ' ' TYR . . . . . . . . . . . . . 25.1 t80 -129.03 110.1 18.28 Favored Pre-proline 0 CA--C 1.536 0.41 0 CA-C-O 118.197 -0.906 . . . . 0.0 110.048 179.391 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 55' ' ' PRO . . . . . . . . . . . . . 74.2 Cg_endo -77.17 170.01 72.67 Favored 'Cis proline' 0 N--CA 1.499 1.851 0 CA-C-N 121.877 1.706 . . . . 0.0 112.542 -4.103 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 56' ' ' SER . . . . . . . . . . . . . 13.6 m -115.55 127.61 26.65 Favored Pre-proline 0 CA--C 1.538 0.485 0 CA-C-O 118.344 -0.836 . . . . 0.0 109.506 176.214 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 57' ' ' PRO . . . . . . . . . . . . . 38.0 Cg_endo -66.6 168.5 50.82 Favored 'Cis proline' 0 N--CA 1.498 1.739 0 CA-C-N 122.081 1.779 . . . . 0.0 111.41 -0.657 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 58' ' ' LEU . . . . . 0.425 HD23 HD12 ' A' ' 4' ' ' LEU . 32.7 tp -130.55 136.15 48.63 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-O 120.926 0.393 . . . . 0.0 110.622 -178.997 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 59' ' ' ARG . . . . . . . . . . . . . 49.3 ttp180 -103.69 127.65 51.12 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 115.974 -0.557 . . . . 0.0 109.554 177.303 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 41.7 t -79.67 120.89 31.89 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.181 0 C-N-CA 120.57 -0.452 . . . . 0.0 110.143 -176.247 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 90.7 mt-10 -131.05 161.16 32.63 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 115.86 -0.609 . . . . 0.0 109.88 179.956 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 62' ' ' ASP . . . . . . . . . . . . . 12.7 t70 -54.34 -32.26 56.37 Favored 'General case' 0 C--N 1.328 -0.345 0 C-N-CA 120.926 -0.309 . . . . 0.0 111.714 177.728 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 63' ' ' ARG . . . . . . . . . . . . . 8.1 ptp180 -87.79 9.86 20.35 Favored 'General case' 0 CA--C 1.535 0.391 0 N-CA-C 113.568 0.951 . . . . 0.0 113.568 -175.405 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 39.5 m -92.2 141.0 29.06 Favored 'General case' 0 C--N 1.334 -0.085 0 CA-C-N 118.199 0.454 . . . . 0.0 110.437 -179.426 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 65' ' ' LYS . . . . . . . . . . . . . 67.0 mttm -88.82 127.16 35.61 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.151 -0.477 . . . . 0.0 110.258 179.915 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 66' ' ' ILE . . . . . . . . . . . . . 67.2 mt -115.18 129.13 71.93 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.236 0 N-CA-C 109.87 -0.419 . . . . 0.0 109.87 179.741 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 67' ' ' THR . . . . . . . . . . . . . 31.0 m -126.7 139.4 53.18 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-O 121.076 0.465 . . . . 0.0 111.107 -177.404 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 68' ' ' LEU . . . . . . . . . . . . . 33.8 mt -102.32 131.67 48.77 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 115.825 -0.625 . . . . 0.0 110.229 176.481 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 69' ' ' VAL . . . . . . . . . . . . . 42.5 t -97.31 133.18 39.97 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.369 0 CA-C-N 116.137 -0.483 . . . . 0.0 109.855 179.322 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 70' ' ' THR . . . . . . . . . . . . . 19.8 p -131.81 -38.1 1.14 Allowed 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.187 -0.46 . . . . 0.0 110.974 -178.906 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 71' ' ' HIS . . . . . . . . . . . . . 48.7 m80 -65.11 128.65 93.98 Favored Pre-proline 0 CA--C 1.535 0.367 0 CA-C-O 118.824 -0.608 . . . . 0.0 109.939 -179.617 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 72' ' ' PRO . . . . . . . . . . . . . 96.5 Cg_endo -90.71 -22.46 0.66 Allowed 'Trans proline' 0 N--CA 1.493 1.471 0 C-N-CA 121.628 1.552 . . . . 0.0 113.286 179.338 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 73' ' ' VAL . . . . . . . . . . . . . 34.5 m -127.01 162.3 32.15 Favored 'Isoleucine or valine' 0 C--N 1.333 -0.151 0 CA-C-O 120.939 0.4 . . . . 0.0 110.72 -177.459 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 74' ' ' ASP . . . . . . . . . . . . . 12.1 t70 -99.14 120.25 39.18 Favored 'General case' 0 C--N 1.331 -0.225 0 CA-C-N 116.088 -0.506 . . . . 0.0 109.713 179.399 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 42.4 t -110.98 121.06 62.99 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.263 0 CA-C-O 121.17 0.509 . . . . 0.0 110.534 -177.671 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 76' ' ' LEU . . . . . . . . . . . . . 29.7 mt -123.9 137.48 54.63 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 115.483 -0.781 . . . . 0.0 109.083 177.149 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 77' ' ' GLU . . . . . . . . . . . . . 33.5 tt0 -136.7 135.84 38.53 Favored 'General case' 0 C--N 1.33 -0.257 0 C-N-CA 120.745 -0.382 . . . . 0.0 111.111 -175.727 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 78' ' ' ALA . . . . . 0.592 ' HB2' HD21 ' A' ' 109' ' ' LEU . . . -124.72 140.77 52.63 Favored 'General case' 0 N--CA 1.463 0.211 0 CA-C-N 116.059 -0.518 . . . . 0.0 110.281 179.064 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 79' ' ' LYS . . . . . 0.589 ' O ' HD13 ' A' ' 80' ' ' ILE . 63.6 mttp -83.25 123.66 29.81 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.358 -0.383 . . . . 0.0 110.546 -179.501 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 80' ' ' ILE . . . . . 0.589 HD13 ' O ' ' A' ' 79' ' ' LYS . 23.3 mm -139.23 114.1 7.96 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.247 0 N-CA-C 108.967 -0.753 . . . . 0.0 108.967 -178.822 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 81' ' ' LYS . . . . . . . . . . . . . 84.2 tttt -103.16 123.92 47.62 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-O 120.92 0.39 . . . . 0.0 111.35 -175.696 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . 89.1 42.17 5.68 Favored Glycine 0 CA--C 1.525 0.707 0 C-N-CA 120.95 -0.643 . . . . 0.0 111.933 173.185 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 83' ' ' ILE . . . . . . . . . . . . . 71.2 mt -68.33 136.9 25.54 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.287 0 N-CA-C 109.847 -0.427 . . . . 0.0 109.847 177.925 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 84' ' ' LYS . . . . . . . . . . . . . 28.6 ttpp -99.66 -48.29 4.78 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.086 -0.506 . . . . 0.0 109.999 179.858 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 85' ' ' ASP . . . . . . . . . . . . . 8.9 t70 -153.36 149.09 27.48 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 115.842 -0.617 . . . . 0.0 110.542 179.303 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 86' ' ' VAL . . . . . . . . . . . . . 45.0 t -128.16 130.51 69.6 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.218 0 CA-C-O 120.917 0.389 . . . . 0.0 110.245 179.558 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 87' ' ' ILE . . . . . 0.492 HD12 ' N ' ' A' ' 87' ' ' ILE . 5.1 mp -122.1 126.18 74.03 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.23 0 CA-C-N 116.007 -0.542 . . . . 0.0 109.58 177.721 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 88' ' ' LEU . . . . . . . . . . . . . 39.0 mt -113.21 137.99 50.64 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-O 121.207 0.527 . . . . 0.0 111.294 -178.104 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 89' ' ' ASP . . . . . . . . . . . . . 13.0 t70 -128.8 157.75 40.59 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 115.376 -0.829 . . . . 0.0 109.008 175.781 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 85.0 tt0 -46.79 -37.9 9.32 Favored 'General case' 0 C--N 1.33 -0.271 0 N-CA-C 112.97 0.73 . . . . 0.0 112.97 -172.07 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 91' ' ' ASN . . . . . . . . . . . . . 28.7 p30 -132.06 23.91 4.56 Favored 'General case' 0 N--CA 1.465 0.306 0 N-CA-C 112.863 0.69 . . . . 0.0 112.863 -177.89 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 92' ' ' LEU . . . . . . . . . . . . . 9.8 mt -149.24 144.45 26.54 Favored 'General case' 0 C--N 1.331 -0.206 0 N-CA-C 110.131 -0.322 . . . . 0.0 110.131 -177.547 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 93' ' ' ILE . . . . . . . . . . . . . 75.8 mt -127.69 119.0 50.63 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.247 0 N-CA-C 109.428 -0.582 . . . . 0.0 109.428 177.757 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 94' ' ' VAL . . . . . 0.427 HG21 HG21 ' A' ' 125' ' ' VAL . 45.5 t -121.39 128.3 75.87 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.261 0 CA-C-O 120.925 0.393 . . . . 0.0 110.133 179.984 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 95' ' ' VAL . . . . . . . . . . . . . 47.2 t -122.63 134.1 66.82 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.298 0 CA-C-N 115.863 -0.608 . . . . 0.0 109.754 -179.307 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 96' ' ' ILE . . . . . . . . . . . . . 60.0 mt -115.21 130.02 70.45 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.294 0 N-CA-C 109.273 -0.64 . . . . 0.0 109.273 179.127 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 97' ' ' THR . . . . . . . . . . . . . 73.1 p -103.81 156.28 17.94 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-O 121.253 0.549 . . . . 0.0 111.243 -178.107 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 98' ' ' GLU . . . . . . . . . . . . . 96.2 mt-10 -54.95 -26.89 39.45 Favored 'General case' 0 CA--C 1.532 0.276 0 CA-C-N 116.091 -0.504 . . . . 0.0 112.325 -179.041 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 99' ' ' GLU . . . . . . . . . . . . . 12.7 pt-20 -78.9 16.67 0.85 Allowed 'General case' 0 CA--C 1.535 0.382 0 N-CA-C 113.261 0.838 . . . . 0.0 113.261 -177.638 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 100' ' ' ASN . . . . . . . . . . . . . 3.1 m-20 63.53 37.59 10.35 Favored 'General case' 0 C--O 1.232 0.147 0 CA-C-O 121.072 0.463 . . . . 0.0 111.106 176.992 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 101' ' ' GLU . . . . . . . . . . . . . 85.0 tt0 -116.36 142.63 46.59 Favored 'General case' 0 C--N 1.331 -0.238 0 N-CA-C 109.709 -0.478 . . . . 0.0 109.709 175.819 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 102' ' ' VAL . . . . . . . . . . . . . 46.6 t -117.4 125.79 74.23 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.29 0 CA-C-N 116.179 -0.464 . . . . 0.0 109.908 -178.057 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 103' ' ' LEU . . . . . 0.483 HD12 ' N ' ' A' ' 103' ' ' LEU . 6.3 mp -116.5 134.57 54.7 Favored 'General case' 0 N--CA 1.463 0.185 0 CA-C-N 115.813 -0.631 . . . . 0.0 110.287 177.311 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 104' ' ' ILE . . . . . 0.43 HD12 ' HB3' ' A' ' 113' ' ' TYR . 66.0 mt -121.39 120.94 63.37 Favored 'Isoleucine or valine' 0 C--O 1.234 0.261 0 N-CA-C 110.051 -0.352 . . . . 0.0 110.051 -179.065 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 105' ' ' PHE . . . . . . . . . . . . . 66.3 m-85 -120.89 164.7 16.28 Favored 'General case' 0 C--N 1.331 -0.234 0 O-C-N 124.012 0.82 . . . . 0.0 109.688 179.593 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 106' ' ' ASN . . . . . . . . . . . . . 44.2 p-10 -100.88 -171.13 1.95 Allowed 'General case' 0 C--N 1.33 -0.276 0 N-CA-C 109.737 -0.468 . . . . 0.0 109.737 172.842 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 107' ' ' GLN . . . . . . . . . . . . . 29.7 tt0 -60.83 -27.59 68.19 Favored 'General case' 0 CA--C 1.533 0.31 0 N-CA-C 111.96 0.355 . . . . 0.0 111.96 178.785 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 108' ' ' ASN . . . . . . . . . . . . . 6.3 t-20 -81.97 6.0 17.4 Favored 'General case' 0 CA--C 1.538 0.501 0 N-CA-C 113.06 0.763 . . . . 0.0 113.06 -178.693 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 109' ' ' LEU . . . . . 0.592 HD21 ' HB2' ' A' ' 78' ' ' ALA . 11.2 tp 61.58 37.52 16.17 Favored 'General case' 0 C--O 1.233 0.204 0 CA-C-O 120.952 0.406 . . . . 0.0 111.3 178.319 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 110' ' ' GLU . . . . . . . . . . . . . 43.2 mt-10 -109.02 153.97 22.87 Favored 'General case' 0 C--N 1.33 -0.245 0 N-CA-C 110.091 -0.337 . . . . 0.0 110.091 177.375 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 111' ' ' GLU . . . . . . . . . . . . . 98.3 mt-10 -81.7 121.94 27.02 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-O 120.974 0.416 . . . . 0.0 111.098 -179.814 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 112' ' ' LEU . . . . . . . . . . . . . 21.3 mt -107.45 -45.47 4.07 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 115.887 -0.597 . . . . 0.0 109.963 175.835 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 113' ' ' TYR . . . . . 0.43 ' HB3' HD12 ' A' ' 104' ' ' ILE . 50.4 t80 -139.37 140.51 37.48 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 115.944 -0.571 . . . . 0.0 110.502 179.678 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 114' ' ' ARG . . . . . . . . . . . . . 32.0 ptt180 -150.92 120.74 7.06 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-O 120.917 0.389 . . . . 0.0 110.818 178.476 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 115' ' ' GLY . . . . . . . . . . . . . . . -150.24 163.04 29.42 Favored Glycine 0 CA--C 1.525 0.7 0 N-CA-C 111.314 -0.714 . . . . 0.0 111.314 -179.309 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 116' ' ' LYS . . . . . . . . . . . . . 36.2 ttpt -122.87 136.63 54.93 Favored 'General case' 0 C--N 1.33 -0.261 0 N-CA-C 109.671 -0.492 . . . . 0.0 109.671 175.988 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 117' ' ' PHE . . . . . . . . . . . . . 43.9 m-85 -134.21 115.55 14.3 Favored 'General case' 0 C--N 1.331 -0.22 0 CA-C-O 121.006 0.431 . . . . 0.0 110.343 -176.791 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 118' ' ' GLU . . . . . . . . . . . . . 84.2 tt0 -52.31 -49.16 64.75 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.271 -0.422 . . . . 0.0 111.785 -175.574 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 119' ' ' ASN . . . . . . . . . . . . . 86.2 m-20 -97.57 31.02 2.69 Favored 'General case' 0 C--N 1.33 -0.273 0 N-CA-C 112.284 0.475 . . . . 0.0 112.284 -173.791 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 120' ' ' LEU . . . . . . . . . . . . . 14.7 tp -58.24 121.8 11.63 Favored 'General case' 0 C--N 1.332 -0.177 0 N-CA-C 110.039 -0.356 . . . . 0.0 110.039 177.354 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 121' ' ' ASN . . . . . . . . . . . . . 72.7 m-20 -113.47 -44.05 3.26 Favored 'General case' 0 C--N 1.331 -0.203 0 CA-C-N 116.537 -0.301 . . . . 0.0 111.044 -177.176 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 122' ' ' LYS . . . . . . . . . . . . . 98.9 mttt -144.62 149.07 35.12 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-O 121.068 0.461 . . . . 0.0 111.689 -177.409 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 123' ' ' VAL . . . . . . . . . . . . . 40.3 t -128.81 129.63 68.4 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.305 0 N-CA-C 109.124 -0.695 . . . . 0.0 109.124 173.723 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 124' ' ' LEU . . . . . . . . . . . . . 66.2 mt -124.6 133.68 53.19 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-O 120.892 0.377 . . . . 0.0 111.017 -176.162 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 125' ' ' VAL . . . . . 0.427 HG21 HG21 ' A' ' 94' ' ' VAL . 42.0 t -124.92 125.07 69.08 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.239 0 CA-C-N 115.866 -0.606 . . . . 0.0 109.619 177.257 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 126' ' ' ARG . . . . . . . . . . . . . 84.7 mtt180 -149.08 130.35 14.62 Favored 'General case' 0 C--N 1.328 -0.35 0 N-CA-C 110.034 -0.358 . . . . 0.0 110.034 179.058 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 127' ' ' ASN . . . . . . . . . . . . . 3.4 t-20 55.75 -151.72 0.39 Allowed 'General case' 0 CA--C 1.54 0.57 0 N-CA-C 109.841 -0.429 . . . . 0.0 109.841 -179.514 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 128' ' ' ASP . . . . . . . . . . . . . 18.8 p-10 -83.64 17.27 2.31 Favored 'General case' 0 CA--C 1.535 0.37 0 N-CA-C 112.695 0.628 . . . . 0.0 112.695 178.44 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 129' ' ' LEU . . . . . . . . . . . . . 47.4 mt -116.96 138.87 51.27 Favored 'General case' 0 C--O 1.232 0.133 0 CA-C-N 118.1 0.409 . . . . 0.0 110.697 179.563 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 130' ' ' VAL . . . . . . . . . . . . . 45.6 t -124.66 138.64 53.39 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.215 0 CA-C-N 116.127 -0.488 . . . . 0.0 109.814 179.419 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 131' ' ' VAL . . . . . 0.489 HG12 HD12 ' A' ' 140' ' ' LEU . 35.3 m -136.0 144.36 33.56 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.24 0 CA-C-O 121.236 0.541 . . . . 0.0 111.359 -179.738 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 132' ' ' ILE . . . . . . . . . . . . . 73.9 mt -117.36 133.64 63.49 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.297 0 CA-C-N 115.326 -0.852 . . . . 0.0 109.269 179.202 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 133' ' ' ILE . . . . . . . . . . . . . 40.9 mm -116.03 119.09 60.87 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.255 0 CA-C-O 120.806 0.336 . . . . 0.0 111.159 -175.204 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 134' ' ' ASP . . . . . . . . . . . . . 8.0 p-10 -133.85 145.59 49.83 Favored 'General case' 0 C--N 1.331 -0.212 0 N-CA-C 109.365 -0.605 . . . . 0.0 109.365 174.181 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 135' ' ' GLU . . . . . . . . . . . . . 43.3 tp10 -50.03 -28.01 6.38 Favored 'General case' 0 C--N 1.327 -0.375 0 N-CA-C 112.616 0.598 . . . . 0.0 112.616 -172.755 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 136' ' ' GLN . . . . . . . . . . . . . 97.4 mt-30 -78.11 -37.19 46.88 Favored 'General case' 0 C--N 1.331 -0.221 0 N-CA-C 112.35 0.5 . . . . 0.0 112.35 -177.188 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 137' ' ' LYS . . . . . . . . . . . . . 53.4 pttt -165.85 172.87 11.17 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-O 121.683 0.754 . . . . 0.0 112.271 -171.964 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 138' ' ' LEU . . . . . . . . . . . . . 6.5 tt -118.14 130.93 56.4 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 114.902 -1.045 . . . . 0.0 109.787 178.359 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 139' ' ' THR . . . . . . . . . . . . . 37.2 m -108.16 129.93 55.15 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.353 179.727 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 140' ' ' LEU . . . . . 0.489 HD12 HG12 ' A' ' 131' ' ' VAL . 36.7 tp -113.46 121.83 45.47 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 115.478 -0.783 . . . . 0.0 109.254 -178.298 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 141' ' ' ILE . . . . . . . . . . . . . 19.8 mt -119.65 116.26 50.11 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.292 0 N-CA-C 109.797 -0.446 . . . . 0.0 109.797 -176.42 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 142' ' ' ARG . . . . . . . . . . . . . 84.3 mtp180 -104.88 124.17 49.0 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 115.329 -0.851 . . . . 0.0 110.537 -178.832 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 143' ' ' THR . . . . . . . . . . . . . 37.0 p . . . . . 0 C--O 1.221 -0.412 0 CA-C-O 117.972 -1.013 . . . . 0.0 110.595 -179.912 . . . . . . . . 0 0 . 1 . 008 nuclear nobuild full ' B' B ' -3' ' ' GLU . . . . . . . . . . . . . 95.8 mt-10 . . . . . 0 N--CA 1.491 1.591 0 N-CA-C 109.354 -0.61 . . . . 0.0 109.354 . . . . . . . . . 0 0 . 1 . 008 nuclear nobuild full ' B' B ' -2' ' ' GLY . . . . . . . . . . . . . . . -61.45 149.98 45.17 Favored Glycine 0 CA--C 1.526 0.728 0 N-CA-C 110.775 -0.93 . . . . 0.0 110.775 179.804 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' -1' ' ' VAL . . . . . . . . . . . . . 45.2 t -95.77 134.21 34.11 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.332 0 N-CA-C 110.021 -0.363 . . . . 0.0 110.021 -179.796 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 0' ' ' ILE . . . . . . . . . . . . . 43.2 mm -114.51 128.96 71.35 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.236 0 CA-C-N 116.104 -0.498 . . . . 0.0 109.953 179.935 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 1' ' ' MET . . . . . . . . . . . . . 25.4 ptp -81.64 144.37 31.26 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.168 -0.469 . . . . 0.0 110.406 179.534 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 2' ' ' SER . . . . . . . . . . . . . 6.1 p -108.1 132.41 53.61 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-O 121.026 0.441 . . . . 0.0 110.481 -179.879 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 3' ' ' GLU . . . . . . . . . . . . . 84.6 tt0 -141.24 139.35 33.74 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 115.901 -0.591 . . . . 0.0 111.188 -179.108 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 4' ' ' LEU . . . . . . . . . . . . . 48.4 mt -119.75 129.77 54.65 Favored 'General case' 0 C--N 1.331 -0.212 0 CA-C-N 115.791 -0.64 . . . . 0.0 110.37 176.814 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 5' ' ' LYS . . . . . . . . . . . . . 59.9 mttp -104.75 119.22 38.48 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.167 -0.47 . . . . 0.0 110.257 177.187 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 6' ' ' LEU . . . . . . . . . . . . . 62.4 mt -117.46 144.16 45.3 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 115.516 -0.766 . . . . 0.0 110.075 -178.395 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 7' ' ' LYS . . . . . . . . . . . . . 33.7 ttpt -132.71 140.26 37.2 Favored Pre-proline 0 CA--C 1.532 0.279 0 CA-C-O 119.176 -0.44 . . . . 0.0 110.231 176.549 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 8' ' ' PRO . . . . . . . . . . . . . 91.5 Cg_endo -91.98 134.74 1.47 Allowed 'Trans proline' 0 N--CA 1.488 1.191 0 C-N-CA 121.795 1.663 . . . . 0.0 111.543 176.864 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 9' ' ' LEU . . . . . 0.436 HD12 ' HB2' ' B' ' 47' ' ' LYS . 26.8 mt -70.19 -46.99 21.33 Favored Pre-proline 0 CA--C 1.533 0.308 0 CA-C-O 118.683 -0.675 . . . . 0.0 112.026 -178.855 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' B' B ' 10' ' ' PRO . . . . . . . . . . . . . 94.6 Cg_endo -81.89 155.26 17.66 Favored 'Trans proline' 0 N--CA 1.496 1.631 0 C-N-CA 121.29 1.327 . . . . 0.0 111.883 175.372 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 11' ' ' LYS . . . . . . . . . . . . . 38.6 mmtm -88.18 102.6 14.96 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-O 120.793 0.33 . . . . 0.0 110.65 178.105 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 12' ' ' VAL . . . . . . . . . . . . . 12.2 p -146.45 146.47 18.89 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.26 0 CA-C-N 116.207 -0.451 . . . . 0.0 110.267 178.946 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 13' ' ' GLU . . . . . . . . . . . . . 80.6 tt0 -86.54 131.32 34.2 Favored 'General case' 0 C--N 1.33 -0.269 0 N-CA-C 109.941 -0.392 . . . . 0.0 109.941 178.312 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 14' ' ' LEU . . . . . . . . . . . . . 29.5 mt -96.57 151.67 38.11 Favored Pre-proline 0 CA--C 1.533 0.32 0 CA-C-N 116.402 -0.363 . . . . 0.0 110.814 -176.703 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 15' ' ' PRO . . . . . . . . . . . . . 25.8 Cg_exo -62.03 158.64 37.93 Favored 'Trans proline' 0 N--CA 1.497 1.735 0 C-N-CA 121.273 1.315 . . . . 0.0 111.93 176.793 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 16' ' ' PRO . . . . . . . . . . . . . 37.9 Cg_exo -58.71 -38.99 86.29 Favored 'Trans proline' 0 N--CA 1.498 1.741 0 C-N-CA 121.388 1.392 . . . . 0.0 112.835 -178.899 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 17' ' ' ASP . . . . . . . . . . . . . 10.7 p-10 -87.67 10.26 18.71 Favored 'General case' 0 CA--C 1.535 0.371 0 N-CA-C 113.279 0.844 . . . . 0.0 113.279 -176.951 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 18' ' ' PHE . . . . . . . . . . . . . 42.7 t80 -58.0 -44.95 87.5 Favored 'General case' 0 N--CA 1.457 -0.087 0 O-C-N 121.973 -0.454 . . . . 0.0 110.26 -177.489 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 19' ' ' VAL . . . . . 0.41 HG13 ' N ' ' B' ' 20' ' ' ASP . 13.6 p -56.15 -41.68 70.27 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.327 0 CA-C-N 116.62 -0.263 . . . . 0.0 110.958 -178.589 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' B' B ' 20' ' ' ASP . . . . . 0.41 ' N ' HG13 ' B' ' 19' ' ' VAL . 82.5 m-20 -60.83 -43.53 98.14 Favored 'General case' 0 C--N 1.331 -0.21 0 CA-C-O 120.799 0.333 . . . . 0.0 110.82 -178.278 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' B' B ' 21' ' ' VAL . . . . . . . . . . . . . 49.1 t -63.94 -48.46 86.05 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.285 0 C-N-CA 120.744 -0.383 . . . . 0.0 110.509 -177.347 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 22' ' ' ILE . . . . . 0.496 HG22 HD12 ' B' ' 26' ' ' LEU . 49.8 mm -55.61 -47.06 79.35 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.274 0 C-N-CA 120.978 -0.289 . . . . 0.0 110.892 -179.34 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' B' B ' 23' ' ' ARG . . . . . . . . . . . . . 45.7 ttp180 -55.69 -48.94 74.25 Favored 'General case' 0 C--N 1.33 -0.255 0 C-N-CA 120.83 -0.348 . . . . 0.0 111.234 -177.841 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 24' ' ' ILE . . . . . . . . . . . . . 76.3 mt -59.85 -41.63 86.39 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.215 0 C-N-CA 121.081 -0.248 . . . . 0.0 111.203 -177.407 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 25' ' ' LYS . . . . . . . . . . . . . 40.3 mmtm -64.08 -43.03 96.67 Favored 'General case' 0 C--N 1.329 -0.3 0 N-CA-C 112.216 0.451 . . . . 0.0 112.216 -179.593 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 26' ' ' LEU . . . . . 0.496 HD12 HG22 ' B' ' 22' ' ' ILE . 71.4 mt -78.69 -38.51 39.05 Favored 'General case' 0 C--N 1.328 -0.327 0 N-CA-C 113.502 0.927 . . . . 0.0 113.502 -169.888 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' B' B ' 27' ' ' GLN . . . . . . . . . . . . . 10.3 pt20 -47.52 140.13 6.21 Favored 'General case' 0 N--CA 1.469 0.51 0 N-CA-C 112.704 0.631 . . . . 0.0 112.704 -174.788 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 28' ' ' GLY . . . . . . . . . . . . . . . 98.73 -27.46 19.64 Favored Glycine 0 CA--C 1.532 1.137 0 CA-C-N 115.53 -0.759 . . . . 0.0 112.179 -178.438 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 29' ' ' LYS . . . . . . . . . . . . . 61.3 mtpt -98.25 155.03 17.38 Favored 'General case' 0 C--N 1.332 -0.181 0 CA-C-N 117.314 0.557 . . . . 0.0 111.06 179.602 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 30' ' ' THR . . . . . . . . . . . . . 30.1 m -94.54 136.73 34.51 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.032 -0.531 . . . . 0.0 110.003 176.321 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 31' ' ' VAL . . . . . . . . . . . . . 35.1 m -124.87 148.4 29.28 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.228 0 CA-C-N 116.308 -0.406 . . . . 0.0 110.549 -179.798 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 32' ' ' ARG . . . . . . . . . . . . . 33.6 ttm180 -136.02 146.52 47.24 Favored 'General case' 0 C--N 1.331 -0.219 0 CA-C-O 121.267 0.555 . . . . 0.0 110.583 178.501 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 33' ' ' THR . . . . . . . . . . . . . 22.8 m -53.04 139.93 26.72 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.206 -0.452 . . . . 0.0 111.317 -178.56 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 34' ' ' GLY . . . . . . . . . . . . . . . 101.23 -17.18 56.19 Favored Glycine 0 CA--C 1.534 1.254 0 CA-C-O 119.669 -0.517 . . . . 0.0 113.172 -179.989 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 35' ' ' ASP . . . . . . . . . . . . . 80.2 m-20 -66.57 146.99 53.9 Favored 'General case' 0 N--CA 1.461 0.108 0 CA-C-N 118.024 0.912 . . . . 0.0 111.086 178.421 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 36' ' ' VAL . . . . . . . . . . . . . 43.6 t -123.1 130.99 74.06 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.258 0 CA-C-N 116.009 -0.541 . . . . 0.0 109.781 177.898 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 37' ' ' ILE . . . . . . . . . . . . . 66.7 mt -122.17 138.84 51.02 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.289 0 CA-C-N 116.285 -0.416 . . . . 0.0 110.093 -179.401 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 38' ' ' GLY . . . . . . . . . . . . . . . -108.76 128.63 9.15 Favored Glycine 0 CA--C 1.526 0.746 0 N-CA-C 110.995 -0.842 . . . . 0.0 110.995 178.878 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 39' ' ' ILE . . . . . . . . . . . . . 74.6 mt -125.77 136.84 59.61 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.21 0 N-CA-C 110.16 -0.311 . . . . 0.0 110.16 179.766 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 40' ' ' SER . . . . . . . . . . . . . 38.0 t -92.59 115.33 28.0 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.363 -0.38 . . . . 0.0 110.832 175.822 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 41' ' ' ILE . . . . . . . . . . . . . 44.3 mm -121.48 119.1 58.03 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.198 0 CA-C-N 116.509 -0.314 . . . . 0.0 110.412 -179.905 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 42' ' ' LEU . . . . . . . . . . . . . 9.6 tp 53.27 36.88 23.86 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.194 -0.457 . . . . 0.0 111.576 176.964 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 43' ' ' GLY . . . . . . . . . . . . . . . 72.99 27.26 69.06 Favored Glycine 0 CA--C 1.53 0.993 0 C-N-CA 121.145 -0.55 . . . . 0.0 112.591 177.02 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 44' ' ' LYS . . . . . . . . . . . . . 97.8 mttt -136.67 134.91 37.76 Favored 'General case' 0 C--N 1.331 -0.212 0 N-CA-C 109.58 -0.526 . . . . 0.0 109.58 177.47 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 45' ' ' GLU . . . . . . . . . . . . . 84.3 tt0 -82.82 122.55 28.36 Favored 'General case' 0 C--N 1.329 -0.321 0 C-N-CA 120.701 -0.4 . . . . 0.0 111.066 -177.726 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 46' ' ' VAL . . . . . . . . . . . . . 7.1 p -121.04 128.53 76.08 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.206 0 N-CA-C 109.391 -0.596 . . . . 0.0 109.391 175.768 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 47' ' ' LYS . . . . . 0.436 ' HB2' HD12 ' B' ' 9' ' ' LEU . 68.5 mttm -100.31 126.87 46.69 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 115.979 -0.555 . . . . 0.0 110.971 178.335 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' B' B ' 48' ' ' PHE . . . . . . . . . . . . . 90.3 m-85 -109.14 131.95 54.58 Favored 'General case' 0 C--N 1.331 -0.228 0 N-CA-C 109.697 -0.483 . . . . 0.0 109.697 176.661 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 49' ' ' LYS . . . . . . . . . . . . . 83.1 tttt -108.54 135.5 49.7 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.282 -0.417 . . . . 0.0 110.371 179.037 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 50' ' ' VAL . . . . . . . . . . . . . 47.4 t -79.8 106.84 11.49 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.273 0 N-CA-C 109.164 -0.68 . . . . 0.0 109.164 175.906 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 51' ' ' VAL . . . . . . . . . . . . . 47.9 t -72.65 -48.62 45.55 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.273 0 CA-C-N 115.961 -0.563 . . . . 0.0 110.098 -173.547 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 52' ' ' GLN . . . . . . . . . . . . . 62.5 tt0 -161.83 145.58 12.4 Favored 'General case' 0 C--N 1.33 -0.246 0 C-N-CA 120.207 -0.597 . . . . 0.0 111.597 -177.341 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 53' ' ' ALA . . . . . . . . . . . . . . . -122.71 134.73 54.45 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 115.877 -0.602 . . . . 0.0 109.852 175.852 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 54' ' ' TYR . . . . . . . . . . . . . 31.2 t80 -129.07 111.71 18.4 Favored Pre-proline 0 CA--C 1.534 0.361 0 CA-C-O 118.331 -0.842 . . . . 0.0 110.506 -179.716 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 55' ' ' PRO . . . . . . . . . . . . . 74.3 Cg_endo -77.18 168.28 77.37 Favored 'Cis proline' 0 N--CA 1.5 1.882 0 CA-C-N 121.832 1.69 . . . . 0.0 112.005 -8.089 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 56' ' ' SER . . . . . . . . . . . . . 49.8 m -117.03 136.38 23.3 Favored Pre-proline 0 CA--C 1.537 0.468 0 CA-C-O 118.525 -0.75 . . . . 0.0 109.796 175.952 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 57' ' ' PRO . . . . . . . . . . . . . 43.1 Cg_endo -69.61 163.52 81.22 Favored 'Cis proline' 0 N--CA 1.497 1.714 0 CA-C-N 121.794 1.677 . . . . 0.0 111.259 -4.277 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 58' ' ' LEU . . . . . . . . . . . . . 20.8 tp -130.4 138.95 50.61 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-O 120.811 0.338 . . . . 0.0 110.829 -178.583 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 59' ' ' ARG . . . . . . . . . . . . . 55.9 ttp180 -99.18 124.17 44.02 Favored 'General case' 0 C--N 1.328 -0.352 0 N-CA-C 109.2 -0.667 . . . . 0.0 109.2 174.035 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 60' ' ' VAL . . . . . . . . . . . . . 40.7 t -73.77 125.35 32.77 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.289 0 C-N-CA 120.595 -0.442 . . . . 0.0 110.341 -175.113 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 61' ' ' GLU . . . . . . . . . . . . . 95.9 mt-10 -130.26 160.9 32.48 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 115.837 -0.619 . . . . 0.0 110.092 179.699 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 62' ' ' ASP . . . . . . . . . . . . . 7.3 p-10 -56.08 -32.9 64.56 Favored 'General case' 0 C--N 1.328 -0.349 0 C-N-CA 120.852 -0.339 . . . . 0.0 111.435 178.69 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 63' ' ' ARG . . . . . . . . . . . . . 15.5 ptm180 -82.59 6.7 16.82 Favored 'General case' 0 CA--C 1.537 0.473 0 N-CA-C 113.52 0.933 . . . . 0.0 113.52 -177.361 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 64' ' ' THR . . . . . . . . . . . . . 21.3 m -87.2 139.39 30.61 Favored 'General case' 0 C--N 1.333 -0.13 0 CA-C-N 118.119 0.418 . . . . 0.0 110.611 -178.262 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 65' ' ' LYS . . . . . . . . . . . . . 48.7 mtmt -88.89 128.71 35.68 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.082 -0.508 . . . . 0.0 110.373 179.291 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 66' ' ' ILE . . . . . . . . . . . . . 66.9 mt -117.73 128.31 74.94 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.261 0 N-CA-C 109.783 -0.451 . . . . 0.0 109.783 179.928 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 67' ' ' THR . . . . . . . . . . . . . 25.2 m -122.2 135.88 54.83 Favored 'General case' 0 C--N 1.332 -0.172 0 CA-C-O 121.074 0.464 . . . . 0.0 110.727 -179.096 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 68' ' ' LEU . . . . . 0.478 HD12 ' N ' ' B' ' 68' ' ' LEU . 8.0 mp -106.48 126.98 52.94 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 115.815 -0.63 . . . . 0.0 110.344 178.781 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' B' B ' 69' ' ' VAL . . . . . . . . . . . . . 44.1 t -98.17 130.91 46.25 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.247 0 CA-C-N 116.037 -0.529 . . . . 0.0 109.717 178.487 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 70' ' ' THR . . . . . . . . . . . . . 36.7 p -139.35 -54.63 0.57 Allowed 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.295 -0.411 . . . . 0.0 110.723 -178.389 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 71' ' ' HIS . . . . . . . . . . . . . 77.7 m80 -121.03 155.27 58.03 Favored Pre-proline 0 C--N 1.33 -0.261 0 CA-C-N 116.335 -0.393 . . . . 0.0 110.591 -179.504 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 72' ' ' PRO . . . . . . . . . . . . . 42.3 Cg_endo -67.94 -29.23 34.74 Favored 'Trans proline' 0 N--CA 1.496 1.622 0 C-N-CA 121.331 1.354 . . . . 0.0 112.481 178.931 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 73' ' ' VAL . . . . . . . . . . . . . 34.9 m -73.08 142.86 14.49 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.236 0 CA-C-O 121.052 0.453 . . . . 0.0 110.828 -179.19 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 74' ' ' ASP . . . . . . . . . . . . . 12.8 t70 -94.07 121.33 35.45 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 115.679 -0.691 . . . . 0.0 109.686 178.067 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 75' ' ' VAL . . . . . . . . . . . . . 45.8 t -110.29 122.57 65.06 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.236 0 CA-C-O 121.246 0.545 . . . . 0.0 110.42 -178.378 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 76' ' ' LEU . . . . . . . . . . . . . 26.7 mt -126.93 146.56 50.27 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 115.39 -0.823 . . . . 0.0 109.422 178.687 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 77' ' ' GLU . . . . . . . . . . . . . 97.6 mt-10 -134.35 138.8 45.18 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-O 121.089 0.471 . . . . 0.0 111.193 -177.346 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 78' ' ' ALA . . . . . 0.533 ' HB2' HD21 ' B' ' 109' ' ' LEU . . . -125.29 130.54 52.22 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 115.636 -0.711 . . . . 0.0 109.607 176.203 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' B' B ' 79' ' ' LYS . . . . . 0.66 ' O ' HD13 ' B' ' 80' ' ' ILE . 79.4 tttt -78.45 119.48 21.81 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-O 120.906 0.384 . . . . 0.0 110.636 -176.508 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' B' B ' 80' ' ' ILE . . . . . 0.66 HD13 ' O ' ' B' ' 79' ' ' LYS . 37.6 mm -139.24 105.02 2.32 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.325 0 N-CA-C 108.926 -0.768 . . . . 0.0 108.926 -178.807 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' B' B ' 81' ' ' LYS . . . . . . . . . . . . . 56.1 pttt -98.54 127.98 44.68 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-O 120.936 0.398 . . . . 0.0 111.557 -176.71 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 82' ' ' GLY . . . . . . . . . . . . . . . 89.14 42.12 5.67 Favored Glycine 0 CA--C 1.526 0.766 0 C-N-CA 121.036 -0.602 . . . . 0.0 111.975 175.148 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 83' ' ' ILE . . . . . . . . . . . . . 74.2 mt -71.81 138.88 20.72 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 N-CA-C 109.646 -0.502 . . . . 0.0 109.646 176.478 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 84' ' ' LYS . . . . . . . . . . . . . 33.1 ttpt -99.88 -52.94 3.3 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-O 120.938 0.399 . . . . 0.0 110.177 -179.802 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 85' ' ' ASP . . . . . . . . . . . . . 11.1 t70 -145.88 147.43 31.77 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 115.915 -0.584 . . . . 0.0 110.518 -178.813 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 86' ' ' VAL . . . . . . . . . . . . . 44.9 t -128.06 131.88 69.04 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.254 0 CA-C-O 120.81 0.338 . . . . 0.0 110.496 -179.105 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 87' ' ' ILE . . . . . 0.496 ' N ' HD12 ' B' ' 87' ' ' ILE . 5.1 mp -122.26 127.15 75.1 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.168 0 N-CA-C 109.692 -0.485 . . . . 0.0 109.692 177.434 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' B' B ' 88' ' ' LEU . . . . . . . . . . . . . 17.4 tp -111.22 131.63 54.97 Favored 'General case' 0 C--N 1.331 -0.201 0 CA-C-O 120.954 0.407 . . . . 0.0 110.934 -178.471 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 89' ' ' ASP . . . . . . . . . . . . . 5.9 t70 -126.09 155.33 41.77 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.014 -0.539 . . . . 0.0 109.73 178.039 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 90' ' ' GLU . . . . . . . . . . . . . 84.2 tt0 -47.12 -38.52 11.68 Favored 'General case' 0 CA--C 1.531 0.248 0 N-CA-C 112.888 0.699 . . . . 0.0 112.888 -172.181 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 91' ' ' ASN . . . . . . . . . . . . . 14.7 m120 -128.09 17.42 6.66 Favored 'General case' 0 N--CA 1.469 0.482 0 N-CA-C 113.007 0.743 . . . . 0.0 113.007 -177.085 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 92' ' ' LEU . . . . . . . . . . . . . 35.6 mt -147.91 144.46 28.09 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-O 120.801 0.334 . . . . 0.0 110.433 -176.171 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 93' ' ' ILE . . . . . . . . . . . . . 70.5 mt -122.84 115.32 45.49 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.373 0 N-CA-C 109.056 -0.72 . . . . 0.0 109.056 177.376 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 94' ' ' VAL . . . . . . . . . . . . . 42.6 t -117.32 126.84 74.81 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.283 0 CA-C-O 120.901 0.381 . . . . 0.0 110.178 -177.111 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 95' ' ' VAL . . . . . . . . . . . . . 46.5 t -122.39 133.18 69.41 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.337 0 CA-C-N 115.933 -0.576 . . . . 0.0 109.773 179.874 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 96' ' ' ILE . . . . . 0.51 HD11 ' HB ' ' B' ' 123' ' ' VAL . 66.0 mt -115.21 125.22 72.43 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.329 0 N-CA-C 109.315 -0.624 . . . . 0.0 109.315 179.097 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' B' B ' 97' ' ' THR . . . . . . . . . . . . . 80.4 p -99.75 158.0 16.09 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-O 121.202 0.525 . . . . 0.0 111.191 -176.127 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 98' ' ' GLU . . . . . . . . . . . . . 44.9 mt-10 -53.95 -26.12 24.03 Favored 'General case' 0 C--N 1.329 -0.319 0 N-CA-C 112.308 0.485 . . . . 0.0 112.308 -179.268 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 99' ' ' GLU . . . . . . . . . . . . . 70.0 mm-40 -78.84 15.73 1.02 Allowed 'General case' 0 CA--C 1.535 0.371 0 N-CA-C 113.203 0.816 . . . . 0.0 113.203 -176.829 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 100' ' ' ASN . . . . . . . . . . . . . 2.4 m-20 62.24 38.01 13.74 Favored 'General case' 0 N--CA 1.463 0.2 0 CA-C-O 121.118 0.485 . . . . 0.0 110.996 178.647 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 101' ' ' GLU . . . . . . . . . . . . . 84.6 tt0 -116.77 142.79 46.46 Favored 'General case' 0 C--N 1.331 -0.224 0 CA-C-N 116.021 -0.536 . . . . 0.0 109.917 176.486 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 102' ' ' VAL . . . . . . . . . . . . . 43.2 t -114.96 125.0 72.17 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.327 0 N-CA-C 109.738 -0.467 . . . . 0.0 109.738 -178.957 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 103' ' ' LEU . . . . . . . . . . . . . 57.5 mt -115.23 131.52 56.9 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 115.637 -0.71 . . . . 0.0 109.906 177.819 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 104' ' ' ILE . . . . . 0.419 HD12 ' HB3' ' B' ' 113' ' ' TYR . 67.4 mt -118.82 118.39 57.61 Favored 'Isoleucine or valine' 0 C--O 1.234 0.271 0 N-CA-C 110.096 -0.335 . . . . 0.0 110.096 -178.831 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' B' B ' 105' ' ' PHE . . . . . . . . . . . . . 68.8 m-85 -115.07 162.95 16.31 Favored 'General case' 0 C--N 1.332 -0.191 0 O-C-N 124.196 0.935 . . . . 0.0 109.893 179.265 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 106' ' ' ASN . . . . . . . . . . . . . 45.0 p-10 -102.62 -170.11 1.76 Allowed 'General case' 0 C--N 1.329 -0.3 0 N-CA-C 109.801 -0.444 . . . . 0.0 109.801 174.392 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 107' ' ' GLN . . . . . . . . . . . . . 60.3 tt0 -58.52 -28.27 65.28 Favored 'General case' 0 C--N 1.33 -0.248 0 N-CA-C 111.968 0.359 . . . . 0.0 111.968 177.682 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 108' ' ' ASN . . . . . . . . . . . . . 10.6 t-20 -84.11 7.09 19.9 Favored 'General case' 0 CA--C 1.536 0.439 0 N-CA-C 113.235 0.828 . . . . 0.0 113.235 -177.625 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 109' ' ' LEU . . . . . 0.533 HD21 ' HB2' ' B' ' 78' ' ' ALA . 6.5 tp 60.52 36.61 19.97 Favored 'General case' 0 C--O 1.233 0.197 0 CA-C-O 120.891 0.377 . . . . 0.0 111.414 178.745 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' B' B ' 110' ' ' GLU . . . . . . . . . . . . . 70.8 mm-40 -115.45 150.64 36.14 Favored 'General case' 0 C--N 1.331 -0.215 0 CA-C-O 120.723 0.297 . . . . 0.0 110.321 177.117 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 111' ' ' GLU . . . . . . . . . . . . . 24.7 mm-40 -78.14 122.69 25.97 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-O 121.188 0.518 . . . . 0.0 111.762 -177.752 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 112' ' ' LEU . . . . . . . . . . . . . 57.7 mt -102.94 -42.63 5.76 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 115.449 -0.796 . . . . 0.0 110.137 173.622 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 113' ' ' TYR . . . . . 0.419 ' HB3' HD12 ' B' ' 104' ' ' ILE . 56.3 t80 -139.12 140.81 38.05 Favored 'General case' 0 N--CA 1.463 0.205 0 CA-C-O 120.978 0.418 . . . . 0.0 111.329 -179.677 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' B' B ' 114' ' ' ARG . . . . . . . . . . . . . 66.4 mtm180 -139.85 125.27 19.06 Favored 'General case' 0 C--N 1.331 -0.22 0 CA-C-N 115.794 -0.639 . . . . 0.0 110.247 177.515 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 115' ' ' GLY . . . . . . . . . . . . . . . -150.03 153.12 24.9 Favored Glycine 0 CA--C 1.524 0.604 0 C-N-CA 120.697 -0.763 . . . . 0.0 111.581 179.46 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 116' ' ' LYS . . . . . . . . . . . . . 39.8 ttpt -122.16 135.15 54.75 Favored 'General case' 0 C--N 1.33 -0.258 0 N-CA-C 109.602 -0.518 . . . . 0.0 109.602 176.104 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 117' ' ' PHE . . . . . . . . . . . . . 47.1 m-85 -134.92 113.96 12.06 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-O 121.037 0.446 . . . . 0.0 110.335 -176.611 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 118' ' ' GLU . . . . . . . . . . . . . 84.8 tt0 -53.41 -49.87 66.38 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.384 -0.371 . . . . 0.0 111.485 -176.771 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 119' ' ' ASN . . . . . . . . . . . . . 19.6 m-80 -94.21 30.99 1.77 Allowed 'General case' 0 C--N 1.329 -0.284 0 N-CA-C 112.111 0.412 . . . . 0.0 112.111 -174.591 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 120' ' ' LEU . . . . . . . . . . . . . 14.9 tp -57.42 122.88 13.65 Favored 'General case' 0 C--N 1.332 -0.188 0 N-CA-C 110.28 -0.267 . . . . 0.0 110.28 178.289 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 121' ' ' ASN . . . . . . . . . . . . . 80.9 m-20 -114.01 -44.07 3.19 Favored 'General case' 0 C--N 1.331 -0.204 0 CA-C-N 116.628 -0.26 . . . . 0.0 111.215 -176.617 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 122' ' ' LYS . . . . . . . . . . . . . 54.0 mttm -143.34 145.71 32.92 Favored 'General case' 0 C--N 1.331 -0.199 0 C-N-CA 120.593 -0.443 . . . . 0.0 111.478 -177.406 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 123' ' ' VAL . . . . . 0.51 ' HB ' HD11 ' B' ' 96' ' ' ILE . 46.3 t -126.31 128.54 71.59 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.259 0 N-CA-C 109.38 -0.6 . . . . 0.0 109.38 175.522 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' B' B ' 124' ' ' LEU . . . . . . . . . . . . . 40.4 mt -126.84 136.45 52.37 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-O 120.812 0.339 . . . . 0.0 110.773 -177.292 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 125' ' ' VAL . . . . . . . . . . . . . 11.4 p -136.23 130.39 47.83 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.298 0 CA-C-N 116.338 -0.392 . . . . 0.0 110.134 177.244 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 126' ' ' ARG . . . . . . . . . . . . . 29.5 mmm180 -138.17 119.91 15.2 Favored 'General case' 0 C--N 1.331 -0.201 0 CA-C-N 116.281 -0.418 . . . . 0.0 110.417 -178.977 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 127' ' ' ASN . . . . . . . . . . . . . 78.3 m-20 50.14 -104.85 0.16 Allowed 'General case' 0 CA--C 1.544 0.713 0 CA-C-O 119.176 -0.44 . . . . 0.0 111.794 176.622 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 128' ' ' ASP . . . . . . . . . . . . . 18.1 p-10 -110.54 -0.43 17.34 Favored 'General case' 0 CA--C 1.536 0.415 0 N-CA-C 113.752 1.019 . . . . 0.0 113.752 -174.759 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 129' ' ' LEU . . . . . . . . . . . . . 83.7 mt -111.01 144.22 40.47 Favored 'General case' 0 C--N 1.332 -0.175 0 O-C-N 121.972 -0.455 . . . . 0.0 110.273 179.349 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 130' ' ' VAL . . . . . 0.566 HG13 ' HB ' ' B' ' 141' ' ' ILE . 13.6 p -130.81 138.58 53.25 Favored 'Isoleucine or valine' 0 C--O 1.233 0.214 0 CA-C-O 121.188 0.518 . . . . 0.0 110.423 178.706 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' B' B ' 131' ' ' VAL . . . . . . . . . . . . . 37.5 t -135.11 138.95 48.06 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.263 0 CA-C-N 115.858 -0.61 . . . . 0.0 110.47 -175.773 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 132' ' ' ILE . . . . . . . . . . . . . 70.1 mt -117.22 129.77 73.21 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.283 0 CA-C-N 115.866 -0.606 . . . . 0.0 109.409 178.869 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 133' ' ' ILE . . . . . . . . . . . . . 43.5 mm -114.0 119.46 61.22 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.244 0 CA-C-O 120.815 0.34 . . . . 0.0 110.652 -176.183 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 134' ' ' ASP . . . . . . . . . . . . . 9.0 p-10 -134.43 143.04 47.33 Favored 'General case' 0 C--N 1.33 -0.27 0 N-CA-C 109.586 -0.524 . . . . 0.0 109.586 177.05 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 135' ' ' GLU . . . . . . . . . . . . . 85.7 tt0 -49.93 -25.84 3.63 Favored 'General case' 0 C--N 1.328 -0.347 0 N-CA-C 112.594 0.59 . . . . 0.0 112.594 -174.316 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 136' ' ' GLN . . . . . . . . . . . . . 53.2 mt-30 -78.95 -38.28 37.48 Favored 'General case' 0 CA--C 1.531 0.216 0 N-CA-C 112.138 0.422 . . . . 0.0 112.138 -178.016 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 137' ' ' LYS . . . . . . . . . . . . . 19.6 ptpt -162.77 174.46 12.44 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-O 121.49 0.662 . . . . 0.0 111.958 -173.458 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 138' ' ' LEU . . . . . . . . . . . . . 6.1 tt -117.88 126.77 53.0 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 115.098 -0.956 . . . . 0.0 109.568 177.007 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 139' ' ' THR . . . . . . . . . . . . . 28.6 m -108.78 124.86 51.26 Favored 'General case' 0 C--N 1.331 -0.204 0 CA-C-N 116.372 -0.376 . . . . 0.0 110.619 -178.882 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 140' ' ' LEU . . . . . . . . . . . . . 17.9 tp -112.17 119.02 36.95 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 115.579 -0.737 . . . . 0.0 109.124 -179.449 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 141' ' ' ILE . . . . . 0.566 ' HB ' HG13 ' B' ' 130' ' ' VAL . 19.9 mt -119.29 121.11 65.74 Favored 'Isoleucine or valine' 0 C--O 1.235 0.309 0 CA-C-O 121.236 0.541 . . . . 0.0 110.375 -176.209 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' B' B ' 142' ' ' ARG . . . . . . . . . . . . . 7.8 mmm180 -94.75 117.34 29.97 Favored 'General case' 0 C--N 1.331 -0.224 0 CA-C-N 114.861 -1.063 . . . . 0.0 109.718 177.86 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 143' ' ' THR . . . . . . . . . . . . . 6.0 p . . . . . 0 C--O 1.221 -0.444 0 CA-C-O 117.929 -1.034 . . . . 0.0 110.523 -177.914 . . . . . . . . 0 0 . 1 . 008 nuclear nobuild full ' C' C ' -3' ' ' GLU . . . . . . . . . . . . . 95.9 mt-10 . . . . . 0 N--CA 1.49 1.541 0 N-CA-C 109.442 -0.577 . . . . 0.0 109.442 . . . . . . . . . 0 0 . 1 . 008 nuclear nobuild full ' C' C ' -2' ' ' GLY . . . . . . . . . . . . . . . -76.62 150.02 37.55 Favored Glycine 0 CA--C 1.525 0.68 0 N-CA-C 110.945 -0.862 . . . . 0.0 110.945 179.665 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' C' C ' -1' ' ' VAL . . . . . . . . . . . . . 47.5 t -88.9 133.85 29.97 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.325 0 CA-C-O 120.892 0.377 . . . . 0.0 110.007 179.792 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' C' C ' 0' ' ' ILE . . . . . . . . . . . . . 73.6 mt -112.27 133.92 56.45 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.242 0 CA-C-N 116.142 -0.481 . . . . 0.0 109.943 -179.606 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' C' C ' 1' ' ' MET . . . . . . . . . . . . . 26.0 ptm -79.67 132.18 36.16 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.224 -0.443 . . . . 0.0 110.246 178.181 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' C' C ' 2' ' ' SER . . . . . . . . . . . . . 3.1 p -130.58 125.96 35.5 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-O 121.041 0.448 . . . . 0.0 110.41 -179.63 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' C' C ' 3' ' ' GLU . . . . . . . . . . . . . 96.0 mt-10 -140.35 141.1 35.68 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 115.72 -0.673 . . . . 0.0 110.951 -177.886 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' C' C ' 4' ' ' LEU . . . . . . . . . . . . . 18.3 tp -123.19 127.06 48.12 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 115.771 -0.65 . . . . 0.0 109.799 175.795 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' C' C ' 5' ' ' LYS . . . . . . . . . . . . . 98.8 mttt -110.41 119.77 40.28 Favored 'General case' 0 C--O 1.234 0.26 0 CA-C-N 116.427 -0.352 . . . . 0.0 110.789 -179.257 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' C' C ' 6' ' ' LEU . . . . . . . . . . . . . 70.9 mt -114.8 143.98 44.23 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 115.302 -0.863 . . . . 0.0 110.277 -179.187 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' C' C ' 7' ' ' LYS . . . . . . . . . . . . . 51.3 tttm -128.26 133.29 24.99 Favored Pre-proline 0 CA--C 1.535 0.39 0 CA-C-O 118.777 -0.63 . . . . 0.0 110.102 177.442 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' C' C ' 8' ' ' PRO . . . . . . . . . . . . . 73.4 Cg_endo -89.01 136.32 2.95 Favored 'Trans proline' 0 N--CA 1.491 1.378 0 C-N-CA 121.61 1.54 . . . . 0.0 111.501 176.699 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' C' C ' 9' ' ' LEU . . . . . . . . . . . . . 75.8 mt -75.29 -52.08 3.16 Favored Pre-proline 0 CA--C 1.533 0.32 0 CA-C-O 118.712 -0.661 . . . . 0.0 112.02 -177.312 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' C' C ' 10' ' ' PRO . . . . . . . . . . . . . 60.4 Cg_endo -72.95 150.23 48.54 Favored 'Trans proline' 0 N--CA 1.5 1.866 0 C-N-CA 121.085 1.19 . . . . 0.0 111.948 174.375 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' C' C ' 11' ' ' LYS . . . . . . . . . . . . . 41.0 mtpt -89.13 100.78 13.49 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.502 -0.317 . . . . 0.0 110.825 179.391 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' C' C ' 12' ' ' VAL . . . . . . . . . . . . . 12.4 p -146.24 143.39 21.09 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.336 0 CA-C-N 116.265 -0.425 . . . . 0.0 110.579 179.223 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' C' C ' 13' ' ' GLU . . . . . . . . . . . . . 95.0 mt-10 -81.09 123.99 28.85 Favored 'General case' 0 C--N 1.33 -0.274 0 N-CA-C 109.98 -0.378 . . . . 0.0 109.98 177.916 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' C' C ' 14' ' ' LEU . . . . . . . . . . . . . 28.2 mt -98.27 152.31 37.92 Favored Pre-proline 0 CA--C 1.532 0.287 0 CA-C-N 116.425 -0.352 . . . . 0.0 110.601 -179.046 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' C' C ' 15' ' ' PRO . . . . . . . . . . . . . 34.3 Cg_exo -58.41 156.07 32.74 Favored 'Trans proline' 0 N--CA 1.497 1.693 0 C-N-CA 121.323 1.348 . . . . 0.0 111.854 178.088 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' C' C ' 16' ' ' PRO . . . . . . . . . . . . . 39.3 Cg_exo -58.85 -34.36 99.01 Favored 'Trans proline' 0 N--CA 1.496 1.64 0 C-N-CA 121.475 1.45 . . . . 0.0 112.677 -179.821 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' C' C ' 17' ' ' ASP . . . . . . . . . . . . . 19.4 p-10 -85.3 9.78 14.37 Favored 'General case' 0 CA--C 1.535 0.375 0 N-CA-C 113.081 0.771 . . . . 0.0 113.081 -177.545 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' C' C ' 18' ' ' PHE . . . . . . . . . . . . . 34.7 t80 -56.79 -42.15 78.96 Favored 'General case' 0 C--N 1.333 -0.118 0 O-C-N 121.939 -0.476 . . . . 0.0 110.365 -179.378 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' C' C ' 19' ' ' VAL . . . . . . . . . . . . . 53.1 t -56.43 -44.47 80.34 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 CA-C-N 116.361 -0.381 . . . . 0.0 110.469 -179.335 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' C' C ' 20' ' ' ASP . . . . . . . . . . . . . 82.8 m-20 -59.8 -42.5 93.55 Favored 'General case' 0 C--N 1.329 -0.308 0 C-N-CA 120.817 -0.353 . . . . 0.0 110.785 -178.271 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' C' C ' 21' ' ' VAL . . . . . . . . . . . . . 56.2 t -63.37 -47.75 90.45 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.303 0 C-N-CA 120.736 -0.385 . . . . 0.0 110.464 -177.294 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' C' C ' 22' ' ' ILE . . . . . 0.569 HG22 HD12 ' C' ' 26' ' ' LEU . 51.3 mm -55.42 -48.75 76.64 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.326 0 C-N-CA 121.077 -0.249 . . . . 0.0 110.8 -179.976 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' C' C ' 23' ' ' ARG . . . . . . . . . . . . . 55.4 ttp180 -55.66 -47.8 76.09 Favored 'General case' 0 C--N 1.33 -0.276 0 C-N-CA 120.806 -0.358 . . . . 0.0 111.415 -177.314 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' C' C ' 24' ' ' ILE . . . . . . . . . . . . . 75.8 mt -59.29 -42.01 85.87 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.311 0 C-N-CA 121.089 -0.244 . . . . 0.0 111.315 -177.284 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' C' C ' 25' ' ' LYS . . . . . . . . . . . . . 93.3 mttt -67.82 -43.79 78.78 Favored 'General case' 0 C--N 1.331 -0.219 0 N-CA-C 112.6 0.592 . . . . 0.0 112.6 -178.903 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' C' C ' 26' ' ' LEU . . . . . 0.569 HD12 HG22 ' C' ' 22' ' ' ILE . 70.6 mt -78.31 -33.96 48.98 Favored 'General case' 0 C--N 1.329 -0.313 0 N-CA-C 113.548 0.944 . . . . 0.0 113.548 -169.967 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' C' C ' 27' ' ' GLN . . . . . . . . . . . . . 6.2 pt20 -46.76 138.79 5.86 Favored 'General case' 0 N--CA 1.467 0.385 0 N-CA-C 112.971 0.73 . . . . 0.0 112.971 -173.925 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' C' C ' 28' ' ' GLY . . . . . . . . . . . . . . . 100.05 -27.18 21.51 Favored Glycine 0 CA--C 1.532 1.116 0 CA-C-N 115.614 -0.721 . . . . 0.0 112.214 -178.906 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' C' C ' 29' ' ' LYS . . . . . . . . . . . . . 61.8 mttp -97.96 155.21 17.2 Favored 'General case' 0 C--O 1.232 0.159 0 CA-C-N 117.341 0.571 . . . . 0.0 111.301 179.475 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' C' C ' 30' ' ' THR . . . . . . . . . . . . . 37.3 m -104.92 139.95 38.89 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-N 115.954 -0.566 . . . . 0.0 109.898 175.817 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' C' C ' 31' ' ' VAL . . . . . . . . . . . . . 34.7 m -127.31 152.26 35.13 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.218 0 CA-C-O 120.947 0.403 . . . . 0.0 111.077 -178.048 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' C' C ' 32' ' ' ARG . . . . . . . . . . . . . 97.1 mtt180 -126.35 149.47 49.17 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 115.834 -0.621 . . . . 0.0 110.622 177.912 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' C' C ' 33' ' ' THR . . . . . 0.401 HG23 ' O ' ' C' ' 51' ' ' VAL . 17.6 m -53.65 138.81 33.93 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-N 116.118 -0.492 . . . . 0.0 111.308 -178.658 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' C' C ' 34' ' ' GLY . . . . . . . . . . . . . . . 100.2 -17.15 57.4 Favored Glycine 0 CA--C 1.533 1.194 0 CA-C-O 119.672 -0.515 . . . . 0.0 113.333 178.967 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' C' C ' 35' ' ' ASP . . . . . . . . . . . . . 77.5 m-20 -65.53 148.35 51.88 Favored 'General case' 0 N--CA 1.462 0.142 0 CA-C-N 117.965 0.883 . . . . 0.0 110.922 178.869 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' C' C ' 36' ' ' VAL . . . . . . . . . . . . . 41.4 t -120.53 131.52 72.49 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.258 0 CA-C-N 116.007 -0.542 . . . . 0.0 109.858 178.943 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' C' C ' 37' ' ' ILE . . . . . . . . . . . . . 67.1 mt -118.68 138.11 50.46 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.225 0 CA-C-N 116.082 -0.508 . . . . 0.0 109.682 179.276 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' C' C ' 38' ' ' GLY . . . . . . . . . . . . . . . -114.85 128.75 8.28 Favored Glycine 0 CA--C 1.525 0.67 0 N-CA-C 111.006 -0.838 . . . . 0.0 111.006 -179.878 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' C' C ' 39' ' ' ILE . . . . . . . . . . . . . 73.0 mt -123.21 137.35 56.89 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.186 0 N-CA-C 110.252 -0.277 . . . . 0.0 110.252 179.585 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' C' C ' 40' ' ' SER . . . . . . . . . . . . . 99.5 p -91.69 117.71 30.0 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.329 -0.396 . . . . 0.0 110.713 175.767 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' C' C ' 41' ' ' ILE . . . . . 0.426 HD12 HG11 ' C' ' 46' ' ' VAL . 72.0 mt -127.79 121.48 56.64 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.202 0 CA-C-O 120.902 0.382 . . . . 0.0 110.397 178.82 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' C' C ' 42' ' ' LEU . . . . . . . . . . . . . 10.8 tp 52.3 35.61 17.5 Favored 'General case' 0 CA--C 1.531 0.23 0 CA-C-N 116.036 -0.529 . . . . 0.0 111.614 177.087 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' C' C ' 43' ' ' GLY . . . . . . . . . . . . . . . 72.07 31.88 63.73 Favored Glycine 0 CA--C 1.529 0.92 0 C-N-CA 121.183 -0.532 . . . . 0.0 111.972 178.047 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' C' C ' 44' ' ' LYS . . . . . . . . . . . . . 40.7 ttpt -138.79 129.75 26.58 Favored 'General case' 0 C--N 1.329 -0.313 0 N-CA-C 109.609 -0.515 . . . . 0.0 109.609 178.743 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' C' C ' 45' ' ' GLU . . . . . . . . . . . . . 84.6 tt0 -82.6 118.23 23.14 Favored 'General case' 0 C--N 1.328 -0.335 0 C-N-CA 120.753 -0.379 . . . . 0.0 110.673 -178.768 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' C' C ' 46' ' ' VAL . . . . . 0.426 HG11 HD12 ' C' ' 41' ' ' ILE . 7.5 p -114.94 127.36 72.52 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.153 0 N-CA-C 109.285 -0.635 . . . . 0.0 109.285 176.795 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' C' C ' 47' ' ' LYS . . . . . . . . . . . . . 64.2 mttp -100.45 128.15 46.59 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 115.817 -0.629 . . . . 0.0 111.306 179.724 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' C' C ' 48' ' ' PHE . . . . . . . . . . . . . 94.9 m-85 -111.83 131.86 55.07 Favored 'General case' 0 C--N 1.329 -0.283 0 N-CA-C 109.652 -0.499 . . . . 0.0 109.652 174.956 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' C' C ' 49' ' ' LYS . . . . . . . . . . . . . 41.8 tttp -107.57 136.57 47.12 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.619 -0.264 . . . . 0.0 110.427 179.287 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' C' C ' 50' ' ' VAL . . . . . . . . . . . . . 46.4 t -79.87 108.75 13.69 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.305 0 N-CA-C 109.164 -0.68 . . . . 0.0 109.164 176.273 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' C' C ' 51' ' ' VAL . . . . . 0.401 ' O ' HG23 ' C' ' 33' ' ' THR . 46.8 t -73.24 -51.63 25.13 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.293 0 CA-C-N 116.153 -0.476 . . . . 0.0 109.737 -175.336 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' C' C ' 52' ' ' GLN . . . . . . . . . . . . . 86.2 mt-30 -154.03 149.17 26.91 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-O 121.334 0.587 . . . . 0.0 112.077 -178.007 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' C' C ' 53' ' ' ALA . . . . . 0.531 ' HB3' ' OG ' ' C' ' 56' ' ' SER . . . -124.25 130.31 52.3 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 115.091 -0.958 . . . . 0.0 109.5 172.885 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' C' C ' 54' ' ' TYR . . . . . . . . . . . . . 45.5 t80 -128.97 107.08 18.1 Favored Pre-proline 0 CA--C 1.535 0.386 0 CA-C-O 118.24 -0.886 . . . . 0.0 110.593 -179.383 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' C' C ' 55' ' ' PRO . . . . . . . . . . . . . 73.3 Cg_endo -77.1 168.68 76.34 Favored 'Cis proline' 0 N--CA 1.499 1.827 0 CA-C-N 121.821 1.686 . . . . 0.0 112.243 -5.413 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' C' C ' 56' ' ' SER . . . . . 0.531 ' OG ' ' HB3' ' C' ' 53' ' ' ALA . 71.1 m -116.57 133.26 23.03 Favored Pre-proline 0 CA--C 1.537 0.472 0 CA-C-O 118.544 -0.741 . . . . 0.0 109.342 174.989 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' C' C ' 57' ' ' PRO . . . . . . . . . . . . . 55.3 Cg_endo -70.79 146.27 83.94 Favored 'Cis proline' 0 N--CA 1.498 1.745 0 CA-C-N 121.844 1.694 . . . . 0.0 111.688 -0.561 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' C' C ' 58' ' ' LEU . . . . . . . . . . . . . 31.4 tp -108.03 137.63 45.7 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.085 -0.507 . . . . 0.0 110.605 -178.7 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' C' C ' 59' ' ' ARG . . . . . . . . . . . . . 37.1 ttm180 -98.91 133.56 43.02 Favored 'General case' 0 C--N 1.328 -0.355 0 N-CA-C 109.453 -0.573 . . . . 0.0 109.453 175.273 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' C' C ' 60' ' ' VAL . . . . . . . . . . . . . 40.1 t -87.01 113.8 25.16 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.236 0 C-N-CA 120.616 -0.434 . . . . 0.0 110.386 -178.112 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' C' C ' 61' ' ' GLU . . . . . . . . . . . . . 15.7 mm-40 -131.1 163.66 27.17 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 115.944 -0.571 . . . . 0.0 109.769 174.246 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' C' C ' 62' ' ' ASP . . . . . . . . . . . . . 81.8 m-20 -52.32 -32.21 36.79 Favored 'General case' 0 C--N 1.329 -0.309 0 N-CA-C 111.802 0.297 . . . . 0.0 111.802 177.743 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' C' C ' 63' ' ' ARG . . . . . . . . . . . . . 41.4 mtp180 -72.07 -22.07 61.42 Favored 'General case' 0 CA--C 1.533 0.299 0 N-CA-C 112.884 0.698 . . . . 0.0 112.884 -176.484 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' C' C ' 64' ' ' THR . . . . . . . . . . . . . 40.5 m -72.27 138.12 47.22 Favored 'General case' 0 C--N 1.332 -0.186 0 CA-C-O 120.918 0.39 . . . . 0.0 110.657 -176.467 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' C' C ' 65' ' ' LYS . . . . . . . . . . . . . 38.8 ttpt -88.63 127.11 35.56 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 115.989 -0.551 . . . . 0.0 110.239 179.549 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' C' C ' 66' ' ' ILE . . . . . . . . . . . . . 72.5 mt -112.96 132.09 62.72 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.28 0 CA-C-O 120.892 0.377 . . . . 0.0 110.064 -178.053 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' C' C ' 67' ' ' THR . . . . . . . . . . . . . 23.4 m -125.29 137.26 54.07 Favored 'General case' 0 C--N 1.331 -0.212 0 CA-C-N 116.091 -0.504 . . . . 0.0 110.655 -179.239 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' C' C ' 68' ' ' LEU . . . . . . . . . . . . . 13.8 tp -104.74 124.82 50.06 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 115.887 -0.597 . . . . 0.0 110.527 179.841 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' C' C ' 69' ' ' VAL . . . . . . . . . . . . . 44.5 t -102.09 129.52 53.33 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.284 0 CA-C-N 116.02 -0.536 . . . . 0.0 109.695 178.589 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' C' C ' 70' ' ' THR . . . . . . . . . . . . . 40.5 p -144.71 -44.74 0.24 Allowed 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.299 -0.41 . . . . 0.0 110.574 -178.997 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' C' C ' 71' ' ' HIS . . . . . . . . . . . . . 31.7 m80 -124.52 166.43 19.84 Favored Pre-proline 0 C--N 1.329 -0.295 0 CA-C-N 115.909 -0.587 . . . . 0.0 110.297 -179.661 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' C' C ' 72' ' ' PRO . . . . . . . . . . . . . 17.3 Cg_exo -64.82 -23.16 62.81 Favored 'Trans proline' 0 N--CA 1.497 1.703 0 C-N-CA 121.356 1.371 . . . . 0.0 112.838 179.924 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' C' C ' 73' ' ' VAL . . . . . . . . . . . . . 34.6 m -126.3 157.57 36.64 Favored 'Isoleucine or valine' 0 N--CA 1.462 0.159 0 CA-C-O 120.752 0.31 . . . . 0.0 110.369 179.134 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' C' C ' 74' ' ' ASP . . . . . . . . . . . . . 42.3 t0 -104.55 121.52 43.66 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-N 116.332 -0.394 . . . . 0.0 110.183 -177.966 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' C' C ' 75' ' ' VAL . . . . . 0.44 ' C ' HD12 ' C' ' 76' ' ' LEU . 40.6 t -118.24 125.91 74.62 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.326 0 CA-C-O 121.107 0.479 . . . . 0.0 111.005 -176.462 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' C' C ' 76' ' ' LEU . . . . . 0.44 HD12 ' C ' ' C' ' 75' ' ' VAL . 6.8 mp -121.53 143.99 48.96 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 115.601 -0.727 . . . . 0.0 109.732 174.681 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' C' C ' 77' ' ' GLU . . . . . . . . . . . . . 97.0 mt-10 -134.47 130.67 37.06 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-O 120.988 0.423 . . . . 0.0 111.016 -177.995 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' C' C ' 78' ' ' ALA . . . . . . . . . . . . . . . -117.98 134.09 55.29 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 115.663 -0.699 . . . . 0.0 109.766 176.933 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' C' C ' 79' ' ' LYS . . . . . 0.58 ' O ' HD13 ' C' ' 80' ' ' ILE . 49.2 mtmt -77.47 120.71 22.85 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-O 120.967 0.413 . . . . 0.0 110.967 -177.956 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' C' C ' 80' ' ' ILE . . . . . 0.58 HD13 ' O ' ' C' ' 79' ' ' LYS . 42.1 mm -139.09 108.54 3.87 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.322 0 N-CA-C 108.933 -0.765 . . . . 0.0 108.933 -179.009 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' C' C ' 81' ' ' LYS . . . . . . . . . . . . . 44.0 mtmt -101.44 123.34 45.34 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-O 120.723 0.297 . . . . 0.0 111.257 -176.382 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' C' C ' 82' ' ' GLY . . . . . . . . . . . . . . . 89.07 42.43 5.62 Favored Glycine 0 CA--C 1.526 0.738 0 C-N-CA 120.652 -0.785 . . . . 0.0 111.794 174.674 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' C' C ' 83' ' ' ILE . . . . . . . . . . . . . 68.0 mt -65.29 137.03 25.73 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 CA-C-O 121.001 0.429 . . . . 0.0 109.862 177.733 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' C' C ' 84' ' ' LYS . . . . . . . . . . . . . 46.3 tttp -92.94 -52.52 4.55 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 115.942 -0.572 . . . . 0.0 109.94 179.891 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' C' C ' 85' ' ' ASP . . . . . . . . . . . . . 7.0 t70 -154.33 151.98 29.71 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 115.478 -0.783 . . . . 0.0 110.321 -179.225 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' C' C ' 86' ' ' VAL . . . . . . . . . . . . . 43.4 t -130.46 129.76 64.8 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.287 0 CA-C-N 116.47 -0.332 . . . . 0.0 110.495 -179.485 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' C' C ' 87' ' ' ILE . . . . . 0.501 ' N ' HD12 ' C' ' 87' ' ' ILE . 5.1 mp -119.37 128.78 75.85 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.285 0 N-CA-C 109.405 -0.591 . . . . 0.0 109.405 176.184 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' C' C ' 88' ' ' LEU . . . . . . . . . . . . . 23.7 tp -117.58 135.96 53.61 Favored 'General case' 0 C--N 1.331 -0.216 0 CA-C-O 121.014 0.435 . . . . 0.0 111.556 -176.126 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' C' C ' 89' ' ' ASP . . . . . . . . . . . . . 10.9 t70 -130.01 154.31 47.53 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 115.665 -0.698 . . . . 0.0 109.19 174.537 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' C' C ' 90' ' ' GLU . . . . . . . . . . . . . 96.6 mt-10 -49.81 -35.0 21.26 Favored 'General case' 0 C--N 1.33 -0.261 0 N-CA-C 112.718 0.636 . . . . 0.0 112.718 -172.277 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' C' C ' 91' ' ' ASN . . . . . . . . . . . . . 86.2 m-20 -130.29 32.61 4.44 Favored 'General case' 0 N--CA 1.465 0.294 0 N-CA-C 111.99 0.367 . . . . 0.0 111.99 -175.902 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' C' C ' 92' ' ' LEU . . . . . . . . . . . . . 8.7 tp -166.1 145.75 6.15 Favored 'General case' 0 C--N 1.331 -0.228 0 C-N-CA 120.933 -0.307 . . . . 0.0 110.782 178.67 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' C' C ' 93' ' ' ILE . . . . . . . . . . . . . 68.0 mt -125.93 124.08 65.47 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.181 0 N-CA-C 109.586 -0.524 . . . . 0.0 109.586 179.391 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' C' C ' 94' ' ' VAL . . . . . . . . . . . . . 43.3 t -122.64 125.21 72.21 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.223 0 N-CA-C 109.937 -0.394 . . . . 0.0 109.937 179.344 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' C' C ' 95' ' ' VAL . . . . . . . . . . . . . 43.8 t -124.08 134.67 65.94 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.299 0 CA-C-N 116.305 -0.407 . . . . 0.0 110.168 -179.461 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' C' C ' 96' ' ' ILE . . . . . . . . . . . . . 61.1 mt -118.99 130.52 73.7 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.238 0 N-CA-C 109.457 -0.571 . . . . 0.0 109.457 179.54 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' C' C ' 97' ' ' THR . . . . . . . . . . . . . 81.1 p -103.46 158.44 16.35 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-O 121.088 0.47 . . . . 0.0 111.44 -177.295 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' C' C ' 98' ' ' GLU . . . . . . . . . . . . . 98.1 mt-10 -53.97 -26.5 26.09 Favored 'General case' 0 CA--C 1.532 0.257 0 N-CA-C 112.392 0.516 . . . . 0.0 112.392 179.998 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' C' C ' 99' ' ' GLU . . . . . . . . . . . . . 95.8 mt-10 -77.78 14.05 1.18 Allowed 'General case' 0 CA--C 1.535 0.391 0 N-CA-C 113.302 0.853 . . . . 0.0 113.302 -177.23 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' C' C ' 100' ' ' ASN . . . . . . . . . . . . . 4.6 m-20 63.01 37.95 11.35 Favored 'General case' 0 C--O 1.232 0.142 0 CA-C-O 121.08 0.467 . . . . 0.0 111.033 178.489 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' C' C ' 101' ' ' GLU . . . . . . . . . . . . . 84.9 tt0 -117.65 140.11 50.1 Favored 'General case' 0 C--N 1.333 -0.151 0 CA-C-N 116.083 -0.508 . . . . 0.0 109.646 175.697 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' C' C ' 102' ' ' VAL . . . . . . . . . . . . . 45.7 t -115.16 128.83 72.18 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.263 0 CA-C-N 116.311 -0.404 . . . . 0.0 110.063 -178.667 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' C' C ' 103' ' ' LEU . . . . . 0.514 HD12 ' N ' ' C' ' 103' ' ' LEU . 6.1 mp -118.4 132.94 56.24 Favored 'General case' 0 C--N 1.331 -0.201 0 CA-C-N 115.695 -0.684 . . . . 0.0 110.131 176.904 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' C' C ' 104' ' ' ILE . . . . . . . . . . . . . 67.9 mt -117.92 122.48 69.82 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.228 0 CA-C-N 116.328 -0.397 . . . . 0.0 109.972 -179.766 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' C' C ' 105' ' ' PHE . . . . . . . . . . . . . 67.1 m-85 -123.16 164.67 18.24 Favored 'General case' 0 C--N 1.333 -0.132 0 O-C-N 123.916 0.76 . . . . 0.0 109.777 -179.972 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' C' C ' 106' ' ' ASN . . . . . . . . . . . . . 47.3 p-10 -102.42 -172.08 2.07 Favored 'General case' 0 C--N 1.33 -0.246 0 N-CA-C 110.151 -0.315 . . . . 0.0 110.151 174.688 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' C' C ' 107' ' ' GLN . . . . . . . . . . . . . 29.1 tt0 -58.81 -28.07 65.67 Favored 'General case' 0 C--N 1.329 -0.311 0 N-CA-C 112.086 0.402 . . . . 0.0 112.086 179.166 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' C' C ' 108' ' ' ASN . . . . . . . . . . . . . 7.9 t-20 -84.75 12.12 7.85 Favored 'General case' 0 CA--C 1.537 0.453 0 N-CA-C 112.89 0.7 . . . . 0.0 112.89 -177.956 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' C' C ' 109' ' ' LEU . . . . . . . . . . . . . 10.7 tp 53.8 37.22 25.89 Favored 'General case' 0 C--N 1.333 -0.148 0 CA-C-O 121.089 0.471 . . . . 0.0 111.315 179.409 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' C' C ' 110' ' ' GLU . . . . . . . . . . . . . 96.0 mt-10 -105.98 141.88 36.64 Favored 'General case' 0 C--N 1.33 -0.272 0 N-CA-C 109.325 -0.62 . . . . 0.0 109.325 174.528 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' C' C ' 111' ' ' GLU . . . . . . . . . . . . . 51.4 tt0 -79.61 121.92 25.87 Favored 'General case' 0 C--N 1.328 -0.332 0 C-N-CA 120.693 -0.403 . . . . 0.0 110.286 -176.478 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' C' C ' 112' ' ' LEU . . . . . . . . . . . . . 34.3 mt -102.85 -46.11 4.79 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.034 -0.53 . . . . 0.0 110.72 -179.668 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' C' C ' 113' ' ' TYR . . . . . . . . . . . . . 59.1 t80 -137.45 140.8 41.46 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.034 -0.53 . . . . 0.0 110.927 -177.824 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' C' C ' 114' ' ' ARG . . . . . . . . . . . . . 28.5 ptt180 -144.83 126.08 14.75 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-O 120.93 0.395 . . . . 0.0 110.664 176.56 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' C' C ' 115' ' ' GLY . . . . . . . . . . . . . . . -150.01 151.8 23.82 Favored Glycine 0 CA--C 1.524 0.61 0 N-CA-C 111.131 -0.788 . . . . 0.0 111.131 179.297 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' C' C ' 116' ' ' LYS . . . . . . . . . . . . . 39.7 ttpt -119.53 132.55 55.78 Favored 'General case' 0 C--N 1.329 -0.296 0 N-CA-C 110.006 -0.368 . . . . 0.0 110.006 178.185 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' C' C ' 117' ' ' PHE . . . . . . . . . . . . . 37.5 m-85 -128.93 113.8 15.66 Favored 'General case' 0 C--N 1.329 -0.286 0 N-CA-C 109.878 -0.416 . . . . 0.0 109.878 -178.257 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' C' C ' 118' ' ' GLU . . . . . . . . . . . . . 85.1 tt0 -55.54 -38.49 69.35 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-N 116.398 -0.364 . . . . 0.0 111.339 -175.308 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' C' C ' 119' ' ' ASN . . . . . . . . . . . . . 10.5 p-10 -108.73 31.14 5.87 Favored 'General case' 0 N--CA 1.463 0.196 0 N-CA-C 112.237 0.458 . . . . 0.0 112.237 -173.106 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' C' C ' 120' ' ' LEU . . . . . . . . . . . . . 15.0 tp -54.36 126.81 24.71 Favored 'General case' 0 N--CA 1.463 0.21 0 O-C-N 122.358 -0.213 . . . . 0.0 110.683 177.024 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' C' C ' 121' ' ' ASN . . . . . . . . . . . . . 27.1 m120 -110.56 -44.22 3.72 Favored 'General case' 0 C--N 1.332 -0.187 0 C-N-CA 121.169 -0.212 . . . . 0.0 111.173 -177.06 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' C' C ' 122' ' ' LYS . . . . . . . . . . . . . 95.2 mttt -148.36 148.15 30.05 Favored 'General case' 0 C--N 1.331 -0.229 0 CA-C-O 121.028 0.442 . . . . 0.0 111.44 -178.266 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' C' C ' 123' ' ' VAL . . . . . . . . . . . . . 47.0 t -127.42 128.33 69.83 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.223 0 N-CA-C 109.569 -0.53 . . . . 0.0 109.569 174.769 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' C' C ' 124' ' ' LEU . . . . . . . . . . . . . 67.9 mt -126.45 135.22 51.1 Favored 'General case' 0 C--N 1.331 -0.217 0 CA-C-N 116.494 -0.321 . . . . 0.0 110.626 -178.785 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' C' C ' 125' ' ' VAL . . . . . 0.515 HG23 HG22 ' C' ' 130' ' ' VAL . 12.4 p -138.05 137.45 44.5 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.284 0 CA-C-N 116.442 -0.345 . . . . 0.0 110.524 179.141 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' C' C ' 126' ' ' ARG . . . . . . . . . . . . . 90.6 mtt180 -143.96 123.32 13.08 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.565 178.676 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' C' C ' 127' ' ' ASN . . . . . . . . . . . . . 1.9 m-80 51.67 -105.02 0.19 Allowed 'General case' 0 CA--C 1.544 0.723 0 CA-C-O 119.134 -0.46 . . . . 0.0 111.279 -179.814 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' C' C ' 128' ' ' ASP . . . . . . . . . . . . . 8.9 p-10 -114.11 1.99 14.77 Favored 'General case' 0 CA--C 1.536 0.406 0 CA-C-N 119.538 1.063 . . . . 0.0 113.49 -176.53 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' C' C ' 129' ' ' LEU . . . . . . . . . . . . . 54.4 mt -104.97 135.49 46.21 Favored 'General case' 0 C--N 1.332 -0.185 0 CA-C-N 118.193 0.451 . . . . 0.0 110.401 179.618 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' C' C ' 130' ' ' VAL . . . . . 0.515 HG22 HG23 ' C' ' 125' ' ' VAL . 47.2 t -123.35 135.16 64.15 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.22 0 N-CA-C 109.913 -0.403 . . . . 0.0 109.913 179.991 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' C' C ' 131' ' ' VAL . . . . . 0.48 HG22 HD12 ' C' ' 140' ' ' LEU . 42.0 t -134.32 135.37 54.29 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.344 0 CA-C-O 121.125 0.488 . . . . 0.0 110.103 178.257 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' C' C ' 132' ' ' ILE . . . . . . . . . . . . . 72.5 mt -115.35 130.2 70.31 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.361 0 CA-C-N 115.498 -0.774 . . . . 0.0 109.179 -179.682 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' C' C ' 133' ' ' ILE . . . . . . . . . . . . . 44.6 mm -114.06 120.03 62.78 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.248 0 CA-C-O 120.981 0.419 . . . . 0.0 110.631 -176.226 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' C' C ' 134' ' ' ASP . . . . . . . . . . . . . 6.7 p-10 -129.58 149.51 51.31 Favored 'General case' 0 C--N 1.331 -0.23 0 CA-C-N 115.97 -0.559 . . . . 0.0 109.539 176.117 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' C' C ' 135' ' ' GLU . . . . . . . . . . . . . 41.4 tp10 -49.96 -27.05 4.81 Favored 'General case' 0 C--N 1.327 -0.378 0 N-CA-C 112.806 0.669 . . . . 0.0 112.806 -169.927 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' C' C ' 136' ' ' GLN . . . . . . . . . . . . . 30.7 tt0 -103.67 -22.82 13.51 Favored 'General case' 0 N--CA 1.465 0.282 0 N-CA-C 113.093 0.775 . . . . 0.0 113.093 -173.402 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' C' C ' 137' ' ' LYS . . . . . . . . . . . . . 54.0 mtmt -148.77 157.16 43.24 Favored 'General case' 0 C--N 1.332 -0.153 0 CA-C-O 121.212 0.529 . . . . 0.0 112.008 -170.649 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' C' C ' 138' ' ' LEU . . . . . 0.415 HD23 ' C ' ' C' ' 138' ' ' LEU . 5.5 tt -120.18 125.48 48.29 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 115.568 -0.742 . . . . 0.0 109.444 175.312 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' C' C ' 139' ' ' THR . . . . . . . . . . . . . 37.6 m -111.57 131.57 55.15 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-O 120.762 0.315 . . . . 0.0 111.126 -176.463 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' C' C ' 140' ' ' LEU . . . . . 0.48 HD12 HG22 ' C' ' 131' ' ' VAL . 14.3 tp -116.35 122.5 45.06 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 115.527 -0.761 . . . . 0.0 109.428 -179.67 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' C' C ' 141' ' ' ILE . . . . . . . . . . . . . 19.5 mt -120.77 119.45 59.59 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.29 0 N-CA-C 109.687 -0.486 . . . . 0.0 109.687 -177.258 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' C' C ' 142' ' ' ARG . . . . . . . . . . . . . 53.2 ttt180 -108.96 125.28 51.87 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 115.301 -0.863 . . . . 0.0 110.501 -176.341 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' C' C ' 143' ' ' THR . . . . . 0.43 HG22 HG12 ' D' ' 73' ' ' VAL . 81.0 p . . . . . 0 C--O 1.219 -0.503 0 CA-C-O 117.945 -1.026 . . . . 0.0 110.522 179.33 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' D' D ' -3' ' ' GLU . . . . . . . . . . . . . 84.6 tt0 . . . . . 0 N--CA 1.491 1.61 0 N-CA-C 109.505 -0.554 . . . . 0.0 109.505 . . . . . . . . . 0 0 . 1 . 008 nuclear nobuild full ' D' D ' -2' ' ' GLY . . . . . . . . . . . . . . . -60.69 146.28 47.07 Favored Glycine 0 CA--C 1.525 0.683 0 N-CA-C 110.501 -1.04 . . . . 0.0 110.501 178.607 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' D' D ' -1' ' ' VAL . . . . . . . . . . . . . 43.0 t -95.08 129.8 44.73 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.28 0 CA-C-O 120.818 0.342 . . . . 0.0 110.143 -178.933 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' D' D ' 0' ' ' ILE . . . . . . . . . . . . . 70.8 mt -118.56 143.43 29.54 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.28 0 CA-C-N 116.066 -0.515 . . . . 0.0 109.78 -179.975 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' D' D ' 1' ' ' MET . . . . . . . . . . . . . 22.2 ptm -142.91 125.53 15.86 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.043 -0.526 . . . . 0.0 110.382 -179.62 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' D' D ' 2' ' ' SER . . . . . . . . . . . . . 4.2 p -107.28 127.81 53.87 Favored 'General case' 0 C--N 1.331 -0.206 0 CA-C-O 121.167 0.508 . . . . 0.0 110.698 -179.343 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' D' D ' 3' ' ' GLU . . . . . . . . . . . . . 84.8 tt0 -141.28 141.97 33.92 Favored 'General case' 0 C--N 1.326 -0.423 0 CA-C-N 115.578 -0.737 . . . . 0.0 111.121 -178.25 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' D' D ' 4' ' ' LEU . . . . . . . . . . . . . 65.2 mt -119.9 128.98 54.14 Favored 'General case' 0 C--N 1.331 -0.224 0 CA-C-N 115.739 -0.664 . . . . 0.0 110.436 176.303 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' D' D ' 5' ' ' LYS . . . . . . . . . . . . . 61.1 mttp -106.02 119.55 39.49 Favored 'General case' 0 C--O 1.235 0.322 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.303 176.62 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' D' D ' 6' ' ' LEU . . . . . . . . . . . . . 73.2 mt -118.18 152.08 36.36 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-N 115.457 -0.792 . . . . 0.0 110.726 -177.72 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' D' D ' 7' ' ' LYS . . . . . . . . . . . . . 29.2 ttpt -143.27 140.92 18.28 Favored Pre-proline 0 CA--C 1.534 0.354 0 CA-C-O 119.19 -0.434 . . . . 0.0 110.067 174.33 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' D' D ' 8' ' ' PRO . . . . . . . . . . . . . 93.9 Cg_endo -89.27 138.23 3.25 Favored 'Trans proline' 0 N--CA 1.489 1.23 0 C-N-CA 121.752 1.635 . . . . 0.0 111.555 177.875 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' D' D ' 9' ' ' LEU . . . . . . . . . . . . . 84.9 mt -70.85 -48.81 14.59 Favored Pre-proline 0 C--N 1.329 -0.306 0 CA-C-O 119.143 -0.456 . . . . 0.0 111.045 -178.824 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' D' D ' 10' ' ' PRO . . . . . . . . . . . . . 95.6 Cg_endo -79.75 138.44 13.36 Favored 'Trans proline' 0 N--CA 1.495 1.57 0 C-N-CA 121.098 1.198 . . . . 0.0 111.228 169.398 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' D' D ' 11' ' ' LYS . . . . . . . . . . . . . 82.3 tttt -87.88 102.86 15.11 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-O 120.886 0.375 . . . . 0.0 110.472 -178.923 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' D' D ' 12' ' ' VAL . . . . . . . . . . . . . 12.1 p -140.77 147.86 22.43 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.248 0 CA-C-N 116.127 -0.488 . . . . 0.0 110.518 -179.391 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' D' D ' 13' ' ' GLU . . . . . . . . . . . . . 95.2 mt-10 -78.93 123.36 27.19 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 116.3 -0.409 . . . . 0.0 110.041 178.392 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' D' D ' 14' ' ' LEU . . . . . . . . . . . . . 21.8 mt -98.55 153.88 37.76 Favored Pre-proline 0 C--N 1.33 -0.24 0 CA-C-N 116.427 -0.351 . . . . 0.0 111.103 -178.072 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' D' D ' 15' ' ' PRO . . . . . . . . . . . . . 37.9 Cg_exo -59.72 158.8 26.85 Favored 'Trans proline' 0 N--CA 1.497 1.717 0 C-N-CA 121.359 1.373 . . . . 0.0 111.83 178.295 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' D' D ' 16' ' ' PRO . . . . . . . . . . . . . 26.4 Cg_exo -60.47 -37.96 77.21 Favored 'Trans proline' 0 N--CA 1.498 1.787 0 C-N-CA 121.424 1.416 . . . . 0.0 112.911 -177.347 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' D' D ' 17' ' ' ASP . . . . . . . . . . . . . 22.6 p-10 -89.93 11.01 21.71 Favored 'General case' 0 CA--C 1.537 0.464 0 N-CA-C 113.303 0.853 . . . . 0.0 113.303 -176.47 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' D' D ' 18' ' ' PHE . . . . . . . . . . . . . 51.2 t80 -57.97 -42.81 85.83 Favored 'General case' 0 C--O 1.227 -0.081 0 O-C-N 121.996 -0.44 . . . . 0.0 110.113 -178.933 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' D' D ' 19' ' ' VAL . . . . . . . . . . . . . 48.2 t -57.34 -41.22 77.93 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.306 0 CA-C-N 116.234 -0.439 . . . . 0.0 110.391 -178.624 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' D' D ' 20' ' ' ASP . . . . . . . . . . . . . 79.7 m-20 -59.9 -43.53 94.77 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-O 120.798 0.333 . . . . 0.0 110.876 -177.916 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' D' D ' 21' ' ' VAL . . . . . . . . . . . . . 45.4 t -64.63 -46.46 92.37 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.312 0 C-N-CA 120.719 -0.392 . . . . 0.0 110.527 -177.801 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' D' D ' 22' ' ' ILE . . . . . 0.646 HG22 HD12 ' D' ' 26' ' ' LEU . 50.3 mm -56.44 -45.6 81.86 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.276 0 CA-C-O 120.727 0.299 . . . . 0.0 110.571 179.215 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' D' D ' 23' ' ' ARG . . . . . . . . . . . . . 59.4 ttp180 -53.34 -49.7 66.56 Favored 'General case' 0 C--N 1.331 -0.224 0 CA-C-O 120.835 0.35 . . . . 0.0 111.412 -178.704 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' D' D ' 24' ' ' ILE . . . . . . . . . . . . . 72.9 mt -59.61 -45.76 93.83 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.262 0 CA-C-N 116.281 -0.418 . . . . 0.0 111.136 -177.32 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' D' D ' 25' ' ' LYS . . . . . . . . . . . . . 59.4 mtpt -65.32 -37.35 86.83 Favored 'General case' 0 C--N 1.33 -0.263 0 N-CA-C 112.354 0.502 . . . . 0.0 112.354 -177.121 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' D' D ' 26' ' ' LEU . . . . . 0.646 HD12 HG22 ' D' ' 22' ' ' ILE . 25.9 mt -78.25 -45.68 22.26 Favored 'General case' 0 C--N 1.329 -0.296 0 N-CA-C 112.979 0.733 . . . . 0.0 112.979 -172.781 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' D' D ' 27' ' ' GLN . . . . . . . . . . . . . 11.3 pt20 -46.89 138.52 6.29 Favored 'General case' 0 N--CA 1.468 0.452 0 N-CA-C 112.728 0.64 . . . . 0.0 112.728 -175.68 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' D' D ' 28' ' ' GLY . . . . . . . . . . . . . . . 100.89 -26.6 24.04 Favored Glycine 0 CA--C 1.534 1.223 0 CA-C-N 115.542 -0.754 . . . . 0.0 112.274 -176.596 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' D' D ' 29' ' ' LYS . . . . . . . . . . . . . 65.8 mttm -98.74 155.12 17.51 Favored 'General case' 0 C--N 1.332 -0.154 0 CA-C-N 117.261 0.53 . . . . 0.0 111.217 179.259 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' D' D ' 30' ' ' THR . . . . . . . . . . . . . 17.7 m -102.73 137.13 41.35 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.185 -0.461 . . . . 0.0 110.084 176.128 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' D' D ' 31' ' ' VAL . . . . . . . . . . . . . 33.8 m -130.87 156.88 43.04 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.263 0 CA-C-O 120.816 0.341 . . . . 0.0 110.857 -179.158 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' D' D ' 32' ' ' ARG . . . . . . . . . . . . . 60.9 ttt180 -134.62 150.0 50.63 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 115.992 -0.549 . . . . 0.0 110.218 178.283 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' D' D ' 33' ' ' THR . . . . . . . . . . . . . 31.7 m -52.38 140.17 22.79 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-O 120.826 0.346 . . . . 0.0 111.421 -177.737 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' D' D ' 34' ' ' GLY . . . . . . . . . . . . . . . 99.68 -17.1 57.99 Favored Glycine 0 CA--C 1.531 1.053 0 C-N-CA 121.199 -0.524 . . . . 0.0 113.286 179.105 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' D' D ' 35' ' ' ASP . . . . . . . . . . . . . 72.5 m-20 -65.16 149.1 50.49 Favored 'General case' 0 C--O 1.231 0.101 0 CA-C-N 118.086 0.943 . . . . 0.0 111.141 179.427 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' D' D ' 36' ' ' VAL . . . . . . . . . . . . . 46.1 t -123.1 131.13 73.81 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.223 0 CA-C-N 115.683 -0.69 . . . . 0.0 109.798 178.409 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' D' D ' 37' ' ' ILE . . . . . . . . . . . . . 71.5 mt -119.59 139.79 45.75 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.251 0 CA-C-N 116.166 -0.47 . . . . 0.0 109.958 -179.709 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' D' D ' 38' ' ' GLY . . . . . . . . . . . . . . . -113.01 128.74 8.55 Favored Glycine 0 CA--C 1.526 0.721 0 N-CA-C 111.051 -0.82 . . . . 0.0 111.051 179.492 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' D' D ' 39' ' ' ILE . . . . . . . . . . . . . 68.3 mt -123.28 133.65 68.53 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.185 0 N-CA-C 110.103 -0.332 . . . . 0.0 110.103 179.241 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' D' D ' 40' ' ' SER . . . . . . . . . . . . . 93.4 p -92.69 122.67 35.32 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.394 -0.366 . . . . 0.0 110.729 175.859 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' D' D ' 41' ' ' ILE . . . . . . . . . . . . . 68.2 mt -129.04 119.64 49.76 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.219 0 CA-C-O 120.754 0.312 . . . . 0.0 110.482 178.218 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' D' D ' 42' ' ' LEU . . . . . . . . . . . . . 10.4 tp 51.94 37.21 20.4 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.143 -0.48 . . . . 0.0 111.594 176.907 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' D' D ' 43' ' ' GLY . . . . . . . . . . . . . . . 72.96 30.13 63.84 Favored Glycine 0 CA--C 1.528 0.886 0 C-N-CA 121.007 -0.616 . . . . 0.0 112.34 177.512 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' D' D ' 44' ' ' LYS . . . . . . . . . . . . . 81.9 mttt -136.57 129.39 30.78 Favored 'General case' 0 C--N 1.329 -0.313 0 N-CA-C 109.667 -0.494 . . . . 0.0 109.667 177.925 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' D' D ' 45' ' ' GLU . . . . . . . . . . . . . 85.2 tt0 -83.56 123.42 29.74 Favored 'General case' 0 C--N 1.329 -0.3 0 C-N-CA 120.812 -0.355 . . . . 0.0 111.141 -177.854 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' D' D ' 46' ' ' VAL . . . . . . . . . . . . . 7.7 p -120.97 128.3 76.06 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.231 0 N-CA-C 109.481 -0.563 . . . . 0.0 109.481 175.972 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' D' D ' 47' ' ' LYS . . . . . . . . . . . . . 35.3 mtmm -102.11 129.72 48.52 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 115.809 -0.632 . . . . 0.0 111.645 -179.892 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' D' D ' 48' ' ' PHE . . . . . . . . . . . . . 88.3 m-85 -112.8 131.97 55.46 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.368 -0.378 . . . . 0.0 110.37 177.224 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' D' D ' 49' ' ' LYS . . . . . . . . . . . . . 60.5 tttt -106.01 137.39 44.0 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.517 -0.31 . . . . 0.0 110.576 178.796 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' D' D ' 50' ' ' VAL . . . . . . . . . . . . . 45.5 t -84.82 107.84 16.24 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.241 0 N-CA-C 109.198 -0.667 . . . . 0.0 109.198 174.735 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' D' D ' 51' ' ' VAL . . . . . . . . . . . . . 47.2 t -73.07 -47.61 47.1 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.302 0 CA-C-N 116.153 -0.476 . . . . 0.0 110.159 -173.099 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' D' D ' 52' ' ' GLN . . . . . . . . . . . . . 62.8 tt0 -161.4 139.18 9.16 Favored 'General case' 0 C--N 1.331 -0.226 0 C-N-CA 120.231 -0.588 . . . . 0.0 111.884 -177.321 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' D' D ' 53' ' ' ALA . . . . . . . . . . . . . . . -115.96 133.61 55.85 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 115.655 -0.702 . . . . 0.0 109.609 174.144 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' D' D ' 54' ' ' TYR . . . . . . . . . . . . . 44.3 t80 -128.94 110.77 18.49 Favored Pre-proline 0 CA--C 1.537 0.449 0 CA-C-O 118.112 -0.947 . . . . 0.0 110.489 -179.531 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' D' D ' 55' ' ' PRO . . . . . . . . . . . . . 73.6 Cg_endo -77.13 169.9 73.03 Favored 'Cis proline' 0 N--CA 1.5 1.869 0 CA-C-N 121.853 1.698 . . . . 0.0 112.155 -6.987 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' D' D ' 56' ' ' SER . . . . . . . . . . . . . 49.1 m -117.79 135.01 23.19 Favored Pre-proline 0 CA--C 1.54 0.574 0 CA-C-O 118.42 -0.8 . . . . 0.0 109.949 175.901 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' D' D ' 57' ' ' PRO . . . . . . . . . . . . . 38.3 Cg_endo -68.45 163.73 77.04 Favored 'Cis proline' 0 N--CA 1.498 1.773 0 CA-C-N 121.875 1.705 . . . . 0.0 111.361 -3.754 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' D' D ' 58' ' ' LEU . . . . . . . . . . . . . 37.4 tp -129.78 137.94 50.79 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-O 120.877 0.37 . . . . 0.0 110.595 -179.866 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' D' D ' 59' ' ' ARG . . . . . . . . . . . . . 62.0 ttm-85 -100.62 121.28 41.35 Favored 'General case' 0 C--N 1.326 -0.414 0 N-CA-C 109.142 -0.688 . . . . 0.0 109.142 174.593 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' D' D ' 60' ' ' VAL . . . . . . . . . . . . . 42.3 t -74.54 124.81 32.92 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 C-N-CA 120.778 -0.369 . . . . 0.0 110.391 -173.786 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' D' D ' 61' ' ' GLU . . . . . . . . . . . . . 70.5 mm-40 -131.01 163.39 27.68 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 115.913 -0.585 . . . . 0.0 109.868 177.569 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' D' D ' 62' ' ' ASP . . . . . . . . . . . . . 14.9 p-10 -55.67 -31.64 62.56 Favored 'General case' 0 C--N 1.328 -0.346 0 N-CA-C 111.749 0.278 . . . . 0.0 111.749 -178.898 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' D' D ' 63' ' ' ARG . . . . . . . . . . . . . 10.0 ptm180 -83.68 6.75 19.81 Favored 'General case' 0 CA--C 1.536 0.438 0 N-CA-C 113.553 0.946 . . . . 0.0 113.553 -176.121 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' D' D ' 64' ' ' THR . . . . . . . . . . . . . 29.3 m -85.64 139.68 31.2 Favored 'General case' 0 C--N 1.332 -0.184 0 CA-C-N 118.192 0.451 . . . . 0.0 110.651 -179.074 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' D' D ' 65' ' ' LYS . . . . . . . . . . . . . 38.1 mtmt -89.07 132.6 34.7 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.273 -0.421 . . . . 0.0 110.419 179.657 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' D' D ' 66' ' ' ILE . . . . . . . . . . . . . 61.6 mt -120.38 128.16 75.97 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.221 0 CA-C-N 116.366 -0.379 . . . . 0.0 110.046 -177.244 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' D' D ' 67' ' ' THR . . . . . . . . . . . . . 27.8 m -130.21 142.65 50.55 Favored 'General case' 0 C--N 1.332 -0.177 0 CA-C-O 120.978 0.418 . . . . 0.0 111.234 -178.638 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' D' D ' 68' ' ' LEU . . . . . 0.456 ' N ' HD12 ' D' ' 68' ' ' LEU . 7.2 mp -107.09 140.53 39.77 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.049 -0.523 . . . . 0.0 110.65 177.827 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' D' D ' 69' ' ' VAL . . . . . . . . . . . . . 43.2 t -100.18 126.53 53.68 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.263 0 CA-C-N 116.209 -0.451 . . . . 0.0 109.976 177.129 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' D' D ' 70' ' ' THR . . . . . . . . . . . . . 81.8 p -148.41 169.17 20.78 Favored 'General case' 0 C--N 1.332 -0.195 0 CA-C-O 120.91 0.386 . . . . 0.0 111.192 -179.585 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' D' D ' 71' ' ' HIS . . . . . . . . . . . . . 6.1 m-70 -136.77 157.13 75.52 Favored Pre-proline 0 C--N 1.329 -0.301 0 CA-C-N 115.882 -0.599 . . . . 0.0 109.952 177.591 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' D' D ' 72' ' ' PRO . . . . . 0.523 ' O ' HG13 ' D' ' 73' ' ' VAL . 56.0 Cg_endo -71.07 -30.24 16.62 Favored 'Trans proline' 0 N--CA 1.497 1.688 0 C-N-CA 121.128 1.219 . . . . 0.0 112.397 -179.38 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' D' D ' 73' ' ' VAL . . . . . 0.523 HG13 ' O ' ' D' ' 72' ' ' PRO . 2.5 m -158.97 132.83 1.32 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.214 0 CA-C-N 116.224 -0.444 . . . . 0.0 110.262 176.242 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' D' D ' 74' ' ' ASP . . . . . . . . . . . . . 15.3 t0 -99.06 118.81 36.67 Favored 'General case' 0 C--N 1.325 -0.497 0 N-CA-C 108.829 -0.804 . . . . 0.0 108.829 173.894 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' D' D ' 75' ' ' VAL . . . . . . . . . . . . . 47.8 t -110.19 122.04 64.07 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.218 0 CA-C-O 121.132 0.491 . . . . 0.0 110.671 -176.325 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' D' D ' 76' ' ' LEU . . . . . . . . . . . . . 5.1 mp -124.08 138.66 54.41 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 115.657 -0.701 . . . . 0.0 109.28 174.5 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' D' D ' 77' ' ' GLU . . . . . . . . . . . . . 69.3 tt0 -134.37 136.9 43.71 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-O 120.955 0.407 . . . . 0.0 110.803 -177.801 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' D' D ' 78' ' ' ALA . . . . . . . . . . . . . . . -121.52 138.59 54.23 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 115.959 -0.564 . . . . 0.0 110.434 178.774 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' D' D ' 79' ' ' LYS . . . . . 0.581 ' O ' HD13 ' D' ' 80' ' ' ILE . 7.6 ttpm? -77.75 115.38 17.46 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 116.438 -0.346 . . . . 0.0 110.419 179.582 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' D' D ' 80' ' ' ILE . . . . . 0.581 HD13 ' O ' ' D' ' 79' ' ' LYS . 42.1 mm -139.06 108.09 3.68 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.273 0 N-CA-C 109.328 -0.619 . . . . 0.0 109.328 -178.369 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' D' D ' 81' ' ' LYS . . . . . . . . . . . . . 55.1 pttt -106.76 129.82 54.57 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-O 120.921 0.391 . . . . 0.0 111.518 -176.33 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' D' D ' 82' ' ' GLY . . . . . . . . . . . . . . . 88.95 42.19 5.72 Favored Glycine 0 CA--C 1.526 0.778 0 N-CA-C 111.529 -0.628 . . . . 0.0 111.529 176.752 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' D' D ' 83' ' ' ILE . . . . . . . . . . . . . 73.3 mt -71.92 138.76 20.95 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.32 0 N-CA-C 109.718 -0.475 . . . . 0.0 109.718 178.064 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' D' D ' 84' ' ' LYS . . . . . . . . . . . . . 50.4 tttp -95.7 -53.87 3.56 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 116.023 -0.535 . . . . 0.0 110.207 -178.136 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' D' D ' 85' ' ' ASP . . . . . . . . . . . . . 8.3 t70 -152.55 152.26 31.66 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 115.795 -0.639 . . . . 0.0 110.14 -179.594 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' D' D ' 86' ' ' VAL . . . . . . . . . . . . . 46.6 t -127.74 129.07 70.01 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.224 0 CA-C-O 120.883 0.373 . . . . 0.0 110.44 -179.041 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' D' D ' 87' ' ' ILE . . . . . . . . . . . . . 44.5 mm -117.97 127.5 75.2 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.217 0 CA-C-N 115.941 -0.572 . . . . 0.0 109.461 176.682 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' D' D ' 88' ' ' LEU . . . . . . . . . . . . . 12.5 tp -113.98 131.63 56.26 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-O 120.998 0.427 . . . . 0.0 111.154 -176.861 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' D' D ' 89' ' ' ASP . . . . . . . . . . . . . 13.8 t70 -123.88 152.08 42.76 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 115.78 -0.646 . . . . 0.0 109.432 176.837 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' D' D ' 90' ' ' GLU . . . . . . . . . . . . . 46.2 tp10 -47.84 -36.85 12.65 Favored 'General case' 0 CA--C 1.531 0.242 0 N-CA-C 112.735 0.643 . . . . 0.0 112.735 -172.967 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' D' D ' 91' ' ' ASN . . . . . . . . . . . . . 28.7 m120 -132.02 32.39 4.04 Favored 'General case' 0 N--CA 1.466 0.338 0 C-N-CA 120.846 -0.342 . . . . 0.0 111.916 -176.508 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' D' D ' 92' ' ' LEU . . . . . . . . . . . . . 9.7 tp -166.11 148.14 6.97 Favored 'General case' 0 C--N 1.329 -0.291 0 C-N-CA 121.008 -0.277 . . . . 0.0 110.591 -179.839 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' D' D ' 93' ' ' ILE . . . . . . . . . . . . . 64.1 mt -127.06 124.54 64.68 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.284 0 N-CA-C 109.58 -0.526 . . . . 0.0 109.58 -179.356 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' D' D ' 94' ' ' VAL . . . . . 0.624 HG21 HG11 ' D' ' 125' ' ' VAL . 46.7 t -124.08 127.74 73.64 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.234 0 CA-C-O 121.004 0.431 . . . . 0.0 110.181 179.99 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' D' D ' 95' ' ' VAL . . . . . . . . . . . . . 44.6 t -121.88 135.47 61.9 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.261 0 CA-C-N 116.054 -0.521 . . . . 0.0 109.931 179.984 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' D' D ' 96' ' ' ILE . . . . . . . . . . . . . 66.2 mt -116.3 129.49 72.64 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 N-CA-C 109.356 -0.609 . . . . 0.0 109.356 178.82 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' D' D ' 97' ' ' THR . . . . . . . . . . . . . 79.6 p -100.0 158.48 15.8 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-O 121.02 0.438 . . . . 0.0 111.105 -177.334 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' D' D ' 98' ' ' GLU . . . . . . . . . . . . . 97.1 mt-10 -54.06 -26.36 26.43 Favored 'General case' 0 C--N 1.329 -0.288 0 N-CA-C 112.219 0.451 . . . . 0.0 112.219 -179.795 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' D' D ' 99' ' ' GLU . . . . . . . . . . . . . 41.0 mt-10 -80.04 16.85 1.1 Allowed 'General case' 0 CA--C 1.536 0.412 0 N-CA-C 112.99 0.737 . . . . 0.0 112.99 -177.759 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' D' D ' 100' ' ' ASN . . . . . . . . . . . . . 3.3 m-20 63.16 37.94 10.99 Favored 'General case' 0 N--CA 1.463 0.197 0 CA-C-O 121.05 0.452 . . . . 0.0 111.085 177.453 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' D' D ' 101' ' ' GLU . . . . . . . . . . . . . 98.2 mt-10 -112.18 146.0 38.87 Favored 'General case' 0 C--N 1.332 -0.162 0 CA-C-N 116.2 -0.455 . . . . 0.0 110.419 174.981 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' D' D ' 102' ' ' VAL . . . . . 0.449 ' C ' HD12 ' D' ' 103' ' ' LEU . 45.3 t -117.01 127.18 74.69 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.363 0 CA-C-N 115.762 -0.654 . . . . 0.0 109.606 179.134 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' D' D ' 103' ' ' LEU . . . . . 0.449 HD12 ' C ' ' D' ' 102' ' ' VAL . 7.4 mp -119.45 129.76 54.92 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 115.883 -0.599 . . . . 0.0 110.207 175.716 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' D' D ' 104' ' ' ILE . . . . . . . . . . . . . 73.8 mt -114.13 122.22 67.81 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.335 0 CA-C-N 116.024 -0.534 . . . . 0.0 109.885 -179.341 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' D' D ' 105' ' ' PHE . . . . . . . . . . . . . 85.8 m-85 -119.23 160.03 22.94 Favored 'General case' 0 C--N 1.331 -0.229 0 O-C-N 124.17 0.919 . . . . 0.0 109.894 179.96 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' D' D ' 106' ' ' ASN . . . . . . . . . . . . . 42.8 p-10 -95.04 -170.22 2.15 Favored 'General case' 0 C--N 1.329 -0.321 0 N-CA-C 109.557 -0.534 . . . . 0.0 109.557 172.799 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' D' D ' 107' ' ' GLN . . . . . . . . . . . . . 58.2 tt0 -61.07 -25.57 67.03 Favored 'General case' 0 C--N 1.329 -0.314 0 N-CA-C 112.123 0.416 . . . . 0.0 112.123 178.54 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' D' D ' 108' ' ' ASN . . . . . . . . . . . . . 5.7 t-20 -83.66 3.2 33.93 Favored 'General case' 0 CA--C 1.538 0.518 0 N-CA-C 113.133 0.79 . . . . 0.0 113.133 -178.703 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' D' D ' 109' ' ' LEU . . . . . . . . . . . . . 9.1 tp 62.86 37.23 12.35 Favored 'General case' 0 C--O 1.232 0.151 0 CA-C-O 120.945 0.402 . . . . 0.0 111.36 179.39 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' D' D ' 110' ' ' GLU . . . . . . . . . . . . . 96.3 mt-10 -106.82 149.95 26.86 Favored 'General case' 0 C--N 1.331 -0.216 0 N-CA-C 110.025 -0.361 . . . . 0.0 110.025 176.458 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' D' D ' 111' ' ' GLU . . . . . . . . . . . . . 43.0 tp10 -79.67 121.98 25.98 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-O 121.114 0.483 . . . . 0.0 110.803 -176.889 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' D' D ' 112' ' ' LEU . . . . . . . . . . . . . 28.4 mt -103.93 -46.08 4.58 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 115.747 -0.661 . . . . 0.0 110.119 176.541 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' D' D ' 113' ' ' TYR . . . . . . . . . . . . . 65.2 t80 -142.53 135.5 28.37 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.226 -0.443 . . . . 0.0 111.33 -179.614 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' D' D ' 114' ' ' ARG . . . . . . . . . . . . . 79.0 ttt-85 -139.98 121.94 15.62 Favored 'General case' 0 C--N 1.331 -0.229 0 CA-C-N 116.321 -0.399 . . . . 0.0 110.121 177.17 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' D' D ' 115' ' ' GLY . . . . . . . . . . . . . . . -150.15 161.98 29.07 Favored Glycine 0 CA--C 1.525 0.656 0 N-CA-C 110.982 -0.847 . . . . 0.0 110.982 -178.761 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' D' D ' 116' ' ' LYS . . . . . . . . . . . . . 39.0 ttpt -120.08 137.32 54.2 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-O 120.741 0.305 . . . . 0.0 110.307 178.622 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' D' D ' 117' ' ' PHE . . . . . . . . . . . . . 31.6 m-85 -133.39 113.95 13.13 Favored 'General case' 0 C--N 1.33 -0.244 0 N-CA-C 109.859 -0.423 . . . . 0.0 109.859 179.224 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' D' D ' 118' ' ' GLU . . . . . . . . . . . . . 95.9 mt-10 -55.72 -44.8 77.83 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.33 -0.396 . . . . 0.0 111.228 -174.898 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' D' D ' 119' ' ' ASN . . . . . . . . . . . . . 20.2 m120 -95.89 30.93 2.23 Favored 'General case' 0 C--N 1.33 -0.275 0 N-CA-C 112.132 0.419 . . . . 0.0 112.132 -174.11 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' D' D ' 120' ' ' LEU . . . . . . . . . . . . . 13.3 tp -57.35 119.74 6.99 Favored 'General case' 0 C--N 1.334 -0.083 0 C-N-CA 120.984 -0.287 . . . . 0.0 110.259 178.078 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' D' D ' 121' ' ' ASN . . . . . . . . . . . . . 73.4 m-20 -114.12 -44.06 3.17 Favored 'General case' 0 C--N 1.332 -0.156 0 CA-C-N 116.409 -0.359 . . . . 0.0 111.118 -178.405 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' D' D ' 122' ' ' LYS . . . . . . . . . . . . . 63.1 mtpt -141.96 148.73 39.09 Favored 'General case' 0 C--N 1.331 -0.219 0 CA-C-O 121.079 0.466 . . . . 0.0 111.607 -176.611 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' D' D ' 123' ' ' VAL . . . . . . . . . . . . . 43.9 t -131.53 125.9 57.1 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.252 0 CA-C-N 115.854 -0.612 . . . . 0.0 109.512 174.565 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' D' D ' 124' ' ' LEU . . . . . . . . . . . . . 49.7 mt -122.79 137.46 54.92 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-O 120.74 0.305 . . . . 0.0 110.697 -178.157 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' D' D ' 125' ' ' VAL . . . . . 0.624 HG11 HG21 ' D' ' 94' ' ' VAL . 34.8 m -129.69 130.1 66.69 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.25 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.789 179.735 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' D' D ' 126' ' ' ARG . . . . . . . . . . . . . 83.0 mtt180 -144.94 118.96 9.37 Favored 'General case' 0 C--N 1.328 -0.348 0 N-CA-C 109.56 -0.533 . . . . 0.0 109.56 177.164 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' D' D ' 127' ' ' ASN . . . . . . . . . . . . . 30.8 m120 56.73 -149.05 0.47 Allowed 'General case' 0 CA--C 1.54 0.596 0 N-CA-C 109.648 -0.501 . . . . 0.0 109.648 -178.229 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' D' D ' 128' ' ' ASP . . . . . . . . . . . . . 23.3 p-10 -82.41 12.96 3.92 Favored 'General case' 0 CA--C 1.536 0.429 0 CA-C-N 118.773 0.715 . . . . 0.0 112.88 178.364 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' D' D ' 129' ' ' LEU . . . . . . . . . . . . . 16.1 tp -108.64 134.98 50.64 Favored 'General case' 0 C--O 1.233 0.196 0 CA-C-N 118.261 0.482 . . . . 0.0 110.088 178.637 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' D' D ' 130' ' ' VAL . . . . . . . . . . . . . 44.0 t -126.26 141.36 46.05 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.303 0 CA-C-O 120.929 0.395 . . . . 0.0 110.623 -177.539 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' D' D ' 131' ' ' VAL . . . . . . . . . . . . . 42.6 t -133.63 133.99 56.8 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.305 0 CA-C-N 116.049 -0.523 . . . . 0.0 110.126 177.994 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' D' D ' 132' ' ' ILE . . . . . . . . . . . . . 65.8 mt -118.41 134.0 63.42 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.343 0 N-CA-C 109.364 -0.606 . . . . 0.0 109.364 178.834 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' D' D ' 133' ' ' ILE . . . . . . . . . . . . . 37.6 mm -117.14 123.56 71.96 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.254 0 CA-C-O 120.619 0.247 . . . . 0.0 111.122 -174.367 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' D' D ' 134' ' ' ASP . . . . . . . . . . . . . 9.8 p-10 -135.82 147.62 48.36 Favored 'General case' 0 C--N 1.331 -0.202 0 N-CA-C 109.537 -0.542 . . . . 0.0 109.537 173.295 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' D' D ' 135' ' ' GLU . . . . . . . . . . . . . 85.2 tt0 -49.9 -27.7 5.58 Favored 'General case' 0 C--N 1.328 -0.356 0 N-CA-C 112.89 0.7 . . . . 0.0 112.89 -170.184 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' D' D ' 136' ' ' GLN . . . . . . . . . . . . . 98.0 mt-30 -82.21 -40.03 22.26 Favored 'General case' 0 C--O 1.235 0.297 0 N-CA-C 112.185 0.439 . . . . 0.0 112.185 -176.92 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' D' D ' 137' ' ' LYS . . . . . . . . . . . . . 56.6 pttt -156.73 167.04 31.66 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-O 121.523 0.678 . . . . 0.0 112.294 -169.745 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' D' D ' 138' ' ' LEU . . . . . . . . . . . . . 6.0 tt -116.24 127.74 55.01 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 115.06 -0.973 . . . . 0.0 109.664 178.156 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' D' D ' 139' ' ' THR . . . . . . . . . . . . . 29.0 m -106.71 126.62 52.52 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-N 116.281 -0.418 . . . . 0.0 110.712 -178.313 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' D' D ' 140' ' ' LEU . . . . . . . . . . . . . 21.1 tp -111.51 122.83 48.86 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 115.664 -0.698 . . . . 0.0 109.191 179.553 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' D' D ' 141' ' ' ILE . . . . . . . . . . . . . 19.5 mt -121.16 118.89 57.61 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.279 0 N-CA-C 109.87 -0.419 . . . . 0.0 109.87 -174.664 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' D' D ' 142' ' ' ARG . . . . . . . . . . . . . 48.5 mtm180 -109.0 127.97 54.55 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 115.481 -0.781 . . . . 0.0 110.098 -178.527 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' D' D ' 143' ' ' THR . . . . . . . . . . . . . 6.9 p . . . . . 0 C--O 1.22 -0.497 0 CA-C-O 117.989 -1.005 . . . . 0.0 110.61 -179.472 . . . . . . . . 0 0 . 1 . 008 nuclear nobuild full ' E' E ' -3' ' ' GLU . . . . . . . . . . . . . 95.9 mt-10 . . . . . 0 N--CA 1.489 1.523 0 N-CA-C 109.432 -0.581 . . . . 0.0 109.432 . . . . . . . . . 0 0 . 1 . 008 nuclear nobuild full ' E' E ' -2' ' ' GLY . . . . . . . . . . . . . . . -69.71 130.89 23.34 Favored Glycine 0 CA--C 1.526 0.737 0 N-CA-C 111.065 -0.814 . . . . 0.0 111.065 -179.444 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' E' E ' -1' ' ' VAL . . . . . . . . . . . . . 45.4 t -141.4 140.85 31.19 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.285 0 N-CA-C 109.806 -0.442 . . . . 0.0 109.806 179.271 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' E' E ' 0' ' ' ILE . . . . . . . . . . . . . 71.6 mt -107.72 135.95 44.67 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.288 0 CA-C-O 120.89 0.376 . . . . 0.0 110.078 -178.748 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' E' E ' 1' ' ' MET . . . . . . . . . . . . . 26.1 ptm -78.67 138.41 38.28 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 116.011 -0.541 . . . . 0.0 110.549 179.397 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' E' E ' 2' ' ' SER . . . . . . . . . . . . . 2.9 p -128.59 130.56 47.52 Favored 'General case' 0 C--N 1.331 -0.201 0 CA-C-N 116.24 -0.436 . . . . 0.0 110.449 179.101 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' E' E ' 3' ' ' GLU . . . . . . . . . . . . . 84.7 tt0 -141.99 141.59 32.88 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.089 -0.505 . . . . 0.0 111.06 -179.302 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' E' E ' 4' ' ' LEU . . . . . . . . . . . . . 17.0 tp -126.12 126.86 44.85 Favored 'General case' 0 C--N 1.332 -0.195 0 CA-C-N 116.136 -0.483 . . . . 0.0 110.257 177.664 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' E' E ' 5' ' ' LYS . . . . . . . . . . . . . 61.6 mttp -107.06 121.39 44.39 Favored 'General case' 0 C--O 1.235 0.319 0 CA-C-N 116.251 -0.431 . . . . 0.0 110.7 178.5 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' E' E ' 6' ' ' LEU . . . . . . . . . . . . . 72.6 mt -116.84 146.25 43.02 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 115.326 -0.852 . . . . 0.0 110.46 -178.784 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' E' E ' 7' ' ' LYS . . . . . . . . . . . . . 55.6 tttm -135.24 139.75 32.55 Favored Pre-proline 0 CA--C 1.534 0.351 0 CA-C-O 119.135 -0.459 . . . . 0.0 110.361 176.927 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' E' E ' 8' ' ' PRO . . . . . . . . . . . . . 84.7 Cg_endo -91.85 139.46 2.19 Favored 'Trans proline' 0 N--CA 1.489 1.262 0 C-N-CA 121.694 1.596 . . . . 0.0 111.632 176.602 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' E' E ' 9' ' ' LEU . . . . . . . . . . . . . 38.7 mt -76.03 -48.4 3.52 Favored Pre-proline 0 CA--C 1.534 0.363 0 CA-C-O 118.631 -0.7 . . . . 0.0 112.569 -178.036 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' E' E ' 10' ' ' PRO . . . . . . . . . . . . . 91.3 Cg_endo -80.06 157.13 23.49 Favored 'Trans proline' 0 N--CA 1.497 1.723 0 C-N-CA 121.315 1.343 . . . . 0.0 111.912 178.126 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' E' E ' 11' ' ' LYS . . . . . . . . . . . . . 17.4 pttp -83.17 112.54 19.93 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-O 121.55 0.691 . . . . 0.0 110.428 176.84 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' E' E ' 12' ' ' VAL . . . . . . . . . . . . . 12.5 p -151.13 151.19 12.65 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.248 0 CA-C-N 115.629 -0.714 . . . . 0.0 110.58 -178.769 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' E' E ' 13' ' ' GLU . . . . . . . . . . . . . 96.5 mt-10 -97.71 121.68 39.9 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.3 -0.409 . . . . 0.0 110.351 177.679 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' E' E ' 14' ' ' LEU . . . . . . . . . . . . . 39.4 mt -98.45 137.65 20.72 Favored Pre-proline 0 CA--C 1.534 0.351 0 CA-C-O 118.808 -0.615 . . . . 0.0 110.213 -179.377 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' E' E ' 15' ' ' PRO . . . . . . . . . . . . . 25.3 Cg_exo -62.59 162.24 25.25 Favored 'Trans proline' 0 N--CA 1.498 1.765 0 C-N-CA 121.299 1.333 . . . . 0.0 112.013 176.942 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' E' E ' 16' ' ' PRO . . . . . . . . . . . . . 28.1 Cg_exo -59.95 -32.71 95.48 Favored 'Trans proline' 0 N--CA 1.497 1.691 0 C-N-CA 121.568 1.512 . . . . 0.0 112.931 -178.219 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' E' E ' 17' ' ' ASP . . . . . . . . . . . . . 10.1 p-10 -81.52 -3.93 54.54 Favored 'General case' 0 CA--C 1.535 0.383 0 N-CA-C 113.357 0.873 . . . . 0.0 113.357 -177.451 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' E' E ' 18' ' ' PHE . . . . . . . . . . . . . 30.0 t80 -56.62 -44.49 81.24 Favored 'General case' 0 C--N 1.334 -0.09 0 O-C-N 121.885 -0.509 . . . . 0.0 110.242 -179.182 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' E' E ' 19' ' ' VAL . . . . . . . . . . . . . 14.4 p -57.38 -40.67 75.66 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.329 0 CA-C-N 116.346 -0.388 . . . . 0.0 110.698 -179.707 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' E' E ' 20' ' ' ASP . . . . . . . . . . . . . 8.2 t70 -60.33 -42.74 96.29 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-O 120.921 0.391 . . . . 0.0 110.781 -177.827 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' E' E ' 21' ' ' VAL . . . . . . . . . . . . . 46.4 t -64.46 -47.33 89.78 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.297 0 CA-C-N 116.331 -0.395 . . . . 0.0 110.476 -177.751 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' E' E ' 22' ' ' ILE . . . . . 0.448 HG22 HD12 ' E' ' 26' ' ' LEU . 49.1 mm -57.5 -42.04 80.11 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.362 0 C-N-CA 120.934 -0.306 . . . . 0.0 110.673 -179.633 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' E' E ' 23' ' ' ARG . . . . . . . . . . . . . 61.9 ttp180 -54.8 -51.09 66.87 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-O 120.981 0.42 . . . . 0.0 110.9 178.935 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' E' E ' 24' ' ' ILE . . . . . . . . . . . . . 73.0 mt -60.85 -41.64 89.47 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.355 0 CA-C-N 115.92 -0.582 . . . . 0.0 111.764 -176.564 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' E' E ' 25' ' ' LYS . . . . . . . . . . . . . 15.1 ptpt -70.39 -39.64 74.4 Favored 'General case' 0 CA--C 1.535 0.373 0 N-CA-C 112.174 0.435 . . . . 0.0 112.174 -174.804 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' E' E ' 26' ' ' LEU . . . . . 0.448 HD12 HG22 ' E' ' 22' ' ' ILE . 15.4 mt -78.87 -39.27 35.61 Favored 'General case' 0 C--N 1.33 -0.278 0 N-CA-C 113.268 0.84 . . . . 0.0 113.268 -171.291 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' E' E ' 27' ' ' GLN . . . . . . . . . . . . . 10.5 pt20 -47.0 135.69 9.21 Favored 'General case' 0 N--CA 1.469 0.499 0 N-CA-C 112.763 0.653 . . . . 0.0 112.763 -175.13 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' E' E ' 28' ' ' GLY . . . . . . . . . . . . . . . 101.05 -24.02 33.44 Favored Glycine 0 CA--C 1.534 1.259 0 CA-C-N 115.606 -0.725 . . . . 0.0 112.378 -176.784 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' E' E ' 29' ' ' LYS . . . . . . . . . . . . . 91.8 mttt -98.82 155.17 17.51 Favored 'General case' 0 C--O 1.233 0.208 0 CA-C-N 117.443 0.622 . . . . 0.0 111.311 179.534 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' E' E ' 30' ' ' THR . . . . . . . . . . . . . 28.8 m -109.39 138.57 45.55 Favored 'General case' 0 C--N 1.331 -0.209 0 CA-C-N 116.27 -0.423 . . . . 0.0 110.005 175.841 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' E' E ' 31' ' ' VAL . . . . . . . . . . . . . 34.5 m -132.13 160.92 42.16 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.22 0 CA-C-N 116.392 -0.367 . . . . 0.0 110.857 -178.95 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' E' E ' 32' ' ' ARG . . . . . . . . . . . . . 63.5 mtt85 -130.44 149.04 52.3 Favored 'General case' 0 C--N 1.332 -0.19 0 CA-C-O 121.199 0.523 . . . . 0.0 110.667 177.303 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' E' E ' 33' ' ' THR . . . . . . . . . . . . . 31.5 m -53.59 141.38 25.91 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.129 -0.487 . . . . 0.0 111.259 -179.581 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' E' E ' 34' ' ' GLY . . . . . . . . . . . . . . . 99.28 -17.16 58.27 Favored Glycine 0 CA--C 1.533 1.2 0 CA-C-O 119.643 -0.532 . . . . 0.0 113.156 179.874 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' E' E ' 35' ' ' ASP . . . . . . . . . . . . . 78.8 m-20 -66.5 147.72 52.9 Favored 'General case' 0 C--O 1.232 0.145 0 CA-C-N 118.026 0.913 . . . . 0.0 110.999 178.163 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' E' E ' 36' ' ' VAL . . . . . . . . . . . . . 46.9 t -119.85 129.78 74.99 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.212 0 CA-C-N 115.829 -0.623 . . . . 0.0 109.829 178.611 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' E' E ' 37' ' ' ILE . . . . . . . . . . . . . 66.7 mt -120.13 138.18 51.55 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.269 0 N-CA-C 109.748 -0.464 . . . . 0.0 109.748 179.833 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' E' E ' 38' ' ' GLY . . . . . . . . . . . . . . . -113.77 128.78 8.46 Favored Glycine 0 CA--C 1.524 0.624 0 N-CA-C 111.389 -0.684 . . . . 0.0 111.389 -179.024 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' E' E ' 39' ' ' ILE . . . . . . . . . . . . . 71.2 mt -122.51 126.74 74.52 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.24 0 N-CA-C 109.747 -0.464 . . . . 0.0 109.747 177.336 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' E' E ' 40' ' ' SER . . . . . . . . . . . . . 43.1 t -92.16 119.51 31.88 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.442 -0.344 . . . . 0.0 110.786 177.162 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' E' E ' 41' ' ' ILE . . . . . . . . . . . . . 71.8 mt -131.47 123.9 53.55 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.225 0 N-CA-C 110.052 -0.351 . . . . 0.0 110.052 178.594 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' E' E ' 42' ' ' LEU . . . . . . . . . . . . . 82.6 mt 57.8 33.74 23.58 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.2 -0.455 . . . . 0.0 111.87 178.485 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' E' E ' 43' ' ' GLY . . . . . . . . . . . . . . . 77.87 -10.15 27.25 Favored Glycine 0 CA--C 1.535 1.306 0 C-N-CA 121.274 -0.489 . . . . 0.0 113.431 177.79 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' E' E ' 44' ' ' LYS . . . . . . . . . . . . . 62.8 tttm -98.78 127.24 44.65 Favored 'General case' 0 C--O 1.232 0.138 0 CA-C-N 117.808 0.804 . . . . 0.0 109.696 176.723 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' E' E ' 45' ' ' GLU . . . . . . . . . . . . . 39.2 tp10 -84.76 126.84 33.77 Favored 'General case' 0 C--N 1.328 -0.336 0 C-N-CA 120.811 -0.356 . . . . 0.0 110.662 -179.935 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' E' E ' 46' ' ' VAL . . . . . . . . . . . . . 7.6 p -117.09 128.71 74.41 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.199 0 N-CA-C 109.368 -0.604 . . . . 0.0 109.368 176.585 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' E' E ' 47' ' ' LYS . . . . . . . . . . . . . 64.6 mttp -100.32 129.35 46.29 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 115.884 -0.598 . . . . 0.0 111.142 179.052 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' E' E ' 48' ' ' PHE . . . . . . . . . . . . . 93.5 m-85 -112.19 131.86 55.23 Favored 'General case' 0 C--N 1.33 -0.27 0 N-CA-C 109.604 -0.517 . . . . 0.0 109.604 175.889 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' E' E ' 49' ' ' LYS . . . . . . . . . . . . . 52.5 tttp -108.05 135.46 49.37 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 116.434 -0.348 . . . . 0.0 110.332 179.244 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' E' E ' 50' ' ' VAL . . . . . . . . . . . . . 46.2 t -78.43 106.53 9.29 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.281 0 N-CA-C 108.954 -0.758 . . . . 0.0 108.954 175.317 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' E' E ' 51' ' ' VAL . . . . . . . . . . . . . 51.5 t -71.74 -47.05 58.89 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.319 0 CA-C-N 116.18 -0.464 . . . . 0.0 110.106 -172.98 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' E' E ' 52' ' ' GLN . . . . . . . . . . . . . 46.9 tt0 -163.5 136.86 5.6 Favored 'General case' 0 C--N 1.329 -0.297 0 C-N-CA 120.175 -0.61 . . . . 0.0 111.834 -178.281 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' E' E ' 53' ' ' ALA . . . . . . . . . . . . . . . -113.01 134.36 54.55 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 115.721 -0.672 . . . . 0.0 109.699 174.566 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' E' E ' 54' ' ' TYR . . . . . . . . . . . . . 24.8 t80 -129.03 111.28 18.4 Favored Pre-proline 0 CA--C 1.536 0.419 0 CA-C-O 118.17 -0.919 . . . . 0.0 110.555 -179.889 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' E' E ' 55' ' ' PRO . . . . . . . . . . . . . 73.6 Cg_endo -77.08 168.8 76.03 Favored 'Cis proline' 0 N--CA 1.501 1.946 0 CA-C-N 121.899 1.714 . . . . 0.0 112.068 -7.245 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' E' E ' 56' ' ' SER . . . . . . . . . . . . . 27.0 m -115.04 131.27 23.61 Favored Pre-proline 0 CA--C 1.539 0.525 0 CA-C-O 118.456 -0.783 . . . . 0.0 109.533 176.24 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' E' E ' 57' ' ' PRO . . . . . . . . . . . . . 36.5 Cg_endo -66.6 164.17 68.67 Favored 'Cis proline' 0 N--CA 1.496 1.671 0 CA-C-N 121.957 1.734 . . . . 0.0 111.503 -1.501 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' E' E ' 58' ' ' LEU . . . . . . . . . . . . . 28.7 tp -129.45 135.47 48.7 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.436 -0.347 . . . . 0.0 110.623 -179.693 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' E' E ' 59' ' ' ARG . . . . . . . . . . . . . 73.5 ttt-85 -103.21 127.2 50.59 Favored 'General case' 0 C--N 1.327 -0.4 0 N-CA-C 109.028 -0.73 . . . . 0.0 109.028 175.504 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' E' E ' 60' ' ' VAL . . . . . . . . . . . . . 40.1 t -87.41 124.39 40.75 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.305 0 C-N-CA 120.767 -0.373 . . . . 0.0 110.878 -173.071 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' E' E ' 61' ' ' GLU . . . . . . . . . . . . . 40.6 mt-10 -131.01 166.52 20.82 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.01 -0.541 . . . . 0.0 109.703 176.002 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' E' E ' 62' ' ' ASP . . . . . . . . . . . . . 5.5 t70 -53.57 -32.92 52.87 Favored 'General case' 0 C--N 1.329 -0.318 0 N-CA-C 111.746 0.276 . . . . 0.0 111.746 -179.166 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' E' E ' 63' ' ' ARG . . . . . . . . . . . . . 35.2 mmt180 -73.51 -19.07 61.02 Favored 'General case' 0 N--CA 1.465 0.318 0 N-CA-C 113.023 0.749 . . . . 0.0 113.023 -176.863 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' E' E ' 64' ' ' THR . . . . . . . . . . . . . 25.0 m -66.23 141.9 57.89 Favored 'General case' 0 C--N 1.331 -0.2 0 CA-C-O 120.862 0.363 . . . . 0.0 110.876 -174.935 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' E' E ' 65' ' ' LYS . . . . . . . . . . . . . 92.1 mttt -87.83 128.71 35.34 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 115.995 -0.548 . . . . 0.0 109.893 178.285 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' E' E ' 66' ' ' ILE . . . . . . . . . . . . . 51.7 mt -116.18 131.24 69.27 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 N-CA-C 110.036 -0.357 . . . . 0.0 110.036 179.82 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' E' E ' 67' ' ' THR . . . . . . . . . . . . . 22.5 m -127.26 135.82 51.13 Favored 'General case' 0 C--N 1.332 -0.157 0 CA-C-O 121.036 0.446 . . . . 0.0 110.948 -179.89 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' E' E ' 68' ' ' LEU . . . . . . . . . . . . . 32.8 mt -107.93 133.33 52.43 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 115.938 -0.574 . . . . 0.0 110.337 176.918 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' E' E ' 69' ' ' VAL . . . . . . . . . . . . . 43.2 t -97.31 138.66 21.63 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.307 0 CA-C-N 116.356 -0.384 . . . . 0.0 110.328 179.579 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' E' E ' 70' ' ' THR . . . . . . . . . . . . . 7.9 t -146.02 -33.42 0.33 Allowed 'General case' 0 C--N 1.331 -0.224 0 N-CA-C 111.913 0.338 . . . . 0.0 111.913 -178.067 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' E' E ' 71' ' ' HIS . . . . . . . . . . . . . 15.4 m80 -117.92 90.4 36.68 Favored Pre-proline 0 CA--C 1.534 0.359 0 CA-C-O 119.5 -0.286 . . . . 0.0 110.952 -176.484 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' E' E ' 72' ' ' PRO . . . . . . . . . . . . . 58.4 Cg_endo -71.32 -15.22 31.46 Favored 'Trans proline' 0 N--CA 1.498 1.744 0 C-N-CA 121.402 1.401 . . . . 0.0 113.737 -178.433 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' E' E ' 73' ' ' VAL . . . . . . . . . . . . . 33.5 m -114.59 163.69 11.61 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.281 0 CA-C-O 121.019 0.438 . . . . 0.0 110.784 -178.174 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' E' E ' 74' ' ' ASP . . . . . . . . . . . . . 5.0 t70 -100.13 120.12 39.38 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 115.859 -0.609 . . . . 0.0 109.795 -178.613 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' E' E ' 75' ' ' VAL . . . . . . . . . . . . . 44.0 t -119.75 126.4 75.27 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.246 0 CA-C-O 121.014 0.435 . . . . 0.0 110.749 -176.262 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' E' E ' 76' ' ' LEU . . . . . . . . . . . . . 5.9 mp -124.03 149.65 45.83 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 115.671 -0.695 . . . . 0.0 109.683 175.503 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' E' E ' 77' ' ' GLU . . . . . . . . . . . . . 96.2 mt-10 -136.01 131.54 35.14 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-O 121.022 0.439 . . . . 0.0 110.989 -178.646 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' E' E ' 78' ' ' ALA . . . . . . . . . . . . . . . -115.12 140.8 48.77 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 115.71 -0.677 . . . . 0.0 109.822 177.367 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' E' E ' 79' ' ' LYS . . . . . 0.58 ' O ' HD13 ' E' ' 80' ' ' ILE . 69.4 mttm -87.99 116.73 26.36 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-O 120.846 0.355 . . . . 0.0 111.223 -176.442 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' E' E ' 80' ' ' ILE . . . . . 0.58 HD13 ' O ' ' E' ' 79' ' ' LYS . 40.1 mm -139.19 102.32 1.69 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.312 0 N-CA-C 109.074 -0.713 . . . . 0.0 109.074 179.438 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' E' E ' 81' ' ' LYS . . . . . . . . . . . . . 41.0 tttp -91.3 126.15 36.29 Favored 'General case' 0 C--N 1.328 -0.351 0 C-N-CA 120.695 -0.402 . . . . 0.0 110.892 -177.171 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' E' E ' 82' ' ' GLY . . . . . . . . . . . . . . . 89.12 42.08 5.69 Favored Glycine 0 CA--C 1.524 0.629 0 C-N-CA 120.885 -0.674 . . . . 0.0 111.721 176.038 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' E' E ' 83' ' ' ILE . . . . . . . . . . . . . 72.6 mt -69.61 137.95 23.12 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.37 0 N-CA-C 109.711 -0.478 . . . . 0.0 109.711 177.027 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' E' E ' 84' ' ' LYS . . . . . . . . . . . . . 38.9 ttpt -100.87 -49.27 4.19 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-O 120.752 0.31 . . . . 0.0 110.234 -179.378 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' E' E ' 85' ' ' ASP . . . . . . . . . . . . . 9.0 t70 -151.85 154.06 35.42 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.243 -0.435 . . . . 0.0 110.7 -178.771 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' E' E ' 86' ' ' VAL . . . . . . . . . . . . . 44.6 t -132.57 136.36 56.14 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.22 0 CA-C-O 121.003 0.43 . . . . 0.0 110.392 -179.812 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' E' E ' 87' ' ' ILE . . . . . . . . . . . . . 47.4 mm -122.74 128.14 75.15 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.289 0 CA-C-N 115.71 -0.677 . . . . 0.0 109.674 178.919 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' E' E ' 88' ' ' LEU . . . . . . . . . . . . . 70.3 mt -111.99 136.52 51.22 Favored 'General case' 0 C--N 1.332 -0.185 0 CA-C-O 121.094 0.473 . . . . 0.0 111.396 -177.759 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' E' E ' 89' ' ' ASP . . . . . . . . . . . . . 9.5 t70 -127.2 154.87 44.28 Favored 'General case' 0 C--N 1.33 -0.274 0 N-CA-C 109.067 -0.716 . . . . 0.0 109.067 175.576 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' E' E ' 90' ' ' GLU . . . . . . . . . . . . . 82.9 tt0 -48.04 -34.32 9.34 Favored 'General case' 0 C--N 1.331 -0.235 0 N-CA-C 112.933 0.716 . . . . 0.0 112.933 -171.74 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' E' E ' 91' ' ' ASN . . . . . . . . . . . . . 13.6 p30 -131.99 18.25 4.59 Favored 'General case' 0 N--CA 1.468 0.454 0 N-CA-C 113.207 0.818 . . . . 0.0 113.207 -177.717 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' E' E ' 92' ' ' LEU . . . . . . . . . . . . . 25.3 mt -146.98 151.08 36.39 Favored 'General case' 0 C--N 1.332 -0.175 0 CA-C-N 117.861 0.301 . . . . 0.0 110.404 -177.069 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' E' E ' 93' ' ' ILE . . . . . . . . . . . . . 67.1 mt -127.1 121.73 58.49 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.213 0 N-CA-C 109.43 -0.582 . . . . 0.0 109.43 178.189 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' E' E ' 94' ' ' VAL . . . . . . . . . . . . . 45.9 t -120.62 129.91 75.1 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.291 0 CA-C-O 120.889 0.376 . . . . 0.0 110.013 -179.816 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' E' E ' 95' ' ' VAL . . . . . . . . . . . . . 44.3 t -122.7 136.0 60.94 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 CA-C-N 116.015 -0.539 . . . . 0.0 109.867 -179.562 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' E' E ' 96' ' ' ILE . . . . . . . . . . . . . 63.1 mt -118.26 127.18 75.41 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.232 0 N-CA-C 109.402 -0.592 . . . . 0.0 109.402 178.896 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' E' E ' 97' ' ' THR . . . . . . . . . . . . . 77.8 p -100.75 158.52 15.9 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-O 121.083 0.468 . . . . 0.0 111.106 -177.464 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' E' E ' 98' ' ' GLU . . . . . . . . . . . . . 47.1 tp10 -53.85 -26.32 23.93 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.279 -0.419 . . . . 0.0 112.105 -179.861 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' E' E ' 99' ' ' GLU . . . . . . . . . . . . . 96.0 mt-10 -76.1 11.61 1.42 Allowed 'General case' 0 CA--C 1.535 0.381 0 N-CA-C 113.404 0.89 . . . . 0.0 113.404 -177.204 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' E' E ' 100' ' ' ASN . . . . . . . . . . . . . 4.0 m-20 63.42 37.67 10.55 Favored 'General case' 0 CA--C 1.529 0.156 0 CA-C-O 121.143 0.497 . . . . 0.0 111.023 179.792 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' E' E ' 101' ' ' GLU . . . . . . . . . . . . . 85.0 tt0 -114.97 140.07 49.32 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.025 -0.534 . . . . 0.0 109.6 175.559 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' E' E ' 102' ' ' VAL . . . . . . . . . . . . . 47.5 t -114.88 126.1 72.37 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.243 0 N-CA-C 109.795 -0.446 . . . . 0.0 109.795 -178.508 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' E' E ' 103' ' ' LEU . . . . . . . . . . . . . 45.7 mt -119.15 133.15 55.95 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 115.768 -0.651 . . . . 0.0 110.483 178.233 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' E' E ' 104' ' ' ILE . . . . . . . . . . . . . 69.4 mt -119.0 122.42 69.28 Favored 'Isoleucine or valine' 0 C--O 1.235 0.296 0 CA-C-N 116.399 -0.364 . . . . 0.0 110.41 -179.618 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' E' E ' 105' ' ' PHE . . . . . . . . . . . . . 61.9 m-85 -121.72 167.1 13.34 Favored 'General case' 0 C--N 1.333 -0.142 0 O-C-N 124.013 0.821 . . . . 0.0 109.498 178.208 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' E' E ' 106' ' ' ASN . . . . . . . . . . . . . 46.3 p-10 -101.05 -170.36 1.83 Allowed 'General case' 0 C--N 1.33 -0.261 0 N-CA-C 109.95 -0.389 . . . . 0.0 109.95 172.99 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' E' E ' 107' ' ' GLN . . . . . . . . . . . . . 58.6 tt0 -58.99 -29.82 67.5 Favored 'General case' 0 C--N 1.328 -0.327 0 N-CA-C 111.902 0.334 . . . . 0.0 111.902 -179.998 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' E' E ' 108' ' ' ASN . . . . . . . . . . . . . 51.3 t30 -84.77 11.32 9.35 Favored 'General case' 0 CA--C 1.535 0.4 0 N-CA-C 112.838 0.681 . . . . 0.0 112.838 -177.307 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' E' E ' 109' ' ' LEU . . . . . . . . . . . . . 17.8 mt 57.58 36.46 26.82 Favored 'General case' 0 CA--C 1.53 0.185 0 CA-C-O 120.898 0.38 . . . . 0.0 111.342 178.63 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' E' E ' 110' ' ' GLU . . . . . . . . . . . . . 70.4 mm-40 -101.87 138.18 39.18 Favored 'General case' 0 C--N 1.33 -0.281 0 N-CA-C 109.172 -0.677 . . . . 0.0 109.172 174.909 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' E' E ' 111' ' ' GLU . . . . . . . . . . . . . 73.1 tt0 -82.55 121.81 27.27 Favored 'General case' 0 C--N 1.33 -0.28 0 C-N-CA 120.665 -0.414 . . . . 0.0 110.029 -176.655 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' E' E ' 112' ' ' LEU . . . . . . . . . . . . . 22.5 mt -108.95 -44.76 3.92 Favored 'General case' 0 C--N 1.332 -0.195 0 CA-C-N 116.129 -0.487 . . . . 0.0 110.789 -177.655 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' E' E ' 113' ' ' TYR . . . . . . . . . . . . . 50.9 t80 -132.91 137.07 46.51 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.365 -0.38 . . . . 0.0 110.911 -177.739 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' E' E ' 114' ' ' ARG . . . . . . . . . . . . . 16.3 ptm180 -143.31 126.95 17.0 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-O 121.034 0.445 . . . . 0.0 110.664 176.57 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' E' E ' 115' ' ' GLY . . . . . . . . . . . . . . . -150.11 140.27 7.9 Favored Glycine 0 CA--C 1.524 0.64 0 N-CA-C 111.147 -0.781 . . . . 0.0 111.147 178.599 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' E' E ' 116' ' ' LYS . . . . . . . . . . . . . 39.6 ttpt -104.89 128.98 53.33 Favored 'General case' 0 C--N 1.33 -0.269 0 N-CA-C 109.721 -0.474 . . . . 0.0 109.721 175.67 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' E' E ' 117' ' ' PHE . . . . . . . . . . . . . 69.8 m-85 -125.68 114.96 19.36 Favored 'General case' 0 C--N 1.331 -0.22 0 CA-C-O 121.019 0.438 . . . . 0.0 110.129 -177.268 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' E' E ' 118' ' ' GLU . . . . . . . . . . . . . 96.0 mt-10 -54.55 -41.35 69.68 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.462 -0.336 . . . . 0.0 111.265 -175.825 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' E' E ' 119' ' ' ASN . . . . . . . . . . . . . 69.9 m-80 -104.07 31.07 4.76 Favored 'General case' 0 C--O 1.234 0.246 0 CA-C-N 116.229 -0.441 . . . . 0.0 112.111 -173.92 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' E' E ' 120' ' ' LEU . . . . . . . . . . . . . 11.7 tp -56.24 120.05 6.95 Favored 'General case' 0 N--CA 1.462 0.147 0 CA-C-O 120.715 0.293 . . . . 0.0 110.311 178.884 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' E' E ' 121' ' ' ASN . . . . . . . . . . . . . 45.7 m-80 -114.34 -44.03 3.15 Favored 'General case' 0 C--O 1.232 0.153 0 CA-C-N 116.385 -0.37 . . . . 0.0 111.169 -176.655 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' E' E ' 122' ' ' LYS . . . . . . . . . . . . . 97.8 mttt -142.59 147.62 36.16 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-O 121.021 0.439 . . . . 0.0 111.596 -175.915 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' E' E ' 123' ' ' VAL . . . . . . . . . . . . . 44.1 t -127.09 129.16 71.07 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.275 0 N-CA-C 109.278 -0.638 . . . . 0.0 109.278 174.126 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' E' E ' 124' ' ' LEU . . . . . . . . . . . . . 38.1 mt -129.52 137.06 50.58 Favored 'General case' 0 C--N 1.331 -0.202 0 CA-C-O 120.838 0.352 . . . . 0.0 110.948 -178.394 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' E' E ' 125' ' ' VAL . . . . . . . . . . . . . 12.8 p -137.55 138.22 44.88 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.255 0 CA-C-N 116.282 -0.417 . . . . 0.0 110.329 177.908 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' E' E ' 126' ' ' ARG . . . . . . . . . . . . . 37.8 mtp180 -146.2 127.67 15.01 Favored 'General case' 0 C--N 1.331 -0.229 0 CA-C-O 120.954 0.406 . . . . 0.0 110.839 179.159 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' E' E ' 127' ' ' ASN . . . . . . . . . . . . . 62.1 t30 49.55 -104.93 0.15 Allowed 'General case' 0 CA--C 1.543 0.684 0 CA-C-O 118.953 -0.546 . . . . 0.0 111.826 179.157 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' E' E ' 128' ' ' ASP . . . . . . . . . . . . . 12.0 p-10 -114.19 0.61 14.28 Favored 'General case' 0 CA--C 1.537 0.445 0 CA-C-N 119.612 1.096 . . . . 0.0 113.591 -175.148 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' E' E ' 129' ' ' LEU . . . . . . . . . . . . . 84.3 mt -112.32 145.16 40.52 Favored 'General case' 0 C--N 1.333 -0.133 0 CA-C-N 118.203 0.456 . . . . 0.0 110.03 179.839 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' E' E ' 130' ' ' VAL . . . . . 0.507 HG13 ' HB ' ' E' ' 141' ' ' ILE . 12.0 p -131.95 141.93 44.26 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.175 0 CA-C-O 121.059 0.457 . . . . 0.0 110.25 179.954 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' E' E ' 131' ' ' VAL . . . . . 0.673 HG22 HD12 ' E' ' 140' ' ' LEU . 27.0 t -135.42 139.32 46.92 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.315 0 CA-C-N 115.961 -0.563 . . . . 0.0 110.397 -177.348 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' E' E ' 132' ' ' ILE . . . . . . . . . . . . . 74.6 mt -115.97 130.45 70.65 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.332 0 N-CA-C 109.215 -0.661 . . . . 0.0 109.215 178.582 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' E' E ' 133' ' ' ILE . . . . . . . . . . . . . 39.5 mm -116.47 123.08 71.14 Favored 'Isoleucine or valine' 0 N--CA 1.462 0.159 0 CA-C-O 120.727 0.299 . . . . 0.0 110.923 -174.662 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' E' E ' 134' ' ' ASP . . . . . . . . . . . . . 12.1 p-10 -136.47 151.71 49.76 Favored 'General case' 0 C--N 1.332 -0.173 0 N-CA-C 109.883 -0.414 . . . . 0.0 109.883 174.422 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' E' E ' 135' ' ' GLU . . . . . . . . . . . . . 41.2 tp10 -50.05 -26.42 4.35 Favored 'General case' 0 C--N 1.328 -0.343 0 N-CA-C 113.025 0.75 . . . . 0.0 113.025 -171.781 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' E' E ' 136' ' ' GLN . . . . . . . . . . . . . 47.1 tt0 -91.47 -25.11 19.46 Favored 'General case' 0 C--O 1.234 0.264 0 N-CA-C 112.977 0.732 . . . . 0.0 112.977 -173.121 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' E' E ' 137' ' ' LYS . . . . . . . . . . . . . 22.6 pttm -170.06 171.36 7.02 Favored 'General case' 0 C--O 1.232 0.148 0 CA-C-O 121.501 0.667 . . . . 0.0 112.659 -172.522 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' E' E ' 138' ' ' LEU . . . . . 0.439 HD23 ' N ' ' E' ' 139' ' ' THR . 5.1 tt -122.28 129.01 51.78 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 115.009 -0.996 . . . . 0.0 109.817 179.727 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' E' E ' 139' ' ' THR . . . . . 0.439 ' N ' HD23 ' E' ' 138' ' ' LEU . 43.5 m -111.46 127.61 55.74 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.528 -0.306 . . . . 0.0 110.354 179.288 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' E' E ' 140' ' ' LEU . . . . . 0.673 HD12 HG22 ' E' ' 131' ' ' VAL . 11.9 tp -114.27 123.34 49.3 Favored 'General case' 0 C--N 1.33 -0.268 0 N-CA-C 109.554 -0.535 . . . . 0.0 109.554 -178.976 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' E' E ' 141' ' ' ILE . . . . . 0.507 ' HB ' HG13 ' E' ' 130' ' ' VAL . 19.6 mt -121.5 124.79 72.54 Favored 'Isoleucine or valine' 0 C--O 1.234 0.253 0 CA-C-O 120.943 0.401 . . . . 0.0 110.261 -174.648 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' E' E ' 142' ' ' ARG . . . . . . . . . . . . . 82.2 mtp180 -108.68 128.13 54.59 Favored 'General case' 0 C--N 1.331 -0.222 0 CA-C-N 115.229 -0.896 . . . . 0.0 110.181 -178.654 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' E' E ' 143' ' ' THR . . . . . . . . . . . . . 24.9 p . . . . . 0 C--O 1.221 -0.412 0 CA-C-O 117.964 -1.017 . . . . 0.0 110.52 -179.754 . . . . . . . . 0 0 . 1 . 008 nuclear nobuild full ' F' F ' -3' ' ' GLU . . . . . . . . . . . . . 45.3 tp10 . . . . . 0 N--CA 1.49 1.553 0 N-CA-C 109.215 -0.661 . . . . 0.0 109.215 . . . . . . . . . 0 0 . 1 . 008 nuclear nobuild full ' F' F ' -2' ' ' GLY . . . . . . . . . . . . . . . -62.26 150.04 47.23 Favored Glycine 0 CA--C 1.525 0.714 0 N-CA-C 110.925 -0.87 . . . . 0.0 110.925 -179.434 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' F' F ' -1' ' ' VAL . . . . . . . . . . . . . 43.5 t -95.47 137.06 24.59 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.316 0 N-CA-C 109.944 -0.391 . . . . 0.0 109.944 -179.86 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' F' F ' 0' ' ' ILE . . . . . . . . . . . . . 42.9 mm -112.77 141.04 29.64 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.263 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.321 -177.662 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' F' F ' 1' ' ' MET . . . . . . . . . . . . . 25.2 ptp -81.59 137.63 35.48 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.061 -0.518 . . . . 0.0 110.789 179.929 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' F' F ' 2' ' ' SER . . . . . . . . . . . . . 2.5 p -131.03 125.44 33.28 Favored 'General case' 0 C--N 1.331 -0.224 0 CA-C-N 116.461 -0.336 . . . . 0.0 110.358 178.738 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' F' F ' 3' ' ' GLU . . . . . . . . . . . . . 93.9 mt-10 -139.47 139.66 37.07 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 116.144 -0.48 . . . . 0.0 111.056 -176.439 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' F' F ' 4' ' ' LEU . . . . . . . . . . . . . 20.6 tp -123.24 127.66 48.9 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 115.805 -0.634 . . . . 0.0 109.91 175.387 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' F' F ' 5' ' ' LYS . . . . . . . . . . . . . 90.9 mttt -109.76 122.25 47.07 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 116.466 -0.334 . . . . 0.0 110.829 179.891 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' F' F ' 6' ' ' LEU . . . . . . . . . . . . . 71.7 mt -116.69 147.2 42.2 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 115.551 -0.75 . . . . 0.0 110.094 179.274 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' F' F ' 7' ' ' LYS . . . . . . . . . . . . . 39.4 ttmt -137.44 142.29 36.8 Favored Pre-proline 0 CA--C 1.533 0.319 0 CA-C-O 119.298 -0.382 . . . . 0.0 110.043 175.845 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' F' F ' 8' ' ' PRO . . . . . . . . . . . . . 87.7 Cg_endo -90.51 143.89 3.75 Favored 'Trans proline' 0 N--CA 1.489 1.244 0 C-N-CA 121.761 1.641 . . . . 0.0 111.846 178.376 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' F' F ' 9' ' ' LEU . . . . . . . . . . . . . 50.4 mt -76.84 -47.97 2.81 Favored Pre-proline 0 CA--C 1.534 0.347 0 CA-C-O 118.709 -0.663 . . . . 0.0 112.27 -179.652 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' F' F ' 10' ' ' PRO . . . . . . . . . . . . . 84.5 Cg_endo -80.41 157.76 22.48 Favored 'Trans proline' 0 N--CA 1.497 1.702 0 C-N-CA 121.237 1.291 . . . . 0.0 111.967 176.561 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' F' F ' 11' ' ' LYS . . . . . . . . . . . . . 53.3 mttm -87.48 100.54 12.84 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-O 120.817 0.341 . . . . 0.0 110.539 178.049 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' F' F ' 12' ' ' VAL . . . . . . . . . . . . . 11.4 p -139.97 144.2 28.62 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.275 0 CA-C-N 116.05 -0.523 . . . . 0.0 110.071 179.281 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' F' F ' 13' ' ' GLU . . . . . . . . . . . . . 41.6 tp10 -91.01 116.67 28.97 Favored 'General case' 0 C--N 1.329 -0.325 0 N-CA-C 109.989 -0.374 . . . . 0.0 109.989 178.611 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' F' F ' 14' ' ' LEU . . . . . . . . . . . . . 23.0 mt -98.24 153.67 37.98 Favored Pre-proline 0 C--N 1.33 -0.269 0 CA-C-N 116.251 -0.431 . . . . 0.0 111.177 -176.124 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' F' F ' 15' ' ' PRO . . . . . . . . . . . . . 37.4 Cg_exo -59.7 156.88 35.11 Favored 'Trans proline' 0 N--CA 1.497 1.733 0 C-N-CA 121.332 1.355 . . . . 0.0 112.132 179.065 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' F' F ' 16' ' ' PRO . . . . . . . . . . . . . 28.1 Cg_exo -60.68 -34.34 92.17 Favored 'Trans proline' 0 N--CA 1.497 1.701 0 C-N-CA 121.404 1.403 . . . . 0.0 112.187 178.043 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' F' F ' 17' ' ' ASP . . . . . . . . . . . . . 15.1 p-10 -85.11 12.29 8.07 Favored 'General case' 0 CA--C 1.536 0.427 0 N-CA-C 113.113 0.783 . . . . 0.0 113.113 -177.939 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' F' F ' 18' ' ' PHE . . . . . . . . . . . . . 33.4 t80 -57.83 -42.36 84.2 Favored 'General case' 0 C--N 1.333 -0.115 0 O-C-N 121.988 -0.445 . . . . 0.0 110.142 -179.678 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' F' F ' 19' ' ' VAL . . . . . . . . . . . . . 49.8 t -55.89 -52.98 43.18 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.316 0 CA-C-N 116.352 -0.385 . . . . 0.0 111.102 -176.675 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' F' F ' 20' ' ' ASP . . . . . . . . . . . . . 2.5 p-10 -59.82 -36.25 76.38 Favored 'General case' 0 N--CA 1.464 0.268 0 C-N-CA 120.582 -0.447 . . . . 0.0 111.342 -176.452 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' F' F ' 21' ' ' VAL . . . . . . . . . . . . . 51.7 t -63.93 -47.13 91.96 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.239 0 C-N-CA 120.575 -0.45 . . . . 0.0 110.34 -179.853 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' F' F ' 22' ' ' ILE . . . . . 0.446 HG22 HD12 ' F' ' 26' ' ' LEU . 49.2 mm -55.54 -48.35 77.48 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.219 0 CA-C-O 120.736 0.303 . . . . 0.0 110.505 178.129 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' F' F ' 23' ' ' ARG . . . . . . . . . . . . . 53.2 ttp180 -54.41 -49.54 69.7 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.521 -0.309 . . . . 0.0 111.572 -177.109 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' F' F ' 24' ' ' ILE . . . . . . . . . . . . . 78.0 mt -59.16 -46.15 92.24 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.316 0 C-N-CA 120.971 -0.291 . . . . 0.0 111.166 -176.7 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' F' F ' 25' ' ' LYS . . . . . . . . . . . . . 90.8 mttt -64.76 -44.05 91.34 Favored 'General case' 0 C--N 1.33 -0.275 0 N-CA-C 112.54 0.57 . . . . 0.0 112.54 -177.25 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' F' F ' 26' ' ' LEU . . . . . 0.446 HD12 HG22 ' F' ' 22' ' ' ILE . 61.4 mt -83.67 -24.16 31.44 Favored 'General case' 0 C--N 1.329 -0.302 0 N-CA-C 113.467 0.914 . . . . 0.0 113.467 -171.508 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' F' F ' 27' ' ' GLN . . . . . . . . . . . . . 6.4 pt20 -46.15 136.58 6.76 Favored 'General case' 0 CA--C 1.534 0.351 0 N-CA-C 112.813 0.671 . . . . 0.0 112.813 -174.633 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' F' F ' 28' ' ' GLY . . . . . . . . . . . . . . . 100.53 -21.56 43.58 Favored Glycine 0 CA--C 1.533 1.214 0 CA-C-N 115.701 -0.681 . . . . 0.0 112.786 -178.623 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' F' F ' 29' ' ' LYS . . . . . . . . . . . . . 63.2 mttp -97.79 155.08 17.2 Favored 'General case' 0 C--N 1.331 -0.199 0 CA-C-N 117.604 0.702 . . . . 0.0 111.144 179.125 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' F' F ' 30' ' ' THR . . . . . . . . . . . . . 24.2 m -104.7 139.23 39.82 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.196 177.366 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' F' F ' 31' ' ' VAL . . . . . . . . . . . . . 34.3 m -129.33 157.45 42.1 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.19 0 CA-C-O 120.856 0.36 . . . . 0.0 110.915 -178.741 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' F' F ' 32' ' ' ARG . . . . . . . . . . . . . 93.4 mtt180 -133.74 152.33 51.85 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 115.959 -0.564 . . . . 0.0 110.779 177.934 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' F' F ' 33' ' ' THR . . . . . . . . . . . . . 28.5 m -53.31 139.97 28.33 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.133 -0.485 . . . . 0.0 111.399 -178.852 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' F' F ' 34' ' ' GLY . . . . . . . . . . . . . . . 99.21 -17.17 58.33 Favored Glycine 0 CA--C 1.532 1.118 0 C-N-CA 121.16 -0.543 . . . . 0.0 113.222 178.81 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' F' F ' 35' ' ' ASP . . . . . . . . . . . . . 76.0 m-20 -65.83 148.66 51.42 Favored 'General case' 0 C--O 1.232 0.176 0 CA-C-N 118.065 0.933 . . . . 0.0 111.188 179.092 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' F' F ' 36' ' ' VAL . . . . . . . . . . . . . 45.0 t -122.3 129.76 75.06 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.243 0 CA-C-N 115.981 -0.554 . . . . 0.0 109.874 178.468 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' F' F ' 37' ' ' ILE . . . . . . . . . . . . . 66.1 mt -119.77 138.79 49.24 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.201 0 CA-C-N 116.21 -0.45 . . . . 0.0 109.933 -179.776 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' F' F ' 38' ' ' GLY . . . . . . . . . . . . . . . -110.76 128.78 8.93 Favored Glycine 0 CA--C 1.525 0.691 0 N-CA-C 111.193 -0.763 . . . . 0.0 111.193 -179.331 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' F' F ' 39' ' ' ILE . . . . . . . . . . . . . 72.9 mt -123.85 132.69 70.96 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.216 0 N-CA-C 110.137 -0.32 . . . . 0.0 110.137 178.89 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' F' F ' 40' ' ' SER . . . . . . . . . . . . . 23.0 t -92.7 118.86 31.51 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.332 -0.394 . . . . 0.0 110.685 175.34 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' F' F ' 41' ' ' ILE . . . . . . . . . . . . . 70.5 mt -130.69 125.33 58.47 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.229 0 CA-C-O 120.884 0.374 . . . . 0.0 110.469 179.219 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' F' F ' 42' ' ' LEU . . . . . . . . . . . . . 48.3 mt 51.94 34.46 13.69 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 115.994 -0.548 . . . . 0.0 111.913 176.833 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' F' F ' 43' ' ' GLY . . . . . . . . . . . . . . . 72.92 31.36 62.18 Favored Glycine 0 CA--C 1.53 0.993 0 C-N-CA 121.076 -0.583 . . . . 0.0 112.187 177.089 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' F' F ' 44' ' ' LYS . . . . . . . . . . . . . 40.6 ttpt -138.31 130.89 29.23 Favored 'General case' 0 C--N 1.329 -0.314 0 N-CA-C 109.613 -0.514 . . . . 0.0 109.613 178.081 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' F' F ' 45' ' ' GLU . . . . . . . . . . . . . 84.6 tt0 -83.06 118.91 23.86 Favored 'General case' 0 C--N 1.328 -0.351 0 C-N-CA 120.815 -0.354 . . . . 0.0 110.847 -179.66 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' F' F ' 46' ' ' VAL . . . . . . . . . . . . . 7.6 p -119.13 126.74 75.62 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.27 0 N-CA-C 109.375 -0.602 . . . . 0.0 109.375 176.623 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' F' F ' 47' ' ' LYS . . . . . . . . . . . . . 61.0 mttm -100.12 130.61 46.28 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.033 -0.53 . . . . 0.0 111.342 177.813 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' F' F ' 48' ' ' PHE . . . . . . . . . . . . . 90.0 m-85 -111.03 131.91 54.67 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 115.969 -0.559 . . . . 0.0 109.777 175.589 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' F' F ' 49' ' ' LYS . . . . . . . . . . . . . 83.6 tttt -106.81 134.68 49.6 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 116.213 -0.448 . . . . 0.0 110.379 -179.559 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' F' F ' 50' ' ' VAL . . . . . . . . . . . . . 46.8 t -77.07 106.98 7.68 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.283 0 N-CA-C 109.142 -0.688 . . . . 0.0 109.142 176.368 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' F' F ' 51' ' ' VAL . . . . . . . . . . . . . 47.9 t -69.57 -47.95 68.76 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.325 0 CA-C-N 115.932 -0.577 . . . . 0.0 109.979 -173.278 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' F' F ' 52' ' ' GLN . . . . . . . . . . . . . 61.1 tt0 -168.22 148.39 4.8 Favored 'General case' 0 C--N 1.331 -0.22 0 C-N-CA 120.228 -0.589 . . . . 0.0 111.678 -178.838 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' F' F ' 53' ' ' ALA . . . . . . . . . . . . . . . -123.25 132.07 53.9 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 115.651 -0.704 . . . . 0.0 109.86 176.492 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' F' F ' 54' ' ' TYR . . . . . . . . . . . . . 54.3 t80 -129.04 110.11 18.27 Favored Pre-proline 0 CA--C 1.535 0.385 0 CA-C-O 118.317 -0.849 . . . . 0.0 110.166 179.92 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' F' F ' 55' ' ' PRO . . . . . . . . . . . . . 73.9 Cg_endo -77.07 170.03 72.74 Favored 'Cis proline' 0 N--CA 1.497 1.713 0 CA-C-N 121.861 1.7 . . . . 0.0 112.27 -4.661 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' F' F ' 56' ' ' SER . . . . . . . . . . . . . 13.5 m -113.93 131.91 22.91 Favored Pre-proline 0 CA--C 1.538 0.484 0 CA-C-O 118.513 -0.756 . . . . 0.0 109.326 175.652 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' F' F ' 57' ' ' PRO . . . . . . . . . . . . . 55.6 Cg_endo -71.33 166.88 76.79 Favored 'Cis proline' 0 N--CA 1.498 1.757 0 CA-C-N 121.923 1.722 . . . . 0.0 111.643 -0.321 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' F' F ' 58' ' ' LEU . . . . . . . . . . . . . 35.3 tp -129.54 137.34 50.72 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.271 -0.422 . . . . 0.0 110.152 179.491 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' F' F ' 59' ' ' ARG . . . . . . . . . . . . . 38.5 ttm180 -103.71 133.89 47.95 Favored 'General case' 0 C--N 1.327 -0.381 0 N-CA-C 109.706 -0.479 . . . . 0.0 109.706 177.836 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' F' F ' 60' ' ' VAL . . . . . . . . . . . . . 44.1 t -85.28 111.38 20.65 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.264 0 C-N-CA 120.761 -0.376 . . . . 0.0 110.36 -176.428 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' F' F ' 61' ' ' GLU . . . . . . . . . . . . . 95.5 mt-10 -131.06 165.26 23.63 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 115.835 -0.621 . . . . 0.0 109.677 176.043 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' F' F ' 62' ' ' ASP . . . . . . . . . . . . . 19.9 p-10 -53.7 -32.47 51.98 Favored 'General case' 0 C--N 1.328 -0.365 0 N-CA-C 111.85 0.315 . . . . 0.0 111.85 -179.42 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' F' F ' 63' ' ' ARG . . . . . . . . . . . . . 81.3 mtp180 -72.97 -21.93 60.78 Favored 'General case' 0 CA--C 1.533 0.299 0 N-CA-C 113.041 0.756 . . . . 0.0 113.041 -176.313 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' F' F ' 64' ' ' THR . . . . . . . . . . . . . 17.8 m -71.17 142.01 50.7 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-O 120.952 0.406 . . . . 0.0 111.09 -174.568 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' F' F ' 65' ' ' LYS . . . . . . . . . . . . . 39.7 mtpt -89.48 125.46 35.19 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 115.883 -0.599 . . . . 0.0 109.925 178.784 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' F' F ' 66' ' ' ILE . . . . . . . . . . . . . 68.1 mt -119.07 131.64 71.25 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.339 0 CA-C-O 120.874 0.368 . . . . 0.0 110.277 -178.15 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' F' F ' 67' ' ' THR . . . . . . . . . . . . . 26.1 m -123.98 136.89 54.6 Favored 'General case' 0 C--N 1.331 -0.215 0 CA-C-N 116.015 -0.539 . . . . 0.0 110.742 -179.048 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' F' F ' 68' ' ' LEU . . . . . 0.472 HD23 ' C ' ' F' ' 68' ' ' LEU . 5.7 tt -108.39 119.15 38.67 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 115.968 -0.56 . . . . 0.0 110.515 179.485 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' F' F ' 69' ' ' VAL . . . . . . . . . . . . . 44.7 t -104.36 137.01 35.16 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.238 0 CA-C-N 116.139 -0.482 . . . . 0.0 110.069 179.138 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' F' F ' 70' ' ' THR . . . . . 0.425 HG23 ' N ' ' F' ' 71' ' ' HIS . 7.2 t -132.21 -39.58 1.05 Allowed 'General case' 0 C--N 1.331 -0.203 0 CA-C-O 120.75 0.31 . . . . 0.0 110.789 179.156 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' F' F ' 71' ' ' HIS . . . . . 0.425 ' N ' HG23 ' F' ' 70' ' ' THR . 39.1 m80 -128.32 154.95 79.1 Favored Pre-proline 0 CA--C 1.531 0.234 0 CA-C-N 116.503 -0.317 . . . . 0.0 110.452 179.944 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' F' F ' 72' ' ' PRO . . . . . . . . . . . . . 59.6 Cg_endo -73.95 -30.16 9.42 Favored 'Trans proline' 0 N--CA 1.494 1.554 0 C-N-CA 121.335 1.357 . . . . 0.0 112.462 -179.31 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' F' F ' 73' ' ' VAL . . . . . . . . . . . . . 35.9 m -137.34 163.41 31.6 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.262 0 CA-C-O 120.837 0.351 . . . . 0.0 110.686 179.005 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' F' F ' 74' ' ' ASP . . . . . . . . . . . . . 19.5 t0 -107.05 123.04 47.64 Favored 'General case' 0 C--N 1.328 -0.329 0 N-CA-C 109.584 -0.525 . . . . 0.0 109.584 179.156 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' F' F ' 75' ' ' VAL . . . . . 0.429 ' C ' HD12 ' F' ' 76' ' ' LEU . 46.2 t -117.34 126.26 74.48 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.233 0 CA-C-O 121.173 0.511 . . . . 0.0 110.771 -177.43 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' F' F ' 76' ' ' LEU . . . . . 0.429 HD12 ' C ' ' F' ' 75' ' ' VAL . 6.5 mp -122.82 143.66 49.7 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 115.463 -0.79 . . . . 0.0 109.128 174.546 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' F' F ' 77' ' ' GLU . . . . . . . . . . . . . 30.1 tt0 -135.85 140.76 44.42 Favored 'General case' 0 C--N 1.331 -0.225 0 C-N-CA 120.734 -0.386 . . . . 0.0 111.273 -174.73 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' F' F ' 78' ' ' ALA . . . . . . . . . . . . . . . -130.16 134.96 47.68 Favored 'General case' 0 C--N 1.331 -0.239 0 CA-C-N 115.933 -0.576 . . . . 0.0 110.013 176.762 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' F' F ' 79' ' ' LYS . . . . . 0.403 ' O ' HD13 ' F' ' 80' ' ' ILE . 31.1 ttmt -82.4 125.71 31.36 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-O 120.74 0.305 . . . . 0.0 110.822 -178.607 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' F' F ' 80' ' ' ILE . . . . . 0.403 HD13 ' O ' ' F' ' 79' ' ' LYS . 28.0 mm -139.12 114.81 8.98 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.265 0 N-CA-C 109.062 -0.718 . . . . 0.0 109.062 -177.8 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' F' F ' 81' ' ' LYS . . . . . . . . . . . . . 70.1 tttt -103.69 122.11 44.36 Favored 'General case' 0 C--N 1.328 -0.334 0 C-N-CA 121.027 -0.269 . . . . 0.0 111.116 -175.884 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' F' F ' 82' ' ' GLY . . . . . . . . . . . . . . . 89.09 42.18 5.68 Favored Glycine 0 CA--C 1.525 0.66 0 C-N-CA 120.715 -0.755 . . . . 0.0 111.892 174.789 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' F' F ' 83' ' ' ILE . . . . . . . . . . . . . 69.0 mt -65.27 136.49 26.6 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.243 0 N-CA-C 109.91 -0.404 . . . . 0.0 109.91 178.044 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' F' F ' 84' ' ' LYS . . . . . . . . . . . . . 29.0 ttmt -94.32 -51.78 4.64 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.088 -0.506 . . . . 0.0 109.93 179.482 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' F' F ' 85' ' ' ASP . . . . . . . . . . . . . 4.3 t70 -157.29 153.59 27.7 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 115.621 -0.718 . . . . 0.0 110.504 -179.659 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' F' F ' 86' ' ' VAL . . . . . . . . . . . . . 43.8 t -131.52 133.41 61.85 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.232 0 CA-C-O 120.98 0.419 . . . . 0.0 110.356 -179.181 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' F' F ' 87' ' ' ILE . . . . . 0.497 HD12 ' N ' ' F' ' 87' ' ' ILE . 5.0 mp -120.37 126.29 75.1 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.241 0 CA-C-N 115.943 -0.572 . . . . 0.0 109.528 177.765 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' F' F ' 88' ' ' LEU . . . . . . . . . . . . . 10.7 tp -109.5 128.2 55.0 Favored 'General case' 0 C--N 1.331 -0.226 0 CA-C-O 120.902 0.382 . . . . 0.0 110.895 -177.929 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' F' F ' 89' ' ' ASP . . . . . . . . . . . . . 4.2 t0 -120.69 158.14 28.1 Favored 'General case' 0 C--N 1.329 -0.286 0 N-CA-C 109.497 -0.557 . . . . 0.0 109.497 177.441 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' F' F ' 90' ' ' GLU . . . . . . . . . . . . . 84.0 tt0 -45.12 -46.19 11.68 Favored 'General case' 0 N--CA 1.465 0.291 0 N-CA-C 112.985 0.735 . . . . 0.0 112.985 -172.484 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' F' F ' 91' ' ' ASN . . . . . . . . . . . . . 79.4 m-20 -132.05 30.84 4.22 Favored 'General case' 0 N--CA 1.465 0.29 0 N-CA-C 112.189 0.44 . . . . 0.0 112.189 -179.608 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' F' F ' 92' ' ' LEU . . . . . . . . . . . . . 7.2 mt -150.35 140.94 22.56 Favored 'General case' 0 C--N 1.331 -0.204 0 N-CA-C 109.564 -0.532 . . . . 0.0 109.564 -178.088 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' F' F ' 93' ' ' ILE . . . . . . . . . . . . . 73.5 mt -124.01 119.45 56.87 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.289 0 N-CA-C 109.338 -0.616 . . . . 0.0 109.338 178.997 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' F' F ' 94' ' ' VAL . . . . . . . . . . . . . 44.0 t -119.55 126.59 75.46 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.198 0 CA-C-O 120.892 0.377 . . . . 0.0 109.998 -179.648 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' F' F ' 95' ' ' VAL . . . . . . . . . . . . . 44.1 t -121.58 133.14 69.01 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.298 0 CA-C-N 116.101 -0.5 . . . . 0.0 109.738 179.623 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' F' F ' 96' ' ' ILE . . . . . . . . . . . . . 64.3 mt -114.26 126.15 71.71 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.326 0 N-CA-C 109.234 -0.654 . . . . 0.0 109.234 178.88 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' F' F ' 97' ' ' THR . . . . . . . . . . . . . 64.6 p -98.62 154.8 17.67 Favored 'General case' 0 C--N 1.327 -0.385 0 CA-C-O 121.109 0.48 . . . . 0.0 110.952 -178.311 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' F' F ' 98' ' ' GLU . . . . . . . . . . . . . 83.4 tt0 -53.89 -23.5 12.91 Favored 'General case' 0 CA--C 1.535 0.371 0 N-CA-C 112.419 0.525 . . . . 0.0 112.419 179.966 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' F' F ' 99' ' ' GLU . . . . . . . . . . . . . 13.8 mm-40 -77.54 13.92 1.14 Allowed 'General case' 0 CA--C 1.536 0.431 0 N-CA-C 113.272 0.841 . . . . 0.0 113.272 -178.444 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' F' F ' 100' ' ' ASN . . . . . . . . . . . . . 2.2 m-20 63.65 37.73 9.95 Favored 'General case' 0 N--CA 1.463 0.212 0 CA-C-O 121.111 0.481 . . . . 0.0 110.948 178.322 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' F' F ' 101' ' ' GLU . . . . . . . . . . . . . 84.9 tt0 -120.09 140.93 50.3 Favored 'General case' 0 C--N 1.333 -0.151 0 CA-C-N 116.203 -0.453 . . . . 0.0 109.853 176.68 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' F' F ' 102' ' ' VAL . . . . . . . . . . . . . 43.2 t -115.03 126.74 72.7 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 CA-C-N 116.197 -0.456 . . . . 0.0 109.881 -178.32 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' F' F ' 103' ' ' LEU . . . . . 0.516 HD12 ' N ' ' F' ' 103' ' ' LEU . 6.2 mp -117.29 134.89 54.27 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 115.994 -0.548 . . . . 0.0 110.294 177.784 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' F' F ' 104' ' ' ILE . . . . . . . . . . . . . 66.3 mt -119.0 122.22 68.78 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.218 0 CA-C-N 116.422 -0.354 . . . . 0.0 110.217 -179.147 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' F' F ' 105' ' ' PHE . . . . . . . . . . . . . 79.3 m-85 -120.54 161.46 21.27 Favored 'General case' 0 C--N 1.331 -0.235 0 O-C-N 124.046 0.841 . . . . 0.0 109.987 179.614 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' F' F ' 106' ' ' ASN . . . . . . . . . . . . . 46.8 p-10 -97.4 -169.85 1.92 Allowed 'General case' 0 CA--C 1.531 0.228 0 N-CA-C 110.19 -0.3 . . . . 0.0 110.19 175.559 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' F' F ' 107' ' ' GLN . . . . . . . . . . . . . 63.0 tt0 -59.0 -30.09 67.72 Favored 'General case' 0 C--N 1.33 -0.271 0 N-CA-C 111.954 0.353 . . . . 0.0 111.954 179.618 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' F' F ' 108' ' ' ASN . . . . . . . . . . . . . 8.5 t-20 -83.98 11.76 7.32 Favored 'General case' 0 CA--C 1.536 0.428 0 N-CA-C 112.877 0.695 . . . . 0.0 112.877 -178.124 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' F' F ' 109' ' ' LEU . . . . . . . . . . . . . 10.5 tp 54.96 35.41 24.49 Favored 'General case' 0 C--N 1.331 -0.201 0 CA-C-O 120.902 0.382 . . . . 0.0 111.431 -179.602 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' F' F ' 110' ' ' GLU . . . . . . . . . . . . . 94.9 mt-10 -104.46 147.06 28.0 Favored 'General case' 0 C--N 1.331 -0.233 0 N-CA-C 109.335 -0.617 . . . . 0.0 109.335 175.38 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' F' F ' 111' ' ' GLU . . . . . . . . . . . . . 64.8 tt0 -81.47 121.95 26.92 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-O 120.913 0.387 . . . . 0.0 110.639 -174.97 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' F' F ' 112' ' ' LEU . . . . . . . . . . . . . 16.9 mt -104.7 -46.04 4.44 Favored 'General case' 0 C--N 1.331 -0.227 0 CA-C-N 116.04 -0.527 . . . . 0.0 110.623 179.513 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' F' F ' 113' ' ' TYR . . . . . . . . . . . . . 49.5 t80 -137.25 146.04 44.28 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.166 -0.47 . . . . 0.0 111.026 -177.919 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' F' F ' 114' ' ' ARG . . . . . . . . . . . . . 37.6 ptt180 -148.58 126.58 12.0 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.141 -0.481 . . . . 0.0 110.779 178.505 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' F' F ' 115' ' ' GLY . . . . . . . . . . . . . . . -150.16 142.78 9.98 Favored Glycine 0 CA--C 1.524 0.641 0 N-CA-C 111.062 -0.815 . . . . 0.0 111.062 179.159 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' F' F ' 116' ' ' LYS . . . . . . . . . . . . . 39.1 ttpt -112.37 134.09 54.09 Favored 'General case' 0 C--N 1.331 -0.236 0 N-CA-C 109.694 -0.484 . . . . 0.0 109.694 176.908 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' F' F ' 117' ' ' PHE . . . . . . . . . . . . . 28.1 m-85 -136.54 114.38 11.25 Favored 'General case' 0 C--N 1.329 -0.313 0 N-CA-C 110.055 -0.35 . . . . 0.0 110.055 -175.351 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' F' F ' 118' ' ' GLU . . . . . . . . . . . . . 43.7 mt-10 -54.94 -44.1 74.0 Favored 'General case' 0 C--N 1.33 -0.274 0 C-N-CA 120.883 -0.327 . . . . 0.0 111.348 -176.618 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' F' F ' 119' ' ' ASN . . . . . . . . . . . . . 30.6 m120 -94.87 30.49 2.07 Favored 'General case' 0 C--N 1.33 -0.263 0 N-CA-C 112.161 0.43 . . . . 0.0 112.161 -174.659 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' F' F ' 120' ' ' LEU . . . . . . . . . . . . . 22.0 tp -57.5 120.08 7.65 Favored 'General case' 0 C--N 1.331 -0.211 0 C-N-CA 120.925 -0.31 . . . . 0.0 110.293 177.577 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' F' F ' 121' ' ' ASN . . . . . . . . . . . . . 76.2 m-20 -111.63 -44.1 3.55 Favored 'General case' 0 C--N 1.331 -0.221 0 CA-C-N 116.425 -0.352 . . . . 0.0 110.711 -179.273 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' F' F ' 122' ' ' LYS . . . . . . . . . . . . . 97.0 mttt -146.93 145.08 29.67 Favored 'General case' 0 C--N 1.331 -0.216 0 C-N-CA 120.536 -0.466 . . . . 0.0 111.899 -179.316 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' F' F ' 123' ' ' VAL . . . . . . . . . . . . . 45.1 t -122.95 125.86 72.89 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.234 0 N-CA-C 108.998 -0.742 . . . . 0.0 108.998 171.531 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' F' F ' 124' ' ' LEU . . . . . 0.462 HD23 ' N ' ' F' ' 125' ' ' VAL . 3.3 tt -125.26 131.86 53.03 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.461 -0.336 . . . . 0.0 110.482 -175.28 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' F' F ' 125' ' ' VAL . . . . . 0.462 ' N ' HD23 ' F' ' 124' ' ' LEU . 11.7 p -131.14 135.95 58.78 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.224 0 CA-C-N 116.377 -0.374 . . . . 0.0 110.502 178.961 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' F' F ' 126' ' ' ARG . . . . . . . . . . . . . 96.6 mtt180 -149.43 128.37 12.63 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 116.109 -0.496 . . . . 0.0 110.873 177.333 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' F' F ' 127' ' ' ASN . . . . . . . . . . . . . 17.3 t-20 50.46 -106.77 0.24 Allowed 'General case' 0 CA--C 1.543 0.677 0 CA-C-O 118.975 -0.536 . . . . 0.0 111.543 178.85 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' F' F ' 128' ' ' ASP . . . . . . . . . . . . . 18.7 p-10 -114.14 5.17 15.85 Favored 'General case' 0 N--CA 1.469 0.476 0 CA-C-N 119.667 1.121 . . . . 0.0 113.531 -176.332 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' F' F ' 129' ' ' LEU . . . . . . . . . . . . . 61.9 mt -109.39 137.52 47.12 Favored 'General case' 0 C--O 1.232 0.159 0 CA-C-N 118.155 0.434 . . . . 0.0 110.702 -179.428 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' F' F ' 130' ' ' VAL . . . . . . . . . . . . . 44.4 t -124.02 132.0 72.05 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.194 0 N-CA-C 109.609 -0.515 . . . . 0.0 109.609 177.596 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' F' F ' 131' ' ' VAL . . . . . 0.464 HG22 HD12 ' F' ' 140' ' ' LEU . 41.4 t -135.56 137.08 50.06 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.208 0 CA-C-O 121.091 0.472 . . . . 0.0 110.511 -179.452 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' F' F ' 132' ' ' ILE . . . . . . . . . . . . . 71.0 mt -118.26 132.82 66.99 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.239 0 CA-C-N 115.815 -0.629 . . . . 0.0 109.542 178.717 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' F' F ' 133' ' ' ILE . . . . . . . . . . . . . 43.1 mm -118.31 124.6 73.37 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.238 0 CA-C-N 116.519 -0.31 . . . . 0.0 111.205 -174.758 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' F' F ' 134' ' ' ASP . . . . . . . . . . . . . 13.9 p-10 -140.52 151.42 44.76 Favored 'General case' 0 C--N 1.332 -0.19 0 N-CA-C 109.737 -0.468 . . . . 0.0 109.737 172.655 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' F' F ' 135' ' ' GLU . . . . . . . . . . . . . 42.5 tp10 -50.89 -27.44 7.5 Favored 'General case' 0 C--N 1.328 -0.357 0 N-CA-C 112.971 0.73 . . . . 0.0 112.971 -171.028 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' F' F ' 136' ' ' GLN . . . . . . . . . . . . . 99.3 mm-40 -86.28 -29.62 22.93 Favored 'General case' 0 C--O 1.233 0.23 0 N-CA-C 112.705 0.631 . . . . 0.0 112.705 -174.332 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' F' F ' 137' ' ' LYS . . . . . . . . . . . . . 55.7 pttt -164.95 169.11 16.84 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-O 121.524 0.678 . . . . 0.0 112.545 -170.605 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' F' F ' 138' ' ' LEU . . . . . 0.417 HD23 ' N ' ' F' ' 139' ' ' THR . 5.3 tt -122.26 127.52 50.01 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 114.986 -1.006 . . . . 0.0 109.598 178.565 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' F' F ' 139' ' ' THR . . . . . 0.417 ' N ' HD23 ' F' ' 138' ' ' LEU . 35.0 m -108.07 124.59 50.43 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.423 -0.353 . . . . 0.0 110.333 -179.299 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' F' F ' 140' ' ' LEU . . . . . 0.464 HD12 HG22 ' F' ' 131' ' ' VAL . 14.5 tp -113.0 120.2 40.56 Favored 'General case' 0 C--N 1.329 -0.284 0 N-CA-C 109.337 -0.616 . . . . 0.0 109.337 -179.069 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' F' F ' 141' ' ' ILE . . . . . . . . . . . . . 18.9 mt -120.94 121.96 66.48 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.28 0 CA-C-O 120.961 0.41 . . . . 0.0 110.052 -175.364 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' F' F ' 142' ' ' ARG . . . . . . . . . . . . . 75.3 mtp180 -105.84 117.18 33.37 Favored 'General case' 0 C--O 1.232 0.163 0 CA-C-N 115.548 -0.751 . . . . 0.0 109.945 179.113 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' F' F ' 143' ' ' THR . . . . . . . . . . . . . 18.8 p . . . . . 0 C--O 1.219 -0.505 0 CA-C-O 118.029 -0.986 . . . . 0.0 110.663 -179.015 . . . . . . . . 0 0 . 1 . 009 nuclear nobuild full ' A' A ' -3' ' ' GLU . . . . . . . . . . . . . 70.8 mm-40 . . . . . 0 N--CA 1.49 1.557 0 N-CA-C 109.343 -0.614 . . . . 0.0 109.343 . . . . . . . . . 0 0 . 1 . 009 nuclear nobuild full ' A' A ' -2' ' ' GLY . . . . . . . . . . . . . . . -69.81 145.28 41.49 Favored Glycine 0 CA--C 1.525 0.702 0 N-CA-C 111.049 -0.82 . . . . 0.0 111.049 -179.55 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' -1' ' ' VAL . . . . . . . . . . . . . 44.7 t -141.86 135.67 29.77 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.34 0 N-CA-C 109.938 -0.393 . . . . 0.0 109.938 179.361 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 0' ' ' ILE . . . . . . . . . . . . . 71.2 mt -107.13 133.0 53.08 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.322 0 N-CA-C 109.779 -0.452 . . . . 0.0 109.779 179.574 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 25.7 ptm -77.69 140.55 39.57 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.198 -0.455 . . . . 0.0 111.17 -177.264 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 5.3 p -115.97 132.99 56.49 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 115.967 -0.56 . . . . 0.0 110.013 177.29 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 84.9 tt0 -146.14 143.85 29.59 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.27 -0.423 . . . . 0.0 111.371 -178.232 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 4' ' ' LEU . . . . . . . . . . . . . 16.8 tp -127.54 132.84 49.84 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 115.937 -0.574 . . . . 0.0 110.079 176.934 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 5' ' ' LYS . . . . . . . . . . . . . 91.6 mttt -112.05 120.64 42.55 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.589 -179.555 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 6' ' ' LEU . . . . . 0.465 HD23 ' HA ' ' A' ' 50' ' ' VAL . 71.5 mt -115.95 142.67 46.47 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 115.471 -0.786 . . . . 0.0 110.305 -178.685 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 39.4 ttmt -122.71 138.42 29.42 Favored Pre-proline 0 CA--C 1.532 0.286 0 CA-C-O 118.991 -0.528 . . . . 0.0 109.807 176.013 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 8' ' ' PRO . . . . . . . . . . . . . 91.3 Cg_endo -91.44 131.76 1.37 Allowed 'Trans proline' 0 N--CA 1.489 1.229 0 C-N-CA 121.702 1.602 . . . . 0.0 111.803 178.688 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 41.2 mt -71.91 -46.98 11.88 Favored Pre-proline 0 C--N 1.327 -0.376 0 CA-C-O 118.648 -0.691 . . . . 0.0 112.004 -179.388 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 83.6 Cg_endo -81.05 150.42 17.93 Favored 'Trans proline' 0 N--CA 1.495 1.581 0 C-N-CA 121.213 1.276 . . . . 0.0 111.878 175.412 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 68.8 mttm -88.85 99.33 12.3 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.401 -0.363 . . . . 0.0 110.496 178.932 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 12.4 p -144.52 149.16 17.52 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.282 0 CA-C-N 116.239 -0.437 . . . . 0.0 110.522 -179.494 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 44.2 mp0 -90.48 120.61 31.72 Favored 'General case' 0 C--N 1.331 -0.208 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.436 179.064 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 14' ' ' LEU . . . . . . . . . . . . . 24.2 mt -98.24 154.23 37.74 Favored Pre-proline 0 C--N 1.329 -0.291 0 CA-C-N 116.351 -0.386 . . . . 0.0 110.867 -179.744 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 15' ' ' PRO . . . . . . . . . . . . . 37.5 Cg_exo -59.63 155.93 39.84 Favored 'Trans proline' 0 N--CA 1.497 1.729 0 C-N-CA 121.272 1.315 . . . . 0.0 111.615 177.742 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 16' ' ' PRO . . . . . . . . . . . . . 35.8 Cg_exo -58.18 -38.29 91.84 Favored 'Trans proline' 0 N--CA 1.496 1.643 0 C-N-CA 121.491 1.461 . . . . 0.0 112.697 -179.514 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 17' ' ' ASP . . . . . . . . . . . . . 15.9 p-10 -85.18 10.69 11.59 Favored 'General case' 0 CA--C 1.534 0.363 0 N-CA-C 113.215 0.82 . . . . 0.0 113.215 -177.816 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 18' ' ' PHE . . . . . . . . . . . . . 42.1 t80 -58.2 -42.3 85.86 Favored 'General case' 0 N--CA 1.458 -0.046 0 O-C-N 121.95 -0.469 . . . . 0.0 110.116 -179.158 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 19' ' ' VAL . . . . . 0.403 HG13 ' N ' ' A' ' 20' ' ' ASP . 12.6 p -55.9 -40.51 62.74 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.287 0 CA-C-N 116.436 -0.347 . . . . 0.0 110.709 179.65 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 20' ' ' ASP . . . . . 0.403 ' N ' HG13 ' A' ' 19' ' ' VAL . 53.9 m-20 -60.59 -44.0 96.74 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-O 120.83 0.348 . . . . 0.0 110.722 -179.394 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 47.0 t -63.64 -47.13 92.67 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.324 0 CA-C-N 116.358 -0.383 . . . . 0.0 110.587 -177.643 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 22' ' ' ILE . . . . . 0.581 HG22 HD12 ' A' ' 26' ' ' LEU . 50.7 mm -54.97 -49.51 70.52 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.204 0 O-C-N 122.227 -0.296 . . . . 0.0 110.835 179.3 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 23' ' ' ARG . . . . . . . . . . . . . 34.8 ttp180 -54.04 -49.32 69.21 Favored 'General case' 0 C--N 1.33 -0.247 0 C-N-CA 121.043 -0.263 . . . . 0.0 111.53 -178.339 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 24' ' ' ILE . . . . . . . . . . . . . 79.1 mt -58.85 -42.0 84.45 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.281 0 C-N-CA 121.181 -0.208 . . . . 0.0 111.428 -177.147 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 45.2 mttm -67.97 -42.13 81.33 Favored 'General case' 0 C--N 1.328 -0.347 0 N-CA-C 112.212 0.449 . . . . 0.0 112.212 -178.442 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 26' ' ' LEU . . . . . 0.581 HD12 HG22 ' A' ' 22' ' ' ILE . 81.6 mt -80.19 -34.72 37.22 Favored 'General case' 0 C--N 1.328 -0.34 0 N-CA-C 113.501 0.926 . . . . 0.0 113.501 -169.64 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 27' ' ' GLN . . . . . . . . . . . . . 9.7 pt20 -46.64 141.52 3.75 Favored 'General case' 0 N--CA 1.467 0.412 0 N-CA-C 112.876 0.695 . . . . 0.0 112.876 -174.84 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 100.25 -26.89 22.83 Favored Glycine 0 CA--C 1.534 1.225 0 CA-C-N 115.644 -0.707 . . . . 0.0 112.166 -177.485 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 49.2 mtpt -97.52 155.04 17.13 Favored 'General case' 0 C--O 1.233 0.205 0 CA-C-N 117.322 0.561 . . . . 0.0 110.976 178.802 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 30' ' ' THR . . . . . . . . . . . . . 25.6 m -106.21 137.71 43.67 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.189 -0.459 . . . . 0.0 110.007 176.436 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 34.9 m -129.14 159.21 41.43 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.275 0 CA-C-N 116.409 -0.359 . . . . 0.0 110.866 -178.286 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 32' ' ' ARG . . . . . . . . . . . . . 76.7 mtm180 -133.46 150.82 51.73 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-O 121.209 0.528 . . . . 0.0 110.564 178.391 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 33' ' ' THR . . . . . . . . . . . . . 13.6 m -52.69 140.23 24.12 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.203 -0.453 . . . . 0.0 111.416 -178.148 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 100.53 -17.16 57.08 Favored Glycine 0 CA--C 1.532 1.111 0 CA-C-O 119.805 -0.442 . . . . 0.0 113.315 179.673 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 74.1 m-20 -66.82 149.31 50.76 Favored 'General case' 0 N--CA 1.461 0.098 0 CA-C-N 118.021 0.91 . . . . 0.0 111.205 178.931 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 45.3 t -119.42 129.87 74.74 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.2 0 CA-C-N 115.915 -0.584 . . . . 0.0 109.737 178.007 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 37' ' ' ILE . . . . . . . . . . . . . 64.1 mt -120.48 138.71 50.1 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.238 0 CA-C-N 116.091 -0.504 . . . . 0.0 109.854 -179.332 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . -116.52 128.8 8.11 Favored Glycine 0 CA--C 1.525 0.701 0 N-CA-C 111.052 -0.819 . . . . 0.0 111.052 179.953 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 39' ' ' ILE . . . . . . . . . . . . . 71.1 mt -126.72 134.24 66.71 Favored 'Isoleucine or valine' 0 C--N 1.333 -0.138 0 CA-C-O 120.822 0.344 . . . . 0.0 110.219 178.988 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 40' ' ' SER . . . . . . . . . . . . . 8.6 t -92.79 114.52 27.1 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.224 -0.444 . . . . 0.0 110.938 175.139 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 41' ' ' ILE . . . . . . . . . . . . . 44.3 mm -121.79 119.37 58.57 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.232 0 CA-C-O 120.87 0.367 . . . . 0.0 110.353 179.912 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 9.4 tp 55.45 36.63 27.52 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.182 -0.463 . . . . 0.0 111.483 177.254 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . 72.43 24.9 75.53 Favored Glycine 0 CA--C 1.532 1.111 0 C-N-CA 121.14 -0.553 . . . . 0.0 112.659 177.929 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 44' ' ' LYS . . . . . . . . . . . . . 43.4 mmtm -132.02 130.9 41.98 Favored 'General case' 0 C--N 1.332 -0.174 0 CA-C-N 117.28 0.54 . . . . 0.0 109.748 178.609 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 84.0 tt0 -83.32 121.22 26.84 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.479 -0.328 . . . . 0.0 111.154 -178.286 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 46' ' ' VAL . . . . . 0.429 HG13 ' O ' ' A' ' 46' ' ' VAL . 11.2 p -119.73 121.41 66.09 Favored 'Isoleucine or valine' 0 C--O 1.232 0.166 0 N-CA-C 109.6 -0.518 . . . . 0.0 109.6 173.935 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 51.9 mtmt -98.72 126.48 44.35 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 115.968 -0.56 . . . . 0.0 110.657 178.243 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 48' ' ' PHE . . . . . . . . . . . . . 46.2 m-85 -110.99 131.85 54.7 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.201 -0.454 . . . . 0.0 109.816 178.631 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 80.9 tttt -106.43 130.89 54.16 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.362 -0.381 . . . . 0.0 110.044 178.329 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 50' ' ' VAL . . . . . 0.465 ' HA ' HD23 ' A' ' 6' ' ' LEU . 43.3 t -75.04 105.54 4.1 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.322 0 N-CA-C 109.414 -0.587 . . . . 0.0 109.414 177.785 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 51' ' ' VAL . . . . . . . . . . . . . 45.8 t -71.24 -51.95 30.54 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.363 0 CA-C-N 116.053 -0.521 . . . . 0.0 109.713 -175.015 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 52' ' ' GLN . . . . . . . . . . . . . 87.1 mt-30 -153.74 151.91 30.16 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-O 121.146 0.498 . . . . 0.0 111.44 -178.313 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -128.08 133.69 49.08 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 115.253 -0.885 . . . . 0.0 109.828 175.819 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 54' ' ' TYR . . . . . . . . . . . . . 58.1 t80 -129.03 108.81 18.15 Favored Pre-proline 0 CA--C 1.535 0.373 0 CA-C-O 118.363 -0.827 . . . . 0.0 110.324 -179.421 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 55' ' ' PRO . . . . . . . . . . . . . 73.5 Cg_endo -77.14 170.13 72.39 Favored 'Cis proline' 0 N--CA 1.499 1.845 0 CA-C-N 121.766 1.666 . . . . 0.0 112.372 -5.47 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 56' ' ' SER . . . . . . . . . . . . . 32.3 m -115.54 127.2 26.99 Favored Pre-proline 0 CA--C 1.538 0.494 0 CA-C-O 118.384 -0.817 . . . . 0.0 109.322 175.495 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 57' ' ' PRO . . . . . . . . . . . . . 36.9 Cg_endo -66.28 167.43 53.59 Favored 'Cis proline' 0 N--CA 1.497 1.682 0 CA-C-N 121.977 1.742 . . . . 0.0 111.708 0.063 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 58' ' ' LEU . . . . . . . . . . . . . 28.5 tp -130.98 137.26 49.16 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.136 -0.484 . . . . 0.0 110.447 -179.912 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 59' ' ' ARG . . . . . . . . . . . . . 70.8 ttt180 -102.44 130.94 49.38 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 116.149 -0.478 . . . . 0.0 109.791 177.163 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 40.8 t -80.43 112.39 18.39 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 CA-C-O 120.878 0.37 . . . . 0.0 110.397 -177.101 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 83.0 tt0 -131.0 155.41 46.87 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 115.84 -0.618 . . . . 0.0 109.461 177.433 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 62' ' ' ASP . . . . . . . . . . . . . 76.3 m-20 -50.5 -30.38 12.72 Favored 'General case' 0 C--N 1.328 -0.356 0 N-CA-C 112.208 0.447 . . . . 0.0 112.208 179.733 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 63' ' ' ARG . . . . . . . . . . . . . 77.2 mtp180 -71.99 -21.6 61.55 Favored 'General case' 0 CA--C 1.534 0.352 0 N-CA-C 112.843 0.682 . . . . 0.0 112.843 -176.768 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 27.5 m -71.59 139.3 49.33 Favored 'General case' 0 C--N 1.332 -0.159 0 CA-C-O 120.971 0.415 . . . . 0.0 111.0 -176.687 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 65' ' ' LYS . . . . . . . . . . . . . 55.0 mtmt -89.09 134.51 33.97 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-N 115.902 -0.59 . . . . 0.0 109.896 176.714 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 66' ' ' ILE . . . . . . . . . . . . . 63.3 mt -115.55 129.83 71.18 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.259 0 N-CA-C 109.925 -0.398 . . . . 0.0 109.925 -178.643 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 67' ' ' THR . . . . . . . . . . . . . 24.5 m -120.02 135.78 54.8 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.851 -179.148 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 68' ' ' LEU . . . . . 0.478 HD23 ' C ' ' A' ' 68' ' ' LEU . 6.6 tt -106.16 123.54 48.18 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 115.701 -0.681 . . . . 0.0 110.039 178.168 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 69' ' ' VAL . . . . . . . . . . . . . 42.3 t -98.46 127.19 51.23 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.293 0 CA-C-N 116.185 -0.461 . . . . 0.0 110.191 -179.259 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 70' ' ' THR . . . . . . . . . . . . . 9.1 m -93.19 -59.97 1.9 Allowed 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.747 -179.69 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 71' ' ' HIS . . . . . . . . . . . . . 46.1 m80 -79.27 161.09 69.07 Favored Pre-proline 0 C--N 1.33 -0.264 0 CA-C-N 116.299 -0.409 . . . . 0.0 110.618 -178.927 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 72' ' ' PRO . . . . . . . . . . . . . 15.6 Cg_endo -84.19 -25.45 2.19 Favored 'Trans proline' 0 N--CA 1.49 1.32 0 C-N-CA 121.605 1.537 . . . . 0.0 112.94 -179.103 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 73' ' ' VAL . . . . . . . . . . . . . 35.6 m -89.52 172.9 0.93 Allowed 'Isoleucine or valine' 0 C--N 1.332 -0.183 0 CA-C-O 120.984 0.421 . . . . 0.0 110.895 -178.544 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 74' ' ' ASP . . . . . . . . . . . . . 9.0 t0 -102.86 124.82 49.1 Favored 'General case' 0 C--N 1.331 -0.22 0 CA-C-N 115.979 -0.555 . . . . 0.0 109.904 -179.285 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 41.0 t -114.26 121.98 67.46 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.255 0 CA-C-O 121.213 0.53 . . . . 0.0 110.521 -178.321 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 76' ' ' LEU . . . . . . . . . . . . . 29.9 mt -117.74 141.29 48.57 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 115.446 -0.797 . . . . 0.0 109.165 176.28 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 77' ' ' GLU . . . . . . . . . . . . . 16.8 tt0 -137.31 133.53 35.05 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-O 120.851 0.358 . . . . 0.0 111.135 -176.11 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 78' ' ' ALA . . . . . . . . . . . . . . . -125.99 141.06 52.13 Favored 'General case' 0 C--N 1.331 -0.202 0 CA-C-N 116.058 -0.519 . . . . 0.0 110.457 178.913 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 79' ' ' LYS . . . . . 0.638 ' O ' HD13 ' A' ' 80' ' ' ILE . 45.0 mmtt -79.63 121.89 25.85 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.382 -0.372 . . . . 0.0 110.38 177.992 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 80' ' ' ILE . . . . . 0.638 HD13 ' O ' ' A' ' 79' ' ' LYS . 38.5 mm -138.9 107.41 3.5 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.343 0 N-CA-C 109.386 -0.598 . . . . 0.0 109.386 -179.413 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 81' ' ' LYS . . . . . . . . . . . . . 28.7 ttpp -103.25 125.22 49.8 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-O 120.811 0.339 . . . . 0.0 111.64 -175.321 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . 89.19 42.05 5.68 Favored Glycine 0 CA--C 1.524 0.646 0 C-N-CA 121.102 -0.57 . . . . 0.0 112.012 172.48 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 83' ' ' ILE . . . . . . . . . . . . . 71.3 mt -72.85 136.75 24.87 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 N-CA-C 109.851 -0.426 . . . . 0.0 109.851 176.965 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 84' ' ' LYS . . . . . . . . . . . . . 39.6 ttpt -100.54 -48.14 4.64 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-O 120.966 0.412 . . . . 0.0 110.105 -179.438 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 85' ' ' ASP . . . . . . . . . . . . . 6.3 t70 -151.41 152.51 33.17 Favored 'General case' 0 C--N 1.331 -0.23 0 CA-C-N 115.891 -0.595 . . . . 0.0 110.548 179.1 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 86' ' ' VAL . . . . . . . . . . . . . 41.5 t -131.16 133.64 62.3 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.266 0 CA-C-O 121.034 0.445 . . . . 0.0 110.664 -178.461 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 87' ' ' ILE . . . . . . . . . . . . . 44.2 mm -119.75 125.48 74.36 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.247 0 CA-C-N 115.757 -0.656 . . . . 0.0 109.434 175.924 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 88' ' ' LEU . . . . . . . . . . . . . 14.5 tp -110.74 134.2 52.68 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-O 121.018 0.437 . . . . 0.0 111.309 -176.069 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 89' ' ' ASP . . . . . . . . . . . . . 12.9 t70 -127.5 155.1 44.28 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 115.875 -0.602 . . . . 0.0 109.829 177.497 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 43.1 tp10 -45.61 -44.09 12.78 Favored 'General case' 0 N--CA 1.465 0.308 0 N-CA-C 113.105 0.78 . . . . 0.0 113.105 -172.432 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 91' ' ' ASN . . . . . . . . . . . . . 66.0 m-80 -128.3 24.42 5.9 Favored 'General case' 0 N--CA 1.467 0.42 0 N-CA-C 112.547 0.573 . . . . 0.0 112.547 -178.421 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 92' ' ' LEU . . . . . . . . . . . . . 13.8 mt -149.78 145.68 26.76 Favored 'General case' 0 C--N 1.332 -0.169 0 N-CA-C 109.689 -0.486 . . . . 0.0 109.689 -176.832 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 93' ' ' ILE . . . . . . . . . . . . . 68.2 mt -128.47 118.54 48.0 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.306 0 N-CA-C 109.491 -0.559 . . . . 0.0 109.491 179.003 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 94' ' ' VAL . . . . . 0.451 HG21 HG11 ' A' ' 125' ' ' VAL . 46.4 t -118.53 126.14 74.91 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.252 0 N-CA-C 109.92 -0.4 . . . . 0.0 109.92 -179.6 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 95' ' ' VAL . . . . . . . . . . . . . 42.1 t -122.21 135.15 63.25 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.317 0 CA-C-N 116.054 -0.521 . . . . 0.0 109.988 -179.336 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 96' ' ' ILE . . . . . 0.423 HD11 ' HB ' ' A' ' 123' ' ' VAL . 67.1 mt -114.07 127.1 71.64 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.291 0 N-CA-C 109.366 -0.605 . . . . 0.0 109.366 179.075 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 97' ' ' THR . . . . . . . . . . . . . 68.0 p -100.08 156.73 17.02 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-O 121.397 0.617 . . . . 0.0 111.442 -176.879 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 98' ' ' GLU . . . . . . . . . . . . . 97.5 mt-10 -53.93 -25.79 22.13 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 115.822 -0.626 . . . . 0.0 112.312 -179.983 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 99' ' ' GLU . . . . . . . . . . . . . 41.5 mt-10 -80.4 18.11 0.96 Allowed 'General case' 0 CA--C 1.534 0.353 0 N-CA-C 113.003 0.742 . . . . 0.0 113.003 -177.148 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 100' ' ' ASN . . . . . . . . . . . . . 1.8 m120 63.87 35.48 10.95 Favored 'General case' 0 CA--C 1.531 0.222 0 CA-C-O 120.93 0.395 . . . . 0.0 111.145 176.634 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 101' ' ' GLU . . . . . . . . . . . . . 85.0 tt0 -118.47 142.33 47.68 Favored 'General case' 0 C--N 1.333 -0.14 0 N-CA-C 110.018 -0.364 . . . . 0.0 110.018 178.369 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 102' ' ' VAL . . . . . . . . . . . . . 45.6 t -116.39 126.67 73.97 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.297 0 N-CA-C 109.851 -0.425 . . . . 0.0 109.851 -178.686 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 103' ' ' LEU . . . . . . . . . . . . . 6.1 mp -118.37 133.48 55.84 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-N 115.807 -0.633 . . . . 0.0 110.458 177.95 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 104' ' ' ILE . . . . . . . . . . . . . 64.5 mt -117.88 119.54 61.85 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.22 0 CA-C-N 116.441 -0.345 . . . . 0.0 110.216 -179.761 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 105' ' ' PHE . . . . . . . . . . . . . 85.3 m-85 -114.87 165.26 13.04 Favored 'General case' 0 C--N 1.333 -0.146 0 O-C-N 124.042 0.839 . . . . 0.0 109.873 178.194 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 106' ' ' ASN . . . . . . . . . . . . . 49.3 p-10 -100.93 -170.27 1.82 Allowed 'General case' 0 C--N 1.331 -0.236 0 N-CA-C 109.636 -0.505 . . . . 0.0 109.636 171.727 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 107' ' ' GLN . . . . . . . . . . . . . 28.8 tt0 -58.06 -28.63 64.71 Favored 'General case' 0 C--N 1.328 -0.347 0 N-CA-C 112.261 0.467 . . . . 0.0 112.261 -179.201 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 108' ' ' ASN . . . . . . . . . . . . . 12.1 t-20 -90.88 14.19 14.4 Favored 'General case' 0 CA--C 1.533 0.314 0 N-CA-C 112.942 0.719 . . . . 0.0 112.942 -176.059 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 109' ' ' LEU . . . . . . . . . . . . . 63.4 mt 57.68 33.76 23.63 Favored 'General case' 0 CA--C 1.53 0.176 0 O-C-N 122.211 -0.306 . . . . 0.0 111.738 179.193 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 110' ' ' GLU . . . . . . . . . . . . . 70.6 mm-40 -99.66 140.83 33.29 Favored 'General case' 0 C--N 1.331 -0.225 0 N-CA-C 109.334 -0.617 . . . . 0.0 109.334 174.527 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 111' ' ' GLU . . . . . . . . . . . . . 47.5 tt0 -81.06 121.89 26.63 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-O 120.889 0.376 . . . . 0.0 110.714 -176.04 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 112' ' ' LEU . . . . . . . . . . . . . 30.9 mt -104.72 -46.02 4.44 Favored 'General case' 0 C--N 1.331 -0.219 0 CA-C-N 115.992 -0.549 . . . . 0.0 110.588 -179.857 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 113' ' ' TYR . . . . . . . . . . . . . 59.4 t80 -135.31 141.12 45.58 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.235 -0.439 . . . . 0.0 110.813 -178.682 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 114' ' ' ARG . . . . . . . . . . . . . 44.5 ptt85 -146.54 121.18 9.8 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.396 -0.366 . . . . 0.0 110.7 178.962 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 115' ' ' GLY . . . . . . . . . . . . . . . -150.15 160.4 28.52 Favored Glycine 0 CA--C 1.525 0.665 0 N-CA-C 111.008 -0.837 . . . . 0.0 111.008 179.296 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 116' ' ' LYS . . . . . . . . . . . . . 27.8 ttmt -125.59 137.41 53.9 Favored 'General case' 0 C--N 1.33 -0.248 0 N-CA-C 109.883 -0.414 . . . . 0.0 109.883 176.966 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 117' ' ' PHE . . . . . . . . . . . . . 44.1 m-85 -134.34 114.93 13.48 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.265 -0.425 . . . . 0.0 110.351 -175.513 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 118' ' ' GLU . . . . . . . . . . . . . 84.1 tt0 -50.62 -53.07 33.73 Favored 'General case' 0 C--N 1.329 -0.305 0 N-CA-C 111.98 0.363 . . . . 0.0 111.98 -176.019 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 119' ' ' ASN . . . . . . . . . . . . . 73.5 m-20 -94.94 31.01 1.94 Allowed 'General case' 0 C--N 1.33 -0.246 0 N-CA-C 112.308 0.484 . . . . 0.0 112.308 -173.505 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 120' ' ' LEU . . . . . . . . . . . . . 16.9 tp -56.4 123.07 13.42 Favored 'General case' 0 C--N 1.332 -0.178 0 C-N-CA 120.87 -0.332 . . . . 0.0 110.528 177.281 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 121' ' ' ASN . . . . . . . . . . . . . 9.9 m120 -114.09 -44.12 3.17 Favored 'General case' 0 C--N 1.331 -0.212 0 CA-C-N 116.55 -0.296 . . . . 0.0 110.985 -177.494 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 122' ' ' LYS . . . . . . . . . . . . . 91.4 mttt -145.15 148.78 33.97 Favored 'General case' 0 C--N 1.331 -0.209 0 CA-C-O 121.028 0.442 . . . . 0.0 111.728 -177.362 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 123' ' ' VAL . . . . . 0.423 ' HB ' HD11 ' A' ' 96' ' ' ILE . 44.6 t -128.63 125.73 64.0 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 N-CA-C 109.071 -0.714 . . . . 0.0 109.071 173.403 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 124' ' ' LEU . . . . . . . . . . . . . 5.8 mp -122.65 142.83 50.24 Favored 'General case' 0 C--N 1.332 -0.188 0 CA-C-O 120.836 0.351 . . . . 0.0 111.014 -175.68 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 125' ' ' VAL . . . . . 0.451 HG11 HG21 ' A' ' 94' ' ' VAL . 35.5 m -137.37 140.58 41.7 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.265 0 CA-C-N 115.999 -0.546 . . . . 0.0 110.581 179.053 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 126' ' ' ARG . . . . . . . . . . . . . 7.2 ptm85 -153.18 131.1 11.73 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-O 120.906 0.384 . . . . 0.0 110.577 176.068 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 127' ' ' ASN . . . . . . . . . . . . . 30.5 m120 50.6 -110.54 0.47 Allowed 'General case' 0 CA--C 1.545 0.763 0 CA-C-O 118.86 -0.591 . . . . 0.0 111.229 -179.691 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 128' ' ' ASP . . . . . . . . . . . . . 8.9 p-10 -114.11 7.79 16.8 Favored 'General case' 0 N--CA 1.468 0.428 0 CA-C-N 119.878 1.217 . . . . 0.0 113.314 -178.081 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 129' ' ' LEU . . . . . . . . . . . . . 11.8 tp -108.92 138.5 45.16 Favored 'General case' 0 C--N 1.332 -0.167 0 CA-C-N 118.153 0.433 . . . . 0.0 110.423 -178.825 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 130' ' ' VAL . . . . . . . . . . . . . 44.5 t -121.56 136.29 58.96 Favored 'Isoleucine or valine' 0 N--CA 1.462 0.169 0 N-CA-C 109.691 -0.485 . . . . 0.0 109.691 179.843 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 131' ' ' VAL . . . . . 0.512 HG22 HD12 ' A' ' 140' ' ' LEU . 39.0 t -134.46 136.31 52.95 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.235 0 CA-C-O 120.974 0.416 . . . . 0.0 110.504 -178.84 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 132' ' ' ILE . . . . . . . . . . . . . 71.0 mt -116.77 131.39 69.56 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 CA-C-N 115.746 -0.661 . . . . 0.0 109.267 178.722 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 133' ' ' ILE . . . . . . . . . . . . . 42.7 mm -119.36 122.3 68.69 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.223 0 CA-C-O 120.746 0.308 . . . . 0.0 110.987 -174.793 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 134' ' ' ASP . . . . . . . . . . . . . 16.6 p-10 -138.82 146.86 41.8 Favored 'General case' 0 C--N 1.332 -0.163 0 CA-C-N 116.272 -0.422 . . . . 0.0 109.872 173.744 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 135' ' ' GLU . . . . . . . . . . . . . 77.8 tt0 -49.9 -23.05 1.73 Allowed 'General case' 0 C--N 1.329 -0.305 0 N-CA-C 113.606 0.965 . . . . 0.0 113.606 -168.013 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 136' ' ' GLN . . . . . . . . . . . . . 22.3 pt20 -96.69 -27.21 14.88 Favored 'General case' 0 C--O 1.235 0.293 0 N-CA-C 112.551 0.574 . . . . 0.0 112.551 -174.011 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 137' ' ' LYS . . . . . . . . . . . . . 53.7 pttt -156.01 165.32 36.8 Favored 'General case' 0 C--O 1.233 0.205 0 CA-C-O 121.599 0.714 . . . . 0.0 112.125 -176.95 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 138' ' ' LEU . . . . . 0.408 ' C ' HD23 ' A' ' 138' ' ' LEU . 6.0 tt -119.58 127.04 52.6 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 115.02 -0.991 . . . . 0.0 109.416 176.375 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 139' ' ' THR . . . . . 0.407 ' N ' HD23 ' A' ' 138' ' ' LEU . 34.1 m -111.78 131.08 55.57 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.368 -0.378 . . . . 0.0 110.572 -178.458 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 140' ' ' LEU . . . . . 0.512 HD12 HG22 ' A' ' 131' ' ' VAL . 12.7 tp -117.31 123.81 47.44 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 115.657 -0.701 . . . . 0.0 109.273 -178.328 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 141' ' ' ILE . . . . . . . . . . . . . 19.5 mt -120.28 118.76 57.84 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.332 0 CA-C-O 120.983 0.42 . . . . 0.0 109.88 -174.859 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 142' ' ' ARG . . . . . . . . . . . . . 29.6 tpt85 -105.3 122.08 45.2 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 115.302 -0.863 . . . . 0.0 109.932 -178.251 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 143' ' ' THR . . . . . . . . . . . . . 57.2 p . . . . . 0 C--O 1.221 -0.445 0 CA-C-O 117.949 -1.024 . . . . 0.0 110.632 -178.721 . . . . . . . . 0 0 . 1 . 009 nuclear nobuild full ' B' B ' -3' ' ' GLU . . . . . . . . . . . . . 84.6 tt0 . . . . . 0 N--CA 1.49 1.569 0 N-CA-C 109.445 -0.576 . . . . 0.0 109.445 . . . . . . . . . 0 0 . 1 . 009 nuclear nobuild full ' B' B ' -2' ' ' GLY . . . . . . . . . . . . . . . -82.31 150.01 28.24 Favored Glycine 0 CA--C 1.525 0.675 0 N-CA-C 111.191 -0.764 . . . . 0.0 111.191 -179.716 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' -1' ' ' VAL . . . . . . . . . . . . . 45.0 t -95.57 135.06 30.85 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.284 0 N-CA-C 109.998 -0.371 . . . . 0.0 109.998 179.257 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 0' ' ' ILE . . . . . . . . . . . . . 71.5 mt -117.07 136.88 52.8 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.241 0 CA-C-N 116.346 -0.388 . . . . 0.0 110.202 -179.247 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 1' ' ' MET . . . . . . . . . . . . . 23.9 ptp -86.97 148.76 25.19 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 116.128 -0.487 . . . . 0.0 110.608 179.553 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 2' ' ' SER . . . . . . . . . . . . . 2.9 p -120.88 131.09 54.19 Favored 'General case' 0 C--N 1.332 -0.192 0 CA-C-N 116.302 -0.408 . . . . 0.0 110.913 -178.236 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 3' ' ' GLU . . . . . . . . . . . . . 84.9 tt0 -144.21 143.15 30.92 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.14 -0.482 . . . . 0.0 111.206 179.998 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 4' ' ' LEU . . . . . . . . . . . . . 15.5 tp -127.04 132.88 50.61 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 115.892 -0.595 . . . . 0.0 110.187 177.264 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 5' ' ' LYS . . . . . . . . . . . . . 95.8 mttt -112.61 122.25 47.13 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.326 -0.397 . . . . 0.0 110.799 -179.279 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 6' ' ' LEU . . . . . . . . . . . . . 38.7 mt -114.05 141.0 47.99 Favored 'General case' 0 C--N 1.332 -0.19 0 CA-C-N 115.506 -0.77 . . . . 0.0 110.266 -179.452 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 7' ' ' LYS . . . . . . . . . . . . . 74.6 tttt -121.97 136.26 26.08 Favored Pre-proline 0 CA--C 1.535 0.385 0 CA-C-O 118.839 -0.601 . . . . 0.0 109.697 176.304 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 8' ' ' PRO . . . . . . . . . . . . . 84.4 Cg_endo -90.47 135.31 2.1 Favored 'Trans proline' 0 N--CA 1.491 1.349 0 C-N-CA 121.656 1.57 . . . . 0.0 112.011 178.357 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 9' ' ' LEU . . . . . . . . . . . . . 53.9 mt -74.2 -47.93 5.96 Favored Pre-proline 0 CA--C 1.535 0.366 0 CA-C-O 118.628 -0.701 . . . . 0.0 112.336 -179.738 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 10' ' ' PRO . . . . . . . . . . . . . 97.4 Cg_endo -79.11 151.98 24.01 Favored 'Trans proline' 0 N--CA 1.497 1.677 0 C-N-CA 121.092 1.195 . . . . 0.0 111.882 177.563 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 11' ' ' LYS . . . . . . . . . . . . . 62.1 tttm -81.27 95.7 7.05 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.333 -0.394 . . . . 0.0 110.167 178.341 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 12' ' ' VAL . . . . . . . . . . . . . 12.3 p -141.69 146.43 23.09 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.321 0 CA-C-N 116.273 -0.421 . . . . 0.0 110.752 -177.629 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 13' ' ' GLU . . . . . . . . . . . . . 85.2 tt0 -99.5 114.61 27.69 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.067 -0.515 . . . . 0.0 109.895 176.581 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 14' ' ' LEU . . . . . . . . . . . . . 32.2 mt -92.46 160.6 34.48 Favored Pre-proline 0 C--N 1.328 -0.33 0 CA-C-N 116.328 -0.396 . . . . 0.0 111.115 -176.341 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 15' ' ' PRO . . . . . . . . . . . . . 35.3 Cg_exo -57.64 155.26 32.51 Favored 'Trans proline' 0 N--CA 1.496 1.62 0 C-N-CA 121.341 1.361 . . . . 0.0 111.874 -179.464 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 16' ' ' PRO . . . . . . . . . . . . . 33.7 Cg_exo -57.19 -40.91 79.22 Favored 'Trans proline' 0 N--CA 1.498 1.74 0 C-N-CA 121.347 1.364 . . . . 0.0 112.734 -178.262 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 17' ' ' ASP . . . . . . . . . . . . . 16.9 p-10 -89.46 15.69 8.85 Favored 'General case' 0 CA--C 1.534 0.362 0 N-CA-C 112.929 0.714 . . . . 0.0 112.929 -177.239 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 18' ' ' PHE . . . . . 0.447 ' CE2' HD11 ' B' ' 22' ' ' ILE . 27.3 t80 -57.14 -39.9 76.11 Favored 'General case' 0 C--O 1.227 -0.089 0 O-C-N 122.052 -0.405 . . . . 0.0 110.438 -179.07 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' B' B ' 19' ' ' VAL . . . . . . . . . . . . . 46.0 t -54.91 -44.59 73.57 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.201 0 CA-C-O 120.762 0.315 . . . . 0.0 110.584 -179.96 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 20' ' ' ASP . . . . . . . . . . . . . 74.8 m-20 -59.92 -40.99 90.76 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.482 -0.326 . . . . 0.0 110.631 -179.738 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 21' ' ' VAL . . . . . . . . . . . . . 47.5 t -62.69 -45.08 99.7 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.305 0 CA-C-N 116.448 -0.342 . . . . 0.0 110.265 -178.526 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 22' ' ' ILE . . . . . 0.714 HG22 HD12 ' B' ' 26' ' ' LEU . 51.0 mm -55.14 -49.74 69.52 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.332 0 C-N-CA 121.136 -0.226 . . . . 0.0 110.649 178.224 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' B' B ' 23' ' ' ARG . . . . . 0.46 ' HB2' HD12 ' B' ' 66' ' ' ILE . 58.7 ttp180 -53.83 -47.05 71.29 Favored 'General case' 0 C--N 1.33 -0.281 0 C-N-CA 121.079 -0.248 . . . . 0.0 111.538 -179.019 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' B' B ' 24' ' ' ILE . . . . . . . . . . . . . 70.9 mt -57.88 -45.42 87.53 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.322 0 C-N-CA 121.065 -0.254 . . . . 0.0 111.067 -177.224 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 25' ' ' LYS . . . . . . . . . . . . . 46.1 mtmt -70.21 -34.19 72.61 Favored 'General case' 0 C--N 1.328 -0.34 0 N-CA-C 112.378 0.51 . . . . 0.0 112.378 -177.607 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 26' ' ' LEU . . . . . 0.714 HD12 HG22 ' B' ' 22' ' ' ILE . 31.2 mt -80.87 -38.17 28.59 Favored 'General case' 0 C--N 1.331 -0.232 0 N-CA-C 113.579 0.955 . . . . 0.0 113.579 -171.514 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' B' B ' 27' ' ' GLN . . . . . . . . . . . . . 11.3 pt20 -45.39 139.42 3.64 Favored 'General case' 0 N--CA 1.47 0.557 0 N-CA-C 113.071 0.767 . . . . 0.0 113.071 -173.2 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 28' ' ' GLY . . . . . . . . . . . . . . . 98.27 -27.17 20.58 Favored Glycine 0 CA--C 1.532 1.124 0 CA-C-N 115.53 -0.759 . . . . 0.0 112.257 -178.003 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 29' ' ' LYS . . . . . . . . . . . . . 99.1 mttt -97.46 155.18 17.05 Favored 'General case' 0 C--O 1.233 0.22 0 CA-C-N 117.257 0.529 . . . . 0.0 111.066 179.159 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 30' ' ' THR . . . . . . . . . . . . . 34.7 m -105.26 138.57 41.25 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 115.879 -0.601 . . . . 0.0 110.035 176.108 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 31' ' ' VAL . . . . . . . . . . . . . 34.6 m -127.52 151.38 34.29 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.225 0 CA-C-O 120.925 0.393 . . . . 0.0 110.855 -178.634 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 32' ' ' ARG . . . . . . . . . . . . . 58.3 ttp180 -127.18 148.8 50.18 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.042 -0.526 . . . . 0.0 110.551 179.43 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 33' ' ' THR . . . . . . . . . . . . . 25.4 m -52.93 137.43 32.56 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.339 -0.391 . . . . 0.0 111.289 179.985 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 34' ' ' GLY . . . . . . . . . . . . . . . 100.96 -17.17 56.64 Favored Glycine 0 CA--C 1.533 1.175 0 C-N-CA 121.191 -0.528 . . . . 0.0 113.202 179.764 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 35' ' ' ASP . . . . . . . . . . . . . 57.3 m-20 -65.75 151.26 47.0 Favored 'General case' 0 C--O 1.232 0.168 0 CA-C-N 118.007 0.903 . . . . 0.0 111.089 179.86 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 36' ' ' VAL . . . . . . . . . . . . . 45.1 t -123.93 130.36 73.91 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.245 0 CA-C-N 116.048 -0.524 . . . . 0.0 109.868 178.717 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 37' ' ' ILE . . . . . . . . . . . . . 62.1 mt -120.09 137.63 53.29 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.206 0 CA-C-N 116.136 -0.484 . . . . 0.0 109.919 -179.969 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 38' ' ' GLY . . . . . . . . . . . . . . . -118.72 128.78 7.84 Favored Glycine 0 CA--C 1.525 0.712 0 N-CA-C 111.028 -0.829 . . . . 0.0 111.028 179.597 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 39' ' ' ILE . . . . . . . . . . . . . 70.8 mt -126.7 131.85 70.74 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.245 0 CA-C-O 120.825 0.345 . . . . 0.0 110.158 178.87 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 40' ' ' SER . . . . . . . . . . . . . 33.6 t -91.66 120.9 32.84 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.28 -0.418 . . . . 0.0 110.797 177.039 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 41' ' ' ILE . . . . . . . . . . . . . 72.7 mt -133.84 126.49 50.83 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.18 0 CA-C-O 120.884 0.373 . . . . 0.0 110.539 178.772 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 42' ' ' LEU . . . . . . . . . . . . . 42.7 mt 54.79 34.64 22.31 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-N 116.018 -0.537 . . . . 0.0 111.79 176.15 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 43' ' ' GLY . . . . . . . . . . . . . . . 71.89 29.36 67.28 Favored Glycine 0 CA--C 1.531 1.053 0 C-N-CA 121.027 -0.606 . . . . 0.0 112.311 177.683 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 44' ' ' LYS . . . . . . . . . . . . . 53.6 tttm -141.53 127.11 18.95 Favored 'General case' 0 C--N 1.33 -0.259 0 N-CA-C 109.754 -0.461 . . . . 0.0 109.754 178.144 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 45' ' ' GLU . . . . . . . . . . . . . 80.4 tt0 -84.07 123.36 29.95 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 116.441 -0.345 . . . . 0.0 111.133 -178.386 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 46' ' ' VAL . . . . . 0.43 ' O ' HG13 ' B' ' 46' ' ' VAL . 10.6 p -115.59 120.83 65.86 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.195 0 N-CA-C 109.473 -0.566 . . . . 0.0 109.473 175.034 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' B' B ' 47' ' ' LYS . . . . . . . . . . . . . 52.2 mtpt -99.2 126.98 45.11 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.047 -0.524 . . . . 0.0 110.968 178.248 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 48' ' ' PHE . . . . . . . . . . . . . 37.7 m-85 -110.12 132.0 54.55 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.049 -0.523 . . . . 0.0 109.746 176.7 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 49' ' ' LYS . . . . . . . . . . . . . 85.6 tttt -106.21 132.05 52.73 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.319 -0.401 . . . . 0.0 110.002 178.407 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 50' ' ' VAL . . . . . . . . . . . . . 44.4 t -76.19 105.46 5.12 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.392 0 N-CA-C 109.471 -0.566 . . . . 0.0 109.471 178.252 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 51' ' ' VAL . . . . . . . . . . . . . 50.6 t -73.41 -46.42 49.27 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.261 0 CA-C-N 116.042 -0.526 . . . . 0.0 110.089 -174.05 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 52' ' ' GLN . . . . . . . . . . . . . 30.6 tt0 -157.87 144.4 17.72 Favored 'General case' 0 C--N 1.332 -0.166 0 C-N-CA 120.09 -0.644 . . . . 0.0 111.894 -178.085 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 53' ' ' ALA . . . . . . . . . . . . . . . -123.5 130.91 53.38 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 115.442 -0.799 . . . . 0.0 109.775 176.364 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 54' ' ' TYR . . . . . . . . . . . . . 64.8 t80 -128.95 109.84 18.37 Favored Pre-proline 0 CA--C 1.535 0.377 0 CA-C-O 118.15 -0.928 . . . . 0.0 110.449 179.99 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 55' ' ' PRO . . . . . . . . . . . . . 74.1 Cg_endo -77.05 169.94 73.01 Favored 'Cis proline' 0 N--CA 1.499 1.841 0 CA-C-N 121.993 1.748 . . . . 0.0 112.436 -5.299 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 56' ' ' SER . . . . . . . . . . . . . 13.6 m -114.95 126.14 28.19 Favored Pre-proline 0 CA--C 1.537 0.463 0 CA-C-O 118.416 -0.802 . . . . 0.0 109.241 175.824 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 57' ' ' PRO . . . . . . . . . . . . . 61.3 Cg_endo -74.18 152.65 98.5 Favored 'Cis proline' 0 N--CA 1.495 1.61 0 CA-C-N 121.976 1.741 . . . . 0.0 111.873 1.36 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 58' ' ' LEU . . . . . . . . . . . . . 17.8 tp -109.44 136.09 49.41 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.165 -0.471 . . . . 0.0 110.819 -178.292 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 59' ' ' ARG . . . . . . . . . . . . . 57.4 ttp180 -105.2 126.2 51.82 Favored 'General case' 0 C--N 1.329 -0.319 0 N-CA-C 109.509 -0.552 . . . . 0.0 109.509 176.076 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 60' ' ' VAL . . . . . . . . . . . . . 40.4 t -83.23 121.03 35.58 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.315 0 C-N-CA 120.694 -0.402 . . . . 0.0 111.046 -174.498 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 61' ' ' GLU . . . . . . . . . . . . . 95.4 mt-10 -131.01 165.68 22.65 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 115.674 -0.694 . . . . 0.0 109.424 175.243 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 62' ' ' ASP . . . . . . . . . . . . . 79.8 m-20 -52.47 -33.45 44.6 Favored 'General case' 0 C--N 1.329 -0.324 0 N-CA-C 112.056 0.391 . . . . 0.0 112.056 -175.64 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 63' ' ' ARG . . . . . . . . . . . . . 65.8 mtp180 -76.58 -21.97 54.89 Favored 'General case' 0 C--N 1.329 -0.297 0 N-CA-C 113.088 0.773 . . . . 0.0 113.088 -175.512 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 64' ' ' THR . . . . . . . . . . . . . 29.8 m -61.1 138.28 58.21 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-O 120.915 0.388 . . . . 0.0 111.164 -175.137 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 65' ' ' LYS . . . . . . . . . . . . . 55.6 mttm -89.99 133.32 34.87 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 115.913 -0.585 . . . . 0.0 110.38 179.129 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 66' ' ' ILE . . . . . 0.46 HD12 ' HB2' ' B' ' 23' ' ' ARG . 66.8 mt -120.05 129.84 74.98 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.202 0 N-CA-C 109.93 -0.396 . . . . 0.0 109.93 178.0 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' B' B ' 67' ' ' THR . . . . . . . . . . . . . 31.4 m -121.33 140.13 52.5 Favored 'General case' 0 C--N 1.331 -0.213 0 CA-C-N 116.062 -0.517 . . . . 0.0 111.002 -178.352 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 68' ' ' LEU . . . . . 0.476 ' C ' HD23 ' B' ' 68' ' ' LEU . 6.1 tt -104.05 123.6 47.53 Favored 'General case' 0 C--N 1.331 -0.225 0 CA-C-N 115.863 -0.608 . . . . 0.0 110.238 178.882 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' B' B ' 69' ' ' VAL . . . . . 0.424 ' N ' HD23 ' B' ' 68' ' ' LEU . 45.0 t -101.44 136.84 31.39 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.327 0 CA-C-N 116.069 -0.514 . . . . 0.0 109.888 179.704 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' B' B ' 70' ' ' THR . . . . . . . . . . . . . 5.6 t -85.44 161.7 19.3 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.329 -0.396 . . . . 0.0 110.924 -178.643 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 71' ' ' HIS . . . . . . . . . . . . . 4.0 t60 -73.58 112.52 16.49 Favored Pre-proline 0 CA--C 1.534 0.357 0 CA-C-O 118.845 -0.598 . . . . 0.0 110.754 -178.788 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 72' ' ' PRO . . . . . . . . . . . . . 97.7 Cg_endo -94.19 156.96 2.13 Favored 'Trans proline' 0 N--CA 1.491 1.347 0 C-N-CA 121.758 1.639 . . . . 0.0 112.255 179.054 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 73' ' ' VAL . . . . . . . . . . . . . 35.5 m -70.1 178.01 0.44 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.325 0 CA-C-N 116.283 -0.417 . . . . 0.0 109.882 177.288 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 74' ' ' ASP . . . . . . . . . . . . . 27.6 t0 -99.86 116.46 31.98 Favored 'General case' 0 C--N 1.331 -0.217 0 C-N-CA 120.794 -0.363 . . . . 0.0 110.041 -178.804 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 75' ' ' VAL . . . . . . . . . . . . . 44.4 t -114.97 123.13 70.36 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.217 0 CA-C-O 120.96 0.41 . . . . 0.0 110.401 -177.658 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 76' ' ' LEU . . . . . . . . . . . . . 26.0 mt -125.31 146.95 49.33 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 115.775 -0.648 . . . . 0.0 109.65 178.806 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 77' ' ' GLU . . . . . . . . . . . . . 96.8 mt-10 -138.48 141.95 39.42 Favored 'General case' 0 C--N 1.332 -0.188 0 CA-C-O 121.016 0.436 . . . . 0.0 111.57 -177.656 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 78' ' ' ALA . . . . . 0.58 ' HB2' HD21 ' B' ' 109' ' ' LEU . . . -129.81 139.41 51.24 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 115.801 -0.636 . . . . 0.0 110.003 175.827 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' B' B ' 79' ' ' LYS . . . . . 0.45 ' O ' HD13 ' B' ' 80' ' ' ILE . 98.2 mttt -79.4 119.54 22.56 Favored 'General case' 0 C--N 1.331 -0.198 0 CA-C-O 120.78 0.324 . . . . 0.0 110.937 -178.128 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' B' B ' 80' ' ' ILE . . . . . 0.45 HD13 ' O ' ' B' ' 79' ' ' LYS . 25.9 mm -139.19 113.08 6.91 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 N-CA-C 109.171 -0.678 . . . . 0.0 109.171 -178.673 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' B' B ' 81' ' ' LYS . . . . . . . . . . . . . 62.4 mttm -108.99 127.27 53.93 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-O 121.04 0.448 . . . . 0.0 111.376 -177.173 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 82' ' ' GLY . . . . . . . . . . . . . . . 89.15 41.99 5.71 Favored Glycine 0 CA--C 1.526 0.747 0 CA-C-N 115.833 -0.621 . . . . 0.0 111.823 174.199 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 83' ' ' ILE . . . . . . . . . . . . . 71.0 mt -72.95 140.44 17.88 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.318 0 N-CA-C 110.099 -0.334 . . . . 0.0 110.099 178.329 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 84' ' ' LYS . . . . . . . . . . . . . 28.5 ttmt -97.53 -53.22 3.51 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.174 -0.466 . . . . 0.0 109.94 179.175 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 85' ' ' ASP . . . . . . . . . . . . . 7.0 t70 -152.38 151.51 30.92 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 115.76 -0.655 . . . . 0.0 110.556 -179.535 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 86' ' ' VAL . . . . . . . . . . . . . 42.8 t -128.82 130.11 68.52 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.24 0 CA-C-O 120.912 0.387 . . . . 0.0 110.289 -179.238 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 87' ' ' ILE . . . . . 0.498 ' N ' HD12 ' B' ' 87' ' ' ILE . 5.1 mp -119.44 128.26 75.86 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.178 0 N-CA-C 109.531 -0.544 . . . . 0.0 109.531 177.134 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' B' B ' 88' ' ' LEU . . . . . . . . . . . . . 57.0 mt -114.34 140.89 48.26 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-O 121.204 0.526 . . . . 0.0 111.263 -177.764 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 89' ' ' ASP . . . . . . . . . . . . . 5.0 t70 -132.27 158.94 40.53 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 115.376 -0.829 . . . . 0.0 109.457 176.517 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 90' ' ' GLU . . . . . . . . . . . . . 83.0 tt0 -46.33 -41.68 13.7 Favored 'General case' 0 C--N 1.331 -0.238 0 N-CA-C 112.975 0.731 . . . . 0.0 112.975 -173.19 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 91' ' ' ASN . . . . . . . . . . . . . 9.5 p-10 -132.19 38.01 3.52 Favored 'General case' 0 N--CA 1.464 0.231 0 CA-C-O 120.704 0.288 . . . . 0.0 111.391 -177.696 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 92' ' ' LEU . . . . . . . . . . . . . 11.6 tp -163.45 142.23 8.11 Favored 'General case' 0 C--N 1.331 -0.226 0 C-N-CA 120.865 -0.334 . . . . 0.0 110.89 -177.978 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 93' ' ' ILE . . . . . . . . . . . . . 76.9 mt -127.65 119.08 50.92 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 N-CA-C 109.284 -0.635 . . . . 0.0 109.284 177.715 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 94' ' ' VAL . . . . . 0.749 HG21 HG11 ' B' ' 125' ' ' VAL . 47.3 t -123.44 127.11 74.07 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.234 0 CA-C-O 120.978 0.418 . . . . 0.0 110.123 -179.8 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' B' B ' 95' ' ' VAL . . . . . . . . . . . . . 41.9 t -121.97 137.18 56.43 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.337 0 CA-C-N 115.741 -0.663 . . . . 0.0 109.91 -178.377 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 96' ' ' ILE . . . . . 0.522 HD11 ' HB ' ' B' ' 123' ' ' VAL . 58.0 mt -114.75 127.8 72.12 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.263 0 N-CA-C 109.362 -0.607 . . . . 0.0 109.362 179.126 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' B' B ' 97' ' ' THR . . . . . . . . . . . . . 67.6 p -102.5 154.34 19.19 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-O 121.199 0.524 . . . . 0.0 111.383 -177.626 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 98' ' ' GLU . . . . . . . . . . . . . 46.5 tp10 -53.95 -25.56 21.24 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 115.984 -0.553 . . . . 0.0 112.207 179.751 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 99' ' ' GLU . . . . . . . . . . . . . 32.6 tt0 -78.82 16.74 0.82 Allowed 'General case' 0 CA--C 1.537 0.469 0 N-CA-C 112.812 0.671 . . . . 0.0 112.812 -177.82 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 100' ' ' ASN . . . . . . . . . . . . . 4.1 m-20 61.67 37.94 15.59 Favored 'General case' 0 CA--C 1.53 0.181 0 O-C-N 121.894 -0.503 . . . . 0.0 110.855 178.066 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 101' ' ' GLU . . . . . . . . . . . . . 84.5 tt0 -116.54 143.35 45.71 Favored 'General case' 0 C--N 1.333 -0.149 0 CA-C-N 115.935 -0.575 . . . . 0.0 109.724 177.603 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 102' ' ' VAL . . . . . . . . . . . . . 44.7 t -114.98 125.05 72.2 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.331 0 CA-C-N 116.206 -0.452 . . . . 0.0 109.857 -178.822 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 103' ' ' LEU . . . . . . . . . . . . . 24.2 mt -116.84 128.26 55.09 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 115.807 -0.633 . . . . 0.0 110.348 177.84 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 104' ' ' ILE . . . . . . . . . . . . . 68.1 mt -120.39 121.04 64.57 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.26 0 CA-C-N 116.64 -0.254 . . . . 0.0 110.428 179.688 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 105' ' ' PHE . . . . . . . . . . . . . 52.5 m-85 -121.85 166.77 13.88 Favored 'General case' 0 C--N 1.333 -0.139 0 CA-C-N 115.674 -0.693 . . . . 0.0 109.678 178.611 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 106' ' ' ASN . . . . . . . . . . . . . 45.1 p-10 -99.57 -171.02 1.99 Allowed 'General case' 0 C--N 1.329 -0.285 0 N-CA-C 109.876 -0.416 . . . . 0.0 109.876 173.318 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 107' ' ' GLN . . . . . . . . . . . . . 45.4 tt0 -60.23 -29.63 68.87 Favored 'General case' 0 C--N 1.329 -0.293 0 N-CA-C 112.001 0.371 . . . . 0.0 112.001 179.979 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 108' ' ' ASN . . . . . . . . . . . . . 4.5 t-20 -82.49 7.34 14.64 Favored 'General case' 0 CA--C 1.536 0.431 0 N-CA-C 113.163 0.801 . . . . 0.0 113.163 -177.633 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 109' ' ' LEU . . . . . 0.58 HD21 ' HB2' ' B' ' 78' ' ' ALA . 12.5 tp 61.63 38.18 15.53 Favored 'General case' 0 C--N 1.333 -0.139 0 CA-C-O 121.165 0.507 . . . . 0.0 111.205 179.073 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' B' B ' 110' ' ' GLU . . . . . . . . . . . . . 95.7 mt-10 -108.07 148.13 30.21 Favored 'General case' 0 C--N 1.33 -0.281 0 N-CA-C 109.539 -0.541 . . . . 0.0 109.539 174.871 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 111' ' ' GLU . . . . . . . . . . . . . 49.3 tt0 -83.21 122.03 27.87 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-O 120.896 0.379 . . . . 0.0 111.023 -175.624 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 112' ' ' LEU . . . . . . . . . . . . . 84.8 mt -104.83 -46.03 4.41 Favored 'General case' 0 C--N 1.331 -0.203 0 CA-C-N 116.025 -0.534 . . . . 0.0 110.591 178.844 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 113' ' ' TYR . . . . . . . . . . . . . 42.3 t80 -137.15 136.71 38.48 Favored 'General case' 0 C--N 1.331 -0.223 0 CA-C-N 116.357 -0.383 . . . . 0.0 111.363 -177.823 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 114' ' ' ARG . . . . . . . . . . . . . 46.2 ttp180 -137.17 125.64 23.51 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 115.913 -0.585 . . . . 0.0 110.039 176.474 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 115' ' ' GLY . . . . . . . . . . . . . . . -150.03 154.71 25.85 Favored Glycine 0 CA--C 1.525 0.667 0 C-N-CA 120.756 -0.735 . . . . 0.0 111.271 178.932 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 116' ' ' LYS . . . . . . . . . . . . . 30.8 ttpt -128.62 130.67 47.62 Favored 'General case' 0 C--N 1.329 -0.304 0 N-CA-C 109.797 -0.446 . . . . 0.0 109.797 177.778 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 117' ' ' PHE . . . . . . . . . . . . . 46.1 m-85 -128.79 116.21 19.13 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-O 120.926 0.393 . . . . 0.0 110.464 -175.987 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 118' ' ' GLU . . . . . . . . . . . . . 95.9 mt-10 -52.65 -46.76 67.29 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.361 -0.381 . . . . 0.0 111.573 -176.942 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 119' ' ' ASN . . . . . . . . . . . . . 9.8 m120 -99.57 30.97 3.35 Favored 'General case' 0 C--N 1.33 -0.272 0 N-CA-C 112.22 0.452 . . . . 0.0 112.22 -174.35 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 120' ' ' LEU . . . . . . . . . . . . . 15.8 tp -54.21 125.78 20.47 Favored 'General case' 0 N--CA 1.462 0.17 0 CA-C-O 120.718 0.294 . . . . 0.0 110.984 179.22 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 121' ' ' ASN . . . . . . . . . . . . . 31.3 m120 -107.92 -44.1 4.28 Favored 'General case' 0 C--N 1.331 -0.212 0 CA-C-N 116.367 -0.379 . . . . 0.0 110.806 -177.98 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 122' ' ' LYS . . . . . . . . . . . . . 1.2 ptpm? -160.29 157.35 27.9 Favored 'General case' 0 C--N 1.332 -0.19 0 CA-C-O 121.231 0.538 . . . . 0.0 112.056 -179.348 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 123' ' ' VAL . . . . . 0.522 ' HB ' HD11 ' B' ' 96' ' ' ILE . 46.8 t -127.23 131.51 70.53 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.224 0 CA-C-N 115.587 -0.733 . . . . 0.0 109.526 176.707 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' B' B ' 124' ' ' LEU . . . . . . . . . . . . . 14.4 tp -126.8 138.81 53.41 Favored 'General case' 0 N--CA 1.463 0.19 0 CA-C-N 116.496 -0.32 . . . . 0.0 110.541 -177.988 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 125' ' ' VAL . . . . . 0.749 HG11 HG21 ' B' ' 94' ' ' VAL . 34.7 m -132.68 141.99 43.6 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.182 0 CA-C-O 120.835 0.35 . . . . 0.0 111.328 -177.654 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' B' B ' 126' ' ' ARG . . . . . . . . . . . . . 88.9 mtt180 -146.57 118.07 7.97 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.658 175.128 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 127' ' ' ASN . . . . . . . . . . . . . 75.2 m-80 52.0 -106.43 0.27 Allowed 'General case' 0 CA--C 1.544 0.715 0 CA-C-O 118.97 -0.538 . . . . 0.0 111.256 178.996 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 128' ' ' ASP . . . . . . . . . . . . . 15.5 p-10 -114.07 3.16 15.18 Favored 'General case' 0 N--CA 1.469 0.484 0 CA-C-N 119.649 1.113 . . . . 0.0 113.295 -177.893 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 129' ' ' LEU . . . . . . . . . . . . . 15.6 tp -105.34 135.48 46.65 Favored 'General case' 0 C--N 1.332 -0.184 0 N-CA-C 109.553 -0.536 . . . . 0.0 109.553 178.084 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 130' ' ' VAL . . . . . . . . . . . . . 41.1 t -124.63 140.46 47.79 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.235 0 N-CA-C 110.136 -0.32 . . . . 0.0 110.136 -177.751 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 131' ' ' VAL . . . . . 0.403 HG22 HD12 ' B' ' 140' ' ' LEU . 41.5 t -133.51 135.07 56.39 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 CA-C-O 120.963 0.411 . . . . 0.0 110.145 178.788 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' B' B ' 132' ' ' ILE . . . . . . . . . . . . . 70.1 mt -116.92 131.41 69.68 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.314 0 N-CA-C 109.197 -0.668 . . . . 0.0 109.197 178.297 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 133' ' ' ILE . . . . . . . . . . . . . 43.3 mm -115.94 120.94 66.3 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.316 0 CA-C-N 116.406 -0.361 . . . . 0.0 110.819 -174.901 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 134' ' ' ASP . . . . . . . . . . . . . 8.6 p-10 -134.37 147.48 50.52 Favored 'General case' 0 C--N 1.331 -0.2 0 N-CA-C 109.545 -0.539 . . . . 0.0 109.545 174.346 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 135' ' ' GLU . . . . . . . . . . . . . 84.9 tt0 -49.84 -24.36 2.39 Favored 'General case' 0 C--N 1.328 -0.357 0 N-CA-C 112.894 0.702 . . . . 0.0 112.894 -172.537 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 136' ' ' GLN . . . . . . . . . . . . . 96.1 mt-30 -99.81 -27.93 13.39 Favored 'General case' 0 N--CA 1.463 0.182 0 N-CA-C 112.727 0.64 . . . . 0.0 112.727 -174.672 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 137' ' ' LYS . . . . . . . . . . . . . 94.4 mttt -141.94 150.66 41.73 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-O 121.467 0.651 . . . . 0.0 112.296 -169.531 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 138' ' ' LEU . . . . . . . . . . . . . 11.3 tp -112.06 118.48 35.53 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 114.988 -1.005 . . . . 0.0 108.987 170.945 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 139' ' ' THR . . . . . . . . . . . . . 25.6 m -110.38 125.22 52.98 Favored 'General case' 0 C--N 1.331 -0.216 0 CA-C-O 120.644 0.259 . . . . 0.0 111.127 -177.014 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 140' ' ' LEU . . . . . 0.403 HD12 HG22 ' B' ' 131' ' ' VAL . 23.3 tp -114.56 122.8 47.65 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 115.652 -0.704 . . . . 0.0 109.354 179.586 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' B' B ' 141' ' ' ILE . . . . . . . . . . . . . 19.3 mt -121.87 125.16 72.86 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.247 0 CA-C-O 120.856 0.36 . . . . 0.0 110.199 -174.094 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 142' ' ' ARG . . . . . . . . . . . . . 79.0 mtp180 -114.53 129.38 56.66 Favored 'General case' 0 C--N 1.331 -0.212 0 CA-C-N 115.67 -0.695 . . . . 0.0 110.351 -179.34 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 143' ' ' THR . . . . . . . . . . . . . 26.0 p . . . . . 0 C--O 1.221 -0.424 0 CA-C-O 118.015 -0.993 . . . . 0.0 110.525 179.749 . . . . . . . . 0 0 . 1 . 009 nuclear nobuild full ' C' C ' -3' ' ' GLU . . . . . . . . . . . . . 95.8 mt-10 . . . . . 0 N--CA 1.49 1.557 0 N-CA-C 109.368 -0.604 . . . . 0.0 109.368 . . . . . . . . . 0 0 . 1 . 009 nuclear nobuild full ' C' C ' -2' ' ' GLY . . . . . . . . . . . . . . . -88.18 135.44 13.09 Favored Glycine 0 CA--C 1.525 0.689 0 N-CA-C 110.916 -0.873 . . . . 0.0 110.916 179.751 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' C' C ' -1' ' ' VAL . . . . . . . . . . . . . 43.3 t -142.21 139.55 29.83 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.284 0 CA-C-O 120.773 0.321 . . . . 0.0 110.144 -179.996 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' C' C ' 0' ' ' ILE . . . . . . . . . . . . . 72.1 mt -109.78 136.52 45.45 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.257 0 CA-C-N 116.141 -0.481 . . . . 0.0 109.772 179.357 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' C' C ' 1' ' ' MET . . . . . . . . . . . . . 25.6 ptp -77.92 157.61 29.7 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.104 -0.498 . . . . 0.0 110.935 -178.541 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' C' C ' 2' ' ' SER . . . . . . . . . . . . . 2.3 p -126.99 123.93 38.26 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.095 -0.502 . . . . 0.0 110.36 178.287 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' C' C ' 3' ' ' GLU . . . . . . . . . . . . . 85.3 tt0 -140.12 141.6 36.09 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 115.795 -0.639 . . . . 0.0 111.088 -177.001 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' C' C ' 4' ' ' LEU . . . . . 0.422 HD21 HD21 ' C' ' 6' ' ' LEU . 13.2 tp -124.11 130.39 52.46 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 115.765 -0.652 . . . . 0.0 110.116 177.497 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' C' C ' 5' ' ' LYS . . . . . . . . . . . . . 53.5 mttp -108.65 120.35 42.21 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.185 -0.462 . . . . 0.0 110.541 179.817 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' C' C ' 6' ' ' LEU . . . . . 0.422 HD21 HD21 ' C' ' 4' ' ' LEU . 55.4 mt -114.48 147.93 38.6 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 115.427 -0.806 . . . . 0.0 110.45 -178.827 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' C' C ' 7' ' ' LYS . . . . . . . . . . . . . 78.7 tttt -139.85 138.87 20.4 Favored Pre-proline 0 CA--C 1.534 0.328 0 CA-C-O 119.081 -0.485 . . . . 0.0 110.162 176.249 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' C' C ' 8' ' ' PRO . . . . . . . . . . . . . 98.2 Cg_endo -92.08 144.43 2.81 Favored 'Trans proline' 0 N--CA 1.49 1.267 0 C-N-CA 121.69 1.593 . . . . 0.0 111.812 177.482 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' C' C ' 9' ' ' LEU . . . . . . . . . . . . . 53.0 mt -74.94 -47.1 4.88 Favored Pre-proline 0 CA--C 1.534 0.353 0 CA-C-O 118.699 -0.667 . . . . 0.0 112.051 -179.524 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' C' C ' 10' ' ' PRO . . . . . . . . . . . . . 96.5 Cg_endo -82.28 156.56 17.04 Favored 'Trans proline' 0 N--CA 1.496 1.64 0 C-N-CA 121.221 1.281 . . . . 0.0 111.808 175.27 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' C' C ' 11' ' ' LYS . . . . . . . . . . . . . 59.3 tttm -88.7 106.57 18.42 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.428 -0.351 . . . . 0.0 110.24 178.32 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' C' C ' 12' ' ' VAL . . . . . . . . . . . . . 12.4 p -140.46 148.47 22.19 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.243 0 CA-C-N 116.248 -0.433 . . . . 0.0 110.632 -178.659 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' C' C ' 13' ' ' GLU . . . . . . . . . . . . . 83.2 tt0 -90.91 122.0 33.23 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 116.131 -0.486 . . . . 0.0 110.21 178.522 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' C' C ' 14' ' ' LEU . . . . . . . . . . . . . 35.5 mt -98.55 151.84 37.64 Favored Pre-proline 0 CA--C 1.532 0.282 0 CA-C-N 116.383 -0.371 . . . . 0.0 110.948 -176.706 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' C' C ' 15' ' ' PRO . . . . . . . . . . . . . 24.2 Cg_exo -63.96 158.01 49.75 Favored 'Trans proline' 0 N--CA 1.497 1.722 0 C-N-CA 121.266 1.311 . . . . 0.0 111.721 174.871 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' C' C ' 16' ' ' PRO . . . . . . . . . . . . . 39.4 Cg_exo -58.72 -38.87 86.86 Favored 'Trans proline' 0 N--CA 1.496 1.665 0 C-N-CA 121.409 1.406 . . . . 0.0 112.776 -178.965 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' C' C ' 17' ' ' ASP . . . . . . . . . . . . . 12.7 p-10 -87.95 11.94 14.54 Favored 'General case' 0 CA--C 1.536 0.424 0 N-CA-C 113.148 0.796 . . . . 0.0 113.148 -177.402 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' C' C ' 18' ' ' PHE . . . . . . . . . . . . . 44.9 t80 -57.95 -44.74 87.17 Favored 'General case' 0 C--N 1.335 -0.065 0 O-C-N 122.007 -0.433 . . . . 0.0 110.113 -178.826 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' C' C ' 19' ' ' VAL . . . . . 0.413 HG13 ' N ' ' C' ' 20' ' ' ASP . 12.7 p -56.94 -41.61 77.15 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.357 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.726 -179.145 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' C' C ' 20' ' ' ASP . . . . . 0.413 ' N ' HG13 ' C' ' 19' ' ' VAL . 79.6 m-20 -60.65 -42.93 97.97 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-O 120.843 0.354 . . . . 0.0 111.015 -177.709 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' C' C ' 21' ' ' VAL . . . . . . . . . . . . . 47.1 t -63.94 -47.98 88.18 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.338 0 C-N-CA 120.782 -0.367 . . . . 0.0 110.383 -178.076 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' C' C ' 22' ' ' ILE . . . . . 0.485 HG22 HD12 ' C' ' 26' ' ' LEU . 46.4 mm -58.11 -38.49 67.96 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.298 0 CA-C-O 120.841 0.353 . . . . 0.0 110.56 179.407 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' C' C ' 23' ' ' ARG . . . . . . . . . . . . . 56.3 ttp180 -55.53 -48.24 75.01 Favored 'General case' 0 C--N 1.33 -0.253 0 O-C-N 122.094 -0.379 . . . . 0.0 110.845 177.429 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' C' C ' 24' ' ' ILE . . . . . . . . . . . . . 67.2 mt -60.24 -41.9 88.54 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.358 0 CA-C-N 116.148 -0.478 . . . . 0.0 111.75 -177.776 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' C' C ' 25' ' ' LYS . . . . . . . . . . . . . 16.1 ptmt -72.33 -36.08 68.76 Favored 'General case' 0 CA--C 1.534 0.328 0 C-N-CA 120.561 -0.455 . . . . 0.0 112.077 -176.044 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' C' C ' 26' ' ' LEU . . . . . 0.485 HD12 HG22 ' C' ' 22' ' ' ILE . 78.3 mt -78.54 -41.78 31.19 Favored 'General case' 0 C--N 1.33 -0.247 0 N-CA-C 112.887 0.699 . . . . 0.0 112.887 -172.952 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' C' C ' 27' ' ' GLN . . . . . . . . . . . . . 9.9 pt20 -46.38 138.53 5.56 Favored 'General case' 0 N--CA 1.468 0.466 0 N-CA-C 112.812 0.671 . . . . 0.0 112.812 -175.338 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' C' C ' 28' ' ' GLY . . . . . . . . . . . . . . . 100.62 -26.65 23.82 Favored Glycine 0 CA--C 1.532 1.119 0 CA-C-N 115.55 -0.75 . . . . 0.0 112.135 -177.891 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' C' C ' 29' ' ' LYS . . . . . . . . . . . . . 59.7 mmtt -97.82 155.23 17.14 Favored 'General case' 0 C--O 1.233 0.217 0 CA-C-N 117.445 0.623 . . . . 0.0 111.019 178.699 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' C' C ' 30' ' ' THR . . . . . . . . . . . . . 40.5 m -100.08 135.79 40.97 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 115.883 -0.599 . . . . 0.0 109.688 174.24 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' C' C ' 31' ' ' VAL . . . . . . . . . . . . . 34.9 m -125.91 154.8 35.23 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.211 0 CA-C-N 116.5 -0.318 . . . . 0.0 110.602 -178.367 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' C' C ' 32' ' ' ARG . . . . . . . . . . . . . 46.3 ttt180 -135.71 149.13 49.13 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-O 121.225 0.536 . . . . 0.0 110.667 179.624 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' C' C ' 33' ' ' THR . . . . . . . . . . . . . 18.2 m -52.48 140.51 22.35 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.286 -0.415 . . . . 0.0 111.426 -178.339 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' C' C ' 34' ' ' GLY . . . . . . . . . . . . . . . 99.71 -17.04 58.03 Favored Glycine 0 CA--C 1.532 1.11 0 CA-C-O 119.656 -0.524 . . . . 0.0 113.224 179.073 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' C' C ' 35' ' ' ASP . . . . . . . . . . . . . 72.6 m-20 -64.59 149.19 49.33 Favored 'General case' 0 C--O 1.231 0.1 0 CA-C-N 118.13 0.965 . . . . 0.0 111.081 179.426 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' C' C ' 36' ' ' VAL . . . . . . . . . . . . . 45.6 t -126.01 130.69 72.24 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.249 0 CA-C-N 115.995 -0.548 . . . . 0.0 109.838 178.477 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' C' C ' 37' ' ' ILE . . . . . . . . . . . . . 66.6 mt -121.93 139.69 48.2 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.299 0 CA-C-N 116.292 -0.413 . . . . 0.0 110.194 -178.953 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' C' C ' 38' ' ' GLY . . . . . . . . . . . . . . . -108.7 128.85 9.25 Favored Glycine 0 CA--C 1.526 0.748 0 N-CA-C 110.96 -0.856 . . . . 0.0 110.96 179.285 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' C' C ' 39' ' ' ILE . . . . . . . . . . . . . 72.6 mt -125.78 132.22 71.02 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.181 0 N-CA-C 110.191 -0.3 . . . . 0.0 110.191 179.829 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' C' C ' 40' ' ' SER . . . . . . . . . . . . . 27.6 t -92.78 122.16 34.9 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.418 -0.356 . . . . 0.0 110.886 175.581 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' C' C ' 41' ' ' ILE . . . . . . . . . . . . . 72.3 mt -131.01 116.89 35.43 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.223 0 CA-C-O 121.031 0.443 . . . . 0.0 110.55 178.699 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' C' C ' 42' ' ' LEU . . . . . 0.532 ' O ' HD23 ' C' ' 42' ' ' LEU . 1.3 tt 51.46 47.4 24.89 Favored 'General case' 0 CA--C 1.531 0.217 0 CA-C-N 115.768 -0.651 . . . . 0.0 111.208 175.996 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' C' C ' 43' ' ' GLY . . . . . . . . . . . . . . . 70.17 21.38 77.09 Favored Glycine 0 CA--C 1.531 1.075 0 C-N-CA 121.081 -0.58 . . . . 0.0 112.79 175.016 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' C' C ' 44' ' ' LYS . . . . . . . . . . . . . 59.4 mtpt -131.65 128.35 38.88 Favored 'General case' 0 C--N 1.331 -0.212 0 CA-C-N 117.692 0.746 . . . . 0.0 110.098 179.068 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' C' C ' 45' ' ' GLU . . . . . . . . . . . . . 83.2 tt0 -83.8 123.14 29.58 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 116.441 -0.345 . . . . 0.0 110.997 -179.68 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' C' C ' 46' ' ' VAL . . . . . . . . . . . . . 7.2 p -123.15 128.26 74.92 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.204 0 N-CA-C 109.722 -0.473 . . . . 0.0 109.722 176.669 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' C' C ' 47' ' ' LYS . . . . . . . . . . . . . 63.2 mttp -100.19 128.65 46.23 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.085 -0.507 . . . . 0.0 111.089 177.664 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' C' C ' 48' ' ' PHE . . . . . . . . . . . . . 91.1 m-85 -110.5 131.83 54.71 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.206 -0.452 . . . . 0.0 109.863 176.346 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' C' C ' 49' ' ' LYS . . . . . . . . . . . . . 79.2 tttt -108.61 137.99 45.66 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.377 -0.374 . . . . 0.0 110.424 178.978 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' C' C ' 50' ' ' VAL . . . . . . . . . . . . . 44.9 t -79.73 106.28 10.55 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.335 0 N-CA-C 109.335 -0.617 . . . . 0.0 109.335 175.828 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' C' C ' 51' ' ' VAL . . . . . . . . . . . . . 48.2 t -69.81 -47.67 68.69 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.284 0 CA-C-N 116.052 -0.522 . . . . 0.0 109.863 -173.486 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' C' C ' 52' ' ' GLN . . . . . . . . . . . . . 21.4 pt20 -167.85 158.88 11.11 Favored 'General case' 0 C--N 1.332 -0.192 0 C-N-CA 120.165 -0.614 . . . . 0.0 111.643 179.482 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' C' C ' 53' ' ' ALA . . . . . . . . . . . . . . . -135.56 138.68 43.24 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 115.564 -0.743 . . . . 0.0 110.229 178.94 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' C' C ' 54' ' ' TYR . . . . . . . . . . . . . 63.6 t80 -128.9 110.31 18.52 Favored Pre-proline 0 CA--C 1.534 0.36 0 CA-C-O 118.156 -0.926 . . . . 0.0 110.259 179.772 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' C' C ' 55' ' ' PRO . . . . . . . . . . . . . 73.4 Cg_endo -77.17 170.06 72.55 Favored 'Cis proline' 0 N--CA 1.501 1.926 0 CA-C-N 121.908 1.717 . . . . 0.0 112.236 -7.91 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' C' C ' 56' ' ' SER . . . . . . . . . . . . . 51.1 m -121.24 134.6 24.49 Favored Pre-proline 0 CA--C 1.537 0.457 0 CA-C-O 118.582 -0.723 . . . . 0.0 109.619 175.09 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' C' C ' 57' ' ' PRO . . . . . . . . . . . . . 36.3 Cg_endo -66.41 164.68 66.05 Favored 'Cis proline' 0 N--CA 1.499 1.799 0 CA-C-N 121.841 1.693 . . . . 0.0 111.521 -2.944 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' C' C ' 58' ' ' LEU . . . . . . . . . . . . . 32.8 tp -130.77 139.68 50.25 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-O 120.947 0.403 . . . . 0.0 110.663 -178.338 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' C' C ' 59' ' ' ARG . . . . . . . . . . . . . 55.2 ttm-85 -96.1 129.5 43.37 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-N 115.762 -0.654 . . . . 0.0 109.338 174.367 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' C' C ' 60' ' ' VAL . . . . . . . . . . . . . 40.9 t -86.14 121.11 37.02 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.268 0 C-N-CA 120.624 -0.431 . . . . 0.0 110.4 -177.917 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' C' C ' 61' ' ' GLU . . . . . . . . . . . . . 71.6 tt0 -130.57 157.66 42.1 Favored 'General case' 0 C--N 1.329 -0.31 0 N-CA-C 109.113 -0.699 . . . . 0.0 109.113 177.523 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' C' C ' 62' ' ' ASP . . . . . . . . . . . . . 12.8 t70 -51.22 -32.28 23.45 Favored 'General case' 0 C--N 1.327 -0.404 0 N-CA-C 112.07 0.396 . . . . 0.0 112.07 -178.282 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' C' C ' 63' ' ' ARG . . . . . . . . . . . . . 98.2 mtt180 -77.18 -21.94 53.21 Favored 'General case' 0 CA--C 1.533 0.29 0 N-CA-C 112.857 0.688 . . . . 0.0 112.857 -177.812 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' C' C ' 64' ' ' THR . . . . . . . . . . . . . 20.0 m -57.46 141.8 46.27 Favored 'General case' 0 C--N 1.331 -0.207 0 CA-C-O 120.842 0.353 . . . . 0.0 110.642 -176.478 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' C' C ' 65' ' ' LYS . . . . . . . . . . . . . 40.2 ttpt -89.13 121.44 31.45 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.1 -0.5 . . . . 0.0 110.279 -179.63 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' C' C ' 66' ' ' ILE . . . . . . . . . . . . . 63.1 mt -113.5 129.15 69.82 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.241 0 N-CA-C 109.87 -0.418 . . . . 0.0 109.87 -179.718 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' C' C ' 67' ' ' THR . . . . . . . . . . . . . 18.8 m -129.08 143.86 51.0 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-O 121.142 0.496 . . . . 0.0 111.236 -177.433 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' C' C ' 68' ' ' LEU . . . . . . . . . . . . . 17.1 tp -101.39 132.28 47.04 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 115.827 -0.624 . . . . 0.0 110.092 177.58 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' C' C ' 69' ' ' VAL . . . . . . . . . . . . . 41.1 t -92.5 136.05 25.82 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.346 0 CA-C-N 116.281 -0.418 . . . . 0.0 110.529 -177.7 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' C' C ' 70' ' ' THR . . . . . . . . . . . . . 40.2 p -91.12 -172.45 3.32 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 115.955 -0.566 . . . . 0.0 110.265 178.616 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' C' C ' 71' ' ' HIS . . . . . . . . . . . . . 66.1 t-80 -121.31 76.19 32.93 Favored Pre-proline 0 CA--C 1.533 0.31 0 CA-C-N 116.758 -0.201 . . . . 0.0 111.12 -178.561 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' C' C ' 72' ' ' PRO . . . . . . . . . . . . . 92.0 Cg_endo -93.48 160.08 2.43 Favored 'Trans proline' 0 N--CA 1.489 1.24 0 C-N-CA 122.079 1.853 . . . . 0.0 111.932 175.493 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' C' C ' 73' ' ' VAL . . . . . . . . . . . . . 35.5 m -69.92 178.88 0.39 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.286 0 N-CA-C 109.598 -0.519 . . . . 0.0 109.598 177.508 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' C' C ' 74' ' ' ASP . . . . . . . . . . . . . 27.6 t0 -98.71 119.81 38.08 Favored 'General case' 0 C--N 1.331 -0.203 0 C-N-CA 120.805 -0.358 . . . . 0.0 110.193 -176.185 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' C' C ' 75' ' ' VAL . . . . . 0.402 ' C ' HD12 ' C' ' 76' ' ' LEU . 40.6 t -119.13 121.9 67.87 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.237 0 CA-C-O 121.094 0.473 . . . . 0.0 110.63 -178.009 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' C' C ' 76' ' ' LEU . . . . . 0.402 HD12 ' C ' ' C' ' 75' ' ' VAL . 7.1 mp -117.25 139.78 50.37 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 115.669 -0.696 . . . . 0.0 109.402 175.437 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' C' C ' 77' ' ' GLU . . . . . . . . . . . . . 98.0 mt-10 -135.47 129.08 32.6 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-O 121.072 0.463 . . . . 0.0 111.007 -178.401 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' C' C ' 78' ' ' ALA . . . . . 0.481 ' HB2' HD21 ' C' ' 109' ' ' LEU . . . -117.66 136.69 53.15 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 115.638 -0.71 . . . . 0.0 109.957 177.778 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' C' C ' 79' ' ' LYS . . . . . 0.612 ' O ' HD13 ' C' ' 80' ' ' ILE . 68.4 mmtt -73.37 116.01 13.42 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.512 -0.313 . . . . 0.0 110.16 -179.107 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' C' C ' 80' ' ' ILE . . . . . 0.612 HD13 ' O ' ' C' ' 79' ' ' LYS . 39.7 mm -139.09 110.63 5.13 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.303 0 N-CA-C 109.56 -0.533 . . . . 0.0 109.56 -177.433 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' C' C ' 81' ' ' LYS . . . . . . . . . . . . . 99.5 mttt -112.56 128.73 56.44 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-O 120.95 0.405 . . . . 0.0 110.775 -178.852 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' C' C ' 82' ' ' GLY . . . . . . . . . . . . . . . 89.08 42.16 5.68 Favored Glycine 0 CA--C 1.525 0.679 0 C-N-CA 121.024 -0.608 . . . . 0.0 111.649 176.835 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' C' C ' 83' ' ' ILE . . . . . . . . . . . . . 72.0 mt -69.51 136.17 26.78 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.22 0 N-CA-C 109.718 -0.475 . . . . 0.0 109.718 177.23 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' C' C ' 84' ' ' LYS . . . . . . . . . . . . . 60.2 tttp -97.81 -53.56 3.37 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.054 -0.521 . . . . 0.0 110.195 -178.187 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' C' C ' 85' ' ' ASP . . . . . . . . . . . . . 13.1 t70 -151.17 148.67 28.54 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 115.746 -0.661 . . . . 0.0 110.232 -179.342 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' C' C ' 86' ' ' VAL . . . . . . . . . . . . . 41.4 t -129.2 129.62 67.63 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.264 0 CA-C-O 120.944 0.402 . . . . 0.0 110.397 -179.294 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' C' C ' 87' ' ' ILE . . . . . . . . . . . . . 44.6 mm -119.14 126.0 74.97 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.263 0 CA-C-N 115.923 -0.58 . . . . 0.0 109.657 177.097 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' C' C ' 88' ' ' LEU . . . . . . . . . . . . . 19.4 tp -109.82 123.4 49.49 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-O 121.005 0.431 . . . . 0.0 110.826 -178.333 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' C' C ' 89' ' ' ASP . . . . . . . . . . . . . 13.6 t70 -113.61 156.86 22.92 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 115.81 -0.632 . . . . 0.0 109.336 176.325 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' C' C ' 90' ' ' GLU . . . . . . . . . . . . . 81.8 tt0 -45.14 -42.28 8.82 Favored 'General case' 0 N--CA 1.465 0.282 0 N-CA-C 113.266 0.839 . . . . 0.0 113.266 -171.694 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' C' C ' 91' ' ' ASN . . . . . . . . . . . . . 73.1 m-20 -132.02 25.19 4.6 Favored 'General case' 0 N--CA 1.467 0.377 0 N-CA-C 112.652 0.612 . . . . 0.0 112.652 -178.539 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' C' C ' 92' ' ' LEU . . . . . . . . . . . . . 38.1 mt -148.17 142.02 25.74 Favored 'General case' 0 C--N 1.332 -0.19 0 N-CA-C 110.171 -0.307 . . . . 0.0 110.171 -177.635 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' C' C ' 93' ' ' ILE . . . . . . . . . . . . . 62.7 mt -118.62 116.9 52.72 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.266 0 N-CA-C 109.425 -0.583 . . . . 0.0 109.425 179.986 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' C' C ' 94' ' ' VAL . . . . . 0.506 HG21 HG11 ' C' ' 125' ' ' VAL . 44.2 t -119.39 124.13 72.45 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.2 0 CA-C-O 121.026 0.441 . . . . 0.0 110.075 -179.671 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' C' C ' 95' ' ' VAL . . . . . . . . . . . . . 42.7 t -121.23 135.35 61.68 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.297 0 CA-C-N 115.803 -0.635 . . . . 0.0 109.96 -179.258 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' C' C ' 96' ' ' ILE . . . . . . . . . . . . . 60.4 mt -115.9 128.86 73.04 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.288 0 N-CA-C 109.411 -0.588 . . . . 0.0 109.411 178.264 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' C' C ' 97' ' ' THR . . . . . . . . . . . . . 80.5 p -98.67 160.08 14.51 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-O 121.08 0.467 . . . . 0.0 110.828 -179.184 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' C' C ' 98' ' ' GLU . . . . . . . . . . . . . 97.6 mt-10 -53.82 -25.73 20.86 Favored 'General case' 0 CA--C 1.532 0.265 0 N-CA-C 112.257 0.465 . . . . 0.0 112.257 -179.927 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' C' C ' 99' ' ' GLU . . . . . . . . . . . . . 43.2 mt-10 -79.86 16.37 1.18 Allowed 'General case' 0 CA--C 1.535 0.375 0 N-CA-C 113.071 0.767 . . . . 0.0 113.071 -177.732 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' C' C ' 100' ' ' ASN . . . . . . . . . . . . . 3.9 m-20 61.83 38.07 15.0 Favored 'General case' 0 CA--C 1.529 0.155 0 CA-C-O 121.12 0.486 . . . . 0.0 110.91 178.27 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' C' C ' 101' ' ' GLU . . . . . . . . . . . . . 84.7 tt0 -113.18 141.42 46.96 Favored 'General case' 0 C--N 1.331 -0.199 0 CA-C-N 116.159 -0.473 . . . . 0.0 109.854 176.55 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' C' C ' 102' ' ' VAL . . . . . . . . . . . . . 46.1 t -114.86 125.08 72.09 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.272 0 CA-C-N 116.221 -0.445 . . . . 0.0 109.917 -178.55 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' C' C ' 103' ' ' LEU . . . . . . . . . . . . . 16.8 mt -116.65 129.83 56.38 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 115.616 -0.72 . . . . 0.0 110.182 177.763 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' C' C ' 104' ' ' ILE . . . . . . . . . . . . . 61.5 mt -117.7 120.71 65.53 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.286 0 N-CA-C 110.296 -0.261 . . . . 0.0 110.296 179.028 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' C' C ' 105' ' ' PHE . . . . . . . . . . . . . 46.0 m-85 -120.75 163.28 18.35 Favored 'General case' 0 C--N 1.332 -0.171 0 O-C-N 123.97 0.794 . . . . 0.0 109.654 177.86 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' C' C ' 106' ' ' ASN . . . . . . . . . . . . . 45.8 p-10 -97.42 -171.02 2.11 Favored 'General case' 0 C--N 1.331 -0.219 0 N-CA-C 109.783 -0.451 . . . . 0.0 109.783 173.719 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' C' C ' 107' ' ' GLN . . . . . . . . . . . . . 51.1 tt0 -59.67 -28.69 67.49 Favored 'General case' 0 C--N 1.329 -0.309 0 N-CA-C 112.043 0.386 . . . . 0.0 112.043 179.687 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' C' C ' 108' ' ' ASN . . . . . . . . . . . . . 24.6 t30 -84.88 11.94 8.37 Favored 'General case' 0 CA--C 1.537 0.447 0 N-CA-C 112.955 0.724 . . . . 0.0 112.955 -178.012 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' C' C ' 109' ' ' LEU . . . . . 0.481 HD21 ' HB2' ' C' ' 78' ' ' ALA . 11.6 tp 55.76 38.19 29.79 Favored 'General case' 0 C--O 1.232 0.154 0 CA-C-O 121.099 0.476 . . . . 0.0 111.338 178.722 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' C' C ' 110' ' ' GLU . . . . . . . . . . . . . 70.7 mm-40 -101.97 148.91 24.78 Favored 'General case' 0 C--N 1.328 -0.336 0 N-CA-C 109.636 -0.505 . . . . 0.0 109.636 175.707 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' C' C ' 111' ' ' GLU . . . . . . . . . . . . . 82.8 tt0 -81.85 121.91 27.05 Favored 'General case' 0 C--N 1.326 -0.415 0 CA-C-O 120.834 0.349 . . . . 0.0 110.357 -179.45 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' C' C ' 112' ' ' LEU . . . . . . . . . . . . . 34.1 mt -111.56 -46.04 3.31 Favored 'General case' 0 C--N 1.331 -0.203 0 CA-C-N 116.107 -0.497 . . . . 0.0 110.595 -179.689 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' C' C ' 113' ' ' TYR . . . . . . . . . . . . . 56.9 t80 -138.58 135.29 34.83 Favored 'General case' 0 C--N 1.33 -0.259 0 C-N-CA 120.772 -0.371 . . . . 0.0 111.332 -179.154 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' C' C ' 114' ' ' ARG . . . . . . . . . . . . . 63.8 ttp85 -137.88 122.08 18.07 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 115.949 -0.569 . . . . 0.0 110.026 178.956 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' C' C ' 115' ' ' GLY . . . . . . . . . . . . . . . -150.12 142.81 10.02 Favored Glycine 0 CA--C 1.525 0.671 0 C-N-CA 120.79 -0.719 . . . . 0.0 111.336 178.826 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' C' C ' 116' ' ' LYS . . . . . . . . . . . . . 38.8 ttpt -111.49 132.94 54.13 Favored 'General case' 0 C--N 1.33 -0.25 0 N-CA-C 109.782 -0.451 . . . . 0.0 109.782 176.379 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' C' C ' 117' ' ' PHE . . . . . . . . . . . . . 57.8 m-85 -130.69 113.97 14.82 Favored 'General case' 0 C--N 1.332 -0.193 0 CA-C-O 120.983 0.421 . . . . 0.0 110.385 -176.631 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' C' C ' 118' ' ' GLU . . . . . . . . . . . . . 71.0 mm-40 -54.28 -47.52 72.27 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.284 -0.416 . . . . 0.0 111.283 -177.276 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' C' C ' 119' ' ' ASN . . . . . . . . . . . . . 33.3 m120 -94.63 30.99 1.87 Allowed 'General case' 0 C--N 1.33 -0.251 0 N-CA-C 112.194 0.442 . . . . 0.0 112.194 -175.043 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' C' C ' 120' ' ' LEU . . . . . . . . . . . . . 13.7 tp -57.64 121.21 9.82 Favored 'General case' 0 C--N 1.332 -0.165 0 N-CA-C 110.204 -0.295 . . . . 0.0 110.204 177.163 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' C' C ' 121' ' ' ASN . . . . . . . . . . . . . 94.2 m-20 -114.01 -43.91 3.2 Favored 'General case' 0 C--O 1.232 0.171 0 CA-C-N 116.484 -0.326 . . . . 0.0 111.338 -176.113 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' C' C ' 122' ' ' LYS . . . . . . . . . . . . . 39.5 ttpt -150.97 148.88 28.93 Favored 'General case' 0 C--N 1.331 -0.227 0 CA-C-O 121.04 0.448 . . . . 0.0 111.637 -176.617 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' C' C ' 123' ' ' VAL . . . . . . . . . . . . . 44.9 t -128.65 133.87 65.62 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.227 0 CA-C-N 116.007 -0.542 . . . . 0.0 109.737 177.417 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' C' C ' 124' ' ' LEU . . . . . . . . . . . . . 79.5 mt -128.93 139.35 52.16 Favored 'General case' 0 C--N 1.331 -0.201 0 CA-C-O 120.759 0.314 . . . . 0.0 110.942 -178.595 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' C' C ' 125' ' ' VAL . . . . . 0.506 HG11 HG21 ' C' ' 94' ' ' VAL . 35.6 m -133.17 128.93 56.58 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.206 0 CA-C-N 116.254 -0.43 . . . . 0.0 110.53 178.242 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' C' C ' 126' ' ' ARG . . . . . . . . . . . . . 91.0 mtt180 -150.78 128.33 11.48 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.419 -0.355 . . . . 0.0 110.177 178.199 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' C' C ' 127' ' ' ASN . . . . . . . . . . . . . 77.5 m-20 54.52 -151.58 0.36 Allowed 'General case' 0 CA--C 1.541 0.6 0 CA-C-O 119.449 -0.31 . . . . 0.0 110.228 178.017 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' C' C ' 128' ' ' ASP . . . . . . . . . . . . . 23.5 p-10 -81.03 18.14 1.09 Allowed 'General case' 0 CA--C 1.536 0.405 0 N-CA-C 112.881 0.697 . . . . 0.0 112.881 -179.62 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' C' C ' 129' ' ' LEU . . . . . . . . . . . . . 15.9 tp -123.92 137.02 54.69 Favored 'General case' 0 C--O 1.232 0.165 0 CA-C-N 117.983 0.356 . . . . 0.0 110.185 178.715 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' C' C ' 130' ' ' VAL . . . . . 0.496 HG23 ' HB ' ' C' ' 141' ' ' ILE . 32.1 m -131.78 145.81 34.4 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.197 0 CA-C-O 120.905 0.383 . . . . 0.0 110.327 178.575 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' C' C ' 131' ' ' VAL . . . . . 0.515 HG22 HD12 ' C' ' 140' ' ' LEU . 40.7 t -136.1 140.49 43.8 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.325 0 CA-C-O 121.058 0.456 . . . . 0.0 110.553 -177.704 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' C' C ' 132' ' ' ILE . . . . . . . . . . . . . 73.9 mt -116.8 129.68 72.92 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 CA-C-N 115.585 -0.734 . . . . 0.0 109.032 177.45 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' C' C ' 133' ' ' ILE . . . . . . . . . . . . . 40.3 mm -114.06 121.84 66.99 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.275 0 CA-C-O 120.698 0.285 . . . . 0.0 110.942 -174.428 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' C' C ' 134' ' ' ASP . . . . . . . . . . . . . 9.0 p-10 -135.23 146.54 48.72 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.116 -0.493 . . . . 0.0 109.786 175.501 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' C' C ' 135' ' ' GLU . . . . . . . . . . . . . 81.2 tt0 -49.92 -25.41 3.21 Favored 'General case' 0 CA--C 1.533 0.325 0 N-CA-C 112.77 0.656 . . . . 0.0 112.77 -175.465 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' C' C ' 136' ' ' GLN . . . . . . . . . . . . . 58.3 tp60 -80.88 -34.28 33.7 Favored 'General case' 0 C--O 1.233 0.2 0 N-CA-C 112.036 0.384 . . . . 0.0 112.036 -176.032 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' C' C ' 137' ' ' LYS . . . . . . . . . . . . . 40.3 pttt -169.57 175.49 5.38 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-O 121.522 0.677 . . . . 0.0 112.085 -173.597 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' C' C ' 138' ' ' LEU . . . . . 0.479 HD23 ' N ' ' C' ' 139' ' ' THR . 4.8 tt -117.74 125.34 50.47 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 115.05 -0.977 . . . . 0.0 109.81 177.931 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' C' C ' 139' ' ' THR . . . . . 0.479 ' N ' HD23 ' C' ' 138' ' ' LEU . 28.6 m -105.18 124.01 48.81 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.312 -0.404 . . . . 0.0 110.497 179.701 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' C' C ' 140' ' ' LEU . . . . . 0.515 HD12 HG22 ' C' ' 131' ' ' VAL . 19.6 tp -110.68 117.89 34.71 Favored 'General case' 0 C--N 1.329 -0.302 0 N-CA-C 109.046 -0.724 . . . . 0.0 109.046 -179.496 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' C' C ' 141' ' ' ILE . . . . . 0.496 ' HB ' HG23 ' C' ' 130' ' ' VAL . 19.9 mt -118.63 121.29 66.63 Favored 'Isoleucine or valine' 0 C--O 1.234 0.25 0 CA-C-O 121.24 0.543 . . . . 0.0 109.877 -175.496 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' C' C ' 142' ' ' ARG . . . . . . . . . . . . . 70.5 mtt180 -104.11 113.31 26.77 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 115.042 -0.981 . . . . 0.0 110.112 -177.952 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' C' C ' 143' ' ' THR . . . . . . . . . . . . . 80.3 p . . . . . 0 C--O 1.219 -0.514 0 CA-C-O 117.921 -1.037 . . . . 0.0 110.636 -179.406 . . . . . . . . 0 0 . 1 . 009 nuclear nobuild full ' D' D ' -3' ' ' GLU . . . . . . . . . . . . . 84.1 tt0 . . . . . 0 N--CA 1.489 1.508 0 N-CA-C 109.315 -0.624 . . . . 0.0 109.315 . . . . . . . . . 0 0 . 1 . 009 nuclear nobuild full ' D' D ' -2' ' ' GLY . . . . . . . . . . . . . . . -62.2 145.52 49.38 Favored Glycine 0 CA--C 1.525 0.685 0 N-CA-C 111.24 -0.744 . . . . 0.0 111.24 -178.325 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' D' D ' -1' ' ' VAL . . . . . . . . . . . . . 44.8 t -95.92 129.61 45.77 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.262 0 N-CA-C 109.93 -0.396 . . . . 0.0 109.93 179.216 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' D' D ' 0' ' ' ILE . . . . . . . . . . . . . 73.6 mt -121.28 143.49 33.46 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.242 0 CA-C-N 116.293 -0.412 . . . . 0.0 110.181 -178.573 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' D' D ' 1' ' ' MET . . . . . . . . . . . . . 23.2 ptp -144.07 148.33 35.01 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 115.954 -0.566 . . . . 0.0 110.568 -179.63 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' D' D ' 2' ' ' SER . . . . . . . . . . . . . 12.7 p -117.44 133.32 56.1 Favored 'General case' 0 C--N 1.331 -0.227 0 CA-C-O 121.164 0.507 . . . . 0.0 110.677 -179.868 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' D' D ' 3' ' ' GLU . . . . . . . . . . . . . 84.9 tt0 -143.99 140.87 29.85 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 115.748 -0.66 . . . . 0.0 111.161 -178.709 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' D' D ' 4' ' ' LEU . . . . . . . . . . . . . 19.2 tp -124.56 131.74 53.47 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.014 -0.539 . . . . 0.0 110.06 177.093 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' D' D ' 5' ' ' LYS . . . . . . . . . . . . . 77.9 mttt -111.93 120.91 43.51 Favored 'General case' 0 C--O 1.234 0.259 0 CA-C-N 116.365 -0.379 . . . . 0.0 110.767 -179.406 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' D' D ' 6' ' ' LEU . . . . . . . . . . . . . 54.5 mt -114.57 142.47 46.39 Favored 'General case' 0 C--N 1.332 -0.174 0 CA-C-N 115.553 -0.749 . . . . 0.0 110.163 -179.563 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' D' D ' 7' ' ' LYS . . . . . . . . . . . . . 31.0 ttpt -122.3 136.87 26.86 Favored Pre-proline 0 CA--C 1.534 0.351 0 CA-C-O 118.84 -0.6 . . . . 0.0 109.602 175.794 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' D' D ' 8' ' ' PRO . . . . . . . . . . . . . 98.8 Cg_endo -91.22 131.78 1.44 Allowed 'Trans proline' 0 N--CA 1.489 1.255 0 C-N-CA 121.687 1.591 . . . . 0.0 111.799 178.215 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' D' D ' 9' ' ' LEU . . . . . . . . . . . . . 36.1 mt -72.8 -47.48 8.83 Favored Pre-proline 0 CA--C 1.535 0.38 0 CA-C-O 118.49 -0.767 . . . . 0.0 112.128 -178.593 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' D' D ' 10' ' ' PRO . . . . . . . . . . . . . 75.8 Cg_endo -78.62 149.1 23.53 Favored 'Trans proline' 0 N--CA 1.496 1.623 0 CA-C-N 120.347 1.159 . . . . 0.0 111.794 176.397 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' D' D ' 11' ' ' LYS . . . . . . . . . . . . . 53.7 mttp -85.51 95.85 9.43 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.481 -0.327 . . . . 0.0 110.693 -179.721 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' D' D ' 12' ' ' VAL . . . . . . . . . . . . . 12.1 p -144.35 145.19 21.79 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.278 0 CA-C-N 116.285 -0.416 . . . . 0.0 110.43 179.361 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' D' D ' 13' ' ' GLU . . . . . . . . . . . . . 95.7 mt-10 -90.11 122.09 32.76 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.254 -0.43 . . . . 0.0 110.271 178.681 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' D' D ' 14' ' ' LEU . . . . . . . . . . . . . 23.1 mt -98.07 154.34 37.77 Favored Pre-proline 0 CA--C 1.532 0.265 0 CA-C-N 116.283 -0.417 . . . . 0.0 111.174 -177.874 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' D' D ' 15' ' ' PRO . . . . . . . . . . . . . 36.6 Cg_exo -59.35 162.29 14.88 Favored 'Trans proline' 0 N--CA 1.496 1.669 0 C-N-CA 121.4 1.4 . . . . 0.0 112.079 178.581 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' D' D ' 16' ' ' PRO . . . . . . . . . . . . . 23.7 Cg_exo -63.01 -41.42 28.83 Favored 'Trans proline' 0 N--CA 1.497 1.703 0 C-N-CA 121.493 1.462 . . . . 0.0 112.815 -179.175 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' D' D ' 17' ' ' ASP . . . . . . . . . . . . . 22.8 p-10 -82.91 9.53 9.81 Favored 'General case' 0 CA--C 1.537 0.47 0 N-CA-C 113.241 0.83 . . . . 0.0 113.241 -176.859 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' D' D ' 18' ' ' PHE . . . . . . . . . . . . . 29.3 t80 -56.98 -41.81 79.09 Favored 'General case' 0 C--N 1.334 -0.09 0 O-C-N 121.986 -0.446 . . . . 0.0 110.369 -179.562 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' D' D ' 19' ' ' VAL . . . . . . . . . . . . . 46.5 t -56.23 -44.44 79.35 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.252 0 CA-C-N 116.327 -0.397 . . . . 0.0 110.599 -179.379 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' D' D ' 20' ' ' ASP . . . . . . . . . . . . . 41.6 m-20 -59.81 -41.26 90.87 Favored 'General case' 0 C--N 1.33 -0.247 0 C-N-CA 120.84 -0.344 . . . . 0.0 110.943 -178.091 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' D' D ' 21' ' ' VAL . . . . . . . . . . . . . 47.2 t -63.66 -47.54 90.78 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 C-N-CA 120.759 -0.377 . . . . 0.0 110.494 -178.357 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' D' D ' 22' ' ' ILE . . . . . 0.667 HG22 HD12 ' D' ' 26' ' ' LEU . 49.8 mm -54.78 -47.28 74.55 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.273 0 C-N-CA 120.97 -0.292 . . . . 0.0 110.798 178.907 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' D' D ' 23' ' ' ARG . . . . . . . . . . . . . 53.2 ttp180 -53.74 -52.0 61.55 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-O 120.609 0.242 . . . . 0.0 111.533 -178.953 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' D' D ' 24' ' ' ILE . . . . . . . . . . . . . 76.7 mt -58.61 -41.26 81.6 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.377 0 CA-C-N 116.749 -0.205 . . . . 0.0 111.367 -176.339 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' D' D ' 25' ' ' LYS . . . . . . . . . . . . . 73.0 mmtt -68.4 -42.29 79.23 Favored 'General case' 0 C--N 1.329 -0.292 0 N-CA-C 112.277 0.473 . . . . 0.0 112.277 -178.338 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' D' D ' 26' ' ' LEU . . . . . 0.667 HD12 HG22 ' D' ' 22' ' ' ILE . 33.1 mt -80.47 -34.31 35.99 Favored 'General case' 0 C--N 1.33 -0.258 0 N-CA-C 113.661 0.986 . . . . 0.0 113.661 -169.41 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' D' D ' 27' ' ' GLN . . . . . . . . . . . . . 9.1 pt20 -46.1 139.71 4.34 Favored 'General case' 0 N--CA 1.469 0.489 0 N-CA-C 112.853 0.686 . . . . 0.0 112.853 -175.17 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' D' D ' 28' ' ' GLY . . . . . . . . . . . . . . . 101.05 -27.01 22.54 Favored Glycine 0 CA--C 1.532 1.144 0 CA-C-N 115.657 -0.701 . . . . 0.0 112.163 -175.99 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' D' D ' 29' ' ' LYS . . . . . . . . . . . . . 64.9 mttp -97.65 155.09 17.15 Favored 'General case' 0 C--O 1.233 0.226 0 CA-C-N 117.336 0.568 . . . . 0.0 110.986 178.751 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' D' D ' 30' ' ' THR . . . . . . . . . . . . . 40.1 m -106.77 140.63 39.32 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.232 -0.44 . . . . 0.0 110.151 177.251 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' D' D ' 31' ' ' VAL . . . . . . . . . . . . . 34.9 m -128.22 156.12 40.21 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.19 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.851 -179.125 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' D' D ' 32' ' ' ARG . . . . . . . . . . . . . 67.3 ttt180 -131.65 147.0 52.48 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 115.974 -0.557 . . . . 0.0 110.314 178.285 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' D' D ' 33' ' ' THR . . . . . . . . . . . . . 22.8 m -52.52 139.22 25.94 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-O 120.762 0.315 . . . . 0.0 111.502 -178.329 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' D' D ' 34' ' ' GLY . . . . . . . . . . . . . . . 99.67 -17.05 58.07 Favored Glycine 0 CA--C 1.533 1.159 0 CA-C-O 119.762 -0.466 . . . . 0.0 113.32 179.26 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' D' D ' 35' ' ' ASP . . . . . . . . . . . . . 76.7 m-20 -66.44 149.24 50.72 Favored 'General case' 0 N--CA 1.46 0.074 0 CA-C-N 117.992 0.896 . . . . 0.0 111.17 179.787 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' D' D ' 36' ' ' VAL . . . . . . . . . . . . . 45.6 t -120.18 128.9 76.0 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.202 0 CA-C-N 115.749 -0.66 . . . . 0.0 109.687 177.439 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' D' D ' 37' ' ' ILE . . . . . . . . . . . . . 64.1 mt -121.37 138.85 50.38 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.229 0 CA-C-N 116.194 -0.457 . . . . 0.0 109.889 -179.145 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' D' D ' 38' ' ' GLY . . . . . . . . . . . . . . . -117.97 128.87 7.97 Favored Glycine 0 CA--C 1.526 0.749 0 N-CA-C 110.97 -0.852 . . . . 0.0 110.97 -179.943 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' D' D ' 39' ' ' ILE . . . . . . . . . . . . . 71.5 mt -128.05 129.83 69.64 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.198 0 N-CA-C 110.036 -0.357 . . . . 0.0 110.036 178.815 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' D' D ' 40' ' ' SER . . . . . . . . . . . . . 87.2 p -92.16 123.73 35.72 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.267 -0.424 . . . . 0.0 110.861 176.804 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' D' D ' 41' ' ' ILE . . . . . . . . . . . . . 71.9 mt -134.14 121.04 36.83 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.263 0 CA-C-O 120.993 0.425 . . . . 0.0 110.278 177.82 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' D' D ' 42' ' ' LEU . . . . . 0.546 HD23 ' O ' ' D' ' 42' ' ' LEU . 1.3 tt 57.81 44.78 19.66 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-O 121.42 0.629 . . . . 0.0 110.187 178.46 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' D' D ' 43' ' ' GLY . . . . . . . . . . . . . . . 72.36 -5.75 13.89 Favored Glycine 0 CA--C 1.534 1.276 0 C-N-CA 121.146 -0.549 . . . . 0.0 113.644 175.897 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' D' D ' 44' ' ' LYS . . . . . . . . . . . . . 22.9 tptm -109.27 126.05 52.93 Favored 'General case' 0 N--CA 1.462 0.129 0 CA-C-N 118.141 0.971 . . . . 0.0 110.183 -178.908 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' D' D ' 45' ' ' GLU . . . . . . . . . . . . . 43.6 tp10 -84.69 130.31 34.72 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-O 120.816 0.341 . . . . 0.0 111.124 -179.482 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' D' D ' 46' ' ' VAL . . . . . . . . . . . . . 10.3 p -120.3 126.99 75.86 Favored 'Isoleucine or valine' 0 N--CA 1.462 0.167 0 N-CA-C 109.818 -0.438 . . . . 0.0 109.818 175.25 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' D' D ' 47' ' ' LYS . . . . . . . . . . . . . 86.4 mttt -99.09 126.16 44.77 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 115.912 -0.585 . . . . 0.0 110.931 178.248 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' D' D ' 48' ' ' PHE . . . . . . . . . . . . . 34.2 m-85 -111.43 131.97 54.8 Favored 'General case' 0 C--N 1.331 -0.207 0 N-CA-C 109.812 -0.44 . . . . 0.0 109.812 177.665 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' D' D ' 49' ' ' LYS . . . . . . . . . . . . . 38.4 tttp -107.71 132.15 53.66 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.362 -0.381 . . . . 0.0 110.274 177.655 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' D' D ' 50' ' ' VAL . . . . . . . . . . . . . 45.5 t -76.56 104.11 4.38 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.332 0 N-CA-C 109.361 -0.607 . . . . 0.0 109.361 177.06 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' D' D ' 51' ' ' VAL . . . . . . . . . . . . . 47.5 t -69.48 -53.2 26.11 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.341 0 N-CA-C 109.554 -0.536 . . . . 0.0 109.554 -175.692 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' D' D ' 52' ' ' GLN . . . . . . . . . . . . . 81.8 mt-30 -154.86 152.45 29.79 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.053 -0.522 . . . . 0.0 111.677 -178.381 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' D' D ' 53' ' ' ALA . . . . . 0.44 ' HB3' ' OG ' ' D' ' 56' ' ' SER . . . -129.29 133.29 47.4 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 115.361 -0.836 . . . . 0.0 109.703 175.539 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' D' D ' 54' ' ' TYR . . . . . . . . . . . . . 45.8 t80 -129.0 109.69 18.28 Favored Pre-proline 0 CA--C 1.535 0.397 0 CA-C-O 118.162 -0.923 . . . . 0.0 110.463 179.217 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' D' D ' 55' ' ' PRO . . . . . . . . . . . . . 73.7 Cg_endo -77.17 167.47 79.58 Favored 'Cis proline' 0 N--CA 1.5 1.871 0 CA-C-N 121.808 1.681 . . . . 0.0 112.103 -6.676 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' D' D ' 56' ' ' SER . . . . . 0.44 ' OG ' ' HB3' ' D' ' 53' ' ' ALA . 62.7 m -117.41 133.04 23.27 Favored Pre-proline 0 CA--C 1.54 0.567 0 CA-C-O 118.437 -0.792 . . . . 0.0 109.458 174.803 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' D' D ' 57' ' ' PRO . . . . . . . . . . . . . 38.4 Cg_endo -67.7 164.5 72.51 Favored 'Cis proline' 0 N--CA 1.498 1.774 0 CA-C-N 121.881 1.707 . . . . 0.0 111.433 -1.407 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' D' D ' 58' ' ' LEU . . . . . . . . . . . . . 24.0 tp -130.73 138.05 49.8 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 116.321 -0.399 . . . . 0.0 110.612 -179.478 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' D' D ' 59' ' ' ARG . . . . . . . . . . . . . 56.7 ttp180 -103.24 127.96 50.4 Favored 'General case' 0 C--N 1.328 -0.342 0 N-CA-C 109.362 -0.607 . . . . 0.0 109.362 174.882 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' D' D ' 60' ' ' VAL . . . . . . . . . . . . . 43.5 t -78.48 119.47 27.57 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.28 0 C-N-CA 120.75 -0.38 . . . . 0.0 110.836 -174.591 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' D' D ' 61' ' ' GLU . . . . . . . . . . . . . 15.6 mm-40 -131.09 161.33 32.31 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 115.729 -0.669 . . . . 0.0 109.666 175.378 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' D' D ' 62' ' ' ASP . . . . . . . . . . . . . 54.0 m-20 -52.6 -31.65 37.51 Favored 'General case' 0 C--N 1.328 -0.343 0 N-CA-C 112.085 0.402 . . . . 0.0 112.085 -178.252 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' D' D ' 63' ' ' ARG . . . . . . . . . . . . . 79.7 mtp180 -73.2 -21.91 60.57 Favored 'General case' 0 CA--C 1.532 0.256 0 N-CA-C 112.949 0.722 . . . . 0.0 112.949 -175.41 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' D' D ' 64' ' ' THR . . . . . . . . . . . . . 25.7 m -69.31 139.96 54.33 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-O 120.951 0.405 . . . . 0.0 110.965 -175.752 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' D' D ' 65' ' ' LYS . . . . . . . . . . . . . 67.5 mttm -89.34 132.14 35.09 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 115.945 -0.57 . . . . 0.0 110.134 178.341 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' D' D ' 66' ' ' ILE . . . . . . . . . . . . . 62.7 mt -117.51 129.52 73.85 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.261 0 N-CA-C 109.893 -0.41 . . . . 0.0 109.893 179.446 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' D' D ' 67' ' ' THR . . . . . . . . . . . . . 25.5 m -122.86 137.47 54.93 Favored 'General case' 0 C--N 1.332 -0.181 0 CA-C-N 116.128 -0.487 . . . . 0.0 110.769 -178.872 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' D' D ' 68' ' ' LEU . . . . . . . . . . . . . 14.9 tp -107.33 129.36 54.91 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 115.964 -0.562 . . . . 0.0 110.348 178.805 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' D' D ' 69' ' ' VAL . . . . . . . . . . . . . 43.3 t -92.72 134.12 31.74 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.352 0 CA-C-N 116.033 -0.531 . . . . 0.0 110.005 178.495 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' D' D ' 70' ' ' THR . . . . . . . . . . . . . 21.5 p -84.85 -54.36 4.73 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.36 -0.382 . . . . 0.0 110.422 -179.455 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' D' D ' 71' ' ' HIS . . . . . . . . . . . . . 96.7 m-70 -149.98 151.61 32.49 Favored Pre-proline 0 C--N 1.329 -0.296 0 CA-C-N 116.314 -0.403 . . . . 0.0 110.561 178.671 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' D' D ' 72' ' ' PRO . . . . . . . . . . . . . 86.5 Cg_endo -89.88 158.25 5.01 Favored 'Trans proline' 0 N--CA 1.49 1.266 0 C-N-CA 121.762 1.641 . . . . 0.0 111.988 178.859 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' D' D ' 73' ' ' VAL . . . . . . . . . . . . . 30.3 m -77.97 143.51 12.66 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.238 0 CA-C-O 120.936 0.398 . . . . 0.0 110.404 178.906 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' D' D ' 74' ' ' ASP . . . . . . . . . . . . . 15.2 t0 -97.04 124.46 41.04 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 115.997 -0.547 . . . . 0.0 109.59 178.905 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' D' D ' 75' ' ' VAL . . . . . . . . . . . . . 41.9 t -116.75 125.29 73.62 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.211 0 CA-C-O 121.091 0.472 . . . . 0.0 110.891 -175.29 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' D' D ' 76' ' ' LEU . . . . . . . . . . . . . 5.7 mp -125.73 144.71 50.5 Favored 'General case' 0 C--N 1.331 -0.205 0 CA-C-N 115.704 -0.68 . . . . 0.0 109.55 173.896 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' D' D ' 77' ' ' GLU . . . . . . . . . . . . . 98.0 mt-10 -133.52 131.03 39.31 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-O 120.961 0.41 . . . . 0.0 111.007 -177.666 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' D' D ' 78' ' ' ALA . . . . . . . . . . . . . . . -116.13 130.95 57.04 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 115.833 -0.621 . . . . 0.0 109.697 177.516 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' D' D ' 79' ' ' LYS . . . . . 0.614 ' O ' HD13 ' D' ' 80' ' ' ILE . 88.1 mttt -77.34 123.85 27.07 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-O 120.854 0.359 . . . . 0.0 110.906 -177.059 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' D' D ' 80' ' ' ILE . . . . . 0.614 HD13 ' O ' ' D' ' 79' ' ' LYS . 39.5 mm -139.1 114.4 8.56 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.277 0 N-CA-C 109.309 -0.626 . . . . 0.0 109.309 -177.858 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' D' D ' 81' ' ' LYS . . . . . . . . . . . . . 69.3 mttm -100.48 118.93 37.68 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-O 120.793 0.33 . . . . 0.0 111.245 -177.234 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' D' D ' 82' ' ' GLY . . . . . . . . . . . . . . . 89.17 42.22 5.64 Favored Glycine 0 CA--C 1.526 0.738 0 C-N-CA 120.668 -0.777 . . . . 0.0 111.989 172.888 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' D' D ' 83' ' ' ILE . . . . . . . . . . . . . 72.3 mt -61.99 135.92 25.97 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.341 0 N-CA-C 109.835 -0.431 . . . . 0.0 109.835 176.434 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' D' D ' 84' ' ' LYS . . . . . . . . . . . . . 15.5 ttmm -95.21 -51.45 4.61 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-O 121.118 0.485 . . . . 0.0 109.744 179.115 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' D' D ' 85' ' ' ASP . . . . . . . . . . . . . 7.5 t70 -158.38 154.9 27.73 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 115.548 -0.751 . . . . 0.0 110.145 179.105 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' D' D ' 86' ' ' VAL . . . . . . . . . . . . . 44.4 t -130.56 133.98 62.81 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.176 0 CA-C-O 121.055 0.455 . . . . 0.0 110.459 -179.436 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' D' D ' 87' ' ' ILE . . . . . . . . . . . . . 44.3 mm -119.25 125.72 74.7 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.253 0 CA-C-N 115.653 -0.703 . . . . 0.0 109.664 177.657 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' D' D ' 88' ' ' LEU . . . . . . . . . . . . . 14.2 tp -108.14 127.17 53.58 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.299 -0.409 . . . . 0.0 110.848 -178.331 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' D' D ' 89' ' ' ASP . . . . . . . . . . . . . 13.6 t70 -121.22 154.41 36.32 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.002 -0.545 . . . . 0.0 109.843 178.23 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' D' D ' 90' ' ' GLU . . . . . . . . . . . . . 82.3 tt0 -46.32 -37.58 7.61 Favored 'General case' 0 C--N 1.33 -0.271 0 N-CA-C 113.079 0.77 . . . . 0.0 113.079 -172.754 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' D' D ' 91' ' ' ASN . . . . . . . . . . . . . 13.4 t-20 -132.0 22.02 4.53 Favored 'General case' 0 N--CA 1.469 0.477 0 N-CA-C 112.779 0.659 . . . . 0.0 112.779 -177.446 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' D' D ' 92' ' ' LEU . . . . . . . . . . . . . 19.9 mt -150.49 144.15 25.19 Favored 'General case' 0 C--N 1.331 -0.204 0 CA-C-O 120.773 0.321 . . . . 0.0 110.269 -176.59 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' D' D ' 93' ' ' ILE . . . . . . . . . . . . . 74.6 mt -121.78 115.08 45.33 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.276 0 N-CA-C 109.168 -0.678 . . . . 0.0 109.168 176.944 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' D' D ' 94' ' ' VAL . . . . . . . . . . . . . 46.8 t -118.06 127.04 75.32 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.217 0 CA-C-O 121.071 0.462 . . . . 0.0 110.111 -177.883 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' D' D ' 95' ' ' VAL . . . . . . . . . . . . . 41.1 t -121.42 134.55 64.41 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.277 0 CA-C-N 115.769 -0.651 . . . . 0.0 109.772 -179.678 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' D' D ' 96' ' ' ILE . . . . . . . . . . . . . 63.4 mt -113.57 127.58 70.84 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.287 0 N-CA-C 109.209 -0.663 . . . . 0.0 109.209 178.381 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' D' D ' 97' ' ' THR . . . . . . . . . . . . . 59.9 p -101.44 156.15 17.63 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-O 121.289 0.566 . . . . 0.0 111.379 -177.106 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' D' D ' 98' ' ' GLU . . . . . . . . . . . . . 45.5 tp10 -53.81 -26.65 25.1 Favored 'General case' 0 CA--C 1.533 0.32 0 CA-C-N 116.009 -0.542 . . . . 0.0 112.075 179.309 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' D' D ' 99' ' ' GLU . . . . . . . . . . . . . 96.7 mt-10 -79.97 17.49 0.96 Allowed 'General case' 0 CA--C 1.534 0.357 0 N-CA-C 113.084 0.772 . . . . 0.0 113.084 -177.217 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' D' D ' 100' ' ' ASN . . . . . . . . . . . . . 2.7 m-20 62.41 37.65 13.45 Favored 'General case' 0 C--O 1.233 0.19 0 CA-C-O 121.004 0.43 . . . . 0.0 110.959 177.456 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' D' D ' 101' ' ' GLU . . . . . . . . . . . . . 84.5 tt0 -116.27 143.64 45.26 Favored 'General case' 0 C--N 1.332 -0.173 0 CA-C-N 116.22 -0.445 . . . . 0.0 109.864 177.356 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' D' D ' 102' ' ' VAL . . . . . . . . . . . . . 45.3 t -114.93 124.37 71.52 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.267 0 CA-C-N 116.103 -0.499 . . . . 0.0 109.842 -179.122 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' D' D ' 103' ' ' LEU . . . . . . . . . . . . . 30.9 mt -115.88 131.31 56.98 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-N 115.815 -0.63 . . . . 0.0 110.464 178.075 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' D' D ' 104' ' ' ILE . . . . . 0.51 HD13 HG11 ' D' ' 130' ' ' VAL . 68.9 mt -120.77 120.1 61.49 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.302 0 N-CA-C 110.268 -0.271 . . . . 0.0 110.268 179.425 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' D' D ' 105' ' ' PHE . . . . . . . . . . . . . 59.1 m-85 -121.64 166.95 13.49 Favored 'General case' 0 C--N 1.333 -0.149 0 O-C-N 123.886 0.741 . . . . 0.0 110.043 178.494 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' D' D ' 106' ' ' ASN . . . . . . . . . . . . . 45.2 p-10 -104.1 -170.63 1.8 Allowed 'General case' 0 CA--C 1.531 0.227 0 N-CA-C 110.088 -0.338 . . . . 0.0 110.088 173.187 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' D' D ' 107' ' ' GLN . . . . . . . . . . . . . 63.3 tt0 -57.56 -29.77 64.69 Favored 'General case' 0 C--N 1.33 -0.255 0 N-CA-C 112.071 0.396 . . . . 0.0 112.071 179.338 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' D' D ' 108' ' ' ASN . . . . . . . . . . . . . 10.8 t30 -87.3 12.62 11.46 Favored 'General case' 0 CA--C 1.536 0.415 0 N-CA-C 113.045 0.757 . . . . 0.0 113.045 -176.295 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' D' D ' 109' ' ' LEU . . . . . . . . . . . . . 24.9 mt 55.1 36.75 27.66 Favored 'General case' 0 CA--C 1.528 0.132 0 CA-C-O 120.943 0.401 . . . . 0.0 111.43 178.665 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' D' D ' 110' ' ' GLU . . . . . . . . . . . . . 95.8 mt-10 -102.28 148.86 24.93 Favored 'General case' 0 C--N 1.33 -0.251 0 N-CA-C 109.689 -0.485 . . . . 0.0 109.689 175.917 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' D' D ' 111' ' ' GLU . . . . . . . . . . . . . 79.9 tt0 -79.34 122.0 25.82 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.339 -0.392 . . . . 0.0 110.565 -178.027 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' D' D ' 112' ' ' LEU . . . . . . . . . . . . . 43.4 mt -109.05 -46.01 3.67 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-N 116.128 -0.487 . . . . 0.0 110.245 178.677 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' D' D ' 113' ' ' TYR . . . . . . . . . . . . . 60.3 t80 -140.94 137.49 33.14 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.32 -0.4 . . . . 0.0 111.147 -179.959 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' D' D ' 114' ' ' ARG . . . . . . . . . . . . . 68.5 ttp85 -140.72 119.25 12.3 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 115.881 -0.6 . . . . 0.0 109.98 177.377 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' D' D ' 115' ' ' GLY . . . . . . . . . . . . . . . -150.08 151.13 23.24 Favored Glycine 0 CA--C 1.523 0.588 0 N-CA-C 110.919 -0.872 . . . . 0.0 110.919 179.554 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' D' D ' 116' ' ' LYS . . . . . . . . . . . . . 35.2 ttmt -124.29 140.0 53.38 Favored 'General case' 0 C--N 1.329 -0.298 0 N-CA-C 109.968 -0.382 . . . . 0.0 109.968 177.449 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' D' D ' 117' ' ' PHE . . . . . . . . . . . . . 28.9 m-85 -136.16 118.89 16.08 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.04 -176.232 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' D' D ' 118' ' ' GLU . . . . . . . . . . . . . 96.1 mt-10 -53.45 -46.55 69.91 Favored 'General case' 0 C--N 1.33 -0.278 0 C-N-CA 121.041 -0.264 . . . . 0.0 111.307 -177.88 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' D' D ' 119' ' ' ASN . . . . . . . . . . . . . 24.3 m120 -95.87 31.04 2.19 Favored 'General case' 0 C--N 1.331 -0.216 0 CA-C-N 116.149 -0.478 . . . . 0.0 112.198 -175.891 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' D' D ' 120' ' ' LEU . . . . . . . . . . . . . 19.4 tp -57.59 122.04 11.78 Favored 'General case' 0 C--O 1.231 0.123 0 N-CA-C 110.077 -0.342 . . . . 0.0 110.077 177.271 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' D' D ' 121' ' ' ASN . . . . . . . . . . . . . 29.2 t-20 -113.56 -44.0 3.26 Favored 'General case' 0 C--O 1.233 0.199 0 CA-C-N 116.683 -0.235 . . . . 0.0 111.329 -175.37 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' D' D ' 122' ' ' LYS . . . . . . . . . . . . . 34.7 ttmt -150.98 141.81 22.85 Favored 'General case' 0 C--N 1.331 -0.201 0 C-N-CA 120.513 -0.475 . . . . 0.0 111.703 -177.457 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' D' D ' 123' ' ' VAL . . . . . . . . . . . . . 46.5 t -119.57 127.87 75.87 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.231 0 N-CA-C 108.972 -0.751 . . . . 0.0 108.972 173.539 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' D' D ' 124' ' ' LEU . . . . . . . . . . . . . 17.7 tp -127.16 140.72 52.05 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-O 120.867 0.365 . . . . 0.0 110.924 -175.506 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' D' D ' 125' ' ' VAL . . . . . 0.585 HG12 HG23 ' D' ' 130' ' ' VAL . 35.6 m -126.82 140.91 47.65 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.276 0 CA-C-N 116.065 -0.516 . . . . 0.0 110.629 179.787 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' D' D ' 126' ' ' ARG . . . . . . . . . . . . . 47.7 ttt180 -159.34 134.08 7.98 Favored 'General case' 0 C--N 1.329 -0.318 0 N-CA-C 109.53 -0.544 . . . . 0.0 109.53 178.287 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' D' D ' 127' ' ' ASN . . . . . . . . . . . . . 1.6 t-20 56.68 -154.0 0.35 Allowed 'General case' 0 CA--C 1.537 0.47 0 N-CA-C 109.588 -0.523 . . . . 0.0 109.588 -178.333 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' D' D ' 128' ' ' ASP . . . . . . . . . . . . . 13.7 p-10 -84.99 20.7 1.79 Allowed 'General case' 0 CA--C 1.535 0.381 0 CA-C-N 118.433 0.561 . . . . 0.0 112.346 177.178 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' D' D ' 129' ' ' LEU . . . . . . . . . . . . . 59.1 mt -122.87 150.3 43.07 Favored 'General case' 0 C--O 1.233 0.228 0 O-C-N 122.119 -0.363 . . . . 0.0 110.307 -179.699 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' D' D ' 130' ' ' VAL . . . . . 0.585 HG23 HG12 ' D' ' 125' ' ' VAL . 12.9 p -134.46 147.15 30.07 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.205 0 CA-C-O 120.891 0.377 . . . . 0.0 110.412 -179.16 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' D' D ' 131' ' ' VAL . . . . . . . . . . . . . 14.9 p -136.23 142.84 37.48 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.211 0 CA-C-O 121.121 0.486 . . . . 0.0 110.904 -179.528 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' D' D ' 132' ' ' ILE . . . . . . . . . . . . . 72.4 mt -115.63 131.41 68.09 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.231 0 CA-C-N 115.689 -0.687 . . . . 0.0 109.374 178.333 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' D' D ' 133' ' ' ILE . . . . . . . . . . . . . 42.5 mm -115.61 124.23 71.85 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.307 0 CA-C-O 120.878 0.371 . . . . 0.0 110.911 -175.597 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' D' D ' 134' ' ' ASP . . . . . . . . . . . . . 10.3 p-10 -137.46 146.33 44.17 Favored 'General case' 0 C--N 1.331 -0.201 0 CA-C-N 116.103 -0.499 . . . . 0.0 109.762 174.294 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' D' D ' 135' ' ' GLU . . . . . . . . . . . . . 84.9 tt0 -49.87 -25.95 3.63 Favored 'General case' 0 C--N 1.329 -0.309 0 N-CA-C 112.776 0.658 . . . . 0.0 112.776 -173.798 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' D' D ' 136' ' ' GLN . . . . . . . . . . . . . 48.0 tt0 -81.91 -34.04 30.12 Favored 'General case' 0 C--N 1.331 -0.231 0 N-CA-C 111.939 0.348 . . . . 0.0 111.939 -175.828 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' D' D ' 137' ' ' LYS . . . . . . . . . . . . . 53.7 pttt -167.78 175.3 6.99 Favored 'General case' 0 C--N 1.331 -0.223 0 CA-C-O 121.561 0.696 . . . . 0.0 112.079 -173.396 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' D' D ' 138' ' ' LEU . . . . . 0.454 HD23 ' N ' ' D' ' 139' ' ' THR . 5.5 tt -119.2 129.6 55.05 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 115.095 -0.957 . . . . 0.0 109.853 179.07 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' D' D ' 139' ' ' THR . . . . . 0.454 ' N ' HD23 ' D' ' 138' ' ' LEU . 39.1 m -112.49 124.22 52.02 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.289 -0.414 . . . . 0.0 110.353 178.829 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' D' D ' 140' ' ' LEU . . . . . . . . . . . . . 31.7 tp -112.07 124.97 53.57 Favored 'General case' 0 C--N 1.327 -0.378 0 N-CA-C 109.186 -0.672 . . . . 0.0 109.186 -178.663 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' D' D ' 141' ' ' ILE . . . . . 0.416 ' HB ' HG13 ' D' ' 130' ' ' VAL . 19.7 mt -121.99 117.16 51.44 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.292 0 CA-C-O 120.954 0.406 . . . . 0.0 109.983 -173.071 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' D' D ' 142' ' ' ARG . . . . . . . . . . . . . 78.6 mtp180 -107.11 125.26 50.83 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-N 115.382 -0.826 . . . . 0.0 110.445 -177.35 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' D' D ' 143' ' ' THR . . . . . . . . . . . . . 25.4 p . . . . . 0 C--O 1.219 -0.544 0 CA-C-O 118.004 -0.998 . . . . 0.0 110.61 -179.748 . . . . . . . . 0 0 . 1 . 009 nuclear nobuild full ' E' E ' -3' ' ' GLU . . . . . . . . . . . . . 45.1 tp10 . . . . . 0 N--CA 1.49 1.558 0 N-CA-C 109.378 -0.601 . . . . 0.0 109.378 . . . . . . . . . 0 0 . 1 . 009 nuclear nobuild full ' E' E ' -2' ' ' GLY . . . . . . . . . . . . . . . -77.88 138.34 21.32 Favored Glycine 0 CA--C 1.524 0.646 0 N-CA-C 110.893 -0.883 . . . . 0.0 110.893 179.647 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' E' E ' -1' ' ' VAL . . . . . . . . . . . . . 43.9 t -96.04 130.07 45.24 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.289 0 N-CA-C 110.065 -0.346 . . . . 0.0 110.065 179.733 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' E' E ' 0' ' ' ILE . . . . . . . . . . . . . 44.0 mm -117.67 140.09 42.16 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.222 0 CA-C-O 120.901 0.382 . . . . 0.0 110.46 -178.649 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' E' E ' 1' ' ' MET . . . . . . . . . . . . . 20.1 ptt? -144.4 140.47 29.05 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 115.924 -0.58 . . . . 0.0 110.503 -179.832 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' E' E ' 2' ' ' SER . . . . . . . . . . . . . 2.0 p -128.3 122.27 31.22 Favored 'General case' 0 C--O 1.233 0.207 0 CA-C-O 121.014 0.435 . . . . 0.0 110.67 -178.6 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' E' E ' 3' ' ' GLU . . . . . . . . . . . . . 66.3 tt0 -144.87 142.52 29.98 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-N 115.794 -0.639 . . . . 0.0 111.251 -175.29 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' E' E ' 4' ' ' LEU . . . . . . . . . . . . . 15.9 tp -123.37 135.0 53.94 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 115.918 -0.583 . . . . 0.0 110.001 175.583 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' E' E ' 5' ' ' LYS . . . . . . . . . . . . . 89.9 mttt -115.42 121.98 44.41 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.581 -0.281 . . . . 0.0 110.89 -179.125 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' E' E ' 6' ' ' LEU . . . . . . . . . . . . . 69.4 mt -114.48 145.93 41.3 Favored 'General case' 0 C--N 1.331 -0.225 0 CA-C-N 115.808 -0.633 . . . . 0.0 110.19 178.227 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' E' E ' 7' ' ' LYS . . . . . . . . . . . . . 26.3 ttpp -127.76 142.58 44.69 Favored Pre-proline 0 CA--C 1.533 0.323 0 CA-C-O 119.129 -0.462 . . . . 0.0 109.826 175.928 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' E' E ' 8' ' ' PRO . . . . . . . . . . . . . 87.2 Cg_endo -91.04 132.49 1.54 Allowed 'Trans proline' 0 N--CA 1.489 1.234 0 C-N-CA 121.652 1.568 . . . . 0.0 111.843 178.769 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' E' E ' 9' ' ' LEU . . . . . . . . . . . . . 71.6 mt -71.0 -47.17 14.73 Favored Pre-proline 0 CA--C 1.534 0.331 0 CA-C-O 118.663 -0.684 . . . . 0.0 112.111 -179.696 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' E' E ' 10' ' ' PRO . . . . . . . . . . . . . 98.3 Cg_endo -79.96 155.95 23.37 Favored 'Trans proline' 0 N--CA 1.495 1.614 0 C-N-CA 121.106 1.204 . . . . 0.0 111.878 175.573 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' E' E ' 11' ' ' LYS . . . . . . . . . . . . . 62.4 mttp -88.14 96.03 10.38 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-O 120.774 0.321 . . . . 0.0 110.695 179.696 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' E' E ' 12' ' ' VAL . . . . . . . . . . . . . 12.5 p -143.35 147.01 20.74 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.248 0 CA-C-N 116.231 -0.44 . . . . 0.0 110.37 179.228 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' E' E ' 13' ' ' GLU . . . . . . . . . . . . . 84.8 tt0 -92.06 123.59 35.53 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.321 -0.399 . . . . 0.0 110.276 179.175 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' E' E ' 14' ' ' LEU . . . . . . . . . . . . . 41.7 mt -97.9 149.01 35.28 Favored Pre-proline 0 CA--C 1.533 0.307 0 CA-C-O 119.352 -0.356 . . . . 0.0 110.6 -178.099 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' E' E ' 15' ' ' PRO . . . . . . . . . . . . . 26.1 Cg_exo -62.08 157.57 43.58 Favored 'Trans proline' 0 N--CA 1.498 1.751 0 C-N-CA 121.349 1.366 . . . . 0.0 111.906 177.412 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' E' E ' 16' ' ' PRO . . . . . . . . . . . . . 34.0 Cg_exo -59.36 -37.85 87.89 Favored 'Trans proline' 0 N--CA 1.498 1.758 0 C-N-CA 121.49 1.46 . . . . 0.0 112.875 -179.228 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' E' E ' 17' ' ' ASP . . . . . . . . . . . . . 18.2 p-10 -79.43 1.86 23.95 Favored 'General case' 0 CA--C 1.538 0.499 0 N-CA-C 113.327 0.862 . . . . 0.0 113.327 -177.34 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' E' E ' 18' ' ' PHE . . . . . . . . . . . . . 46.9 t80 -57.61 -47.18 82.88 Favored 'General case' 0 N--CA 1.458 -0.074 0 O-C-N 121.97 -0.456 . . . . 0.0 110.142 -178.605 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' E' E ' 19' ' ' VAL . . . . . 0.41 HG13 ' N ' ' E' ' 20' ' ' ASP . 13.8 p -55.34 -41.49 62.11 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.319 0 CA-C-N 116.26 -0.427 . . . . 0.0 111.095 -178.553 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' E' E ' 20' ' ' ASP . . . . . 0.41 ' N ' HG13 ' E' ' 19' ' ' VAL . 9.5 t0 -60.44 -43.16 97.11 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-O 120.925 0.393 . . . . 0.0 110.899 -177.977 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' E' E ' 21' ' ' VAL . . . . . . . . . . . . . 47.2 t -64.34 -45.98 94.45 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.287 0 CA-C-N 116.272 -0.422 . . . . 0.0 110.496 -178.177 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' E' E ' 22' ' ' ILE . . . . . 0.62 HG22 HD12 ' E' ' 26' ' ' LEU . 50.2 mm -54.63 -47.09 73.05 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.287 0 CA-C-O 120.676 0.275 . . . . 0.0 110.753 178.809 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' E' E ' 23' ' ' ARG . . . . . . . . . . . . . 25.1 ttm-85 -53.3 -54.17 40.28 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-O 121.258 0.551 . . . . 0.0 111.677 179.963 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' E' E ' 24' ' ' ILE . . . . . . . . . . . . . 76.4 mt -61.0 -36.52 72.94 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.38 0 CA-C-N 115.67 -0.696 . . . . 0.0 111.59 -172.857 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' E' E ' 25' ' ' LYS . . . . . . . . . . . . . 64.1 mttm -75.22 -40.66 58.91 Favored 'General case' 0 C--N 1.33 -0.267 0 N-CA-C 112.349 0.5 . . . . 0.0 112.349 -178.855 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' E' E ' 26' ' ' LEU . . . . . 0.62 HD12 HG22 ' E' ' 22' ' ' ILE . 75.9 mt -80.22 -25.64 39.52 Favored 'General case' 0 C--N 1.331 -0.201 0 N-CA-C 113.195 0.813 . . . . 0.0 113.195 -171.112 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' E' E ' 27' ' ' GLN . . . . . . . . . . . . . 4.2 pt20 -46.38 136.67 7.1 Favored 'General case' 0 N--CA 1.469 0.495 0 N-CA-C 112.594 0.59 . . . . 0.0 112.594 -177.368 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' E' E ' 28' ' ' GLY . . . . . . . . . . . . . . . 99.8 -21.06 46.67 Favored Glycine 0 CA--C 1.535 1.305 0 CA-C-N 115.824 -0.626 . . . . 0.0 112.661 -177.162 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' E' E ' 29' ' ' LYS . . . . . . . . . . . . . 61.1 mttp -97.02 155.14 16.91 Favored 'General case' 0 C--O 1.233 0.218 0 CA-C-N 117.471 0.636 . . . . 0.0 110.935 179.492 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' E' E ' 30' ' ' THR . . . . . . . . . . . . . 28.5 m -108.65 137.45 46.57 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.042 -0.526 . . . . 0.0 110.031 176.748 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' E' E ' 31' ' ' VAL . . . . . . . . . . . . . 35.3 m -130.35 152.77 37.98 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.223 0 CA-C-O 120.919 0.39 . . . . 0.0 110.778 -178.751 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' E' E ' 32' ' ' ARG . . . . . . . . . . . . . 37.9 ttm180 -133.23 148.23 51.99 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-O 121.246 0.546 . . . . 0.0 110.398 179.568 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' E' E ' 33' ' ' THR . . . . . . . . . . . . . 16.4 m -52.11 139.33 23.49 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.244 -0.434 . . . . 0.0 111.624 -177.145 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' E' E ' 34' ' ' GLY . . . . . . . . . . . . . . . 101.03 -17.24 56.45 Favored Glycine 0 CA--C 1.534 1.235 0 CA-C-O 119.667 -0.519 . . . . 0.0 113.201 179.051 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' E' E ' 35' ' ' ASP . . . . . . . . . . . . . 79.2 m-20 -66.78 147.3 53.43 Favored 'General case' 0 N--CA 1.462 0.163 0 CA-C-N 118.026 0.913 . . . . 0.0 111.229 179.25 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' E' E ' 36' ' ' VAL . . . . . . . . . . . . . 45.8 t -122.51 129.1 75.49 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.204 0 CA-C-N 115.779 -0.646 . . . . 0.0 109.737 177.802 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' E' E ' 37' ' ' ILE . . . . . . . . . . . . . 63.2 mt -123.16 139.23 50.53 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.256 0 CA-C-N 116.286 -0.416 . . . . 0.0 109.953 -179.011 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' E' E ' 38' ' ' GLY . . . . . . . . . . . . . . . -115.46 128.65 8.16 Favored Glycine 0 CA--C 1.524 0.605 0 N-CA-C 110.982 -0.847 . . . . 0.0 110.982 178.661 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' E' E ' 39' ' ' ILE . . . . . . . . . . . . . 68.7 mt -126.98 125.71 67.05 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.271 0 N-CA-C 110.019 -0.363 . . . . 0.0 110.019 179.501 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' E' E ' 40' ' ' SER . . . . . . . . . . . . . 24.0 t -91.99 118.66 30.99 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.388 -0.369 . . . . 0.0 110.794 176.545 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' E' E ' 41' ' ' ILE . . . . . . . . . . . . . 70.9 mt -130.35 131.05 65.63 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.227 0 CA-C-O 120.927 0.394 . . . . 0.0 110.299 179.283 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' E' E ' 42' ' ' LEU . . . . . . . . . . . . . 47.3 mt 54.94 33.47 20.15 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-N 116.039 -0.528 . . . . 0.0 111.817 177.954 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' E' E ' 43' ' ' GLY . . . . . . . . . . . . . . . 71.77 28.99 68.03 Favored Glycine 0 CA--C 1.53 0.983 0 C-N-CA 121.075 -0.583 . . . . 0.0 112.299 178.094 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' E' E ' 44' ' ' LYS . . . . . . . . . . . . . 20.0 tptm -142.43 125.92 16.75 Favored 'General case' 0 C--N 1.331 -0.205 0 N-CA-C 109.748 -0.464 . . . . 0.0 109.748 178.46 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' E' E ' 45' ' ' GLU . . . . . . . . . . . . . 41.0 tp10 -85.21 128.6 34.74 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-O 120.843 0.354 . . . . 0.0 111.589 -177.413 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' E' E ' 46' ' ' VAL . . . . . . . . . . . . . 8.9 p -120.15 127.74 75.92 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.188 0 N-CA-C 109.525 -0.546 . . . . 0.0 109.525 174.261 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' E' E ' 47' ' ' LYS . . . . . . . . . . . . . 52.7 mtpt -98.55 124.41 43.28 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.035 -0.529 . . . . 0.0 110.792 178.01 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' E' E ' 48' ' ' PHE . . . . . . . . . . . . . 37.6 m-85 -109.27 131.82 54.7 Favored 'General case' 0 C--N 1.33 -0.265 0 N-CA-C 109.782 -0.451 . . . . 0.0 109.782 178.069 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' E' E ' 49' ' ' LYS . . . . . . . . . . . . . 76.8 tttt -108.63 132.58 53.75 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.417 -0.356 . . . . 0.0 110.344 178.009 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' E' E ' 50' ' ' VAL . . . . . . . . . . . . . 45.6 t -76.29 105.07 4.83 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.367 0 N-CA-C 109.249 -0.649 . . . . 0.0 109.249 176.087 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' E' E ' 51' ' ' VAL . . . . . . . . . . . . . 47.0 t -68.64 -53.92 24.32 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.351 0 N-CA-C 109.401 -0.592 . . . . 0.0 109.401 -175.64 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' E' E ' 52' ' ' GLN . . . . . . . . . . . . . 80.8 mt-30 -155.7 154.61 31.78 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 115.967 -0.561 . . . . 0.0 111.584 -178.163 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' E' E ' 53' ' ' ALA . . . . . . . . . . . . . . . -130.9 132.17 44.97 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 115.371 -0.831 . . . . 0.0 109.667 174.91 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' E' E ' 54' ' ' TYR . . . . . . . . . . . . . 39.7 t80 -129.07 108.92 18.1 Favored Pre-proline 0 CA--C 1.534 0.353 0 CA-C-O 118.273 -0.87 . . . . 0.0 110.421 179.892 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' E' E ' 55' ' ' PRO . . . . . . . . . . . . . 73.2 Cg_endo -77.21 169.89 72.94 Favored 'Cis proline' 0 N--CA 1.5 1.866 0 CA-C-N 121.84 1.693 . . . . 0.0 112.32 -6.428 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' E' E ' 56' ' ' SER . . . . . . . . . . . . . 13.6 m -117.22 134.71 23.03 Favored Pre-proline 0 CA--C 1.539 0.528 0 CA-C-O 118.401 -0.809 . . . . 0.0 109.45 174.031 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' E' E ' 57' ' ' PRO . . . . . . . . . . . . . 50.8 Cg_endo -70.07 146.79 83.81 Favored 'Cis proline' 0 N--CA 1.496 1.672 0 CA-C-N 121.85 1.696 . . . . 0.0 111.519 -1.379 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' E' E ' 58' ' ' LEU . . . . . . . . . . . . . 33.6 tp -107.89 138.76 43.57 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-O 120.87 0.367 . . . . 0.0 110.689 -177.838 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' E' E ' 59' ' ' ARG . . . . . . . . . . . . . 72.7 ttt180 -102.66 131.59 49.34 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 115.813 -0.63 . . . . 0.0 109.679 176.952 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' E' E ' 60' ' ' VAL . . . . . . . . . . . . . 41.7 t -86.29 118.65 33.08 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.213 0 C-N-CA 120.775 -0.37 . . . . 0.0 110.602 -177.167 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' E' E ' 61' ' ' GLU . . . . . . . . . . . . . 96.6 mt-10 -131.11 158.17 41.13 Favored 'General case' 0 C--N 1.331 -0.229 0 CA-C-N 115.874 -0.603 . . . . 0.0 109.748 177.302 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' E' E ' 62' ' ' ASP . . . . . . . . . . . . . 48.5 m-20 -52.44 -32.94 41.92 Favored 'General case' 0 C--N 1.329 -0.324 0 N-CA-C 111.816 0.302 . . . . 0.0 111.816 -178.663 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' E' E ' 63' ' ' ARG . . . . . . . . . . . . . 75.5 mtp180 -78.91 -19.96 50.53 Favored 'General case' 0 CA--C 1.533 0.301 0 N-CA-C 113.153 0.797 . . . . 0.0 113.153 -176.258 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' E' E ' 64' ' ' THR . . . . . . . . . . . . . 24.9 m -66.34 149.2 50.74 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-O 120.993 0.425 . . . . 0.0 111.117 -174.739 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' E' E ' 65' ' ' LYS . . . . . . . . . . . . . 24.6 mtpp -89.67 127.26 35.9 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 115.964 -0.562 . . . . 0.0 110.651 179.997 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' E' E ' 66' ' ' ILE . . . . . . . . . . . . . 64.1 mt -117.64 128.52 74.84 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.272 0 N-CA-C 109.842 -0.429 . . . . 0.0 109.842 177.476 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' E' E ' 67' ' ' THR . . . . . . . . . . . . . 28.8 m -120.56 137.76 54.23 Favored 'General case' 0 C--N 1.331 -0.229 0 CA-C-O 121.123 0.487 . . . . 0.0 110.928 -178.587 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' E' E ' 68' ' ' LEU . . . . . . . . . . . . . 13.3 tp -106.03 122.37 46.01 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 115.706 -0.679 . . . . 0.0 110.254 178.44 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' E' E ' 69' ' ' VAL . . . . . . . . . . . . . 43.4 t -99.6 123.84 52.6 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.271 0 CA-C-N 116.219 -0.446 . . . . 0.0 109.922 179.881 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' E' E ' 70' ' ' THR . . . . . 0.413 HG23 ' N ' ' E' ' 71' ' ' HIS . 8.8 t -96.11 -42.28 8.31 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.185 -0.461 . . . . 0.0 110.764 -179.552 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' E' E ' 71' ' ' HIS . . . . . 0.413 ' N ' HG23 ' E' ' 70' ' ' THR . 92.4 m-70 -149.96 156.78 38.15 Favored Pre-proline 0 C--N 1.328 -0.336 0 CA-C-O 119.519 -0.276 . . . . 0.0 110.653 178.936 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' E' E ' 72' ' ' PRO . . . . . . . . . . . . . 16.6 Cg_exo -65.02 -26.24 58.53 Favored 'Trans proline' 0 N--CA 1.497 1.679 0 C-N-CA 121.258 1.306 . . . . 0.0 112.447 176.264 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' E' E ' 73' ' ' VAL . . . . . . . . . . . . . 35.2 m -123.15 170.62 13.21 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.198 0 CA-C-O 120.709 0.29 . . . . 0.0 110.466 -178.664 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' E' E ' 74' ' ' ASP . . . . . . . . . . . . . 10.8 t70 -98.04 118.04 33.74 Favored 'General case' 0 C--N 1.33 -0.274 0 N-CA-C 109.935 -0.394 . . . . 0.0 109.935 -178.471 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' E' E ' 75' ' ' VAL . . . . . . . . . . . . . 42.0 t -112.32 122.65 66.97 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.2 0 CA-C-O 121.09 0.471 . . . . 0.0 110.369 -178.31 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' E' E ' 76' ' ' LEU . . . . . . . . . . . . . 29.9 mt -122.79 137.62 54.87 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 115.63 -0.713 . . . . 0.0 109.432 178.398 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' E' E ' 77' ' ' GLU . . . . . . . . . . . . . 96.4 mt-10 -133.27 140.3 47.39 Favored 'General case' 0 C--N 1.331 -0.217 0 CA-C-O 121.035 0.445 . . . . 0.0 111.301 -177.29 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' E' E ' 78' ' ' ALA . . . . . 0.577 ' HB2' HD21 ' E' ' 109' ' ' LEU . . . -130.12 129.62 43.76 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 115.678 -0.692 . . . . 0.0 109.957 176.377 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' E' E ' 79' ' ' LYS . . . . . 0.583 ' O ' HD13 ' E' ' 80' ' ' ILE . 32.7 mmtp -75.24 119.09 18.9 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-O 120.949 0.404 . . . . 0.0 110.58 -179.428 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' E' E ' 80' ' ' ILE . . . . . 0.583 HD13 ' O ' ' E' ' 79' ' ' LYS . 22.7 mm -139.25 112.53 6.36 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.269 0 N-CA-C 108.947 -0.76 . . . . 0.0 108.947 -178.578 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' E' E ' 81' ' ' LYS . . . . . . . . . . . . . 40.6 mttp -99.72 126.75 45.82 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-O 120.875 0.369 . . . . 0.0 111.293 -176.07 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' E' E ' 82' ' ' GLY . . . . . . . . . . . . . . . 89.11 42.21 5.66 Favored Glycine 0 CA--C 1.526 0.744 0 C-N-CA 120.989 -0.624 . . . . 0.0 111.892 174.119 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' E' E ' 83' ' ' ILE . . . . . . . . . . . . . 69.8 mt -67.93 137.99 23.5 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.34 0 N-CA-C 109.793 -0.447 . . . . 0.0 109.793 177.099 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' E' E ' 84' ' ' LYS . . . . . . . . . . . . . 70.4 tttt -100.24 -53.63 3.08 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.165 -0.471 . . . . 0.0 110.226 -178.58 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' E' E ' 85' ' ' ASP . . . . . . . . . . . . . 8.5 t70 -151.23 148.45 28.23 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 115.837 -0.619 . . . . 0.0 110.387 -178.985 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' E' E ' 86' ' ' VAL . . . . . . . . . . . . . 43.7 t -129.47 129.42 66.93 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.269 0 CA-C-O 120.928 0.394 . . . . 0.0 110.377 -179.648 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' E' E ' 87' ' ' ILE . . . . . . . . . . . . . 4.6 mp -122.19 134.28 65.93 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.255 0 CA-C-N 115.972 -0.558 . . . . 0.0 109.709 178.593 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' E' E ' 88' ' ' LEU . . . . . . . . . . . . . 10.2 tp -111.59 134.89 52.85 Favored 'General case' 0 C--N 1.331 -0.205 0 CA-C-O 121.105 0.479 . . . . 0.0 111.059 -178.206 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' E' E ' 89' ' ' ASP . . . . . . . . . . . . . 4.7 t70 -121.53 159.12 27.01 Favored 'General case' 0 C--N 1.331 -0.205 0 CA-C-N 115.651 -0.704 . . . . 0.0 109.634 177.515 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' E' E ' 90' ' ' GLU . . . . . . . . . . . . . 84.3 tt0 -44.97 -44.37 9.8 Favored 'General case' 0 N--CA 1.465 0.301 0 N-CA-C 113.094 0.775 . . . . 0.0 113.094 -172.224 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' E' E ' 91' ' ' ASN . . . . . . . . . . . . . 23.8 m120 -132.02 26.34 4.59 Favored 'General case' 0 N--CA 1.467 0.419 0 N-CA-C 112.401 0.519 . . . . 0.0 112.401 -179.427 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' E' E ' 92' ' ' LEU . . . . . . . . . . . . . 12.8 mt -149.24 151.88 35.02 Favored 'General case' 0 C--N 1.333 -0.143 0 N-CA-C 110.105 -0.332 . . . . 0.0 110.105 -176.159 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' E' E ' 93' ' ' ILE . . . . . . . . . . . . . 72.2 mt -127.71 121.98 57.93 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.28 0 N-CA-C 109.349 -0.612 . . . . 0.0 109.349 177.812 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' E' E ' 94' ' ' VAL . . . . . 0.46 HG21 HG11 ' E' ' 125' ' ' VAL . 44.6 t -118.07 128.1 75.19 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.294 0 CA-C-O 120.813 0.34 . . . . 0.0 110.119 -178.343 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' E' E ' 95' ' ' VAL . . . . . . . . . . . . . 43.6 t -122.19 135.11 63.37 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.381 0 CA-C-N 115.986 -0.552 . . . . 0.0 109.996 -179.238 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' E' E ' 96' ' ' ILE . . . . . . . . . . . . . 62.2 mt -115.3 128.04 72.65 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.346 0 N-CA-C 109.241 -0.652 . . . . 0.0 109.241 178.392 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' E' E ' 97' ' ' THR . . . . . . . . . . . . . 66.5 p -101.32 155.74 17.86 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-O 121.056 0.455 . . . . 0.0 111.04 -177.521 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' E' E ' 98' ' ' GLU . . . . . . . . . . . . . 97.1 mt-10 -53.91 -26.22 24.08 Favored 'General case' 0 CA--C 1.532 0.265 0 N-CA-C 112.194 0.442 . . . . 0.0 112.194 179.874 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' E' E ' 99' ' ' GLU . . . . . . . . . . . . . 97.0 mt-10 -78.86 15.53 1.06 Allowed 'General case' 0 CA--C 1.535 0.37 0 N-CA-C 113.167 0.803 . . . . 0.0 113.167 -177.383 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' E' E ' 100' ' ' ASN . . . . . . . . . . . . . 3.6 m-20 61.54 37.41 16.4 Favored 'General case' 0 CA--C 1.529 0.17 0 CA-C-O 120.974 0.416 . . . . 0.0 111.124 178.728 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' E' E ' 101' ' ' GLU . . . . . . . . . . . . . 80.9 tt0 -115.23 145.45 42.41 Favored 'General case' 0 C--N 1.332 -0.173 0 CA-C-N 115.951 -0.568 . . . . 0.0 109.616 175.803 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' E' E ' 102' ' ' VAL . . . . . . . . . . . . . 43.4 t -115.59 125.98 72.97 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.335 0 CA-C-N 116.318 -0.401 . . . . 0.0 110.143 -177.043 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' E' E ' 103' ' ' LEU . . . . . . . . . . . . . 23.4 mt -117.92 130.5 56.26 Favored 'General case' 0 C--N 1.331 -0.226 0 CA-C-N 115.888 -0.596 . . . . 0.0 110.15 177.747 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' E' E ' 104' ' ' ILE . . . . . 0.556 HD13 HG21 ' E' ' 130' ' ' VAL . 68.8 mt -119.9 120.85 64.45 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.189 0 CA-C-O 120.646 0.26 . . . . 0.0 110.308 179.02 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' E' E ' 105' ' ' PHE . . . . . . . . . . . . . 55.6 m-85 -119.86 166.5 13.21 Favored 'General case' 0 C--N 1.332 -0.18 0 CA-C-N 115.352 -0.84 . . . . 0.0 109.796 178.618 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' E' E ' 106' ' ' ASN . . . . . . . . . . . . . 47.1 p-10 -97.87 -169.94 1.91 Allowed 'General case' 0 C--N 1.331 -0.231 0 N-CA-C 109.708 -0.478 . . . . 0.0 109.708 172.972 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' E' E ' 107' ' ' GLN . . . . . . . . . . . . . 39.0 tp60 -60.89 -28.17 68.69 Favored 'General case' 0 CA--C 1.533 0.295 0 N-CA-C 112.012 0.375 . . . . 0.0 112.012 179.564 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' E' E ' 108' ' ' ASN . . . . . . . . . . . . . 15.6 t-20 -82.94 9.43 10.07 Favored 'General case' 0 CA--C 1.536 0.42 0 N-CA-C 112.94 0.718 . . . . 0.0 112.94 -179.125 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' E' E ' 109' ' ' LEU . . . . . 0.577 HD21 ' HB2' ' E' ' 78' ' ' ALA . 9.4 tp 57.78 36.92 26.94 Favored 'General case' 0 C--O 1.232 0.164 0 CA-C-O 120.877 0.37 . . . . 0.0 111.278 179.973 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' E' E ' 110' ' ' GLU . . . . . . . . . . . . . 96.6 mt-10 -102.14 150.07 23.64 Favored 'General case' 0 C--N 1.331 -0.23 0 N-CA-C 109.788 -0.449 . . . . 0.0 109.788 176.364 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' E' E ' 111' ' ' GLU . . . . . . . . . . . . . 68.0 tt0 -83.24 121.93 27.75 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 116.47 -0.332 . . . . 0.0 110.846 -176.509 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' E' E ' 112' ' ' LEU . . . . . . . . . . . . . 13.4 mt -110.47 -45.99 3.46 Favored 'General case' 0 C--N 1.332 -0.182 0 CA-C-N 116.228 -0.442 . . . . 0.0 110.553 179.685 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' E' E ' 113' ' ' TYR . . . . . . . . . . . . . 57.3 t80 -135.77 133.74 38.26 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.341 -0.391 . . . . 0.0 110.936 -178.346 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' E' E ' 114' ' ' ARG . . . . . . . . . . . . . 76.7 ttt180 -134.57 120.18 19.32 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.14 -0.482 . . . . 0.0 110.054 176.938 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' E' E ' 115' ' ' GLY . . . . . . . . . . . . . . . -148.32 162.46 28.82 Favored Glycine 0 CA--C 1.524 0.635 0 N-CA-C 110.694 -0.962 . . . . 0.0 110.694 -179.773 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' E' E ' 116' ' ' LYS . . . . . . . . . . . . . 33.6 ttmt -136.81 139.09 41.5 Favored 'General case' 0 C--N 1.327 -0.371 0 N-CA-C 110.224 -0.287 . . . . 0.0 110.224 -179.623 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' E' E ' 117' ' ' PHE . . . . . . . . . . . . . 32.9 m-85 -137.51 113.94 10.21 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-O 121.047 0.451 . . . . 0.0 110.272 -176.487 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' E' E ' 118' ' ' GLU . . . . . . . . . . . . . 96.5 mt-10 -53.59 -45.6 70.07 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.142 -0.481 . . . . 0.0 111.514 -176.425 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' E' E ' 119' ' ' ASN . . . . . . . . . . . . . 32.7 m120 -96.55 30.93 2.41 Favored 'General case' 0 C--N 1.329 -0.299 0 N-CA-C 112.306 0.484 . . . . 0.0 112.306 -174.316 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' E' E ' 120' ' ' LEU . . . . . . . . . . . . . 12.9 tp -56.24 122.94 12.94 Favored 'General case' 0 C--N 1.332 -0.191 0 C-N-CA 121.139 -0.224 . . . . 0.0 110.559 177.645 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' E' E ' 121' ' ' ASN . . . . . . . . . . . . . 44.7 t30 -114.07 -44.01 3.19 Favored 'General case' 0 C--N 1.333 -0.131 0 CA-C-N 116.684 -0.235 . . . . 0.0 111.559 -176.641 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' E' E ' 122' ' ' LYS . . . . . 0.424 ' HE3' HD11 ' E' ' 124' ' ' LEU . 33.6 ttpt -149.1 149.16 30.61 Favored 'General case' 0 C--N 1.332 -0.158 0 CA-C-O 121.077 0.465 . . . . 0.0 111.431 -174.647 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' E' E ' 123' ' ' VAL . . . . . . . . . . . . . 45.7 t -126.52 136.49 60.67 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.265 0 CA-C-N 116.11 -0.495 . . . . 0.0 109.935 179.126 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' E' E ' 124' ' ' LEU . . . . . 0.424 HD11 ' HE3' ' E' ' 122' ' ' LYS . 57.3 mt -129.86 138.32 50.91 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-O 120.714 0.292 . . . . 0.0 110.655 -178.926 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' E' E ' 125' ' ' VAL . . . . . 0.46 HG11 HG21 ' E' ' 94' ' ' VAL . 35.7 m -135.9 143.67 35.58 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.269 0 CA-C-N 116.341 -0.391 . . . . 0.0 110.644 178.509 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' E' E ' 126' ' ' ARG . . . . . . . . . . . . . 67.6 ttt180 -162.02 122.09 2.51 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 116.128 -0.487 . . . . 0.0 110.103 177.921 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' E' E ' 127' ' ' ASN . . . . . . . . . . . . . 3.7 t-20 56.02 -149.58 0.45 Allowed 'General case' 0 CA--C 1.54 0.591 0 N-CA-C 109.973 -0.38 . . . . 0.0 109.973 179.822 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' E' E ' 128' ' ' ASP . . . . . . . . . . . . . 14.2 p-10 -80.01 13.54 2.21 Favored 'General case' 0 CA--C 1.536 0.441 0 N-CA-C 112.879 0.696 . . . . 0.0 112.879 -179.792 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' E' E ' 129' ' ' LEU . . . . . . . . . . . . . 39.6 mt -110.82 138.58 47.03 Favored 'General case' 0 C--O 1.231 0.129 0 CA-C-N 118.143 0.429 . . . . 0.0 109.981 178.053 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' E' E ' 130' ' ' VAL . . . . . 0.556 HG21 HD13 ' E' ' 104' ' ' ILE . 30.6 m -132.63 140.76 46.78 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.185 0 CA-C-O 120.957 0.408 . . . . 0.0 110.377 178.478 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' E' E ' 131' ' ' VAL . . . . . 0.537 HG22 HD12 ' E' ' 140' ' ' LEU . 39.7 t -136.06 139.31 46.02 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.256 0 CA-C-O 121.166 0.507 . . . . 0.0 110.392 -178.419 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' E' E ' 132' ' ' ILE . . . . . . . . . . . . . 68.1 mt -116.63 130.95 70.62 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.325 0 CA-C-N 115.552 -0.749 . . . . 0.0 109.379 179.932 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' E' E ' 133' ' ' ILE . . . . . . . . . . . . . 41.8 mm -114.47 119.12 60.59 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.214 0 CA-C-O 121.026 0.441 . . . . 0.0 110.797 -176.07 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' E' E ' 134' ' ' ASP . . . . . . . . . . . . . 7.0 p-10 -128.18 147.44 50.57 Favored 'General case' 0 C--N 1.33 -0.259 0 N-CA-C 109.649 -0.5 . . . . 0.0 109.649 175.684 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' E' E ' 135' ' ' GLU . . . . . . . . . . . . . 85.6 tt0 -49.81 -24.21 2.28 Favored 'General case' 0 C--N 1.327 -0.371 0 N-CA-C 112.971 0.73 . . . . 0.0 112.971 -171.084 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' E' E ' 136' ' ' GLN . . . . . . . . . . . . . 63.0 tt0 -100.03 -31.16 11.58 Favored 'General case' 0 CA--C 1.529 0.165 0 N-CA-C 112.145 0.424 . . . . 0.0 112.145 -175.318 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' E' E ' 137' ' ' LYS . . . . . . . . . . . . . 74.5 mttt -142.23 155.52 45.26 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-O 121.384 0.612 . . . . 0.0 111.818 -169.66 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' E' E ' 138' ' ' LEU . . . . . 0.407 ' C ' HD23 ' E' ' 138' ' ' LEU . 4.4 tt -116.47 120.98 40.51 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 115.323 -0.853 . . . . 0.0 109.054 171.772 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' E' E ' 139' ' ' THR . . . . . . . . . . . . . 26.3 m -108.39 126.39 52.82 Favored 'General case' 0 C--N 1.331 -0.204 0 CA-C-N 116.381 -0.372 . . . . 0.0 110.974 -176.764 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' E' E ' 140' ' ' LEU . . . . . 0.537 HD12 HG22 ' E' ' 131' ' ' VAL . 15.4 tp -112.34 122.43 47.71 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 115.486 -0.779 . . . . 0.0 109.418 -179.618 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' E' E ' 141' ' ' ILE . . . . . 0.523 ' HB ' HG23 ' E' ' 130' ' ' VAL . 19.2 mt -123.14 121.36 62.83 Favored 'Isoleucine or valine' 0 C--O 1.234 0.259 0 N-CA-C 109.778 -0.452 . . . . 0.0 109.778 -177.339 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' E' E ' 142' ' ' ARG . . . . . . . . . . . . . 29.2 ttp180 -118.68 127.06 53.22 Favored 'General case' 0 C--N 1.331 -0.22 0 CA-C-N 115.437 -0.801 . . . . 0.0 110.276 -177.7 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' E' E ' 143' ' ' THR . . . . . . . . . . . . . 72.9 p . . . . . 0 C--O 1.221 -0.432 0 CA-C-O 118.108 -0.948 . . . . 0.0 110.677 -179.265 . . . . . . . . 0 0 . 1 . 009 nuclear nobuild full ' F' F ' -3' ' ' GLU . . . . . . . . . . . . . 95.8 mt-10 . . . . . 0 N--CA 1.49 1.567 0 N-CA-C 109.291 -0.633 . . . . 0.0 109.291 . . . . . . . . . 0 0 . 1 . 009 nuclear nobuild full ' F' F ' -2' ' ' GLY . . . . . . . . . . . . . . . -66.72 149.09 51.13 Favored Glycine 0 CA--C 1.525 0.705 0 N-CA-C 111.221 -0.751 . . . . 0.0 111.221 -179.096 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' F' F ' -1' ' ' VAL . . . . . . . . . . . . . 44.5 t -96.3 134.79 32.58 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.367 0 N-CA-C 110.123 -0.325 . . . . 0.0 110.123 179.616 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' F' F ' 0' ' ' ILE . . . . . . . . . . . . . 69.1 mt -116.59 137.96 48.72 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.251 0 CA-C-N 116.29 -0.413 . . . . 0.0 110.095 -179.576 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' F' F ' 1' ' ' MET . . . . . . . . . . . . . 26.2 ptt? -89.35 134.06 34.23 Favored 'General case' 0 C--N 1.331 -0.211 0 CA-C-N 116.151 -0.477 . . . . 0.0 110.7 179.768 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' F' F ' 2' ' ' SER . . . . . 0.566 ' HB2' HD11 ' F' ' 58' ' ' LEU . 9.1 p -126.83 147.62 50.01 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-N 116.261 -0.427 . . . . 0.0 110.684 179.985 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' F' F ' 3' ' ' GLU . . . . . . . . . . . . . 81.9 tt0 -140.78 140.13 34.71 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.068 -0.515 . . . . 0.0 111.132 -178.424 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' F' F ' 4' ' ' LEU . . . . . . . . . . . . . 18.1 tp -122.1 131.11 53.8 Favored 'General case' 0 C--N 1.332 -0.185 0 CA-C-N 115.971 -0.559 . . . . 0.0 109.907 176.418 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' F' F ' 5' ' ' LYS . . . . . . . . . . . . . 64.1 mttp -109.72 121.14 44.54 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.238 -0.437 . . . . 0.0 110.576 -179.041 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' F' F ' 6' ' ' LEU . . . . . . . . . . . . . 63.0 mt -114.0 149.33 35.51 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 115.467 -0.788 . . . . 0.0 110.811 -177.878 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' F' F ' 7' ' ' LYS . . . . . . . . . . . . . 29.6 ttpt -135.0 134.87 22.07 Favored Pre-proline 0 CA--C 1.534 0.357 0 CA-C-O 118.929 -0.558 . . . . 0.0 109.728 176.72 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' F' F ' 8' ' ' PRO . . . . . . . . . . . . . 97.1 Cg_endo -91.05 131.2 1.46 Allowed 'Trans proline' 0 N--CA 1.49 1.265 0 C-N-CA 121.73 1.62 . . . . 0.0 111.396 175.331 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' F' F ' 9' ' ' LEU . . . . . . . . . . . . . 27.9 mt -68.63 -46.84 35.11 Favored Pre-proline 0 CA--C 1.532 0.28 0 CA-C-O 118.791 -0.623 . . . . 0.0 111.509 -177.067 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' F' F ' 10' ' ' PRO . . . . . . . . . . . . . 98.4 Cg_endo -80.71 140.96 13.37 Favored 'Trans proline' 0 N--CA 1.496 1.643 0 C-N-CA 121.012 1.141 . . . . 0.0 111.25 171.542 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' F' F ' 11' ' ' LYS . . . . . . . . . . . . . 54.0 tttp -84.82 106.47 16.38 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-O 120.86 0.362 . . . . 0.0 110.586 -179.433 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' F' F ' 12' ' ' VAL . . . . . . . . . . . . . 12.2 p -142.98 148.72 19.23 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.344 0 CA-C-N 116.101 -0.5 . . . . 0.0 110.497 -179.758 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' F' F ' 13' ' ' GLU . . . . . . . . . . . . . 43.8 tp10 -82.18 117.07 22.04 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.211 -0.449 . . . . 0.0 109.984 177.74 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' F' F ' 14' ' ' LEU . . . . . . . . . . . . . 32.3 mt -89.61 149.79 43.0 Favored Pre-proline 0 C--N 1.33 -0.263 0 CA-C-O 119.326 -0.369 . . . . 0.0 110.618 -177.62 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' F' F ' 15' ' ' PRO . . . . . . . . . . . . . 26.0 Cg_exo -61.67 159.12 33.94 Favored 'Trans proline' 0 N--CA 1.496 1.631 0 C-N-CA 121.186 1.257 . . . . 0.0 111.627 176.756 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' F' F ' 16' ' ' PRO . . . . . . . . . . . . . 38.5 Cg_exo -58.52 -36.17 97.73 Favored 'Trans proline' 0 N--CA 1.497 1.712 0 C-N-CA 121.386 1.391 . . . . 0.0 112.931 -177.499 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' F' F ' 17' ' ' ASP . . . . . . . . . . . . . 7.2 p-10 -90.77 8.42 34.76 Favored 'General case' 0 CA--C 1.535 0.372 0 N-CA-C 113.393 0.886 . . . . 0.0 113.393 -176.867 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' F' F ' 18' ' ' PHE . . . . . . . . . . . . . 34.9 t80 -58.42 -45.45 88.42 Favored 'General case' 0 C--O 1.231 0.102 0 O-C-N 121.983 -0.448 . . . . 0.0 110.018 -178.187 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' F' F ' 19' ' ' VAL . . . . . 0.4 HG13 ' N ' ' F' ' 20' ' ' ASP . 13.2 p -57.22 -40.66 75.04 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.372 0 CA-C-N 116.156 -0.475 . . . . 0.0 110.571 179.939 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' F' F ' 20' ' ' ASP . . . . . 0.4 ' N ' HG13 ' F' ' 19' ' ' VAL . 65.8 m-20 -60.02 -43.12 95.48 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-O 120.798 0.333 . . . . 0.0 110.84 -178.013 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' F' F ' 21' ' ' VAL . . . . . . . . . . . . . 46.6 t -64.06 -47.33 90.76 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.284 0 CA-C-N 116.398 -0.365 . . . . 0.0 110.377 -178.183 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' F' F ' 22' ' ' ILE . . . . . 0.446 HG22 HD12 ' F' ' 26' ' ' LEU . 49.9 mm -57.73 -39.24 69.43 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.353 0 CA-C-O 120.793 0.33 . . . . 0.0 110.896 -179.941 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' F' F ' 23' ' ' ARG . . . . . . . . . . . . . 54.6 ttp180 -57.13 -50.55 72.45 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-O 120.904 0.383 . . . . 0.0 110.562 177.243 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' F' F ' 24' ' ' ILE . . . . . . . . . . . . . 72.8 mt -61.0 -40.1 84.44 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.287 0 CA-C-N 115.986 -0.552 . . . . 0.0 111.968 -176.979 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' F' F ' 25' ' ' LYS . . . . . . . . . . . . . 13.8 pttp -75.48 -35.18 60.9 Favored 'General case' 0 CA--C 1.534 0.348 0 C-N-CA 120.671 -0.412 . . . . 0.0 112.046 -174.03 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' F' F ' 26' ' ' LEU . . . . . 0.446 HD12 HG22 ' F' ' 22' ' ' ILE . 34.3 mt -80.32 -41.42 24.89 Favored 'General case' 0 C--N 1.33 -0.256 0 N-CA-C 112.841 0.682 . . . . 0.0 112.841 -174.762 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' F' F ' 27' ' ' GLN . . . . . . . . . . . . . 9.0 pt20 -46.3 139.63 4.63 Favored 'General case' 0 N--CA 1.467 0.392 0 N-CA-C 113.006 0.743 . . . . 0.0 113.006 -174.551 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' F' F ' 28' ' ' GLY . . . . . . . . . . . . . . . 99.61 -25.85 26.66 Favored Glycine 0 CA--C 1.534 1.243 0 CA-C-N 115.539 -0.755 . . . . 0.0 112.199 -175.362 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' F' F ' 29' ' ' LYS . . . . . . . . . . . . . 25.7 mtpp -98.43 155.18 17.37 Favored 'General case' 0 C--N 1.333 -0.146 0 CA-C-N 117.18 0.49 . . . . 0.0 111.167 179.648 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' F' F ' 30' ' ' THR . . . . . . . . . . . . . 29.8 m -101.17 137.73 39.14 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.036 -0.529 . . . . 0.0 109.96 175.657 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' F' F ' 31' ' ' VAL . . . . . . . . . . . . . 35.3 m -129.26 154.24 39.82 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.254 0 CA-C-O 120.94 0.4 . . . . 0.0 110.742 -179.754 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' F' F ' 32' ' ' ARG . . . . . . . . . . . . . 80.8 mtm180 -132.53 148.29 52.38 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 115.849 -0.614 . . . . 0.0 110.335 178.395 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' F' F ' 33' ' ' THR . . . . . . . . . . . . . 25.3 m -52.79 138.01 30.33 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.344 -0.389 . . . . 0.0 111.418 -178.688 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' F' F ' 34' ' ' GLY . . . . . . . . . . . . . . . 101.64 -17.14 55.56 Favored Glycine 0 CA--C 1.532 1.155 0 CA-C-O 119.697 -0.501 . . . . 0.0 113.28 179.369 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' F' F ' 35' ' ' ASP . . . . . . . . . . . . . 73.3 m-20 -65.84 149.17 50.61 Favored 'General case' 0 C--O 1.232 0.136 0 CA-C-N 117.981 0.89 . . . . 0.0 110.952 179.23 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' F' F ' 36' ' ' VAL . . . . . . . . . . . . . 45.8 t -126.0 131.61 71.54 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.289 0 CA-C-N 116.049 -0.523 . . . . 0.0 109.854 178.302 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' F' F ' 37' ' ' ILE . . . . . . . . . . . . . 65.2 mt -121.06 139.15 49.18 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.233 0 CA-C-N 116.162 -0.472 . . . . 0.0 109.891 -178.995 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' F' F ' 38' ' ' GLY . . . . . . . . . . . . . . . -110.36 128.8 9.0 Favored Glycine 0 CA--C 1.525 0.662 0 N-CA-C 111.059 -0.816 . . . . 0.0 111.059 179.916 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' F' F ' 39' ' ' ILE . . . . . . . . . . . . . 73.7 mt -123.9 133.68 68.59 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.185 0 N-CA-C 110.049 -0.352 . . . . 0.0 110.049 179.347 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' F' F ' 40' ' ' SER . . . . . . . . . . . . . 99.8 p -93.23 123.66 36.66 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.398 -0.364 . . . . 0.0 111.0 176.298 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' F' F ' 41' ' ' ILE . . . . . . . . . . . . . 70.9 mt -131.21 120.69 47.28 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.209 0 CA-C-O 120.918 0.39 . . . . 0.0 110.345 177.869 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' F' F ' 42' ' ' LEU . . . . . . . . . . . . . 48.9 mt 52.76 35.45 18.64 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.011 -0.54 . . . . 0.0 111.699 177.166 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' F' F ' 43' ' ' GLY . . . . . . . . . . . . . . . 72.31 31.48 63.55 Favored Glycine 0 CA--C 1.53 1.027 0 C-N-CA 121.139 -0.553 . . . . 0.0 112.142 178.064 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' F' F ' 44' ' ' LYS . . . . . . . . . . . . . 58.8 mtpt -135.91 131.49 35.28 Favored 'General case' 0 C--N 1.33 -0.278 0 N-CA-C 109.714 -0.476 . . . . 0.0 109.714 177.783 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' F' F ' 45' ' ' GLU . . . . . . . . . . . . . 83.8 tt0 -83.6 119.39 24.68 Favored 'General case' 0 C--N 1.328 -0.343 0 C-N-CA 120.844 -0.342 . . . . 0.0 111.219 -178.631 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' F' F ' 46' ' ' VAL . . . . . . . . . . . . . 7.7 p -118.66 122.75 70.21 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.198 0 N-CA-C 109.195 -0.669 . . . . 0.0 109.195 174.824 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' F' F ' 47' ' ' LYS . . . . . . . . . . . . . 55.5 mtmt -100.22 128.64 46.25 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 115.999 -0.546 . . . . 0.0 111.303 -179.815 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' F' F ' 48' ' ' PHE . . . . . . . . . . . . . 93.6 m-85 -110.55 131.92 54.64 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-N 116.099 -0.501 . . . . 0.0 109.872 177.529 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' F' F ' 49' ' ' LYS . . . . . . . . . . . . . 84.3 tttt -107.77 137.09 46.4 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.281 -0.418 . . . . 0.0 110.683 179.339 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' F' F ' 50' ' ' VAL . . . . . . . . . . . . . 43.5 t -82.32 106.29 13.07 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.24 0 N-CA-C 109.279 -0.637 . . . . 0.0 109.279 175.389 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' F' F ' 51' ' ' VAL . . . . . . . . . . . . . 47.7 t -71.06 -52.58 26.32 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.373 0 N-CA-C 109.707 -0.479 . . . . 0.0 109.707 -174.475 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' F' F ' 52' ' ' GLN . . . . . . . . . . . . . 88.5 mt-30 -154.81 153.67 31.56 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-O 121.206 0.527 . . . . 0.0 111.748 -176.64 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' F' F ' 53' ' ' ALA . . . . . . . . . . . . . . . -132.17 133.01 43.72 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 115.333 -0.849 . . . . 0.0 109.526 174.42 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' F' F ' 54' ' ' TYR . . . . . . . . . . . . . 17.2 t80 -129.13 111.47 18.29 Favored Pre-proline 0 CA--C 1.535 0.385 0 CA-C-O 118.16 -0.924 . . . . 0.0 110.204 179.088 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' F' F ' 55' ' ' PRO . . . . . . . . . . . . . 73.9 Cg_endo -77.14 168.88 75.76 Favored 'Cis proline' 0 N--CA 1.5 1.876 0 CA-C-N 121.872 1.704 . . . . 0.0 112.321 -6.644 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' F' F ' 56' ' ' SER . . . . . . . . . . . . . 13.4 m -117.32 135.04 23.05 Favored Pre-proline 0 CA--C 1.539 0.531 0 CA-C-O 118.477 -0.773 . . . . 0.0 109.627 175.243 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' F' F ' 57' ' ' PRO . . . . . . . . . . . . . 35.4 Cg_endo -66.38 164.68 65.91 Favored 'Cis proline' 0 N--CA 1.498 1.774 0 CA-C-N 121.809 1.682 . . . . 0.0 111.338 -3.225 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' F' F ' 58' ' ' LEU . . . . . 0.566 HD11 ' HB2' ' F' ' 2' ' ' SER . 16.4 tp -130.77 139.08 50.21 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-O 120.996 0.427 . . . . 0.0 110.38 179.738 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' F' F ' 59' ' ' ARG . . . . . . . . . . . . . 60.3 ttm-85 -104.48 127.93 52.29 Favored 'General case' 0 C--N 1.327 -0.397 0 N-CA-C 109.152 -0.685 . . . . 0.0 109.152 174.986 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' F' F ' 60' ' ' VAL . . . . . . . . . . . . . 41.6 t -81.0 119.38 30.55 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.271 0 C-N-CA 120.732 -0.387 . . . . 0.0 110.604 -174.941 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' F' F ' 61' ' ' GLU . . . . . . . . . . . . . 95.5 mt-10 -131.05 163.07 28.43 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 115.853 -0.612 . . . . 0.0 109.689 175.301 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' F' F ' 62' ' ' ASP . . . . . . . . . . . . . 41.2 m-20 -52.51 -31.64 36.35 Favored 'General case' 0 C--N 1.328 -0.354 0 N-CA-C 112.045 0.387 . . . . 0.0 112.045 -178.942 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' F' F ' 63' ' ' ARG . . . . . . . . . . . . . 79.3 mtt85 -72.94 -22.03 60.79 Favored 'General case' 0 CA--C 1.533 0.324 0 N-CA-C 112.896 0.702 . . . . 0.0 112.896 -176.205 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' F' F ' 64' ' ' THR . . . . . . . . . . . . . 20.3 m -72.54 141.48 48.47 Favored 'General case' 0 C--N 1.331 -0.206 0 CA-C-O 120.833 0.349 . . . . 0.0 110.999 -175.755 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' F' F ' 65' ' ' LYS . . . . . . . . . . . . . 67.1 mttm -90.01 137.09 32.63 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.009 -0.541 . . . . 0.0 110.49 179.578 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' F' F ' 66' ' ' ILE . . . . . . . . . . . . . 60.4 mt -119.33 130.03 74.5 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.268 0 N-CA-C 109.68 -0.489 . . . . 0.0 109.68 177.856 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' F' F ' 67' ' ' THR . . . . . . . . . . . . . 31.9 m -125.97 145.33 50.33 Favored 'General case' 0 C--N 1.331 -0.21 0 CA-C-O 121.089 0.471 . . . . 0.0 111.37 -176.81 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' F' F ' 68' ' ' LEU . . . . . 0.462 HD23 ' N ' ' F' ' 69' ' ' VAL . 4.8 tt -100.56 124.7 46.48 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 115.721 -0.672 . . . . 0.0 109.786 176.553 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' F' F ' 69' ' ' VAL . . . . . 0.462 ' N ' HD23 ' F' ' 68' ' ' LEU . 41.2 t -96.68 142.43 14.0 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.298 0 CA-C-O 120.929 0.395 . . . . 0.0 111.0 -175.804 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' F' F ' 70' ' ' THR . . . . . . . . . . . . . 27.7 m -85.2 146.05 27.28 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 115.976 -0.556 . . . . 0.0 109.792 176.985 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' F' F ' 71' ' ' HIS . . . . . . . . . . . . . 10.6 m-70 -149.91 175.86 2.58 Favored Pre-proline 0 C--N 1.328 -0.337 0 C-N-CA 120.846 -0.342 . . . . 0.0 111.233 -174.046 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' F' F ' 72' ' ' PRO . . . . . . . . . . . . . 24.2 Cg_exo -64.93 160.28 42.02 Favored 'Trans proline' 0 N--CA 1.495 1.61 0 C-N-CA 121.695 1.597 . . . . 0.0 111.474 176.56 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' F' F ' 73' ' ' VAL . . . . . . . . . . . . . 34.9 m -69.6 -178.31 0.23 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.276 0 CA-C-N 116.368 -0.378 . . . . 0.0 110.305 -172.054 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' F' F ' 74' ' ' ASP . . . . . . . . . . . . . 47.4 t0 -84.98 114.92 22.51 Favored 'General case' 0 C--N 1.33 -0.264 0 C-N-CA 120.524 -0.47 . . . . 0.0 110.381 -171.112 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' F' F ' 75' ' ' VAL . . . . . . . . . . . . . 46.5 t -118.16 117.89 56.28 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.27 0 CA-C-O 121.178 0.513 . . . . 0.0 109.74 178.643 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' F' F ' 76' ' ' LEU . . . . . . . . . . . . . 13.9 mt -120.86 142.44 49.66 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 115.453 -0.794 . . . . 0.0 109.216 179.385 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' F' F ' 77' ' ' GLU . . . . . . . . . . . . . 97.7 mt-10 -135.49 130.05 34.08 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-O 121.225 0.536 . . . . 0.0 111.343 -176.713 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' F' F ' 78' ' ' ALA . . . . . . . . . . . . . . . -118.7 134.46 55.11 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-N 115.47 -0.786 . . . . 0.0 109.649 176.373 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' F' F ' 79' ' ' LYS . . . . . 0.512 ' O ' HD13 ' F' ' 80' ' ' ILE . 39.7 mtmt -83.81 115.44 22.24 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-O 120.958 0.408 . . . . 0.0 110.751 -178.784 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' F' F ' 80' ' ' ILE . . . . . 0.512 HD13 ' O ' ' F' ' 79' ' ' LYS . 24.0 mm -139.19 114.73 8.74 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.323 0 CA-C-N 115.722 -0.672 . . . . 0.0 109.266 -177.93 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' F' F ' 81' ' ' LYS . . . . . . . . . . . . . 75.6 mttt -101.65 126.49 48.5 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-O 120.802 0.334 . . . . 0.0 111.029 -178.086 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' F' F ' 82' ' ' GLY . . . . . . . . . . . . . . . 89.04 42.14 5.7 Favored Glycine 0 CA--C 1.525 0.718 0 C-N-CA 120.905 -0.665 . . . . 0.0 111.933 175.423 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' F' F ' 83' ' ' ILE . . . . . . . . . . . . . 74.1 mt -66.69 138.41 22.98 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 N-CA-C 109.634 -0.506 . . . . 0.0 109.634 176.461 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' F' F ' 84' ' ' LYS . . . . . . . . . . . . . 53.8 tttp -99.34 -51.85 3.68 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.597 -176.729 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' F' F ' 85' ' ' ASP . . . . . . . . . . . . . 7.3 t70 -154.7 154.81 33.49 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.024 -0.534 . . . . 0.0 110.633 -179.807 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' F' F ' 86' ' ' VAL . . . . . . . . . . . . . 41.4 t -130.68 132.6 64.2 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.258 0 CA-C-O 121.032 0.444 . . . . 0.0 110.535 -179.516 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' F' F ' 87' ' ' ILE . . . . . . . . . . . . . 45.1 mm -120.76 128.37 76.04 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.229 0 CA-C-N 115.72 -0.673 . . . . 0.0 109.582 177.738 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' F' F ' 88' ' ' LEU . . . . . . . . . . . . . 37.4 mt -109.39 138.72 45.33 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-O 121.159 0.504 . . . . 0.0 111.312 -178.389 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' F' F ' 89' ' ' ASP . . . . . . . . . . . . . 11.7 t70 -130.07 154.89 47.0 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 115.485 -0.78 . . . . 0.0 109.197 175.319 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' F' F ' 90' ' ' GLU . . . . . . . . . . . . . 84.8 tt0 -46.12 -39.1 8.98 Favored 'General case' 0 N--CA 1.465 0.276 0 N-CA-C 113.175 0.806 . . . . 0.0 113.175 -172.315 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' F' F ' 91' ' ' ASN . . . . . . . . . . . . . 14.5 p30 -132.09 25.03 4.58 Favored 'General case' 0 N--CA 1.467 0.393 0 N-CA-C 112.71 0.633 . . . . 0.0 112.71 -178.391 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' F' F ' 92' ' ' LEU . . . . . . . . . . . . . 13.6 mt -150.38 147.22 27.32 Favored 'General case' 0 C--N 1.331 -0.218 0 N-CA-C 109.963 -0.384 . . . . 0.0 109.963 -177.398 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' F' F ' 93' ' ' ILE . . . . . . . . . . . . . 71.3 mt -126.98 117.79 48.66 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.269 0 N-CA-C 109.294 -0.632 . . . . 0.0 109.294 178.705 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' F' F ' 94' ' ' VAL . . . . . . . . . . . . . 44.3 t -118.09 127.98 75.22 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.217 0 N-CA-C 109.955 -0.387 . . . . 0.0 109.955 -178.584 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' F' F ' 95' ' ' VAL . . . . . . . . . . . . . 42.7 t -124.31 134.35 66.9 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.293 0 CA-C-N 116.18 -0.463 . . . . 0.0 109.992 -179.409 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' F' F ' 96' ' ' ILE . . . . . . . . . . . . . 57.5 mt -113.27 129.9 68.18 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.284 0 N-CA-C 109.423 -0.584 . . . . 0.0 109.423 178.722 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' F' F ' 97' ' ' THR . . . . . . . . . . . . . 59.7 p -102.1 156.92 17.24 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-O 120.946 0.403 . . . . 0.0 110.782 179.958 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' F' F ' 98' ' ' GLU . . . . . . . . . . . . . 97.8 mt-10 -53.95 -24.42 16.45 Favored 'General case' 0 CA--C 1.533 0.304 0 N-CA-C 112.344 0.498 . . . . 0.0 112.344 179.854 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' F' F ' 99' ' ' GLU . . . . . . . . . . . . . 97.1 mt-10 -75.49 9.07 2.38 Favored 'General case' 0 CA--C 1.536 0.435 0 N-CA-C 113.402 0.889 . . . . 0.0 113.402 -178.22 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' F' F ' 100' ' ' ASN . . . . . . . . . . . . . 4.2 m-20 63.07 33.94 14.2 Favored 'General case' 0 CA--C 1.532 0.263 0 CA-C-N 118.131 0.423 . . . . 0.0 111.332 -178.512 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' F' F ' 101' ' ' GLU . . . . . . . . . . . . . 84.0 tt0 -110.1 142.29 41.77 Favored 'General case' 0 C--N 1.333 -0.146 0 N-CA-C 109.475 -0.565 . . . . 0.0 109.475 172.39 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' F' F ' 102' ' ' VAL . . . . . . . . . . . . . 45.6 t -114.9 124.57 71.68 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.319 0 CA-C-N 116.226 -0.443 . . . . 0.0 109.814 -179.242 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' F' F ' 103' ' ' LEU . . . . . . . . . . . . . 26.1 mt -112.27 132.55 54.89 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 115.508 -0.769 . . . . 0.0 109.798 177.245 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' F' F ' 104' ' ' ILE . . . . . . . . . . . . . 69.9 mt -123.02 117.8 52.84 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.286 0 N-CA-C 109.983 -0.377 . . . . 0.0 109.983 -178.84 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' F' F ' 105' ' ' PHE . . . . . . . . . . . . . 20.8 m-85 -120.3 165.68 14.53 Favored 'General case' 0 C--N 1.331 -0.221 0 CA-C-N 115.568 -0.742 . . . . 0.0 109.892 179.838 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' F' F ' 106' ' ' ASN . . . . . . . . . . . . . 45.8 p-10 -98.67 -169.96 1.87 Allowed 'General case' 0 C--N 1.329 -0.288 0 N-CA-C 109.702 -0.481 . . . . 0.0 109.702 173.993 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' F' F ' 107' ' ' GLN . . . . . . . . . . . . . 45.4 tt0 -58.85 -28.09 65.75 Favored 'General case' 0 C--N 1.327 -0.379 0 N-CA-C 112.168 0.433 . . . . 0.0 112.168 179.272 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' F' F ' 108' ' ' ASN . . . . . . . . . . . . . 14.1 t30 -86.22 10.24 15.23 Favored 'General case' 0 CA--C 1.535 0.377 0 N-CA-C 113.136 0.791 . . . . 0.0 113.136 -177.72 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' F' F ' 109' ' ' LEU . . . . . . . . . . . . . 9.9 tp 59.7 35.89 22.34 Favored 'General case' 0 C--O 1.233 0.187 0 O-C-N 122.106 -0.371 . . . . 0.0 111.426 178.612 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' F' F ' 110' ' ' GLU . . . . . . . . . . . . . 70.9 mm-40 -106.79 149.9 26.88 Favored 'General case' 0 C--N 1.33 -0.275 0 N-CA-C 110.207 -0.294 . . . . 0.0 110.207 177.168 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' F' F ' 111' ' ' GLU . . . . . . . . . . . . . 98.5 mt-10 -77.85 122.11 25.01 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.264 -0.426 . . . . 0.0 111.389 -176.944 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' F' F ' 112' ' ' LEU . . . . . . . . . . . . . 17.8 mt -107.45 -44.71 4.24 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 115.928 -0.578 . . . . 0.0 109.954 176.21 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' F' F ' 113' ' ' TYR . . . . . . . . . . . . . 42.1 t80 -141.59 137.44 31.91 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.054 -0.521 . . . . 0.0 110.987 -179.3 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' F' F ' 114' ' ' ARG . . . . . . . . . . . . . 23.9 ttm180 -138.13 125.76 22.19 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.109 -0.496 . . . . 0.0 109.869 175.823 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' F' F ' 115' ' ' GLY . . . . . . . . . . . . . . . -150.12 142.07 9.36 Favored Glycine 0 CA--C 1.524 0.597 0 N-CA-C 110.756 -0.938 . . . . 0.0 110.756 178.454 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' F' F ' 116' ' ' LYS . . . . . . . . . . . . . 84.8 tttt -118.76 128.06 54.13 Favored 'General case' 0 C--N 1.33 -0.25 0 N-CA-C 109.693 -0.484 . . . . 0.0 109.693 177.754 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' F' F ' 117' ' ' PHE . . . . . . . . . . . . . 22.7 m-85 -129.57 117.48 20.49 Favored 'General case' 0 C--N 1.332 -0.166 0 CA-C-O 120.921 0.391 . . . . 0.0 110.32 -172.954 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' F' F ' 118' ' ' GLU . . . . . . . . . . . . . 43.4 mt-10 -52.35 -49.27 64.66 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.349 -0.387 . . . . 0.0 111.765 -176.242 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' F' F ' 119' ' ' ASN . . . . . . . . . . . . . 90.3 m-20 -97.32 31.06 2.6 Favored 'General case' 0 C--N 1.33 -0.24 0 N-CA-C 112.164 0.431 . . . . 0.0 112.164 -174.293 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' F' F ' 120' ' ' LEU . . . . . . . . . . . . . 12.5 tp -56.33 124.32 17.64 Favored 'General case' 0 C--N 1.331 -0.21 0 CA-C-O 120.588 0.233 . . . . 0.0 110.604 178.273 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' F' F ' 121' ' ' ASN . . . . . . . . . . . . . 31.4 m120 -114.08 -44.04 3.18 Favored 'General case' 0 C--N 1.331 -0.198 0 CA-C-N 116.524 -0.307 . . . . 0.0 111.149 -177.327 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' F' F ' 122' ' ' LYS . . . . . . . . . . . . . 98.6 mttt -144.35 148.79 35.18 Favored 'General case' 0 C--N 1.332 -0.194 0 CA-C-O 121.198 0.523 . . . . 0.0 112.028 -175.921 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' F' F ' 123' ' ' VAL . . . . . . . . . . . . . 45.6 t -127.42 124.5 63.92 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.239 0 CA-C-N 115.624 -0.716 . . . . 0.0 109.078 172.711 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' F' F ' 124' ' ' LEU . . . . . . . . . . . . . 57.9 mt -118.93 138.8 52.53 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-O 120.837 0.351 . . . . 0.0 111.078 -175.567 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' F' F ' 125' ' ' VAL . . . . . . . . . . . . . 34.3 m -130.34 129.58 64.99 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.273 0 CA-C-N 115.961 -0.563 . . . . 0.0 110.284 177.888 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' F' F ' 126' ' ' ARG . . . . . . . . . . . . . 31.1 mmt180 -135.9 108.11 7.26 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.224 -0.444 . . . . 0.0 110.29 179.074 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' F' F ' 127' ' ' ASN . . . . . . . . . . . . . 42.1 m-80 54.26 -104.81 0.23 Allowed 'General case' 0 CA--C 1.541 0.628 0 CA-C-O 119.163 -0.446 . . . . 0.0 110.934 179.403 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' F' F ' 128' ' ' ASP . . . . . . . . . . . . . 7.5 p-10 -111.41 1.6 17.1 Favored 'General case' 0 N--CA 1.468 0.437 0 CA-C-N 119.45 1.023 . . . . 0.0 113.447 -176.053 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' F' F ' 129' ' ' LEU . . . . . . . . . . . . . 38.2 mt -104.97 141.82 35.88 Favored 'General case' 0 C--O 1.231 0.131 0 CA-C-N 118.195 0.452 . . . . 0.0 110.257 178.915 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' F' F ' 130' ' ' VAL . . . . . . . . . . . . . 44.0 t -123.37 137.08 57.9 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.224 0 CA-C-N 116.268 -0.424 . . . . 0.0 109.916 -179.275 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' F' F ' 131' ' ' VAL . . . . . . . . . . . . . 42.7 t -135.69 136.44 50.35 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.29 0 CA-C-O 121.041 0.448 . . . . 0.0 110.408 179.326 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' F' F ' 132' ' ' ILE . . . . . . . . . . . . . 67.7 mt -117.71 130.2 72.96 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.232 0 CA-C-N 115.74 -0.664 . . . . 0.0 109.286 179.567 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' F' F ' 133' ' ' ILE . . . . . . . . . . . . . 41.9 mm -118.06 120.02 63.22 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.227 0 CA-C-O 120.831 0.348 . . . . 0.0 111.221 -174.329 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' F' F ' 134' ' ' ASP . . . . . . . . . . . . . 7.1 p-10 -131.58 145.59 51.78 Favored 'General case' 0 C--N 1.332 -0.173 0 N-CA-C 109.422 -0.584 . . . . 0.0 109.422 173.403 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' F' F ' 135' ' ' GLU . . . . . . . . . . . . . 73.6 tt0 -49.92 -22.97 1.71 Allowed 'General case' 0 C--N 1.329 -0.322 0 N-CA-C 113.286 0.847 . . . . 0.0 113.286 -170.615 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' F' F ' 136' ' ' GLN . . . . . . . . . . . . . 57.1 tp60 -99.04 -34.08 10.55 Favored 'General case' 0 C--N 1.331 -0.225 0 N-CA-C 111.94 0.348 . . . . 0.0 111.94 -176.135 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' F' F ' 137' ' ' LYS . . . . . . . . . . . . . 57.5 mtpt -138.77 151.84 47.43 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-O 121.13 0.491 . . . . 0.0 111.128 -169.612 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' F' F ' 138' ' ' LEU . . . . . 0.441 HD23 ' C ' ' F' ' 138' ' ' LEU . 5.2 tt -119.29 122.76 42.63 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 115.809 -0.632 . . . . 0.0 109.437 174.445 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' F' F ' 139' ' ' THR . . . . . 0.413 ' N ' HD23 ' F' ' 138' ' ' LEU . 19.8 m -110.36 130.39 55.56 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-N 116.323 -0.399 . . . . 0.0 110.838 -177.27 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' F' F ' 140' ' ' LEU . . . . . 0.476 HD23 ' C ' ' F' ' 140' ' ' LEU . 8.9 tt -118.75 123.58 45.2 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 115.821 -0.627 . . . . 0.0 109.404 -179.232 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' F' F ' 141' ' ' ILE . . . . . . . . . . . . . 19.8 mt -120.47 120.72 63.56 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.309 0 CA-C-O 121.039 0.447 . . . . 0.0 109.887 -175.698 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' F' F ' 142' ' ' ARG . . . . . . . . . . . . . 68.9 ttt180 -110.69 130.77 55.48 Favored 'General case' 0 C--N 1.331 -0.22 0 CA-C-N 115.2 -0.909 . . . . 0.0 110.717 -175.494 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' F' F ' 143' ' ' THR . . . . . . . . . . . . . 41.2 p . . . . . 0 C--O 1.22 -0.475 0 CA-C-O 118.158 -0.925 . . . . 0.0 110.958 179.469 . . . . . . . . 0 0 . 1 . 010 nuclear nobuild full ' A' A ' -3' ' ' GLU . . . . . . . . . . . . . 95.6 mt-10 . . . . . 0 N--CA 1.491 1.588 0 N-CA-C 109.371 -0.603 . . . . 0.0 109.371 . . . . . . . . . 0 0 . 1 . 010 nuclear nobuild full ' A' A ' -2' ' ' GLY . . . . . . . . . . . . . . . -62.75 141.78 47.11 Favored Glycine 0 CA--C 1.524 0.654 0 N-CA-C 110.944 -0.862 . . . . 0.0 110.944 179.767 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' -1' ' ' VAL . . . . . . . . . . . . . 47.6 t -96.06 138.92 20.22 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.297 0 CA-C-O 120.853 0.358 . . . . 0.0 110.109 179.723 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 0' ' ' ILE . . . . . . . . . . . . . 66.8 mt -110.43 133.76 54.82 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.267 0 CA-C-N 116.146 -0.479 . . . . 0.0 110.056 179.941 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 24.8 ptp -85.35 143.29 28.74 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.29 -0.414 . . . . 0.0 110.538 179.662 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 10.5 p -121.96 135.28 54.85 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.196 -0.457 . . . . 0.0 110.588 179.265 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 95.7 mt-10 -141.06 136.8 32.37 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.111 -0.495 . . . . 0.0 110.746 179.836 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 4' ' ' LEU . . . . . 0.477 HD21 HD21 ' A' ' 6' ' ' LEU . 14.5 tp -125.42 132.05 52.81 Favored 'General case' 0 C--N 1.332 -0.176 0 CA-C-N 116.114 -0.494 . . . . 0.0 110.218 177.616 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 5' ' ' LYS . . . . . . . . . . . . . 97.9 mttt -110.26 120.88 43.87 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.145 -0.479 . . . . 0.0 110.403 179.342 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 6' ' ' LEU . . . . . 0.477 HD21 HD21 ' A' ' 4' ' ' LEU . 66.3 mt -117.44 145.81 43.89 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 115.535 -0.757 . . . . 0.0 110.157 -178.864 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 25.8 ttpp -135.69 139.78 31.86 Favored Pre-proline 0 CA--C 1.534 0.334 0 CA-C-O 119.087 -0.483 . . . . 0.0 110.156 176.929 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 8' ' ' PRO . . . . . . . . . . . . . 92.7 Cg_endo -91.84 141.12 2.49 Favored 'Trans proline' 0 N--CA 1.489 1.227 0 C-N-CA 121.806 1.67 . . . . 0.0 111.766 177.157 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 58.8 mt -75.8 -49.65 3.46 Favored Pre-proline 0 CA--C 1.533 0.324 0 CA-C-O 118.507 -0.759 . . . . 0.0 112.588 -178.588 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 74.2 Cg_endo -76.33 155.56 36.94 Favored 'Trans proline' 0 N--CA 1.498 1.751 0 C-N-CA 121.062 1.175 . . . . 0.0 112.171 -179.436 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 27.0 tptp -87.74 92.47 9.12 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.117 -0.492 . . . . 0.0 110.468 179.42 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 12.6 p -143.63 148.75 18.66 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.32 0 CA-C-O 120.889 0.376 . . . . 0.0 110.837 -179.181 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 42.4 mp0 -87.68 129.6 35.09 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.1 -0.5 . . . . 0.0 110.332 178.47 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 14' ' ' LEU . . . . . . . . . . . . . 34.5 mt -99.24 151.66 37.49 Favored Pre-proline 0 C--N 1.33 -0.281 0 CA-C-N 116.41 -0.359 . . . . 0.0 110.813 -179.38 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 15' ' ' PRO . . . . . . . . . . . . . 27.4 Cg_exo -61.24 155.67 50.13 Favored 'Trans proline' 0 N--CA 1.497 1.717 0 C-N-CA 121.348 1.365 . . . . 0.0 111.624 177.051 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 16' ' ' PRO . . . . . . . . . . . . . 39.4 Cg_exo -58.58 -38.0 91.71 Favored 'Trans proline' 0 N--CA 1.498 1.74 0 C-N-CA 121.347 1.365 . . . . 0.0 112.798 -178.398 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 17' ' ' ASP . . . . . . . . . . . . . 12.3 p-10 -87.12 10.56 16.33 Favored 'General case' 0 CA--C 1.535 0.402 0 N-CA-C 113.231 0.826 . . . . 0.0 113.231 -177.476 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 18' ' ' PHE . . . . . . . . . . . . . 44.1 t80 -57.76 -43.14 85.26 Favored 'General case' 0 C--N 1.334 -0.085 0 O-C-N 121.942 -0.474 . . . . 0.0 110.229 -178.327 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 19' ' ' VAL . . . . . . . . . . . . . 48.1 t -56.32 -43.97 78.5 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.325 0 CA-C-N 116.291 -0.413 . . . . 0.0 110.64 -178.399 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 66.4 m-20 -59.57 -42.99 93.72 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-O 121.059 0.457 . . . . 0.0 110.815 -177.681 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 46.0 t -64.21 -48.79 84.09 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.253 0 CA-C-N 116.349 -0.387 . . . . 0.0 110.669 -177.856 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 22' ' ' ILE . . . . . 0.55 HG22 HD12 ' A' ' 26' ' ' LEU . 50.1 mm -55.65 -43.66 73.99 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.211 0 C-N-CA 120.911 -0.316 . . . . 0.0 110.689 179.861 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 23' ' ' ARG . . . . . . . . . . . . . 53.8 ttp180 -52.92 -51.92 59.62 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-O 120.55 0.214 . . . . 0.0 111.554 -179.367 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 24' ' ' ILE . . . . . . . . . . . . . 73.1 mt -60.01 -41.47 86.32 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.37 0 C-N-CA 121.095 -0.242 . . . . 0.0 111.295 -178.218 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 69.6 mmtt -64.19 -40.76 96.78 Favored 'General case' 0 C--N 1.328 -0.345 0 N-CA-C 112.187 0.44 . . . . 0.0 112.187 -178.516 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 26' ' ' LEU . . . . . 0.55 HD12 HG22 ' A' ' 22' ' ' ILE . 36.1 mt -79.61 -42.45 24.89 Favored 'General case' 0 C--N 1.329 -0.307 0 N-CA-C 113.025 0.75 . . . . 0.0 113.025 -171.289 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 27' ' ' GLN . . . . . . . . . . . . . 9.6 pt20 -46.4 140.08 4.45 Favored 'General case' 0 N--CA 1.469 0.492 0 N-CA-C 112.808 0.67 . . . . 0.0 112.808 -175.447 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 101.19 -27.93 18.35 Favored Glycine 0 CA--C 1.531 1.05 0 CA-C-N 115.591 -0.731 . . . . 0.0 112.214 -177.67 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 99.2 mttt -98.57 155.06 17.48 Favored 'General case' 0 C--O 1.232 0.18 0 CA-C-N 117.338 0.569 . . . . 0.0 111.228 179.095 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 30' ' ' THR . . . . . . . . . . . . . 49.3 m -105.29 135.54 46.48 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.117 -0.492 . . . . 0.0 109.709 174.994 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 34.4 m -129.26 159.99 40.67 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.206 0 CA-C-O 120.803 0.335 . . . . 0.0 110.996 -177.768 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 32' ' ' ARG . . . . . . . . . . . . . 38.2 ttm180 -130.66 147.88 52.39 Favored 'General case' 0 C--N 1.331 -0.217 0 CA-C-N 116.008 -0.542 . . . . 0.0 110.357 179.17 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 33' ' ' THR . . . . . . . . . . . . . 30.6 m -52.2 140.73 20.51 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-O 120.849 0.357 . . . . 0.0 111.386 -179.099 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 99.65 -17.13 57.96 Favored Glycine 0 CA--C 1.533 1.207 0 C-N-CA 121.156 -0.545 . . . . 0.0 113.202 -179.455 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 60.7 m-20 -64.92 150.1 48.47 Favored 'General case' 0 C--O 1.231 0.129 0 CA-C-N 118.059 0.93 . . . . 0.0 111.205 179.686 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 45.8 t -124.44 130.88 73.43 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.221 0 CA-C-N 115.762 -0.654 . . . . 0.0 109.838 178.963 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 37' ' ' ILE . . . . . . . . . . . . . 66.9 mt -122.89 139.86 48.4 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.221 0 CA-C-N 116.181 -0.463 . . . . 0.0 109.929 -179.647 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . -108.93 128.87 9.24 Favored Glycine 0 CA--C 1.525 0.668 0 N-CA-C 111.034 -0.826 . . . . 0.0 111.034 179.456 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 39' ' ' ILE . . . . . . . . . . . . . 70.3 mt -124.93 137.67 56.79 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.282 0 N-CA-C 110.008 -0.367 . . . . 0.0 110.008 179.59 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 40' ' ' SER . . . . . . . . . . . . . 53.6 p -91.37 114.28 26.76 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.443 -0.344 . . . . 0.0 110.789 176.697 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 41' ' ' ILE . . . . . . . . . . . . . 43.3 mm -121.69 113.44 39.17 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.185 0 N-CA-C 109.939 -0.393 . . . . 0.0 109.939 179.075 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 85.6 mt 58.83 35.46 24.26 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.36 -0.382 . . . . 0.0 111.475 178.61 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . 77.57 -10.14 25.24 Favored Glycine 0 CA--C 1.534 1.264 0 C-N-CA 121.283 -0.484 . . . . 0.0 113.434 178.419 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 44' ' ' LYS . . . . . . . . . . . . . 18.7 tptm -97.13 135.17 39.48 Favored 'General case' 0 C--N 1.333 -0.149 0 CA-C-N 117.941 0.87 . . . . 0.0 109.767 176.918 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 85.9 tt0 -82.38 123.96 29.58 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-O 120.802 0.334 . . . . 0.0 110.959 -178.977 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 46' ' ' VAL . . . . . . . . . . . . . 7.4 p -118.64 127.44 75.62 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.217 0 N-CA-C 109.465 -0.568 . . . . 0.0 109.465 176.765 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 62.3 mtpt -99.57 127.73 45.66 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.027 -0.533 . . . . 0.0 110.981 179.318 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 48' ' ' PHE . . . . . . . . . . . . . 86.8 m-85 -110.65 131.85 54.7 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.41 -0.359 . . . . 0.0 110.132 177.425 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 77.7 tttt -108.93 136.59 48.23 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.115 -0.493 . . . . 0.0 110.464 179.117 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 50' ' ' VAL . . . . . . . . . . . . . 44.6 t -81.0 106.19 11.86 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.288 0 N-CA-C 109.357 -0.609 . . . . 0.0 109.357 175.612 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 51' ' ' VAL . . . . . . . . . . . . . 55.3 t -69.38 -48.29 68.15 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.255 0 CA-C-N 116.065 -0.516 . . . . 0.0 109.89 -173.896 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 52' ' ' GLN . . . . . . . . . . . . . 21.5 pt20 -164.34 158.21 18.44 Favored 'General case' 0 C--N 1.331 -0.215 0 C-N-CA 120.198 -0.601 . . . . 0.0 111.786 179.549 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -135.87 136.4 40.53 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-N 115.292 -0.867 . . . . 0.0 110.062 179.126 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 54' ' ' TYR . . . . . . . . . . . . . 41.5 t80 -129.15 113.23 18.45 Favored Pre-proline 0 CA--C 1.535 0.368 0 CA-C-O 118.164 -0.922 . . . . 0.0 110.126 177.5 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 55' ' ' PRO . . . . . . . . . . . . . 74.3 Cg_endo -77.11 167.82 78.7 Favored 'Cis proline' 0 N--CA 1.499 1.804 0 CA-C-N 122.01 1.754 . . . . 0.0 112.343 -6.878 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 56' ' ' SER . . . . . . . . . . . . . 13.7 m -117.6 131.53 24.04 Favored Pre-proline 0 CA--C 1.539 0.531 0 CA-C-O 118.389 -0.815 . . . . 0.0 109.609 175.526 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 57' ' ' PRO . . . . . . . . . . . . . 36.6 Cg_endo -66.73 167.28 56.98 Favored 'Cis proline' 0 N--CA 1.498 1.756 0 CA-C-N 121.937 1.727 . . . . 0.0 111.253 -2.472 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 58' ' ' LEU . . . . . . . . . . . . . 34.5 tp -130.47 136.48 49.04 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.348 -0.387 . . . . 0.0 110.525 -179.831 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 59' ' ' ARG . . . . . . . . . . . . . 58.2 ttp180 -101.67 121.0 41.22 Favored 'General case' 0 C--N 1.326 -0.422 0 N-CA-C 109.164 -0.68 . . . . 0.0 109.164 175.721 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 43.7 t -76.28 120.29 26.05 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.308 0 C-N-CA 120.723 -0.391 . . . . 0.0 110.637 -173.049 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 95.0 mt-10 -131.02 163.21 28.09 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 115.78 -0.646 . . . . 0.0 109.726 176.891 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 62' ' ' ASP . . . . . . . . . . . . . 77.8 m-20 -53.99 -32.27 53.57 Favored 'General case' 0 C--N 1.329 -0.318 0 C-N-CA 120.981 -0.288 . . . . 0.0 111.695 -179.793 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 63' ' ' ARG . . . . . . . . . . . . . 39.7 ptt180 -78.47 2.35 19.25 Favored 'General case' 0 CA--C 1.537 0.465 0 N-CA-C 113.682 0.993 . . . . 0.0 113.682 -175.738 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 29.0 m -89.55 139.49 30.48 Favored 'General case' 0 C--N 1.333 -0.121 0 CA-C-N 118.131 0.423 . . . . 0.0 110.91 -178.446 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 65' ' ' LYS . . . . . . . . . . . . . 98.2 mttt -88.83 129.71 35.53 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.076 -0.511 . . . . 0.0 110.2 178.579 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 66' ' ' ILE . . . . . . . . . . . . . 60.6 mt -115.27 129.75 70.99 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.275 0 N-CA-C 109.903 -0.406 . . . . 0.0 109.903 179.296 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 67' ' ' THR . . . . . . . . . . . . . 25.7 m -120.25 136.97 54.48 Favored 'General case' 0 C--N 1.331 -0.224 0 CA-C-N 116.061 -0.518 . . . . 0.0 110.674 -179.587 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 68' ' ' LEU . . . . . 0.468 HD23 ' C ' ' A' ' 68' ' ' LEU . 6.6 tt -103.92 124.28 48.68 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 115.863 -0.608 . . . . 0.0 110.158 178.778 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 69' ' ' VAL . . . . . . . . . . . . . 46.3 t -96.58 127.74 48.44 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 CA-C-N 116.218 -0.446 . . . . 0.0 110.162 -179.379 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 70' ' ' THR . . . . . . . . . . . . . 67.6 p -106.88 -176.04 2.97 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.049 -0.523 . . . . 0.0 110.26 179.028 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 71' ' ' HIS . . . . . . . . . . . . . 1.8 t-80 -65.13 145.66 99.06 Favored Pre-proline 0 CA--C 1.534 0.353 0 N-CA-C 109.665 -0.494 . . . . 0.0 109.665 179.907 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 72' ' ' PRO . . . . . . . . . . . . . 71.5 Cg_endo -80.0 -23.63 6.45 Favored 'Trans proline' 0 N--CA 1.493 1.469 0 C-N-CA 121.395 1.397 . . . . 0.0 113.161 -176.905 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 73' ' ' VAL . . . . . . . . . . . . . 35.5 m -129.03 160.55 39.77 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.196 0 CA-C-O 121.144 0.497 . . . . 0.0 111.198 -178.988 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 74' ' ' ASP . . . . . . . . . . . . . 30.7 t0 -104.9 122.42 45.77 Favored 'General case' 0 C--N 1.327 -0.385 0 CA-C-N 115.308 -0.86 . . . . 0.0 109.617 177.327 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 39.4 t -112.71 122.76 67.51 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.207 0 CA-C-O 120.953 0.406 . . . . 0.0 110.481 -177.897 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 76' ' ' LEU . . . . . . . . . . . . . 25.0 mt -125.64 149.27 48.57 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 115.844 -0.616 . . . . 0.0 109.829 178.195 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 77' ' ' GLU . . . . . . . . . . . . . 96.8 mt-10 -137.03 138.04 40.04 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-O 121.015 0.436 . . . . 0.0 111.213 -177.986 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 78' ' ' ALA . . . . . . . . . . . . . . . -123.1 136.61 54.87 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 115.642 -0.708 . . . . 0.0 109.813 177.076 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 79' ' ' LYS . . . . . 0.62 ' O ' HD13 ' A' ' 80' ' ' ILE . 24.9 pttm -79.3 119.82 22.9 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-O 121.262 0.553 . . . . 0.0 111.018 -177.479 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 80' ' ' ILE . . . . . 0.62 HD13 ' O ' ' A' ' 79' ' ' LYS . 35.7 mm -139.28 104.67 2.21 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.252 0 CA-C-N 115.75 -0.659 . . . . 0.0 109.33 179.822 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 81' ' ' LYS . . . . . . . . . . . . . 99.3 mttt -102.21 127.03 49.33 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-O 120.958 0.409 . . . . 0.0 111.211 -176.726 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . 89.29 42.03 5.65 Favored Glycine 0 CA--C 1.525 0.673 0 N-CA-C 111.504 -0.638 . . . . 0.0 111.504 175.883 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 83' ' ' ILE . . . . . . . . . . . . . 71.0 mt -69.66 137.49 24.04 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.298 0 N-CA-C 109.77 -0.455 . . . . 0.0 109.77 176.749 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 84' ' ' LYS . . . . . . . . . . . . . 6.9 ttpm? -101.96 -48.56 4.21 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.102 179.362 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 85' ' ' ASP . . . . . . . . . . . . . 11.1 t70 -150.44 151.39 32.69 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 115.85 -0.614 . . . . 0.0 110.38 -179.721 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 86' ' ' VAL . . . . . 0.402 HG21 HG21 ' F' ' 133' ' ' ILE . 45.1 t -131.33 132.88 62.78 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.283 0 CA-C-O 120.958 0.409 . . . . 0.0 110.447 -179.134 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 87' ' ' ILE . . . . . 0.494 HD12 ' N ' ' A' ' 87' ' ' ILE . 5.1 mp -119.31 123.64 71.62 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.206 0 N-CA-C 109.169 -0.678 . . . . 0.0 109.169 175.891 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 88' ' ' LEU . . . . . 0.709 HD13 HG21 ' F' ' 131' ' ' VAL . 23.2 mt -114.0 129.71 56.59 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.164 -0.471 . . . . 0.0 111.148 -176.089 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 89' ' ' ASP . . . . . . . . . . . . . 13.6 t70 -124.02 154.6 39.64 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 115.83 -0.623 . . . . 0.0 109.677 176.709 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 41.6 mp0 -50.69 -37.33 40.66 Favored 'General case' 0 C--N 1.329 -0.316 0 N-CA-C 112.396 0.517 . . . . 0.0 112.396 -171.789 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 91' ' ' ASN . . . . . . . . . . . . . 20.2 p-10 -132.23 35.64 3.68 Favored 'General case' 0 N--CA 1.464 0.268 0 CA-C-O 120.679 0.276 . . . . 0.0 111.727 -177.112 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 92' ' ' LEU . . . . . . . . . . . . . 7.1 tp -166.12 139.76 4.24 Favored 'General case' 0 C--N 1.33 -0.282 0 N-CA-C 110.08 -0.341 . . . . 0.0 110.08 179.792 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 93' ' ' ILE . . . . . . . . . . . . . 66.7 mt -124.93 122.96 64.63 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.178 0 N-CA-C 109.749 -0.463 . . . . 0.0 109.749 -178.758 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 94' ' ' VAL . . . . . 0.486 HG11 HG11 ' A' ' 123' ' ' VAL . 41.8 t -125.6 127.84 71.9 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.181 0 CA-C-O 120.958 0.408 . . . . 0.0 110.142 179.44 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 95' ' ' VAL . . . . . . . . . . . . . 47.7 t -120.58 135.41 60.9 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.343 0 CA-C-N 115.909 -0.587 . . . . 0.0 109.875 -179.951 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 96' ' ' ILE . . . . . . . . . . . . . 65.7 mt -114.08 127.04 71.68 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.279 0 N-CA-C 109.341 -0.615 . . . . 0.0 109.341 178.388 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 97' ' ' THR . . . . . . . . . . . . . 67.8 p -97.72 162.8 13.1 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-O 121.331 0.586 . . . . 0.0 111.316 -176.918 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 98' ' ' GLU . . . . . . . . . . . . . 79.7 tt0 -53.84 -29.05 39.36 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 115.86 -0.609 . . . . 0.0 112.1 -178.993 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 99' ' ' GLU . . . . . . . . . . . . . 95.6 mt-10 -79.2 13.38 1.88 Allowed 'General case' 0 CA--C 1.534 0.365 0 N-CA-C 113.224 0.824 . . . . 0.0 113.224 -176.936 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 100' ' ' ASN . . . . . . . . . . . . . 4.0 m-20 61.18 34.41 18.88 Favored 'General case' 0 CA--C 1.53 0.179 0 CA-C-N 118.058 0.39 . . . . 0.0 111.414 -179.388 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 101' ' ' GLU . . . . . . . . . . . . . 84.0 tt0 -107.74 143.99 35.5 Favored 'General case' 0 C--N 1.333 -0.138 0 N-CA-C 109.537 -0.542 . . . . 0.0 109.537 172.993 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 102' ' ' VAL . . . . . . . . . . . . . 42.6 t -115.52 125.98 72.91 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.302 0 CA-C-N 116.273 -0.421 . . . . 0.0 110.007 -177.195 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 103' ' ' LEU . . . . . . . . . . . . . 66.2 mt -116.72 130.77 56.93 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 115.767 -0.651 . . . . 0.0 110.189 176.749 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 104' ' ' ILE . . . . . . . . . . . . . 68.6 mt -118.63 123.33 71.38 Favored 'Isoleucine or valine' 0 C--O 1.234 0.247 0 N-CA-C 110.26 -0.274 . . . . 0.0 110.26 -178.854 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 105' ' ' PHE . . . . . . . . . . . . . 67.6 m-85 -122.99 163.7 19.94 Favored 'General case' 0 C--O 1.232 0.148 0 O-C-N 124.003 0.815 . . . . 0.0 110.136 -178.176 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 106' ' ' ASN . . . . . . . . . . . . . 43.5 p-10 -97.77 -169.9 1.9 Allowed 'General case' 0 C--N 1.329 -0.283 0 N-CA-C 109.566 -0.531 . . . . 0.0 109.566 171.93 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 107' ' ' GLN . . . . . . . . . . . . . 31.7 tt0 -57.38 -29.68 64.26 Favored 'General case' 0 C--N 1.328 -0.348 0 N-CA-C 111.988 0.366 . . . . 0.0 111.988 178.983 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 108' ' ' ASN . . . . . . . . . . . . . 6.1 t-20 -86.98 11.57 13.29 Favored 'General case' 0 CA--C 1.536 0.421 0 N-CA-C 113.09 0.774 . . . . 0.0 113.09 -175.792 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 109' ' ' LEU . . . . . . . . . . . . . 41.6 mt 57.69 37.03 27.21 Favored 'General case' 0 C--N 1.332 -0.181 0 CA-C-O 120.88 0.372 . . . . 0.0 111.475 177.303 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 110' ' ' GLU . . . . . . . . . . . . . 43.5 mt-10 -104.73 146.72 28.56 Favored 'General case' 0 C--N 1.331 -0.228 0 N-CA-C 110.108 -0.33 . . . . 0.0 110.108 176.475 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 111' ' ' GLU . . . . . . . . . . . . . 99.3 mt-10 -76.89 121.98 24.19 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-O 120.92 0.39 . . . . 0.0 110.928 -178.57 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 112' ' ' LEU . . . . . . . . . . . . . 49.0 mt -110.12 -45.69 3.56 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 115.941 -0.572 . . . . 0.0 110.158 177.575 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 113' ' ' TYR . . . . . . . . . . . . . 64.8 t80 -134.15 135.86 43.4 Favored 'General case' 0 C--N 1.332 -0.187 0 CA-C-N 116.119 -0.491 . . . . 0.0 110.99 179.845 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 114' ' ' ARG . . . . . . . . . . . . . 83.3 mtp180 -135.17 123.25 22.81 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 116.043 -0.526 . . . . 0.0 110.248 177.937 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 115' ' ' GLY . . . . . . . . . . . . . . . -150.08 158.8 27.83 Favored Glycine 0 CA--C 1.524 0.625 0 N-CA-C 110.854 -0.898 . . . . 0.0 110.854 178.761 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 116' ' ' LYS . . . . . . . . . . . . . 79.8 tttt -134.18 131.76 38.99 Favored 'General case' 0 C--N 1.329 -0.32 0 N-CA-C 110.016 -0.365 . . . . 0.0 110.016 178.199 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 117' ' ' PHE . . . . . . . . . . . . . 20.0 m-85 -136.36 114.07 11.1 Favored 'General case' 0 C--N 1.331 -0.216 0 CA-C-N 116.362 -0.381 . . . . 0.0 110.066 -174.65 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 118' ' ' GLU . . . . . . . . . . . . . 96.1 mt-10 -54.5 -38.57 66.63 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.557 -0.292 . . . . 0.0 111.283 -177.945 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 119' ' ' ASN . . . . . . . . . . . . . 7.9 m-80 -100.44 30.53 3.85 Favored 'General case' 0 C--N 1.331 -0.232 0 N-CA-C 112.142 0.423 . . . . 0.0 112.142 -175.24 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 120' ' ' LEU . . . . . . . . . . . . . 16.3 tp -58.33 122.27 12.83 Favored 'General case' 0 C--N 1.331 -0.196 0 N-CA-C 110.084 -0.339 . . . . 0.0 110.084 177.322 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 121' ' ' ASN . . . . . . . . . . . . . 60.8 t30 -114.13 -44.09 3.17 Favored 'General case' 0 N--CA 1.462 0.169 0 CA-C-N 116.712 -0.222 . . . . 0.0 111.426 -176.986 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 122' ' ' LYS . . . . . . . . . . . . . 98.5 mttt -147.02 150.69 35.6 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-O 121.016 0.436 . . . . 0.0 111.665 -176.39 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 123' ' ' VAL . . . . . 0.486 HG11 HG11 ' A' ' 94' ' ' VAL . 40.9 t -128.79 129.16 68.31 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.319 0 CA-C-N 115.89 -0.596 . . . . 0.0 109.414 174.691 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 124' ' ' LEU . . . . . . . . . . . . . 52.6 mt -117.2 132.94 56.53 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-O 120.723 0.297 . . . . 0.0 110.372 -178.787 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 125' ' ' VAL . . . . . 0.473 HG12 HG23 ' A' ' 130' ' ' VAL . 34.9 m -134.32 133.75 55.19 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.252 0 CA-C-N 116.152 -0.477 . . . . 0.0 111.045 -178.092 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 126' ' ' ARG . . . . . . . . . . . . . 14.9 ptm180 -163.4 137.19 5.82 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.185 -0.461 . . . . 0.0 109.85 175.291 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 127' ' ' ASN . . . . . . . . . . . . . 69.4 m-20 55.56 -154.82 0.29 Allowed 'General case' 0 CA--C 1.539 0.531 0 N-CA-C 109.818 -0.438 . . . . 0.0 109.818 -178.77 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 128' ' ' ASP . . . . . . . . . . . . . 23.8 p-10 -84.65 22.25 1.36 Allowed 'General case' 0 CA--C 1.534 0.334 0 CA-C-N 118.383 0.538 . . . . 0.0 112.339 177.419 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 129' ' ' LEU . . . . . . . . . . . . . 16.5 tp -118.58 138.92 52.23 Favored 'General case' 0 C--O 1.234 0.249 0 O-C-N 122.112 -0.367 . . . . 0.0 110.178 178.764 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 130' ' ' VAL . . . . . 0.515 HG13 ' HB ' ' A' ' 141' ' ' ILE . 12.3 p -135.37 140.35 44.99 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.2 0 CA-C-O 120.96 0.41 . . . . 0.0 110.396 -178.773 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 131' ' ' VAL . . . . . 0.461 HG23 ' O ' ' A' ' 139' ' ' THR . 14.6 p -136.17 141.12 42.42 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.233 0 CA-C-O 120.981 0.42 . . . . 0.0 110.891 179.29 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 132' ' ' ILE . . . . . . . . . . . . . 73.4 mt -112.96 134.02 56.93 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.292 0 CA-C-N 115.859 -0.61 . . . . 0.0 109.637 179.756 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 133' ' ' ILE . . . . . . . . . . . . . 41.7 mm -117.66 124.35 72.94 Favored 'Isoleucine or valine' 0 C--O 1.233 0.198 0 CA-C-O 120.806 0.336 . . . . 0.0 110.976 -176.192 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 134' ' ' ASP . . . . . . . . . . . . . 7.1 p-10 -136.61 148.46 47.49 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.253 -0.43 . . . . 0.0 109.85 175.747 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 135' ' ' GLU . . . . . . . . . . . . . 83.0 tt0 -50.02 -26.9 4.76 Favored 'General case' 0 C--N 1.328 -0.341 0 N-CA-C 112.67 0.619 . . . . 0.0 112.67 -174.66 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 136' ' ' GLN . . . . . . . . . . . . . 94.3 mt-30 -82.67 -32.44 28.14 Favored 'General case' 0 C--N 1.33 -0.251 0 N-CA-C 112.344 0.498 . . . . 0.0 112.344 -175.596 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 137' ' ' LYS . . . . . . . . . . . . . 56.5 pttt -170.01 176.63 4.62 Favored 'General case' 0 C--N 1.333 -0.133 0 CA-C-O 121.592 0.71 . . . . 0.0 112.29 -172.795 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 138' ' ' LEU . . . . . 0.427 ' C ' HD23 ' A' ' 138' ' ' LEU . 7.5 tt -122.18 130.17 52.96 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-N 115.006 -0.997 . . . . 0.0 110.045 179.201 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 139' ' ' THR . . . . . 0.461 ' O ' HG23 ' A' ' 131' ' ' VAL . 85.2 m -115.42 124.54 51.43 Favored 'General case' 0 C--N 1.331 -0.224 0 CA-C-N 116.253 -0.431 . . . . 0.0 110.212 179.206 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 140' ' ' LEU . . . . . . . . . . . . . 21.0 tp -111.86 125.93 54.55 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.005 -0.543 . . . . 0.0 109.606 -178.979 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 141' ' ' ILE . . . . . 0.515 ' HB ' HG13 ' A' ' 130' ' ' VAL . 19.6 mt -123.31 124.56 70.14 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.252 0 CA-C-O 120.996 0.427 . . . . 0.0 110.234 -172.814 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 142' ' ' ARG . . . . . . . . . . . . . 81.1 mtp180 -111.84 125.78 54.38 Favored 'General case' 0 C--O 1.233 0.22 0 CA-C-N 115.429 -0.805 . . . . 0.0 109.843 -178.895 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 143' ' ' THR . . . . . . . . . . . . . 40.0 p . . . . . 0 C--O 1.22 -0.452 0 CA-C-O 118.014 -0.994 . . . . 0.0 110.555 -179.226 . . . . . . . . 0 0 . 1 . 010 nuclear nobuild full ' B' B ' -3' ' ' GLU . . . . . . . . . . . . . 95.7 mt-10 . . . . . 0 N--CA 1.488 1.463 0 N-CA-C 109.326 -0.62 . . . . 0.0 109.326 . . . . . . . . . 0 0 . 1 . 010 nuclear nobuild full ' B' B ' -2' ' ' GLY . . . . . . . . . . . . . . . -70.5 129.49 19.7 Favored Glycine 0 CA--C 1.525 0.663 0 N-CA-C 110.956 -0.858 . . . . 0.0 110.956 179.537 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' -1' ' ' VAL . . . . . . . . . . . . . 43.4 t -96.46 138.43 21.73 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.305 0 N-CA-C 110.098 -0.334 . . . . 0.0 110.098 179.76 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 0' ' ' ILE . . . . . . . . . . . . . 72.0 mt -88.33 129.58 39.28 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.222 0 CA-C-N 116.346 -0.388 . . . . 0.0 110.275 -178.695 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 1' ' ' MET . . . . . . . . . . . . . 26.2 ptt? -78.3 131.58 37.11 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.044 -0.526 . . . . 0.0 110.764 179.743 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 2' ' ' SER . . . . . . . . . . . . . 4.9 p -113.05 135.14 54.11 Favored 'General case' 0 C--N 1.331 -0.201 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.585 -179.687 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 3' ' ' GLU . . . . . . . . . . . . . 40.7 mt-10 -141.08 141.44 34.25 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.243 -0.435 . . . . 0.0 111.09 -178.962 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 4' ' ' LEU . . . . . . . . . . . . . 16.4 tp -125.9 129.82 50.09 Favored 'General case' 0 C--N 1.333 -0.143 0 CA-C-N 116.011 -0.541 . . . . 0.0 109.912 176.047 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 5' ' ' LYS . . . . . . . . . . . . . 57.1 mttp -108.79 123.24 48.71 Favored 'General case' 0 C--O 1.236 0.359 0 CA-C-N 116.625 -0.262 . . . . 0.0 110.891 -179.394 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 6' ' ' LEU . . . . . . . . . . . . . 66.6 mt -114.62 145.88 41.48 Favored 'General case' 0 C--N 1.331 -0.223 0 CA-C-N 115.71 -0.677 . . . . 0.0 110.557 179.646 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 7' ' ' LYS . . . . . . . . . . . . . 83.7 tttt -128.12 142.0 43.08 Favored Pre-proline 0 CA--C 1.533 0.303 0 CA-C-O 119.057 -0.497 . . . . 0.0 109.787 175.569 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 8' ' ' PRO . . . . . . . . . . . . . 93.7 Cg_endo -90.37 136.06 2.26 Favored 'Trans proline' 0 N--CA 1.49 1.318 0 C-N-CA 121.717 1.611 . . . . 0.0 111.832 179.131 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 9' ' ' LEU . . . . . . . . . . . . . 28.0 mt -82.96 -47.2 0.84 Allowed Pre-proline 0 CA--C 1.535 0.401 0 CA-C-O 118.631 -0.699 . . . . 0.0 112.061 -179.358 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 10' ' ' PRO . . . . . . . . . . . . . 83.8 Cg_endo -82.53 157.03 16.52 Favored 'Trans proline' 0 N--CA 1.495 1.592 0 C-N-CA 121.29 1.326 . . . . 0.0 111.802 175.688 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 11' ' ' LYS . . . . . . . . . . . . . 18.2 pttp -86.03 110.38 19.46 Favored 'General case' 0 C--N 1.331 -0.216 0 CA-C-O 121.523 0.677 . . . . 0.0 110.329 177.42 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 12' ' ' VAL . . . . . . . . . . . . . 12.0 p -151.07 149.53 14.09 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.359 0 CA-C-N 115.72 -0.673 . . . . 0.0 110.329 -179.978 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 13' ' ' GLU . . . . . . . . . . . . . 42.0 tp10 -95.73 120.6 36.28 Favored 'General case' 0 C--N 1.329 -0.293 0 C-N-CA 120.853 -0.339 . . . . 0.0 110.217 177.714 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 14' ' ' LEU . . . . . . . . . . . . . 37.2 mt -97.94 149.05 35.32 Favored Pre-proline 0 CA--C 1.533 0.316 0 CA-C-O 119.318 -0.372 . . . . 0.0 110.592 -177.736 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 15' ' ' PRO . . . . . . . . . . . . . 26.7 Cg_exo -61.8 157.11 44.55 Favored 'Trans proline' 0 N--CA 1.499 1.83 0 C-N-CA 121.286 1.324 . . . . 0.0 111.663 176.998 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 16' ' ' PRO . . . . . . . . . . . . . 39.1 Cg_exo -58.97 -33.95 98.94 Favored 'Trans proline' 0 N--CA 1.497 1.685 0 C-N-CA 121.416 1.411 . . . . 0.0 112.498 179.584 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 17' ' ' ASP . . . . . . . . . . . . . 18.7 p-10 -88.02 9.69 21.54 Favored 'General case' 0 CA--C 1.536 0.413 0 N-CA-C 113.234 0.828 . . . . 0.0 113.234 -177.791 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 18' ' ' PHE . . . . . . . . . . . . . 43.5 t80 -58.32 -46.49 86.08 Favored 'General case' 0 CA--C 1.523 -0.06 0 O-C-N 121.965 -0.459 . . . . 0.0 109.996 -177.983 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 19' ' ' VAL . . . . . 0.417 HG13 ' N ' ' B' ' 20' ' ' ASP . 12.9 p -53.91 -41.4 48.95 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.328 0 CA-C-N 116.501 -0.318 . . . . 0.0 111.188 -178.422 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' B' B ' 20' ' ' ASP . . . . . 0.417 ' N ' HG13 ' B' ' 19' ' ' VAL . 81.2 m-20 -60.82 -45.15 95.57 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-O 120.935 0.398 . . . . 0.0 110.83 -178.841 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' B' B ' 21' ' ' VAL . . . . . . . . . . . . . 40.7 t -64.16 -44.32 97.54 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.287 0 CA-C-N 116.272 -0.422 . . . . 0.0 110.654 -177.614 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 22' ' ' ILE . . . . . 0.553 HG22 HD12 ' B' ' 26' ' ' LEU . 50.3 mm -59.68 -40.01 81.16 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.199 0 C-N-CA 120.816 -0.354 . . . . 0.0 110.829 -179.65 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' B' B ' 23' ' ' ARG . . . . . . . . . . . . . 57.7 ttp180 -55.16 -49.14 72.6 Favored 'General case' 0 N--CA 1.463 0.219 0 CA-C-O 121.103 0.478 . . . . 0.0 110.692 177.736 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 24' ' ' ILE . . . . . . . . . . . . . 72.4 mt -60.39 -42.85 92.43 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 CA-C-N 115.729 -0.668 . . . . 0.0 111.845 -177.047 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 25' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -72.01 -37.43 69.79 Favored 'General case' 0 CA--C 1.535 0.37 0 N-CA-C 112.103 0.409 . . . . 0.0 112.103 -175.157 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' B' B ' 26' ' ' LEU . . . . . 0.553 HD12 HG22 ' B' ' 22' ' ' ILE . 40.4 mt -79.54 -39.7 31.25 Favored 'General case' 0 C--N 1.331 -0.231 0 N-CA-C 112.91 0.707 . . . . 0.0 112.91 -172.569 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' B' B ' 27' ' ' GLN . . . . . . . . . . . . . 9.6 pt20 -45.78 139.03 4.36 Favored 'General case' 0 N--CA 1.469 0.523 0 N-CA-C 112.84 0.682 . . . . 0.0 112.84 -175.095 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 28' ' ' GLY . . . . . . . . . . . . . . . 102.01 -26.65 23.57 Favored Glycine 0 CA--C 1.531 1.066 0 CA-C-N 115.367 -0.833 . . . . 0.0 112.191 -176.737 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 29' ' ' LYS . . . . . . . . . . . . . 54.8 mtpt -98.59 155.18 17.42 Favored 'General case' 0 C--O 1.233 0.198 0 CA-C-N 117.523 0.661 . . . . 0.0 111.237 179.058 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 30' ' ' THR . . . . . . . . . . . . . 53.7 m -101.03 139.43 36.73 Favored 'General case' 0 C--N 1.331 -0.216 0 CA-C-N 116.045 -0.525 . . . . 0.0 110.1 176.03 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 31' ' ' VAL . . . . . . . . . . . . . 34.5 m -130.47 155.4 41.7 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.305 0 CA-C-N 116.142 -0.481 . . . . 0.0 110.413 179.394 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 32' ' ' ARG . . . . . . . . . . . . . 71.5 ttt-85 -135.41 150.25 49.84 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-O 121.048 0.451 . . . . 0.0 110.24 178.211 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 33' ' ' THR . . . . . . . . . . . . . 19.8 m -52.28 137.67 28.2 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-O 120.894 0.378 . . . . 0.0 111.634 -177.068 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 34' ' ' GLY . . . . . . . . . . . . . . . 101.97 -17.2 54.86 Favored Glycine 0 CA--C 1.533 1.179 0 CA-C-O 119.622 -0.543 . . . . 0.0 113.21 179.087 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 35' ' ' ASP . . . . . . . . . . . . . 76.3 m-20 -67.28 148.58 51.51 Favored 'General case' 0 N--CA 1.462 0.128 0 CA-C-N 118.087 0.943 . . . . 0.0 111.299 179.514 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 36' ' ' VAL . . . . . . . . . . . . . 46.3 t -121.44 131.15 73.74 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.198 0 CA-C-N 115.935 -0.575 . . . . 0.0 109.873 177.737 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 37' ' ' ILE . . . . . . . . . . . . . 63.8 mt -121.27 138.57 51.21 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.299 0 CA-C-N 116.26 -0.427 . . . . 0.0 109.957 -179.921 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 38' ' ' GLY . . . . . . . . . . . . . . . -114.42 127.52 7.78 Favored Glycine 0 CA--C 1.524 0.636 0 N-CA-C 111.01 -0.836 . . . . 0.0 111.01 179.126 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 39' ' ' ILE . . . . . . . . . . . . . 70.8 mt -128.94 130.92 68.57 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.213 0 N-CA-C 110.003 -0.369 . . . . 0.0 110.003 178.685 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 40' ' ' SER . . . . . 0.428 ' O ' HD13 ' B' ' 41' ' ' ILE . 59.7 p -90.93 118.19 30.12 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.422 -0.354 . . . . 0.0 110.693 176.959 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' B' B ' 41' ' ' ILE . . . . . 0.428 HD13 ' O ' ' B' ' 40' ' ' SER . 48.2 mm -125.08 116.95 48.58 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.19 0 CA-C-O 120.974 0.416 . . . . 0.0 110.237 179.686 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' B' B ' 42' ' ' LEU . . . . . 0.542 ' O ' HD23 ' B' ' 42' ' ' LEU . 1.3 tt 56.65 45.58 21.8 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-O 121.414 0.626 . . . . 0.0 110.366 178.217 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' B' B ' 43' ' ' GLY . . . . . . . . . . . . . . . 75.16 -9.65 12.21 Favored Glycine 0 CA--C 1.534 1.238 0 CA-C-N 116.062 -0.517 . . . . 0.0 113.726 175.378 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 44' ' ' LYS . . . . . . . . . . . . . 46.8 tttp -107.29 126.9 53.03 Favored 'General case' 0 C--N 1.333 -0.121 0 CA-C-N 118.064 0.932 . . . . 0.0 110.189 -179.216 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 45' ' ' GLU . . . . . . . . . . . . . 42.6 tp10 -83.51 128.84 34.83 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-O 120.829 0.347 . . . . 0.0 111.222 -178.781 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 46' ' ' VAL . . . . . . . . . . . . . 8.7 p -120.18 127.08 75.88 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.198 0 N-CA-C 109.574 -0.528 . . . . 0.0 109.574 176.004 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 47' ' ' LYS . . . . . . . . . . . . . 87.0 mttt -98.94 124.82 44.16 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.03 -0.532 . . . . 0.0 110.603 177.092 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 48' ' ' PHE . . . . . . . . . . . . . 40.5 m-85 -108.96 131.8 54.71 Favored 'General case' 0 C--N 1.327 -0.379 0 N-CA-C 109.698 -0.482 . . . . 0.0 109.698 177.145 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 49' ' ' LYS . . . . . . . . . . . . . 84.3 tttt -107.89 134.71 50.44 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.452 -0.34 . . . . 0.0 110.406 178.21 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 50' ' ' VAL . . . . . . . . . . . . . 43.4 t -76.34 104.86 4.72 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.303 0 N-CA-C 109.25 -0.648 . . . . 0.0 109.25 176.729 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 51' ' ' VAL . . . . . . . . . . . . . 47.0 t -69.6 -49.79 55.87 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.275 0 CA-C-N 116.088 -0.505 . . . . 0.0 109.799 -174.428 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 52' ' ' GLN . . . . . . . . . . . . . 34.2 tt0 -161.91 145.05 11.99 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 115.928 -0.578 . . . . 0.0 111.569 -178.458 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 53' ' ' ALA . . . . . . . . . . . . . . . -120.71 133.57 55.34 Favored 'General case' 0 C--N 1.331 -0.219 0 CA-C-N 115.792 -0.64 . . . . 0.0 110.051 176.963 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 54' ' ' TYR . . . . . . . . . . . . . 45.9 t80 -129.06 109.63 18.19 Favored Pre-proline 0 CA--C 1.534 0.362 0 CA-C-O 118.27 -0.871 . . . . 0.0 110.243 178.276 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 55' ' ' PRO . . . . . . . . . . . . . 73.6 Cg_endo -77.11 168.24 77.54 Favored 'Cis proline' 0 N--CA 1.5 1.862 0 CA-C-N 121.818 1.685 . . . . 0.0 112.518 -5.921 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 56' ' ' SER . . . . . . . . . . . . . 50.5 m -117.3 134.02 23.13 Favored Pre-proline 0 CA--C 1.539 0.532 0 CA-C-O 118.418 -0.801 . . . . 0.0 109.557 174.851 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 57' ' ' PRO . . . . . . . . . . . . . 35.2 Cg_endo -66.27 164.37 66.14 Favored 'Cis proline' 0 N--CA 1.497 1.713 0 CA-C-N 121.838 1.692 . . . . 0.0 111.341 -2.547 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 58' ' ' LEU . . . . . . . . . . . . . 20.7 tp -129.78 136.05 49.16 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-O 120.966 0.413 . . . . 0.0 110.321 -179.061 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 59' ' ' ARG . . . . . . . . . . . . . 36.4 ttm180 -104.47 126.89 51.98 Favored 'General case' 0 C--N 1.326 -0.455 0 N-CA-C 109.169 -0.678 . . . . 0.0 109.169 175.69 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 60' ' ' VAL . . . . . . . . . . . . . 49.3 t -77.3 117.51 22.43 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.243 0 C-N-CA 120.638 -0.425 . . . . 0.0 109.933 -176.159 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 61' ' ' GLU . . . . . . . . . . . . . 94.9 mt-10 -130.99 167.9 18.27 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.088 -0.505 . . . . 0.0 110.247 -179.789 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 62' ' ' ASP . . . . . . . . . . . . . 24.6 t0 -54.26 -32.5 56.28 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-N 116.506 -0.315 . . . . 0.0 111.799 -178.816 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 63' ' ' ARG . . . . . . . . . . . . . 5.0 ptp180 -88.9 10.14 22.35 Favored 'General case' 0 CA--C 1.534 0.353 0 N-CA-C 113.499 0.926 . . . . 0.0 113.499 -175.147 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 64' ' ' THR . . . . . . . . . . . . . 27.2 m -94.02 134.4 36.46 Favored 'General case' 0 C--N 1.333 -0.122 0 CA-C-N 118.199 0.454 . . . . 0.0 110.507 -179.557 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 65' ' ' LYS . . . . . . . . . . . . . 67.2 mttm -90.7 133.31 35.24 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.011 -0.54 . . . . 0.0 110.616 179.706 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 66' ' ' ILE . . . . . . . . . . . . . 61.5 mt -110.75 129.6 65.64 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.21 0 N-CA-C 109.737 -0.468 . . . . 0.0 109.737 178.959 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 67' ' ' THR . . . . . . . . . . . . . 27.5 m -123.47 145.52 48.76 Favored 'General case' 0 C--N 1.331 -0.23 0 CA-C-N 116.055 -0.52 . . . . 0.0 110.644 -178.277 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 68' ' ' LEU . . . . . . . . . . . . . 52.9 mt -107.84 147.22 31.2 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-N 115.931 -0.577 . . . . 0.0 111.135 -178.442 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 69' ' ' VAL . . . . . . . . . . . . . 48.5 t -82.81 155.28 3.87 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.293 0 CA-C-N 115.664 -0.698 . . . . 0.0 109.122 175.602 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 70' ' ' THR . . . . . . . . . . . . . 9.9 t -73.69 166.49 23.18 Favored 'General case' 0 C--N 1.331 -0.208 0 CA-C-O 121.257 0.551 . . . . 0.0 110.996 -169.921 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 71' ' ' HIS . . . . . . . . . . . . . 64.6 m-70 -64.99 156.38 80.56 Favored Pre-proline 0 CA--C 1.533 0.32 0 CA-C-N 115.399 -0.819 . . . . 0.0 112.341 -170.562 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 72' ' ' PRO . . . . . . . . . . . . . 38.8 Cg_endo -67.5 160.28 48.65 Favored 'Trans proline' 0 N--CA 1.497 1.678 0 C-N-CA 121.729 1.62 . . . . 0.0 111.856 175.706 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 73' ' ' VAL . . . . . . . . . . . . . 34.5 m -69.68 -174.27 0.11 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.235 0 N-CA-C 109.629 -0.508 . . . . 0.0 109.629 -179.163 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 74' ' ' ASP . . . . . . . . . . . . . 28.9 t0 -84.85 115.35 22.7 Favored 'General case' 0 C--N 1.329 -0.323 0 C-N-CA 120.474 -0.49 . . . . 0.0 110.242 -170.972 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 75' ' ' VAL . . . . . . . . . . . . . 40.8 t -120.26 122.19 67.66 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.211 0 CA-C-O 121.099 0.476 . . . . 0.0 110.55 -177.842 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 76' ' ' LEU . . . . . . . . . . . . . 5.9 mp -119.25 137.64 53.53 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 115.609 -0.723 . . . . 0.0 109.288 174.627 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 77' ' ' GLU . . . . . . . . . . . . . 96.8 mt-10 -129.6 138.11 51.08 Favored 'General case' 0 C--N 1.331 -0.208 0 CA-C-O 121.159 0.504 . . . . 0.0 111.106 -176.405 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 78' ' ' ALA . . . . . . . . . . . . . . . -127.35 129.19 47.17 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 115.591 -0.731 . . . . 0.0 109.681 176.785 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 79' ' ' LYS . . . . . 0.611 ' O ' HD13 ' B' ' 80' ' ' ILE . 79.9 tttt -76.35 119.34 20.09 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.413 -0.358 . . . . 0.0 110.304 -178.294 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' B' B ' 80' ' ' ILE . . . . . 0.611 HD13 ' O ' ' B' ' 79' ' ' LYS . 40.6 mm -139.2 113.86 7.75 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.306 0 N-CA-C 109.469 -0.567 . . . . 0.0 109.469 -175.027 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' B' B ' 81' ' ' LYS . . . . . . . . . . . . . 86.9 tttt -99.33 122.89 43.1 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-O 120.82 0.343 . . . . 0.0 111.214 -177.219 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 82' ' ' GLY . . . . . . . . . . . . . . . 89.15 42.18 5.66 Favored Glycine 0 CA--C 1.526 0.752 0 C-N-CA 120.683 -0.77 . . . . 0.0 112.413 171.715 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 83' ' ' ILE . . . . . . . . . . . . . 71.3 mt -63.83 137.93 23.9 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.283 0 N-CA-C 109.484 -0.562 . . . . 0.0 109.484 174.818 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 84' ' ' LYS . . . . . . . . . . . . . 36.7 ttpt -106.58 -51.22 2.98 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-O 120.878 0.37 . . . . 0.0 110.352 -178.152 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 85' ' ' ASP . . . . . . . . . . . . . 13.1 t70 -145.25 146.16 31.58 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 115.969 -0.559 . . . . 0.0 110.54 -178.108 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 86' ' ' VAL . . . . . . . . . . . . . 46.2 t -129.97 131.89 65.89 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.263 0 CA-C-O 120.996 0.427 . . . . 0.0 110.448 -179.098 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 87' ' ' ILE . . . . . 0.489 ' N ' HD12 ' B' ' 87' ' ' ILE . 5.0 mp -120.47 127.29 75.9 Favored 'Isoleucine or valine' 0 C--O 1.233 0.22 0 CA-C-N 115.86 -0.609 . . . . 0.0 109.494 176.846 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' B' B ' 88' ' ' LEU . . . . . . . . . . . . . 13.7 tp -113.68 132.93 55.61 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-O 120.963 0.411 . . . . 0.0 111.284 -177.036 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 89' ' ' ASP . . . . . . . . . . . . . 11.4 t70 -130.38 155.25 46.69 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 115.745 -0.661 . . . . 0.0 109.675 176.602 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 90' ' ' GLU . . . . . . . . . . . . . 84.4 tt0 -45.74 -48.56 15.27 Favored 'General case' 0 N--CA 1.466 0.34 0 N-CA-C 112.798 0.666 . . . . 0.0 112.798 -173.194 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 91' ' ' ASN . . . . . . . . . . . . . 2.6 p30 -126.04 39.33 3.97 Favored 'General case' 0 N--CA 1.465 0.294 0 CA-C-O 120.958 0.409 . . . . 0.0 110.966 -177.904 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 92' ' ' LEU . . . . . . . . . . . . . 10.8 tp -165.5 140.17 4.87 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.312 -0.404 . . . . 0.0 110.383 -179.376 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 93' ' ' ILE . . . . . . . . . . . . . 69.6 mt -128.77 122.56 57.3 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.289 0 N-CA-C 109.294 -0.632 . . . . 0.0 109.294 179.55 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 94' ' ' VAL . . . . . . . . . . . . . 46.4 t -122.54 128.62 75.42 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.229 0 CA-C-O 120.947 0.403 . . . . 0.0 110.147 -178.838 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 95' ' ' VAL . . . . . . . . . . . . . 42.1 t -123.16 134.28 66.67 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.283 0 CA-C-N 116.017 -0.538 . . . . 0.0 109.834 -179.785 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 96' ' ' ILE . . . . . . . . . . . . . 62.1 mt -117.8 129.92 73.47 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.237 0 N-CA-C 109.464 -0.569 . . . . 0.0 109.464 179.845 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 97' ' ' THR . . . . . . . . . . . . . 70.8 p -103.38 161.2 14.04 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-O 121.23 0.538 . . . . 0.0 111.547 -176.522 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 98' ' ' GLU . . . . . . . . . . . . . 71.0 mm-40 -53.79 -27.42 29.06 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 115.97 -0.559 . . . . 0.0 112.149 178.679 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 99' ' ' GLU . . . . . . . . . . . . . 95.5 mt-10 -76.6 11.8 1.51 Allowed 'General case' 0 CA--C 1.536 0.433 0 N-CA-C 113.235 0.828 . . . . 0.0 113.235 -178.113 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 100' ' ' ASN . . . . . . . . . . . . . 6.2 m-20 61.24 37.61 17.19 Favored 'General case' 0 CA--C 1.528 0.116 0 CA-C-O 120.912 0.387 . . . . 0.0 110.984 179.524 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 101' ' ' GLU . . . . . . . . . . . . . 85.0 tt0 -113.44 142.89 45.36 Favored 'General case' 0 C--N 1.331 -0.197 0 N-CA-C 109.606 -0.516 . . . . 0.0 109.606 174.321 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 102' ' ' VAL . . . . . . . . . . . . . 40.3 t -115.69 125.67 72.95 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.312 0 CA-C-N 116.158 -0.474 . . . . 0.0 109.968 -178.173 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 103' ' ' LEU . . . . . . . . . . . . . 23.5 mt -115.87 126.97 54.64 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 115.736 -0.665 . . . . 0.0 109.959 176.296 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 104' ' ' ILE . . . . . . . . . . . . . 66.2 mt -117.38 120.26 64.32 Favored 'Isoleucine or valine' 0 C--O 1.235 0.29 0 CA-C-N 116.612 -0.267 . . . . 0.0 110.355 -179.429 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 105' ' ' PHE . . . . . . . . . . . . . 17.7 m-85 -122.97 168.4 12.37 Favored 'General case' 0 C--N 1.332 -0.188 0 O-C-N 123.797 0.686 . . . . 0.0 109.949 178.686 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 106' ' ' ASN . . . . . . . . . . . . . 41.7 p-10 -96.93 -169.86 1.94 Allowed 'General case' 0 C--N 1.329 -0.316 0 N-CA-C 109.627 -0.508 . . . . 0.0 109.627 173.485 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 107' ' ' GLN . . . . . . . . . . . . . 60.4 tt0 -59.5 -30.04 68.28 Favored 'General case' 0 CA--C 1.532 0.274 0 C-N-CA 120.968 -0.293 . . . . 0.0 111.775 178.438 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 108' ' ' ASN . . . . . . . . . . . . . 4.8 t-20 -82.0 5.76 18.22 Favored 'General case' 0 CA--C 1.537 0.47 0 N-CA-C 113.167 0.803 . . . . 0.0 113.167 -178.053 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 109' ' ' LEU . . . . . . . . . . . . . 10.2 tp 61.97 37.8 14.73 Favored 'General case' 0 C--N 1.332 -0.166 0 O-C-N 122.047 -0.408 . . . . 0.0 111.377 178.106 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 110' ' ' GLU . . . . . . . . . . . . . 70.9 mm-40 -103.17 159.41 15.56 Favored 'General case' 0 C--N 1.33 -0.277 0 N-CA-C 109.749 -0.463 . . . . 0.0 109.749 175.688 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 111' ' ' GLU . . . . . . . . . . . . . 84.0 tt0 -85.17 123.31 30.53 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-O 120.974 0.416 . . . . 0.0 111.053 -177.397 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 112' ' ' LEU . . . . . . . . . . . . . 12.7 mt -110.04 -45.96 3.53 Favored 'General case' 0 C--N 1.331 -0.216 0 CA-C-N 115.884 -0.598 . . . . 0.0 110.144 176.776 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 113' ' ' TYR . . . . . . . . . . . . . 63.8 t80 -141.46 138.23 32.71 Favored 'General case' 0 C--N 1.331 -0.217 0 CA-C-N 116.212 -0.449 . . . . 0.0 111.152 179.977 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 114' ' ' ARG . . . . . . . . . . . . . 67.0 ttt180 -138.62 119.58 14.37 Favored 'General case' 0 C--N 1.332 -0.191 0 CA-C-N 116.015 -0.539 . . . . 0.0 110.132 178.41 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 115' ' ' GLY . . . . . . . . . . . . . . . -150.15 158.04 27.49 Favored Glycine 0 CA--C 1.525 0.696 0 C-N-CA 120.666 -0.778 . . . . 0.0 111.367 179.342 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 116' ' ' LYS . . . . . . . . . . . . . 29.8 ttmt -130.81 139.31 50.17 Favored 'General case' 0 C--N 1.331 -0.231 0 N-CA-C 109.898 -0.408 . . . . 0.0 109.898 176.643 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 117' ' ' PHE . . . . . . . . . . . . . 30.7 m-85 -135.84 114.5 11.9 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.329 -0.396 . . . . 0.0 110.372 -176.047 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 118' ' ' GLU . . . . . . . . . . . . . 96.0 mt-10 -52.82 -47.63 67.52 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.351 -0.386 . . . . 0.0 111.579 -176.473 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 119' ' ' ASN . . . . . . . . . . . . . 32.4 m120 -94.91 31.03 1.93 Allowed 'General case' 0 C--N 1.331 -0.238 0 N-CA-C 112.199 0.444 . . . . 0.0 112.199 -174.553 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 120' ' ' LEU . . . . . . . . . . . . . 11.8 tp -56.48 120.46 7.75 Favored 'General case' 0 C--N 1.332 -0.156 0 CA-C-O 120.728 0.299 . . . . 0.0 110.504 177.68 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 121' ' ' ASN . . . . . . . . . . . . . 64.3 t30 -112.53 -44.09 3.4 Favored 'General case' 0 C--N 1.331 -0.23 0 CA-C-N 116.317 -0.401 . . . . 0.0 110.874 -176.502 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 122' ' ' LYS . . . . . . . . . . . . . 34.2 mtmm -147.45 145.97 29.37 Favored 'General case' 0 C--N 1.331 -0.217 0 CA-C-O 121.08 0.467 . . . . 0.0 111.445 -178.191 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 123' ' ' VAL . . . . . . . . . . . . . 46.6 t -125.92 129.64 72.39 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.24 0 CA-C-N 115.831 -0.622 . . . . 0.0 109.409 176.395 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 124' ' ' LEU . . . . . . . . . . . . . 44.9 mt -118.88 128.33 54.34 Favored 'General case' 0 C--N 1.331 -0.239 0 CA-C-N 116.308 -0.405 . . . . 0.0 110.431 -179.204 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 125' ' ' VAL . . . . . . . . . . . . . 47.7 t -130.61 124.35 56.78 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.324 0 CA-C-N 116.141 -0.481 . . . . 0.0 109.824 179.105 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 126' ' ' ARG . . . . . . . . . . . . . 37.0 mtm105 -145.0 119.72 9.83 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-O 120.973 0.416 . . . . 0.0 110.195 178.248 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 127' ' ' ASN . . . . . . . . . . . . . 89.8 m-20 55.44 -130.17 1.99 Allowed 'General case' 0 CA--C 1.545 0.759 0 CA-C-O 118.516 -0.754 . . . . 0.0 110.196 -179.398 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 128' ' ' ASP . . . . . . . . . . . . . 11.5 p-10 -97.23 10.05 40.55 Favored 'General case' 0 CA--C 1.536 0.417 0 CA-C-N 120.04 1.291 . . . . 0.0 113.237 -178.1 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 129' ' ' LEU . . . . . . . . . . . . . 6.2 tt -109.05 133.57 52.82 Favored 'General case' 0 C--O 1.232 0.178 0 CA-C-N 118.28 0.491 . . . . 0.0 110.065 -179.923 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 130' ' ' VAL . . . . . . . . . . . . . 46.4 t -125.89 137.35 57.99 Favored 'Isoleucine or valine' 0 N--CA 1.462 0.175 0 CA-C-O 120.953 0.406 . . . . 0.0 110.453 -176.947 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 131' ' ' VAL . . . . . 0.538 HG22 HD12 ' B' ' 140' ' ' LEU . 46.9 t -136.1 135.4 50.15 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.277 0 CA-C-N 116.137 -0.483 . . . . 0.0 110.187 178.414 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' B' B ' 132' ' ' ILE . . . . . . . . . . . . . 74.1 mt -120.28 131.65 71.99 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.271 0 N-CA-C 109.708 -0.479 . . . . 0.0 109.708 -179.833 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 133' ' ' ILE . . . . . . . . . . . . . 39.0 mm -117.83 121.47 67.46 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.271 0 CA-C-N 116.493 -0.321 . . . . 0.0 110.868 -176.989 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 134' ' ' ASP . . . . . . . . . . . . . 8.8 p-10 -132.69 149.43 52.29 Favored 'General case' 0 CA--C 1.528 0.128 0 N-CA-C 109.898 -0.408 . . . . 0.0 109.898 173.837 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 135' ' ' GLU . . . . . . . . . . . . . 85.4 tt0 -49.89 -25.5 3.25 Favored 'General case' 0 C--N 1.328 -0.357 0 N-CA-C 113.083 0.771 . . . . 0.0 113.083 -170.315 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 136' ' ' GLN . . . . . . . . . . . . . 97.5 mt-30 -92.86 -29.95 15.68 Favored 'General case' 0 C--N 1.33 -0.269 0 N-CA-C 112.581 0.585 . . . . 0.0 112.581 -173.932 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 137' ' ' LYS . . . . . . . . . . . . . 43.8 pttt -161.11 165.69 29.22 Favored 'General case' 0 C--O 1.233 0.212 0 CA-C-O 121.475 0.655 . . . . 0.0 112.19 -173.221 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 138' ' ' LEU . . . . . . . . . . . . . 7.0 tt -117.44 129.92 56.14 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 115.103 -0.953 . . . . 0.0 110.01 178.798 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 139' ' ' THR . . . . . . . . . . . . . 31.0 m -112.57 128.18 56.29 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.157 -0.474 . . . . 0.0 110.51 -179.888 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 140' ' ' LEU . . . . . 0.538 HD12 HG22 ' B' ' 131' ' ' VAL . 11.5 tp -117.1 120.82 39.51 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 115.814 -0.63 . . . . 0.0 109.352 -178.761 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' B' B ' 141' ' ' ILE . . . . . . . . . . . . . 19.9 mt -116.96 119.69 62.78 Favored 'Isoleucine or valine' 0 C--O 1.233 0.193 0 CA-C-O 121.037 0.446 . . . . 0.0 110.417 -173.657 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 142' ' ' ARG . . . . . . . . . . . . . 84.2 mtp180 -108.06 133.77 51.89 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 115.009 -0.996 . . . . 0.0 110.507 -177.565 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 143' ' ' THR . . . . . . . . . . . . . 15.1 p . . . . . 0 C--O 1.219 -0.503 0 CA-C-O 117.907 -1.044 . . . . 0.0 110.984 179.886 . . . . . . . . 0 0 . 1 . 010 nuclear nobuild full ' C' C ' -3' ' ' GLU . . . . . . . . . . . . . 70.8 mm-40 . . . . . 0 N--CA 1.49 1.529 0 N-CA-C 109.394 -0.595 . . . . 0.0 109.394 . . . . . . . . . 0 0 . 1 . 010 nuclear nobuild full ' C' C ' -2' ' ' GLY . . . . . . . . . . . . . . . -82.09 140.82 21.06 Favored Glycine 0 CA--C 1.524 0.654 0 N-CA-C 110.85 -0.9 . . . . 0.0 110.85 179.398 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' C' C ' -1' ' ' VAL . . . . . . . . . . . . . 46.1 t -95.58 140.61 16.66 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.302 0 CA-C-O 120.785 0.326 . . . . 0.0 110.192 -179.732 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' C' C ' 0' ' ' ILE . . . . . . . . . . . . . 71.1 mt -95.23 131.01 43.19 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.332 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.248 -179.879 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' C' C ' 1' ' ' MET . . . . . . . . . . . . . 25.1 ptp -79.2 148.83 32.12 Favored 'General case' 0 C--N 1.327 -0.395 0 CA-C-N 116.023 -0.535 . . . . 0.0 110.471 178.247 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' C' C ' 2' ' ' SER . . . . . . . . . . . . . 3.3 p -113.73 129.97 56.5 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.315 -0.402 . . . . 0.0 110.487 -179.988 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' C' C ' 3' ' ' GLU . . . . . . . . . . . . . 95.3 mt-10 -140.29 139.34 35.47 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.057 -0.52 . . . . 0.0 110.953 -178.34 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' C' C ' 4' ' ' LEU . . . . . . . . . . . . . 20.2 tp -127.05 128.48 46.35 Favored 'General case' 0 C--N 1.331 -0.221 0 CA-C-N 115.891 -0.595 . . . . 0.0 109.838 176.067 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' C' C ' 5' ' ' LYS . . . . . . . . . . . . . 96.3 mttt -112.48 122.8 48.73 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-O 120.769 0.318 . . . . 0.0 110.872 -178.581 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' C' C ' 6' ' ' LEU . . . . . . . . . . . . . 47.8 mt -114.24 142.61 46.05 Favored 'General case' 0 N--CA 1.462 0.143 0 CA-C-N 115.404 -0.817 . . . . 0.0 110.271 -179.451 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' C' C ' 7' ' ' LYS . . . . . . . . . . . . . 40.1 ttmt -123.45 137.16 28.05 Favored Pre-proline 0 CA--C 1.533 0.305 0 CA-C-O 119.001 -0.523 . . . . 0.0 109.622 175.545 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' C' C ' 8' ' ' PRO . . . . . . . . . . . . . 85.4 Cg_endo -91.83 136.01 1.69 Allowed 'Trans proline' 0 N--CA 1.489 1.231 0 C-N-CA 121.692 1.595 . . . . 0.0 111.895 179.314 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' C' C ' 9' ' ' LEU . . . . . . . . . . . . . 71.1 mt -74.62 -47.65 5.3 Favored Pre-proline 0 CA--C 1.534 0.35 0 CA-C-O 118.578 -0.725 . . . . 0.0 112.283 -179.744 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' C' C ' 10' ' ' PRO . . . . . . . . . . . . . 85.4 Cg_endo -80.15 151.49 20.81 Favored 'Trans proline' 0 N--CA 1.496 1.623 0 C-N-CA 121.162 1.241 . . . . 0.0 111.898 176.82 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' C' C ' 11' ' ' LYS . . . . . . . . . . . . . 50.5 tttp -87.21 98.25 11.22 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-O 120.752 0.311 . . . . 0.0 110.444 178.813 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' C' C ' 12' ' ' VAL . . . . . . . . . . . . . 11.9 p -144.55 144.88 21.86 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.289 0 CA-C-N 116.198 -0.455 . . . . 0.0 110.433 179.954 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' C' C ' 13' ' ' GLU . . . . . . . . . . . . . 95.2 mt-10 -82.05 126.76 32.37 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-N 116.352 -0.385 . . . . 0.0 110.041 177.846 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' C' C ' 14' ' ' LEU . . . . . . . . . . . . . 46.3 mt -95.48 148.48 34.68 Favored Pre-proline 0 C--N 1.329 -0.29 0 CA-C-O 119.235 -0.412 . . . . 0.0 110.4 -179.11 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' C' C ' 15' ' ' PRO . . . . . . . . . . . . . 38.8 Cg_exo -58.65 156.86 30.03 Favored 'Trans proline' 0 N--CA 1.496 1.651 0 C-N-CA 121.187 1.258 . . . . 0.0 111.772 178.97 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' C' C ' 16' ' ' PRO . . . . . . . . . . . . . 35.5 Cg_exo -58.49 -42.84 50.97 Favored 'Trans proline' 0 N--CA 1.498 1.762 0 C-N-CA 121.315 1.344 . . . . 0.0 112.703 -177.206 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' C' C ' 17' ' ' ASP . . . . . . . . . . . . . 12.8 p-10 -86.86 13.21 9.35 Favored 'General case' 0 C--N 1.327 -0.402 0 N-CA-C 112.999 0.741 . . . . 0.0 112.999 -177.961 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' C' C ' 18' ' ' PHE . . . . . . . . . . . . . 44.2 t80 -57.63 -50.52 72.87 Favored 'General case' 0 N--CA 1.456 -0.166 0 O-C-N 121.991 -0.443 . . . . 0.0 110.459 -176.958 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' C' C ' 19' ' ' VAL . . . . . . . . . . . . . 13.9 p -54.25 -40.46 47.62 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.285 0 CA-C-N 116.493 -0.321 . . . . 0.0 111.209 -177.911 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' C' C ' 20' ' ' ASP . . . . . . . . . . . . . 82.5 m-20 -60.53 -44.75 95.75 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-O 120.969 0.414 . . . . 0.0 110.86 -178.566 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' C' C ' 21' ' ' VAL . . . . . . . . . . . . . 46.4 t -64.16 -44.48 97.56 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.319 0 CA-C-N 116.291 -0.413 . . . . 0.0 110.396 -178.141 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' C' C ' 22' ' ' ILE . . . . . 0.669 HG22 HD12 ' C' ' 26' ' ' LEU . 50.6 mm -55.9 -44.71 78.8 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.248 0 C-N-CA 121.026 -0.269 . . . . 0.0 110.712 179.019 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' C' C ' 23' ' ' ARG . . . . . . . . . . . . . 55.5 ttp180 -53.8 -50.61 65.74 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-O 120.674 0.274 . . . . 0.0 111.439 179.727 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' C' C ' 24' ' ' ILE . . . . . . . . . . . . . 66.9 mt -58.34 -42.18 83.24 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.274 0 CA-C-N 116.558 -0.292 . . . . 0.0 110.884 -178.183 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' C' C ' 25' ' ' LYS . . . . . . . . . . . . . 53.1 mtpt -66.71 -43.82 83.29 Favored 'General case' 0 C--N 1.328 -0.367 0 N-CA-C 112.531 0.567 . . . . 0.0 112.531 -177.481 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' C' C ' 26' ' ' LEU . . . . . 0.669 HD12 HG22 ' C' ' 22' ' ' ILE . 62.9 mt -80.47 -36.23 33.74 Favored 'General case' 0 C--N 1.33 -0.256 0 N-CA-C 113.542 0.941 . . . . 0.0 113.542 -169.117 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' C' C ' 27' ' ' GLN . . . . . . . . . . . . . 10.0 pt20 -46.81 141.01 4.21 Favored 'General case' 0 N--CA 1.47 0.573 0 N-CA-C 112.674 0.62 . . . . 0.0 112.674 -176.006 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' C' C ' 28' ' ' GLY . . . . . . . . . . . . . . . 101.23 -25.77 27.02 Favored Glycine 0 CA--C 1.532 1.107 0 CA-C-N 115.752 -0.658 . . . . 0.0 112.235 -175.959 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' C' C ' 29' ' ' LYS . . . . . . . . . . . . . 73.3 mmtt -97.24 155.11 17.0 Favored 'General case' 0 C--O 1.234 0.247 0 CA-C-N 117.462 0.631 . . . . 0.0 111.191 178.46 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' C' C ' 30' ' ' THR . . . . . . . . . . . . . 23.7 m -104.8 136.01 45.11 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 115.807 -0.633 . . . . 0.0 109.785 174.841 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' C' C ' 31' ' ' VAL . . . . . . . . . . . . . 34.3 m -128.34 154.79 39.53 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.254 0 CA-C-O 120.918 0.39 . . . . 0.0 111.022 -176.916 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' C' C ' 32' ' ' ARG . . . . . . . . . . . . . 94.3 mtm-85 -133.32 150.37 51.87 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-O 121.249 0.547 . . . . 0.0 110.625 178.351 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' C' C ' 33' ' ' THR . . . . . . . . . . . . . 25.9 m -52.45 139.89 23.8 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 116.188 -0.46 . . . . 0.0 111.513 -178.327 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' C' C ' 34' ' ' GLY . . . . . . . . . . . . . . . 99.29 -17.06 58.4 Favored Glycine 0 CA--C 1.532 1.143 0 CA-C-O 119.533 -0.593 . . . . 0.0 113.214 179.228 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' C' C ' 35' ' ' ASP . . . . . . . . . . . . . 59.6 m-20 -63.15 149.76 44.48 Favored 'General case' 0 C--O 1.231 0.126 0 CA-C-N 118.138 0.969 . . . . 0.0 110.911 179.205 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' C' C ' 36' ' ' VAL . . . . . . . . . . . . . 42.0 t -122.45 129.33 75.34 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.251 0 CA-C-N 115.897 -0.592 . . . . 0.0 109.766 179.068 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' C' C ' 37' ' ' ILE . . . . . . . . . . . . . 66.2 mt -122.93 138.65 52.28 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.226 0 CA-C-N 116.265 -0.425 . . . . 0.0 109.968 179.815 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' C' C ' 38' ' ' GLY . . . . . . . . . . . . . . . -118.93 129.0 7.91 Favored Glycine 0 CA--C 1.525 0.683 0 N-CA-C 110.891 -0.884 . . . . 0.0 110.891 178.978 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' C' C ' 39' ' ' ILE . . . . . . . . . . . . . 70.2 mt -125.07 134.53 66.66 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.241 0 CA-C-O 120.764 0.316 . . . . 0.0 110.297 179.269 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' C' C ' 40' ' ' SER . . . . . . . . . . . . . 36.3 t -91.3 117.87 30.02 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.078 -0.51 . . . . 0.0 110.723 176.196 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' C' C ' 41' ' ' ILE . . . . . . . . . . . . . 65.7 mt -126.5 122.25 60.63 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.164 0 CA-C-O 120.816 0.341 . . . . 0.0 110.209 179.506 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' C' C ' 42' ' ' LEU . . . . . . . . . . . . . 5.5 mp 52.9 35.88 20.25 Favored 'General case' 0 CA--C 1.532 0.279 0 CA-C-N 116.186 -0.461 . . . . 0.0 111.399 178.099 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' C' C ' 43' ' ' GLY . . . . . . . . . . . . . . . 73.87 27.99 65.73 Favored Glycine 0 CA--C 1.531 1.087 0 C-N-CA 121.15 -0.548 . . . . 0.0 112.542 176.528 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' C' C ' 44' ' ' LYS . . . . . . . . . . . . . 95.7 mttt -139.52 128.71 23.9 Favored 'General case' 0 C--N 1.33 -0.282 0 N-CA-C 109.744 -0.465 . . . . 0.0 109.744 176.971 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' C' C ' 45' ' ' GLU . . . . . . . . . . . . . 85.2 tt0 -84.08 127.75 34.11 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-O 120.882 0.372 . . . . 0.0 111.533 -177.473 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' C' C ' 46' ' ' VAL . . . . . . . . . . . . . 9.3 p -118.41 126.76 75.34 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.21 0 N-CA-C 109.569 -0.53 . . . . 0.0 109.569 174.342 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' C' C ' 47' ' ' LYS . . . . . . . . . . . . . 75.9 mttt -98.28 123.89 42.61 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.044 -0.526 . . . . 0.0 110.808 178.315 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' C' C ' 48' ' ' PHE . . . . . . . . . . . . . 34.5 m-85 -109.18 131.77 54.75 Favored 'General case' 0 C--N 1.329 -0.299 0 N-CA-C 109.691 -0.485 . . . . 0.0 109.691 176.75 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' C' C ' 49' ' ' LYS . . . . . . . . . . . . . 49.1 tttp -107.37 132.54 53.04 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.432 -0.349 . . . . 0.0 110.164 177.638 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' C' C ' 50' ' ' VAL . . . . . . . . . . . . . 44.5 t -75.6 107.25 6.19 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.327 0 N-CA-C 109.594 -0.521 . . . . 0.0 109.594 178.314 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' C' C ' 51' ' ' VAL . . . . . . . . . . . . . 47.1 t -68.94 -49.12 66.12 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.305 0 CA-C-N 116.116 -0.493 . . . . 0.0 109.721 -175.594 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' C' C ' 52' ' ' GLN . . . . . . . . . . . . . 49.1 tt0 -162.84 143.03 9.38 Favored 'General case' 0 C--N 1.329 -0.291 0 C-N-CA 120.211 -0.596 . . . . 0.0 111.773 -178.836 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' C' C ' 53' ' ' ALA . . . . . . . . . . . . . . . -114.86 130.92 56.97 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 115.32 -0.855 . . . . 0.0 109.456 174.096 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' C' C ' 54' ' ' TYR . . . . . . . . . . . . . 22.2 t80 -128.62 110.27 19.0 Favored Pre-proline 0 CA--C 1.534 0.363 0 CA-C-O 118.34 -0.838 . . . . 0.0 110.306 -178.891 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' C' C ' 55' ' ' PRO . . . . . . . . . . . . . 74.5 Cg_endo -77.23 170.06 72.46 Favored 'Cis proline' 0 N--CA 1.499 1.831 0 CA-C-N 121.827 1.688 . . . . 0.0 112.367 -5.623 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' C' C ' 56' ' ' SER . . . . . . . . . . . . . 13.8 m -114.73 129.13 25.25 Favored Pre-proline 0 CA--C 1.538 0.496 0 CA-C-O 118.451 -0.785 . . . . 0.0 109.451 175.855 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' C' C ' 57' ' ' PRO . . . . . . . . . . . . . 59.6 Cg_endo -73.61 148.95 93.29 Favored 'Cis proline' 0 N--CA 1.497 1.689 0 CA-C-N 121.99 1.747 . . . . 0.0 111.759 -0.352 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' C' C ' 58' ' ' LEU . . . . . . . . . . . . . 23.8 tp -108.3 136.6 47.68 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.376 -0.374 . . . . 0.0 110.836 -178.174 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' C' C ' 59' ' ' ARG . . . . . . . . . . . . . 60.1 ttm-85 -103.13 123.21 46.25 Favored 'General case' 0 C--N 1.329 -0.323 0 N-CA-C 109.242 -0.651 . . . . 0.0 109.242 174.779 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' C' C ' 60' ' ' VAL . . . . . . . . . . . . . 44.1 t -80.56 121.6 34.28 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.264 0 C-N-CA 120.712 -0.395 . . . . 0.0 110.246 -176.94 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' C' C ' 61' ' ' GLU . . . . . . . . . . . . . 40.3 mt-10 -130.72 172.37 12.05 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 115.958 -0.565 . . . . 0.0 109.863 178.821 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' C' C ' 62' ' ' ASP . . . . . . . . . . . . . 60.1 m-20 -54.92 -32.52 61.28 Favored 'General case' 0 C--N 1.328 -0.365 0 N-CA-C 111.773 0.286 . . . . 0.0 111.773 -178.978 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' C' C ' 63' ' ' ARG . . . . . . . . . . . . . 17.5 ptm180 -88.92 6.31 39.94 Favored 'General case' 0 CA--C 1.536 0.437 0 N-CA-C 113.507 0.929 . . . . 0.0 113.507 -176.226 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' C' C ' 64' ' ' THR . . . . . . . . . . . . . 32.8 m -82.39 131.53 35.22 Favored 'General case' 0 C--N 1.331 -0.203 0 CA-C-N 118.143 0.429 . . . . 0.0 110.559 -178.874 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' C' C ' 65' ' ' LYS . . . . . . . . . . . . . 96.6 mttt -88.77 129.34 35.58 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.155 -0.475 . . . . 0.0 110.104 179.744 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' C' C ' 66' ' ' ILE . . . . . . . . . . . . . 64.2 mt -114.17 130.36 68.52 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.252 0 N-CA-C 109.82 -0.437 . . . . 0.0 109.82 179.305 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' C' C ' 67' ' ' THR . . . . . . . . . . . . . 22.4 m -121.53 140.09 52.66 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-N 116.118 -0.492 . . . . 0.0 111.0 -177.732 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' C' C ' 68' ' ' LEU . . . . . . . . . . . . . 44.1 mt -103.71 132.31 50.08 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 115.832 -0.622 . . . . 0.0 110.415 178.173 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' C' C ' 69' ' ' VAL . . . . . . . . . . . . . 42.0 t -96.95 144.44 10.59 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.367 0 CA-C-N 116.164 -0.471 . . . . 0.0 109.891 178.461 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' C' C ' 70' ' ' THR . . . . . . . . . . . . . 68.6 p -130.54 45.34 2.83 Favored 'General case' 0 C--N 1.331 -0.203 0 CA-C-O 121.408 0.623 . . . . 0.0 110.866 -176.675 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' C' C ' 71' ' ' HIS . . . . . . . . . . . . . 58.5 t-80 -131.07 66.23 78.54 Favored Pre-proline 0 CA--C 1.536 0.421 0 CA-C-N 116.097 -0.502 . . . . 0.0 110.277 178.196 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' C' C ' 72' ' ' PRO . . . . . . . . . . . . . 97.7 Cg_endo -91.97 160.04 3.31 Favored 'Trans proline' 0 N--CA 1.49 1.277 0 C-N-CA 121.999 1.799 . . . . 0.0 112.412 179.263 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' C' C ' 73' ' ' VAL . . . . . . . . . . . . . 27.6 m -103.0 165.07 3.15 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.232 0 CA-C-N 116.314 -0.403 . . . . 0.0 110.191 177.326 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' C' C ' 74' ' ' ASP . . . . . 0.436 ' OD1' HD11 ' C' ' 76' ' ' LEU . 3.1 t70 -105.53 121.68 44.44 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.273 -0.421 . . . . 0.0 109.964 -178.563 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' C' C ' 75' ' ' VAL . . . . . 0.42 ' C ' HD12 ' C' ' 76' ' ' LEU . 40.4 t -117.47 123.77 72.19 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.229 0 CA-C-O 121.095 0.474 . . . . 0.0 110.566 -177.41 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' C' C ' 76' ' ' LEU . . . . . 0.455 ' N ' HD12 ' C' ' 76' ' ' LEU . 7.0 mp -117.86 142.0 47.8 Favored 'General case' 0 C--N 1.332 -0.189 0 CA-C-N 115.683 -0.689 . . . . 0.0 109.468 176.147 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' C' C ' 77' ' ' GLU . . . . . . . . . . . . . 96.5 mt-10 -133.02 136.94 46.3 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-O 121.022 0.439 . . . . 0.0 111.259 -178.261 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' C' C ' 78' ' ' ALA . . . . . . . . . . . . . . . -126.84 135.44 51.0 Favored 'General case' 0 C--N 1.331 -0.225 0 CA-C-N 115.8 -0.636 . . . . 0.0 109.877 176.428 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' C' C ' 79' ' ' LYS . . . . . 0.477 ' O ' HD13 ' C' ' 80' ' ' ILE . 90.6 mttt -74.72 122.82 23.85 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-O 120.802 0.334 . . . . 0.0 110.553 -179.678 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' C' C ' 80' ' ' ILE . . . . . 0.477 HD13 ' O ' ' C' ' 79' ' ' LYS . 26.0 mm -139.16 113.36 7.27 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.306 0 N-CA-C 109.059 -0.719 . . . . 0.0 109.059 -178.47 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' C' C ' 81' ' ' LYS . . . . . . . . . . . . . 19.5 pttp -105.88 124.69 49.97 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-O 121.02 0.438 . . . . 0.0 111.363 -176.225 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' C' C ' 82' ' ' GLY . . . . . . . . . . . . . . . 88.99 42.09 5.73 Favored Glycine 0 CA--C 1.525 0.702 0 C-N-CA 120.73 -0.748 . . . . 0.0 111.75 173.152 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' C' C ' 83' ' ' ILE . . . . . . . . . . . . . 72.9 mt -65.75 136.14 27.2 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.311 0 CA-C-O 121.001 0.429 . . . . 0.0 110.081 178.668 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' C' C ' 84' ' ' LYS . . . . . . . . . . . . . 33.8 tttp -97.42 -53.54 3.43 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 115.824 -0.625 . . . . 0.0 110.128 -178.988 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' C' C ' 85' ' ' ASP . . . . . . . . . . . . . 12.7 t70 -153.99 153.16 31.48 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 115.596 -0.729 . . . . 0.0 110.251 179.569 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' C' C ' 86' ' ' VAL . . . . . . . . . . . . . 47.2 t -129.75 131.32 66.69 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.258 0 CA-C-O 121.003 0.43 . . . . 0.0 110.552 -179.312 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' C' C ' 87' ' ' ILE . . . . . . . . . . . . . 4.8 mp -119.92 127.28 75.88 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.236 0 CA-C-N 115.738 -0.664 . . . . 0.0 109.509 175.529 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' C' C ' 88' ' ' LEU . . . . . . . . . . . . . 11.0 tp -112.66 130.19 56.13 Favored 'General case' 0 C--N 1.331 -0.198 0 CA-C-O 120.994 0.425 . . . . 0.0 111.083 -177.144 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' C' C ' 89' ' ' ASP . . . . . . . . . . . . . 6.3 t70 -128.64 154.25 46.45 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 115.884 -0.598 . . . . 0.0 109.749 177.087 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' C' C ' 90' ' ' GLU . . . . . . . . . . . . . 81.4 tt0 -47.52 -41.41 20.95 Favored 'General case' 0 N--CA 1.464 0.229 0 N-CA-C 112.915 0.709 . . . . 0.0 112.915 -172.952 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' C' C ' 91' ' ' ASN . . . . . . . . . . . . . 19.7 m120 -121.54 16.79 11.25 Favored 'General case' 0 N--CA 1.467 0.401 0 N-CA-C 113.255 0.835 . . . . 0.0 113.255 -175.938 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' C' C ' 92' ' ' LEU . . . . . . . . . . . . . 55.2 mt -150.97 142.78 23.8 Favored 'General case' 0 C--N 1.332 -0.193 0 CA-C-O 120.818 0.342 . . . . 0.0 110.33 -177.096 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' C' C ' 93' ' ' ILE . . . . . . . . . . . . . 69.1 mt -123.28 115.41 45.45 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.32 0 N-CA-C 108.904 -0.776 . . . . 0.0 108.904 175.767 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' C' C ' 94' ' ' VAL . . . . . . . . . . . . . 45.2 t -116.58 123.9 72.11 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.308 0 CA-C-O 120.886 0.374 . . . . 0.0 110.085 -176.765 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' C' C ' 95' ' ' VAL . . . . . . . . . . . . . 42.2 t -121.04 131.92 71.79 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 CA-C-N 116.001 -0.545 . . . . 0.0 109.788 -179.815 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' C' C ' 96' ' ' ILE . . . . . 0.508 HD11 ' HB ' ' C' ' 123' ' ' VAL . 62.9 mt -112.94 127.16 70.33 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.284 0 N-CA-C 109.366 -0.605 . . . . 0.0 109.366 179.439 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' C' C ' 97' ' ' THR . . . . . . . . . . . . . 81.0 p -96.89 154.36 17.34 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-O 120.896 0.379 . . . . 0.0 110.733 -178.965 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' C' C ' 98' ' ' GLU . . . . . . . . . . . . . 97.3 mt-10 -53.91 -25.85 22.27 Favored 'General case' 0 C--N 1.328 -0.329 0 N-CA-C 112.335 0.495 . . . . 0.0 112.335 -179.722 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' C' C ' 99' ' ' GLU . . . . . . . . . . . . . 94.3 mt-10 -77.11 12.27 1.5 Allowed 'General case' 0 CA--C 1.537 0.466 0 N-CA-C 113.218 0.822 . . . . 0.0 113.218 -178.147 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' C' C ' 100' ' ' ASN . . . . . . . . . . . . . 4.0 m-20 65.08 32.81 10.03 Favored 'General case' 0 CA--C 1.531 0.248 0 CA-C-N 117.998 0.363 . . . . 0.0 111.68 178.242 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' C' C ' 101' ' ' GLU . . . . . . . . . . . . . 84.6 tt0 -112.26 143.48 43.27 Favored 'General case' 0 C--O 1.232 0.162 0 N-CA-C 109.457 -0.572 . . . . 0.0 109.457 173.149 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' C' C ' 102' ' ' VAL . . . . . . . . . . . . . 45.3 t -115.52 127.76 72.99 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.336 0 CA-C-O 120.886 0.374 . . . . 0.0 110.165 -177.591 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' C' C ' 103' ' ' LEU . . . . . . . . . . . . . 42.0 mt -114.8 127.42 55.72 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 115.489 -0.778 . . . . 0.0 109.874 176.518 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' C' C ' 104' ' ' ILE . . . . . 0.464 HD12 ' HB3' ' C' ' 113' ' ' TYR . 66.7 mt -116.48 118.52 59.05 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.292 0 N-CA-C 110.054 -0.351 . . . . 0.0 110.054 179.955 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' C' C ' 105' ' ' PHE . . . . . . . . . . . . . 63.8 m-85 -118.37 164.85 14.63 Favored 'General case' 0 C--N 1.333 -0.146 0 O-C-N 123.952 0.782 . . . . 0.0 110.523 179.613 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' C' C ' 106' ' ' ASN . . . . . . . . . . . . . 45.8 p-10 -97.96 -169.97 1.91 Allowed 'General case' 0 C--N 1.33 -0.28 0 N-CA-C 109.699 -0.482 . . . . 0.0 109.699 171.868 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' C' C ' 107' ' ' GLN . . . . . . . . . . . . . 58.7 tt0 -57.66 -29.11 64.35 Favored 'General case' 0 C--N 1.329 -0.291 0 N-CA-C 112.044 0.387 . . . . 0.0 112.044 -179.682 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' C' C ' 108' ' ' ASN . . . . . . . . . . . . . 50.8 t30 -90.4 14.08 13.85 Favored 'General case' 0 CA--C 1.534 0.329 0 N-CA-C 113.103 0.779 . . . . 0.0 113.103 -175.661 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' C' C ' 109' ' ' LEU . . . . . . . . . . . . . 59.9 mt 58.43 35.69 24.89 Favored 'General case' 0 CA--C 1.529 0.165 0 CA-C-O 120.775 0.321 . . . . 0.0 111.651 176.783 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' C' C ' 110' ' ' GLU . . . . . . . . . . . . . 95.4 mt-10 -101.78 152.85 20.38 Favored 'General case' 0 C--N 1.33 -0.254 0 N-CA-C 109.566 -0.531 . . . . 0.0 109.566 175.313 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' C' C ' 111' ' ' GLU . . . . . . . . . . . . . 44.0 tp10 -82.21 121.93 27.25 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-O 120.903 0.382 . . . . 0.0 110.954 -177.673 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' C' C ' 112' ' ' LEU . . . . . . . . . . . . . 17.6 mt -106.53 -45.94 4.12 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.006 -0.543 . . . . 0.0 110.147 177.319 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' C' C ' 113' ' ' TYR . . . . . 0.464 ' HB3' HD12 ' C' ' 104' ' ' ILE . 59.6 t80 -137.88 135.56 36.26 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.079 -0.51 . . . . 0.0 110.929 179.153 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' C' C ' 114' ' ' ARG . . . . . . . . . . . . . 41.1 ttm180 -135.7 119.82 17.67 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.027 -0.533 . . . . 0.0 110.038 177.474 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' C' C ' 115' ' ' GLY . . . . . . . . . . . . . . . -150.03 159.14 27.98 Favored Glycine 0 CA--C 1.525 0.664 0 N-CA-C 111.016 -0.834 . . . . 0.0 111.016 179.168 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' C' C ' 116' ' ' LYS . . . . . . . . . . . . . 69.4 tttt -131.15 130.32 42.91 Favored 'General case' 0 C--N 1.329 -0.316 0 N-CA-C 109.963 -0.384 . . . . 0.0 109.963 178.122 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' C' C ' 117' ' ' PHE . . . . . 0.422 ' CE2' HG21 ' C' ' 132' ' ' ILE . 41.7 m-85 -125.83 117.3 23.09 Favored 'General case' 0 C--N 1.331 -0.215 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.228 -175.271 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' C' C ' 118' ' ' GLU . . . . . . . . . . . . . 81.9 tt0 -51.94 -46.68 64.82 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.428 -0.351 . . . . 0.0 111.702 -176.422 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' C' C ' 119' ' ' ASN . . . . . . . . . . . . . 83.6 m-20 -101.47 31.26 3.82 Favored 'General case' 0 C--N 1.33 -0.239 0 N-CA-C 112.174 0.435 . . . . 0.0 112.174 -173.971 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' C' C ' 120' ' ' LEU . . . . . . . . . . . . . 13.8 tp -53.53 122.97 10.83 Favored 'General case' 0 N--CA 1.464 0.254 0 CA-C-O 120.832 0.349 . . . . 0.0 111.078 179.506 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' C' C ' 121' ' ' ASN . . . . . . . . . . . . . 9.9 t-20 -112.86 -44.07 3.35 Favored 'General case' 0 C--N 1.331 -0.199 0 CA-C-N 116.257 -0.429 . . . . 0.0 110.746 -177.507 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' C' C ' 122' ' ' LYS . . . . . . . . . . . . . 98.4 mttt -147.98 148.53 30.84 Favored 'General case' 0 C--N 1.332 -0.181 0 CA-C-O 121.061 0.458 . . . . 0.0 111.855 -178.593 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' C' C ' 123' ' ' VAL . . . . . 0.508 ' HB ' HD11 ' C' ' 96' ' ' ILE . 45.1 t -129.41 124.58 60.17 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.316 0 N-CA-C 109.175 -0.676 . . . . 0.0 109.175 173.278 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' C' C ' 124' ' ' LEU . . . . . . . . . . . . . 48.0 mt -129.55 143.79 50.98 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-O 120.946 0.403 . . . . 0.0 110.988 -176.175 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' C' C ' 125' ' ' VAL . . . . . . . . . . . . . 11.4 p -135.95 138.64 47.23 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.249 0 CA-C-N 115.881 -0.599 . . . . 0.0 110.235 178.752 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' C' C ' 126' ' ' ARG . . . . . . . . . . . . . 26.8 ttm180 -144.46 127.64 16.66 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-N 116.209 -0.45 . . . . 0.0 110.224 178.557 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' C' C ' 127' ' ' ASN . . . . . . . . . . . . . 80.7 m-20 53.16 -110.4 0.53 Allowed 'General case' 0 CA--C 1.545 0.772 0 CA-C-O 118.843 -0.599 . . . . 0.0 110.927 -179.402 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' C' C ' 128' ' ' ASP . . . . . . . . . . . . . 19.0 p-10 -114.2 5.64 15.96 Favored 'General case' 0 CA--C 1.536 0.416 0 CA-C-N 119.893 1.224 . . . . 0.0 113.384 -177.819 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' C' C ' 129' ' ' LEU . . . . . . . . . . . . . 58.4 mt -108.6 141.11 41.01 Favored 'General case' 0 C--N 1.334 -0.093 0 CA-C-N 118.133 0.424 . . . . 0.0 110.351 -179.185 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' C' C ' 130' ' ' VAL . . . . . 0.403 HG11 HD13 ' C' ' 104' ' ' ILE . 42.5 t -122.69 136.73 58.54 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.246 0 N-CA-C 109.884 -0.413 . . . . 0.0 109.884 -179.806 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' C' C ' 131' ' ' VAL . . . . . 0.447 HG22 HD12 ' C' ' 140' ' ' LEU . 44.3 t -134.63 135.14 53.88 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.214 0 CA-C-O 121.066 0.46 . . . . 0.0 110.342 -179.591 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' C' C ' 132' ' ' ILE . . . . . 0.422 HG21 ' CE2' ' C' ' 117' ' ' PHE . 68.9 mt -118.43 131.21 71.86 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.264 0 CA-C-N 115.753 -0.658 . . . . 0.0 109.371 178.854 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' C' C ' 133' ' ' ILE . . . . . . . . . . . . . 40.4 mm -116.07 122.77 70.33 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.237 0 CA-C-N 116.515 -0.311 . . . . 0.0 110.913 -175.301 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' C' C ' 134' ' ' ASP . . . . . . . . . . . . . 7.1 p-10 -133.62 148.74 51.58 Favored 'General case' 0 C--N 1.331 -0.224 0 N-CA-C 110.043 -0.354 . . . . 0.0 110.043 174.934 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' C' C ' 135' ' ' GLU . . . . . . . . . . . . . 81.3 tt0 -49.72 -25.11 2.69 Favored 'General case' 0 C--N 1.327 -0.384 0 N-CA-C 112.99 0.737 . . . . 0.0 112.99 -172.206 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' C' C ' 136' ' ' GLN . . . . . . . . . . . . . 63.1 tt0 -88.51 -37.52 15.69 Favored 'General case' 0 C--O 1.234 0.24 0 N-CA-C 112.111 0.411 . . . . 0.0 112.111 -175.656 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' C' C ' 137' ' ' LYS . . . . . . . . . . . . . 45.0 pttt -159.44 169.08 24.7 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-O 121.568 0.699 . . . . 0.0 112.252 -171.34 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' C' C ' 138' ' ' LEU . . . . . 0.449 HD23 ' C ' ' C' ' 138' ' ' LEU . 6.4 tt -116.33 126.43 53.51 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 114.942 -1.027 . . . . 0.0 109.829 178.362 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' C' C ' 139' ' ' THR . . . . . 0.411 ' N ' HD23 ' C' ' 138' ' ' LEU . 49.8 m -107.73 128.4 54.54 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.178 -0.464 . . . . 0.0 110.357 179.928 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' C' C ' 140' ' ' LEU . . . . . 0.447 HD12 HG22 ' C' ' 131' ' ' VAL . 9.5 tp -114.36 122.65 47.34 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 115.736 -0.665 . . . . 0.0 109.368 -178.748 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' C' C ' 141' ' ' ILE . . . . . . . . . . . . . 19.6 mt -120.18 124.57 72.9 Favored 'Isoleucine or valine' 0 C--O 1.234 0.238 0 CA-C-O 120.912 0.387 . . . . 0.0 110.034 -173.402 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' C' C ' 142' ' ' ARG . . . . . . . . . . . . . 64.9 mtt180 -114.05 130.43 56.56 Favored 'General case' 0 C--O 1.233 0.19 0 CA-C-N 115.574 -0.739 . . . . 0.0 110.05 -175.77 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' C' C ' 143' ' ' THR . . . . . . . . . . . . . 22.5 p . . . . . 0 C--O 1.219 -0.507 0 CA-C-O 118.014 -0.993 . . . . 0.0 110.542 -179.634 . . . . . . . . 0 0 . 1 . 010 nuclear nobuild full ' D' D ' -3' ' ' GLU . . . . . . . . . . . . . 85.6 tt0 . . . . . 0 N--CA 1.49 1.547 0 N-CA-C 109.303 -0.629 . . . . 0.0 109.303 . . . . . . . . . 0 0 . 1 . 010 nuclear nobuild full ' D' D ' -2' ' ' GLY . . . . . . . . . . . . . . . -72.12 137.0 24.58 Favored Glycine 0 CA--C 1.524 0.62 0 N-CA-C 111.256 -0.738 . . . . 0.0 111.256 -178.644 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' D' D ' -1' ' ' VAL . . . . . . . . . . . . . 41.7 t -96.45 135.35 30.86 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.337 0 N-CA-C 110.179 -0.304 . . . . 0.0 110.179 179.424 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' D' D ' 0' ' ' ILE . . . . . . . . . . . . . 45.9 mm -115.36 138.01 47.09 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.201 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.115 179.761 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' D' D ' 1' ' ' MET . . . . . . . . . . . . . 24.5 ptp -143.89 163.23 34.02 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.313 -0.403 . . . . 0.0 110.789 -179.435 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' D' D ' 2' ' ' SER . . . . . . . . . . . . . 99.1 p -114.71 157.06 23.67 Favored 'General case' 0 N--CA 1.462 0.149 0 CA-C-N 116.247 -0.433 . . . . 0.0 110.761 -178.357 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' D' D ' 3' ' ' GLU . . . . . . . . . . . . . 95.7 mt-10 -141.65 145.28 34.77 Favored 'General case' 0 C--N 1.331 -0.223 0 CA-C-N 116.031 -0.531 . . . . 0.0 111.246 -177.56 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' D' D ' 4' ' ' LEU . . . . . . . . . . . . . 15.4 tp -125.58 129.45 49.71 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-N 116.047 -0.524 . . . . 0.0 109.936 174.828 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' D' D ' 5' ' ' LYS . . . . . . . . . . . . . 52.4 mttm -110.63 123.63 50.37 Favored 'General case' 0 C--O 1.233 0.235 0 CA-C-O 120.71 0.291 . . . . 0.0 110.857 -179.248 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' D' D ' 6' ' ' LEU . . . . . . . . . . . . . 68.9 mt -116.63 144.57 44.24 Favored 'General case' 0 C--N 1.333 -0.148 0 CA-C-N 115.739 -0.664 . . . . 0.0 110.554 179.838 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' D' D ' 7' ' ' LYS . . . . . . . . . . . . . 55.3 tttm -126.93 141.84 41.79 Favored Pre-proline 0 CA--C 1.533 0.305 0 N-CA-C 109.704 -0.48 . . . . 0.0 109.704 175.293 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' D' D ' 8' ' ' PRO . . . . . . . . . . . . . 87.5 Cg_endo -91.4 144.15 3.17 Favored 'Trans proline' 0 N--CA 1.49 1.308 0 C-N-CA 121.645 1.563 . . . . 0.0 112.271 179.577 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' D' D ' 9' ' ' LEU . . . . . . . . . . . . . 49.6 mt -85.46 -47.17 0.61 Allowed Pre-proline 0 C--N 1.328 -0.334 0 CA-C-O 118.645 -0.693 . . . . 0.0 112.024 178.131 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' D' D ' 10' ' ' PRO . . . . . . . . . . . . . 86.4 Cg_endo -81.03 154.88 19.62 Favored 'Trans proline' 0 N--CA 1.495 1.605 0 C-N-CA 121.244 1.296 . . . . 0.0 111.8 175.956 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' D' D ' 11' ' ' LYS . . . . . . . . . . . . . 60.3 mttp -87.79 95.16 9.98 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-O 120.846 0.355 . . . . 0.0 110.654 178.824 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' D' D ' 12' ' ' VAL . . . . . . . . . . . . . 11.3 p -142.08 139.07 30.51 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.268 0 CA-C-N 116.133 -0.485 . . . . 0.0 110.303 178.691 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' D' D ' 13' ' ' GLU . . . . . . . . . . . . . 42.2 mp0 -82.5 127.15 33.04 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.311 -0.404 . . . . 0.0 110.06 178.313 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' D' D ' 14' ' ' LEU . . . . . . . . . . . . . 47.0 mt -93.68 149.69 37.53 Favored Pre-proline 0 C--N 1.329 -0.288 0 CA-C-O 119.207 -0.425 . . . . 0.0 110.27 -178.917 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' D' D ' 15' ' ' PRO . . . . . . . . . . . . . 25.6 Cg_exo -61.74 159.41 33.05 Favored 'Trans proline' 0 N--CA 1.497 1.7 0 C-N-CA 121.158 1.238 . . . . 0.0 111.381 177.007 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' D' D ' 16' ' ' PRO . . . . . . . . . . . . . 26.5 Cg_exo -60.78 -31.98 92.42 Favored 'Trans proline' 0 N--CA 1.497 1.731 0 C-N-CA 121.368 1.378 . . . . 0.0 112.362 -179.343 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' D' D ' 17' ' ' ASP . . . . . . . . . . . . . 10.2 p-10 -90.38 9.19 29.94 Favored 'General case' 0 CA--C 1.536 0.423 0 N-CA-C 113.166 0.802 . . . . 0.0 113.166 -178.506 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' D' D ' 18' ' ' PHE . . . . . . . . . . . . . 41.2 t80 -57.86 -46.73 84.38 Favored 'General case' 0 CA--C 1.522 -0.108 0 O-C-N 122.006 -0.434 . . . . 0.0 110.298 -176.915 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' D' D ' 19' ' ' VAL . . . . . . . . . . . . . 45.9 t -55.33 -44.25 74.67 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.259 0 CA-C-N 116.379 -0.373 . . . . 0.0 110.8 -177.555 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' D' D ' 20' ' ' ASP . . . . . . . . . . . . . 75.6 m-20 -59.87 -43.63 94.61 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-O 120.86 0.362 . . . . 0.0 110.965 -176.918 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' D' D ' 21' ' ' VAL . . . . . . . . . . . . . 48.9 t -64.62 -47.68 87.93 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.251 0 C-N-CA 120.817 -0.353 . . . . 0.0 110.54 -177.861 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' D' D ' 22' ' ' ILE . . . . . 0.544 HG22 HD12 ' D' ' 26' ' ' LEU . 47.1 mm -56.05 -44.4 78.47 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.282 0 CA-C-O 120.796 0.332 . . . . 0.0 110.557 179.3 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' D' D ' 23' ' ' ARG . . . . . . . . . . . . . 54.6 ttp180 -53.22 -52.29 59.4 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-O 120.848 0.356 . . . . 0.0 111.378 -179.662 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' D' D ' 24' ' ' ILE . . . . . . . . . . . . . 71.8 mt -59.08 -40.94 82.02 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.268 0 CA-C-N 116.232 -0.44 . . . . 0.0 111.404 -176.561 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' D' D ' 25' ' ' LYS . . . . . . . . . . . . . 55.8 mmtt -67.89 -39.88 83.57 Favored 'General case' 0 C--N 1.33 -0.279 0 N-CA-C 112.462 0.541 . . . . 0.0 112.462 -178.796 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' D' D ' 26' ' ' LEU . . . . . 0.544 HD12 HG22 ' D' ' 22' ' ' ILE . 76.2 mt -78.29 -39.29 40.31 Favored 'General case' 0 C--N 1.329 -0.284 0 N-CA-C 113.255 0.835 . . . . 0.0 113.255 -169.825 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' D' D ' 27' ' ' GLN . . . . . . . . . . . . . 10.1 pt20 -46.6 138.67 5.74 Favored 'General case' 0 N--CA 1.47 0.559 0 N-CA-C 112.742 0.645 . . . . 0.0 112.742 -175.81 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' D' D ' 28' ' ' GLY . . . . . . . . . . . . . . . 102.34 -26.3 24.71 Favored Glycine 0 CA--C 1.533 1.174 0 CA-C-N 115.638 -0.71 . . . . 0.0 112.297 -176.767 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' D' D ' 29' ' ' LYS . . . . . . . . . . . . . 61.5 mttm -98.45 155.19 17.37 Favored 'General case' 0 CA--C 1.528 0.105 0 CA-C-N 117.364 0.582 . . . . 0.0 111.045 178.191 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' D' D ' 30' ' ' THR . . . . . . . . . . . . . 55.5 m -107.2 138.72 42.87 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-N 116.155 -0.475 . . . . 0.0 109.906 175.937 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' D' D ' 31' ' ' VAL . . . . . . . . . . . . . 34.7 m -130.43 159.07 42.78 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.232 0 CA-C-O 120.817 0.341 . . . . 0.0 111.019 -178.016 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' D' D ' 32' ' ' ARG . . . . . . . . . . . . . 96.8 mtt180 -132.58 149.07 52.37 Favored 'General case' 0 C--N 1.332 -0.176 0 CA-C-N 115.934 -0.576 . . . . 0.0 110.662 178.65 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' D' D ' 33' ' ' THR . . . . . . . . . . . . . 18.7 m -52.96 140.4 24.93 Favored 'General case' 0 C--N 1.331 -0.23 0 CA-C-N 116.33 -0.396 . . . . 0.0 111.412 -179.387 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' D' D ' 34' ' ' GLY . . . . . . . . . . . . . . . 99.17 -17.1 58.48 Favored Glycine 0 CA--C 1.532 1.13 0 CA-C-O 119.62 -0.545 . . . . 0.0 113.274 179.335 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' D' D ' 35' ' ' ASP . . . . . . . . . . . . . 77.9 m-20 -66.61 148.9 51.26 Favored 'General case' 0 C--O 1.231 0.112 0 CA-C-N 118.037 0.919 . . . . 0.0 111.131 179.076 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' D' D ' 36' ' ' VAL . . . . . . . . . . . . . 45.5 t -119.56 128.7 75.88 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.213 0 CA-C-N 115.931 -0.577 . . . . 0.0 109.734 177.962 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' D' D ' 37' ' ' ILE . . . . . . . . . . . . . 63.3 mt -120.1 138.25 51.29 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.271 0 CA-C-N 116.158 -0.474 . . . . 0.0 109.83 -179.179 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' D' D ' 38' ' ' GLY . . . . . . . . . . . . . . . -118.38 128.86 7.91 Favored Glycine 0 CA--C 1.524 0.638 0 N-CA-C 111.058 -0.817 . . . . 0.0 111.058 -179.859 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' D' D ' 39' ' ' ILE . . . . . . . . . . . . . 68.0 mt -123.88 129.78 74.2 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.196 0 N-CA-C 110.026 -0.361 . . . . 0.0 110.026 178.808 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' D' D ' 40' ' ' SER . . . . . . . . . . . . . 20.3 t -92.09 117.42 29.82 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.142 -0.481 . . . . 0.0 110.734 176.453 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' D' D ' 41' ' ' ILE . . . . . . . . . . . . . 72.6 mt -131.95 122.56 49.43 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.232 0 CA-C-O 120.813 0.34 . . . . 0.0 110.095 178.376 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' D' D ' 42' ' ' LEU . . . . . . . . . . . . . 76.3 mt 58.3 34.9 24.48 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.023 -0.535 . . . . 0.0 111.506 179.012 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' D' D ' 43' ' ' GLY . . . . . . . . . . . . . . . 77.23 -10.15 22.8 Favored Glycine 0 CA--C 1.535 1.342 0 CA-C-O 119.785 -0.453 . . . . 0.0 113.427 178.123 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' D' D ' 44' ' ' LYS . . . . . . . . . . . . . 21.4 tptm -99.86 128.21 45.97 Favored 'General case' 0 C--N 1.332 -0.175 0 CA-C-N 117.915 0.858 . . . . 0.0 110.064 178.452 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' D' D ' 45' ' ' GLU . . . . . . . . . . . . . 85.0 tt0 -85.25 129.65 34.76 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.393 -0.367 . . . . 0.0 111.239 179.911 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' D' D ' 46' ' ' VAL . . . . . 0.423 HG13 ' O ' ' D' ' 46' ' ' VAL . 10.3 p -119.14 124.19 72.69 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.16 0 N-CA-C 109.654 -0.499 . . . . 0.0 109.654 174.82 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' D' D ' 47' ' ' LYS . . . . . . . . . . . . . 63.6 mttp -98.19 125.07 43.08 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.072 -0.513 . . . . 0.0 110.614 177.24 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' D' D ' 48' ' ' PHE . . . . . . . . . . . . . 40.0 m-85 -111.4 131.83 54.9 Favored 'General case' 0 C--N 1.329 -0.29 0 N-CA-C 109.481 -0.562 . . . . 0.0 109.481 176.985 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' D' D ' 49' ' ' LYS . . . . . . . . . . . . . 42.2 tttp -107.36 132.1 53.52 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.29 -0.413 . . . . 0.0 110.206 179.08 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' D' D ' 50' ' ' VAL . . . . . . . . . . . . . 41.9 t -74.86 105.03 3.59 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.289 0 N-CA-C 109.34 -0.615 . . . . 0.0 109.34 177.495 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' D' D ' 51' ' ' VAL . . . . . . . . . . . . . 51.4 t -72.3 -48.6 47.55 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.331 0 CA-C-N 116.182 -0.463 . . . . 0.0 109.996 -174.038 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' D' D ' 52' ' ' GLN . . . . . . . . . . . . . 60.2 tt0 -162.21 148.21 13.13 Favored 'General case' 0 C--N 1.329 -0.29 0 C-N-CA 120.242 -0.583 . . . . 0.0 111.757 -179.21 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' D' D ' 53' ' ' ALA . . . . . . . . . . . . . . . -126.33 134.47 51.09 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 115.597 -0.729 . . . . 0.0 110.117 177.892 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' D' D ' 54' ' ' TYR . . . . . . . . . . . . . 59.9 t80 -129.09 111.06 18.3 Favored Pre-proline 0 CA--C 1.535 0.376 0 CA-C-O 118.198 -0.906 . . . . 0.0 110.086 177.879 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' D' D ' 55' ' ' PRO . . . . . . . . . . . . . 72.5 Cg_endo -77.19 169.93 72.86 Favored 'Cis proline' 0 N--CA 1.5 1.887 0 CA-C-N 121.932 1.726 . . . . 0.0 112.643 -4.822 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' D' D ' 56' ' ' SER . . . . . . . . . . . . . 13.6 m -118.49 130.82 24.55 Favored Pre-proline 0 CA--C 1.539 0.545 0 CA-C-O 118.431 -0.795 . . . . 0.0 109.743 174.737 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' D' D ' 57' ' ' PRO . . . . . . . . . . . . . 32.9 Cg_endo -65.16 167.65 46.12 Favored 'Cis proline' 0 N--CA 1.498 1.753 0 CA-C-N 121.953 1.733 . . . . 0.0 111.147 -2.952 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' D' D ' 58' ' ' LEU . . . . . . . . . . . . . 14.9 tp -128.38 134.79 48.9 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-O 121.069 0.461 . . . . 0.0 110.255 -179.812 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' D' D ' 59' ' ' ARG . . . . . . . . . . . . . 58.6 ttt-85 -103.05 119.58 39.11 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 115.406 -0.815 . . . . 0.0 109.133 176.817 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' D' D ' 60' ' ' VAL . . . . . . . . . . . . . 40.6 t -74.17 117.07 17.57 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.315 0 C-N-CA 120.867 -0.333 . . . . 0.0 110.731 -172.939 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' D' D ' 61' ' ' GLU . . . . . . . . . . . . . 40.5 mt-10 -131.08 161.18 32.62 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 115.982 -0.554 . . . . 0.0 109.952 175.977 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' D' D ' 62' ' ' ASP . . . . . . . . . . . . . 61.6 m-20 -52.09 -31.43 30.44 Favored 'General case' 0 C--N 1.328 -0.33 0 N-CA-C 112.157 0.428 . . . . 0.0 112.157 -177.664 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' D' D ' 63' ' ' ARG . . . . . . . . . . . . . 78.3 mtp180 -72.58 -22.04 61.05 Favored 'General case' 0 CA--C 1.532 0.268 0 N-CA-C 113.091 0.775 . . . . 0.0 113.091 -174.607 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' D' D ' 64' ' ' THR . . . . . . . . . . . . . 34.5 m -71.2 140.39 50.45 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-O 120.888 0.375 . . . . 0.0 111.244 -175.118 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' D' D ' 65' ' ' LYS . . . . . . . . . . . . . 3.9 mptp? -90.06 138.76 31.24 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 115.85 -0.614 . . . . 0.0 110.261 178.196 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' D' D ' 66' ' ' ILE . . . . . . . . . . . . . 60.6 mt -114.1 128.25 71.15 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.231 0 N-CA-C 109.658 -0.497 . . . . 0.0 109.658 178.754 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' D' D ' 67' ' ' THR . . . . . . . . . . . . . 15.5 m -122.35 146.71 47.07 Favored 'General case' 0 C--N 1.332 -0.159 0 CA-C-O 121.233 0.54 . . . . 0.0 111.133 -176.253 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' D' D ' 68' ' ' LEU . . . . . . . . . . . . . 15.1 tp -102.38 140.46 36.63 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 115.647 -0.706 . . . . 0.0 110.765 -179.467 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' D' D ' 69' ' ' VAL . . . . . 0.4 HG12 ' N ' ' D' ' 70' ' ' THR . 46.6 t -82.93 155.3 3.85 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 CA-C-N 116.078 -0.51 . . . . 0.0 109.848 177.851 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' D' D ' 70' ' ' THR . . . . . 0.412 HG22 ' N ' ' D' ' 71' ' ' HIS . 7.6 m -79.62 158.82 26.99 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-O 121.116 0.484 . . . . 0.0 110.942 -174.01 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' D' D ' 71' ' ' HIS . . . . . 0.412 ' N ' HG22 ' D' ' 70' ' ' THR . 79.9 m80 -65.14 156.96 79.25 Favored Pre-proline 0 CA--C 1.534 0.352 0 CA-C-N 115.563 -0.744 . . . . 0.0 112.055 -173.578 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' D' D ' 72' ' ' PRO . . . . . . . . . . . . . 57.2 Cg_endo -71.97 160.17 48.35 Favored 'Trans proline' 0 N--CA 1.496 1.647 0 C-N-CA 121.704 1.603 . . . . 0.0 112.673 178.175 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' D' D ' 73' ' ' VAL . . . . . . . . . . . . . 33.5 m -69.82 -171.59 0.08 OUTLIER 'Isoleucine or valine' 0 C--N 1.33 -0.27 0 CA-C-N 116.122 -0.49 . . . . 0.0 110.124 179.898 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' D' D ' 74' ' ' ASP . . . . . . . . . . . . . 22.4 t0 -84.56 118.36 24.29 Favored 'General case' 0 C--N 1.33 -0.258 0 C-N-CA 120.601 -0.44 . . . . 0.0 110.295 -172.538 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' D' D ' 75' ' ' VAL . . . . . . . . . . . . . 39.4 t -122.22 121.93 65.15 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.271 0 CA-C-O 120.961 0.41 . . . . 0.0 110.659 -176.948 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' D' D ' 76' ' ' LEU . . . . . . . . . . . . . 5.8 mp -122.03 149.13 43.94 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 115.735 -0.666 . . . . 0.0 109.39 174.861 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' D' D ' 77' ' ' GLU . . . . . . . . . . . . . 96.5 mt-10 -136.68 137.12 39.67 Favored 'General case' 0 C--N 1.332 -0.189 0 CA-C-O 121.16 0.505 . . . . 0.0 111.516 -176.644 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' D' D ' 78' ' ' ALA . . . . . . . . . . . . . . . -123.58 135.37 53.94 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 115.587 -0.733 . . . . 0.0 109.414 175.156 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' D' D ' 79' ' ' LYS . . . . . 0.597 ' O ' HD13 ' D' ' 80' ' ' ILE . 59.4 mtpt -82.73 120.63 25.84 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-O 120.907 0.384 . . . . 0.0 111.129 -176.42 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' D' D ' 80' ' ' ILE . . . . . 0.597 HD13 ' O ' ' D' ' 79' ' ' LYS . 40.2 mm -139.19 105.8 2.63 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.305 0 N-CA-C 109.103 -0.703 . . . . 0.0 109.103 -178.769 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' D' D ' 81' ' ' LYS . . . . . . . . . . . . . 19.2 pttp -98.14 128.69 44.77 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-O 120.869 0.366 . . . . 0.0 111.225 -176.544 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' D' D ' 82' ' ' GLY . . . . . . . . . . . . . . . 89.21 41.99 5.69 Favored Glycine 0 CA--C 1.524 0.651 0 C-N-CA 120.685 -0.769 . . . . 0.0 111.52 176.2 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' D' D ' 83' ' ' ILE . . . . . . . . . . . . . 71.7 mt -65.3 139.25 21.67 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.328 0 CA-C-O 121.009 0.433 . . . . 0.0 110.046 178.86 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' D' D ' 84' ' ' LYS . . . . . . . . . . . . . 59.5 tttm -99.17 -53.93 3.11 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 115.89 -0.595 . . . . 0.0 109.906 -179.609 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' D' D ' 85' ' ' ASP . . . . . . . . . . . . . 13.4 t70 -156.7 150.11 24.37 Favored 'General case' 0 C--N 1.326 -0.42 0 CA-C-N 115.646 -0.706 . . . . 0.0 110.187 -179.991 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' D' D ' 86' ' ' VAL . . . . . . . . . . . . . 42.8 t -128.41 128.74 68.6 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.279 0 CA-C-O 120.93 0.395 . . . . 0.0 110.41 -179.227 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' D' D ' 87' ' ' ILE . . . . . . . . . . . . . 44.1 mm -118.08 127.63 75.26 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.284 0 CA-C-N 115.824 -0.626 . . . . 0.0 109.488 176.679 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' D' D ' 88' ' ' LEU . . . . . . . . . . . . . 18.7 tp -112.74 133.65 54.65 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-O 121.137 0.494 . . . . 0.0 111.123 -177.64 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' D' D ' 89' ' ' ASP . . . . . . . . . . . . . 10.7 t70 -125.35 158.51 34.07 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 115.587 -0.733 . . . . 0.0 109.431 176.256 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' D' D ' 90' ' ' GLU . . . . . . . . . . . . . 96.0 mt-10 -46.74 -37.74 8.96 Favored 'General case' 0 C--N 1.331 -0.237 0 N-CA-C 113.17 0.804 . . . . 0.0 113.17 -172.138 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' D' D ' 91' ' ' ASN . . . . . . . . . . . . . 4.7 p-10 -132.04 23.35 4.54 Favored 'General case' 0 N--CA 1.467 0.413 0 N-CA-C 112.815 0.672 . . . . 0.0 112.815 -177.747 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' D' D ' 92' ' ' LEU . . . . . . . . . . . . . 16.5 mt -148.97 144.45 26.79 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-O 120.858 0.361 . . . . 0.0 110.56 -176.522 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' D' D ' 93' ' ' ILE . . . . . . . . . . . . . 71.4 mt -122.6 115.31 45.61 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.316 0 N-CA-C 109.224 -0.658 . . . . 0.0 109.224 176.728 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' D' D ' 94' ' ' VAL . . . . . . . . . . . . . 44.9 t -117.06 123.0 71.31 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.267 0 N-CA-C 109.867 -0.42 . . . . 0.0 109.867 -178.932 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' D' D ' 95' ' ' VAL . . . . . . . . . . . . . 42.0 t -120.18 133.75 65.89 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.236 0 CA-C-N 116.021 -0.536 . . . . 0.0 110.025 -178.039 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' D' D ' 96' ' ' ILE . . . . . . . . . . . . . 56.1 mt -113.88 130.76 67.46 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 N-CA-C 109.124 -0.695 . . . . 0.0 109.124 177.145 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' D' D ' 97' ' ' THR . . . . . . . . . . . . . 68.6 p -103.48 157.18 17.21 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-O 120.872 0.368 . . . . 0.0 110.988 -178.638 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' D' D ' 98' ' ' GLU . . . . . . . . . . . . . 97.4 mt-10 -53.89 -22.89 10.96 Favored 'General case' 0 CA--C 1.535 0.375 0 N-CA-C 112.307 0.484 . . . . 0.0 112.307 179.121 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' D' D ' 99' ' ' GLU . . . . . . . . . . . . . 95.6 mt-10 -77.49 12.55 1.54 Allowed 'General case' 0 CA--C 1.536 0.441 0 N-CA-C 113.208 0.818 . . . . 0.0 113.208 -178.714 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' D' D ' 100' ' ' ASN . . . . . . . . . . . . . 3.0 m-20 61.85 37.46 15.36 Favored 'General case' 0 CA--C 1.531 0.217 0 CA-C-O 121.023 0.439 . . . . 0.0 110.979 179.833 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' D' D ' 101' ' ' GLU . . . . . . . . . . . . . 85.4 tt0 -116.84 145.63 43.43 Favored 'General case' 0 C--N 1.333 -0.137 0 CA-C-N 116.086 -0.506 . . . . 0.0 109.886 176.239 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' D' D ' 102' ' ' VAL . . . . . . . . . . . . . 42.9 t -117.64 127.1 75.07 Favored 'Isoleucine or valine' 0 C--O 1.233 0.224 0 CA-C-N 116.277 -0.42 . . . . 0.0 109.929 -178.284 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' D' D ' 103' ' ' LEU . . . . . . . . . . . . . 63.0 mt -119.57 134.61 55.15 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 115.991 -0.549 . . . . 0.0 110.511 178.058 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' D' D ' 104' ' ' ILE . . . . . . . . . . . . . 66.1 mt -120.99 120.18 61.52 Favored 'Isoleucine or valine' 0 C--O 1.234 0.252 0 CA-C-N 116.567 -0.288 . . . . 0.0 110.513 -179.09 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' D' D ' 105' ' ' PHE . . . . . . . . . . . . . 54.2 m-85 -120.53 167.71 12.11 Favored 'General case' 0 N--CA 1.462 0.146 0 O-C-N 124.066 0.854 . . . . 0.0 109.829 177.707 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' D' D ' 106' ' ' ASN . . . . . . . . . . . . . 47.5 p-10 -104.04 -170.39 1.77 Allowed 'General case' 0 CA--C 1.532 0.264 0 N-CA-C 110.221 -0.288 . . . . 0.0 110.221 173.091 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' D' D ' 107' ' ' GLN . . . . . . . . . . . . . 61.7 tt0 -57.75 -29.85 65.12 Favored 'General case' 0 CA--C 1.532 0.286 0 N-CA-C 111.97 0.359 . . . . 0.0 111.97 178.987 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' D' D ' 108' ' ' ASN . . . . . . . . . . . . . 10.2 t-20 -86.52 12.7 9.81 Favored 'General case' 0 CA--C 1.535 0.367 0 N-CA-C 112.922 0.712 . . . . 0.0 112.922 -176.681 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' D' D ' 109' ' ' LEU . . . . . . . . . . . . . 26.4 mt 56.76 32.34 21.06 Favored 'General case' 0 CA--C 1.53 0.211 0 N-CA-C 111.75 0.278 . . . . 0.0 111.75 179.356 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' D' D ' 110' ' ' GLU . . . . . . . . . . . . . 69.3 mm-40 -98.27 143.38 28.81 Favored 'General case' 0 C--N 1.33 -0.28 0 N-CA-C 109.258 -0.645 . . . . 0.0 109.258 175.372 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' D' D ' 111' ' ' GLU . . . . . . . . . . . . . 58.9 tt0 -83.33 121.88 27.72 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-O 121.082 0.467 . . . . 0.0 110.344 -177.162 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' D' D ' 112' ' ' LEU . . . . . . . . . . . . . 23.7 mt -104.31 -45.83 4.57 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 115.816 -0.629 . . . . 0.0 110.413 -178.759 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' D' D ' 113' ' ' TYR . . . . . . . . . . . . . 61.1 t80 -140.39 140.75 35.56 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.096 -0.502 . . . . 0.0 111.008 -178.361 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' D' D ' 114' ' ' ARG . . . . . . . . . . . . . 35.6 ptt-85 -142.21 125.41 16.41 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.305 -0.407 . . . . 0.0 110.489 176.427 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' D' D ' 115' ' ' GLY . . . . . . . . . . . . . . . -150.14 159.79 28.26 Favored Glycine 0 CA--C 1.522 0.522 0 N-CA-C 110.691 -0.964 . . . . 0.0 110.691 179.203 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' D' D ' 116' ' ' LYS . . . . . . . . . . . . . 2.1 ttmp? -127.84 138.95 52.88 Favored 'General case' 0 C--N 1.329 -0.312 0 N-CA-C 110.027 -0.361 . . . . 0.0 110.027 177.566 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' D' D ' 117' ' ' PHE . . . . . . . . . . . . . 43.8 m-85 -135.68 113.89 11.43 Favored 'General case' 0 C--N 1.331 -0.23 0 CA-C-N 116.207 -0.451 . . . . 0.0 109.895 -177.032 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' D' D ' 118' ' ' GLU . . . . . . . . . . . . . 70.8 mm-40 -54.69 -42.66 71.68 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.448 -0.342 . . . . 0.0 111.294 -176.3 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' D' D ' 119' ' ' ASN . . . . . . . . . . . . . 19.9 m120 -100.94 31.03 3.75 Favored 'General case' 0 C--N 1.331 -0.227 0 N-CA-C 112.188 0.44 . . . . 0.0 112.188 -174.287 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' D' D ' 120' ' ' LEU . . . . . . . . . . . . . 16.3 tp -56.96 121.1 9.14 Favored 'General case' 0 N--CA 1.462 0.167 0 C-N-CA 121.009 -0.276 . . . . 0.0 110.345 177.727 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' D' D ' 121' ' ' ASN . . . . . . . . . . . . . 60.5 m-20 -114.2 -44.06 3.16 Favored 'General case' 0 C--N 1.332 -0.154 0 CA-C-N 116.678 -0.237 . . . . 0.0 111.26 -176.898 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' D' D ' 122' ' ' LYS . . . . . 0.446 ' HE3' HD11 ' D' ' 124' ' ' LEU . 39.0 ttpt -144.82 143.12 30.47 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-O 120.953 0.406 . . . . 0.0 111.343 -175.976 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' D' D ' 123' ' ' VAL . . . . . . . . . . . . . 43.6 t -128.77 134.23 64.8 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.219 0 CA-C-N 116.172 -0.467 . . . . 0.0 109.762 177.18 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' D' D ' 124' ' ' LEU . . . . . 0.446 HD11 ' HE3' ' D' ' 122' ' ' LYS . 59.0 mt -129.51 135.27 48.41 Favored 'General case' 0 C--N 1.331 -0.196 0 CA-C-O 120.815 0.341 . . . . 0.0 110.949 -179.048 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' D' D ' 125' ' ' VAL . . . . . . . . . . . . . 10.6 p -132.33 131.12 60.67 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.274 0 CA-C-N 116.11 -0.496 . . . . 0.0 109.958 177.526 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' D' D ' 126' ' ' ARG . . . . . . . . . . . . . 53.8 ttm-85 -143.08 116.04 8.83 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.462 -0.335 . . . . 0.0 110.815 -178.72 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' D' D ' 127' ' ' ASN . . . . . . . . . . . . . 3.1 m120 51.97 -105.0 0.2 Allowed 'General case' 0 CA--C 1.544 0.721 0 CA-C-O 119.172 -0.442 . . . . 0.0 111.323 178.214 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' D' D ' 128' ' ' ASP . . . . . . . . . . . . . 19.1 p-10 -113.9 3.95 15.62 Favored 'General case' 0 CA--C 1.538 0.496 0 CA-C-N 119.42 1.009 . . . . 0.0 113.426 -176.208 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' D' D ' 129' ' ' LEU . . . . . . . . . . . . . 21.6 tp -110.43 137.01 48.71 Favored 'General case' 0 C--N 1.331 -0.222 0 CA-C-N 118.047 0.385 . . . . 0.0 110.05 178.857 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' D' D ' 130' ' ' VAL . . . . . . . . . . . . . 54.6 t -124.99 137.25 58.2 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.284 0 CA-C-O 120.833 0.349 . . . . 0.0 110.15 -179.475 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' D' D ' 131' ' ' VAL . . . . . . . . . . . . . 42.9 t -135.98 136.27 49.84 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.274 0 CA-C-N 116.271 -0.422 . . . . 0.0 110.363 179.698 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' D' D ' 132' ' ' ILE . . . . . . . . . . . . . 74.1 mt -119.33 133.37 66.35 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.298 0 N-CA-C 109.52 -0.548 . . . . 0.0 109.52 178.784 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' D' D ' 133' ' ' ILE . . . . . . . . . . . . . 40.4 mm -119.12 124.3 72.88 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.223 0 CA-C-O 120.829 0.347 . . . . 0.0 111.315 -174.831 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' D' D ' 134' ' ' ASP . . . . . . . . . . . . . 9.7 p-10 -137.68 150.1 47.07 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-N 116.307 -0.406 . . . . 0.0 109.932 173.637 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' D' D ' 135' ' ' GLU . . . . . . . . . . . . . 86.0 tt0 -49.77 -22.93 1.57 Allowed 'General case' 0 C--N 1.328 -0.359 0 N-CA-C 113.067 0.765 . . . . 0.0 113.067 -174.21 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' D' D ' 136' ' ' GLN . . . . . . . . . . . . . 63.1 tt0 -93.16 -28.76 16.11 Favored 'General case' 0 C--O 1.234 0.265 0 N-CA-C 112.384 0.512 . . . . 0.0 112.384 -174.004 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' D' D ' 137' ' ' LYS . . . . . . . . . . . . . 47.7 pttt -166.04 170.58 13.4 Favored 'General case' 0 C--N 1.332 -0.185 0 CA-C-O 121.55 0.69 . . . . 0.0 112.317 -172.849 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' D' D ' 138' ' ' LEU . . . . . 0.406 HD23 ' N ' ' D' ' 139' ' ' THR . 5.6 tt -121.96 128.61 51.7 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 114.882 -1.053 . . . . 0.0 109.836 178.797 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' D' D ' 139' ' ' THR . . . . . 0.406 ' N ' HD23 ' D' ' 138' ' ' LEU . 26.4 m -109.69 132.65 53.95 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-N 116.198 -0.455 . . . . 0.0 110.629 -179.254 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' D' D ' 140' ' ' LEU . . . . . 0.464 HD21 ' O ' ' E' ' 107' ' ' GLN . 12.1 tp -118.58 124.14 46.74 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 115.583 -0.735 . . . . 0.0 109.381 -178.425 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' D' D ' 141' ' ' ILE . . . . . . . . . . . . . 19.6 mt -120.48 119.62 60.32 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.344 0 N-CA-C 109.87 -0.418 . . . . 0.0 109.87 -175.795 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' D' D ' 142' ' ' ARG . . . . . . . . . . . . . 7.8 mmm180 -109.03 126.13 52.81 Favored 'General case' 0 C--N 1.331 -0.227 0 CA-C-N 115.496 -0.775 . . . . 0.0 110.508 -177.857 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' D' D ' 143' ' ' THR . . . . . . . . . . . . . 49.5 p . . . . . 0 C--O 1.219 -0.501 0 CA-C-O 117.998 -1.001 . . . . 0.0 110.627 -179.864 . . . . . . . . 0 0 . 1 . 010 nuclear nobuild full ' E' E ' -3' ' ' GLU . . . . . . . . . . . . . 95.7 mt-10 . . . . . 0 N--CA 1.491 1.578 0 N-CA-C 109.289 -0.634 . . . . 0.0 109.289 . . . . . . . . . 0 0 . 1 . 010 nuclear nobuild full ' E' E ' -2' ' ' GLY . . . . . . . . . . . . . . . -73.35 120.82 7.24 Favored Glycine 0 CA--C 1.524 0.654 0 N-CA-C 110.894 -0.882 . . . . 0.0 110.894 179.463 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' E' E ' -1' ' ' VAL . . . . . . . . . . . . . 40.8 t -96.41 136.15 28.19 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.273 0 N-CA-C 110.17 -0.307 . . . . 0.0 110.17 179.849 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' E' E ' 0' ' ' ILE . . . . . . . . . . . . . 70.5 mt -104.35 135.87 40.22 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.321 0 N-CA-C 109.936 -0.394 . . . . 0.0 109.936 -179.588 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' E' E ' 1' ' ' MET . . . . . . . . . . . . . 24.3 ptp -143.46 154.0 43.21 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.044 -0.526 . . . . 0.0 110.66 -178.342 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' E' E ' 2' ' ' SER . . . . . . . . . . . . . 94.5 p -116.97 152.12 35.25 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-O 121.106 0.479 . . . . 0.0 110.637 -179.771 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' E' E ' 3' ' ' GLU . . . . . . . . . . . . . 82.4 tt0 -140.63 143.99 35.49 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 115.935 -0.575 . . . . 0.0 110.851 -177.842 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' E' E ' 4' ' ' LEU . . . . . . . . . . . . . 20.6 tp -124.86 130.87 53.24 Favored 'General case' 0 C--N 1.331 -0.216 0 CA-C-N 116.016 -0.538 . . . . 0.0 110.176 177.673 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' E' E ' 5' ' ' LYS . . . . . . . . . . . . . 61.3 mttp -108.44 121.84 45.78 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-O 120.876 0.37 . . . . 0.0 110.616 178.856 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' E' E ' 6' ' ' LEU . . . . . . . . . . . . . 67.2 mt -114.05 150.21 34.31 Favored 'General case' 0 C--N 1.331 -0.217 0 CA-C-N 115.548 -0.751 . . . . 0.0 110.702 -179.982 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' E' E ' 7' ' ' LYS . . . . . . . . . . . . . 84.6 tttt -140.46 140.11 22.06 Favored Pre-proline 0 CA--C 1.534 0.354 0 CA-C-O 119.09 -0.481 . . . . 0.0 110.02 175.189 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' E' E ' 8' ' ' PRO . . . . . . . . . . . . . 95.2 Cg_endo -92.01 143.7 2.76 Favored 'Trans proline' 0 N--CA 1.49 1.315 0 C-N-CA 121.765 1.643 . . . . 0.0 111.73 177.593 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' E' E ' 9' ' ' LEU . . . . . . . . . . . . . 60.7 mt -78.36 -47.51 1.99 Allowed Pre-proline 0 CA--C 1.533 0.298 0 CA-C-O 118.715 -0.66 . . . . 0.0 112.242 -179.257 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' E' E ' 10' ' ' PRO . . . . . . . . . . . . . 92.9 Cg_endo -80.36 153.84 21.26 Favored 'Trans proline' 0 N--CA 1.496 1.63 0 C-N-CA 121.067 1.178 . . . . 0.0 111.904 176.129 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' E' E ' 11' ' ' LYS . . . . . . . . . . . . . 55.7 mtmt -88.35 98.95 11.89 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.376 -0.374 . . . . 0.0 110.604 179.312 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' E' E ' 12' ' ' VAL . . . . . . . . . . . . . 11.2 p -145.06 144.04 21.91 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.294 0 CA-C-N 116.111 -0.495 . . . . 0.0 110.357 -179.718 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' E' E ' 13' ' ' GLU . . . . . . . . . . . . . 95.4 mt-10 -85.02 121.51 27.9 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.176 -0.465 . . . . 0.0 109.972 177.774 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' E' E ' 14' ' ' LEU . . . . . . . . . . . . . 20.0 mt -93.62 156.5 39.58 Favored Pre-proline 0 C--N 1.329 -0.323 0 CA-C-N 116.349 -0.387 . . . . 0.0 110.784 -177.188 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' E' E ' 15' ' ' PRO . . . . . . . . . . . . . 27.0 Cg_exo -60.73 155.07 50.8 Favored 'Trans proline' 0 N--CA 1.496 1.625 0 C-N-CA 121.354 1.369 . . . . 0.0 111.764 179.614 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' E' E ' 16' ' ' PRO . . . . . . . . . . . . . 32.3 Cg_exo -57.63 -36.48 98.51 Favored 'Trans proline' 0 N--CA 1.497 1.689 0 C-N-CA 121.328 1.352 . . . . 0.0 112.572 179.598 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' E' E ' 17' ' ' ASP . . . . . . . . . . . . . 8.8 p-10 -88.74 13.78 11.65 Favored 'General case' 0 CA--C 1.535 0.389 0 N-CA-C 113.027 0.751 . . . . 0.0 113.027 -177.74 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' E' E ' 18' ' ' PHE . . . . . . . . . . . . . 40.8 t80 -58.43 -44.37 89.08 Favored 'General case' 0 C--N 1.333 -0.134 0 O-C-N 121.968 -0.457 . . . . 0.0 110.198 -178.599 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' E' E ' 19' ' ' VAL . . . . . 0.44 HG13 ' N ' ' E' ' 20' ' ' ASP . 14.4 p -58.42 -46.42 89.46 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.354 0 CA-C-N 116.459 -0.337 . . . . 0.0 111.807 -174.83 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' E' E ' 20' ' ' ASP . . . . . 0.44 ' N ' HG13 ' E' ' 19' ' ' VAL . 2.7 p-10 -64.75 -36.17 83.44 Favored 'General case' 0 N--CA 1.463 0.224 0 C-N-CA 120.655 -0.418 . . . . 0.0 111.169 -177.383 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' E' E ' 21' ' ' VAL . . . . . . . . . . . . . 48.2 t -63.95 -48.19 87.2 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.217 0 C-N-CA 120.632 -0.427 . . . . 0.0 110.193 179.374 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' E' E ' 22' ' ' ILE . . . . . 0.483 HG22 HD12 ' E' ' 26' ' ' LEU . 51.0 mm -56.17 -43.09 75.15 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.216 0 C-N-CA 121.019 -0.272 . . . . 0.0 110.416 177.321 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' E' E ' 23' ' ' ARG . . . . . . . . . . . . . 43.2 ttp180 -52.1 -51.11 59.84 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-O 120.723 0.297 . . . . 0.0 111.498 -179.457 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' E' E ' 24' ' ' ILE . . . . . . . . . . . . . 70.3 mt -59.78 -41.69 86.4 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.256 0 CA-C-N 116.471 -0.331 . . . . 0.0 110.963 -179.047 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' E' E ' 25' ' ' LYS . . . . . . . . . . . . . 60.6 mtpt -62.98 -41.85 99.68 Favored 'General case' 0 C--N 1.327 -0.388 0 N-CA-C 112.076 0.399 . . . . 0.0 112.076 -178.598 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' E' E ' 26' ' ' LEU . . . . . 0.483 HD12 HG22 ' E' ' 22' ' ' ILE . 72.4 mt -80.42 -39.65 27.88 Favored 'General case' 0 C--N 1.33 -0.256 0 N-CA-C 113.27 0.841 . . . . 0.0 113.27 -170.916 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' E' E ' 27' ' ' GLN . . . . . . . . . . . . . 9.1 pt20 -46.59 135.08 8.93 Favored 'General case' 0 N--CA 1.468 0.462 0 N-CA-C 113.003 0.742 . . . . 0.0 113.003 -174.768 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' E' E ' 28' ' ' GLY . . . . . . . . . . . . . . . 100.44 -21.79 42.68 Favored Glycine 0 CA--C 1.534 1.251 0 CA-C-N 115.523 -0.762 . . . . 0.0 112.719 -178.416 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' E' E ' 29' ' ' LYS . . . . . . . . . . . . . 65.6 mttm -98.79 155.12 17.52 Favored 'General case' 0 C--O 1.232 0.177 0 CA-C-N 117.512 0.656 . . . . 0.0 111.29 -179.767 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' E' E ' 30' ' ' THR . . . . . . . . . . . . . 38.1 m -104.07 133.64 48.66 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 115.901 -0.591 . . . . 0.0 109.73 175.223 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' E' E ' 31' ' ' VAL . . . . . . . . . . . . . 33.6 m -131.72 154.91 41.14 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.211 0 CA-C-O 121.03 0.443 . . . . 0.0 111.343 -176.984 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' E' E ' 32' ' ' ARG . . . . . . . . . . . . . 55.7 mtp180 -132.25 152.33 51.4 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 115.771 -0.65 . . . . 0.0 110.436 177.553 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' E' E ' 33' ' ' THR . . . . . . . . . . . . . 20.5 m -53.18 139.68 28.36 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.271 -0.422 . . . . 0.0 111.322 -179.121 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' E' E ' 34' ' ' GLY . . . . . . . . . . . . . . . 100.82 -17.28 56.61 Favored Glycine 0 CA--C 1.532 1.126 0 CA-C-O 119.608 -0.551 . . . . 0.0 113.279 179.709 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' E' E ' 35' ' ' ASP . . . . . . . . . . . . . 66.7 m-20 -65.93 149.58 49.99 Favored 'General case' 0 C--O 1.231 0.131 0 CA-C-N 118.036 0.918 . . . . 0.0 110.998 179.059 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' E' E ' 36' ' ' VAL . . . . . . . . . . . . . 46.4 t -122.1 131.75 72.48 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.196 0 CA-C-N 115.911 -0.586 . . . . 0.0 110.134 179.825 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' E' E ' 37' ' ' ILE . . . . . . . . . . . . . 67.7 mt -119.92 139.02 48.62 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.245 0 CA-C-N 116.086 -0.506 . . . . 0.0 109.797 178.637 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' E' E ' 38' ' ' GLY . . . . . . . . . . . . . . . -113.48 128.99 8.6 Favored Glycine 0 CA--C 1.526 0.741 0 N-CA-C 111.139 -0.784 . . . . 0.0 111.139 -179.614 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' E' E ' 39' ' ' ILE . . . . . . . . . . . . . 72.1 mt -123.43 135.78 62.15 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.186 0 N-CA-C 110.015 -0.365 . . . . 0.0 110.015 178.656 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' E' E ' 40' ' ' SER . . . . . . . . . . . . . 30.0 t -92.67 123.02 35.65 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.225 -0.443 . . . . 0.0 110.835 175.8 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' E' E ' 41' ' ' ILE . . . . . . . . . . . . . 71.4 mt -131.34 114.57 26.36 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.214 0 N-CA-C 110.08 -0.341 . . . . 0.0 110.08 177.69 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' E' E ' 42' ' ' LEU . . . . . . . . . . . . . 84.4 mt 58.11 33.28 23.01 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.038 -0.528 . . . . 0.0 111.797 178.893 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' E' E ' 43' ' ' GLY . . . . . . . . . . . . . . . 83.24 -10.18 59.18 Favored Glycine 0 CA--C 1.535 1.283 0 C-N-CA 121.156 -0.545 . . . . 0.0 113.497 177.018 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' E' E ' 44' ' ' LYS . . . . . . . . . . . . . 64.6 mttp -98.46 136.18 38.96 Favored 'General case' 0 C--N 1.333 -0.115 0 CA-C-N 117.892 0.846 . . . . 0.0 110.271 177.785 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' E' E ' 45' ' ' GLU . . . . . . . . . . . . . 84.3 tt0 -85.26 128.87 34.85 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-N 116.464 -0.334 . . . . 0.0 111.373 179.946 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' E' E ' 46' ' ' VAL . . . . . . . . . . . . . 7.4 p -121.8 126.33 74.47 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.18 0 N-CA-C 109.457 -0.571 . . . . 0.0 109.457 174.697 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' E' E ' 47' ' ' LYS . . . . . . . . . . . . . 61.6 mttm -100.06 129.18 46.08 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-N 116.052 -0.522 . . . . 0.0 111.162 179.004 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' E' E ' 48' ' ' PHE . . . . . . . . . . . . . 92.6 m-85 -111.43 131.93 54.83 Favored 'General case' 0 C--N 1.332 -0.182 0 CA-C-N 116.28 -0.418 . . . . 0.0 109.954 176.28 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' E' E ' 49' ' ' LYS . . . . . . . . . . . . . 54.8 tttp -107.68 137.17 46.17 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.464 -0.335 . . . . 0.0 110.564 179.368 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' E' E ' 50' ' ' VAL . . . . . . . . . . . . . 45.6 t -79.92 108.25 13.2 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.25 0 N-CA-C 109.258 -0.645 . . . . 0.0 109.258 174.894 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' E' E ' 51' ' ' VAL . . . . . . . . . . . . . 48.7 t -71.46 -47.62 57.74 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.326 0 CA-C-N 116.223 -0.444 . . . . 0.0 110.004 -173.795 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' E' E ' 52' ' ' GLN . . . . . . . . . . . . . 62.3 tt0 -166.13 143.83 5.45 Favored 'General case' 0 C--N 1.329 -0.307 0 C-N-CA 120.441 -0.504 . . . . 0.0 111.847 -178.952 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' E' E ' 53' ' ' ALA . . . . . . . . . . . . . . . -119.66 134.11 55.36 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 115.915 -0.584 . . . . 0.0 109.774 175.599 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' E' E ' 54' ' ' TYR . . . . . . . . . . . . . 10.9 t80 -129.1 112.33 18.42 Favored Pre-proline 0 CA--C 1.534 0.348 0 CA-C-O 118.191 -0.909 . . . . 0.0 110.028 177.917 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' E' E ' 55' ' ' PRO . . . . . . . . . . . . . 71.7 Cg_endo -77.2 170.17 72.2 Favored 'Cis proline' 0 N--CA 1.5 1.911 0 CA-C-N 122.002 1.751 . . . . 0.0 112.527 -5.94 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' E' E ' 56' ' ' SER . . . . . . . . . . . . . 15.8 m -123.47 139.02 31.12 Favored Pre-proline 0 CA--C 1.539 0.545 0 CA-C-O 118.553 -0.737 . . . . 0.0 109.443 174.06 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' E' E ' 57' ' ' PRO . . . . . . . . . . . . . 37.6 Cg_endo -67.45 145.2 73.48 Favored 'Cis proline' 0 N--CA 1.498 1.773 0 CA-C-N 121.616 1.613 . . . . 0.0 111.53 -3.128 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' E' E ' 58' ' ' LEU . . . . . . . . . . . . . 16.2 tp -107.99 139.05 43.19 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-O 120.999 0.428 . . . . 0.0 110.837 -177.331 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' E' E ' 59' ' ' ARG . . . . . . . . . . . . . 21.3 ttm180 -102.45 122.54 44.52 Favored 'General case' 0 C--N 1.327 -0.389 0 N-CA-C 108.985 -0.746 . . . . 0.0 108.985 173.393 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' E' E ' 60' ' ' VAL . . . . . . . . . . . . . 45.6 t -81.55 119.17 30.62 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.35 0 C-N-CA 120.689 -0.404 . . . . 0.0 110.634 -174.281 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' E' E ' 61' ' ' GLU . . . . . . . . . . . . . 95.5 mt-10 -131.19 160.96 33.3 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 115.765 -0.652 . . . . 0.0 109.71 175.422 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' E' E ' 62' ' ' ASP . . . . . . . . . . . . . 10.9 p-10 -52.77 -29.93 30.08 Favored 'General case' 0 C--N 1.328 -0.363 0 N-CA-C 112.067 0.395 . . . . 0.0 112.067 -179.302 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' E' E ' 63' ' ' ARG . . . . . . . . . . . . . 60.0 mtp180 -72.35 -22.06 61.22 Favored 'General case' 0 CA--C 1.533 0.295 0 N-CA-C 113.002 0.742 . . . . 0.0 113.002 -175.616 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' E' E ' 64' ' ' THR . . . . . . . . . . . . . 36.8 m -66.7 142.27 57.48 Favored 'General case' 0 C--N 1.331 -0.225 0 CA-C-O 120.983 0.421 . . . . 0.0 110.913 -176.444 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' E' E ' 65' ' ' LYS . . . . . . . . . . . . . 46.6 mtmt -88.4 129.52 35.4 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 115.938 -0.574 . . . . 0.0 109.912 177.684 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' E' E ' 66' ' ' ILE . . . . . . . . . . . . . 60.7 mt -113.54 126.65 71.03 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.347 0 N-CA-C 109.976 -0.379 . . . . 0.0 109.976 -178.089 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' E' E ' 67' ' ' THR . . . . . . . . . . . . . 25.8 m -127.14 149.73 49.82 Favored 'General case' 0 C--N 1.331 -0.226 0 CA-C-O 121.147 0.498 . . . . 0.0 111.112 -176.896 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' E' E ' 68' ' ' LEU . . . . . . . . . . . . . 72.3 mt -106.46 147.15 29.67 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 115.909 -0.587 . . . . 0.0 110.791 179.543 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' E' E ' 69' ' ' VAL . . . . . . . . . . . . . 45.9 t -82.83 155.23 3.87 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.281 0 CA-C-N 115.906 -0.588 . . . . 0.0 109.731 177.208 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' E' E ' 70' ' ' THR . . . . . . . . . . . . . 69.8 p -79.49 162.85 25.16 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-O 121.108 0.48 . . . . 0.0 111.033 -172.959 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' E' E ' 71' ' ' HIS . . . . . . . . . . . . . 48.4 m80 -75.84 168.47 27.48 Favored Pre-proline 0 CA--C 1.533 0.311 0 CA-C-N 115.544 -0.753 . . . . 0.0 111.676 -174.982 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' E' E ' 72' ' ' PRO . . . . . . . . . . . . . 18.6 Cg_exo -65.04 160.16 43.02 Favored 'Trans proline' 0 N--CA 1.495 1.594 0 C-N-CA 121.7 1.6 . . . . 0.0 112.132 177.513 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' E' E ' 73' ' ' VAL . . . . . . . . . . . . . 32.6 m -69.77 165.12 2.67 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.279 0 CA-C-N 116.124 -0.489 . . . . 0.0 110.634 -176.894 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' E' E ' 74' ' ' ASP . . . . . . . . . . . . . 42.1 t0 -93.3 122.54 35.8 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-N 116.348 -0.387 . . . . 0.0 110.264 -175.607 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' E' E ' 75' ' ' VAL . . . . . . . . . . . . . 41.3 t -116.97 123.34 71.71 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.237 0 CA-C-O 121.051 0.453 . . . . 0.0 110.345 -178.845 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' E' E ' 76' ' ' LEU . . . . . . . . . . . . . 20.4 mt -123.82 148.73 46.47 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 115.659 -0.701 . . . . 0.0 109.64 178.518 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' E' E ' 77' ' ' GLU . . . . . . . . . . . . . 46.0 mt-10 -139.1 136.39 35.14 Favored 'General case' 0 C--N 1.331 -0.208 0 CA-C-O 121.052 0.453 . . . . 0.0 111.334 -177.946 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' E' E ' 78' ' ' ALA . . . . . 0.599 ' HB2' HD21 ' E' ' 109' ' ' LEU . . . -123.42 134.82 53.91 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 115.707 -0.678 . . . . 0.0 109.724 176.28 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' E' E ' 79' ' ' LYS . . . . . 0.642 ' O ' HD13 ' E' ' 80' ' ' ILE . 77.8 mttt -77.98 121.51 24.3 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-O 120.791 0.329 . . . . 0.0 110.837 -177.065 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' E' E ' 80' ' ' ILE . . . . . 0.642 HD13 ' O ' ' E' ' 79' ' ' LYS . 38.2 mm -139.21 109.95 4.57 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.327 0 N-CA-C 109.538 -0.541 . . . . 0.0 109.538 -178.571 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' E' E ' 81' ' ' LYS . . . . . . . . . . . . . 15.4 ptpt -103.85 126.84 51.26 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-O 121.114 0.483 . . . . 0.0 111.102 -177.808 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' E' E ' 82' ' ' GLY . . . . . . . . . . . . . . . 89.13 42.11 5.68 Favored Glycine 0 CA--C 1.524 0.624 0 N-CA-C 111.512 -0.635 . . . . 0.0 111.512 175.047 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' E' E ' 83' ' ' ILE . . . . . . . . . . . . . 72.0 mt -67.63 140.24 19.57 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.293 0 CA-C-O 120.889 0.376 . . . . 0.0 110.132 179.252 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' E' E ' 84' ' ' LYS . . . . . . . . . . . . . 82.6 tttt -100.82 -53.85 2.96 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 115.895 -0.593 . . . . 0.0 110.089 -179.403 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' E' E ' 85' ' ' ASP . . . . . . . . . . . . . 5.8 t70 -157.57 155.66 30.58 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 115.731 -0.668 . . . . 0.0 110.477 -178.577 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' E' E ' 86' ' ' VAL . . . . . . . . . . . . . 42.9 t -133.27 132.67 58.26 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.258 0 CA-C-O 121.02 0.438 . . . . 0.0 110.533 -178.662 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' E' E ' 87' ' ' ILE . . . . . 0.401 HG21 ' CG1' ' E' ' 125' ' ' VAL . 43.3 mm -117.63 130.5 72.42 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.259 0 CA-C-N 115.813 -0.631 . . . . 0.0 109.503 174.714 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' E' E ' 88' ' ' LEU . . . . . . . . . . . . . 18.6 tp -114.7 134.61 54.95 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-O 121.127 0.489 . . . . 0.0 111.493 -175.995 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' E' E ' 89' ' ' ASP . . . . . . . . . . . . . 7.0 t70 -127.39 155.37 43.74 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 115.605 -0.725 . . . . 0.0 109.426 174.931 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' E' E ' 90' ' ' GLU . . . . . . . . . . . . . 96.0 mt-10 -47.49 -42.07 22.16 Favored 'General case' 0 N--CA 1.463 0.217 0 N-CA-C 112.781 0.659 . . . . 0.0 112.781 -172.862 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' E' E ' 91' ' ' ASN . . . . . . . . . . . . . 87.2 m-20 -132.02 39.9 3.39 Favored 'General case' 0 C--O 1.233 0.227 0 CA-C-O 120.871 0.367 . . . . 0.0 111.161 -178.279 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' E' E ' 92' ' ' LEU . . . . . . . . . . . . . 10.5 tp -166.11 141.77 4.82 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.517 -0.311 . . . . 0.0 110.521 -179.579 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' E' E ' 93' ' ' ILE . . . . . . . . . . . . . 65.1 mt -126.98 124.34 64.4 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.283 0 N-CA-C 109.695 -0.483 . . . . 0.0 109.695 -178.965 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' E' E ' 94' ' ' VAL . . . . . . . . . . . . . 41.9 t -121.64 124.7 72.2 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.28 0 N-CA-C 109.794 -0.447 . . . . 0.0 109.794 179.71 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' E' E ' 95' ' ' VAL . . . . . . . . . . . . . 45.6 t -122.53 135.5 62.43 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.237 0 CA-C-N 116.443 -0.344 . . . . 0.0 110.147 -178.952 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' E' E ' 96' ' ' ILE . . . . . . . . . . . . . 60.0 mt -117.54 130.99 71.56 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.294 0 CA-C-N 115.954 -0.566 . . . . 0.0 109.476 179.155 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' E' E ' 97' ' ' THR . . . . . . . . . . . . . 40.7 p -101.01 157.37 16.8 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-O 121.095 0.474 . . . . 0.0 111.127 -179.403 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' E' E ' 98' ' ' GLU . . . . . . . . . . . . . 46.0 mt-10 -54.85 -29.49 55.4 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.231 -0.44 . . . . 0.0 112.138 -179.216 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' E' E ' 99' ' ' GLU . . . . . . . . . . . . . 71.2 mm-40 -78.64 14.18 1.39 Allowed 'General case' 0 CA--C 1.536 0.409 0 N-CA-C 113.124 0.787 . . . . 0.0 113.124 -177.361 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' E' E ' 100' ' ' ASN . . . . . . . . . . . . . 38.1 m-20 63.46 36.23 11.46 Favored 'General case' 0 N--CA 1.462 0.141 0 CA-C-O 120.947 0.403 . . . . 0.0 111.585 178.728 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' E' E ' 101' ' ' GLU . . . . . . . . . . . . . 84.8 tt0 -107.38 140.21 40.67 Favored 'General case' 0 C--N 1.331 -0.201 0 N-CA-C 109.372 -0.603 . . . . 0.0 109.372 170.989 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' E' E ' 102' ' ' VAL . . . . . . . . . . . . . 47.9 t -115.1 128.53 72.24 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.269 0 CA-C-N 116.256 -0.429 . . . . 0.0 109.9 -178.187 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' E' E ' 103' ' ' LEU . . . . . . . . . . . . . 31.0 mt -120.42 131.31 54.73 Favored 'General case' 0 C--N 1.331 -0.215 0 CA-C-N 115.757 -0.656 . . . . 0.0 110.368 177.43 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' E' E ' 104' ' ' ILE . . . . . . . . . . . . . 65.8 mt -117.64 121.61 67.87 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.241 0 CA-C-N 116.346 -0.388 . . . . 0.0 110.007 179.038 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' E' E ' 105' ' ' PHE . . . . . . . . . . . . . 75.6 m-85 -121.87 165.24 16.21 Favored 'General case' 0 C--N 1.332 -0.158 0 O-C-N 123.885 0.741 . . . . 0.0 109.823 179.819 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' E' E ' 106' ' ' ASN . . . . . . . . . . . . . 46.6 p-10 -100.21 -169.99 1.81 Allowed 'General case' 0 C--N 1.329 -0.291 0 N-CA-C 109.716 -0.476 . . . . 0.0 109.716 173.437 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' E' E ' 107' ' ' GLN . . . . . 0.464 ' O ' HD21 ' D' ' 140' ' ' LEU . 46.7 tt0 -59.27 -30.06 68.02 Favored 'General case' 0 C--N 1.329 -0.301 0 N-CA-C 111.89 0.33 . . . . 0.0 111.89 179.2 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' E' E ' 108' ' ' ASN . . . . . . . . . . . . . 58.6 t30 -82.19 6.94 15.01 Favored 'General case' 0 CA--C 1.536 0.429 0 N-CA-C 113.161 0.8 . . . . 0.0 113.161 -177.536 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' E' E ' 109' ' ' LEU . . . . . 0.599 HD21 ' HB2' ' E' ' 78' ' ' ALA . 7.4 tp 59.69 34.79 22.21 Favored 'General case' 0 C--O 1.232 0.167 0 O-C-N 122.07 -0.394 . . . . 0.0 111.602 179.42 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' E' E ' 110' ' ' GLU . . . . . . . . . . . . . 42.7 mt-10 -101.9 148.67 25.05 Favored 'General case' 0 C--N 1.33 -0.282 0 N-CA-C 109.52 -0.548 . . . . 0.0 109.52 175.118 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' E' E ' 111' ' ' GLU . . . . . . . . . . . . . 53.0 tt0 -81.98 121.97 27.2 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-O 120.849 0.357 . . . . 0.0 110.759 -176.288 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' E' E ' 112' ' ' LEU . . . . . . . . . . . . . 14.5 mt -106.91 -45.89 4.07 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.071 -0.513 . . . . 0.0 110.594 -179.958 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' E' E ' 113' ' ' TYR . . . . . . . . . . . . . 49.4 t80 -134.88 134.85 41.13 Favored 'General case' 0 C--N 1.331 -0.209 0 CA-C-N 116.28 -0.418 . . . . 0.0 111.026 -178.489 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' E' E ' 114' ' ' ARG . . . . . . . . . . . . . 78.7 ttt-85 -134.06 121.74 21.97 Favored 'General case' 0 C--N 1.331 -0.2 0 CA-C-N 116.04 -0.527 . . . . 0.0 110.262 179.655 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' E' E ' 115' ' ' GLY . . . . . . . . . . . . . . . -150.11 146.67 16.06 Favored Glycine 0 CA--C 1.523 0.553 0 N-CA-C 111.114 -0.794 . . . . 0.0 111.114 179.007 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' E' E ' 116' ' ' LYS . . . . . . . . . . . . . 61.8 tttm -128.04 126.88 42.13 Favored 'General case' 0 C--N 1.33 -0.267 0 N-CA-C 109.734 -0.469 . . . . 0.0 109.734 177.087 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' E' E ' 117' ' ' PHE . . . . . . . . . . . . . 33.6 m-85 -125.22 117.28 23.5 Favored 'General case' 0 N--CA 1.463 0.203 0 CA-C-O 121.037 0.446 . . . . 0.0 110.455 -174.47 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' E' E ' 118' ' ' GLU . . . . . . . . . . . . . 84.0 tt0 -52.08 -50.76 60.93 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.367 -0.379 . . . . 0.0 111.537 -177.891 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' E' E ' 119' ' ' ASN . . . . . . . . . . . . . 23.9 m120 -94.53 31.17 1.82 Allowed 'General case' 0 C--N 1.33 -0.243 0 N-CA-C 112.2 0.444 . . . . 0.0 112.2 -174.735 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' E' E ' 120' ' ' LEU . . . . . . . . . . . . . 20.5 tp -56.4 124.51 18.34 Favored 'General case' 0 N--CA 1.462 0.136 0 C-N-CA 120.992 -0.283 . . . . 0.0 110.448 177.789 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' E' E ' 121' ' ' ASN . . . . . . . . . . . . . 33.6 m120 -113.58 -43.97 3.26 Favored 'General case' 0 C--N 1.331 -0.217 0 CA-C-N 116.588 -0.278 . . . . 0.0 111.137 -175.948 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' E' E ' 122' ' ' LYS . . . . . . . . . . . . . 39.6 ttpt -148.59 147.29 28.83 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-O 121.016 0.436 . . . . 0.0 111.419 -176.888 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' E' E ' 123' ' ' VAL . . . . . . . . . . . . . 46.2 t -132.41 135.71 57.41 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.281 0 CA-C-N 116.021 -0.536 . . . . 0.0 109.644 176.06 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' E' E ' 124' ' ' LEU . . . . . . . . . . . . . 37.8 mt -132.8 141.63 48.58 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-O 120.791 0.329 . . . . 0.0 110.973 -178.567 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' E' E ' 125' ' ' VAL . . . . . 0.653 HG23 HG22 ' E' ' 130' ' ' VAL . 10.6 p -139.26 141.54 35.55 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.23 0 CA-C-N 116.258 -0.428 . . . . 0.0 110.309 177.964 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' E' E ' 126' ' ' ARG . . . . . . . . . . . . . 35.0 ptt-85 -150.88 126.77 10.36 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.09 -0.505 . . . . 0.0 110.579 178.486 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' E' E ' 127' ' ' ASN . . . . . . . . . . . . . 39.2 m-20 49.17 -107.37 0.23 Allowed 'General case' 0 CA--C 1.546 0.807 0 CA-C-O 119.033 -0.508 . . . . 0.0 111.792 178.715 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' E' E ' 128' ' ' ASP . . . . . . . . . . . . . 11.2 p-10 -114.06 11.88 17.78 Favored 'General case' 0 N--CA 1.467 0.408 0 CA-C-N 119.627 1.103 . . . . 0.0 113.416 -175.33 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' E' E ' 129' ' ' LEU . . . . . . . . . . . . . 81.9 mt -120.04 140.74 50.53 Favored 'General case' 0 C--N 1.333 -0.143 0 CA-C-N 118.058 0.39 . . . . 0.0 110.274 178.978 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' E' E ' 130' ' ' VAL . . . . . 0.653 HG22 HG23 ' E' ' 125' ' ' VAL . 46.2 t -128.25 138.91 53.35 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.212 0 N-CA-C 109.741 -0.466 . . . . 0.0 109.741 -179.988 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' E' E ' 131' ' ' VAL . . . . . . . . . . . . . 41.6 t -134.53 138.03 50.34 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.321 0 CA-C-N 116.287 -0.415 . . . . 0.0 110.242 -179.725 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' E' E ' 132' ' ' ILE . . . . . . . . . . . . . 72.9 mt -119.55 132.61 68.85 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.306 0 N-CA-C 109.374 -0.602 . . . . 0.0 109.374 179.942 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' E' E ' 133' ' ' ILE . . . . . . . . . . . . . 39.7 mm -117.64 119.23 61.02 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.253 0 CA-C-N 116.307 -0.406 . . . . 0.0 110.883 -175.991 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' E' E ' 134' ' ' ASP . . . . . . . . . . . . . 8.1 p-10 -131.68 146.46 52.19 Favored 'General case' 0 C--N 1.331 -0.217 0 N-CA-C 109.536 -0.542 . . . . 0.0 109.536 174.504 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' E' E ' 135' ' ' GLU . . . . . . . . . . . . . 43.5 tp10 -49.88 -23.66 2.05 Favored 'General case' 0 C--N 1.328 -0.344 0 N-CA-C 112.941 0.719 . . . . 0.0 112.941 -172.061 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' E' E ' 136' ' ' GLN . . . . . . . . . . . . . 55.6 tp60 -100.97 -27.91 13.03 Favored 'General case' 0 C--O 1.233 0.237 0 N-CA-C 112.46 0.541 . . . . 0.0 112.46 -174.838 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' E' E ' 137' ' ' LYS . . . . . . . . . . . . . 86.6 mttt -142.39 151.35 41.76 Favored 'General case' 0 C--N 1.332 -0.193 0 CA-C-O 121.464 0.649 . . . . 0.0 112.188 -170.396 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' E' E ' 138' ' ' LEU . . . . . . . . . . . . . 14.3 tp -112.49 122.21 47.05 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 115.11 -0.95 . . . . 0.0 108.925 171.977 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' E' E ' 139' ' ' THR . . . . . . . . . . . . . 24.0 m -114.61 124.08 50.95 Favored 'General case' 0 C--N 1.331 -0.212 0 CA-C-O 120.82 0.343 . . . . 0.0 110.868 -177.92 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' E' E ' 140' ' ' LEU . . . . . . . . . . . . . 13.2 tp -111.48 118.48 35.88 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 115.5 -0.773 . . . . 0.0 108.926 178.73 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' E' E ' 141' ' ' ILE . . . . . . . . . . . . . 19.6 mt -119.77 114.31 43.8 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.193 0 N-CA-C 109.726 -0.472 . . . . 0.0 109.726 -176.009 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' E' E ' 142' ' ' ARG . . . . . . . . . . . . . 79.5 mtm180 -90.98 113.67 25.98 Favored 'General case' 0 C--N 1.326 -0.43 0 CA-C-N 115.882 -0.599 . . . . 0.0 110.621 178.039 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' E' E ' 143' ' ' THR . . . . . . . . . . . . . 2.4 p . . . . . 0 C--O 1.221 -0.447 0 CA-C-O 117.951 -1.023 . . . . 0.0 110.559 -179.229 . . . . . . . . 0 0 . 1 . 010 nuclear nobuild full ' F' F ' -3' ' ' GLU . . . . . . . . . . . . . 84.9 tt0 . . . . . 0 N--CA 1.49 1.545 0 N-CA-C 109.298 -0.63 . . . . 0.0 109.298 . . . . . . . . . 0 0 . 1 . 010 nuclear nobuild full ' F' F ' -2' ' ' GLY . . . . . . . . . . . . . . . -73.79 149.95 42.21 Favored Glycine 0 CA--C 1.526 0.739 0 N-CA-C 110.804 -0.918 . . . . 0.0 110.804 179.193 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' F' F ' -1' ' ' VAL . . . . . . . . . . . . . 42.3 t -93.84 134.87 30.03 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 CA-C-O 120.874 0.369 . . . . 0.0 110.068 -179.894 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' F' F ' 0' ' ' ILE . . . . . . . . . . . . . 70.9 mt -111.76 133.63 56.8 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.185 0 CA-C-N 116.16 -0.473 . . . . 0.0 109.877 179.685 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' F' F ' 1' ' ' MET . . . . . . . . . . . . . 25.1 ptt? -82.86 139.28 33.55 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.18 -0.463 . . . . 0.0 110.772 -179.347 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' F' F ' 2' ' ' SER . . . . . . . . . . . . . 6.3 p -116.12 132.9 56.53 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 116.255 -0.429 . . . . 0.0 110.142 178.42 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' F' F ' 3' ' ' GLU . . . . . . . . . . . . . 95.7 mt-10 -140.8 138.04 33.78 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.095 -0.502 . . . . 0.0 110.829 -178.351 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' F' F ' 4' ' ' LEU . . . . . 0.485 HD21 HD21 ' F' ' 6' ' ' LEU . 23.4 tp -123.92 125.31 44.4 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 115.994 -0.548 . . . . 0.0 109.971 175.956 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' F' F ' 5' ' ' LYS . . . . . . . . . . . . . 62.2 mttp -103.78 119.14 38.31 Favored 'General case' 0 C--O 1.234 0.281 0 CA-C-N 116.32 -0.4 . . . . 0.0 110.457 178.395 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' F' F ' 6' ' ' LEU . . . . . 0.485 HD21 HD21 ' F' ' 4' ' ' LEU . 58.1 mt -115.08 141.6 47.79 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 115.398 -0.819 . . . . 0.0 110.223 -178.488 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' F' F ' 7' ' ' LYS . . . . . . . . . . . . . 35.3 ttpt -121.45 136.24 25.73 Favored Pre-proline 0 CA--C 1.534 0.359 0 CA-C-O 118.784 -0.627 . . . . 0.0 109.896 176.627 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' F' F ' 8' ' ' PRO . . . . . . . . . . . . . 95.8 Cg_endo -91.92 133.23 1.32 Allowed 'Trans proline' 0 N--CA 1.489 1.25 0 C-N-CA 121.698 1.599 . . . . 0.0 111.901 178.048 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' F' F ' 9' ' ' LEU . . . . . . . . . . . . . 57.6 mt -73.31 -47.2 7.74 Favored Pre-proline 0 CA--C 1.534 0.336 0 CA-C-O 118.616 -0.707 . . . . 0.0 112.13 -179.117 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' F' F ' 10' ' ' PRO . . . . . . . . . . . . . 97.2 Cg_endo -81.54 147.6 15.78 Favored 'Trans proline' 0 N--CA 1.496 1.622 0 C-N-CA 121.226 1.284 . . . . 0.0 111.504 175.817 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' F' F ' 11' ' ' LYS . . . . . . . . . . . . . 32.3 ttmt -86.51 90.7 8.31 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-O 120.941 0.401 . . . . 0.0 110.498 179.469 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' F' F ' 12' ' ' VAL . . . . . . . . . . . . . 12.6 p -136.11 147.57 28.04 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.252 0 CA-C-N 116.064 -0.517 . . . . 0.0 110.29 179.562 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' F' F ' 13' ' ' GLU . . . . . . . . . . . . . 84.9 tt0 -85.55 130.08 34.66 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.391 -0.368 . . . . 0.0 110.464 179.685 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' F' F ' 14' ' ' LEU . . . . . . . . . . . . . 22.9 mt -97.72 150.7 37.05 Favored Pre-proline 0 C--N 1.33 -0.252 0 CA-C-N 116.207 -0.451 . . . . 0.0 110.354 -179.506 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' F' F ' 15' ' ' PRO . . . . . . . . . . . . . 29.9 Cg_exo -60.36 158.56 30.71 Favored 'Trans proline' 0 N--CA 1.496 1.653 0 C-N-CA 121.199 1.266 . . . . 0.0 111.9 178.096 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' F' F ' 16' ' ' PRO . . . . . . . . . . . . . 39.0 Cg_exo -58.54 -44.37 37.77 Favored 'Trans proline' 0 N--CA 1.497 1.713 0 C-N-CA 121.445 1.43 . . . . 0.0 112.662 -178.373 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' F' F ' 17' ' ' ASP . . . . . . . . . . . . . 12.3 p-10 -83.29 12.89 4.74 Favored 'General case' 0 CA--C 1.536 0.426 0 N-CA-C 112.973 0.731 . . . . 0.0 112.973 -178.718 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' F' F ' 18' ' ' PHE . . . . . 0.505 ' CZ ' HD11 ' F' ' 22' ' ' ILE . 51.4 t80 -56.98 -41.18 77.93 Favored 'General case' 0 C--O 1.227 -0.108 0 O-C-N 122.016 -0.427 . . . . 0.0 110.477 -178.537 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' F' F ' 19' ' ' VAL . . . . . . . . . . . . . 47.0 t -55.78 -44.95 79.17 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.244 0 CA-C-N 116.57 -0.287 . . . . 0.0 110.649 -178.726 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' F' F ' 20' ' ' ASP . . . . . . . . . . . . . 83.1 m-20 -59.95 -41.91 92.92 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-O 120.847 0.356 . . . . 0.0 110.723 -178.851 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' F' F ' 21' ' ' VAL . . . . . . . . . . . . . 57.6 t -63.86 -46.91 92.94 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.303 0 CA-C-N 116.377 -0.374 . . . . 0.0 110.727 -177.809 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' F' F ' 22' ' ' ILE . . . . . 0.616 HG22 HD12 ' F' ' 26' ' ' LEU . 51.6 mm -55.59 -46.37 79.15 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.206 0 CA-C-O 120.694 0.283 . . . . 0.0 110.566 178.628 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' F' F ' 23' ' ' ARG . . . . . . . . . . . . . 41.6 ttp180 -54.39 -51.62 64.27 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.71 -0.223 . . . . 0.0 111.489 -179.502 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' F' F ' 24' ' ' ILE . . . . . . . . . . . . . 75.9 mt -58.65 -44.36 89.52 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.323 0 CA-C-N 116.652 -0.249 . . . . 0.0 111.433 -175.861 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' F' F ' 25' ' ' LYS . . . . . . . . . . . . . 95.3 mttt -68.14 -42.7 79.74 Favored 'General case' 0 C--N 1.328 -0.337 0 N-CA-C 112.331 0.493 . . . . 0.0 112.331 -176.928 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' F' F ' 26' ' ' LEU . . . . . 0.616 HD12 HG22 ' F' ' 22' ' ' ILE . 80.0 mt -78.81 -38.19 38.86 Favored 'General case' 0 C--N 1.329 -0.326 0 N-CA-C 112.984 0.735 . . . . 0.0 112.984 -170.636 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' F' F ' 27' ' ' GLN . . . . . . . . . . . . . 9.7 pt20 -46.97 139.42 5.62 Favored 'General case' 0 N--CA 1.47 0.547 0 N-CA-C 112.633 0.605 . . . . 0.0 112.633 -176.431 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' F' F ' 28' ' ' GLY . . . . . . . . . . . . . . . 101.05 -25.36 28.62 Favored Glycine 0 CA--C 1.533 1.202 0 CA-C-N 115.437 -0.801 . . . . 0.0 112.197 -176.058 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' F' F ' 29' ' ' LYS . . . . . . . . . . . . . 95.1 mttt -97.98 155.2 17.21 Favored 'General case' 0 C--O 1.233 0.192 0 CA-C-N 117.427 0.614 . . . . 0.0 111.01 178.5 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' F' F ' 30' ' ' THR . . . . . . . . . . . . . 21.7 m -107.13 135.93 47.83 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 115.882 -0.599 . . . . 0.0 109.913 175.41 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' F' F ' 31' ' ' VAL . . . . . . . . . . . . . 34.5 m -132.12 156.73 42.76 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.207 0 CA-C-O 120.876 0.369 . . . . 0.0 111.159 -177.107 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' F' F ' 32' ' ' ARG . . . . . . . . . . . . . 82.8 mtt180 -132.18 152.53 51.24 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-O 121.333 0.587 . . . . 0.0 110.673 179.214 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' F' F ' 33' ' ' THR . . . . . . . . . . . . . 18.3 m -52.87 139.95 25.72 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.096 -0.502 . . . . 0.0 111.311 -178.758 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' F' F ' 34' ' ' GLY . . . . . . . . . . . . . . . 100.18 -17.3 57.21 Favored Glycine 0 CA--C 1.533 1.172 0 CA-C-O 119.619 -0.545 . . . . 0.0 113.242 179.274 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' F' F ' 35' ' ' ASP . . . . . . . . . . . . . 74.3 m-20 -67.15 150.03 49.69 Favored 'General case' 0 N--CA 1.46 0.07 0 CA-C-N 118.086 0.943 . . . . 0.0 110.991 178.774 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' F' F ' 36' ' ' VAL . . . . . . . . . . . . . 44.3 t -122.47 130.3 74.62 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.205 0 CA-C-N 116.055 -0.52 . . . . 0.0 109.909 178.44 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' F' F ' 37' ' ' ILE . . . . . . . . . . . . . 69.6 mt -122.34 140.87 44.88 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.218 0 CA-C-N 116.105 -0.498 . . . . 0.0 110.017 -178.527 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' F' F ' 38' ' ' GLY . . . . . . . . . . . . . . . -115.82 128.85 8.21 Favored Glycine 0 CA--C 1.526 0.744 0 N-CA-C 111.179 -0.768 . . . . 0.0 111.179 179.736 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' F' F ' 39' ' ' ILE . . . . . . . . . . . . . 76.3 mt -127.63 140.23 49.7 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.228 0 CA-C-O 120.746 0.308 . . . . 0.0 110.218 179.247 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' F' F ' 40' ' ' SER . . . . . . . . . . . . . 52.8 p -93.32 115.85 28.42 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 116.298 -0.41 . . . . 0.0 111.19 176.229 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' F' F ' 41' ' ' ILE . . . . . . . . . . . . . 44.8 mm -122.58 118.99 56.91 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.214 0 N-CA-C 110.19 -0.3 . . . . 0.0 110.19 178.72 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' F' F ' 42' ' ' LEU . . . . . . . . . . . . . 69.2 mt 55.89 35.64 25.82 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.191 -0.458 . . . . 0.0 111.63 177.412 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' F' F ' 43' ' ' GLY . . . . . . . . . . . . . . . 73.22 23.75 76.88 Favored Glycine 0 CA--C 1.532 1.144 0 C-N-CA 121.151 -0.547 . . . . 0.0 112.795 177.818 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' F' F ' 44' ' ' LYS . . . . . . . . . . . . . 34.7 mmtp -131.5 133.81 45.49 Favored 'General case' 0 C--N 1.331 -0.206 0 CA-C-N 117.264 0.532 . . . . 0.0 109.572 177.538 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' F' F ' 45' ' ' GLU . . . . . . . . . . . . . 85.9 tt0 -82.7 120.21 25.3 Favored 'General case' 0 C--N 1.329 -0.322 0 C-N-CA 120.745 -0.382 . . . . 0.0 110.89 -179.331 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' F' F ' 46' ' ' VAL . . . . . . . . . . . . . 11.2 p -116.83 124.28 72.71 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.154 0 N-CA-C 109.647 -0.501 . . . . 0.0 109.647 175.724 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' F' F ' 47' ' ' LYS . . . . . . . . . . . . . 55.3 mttp -98.58 126.5 44.18 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-N 116.101 -0.5 . . . . 0.0 110.955 179.208 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' F' F ' 48' ' ' PHE . . . . . . . . . . . . . 29.1 m-85 -109.3 131.82 54.71 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.168 -0.469 . . . . 0.0 109.971 177.056 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' F' F ' 49' ' ' LYS . . . . . . . . . . . . . 37.5 tttp -107.66 132.31 53.46 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-N 116.24 -0.436 . . . . 0.0 110.091 177.751 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' F' F ' 50' ' ' VAL . . . . . 0.44 HG13 HD11 ' F' ' 4' ' ' LEU . 42.4 t -75.53 107.05 5.86 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.345 0 N-CA-C 109.453 -0.573 . . . . 0.0 109.453 178.151 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' F' F ' 51' ' ' VAL . . . . . . . . . . . . . 47.4 t -74.5 -48.75 34.09 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.309 0 N-CA-C 109.759 -0.46 . . . . 0.0 109.759 -175.661 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' F' F ' 52' ' ' GLN . . . . . . . . . . . . . 49.4 tt0 -160.11 137.15 9.3 Favored 'General case' 0 C--N 1.33 -0.28 0 C-N-CA 120.316 -0.553 . . . . 0.0 111.568 -179.262 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' F' F ' 53' ' ' ALA . . . . . 0.484 ' HB1' ' HB2' ' F' ' 58' ' ' LEU . . . -113.46 133.06 55.41 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 115.708 -0.678 . . . . 0.0 109.81 175.94 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' F' F ' 54' ' ' TYR . . . . . . . . . . . . . 65.3 t80 -129.18 112.63 18.35 Favored Pre-proline 0 CA--C 1.535 0.386 0 CA-C-O 118.292 -0.861 . . . . 0.0 110.294 178.219 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' F' F ' 55' ' ' PRO . . . . . . . . . . . . . 73.2 Cg_endo -77.18 168.08 77.89 Favored 'Cis proline' 0 N--CA 1.499 1.822 0 CA-C-N 121.935 1.727 . . . . 0.0 112.238 -5.903 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' F' F ' 56' ' ' SER . . . . . . . . . . . . . 13.9 m -116.66 130.51 24.49 Favored Pre-proline 0 CA--C 1.538 0.484 0 CA-C-O 118.536 -0.745 . . . . 0.0 109.413 174.906 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' F' F ' 57' ' ' PRO . . . . . . . . . . . . . 39.3 Cg_endo -67.46 146.74 76.93 Favored 'Cis proline' 0 N--CA 1.498 1.76 0 CA-C-N 121.898 1.713 . . . . 0.0 111.434 -0.786 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' F' F ' 58' ' ' LEU . . . . . 0.484 ' HB2' ' HB1' ' F' ' 53' ' ' ALA . 20.6 tp -106.12 135.82 46.91 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.409 -0.359 . . . . 0.0 110.492 -178.634 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' F' F ' 59' ' ' ARG . . . . . . . . . . . . . 39.3 ttm180 -105.76 126.55 52.29 Favored 'General case' 0 C--N 1.326 -0.438 0 N-CA-C 109.211 -0.663 . . . . 0.0 109.211 175.889 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' F' F ' 60' ' ' VAL . . . . . . . . . . . . . 46.6 t -83.58 119.6 33.15 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.27 0 C-N-CA 120.665 -0.414 . . . . 0.0 110.514 -175.624 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' F' F ' 61' ' ' GLU . . . . . . . . . . . . . 91.6 mt-10 -130.98 165.72 22.55 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 115.926 -0.579 . . . . 0.0 109.775 177.507 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' F' F ' 62' ' ' ASP . . . . . . . . . . . . . 59.7 m-20 -53.34 -32.46 49.25 Favored 'General case' 0 C--N 1.329 -0.303 0 N-CA-C 111.858 0.318 . . . . 0.0 111.858 -178.563 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' F' F ' 63' ' ' ARG . . . . . . . . . . . . . 92.7 mtt180 -74.72 -22.06 59.03 Favored 'General case' 0 C--N 1.33 -0.25 0 N-CA-C 113.02 0.748 . . . . 0.0 113.02 -176.796 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' F' F ' 64' ' ' THR . . . . . . . . . . . . . 39.5 m -65.89 136.52 56.24 Favored 'General case' 0 C--N 1.331 -0.197 0 CA-C-O 120.894 0.378 . . . . 0.0 110.95 -174.547 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' F' F ' 65' ' ' LYS . . . . . . . . . . . . . 96.8 mttt -89.75 133.01 34.92 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 115.912 -0.586 . . . . 0.0 110.153 177.512 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' F' F ' 66' ' ' ILE . . . . . 0.486 HD12 ' N ' ' F' ' 66' ' ' ILE . 4.7 mp -113.29 125.54 70.57 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.284 0 N-CA-C 109.596 -0.52 . . . . 0.0 109.596 178.65 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' F' F ' 67' ' ' THR . . . . . . . . . . . . . 25.6 m -120.59 141.89 49.89 Favored 'General case' 0 C--N 1.331 -0.204 0 CA-C-N 116.111 -0.495 . . . . 0.0 110.997 -176.235 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' F' F ' 68' ' ' LEU . . . . . . . . . . . . . 25.4 tp -100.76 135.26 42.49 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 115.823 -0.626 . . . . 0.0 110.344 179.021 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' F' F ' 69' ' ' VAL . . . . . . . . . . . . . 39.2 t -82.86 130.36 35.86 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.315 0 CA-C-N 116.175 -0.466 . . . . 0.0 109.97 179.285 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' F' F ' 70' ' ' THR . . . . . . . . . . . . . 71.3 p -103.57 -175.31 2.76 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 115.962 -0.563 . . . . 0.0 109.741 -177.801 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' F' F ' 71' ' ' HIS . . . . . . . . . . . . . 5.8 m-70 -64.95 173.12 1.83 Allowed Pre-proline 0 C--N 1.329 -0.324 0 N-CA-C 109.576 -0.527 . . . . 0.0 109.576 177.876 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' F' F ' 72' ' ' PRO . . . . . 0.417 ' O ' HG13 ' F' ' 73' ' ' VAL . 20.2 Cg_exo -64.81 -29.28 59.06 Favored 'Trans proline' 0 N--CA 1.497 1.731 0 C-N-CA 121.15 1.233 . . . . 0.0 111.974 -179.905 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' F' F ' 73' ' ' VAL . . . . . 0.417 HG13 ' O ' ' F' ' 72' ' ' PRO . 3.1 m -150.82 102.64 0.28 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.227 0 CA-C-O 121.227 0.537 . . . . 0.0 111.25 174.143 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' F' F ' 74' ' ' ASP . . . . . . . . . . . . . 13.2 t0 -96.42 115.81 28.03 Favored 'General case' 0 C--N 1.325 -0.469 0 N-CA-C 108.271 -1.011 . . . . 0.0 108.271 171.175 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' F' F ' 75' ' ' VAL . . . . . . . . . . . . . 42.9 t -107.39 124.77 63.53 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.268 0 CA-C-O 121.156 0.503 . . . . 0.0 111.064 -171.235 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' F' F ' 76' ' ' LEU . . . . . . . . . . . . . 24.3 mt -125.24 133.59 52.65 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 115.399 -0.819 . . . . 0.0 109.442 176.452 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' F' F ' 77' ' ' GLU . . . . . . . . . . . . . 98.3 mt-10 -129.35 136.41 49.96 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-O 121.046 0.451 . . . . 0.0 111.126 -178.147 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' F' F ' 78' ' ' ALA . . . . . . . . . . . . . . . -128.2 138.14 52.34 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 115.748 -0.66 . . . . 0.0 109.868 177.124 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' F' F ' 79' ' ' LYS . . . . . 0.603 ' O ' HD13 ' F' ' 80' ' ' ILE . 19.9 pttp -76.07 121.9 23.47 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-O 121.193 0.52 . . . . 0.0 110.599 -179.025 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' F' F ' 80' ' ' ILE . . . . . 0.603 HD13 ' O ' ' F' ' 79' ' ' LYS . 39.1 mm -139.22 116.58 11.18 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.282 0 N-CA-C 109.25 -0.648 . . . . 0.0 109.25 -178.242 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' F' F ' 81' ' ' LYS . . . . . . . . . . . . . 83.7 tttt -112.56 126.39 55.29 Favored 'General case' 0 C--N 1.331 -0.215 0 CA-C-O 120.958 0.408 . . . . 0.0 111.206 -176.139 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' F' F ' 82' ' ' GLY . . . . . . . . . . . . . . . 89.0 42.24 5.69 Favored Glycine 0 CA--C 1.525 0.714 0 C-N-CA 120.86 -0.686 . . . . 0.0 111.569 174.652 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' F' F ' 83' ' ' ILE . . . . . . . . . . . . . 72.8 mt -69.15 141.81 16.89 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.342 0 CA-C-O 120.975 0.417 . . . . 0.0 110.001 178.446 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' F' F ' 84' ' ' LYS . . . . . . . . . . . . . 57.0 tttp -103.59 -52.57 2.96 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 115.884 -0.598 . . . . 0.0 110.356 -178.663 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' F' F ' 85' ' ' ASP . . . . . . . . . . . . . 11.1 t70 -153.55 155.56 36.4 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 115.988 -0.551 . . . . 0.0 110.587 -178.904 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' F' F ' 86' ' ' VAL . . . . . 0.45 ' O ' HD13 ' F' ' 87' ' ' ILE . 45.1 t -130.72 133.39 63.41 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.236 0 CA-C-O 120.976 0.417 . . . . 0.0 110.682 -177.765 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' F' F ' 87' ' ' ILE . . . . . 0.45 HD13 ' O ' ' F' ' 86' ' ' VAL . 46.1 mm -124.76 126.61 71.77 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.221 0 CA-C-N 115.883 -0.599 . . . . 0.0 109.748 176.432 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' F' F ' 88' ' ' LEU . . . . . . . . . . . . . 36.4 mt -116.22 136.54 52.92 Favored 'General case' 0 N--CA 1.464 0.239 0 CA-C-O 121.129 0.49 . . . . 0.0 111.504 -177.02 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' F' F ' 89' ' ' ASP . . . . . . . . . . . . . 10.6 t70 -130.01 159.33 37.04 Favored 'General case' 0 C--N 1.331 -0.221 0 CA-C-N 115.566 -0.743 . . . . 0.0 109.605 175.439 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' F' F ' 90' ' ' GLU . . . . . . . . . . . . . 95.4 mt-10 -46.7 -39.34 11.32 Favored 'General case' 0 CA--C 1.531 0.237 0 N-CA-C 113.118 0.784 . . . . 0.0 113.118 -171.68 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' F' F ' 91' ' ' ASN . . . . . . . . . . . . . 23.9 p30 -131.73 23.55 4.66 Favored 'General case' 0 N--CA 1.466 0.35 0 N-CA-C 112.725 0.639 . . . . 0.0 112.725 -177.383 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' F' F ' 92' ' ' LEU . . . . . . . . . . . . . 16.3 mt -148.7 141.13 24.24 Favored 'General case' 0 C--N 1.33 -0.243 0 N-CA-C 110.137 -0.32 . . . . 0.0 110.137 -176.691 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' F' F ' 93' ' ' ILE . . . . . . . . . . . . . 69.6 mt -124.93 117.39 50.02 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.362 0 N-CA-C 109.604 -0.517 . . . . 0.0 109.604 179.029 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' F' F ' 94' ' ' VAL . . . . . 0.428 HG21 HG21 ' F' ' 125' ' ' VAL . 46.7 t -117.13 127.07 74.78 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.242 0 CA-C-O 120.959 0.409 . . . . 0.0 110.106 179.844 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' F' F ' 95' ' ' VAL . . . . . . . . . . . . . 47.7 t -121.59 132.51 70.58 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.322 0 CA-C-N 115.844 -0.616 . . . . 0.0 109.626 178.799 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' F' F ' 96' ' ' ILE . . . . . . . . . . . . . 63.0 mt -113.71 129.09 70.18 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.269 0 N-CA-C 109.351 -0.611 . . . . 0.0 109.351 179.476 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' F' F ' 97' ' ' THR . . . . . . . . . . . . . 72.8 p -101.21 158.34 16.11 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-O 121.136 0.493 . . . . 0.0 111.121 -178.299 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' F' F ' 98' ' ' GLU . . . . . . . . . . . . . 96.9 mt-10 -54.0 -25.79 22.8 Favored 'General case' 0 CA--C 1.532 0.274 0 N-CA-C 112.316 0.487 . . . . 0.0 112.316 -179.037 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' F' F ' 99' ' ' GLU . . . . . . . . . . . . . 71.4 mm-40 -80.7 16.68 1.32 Allowed 'General case' 0 CA--C 1.535 0.385 0 N-CA-C 113.031 0.752 . . . . 0.0 113.031 -177.298 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' F' F ' 100' ' ' ASN . . . . . . . . . . . . . 3.8 m-20 62.11 37.57 14.48 Favored 'General case' 0 C--N 1.332 -0.156 0 CA-C-O 121.076 0.465 . . . . 0.0 111.088 177.847 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' F' F ' 101' ' ' GLU . . . . . . . . . . . . . 84.0 tt0 -114.79 143.12 45.59 Favored 'General case' 0 C--N 1.333 -0.111 0 N-CA-C 109.704 -0.48 . . . . 0.0 109.704 175.922 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' F' F ' 102' ' ' VAL . . . . . . . . . . . . . 43.0 t -115.22 125.02 72.37 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 CA-C-N 116.146 -0.479 . . . . 0.0 110.055 -178.184 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' F' F ' 103' ' ' LEU . . . . . . . . . . . . . 20.2 mt -114.1 128.64 56.47 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 115.695 -0.684 . . . . 0.0 109.973 176.251 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' F' F ' 104' ' ' ILE . . . . . . . . . . . . . 71.2 mt -117.49 118.97 60.31 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.253 0 N-CA-C 110.371 -0.233 . . . . 0.0 110.371 179.999 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' F' F ' 105' ' ' PHE . . . . . . . . . . . . . 66.0 m-85 -117.54 166.3 12.53 Favored 'General case' 0 C--N 1.333 -0.152 0 CA-C-N 115.455 -0.793 . . . . 0.0 109.898 178.401 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' F' F ' 106' ' ' ASN . . . . . . . . . . . . . 44.4 p-10 -100.4 -169.98 1.8 Allowed 'General case' 0 C--N 1.33 -0.275 0 N-CA-C 109.91 -0.404 . . . . 0.0 109.91 173.988 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' F' F ' 107' ' ' GLN . . . . . . . . . . . . . 30.1 tt0 -59.38 -29.99 68.1 Favored 'General case' 0 C--N 1.329 -0.298 0 N-CA-C 111.855 0.317 . . . . 0.0 111.855 178.221 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' F' F ' 108' ' ' ASN . . . . . . . . . . . . . 14.1 t-20 -81.98 5.17 20.05 Favored 'General case' 0 CA--C 1.537 0.448 0 N-CA-C 113.276 0.843 . . . . 0.0 113.276 -177.796 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' F' F ' 109' ' ' LEU . . . . . . . . . . . . . 9.9 tp 62.61 36.28 13.77 Favored 'General case' 0 CA--C 1.53 0.2 0 O-C-N 122.073 -0.392 . . . . 0.0 111.476 178.119 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' F' F ' 110' ' ' GLU . . . . . . . . . . . . . 96.0 mt-10 -108.1 156.24 19.5 Favored 'General case' 0 C--N 1.332 -0.193 0 N-CA-C 109.894 -0.41 . . . . 0.0 109.894 176.304 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' F' F ' 111' ' ' GLU . . . . . . . . . . . . . 46.2 tp10 -82.91 123.05 29.03 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-O 121.02 0.438 . . . . 0.0 110.852 -177.479 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' F' F ' 112' ' ' LEU . . . . . . . . . . . . . 12.5 mt -108.3 -46.01 3.8 Favored 'General case' 0 C--N 1.332 -0.184 0 CA-C-N 115.93 -0.577 . . . . 0.0 110.136 177.577 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' F' F ' 113' ' ' TYR . . . . . . . . . . . . . 62.3 t80 -140.67 136.54 32.75 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.443 -0.344 . . . . 0.0 110.981 179.863 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' F' F ' 114' ' ' ARG . . . . . . . . . . . . . 59.6 ttp180 -137.97 125.25 21.74 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.28 -0.418 . . . . 0.0 110.169 177.536 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' F' F ' 115' ' ' GLY . . . . . . . . . . . . . . . -150.2 161.87 29.05 Favored Glycine 0 CA--C 1.524 0.613 0 N-CA-C 111.167 -0.773 . . . . 0.0 111.167 179.94 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' F' F ' 116' ' ' LYS . . . . . . . . . . . . . 36.3 ttpt -128.27 134.55 48.97 Favored 'General case' 0 C--N 1.33 -0.273 0 N-CA-C 109.855 -0.424 . . . . 0.0 109.855 178.09 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' F' F ' 117' ' ' PHE . . . . . . . . . . . . . 39.9 m-85 -133.33 113.84 13.04 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-O 120.968 0.414 . . . . 0.0 110.404 -176.412 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' F' F ' 118' ' ' GLU . . . . . . . . . . . . . 44.0 mp0 -57.55 -44.1 84.93 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.088 -0.505 . . . . 0.0 110.71 -175.011 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' F' F ' 119' ' ' ASN . . . . . . . . . . . . . 14.8 m120 -99.12 30.99 3.2 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.201 -0.454 . . . . 0.0 112.192 -173.722 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' F' F ' 120' ' ' LEU . . . . . . . . . . . . . 14.2 tp -55.49 121.6 9.38 Favored 'General case' 0 C--O 1.232 0.16 0 O-C-N 122.235 -0.29 . . . . 0.0 110.671 177.78 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' F' F ' 121' ' ' ASN . . . . . . . . . . . . . 38.6 m-80 -113.9 -44.14 3.2 Favored 'General case' 0 C--N 1.332 -0.183 0 CA-C-N 116.544 -0.298 . . . . 0.0 111.301 -177.756 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' F' F ' 122' ' ' LYS . . . . . . . . . . . . . 33.6 ttpt -145.27 143.5 30.26 Favored 'General case' 0 C--N 1.331 -0.21 0 C-N-CA 120.66 -0.416 . . . . 0.0 111.639 -176.514 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' F' F ' 123' ' ' VAL . . . . . . . . . . . . . 42.1 t -124.86 131.65 72.34 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.237 0 N-CA-C 109.385 -0.598 . . . . 0.0 109.385 175.15 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' F' F ' 124' ' ' LEU . . . . . 0.569 HD13 HD12 ' A' ' 88' ' ' LEU . 9.6 tt -133.9 130.75 38.22 Favored 'General case' 0 C--N 1.332 -0.194 0 CA-C-O 121.073 0.464 . . . . 0.0 111.105 -178.402 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' F' F ' 125' ' ' VAL . . . . . 0.428 HG21 HG21 ' F' ' 94' ' ' VAL . 43.3 t -121.16 133.54 67.44 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.233 0 CA-C-N 115.783 -0.644 . . . . 0.0 109.543 176.867 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' F' F ' 126' ' ' ARG . . . . . . . . . . . . . 36.6 ptt-85 -142.83 125.03 15.4 Favored 'General case' 0 C--N 1.331 -0.226 0 CA-C-O 121.021 0.438 . . . . 0.0 111.087 179.759 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' F' F ' 127' ' ' ASN . . . . . . . . . . . . . 58.8 m-80 49.21 -105.06 0.15 Allowed 'General case' 0 CA--C 1.544 0.738 0 CA-C-N 116.126 -0.488 . . . . 0.0 111.748 177.42 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' F' F ' 128' ' ' ASP . . . . . . . . . . . . . 8.8 p-10 -114.15 1.79 14.67 Favored 'General case' 0 CA--C 1.534 0.359 0 CA-C-N 119.524 1.057 . . . . 0.0 113.57 -176.366 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' F' F ' 129' ' ' LEU . . . . . . . . . . . . . 82.9 mt -113.7 145.7 40.94 Favored 'General case' 0 C--N 1.333 -0.131 0 O-C-N 121.92 -0.488 . . . . 0.0 110.5 -178.805 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' F' F ' 130' ' ' VAL . . . . . . . . . . . . . 45.7 t -125.41 135.78 62.91 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.22 0 CA-C-N 116.123 -0.49 . . . . 0.0 109.769 179.955 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' F' F ' 131' ' ' VAL . . . . . 0.709 HG21 HD13 ' A' ' 88' ' ' LEU . 27.5 m -136.03 143.1 37.01 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.251 0 CA-C-O 121.356 0.598 . . . . 0.0 111.126 178.774 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' F' F ' 132' ' ' ILE . . . . . . . . . . . . . 70.7 mt -123.6 133.95 67.74 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.288 0 CA-C-N 115.219 -0.9 . . . . 0.0 109.502 -179.336 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' F' F ' 133' ' ' ILE . . . . . 0.402 HG21 HG21 ' A' ' 86' ' ' VAL . 39.6 mm -115.57 122.01 68.48 Favored 'Isoleucine or valine' 0 C--O 1.233 0.225 0 CA-C-O 120.735 0.302 . . . . 0.0 110.89 -176.165 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' F' F ' 134' ' ' ASP . . . . . . . . . . . . . 6.7 p-10 -131.98 146.39 52.06 Favored 'General case' 0 C--N 1.331 -0.216 0 N-CA-C 109.457 -0.571 . . . . 0.0 109.457 174.098 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' F' F ' 135' ' ' GLU . . . . . . . . . . . . . 42.7 tp10 -49.82 -23.9 2.12 Favored 'General case' 0 C--N 1.328 -0.348 0 N-CA-C 112.883 0.697 . . . . 0.0 112.883 -171.406 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' F' F ' 136' ' ' GLN . . . . . . . . . . . . . 94.3 mt-30 -92.73 -37.21 12.49 Favored 'General case' 0 C--N 1.332 -0.185 0 N-CA-C 112.115 0.413 . . . . 0.0 112.115 -176.284 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' F' F ' 137' ' ' LYS . . . . . . . . . . . . . 45.9 mtmt -148.48 159.17 44.31 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-O 121.512 0.672 . . . . 0.0 111.819 -168.968 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' F' F ' 138' ' ' LEU . . . . . . . . . . . . . 5.0 tt -115.43 124.74 51.93 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 115.173 -0.921 . . . . 0.0 109.365 175.737 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' F' F ' 139' ' ' THR . . . . . . . . . . . . . 27.5 m -108.27 129.52 55.21 Favored 'General case' 0 C--N 1.331 -0.22 0 CA-C-N 116.437 -0.347 . . . . 0.0 110.878 -177.523 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' F' F ' 140' ' ' LEU . . . . . 0.455 HD23 ' C ' ' F' ' 140' ' ' LEU . 5.9 tt -117.31 122.56 44.25 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 115.607 -0.724 . . . . 0.0 109.109 -178.427 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' F' F ' 141' ' ' ILE . . . . . 0.444 ' N ' HD23 ' F' ' 140' ' ' LEU . 19.3 mt -120.06 116.97 52.02 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.345 0 N-CA-C 109.815 -0.439 . . . . 0.0 109.815 -175.969 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' F' F ' 142' ' ' ARG . . . . . . . . . . . . . 56.4 ttp180 -104.67 129.04 52.9 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 115.445 -0.798 . . . . 0.0 110.638 -178.829 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' F' F ' 143' ' ' THR . . . . . . . . . . . . . 55.8 p . . . . . 0 C--O 1.221 -0.427 0 CA-C-O 117.962 -1.018 . . . . 0.0 110.467 178.603 . . . . . . . . 0 0 . 1 . 011 nuclear nobuild full ' A' A ' -3' ' ' GLU . . . . . . . . . . . . . 95.6 mt-10 . . . . . 0 N--CA 1.49 1.53 0 N-CA-C 109.346 -0.613 . . . . 0.0 109.346 . . . . . . . . . 0 0 . 1 . 011 nuclear nobuild full ' A' A ' -2' ' ' GLY . . . . . . . . . . . . . . . -67.31 141.83 39.9 Favored Glycine 0 CA--C 1.525 0.663 0 N-CA-C 111.057 -0.817 . . . . 0.0 111.057 -179.609 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' -1' ' ' VAL . . . . . . . . . . . . . 42.9 t -141.12 144.29 26.78 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.308 0 N-CA-C 110.023 -0.362 . . . . 0.0 110.023 179.804 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 0' ' ' ILE . . . . . . . . . . . . . 72.4 mt -99.9 137.16 28.26 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.343 0 CA-C-O 120.931 0.396 . . . . 0.0 110.162 -179.407 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 25.4 ptp -91.46 153.55 19.75 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 115.966 -0.561 . . . . 0.0 110.563 -179.827 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 2.8 p -126.49 129.92 49.6 Favored 'General case' 0 C--N 1.331 -0.223 0 CA-C-N 116.296 -0.411 . . . . 0.0 110.609 179.537 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 84.9 tt0 -141.74 138.14 32.15 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.097 -0.501 . . . . 0.0 110.856 179.501 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 4' ' ' LEU . . . . . 0.445 HD21 HD21 ' A' ' 6' ' ' LEU . 12.7 tp -123.27 133.19 54.2 Favored 'General case' 0 C--N 1.332 -0.155 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.166 177.157 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 5' ' ' LYS . . . . . . . . . . . . . 95.6 mttt -108.48 120.62 42.94 Favored 'General case' 0 C--O 1.234 0.271 0 CA-C-N 116.421 -0.354 . . . . 0.0 110.417 179.737 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 6' ' ' LEU . . . . . 0.445 HD21 HD21 ' A' ' 4' ' ' LEU . 56.2 mt -115.89 148.23 40.22 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 115.457 -0.792 . . . . 0.0 110.715 -177.755 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 31.9 ttpt -138.57 140.59 28.29 Favored Pre-proline 0 CA--C 1.534 0.357 0 CA-C-O 119.164 -0.446 . . . . 0.0 110.075 175.421 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 8' ' ' PRO . . . . . . . . . . . . . 85.5 Cg_endo -92.02 141.96 2.52 Favored 'Trans proline' 0 N--CA 1.491 1.332 0 C-N-CA 121.734 1.622 . . . . 0.0 111.802 177.794 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 51.2 mt -77.4 -48.19 2.42 Favored Pre-proline 0 CA--C 1.534 0.338 0 CA-C-O 118.649 -0.691 . . . . 0.0 112.435 -179.459 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 90.1 Cg_endo -79.82 156.66 24.1 Favored 'Trans proline' 0 N--CA 1.496 1.636 0 C-N-CA 121.15 1.233 . . . . 0.0 111.812 177.292 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 61.6 tttm -87.97 95.66 10.21 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.378 -0.374 . . . . 0.0 110.281 178.292 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 12.4 p -140.14 144.57 27.68 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.263 0 CA-C-N 116.145 -0.479 . . . . 0.0 110.532 -179.43 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 95.6 mt-10 -82.18 127.13 32.85 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.234 -0.439 . . . . 0.0 110.07 177.392 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 14' ' ' LEU . . . . . . . . . . . . . 23.9 mt -97.94 139.42 21.28 Favored Pre-proline 0 CA--C 1.533 0.318 0 CA-C-O 118.796 -0.621 . . . . 0.0 109.767 179.871 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 15' ' ' PRO . . . . . . . . . . . . . 26.6 Cg_exo -60.99 160.57 25.27 Favored 'Trans proline' 0 N--CA 1.498 1.758 0 C-N-CA 121.161 1.241 . . . . 0.0 111.713 178.348 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 16' ' ' PRO . . . . . . . . . . . . . 30.7 Cg_exo -59.66 -32.71 96.29 Favored 'Trans proline' 0 N--CA 1.499 1.794 0 C-N-CA 121.396 1.397 . . . . 0.0 112.863 -177.618 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 17' ' ' ASP . . . . . . . . . . . . . 9.6 p-10 -91.56 6.1 47.0 Favored 'General case' 0 CA--C 1.538 0.498 0 N-CA-C 113.254 0.835 . . . . 0.0 113.254 -177.275 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 18' ' ' PHE . . . . . . . . . . . . . 47.1 t80 -58.54 -46.08 87.55 Favored 'General case' 0 C--N 1.333 -0.122 0 CA-C-O 120.985 0.421 . . . . 0.0 109.975 -178.356 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 19' ' ' VAL . . . . . . . . . . . . . 48.5 t -57.37 -40.9 76.95 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.328 0 CA-C-N 116.074 -0.512 . . . . 0.0 110.41 -178.784 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 9.2 t70 -60.07 -44.11 94.98 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-O 120.743 0.306 . . . . 0.0 111.099 -177.613 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 49.0 t -64.66 -46.71 91.53 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.248 0 C-N-CA 120.694 -0.402 . . . . 0.0 110.512 -177.893 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 22' ' ' ILE . . . . . 0.504 HG22 HD12 ' A' ' 26' ' ' LEU . 50.7 mm -56.19 -45.19 80.85 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.246 0 C-N-CA 120.915 -0.314 . . . . 0.0 110.626 178.912 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 23' ' ' ARG . . . . . . . . . . . . . 55.7 ttp180 -54.76 -49.82 69.92 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-O 120.658 0.266 . . . . 0.0 111.296 -178.626 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 24' ' ' ILE . . . . . . . . . . . . . 75.9 mt -59.72 -42.22 87.92 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.249 0 CA-C-N 116.574 -0.285 . . . . 0.0 111.178 -177.522 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 99.4 mttt -67.6 -38.16 83.6 Favored 'General case' 0 C--N 1.328 -0.362 0 N-CA-C 112.604 0.594 . . . . 0.0 112.604 -178.686 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 26' ' ' LEU . . . . . 0.504 HD12 HG22 ' A' ' 22' ' ' ILE . 83.1 mt -78.13 -41.27 35.55 Favored 'General case' 0 C--N 1.33 -0.261 0 N-CA-C 113.144 0.794 . . . . 0.0 113.144 -172.168 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 27' ' ' GLN . . . . . . . . . . . . . 10.5 pt20 -46.98 138.06 6.85 Favored 'General case' 0 N--CA 1.47 0.551 0 N-CA-C 112.704 0.631 . . . . 0.0 112.704 -175.675 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 101.63 -26.43 24.48 Favored Glycine 0 CA--C 1.532 1.115 0 CA-C-N 115.571 -0.74 . . . . 0.0 112.306 -177.331 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 71.6 mmtt -98.17 155.14 17.3 Favored 'General case' 0 C--N 1.331 -0.209 0 CA-C-N 117.51 0.655 . . . . 0.0 111.097 177.802 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 30' ' ' THR . . . . . . . . . . . . . 41.4 m -105.33 137.52 43.01 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 115.895 -0.593 . . . . 0.0 109.862 176.068 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 34.8 m -129.51 157.38 42.24 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.245 0 CA-C-N 116.354 -0.385 . . . . 0.0 110.798 -178.468 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 32' ' ' ARG . . . . . . . . . . . . . 73.5 mtt85 -131.37 153.13 49.97 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-O 121.282 0.563 . . . . 0.0 110.701 177.899 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 33' ' ' THR . . . . . . . . . . . . . 22.7 m -53.02 139.66 27.32 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.051 -0.522 . . . . 0.0 111.397 -177.84 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 99.13 -16.99 58.66 Favored Glycine 0 CA--C 1.533 1.17 0 CA-C-O 119.593 -0.56 . . . . 0.0 113.327 178.345 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 61.3 m-20 -62.81 148.82 45.81 Favored 'General case' 0 C--O 1.231 0.11 0 CA-C-N 118.044 0.922 . . . . 0.0 111.084 179.696 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 45.1 t -123.66 130.69 73.93 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.257 0 CA-C-N 115.585 -0.734 . . . . 0.0 109.853 179.343 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 37' ' ' ILE . . . . . . . . . . . . . 69.6 mt -122.71 139.19 50.32 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.237 0 CA-C-N 116.248 -0.433 . . . . 0.0 110.04 -179.773 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . -110.72 128.78 8.94 Favored Glycine 0 CA--C 1.525 0.665 0 N-CA-C 111.037 -0.825 . . . . 0.0 111.037 179.556 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 39' ' ' ILE . . . . . . . . . . . . . 72.1 mt -123.06 135.62 62.51 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.257 0 N-CA-C 110.109 -0.33 . . . . 0.0 110.109 179.33 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 40' ' ' SER . . . . . . . . . . . . . 41.5 t -93.6 116.91 29.44 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.394 -0.366 . . . . 0.0 111.039 176.01 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 41' ' ' ILE . . . . . . . . . . . . . 44.2 mm -121.53 115.26 45.99 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.241 0 CA-C-N 116.476 -0.329 . . . . 0.0 110.333 179.34 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 78.5 mt 54.38 37.07 26.89 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-O 120.93 0.395 . . . . 0.0 111.548 176.942 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . 74.13 24.46 73.54 Favored Glycine 0 CA--C 1.532 1.123 0 C-N-CA 121.061 -0.59 . . . . 0.0 112.797 177.622 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 44' ' ' LYS . . . . . . . . . . . . . 70.0 mmtt -130.36 132.54 45.85 Favored 'General case' 0 C--N 1.331 -0.223 0 N-CA-C 109.57 -0.529 . . . . 0.0 109.57 177.74 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 81.3 tt0 -84.02 122.5 28.87 Favored 'General case' 0 C--N 1.329 -0.308 0 C-N-CA 120.74 -0.384 . . . . 0.0 111.099 -178.142 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 46' ' ' VAL . . . . . . . . . . . . . 7.1 p -120.86 128.15 76.03 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.194 0 N-CA-C 109.356 -0.609 . . . . 0.0 109.356 175.241 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 60.3 mttp -100.48 127.78 46.73 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 115.988 -0.551 . . . . 0.0 111.015 179.277 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 48' ' ' PHE . . . . . . . . . . . . . 92.2 m-85 -110.48 131.83 54.71 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.368 -0.378 . . . . 0.0 110.099 176.44 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 45.5 tttp -108.46 136.96 47.21 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.246 -0.433 . . . . 0.0 110.598 179.158 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 50' ' ' VAL . . . . . . . . . . . . . 47.0 t -82.33 107.35 14.18 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.33 0 N-CA-C 109.161 -0.681 . . . . 0.0 109.161 175.416 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 51' ' ' VAL . . . . . . . . . . . . . 47.8 t -71.68 -52.26 26.96 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.364 0 CA-C-N 115.952 -0.567 . . . . 0.0 109.668 -174.295 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 52' ' ' GLN . . . . . . . . . . . . . 90.8 mt-30 -152.94 151.09 29.93 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-O 121.182 0.515 . . . . 0.0 111.572 -177.755 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -126.46 131.88 51.57 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 115.214 -0.903 . . . . 0.0 109.639 175.087 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 54' ' ' TYR . . . . . . . . . . . . . 51.7 t80 -128.93 108.43 18.29 Favored Pre-proline 0 CA--C 1.533 0.323 0 CA-C-O 118.294 -0.86 . . . . 0.0 110.421 -179.826 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 55' ' ' PRO . . . . . . . . . . . . . 73.4 Cg_endo -77.12 170.0 72.77 Favored 'Cis proline' 0 N--CA 1.499 1.837 0 CA-C-N 121.809 1.682 . . . . 0.0 112.501 -5.54 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 56' ' ' SER . . . . . . . . . . . . . 15.2 m -115.27 129.05 25.41 Favored Pre-proline 0 CA--C 1.539 0.554 0 CA-C-O 118.448 -0.787 . . . . 0.0 109.462 174.994 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 57' ' ' PRO . . . . . . . . . . . . . 38.4 Cg_endo -67.48 165.73 67.61 Favored 'Cis proline' 0 N--CA 1.498 1.741 0 CA-C-N 121.979 1.742 . . . . 0.0 111.517 -0.601 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 58' ' ' LEU . . . . . . . . . . . . . 27.9 tp -129.28 135.89 49.35 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.268 179.646 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 59' ' ' ARG . . . . . . . . . . . . . 74.0 ttt180 -104.72 128.69 52.89 Favored 'General case' 0 C--N 1.326 -0.421 0 N-CA-C 109.188 -0.671 . . . . 0.0 109.188 176.562 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 46.2 t -79.92 122.4 35.06 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.212 0 C-N-CA 120.566 -0.453 . . . . 0.0 109.982 -175.945 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 78.9 tt0 -130.75 157.82 41.78 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 115.713 -0.676 . . . . 0.0 109.264 -179.511 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 62' ' ' ASP . . . . . . . . . . . . . 79.9 m-20 -51.58 -32.21 27.62 Favored 'General case' 0 C--N 1.328 -0.339 0 N-CA-C 112.125 0.417 . . . . 0.0 112.125 -177.642 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 63' ' ' ARG . . . . . . . . . . . . . 46.8 ptt85 -88.97 5.11 45.69 Favored 'General case' 0 CA--C 1.538 0.518 0 N-CA-C 113.767 1.025 . . . . 0.0 113.767 -175.598 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 30.4 m -80.14 141.03 36.12 Favored 'General case' 0 C--N 1.331 -0.206 0 CA-C-N 117.981 0.355 . . . . 0.0 110.742 -178.483 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 65' ' ' LYS . . . . . . . . . . . . . 97.0 mttt -88.67 131.36 35.03 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.237 -0.438 . . . . 0.0 110.262 178.895 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 66' ' ' ILE . . . . . . . . . . . . . 59.1 mt -115.26 126.45 72.83 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.297 0 N-CA-C 109.502 -0.555 . . . . 0.0 109.502 179.061 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 67' ' ' THR . . . . . . . . . . . . . 26.4 m -117.56 136.61 53.15 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-O 121.05 0.452 . . . . 0.0 110.731 -177.756 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 68' ' ' LEU . . . . . 0.462 HD23 ' C ' ' A' ' 68' ' ' LEU . 6.3 tt -104.71 123.96 48.53 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 115.782 -0.645 . . . . 0.0 109.69 178.277 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 69' ' ' VAL . . . . . . . . . . . . . 45.6 t -92.55 131.27 40.08 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.269 0 CA-C-O 120.974 0.416 . . . . 0.0 110.131 -178.474 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 70' ' ' THR . . . . . . . . . . . . . 6.5 m -90.03 145.67 24.91 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 115.924 -0.58 . . . . 0.0 110.566 -179.216 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 71' ' ' HIS . . . . . . . . . . . . . 65.3 m80 -64.87 160.3 56.12 Favored Pre-proline 0 C--N 1.329 -0.318 0 CA-C-N 116.254 -0.43 . . . . 0.0 110.458 -179.976 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 72' ' ' PRO . . . . . . . . . . . . . 47.7 Cg_endo -85.67 155.74 10.38 Favored 'Trans proline' 0 N--CA 1.49 1.314 0 C-N-CA 121.697 1.598 . . . . 0.0 112.384 -178.697 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 73' ' ' VAL . . . . . . . . . . . . . 35.4 m -80.63 167.1 2.24 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.246 0 CA-C-N 116.168 -0.469 . . . . 0.0 110.622 -179.709 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 74' ' ' ASP . . . . . . . . . . . . . 30.2 t0 -101.45 121.42 41.92 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.227 -0.442 . . . . 0.0 109.845 -179.623 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 43.5 t -115.7 124.27 71.95 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.215 0 CA-C-O 121.071 0.462 . . . . 0.0 110.467 -178.62 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 76' ' ' LEU . . . . . . . . . . . . . 6.3 mp -118.35 138.52 52.36 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 115.692 -0.685 . . . . 0.0 109.501 175.569 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 77' ' ' GLU . . . . . . . . . . . . . 96.8 mt-10 -134.15 136.3 43.71 Favored 'General case' 0 C--N 1.331 -0.204 0 CA-C-O 121.079 0.466 . . . . 0.0 111.017 -179.222 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 78' ' ' ALA . . . . . . . . . . . . . . . -124.81 141.68 51.95 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 115.632 -0.713 . . . . 0.0 110.077 177.704 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 79' ' ' LYS . . . . . 0.596 ' O ' HD13 ' A' ' 80' ' ' ILE . 11.4 mptt -81.52 109.83 16.35 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-O 120.858 0.361 . . . . 0.0 110.379 -179.922 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 80' ' ' ILE . . . . . 0.596 HD13 ' O ' ' A' ' 79' ' ' LYS . 41.5 mm -139.09 103.77 2.04 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.356 0 N-CA-C 109.2 -0.667 . . . . 0.0 109.2 -178.122 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 81' ' ' LYS . . . . . . . . . . . . . 19.7 pttp -112.38 140.39 47.15 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-O 121.002 0.429 . . . . 0.0 111.335 -176.857 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . 89.2 42.07 5.67 Favored Glycine 0 CA--C 1.526 0.724 0 N-CA-C 110.865 -0.894 . . . . 0.0 110.865 178.599 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 83' ' ' ILE . . . . . . . . . . . . . 70.7 mt -75.79 140.94 16.5 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.333 0 CA-C-O 120.88 0.372 . . . . 0.0 110.205 -179.139 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 84' ' ' LYS . . . . . . . . . . . . . 58.0 tttp -95.13 -53.4 3.82 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 115.904 -0.589 . . . . 0.0 109.991 179.597 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 85' ' ' ASP . . . . . . . . . . . . . 10.2 t70 -155.04 154.16 32.06 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 115.629 -0.714 . . . . 0.0 110.349 -179.627 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 86' ' ' VAL . . . . . . . . . . . . . 41.6 t -126.01 131.09 72.12 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.205 0 CA-C-O 120.925 0.393 . . . . 0.0 110.422 -179.197 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 87' ' ' ILE . . . . . . . . . . . . . 46.0 mm -120.33 124.75 73.19 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.285 0 CA-C-N 115.849 -0.614 . . . . 0.0 109.39 177.423 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 88' ' ' LEU . . . . . 0.458 HD13 HG21 ' F' ' 131' ' ' VAL . 30.1 mt -118.66 136.1 54.1 Favored 'General case' 0 C--N 1.331 -0.22 0 CA-C-O 121.209 0.528 . . . . 0.0 111.29 -176.147 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 89' ' ' ASP . . . . . . . . . . . . . 6.6 t0 -131.13 157.91 41.87 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 115.448 -0.796 . . . . 0.0 109.533 177.759 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 14.2 pt-20 -46.4 -36.93 6.96 Favored 'General case' 0 C--N 1.33 -0.272 0 N-CA-C 113.218 0.822 . . . . 0.0 113.218 -172.326 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 91' ' ' ASN . . . . . . . . . . . . . 11.9 t-20 -131.99 20.81 4.52 Favored 'General case' 0 N--CA 1.468 0.467 0 N-CA-C 112.93 0.715 . . . . 0.0 112.93 -177.083 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 92' ' ' LEU . . . . . . . . . . . . . 35.2 mt -147.52 142.61 27.09 Favored 'General case' 0 C--N 1.33 -0.267 0 N-CA-C 110.323 -0.251 . . . . 0.0 110.323 -177.625 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 93' ' ' ILE . . . . . . . . . . . . . 71.5 mt -125.34 116.02 45.48 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.336 0 N-CA-C 109.416 -0.587 . . . . 0.0 109.416 179.09 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 94' ' ' VAL . . . . . 0.437 HG21 HG11 ' A' ' 125' ' ' VAL . 46.7 t -119.13 126.79 75.67 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.295 0 CA-C-O 121.001 0.429 . . . . 0.0 110.114 -178.814 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 95' ' ' VAL . . . . . . . . . . . . . 47.3 t -118.66 131.16 72.26 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.376 0 CA-C-N 115.704 -0.68 . . . . 0.0 109.455 178.982 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 96' ' ' ILE . . . . . . . . . . . . . 65.6 mt -112.04 125.82 69.37 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.299 0 N-CA-C 109.127 -0.694 . . . . 0.0 109.127 178.699 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 97' ' ' THR . . . . . . . . . . . . . 71.2 p -98.25 157.1 16.37 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-O 121.216 0.532 . . . . 0.0 111.06 -177.22 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 98' ' ' GLU . . . . . . . . . . . . . 97.1 mt-10 -54.34 -24.25 18.61 Favored 'General case' 0 C--N 1.329 -0.322 0 N-CA-C 112.434 0.531 . . . . 0.0 112.434 -179.571 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 99' ' ' GLU . . . . . . . . . . . . . 35.3 tt0 -80.78 16.74 1.33 Allowed 'General case' 0 CA--C 1.538 0.51 0 N-CA-C 112.642 0.608 . . . . 0.0 112.642 -177.551 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 100' ' ' ASN . . . . . . . . . . . . . 3.4 m-20 61.83 37.91 15.1 Favored 'General case' 0 C--O 1.232 0.153 0 O-C-N 121.91 -0.494 . . . . 0.0 111.151 178.129 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 101' ' ' GLU . . . . . . . . . . . . . 84.7 tt0 -116.31 144.55 44.1 Favored 'General case' 0 C--N 1.331 -0.214 0 CA-C-N 116.165 -0.471 . . . . 0.0 109.858 176.501 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 102' ' ' VAL . . . . . . . . . . . . . 41.3 t -115.8 125.54 72.99 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.26 0 CA-C-N 116.207 -0.451 . . . . 0.0 110.177 -178.299 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 103' ' ' LEU . . . . . . . . . . . . . 22.6 mt -116.25 127.86 55.1 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 115.782 -0.645 . . . . 0.0 109.867 175.811 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 104' ' ' ILE . . . . . . . . . . . . . 62.4 mt -118.15 122.55 69.91 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.295 0 N-CA-C 110.342 -0.244 . . . . 0.0 110.342 179.639 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 105' ' ' PHE . . . . . . . . . . . . . 62.4 m-85 -120.18 163.58 17.52 Favored 'General case' 0 C--N 1.332 -0.182 0 O-C-N 124.136 0.897 . . . . 0.0 109.679 178.689 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 106' ' ' ASN . . . . . . . . . . . . . 46.8 p-10 -95.24 -170.69 2.23 Favored 'General case' 0 C--N 1.331 -0.232 0 N-CA-C 109.752 -0.462 . . . . 0.0 109.752 173.23 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 107' ' ' GLN . . . . . . . . . . . . . 49.3 tt0 -59.32 -30.1 68.12 Favored 'General case' 0 C--N 1.33 -0.278 0 N-CA-C 111.879 0.326 . . . . 0.0 111.879 179.144 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 108' ' ' ASN . . . . . . . . . . . . . 6.8 t-20 -82.23 9.68 8.31 Favored 'General case' 0 CA--C 1.536 0.438 0 N-CA-C 113.052 0.76 . . . . 0.0 113.052 -177.809 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 109' ' ' LEU . . . . . . . . . . . . . 11.1 tp 58.03 35.71 25.43 Favored 'General case' 0 CA--C 1.531 0.215 0 CA-C-O 120.965 0.412 . . . . 0.0 111.409 179.203 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 110' ' ' GLU . . . . . . . . . . . . . 70.7 mm-40 -104.98 143.53 33.05 Favored 'General case' 0 C--N 1.331 -0.222 0 N-CA-C 109.264 -0.643 . . . . 0.0 109.264 174.812 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 111' ' ' GLU . . . . . . . . . . . . . 62.6 tt0 -81.64 121.97 27.02 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-O 121.058 0.456 . . . . 0.0 110.678 -175.144 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 112' ' ' LEU . . . . . . . . . . . . . 29.5 mt -104.58 -45.62 4.57 Favored 'General case' 0 C--N 1.331 -0.211 0 CA-C-N 115.935 -0.575 . . . . 0.0 110.736 179.716 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 113' ' ' TYR . . . . . . . . . . . . . 63.6 t80 -133.02 135.69 45.57 Favored 'General case' 0 C--N 1.331 -0.218 0 CA-C-N 116.376 -0.375 . . . . 0.0 111.277 -177.604 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 114' ' ' ARG . . . . . . . . . . . . . 55.6 ttp180 -133.98 121.22 21.31 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 115.868 -0.605 . . . . 0.0 110.109 177.333 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 115' ' ' GLY . . . . . . . . . . . . . . . -150.12 160.8 28.68 Favored Glycine 0 CA--C 1.524 0.642 0 N-CA-C 111.013 -0.835 . . . . 0.0 111.013 -179.987 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 116' ' ' LYS . . . . . . . . . . . . . 33.4 ttmt -135.97 139.43 43.2 Favored 'General case' 0 C--N 1.328 -0.368 0 N-CA-C 109.971 -0.381 . . . . 0.0 109.971 177.312 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 117' ' ' PHE . . . . . . . . . . . . . 39.9 m-85 -136.88 114.68 11.28 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-O 121.053 0.454 . . . . 0.0 110.312 -175.127 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 118' ' ' GLU . . . . . . . . . . . . . 96.6 mt-10 -53.38 -45.06 69.1 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 116.287 -0.415 . . . . 0.0 111.664 -175.413 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 119' ' ' ASN . . . . . . . . . . . . . 69.5 m-80 -98.66 31.08 3.02 Favored 'General case' 0 C--N 1.33 -0.271 0 N-CA-C 112.255 0.465 . . . . 0.0 112.255 -173.035 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 120' ' ' LEU . . . . . . . . . . . . . 26.8 tp -56.44 122.53 12.15 Favored 'General case' 0 C--N 1.332 -0.171 0 C-N-CA 121.059 -0.256 . . . . 0.0 110.494 177.638 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 121' ' ' ASN . . . . . . . . . . . . . 34.9 m120 -114.0 -44.15 3.18 Favored 'General case' 0 C--O 1.232 0.149 0 CA-C-N 116.687 -0.233 . . . . 0.0 111.181 -178.373 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 122' ' ' LYS . . . . . . . . . . . . . 97.3 mttt -148.31 152.92 37.92 Favored 'General case' 0 C--N 1.332 -0.156 0 CA-C-O 121.126 0.489 . . . . 0.0 111.468 -177.896 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 123' ' ' VAL . . . . . . . . . . . . . 45.0 t -127.19 132.41 69.72 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.217 0 CA-C-N 115.897 -0.592 . . . . 0.0 109.679 176.931 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 124' ' ' LEU . . . . . . . . . . . . . 75.8 mt -126.67 131.04 51.5 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.455 -0.339 . . . . 0.0 110.307 -179.993 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 125' ' ' VAL . . . . . 0.437 HG11 HG21 ' A' ' 94' ' ' VAL . 35.3 m -136.59 138.85 46.02 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.258 0 CA-C-O 120.844 0.354 . . . . 0.0 110.829 -179.748 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 126' ' ' ARG . . . . . . . . . . . . . 14.5 ptm180 -165.96 143.55 5.53 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.066 -0.515 . . . . 0.0 110.081 177.216 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 127' ' ' ASN . . . . . . . . . . . . . 4.3 t30 55.24 -153.82 0.31 Allowed 'General case' 0 CA--C 1.539 0.539 0 N-CA-C 110.017 -0.364 . . . . 0.0 110.017 -179.844 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 128' ' ' ASP . . . . . . . . . . . . . 8.2 p-10 -83.66 18.53 1.89 Allowed 'General case' 0 CA--C 1.535 0.37 0 N-CA-C 112.679 0.622 . . . . 0.0 112.679 179.269 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 129' ' ' LEU . . . . . . . . . . . . . 15.5 tp -122.94 138.25 54.72 Favored 'General case' 0 C--O 1.232 0.157 0 O-C-N 121.983 -0.448 . . . . 0.0 110.503 -179.608 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 130' ' ' VAL . . . . . 0.478 HG23 ' HB ' ' A' ' 141' ' ' ILE . 32.7 m -131.23 141.75 45.19 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.184 0 CA-C-O 120.805 0.336 . . . . 0.0 110.449 177.578 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 131' ' ' VAL . . . . . . . . . . . . . 47.9 t -136.14 138.61 46.99 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.285 0 CA-C-O 121.274 0.559 . . . . 0.0 110.682 -179.526 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 132' ' ' ILE . . . . . . . . . . . . . 72.1 mt -111.74 133.27 57.92 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.329 0 CA-C-N 115.41 -0.814 . . . . 0.0 109.135 178.089 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 133' ' ' ILE . . . . . . . . . . . . . 43.4 mm -114.82 120.04 63.35 Favored 'Isoleucine or valine' 0 C--O 1.233 0.229 0 CA-C-O 120.884 0.373 . . . . 0.0 110.964 -175.294 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 134' ' ' ASP . . . . . . . . . . . . . 6.2 p-10 -130.46 144.83 51.65 Favored 'General case' 0 C--N 1.331 -0.227 0 N-CA-C 109.366 -0.605 . . . . 0.0 109.366 173.83 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 135' ' ' GLU . . . . . . . . . . . . . 43.4 tp10 -49.78 -24.97 2.65 Favored 'General case' 0 C--N 1.328 -0.334 0 N-CA-C 112.793 0.664 . . . . 0.0 112.793 -170.799 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 136' ' ' GLN . . . . . . . . . . . . . 96.0 mt-30 -91.53 -40.08 11.57 Favored 'General case' 0 C--N 1.331 -0.231 0 N-CA-C 112.305 0.483 . . . . 0.0 112.305 -177.389 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 137' ' ' LYS . . . . . . . . . . . . . 61.2 mtpt -141.96 155.81 45.47 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-O 121.34 0.59 . . . . 0.0 111.718 -167.989 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 138' ' ' LEU . . . . . 0.426 ' C ' HD23 ' A' ' 138' ' ' LEU . 5.9 tt -116.0 124.69 51.13 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 115.519 -0.764 . . . . 0.0 109.177 173.832 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 139' ' ' THR . . . . . . . . . . . . . 31.1 m -111.12 124.38 52.08 Favored 'General case' 0 C--N 1.331 -0.196 0 CA-C-N 116.438 -0.346 . . . . 0.0 110.794 -176.993 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 140' ' ' LEU . . . . . 0.479 HD23 ' C ' ' A' ' 140' ' ' LEU . 9.9 tt -112.07 126.85 55.62 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 115.762 -0.653 . . . . 0.0 109.591 -178.468 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 141' ' ' ILE . . . . . 0.478 ' HB ' HG23 ' A' ' 130' ' ' VAL . 19.5 mt -125.21 123.88 66.15 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.302 0 CA-C-O 121.008 0.432 . . . . 0.0 109.873 -176.543 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 142' ' ' ARG . . . . . . . . . . . . . 61.5 ttt180 -110.06 124.88 52.27 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 115.119 -0.946 . . . . 0.0 110.459 -177.794 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 143' ' ' THR . . . . . . . . . . . . . 9.3 p . . . . . 0 C--O 1.22 -0.49 0 CA-C-O 117.979 -1.01 . . . . 0.0 110.592 179.959 . . . . . . . . 0 0 . 1 . 011 nuclear nobuild full ' B' B ' -3' ' ' GLU . . . . . . . . . . . . . 95.2 mt-10 . . . . . 0 N--CA 1.49 1.553 0 N-CA-C 109.319 -0.623 . . . . 0.0 109.319 . . . . . . . . . 0 0 . 1 . 011 nuclear nobuild full ' B' B ' -2' ' ' GLY . . . . . . . . . . . . . . . -72.55 135.2 21.78 Favored Glycine 0 CA--C 1.524 0.652 0 N-CA-C 111.059 -0.816 . . . . 0.0 111.059 -179.668 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' B' B ' -1' ' ' VAL . . . . . . . . . . . . . 46.4 t -96.52 136.08 28.52 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.284 0 N-CA-C 109.871 -0.418 . . . . 0.0 109.871 179.072 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' B' B ' 0' ' ' ILE . . . . . . . . . . . . . 71.9 mt -109.66 132.01 59.02 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.234 0 CA-C-N 116.27 -0.423 . . . . 0.0 110.053 -179.058 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' B' B ' 1' ' ' MET . . . . . . . . . . . . . 25.0 ptp -88.04 134.08 33.82 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.05 -0.523 . . . . 0.0 110.429 178.938 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' B' B ' 2' ' ' SER . . . . . . . . . . . . . 11.6 p -112.89 134.45 54.4 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-O 120.953 0.406 . . . . 0.0 110.549 179.976 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' B' B ' 3' ' ' GLU . . . . . . . . . . . . . 95.0 mt-10 -140.91 140.48 34.5 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 115.941 -0.572 . . . . 0.0 111.0 -178.762 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' B' B ' 4' ' ' LEU . . . . . . . . . . . . . 18.2 tp -125.23 130.73 52.68 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 115.915 -0.584 . . . . 0.0 110.119 176.558 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' B' B ' 5' ' ' LYS . . . . . . . . . . . . . 93.6 mttt -112.19 121.43 44.9 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-O 120.843 0.354 . . . . 0.0 110.569 179.588 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' B' B ' 6' ' ' LEU . . . . . . . . . . . . . 62.7 mt -114.1 147.16 39.22 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 115.388 -0.823 . . . . 0.0 111.157 -177.869 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' B' B ' 7' ' ' LYS . . . . . . . . . . . . . 79.4 tttt -137.0 140.26 31.0 Favored Pre-proline 0 CA--C 1.534 0.333 0 CA-C-N 116.07 -0.514 . . . . 0.0 109.724 175.715 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' B' B ' 8' ' ' PRO . . . . . . . . . . . . . 89.4 Cg_endo -91.58 146.45 3.31 Favored 'Trans proline' 0 N--CA 1.491 1.333 0 C-N-CA 121.735 1.624 . . . . 0.0 111.972 178.968 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' B' B ' 9' ' ' LEU . . . . . . . . . . . . . 41.4 mt -82.57 -46.84 0.91 Allowed Pre-proline 0 CA--C 1.534 0.353 0 CA-C-O 118.78 -0.628 . . . . 0.0 111.909 179.317 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' B' B ' 10' ' ' PRO . . . . . . . . . . . . . 94.3 Cg_endo -82.05 155.84 17.42 Favored 'Trans proline' 0 N--CA 1.495 1.56 0 C-N-CA 121.253 1.302 . . . . 0.0 111.767 174.433 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' B' B ' 11' ' ' LYS . . . . . . . . . . . . . 92.2 mttt -88.53 98.43 11.64 Favored 'General case' 0 C--N 1.329 -0.316 0 C-N-CA 120.883 -0.327 . . . . 0.0 110.513 178.725 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' B' B ' 12' ' ' VAL . . . . . . . . . . . . . 12.2 p -140.34 147.4 23.34 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.302 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.433 -179.976 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' B' B ' 13' ' ' GLU . . . . . . . . . . . . . 43.0 tp10 -89.21 129.93 35.7 Favored 'General case' 0 C--N 1.329 -0.298 0 N-CA-C 109.862 -0.421 . . . . 0.0 109.862 178.298 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' B' B ' 14' ' ' LEU . . . . . . . . . . . . . 53.8 mt -97.33 147.58 33.16 Favored Pre-proline 0 CA--C 1.532 0.286 0 CA-C-O 119.196 -0.43 . . . . 0.0 110.727 -176.94 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' B' B ' 15' ' ' PRO . . . . . . . . . . . . . 24.4 Cg_exo -63.31 161.11 32.03 Favored 'Trans proline' 0 N--CA 1.498 1.738 0 C-N-CA 121.248 1.299 . . . . 0.0 111.762 175.881 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' B' B ' 16' ' ' PRO . . . . . . . . . . . . . 31.2 Cg_exo -59.24 -38.15 87.22 Favored 'Trans proline' 0 N--CA 1.497 1.721 0 C-N-CA 121.471 1.447 . . . . 0.0 112.78 -177.706 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' B' B ' 17' ' ' ASP . . . . . . . . . . . . . 18.2 p-10 -88.79 9.44 24.58 Favored 'General case' 0 CA--C 1.536 0.419 0 N-CA-C 113.243 0.831 . . . . 0.0 113.243 -177.735 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' B' B ' 18' ' ' PHE . . . . . . . . . . . . . 34.2 t80 -58.25 -43.74 88.01 Favored 'General case' 0 C--N 1.334 -0.081 0 O-C-N 122.023 -0.423 . . . . 0.0 109.9 -178.446 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' B' B ' 19' ' ' VAL . . . . . . . . . . . . . 53.9 t -56.92 -42.91 79.54 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.369 0 CA-C-N 116.18 -0.464 . . . . 0.0 110.494 -179.479 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' B' B ' 20' ' ' ASP . . . . . . . . . . . . . 10.4 t0 -60.04 -42.6 94.77 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-O 120.847 0.356 . . . . 0.0 111.049 -177.796 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' B' B ' 21' ' ' VAL . . . . . . . . . . . . . 51.3 t -64.25 -47.01 91.67 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.335 0 CA-C-N 116.448 -0.342 . . . . 0.0 110.515 -177.685 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' B' B ' 22' ' ' ILE . . . . . 0.507 HG22 HD12 ' B' ' 26' ' ' LEU . 49.7 mm -56.48 -45.42 81.97 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.252 0 C-N-CA 120.982 -0.287 . . . . 0.0 110.572 178.819 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' B' B ' 23' ' ' ARG . . . . . . . . . . . . . 24.8 ttp180 -53.8 -50.16 66.75 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-O 120.58 0.229 . . . . 0.0 111.48 -178.446 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' B' B ' 24' ' ' ILE . . . . . . . . . . . . . 73.9 mt -59.86 -45.15 95.27 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.316 0 CA-C-N 116.574 -0.284 . . . . 0.0 111.281 -176.536 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' B' B ' 25' ' ' LYS . . . . . . . . . . . . . 50.2 mttm -65.44 -39.28 91.86 Favored 'General case' 0 C--N 1.329 -0.289 0 N-CA-C 112.607 0.595 . . . . 0.0 112.607 -177.629 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' B' B ' 26' ' ' LEU . . . . . 0.507 HD12 HG22 ' B' ' 22' ' ' ILE . 26.8 mt -77.55 -43.19 32.69 Favored 'General case' 0 C--N 1.33 -0.272 0 N-CA-C 112.763 0.653 . . . . 0.0 112.763 -172.838 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' B' B ' 27' ' ' GLN . . . . . . . . . . . . . 10.6 pt20 -47.0 137.49 7.42 Favored 'General case' 0 N--CA 1.469 0.51 0 N-CA-C 112.629 0.603 . . . . 0.0 112.629 -177.071 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' B' B ' 28' ' ' GLY . . . . . . . . . . . . . . . 100.72 -26.84 23.13 Favored Glycine 0 CA--C 1.533 1.183 0 CA-C-N 115.565 -0.743 . . . . 0.0 112.209 -176.477 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' B' B ' 29' ' ' LYS . . . . . . . . . . . . . 94.8 mttt -98.38 155.13 17.38 Favored 'General case' 0 C--O 1.232 0.166 0 CA-C-N 117.219 0.509 . . . . 0.0 110.842 178.555 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' B' B ' 30' ' ' THR . . . . . . . . . . . . . 28.5 m -103.04 136.45 42.82 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.279 -0.419 . . . . 0.0 109.962 175.269 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' B' B ' 31' ' ' VAL . . . . . . . . . . . . . 35.5 m -128.99 153.39 38.52 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.216 0 CA-C-O 121.047 0.451 . . . . 0.0 111.019 -177.856 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' B' B ' 32' ' ' ARG . . . . . . . . . . . . . 90.0 mtm-85 -128.81 148.98 50.92 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 115.905 -0.589 . . . . 0.0 110.457 178.877 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' B' B ' 33' ' ' THR . . . . . . . . . . . . . 18.7 m -53.42 138.6 32.86 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.326 -0.397 . . . . 0.0 111.279 -177.978 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' B' B ' 34' ' ' GLY . . . . . . . . . . . . . . . 101.06 -17.1 56.62 Favored Glycine 0 CA--C 1.533 1.167 0 CA-C-O 119.609 -0.55 . . . . 0.0 113.284 179.574 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' B' B ' 35' ' ' ASP . . . . . . . . . . . . . 69.0 m-20 -64.26 148.88 49.18 Favored 'General case' 0 C--N 1.334 -0.106 0 CA-C-N 118.07 0.935 . . . . 0.0 111.029 179.537 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' B' B ' 36' ' ' VAL . . . . . . . . . . . . . 45.6 t -123.8 131.58 72.77 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.215 0 CA-C-N 115.774 -0.648 . . . . 0.0 109.8 178.899 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' B' B ' 37' ' ' ILE . . . . . . . . . . . . . 65.6 mt -121.2 139.23 49.04 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.217 0 CA-C-N 116.197 -0.456 . . . . 0.0 109.973 -179.925 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' B' B ' 38' ' ' GLY . . . . . . . . . . . . . . . -112.31 128.78 8.68 Favored Glycine 0 CA--C 1.526 0.767 0 N-CA-C 111.033 -0.827 . . . . 0.0 111.033 179.799 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' B' B ' 39' ' ' ILE . . . . . . . . . . . . . 71.6 mt -124.12 134.81 65.56 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.21 0 N-CA-C 110.091 -0.337 . . . . 0.0 110.091 179.199 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' B' B ' 40' ' ' SER . . . . . . . . . . . . . 95.0 p -93.64 124.49 37.66 Favored 'General case' 0 C--N 1.331 -0.225 0 CA-C-N 116.338 -0.392 . . . . 0.0 111.096 176.24 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' B' B ' 41' ' ' ILE . . . . . . . . . . . . . 75.0 mt -130.63 122.5 52.87 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.254 0 CA-C-N 116.488 -0.324 . . . . 0.0 110.331 176.749 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' B' B ' 42' ' ' LEU . . . . . . . . . . . . . 6.6 tp 52.16 36.03 18.11 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 116.279 -0.419 . . . . 0.0 111.652 176.823 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' B' B ' 43' ' ' GLY . . . . . . . . . . . . . . . 71.84 32.56 63.7 Favored Glycine 0 CA--C 1.529 0.964 0 C-N-CA 121.085 -0.578 . . . . 0.0 112.033 178.543 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' B' B ' 44' ' ' LYS . . . . . . . . . . . . . 84.8 tttt -137.19 127.18 25.87 Favored 'General case' 0 C--N 1.328 -0.356 0 N-CA-C 109.74 -0.467 . . . . 0.0 109.74 178.915 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' B' B ' 45' ' ' GLU . . . . . . . . . . . . . 84.7 tt0 -83.01 122.84 28.83 Favored 'General case' 0 C--N 1.327 -0.409 0 CA-C-O 120.802 0.334 . . . . 0.0 110.923 -178.874 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' B' B ' 46' ' ' VAL . . . . . . . . . . . . . 7.6 p -120.16 127.74 75.92 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.229 0 N-CA-C 109.35 -0.611 . . . . 0.0 109.35 175.35 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' B' B ' 47' ' ' LYS . . . . . . . . . . . . . 58.2 mtpt -101.26 128.14 47.53 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 115.798 -0.637 . . . . 0.0 111.148 -179.658 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' B' B ' 48' ' ' PHE . . . . . . . . . . . . . 95.6 m-85 -112.44 131.94 55.3 Favored 'General case' 0 C--N 1.331 -0.223 0 CA-C-N 116.335 -0.393 . . . . 0.0 110.196 176.946 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' B' B ' 49' ' ' LYS . . . . . . . . . . . . . 74.4 tttt -108.39 137.45 46.33 Favored 'General case' 0 C--N 1.331 -0.229 0 CA-C-N 116.449 -0.342 . . . . 0.0 110.664 179.022 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' B' B ' 50' ' ' VAL . . . . . . . . . . . . . 47.1 t -82.88 110.59 18.1 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.254 0 N-CA-C 109.434 -0.58 . . . . 0.0 109.434 176.265 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' B' B ' 51' ' ' VAL . . . . . . . . . . . . . 47.5 t -73.78 -51.53 24.27 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.231 0 CA-C-N 116.108 -0.496 . . . . 0.0 109.754 -174.774 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' B' B ' 52' ' ' GLN . . . . . . . . . . . . . 92.6 mt-30 -153.26 152.82 31.61 Favored 'General case' 0 C--N 1.331 -0.211 0 CA-C-O 121.176 0.513 . . . . 0.0 111.82 -177.739 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' B' B ' 53' ' ' ALA . . . . . . . . . . . . . . . -132.27 133.59 44.28 Favored 'General case' 0 C--N 1.327 -0.404 0 CA-C-N 115.113 -0.949 . . . . 0.0 109.677 174.9 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' B' B ' 54' ' ' TYR . . . . . . . . . . . . . 63.1 t80 -129.2 113.6 18.43 Favored Pre-proline 0 CA--C 1.536 0.411 0 CA-C-O 118.077 -0.963 . . . . 0.0 110.569 179.07 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' B' B ' 55' ' ' PRO . . . . . . . . . . . . . 71.8 Cg_endo -77.25 164.11 87.57 Favored 'Cis proline' 0 N--CA 1.5 1.879 0 CA-C-N 121.993 1.748 . . . . 0.0 112.123 -8.831 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' B' B ' 56' ' ' SER . . . . . . . . . . . . . 13.7 m -114.03 132.82 22.51 Favored Pre-proline 0 CA--C 1.539 0.52 0 CA-C-O 118.495 -0.764 . . . . 0.0 109.388 175.173 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' B' B ' 57' ' ' PRO . . . . . . . . . . . . . 43.5 Cg_endo -69.02 143.81 73.45 Favored 'Cis proline' 0 N--CA 1.498 1.763 0 CA-C-N 121.865 1.702 . . . . 0.0 111.439 -0.713 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' B' B ' 58' ' ' LEU . . . . . . . . . . . . . 24.2 tp -105.68 135.51 46.96 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.382 -0.372 . . . . 0.0 110.667 -178.282 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' B' B ' 59' ' ' ARG . . . . . . . . . . . . . 41.7 ttm180 -99.98 121.54 41.51 Favored 'General case' 0 C--N 1.326 -0.438 0 N-CA-C 108.983 -0.747 . . . . 0.0 108.983 174.133 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' B' B ' 60' ' ' VAL . . . . . . . . . . . . . 39.9 t -79.53 122.57 35.02 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.225 0 C-N-CA 120.587 -0.445 . . . . 0.0 110.205 -174.107 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' B' B ' 61' ' ' GLU . . . . . . . . . . . . . 34.9 tp10 -130.89 156.7 44.61 Favored 'General case' 0 C--N 1.329 -0.32 0 N-CA-C 109.071 -0.715 . . . . 0.0 109.071 179.131 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' B' B ' 62' ' ' ASP . . . . . . . . . . . . . 5.5 t70 -51.42 -32.53 26.83 Favored 'General case' 0 C--N 1.326 -0.454 0 N-CA-C 111.946 0.35 . . . . 0.0 111.946 -178.945 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' B' B ' 63' ' ' ARG . . . . . . . . . . . . . 48.0 mmm-85 -73.91 -19.17 60.78 Favored 'General case' 0 CA--C 1.536 0.431 0 N-CA-C 113.095 0.776 . . . . 0.0 113.095 -176.928 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' B' B ' 64' ' ' THR . . . . . . . . . . . . . 32.0 m -67.9 141.69 56.3 Favored 'General case' 0 C--N 1.331 -0.209 0 CA-C-O 120.978 0.418 . . . . 0.0 111.114 -175.307 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' B' B ' 65' ' ' LYS . . . . . . . . . . . . . 68.4 mttm -90.23 132.88 35.26 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 115.833 -0.621 . . . . 0.0 110.322 179.639 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' B' B ' 66' ' ' ILE . . . . . . . . . . . . . 66.4 mt -112.56 131.2 64.75 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.239 0 N-CA-C 109.865 -0.42 . . . . 0.0 109.865 179.574 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' B' B ' 67' ' ' THR . . . . . . . . . . . . . 22.6 m -126.05 142.84 51.35 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-N 115.989 -0.551 . . . . 0.0 110.917 -177.723 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' B' B ' 68' ' ' LEU . . . . . . . . . . . . . 16.5 tp -98.69 141.21 31.8 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 115.845 -0.616 . . . . 0.0 109.829 177.282 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' B' B ' 69' ' ' VAL . . . . . . . . . . . . . 42.5 t -82.9 136.93 21.86 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.292 0 CA-C-O 121.3 0.572 . . . . 0.0 110.231 -178.231 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' B' B ' 70' ' ' THR . . . . . . . . . . . . . 12.2 t -89.61 -169.89 2.63 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 115.34 -0.845 . . . . 0.0 111.058 -176.328 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' B' B ' 71' ' ' HIS . . . . . . . . . . . . . 2.0 m-70 -64.82 172.94 1.87 Allowed Pre-proline 0 CA--C 1.533 0.305 0 CA-C-N 116.284 -0.416 . . . . 0.0 110.028 -177.975 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' B' B ' 72' ' ' PRO . . . . . . . . . . . . . 23.6 Cg_exo -64.74 1.06 1.99 Allowed 'Trans proline' 0 N--CA 1.498 1.784 0 C-N-CA 121.309 1.339 . . . . 0.0 113.985 -174.469 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' B' B ' 73' ' ' VAL . . . . . . . . . . . . . 27.6 m -104.64 145.17 13.53 Favored 'Isoleucine or valine' 0 C--O 1.232 0.164 0 N-CA-C 109.422 -0.584 . . . . 0.0 109.422 170.841 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' B' B ' 74' ' ' ASP . . . . . . . . . . . . . 36.2 t0 -92.62 123.71 36.12 Favored 'General case' 0 C--N 1.327 -0.397 0 CA-C-N 116.252 -0.431 . . . . 0.0 110.195 -176.764 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' B' B ' 75' ' ' VAL . . . . . . . . . . . . . 43.0 t -118.23 123.64 71.92 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.267 0 CA-C-O 121.16 0.505 . . . . 0.0 110.455 -178.592 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' B' B ' 76' ' ' LEU . . . . . . . . . . . . . 5.7 mp -123.48 146.04 48.36 Favored 'General case' 0 C--N 1.331 -0.22 0 CA-C-N 115.572 -0.74 . . . . 0.0 109.554 175.812 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' B' B ' 77' ' ' GLU . . . . . . . . . . . . . 96.9 mt-10 -134.5 132.29 39.05 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-O 121.085 0.469 . . . . 0.0 111.106 -178.267 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' B' B ' 78' ' ' ALA . . . . . . . . . . . . . . . -117.18 136.81 52.77 Favored 'General case' 0 C--N 1.331 -0.229 0 CA-C-N 115.657 -0.701 . . . . 0.0 109.91 176.898 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' B' B ' 79' ' ' LYS . . . . . 0.61 ' O ' HD13 ' B' ' 80' ' ' ILE . 55.6 mtmt -85.37 112.8 21.16 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.501 -0.318 . . . . 0.0 110.721 -178.359 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' B' B ' 80' ' ' ILE . . . . . 0.61 HD13 ' O ' ' B' ' 79' ' ' LYS . 41.0 mm -139.04 104.2 2.18 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.302 0 N-CA-C 109.33 -0.619 . . . . 0.0 109.33 -178.164 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' B' B ' 81' ' ' LYS . . . . . . . . . . . . . 52.9 pttt -98.99 130.87 45.36 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-O 120.923 0.392 . . . . 0.0 111.123 -178.497 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' B' B ' 82' ' ' GLY . . . . . . . . . . . . . . . 89.22 42.1 5.66 Favored Glycine 0 CA--C 1.524 0.649 0 N-CA-C 111.191 -0.764 . . . . 0.0 111.191 178.087 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' B' B ' 83' ' ' ILE . . . . . . . . . . . . . 66.6 mt -70.23 135.55 27.94 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.342 0 N-CA-C 109.539 -0.541 . . . . 0.0 109.539 177.676 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' B' B ' 84' ' ' LYS . . . . . . . . . . . . . 16.4 ttmm -89.37 -52.24 5.14 Favored 'General case' 0 C--N 1.328 -0.36 0 N-CA-C 109.734 -0.469 . . . . 0.0 109.734 179.687 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' B' B ' 85' ' ' ASP . . . . . . . . . . . . . 8.5 t70 -160.46 154.39 22.84 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 115.615 -0.72 . . . . 0.0 110.476 178.845 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' B' B ' 86' ' ' VAL . . . . . . . . . . . . . 40.5 t -128.34 131.47 69.03 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.259 0 CA-C-O 120.89 0.376 . . . . 0.0 110.194 179.985 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' B' B ' 87' ' ' ILE . . . . . 0.491 ' N ' HD12 ' B' ' 87' ' ' ILE . 5.0 mp -120.54 127.12 75.89 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.238 0 CA-C-N 116.021 -0.536 . . . . 0.0 109.755 177.855 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' B' B ' 88' ' ' LEU . . . . . . . . . . . . . 42.4 mt -104.75 139.78 39.04 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 116.248 -0.433 . . . . 0.0 111.0 -179.842 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' B' B ' 89' ' ' ASP . . . . . . . . . . . . . 9.5 t70 -132.98 158.4 42.77 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 115.922 -0.581 . . . . 0.0 109.672 176.917 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' B' B ' 90' ' ' GLU . . . . . . . . . . . . . 43.0 mt-10 -46.83 -39.69 12.43 Favored 'General case' 0 C--N 1.329 -0.306 0 N-CA-C 113.139 0.792 . . . . 0.0 113.139 -170.469 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' B' B ' 91' ' ' ASN . . . . . . . . . . . . . 29.2 m-80 -131.99 21.33 4.52 Favored 'General case' 0 N--CA 1.468 0.444 0 N-CA-C 113.044 0.757 . . . . 0.0 113.044 -177.591 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' B' B ' 92' ' ' LEU . . . . . . . . . . . . . 34.1 mt -150.37 150.34 31.28 Favored 'General case' 0 C--N 1.331 -0.222 0 CA-C-O 120.766 0.317 . . . . 0.0 110.451 -176.923 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' B' B ' 93' ' ' ILE . . . . . . . . . . . . . 73.3 mt -127.07 121.48 57.97 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.251 0 N-CA-C 109.133 -0.691 . . . . 0.0 109.133 175.361 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' B' B ' 94' ' ' VAL . . . . . . . . . . . . . 46.9 t -118.64 126.25 75.05 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.215 0 N-CA-C 109.814 -0.439 . . . . 0.0 109.814 -179.192 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' B' B ' 95' ' ' VAL . . . . . . . . . . . . . 46.5 t -118.91 133.19 66.56 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.316 0 CA-C-N 115.901 -0.591 . . . . 0.0 109.643 -179.951 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' B' B ' 96' ' ' ILE . . . . . . . . . . . . . 64.4 mt -111.91 126.22 69.28 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.317 0 N-CA-C 109.081 -0.711 . . . . 0.0 109.081 178.982 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' B' B ' 97' ' ' THR . . . . . . . . . . . . . 74.3 p -99.34 154.12 18.44 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-O 121.192 0.52 . . . . 0.0 111.117 -176.877 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' B' B ' 98' ' ' GLU . . . . . . . . . . . . . 84.9 tt0 -53.88 -25.51 20.34 Favored 'General case' 0 CA--C 1.535 0.372 0 CA-C-N 116.069 -0.514 . . . . 0.0 112.231 -179.513 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' B' B ' 99' ' ' GLU . . . . . . . . . . . . . 45.5 mp0 -80.91 18.08 1.08 Allowed 'General case' 0 CA--C 1.535 0.386 0 N-CA-C 112.989 0.737 . . . . 0.0 112.989 -176.619 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' B' B ' 100' ' ' ASN . . . . . . . . . . . . . 3.1 m-20 62.4 37.97 13.24 Favored 'General case' 0 C--O 1.232 0.171 0 CA-C-O 121.193 0.52 . . . . 0.0 110.997 178.121 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' B' B ' 101' ' ' GLU . . . . . . . . . . . . . 84.8 tt0 -118.77 144.77 46.08 Favored 'General case' 0 C--N 1.332 -0.175 0 CA-C-N 116.211 -0.449 . . . . 0.0 109.954 177.136 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' B' B ' 102' ' ' VAL . . . . . . . . . . . . . 44.1 t -115.09 125.34 72.37 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.29 0 N-CA-C 109.797 -0.445 . . . . 0.0 109.797 -178.034 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' B' B ' 103' ' ' LEU . . . . . . . . . . . . . 34.6 mt -117.07 130.23 56.52 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-N 115.814 -0.63 . . . . 0.0 110.006 177.874 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' B' B ' 104' ' ' ILE . . . . . . . . . . . . . 69.7 mt -118.05 122.73 70.37 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.249 0 N-CA-C 110.222 -0.288 . . . . 0.0 110.222 -179.115 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' B' B ' 105' ' ' PHE . . . . . . . . . . . . . 90.9 m-85 -122.77 164.31 18.59 Favored 'General case' 0 C--N 1.332 -0.168 0 O-C-N 123.783 0.677 . . . . 0.0 110.236 -178.496 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' B' B ' 106' ' ' ASN . . . . . . . . . . . . . 49.6 p-10 -98.14 -170.74 2.02 Favored 'General case' 0 C--N 1.33 -0.28 0 N-CA-C 109.866 -0.42 . . . . 0.0 109.866 174.933 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' B' B ' 107' ' ' GLN . . . . . . . . . . . . . 58.9 tt0 -58.24 -30.01 66.2 Favored 'General case' 0 C--N 1.328 -0.332 0 N-CA-C 112.038 0.384 . . . . 0.0 112.038 -178.407 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' B' B ' 108' ' ' ASN . . . . . . . . . . . . . 10.6 t-20 -89.88 14.02 13.11 Favored 'General case' 0 CA--C 1.534 0.348 0 N-CA-C 113.098 0.777 . . . . 0.0 113.098 -176.033 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' B' B ' 109' ' ' LEU . . . . . . . . . . . . . 14.5 mt 58.61 35.38 24.49 Favored 'General case' 0 C--N 1.331 -0.201 0 CA-C-O 120.924 0.392 . . . . 0.0 111.502 179.628 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' B' B ' 110' ' ' GLU . . . . . . . . . . . . . 96.5 mt-10 -101.92 143.3 31.97 Favored 'General case' 0 C--N 1.328 -0.34 0 N-CA-C 109.189 -0.671 . . . . 0.0 109.189 174.392 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' B' B ' 111' ' ' GLU . . . . . . . . . . . . . 51.1 tt0 -81.23 121.83 26.65 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-O 120.97 0.414 . . . . 0.0 110.653 -175.299 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' B' B ' 112' ' ' LEU . . . . . . . . . . . . . 23.2 mt -103.67 -46.09 4.63 Favored 'General case' 0 C--N 1.331 -0.212 0 CA-C-N 115.88 -0.6 . . . . 0.0 110.691 179.668 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' B' B ' 113' ' ' TYR . . . . . . . . . . . . . 58.7 t80 -137.67 146.73 44.19 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.961 -178.929 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' B' B ' 114' ' ' ARG . . . . . . . . . . . . . 30.4 ptt180 -149.69 124.58 9.92 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-N 116.158 -0.473 . . . . 0.0 111.051 -178.527 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' B' B ' 115' ' ' GLY . . . . . . . . . . . . . . . -150.16 162.42 29.21 Favored Glycine 0 CA--C 1.525 0.692 0 N-CA-C 110.928 -0.869 . . . . 0.0 110.928 178.806 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' B' B ' 116' ' ' LYS . . . . . . . . . . . . . 38.3 ttpt -131.95 138.67 48.42 Favored 'General case' 0 C--N 1.33 -0.259 0 N-CA-C 109.979 -0.378 . . . . 0.0 109.979 177.13 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' B' B ' 117' ' ' PHE . . . . . . . . . . . . . 41.8 m-85 -136.37 117.31 14.23 Favored 'General case' 0 C--N 1.331 -0.227 0 C-N-CA 120.874 -0.331 . . . . 0.0 110.362 -175.716 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' B' B ' 118' ' ' GLU . . . . . . . . . . . . . 70.6 mm-40 -54.11 -45.23 71.82 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.616 -0.265 . . . . 0.0 111.246 -177.515 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' B' B ' 119' ' ' ASN . . . . . . . . . . . . . 84.1 m-20 -98.87 31.06 3.09 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.181 -0.463 . . . . 0.0 112.171 -174.479 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' B' B ' 120' ' ' LEU . . . . . . . . . . . . . 23.0 tp -56.23 120.78 8.13 Favored 'General case' 0 C--N 1.332 -0.17 0 CA-C-O 120.626 0.25 . . . . 0.0 110.393 178.512 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' B' B ' 121' ' ' ASN . . . . . . . . . . . . . 34.3 m120 -109.66 -44.21 3.9 Favored 'General case' 0 N--CA 1.462 0.152 0 CA-C-N 116.649 -0.251 . . . . 0.0 111.211 -176.118 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' B' B ' 122' ' ' LYS . . . . . . . . . . . . . 94.3 mttt -147.94 148.14 30.47 Favored 'General case' 0 C--N 1.333 -0.139 0 C-N-CA 120.392 -0.523 . . . . 0.0 111.966 -177.918 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' B' B ' 123' ' ' VAL . . . . . . . . . . . . . 48.0 t -124.09 128.17 73.88 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.255 0 N-CA-C 109.251 -0.648 . . . . 0.0 109.251 173.792 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' B' B ' 124' ' ' LEU . . . . . . . . . . . . . 12.9 tp -129.07 132.42 47.43 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-O 120.651 0.262 . . . . 0.0 110.729 -177.092 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' B' B ' 125' ' ' VAL . . . . . . . . . . . . . 12.3 p -135.45 136.08 51.17 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.23 0 CA-C-O 120.735 0.302 . . . . 0.0 110.393 179.095 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' B' B ' 126' ' ' ARG . . . . . . . . . . . . . 96.4 mtt180 -148.72 134.16 18.58 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-O 120.977 0.418 . . . . 0.0 111.052 179.583 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' B' B ' 127' ' ' ASN . . . . . . . . . . . . . 86.3 m-20 50.32 -111.52 0.52 Allowed 'General case' 0 CA--C 1.545 0.778 0 CA-C-O 118.786 -0.626 . . . . 0.0 111.398 178.827 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' B' B ' 128' ' ' ASP . . . . . . . . . . . . . 8.2 p-10 -114.12 8.62 17.01 Favored 'General case' 0 CA--C 1.536 0.423 0 CA-C-N 119.908 1.231 . . . . 0.0 113.322 -176.934 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' B' B ' 129' ' ' LEU . . . . . . . . . . . . . 42.3 mt -117.72 144.75 44.99 Favored 'General case' 0 C--O 1.232 0.134 0 CA-C-N 118.028 0.376 . . . . 0.0 110.197 179.73 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' B' B ' 130' ' ' VAL . . . . . 0.506 HG13 ' HB ' ' B' ' 141' ' ' ILE . 12.1 p -132.97 140.31 47.58 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.212 0 CA-C-O 120.967 0.413 . . . . 0.0 110.366 -179.572 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' B' B ' 131' ' ' VAL . . . . . 0.565 HG22 HD12 ' B' ' 140' ' ' LEU . 44.1 t -136.01 139.95 44.9 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.287 0 CA-C-N 116.046 -0.524 . . . . 0.0 110.337 -178.531 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' B' B ' 132' ' ' ILE . . . . . . . . . . . . . 74.4 mt -115.92 131.43 68.39 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.364 0 CA-C-N 115.548 -0.751 . . . . 0.0 109.05 177.735 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' B' B ' 133' ' ' ILE . . . . . . . . . . . . . 42.9 mm -114.86 121.07 66.2 Favored 'Isoleucine or valine' 0 C--O 1.234 0.252 0 CA-C-O 120.867 0.365 . . . . 0.0 111.027 -174.744 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' B' B ' 134' ' ' ASP . . . . . . . . . . . . . 6.3 p-10 -129.74 146.41 51.5 Favored 'General case' 0 C--N 1.332 -0.191 0 CA-C-N 115.834 -0.621 . . . . 0.0 109.485 174.605 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' B' B ' 135' ' ' GLU . . . . . . . . . . . . . 41.7 tp10 -49.9 -24.25 2.4 Favored 'General case' 0 C--N 1.328 -0.369 0 N-CA-C 112.976 0.732 . . . . 0.0 112.976 -169.808 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' B' B ' 136' ' ' GLN . . . . . . . . . . . . . 21.3 pt20 -102.4 -30.45 11.02 Favored 'General case' 0 CA--C 1.532 0.255 0 N-CA-C 112.709 0.633 . . . . 0.0 112.709 -174.603 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' B' B ' 137' ' ' LYS . . . . . . . . . . . . . 27.4 mtpp -141.48 153.86 45.2 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-O 121.278 0.561 . . . . 0.0 111.519 -172.044 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' B' B ' 138' ' ' LEU . . . . . . . . . . . . . 5.0 tt -114.94 124.43 51.66 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 115.615 -0.72 . . . . 0.0 109.382 174.72 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' B' B ' 139' ' ' THR . . . . . . . . . . . . . 44.0 m -108.04 122.97 47.96 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.471 -0.331 . . . . 0.0 110.727 -177.994 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' B' B ' 140' ' ' LEU . . . . . 0.565 HD12 HG22 ' B' ' 131' ' ' VAL . 38.8 tp -112.97 121.56 45.0 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 115.665 -0.698 . . . . 0.0 109.322 -179.294 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' B' B ' 141' ' ' ILE . . . . . 0.506 ' HB ' HG13 ' B' ' 130' ' ' VAL . 19.2 mt -123.91 125.84 71.63 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.268 0 CA-C-O 121.012 0.434 . . . . 0.0 109.937 -176.991 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' B' B ' 142' ' ' ARG . . . . . . . . . . . . . 72.7 mtp180 -108.53 124.01 49.8 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 115.304 -0.862 . . . . 0.0 110.344 179.716 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' B' B ' 143' ' ' THR . . . . . . . . . . . . . 77.2 p . . . . . 0 C--O 1.219 -0.501 0 CA-C-O 118.016 -0.992 . . . . 0.0 110.522 -179.316 . . . . . . . . 0 0 . 1 . 011 nuclear nobuild full ' C' C ' -3' ' ' GLU . . . . . . . . . . . . . 70.5 mm-40 . . . . . 0 N--CA 1.489 1.513 0 N-CA-C 109.278 -0.638 . . . . 0.0 109.278 . . . . . . . . . 0 0 . 1 . 011 nuclear nobuild full ' C' C ' -2' ' ' GLY . . . . . . . . . . . . . . . -62.31 127.86 40.67 Favored Glycine 0 CA--C 1.526 0.743 0 N-CA-C 110.676 -0.97 . . . . 0.0 110.676 179.548 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' C' C ' -1' ' ' VAL . . . . . . . . . . . . . 46.2 t -96.58 135.85 29.33 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.321 0 CA-C-O 120.848 0.356 . . . . 0.0 110.069 -179.215 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' C' C ' 0' ' ' ILE . . . . . . . . . . . . . 71.2 mt -107.91 127.14 64.26 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.256 0 CA-C-N 116.154 -0.476 . . . . 0.0 109.845 178.675 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' C' C ' 1' ' ' MET . . . . . . . . . . . . . 25.8 ptt? -82.54 149.23 27.62 Favored 'General case' 0 C--N 1.326 -0.429 0 CA-C-N 115.935 -0.575 . . . . 0.0 110.487 179.747 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' C' C ' 2' ' ' SER . . . . . . . . . . . . . 5.5 p -107.75 132.06 53.78 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.361 -0.381 . . . . 0.0 110.128 177.143 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' C' C ' 3' ' ' GLU . . . . . . . . . . . . . 94.7 mt-10 -141.28 136.6 31.78 Favored 'General case' 0 C--N 1.327 -0.407 0 CA-C-N 116.129 -0.487 . . . . 0.0 111.066 -178.681 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' C' C ' 4' ' ' LEU . . . . . . . . . . . . . 15.2 tp -123.04 126.38 46.99 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 115.983 -0.553 . . . . 0.0 109.806 175.554 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' C' C ' 5' ' ' LYS . . . . . . . . . . . . . 69.2 mttm -113.49 121.49 44.41 Favored 'General case' 0 C--N 1.331 -0.221 0 CA-C-N 116.371 -0.377 . . . . 0.0 110.669 -179.267 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' C' C ' 6' ' ' LEU . . . . . . . . . . . . . 58.2 mt -115.83 143.57 45.22 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 115.415 -0.812 . . . . 0.0 110.264 -178.726 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' C' C ' 7' ' ' LYS . . . . . . . . . . . . . 82.8 tttt -124.19 135.17 26.09 Favored Pre-proline 0 CA--C 1.534 0.359 0 CA-C-O 118.792 -0.623 . . . . 0.0 109.575 175.098 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' C' C ' 8' ' ' PRO . . . . . . . . . . . . . 88.3 Cg_endo -91.27 137.99 2.18 Favored 'Trans proline' 0 N--CA 1.49 1.317 0 C-N-CA 121.665 1.577 . . . . 0.0 111.901 179.357 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' C' C ' 9' ' ' LEU . . . . . . . . . . . . . 65.1 mt -71.8 -47.44 12.02 Favored Pre-proline 0 CA--C 1.533 0.312 0 CA-C-O 118.725 -0.655 . . . . 0.0 112.071 179.628 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' C' C ' 10' ' ' PRO . . . . . . . . . . . . . 98.7 Cg_endo -79.53 151.95 22.78 Favored 'Trans proline' 0 N--CA 1.495 1.57 0 C-N-CA 121.156 1.237 . . . . 0.0 111.779 175.696 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' C' C ' 11' ' ' LYS . . . . . . . . . . . . . 64.3 mttp -88.32 91.83 8.93 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-O 120.783 0.325 . . . . 0.0 110.69 179.807 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' C' C ' 12' ' ' VAL . . . . . . . . . . . . . 12.6 p -140.47 145.93 25.13 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.325 0 CA-C-N 116.16 -0.473 . . . . 0.0 110.34 178.684 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' C' C ' 13' ' ' GLU . . . . . . . . . . . . . 13.9 pt-20 -86.81 134.07 33.59 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.784 179.828 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' C' C ' 14' ' ' LEU . . . . . . . . . . . . . 50.0 mt -97.65 149.33 35.6 Favored Pre-proline 0 CA--C 1.532 0.28 0 CA-C-O 119.244 -0.407 . . . . 0.0 110.27 179.492 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' C' C ' 15' ' ' PRO . . . . . . . . . . . . . 26.8 Cg_exo -60.7 160.23 25.49 Favored 'Trans proline' 0 N--CA 1.498 1.786 0 C-N-CA 121.321 1.347 . . . . 0.0 111.834 178.584 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' C' C ' 16' ' ' PRO . . . . . . . . . . . . . 33.7 Cg_exo -59.17 -41.99 54.81 Favored 'Trans proline' 0 N--CA 1.497 1.705 0 C-N-CA 121.5 1.467 . . . . 0.0 112.587 -178.16 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' C' C ' 17' ' ' ASP . . . . . . . . . . . . . 8.7 p-10 -85.27 11.07 10.78 Favored 'General case' 0 CA--C 1.537 0.456 0 N-CA-C 113.065 0.765 . . . . 0.0 113.065 -178.816 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' C' C ' 18' ' ' PHE . . . . . . . . . . . . . 51.3 t80 -58.21 -42.96 87.36 Favored 'General case' 0 C--N 1.333 -0.109 0 O-C-N 122.06 -0.4 . . . . 0.0 110.082 -177.54 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' C' C ' 19' ' ' VAL . . . . . . . . . . . . . 48.3 t -57.54 -42.09 80.34 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.319 0 CA-C-N 116.385 -0.37 . . . . 0.0 110.522 -177.919 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' C' C ' 20' ' ' ASP . . . . . . . . . . . . . 83.4 m-20 -59.86 -43.52 94.65 Favored 'General case' 0 C--O 1.234 0.261 0 CA-C-O 120.96 0.409 . . . . 0.0 110.848 -178.493 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' C' C ' 21' ' ' VAL . . . . . . . . . . . . . 49.1 t -64.39 -48.54 84.81 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.251 0 CA-C-N 116.376 -0.374 . . . . 0.0 110.433 -178.097 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' C' C ' 22' ' ' ILE . . . . . . . . . . . . . 51.7 mm -56.68 -43.05 78.31 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.254 0 C-N-CA 121.079 -0.248 . . . . 0.0 110.574 179.175 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' C' C ' 23' ' ' ARG . . . . . . . . . . . . . 47.3 ttp180 -55.06 -46.64 75.38 Favored 'General case' 0 C--N 1.33 -0.255 0 C-N-CA 121.065 -0.254 . . . . 0.0 111.212 -178.495 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' C' C ' 24' ' ' ILE . . . . . . . . . . . . . 72.4 mt -59.57 -42.95 89.8 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.229 0 C-N-CA 120.869 -0.333 . . . . 0.0 110.758 179.571 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' C' C ' 25' ' ' LYS . . . . . . . . . . . . . 45.9 mmtt -62.0 -43.35 99.03 Favored 'General case' 0 C--N 1.328 -0.36 0 N-CA-C 112.037 0.384 . . . . 0.0 112.037 -179.425 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' C' C ' 26' ' ' LEU . . . . . . . . . . . . . 92.8 mt -79.67 -39.28 31.73 Favored 'General case' 0 C--N 1.329 -0.288 0 N-CA-C 113.646 0.98 . . . . 0.0 113.646 -169.899 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' C' C ' 27' ' ' GLN . . . . . . . . . . . . . 9.9 pt20 -46.77 137.51 7.02 Favored 'General case' 0 N--CA 1.469 0.502 0 N-CA-C 112.925 0.713 . . . . 0.0 112.925 -173.627 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' C' C ' 28' ' ' GLY . . . . . . . . . . . . . . . 99.47 -25.53 27.9 Favored Glycine 0 CA--C 1.533 1.179 0 CA-C-N 115.45 -0.796 . . . . 0.0 112.367 -176.934 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' C' C ' 29' ' ' LYS . . . . . . . . . . . . . 68.5 mttm -98.38 155.16 17.36 Favored 'General case' 0 C--O 1.233 0.187 0 CA-C-N 117.256 0.528 . . . . 0.0 111.061 179.537 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' C' C ' 30' ' ' THR . . . . . . . . . . . . . 25.9 m -108.59 139.92 42.69 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.149 176.267 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' C' C ' 31' ' ' VAL . . . . . . . . . . . . . 34.6 m -130.06 153.92 39.63 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.277 0 CA-C-N 116.292 -0.413 . . . . 0.0 110.9 -178.738 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' C' C ' 32' ' ' ARG . . . . . . . . . . . . . 84.3 mtm180 -128.82 147.55 50.81 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-O 121.325 0.583 . . . . 0.0 110.702 179.436 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' C' C ' 33' ' ' THR . . . . . . . . . . . . . 19.0 m -53.58 139.8 30.57 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.133 -0.485 . . . . 0.0 111.329 -178.902 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' C' C ' 34' ' ' GLY . . . . . . . . . . . . . . . 98.45 -17.13 58.92 Favored Glycine 0 CA--C 1.533 1.207 0 CA-C-O 119.706 -0.496 . . . . 0.0 113.266 178.969 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' C' C ' 35' ' ' ASP . . . . . . . . . . . . . 81.9 m-20 -66.75 149.34 50.69 Favored 'General case' 0 N--CA 1.461 0.109 0 CA-C-N 118.017 0.908 . . . . 0.0 111.044 178.978 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' C' C ' 36' ' ' VAL . . . . . . . . . . . . . 43.6 t -118.71 128.27 75.6 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.211 0 CA-C-N 116.154 -0.475 . . . . 0.0 109.725 176.832 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' C' C ' 37' ' ' ILE . . . . . . . . . . . . . 61.6 mt -119.46 137.47 53.27 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.251 0 CA-C-N 116.105 -0.498 . . . . 0.0 109.867 -179.515 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' C' C ' 38' ' ' GLY . . . . . . . . . . . . . . . -115.45 127.9 7.82 Favored Glycine 0 CA--C 1.525 0.668 0 N-CA-C 110.95 -0.86 . . . . 0.0 110.95 178.971 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' C' C ' 39' ' ' ILE . . . . . . . . . . . . . 70.5 mt -126.72 127.78 70.41 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.232 0 N-CA-C 109.905 -0.405 . . . . 0.0 109.905 178.493 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' C' C ' 40' ' ' SER . . . . . . . . . . . . . 60.4 p -91.97 119.63 31.88 Favored 'General case' 0 C--N 1.33 -0.264 0 C-N-CA 120.968 -0.293 . . . . 0.0 110.667 176.463 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' C' C ' 41' ' ' ILE . . . . . . . . . . . . . 73.3 mt -131.45 130.33 62.62 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.215 0 CA-C-O 120.868 0.366 . . . . 0.0 110.367 179.708 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' C' C ' 42' ' ' LEU . . . . . . . . . . . . . 72.8 mt 57.38 33.06 22.76 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 116.105 -0.498 . . . . 0.0 111.895 177.589 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' C' C ' 43' ' ' GLY . . . . . . . . . . . . . . . 72.55 23.06 78.57 Favored Glycine 0 CA--C 1.532 1.138 0 C-N-CA 121.132 -0.556 . . . . 0.0 112.727 177.882 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' C' C ' 44' ' ' LYS . . . . . . . . . . . . . 33.4 ttmt -139.09 129.56 25.73 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 117.315 0.557 . . . . 0.0 109.746 178.379 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' C' C ' 45' ' ' GLU . . . . . . . . . . . . . 45.9 tp10 -84.14 129.66 34.89 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-O 120.836 0.35 . . . . 0.0 111.279 -177.172 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' C' C ' 46' ' ' VAL . . . . . . . . . . . . . 9.1 p -122.75 126.12 73.43 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.246 0 N-CA-C 109.409 -0.589 . . . . 0.0 109.409 174.578 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' C' C ' 47' ' ' LYS . . . . . . . . . . . . . 64.3 mttm -100.03 128.76 46.07 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.03 -0.532 . . . . 0.0 111.339 179.068 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' C' C ' 48' ' ' PHE . . . . . . . . . . . . . 28.4 m-85 -112.51 131.97 55.32 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 116.015 -0.539 . . . . 0.0 109.795 177.549 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' C' C ' 49' ' ' LYS . . . . . . . . . . . . . 46.2 tttp -105.45 132.21 51.91 Favored 'General case' 0 C--N 1.329 -0.315 0 N-CA-C 109.812 -0.44 . . . . 0.0 109.812 177.741 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' C' C ' 50' ' ' VAL . . . . . . . . . . . . . 46.2 t -72.86 106.03 2.74 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.324 0 N-CA-C 109.454 -0.573 . . . . 0.0 109.454 178.454 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' C' C ' 51' ' ' VAL . . . . . . . . . . . . . 49.0 t -68.5 -50.61 54.8 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.279 0 N-CA-C 109.5 -0.556 . . . . 0.0 109.5 -176.357 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' C' C ' 52' ' ' GLN . . . . . . . . . . . . . 21.5 pt20 -162.67 157.81 22.31 Favored 'General case' 0 C--N 1.331 -0.201 0 CA-C-N 115.908 -0.587 . . . . 0.0 111.649 179.239 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' C' C ' 53' ' ' ALA . . . . . . . . . . . . . . . -130.97 132.61 45.16 Favored 'General case' 0 C--N 1.326 -0.422 0 CA-C-N 115.176 -0.92 . . . . 0.0 109.817 178.165 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' C' C ' 54' ' ' TYR . . . . . . . . . . . . . 29.3 t80 -128.98 108.37 18.19 Favored Pre-proline 0 CA--C 1.534 0.358 0 CA-C-O 118.204 -0.903 . . . . 0.0 110.413 -179.008 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' C' C ' 55' ' ' PRO . . . . . . . . . . . . . 73.1 Cg_endo -77.16 170.03 72.63 Favored 'Cis proline' 0 N--CA 1.501 1.916 0 CA-C-N 121.833 1.69 . . . . 0.0 112.451 -5.776 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' C' C ' 56' ' ' SER . . . . . . . . . . . . . 14.5 m -114.23 128.34 25.91 Favored Pre-proline 0 CA--C 1.54 0.568 0 CA-C-O 118.368 -0.825 . . . . 0.0 109.348 175.356 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' C' C ' 57' ' ' PRO . . . . . . . . . . . . . 57.0 Cg_endo -71.97 149.5 92.95 Favored 'Cis proline' 0 N--CA 1.497 1.689 0 CA-C-N 121.98 1.743 . . . . 0.0 111.857 -0.556 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' C' C ' 58' ' ' LEU . . . . . . . . . . . . . 24.9 tp -108.64 137.03 47.26 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.294 -0.412 . . . . 0.0 110.643 -178.622 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' C' C ' 59' ' ' ARG . . . . . . . . . . . . . 57.0 ttm-85 -107.11 127.53 53.57 Favored 'General case' 0 C--N 1.329 -0.321 0 N-CA-C 109.322 -0.621 . . . . 0.0 109.322 175.95 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' C' C ' 60' ' ' VAL . . . . . . . . . . . . . 40.9 t -81.71 120.69 33.75 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.231 0 CA-C-O 121.074 0.464 . . . . 0.0 110.968 -173.733 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' C' C ' 61' ' ' GLU . . . . . . . . . . . . . 80.4 tt0 -131.15 158.21 41.08 Favored 'General case' 0 C--N 1.33 -0.275 0 N-CA-C 108.73 -0.841 . . . . 0.0 108.73 174.729 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' C' C ' 62' ' ' ASP . . . . . . . . . . . . . 52.8 m-20 -49.82 -32.2 13.56 Favored 'General case' 0 C--N 1.329 -0.294 0 N-CA-C 112.352 0.501 . . . . 0.0 112.352 -178.146 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' C' C ' 63' ' ' ARG . . . . . . . . . . . . . 26.7 mmm180 -71.25 -20.79 62.19 Favored 'General case' 0 CA--C 1.536 0.415 0 N-CA-C 112.999 0.741 . . . . 0.0 112.999 -176.357 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' C' C ' 64' ' ' THR . . . . . . . . . . . . . 36.8 m -67.87 141.76 56.31 Favored 'General case' 0 C--N 1.331 -0.239 0 CA-C-O 121.051 0.453 . . . . 0.0 111.222 -175.592 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' C' C ' 65' ' ' LYS . . . . . . . . . . . . . 63.6 mttm -89.65 132.94 34.89 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 115.749 -0.66 . . . . 0.0 109.86 177.35 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' C' C ' 66' ' ' ILE . . . . . . . . . . . . . 63.1 mt -118.59 132.04 69.61 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.22 0 N-CA-C 110.055 -0.35 . . . . 0.0 110.055 -179.276 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' C' C ' 67' ' ' THR . . . . . . . . . . . . . 25.9 m -129.24 139.08 51.97 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-O 121.048 0.451 . . . . 0.0 111.26 -178.348 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' C' C ' 68' ' ' LEU . . . . . . . . . . . . . 39.3 mt -102.38 122.9 45.19 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 115.891 -0.595 . . . . 0.0 110.165 176.066 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' C' C ' 69' ' ' VAL . . . . . . . . . . . . . 43.3 t -102.99 136.02 37.59 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.338 0 CA-C-N 116.088 -0.505 . . . . 0.0 110.31 -178.922 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' C' C ' 70' ' ' THR . . . . . . . . . . . . . 17.2 p -136.55 97.61 3.6 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.266 -0.425 . . . . 0.0 110.4 178.454 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' C' C ' 71' ' ' HIS . . . . . . . . . . . . . 83.7 m-70 -142.5 154.25 63.19 Favored Pre-proline 0 C--N 1.33 -0.241 0 CA-C-N 116.131 -0.486 . . . . 0.0 110.468 179.692 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' C' C ' 72' ' ' PRO . . . . . . . . . . . . . 70.3 Cg_endo -76.1 -28.04 7.77 Favored 'Trans proline' 0 N--CA 1.495 1.561 0 C-N-CA 121.304 1.336 . . . . 0.0 112.562 178.266 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' C' C ' 73' ' ' VAL . . . . . . . . . . . . . 32.9 m -77.99 156.57 5.15 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.203 0 CA-C-O 120.888 0.375 . . . . 0.0 110.782 -179.175 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' C' C ' 74' ' ' ASP . . . . . . . . . . . . . 10.8 t70 -97.04 122.29 39.87 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.109 -0.496 . . . . 0.0 109.734 179.222 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' C' C ' 75' ' ' VAL . . . . . . . . . . . . . 46.0 t -116.98 125.54 73.93 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.196 0 CA-C-O 120.879 0.371 . . . . 0.0 110.698 -175.27 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' C' C ' 76' ' ' LEU . . . . . . . . . . . . . 19.4 mt -131.51 145.57 51.82 Favored 'General case' 0 C--N 1.333 -0.148 0 CA-C-N 116.012 -0.54 . . . . 0.0 110.488 179.559 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' C' C ' 77' ' ' GLU . . . . . . . . . . . . . 33.1 mp0 -135.48 141.92 45.42 Favored 'General case' 0 C--N 1.331 -0.225 0 CA-C-O 121.136 0.493 . . . . 0.0 111.046 178.345 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' C' C ' 78' ' ' ALA . . . . . 0.697 ' HB2' HD21 ' C' ' 109' ' ' LEU . . . -126.57 135.03 50.73 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 115.677 -0.692 . . . . 0.0 109.86 176.184 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' C' C ' 79' ' ' LYS . . . . . 0.58 ' O ' HD13 ' C' ' 80' ' ' ILE . 76.5 tttt -81.73 111.19 17.76 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.315 -0.402 . . . . 0.0 110.57 -177.57 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' C' C ' 80' ' ' ILE . . . . . 0.58 HD13 ' O ' ' C' ' 79' ' ' LYS . 42.8 mm -139.14 105.92 2.7 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.341 0 N-CA-C 109.15 -0.685 . . . . 0.0 109.15 -177.45 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' C' C ' 81' ' ' LYS . . . . . . . . . . . . . 32.1 ttpt -102.24 132.29 48.27 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-O 120.921 0.391 . . . . 0.0 110.845 -176.213 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' C' C ' 82' ' ' GLY . . . . . . . . . . . . . . . 89.19 42.09 5.67 Favored Glycine 0 CA--C 1.526 0.78 0 N-CA-C 111.563 -0.615 . . . . 0.0 111.563 177.623 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' C' C ' 83' ' ' ILE . . . . . 0.403 HD11 ' HB ' ' C' ' 80' ' ' ILE . 69.1 mt -79.26 141.87 14.78 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.284 0 N-CA-C 109.717 -0.475 . . . . 0.0 109.717 177.562 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' C' C ' 84' ' ' LYS . . . . . . . . . . . . . 38.8 ttpt -101.08 -54.02 2.89 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.309 -0.405 . . . . 0.0 110.464 -178.454 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' C' C ' 85' ' ' ASP . . . . . . . . . . . . . 7.2 t0 -146.46 150.61 35.94 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.097 -0.501 . . . . 0.0 110.781 -176.949 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' C' C ' 86' ' ' VAL . . . . . . . . . . . . . 44.1 t -128.12 131.2 69.58 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.259 0 CA-C-N 116.34 -0.391 . . . . 0.0 110.275 -179.065 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' C' C ' 87' ' ' ILE . . . . . . . . . . . . . 44.9 mm -118.61 126.84 75.5 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.254 0 N-CA-C 109.696 -0.483 . . . . 0.0 109.696 176.827 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' C' C ' 88' ' ' LEU . . . . . . . . . . . . . 13.7 tp -115.61 130.21 56.78 Favored 'General case' 0 C--N 1.331 -0.227 0 CA-C-O 120.964 0.411 . . . . 0.0 111.067 -177.014 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' C' C ' 89' ' ' ASP . . . . . . . . . . . . . 6.1 t0 -126.1 152.57 45.71 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 115.836 -0.62 . . . . 0.0 109.449 176.829 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' C' C ' 90' ' ' GLU . . . . . . . . . . . . . 84.8 tt0 -48.23 -35.72 12.5 Favored 'General case' 0 C--N 1.329 -0.312 0 N-CA-C 112.751 0.648 . . . . 0.0 112.751 -173.219 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' C' C ' 91' ' ' ASN . . . . . . . . . . . . . 85.1 m-20 -131.97 33.59 3.92 Favored 'General case' 0 N--CA 1.465 0.314 0 N-CA-C 111.877 0.325 . . . . 0.0 111.877 -176.804 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' C' C ' 92' ' ' LEU . . . . . . . . . . . . . 8.2 tp -166.07 142.6 5.11 Favored 'General case' 0 C--N 1.331 -0.215 0 C-N-CA 121.014 -0.274 . . . . 0.0 110.566 -179.002 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' C' C ' 93' ' ' ILE . . . . . . . . . . . . . 74.0 mt -127.14 125.17 65.8 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.26 0 N-CA-C 109.493 -0.558 . . . . 0.0 109.493 178.227 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' C' C ' 94' ' ' VAL . . . . . 0.578 HG21 HG11 ' C' ' 125' ' ' VAL . 45.2 t -127.1 129.83 71.11 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.259 0 CA-C-O 120.968 0.414 . . . . 0.0 110.197 179.914 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' C' C ' 95' ' ' VAL . . . . . . . . . . . . . 42.3 t -121.35 134.4 64.84 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.339 0 CA-C-N 115.936 -0.574 . . . . 0.0 109.76 179.324 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' C' C ' 96' ' ' ILE . . . . . . . . . . . . . 64.1 mt -116.15 128.71 73.37 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 N-CA-C 109.371 -0.604 . . . . 0.0 109.371 179.64 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' C' C ' 97' ' ' THR . . . . . . . . . . . . . 73.3 p -101.82 160.56 14.37 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-O 121.185 0.517 . . . . 0.0 111.13 -177.577 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' C' C ' 98' ' ' GLU . . . . . . . . . . . . . 12.5 pt-20 -54.04 -25.94 24.0 Favored 'General case' 0 C--N 1.328 -0.337 0 N-CA-C 112.39 0.515 . . . . 0.0 112.39 -178.108 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' C' C ' 99' ' ' GLU . . . . . . . . . . . . . 95.5 mt-10 -79.87 15.44 1.43 Allowed 'General case' 0 CA--C 1.536 0.404 0 N-CA-C 113.131 0.789 . . . . 0.0 113.131 -176.164 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' C' C ' 100' ' ' ASN . . . . . . . . . . . . . 3.5 m-20 61.82 37.35 15.54 Favored 'General case' 0 CA--C 1.531 0.245 0 CA-C-O 121.047 0.451 . . . . 0.0 110.995 179.499 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' C' C ' 101' ' ' GLU . . . . . . . . . . . . . 84.9 tt0 -114.82 141.27 48.12 Favored 'General case' 0 C--N 1.332 -0.159 0 CA-C-N 116.071 -0.513 . . . . 0.0 109.62 175.98 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' C' C ' 102' ' ' VAL . . . . . . . . . . . . . 43.7 t -116.46 127.01 74.19 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.341 0 CA-C-N 116.298 -0.41 . . . . 0.0 110.047 -178.122 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' C' C ' 103' ' ' LEU . . . . . . . . . . . . . 40.6 mt -114.85 130.14 56.83 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 115.719 -0.673 . . . . 0.0 110.071 176.496 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' C' C ' 104' ' ' ILE . . . . . . . . . . . . . 66.4 mt -114.95 122.22 68.62 Favored 'Isoleucine or valine' 0 C--O 1.234 0.254 0 N-CA-C 110.161 -0.311 . . . . 0.0 110.161 -178.693 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' C' C ' 105' ' ' PHE . . . . . . . . . . . . . 81.2 m-85 -123.24 163.57 20.41 Favored 'General case' 0 C--O 1.231 0.121 0 O-C-N 124.02 0.825 . . . . 0.0 109.591 -179.17 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' C' C ' 106' ' ' ASN . . . . . . . . . . . . . 47.4 p-10 -98.32 -170.61 1.99 Allowed 'General case' 0 C--N 1.33 -0.265 0 N-CA-C 109.828 -0.434 . . . . 0.0 109.828 173.525 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' C' C ' 107' ' ' GLN . . . . . . . . . . . . . 49.0 tt0 -59.44 -30.1 68.25 Favored 'General case' 0 C--N 1.33 -0.273 0 N-CA-C 112.128 0.418 . . . . 0.0 112.128 -179.252 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' C' C ' 108' ' ' ASN . . . . . . . . . . . . . 30.7 t30 -84.75 9.2 14.67 Favored 'General case' 0 CA--C 1.536 0.419 0 N-CA-C 113.181 0.808 . . . . 0.0 113.181 -177.009 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' C' C ' 109' ' ' LEU . . . . . 0.697 HD21 ' HB2' ' C' ' 78' ' ' ALA . 12.4 tp 61.56 37.51 16.24 Favored 'General case' 0 CA--C 1.53 0.188 0 CA-C-O 120.993 0.425 . . . . 0.0 111.249 178.573 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' C' C ' 110' ' ' GLU . . . . . . . . . . . . . 95.3 mt-10 -105.12 149.55 25.78 Favored 'General case' 0 C--N 1.33 -0.254 0 N-CA-C 109.687 -0.486 . . . . 0.0 109.687 175.584 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' C' C ' 111' ' ' GLU . . . . . . . . . . . . . 74.1 tt0 -87.45 121.92 30.52 Favored 'General case' 0 C--N 1.33 -0.272 0 C-N-CA 120.77 -0.372 . . . . 0.0 110.583 -175.31 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' C' C ' 112' ' ' LEU . . . . . . . . . . . . . 17.8 mt -108.01 -45.98 3.86 Favored 'General case' 0 C--N 1.332 -0.176 0 CA-C-N 115.992 -0.549 . . . . 0.0 110.78 -179.856 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' C' C ' 113' ' ' TYR . . . . . . . . . . . . . 46.8 t80 -135.55 141.89 45.27 Favored 'General case' 0 C--N 1.331 -0.23 0 CA-C-N 116.361 -0.381 . . . . 0.0 111.213 -178.179 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' C' C ' 114' ' ' ARG . . . . . . . . . . . . . 38.8 ptt180 -142.48 125.26 15.99 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.254 -0.43 . . . . 0.0 110.475 176.757 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' C' C ' 115' ' ' GLY . . . . . . . . . . . . . . . -150.09 162.25 29.14 Favored Glycine 0 CA--C 1.524 0.628 0 C-N-CA 120.693 -0.765 . . . . 0.0 111.55 -179.92 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' C' C ' 116' ' ' LYS . . . . . . . . . . . . . 39.1 ttpt -125.83 135.52 52.07 Favored 'General case' 0 C--N 1.332 -0.185 0 N-CA-C 109.866 -0.42 . . . . 0.0 109.866 176.994 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' C' C ' 117' ' ' PHE . . . . . . . . . . . . . 64.3 m-85 -130.65 113.81 14.64 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-O 120.856 0.36 . . . . 0.0 110.365 -178.256 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' C' C ' 118' ' ' GLU . . . . . . . . . . . . . 14.3 mm-40 -55.76 -48.19 75.71 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 116.397 -0.365 . . . . 0.0 111.056 -175.916 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' C' C ' 119' ' ' ASN . . . . . . . . . . . . . 68.1 m-80 -97.19 31.11 2.54 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.005 -0.543 . . . . 0.0 112.12 -174.185 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' C' C ' 120' ' ' LEU . . . . . . . . . . . . . 13.8 tp -52.63 119.88 5.04 Favored 'General case' 0 N--CA 1.466 0.325 0 O-C-N 122.238 -0.289 . . . . 0.0 111.029 178.999 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' C' C ' 121' ' ' ASN . . . . . . . . . . . . . 90.9 m-20 -113.93 -44.05 3.2 Favored 'General case' 0 C--N 1.331 -0.226 0 CA-C-N 116.317 -0.401 . . . . 0.0 111.242 -177.959 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' C' C ' 122' ' ' LYS . . . . . . . . . . . . . 38.4 ttpt -143.9 143.44 31.28 Favored 'General case' 0 C--N 1.333 -0.113 0 C-N-CA 120.507 -0.477 . . . . 0.0 111.577 -177.163 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' C' C ' 123' ' ' VAL . . . . . . . . . . . . . 43.9 t -126.41 127.44 70.5 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.285 0 N-CA-C 109.148 -0.686 . . . . 0.0 109.148 173.773 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' C' C ' 124' ' ' LEU . . . . . 0.652 HD13 HD12 ' D' ' 88' ' ' LEU . 8.7 tt -131.39 133.03 44.84 Favored 'General case' 0 N--CA 1.463 0.219 0 CA-C-O 120.961 0.41 . . . . 0.0 111.142 -176.377 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' C' C ' 125' ' ' VAL . . . . . 0.729 HG12 HG23 ' C' ' 130' ' ' VAL . 35.8 m -126.68 144.96 35.11 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.238 0 CA-C-N 115.798 -0.637 . . . . 0.0 110.441 179.607 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' C' C ' 126' ' ' ARG . . . . . . . . . . . . . 34.8 ttm180 -150.0 117.04 5.95 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-O 120.996 0.427 . . . . 0.0 110.412 177.819 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' C' C ' 127' ' ' ASN . . . . . . . . . . . . . 96.2 m-20 53.77 -107.6 0.37 Allowed 'General case' 0 CA--C 1.542 0.651 0 CA-C-N 116.0 -0.546 . . . . 0.0 110.859 -178.268 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' C' C ' 128' ' ' ASP . . . . . . . . . . . . . 8.4 p-10 -114.13 1.9 14.73 Favored 'General case' 0 CA--C 1.537 0.447 0 CA-C-N 119.742 1.156 . . . . 0.0 113.271 -177.994 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' C' C ' 129' ' ' LEU . . . . . . . . . . . . . 12.7 tp -105.15 139.59 39.58 Favored 'General case' 0 C--O 1.232 0.156 0 N-CA-C 109.429 -0.582 . . . . 0.0 109.429 178.789 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' C' C ' 130' ' ' VAL . . . . . 0.729 HG23 HG12 ' C' ' 125' ' ' VAL . 12.2 p -135.81 140.29 44.54 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.21 0 CA-C-O 121.295 0.569 . . . . 0.0 110.869 -177.564 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' C' C ' 131' ' ' VAL . . . . . . . . . . . . . 35.6 m -136.11 146.43 29.26 Favored 'Isoleucine or valine' 0 C--O 1.234 0.251 0 CA-C-N 115.793 -0.64 . . . . 0.0 110.935 178.782 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' C' C ' 132' ' ' ILE . . . . . . . . . . . . . 68.1 mt -122.88 134.0 67.32 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.293 0 CA-C-N 115.596 -0.729 . . . . 0.0 109.521 179.69 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' C' C ' 133' ' ' ILE . . . . . . . . . . . . . 42.7 mm -116.26 120.43 64.89 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.212 0 CA-C-N 116.548 -0.297 . . . . 0.0 110.733 -176.996 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' C' C ' 134' ' ' ASP . . . . . . . . . . . . . 6.1 p-10 -131.83 146.56 52.21 Favored 'General case' 0 C--N 1.331 -0.214 0 CA-C-N 116.21 -0.45 . . . . 0.0 109.806 176.379 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' C' C ' 135' ' ' GLU . . . . . . . . . . . . . 84.2 tt0 -50.0 -26.31 4.17 Favored 'General case' 0 C--N 1.328 -0.359 0 N-CA-C 112.937 0.718 . . . . 0.0 112.937 -170.779 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' C' C ' 136' ' ' GLN . . . . . . . . . . . . . 97.4 mt-30 -92.6 -35.47 13.53 Favored 'General case' 0 C--N 1.331 -0.196 0 N-CA-C 112.461 0.541 . . . . 0.0 112.461 -176.819 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' C' C ' 137' ' ' LYS . . . . . . . . . . . . . 54.4 mtmt -147.14 157.97 43.79 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-O 121.501 0.667 . . . . 0.0 112.048 -169.543 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' C' C ' 138' ' ' LEU . . . . . 0.444 HD23 ' C ' ' C' ' 138' ' ' LEU . 6.9 tt -116.08 126.26 53.5 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 115.203 -0.908 . . . . 0.0 109.317 174.621 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' C' C ' 139' ' ' THR . . . . . . . . . . . . . 33.8 m -111.47 127.98 55.86 Favored 'General case' 0 C--N 1.331 -0.212 0 CA-C-N 116.401 -0.363 . . . . 0.0 110.713 -177.831 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' C' C ' 140' ' ' LEU . . . . . 0.481 ' C ' HD23 ' C' ' 140' ' ' LEU . 9.0 tt -115.39 122.84 47.06 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 115.48 -0.782 . . . . 0.0 109.203 -179.781 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' C' C ' 141' ' ' ILE . . . . . 0.529 ' HB ' HG13 ' C' ' 130' ' ' VAL . 20.2 mt -120.5 117.72 54.24 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.27 0 CA-C-O 120.973 0.416 . . . . 0.0 110.046 -176.309 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' C' C ' 142' ' ' ARG . . . . . . . . . . . . . 62.6 ttp85 -106.64 130.83 54.32 Favored 'General case' 0 C--N 1.331 -0.205 0 CA-C-N 115.096 -0.956 . . . . 0.0 110.621 -177.72 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' C' C ' 143' ' ' THR . . . . . . . . . . . . . 63.6 p . . . . . 0 C--O 1.22 -0.473 0 CA-C-O 118.047 -0.978 . . . . 0.0 110.527 179.162 . . . . . . . . 0 0 . 1 . 011 nuclear nobuild full ' D' D ' -3' ' ' GLU . . . . . . . . . . . . . 45.2 tp10 . . . . . 0 N--CA 1.488 1.46 0 N-CA-C 109.408 -0.59 . . . . 0.0 109.408 . . . . . . . . . 0 0 . 1 . 011 nuclear nobuild full ' D' D ' -2' ' ' GLY . . . . . . . . . . . . . . . -64.67 141.97 44.72 Favored Glycine 0 CA--C 1.525 0.705 0 N-CA-C 110.938 -0.865 . . . . 0.0 110.938 -179.541 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' D' D ' -1' ' ' VAL . . . . . . . . . . . . . 45.5 t -141.08 134.18 31.02 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.282 0 CA-C-O 120.817 0.342 . . . . 0.0 110.109 -179.981 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' D' D ' 0' ' ' ILE . . . . . . . . . . . . . 71.2 mt -118.94 137.12 53.93 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.234 0 CA-C-N 116.059 -0.519 . . . . 0.0 109.943 179.529 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' D' D ' 1' ' ' MET . . . . . . . . . . . . . 24.9 ptp -143.24 150.15 38.91 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.252 -0.431 . . . . 0.0 110.691 -179.862 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' D' D ' 2' ' ' SER . . . . . . . . . . . . . 5.8 p -111.74 133.37 54.01 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.236 -0.438 . . . . 0.0 110.354 178.779 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' D' D ' 3' ' ' GLU . . . . . . . . . . . . . 94.2 mt-10 -141.28 137.92 32.82 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-N 116.072 -0.513 . . . . 0.0 111.014 -178.376 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' D' D ' 4' ' ' LEU . . . . . 0.407 HD21 HD21 ' D' ' 6' ' ' LEU . 15.5 tp -122.49 128.69 51.15 Favored 'General case' 0 C--N 1.33 -0.282 0 N-CA-C 109.86 -0.422 . . . . 0.0 109.86 175.695 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' D' D ' 5' ' ' LYS . . . . . . . . . . . . . 55.7 mttp -107.93 119.13 38.6 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.432 -0.349 . . . . 0.0 110.48 179.699 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' D' D ' 6' ' ' LEU . . . . . 0.407 HD21 HD21 ' D' ' 4' ' ' LEU . 71.3 mt -114.8 145.7 41.84 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 115.464 -0.789 . . . . 0.0 110.386 -177.698 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' D' D ' 7' ' ' LYS . . . . . . . . . . . . . 52.3 tttm -135.0 137.66 27.64 Favored Pre-proline 0 CA--C 1.534 0.329 0 CA-C-O 118.966 -0.54 . . . . 0.0 109.818 176.757 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' D' D ' 8' ' ' PRO . . . . . . . . . . . . . 94.0 Cg_endo -91.48 143.92 3.09 Favored 'Trans proline' 0 N--CA 1.49 1.322 0 C-N-CA 121.652 1.568 . . . . 0.0 111.877 178.495 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' D' D ' 9' ' ' LEU . . . . . . . . . . . . . 69.5 mt -80.31 -48.46 1.26 Allowed Pre-proline 0 C--N 1.328 -0.331 0 CA-C-O 118.467 -0.778 . . . . 0.0 112.372 -179.488 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' D' D ' 10' ' ' PRO . . . . . . . . . . . . . 77.7 Cg_endo -77.64 151.73 28.85 Favored 'Trans proline' 0 N--CA 1.496 1.635 0 C-N-CA 121.09 1.193 . . . . 0.0 112.009 177.618 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' D' D ' 11' ' ' LYS . . . . . . . . . . . . . 24.8 mtmt -88.29 92.32 9.12 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.311 -0.404 . . . . 0.0 110.616 179.965 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' D' D ' 12' ' ' VAL . . . . . . . . . . . . . 12.4 p -139.61 148.67 23.02 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.242 0 CA-C-N 116.073 -0.512 . . . . 0.0 110.454 -179.972 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' D' D ' 13' ' ' GLU . . . . . . . . . . . . . 84.6 tt0 -88.38 125.34 34.66 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.251 -0.431 . . . . 0.0 109.962 177.321 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' D' D ' 14' ' ' LEU . . . . . . . . . . . . . 38.2 mt -97.94 150.79 37.12 Favored Pre-proline 0 CA--C 1.531 0.249 0 CA-C-N 116.297 -0.41 . . . . 0.0 110.719 -176.328 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' D' D ' 15' ' ' PRO . . . . . . . . . . . . . 25.3 Cg_exo -62.66 155.61 57.88 Favored 'Trans proline' 0 N--CA 1.497 1.722 0 C-N-CA 121.347 1.365 . . . . 0.0 111.939 176.732 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' D' D ' 16' ' ' PRO . . . . . . . . . . . . . 35.4 Cg_exo -59.8 -30.65 92.47 Favored 'Trans proline' 0 N--CA 1.498 1.736 0 C-N-CA 121.345 1.363 . . . . 0.0 112.57 179.331 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' D' D ' 17' ' ' ASP . . . . . . . . . . . . . 7.9 p-10 -84.09 3.26 35.51 Favored 'General case' 0 C--N 1.327 -0.384 0 N-CA-C 113.329 0.862 . . . . 0.0 113.329 -177.448 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' D' D ' 18' ' ' PHE . . . . . . . . . . . . . 10.8 t80 -57.99 -45.98 85.93 Favored 'General case' 0 C--O 1.227 -0.118 0 O-C-N 121.871 -0.518 . . . . 0.0 110.058 -177.819 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' D' D ' 19' ' ' VAL . . . . . . . . . . . . . 48.6 t -56.23 -42.82 74.71 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.273 0 CA-C-N 116.168 -0.469 . . . . 0.0 110.61 -178.075 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' D' D ' 20' ' ' ASP . . . . . . . . . . . . . 83.3 m-20 -60.05 -44.05 94.94 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-O 120.782 0.325 . . . . 0.0 111.231 -177.338 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' D' D ' 21' ' ' VAL . . . . . . . . . . . . . 46.7 t -64.8 -45.6 94.55 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 C-N-CA 120.72 -0.392 . . . . 0.0 110.528 -177.532 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' D' D ' 22' ' ' ILE . . . . . 0.631 HG22 HD12 ' D' ' 26' ' ' LEU . 51.3 mm -56.63 -45.83 82.62 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.168 0 C-N-CA 120.87 -0.332 . . . . 0.0 110.547 179.386 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' D' D ' 23' ' ' ARG . . . . . . . . . . . . . 54.8 ttp180 -54.2 -49.52 69.18 Favored 'General case' 0 C--N 1.33 -0.258 0 C-N-CA 121.09 -0.244 . . . . 0.0 111.315 -178.165 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' D' D ' 24' ' ' ILE . . . . . . . . . . . . . 71.8 mt -60.32 -43.1 92.92 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.216 0 C-N-CA 121.059 -0.256 . . . . 0.0 111.32 -178.478 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' D' D ' 25' ' ' LYS . . . . . . . . . . . . . 62.4 mtpt -65.13 -40.99 95.22 Favored 'General case' 0 C--N 1.329 -0.323 0 N-CA-C 112.32 0.489 . . . . 0.0 112.32 -177.499 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' D' D ' 26' ' ' LEU . . . . . 0.631 HD12 HG22 ' D' ' 22' ' ' ILE . 45.2 mt -79.15 -41.61 28.09 Favored 'General case' 0 C--N 1.329 -0.324 0 N-CA-C 113.354 0.872 . . . . 0.0 113.354 -171.202 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' D' D ' 27' ' ' GLN . . . . . . . . . . . . . 10.2 pt20 -46.43 137.52 6.47 Favored 'General case' 0 N--CA 1.469 0.512 0 N-CA-C 112.823 0.675 . . . . 0.0 112.823 -174.882 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' D' D ' 28' ' ' GLY . . . . . . . . . . . . . . . 100.17 -27.27 21.12 Favored Glycine 0 CA--C 1.532 1.146 0 CA-C-N 115.591 -0.731 . . . . 0.0 112.249 -177.765 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' D' D ' 29' ' ' LYS . . . . . . . . . . . . . 97.2 mttt -98.21 155.24 17.27 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 117.142 0.471 . . . . 0.0 111.123 179.218 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' D' D ' 30' ' ' THR . . . . . . . . . . . . . 28.2 m -101.0 138.52 37.94 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 115.953 -0.567 . . . . 0.0 110.172 176.044 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' D' D ' 31' ' ' VAL . . . . . . . . . . . . . 34.9 m -131.07 152.57 37.76 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.255 0 CA-C-N 116.32 -0.4 . . . . 0.0 110.759 -179.586 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' D' D ' 32' ' ' ARG . . . . . . . . . . . . . 58.5 ttp180 -129.28 148.98 51.26 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-O 121.202 0.525 . . . . 0.0 110.673 179.676 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' D' D ' 33' ' ' THR . . . . . . . . . . . . . 27.4 m -53.52 138.96 32.65 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 116.276 -0.42 . . . . 0.0 111.24 179.964 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' D' D ' 34' ' ' GLY . . . . . . . . . . . . . . . 100.51 -17.11 57.17 Favored Glycine 0 CA--C 1.531 1.077 0 C-N-CA 121.272 -0.489 . . . . 0.0 113.225 -179.871 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' D' D ' 35' ' ' ASP . . . . . . . . . . . . . 69.3 m-20 -65.67 149.76 49.58 Favored 'General case' 0 C--O 1.232 0.147 0 CA-C-N 118.014 0.907 . . . . 0.0 111.314 179.564 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' D' D ' 36' ' ' VAL . . . . . . . . . . . . . 45.6 t -121.72 129.58 75.36 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.23 0 CA-C-N 115.774 -0.648 . . . . 0.0 109.771 177.511 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' D' D ' 37' ' ' ILE . . . . . . . . . . . . . 69.2 mt -121.41 138.98 49.97 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.282 0 CA-C-N 116.3 -0.409 . . . . 0.0 109.956 -179.504 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' D' D ' 38' ' ' GLY . . . . . . . . . . . . . . . -109.08 128.79 9.18 Favored Glycine 0 CA--C 1.526 0.762 0 N-CA-C 111.073 -0.811 . . . . 0.0 111.073 179.914 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' D' D ' 39' ' ' ILE . . . . . . . . . . . . . 71.7 mt -123.83 136.08 61.39 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.234 0 CA-C-O 120.842 0.353 . . . . 0.0 110.091 179.728 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' D' D ' 40' ' ' SER . . . . . . . . . . . . . 59.9 p -92.88 114.23 26.73 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.245 -0.434 . . . . 0.0 110.641 174.335 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' D' D ' 41' ' ' ILE . . . . . . . . . . . . . 47.0 mm -122.91 112.85 35.65 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.211 0 CA-C-O 120.724 0.297 . . . . 0.0 110.379 179.473 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' D' D ' 42' ' ' LEU . . . . . 0.529 HD23 ' O ' ' D' ' 42' ' ' LEU . 1.3 tt 55.23 45.79 25.05 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-O 121.443 0.639 . . . . 0.0 110.521 178.111 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' D' D ' 43' ' ' GLY . . . . . . . . . . . . . . . 74.99 -9.67 11.15 Favored Glycine 0 CA--C 1.535 1.324 0 C-N-CA 121.342 -0.456 . . . . 0.0 113.712 175.687 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' D' D ' 44' ' ' LYS . . . . . . . . . . . . . 22.0 tptp -100.37 134.19 43.68 Favored 'General case' 0 C--N 1.331 -0.206 0 CA-C-N 117.927 0.863 . . . . 0.0 110.153 -178.998 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' D' D ' 45' ' ' GLU . . . . . . . . . . . . . 84.8 tt0 -83.29 123.03 29.21 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 116.458 -0.337 . . . . 0.0 110.732 -179.869 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' D' D ' 46' ' ' VAL . . . . . . . . . . . . . 7.1 p -123.49 127.64 74.26 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.182 0 N-CA-C 109.715 -0.476 . . . . 0.0 109.715 177.643 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' D' D ' 47' ' ' LYS . . . . . . . . . . . . . 63.7 mttp -100.23 129.98 46.3 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 115.954 -0.566 . . . . 0.0 111.172 178.59 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' D' D ' 48' ' ' PHE . . . . . . . . . . . . . 90.7 m-85 -113.19 131.89 55.7 Favored 'General case' 0 C--N 1.331 -0.213 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.09 177.054 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' D' D ' 49' ' ' LYS . . . . . . . . . . . . . 82.5 tttt -107.92 137.14 46.44 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.489 179.262 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' D' D ' 50' ' ' VAL . . . . . . . . . . . . . 46.4 t -83.04 108.79 16.13 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.312 0 N-CA-C 109.311 -0.625 . . . . 0.0 109.311 176.219 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' D' D ' 51' ' ' VAL . . . . . . . . . . . . . 46.1 t -73.4 -50.76 28.78 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.328 0 CA-C-N 116.142 -0.481 . . . . 0.0 109.907 -174.573 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' D' D ' 52' ' ' GLN . . . . . . . . . . . . . 92.4 mt-30 -152.72 154.22 34.81 Favored 'General case' 0 C--N 1.332 -0.18 0 CA-C-O 121.285 0.564 . . . . 0.0 111.552 -178.167 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' D' D ' 53' ' ' ALA . . . . . . . . . . . . . . . -132.56 132.59 42.74 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 115.212 -0.904 . . . . 0.0 109.788 175.832 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' D' D ' 54' ' ' TYR . . . . . . . . . . . . . 41.7 t80 -129.08 109.23 18.11 Favored Pre-proline 0 CA--C 1.534 0.364 0 CA-C-O 118.251 -0.88 . . . . 0.0 110.355 179.509 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' D' D ' 55' ' ' PRO . . . . . . . . . . . . . 73.2 Cg_endo -77.18 168.91 75.62 Favored 'Cis proline' 0 N--CA 1.5 1.873 0 CA-C-N 121.839 1.692 . . . . 0.0 112.43 -6.826 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' D' D ' 56' ' ' SER . . . . . . . . . . . . . 13.6 m -116.98 129.49 25.28 Favored Pre-proline 0 CA--C 1.538 0.49 0 CA-C-O 118.459 -0.781 . . . . 0.0 109.262 173.911 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' D' D ' 57' ' ' PRO . . . . . . . . . . . . . 56.1 Cg_endo -71.65 149.4 92.36 Favored 'Cis proline' 0 N--CA 1.498 1.768 0 CA-C-N 122.002 1.751 . . . . 0.0 111.691 0.37 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' D' D ' 58' ' ' LEU . . . . . . . . . . . . . 23.7 tp -108.98 137.99 46.03 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.176 -0.466 . . . . 0.0 110.843 -177.723 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' D' D ' 59' ' ' ARG . . . . . . . . . . . . . 31.7 ttp180 -102.23 122.87 45.03 Favored 'General case' 0 C--N 1.329 -0.315 0 N-CA-C 109.158 -0.682 . . . . 0.0 109.158 175.111 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' D' D ' 60' ' ' VAL . . . . . . . . . . . . . 43.3 t -79.84 122.37 34.93 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.262 0 C-N-CA 120.703 -0.399 . . . . 0.0 110.802 -173.36 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' D' D ' 61' ' ' GLU . . . . . . . . . . . . . 84.1 mt-10 -131.1 161.18 32.66 Favored 'General case' 0 C--N 1.332 -0.184 0 CA-C-N 115.91 -0.586 . . . . 0.0 109.562 177.214 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' D' D ' 62' ' ' ASP . . . . . . . . . . . . . 79.0 m-20 -53.3 -33.16 52.15 Favored 'General case' 0 C--N 1.329 -0.291 0 N-CA-C 111.782 0.29 . . . . 0.0 111.782 178.319 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' D' D ' 63' ' ' ARG . . . . . . . . . . . . . 92.8 mtt-85 -72.97 -21.97 60.77 Favored 'General case' 0 CA--C 1.533 0.324 0 N-CA-C 113.004 0.742 . . . . 0.0 113.004 -176.004 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' D' D ' 64' ' ' THR . . . . . . . . . . . . . 30.8 m -65.2 141.72 58.56 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-O 120.974 0.416 . . . . 0.0 111.085 -174.509 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' D' D ' 65' ' ' LYS . . . . . . . . . . . . . 68.9 mttm -87.7 131.31 34.51 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 115.787 -0.642 . . . . 0.0 109.915 178.17 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' D' D ' 66' ' ' ILE . . . . . . . . . . . . . 60.0 mt -116.27 124.93 73.05 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.272 0 N-CA-C 109.552 -0.536 . . . . 0.0 109.552 179.375 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' D' D ' 67' ' ' THR . . . . . . . . . . . . . 22.7 m -121.28 144.0 48.86 Favored 'General case' 0 C--O 1.233 0.218 0 CA-C-O 121.035 0.445 . . . . 0.0 111.242 -175.307 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' D' D ' 68' ' ' LEU . . . . . . . . . . . . . 14.2 tp -101.91 121.02 41.32 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 115.834 -0.621 . . . . 0.0 110.465 179.486 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' D' D ' 69' ' ' VAL . . . . . . . . . . . . . 44.0 t -103.84 133.39 47.95 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.361 0 CA-C-N 116.137 -0.483 . . . . 0.0 110.001 178.088 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' D' D ' 70' ' ' THR . . . . . . . . . . . . . 18.0 m -138.11 113.95 9.87 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.437 -0.347 . . . . 0.0 110.234 177.757 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' D' D ' 71' ' ' HIS . . . . . . . . . . . . . 41.8 m80 -102.1 152.04 38.16 Favored Pre-proline 0 C--N 1.331 -0.233 0 CA-C-N 116.28 -0.418 . . . . 0.0 110.294 179.612 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' D' D ' 72' ' ' PRO . . . . . . . . . . . . . 96.7 Cg_endo -84.84 -28.44 0.96 Allowed 'Trans proline' 0 N--CA 1.492 1.4 0 C-N-CA 121.552 1.501 . . . . 0.0 112.778 -178.737 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' D' D ' 73' ' ' VAL . . . . . . . . . . . . . 33.5 m -81.16 157.71 4.19 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.341 0 CA-C-O 120.978 0.418 . . . . 0.0 111.003 -178.087 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' D' D ' 74' ' ' ASP . . . . . . . . . . . . . 27.4 t0 -95.56 120.91 36.63 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 115.834 -0.621 . . . . 0.0 109.838 179.872 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' D' D ' 75' ' ' VAL . . . . . . . . . . . . . 42.9 t -112.02 122.76 66.92 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.234 0 CA-C-O 121.245 0.545 . . . . 0.0 110.337 -178.454 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' D' D ' 76' ' ' LEU . . . . . . . . . . . . . 33.7 mt -120.79 142.36 49.66 Favored 'General case' 0 C--N 1.331 -0.225 0 CA-C-N 115.555 -0.748 . . . . 0.0 109.617 177.814 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' D' D ' 77' ' ' GLU . . . . . . . . . . . . . 97.5 mt-10 -135.23 136.98 42.15 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-O 121.091 0.472 . . . . 0.0 111.382 -178.091 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' D' D ' 78' ' ' ALA . . . . . 0.534 ' HB2' HD21 ' D' ' 109' ' ' LEU . . . -124.83 138.37 54.27 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 115.706 -0.679 . . . . 0.0 109.816 176.804 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' D' D ' 79' ' ' LYS . . . . . 0.58 ' O ' HD13 ' D' ' 80' ' ' ILE . 62.0 mttp -81.54 118.07 22.45 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-O 120.871 0.367 . . . . 0.0 110.666 -178.568 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' D' D ' 80' ' ' ILE . . . . . 0.58 HD13 ' O ' ' D' ' 79' ' ' LYS . 42.3 mm -139.07 107.27 3.28 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.306 0 N-CA-C 109.264 -0.643 . . . . 0.0 109.264 -178.408 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' D' D ' 81' ' ' LYS . . . . . . . . . . . . . 38.0 ttpt -102.13 128.12 48.76 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-O 120.817 0.341 . . . . 0.0 110.932 -178.054 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' D' D ' 82' ' ' GLY . . . . . . . . . . . . . . . 89.05 42.17 5.69 Favored Glycine 0 CA--C 1.524 0.615 0 C-N-CA 120.725 -0.75 . . . . 0.0 111.444 174.817 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' D' D ' 83' ' ' ILE . . . . . . . . . . . . . 72.4 mt -68.25 134.88 29.5 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.264 0 N-CA-C 109.838 -0.43 . . . . 0.0 109.838 178.319 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' D' D ' 84' ' ' LYS . . . . . . . . . . . . . 30.8 tttp -94.15 -52.71 4.26 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 115.886 -0.597 . . . . 0.0 110.046 -178.22 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' D' D ' 85' ' ' ASP . . . . . . . . . . . . . 6.4 t70 -156.98 154.84 30.28 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 115.767 -0.651 . . . . 0.0 110.167 179.021 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' D' D ' 86' ' ' VAL . . . . . . . . . . . . . 44.5 t -128.72 133.61 66.05 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.219 0 CA-C-O 121.046 0.451 . . . . 0.0 110.791 179.964 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' D' D ' 87' ' ' ILE . . . . . . . . . . . . . 44.2 mm -114.62 122.39 68.64 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.249 0 CA-C-N 115.619 -0.718 . . . . 0.0 109.216 175.304 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' D' D ' 88' ' ' LEU . . . . . 0.652 HD12 HD13 ' C' ' 124' ' ' LEU . 34.8 mt -110.92 134.07 52.86 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-O 121.085 0.469 . . . . 0.0 111.34 -176.013 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' D' D ' 89' ' ' ASP . . . . . . . . . . . . . 9.8 t70 -131.92 154.94 48.74 Favored 'General case' 0 C--N 1.331 -0.211 0 CA-C-N 115.793 -0.639 . . . . 0.0 109.508 175.686 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' D' D ' 90' ' ' GLU . . . . . . . . . . . . . 84.7 tt0 -48.33 -38.13 18.31 Favored 'General case' 0 C--N 1.329 -0.284 0 N-CA-C 112.802 0.668 . . . . 0.0 112.802 -171.902 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' D' D ' 91' ' ' ASN . . . . . . . . . . . . . 35.0 m120 -132.0 36.74 3.64 Favored 'General case' 0 N--CA 1.466 0.328 0 N-CA-C 111.782 0.29 . . . . 0.0 111.782 -177.167 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' D' D ' 92' ' ' LEU . . . . . . . . . . . . . 12.9 tp -166.0 145.31 6.11 Favored 'General case' 0 C--N 1.332 -0.195 0 C-N-CA 120.827 -0.349 . . . . 0.0 110.91 -179.393 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' D' D ' 93' ' ' ILE . . . . . . . . . . . . . 68.1 mt -130.26 120.48 49.08 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.189 0 N-CA-C 109.579 -0.526 . . . . 0.0 109.579 -179.684 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' D' D ' 94' ' ' VAL . . . . . . . . . . . . . 46.9 t -121.66 126.13 74.31 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.253 0 N-CA-C 109.723 -0.473 . . . . 0.0 109.723 179.038 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' D' D ' 95' ' ' VAL . . . . . . . . . . . . . 44.1 t -121.16 134.79 63.4 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.236 0 CA-C-N 116.354 -0.385 . . . . 0.0 110.125 -178.902 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' D' D ' 96' ' ' ILE . . . . . . . . . . . . . 63.8 mt -113.68 128.63 70.47 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.316 0 N-CA-C 109.257 -0.646 . . . . 0.0 109.257 178.841 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' D' D ' 97' ' ' THR . . . . . . . . . . . . . 65.8 p -95.35 159.17 15.13 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-O 120.865 0.364 . . . . 0.0 110.443 179.746 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' D' D ' 98' ' ' GLU . . . . . . . . . . . . . 97.4 mt-10 -53.98 -27.5 31.91 Favored 'General case' 0 C--N 1.328 -0.36 0 N-CA-C 112.215 0.45 . . . . 0.0 112.215 -179.372 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' D' D ' 99' ' ' GLU . . . . . . . . . . . . . 45.8 mp0 -76.59 7.92 4.07 Favored 'General case' 0 CA--C 1.536 0.41 0 N-CA-C 113.502 0.927 . . . . 0.0 113.502 -176.733 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' D' D ' 100' ' ' ASN . . . . . . . . . . . . . 4.1 m-20 65.7 35.95 6.62 Favored 'General case' 0 N--CA 1.464 0.238 0 CA-C-N 118.133 0.424 . . . . 0.0 111.335 -178.064 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' D' D ' 101' ' ' GLU . . . . . . . . . . . . . 85.2 tt0 -109.93 142.68 40.94 Favored 'General case' 0 C--N 1.332 -0.179 0 N-CA-C 109.361 -0.607 . . . . 0.0 109.361 172.187 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' D' D ' 102' ' ' VAL . . . . . . . . . . . . . 44.5 t -115.02 126.86 72.72 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.312 0 CA-C-N 116.39 -0.368 . . . . 0.0 110.229 -175.84 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' D' D ' 103' ' ' LEU . . . . . . . . . . . . . 39.3 mt -116.62 129.91 56.43 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 115.678 -0.692 . . . . 0.0 109.897 175.629 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' D' D ' 104' ' ' ILE . . . . . . . . . . . . . 66.6 mt -117.7 124.41 73.02 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.259 0 N-CA-C 110.079 -0.341 . . . . 0.0 110.079 -179.996 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' D' D ' 105' ' ' PHE . . . . . . . . . . . . . 52.9 m-85 -123.72 163.54 20.91 Favored 'General case' 0 C--N 1.333 -0.142 0 O-C-N 123.963 0.79 . . . . 0.0 109.72 -179.376 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' D' D ' 106' ' ' ASN . . . . . . . . . . . . . 45.1 p-10 -97.86 -170.41 1.98 Allowed 'General case' 0 C--N 1.33 -0.281 0 N-CA-C 109.859 -0.422 . . . . 0.0 109.859 175.073 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' D' D ' 107' ' ' GLN . . . . . . . . . . . . . 62.4 tt0 -58.37 -30.04 66.46 Favored 'General case' 0 C--N 1.329 -0.297 0 N-CA-C 111.771 0.286 . . . . 0.0 111.771 179.097 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' D' D ' 108' ' ' ASN . . . . . . . . . . . . . 18.0 t30 -83.8 6.86 19.78 Favored 'General case' 0 CA--C 1.537 0.442 0 N-CA-C 113.389 0.885 . . . . 0.0 113.389 -176.53 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' D' D ' 109' ' ' LEU . . . . . 0.534 HD21 ' HB2' ' D' ' 78' ' ' ALA . 11.0 tp 62.37 37.54 13.68 Favored 'General case' 0 C--O 1.232 0.152 0 CA-C-O 120.957 0.408 . . . . 0.0 111.29 177.972 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' D' D ' 110' ' ' GLU . . . . . . . . . . . . . 95.5 mt-10 -106.44 153.99 21.47 Favored 'General case' 0 C--N 1.331 -0.198 0 CA-C-N 116.518 -0.31 . . . . 0.0 110.198 176.487 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' D' D ' 111' ' ' GLU . . . . . . . . . . . . . 85.0 tt0 -82.31 121.89 27.26 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.366 -0.379 . . . . 0.0 110.761 -177.721 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' D' D ' 112' ' ' LEU . . . . . . . . . . . . . 16.1 mt -110.44 -46.13 3.45 Favored 'General case' 0 C--N 1.331 -0.214 0 CA-C-N 116.198 -0.456 . . . . 0.0 110.723 179.367 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' D' D ' 113' ' ' TYR . . . . . . . . . . . . . 49.2 t80 -136.4 138.25 41.36 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-N 116.361 -0.381 . . . . 0.0 111.106 -179.104 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' D' D ' 114' ' ' ARG . . . . . . . . . . . . . 60.2 ttp180 -137.25 121.72 18.33 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 115.995 -0.548 . . . . 0.0 110.205 176.438 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' D' D ' 115' ' ' GLY . . . . . . . . . . . . . . . -150.05 162.2 29.12 Favored Glycine 0 CA--C 1.523 0.548 0 N-CA-C 110.481 -1.048 . . . . 0.0 110.481 178.903 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' D' D ' 116' ' ' LYS . . . . . . . . . . . . . 54.6 tttm -137.61 133.81 34.81 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.917 0.359 . . . . 0.0 110.219 -179.824 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' D' D ' 117' ' ' PHE . . . . . . . . . . . . . 38.5 m-85 -129.27 115.43 17.6 Favored 'General case' 0 C--N 1.331 -0.2 0 CA-C-O 120.901 0.381 . . . . 0.0 110.393 -175.689 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' D' D ' 118' ' ' GLU . . . . . . . . . . . . . 46.0 tp10 -52.86 -49.86 64.94 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.462 -0.336 . . . . 0.0 111.492 -176.792 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' D' D ' 119' ' ' ASN . . . . . . . . . . . . . 31.3 m120 -94.75 31.07 1.89 Allowed 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.257 -0.429 . . . . 0.0 112.138 -174.099 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' D' D ' 120' ' ' LEU . . . . . . . . . . . . . 17.9 tp -54.87 121.67 9.15 Favored 'General case' 0 C--N 1.332 -0.166 0 CA-C-O 120.698 0.285 . . . . 0.0 110.809 179.078 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' D' D ' 121' ' ' ASN . . . . . . . . . . . . . 15.0 m120 -114.03 -44.07 3.19 Favored 'General case' 0 C--N 1.331 -0.217 0 CA-C-N 116.356 -0.384 . . . . 0.0 110.909 -178.3 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' D' D ' 122' ' ' LYS . . . . . . . . . . . . . 59.9 mtpt -142.91 148.77 37.49 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-O 121.066 0.46 . . . . 0.0 111.74 -176.98 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' D' D ' 123' ' ' VAL . . . . . . . . . . . . . 44.5 t -131.33 128.2 61.11 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.246 0 CA-C-N 115.857 -0.611 . . . . 0.0 109.428 173.765 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' D' D ' 124' ' ' LEU . . . . . . . . . . . . . 60.8 mt -121.52 134.89 55.05 Favored 'General case' 0 C--N 1.331 -0.203 0 CA-C-N 116.357 -0.383 . . . . 0.0 110.558 -178.417 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' D' D ' 125' ' ' VAL . . . . . . . . . . . . . 40.8 t -130.19 131.8 65.54 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.266 0 CA-C-N 116.315 -0.402 . . . . 0.0 110.129 -179.785 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' D' D ' 126' ' ' ARG . . . . . . . . . . . . . 96.2 mtt-85 -140.08 117.69 11.55 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.333 -0.394 . . . . 0.0 110.627 178.487 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' D' D ' 127' ' ' ASN . . . . . . . . . . . . . 82.8 m-20 51.27 -104.96 0.18 Allowed 'General case' 0 CA--C 1.544 0.746 0 CA-C-O 119.032 -0.509 . . . . 0.0 111.408 178.718 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' D' D ' 128' ' ' ASP . . . . . . . . . . . . . 22.8 p-10 -114.03 1.1 14.54 Favored 'General case' 0 N--CA 1.468 0.473 0 CA-C-N 119.518 1.054 . . . . 0.0 113.489 -177.467 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' D' D ' 129' ' ' LEU . . . . . . . . . . . . . 44.7 mt -105.01 141.03 37.32 Favored 'General case' 0 C--O 1.231 0.129 0 CA-C-N 118.105 0.411 . . . . 0.0 110.078 179.245 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' D' D ' 130' ' ' VAL . . . . . . . . . . . . . 44.3 t -126.15 137.63 57.14 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.247 0 CA-C-N 116.388 -0.369 . . . . 0.0 110.153 -178.203 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' D' D ' 131' ' ' VAL . . . . . 0.463 HG21 ' CD1' ' E' ' 88' ' ' LEU . 44.2 t -134.13 134.17 55.48 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.324 0 CA-C-O 121.005 0.431 . . . . 0.0 110.011 177.629 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' D' D ' 132' ' ' ILE . . . . . . . . . . . . . 68.0 mt -117.28 133.61 63.48 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.297 0 CA-C-N 115.919 -0.582 . . . . 0.0 109.49 179.927 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' D' D ' 133' ' ' ILE . . . . . . . . . . . . . 37.1 mm -117.05 120.89 66.43 Favored 'Isoleucine or valine' 0 C--O 1.233 0.206 0 CA-C-O 120.682 0.277 . . . . 0.0 111.093 -175.218 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' D' D ' 134' ' ' ASP . . . . . . . . . . . . . 8.1 p-10 -132.91 147.06 52.29 Favored 'General case' 0 C--N 1.331 -0.234 0 N-CA-C 109.276 -0.638 . . . . 0.0 109.276 174.403 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' D' D ' 135' ' ' GLU . . . . . . . . . . . . . 84.4 tt0 -49.91 -26.42 4.11 Favored 'General case' 0 C--N 1.329 -0.316 0 N-CA-C 112.9 0.704 . . . . 0.0 112.9 -172.222 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' D' D ' 136' ' ' GLN . . . . . . . . . . . . . 31.4 tt0 -83.61 -34.29 25.15 Favored 'General case' 0 C--N 1.331 -0.224 0 N-CA-C 112.399 0.518 . . . . 0.0 112.399 -175.559 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' D' D ' 137' ' ' LYS . . . . . . . . . . . . . 20.5 pttp -168.35 172.37 8.47 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-O 121.544 0.688 . . . . 0.0 112.221 -172.076 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' D' D ' 138' ' ' LEU . . . . . 0.403 ' C ' HD23 ' D' ' 138' ' ' LEU . 7.7 tt -120.03 131.16 55.03 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 115.093 -0.958 . . . . 0.0 110.258 -178.46 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' D' D ' 139' ' ' THR . . . . . . . . . . . . . 33.8 m -109.04 130.08 55.47 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 116.133 -0.485 . . . . 0.0 110.675 -179.497 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' D' D ' 140' ' ' LEU . . . . . 0.428 HD12 HG22 ' D' ' 131' ' ' VAL . 27.1 tp -114.9 121.15 42.32 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 115.765 -0.652 . . . . 0.0 109.315 -179.201 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' D' D ' 141' ' ' ILE . . . . . . . . . . . . . 19.5 mt -119.85 121.96 67.41 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.222 0 N-CA-C 109.858 -0.423 . . . . 0.0 109.858 -175.158 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' D' D ' 142' ' ' ARG . . . . . . . . . . . . . 81.5 mtm180 -116.61 131.59 56.91 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 115.496 -0.775 . . . . 0.0 110.299 -176.823 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' D' D ' 143' ' ' THR . . . . . . . . . . . . . 59.5 p . . . . . 0 C--O 1.221 -0.421 0 CA-C-O 118.044 -0.979 . . . . 0.0 110.62 -179.819 . . . . . . . . 0 0 . 1 . 011 nuclear nobuild full ' E' E ' -3' ' ' GLU . . . . . . . . . . . . . 95.6 mt-10 . . . . . 0 N--CA 1.489 1.503 0 N-CA-C 109.359 -0.608 . . . . 0.0 109.359 . . . . . . . . . 0 0 . 1 . 011 nuclear nobuild full ' E' E ' -2' ' ' GLY . . . . . . . . . . . . . . . -71.13 147.31 42.58 Favored Glycine 0 CA--C 1.525 0.688 0 N-CA-C 111.024 -0.83 . . . . 0.0 111.024 -179.733 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' E' E ' -1' ' ' VAL . . . . . . . . . . . . . 44.8 t -96.22 137.63 23.66 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.294 0 N-CA-C 109.918 -0.401 . . . . 0.0 109.918 179.58 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' E' E ' 0' ' ' ILE . . . . . . . . . . . . . 68.3 mt -104.38 133.09 49.42 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.263 0 CA-C-N 116.333 -0.394 . . . . 0.0 110.059 -179.479 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' E' E ' 1' ' ' MET . . . . . . . . . . . . . 25.2 ptp -86.17 150.15 24.6 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-N 116.0 -0.546 . . . . 0.0 110.788 -179.328 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' E' E ' 2' ' ' SER . . . . . . . . . . . . . 2.1 p -123.66 124.53 42.97 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.227 -0.442 . . . . 0.0 109.944 177.872 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' E' E ' 3' ' ' GLU . . . . . . . . . . . . . 80.4 tt0 -143.48 142.3 31.11 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 116.149 -0.478 . . . . 0.0 111.246 -175.384 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' E' E ' 4' ' ' LEU . . . . . . . . . . . . . 16.8 tp -122.26 132.24 54.33 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-N 116.079 -0.509 . . . . 0.0 110.163 176.172 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' E' E ' 5' ' ' LYS . . . . . . . . . . . . . 52.0 mttp -107.25 119.61 39.85 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.469 -0.332 . . . . 0.0 110.51 178.597 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' E' E ' 6' ' ' LEU . . . . . . . . . . . . . 37.6 mt -114.19 147.33 39.09 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 115.354 -0.839 . . . . 0.0 110.669 -178.571 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' E' E ' 7' ' ' LYS . . . . . . . . . . . . . 47.6 tttp -138.47 141.3 30.85 Favored Pre-proline 0 CA--C 1.534 0.343 0 CA-C-O 119.128 -0.463 . . . . 0.0 110.075 174.811 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' E' E ' 8' ' ' PRO . . . . . . . . . . . . . 73.7 Cg_endo -91.51 141.36 2.7 Favored 'Trans proline' 0 N--CA 1.49 1.298 0 C-N-CA 121.664 1.576 . . . . 0.0 111.561 176.047 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' E' E ' 9' ' ' LEU . . . . . . . . . . . . . 67.7 mt -77.2 -47.68 2.59 Favored Pre-proline 0 CA--C 1.533 0.322 0 CA-C-O 118.645 -0.693 . . . . 0.0 112.428 -179.288 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' E' E ' 10' ' ' PRO . . . . . . . . . . . . . 90.6 Cg_endo -79.98 155.36 23.09 Favored 'Trans proline' 0 N--CA 1.496 1.642 0 C-N-CA 121.282 1.321 . . . . 0.0 111.892 176.733 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' E' E ' 11' ' ' LYS . . . . . . . . . . . . . 28.2 ttpt -88.29 92.33 9.12 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-O 120.833 0.349 . . . . 0.0 110.532 178.876 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' E' E ' 12' ' ' VAL . . . . . . . . . . . . . 12.5 p -141.39 143.88 27.02 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.283 0 CA-C-N 116.241 -0.436 . . . . 0.0 110.343 178.68 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' E' E ' 13' ' ' GLU . . . . . . . . . . . . . 15.2 pt-20 -87.13 131.13 34.25 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.362 -0.381 . . . . 0.0 110.704 179.345 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' E' E ' 14' ' ' LEU . . . . . . . . . . . . . 17.5 mt -98.41 155.08 37.25 Favored Pre-proline 0 C--N 1.33 -0.266 0 CA-C-N 116.246 -0.433 . . . . 0.0 110.686 -179.967 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' E' E ' 15' ' ' PRO . . . . . . . . . . . . . 26.5 Cg_exo -61.57 160.07 29.62 Favored 'Trans proline' 0 N--CA 1.496 1.647 0 C-N-CA 121.363 1.375 . . . . 0.0 111.667 176.233 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' E' E ' 16' ' ' PRO . . . . . . . . . . . . . 34.7 Cg_exo -58.87 -40.76 68.97 Favored 'Trans proline' 0 N--CA 1.496 1.667 0 C-N-CA 121.4 1.4 . . . . 0.0 112.963 -177.304 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' E' E ' 17' ' ' ASP . . . . . . . . . . . . . 23.5 p-10 -89.01 11.33 18.58 Favored 'General case' 0 C--N 1.326 -0.417 0 N-CA-C 113.156 0.799 . . . . 0.0 113.156 -177.175 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' E' E ' 18' ' ' PHE . . . . . . . . . . . . . 47.1 t80 -58.04 -43.75 87.0 Favored 'General case' 0 C--N 1.334 -0.1 0 O-C-N 121.944 -0.473 . . . . 0.0 109.972 -179.619 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' E' E ' 19' ' ' VAL . . . . . . . . . . . . . 47.8 t -57.54 -39.3 68.51 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.309 0 CA-C-N 116.028 -0.533 . . . . 0.0 110.406 179.206 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' E' E ' 20' ' ' ASP . . . . . . . . . . . . . 28.3 t0 -58.94 -43.61 91.26 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-O 120.691 0.281 . . . . 0.0 110.579 -178.507 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' E' E ' 21' ' ' VAL . . . . . . . . . . . . . 52.4 t -64.22 -45.14 97.13 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.326 0 C-N-CA 120.689 -0.404 . . . . 0.0 110.354 -178.642 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' E' E ' 22' ' ' ILE . . . . . 0.687 HG22 HD12 ' E' ' 26' ' ' LEU . 49.3 mm -58.93 -41.59 83.48 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.327 0 C-N-CA 120.969 -0.292 . . . . 0.0 110.908 -179.929 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' E' E ' 23' ' ' ARG . . . . . . . . . . . . . 42.6 ttp180 -57.07 -47.02 82.01 Favored 'General case' 0 C--N 1.331 -0.209 0 C-N-CA 120.7 -0.4 . . . . 0.0 110.522 178.899 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' E' E ' 24' ' ' ILE . . . . . . . . . . . . . 79.6 mt -61.63 -44.95 99.5 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.302 0 CA-C-N 116.153 -0.476 . . . . 0.0 111.88 -178.559 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' E' E ' 25' ' ' LYS . . . . . . . . . . . . . 13.6 pttp -70.1 -36.21 74.71 Favored 'General case' 0 CA--C 1.533 0.307 0 C-N-CA 120.487 -0.485 . . . . 0.0 111.61 -173.729 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' E' E ' 26' ' ' LEU . . . . . 0.687 HD12 HG22 ' E' ' 22' ' ' ILE . 20.7 mt -79.05 -40.52 31.11 Favored 'General case' 0 C--N 1.33 -0.254 0 N-CA-C 112.86 0.689 . . . . 0.0 112.86 -174.482 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' E' E ' 27' ' ' GLN . . . . . . . . . . . . . 8.4 pt20 -47.32 139.47 6.36 Favored 'General case' 0 N--CA 1.467 0.4 0 N-CA-C 112.795 0.665 . . . . 0.0 112.795 -174.644 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' E' E ' 28' ' ' GLY . . . . . . . . . . . . . . . 98.77 -26.63 23.29 Favored Glycine 0 CA--C 1.534 1.239 0 CA-C-N 115.582 -0.736 . . . . 0.0 112.184 -176.021 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' E' E ' 29' ' ' LYS . . . . . . . . . . . . . 98.8 mttt -98.07 155.2 17.24 Favored 'General case' 0 C--O 1.233 0.202 0 CA-C-N 117.116 0.458 . . . . 0.0 111.154 179.21 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' E' E ' 30' ' ' THR . . . . . . . . . . . . . 24.6 m -104.82 137.11 43.1 Favored 'General case' 0 C--N 1.332 -0.186 0 CA-C-N 115.851 -0.613 . . . . 0.0 109.79 174.643 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' E' E ' 31' ' ' VAL . . . . . . . . . . . . . 34.9 m -127.94 159.37 39.01 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.19 0 CA-C-N 116.416 -0.356 . . . . 0.0 110.747 -178.185 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' E' E ' 32' ' ' ARG . . . . . . . . . . . . . 73.9 mtt85 -133.79 149.42 51.42 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-O 121.394 0.616 . . . . 0.0 110.773 179.241 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' E' E ' 33' ' ' THR . . . . . . . . . . . . . 18.4 m -53.54 140.09 29.47 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.143 -0.48 . . . . 0.0 111.18 -179.327 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' E' E ' 34' ' ' GLY . . . . . . . . . . . . . . . 100.69 -17.23 56.82 Favored Glycine 0 CA--C 1.533 1.164 0 CA-C-O 119.622 -0.544 . . . . 0.0 113.151 179.517 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' E' E ' 35' ' ' ASP . . . . . . . . . . . . . 77.1 m-20 -65.78 147.51 53.27 Favored 'General case' 0 C--N 1.333 -0.121 0 CA-C-N 118.058 0.929 . . . . 0.0 111.067 178.764 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' E' E ' 36' ' ' VAL . . . . . . . . . . . . . 45.3 t -125.02 131.71 72.21 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.245 0 CA-C-N 115.843 -0.617 . . . . 0.0 109.874 178.455 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' E' E ' 37' ' ' ILE . . . . . . . . . . . . . 68.1 mt -122.46 139.18 50.17 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.26 0 CA-C-N 116.331 -0.395 . . . . 0.0 109.948 -179.79 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' E' E ' 38' ' ' GLY . . . . . . . . . . . . . . . -111.79 128.63 8.7 Favored Glycine 0 CA--C 1.525 0.714 0 N-CA-C 111.243 -0.743 . . . . 0.0 111.243 179.928 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' E' E ' 39' ' ' ILE . . . . . . . . . . . . . 73.1 mt -127.74 129.94 70.14 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.229 0 N-CA-C 109.984 -0.376 . . . . 0.0 109.984 178.512 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' E' E ' 40' ' ' SER . . . . . . . . . . . . . 43.4 t -92.25 113.91 26.31 Favored 'General case' 0 C--N 1.329 -0.303 0 C-N-CA 120.997 -0.281 . . . . 0.0 110.92 177.501 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' E' E ' 41' ' ' ILE . . . . . . . . . . . . . 45.2 mm -123.06 124.45 70.24 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.207 0 N-CA-C 109.864 -0.421 . . . . 0.0 109.864 179.853 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' E' E ' 42' ' ' LEU . . . . . . . . . . . . . 55.6 mt 57.48 34.47 24.66 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.35 -0.387 . . . . 0.0 111.681 178.755 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' E' E ' 43' ' ' GLY . . . . . . . . . . . . . . . 77.6 -10.1 25.67 Favored Glycine 0 CA--C 1.535 1.314 0 C-N-CA 121.297 -0.478 . . . . 0.0 113.396 177.601 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' E' E ' 44' ' ' LYS . . . . . . . . . . . . . 60.2 tttm -101.65 130.29 47.97 Favored 'General case' 0 C--N 1.332 -0.172 0 CA-C-N 117.976 0.888 . . . . 0.0 109.814 177.396 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' E' E ' 45' ' ' GLU . . . . . . . . . . . . . 39.6 tp10 -83.8 128.72 34.74 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.389 -0.369 . . . . 0.0 110.813 -178.57 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' E' E ' 46' ' ' VAL . . . . . . . . . . . . . 7.3 p -120.64 132.24 70.72 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.277 0 N-CA-C 109.659 -0.497 . . . . 0.0 109.659 177.509 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' E' E ' 47' ' ' LYS . . . . . . . . . . . . . 62.5 mttp -100.72 127.95 46.95 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 115.929 -0.578 . . . . 0.0 111.088 177.245 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' E' E ' 48' ' ' PHE . . . . . . . . . . . . . 92.4 m-85 -109.61 131.73 54.79 Favored 'General case' 0 C--N 1.329 -0.298 0 N-CA-C 109.57 -0.53 . . . . 0.0 109.57 175.304 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' E' E ' 49' ' ' LYS . . . . . . . . . . . . . 47.5 tttp -111.57 139.12 47.28 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.661 -0.245 . . . . 0.0 110.656 -179.953 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' E' E ' 50' ' ' VAL . . . . . . . . . . . . . 45.1 t -83.49 108.42 16.03 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.307 0 N-CA-C 109.34 -0.615 . . . . 0.0 109.34 175.731 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' E' E ' 51' ' ' VAL . . . . . . . . . . . . . 46.7 t -74.2 -50.84 25.83 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.305 0 CA-C-N 116.117 -0.492 . . . . 0.0 109.955 -174.461 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' E' E ' 52' ' ' GLN . . . . . . . . . . . . . 92.2 mt-30 -152.69 152.7 32.03 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-O 121.18 0.514 . . . . 0.0 111.766 -178.54 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' E' E ' 53' ' ' ALA . . . . . . . . . . . . . . . -130.69 131.89 45.08 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 115.213 -0.903 . . . . 0.0 109.762 175.644 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' E' E ' 54' ' ' TYR . . . . . . . . . . . . . 39.5 t80 -129.07 108.96 18.09 Favored Pre-proline 0 CA--C 1.535 0.398 0 CA-C-O 118.306 -0.854 . . . . 0.0 110.277 179.348 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' E' E ' 55' ' ' PRO . . . . . . . . . . . . . 73.7 Cg_endo -77.27 169.28 74.53 Favored 'Cis proline' 0 N--CA 1.499 1.825 0 CA-C-N 121.829 1.689 . . . . 0.0 112.384 -4.473 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' E' E ' 56' ' ' SER . . . . . . . . . . . . . 14.5 m -113.88 122.62 34.44 Favored Pre-proline 0 CA--C 1.539 0.535 0 CA-C-O 118.309 -0.853 . . . . 0.0 109.372 175.275 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' E' E ' 57' ' ' PRO . . . . . . . . . . . . . 42.0 Cg_endo -67.72 167.96 59.48 Favored 'Cis proline' 0 N--CA 1.498 1.787 0 CA-C-N 122.104 1.787 . . . . 0.0 112.076 2.004 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' E' E ' 58' ' ' LEU . . . . . . . . . . . . . 25.6 tp -130.05 137.96 50.5 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-N 115.915 -0.584 . . . . 0.0 110.317 179.875 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' E' E ' 59' ' ' ARG . . . . . . . . . . . . . 66.6 ttt180 -102.36 134.34 45.82 Favored 'General case' 0 C--N 1.329 -0.298 0 N-CA-C 109.671 -0.492 . . . . 0.0 109.671 176.267 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' E' E ' 60' ' ' VAL . . . . . . . . . . . . . 41.1 t -90.34 122.53 41.81 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.192 0 C-N-CA 120.586 -0.446 . . . . 0.0 110.614 -177.851 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' E' E ' 61' ' ' GLU . . . . . . . . . . . . . 77.5 tt0 -131.06 158.14 41.17 Favored 'General case' 0 C--N 1.33 -0.269 0 N-CA-C 109.069 -0.715 . . . . 0.0 109.069 176.696 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' E' E ' 62' ' ' ASP . . . . . . . . . . . . . 64.2 m-20 -52.98 -34.3 55.46 Favored 'General case' 0 C--N 1.328 -0.355 0 N-CA-C 111.686 0.254 . . . . 0.0 111.686 -179.03 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' E' E ' 63' ' ' ARG . . . . . . . . . . . . . 22.6 mmt85 -78.67 -13.02 60.03 Favored 'General case' 0 CA--C 1.535 0.37 0 N-CA-C 113.384 0.883 . . . . 0.0 113.384 -178.549 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' E' E ' 64' ' ' THR . . . . . . . . . . . . . 18.2 m -64.58 146.71 54.23 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-O 120.977 0.417 . . . . 0.0 111.022 -175.654 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' E' E ' 65' ' ' LYS . . . . . . . . . . . . . 22.6 mtpp -86.32 127.2 34.76 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 115.736 -0.665 . . . . 0.0 110.32 -179.883 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' E' E ' 66' ' ' ILE . . . . . . . . . . . . . 60.4 mt -118.2 128.09 75.28 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.307 0 N-CA-C 109.774 -0.454 . . . . 0.0 109.774 178.458 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' E' E ' 67' ' ' THR . . . . . . . . . . . . . 30.7 m -125.88 144.16 50.78 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-O 121.052 0.453 . . . . 0.0 111.168 -176.989 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' E' E ' 68' ' ' LEU . . . . . . . . . . . . . 13.4 tp -104.86 135.66 45.81 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 115.754 -0.657 . . . . 0.0 110.192 179.098 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' E' E ' 69' ' ' VAL . . . . . . . . . . . . . 37.5 t -83.07 146.29 7.22 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.323 0 CA-C-O 121.009 0.433 . . . . 0.0 110.759 -178.607 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' E' E ' 70' ' ' THR . . . . . . . . . . . . . 68.0 p -85.76 174.59 9.24 Favored 'General case' 0 C--N 1.331 -0.2 0 CA-C-N 115.817 -0.629 . . . . 0.0 110.873 -178.978 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' E' E ' 71' ' ' HIS . . . . . . . . . . . . . 73.6 m-70 -67.65 153.4 95.09 Favored Pre-proline 0 CA--C 1.533 0.292 0 CA-C-N 115.955 -0.566 . . . . 0.0 111.207 -177.807 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' E' E ' 72' ' ' PRO . . . . . . . . . . . . . 72.2 Cg_endo -93.25 160.0 2.54 Favored 'Trans proline' 0 N--CA 1.49 1.267 0 C-N-CA 122.045 1.83 . . . . 0.0 112.564 178.189 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' E' E ' 73' ' ' VAL . . . . . . . . . . . . . 35.3 m -70.84 -173.78 0.11 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.228 0 CA-C-N 116.202 -0.454 . . . . 0.0 110.315 176.95 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' E' E ' 74' ' ' ASP . . . . . . . . . . . . . 22.0 t0 -104.04 125.04 50.09 Favored 'General case' 0 C--N 1.332 -0.191 0 C-N-CA 121.02 -0.272 . . . . 0.0 110.27 -178.885 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' E' E ' 75' ' ' VAL . . . . . . . . . . . . . 46.3 t -121.48 124.12 71.09 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.258 0 CA-C-O 121.049 0.452 . . . . 0.0 110.691 -178.86 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' E' E ' 76' ' ' LEU . . . . . 0.438 ' N ' HD12 ' E' ' 76' ' ' LEU . 6.4 mp -121.39 149.21 43.31 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-N 115.764 -0.653 . . . . 0.0 109.787 176.027 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' E' E ' 77' ' ' GLU . . . . . . . . . . . . . 97.1 mt-10 -138.38 134.45 34.18 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-O 121.028 0.442 . . . . 0.0 111.214 -179.604 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' E' E ' 78' ' ' ALA . . . . . 0.656 ' HB2' HD21 ' E' ' 109' ' ' LEU . . . -121.33 136.18 55.0 Favored 'General case' 0 C--N 1.331 -0.21 0 CA-C-N 115.763 -0.653 . . . . 0.0 109.773 176.709 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' E' E ' 79' ' ' LYS . . . . . 0.635 ' O ' HD13 ' E' ' 80' ' ' ILE . 40.7 mttm -81.4 117.3 21.74 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-O 120.828 0.347 . . . . 0.0 110.949 -177.478 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' E' E ' 80' ' ' ILE . . . . . 0.635 HD13 ' O ' ' E' ' 79' ' ' LYS . 38.4 mm -139.28 106.07 2.68 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.27 0 N-CA-C 109.164 -0.68 . . . . 0.0 109.164 -179.475 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' E' E ' 81' ' ' LYS . . . . . . . . . . . . . 42.4 mtmt -99.61 126.74 45.66 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-O 121.041 0.448 . . . . 0.0 111.056 -177.992 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' E' E ' 82' ' ' GLY . . . . . . . . . . . . . . . 89.1 42.23 5.66 Favored Glycine 0 CA--C 1.525 0.695 0 C-N-CA 120.881 -0.676 . . . . 0.0 111.615 176.34 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' E' E ' 83' ' ' ILE . . . . . . . . . . . . . 75.3 mt -68.93 137.09 25.03 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.271 0 N-CA-C 109.734 -0.469 . . . . 0.0 109.734 177.149 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' E' E ' 84' ' ' LYS . . . . . . . . . . . . . 29.8 ttmt -92.49 -51.65 5.03 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-O 121.091 0.472 . . . . 0.0 109.8 -179.958 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' E' E ' 85' ' ' ASP . . . . . . . . . . . . . 5.8 t70 -156.19 152.26 27.63 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 115.492 -0.776 . . . . 0.0 110.234 -179.93 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' E' E ' 86' ' ' VAL . . . . . . . . . . . . . 44.1 t -128.07 130.62 69.75 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.27 0 CA-C-O 120.866 0.365 . . . . 0.0 110.258 179.718 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' E' E ' 87' ' ' ILE . . . . . . . . . . . . . 45.4 mm -117.3 124.19 72.73 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.291 0 CA-C-N 115.907 -0.588 . . . . 0.0 109.5 176.771 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' E' E ' 88' ' ' LEU . . . . . 0.463 ' CD1' HG21 ' D' ' 131' ' ' VAL . 13.4 tp -113.64 131.92 55.96 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-O 121.144 0.497 . . . . 0.0 111.218 -175.75 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' E' E ' 89' ' ' ASP . . . . . . . . . . . . . 9.5 t70 -125.94 153.92 43.58 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 115.63 -0.714 . . . . 0.0 109.312 174.679 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' E' E ' 90' ' ' GLU . . . . . . . . . . . . . 96.2 mt-10 -49.05 -34.55 13.77 Favored 'General case' 0 C--N 1.328 -0.367 0 N-CA-C 112.804 0.668 . . . . 0.0 112.804 -172.402 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' E' E ' 91' ' ' ASN . . . . . . . . . . . . . 85.1 m-20 -132.08 33.03 3.95 Favored 'General case' 0 N--CA 1.465 0.3 0 N-CA-C 112.099 0.407 . . . . 0.0 112.099 -176.285 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' E' E ' 92' ' ' LEU . . . . . . . . . . . . . 14.2 tp -166.05 143.8 5.53 Favored 'General case' 0 C--N 1.331 -0.231 0 C-N-CA 120.994 -0.282 . . . . 0.0 110.819 179.767 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' E' E ' 93' ' ' ILE . . . . . . . . . . . . . 69.9 mt -124.45 118.6 54.05 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.244 0 N-CA-C 109.577 -0.527 . . . . 0.0 109.577 179.863 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' E' E ' 94' ' ' VAL . . . . . 0.489 HG21 HG21 ' E' ' 125' ' ' VAL . 46.4 t -118.75 125.77 74.7 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.213 0 N-CA-C 109.73 -0.47 . . . . 0.0 109.73 179.333 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' E' E ' 95' ' ' VAL . . . . . . . . . . . . . 41.8 t -122.97 133.71 68.25 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.356 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.03 -179.08 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' E' E ' 96' ' ' ILE . . . . . . . . . . . . . 60.9 mt -115.42 127.79 72.87 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.324 0 N-CA-C 109.217 -0.66 . . . . 0.0 109.217 178.658 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' E' E ' 97' ' ' THR . . . . . . . . . . . . . 68.2 p -99.56 155.42 17.59 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-O 120.98 0.419 . . . . 0.0 110.678 -178.876 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' E' E ' 98' ' ' GLU . . . . . . . . . . . . . 45.2 mt-10 -55.64 -23.58 28.72 Favored 'General case' 0 CA--C 1.533 0.325 0 N-CA-C 112.366 0.506 . . . . 0.0 112.366 -179.717 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' E' E ' 99' ' ' GLU . . . . . . . . . . . . . 96.4 mt-10 -76.95 13.06 1.14 Allowed 'General case' 0 CA--C 1.536 0.431 0 N-CA-C 113.192 0.812 . . . . 0.0 113.192 -179.273 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' E' E ' 100' ' ' ASN . . . . . . . . . . . . . 4.0 m-20 63.69 38.07 9.63 Favored 'General case' 0 CA--C 1.529 0.149 0 CA-C-O 121.065 0.459 . . . . 0.0 111.076 178.129 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' E' E ' 101' ' ' GLU . . . . . . . . . . . . . 85.3 tt0 -118.58 144.15 46.3 Favored 'General case' 0 C--N 1.333 -0.134 0 CA-C-N 115.922 -0.581 . . . . 0.0 109.731 176.064 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' E' E ' 102' ' ' VAL . . . . . . . . . . . . . 47.2 t -116.13 127.58 73.69 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.238 0 CA-C-N 116.307 -0.406 . . . . 0.0 110.221 -177.244 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' E' E ' 103' ' ' LEU . . . . . . . . . . . . . 27.9 mt -117.73 132.99 56.39 Favored 'General case' 0 C--N 1.331 -0.213 0 CA-C-N 115.632 -0.713 . . . . 0.0 110.196 176.768 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' E' E ' 104' ' ' ILE . . . . . . . . . . . . . 67.6 mt -120.99 123.35 69.92 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.238 0 N-CA-C 110.198 -0.297 . . . . 0.0 110.198 179.378 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' E' E ' 105' ' ' PHE . . . . . . . . . . . . . 55.8 m-85 -124.91 165.69 17.64 Favored 'General case' 0 C--N 1.332 -0.164 0 O-C-N 123.896 0.748 . . . . 0.0 109.813 179.278 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' E' E ' 106' ' ' ASN . . . . . . . . . . . . . 47.3 p-10 -101.84 -170.96 1.9 Allowed 'General case' 0 C--N 1.331 -0.237 0 N-CA-C 109.966 -0.383 . . . . 0.0 109.966 173.568 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' E' E ' 107' ' ' GLN . . . . . . . . . . . . . 50.3 tt0 -58.57 -30.2 66.98 Favored 'General case' 0 C--N 1.329 -0.299 0 N-CA-C 111.998 0.37 . . . . 0.0 111.998 179.638 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' E' E ' 108' ' ' ASN . . . . . . . . . . . . . 58.1 t30 -83.11 10.79 7.39 Favored 'General case' 0 CA--C 1.537 0.463 0 N-CA-C 112.987 0.736 . . . . 0.0 112.987 -177.422 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' E' E ' 109' ' ' LEU . . . . . 0.656 HD21 ' HB2' ' E' ' 78' ' ' ALA . 8.6 tp 55.09 37.61 29.18 Favored 'General case' 0 C--N 1.332 -0.186 0 CA-C-O 121.039 0.447 . . . . 0.0 111.277 179.006 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' E' E ' 110' ' ' GLU . . . . . . . . . . . . . 70.6 mm-40 -102.9 154.94 18.71 Favored 'General case' 0 C--N 1.331 -0.235 0 N-CA-C 109.771 -0.455 . . . . 0.0 109.771 176.319 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' E' E ' 111' ' ' GLU . . . . . . . . . . . . . 85.0 tt0 -82.84 121.94 27.59 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-O 120.908 0.385 . . . . 0.0 110.598 -177.924 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' E' E ' 112' ' ' LEU . . . . . . . . . . . . . 18.8 mt -108.6 -45.92 3.76 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 115.964 -0.562 . . . . 0.0 110.38 178.34 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' E' E ' 113' ' ' TYR . . . . . . . . . . . . . 64.2 t80 -142.03 139.96 32.48 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.37 -0.377 . . . . 0.0 111.573 -179.9 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' E' E ' 114' ' ' ARG . . . . . . . . . . . . . 59.3 ttp180 -140.71 121.93 14.83 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.031 -0.531 . . . . 0.0 110.104 176.835 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' E' E ' 115' ' ' GLY . . . . . . . . . . . . . . . -150.06 161.35 28.87 Favored Glycine 0 CA--C 1.525 0.698 0 N-CA-C 111.296 -0.721 . . . . 0.0 111.296 178.563 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' E' E ' 116' ' ' LYS . . . . . . . . . . . . . 40.0 ttpt -130.9 140.7 50.23 Favored 'General case' 0 C--N 1.331 -0.215 0 N-CA-C 110.253 -0.277 . . . . 0.0 110.253 179.002 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' E' E ' 117' ' ' PHE . . . . . . . . . . . . . 30.3 m-85 -139.11 114.01 9.33 Favored 'General case' 0 C--N 1.331 -0.214 0 C-N-CA 120.839 -0.344 . . . . 0.0 110.188 -178.517 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' E' E ' 118' ' ' GLU . . . . . . . . . . . . . 95.9 mt-10 -54.83 -41.44 70.7 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 116.47 -0.332 . . . . 0.0 111.216 -176.401 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' E' E ' 119' ' ' ASN . . . . . . . . . . . . . 28.4 m120 -100.36 30.96 3.6 Favored 'General case' 0 C--N 1.33 -0.249 0 N-CA-C 112.176 0.435 . . . . 0.0 112.176 -174.016 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' E' E ' 120' ' ' LEU . . . . . . . . . . . . . 24.8 tp -57.57 119.98 7.51 Favored 'General case' 0 C--N 1.332 -0.155 0 C-N-CA 120.903 -0.319 . . . . 0.0 110.179 177.546 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' E' E ' 121' ' ' ASN . . . . . . . . . . . . . 21.1 m120 -114.19 -44.02 3.17 Favored 'General case' 0 N--CA 1.462 0.149 0 CA-C-N 116.553 -0.294 . . . . 0.0 111.319 -176.708 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' E' E ' 122' ' ' LYS . . . . . . . . . . . . . 35.8 mtmm -140.17 146.29 38.57 Favored 'General case' 0 C--N 1.331 -0.224 0 CA-C-O 121.032 0.444 . . . . 0.0 111.618 -175.825 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' E' E ' 123' ' ' VAL . . . . . . . . . . . . . 44.3 t -128.58 130.81 69.05 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.269 0 CA-C-N 115.998 -0.547 . . . . 0.0 109.796 177.038 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' E' E ' 124' ' ' LEU . . . . . . . . . . . . . 45.9 mt -123.39 129.7 51.66 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-N 116.49 -0.323 . . . . 0.0 110.597 179.645 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' E' E ' 125' ' ' VAL . . . . . 0.489 HG21 HG21 ' E' ' 94' ' ' VAL . 42.2 t -132.71 126.72 54.94 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.248 0 CA-C-N 116.231 -0.44 . . . . 0.0 109.982 178.68 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' E' E ' 126' ' ' ARG . . . . . . . . . . . . . 51.8 mmm-85 -140.05 125.14 18.63 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-O 120.918 0.389 . . . . 0.0 110.329 177.996 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' E' E ' 127' ' ' ASN . . . . . . . . . . . . . 67.3 m-80 51.25 -111.61 0.56 Allowed 'General case' 0 CA--C 1.546 0.794 0 CA-C-O 118.598 -0.715 . . . . 0.0 111.172 179.817 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' E' E ' 128' ' ' ASP . . . . . . . . . . . . . 11.6 p-10 -114.14 9.97 17.28 Favored 'General case' 0 CA--C 1.535 0.384 0 CA-C-N 120.089 1.313 . . . . 0.0 113.26 -178.357 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' E' E ' 129' ' ' LEU . . . . . . . . . . . . . 17.2 tp -109.52 138.33 46.05 Favored 'General case' 0 C--O 1.233 0.216 0 O-C-N 121.987 -0.445 . . . . 0.0 110.053 179.199 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' E' E ' 130' ' ' VAL . . . . . . . . . . . . . 41.2 t -125.02 137.19 58.43 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.226 0 CA-C-O 120.958 0.409 . . . . 0.0 110.494 -176.802 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' E' E ' 131' ' ' VAL . . . . . 0.517 HG22 HD12 ' E' ' 140' ' ' LEU . 41.8 t -135.82 136.68 49.9 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.259 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.242 177.39 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' E' E ' 132' ' ' ILE . . . . . . . . . . . . . 71.6 mt -118.3 132.98 66.58 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.337 0 CA-C-N 115.886 -0.597 . . . . 0.0 109.446 -179.031 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' E' E ' 133' ' ' ILE . . . . . . . . . . . . . 40.3 mm -117.16 123.77 72.22 Favored 'Isoleucine or valine' 0 C--O 1.233 0.214 0 CA-C-O 121.001 0.429 . . . . 0.0 111.053 -174.914 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' E' E ' 134' ' ' ASP . . . . . . . . . . . . . 6.7 p-10 -131.07 152.75 50.04 Favored 'General case' 0 C--N 1.332 -0.157 0 CA-C-N 116.048 -0.524 . . . . 0.0 109.786 174.723 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' E' E ' 135' ' ' GLU . . . . . . . . . . . . . 46.4 tp10 -49.93 -28.33 6.58 Favored 'General case' 0 C--N 1.328 -0.356 0 N-CA-C 112.91 0.707 . . . . 0.0 112.91 -169.263 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' E' E ' 136' ' ' GLN . . . . . . . . . . . . . 52.7 mt-30 -105.03 -24.96 12.73 Favored 'General case' 0 N--CA 1.464 0.275 0 N-CA-C 112.982 0.734 . . . . 0.0 112.982 -173.767 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' E' E ' 137' ' ' LYS . . . . . . . . . . . . . 59.6 mtpt -143.11 154.14 43.62 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-O 121.229 0.538 . . . . 0.0 111.891 -169.589 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' E' E ' 138' ' ' LEU . . . . . 0.423 ' C ' HD23 ' E' ' 138' ' ' LEU . 5.7 tt -119.09 124.18 46.27 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 115.546 -0.752 . . . . 0.0 109.378 174.587 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' E' E ' 139' ' ' THR . . . . . . . . . . . . . 30.6 m -110.39 130.54 55.53 Favored 'General case' 0 C--N 1.331 -0.229 0 CA-C-O 120.795 0.331 . . . . 0.0 110.774 -177.173 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' E' E ' 140' ' ' LEU . . . . . 0.517 HD12 HG22 ' E' ' 131' ' ' VAL . 12.6 tp -116.52 125.29 51.7 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 115.664 -0.698 . . . . 0.0 109.429 -178.093 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' E' E ' 141' ' ' ILE . . . . . . . . . . . . . 19.3 mt -122.56 117.75 52.99 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.308 0 N-CA-C 109.736 -0.468 . . . . 0.0 109.736 -177.205 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' E' E ' 142' ' ' ARG . . . . . . . . . . . . . 81.2 mtp180 -108.1 128.45 54.69 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 115.39 -0.823 . . . . 0.0 110.398 -176.473 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' E' E ' 143' ' ' THR . . . . . . . . . . . . . 77.8 p . . . . . 0 C--O 1.22 -0.459 0 CA-C-O 118.058 -0.972 . . . . 0.0 110.48 -179.994 . . . . . . . . 0 0 . 1 . 011 nuclear nobuild full ' F' F ' -3' ' ' GLU . . . . . . . . . . . . . 95.8 mt-10 . . . . . 0 N--CA 1.491 1.602 0 N-CA-C 109.38 -0.6 . . . . 0.0 109.38 . . . . . . . . . 0 0 . 1 . 011 nuclear nobuild full ' F' F ' -2' ' ' GLY . . . . . . . . . . . . . . . -70.25 130.94 22.06 Favored Glycine 0 CA--C 1.525 0.709 0 N-CA-C 110.679 -0.968 . . . . 0.0 110.679 178.454 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' F' F ' -1' ' ' VAL . . . . . . . . . . . . . 45.1 t -96.03 138.29 21.82 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.343 0 CA-C-O 120.876 0.37 . . . . 0.0 110.168 -179.327 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' F' F ' 0' ' ' ILE . . . . . . . . . . . . . 69.3 mt -105.83 125.04 61.3 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.241 0 N-CA-C 109.718 -0.475 . . . . 0.0 109.718 179.455 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' F' F ' 1' ' ' MET . . . . . . . . . . . . . 27.4 ptm -79.96 138.56 37.11 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.262 -0.426 . . . . 0.0 110.756 -179.598 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' F' F ' 2' ' ' SER . . . . . . . . . . . . . 7.4 p -118.99 133.92 55.52 Favored 'General case' 0 C--N 1.331 -0.21 0 CA-C-O 121.157 0.503 . . . . 0.0 110.356 177.9 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' F' F ' 3' ' ' GLU . . . . . . . . . . . . . 84.7 tt0 -145.19 142.32 29.46 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 115.878 -0.601 . . . . 0.0 110.965 179.951 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' F' F ' 4' ' ' LEU . . . . . . . . . . . . . 17.5 tp -121.34 128.21 52.05 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 115.84 -0.618 . . . . 0.0 109.998 176.597 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' F' F ' 5' ' ' LYS . . . . . . . . . . . . . 62.4 mttp -108.3 121.0 44.0 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.415 -0.357 . . . . 0.0 110.745 179.407 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' F' F ' 6' ' ' LEU . . . . . 0.461 HD23 ' HA ' ' F' ' 50' ' ' VAL . 23.8 mt -114.23 148.47 37.33 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 115.331 -0.85 . . . . 0.0 110.46 -179.461 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' F' F ' 7' ' ' LYS . . . . . . . . . . . . . 77.1 tttt -128.5 138.27 32.7 Favored Pre-proline 0 CA--C 1.533 0.302 0 CA-C-O 118.85 -0.595 . . . . 0.0 109.681 173.518 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' F' F ' 8' ' ' PRO . . . . . . . . . . . . . 95.7 Cg_endo -91.48 135.38 1.72 Allowed 'Trans proline' 0 N--CA 1.49 1.288 0 C-N-CA 121.727 1.618 . . . . 0.0 111.953 178.373 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' F' F ' 9' ' ' LEU . . . . . . . . . . . . . 55.6 mt -75.94 -46.98 3.85 Favored Pre-proline 0 CA--C 1.534 0.338 0 CA-C-O 118.777 -0.63 . . . . 0.0 111.725 179.639 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' F' F ' 10' ' ' PRO . . . . . . . . . . . . . 78.9 Cg_endo -82.86 149.04 13.9 Favored 'Trans proline' 0 N--CA 1.495 1.579 0 C-N-CA 121.246 1.297 . . . . 0.0 111.531 174.098 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' F' F ' 11' ' ' LYS . . . . . . . . . . . . . 53.8 pttt -86.59 112.17 21.32 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-O 121.588 0.709 . . . . 0.0 110.592 178.035 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' F' F ' 12' ' ' VAL . . . . . . . . . . . . . 12.2 p -151.15 149.22 14.32 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.253 0 CA-C-N 115.621 -0.718 . . . . 0.0 110.545 -179.673 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' F' F ' 13' ' ' GLU . . . . . . . . . . . . . 95.7 mt-10 -87.74 125.74 34.59 Favored 'General case' 0 C--N 1.329 -0.283 0 N-CA-C 109.85 -0.426 . . . . 0.0 109.85 176.224 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' F' F ' 14' ' ' LEU . . . . . . . . . . . . . 31.4 mt -97.86 150.71 37.04 Favored Pre-proline 0 C--N 1.33 -0.254 0 CA-C-O 119.407 -0.33 . . . . 0.0 110.679 -178.378 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' F' F ' 15' ' ' PRO . . . . . . . . . . . . . 28.1 Cg_exo -60.69 159.56 27.98 Favored 'Trans proline' 0 N--CA 1.497 1.702 0 C-N-CA 121.297 1.331 . . . . 0.0 112.007 177.826 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' F' F ' 16' ' ' PRO . . . . . . . . . . . . . 31.6 Cg_exo -59.76 -44.27 32.26 Favored 'Trans proline' 0 N--CA 1.497 1.689 0 C-N-CA 121.495 1.463 . . . . 0.0 112.688 -178.594 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' F' F ' 17' ' ' ASP . . . . . . . . . . . . . 9.1 p-10 -83.8 12.55 5.86 Favored 'General case' 0 CA--C 1.534 0.345 0 N-CA-C 113.156 0.799 . . . . 0.0 113.156 -177.709 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' F' F ' 18' ' ' PHE . . . . . . . . . . . . . 52.6 t80 -57.46 -43.77 84.28 Favored 'General case' 0 N--CA 1.458 -0.07 0 O-C-N 121.986 -0.447 . . . . 0.0 110.332 -178.39 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' F' F ' 19' ' ' VAL . . . . . . . . . . . . . 47.7 t -56.48 -44.06 79.5 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.302 0 CA-C-N 116.332 -0.394 . . . . 0.0 110.54 -178.11 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' F' F ' 20' ' ' ASP . . . . . . . . . . . . . 64.0 m-20 -60.01 -42.52 94.48 Favored 'General case' 0 C--N 1.329 -0.288 0 C-N-CA 120.905 -0.318 . . . . 0.0 110.951 -178.115 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' F' F ' 21' ' ' VAL . . . . . . . . . . . . . 50.6 t -64.5 -46.75 91.81 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.246 0 C-N-CA 120.745 -0.382 . . . . 0.0 110.691 -177.556 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' F' F ' 22' ' ' ILE . . . . . 0.514 HG22 HD12 ' F' ' 26' ' ' LEU . 51.4 mm -55.49 -46.79 78.95 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.224 0 C-N-CA 120.957 -0.297 . . . . 0.0 110.625 179.623 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' F' F ' 23' ' ' ARG . . . . . . . . . . . . . 55.9 ttp180 -54.8 -50.8 67.63 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-O 120.645 0.26 . . . . 0.0 111.314 -178.707 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' F' F ' 24' ' ' ILE . . . . . . . . . . . . . 75.6 mt -59.48 -41.86 86.0 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.268 0 CA-C-N 116.536 -0.302 . . . . 0.0 111.499 -176.266 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' F' F ' 25' ' ' LYS . . . . . . . . . . . . . 40.5 mmtt -66.41 -43.93 84.41 Favored 'General case' 0 C--N 1.329 -0.291 0 N-CA-C 112.468 0.544 . . . . 0.0 112.468 -178.655 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' F' F ' 26' ' ' LEU . . . . . 0.514 HD12 HG22 ' F' ' 22' ' ' ILE . 58.0 mt -78.77 -35.1 45.03 Favored 'General case' 0 C--N 1.33 -0.271 0 N-CA-C 113.77 1.026 . . . . 0.0 113.77 -169.837 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' F' F ' 27' ' ' GLN . . . . . . . . . . . . . 10.3 pt20 -47.39 139.41 6.58 Favored 'General case' 0 N--CA 1.469 0.524 0 N-CA-C 112.758 0.651 . . . . 0.0 112.758 -175.653 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' F' F ' 28' ' ' GLY . . . . . . . . . . . . . . . 101.22 -24.46 31.74 Favored Glycine 0 CA--C 1.534 1.274 0 CA-C-N 115.536 -0.756 . . . . 0.0 112.308 -176.242 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' F' F ' 29' ' ' LYS . . . . . . . . . . . . . 55.2 mttp -97.35 155.1 17.04 Favored 'General case' 0 C--O 1.231 0.129 0 CA-C-N 117.535 0.667 . . . . 0.0 111.253 178.589 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' F' F ' 30' ' ' THR . . . . . . . . . . . . . 41.2 m -106.17 137.49 44.02 Favored 'General case' 0 C--N 1.331 -0.23 0 CA-C-N 116.02 -0.536 . . . . 0.0 109.854 175.828 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' F' F ' 31' ' ' VAL . . . . . . . . . . . . . 34.6 m -130.21 153.08 38.42 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.243 0 CA-C-O 121.055 0.455 . . . . 0.0 111.192 -177.49 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' F' F ' 32' ' ' ARG . . . . . . . . . . . . . 55.5 mtp180 -128.92 152.53 48.46 Favored 'General case' 0 C--N 1.332 -0.187 0 CA-C-N 115.749 -0.66 . . . . 0.0 110.668 177.885 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' F' F ' 33' ' ' THR . . . . . . . . . . . . . 14.0 m -54.09 137.83 39.18 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 115.98 -0.554 . . . . 0.0 111.26 -179.206 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' F' F ' 34' ' ' GLY . . . . . . . . . . . . . . . 101.68 -17.17 55.44 Favored Glycine 0 CA--C 1.533 1.159 0 CA-C-O 119.59 -0.561 . . . . 0.0 113.354 178.804 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' F' F ' 35' ' ' ASP . . . . . . . . . . . . . 75.2 m-20 -65.88 148.03 52.43 Favored 'General case' 0 N--CA 1.461 0.091 0 CA-C-N 118.09 0.945 . . . . 0.0 111.192 179.469 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' F' F ' 36' ' ' VAL . . . . . . . . . . . . . 47.2 t -120.48 129.07 75.98 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.196 0 CA-C-N 115.872 -0.604 . . . . 0.0 109.829 178.789 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' F' F ' 37' ' ' ILE . . . . . . . . . . . . . 63.3 mt -122.29 138.85 51.08 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.226 0 CA-C-N 116.19 -0.459 . . . . 0.0 109.963 -178.958 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' F' F ' 38' ' ' GLY . . . . . . . . . . . . . . . -115.03 128.74 8.25 Favored Glycine 0 CA--C 1.526 0.72 0 N-CA-C 111.143 -0.783 . . . . 0.0 111.143 179.411 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' F' F ' 39' ' ' ILE . . . . . . . . . . . . . 76.6 mt -125.91 138.32 54.91 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.212 0 CA-C-O 120.808 0.337 . . . . 0.0 110.421 179.659 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' F' F ' 40' ' ' SER . . . . . . . . . . . . . 23.0 t -92.71 114.69 27.32 Favored 'General case' 0 C--N 1.332 -0.192 0 CA-C-N 116.335 -0.393 . . . . 0.0 111.059 176.131 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' F' F ' 41' ' ' ILE . . . . . . . . . . . . . 44.6 mm -121.43 122.75 68.05 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.215 0 CA-C-O 120.846 0.355 . . . . 0.0 110.303 179.274 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' F' F ' 42' ' ' LEU . . . . . . . . . . . . . 9.1 tp 52.84 35.38 18.73 Favored 'General case' 0 CA--C 1.532 0.252 0 CA-C-N 116.254 -0.43 . . . . 0.0 111.643 177.128 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' F' F ' 43' ' ' GLY . . . . . . . . . . . . . . . 72.15 30.41 65.26 Favored Glycine 0 CA--C 1.529 0.966 0 C-N-CA 121.058 -0.591 . . . . 0.0 112.165 178.066 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' F' F ' 44' ' ' LYS . . . . . . . . . . . . . 85.9 tttt -139.71 130.66 26.24 Favored 'General case' 0 C--N 1.33 -0.259 0 N-CA-C 109.564 -0.532 . . . . 0.0 109.564 178.886 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' F' F ' 45' ' ' GLU . . . . . . . . . . . . . 85.1 tt0 -82.5 121.66 27.05 Favored 'General case' 0 C--N 1.326 -0.425 0 CA-C-O 120.9 0.381 . . . . 0.0 110.985 -177.496 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' F' F ' 46' ' ' VAL . . . . . . . . . . . . . 9.7 p -118.2 125.74 74.48 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.171 0 N-CA-C 109.385 -0.598 . . . . 0.0 109.385 175.434 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' F' F ' 47' ' ' LYS . . . . . . . . . . . . . 98.8 mttt -98.84 125.56 44.26 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 115.948 -0.569 . . . . 0.0 110.705 179.1 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' F' F ' 48' ' ' PHE . . . . . . . . . . . . . 31.5 m-85 -110.56 131.89 54.66 Favored 'General case' 0 C--N 1.33 -0.267 0 N-CA-C 109.8 -0.444 . . . . 0.0 109.8 178.062 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' F' F ' 49' ' ' LYS . . . . . . . . . . . . . 46.1 tttp -107.05 132.75 52.61 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.26 -0.427 . . . . 0.0 110.081 178.337 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' F' F ' 50' ' ' VAL . . . . . 0.461 ' HA ' HD23 ' F' ' 6' ' ' LEU . 46.5 t -76.47 104.22 4.38 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.295 0 N-CA-C 109.263 -0.644 . . . . 0.0 109.263 177.215 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' F' F ' 51' ' ' VAL . . . . . . . . . . . . . 49.0 t -72.45 -52.41 23.86 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.298 0 N-CA-C 109.538 -0.541 . . . . 0.0 109.538 -175.239 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' F' F ' 52' ' ' GLN . . . . . . . . . . . . . 86.6 mt-30 -151.77 140.73 21.09 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-O 121.245 0.545 . . . . 0.0 111.675 -178.99 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' F' F ' 53' ' ' ALA . . . . . 0.424 ' HB1' ' HB2' ' F' ' 58' ' ' LEU . . . -116.22 127.58 54.88 Favored 'General case' 0 C--N 1.325 -0.46 0 CA-C-N 114.918 -1.037 . . . . 0.0 109.491 174.712 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' F' F ' 54' ' ' TYR . . . . . . . . . . . . . 27.4 t80 -125.92 109.06 25.02 Favored Pre-proline 0 CA--C 1.534 0.359 0 CA-C-O 118.21 -0.9 . . . . 0.0 110.511 -179.342 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' F' F ' 55' ' ' PRO . . . . . . . . . . . . . 73.3 Cg_endo -77.24 170.09 72.39 Favored 'Cis proline' 0 N--CA 1.501 1.914 0 CA-C-N 121.852 1.697 . . . . 0.0 112.658 -4.617 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' F' F ' 56' ' ' SER . . . . . . . . . . . . . 13.5 m -113.51 126.88 27.49 Favored Pre-proline 0 CA--C 1.54 0.585 0 CA-C-O 118.32 -0.848 . . . . 0.0 109.271 174.511 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' F' F ' 57' ' ' PRO . . . . . . . . . . . . . 57.3 Cg_endo -72.47 150.4 95.01 Favored 'Cis proline' 0 N--CA 1.496 1.66 0 CA-C-N 122.053 1.769 . . . . 0.0 111.692 0.043 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' F' F ' 58' ' ' LEU . . . . . 0.424 ' HB2' ' HB1' ' F' ' 53' ' ' ALA . 29.6 tp -107.9 137.36 46.03 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.221 -0.445 . . . . 0.0 110.659 -178.143 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' F' F ' 59' ' ' ARG . . . . . . . . . . . . . 73.6 ttt-85 -101.67 123.86 46.36 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 115.845 -0.616 . . . . 0.0 109.498 176.034 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' F' F ' 60' ' ' VAL . . . . . . . . . . . . . 44.6 t -76.51 114.9 17.38 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.239 0 C-N-CA 120.658 -0.417 . . . . 0.0 110.109 -177.426 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' F' F ' 61' ' ' GLU . . . . . . . . . . . . . 84.6 tt0 -131.11 154.21 48.54 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 115.759 -0.655 . . . . 0.0 109.503 179.532 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' F' F ' 62' ' ' ASP . . . . . . . . . . . . . 9.7 t0 -51.54 -32.59 28.6 Favored 'General case' 0 C--N 1.327 -0.376 0 N-CA-C 112.0 0.37 . . . . 0.0 112.0 -177.924 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' F' F ' 63' ' ' ARG . . . . . . . . . . . . . 27.2 mmm180 -72.4 -22.03 61.18 Favored 'General case' 0 N--CA 1.466 0.353 0 N-CA-C 112.934 0.716 . . . . 0.0 112.934 -177.627 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' F' F ' 64' ' ' THR . . . . . . . . . . . . . 21.6 m -67.84 137.87 55.65 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-O 120.825 0.345 . . . . 0.0 110.979 -175.461 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' F' F ' 65' ' ' LYS . . . . . . . . . . . . . 55.9 mtmt -88.95 140.21 29.67 Favored 'General case' 0 C--N 1.331 -0.224 0 CA-C-N 116.224 -0.444 . . . . 0.0 110.573 178.351 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' F' F ' 66' ' ' ILE . . . . . . . . . . . . . 4.3 mp -116.13 127.4 73.74 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.244 0 N-CA-C 109.755 -0.461 . . . . 0.0 109.755 -179.184 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' F' F ' 67' ' ' THR . . . . . . . . . . . . . 21.4 m -124.82 136.95 54.28 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-O 121.002 0.429 . . . . 0.0 110.873 -177.431 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' F' F ' 68' ' ' LEU . . . . . . . . . . . . . 15.9 tp -108.68 133.83 52.23 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.099 -0.501 . . . . 0.0 110.561 178.241 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' F' F ' 69' ' ' VAL . . . . . . . . . . . . . 48.1 t -84.94 135.47 24.77 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.314 0 CA-C-N 116.278 -0.419 . . . . 0.0 109.915 177.814 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' F' F ' 70' ' ' THR . . . . . . . . . . . . . 66.5 p -106.22 174.83 5.71 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.962 -178.308 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' F' F ' 71' ' ' HIS . . . . . . . . . . . . . 80.4 m80 -64.97 156.66 79.56 Favored Pre-proline 0 C--N 1.329 -0.284 0 CA-C-N 116.065 -0.516 . . . . 0.0 110.933 -178.345 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' F' F ' 72' ' ' PRO . . . . . . . . . . . . . 72.1 Cg_endo -80.75 159.99 21.62 Favored 'Trans proline' 0 N--CA 1.493 1.467 0 C-N-CA 121.71 1.607 . . . . 0.0 112.549 -178.512 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' F' F ' 73' ' ' VAL . . . . . . . . . . . . . 31.1 m -107.28 167.29 3.63 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.283 0 CA-C-N 115.989 -0.55 . . . . 0.0 110.165 179.005 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' F' F ' 74' ' ' ASP . . . . . . . . . . . . . 13.5 t70 -95.49 118.72 32.71 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.296 -0.411 . . . . 0.0 110.24 -177.575 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' F' F ' 75' ' ' VAL . . . . . . . . . . . . . 40.3 t -114.82 124.59 71.63 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.241 0 CA-C-O 121.043 0.449 . . . . 0.0 110.297 -178.746 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' F' F ' 76' ' ' LEU . . . . . . . . . . . . . 15.0 mt -128.78 146.15 50.99 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 115.661 -0.7 . . . . 0.0 109.723 178.88 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' F' F ' 77' ' ' GLU . . . . . . . . . . . . . 97.6 mt-10 -135.38 135.94 41.07 Favored 'General case' 0 C--N 1.331 -0.198 0 CA-C-O 121.075 0.464 . . . . 0.0 111.32 -178.502 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' F' F ' 78' ' ' ALA . . . . . . . . . . . . . . . -121.51 140.97 51.51 Favored 'General case' 0 C--N 1.332 -0.184 0 CA-C-N 115.775 -0.648 . . . . 0.0 109.735 176.09 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' F' F ' 79' ' ' LYS . . . . . 0.628 ' O ' HD13 ' F' ' 80' ' ' ILE . 96.1 mttt -85.26 115.1 22.84 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-O 120.909 0.385 . . . . 0.0 110.865 -178.3 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' F' F ' 80' ' ' ILE . . . . . 0.628 HD13 ' O ' ' F' ' 79' ' ' LYS . 39.7 mm -139.09 108.39 3.8 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.325 0 N-CA-C 109.239 -0.652 . . . . 0.0 109.239 -178.197 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' F' F ' 81' ' ' LYS . . . . . . . . . . . . . 39.2 ttpt -106.66 134.91 49.07 Favored 'General case' 0 C--N 1.331 -0.226 0 CA-C-O 120.939 0.4 . . . . 0.0 111.178 -177.242 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' F' F ' 82' ' ' GLY . . . . . . . . . . . . . . . 89.09 41.92 5.74 Favored Glycine 0 CA--C 1.523 0.556 0 N-CA-C 111.114 -0.795 . . . . 0.0 111.114 176.404 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' F' F ' 83' ' ' ILE . . . . . . . . . . . . . 68.0 mt -78.13 130.69 35.88 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.363 0 N-CA-C 109.525 -0.546 . . . . 0.0 109.525 178.398 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' F' F ' 84' ' ' LYS . . . . . . . . . . . . . 38.2 ttpt -95.73 -46.35 6.63 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-O 120.863 0.363 . . . . 0.0 110.147 -178.783 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' F' F ' 85' ' ' ASP . . . . . . . . . . . . . 7.2 t70 -152.08 149.15 28.51 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.111 -0.495 . . . . 0.0 110.629 178.581 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' F' F ' 86' ' ' VAL . . . . . . . . . . . . . 42.1 t -126.84 132.7 69.77 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.26 0 CA-C-O 120.859 0.361 . . . . 0.0 110.448 -179.524 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' F' F ' 87' ' ' ILE . . . . . . . . . . . . . 45.5 mm -119.27 124.59 73.33 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.223 0 N-CA-C 109.412 -0.588 . . . . 0.0 109.412 176.439 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' F' F ' 88' ' ' LEU . . . . . . . . . . . . . 16.8 tp -112.36 130.51 55.94 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-O 121.116 0.484 . . . . 0.0 111.19 -176.912 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' F' F ' 89' ' ' ASP . . . . . . . . . . . . . 9.1 t70 -123.64 155.15 38.27 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-N 115.754 -0.657 . . . . 0.0 109.388 175.443 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' F' F ' 90' ' ' GLU . . . . . . . . . . . . . 84.5 tt0 -47.59 -40.55 19.57 Favored 'General case' 0 C--N 1.329 -0.287 0 N-CA-C 112.818 0.673 . . . . 0.0 112.818 -172.07 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' F' F ' 91' ' ' ASN . . . . . . . . . . . . . 33.6 m120 -132.16 38.96 3.45 Favored 'General case' 0 CA--C 1.53 0.187 0 CA-C-O 120.856 0.36 . . . . 0.0 111.496 -178.208 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' F' F ' 92' ' ' LEU . . . . . . . . . . . . . 12.5 tp -166.0 139.63 4.3 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.593 -0.276 . . . . 0.0 110.325 -178.613 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' F' F ' 93' ' ' ILE . . . . . . . . . . . . . 68.2 mt -125.65 122.76 63.08 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.18 0 N-CA-C 109.588 -0.523 . . . . 0.0 109.588 179.851 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' F' F ' 94' ' ' VAL . . . . . 0.486 HG21 HG21 ' F' ' 125' ' ' VAL . 45.1 t -122.2 128.41 75.51 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.206 0 CA-C-O 120.977 0.417 . . . . 0.0 109.957 179.703 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' F' F ' 95' ' ' VAL . . . . . . . . . . . . . 41.3 t -119.91 132.93 68.26 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.323 0 CA-C-N 115.899 -0.591 . . . . 0.0 109.744 179.951 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' F' F ' 96' ' ' ILE . . . . . . . . . . . . . 69.5 mt -112.85 124.03 69.1 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 N-CA-C 108.96 -0.756 . . . . 0.0 108.96 177.912 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' F' F ' 97' ' ' THR . . . . . . . . . . . . . 43.6 p -98.51 155.89 17.05 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-O 121.544 0.688 . . . . 0.0 111.545 -175.424 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' F' F ' 98' ' ' GLU . . . . . . . . . . . . . 84.5 tt0 -54.11 -27.38 32.72 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 115.54 -0.755 . . . . 0.0 112.151 -179.864 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' F' F ' 99' ' ' GLU . . . . . . . . . . . . . 95.4 mt-10 -80.32 14.98 1.73 Allowed 'General case' 0 CA--C 1.535 0.381 0 N-CA-C 113.173 0.805 . . . . 0.0 113.173 -176.538 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' F' F ' 100' ' ' ASN . . . . . . . . . . . . . 3.6 m-20 63.0 35.38 13.22 Favored 'General case' 0 C--O 1.233 0.236 0 CA-C-N 118.126 0.421 . . . . 0.0 111.392 179.229 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' F' F ' 101' ' ' GLU . . . . . . . . . . . . . 85.0 tt0 -113.64 145.03 41.92 Favored 'General case' 0 C--N 1.331 -0.238 0 N-CA-C 109.633 -0.506 . . . . 0.0 109.633 174.393 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' F' F ' 102' ' ' VAL . . . . . . . . . . . . . 45.4 t -115.1 125.75 72.49 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.281 0 CA-C-N 116.22 -0.445 . . . . 0.0 109.929 -178.202 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' F' F ' 103' ' ' LEU . . . . . . . . . . . . . 61.2 mt -117.46 129.12 55.63 Favored 'General case' 0 C--N 1.332 -0.191 0 CA-C-N 115.743 -0.662 . . . . 0.0 110.325 177.445 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' F' F ' 104' ' ' ILE . . . . . . . . . . . . . 67.1 mt -119.04 124.49 73.25 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.181 0 N-CA-C 110.11 -0.33 . . . . 0.0 110.11 179.494 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' F' F ' 105' ' ' PHE . . . . . . . . . . . . . 88.9 m-85 -123.41 163.39 20.92 Favored 'General case' 0 C--O 1.232 0.168 0 O-C-N 123.954 0.784 . . . . 0.0 109.937 -179.497 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' F' F ' 106' ' ' ASN . . . . . . . . . . . . . 46.3 p-10 -97.66 -173.09 2.54 Favored 'General case' 0 C--N 1.33 -0.252 0 N-CA-C 109.821 -0.437 . . . . 0.0 109.821 171.821 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' F' F ' 107' ' ' GLN . . . . . . . . . . . . . 55.4 tt0 -60.12 -26.4 66.22 Favored 'General case' 0 C--N 1.328 -0.332 0 N-CA-C 112.19 0.441 . . . . 0.0 112.19 -178.823 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' F' F ' 108' ' ' ASN . . . . . . . . . . . . . 11.9 t-20 -88.68 13.99 11.08 Favored 'General case' 0 CA--C 1.535 0.389 0 N-CA-C 112.865 0.691 . . . . 0.0 112.865 -177.824 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' F' F ' 109' ' ' LEU . . . . . . . . . . . . . 43.2 mt 58.25 34.17 23.84 Favored 'General case' 0 CA--C 1.53 0.202 0 O-C-N 122.138 -0.351 . . . . 0.0 111.84 177.464 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' F' F ' 110' ' ' GLU . . . . . . . . . . . . . 70.5 mm-40 -103.14 142.95 33.27 Favored 'General case' 0 C--N 1.329 -0.31 0 N-CA-C 109.006 -0.738 . . . . 0.0 109.006 173.315 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' F' F ' 111' ' ' GLU . . . . . . . . . . . . . 51.1 tt0 -85.28 121.78 28.51 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-O 121.017 0.437 . . . . 0.0 110.538 -175.41 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' F' F ' 112' ' ' LEU . . . . . . . . . . . . . 44.8 mt -100.95 -42.96 6.21 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 115.708 -0.678 . . . . 0.0 110.68 179.636 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' F' F ' 113' ' ' TYR . . . . . . . . . . . . . 57.5 t80 -133.09 136.54 45.92 Favored 'General case' 0 C--N 1.331 -0.2 0 CA-C-N 116.329 -0.396 . . . . 0.0 111.221 -177.85 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' F' F ' 114' ' ' ARG . . . . . . . . . . . . . 69.8 ttt180 -137.53 118.61 14.41 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 115.716 -0.675 . . . . 0.0 110.142 178.197 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' F' F ' 115' ' ' GLY . . . . . . . . . . . . . . . -149.99 162.3 29.13 Favored Glycine 0 CA--C 1.524 0.605 0 C-N-CA 120.693 -0.765 . . . . 0.0 111.405 179.746 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' F' F ' 116' ' ' LYS . . . . . . . . . . . . . 74.2 tttt -136.97 140.42 42.17 Favored 'General case' 0 C--N 1.328 -0.338 0 N-CA-C 110.085 -0.339 . . . . 0.0 110.085 178.401 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' F' F ' 117' ' ' PHE . . . . . . . . . . . . . 34.8 m-85 -136.6 113.88 10.76 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.309 -0.405 . . . . 0.0 110.214 -177.45 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' F' F ' 118' ' ' GLU . . . . . . . . . . . . . 84.9 tt0 -53.79 -48.93 69.32 Favored 'General case' 0 C--N 1.329 -0.307 0 C-N-CA 121.112 -0.235 . . . . 0.0 111.292 -177.39 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' F' F ' 119' ' ' ASN . . . . . . . . . . . . . 6.0 m120 -92.98 31.12 1.46 Allowed 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 116.273 -0.421 . . . . 0.0 111.999 -175.464 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' F' F ' 120' ' ' LEU . . . . . . . . . . . . . 25.2 tp -55.56 122.77 12.05 Favored 'General case' 0 N--CA 1.462 0.173 0 CA-C-O 120.698 0.285 . . . . 0.0 110.535 178.413 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' F' F ' 121' ' ' ASN . . . . . . . . . . . . . 3.8 m-20 -113.86 -44.03 3.21 Favored 'General case' 0 C--O 1.232 0.146 0 CA-C-N 116.426 -0.352 . . . . 0.0 111.162 -176.189 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' F' F ' 122' ' ' LYS . . . . . . . . . . . . . 39.2 ttpt -146.01 141.6 27.83 Favored 'General case' 0 C--N 1.33 -0.24 0 C-N-CA 120.689 -0.404 . . . . 0.0 111.531 -175.1 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' F' F ' 123' ' ' VAL . . . . . . . . . . . . . 43.9 t -129.28 131.45 67.56 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.267 0 N-CA-C 109.486 -0.561 . . . . 0.0 109.486 174.786 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' F' F ' 124' ' ' LEU . . . . . 0.41 HD22 HD12 ' A' ' 88' ' ' LEU . 14.6 tp -127.37 131.85 50.28 Favored 'General case' 0 N--CA 1.464 0.227 0 CA-C-O 120.859 0.362 . . . . 0.0 110.919 -178.718 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' F' F ' 125' ' ' VAL . . . . . 0.522 HG22 HG23 ' F' ' 130' ' ' VAL . 45.4 t -126.13 129.43 72.17 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.218 0 CA-C-N 115.992 -0.549 . . . . 0.0 110.059 179.362 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' F' F ' 126' ' ' ARG . . . . . . . . . . . . . 42.0 ttm180 -154.22 131.26 10.99 Favored 'General case' 0 C--N 1.33 -0.27 0 N-CA-C 109.808 -0.441 . . . . 0.0 109.808 177.306 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' F' F ' 127' ' ' ASN . . . . . . . . . . . . . 3.4 t-20 56.67 -155.02 0.32 Allowed 'General case' 0 CA--C 1.538 0.507 0 N-CA-C 109.595 -0.521 . . . . 0.0 109.595 -178.319 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' F' F ' 128' ' ' ASP . . . . . . . . . . . . . 22.1 p-10 -82.5 17.24 1.81 Allowed 'General case' 0 CA--C 1.539 0.52 0 N-CA-C 112.491 0.552 . . . . 0.0 112.491 176.879 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' F' F ' 129' ' ' LEU . . . . . . . . . . . . . 16.5 tp -116.37 137.36 52.22 Favored 'General case' 0 C--O 1.232 0.18 0 N-CA-C 109.934 -0.395 . . . . 0.0 109.934 179.148 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' F' F ' 130' ' ' VAL . . . . . 0.522 HG23 HG22 ' F' ' 125' ' ' VAL . 12.6 p -136.9 143.37 35.19 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.25 0 CA-C-O 121.033 0.444 . . . . 0.0 110.663 -179.951 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' F' F ' 131' ' ' VAL . . . . . 0.458 HG21 HD13 ' A' ' 88' ' ' LEU . 32.5 m -136.09 146.94 28.42 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.275 0 CA-C-O 121.238 0.542 . . . . 0.0 110.912 178.804 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' F' F ' 132' ' ' ILE . . . . . . . . . . . . . 73.2 mt -122.36 134.01 66.88 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.228 0 CA-C-N 115.505 -0.771 . . . . 0.0 109.581 -179.572 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' F' F ' 133' ' ' ILE . . . . . . . . . . . . . 40.1 mm -115.91 122.79 70.3 Favored 'Isoleucine or valine' 0 C--O 1.234 0.262 0 CA-C-N 116.353 -0.385 . . . . 0.0 110.86 -176.304 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' F' F ' 134' ' ' ASP . . . . . . . . . . . . . 7.3 p-10 -131.88 150.97 52.0 Favored 'General case' 0 C--N 1.331 -0.23 0 CA-C-N 116.128 -0.487 . . . . 0.0 109.744 174.441 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' F' F ' 135' ' ' GLU . . . . . . . . . . . . . 85.6 tt0 -49.92 -25.86 3.62 Favored 'General case' 0 C--N 1.327 -0.378 0 N-CA-C 112.896 0.702 . . . . 0.0 112.896 -170.738 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' F' F ' 136' ' ' GLN . . . . . . . . . . . . . 97.8 mt-30 -105.05 -25.22 12.62 Favored 'General case' 0 N--CA 1.464 0.266 0 N-CA-C 113.015 0.746 . . . . 0.0 113.015 -175.081 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' F' F ' 137' ' ' LYS . . . . . . . . . . . . . 66.2 mttm -140.27 150.21 43.77 Favored 'General case' 0 C--N 1.331 -0.217 0 CA-C-O 121.587 0.708 . . . . 0.0 112.529 -167.529 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' F' F ' 138' ' ' LEU . . . . . . . . . . . . . 13.0 tp -112.99 121.55 44.98 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 114.787 -1.097 . . . . 0.0 109.003 173.103 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' F' F ' 139' ' ' THR . . . . . . . . . . . . . 31.8 m -113.95 126.96 55.73 Favored 'General case' 0 C--N 1.331 -0.215 0 CA-C-O 120.837 0.351 . . . . 0.0 110.862 -178.761 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' F' F ' 140' ' ' LEU . . . . . 0.485 HD23 ' C ' ' F' ' 140' ' ' LEU . 8.8 tt -116.34 124.13 49.34 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 115.577 -0.738 . . . . 0.0 109.354 179.913 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' F' F ' 141' ' ' ILE . . . . . 0.509 ' HB ' HG13 ' F' ' 130' ' ' VAL . 19.3 mt -121.48 120.88 63.11 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.275 0 CA-C-O 120.923 0.392 . . . . 0.0 109.971 -175.199 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' F' F ' 142' ' ' ARG . . . . . . . . . . . . . 34.7 tpt85 -110.22 127.07 54.77 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-N 115.337 -0.847 . . . . 0.0 109.965 -178.136 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' F' F ' 143' ' ' THR . . . . . . . . . . . . . 34.4 p . . . . . 0 C--O 1.22 -0.458 0 CA-C-O 118.02 -0.991 . . . . 0.0 110.656 -179.748 . . . . . . . . 0 0 . 1 . 012 nuclear nobuild full ' A' A ' -3' ' ' GLU . . . . . . . . . . . . . 96.0 mt-10 . . . . . 0 N--CA 1.489 1.483 0 N-CA-C 109.469 -0.567 . . . . 0.0 109.469 . . . . . . . . . 0 0 . 1 . 012 nuclear nobuild full ' A' A ' -2' ' ' GLY . . . . . . . . . . . . . . . -72.93 112.92 4.12 Favored Glycine 0 CA--C 1.526 0.73 0 N-CA-C 111.077 -0.809 . . . . 0.0 111.077 -179.533 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' -1' ' ' VAL . . . . . . . . . . . . . 46.5 t -96.95 135.6 30.54 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.331 0 N-CA-C 110.019 -0.363 . . . . 0.0 110.019 179.006 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 0' ' ' ILE . . . . . . . . . . . . . 44.1 mm -112.47 130.49 66.13 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.215 0 CA-C-N 116.23 -0.441 . . . . 0.0 110.153 179.966 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 27.2 ptm -90.9 138.26 31.73 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.573 179.902 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 1.7 p -113.3 119.48 37.84 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-O 121.377 0.608 . . . . 0.0 110.336 177.931 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 85.1 tt0 -143.05 142.1 31.47 Favored 'General case' 0 C--N 1.327 -0.399 0 CA-C-N 115.451 -0.795 . . . . 0.0 111.114 -178.325 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 4' ' ' LEU . . . . . . . . . . . . . 18.9 tp -123.93 128.18 49.05 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 115.887 -0.597 . . . . 0.0 109.952 176.922 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 5' ' ' LYS . . . . . . . . . . . . . 95.2 mttt -107.24 122.56 46.79 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.572 -0.285 . . . . 0.0 110.71 -179.873 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 58.1 mt -115.54 147.65 40.45 Favored 'General case' 0 C--N 1.331 -0.215 0 CA-C-N 115.577 -0.738 . . . . 0.0 110.244 -179.123 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 26.5 ttpp -125.98 139.7 34.98 Favored Pre-proline 0 CA--C 1.532 0.284 0 CA-C-O 118.983 -0.532 . . . . 0.0 109.725 174.244 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 8' ' ' PRO . . . . . . . . . . . . . 83.7 Cg_endo -91.75 133.61 1.42 Allowed 'Trans proline' 0 N--CA 1.489 1.224 0 C-N-CA 121.786 1.657 . . . . 0.0 111.808 178.275 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 73.2 mt -75.64 -47.01 4.14 Favored Pre-proline 0 CA--C 1.534 0.339 0 CA-C-O 118.527 -0.749 . . . . 0.0 111.948 179.03 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 73.9 Cg_endo -77.88 145.66 22.71 Favored 'Trans proline' 0 N--CA 1.496 1.635 0 CA-C-N 120.427 1.188 . . . . 0.0 111.656 175.154 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 58.1 mttm -84.76 89.53 7.54 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-O 120.815 0.34 . . . . 0.0 110.701 -179.781 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 12.3 p -139.55 146.24 25.72 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.293 0 CA-C-N 116.096 -0.502 . . . . 0.0 110.289 178.989 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 45.4 tp10 -89.47 129.35 35.97 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.342 -0.39 . . . . 0.0 110.254 178.554 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 14' ' ' LEU . . . . . . . . . . . . . 35.2 mt -97.36 144.88 28.69 Favored Pre-proline 0 C--N 1.329 -0.3 0 CA-C-O 119.14 -0.457 . . . . 0.0 110.05 -179.01 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 15' ' ' PRO . . . . . . . . . . . . . 24.8 Cg_exo -61.83 163.03 20.03 Favored 'Trans proline' 0 N--CA 1.498 1.783 0 C-N-CA 121.268 1.312 . . . . 0.0 111.751 178.447 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 16' ' ' PRO . . . . . . . . . . . . . 31.7 Cg_exo -59.52 -36.07 94.1 Favored 'Trans proline' 0 N--CA 1.497 1.698 0 C-N-CA 121.562 1.508 . . . . 0.0 112.971 -177.502 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 17' ' ' ASP . . . . . . . . . . . . . 7.9 p-10 -84.64 0.16 51.24 Favored 'General case' 0 CA--C 1.537 0.459 0 N-CA-C 113.274 0.842 . . . . 0.0 113.274 -177.748 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 18' ' ' PHE . . . . . . . . . . . . . 35.3 t80 -58.64 -43.75 89.85 Favored 'General case' 0 C--N 1.333 -0.128 0 O-C-N 121.95 -0.469 . . . . 0.0 109.963 -177.75 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 19' ' ' VAL . . . . . . . . . . . . . 53.3 t -57.19 -42.51 80.0 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.253 0 CA-C-N 116.155 -0.475 . . . . 0.0 110.383 -179.366 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 19.1 t0 -60.02 -42.89 95.33 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-O 120.775 0.322 . . . . 0.0 111.057 -177.869 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 45.4 t -64.38 -46.49 92.86 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.269 0 C-N-CA 120.784 -0.367 . . . . 0.0 110.361 -177.693 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 22' ' ' ILE . . . . . 0.411 HG22 HD12 ' A' ' 26' ' ' LEU . 51.9 mm -56.27 -44.23 78.97 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.223 0 CA-C-O 120.73 0.3 . . . . 0.0 110.54 178.633 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 23' ' ' ARG . . . . . . . . . . . . . 57.3 ttp180 -54.53 -47.82 72.71 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-O 120.774 0.321 . . . . 0.0 111.305 -179.934 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 24' ' ' ILE . . . . . . . . . . . . . 79.9 mt -59.15 -41.41 83.62 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.295 0 CA-C-N 116.438 -0.346 . . . . 0.0 111.022 -178.574 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 58.3 mttm -67.48 -41.0 85.31 Favored 'General case' 0 C--N 1.328 -0.343 0 N-CA-C 112.571 0.582 . . . . 0.0 112.571 -179.006 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 26' ' ' LEU . . . . . 0.411 HD12 HG22 ' A' ' 22' ' ' ILE . 79.5 mt -77.92 -38.67 45.05 Favored 'General case' 0 C--N 1.331 -0.233 0 N-CA-C 113.512 0.93 . . . . 0.0 113.512 -170.227 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 27' ' ' GLN . . . . . . . . . . . . . 9.7 pt20 -46.94 138.62 6.26 Favored 'General case' 0 N--CA 1.468 0.429 0 N-CA-C 112.796 0.665 . . . . 0.0 112.796 -174.722 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 101.13 -25.69 27.36 Favored Glycine 0 CA--C 1.533 1.165 0 CA-C-N 115.609 -0.723 . . . . 0.0 112.341 -177.865 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 69.8 mmtt -98.31 155.18 17.33 Favored 'General case' 0 C--N 1.333 -0.128 0 CA-C-N 117.4 0.6 . . . . 0.0 111.31 178.443 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 30' ' ' THR . . . . . . . . . . . . . 40.2 m -108.88 139.87 43.13 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 115.804 -0.634 . . . . 0.0 109.792 175.244 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 33.6 m -130.69 155.77 42.08 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.222 0 CA-C-O 121.032 0.444 . . . . 0.0 111.144 -177.542 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 32' ' ' ARG . . . . . . . . . . . . . 61.5 mtt85 -129.02 150.58 50.37 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-N 115.862 -0.608 . . . . 0.0 110.733 178.36 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 33' ' ' THR . . . . . . . . . . . . . 23.3 m -53.26 138.91 31.09 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.054 -0.521 . . . . 0.0 111.39 -178.087 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 100.65 -17.2 56.91 Favored Glycine 0 CA--C 1.534 1.266 0 CA-C-O 119.607 -0.552 . . . . 0.0 113.232 178.526 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 79.5 m-20 -66.44 147.31 53.48 Favored 'General case' 0 N--CA 1.461 0.097 0 CA-C-N 118.008 0.904 . . . . 0.0 111.117 178.63 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 42.1 t -121.74 130.35 74.68 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.288 0 CA-C-N 116.083 -0.508 . . . . 0.0 109.865 178.403 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 37' ' ' ILE . . . . . . . . . . . . . 68.4 mt -120.4 138.55 50.56 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.279 0 CA-C-N 116.161 -0.472 . . . . 0.0 109.877 -179.813 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . -117.48 128.72 7.96 Favored Glycine 0 CA--C 1.526 0.735 0 N-CA-C 110.636 -0.986 . . . . 0.0 110.636 178.611 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 39' ' ' ILE . . . . . . . . . . . . . 69.9 mt -123.75 132.46 71.34 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.24 0 CA-C-O 120.735 0.302 . . . . 0.0 110.3 -179.986 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 40' ' ' SER . . . . . . . . . . . . . 30.1 t -92.37 118.35 30.83 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.14 -0.482 . . . . 0.0 110.605 175.698 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 41' ' ' ILE . . . . . . . . . . . . . 69.2 mt -130.71 122.5 52.67 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.234 0 CA-C-O 120.849 0.357 . . . . 0.0 110.499 178.612 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 45.8 mt 55.12 33.91 21.45 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.033 -0.53 . . . . 0.0 111.897 176.666 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . 72.81 28.4 67.09 Favored Glycine 0 CA--C 1.531 1.046 0 C-N-CA 121.016 -0.611 . . . . 0.0 112.375 178.026 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 44' ' ' LYS . . . . . . . . . . . . . 26.4 ttpp -137.24 127.61 26.5 Favored 'General case' 0 C--N 1.331 -0.228 0 N-CA-C 109.54 -0.541 . . . . 0.0 109.54 177.288 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 67.6 tt0 -86.05 126.68 34.35 Favored 'General case' 0 C--N 1.327 -0.392 0 CA-C-N 116.336 -0.393 . . . . 0.0 111.12 -176.851 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 46' ' ' VAL . . . . . . . . . . . . . 10.2 p -119.55 126.81 75.68 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.172 0 N-CA-C 109.909 -0.404 . . . . 0.0 109.909 175.436 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 72.7 mmtt -98.2 125.54 43.29 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 115.927 -0.579 . . . . 0.0 110.752 176.148 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 48' ' ' PHE . . . . . . . . . . . . . 32.8 m-85 -112.16 131.61 55.36 Favored 'General case' 0 C--N 1.329 -0.295 0 N-CA-C 109.185 -0.672 . . . . 0.0 109.185 174.651 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 42.2 tttp -108.4 132.92 53.27 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.484 -0.325 . . . . 0.0 110.208 178.931 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 50' ' ' VAL . . . . . . . . . . . . . 41.3 t -76.23 103.99 4.04 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.332 0 N-CA-C 109.21 -0.663 . . . . 0.0 109.21 177.427 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 51' ' ' VAL . . . . . . . . . . . . . 47.8 t -69.65 -50.19 52.21 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.347 0 CA-C-N 116.086 -0.506 . . . . 0.0 109.801 -174.722 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 52' ' ' GLN . . . . . . . . . . . . . 62.2 tt0 -160.3 140.15 11.25 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 115.875 -0.602 . . . . 0.0 111.724 -177.84 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 53' ' ' ALA . . . . . 0.411 ' HB1' ' HB2' ' A' ' 58' ' ' LEU . . . -112.76 130.67 55.99 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-N 115.735 -0.666 . . . . 0.0 109.709 175.017 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 54' ' ' TYR . . . . . . . . . . . . . 59.5 t80 -129.16 107.94 17.89 Favored Pre-proline 0 CA--C 1.535 0.394 0 CA-C-O 118.324 -0.846 . . . . 0.0 110.457 -179.661 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 55' ' ' PRO . . . . . . . . . . . . . 73.7 Cg_endo -77.1 170.09 72.56 Favored 'Cis proline' 0 N--CA 1.499 1.821 0 CA-C-N 121.829 1.689 . . . . 0.0 112.339 -5.624 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 56' ' ' SER . . . . . . . . . . . . . 20.1 m -114.5 130.71 23.8 Favored Pre-proline 0 CA--C 1.539 0.526 0 CA-C-O 118.412 -0.804 . . . . 0.0 109.506 175.441 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 57' ' ' PRO . . . . . . . . . . . . . 55.2 Cg_endo -71.44 146.99 86.78 Favored 'Cis proline' 0 N--CA 1.496 1.664 0 CA-C-N 121.947 1.731 . . . . 0.0 111.622 -0.914 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 58' ' ' LEU . . . . . 0.411 ' HB2' ' HB1' ' A' ' 53' ' ' ALA . 22.3 tp -106.53 135.28 48.31 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.28 -0.418 . . . . 0.0 110.22 -179.506 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 59' ' ' ARG . . . . . . . . . . . . . 56.7 ttt85 -105.55 127.12 52.85 Favored 'General case' 0 C--N 1.326 -0.426 0 N-CA-C 109.2 -0.667 . . . . 0.0 109.2 176.639 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 43.4 t -86.03 124.1 40.01 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.234 0 C-N-CA 120.588 -0.445 . . . . 0.0 110.61 -174.528 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 96.0 mt-10 -131.02 172.48 12.04 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 115.774 -0.648 . . . . 0.0 109.877 177.999 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 62' ' ' ASP . . . . . . . . . . . . . 7.5 p-10 -55.56 -32.75 63.25 Favored 'General case' 0 C--N 1.328 -0.339 0 C-N-CA 120.922 -0.311 . . . . 0.0 111.557 179.42 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 63' ' ' ARG . . . . . . . . . . . . . 25.8 ptt180 -86.33 3.74 42.18 Favored 'General case' 0 CA--C 1.537 0.477 0 N-CA-C 113.724 1.009 . . . . 0.0 113.724 -176.94 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 30.7 m -83.51 135.29 34.71 Favored 'General case' 0 C--N 1.333 -0.135 0 CA-C-N 118.04 0.382 . . . . 0.0 110.612 -177.427 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 65' ' ' LYS . . . . . . . . . . . . . 52.1 mtmt -89.72 129.28 36.15 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.064 -0.517 . . . . 0.0 110.503 179.556 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 66' ' ' ILE . . . . . . . . . . . . . 66.4 mt -114.45 129.08 71.1 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.309 0 N-CA-C 109.41 -0.589 . . . . 0.0 109.41 177.61 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 67' ' ' THR . . . . . . . . . . . . . 22.0 m -125.74 144.64 50.54 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.215 -0.448 . . . . 0.0 111.345 -175.66 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 68' ' ' LEU . . . . . 0.449 HD23 ' N ' ' A' ' 69' ' ' VAL . 5.6 tt -95.64 126.66 41.07 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 115.805 -0.634 . . . . 0.0 109.43 175.788 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 69' ' ' VAL . . . . . 0.449 ' N ' HD23 ' A' ' 68' ' ' LEU . 45.6 t -91.12 130.28 40.54 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.326 0 CA-C-O 121.221 0.534 . . . . 0.0 110.959 -175.551 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 70' ' ' THR . . . . . . . . . . . . . 14.4 p -139.0 42.3 2.1 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 115.374 -0.83 . . . . 0.0 109.92 176.422 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 71' ' ' HIS . . . . . . . . . . . . . 22.1 m-70 -95.8 173.3 4.4 Favored Pre-proline 0 CA--C 1.532 0.282 0 CA-C-N 115.932 -0.576 . . . . 0.0 111.245 -174.923 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 72' ' ' PRO . . . . . . . . . . . . . 22.4 Cg_exo -64.95 160.13 42.81 Favored 'Trans proline' 0 N--CA 1.496 1.667 0 C-N-CA 121.617 1.545 . . . . 0.0 111.603 176.395 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 73' ' ' VAL . . . . . . . . . . . . . 34.9 m -69.68 -177.42 0.2 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.275 0 CA-C-N 116.333 -0.394 . . . . 0.0 110.495 -174.364 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 74' ' ' ASP . . . . . . . . . . . . . 25.1 t0 -89.32 120.5 30.72 Favored 'General case' 0 C--N 1.329 -0.292 0 C-N-CA 120.724 -0.39 . . . . 0.0 110.507 -171.208 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 75' ' ' VAL . . . . . 0.45 ' C ' HD12 ' A' ' 76' ' ' LEU . 40.0 t -118.67 121.01 65.91 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.212 0 CA-C-O 120.955 0.407 . . . . 0.0 110.52 -178.561 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 76' ' ' LEU . . . . . 0.45 HD12 ' C ' ' A' ' 75' ' ' VAL . 7.5 mp -117.3 141.31 48.46 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 115.79 -0.641 . . . . 0.0 109.502 175.608 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 77' ' ' GLU . . . . . . . . . . . . . 97.0 mt-10 -132.56 136.13 46.39 Favored 'General case' 0 C--N 1.331 -0.197 0 CA-C-O 121.151 0.5 . . . . 0.0 111.465 -177.724 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 78' ' ' ALA . . . . . . . . . . . . . . . -124.24 131.45 53.53 Favored 'General case' 0 C--N 1.332 -0.185 0 CA-C-N 115.482 -0.781 . . . . 0.0 109.7 176.079 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 79' ' ' LYS . . . . . 0.645 ' O ' HD13 ' A' ' 80' ' ' ILE . 99.2 mttt -78.31 117.48 19.6 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-O 120.918 0.39 . . . . 0.0 110.714 -177.533 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 80' ' ' ILE . . . . . 0.645 HD13 ' O ' ' A' ' 79' ' ' LYS . 38.7 mm -139.24 111.47 5.55 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.311 0 N-CA-C 109.241 -0.652 . . . . 0.0 109.241 -177.448 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 81' ' ' LYS . . . . . . . . . . . . . 20.0 pttp -106.31 127.41 53.23 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-O 121.165 0.507 . . . . 0.0 111.608 -176.721 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . 89.01 42.16 5.71 Favored Glycine 0 CA--C 1.525 0.691 0 C-N-CA 120.883 -0.675 . . . . 0.0 111.832 174.267 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 83' ' ' ILE . . . . . . . . . . . . . 71.1 mt -71.49 138.0 22.58 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.231 0 N-CA-C 109.921 -0.4 . . . . 0.0 109.921 178.314 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 84' ' ' LYS . . . . . . . . . . . . . 31.0 ttmt -88.96 -53.09 4.75 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 115.943 -0.572 . . . . 0.0 109.788 -179.605 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 85' ' ' ASP . . . . . . . . . . . . . 7.2 t0 -157.39 151.91 25.19 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 115.51 -0.768 . . . . 0.0 110.136 179.637 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 86' ' ' VAL . . . . . . . . . . . . . 41.9 t -126.59 131.7 70.99 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.187 0 CA-C-O 120.956 0.408 . . . . 0.0 110.375 -179.138 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 87' ' ' ILE . . . . . 0.494 HD12 ' N ' ' A' ' 87' ' ' ILE . 5.0 mp -117.37 124.75 73.43 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.224 0 N-CA-C 109.351 -0.611 . . . . 0.0 109.351 175.998 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 88' ' ' LEU . . . . . . . . . . . . . 10.6 tp -111.88 129.54 56.13 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-O 120.991 0.424 . . . . 0.0 111.098 -176.15 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 89' ' ' ASP . . . . . . . . . . . . . 13.4 t70 -125.22 150.55 46.9 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-N 115.789 -0.641 . . . . 0.0 109.535 175.428 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 84.4 tt0 -48.67 -34.88 12.68 Favored 'General case' 0 C--N 1.328 -0.351 0 N-CA-C 112.772 0.656 . . . . 0.0 112.772 -172.946 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 91' ' ' ASN . . . . . . . . . . . . . 25.1 m120 -130.48 29.79 4.79 Favored 'General case' 0 N--CA 1.468 0.459 0 N-CA-C 112.184 0.439 . . . . 0.0 112.184 -176.559 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 92' ' ' LEU . . . . . . . . . . . . . 12.4 tp -166.09 141.99 4.9 Favored 'General case' 0 C--N 1.33 -0.275 0 C-N-CA 121.103 -0.239 . . . . 0.0 110.384 179.569 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 93' ' ' ILE . . . . . . . . . . . . . 74.2 mt -124.79 123.49 65.93 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.23 0 N-CA-C 109.609 -0.515 . . . . 0.0 109.609 179.191 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 94' ' ' VAL . . . . . . . . . . . . . 45.5 t -122.56 126.87 74.66 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.241 0 N-CA-C 109.876 -0.416 . . . . 0.0 109.876 179.856 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 95' ' ' VAL . . . . . . . . . . . . . 47.8 t -121.46 132.53 70.47 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.292 0 CA-C-N 116.028 -0.533 . . . . 0.0 109.862 -179.293 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 96' ' ' ILE . . . . . . . . . . . . . 57.3 mt -112.83 126.42 70.22 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.337 0 N-CA-C 109.021 -0.733 . . . . 0.0 109.021 178.62 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 97' ' ' THR . . . . . . . . . . . . . 72.9 p -101.73 154.27 19.05 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-O 121.265 0.555 . . . . 0.0 111.137 -176.426 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 98' ' ' GLU . . . . . . . . . . . . . 48.0 tp10 -54.14 -25.92 24.84 Favored 'General case' 0 CA--C 1.535 0.366 0 CA-C-N 116.111 -0.495 . . . . 0.0 112.107 -179.809 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 99' ' ' GLU . . . . . . . . . . . . . 40.0 tt0 -80.13 18.11 0.91 Allowed 'General case' 0 CA--C 1.539 0.522 0 N-CA-C 112.573 0.582 . . . . 0.0 112.573 -176.688 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 100' ' ' ASN . . . . . . . . . . . . . 2.9 m-20 62.97 37.12 12.09 Favored 'General case' 0 CA--C 1.529 0.163 0 O-C-N 121.738 -0.601 . . . . 0.0 111.141 176.378 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 101' ' ' GLU . . . . . . . . . . . . . 84.5 tt0 -118.71 143.09 47.09 Favored 'General case' 0 C--N 1.332 -0.182 0 CA-C-N 116.072 -0.513 . . . . 0.0 109.925 176.231 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 102' ' ' VAL . . . . . . . . . . . . . 47.0 t -114.97 125.57 72.33 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.278 0 N-CA-C 109.761 -0.459 . . . . 0.0 109.761 179.858 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 103' ' ' LEU . . . . . . . . . . . . . 54.4 mt -116.71 135.12 54.03 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 115.732 -0.667 . . . . 0.0 109.955 178.886 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 104' ' ' ILE . . . . . . . . . . . . . 72.9 mt -122.97 123.09 67.25 Favored 'Isoleucine or valine' 0 C--O 1.234 0.246 0 N-CA-C 110.349 -0.241 . . . . 0.0 110.349 -178.674 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 105' ' ' PHE . . . . . . . . . . . . . 85.5 m-85 -123.82 165.43 17.35 Favored 'General case' 0 C--O 1.232 0.184 0 O-C-N 123.996 0.81 . . . . 0.0 110.071 -178.618 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 106' ' ' ASN . . . . . . . . . . . . . 47.4 p-10 -101.3 -169.96 1.77 Allowed 'General case' 0 C--N 1.329 -0.317 0 N-CA-C 109.577 -0.527 . . . . 0.0 109.577 171.769 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 107' ' ' GLN . . . . . . . . . . . . . 47.7 tt0 -59.01 -29.97 67.65 Favored 'General case' 0 C--N 1.329 -0.312 0 N-CA-C 112.006 0.373 . . . . 0.0 112.006 -178.975 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 108' ' ' ASN . . . . . . . . . . . . . 6.7 t-20 -87.07 12.31 11.73 Favored 'General case' 0 CA--C 1.533 0.321 0 N-CA-C 113.015 0.746 . . . . 0.0 113.015 -176.653 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 109' ' ' LEU . . . . . . . . . . . . . 24.9 mt 58.56 37.03 25.5 Favored 'General case' 0 C--O 1.233 0.191 0 CA-C-O 120.828 0.346 . . . . 0.0 111.497 177.245 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 110' ' ' GLU . . . . . . . . . . . . . 95.4 mt-10 -104.66 146.87 28.32 Favored 'General case' 0 C--N 1.329 -0.293 0 N-CA-C 110.013 -0.365 . . . . 0.0 110.013 176.513 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 111' ' ' GLU . . . . . . . . . . . . . 98.8 mt-10 -76.16 121.94 23.59 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-O 120.989 0.423 . . . . 0.0 111.204 -178.304 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 112' ' ' LEU . . . . . . . . . . . . . 50.3 mt -107.47 -45.81 3.99 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 115.767 -0.651 . . . . 0.0 110.033 175.985 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 113' ' ' TYR . . . . . . . . . . . . . 63.2 t80 -140.64 138.71 34.55 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.012 -0.54 . . . . 0.0 110.859 179.973 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 114' ' ' ARG . . . . . . . . . . . . . 36.5 mtm105 -144.03 124.15 13.67 Favored 'General case' 0 C--N 1.331 -0.221 0 CA-C-N 116.388 -0.369 . . . . 0.0 110.494 176.309 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 115' ' ' GLY . . . . . . . . . . . . . . . -150.15 143.66 10.98 Favored Glycine 0 CA--C 1.524 0.614 0 N-CA-C 110.939 -0.864 . . . . 0.0 110.939 179.345 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 116' ' ' LYS . . . . . . . . . . . . . 35.3 ttmt -114.15 140.43 48.53 Favored 'General case' 0 C--N 1.331 -0.201 0 CA-C-O 120.861 0.362 . . . . 0.0 110.054 177.032 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 117' ' ' PHE . . . . . . . . . . . . . 32.5 m-85 -137.63 115.04 11.09 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.19 -0.459 . . . . 0.0 109.889 -176.487 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 118' ' ' GLU . . . . . . . . . . . . . 96.0 mt-10 -54.64 -44.12 72.91 Favored 'General case' 0 C--N 1.328 -0.335 0 C-N-CA 120.965 -0.294 . . . . 0.0 111.321 -175.698 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 119' ' ' ASN . . . . . . . . . . . . . 25.1 m120 -96.44 30.58 2.5 Favored 'General case' 0 C--N 1.33 -0.248 0 N-CA-C 112.29 0.478 . . . . 0.0 112.29 -174.878 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 120' ' ' LEU . . . . . . . . . . . . . 28.7 tp -60.6 126.74 28.55 Favored 'General case' 0 C--N 1.332 -0.189 0 N-CA-C 109.83 -0.433 . . . . 0.0 109.83 177.287 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 121' ' ' ASN . . . . . . . . . . . . . 55.8 m-80 -110.88 -44.09 3.68 Favored 'General case' 0 C--N 1.331 -0.225 0 CA-C-N 116.361 -0.381 . . . . 0.0 111.128 -176.863 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 122' ' ' LYS . . . . . . . . . . . . . 56.2 pttt -161.44 159.21 27.82 Favored 'General case' 0 C--N 1.332 -0.167 0 C-N-CA 120.428 -0.509 . . . . 0.0 111.84 -179.266 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 123' ' ' VAL . . . . . . . . . . . . . 38.0 t -131.18 135.86 58.89 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.221 0 CA-C-N 116.094 -0.503 . . . . 0.0 110.321 -179.481 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 124' ' ' LEU . . . . . . . . . . . . . 46.0 mt -119.85 130.53 54.92 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.068 -0.514 . . . . 0.0 109.788 177.773 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 125' ' ' VAL . . . . . 0.409 ' CG1' HG21 ' A' ' 87' ' ' ILE . 13.6 p -138.29 137.49 43.91 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.2 0 CA-C-O 121.073 0.464 . . . . 0.0 111.166 -179.026 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 126' ' ' ARG . . . . . . . . . . . . . 14.0 ptm180 -163.28 135.97 5.41 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 115.804 -0.634 . . . . 0.0 109.776 175.673 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 127' ' ' ASN . . . . . . . . . . . . . 78.6 m-20 55.34 -154.55 0.3 Allowed 'General case' 0 CA--C 1.539 0.544 0 N-CA-C 110.074 -0.343 . . . . 0.0 110.074 179.875 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 128' ' ' ASP . . . . . . . . . . . . . 20.0 p-10 -80.15 15.49 1.51 Allowed 'General case' 0 CA--C 1.536 0.411 0 N-CA-C 112.938 0.718 . . . . 0.0 112.938 179.394 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 129' ' ' LEU . . . . . . . . . . . . . 13.9 tp -119.68 132.42 55.67 Favored 'General case' 0 C--O 1.232 0.142 0 CA-C-N 118.154 0.434 . . . . 0.0 110.223 179.575 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 130' ' ' VAL . . . . . 0.402 HG13 ' HB ' ' A' ' 141' ' ' ILE . 14.1 p -138.87 145.36 27.88 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.292 0 CA-C-O 120.979 0.418 . . . . 0.0 110.604 178.912 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 131' ' ' VAL . . . . . . . . . . . . . 43.1 t -135.04 138.68 48.57 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.252 0 CA-C-N 116.18 -0.464 . . . . 0.0 110.223 179.3 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 132' ' ' ILE . . . . . . . . . . . . . 67.6 mt -112.52 131.68 63.36 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.331 0 N-CA-C 109.349 -0.611 . . . . 0.0 109.349 179.849 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 133' ' ' ILE . . . . . . . . . . . . . 43.8 mm -115.02 123.21 70.48 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.254 0 CA-C-O 120.667 0.27 . . . . 0.0 111.083 -174.945 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 134' ' ' ASP . . . . . . . . . . . . . 7.2 p-10 -135.93 147.64 48.2 Favored 'General case' 0 C--N 1.332 -0.186 0 N-CA-C 109.584 -0.524 . . . . 0.0 109.584 172.896 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 135' ' ' GLU . . . . . . . . . . . . . 84.6 tt0 -49.81 -27.65 5.3 Favored 'General case' 0 C--N 1.327 -0.409 0 N-CA-C 112.767 0.654 . . . . 0.0 112.767 -172.749 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 136' ' ' GLN . . . . . . . . . . . . . 48.2 tt0 -83.57 -32.76 25.63 Favored 'General case' 0 C--O 1.235 0.323 0 N-CA-C 112.34 0.496 . . . . 0.0 112.34 -174.967 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 137' ' ' LYS . . . . . . . . . . . . . 52.0 pttt -167.04 169.88 12.49 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-O 121.497 0.665 . . . . 0.0 112.098 -172.365 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 138' ' ' LEU . . . . . 0.466 ' C ' HD23 ' A' ' 138' ' ' LEU . 8.8 tt -119.87 129.25 54.3 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 115.273 -0.876 . . . . 0.0 110.065 179.439 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 139' ' ' THR . . . . . . . . . . . . . 44.4 m -110.03 127.01 54.57 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.084 -0.507 . . . . 0.0 110.294 179.657 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 140' ' ' LEU . . . . . 0.475 HD23 ' C ' ' A' ' 140' ' ' LEU . 8.7 tt -110.8 123.33 49.87 Favored 'General case' 0 C--N 1.328 -0.329 0 N-CA-C 109.421 -0.585 . . . . 0.0 109.421 179.782 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 141' ' ' ILE . . . . . 0.402 ' HB ' HG13 ' A' ' 130' ' ' VAL . 18.9 mt -124.64 123.59 66.33 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.259 0 CA-C-O 120.964 0.412 . . . . 0.0 109.933 -175.336 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 142' ' ' ARG . . . . . . . . . . . . . 69.4 ttt180 -111.59 119.73 39.69 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 115.75 -0.659 . . . . 0.0 109.587 178.598 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 143' ' ' THR . . . . . . . . . . . . . 71.0 p . . . . . 0 C--O 1.22 -0.46 0 CA-C-O 117.981 -1.009 . . . . 0.0 110.606 -178.451 . . . . . . . . 0 0 . 1 . 012 nuclear nobuild full ' B' B ' -3' ' ' GLU . . . . . . . . . . . . . 95.2 mt-10 . . . . . 0 N--CA 1.489 1.525 0 N-CA-C 109.245 -0.65 . . . . 0.0 109.245 . . . . . . . . . 0 0 . 1 . 012 nuclear nobuild full ' B' B ' -2' ' ' GLY . . . . . . . . . . . . . . . -68.59 150.06 50.31 Favored Glycine 0 CA--C 1.524 0.616 0 N-CA-C 110.904 -0.878 . . . . 0.0 110.904 179.623 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' B' B ' -1' ' ' VAL . . . . . . . . . . . . . 44.0 t -96.14 132.92 39.18 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.282 0 CA-C-O 120.873 0.368 . . . . 0.0 110.032 -179.641 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' B' B ' 0' ' ' ILE . . . . . . . . . . . . . 70.4 mt -116.67 134.04 61.4 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.239 0 CA-C-N 116.202 -0.454 . . . . 0.0 109.95 -179.779 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' B' B ' 1' ' ' MET . . . . . . . . . . . . . 25.6 ptp -81.51 151.34 27.83 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.146 -0.479 . . . . 0.0 110.509 179.395 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' B' B ' 2' ' ' SER . . . . . . . . . . . . . 9.6 p -107.78 135.25 49.52 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.16 -0.473 . . . . 0.0 110.558 179.554 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' B' B ' 3' ' ' GLU . . . . . . . . . . . . . 95.0 mt-10 -139.84 142.39 36.6 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.021 -0.536 . . . . 0.0 110.954 -178.532 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' B' B ' 4' ' ' LEU . . . . . 0.404 HD23 ' N ' ' B' ' 5' ' ' LYS . 4.3 tt -126.14 124.73 41.19 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 115.829 -0.623 . . . . 0.0 109.559 176.899 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' B' B ' 5' ' ' LYS . . . . . 0.404 ' N ' HD23 ' B' ' 4' ' ' LEU . 96.1 mttt -108.12 120.87 43.58 Favored 'General case' 0 C--O 1.234 0.265 0 CA-C-O 120.755 0.312 . . . . 0.0 110.913 -178.2 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' B' B ' 6' ' ' LEU . . . . . 0.412 HD23 ' HA ' ' B' ' 50' ' ' VAL . 54.4 mt -114.82 148.96 37.79 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 115.439 -0.8 . . . . 0.0 110.656 -178.992 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' B' B ' 7' ' ' LYS . . . . . . . . . . . . . 26.3 ttpp -136.53 140.78 33.33 Favored Pre-proline 0 CA--C 1.532 0.267 0 CA-C-O 119.166 -0.445 . . . . 0.0 109.991 174.701 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' B' B ' 8' ' ' PRO . . . . . . . . . . . . . 87.9 Cg_endo -91.88 138.98 2.09 Favored 'Trans proline' 0 N--CA 1.49 1.274 0 C-N-CA 121.756 1.638 . . . . 0.0 111.638 177.645 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' B' B ' 9' ' ' LEU . . . . . . . . . . . . . 69.0 mt -73.65 -46.99 7.2 Favored Pre-proline 0 CA--C 1.534 0.357 0 CA-C-O 118.682 -0.675 . . . . 0.0 111.961 -179.991 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' B' B ' 10' ' ' PRO . . . . . . . . . . . . . 83.1 Cg_endo -81.36 150.81 17.43 Favored 'Trans proline' 0 N--CA 1.497 1.7 0 C-N-CA 121.166 1.244 . . . . 0.0 111.824 174.738 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' B' B ' 11' ' ' LYS . . . . . . . . . . . . . 39.4 ttpt -87.6 94.26 9.67 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.442 -0.345 . . . . 0.0 110.325 178.648 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' B' B ' 12' ' ' VAL . . . . . . . . . . . . . 12.0 p -140.07 142.19 32.29 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.297 0 CA-C-N 116.211 -0.449 . . . . 0.0 110.394 179.252 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' B' B ' 13' ' ' GLU . . . . . . . . . . . . . 41.9 mt-10 -75.69 132.24 40.41 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-O 120.802 0.335 . . . . 0.0 110.251 178.623 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' B' B ' 14' ' ' LEU . . . . . . . . . . . . . 30.5 mt -98.32 153.16 38.16 Favored Pre-proline 0 C--N 1.33 -0.253 0 CA-C-N 116.346 -0.388 . . . . 0.0 110.666 -179.224 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' B' B ' 15' ' ' PRO . . . . . . . . . . . . . 27.7 Cg_exo -61.12 154.12 59.66 Favored 'Trans proline' 0 N--CA 1.496 1.667 0 C-N-CA 121.276 1.317 . . . . 0.0 111.599 177.626 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' B' B ' 16' ' ' PRO . . . . . . . . . . . . . 33.9 Cg_exo -57.74 -36.44 98.39 Favored 'Trans proline' 0 N--CA 1.498 1.751 0 C-N-CA 121.389 1.393 . . . . 0.0 112.793 -178.896 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' B' B ' 17' ' ' ASP . . . . . . . . . . . . . 18.0 p-10 -92.43 15.04 14.89 Favored 'General case' 0 C--N 1.327 -0.383 0 N-CA-C 113.02 0.748 . . . . 0.0 113.02 -177.489 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' B' B ' 18' ' ' PHE . . . . . . . . . . . . . 44.4 t80 -58.38 -44.69 89.0 Favored 'General case' 0 C--O 1.228 -0.078 0 O-C-N 122.008 -0.432 . . . . 0.0 110.057 -177.722 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' B' B ' 19' ' ' VAL . . . . . . . . . . . . . 48.4 t -56.91 -42.97 79.59 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.305 0 CA-C-N 116.055 -0.521 . . . . 0.0 110.53 -178.346 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' B' B ' 20' ' ' ASP . . . . . . . . . . . . . 32.9 t0 -59.59 -43.49 93.67 Favored 'General case' 0 C--N 1.329 -0.315 0 C-N-CA 120.887 -0.325 . . . . 0.0 111.026 -177.22 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' B' B ' 21' ' ' VAL . . . . . . . . . . . . . 45.1 t -64.88 -46.52 91.58 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.248 0 C-N-CA 120.716 -0.393 . . . . 0.0 110.43 -178.116 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' B' B ' 22' ' ' ILE . . . . . 0.632 HG22 HD12 ' B' ' 26' ' ' LEU . 50.9 mm -57.8 -38.87 67.98 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.324 0 CA-C-O 120.668 0.271 . . . . 0.0 110.407 179.272 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' B' B ' 23' ' ' ARG . . . . . . . . . . . . . 57.1 ttp180 -55.84 -49.87 72.11 Favored 'General case' 0 C--N 1.331 -0.216 0 CA-C-O 120.976 0.417 . . . . 0.0 110.558 177.861 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' B' B ' 24' ' ' ILE . . . . . . . . . . . . . 74.0 mt -60.85 -43.85 96.45 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.334 0 CA-C-N 115.834 -0.621 . . . . 0.0 111.73 -177.398 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' B' B ' 25' ' ' LYS . . . . . . . . . . . . . 14.8 pttp -72.97 -36.62 67.14 Favored 'General case' 0 CA--C 1.533 0.298 0 C-N-CA 120.526 -0.47 . . . . 0.0 111.901 -172.933 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' B' B ' 26' ' ' LEU . . . . . 0.632 HD12 HG22 ' B' ' 22' ' ' ILE . 42.0 mt -80.21 -41.78 24.53 Favored 'General case' 0 C--N 1.331 -0.22 0 N-CA-C 113.185 0.809 . . . . 0.0 113.185 -173.796 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' B' B ' 27' ' ' GLN . . . . . . . . . . . . . 10.6 pt20 -47.18 139.28 6.19 Favored 'General case' 0 N--CA 1.469 0.484 0 N-CA-C 112.73 0.641 . . . . 0.0 112.73 -174.539 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' B' B ' 28' ' ' GLY . . . . . . . . . . . . . . . 99.48 -26.0 26.08 Favored Glycine 0 CA--C 1.533 1.179 0 CA-C-N 115.687 -0.688 . . . . 0.0 112.255 -176.877 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' B' B ' 29' ' ' LYS . . . . . . . . . . . . . 56.4 mtmt -98.9 155.16 17.54 Favored 'General case' 0 C--O 1.232 0.164 0 CA-C-N 117.247 0.523 . . . . 0.0 111.103 179.425 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' B' B ' 30' ' ' THR . . . . . . . . . . . . . 31.4 m -105.38 137.73 42.72 Favored 'General case' 0 C--N 1.332 -0.195 0 CA-C-N 116.101 -0.499 . . . . 0.0 110.094 176.949 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' B' B ' 31' ' ' VAL . . . . . . . . . . . . . 34.3 m -130.71 160.41 41.93 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.236 0 CA-C-O 120.911 0.386 . . . . 0.0 110.971 -178.372 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' B' B ' 32' ' ' ARG . . . . . . . . . . . . . 80.3 mtm180 -134.24 149.26 50.95 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 115.907 -0.588 . . . . 0.0 110.477 177.844 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' B' B ' 33' ' ' THR . . . . . . . . . . . . . 24.7 m -53.41 141.63 24.11 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.443 -0.344 . . . . 0.0 111.39 -178.363 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' B' B ' 34' ' ' GLY . . . . . . . . . . . . . . . 99.49 -17.13 58.12 Favored Glycine 0 CA--C 1.533 1.194 0 CA-C-O 119.687 -0.507 . . . . 0.0 113.23 179.762 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' B' B ' 35' ' ' ASP . . . . . . . . . . . . . 76.1 m-20 -65.33 147.99 52.47 Favored 'General case' 0 C--O 1.231 0.123 0 CA-C-N 118.037 0.919 . . . . 0.0 111.041 178.739 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' B' B ' 36' ' ' VAL . . . . . . . . . . . . . 46.7 t -120.58 129.96 75.03 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.204 0 CA-C-N 115.829 -0.623 . . . . 0.0 109.887 179.099 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' B' B ' 37' ' ' ILE . . . . . . . . . . . . . 69.9 mt -120.31 139.18 48.42 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.219 0 N-CA-C 109.841 -0.429 . . . . 0.0 109.841 179.848 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' B' B ' 38' ' ' GLY . . . . . . . . . . . . . . . -114.04 128.74 8.4 Favored Glycine 0 CA--C 1.525 0.691 0 N-CA-C 111.256 -0.738 . . . . 0.0 111.256 -179.683 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' B' B ' 39' ' ' ILE . . . . . . . . . . . . . 69.4 mt -122.9 127.97 75.01 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.218 0 N-CA-C 109.64 -0.504 . . . . 0.0 109.64 177.418 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' B' B ' 40' ' ' SER . . . . . . . . . . . . . 56.3 p -91.95 118.12 30.45 Favored 'General case' 0 C--N 1.33 -0.257 0 C-N-CA 120.908 -0.317 . . . . 0.0 110.75 177.527 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' B' B ' 41' ' ' ILE . . . . . . . . . . . . . 73.8 mt -134.63 128.25 50.68 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.234 0 CA-C-O 120.732 0.301 . . . . 0.0 110.266 178.786 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' B' B ' 42' ' ' LEU . . . . . . . . . . . . . 49.3 mt 57.76 33.08 22.8 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.24 -0.436 . . . . 0.0 111.858 178.543 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' B' B ' 43' ' ' GLY . . . . . . . . . . . . . . . 77.29 -10.05 23.77 Favored Glycine 0 CA--C 1.535 1.334 0 C-N-CA 121.276 -0.487 . . . . 0.0 113.472 178.03 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' B' B ' 44' ' ' LYS . . . . . . . . . . . . . 65.3 tttm -102.22 129.91 48.75 Favored 'General case' 0 C--O 1.233 0.195 0 CA-C-N 117.948 0.874 . . . . 0.0 109.964 177.224 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' B' B ' 45' ' ' GLU . . . . . . . . . . . . . 44.7 tp10 -84.7 125.66 32.71 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.43 -0.35 . . . . 0.0 110.55 178.998 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' B' B ' 46' ' ' VAL . . . . . . . . . . . . . 7.5 p -113.74 128.77 70.48 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.258 0 N-CA-C 109.336 -0.616 . . . . 0.0 109.336 177.108 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' B' B ' 47' ' ' LYS . . . . . . . . . . . . . 93.5 mttt -100.05 126.58 46.27 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 115.849 -0.614 . . . . 0.0 111.12 178.725 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' B' B ' 48' ' ' PHE . . . . . . . . . . . . . 95.3 m-85 -109.48 131.9 54.64 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.079 -0.51 . . . . 0.0 109.679 176.358 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' B' B ' 49' ' ' LYS . . . . . . . . . . . . . 86.4 tttt -107.12 134.73 49.8 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.18 -0.463 . . . . 0.0 110.366 179.25 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' B' B ' 50' ' ' VAL . . . . . 0.412 ' HA ' HD23 ' B' ' 6' ' ' LEU . 46.2 t -79.0 106.42 9.97 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.336 0 N-CA-C 109.167 -0.679 . . . . 0.0 109.167 175.695 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' B' B ' 51' ' ' VAL . . . . . . . . . . . . . 52.5 t -69.9 -52.81 27.73 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.354 0 N-CA-C 109.613 -0.514 . . . . 0.0 109.613 -174.844 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' B' B ' 52' ' ' GLN . . . . . . . . . . . . . 90.7 mt-30 -153.75 151.64 29.82 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-O 121.274 0.559 . . . . 0.0 111.86 -178.114 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' B' B ' 53' ' ' ALA . . . . . . . . . . . . . . . -127.29 132.55 50.29 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 115.065 -0.971 . . . . 0.0 109.323 174.561 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' B' B ' 54' ' ' TYR . . . . . . . . . . . . . 39.7 t80 -129.06 109.78 18.2 Favored Pre-proline 0 CA--C 1.533 0.318 0 CA-C-O 118.183 -0.913 . . . . 0.0 110.381 -179.697 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' B' B ' 55' ' ' PRO . . . . . . . . . . . . . 73.6 Cg_endo -77.1 170.1 72.53 Favored 'Cis proline' 0 N--CA 1.502 2.006 0 CA-C-N 121.907 1.717 . . . . 0.0 112.594 -5.443 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' B' B ' 56' ' ' SER . . . . . . . . . . . . . 15.5 m -116.56 128.05 26.29 Favored Pre-proline 0 CA--C 1.539 0.537 0 CA-C-O 118.409 -0.805 . . . . 0.0 109.37 175.276 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' B' B ' 57' ' ' PRO . . . . . . . . . . . . . 36.6 Cg_endo -66.2 166.04 59.15 Favored 'Cis proline' 0 N--CA 1.499 1.799 0 CA-C-N 121.986 1.745 . . . . 0.0 111.662 -0.113 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' B' B ' 58' ' ' LEU . . . . . . . . . . . . . 29.7 tp -130.21 135.92 48.66 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.318 -0.401 . . . . 0.0 110.734 -179.716 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' B' B ' 59' ' ' ARG . . . . . . . . . . . . . 58.2 ttp180 -101.82 126.75 48.76 Favored 'General case' 0 C--N 1.328 -0.366 0 N-CA-C 109.237 -0.653 . . . . 0.0 109.237 175.815 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' B' B ' 60' ' ' VAL . . . . . . . . . . . . . 46.9 t -78.56 117.98 24.96 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.192 0 C-N-CA 120.546 -0.462 . . . . 0.0 109.915 -177.352 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' B' B ' 61' ' ' GLU . . . . . . . . . . . . . 74.4 tt0 -131.12 159.6 37.16 Favored 'General case' 0 C--N 1.328 -0.337 0 N-CA-C 109.422 -0.584 . . . . 0.0 109.422 -179.504 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' B' B ' 62' ' ' ASP . . . . . . . . . . . . . 52.2 m-20 -51.51 -32.17 26.62 Favored 'General case' 0 C--N 1.328 -0.355 0 N-CA-C 112.074 0.398 . . . . 0.0 112.074 -179.367 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' B' B ' 63' ' ' ARG . . . . . . . . . . . . . 14.5 ptm180 -85.15 5.4 30.06 Favored 'General case' 0 CA--C 1.535 0.403 0 N-CA-C 113.733 1.012 . . . . 0.0 113.733 -175.739 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' B' B ' 64' ' ' THR . . . . . . . . . . . . . 24.4 m -89.72 136.4 33.06 Favored 'General case' 0 C--N 1.332 -0.18 0 CA-C-N 118.151 0.432 . . . . 0.0 110.401 -178.647 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' B' B ' 65' ' ' LYS . . . . . . . . . . . . . 55.1 mtmt -89.1 128.38 35.76 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.299 -0.41 . . . . 0.0 110.31 -179.994 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' B' B ' 66' ' ' ILE . . . . . . . . . . . . . 66.1 mt -113.68 127.18 71.16 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.294 0 N-CA-C 109.638 -0.504 . . . . 0.0 109.638 179.998 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' B' B ' 67' ' ' THR . . . . . . . . . . . . . 23.4 m -126.97 144.09 51.11 Favored 'General case' 0 C--N 1.332 -0.185 0 CA-C-N 116.122 -0.49 . . . . 0.0 111.069 -175.903 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' B' B ' 68' ' ' LEU . . . . . . . . . . . . . 42.8 mt -104.07 135.18 46.05 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 115.942 -0.572 . . . . 0.0 110.61 177.887 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' B' B ' 69' ' ' VAL . . . . . . . . . . . . . 43.1 t -100.42 140.76 18.67 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.339 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.004 178.969 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' B' B ' 70' ' ' THR . . . . . . . . . . . . . 6.7 p -131.13 -45.25 1.02 Allowed 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.088 -0.505 . . . . 0.0 110.531 -178.58 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' B' B ' 71' ' ' HIS . . . . . . . . . . . . . 89.2 m-70 -106.18 154.4 39.68 Favored Pre-proline 0 C--N 1.33 -0.277 0 CA-C-N 116.267 -0.424 . . . . 0.0 110.521 -179.792 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' B' B ' 72' ' ' PRO . . . . . . . . . . . . . 93.9 Cg_endo -83.19 -7.76 10.94 Favored 'Trans proline' 0 N--CA 1.496 1.654 0 C-N-CA 121.532 1.488 . . . . 0.0 113.809 179.401 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' B' B ' 73' ' ' VAL . . . . . . . . . . . . . 33.8 m -125.68 171.13 14.81 Favored 'Isoleucine or valine' 0 C--N 1.334 -0.092 0 CA-C-O 120.66 0.267 . . . . 0.0 110.376 -179.289 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' B' B ' 74' ' ' ASP . . . . . . . . . . . . . 38.8 t0 -95.66 119.28 33.89 Favored 'General case' 0 C--N 1.329 -0.287 0 N-CA-C 110.121 -0.326 . . . . 0.0 110.121 -177.644 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' B' B ' 75' ' ' VAL . . . . . . . . . . . . . 40.6 t -122.52 125.2 72.31 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.295 0 CA-C-O 121.142 0.496 . . . . 0.0 110.818 -177.652 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' B' B ' 76' ' ' LEU . . . . . . . . . . . . . 5.9 mp -121.99 145.29 48.27 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 115.67 -0.695 . . . . 0.0 109.619 175.361 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' B' B ' 77' ' ' GLU . . . . . . . . . . . . . 97.3 mt-10 -134.38 132.06 38.97 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-O 121.061 0.458 . . . . 0.0 111.133 -178.634 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' B' B ' 78' ' ' ALA . . . . . . . . . . . . . . . -120.84 134.28 55.29 Favored 'General case' 0 C--N 1.33 -0.239 0 CA-C-N 115.761 -0.654 . . . . 0.0 109.84 177.028 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' B' B ' 79' ' ' LYS . . . . . 0.438 ' O ' HD13 ' B' ' 80' ' ' ILE . 94.4 mttt -79.1 120.79 24.14 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-O 120.809 0.337 . . . . 0.0 110.566 -178.575 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' B' B ' 80' ' ' ILE . . . . . 0.438 HD13 ' O ' ' B' ' 79' ' ' LYS . 26.8 mm -139.09 110.06 4.76 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.28 0 N-CA-C 109.148 -0.686 . . . . 0.0 109.148 -177.465 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' B' B ' 81' ' ' LYS . . . . . . . . . . . . . 49.0 pttt -99.42 123.39 43.66 Favored 'General case' 0 C--N 1.33 -0.283 0 CA-C-O 121.104 0.478 . . . . 0.0 111.419 -176.778 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' B' B ' 82' ' ' GLY . . . . . . . . . . . . . . . 88.85 42.18 5.76 Favored Glycine 0 CA--C 1.524 0.617 0 C-N-CA 120.769 -0.729 . . . . 0.0 111.664 173.404 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' B' B ' 83' ' ' ILE . . . . . . . . . . . . . 76.8 mt -64.38 135.13 28.45 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.285 0 N-CA-C 109.861 -0.422 . . . . 0.0 109.861 178.669 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' B' B ' 84' ' ' LYS . . . . . . . . . . . . . 84.7 tttt -92.63 -53.85 4.02 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 115.903 -0.589 . . . . 0.0 110.348 -177.326 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' B' B ' 85' ' ' ASP . . . . . . . . . . . . . 3.7 t70 -158.29 158.01 33.58 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 115.678 -0.692 . . . . 0.0 110.147 -178.783 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' B' B ' 86' ' ' VAL . . . . . . . . . . . . . 40.3 t -135.56 134.08 51.87 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.248 0 CA-C-O 121.023 0.44 . . . . 0.0 110.746 -177.69 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' B' B ' 87' ' ' ILE . . . . . . . . . . . . . 44.2 mm -117.48 127.68 74.88 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.226 0 CA-C-N 115.751 -0.659 . . . . 0.0 109.389 174.386 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' B' B ' 88' ' ' LEU . . . . . . . . . . . . . 17.3 tp -112.55 133.06 54.81 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-O 121.01 0.434 . . . . 0.0 111.19 -176.673 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' B' B ' 89' ' ' ASP . . . . . . . . . . . . . 9.0 t0 -128.22 150.51 50.0 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 115.743 -0.662 . . . . 0.0 109.43 176.591 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' B' B ' 90' ' ' GLU . . . . . . . . . . . . . 84.3 tt0 -48.03 -37.63 15.32 Favored 'General case' 0 CA--C 1.531 0.25 0 N-CA-C 112.612 0.597 . . . . 0.0 112.612 -173.336 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' B' B ' 91' ' ' ASN . . . . . . . . . . . . . 84.9 m-20 -131.6 35.07 3.85 Favored 'General case' 0 N--CA 1.465 0.285 0 CA-C-O 120.816 0.341 . . . . 0.0 111.639 -177.301 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' B' B ' 92' ' ' LEU . . . . . . . . . . . . . 11.6 tp -166.07 142.41 5.05 Favored 'General case' 0 C--N 1.331 -0.22 0 CA-C-O 120.673 0.273 . . . . 0.0 110.339 179.723 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' B' B ' 93' ' ' ILE . . . . . . . . . . . . . 70.1 mt -125.47 124.36 66.77 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.343 0 N-CA-C 109.622 -0.51 . . . . 0.0 109.622 -179.896 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' B' B ' 94' ' ' VAL . . . . . . . . . . . . . 41.0 t -124.79 127.33 72.58 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.252 0 N-CA-C 110.008 -0.368 . . . . 0.0 110.008 179.39 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' B' B ' 95' ' ' VAL . . . . . . . . . . . . . 40.1 t -123.37 137.67 55.88 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.293 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.036 -179.48 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' B' B ' 96' ' ' ILE . . . . . . . . . . . . . 65.1 mt -116.46 130.43 71.29 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.256 0 N-CA-C 109.158 -0.682 . . . . 0.0 109.158 178.254 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' B' B ' 97' ' ' THR . . . . . . . . . . . . . 65.4 p -103.96 155.78 18.38 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-O 121.029 0.443 . . . . 0.0 111.255 -177.324 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' B' B ' 98' ' ' GLU . . . . . . . . . . . . . 85.1 tt0 -54.04 -24.54 17.49 Favored 'General case' 0 CA--C 1.534 0.332 0 N-CA-C 112.068 0.396 . . . . 0.0 112.068 178.922 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' B' B ' 99' ' ' GLU . . . . . . . . . . . . . 70.9 mm-40 -76.4 13.49 0.94 Allowed 'General case' 0 CA--C 1.535 0.4 0 N-CA-C 113.2 0.815 . . . . 0.0 113.2 -179.333 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' B' B ' 100' ' ' ASN . . . . . . . . . . . . . 2.3 m-20 64.62 38.1 7.37 Favored 'General case' 0 C--O 1.232 0.15 0 CA-C-O 120.988 0.423 . . . . 0.0 110.788 177.813 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' B' B ' 101' ' ' GLU . . . . . . . . . . . . . 46.2 mt-10 -115.84 143.94 44.72 Favored 'General case' 0 C--N 1.332 -0.16 0 CA-C-N 116.074 -0.512 . . . . 0.0 110.399 177.078 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' B' B ' 102' ' ' VAL . . . . . 0.435 ' C ' HD12 ' B' ' 103' ' ' LEU . 47.2 t -115.11 126.46 72.7 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.357 0 N-CA-C 109.245 -0.65 . . . . 0.0 109.245 176.864 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' B' B ' 103' ' ' LEU . . . . . 0.435 HD12 ' C ' ' B' ' 102' ' ' VAL . 6.4 mp -121.9 132.88 54.8 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-N 116.008 -0.542 . . . . 0.0 110.386 177.796 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' B' B ' 104' ' ' ILE . . . . . . . . . . . . . 71.6 mt -117.62 124.77 73.5 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.315 0 CA-C-N 115.834 -0.621 . . . . 0.0 109.914 -179.092 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' B' B ' 105' ' ' PHE . . . . . . . . . . . . . 75.9 m-85 -123.46 162.23 23.25 Favored 'General case' 0 C--N 1.331 -0.222 0 O-C-N 123.985 0.803 . . . . 0.0 109.823 179.786 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' B' B ' 106' ' ' ASN . . . . . . . . . . . . . 47.9 p-10 -97.22 -170.41 2.02 Favored 'General case' 0 C--N 1.329 -0.31 0 N-CA-C 109.919 -0.4 . . . . 0.0 109.919 173.939 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' B' B ' 107' ' ' GLN . . . . . . . . . . . . . 47.5 tt0 -59.0 -30.05 67.69 Favored 'General case' 0 C--N 1.329 -0.287 0 N-CA-C 111.888 0.329 . . . . 0.0 111.888 179.607 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' B' B ' 108' ' ' ASN . . . . . . . . . . . . . 56.4 t30 -83.96 7.76 17.32 Favored 'General case' 0 CA--C 1.536 0.412 0 N-CA-C 113.259 0.837 . . . . 0.0 113.259 -177.022 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' B' B ' 109' ' ' LEU . . . . . . . . . . . . . 9.8 tp 60.52 36.35 20.0 Favored 'General case' 0 CA--C 1.529 0.165 0 CA-C-O 120.965 0.412 . . . . 0.0 111.413 178.613 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' B' B ' 110' ' ' GLU . . . . . . . . . . . . . 70.6 mm-40 -101.35 147.5 26.25 Favored 'General case' 0 C--N 1.329 -0.322 0 N-CA-C 109.685 -0.487 . . . . 0.0 109.685 175.837 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' B' B ' 111' ' ' GLU . . . . . . . . . . . . . 85.2 tt0 -79.51 121.95 25.85 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-O 120.94 0.4 . . . . 0.0 110.483 -177.508 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' B' B ' 112' ' ' LEU . . . . . . . . . . . . . 20.5 mt -108.26 -46.04 3.8 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 115.911 -0.586 . . . . 0.0 110.548 179.379 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' B' B ' 113' ' ' TYR . . . . . . . . . . . . . 64.4 t80 -140.27 135.17 32.01 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.145 -0.48 . . . . 0.0 111.364 -178.667 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' B' B ' 114' ' ' ARG . . . . . . . . . . . . . 71.6 ttt180 -142.16 125.16 16.2 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.306 -0.406 . . . . 0.0 110.158 176.141 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' B' B ' 115' ' ' GLY . . . . . . . . . . . . . . . -150.04 149.14 21.0 Favored Glycine 0 CA--C 1.523 0.582 0 N-CA-C 111.175 -0.77 . . . . 0.0 111.175 179.115 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' B' B ' 116' ' ' LYS . . . . . . . . . . . . . 35.3 ttpt -114.22 131.75 56.36 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-O 120.732 0.301 . . . . 0.0 110.422 178.283 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' B' B ' 117' ' ' PHE . . . . . 0.426 ' HE2' HD13 ' B' ' 132' ' ' ILE . 43.1 m-85 -129.46 113.94 15.52 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.279 -0.419 . . . . 0.0 109.938 -179.244 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' B' B ' 118' ' ' GLU . . . . . . . . . . . . . 84.6 tt0 -54.91 -48.5 73.0 Favored 'General case' 0 C--N 1.329 -0.318 0 C-N-CA 120.901 -0.319 . . . . 0.0 111.419 -175.601 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' B' B ' 119' ' ' ASN . . . . . . . . . . . . . 91.0 m-20 -94.44 31.2 1.79 Allowed 'General case' 0 C--N 1.33 -0.279 0 N-CA-C 112.187 0.44 . . . . 0.0 112.187 -174.199 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' B' B ' 120' ' ' LEU . . . . . . . . . . . . . 21.9 tp -53.28 123.67 12.51 Favored 'General case' 0 N--CA 1.464 0.254 0 CA-C-O 120.713 0.292 . . . . 0.0 110.953 178.221 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' B' B ' 121' ' ' ASN . . . . . . . . . . . . . 43.2 m-20 -106.37 -44.16 4.59 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-N 116.337 -0.392 . . . . 0.0 110.909 -177.533 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' B' B ' 122' ' ' LYS . . . . . . . . . . . . . 50.7 pttt -161.14 157.73 26.41 Favored 'General case' 0 C--N 1.331 -0.225 0 C-N-CA 120.454 -0.498 . . . . 0.0 112.204 -179.462 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' B' B ' 123' ' ' VAL . . . . . . . . . . . . . 44.0 t -125.6 131.16 72.4 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.246 0 CA-C-N 115.805 -0.634 . . . . 0.0 109.845 177.522 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' B' B ' 124' ' ' LEU . . . . . . . . . . . . . 76.8 mt -116.73 133.3 56.17 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.301 -0.408 . . . . 0.0 110.392 179.979 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' B' B ' 125' ' ' VAL . . . . . . . . . . . . . 47.3 t -131.74 129.51 61.27 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.215 0 CA-C-N 116.284 -0.417 . . . . 0.0 110.228 -179.057 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' B' B ' 126' ' ' ARG . . . . . . . . . . . . . 77.0 mtt180 -141.3 119.79 12.36 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-O 121.076 0.465 . . . . 0.0 110.458 176.538 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' B' B ' 127' ' ' ASN . . . . . . . . . . . . . 42.4 t-20 50.63 -106.47 0.24 Allowed 'General case' 0 CA--C 1.543 0.711 0 CA-C-O 119.003 -0.523 . . . . 0.0 111.37 -179.106 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' B' B ' 128' ' ' ASP . . . . . . . . . . . . . 11.7 p-10 -114.12 2.51 14.92 Favored 'General case' 0 N--CA 1.467 0.407 0 CA-C-N 119.642 1.11 . . . . 0.0 113.466 -177.334 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' B' B ' 129' ' ' LEU . . . . . . . . . . . . . 11.6 tp -104.96 136.85 43.68 Favored 'General case' 0 C--O 1.232 0.134 0 CA-C-N 118.267 0.485 . . . . 0.0 109.849 -179.916 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' B' B ' 130' ' ' VAL . . . . . . . . . . . . . 43.0 t -125.14 138.08 55.51 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.268 0 CA-C-O 121.061 0.457 . . . . 0.0 110.406 -176.885 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' B' B ' 131' ' ' VAL . . . . . 0.461 HG22 HD12 ' B' ' 140' ' ' LEU . 44.2 t -134.52 135.24 54.01 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.34 0 CA-C-N 115.895 -0.593 . . . . 0.0 110.008 177.915 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' B' B ' 132' ' ' ILE . . . . . 0.426 HD13 ' HE2' ' B' ' 117' ' ' PHE . 73.7 mt -115.79 132.28 65.69 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.281 0 N-CA-C 109.501 -0.555 . . . . 0.0 109.501 179.752 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' B' B ' 133' ' ' ILE . . . . . . . . . . . . . 42.7 mm -116.33 125.14 73.24 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.226 0 CA-C-N 116.569 -0.287 . . . . 0.0 111.074 -174.624 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' B' B ' 134' ' ' ASP . . . . . . . . . . . . . 10.1 p-10 -137.45 150.07 47.34 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 116.19 -0.459 . . . . 0.0 109.846 173.378 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' B' B ' 135' ' ' GLU . . . . . . . . . . . . . 40.1 tp10 -49.91 -27.2 4.91 Favored 'General case' 0 C--N 1.327 -0.371 0 N-CA-C 112.791 0.663 . . . . 0.0 112.791 -172.066 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' B' B ' 136' ' ' GLN . . . . . . . . . . . . . 63.2 tt0 -87.14 -33.72 19.32 Favored 'General case' 0 C--N 1.331 -0.221 0 N-CA-C 112.497 0.554 . . . . 0.0 112.497 -174.747 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' B' B ' 137' ' ' LYS . . . . . . . . . . . . . 48.3 pttt -162.1 171.22 17.84 Favored 'General case' 0 C--N 1.332 -0.181 0 CA-C-O 121.537 0.684 . . . . 0.0 112.525 -171.445 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' B' B ' 138' ' ' LEU . . . . . 0.427 ' C ' HD23 ' B' ' 138' ' ' LEU . 7.2 tt -121.45 128.74 52.45 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 114.918 -1.037 . . . . 0.0 109.896 178.531 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' B' B ' 139' ' ' THR . . . . . . . . . . . . . 39.4 m -108.18 127.13 53.55 Favored 'General case' 0 C--N 1.331 -0.221 0 CA-C-N 116.292 -0.413 . . . . 0.0 110.425 -179.929 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' B' B ' 140' ' ' LEU . . . . . 0.461 HD12 HG22 ' B' ' 131' ' ' VAL . 29.6 tp -112.2 120.9 43.35 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 115.788 -0.642 . . . . 0.0 109.531 -179.09 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' B' B ' 141' ' ' ILE . . . . . . . . . . . . . 19.1 mt -121.72 119.63 59.35 Favored 'Isoleucine or valine' 0 C--O 1.233 0.198 0 CA-C-O 121.09 0.471 . . . . 0.0 110.282 -175.249 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' B' B ' 142' ' ' ARG . . . . . . . . . . . . . 83.1 mtp180 -108.03 125.87 52.06 Favored 'General case' 0 C--N 1.331 -0.217 0 CA-C-N 115.206 -0.906 . . . . 0.0 110.091 179.044 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' B' B ' 143' ' ' THR . . . . . . . . . . . . . 15.2 p . . . . . 0 C--O 1.219 -0.501 0 CA-C-O 118.046 -0.978 . . . . 0.0 110.495 179.831 . . . . . . . . 0 0 . 1 . 012 nuclear nobuild full ' C' C ' -3' ' ' GLU . . . . . . . . . . . . . 96.1 mt-10 . . . . . 0 N--CA 1.489 1.499 0 N-CA-C 109.427 -0.583 . . . . 0.0 109.427 . . . . . . . . . 0 0 . 1 . 012 nuclear nobuild full ' C' C ' -2' ' ' GLY . . . . . . . . . . . . . . . -67.78 131.45 28.68 Favored Glycine 0 CA--C 1.524 0.641 0 N-CA-C 111.094 -0.802 . . . . 0.0 111.094 -179.348 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' C' C ' -1' ' ' VAL . . . . . . . . . . . . . 45.1 t -96.54 126.39 49.23 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 N-CA-C 109.689 -0.486 . . . . 0.0 109.689 178.98 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' C' C ' 0' ' ' ILE . . . . . . . . . . . . . 71.6 mt -120.31 139.29 48.07 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.222 0 CA-C-N 116.251 -0.431 . . . . 0.0 110.35 -177.599 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' C' C ' 1' ' ' MET . . . . . . . . . . . . . 25.2 ptp -143.51 149.09 36.98 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 115.947 -0.57 . . . . 0.0 110.411 178.253 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' C' C ' 2' ' ' SER . . . . . . . . . . . . . 4.1 p -118.89 132.49 56.1 Favored 'General case' 0 C--N 1.332 -0.184 0 CA-C-O 120.85 0.357 . . . . 0.0 110.826 -179.264 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' C' C ' 3' ' ' GLU . . . . . . . . . . . . . 57.0 mp0 -140.49 140.35 35.3 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.074 -0.512 . . . . 0.0 110.867 179.267 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' C' C ' 4' ' ' LEU . . . . . . . . . . . . . 14.8 tp -125.17 127.94 47.6 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.046 -0.525 . . . . 0.0 110.111 176.46 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' C' C ' 5' ' ' LYS . . . . . . . . . . . . . 87.9 mttt -109.3 122.93 48.41 Favored 'General case' 0 C--O 1.235 0.294 0 CA-C-O 120.66 0.267 . . . . 0.0 110.888 178.929 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' C' C ' 6' ' ' LEU . . . . . . . . . . . . . 67.2 mt -114.72 145.07 42.49 Favored 'General case' 0 N--CA 1.463 0.216 0 CA-C-N 115.676 -0.693 . . . . 0.0 110.362 179.491 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' C' C ' 7' ' ' LYS . . . . . . . . . . . . . 73.6 tttt -125.25 137.02 28.99 Favored Pre-proline 0 CA--C 1.534 0.335 0 CA-C-O 118.866 -0.588 . . . . 0.0 109.703 174.635 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' C' C ' 8' ' ' PRO . . . . . . . . . . . . . 83.5 Cg_endo -92.04 132.68 1.24 Allowed 'Trans proline' 0 N--CA 1.489 1.249 0 C-N-CA 121.663 1.575 . . . . 0.0 111.759 178.528 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' C' C ' 9' ' ' LEU . . . . . . . . . . . . . 55.7 mt -69.63 -46.74 25.76 Favored Pre-proline 0 CA--C 1.532 0.272 0 CA-C-O 118.742 -0.647 . . . . 0.0 112.079 -179.557 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' C' C ' 10' ' ' PRO . . . . . . . . . . . . . 88.4 Cg_endo -80.79 155.65 20.61 Favored 'Trans proline' 0 N--CA 1.495 1.611 0 C-N-CA 121.184 1.256 . . . . 0.0 111.78 174.769 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' C' C ' 11' ' ' LYS . . . . . . . . . . . . . 79.1 mttt -87.7 101.37 13.6 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.415 -0.357 . . . . 0.0 110.503 178.978 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' C' C ' 12' ' ' VAL . . . . . . . . . . . . . 12.2 p -145.33 144.36 21.45 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.299 0 CA-C-N 116.299 -0.41 . . . . 0.0 110.836 -179.251 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' C' C ' 13' ' ' GLU . . . . . . . . . . . . . 43.5 mt-10 -92.36 126.23 37.35 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.252 -0.431 . . . . 0.0 109.879 176.25 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' C' C ' 14' ' ' LEU . . . . . . . . . . . . . 17.3 mt -97.22 152.81 38.49 Favored Pre-proline 0 C--N 1.33 -0.267 0 CA-C-N 116.501 -0.318 . . . . 0.0 110.742 -177.649 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' C' C ' 15' ' ' PRO . . . . . . . . . . . . . 33.6 Cg_exo -59.77 159.23 25.44 Favored 'Trans proline' 0 N--CA 1.496 1.67 0 C-N-CA 121.311 1.341 . . . . 0.0 111.884 178.348 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' C' C ' 16' ' ' PRO . . . . . . . . . . . . . 29.6 Cg_exo -59.9 -34.84 95.15 Favored 'Trans proline' 0 N--CA 1.497 1.725 0 C-N-CA 121.383 1.389 . . . . 0.0 112.811 -177.675 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' C' C ' 17' ' ' ASP . . . . . . . . . . . . . 10.7 p-10 -90.18 8.74 31.46 Favored 'General case' 0 CA--C 1.536 0.423 0 N-CA-C 113.284 0.846 . . . . 0.0 113.284 -176.896 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' C' C ' 18' ' ' PHE . . . . . . . . . . . . . 53.6 t80 -57.8 -45.55 85.91 Favored 'General case' 0 C--N 1.334 -0.101 0 O-C-N 122.057 -0.402 . . . . 0.0 110.33 -178.516 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' C' C ' 19' ' ' VAL . . . . . . . . . . . . . 48.7 t -56.75 -42.11 76.62 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.289 0 CA-C-N 116.523 -0.308 . . . . 0.0 110.414 -178.633 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' C' C ' 20' ' ' ASP . . . . . . . . . . . . . 14.9 t0 -59.7 -44.0 93.87 Favored 'General case' 0 C--N 1.328 -0.352 0 C-N-CA 120.841 -0.343 . . . . 0.0 110.762 -177.939 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' C' C ' 21' ' ' VAL . . . . . . . . . . . . . 45.3 t -64.8 -46.28 92.51 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.279 0 C-N-CA 120.753 -0.379 . . . . 0.0 110.498 -177.636 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' C' C ' 22' ' ' ILE . . . . . 0.597 HG22 HD12 ' C' ' 26' ' ' LEU . 50.3 mm -56.9 -39.98 68.76 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.333 0 C-N-CA 120.983 -0.287 . . . . 0.0 110.637 179.957 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' C' C ' 23' ' ' ARG . . . . . . . . . . . . . 45.1 ttp180 -57.26 -50.38 73.09 Favored 'General case' 0 C--N 1.331 -0.21 0 C-N-CA 120.673 -0.411 . . . . 0.0 110.386 177.194 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' C' C ' 24' ' ' ILE . . . . . . . . . . . . . 71.8 mt -60.44 -39.84 82.35 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.335 0 CA-C-N 115.995 -0.548 . . . . 0.0 111.827 -176.824 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' C' C ' 25' ' ' LYS . . . . . . . . . . . . . 14.9 pttp -77.11 -37.28 54.56 Favored 'General case' 0 CA--C 1.534 0.33 0 C-N-CA 120.592 -0.443 . . . . 0.0 111.938 -173.597 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' C' C ' 26' ' ' LEU . . . . . 0.597 HD12 HG22 ' C' ' 22' ' ' ILE . 49.0 mt -79.43 -32.42 42.82 Favored 'General case' 0 C--N 1.333 -0.146 0 N-CA-C 113.479 0.918 . . . . 0.0 113.479 -173.083 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' C' C ' 27' ' ' GLN . . . . . . . . . . . . . 11.0 pt20 -46.32 139.54 4.72 Favored 'General case' 0 N--CA 1.47 0.538 0 N-CA-C 112.922 0.712 . . . . 0.0 112.922 -174.839 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' C' C ' 28' ' ' GLY . . . . . . . . . . . . . . . 99.86 -26.66 23.58 Favored Glycine 0 CA--C 1.531 1.084 0 CA-C-N 115.697 -0.683 . . . . 0.0 112.255 -177.528 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' C' C ' 29' ' ' LYS . . . . . . . . . . . . . 94.0 mttt -97.09 155.09 16.96 Favored 'General case' 0 C--N 1.332 -0.193 0 CA-C-N 117.351 0.575 . . . . 0.0 110.854 178.237 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' C' C ' 30' ' ' THR . . . . . . . . . . . . . 28.5 m -107.27 138.13 44.02 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 116.104 -0.498 . . . . 0.0 110.104 177.072 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' C' C ' 31' ' ' VAL . . . . . . . . . . . . . 34.4 m -127.51 151.97 34.99 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.244 0 CA-C-N 116.242 -0.435 . . . . 0.0 110.571 -179.393 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' C' C ' 32' ' ' ARG . . . . . . . . . . . . . 67.0 ttt180 -132.74 149.83 52.23 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-O 121.179 0.514 . . . . 0.0 110.267 179.809 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' C' C ' 33' ' ' THR . . . . . . . . . . . . . 26.1 m -52.82 138.4 29.56 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.368 -0.378 . . . . 0.0 111.499 -177.394 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' C' C ' 34' ' ' GLY . . . . . . . . . . . . . . . 101.42 -17.21 55.81 Favored Glycine 0 CA--C 1.534 1.278 0 CA-C-O 119.651 -0.527 . . . . 0.0 113.17 179.444 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' C' C ' 35' ' ' ASP . . . . . . . . . . . . . 75.2 m-20 -66.56 148.34 52.03 Favored 'General case' 0 N--CA 1.461 0.111 0 CA-C-N 118.072 0.936 . . . . 0.0 111.224 178.869 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' C' C ' 36' ' ' VAL . . . . . . . . . . . . . 42.5 t -121.5 129.0 75.97 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.247 0 CA-C-N 115.88 -0.6 . . . . 0.0 109.809 177.638 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' C' C ' 37' ' ' ILE . . . . . . . . . . . . . 64.5 mt -120.92 138.15 52.32 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.244 0 CA-C-N 116.237 -0.438 . . . . 0.0 109.948 -179.811 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' C' C ' 38' ' ' GLY . . . . . . . . . . . . . . . -116.47 126.93 7.25 Favored Glycine 0 CA--C 1.524 0.645 0 N-CA-C 110.828 -0.909 . . . . 0.0 110.828 178.402 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' C' C ' 39' ' ' ILE . . . . . . . . . . . . . 72.1 mt -123.71 131.18 73.45 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.247 0 N-CA-C 110.136 -0.32 . . . . 0.0 110.136 179.395 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' C' C ' 40' ' ' SER . . . . . . . . . . . . . 54.4 p -91.33 117.51 29.72 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.43 -0.35 . . . . 0.0 110.823 177.615 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' C' C ' 41' ' ' ILE . . . . . . . . . . . . . 72.6 mt -134.4 127.51 50.47 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.197 0 N-CA-C 110.067 -0.346 . . . . 0.0 110.067 177.857 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' C' C ' 42' ' ' LEU . . . . . . . . . . . . . 9.5 tp 57.73 34.72 24.8 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.163 -0.471 . . . . 0.0 111.562 178.258 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' C' C ' 43' ' ' GLY . . . . . . . . . . . . . . . 77.42 -10.08 24.52 Favored Glycine 0 CA--C 1.534 1.261 0 C-N-CA 121.334 -0.46 . . . . 0.0 113.467 177.32 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' C' C ' 44' ' ' LYS . . . . . . . . . . . . . 95.0 mttt -104.65 134.26 48.12 Favored 'General case' 0 C--N 1.333 -0.11 0 CA-C-N 117.993 0.897 . . . . 0.0 110.361 178.357 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' C' C ' 45' ' ' GLU . . . . . . . . . . . . . 84.8 tt0 -85.85 128.68 34.88 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.337 -0.392 . . . . 0.0 110.866 178.275 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' C' C ' 46' ' ' VAL . . . . . 0.403 ' O ' HG13 ' C' ' 46' ' ' VAL . 9.7 p -115.38 124.57 72.05 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.167 0 N-CA-C 109.417 -0.586 . . . . 0.0 109.417 175.219 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' C' C ' 47' ' ' LYS . . . . . . . . . . . . . 98.5 mttt -98.96 122.91 42.84 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.021 -0.536 . . . . 0.0 110.673 178.562 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' C' C ' 48' ' ' PHE . . . . . . . . . . . . . 40.2 m-85 -109.78 131.86 54.68 Favored 'General case' 0 C--N 1.329 -0.283 0 N-CA-C 109.607 -0.516 . . . . 0.0 109.607 177.5 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' C' C ' 49' ' ' LYS . . . . . . . . . . . . . 48.5 tttp -108.12 133.64 52.11 Favored 'General case' 0 C--N 1.329 -0.285 0 N-CA-C 109.96 -0.385 . . . . 0.0 109.96 178.201 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' C' C ' 50' ' ' VAL . . . . . . . . . . . . . 44.5 t -74.91 107.04 5.1 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.322 0 N-CA-C 109.261 -0.644 . . . . 0.0 109.261 177.854 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' C' C ' 51' ' ' VAL . . . . . . . . . . . . . 46.4 t -71.14 -48.91 52.29 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.252 0 CA-C-N 116.155 -0.475 . . . . 0.0 109.731 -174.735 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' C' C ' 52' ' ' GLN . . . . . . . . . . . . . 50.3 tt0 -163.73 139.49 6.49 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 115.823 -0.626 . . . . 0.0 111.442 -178.859 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' C' C ' 53' ' ' ALA . . . . . . . . . . . . . . . -116.13 132.88 56.53 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-N 115.78 -0.646 . . . . 0.0 109.728 174.863 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' C' C ' 54' ' ' TYR . . . . . . . . . . . . . 46.8 t80 -129.02 111.88 18.48 Favored Pre-proline 0 CA--C 1.535 0.397 0 CA-C-O 118.22 -0.895 . . . . 0.0 110.395 179.455 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' C' C ' 55' ' ' PRO . . . . . . . . . . . . . 73.2 Cg_endo -77.27 169.04 75.18 Favored 'Cis proline' 0 N--CA 1.501 1.912 0 CA-C-N 121.897 1.713 . . . . 0.0 112.22 -6.949 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' C' C ' 56' ' ' SER . . . . . . . . . . . . . 15.4 m -116.84 137.21 23.57 Favored Pre-proline 0 CA--C 1.538 0.495 0 CA-C-O 118.552 -0.737 . . . . 0.0 109.667 175.477 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' C' C ' 57' ' ' PRO . . . . . . . . . . . . . 48.6 Cg_endo -70.38 145.67 81.44 Favored 'Cis proline' 0 N--CA 1.497 1.701 0 CA-C-N 121.683 1.637 . . . . 0.0 111.334 -3.955 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' C' C ' 58' ' ' LEU . . . . . . . . . . . . . 19.3 tp -106.89 135.91 47.64 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.469 -0.332 . . . . 0.0 110.659 -177.402 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' C' C ' 59' ' ' ARG . . . . . . . . . . . . . 28.6 ttm180 -100.97 126.77 47.65 Favored 'General case' 0 C--N 1.327 -0.409 0 N-CA-C 109.51 -0.552 . . . . 0.0 109.51 176.134 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' C' C ' 60' ' ' VAL . . . . . . . . . . . . . 43.3 t -76.01 116.4 18.96 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.249 0 C-N-CA 120.729 -0.388 . . . . 0.0 110.047 -177.202 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' C' C ' 61' ' ' GLU . . . . . . . . . . . . . 95.8 mt-10 -131.02 167.32 19.24 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 115.84 -0.618 . . . . 0.0 110.104 178.994 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' C' C ' 62' ' ' ASP . . . . . . . . . . . . . 12.1 p-10 -55.65 -32.47 63.22 Favored 'General case' 0 C--N 1.328 -0.351 0 N-CA-C 111.837 0.31 . . . . 0.0 111.837 -178.46 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' C' C ' 63' ' ' ARG . . . . . . . . . . . . . 40.4 ptt180 -82.52 0.52 42.17 Favored 'General case' 0 CA--C 1.537 0.463 0 N-CA-C 113.749 1.018 . . . . 0.0 113.749 -175.068 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' C' C ' 64' ' ' THR . . . . . . . . . . . . . 33.2 m -82.55 134.33 35.19 Favored 'General case' 0 C--N 1.333 -0.151 0 CA-C-N 118.159 0.436 . . . . 0.0 110.903 -176.258 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' C' C ' 65' ' ' LYS . . . . . . . . . . . . . 53.6 mtmt -89.26 127.35 35.76 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 115.935 -0.575 . . . . 0.0 109.879 177.017 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' C' C ' 66' ' ' ILE . . . . . . . . . . . . . 64.5 mt -111.82 126.6 69.23 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.314 0 N-CA-C 109.656 -0.498 . . . . 0.0 109.656 -179.115 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' C' C ' 67' ' ' THR . . . . . . . . . . . . . 23.5 m -124.49 144.69 49.96 Favored 'General case' 0 C--N 1.331 -0.229 0 CA-C-O 121.281 0.562 . . . . 0.0 111.227 -175.453 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' C' C ' 68' ' ' LEU . . . . . . . . . . . . . 20.6 tp -100.33 135.72 41.33 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 115.573 -0.74 . . . . 0.0 110.243 177.731 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' C' C ' 69' ' ' VAL . . . . . . . . . . . . . 46.0 t -82.94 134.31 27.19 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 N-CA-C 109.839 -0.43 . . . . 0.0 109.839 178.931 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' C' C ' 70' ' ' THR . . . . . . . . . . . . . 33.6 p -107.25 -175.96 2.94 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 116.11 -0.495 . . . . 0.0 110.964 -177.049 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' C' C ' 71' ' ' HIS . . . . . . . . . . . . . 84.7 m-70 -64.94 158.41 70.69 Favored Pre-proline 0 C--N 1.329 -0.296 0 CA-C-N 115.848 -0.615 . . . . 0.0 110.207 179.895 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' C' C ' 72' ' ' PRO . . . . . . . . . . . . . 32.1 Cg_endo -64.85 -20.14 64.45 Favored 'Trans proline' 0 N--CA 1.498 1.74 0 C-N-CA 121.241 1.294 . . . . 0.0 112.993 -178.622 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' C' C ' 73' ' ' VAL . . . . . . . . . . . . . 31.5 m -127.19 146.56 32.84 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.184 0 CA-C-O 121.077 0.465 . . . . 0.0 110.844 178.456 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' C' C ' 74' ' ' ASP . . . . . . . . . . . . . 26.0 t0 -98.47 122.07 41.2 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-N 115.571 -0.741 . . . . 0.0 109.411 177.19 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' C' C ' 75' ' ' VAL . . . . . 0.403 ' C ' HD12 ' C' ' 76' ' ' LEU . 44.3 t -114.09 123.78 70.09 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.226 0 CA-C-O 121.095 0.474 . . . . 0.0 110.742 -176.38 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' C' C ' 76' ' ' LEU . . . . . 0.403 HD12 ' C ' ' C' ' 75' ' ' VAL . 5.9 mp -124.93 144.8 50.16 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 115.669 -0.696 . . . . 0.0 109.696 175.288 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' C' C ' 77' ' ' GLU . . . . . . . . . . . . . 97.3 mt-10 -134.12 134.92 42.78 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-O 120.98 0.419 . . . . 0.0 111.141 -178.219 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' C' C ' 78' ' ' ALA . . . . . . . . . . . . . . . -120.19 135.44 54.98 Favored 'General case' 0 C--N 1.331 -0.219 0 CA-C-N 115.825 -0.625 . . . . 0.0 109.953 177.166 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' C' C ' 79' ' ' LYS . . . . . 0.606 ' O ' HD13 ' C' ' 80' ' ' ILE . 28.9 mtpp -84.0 117.1 23.17 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-O 120.81 0.338 . . . . 0.0 110.79 -177.91 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' C' C ' 80' ' ' ILE . . . . . 0.606 HD13 ' O ' ' C' ' 79' ' ' LYS . 41.6 mm -139.15 112.15 6.2 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.28 0 N-CA-C 109.355 -0.609 . . . . 0.0 109.355 -177.877 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' C' C ' 81' ' ' LYS . . . . . . . . . . . . . 49.6 pttt -98.72 125.96 44.19 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-O 120.969 0.414 . . . . 0.0 111.402 -177.922 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' C' C ' 82' ' ' GLY . . . . . . . . . . . . . . . 89.05 42.18 5.69 Favored Glycine 0 CA--C 1.526 0.73 0 C-N-CA 121.003 -0.618 . . . . 0.0 112.013 174.25 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' C' C ' 83' ' ' ILE . . . . . . . . . . . . . 72.7 mt -71.23 135.57 27.71 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.281 0 N-CA-C 109.326 -0.62 . . . . 0.0 109.326 176.038 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' C' C ' 84' ' ' LYS . . . . . . . . . . . . . 28.4 ttpp -102.68 -51.27 3.35 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-O 120.913 0.387 . . . . 0.0 110.597 -177.289 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' C' C ' 85' ' ' ASP . . . . . . . . . . . . . 8.5 t0 -143.69 144.07 31.7 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.008 -0.542 . . . . 0.0 110.545 -178.651 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' C' C ' 86' ' ' VAL . . . . . . . . . . . . . 42.9 t -125.91 131.19 72.1 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 CA-C-O 120.897 0.38 . . . . 0.0 110.24 179.742 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' C' C ' 87' ' ' ILE . . . . . 0.49 ' N ' HD12 ' C' ' 87' ' ' ILE . 5.1 mp -119.23 125.39 74.41 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.261 0 N-CA-C 109.573 -0.528 . . . . 0.0 109.573 176.808 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' C' C ' 88' ' ' LEU . . . . . . . . . . . . . 11.6 tp -115.91 131.35 56.96 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-O 120.992 0.425 . . . . 0.0 110.992 -177.159 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' C' C ' 89' ' ' ASP . . . . . . . . . . . . . 9.5 t70 -128.19 158.86 36.93 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-N 115.906 -0.588 . . . . 0.0 109.495 176.625 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' C' C ' 90' ' ' GLU . . . . . . . . . . . . . 83.7 tt0 -46.92 -38.81 11.12 Favored 'General case' 0 CA--C 1.531 0.217 0 N-CA-C 113.029 0.752 . . . . 0.0 113.029 -171.905 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' C' C ' 91' ' ' ASN . . . . . . . . . . . . . 30.5 t30 -132.09 26.36 4.56 Favored 'General case' 0 N--CA 1.467 0.416 0 N-CA-C 112.552 0.575 . . . . 0.0 112.552 -177.553 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' C' C ' 92' ' ' LEU . . . . . . . . . . . . . 9.2 mt -149.32 142.38 24.91 Favored 'General case' 0 C--N 1.331 -0.238 0 N-CA-C 109.98 -0.378 . . . . 0.0 109.98 -177.843 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' C' C ' 93' ' ' ILE . . . . . . . . . . . . . 75.3 mt -127.43 117.71 47.66 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.283 0 N-CA-C 109.38 -0.6 . . . . 0.0 109.38 177.256 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' C' C ' 94' ' ' VAL . . . . . 0.53 HG21 HG11 ' C' ' 125' ' ' VAL . 44.1 t -122.9 127.55 74.84 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.225 0 CA-C-O 120.959 0.409 . . . . 0.0 110.066 -179.229 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' C' C ' 95' ' ' VAL . . . . . . . . . . . . . 44.8 t -120.34 132.62 69.47 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.355 0 CA-C-N 115.886 -0.597 . . . . 0.0 109.688 -179.982 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' C' C ' 96' ' ' ILE . . . . . . . . . . . . . 66.3 mt -115.58 128.5 72.79 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.243 0 N-CA-C 109.218 -0.66 . . . . 0.0 109.218 178.789 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' C' C ' 97' ' ' THR . . . . . . . . . . . . . 67.6 p -101.53 160.46 14.42 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-O 121.144 0.497 . . . . 0.0 111.131 -176.949 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' C' C ' 98' ' ' GLU . . . . . . . . . . . . . 96.8 mt-10 -54.01 -26.6 27.14 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.117 -0.492 . . . . 0.0 112.284 -179.318 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' C' C ' 99' ' ' GLU . . . . . . . . . . . . . 71.0 mm-40 -79.18 15.65 1.13 Allowed 'General case' 0 CA--C 1.534 0.342 0 N-CA-C 113.183 0.808 . . . . 0.0 113.183 -177.549 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' C' C ' 100' ' ' ASN . . . . . . . . . . . . . 3.2 m-20 61.6 38.08 15.7 Favored 'General case' 0 N--CA 1.463 0.191 0 CA-C-O 121.14 0.495 . . . . 0.0 110.978 178.476 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' C' C ' 101' ' ' GLU . . . . . . . . . . . . . 84.6 tt0 -114.44 141.14 48.05 Favored 'General case' 0 C--N 1.332 -0.169 0 CA-C-N 116.108 -0.496 . . . . 0.0 109.762 176.306 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' C' C ' 102' ' ' VAL . . . . . . . . . . . . . 43.0 t -115.13 125.79 72.52 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.324 0 CA-C-N 116.17 -0.468 . . . . 0.0 109.894 -178.234 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' C' C ' 103' ' ' LEU . . . . . . . . . . . . . 34.9 mt -115.41 129.0 56.44 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 115.732 -0.667 . . . . 0.0 109.9 175.821 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' C' C ' 104' ' ' ILE . . . . . 0.609 HD13 HG11 ' C' ' 130' ' ' VAL . 65.1 mt -117.19 120.56 65.37 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.193 0 N-CA-C 110.261 -0.274 . . . . 0.0 110.261 -178.273 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' C' C ' 105' ' ' PHE . . . . . . . . . . . . . 56.9 m-85 -122.12 166.27 14.82 Favored 'General case' 0 C--N 1.333 -0.119 0 O-C-N 124.009 0.818 . . . . 0.0 109.722 178.931 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' C' C ' 106' ' ' ASN . . . . . . . . . . . . . 46.3 p-10 -101.07 -171.15 1.95 Allowed 'General case' 0 C--N 1.331 -0.203 0 N-CA-C 110.062 -0.347 . . . . 0.0 110.062 173.714 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' C' C ' 107' ' ' GLN . . . . . . . . . . . . . 46.2 tt0 -60.34 -26.97 66.98 Favored 'General case' 0 CA--C 1.533 0.31 0 N-CA-C 112.142 0.423 . . . . 0.0 112.142 179.494 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' C' C ' 108' ' ' ASN . . . . . . . . . . . . . 53.3 t30 -84.2 6.96 20.62 Favored 'General case' 0 CA--C 1.537 0.459 0 N-CA-C 113.159 0.8 . . . . 0.0 113.159 -178.343 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' C' C ' 109' ' ' LEU . . . . . . . . . . . . . 11.9 tp 61.64 36.86 16.42 Favored 'General case' 0 C--O 1.232 0.177 0 CA-C-O 120.932 0.396 . . . . 0.0 111.405 179.013 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' C' C ' 110' ' ' GLU . . . . . . . . . . . . . 95.7 mt-10 -108.01 153.46 23.06 Favored 'General case' 0 C--N 1.33 -0.262 0 N-CA-C 109.6 -0.519 . . . . 0.0 109.6 175.059 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' C' C ' 111' ' ' GLU . . . . . . . . . . . . . 55.8 tt0 -90.73 124.14 34.87 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-O 121.017 0.437 . . . . 0.0 111.146 -174.694 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' C' C ' 112' ' ' LEU . . . . . . . . . . . . . 25.6 mt -106.84 -46.07 4.04 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 115.87 -0.604 . . . . 0.0 110.914 179.787 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' C' C ' 113' ' ' TYR . . . . . 0.504 ' HB3' HD12 ' C' ' 104' ' ' ILE . 49.0 t80 -137.63 141.44 41.21 Favored 'General case' 0 C--N 1.331 -0.209 0 CA-C-N 116.319 -0.401 . . . . 0.0 110.802 -177.367 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' C' C ' 114' ' ' ARG . . . . . . . . . . . . . 36.7 ptt-85 -145.39 125.03 13.25 Favored 'General case' 0 C--N 1.331 -0.235 0 C-N-CA 120.94 -0.304 . . . . 0.0 110.825 178.002 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' C' C ' 115' ' ' GLY . . . . . . . . . . . . . . . -150.19 160.78 28.69 Favored Glycine 0 CA--C 1.525 0.666 0 C-N-CA 120.699 -0.762 . . . . 0.0 111.408 179.791 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' C' C ' 116' ' ' LYS . . . . . . . . . . . . . 36.7 ttpt -125.75 130.15 50.91 Favored 'General case' 0 C--N 1.331 -0.219 0 N-CA-C 109.412 -0.588 . . . . 0.0 109.412 174.344 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' C' C ' 117' ' ' PHE . . . . . . . . . . . . . 49.9 m-85 -130.56 114.64 15.72 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-O 120.958 0.409 . . . . 0.0 110.598 -174.215 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' C' C ' 118' ' ' GLU . . . . . . . . . . . . . 46.2 tp10 -52.88 -51.28 61.72 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.301 -0.409 . . . . 0.0 111.622 -176.086 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' C' C ' 119' ' ' ASN . . . . . . . . . . . . . 28.9 m120 -95.41 31.01 2.07 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.259 -0.428 . . . . 0.0 112.075 -174.103 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' C' C ' 120' ' ' LEU . . . . . . . . . . . . . 19.3 tp -54.94 122.54 11.09 Favored 'General case' 0 C--O 1.232 0.157 0 CA-C-O 120.729 0.299 . . . . 0.0 110.813 179.228 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' C' C ' 121' ' ' ASN . . . . . . . . . . . . . 17.3 m120 -103.26 -44.07 5.28 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.399 -0.364 . . . . 0.0 110.681 -177.316 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' C' C ' 122' ' ' LYS . . . . . . . . . . . . . 24.2 pttm -166.96 155.11 9.71 Favored 'General case' 0 C--N 1.331 -0.219 0 C-N-CA 120.572 -0.451 . . . . 0.0 111.843 -179.732 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' C' C ' 123' ' ' VAL . . . . . . . . . . . . . 43.0 t -123.33 135.26 63.82 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.284 0 CA-C-N 116.021 -0.536 . . . . 0.0 109.626 176.82 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' C' C ' 124' ' ' LEU . . . . . . . . . . . . . 31.5 mt -128.19 142.19 51.25 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-O 120.954 0.407 . . . . 0.0 110.977 -177.604 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' C' C ' 125' ' ' VAL . . . . . 0.53 HG11 HG21 ' C' ' 94' ' ' VAL . 35.9 m -133.48 141.18 45.07 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.293 0 CA-C-N 115.994 -0.548 . . . . 0.0 110.55 178.16 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' C' C ' 126' ' ' ARG . . . . . . . . . . . . . 19.6 ttm180 -162.86 127.61 3.1 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.122 -0.49 . . . . 0.0 109.72 178.196 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' C' C ' 127' ' ' ASN . . . . . . . . . . . . . 36.0 m120 56.4 -150.78 0.43 Allowed 'General case' 0 CA--C 1.541 0.627 0 N-CA-C 109.519 -0.548 . . . . 0.0 109.519 -176.494 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' C' C ' 128' ' ' ASP . . . . . . . . . . . . . 12.7 p-10 -82.35 16.32 2.1 Favored 'General case' 0 CA--C 1.535 0.393 0 CA-C-N 118.875 0.761 . . . . 0.0 112.762 178.725 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' C' C ' 129' ' ' LEU . . . . . . . . . . . . . 17.9 tp -107.22 133.31 51.98 Favored 'General case' 0 C--O 1.232 0.141 0 CA-C-N 118.084 0.402 . . . . 0.0 110.51 179.845 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' C' C ' 130' ' ' VAL . . . . . 0.609 HG11 HD13 ' C' ' 104' ' ' ILE . 45.2 t -121.71 133.25 68.72 Favored 'Isoleucine or valine' 0 C--N 1.333 -0.144 0 N-CA-C 109.374 -0.602 . . . . 0.0 109.374 177.787 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' C' C ' 131' ' ' VAL . . . . . 0.548 HG22 HD12 ' C' ' 140' ' ' LEU . 43.9 t -135.28 136.61 51.09 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.208 0 CA-C-O 121.084 0.468 . . . . 0.0 110.919 -177.904 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' C' C ' 132' ' ' ILE . . . . . . . . . . . . . 69.8 mt -116.69 128.91 73.94 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.292 0 CA-C-N 115.658 -0.701 . . . . 0.0 109.231 178.302 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' C' C ' 133' ' ' ILE . . . . . . . . . . . . . 42.1 mm -114.49 123.58 70.3 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.213 0 CA-C-O 120.741 0.305 . . . . 0.0 110.947 -175.239 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' C' C ' 134' ' ' ASP . . . . . . . . . . . . . 8.9 p-10 -135.31 146.65 48.68 Favored 'General case' 0 C--N 1.331 -0.2 0 N-CA-C 109.553 -0.536 . . . . 0.0 109.553 173.396 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' C' C ' 135' ' ' GLU . . . . . . . . . . . . . 85.4 tt0 -50.09 -26.17 4.18 Favored 'General case' 0 C--N 1.327 -0.405 0 N-CA-C 112.878 0.695 . . . . 0.0 112.878 -172.696 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' C' C ' 136' ' ' GLN . . . . . . . . . . . . . 96.1 mt-30 -85.18 -30.63 23.77 Favored 'General case' 0 C--O 1.234 0.278 0 N-CA-C 112.581 0.585 . . . . 0.0 112.581 -175.384 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' C' C ' 137' ' ' LYS . . . . . . . . . . . . . 19.8 pttp -168.19 170.14 10.41 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-O 121.513 0.673 . . . . 0.0 112.242 -173.29 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' C' C ' 138' ' ' LEU . . . . . 0.453 HD23 ' C ' ' C' ' 138' ' ' LEU . 7.4 tt -118.89 128.16 54.17 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 115.126 -0.943 . . . . 0.0 109.933 -179.9 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' C' C ' 139' ' ' THR . . . . . . . . . . . . . 39.1 m -109.03 126.11 52.78 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-N 116.246 -0.434 . . . . 0.0 110.09 178.63 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' C' C ' 140' ' ' LEU . . . . . 0.548 HD12 HG22 ' C' ' 131' ' ' VAL . 9.0 tp -112.77 123.4 50.22 Favored 'General case' 0 C--N 1.329 -0.303 0 N-CA-C 109.292 -0.633 . . . . 0.0 109.292 -178.588 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' C' C ' 141' ' ' ILE . . . . . . . . . . . . . 19.0 mt -121.9 125.53 73.33 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.29 0 CA-C-O 121.085 0.469 . . . . 0.0 110.303 -173.887 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' C' C ' 142' ' ' ARG . . . . . . . . . . . . . 23.2 mmm180 -109.44 129.33 55.55 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 115.459 -0.791 . . . . 0.0 109.93 179.13 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' C' C ' 143' ' ' THR . . . . . . . . . . . . . 26.9 p . . . . . 0 C--O 1.22 -0.493 0 CA-C-O 117.997 -1.002 . . . . 0.0 110.628 -179.465 . . . . . . . . 0 0 . 1 . 012 nuclear nobuild full ' D' D ' -3' ' ' GLU . . . . . . . . . . . . . 95.7 mt-10 . . . . . 0 N--CA 1.489 1.514 0 N-CA-C 109.362 -0.607 . . . . 0.0 109.362 . . . . . . . . . 0 0 . 1 . 012 nuclear nobuild full ' D' D ' -2' ' ' GLY . . . . . . . . . . . . . . . -82.71 144.77 23.29 Favored Glycine 0 CA--C 1.525 0.678 0 N-CA-C 111.041 -0.823 . . . . 0.0 111.041 179.872 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' D' D ' -1' ' ' VAL . . . . . . . . . . . . . 47.3 t -142.1 143.61 26.32 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.249 0 N-CA-C 110.039 -0.356 . . . . 0.0 110.039 179.731 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' D' D ' 0' ' ' ILE . . . . . . . . . . . . . 69.6 mt -99.83 130.61 48.67 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.258 0 N-CA-C 109.869 -0.419 . . . . 0.0 109.869 179.569 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' D' D ' 1' ' ' MET . . . . . . . . . . . . . 25.4 ptt? -80.32 136.52 36.43 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.319 -0.401 . . . . 0.0 110.659 -179.197 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' D' D ' 2' ' ' SER . . . . . . . . . . . . . 4.4 p -106.01 128.78 54.06 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-O 121.009 0.433 . . . . 0.0 110.374 178.704 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' D' D ' 3' ' ' GLU . . . . . . . . . . . . . 85.0 tt0 -141.12 139.65 34.0 Favored 'General case' 0 C--N 1.326 -0.424 0 CA-C-N 115.873 -0.603 . . . . 0.0 111.147 -177.957 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' D' D ' 4' ' ' LEU . . . . . . . . . . . . . 18.0 tp -123.68 125.61 45.09 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 115.936 -0.575 . . . . 0.0 110.084 176.956 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' D' D ' 5' ' ' LYS . . . . . . . . . . . . . 67.1 mttm -104.22 119.91 40.0 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.218 -0.446 . . . . 0.0 110.401 178.768 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' D' D ' 6' ' ' LEU . . . . . . . . . . . . . 59.1 mt -116.32 147.31 41.69 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 115.393 -0.821 . . . . 0.0 110.324 -178.241 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' D' D ' 7' ' ' LYS . . . . . . . . . . . . . 83.7 tttt -134.67 136.23 25.03 Favored Pre-proline 0 CA--C 1.535 0.372 0 CA-C-O 118.931 -0.557 . . . . 0.0 109.844 176.254 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' D' D ' 8' ' ' PRO . . . . . . . . . . . . . 90.2 Cg_endo -91.6 140.59 2.52 Favored 'Trans proline' 0 N--CA 1.488 1.195 0 C-N-CA 121.751 1.634 . . . . 0.0 111.506 177.323 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' D' D ' 9' ' ' LEU . . . . . . . . . . . . . 62.3 mt -75.55 -47.9 4.07 Favored Pre-proline 0 CA--C 1.534 0.355 0 CA-C-O 118.586 -0.721 . . . . 0.0 112.336 -178.525 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' D' D ' 10' ' ' PRO . . . . . . . . . . . . . 88.1 Cg_endo -80.01 154.92 22.81 Favored 'Trans proline' 0 N--CA 1.497 1.689 0 C-N-CA 121.224 1.282 . . . . 0.0 112.187 177.166 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' D' D ' 11' ' ' LYS . . . . . . . . . . . . . 55.0 tptt -85.97 100.0 11.83 Favored 'General case' 0 C--N 1.328 -0.329 0 N-CA-C 109.914 -0.402 . . . . 0.0 109.914 176.767 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' D' D ' 12' ' ' VAL . . . . . . . . . . . . . 12.2 p -141.17 146.14 24.04 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.346 0 CA-C-O 120.956 0.408 . . . . 0.0 110.819 -178.386 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' D' D ' 13' ' ' GLU . . . . . . . . . . . . . 95.6 mt-10 -93.57 114.86 27.31 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 115.99 -0.55 . . . . 0.0 109.76 176.324 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' D' D ' 14' ' ' LEU . . . . . . . . . . . . . 38.8 mt -87.75 151.96 50.8 Favored Pre-proline 0 C--N 1.329 -0.304 0 CA-C-N 116.442 -0.344 . . . . 0.0 110.718 -177.164 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' D' D ' 15' ' ' PRO . . . . . . . . . . . . . 33.7 Cg_exo -57.34 158.66 18.07 Favored 'Trans proline' 0 N--CA 1.496 1.62 0 C-N-CA 121.26 1.306 . . . . 0.0 111.809 179.511 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' D' D ' 16' ' ' PRO . . . . . . . . . . . . . 30.7 Cg_exo -59.31 -36.64 94.15 Favored 'Trans proline' 0 N--CA 1.497 1.701 0 C-N-CA 121.432 1.421 . . . . 0.0 112.845 -177.776 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' D' D ' 17' ' ' ASP . . . . . . . . . . . . . 22.0 p-10 -89.96 11.29 20.94 Favored 'General case' 0 CA--C 1.537 0.46 0 N-CA-C 113.139 0.792 . . . . 0.0 113.139 -177.939 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' D' D ' 18' ' ' PHE . . . . . . . . . . . . . 47.7 t80 -58.0 -42.97 86.34 Favored 'General case' 0 N--CA 1.457 -0.108 0 O-C-N 121.983 -0.448 . . . . 0.0 110.16 -178.451 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' D' D ' 19' ' ' VAL . . . . . . . . . . . . . 48.1 t -57.51 -42.48 81.06 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.326 0 CA-C-N 116.244 -0.435 . . . . 0.0 110.376 -179.067 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' D' D ' 20' ' ' ASP . . . . . . . . . . . . . 11.7 t70 -59.62 -42.8 93.48 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-O 120.756 0.313 . . . . 0.0 110.857 -177.802 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' D' D ' 21' ' ' VAL . . . . . . . . . . . . . 46.5 t -64.42 -47.6 88.74 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.303 0 C-N-CA 120.74 -0.384 . . . . 0.0 110.507 -177.999 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' D' D ' 22' ' ' ILE . . . . . 0.72 HG22 HD12 ' D' ' 26' ' ' LEU . 49.9 mm -58.53 -38.46 70.72 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.283 0 C-N-CA 120.904 -0.319 . . . . 0.0 110.734 -179.644 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' D' D ' 23' ' ' ARG . . . . . . . . . . . . . 55.1 ttp180 -56.62 -49.23 75.56 Favored 'General case' 0 C--N 1.331 -0.22 0 CA-C-O 120.837 0.351 . . . . 0.0 110.533 178.066 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' D' D ' 24' ' ' ILE . . . . . . . . . . . . . 74.5 mt -61.26 -43.45 96.53 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.272 0 CA-C-N 116.04 -0.527 . . . . 0.0 111.968 -177.883 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' D' D ' 25' ' ' LYS . . . . . . . . . . . . . 15.1 pttp -71.65 -36.59 70.75 Favored 'General case' 0 CA--C 1.533 0.315 0 C-N-CA 120.364 -0.534 . . . . 0.0 111.702 -173.621 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' D' D ' 26' ' ' LEU . . . . . 0.72 HD12 HG22 ' D' ' 22' ' ' ILE . 18.9 mt -78.16 -43.38 28.86 Favored 'General case' 0 C--N 1.332 -0.177 0 N-CA-C 112.735 0.643 . . . . 0.0 112.735 -173.558 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' D' D ' 27' ' ' GLN . . . . . . . . . . . . . 11.1 pt20 -47.58 137.86 8.62 Favored 'General case' 0 N--CA 1.468 0.472 0 N-CA-C 112.647 0.61 . . . . 0.0 112.647 -175.946 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' D' D ' 28' ' ' GLY . . . . . . . . . . . . . . . 100.17 -27.38 20.6 Favored Glycine 0 CA--C 1.534 1.231 0 CA-C-N 115.631 -0.713 . . . . 0.0 112.013 -176.35 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' D' D ' 29' ' ' LYS . . . . . . . . . . . . . 56.1 mttm -98.52 155.16 17.41 Favored 'General case' 0 C--O 1.233 0.215 0 CA-C-N 117.144 0.472 . . . . 0.0 110.979 179.267 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' D' D ' 30' ' ' THR . . . . . . . . . . . . . 39.5 m -106.38 139.46 40.83 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 116.13 -0.486 . . . . 0.0 110.03 175.668 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' D' D ' 31' ' ' VAL . . . . . . . . . . . . . 34.5 m -128.66 158.67 40.97 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.289 0 CA-C-N 116.305 -0.407 . . . . 0.0 110.847 -178.304 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' D' D ' 32' ' ' ARG . . . . . . . . . . . . . 59.7 mtm180 -135.5 149.48 49.52 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.048 -0.523 . . . . 0.0 110.587 178.415 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' D' D ' 33' ' ' THR . . . . . . . . . . . . . 25.6 m -53.67 139.88 30.94 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.346 -0.388 . . . . 0.0 111.323 -178.186 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' D' D ' 34' ' ' GLY . . . . . . . . . . . . . . . 100.47 -17.13 57.18 Favored Glycine 0 CA--C 1.533 1.185 0 CA-C-O 119.702 -0.499 . . . . 0.0 113.304 178.672 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' D' D ' 35' ' ' ASP . . . . . . . . . . . . . 79.9 m-20 -66.2 147.88 52.66 Favored 'General case' 0 C--O 1.232 0.143 0 CA-C-N 118.053 0.926 . . . . 0.0 111.14 178.931 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' D' D ' 36' ' ' VAL . . . . . . . . . . . . . 45.1 t -123.42 131.13 73.68 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.224 0 CA-C-N 116.007 -0.542 . . . . 0.0 109.908 178.111 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' D' D ' 37' ' ' ILE . . . . . . . . . . . . . 66.4 mt -122.36 139.69 48.52 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.268 0 CA-C-N 116.28 -0.418 . . . . 0.0 110.042 -178.454 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' D' D ' 38' ' ' GLY . . . . . . . . . . . . . . . -111.81 128.77 8.76 Favored Glycine 0 CA--C 1.526 0.759 0 N-CA-C 111.08 -0.808 . . . . 0.0 111.08 179.472 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' D' D ' 39' ' ' ILE . . . . . . . . . . . . . 71.2 mt -122.54 134.18 66.5 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.187 0 N-CA-C 110.077 -0.342 . . . . 0.0 110.077 179.071 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' D' D ' 40' ' ' SER . . . . . . . . . . . . . 35.0 t -93.58 124.32 37.49 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.412 -0.358 . . . . 0.0 111.009 176.6 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' D' D ' 41' ' ' ILE . . . . . . . . . . . . . 71.3 mt -129.22 118.41 46.13 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.171 0 CA-C-O 120.826 0.346 . . . . 0.0 110.371 177.954 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' D' D ' 42' ' ' LEU . . . . . . . . . . . . . 56.2 mt 51.94 35.96 17.2 Favored 'General case' 0 C--O 1.233 0.201 0 CA-C-N 116.182 -0.463 . . . . 0.0 111.882 176.107 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' D' D ' 43' ' ' GLY . . . . . . . . . . . . . . . 73.98 31.65 59.65 Favored Glycine 0 CA--C 1.53 0.988 0 C-N-CA 121.115 -0.564 . . . . 0.0 112.123 178.162 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' D' D ' 44' ' ' LYS . . . . . . . . . . . . . 53.4 tttm -137.21 128.28 27.66 Favored 'General case' 0 C--N 1.329 -0.316 0 N-CA-C 109.536 -0.542 . . . . 0.0 109.536 177.94 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' D' D ' 45' ' ' GLU . . . . . . . . . . . . . 84.4 tt0 -83.83 123.14 29.6 Favored 'General case' 0 C--N 1.329 -0.318 0 C-N-CA 120.748 -0.381 . . . . 0.0 111.244 -177.766 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' D' D ' 46' ' ' VAL . . . . . . . . . . . . . 7.5 p -121.06 127.2 75.88 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.226 0 N-CA-C 109.342 -0.614 . . . . 0.0 109.342 175.497 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' D' D ' 47' ' ' LYS . . . . . . . . . . . . . 97.9 mttt -100.83 130.28 46.82 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.121 -0.491 . . . . 0.0 111.486 179.702 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' D' D ' 48' ' ' PHE . . . . . . . . . . . . . 93.6 m-85 -114.13 131.84 56.28 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.11 -0.495 . . . . 0.0 109.72 176.1 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' D' D ' 49' ' ' LYS . . . . . . . . . . . . . 71.5 tttt -108.66 138.66 44.62 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.628 -0.26 . . . . 0.0 110.494 179.148 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' D' D ' 50' ' ' VAL . . . . . . . . . . . . . 45.4 t -81.55 109.87 16.27 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.259 0 N-CA-C 109.443 -0.577 . . . . 0.0 109.443 177.047 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' D' D ' 51' ' ' VAL . . . . . . . . . . . . . 47.6 t -73.92 -47.63 42.11 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.304 0 CA-C-N 116.131 -0.486 . . . . 0.0 110.11 -174.322 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' D' D ' 52' ' ' GLN . . . . . . . . . . . . . 49.5 tt0 -162.65 139.09 7.54 Favored 'General case' 0 C--N 1.331 -0.219 0 C-N-CA 120.21 -0.596 . . . . 0.0 111.731 -178.126 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' D' D ' 53' ' ' ALA . . . . . . . . . . . . . . . -110.09 130.77 55.48 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 115.573 -0.739 . . . . 0.0 109.49 173.764 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' D' D ' 54' ' ' TYR . . . . . . . . . . . . . 24.9 t80 -126.76 108.09 22.67 Favored Pre-proline 0 CA--C 1.534 0.353 0 CA-C-O 118.379 -0.819 . . . . 0.0 110.553 -177.669 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' D' D ' 55' ' ' PRO . . . . . . . . . . . . . 73.3 Cg_endo -77.17 170.02 72.66 Favored 'Cis proline' 0 N--CA 1.5 1.896 0 CA-C-N 121.747 1.66 . . . . 0.0 112.139 -6.248 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' D' D ' 56' ' ' SER . . . . . . . . . . . . . 20.3 m -110.56 128.35 25.49 Favored Pre-proline 0 CA--C 1.538 0.511 0 CA-C-O 118.435 -0.793 . . . . 0.0 109.674 176.441 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' D' D ' 57' ' ' PRO . . . . . . . . . . . . . 46.6 Cg_endo -70.21 165.44 77.92 Favored 'Cis proline' 0 N--CA 1.496 1.676 0 CA-C-N 121.932 1.726 . . . . 0.0 111.677 -0.455 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' D' D ' 58' ' ' LEU . . . . . . . . . . . . . 25.0 tp -129.92 135.99 48.97 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.441 -0.345 . . . . 0.0 110.538 -179.234 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' D' D ' 59' ' ' ARG . . . . . . . . . . . . . 76.3 ttt180 -105.31 134.37 48.53 Favored 'General case' 0 C--N 1.327 -0.388 0 N-CA-C 109.419 -0.586 . . . . 0.0 109.419 175.725 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' D' D ' 60' ' ' VAL . . . . . . . . . . . . . 43.9 t -88.58 123.07 40.75 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.275 0 C-N-CA 120.644 -0.423 . . . . 0.0 110.359 -177.062 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' D' D ' 61' ' ' GLU . . . . . . . . . . . . . 94.7 mt-10 -131.09 173.42 11.03 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.077 -0.51 . . . . 0.0 109.962 177.242 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' D' D ' 62' ' ' ASP . . . . . . . . . . . . . 75.9 m-20 -54.39 -32.81 57.95 Favored 'General case' 0 C--N 1.327 -0.376 0 C-N-CA 120.964 -0.294 . . . . 0.0 111.635 179.786 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' D' D ' 63' ' ' ARG . . . . . . . . . . . . . 26.4 ptt180 -87.41 5.25 39.74 Favored 'General case' 0 CA--C 1.537 0.476 0 N-CA-C 113.652 0.982 . . . . 0.0 113.652 -176.32 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' D' D ' 64' ' ' THR . . . . . . . . . . . . . 28.5 m -82.3 133.74 35.25 Favored 'General case' 0 C--N 1.331 -0.211 0 CA-C-N 118.027 0.376 . . . . 0.0 110.602 -178.724 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' D' D ' 65' ' ' LYS . . . . . . . . . . . . . 87.1 mttt -89.71 124.62 34.77 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 116.106 -0.497 . . . . 0.0 110.02 178.75 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' D' D ' 66' ' ' ILE . . . . . . . . . . . . . 58.8 mt -113.6 129.4 69.49 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.305 0 N-CA-C 109.68 -0.489 . . . . 0.0 109.68 179.329 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' D' D ' 67' ' ' THR . . . . . . . . . . . . . 24.4 m -127.82 138.55 52.75 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-O 121.063 0.458 . . . . 0.0 111.124 -177.672 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' D' D ' 68' ' ' LEU . . . . . 0.509 ' N ' HD12 ' D' ' 68' ' ' LEU . 7.0 mp -100.65 124.15 45.84 Favored 'General case' 0 C--N 1.331 -0.206 0 CA-C-N 115.927 -0.579 . . . . 0.0 109.908 176.217 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' D' D ' 69' ' ' VAL . . . . . . . . . . . . . 41.9 t -102.24 137.0 31.75 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.29 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.495 -176.729 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' D' D ' 70' ' ' THR . . . . . 0.432 HG23 ' N ' ' D' ' 71' ' ' HIS . 7.3 t -150.0 -40.57 0.14 Allowed 'General case' 0 C--N 1.331 -0.205 0 CA-C-N 116.148 -0.478 . . . . 0.0 110.966 178.847 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' D' D ' 71' ' ' HIS . . . . . 0.432 ' N ' HG23 ' D' ' 70' ' ' THR . 58.0 m-70 -148.66 86.44 5.82 Favored Pre-proline 0 CA--C 1.534 0.33 0 CA-C-N 116.478 -0.328 . . . . 0.0 110.605 -178.215 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' D' D ' 72' ' ' PRO . . . . . . . . . . . . . 91.1 Cg_endo -84.55 132.46 4.99 Favored 'Trans proline' 0 N--CA 1.495 1.565 0 C-N-CA 121.537 1.491 . . . . 0.0 113.382 -176.544 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' D' D ' 73' ' ' VAL . . . . . . . . . . . . . 26.9 m -138.99 170.8 15.68 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.265 0 CA-C-N 115.76 -0.655 . . . . 0.0 109.815 174.001 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' D' D ' 74' ' ' ASP . . . . . . . . . . . . . 30.3 t0 -104.21 117.22 33.7 Favored 'General case' 0 C--N 1.33 -0.274 0 N-CA-C 109.884 -0.413 . . . . 0.0 109.884 179.466 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' D' D ' 75' ' ' VAL . . . . . . . . . . . . . 46.7 t -119.63 126.15 75.04 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.281 0 CA-C-O 121.066 0.46 . . . . 0.0 110.817 -176.91 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' D' D ' 76' ' ' LEU . . . . . . . . . . . . . 5.5 mp -125.23 143.97 50.69 Favored 'General case' 0 C--N 1.332 -0.178 0 CA-C-N 115.71 -0.677 . . . . 0.0 109.787 175.388 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' D' D ' 77' ' ' GLU . . . . . . . . . . . . . 97.1 mt-10 -133.63 136.42 44.8 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-O 120.986 0.422 . . . . 0.0 111.074 -178.31 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' D' D ' 78' ' ' ALA . . . . . . . . . . . . . . . -124.31 132.85 53.58 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 115.883 -0.598 . . . . 0.0 109.919 176.953 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' D' D ' 79' ' ' LYS . . . . . 0.578 ' O ' HD13 ' D' ' 80' ' ' ILE . 59.5 mtpt -79.26 117.09 19.94 Favored 'General case' 0 C--N 1.331 -0.225 0 CA-C-N 116.312 -0.404 . . . . 0.0 110.644 -178.027 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' D' D ' 80' ' ' ILE . . . . . 0.578 HD13 ' O ' ' D' ' 79' ' ' LYS . 43.3 mm -139.16 112.16 6.2 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.322 0 N-CA-C 109.079 -0.711 . . . . 0.0 109.079 -177.426 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' D' D ' 81' ' ' LYS . . . . . . . . . . . . . 55.4 pttt -104.6 129.44 52.71 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-O 120.995 0.426 . . . . 0.0 111.65 -175.909 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' D' D ' 82' ' ' GLY . . . . . . . . . . . . . . . 89.12 42.11 5.68 Favored Glycine 0 CA--C 1.524 0.653 0 CA-C-N 115.835 -0.621 . . . . 0.0 111.701 174.478 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' D' D ' 83' ' ' ILE . . . . . . . . . . . . . 69.2 mt -73.21 136.87 24.55 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.27 0 N-CA-C 109.526 -0.546 . . . . 0.0 109.526 177.207 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' D' D ' 84' ' ' LYS . . . . . . . . . . . . . 39.7 ttpt -102.25 -48.42 4.2 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-O 120.849 0.357 . . . . 0.0 110.517 -178.348 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' D' D ' 85' ' ' ASP . . . . . . . . . . . . . 12.8 t70 -146.8 145.2 29.83 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.7 -179.33 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' D' D ' 86' ' ' VAL . . . . . . . . . . . . . 43.7 t -126.38 129.56 71.9 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.223 0 CA-C-N 116.325 -0.398 . . . . 0.0 110.204 179.855 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' D' D ' 87' ' ' ILE . . . . . 0.498 HD12 ' N ' ' D' ' 87' ' ' ILE . 5.0 mp -122.27 128.16 75.4 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.227 0 N-CA-C 109.865 -0.42 . . . . 0.0 109.865 177.689 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' D' D ' 88' ' ' LEU . . . . . . . . . . . . . 68.4 mt -112.01 136.18 51.68 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-O 121.011 0.434 . . . . 0.0 111.211 -178.814 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' D' D ' 89' ' ' ASP . . . . . . . . . . . . . 9.1 t70 -130.12 154.28 47.65 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 115.812 -0.631 . . . . 0.0 109.55 175.334 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' D' D ' 90' ' ' GLU . . . . . . . . . . . . . 96.2 mt-10 -48.92 -37.4 19.76 Favored 'General case' 0 C--N 1.329 -0.325 0 N-CA-C 112.773 0.657 . . . . 0.0 112.773 -172.207 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' D' D ' 91' ' ' ASN . . . . . . . . . . . . . 86.5 m-20 -132.03 33.39 3.92 Favored 'General case' 0 N--CA 1.465 0.297 0 N-CA-C 111.914 0.338 . . . . 0.0 111.914 -176.966 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' D' D ' 92' ' ' LEU . . . . . . . . . . . . . 7.4 tp -166.06 142.37 5.04 Favored 'General case' 0 C--N 1.332 -0.17 0 C-N-CA 120.952 -0.299 . . . . 0.0 110.635 -179.344 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' D' D ' 93' ' ' ILE . . . . . . . . . . . . . 73.8 mt -124.05 124.81 69.72 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.261 0 N-CA-C 109.479 -0.563 . . . . 0.0 109.479 178.605 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' D' D ' 94' ' ' VAL . . . . . . . . . . . . . 43.8 t -123.34 125.89 72.45 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.188 0 CA-C-O 120.972 0.415 . . . . 0.0 109.96 -179.798 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' D' D ' 95' ' ' VAL . . . . . . . . . . . . . 44.6 t -120.78 131.46 72.8 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.261 0 CA-C-N 115.964 -0.562 . . . . 0.0 109.643 179.31 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' D' D ' 96' ' ' ILE . . . . . . . . . . . . . 63.2 mt -115.72 128.04 73.11 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.256 0 N-CA-C 109.446 -0.575 . . . . 0.0 109.446 -179.282 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' D' D ' 97' ' ' THR . . . . . . . . . . . . . 70.7 p -100.9 159.15 15.44 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-O 121.152 0.501 . . . . 0.0 111.111 -177.307 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' D' D ' 98' ' ' GLU . . . . . . . . . . . . . 46.5 tp10 -53.9 -26.53 25.55 Favored 'General case' 0 C--N 1.327 -0.392 0 CA-C-N 116.079 -0.509 . . . . 0.0 112.098 179.751 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' D' D ' 99' ' ' GLU . . . . . . . . . . . . . 19.9 tp10 -79.72 16.76 1.04 Allowed 'General case' 0 CA--C 1.539 0.524 0 N-CA-C 112.777 0.658 . . . . 0.0 112.777 -175.998 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' D' D ' 100' ' ' ASN . . . . . . . . . . . . . 3.7 m-20 60.88 30.87 19.91 Favored 'General case' 0 CA--C 1.532 0.285 0 O-C-N 121.958 -0.464 . . . . 0.0 111.682 178.424 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' D' D ' 101' ' ' GLU . . . . . . . . . . . . . 84.7 tt0 -112.53 144.21 42.39 Favored 'General case' 0 C--N 1.332 -0.157 0 N-CA-C 109.548 -0.538 . . . . 0.0 109.548 175.045 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' D' D ' 102' ' ' VAL . . . . . . . . . . . . . 44.3 t -118.71 130.12 73.99 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.252 0 CA-C-O 120.954 0.407 . . . . 0.0 110.16 -176.587 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' D' D ' 103' ' ' LEU . . . . . . . . . . . . . 21.2 mt -113.01 129.65 56.42 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 115.435 -0.802 . . . . 0.0 109.989 176.359 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' D' D ' 104' ' ' ILE . . . . . . . . . . . . . 66.3 mt -115.46 120.14 63.85 Favored 'Isoleucine or valine' 0 C--O 1.234 0.248 0 N-CA-C 110.169 -0.308 . . . . 0.0 110.169 -179.604 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' D' D ' 105' ' ' PHE . . . . . . . . . . . . . 73.5 m-85 -123.83 167.08 14.55 Favored 'General case' 0 C--N 1.333 -0.117 0 O-C-N 123.876 0.735 . . . . 0.0 109.976 -179.736 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' D' D ' 106' ' ' ASN . . . . . . . . . . . . . 48.8 p-10 -102.97 -170.81 1.85 Allowed 'General case' 0 C--N 1.33 -0.256 0 N-CA-C 109.903 -0.406 . . . . 0.0 109.903 172.762 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' D' D ' 107' ' ' GLN . . . . . . . . . . . . . 42.9 tt0 -61.23 -29.25 69.72 Favored 'General case' 0 N--CA 1.464 0.249 0 N-CA-C 111.902 0.334 . . . . 0.0 111.902 -179.893 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' D' D ' 108' ' ' ASN . . . . . . . . . . . . . 4.2 t-20 -81.9 11.7 4.77 Favored 'General case' 0 CA--C 1.538 0.511 0 N-CA-C 112.771 0.656 . . . . 0.0 112.771 -179.498 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' D' D ' 109' ' ' LEU . . . . . . . . . . . . . 10.9 tp 54.58 36.72 26.56 Favored 'General case' 0 C--O 1.233 0.202 0 CA-C-O 120.982 0.42 . . . . 0.0 111.4 178.554 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' D' D ' 110' ' ' GLU . . . . . . . . . . . . . 95.3 mt-10 -103.02 143.22 32.86 Favored 'General case' 0 C--N 1.328 -0.328 0 N-CA-C 109.369 -0.604 . . . . 0.0 109.369 175.091 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' D' D ' 111' ' ' GLU . . . . . . . . . . . . . 73.7 tt0 -82.67 121.87 27.41 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-O 121.017 0.437 . . . . 0.0 110.296 -176.479 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' D' D ' 112' ' ' LEU . . . . . . . . . . . . . 45.9 mt -107.0 -45.96 4.03 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-N 115.86 -0.609 . . . . 0.0 110.65 -179.137 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' D' D ' 113' ' ' TYR . . . . . . . . . . . . . 55.3 t80 -135.23 138.53 43.65 Favored 'General case' 0 C--N 1.332 -0.188 0 CA-C-O 120.845 0.355 . . . . 0.0 111.278 -178.567 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' D' D ' 114' ' ' ARG . . . . . . . . . . . . . 70.1 ttt180 -136.13 123.81 22.41 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 115.914 -0.584 . . . . 0.0 110.077 177.67 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' D' D ' 115' ' ' GLY . . . . . . . . . . . . . . . -149.96 157.46 27.23 Favored Glycine 0 CA--C 1.523 0.591 0 N-CA-C 111.136 -0.786 . . . . 0.0 111.136 -179.91 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' D' D ' 116' ' ' LYS . . . . . . . . . . . . . 67.3 tttt -131.77 129.79 41.02 Favored 'General case' 0 C--N 1.328 -0.352 0 N-CA-C 109.734 -0.469 . . . . 0.0 109.734 178.846 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' D' D ' 117' ' ' PHE . . . . . . . . . . . . . 49.0 m-85 -125.17 114.23 18.72 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.289 -0.414 . . . . 0.0 110.184 -174.837 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' D' D ' 118' ' ' GLU . . . . . . . . . . . . . 48.7 mp0 -56.9 -46.14 82.12 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.344 -0.389 . . . . 0.0 110.851 -175.297 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' D' D ' 119' ' ' ASN . . . . . . . . . . . . . 23.9 m120 -97.36 31.1 2.6 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.099 -0.5 . . . . 0.0 112.109 -174.678 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' D' D ' 120' ' ' LEU . . . . . 0.473 ' C ' HD23 ' D' ' 120' ' ' LEU . 7.2 tt -54.91 120.1 6.37 Favored 'General case' 0 N--CA 1.462 0.148 0 CA-C-O 120.817 0.341 . . . . 0.0 110.598 178.337 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' D' D ' 121' ' ' ASN . . . . . . . . . . . . . 43.3 m-20 -105.11 -44.03 4.88 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 116.303 -0.408 . . . . 0.0 110.874 -176.731 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' D' D ' 122' ' ' LYS . . . . . . . . . . . . . 55.8 pttt -162.41 153.89 18.14 Favored 'General case' 0 C--N 1.331 -0.204 0 C-N-CA 120.427 -0.509 . . . . 0.0 112.028 -179.118 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' D' D ' 123' ' ' VAL . . . . . . . . . . . . . 42.0 t -125.81 136.49 60.67 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.248 0 CA-C-N 115.806 -0.633 . . . . 0.0 109.948 179.663 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' D' D ' 124' ' ' LEU . . . . . . . . . . . . . 48.4 mt -125.72 131.13 52.61 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.278 -0.419 . . . . 0.0 110.133 178.782 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' D' D ' 125' ' ' VAL . . . . . . . . . . . . . 13.5 p -134.88 134.06 53.7 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.259 0 CA-C-O 121.113 0.482 . . . . 0.0 110.809 179.616 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' D' D ' 126' ' ' ARG . . . . . . . . . . . . . 79.0 mtp180 -147.6 122.69 10.13 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 115.513 -0.767 . . . . 0.0 109.301 177.969 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' D' D ' 127' ' ' ASN . . . . . . . . . . . . . 1.5 t-20 57.03 -148.65 0.49 Allowed 'General case' 0 CA--C 1.542 0.643 0 N-CA-C 109.579 -0.526 . . . . 0.0 109.579 -178.371 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' D' D ' 128' ' ' ASP . . . . . . . . . . . . . 19.7 p-10 -81.44 12.99 3.23 Favored 'General case' 0 CA--C 1.538 0.488 0 N-CA-C 113.044 0.757 . . . . 0.0 113.044 178.507 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' D' D ' 129' ' ' LEU . . . . . . . . . . . . . 32.9 mt -107.41 133.0 52.57 Favored 'General case' 0 C--O 1.231 0.128 0 N-CA-C 109.542 -0.54 . . . . 0.0 109.542 178.545 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' D' D ' 130' ' ' VAL . . . . . 0.531 HG13 ' HB ' ' D' ' 141' ' ' ILE . 14.7 p -138.32 139.69 41.31 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.204 0 CA-C-O 121.273 0.559 . . . . 0.0 111.314 -179.758 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' D' D ' 131' ' ' VAL . . . . . . . . . . . . . 46.4 t -136.08 140.16 44.43 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.237 0 CA-C-N 115.784 -0.644 . . . . 0.0 110.271 179.446 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' D' D ' 132' ' ' ILE . . . . . . . . . . . . . 72.4 mt -116.78 133.99 61.73 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.263 0 CA-C-N 115.966 -0.561 . . . . 0.0 109.754 -179.717 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' D' D ' 133' ' ' ILE . . . . . . . . . . . . . 42.8 mm -114.25 123.64 70.11 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.222 0 CA-C-N 116.603 -0.271 . . . . 0.0 110.926 -176.434 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' D' D ' 134' ' ' ASP . . . . . . . . . . . . . 7.0 p-10 -135.21 147.95 49.49 Favored 'General case' 0 C--N 1.332 -0.16 0 N-CA-C 109.637 -0.505 . . . . 0.0 109.637 174.459 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' D' D ' 135' ' ' GLU . . . . . . . . . . . . . 84.9 tt0 -50.06 -28.2 6.74 Favored 'General case' 0 C--N 1.328 -0.355 0 N-CA-C 112.923 0.712 . . . . 0.0 112.923 -171.287 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' D' D ' 136' ' ' GLN . . . . . . . . . . . . . 97.2 mt-30 -83.26 -35.11 25.59 Favored 'General case' 0 C--O 1.234 0.253 0 N-CA-C 112.538 0.569 . . . . 0.0 112.538 -175.829 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' D' D ' 137' ' ' LYS . . . . . . . . . . . . . 24.8 pttm -163.36 172.07 15.14 Favored 'General case' 0 C--N 1.331 -0.217 0 CA-C-O 121.525 0.678 . . . . 0.0 112.413 -171.455 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' D' D ' 138' ' ' LEU . . . . . 0.407 ' C ' HD23 ' D' ' 138' ' ' LEU . 5.9 tt -117.36 127.6 54.21 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 114.938 -1.028 . . . . 0.0 109.748 178.512 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' D' D ' 139' ' ' THR . . . . . . . . . . . . . 36.9 m -107.64 125.76 51.74 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.207 -0.451 . . . . 0.0 110.187 -179.414 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' D' D ' 140' ' ' LEU . . . . . 0.541 HD21 ' NE ' ' D' ' 142' ' ' ARG . 6.1 tt -113.06 119.34 37.52 Favored 'General case' 0 C--N 1.327 -0.392 0 CA-C-N 115.824 -0.626 . . . . 0.0 109.651 -176.951 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' D' D ' 141' ' ' ILE . . . . . 0.531 ' HB ' HG13 ' D' ' 130' ' ' VAL . 22.2 mt -123.05 125.48 72.21 Favored 'Isoleucine or valine' 0 C--O 1.234 0.244 0 CA-C-O 121.033 0.444 . . . . 0.0 110.396 -175.03 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' D' D ' 142' ' ' ARG . . . . . 0.541 ' NE ' HD21 ' D' ' 140' ' ' LEU . 61.4 mmt-85 -121.96 129.33 52.41 Favored 'General case' 0 C--N 1.331 -0.203 0 CA-C-N 115.548 -0.751 . . . . 0.0 110.466 -178.62 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' D' D ' 143' ' ' THR . . . . . . . . . . . . . 41.1 p . . . . . 0 C--O 1.219 -0.55 0 CA-C-O 118.046 -0.978 . . . . 0.0 110.6 -179.874 . . . . . . . . 0 0 . 1 . 012 nuclear nobuild full ' E' E ' -3' ' ' GLU . . . . . . . . . . . . . 12.8 pt-20 . . . . . 0 N--CA 1.49 1.574 0 N-CA-C 109.947 -0.39 . . . . 0.0 109.947 . . . . . . . . . 0 0 . 1 . 012 nuclear nobuild full ' E' E ' -2' ' ' GLY . . . . . . . . . . . . . . . -82.59 127.53 8.01 Favored Glycine 0 CA--C 1.523 0.563 0 N-CA-C 110.856 -0.898 . . . . 0.0 110.856 178.787 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' E' E ' -1' ' ' VAL . . . . . . . . . . . . . 43.0 t -96.79 133.41 38.33 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.329 0 CA-C-O 120.818 0.342 . . . . 0.0 110.08 -179.942 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' E' E ' 0' ' ' ILE . . . . . . . . . . . . . 42.9 mm -111.35 132.41 59.97 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.204 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.087 -179.811 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' E' E ' 1' ' ' MET . . . . . . . . . . . . . 25.5 ptp -91.39 155.19 18.66 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.322 -0.399 . . . . 0.0 110.684 -179.637 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' E' E ' 2' ' ' SER . . . . . . . . . . . . . 2.4 p -122.48 128.95 51.49 Favored 'General case' 0 C--N 1.332 -0.178 0 CA-C-N 116.168 -0.469 . . . . 0.0 110.395 178.87 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' E' E ' 3' ' ' GLU . . . . . . . . . . . . . 84.8 tt0 -142.6 142.84 32.2 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.083 -0.508 . . . . 0.0 111.045 179.238 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' E' E ' 4' ' ' LEU . . . . . . . . . . . . . 21.4 tp -122.01 128.19 51.14 Favored 'General case' 0 C--N 1.331 -0.21 0 CA-C-N 115.875 -0.602 . . . . 0.0 110.183 177.918 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' E' E ' 5' ' ' LYS . . . . . . . . . . . . . 89.2 mttt -105.43 121.11 43.24 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.3 -0.409 . . . . 0.0 110.485 178.298 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' E' E ' 6' ' ' LEU . . . . . . . . . . . . . 29.6 mt -116.79 150.29 38.56 Favored 'General case' 0 C--N 1.332 -0.187 0 CA-C-N 115.289 -0.869 . . . . 0.0 110.735 -178.097 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' E' E ' 7' ' ' LYS . . . . . . . . . . . . . 23.7 ttmt -138.35 135.32 18.16 Favored Pre-proline 0 CA--C 1.535 0.392 0 CA-C-O 118.846 -0.597 . . . . 0.0 109.933 174.984 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' E' E ' 8' ' ' PRO . . . . . . . . . . . . . 93.1 Cg_endo -90.72 143.11 3.45 Favored 'Trans proline' 0 N--CA 1.492 1.43 0 C-N-CA 121.602 1.535 . . . . 0.0 111.837 178.394 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' E' E ' 9' ' ' LEU . . . . . . . . . . . . . 35.3 mt -78.14 -47.67 2.09 Favored Pre-proline 0 CA--C 1.533 0.307 0 CA-C-O 118.759 -0.638 . . . . 0.0 112.099 -179.179 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' E' E ' 10' ' ' PRO . . . . . . . . . . . . . 76.8 Cg_endo -82.31 145.38 13.48 Favored 'Trans proline' 0 N--CA 1.495 1.593 0 C-N-CA 121.235 1.29 . . . . 0.0 111.681 175.689 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' E' E ' 11' ' ' LYS . . . . . . . . . . . . . 53.3 pttt -85.27 114.72 22.57 Favored 'General case' 0 C--N 1.331 -0.214 0 CA-C-O 121.453 0.644 . . . . 0.0 110.326 177.426 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' E' E ' 12' ' ' VAL . . . . . . . . . . . . . 12.1 p -151.11 150.93 12.92 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.299 0 CA-C-N 115.732 -0.667 . . . . 0.0 110.83 -177.538 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' E' E ' 13' ' ' GLU . . . . . . . . . . . . . 14.6 mm-40 -86.93 122.38 30.72 Favored 'General case' 0 C--N 1.331 -0.239 0 N-CA-C 110.019 -0.363 . . . . 0.0 110.019 175.901 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' E' E ' 14' ' ' LEU . . . . . . . . . . . . . 46.3 mt -98.7 149.54 35.84 Favored Pre-proline 0 CA--C 1.533 0.308 0 CA-C-O 119.318 -0.372 . . . . 0.0 110.632 -178.533 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' E' E ' 15' ' ' PRO . . . . . . . . . . . . . 24.6 Cg_exo -62.94 161.7 28.46 Favored 'Trans proline' 0 N--CA 1.499 1.818 0 C-N-CA 121.297 1.331 . . . . 0.0 111.876 176.81 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' E' E ' 16' ' ' PRO . . . . . . . . . . . . . 25.8 Cg_exo -61.28 -37.46 73.09 Favored 'Trans proline' 0 N--CA 1.499 1.807 0 C-N-CA 121.546 1.498 . . . . 0.0 112.967 -177.719 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' E' E ' 17' ' ' ASP . . . . . . . . . . . . . 13.0 p-10 -89.34 8.2 31.81 Favored 'General case' 0 CA--C 1.536 0.406 0 N-CA-C 113.351 0.871 . . . . 0.0 113.351 -176.786 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' E' E ' 18' ' ' PHE . . . . . . . . . . . . . 42.7 t80 -58.18 -42.78 86.82 Favored 'General case' 0 C--N 1.334 -0.086 0 O-C-N 121.925 -0.485 . . . . 0.0 110.099 -178.267 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' E' E ' 19' ' ' VAL . . . . . . . . . . . . . 54.9 t -57.12 -43.09 80.8 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.352 0 CA-C-N 116.225 -0.443 . . . . 0.0 110.306 -179.678 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' E' E ' 20' ' ' ASP . . . . . . . . . . . . . 75.2 m-20 -59.83 -41.74 91.99 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-O 120.782 0.325 . . . . 0.0 110.928 -177.846 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' E' E ' 21' ' ' VAL . . . . . . . . . . . . . 44.7 t -63.81 -46.36 94.61 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 C-N-CA 120.79 -0.364 . . . . 0.0 110.328 -177.76 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' E' E ' 22' ' ' ILE . . . . . 0.62 HG22 HD12 ' E' ' 26' ' ' LEU . 49.7 mm -55.95 -47.0 80.6 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.275 0 C-N-CA 120.971 -0.292 . . . . 0.0 110.827 178.932 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' E' E ' 23' ' ' ARG . . . . . . . . . . . . . 55.5 ttp180 -54.8 -48.73 72.38 Favored 'General case' 0 C--N 1.33 -0.275 0 C-N-CA 120.982 -0.287 . . . . 0.0 111.461 -178.323 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' E' E ' 24' ' ' ILE . . . . . . . . . . . . . 81.2 mt -59.0 -44.68 91.72 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.332 0 C-N-CA 121.102 -0.239 . . . . 0.0 111.179 -177.035 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' E' E ' 25' ' ' LYS . . . . . . . . . . . . . 57.3 mttm -64.5 -40.07 94.97 Favored 'General case' 0 C--N 1.327 -0.406 0 N-CA-C 112.356 0.502 . . . . 0.0 112.356 -178.48 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' E' E ' 26' ' ' LEU . . . . . 0.62 HD12 HG22 ' E' ' 22' ' ' ILE . 47.2 mt -79.27 -40.65 29.98 Favored 'General case' 0 C--N 1.33 -0.271 0 N-CA-C 113.573 0.953 . . . . 0.0 113.573 -171.367 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' E' E ' 27' ' ' GLN . . . . . . . . . . . . . 10.3 pt20 -46.7 137.04 7.33 Favored 'General case' 0 N--CA 1.47 0.544 0 N-CA-C 112.75 0.648 . . . . 0.0 112.75 -174.591 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' E' E ' 28' ' ' GLY . . . . . . . . . . . . . . . 100.52 -25.86 26.73 Favored Glycine 0 CA--C 1.534 1.222 0 CA-C-N 115.531 -0.759 . . . . 0.0 112.252 -176.082 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' E' E ' 29' ' ' LYS . . . . . . . . . . . . . 62.2 mttp -97.94 155.22 17.19 Favored 'General case' 0 C--N 1.332 -0.175 0 CA-C-N 117.265 0.532 . . . . 0.0 111.148 179.073 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' E' E ' 30' ' ' THR . . . . . . . . . . . . . 34.4 m -105.2 140.79 37.82 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 115.78 -0.645 . . . . 0.0 110.075 176.184 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' E' E ' 31' ' ' VAL . . . . . . . . . . . . . 35.0 m -126.44 151.16 32.67 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.234 0 CA-C-O 121.004 0.43 . . . . 0.0 111.229 -177.791 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' E' E ' 32' ' ' ARG . . . . . . . . . . . . . 67.0 mtp85 -128.12 151.04 49.69 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 115.68 -0.691 . . . . 0.0 110.846 177.362 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' E' E ' 33' ' ' THR . . . . . . . . . . . . . 15.2 m -54.29 139.34 36.67 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 115.987 -0.552 . . . . 0.0 111.186 -178.817 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' E' E ' 34' ' ' GLY . . . . . . . . . . . . . . . 98.77 -17.16 58.68 Favored Glycine 0 CA--C 1.533 1.162 0 C-N-CA 121.019 -0.61 . . . . 0.0 113.306 178.27 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' E' E ' 35' ' ' ASP . . . . . . . . . . . . . 73.3 m-20 -63.88 149.86 46.16 Favored 'General case' 0 C--O 1.231 0.09 0 CA-C-N 118.081 0.941 . . . . 0.0 111.016 179.685 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' E' E ' 36' ' ' VAL . . . . . . . . . . . . . 44.6 t -124.08 130.16 73.89 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.217 0 CA-C-N 116.05 -0.523 . . . . 0.0 109.923 178.971 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' E' E ' 37' ' ' ILE . . . . . . . . . . . . . 62.6 mt -122.03 140.41 46.04 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.244 0 CA-C-N 116.378 -0.374 . . . . 0.0 110.069 -179.465 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' E' E ' 38' ' ' GLY . . . . . . . . . . . . . . . -114.06 128.84 8.44 Favored Glycine 0 CA--C 1.524 0.638 0 N-CA-C 111.086 -0.806 . . . . 0.0 111.086 178.766 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' E' E ' 39' ' ' ILE . . . . . . . . . . . . . 71.7 mt -122.59 135.87 61.25 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.217 0 N-CA-C 110.075 -0.343 . . . . 0.0 110.075 178.935 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' E' E ' 40' ' ' SER . . . . . . . . . . . . . 53.0 p -93.4 117.37 29.99 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.519 -0.31 . . . . 0.0 111.202 176.015 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' E' E ' 41' ' ' ILE . . . . . . . . . . . . . 44.4 mm -121.71 121.61 64.83 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.181 0 CA-C-N 116.469 -0.332 . . . . 0.0 110.118 178.176 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' E' E ' 42' ' ' LEU . . . . . . . . . . . . . 83.8 mt 52.53 33.66 13.87 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.43 -0.35 . . . . 0.0 111.853 177.41 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' E' E ' 43' ' ' GLY . . . . . . . . . . . . . . . 73.22 32.09 60.68 Favored Glycine 0 CA--C 1.529 0.915 0 C-N-CA 121.049 -0.596 . . . . 0.0 112.125 178.797 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' E' E ' 44' ' ' LYS . . . . . . . . . . . . . 80.2 tttt -138.72 130.37 27.61 Favored 'General case' 0 C--N 1.33 -0.257 0 N-CA-C 109.482 -0.562 . . . . 0.0 109.482 179.064 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' E' E ' 45' ' ' GLU . . . . . . . . . . . . . 82.0 tt0 -83.1 124.83 30.85 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-O 120.799 0.333 . . . . 0.0 111.248 -176.144 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' E' E ' 46' ' ' VAL . . . . . . . . . . . . . 7.3 p -122.09 128.11 75.48 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.175 0 N-CA-C 109.493 -0.558 . . . . 0.0 109.493 174.909 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' E' E ' 47' ' ' LYS . . . . . . . . . . . . . 94.6 mttt -100.27 129.56 46.29 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.035 -0.53 . . . . 0.0 111.38 179.099 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' E' E ' 48' ' ' PHE . . . . . . . . . . . . . 95.3 m-85 -113.27 132.01 55.7 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.088 -0.505 . . . . 0.0 109.826 175.383 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' E' E ' 49' ' ' LYS . . . . . . . . . . . . . 80.6 tttt -105.51 137.74 42.84 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.41 -0.359 . . . . 0.0 110.21 179.278 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' E' E ' 50' ' ' VAL . . . . . . . . . . . . . 42.1 t -78.06 107.3 9.8 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.332 0 N-CA-C 109.533 -0.543 . . . . 0.0 109.533 177.427 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' E' E ' 51' ' ' VAL . . . . . . . . . . . . . 52.1 t -71.54 -48.76 50.96 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.288 0 CA-C-N 116.082 -0.508 . . . . 0.0 109.882 -174.557 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' E' E ' 52' ' ' GLN . . . . . . . . . . . . . 62.5 tt0 -167.46 138.68 3.05 Favored 'General case' 0 C--N 1.331 -0.211 0 C-N-CA 120.323 -0.551 . . . . 0.0 111.682 -179.271 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' E' E ' 53' ' ' ALA . . . . . 0.52 ' HB1' ' HB2' ' E' ' 58' ' ' LEU . . . -107.19 130.82 54.67 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 115.669 -0.696 . . . . 0.0 109.642 175.098 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' E' E ' 54' ' ' TYR . . . . . . . . . . . . . 30.1 t80 -127.65 106.9 20.76 Favored Pre-proline 0 CA--C 1.534 0.348 0 CA-C-O 118.39 -0.814 . . . . 0.0 110.598 -177.975 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' E' E ' 55' ' ' PRO . . . . . . . . . . . . . 73.1 Cg_endo -77.19 170.07 72.49 Favored 'Cis proline' 0 N--CA 1.5 1.867 0 CA-C-N 121.725 1.652 . . . . 0.0 112.323 -5.726 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' E' E ' 56' ' ' SER . . . . . . . . . . . . . 16.3 m -111.39 129.99 23.52 Favored Pre-proline 0 CA--C 1.538 0.502 0 CA-C-O 118.414 -0.803 . . . . 0.0 109.48 175.272 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' E' E ' 57' ' ' PRO . . . . . . . . . . . . . 56.9 Cg_endo -72.36 147.7 89.56 Favored 'Cis proline' 0 N--CA 1.497 1.702 0 CA-C-N 121.956 1.734 . . . . 0.0 111.792 -0.918 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' E' E ' 58' ' ' LEU . . . . . 0.52 ' HB2' ' HB1' ' E' ' 53' ' ' ALA . 18.1 tp -108.08 136.6 47.49 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.32 -0.4 . . . . 0.0 110.534 -179.203 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' E' E ' 59' ' ' ARG . . . . . . . . . . . . . 32.2 ttm180 -106.1 130.02 54.08 Favored 'General case' 0 C--N 1.328 -0.329 0 N-CA-C 109.565 -0.532 . . . . 0.0 109.565 176.35 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' E' E ' 60' ' ' VAL . . . . . . . . . . . . . 40.4 t -86.71 123.0 39.47 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.219 0 C-N-CA 120.544 -0.463 . . . . 0.0 110.487 -176.904 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' E' E ' 61' ' ' GLU . . . . . . . . . . . . . 95.0 mt-10 -131.01 170.79 14.01 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 115.895 -0.593 . . . . 0.0 109.909 177.727 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' E' E ' 62' ' ' ASP . . . . . . . . . . . . . 60.3 m-20 -55.0 -33.63 62.73 Favored 'General case' 0 C--N 1.328 -0.361 0 N-CA-C 111.827 0.306 . . . . 0.0 111.827 -177.627 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' E' E ' 63' ' ' ARG . . . . . . . . . . . . . 40.0 ptt180 -89.55 5.28 46.25 Favored 'General case' 0 CA--C 1.536 0.438 0 N-CA-C 113.818 1.044 . . . . 0.0 113.818 -175.496 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' E' E ' 64' ' ' THR . . . . . . . . . . . . . 31.4 m -76.27 139.85 41.3 Favored 'General case' 0 C--N 1.332 -0.184 0 CA-C-O 120.851 0.358 . . . . 0.0 110.859 -177.874 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' E' E ' 65' ' ' LYS . . . . . . . . . . . . . 99.6 mttt -88.32 129.4 35.4 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.05 -0.523 . . . . 0.0 110.192 178.601 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' E' E ' 66' ' ' ILE . . . . . . . . . . . . . 57.7 mt -114.04 127.34 71.49 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.312 0 N-CA-C 109.728 -0.471 . . . . 0.0 109.728 -179.705 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' E' E ' 67' ' ' THR . . . . . . . . . . . . . 26.9 m -128.26 139.11 52.61 Favored 'General case' 0 C--N 1.331 -0.221 0 CA-C-O 121.063 0.459 . . . . 0.0 111.001 -177.426 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' E' E ' 68' ' ' LEU . . . . . 0.475 HD12 ' N ' ' E' ' 68' ' ' LEU . 7.7 mp -106.0 136.71 45.18 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 115.922 -0.581 . . . . 0.0 110.28 176.778 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' E' E ' 69' ' ' VAL . . . . . . . . . . . . . 39.2 t -90.41 131.76 36.79 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.371 0 N-CA-C 109.932 -0.396 . . . . 0.0 109.932 178.731 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' E' E ' 70' ' ' THR . . . . . . . . . . . . . 80.4 p -105.98 178.06 4.67 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.163 -0.471 . . . . 0.0 110.532 -179.01 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' E' E ' 71' ' ' HIS . . . . . . . . . . . . . 34.9 t60 -64.99 130.9 95.05 Favored Pre-proline 0 CA--C 1.535 0.396 0 CA-C-O 118.827 -0.606 . . . . 0.0 109.978 -178.53 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' E' E ' 72' ' ' PRO . . . . . . . . . . . . . 96.3 Cg_endo -91.04 159.03 3.91 Favored 'Trans proline' 0 N--CA 1.49 1.284 0 C-N-CA 121.69 1.593 . . . . 0.0 112.26 -179.434 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' E' E ' 73' ' ' VAL . . . . . . . . . . . . . 32.8 m -70.02 168.6 1.58 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.318 0 CA-C-N 116.136 -0.484 . . . . 0.0 110.421 178.862 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' E' E ' 74' ' ' ASP . . . . . . . . . . . . . 46.8 t0 -92.29 118.82 31.28 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.161 -0.472 . . . . 0.0 109.925 -179.615 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' E' E ' 75' ' ' VAL . . . . . . . . . . . . . 38.9 t -119.35 121.22 65.94 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.208 0 CA-C-O 120.988 0.423 . . . . 0.0 110.373 -179.756 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' E' E ' 76' ' ' LEU . . . . . . . . . . . . . 5.1 mp -122.26 146.41 47.31 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 115.851 -0.613 . . . . 0.0 109.752 176.527 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' E' E ' 77' ' ' GLU . . . . . . . . . . . . . 97.9 mt-10 -135.8 133.39 37.83 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-O 121.021 0.439 . . . . 0.0 111.125 -179.208 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' E' E ' 78' ' ' ALA . . . . . 0.632 ' HB2' HD21 ' E' ' 109' ' ' LEU . . . -121.81 133.28 54.9 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 115.729 -0.669 . . . . 0.0 109.727 176.364 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' E' E ' 79' ' ' LYS . . . . . 0.607 ' O ' HD13 ' E' ' 80' ' ' ILE . 49.1 tptt -80.01 118.04 21.39 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-O 120.899 0.38 . . . . 0.0 110.477 -177.3 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' E' E ' 80' ' ' ILE . . . . . 0.607 HD13 ' O ' ' E' ' 79' ' ' LYS . 41.2 mm -139.17 109.25 4.18 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.288 0 N-CA-C 109.235 -0.654 . . . . 0.0 109.235 -177.369 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' E' E ' 81' ' ' LYS . . . . . . . . . . . . . 57.5 pttt -102.23 127.31 49.24 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-O 120.938 0.399 . . . . 0.0 111.493 -177.283 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' E' E ' 82' ' ' GLY . . . . . . . . . . . . . . . 89.09 42.09 5.7 Favored Glycine 0 CA--C 1.526 0.735 0 C-N-CA 120.637 -0.792 . . . . 0.0 111.78 173.852 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' E' E ' 83' ' ' ILE . . . . . . . . . . . . . 74.0 mt -68.28 138.61 22.19 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.28 0 N-CA-C 109.932 -0.396 . . . . 0.0 109.932 178.203 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' E' E ' 84' ' ' LYS . . . . . . . . . . . . . 23.5 ttmt -95.92 -53.58 3.63 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.09 -0.505 . . . . 0.0 110.306 -179.721 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' E' E ' 85' ' ' ASP . . . . . . . . . . . . . 12.4 t70 -154.49 157.67 38.73 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 115.724 -0.671 . . . . 0.0 110.33 -178.401 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' E' E ' 86' ' ' VAL . . . . . . . . . . . . . 42.0 t -137.02 136.13 47.63 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.307 0 CA-C-O 120.939 0.4 . . . . 0.0 110.67 -178.172 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' E' E ' 87' ' ' ILE . . . . . 0.487 ' N ' HD12 ' E' ' 87' ' ' ILE . 5.1 mp -119.78 127.58 75.88 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 CA-C-N 115.774 -0.648 . . . . 0.0 109.42 176.608 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' E' E ' 88' ' ' LEU . . . . . . . . . . . . . 18.8 tp -115.69 136.41 53.09 Favored 'General case' 0 C--N 1.332 -0.192 0 CA-C-O 121.02 0.438 . . . . 0.0 111.406 -177.0 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' E' E ' 89' ' ' ASP . . . . . . . . . . . . . 42.0 t0 -134.87 160.75 37.26 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 115.777 -0.647 . . . . 0.0 109.729 176.532 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' E' E ' 90' ' ' GLU . . . . . . . . . . . . . 96.3 mt-10 -47.65 -37.6 13.15 Favored 'General case' 0 N--CA 1.463 0.179 0 N-CA-C 113.064 0.764 . . . . 0.0 113.064 -171.82 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' E' E ' 91' ' ' ASN . . . . . . . . . . . . . 5.2 p30 -132.06 23.89 4.56 Favored 'General case' 0 N--CA 1.469 0.483 0 N-CA-C 112.79 0.663 . . . . 0.0 112.79 -176.833 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' E' E ' 92' ' ' LEU . . . . . . . . . . . . . 44.5 mt -148.39 141.2 24.66 Favored 'General case' 0 C--N 1.331 -0.225 0 CA-C-O 120.823 0.344 . . . . 0.0 110.589 -178.556 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' E' E ' 93' ' ' ILE . . . . . . . . . . . . . 72.1 mt -123.7 114.27 40.79 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.362 0 N-CA-C 109.098 -0.705 . . . . 0.0 109.098 176.288 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' E' E ' 94' ' ' VAL . . . . . . . . . . . . . 43.7 t -116.55 127.02 74.28 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.236 0 N-CA-C 109.823 -0.436 . . . . 0.0 109.823 -178.741 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' E' E ' 95' ' ' VAL . . . . . . . . . . . . . 43.9 t -123.21 135.02 64.55 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 CA-C-N 116.217 -0.447 . . . . 0.0 109.934 -179.059 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' E' E ' 96' ' ' ILE . . . . . . . . . . . . . 65.2 mt -115.31 127.4 72.9 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.351 0 N-CA-C 109.391 -0.596 . . . . 0.0 109.391 178.506 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' E' E ' 97' ' ' THR . . . . . . . . . . . . . 66.7 p -101.8 157.29 16.95 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-O 121.05 0.452 . . . . 0.0 111.077 -177.852 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' E' E ' 98' ' ' GLU . . . . . . . . . . . . . 12.8 pt-20 -55.63 -21.7 19.1 Favored 'General case' 0 CA--C 1.533 0.314 0 N-CA-C 112.669 0.618 . . . . 0.0 112.669 -179.42 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' E' E ' 99' ' ' GLU . . . . . . . . . . . . . 48.4 mp0 -78.74 14.29 1.38 Allowed 'General case' 0 CA--C 1.537 0.463 0 N-CA-C 113.04 0.755 . . . . 0.0 113.04 -179.68 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' E' E ' 100' ' ' ASN . . . . . . . . . . . . . 3.0 m-20 62.76 37.88 12.2 Favored 'General case' 0 C--O 1.233 0.201 0 CA-C-O 121.068 0.461 . . . . 0.0 110.949 178.24 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' E' E ' 101' ' ' GLU . . . . . . . . . . . . . 84.9 tt0 -118.99 141.69 48.45 Favored 'General case' 0 C--N 1.332 -0.164 0 CA-C-N 116.014 -0.539 . . . . 0.0 109.895 177.223 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' E' E ' 102' ' ' VAL . . . . . . . . . . . . . 46.5 t -114.93 127.47 72.46 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.293 0 CA-C-N 116.324 -0.398 . . . . 0.0 110.041 -178.68 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' E' E ' 103' ' ' LEU . . . . . . . . . . . . . 25.7 mt -117.08 132.54 56.66 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 115.561 -0.745 . . . . 0.0 110.503 177.82 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' E' E ' 104' ' ' ILE . . . . . 0.434 HD13 HG11 ' E' ' 130' ' ' VAL . 65.9 mt -119.53 122.16 68.17 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.237 0 N-CA-C 110.22 -0.289 . . . . 0.0 110.22 178.782 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' E' E ' 105' ' ' PHE . . . . . . . . . . . . . 47.2 m-85 -122.26 162.3 21.71 Favored 'General case' 0 C--N 1.333 -0.146 0 O-C-N 124.005 0.815 . . . . 0.0 109.981 177.748 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' E' E ' 106' ' ' ASN . . . . . . . . . . . . . 41.4 p-10 -97.03 -169.93 1.95 Allowed 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.606 -0.27 . . . . 0.0 110.499 175.554 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' E' E ' 107' ' ' GLN . . . . . . . . . . . . . 46.4 tt0 -56.15 -30.2 61.83 Favored 'General case' 0 CA--C 1.531 0.247 0 N-CA-C 112.05 0.389 . . . . 0.0 112.05 -179.516 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' E' E ' 108' ' ' ASN . . . . . . . . . . . . . 30.6 t30 -90.79 12.9 17.82 Favored 'General case' 0 CA--C 1.535 0.373 0 N-CA-C 113.41 0.893 . . . . 0.0 113.41 -175.356 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' E' E ' 109' ' ' LEU . . . . . 0.632 HD21 ' HB2' ' E' ' 78' ' ' ALA . 11.3 tp 58.8 38.92 24.61 Favored 'General case' 0 C--N 1.331 -0.212 0 CA-C-O 121.168 0.508 . . . . 0.0 111.103 178.552 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' E' E ' 110' ' ' GLU . . . . . . . . . . . . . 96.0 mt-10 -102.64 151.93 21.78 Favored 'General case' 0 C--N 1.329 -0.292 0 N-CA-C 109.788 -0.449 . . . . 0.0 109.788 175.419 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' E' E ' 111' ' ' GLU . . . . . . . . . . . . . 85.1 tt0 -81.68 121.98 27.05 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-O 120.922 0.391 . . . . 0.0 110.507 -178.872 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' E' E ' 112' ' ' LEU . . . . . . . . . . . . . 17.5 mt -110.04 -45.98 3.53 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 115.962 -0.563 . . . . 0.0 110.518 179.185 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' E' E ' 113' ' ' TYR . . . . . . . . . . . . . 58.7 t80 -140.72 136.87 33.02 Favored 'General case' 0 C--N 1.331 -0.227 0 C-N-CA 120.771 -0.372 . . . . 0.0 111.398 -179.06 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' E' E ' 114' ' ' ARG . . . . . . . . . . . . . 22.0 ttm180 -135.69 124.77 24.36 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 115.958 -0.564 . . . . 0.0 109.721 174.979 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' E' E ' 115' ' ' GLY . . . . . . . . . . . . . . . -149.38 148.79 20.48 Favored Glycine 0 CA--C 1.525 0.701 0 N-CA-C 111.12 -0.792 . . . . 0.0 111.12 178.758 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' E' E ' 116' ' ' LYS . . . . . . . . . . . . . 40.3 ttpt -119.86 136.85 54.33 Favored 'General case' 0 C--N 1.33 -0.266 0 N-CA-C 110.096 -0.335 . . . . 0.0 110.096 179.172 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' E' E ' 117' ' ' PHE . . . . . . . . . . . . . 46.1 m-85 -134.49 116.11 14.72 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-N 116.302 -0.408 . . . . 0.0 110.229 -177.148 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' E' E ' 118' ' ' GLU . . . . . . . . . . . . . 84.8 tt0 -53.64 -45.07 70.07 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 116.597 -0.274 . . . . 0.0 111.515 -177.252 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' E' E ' 119' ' ' ASN . . . . . . . . . . . . . 4.2 m-80 -99.27 31.12 3.2 Favored 'General case' 0 C--N 1.33 -0.263 0 N-CA-C 112.156 0.428 . . . . 0.0 112.156 -175.225 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' E' E ' 120' ' ' LEU . . . . . . . . . . . . . 15.0 tp -55.22 120.69 7.42 Favored 'General case' 0 C--N 1.333 -0.151 0 O-C-N 122.308 -0.245 . . . . 0.0 110.694 178.465 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' E' E ' 121' ' ' ASN . . . . . . . . . . . . . 72.1 m-20 -108.82 -44.05 4.1 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.478 -0.328 . . . . 0.0 111.084 -176.728 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' E' E ' 122' ' ' LYS . . . . . . . . . . . . . 57.2 pttt -162.4 160.21 26.14 Favored 'General case' 0 CA--C 1.529 0.143 0 C-N-CA 120.43 -0.508 . . . . 0.0 112.064 -178.59 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' E' E ' 123' ' ' VAL . . . . . . . . . . . . . 42.1 t -129.08 137.87 55.99 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.201 0 CA-C-N 115.947 -0.57 . . . . 0.0 109.86 179.011 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' E' E ' 124' ' ' LEU . . . . . . . . . . . . . 80.9 mt -124.94 140.35 53.0 Favored 'General case' 0 C--N 1.332 -0.189 0 CA-C-O 120.87 0.367 . . . . 0.0 110.794 -179.007 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' E' E ' 125' ' ' VAL . . . . . . . . . . . . . 46.5 t -127.55 133.95 66.66 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.234 0 CA-C-N 116.105 -0.498 . . . . 0.0 109.822 178.118 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' E' E ' 126' ' ' ARG . . . . . . . . . . . . . 49.3 ttt85 -138.57 113.76 9.43 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-O 120.884 0.374 . . . . 0.0 110.28 -179.647 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' E' E ' 127' ' ' ASN . . . . . . . . . . . . . 12.1 m120 53.04 -104.82 0.21 Allowed 'General case' 0 CA--C 1.543 0.68 0 CA-C-O 119.2 -0.429 . . . . 0.0 111.196 179.513 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' E' E ' 128' ' ' ASP . . . . . . . . . . . . . 13.5 p-10 -113.57 0.78 14.76 Favored 'General case' 0 N--CA 1.467 0.422 0 CA-C-N 119.447 1.021 . . . . 0.0 113.549 -176.108 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' E' E ' 129' ' ' LEU . . . . . . . . . . . . . 71.4 mt -108.18 147.36 31.43 Favored 'General case' 0 C--N 1.332 -0.174 0 O-C-N 121.952 -0.467 . . . . 0.0 110.061 179.454 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' E' E ' 130' ' ' VAL . . . . . 0.469 HG13 ' HB ' ' E' ' 141' ' ' ILE . 12.4 p -129.42 140.05 50.15 Favored 'Isoleucine or valine' 0 C--O 1.233 0.22 0 CA-C-O 120.981 0.42 . . . . 0.0 110.595 -178.831 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' E' E ' 131' ' ' VAL . . . . . 0.589 HG22 HD12 ' E' ' 140' ' ' LEU . 40.7 t -135.94 139.28 46.25 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.25 0 CA-C-N 115.953 -0.567 . . . . 0.0 110.425 -178.506 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' E' E ' 132' ' ' ILE . . . . . . . . . . . . . 73.2 mt -114.09 133.51 59.88 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 N-CA-C 109.406 -0.59 . . . . 0.0 109.406 178.838 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' E' E ' 133' ' ' ILE . . . . . . . . . . . . . 43.3 mm -115.34 123.3 70.75 Favored 'Isoleucine or valine' 0 C--O 1.234 0.251 0 CA-C-O 120.936 0.398 . . . . 0.0 111.113 -174.36 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' E' E ' 134' ' ' ASP . . . . . . . . . . . . . 9.5 p-10 -136.18 147.41 47.66 Favored 'General case' 0 C--N 1.331 -0.224 0 N-CA-C 109.337 -0.616 . . . . 0.0 109.337 173.666 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' E' E ' 135' ' ' GLU . . . . . . . . . . . . . 43.3 tp10 -51.33 -28.06 11.28 Favored 'General case' 0 C--N 1.327 -0.408 0 N-CA-C 112.641 0.608 . . . . 0.0 112.641 -172.893 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' E' E ' 136' ' ' GLN . . . . . . . . . . . . . 97.6 mt-30 -80.48 -31.62 37.28 Favored 'General case' 0 C--N 1.33 -0.239 0 N-CA-C 112.629 0.603 . . . . 0.0 112.629 -176.63 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' E' E ' 137' ' ' LYS . . . . . . . . . . . . . 17.6 ptpt -170.08 175.26 5.1 Favored 'General case' 0 C--N 1.331 -0.227 0 CA-C-O 121.526 0.679 . . . . 0.0 112.374 -171.669 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' E' E ' 138' ' ' LEU . . . . . 0.417 ' C ' HD23 ' E' ' 138' ' ' LEU . 7.8 tt -123.16 130.16 52.39 Favored 'General case' 0 C--N 1.331 -0.199 0 CA-C-N 115.145 -0.934 . . . . 0.0 110.23 -179.524 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' E' E ' 139' ' ' THR . . . . . . . . . . . . . 35.1 m -107.26 125.88 51.71 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.245 -0.434 . . . . 0.0 110.442 179.518 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' E' E ' 140' ' ' LEU . . . . . 0.589 HD12 HG22 ' E' ' 131' ' ' VAL . 19.0 tp -113.84 121.37 43.81 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 115.788 -0.642 . . . . 0.0 109.555 -177.594 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' E' E ' 141' ' ' ILE . . . . . 0.469 ' HB ' HG13 ' E' ' 130' ' ' VAL . 19.3 mt -122.01 119.9 59.89 Favored 'Isoleucine or valine' 0 C--O 1.235 0.296 0 CA-C-O 120.974 0.416 . . . . 0.0 110.081 -177.229 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' E' E ' 142' ' ' ARG . . . . . . . . . . . . . 78.0 mtp180 -103.9 123.85 47.88 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 115.264 -0.88 . . . . 0.0 110.382 179.644 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' E' E ' 143' ' ' THR . . . . . . . . . . . . . 37.3 p . . . . . 0 C--O 1.22 -0.456 0 CA-C-O 118.028 -0.987 . . . . 0.0 110.648 -179.989 . . . . . . . . 0 0 . 1 . 012 nuclear nobuild full ' F' F ' -3' ' ' GLU . . . . . . . . . . . . . 69.2 mm-40 . . . . . 0 N--CA 1.49 1.566 0 N-CA-C 109.258 -0.645 . . . . 0.0 109.258 . . . . . . . . . 0 0 . 1 . 012 nuclear nobuild full ' F' F ' -2' ' ' GLY . . . . . . . . . . . . . . . -69.31 143.8 39.79 Favored Glycine 0 CA--C 1.525 0.676 0 N-CA-C 110.959 -0.856 . . . . 0.0 110.959 179.956 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' F' F ' -1' ' ' VAL . . . . . . . . . . . . . 46.9 t -141.38 138.0 32.92 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.258 0 N-CA-C 109.984 -0.376 . . . . 0.0 109.984 179.85 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' F' F ' 0' ' ' ILE . . . . . . . . . . . . . 72.5 mt -111.48 134.03 55.2 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.195 0 CA-C-N 116.206 -0.452 . . . . 0.0 109.959 179.802 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' F' F ' 1' ' ' MET . . . . . . . . . . . . . 25.6 ptp -94.98 163.97 13.09 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.085 -0.507 . . . . 0.0 111.006 -178.966 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' F' F ' 2' ' ' SER . . . . . . . . . . . . . 11.8 p -111.89 135.46 52.48 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.135 -0.484 . . . . 0.0 110.403 178.676 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' F' F ' 3' ' ' GLU . . . . . . . . . . . . . 95.5 mt-10 -140.81 141.87 34.7 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.117 -0.492 . . . . 0.0 110.982 -177.817 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' F' F ' 4' ' ' LEU . . . . . . . . . . . . . 28.6 tp -128.42 128.62 44.8 Favored 'General case' 0 C--N 1.331 -0.22 0 CA-C-N 115.928 -0.578 . . . . 0.0 110.22 176.869 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' F' F ' 5' ' ' LYS . . . . . . . . . . . . . 99.0 mttt -108.16 121.61 45.21 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-O 120.954 0.407 . . . . 0.0 110.538 178.376 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' F' F ' 6' ' ' LEU . . . . . . . . . . . . . 70.3 mt -116.41 148.49 40.63 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 115.364 -0.835 . . . . 0.0 110.483 -179.122 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' F' F ' 7' ' ' LYS . . . . . . . . . . . . . 78.0 tttt -139.57 139.02 21.11 Favored Pre-proline 0 CA--C 1.533 0.305 0 CA-C-O 119.086 -0.483 . . . . 0.0 109.924 175.894 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' F' F ' 8' ' ' PRO . . . . . . . . . . . . . 93.5 Cg_endo -91.41 145.11 3.3 Favored 'Trans proline' 0 N--CA 1.491 1.34 0 C-N-CA 121.724 1.616 . . . . 0.0 111.944 178.414 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' F' F ' 9' ' ' LEU . . . . . . . . . . . . . 64.4 mt -80.89 -47.67 1.15 Allowed Pre-proline 0 CA--C 1.534 0.331 0 CA-C-O 118.671 -0.68 . . . . 0.0 112.078 179.805 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' F' F ' 10' ' ' PRO . . . . . . . . . . . . . 88.5 Cg_endo -80.81 145.24 15.84 Favored 'Trans proline' 0 N--CA 1.497 1.686 0 C-N-CA 121.104 1.203 . . . . 0.0 111.555 175.995 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' F' F ' 11' ' ' LYS . . . . . . . . . . . . . 39.0 pttt -78.56 111.33 14.51 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-O 121.563 0.697 . . . . 0.0 110.382 177.873 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' F' F ' 12' ' ' VAL . . . . . . . . . . . . . 11.7 p -151.02 144.83 16.76 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.351 0 CA-C-N 115.629 -0.714 . . . . 0.0 110.512 -178.292 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' F' F ' 13' ' ' GLU . . . . . . . . . . . . . 40.1 mt-10 -86.25 124.55 32.75 Favored 'General case' 0 C--N 1.33 -0.26 0 N-CA-C 109.965 -0.383 . . . . 0.0 109.965 177.015 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' F' F ' 14' ' ' LEU . . . . . . . . . . . . . 19.3 mt -96.76 148.05 33.85 Favored Pre-proline 0 C--N 1.33 -0.273 0 CA-C-O 119.184 -0.436 . . . . 0.0 110.072 -179.263 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' F' F ' 15' ' ' PRO . . . . . . . . . . . . . 28.3 Cg_exo -60.54 159.13 28.99 Favored 'Trans proline' 0 N--CA 1.497 1.705 0 C-N-CA 121.28 1.32 . . . . 0.0 111.439 177.318 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' F' F ' 16' ' ' PRO . . . . . . . . . . . . . 38.7 Cg_exo -58.49 -35.95 98.04 Favored 'Trans proline' 0 N--CA 1.496 1.668 0 C-N-CA 121.418 1.412 . . . . 0.0 112.639 -178.617 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' F' F ' 17' ' ' ASP . . . . . . . . . . . . . 7.3 p-10 -91.66 11.55 24.06 Favored 'General case' 0 CA--C 1.535 0.396 0 N-CA-C 113.152 0.797 . . . . 0.0 113.152 -177.637 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' F' F ' 18' ' ' PHE . . . . . . . . . . . . . 52.2 t80 -58.29 -45.47 87.89 Favored 'General case' 0 C--N 1.333 -0.112 0 O-C-N 122.02 -0.425 . . . . 0.0 110.075 -177.67 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' F' F ' 19' ' ' VAL . . . . . 0.411 HG13 ' N ' ' F' ' 20' ' ' ASP . 13.7 p -55.89 -40.99 65.21 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 CA-C-N 116.114 -0.494 . . . . 0.0 110.904 -179.125 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' F' F ' 20' ' ' ASP . . . . . 0.411 ' N ' HG13 ' F' ' 19' ' ' VAL . 80.7 m-20 -61.22 -42.84 99.29 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-O 120.818 0.342 . . . . 0.0 110.975 -178.558 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' F' F ' 21' ' ' VAL . . . . . . . . . . . . . 48.1 t -63.84 -46.07 95.32 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.291 0 C-N-CA 120.759 -0.376 . . . . 0.0 110.318 -178.03 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' F' F ' 22' ' ' ILE . . . . . 0.621 HG22 HD12 ' F' ' 26' ' ' LEU . 49.2 mm -56.58 -46.02 82.47 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.258 0 C-N-CA 120.948 -0.301 . . . . 0.0 110.622 178.917 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' F' F ' 23' ' ' ARG . . . . . . . . . . . . . 25.8 ttp180 -54.33 -49.43 69.75 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-O 120.594 0.235 . . . . 0.0 111.418 -178.843 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' F' F ' 24' ' ' ILE . . . . . . . . . . . . . 77.1 mt -59.71 -44.07 92.87 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.368 0 CA-C-N 116.629 -0.259 . . . . 0.0 111.291 -177.194 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' F' F ' 25' ' ' LYS . . . . . . . . . . . . . 62.8 mttm -66.18 -38.18 87.41 Favored 'General case' 0 C--N 1.327 -0.371 0 N-CA-C 112.28 0.474 . . . . 0.0 112.28 -178.455 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' F' F ' 26' ' ' LEU . . . . . 0.621 HD12 HG22 ' F' ' 22' ' ' ILE . 58.2 mt -79.13 -40.52 30.8 Favored 'General case' 0 C--N 1.33 -0.241 0 N-CA-C 113.349 0.87 . . . . 0.0 113.349 -172.446 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' F' F ' 27' ' ' GLN . . . . . . . . . . . . . 11.2 pt20 -47.1 141.49 4.28 Favored 'General case' 0 N--CA 1.47 0.534 0 N-CA-C 112.726 0.639 . . . . 0.0 112.726 -174.359 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' F' F ' 28' ' ' GLY . . . . . . . . . . . . . . . 96.91 -25.76 25.39 Favored Glycine 0 CA--C 1.534 1.227 0 CA-C-N 115.626 -0.715 . . . . 0.0 112.1 -176.638 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' F' F ' 29' ' ' LYS . . . . . . . . . . . . . 59.1 mtpt -98.33 155.1 17.37 Favored 'General case' 0 C--O 1.233 0.217 0 CA-C-N 117.275 0.538 . . . . 0.0 111.002 179.284 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' F' F ' 30' ' ' THR . . . . . . . . . . . . . 31.4 m -111.45 139.27 47.0 Favored 'General case' 0 C--N 1.331 -0.217 0 CA-C-N 116.093 -0.503 . . . . 0.0 110.217 175.743 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' F' F ' 31' ' ' VAL . . . . . . . . . . . . . 35.2 m -134.37 164.43 34.26 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.225 0 CA-C-O 120.796 0.331 . . . . 0.0 110.981 -179.22 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' F' F ' 32' ' ' ARG . . . . . . . . . . . . . 77.9 mtp180 -131.3 153.97 49.01 Favored 'General case' 0 C--N 1.331 -0.223 0 CA-C-O 121.227 0.537 . . . . 0.0 110.735 177.908 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' F' F ' 33' ' ' THR . . . . . . . . . . . . . 32.3 m -53.78 140.94 28.41 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.221 -0.445 . . . . 0.0 111.222 -179.603 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' F' F ' 34' ' ' GLY . . . . . . . . . . . . . . . 99.9 -17.13 57.72 Favored Glycine 0 CA--C 1.531 1.068 0 C-N-CA 121.211 -0.519 . . . . 0.0 113.26 179.371 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' F' F ' 35' ' ' ASP . . . . . . . . . . . . . 65.6 m-20 -65.23 149.34 50.1 Favored 'General case' 0 C--O 1.231 0.121 0 CA-C-N 118.089 0.945 . . . . 0.0 111.188 179.044 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' F' F ' 36' ' ' VAL . . . . . . . . . . . . . 46.4 t -122.71 130.16 74.69 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.256 0 CA-C-N 115.78 -0.645 . . . . 0.0 109.867 178.909 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' F' F ' 37' ' ' ILE . . . . . . . . . . . . . 69.7 mt -122.07 139.47 48.95 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.234 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.044 -179.524 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' F' F ' 38' ' ' GLY . . . . . . . . . . . . . . . -113.86 129.17 8.64 Favored Glycine 0 CA--C 1.525 0.703 0 N-CA-C 111.115 -0.794 . . . . 0.0 111.115 -179.933 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' F' F ' 39' ' ' ILE . . . . . . . . . . . . . 67.7 mt -120.0 133.73 65.79 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.216 0 N-CA-C 110.084 -0.339 . . . . 0.0 110.084 178.964 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' F' F ' 40' ' ' SER . . . . . . . . . . . . . 53.6 p -93.4 120.04 33.21 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.343 -0.389 . . . . 0.0 110.844 175.399 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' F' F ' 41' ' ' ILE . . . . . . . . . . . . . 68.9 mt -129.81 122.55 54.94 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.179 0 CA-C-O 120.787 0.327 . . . . 0.0 110.462 177.903 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' F' F ' 42' ' ' LEU . . . . . . . . . . . . . 8.9 tp 52.23 35.11 16.0 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-N 116.131 -0.486 . . . . 0.0 111.628 177.308 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' F' F ' 43' ' ' GLY . . . . . . . . . . . . . . . 72.07 32.32 63.32 Favored Glycine 0 CA--C 1.529 0.952 0 C-N-CA 121.05 -0.595 . . . . 0.0 111.907 178.253 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' F' F ' 44' ' ' LYS . . . . . . . . . . . . . 54.4 tttp -137.94 128.79 27.02 Favored 'General case' 0 C--N 1.329 -0.296 0 N-CA-C 109.668 -0.493 . . . . 0.0 109.668 179.259 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' F' F ' 45' ' ' GLU . . . . . . . . . . . . . 84.6 tt0 -84.23 124.68 31.46 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-O 120.878 0.37 . . . . 0.0 111.298 -178.215 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' F' F ' 46' ' ' VAL . . . . . . . . . . . . . 7.1 p -121.0 127.74 75.99 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.209 0 N-CA-C 109.299 -0.63 . . . . 0.0 109.299 174.261 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' F' F ' 47' ' ' LYS . . . . . . . . . . . . . 93.1 mttt -99.98 127.24 46.21 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.062 -0.517 . . . . 0.0 111.006 179.583 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' F' F ' 48' ' ' PHE . . . . . . . . . . . . . 94.0 m-85 -111.07 131.96 54.65 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.305 -0.407 . . . . 0.0 109.951 175.961 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' F' F ' 49' ' ' LYS . . . . . . . . . . . . . 84.0 tttt -107.24 135.5 48.65 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.281 -0.418 . . . . 0.0 110.218 179.457 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' F' F ' 50' ' ' VAL . . . . . . . . . . . . . 46.4 t -79.38 108.02 12.47 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.295 0 N-CA-C 109.22 -0.659 . . . . 0.0 109.22 176.541 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' F' F ' 51' ' ' VAL . . . . . . . . . . . . . 47.8 t -70.9 -48.11 58.54 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.267 0 CA-C-N 115.991 -0.549 . . . . 0.0 109.974 -173.768 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' F' F ' 52' ' ' GLN . . . . . . . . . . . . . 63.2 tt0 -163.67 140.08 6.83 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.05 -0.523 . . . . 0.0 111.553 -178.233 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' F' F ' 53' ' ' ALA . . . . . 0.49 ' HB1' ' HB2' ' F' ' 58' ' ' LEU . . . -111.9 130.49 55.81 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-N 115.565 -0.743 . . . . 0.0 109.54 174.137 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' F' F ' 54' ' ' TYR . . . . . . . . . . . . . 41.8 t80 -129.06 110.16 18.24 Favored Pre-proline 0 C--N 1.327 -0.38 0 CA-C-O 118.358 -0.829 . . . . 0.0 110.484 -179.3 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' F' F ' 55' ' ' PRO . . . . . . . . . . . . . 73.8 Cg_endo -76.99 169.69 73.74 Favored 'Cis proline' 0 N--CA 1.498 1.783 0 CA-C-N 121.906 1.716 . . . . 0.0 112.296 -4.343 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' F' F ' 56' ' ' SER . . . . . . . . . . . . . 13.7 m -113.45 128.03 26.16 Favored Pre-proline 0 CA--C 1.539 0.553 0 CA-C-O 118.448 -0.787 . . . . 0.0 109.383 176.706 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' F' F ' 57' ' ' PRO . . . . . . . . . . . . . 38.5 Cg_endo -66.96 165.35 67.11 Favored 'Cis proline' 0 N--CA 1.497 1.693 0 CA-C-N 121.924 1.723 . . . . 0.0 111.463 0.388 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' F' F ' 58' ' ' LEU . . . . . 0.49 ' HB2' ' HB1' ' F' ' 53' ' ' ALA . 27.7 tp -129.26 135.76 49.2 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-O 120.934 0.397 . . . . 0.0 110.612 -179.31 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' F' F ' 59' ' ' ARG . . . . . . . . . . . . . 40.6 ttm180 -106.56 137.21 44.98 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-N 115.897 -0.592 . . . . 0.0 109.569 176.309 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' F' F ' 60' ' ' VAL . . . . . . . . . . . . . 44.2 t -91.0 122.7 42.66 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 C-N-CA 120.601 -0.44 . . . . 0.0 110.272 -178.178 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' F' F ' 61' ' ' GLU . . . . . . . . . . . . . 70.6 mm-40 -131.09 167.76 18.57 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 115.938 -0.574 . . . . 0.0 110.006 177.208 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' F' F ' 62' ' ' ASP . . . . . . . . . . . . . 75.1 m-20 -54.68 -32.95 60.16 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-N 116.58 -0.282 . . . . 0.0 111.748 -178.715 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' F' F ' 63' ' ' ARG . . . . . . . . . . . . . 7.0 ptp180 -89.45 8.55 30.36 Favored 'General case' 0 CA--C 1.536 0.413 0 N-CA-C 113.527 0.936 . . . . 0.0 113.527 -175.499 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' F' F ' 64' ' ' THR . . . . . . . . . . . . . 30.3 m -85.2 137.77 32.79 Favored 'General case' 0 C--O 1.232 0.155 0 CA-C-N 118.115 0.416 . . . . 0.0 110.343 -178.644 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' F' F ' 65' ' ' LYS . . . . . . . . . . . . . 97.3 mttt -88.58 125.94 35.03 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-N 116.27 -0.423 . . . . 0.0 110.041 -179.899 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' F' F ' 66' ' ' ILE . . . . . . . . . . . . . 64.9 mt -115.24 128.77 72.3 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.279 0 N-CA-C 109.812 -0.44 . . . . 0.0 109.812 -179.825 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' F' F ' 67' ' ' THR . . . . . . . . . . . . . 18.6 m -124.65 138.7 54.29 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.74 -177.726 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' F' F ' 68' ' ' LEU . . . . . 0.504 HD12 ' N ' ' F' ' 68' ' ' LEU . 7.1 mp -103.98 128.87 51.54 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 115.895 -0.593 . . . . 0.0 110.226 177.218 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' F' F ' 69' ' ' VAL . . . . . . . . . . . . . 43.9 t -101.29 133.51 44.42 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.303 0 CA-C-N 116.287 -0.415 . . . . 0.0 109.967 179.658 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' F' F ' 70' ' ' THR . . . . . . . . . . . . . 9.5 m -136.99 95.56 3.14 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.344 -0.389 . . . . 0.0 110.806 -179.573 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' F' F ' 71' ' ' HIS . . . . . . . . . . . . . 40.6 t-80 -148.26 64.87 8.36 Favored Pre-proline 0 CA--C 1.536 0.436 0 CA-C-N 116.089 -0.505 . . . . 0.0 110.199 176.015 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' F' F ' 72' ' ' PRO . . . . . . . . . . . . . 68.9 Cg_endo -94.96 37.39 0.16 Allowed 'Trans proline' 0 N--CA 1.488 1.172 0 C-N-CA 121.955 1.77 . . . . 0.0 112.75 -177.827 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' F' F ' 73' ' ' VAL . . . . . . . . . . . . . 27.5 m -104.08 141.11 20.37 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.235 0 CA-C-O 121.248 0.547 . . . . 0.0 111.079 -178.937 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' F' F ' 74' ' ' ASP . . . . . . . . . . . . . 33.5 t0 -96.61 119.83 35.81 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 115.477 -0.783 . . . . 0.0 109.236 176.583 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' F' F ' 75' ' ' VAL . . . . . . . . . . . . . 42.0 t -109.6 123.15 65.25 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.247 0 CA-C-O 121.178 0.514 . . . . 0.0 110.521 -176.73 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' F' F ' 76' ' ' LEU . . . . . . . . . . . . . 23.8 mt -128.9 141.27 51.33 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 115.485 -0.78 . . . . 0.0 109.281 177.508 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' F' F ' 77' ' ' GLU . . . . . . . . . . . . . 45.7 tt0 -136.76 133.07 35.62 Favored 'General case' 0 C--N 1.331 -0.225 0 C-N-CA 120.736 -0.386 . . . . 0.0 110.978 -176.354 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' F' F ' 78' ' ' ALA . . . . . . . . . . . . . . . -120.6 135.55 55.07 Favored 'General case' 0 C--N 1.332 -0.177 0 CA-C-N 116.259 -0.428 . . . . 0.0 110.281 179.796 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' F' F ' 79' ' ' LYS . . . . . 0.655 ' O ' HD13 ' F' ' 80' ' ' ILE . 87.1 mttt -79.49 120.87 24.48 Favored 'General case' 0 C--N 1.331 -0.209 0 CA-C-O 120.853 0.359 . . . . 0.0 110.787 -179.242 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' F' F ' 80' ' ' ILE . . . . . 0.655 HD13 ' O ' ' F' ' 79' ' ' LYS . 37.2 mm -139.14 108.16 3.65 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.314 0 N-CA-C 108.869 -0.789 . . . . 0.0 108.869 -177.78 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' F' F ' 81' ' ' LYS . . . . . . . . . . . . . 79.5 tttt -99.96 125.79 46.02 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-O 120.837 0.351 . . . . 0.0 111.43 -174.834 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' F' F ' 82' ' ' GLY . . . . . . . . . . . . . . . 89.05 42.14 5.7 Favored Glycine 0 CA--C 1.525 0.683 0 C-N-CA 120.956 -0.64 . . . . 0.0 111.617 174.417 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' F' F ' 83' ' ' ILE . . . . . . . . . . . . . 68.5 mt -68.83 138.23 22.78 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.29 0 CA-C-O 120.921 0.391 . . . . 0.0 110.019 179.695 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' F' F ' 84' ' ' LYS . . . . . . . . . . . . . 38.2 tttp -99.91 -53.12 3.25 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 115.924 -0.58 . . . . 0.0 110.158 -179.475 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' F' F ' 85' ' ' ASP . . . . . . . . . . . . . 11.1 t0 -151.85 148.31 27.66 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 115.748 -0.66 . . . . 0.0 110.241 179.72 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' F' F ' 86' ' ' VAL . . . . . . . . . . . . . 45.3 t -125.94 130.24 72.33 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.191 0 CA-C-O 120.898 0.38 . . . . 0.0 110.308 -179.309 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' F' F ' 87' ' ' ILE . . . . . . . . . . . . . 46.2 mm -121.75 130.21 74.8 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.246 0 CA-C-N 115.926 -0.579 . . . . 0.0 109.948 177.365 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' F' F ' 88' ' ' LEU . . . . . . . . . . . . . 58.5 mt -108.17 137.25 46.47 Favored 'General case' 0 C--N 1.332 -0.194 0 CA-C-O 121.04 0.448 . . . . 0.0 111.361 -177.966 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' F' F ' 89' ' ' ASP . . . . . . . . . . . . . 13.8 t70 -126.58 153.14 45.67 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 115.653 -0.703 . . . . 0.0 109.489 176.695 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' F' F ' 90' ' ' GLU . . . . . . . . . . . . . 84.8 tt0 -47.54 -36.12 10.0 Favored 'General case' 0 C--N 1.329 -0.288 0 N-CA-C 112.851 0.686 . . . . 0.0 112.851 -172.259 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' F' F ' 91' ' ' ASN . . . . . . . . . . . . . 16.9 t30 -131.96 19.99 4.55 Favored 'General case' 0 N--CA 1.468 0.435 0 N-CA-C 112.995 0.739 . . . . 0.0 112.995 -178.411 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' F' F ' 92' ' ' LEU . . . . . . . . . . . . . 35.7 mt -150.28 152.83 35.12 Favored 'General case' 0 C--N 1.331 -0.209 0 CA-C-O 120.824 0.345 . . . . 0.0 110.513 -177.114 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' F' F ' 93' ' ' ILE . . . . . . . . . . . . . 71.9 mt -126.77 121.27 57.99 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.379 0 N-CA-C 109.319 -0.623 . . . . 0.0 109.319 177.206 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' F' F ' 94' ' ' VAL . . . . . . . . . . . . . 45.4 t -117.47 125.83 74.27 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.268 0 N-CA-C 109.829 -0.434 . . . . 0.0 109.829 -178.907 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' F' F ' 95' ' ' VAL . . . . . . . . . . . . . 46.1 t -122.16 133.03 69.72 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.291 0 CA-C-N 116.071 -0.513 . . . . 0.0 109.919 -179.468 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' F' F ' 96' ' ' ILE . . . . . . . . . . . . . 57.4 mt -114.77 127.77 72.15 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.323 0 N-CA-C 109.141 -0.689 . . . . 0.0 109.141 178.473 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' F' F ' 97' ' ' THR . . . . . . . . . . . . . 74.0 p -99.33 159.34 15.08 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-O 121.139 0.495 . . . . 0.0 111.423 -177.303 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' F' F ' 98' ' ' GLU . . . . . . . . . . . . . 12.6 pt-20 -54.69 -28.02 44.62 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.091 -0.504 . . . . 0.0 112.263 -179.135 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' F' F ' 99' ' ' GLU . . . . . . . . . . . . . 70.9 mm-40 -80.28 14.39 1.97 Allowed 'General case' 0 CA--C 1.535 0.397 0 N-CA-C 113.084 0.772 . . . . 0.0 113.084 -177.684 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' F' F ' 100' ' ' ASN . . . . . . . . . . . . . 5.3 m-20 62.09 35.25 15.91 Favored 'General case' 0 C--N 1.332 -0.164 0 CA-C-O 120.96 0.41 . . . . 0.0 111.354 179.56 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' F' F ' 101' ' ' GLU . . . . . . . . . . . . . 84.5 tt0 -106.61 143.0 35.35 Favored 'General case' 0 C--N 1.333 -0.145 0 N-CA-C 109.513 -0.551 . . . . 0.0 109.513 172.008 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' F' F ' 102' ' ' VAL . . . . . . . . . . . . . 43.2 t -115.02 125.45 72.34 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.311 0 N-CA-C 109.823 -0.436 . . . . 0.0 109.823 -177.867 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' F' F ' 103' ' ' LEU . . . . . . . . . . . . . 42.5 mt -116.81 129.13 55.9 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 115.762 -0.654 . . . . 0.0 110.17 177.508 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' F' F ' 104' ' ' ILE . . . . . . . . . . . . . 70.3 mt -118.36 119.43 61.24 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.261 0 N-CA-C 110.118 -0.327 . . . . 0.0 110.118 179.187 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' F' F ' 105' ' ' PHE . . . . . . . . . . . . . 65.8 m-85 -119.81 166.32 13.42 Favored 'General case' 0 C--N 1.331 -0.202 0 O-C-N 124.169 0.918 . . . . 0.0 109.591 178.858 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' F' F ' 106' ' ' ASN . . . . . . . . . . . . . 43.6 p-10 -99.3 -170.91 1.98 Allowed 'General case' 0 C--N 1.329 -0.284 0 N-CA-C 109.756 -0.461 . . . . 0.0 109.756 171.834 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' F' F ' 107' ' ' GLN . . . . . . . . . . . . . 43.0 tp60 -57.82 -27.91 63.58 Favored 'General case' 0 CA--C 1.533 0.323 0 N-CA-C 112.005 0.372 . . . . 0.0 112.005 -179.815 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' F' F ' 108' ' ' ASN . . . . . . . . . . . . . 23.5 t30 -90.47 13.85 14.6 Favored 'General case' 0 CA--C 1.534 0.336 0 N-CA-C 113.067 0.766 . . . . 0.0 113.067 -175.997 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' F' F ' 109' ' ' LEU . . . . . . . . . . . . . 47.5 mt 57.95 38.0 26.85 Favored 'General case' 0 C--O 1.232 0.144 0 CA-C-O 120.975 0.416 . . . . 0.0 111.468 177.292 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' F' F ' 110' ' ' GLU . . . . . . . . . . . . . 95.7 mt-10 -102.07 155.12 18.39 Favored 'General case' 0 C--N 1.329 -0.319 0 N-CA-C 109.939 -0.393 . . . . 0.0 109.939 176.076 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' F' F ' 111' ' ' GLU . . . . . . . . . . . . . 84.9 tt0 -85.85 121.91 29.17 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-O 120.914 0.388 . . . . 0.0 110.698 -178.067 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' F' F ' 112' ' ' LEU . . . . . . . . . . . . . 32.5 mt -111.8 -45.97 3.29 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.043 -0.526 . . . . 0.0 110.414 178.297 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' F' F ' 113' ' ' TYR . . . . . . . . . . . . . 63.3 t80 -138.79 135.79 35.0 Favored 'General case' 0 C--N 1.331 -0.213 0 CA-C-N 116.43 -0.35 . . . . 0.0 111.117 179.351 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' F' F ' 114' ' ' ARG . . . . . . . . . . . . . 59.6 ttp180 -137.69 122.3 18.55 Favored 'General case' 0 C--N 1.331 -0.227 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.308 177.65 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' F' F ' 115' ' ' GLY . . . . . . . . . . . . . . . -150.08 161.1 28.79 Favored Glycine 0 CA--C 1.525 0.668 0 N-CA-C 111.053 -0.819 . . . . 0.0 111.053 177.943 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' F' F ' 116' ' ' LYS . . . . . . . . . . . . . 83.4 tttt -134.9 128.97 33.59 Favored 'General case' 0 C--N 1.33 -0.274 0 N-CA-C 109.972 -0.381 . . . . 0.0 109.972 177.703 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' F' F ' 117' ' ' PHE . . . . . . . . . . . . . 30.8 m-85 -129.03 118.85 23.23 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 116.402 -0.363 . . . . 0.0 110.047 -174.778 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' F' F ' 118' ' ' GLU . . . . . . . . . . . . . 95.9 mt-10 -55.59 -40.25 71.77 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.469 -0.332 . . . . 0.0 110.987 -177.264 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' F' F ' 119' ' ' ASN . . . . . . . . . . . . . 19.1 m120 -101.28 30.99 3.88 Favored 'General case' 0 C--N 1.33 -0.257 0 N-CA-C 112.047 0.388 . . . . 0.0 112.047 -175.022 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' F' F ' 120' ' ' LEU . . . . . . . . . . . . . 17.5 tp -58.08 124.48 19.5 Favored 'General case' 0 C--N 1.333 -0.15 0 CA-C-O 120.752 0.311 . . . . 0.0 110.221 178.781 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' F' F ' 121' ' ' ASN . . . . . . . . . . . . . 17.6 m120 -109.23 -44.19 3.99 Favored 'General case' 0 C--N 1.331 -0.222 0 CA-C-N 116.328 -0.396 . . . . 0.0 111.116 -176.962 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' F' F ' 122' ' ' LYS . . . . . . . . . . . . . 19.5 ptpt -163.65 163.15 24.42 Favored 'General case' 0 C--N 1.331 -0.199 0 CA-C-O 121.099 0.476 . . . . 0.0 111.726 -179.043 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' F' F ' 123' ' ' VAL . . . . . . . . . . . . . 42.2 t -132.95 137.15 54.38 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.251 0 CA-C-N 116.023 -0.535 . . . . 0.0 110.006 178.613 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' F' F ' 124' ' ' LEU . . . . . . . . . . . . . 80.0 mt -120.77 138.52 53.97 Favored 'General case' 0 C--N 1.331 -0.224 0 CA-C-N 116.293 -0.412 . . . . 0.0 110.535 -179.418 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' F' F ' 125' ' ' VAL . . . . . 0.53 HG23 HG12 ' F' ' 130' ' ' VAL . 12.0 p -133.63 130.28 56.25 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.246 0 CA-C-O 120.938 0.399 . . . . 0.0 110.785 179.641 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' F' F ' 126' ' ' ARG . . . . . . . . . . . . . 79.4 mtt85 -151.32 125.12 9.1 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 115.851 -0.613 . . . . 0.0 109.948 175.469 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' F' F ' 127' ' ' ASN . . . . . . . . . . . . . 17.3 m120 55.99 -149.32 0.46 Allowed 'General case' 0 CA--C 1.54 0.579 0 N-CA-C 109.897 -0.408 . . . . 0.0 109.897 178.99 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' F' F ' 128' ' ' ASP . . . . . . . . . . . . . 24.3 p-10 -82.17 13.08 3.67 Favored 'General case' 0 CA--C 1.537 0.446 0 N-CA-C 112.995 0.739 . . . . 0.0 112.995 -179.96 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' F' F ' 129' ' ' LEU . . . . . . . . . . . . . 19.9 tp -112.5 133.45 54.56 Favored 'General case' 0 C--O 1.232 0.182 0 CA-C-N 118.171 0.441 . . . . 0.0 110.104 179.196 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' F' F ' 130' ' ' VAL . . . . . 0.53 HG12 HG23 ' F' ' 125' ' ' VAL . 33.7 m -131.55 141.56 45.46 Favored 'Isoleucine or valine' 0 C--O 1.232 0.136 0 CA-C-O 120.782 0.325 . . . . 0.0 110.506 -179.651 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' F' F ' 131' ' ' VAL . . . . . 0.428 ' CG1' HD21 ' F' ' 138' ' ' LEU . 40.0 t -136.09 140.29 44.17 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.305 0 CA-C-O 120.986 0.422 . . . . 0.0 110.525 -179.104 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' F' F ' 132' ' ' ILE . . . . . . . . . . . . . 69.4 mt -115.16 133.8 60.28 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.249 0 N-CA-C 109.255 -0.646 . . . . 0.0 109.255 178.035 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' F' F ' 133' ' ' ILE . . . . . . . . . . . . . 42.7 mm -115.11 124.4 71.7 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.229 0 CA-C-N 116.568 -0.287 . . . . 0.0 110.859 -175.051 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' F' F ' 134' ' ' ASP . . . . . . . . . . . . . 7.2 p-10 -134.6 147.5 50.23 Favored 'General case' 0 C--N 1.332 -0.195 0 N-CA-C 109.605 -0.517 . . . . 0.0 109.605 174.089 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' F' F ' 135' ' ' GLU . . . . . . . . . . . . . 85.2 tt0 -50.7 -27.55 7.3 Favored 'General case' 0 C--N 1.328 -0.335 0 N-CA-C 112.822 0.675 . . . . 0.0 112.822 -173.129 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' F' F ' 136' ' ' GLN . . . . . . . . . . . . . 97.5 mt-30 -81.55 -32.47 32.2 Favored 'General case' 0 C--N 1.331 -0.239 0 N-CA-C 112.663 0.616 . . . . 0.0 112.663 -176.784 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' F' F ' 137' ' ' LYS . . . . . . . . . . . . . 53.3 pttt -169.02 173.54 6.83 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-O 121.562 0.696 . . . . 0.0 112.576 -172.458 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' F' F ' 138' ' ' LEU . . . . . 0.463 HD23 ' N ' ' F' ' 139' ' ' THR . 4.6 tt -117.07 129.74 56.19 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 115.113 -0.949 . . . . 0.0 109.923 179.622 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' F' F ' 139' ' ' THR . . . . . 0.463 ' N ' HD23 ' F' ' 138' ' ' LEU . 33.2 m -112.22 124.68 52.97 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.421 -0.354 . . . . 0.0 110.199 178.917 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' F' F ' 140' ' ' LEU . . . . . 0.482 HD23 ' C ' ' F' ' 140' ' ' LEU . 7.8 tt -113.86 125.19 53.79 Favored 'General case' 0 C--N 1.33 -0.281 0 N-CA-C 109.326 -0.62 . . . . 0.0 109.326 -178.724 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' F' F ' 141' ' ' ILE . . . . . 0.509 ' HB ' HG23 ' F' ' 130' ' ' VAL . 20.1 mt -121.98 125.32 72.97 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.272 0 CA-C-O 121.03 0.443 . . . . 0.0 110.022 -175.39 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' F' F ' 142' ' ' ARG . . . . . . . . . . . . . 39.1 tpt85 -113.8 128.04 56.25 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 115.132 -0.94 . . . . 0.0 109.944 -177.403 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' F' F ' 143' ' ' THR . . . . . . . . . . . . . 23.5 p . . . . . 0 C--O 1.22 -0.49 0 CA-C-O 117.953 -1.023 . . . . 0.0 110.516 -179.328 . . . . . . . . 0 0 . 1 . 013 nuclear nobuild full ' A' A ' -3' ' ' GLU . . . . . . . . . . . . . 95.8 mt-10 . . . . . 0 N--CA 1.489 1.52 0 N-CA-C 109.401 -0.592 . . . . 0.0 109.401 . . . . . . . . . 0 0 . 1 . 013 nuclear nobuild full ' A' A ' -2' ' ' GLY . . . . . . . . . . . . . . . -69.92 137.86 29.0 Favored Glycine 0 CA--C 1.523 0.559 0 N-CA-C 110.786 -0.926 . . . . 0.0 110.786 179.152 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' -1' ' ' VAL . . . . . . . . . . . . . 43.1 t -96.18 134.38 33.97 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.321 0 CA-C-O 120.821 0.343 . . . . 0.0 110.108 -179.875 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 0' ' ' ILE . . . . . . . . . . . . . 70.2 mt -109.78 121.08 62.13 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.272 0 N-CA-C 109.704 -0.48 . . . . 0.0 109.704 179.258 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 25.6 ptp -82.62 142.25 31.88 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.102 -0.499 . . . . 0.0 110.662 -179.219 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 2.6 p -114.34 130.96 56.7 Favored 'General case' 0 C--N 1.331 -0.224 0 CA-C-N 115.977 -0.556 . . . . 0.0 110.711 -178.971 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 82.8 tt0 -145.87 144.03 29.96 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.169 -0.469 . . . . 0.0 111.011 179.58 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 4' ' ' LEU . . . . . . . . . . . . . 14.8 tp -125.9 132.43 52.14 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.069 -0.514 . . . . 0.0 110.109 177.227 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 5' ' ' LYS . . . . . . . . . . . . . 68.3 mttm -109.75 122.74 48.18 Favored 'General case' 0 C--O 1.233 0.195 0 CA-C-N 116.345 -0.389 . . . . 0.0 110.823 179.941 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 31.2 mt -113.84 150.0 34.21 Favored 'General case' 0 C--N 1.331 -0.217 0 CA-C-N 115.349 -0.841 . . . . 0.0 110.196 -179.781 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 81.9 tttt -133.0 138.8 32.65 Favored Pre-proline 0 CA--C 1.534 0.332 0 CA-C-O 118.949 -0.548 . . . . 0.0 109.525 174.077 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 8' ' ' PRO . . . . . . . . . . . . . 88.5 Cg_endo -91.66 141.3 2.61 Favored 'Trans proline' 0 N--CA 1.489 1.253 0 C-N-CA 121.747 1.631 . . . . 0.0 112.16 179.741 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 62.5 mt -77.41 -47.4 2.51 Favored Pre-proline 0 CA--C 1.535 0.393 0 CA-C-O 118.69 -0.672 . . . . 0.0 112.074 178.729 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 97.8 Cg_endo -81.77 152.98 17.26 Favored 'Trans proline' 0 N--CA 1.495 1.604 0 C-N-CA 121.293 1.329 . . . . 0.0 111.995 176.088 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 46.3 tttp -88.68 98.08 11.49 Favored 'General case' 0 C--N 1.331 -0.237 0 C-N-CA 120.89 -0.324 . . . . 0.0 110.189 177.682 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 12.3 p -141.47 147.94 21.6 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.308 0 CA-C-N 116.283 -0.417 . . . . 0.0 110.673 -178.48 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 93.6 mt-10 -88.94 124.35 34.15 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.259 -0.428 . . . . 0.0 109.993 177.904 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 14' ' ' LEU . . . . . . . . . . . . . 26.2 mt -98.15 149.81 36.1 Favored Pre-proline 0 CA--C 1.534 0.335 0 CA-C-O 119.266 -0.397 . . . . 0.0 110.508 -179.25 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 15' ' ' PRO . . . . . . . . . . . . . 26.9 Cg_exo -62.06 158.55 38.52 Favored 'Trans proline' 0 N--CA 1.498 1.744 0 C-N-CA 121.282 1.322 . . . . 0.0 112.015 177.416 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 16' ' ' PRO . . . . . . . . . . . . . 32.9 Cg_exo -59.78 -35.66 93.64 Favored 'Trans proline' 0 N--CA 1.498 1.765 0 C-N-CA 121.384 1.389 . . . . 0.0 112.676 -179.739 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 17' ' ' ASP . . . . . . . . . . . . . 18.7 p-10 -86.91 8.81 21.5 Favored 'General case' 0 C--N 1.327 -0.376 0 N-CA-C 113.276 0.843 . . . . 0.0 113.276 -177.644 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 18' ' ' PHE . . . . . . . . . . . . . 37.9 t80 -58.12 -47.86 81.99 Favored 'General case' 0 N--CA 1.457 -0.081 0 O-C-N 121.963 -0.46 . . . . 0.0 110.194 -177.158 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 19' ' ' VAL . . . . . 0.408 HG13 ' N ' ' A' ' 20' ' ' ASP . 14.8 p -55.92 -41.3 66.79 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.339 0 CA-C-N 116.359 -0.382 . . . . 0.0 111.141 -177.614 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 20' ' ' ASP . . . . . 0.408 ' N ' HG13 ' A' ' 19' ' ' VAL . 49.8 m-20 -60.26 -44.74 95.04 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-O 120.805 0.336 . . . . 0.0 111.045 -177.387 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 47.0 t -64.78 -48.44 84.47 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.283 0 C-N-CA 120.726 -0.39 . . . . 0.0 110.495 -177.648 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 22' ' ' ILE . . . . . 0.542 HG22 HD12 ' A' ' 26' ' ' LEU . 44.5 mm -56.92 -43.86 81.3 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.247 0 CA-C-O 120.777 0.322 . . . . 0.0 110.489 179.957 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 23' ' ' ARG . . . . . . . . . . . . . 32.1 ttp180 -54.58 -49.76 69.62 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.65 -0.25 . . . . 0.0 111.283 -178.637 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 24' ' ' ILE . . . . . . . . . . . . . 75.9 mt -59.41 -41.39 84.3 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.238 0 C-N-CA 120.971 -0.291 . . . . 0.0 111.148 -177.622 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 91.9 mttt -64.97 -43.47 92.56 Favored 'General case' 0 C--N 1.329 -0.295 0 N-CA-C 112.439 0.533 . . . . 0.0 112.439 -179.437 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 26' ' ' LEU . . . . . 0.542 HD12 HG22 ' A' ' 22' ' ' ILE . 88.7 mt -79.75 -36.81 36.74 Favored 'General case' 0 C--N 1.331 -0.217 0 N-CA-C 113.589 0.959 . . . . 0.0 113.589 -170.541 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 27' ' ' GLN . . . . . . . . . . . . . 9.1 pt20 -47.13 142.17 3.9 Favored 'General case' 0 N--CA 1.469 0.508 0 N-CA-C 112.699 0.629 . . . . 0.0 112.699 -175.04 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 99.15 -24.99 30.02 Favored Glycine 0 CA--C 1.534 1.237 0 CA-C-N 115.591 -0.732 . . . . 0.0 112.251 -176.155 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 68.3 mttm -97.52 155.15 17.08 Favored 'General case' 0 C--O 1.232 0.177 0 CA-C-N 117.399 0.599 . . . . 0.0 111.028 178.635 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 30' ' ' THR . . . . . . . . . . . . . 30.2 m -103.25 137.68 41.06 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 115.887 -0.597 . . . . 0.0 109.933 176.13 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 35.2 m -126.33 153.52 34.89 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.248 0 CA-C-N 116.404 -0.362 . . . . 0.0 110.468 -179.4 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 32' ' ' ARG . . . . . . . . . . . . . 60.3 ttp180 -131.23 148.58 52.71 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.048 -0.524 . . . . 0.0 110.458 179.293 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 33' ' ' THR . . . . . . . . . . . . . 17.2 m -53.12 138.7 30.61 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.266 -0.425 . . . . 0.0 111.365 -177.936 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 99.91 -17.2 57.62 Favored Glycine 0 CA--C 1.532 1.155 0 CA-C-O 119.718 -0.49 . . . . 0.0 113.228 179.873 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 72.9 m-20 -66.2 151.73 46.35 Favored 'General case' 0 C--N 1.334 -0.107 0 CA-C-N 118.039 0.92 . . . . 0.0 111.288 179.404 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 45.2 t -122.73 130.46 74.47 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.198 0 CA-C-N 115.756 -0.656 . . . . 0.0 109.884 177.784 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 37' ' ' ILE . . . . . . . . . . . . . 65.3 mt -120.66 138.06 52.37 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.231 0 CA-C-N 116.18 -0.464 . . . . 0.0 109.834 -179.921 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . -116.04 128.55 8.05 Favored Glycine 0 CA--C 1.525 0.665 0 N-CA-C 110.991 -0.844 . . . . 0.0 110.991 179.582 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 39' ' ' ILE . . . . . . . . . . . . . 75.1 mt -126.82 134.28 66.59 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.226 0 CA-C-O 120.695 0.283 . . . . 0.0 110.285 179.445 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 40' ' ' SER . . . . . . . . . . . . . 53.2 p -92.39 114.61 27.2 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-N 116.225 -0.443 . . . . 0.0 110.758 175.949 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 41' ' ' ILE . . . . . . . . . . . . . 43.1 mm -120.47 117.42 53.26 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.26 0 CA-C-O 120.937 0.398 . . . . 0.0 110.601 179.545 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 42' ' ' LEU . . . . . 0.546 ' O ' HD23 ' A' ' 42' ' ' LEU . 1.3 tt 51.66 45.96 27.29 Favored 'General case' 0 CA--C 1.531 0.248 0 CA-C-O 121.404 0.621 . . . . 0.0 111.004 176.701 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . 70.76 21.68 78.01 Favored Glycine 0 CA--C 1.532 1.138 0 C-N-CA 121.175 -0.536 . . . . 0.0 112.851 175.523 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 44' ' ' LYS . . . . . . . . . . . . . 56.5 mttm -133.14 129.31 37.71 Favored 'General case' 0 C--N 1.332 -0.178 0 CA-C-N 117.55 0.675 . . . . 0.0 110.09 179.195 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 84.5 tt0 -83.95 123.81 30.36 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 116.552 -0.294 . . . . 0.0 111.067 -178.568 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 46' ' ' VAL . . . . . 0.415 HG13 ' O ' ' A' ' 46' ' ' VAL . 10.4 p -121.21 124.17 71.49 Favored 'Isoleucine or valine' 0 C--O 1.233 0.194 0 N-CA-C 109.687 -0.486 . . . . 0.0 109.687 174.674 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 93.8 mttt -99.6 127.18 45.69 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.095 -0.502 . . . . 0.0 110.783 177.702 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 48' ' ' PHE . . . . . . . . . . . . . 35.8 m-85 -110.81 131.95 54.61 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 115.855 -0.612 . . . . 0.0 109.666 177.593 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 84.2 tttt -106.52 135.78 47.44 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.246 -0.434 . . . . 0.0 110.215 179.058 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 50' ' ' VAL . . . . . . . . . . . . . 45.1 t -79.21 105.33 8.38 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.317 0 N-CA-C 109.549 -0.537 . . . . 0.0 109.549 177.622 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 51' ' ' VAL . . . . . . . . . . . . . 50.5 t -70.14 -54.32 19.33 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.366 0 N-CA-C 109.36 -0.607 . . . . 0.0 109.36 -176.347 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 52' ' ' GLN . . . . . . . . . . . . . 91.7 mt-30 -153.52 154.35 34.16 Favored 'General case' 0 C--N 1.331 -0.22 0 CA-C-N 115.913 -0.585 . . . . 0.0 111.595 -178.864 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -129.35 134.34 47.85 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 115.148 -0.933 . . . . 0.0 109.779 175.984 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 54' ' ' TYR . . . . . . . . . . . . . 57.3 t80 -128.75 107.24 18.54 Favored Pre-proline 0 CA--C 1.534 0.345 0 CA-C-O 118.281 -0.866 . . . . 0.0 110.449 -178.891 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 55' ' ' PRO . . . . . . . . . . . . . 73.5 Cg_endo -77.16 170.07 72.52 Favored 'Cis proline' 0 N--CA 1.5 1.854 0 CA-C-N 121.688 1.639 . . . . 0.0 112.405 -5.77 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 56' ' ' SER . . . . . . . . . . . . . 32.6 m -113.93 126.94 27.38 Favored Pre-proline 0 CA--C 1.54 0.57 0 CA-C-O 118.31 -0.852 . . . . 0.0 109.51 175.486 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 57' ' ' PRO . . . . . . . . . . . . . 52.7 Cg_endo -71.06 167.21 75.33 Favored 'Cis proline' 0 N--CA 1.497 1.677 0 CA-C-N 122.084 1.78 . . . . 0.0 111.89 -0.387 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 58' ' ' LEU . . . . . . . . . . . . . 18.9 tp -130.57 138.27 50.09 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.232 -0.44 . . . . 0.0 110.542 -179.426 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 59' ' ' ARG . . . . . . . . . . . . . 55.2 ttp180 -105.38 128.17 53.36 Favored 'General case' 0 C--N 1.329 -0.317 0 N-CA-C 109.118 -0.697 . . . . 0.0 109.118 175.031 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 40.2 t -82.84 123.12 38.22 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.196 0 C-N-CA 120.581 -0.448 . . . . 0.0 110.638 -173.835 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 95.1 mt-10 -131.07 168.76 16.87 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 115.78 -0.646 . . . . 0.0 109.998 177.958 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 62' ' ' ASP . . . . . . . . . . . . . 51.7 m-20 -54.36 -32.4 56.83 Favored 'General case' 0 C--N 1.329 -0.283 0 N-CA-C 111.747 0.277 . . . . 0.0 111.747 -179.712 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 63' ' ' ARG . . . . . . . . . . . . . 41.0 ptt180 -87.45 5.65 37.87 Favored 'General case' 0 CA--C 1.537 0.473 0 N-CA-C 113.712 1.004 . . . . 0.0 113.712 -174.999 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 28.8 m -87.4 139.14 30.85 Favored 'General case' 0 C--N 1.332 -0.179 0 CA-C-N 117.994 0.361 . . . . 0.0 110.537 -179.867 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 65' ' ' LYS . . . . . . . . . . . . . 61.8 mttm -87.63 130.44 34.77 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.096 -0.502 . . . . 0.0 110.281 179.154 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 66' ' ' ILE . . . . . . . . . . . . . 57.7 mt -115.47 124.93 72.47 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.316 0 N-CA-C 109.436 -0.579 . . . . 0.0 109.436 178.231 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 67' ' ' THR . . . . . . . . . . . . . 24.9 m -129.42 148.3 51.32 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-O 121.189 0.518 . . . . 0.0 111.531 -175.608 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 68' ' ' LEU . . . . . 0.408 HD23 ' N ' ' A' ' 69' ' ' VAL . 4.0 tt -102.3 129.33 48.7 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 115.764 -0.653 . . . . 0.0 109.589 176.52 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 69' ' ' VAL . . . . . 0.408 ' N ' HD23 ' A' ' 68' ' ' LEU . 41.7 t -96.34 138.62 21.14 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.241 0 CA-C-O 120.962 0.41 . . . . 0.0 110.826 -175.562 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 70' ' ' THR . . . . . . . . . . . . . 10.2 t -88.35 -175.42 5.0 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-N 115.754 -0.657 . . . . 0.0 110.29 179.393 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 71' ' ' HIS . . . . . . . . . . . . . 82.2 t60 -117.6 81.69 14.88 Favored Pre-proline 0 CA--C 1.533 0.296 0 CA-C-N 116.746 -0.206 . . . . 0.0 111.096 -177.295 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 72' ' ' PRO . . . . . . . . . . . . . 94.4 Cg_endo -93.0 154.46 2.67 Favored 'Trans proline' 0 N--CA 1.489 1.225 0 C-N-CA 122.022 1.814 . . . . 0.0 111.916 176.698 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 73' ' ' VAL . . . . . . . . . . . . . 33.7 m -71.5 151.16 8.82 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.184 0 CA-C-O 121.029 0.442 . . . . 0.0 110.933 179.875 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 74' ' ' ASP . . . . . . . . . . . . . 5.3 t0 -98.87 123.41 43.12 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 115.724 -0.671 . . . . 0.0 109.655 177.628 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 42.4 t -115.09 122.36 69.0 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.178 0 CA-C-O 121.038 0.446 . . . . 0.0 110.572 -177.783 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 76' ' ' LEU . . . . . . . . . . . . . 5.2 mp -121.09 142.87 49.44 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 115.623 -0.717 . . . . 0.0 109.739 176.386 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 77' ' ' GLU . . . . . . . . . . . . . 45.9 mt-10 -134.65 137.54 43.71 Favored 'General case' 0 C--N 1.331 -0.196 0 CA-C-O 120.955 0.407 . . . . 0.0 111.158 -179.355 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 78' ' ' ALA . . . . . 0.603 ' HB2' HD21 ' A' ' 109' ' ' LEU . . . -126.68 144.32 50.96 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 115.934 -0.576 . . . . 0.0 110.299 177.92 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 79' ' ' LYS . . . . . 0.624 ' O ' HD13 ' A' ' 80' ' ' ILE . 40.8 mmtm -82.99 116.04 22.09 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.392 -0.367 . . . . 0.0 110.688 -179.541 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 80' ' ' ILE . . . . . 0.624 HD13 ' O ' ' A' ' 79' ' ' LYS . 39.5 mm -139.09 110.69 5.16 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.286 0 N-CA-C 109.42 -0.585 . . . . 0.0 109.42 -179.288 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 81' ' ' LYS . . . . . . . . . . . . . 63.8 tttt -111.26 132.59 54.24 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-O 120.877 0.37 . . . . 0.0 111.064 -178.05 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . 89.04 42.11 5.71 Favored Glycine 0 CA--C 1.524 0.654 0 N-CA-C 111.432 -0.667 . . . . 0.0 111.432 175.46 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 83' ' ' ILE . . . . . . . . . . . . . 72.4 mt -76.54 137.68 22.12 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.326 0 N-CA-C 109.673 -0.491 . . . . 0.0 109.673 178.364 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 84' ' ' LYS . . . . . . . . . . . . . 39.3 ttpt -98.27 -48.14 5.18 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-N 116.241 -0.436 . . . . 0.0 110.036 -179.07 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 85' ' ' ASP . . . . . . . . . . . . . 5.5 t70 -155.12 155.77 34.58 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.089 -0.505 . . . . 0.0 110.814 179.357 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 86' ' ' VAL . . . . . . . . . . . . . 41.6 t -132.24 135.79 57.51 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.222 0 CA-C-O 120.962 0.411 . . . . 0.0 110.803 -178.423 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 87' ' ' ILE . . . . . . . . . . . . . 47.9 mm -119.22 123.59 71.6 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.308 0 CA-C-N 115.883 -0.599 . . . . 0.0 109.632 175.027 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 88' ' ' LEU . . . . . . . . . . . . . 14.2 tp -111.46 130.58 55.67 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-O 120.816 0.341 . . . . 0.0 110.89 -177.798 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 89' ' ' ASP . . . . . . . . . . . . . 6.9 t0 -130.89 156.02 45.76 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.048 -0.523 . . . . 0.0 109.704 178.328 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 79.5 tt0 -47.86 -39.61 19.12 Favored 'General case' 0 C--N 1.33 -0.27 0 N-CA-C 112.845 0.683 . . . . 0.0 112.845 -171.675 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 91' ' ' ASN . . . . . . . . . . . . . 16.4 m120 -123.58 14.98 9.52 Favored 'General case' 0 N--CA 1.467 0.406 0 N-CA-C 113.312 0.856 . . . . 0.0 113.312 -175.884 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 92' ' ' LEU . . . . . . . . . . . . . 33.4 mt -149.82 146.03 26.92 Favored 'General case' 0 C--N 1.331 -0.225 0 CA-C-N 117.93 0.332 . . . . 0.0 110.52 -176.214 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 93' ' ' ILE . . . . . . . . . . . . . 73.6 mt -127.62 116.92 45.12 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.331 0 N-CA-C 109.113 -0.699 . . . . 0.0 109.113 175.913 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 94' ' ' VAL . . . . . . . . . . . . . 45.0 t -116.7 126.87 74.36 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.278 0 N-CA-C 109.889 -0.412 . . . . 0.0 109.889 -177.941 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 95' ' ' VAL . . . . . . . . . . . . . 43.0 t -121.06 133.93 66.11 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.293 0 CA-C-N 116.177 -0.465 . . . . 0.0 109.807 179.465 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 96' ' ' ILE . . . . . 0.402 HD11 ' HB ' ' A' ' 123' ' ' VAL . 66.3 mt -113.52 126.1 70.9 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.365 0 N-CA-C 109.071 -0.714 . . . . 0.0 109.071 178.818 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 97' ' ' THR . . . . . . . . . . . . . 72.5 p -101.75 158.24 16.26 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-O 121.519 0.676 . . . . 0.0 111.593 -175.701 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 98' ' ' GLU . . . . . . . . . . . . . 82.4 tt0 -53.83 -27.3 28.73 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 115.549 -0.75 . . . . 0.0 112.295 179.991 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 99' ' ' GLU . . . . . . . . . . . . . 95.3 mt-10 -78.83 14.42 1.36 Allowed 'General case' 0 CA--C 1.535 0.369 0 N-CA-C 113.282 0.845 . . . . 0.0 113.282 -176.866 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 100' ' ' ASN . . . . . . . . . . . . . 3.2 m-20 61.03 37.5 17.92 Favored 'General case' 0 CA--C 1.53 0.211 0 CA-C-O 121.08 0.467 . . . . 0.0 110.891 -179.782 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 101' ' ' GLU . . . . . . . . . . . . . 84.3 tt0 -115.78 145.78 42.51 Favored 'General case' 0 C--O 1.232 0.16 0 CA-C-N 116.142 -0.481 . . . . 0.0 109.732 176.473 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 102' ' ' VAL . . . . . . . . . . . . . 45.7 t -114.95 125.3 72.24 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.298 0 N-CA-C 109.805 -0.442 . . . . 0.0 109.805 -177.332 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 103' ' ' LEU . . . . . . . . . . . . . 39.0 mt -116.3 126.48 53.6 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 115.634 -0.712 . . . . 0.0 110.185 177.263 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 104' ' ' ILE . . . . . 0.402 HD13 HG11 ' A' ' 130' ' ' VAL . 64.3 mt -117.59 120.11 63.75 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.214 0 N-CA-C 110.142 -0.318 . . . . 0.0 110.142 -179.993 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 105' ' ' PHE . . . . . . . . . . . . . 68.6 m-85 -119.95 165.57 14.47 Favored 'General case' 0 C--N 1.332 -0.19 0 O-C-N 123.818 0.698 . . . . 0.0 109.526 178.94 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 106' ' ' ASN . . . . . . . . . . . . . 36.7 p-10 -99.59 -170.33 1.88 Allowed 'General case' 0 C--N 1.331 -0.218 0 N-CA-C 109.952 -0.388 . . . . 0.0 109.952 174.926 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 107' ' ' GLN . . . . . . . . . . . . . 48.6 tp60 -59.47 -30.15 68.32 Favored 'General case' 0 C--N 1.328 -0.328 0 N-CA-C 111.94 0.348 . . . . 0.0 111.94 179.474 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 108' ' ' ASN . . . . . . . . . . . . . 4.7 t-20 -84.35 9.19 13.78 Favored 'General case' 0 CA--C 1.537 0.477 0 N-CA-C 113.204 0.816 . . . . 0.0 113.204 -177.326 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 109' ' ' LEU . . . . . 0.603 HD21 ' HB2' ' A' ' 78' ' ' ALA . 9.8 tp 61.67 35.04 17.23 Favored 'General case' 0 CA--C 1.531 0.222 0 CA-C-O 120.868 0.366 . . . . 0.0 111.545 178.64 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 110' ' ' GLU . . . . . . . . . . . . . 70.6 mm-40 -104.86 142.92 33.89 Favored 'General case' 0 C--N 1.33 -0.276 0 N-CA-C 109.373 -0.603 . . . . 0.0 109.373 174.719 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 111' ' ' GLU . . . . . . . . . . . . . 48.7 tt0 -83.63 121.85 27.81 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-O 120.892 0.377 . . . . 0.0 110.201 -176.725 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 112' ' ' LEU . . . . . . . . . . . . . 52.2 mt -105.1 -42.25 5.35 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 115.86 -0.609 . . . . 0.0 110.619 -179.526 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 113' ' ' TYR . . . . . . . . . . . . . 51.7 t80 -133.05 131.61 40.84 Favored 'General case' 0 C--N 1.331 -0.204 0 CA-C-O 121.01 0.433 . . . . 0.0 111.042 -179.095 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 114' ' ' ARG . . . . . . . . . . . . . 57.1 ttt180 -132.48 119.01 20.02 Favored 'General case' 0 C--N 1.331 -0.226 0 CA-C-N 115.745 -0.661 . . . . 0.0 109.812 177.242 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 115' ' ' GLY . . . . . . . . . . . . . . . -150.14 159.28 28.04 Favored Glycine 0 CA--C 1.522 0.522 0 N-CA-C 110.766 -0.934 . . . . 0.0 110.766 179.136 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 116' ' ' LYS . . . . . . . . . . . . . 34.3 ttmt -130.24 139.61 50.78 Favored 'General case' 0 C--N 1.329 -0.296 0 N-CA-C 110.03 -0.359 . . . . 0.0 110.03 177.646 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 117' ' ' PHE . . . . . . . . . . . . . 49.1 m-85 -134.87 113.96 12.09 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.288 -0.415 . . . . 0.0 110.012 -176.832 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 118' ' ' GLU . . . . . . . . . . . . . 79.6 tt0 -53.72 -43.28 68.91 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.64 -0.254 . . . . 0.0 111.263 -176.47 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 119' ' ' ASN . . . . . . . . . . . . . 32.5 m120 -99.31 30.99 3.26 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.091 -0.504 . . . . 0.0 112.119 -174.781 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 120' ' ' LEU . . . . . . . . . . . . . 15.4 tp -55.24 122.83 11.96 Favored 'General case' 0 N--CA 1.462 0.171 0 CA-C-O 120.751 0.31 . . . . 0.0 110.66 179.22 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 121' ' ' ASN . . . . . . . . . . . . . 64.9 t30 -113.33 -44.15 3.27 Favored 'General case' 0 C--N 1.331 -0.197 0 CA-C-N 116.362 -0.381 . . . . 0.0 111.046 -176.871 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 122' ' ' LYS . . . . . . . . . . . . . 93.4 mttt -144.26 148.1 34.43 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-O 121.057 0.456 . . . . 0.0 112.014 -177.869 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 123' ' ' VAL . . . . . 0.402 ' HB ' HD11 ' A' ' 96' ' ' ILE . 45.6 t -126.66 123.59 63.33 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.288 0 N-CA-C 109.066 -0.716 . . . . 0.0 109.066 172.567 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 124' ' ' LEU . . . . . . . . . . . . . 62.1 mt -125.74 136.93 53.72 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-O 120.855 0.36 . . . . 0.0 111.047 -176.954 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 125' ' ' VAL . . . . . . . . . . . . . 11.4 p -134.75 130.31 52.69 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.308 0 CA-C-N 115.967 -0.56 . . . . 0.0 110.148 178.196 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 126' ' ' ARG . . . . . . . . . . . . . 35.7 mmt180 -140.46 127.2 20.42 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.186 179.14 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 127' ' ' ASN . . . . . . . . . . . . . 12.5 t-20 52.04 -111.58 0.59 Allowed 'General case' 0 CA--C 1.544 0.742 0 CA-C-O 118.696 -0.668 . . . . 0.0 110.933 -179.969 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 128' ' ' ASP . . . . . . . . . . . . . 13.3 p-10 -114.06 8.6 17.09 Favored 'General case' 0 CA--C 1.537 0.45 0 CA-C-N 120.073 1.306 . . . . 0.0 113.23 179.918 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 129' ' ' LEU . . . . . . . . . . . . . 14.3 tp -106.41 135.61 47.61 Favored 'General case' 0 C--O 1.231 0.115 0 CA-C-N 118.037 0.38 . . . . 0.0 110.144 -179.993 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 130' ' ' VAL . . . . . 0.402 HG11 HD13 ' A' ' 104' ' ' ILE . 43.1 t -119.82 135.86 58.79 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.202 0 N-CA-C 109.831 -0.433 . . . . 0.0 109.831 -179.475 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 131' ' ' VAL . . . . . 0.498 HG12 HD12 ' A' ' 140' ' ' LEU . 21.0 m -136.04 138.8 46.88 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.239 0 CA-C-O 121.314 0.578 . . . . 0.0 110.94 177.928 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 132' ' ' ILE . . . . . . . . . . . . . 72.2 mt -118.86 131.12 72.58 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.319 0 CA-C-N 115.353 -0.84 . . . . 0.0 109.001 178.871 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 133' ' ' ILE . . . . . . . . . . . . . 39.3 mm -115.86 123.96 71.73 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.271 0 CA-C-N 116.596 -0.275 . . . . 0.0 110.747 -174.211 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 134' ' ' ASP . . . . . . . . . . . . . 13.4 p-10 -136.02 154.57 51.02 Favored 'General case' 0 C--N 1.332 -0.181 0 CA-C-N 116.295 -0.412 . . . . 0.0 110.086 176.409 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 135' ' ' GLU . . . . . . . . . . . . . 75.9 tt0 -50.02 -29.27 8.38 Favored 'General case' 0 C--N 1.328 -0.346 0 N-CA-C 113.4 0.889 . . . . 0.0 113.4 -168.815 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 136' ' ' GLN . . . . . . . . . . . . . 14.5 pt20 -99.83 -17.01 17.86 Favored 'General case' 0 C--O 1.235 0.34 0 N-CA-C 113.596 0.962 . . . . 0.0 113.596 -171.233 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 137' ' ' LYS . . . . . . . . . . . . . 19.2 pttp -168.04 172.2 9.01 Favored 'General case' 0 C--O 1.232 0.152 0 CA-C-O 121.692 0.758 . . . . 0.0 112.661 -175.41 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 138' ' ' LEU . . . . . . . . . . . . . 7.0 tt -123.26 129.55 51.52 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 114.71 -1.132 . . . . 0.0 110.01 178.985 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 139' ' ' THR . . . . . . . . . . . . . 30.4 m -108.3 127.99 54.35 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-N 116.247 -0.433 . . . . 0.0 110.579 179.69 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 140' ' ' LEU . . . . . 0.498 HD12 HG12 ' A' ' 131' ' ' VAL . 29.1 tp -111.93 123.33 50.02 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 115.61 -0.723 . . . . 0.0 109.159 -179.074 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 141' ' ' ILE . . . . . . . . . . . . . 19.6 mt -122.13 121.57 64.34 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.354 0 CA-C-O 120.911 0.386 . . . . 0.0 110.07 -174.662 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 142' ' ' ARG . . . . . . . . . . . . . 77.6 mtp180 -105.04 118.51 36.71 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 115.588 -0.733 . . . . 0.0 109.836 179.413 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 143' ' ' THR . . . . . . . . . . . . . 73.0 p . . . . . 0 C--O 1.221 -0.428 0 CA-C-O 117.976 -1.011 . . . . 0.0 110.592 -178.69 . . . . . . . . 0 0 . 1 . 013 nuclear nobuild full ' B' B ' -3' ' ' GLU . . . . . . . . . . . . . 95.5 mt-10 . . . . . 0 N--CA 1.492 1.634 0 N-CA-C 109.299 -0.63 . . . . 0.0 109.299 . . . . . . . . . 0 0 . 1 . 013 nuclear nobuild full ' B' B ' -2' ' ' GLY . . . . . . . . . . . . . . . -91.98 143.91 16.83 Favored Glycine 0 CA--C 1.525 0.669 0 N-CA-C 111.049 -0.821 . . . . 0.0 111.049 179.645 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' B' B ' -1' ' ' VAL . . . . . . . . . . . . . 44.6 t -96.82 136.94 25.95 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.323 0 CA-C-O 120.821 0.343 . . . . 0.0 110.082 179.855 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' B' B ' 0' ' ' ILE . . . . . . . . . . . . . 71.2 mt -108.17 131.46 58.55 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 N-CA-C 109.537 -0.542 . . . . 0.0 109.537 178.92 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' B' B ' 1' ' ' MET . . . . . . . . . . . . . 22.7 ptt? -78.99 128.04 32.76 Favored 'General case' 0 C--N 1.331 -0.21 0 C-N-CA 120.743 -0.383 . . . . 0.0 110.87 -177.905 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' B' B ' 2' ' ' SER . . . . . . . . . . . . . 3.1 p -123.1 131.02 53.52 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.096 -0.502 . . . . 0.0 110.077 177.445 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' B' B ' 3' ' ' GLU . . . . . . . . . . . . . 78.2 tt0 -140.64 137.57 33.7 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.622 -179.4 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' B' B ' 4' ' ' LEU . . . . . . . . . . . . . 12.6 tp -121.77 127.67 50.89 Favored 'General case' 0 C--N 1.331 -0.2 0 CA-C-N 116.096 -0.502 . . . . 0.0 110.143 177.501 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' B' B ' 5' ' ' LYS . . . . . . . . . . . . . 94.9 mttt -102.44 121.27 42.01 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.34 -0.391 . . . . 0.0 110.422 178.2 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' B' B ' 6' ' ' LEU . . . . . . . . . . . . . 59.5 mt -116.34 148.43 40.6 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-N 115.538 -0.756 . . . . 0.0 110.507 -178.98 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' B' B ' 7' ' ' LYS . . . . . . . . . . . . . 47.8 tttp -137.67 138.3 23.91 Favored Pre-proline 0 CA--C 1.534 0.341 0 CA-C-O 118.935 -0.555 . . . . 0.0 110.14 175.502 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' B' B ' 8' ' ' PRO . . . . . . . . . . . . . 98.9 Cg_endo -91.98 138.31 1.95 Allowed 'Trans proline' 0 N--CA 1.491 1.326 0 C-N-CA 121.803 1.669 . . . . 0.0 111.544 176.51 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' B' B ' 9' ' ' LEU . . . . . . . . . . . . . 65.7 mt -73.27 -47.33 7.77 Favored Pre-proline 0 CA--C 1.533 0.326 0 CA-C-O 118.751 -0.642 . . . . 0.0 112.238 -178.583 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' B' B ' 10' ' ' PRO . . . . . . . . . . . . . 87.8 Cg_endo -81.16 152.58 18.51 Favored 'Trans proline' 0 N--CA 1.496 1.672 0 C-N-CA 121.234 1.29 . . . . 0.0 111.894 175.807 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' B' B ' 11' ' ' LYS . . . . . . . . . . . . . 68.1 mttm -85.54 102.91 13.92 Favored 'General case' 0 C--N 1.33 -0.24 0 N-CA-C 110.106 -0.331 . . . . 0.0 110.106 177.459 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' B' B ' 12' ' ' VAL . . . . . . . . . . . . . 12.2 p -139.79 145.31 26.84 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.281 0 CA-C-N 116.335 -0.393 . . . . 0.0 110.722 -178.242 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' B' B ' 13' ' ' GLU . . . . . . . . . . . . . 95.5 mt-10 -87.83 121.32 30.11 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.094 -0.503 . . . . 0.0 109.887 177.13 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' B' B ' 14' ' ' LEU . . . . . . . . . . . . . 16.3 mt -97.71 153.0 38.43 Favored Pre-proline 0 C--N 1.329 -0.321 0 CA-C-N 116.498 -0.319 . . . . 0.0 110.678 -176.931 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' B' B ' 15' ' ' PRO . . . . . . . . . . . . . 26.0 Cg_exo -62.24 155.67 55.34 Favored 'Trans proline' 0 N--CA 1.497 1.713 0 C-N-CA 121.288 1.325 . . . . 0.0 111.581 176.076 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' B' B ' 16' ' ' PRO . . . . . . . . . . . . . 35.0 Cg_exo -58.0 -35.75 98.54 Favored 'Trans proline' 0 N--CA 1.498 1.742 0 C-N-CA 121.418 1.412 . . . . 0.0 112.704 -179.619 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' B' B ' 17' ' ' ASP . . . . . . . . . . . . . 17.8 p-10 -89.15 11.53 18.36 Favored 'General case' 0 C--N 1.327 -0.39 0 N-CA-C 113.202 0.816 . . . . 0.0 113.202 -177.462 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' B' B ' 18' ' ' PHE . . . . . . . . . . . . . 47.3 t80 -58.1 -42.64 86.13 Favored 'General case' 0 C--N 1.334 -0.088 0 O-C-N 121.905 -0.497 . . . . 0.0 110.023 -178.174 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' B' B ' 19' ' ' VAL . . . . . . . . . . . . . 49.1 t -58.0 -42.89 83.8 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.319 0 CA-C-N 116.438 -0.346 . . . . 0.0 110.283 -178.42 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' B' B ' 20' ' ' ASP . . . . . . . . . . . . . 81.2 m-20 -59.66 -42.16 92.19 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-O 120.796 0.331 . . . . 0.0 110.91 -177.955 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' B' B ' 21' ' ' VAL . . . . . . . . . . . . . 47.0 t -64.35 -49.31 81.53 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.321 0 CA-C-N 116.361 -0.381 . . . . 0.0 110.412 -178.215 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' B' B ' 22' ' ' ILE . . . . . 0.456 HG22 HD12 ' B' ' 26' ' ' LEU . 49.5 mm -56.89 -43.29 80.06 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.271 0 C-N-CA 120.993 -0.283 . . . . 0.0 110.542 179.592 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' B' B ' 23' ' ' ARG . . . . . . . . . . . . . 38.3 ttp180 -54.17 -49.63 68.86 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-O 120.732 0.301 . . . . 0.0 111.303 -178.73 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' B' B ' 24' ' ' ILE . . . . . . . . . . . . . 69.6 mt -60.44 -41.92 89.22 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.265 0 CA-C-N 116.416 -0.357 . . . . 0.0 110.899 -178.573 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' B' B ' 25' ' ' LYS . . . . . . . . . . . . . 88.4 mttt -64.91 -40.17 94.66 Favored 'General case' 0 C--N 1.328 -0.344 0 N-CA-C 112.469 0.544 . . . . 0.0 112.469 -179.096 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' B' B ' 26' ' ' LEU . . . . . 0.456 HD12 HG22 ' B' ' 22' ' ' ILE . 57.8 mt -77.81 -41.81 35.95 Favored 'General case' 0 C--N 1.33 -0.276 0 N-CA-C 113.141 0.793 . . . . 0.0 113.141 -171.408 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' B' B ' 27' ' ' GLN . . . . . . . . . . . . . 10.3 pt20 -46.86 135.62 9.0 Favored 'General case' 0 N--CA 1.469 0.516 0 N-CA-C 112.717 0.636 . . . . 0.0 112.717 -175.929 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' B' B ' 28' ' ' GLY . . . . . . . . . . . . . . . 101.06 -25.38 28.51 Favored Glycine 0 CA--C 1.533 1.161 0 CA-C-N 115.671 -0.695 . . . . 0.0 112.483 -177.792 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' B' B ' 29' ' ' LYS . . . . . . . . . . . . . 97.5 mttt -98.63 155.09 17.48 Favored 'General case' 0 C--N 1.331 -0.207 0 CA-C-N 117.398 0.599 . . . . 0.0 111.163 178.78 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' B' B ' 30' ' ' THR . . . . . . . . . . . . . 25.7 m -104.65 137.71 42.06 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.076 -0.511 . . . . 0.0 109.921 175.186 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' B' B ' 31' ' ' VAL . . . . . . . . . . . . . 34.5 m -128.26 155.64 40.02 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.254 0 CA-C-O 120.824 0.345 . . . . 0.0 110.894 -178.798 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' B' B ' 32' ' ' ARG . . . . . . . . . . . . . 97.1 mtt180 -133.51 149.93 51.7 Favored 'General case' 0 C--N 1.331 -0.225 0 CA-C-O 121.193 0.521 . . . . 0.0 110.654 177.823 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' B' B ' 33' ' ' THR . . . . . . . . . . . . . 23.6 m -53.21 139.64 28.65 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.237 -0.438 . . . . 0.0 111.419 -178.2 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' B' B ' 34' ' ' GLY . . . . . . . . . . . . . . . 99.4 -17.12 58.22 Favored Glycine 0 CA--C 1.531 1.092 0 C-N-CA 121.18 -0.533 . . . . 0.0 113.28 178.891 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' B' B ' 35' ' ' ASP . . . . . . . . . . . . . 75.6 m-20 -65.79 148.95 50.95 Favored 'General case' 0 C--O 1.232 0.145 0 CA-C-N 118.109 0.954 . . . . 0.0 111.152 179.631 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' B' B ' 36' ' ' VAL . . . . . . . . . . . . . 42.5 t -122.71 130.59 74.39 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.207 0 CA-C-N 115.938 -0.574 . . . . 0.0 109.966 177.7 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' B' B ' 37' ' ' ILE . . . . . . . . . . . . . 66.4 mt -121.63 139.23 49.36 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.305 0 N-CA-C 109.772 -0.455 . . . . 0.0 109.772 -179.721 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' B' B ' 38' ' ' GLY . . . . . . . . . . . . . . . -113.37 128.8 8.53 Favored Glycine 0 CA--C 1.526 0.77 0 N-CA-C 111.384 -0.686 . . . . 0.0 111.384 -178.673 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' B' B ' 39' ' ' ILE . . . . . . . . . . . . . 68.5 mt -123.89 127.91 73.95 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.204 0 N-CA-C 109.771 -0.455 . . . . 0.0 109.771 178.084 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' B' B ' 40' ' ' SER . . . . . . . . . . . . . 30.6 t -93.81 123.15 36.96 Favored 'General case' 0 C--N 1.329 -0.294 0 C-N-CA 120.923 -0.311 . . . . 0.0 111.005 176.589 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' B' B ' 41' ' ' ILE . . . . . . . . . . . . . 70.4 mt -131.73 125.67 56.09 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.233 0 CA-C-O 120.877 0.37 . . . . 0.0 110.588 178.834 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' B' B ' 42' ' ' LEU . . . . . . . . . . . . . 9.9 tp 54.62 35.45 23.69 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.067 -0.515 . . . . 0.0 111.623 176.88 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' B' B ' 43' ' ' GLY . . . . . . . . . . . . . . . 71.96 27.29 70.75 Favored Glycine 0 CA--C 1.531 1.087 0 C-N-CA 121.078 -0.582 . . . . 0.0 112.392 177.34 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' B' B ' 44' ' ' LYS . . . . . . . . . . . . . 91.4 mttt -138.05 126.84 23.82 Favored 'General case' 0 C--N 1.331 -0.211 0 N-CA-C 109.434 -0.58 . . . . 0.0 109.434 178.292 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' B' B ' 45' ' ' GLU . . . . . . . . . . . . . 29.1 tp10 -85.25 129.22 34.85 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-O 120.801 0.334 . . . . 0.0 111.233 -175.887 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' B' B ' 46' ' ' VAL . . . . . . . . . . . . . 7.4 p -122.36 129.48 75.26 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.2 0 N-CA-C 109.435 -0.58 . . . . 0.0 109.435 174.865 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' B' B ' 47' ' ' LYS . . . . . . . . . . . . . 69.0 mmtt -100.42 128.26 46.53 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.023 -0.535 . . . . 0.0 111.336 177.545 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' B' B ' 48' ' ' PHE . . . . . . . . . . . . . 91.7 m-85 -109.93 131.84 54.69 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 115.954 -0.566 . . . . 0.0 109.58 175.096 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' B' B ' 49' ' ' LYS . . . . . . . . . . . . . 41.5 tttp -108.62 137.63 46.25 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.422 -0.353 . . . . 0.0 110.365 179.638 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' B' B ' 50' ' ' VAL . . . . . . . . . . . . . 44.8 t -78.98 107.1 11.05 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.213 0 N-CA-C 109.326 -0.62 . . . . 0.0 109.326 176.352 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' B' B ' 51' ' ' VAL . . . . . . . . . . . . . 46.4 t -69.0 -48.97 67.06 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.329 0 CA-C-N 115.935 -0.575 . . . . 0.0 109.8 -174.097 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' B' B ' 52' ' ' GLN . . . . . . . . . . . . . 60.1 tt0 -170.1 147.93 3.28 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 115.838 -0.619 . . . . 0.0 111.274 -178.863 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' B' B ' 53' ' ' ALA . . . . . . . . . . . . . . . -122.77 136.78 54.98 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.085 -0.507 . . . . 0.0 110.34 178.843 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' B' B ' 54' ' ' TYR . . . . . . . . . . . . . 47.0 t80 -129.16 111.84 18.29 Favored Pre-proline 0 CA--C 1.535 0.387 0 CA-C-O 118.265 -0.874 . . . . 0.0 110.212 177.995 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' B' B ' 55' ' ' PRO . . . . . . . . . . . . . 73.4 Cg_endo -77.17 167.88 78.46 Favored 'Cis proline' 0 N--CA 1.5 1.901 0 CA-C-N 121.932 1.726 . . . . 0.0 112.127 -6.991 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' B' B ' 56' ' ' SER . . . . . . . . . . . . . 24.0 m -117.22 133.12 23.21 Favored Pre-proline 0 CA--C 1.537 0.476 0 CA-C-O 118.492 -0.766 . . . . 0.0 109.576 175.102 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' B' B ' 57' ' ' PRO . . . . . . . . . . . . . 36.4 Cg_endo -66.34 164.0 67.66 Favored 'Cis proline' 0 N--CA 1.499 1.809 0 CA-C-N 121.953 1.733 . . . . 0.0 111.375 -2.504 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' B' B ' 58' ' ' LEU . . . . . . . . . . . . . 23.0 tp -129.27 135.72 49.15 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.328 -0.396 . . . . 0.0 110.513 -179.217 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' B' B ' 59' ' ' ARG . . . . . . . . . . . . . 74.7 ttt180 -102.45 126.86 49.62 Favored 'General case' 0 C--N 1.327 -0.376 0 N-CA-C 109.241 -0.652 . . . . 0.0 109.241 175.362 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' B' B ' 60' ' ' VAL . . . . . . . . . . . . . 40.7 t -81.35 121.81 35.39 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.322 0 C-N-CA 120.634 -0.426 . . . . 0.0 110.402 -175.045 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' B' B ' 61' ' ' GLU . . . . . . . . . . . . . 95.1 mt-10 -131.11 165.38 23.4 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 115.803 -0.635 . . . . 0.0 109.634 176.698 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' B' B ' 62' ' ' ASP . . . . . . . . . . . . . 80.0 m-20 -53.82 -32.62 53.41 Favored 'General case' 0 C--N 1.328 -0.364 0 N-CA-C 111.787 0.291 . . . . 0.0 111.787 -179.852 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' B' B ' 63' ' ' ARG . . . . . . . . . . . . . 24.7 mmm180 -72.82 -18.96 61.41 Favored 'General case' 0 CA--C 1.535 0.379 0 N-CA-C 113.092 0.775 . . . . 0.0 113.092 -177.085 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' B' B ' 64' ' ' THR . . . . . . . . . . . . . 25.8 m -72.44 138.98 47.47 Favored 'General case' 0 C--N 1.331 -0.204 0 CA-C-O 120.962 0.411 . . . . 0.0 111.24 -174.642 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' B' B ' 65' ' ' LYS . . . . . . . . . . . . . 98.4 mttt -90.81 136.45 33.06 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 115.887 -0.597 . . . . 0.0 110.429 178.615 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' B' B ' 66' ' ' ILE . . . . . . . . . . . . . 60.6 mt -117.1 129.33 73.82 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.233 0 N-CA-C 109.662 -0.496 . . . . 0.0 109.662 179.147 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' B' B ' 67' ' ' THR . . . . . . . . . . . . . 28.0 m -125.74 144.85 50.45 Favored 'General case' 0 N--CA 1.463 0.205 0 CA-C-O 121.133 0.492 . . . . 0.0 111.581 -175.581 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' B' B ' 68' ' ' LEU . . . . . 0.492 HD23 ' N ' ' B' ' 69' ' ' VAL . 4.4 tt -96.45 127.27 42.29 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 115.614 -0.721 . . . . 0.0 109.559 177.026 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' B' B ' 69' ' ' VAL . . . . . 0.492 ' N ' HD23 ' B' ' 68' ' ' LEU . 40.7 t -83.87 134.43 26.97 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.361 0 CA-C-O 121.155 0.502 . . . . 0.0 111.14 -176.121 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' B' B ' 70' ' ' THR . . . . . . . . . . . . . 15.4 p -134.73 -170.04 2.47 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 115.419 -0.809 . . . . 0.0 109.442 177.227 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' B' B ' 71' ' ' HIS . . . . . . . . . . . . . 50.4 t60 -120.38 59.98 7.22 Favored Pre-proline 0 CA--C 1.54 0.569 0 CA-C-O 120.774 0.321 . . . . 0.0 111.775 179.584 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' B' B ' 72' ' ' PRO . . . . . . . . . . . . . 45.3 Cg_endo -91.34 160.08 3.71 Favored 'Trans proline' 0 N--CA 1.492 1.433 0 C-N-CA 121.965 1.777 . . . . 0.0 112.015 170.784 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' B' B ' 73' ' ' VAL . . . . . . . . . . . . . 33.8 m -69.98 165.62 2.52 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.229 0 N-CA-C 109.616 -0.512 . . . . 0.0 109.616 175.168 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' B' B ' 74' ' ' ASP . . . . . . . . . . . . . 12.6 t70 -96.62 121.2 38.19 Favored 'General case' 0 C--N 1.33 -0.264 0 C-N-CA 120.779 -0.369 . . . . 0.0 110.346 -176.082 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' B' B ' 75' ' ' VAL . . . . . . . . . . . . . 41.3 t -115.87 126.04 73.23 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.184 0 CA-C-O 121.057 0.456 . . . . 0.0 110.66 -178.263 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' B' B ' 76' ' ' LEU . . . . . . . . . . . . . 15.6 mt -127.59 148.16 50.36 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 115.587 -0.733 . . . . 0.0 109.367 176.929 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' B' B ' 77' ' ' GLU . . . . . . . . . . . . . 98.0 mt-10 -136.87 141.44 42.78 Favored 'General case' 0 C--N 1.333 -0.125 0 CA-C-O 121.173 0.511 . . . . 0.0 111.532 -176.423 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' B' B ' 78' ' ' ALA . . . . . . . . . . . . . . . -127.01 133.5 50.52 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 115.529 -0.76 . . . . 0.0 109.794 176.394 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' B' B ' 79' ' ' LYS . . . . . 0.637 ' O ' HD13 ' B' ' 80' ' ' ILE . 85.8 tttt -78.12 116.68 18.76 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-O 120.891 0.377 . . . . 0.0 110.728 -177.608 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' B' B ' 80' ' ' ILE . . . . . 0.637 HD13 ' O ' ' B' ' 79' ' ' LYS . 37.9 mm -139.15 108.43 3.77 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.302 0 N-CA-C 109.432 -0.581 . . . . 0.0 109.432 -176.447 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' B' B ' 81' ' ' LYS . . . . . . . . . . . . . 38.6 ttpt -104.36 127.7 52.07 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-O 120.839 0.352 . . . . 0.0 110.939 -177.629 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' B' B ' 82' ' ' GLY . . . . . . . . . . . . . . . 89.05 42.13 5.7 Favored Glycine 0 CA--C 1.525 0.675 0 C-N-CA 120.847 -0.692 . . . . 0.0 111.687 175.522 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' B' B ' 83' ' ' ILE . . . . . . . . . . . . . 72.2 mt -70.12 136.05 26.9 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.339 0 N-CA-C 109.669 -0.493 . . . . 0.0 109.669 177.515 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' B' B ' 84' ' ' LYS . . . . . . . . . . . . . 81.1 tttt -94.19 -52.12 4.51 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 115.996 -0.547 . . . . 0.0 110.307 -179.025 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' B' B ' 85' ' ' ASP . . . . . . . . . . . . . 9.5 t70 -156.33 155.79 32.85 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 115.838 -0.619 . . . . 0.0 110.439 179.936 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' B' B ' 86' ' ' VAL . . . . . . . . . . . . . 42.5 t -126.35 133.67 68.21 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.18 0 CA-C-O 121.048 0.451 . . . . 0.0 110.67 -178.338 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' B' B ' 87' ' ' ILE . . . . . . . . . . . . . 44.7 mm -118.42 121.15 66.4 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.282 0 CA-C-N 115.644 -0.707 . . . . 0.0 109.245 175.264 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' B' B ' 88' ' ' LEU . . . . . 0.405 HD22 ' CG2' ' A' ' 131' ' ' VAL . 17.7 tp -109.98 132.51 54.09 Favored 'General case' 0 C--N 1.332 -0.194 0 CA-C-O 120.907 0.384 . . . . 0.0 111.428 -175.055 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' B' B ' 89' ' ' ASP . . . . . . . . . . . . . 9.8 t70 -129.49 153.33 48.09 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 115.91 -0.586 . . . . 0.0 109.56 175.869 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' B' B ' 90' ' ' GLU . . . . . . . . . . . . . 83.5 tt0 -48.21 -36.33 13.54 Favored 'General case' 0 C--N 1.329 -0.294 0 N-CA-C 112.738 0.644 . . . . 0.0 112.738 -172.641 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' B' B ' 91' ' ' ASN . . . . . . . . . . . . . 7.1 p30 -132.09 29.37 4.37 Favored 'General case' 0 N--CA 1.466 0.341 0 N-CA-C 112.301 0.482 . . . . 0.0 112.301 -177.378 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' B' B ' 92' ' ' LEU . . . . . . . . . . . . . 5.0 mt -154.78 143.16 20.48 Favored 'General case' 0 C--N 1.331 -0.213 0 N-CA-C 109.809 -0.441 . . . . 0.0 109.809 -178.474 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' B' B ' 93' ' ' ILE . . . . . . . . . . . . . 70.6 mt -123.38 112.26 32.75 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.213 0 N-CA-C 108.926 -0.768 . . . . 0.0 108.926 176.752 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' B' B ' 94' ' ' VAL . . . . . . . . . . . . . 46.3 t -116.05 125.56 73.2 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.258 0 N-CA-C 109.589 -0.523 . . . . 0.0 109.589 -179.599 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' B' B ' 95' ' ' VAL . . . . . . . . . . . . . 43.2 t -122.93 135.81 61.79 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.349 0 CA-C-N 116.127 -0.488 . . . . 0.0 109.976 -178.141 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' B' B ' 96' ' ' ILE . . . . . . . . . . . . . 63.8 mt -111.6 127.58 68.67 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.355 0 N-CA-C 109.075 -0.713 . . . . 0.0 109.075 178.145 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' B' B ' 97' ' ' THR . . . . . . . . . . . . . 78.4 p -101.18 156.79 17.22 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-O 120.967 0.413 . . . . 0.0 111.136 -177.479 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' B' B ' 98' ' ' GLU . . . . . . . . . . . . . 13.5 pt-20 -53.87 -23.62 13.16 Favored 'General case' 0 CA--C 1.533 0.319 0 N-CA-C 112.434 0.531 . . . . 0.0 112.434 -179.97 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' B' B ' 99' ' ' GLU . . . . . . . . . . . . . 95.6 mt-10 -79.24 14.5 1.48 Allowed 'General case' 0 CA--C 1.536 0.433 0 N-CA-C 112.969 0.729 . . . . 0.0 112.969 -178.212 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' B' B ' 100' ' ' ASN . . . . . . . . . . . . . 2.4 m-20 61.71 37.95 15.47 Favored 'General case' 0 CA--C 1.529 0.169 0 CA-C-O 121.081 0.467 . . . . 0.0 110.893 178.9 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' B' B ' 101' ' ' GLU . . . . . . . . . . . . . 83.5 tt0 -116.53 144.74 43.98 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-N 116.039 -0.528 . . . . 0.0 109.728 176.561 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' B' B ' 102' ' ' VAL . . . . . . . . . . . . . 46.1 t -114.94 123.6 70.78 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.314 0 N-CA-C 109.592 -0.521 . . . . 0.0 109.592 -179.942 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' B' B ' 103' ' ' LEU . . . . . . . . . . . . . 70.9 mt -114.34 131.78 56.43 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 115.806 -0.634 . . . . 0.0 110.255 178.411 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' B' B ' 104' ' ' ILE . . . . . 0.612 HD12 ' HB3' ' B' ' 113' ' ' TYR . 66.7 mt -117.9 117.54 55.26 Favored 'Isoleucine or valine' 0 C--O 1.234 0.252 0 CA-C-N 116.441 -0.345 . . . . 0.0 110.247 -178.756 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' B' B ' 105' ' ' PHE . . . . . . . . . . . . . 82.7 m-85 -117.43 163.29 16.6 Favored 'General case' 0 C--N 1.332 -0.157 0 O-C-N 124.241 0.963 . . . . 0.0 109.846 -179.906 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' B' B ' 106' ' ' ASN . . . . . . . . . . . . . 52.9 p-10 -102.41 -172.26 2.1 Favored 'General case' 0 C--N 1.331 -0.211 0 N-CA-C 109.757 -0.46 . . . . 0.0 109.757 171.256 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' B' B ' 107' ' ' GLN . . . . . . . . . . . . . 48.9 tt0 -58.45 -29.73 66.4 Favored 'General case' 0 C--N 1.328 -0.329 0 N-CA-C 112.227 0.454 . . . . 0.0 112.227 -178.066 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' B' B ' 108' ' ' ASN . . . . . . . . . . . . . 11.7 t-20 -88.74 14.16 10.8 Favored 'General case' 0 CA--C 1.535 0.385 0 N-CA-C 112.862 0.69 . . . . 0.0 112.862 -176.22 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' B' B ' 109' ' ' LEU . . . . . . . . . . . . . 71.6 mt 58.61 35.53 24.56 Favored 'General case' 0 C--O 1.234 0.238 0 CA-C-O 120.822 0.344 . . . . 0.0 111.547 178.771 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' B' B ' 110' ' ' GLU . . . . . . . . . . . . . 43.3 mt-10 -105.27 141.32 37.0 Favored 'General case' 0 C--N 1.329 -0.299 0 N-CA-C 109.771 -0.455 . . . . 0.0 109.771 176.35 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' B' B ' 111' ' ' GLU . . . . . . . . . . . . . 97.7 mt-10 -77.29 125.51 29.44 Favored 'General case' 0 C--N 1.327 -0.399 0 CA-C-N 116.331 -0.395 . . . . 0.0 111.257 -176.77 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' B' B ' 112' ' ' LEU . . . . . . . . . . . . . 11.6 mt -106.71 -45.99 4.08 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.041 -0.527 . . . . 0.0 110.176 176.889 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' B' B ' 113' ' ' TYR . . . . . 0.612 ' HB3' HD12 ' B' ' 104' ' ' ILE . 55.9 t80 -140.45 140.69 35.43 Favored 'General case' 0 C--N 1.33 -0.243 0 C-N-CA 120.74 -0.384 . . . . 0.0 110.956 -178.84 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' B' B ' 114' ' ' ARG . . . . . . . . . . . . . 21.0 mtp-105 -139.36 126.22 20.88 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.244 -0.435 . . . . 0.0 110.209 176.04 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' B' B ' 115' ' ' GLY . . . . . . . . . . . . . . . -150.07 142.81 10.03 Favored Glycine 0 CA--C 1.523 0.532 0 N-CA-C 111.229 -0.748 . . . . 0.0 111.229 179.826 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' B' B ' 116' ' ' LYS . . . . . . . . . . . . . 39.1 ttpt -112.02 132.82 54.57 Favored 'General case' 0 C--N 1.33 -0.245 0 N-CA-C 109.774 -0.454 . . . . 0.0 109.774 177.955 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' B' B ' 117' ' ' PHE . . . . . . . . . . . . . 40.9 m-85 -134.27 113.87 12.42 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-O 120.942 0.401 . . . . 0.0 110.198 -176.532 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' B' B ' 118' ' ' GLU . . . . . . . . . . . . . 95.8 mt-10 -56.34 -41.93 76.9 Favored 'General case' 0 C--N 1.326 -0.426 0 CA-C-N 116.13 -0.487 . . . . 0.0 111.196 -174.594 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' B' B ' 119' ' ' ASN . . . . . . . . . . . . . 88.5 m-20 -100.6 31.12 3.61 Favored 'General case' 0 C--N 1.329 -0.295 0 N-CA-C 112.213 0.449 . . . . 0.0 112.213 -173.853 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' B' B ' 120' ' ' LEU . . . . . . . . . . . . . 9.7 tp -55.25 122.03 10.18 Favored 'General case' 0 N--CA 1.462 0.158 0 C-N-CA 121.044 -0.262 . . . . 0.0 110.674 178.062 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' B' B ' 121' ' ' ASN . . . . . . . . . . . . . 3.5 m-20 -114.09 -44.14 3.17 Favored 'General case' 0 C--N 1.332 -0.153 0 CA-C-N 116.63 -0.259 . . . . 0.0 111.18 -176.242 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' B' B ' 122' ' ' LYS . . . . . . . . . . . . . 16.1 ttmm -151.79 142.65 22.97 Favored 'General case' 0 C--N 1.331 -0.206 0 C-N-CA 120.363 -0.535 . . . . 0.0 111.712 -176.828 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' B' B ' 123' ' ' VAL . . . . . . . . . . . . . 46.2 t -120.72 130.79 74.18 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.256 0 CA-C-N 115.825 -0.625 . . . . 0.0 109.628 177.139 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' B' B ' 124' ' ' LEU . . . . . . . . . . . . . 75.4 mt -127.83 138.48 52.72 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-O 120.831 0.348 . . . . 0.0 110.692 -178.424 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' B' B ' 125' ' ' VAL . . . . . . . . . . . . . 35.0 m -130.7 143.15 41.78 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.245 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.909 -179.567 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' B' B ' 126' ' ' ARG . . . . . . . . . . . . . 94.3 mtt-85 -148.34 117.72 6.94 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 115.832 -0.622 . . . . 0.0 109.397 176.205 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' B' B ' 127' ' ' ASN . . . . . . . . . . . . . 79.8 m-20 56.61 -143.35 0.71 Allowed 'General case' 0 CA--C 1.541 0.615 0 CA-C-O 119.138 -0.458 . . . . 0.0 109.773 -179.39 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' B' B ' 128' ' ' ASP . . . . . . . . . . . . . 12.0 p-10 -85.76 10.28 14.06 Favored 'General case' 0 CA--C 1.535 0.396 0 CA-C-N 119.248 0.931 . . . . 0.0 113.229 179.953 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' B' B ' 129' ' ' LEU . . . . . 0.47 HD13 HH21 ' B' ' 142' ' ' ARG . 28.2 mt -111.22 145.15 39.22 Favored 'General case' 0 N--CA 1.463 0.189 0 O-C-N 121.841 -0.537 . . . . 0.0 109.762 179.112 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' B' B ' 130' ' ' VAL . . . . . 0.475 HG23 ' HB ' ' B' ' 141' ' ' ILE . 32.6 m -137.13 148.09 26.53 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.262 0 CA-C-O 121.315 0.578 . . . . 0.0 111.923 -175.943 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' B' B ' 131' ' ' VAL . . . . . 0.461 HG22 HD12 ' B' ' 140' ' ' LEU . 43.9 t -136.14 137.7 48.14 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.225 0 CA-C-N 115.535 -0.757 . . . . 0.0 110.087 177.504 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' B' B ' 132' ' ' ILE . . . . . . . . . . . . . 75.3 mt -118.77 132.02 69.87 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.287 0 CA-C-N 116.028 -0.533 . . . . 0.0 109.669 -179.757 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' B' B ' 133' ' ' ILE . . . . . . . . . . . . . 41.0 mm -115.62 122.83 70.23 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.251 0 CA-C-N 116.414 -0.357 . . . . 0.0 110.883 -175.339 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' B' B ' 134' ' ' ASP . . . . . . . . . . . . . 9.3 p-10 -136.91 144.24 43.37 Favored 'General case' 0 C--N 1.331 -0.222 0 N-CA-C 109.691 -0.485 . . . . 0.0 109.691 173.282 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' B' B ' 135' ' ' GLU . . . . . . . . . . . . . 33.0 tp10 -49.91 -24.38 2.48 Favored 'General case' 0 C--N 1.326 -0.431 0 N-CA-C 112.806 0.669 . . . . 0.0 112.806 -172.394 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' B' B ' 136' ' ' GLN . . . . . . . . . . . . . 48.1 tt0 -82.51 -38.57 23.65 Favored 'General case' 0 C--N 1.332 -0.168 0 N-CA-C 112.082 0.401 . . . . 0.0 112.082 -176.934 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' B' B ' 137' ' ' LYS . . . . . . . . . . . . . 58.7 pttt -160.01 168.55 25.37 Favored 'General case' 0 C--O 1.234 0.256 0 CA-C-O 121.495 0.664 . . . . 0.0 112.119 -173.1 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' B' B ' 138' ' ' LEU . . . . . 0.445 HD23 ' N ' ' B' ' 139' ' ' THR . 5.1 tt -116.39 127.45 54.65 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 115.155 -0.93 . . . . 0.0 109.781 178.38 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' B' B ' 139' ' ' THR . . . . . 0.445 ' N ' HD23 ' B' ' 138' ' ' LEU . 31.8 m -109.79 124.83 51.96 Favored 'General case' 0 C--N 1.331 -0.217 0 CA-C-O 120.738 0.304 . . . . 0.0 110.381 179.926 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' B' B ' 140' ' ' LEU . . . . . 0.461 HD12 HG22 ' B' ' 131' ' ' VAL . 11.2 tp -114.86 117.27 30.23 Favored 'General case' 0 C--N 1.328 -0.367 0 N-CA-C 108.897 -0.779 . . . . 0.0 108.897 -179.183 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' B' B ' 141' ' ' ILE . . . . . 0.475 ' HB ' HG23 ' B' ' 130' ' ' VAL . 18.9 mt -117.22 117.01 53.85 Favored 'Isoleucine or valine' 0 C--O 1.236 0.361 0 CA-C-O 121.129 0.49 . . . . 0.0 110.069 -174.373 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' B' B ' 142' ' ' ARG . . . . . 0.47 HH21 HD13 ' B' ' 129' ' ' LEU . 2.0 mtp85 -103.72 135.01 46.09 Favored 'General case' 0 C--N 1.331 -0.201 0 CA-C-N 115.033 -0.985 . . . . 0.0 109.824 -177.353 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' B' B ' 143' ' ' THR . . . . . . . . . . . . . 72.7 p . . . . . 0 C--O 1.22 -0.478 0 CA-C-O 118.241 -0.885 . . . . 0.0 110.763 -179.722 . . . . . . . . 0 0 . 1 . 013 nuclear nobuild full ' C' C ' -3' ' ' GLU . . . . . . . . . . . . . 84.8 tt0 . . . . . 0 N--CA 1.491 1.609 0 N-CA-C 109.256 -0.646 . . . . 0.0 109.256 . . . . . . . . . 0 0 . 1 . 013 nuclear nobuild full ' C' C ' -2' ' ' GLY . . . . . . . . . . . . . . . -71.31 145.16 38.72 Favored Glycine 0 CA--C 1.524 0.617 0 N-CA-C 110.686 -0.966 . . . . 0.0 110.686 178.718 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' C' C ' -1' ' ' VAL . . . . . . . . . . . . . 47.4 t -93.88 133.78 33.78 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.275 0 N-CA-C 109.902 -0.407 . . . . 0.0 109.902 179.868 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' C' C ' 0' ' ' ILE . . . . . . . . . . . . . 71.6 mt -110.41 129.94 64.58 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.217 0 CA-C-N 116.127 -0.488 . . . . 0.0 109.875 -179.082 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' C' C ' 1' ' ' MET . . . . . . . . . . . . . 24.9 ptp -80.98 133.3 35.48 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.062 -0.517 . . . . 0.0 110.938 -178.626 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' C' C ' 2' ' ' SER . . . . . . . . . . . . . 2.4 p -127.24 124.95 40.08 Favored 'General case' 0 C--N 1.332 -0.191 0 CA-C-N 116.084 -0.507 . . . . 0.0 110.274 177.919 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' C' C ' 3' ' ' GLU . . . . . . . . . . . . . 84.2 tt0 -139.77 140.1 36.62 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 115.918 -0.583 . . . . 0.0 111.045 -177.244 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' C' C ' 4' ' ' LEU . . . . . . . . . . . . . 18.0 tp -126.7 130.16 49.83 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.028 -0.533 . . . . 0.0 110.203 177.752 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' C' C ' 5' ' ' LYS . . . . . . . . . . . . . 61.4 mttp -109.06 119.8 40.63 Favored 'General case' 0 C--O 1.233 0.22 0 CA-C-O 120.9 0.381 . . . . 0.0 110.693 179.054 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' C' C ' 6' ' ' LEU . . . . . 0.473 HD23 ' HA ' ' C' ' 50' ' ' VAL . 36.6 mt -115.04 148.82 38.38 Favored 'General case' 0 C--N 1.331 -0.211 0 CA-C-N 115.359 -0.837 . . . . 0.0 110.554 179.495 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' C' C ' 7' ' ' LYS . . . . . . . . . . . . . 25.9 ttpp -135.25 135.29 22.36 Favored Pre-proline 0 CA--C 1.535 0.392 0 CA-C-O 118.773 -0.632 . . . . 0.0 109.966 176.418 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' C' C ' 8' ' ' PRO . . . . . . . . . . . . . 89.7 Cg_endo -88.82 136.6 3.12 Favored 'Trans proline' 0 N--CA 1.492 1.383 0 C-N-CA 121.534 1.489 . . . . 0.0 111.515 176.344 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' C' C ' 9' ' ' LEU . . . . . . . . . . . . . 51.1 mt -73.32 -47.62 7.57 Favored Pre-proline 0 CA--C 1.534 0.335 0 CA-C-O 118.616 -0.707 . . . . 0.0 112.17 -178.237 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' C' C ' 10' ' ' PRO . . . . . . . . . . . . . 97.8 Cg_endo -79.8 145.57 18.06 Favored 'Trans proline' 0 N--CA 1.495 1.598 0 C-N-CA 121.104 1.202 . . . . 0.0 111.639 175.381 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' C' C ' 11' ' ' LYS . . . . . . . . . . . . . 52.9 pttt -78.43 111.88 14.9 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-O 121.601 0.715 . . . . 0.0 110.561 179.026 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' C' C ' 12' ' ' VAL . . . . . . . . . . . . . 12.4 p -151.11 148.32 14.99 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.295 0 CA-C-N 115.609 -0.723 . . . . 0.0 110.612 -179.437 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' C' C ' 13' ' ' GLU . . . . . . . . . . . . . 49.1 mp0 -91.65 120.78 32.72 Favored 'General case' 0 C--N 1.331 -0.236 0 N-CA-C 109.752 -0.462 . . . . 0.0 109.752 174.997 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' C' C ' 14' ' ' LEU . . . . . . . . . . . . . 14.7 mt -89.01 152.11 47.88 Favored Pre-proline 0 C--N 1.329 -0.287 0 CA-C-N 116.501 -0.318 . . . . 0.0 110.768 -176.984 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' C' C ' 15' ' ' PRO . . . . . . . . . . . . . 37.0 Cg_exo -59.8 162.33 16.11 Favored 'Trans proline' 0 N--CA 1.498 1.768 0 C-N-CA 121.329 1.353 . . . . 0.0 111.835 176.771 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' C' C ' 16' ' ' PRO . . . . . . . . . . . . . 37.9 Cg_exo -58.46 -44.02 41.13 Favored 'Trans proline' 0 N--CA 1.497 1.731 0 C-N-CA 121.444 1.429 . . . . 0.0 112.861 -177.242 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' C' C ' 17' ' ' ASP . . . . . . . . . . . . . 23.3 p-10 -92.44 17.05 10.53 Favored 'General case' 0 CA--C 1.536 0.433 0 N-CA-C 112.924 0.712 . . . . 0.0 112.924 -176.964 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' C' C ' 18' ' ' PHE . . . . . . . . . . . . . 52.8 t80 -57.24 -41.8 80.25 Favored 'General case' 0 C--N 1.333 -0.128 0 O-C-N 122.106 -0.371 . . . . 0.0 110.227 -179.193 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' C' C ' 19' ' ' VAL . . . . . . . . . . . . . 48.7 t -56.93 -43.41 80.51 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.303 0 CA-C-N 116.434 -0.348 . . . . 0.0 110.317 -179.468 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' C' C ' 20' ' ' ASP . . . . . . . . . . . . . 16.4 m-20 -60.1 -42.57 94.97 Favored 'General case' 0 C--N 1.33 -0.272 0 C-N-CA 120.98 -0.288 . . . . 0.0 111.173 -178.821 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' C' C ' 21' ' ' VAL . . . . . . . . . . . . . 48.3 t -63.96 -46.62 93.52 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.278 0 C-N-CA 120.794 -0.362 . . . . 0.0 110.37 -177.491 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' C' C ' 22' ' ' ILE . . . . . 0.562 HG22 HD12 ' C' ' 26' ' ' LEU . 51.4 mm -56.42 -45.82 81.88 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.208 0 CA-C-O 120.747 0.308 . . . . 0.0 110.423 178.221 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' C' C ' 23' ' ' ARG . . . . . . . . . . . . . 50.6 ttp180 -54.6 -47.83 72.9 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.589 -0.278 . . . . 0.0 111.488 -178.501 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' C' C ' 24' ' ' ILE . . . . . . . . . . . . . 76.5 mt -59.85 -44.09 93.38 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.362 0 CA-C-O 120.606 0.241 . . . . 0.0 111.045 -178.376 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' C' C ' 25' ' ' LYS . . . . . . . . . . . . . 54.7 mtmt -64.62 -41.44 96.19 Favored 'General case' 0 C--N 1.327 -0.377 0 N-CA-C 112.367 0.506 . . . . 0.0 112.367 -178.332 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' C' C ' 26' ' ' LEU . . . . . 0.562 HD12 HG22 ' C' ' 22' ' ' ILE . 79.6 mt -79.2 -40.35 31.0 Favored 'General case' 0 C--N 1.33 -0.266 0 N-CA-C 113.416 0.895 . . . . 0.0 113.416 -171.397 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' C' C ' 27' ' ' GLN . . . . . . . . . . . . . 9.9 pt20 -46.78 139.5 5.32 Favored 'General case' 0 N--CA 1.47 0.526 0 N-CA-C 112.703 0.631 . . . . 0.0 112.703 -175.041 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' C' C ' 28' ' ' GLY . . . . . . . . . . . . . . . 100.72 -26.19 25.54 Favored Glycine 0 CA--C 1.534 1.271 0 CA-C-N 115.467 -0.788 . . . . 0.0 112.179 -176.586 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' C' C ' 29' ' ' LYS . . . . . . . . . . . . . 99.1 mttt -98.6 155.12 17.46 Favored 'General case' 0 C--N 1.331 -0.198 0 CA-C-N 117.411 0.605 . . . . 0.0 111.365 179.277 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' C' C ' 30' ' ' THR . . . . . . . . . . . . . 38.1 m -103.28 135.91 44.03 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 115.886 -0.597 . . . . 0.0 109.979 175.758 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' C' C ' 31' ' ' VAL . . . . . . . . . . . . . 34.7 m -130.01 152.95 38.17 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.229 0 CA-C-O 120.934 0.397 . . . . 0.0 110.867 -178.597 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' C' C ' 32' ' ' ARG . . . . . . . . . . . . . 34.5 ttp180 -130.59 149.84 52.07 Favored 'General case' 0 C--N 1.331 -0.221 0 CA-C-N 116.027 -0.533 . . . . 0.0 110.452 179.519 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' C' C ' 33' ' ' THR . . . . . . . . . . . . . 19.1 m -52.65 139.17 26.77 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.241 -0.436 . . . . 0.0 111.498 -177.111 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' C' C ' 34' ' ' GLY . . . . . . . . . . . . . . . 100.21 -17.19 57.34 Favored Glycine 0 CA--C 1.533 1.165 0 CA-C-O 119.644 -0.531 . . . . 0.0 113.179 179.321 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' C' C ' 35' ' ' ASP . . . . . . . . . . . . . 70.9 m-20 -65.41 149.24 50.35 Favored 'General case' 0 C--O 1.231 0.083 0 CA-C-N 118.087 0.944 . . . . 0.0 111.276 179.303 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' C' C ' 36' ' ' VAL . . . . . . . . . . . . . 45.2 t -123.3 130.71 74.12 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.215 0 CA-C-N 115.735 -0.666 . . . . 0.0 109.658 178.065 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' C' C ' 37' ' ' ILE . . . . . . . . . . . . . 67.8 mt -121.06 138.57 51.04 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.24 0 CA-C-N 116.306 -0.406 . . . . 0.0 110.05 -179.609 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' C' C ' 38' ' ' GLY . . . . . . . . . . . . . . . -110.47 128.77 8.97 Favored Glycine 0 CA--C 1.525 0.703 0 N-CA-C 110.859 -0.896 . . . . 0.0 110.859 179.263 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' C' C ' 39' ' ' ILE . . . . . . . . . . . . . 73.2 mt -122.68 129.56 75.11 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.226 0 N-CA-C 110.069 -0.345 . . . . 0.0 110.069 179.812 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' C' C ' 40' ' ' SER . . . . . . . . . . . . . 87.3 p -93.15 120.34 33.34 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.425 -0.352 . . . . 0.0 110.991 176.744 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' C' C ' 41' ' ' ILE . . . . . . . . . . . . . 70.2 mt -133.3 127.49 54.17 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.258 0 CA-C-O 120.886 0.374 . . . . 0.0 110.446 177.955 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' C' C ' 42' ' ' LEU . . . . . . . . . . . . . 11.2 tp 53.23 34.53 17.85 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.035 -0.53 . . . . 0.0 111.593 177.1 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' C' C ' 43' ' ' GLY . . . . . . . . . . . . . . . 71.2 31.07 66.62 Favored Glycine 0 CA--C 1.531 1.061 0 C-N-CA 121.094 -0.574 . . . . 0.0 111.941 177.907 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' C' C ' 44' ' ' LYS . . . . . . . . . . . . . 80.5 tttt -138.43 126.83 23.14 Favored 'General case' 0 C--N 1.329 -0.296 0 N-CA-C 109.751 -0.463 . . . . 0.0 109.751 179.834 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' C' C ' 45' ' ' GLU . . . . . . . . . . . . . 81.9 tt0 -84.37 122.83 29.49 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-N 116.45 -0.341 . . . . 0.0 111.003 -178.398 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' C' C ' 46' ' ' VAL . . . . . . . . . . . . . 7.2 p -119.88 130.29 74.38 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.302 0 N-CA-C 109.449 -0.574 . . . . 0.0 109.449 175.877 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' C' C ' 47' ' ' LYS . . . . . . . . . . . . . 64.9 mttp -100.27 127.86 46.47 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 115.979 -0.555 . . . . 0.0 111.356 178.768 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' C' C ' 48' ' ' PHE . . . . . . . . . . . . . 94.6 m-85 -111.33 131.88 54.83 Favored 'General case' 0 C--N 1.33 -0.273 0 N-CA-C 109.674 -0.491 . . . . 0.0 109.674 175.495 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' C' C ' 49' ' ' LYS . . . . . . . . . . . . . 83.3 tttt -108.48 137.06 47.06 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.401 -0.363 . . . . 0.0 110.654 179.869 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' C' C ' 50' ' ' VAL . . . . . 0.473 ' HA ' HD23 ' C' ' 6' ' ' LEU . 41.0 t -83.21 107.57 15.01 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.243 0 N-CA-C 109.421 -0.585 . . . . 0.0 109.421 176.465 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' C' C ' 51' ' ' VAL . . . . . . . . . . . . . 48.9 t -72.46 -53.48 19.23 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.275 0 N-CA-C 109.581 -0.525 . . . . 0.0 109.581 -175.455 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' C' C ' 52' ' ' GLN . . . . . . . . . . . . . 90.9 mt-30 -154.07 151.6 29.5 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.02 -0.536 . . . . 0.0 111.832 -177.647 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' C' C ' 53' ' ' ALA . . . . . . . . . . . . . . . -130.12 133.78 46.88 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 115.318 -0.855 . . . . 0.0 109.827 174.463 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' C' C ' 54' ' ' TYR . . . . . . . . . . . . . 53.7 t80 -129.16 111.27 18.22 Favored Pre-proline 0 CA--C 1.535 0.377 0 CA-C-O 118.267 -0.873 . . . . 0.0 110.395 178.662 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' C' C ' 55' ' ' PRO . . . . . . . . . . . . . 73.3 Cg_endo -77.1 166.33 82.64 Favored 'Cis proline' 0 N--CA 1.499 1.84 0 CA-C-N 121.919 1.721 . . . . 0.0 112.348 -6.855 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' C' C ' 56' ' ' SER . . . . . . . . . . . . . 20.3 m -116.74 135.94 23.09 Favored Pre-proline 0 CA--C 1.538 0.519 0 CA-C-O 118.423 -0.798 . . . . 0.0 109.363 173.775 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' C' C ' 57' ' ' PRO . . . . . . . . . . . . . 49.4 Cg_endo -70.0 146.03 81.58 Favored 'Cis proline' 0 N--CA 1.497 1.733 0 CA-C-N 121.832 1.69 . . . . 0.0 111.473 -1.837 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' C' C ' 58' ' ' LEU . . . . . . . . . . . . . 31.9 tp -108.16 137.65 45.77 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.331 -0.395 . . . . 0.0 110.696 -177.704 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' C' C ' 59' ' ' ARG . . . . . . . . . . . . . 55.6 ttp180 -102.89 125.23 49.56 Favored 'General case' 0 C--N 1.327 -0.377 0 N-CA-C 109.227 -0.657 . . . . 0.0 109.227 174.653 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' C' C ' 60' ' ' VAL . . . . . . . . . . . . . 45.8 t -79.66 120.78 31.66 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.293 0 C-N-CA 120.689 -0.404 . . . . 0.0 110.65 -174.717 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' C' C ' 61' ' ' GLU . . . . . . . . . . . . . 43.3 mt-10 -131.03 163.05 28.44 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 115.747 -0.661 . . . . 0.0 109.675 176.542 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' C' C ' 62' ' ' ASP . . . . . . . . . . . . . 9.3 p-10 -53.36 -32.58 49.93 Favored 'General case' 0 C--N 1.328 -0.342 0 N-CA-C 111.894 0.331 . . . . 0.0 111.894 -178.634 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' C' C ' 63' ' ' ARG . . . . . . . . . . . . . 47.8 mtp180 -73.52 -21.5 60.37 Favored 'General case' 0 CA--C 1.534 0.335 0 N-CA-C 113.033 0.753 . . . . 0.0 113.033 -176.216 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' C' C ' 64' ' ' THR . . . . . . . . . . . . . 30.2 m -61.53 138.53 58.29 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-O 120.973 0.416 . . . . 0.0 111.341 -174.02 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' C' C ' 65' ' ' LYS . . . . . . . . . . . . . 40.5 ttpt -89.34 120.37 30.62 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 115.821 -0.627 . . . . 0.0 109.946 177.631 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' C' C ' 66' ' ' ILE . . . . . . . . . . . . . 64.0 mt -113.19 130.26 67.42 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.201 0 CA-C-O 120.894 0.378 . . . . 0.0 109.989 -178.434 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' C' C ' 67' ' ' THR . . . . . . . . . . . . . 25.5 m -129.41 147.36 51.22 Favored 'General case' 0 C--N 1.332 -0.186 0 CA-C-N 116.106 -0.497 . . . . 0.0 111.173 -177.815 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' C' C ' 68' ' ' LEU . . . . . . . . . . . . . 62.8 mt -100.38 136.67 39.91 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 115.851 -0.613 . . . . 0.0 110.381 177.038 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' C' C ' 69' ' ' VAL . . . . . . . . . . . . . 43.3 t -96.99 135.47 30.99 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.361 0 CA-C-N 116.136 -0.484 . . . . 0.0 109.995 179.266 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' C' C ' 70' ' ' THR . . . . . . . . . . . . . 47.9 p -131.33 174.83 9.67 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 116.209 -0.451 . . . . 0.0 110.886 -178.076 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' C' C ' 71' ' ' HIS . . . . . . . . . . . . . 19.6 m-70 -64.9 159.47 63.28 Favored Pre-proline 0 C--N 1.329 -0.315 0 CA-C-N 115.842 -0.617 . . . . 0.0 110.478 179.832 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' C' C ' 72' ' ' PRO . . . . . . . . . . . . . 30.9 Cg_endo -64.97 -28.4 57.96 Favored 'Trans proline' 0 N--CA 1.497 1.704 0 C-N-CA 121.114 1.209 . . . . 0.0 112.179 177.816 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' C' C ' 73' ' ' VAL . . . . . . . . . . . . . 33.2 m -132.21 151.91 35.73 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.19 0 CA-C-O 120.978 0.418 . . . . 0.0 110.718 177.827 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' C' C ' 74' ' ' ASP . . . . . . . . . . . . . 27.7 t0 -102.16 121.62 42.58 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 115.698 -0.683 . . . . 0.0 109.405 176.745 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' C' C ' 75' ' ' VAL . . . . . . . . . . . . . 43.1 t -110.82 121.32 63.33 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.249 0 CA-C-O 121.056 0.455 . . . . 0.0 110.825 -175.543 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' C' C ' 76' ' ' LEU . . . . . . . . . . . . . 21.9 mt -117.86 141.9 47.91 Favored 'General case' 0 C--N 1.331 -0.206 0 CA-C-N 115.598 -0.728 . . . . 0.0 109.693 176.114 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' C' C ' 77' ' ' GLU . . . . . . . . . . . . . 97.9 mt-10 -136.2 135.53 39.2 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-O 120.98 0.419 . . . . 0.0 111.307 -178.168 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' C' C ' 78' ' ' ALA . . . . . 0.595 ' HB2' HD21 ' C' ' 109' ' ' LEU . . . -124.61 134.56 52.88 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 115.627 -0.715 . . . . 0.0 109.882 176.801 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' C' C ' 79' ' ' LYS . . . . . 0.582 ' O ' HD13 ' C' ' 80' ' ' ILE . 66.3 mmtt -78.54 121.25 24.36 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-O 120.976 0.417 . . . . 0.0 110.597 179.851 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' C' C ' 80' ' ' ILE . . . . . 0.582 HD13 ' O ' ' C' ' 79' ' ' LYS . 42.2 mm -139.06 115.06 9.41 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.305 0 N-CA-C 109.291 -0.633 . . . . 0.0 109.291 -178.422 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' C' C ' 81' ' ' LYS . . . . . . . . . . . . . 46.7 pttt -104.11 123.37 47.13 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-O 121.085 0.469 . . . . 0.0 111.096 -178.437 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' C' C ' 82' ' ' GLY . . . . . . . . . . . . . . . 89.07 42.13 5.69 Favored Glycine 0 CA--C 1.525 0.697 0 C-N-CA 120.701 -0.761 . . . . 0.0 111.838 174.358 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' C' C ' 83' ' ' ILE . . . . . . . . . . . . . 70.6 mt -64.22 138.45 23.04 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.272 0 N-CA-C 109.73 -0.471 . . . . 0.0 109.73 177.691 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' C' C ' 84' ' ' LYS . . . . . . . . . . . . . 77.4 tttt -100.14 -51.15 3.75 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 115.995 -0.548 . . . . 0.0 110.465 -177.325 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' C' C ' 85' ' ' ASP . . . . . . . . . . . . . 5.1 t0 -156.51 152.26 27.13 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.014 -0.539 . . . . 0.0 110.319 -179.707 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' C' C ' 86' ' ' VAL . . . . . 0.42 ' O ' HD13 ' C' ' 87' ' ' ILE . 44.0 t -130.16 132.73 65.04 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.229 0 CA-C-O 121.021 0.438 . . . . 0.0 110.622 -179.461 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' C' C ' 87' ' ' ILE . . . . . 0.42 HD13 ' O ' ' C' ' 86' ' ' VAL . 43.5 mm -122.04 125.19 72.75 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.29 0 CA-C-N 115.948 -0.569 . . . . 0.0 109.604 176.098 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' C' C ' 88' ' ' LEU . . . . . . . . . . . . . 14.8 tp -111.03 129.27 55.96 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-O 120.84 0.352 . . . . 0.0 111.139 -177.145 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' C' C ' 89' ' ' ASP . . . . . . . . . . . . . 12.6 t70 -121.38 151.25 40.36 Favored 'General case' 0 C--N 1.33 -0.258 0 N-CA-C 109.555 -0.535 . . . . 0.0 109.555 176.67 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' C' C ' 90' ' ' GLU . . . . . . . . . . . . . 83.5 tt0 -48.86 -33.24 10.24 Favored 'General case' 0 C--N 1.328 -0.342 0 N-CA-C 112.64 0.607 . . . . 0.0 112.64 -173.082 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' C' C ' 91' ' ' ASN . . . . . . . . . . . . . 79.2 m-20 -131.99 28.14 4.5 Favored 'General case' 0 N--CA 1.466 0.333 0 N-CA-C 112.411 0.523 . . . . 0.0 112.411 -175.764 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' C' C ' 92' ' ' LEU . . . . . . . . . . . . . 11.7 tp -166.2 150.94 8.05 Favored 'General case' 0 C--N 1.33 -0.245 0 C-N-CA 120.835 -0.346 . . . . 0.0 110.851 -179.281 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' C' C ' 93' ' ' ILE . . . . . . . . . . . . . 69.0 mt -126.87 125.72 67.21 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.173 0 N-CA-C 109.757 -0.46 . . . . 0.0 109.757 179.629 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' C' C ' 94' ' ' VAL . . . . . . . . . . . . . 43.2 t -123.14 128.67 75.1 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.238 0 N-CA-C 110.077 -0.342 . . . . 0.0 110.077 178.957 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' C' C ' 95' ' ' VAL . . . . . . . . . . . . . 40.9 t -124.23 136.86 59.08 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.235 0 CA-C-O 120.933 0.397 . . . . 0.0 110.072 -179.406 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' C' C ' 96' ' ' ILE . . . . . . . . . . . . . 59.7 mt -114.31 130.11 69.16 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.335 0 N-CA-C 109.266 -0.642 . . . . 0.0 109.266 179.035 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' C' C ' 97' ' ' THR . . . . . . . . . . . . . 68.1 p -102.93 154.36 19.29 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-O 121.253 0.549 . . . . 0.0 111.192 -177.704 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' C' C ' 98' ' ' GLU . . . . . . . . . . . . . 84.0 tt0 -53.86 -24.61 16.41 Favored 'General case' 0 CA--C 1.533 0.322 0 N-CA-C 112.299 0.481 . . . . 0.0 112.299 179.625 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' C' C ' 99' ' ' GLU . . . . . . . . . . . . . 13.8 mm-40 -77.67 14.71 0.97 Allowed 'General case' 0 CA--C 1.535 0.391 0 N-CA-C 113.266 0.839 . . . . 0.0 113.266 -177.471 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' C' C ' 100' ' ' ASN . . . . . . . . . . . . . 2.9 m-20 62.89 38.05 11.64 Favored 'General case' 0 N--CA 1.464 0.245 0 CA-C-O 121.116 0.484 . . . . 0.0 110.757 178.686 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' C' C ' 101' ' ' GLU . . . . . . . . . . . . . 83.6 tt0 -122.36 145.97 47.77 Favored 'General case' 0 C--N 1.331 -0.217 0 CA-C-N 116.182 -0.463 . . . . 0.0 109.924 177.773 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' C' C ' 102' ' ' VAL . . . . . . . . . . . . . 44.1 t -114.95 129.26 71.44 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.232 0 CA-C-N 116.302 -0.408 . . . . 0.0 110.047 -177.396 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' C' C ' 103' ' ' LEU . . . . . . . . . . . . . 27.6 mt -119.63 131.55 55.49 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 115.59 -0.732 . . . . 0.0 110.131 177.06 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' C' C ' 104' ' ' ILE . . . . . . . . . . . . . 72.3 mt -117.15 125.07 73.73 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.276 0 N-CA-C 109.816 -0.438 . . . . 0.0 109.816 178.872 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' C' C ' 105' ' ' PHE . . . . . . . . . . . . . 93.8 m-85 -122.49 163.44 19.89 Favored 'General case' 0 C--O 1.232 0.144 0 O-C-N 123.904 0.752 . . . . 0.0 109.945 -177.909 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' C' C ' 106' ' ' ASN . . . . . . . . . . . . . 44.9 p-10 -101.08 -171.25 1.96 Allowed 'General case' 0 C--N 1.332 -0.19 0 CA-C-N 116.549 -0.296 . . . . 0.0 110.249 174.755 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' C' C ' 107' ' ' GLN . . . . . . . . . . . . . 40.4 tt0 -58.32 -29.51 65.97 Favored 'General case' 0 CA--C 1.533 0.297 0 N-CA-C 112.027 0.38 . . . . 0.0 112.027 -179.972 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' C' C ' 108' ' ' ASN . . . . . . . . . . . . . 5.1 t-20 -85.27 7.9 20.51 Favored 'General case' 0 CA--C 1.538 0.506 0 N-CA-C 113.279 0.844 . . . . 0.0 113.279 -176.559 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' C' C ' 109' ' ' LEU . . . . . 0.595 HD21 ' HB2' ' C' ' 78' ' ' ALA . 10.7 tp 60.07 36.97 21.3 Favored 'General case' 0 CA--C 1.531 0.225 0 CA-C-O 120.98 0.419 . . . . 0.0 111.28 179.513 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' C' C ' 110' ' ' GLU . . . . . . . . . . . . . 70.6 mm-40 -108.83 147.96 31.3 Favored 'General case' 0 C--N 1.33 -0.269 0 N-CA-C 109.653 -0.499 . . . . 0.0 109.653 175.199 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' C' C ' 111' ' ' GLU . . . . . . . . . . . . . 55.4 tt0 -82.57 121.92 27.42 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-O 120.958 0.409 . . . . 0.0 111.022 -174.122 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' C' C ' 112' ' ' LEU . . . . . . . . . . . . . 11.8 mt -103.28 -46.2 4.67 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 115.936 -0.574 . . . . 0.0 110.888 179.47 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' C' C ' 113' ' ' TYR . . . . . . . . . . . . . 64.2 t80 -133.34 136.6 45.48 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 116.464 -0.335 . . . . 0.0 111.397 -177.444 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' C' C ' 114' ' ' ARG . . . . . . . . . . . . . 35.8 ttp180 -135.44 121.0 19.36 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 115.918 -0.583 . . . . 0.0 110.316 177.841 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' C' C ' 115' ' ' GLY . . . . . . . . . . . . . . . -150.01 145.44 13.54 Favored Glycine 0 CA--C 1.524 0.638 0 N-CA-C 111.062 -0.815 . . . . 0.0 111.062 178.122 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' C' C ' 116' ' ' LYS . . . . . . . . . . . . . 34.6 ttpt -117.16 138.34 51.73 Favored 'General case' 0 C--N 1.33 -0.249 0 N-CA-C 109.9 -0.407 . . . . 0.0 109.9 177.974 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' C' C ' 117' ' ' PHE . . . . . 0.403 ' HE2' HD13 ' C' ' 132' ' ' ILE . 46.1 m-85 -135.47 113.97 11.66 Favored 'General case' 0 C--N 1.33 -0.264 0 N-CA-C 109.941 -0.392 . . . . 0.0 109.941 -178.573 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' C' C ' 118' ' ' GLU . . . . . . . . . . . . . 45.8 tp10 -55.05 -42.66 72.98 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.391 -0.368 . . . . 0.0 111.211 -176.304 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' C' C ' 119' ' ' ASN . . . . . . . . . . . . . 4.7 m120 -99.81 31.11 3.37 Favored 'General case' 0 C--N 1.33 -0.247 0 N-CA-C 112.255 0.465 . . . . 0.0 112.255 -173.852 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' C' C ' 120' ' ' LEU . . . . . . . . . . . . . 15.9 tp -56.02 119.99 6.75 Favored 'General case' 0 N--CA 1.461 0.118 0 CA-C-O 120.783 0.325 . . . . 0.0 110.377 177.603 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' C' C ' 121' ' ' ASN . . . . . . . . . . . . . 7.8 t-20 -113.84 -44.1 3.21 Favored 'General case' 0 C--N 1.332 -0.157 0 CA-C-N 116.457 -0.338 . . . . 0.0 110.944 -176.208 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' C' C ' 122' ' ' LYS . . . . . . . . . . . . . 61.8 mtpt -140.23 146.17 38.32 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-O 121.079 0.466 . . . . 0.0 111.518 -177.682 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' C' C ' 123' ' ' VAL . . . . . . . . . . . . . 47.7 t -124.16 126.88 72.93 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.319 0 CA-C-N 115.816 -0.629 . . . . 0.0 109.582 175.557 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' C' C ' 124' ' ' LEU . . . . . . . . . . . . . 50.9 mt -114.5 127.75 55.97 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.141 -0.481 . . . . 0.0 110.126 -179.331 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' C' C ' 125' ' ' VAL . . . . . . . . . . . . . 41.4 t -135.6 121.93 32.3 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.33 0 CA-C-O 120.765 0.317 . . . . 0.0 110.259 179.478 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' C' C ' 126' ' ' ARG . . . . . . . . . . . . . 79.0 mtt85 -151.39 136.15 17.19 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 116.094 -0.503 . . . . 0.0 109.696 175.831 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' C' C ' 127' ' ' ASN . . . . . . . . . . . . . 75.6 m-20 56.13 -152.1 0.38 Allowed 'General case' 0 CA--C 1.539 0.532 0 N-CA-C 109.702 -0.481 . . . . 0.0 109.702 -178.202 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' C' C ' 128' ' ' ASP . . . . . . . . . . . . . 20.2 p-10 -88.08 21.54 2.72 Favored 'General case' 0 CA--C 1.534 0.346 0 CA-C-N 118.596 0.635 . . . . 0.0 112.377 176.806 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' C' C ' 129' ' ' LEU . . . . . 0.478 HD11 ' NE2' ' D' ' 107' ' ' GLN . 1.4 tt -115.43 134.67 54.87 Favored 'General case' 0 C--O 1.235 0.312 0 O-C-N 122.039 -0.413 . . . . 0.0 109.963 -179.338 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' C' C ' 130' ' ' VAL . . . . . . . . . . . . . 41.6 t -123.06 139.88 48.45 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.313 0 CA-C-O 121.017 0.437 . . . . 0.0 110.579 -175.788 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' C' C ' 131' ' ' VAL . . . . . 0.465 HG22 HD12 ' C' ' 140' ' ' LEU . 41.4 t -135.99 135.8 50.14 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.278 0 CA-C-N 116.097 -0.501 . . . . 0.0 110.266 178.209 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' C' C ' 132' ' ' ILE . . . . . 0.403 HD13 ' HE2' ' C' ' 117' ' ' PHE . 71.8 mt -117.44 131.53 69.88 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.314 0 N-CA-C 109.502 -0.555 . . . . 0.0 109.502 179.297 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' C' C ' 133' ' ' ILE . . . . . . . . . . . . . 35.7 mm -115.6 119.62 62.36 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.25 0 CA-C-O 120.803 0.335 . . . . 0.0 110.86 -176.387 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' C' C ' 134' ' ' ASP . . . . . . . . . . . . . 5.9 p-10 -129.71 148.81 51.63 Favored 'General case' 0 C--N 1.332 -0.193 0 CA-C-N 116.016 -0.538 . . . . 0.0 109.734 176.502 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' C' C ' 135' ' ' GLU . . . . . . . . . . . . . 75.2 tt0 -50.29 -27.55 6.31 Favored 'General case' 0 C--N 1.328 -0.333 0 N-CA-C 113.096 0.776 . . . . 0.0 113.096 -170.884 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' C' C ' 136' ' ' GLN . . . . . . . . . . . . . 13.9 pt20 -101.94 -14.65 17.11 Favored 'General case' 0 CA--C 1.535 0.378 0 N-CA-C 113.514 0.931 . . . . 0.0 113.514 -172.237 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' C' C ' 137' ' ' LYS . . . . . . . . . . . . . 13.3 ptpt -168.52 168.2 11.17 Favored 'General case' 0 N--CA 1.462 0.175 0 CA-C-O 121.622 0.725 . . . . 0.0 112.228 178.743 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' C' C ' 138' ' ' LEU . . . . . . . . . . . . . 5.8 tt -119.39 129.57 54.87 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 114.957 -1.019 . . . . 0.0 109.737 179.395 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' C' C ' 139' ' ' THR . . . . . . . . . . . . . 38.6 m -110.29 130.04 55.62 Favored 'General case' 0 C--N 1.331 -0.214 0 CA-C-N 116.449 -0.341 . . . . 0.0 110.488 -179.218 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' C' C ' 140' ' ' LEU . . . . . 0.465 HD12 HG22 ' C' ' 131' ' ' VAL . 15.2 tp -115.71 125.29 52.62 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 115.688 -0.687 . . . . 0.0 109.41 -178.661 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' C' C ' 141' ' ' ILE . . . . . . . . . . . . . 19.2 mt -122.73 117.4 51.77 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.24 0 CA-C-O 120.861 0.362 . . . . 0.0 110.032 -175.33 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' C' C ' 142' ' ' ARG . . . . . . . . . . . . . 81.3 mtm180 -108.26 125.32 51.53 Favored 'General case' 0 C--N 1.331 -0.196 0 CA-C-N 115.499 -0.773 . . . . 0.0 109.939 179.917 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' C' C ' 143' ' ' THR . . . . . . . . . . . . . 43.7 p . . . . . 0 C--O 1.221 -0.417 0 CA-C-O 117.991 -1.004 . . . . 0.0 110.648 -178.532 . . . . . . . . 0 0 . 1 . 013 nuclear nobuild full ' D' D ' -3' ' ' GLU . . . . . . . . . . . . . 21.3 pt-20 . . . . . 0 N--CA 1.491 1.581 0 N-CA-C 109.443 -0.577 . . . . 0.0 109.443 . . . . . . . . . 0 0 . 1 . 013 nuclear nobuild full ' D' D ' -2' ' ' GLY . . . . . . . . . . . . . . . -94.85 139.8 14.7 Favored Glycine 0 CA--C 1.525 0.68 0 N-CA-C 111.037 -0.825 . . . . 0.0 111.037 179.993 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' D' D ' -1' ' ' VAL . . . . . . . . . . . . . 44.4 t -96.48 136.6 26.79 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.361 0 N-CA-C 110.008 -0.367 . . . . 0.0 110.008 179.494 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' D' D ' 0' ' ' ILE . . . . . . . . . . . . . 70.9 mt -114.99 137.79 47.35 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.191 0 CA-C-N 116.249 -0.432 . . . . 0.0 110.204 -179.355 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' D' D ' 1' ' ' MET . . . . . . . . . . . . . 25.7 ptm -79.76 140.2 37.0 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 115.999 -0.546 . . . . 0.0 110.728 -179.893 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' D' D ' 2' ' ' SER . . . . . . . . . . . . . 2.5 p -128.0 124.98 38.52 Favored 'General case' 0 C--N 1.331 -0.218 0 CA-C-N 116.254 -0.43 . . . . 0.0 110.36 177.792 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' D' D ' 3' ' ' GLU . . . . . . . . . . . . . 83.7 tt0 -141.54 142.26 33.54 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-N 115.931 -0.577 . . . . 0.0 111.056 -177.123 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' D' D ' 4' ' ' LEU . . . . . . . . . . . . . 21.6 tp -124.81 129.77 51.08 Favored 'General case' 0 C--N 1.331 -0.213 0 CA-C-N 116.109 -0.496 . . . . 0.0 110.192 175.803 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' D' D ' 5' ' ' LYS . . . . . . . . . . . . . 68.7 mttm -104.7 120.08 40.51 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-N 116.25 -0.432 . . . . 0.0 110.542 178.635 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' D' D ' 6' ' ' LEU . . . . . . . . . . . . . 45.5 mt -115.22 146.76 41.12 Favored 'General case' 0 C--N 1.331 -0.223 0 CA-C-N 115.389 -0.823 . . . . 0.0 110.236 -179.872 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' D' D ' 7' ' ' LYS . . . . . . . . . . . . . 85.5 tttt -132.71 131.76 22.26 Favored Pre-proline 0 CA--C 1.537 0.453 0 CA-C-O 118.67 -0.681 . . . . 0.0 110.2 176.465 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' D' D ' 8' ' ' PRO . . . . . . . . . . . . . 95.1 Cg_endo -87.37 140.78 5.55 Favored 'Trans proline' 0 N--CA 1.491 1.362 0 C-N-CA 121.508 1.472 . . . . 0.0 111.632 175.776 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' D' D ' 9' ' ' LEU . . . . . . . . . . . . . 37.2 mt -79.98 -49.21 1.3 Allowed Pre-proline 0 CA--C 1.535 0.376 0 CA-C-O 118.566 -0.731 . . . . 0.0 112.494 -177.927 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' D' D ' 10' ' ' PRO . . . . . . . . . . . . . 85.6 Cg_endo -77.5 154.32 31.29 Favored 'Trans proline' 0 N--CA 1.498 1.752 0 C-N-CA 121.183 1.255 . . . . 0.0 112.27 179.808 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' D' D ' 11' ' ' LYS . . . . . . . . . . . . . 80.8 tttt -88.1 100.18 12.75 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 116.236 -0.438 . . . . 0.0 110.382 178.438 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' D' D ' 12' ' ' VAL . . . . . . . . . . . . . 12.3 p -143.94 147.89 19.31 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.273 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.667 -178.985 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' D' D ' 13' ' ' GLU . . . . . . . . . . . . . 70.7 mm-40 -81.55 123.14 28.4 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.229 -0.441 . . . . 0.0 109.999 177.13 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' D' D ' 14' ' ' LEU . . . . . . . . . . . . . 18.2 mt -98.12 147.02 32.51 Favored Pre-proline 0 CA--C 1.532 0.285 0 CA-C-O 119.158 -0.448 . . . . 0.0 110.444 -179.203 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' D' D ' 15' ' ' PRO . . . . . . . . . . . . . 27.1 Cg_exo -61.8 156.0 51.02 Favored 'Trans proline' 0 N--CA 1.499 1.807 0 C-N-CA 121.316 1.344 . . . . 0.0 112.004 177.489 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' D' D ' 16' ' ' PRO . . . . . . . . . . . . . 32.1 Cg_exo -59.85 -37.2 87.77 Favored 'Trans proline' 0 N--CA 1.497 1.689 0 C-N-CA 121.398 1.399 . . . . 0.0 112.55 178.962 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' D' D ' 17' ' ' ASP . . . . . . . . . . . . . 8.8 p-10 -87.53 15.77 6.29 Favored 'General case' 0 CA--C 1.536 0.419 0 N-CA-C 112.869 0.692 . . . . 0.0 112.869 -177.529 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' D' D ' 18' ' ' PHE . . . . . . . . . . . . . 35.7 t80 -56.38 -47.34 79.13 Favored 'General case' 0 C--N 1.334 -0.089 0 O-C-N 122.031 -0.418 . . . . 0.0 110.536 -178.283 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' D' D ' 19' ' ' VAL . . . . . . . . . . . . . 48.5 t -55.05 -40.89 56.28 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.259 0 C-N-CA 121.139 -0.224 . . . . 0.0 110.915 -177.337 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' D' D ' 20' ' ' ASP . . . . . . . . . . . . . 70.0 m-20 -60.06 -45.01 94.29 Favored 'General case' 0 C--N 1.331 -0.233 0 C-N-CA 120.864 -0.335 . . . . 0.0 110.959 -178.143 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' D' D ' 21' ' ' VAL . . . . . . . . . . . . . 47.5 t -65.52 -46.27 90.26 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.336 0 C-N-CA 120.631 -0.428 . . . . 0.0 110.585 -178.316 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' D' D ' 22' ' ' ILE . . . . . 0.497 HG22 HD12 ' D' ' 26' ' ' LEU . 49.4 mm -55.61 -58.67 4.01 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.295 0 C-N-CA 121.074 -0.25 . . . . 0.0 111.038 -178.101 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' D' D ' 23' ' ' ARG . . . . . . . . . . . . . 12.2 ptm180 -55.83 -42.78 76.25 Favored 'General case' 0 C--N 1.332 -0.183 0 C-N-CA 120.71 -0.396 . . . . 0.0 111.747 -174.662 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' D' D ' 24' ' ' ILE . . . . . . . . . . . . . 74.4 mt -59.78 -42.66 89.59 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.321 0 C-N-CA 120.871 -0.331 . . . . 0.0 111.314 -177.502 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' D' D ' 25' ' ' LYS . . . . . . . . . . . . . 97.5 mttt -69.08 -42.02 76.76 Favored 'General case' 0 C--N 1.329 -0.298 0 N-CA-C 112.457 0.54 . . . . 0.0 112.457 -179.808 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' D' D ' 26' ' ' LEU . . . . . 0.497 HD12 HG22 ' D' ' 22' ' ' ILE . 86.9 mt -78.87 -30.9 45.32 Favored 'General case' 0 C--N 1.329 -0.3 0 N-CA-C 113.708 1.003 . . . . 0.0 113.708 -169.851 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' D' D ' 27' ' ' GLN . . . . . . . . . . . . . 10.7 pt20 -47.45 141.4 4.98 Favored 'General case' 0 N--CA 1.469 0.497 0 N-CA-C 112.679 0.622 . . . . 0.0 112.679 -175.223 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' D' D ' 28' ' ' GLY . . . . . . . . . . . . . . . 100.07 -22.38 40.43 Favored Glycine 0 CA--C 1.533 1.158 0 CA-C-N 115.709 -0.678 . . . . 0.0 112.495 -177.109 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' D' D ' 29' ' ' LYS . . . . . . . . . . . . . 74.2 mmtt -96.59 155.02 16.95 Favored 'General case' 0 C--O 1.232 0.137 0 CA-C-N 117.588 0.694 . . . . 0.0 110.721 177.901 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' D' D ' 30' ' ' THR . . . . . . . . . . . . . 32.3 m -106.6 136.76 45.83 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.154 -0.475 . . . . 0.0 109.885 176.225 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' D' D ' 31' ' ' VAL . . . . . . . . . . . . . 34.8 m -129.47 156.27 41.8 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.203 0 CA-C-O 120.907 0.384 . . . . 0.0 110.864 -178.289 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' D' D ' 32' ' ' ARG . . . . . . . . . . . . . 54.0 ttp180 -133.99 150.82 51.28 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 115.857 -0.611 . . . . 0.0 110.384 178.652 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' D' D ' 33' ' ' THR . . . . . . . . . . . . . 27.4 m -53.06 139.99 26.66 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.419 -0.355 . . . . 0.0 111.339 -179.37 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' D' D ' 34' ' ' GLY . . . . . . . . . . . . . . . 99.74 -17.18 57.81 Favored Glycine 0 CA--C 1.533 1.181 0 CA-C-O 119.762 -0.466 . . . . 0.0 113.218 179.909 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' D' D ' 35' ' ' ASP . . . . . . . . . . . . . 73.4 m-20 -66.89 149.21 50.92 Favored 'General case' 0 C--O 1.231 0.122 0 CA-C-N 118.019 0.909 . . . . 0.0 111.3 178.609 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' D' D ' 36' ' ' VAL . . . . . . . . . . . . . 45.9 t -122.24 129.46 75.31 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.286 0 CA-C-N 115.815 -0.63 . . . . 0.0 109.692 177.463 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' D' D ' 37' ' ' ILE . . . . . . . . . . . . . 66.6 mt -119.9 138.08 51.65 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.264 0 CA-C-N 116.367 -0.379 . . . . 0.0 110.042 -178.942 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' D' D ' 38' ' ' GLY . . . . . . . . . . . . . . . -112.3 128.79 8.69 Favored Glycine 0 CA--C 1.524 0.653 0 N-CA-C 111.009 -0.836 . . . . 0.0 111.009 179.487 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' D' D ' 39' ' ' ILE . . . . . . . . . . . . . 72.1 mt -122.91 132.58 71.1 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.184 0 N-CA-C 110.039 -0.356 . . . . 0.0 110.039 179.319 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' D' D ' 40' ' ' SER . . . . . . . . . . . . . 13.6 t -92.51 119.41 31.97 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.474 -0.33 . . . . 0.0 110.647 176.153 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' D' D ' 41' ' ' ILE . . . . . . . . . . . . . 73.0 mt -131.1 115.99 31.74 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.208 0 CA-C-O 120.987 0.422 . . . . 0.0 110.691 179.51 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' D' D ' 42' ' ' LEU . . . . . 0.519 HD23 ' O ' ' D' ' 42' ' ' LEU . 1.4 tt 52.58 48.17 23.12 Favored 'General case' 0 CA--C 1.532 0.288 0 CA-C-N 115.738 -0.665 . . . . 0.0 110.989 175.9 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' D' D ' 43' ' ' GLY . . . . . . . . . . . . . . . 70.19 16.44 73.13 Favored Glycine 0 CA--C 1.534 1.266 0 C-N-CA 121.064 -0.589 . . . . 0.0 113.089 174.75 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' D' D ' 44' ' ' LYS . . . . . . . . . . . . . 53.3 mtmt -128.38 130.01 47.07 Favored 'General case' 0 C--N 1.333 -0.133 0 CA-C-N 117.788 0.794 . . . . 0.0 110.304 179.629 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' D' D ' 45' ' ' GLU . . . . . . . . . . . . . 81.4 tt0 -84.84 124.51 31.67 Favored 'General case' 0 C--N 1.327 -0.406 0 CA-C-N 116.451 -0.341 . . . . 0.0 110.737 -179.858 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' D' D ' 46' ' ' VAL . . . . . . . . . . . . . 7.3 p -122.26 127.06 75.07 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.235 0 N-CA-C 109.651 -0.5 . . . . 0.0 109.651 176.498 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' D' D ' 47' ' ' LYS . . . . . . . . . . . . . 99.3 mttt -101.03 130.66 47.07 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.008 -0.542 . . . . 0.0 111.481 178.171 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' D' D ' 48' ' ' PHE . . . . . . . . . . . . . 92.1 m-85 -113.86 131.95 56.08 Favored 'General case' 0 C--N 1.329 -0.303 0 N-CA-C 109.559 -0.534 . . . . 0.0 109.559 174.592 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' D' D ' 49' ' ' LYS . . . . . . . . . . . . . 80.6 tttt -107.99 137.44 45.98 Favored 'General case' 0 C--N 1.329 -0.309 0 N-CA-C 110.284 -0.265 . . . . 0.0 110.284 178.8 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' D' D ' 50' ' ' VAL . . . . . . . . . . . . . 45.6 t -81.69 109.2 15.61 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.252 0 N-CA-C 109.236 -0.653 . . . . 0.0 109.236 176.889 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' D' D ' 51' ' ' VAL . . . . . . . . . . . . . 48.8 t -74.35 -47.07 41.96 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.278 0 CA-C-N 115.902 -0.59 . . . . 0.0 110.213 -173.809 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' D' D ' 52' ' ' GLN . . . . . . . . . . . . . 31.2 tt0 -163.88 142.49 7.63 Favored 'General case' 0 C--N 1.332 -0.19 0 C-N-CA 120.26 -0.576 . . . . 0.0 111.789 -178.432 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' D' D ' 53' ' ' ALA . . . . . . . . . . . . . . . -118.55 132.33 56.21 Favored 'General case' 0 C--N 1.332 -0.184 0 CA-C-N 115.812 -0.631 . . . . 0.0 110.194 177.207 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' D' D ' 54' ' ' TYR . . . . . . . . . . . . . 55.0 t80 -128.98 107.92 18.14 Favored Pre-proline 0 CA--C 1.534 0.362 0 CA-C-O 118.252 -0.88 . . . . 0.0 110.557 -179.849 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' D' D ' 55' ' ' PRO . . . . . . . . . . . . . 73.8 Cg_endo -77.27 170.08 72.37 Favored 'Cis proline' 0 N--CA 1.501 1.914 0 CA-C-N 121.89 1.711 . . . . 0.0 112.274 -5.67 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' D' D ' 56' ' ' SER . . . . . . . . . . . . . 32.8 m -116.46 133.57 22.97 Favored Pre-proline 0 CA--C 1.539 0.547 0 CA-C-O 118.418 -0.801 . . . . 0.0 109.408 174.447 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' D' D ' 57' ' ' PRO . . . . . . . . . . . . . 41.9 Cg_endo -67.8 166.33 66.7 Favored 'Cis proline' 0 N--CA 1.499 1.8 0 CA-C-N 121.874 1.705 . . . . 0.0 111.524 -1.446 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' D' D ' 58' ' ' LEU . . . . . . . . . . . . . 38.5 tp -129.27 138.03 51.41 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.239 -0.437 . . . . 0.0 110.173 179.657 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' D' D ' 59' ' ' ARG . . . . . . . . . . . . . 72.7 ttt-85 -101.95 129.32 48.19 Favored 'General case' 0 C--N 1.329 -0.306 0 N-CA-C 109.405 -0.591 . . . . 0.0 109.405 178.013 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' D' D ' 60' ' ' VAL . . . . . . . . . . . . . 41.5 t -78.5 113.77 18.23 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.299 0 C-N-CA 120.782 -0.367 . . . . 0.0 110.255 -176.165 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' D' D ' 61' ' ' GLU . . . . . . . . . . . . . 82.8 tt0 -131.24 151.57 51.35 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 115.913 -0.585 . . . . 0.0 109.66 175.998 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' D' D ' 62' ' ' ASP . . . . . . . . . . . . . 50.6 m-20 -49.58 -32.08 11.92 Favored 'General case' 0 C--N 1.327 -0.396 0 N-CA-C 112.129 0.418 . . . . 0.0 112.129 179.394 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' D' D ' 63' ' ' ARG . . . . . . . . . . . . . 35.0 mtp180 -75.0 -21.75 58.95 Favored 'General case' 0 CA--C 1.533 0.32 0 N-CA-C 113.1 0.778 . . . . 0.0 113.1 -174.859 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' D' D ' 64' ' ' THR . . . . . . . . . . . . . 23.1 m -70.23 146.72 50.48 Favored 'General case' 0 C--N 1.331 -0.222 0 CA-C-O 120.726 0.298 . . . . 0.0 110.995 -175.536 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' D' D ' 65' ' ' LYS . . . . . . . . . . . . . 40.2 ttpt -88.28 121.64 30.9 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-O 121.068 0.461 . . . . 0.0 110.306 179.64 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' D' D ' 66' ' ' ILE . . . . . . . . . . . . . 69.1 mt -113.75 125.22 70.99 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.271 0 N-CA-C 109.556 -0.535 . . . . 0.0 109.556 -178.24 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' D' D ' 67' ' ' THR . . . . . . . . . . . . . 10.8 m -123.92 141.73 51.78 Favored 'General case' 0 C--N 1.331 -0.216 0 CA-C-O 121.062 0.458 . . . . 0.0 111.295 -174.57 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' D' D ' 68' ' ' LEU . . . . . 0.409 ' C ' HD23 ' D' ' 68' ' ' LEU . 5.7 tt -100.21 125.48 46.37 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 115.746 -0.661 . . . . 0.0 109.735 177.132 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' D' D ' 69' ' ' VAL . . . . . . . . . . . . . 45.2 t -99.71 130.59 48.54 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 CA-C-O 121.048 0.452 . . . . 0.0 110.5 -176.697 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' D' D ' 70' ' ' THR . . . . . . . . . . . . . 7.8 t -150.04 24.9 0.83 Allowed 'General case' 0 CA--C 1.535 0.375 0 CA-C-N 115.875 -0.602 . . . . 0.0 112.175 177.645 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' D' D ' 71' ' ' HIS . . . . . . . . . . . . . 10.9 m80 -149.97 86.45 5.28 Favored Pre-proline 0 CA--C 1.534 0.328 0 N-CA-C 110.192 -0.299 . . . . 0.0 110.192 -179.705 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' D' D ' 72' ' ' PRO . . . . . . . . . . . . . 74.5 Cg_endo -80.58 -26.7 3.74 Favored 'Trans proline' 0 N--CA 1.494 1.516 0 C-N-CA 121.473 1.448 . . . . 0.0 113.195 -175.728 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' D' D ' 73' ' ' VAL . . . . . . . . . . . . . 34.5 m -72.91 179.95 0.39 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.299 0 C-N-CA 121.035 -0.266 . . . . 0.0 110.534 -179.218 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' D' D ' 74' ' ' ASP . . . . . . . . . . . . . 15.6 t0 -100.85 116.48 32.82 Favored 'General case' 0 C--N 1.332 -0.162 0 N-CA-C 109.965 -0.383 . . . . 0.0 109.965 -178.795 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' D' D ' 75' ' ' VAL . . . . . . . . . . . . . 45.2 t -113.77 124.08 70.07 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.196 0 CA-C-O 121.057 0.456 . . . . 0.0 110.304 -177.992 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' D' D ' 76' ' ' LEU . . . . . . . . . . . . . 19.2 mt -127.85 145.51 50.91 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 115.726 -0.67 . . . . 0.0 109.872 179.014 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' D' D ' 77' ' ' GLU . . . . . . . . . . . . . 97.0 mt-10 -134.03 138.62 45.48 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-O 121.092 0.472 . . . . 0.0 111.359 -178.526 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' D' D ' 78' ' ' ALA . . . . . . . . . . . . . . . -125.2 138.83 54.13 Favored 'General case' 0 C--N 1.331 -0.226 0 CA-C-N 115.743 -0.662 . . . . 0.0 109.708 176.301 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' D' D ' 79' ' ' LYS . . . . . 0.516 ' O ' HD13 ' D' ' 80' ' ' ILE . 69.2 mttm -75.12 122.8 24.15 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-O 120.913 0.387 . . . . 0.0 110.797 -177.865 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' D' D ' 80' ' ' ILE . . . . . 0.516 HD13 ' O ' ' D' ' 79' ' ' LYS . 24.5 mm -139.11 114.42 8.54 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.263 0 N-CA-C 109.29 -0.633 . . . . 0.0 109.29 -177.09 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' D' D ' 81' ' ' LYS . . . . . . . . . . . . . 61.7 mttp -113.42 123.24 49.61 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-O 120.866 0.365 . . . . 0.0 111.493 -175.722 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' D' D ' 82' ' ' GLY . . . . . . . . . . . . . . . 89.04 42.08 5.72 Favored Glycine 0 CA--C 1.525 0.715 0 C-N-CA 121.004 -0.617 . . . . 0.0 112.006 174.201 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' D' D ' 83' ' ' ILE . . . . . . . . . . . . . 68.9 mt -68.74 137.39 24.48 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.269 0 N-CA-C 109.992 -0.373 . . . . 0.0 109.992 178.668 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' D' D ' 84' ' ' LYS . . . . . . . . . . . . . 25.6 ttpt -105.94 -47.27 3.9 Favored 'General case' 0 C--N 1.331 -0.217 0 CA-C-N 116.455 -0.339 . . . . 0.0 110.165 177.91 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' D' D ' 85' ' ' ASP . . . . . . . . . . . . . 12.0 t70 -150.34 151.04 32.27 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.043 -0.526 . . . . 0.0 110.441 -179.272 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' D' D ' 86' ' ' VAL . . . . . . . . . . . . . 40.5 t -138.13 137.01 44.7 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.235 0 CA-C-O 121.029 0.443 . . . . 0.0 110.764 -179.266 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' D' D ' 87' ' ' ILE . . . . . . . . . . . . . 46.2 mm -122.16 130.65 74.38 Favored 'Isoleucine or valine' 0 C--O 1.233 0.192 0 CA-C-N 115.781 -0.645 . . . . 0.0 109.793 177.159 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' D' D ' 88' ' ' LEU . . . . . . . . . . . . . 18.8 tp -116.85 132.16 56.77 Favored 'General case' 0 C--N 1.331 -0.201 0 CA-C-O 121.021 0.439 . . . . 0.0 111.161 -177.623 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' D' D ' 89' ' ' ASP . . . . . . . . . . . . . 5.5 t70 -130.66 156.29 45.15 Favored 'General case' 0 C--N 1.331 -0.204 0 CA-C-N 115.835 -0.621 . . . . 0.0 109.668 175.483 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' D' D ' 90' ' ' GLU . . . . . . . . . . . . . 83.9 tt0 -47.04 -39.49 12.9 Favored 'General case' 0 C--N 1.331 -0.201 0 N-CA-C 112.97 0.73 . . . . 0.0 112.97 -172.359 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' D' D ' 91' ' ' ASN . . . . . . . . . . . . . 21.6 p-10 -131.99 36.03 3.7 Favored 'General case' 0 C--O 1.233 0.22 0 N-CA-C 111.767 0.284 . . . . 0.0 111.767 -176.215 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' D' D ' 92' ' ' LEU . . . . . . . . . . . . . 16.0 tp -165.86 138.73 4.17 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-O 120.754 0.312 . . . . 0.0 110.605 -179.821 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' D' D ' 93' ' ' ILE . . . . . . . . . . . . . 73.2 mt -124.27 123.11 65.74 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.204 0 N-CA-C 109.431 -0.581 . . . . 0.0 109.431 179.55 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' D' D ' 94' ' ' VAL . . . . . . . . . . . . . 46.0 t -124.03 128.2 73.94 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.299 0 N-CA-C 109.897 -0.409 . . . . 0.0 109.897 -178.783 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' D' D ' 95' ' ' VAL . . . . . . . . . . . . . 40.7 t -123.78 135.28 63.99 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.346 0 CA-C-N 116.133 -0.485 . . . . 0.0 109.965 -178.611 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' D' D ' 96' ' ' ILE . . . . . . . . . . . . . 66.2 mt -117.13 128.47 74.49 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.237 0 N-CA-C 109.394 -0.595 . . . . 0.0 109.394 178.661 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' D' D ' 97' ' ' THR . . . . . . . . . . . . . 71.2 p -104.35 157.06 17.41 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-O 121.388 0.613 . . . . 0.0 111.502 -176.56 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' D' D ' 98' ' ' GLU . . . . . . . . . . . . . 12.8 pt-20 -54.85 -24.49 23.33 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 115.73 -0.668 . . . . 0.0 112.492 -179.444 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' D' D ' 99' ' ' GLU . . . . . . . . . . . . . 14.8 mm-40 -80.2 16.8 1.16 Allowed 'General case' 0 CA--C 1.536 0.441 0 N-CA-C 112.959 0.725 . . . . 0.0 112.959 -178.578 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' D' D ' 100' ' ' ASN . . . . . . . . . . . . . 4.2 m-20 62.47 37.84 13.13 Favored 'General case' 0 C--O 1.233 0.198 0 CA-C-O 121.019 0.437 . . . . 0.0 110.976 178.344 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' D' D ' 101' ' ' GLU . . . . . . . . . . . . . 84.4 tt0 -114.99 140.84 48.71 Favored 'General case' 0 C--N 1.331 -0.213 0 CA-C-N 116.127 -0.488 . . . . 0.0 109.912 177.364 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' D' D ' 102' ' ' VAL . . . . . . . . . . . . . 44.7 t -114.83 124.77 71.81 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.287 0 N-CA-C 109.656 -0.498 . . . . 0.0 109.656 179.282 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' D' D ' 103' ' ' LEU . . . . . . . . . . . . . 22.0 mt -116.6 133.6 55.82 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 115.805 -0.634 . . . . 0.0 110.155 179.055 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' D' D ' 104' ' ' ILE . . . . . . . . . . . . . 69.1 mt -121.73 121.92 65.59 Favored 'Isoleucine or valine' 0 C--O 1.234 0.239 0 CA-C-N 116.577 -0.283 . . . . 0.0 110.323 -178.35 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' D' D ' 105' ' ' PHE . . . . . . . . . . . . . 74.1 m-85 -123.81 165.81 16.68 Favored 'General case' 0 C--N 1.333 -0.141 0 O-C-N 123.994 0.808 . . . . 0.0 109.937 179.933 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' D' D ' 106' ' ' ASN . . . . . . . . . . . . . 49.8 p-10 -100.54 -174.03 2.55 Favored 'General case' 0 C--N 1.331 -0.209 0 N-CA-C 109.816 -0.438 . . . . 0.0 109.816 171.422 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' D' D ' 107' ' ' GLN . . . . . 0.478 ' NE2' HD11 ' C' ' 129' ' ' LEU . 34.7 tp60 -59.21 -25.37 63.92 Favored 'General case' 0 CA--C 1.533 0.313 0 N-CA-C 112.331 0.493 . . . . 0.0 112.331 -178.016 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' D' D ' 108' ' ' ASN . . . . . . . . . . . . . 9.7 t30 -91.45 14.17 15.52 Favored 'General case' 0 CA--C 1.534 0.365 0 N-CA-C 112.9 0.704 . . . . 0.0 112.9 -176.553 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' D' D ' 109' ' ' LEU . . . . . . . . . . . . . 76.8 mt 58.77 33.57 23.15 Favored 'General case' 0 CA--C 1.529 0.172 0 CA-C-O 120.789 0.328 . . . . 0.0 111.864 179.162 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' D' D ' 110' ' ' GLU . . . . . . . . . . . . . 70.5 mm-40 -100.21 134.82 42.58 Favored 'General case' 0 C--N 1.329 -0.284 0 N-CA-C 108.932 -0.766 . . . . 0.0 108.932 173.85 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' D' D ' 111' ' ' GLU . . . . . . . . . . . . . 45.2 tt0 -82.18 121.79 27.06 Favored 'General case' 0 C--N 1.328 -0.355 0 C-N-CA 120.643 -0.423 . . . . 0.0 110.519 -174.566 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' D' D ' 112' ' ' LEU . . . . . . . . . . . . . 34.2 mt -97.85 -45.99 6.11 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 115.851 -0.613 . . . . 0.0 110.552 179.282 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' D' D ' 113' ' ' TYR . . . . . . . . . . . . . 58.6 t80 -140.84 144.7 35.49 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.072 -0.513 . . . . 0.0 111.1 -177.854 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' D' D ' 114' ' ' ARG . . . . . . . . . . . . . 33.4 ptt180 -145.89 125.11 12.95 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 115.825 -0.625 . . . . 0.0 110.21 173.617 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' D' D ' 115' ' ' GLY . . . . . . . . . . . . . . . -149.98 143.14 10.38 Favored Glycine 0 CA--C 1.523 0.536 0 N-CA-C 110.82 -0.912 . . . . 0.0 110.82 -179.706 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' D' D ' 116' ' ' LYS . . . . . . . . . . . . . 31.4 ttmt -115.86 132.53 56.62 Favored 'General case' 0 C--N 1.329 -0.318 0 N-CA-C 109.974 -0.38 . . . . 0.0 109.974 179.184 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' D' D ' 117' ' ' PHE . . . . . . . . . . . . . 52.0 m-85 -123.52 116.27 22.91 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.123 -0.49 . . . . 0.0 110.087 -177.085 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' D' D ' 118' ' ' GLU . . . . . . . . . . . . . 84.1 tt0 -53.69 -48.47 69.48 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.576 -0.284 . . . . 0.0 111.355 -176.63 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' D' D ' 119' ' ' ASN . . . . . . . . . . . . . 87.0 m-20 -95.25 31.05 2.02 Favored 'General case' 0 C--N 1.33 -0.27 0 N-CA-C 112.203 0.446 . . . . 0.0 112.203 -174.964 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' D' D ' 120' ' ' LEU . . . . . . . . . . . . . 14.6 tp -55.34 120.32 6.92 Favored 'General case' 0 C--N 1.331 -0.202 0 CA-C-O 120.714 0.292 . . . . 0.0 110.525 178.298 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' D' D ' 121' ' ' ASN . . . . . . . . . . . . . 60.3 m-80 -113.99 -44.1 3.19 Favored 'General case' 0 C--O 1.231 0.109 0 CA-C-N 116.522 -0.308 . . . . 0.0 111.332 -176.795 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' D' D ' 122' ' ' LYS . . . . . . . . . . . . . 53.3 mttm -140.86 145.7 36.54 Favored 'General case' 0 C--N 1.331 -0.219 0 CA-C-O 120.965 0.412 . . . . 0.0 111.665 -177.647 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' D' D ' 123' ' ' VAL . . . . . . . . . . . . . 45.5 t -131.58 127.51 59.48 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.258 0 CA-C-N 116.014 -0.539 . . . . 0.0 109.696 175.319 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' D' D ' 124' ' ' LEU . . . . . . . . . . . . . 14.2 tp -131.29 133.47 45.41 Favored 'General case' 0 C--N 1.33 -0.251 0 N-CA-C 110.108 -0.33 . . . . 0.0 110.108 179.13 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' D' D ' 125' ' ' VAL . . . . . 0.559 HG12 HG13 ' D' ' 130' ' ' VAL . 32.8 m -141.24 138.5 33.39 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 CA-C-O 120.883 0.373 . . . . 0.0 111.074 -178.89 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' D' D ' 126' ' ' ARG . . . . . . . . . . . . . 98.5 mtt180 -144.04 131.05 20.5 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 115.933 -0.576 . . . . 0.0 110.249 178.64 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' D' D ' 127' ' ' ASN . . . . . . . . . . . . . 56.5 t30 52.84 -113.46 0.77 Allowed 'General case' 0 CA--C 1.546 0.813 0 CA-C-O 118.626 -0.702 . . . . 0.0 110.849 179.366 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' D' D ' 128' ' ' ASP . . . . . . . . . . . . . 12.9 p-10 -114.03 12.65 18.01 Favored 'General case' 0 CA--C 1.536 0.416 0 CA-C-N 120.126 1.33 . . . . 0.0 113.144 179.929 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' D' D ' 129' ' ' LEU . . . . . . . . . . . . . 15.8 tp -107.0 131.92 53.52 Favored 'General case' 0 C--O 1.232 0.171 0 N-CA-C 110.002 -0.37 . . . . 0.0 110.002 179.095 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' D' D ' 130' ' ' VAL . . . . . 0.559 HG13 HG12 ' D' ' 125' ' ' VAL . 46.5 t -122.7 133.76 67.88 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.246 0 CA-C-O 120.773 0.321 . . . . 0.0 110.353 -177.0 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' D' D ' 131' ' ' VAL . . . . . 0.535 HG22 HD12 ' D' ' 140' ' ' LEU . 42.8 t -135.52 133.55 52.03 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.191 0 CA-C-O 121.093 0.473 . . . . 0.0 110.204 176.441 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' D' D ' 132' ' ' ILE . . . . . . . . . . . . . 72.5 mt -122.15 134.0 66.73 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.25 0 CA-C-N 115.743 -0.662 . . . . 0.0 109.606 -178.728 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' D' D ' 133' ' ' ILE . . . . . . . . . . . . . 40.3 mm -114.98 124.39 71.6 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.251 0 CA-C-O 120.693 0.282 . . . . 0.0 110.92 -175.298 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' D' D ' 134' ' ' ASP . . . . . . . . . . . . . 9.6 p-10 -134.63 147.83 50.27 Favored 'General case' 0 C--N 1.332 -0.179 0 N-CA-C 109.721 -0.474 . . . . 0.0 109.721 174.804 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' D' D ' 135' ' ' GLU . . . . . . . . . . . . . 43.2 tp10 -50.49 -29.48 10.56 Favored 'General case' 0 C--N 1.329 -0.296 0 N-CA-C 112.845 0.683 . . . . 0.0 112.845 -171.43 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' D' D ' 136' ' ' GLN . . . . . . . . . . . . . 98.7 mt-30 -81.17 -32.71 33.48 Favored 'General case' 0 C--N 1.331 -0.197 0 N-CA-C 112.63 0.604 . . . . 0.0 112.63 -176.016 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' D' D ' 137' ' ' LYS . . . . . . . . . . . . . 37.7 pttt -167.67 172.87 8.93 Favored 'General case' 0 C--N 1.331 -0.223 0 CA-C-O 121.625 0.726 . . . . 0.0 112.261 -172.234 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' D' D ' 138' ' ' LEU . . . . . . . . . . . . . 5.5 tt -115.06 127.64 55.75 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 115.029 -0.987 . . . . 0.0 109.828 179.158 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' D' D ' 139' ' ' THR . . . . . . . . . . . . . 28.1 m -106.2 124.86 50.24 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.143 -0.481 . . . . 0.0 110.145 -179.675 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' D' D ' 140' ' ' LEU . . . . . 0.535 HD12 HG22 ' D' ' 131' ' ' VAL . 11.6 tp -115.67 121.65 43.17 Favored 'General case' 0 C--N 1.327 -0.376 0 N-CA-C 109.311 -0.626 . . . . 0.0 109.311 -178.54 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' D' D ' 141' ' ' ILE . . . . . . . . . . . . . 19.5 mt -119.13 116.75 51.95 Favored 'Isoleucine or valine' 0 C--O 1.234 0.274 0 CA-C-O 120.924 0.392 . . . . 0.0 109.966 -174.847 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' D' D ' 142' ' ' ARG . . . . . . . . . . . . . 81.7 mtp180 -106.87 131.23 54.2 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-N 115.27 -0.877 . . . . 0.0 110.626 -177.751 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' D' D ' 143' ' ' THR . . . . . . . . . . . . . 33.6 p . . . . . 0 C--O 1.221 -0.441 0 CA-C-O 117.907 -1.045 . . . . 0.0 110.893 179.624 . . . . . . . . 0 0 . 1 . 013 nuclear nobuild full ' E' E ' -3' ' ' GLU . . . . . . . . . . . . . 45.5 mp0 . . . . . 0 N--CA 1.489 1.484 0 N-CA-C 109.336 -0.616 . . . . 0.0 109.336 . . . . . . . . . 0 0 . 1 . 013 nuclear nobuild full ' E' E ' -2' ' ' GLY . . . . . . . . . . . . . . . -61.87 128.84 43.36 Favored Glycine 0 CA--C 1.525 0.68 0 N-CA-C 110.546 -1.021 . . . . 0.0 110.546 178.788 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' E' E ' -1' ' ' VAL . . . . . . . . . . . . . 46.1 t -93.8 138.1 21.22 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.332 0 N-CA-C 110.014 -0.365 . . . . 0.0 110.014 -179.235 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' E' E ' 0' ' ' ILE . . . . . . . . . . . . . 68.6 mt -103.58 142.25 17.71 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.276 0 CA-C-N 116.071 -0.513 . . . . 0.0 110.041 -177.983 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' E' E ' 1' ' ' MET . . . . . . . . . . . . . 25.2 ptm -77.61 132.82 38.44 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.043 -0.526 . . . . 0.0 110.693 -179.077 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' E' E ' 2' ' ' SER . . . . . . . . . . . . . 11.1 p -123.24 138.31 54.67 Favored 'General case' 0 C--N 1.331 -0.217 0 CA-C-N 116.187 -0.46 . . . . 0.0 110.646 179.851 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' E' E ' 3' ' ' GLU . . . . . . . . . . . . . 77.6 tt0 -141.0 140.7 34.37 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.773 179.787 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' E' E ' 4' ' ' LEU . . . . . . . . . . . . . 5.2 tt -125.82 128.28 47.42 Favored 'General case' 0 C--N 1.331 -0.215 0 CA-C-N 116.087 -0.506 . . . . 0.0 110.124 177.79 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' E' E ' 5' ' ' LYS . . . . . . . . . . . . . 68.9 mttm -105.04 122.59 46.19 Favored 'General case' 0 C--O 1.235 0.291 0 CA-C-N 116.428 -0.351 . . . . 0.0 110.868 -179.307 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' E' E ' 6' ' ' LEU . . . . . . . . . . . . . 64.6 mt -114.61 148.99 37.3 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-N 115.633 -0.712 . . . . 0.0 110.899 -179.153 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' E' E ' 7' ' ' LYS . . . . . . . . . . . . . 79.6 tttt -138.61 134.38 17.29 Favored Pre-proline 0 CA--C 1.535 0.387 0 CA-C-O 118.893 -0.575 . . . . 0.0 109.909 174.676 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' E' E ' 8' ' ' PRO . . . . . . . . . . . . . 88.8 Cg_endo -88.63 142.29 4.9 Favored 'Trans proline' 0 N--CA 1.492 1.42 0 C-N-CA 121.536 1.49 . . . . 0.0 111.624 177.497 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' E' E ' 9' ' ' LEU . . . . . . . . . . . . . 73.7 mt -76.03 -47.27 3.71 Favored Pre-proline 0 CA--C 1.534 0.341 0 CA-C-O 118.792 -0.623 . . . . 0.0 112.058 -178.432 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' E' E ' 10' ' ' PRO . . . . . . . . . . . . . 97.7 Cg_endo -82.34 149.1 14.91 Favored 'Trans proline' 0 N--CA 1.495 1.603 0 C-N-CA 121.276 1.318 . . . . 0.0 111.712 174.463 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' E' E ' 11' ' ' LYS . . . . . . . . . . . . . 59.8 mttp -88.47 97.6 11.16 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-O 120.886 0.374 . . . . 0.0 110.558 178.648 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' E' E ' 12' ' ' VAL . . . . . . . . . . . . . 11.9 p -139.54 148.28 23.45 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.274 0 CA-C-N 115.946 -0.57 . . . . 0.0 110.216 179.79 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' E' E ' 13' ' ' GLU . . . . . . . . . . . . . 81.1 tt0 -81.95 121.72 26.86 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.35 -0.386 . . . . 0.0 109.974 179.085 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' E' E ' 14' ' ' LEU . . . . . . . . . . . . . 31.2 mt -95.89 150.48 37.38 Favored Pre-proline 0 CA--C 1.532 0.271 0 CA-C-N 116.355 -0.384 . . . . 0.0 110.466 -178.581 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' E' E ' 15' ' ' PRO . . . . . . . . . . . . . 33.1 Cg_exo -60.09 158.91 27.98 Favored 'Trans proline' 0 N--CA 1.497 1.728 0 C-N-CA 121.182 1.254 . . . . 0.0 112.024 178.9 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' E' E ' 16' ' ' PRO . . . . . . . . . . . . . 26.8 Cg_exo -60.69 -44.05 28.59 Favored 'Trans proline' 0 N--CA 1.497 1.708 0 C-N-CA 121.453 1.435 . . . . 0.0 112.962 -178.106 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' E' E ' 17' ' ' ASP . . . . . . . . . . . . . 14.3 p-10 -82.69 9.83 8.81 Favored 'General case' 0 C--N 1.327 -0.388 0 N-CA-C 113.259 0.837 . . . . 0.0 113.259 -176.772 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' E' E ' 18' ' ' PHE . . . . . . . . . . . . . 48.0 t80 -57.45 -42.95 83.49 Favored 'General case' 0 N--CA 1.457 -0.089 0 O-C-N 121.896 -0.502 . . . . 0.0 110.243 -178.539 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' E' E ' 19' ' ' VAL . . . . . . . . . . . . . 47.7 t -56.88 -44.63 82.56 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.362 0 CA-C-N 116.384 -0.371 . . . . 0.0 110.473 -177.945 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' E' E ' 20' ' ' ASP . . . . . . . . . . . . . 72.3 m-20 -59.61 -41.31 90.07 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-O 120.773 0.32 . . . . 0.0 110.78 -177.824 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' E' E ' 21' ' ' VAL . . . . . . . . . . . . . 46.4 t -64.24 -46.36 93.6 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.323 0 C-N-CA 120.725 -0.39 . . . . 0.0 110.476 -178.239 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' E' E ' 22' ' ' ILE . . . . . 0.594 HG22 HD12 ' E' ' 26' ' ' LEU . 48.6 mm -61.6 -35.58 68.03 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.266 0 C-N-CA 121.034 -0.267 . . . . 0.0 111.058 -179.852 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' E' E ' 23' ' ' ARG . . . . . . . . . . . . . 58.1 ttp180 -57.38 -47.79 80.74 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-O 120.965 0.412 . . . . 0.0 110.355 176.971 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' E' E ' 24' ' ' ILE . . . . . . . . . . . . . 76.0 mt -61.83 -46.67 96.0 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.238 0 CA-C-N 115.928 -0.578 . . . . 0.0 112.02 -178.037 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' E' E ' 25' ' ' LYS . . . . . . . . . . . . . 12.6 ptmm? -68.45 -35.17 77.21 Favored 'General case' 0 CA--C 1.532 0.283 0 C-N-CA 120.632 -0.427 . . . . 0.0 111.824 -174.05 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' E' E ' 26' ' ' LEU . . . . . 0.594 HD12 HG22 ' E' ' 22' ' ' ILE . 63.3 mt -79.19 -46.45 17.88 Favored 'General case' 0 C--N 1.331 -0.219 0 N-CA-C 112.963 0.727 . . . . 0.0 112.963 -174.918 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' E' E ' 27' ' ' GLN . . . . . . . . . . . . . 11.1 pt20 -46.52 140.84 4.05 Favored 'General case' 0 N--CA 1.468 0.466 0 N-CA-C 112.937 0.717 . . . . 0.0 112.937 -173.786 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' E' E ' 28' ' ' GLY . . . . . . . . . . . . . . . 100.72 -29.93 11.37 Favored Glycine 0 CA--C 1.53 1.01 0 CA-C-N 115.382 -0.827 . . . . 0.0 112.0 -176.776 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' E' E ' 29' ' ' LYS . . . . . . . . . . . . . 98.4 mttt -99.52 155.3 17.64 Favored 'General case' 0 C--O 1.234 0.273 0 CA-C-N 117.137 0.469 . . . . 0.0 111.58 179.435 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' E' E ' 30' ' ' THR . . . . . . . . . . . . . 32.2 m -97.12 140.03 32.23 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 115.93 -0.577 . . . . 0.0 110.266 176.203 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' E' E ' 31' ' ' VAL . . . . . . . . . . . . . 35.1 m -131.13 153.7 39.52 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.238 0 CA-C-N 116.234 -0.439 . . . . 0.0 110.711 -179.616 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' E' E ' 32' ' ' ARG . . . . . . . . . . . . . 75.9 mtt180 -132.7 150.1 52.2 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.04 -0.527 . . . . 0.0 110.489 178.476 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' E' E ' 33' ' ' THR . . . . . . . . . . . . . 26.6 m -53.17 140.56 25.71 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 116.241 -0.436 . . . . 0.0 111.416 -178.016 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' E' E ' 34' ' ' GLY . . . . . . . . . . . . . . . 99.62 -17.22 57.86 Favored Glycine 0 CA--C 1.531 1.082 0 C-N-CA 121.208 -0.52 . . . . 0.0 113.259 179.447 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' E' E ' 35' ' ' ASP . . . . . . . . . . . . . 75.9 m-20 -66.11 148.89 51.14 Favored 'General case' 0 C--N 1.334 -0.098 0 CA-C-N 118.092 0.946 . . . . 0.0 110.908 178.272 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' E' E ' 36' ' ' VAL . . . . . . . . . . . . . 44.1 t -123.76 132.52 71.24 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.214 0 CA-C-N 116.096 -0.502 . . . . 0.0 109.918 178.166 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' E' E ' 37' ' ' ILE . . . . . . . . . . . . . 66.8 mt -118.43 138.79 47.99 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.317 0 CA-C-N 116.12 -0.491 . . . . 0.0 109.766 -179.648 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' E' E ' 38' ' ' GLY . . . . . . . . . . . . . . . -110.87 128.77 8.91 Favored Glycine 0 CA--C 1.526 0.751 0 N-CA-C 111.171 -0.771 . . . . 0.0 111.171 -179.337 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' E' E ' 39' ' ' ILE . . . . . . . . . . . . . 77.0 mt -123.84 136.05 61.5 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.199 0 CA-C-O 120.791 0.329 . . . . 0.0 110.123 179.018 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' E' E ' 40' ' ' SER . . . . . . . . . . . . . 78.0 p -93.64 124.07 37.38 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.705 174.8 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' E' E ' 41' ' ' ILE . . . . . . . . . . . . . 70.7 mt -127.82 118.62 49.4 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.2 0 CA-C-O 120.919 0.39 . . . . 0.0 110.373 177.785 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' E' E ' 42' ' ' LEU . . . . . . . . . . . . . 44.4 mt 51.37 34.32 11.64 Favored 'General case' 0 CA--C 1.531 0.213 0 CA-C-N 116.202 -0.454 . . . . 0.0 111.952 177.621 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' E' E ' 43' ' ' GLY . . . . . . . . . . . . . . . 74.65 32.4 57.41 Favored Glycine 0 CA--C 1.528 0.898 0 C-N-CA 121.138 -0.553 . . . . 0.0 112.095 178.303 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' E' E ' 44' ' ' LYS . . . . . . . . . . . . . 47.8 tptt -137.14 131.32 32.43 Favored 'General case' 0 C--N 1.33 -0.253 0 N-CA-C 109.549 -0.537 . . . . 0.0 109.549 177.776 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' E' E ' 45' ' ' GLU . . . . . . . . . . . . . 69.0 tt0 -85.13 123.3 30.49 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 116.538 -0.301 . . . . 0.0 111.415 -174.666 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' E' E ' 46' ' ' VAL . . . . . . . . . . . . . 7.1 p -124.99 128.7 73.27 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.21 0 CA-C-O 120.904 0.383 . . . . 0.0 110.056 176.412 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' E' E ' 47' ' ' LYS . . . . . . . . . . . . . 34.9 mmtp -101.77 132.81 47.3 Favored 'General case' 0 C--N 1.331 -0.21 0 CA-C-N 115.934 -0.575 . . . . 0.0 111.653 177.604 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' E' E ' 48' ' ' PHE . . . . . . . . . . . . . 89.6 m-85 -114.73 131.9 56.62 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-N 115.922 -0.581 . . . . 0.0 109.734 174.258 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' E' E ' 49' ' ' LYS . . . . . . . . . . . . . 57.6 tttm -106.67 139.8 40.54 Favored 'General case' 0 C--O 1.233 0.23 0 CA-C-N 116.69 -0.232 . . . . 0.0 110.586 179.426 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' E' E ' 50' ' ' VAL . . . . . . . . . . . . . 47.2 t -80.88 108.14 13.92 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.282 0 N-CA-C 109.155 -0.683 . . . . 0.0 109.155 176.026 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' E' E ' 51' ' ' VAL . . . . . . . . . . . . . 47.8 t -71.31 -47.88 57.27 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.309 0 CA-C-N 116.158 -0.474 . . . . 0.0 110.125 -174.266 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' E' E ' 52' ' ' GLN . . . . . . . . . . . . . 48.3 tt0 -164.86 141.58 5.95 Favored 'General case' 0 C--N 1.332 -0.169 0 C-N-CA 120.128 -0.629 . . . . 0.0 111.693 -178.338 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' E' E ' 53' ' ' ALA . . . . . 0.418 ' HB3' ' OG ' ' E' ' 56' ' ' SER . . . -115.0 133.11 56.32 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 115.764 -0.653 . . . . 0.0 110.001 176.5 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' E' E ' 54' ' ' TYR . . . . . . . . . . . . . 13.7 t80 -129.19 110.89 18.14 Favored Pre-proline 0 CA--C 1.534 0.364 0 CA-C-O 118.198 -0.906 . . . . 0.0 110.358 178.556 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' E' E ' 55' ' ' PRO . . . . . . . . . . . . . 72.3 Cg_endo -77.28 170.13 72.23 Favored 'Cis proline' 0 N--CA 1.5 1.862 0 CA-C-N 122.062 1.772 . . . . 0.0 112.075 -6.444 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' E' E ' 56' ' ' SER . . . . . 0.418 ' OG ' ' HB3' ' E' ' 53' ' ' ALA . 48.8 m -123.18 139.09 30.97 Favored Pre-proline 0 CA--C 1.538 0.485 0 CA-C-O 118.501 -0.761 . . . . 0.0 109.505 174.758 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' E' E ' 57' ' ' PRO . . . . . . . . . . . . . 36.7 Cg_endo -67.07 144.29 69.51 Favored 'Cis proline' 0 N--CA 1.499 1.849 0 CA-C-N 121.764 1.666 . . . . 0.0 111.489 -3.54 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' E' E ' 58' ' ' LEU . . . . . . . . . . . . . 19.6 tp -108.37 136.33 48.18 Favored 'General case' 0 C--N 1.331 -0.239 0 CA-C-N 116.313 -0.403 . . . . 0.0 111.024 -176.905 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' E' E ' 59' ' ' ARG . . . . . . . . . . . . . 74.5 ttt180 -103.63 123.78 47.62 Favored 'General case' 0 C--N 1.329 -0.32 0 N-CA-C 108.823 -0.806 . . . . 0.0 108.823 173.04 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' E' E ' 60' ' ' VAL . . . . . . . . . . . . . 43.9 t -81.67 123.02 37.51 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.258 0 C-N-CA 120.475 -0.49 . . . . 0.0 110.58 -173.367 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' E' E ' 61' ' ' GLU . . . . . . . . . . . . . 70.6 mm-40 -131.09 165.06 24.09 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 115.824 -0.625 . . . . 0.0 109.727 176.471 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' E' E ' 62' ' ' ASP . . . . . . . . . . . . . 11.7 t0 -52.62 -30.83 33.49 Favored 'General case' 0 C--N 1.328 -0.338 0 N-CA-C 111.983 0.364 . . . . 0.0 111.983 -179.822 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' E' E ' 63' ' ' ARG . . . . . . . . . . . . . 90.8 mtt-85 -71.78 -22.01 61.64 Favored 'General case' 0 CA--C 1.533 0.302 0 N-CA-C 112.829 0.677 . . . . 0.0 112.829 -176.309 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' E' E ' 64' ' ' THR . . . . . . . . . . . . . 27.3 m -73.03 136.82 45.08 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-O 120.844 0.354 . . . . 0.0 111.203 -174.246 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' E' E ' 65' ' ' LYS . . . . . . . . . . . . . 57.2 mtmt -90.08 132.61 35.32 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 115.956 -0.566 . . . . 0.0 110.454 177.946 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' E' E ' 66' ' ' ILE . . . . . . . . . . . . . 66.4 mt -112.62 128.2 69.43 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.283 0 N-CA-C 109.571 -0.529 . . . . 0.0 109.571 178.837 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' E' E ' 67' ' ' THR . . . . . . . . . . . . . 21.9 m -122.85 144.67 49.05 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-O 121.219 0.533 . . . . 0.0 111.317 -175.425 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' E' E ' 68' ' ' LEU . . . . . 0.452 ' C ' HD23 ' E' ' 68' ' ' LEU . 6.2 tt -98.6 125.29 43.8 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 115.601 -0.727 . . . . 0.0 109.96 178.698 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' E' E ' 69' ' ' VAL . . . . . 0.413 ' N ' HD23 ' E' ' 68' ' ' LEU . 43.0 t -87.95 128.55 40.27 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.284 0 CA-C-O 120.964 0.411 . . . . 0.0 110.258 -178.315 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' E' E ' 70' ' ' THR . . . . . . . . . . . . . 81.5 p -105.72 177.19 4.93 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.033 -0.53 . . . . 0.0 110.95 -177.368 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' E' E ' 71' ' ' HIS . . . . . . . . . . . . . 54.1 m-70 -64.91 168.22 7.7 Favored Pre-proline 0 C--N 1.329 -0.3 0 CA-C-N 115.672 -0.694 . . . . 0.0 110.519 -179.345 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' E' E ' 72' ' ' PRO . . . . . . . . . . . . . 18.7 Cg_exo -64.86 -5.55 10.83 Favored 'Trans proline' 0 N--CA 1.498 1.776 0 C-N-CA 121.322 1.348 . . . . 0.0 113.763 -177.82 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' E' E ' 73' ' ' VAL . . . . . . . . . . . . . 27.0 m -124.4 154.61 31.76 Favored 'Isoleucine or valine' 0 N--CA 1.461 0.112 0 CA-C-O 121.078 0.466 . . . . 0.0 110.564 177.632 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' E' E ' 74' ' ' ASP . . . . . . . . . . . . . 19.2 t0 -98.88 117.77 34.14 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 115.729 -0.669 . . . . 0.0 109.514 178.306 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' E' E ' 75' ' ' VAL . . . . . . . . . . . . . 43.3 t -109.0 119.34 58.38 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.251 0 CA-C-O 121.034 0.445 . . . . 0.0 110.279 -178.235 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' E' E ' 76' ' ' LEU . . . . . . . . . . . . . 28.7 mt -119.77 143.24 47.93 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 115.653 -0.703 . . . . 0.0 109.731 178.254 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' E' E ' 77' ' ' GLU . . . . . . . . . . . . . 97.2 mt-10 -134.86 129.38 34.35 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-O 121.071 0.463 . . . . 0.0 111.011 -178.294 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' E' E ' 78' ' ' ALA . . . . . . . . . . . . . . . -115.1 127.11 55.39 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 115.707 -0.679 . . . . 0.0 109.531 177.121 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' E' E ' 79' ' ' LYS . . . . . 0.545 ' O ' HD13 ' E' ' 80' ' ' ILE . 95.4 mttt -75.18 117.7 17.3 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-O 121.014 0.435 . . . . 0.0 110.747 -177.793 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' E' E ' 80' ' ' ILE . . . . . 0.545 HD13 ' O ' ' E' ' 79' ' ' LYS . 25.2 mm -139.27 111.23 5.33 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.378 0 N-CA-C 108.918 -0.771 . . . . 0.0 108.918 -178.601 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' E' E ' 81' ' ' LYS . . . . . . . . . . . . . 20.4 pttp -101.55 128.48 47.79 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-O 121.179 0.514 . . . . 0.0 111.402 -176.883 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' E' E ' 82' ' ' GLY . . . . . . . . . . . . . . . 89.19 42.14 5.66 Favored Glycine 0 CA--C 1.527 0.789 0 CA-C-N 115.697 -0.683 . . . . 0.0 111.858 175.6 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' E' E ' 83' ' ' ILE . . . . . . . . . . . . . 68.6 mt -69.37 137.37 24.36 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.337 0 N-CA-C 109.675 -0.491 . . . . 0.0 109.675 176.737 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' E' E ' 84' ' ' LYS . . . . . . . . . . . . . 23.4 ttpp -104.72 -51.73 3.01 Favored 'General case' 0 C--N 1.331 -0.212 0 CA-C-O 120.935 0.398 . . . . 0.0 110.252 179.968 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' E' E ' 85' ' ' ASP . . . . . . . . . . . . . 11.3 t70 -147.88 148.73 31.16 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 115.988 -0.551 . . . . 0.0 110.525 -178.865 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' E' E ' 86' ' ' VAL . . . . . . . . . . . . . 43.3 t -130.37 133.58 63.67 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.212 0 CA-C-O 120.984 0.421 . . . . 0.0 110.621 -179.498 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' E' E ' 87' ' ' ILE . . . . . . . . . . . . . 43.3 mm -119.31 122.87 70.16 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 CA-C-N 115.769 -0.651 . . . . 0.0 109.374 176.532 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' E' E ' 88' ' ' LEU . . . . . . . . . . . . . 60.4 mt -113.4 133.06 55.37 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-O 120.962 0.41 . . . . 0.0 111.312 -176.86 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' E' E ' 89' ' ' ASP . . . . . . . . . . . . . 6.5 t0 -134.2 157.56 45.93 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 115.821 -0.627 . . . . 0.0 109.72 176.627 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' E' E ' 90' ' ' GLU . . . . . . . . . . . . . 82.6 tt0 -46.41 -39.08 9.9 Favored 'General case' 0 C--N 1.329 -0.287 0 N-CA-C 113.295 0.85 . . . . 0.0 113.295 -170.588 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' E' E ' 91' ' ' ASN . . . . . . . . . . . . . 44.2 t30 -124.54 11.64 8.6 Favored 'General case' 0 N--CA 1.469 0.499 0 N-CA-C 113.528 0.936 . . . . 0.0 113.528 -174.231 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' E' E ' 92' ' ' LEU . . . . . . . . . . . . . 18.5 mt -148.22 143.48 27.04 Favored 'General case' 0 C--N 1.333 -0.141 0 CA-C-N 117.941 0.337 . . . . 0.0 110.36 -176.322 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' E' E ' 93' ' ' ILE . . . . . . . . . . . . . 70.1 mt -123.98 117.37 50.73 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.294 0 N-CA-C 109.222 -0.658 . . . . 0.0 109.222 176.724 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' E' E ' 94' ' ' VAL . . . . . . . . . . . . . 44.5 t -116.59 125.99 73.83 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.281 0 N-CA-C 109.791 -0.448 . . . . 0.0 109.791 -179.44 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' E' E ' 95' ' ' VAL . . . . . . . . . . . . . 43.4 t -118.81 133.45 65.61 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.34 0 CA-C-N 115.987 -0.552 . . . . 0.0 109.83 -179.601 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' E' E ' 96' ' ' ILE . . . . . 0.434 HD11 ' HB ' ' E' ' 123' ' ' VAL . 68.7 mt -114.17 127.11 71.74 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.305 0 N-CA-C 109.255 -0.646 . . . . 0.0 109.255 178.085 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' E' E ' 97' ' ' THR . . . . . . . . . . . . . 76.4 p -99.59 158.94 15.4 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-O 121.207 0.527 . . . . 0.0 111.117 -177.242 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' E' E ' 98' ' ' GLU . . . . . . . . . . . . . 96.8 mt-10 -53.82 -25.69 20.65 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.079 -0.509 . . . . 0.0 112.181 179.296 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' E' E ' 99' ' ' GLU . . . . . . . . . . . . . 34.7 tt0 -79.34 15.29 1.27 Allowed 'General case' 0 CA--C 1.539 0.533 0 N-CA-C 112.623 0.601 . . . . 0.0 112.623 -177.277 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' E' E ' 100' ' ' ASN . . . . . . . . . . . . . 2.8 m-20 61.16 37.94 17.21 Favored 'General case' 0 CA--C 1.53 0.186 0 O-C-N 121.815 -0.553 . . . . 0.0 110.936 178.752 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' E' E ' 101' ' ' GLU . . . . . . . . . . . . . 84.0 tt0 -115.27 145.11 42.78 Favored 'General case' 0 C--N 1.332 -0.182 0 CA-C-N 116.023 -0.535 . . . . 0.0 109.8 176.89 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' E' E ' 102' ' ' VAL . . . . . . . . . . . . . 45.5 t -115.02 124.22 71.46 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.331 0 CA-C-N 116.121 -0.491 . . . . 0.0 109.867 -178.251 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' E' E ' 103' ' ' LEU . . . . . . . . . . . . . 22.3 mt -118.48 128.16 54.32 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 115.8 -0.636 . . . . 0.0 110.144 176.667 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' E' E ' 104' ' ' ILE . . . . . . . . . . . . . 71.5 mt -118.42 122.28 69.14 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.257 0 N-CA-C 110.284 -0.265 . . . . 0.0 110.284 -179.652 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' E' E ' 105' ' ' PHE . . . . . . . . . . . . . 71.3 m-85 -120.79 165.84 14.58 Favored 'General case' 0 C--N 1.332 -0.161 0 O-C-N 124.035 0.835 . . . . 0.0 110.265 -179.985 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' E' E ' 106' ' ' ASN . . . . . . . . . . . . . 53.4 p-10 -99.35 -169.98 1.84 Allowed 'General case' 0 C--N 1.331 -0.236 0 N-CA-C 109.826 -0.435 . . . . 0.0 109.826 172.731 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' E' E ' 107' ' ' GLN . . . . . . . . . . . . . 38.7 tp60 -57.45 -27.77 62.75 Favored 'General case' 0 CA--C 1.534 0.334 0 N-CA-C 112.193 0.442 . . . . 0.0 112.193 -177.889 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' E' E ' 108' ' ' ASN . . . . . . . . . . . . . 9.1 t-20 -93.68 14.34 19.38 Favored 'General case' 0 CA--C 1.534 0.351 0 N-CA-C 113.136 0.791 . . . . 0.0 113.136 -175.453 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' E' E ' 109' ' ' LEU . . . . . . . . . . . . . 72.5 mt 58.72 35.81 24.57 Favored 'General case' 0 CA--C 1.53 0.176 0 CA-C-O 120.881 0.372 . . . . 0.0 111.55 179.494 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' E' E ' 110' ' ' GLU . . . . . . . . . . . . . 95.9 mt-10 -99.26 148.19 24.39 Favored 'General case' 0 C--N 1.33 -0.282 0 N-CA-C 109.774 -0.454 . . . . 0.0 109.774 175.894 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' E' E ' 111' ' ' GLU . . . . . . . . . . . . . 57.1 tt0 -79.9 122.86 27.2 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.399 -0.364 . . . . 0.0 111.016 -176.273 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' E' E ' 112' ' ' LEU . . . . . . . . . . . . . 17.0 mt -109.89 -45.98 3.55 Favored 'General case' 0 C--N 1.331 -0.202 0 CA-C-N 116.207 -0.451 . . . . 0.0 110.616 177.584 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' E' E ' 113' ' ' TYR . . . . . . . . . . . . . 53.2 t80 -138.47 135.5 35.23 Favored 'General case' 0 C--N 1.331 -0.238 0 C-N-CA 120.837 -0.345 . . . . 0.0 111.079 -179.318 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' E' E ' 114' ' ' ARG . . . . . . . . . . . . . 61.3 ttp180 -136.19 123.45 21.83 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-N 116.228 -0.442 . . . . 0.0 110.373 178.047 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' E' E ' 115' ' ' GLY . . . . . . . . . . . . . . . -150.14 158.91 27.88 Favored Glycine 0 CA--C 1.526 0.726 0 N-CA-C 111.181 -0.768 . . . . 0.0 111.181 177.956 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' E' E ' 116' ' ' LYS . . . . . . . . . . . . . 39.5 ttpt -127.75 137.46 52.44 Favored 'General case' 0 C--N 1.331 -0.238 0 N-CA-C 109.497 -0.557 . . . . 0.0 109.497 175.105 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' E' E ' 117' ' ' PHE . . . . . . . . . . . . . 37.1 m-85 -139.75 113.89 8.95 Favored 'General case' 0 C--N 1.331 -0.209 0 C-N-CA 120.697 -0.401 . . . . 0.0 110.214 -177.094 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' E' E ' 118' ' ' GLU . . . . . . . . . . . . . 96.1 mt-10 -56.86 -43.92 81.66 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.398 -0.364 . . . . 0.0 110.891 -176.67 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' E' E ' 119' ' ' ASN . . . . . . . . . . . . . 79.0 m-20 -93.87 28.66 2.32 Favored 'General case' 0 C--N 1.329 -0.299 0 N-CA-C 112.312 0.486 . . . . 0.0 112.312 -174.943 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' E' E ' 120' ' ' LEU . . . . . . . . . . . . . 18.6 tp -59.3 123.46 16.79 Favored 'General case' 0 C--N 1.333 -0.122 0 N-CA-C 109.945 -0.391 . . . . 0.0 109.945 177.645 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' E' E ' 121' ' ' ASN . . . . . . . . . . . . . 67.3 m-80 -114.13 -43.92 3.19 Favored 'General case' 0 C--N 1.332 -0.19 0 CA-C-N 116.509 -0.314 . . . . 0.0 110.953 -177.526 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' E' E ' 122' ' ' LYS . . . . . . . . . . . . . 98.6 mttt -144.03 148.05 34.69 Favored 'General case' 0 C--N 1.332 -0.195 0 CA-C-O 121.089 0.471 . . . . 0.0 111.714 -177.109 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' E' E ' 123' ' ' VAL . . . . . 0.434 ' HB ' HD11 ' E' ' 96' ' ' ILE . 45.8 t -127.95 129.97 69.82 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.341 0 N-CA-C 109.183 -0.673 . . . . 0.0 109.183 173.528 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' E' E ' 124' ' ' LEU . . . . . . . . . . . . . 28.2 mt -129.31 137.74 51.19 Favored 'General case' 0 N--CA 1.463 0.206 0 CA-C-O 121.047 0.451 . . . . 0.0 111.036 -176.147 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' E' E ' 125' ' ' VAL . . . . . . . . . . . . . 41.4 t -124.71 129.46 73.63 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.225 0 CA-C-N 115.77 -0.65 . . . . 0.0 109.922 179.725 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' E' E ' 126' ' ' ARG . . . . . . . . . . . . . 43.4 mmm-85 -140.61 115.32 9.56 Favored 'General case' 0 C--N 1.329 -0.298 0 N-CA-C 109.416 -0.587 . . . . 0.0 109.416 177.869 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' E' E ' 127' ' ' ASN . . . . . . . . . . . . . 78.5 m-20 56.02 -149.84 0.45 Allowed 'General case' 0 CA--C 1.541 0.629 0 N-CA-C 109.838 -0.43 . . . . 0.0 109.838 -179.93 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' E' E ' 128' ' ' ASP . . . . . . . . . . . . . 38.4 p30 -80.01 14.19 1.93 Allowed 'General case' 0 CA--C 1.535 0.39 0 N-CA-C 112.932 0.716 . . . . 0.0 112.932 179.136 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' E' E ' 129' ' ' LEU . . . . . . . . . . . . . 14.3 tp -111.93 136.46 51.22 Favored 'General case' 0 C--O 1.232 0.141 0 N-CA-C 109.688 -0.486 . . . . 0.0 109.688 177.289 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' E' E ' 130' ' ' VAL . . . . . 0.52 HG13 ' HB ' ' E' ' 141' ' ' ILE . 11.3 p -129.09 140.75 48.4 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.254 0 CA-C-O 120.934 0.397 . . . . 0.0 110.341 -177.924 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' E' E ' 131' ' ' VAL . . . . . . . . . . . . . 35.1 m -136.05 145.1 31.56 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.252 0 CA-C-O 121.237 0.541 . . . . 0.0 111.292 -179.096 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' E' E ' 132' ' ' ILE . . . . . . . . . . . . . 72.5 mt -118.94 133.69 64.98 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.32 0 CA-C-N 115.269 -0.878 . . . . 0.0 109.243 179.986 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' E' E ' 133' ' ' ILE . . . . . . . . . . . . . 39.5 mm -115.37 119.84 62.96 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.274 0 CA-C-O 120.722 0.296 . . . . 0.0 110.885 -175.399 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' E' E ' 134' ' ' ASP . . . . . . . . . . . . . 9.5 p-10 -131.79 148.26 52.55 Favored 'General case' 0 C--N 1.332 -0.173 0 N-CA-C 109.542 -0.54 . . . . 0.0 109.542 175.221 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' E' E ' 135' ' ' GLU . . . . . . . . . . . . . 84.8 tt0 -49.87 -27.61 5.4 Favored 'General case' 0 C--N 1.326 -0.422 0 N-CA-C 112.796 0.665 . . . . 0.0 112.796 -172.567 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' E' E ' 136' ' ' GLN . . . . . . . . . . . . . 98.4 mt-30 -81.85 -34.45 30.11 Favored 'General case' 0 C--N 1.33 -0.249 0 N-CA-C 112.746 0.647 . . . . 0.0 112.746 -176.192 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' E' E ' 137' ' ' LYS . . . . . . . . . . . . . 54.1 pttt -167.93 171.53 9.71 Favored 'General case' 0 C--N 1.332 -0.196 0 CA-C-O 121.66 0.743 . . . . 0.0 112.573 -171.131 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' E' E ' 138' ' ' LEU . . . . . 0.582 HD23 ' N ' ' E' ' 139' ' ' THR . 3.4 tt -114.05 127.91 56.15 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 114.73 -1.123 . . . . 0.0 109.679 -179.958 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' E' E ' 139' ' ' THR . . . . . 0.582 ' N ' HD23 ' E' ' 138' ' ' LEU . 30.5 m -108.86 128.02 54.55 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-O 120.715 0.293 . . . . 0.0 110.401 179.219 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' E' E ' 140' ' ' LEU . . . . . 0.48 ' C ' HD23 ' E' ' 140' ' ' LEU . 8.0 tt -117.57 124.34 48.44 Favored 'General case' 0 C--N 1.329 -0.285 0 N-CA-C 109.359 -0.608 . . . . 0.0 109.359 -178.594 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' E' E ' 141' ' ' ILE . . . . . 0.52 ' HB ' HG13 ' E' ' 130' ' ' VAL . 19.5 mt -120.94 121.73 65.87 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.305 0 N-CA-C 109.714 -0.476 . . . . 0.0 109.714 -175.431 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' E' E ' 142' ' ' ARG . . . . . . . . . . . . . 73.7 ttt180 -112.7 130.21 56.13 Favored 'General case' 0 C--N 1.331 -0.208 0 CA-C-N 115.709 -0.678 . . . . 0.0 110.407 -176.89 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' E' E ' 143' ' ' THR . . . . . . . . . . . . . 50.8 p . . . . . 0 C--O 1.22 -0.475 0 CA-C-O 117.997 -1.001 . . . . 0.0 110.603 -179.81 . . . . . . . . 0 0 . 1 . 013 nuclear nobuild full ' F' F ' -3' ' ' GLU . . . . . . . . . . . . . 95.8 mt-10 . . . . . 0 N--CA 1.491 1.594 0 N-CA-C 109.368 -0.604 . . . . 0.0 109.368 . . . . . . . . . 0 0 . 1 . 013 nuclear nobuild full ' F' F ' -2' ' ' GLY . . . . . . . . . . . . . . . -60.69 150.0 42.9 Favored Glycine 0 CA--C 1.525 0.662 0 N-CA-C 110.706 -0.958 . . . . 0.0 110.706 178.807 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' F' F ' -1' ' ' VAL . . . . . . . . . . . . . 44.0 t -94.85 127.48 46.79 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.358 0 CA-C-O 120.917 0.389 . . . . 0.0 110.17 -179.096 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' F' F ' 0' ' ' ILE . . . . . . . . . . . . . 71.8 mt -120.88 124.16 71.74 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.269 0 CA-C-N 116.05 -0.523 . . . . 0.0 109.676 178.833 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' F' F ' 1' ' ' MET . . . . . . . . . . . . . 25.6 ptp -84.68 140.82 31.03 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.26 -0.427 . . . . 0.0 110.615 -178.712 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' F' F ' 2' ' ' SER . . . . . . . . . . . . . 3.0 p -110.51 127.54 55.22 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-O 121.134 0.492 . . . . 0.0 110.449 178.916 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' F' F ' 3' ' ' GLU . . . . . . . . . . . . . 84.2 tt0 -140.17 139.14 35.66 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 115.69 -0.687 . . . . 0.0 110.771 -178.827 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' F' F ' 4' ' ' LEU . . . . . . . . . . . . . 19.1 tp -122.13 124.75 44.62 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 115.985 -0.552 . . . . 0.0 110.376 178.497 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' F' F ' 5' ' ' LYS . . . . . . . . . . . . . 97.9 mttt -101.92 118.84 37.75 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.146 -0.479 . . . . 0.0 110.28 177.261 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' F' F ' 6' ' ' LEU . . . . . . . . . . . . . 31.0 mt -114.99 148.28 38.99 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 115.486 -0.779 . . . . 0.0 110.242 -179.07 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' F' F ' 7' ' ' LYS . . . . . . . . . . . . . 52.3 tttp -137.2 140.71 31.84 Favored Pre-proline 0 CA--C 1.534 0.34 0 CA-C-O 119.124 -0.465 . . . . 0.0 110.047 175.433 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' F' F ' 8' ' ' PRO . . . . . . . . . . . . . 89.3 Cg_endo -91.85 139.37 2.17 Favored 'Trans proline' 0 N--CA 1.49 1.293 0 C-N-CA 121.736 1.624 . . . . 0.0 111.745 177.898 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' F' F ' 9' ' ' LEU . . . . . . . . . . . . . 46.1 mt -77.68 -47.66 2.34 Favored Pre-proline 0 CA--C 1.534 0.35 0 CA-C-O 118.682 -0.675 . . . . 0.0 112.237 -179.663 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' F' F ' 10' ' ' PRO . . . . . . . . . . . . . 86.2 Cg_endo -80.6 152.93 20.18 Favored 'Trans proline' 0 N--CA 1.495 1.616 0 C-N-CA 121.185 1.257 . . . . 0.0 111.89 176.064 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' F' F ' 11' ' ' LYS . . . . . . . . . . . . . 60.7 tttm -88.8 93.66 9.66 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-O 120.818 0.342 . . . . 0.0 110.456 179.038 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' F' F ' 12' ' ' VAL . . . . . . . . . . . . . 13.0 p -141.38 143.34 27.86 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.231 0 CA-C-N 116.318 -0.401 . . . . 0.0 110.701 -179.525 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' F' F ' 13' ' ' GLU . . . . . . . . . . . . . 45.9 mp0 -77.67 132.83 38.38 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.29 -0.414 . . . . 0.0 110.255 178.065 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' F' F ' 14' ' ' LEU . . . . . . . . . . . . . 31.0 mt -98.37 147.74 33.55 Favored Pre-proline 0 CA--C 1.533 0.307 0 CA-C-O 119.185 -0.436 . . . . 0.0 110.233 -179.738 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' F' F ' 15' ' ' PRO . . . . . . . . . . . . . 25.8 Cg_exo -62.17 158.95 36.94 Favored 'Trans proline' 0 N--CA 1.498 1.741 0 C-N-CA 121.335 1.356 . . . . 0.0 111.876 176.793 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' F' F ' 16' ' ' PRO . . . . . . . . . . . . . 38.7 Cg_exo -58.56 -41.17 67.31 Favored 'Trans proline' 0 N--CA 1.498 1.785 0 C-N-CA 121.497 1.465 . . . . 0.0 112.808 -177.72 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' F' F ' 17' ' ' ASP . . . . . . . . . . . . . 19.2 p-10 -85.71 9.02 17.55 Favored 'General case' 0 C--N 1.326 -0.414 0 N-CA-C 113.23 0.826 . . . . 0.0 113.23 -177.609 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' F' F ' 18' ' ' PHE . . . . . . . . . . . . . 36.7 t80 -58.34 -45.43 88.14 Favored 'General case' 0 C--N 1.333 -0.114 0 O-C-N 121.998 -0.439 . . . . 0.0 110.152 -177.594 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' F' F ' 19' ' ' VAL . . . . . 0.413 HG13 ' N ' ' F' ' 20' ' ' ASP . 13.6 p -56.69 -41.51 74.63 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.329 0 CA-C-N 116.25 -0.432 . . . . 0.0 110.954 -178.738 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' F' F ' 20' ' ' ASP . . . . . 0.413 ' N ' HG13 ' F' ' 19' ' ' VAL . 30.0 m-20 -60.53 -43.5 97.07 Favored 'General case' 0 C--N 1.331 -0.198 0 C-N-CA 120.937 -0.305 . . . . 0.0 111.12 -178.087 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' F' F ' 21' ' ' VAL . . . . . . . . . . . . . 47.0 t -64.58 -46.11 93.52 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.255 0 C-N-CA 120.834 -0.346 . . . . 0.0 110.519 -177.498 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' F' F ' 22' ' ' ILE . . . . . 0.53 HG22 HD12 ' F' ' 26' ' ' LEU . 51.5 mm -57.46 -41.05 77.93 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.288 0 C-N-CA 121.089 -0.244 . . . . 0.0 110.628 179.418 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' F' F ' 23' ' ' ARG . . . . . . . . . . . . . 32.0 ttp180 -56.14 -48.29 76.55 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-O 120.945 0.402 . . . . 0.0 110.718 178.04 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' F' F ' 24' ' ' ILE . . . . . . . . . . . . . 73.0 mt -61.66 -42.48 94.38 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.306 0 CA-C-N 116.014 -0.539 . . . . 0.0 111.941 -177.969 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' F' F ' 25' ' ' LYS . . . . . . . . . . . . . 16.4 pttp -73.58 -35.07 65.4 Favored 'General case' 0 CA--C 1.533 0.314 0 C-N-CA 120.537 -0.465 . . . . 0.0 111.801 -173.326 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' F' F ' 26' ' ' LEU . . . . . 0.53 HD12 HG22 ' F' ' 22' ' ' ILE . 64.5 mt -79.07 -43.06 24.94 Favored 'General case' 0 C--N 1.33 -0.258 0 N-CA-C 112.971 0.73 . . . . 0.0 112.971 -174.528 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' F' F ' 27' ' ' GLN . . . . . . . . . . . . . 10.6 pt20 -46.73 139.67 5.12 Favored 'General case' 0 N--CA 1.469 0.505 0 N-CA-C 112.884 0.698 . . . . 0.0 112.884 -174.54 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' F' F ' 28' ' ' GLY . . . . . . . . . . . . . . . 100.31 -29.99 11.1 Favored Glycine 0 CA--C 1.529 0.948 0 CA-C-N 115.471 -0.786 . . . . 0.0 111.971 -177.915 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' F' F ' 29' ' ' LYS . . . . . . . . . . . . . 98.1 mttt -98.09 155.2 17.25 Favored 'General case' 0 C--O 1.233 0.19 0 CA-C-O 121.061 0.458 . . . . 0.0 111.035 177.988 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' F' F ' 30' ' ' THR . . . . . . . . . . . . . 23.9 m -103.91 139.43 39.09 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.019 -0.537 . . . . 0.0 109.994 175.816 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' F' F ' 31' ' ' VAL . . . . . . . . . . . . . 34.9 m -127.34 157.61 38.93 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.288 0 CA-C-N 116.254 -0.43 . . . . 0.0 110.514 -179.125 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' F' F ' 32' ' ' ARG . . . . . . . . . . . . . 56.3 ttp180 -133.77 151.92 51.73 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-O 121.178 0.514 . . . . 0.0 110.612 179.569 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' F' F ' 33' ' ' THR . . . . . . . . . . . . . 20.7 m -53.09 138.43 31.06 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 116.221 -0.445 . . . . 0.0 111.406 -178.489 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' F' F ' 34' ' ' GLY . . . . . . . . . . . . . . . 100.84 -17.08 56.9 Favored Glycine 0 CA--C 1.534 1.223 0 CA-C-O 119.584 -0.565 . . . . 0.0 113.262 179.16 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' F' F ' 35' ' ' ASP . . . . . . . . . . . . . 63.2 m-20 -65.13 149.45 49.88 Favored 'General case' 0 N--CA 1.461 0.096 0 CA-C-N 118.006 0.903 . . . . 0.0 111.308 179.602 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' F' F ' 36' ' ' VAL . . . . . . . . . . . . . 45.8 t -125.15 129.63 73.2 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.196 0 CA-C-N 115.686 -0.688 . . . . 0.0 109.71 178.399 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' F' F ' 37' ' ' ILE . . . . . . . . . . . . . 68.4 mt -122.29 138.92 50.85 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.265 0 N-CA-C 109.839 -0.43 . . . . 0.0 109.839 -179.948 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' F' F ' 38' ' ' GLY . . . . . . . . . . . . . . . -111.07 128.87 8.93 Favored Glycine 0 CA--C 1.524 0.654 0 N-CA-C 111.191 -0.764 . . . . 0.0 111.191 -179.372 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' F' F ' 39' ' ' ILE . . . . . . . . . . . . . 72.4 mt -122.57 136.47 59.28 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.215 0 N-CA-C 109.902 -0.407 . . . . 0.0 109.902 179.014 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' F' F ' 40' ' ' SER . . . . . 0.518 ' O ' HD13 ' F' ' 41' ' ' ILE . 21.8 t -92.74 118.32 30.95 Favored 'General case' 0 C--N 1.33 -0.25 0 C-N-CA 120.956 -0.298 . . . . 0.0 110.802 176.26 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' F' F ' 41' ' ' ILE . . . . . 0.518 HD13 ' O ' ' F' ' 40' ' ' SER . 47.8 mm -128.77 115.77 38.38 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.207 0 CA-C-O 120.811 0.339 . . . . 0.0 110.273 178.331 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' F' F ' 42' ' ' LEU . . . . . . . . . . . . . 11.4 tp 57.14 37.16 28.34 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 116.137 -0.483 . . . . 0.0 111.386 178.428 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' F' F ' 43' ' ' GLY . . . . . . . . . . . . . . . 77.67 -10.09 26.21 Favored Glycine 0 CA--C 1.534 1.268 0 C-N-CA 121.316 -0.469 . . . . 0.0 113.5 177.074 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' F' F ' 44' ' ' LYS . . . . . . . . . . . . . 38.7 mmtm -97.52 135.5 39.27 Favored 'General case' 0 C--N 1.332 -0.193 0 CA-C-N 117.966 0.883 . . . . 0.0 110.17 177.277 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' F' F ' 45' ' ' GLU . . . . . . . . . . . . . 82.7 tt0 -84.65 125.99 32.96 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.358 -0.383 . . . . 0.0 110.819 179.873 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' F' F ' 46' ' ' VAL . . . . . . . . . . . . . 7.3 p -119.34 126.44 75.34 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.159 0 N-CA-C 109.437 -0.579 . . . . 0.0 109.437 176.135 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' F' F ' 47' ' ' LYS . . . . . . . . . . . . . 60.4 mttp -100.1 127.46 46.33 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 115.865 -0.607 . . . . 0.0 111.007 178.806 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' F' F ' 48' ' ' PHE . . . . . . . . . . . . . 93.9 m-85 -109.89 131.91 54.64 Favored 'General case' 0 C--N 1.33 -0.262 0 N-CA-C 109.817 -0.438 . . . . 0.0 109.817 175.925 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' F' F ' 49' ' ' LYS . . . . . . . . . . . . . 53.7 tttp -108.44 138.83 44.09 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.406 -0.361 . . . . 0.0 110.349 179.128 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' F' F ' 50' ' ' VAL . . . . . . . . . . . . . 45.2 t -81.77 108.69 15.13 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.257 0 N-CA-C 109.384 -0.598 . . . . 0.0 109.384 176.226 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' F' F ' 51' ' ' VAL . . . . . . . . . . . . . 48.5 t -74.89 -48.06 34.66 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.276 0 CA-C-N 115.988 -0.551 . . . . 0.0 110.068 -174.015 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' F' F ' 52' ' ' GLN . . . . . . . . . . . . . 62.6 tt0 -158.7 133.94 8.52 Favored 'General case' 0 C--N 1.331 -0.23 0 C-N-CA 120.241 -0.584 . . . . 0.0 111.811 -177.518 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' F' F ' 53' ' ' ALA . . . . . 0.481 ' HB1' ' HB2' ' F' ' 58' ' ' LEU . . . -108.22 127.29 53.71 Favored 'General case' 0 C--N 1.332 -0.185 0 CA-C-N 115.667 -0.697 . . . . 0.0 109.644 174.395 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' F' F ' 54' ' ' TYR . . . . . . . . . . . . . 56.5 t80 -123.38 107.45 32.24 Favored Pre-proline 0 CA--C 1.534 0.346 0 CA-C-O 118.304 -0.855 . . . . 0.0 110.643 -178.606 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' F' F ' 55' ' ' PRO . . . . . . . . . . . . . 74.0 Cg_endo -76.96 169.86 73.28 Favored 'Cis proline' 0 N--CA 1.5 1.887 0 CA-C-N 121.725 1.652 . . . . 0.0 112.434 -5.681 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' F' F ' 56' ' ' SER . . . . . . . . . . . . . 25.1 m -108.52 124.55 34.1 Favored Pre-proline 0 CA--C 1.538 0.51 0 CA-C-O 118.372 -0.823 . . . . 0.0 109.561 175.819 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' F' F ' 57' ' ' PRO . . . . . . . . . . . . . 48.1 Cg_endo -70.19 166.66 74.6 Favored 'Cis proline' 0 N--CA 1.498 1.771 0 CA-C-N 122.106 1.788 . . . . 0.0 111.824 0.391 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' F' F ' 58' ' ' LEU . . . . . 0.481 ' HB2' ' HB1' ' F' ' 53' ' ' ALA . 24.2 tp -129.09 135.37 48.81 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.137 -0.483 . . . . 0.0 110.296 -179.926 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' F' F ' 59' ' ' ARG . . . . . . . . . . . . . 52.1 ttp180 -104.56 131.87 51.46 Favored 'General case' 0 C--N 1.327 -0.4 0 N-CA-C 109.68 -0.489 . . . . 0.0 109.68 178.749 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' F' F ' 60' ' ' VAL . . . . . . . . . . . . . 45.3 t -86.2 123.22 39.45 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.214 0 C-N-CA 120.671 -0.411 . . . . 0.0 110.404 -175.469 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' F' F ' 61' ' ' GLU . . . . . . . . . . . . . 95.3 mt-10 -131.06 166.26 21.43 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 115.942 -0.572 . . . . 0.0 110.14 177.806 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' F' F ' 62' ' ' ASP . . . . . . . . . . . . . 64.0 m-20 -54.92 -32.75 61.5 Favored 'General case' 0 C--N 1.327 -0.382 0 C-N-CA 121.096 -0.242 . . . . 0.0 111.604 179.536 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' F' F ' 63' ' ' ARG . . . . . . . . . . . . . 10.3 ptm180 -87.78 6.91 32.88 Favored 'General case' 0 CA--C 1.537 0.446 0 N-CA-C 113.59 0.959 . . . . 0.0 113.59 -176.73 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' F' F ' 64' ' ' THR . . . . . . . . . . . . . 11.8 m -82.41 139.98 33.72 Favored 'General case' 0 C--N 1.333 -0.137 0 CA-C-N 118.051 0.387 . . . . 0.0 110.655 -177.967 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' F' F ' 65' ' ' LYS . . . . . . . . . . . . . 97.9 mttt -89.15 125.05 34.89 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.085 179.21 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' F' F ' 66' ' ' ILE . . . . . . . . . . . . . 59.4 mt -116.36 127.93 73.83 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.262 0 N-CA-C 109.679 -0.489 . . . . 0.0 109.679 179.0 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' F' F ' 67' ' ' THR . . . . . . . . . . . . . 25.1 m -129.13 145.63 51.25 Favored 'General case' 0 C--N 1.331 -0.214 0 CA-C-O 121.112 0.482 . . . . 0.0 111.42 -176.658 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' F' F ' 68' ' ' LEU . . . . . . . . . . . . . 15.5 tp -95.09 120.58 35.55 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 115.79 -0.641 . . . . 0.0 109.527 175.899 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' F' F ' 69' ' ' VAL . . . . . . . . . . . . . 40.1 t -103.85 139.68 24.13 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 CA-C-O 121.046 0.451 . . . . 0.0 111.181 -173.847 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' F' F ' 70' ' ' THR . . . . . . . . . . . . . 47.2 m -102.59 134.95 45.11 Favored 'General case' 0 C--N 1.328 -0.341 0 N-CA-C 109.068 -0.715 . . . . 0.0 109.068 172.542 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' F' F ' 71' ' ' HIS . . . . . . . . . . . . . 65.1 m-70 -126.48 165.2 29.54 Favored Pre-proline 0 N--CA 1.464 0.264 0 N-CA-C 111.845 0.313 . . . . 0.0 111.845 -174.499 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' F' F ' 72' ' ' PRO . . . . . . . . . . . . . 8.1 Cg_exo -68.34 160.19 50.09 Favored 'Trans proline' 0 N--CA 1.495 1.607 0 C-N-CA 121.782 1.655 . . . . 0.0 112.07 177.915 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' F' F ' 73' ' ' VAL . . . . . . . . . . . . . 35.8 m -69.9 -174.1 0.11 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.312 0 N-CA-C 109.694 -0.484 . . . . 0.0 109.694 178.928 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' F' F ' 74' ' ' ASP . . . . . . . . . . . . . 7.2 t70 -90.64 115.17 27.54 Favored 'General case' 0 C--N 1.331 -0.226 0 C-N-CA 120.645 -0.422 . . . . 0.0 110.31 -173.593 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' F' F ' 75' ' ' VAL . . . . . . . . . . . . . 44.5 t -114.89 120.45 64.55 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.228 0 CA-C-O 121.038 0.447 . . . . 0.0 110.085 -179.272 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' F' F ' 76' ' ' LEU . . . . . . . . . . . . . 20.6 mt -124.47 144.29 50.17 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 115.662 -0.699 . . . . 0.0 109.717 179.34 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' F' F ' 77' ' ' GLU . . . . . . . . . . . . . 46.6 mt-10 -134.11 135.86 43.48 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-O 121.073 0.463 . . . . 0.0 111.286 -177.761 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' F' F ' 78' ' ' ALA . . . . . . . . . . . . . . . -122.64 127.71 49.7 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 115.483 -0.78 . . . . 0.0 109.457 175.712 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' F' F ' 79' ' ' LYS . . . . . 0.651 ' O ' HD13 ' F' ' 80' ' ' ILE . 37.7 tttp -79.79 120.29 23.86 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-O 120.993 0.425 . . . . 0.0 110.828 -175.785 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' F' F ' 80' ' ' ILE . . . . . 0.651 HD13 ' O ' ' F' ' 79' ' ' LYS . 37.5 mm -139.3 108.85 3.84 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.291 0 N-CA-C 108.983 -0.747 . . . . 0.0 108.983 -179.289 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' F' F ' 81' ' ' LYS . . . . . . . . . . . . . 39.7 ttpt -99.26 123.69 43.74 Favored 'General case' 0 C--N 1.329 -0.298 0 C-N-CA 120.862 -0.335 . . . . 0.0 110.97 -176.236 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' F' F ' 82' ' ' GLY . . . . . . . . . . . . . . . 89.21 42.18 5.64 Favored Glycine 0 CA--C 1.525 0.708 0 C-N-CA 120.7 -0.762 . . . . 0.0 111.677 176.368 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' F' F ' 83' ' ' ILE . . . . . . . . . . . . . 75.3 mt -67.2 140.31 19.57 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.338 0 N-CA-C 109.875 -0.417 . . . . 0.0 109.875 177.603 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' F' F ' 84' ' ' LYS . . . . . . . . . . . . . 47.0 tttp -100.82 -53.94 2.94 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.029 -0.532 . . . . 0.0 110.654 -178.644 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' F' F ' 85' ' ' ASP . . . . . . . . . . . . . 13.5 t70 -146.22 149.43 33.9 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 115.916 -0.584 . . . . 0.0 110.705 -178.095 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' F' F ' 86' ' ' VAL . . . . . . . . . . . . . 41.3 t -128.51 127.56 67.09 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.221 0 CA-C-O 120.815 0.341 . . . . 0.0 110.364 -179.782 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' F' F ' 87' ' ' ILE . . . . . . . . . . . . . 44.4 mm -120.84 130.39 74.67 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.223 0 CA-C-N 116.071 -0.513 . . . . 0.0 109.923 178.674 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' F' F ' 88' ' ' LEU . . . . . . . . . . . . . 27.1 mt -115.47 137.4 52.09 Favored 'General case' 0 C--N 1.332 -0.182 0 CA-C-O 120.951 0.405 . . . . 0.0 111.069 -178.946 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' F' F ' 89' ' ' ASP . . . . . . . . . . . . . 7.4 t70 -135.31 162.19 33.28 Favored 'General case' 0 C--N 1.331 -0.239 0 CA-C-N 115.999 -0.546 . . . . 0.0 110.084 177.335 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' F' F ' 90' ' ' GLU . . . . . . . . . . . . . 96.4 mt-10 -45.15 -48.14 12.27 Favored 'General case' 0 N--CA 1.465 0.307 0 N-CA-C 113.149 0.796 . . . . 0.0 113.149 -171.263 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' F' F ' 91' ' ' ASN . . . . . . . . . . . . . 21.0 t-20 -132.04 39.91 3.39 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-O 120.974 0.416 . . . . 0.0 110.861 -177.606 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' F' F ' 92' ' ' LEU . . . . . . . . . . . . . 10.7 tp -163.45 138.01 6.14 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.355 -0.384 . . . . 0.0 110.89 -177.539 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' F' F ' 93' ' ' ILE . . . . . . . . . . . . . 69.0 mt -122.3 124.81 71.79 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.311 0 N-CA-C 109.226 -0.657 . . . . 0.0 109.226 177.29 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' F' F ' 94' ' ' VAL . . . . . . . . . . . . . 45.8 t -123.54 128.62 74.68 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.258 0 CA-C-O 120.983 0.42 . . . . 0.0 110.069 -178.931 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' F' F ' 95' ' ' VAL . . . . . . . . . . . . . 44.4 t -121.58 134.76 63.89 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.314 0 CA-C-N 115.921 -0.581 . . . . 0.0 109.724 178.958 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' F' F ' 96' ' ' ILE . . . . . . . . . . . . . 61.6 mt -114.47 127.71 71.83 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.354 0 N-CA-C 109.146 -0.687 . . . . 0.0 109.146 178.493 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' F' F ' 97' ' ' THR . . . . . . . . . . . . . 58.3 p -98.5 159.5 14.91 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-O 121.102 0.477 . . . . 0.0 111.177 -177.498 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' F' F ' 98' ' ' GLU . . . . . . . . . . . . . 80.4 tt0 -53.88 -28.16 34.55 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.171 -0.468 . . . . 0.0 112.092 -179.622 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' F' F ' 99' ' ' GLU . . . . . . . . . . . . . 95.6 mt-10 -79.96 16.5 1.17 Allowed 'General case' 0 CA--C 1.535 0.392 0 N-CA-C 113.043 0.757 . . . . 0.0 113.043 -177.263 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' F' F ' 100' ' ' ASN . . . . . . . . . . . . . 4.2 m-20 62.48 38.04 12.95 Favored 'General case' 0 CA--C 1.53 0.198 0 CA-C-O 121.009 0.433 . . . . 0.0 111.072 177.757 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' F' F ' 101' ' ' GLU . . . . . . . . . . . . . 83.6 tt0 -111.8 144.05 41.74 Favored 'General case' 0 C--N 1.332 -0.186 0 CA-C-N 116.004 -0.544 . . . . 0.0 109.775 175.891 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' F' F ' 102' ' ' VAL . . . . . . . . . . . . . 42.7 t -115.02 125.09 72.24 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.293 0 N-CA-C 109.798 -0.445 . . . . 0.0 109.798 -178.67 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' F' F ' 103' ' ' LEU . . . . . . . . . . . . . 44.1 mt -118.3 131.63 56.33 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 115.725 -0.67 . . . . 0.0 110.046 178.395 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' F' F ' 104' ' ' ILE . . . . . 0.614 HD13 HG11 ' F' ' 130' ' ' VAL . 67.3 mt -121.09 123.09 69.25 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.245 0 CA-C-O 120.66 0.266 . . . . 0.0 110.374 -179.787 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' F' F ' 105' ' ' PHE . . . . . . . . . . . . . 48.7 m-85 -123.95 167.42 14.17 Favored 'General case' 0 C--N 1.333 -0.122 0 CA-C-N 115.358 -0.837 . . . . 0.0 109.885 178.931 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' F' F ' 106' ' ' ASN . . . . . . . . . . . . . 36.8 p-10 -98.74 -169.97 1.86 Allowed 'General case' 0 C--N 1.331 -0.207 0 N-CA-C 109.866 -0.42 . . . . 0.0 109.866 172.919 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' F' F ' 107' ' ' GLN . . . . . . . . . . . . . 49.2 tt0 -58.6 -30.08 66.94 Favored 'General case' 0 C--N 1.329 -0.31 0 N-CA-C 112.048 0.388 . . . . 0.0 112.048 -179.339 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' F' F ' 108' ' ' ASN . . . . . . . . . . . . . 5.7 t30 -91.33 14.01 15.77 Favored 'General case' 0 CA--C 1.535 0.394 0 N-CA-C 113.153 0.797 . . . . 0.0 113.153 -176.631 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' F' F ' 109' ' ' LEU . . . . . . . . . . . . . 30.7 mt 59.25 34.61 23.12 Favored 'General case' 0 C--N 1.332 -0.167 0 N-CA-C 111.992 0.367 . . . . 0.0 111.992 177.019 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' F' F ' 110' ' ' GLU . . . . . . . . . . . . . 95.9 mt-10 -98.64 136.37 38.81 Favored 'General case' 0 C--N 1.328 -0.338 0 N-CA-C 109.049 -0.723 . . . . 0.0 109.049 173.187 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' F' F ' 111' ' ' GLU . . . . . . . . . . . . . 56.1 tt0 -78.64 121.9 25.27 Favored 'General case' 0 C--N 1.327 -0.401 0 CA-C-O 120.898 0.38 . . . . 0.0 110.743 -173.727 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' F' F ' 112' ' ' LEU . . . . . . . . . . . . . 15.3 mt -103.73 -45.97 4.65 Favored 'General case' 0 C--N 1.331 -0.204 0 CA-C-N 115.868 -0.606 . . . . 0.0 110.703 179.574 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' F' F ' 113' ' ' TYR . . . . . . . . . . . . . 44.5 t80 -136.26 141.88 43.93 Favored 'General case' 0 C--N 1.331 -0.239 0 CA-C-N 116.193 -0.458 . . . . 0.0 111.181 -177.174 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' F' F ' 114' ' ' ARG . . . . . . . . . . . . . 32.3 ptt180 -147.06 123.25 10.86 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.107 -0.497 . . . . 0.0 110.826 176.893 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' F' F ' 115' ' ' GLY . . . . . . . . . . . . . . . -150.09 163.02 29.37 Favored Glycine 0 CA--C 1.523 0.554 0 N-CA-C 110.789 -0.924 . . . . 0.0 110.789 179.472 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' F' F ' 116' ' ' LYS . . . . . . . . . . . . . 38.3 ttpt -130.17 135.77 48.54 Favored 'General case' 0 C--N 1.329 -0.295 0 O-C-N 122.627 -0.337 . . . . 0.0 110.123 179.066 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' F' F ' 117' ' ' PHE . . . . . . . . . . . . . 48.6 m-85 -133.58 114.85 14.01 Favored 'General case' 0 C--N 1.331 -0.206 0 CA-C-O 120.967 0.413 . . . . 0.0 110.176 -176.95 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' F' F ' 118' ' ' GLU . . . . . . . . . . . . . 70.6 mm-40 -54.54 -41.1 69.34 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 116.412 -0.358 . . . . 0.0 111.371 -176.319 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' F' F ' 119' ' ' ASN . . . . . . . . . . . . . 85.6 m-20 -100.73 31.04 3.68 Favored 'General case' 0 C--N 1.33 -0.276 0 N-CA-C 112.176 0.435 . . . . 0.0 112.176 -173.919 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' F' F ' 120' ' ' LEU . . . . . . . . . . . . . 15.0 tp -56.59 119.92 6.91 Favored 'General case' 0 C--N 1.332 -0.19 0 CA-C-O 120.707 0.289 . . . . 0.0 110.379 178.254 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' F' F ' 121' ' ' ASN . . . . . . . . . . . . . 72.9 m-20 -114.15 -44.13 3.16 Favored 'General case' 0 C--N 1.333 -0.141 0 CA-C-N 116.368 -0.378 . . . . 0.0 111.282 -177.647 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' F' F ' 122' ' ' LYS . . . . . . . . . . . . . 53.4 mtmt -145.3 151.27 38.08 Favored 'General case' 0 C--N 1.331 -0.239 0 CA-C-O 121.042 0.449 . . . . 0.0 111.749 -176.234 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' F' F ' 123' ' ' VAL . . . . . . . . . . . . . 46.7 t -130.8 127.97 62.3 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.235 0 CA-C-N 116.01 -0.541 . . . . 0.0 109.545 174.697 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' F' F ' 124' ' ' LEU . . . . . . . . . . . . . 41.2 mt -115.99 136.99 52.52 Favored 'General case' 0 C--N 1.331 -0.196 0 CA-C-N 116.307 -0.406 . . . . 0.0 110.709 -178.736 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' F' F ' 125' ' ' VAL . . . . . . . . . . . . . 35.1 m -128.43 138.16 55.4 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.209 0 CA-C-N 116.265 -0.425 . . . . 0.0 110.817 -179.359 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' F' F ' 126' ' ' ARG . . . . . . . . . . . . . 96.3 mtt-85 -143.9 111.44 5.98 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.102 -0.499 . . . . 0.0 110.38 177.155 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' F' F ' 127' ' ' ASN . . . . . . . . . . . . . 79.1 m-20 53.13 -104.95 0.22 Allowed 'General case' 0 CA--C 1.544 0.722 0 CA-C-O 119.122 -0.466 . . . . 0.0 111.057 -179.847 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' F' F ' 128' ' ' ASP . . . . . . . . . . . . . 12.3 p-10 -113.98 0.17 14.28 Favored 'General case' 0 CA--C 1.536 0.434 0 CA-C-N 119.509 1.049 . . . . 0.0 113.386 -177.531 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' F' F ' 129' ' ' LEU . . . . . 0.458 HD12 ' N ' ' F' ' 129' ' ' LEU . 9.9 mp -105.0 147.84 27.38 Favored 'General case' 0 CA--C 1.523 -0.096 0 N-CA-C 109.669 -0.493 . . . . 0.0 109.669 177.842 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' F' F ' 130' ' ' VAL . . . . . 0.614 HG11 HD13 ' F' ' 104' ' ' ILE . 13.1 p -137.37 145.19 29.88 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.245 0 CA-C-O 121.23 0.538 . . . . 0.0 110.87 -176.757 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' F' F ' 131' ' ' VAL . . . . . . . . . . . . . 44.1 t -134.61 136.97 51.97 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.294 0 CA-C-N 115.722 -0.672 . . . . 0.0 109.869 178.079 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' F' F ' 132' ' ' ILE . . . . . . . . . . . . . 71.1 mt -114.18 132.2 63.92 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.335 0 N-CA-C 109.452 -0.573 . . . . 0.0 109.452 -178.825 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' F' F ' 133' ' ' ILE . . . . . . . . . . . . . 43.0 mm -117.77 121.8 68.28 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.27 0 CA-C-O 120.791 0.329 . . . . 0.0 110.621 -176.041 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' F' F ' 134' ' ' ASP . . . . . . . . . . . . . 7.1 p-10 -132.38 148.56 52.42 Favored 'General case' 0 C--N 1.33 -0.249 0 N-CA-C 109.578 -0.527 . . . . 0.0 109.578 174.934 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' F' F ' 135' ' ' GLU . . . . . . . . . . . . . 32.3 tp10 -49.9 -24.4 2.48 Favored 'General case' 0 C--N 1.328 -0.328 0 N-CA-C 112.943 0.72 . . . . 0.0 112.943 -169.775 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' F' F ' 136' ' ' GLN . . . . . . . . . . . . . 60.7 tt0 -105.02 -26.42 12.15 Favored 'General case' 0 N--CA 1.466 0.327 0 N-CA-C 112.748 0.647 . . . . 0.0 112.748 -174.637 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' F' F ' 137' ' ' LYS . . . . . . . . . . . . . 77.3 mttt -141.7 154.0 45.02 Favored 'General case' 0 C--N 1.331 -0.198 0 CA-C-O 121.252 0.549 . . . . 0.0 111.798 -171.731 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' F' F ' 138' ' ' LEU . . . . . 0.41 HD23 ' C ' ' F' ' 138' ' ' LEU . 6.1 tt -120.29 124.97 46.9 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 115.616 -0.72 . . . . 0.0 109.299 173.765 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' F' F ' 139' ' ' THR . . . . . . . . . . . . . 31.1 m -114.21 129.83 56.63 Favored 'General case' 0 C--N 1.332 -0.191 0 CA-C-N 116.385 -0.37 . . . . 0.0 110.757 -177.362 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' F' F ' 140' ' ' LEU . . . . . 0.475 HD23 ' C ' ' F' ' 140' ' ' LEU . 7.4 tt -116.87 121.53 41.75 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 115.686 -0.688 . . . . 0.0 109.387 -179.119 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' F' F ' 141' ' ' ILE . . . . . 0.424 ' HB ' HG13 ' F' ' 130' ' ' VAL . 19.0 mt -121.37 118.5 56.2 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.253 0 N-CA-C 109.778 -0.453 . . . . 0.0 109.778 -176.764 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' F' F ' 142' ' ' ARG . . . . . . . . . . . . . 61.7 ttt180 -110.87 127.77 55.55 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 115.5 -0.773 . . . . 0.0 110.403 -176.86 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' F' F ' 143' ' ' THR . . . . . . . . . . . . . 42.3 p . . . . . 0 C--O 1.22 -0.458 0 CA-C-O 117.989 -1.005 . . . . 0.0 110.66 -179.706 . . . . . . . . 0 0 . 1 . 014 nuclear nobuild full ' A' A ' -3' ' ' GLU . . . . . . . . . . . . . 95.8 mt-10 . . . . . 0 N--CA 1.491 1.606 0 N-CA-C 109.269 -0.641 . . . . 0.0 109.269 . . . . . . . . . 0 0 . 1 . 014 nuclear nobuild full ' A' A ' -2' ' ' GLY . . . . . . . . . . . . . . . -65.78 141.06 41.39 Favored Glycine 0 CA--C 1.526 0.723 0 N-CA-C 110.777 -0.929 . . . . 0.0 110.777 179.359 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' -1' ' ' VAL . . . . . . . . . . . . . 46.3 t -96.24 137.68 23.55 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.305 0 N-CA-C 109.83 -0.433 . . . . 0.0 109.83 179.742 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 0' ' ' ILE . . . . . . . . . . . . . 70.3 mt -104.17 132.23 51.17 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.288 0 CA-C-N 116.151 -0.477 . . . . 0.0 110.204 -177.649 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 25.8 ptt? -81.7 170.49 15.71 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.003 -0.544 . . . . 0.0 110.526 179.343 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 41.1 p -118.8 148.57 42.7 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-N 116.252 -0.431 . . . . 0.0 110.485 -179.369 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 95.2 mt-10 -140.54 142.71 35.16 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.174 -0.466 . . . . 0.0 111.243 -178.162 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 4' ' ' LEU . . . . . 0.648 HD21 HD23 ' A' ' 58' ' ' LEU . 56.0 mt -119.73 130.1 54.83 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 115.819 -0.628 . . . . 0.0 110.317 175.319 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 5' ' ' LYS . . . . . . . . . . . . . 67.1 mttm -107.38 120.57 42.52 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.306 -0.406 . . . . 0.0 110.436 177.242 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 73.9 mt -116.82 150.81 37.74 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 115.532 -0.758 . . . . 0.0 110.378 -179.238 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 74.8 tttt -140.69 139.11 19.33 Favored Pre-proline 0 CA--C 1.534 0.335 0 CA-C-O 119.167 -0.444 . . . . 0.0 110.092 175.594 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 8' ' ' PRO . . . . . . . . . . . . . 86.4 Cg_endo -91.76 140.99 2.52 Favored 'Trans proline' 0 N--CA 1.49 1.267 0 C-N-CA 121.733 1.622 . . . . 0.0 111.672 176.971 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 68.8 mt -74.05 -47.93 6.22 Favored Pre-proline 0 C--N 1.328 -0.348 0 CA-C-O 118.622 -0.704 . . . . 0.0 112.243 -178.473 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 89.0 Cg_endo -80.76 146.36 16.58 Favored 'Trans proline' 0 N--CA 1.495 1.614 0 C-N-CA 121.211 1.274 . . . . 0.0 111.931 176.419 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 63.3 mttm -85.8 95.82 9.55 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-O 120.943 0.401 . . . . 0.0 110.416 178.234 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 11.7 p -139.87 149.23 22.34 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.277 0 CA-C-N 115.894 -0.594 . . . . 0.0 110.348 -179.465 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 45.5 tp10 -87.25 122.21 30.73 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 116.337 -0.392 . . . . 0.0 110.322 178.966 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 14' ' ' LEU . . . . . . . . . . . . . 44.7 mt -97.91 157.65 34.23 Favored Pre-proline 0 C--N 1.329 -0.296 0 CA-C-N 116.163 -0.471 . . . . 0.0 110.861 -179.188 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 15' ' ' PRO . . . . . . . . . . . . . 36.9 Cg_exo -59.56 158.31 28.26 Favored 'Trans proline' 0 N--CA 1.496 1.663 0 C-N-CA 121.413 1.408 . . . . 0.0 111.875 178.719 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 16' ' ' PRO . . . . . . . . . . . . . 33.4 Cg_exo -59.2 -42.65 48.27 Favored 'Trans proline' 0 N--CA 1.496 1.649 0 C-N-CA 121.516 1.478 . . . . 0.0 112.84 -177.606 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 17' ' ' ASP . . . . . . . . . . . . . 7.9 p-10 -87.43 13.42 10.01 Favored 'General case' 0 CA--C 1.536 0.414 0 N-CA-C 113.072 0.767 . . . . 0.0 113.072 -177.06 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 18' ' ' PHE . . . . . . . . . . . . . 42.0 t80 -57.16 -45.45 83.61 Favored 'General case' 0 C--N 1.334 -0.088 0 O-C-N 122.041 -0.412 . . . . 0.0 110.238 -178.994 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 19' ' ' VAL . . . . . . . . . . . . . 47.0 t -57.43 -43.37 82.53 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.262 0 CA-C-N 116.154 -0.475 . . . . 0.0 110.378 -178.451 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 32.0 m-20 -59.1 -41.96 89.37 Favored 'General case' 0 C--N 1.331 -0.224 0 C-N-CA 120.916 -0.314 . . . . 0.0 111.082 -177.634 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 46.9 t -64.55 -44.46 96.83 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.264 0 C-N-CA 120.709 -0.396 . . . . 0.0 110.427 -178.372 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 22' ' ' ILE . . . . . 0.582 HG22 HD12 ' A' ' 26' ' ' LEU . 50.9 mm -56.94 -40.14 70.11 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 C-N-CA 120.987 -0.285 . . . . 0.0 110.567 178.709 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 23' ' ' ARG . . . . . . . . . . . . . 53.4 ttp180 -57.13 -48.88 77.58 Favored 'General case' 0 C--N 1.331 -0.214 0 CA-C-O 121.018 0.437 . . . . 0.0 110.468 177.136 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 24' ' ' ILE . . . . . . . . . . . . . 72.7 mt -61.15 -39.5 82.63 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.324 0 CA-C-N 115.839 -0.619 . . . . 0.0 111.944 -177.089 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 16.6 pttp -77.35 -36.07 54.1 Favored 'General case' 0 CA--C 1.535 0.389 0 C-N-CA 120.537 -0.465 . . . . 0.0 111.806 -174.218 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 26' ' ' LEU . . . . . 0.582 HD12 HG22 ' A' ' 22' ' ' ILE . 83.4 mt -77.89 -38.55 45.57 Favored 'General case' 0 C--N 1.33 -0.275 0 N-CA-C 112.979 0.733 . . . . 0.0 112.979 -173.304 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 27' ' ' GLN . . . . . . . . . . . . . 10.1 pt20 -46.92 139.84 5.23 Favored 'General case' 0 N--CA 1.469 0.48 0 N-CA-C 112.867 0.691 . . . . 0.0 112.867 -175.265 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 100.77 -27.76 19.06 Favored Glycine 0 CA--C 1.532 1.122 0 CA-C-N 115.573 -0.739 . . . . 0.0 112.166 -177.544 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 38.0 mmtm -97.84 155.12 17.2 Favored 'General case' 0 C--O 1.232 0.169 0 CA-C-N 117.202 0.501 . . . . 0.0 111.095 178.159 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 30' ' ' THR . . . . . . . . . . . . . 32.3 m -98.92 137.0 38.11 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.107 -0.497 . . . . 0.0 109.884 175.55 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 34.7 m -126.44 151.73 33.27 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.222 0 CA-C-O 120.826 0.346 . . . . 0.0 110.655 -179.296 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 32' ' ' ARG . . . . . . . . . . . . . 76.2 ttt-85 -136.09 149.12 48.58 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.089 -0.505 . . . . 0.0 110.448 178.59 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 33' ' ' THR . . . . . . . . . . . . . 32.1 m -52.92 139.81 26.4 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.386 -0.37 . . . . 0.0 111.301 -178.448 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 100.87 -17.17 56.74 Favored Glycine 0 CA--C 1.533 1.172 0 CA-C-O 119.744 -0.476 . . . . 0.0 113.218 179.644 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 76.7 m-20 -66.69 147.94 52.59 Favored 'General case' 0 N--CA 1.461 0.099 0 CA-C-N 118.028 0.914 . . . . 0.0 111.149 178.728 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 44.6 t -124.25 130.15 73.78 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.197 0 CA-C-N 115.882 -0.599 . . . . 0.0 109.8 178.02 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 37' ' ' ILE . . . . . . . . . . . . . 66.7 mt -122.37 139.65 48.66 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.234 0 CA-C-N 116.266 -0.425 . . . . 0.0 110.126 -179.019 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . -110.18 128.78 9.02 Favored Glycine 0 CA--C 1.526 0.74 0 N-CA-C 111.053 -0.819 . . . . 0.0 111.053 179.586 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 39' ' ' ILE . . . . . . . . . . . . . 73.7 mt -123.87 135.09 64.65 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.171 0 N-CA-C 110.247 -0.279 . . . . 0.0 110.247 179.585 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 40' ' ' SER . . . . . 0.511 ' O ' HD13 ' A' ' 41' ' ' ILE . 96.6 p -92.97 120.94 33.81 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.398 -0.365 . . . . 0.0 110.984 176.07 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 41' ' ' ILE . . . . . 0.511 HD13 ' O ' ' A' ' 40' ' ' SER . 48.1 mm -128.62 115.06 35.92 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.187 0 CA-C-O 120.834 0.35 . . . . 0.0 110.371 177.698 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 42' ' ' LEU . . . . . 0.549 ' O ' HD23 ' A' ' 42' ' ' LEU . 1.3 tt 54.52 44.47 28.71 Favored 'General case' 0 CA--C 1.532 0.251 0 CA-C-O 121.392 0.615 . . . . 0.0 110.546 177.636 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . 70.64 16.28 73.96 Favored Glycine 0 CA--C 1.534 1.278 0 C-N-CA 121.093 -0.575 . . . . 0.0 113.12 175.469 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 44' ' ' LYS . . . . . . . . . . . . . 58.5 mtpt -124.05 132.61 53.7 Favored 'General case' 0 C--N 1.332 -0.17 0 CA-C-N 117.765 0.783 . . . . 0.0 109.902 179.413 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 84.8 tt0 -84.46 123.28 30.07 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 116.444 -0.344 . . . . 0.0 111.115 -179.156 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 46' ' ' VAL . . . . . . . . . . . . . 7.3 p -121.64 128.49 75.8 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.244 0 N-CA-C 109.333 -0.617 . . . . 0.0 109.333 175.731 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 66.6 mttm -100.77 128.58 46.76 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.099 -0.5 . . . . 0.0 111.259 178.602 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 48' ' ' PHE . . . . . . . . . . . . . 93.1 m-85 -110.81 131.79 54.75 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-N 116.129 -0.487 . . . . 0.0 109.811 175.603 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 78.5 tttt -108.61 137.41 46.6 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 116.314 -0.403 . . . . 0.0 110.382 179.342 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 50' ' ' VAL . . . . . . . . . . . . . 45.8 t -79.95 109.72 14.79 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.366 0 N-CA-C 109.275 -0.639 . . . . 0.0 109.275 176.326 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 51' ' ' VAL . . . . . . . . . . . . . 55.9 t -71.47 -47.31 59.39 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.324 0 CA-C-N 116.055 -0.521 . . . . 0.0 109.895 -173.795 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 52' ' ' GLN . . . . . . . . . . . . . 61.6 tt0 -171.14 142.14 1.74 Allowed 'General case' 0 C--N 1.33 -0.244 0 C-N-CA 120.145 -0.622 . . . . 0.0 111.557 -178.657 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -114.38 136.08 53.38 Favored 'General case' 0 C--N 1.331 -0.239 0 CA-C-N 115.711 -0.677 . . . . 0.0 109.99 176.135 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 54' ' ' TYR . . . . . . . . . . . . . 30.5 t80 -129.07 108.33 18.04 Favored Pre-proline 0 CA--C 1.536 0.433 0 CA-C-O 118.21 -0.9 . . . . 0.0 110.393 179.616 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 55' ' ' PRO . . . . . . . . . . . . . 73.8 Cg_endo -77.17 169.99 72.71 Favored 'Cis proline' 0 N--CA 1.5 1.873 0 CA-C-N 121.824 1.687 . . . . 0.0 112.318 -5.371 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 56' ' ' SER . . . . . . . . . . . . . 66.6 m -117.45 136.51 23.55 Favored Pre-proline 0 CA--C 1.538 0.514 0 CA-C-O 118.482 -0.771 . . . . 0.0 109.885 175.688 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 57' ' ' PRO . . . . . . . . . . . . . 50.5 Cg_endo -71.24 163.09 86.6 Favored 'Cis proline' 0 N--CA 1.497 1.706 0 CA-C-N 121.791 1.675 . . . . 0.0 111.291 -5.867 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 58' ' ' LEU . . . . . 0.648 HD23 HD21 ' A' ' 4' ' ' LEU . 39.4 tp -129.69 138.69 51.3 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-O 121.042 0.449 . . . . 0.0 110.67 -179.205 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 59' ' ' ARG . . . . . . . . . . . . . 41.6 ttm180 -95.58 125.5 40.22 Favored 'General case' 0 C--N 1.326 -0.449 0 CA-C-N 115.717 -0.674 . . . . 0.0 109.219 174.177 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 39.9 t -77.18 116.57 20.73 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.241 0 C-N-CA 120.678 -0.409 . . . . 0.0 110.332 -175.082 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 70.6 mm-40 -131.22 161.77 31.48 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.018 -0.537 . . . . 0.0 109.756 175.977 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 62' ' ' ASP . . . . . . . . . . . . . 81.4 m-20 -52.32 -28.0 17.53 Favored 'General case' 0 C--N 1.328 -0.335 0 N-CA-C 112.034 0.383 . . . . 0.0 112.034 177.816 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 63' ' ' ARG . . . . . . . . . . . . . 77.6 mtp85 -70.77 -22.01 62.44 Favored 'General case' 0 CA--C 1.534 0.331 0 N-CA-C 112.879 0.696 . . . . 0.0 112.879 -176.444 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 29.6 m -80.63 142.05 34.38 Favored 'General case' 0 C--N 1.331 -0.227 0 CA-C-O 121.041 0.448 . . . . 0.0 111.119 -175.239 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 65' ' ' LYS . . . . . . . . . . . . . 96.8 mttt -90.11 138.18 31.73 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 115.902 -0.59 . . . . 0.0 110.066 179.176 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 66' ' ' ILE . . . . . . . . . . . . . 63.9 mt -117.55 129.75 73.52 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.212 0 N-CA-C 110.03 -0.359 . . . . 0.0 110.03 179.329 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 67' ' ' THR . . . . . . . . . . . . . 33.4 m -127.19 142.34 51.51 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-O 121.091 0.472 . . . . 0.0 110.861 -178.855 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 68' ' ' LEU . . . . . . . . . . . . . 15.4 tp -101.76 123.3 45.49 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.081 -0.509 . . . . 0.0 110.187 178.057 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 69' ' ' VAL . . . . . . . . . . . . . 45.8 t -102.7 118.46 49.63 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.275 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.07 -179.631 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 70' ' ' THR . . . . . 0.449 HG23 ' N ' ' A' ' 71' ' ' HIS . 5.0 t -150.01 -46.01 0.13 Allowed 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.365 177.689 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 71' ' ' HIS . . . . . 0.449 ' N ' HG23 ' A' ' 70' ' ' THR . 78.8 m80 -150.03 153.91 36.17 Favored Pre-proline 0 C--N 1.329 -0.32 0 CA-C-N 116.253 -0.431 . . . . 0.0 110.637 179.066 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 72' ' ' PRO . . . . . . . . . . . . . 60.8 Cg_endo -73.92 -19.62 20.5 Favored 'Trans proline' 0 N--CA 1.496 1.649 0 C-N-CA 121.364 1.376 . . . . 0.0 113.158 178.212 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 73' ' ' VAL . . . . . . . . . . . . . 34.8 m -125.66 169.5 16.98 Favored 'Isoleucine or valine' 0 C--O 1.232 0.132 0 CA-C-O 120.772 0.32 . . . . 0.0 110.602 -178.49 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 74' ' ' ASP . . . . . . . . . . . . . 10.5 t0 -91.96 118.29 30.62 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.272 -0.422 . . . . 0.0 109.903 -178.336 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 43.9 t -111.63 120.67 62.62 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.254 0 CA-C-O 121.249 0.547 . . . . 0.0 110.329 -178.635 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 76' ' ' LEU . . . . . . . . . . . . . 18.3 mt -121.38 139.44 53.44 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 115.463 -0.79 . . . . 0.0 109.035 176.787 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 77' ' ' GLU . . . . . . . . . . . . . 26.0 tt0 -135.71 141.62 44.94 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-O 120.986 0.422 . . . . 0.0 111.361 -174.476 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 78' ' ' ALA . . . . . 0.58 ' HB2' HD21 ' A' ' 109' ' ' LEU . . . -132.14 135.26 46.26 Favored 'General case' 0 C--N 1.331 -0.201 0 CA-C-N 115.821 -0.627 . . . . 0.0 110.073 176.572 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 79' ' ' LYS . . . . . 0.651 ' O ' HD13 ' A' ' 80' ' ' ILE . 62.3 mtpt -77.95 123.28 26.6 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-O 120.868 0.366 . . . . 0.0 110.43 -179.616 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 80' ' ' ILE . . . . . 0.651 HD13 ' O ' ' A' ' 79' ' ' LYS . 38.1 mm -139.19 108.81 3.92 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.257 0 N-CA-C 109.018 -0.734 . . . . 0.0 109.018 -176.87 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 81' ' ' LYS . . . . . . . . . . . . . 95.0 mttt -102.48 125.63 49.27 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-O 120.897 0.379 . . . . 0.0 111.148 -176.12 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . 89.06 42.05 5.72 Favored Glycine 0 CA--C 1.524 0.618 0 C-N-CA 120.818 -0.706 . . . . 0.0 111.547 174.644 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 83' ' ' ILE . . . . . . . . . . . . . 73.5 mt -68.12 135.7 27.95 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.339 0 N-CA-C 109.674 -0.491 . . . . 0.0 109.674 177.939 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 84' ' ' LYS . . . . . . . . . . . . . 82.9 tttt -96.84 -53.51 3.51 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.025 -0.534 . . . . 0.0 110.18 -179.136 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 85' ' ' ASP . . . . . . . . . . . . . 8.7 t70 -154.52 151.74 29.26 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 115.627 -0.715 . . . . 0.0 110.327 -179.916 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 86' ' ' VAL . . . . . . . . . . . . . 44.1 t -130.15 132.22 65.37 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.298 0 CA-C-O 121.049 0.452 . . . . 0.0 110.383 179.774 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 87' ' ' ILE . . . . . 0.496 HD12 ' N ' ' A' ' 87' ' ' ILE . 5.1 mp -117.78 124.09 72.59 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.242 0 N-CA-C 108.975 -0.75 . . . . 0.0 108.975 176.255 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 88' ' ' LEU . . . . . . . . . . . . . 14.4 tp -112.39 128.45 56.31 Favored 'General case' 0 C--N 1.331 -0.226 0 CA-C-O 121.073 0.463 . . . . 0.0 111.309 -175.497 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 89' ' ' ASP . . . . . . . . . . . . . 5.9 t70 -120.65 155.47 33.75 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 115.831 -0.622 . . . . 0.0 109.415 175.833 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 44.4 mp0 -51.02 -36.35 39.07 Favored 'General case' 0 C--N 1.328 -0.33 0 N-CA-C 112.464 0.542 . . . . 0.0 112.464 -171.448 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 91' ' ' ASN . . . . . . . . . . . . . 84.8 m-20 -132.05 33.07 3.95 Favored 'General case' 0 N--CA 1.465 0.309 0 N-CA-C 111.963 0.357 . . . . 0.0 111.963 -176.729 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 92' ' ' LEU . . . . . . . . . . . . . 10.4 tp -166.09 146.63 6.48 Favored 'General case' 0 C--N 1.331 -0.217 0 C-N-CA 120.997 -0.281 . . . . 0.0 110.593 179.525 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 93' ' ' ILE . . . . . . . . . . . . . 63.8 mt -127.09 125.81 67.03 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.238 0 N-CA-C 109.724 -0.473 . . . . 0.0 109.724 -179.611 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 94' ' ' VAL . . . . . . . . . . . . . 45.1 t -122.21 126.04 73.76 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.197 0 N-CA-C 109.742 -0.466 . . . . 0.0 109.742 177.874 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 95' ' ' VAL . . . . . . . . . . . . . 43.5 t -122.61 134.95 64.27 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.235 0 N-CA-C 110.055 -0.35 . . . . 0.0 110.055 -179.047 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 96' ' ' ILE . . . . . . . . . . . . . 61.6 mt -114.43 129.86 69.76 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.322 0 N-CA-C 109.341 -0.614 . . . . 0.0 109.341 178.632 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 97' ' ' THR . . . . . . . . . . . . . 63.4 p -100.26 156.74 17.05 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-O 121.01 0.434 . . . . 0.0 110.814 -179.706 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 98' ' ' GLU . . . . . . . . . . . . . 45.6 tp10 -54.01 -28.1 36.02 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.304 -0.407 . . . . 0.0 112.071 -178.233 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 99' ' ' GLU . . . . . . . . . . . . . 96.0 mt-10 -79.78 16.89 1.02 Allowed 'General case' 0 CA--C 1.534 0.363 0 N-CA-C 113.218 0.821 . . . . 0.0 113.218 -175.465 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 100' ' ' ASN . . . . . . . . . . . . . 3.7 m-20 62.93 37.91 11.61 Favored 'General case' 0 N--CA 1.464 0.232 0 CA-C-O 121.159 0.504 . . . . 0.0 111.021 177.973 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 101' ' ' GLU . . . . . . . . . . . . . 84.5 tt0 -116.8 144.03 44.97 Favored 'General case' 0 C--N 1.332 -0.169 0 N-CA-C 109.583 -0.525 . . . . 0.0 109.583 175.262 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 102' ' ' VAL . . . . . . . . . . . . . 41.1 t -116.4 128.55 73.7 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.283 0 CA-C-O 120.923 0.392 . . . . 0.0 110.187 -176.035 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 103' ' ' LEU . . . . . . . . . . . . . 27.0 mt -118.21 130.29 55.99 Favored 'General case' 0 C--N 1.331 -0.239 0 CA-C-N 115.643 -0.708 . . . . 0.0 110.053 176.215 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 104' ' ' ILE . . . . . 0.424 HD12 ' HB3' ' A' ' 113' ' ' TYR . 70.3 mt -117.85 122.67 70.3 Favored 'Isoleucine or valine' 0 C--O 1.234 0.259 0 N-CA-C 110.136 -0.32 . . . . 0.0 110.136 179.822 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 105' ' ' PHE . . . . . . . . . . . . . 80.7 m-85 -122.11 164.19 18.17 Favored 'General case' 0 C--N 1.331 -0.208 0 O-C-N 124.037 0.836 . . . . 0.0 110.143 -178.353 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 106' ' ' ASN . . . . . 0.415 ' HB3' HD11 ' A' ' 112' ' ' LEU . 44.3 p-10 -100.54 -170.05 1.81 Allowed 'General case' 0 C--N 1.331 -0.198 0 N-CA-C 109.884 -0.413 . . . . 0.0 109.884 172.35 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 107' ' ' GLN . . . . . . . . . . . . . 30.2 tt0 -59.16 -29.99 67.84 Favored 'General case' 0 C--N 1.328 -0.329 0 N-CA-C 112.008 0.374 . . . . 0.0 112.008 -179.508 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 108' ' ' ASN . . . . . . . . . . . . . 3.0 t-20 -84.67 8.31 17.38 Favored 'General case' 0 CA--C 1.536 0.413 0 N-CA-C 113.271 0.841 . . . . 0.0 113.271 -176.751 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 109' ' ' LEU . . . . . 0.58 HD21 ' HB2' ' A' ' 78' ' ' ALA . 11.3 tp 61.6 36.51 16.74 Favored 'General case' 0 C--O 1.233 0.185 0 CA-C-O 120.89 0.376 . . . . 0.0 111.309 178.823 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 110' ' ' GLU . . . . . . . . . . . . . 16.1 mm-40 -103.35 155.46 18.46 Favored 'General case' 0 C--N 1.33 -0.282 0 N-CA-C 109.847 -0.427 . . . . 0.0 109.847 176.056 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 111' ' ' GLU . . . . . . . . . . . . . 44.6 tp10 -84.83 121.96 28.47 Favored 'General case' 0 C--N 1.331 -0.231 0 C-N-CA 120.807 -0.357 . . . . 0.0 110.791 -178.092 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 112' ' ' LEU . . . . . 0.415 HD11 ' HB3' ' A' ' 106' ' ' ASN . 49.7 mt -107.0 -46.05 4.01 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.091 -0.504 . . . . 0.0 110.397 177.735 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 113' ' ' TYR . . . . . 0.424 ' HB3' HD12 ' A' ' 104' ' ' ILE . 60.0 t80 -136.35 135.45 38.85 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.22 -0.446 . . . . 0.0 110.863 179.68 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 114' ' ' ARG . . . . . . . . . . . . . 61.5 ttp85 -135.66 119.09 16.84 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 116.086 -0.506 . . . . 0.0 110.028 178.624 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 115' ' ' GLY . . . . . . . . . . . . . . . -150.04 159.56 28.15 Favored Glycine 0 CA--C 1.523 0.586 0 C-N-CA 120.693 -0.765 . . . . 0.0 111.441 179.855 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 116' ' ' LYS . . . . . . . . . . . . . 39.3 ttpt -130.04 138.26 50.67 Favored 'General case' 0 C--N 1.33 -0.282 0 N-CA-C 109.858 -0.423 . . . . 0.0 109.858 176.47 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 117' ' ' PHE . . . . . . . . . . . . . 38.6 m-85 -137.38 114.04 10.38 Favored 'General case' 0 C--N 1.329 -0.319 0 N-CA-C 110.121 -0.325 . . . . 0.0 110.121 -176.453 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 118' ' ' GLU . . . . . . . . . . . . . 21.7 pt-20 -55.54 -39.71 70.92 Favored 'General case' 0 C--N 1.33 -0.276 0 C-N-CA 120.942 -0.303 . . . . 0.0 111.08 -176.615 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 119' ' ' ASN . . . . . . . . . . . . . 92.8 m-20 -100.01 29.98 3.97 Favored 'General case' 0 C--N 1.33 -0.251 0 N-CA-C 112.252 0.464 . . . . 0.0 112.252 -175.182 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 120' ' ' LEU . . . . . . . . . . . . . 13.8 tp -59.72 120.36 9.35 Favored 'General case' 0 C--N 1.331 -0.209 0 N-CA-C 109.775 -0.454 . . . . 0.0 109.775 177.751 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 121' ' ' ASN . . . . . . . . . . . . . 83.3 m-20 -113.31 -43.99 3.29 Favored 'General case' 0 C--N 1.332 -0.188 0 CA-C-N 116.578 -0.283 . . . . 0.0 111.027 -176.819 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 122' ' ' LYS . . . . . . . . . . . . . 93.4 mttt -144.2 146.93 33.01 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-O 121.054 0.454 . . . . 0.0 111.672 -178.354 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 123' ' ' VAL . . . . . 0.429 ' C ' HD12 ' A' ' 124' ' ' LEU . 44.2 t -123.22 123.45 67.77 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.334 0 N-CA-C 109.375 -0.602 . . . . 0.0 109.375 174.474 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 124' ' ' LEU . . . . . 0.483 HD12 ' N ' ' A' ' 124' ' ' LEU . 7.3 mp -114.03 127.23 55.85 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.308 -0.405 . . . . 0.0 110.209 -179.064 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 125' ' ' VAL . . . . . . . . . . . . . 11.4 p -135.31 134.08 52.56 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.328 0 CA-C-N 116.504 -0.316 . . . . 0.0 110.326 -179.602 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 126' ' ' ARG . . . . . . . . . . . . . 44.8 ttt180 -146.4 119.67 8.94 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.471 178.903 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 127' ' ' ASN . . . . . . . . . . . . . 19.1 t-20 51.26 -104.88 0.18 Allowed 'General case' 0 CA--C 1.544 0.72 0 CA-C-O 119.121 -0.466 . . . . 0.0 111.42 179.309 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 128' ' ' ASP . . . . . . . . . . . . . 20.1 p-10 -112.12 0.35 15.87 Favored 'General case' 0 N--CA 1.468 0.45 0 CA-C-N 119.448 1.022 . . . . 0.0 113.653 -174.444 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 129' ' ' LEU . . . . . . . . . . . . . 76.3 mt -107.63 138.85 43.1 Favored 'General case' 0 C--O 1.231 0.117 0 CA-C-N 118.33 0.514 . . . . 0.0 110.358 179.676 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 130' ' ' VAL . . . . . . . . . . . . . 44.0 t -127.7 135.63 62.6 Favored 'Isoleucine or valine' 0 N--CA 1.462 0.156 0 CA-C-O 120.925 0.393 . . . . 0.0 110.248 -178.932 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 131' ' ' VAL . . . . . 0.516 ' CG1' HD21 ' A' ' 138' ' ' LEU . 40.9 t -134.01 134.16 55.78 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.283 0 CA-C-N 116.083 -0.508 . . . . 0.0 110.006 178.144 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 132' ' ' ILE . . . . . . . . . . . . . 72.2 mt -111.25 129.78 65.95 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.317 0 N-CA-C 109.363 -0.606 . . . . 0.0 109.363 179.653 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 133' ' ' ILE . . . . . . . . . . . . . 41.9 mm -113.67 118.8 59.26 Favored 'Isoleucine or valine' 0 C--O 1.234 0.265 0 CA-C-O 120.92 0.39 . . . . 0.0 110.865 -175.426 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 134' ' ' ASP . . . . . . . . . . . . . 8.6 p-10 -131.03 147.03 52.58 Favored 'General case' 0 C--N 1.331 -0.218 0 N-CA-C 109.303 -0.629 . . . . 0.0 109.303 174.823 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 135' ' ' GLU . . . . . . . . . . . . . 39.0 tp10 -49.89 -28.15 6.2 Favored 'General case' 0 C--N 1.326 -0.417 0 N-CA-C 112.662 0.616 . . . . 0.0 112.662 -172.564 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 136' ' ' GLN . . . . . . . . . . . . . 97.8 mt-30 -82.59 -33.71 27.92 Favored 'General case' 0 C--N 1.331 -0.226 0 N-CA-C 112.806 0.669 . . . . 0.0 112.806 -176.073 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 137' ' ' LYS . . . . . . . . . . . . . 53.7 pttt -166.33 172.98 10.48 Favored 'General case' 0 C--O 1.232 0.165 0 CA-C-O 121.72 0.772 . . . . 0.0 112.746 -172.458 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 138' ' ' LEU . . . . . 0.516 HD21 ' CG1' ' A' ' 131' ' ' VAL . 4.2 tt -117.83 128.88 55.28 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-N 114.767 -1.106 . . . . 0.0 109.798 179.479 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 139' ' ' THR . . . . . 0.485 ' N ' HD23 ' A' ' 138' ' ' LEU . 29.2 m -108.9 127.27 53.9 Favored 'General case' 0 C--N 1.331 -0.23 0 CA-C-N 116.422 -0.354 . . . . 0.0 110.241 178.611 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 140' ' ' LEU . . . . . 0.482 HD23 ' C ' ' A' ' 140' ' ' LEU . 7.4 tt -111.48 121.77 46.08 Favored 'General case' 0 C--N 1.327 -0.382 0 N-CA-C 109.347 -0.612 . . . . 0.0 109.347 -178.594 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 141' ' ' ILE . . . . . . . . . . . . . 19.3 mt -121.08 120.62 62.73 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 CA-C-O 120.955 0.407 . . . . 0.0 110.181 -175.275 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 142' ' ' ARG . . . . . . . . . . . . . 76.4 mtp180 -106.87 122.11 45.75 Favored 'General case' 0 C--N 1.33 -0.239 0 CA-C-N 115.258 -0.883 . . . . 0.0 109.758 179.527 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 143' ' ' THR . . . . . . . . . . . . . 27.6 p . . . . . 0 C--O 1.22 -0.468 0 CA-C-O 117.996 -1.002 . . . . 0.0 110.523 179.907 . . . . . . . . 0 0 . 1 . 014 nuclear nobuild full ' B' B ' -3' ' ' GLU . . . . . . . . . . . . . 96.1 mt-10 . . . . . 0 N--CA 1.489 1.509 0 N-CA-C 109.473 -0.565 . . . . 0.0 109.473 . . . . . . . . . 0 0 . 1 . 014 nuclear nobuild full ' B' B ' -2' ' ' GLY . . . . . . . . . . . . . . . -61.47 143.35 48.62 Favored Glycine 0 CA--C 1.524 0.628 0 N-CA-C 110.903 -0.879 . . . . 0.0 110.903 179.938 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' B' B ' -1' ' ' VAL . . . . . . . . . . . . . 44.0 t -96.17 135.89 28.82 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.382 0 N-CA-C 110.066 -0.346 . . . . 0.0 110.066 -179.906 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' B' B ' 0' ' ' ILE . . . . . . . . . . . . . 68.3 mt -107.45 131.14 58.37 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.275 0 CA-C-N 116.391 -0.368 . . . . 0.0 110.011 -179.111 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' B' B ' 1' ' ' MET . . . . . . . . . . . . . 26.1 ptt? -84.31 143.87 29.23 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.516 179.642 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' B' B ' 2' ' ' SER . . . . . . . . . . . . . 2.8 p -106.6 135.59 47.85 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.425 179.511 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' B' B ' 3' ' ' GLU . . . . . . . . . . . . . 84.5 tt0 -139.95 139.1 36.04 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-O 120.996 0.426 . . . . 0.0 111.114 -179.248 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' B' B ' 4' ' ' LEU . . . . . . . . . . . . . 4.7 tt -123.24 125.32 44.86 Favored 'General case' 0 C--N 1.331 -0.22 0 CA-C-N 115.689 -0.687 . . . . 0.0 109.752 177.868 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' B' B ' 5' ' ' LYS . . . . . . . . . . . . . 62.7 mttp -106.07 122.57 46.45 Favored 'General case' 0 C--O 1.234 0.269 0 CA-C-O 120.841 0.353 . . . . 0.0 110.877 -179.551 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' B' B ' 6' ' ' LEU . . . . . . . . . . . . . 79.2 mt -114.08 154.43 27.75 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 115.367 -0.833 . . . . 0.0 110.787 -179.179 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' B' B ' 7' ' ' LYS . . . . . . . . . . . . . 62.9 tttm -143.23 140.54 17.89 Favored Pre-proline 0 CA--C 1.533 0.326 0 CA-C-O 119.152 -0.452 . . . . 0.0 110.057 174.007 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' B' B ' 8' ' ' PRO . . . . . . . . . . . . . 71.8 Cg_endo -90.27 139.56 3.01 Favored 'Trans proline' 0 N--CA 1.49 1.282 0 C-N-CA 121.723 1.615 . . . . 0.0 111.407 176.959 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' B' B ' 9' ' ' LEU . . . . . . . . . . . . . 53.6 mt -77.68 -46.69 2.43 Favored Pre-proline 0 C--N 1.329 -0.308 0 CA-C-O 118.811 -0.614 . . . . 0.0 112.102 -177.486 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' B' B ' 10' ' ' PRO . . . . . . . . . . . . . 76.8 Cg_endo -84.08 157.72 13.3 Favored 'Trans proline' 0 N--CA 1.495 1.609 0 C-N-CA 121.353 1.369 . . . . 0.0 111.686 173.771 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' B' B ' 11' ' ' LYS . . . . . . . . . . . . . 24.5 pttm -86.91 114.64 23.71 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-O 121.527 0.68 . . . . 0.0 110.544 177.417 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' B' B ' 12' ' ' VAL . . . . . . . . . . . . . 12.4 p -151.01 148.67 14.79 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.289 0 CA-C-N 115.659 -0.7 . . . . 0.0 110.447 -179.886 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' B' B ' 13' ' ' GLU . . . . . . . . . . . . . 84.5 tt0 -89.06 119.58 29.7 Favored 'General case' 0 C--N 1.329 -0.326 0 N-CA-C 109.877 -0.416 . . . . 0.0 109.877 176.494 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' B' B ' 14' ' ' LEU . . . . . . . . . . . . . 21.4 mt -93.92 147.54 33.68 Favored Pre-proline 0 C--N 1.329 -0.317 0 CA-C-O 119.102 -0.475 . . . . 0.0 110.479 -176.91 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' B' B ' 15' ' ' PRO . . . . . . . . . . . . . 25.3 Cg_exo -62.65 160.41 32.58 Favored 'Trans proline' 0 N--CA 1.497 1.733 0 C-N-CA 121.284 1.322 . . . . 0.0 112.001 177.714 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' B' B ' 16' ' ' PRO . . . . . . . . . . . . . 39.0 Cg_exo -58.88 -44.13 38.07 Favored 'Trans proline' 0 N--CA 1.498 1.781 0 C-N-CA 121.365 1.377 . . . . 0.0 112.892 -178.716 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' B' B ' 17' ' ' ASP . . . . . . . . . . . . . 11.1 p-10 -83.77 10.33 9.74 Favored 'General case' 0 C--N 1.327 -0.404 0 N-CA-C 113.169 0.803 . . . . 0.0 113.169 -177.03 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' B' B ' 18' ' ' PHE . . . . . . . . . . . . . 36.1 t80 -57.91 -43.03 85.91 Favored 'General case' 0 C--N 1.334 -0.084 0 O-C-N 121.975 -0.453 . . . . 0.0 110.088 -178.746 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' B' B ' 19' ' ' VAL . . . . . . . . . . . . . 48.3 t -57.4 -43.39 82.47 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.352 0 CA-C-N 116.247 -0.433 . . . . 0.0 110.403 -179.514 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' B' B ' 20' ' ' ASP . . . . . . . . . . . . . 53.6 m-20 -59.97 -42.57 94.44 Favored 'General case' 0 C--N 1.331 -0.204 0 C-N-CA 120.979 -0.288 . . . . 0.0 110.996 -177.299 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' B' B ' 21' ' ' VAL . . . . . . . . . . . . . 48.3 t -64.53 -45.53 95.34 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.319 0 C-N-CA 120.728 -0.389 . . . . 0.0 110.433 -178.089 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' B' B ' 22' ' ' ILE . . . . . 0.556 HG22 HD12 ' B' ' 26' ' ' LEU . 50.0 mm -58.73 -40.63 80.14 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.318 0 C-N-CA 121.081 -0.247 . . . . 0.0 110.681 179.227 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' B' B ' 23' ' ' ARG . . . . . . . . . . . . . 46.2 ttp180 -56.15 -48.29 76.56 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-O 120.984 0.421 . . . . 0.0 110.585 178.503 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' B' B ' 24' ' ' ILE . . . . . . . . . . . . . 72.5 mt -61.5 -45.19 99.15 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.274 0 CA-C-N 115.94 -0.573 . . . . 0.0 111.769 -177.966 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' B' B ' 25' ' ' LYS . . . . . . . . . . . . . 15.6 pttp -71.22 -37.35 72.05 Favored 'General case' 0 CA--C 1.534 0.36 0 C-N-CA 120.615 -0.434 . . . . 0.0 111.838 -172.545 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' B' B ' 26' ' ' LEU . . . . . 0.556 HD12 HG22 ' B' ' 22' ' ' ILE . 23.7 mt -80.5 -42.23 22.86 Favored 'General case' 0 C--N 1.33 -0.245 0 N-CA-C 113.096 0.776 . . . . 0.0 113.096 -174.674 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' B' B ' 27' ' ' GLN . . . . . . . . . . . . . 10.5 pt20 -47.0 139.98 5.21 Favored 'General case' 0 N--CA 1.469 0.487 0 N-CA-C 112.751 0.649 . . . . 0.0 112.751 -174.875 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' B' B ' 28' ' ' GLY . . . . . . . . . . . . . . . 99.92 -24.51 31.85 Favored Glycine 0 CA--C 1.533 1.187 0 CA-C-N 115.525 -0.762 . . . . 0.0 112.274 -175.539 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' B' B ' 29' ' ' LYS . . . . . . . . . . . . . 65.2 mttm -98.79 155.09 17.53 Favored 'General case' 0 C--O 1.233 0.187 0 CA-C-N 117.288 0.544 . . . . 0.0 111.009 179.525 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' B' B ' 30' ' ' THR . . . . . . . . . . . . . 31.8 m -100.21 135.26 41.92 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.196 -0.457 . . . . 0.0 109.885 175.436 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' B' B ' 31' ' ' VAL . . . . . . . . . . . . . 35.0 m -127.84 154.46 38.4 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.245 0 CA-C-O 120.897 0.379 . . . . 0.0 110.967 -178.379 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' B' B ' 32' ' ' ARG . . . . . . . . . . . . . 85.6 mtm180 -133.32 151.03 51.85 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 115.823 -0.626 . . . . 0.0 110.396 178.259 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' B' B ' 33' ' ' THR . . . . . . . . . . . . . 23.7 m -53.29 138.51 32.23 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.338 -0.392 . . . . 0.0 111.362 -178.336 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' B' B ' 34' ' ' GLY . . . . . . . . . . . . . . . 101.11 -17.05 56.62 Favored Glycine 0 CA--C 1.531 1.084 0 CA-C-O 119.658 -0.523 . . . . 0.0 113.269 178.978 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' B' B ' 35' ' ' ASP . . . . . . . . . . . . . 69.2 m-20 -64.55 148.93 49.75 Favored 'General case' 0 N--CA 1.461 0.107 0 CA-C-N 118.123 0.962 . . . . 0.0 111.018 179.098 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' B' B ' 36' ' ' VAL . . . . . . . . . . . . . 45.3 t -125.47 132.02 71.49 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.217 0 CA-C-N 115.825 -0.625 . . . . 0.0 109.869 179.157 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' B' B ' 37' ' ' ILE . . . . . . . . . . . . . 68.5 mt -120.22 138.07 51.97 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.234 0 CA-C-N 116.141 -0.482 . . . . 0.0 109.853 179.624 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' B' B ' 38' ' ' GLY . . . . . . . . . . . . . . . -108.05 128.74 9.27 Favored Glycine 0 CA--C 1.524 0.61 0 N-CA-C 110.872 -0.891 . . . . 0.0 110.872 179.848 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' B' B ' 39' ' ' ILE . . . . . . . . . . . . . 75.5 mt -125.63 137.12 58.69 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.259 0 N-CA-C 110.186 -0.302 . . . . 0.0 110.186 179.994 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' B' B ' 40' ' ' SER . . . . . 0.528 ' O ' HD13 ' B' ' 41' ' ' ILE . 42.2 p -92.8 119.17 31.88 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.378 -0.374 . . . . 0.0 110.924 176.227 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' B' B ' 41' ' ' ILE . . . . . 0.528 HD13 ' O ' ' B' ' 40' ' ' SER . 47.6 mm -129.59 117.91 43.66 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.189 0 CA-C-O 120.716 0.293 . . . . 0.0 110.325 178.69 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' B' B ' 42' ' ' LEU . . . . . . . . . . . . . 51.0 mt 57.88 34.32 24.21 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.317 -0.401 . . . . 0.0 111.819 177.7 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' B' B ' 43' ' ' GLY . . . . . . . . . . . . . . . 78.74 -10.1 33.45 Favored Glycine 0 CA--C 1.534 1.236 0 C-N-CA 121.215 -0.517 . . . . 0.0 113.438 177.539 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' B' B ' 44' ' ' LYS . . . . . . . . . . . . . 72.9 mmtt -97.82 138.63 34.88 Favored 'General case' 0 C--N 1.333 -0.132 0 CA-C-N 117.854 0.827 . . . . 0.0 109.946 176.912 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' B' B ' 45' ' ' GLU . . . . . . . . . . . . . 84.8 tt0 -84.07 125.16 31.85 Favored 'General case' 0 C--N 1.328 -0.35 0 C-N-CA 120.874 -0.33 . . . . 0.0 110.76 179.447 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' B' B ' 46' ' ' VAL . . . . . . . . . . . . . 7.4 p -121.77 127.8 75.57 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.182 0 N-CA-C 109.627 -0.509 . . . . 0.0 109.627 177.603 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' B' B ' 47' ' ' LYS . . . . . . . . . . . . . 64.0 mttp -100.45 130.43 46.53 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 115.91 -0.586 . . . . 0.0 111.16 178.911 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' B' B ' 48' ' ' PHE . . . . . . . . . . . . . 93.6 m-85 -112.73 131.84 55.49 Favored 'General case' 0 C--N 1.33 -0.258 0 N-CA-C 109.889 -0.411 . . . . 0.0 109.889 175.748 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' B' B ' 49' ' ' LYS . . . . . . . . . . . . . 85.6 tttt -108.82 139.73 43.24 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.279 -0.418 . . . . 0.0 110.846 -178.499 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' B' B ' 50' ' ' VAL . . . . . . . . . . . . . 46.2 t -83.13 108.0 15.39 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.346 0 N-CA-C 109.301 -0.629 . . . . 0.0 109.301 174.852 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' B' B ' 51' ' ' VAL . . . . . . . . . . . . . 47.7 t -72.7 -48.11 47.43 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.306 0 CA-C-N 116.118 -0.492 . . . . 0.0 110.001 -173.06 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' B' B ' 52' ' ' GLN . . . . . . . . . . . . . 60.4 tt0 -165.25 146.97 7.63 Favored 'General case' 0 C--N 1.33 -0.246 0 C-N-CA 120.266 -0.574 . . . . 0.0 111.863 -177.972 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' B' B ' 53' ' ' ALA . . . . . . . . . . . . . . . -123.23 134.54 54.11 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 115.677 -0.692 . . . . 0.0 109.929 176.48 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' B' B ' 54' ' ' TYR . . . . . . . . . . . . . 33.4 t80 -129.14 112.16 18.35 Favored Pre-proline 0 CA--C 1.535 0.403 0 CA-C-O 118.184 -0.912 . . . . 0.0 110.289 178.726 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' B' B ' 55' ' ' PRO . . . . . . . . . . . . . 73.5 Cg_endo -77.11 169.22 74.86 Favored 'Cis proline' 0 N--CA 1.5 1.904 0 CA-C-N 121.99 1.747 . . . . 0.0 112.212 -6.698 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' B' B ' 56' ' ' SER . . . . . . . . . . . . . 13.8 m -117.25 137.19 23.76 Favored Pre-proline 0 CA--C 1.537 0.467 0 CA-C-O 118.537 -0.744 . . . . 0.0 109.802 175.296 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' B' B ' 57' ' ' PRO . . . . . . . . . . . . . 32.4 Cg_endo -65.71 162.94 67.82 Favored 'Cis proline' 0 N--CA 1.498 1.757 0 CA-C-N 121.761 1.665 . . . . 0.0 111.309 -4.724 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' B' B ' 58' ' ' LEU . . . . . . . . . . . . . 31.7 tp -129.18 137.52 51.2 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-O 120.945 0.402 . . . . 0.0 110.511 -178.651 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' B' B ' 59' ' ' ARG . . . . . . . . . . . . . 27.0 ttm180 -101.49 127.43 48.18 Favored 'General case' 0 C--N 1.327 -0.392 0 N-CA-C 109.301 -0.629 . . . . 0.0 109.301 176.151 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' B' B ' 60' ' ' VAL . . . . . . . . . . . . . 46.9 t -79.57 117.73 25.82 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.33 0 C-N-CA 120.677 -0.409 . . . . 0.0 110.095 -175.967 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' B' B ' 61' ' ' GLU . . . . . . . . . . . . . 70.8 mm-40 -131.06 161.83 31.17 Favored 'General case' 0 C--N 1.331 -0.208 0 CA-C-N 116.047 -0.524 . . . . 0.0 110.284 178.846 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' B' B ' 62' ' ' ASP . . . . . . . . . . . . . 67.4 m-20 -54.53 -32.45 58.22 Favored 'General case' 0 C--N 1.327 -0.396 0 CA-C-N 116.463 -0.335 . . . . 0.0 111.748 -179.901 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' B' B ' 63' ' ' ARG . . . . . . . . . . . . . 13.8 ptp180 -84.24 10.09 11.29 Favored 'General case' 0 CA--C 1.535 0.398 0 N-CA-C 113.471 0.915 . . . . 0.0 113.471 -175.854 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' B' B ' 64' ' ' THR . . . . . . . . . . . . . 32.3 m -94.92 143.0 26.82 Favored 'General case' 0 C--O 1.231 0.128 0 CA-C-N 118.02 0.373 . . . . 0.0 110.632 -179.73 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' B' B ' 65' ' ' LYS . . . . . . . . . . . . . 92.3 mttt -88.52 129.0 35.56 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.155 -0.475 . . . . 0.0 110.267 179.633 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' B' B ' 66' ' ' ILE . . . . . . . . . . . . . 59.5 mt -115.08 130.21 69.99 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.196 0 N-CA-C 109.707 -0.479 . . . . 0.0 109.707 179.479 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' B' B ' 67' ' ' THR . . . . . . . . . . . . . 28.0 m -132.49 144.68 50.61 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-O 121.111 0.482 . . . . 0.0 111.3 -177.923 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' B' B ' 68' ' ' LEU . . . . . 0.464 HD12 ' N ' ' B' ' 68' ' ' LEU . 7.3 mp -100.61 132.49 45.98 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 115.96 -0.564 . . . . 0.0 109.94 174.79 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' B' B ' 69' ' ' VAL . . . . . . . . . . . . . 42.6 t -94.25 105.97 17.53 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.268 0 CA-C-N 116.392 -0.367 . . . . 0.0 110.281 -178.9 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' B' B ' 70' ' ' THR . . . . . . . . . . . . . 7.6 t -150.01 32.62 0.68 Allowed 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 116.219 -0.446 . . . . 0.0 111.511 178.877 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' B' B ' 71' ' ' HIS . . . . . . . . . . . . . 18.9 t-80 -133.42 75.87 68.9 Favored Pre-proline 0 CA--C 1.534 0.36 0 N-CA-C 110.403 -0.221 . . . . 0.0 110.403 -179.824 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' B' B ' 72' ' ' PRO . . . . . . . . . . . . . 89.5 Cg_endo -83.59 -18.29 5.79 Favored 'Trans proline' 0 N--CA 1.494 1.538 0 C-N-CA 121.639 1.559 . . . . 0.0 113.471 -179.14 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' B' B ' 73' ' ' VAL . . . . . . . . . . . . . 34.6 m -125.96 165.92 22.97 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.162 0 CA-C-O 120.793 0.33 . . . . 0.0 110.603 -178.198 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' B' B ' 74' ' ' ASP . . . . . . . . . . . . . 36.1 t0 -94.66 117.57 30.34 Favored 'General case' 0 C--N 1.329 -0.309 0 N-CA-C 109.669 -0.493 . . . . 0.0 109.669 -179.443 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' B' B ' 75' ' ' VAL . . . . . . . . . . . . . 44.0 t -117.9 124.66 73.4 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.287 0 CA-C-O 121.123 0.487 . . . . 0.0 110.771 -176.382 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' B' B ' 76' ' ' LEU . . . . . . . . . . . . . 5.3 mp -122.55 148.45 45.18 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 115.539 -0.755 . . . . 0.0 109.47 174.964 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' B' B ' 77' ' ' GLU . . . . . . . . . . . . . 45.8 mt-10 -135.05 139.52 44.85 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-O 120.999 0.428 . . . . 0.0 111.471 -177.645 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' B' B ' 78' ' ' ALA . . . . . 0.618 ' HB2' HD21 ' B' ' 109' ' ' LEU . . . -128.39 132.29 48.52 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 115.701 -0.681 . . . . 0.0 109.642 175.585 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' B' B ' 79' ' ' LYS . . . . . 0.565 ' O ' HD13 ' B' ' 80' ' ' ILE . 84.5 mttt -76.72 121.45 23.31 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-O 121.077 0.465 . . . . 0.0 110.851 -178.072 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' B' B ' 80' ' ' ILE . . . . . 0.565 HD13 ' O ' ' B' ' 79' ' ' LYS . 43.5 mm -139.19 109.36 4.23 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.27 0 N-CA-C 108.963 -0.754 . . . . 0.0 108.963 -177.854 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' B' B ' 81' ' ' LYS . . . . . . . . . . . . . 93.5 mttt -101.98 124.38 47.5 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-O 120.916 0.388 . . . . 0.0 111.346 -176.244 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' B' B ' 82' ' ' GLY . . . . . . . . . . . . . . . 89.07 42.16 5.69 Favored Glycine 0 CA--C 1.526 0.72 0 C-N-CA 120.956 -0.64 . . . . 0.0 111.841 174.666 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' B' B ' 83' ' ' ILE . . . . . . . . . . . . . 69.0 mt -67.39 136.86 25.85 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.28 0 N-CA-C 109.632 -0.507 . . . . 0.0 109.632 177.116 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' B' B ' 84' ' ' LYS . . . . . . . . . . . . . 38.6 ttpt -101.56 -52.4 3.23 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-O 121.022 0.439 . . . . 0.0 110.422 -178.673 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' B' B ' 85' ' ' ASP . . . . . . . . . . . . . 10.7 t70 -145.46 147.77 32.55 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 115.943 -0.571 . . . . 0.0 110.458 -178.644 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' B' B ' 86' ' ' VAL . . . . . . . . . . . . . 42.2 t -129.68 130.85 67.0 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.26 0 CA-C-O 120.905 0.383 . . . . 0.0 110.373 -179.617 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' B' B ' 87' ' ' ILE . . . . . 0.488 ' N ' HD12 ' B' ' 87' ' ' ILE . 5.0 mp -119.74 123.74 71.54 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.214 0 N-CA-C 109.313 -0.625 . . . . 0.0 109.313 176.105 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' B' B ' 88' ' ' LEU . . . . . . . . . . . . . 17.9 tp -111.01 127.77 55.64 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-O 121.038 0.447 . . . . 0.0 110.972 -177.774 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' B' B ' 89' ' ' ASP . . . . . . . . . . . . . 8.2 t70 -121.61 152.12 39.64 Favored 'General case' 0 C--N 1.331 -0.201 0 CA-C-N 115.797 -0.638 . . . . 0.0 109.6 177.005 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' B' B ' 90' ' ' GLU . . . . . . . . . . . . . 96.4 mt-10 -48.84 -36.24 16.43 Favored 'General case' 0 C--N 1.328 -0.337 0 N-CA-C 112.642 0.608 . . . . 0.0 112.642 -173.04 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' B' B ' 91' ' ' ASN . . . . . . . . . . . . . 30.5 m120 -132.21 32.87 3.93 Favored 'General case' 0 N--CA 1.466 0.336 0 N-CA-C 111.909 0.337 . . . . 0.0 111.909 -177.001 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' B' B ' 92' ' ' LEU . . . . . . . . . . . . . 15.5 tp -166.13 144.42 5.66 Favored 'General case' 0 C--N 1.331 -0.206 0 C-N-CA 121.028 -0.269 . . . . 0.0 110.574 179.722 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' B' B ' 93' ' ' ILE . . . . . . . . . . . . . 70.1 mt -123.36 122.38 65.09 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.279 0 N-CA-C 109.594 -0.521 . . . . 0.0 109.594 178.741 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' B' B ' 94' ' ' VAL . . . . . . . . . . . . . 47.3 t -120.65 125.03 73.63 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 N-CA-C 109.776 -0.453 . . . . 0.0 109.776 179.281 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' B' B ' 95' ' ' VAL . . . . . . . . . . . . . 43.5 t -124.04 134.6 66.11 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.325 0 CA-C-N 116.286 -0.415 . . . . 0.0 109.976 -178.726 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' B' B ' 96' ' ' ILE . . . . . . . . . . . . . 58.3 mt -117.6 126.96 75.04 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.255 0 N-CA-C 109.367 -0.605 . . . . 0.0 109.367 179.343 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' B' B ' 97' ' ' THR . . . . . . . . . . . . . 77.1 p -98.32 157.72 16.01 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-O 121.188 0.518 . . . . 0.0 111.137 -178.086 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' B' B ' 98' ' ' GLU . . . . . . . . . . . . . 80.2 tt0 -53.92 -29.23 41.26 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 116.1 -0.5 . . . . 0.0 112.059 -178.675 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' B' B ' 99' ' ' GLU . . . . . . . . . . . . . 39.3 tt0 -80.01 15.89 1.35 Allowed 'General case' 0 CA--C 1.541 0.61 0 N-CA-C 112.599 0.592 . . . . 0.0 112.599 -176.074 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' B' B ' 100' ' ' ASN . . . . . . . . . . . . . 4.8 m-20 63.8 33.18 12.98 Favored 'General case' 0 CA--C 1.532 0.271 0 O-C-N 121.873 -0.517 . . . . 0.0 111.703 177.859 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' B' B ' 101' ' ' GLU . . . . . . . . . . . . . 84.7 tt0 -106.47 141.94 36.95 Favored 'General case' 0 C--N 1.331 -0.215 0 N-CA-C 109.506 -0.553 . . . . 0.0 109.506 172.179 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' B' B ' 102' ' ' VAL . . . . . . . . . . . . . 45.2 t -116.89 128.18 74.35 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.299 0 N-CA-C 109.805 -0.443 . . . . 0.0 109.805 -177.813 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' B' B ' 103' ' ' LEU . . . . . . . . . . . . . 26.8 mt -118.8 131.2 56.09 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 115.839 -0.619 . . . . 0.0 110.611 178.185 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' B' B ' 104' ' ' ILE . . . . . 0.432 HD12 ' HB3' ' B' ' 113' ' ' TYR . 69.7 mt -116.17 120.12 63.93 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.245 0 N-CA-C 109.72 -0.474 . . . . 0.0 109.72 178.076 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' B' B ' 105' ' ' PHE . . . . . . . . . . . . . 70.7 m-85 -123.13 163.87 19.74 Favored 'General case' 0 C--N 1.331 -0.207 0 O-C-N 123.81 0.694 . . . . 0.0 109.722 179.867 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' B' B ' 106' ' ' ASN . . . . . . . . . . . . . 48.1 p-10 -98.87 -170.75 1.98 Allowed 'General case' 0 C--N 1.329 -0.298 0 N-CA-C 109.754 -0.461 . . . . 0.0 109.754 172.742 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' B' B ' 107' ' ' GLN . . . . . . . . . . . . . 44.7 tt0 -61.04 -30.05 70.08 Favored 'General case' 0 C--N 1.328 -0.369 0 N-CA-C 111.851 0.315 . . . . 0.0 111.851 -179.159 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' B' B ' 108' ' ' ASN . . . . . . . . . . . . . 13.7 t-20 -82.77 6.4 18.27 Favored 'General case' 0 CA--C 1.537 0.469 0 N-CA-C 113.215 0.821 . . . . 0.0 113.215 -178.421 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' B' B ' 109' ' ' LEU . . . . . 0.618 HD21 ' HB2' ' B' ' 78' ' ' ALA . 10.7 tp 61.95 39.34 13.59 Favored 'General case' 0 C--O 1.233 0.209 0 CA-C-O 121.246 0.546 . . . . 0.0 111.197 178.267 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' B' B ' 110' ' ' GLU . . . . . . . . . . . . . 70.8 mm-40 -105.77 157.83 17.17 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.105 176.419 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' B' B ' 111' ' ' GLU . . . . . . . . . . . . . 84.6 tt0 -83.17 121.99 27.8 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-O 120.901 0.381 . . . . 0.0 111.064 -176.613 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' B' B ' 112' ' ' LEU . . . . . . . . . . . . . 34.0 mt -108.29 -46.09 3.79 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-N 115.959 -0.564 . . . . 0.0 110.133 176.462 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' B' B ' 113' ' ' TYR . . . . . 0.432 ' HB3' HD12 ' B' ' 104' ' ' ILE . 63.0 t80 -143.39 135.94 27.32 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.091 -0.504 . . . . 0.0 111.182 179.141 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' B' B ' 114' ' ' ARG . . . . . . . . . . . . . 26.3 ttm180 -133.16 122.7 24.41 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.235 -0.439 . . . . 0.0 109.88 175.669 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' B' B ' 115' ' ' GLY . . . . . . . . . . . . . . . -150.08 152.34 24.27 Favored Glycine 0 CA--C 1.523 0.556 0 N-CA-C 110.69 -0.964 . . . . 0.0 110.69 179.293 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' B' B ' 116' ' ' LYS . . . . . . . . . . . . . 60.8 tttm -129.2 127.46 41.36 Favored 'General case' 0 C--N 1.328 -0.343 0 N-CA-C 109.697 -0.482 . . . . 0.0 109.697 178.351 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' B' B ' 117' ' ' PHE . . . . . 0.442 ' HE2' HD13 ' B' ' 132' ' ' ILE . 49.8 m-85 -123.27 114.06 19.72 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.258 -0.428 . . . . 0.0 110.257 -174.917 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' B' B ' 118' ' ' GLU . . . . . . . . . . . . . 84.7 tt0 -53.99 -43.29 69.86 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 116.363 -0.381 . . . . 0.0 111.357 -176.716 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' B' B ' 119' ' ' ASN . . . . . . . . . . . . . 17.7 m-80 -99.26 31.01 3.23 Favored 'General case' 0 C--N 1.33 -0.257 0 N-CA-C 112.275 0.472 . . . . 0.0 112.275 -174.203 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' B' B ' 120' ' ' LEU . . . . . . . . . . . . . 21.3 tp -56.4 120.26 7.37 Favored 'General case' 0 C--O 1.232 0.148 0 C-N-CA 121.014 -0.274 . . . . 0.0 110.445 177.877 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' B' B ' 121' ' ' ASN . . . . . . . . . . . . . 72.2 m-20 -114.16 -43.99 3.17 Favored 'General case' 0 C--O 1.232 0.181 0 CA-C-N 116.574 -0.284 . . . . 0.0 111.162 -177.283 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' B' B ' 122' ' ' LYS . . . . . . . . . . . . . 95.1 mttt -145.55 150.43 36.4 Favored 'General case' 0 C--N 1.329 -0.283 0 C-N-CA 120.69 -0.404 . . . . 0.0 111.489 -177.17 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' B' B ' 123' ' ' VAL . . . . . . . . . . . . . 43.8 t -132.77 133.26 59.36 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.235 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.107 177.896 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' B' B ' 124' ' ' LEU . . . . . . . . . . . . . 77.8 mt -120.76 130.53 54.07 Favored 'General case' 0 C--O 1.233 0.202 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.596 178.745 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' B' B ' 125' ' ' VAL . . . . . . . . . . . . . 44.8 t -128.21 128.04 68.16 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.281 0 N-CA-C 109.861 -0.422 . . . . 0.0 109.861 179.054 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' B' B ' 126' ' ' ARG . . . . . . . . . . . . . 73.3 mtp85 -140.4 115.06 9.49 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-O 120.812 0.339 . . . . 0.0 110.792 179.468 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' B' B ' 127' ' ' ASN . . . . . . . . . . . . . 21.0 t-20 51.39 -104.91 0.18 Allowed 'General case' 0 CA--C 1.544 0.718 0 CA-C-O 119.131 -0.461 . . . . 0.0 111.382 178.367 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' B' B ' 128' ' ' ASP . . . . . . . . . . . . . 18.3 p-10 -114.0 2.51 15.01 Favored 'General case' 0 N--CA 1.468 0.436 0 CA-C-N 119.562 1.074 . . . . 0.0 113.432 -177.14 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' B' B ' 129' ' ' LEU . . . . . . . . . . . . . 13.3 tp -106.45 136.89 45.41 Favored 'General case' 0 C--N 1.331 -0.218 0 CA-C-N 118.146 0.43 . . . . 0.0 109.909 178.835 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' B' B ' 130' ' ' VAL . . . . . . . . . . . . . 42.5 t -124.7 136.18 61.52 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.242 0 CA-C-O 120.881 0.372 . . . . 0.0 110.314 -177.358 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' B' B ' 131' ' ' VAL . . . . . 0.46 HG22 HD12 ' B' ' 140' ' ' LEU . 46.4 t -134.81 133.83 53.94 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.214 0 CA-C-N 116.264 -0.425 . . . . 0.0 110.187 177.984 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' B' B ' 132' ' ' ILE . . . . . 0.442 HD13 ' HE2' ' B' ' 117' ' ' PHE . 75.7 mt -117.59 133.73 63.43 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.343 0 N-CA-C 109.64 -0.504 . . . . 0.0 109.64 -179.688 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' B' B ' 133' ' ' ILE . . . . . . . . . . . . . 35.6 mm -115.76 123.25 70.93 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.242 0 CA-C-O 120.748 0.309 . . . . 0.0 111.064 -175.448 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' B' B ' 134' ' ' ASP . . . . . . . . . . . . . 9.8 p-10 -134.09 149.77 51.13 Favored 'General case' 0 C--N 1.331 -0.22 0 N-CA-C 109.621 -0.511 . . . . 0.0 109.621 174.755 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' B' B ' 135' ' ' GLU . . . . . . . . . . . . . 40.8 tp10 -50.05 -30.05 10.04 Favored 'General case' 0 C--N 1.328 -0.338 0 N-CA-C 112.651 0.612 . . . . 0.0 112.651 -170.896 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' B' B ' 136' ' ' GLN . . . . . . . . . . . . . 98.2 mt-30 -81.41 -36.4 29.54 Favored 'General case' 0 C--N 1.329 -0.3 0 N-CA-C 112.687 0.625 . . . . 0.0 112.687 -175.981 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' B' B ' 137' ' ' LYS . . . . . . . . . . . . . 20.4 pttm -163.07 172.52 14.82 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-O 121.626 0.727 . . . . 0.0 112.391 -169.706 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' B' B ' 138' ' ' LEU . . . . . . . . . . . . . 6.7 tt -118.53 129.16 55.19 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 114.94 -1.027 . . . . 0.0 109.842 178.27 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' B' B ' 139' ' ' THR . . . . . . . . . . . . . 31.5 m -108.23 128.16 54.47 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.207 -0.452 . . . . 0.0 110.328 -179.857 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' B' B ' 140' ' ' LEU . . . . . 0.46 HD12 HG22 ' B' ' 131' ' ' VAL . 9.4 tp -114.02 122.56 47.28 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 115.763 -0.653 . . . . 0.0 109.567 -178.058 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' B' B ' 141' ' ' ILE . . . . . . . . . . . . . 19.6 mt -121.37 119.71 59.85 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.34 0 N-CA-C 109.949 -0.389 . . . . 0.0 109.949 -175.322 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' B' B ' 142' ' ' ARG . . . . . . . . . . . . . 45.2 ttp180 -114.05 127.9 56.15 Favored 'General case' 0 C--N 1.331 -0.229 0 CA-C-N 115.517 -0.765 . . . . 0.0 110.314 -177.216 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' B' B ' 143' ' ' THR . . . . . . . . . . . . . 20.3 p . . . . . 0 C--O 1.22 -0.489 0 CA-C-O 118.09 -0.957 . . . . 0.0 110.625 -179.661 . . . . . . . . 0 0 . 1 . 014 nuclear nobuild full ' C' C ' -3' ' ' GLU . . . . . . . . . . . . . 95.6 mt-10 . . . . . 0 N--CA 1.49 1.562 0 N-CA-C 109.284 -0.636 . . . . 0.0 109.284 . . . . . . . . . 0 0 . 1 . 014 nuclear nobuild full ' C' C ' -2' ' ' GLY . . . . . . . . . . . . . . . -76.91 142.24 27.33 Favored Glycine 0 CA--C 1.525 0.678 0 N-CA-C 111.009 -0.836 . . . . 0.0 111.009 179.998 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' C' C ' -1' ' ' VAL . . . . . . . . . . . . . 42.0 t -96.8 136.51 27.36 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.378 0 N-CA-C 110.026 -0.361 . . . . 0.0 110.026 179.788 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' C' C ' 0' ' ' ILE . . . . . . . . . . . . . 72.5 mt -104.21 127.09 58.75 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.264 0 N-CA-C 109.84 -0.429 . . . . 0.0 109.84 178.844 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' C' C ' 1' ' ' MET . . . . . . . . . . . . . 24.2 ptm -144.84 144.87 31.35 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.849 -178.341 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' C' C ' 2' ' ' SER . . . . . . . . . . . . . 5.5 p -130.95 130.5 43.51 Favored 'General case' 0 C--N 1.331 -0.202 0 CA-C-O 121.119 0.485 . . . . 0.0 110.954 179.129 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' C' C ' 3' ' ' GLU . . . . . . . . . . . . . 45.9 mp0 -139.45 142.19 37.41 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 115.785 -0.643 . . . . 0.0 110.707 179.232 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' C' C ' 4' ' ' LEU . . . . . 0.457 HD21 HD21 ' C' ' 6' ' ' LEU . 14.3 tp -124.52 127.42 47.4 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 116.085 -0.507 . . . . 0.0 110.214 176.593 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' C' C ' 5' ' ' LYS . . . . . . . . . . . . . 60.7 mttp -104.41 121.1 42.71 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.404 -0.362 . . . . 0.0 110.538 177.926 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' C' C ' 6' ' ' LEU . . . . . 0.457 HD21 HD21 ' C' ' 4' ' ' LEU . 54.8 mt -116.8 149.94 39.14 Favored 'General case' 0 C--N 1.331 -0.225 0 CA-C-N 115.603 -0.726 . . . . 0.0 110.927 -178.155 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' C' C ' 7' ' ' LYS . . . . . . . . . . . . . 59.7 tttm -138.07 142.91 37.39 Favored Pre-proline 0 CA--C 1.534 0.341 0 CA-C-N 116.28 -0.418 . . . . 0.0 109.958 175.448 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' C' C ' 8' ' ' PRO . . . . . . . . . . . . . 96.7 Cg_endo -91.46 143.39 3.02 Favored 'Trans proline' 0 N--CA 1.49 1.317 0 C-N-CA 121.763 1.642 . . . . 0.0 112.01 179.04 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' C' C ' 9' ' ' LEU . . . . . . . . . . . . . 50.5 mt -85.57 -48.19 0.58 Allowed Pre-proline 0 CA--C 1.534 0.363 0 CA-C-O 118.661 -0.685 . . . . 0.0 112.393 -179.544 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' C' C ' 10' ' ' PRO . . . . . . . . . . . . . 90.8 Cg_endo -79.97 157.97 23.93 Favored 'Trans proline' 0 N--CA 1.497 1.677 0 C-N-CA 121.17 1.247 . . . . 0.0 111.99 176.976 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' C' C ' 11' ' ' LYS . . . . . . . . . . . . . 1.9 ttmp? -88.35 95.35 10.16 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 116.333 -0.394 . . . . 0.0 110.548 179.358 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' C' C ' 12' ' ' VAL . . . . . . . . . . . . . 12.7 p -144.78 147.34 19.18 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.284 0 CA-C-N 116.296 -0.411 . . . . 0.0 110.669 -179.596 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' C' C ' 13' ' ' GLU . . . . . . . . . . . . . 84.7 tt0 -94.09 129.54 40.59 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.348 -0.387 . . . . 0.0 110.145 177.685 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' C' C ' 14' ' ' LEU . . . . . . . . . . . . . 18.3 mt -97.47 153.05 38.5 Favored Pre-proline 0 C--N 1.329 -0.304 0 CA-C-N 116.458 -0.337 . . . . 0.0 110.9 -176.575 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' C' C ' 15' ' ' PRO . . . . . . . . . . . . . 25.6 Cg_exo -62.48 162.19 25.08 Favored 'Trans proline' 0 N--CA 1.498 1.753 0 C-N-CA 121.242 1.295 . . . . 0.0 111.939 176.905 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' C' C ' 16' ' ' PRO . . . . . . . . . . . . . 25.6 Cg_exo -61.32 -36.58 78.32 Favored 'Trans proline' 0 N--CA 1.499 1.811 0 C-N-CA 121.423 1.415 . . . . 0.0 112.611 -178.488 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' C' C ' 17' ' ' ASP . . . . . . . . . . . . . 19.4 p-10 -89.5 9.72 25.51 Favored 'General case' 0 CA--C 1.535 0.4 0 N-CA-C 113.35 0.87 . . . . 0.0 113.35 -176.882 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' C' C ' 18' ' ' PHE . . . . . . . . . . . . . 47.3 t80 -58.07 -43.24 86.86 Favored 'General case' 0 C--O 1.227 -0.101 0 O-C-N 122.051 -0.406 . . . . 0.0 110.078 -178.281 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' C' C ' 19' ' ' VAL . . . . . . . . . . . . . 54.6 t -57.04 -42.17 78.85 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.321 0 CA-C-N 116.415 -0.357 . . . . 0.0 110.458 -178.751 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' C' C ' 20' ' ' ASP . . . . . . . . . . . . . 38.7 t0 -59.59 -43.52 93.66 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-O 120.874 0.369 . . . . 0.0 110.814 -178.153 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' C' C ' 21' ' ' VAL . . . . . . . . . . . . . 48.2 t -64.81 -46.01 93.3 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.326 0 CA-C-N 116.34 -0.391 . . . . 0.0 110.511 -178.23 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' C' C ' 22' ' ' ILE . . . . . 0.52 HG22 HD12 ' C' ' 26' ' ' LEU . 50.5 mm -59.77 -37.84 73.21 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.311 0 C-N-CA 120.946 -0.302 . . . . 0.0 110.779 -179.353 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' C' C ' 23' ' ' ARG . . . . . . . . . . . . . 36.7 ttp180 -57.75 -49.15 77.53 Favored 'General case' 0 C--N 1.33 -0.263 0 C-N-CA 120.689 -0.404 . . . . 0.0 110.457 178.187 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' C' C ' 24' ' ' ILE . . . . . . . . . . . . . 74.1 mt -61.45 -44.55 98.74 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.295 0 CA-C-N 116.1 -0.5 . . . . 0.0 111.952 -177.225 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' C' C ' 25' ' ' LYS . . . . . 0.472 ' HE3' HD13 ' C' ' 22' ' ' ILE . 0.7 OUTLIER -70.06 -34.52 73.31 Favored 'General case' 0 CA--C 1.534 0.361 0 C-N-CA 120.834 -0.346 . . . . 0.0 111.815 -174.676 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' C' C ' 26' ' ' LEU . . . . . 0.52 HD12 HG22 ' C' ' 22' ' ' ILE . 89.4 mt -78.78 -45.03 21.89 Favored 'General case' 0 C--N 1.331 -0.22 0 N-CA-C 113.085 0.772 . . . . 0.0 113.085 -174.18 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' C' C ' 27' ' ' GLN . . . . . . . . . . . . . 11.3 pt20 -47.29 139.78 6.03 Favored 'General case' 0 N--CA 1.469 0.517 0 N-CA-C 112.674 0.62 . . . . 0.0 112.674 -174.542 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' C' C ' 28' ' ' GLY . . . . . . . . . . . . . . . 99.75 -25.42 28.33 Favored Glycine 0 CA--C 1.535 1.286 0 CA-C-N 115.497 -0.774 . . . . 0.0 112.235 -176.535 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' C' C ' 29' ' ' LYS . . . . . . . . . . . . . 90.2 mttt -97.95 155.17 17.21 Favored 'General case' 0 C--O 1.232 0.169 0 CA-C-N 117.285 0.543 . . . . 0.0 110.963 178.755 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' C' C ' 30' ' ' THR . . . . . . . . . . . . . 24.8 m -106.65 136.63 46.13 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.034 -0.53 . . . . 0.0 109.977 175.515 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' C' C ' 31' ' ' VAL . . . . . . . . . . . . . 34.8 m -132.11 158.05 43.22 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.219 0 CA-C-O 120.889 0.375 . . . . 0.0 111.211 -177.378 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' C' C ' 32' ' ' ARG . . . . . . . . . . . . . 75.2 mtp180 -134.24 153.22 51.98 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-O 121.299 0.571 . . . . 0.0 110.809 178.656 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' C' C ' 33' ' ' THR . . . . . . . . . . . . . 28.0 m -53.52 139.74 30.39 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 116.066 -0.515 . . . . 0.0 111.317 -179.047 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' C' C ' 34' ' ' GLY . . . . . . . . . . . . . . . 99.78 -17.23 57.69 Favored Glycine 0 CA--C 1.533 1.173 0 CA-C-O 119.67 -0.517 . . . . 0.0 113.289 178.21 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' C' C ' 35' ' ' ASP . . . . . . . . . . . . . 79.2 m-20 -66.6 147.9 52.64 Favored 'General case' 0 C--O 1.232 0.172 0 CA-C-N 118.072 0.936 . . . . 0.0 111.166 178.901 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' C' C ' 36' ' ' VAL . . . . . . . . . . . . . 43.1 t -121.79 129.8 75.15 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.239 0 CA-C-N 116.039 -0.528 . . . . 0.0 109.696 177.282 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' C' C ' 37' ' ' ILE . . . . . . . . . . . . . 68.0 mt -120.84 139.57 47.69 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.322 0 CA-C-N 116.343 -0.39 . . . . 0.0 110.052 -178.726 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' C' C ' 38' ' ' GLY . . . . . . . . . . . . . . . -110.62 128.76 8.94 Favored Glycine 0 CA--C 1.526 0.728 0 N-CA-C 111.208 -0.757 . . . . 0.0 111.208 -179.953 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' C' C ' 39' ' ' ILE . . . . . . . . . . . . . 72.8 mt -123.52 137.94 55.04 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.255 0 N-CA-C 109.965 -0.383 . . . . 0.0 109.965 178.999 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' C' C ' 40' ' ' SER . . . . . . . . . . . . . 46.7 t -92.2 113.93 26.33 Favored 'General case' 0 C--N 1.329 -0.296 0 C-N-CA 120.896 -0.321 . . . . 0.0 110.742 176.479 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' C' C ' 41' ' ' ILE . . . . . . . . . . . . . 45.2 mm -122.54 114.91 44.33 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.214 0 N-CA-C 110.026 -0.361 . . . . 0.0 110.026 179.093 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' C' C ' 42' ' ' LEU . . . . . . . . . . . . . 79.5 mt 57.33 35.11 25.66 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.456 -0.338 . . . . 0.0 111.686 178.806 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' C' C ' 43' ' ' GLY . . . . . . . . . . . . . . . 77.98 -10.14 28.05 Favored Glycine 0 CA--C 1.534 1.249 0 C-N-CA 121.311 -0.471 . . . . 0.0 113.575 177.903 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' C' C ' 44' ' ' LYS . . . . . . . . . . . . . 61.9 tttm -96.1 134.2 39.44 Favored 'General case' 0 C--N 1.333 -0.111 0 CA-C-N 117.742 0.771 . . . . 0.0 109.762 176.445 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' C' C ' 45' ' ' GLU . . . . . . . . . . . . . 84.5 tt0 -83.04 123.63 29.66 Favored 'General case' 0 C--N 1.328 -0.335 0 C-N-CA 120.789 -0.365 . . . . 0.0 110.629 -179.73 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' C' C ' 46' ' ' VAL . . . . . . . . . . . . . 7.3 p -117.71 127.26 75.08 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.257 0 N-CA-C 109.448 -0.575 . . . . 0.0 109.448 177.235 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' C' C ' 47' ' ' LYS . . . . . . . . . . . . . 54.8 mtpt -99.51 127.99 45.6 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 115.848 -0.614 . . . . 0.0 110.89 178.858 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' C' C ' 48' ' ' PHE . . . . . . . . . . . . . 92.2 m-85 -110.98 131.97 54.6 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.272 -0.422 . . . . 0.0 110.017 176.153 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' C' C ' 49' ' ' LYS . . . . . . . . . . . . . 78.7 tttt -107.64 135.66 48.7 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.409 -0.36 . . . . 0.0 110.207 179.479 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' C' C ' 50' ' ' VAL . . . . . . . . . . . . . 43.9 t -81.16 109.57 15.64 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.272 0 N-CA-C 109.408 -0.59 . . . . 0.0 109.408 176.833 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' C' C ' 51' ' ' VAL . . . . . . . . . . . . . 48.8 t -70.12 -47.91 65.1 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.292 0 N-CA-C 109.785 -0.45 . . . . 0.0 109.785 -174.923 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' C' C ' 52' ' ' GLN . . . . . . . . . . . . . 46.1 tt0 -168.11 139.95 2.92 Favored 'General case' 0 C--N 1.33 -0.267 0 C-N-CA 120.278 -0.569 . . . . 0.0 111.638 -179.217 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' C' C ' 53' ' ' ALA . . . . . 0.44 ' HB1' ' HB2' ' C' ' 58' ' ' LEU . . . -110.59 133.45 53.3 Favored 'General case' 0 C--N 1.33 -0.239 0 CA-C-N 115.673 -0.694 . . . . 0.0 109.904 176.059 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' C' C ' 54' ' ' TYR . . . . . . . . . . . . . 30.3 t80 -129.08 112.12 18.42 Favored Pre-proline 0 CA--C 1.536 0.44 0 CA-C-O 118.247 -0.882 . . . . 0.0 110.551 179.396 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' C' C ' 55' ' ' PRO . . . . . . . . . . . . . 72.6 Cg_endo -77.07 165.79 84.0 Favored 'Cis proline' 0 N--CA 1.499 1.826 0 CA-C-N 121.953 1.733 . . . . 0.0 112.205 -7.299 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' C' C ' 56' ' ' SER . . . . . . . . . . . . . 41.8 m -113.82 130.8 23.49 Favored Pre-proline 0 CA--C 1.538 0.492 0 CA-C-O 118.529 -0.748 . . . . 0.0 109.337 175.072 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' C' C ' 57' ' ' PRO . . . . . . . . . . . . . 50.0 Cg_endo -69.55 145.47 79.04 Favored 'Cis proline' 0 N--CA 1.498 1.738 0 CA-C-N 121.885 1.709 . . . . 0.0 111.626 0.711 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' C' C ' 58' ' ' LEU . . . . . 0.44 ' HB2' ' HB1' ' C' ' 53' ' ' ALA . 21.8 tp -108.16 134.53 50.89 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.291 -0.413 . . . . 0.0 110.761 -178.784 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' C' C ' 59' ' ' ARG . . . . . . . . . . . . . 31.5 ttm180 -100.78 128.55 46.78 Favored 'General case' 0 C--N 1.328 -0.361 0 N-CA-C 109.325 -0.62 . . . . 0.0 109.325 175.227 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' C' C ' 60' ' ' VAL . . . . . . . . . . . . . 44.2 t -84.35 116.94 28.93 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.266 0 C-N-CA 120.613 -0.435 . . . . 0.0 110.411 -177.522 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' C' C ' 61' ' ' GLU . . . . . . . . . . . . . 65.2 mm-40 -126.14 163.68 22.59 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-N 115.744 -0.662 . . . . 0.0 109.774 176.862 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' C' C ' 62' ' ' ASP . . . . . . . . . . . . . 62.7 m-20 -52.72 -32.38 42.62 Favored 'General case' 0 C--N 1.329 -0.32 0 N-CA-C 111.794 0.294 . . . . 0.0 111.794 178.921 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' C' C ' 63' ' ' ARG . . . . . . . . . . . . . 92.6 mtt-85 -73.69 -22.08 60.04 Favored 'General case' 0 CA--C 1.533 0.312 0 N-CA-C 112.922 0.712 . . . . 0.0 112.922 -177.163 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' C' C ' 64' ' ' THR . . . . . . . . . . . . . 35.7 m -67.82 136.83 54.74 Favored 'General case' 0 C--N 1.332 -0.187 0 CA-C-O 120.982 0.42 . . . . 0.0 110.999 -173.631 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' C' C ' 65' ' ' LYS . . . . . . . . . . . . . 55.2 mtmt -90.56 132.11 35.9 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 115.807 -0.633 . . . . 0.0 110.578 178.484 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' C' C ' 66' ' ' ILE . . . . . . . . . . . . . 64.8 mt -113.65 128.55 70.48 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.258 0 N-CA-C 109.645 -0.502 . . . . 0.0 109.645 178.909 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' C' C ' 67' ' ' THR . . . . . . . . . . . . . 18.0 m -127.27 142.67 51.41 Favored 'General case' 0 C--O 1.233 0.218 0 CA-C-O 121.047 0.451 . . . . 0.0 111.11 -177.147 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' C' C ' 68' ' ' LEU . . . . . . . . . . . . . 13.7 tp -100.43 133.81 44.31 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 115.912 -0.586 . . . . 0.0 109.832 176.975 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' C' C ' 69' ' ' VAL . . . . . . . . . . . . . 42.9 t -82.88 117.58 29.06 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.305 0 C-N-CA 120.745 -0.382 . . . . 0.0 110.274 -178.408 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' C' C ' 70' ' ' THR . . . . . . . . . . . . . 69.7 p -145.48 172.92 12.51 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.016 -0.538 . . . . 0.0 110.675 -179.817 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' C' C ' 71' ' ' HIS . . . . . . . . . . . . . 5.6 t60 -127.04 89.6 51.56 Favored Pre-proline 0 CA--C 1.534 0.335 0 CA-C-N 116.286 -0.415 . . . . 0.0 110.794 -178.76 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' C' C ' 72' ' ' PRO . . . . . . . . . . . . . 73.7 Cg_endo -78.72 158.83 28.2 Favored 'Trans proline' 0 N--CA 1.495 1.591 0 C-N-CA 121.512 1.475 . . . . 0.0 112.886 -178.907 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' C' C ' 73' ' ' VAL . . . . . . . . . . . . . 35.9 m -127.0 174.38 10.89 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.157 0 CA-C-N 115.952 -0.567 . . . . 0.0 110.043 177.46 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' C' C ' 74' ' ' ASP . . . . . . . . . . . . . 21.4 t0 -99.06 122.9 42.9 Favored 'General case' 0 C--N 1.329 -0.291 0 C-N-CA 120.896 -0.322 . . . . 0.0 110.24 -177.552 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' C' C ' 75' ' ' VAL . . . . . . . . . . . . . 41.5 t -119.96 123.33 70.6 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.2 0 CA-C-O 121.044 0.449 . . . . 0.0 110.527 -179.225 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' C' C ' 76' ' ' LEU . . . . . . . . . . . . . 5.3 mp -119.49 147.63 44.2 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 115.671 -0.695 . . . . 0.0 109.788 176.285 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' C' C ' 77' ' ' GLU . . . . . . . . . . . . . 97.8 mt-10 -136.06 134.37 38.36 Favored 'General case' 0 C--N 1.331 -0.211 0 CA-C-O 121.074 0.464 . . . . 0.0 111.327 -179.303 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' C' C ' 78' ' ' ALA . . . . . 0.743 ' HB2' HD21 ' C' ' 109' ' ' LEU . . . -124.22 133.45 53.52 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 115.696 -0.684 . . . . 0.0 109.603 176.083 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' C' C ' 79' ' ' LYS . . . . . 0.563 ' O ' HD13 ' C' ' 80' ' ' ILE . 50.0 mtpt -81.52 119.07 23.29 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-O 120.975 0.417 . . . . 0.0 110.697 -178.273 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' C' C ' 80' ' ' ILE . . . . . 0.563 HD13 ' O ' ' C' ' 79' ' ' LYS . 44.1 mm -139.18 103.09 1.83 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.338 0 N-CA-C 109.009 -0.737 . . . . 0.0 109.009 -177.1 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' C' C ' 81' ' ' LYS . . . . . . . . . . . . . 73.2 mttt -92.2 127.9 37.85 Favored 'General case' 0 C--N 1.328 -0.359 0 C-N-CA 120.644 -0.422 . . . . 0.0 111.037 -176.776 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' C' C ' 82' ' ' GLY . . . . . . . . . . . . . . . 88.98 42.18 5.71 Favored Glycine 0 CA--C 1.523 0.591 0 C-N-CA 120.889 -0.672 . . . . 0.0 112.204 173.978 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' C' C ' 83' ' ' ILE . . . . . . . . . . . . . 67.9 mt -71.26 131.89 33.96 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.217 0 N-CA-C 109.306 -0.627 . . . . 0.0 109.306 176.206 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' C' C ' 84' ' ' LYS . . . . . . . . . . . . . 28.0 ttpp -101.47 -45.73 5.21 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-O 120.724 0.297 . . . . 0.0 110.741 -176.375 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' C' C ' 85' ' ' ASP . . . . . . . . . . . . . 9.1 t70 -148.25 147.08 28.97 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.324 -0.398 . . . . 0.0 110.674 179.897 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' C' C ' 86' ' ' VAL . . . . . . . . . . . . . 44.2 t -131.74 132.41 61.96 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.229 0 CA-C-O 120.967 0.413 . . . . 0.0 110.683 -178.827 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' C' C ' 87' ' ' ILE . . . . . 0.497 ' N ' HD12 ' C' ' 87' ' ' ILE . 5.1 mp -122.9 130.42 74.48 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.256 0 CA-C-N 115.79 -0.641 . . . . 0.0 109.439 175.814 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' C' C ' 88' ' ' LEU . . . . . . . . . . . . . 23.9 tp -115.49 132.53 56.59 Favored 'General case' 0 N--CA 1.463 0.22 0 CA-C-O 120.991 0.424 . . . . 0.0 111.484 -177.086 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' C' C ' 89' ' ' ASP . . . . . . . . . . . . . 13.8 t70 -120.63 156.62 31.29 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 115.709 -0.678 . . . . 0.0 109.477 175.747 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' C' C ' 90' ' ' GLU . . . . . . . . . . . . . 70.9 mm-40 -48.05 -42.32 28.17 Favored 'General case' 0 N--CA 1.465 0.29 0 N-CA-C 112.723 0.638 . . . . 0.0 112.723 -171.629 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' C' C ' 91' ' ' ASN . . . . . . . . . . . . . 6.3 p30 -132.07 38.49 3.5 Favored 'General case' 0 C--O 1.233 0.223 0 CA-C-O 120.692 0.282 . . . . 0.0 111.488 -178.316 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' C' C ' 92' ' ' LEU . . . . . . . . . . . . . 9.9 tp -165.7 145.19 6.4 Favored 'General case' 0 C--N 1.332 -0.191 0 C-N-CA 120.754 -0.378 . . . . 0.0 110.6 -178.966 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' C' C ' 93' ' ' ILE . . . . . . . . . . . . . 55.9 mt -123.53 125.76 71.99 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.226 0 N-CA-C 109.814 -0.439 . . . . 0.0 109.814 -177.715 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' C' C ' 94' ' ' VAL . . . . . . . . . . . . . 45.8 t -124.01 126.41 72.4 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.221 0 N-CA-C 109.872 -0.418 . . . . 0.0 109.872 178.781 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' C' C ' 95' ' ' VAL . . . . . . . . . . . . . 42.4 t -126.63 137.76 56.82 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.229 0 CA-C-N 116.285 -0.416 . . . . 0.0 110.374 -178.203 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' C' C ' 96' ' ' ILE . . . . . . . . . . . . . 54.8 mt -116.65 129.44 73.14 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.28 0 N-CA-C 109.276 -0.638 . . . . 0.0 109.276 178.505 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' C' C ' 97' ' ' THR . . . . . . . . . . . . . 64.6 p -106.08 157.73 17.33 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-O 121.334 0.588 . . . . 0.0 111.628 -175.955 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' C' C ' 98' ' ' GLU . . . . . . . . . . . . . 12.8 pt-20 -53.87 -23.7 13.46 Favored 'General case' 0 CA--C 1.535 0.375 0 CA-C-N 115.818 -0.628 . . . . 0.0 112.491 179.013 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' C' C ' 99' ' ' GLU . . . . . . . . . . . . . 96.5 mt-10 -77.76 13.31 1.37 Allowed 'General case' 0 CA--C 1.536 0.433 0 N-CA-C 113.074 0.768 . . . . 0.0 113.074 -178.321 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' C' C ' 100' ' ' ASN . . . . . . . . . . . . . 1.9 m-20 61.78 37.53 15.54 Favored 'General case' 0 N--CA 1.463 0.18 0 CA-C-O 120.995 0.426 . . . . 0.0 110.759 179.599 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' C' C ' 101' ' ' GLU . . . . . . . . . . . . . 84.4 tt0 -118.92 145.21 45.94 Favored 'General case' 0 C--O 1.232 0.184 0 CA-C-N 116.058 -0.519 . . . . 0.0 109.919 179.221 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' C' C ' 102' ' ' VAL . . . . . . . . . . . . . 46.8 t -114.98 125.32 72.27 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 N-CA-C 109.646 -0.501 . . . . 0.0 109.646 -179.096 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' C' C ' 103' ' ' LEU . . . . . . . . . . . . . 37.5 mt -116.14 131.77 56.85 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-N 115.707 -0.678 . . . . 0.0 110.423 178.567 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' C' C ' 104' ' ' ILE . . . . . 0.4 HD12 ' HB3' ' C' ' 113' ' ' TYR . 66.3 mt -118.46 121.34 66.83 Favored 'Isoleucine or valine' 0 C--O 1.234 0.277 0 CA-C-N 116.332 -0.395 . . . . 0.0 110.003 177.892 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' C' C ' 105' ' ' PHE . . . . . . . . . . . . . 80.0 m-85 -120.65 162.76 19.13 Favored 'General case' 0 C--N 1.331 -0.219 0 O-C-N 123.994 0.809 . . . . 0.0 109.905 -179.749 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' C' C ' 106' ' ' ASN . . . . . . . . . . . . . 46.4 p-10 -101.09 -170.59 1.86 Allowed 'General case' 0 C--N 1.329 -0.296 0 N-CA-C 110.013 -0.366 . . . . 0.0 110.013 173.76 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' C' C ' 107' ' ' GLN . . . . . . . . . . . . . 46.2 tt0 -58.67 -29.87 66.92 Favored 'General case' 0 C--N 1.329 -0.293 0 N-CA-C 111.942 0.349 . . . . 0.0 111.942 -179.999 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' C' C ' 108' ' ' ASN . . . . . . . . . . . . . 9.7 t30 -85.12 9.98 13.39 Favored 'General case' 0 CA--C 1.535 0.381 0 N-CA-C 113.137 0.791 . . . . 0.0 113.137 -177.177 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' C' C ' 109' ' ' LEU . . . . . 0.743 HD21 ' HB2' ' C' ' 78' ' ' ALA . 8.7 tp 59.18 36.25 23.83 Favored 'General case' 0 C--O 1.232 0.159 0 O-C-N 122.159 -0.338 . . . . 0.0 111.406 178.441 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' C' C ' 110' ' ' GLU . . . . . . . . . . . . . 95.6 mt-10 -105.17 159.81 15.57 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-O 120.758 0.313 . . . . 0.0 110.35 177.766 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' C' C ' 111' ' ' GLU . . . . . . . . . . . . . 84.6 tt0 -84.67 121.98 28.42 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.309 -0.405 . . . . 0.0 110.851 -178.402 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' C' C ' 112' ' ' LEU . . . . . . . . . . . . . 14.7 mt -109.93 -46.07 3.53 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-N 116.081 -0.509 . . . . 0.0 110.158 177.211 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' C' C ' 113' ' ' TYR . . . . . 0.4 ' HB3' HD12 ' C' ' 104' ' ' ILE . 53.2 t80 -139.33 136.94 35.34 Favored 'General case' 0 C--N 1.331 -0.224 0 CA-C-N 116.254 -0.43 . . . . 0.0 111.082 179.854 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' C' C ' 114' ' ' ARG . . . . . . . . . . . . . 71.3 ttp85 -139.09 121.11 15.63 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.054 -0.521 . . . . 0.0 110.18 177.785 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' C' C ' 115' ' ' GLY . . . . . . . . . . . . . . . -150.06 159.85 28.28 Favored Glycine 0 CA--C 1.524 0.634 0 N-CA-C 110.908 -0.877 . . . . 0.0 110.908 178.316 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' C' C ' 116' ' ' LYS . . . . . . . . . . . . . 1.4 ttmp? -131.73 142.64 49.85 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-O 120.822 0.344 . . . . 0.0 110.288 178.491 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' C' C ' 117' ' ' PHE . . . . . . . . . . . . . 31.0 m-85 -138.92 115.46 10.56 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.182 -0.463 . . . . 0.0 109.948 -177.183 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' C' C ' 118' ' ' GLU . . . . . . . . . . . . . 82.9 tt0 -52.9 -48.81 66.93 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.528 -0.305 . . . . 0.0 111.662 -176.005 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' C' C ' 119' ' ' ASN . . . . . . . . . . . . . 4.0 p30 -97.25 31.13 2.55 Favored 'General case' 0 C--N 1.33 -0.259 0 N-CA-C 112.101 0.408 . . . . 0.0 112.101 -175.349 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' C' C ' 120' ' ' LEU . . . . . . . . . . . . . 15.1 tp -52.96 126.55 20.82 Favored 'General case' 0 N--CA 1.463 0.212 0 CA-C-O 120.45 0.167 . . . . 0.0 110.862 177.813 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' C' C ' 121' ' ' ASN . . . . . . . . . . . . . 51.3 t30 -113.76 -44.2 3.21 Favored 'General case' 0 C--N 1.33 -0.258 0 C-N-CA 121.165 -0.214 . . . . 0.0 111.258 -176.133 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' C' C ' 122' ' ' LYS . . . . . . . . . . . . . 88.2 mttt -148.08 151.91 36.46 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-O 121.016 0.436 . . . . 0.0 111.81 -177.267 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' C' C ' 123' ' ' VAL . . . . . . . . . . . . . 42.9 t -131.12 128.92 62.67 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 CA-C-N 115.949 -0.569 . . . . 0.0 109.503 173.865 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' C' C ' 124' ' ' LEU . . . . . . . . . . . . . 62.0 mt -122.35 136.79 54.96 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.43 -0.35 . . . . 0.0 110.308 -178.814 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' C' C ' 125' ' ' VAL . . . . . 0.436 HG23 HG22 ' C' ' 130' ' ' VAL . 12.9 p -133.16 134.59 57.52 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.219 0 CA-C-O 120.997 0.427 . . . . 0.0 110.768 -179.463 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' C' C ' 126' ' ' ARG . . . . . . . . . . . . . 88.8 mtt180 -151.67 135.24 16.2 Favored 'General case' 0 C--N 1.327 -0.37 0 N-CA-C 109.094 -0.706 . . . . 0.0 109.094 176.123 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' C' C ' 127' ' ' ASN . . . . . . . . . . . . . 9.7 p30 48.88 -150.37 0.17 Allowed 'General case' 0 CA--C 1.541 0.62 0 CA-C-O 119.431 -0.318 . . . . 0.0 110.932 179.078 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' C' C ' 128' ' ' ASP . . . . . . . . . . . . . 10.2 p-10 -81.83 18.05 1.38 Allowed 'General case' 0 CA--C 1.535 0.4 0 N-CA-C 112.723 0.638 . . . . 0.0 112.723 179.393 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' C' C ' 129' ' ' LEU . . . . . . . . . . . . . 73.0 mt -117.6 137.66 52.46 Favored 'General case' 0 C--O 1.233 0.184 0 O-C-N 122.083 -0.386 . . . . 0.0 110.416 179.477 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' C' C ' 130' ' ' VAL . . . . . 0.436 HG22 HG23 ' C' ' 125' ' ' VAL . 43.8 t -128.72 140.45 49.21 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.212 0 CA-C-N 116.254 -0.43 . . . . 0.0 110.091 -179.151 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' C' C ' 131' ' ' VAL . . . . . 0.438 ' CG1' HD21 ' C' ' 138' ' ' LEU . 41.4 t -135.46 135.27 51.83 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.226 0 CA-C-O 121.033 0.445 . . . . 0.0 110.273 178.504 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' C' C ' 132' ' ' ILE . . . . . . . . . . . . . 70.6 mt -114.51 133.31 61.0 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.352 0 CA-C-N 115.741 -0.663 . . . . 0.0 109.399 179.263 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' C' C ' 133' ' ' ILE . . . . . . . . . . . . . 39.5 mm -114.8 122.77 69.59 Favored 'Isoleucine or valine' 0 C--O 1.234 0.237 0 CA-C-O 120.714 0.292 . . . . 0.0 110.817 -175.389 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' C' C ' 134' ' ' ASP . . . . . . . . . . . . . 8.2 p-10 -131.92 150.61 52.1 Favored 'General case' 0 C--N 1.331 -0.2 0 N-CA-C 109.855 -0.424 . . . . 0.0 109.855 176.091 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' C' C ' 135' ' ' GLU . . . . . . . . . . . . . 84.7 tt0 -49.89 -26.97 4.58 Favored 'General case' 0 C--N 1.327 -0.39 0 N-CA-C 112.902 0.704 . . . . 0.0 112.902 -172.117 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' C' C ' 136' ' ' GLN . . . . . . . . . . . . . 94.0 mt-30 -93.35 -24.71 18.01 Favored 'General case' 0 C--N 1.33 -0.281 0 N-CA-C 113.088 0.774 . . . . 0.0 113.088 -172.626 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' C' C ' 137' ' ' LYS . . . . . . . . . . . . . 55.6 pttt -170.0 173.72 5.87 Favored 'General case' 0 C--O 1.232 0.163 0 CA-C-O 121.583 0.706 . . . . 0.0 112.553 -173.432 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' C' C ' 138' ' ' LEU . . . . . 0.49 HD23 ' N ' ' C' ' 139' ' ' THR . 4.4 tt -118.51 129.75 55.54 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 114.967 -1.015 . . . . 0.0 109.937 179.592 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' C' C ' 139' ' ' THR . . . . . 0.49 ' N ' HD23 ' C' ' 138' ' ' LEU . 25.9 m -109.83 124.75 51.87 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.406 -0.361 . . . . 0.0 110.319 178.834 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' C' C ' 140' ' ' LEU . . . . . 0.484 ' C ' HD23 ' C' ' 140' ' ' LEU . 7.9 tt -111.52 125.18 53.63 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 115.705 -0.679 . . . . 0.0 109.381 -178.665 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' C' C ' 141' ' ' ILE . . . . . . . . . . . . . 19.3 mt -125.08 120.16 57.66 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.251 0 CA-C-O 120.993 0.425 . . . . 0.0 110.058 -176.011 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' C' C ' 142' ' ' ARG . . . . . . . . . . . . . 59.3 ttp180 -110.8 126.96 55.17 Favored 'General case' 0 C--N 1.331 -0.21 0 CA-C-N 115.574 -0.739 . . . . 0.0 110.19 179.352 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' C' C ' 143' ' ' THR . . . . . . . . . . . . . 24.3 p . . . . . 0 C--O 1.22 -0.464 0 CA-C-O 118.078 -0.963 . . . . 0.0 110.524 179.58 . . . . . . . . 0 0 . 1 . 014 nuclear nobuild full ' D' D ' -3' ' ' GLU . . . . . . . . . . . . . 12.1 pt-20 . . . . . 0 N--CA 1.49 1.544 0 N-CA-C 109.483 -0.562 . . . . 0.0 109.483 . . . . . . . . . 0 0 . 1 . 014 nuclear nobuild full ' D' D ' -2' ' ' GLY . . . . . . . . . . . . . . . -79.04 149.94 33.32 Favored Glycine 0 CA--C 1.525 0.67 0 N-CA-C 110.999 -0.84 . . . . 0.0 110.999 -179.95 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' D' D ' -1' ' ' VAL . . . . . . . . . . . . . 45.1 t -96.25 134.15 34.9 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.32 0 CA-C-O 120.85 0.357 . . . . 0.0 110.083 179.688 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' D' D ' 0' ' ' ILE . . . . . . . . . . . . . 73.4 mt -116.55 131.4 69.25 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.196 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.115 -178.98 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' D' D ' 1' ' ' MET . . . . . . . . . . . . . 25.3 ptp -144.21 179.02 7.49 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.789 179.618 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' D' D ' 2' ' ' SER . . . . . . . . . . . . . 2.8 p -108.06 132.87 53.11 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.202 -0.454 . . . . 0.0 110.521 179.541 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' D' D ' 3' ' ' GLU . . . . . . . . . . . . . 95.8 mt-10 -141.3 140.51 33.85 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.168 -0.469 . . . . 0.0 111.166 -179.217 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' D' D ' 4' ' ' LEU . . . . . 0.4 HD21 HD21 ' D' ' 6' ' ' LEU . 17.8 tp -125.34 131.57 52.98 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 115.928 -0.578 . . . . 0.0 110.062 176.139 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' D' D ' 5' ' ' LYS . . . . . . . . . . . . . 95.2 mttt -109.8 119.93 40.88 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.424 -0.353 . . . . 0.0 110.577 179.514 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' D' D ' 6' ' ' LEU . . . . . 0.4 HD21 HD21 ' D' ' 4' ' ' LEU . 51.5 mt -115.07 145.77 41.98 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 115.365 -0.834 . . . . 0.0 110.555 -177.821 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' D' D ' 7' ' ' LYS . . . . . . . . . . . . . 61.8 tttp -132.65 134.36 24.6 Favored Pre-proline 0 CA--C 1.537 0.458 0 CA-C-O 118.7 -0.667 . . . . 0.0 109.966 177.153 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' D' D ' 8' ' ' PRO . . . . . . . . . . . . . 90.5 Cg_endo -89.54 139.39 3.39 Favored 'Trans proline' 0 N--CA 1.491 1.336 0 C-N-CA 121.437 1.425 . . . . 0.0 111.634 176.531 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' D' D ' 9' ' ' LEU . . . . . . . . . . . . . 55.0 mt -78.02 -47.8 2.15 Favored Pre-proline 0 CA--C 1.533 0.301 0 CA-C-O 118.65 -0.69 . . . . 0.0 112.417 -178.356 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' D' D ' 10' ' ' PRO . . . . . . . . . . . . . 84.2 Cg_endo -80.33 152.53 20.79 Favored 'Trans proline' 0 N--CA 1.497 1.711 0 C-N-CA 121.232 1.288 . . . . 0.0 111.83 176.725 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' D' D ' 11' ' ' LYS . . . . . . . . . . . . . 53.5 tttp -87.97 98.37 11.47 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-O 120.924 0.392 . . . . 0.0 110.373 178.767 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' D' D ' 12' ' ' VAL . . . . . . . . . . . . . 11.9 p -141.12 147.07 22.83 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.262 0 CA-C-N 116.037 -0.529 . . . . 0.0 110.432 -179.538 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' D' D ' 13' ' ' GLU . . . . . . . . . . . . . 96.1 mt-10 -84.87 124.01 31.13 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.347 -0.388 . . . . 0.0 110.371 179.06 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' D' D ' 14' ' ' LEU . . . . . . . . . . . . . 39.8 mt -98.88 144.82 28.87 Favored Pre-proline 0 CA--C 1.534 0.356 0 CA-C-O 119.005 -0.522 . . . . 0.0 110.186 -179.511 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' D' D ' 15' ' ' PRO . . . . . . . . . . . . . 25.2 Cg_exo -62.38 159.32 36.26 Favored 'Trans proline' 0 N--CA 1.497 1.728 0 C-N-CA 121.247 1.298 . . . . 0.0 111.964 177.091 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' D' D ' 16' ' ' PRO . . . . . . . . . . . . . 38.2 Cg_exo -58.32 -41.25 68.13 Favored 'Trans proline' 0 N--CA 1.498 1.758 0 C-N-CA 121.463 1.442 . . . . 0.0 112.948 -178.467 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' D' D ' 17' ' ' ASP . . . . . . . . . . . . . 14.5 p-10 -81.9 5.99 17.22 Favored 'General case' 0 C--N 1.326 -0.432 0 N-CA-C 113.208 0.818 . . . . 0.0 113.208 -177.599 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' D' D ' 18' ' ' PHE . . . . . . . . . . . . . 55.1 t80 -57.59 -42.33 82.97 Favored 'General case' 0 N--CA 1.457 -0.075 0 O-C-N 121.937 -0.477 . . . . 0.0 110.228 -179.514 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' D' D ' 19' ' ' VAL . . . . . . . . . . . . . 47.7 t -56.63 -43.26 78.45 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.263 0 CA-C-N 116.301 -0.409 . . . . 0.0 110.371 -179.358 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' D' D ' 20' ' ' ASP . . . . . . . . . . . . . 81.4 m-20 -60.48 -41.95 95.26 Favored 'General case' 0 C--N 1.33 -0.26 0 C-N-CA 120.981 -0.288 . . . . 0.0 110.895 -178.085 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' D' D ' 21' ' ' VAL . . . . . . . . . . . . . 47.2 t -64.18 -47.93 87.87 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.27 0 C-N-CA 120.742 -0.383 . . . . 0.0 110.35 -177.821 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' D' D ' 22' ' ' ILE . . . . . 0.5 HG22 HD12 ' D' ' 26' ' ' LEU . 50.7 mm -56.11 -46.36 80.96 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.25 0 CA-C-O 120.762 0.315 . . . . 0.0 110.604 179.205 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' D' D ' 23' ' ' ARG . . . . . . . . . . . . . 52.8 ttp180 -54.9 -50.53 68.53 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 116.535 -0.302 . . . . 0.0 111.518 -178.064 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' D' D ' 24' ' ' ILE . . . . . . . . . . . . . 74.9 mt -60.16 -42.17 89.23 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 C-N-CA 121.056 -0.258 . . . . 0.0 111.351 -176.397 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' D' D ' 25' ' ' LYS . . . . . . . . . . . . . 43.6 mtmt -66.85 -39.81 87.7 Favored 'General case' 0 C--N 1.329 -0.316 0 N-CA-C 112.386 0.513 . . . . 0.0 112.386 -178.72 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' D' D ' 26' ' ' LEU . . . . . 0.5 HD12 HG22 ' D' ' 22' ' ' ILE . 92.2 mt -78.48 -40.92 34.04 Favored 'General case' 0 C--N 1.331 -0.23 0 N-CA-C 112.881 0.697 . . . . 0.0 112.881 -173.096 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' D' D ' 27' ' ' GLN . . . . . . . . . . . . . 9.1 pt20 -46.61 140.39 4.46 Favored 'General case' 0 N--CA 1.469 0.496 0 N-CA-C 112.691 0.626 . . . . 0.0 112.691 -176.082 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' D' D ' 28' ' ' GLY . . . . . . . . . . . . . . . 99.51 -26.51 24.08 Favored Glycine 0 CA--C 1.532 1.126 0 CA-C-N 115.511 -0.768 . . . . 0.0 112.144 -176.394 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' D' D ' 29' ' ' LYS . . . . . . . . . . . . . 98.7 mttt -97.86 155.2 17.17 Favored 'General case' 0 C--O 1.234 0.269 0 CA-C-N 117.267 0.534 . . . . 0.0 111.134 178.59 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' D' D ' 30' ' ' THR . . . . . . . . . . . . . 18.5 m -105.8 135.58 46.96 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.002 -0.544 . . . . 0.0 109.695 174.922 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' D' D ' 31' ' ' VAL . . . . . . . . . . . . . 35.1 m -128.35 159.68 39.43 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.245 0 CA-C-N 116.382 -0.372 . . . . 0.0 110.681 -177.916 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' D' D ' 32' ' ' ARG . . . . . . . . . . . . . 57.8 ttp180 -132.75 149.8 52.24 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-O 121.22 0.533 . . . . 0.0 110.507 179.561 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' D' D ' 33' ' ' THR . . . . . . . . . . . . . 22.4 m -53.1 139.58 28.07 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 116.333 -0.394 . . . . 0.0 111.326 -178.412 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' D' D ' 34' ' ' GLY . . . . . . . . . . . . . . . 101.26 -17.05 56.36 Favored Glycine 0 CA--C 1.532 1.155 0 CA-C-O 119.645 -0.53 . . . . 0.0 113.251 179.703 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' D' D ' 35' ' ' ASP . . . . . . . . . . . . . 62.8 m-20 -64.09 148.59 49.49 Favored 'General case' 0 C--O 1.231 0.1 0 CA-C-N 118.037 0.918 . . . . 0.0 111.222 179.102 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' D' D ' 36' ' ' VAL . . . . . . . . . . . . . 45.7 t -124.71 128.82 73.62 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.234 0 CA-C-N 115.577 -0.738 . . . . 0.0 109.541 178.185 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' D' D ' 37' ' ' ILE . . . . . . . . . . . . . 66.0 mt -121.21 138.32 52.0 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.256 0 CA-C-N 116.273 -0.421 . . . . 0.0 110.02 -179.293 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' D' D ' 38' ' ' GLY . . . . . . . . . . . . . . . -108.38 128.53 9.14 Favored Glycine 0 CA--C 1.524 0.646 0 N-CA-C 110.754 -0.938 . . . . 0.0 110.754 178.408 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' D' D ' 39' ' ' ILE . . . . . . . . . . . . . 71.9 mt -123.23 138.16 54.13 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.265 0 N-CA-C 109.934 -0.395 . . . . 0.0 109.934 179.803 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' D' D ' 40' ' ' SER . . . . . 0.513 ' O ' HD13 ' D' ' 41' ' ' ILE . 79.2 p -90.32 118.47 29.84 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.316 -0.402 . . . . 0.0 110.55 176.654 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' D' D ' 41' ' ' ILE . . . . . 0.513 HD13 ' O ' ' D' ' 40' ' ' SER . 48.5 mm -129.5 116.11 37.6 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.266 0 CA-C-N 116.453 -0.339 . . . . 0.0 110.177 179.269 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' D' D ' 42' ' ' LEU . . . . . . . . . . . . . 78.1 mt 57.46 35.77 26.27 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.217 -0.447 . . . . 0.0 111.568 177.991 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' D' D ' 43' ' ' GLY . . . . . . . . . . . . . . . 77.79 -10.1 26.99 Favored Glycine 0 CA--C 1.534 1.237 0 C-N-CA 121.303 -0.475 . . . . 0.0 113.537 177.141 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' D' D ' 44' ' ' LYS . . . . . . . . . . . . . 48.5 tttp -101.52 139.8 36.68 Favored 'General case' 0 C--N 1.333 -0.128 0 CA-C-N 117.838 0.819 . . . . 0.0 109.831 177.123 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' D' D ' 45' ' ' GLU . . . . . . . . . . . . . 84.5 tt0 -83.54 127.81 34.02 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-O 120.957 0.408 . . . . 0.0 110.931 -179.201 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' D' D ' 46' ' ' VAL . . . . . . . . . . . . . 7.4 p -121.15 126.9 75.66 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.169 0 N-CA-C 109.339 -0.615 . . . . 0.0 109.339 176.294 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' D' D ' 47' ' ' LYS . . . . . . . . . . . . . 66.3 mttm -100.31 130.12 46.38 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.166 -0.47 . . . . 0.0 111.415 179.063 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' D' D ' 48' ' ' PHE . . . . . . . . . . . . . 95.4 m-85 -112.96 131.99 55.53 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 115.97 -0.559 . . . . 0.0 109.769 176.192 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' D' D ' 49' ' ' LYS . . . . . . . . . . . . . 81.6 tttt -108.31 137.81 45.65 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.297 -0.41 . . . . 0.0 110.497 179.644 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' D' D ' 50' ' ' VAL . . . . . . . . . . . . . 46.2 t -82.41 107.05 13.94 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.287 0 N-CA-C 109.169 -0.678 . . . . 0.0 109.169 175.785 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' D' D ' 51' ' ' VAL . . . . . . . . . . . . . 46.2 t -72.15 -52.38 24.85 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.318 0 CA-C-N 116.041 -0.527 . . . . 0.0 109.683 -174.442 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' D' D ' 52' ' ' GLN . . . . . . . . . . . . . 91.6 mt-30 -152.43 151.57 30.94 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-O 121.291 0.567 . . . . 0.0 111.595 -178.011 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' D' D ' 53' ' ' ALA . . . . . . . . . . . . . . . -127.01 130.66 50.45 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 115.012 -0.995 . . . . 0.0 109.871 176.658 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' D' D ' 54' ' ' TYR . . . . . . . . . . . . . 68.2 t80 -128.66 106.78 18.74 Favored Pre-proline 0 C--N 1.327 -0.384 0 CA-C-O 118.355 -0.831 . . . . 0.0 110.248 -179.776 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' D' D ' 55' ' ' PRO . . . . . . . . . . . . . 73.3 Cg_endo -77.13 170.07 72.56 Favored 'Cis proline' 0 N--CA 1.501 1.919 0 CA-C-N 121.786 1.674 . . . . 0.0 112.631 -3.156 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' D' D ' 56' ' ' SER . . . . . . . . . . . . . 13.6 m -112.15 121.35 39.55 Favored Pre-proline 0 CA--C 1.539 0.522 0 CA-C-O 118.258 -0.877 . . . . 0.0 109.447 175.584 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' D' D ' 57' ' ' PRO . . . . . . . . . . . . . 54.3 Cg_endo -70.6 170.99 59.53 Favored 'Cis proline' 0 N--CA 1.497 1.704 0 CA-C-N 122.11 1.789 . . . . 0.0 112.109 1.35 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' D' D ' 58' ' ' LEU . . . . . . . . . . . . . 19.3 tp -130.15 137.6 50.21 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 115.885 -0.598 . . . . 0.0 110.246 -179.285 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' D' D ' 59' ' ' ARG . . . . . . . . . . . . . 32.6 ttp180 -106.77 126.74 52.69 Favored 'General case' 0 C--N 1.328 -0.338 0 N-CA-C 109.367 -0.605 . . . . 0.0 109.367 176.169 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' D' D ' 60' ' ' VAL . . . . . . . . . . . . . 47.8 t -83.35 122.4 37.51 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.239 0 C-N-CA 120.667 -0.413 . . . . 0.0 110.384 -174.544 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' D' D ' 61' ' ' GLU . . . . . . . . . . . . . 93.8 mt-10 -131.09 166.94 19.97 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-N 115.794 -0.639 . . . . 0.0 110.081 179.656 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' D' D ' 62' ' ' ASP . . . . . . . . . . . . . 81.9 m-20 -55.41 -32.91 63.05 Favored 'General case' 0 C--N 1.328 -0.363 0 C-N-CA 120.951 -0.3 . . . . 0.0 111.49 179.085 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' D' D ' 63' ' ' ARG . . . . . . . . . . . . . 7.4 ptp180 -89.49 10.13 23.92 Favored 'General case' 0 CA--C 1.535 0.389 0 N-CA-C 113.408 0.892 . . . . 0.0 113.408 -176.225 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' D' D ' 64' ' ' THR . . . . . . . . . . . . . 28.6 m -90.91 137.36 32.42 Favored 'General case' 0 C--O 1.232 0.147 0 CA-C-N 118.126 0.421 . . . . 0.0 110.24 -179.732 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' D' D ' 65' ' ' LYS . . . . . . . . . . . . . 2.2 mptp? -88.52 129.25 35.51 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 116.228 -0.442 . . . . 0.0 110.303 -178.317 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' D' D ' 66' ' ' ILE . . . . . . . . . . . . . 63.6 mt -114.68 129.93 69.95 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.298 0 N-CA-C 109.713 -0.477 . . . . 0.0 109.713 178.594 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' D' D ' 67' ' ' THR . . . . . . . . . . . . . 26.7 m -121.73 136.68 54.94 Favored 'General case' 0 C--N 1.33 -0.239 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.536 -179.22 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' D' D ' 68' ' ' LEU . . . . . . . . . . . . . 19.1 tp -105.2 124.75 50.06 Favored 'General case' 0 C--N 1.33 -0.283 0 CA-C-N 115.936 -0.574 . . . . 0.0 110.218 178.819 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' D' D ' 69' ' ' VAL . . . . . . . . . . . . . 46.8 t -100.88 112.18 32.91 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.323 0 N-CA-C 109.757 -0.46 . . . . 0.0 109.757 179.44 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' D' D ' 70' ' ' THR . . . . . . . . . . . . . 7.1 m -150.16 -35.91 0.16 Allowed 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.067 -0.515 . . . . 0.0 111.369 -179.236 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' D' D ' 71' ' ' HIS . . . . . . . . . . . . . 50.6 t-80 -110.12 89.79 8.77 Favored Pre-proline 0 C--N 1.331 -0.203 0 CA-C-N 116.689 -0.232 . . . . 0.0 111.333 -175.593 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' D' D ' 72' ' ' PRO . . . . . . . . . . . . . 71.8 Cg_endo -80.66 -30.19 1.96 Allowed 'Trans proline' 0 N--CA 1.495 1.596 0 C-N-CA 121.364 1.376 . . . . 0.0 111.997 172.555 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' D' D ' 73' ' ' VAL . . . . . . . . . . . . . 30.2 m -145.45 171.41 5.27 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.308 0 N-CA-C 109.566 -0.531 . . . . 0.0 109.566 175.787 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' D' D ' 74' ' ' ASP . . . . . . . . . . . . . 33.2 t0 -96.06 115.04 26.83 Favored 'General case' 0 C--N 1.329 -0.314 0 N-CA-C 109.82 -0.437 . . . . 0.0 109.82 179.384 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' D' D ' 75' ' ' VAL . . . . . . . . . . . . . 40.0 t -113.42 123.76 69.39 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.206 0 CA-C-O 121.069 0.461 . . . . 0.0 110.24 -178.721 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' D' D ' 76' ' ' LEU . . . . . . . . . . . . . 22.0 mt -126.26 140.42 52.54 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 115.706 -0.679 . . . . 0.0 109.782 179.05 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' D' D ' 77' ' ' GLU . . . . . . . . . . . . . 97.2 mt-10 -133.21 134.39 44.0 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-O 121.018 0.437 . . . . 0.0 111.242 -178.635 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' D' D ' 78' ' ' ALA . . . . . 0.502 ' HB2' HD21 ' D' ' 109' ' ' LEU . . . -124.63 132.82 53.4 Favored 'General case' 0 C--N 1.331 -0.202 0 CA-C-N 115.766 -0.652 . . . . 0.0 109.936 177.026 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' D' D ' 79' ' ' LYS . . . . . 0.597 ' O ' HD13 ' D' ' 80' ' ' ILE . 98.3 mttt -77.85 119.01 20.73 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-O 120.948 0.404 . . . . 0.0 110.924 -177.673 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' D' D ' 80' ' ' ILE . . . . . 0.597 HD13 ' O ' ' D' ' 79' ' ' LYS . 41.3 mm -139.17 110.56 4.99 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.271 0 N-CA-C 109.034 -0.728 . . . . 0.0 109.034 -177.839 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' D' D ' 81' ' ' LYS . . . . . . . . . . . . . 84.3 mttt -104.16 127.0 51.73 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-O 120.765 0.316 . . . . 0.0 111.213 -177.023 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' D' D ' 82' ' ' GLY . . . . . . . . . . . . . . . 88.21 42.2 5.98 Favored Glycine 0 CA--C 1.525 0.667 0 C-N-CA 120.621 -0.8 . . . . 0.0 111.857 173.807 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' D' D ' 83' ' ' ILE . . . . . . . . . . . . . 73.1 mt -71.01 134.27 30.31 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.323 0 N-CA-C 109.858 -0.423 . . . . 0.0 109.858 178.093 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' D' D ' 84' ' ' LYS . . . . . . . . . . . . . 53.3 tttp -89.18 -53.43 4.57 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.09 -0.505 . . . . 0.0 110.063 -179.504 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' D' D ' 85' ' ' ASP . . . . . . . . . . . . . 13.2 t70 -151.52 149.52 29.31 Favored 'General case' 0 C--N 1.327 -0.396 0 CA-C-N 115.671 -0.695 . . . . 0.0 110.529 -179.033 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' D' D ' 86' ' ' VAL . . . . . . . . . . . . . 41.0 t -127.48 128.32 69.72 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.242 0 CA-C-O 120.848 0.356 . . . . 0.0 110.069 178.971 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' D' D ' 87' ' ' ILE . . . . . . . . . . . . . 44.5 mm -116.73 126.38 74.15 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.253 0 N-CA-C 109.582 -0.525 . . . . 0.0 109.582 177.452 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' D' D ' 88' ' ' LEU . . . . . . . . . . . . . 13.0 tp -111.89 133.27 54.19 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-O 121.099 0.476 . . . . 0.0 111.108 -176.864 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' D' D ' 89' ' ' ASP . . . . . . . . . . . . . 12.3 t70 -127.34 158.15 38.03 Favored 'General case' 0 C--N 1.331 -0.23 0 CA-C-N 115.705 -0.679 . . . . 0.0 109.424 176.021 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' D' D ' 90' ' ' GLU . . . . . . . . . . . . . 96.4 mt-10 -46.94 -39.46 12.38 Favored 'General case' 0 C--N 1.33 -0.261 0 N-CA-C 113.066 0.765 . . . . 0.0 113.066 -171.342 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' D' D ' 91' ' ' ASN . . . . . . . . . . . . . 87.1 m-20 -132.04 26.05 4.58 Favored 'General case' 0 N--CA 1.467 0.424 0 N-CA-C 112.631 0.604 . . . . 0.0 112.631 -177.742 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' D' D ' 92' ' ' LEU . . . . . . . . . . . . . 10.2 mt -151.37 144.26 24.49 Favored 'General case' 0 C--N 1.329 -0.285 0 N-CA-C 109.962 -0.384 . . . . 0.0 109.962 -177.706 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' D' D ' 93' ' ' ILE . . . . . . . . . . . . . 70.9 mt -126.92 117.72 48.53 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 N-CA-C 109.241 -0.652 . . . . 0.0 109.241 178.133 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' D' D ' 94' ' ' VAL . . . . . . . . . . . . . 44.3 t -118.99 125.71 74.73 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.271 0 N-CA-C 109.77 -0.455 . . . . 0.0 109.77 -178.832 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' D' D ' 95' ' ' VAL . . . . . . . . . . . . . 45.3 t -121.04 132.8 69.59 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.294 0 CA-C-N 115.949 -0.568 . . . . 0.0 109.79 -179.411 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' D' D ' 96' ' ' ILE . . . . . 0.464 HD11 ' HB ' ' D' ' 123' ' ' VAL . 63.2 mt -113.35 125.12 70.57 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.325 0 N-CA-C 109.114 -0.698 . . . . 0.0 109.114 178.72 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' D' D ' 97' ' ' THR . . . . . . . . . . . . . 69.2 p -99.49 157.34 16.5 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-O 121.315 0.579 . . . . 0.0 111.312 -176.471 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' D' D ' 98' ' ' GLU . . . . . . . . . . . . . 78.2 tt0 -53.89 -24.37 15.82 Favored 'General case' 0 CA--C 1.534 0.364 0 CA-C-N 115.953 -0.567 . . . . 0.0 112.245 178.846 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' D' D ' 99' ' ' GLU . . . . . . . . . . . . . 36.1 tt0 -78.4 13.7 1.47 Allowed 'General case' 0 CA--C 1.54 0.586 0 N-CA-C 112.684 0.624 . . . . 0.0 112.684 -177.438 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' D' D ' 100' ' ' ASN . . . . . . . . . . . . . 3.2 m-20 61.32 38.02 16.65 Favored 'General case' 0 CA--C 1.53 0.175 0 O-C-N 121.871 -0.518 . . . . 0.0 110.974 179.651 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' D' D ' 101' ' ' GLU . . . . . . . . . . . . . 84.4 tt0 -118.79 143.94 46.61 Favored 'General case' 0 C--N 1.331 -0.2 0 CA-C-N 115.947 -0.57 . . . . 0.0 109.72 176.932 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' D' D ' 102' ' ' VAL . . . . . . . . . . . . . 47.4 t -115.0 124.65 71.87 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.323 0 CA-C-N 116.251 -0.432 . . . . 0.0 109.863 -178.537 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' D' D ' 103' ' ' LEU . . . . . . . . . . . . . 69.5 mt -114.13 129.89 56.61 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 115.842 -0.617 . . . . 0.0 109.971 176.823 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' D' D ' 104' ' ' ILE . . . . . 0.587 HD13 HG11 ' D' ' 130' ' ' VAL . 66.7 mt -120.0 119.47 60.25 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.225 0 N-CA-C 110.087 -0.338 . . . . 0.0 110.087 -178.028 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' D' D ' 105' ' ' PHE . . . . . . . . . . . . . 54.2 m-85 -121.42 162.77 19.85 Favored 'General case' 0 C--N 1.331 -0.219 0 O-C-N 123.998 0.811 . . . . 0.0 109.661 179.959 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' D' D ' 106' ' ' ASN . . . . . . . . . . . . . 41.1 p-10 -95.52 -169.99 2.07 Favored 'General case' 0 C--N 1.33 -0.272 0 N-CA-C 109.782 -0.451 . . . . 0.0 109.782 173.2 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' D' D ' 107' ' ' GLN . . . . . . . . . . . . . 45.1 tt0 -58.64 -30.04 66.99 Favored 'General case' 0 C--N 1.329 -0.313 0 N-CA-C 111.847 0.314 . . . . 0.0 111.847 178.951 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' D' D ' 108' ' ' ASN . . . . . . . . . . . . . 21.1 t-20 -84.17 6.61 21.85 Favored 'General case' 0 CA--C 1.536 0.425 0 N-CA-C 113.339 0.866 . . . . 0.0 113.339 -176.68 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' D' D ' 109' ' ' LEU . . . . . 0.502 HD21 ' HB2' ' D' ' 78' ' ' ALA . 11.6 tp 62.23 37.71 13.98 Favored 'General case' 0 CA--C 1.531 0.219 0 CA-C-O 121.013 0.435 . . . . 0.0 111.196 178.456 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' D' D ' 110' ' ' GLU . . . . . . . . . . . . . 42.9 mt-10 -107.26 151.49 25.39 Favored 'General case' 0 C--N 1.33 -0.273 0 N-CA-C 109.859 -0.423 . . . . 0.0 109.859 176.016 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' D' D ' 111' ' ' GLU . . . . . . . . . . . . . 97.7 mt-10 -79.02 121.94 25.56 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-O 121.008 0.432 . . . . 0.0 111.136 -178.575 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' D' D ' 112' ' ' LEU . . . . . . . . . . . . . 29.9 mt -106.92 -45.9 4.06 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 115.888 -0.596 . . . . 0.0 109.811 175.468 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' D' D ' 113' ' ' TYR . . . . . 0.412 ' HB3' HD12 ' D' ' 104' ' ' ILE . 53.4 t80 -141.23 142.92 33.92 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 115.858 -0.61 . . . . 0.0 110.381 179.485 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' D' D ' 114' ' ' ARG . . . . . . . . . . . . . 35.6 ptt-85 -150.58 124.06 9.01 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-O 121.128 0.49 . . . . 0.0 110.841 177.316 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' D' D ' 115' ' ' GLY . . . . . . . . . . . . . . . -150.19 163.0 29.39 Favored Glycine 0 CA--C 1.525 0.673 0 N-CA-C 111.076 -0.81 . . . . 0.0 111.076 -179.417 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' D' D ' 116' ' ' LYS . . . . . . . . . . . . . 34.0 ttpt -131.03 134.55 46.78 Favored 'General case' 0 C--N 1.33 -0.265 0 N-CA-C 109.846 -0.428 . . . . 0.0 109.846 177.717 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' D' D ' 117' ' ' PHE . . . . . . . . . . . . . 26.3 m-85 -133.07 120.44 21.31 Favored 'General case' 0 C--N 1.331 -0.218 0 CA-C-O 120.894 0.378 . . . . 0.0 110.232 -174.915 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' D' D ' 118' ' ' GLU . . . . . . . . . . . . . 46.4 tp10 -51.52 -52.08 49.84 Favored 'General case' 0 C--N 1.328 -0.351 0 N-CA-C 112.01 0.374 . . . . 0.0 112.01 -174.757 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' D' D ' 119' ' ' ASN . . . . . . . . . . . . . 3.3 p30 -100.06 31.28 3.38 Favored 'General case' 0 C--N 1.33 -0.265 0 N-CA-C 112.173 0.434 . . . . 0.0 112.173 -173.735 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' D' D ' 120' ' ' LEU . . . . . . . . . . . . . 14.1 tp -52.92 125.95 18.76 Favored 'General case' 0 N--CA 1.464 0.229 0 O-C-N 122.343 -0.223 . . . . 0.0 110.985 178.263 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' D' D ' 121' ' ' ASN . . . . . . . . . . . . . 4.3 t-20 -113.96 -44.15 3.19 Favored 'General case' 0 C--N 1.331 -0.229 0 C-N-CA 121.129 -0.229 . . . . 0.0 111.218 -176.839 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' D' D ' 122' ' ' LYS . . . . . . . . . . . . . 49.3 mttm -141.98 146.91 36.14 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-O 120.983 0.42 . . . . 0.0 111.908 -177.309 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' D' D ' 123' ' ' VAL . . . . . 0.464 ' HB ' HD11 ' D' ' 96' ' ' ILE . 43.7 t -130.44 123.28 55.01 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.261 0 N-CA-C 109.22 -0.659 . . . . 0.0 109.22 173.106 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' D' D ' 124' ' ' LEU . . . . . 0.409 HD12 ' C ' ' D' ' 123' ' ' VAL . 6.2 mp -122.97 139.31 54.21 Favored 'General case' 0 C--N 1.332 -0.173 0 CA-C-O 120.93 0.395 . . . . 0.0 111.222 -175.763 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' D' D ' 125' ' ' VAL . . . . . . . . . . . . . 11.0 p -133.15 131.99 58.52 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.194 0 CA-C-N 115.921 -0.581 . . . . 0.0 110.239 178.182 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' D' D ' 126' ' ' ARG . . . . . . . . . . . . . 55.9 mtp180 -144.49 120.91 10.98 Favored 'General case' 0 C--N 1.331 -0.23 0 CA-C-N 116.482 -0.326 . . . . 0.0 110.947 179.012 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' D' D ' 127' ' ' ASN . . . . . . . . . . . . . 30.8 m120 49.96 -105.97 0.2 Allowed 'General case' 0 CA--C 1.543 0.696 0 CA-C-O 119.043 -0.503 . . . . 0.0 111.546 178.537 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' D' D ' 128' ' ' ASP . . . . . . . . . . . . . 12.0 p-10 -114.06 4.76 15.79 Favored 'General case' 0 N--CA 1.468 0.456 0 CA-C-N 119.684 1.129 . . . . 0.0 113.372 -178.455 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' D' D ' 129' ' ' LEU . . . . . . . . . . . . . 11.4 tp -106.01 131.27 53.5 Favored 'General case' 0 C--N 1.332 -0.19 0 N-CA-C 109.867 -0.42 . . . . 0.0 109.867 178.845 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' D' D ' 130' ' ' VAL . . . . . 0.587 HG11 HD13 ' D' ' 104' ' ' ILE . 44.1 t -119.23 134.06 64.06 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.283 0 N-CA-C 109.603 -0.517 . . . . 0.0 109.603 178.77 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' D' D ' 131' ' ' VAL . . . . . . . . . . . . . 40.4 t -136.06 135.22 50.38 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.246 0 CA-C-O 121.054 0.454 . . . . 0.0 110.504 -178.948 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' D' D ' 132' ' ' ILE . . . . . . . . . . . . . 68.4 mt -115.69 133.39 62.22 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.271 0 CA-C-N 115.75 -0.659 . . . . 0.0 109.24 177.317 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' D' D ' 133' ' ' ILE . . . . . . . . . . . . . 36.9 mm -116.67 120.69 65.76 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.308 0 CA-C-N 116.356 -0.384 . . . . 0.0 110.743 -174.093 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' D' D ' 134' ' ' ASP . . . . . . . . . . . . . 18.9 p-10 -138.93 150.87 46.4 Favored 'General case' 0 C--N 1.331 -0.202 0 N-CA-C 109.821 -0.437 . . . . 0.0 109.821 173.682 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' D' D ' 135' ' ' GLU . . . . . . . . . . . . . 39.8 tp10 -50.07 -25.92 3.91 Favored 'General case' 0 C--N 1.328 -0.356 0 N-CA-C 113.389 0.885 . . . . 0.0 113.389 -168.375 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' D' D ' 136' ' ' GLN . . . . . . . . . . . . . 20.5 pt20 -99.02 -18.15 17.91 Favored 'General case' 0 N--CA 1.464 0.262 0 N-CA-C 113.566 0.95 . . . . 0.0 113.566 -172.356 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' D' D ' 137' ' ' LYS . . . . . . . . . . . . . 54.6 pttt -161.61 166.73 26.44 Favored 'General case' 0 C--O 1.233 0.193 0 CA-C-O 121.999 0.904 . . . . 0.0 113.344 -175.146 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' D' D ' 138' ' ' LEU . . . . . . . . . . . . . 12.2 tp -117.1 125.73 51.73 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 114.143 -1.389 . . . . 0.0 109.345 176.043 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' D' D ' 139' ' ' THR . . . . . . . . . . . . . 19.4 m -108.41 123.19 48.47 Favored 'General case' 0 C--N 1.331 -0.209 0 CA-C-O 120.705 0.288 . . . . 0.0 110.485 179.289 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' D' D ' 140' ' ' LEU . . . . . 0.477 ' C ' HD23 ' D' ' 140' ' ' LEU . 7.6 tt -112.81 120.74 42.51 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 115.568 -0.742 . . . . 0.0 109.136 -179.09 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' D' D ' 141' ' ' ILE . . . . . . . . . . . . . 19.3 mt -120.91 120.24 61.76 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.367 0 CA-C-O 121.007 0.432 . . . . 0.0 109.953 -176.152 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' D' D ' 142' ' ' ARG . . . . . . . . . . . . . 71.5 ttt180 -106.89 120.28 41.61 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 115.332 -0.849 . . . . 0.0 110.188 -179.778 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' D' D ' 143' ' ' THR . . . . . . . . . . . . . 73.2 p . . . . . 0 C--O 1.22 -0.469 0 CA-C-O 118.011 -0.995 . . . . 0.0 110.63 -179.295 . . . . . . . . 0 0 . 1 . 014 nuclear nobuild full ' E' E ' -3' ' ' GLU . . . . . . . . . . . . . 45.8 tp10 . . . . . 0 N--CA 1.491 1.593 0 N-CA-C 109.361 -0.607 . . . . 0.0 109.361 . . . . . . . . . 0 0 . 1 . 014 nuclear nobuild full ' E' E ' -2' ' ' GLY . . . . . . . . . . . . . . . -64.38 148.39 51.08 Favored Glycine 0 CA--C 1.525 0.692 0 N-CA-C 110.803 -0.919 . . . . 0.0 110.803 179.94 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' E' E ' -1' ' ' VAL . . . . . . . . . . . . . 43.2 t -96.38 138.24 22.18 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.309 0 N-CA-C 110.158 -0.312 . . . . 0.0 110.158 -179.197 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' E' E ' 0' ' ' ILE . . . . . . . . . . . . . 70.1 mt -106.16 125.56 61.78 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 N-CA-C 109.664 -0.495 . . . . 0.0 109.664 178.605 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' E' E ' 1' ' ' MET . . . . . . . . . . . . . 24.4 ptp -91.68 131.09 37.32 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.064 -0.516 . . . . 0.0 110.557 -179.491 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' E' E ' 2' ' ' SER . . . . . . . . . . . . . 6.4 p -122.9 136.65 54.94 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-O 121.038 0.447 . . . . 0.0 110.961 -178.378 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' E' E ' 3' ' ' GLU . . . . . . . . . . . . . 83.5 tt0 -141.27 142.18 33.91 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 115.804 -0.634 . . . . 0.0 110.893 179.946 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' E' E ' 4' ' ' LEU . . . . . 0.518 HD23 ' N ' ' E' ' 5' ' ' LYS . 3.6 tt -123.44 123.32 40.4 Favored 'General case' 0 C--N 1.33 -0.251 0 N-CA-C 109.702 -0.481 . . . . 0.0 109.702 177.978 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' E' E ' 5' ' ' LYS . . . . . 0.518 ' N ' HD23 ' E' ' 4' ' ' LEU . 49.1 mtmt -103.31 119.62 39.21 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.205 -0.452 . . . . 0.0 111.035 -179.263 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' E' E ' 6' ' ' LEU . . . . . . . . . . . . . 15.1 mt -116.01 153.36 31.8 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 115.731 -0.668 . . . . 0.0 110.585 178.768 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' E' E ' 7' ' ' LYS . . . . . . . . . . . . . 59.5 tttp -135.02 136.89 25.86 Favored Pre-proline 0 CA--C 1.534 0.35 0 CA-C-O 119.047 -0.502 . . . . 0.0 109.987 174.609 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' E' E ' 8' ' ' PRO . . . . . . . . . . . . . 88.5 Cg_endo -91.4 137.58 2.07 Favored 'Trans proline' 0 N--CA 1.49 1.287 0 C-N-CA 121.76 1.64 . . . . 0.0 111.366 178.119 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' E' E ' 9' ' ' LEU . . . . . . . . . . . . . 27.0 mt -83.03 -47.66 0.81 Allowed Pre-proline 0 CA--C 1.533 0.309 0 CA-C-O 118.743 -0.646 . . . . 0.0 112.429 -177.133 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' E' E ' 10' ' ' PRO . . . . . . . . . . . . . 62.8 Cg_endo -83.75 156.22 13.73 Favored 'Trans proline' 0 N--CA 1.495 1.609 0 C-N-CA 121.39 1.393 . . . . 0.0 112.151 177.115 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' E' E ' 11' ' ' LYS . . . . . . . . . . . . . 20.2 pttp -78.93 116.59 19.34 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-O 121.286 0.565 . . . . 0.0 110.286 175.523 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' E' E ' 12' ' ' VAL . . . . . . . . . . . . . 12.6 p -150.65 151.99 11.95 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.28 0 CA-C-N 115.779 -0.646 . . . . 0.0 110.756 -177.192 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' E' E ' 13' ' ' GLU . . . . . . . . . . . . . 13.0 pt-20 -91.88 130.95 37.54 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.555 178.394 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' E' E ' 14' ' ' LEU . . . . . . . . . . . . . 31.4 mt -99.87 130.69 25.89 Favored Pre-proline 0 CA--C 1.536 0.437 0 CA-C-O 118.715 -0.66 . . . . 0.0 110.621 -178.341 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' E' E ' 15' ' ' PRO . . . . . . . . . . . . . 23.0 Cg_exo -65.1 161.16 38.35 Favored 'Trans proline' 0 N--CA 1.499 1.842 0 C-N-CA 121.301 1.334 . . . . 0.0 111.893 175.826 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' E' E ' 16' ' ' PRO . . . . . . . . . . . . . 30.4 Cg_exo -59.96 -32.94 95.79 Favored 'Trans proline' 0 N--CA 1.496 1.627 0 C-N-CA 121.442 1.428 . . . . 0.0 112.635 -179.096 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' E' E ' 17' ' ' ASP . . . . . . . . . . . . . 11.3 p-10 -91.13 14.44 14.16 Favored 'General case' 0 CA--C 1.535 0.38 0 N-CA-C 112.989 0.737 . . . . 0.0 112.989 -178.412 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' E' E ' 18' ' ' PHE . . . . . . . . . . . . . 47.8 t80 -55.82 -49.13 74.11 Favored 'General case' 0 C--N 1.334 -0.076 0 O-C-N 121.977 -0.452 . . . . 0.0 110.7 -177.839 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' E' E ' 19' ' ' VAL . . . . . . . . . . . . . 47.5 t -55.77 -42.33 69.6 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.304 0 CA-C-N 116.578 -0.283 . . . . 0.0 110.723 -176.703 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' E' E ' 20' ' ' ASP . . . . . . . . . . . . . 60.5 m-20 -60.12 -43.03 95.95 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-O 120.849 0.357 . . . . 0.0 110.922 -177.85 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' E' E ' 21' ' ' VAL . . . . . . . . . . . . . 44.9 t -64.98 -47.54 87.69 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.306 0 C-N-CA 120.718 -0.393 . . . . 0.0 110.415 -178.036 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' E' E ' 22' ' ' ILE . . . . . 0.565 HG22 HD12 ' E' ' 26' ' ' LEU . 50.2 mm -55.71 -58.72 3.92 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.263 0 C-N-CA 120.92 -0.312 . . . . 0.0 111.108 -178.3 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' E' E ' 23' ' ' ARG . . . . . . . . . . . . . 7.5 ptm180 -56.48 -43.44 79.63 Favored 'General case' 0 C--N 1.332 -0.177 0 C-N-CA 120.618 -0.433 . . . . 0.0 111.859 -173.783 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' E' E ' 24' ' ' ILE . . . . . . . . . . . . . 78.0 mt -60.79 -43.68 95.88 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.293 0 C-N-CA 120.996 -0.281 . . . . 0.0 111.588 -176.682 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' E' E ' 25' ' ' LYS . . . . . . . . . . . . . 98.3 mttt -71.07 -40.73 71.42 Favored 'General case' 0 C--N 1.329 -0.299 0 N-CA-C 112.421 0.526 . . . . 0.0 112.421 -178.365 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' E' E ' 26' ' ' LEU . . . . . 0.565 HD12 HG22 ' E' ' 22' ' ' ILE . 77.1 mt -80.31 -32.59 37.98 Favored 'General case' 0 C--N 1.329 -0.289 0 N-CA-C 113.708 1.003 . . . . 0.0 113.708 -170.859 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' E' E ' 27' ' ' GLN . . . . . . . . . . . . . 9.8 pt20 -47.41 142.13 4.38 Favored 'General case' 0 N--CA 1.469 0.516 0 N-CA-C 112.602 0.593 . . . . 0.0 112.602 -175.61 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' E' E ' 28' ' ' GLY . . . . . . . . . . . . . . . 99.02 -22.17 42.27 Favored Glycine 0 CA--C 1.532 1.149 0 CA-C-N 115.63 -0.714 . . . . 0.0 112.561 -177.494 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' E' E ' 29' ' ' LYS . . . . . . . . . . . . . 28.5 mmtp -96.5 154.97 16.97 Favored 'General case' 0 C--O 1.231 0.122 0 CA-C-N 117.734 0.767 . . . . 0.0 110.846 178.424 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' E' E ' 30' ' ' THR . . . . . . . . . . . . . 41.2 m -110.13 138.64 46.22 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-N 115.803 -0.635 . . . . 0.0 110.307 178.446 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' E' E ' 31' ' ' VAL . . . . . . . . . . . . . 34.7 m -133.4 159.33 42.9 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.247 0 CA-C-N 116.233 -0.44 . . . . 0.0 111.026 -179.159 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' E' E ' 32' ' ' ARG . . . . . . . . . . . . . 77.8 mtp180 -131.98 153.34 50.43 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 115.874 -0.603 . . . . 0.0 110.424 176.408 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' E' E ' 33' ' ' THR . . . . . . . . . . . . . 30.6 m -53.1 139.68 27.8 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.37 -0.377 . . . . 0.0 111.395 -177.915 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' E' E ' 34' ' ' GLY . . . . . . . . . . . . . . . 99.39 -17.14 58.2 Favored Glycine 0 CA--C 1.532 1.153 0 CA-C-O 119.601 -0.555 . . . . 0.0 113.274 178.157 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' E' E ' 35' ' ' ASP . . . . . . . . . . . . . 74.2 m-20 -65.37 148.08 52.33 Favored 'General case' 0 N--CA 1.461 0.112 0 CA-C-N 118.043 0.921 . . . . 0.0 111.211 179.318 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' E' E ' 36' ' ' VAL . . . . . . . . . . . . . 44.4 t -119.61 129.59 75.15 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 CA-C-N 115.649 -0.705 . . . . 0.0 109.705 178.875 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' E' E ' 37' ' ' ILE . . . . . . . . . . . . . 68.9 mt -121.17 139.03 49.62 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.29 0 CA-C-N 116.272 -0.422 . . . . 0.0 109.971 -179.374 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' E' E ' 38' ' ' GLY . . . . . . . . . . . . . . . -112.19 128.7 8.67 Favored Glycine 0 CA--C 1.525 0.701 0 N-CA-C 110.502 -1.039 . . . . 0.0 110.502 177.698 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' E' E ' 39' ' ' ILE . . . . . . . . . . . . . 72.1 mt -123.1 133.42 69.14 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.279 0 N-CA-C 109.944 -0.391 . . . . 0.0 109.944 -179.522 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' E' E ' 40' ' ' SER . . . . . . . . . . . . . 43.2 t -93.44 120.62 33.93 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.444 -0.344 . . . . 0.0 110.949 176.281 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' E' E ' 41' ' ' ILE . . . . . . . . . . . . . 73.6 mt -122.47 114.79 43.89 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.195 0 CA-C-O 120.955 0.407 . . . . 0.0 110.104 177.856 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' E' E ' 42' ' ' LEU . . . . . 0.542 ' O ' HD23 ' E' ' 42' ' ' LEU . 1.3 tt 51.01 44.18 28.68 Favored 'General case' 0 CA--C 1.532 0.274 0 CA-C-O 121.479 0.656 . . . . 0.0 110.829 177.866 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' E' E ' 43' ' ' GLY . . . . . . . . . . . . . . . 71.26 27.8 71.07 Favored Glycine 0 CA--C 1.531 1.084 0 C-N-CA 121.113 -0.565 . . . . 0.0 112.392 176.095 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' E' E ' 44' ' ' LYS . . . . . . . . . . . . . 61.2 tttm -133.9 129.88 36.99 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-N 117.188 0.494 . . . . 0.0 109.952 178.8 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' E' E ' 45' ' ' GLU . . . . . . . . . . . . . 82.6 tt0 -83.35 122.92 29.11 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-O 120.873 0.368 . . . . 0.0 111.274 -177.008 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' E' E ' 46' ' ' VAL . . . . . . . . . . . . . 7.4 p -122.53 128.41 75.36 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.228 0 N-CA-C 109.441 -0.577 . . . . 0.0 109.441 175.213 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' E' E ' 47' ' ' LYS . . . . . . . . . . . . . 62.5 mtpt -100.56 133.14 45.43 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 115.992 -0.549 . . . . 0.0 111.262 179.943 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' E' E ' 48' ' ' PHE . . . . . . . . . . . . . 96.0 m-85 -120.47 132.06 55.04 Favored 'General case' 0 C--N 1.331 -0.219 0 CA-C-N 116.102 -0.499 . . . . 0.0 110.075 176.897 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' E' E ' 49' ' ' LYS . . . . . . . . . . . . . 60.6 tttm -106.32 137.73 43.76 Favored 'General case' 0 C--O 1.233 0.202 0 CA-C-N 116.504 -0.316 . . . . 0.0 110.418 178.076 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' E' E ' 50' ' ' VAL . . . . . . . . . . . . . 44.0 t -80.45 105.22 9.9 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.279 0 N-CA-C 109.133 -0.692 . . . . 0.0 109.133 175.101 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' E' E ' 51' ' ' VAL . . . . . . . . . . . . . 48.0 t -70.18 -49.32 55.87 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.35 0 CA-C-N 115.956 -0.566 . . . . 0.0 109.968 -174.057 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' E' E ' 52' ' ' GLN . . . . . . . . . . . . . 60.0 tt0 -163.31 140.09 7.25 Favored 'General case' 0 C--N 1.332 -0.183 0 C-N-CA 120.179 -0.608 . . . . 0.0 111.681 -179.185 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' E' E ' 53' ' ' ALA . . . . . . . . . . . . . . . -113.64 130.96 56.31 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 115.821 -0.627 . . . . 0.0 109.907 176.238 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' E' E ' 54' ' ' TYR . . . . . . . . . . . . . 65.1 t80 -129.08 109.98 18.19 Favored Pre-proline 0 CA--C 1.535 0.385 0 CA-C-O 118.274 -0.869 . . . . 0.0 110.207 179.588 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' E' E ' 55' ' ' PRO . . . . . . . . . . . . . 73.4 Cg_endo -77.18 170.1 72.43 Favored 'Cis proline' 0 N--CA 1.499 1.838 0 CA-C-N 121.948 1.731 . . . . 0.0 112.541 -3.918 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' E' E ' 56' ' ' SER . . . . . . . . . . . . . 13.4 m -115.12 128.97 25.46 Favored Pre-proline 0 CA--C 1.539 0.546 0 CA-C-O 118.356 -0.83 . . . . 0.0 109.315 175.412 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' E' E ' 57' ' ' PRO . . . . . . . . . . . . . 44.3 Cg_endo -68.27 166.56 68.16 Favored 'Cis proline' 0 N--CA 1.497 1.722 0 CA-C-N 122.037 1.763 . . . . 0.0 111.576 0.407 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' E' E ' 58' ' ' LEU . . . . . 0.485 HD23 HD12 ' E' ' 4' ' ' LEU . 23.3 tp -129.84 138.57 51.06 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-O 121.022 0.439 . . . . 0.0 110.417 -179.148 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' E' E ' 59' ' ' ARG . . . . . . . . . . . . . 55.3 ttp180 -107.1 130.16 54.72 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 115.632 -0.713 . . . . 0.0 109.51 176.969 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' E' E ' 60' ' ' VAL . . . . . . . . . . . . . 43.7 t -77.74 119.9 27.35 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.252 0 C-N-CA 120.74 -0.384 . . . . 0.0 110.266 -177.079 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' E' E ' 61' ' ' GLU . . . . . . . . . . . . . 43.0 mt-10 -130.95 155.06 47.43 Favored 'General case' 0 C--N 1.331 -0.213 0 CA-C-N 115.944 -0.571 . . . . 0.0 110.528 179.148 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' E' E ' 62' ' ' ASP . . . . . . . . . . . . . 28.6 m-20 -54.61 -32.99 59.73 Favored 'General case' 0 C--N 1.326 -0.429 0 CA-C-N 116.491 -0.322 . . . . 0.0 111.777 179.683 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' E' E ' 63' ' ' ARG . . . . . . . . . . . . . 9.3 ptm180 -88.96 7.66 33.5 Favored 'General case' 0 CA--C 1.536 0.441 0 N-CA-C 113.652 0.982 . . . . 0.0 113.652 -175.082 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' E' E ' 64' ' ' THR . . . . . . . . . . . . . 23.3 m -89.51 146.15 24.81 Favored 'General case' 0 C--N 1.331 -0.196 0 CA-C-N 118.066 0.394 . . . . 0.0 110.319 179.648 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' E' E ' 65' ' ' LYS . . . . . . . . . . . . . 94.7 mttt -84.74 121.82 28.22 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-O 120.841 0.353 . . . . 0.0 110.211 179.914 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' E' E ' 66' ' ' ILE . . . . . . . . . . . . . 58.1 mt -112.52 122.53 66.91 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.263 0 N-CA-C 109.237 -0.653 . . . . 0.0 109.237 179.648 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' E' E ' 67' ' ' THR . . . . . . . . . . . . . 9.6 m -129.95 143.41 50.78 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-O 121.127 0.489 . . . . 0.0 111.679 -172.911 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' E' E ' 68' ' ' LEU . . . . . 0.479 HD12 ' N ' ' E' ' 68' ' ' LEU . 7.9 mp -94.57 133.18 38.48 Favored 'General case' 0 C--N 1.331 -0.239 0 CA-C-N 115.799 -0.637 . . . . 0.0 109.631 173.859 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' E' E ' 69' ' ' VAL . . . . . . . . . . . . . 41.8 t -90.59 119.18 37.28 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.342 0 CA-C-O 121.034 0.445 . . . . 0.0 110.764 -176.864 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' E' E ' 70' ' ' THR . . . . . . . . . . . . . 28.5 m -150.04 111.36 4.43 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 115.782 -0.645 . . . . 0.0 109.931 175.793 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' E' E ' 71' ' ' HIS . . . . . . . . . . . . . 97.5 m-70 -150.03 160.48 33.45 Favored Pre-proline 0 C--N 1.33 -0.264 0 C-N-CA 120.758 -0.377 . . . . 0.0 111.187 -177.844 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' E' E ' 72' ' ' PRO . . . . . . . . . . . . . 76.1 Cg_endo -87.37 158.19 8.12 Favored 'Trans proline' 0 N--CA 1.491 1.354 0 C-N-CA 121.747 1.631 . . . . 0.0 112.183 178.312 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' E' E ' 73' ' ' VAL . . . . . . . . . . . . . 32.9 m -70.14 156.28 7.22 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.336 0 CA-C-N 116.253 -0.43 . . . . 0.0 111.226 -179.371 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' E' E ' 74' ' ' ASP . . . . . . . . . . . . . 10.6 t0 -101.07 124.11 46.28 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 115.777 -0.647 . . . . 0.0 109.882 178.366 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' E' E ' 75' ' ' VAL . . . . . . . . . . . . . 41.7 t -111.53 125.02 68.82 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.224 0 CA-C-O 121.133 0.492 . . . . 0.0 110.622 -178.111 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' E' E ' 76' ' ' LEU . . . . . . . . . . . . . 42.5 mt -121.28 143.45 49.16 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 115.593 -0.731 . . . . 0.0 109.6 177.22 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' E' E ' 77' ' ' GLU . . . . . . . . . . . . . 97.9 mt-10 -136.47 134.66 37.88 Favored 'General case' 0 C--N 1.331 -0.201 0 CA-C-O 120.996 0.427 . . . . 0.0 111.462 -178.662 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' E' E ' 78' ' ' ALA . . . . . 0.408 ' HB2' HD21 ' E' ' 109' ' ' LEU . . . -121.86 137.11 54.91 Favored 'General case' 0 C--N 1.331 -0.206 0 CA-C-N 115.728 -0.669 . . . . 0.0 109.751 175.738 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' E' E ' 79' ' ' LYS . . . . . 0.582 ' O ' HD13 ' E' ' 80' ' ' ILE . 61.5 mtpt -84.49 120.73 26.66 Favored 'General case' 0 C--N 1.331 -0.219 0 CA-C-O 120.884 0.373 . . . . 0.0 110.831 -178.166 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' E' E ' 80' ' ' ILE . . . . . 0.582 HD13 ' O ' ' E' ' 79' ' ' LYS . 22.6 mm -139.16 124.84 22.38 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.231 0 CA-C-N 115.937 -0.574 . . . . 0.0 109.688 -177.235 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' E' E ' 81' ' ' LYS . . . . . . . . . . . . . 64.8 mmtt -110.22 123.85 50.54 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-O 120.837 0.351 . . . . 0.0 111.419 -179.169 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' E' E ' 82' ' ' GLY . . . . . . . . . . . . . . . 89.06 42.15 5.69 Favored Glycine 0 CA--C 1.524 0.638 0 C-N-CA 120.698 -0.763 . . . . 0.0 112.044 171.664 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' E' E ' 83' ' ' ILE . . . . . . . . . . . . . 71.9 mt -61.66 135.92 25.73 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.335 0 CA-C-O 120.958 0.408 . . . . 0.0 109.957 178.691 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' E' E ' 84' ' ' LYS . . . . . . . . . . . . . 72.7 tttt -96.54 -50.8 4.58 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 115.739 -0.664 . . . . 0.0 110.021 -179.001 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' E' E ' 85' ' ' ASP . . . . . . . . . . . . . 6.1 t0 -156.12 150.11 25.25 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 115.54 -0.755 . . . . 0.0 110.075 179.261 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' E' E ' 86' ' ' VAL . . . . . . . . . . . . . 45.7 t -129.1 129.29 67.77 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.268 0 CA-C-O 120.92 0.391 . . . . 0.0 110.315 -179.26 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' E' E ' 87' ' ' ILE . . . . . 0.473 HG21 HG21 ' E' ' 125' ' ' VAL . 43.1 mm -118.39 125.18 74.13 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.285 0 CA-C-N 115.99 -0.55 . . . . 0.0 109.767 176.489 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' E' E ' 88' ' ' LEU . . . . . . . . . . . . . 52.1 mt -111.04 136.03 50.67 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-O 121.078 0.466 . . . . 0.0 111.437 -178.14 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' E' E ' 89' ' ' ASP . . . . . . . . . . . . . 13.8 t70 -131.42 153.56 49.58 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 115.537 -0.756 . . . . 0.0 109.319 175.384 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' E' E ' 90' ' ' GLU . . . . . . . . . . . . . 46.2 tp10 -47.28 -39.2 14.03 Favored 'General case' 0 N--CA 1.464 0.264 0 N-CA-C 112.817 0.673 . . . . 0.0 112.817 -172.872 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' E' E ' 91' ' ' ASN . . . . . . . . . . . . . 30.2 m120 -132.11 35.51 3.71 Favored 'General case' 0 N--CA 1.464 0.258 0 C-N-CA 120.974 -0.29 . . . . 0.0 111.743 -177.336 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' E' E ' 92' ' ' LEU . . . . . . . . . . . . . 11.3 tp -166.1 145.82 6.19 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-O 120.781 0.324 . . . . 0.0 110.775 -179.835 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' E' E ' 93' ' ' ILE . . . . . . . . . . . . . 72.1 mt -130.63 125.64 59.16 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.24 0 N-CA-C 109.716 -0.475 . . . . 0.0 109.716 -179.736 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' E' E ' 94' ' ' VAL . . . . . 0.462 HG21 HG11 ' E' ' 125' ' ' VAL . 44.3 t -122.89 126.39 73.73 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.292 0 N-CA-C 109.722 -0.473 . . . . 0.0 109.722 178.986 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' E' E ' 95' ' ' VAL . . . . . . . . . . . . . 45.5 t -123.71 132.73 70.89 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.207 0 N-CA-C 109.915 -0.402 . . . . 0.0 109.915 -178.863 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' E' E ' 96' ' ' ILE . . . . . . . . . . . . . 56.0 mt -118.1 134.64 61.08 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.308 0 N-CA-C 109.125 -0.694 . . . . 0.0 109.125 179.51 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' E' E ' 97' ' ' THR . . . . . . . . . . . . . 58.0 p -109.86 157.29 19.36 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-O 121.357 0.599 . . . . 0.0 111.452 -177.174 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' E' E ' 98' ' ' GLU . . . . . . . . . . . . . 96.4 mt-10 -55.13 -22.1 15.56 Favored 'General case' 0 C--N 1.329 -0.306 0 N-CA-C 112.531 0.567 . . . . 0.0 112.531 179.204 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' E' E ' 99' ' ' GLU . . . . . . . . . . . . . 38.4 tt0 -78.75 14.93 1.16 Allowed 'General case' 0 CA--C 1.54 0.57 0 N-CA-C 112.52 0.563 . . . . 0.0 112.52 -178.614 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' E' E ' 100' ' ' ASN . . . . . . . . . . . . . 2.8 m-20 61.96 37.88 14.7 Favored 'General case' 0 CA--C 1.529 0.167 0 O-C-N 121.763 -0.585 . . . . 0.0 110.857 178.537 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' E' E ' 101' ' ' GLU . . . . . . . . . . . . . 84.5 tt0 -120.57 143.57 48.55 Favored 'General case' 0 C--N 1.333 -0.134 0 CA-C-N 116.051 -0.522 . . . . 0.0 109.73 177.821 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' E' E ' 102' ' ' VAL . . . . . . . . . . . . . 41.1 t -120.94 130.85 74.22 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.267 0 CA-C-N 116.313 -0.403 . . . . 0.0 110.049 -178.247 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' E' E ' 103' ' ' LEU . . . . . . . . . . . . . 5.2 mp -121.33 136.8 54.92 Favored 'General case' 0 C--N 1.331 -0.203 0 CA-C-N 115.938 -0.574 . . . . 0.0 110.486 176.456 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' E' E ' 104' ' ' ILE . . . . . . . . . . . . . 68.2 mt -117.56 122.46 69.89 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.297 0 CA-C-N 115.639 -0.71 . . . . 0.0 109.688 -179.551 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' E' E ' 105' ' ' PHE . . . . . . . . . . . . . 55.5 m-85 -123.26 165.76 16.4 Favored 'General case' 0 C--N 1.331 -0.207 0 O-C-N 123.961 0.788 . . . . 0.0 109.455 179.421 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' E' E ' 106' ' ' ASN . . . . . . . . . . . . . 44.0 p-10 -101.65 -171.84 2.05 Favored 'General case' 0 C--N 1.331 -0.225 0 N-CA-C 109.891 -0.411 . . . . 0.0 109.891 173.746 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' E' E ' 107' ' ' GLN . . . . . . . . . . . . . 43.2 tt0 -60.27 -29.88 69.09 Favored 'General case' 0 C--N 1.328 -0.347 0 N-CA-C 111.912 0.338 . . . . 0.0 111.912 179.886 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' E' E ' 108' ' ' ASN . . . . . . . . . . . . . 60.5 t30 -81.9 6.51 15.61 Favored 'General case' 0 CA--C 1.536 0.405 0 N-CA-C 113.278 0.844 . . . . 0.0 113.278 -177.944 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' E' E ' 109' ' ' LEU . . . . . 0.408 HD21 ' HB2' ' E' ' 78' ' ' ALA . 8.8 tp 62.1 36.45 15.23 Favored 'General case' 0 C--O 1.232 0.163 0 CA-C-O 120.966 0.412 . . . . 0.0 111.533 177.905 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' E' E ' 110' ' ' GLU . . . . . . . . . . . . . 70.9 mm-40 -104.26 148.63 26.12 Favored 'General case' 0 C--N 1.329 -0.315 0 N-CA-C 109.807 -0.442 . . . . 0.0 109.807 175.796 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' E' E ' 111' ' ' GLU . . . . . . . . . . . . . 77.3 tt0 -80.22 122.03 26.35 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.429 -0.351 . . . . 0.0 110.971 -176.528 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' E' E ' 112' ' ' LEU . . . . . . . . . . . . . 26.7 mt -105.02 -46.18 4.34 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 116.29 -0.414 . . . . 0.0 110.725 178.596 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' E' E ' 113' ' ' TYR . . . . . . . . . . . . . 64.5 t80 -143.75 139.8 29.61 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.353 -0.385 . . . . 0.0 111.376 -178.875 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' E' E ' 114' ' ' ARG . . . . . . . . . . . . . 60.8 ttp180 -141.07 120.89 13.49 Favored 'General case' 0 C--N 1.33 -0.239 0 CA-C-N 116.274 -0.421 . . . . 0.0 110.165 176.008 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' E' E ' 115' ' ' GLY . . . . . . . . . . . . . . . -150.01 161.7 28.96 Favored Glycine 0 CA--C 1.524 0.652 0 N-CA-C 110.898 -0.881 . . . . 0.0 110.898 178.557 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' E' E ' 116' ' ' LYS . . . . . . . . . . . . . 32.8 ttmt -128.72 139.56 52.16 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-O 120.777 0.322 . . . . 0.0 110.411 179.462 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' E' E ' 117' ' ' PHE . . . . . . . . . . . . . 43.5 m-85 -131.6 115.48 16.14 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.233 -0.44 . . . . 0.0 110.187 -176.949 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' E' E ' 118' ' ' GLU . . . . . . . . . . . . . 96.3 mt-10 -54.64 -46.5 73.95 Favored 'General case' 0 C--N 1.329 -0.299 0 C-N-CA 121.003 -0.279 . . . . 0.0 111.408 -176.004 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' E' E ' 119' ' ' ASN . . . . . . . . . . . . . 28.6 m120 -97.4 31.04 2.63 Favored 'General case' 0 C--N 1.33 -0.269 0 N-CA-C 112.318 0.488 . . . . 0.0 112.318 -174.22 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' E' E ' 120' ' ' LEU . . . . . . . . . . . . . 19.0 tp -55.43 120.82 7.73 Favored 'General case' 0 C--O 1.232 0.175 0 C-N-CA 121.197 -0.201 . . . . 0.0 110.688 178.125 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' E' E ' 121' ' ' ASN . . . . . . . . . . . . . 31.4 m120 -114.04 -44.15 3.18 Favored 'General case' 0 C--N 1.332 -0.195 0 CA-C-N 116.689 -0.232 . . . . 0.0 111.361 -177.321 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' E' E ' 122' ' ' LYS . . . . . . . . . . . . . 93.5 mttt -146.95 154.09 40.85 Favored 'General case' 0 C--N 1.331 -0.222 0 CA-C-O 121.064 0.459 . . . . 0.0 111.895 -176.313 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' E' E ' 123' ' ' VAL . . . . . . . . . . . . . 43.3 t -132.69 133.8 59.07 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.27 0 CA-C-N 115.971 -0.559 . . . . 0.0 110.089 177.142 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' E' E ' 124' ' ' LEU . . . . . . . . . . . . . 54.4 mt -124.17 134.97 53.18 Favored 'General case' 0 C--N 1.33 -0.239 0 CA-C-N 116.591 -0.277 . . . . 0.0 110.545 179.846 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' E' E ' 125' ' ' VAL . . . . . 0.473 HG21 HG21 ' E' ' 87' ' ' ILE . 35.4 m -134.75 135.67 53.07 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.255 0 CA-C-N 116.454 -0.339 . . . . 0.0 110.836 -179.685 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' E' E ' 126' ' ' ARG . . . . . . . . . . . . . 29.9 mtp180 -148.87 124.79 10.61 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-O 121.01 0.433 . . . . 0.0 110.974 175.925 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' E' E ' 127' ' ' ASN . . . . . . . . . . . . . 23.0 t-20 49.92 -106.52 0.22 Allowed 'General case' 0 CA--C 1.543 0.708 0 CA-C-N 116.094 -0.503 . . . . 0.0 111.544 179.066 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' E' E ' 128' ' ' ASP . . . . . . . . . . . . . 23.7 p-10 -114.01 3.26 15.26 Favored 'General case' 0 N--CA 1.467 0.413 0 CA-C-N 119.63 1.105 . . . . 0.0 113.469 -177.014 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' E' E ' 129' ' ' LEU . . . . . . . . . . . . . 15.1 tp -105.23 134.94 47.51 Favored 'General case' 0 C--N 1.334 -0.106 0 N-CA-C 109.876 -0.416 . . . . 0.0 109.876 179.182 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' E' E ' 130' ' ' VAL . . . . . . . . . . . . . 44.6 t -124.29 135.58 63.26 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.246 0 N-CA-C 109.925 -0.398 . . . . 0.0 109.925 -179.532 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' E' E ' 131' ' ' VAL . . . . . 0.446 HG22 HD12 ' E' ' 140' ' ' LEU . 43.4 t -134.01 133.94 55.88 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.262 0 CA-C-O 121.037 0.446 . . . . 0.0 110.094 179.004 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' E' E ' 132' ' ' ILE . . . . . . . . . . . . . 71.0 mt -114.71 132.36 64.12 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.322 0 CA-C-N 115.808 -0.633 . . . . 0.0 109.306 179.36 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' E' E ' 133' ' ' ILE . . . . . . . . . . . . . 39.3 mm -114.93 120.0 63.32 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.231 0 CA-C-O 120.892 0.377 . . . . 0.0 110.954 -174.909 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' E' E ' 134' ' ' ASP . . . . . . . . . . . . . 9.2 p-10 -132.91 145.3 50.8 Favored 'General case' 0 C--N 1.33 -0.25 0 N-CA-C 109.35 -0.611 . . . . 0.0 109.35 174.516 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' E' E ' 135' ' ' GLU . . . . . . . . . . . . . 76.9 tt0 -49.92 -25.72 3.5 Favored 'General case' 0 C--N 1.327 -0.397 0 N-CA-C 112.859 0.688 . . . . 0.0 112.859 -171.304 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' E' E ' 136' ' ' GLN . . . . . . . . . . . . . 44.2 tt0 -82.69 -38.1 23.86 Favored 'General case' 0 C--O 1.233 0.226 0 N-CA-C 112.136 0.421 . . . . 0.0 112.136 -176.172 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' E' E ' 137' ' ' LYS . . . . . . . . . . . . . 18.2 pttp -160.74 169.25 23.14 Favored 'General case' 0 C--O 1.233 0.207 0 CA-C-O 121.451 0.643 . . . . 0.0 112.126 -173.351 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' E' E ' 138' ' ' LEU . . . . . . . . . . . . . 5.9 tt -114.6 127.4 55.76 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 115.221 -0.899 . . . . 0.0 109.63 177.446 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' E' E ' 139' ' ' THR . . . . . . . . . . . . . 23.4 m -105.21 124.03 48.84 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.275 -179.37 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' E' E ' 140' ' ' LEU . . . . . 0.446 HD12 HG22 ' E' ' 131' ' ' VAL . 35.4 tp -110.79 119.94 40.76 Favored 'General case' 0 C--N 1.327 -0.384 0 N-CA-C 109.287 -0.635 . . . . 0.0 109.287 -179.153 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' E' E ' 141' ' ' ILE . . . . . . . . . . . . . 19.3 mt -121.26 117.11 51.73 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.353 0 CA-C-O 121.002 0.43 . . . . 0.0 109.863 -176.211 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' E' E ' 142' ' ' ARG . . . . . . . . . . . . . 73.9 mtp180 -103.76 129.08 51.11 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 115.433 -0.803 . . . . 0.0 110.417 179.653 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' E' E ' 143' ' ' THR . . . . . . . . . . . . . 11.9 p . . . . . 0 C--O 1.219 -0.506 0 CA-C-O 117.997 -1.001 . . . . 0.0 110.531 179.999 . . . . . . . . 0 0 . 1 . 014 nuclear nobuild full ' F' F ' -3' ' ' GLU . . . . . . . . . . . . . 84.2 tt0 . . . . . 0 N--CA 1.49 1.557 0 N-CA-C 109.243 -0.651 . . . . 0.0 109.243 . . . . . . . . . 0 0 . 1 . 014 nuclear nobuild full ' F' F ' -2' ' ' GLY . . . . . . . . . . . . . . . -95.05 149.96 19.53 Favored Glycine 0 CA--C 1.526 0.732 0 N-CA-C 111.488 -0.645 . . . . 0.0 111.488 -177.476 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' F' F ' -1' ' ' VAL . . . . . . . . . . . . . 45.0 t -141.65 139.31 31.76 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.274 0 N-CA-C 109.736 -0.468 . . . . 0.0 109.736 178.684 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' F' F ' 0' ' ' ILE . . . . . . . . . . . . . 71.0 mt -104.4 120.88 55.42 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.253 0 CA-C-O 120.877 0.37 . . . . 0.0 110.048 -179.446 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' F' F ' 1' ' ' MET . . . . . . . . . . . . . 22.4 ptm -145.07 142.39 29.67 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.099 -0.5 . . . . 0.0 110.81 -179.486 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' F' F ' 2' ' ' SER . . . . . . . . . . . . . 3.5 p -121.95 129.07 52.2 Favored 'General case' 0 C--N 1.331 -0.217 0 CA-C-O 120.904 0.383 . . . . 0.0 110.624 178.75 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' F' F ' 3' ' ' GLU . . . . . . . . . . . . . 95.0 mt-10 -140.16 141.43 36.03 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.025 -0.534 . . . . 0.0 111.141 -177.573 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' F' F ' 4' ' ' LEU . . . . . . . . . . . . . 15.5 tp -125.49 126.99 45.76 Favored 'General case' 0 C--N 1.331 -0.225 0 CA-C-N 115.832 -0.622 . . . . 0.0 110.198 176.828 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' F' F ' 5' ' ' LYS . . . . . . . . . . . . . 95.4 mttt -105.35 120.97 42.92 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.412 -0.358 . . . . 0.0 110.812 178.886 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' F' F ' 6' ' ' LEU . . . . . . . . . . . . . 77.6 mt -116.09 150.27 37.61 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-N 115.495 -0.775 . . . . 0.0 110.371 -179.885 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' F' F ' 7' ' ' LYS . . . . . . . . . . . . . 58.3 tttp -140.96 137.87 17.47 Favored Pre-proline 0 CA--C 1.535 0.369 0 CA-C-O 119.025 -0.512 . . . . 0.0 110.26 176.52 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' F' F ' 8' ' ' PRO . . . . . . . . . . . . . 80.9 Cg_endo -91.73 143.76 2.93 Favored 'Trans proline' 0 N--CA 1.491 1.333 0 C-N-CA 121.69 1.593 . . . . 0.0 111.65 177.065 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' F' F ' 9' ' ' LEU . . . . . . . . . . . . . 64.7 mt -76.69 -48.67 2.86 Favored Pre-proline 0 CA--C 1.534 0.33 0 CA-C-O 118.606 -0.712 . . . . 0.0 112.529 -177.796 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' F' F ' 10' ' ' PRO . . . . . . . . . . . . . 83.7 Cg_endo -79.62 147.71 19.92 Favored 'Trans proline' 0 N--CA 1.497 1.729 0 C-N-CA 121.166 1.244 . . . . 0.0 111.627 178.033 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' F' F ' 11' ' ' LYS . . . . . . . . . . . . . 53.5 pttt -79.36 108.85 13.19 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-O 121.778 0.799 . . . . 0.0 110.315 177.563 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' F' F ' 12' ' ' VAL . . . . . . . . . . . . . 11.7 p -148.37 145.25 18.53 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.291 0 CA-C-N 115.425 -0.807 . . . . 0.0 110.12 -179.134 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' F' F ' 13' ' ' GLU . . . . . . . . . . . . . 41.0 tp10 -87.78 123.18 32.31 Favored 'General case' 0 C--N 1.329 -0.312 0 N-CA-C 109.884 -0.413 . . . . 0.0 109.884 179.165 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' F' F ' 14' ' ' LEU . . . . . . . . . . . . . 33.5 mt -98.09 149.08 35.36 Favored Pre-proline 0 CA--C 1.532 0.288 0 CA-C-N 116.404 -0.362 . . . . 0.0 110.644 -177.258 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' F' F ' 15' ' ' PRO . . . . . . . . . . . . . 25.4 Cg_exo -62.62 159.54 36.36 Favored 'Trans proline' 0 N--CA 1.498 1.791 0 C-N-CA 121.25 1.3 . . . . 0.0 111.978 176.86 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' F' F ' 16' ' ' PRO . . . . . . . . . . . . . 27.9 Cg_exo -60.47 -34.83 92.51 Favored 'Trans proline' 0 N--CA 1.496 1.639 0 C-N-CA 121.414 1.409 . . . . 0.0 112.494 -179.659 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' F' F ' 17' ' ' ASP . . . . . . . . . . . . . 22.2 p-10 -88.04 10.79 17.89 Favored 'General case' 0 CA--C 1.535 0.393 0 N-CA-C 113.024 0.75 . . . . 0.0 113.024 -178.431 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' F' F ' 18' ' ' PHE . . . . . . . . . . . . . 30.1 t80 -58.01 -42.01 84.32 Favored 'General case' 0 N--CA 1.457 -0.115 0 O-C-N 121.932 -0.48 . . . . 0.0 110.158 -178.507 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' F' F ' 19' ' ' VAL . . . . . . . . . . . . . 49.1 t -56.35 -42.86 75.61 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.282 0 CA-C-N 116.469 -0.332 . . . . 0.0 110.41 -179.676 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' F' F ' 20' ' ' ASP . . . . . . . . . . . . . 81.7 m-20 -60.15 -43.0 96.08 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.428 -0.351 . . . . 0.0 110.884 -178.049 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' F' F ' 21' ' ' VAL . . . . . . . . . . . . . 48.7 t -64.18 -48.11 87.08 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.309 0 C-N-CA 120.832 -0.347 . . . . 0.0 110.548 -177.39 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' F' F ' 22' ' ' ILE . . . . . 0.572 HG22 HD12 ' F' ' 26' ' ' LEU . 50.1 mm -55.9 -47.44 79.83 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.312 0 C-N-CA 121.036 -0.266 . . . . 0.0 110.74 -179.978 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' F' F ' 23' ' ' ARG . . . . . . . . . . . . . 54.6 ttp180 -55.38 -48.8 73.76 Favored 'General case' 0 C--N 1.33 -0.276 0 C-N-CA 121.038 -0.265 . . . . 0.0 111.337 -178.291 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' F' F ' 24' ' ' ILE . . . . . . . . . . . . . 73.9 mt -58.48 -41.98 83.18 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.281 0 CA-C-O 120.706 0.288 . . . . 0.0 110.799 -177.378 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' F' F ' 25' ' ' LYS . . . . . . . . . . . . . 51.7 mtpt -65.55 -43.66 89.21 Favored 'General case' 0 C--N 1.327 -0.382 0 N-CA-C 112.319 0.489 . . . . 0.0 112.319 -178.697 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' F' F ' 26' ' ' LEU . . . . . 0.572 HD12 HG22 ' F' ' 22' ' ' ILE . 79.5 mt -79.74 -33.2 40.97 Favored 'General case' 0 C--N 1.331 -0.201 0 N-CA-C 113.874 1.064 . . . . 0.0 113.874 -169.549 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' F' F ' 27' ' ' GLN . . . . . . . . . . . . . 10.8 pt20 -46.76 139.42 5.35 Favored 'General case' 0 N--CA 1.469 0.507 0 N-CA-C 113.027 0.751 . . . . 0.0 113.027 -173.497 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' F' F ' 28' ' ' GLY . . . . . . . . . . . . . . . 99.35 -23.61 35.58 Favored Glycine 0 CA--C 1.535 1.292 0 CA-C-N 115.442 -0.799 . . . . 0.0 112.451 -178.962 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' F' F ' 29' ' ' LYS . . . . . . . . . . . . . 61.1 mttp -97.89 155.15 17.2 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 117.527 0.664 . . . . 0.0 111.136 179.682 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' F' F ' 30' ' ' THR . . . . . . . . . . . . . 36.3 m -104.61 137.01 43.09 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 115.931 -0.577 . . . . 0.0 109.852 175.586 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' F' F ' 31' ' ' VAL . . . . . . . . . . . . . 34.9 m -129.64 153.54 38.94 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.21 0 CA-C-O 121.003 0.43 . . . . 0.0 110.953 -178.379 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' F' F ' 32' ' ' ARG . . . . . . . . . . . . . 38.9 ttm180 -133.66 149.41 51.55 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 115.991 -0.549 . . . . 0.0 110.454 -179.991 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' F' F ' 33' ' ' THR . . . . . . . . . . . . . 21.4 m -52.17 138.7 25.27 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.307 -0.406 . . . . 0.0 111.563 -176.17 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' F' F ' 34' ' ' GLY . . . . . . . . . . . . . . . 100.48 -17.1 57.21 Favored Glycine 0 CA--C 1.533 1.209 0 CA-C-O 119.64 -0.533 . . . . 0.0 113.326 178.536 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' F' F ' 35' ' ' ASP . . . . . . . . . . . . . 80.2 m-20 -66.2 147.37 53.42 Favored 'General case' 0 C--N 1.332 -0.155 0 CA-C-N 118.014 0.907 . . . . 0.0 110.953 178.856 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' F' F ' 36' ' ' VAL . . . . . . . . . . . . . 46.3 t -122.32 129.99 74.88 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.197 0 CA-C-N 115.965 -0.561 . . . . 0.0 109.849 178.225 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' F' F ' 37' ' ' ILE . . . . . . . . . . . . . 69.3 mt -121.83 139.93 47.38 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.247 0 CA-C-N 116.194 -0.457 . . . . 0.0 109.955 -179.138 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' F' F ' 38' ' ' GLY . . . . . . . . . . . . . . . -113.64 128.74 8.46 Favored Glycine 0 CA--C 1.526 0.743 0 N-CA-C 111.282 -0.727 . . . . 0.0 111.282 -179.928 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' F' F ' 39' ' ' ILE . . . . . . . . . . . . . 70.0 mt -121.03 134.94 62.8 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.171 0 N-CA-C 109.959 -0.386 . . . . 0.0 109.959 178.269 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' F' F ' 40' ' ' SER . . . . . . . . . . . . . 87.4 p -92.16 120.68 32.97 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 116.422 -0.353 . . . . 0.0 110.62 175.537 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' F' F ' 41' ' ' ILE . . . . . . . . . . . . . 72.2 mt -132.36 117.56 32.45 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.207 0 CA-C-O 120.757 0.313 . . . . 0.0 110.157 178.554 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' F' F ' 42' ' ' LEU . . . . . . . . . . . . . 8.4 tp 57.95 35.85 25.67 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.176 -0.466 . . . . 0.0 111.363 178.515 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' F' F ' 43' ' ' GLY . . . . . . . . . . . . . . . 77.41 -10.08 24.43 Favored Glycine 0 CA--C 1.535 1.326 0 C-N-CA 121.26 -0.495 . . . . 0.0 113.381 177.431 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' F' F ' 44' ' ' LYS . . . . . . . . . . . . . 59.2 tttm -98.28 134.29 41.51 Favored 'General case' 0 C--N 1.333 -0.126 0 CA-C-N 117.996 0.898 . . . . 0.0 109.897 177.905 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' F' F ' 45' ' ' GLU . . . . . . . . . . . . . 82.3 tt0 -84.53 128.14 34.43 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.325 -0.398 . . . . 0.0 110.903 -179.423 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' F' F ' 46' ' ' VAL . . . . . . . . . . . . . 7.3 p -121.87 126.84 75.1 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.211 0 N-CA-C 109.632 -0.507 . . . . 0.0 109.632 175.936 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' F' F ' 47' ' ' LYS . . . . . . . . . . . . . 59.5 mtpt -100.58 128.85 46.5 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 115.895 -0.593 . . . . 0.0 111.24 179.573 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' F' F ' 48' ' ' PHE . . . . . . . . . . . . . 95.8 m-85 -113.28 131.88 55.76 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.279 -0.419 . . . . 0.0 110.064 176.361 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' F' F ' 49' ' ' LYS . . . . . . . . . . . . . 57.0 tttm -108.66 139.69 43.09 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.47 -0.332 . . . . 0.0 110.471 178.326 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' F' F ' 50' ' ' VAL . . . . . . . . . . . . . 45.2 t -82.22 109.18 15.96 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.308 0 N-CA-C 109.137 -0.69 . . . . 0.0 109.137 175.66 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' F' F ' 51' ' ' VAL . . . . . . . . . . . . . 47.0 t -73.5 -48.4 41.48 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.294 0 CA-C-N 116.015 -0.539 . . . . 0.0 110.032 -173.81 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' F' F ' 52' ' ' GLN . . . . . . . . . . . . . 61.4 tt0 -163.82 139.48 6.38 Favored 'General case' 0 C--N 1.33 -0.239 0 C-N-CA 120.264 -0.574 . . . . 0.0 111.817 -177.604 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' F' F ' 53' ' ' ALA . . . . . . . . . . . . . . . -116.63 131.45 56.95 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 115.832 -0.622 . . . . 0.0 110.108 175.839 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' F' F ' 54' ' ' TYR . . . . . . . . . . . . . 69.0 t80 -129.12 110.63 18.22 Favored Pre-proline 0 CA--C 1.534 0.352 0 CA-C-O 118.343 -0.837 . . . . 0.0 110.393 178.959 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' F' F ' 55' ' ' PRO . . . . . . . . . . . . . 73.9 Cg_endo -77.1 170.1 72.53 Favored 'Cis proline' 0 N--CA 1.499 1.831 0 CA-C-N 121.977 1.742 . . . . 0.0 112.292 -5.93 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' F' F ' 56' ' ' SER . . . . . . . . . . . . . 14.3 m -116.16 135.55 22.83 Favored Pre-proline 0 CA--C 1.54 0.571 0 CA-C-O 118.425 -0.798 . . . . 0.0 109.678 176.155 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' F' F ' 57' ' ' PRO . . . . . . . . . . . . . 56.8 Cg_endo -72.47 148.94 92.67 Favored 'Cis proline' 0 N--CA 1.496 1.651 0 CA-C-N 121.694 1.641 . . . . 0.0 111.339 -3.024 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' F' F ' 58' ' ' LEU . . . . . . . . . . . . . 37.7 tp -107.43 137.78 44.85 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-O 120.929 0.395 . . . . 0.0 110.688 -177.096 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' F' F ' 59' ' ' ARG . . . . . . . . . . . . . 61.0 ttt180 -98.92 125.81 44.44 Favored 'General case' 0 C--N 1.325 -0.457 0 CA-C-N 115.783 -0.644 . . . . 0.0 109.292 176.527 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' F' F ' 60' ' ' VAL . . . . . . . . . . . . . 42.0 t -84.34 114.87 25.45 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.246 0 C-N-CA 120.642 -0.423 . . . . 0.0 110.352 -174.975 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' F' F ' 61' ' ' GLU . . . . . . . . . . . . . 41.0 mt-10 -131.16 160.94 33.29 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 115.931 -0.577 . . . . 0.0 109.827 177.329 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' F' F ' 62' ' ' ASP . . . . . . . . . . . . . 74.4 m-20 -53.24 -32.49 48.58 Favored 'General case' 0 C--N 1.329 -0.283 0 N-CA-C 111.858 0.318 . . . . 0.0 111.858 -179.789 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' F' F ' 63' ' ' ARG . . . . . . . . . . . . . 83.1 mtp180 -72.87 -22.03 60.84 Favored 'General case' 0 CA--C 1.533 0.306 0 N-CA-C 112.913 0.708 . . . . 0.0 112.913 -177.048 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' F' F ' 64' ' ' THR . . . . . . . . . . . . . 32.5 m -69.55 142.67 53.57 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-O 120.82 0.343 . . . . 0.0 110.815 -175.455 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' F' F ' 65' ' ' LYS . . . . . . . . . . . . . 97.7 mttt -88.73 123.22 32.95 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.066 -0.515 . . . . 0.0 110.065 179.698 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' F' F ' 66' ' ' ILE . . . . . . . . . . . . . 63.0 mt -113.58 129.35 69.54 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.295 0 N-CA-C 109.702 -0.481 . . . . 0.0 109.702 -179.916 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' F' F ' 67' ' ' THR . . . . . . . . . . . . . 28.1 m -128.26 142.65 51.09 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.144 -0.48 . . . . 0.0 111.082 -177.473 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' F' F ' 68' ' ' LEU . . . . . . . . . . . . . 4.8 tt -103.48 127.16 50.92 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 115.876 -0.602 . . . . 0.0 109.484 177.135 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' F' F ' 69' ' ' VAL . . . . . . . . . . . . . 42.8 t -84.09 129.39 37.68 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.343 0 CA-C-O 121.047 0.451 . . . . 0.0 110.915 -175.225 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' F' F ' 70' ' ' THR . . . . . . . . . . . . . 74.9 p -145.78 -178.29 6.03 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 115.794 -0.639 . . . . 0.0 110.405 178.438 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' F' F ' 71' ' ' HIS . . . . . . . . . . . . . 73.9 m80 -64.92 162.32 38.92 Favored Pre-proline 0 C--N 1.33 -0.279 0 CA-C-N 116.405 -0.361 . . . . 0.0 110.177 178.626 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' F' F ' 72' ' ' PRO . . . . . . . . . . . . . 11.1 Cg_endo -81.07 -30.16 1.76 Allowed 'Trans proline' 0 N--CA 1.491 1.341 0 C-N-CA 121.501 1.467 . . . . 0.0 112.81 -175.051 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' F' F ' 73' ' ' VAL . . . . . . . . . . . . . 29.6 m -150.14 154.26 9.27 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.225 0 CA-C-O 121.203 0.525 . . . . 0.0 111.471 178.618 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' F' F ' 74' ' ' ASP . . . . . . . . . . . . . 10.0 t70 -102.96 119.32 38.64 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 115.441 -0.8 . . . . 0.0 109.503 175.898 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' F' F ' 75' ' ' VAL . . . . . . . . . . . . . 44.9 t -111.13 123.89 67.43 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.217 0 CA-C-O 121.15 0.5 . . . . 0.0 110.556 -177.347 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' F' F ' 76' ' ' LEU . . . . . . . . . . . . . 25.9 mt -125.93 147.37 49.51 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 115.561 -0.745 . . . . 0.0 109.615 178.546 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' F' F ' 77' ' ' GLU . . . . . . . . . . . . . 98.4 mt-10 -136.24 135.6 39.18 Favored 'General case' 0 C--N 1.331 -0.204 0 CA-C-O 121.134 0.493 . . . . 0.0 111.457 -177.318 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' F' F ' 78' ' ' ALA . . . . . 0.658 ' HB2' HD21 ' F' ' 109' ' ' LEU . . . -123.34 129.2 50.98 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 115.493 -0.776 . . . . 0.0 109.699 176.14 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' F' F ' 79' ' ' LYS . . . . . 0.566 ' O ' HD13 ' F' ' 80' ' ' ILE . 96.8 mttt -76.88 119.23 20.36 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-O 120.915 0.388 . . . . 0.0 110.836 -178.585 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' F' F ' 80' ' ' ILE . . . . . 0.566 HD13 ' O ' ' F' ' 79' ' ' LYS . 42.6 mm -139.09 116.68 11.64 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.326 0 N-CA-C 108.781 -0.822 . . . . 0.0 108.781 -178.186 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' F' F ' 81' ' ' LYS . . . . . . . . . . . . . 17.6 ptpt -105.96 127.72 53.34 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-O 121.303 0.573 . . . . 0.0 111.323 -175.696 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' F' F ' 82' ' ' GLY . . . . . . . . . . . . . . . 88.75 42.17 5.8 Favored Glycine 0 CA--C 1.525 0.684 0 CA-C-N 115.725 -0.67 . . . . 0.0 111.838 173.795 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' F' F ' 83' ' ' ILE . . . . . . . . . . . . . 74.6 mt -69.88 140.91 17.86 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.292 0 CA-C-O 121.043 0.449 . . . . 0.0 110.053 179.021 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' F' F ' 84' ' ' LYS . . . . . . . . . . . . . 67.5 tttt -99.75 -53.98 3.04 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 115.868 -0.605 . . . . 0.0 110.204 -178.869 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' F' F ' 85' ' ' ASP . . . . . . . . . . . . . 5.6 t70 -155.38 155.78 34.23 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 115.817 -0.629 . . . . 0.0 110.134 -179.021 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' F' F ' 86' ' ' VAL . . . . . . . . . . . . . 44.3 t -135.6 135.66 51.18 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.238 0 CA-C-O 121.038 0.447 . . . . 0.0 110.806 -178.135 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' F' F ' 87' ' ' ILE . . . . . . . . . . . . . 44.2 mm -119.38 128.5 75.85 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.199 0 CA-C-N 115.708 -0.678 . . . . 0.0 109.466 176.139 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' F' F ' 88' ' ' LEU . . . . . 0.406 HD13 HG21 ' E' ' 131' ' ' VAL . 24.0 tp -111.98 131.51 55.35 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-O 120.89 0.376 . . . . 0.0 110.996 -177.803 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' F' F ' 89' ' ' ASP . . . . . . . . . . . . . 10.0 t70 -126.09 154.05 43.63 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 116.036 -0.529 . . . . 0.0 109.597 176.39 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' F' F ' 90' ' ' GLU . . . . . . . . . . . . . 46.5 tp10 -47.29 -38.36 12.43 Favored 'General case' 0 C--N 1.33 -0.253 0 N-CA-C 112.794 0.665 . . . . 0.0 112.794 -172.394 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' F' F ' 91' ' ' ASN . . . . . . . . . . . . . 15.0 t-20 -132.06 33.34 3.92 Favored 'General case' 0 N--CA 1.466 0.353 0 C-N-CA 120.883 -0.327 . . . . 0.0 111.855 -175.889 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' F' F ' 92' ' ' LEU . . . . . . . . . . . . . 10.1 tp -166.12 148.31 7.01 Favored 'General case' 0 C--N 1.332 -0.169 0 C-N-CA 120.705 -0.398 . . . . 0.0 111.043 179.205 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' F' F ' 93' ' ' ILE . . . . . . . . . . . . . 67.4 mt -125.55 124.49 66.9 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.211 0 N-CA-C 109.588 -0.523 . . . . 0.0 109.588 -179.883 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' F' F ' 94' ' ' VAL . . . . . . . . . . . . . 43.7 t -122.27 126.57 74.45 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.186 0 N-CA-C 109.91 -0.404 . . . . 0.0 109.91 179.466 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' F' F ' 95' ' ' VAL . . . . . . . . . . . . . 46.3 t -123.59 135.0 64.81 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.175 0 CA-C-N 116.338 -0.392 . . . . 0.0 110.103 -179.175 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' F' F ' 96' ' ' ILE . . . . . . . . . . . . . 65.1 mt -116.48 130.64 70.95 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.265 0 N-CA-C 109.38 -0.6 . . . . 0.0 109.38 178.606 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' F' F ' 97' ' ' THR . . . . . . . . . . . . . 81.5 p -101.3 159.86 14.9 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-O 121.039 0.447 . . . . 0.0 111.19 -179.154 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' F' F ' 98' ' ' GLU . . . . . . . . . . . . . 45.1 mt-10 -54.35 -26.32 29.31 Favored 'General case' 0 C--N 1.328 -0.359 0 N-CA-C 112.257 0.465 . . . . 0.0 112.257 -179.497 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' F' F ' 99' ' ' GLU . . . . . . . . . . . . . 14.3 mm-40 -78.53 14.86 1.14 Allowed 'General case' 0 CA--C 1.535 0.366 0 N-CA-C 113.183 0.808 . . . . 0.0 113.183 -178.012 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' F' F ' 100' ' ' ASN . . . . . . . . . . . . . 7.6 m-20 60.13 37.46 20.85 Favored 'General case' 0 CA--C 1.529 0.138 0 CA-C-O 121.019 0.437 . . . . 0.0 111.091 -179.845 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' F' F ' 101' ' ' GLU . . . . . . . . . . . . . 84.7 tt0 -112.04 141.03 46.22 Favored 'General case' 0 C--N 1.331 -0.223 0 CA-C-N 116.023 -0.535 . . . . 0.0 109.659 174.09 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' F' F ' 102' ' ' VAL . . . . . . . . . . . . . 42.8 t -114.98 127.8 72.39 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.293 0 N-CA-C 109.9 -0.408 . . . . 0.0 109.9 -178.848 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' F' F ' 103' ' ' LEU . . . . . 0.488 HD12 ' N ' ' F' ' 103' ' ' LEU . 6.4 mp -117.6 134.48 54.83 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 115.668 -0.696 . . . . 0.0 110.164 176.739 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' F' F ' 104' ' ' ILE . . . . . . . . . . . . . 66.2 mt -117.37 123.87 72.32 Favored 'Isoleucine or valine' 0 C--O 1.233 0.211 0 CA-C-N 116.267 -0.424 . . . . 0.0 109.957 -179.601 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' F' F ' 105' ' ' PHE . . . . . . . . . . . . . 92.3 m-85 -123.25 161.36 24.72 Favored 'General case' 0 C--N 1.332 -0.184 0 O-C-N 123.992 0.808 . . . . 0.0 109.97 -179.548 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' F' F ' 106' ' ' ASN . . . . . . . . . . . . . 44.3 p-10 -99.42 -171.74 2.13 Favored 'General case' 0 C--N 1.33 -0.277 0 N-CA-C 110.209 -0.293 . . . . 0.0 110.209 175.266 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' F' F ' 107' ' ' GLN . . . . . . . . . . . . . 50.7 tt0 -58.87 -28.21 65.92 Favored 'General case' 0 C--N 1.329 -0.316 0 N-CA-C 112.176 0.436 . . . . 0.0 112.176 179.7 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' F' F ' 108' ' ' ASN . . . . . . . . . . . . . 2.7 t-20 -85.63 7.75 22.11 Favored 'General case' 0 CA--C 1.538 0.486 0 N-CA-C 113.252 0.834 . . . . 0.0 113.252 -176.857 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' F' F ' 109' ' ' LEU . . . . . 0.658 HD21 ' HB2' ' F' ' 78' ' ' ALA . 11.7 tp 59.94 38.13 21.15 Favored 'General case' 0 CA--C 1.53 0.181 0 CA-C-O 121.086 0.47 . . . . 0.0 111.166 178.984 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' F' F ' 110' ' ' GLU . . . . . . . . . . . . . 95.7 mt-10 -108.22 148.76 29.5 Favored 'General case' 0 C--N 1.33 -0.267 0 N-CA-C 109.73 -0.47 . . . . 0.0 109.73 175.274 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' F' F ' 111' ' ' GLU . . . . . . . . . . . . . 60.0 tt0 -83.51 121.88 27.8 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-O 120.774 0.321 . . . . 0.0 110.725 -175.763 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' F' F ' 112' ' ' LEU . . . . . . . . . . . . . 27.7 mt -106.92 -46.05 4.03 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.1 -0.5 . . . . 0.0 110.814 179.673 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' F' F ' 113' ' ' TYR . . . . . . . . . . . . . 60.1 t80 -134.86 141.88 46.47 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 116.437 -0.347 . . . . 0.0 111.229 -178.227 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' F' F ' 114' ' ' ARG . . . . . . . . . . . . . 36.9 ptt180 -146.61 121.05 9.66 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.738 178.12 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' F' F ' 115' ' ' GLY . . . . . . . . . . . . . . . -150.12 149.75 21.69 Favored Glycine 0 CA--C 1.526 0.744 0 N-CA-C 111.203 -0.759 . . . . 0.0 111.203 178.332 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' F' F ' 116' ' ' LYS . . . . . . . . . . . . . 35.1 ttmt -115.35 136.77 52.75 Favored 'General case' 0 C--N 1.331 -0.233 0 N-CA-C 110.133 -0.321 . . . . 0.0 110.133 176.678 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' F' F ' 117' ' ' PHE . . . . . . . . . . . . . 44.1 m-85 -132.35 114.52 14.48 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-O 120.974 0.416 . . . . 0.0 110.137 -177.344 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' F' F ' 118' ' ' GLU . . . . . . . . . . . . . 96.2 mt-10 -53.97 -46.94 71.8 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.336 -0.393 . . . . 0.0 111.427 -175.775 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' F' F ' 119' ' ' ASN . . . . . . . . . . . . . 28.6 m120 -94.43 31.06 1.81 Allowed 'General case' 0 C--N 1.328 -0.342 0 N-CA-C 112.165 0.432 . . . . 0.0 112.165 -174.334 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' F' F ' 120' ' ' LEU . . . . . . . . . . . . . 16.0 tp -57.35 119.98 7.39 Favored 'General case' 0 C--N 1.332 -0.169 0 N-CA-C 110.175 -0.305 . . . . 0.0 110.175 177.657 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' F' F ' 121' ' ' ASN . . . . . . . . . . . . . 81.2 m-20 -114.1 -44.08 3.17 Favored 'General case' 0 C--O 1.233 0.223 0 CA-C-N 116.365 -0.379 . . . . 0.0 111.026 -178.419 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' F' F ' 122' ' ' LYS . . . . . . . . . . . . . 98.4 mttt -145.77 149.55 34.57 Favored 'General case' 0 C--N 1.333 -0.128 0 CA-C-O 121.092 0.472 . . . . 0.0 111.856 -178.319 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' F' F ' 123' ' ' VAL . . . . . . . . . . . . . 46.8 t -124.92 126.66 71.64 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.211 0 CA-C-N 115.694 -0.684 . . . . 0.0 109.497 175.043 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' F' F ' 124' ' ' LEU . . . . . 0.42 HD12 ' N ' ' F' ' 124' ' ' LEU . 6.2 mp -117.88 133.94 55.43 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.473 -0.331 . . . . 0.0 110.434 -179.314 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' F' F ' 125' ' ' VAL . . . . . . . . . . . . . 12.0 p -133.77 135.91 54.74 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.285 0 CA-C-N 116.233 -0.44 . . . . 0.0 110.522 -179.875 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' F' F ' 126' ' ' ARG . . . . . . . . . . . . . 95.9 mtt-85 -143.31 116.88 9.17 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.115 -0.493 . . . . 0.0 110.267 177.716 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' F' F ' 127' ' ' ASN . . . . . . . . . . . . . 64.3 t30 52.56 -104.98 0.21 Allowed 'General case' 0 CA--C 1.544 0.744 0 CA-C-O 118.986 -0.53 . . . . 0.0 111.357 179.74 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' F' F ' 128' ' ' ASP . . . . . . . . . . . . . 8.6 p-10 -114.08 4.43 15.64 Favored 'General case' 0 CA--C 1.537 0.463 0 CA-C-N 119.526 1.057 . . . . 0.0 113.547 -176.623 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' F' F ' 129' ' ' LEU . . . . . . . . . . . . . 14.6 tp -107.37 139.0 42.53 Favored 'General case' 0 C--N 1.332 -0.173 0 CA-C-N 118.207 0.458 . . . . 0.0 110.292 179.693 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' F' F ' 130' ' ' VAL . . . . . . . . . . . . . 41.3 t -126.71 137.14 58.73 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.233 0 CA-C-O 120.942 0.401 . . . . 0.0 110.424 -178.339 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' F' F ' 131' ' ' VAL . . . . . . . . . . . . . 43.0 t -136.02 136.46 49.63 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.271 0 CA-C-N 116.239 -0.437 . . . . 0.0 110.198 176.916 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' F' F ' 132' ' ' ILE . . . . . . . . . . . . . 77.5 mt -116.57 133.16 64.07 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.257 0 CA-C-N 115.908 -0.587 . . . . 0.0 109.605 -179.071 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' F' F ' 133' ' ' ILE . . . . . . . . . . . . . 41.2 mm -116.53 125.26 73.44 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.249 0 CA-C-N 116.377 -0.374 . . . . 0.0 111.112 -174.66 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' F' F ' 134' ' ' ASP . . . . . . . . . . . . . 11.7 p-10 -139.02 151.6 46.94 Favored 'General case' 0 C--N 1.333 -0.135 0 CA-C-N 116.198 -0.455 . . . . 0.0 109.912 174.037 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' F' F ' 135' ' ' GLU . . . . . . . . . . . . . 84.8 tt0 -50.82 -27.94 8.39 Favored 'General case' 0 C--N 1.33 -0.267 0 N-CA-C 112.862 0.69 . . . . 0.0 112.862 -172.513 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' F' F ' 136' ' ' GLN . . . . . . . . . . . . . 96.9 mt-30 -84.9 -30.02 24.73 Favored 'General case' 0 C--N 1.329 -0.291 0 N-CA-C 112.63 0.604 . . . . 0.0 112.63 -174.663 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' F' F ' 137' ' ' LYS . . . . . . . . . . . . . 56.7 pttt -169.08 173.16 7.01 Favored 'General case' 0 C--O 1.233 0.212 0 CA-C-O 121.683 0.754 . . . . 0.0 112.672 -170.267 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' F' F ' 138' ' ' LEU . . . . . 0.46 HD23 ' N ' ' F' ' 139' ' ' THR . 4.7 tt -121.73 128.9 52.29 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 114.77 -1.105 . . . . 0.0 109.673 178.862 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' F' F ' 139' ' ' THR . . . . . 0.46 ' N ' HD23 ' F' ' 138' ' ' LEU . 42.1 m -111.71 126.09 54.67 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.443 -0.344 . . . . 0.0 110.146 179.402 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' F' F ' 140' ' ' LEU . . . . . 0.471 HD23 ' C ' ' F' ' 140' ' ' LEU . 6.3 tt -113.0 124.14 51.94 Favored 'General case' 0 C--N 1.329 -0.291 0 N-CA-C 109.579 -0.526 . . . . 0.0 109.579 -178.625 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' F' F ' 141' ' ' ILE . . . . . 0.433 ' N ' HD23 ' F' ' 140' ' ' LEU . 19.4 mt -122.55 120.42 60.91 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.309 0 CA-C-O 121.014 0.435 . . . . 0.0 110.049 -175.128 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' F' F ' 142' ' ' ARG . . . . . . . . . . . . . 67.7 ttt180 -111.4 126.97 55.5 Favored 'General case' 0 C--N 1.332 -0.17 0 CA-C-N 115.376 -0.829 . . . . 0.0 110.492 -177.114 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' F' F ' 143' ' ' THR . . . . . . . . . . . . . 56.0 p . . . . . 0 C--O 1.219 -0.52 0 CA-C-O 118.12 -0.943 . . . . 0.0 110.623 179.921 . . . . . . . . 0 0 . 1 . 015 nuclear nobuild full ' A' A ' -3' ' ' GLU . . . . . . . . . . . . . 96.2 mt-10 . . . . . 0 N--CA 1.489 1.519 0 N-CA-C 109.52 -0.548 . . . . 0.0 109.52 . . . . . . . . . 0 0 . 1 . 015 nuclear nobuild full ' A' A ' -2' ' ' GLY . . . . . . . . . . . . . . . -71.97 150.03 45.37 Favored Glycine 0 CA--C 1.524 0.614 0 N-CA-C 110.733 -0.947 . . . . 0.0 110.733 178.581 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' -1' ' ' VAL . . . . . . . . . . . . . 44.3 t -89.86 129.19 41.17 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.318 0 CA-C-O 120.921 0.391 . . . . 0.0 110.036 -179.085 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 0' ' ' ILE . . . . . . . . . . . . . 74.2 mt -119.5 131.3 72.49 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.25 0 CA-C-N 116.023 -0.535 . . . . 0.0 109.804 179.79 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 25.5 ptp -83.01 140.87 32.47 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.319 -0.4 . . . . 0.0 110.661 -179.704 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 40.9 p -115.56 141.17 48.42 Favored 'General case' 0 C--N 1.331 -0.218 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.384 179.466 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 95.2 mt-10 -141.32 140.56 33.83 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.194 -0.457 . . . . 0.0 111.355 -177.861 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 4' ' ' LEU . . . . . . . . . . . . . 75.9 mt -121.82 128.38 51.6 Favored 'General case' 0 C--O 1.233 0.226 0 CA-C-N 115.951 -0.568 . . . . 0.0 110.17 174.884 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 5' ' ' LYS . . . . . . . . . . . . . 68.5 mttm -107.55 122.15 46.09 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.451 -0.341 . . . . 0.0 110.259 177.769 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 6' ' ' LEU . . . . . 0.422 HD23 ' HA ' ' A' ' 50' ' ' VAL . 70.5 mt -118.14 144.29 45.8 Favored 'General case' 0 C--N 1.331 -0.224 0 CA-C-N 115.769 -0.65 . . . . 0.0 110.287 -179.105 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 59.3 tttm -121.64 135.13 24.89 Favored Pre-proline 0 CA--C 1.534 0.363 0 CA-C-O 118.675 -0.679 . . . . 0.0 109.603 175.475 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 8' ' ' PRO . . . . . . . . . . . . . 84.9 Cg_endo -90.04 131.79 1.86 Allowed 'Trans proline' 0 N--CA 1.488 1.176 0 C-N-CA 121.605 1.537 . . . . 0.0 111.735 178.054 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 28.2 mt -73.65 -47.4 7.06 Favored Pre-proline 0 CA--C 1.535 0.384 0 CA-C-O 118.604 -0.712 . . . . 0.0 111.972 -179.072 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 95.5 Cg_endo -79.76 151.04 21.66 Favored 'Trans proline' 0 N--CA 1.497 1.697 0 C-N-CA 121.056 1.171 . . . . 0.0 111.873 176.049 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 19.2 ttpp -85.65 107.06 17.37 Favored 'General case' 0 C--N 1.33 -0.27 0 C-N-CA 120.885 -0.326 . . . . 0.0 110.31 178.895 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 12.0 p -149.22 147.68 16.34 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.323 0 CA-C-N 116.352 -0.385 . . . . 0.0 110.805 -179.153 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 94.7 mt-10 -95.75 110.05 22.26 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.087 -0.506 . . . . 0.0 109.668 175.843 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 14' ' ' LEU . . . . . . . . . . . . . 51.2 mt -86.54 148.78 47.39 Favored Pre-proline 0 CA--C 1.533 0.307 0 CA-C-O 119.303 -0.379 . . . . 0.0 110.481 -176.793 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 15' ' ' PRO . . . . . . . . . . . . . 28.6 Cg_exo -61.03 159.57 29.28 Favored 'Trans proline' 0 N--CA 1.497 1.685 0 C-N-CA 121.269 1.313 . . . . 0.0 111.738 177.263 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 16' ' ' PRO . . . . . . . . . . . . . 32.7 Cg_exo -59.75 -35.89 93.14 Favored 'Trans proline' 0 N--CA 1.498 1.74 0 C-N-CA 121.374 1.383 . . . . 0.0 112.692 -178.736 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 17' ' ' ASP . . . . . . . . . . . . . 8.5 p-10 -84.03 4.85 28.14 Favored 'General case' 0 CA--C 1.536 0.423 0 N-CA-C 113.26 0.837 . . . . 0.0 113.26 -177.959 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 18' ' ' PHE . . . . . . . . . . . . . 40.2 t80 -58.47 -46.03 87.43 Favored 'General case' 0 N--CA 1.456 -0.145 0 O-C-N 121.912 -0.493 . . . . 0.0 109.978 -178.699 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 19' ' ' VAL . . . . . . . . . . . . . 47.9 t -57.12 -41.22 77.3 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.368 0 CA-C-N 116.236 -0.438 . . . . 0.0 110.479 -177.743 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 74.9 m-20 -60.34 -45.16 94.43 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-O 120.756 0.313 . . . . 0.0 111.043 -177.356 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 46.5 t -64.98 -46.46 91.52 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.276 0 C-N-CA 120.692 -0.403 . . . . 0.0 110.436 -177.761 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 22' ' ' ILE . . . . . . . . . . . . . 51.6 mm -57.32 -42.36 80.16 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.218 0 CA-C-O 120.899 0.38 . . . . 0.0 110.362 178.389 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 23' ' ' ARG . . . . . . . . . . . . . 59.7 ttp180 -53.71 -49.17 68.67 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-O 120.794 0.33 . . . . 0.0 111.278 -179.223 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 24' ' ' ILE . . . . . . . . . . . . . 70.2 mt -60.67 -41.48 88.33 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.255 0 CA-C-N 116.497 -0.32 . . . . 0.0 110.935 -179.488 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 52.9 mmtt -63.15 -37.4 87.07 Favored 'General case' 0 C--N 1.329 -0.314 0 N-CA-C 112.073 0.397 . . . . 0.0 112.073 179.239 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 58.9 mt -79.06 -42.4 26.51 Favored 'General case' 0 C--N 1.329 -0.297 0 N-CA-C 113.347 0.869 . . . . 0.0 113.347 -172.125 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 27' ' ' GLN . . . . . . . . . . . . . 10.3 pt20 -47.37 140.68 5.42 Favored 'General case' 0 N--CA 1.47 0.545 0 N-CA-C 112.716 0.636 . . . . 0.0 112.716 -174.735 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 98.09 -25.21 28.55 Favored Glycine 0 CA--C 1.532 1.147 0 CA-C-N 115.541 -0.754 . . . . 0.0 112.398 -178.627 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 69.1 mttm -97.73 155.11 17.17 Favored 'General case' 0 C--N 1.332 -0.181 0 CA-C-N 117.397 0.598 . . . . 0.0 110.81 179.375 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 30' ' ' THR . . . . . . . . . . . . . 33.1 m -102.96 137.53 41.03 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.242 -0.435 . . . . 0.0 110.076 177.297 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 35.0 m -126.67 151.4 33.28 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.251 0 CA-C-N 116.325 -0.398 . . . . 0.0 110.97 -178.998 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 32' ' ' ARG . . . . . . . . . . . . . 62.0 mtt85 -133.26 148.71 51.97 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 115.665 -0.698 . . . . 0.0 110.202 176.645 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 33' ' ' THR . . . . . . . . . . . . . 21.5 m -53.4 138.24 33.59 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-O 120.86 0.362 . . . . 0.0 111.372 -177.644 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 101.0 -17.05 56.79 Favored Glycine 0 CA--C 1.533 1.165 0 CA-C-O 119.656 -0.525 . . . . 0.0 113.359 178.587 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 80.3 m-20 -66.5 150.03 49.57 Favored 'General case' 0 N--CA 1.463 0.202 0 CA-C-N 118.043 0.922 . . . . 0.0 111.359 179.592 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 46.2 t -122.58 129.59 75.11 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.236 0 CA-C-N 116.029 -0.532 . . . . 0.0 109.852 177.524 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 37' ' ' ILE . . . . . . . . . . . . . 62.1 mt -122.08 139.83 47.87 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.235 0 CA-C-N 116.228 -0.442 . . . . 0.0 109.962 -178.495 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . -117.01 128.3 7.82 Favored Glycine 0 CA--C 1.524 0.605 0 N-CA-C 110.89 -0.884 . . . . 0.0 110.89 178.284 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 39' ' ' ILE . . . . . . . . . . . . . 75.6 mt -127.25 132.46 69.58 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.29 0 CA-C-O 120.765 0.317 . . . . 0.0 110.199 179.754 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 40' ' ' SER . . . . . . . . . . . . . 13.0 t -93.04 122.18 35.14 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.304 -0.407 . . . . 0.0 110.923 176.419 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 41' ' ' ILE . . . . . 0.492 HD12 ' N ' ' A' ' 41' ' ' ILE . 5.1 mp -128.72 120.83 53.37 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.232 0 N-CA-C 109.902 -0.407 . . . . 0.0 109.902 176.728 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 6.8 mp 56.62 35.42 26.07 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-O 121.088 0.47 . . . . 0.0 111.203 -179.704 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . 80.14 -10.14 43.27 Favored Glycine 0 CA--C 1.533 1.198 0 C-N-CA 121.255 -0.498 . . . . 0.0 113.538 176.169 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 44' ' ' LYS . . . . . . . . . . . . . 61.7 mttp -99.68 131.25 45.79 Favored 'General case' 0 C--O 1.23 0.049 0 CA-C-N 117.891 0.846 . . . . 0.0 110.207 178.419 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 83.0 tt0 -85.57 131.06 34.43 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.371 -0.377 . . . . 0.0 111.301 -178.989 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 46' ' ' VAL . . . . . 0.405 ' O ' HG13 ' A' ' 46' ' ' VAL . 10.0 p -123.09 125.06 71.51 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.167 0 N-CA-C 109.565 -0.531 . . . . 0.0 109.565 173.786 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 66.6 mttm -99.28 127.07 45.23 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.133 -0.485 . . . . 0.0 111.042 177.856 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 48' ' ' PHE . . . . . . . . . . . . . 39.4 m-85 -112.68 131.81 55.47 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 115.918 -0.583 . . . . 0.0 110.004 178.656 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 77.8 tttt -106.4 132.36 52.52 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.471 -0.331 . . . . 0.0 110.231 178.204 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 50' ' ' VAL . . . . . 0.422 ' HA ' HD23 ' A' ' 6' ' ' LEU . 45.3 t -75.63 105.16 4.34 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.244 0 N-CA-C 109.401 -0.592 . . . . 0.0 109.401 178.002 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 51' ' ' VAL . . . . . . . . . . . . . 48.5 t -69.73 -49.64 56.29 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 N-CA-C 109.751 -0.463 . . . . 0.0 109.751 -175.035 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 52' ' ' GLN . . . . . . . . . . . . . 62.7 tt0 -167.01 147.42 5.61 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 115.971 -0.559 . . . . 0.0 111.498 -178.718 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -123.11 134.99 54.19 Favored 'General case' 0 C--N 1.332 -0.19 0 CA-C-N 116.035 -0.53 . . . . 0.0 109.972 176.884 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 54' ' ' TYR . . . . . . . . . . . . . 64.0 t80 -129.11 113.88 18.58 Favored Pre-proline 0 CA--C 1.535 0.375 0 CA-C-O 118.103 -0.951 . . . . 0.0 110.246 178.443 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 55' ' ' PRO . . . . . . . . . . . . . 72.8 Cg_endo -77.16 170.15 72.31 Favored 'Cis proline' 0 N--CA 1.501 1.956 0 CA-C-N 122.154 1.805 . . . . 0.0 111.842 -8.476 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 56' ' ' SER . . . . . . . . . . . . . 14.7 m -123.67 141.91 37.8 Favored Pre-proline 0 CA--C 1.538 0.51 0 CA-C-O 118.755 -0.641 . . . . 0.0 109.81 175.483 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 57' ' ' PRO . . . . . . . . . . . . . 37.1 Cg_endo -67.27 158.39 82.78 Favored 'Cis proline' 0 N--CA 1.5 1.892 0 CA-C-N 121.466 1.559 . . . . 0.0 111.179 -5.023 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 58' ' ' LEU . . . . . . . . . . . . . 27.9 tp -128.44 137.19 51.71 Favored 'General case' 0 C--N 1.331 -0.223 0 CA-C-O 120.833 0.349 . . . . 0.0 110.808 -178.201 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 59' ' ' ARG . . . . . . . . . . . . . 57.2 ttp180 -100.34 122.92 43.88 Favored 'General case' 0 C--N 1.328 -0.357 0 N-CA-C 108.919 -0.771 . . . . 0.0 108.919 173.613 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 40.1 t -70.25 124.62 26.74 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.327 0 C-N-CA 120.718 -0.393 . . . . 0.0 110.396 -174.21 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 42.9 mt-10 -131.04 160.69 33.88 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 115.851 -0.613 . . . . 0.0 109.907 176.798 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 62' ' ' ASP . . . . . . . . . . . . . 70.6 m-20 -52.36 -31.72 35.0 Favored 'General case' 0 CA--C 1.533 0.314 0 N-CA-C 111.957 0.355 . . . . 0.0 111.957 179.137 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 63' ' ' ARG . . . . . . . . . . . . . 79.3 mtp180 -71.41 -21.74 61.95 Favored 'General case' 0 CA--C 1.532 0.281 0 N-CA-C 113.026 0.75 . . . . 0.0 113.026 -175.5 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 19.4 m -70.81 140.56 51.25 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-O 120.948 0.404 . . . . 0.0 111.288 -173.786 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 65' ' ' LYS . . . . . . . . . . . . . 97.8 mttt -89.24 136.7 32.88 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-N 115.936 -0.575 . . . . 0.0 109.972 177.407 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 66' ' ' ILE . . . . . . . . . . . . . 65.4 mt -123.02 128.8 75.27 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.264 0 N-CA-C 110.009 -0.367 . . . . 0.0 110.009 -178.575 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 67' ' ' THR . . . . . . . . . . . . . 9.3 m -124.04 144.24 49.96 Favored 'General case' 0 N--CA 1.463 0.213 0 CA-C-O 120.951 0.405 . . . . 0.0 111.421 -176.224 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 68' ' ' LEU . . . . . 0.458 HD23 ' C ' ' A' ' 68' ' ' LEU . 5.9 tt -104.56 123.95 48.44 Favored 'General case' 0 C--N 1.332 -0.158 0 CA-C-N 116.041 -0.527 . . . . 0.0 110.283 178.83 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 69' ' ' VAL . . . . . 0.425 ' N ' HD23 ' A' ' 68' ' ' LEU . 41.9 t -104.47 142.23 18.33 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.277 0 CA-C-O 121.021 0.439 . . . . 0.0 111.163 -177.549 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 70' ' ' THR . . . . . . . . . . . . . 7.4 p -130.1 173.6 10.59 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-N 115.814 -0.63 . . . . 0.0 109.505 174.926 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 71' ' ' HIS . . . . . . . . . . . . . 7.4 t60 -120.17 61.06 7.6 Favored Pre-proline 0 CA--C 1.538 0.483 0 N-CA-C 112.247 0.462 . . . . 0.0 112.247 -176.608 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 72' ' ' PRO . . . . . . . . . . . . . 62.0 Cg_endo -91.9 156.89 3.37 Favored 'Trans proline' 0 N--CA 1.491 1.381 0 C-N-CA 121.762 1.641 . . . . 0.0 111.102 168.137 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 73' ' ' VAL . . . . . . . . . . . . . 35.4 m -71.88 141.91 16.03 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.175 0 C-N-CA 120.562 -0.455 . . . . 0.0 110.332 177.946 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 74' ' ' ASP . . . . . . . . . . . . . 17.9 t0 -97.68 124.89 42.17 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 115.867 -0.606 . . . . 0.0 109.744 179.712 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 75' ' ' VAL . . . . . 0.408 ' C ' HD12 ' A' ' 76' ' ' LEU . 40.6 t -115.75 124.48 72.21 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.311 0 CA-C-O 121.061 0.458 . . . . 0.0 110.682 -176.163 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 76' ' ' LEU . . . . . 0.408 HD12 ' C ' ' A' ' 75' ' ' VAL . 6.4 mp -122.43 142.72 50.25 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-N 115.848 -0.615 . . . . 0.0 110.007 176.358 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 77' ' ' GLU . . . . . . . . . . . . . 96.8 mt-10 -134.38 143.12 47.44 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-O 121.097 0.475 . . . . 0.0 111.242 179.739 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 78' ' ' ALA . . . . . . . . . . . . . . . -129.83 145.17 51.59 Favored 'General case' 0 C--N 1.332 -0.185 0 CA-C-N 115.712 -0.676 . . . . 0.0 109.997 176.492 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 79' ' ' LYS . . . . . 0.676 ' O ' HD13 ' A' ' 80' ' ' ILE . 33.8 mmtm -77.39 116.7 18.2 Favored 'General case' 0 C--N 1.331 -0.219 0 CA-C-N 116.374 -0.375 . . . . 0.0 110.405 179.538 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 80' ' ' ILE . . . . . 0.676 HD13 ' O ' ' A' ' 79' ' ' LYS . 35.3 mm -139.11 106.78 3.04 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.251 0 N-CA-C 109.26 -0.644 . . . . 0.0 109.26 -178.243 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 81' ' ' LYS . . . . . . . . . . . . . 38.7 tttp -109.77 130.93 55.47 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-O 120.971 0.415 . . . . 0.0 111.104 -177.135 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . 88.99 42.07 5.73 Favored Glycine 0 CA--C 1.525 0.689 0 C-N-CA 121.03 -0.605 . . . . 0.0 111.66 175.336 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 83' ' ' ILE . . . . . . . . . . . . . 67.9 mt -74.02 137.1 23.9 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.265 0 N-CA-C 110.007 -0.368 . . . . 0.0 110.007 179.307 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 84' ' ' LYS . . . . . . . . . . . . . 58.0 tttp -96.26 -52.88 3.82 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-N 116.007 -0.542 . . . . 0.0 109.875 179.035 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 85' ' ' ASP . . . . . . . . . . . . . 4.0 t70 -155.67 157.26 36.37 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 115.871 -0.604 . . . . 0.0 110.593 -179.101 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 86' ' ' VAL . . . . . . . . . . . . . 45.2 t -132.37 135.89 57.16 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.204 0 CA-C-O 120.994 0.426 . . . . 0.0 110.408 179.856 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 87' ' ' ILE . . . . . . . . . . . . . 42.3 mm -116.16 123.14 71.03 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.356 0 N-CA-C 109.161 -0.681 . . . . 0.0 109.161 176.968 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 88' ' ' LEU . . . . . . . . . . . . . 14.0 tp -109.61 130.47 55.51 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-O 121.075 0.464 . . . . 0.0 110.956 -176.597 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 89' ' ' ASP . . . . . . . . . . . . . 10.9 t70 -128.95 154.86 46.16 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-N 115.87 -0.604 . . . . 0.0 109.489 177.162 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 76.2 tt0 -48.22 -35.58 12.17 Favored 'General case' 0 C--N 1.329 -0.307 0 N-CA-C 112.808 0.669 . . . . 0.0 112.808 -172.444 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 91' ' ' ASN . . . . . . . . . . . . . 94.5 m-20 -128.43 18.3 6.4 Favored 'General case' 0 N--CA 1.469 0.487 0 N-CA-C 113.127 0.788 . . . . 0.0 113.127 -176.519 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 92' ' ' LEU . . . . . . . . . . . . . 28.5 mt -149.66 147.48 28.15 Favored 'General case' 0 C--N 1.331 -0.226 0 CA-C-O 121.0 0.429 . . . . 0.0 110.752 -177.637 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 93' ' ' ILE . . . . . . . . . . . . . 65.7 mt -127.0 113.48 32.86 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.315 0 N-CA-C 108.892 -0.781 . . . . 0.0 108.892 177.284 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 94' ' ' VAL . . . . . . . . . . . . . 45.4 t -116.08 129.42 72.5 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.241 0 N-CA-C 110.044 -0.354 . . . . 0.0 110.044 -177.93 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 95' ' ' VAL . . . . . . . . . . . . . 41.4 t -122.74 135.17 63.69 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.388 0 CA-C-N 116.111 -0.495 . . . . 0.0 110.078 -178.338 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 96' ' ' ILE . . . . . . . . . . . . . 66.0 mt -115.62 128.61 72.8 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.271 0 N-CA-C 109.364 -0.606 . . . . 0.0 109.364 178.278 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 97' ' ' THR . . . . . . . . . . . . . 79.0 p -102.43 159.51 15.36 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-O 121.132 0.492 . . . . 0.0 111.386 -177.675 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 98' ' ' GLU . . . . . . . . . . . . . 45.6 mt-10 -54.06 -25.88 23.86 Favored 'General case' 0 CA--C 1.532 0.264 0 N-CA-C 112.335 0.494 . . . . 0.0 112.335 179.736 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 99' ' ' GLU . . . . . . . . . . . . . 95.8 mt-10 -77.84 13.48 1.35 Allowed 'General case' 0 CA--C 1.535 0.37 0 N-CA-C 113.167 0.803 . . . . 0.0 113.167 -178.048 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 100' ' ' ASN . . . . . . . . . . . . . 3.3 m-20 60.87 36.59 18.93 Favored 'General case' 0 CA--C 1.529 0.173 0 CA-C-O 120.956 0.408 . . . . 0.0 110.998 -179.833 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 101' ' ' GLU . . . . . . . . . . . . . 82.9 tt0 -113.59 143.22 44.92 Favored 'General case' 0 C--N 1.332 -0.178 0 N-CA-C 109.381 -0.6 . . . . 0.0 109.381 176.348 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 102' ' ' VAL . . . . . . . . . . . . . 43.1 t -115.29 125.74 72.64 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.356 0 CA-C-O 120.909 0.385 . . . . 0.0 109.996 -177.625 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 103' ' ' LEU . . . . . . . . . . . . . 23.4 mt -114.15 130.92 56.59 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 115.518 -0.764 . . . . 0.0 109.966 176.667 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 104' ' ' ILE . . . . . 0.521 HD12 ' HB3' ' A' ' 113' ' ' TYR . 67.8 mt -119.37 118.84 58.77 Favored 'Isoleucine or valine' 0 C--O 1.234 0.27 0 N-CA-C 110.118 -0.327 . . . . 0.0 110.118 -179.846 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 105' ' ' PHE . . . . . . . . . . . . . 79.7 m-85 -117.98 164.07 15.64 Favored 'General case' 0 C--N 1.332 -0.182 0 O-C-N 123.979 0.799 . . . . 0.0 109.604 178.04 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 106' ' ' ASN . . . . . . . . . . . . . 44.2 p-10 -101.11 -170.49 1.85 Allowed 'General case' 0 C--N 1.331 -0.22 0 N-CA-C 109.992 -0.373 . . . . 0.0 109.992 173.652 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 107' ' ' GLN . . . . . . . . . . . . . 57.9 tt0 -57.43 -29.99 64.61 Favored 'General case' 0 CA--C 1.534 0.36 0 N-CA-C 111.839 0.311 . . . . 0.0 111.839 178.673 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 108' ' ' ASN . . . . . . . . . . . . . 60.3 t30 -83.94 7.42 18.37 Favored 'General case' 0 CA--C 1.536 0.434 0 N-CA-C 113.373 0.879 . . . . 0.0 113.373 -176.515 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 109' ' ' LEU . . . . . . . . . . . . . 11.2 tp 60.32 37.38 20.3 Favored 'General case' 0 CA--C 1.53 0.194 0 CA-C-O 120.955 0.407 . . . . 0.0 111.208 179.434 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 110' ' ' GLU . . . . . . . . . . . . . 70.8 mm-40 -106.88 160.95 15.13 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 116.466 -0.334 . . . . 0.0 110.169 177.85 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 111' ' ' GLU . . . . . . . . . . . . . 83.0 tt0 -85.31 122.75 29.92 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.312 -0.404 . . . . 0.0 110.801 -178.15 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 112' ' ' LEU . . . . . . . . . . . . . 17.0 mt -111.19 -46.11 3.35 Favored 'General case' 0 C--N 1.332 -0.189 0 CA-C-N 116.223 -0.444 . . . . 0.0 110.566 177.176 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 113' ' ' TYR . . . . . 0.521 ' HB3' HD12 ' A' ' 104' ' ' ILE . 46.8 t80 -141.67 139.71 33.05 Favored 'General case' 0 C--N 1.332 -0.195 0 CA-C-N 116.371 -0.377 . . . . 0.0 110.97 179.895 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 114' ' ' ARG . . . . . . . . . . . . . 58.7 ttp180 -143.09 116.02 8.81 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.068 -0.515 . . . . 0.0 110.125 178.921 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 115' ' ' GLY . . . . . . . . . . . . . . . -150.26 163.05 29.43 Favored Glycine 0 CA--C 1.525 0.678 0 N-CA-C 111.0 -0.84 . . . . 0.0 111.0 -179.506 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 116' ' ' LYS . . . . . . . . . . . . . 34.5 ttmt -128.38 137.54 51.94 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-O 120.723 0.297 . . . . 0.0 110.27 177.229 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 117' ' ' PHE . . . . . . . . . . . . . 54.4 m-85 -131.47 114.95 15.54 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.324 -0.398 . . . . 0.0 110.286 -177.007 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 118' ' ' GLU . . . . . . . . . . . . . 46.4 tp10 -53.76 -47.81 70.35 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.554 -0.294 . . . . 0.0 111.491 -176.067 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 119' ' ' ASN . . . . . . . . . . . . . 6.4 m120 -97.14 31.02 2.55 Favored 'General case' 0 C--N 1.329 -0.302 0 N-CA-C 112.088 0.403 . . . . 0.0 112.088 -174.126 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 120' ' ' LEU . . . . . 0.411 HD11 HG23 ' A' ' 132' ' ' ILE . 12.3 tp -56.63 122.22 11.55 Favored 'General case' 0 C--N 1.331 -0.224 0 C-N-CA 121.026 -0.27 . . . . 0.0 110.496 179.08 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 121' ' ' ASN . . . . . . . . . . . . . 29.2 m120 -112.78 -44.01 3.37 Favored 'General case' 0 C--O 1.232 0.157 0 CA-C-N 116.564 -0.289 . . . . 0.0 111.115 -177.299 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 122' ' ' LYS . . . . . . . . . . . . . 96.1 mttt -146.42 149.17 33.2 Favored 'General case' 0 C--N 1.331 -0.218 0 CA-C-O 120.996 0.427 . . . . 0.0 111.725 -179.544 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 123' ' ' VAL . . . . . . . . . . . . . 44.5 t -126.87 123.48 62.77 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.327 0 N-CA-C 108.971 -0.752 . . . . 0.0 108.971 171.628 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 124' ' ' LEU . . . . . . . . . . . . . 13.6 tp -120.54 137.31 54.45 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.395 -0.366 . . . . 0.0 110.537 -175.703 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 125' ' ' VAL . . . . . . . . . . . . . 43.9 t -125.36 132.76 70.67 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.243 0 CA-C-N 116.101 -0.499 . . . . 0.0 110.27 -179.412 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 126' ' ' ARG . . . . . . . . . . . . . 40.3 mmt180 -131.77 108.06 9.19 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 115.96 -0.563 . . . . 0.0 109.933 176.686 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 127' ' ' ASN . . . . . . . . . . . . . 7.8 m120 54.12 -104.83 0.23 Allowed 'General case' 0 CA--C 1.543 0.688 0 CA-C-O 119.037 -0.506 . . . . 0.0 110.935 179.85 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 128' ' ' ASP . . . . . . . . . . . . . 7.5 p-10 -113.31 4.17 16.28 Favored 'General case' 0 N--CA 1.468 0.458 0 CA-C-N 119.575 1.08 . . . . 0.0 113.387 -176.886 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 129' ' ' LEU . . . . . . . . . . . . . 76.3 mt -104.97 139.51 39.57 Favored 'General case' 0 C--N 1.332 -0.162 0 CA-C-N 118.17 0.441 . . . . 0.0 110.051 177.412 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 130' ' ' VAL . . . . . . . . . . . . . 44.8 t -120.5 135.45 60.68 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.223 0 CA-C-N 116.271 -0.422 . . . . 0.0 110.004 -177.485 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 131' ' ' VAL . . . . . 0.428 HG22 HD12 ' A' ' 140' ' ' LEU . 42.7 t -132.6 132.53 59.94 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.29 0 CA-C-O 120.985 0.421 . . . . 0.0 109.993 177.562 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 132' ' ' ILE . . . . . 0.411 HG23 HD11 ' A' ' 120' ' ' LEU . 70.8 mt -115.3 130.76 69.31 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 N-CA-C 109.251 -0.648 . . . . 0.0 109.251 178.903 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 133' ' ' ILE . . . . . . . . . . . . . 43.1 mm -115.97 121.11 66.72 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.287 0 CA-C-N 116.305 -0.407 . . . . 0.0 110.531 -175.651 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 134' ' ' ASP . . . . . . . . . . . . . 7.1 p-10 -133.0 149.98 52.19 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.045 -0.525 . . . . 0.0 109.626 175.8 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 135' ' ' GLU . . . . . . . . . . . . . 78.7 tt0 -49.79 -25.99 3.54 Favored 'General case' 0 C--N 1.327 -0.391 0 N-CA-C 113.005 0.743 . . . . 0.0 113.005 -169.244 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 136' ' ' GLN . . . . . . . . . . . . . 87.7 mt-30 -103.95 -27.43 12.17 Favored 'General case' 0 N--CA 1.465 0.32 0 N-CA-C 112.955 0.724 . . . . 0.0 112.955 -174.745 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 137' ' ' LYS . . . . . . . . . . . . . 60.5 mtpt -140.48 152.54 45.7 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-O 121.333 0.587 . . . . 0.0 111.775 -170.227 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 138' ' ' LEU . . . . . 0.4 ' C ' HD23 ' A' ' 138' ' ' LEU . 5.1 tt -117.7 121.69 41.53 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 115.504 -0.771 . . . . 0.0 109.145 172.684 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 139' ' ' THR . . . . . . . . . . . . . 26.5 m -108.5 126.63 53.13 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.425 -0.352 . . . . 0.0 110.604 -177.242 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 140' ' ' LEU . . . . . 0.428 HD12 HG22 ' A' ' 131' ' ' VAL . 12.9 tp -113.63 119.07 36.19 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 115.651 -0.704 . . . . 0.0 109.156 -179.73 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 141' ' ' ILE . . . . . . . . . . . . . 19.4 mt -119.02 120.73 64.88 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.328 0 N-CA-C 109.851 -0.426 . . . . 0.0 109.851 -174.734 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 142' ' ' ARG . . . . . . . . . . . . . 81.1 mtm180 -110.7 125.46 53.5 Favored 'General case' 0 C--N 1.331 -0.218 0 CA-C-N 115.677 -0.692 . . . . 0.0 110.203 -178.493 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 143' ' ' THR . . . . . . . . . . . . . 82.3 p . . . . . 0 C--O 1.22 -0.483 0 CA-C-O 118.04 -0.981 . . . . 0.0 110.589 -179.199 . . . . . . . . 0 0 . 1 . 015 nuclear nobuild full ' B' B ' -3' ' ' GLU . . . . . . . . . . . . . 73.7 tt0 . . . . . 0 N--CA 1.49 1.543 0 N-CA-C 109.112 -0.699 . . . . 0.0 109.112 . . . . . . . . . 0 0 . 1 . 015 nuclear nobuild full ' B' B ' -2' ' ' GLY . . . . . . . . . . . . . . . -82.95 149.75 27.01 Favored Glycine 0 CA--C 1.524 0.617 0 N-CA-C 110.721 -0.951 . . . . 0.0 110.721 178.58 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' B' B ' -1' ' ' VAL . . . . . . . . . . . . . 46.0 t -86.95 133.06 30.88 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.295 0 N-CA-C 109.793 -0.447 . . . . 0.0 109.793 179.826 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' B' B ' 0' ' ' ILE . . . . . . . . . . . . . 43.7 mm -96.2 126.9 48.71 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.346 0 CA-C-N 116.248 -0.433 . . . . 0.0 110.011 -178.699 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' B' B ' 1' ' ' MET . . . . . . . . . . . . . 23.5 ptm -81.21 133.72 35.5 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.191 -0.458 . . . . 0.0 111.005 -177.715 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' B' B ' 2' ' ' SER . . . . . . . . . . . . . 7.0 p -124.47 134.91 52.9 Favored 'General case' 0 C--N 1.331 -0.199 0 CA-C-N 116.124 -0.489 . . . . 0.0 110.59 179.831 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' B' B ' 3' ' ' GLU . . . . . . . . . . . . . 92.4 mt-10 -141.74 142.02 33.26 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 115.977 -0.556 . . . . 0.0 110.821 -179.299 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' B' B ' 4' ' ' LEU . . . . . . . . . . . . . 18.6 tp -127.41 130.95 50.26 Favored 'General case' 0 C--N 1.331 -0.23 0 CA-C-N 116.37 -0.377 . . . . 0.0 110.219 176.179 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' B' B ' 5' ' ' LYS . . . . . . . . . . . . . 68.5 mttm -110.64 120.46 42.49 Favored 'General case' 0 C--N 1.331 -0.215 0 CA-C-N 116.347 -0.388 . . . . 0.0 110.581 179.393 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' B' B ' 6' ' ' LEU . . . . . . . . . . . . . 65.5 mt -114.82 147.94 39.15 Favored 'General case' 0 C--N 1.331 -0.225 0 CA-C-N 115.303 -0.862 . . . . 0.0 110.687 -178.492 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' B' B ' 7' ' ' LYS . . . . . . . . . . . . . 74.7 tttt -133.55 135.06 24.42 Favored Pre-proline 0 CA--C 1.535 0.366 0 CA-C-O 118.848 -0.596 . . . . 0.0 109.933 176.174 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' B' B ' 8' ' ' PRO . . . . . . . . . . . . . 93.9 Cg_endo -90.79 142.26 3.25 Favored 'Trans proline' 0 N--CA 1.489 1.263 0 C-N-CA 121.666 1.577 . . . . 0.0 111.721 177.579 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' B' B ' 9' ' ' LEU . . . . . . . . . . . . . 47.0 mt -81.13 -47.22 1.13 Allowed Pre-proline 0 CA--C 1.533 0.323 0 CA-C-O 118.714 -0.66 . . . . 0.0 112.258 -178.544 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' B' B ' 10' ' ' PRO . . . . . . . . . . . . . 86.5 Cg_endo -80.69 150.46 18.85 Favored 'Trans proline' 0 N--CA 1.497 1.722 0 C-N-CA 121.179 1.253 . . . . 0.0 111.879 175.17 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' B' B ' 11' ' ' LYS . . . . . . . . . . . . . 33.9 ttmt -85.65 100.04 11.7 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-O 120.879 0.371 . . . . 0.0 110.57 178.463 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' B' B ' 12' ' ' VAL . . . . . . . . . . . . . 12.1 p -143.66 138.82 25.7 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.273 0 CA-C-N 116.125 -0.489 . . . . 0.0 110.493 179.22 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' B' B ' 13' ' ' GLU . . . . . . . . . . . . . 15.0 mm-40 -74.93 129.49 37.74 Favored 'General case' 0 C--N 1.329 -0.316 0 N-CA-C 109.955 -0.387 . . . . 0.0 109.955 177.098 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' B' B ' 14' ' ' LEU . . . . . . . . . . . . . 33.2 mt -97.86 146.32 31.26 Favored Pre-proline 0 CA--C 1.533 0.304 0 CA-C-O 119.142 -0.456 . . . . 0.0 110.265 -179.379 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' B' B ' 15' ' ' PRO . . . . . . . . . . . . . 26.2 Cg_exo -61.96 160.04 31.36 Favored 'Trans proline' 0 N--CA 1.498 1.768 0 C-N-CA 121.251 1.3 . . . . 0.0 112.001 177.818 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' B' B ' 16' ' ' PRO . . . . . . . . . . . . . 27.5 Cg_exo -60.37 -35.04 92.69 Favored 'Trans proline' 0 N--CA 1.496 1.634 0 C-N-CA 121.452 1.435 . . . . 0.0 112.659 -179.446 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' B' B ' 17' ' ' ASP . . . . . . . . . . . . . 10.3 p-10 -87.61 9.49 21.07 Favored 'General case' 0 CA--C 1.535 0.399 0 N-CA-C 113.168 0.803 . . . . 0.0 113.168 -178.073 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' B' B ' 18' ' ' PHE . . . . . . . . . . . . . 28.8 t80 -57.25 -41.38 79.51 Favored 'General case' 0 CA--C 1.527 0.073 0 O-C-N 121.939 -0.476 . . . . 0.0 110.296 -178.971 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' B' B ' 19' ' ' VAL . . . . . . . . . . . . . 50.0 t -56.94 -42.73 79.28 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 CA-C-N 116.399 -0.364 . . . . 0.0 110.396 -179.983 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' B' B ' 20' ' ' ASP . . . . . 0.557 ' OD1' HD11 ' B' ' 24' ' ' ILE . 4.9 t70 -60.28 -39.68 87.76 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-O 120.849 0.357 . . . . 0.0 110.747 -178.603 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' B' B ' 21' ' ' VAL . . . . . . . . . . . . . 46.2 t -64.28 -47.99 87.37 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.314 0 C-N-CA 120.755 -0.378 . . . . 0.0 110.24 -179.316 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' B' B ' 22' ' ' ILE . . . . . 0.404 HG22 HD12 ' B' ' 26' ' ' LEU . 51.7 mm -55.59 -58.04 5.93 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.237 0 C-N-CA 120.954 -0.298 . . . . 0.0 111.171 -178.38 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' B' B ' 23' ' ' ARG . . . . . . . . . . . . . 12.0 ptm180 -55.85 -42.97 76.59 Favored 'General case' 0 CA--C 1.531 0.223 0 C-N-CA 120.527 -0.469 . . . . 0.0 111.792 -173.797 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' B' B ' 24' ' ' ILE . . . . . 0.557 HD11 ' OD1' ' B' ' 20' ' ' ASP . 75.5 mt -60.81 -44.17 96.98 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.264 0 C-N-CA 120.815 -0.354 . . . . 0.0 111.421 -177.958 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' B' B ' 25' ' ' LYS . . . . . . . . . . . . . 68.6 mttm -67.71 -42.66 81.64 Favored 'General case' 0 C--N 1.329 -0.311 0 N-CA-C 112.558 0.577 . . . . 0.0 112.558 -178.306 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' B' B ' 26' ' ' LEU . . . . . 0.404 HD12 HG22 ' B' ' 22' ' ' ILE . 29.3 mt -79.45 -35.83 39.77 Favored 'General case' 0 C--N 1.33 -0.265 0 N-CA-C 113.522 0.934 . . . . 0.0 113.522 -170.782 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' B' B ' 27' ' ' GLN . . . . . . . . . . . . . 9.4 pt20 -47.13 138.62 6.69 Favored 'General case' 0 N--CA 1.47 0.556 0 N-CA-C 112.742 0.645 . . . . 0.0 112.742 -175.502 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' B' B ' 28' ' ' GLY . . . . . . . . . . . . . . . 98.4 -23.19 37.24 Favored Glycine 0 CA--C 1.534 1.279 0 CA-C-N 115.636 -0.711 . . . . 0.0 112.386 -177.298 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' B' B ' 29' ' ' LYS . . . . . . . . . . . . . 64.6 mttp -97.64 155.1 17.14 Favored 'General case' 0 C--O 1.233 0.229 0 CA-C-N 117.382 0.591 . . . . 0.0 111.084 179.297 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' B' B ' 30' ' ' THR . . . . . . . . . . . . . 27.4 m -102.95 135.87 43.82 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.119 -0.491 . . . . 0.0 109.87 175.565 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' B' B ' 31' ' ' VAL . . . . . . . . . . . . . 34.9 m -128.48 153.85 38.51 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.212 0 CA-C-O 120.928 0.394 . . . . 0.0 110.706 -178.161 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' B' B ' 32' ' ' ARG . . . . . . . . . . . . . 91.8 mtm-85 -132.68 147.71 52.33 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-O 121.283 0.563 . . . . 0.0 110.883 179.868 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' B' B ' 33' ' ' THR . . . . . . . . . . . . . 26.4 m -53.23 140.18 27.19 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.127 -0.488 . . . . 0.0 111.344 -177.971 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' B' B ' 34' ' ' GLY . . . . . . . . . . . . . . . 100.15 -17.09 57.55 Favored Glycine 0 CA--C 1.533 1.166 0 CA-C-O 119.608 -0.551 . . . . 0.0 113.22 179.574 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' B' B ' 35' ' ' ASP . . . . . . . . . . . . . 76.9 m-20 -65.19 148.92 50.82 Favored 'General case' 0 C--N 1.333 -0.109 0 CA-C-N 118.037 0.918 . . . . 0.0 111.08 178.924 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' B' B ' 36' ' ' VAL . . . . . . . . . . . . . 46.8 t -120.53 129.95 75.02 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.275 0 CA-C-N 115.83 -0.623 . . . . 0.0 109.625 177.337 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' B' B ' 37' ' ' ILE . . . . . . . . . . . . . 70.0 mt -118.8 138.93 47.91 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.274 0 CA-C-N 116.137 -0.483 . . . . 0.0 109.867 -178.242 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' B' B ' 38' ' ' GLY . . . . . . . . . . . . . . . -115.36 128.88 8.28 Favored Glycine 0 CA--C 1.525 0.707 0 N-CA-C 110.915 -0.874 . . . . 0.0 110.915 179.596 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' B' B ' 39' ' ' ILE . . . . . . . . . . . . . 76.2 mt -125.09 137.0 59.07 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.28 0 N-CA-C 110.195 -0.298 . . . . 0.0 110.195 -179.839 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' B' B ' 40' ' ' SER . . . . . . . . . . . . . 32.0 t -93.12 122.94 36.02 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.346 -0.388 . . . . 0.0 110.726 175.181 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' B' B ' 41' ' ' ILE . . . . . . . . . . . . . 71.4 mt -129.19 118.33 45.98 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.226 0 CA-C-O 120.929 0.395 . . . . 0.0 110.344 178.367 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' B' B ' 42' ' ' LEU . . . . . 0.541 ' O ' HD23 ' B' ' 42' ' ' LEU . 1.3 tt 50.68 45.27 27.16 Favored 'General case' 0 N--CA 1.465 0.288 0 CA-C-O 121.421 0.629 . . . . 0.0 111.047 176.621 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' B' B ' 43' ' ' GLY . . . . . . . . . . . . . . . 70.43 24.7 76.56 Favored Glycine 0 CA--C 1.531 1.064 0 C-N-CA 121.093 -0.575 . . . . 0.0 112.585 175.433 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' B' B ' 44' ' ' LYS . . . . . . . . . . . . . 35.5 ttpt -136.57 133.43 36.38 Favored 'General case' 0 C--N 1.333 -0.145 0 CA-C-N 117.438 0.619 . . . . 0.0 110.213 179.672 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' B' B ' 45' ' ' GLU . . . . . . . . . . . . . 68.0 tt0 -84.08 127.8 34.14 Favored 'General case' 0 C--N 1.326 -0.419 0 CA-C-N 116.437 -0.347 . . . . 0.0 111.203 -177.096 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' B' B ' 46' ' ' VAL . . . . . . . . . . . . . 7.5 p -125.51 128.38 72.42 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.2 0 CA-C-O 121.138 0.494 . . . . 0.0 109.837 175.88 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' B' B ' 47' ' ' LYS . . . . . . . . . . . . . 34.0 mmtp -100.29 131.78 46.03 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 115.789 -0.641 . . . . 0.0 111.457 178.417 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' B' B ' 48' ' ' PHE . . . . . . . . . . . . . 96.3 m-85 -118.04 131.98 56.41 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 115.976 -0.556 . . . . 0.0 109.812 175.313 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' B' B ' 49' ' ' LYS . . . . . . . . . . . . . 83.4 tttt -106.95 138.68 42.66 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.757 -0.202 . . . . 0.0 110.468 178.984 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' B' B ' 50' ' ' VAL . . . . . . . . . . . . . 43.4 t -84.14 108.57 16.57 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.298 0 N-CA-C 109.423 -0.584 . . . . 0.0 109.423 176.768 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' B' B ' 51' ' ' VAL . . . . . . . . . . . . . 47.1 t -73.51 -51.79 23.9 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.277 0 CA-C-N 116.022 -0.536 . . . . 0.0 109.842 -174.603 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' B' B ' 52' ' ' GLN . . . . . . . . . . . . . 88.0 mt-30 -153.89 151.45 29.48 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-N 116.06 -0.518 . . . . 0.0 111.769 -177.912 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' B' B ' 53' ' ' ALA . . . . . . . . . . . . . . . -130.85 134.61 46.96 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 115.371 -0.832 . . . . 0.0 109.651 174.468 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' B' B ' 54' ' ' TYR . . . . . . . . . . . . . 35.8 t80 -129.09 114.2 18.65 Favored Pre-proline 0 CA--C 1.535 0.366 0 CA-C-O 118.062 -0.97 . . . . 0.0 110.407 178.669 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' B' B ' 55' ' ' PRO . . . . . . . . . . . . . 74.1 Cg_endo -77.2 166.19 82.81 Favored 'Cis proline' 0 N--CA 1.5 1.875 0 CA-C-N 122.181 1.815 . . . . 0.0 112.081 -7.468 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' B' B ' 56' ' ' SER . . . . . . . . . . . . . 13.7 m -115.79 127.38 26.83 Favored Pre-proline 0 CA--C 1.538 0.502 0 CA-C-O 118.436 -0.793 . . . . 0.0 109.048 175.297 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' B' B ' 57' ' ' PRO . . . . . . . . . . . . . 44.3 Cg_endo -68.09 146.95 79.3 Favored 'Cis proline' 0 N--CA 1.498 1.75 0 CA-C-N 121.981 1.743 . . . . 0.0 111.855 2.007 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' B' B ' 58' ' ' LEU . . . . . . . . . . . . . 22.7 tp -108.31 137.1 46.85 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.158 -0.473 . . . . 0.0 110.556 -179.381 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' B' B ' 59' ' ' ARG . . . . . . . . . . . . . 23.6 ttm180 -100.91 124.85 47.22 Favored 'General case' 0 C--N 1.326 -0.434 0 N-CA-C 109.341 -0.614 . . . . 0.0 109.341 176.281 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' B' B ' 60' ' ' VAL . . . . . . . . . . . . . 40.9 t -82.68 120.16 33.56 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.281 0 C-N-CA 120.739 -0.385 . . . . 0.0 110.684 -174.374 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' B' B ' 61' ' ' GLU . . . . . . . . . . . . . 71.0 mm-40 -131.17 155.98 46.1 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 115.926 -0.579 . . . . 0.0 109.845 175.138 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' B' B ' 62' ' ' ASP . . . . . . . . . . . . . 21.6 m-20 -52.25 -33.86 43.45 Favored 'General case' 0 C--N 1.328 -0.33 0 N-CA-C 111.842 0.312 . . . . 0.0 111.842 -179.998 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' B' B ' 63' ' ' ARG . . . . . . . . . . . . . 94.6 mtt180 -73.17 -21.89 60.6 Favored 'General case' 0 CA--C 1.532 0.273 0 N-CA-C 113.05 0.759 . . . . 0.0 113.05 -176.559 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' B' B ' 64' ' ' THR . . . . . . . . . . . . . 27.1 m -62.61 143.42 57.31 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-O 120.731 0.3 . . . . 0.0 110.514 -176.983 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' B' B ' 65' ' ' LYS . . . . . . . . . . . . . 54.6 mttm -85.18 124.17 31.53 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.283 -0.417 . . . . 0.0 110.097 179.38 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' B' B ' 66' ' ' ILE . . . . . . . . . . . . . 58.2 mt -115.22 124.06 71.44 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.307 0 N-CA-C 109.646 -0.502 . . . . 0.0 109.646 -179.42 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' B' B ' 67' ' ' THR . . . . . . . . . . . . . 14.4 m -127.64 144.58 51.06 Favored 'General case' 0 C--N 1.333 -0.151 0 CA-C-O 121.01 0.433 . . . . 0.0 111.118 -176.617 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' B' B ' 68' ' ' LEU . . . . . 0.451 HD12 ' N ' ' B' ' 68' ' ' LEU . 6.5 mp -107.06 140.63 39.57 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.132 -0.485 . . . . 0.0 110.901 178.538 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' B' B ' 69' ' ' VAL . . . . . . . . . . . . . 42.7 t -95.27 147.46 5.83 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 CA-C-N 115.883 -0.598 . . . . 0.0 110.23 179.728 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' B' B ' 70' ' ' THR . . . . . . . . . . . . . 69.5 p -84.69 166.08 17.35 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-O 120.973 0.416 . . . . 0.0 110.957 -178.32 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' B' B ' 71' ' ' HIS . . . . . . . . . . . . . 65.8 m80 -75.01 161.95 75.39 Favored Pre-proline 0 CA--C 1.532 0.277 0 CA-C-N 115.999 -0.546 . . . . 0.0 111.221 -177.784 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' B' B ' 72' ' ' PRO . . . . . . . . . . . . . 72.6 Cg_endo -87.93 159.98 7.41 Favored 'Trans proline' 0 N--CA 1.489 1.263 0 C-N-CA 121.878 1.718 . . . . 0.0 112.773 -179.232 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' B' B ' 73' ' ' VAL . . . . . . . . . . . . . 34.7 m -70.04 179.58 0.35 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.295 0 CA-C-N 116.094 -0.503 . . . . 0.0 110.83 -179.956 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' B' B ' 74' ' ' ASP . . . . . . . . . . . . . 19.3 t0 -104.62 123.61 47.87 Favored 'General case' 0 C--N 1.331 -0.225 0 CA-C-N 116.389 -0.368 . . . . 0.0 110.087 -179.699 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' B' B ' 75' ' ' VAL . . . . . . . . . . . . . 42.6 t -117.44 121.72 68.24 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.221 0 CA-C-O 120.993 0.425 . . . . 0.0 110.538 -178.381 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' B' B ' 76' ' ' LEU . . . . . . . . . . . . . 5.7 mp -120.99 142.09 50.11 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 115.846 -0.615 . . . . 0.0 109.904 176.012 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' B' B ' 77' ' ' GLU . . . . . . . . . . . . . 97.5 mt-10 -133.59 134.89 43.85 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-O 121.01 0.433 . . . . 0.0 110.962 -178.991 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' B' B ' 78' ' ' ALA . . . . . 0.552 ' HB2' HD21 ' B' ' 109' ' ' LEU . . . -122.82 140.88 52.45 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 115.896 -0.593 . . . . 0.0 109.977 177.26 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' B' B ' 79' ' ' LYS . . . . . 0.687 ' O ' HD13 ' B' ' 80' ' ' ILE . 70.4 mmtt -75.0 115.86 15.09 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-O 120.972 0.415 . . . . 0.0 110.442 179.905 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' B' B ' 80' ' ' ILE . . . . . 0.687 HD13 ' O ' ' B' ' 79' ' ' LYS . 35.2 mm -139.04 105.87 2.74 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.328 0 N-CA-C 109.022 -0.733 . . . . 0.0 109.022 -178.302 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' B' B ' 81' ' ' LYS . . . . . . . . . . . . . 54.6 pttt -115.44 132.29 56.67 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-O 121.1 0.476 . . . . 0.0 111.195 -177.313 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' B' B ' 82' ' ' GLY . . . . . . . . . . . . . . . 89.07 42.09 5.71 Favored Glycine 0 CA--C 1.526 0.731 0 N-CA-C 111.135 -0.786 . . . . 0.0 111.135 179.239 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' B' B ' 83' ' ' ILE . . . . . . . . . . . . . 72.6 mt -71.55 139.27 20.1 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.293 0 CA-C-O 120.827 0.346 . . . . 0.0 110.162 -179.813 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' B' B ' 84' ' ' LYS . . . . . . . . . . . . . 15.2 ttmm -96.55 -54.07 3.37 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-O 121.179 0.514 . . . . 0.0 109.939 178.2 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' B' B ' 85' ' ' ASP . . . . . . . . . . . . . 8.9 t70 -155.44 146.41 22.45 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 115.508 -0.769 . . . . 0.0 110.125 -179.425 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' B' B ' 86' ' ' VAL . . . . . . . . . . . . . 43.6 t -124.2 129.2 74.16 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.256 0 CA-C-O 120.93 0.395 . . . . 0.0 110.249 179.888 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' B' B ' 87' ' ' ILE . . . . . . . . . . . . . 44.2 mm -118.34 124.76 73.61 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.262 0 CA-C-N 115.887 -0.597 . . . . 0.0 109.496 177.297 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' B' B ' 88' ' ' LEU . . . . . . . . . . . . . 15.3 tp -114.26 124.36 51.84 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-O 121.088 0.471 . . . . 0.0 111.238 -176.898 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' B' B ' 89' ' ' ASP . . . . . . . . . . . . . 5.7 t70 -112.44 159.61 18.58 Favored 'General case' 0 C--N 1.33 -0.24 0 N-CA-C 108.99 -0.744 . . . . 0.0 108.99 175.419 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' B' B ' 90' ' ' GLU . . . . . . . . . . . . . 94.5 mt-10 -48.28 -42.61 31.3 Favored 'General case' 0 N--CA 1.465 0.291 0 N-CA-C 112.689 0.626 . . . . 0.0 112.689 -171.479 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' B' B ' 91' ' ' ASN . . . . . . . . . . . . . 33.8 p-10 -132.2 37.06 3.58 Favored 'General case' 0 N--CA 1.464 0.251 0 N-CA-C 111.753 0.279 . . . . 0.0 111.753 -178.691 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' B' B ' 92' ' ' LEU . . . . . . . . . . . . . 15.9 tp -160.6 140.1 10.82 Favored 'General case' 0 C--N 1.331 -0.237 0 C-N-CA 120.826 -0.35 . . . . 0.0 110.667 -177.877 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' B' B ' 93' ' ' ILE . . . . . . . . . . . . . 68.2 mt -122.7 123.12 67.61 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.198 0 N-CA-C 109.679 -0.489 . . . . 0.0 109.679 -178.663 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' B' B ' 94' ' ' VAL . . . . . . . . . . . . . 46.8 t -124.46 125.77 70.8 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.243 0 N-CA-C 109.718 -0.475 . . . . 0.0 109.718 177.629 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' B' B ' 95' ' ' VAL . . . . . . . . . . . . . 44.4 t -122.3 133.44 68.56 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.341 0 CA-C-N 116.022 -0.536 . . . . 0.0 109.789 -179.178 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' B' B ' 96' ' ' ILE . . . . . 0.405 HD11 ' HB ' ' B' ' 123' ' ' VAL . 51.7 mt -114.07 127.33 71.53 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.329 0 N-CA-C 108.782 -0.822 . . . . 0.0 108.782 178.301 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' B' B ' 97' ' ' THR . . . . . . . . . . . . . 82.7 p -99.0 153.76 18.61 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-O 121.292 0.568 . . . . 0.0 111.279 -176.85 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' B' B ' 98' ' ' GLU . . . . . . . . . . . . . 73.0 tt0 -53.97 -24.02 15.21 Favored 'General case' 0 C--N 1.325 -0.471 0 CA-C-N 115.811 -0.631 . . . . 0.0 112.166 179.322 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' B' B ' 99' ' ' GLU . . . . . . . . . . . . . 91.1 mt-10 -82.07 16.09 2.07 Favored 'General case' 0 CA--C 1.535 0.389 0 N-CA-C 113.082 0.771 . . . . 0.0 113.082 -176.981 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' B' B ' 100' ' ' ASN . . . . . . . . . . . . . 2.7 m-20 64.78 36.97 7.66 Favored 'General case' 0 CA--C 1.53 0.201 0 CA-C-O 121.001 0.429 . . . . 0.0 111.343 177.218 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' B' B ' 101' ' ' GLU . . . . . . . . . . . . . 82.7 tt0 -118.1 145.05 45.15 Favored 'General case' 0 C--N 1.331 -0.199 0 CA-C-N 116.147 -0.479 . . . . 0.0 110.031 175.294 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' B' B ' 102' ' ' VAL . . . . . . . . . . . . . 44.4 t -118.13 128.5 75.18 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.295 0 N-CA-C 110.137 -0.32 . . . . 0.0 110.137 -179.286 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' B' B ' 103' ' ' LEU . . . . . . . . . . . . . 6.1 mp -120.95 135.37 55.22 Favored 'General case' 0 C--N 1.331 -0.224 0 CA-C-N 115.94 -0.573 . . . . 0.0 110.489 177.642 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' B' B ' 104' ' ' ILE . . . . . . . . . . . . . 70.0 mt -121.82 124.74 72.11 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.276 0 CA-C-N 116.509 -0.314 . . . . 0.0 110.454 -179.848 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' B' B ' 105' ' ' PHE . . . . . . . . . . . . . 62.8 m-85 -123.23 166.0 15.98 Favored 'General case' 0 C--O 1.232 0.134 0 O-C-N 124.033 0.833 . . . . 0.0 109.873 -179.534 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' B' B ' 106' ' ' ASN . . . . . . . . . . . . . 43.7 p-10 -102.52 -170.66 1.84 Allowed 'General case' 0 CA--C 1.53 0.197 0 N-CA-C 110.164 -0.309 . . . . 0.0 110.164 173.894 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' B' B ' 107' ' ' GLN . . . . . . . . . . . . . 40.4 tt0 -59.05 -30.09 67.79 Favored 'General case' 0 C--N 1.33 -0.267 0 N-CA-C 112.085 0.402 . . . . 0.0 112.085 -179.265 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' B' B ' 108' ' ' ASN . . . . . . . . . . . . . 5.3 t30 -85.53 11.03 11.42 Favored 'General case' 0 CA--C 1.536 0.412 0 N-CA-C 113.052 0.76 . . . . 0.0 113.052 -176.915 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' B' B ' 109' ' ' LEU . . . . . 0.552 HD21 ' HB2' ' B' ' 78' ' ' ALA . 9.0 tp 60.59 34.81 20.15 Favored 'General case' 0 C--N 1.331 -0.215 0 CA-C-O 120.758 0.313 . . . . 0.0 111.558 178.905 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' B' B ' 110' ' ' GLU . . . . . . . . . . . . . 95.7 mt-10 -103.01 147.02 27.47 Favored 'General case' 0 C--N 1.33 -0.258 0 N-CA-C 109.68 -0.489 . . . . 0.0 109.68 176.205 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' B' B ' 111' ' ' GLU . . . . . . . . . . . . . 55.5 tt0 -85.49 121.88 28.83 Favored 'General case' 0 C--N 1.328 -0.362 0 C-N-CA 120.831 -0.348 . . . . 0.0 110.68 -177.273 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' B' B ' 112' ' ' LEU . . . . . . . . . . . . . 37.3 mt -104.39 -46.03 4.5 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.122 -0.49 . . . . 0.0 110.88 179.151 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' B' B ' 113' ' ' TYR . . . . . 0.418 ' CE1' HG21 ' C' ' 75' ' ' VAL . 66.3 t80 -136.5 144.9 44.55 Favored 'General case' 0 N--CA 1.464 0.23 0 CA-C-O 120.969 0.414 . . . . 0.0 111.132 -179.053 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' B' B ' 114' ' ' ARG . . . . . . . . . . . . . 14.3 ptt180 -146.55 124.39 11.94 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 115.621 -0.718 . . . . 0.0 110.365 178.765 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' B' B ' 115' ' ' GLY . . . . . . . . . . . . . . . -150.16 155.26 26.14 Favored Glycine 0 CA--C 1.523 0.539 0 N-CA-C 110.908 -0.877 . . . . 0.0 110.908 -179.948 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' B' B ' 116' ' ' LYS . . . . . . . . . . . . . 19.8 ttmt -126.66 140.46 52.4 Favored 'General case' 0 C--N 1.331 -0.228 0 N-CA-C 109.638 -0.504 . . . . 0.0 109.638 178.667 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' B' B ' 117' ' ' PHE . . . . . . . . . . . . . 32.2 m-85 -138.51 114.02 9.68 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-O 120.935 0.398 . . . . 0.0 110.258 -176.35 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' B' B ' 118' ' ' GLU . . . . . . . . . . . . . 75.1 tt0 -53.42 -49.73 66.7 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 116.528 -0.306 . . . . 0.0 111.432 -176.638 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' B' B ' 119' ' ' ASN . . . . . . . . . . . . . 33.7 m120 -91.45 30.47 1.3 Allowed 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.081 -0.508 . . . . 0.0 112.213 -174.324 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' B' B ' 120' ' ' LEU . . . . . . . . . . . . . 14.2 tp -56.73 122.14 11.42 Favored 'General case' 0 C--N 1.332 -0.154 0 CA-C-O 120.666 0.27 . . . . 0.0 110.459 178.579 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' B' B ' 121' ' ' ASN . . . . . . . . . . . . . 44.8 m-20 -114.01 -44.08 3.19 Favored 'General case' 0 C--N 1.332 -0.174 0 CA-C-N 116.485 -0.325 . . . . 0.0 110.956 -176.844 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' B' B ' 122' ' ' LYS . . . . . . . . . . . . . 99.1 mttt -143.76 148.64 35.91 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-O 121.027 0.441 . . . . 0.0 111.448 -177.765 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' B' B ' 123' ' ' VAL . . . . . 0.405 ' HB ' HD11 ' B' ' 96' ' ' ILE . 45.2 t -125.0 125.85 70.21 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.292 0 CA-C-N 115.885 -0.598 . . . . 0.0 109.572 175.605 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' B' B ' 124' ' ' LEU . . . . . . . . . . . . . 28.2 mt -112.08 125.44 54.1 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 116.239 -0.437 . . . . 0.0 110.333 -179.448 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' B' B ' 125' ' ' VAL . . . . . . . . . . . . . 44.2 t -133.54 126.4 51.71 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.276 0 CA-C-N 116.495 -0.32 . . . . 0.0 110.365 -179.124 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' B' B ' 126' ' ' ARG . . . . . . . . . . . . . 69.2 ttt-85 -162.61 141.67 9.0 Favored 'General case' 0 C--N 1.329 -0.32 0 N-CA-C 109.611 -0.515 . . . . 0.0 109.611 175.094 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' B' B ' 127' ' ' ASN . . . . . . . . . . . . . 10.1 p30 48.88 -151.99 0.13 Allowed 'General case' 0 CA--C 1.54 0.563 0 CA-C-O 119.373 -0.346 . . . . 0.0 111.001 178.988 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' B' B ' 128' ' ' ASP . . . . . . . . . . . . . 13.7 p-10 -83.55 21.54 1.19 Allowed 'General case' 0 CA--C 1.533 0.307 0 CA-C-N 118.512 0.596 . . . . 0.0 112.517 179.271 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' B' B ' 129' ' ' LEU . . . . . . . . . . . . . 17.1 tp -119.66 135.23 54.9 Favored 'General case' 0 C--O 1.233 0.235 0 CA-C-O 120.969 0.414 . . . . 0.0 110.327 179.541 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' B' B ' 130' ' ' VAL . . . . . . . . . . . . . 44.6 t -128.58 135.65 61.88 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.233 0 CA-C-N 115.961 -0.563 . . . . 0.0 109.802 179.322 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' B' B ' 131' ' ' VAL . . . . . 0.44 HG22 HD12 ' B' ' 140' ' ' LEU . 43.1 t -133.82 135.59 55.05 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.285 0 CA-C-O 120.924 0.392 . . . . 0.0 110.16 179.705 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' B' B ' 132' ' ' ILE . . . . . . . . . . . . . 72.8 mt -116.22 129.76 72.1 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.327 0 N-CA-C 109.341 -0.614 . . . . 0.0 109.341 -179.958 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' B' B ' 133' ' ' ILE . . . . . . . . . . . . . 41.9 mm -116.72 120.51 65.22 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.21 0 CA-C-O 120.807 0.337 . . . . 0.0 110.859 -175.779 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' B' B ' 134' ' ' ASP . . . . . . . . . . . . . 7.7 p-10 -134.22 145.59 49.31 Favored 'General case' 0 C--N 1.33 -0.265 0 N-CA-C 109.601 -0.518 . . . . 0.0 109.601 175.11 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' B' B ' 135' ' ' GLU . . . . . . . . . . . . . 73.9 tt0 -49.96 -25.45 3.3 Favored 'General case' 0 C--N 1.329 -0.309 0 N-CA-C 112.975 0.731 . . . . 0.0 112.975 -170.578 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' B' B ' 136' ' ' GLN . . . . . . . . . . . . . 97.1 mt-30 -96.81 -31.83 12.42 Favored 'General case' 0 C--O 1.234 0.276 0 N-CA-C 112.256 0.465 . . . . 0.0 112.256 -176.291 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' B' B ' 137' ' ' LYS . . . . . . . . . . . . . 92.5 mttt -139.53 152.87 47.27 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-O 121.172 0.511 . . . . 0.0 111.48 -170.408 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' B' B ' 138' ' ' LEU . . . . . 0.469 ' C ' HD23 ' B' ' 138' ' ' LEU . 6.2 tt -119.34 119.55 34.33 Favored 'General case' 0 C--N 1.327 -0.4 0 N-CA-C 108.977 -0.749 . . . . 0.0 108.977 172.682 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' B' B ' 139' ' ' THR . . . . . . . . . . . . . 28.3 m -111.16 130.32 55.67 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-O 120.655 0.264 . . . . 0.0 110.803 -175.899 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' B' B ' 140' ' ' LEU . . . . . 0.44 HD12 HG22 ' B' ' 131' ' ' VAL . 10.6 tp -115.28 120.62 40.28 Favored 'General case' 0 C--N 1.328 -0.353 0 N-CA-C 109.299 -0.63 . . . . 0.0 109.299 -179.526 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' B' B ' 141' ' ' ILE . . . . . . . . . . . . . 19.5 mt -119.88 124.92 73.69 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.242 0 CA-C-O 121.077 0.465 . . . . 0.0 110.158 -175.044 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' B' B ' 142' ' ' ARG . . . . . . . . . . . . . 82.1 mtp180 -108.35 121.66 45.38 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 115.404 -0.816 . . . . 0.0 110.004 179.472 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' B' B ' 143' ' ' THR . . . . . . . . . . . . . 81.2 p . . . . . 0 C--O 1.219 -0.516 0 CA-C-O 117.932 -1.032 . . . . 0.0 110.747 -178.885 . . . . . . . . 0 0 . 1 . 015 nuclear nobuild full ' C' C ' -3' ' ' GLU . . . . . . . . . . . . . 21.9 pt-20 . . . . . 0 N--CA 1.491 1.62 0 N-CA-C 110.215 -0.291 . . . . 0.0 110.215 . . . . . . . . . 0 0 . 1 . 015 nuclear nobuild full ' C' C ' -2' ' ' GLY . . . . . . . . . . . . . . . -100.09 132.94 11.11 Favored Glycine 0 CA--C 1.524 0.609 0 N-CA-C 111.066 -0.814 . . . . 0.0 111.066 -179.945 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' C' C ' -1' ' ' VAL . . . . . . . . . . . . . 45.1 t -140.59 138.33 35.78 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.255 0 N-CA-C 109.829 -0.434 . . . . 0.0 109.829 179.0 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' C' C ' 0' ' ' ILE . . . . . . . . . . . . . 69.3 mt -106.08 129.78 58.74 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.34 0 CA-C-N 116.243 -0.435 . . . . 0.0 109.83 -179.48 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' C' C ' 1' ' ' MET . . . . . . . . . . . . . 25.3 ptt? -77.89 137.52 38.41 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.363 -0.38 . . . . 0.0 110.393 179.696 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' C' C ' 2' ' ' SER . . . . . . . . . . . . . 8.0 p -124.61 149.47 47.03 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-O 121.094 0.473 . . . . 0.0 111.146 -178.184 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' C' C ' 3' ' ' GLU . . . . . . . . . . . . . 47.7 mp0 -137.72 140.44 40.71 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 115.81 -0.632 . . . . 0.0 110.578 179.789 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' C' C ' 4' ' ' LEU . . . . . . . . . . . . . 13.4 tp -123.19 128.66 50.34 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 115.813 -0.63 . . . . 0.0 109.923 178.259 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' C' C ' 5' ' ' LYS . . . . . . . . . . . . . 61.3 mttp -108.89 119.61 40.07 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.538 -0.301 . . . . 0.0 110.922 -179.801 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' C' C ' 6' ' ' LEU . . . . . . . . . . . . . 38.8 mt -114.04 147.68 38.28 Favored 'General case' 0 C--N 1.331 -0.227 0 CA-C-N 115.279 -0.873 . . . . 0.0 110.232 179.286 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' C' C ' 7' ' ' LYS . . . . . . . . . . . . . 75.1 tttt -136.87 137.15 22.48 Favored Pre-proline 0 CA--C 1.534 0.33 0 CA-C-O 118.999 -0.524 . . . . 0.0 110.113 176.763 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' C' C ' 8' ' ' PRO . . . . . . . . . . . . . 98.5 Cg_endo -90.86 139.67 2.7 Favored 'Trans proline' 0 N--CA 1.491 1.328 0 C-N-CA 121.646 1.564 . . . . 0.0 111.813 177.839 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' C' C ' 9' ' ' LEU . . . . . . . . . . . . . 37.9 mt -76.3 -48.09 3.31 Favored Pre-proline 0 CA--C 1.533 0.307 0 CA-C-O 118.649 -0.691 . . . . 0.0 112.288 -179.242 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' C' C ' 10' ' ' PRO . . . . . . . . . . . . . 81.4 Cg_endo -78.26 147.36 23.11 Favored 'Trans proline' 0 N--CA 1.496 1.666 0 C-N-CA 121.003 1.135 . . . . 0.0 111.648 176.714 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' C' C ' 11' ' ' LYS . . . . . . . . . . . . . 7.3 ttpm? -86.56 87.69 7.5 Favored 'General case' 0 C--N 1.33 -0.273 0 C-N-CA 120.846 -0.342 . . . . 0.0 110.428 -179.652 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' C' C ' 12' ' ' VAL . . . . . . . . . . . . . 11.6 p -136.32 143.45 35.68 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.271 0 CA-C-N 116.03 -0.532 . . . . 0.0 110.324 179.776 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' C' C ' 13' ' ' GLU . . . . . . . . . . . . . 94.8 mt-10 -79.03 131.03 36.14 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.349 -0.387 . . . . 0.0 110.581 -179.664 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' C' C ' 14' ' ' LEU . . . . . . . . . . . . . 21.2 mt -99.42 152.52 37.83 Favored Pre-proline 0 CA--C 1.532 0.276 0 CA-C-N 116.275 -0.421 . . . . 0.0 110.787 179.236 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' C' C ' 15' ' ' PRO . . . . . . . . . . . . . 26.6 Cg_exo -61.91 157.28 44.26 Favored 'Trans proline' 0 N--CA 1.498 1.738 0 C-N-CA 121.312 1.341 . . . . 0.0 111.793 175.961 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' C' C ' 16' ' ' PRO . . . . . . . . . . . . . 33.1 Cg_exo -57.47 -41.62 70.01 Favored 'Trans proline' 0 N--CA 1.497 1.694 0 C-N-CA 121.418 1.412 . . . . 0.0 112.901 -178.478 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' C' C ' 17' ' ' ASP . . . . . . . . . . . . . 19.8 p-10 -86.35 11.93 11.21 Favored 'General case' 0 CA--C 1.536 0.433 0 N-CA-C 113.105 0.78 . . . . 0.0 113.105 -177.64 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' C' C ' 18' ' ' PHE . . . . . . . . . . . . . 51.7 t80 -57.59 -43.33 84.53 Favored 'General case' 0 C--N 1.334 -0.08 0 O-C-N 121.986 -0.446 . . . . 0.0 110.171 -178.431 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' C' C ' 19' ' ' VAL . . . . . 0.402 HG13 ' N ' ' C' ' 20' ' ' ASP . 14.9 p -56.59 -41.94 74.89 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.243 0 CA-C-N 116.29 -0.414 . . . . 0.0 110.919 -178.732 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' C' C ' 20' ' ' ASP . . . . . 0.402 ' N ' HG13 ' C' ' 19' ' ' VAL . 34.7 m-20 -60.44 -41.59 94.36 Favored 'General case' 0 C--N 1.331 -0.222 0 CA-C-O 120.831 0.348 . . . . 0.0 110.9 -178.758 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' C' C ' 21' ' ' VAL . . . . . . . . . . . . . 48.6 t -63.69 -46.96 93.23 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.287 0 CA-C-N 116.343 -0.389 . . . . 0.0 110.261 -178.828 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' C' C ' 22' ' ' ILE . . . . . 0.402 HG22 HD12 ' C' ' 26' ' ' LEU . 50.3 mm -56.68 -45.31 82.64 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.243 0 CA-C-O 120.822 0.344 . . . . 0.0 110.577 178.851 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' C' C ' 23' ' ' ARG . . . . . . . . . . . . . 49.1 ttp180 -54.22 -49.0 70.45 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.649 -0.25 . . . . 0.0 111.374 -178.018 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' C' C ' 24' ' ' ILE . . . . . . . . . . . . . 73.2 mt -59.49 -43.8 91.48 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.321 0 CA-C-O 120.864 0.364 . . . . 0.0 110.842 -178.751 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' C' C ' 25' ' ' LYS . . . . . . . . . . . . . 60.6 mtpt -62.61 -40.52 97.19 Favored 'General case' 0 C--N 1.327 -0.409 0 N-CA-C 112.113 0.412 . . . . 0.0 112.113 -178.298 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' C' C ' 26' ' ' LEU . . . . . 0.402 HD12 HG22 ' C' ' 22' ' ' ILE . 89.8 mt -79.86 -43.43 22.32 Favored 'General case' 0 C--N 1.33 -0.246 0 N-CA-C 113.352 0.871 . . . . 0.0 113.352 -171.759 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' C' C ' 27' ' ' GLN . . . . . . . . . . . . . 10.3 pt20 -46.78 138.62 6.05 Favored 'General case' 0 N--CA 1.468 0.468 0 N-CA-C 112.822 0.675 . . . . 0.0 112.822 -173.813 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' C' C ' 28' ' ' GLY . . . . . . . . . . . . . . . 100.22 -25.87 26.66 Favored Glycine 0 CA--C 1.533 1.174 0 CA-C-N 115.402 -0.817 . . . . 0.0 112.359 -177.338 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' C' C ' 29' ' ' LYS . . . . . . . . . . . . . 63.0 mttp -98.71 155.09 17.51 Favored 'General case' 0 C--N 1.332 -0.194 0 CA-C-N 117.396 0.598 . . . . 0.0 111.367 179.779 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' C' C ' 30' ' ' THR . . . . . . . . . . . . . 28.6 m -96.87 136.4 37.48 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 115.985 -0.552 . . . . 0.0 110.012 175.445 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' C' C ' 31' ' ' VAL . . . . . . . . . . . . . 34.9 m -128.94 148.76 33.26 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.316 0 CA-C-N 116.282 -0.417 . . . . 0.0 110.654 -179.368 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' C' C ' 32' ' ' ARG . . . . . . . . . . . . . 53.9 ttp180 -131.34 147.78 52.61 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-O 121.191 0.52 . . . . 0.0 110.332 178.661 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' C' C ' 33' ' ' THR . . . . . . . . . . . . . 17.5 m -52.99 138.82 29.47 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.383 -0.371 . . . . 0.0 111.46 -177.4 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' C' C ' 34' ' ' GLY . . . . . . . . . . . . . . . 101.51 -17.2 55.68 Favored Glycine 0 CA--C 1.533 1.214 0 CA-C-O 119.66 -0.522 . . . . 0.0 113.135 -179.782 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' C' C ' 35' ' ' ASP . . . . . . . . . . . . . 67.2 m-20 -65.14 149.84 49.2 Favored 'General case' 0 C--O 1.231 0.127 0 CA-C-N 118.046 0.923 . . . . 0.0 111.249 179.127 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' C' C ' 36' ' ' VAL . . . . . . . . . . . . . 46.0 t -123.3 131.46 73.13 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.239 0 CA-C-N 115.788 -0.642 . . . . 0.0 109.835 177.784 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' C' C ' 37' ' ' ILE . . . . . . . . . . . . . 69.7 mt -120.57 139.36 48.08 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.234 0 CA-C-N 116.254 -0.43 . . . . 0.0 109.984 -179.115 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' C' C ' 38' ' ' GLY . . . . . . . . . . . . . . . -113.83 128.84 8.48 Favored Glycine 0 CA--C 1.526 0.721 0 N-CA-C 111.095 -0.802 . . . . 0.0 111.095 -179.972 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' C' C ' 39' ' ' ILE . . . . . . . . . . . . . 72.8 mt -123.18 133.44 69.09 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.265 0 N-CA-C 110.026 -0.361 . . . . 0.0 110.026 179.116 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' C' C ' 40' ' ' SER . . . . . . . . . . . . . 85.8 p -92.11 122.64 34.8 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.454 -0.339 . . . . 0.0 110.684 176.222 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' C' C ' 41' ' ' ILE . . . . . . . . . . . . . 73.3 mt -135.39 118.13 22.65 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.176 0 CA-C-O 120.95 0.405 . . . . 0.0 110.467 178.738 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' C' C ' 42' ' ' LEU . . . . . 0.533 ' O ' HD23 ' C' ' 42' ' ' LEU . 1.4 tt 55.17 45.48 25.87 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-O 121.496 0.665 . . . . 0.0 110.424 177.79 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' C' C ' 43' ' ' GLY . . . . . . . . . . . . . . . 74.99 -10.01 10.4 Favored Glycine 0 CA--C 1.535 1.31 0 C-N-CA 121.239 -0.505 . . . . 0.0 113.761 174.679 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' C' C ' 44' ' ' LYS . . . . . . . . . . . . . 93.1 mttt -104.79 137.61 42.32 Favored 'General case' 0 C--N 1.334 -0.103 0 CA-C-N 118.116 0.958 . . . . 0.0 110.6 -179.464 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' C' C ' 45' ' ' GLU . . . . . . . . . . . . . 79.5 tt0 -85.58 130.0 34.68 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.247 -0.433 . . . . 0.0 111.002 179.453 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' C' C ' 46' ' ' VAL . . . . . . . . . . . . . 7.4 p -123.24 127.96 74.69 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.247 0 N-CA-C 109.587 -0.523 . . . . 0.0 109.587 175.369 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' C' C ' 47' ' ' LYS . . . . . . . . . . . . . 57.3 mtmt -101.47 129.71 47.58 Favored 'General case' 0 C--N 1.331 -0.201 0 CA-C-N 115.888 -0.596 . . . . 0.0 111.626 179.824 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' C' C ' 48' ' ' PHE . . . . . . . . . . . . . 93.1 m-85 -113.85 132.07 56.03 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.079 -0.509 . . . . 0.0 110.154 176.861 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' C' C ' 49' ' ' LYS . . . . . . . . . . . . . 77.8 tttt -106.18 139.56 40.5 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.558 -0.292 . . . . 0.0 110.635 178.978 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' C' C ' 50' ' ' VAL . . . . . . . . . . . . . 44.9 t -83.64 105.61 13.38 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.252 0 N-CA-C 109.194 -0.669 . . . . 0.0 109.194 174.64 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' C' C ' 51' ' ' VAL . . . . . . . . . . . . . 48.7 t -69.65 -54.89 17.13 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.39 0 CA-C-N 115.791 -0.64 . . . . 0.0 109.513 -175.041 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' C' C ' 52' ' ' GLN . . . . . . . . . . . . . 88.5 mt-30 -155.26 154.36 32.04 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 115.882 -0.599 . . . . 0.0 111.906 -177.561 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' C' C ' 53' ' ' ALA . . . . . 0.639 ' HB3' ' OG ' ' C' ' 56' ' ' SER . . . -131.6 132.49 44.11 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 115.334 -0.848 . . . . 0.0 109.782 174.1 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' C' C ' 54' ' ' TYR . . . . . . . . . . . . . 19.8 t80 -129.11 110.45 18.21 Favored Pre-proline 0 CA--C 1.533 0.32 0 CA-C-O 118.142 -0.932 . . . . 0.0 110.092 177.224 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' C' C ' 55' ' ' PRO . . . . . . . . . . . . . 72.7 Cg_endo -77.1 170.1 72.51 Favored 'Cis proline' 0 N--CA 1.5 1.869 0 CA-C-N 121.983 1.744 . . . . 0.0 112.326 -4.973 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' C' C ' 56' ' ' SER . . . . . 0.639 ' OG ' ' HB3' ' C' ' 53' ' ' ALA . 67.2 m -128.19 138.9 33.98 Favored Pre-proline 0 CA--C 1.536 0.429 0 CA-C-O 118.585 -0.721 . . . . 0.0 109.32 174.039 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' C' C ' 57' ' ' PRO . . . . . . . . . . . . . 40.4 Cg_endo -68.53 143.12 70.03 Favored 'Cis proline' 0 N--CA 1.498 1.789 0 CA-C-N 121.662 1.629 . . . . 0.0 111.678 -1.093 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' C' C ' 58' ' ' LEU . . . . . . . . . . . . . 27.8 tp -107.58 138.03 44.54 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.055 -0.52 . . . . 0.0 110.764 -176.085 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' C' C ' 59' ' ' ARG . . . . . . . . . . . . . 43.1 ttp180 -101.44 119.31 38.57 Favored 'General case' 0 C--N 1.328 -0.354 0 N-CA-C 108.894 -0.78 . . . . 0.0 108.894 173.698 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' C' C ' 60' ' ' VAL . . . . . . . . . . . . . 45.0 t -72.25 120.04 19.97 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.258 0 C-N-CA 120.644 -0.423 . . . . 0.0 110.3 -173.677 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' C' C ' 61' ' ' GLU . . . . . . . . . . . . . 42.8 mt-10 -131.04 162.61 29.42 Favored 'General case' 0 C--N 1.331 -0.23 0 CA-C-N 116.03 -0.532 . . . . 0.0 110.284 178.411 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' C' C ' 62' ' ' ASP . . . . . . . . . . . . . 7.7 p-10 -56.19 -32.54 64.46 Favored 'General case' 0 C--N 1.329 -0.304 0 N-CA-C 111.922 0.342 . . . . 0.0 111.922 -178.412 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' C' C ' 63' ' ' ARG . . . . . . . . . . . . . 40.4 ptt180 -81.4 3.83 23.05 Favored 'General case' 0 CA--C 1.537 0.452 0 N-CA-C 113.746 1.017 . . . . 0.0 113.746 -175.582 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' C' C ' 64' ' ' THR . . . . . . . . . . . . . 26.4 m -87.99 138.75 31.17 Favored 'General case' 0 C--N 1.332 -0.166 0 CA-C-N 118.103 0.41 . . . . 0.0 110.48 -179.061 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' C' C ' 65' ' ' LYS . . . . . . . . . . . . . 95.4 mttt -87.93 128.31 35.37 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.373 -0.376 . . . . 0.0 110.127 -179.755 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' C' C ' 66' ' ' ILE . . . . . . . . . . . . . 59.1 mt -115.64 131.62 67.48 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.215 0 N-CA-C 109.936 -0.394 . . . . 0.0 109.936 -179.329 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' C' C ' 67' ' ' THR . . . . . . . . . . . . . 26.3 m -124.69 138.21 54.31 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-N 116.151 -0.477 . . . . 0.0 110.723 -179.689 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' C' C ' 68' ' ' LEU . . . . . . . . . . . . . 48.2 mt -103.06 122.82 45.44 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 115.902 -0.59 . . . . 0.0 110.297 177.367 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' C' C ' 69' ' ' VAL . . . . . . . . . . . . . 43.3 t -102.44 144.89 12.87 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.351 0 CA-C-N 115.926 -0.579 . . . . 0.0 110.042 -179.809 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' C' C ' 70' ' ' THR . . . . . . . . . . . . . 8.5 m -128.43 -41.86 1.52 Allowed 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.097 -0.501 . . . . 0.0 110.011 178.809 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' C' C ' 71' ' ' HIS . . . . . . . . . . . . . 24.0 m-70 -105.54 152.69 40.06 Favored Pre-proline 0 C--N 1.331 -0.229 0 N-CA-C 109.812 -0.44 . . . . 0.0 109.812 175.647 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' C' C ' 72' ' ' PRO . . . . . . . . . . . . . 33.3 Cg_endo -65.01 -22.71 62.13 Favored 'Trans proline' 0 N--CA 1.496 1.667 0 C-N-CA 121.219 1.279 . . . . 0.0 112.867 179.159 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' C' C ' 73' ' ' VAL . . . . . . . . . . . . . 30.4 m -105.44 164.3 4.15 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.211 0 N-CA-C 110.138 -0.319 . . . . 0.0 110.138 179.289 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' C' C ' 74' ' ' ASP . . . . . 0.407 ' OD1' HD11 ' C' ' 76' ' ' LEU . 13.6 t0 -96.38 119.04 34.15 Favored 'General case' 0 C--N 1.33 -0.253 0 N-CA-C 109.919 -0.401 . . . . 0.0 109.919 -177.498 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' C' C ' 75' ' ' VAL . . . . . 0.418 HG21 ' CE1' ' B' ' 113' ' ' TYR . 43.2 t -119.44 122.95 70.25 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.208 0 CA-C-O 121.125 0.488 . . . . 0.0 110.811 -176.954 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' C' C ' 76' ' ' LEU . . . . . 0.48 ' N ' HD12 ' C' ' 76' ' ' LEU . 5.8 mp -121.05 141.48 50.72 Favored 'General case' 0 C--N 1.331 -0.205 0 CA-C-N 115.647 -0.706 . . . . 0.0 109.12 174.112 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' C' C ' 77' ' ' GLU . . . . . . . . . . . . . 31.3 tt0 -132.08 132.13 43.02 Favored 'General case' 0 C--N 1.331 -0.209 0 CA-C-O 120.841 0.353 . . . . 0.0 110.902 -176.161 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' C' C ' 78' ' ' ALA . . . . . . . . . . . . . . . -119.1 142.44 47.9 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 116.002 -0.545 . . . . 0.0 109.869 177.454 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' C' C ' 79' ' ' LYS . . . . . 0.565 ' O ' HD13 ' C' ' 80' ' ' ILE . 81.3 tttt -84.45 119.73 25.47 Favored 'General case' 0 C--N 1.328 -0.332 0 C-N-CA 120.934 -0.307 . . . . 0.0 110.58 -178.69 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' C' C ' 80' ' ' ILE . . . . . 0.565 HD13 ' O ' ' C' ' 79' ' ' LYS . 44.8 mm -138.26 117.94 14.96 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.27 0 N-CA-C 109.533 -0.543 . . . . 0.0 109.533 -177.486 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' C' C ' 81' ' ' LYS . . . . . . . . . . . . . 59.4 mtmt -112.83 125.69 54.62 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.407 -0.361 . . . . 0.0 111.37 -176.298 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' C' C ' 82' ' ' GLY . . . . . . . . . . . . . . . 89.13 42.11 5.68 Favored Glycine 0 CA--C 1.524 0.595 0 C-N-CA 120.865 -0.683 . . . . 0.0 111.458 175.485 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' C' C ' 83' ' ' ILE . . . . . . . . . . . . . 70.1 mt -67.59 132.77 32.34 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.291 0 N-CA-C 109.835 -0.431 . . . . 0.0 109.835 178.909 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' C' C ' 84' ' ' LYS . . . . . . . . . . . . . 59.4 tttp -93.5 -49.25 6.0 Favored 'General case' 0 C--N 1.327 -0.407 0 CA-C-N 116.011 -0.54 . . . . 0.0 109.837 179.967 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' C' C ' 85' ' ' ASP . . . . . . . . . . . . . 5.1 t0 -159.84 153.14 22.15 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 115.71 -0.677 . . . . 0.0 110.28 179.031 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' C' C ' 86' ' ' VAL . . . . . . . . . . . . . 42.6 t -125.92 131.75 71.46 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.274 0 CA-C-O 120.868 0.366 . . . . 0.0 110.199 -179.939 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' C' C ' 87' ' ' ILE . . . . . . . . . . . . . 44.2 mm -120.13 129.27 75.68 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.264 0 CA-C-N 116.027 -0.533 . . . . 0.0 109.632 178.981 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' C' C ' 88' ' ' LEU . . . . . . . . . . . . . 12.4 tp -112.31 130.77 55.84 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-O 120.985 0.421 . . . . 0.0 111.296 -175.857 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' C' C ' 89' ' ' ASP . . . . . . . . . . . . . 13.1 t70 -125.27 152.01 45.2 Favored 'General case' 0 C--N 1.33 -0.249 0 N-CA-C 109.272 -0.64 . . . . 0.0 109.272 175.016 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' C' C ' 90' ' ' GLU . . . . . . . . . . . . . 95.4 mt-10 -48.92 -37.8 20.93 Favored 'General case' 0 C--N 1.329 -0.324 0 N-CA-C 112.754 0.649 . . . . 0.0 112.754 -171.804 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' C' C ' 91' ' ' ASN . . . . . . . . . . . . . 14.7 m-80 -125.49 16.7 8.23 Favored 'General case' 0 N--CA 1.468 0.474 0 N-CA-C 113.21 0.819 . . . . 0.0 113.21 -177.352 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' C' C ' 92' ' ' LEU . . . . . . . . . . . . . 12.5 mt -148.86 143.26 26.15 Favored 'General case' 0 C--N 1.333 -0.114 0 N-CA-C 110.112 -0.329 . . . . 0.0 110.112 -176.605 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' C' C ' 93' ' ' ILE . . . . . . . . . . . . . 73.7 mt -121.23 119.27 58.7 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.353 0 N-CA-C 109.157 -0.683 . . . . 0.0 109.157 177.55 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' C' C ' 94' ' ' VAL . . . . . . . . . . . . . 45.3 t -118.73 127.16 75.68 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.201 0 CA-C-O 121.023 0.439 . . . . 0.0 110.061 -178.314 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' C' C ' 95' ' ' VAL . . . . . . . . . . . . . 44.9 t -118.97 132.91 67.5 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.357 0 CA-C-N 115.784 -0.644 . . . . 0.0 109.519 178.681 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' C' C ' 96' ' ' ILE . . . . . . . . . . . . . 68.3 mt -112.67 126.06 70.01 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.346 0 N-CA-C 109.214 -0.662 . . . . 0.0 109.214 178.775 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' C' C ' 97' ' ' THR . . . . . . . . . . . . . 60.6 p -99.76 158.27 15.91 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-O 121.313 0.578 . . . . 0.0 111.386 -176.904 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' C' C ' 98' ' ' GLU . . . . . . . . . . . . . 83.8 tt0 -53.88 -26.71 26.17 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.049 -0.523 . . . . 0.0 112.23 179.73 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' C' C ' 99' ' ' GLU . . . . . . . . . . . . . 71.0 mm-40 -78.87 15.35 1.1 Allowed 'General case' 0 CA--C 1.534 0.353 0 N-CA-C 113.185 0.809 . . . . 0.0 113.185 -177.691 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' C' C ' 100' ' ' ASN . . . . . . . . . . . . . 4.1 m-20 60.88 38.16 17.97 Favored 'General case' 0 C--O 1.232 0.146 0 CA-C-O 121.101 0.477 . . . . 0.0 110.823 179.833 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' C' C ' 101' ' ' GLU . . . . . . . . . . . . . 83.7 tt0 -114.83 144.36 43.65 Favored 'General case' 0 C--N 1.332 -0.16 0 CA-C-N 116.001 -0.545 . . . . 0.0 109.64 177.016 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' C' C ' 102' ' ' VAL . . . . . . . . . . . . . 44.4 t -114.93 124.84 71.98 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.306 0 N-CA-C 109.919 -0.401 . . . . 0.0 109.919 -178.156 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' C' C ' 103' ' ' LEU . . . . . . . . . . . . . 28.7 mt -113.64 131.28 56.2 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 115.717 -0.674 . . . . 0.0 110.198 176.6 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' C' C ' 104' ' ' ILE . . . . . . . . . . . . . 73.5 mt -120.36 119.06 58.76 Favored 'Isoleucine or valine' 0 C--O 1.235 0.325 0 N-CA-C 110.295 -0.261 . . . . 0.0 110.295 -179.79 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' C' C ' 105' ' ' PHE . . . . . . . . . . . . . 79.7 m-85 -120.19 167.37 12.32 Favored 'General case' 0 C--N 1.331 -0.217 0 O-C-N 124.205 0.941 . . . . 0.0 109.766 178.956 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' C' C ' 106' ' ' ASN . . . . . . . . . . . . . 39.7 p-10 -103.77 -169.91 1.7 Allowed 'General case' 0 CA--C 1.53 0.181 0 N-CA-C 109.703 -0.48 . . . . 0.0 109.703 171.394 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' C' C ' 107' ' ' GLN . . . . . . . . . . . . . 50.0 tt0 -58.69 -30.12 67.15 Favored 'General case' 0 C--N 1.329 -0.302 0 N-CA-C 111.862 0.319 . . . . 0.0 111.862 179.361 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' C' C ' 108' ' ' ASN . . . . . . . . . . . . . 45.7 t30 -89.21 12.88 14.66 Favored 'General case' 0 CA--C 1.535 0.393 0 N-CA-C 113.048 0.759 . . . . 0.0 113.048 -176.855 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' C' C ' 109' ' ' LEU . . . . . . . . . . . . . 63.3 mt 58.28 35.72 25.12 Favored 'General case' 0 C--N 1.332 -0.182 0 CA-C-O 120.755 0.312 . . . . 0.0 111.767 175.934 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' C' C ' 110' ' ' GLU . . . . . . . . . . . . . 70.3 mm-40 -103.91 135.28 45.74 Favored 'General case' 0 C--N 1.33 -0.264 0 N-CA-C 110.014 -0.365 . . . . 0.0 110.014 175.238 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' C' C ' 111' ' ' GLU . . . . . . . . . . . . . 98.1 mt-10 -67.14 123.62 20.78 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-O 121.044 0.45 . . . . 0.0 111.071 -178.39 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' C' C ' 112' ' ' LEU . . . . . . . . . . . . . 13.9 mt -105.99 -43.88 4.74 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-N 115.793 -0.64 . . . . 0.0 109.946 175.78 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' C' C ' 113' ' ' TYR . . . . . . . . . . . . . 65.0 t80 -143.86 140.76 29.96 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.236 -0.438 . . . . 0.0 111.637 -179.315 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' C' C ' 114' ' ' ARG . . . . . . . . . . . . . 37.2 ttm180 -136.31 128.1 29.16 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 115.797 -0.638 . . . . 0.0 109.96 174.026 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' C' C ' 115' ' ' GLY . . . . . . . . . . . . . . . -150.04 159.41 28.09 Favored Glycine 0 CA--C 1.526 0.774 0 N-CA-C 111.169 -0.772 . . . . 0.0 111.169 177.441 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' C' C ' 116' ' ' LYS . . . . . . . . . . . . . 33.7 ttpt -130.81 136.6 48.85 Favored 'General case' 0 C--N 1.33 -0.244 0 N-CA-C 109.974 -0.38 . . . . 0.0 109.974 177.555 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' C' C ' 117' ' ' PHE . . . . . . . . . . . . . 40.8 m-85 -135.14 117.14 15.3 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-O 120.703 0.287 . . . . 0.0 110.39 -176.672 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' C' C ' 118' ' ' GLU . . . . . . . . . . . . . 70.6 mm-40 -54.65 -46.32 73.96 Favored 'General case' 0 C--N 1.329 -0.29 0 C-N-CA 120.996 -0.282 . . . . 0.0 111.38 -177.014 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' C' C ' 119' ' ' ASN . . . . . . . . . . . . . 6.0 m120 -95.99 30.99 2.24 Favored 'General case' 0 C--N 1.329 -0.322 0 N-CA-C 112.046 0.387 . . . . 0.0 112.046 -175.457 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' C' C ' 120' ' ' LEU . . . . . . . . . . . . . 14.0 tp -57.82 120.93 9.3 Favored 'General case' 0 C--O 1.232 0.154 0 CA-C-O 120.679 0.276 . . . . 0.0 110.39 179.008 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' C' C ' 121' ' ' ASN . . . . . . . . . . . . . 93.9 m-20 -114.16 -43.96 3.18 Favored 'General case' 0 C--N 1.331 -0.217 0 CA-C-N 116.38 -0.373 . . . . 0.0 111.311 -178.304 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' C' C ' 122' ' ' LYS . . . . . . . . . . . . . 97.2 mttt -144.28 151.11 38.93 Favored 'General case' 0 C--N 1.331 -0.215 0 C-N-CA 120.647 -0.421 . . . . 0.0 111.848 -175.993 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' C' C ' 123' ' ' VAL . . . . . . . . . . . . . 46.1 t -132.08 128.59 59.4 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.311 0 N-CA-C 109.259 -0.645 . . . . 0.0 109.259 172.159 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' C' C ' 124' ' ' LEU . . . . . . . . . . . . . 8.7 tp -128.31 143.27 51.0 Favored 'General case' 0 N--CA 1.464 0.245 0 CA-C-O 120.726 0.298 . . . . 0.0 110.91 -175.845 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' C' C ' 125' ' ' VAL . . . . . 0.474 HG12 HG23 ' C' ' 130' ' ' VAL . 35.0 m -130.19 143.84 39.78 Favored 'Isoleucine or valine' 0 C--O 1.232 0.177 0 CA-C-N 116.35 -0.386 . . . . 0.0 111.254 -178.637 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' C' C ' 126' ' ' ARG . . . . . . . . . . . . . 96.0 mtt-85 -149.73 124.9 10.08 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 116.246 -0.434 . . . . 0.0 110.781 175.634 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' C' C ' 127' ' ' ASN . . . . . . . . . . . . . 24.8 m120 49.63 -109.18 0.35 Allowed 'General case' 0 CA--C 1.545 0.764 0 CA-C-O 118.828 -0.606 . . . . 0.0 111.649 178.938 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' C' C ' 128' ' ' ASP . . . . . . . . . . . . . 19.5 p-10 -114.09 7.3 16.68 Favored 'General case' 0 N--CA 1.469 0.482 0 CA-C-N 119.891 1.223 . . . . 0.0 113.371 -177.442 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' C' C ' 129' ' ' LEU . . . . . . . . . . . . . 42.1 mt -113.7 147.88 37.4 Favored 'General case' 0 C--O 1.232 0.14 0 N-CA-C 109.795 -0.446 . . . . 0.0 109.795 178.723 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' C' C ' 130' ' ' VAL . . . . . 0.49 HG13 ' HB ' ' C' ' 141' ' ' ILE . 12.9 p -133.62 143.18 39.55 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.222 0 CA-C-O 121.166 0.508 . . . . 0.0 110.511 -179.758 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' C' C ' 131' ' ' VAL . . . . . 0.476 HG22 HD12 ' C' ' 140' ' ' LEU . 41.1 t -132.92 138.4 51.82 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.248 0 CA-C-N 115.848 -0.614 . . . . 0.0 110.234 -178.068 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' C' C ' 132' ' ' ILE . . . . . . . . . . . . . 72.2 mt -116.8 133.86 62.15 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.331 0 N-CA-C 109.308 -0.627 . . . . 0.0 109.308 179.471 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' C' C ' 133' ' ' ILE . . . . . . . . . . . . . 40.1 mm -117.02 122.89 71.08 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.245 0 CA-C-N 116.673 -0.239 . . . . 0.0 110.81 -174.756 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' C' C ' 134' ' ' ASP . . . . . . . . . . . . . 7.2 p-10 -135.59 150.28 49.63 Favored 'General case' 0 C--N 1.331 -0.225 0 N-CA-C 110.003 -0.369 . . . . 0.0 110.003 175.55 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' C' C ' 135' ' ' GLU . . . . . . . . . . . . . 44.8 tp10 -50.67 -28.08 8.26 Favored 'General case' 0 C--N 1.328 -0.361 0 N-CA-C 112.756 0.65 . . . . 0.0 112.756 -173.218 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' C' C ' 136' ' ' GLN . . . . . . . . . . . . . 96.9 mt-30 -86.17 -29.22 23.41 Favored 'General case' 0 C--N 1.33 -0.253 0 N-CA-C 112.805 0.669 . . . . 0.0 112.805 -174.98 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' C' C ' 137' ' ' LYS . . . . . . . . . . . . . 43.1 pttt -170.14 173.67 5.77 Favored 'General case' 0 C--N 1.332 -0.189 0 CA-C-O 121.53 0.681 . . . . 0.0 112.503 -172.544 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' C' C ' 138' ' ' LEU . . . . . 0.42 HD23 ' N ' ' C' ' 139' ' ' THR . 5.5 tt -118.55 128.62 54.74 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 114.967 -1.015 . . . . 0.0 109.766 179.168 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' C' C ' 139' ' ' THR . . . . . 0.42 ' N ' HD23 ' C' ' 138' ' ' LEU . 31.9 m -107.09 128.16 54.13 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.43 -0.35 . . . . 0.0 110.281 179.798 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' C' C ' 140' ' ' LEU . . . . . 0.476 HD12 HG22 ' C' ' 131' ' ' VAL . 11.0 tp -114.6 121.42 43.38 Favored 'General case' 0 C--N 1.328 -0.339 0 N-CA-C 109.23 -0.655 . . . . 0.0 109.23 -178.718 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' C' C ' 141' ' ' ILE . . . . . 0.49 ' HB ' HG13 ' C' ' 130' ' ' VAL . 20.1 mt -119.28 121.6 66.97 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 CA-C-O 121.032 0.444 . . . . 0.0 110.04 -175.803 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' C' C ' 142' ' ' ARG . . . . . . . . . . . . . 69.5 mtt180 -109.35 128.83 55.41 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 114.989 -1.005 . . . . 0.0 109.849 -175.263 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' C' C ' 143' ' ' THR . . . . . . . . . . . . . 36.3 p . . . . . 0 C--O 1.219 -0.513 0 CA-C-O 118.098 -0.954 . . . . 0.0 110.608 -179.3 . . . . . . . . 0 0 . 1 . 015 nuclear nobuild full ' D' D ' -3' ' ' GLU . . . . . . . . . . . . . 96.0 mt-10 . . . . . 0 N--CA 1.49 1.537 0 N-CA-C 109.504 -0.554 . . . . 0.0 109.504 . . . . . . . . . 0 0 . 1 . 015 nuclear nobuild full ' D' D ' -2' ' ' GLY . . . . . . . . . . . . . . . -77.71 150.04 35.71 Favored Glycine 0 CA--C 1.524 0.653 0 N-CA-C 111.043 -0.823 . . . . 0.0 111.043 179.947 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' D' D ' -1' ' ' VAL . . . . . . . . . . . . . 44.7 t -94.28 130.48 43.11 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.302 0 CA-C-O 120.89 0.376 . . . . 0.0 110.0 179.932 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' D' D ' 0' ' ' ILE . . . . . . . . . . . . . 72.9 mt -120.68 134.58 63.66 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.192 0 CA-C-N 116.131 -0.486 . . . . 0.0 109.874 -179.513 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' D' D ' 1' ' ' MET . . . . . . . . . . . . . 25.6 ptp -83.3 136.39 34.39 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.316 -0.402 . . . . 0.0 110.728 -179.905 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' D' D ' 2' ' ' SER . . . . . . . . . . . . . 25.2 p -122.56 138.96 54.41 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.211 -0.45 . . . . 0.0 110.574 179.517 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' D' D ' 3' ' ' GLU . . . . . . . . . . . . . 95.3 mt-10 -141.13 138.78 33.72 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.1 -0.5 . . . . 0.0 111.489 -177.498 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' D' D ' 4' ' ' LEU . . . . . . . . . . . . . 70.1 mt -118.96 127.74 53.75 Favored 'General case' 0 C--N 1.331 -0.214 0 CA-C-N 115.953 -0.567 . . . . 0.0 110.079 174.392 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' D' D ' 5' ' ' LYS . . . . . . . . . . . . . 98.7 mttt -109.67 122.4 47.38 Favored 'General case' 0 C--O 1.235 0.311 0 CA-C-O 120.673 0.273 . . . . 0.0 110.659 177.225 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' D' D ' 6' ' ' LEU . . . . . . . . . . . . . 46.8 mt -113.94 146.55 39.93 Favored 'General case' 0 C--N 1.331 -0.219 0 CA-C-N 115.435 -0.802 . . . . 0.0 109.919 179.786 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' D' D ' 7' ' ' LYS . . . . . . . . . . . . . 76.4 tttt -131.28 137.63 31.01 Favored Pre-proline 0 CA--C 1.533 0.318 0 CA-C-O 118.935 -0.555 . . . . 0.0 109.732 175.74 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' D' D ' 8' ' ' PRO . . . . . . . . . . . . . 85.9 Cg_endo -90.96 135.18 1.86 Allowed 'Trans proline' 0 N--CA 1.489 1.225 0 C-N-CA 121.705 1.603 . . . . 0.0 111.825 179.316 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' D' D ' 9' ' ' LEU . . . . . . . . . . . . . 38.0 mt -73.3 -45.13 7.86 Favored Pre-proline 0 CA--C 1.533 0.311 0 CA-C-O 119.019 -0.515 . . . . 0.0 111.036 179.79 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' D' D ' 10' ' ' PRO . . . . . . . . . . . . . 64.5 Cg_endo -86.11 152.82 9.6 Favored 'Trans proline' 0 N--CA 1.492 1.425 0 C-N-CA 121.241 1.294 . . . . 0.0 111.066 169.041 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' D' D ' 11' ' ' LYS . . . . . . . . . . . . . 25.5 pttm -86.1 119.86 26.86 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-O 121.291 0.567 . . . . 0.0 110.461 177.084 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' D' D ' 12' ' ' VAL . . . . . . . . . . . . . 13.1 p -150.47 143.29 17.22 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.327 0 CA-C-N 115.928 -0.578 . . . . 0.0 110.523 -179.966 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' D' D ' 13' ' ' GLU . . . . . . . . . . . . . 43.3 mt-10 -90.36 110.47 21.55 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.296 -0.411 . . . . 0.0 110.04 177.808 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' D' D ' 14' ' ' LEU . . . . . . . . . . . . . 15.8 mt -88.08 153.05 51.47 Favored Pre-proline 0 C--N 1.33 -0.281 0 CA-C-N 116.345 -0.389 . . . . 0.0 110.646 -178.154 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' D' D ' 15' ' ' PRO . . . . . . . . . . . . . 25.4 Cg_exo -62.58 155.16 60.19 Favored 'Trans proline' 0 N--CA 1.497 1.679 0 C-N-CA 121.267 1.311 . . . . 0.0 111.35 175.17 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' D' D ' 16' ' ' PRO . . . . . . . . . . . . . 36.5 Cg_exo -58.02 -35.64 98.61 Favored 'Trans proline' 0 N--CA 1.497 1.723 0 C-N-CA 121.318 1.345 . . . . 0.0 112.923 -178.68 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' D' D ' 17' ' ' ASP . . . . . . . . . . . . . 10.8 p-10 -85.48 5.96 28.99 Favored 'General case' 0 CA--C 1.536 0.411 0 N-CA-C 113.336 0.865 . . . . 0.0 113.336 -176.508 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' D' D ' 18' ' ' PHE . . . . . . . . . . . . . 42.3 t80 -58.37 -44.49 88.9 Favored 'General case' 0 C--N 1.334 -0.101 0 O-C-N 121.939 -0.475 . . . . 0.0 109.892 -179.251 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' D' D ' 19' ' ' VAL . . . . . . . . . . . . . 47.6 t -56.76 -42.6 77.79 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.284 0 CA-C-N 116.243 -0.435 . . . . 0.0 110.316 -179.423 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' D' D ' 20' ' ' ASP . . . . . . . . . . . . . 9.6 t70 -59.47 -42.59 92.39 Favored 'General case' 0 C--N 1.33 -0.278 0 C-N-CA 120.853 -0.339 . . . . 0.0 110.72 -177.522 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' D' D ' 21' ' ' VAL . . . . . . . . . . . . . 47.3 t -64.42 -46.37 93.12 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 C-N-CA 120.754 -0.378 . . . . 0.0 110.646 -177.611 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' D' D ' 22' ' ' ILE . . . . . 0.551 HG22 HD12 ' D' ' 26' ' ' LEU . 45.4 mm -58.57 -40.27 78.38 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.267 0 C-N-CA 121.05 -0.26 . . . . 0.0 110.758 -179.449 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' D' D ' 23' ' ' ARG . . . . . . . . . . . . . 35.4 ttp180 -57.73 -49.64 75.88 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-O 121.148 0.499 . . . . 0.0 110.32 177.285 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' D' D ' 24' ' ' ILE . . . . . . . . . . . . . 66.0 mt -60.96 -38.41 79.32 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.304 0 CA-C-N 115.737 -0.665 . . . . 0.0 111.841 -176.781 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' D' D ' 25' ' ' LYS . . . . . . . . . . . . . 35.5 pttt -77.21 -37.57 53.14 Favored 'General case' 0 CA--C 1.534 0.341 0 C-N-CA 120.396 -0.521 . . . . 0.0 111.864 -174.952 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' D' D ' 26' ' ' LEU . . . . . 0.551 HD12 HG22 ' D' ' 22' ' ' ILE . 72.0 mt -77.7 -32.42 52.99 Favored 'General case' 0 C--N 1.331 -0.238 0 N-CA-C 113.237 0.828 . . . . 0.0 113.237 -172.354 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' D' D ' 27' ' ' GLN . . . . . . . . . . . . . 5.8 pt20 -45.71 135.71 6.58 Favored 'General case' 0 N--CA 1.469 0.517 0 N-CA-C 112.951 0.723 . . . . 0.0 112.951 -175.49 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' D' D ' 28' ' ' GLY . . . . . . . . . . . . . . . 99.37 -24.76 30.93 Favored Glycine 0 CA--C 1.534 1.223 0 CA-C-N 115.62 -0.718 . . . . 0.0 112.441 -177.713 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' D' D ' 29' ' ' LYS . . . . . . . . . . . . . 69.0 mttm -98.05 155.17 17.25 Favored 'General case' 0 C--N 1.333 -0.12 0 CA-C-N 117.29 0.545 . . . . 0.0 111.002 179.599 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' D' D ' 30' ' ' THR . . . . . . . . . . . . . 21.6 m -101.1 140.19 35.74 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.36 -0.382 . . . . 0.0 110.465 178.206 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' D' D ' 31' ' ' VAL . . . . . . . . . . . . . 34.9 m -130.14 150.4 34.58 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.232 0 CA-C-N 116.232 -0.44 . . . . 0.0 110.992 -179.418 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' D' D ' 32' ' ' ARG . . . . . . . . . . . . . 82.0 mtm180 -135.42 151.09 50.1 Favored 'General case' 0 C--N 1.331 -0.23 0 CA-C-O 121.258 0.551 . . . . 0.0 110.672 178.275 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' D' D ' 33' ' ' THR . . . . . . . . . . . . . 29.3 m -53.65 139.93 30.6 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.273 -0.421 . . . . 0.0 111.193 -179.49 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' D' D ' 34' ' ' GLY . . . . . . . . . . . . . . . 101.01 -17.02 56.82 Favored Glycine 0 CA--C 1.532 1.131 0 CA-C-O 119.703 -0.498 . . . . 0.0 113.244 179.609 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' D' D ' 35' ' ' ASP . . . . . . . . . . . . . 67.5 m-20 -65.15 148.63 51.33 Favored 'General case' 0 C--O 1.232 0.133 0 CA-C-N 118.103 0.951 . . . . 0.0 110.999 178.739 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' D' D ' 36' ' ' VAL . . . . . . . . . . . . . 45.4 t -126.75 131.76 70.79 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.232 0 CA-C-N 116.044 -0.525 . . . . 0.0 109.935 179.444 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' D' D ' 37' ' ' ILE . . . . . . . . . . . . . 63.0 mt -124.89 139.78 50.01 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.215 0 CA-C-N 116.226 -0.443 . . . . 0.0 110.173 -179.09 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' D' D ' 38' ' ' GLY . . . . . . . . . . . . . . . -113.83 128.41 8.28 Favored Glycine 0 CA--C 1.526 0.724 0 N-CA-C 110.741 -0.944 . . . . 0.0 110.741 177.73 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' D' D ' 39' ' ' ILE . . . . . . . . . . . . . 70.6 mt -126.92 137.72 57.0 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.282 0 CA-C-O 120.654 0.264 . . . . 0.0 110.297 -179.758 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' D' D ' 40' ' ' SER . . . . . . . . . . . . . 42.9 t -92.11 120.8 33.06 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.307 -0.406 . . . . 0.0 110.755 176.058 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' D' D ' 41' ' ' ILE . . . . . . . . . . . . . 67.7 mt -126.57 117.51 48.4 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.193 0 CA-C-O 120.707 0.289 . . . . 0.0 110.268 178.672 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' D' D ' 42' ' ' LEU . . . . . . . . . . . . . 8.2 mp 50.94 39.13 22.05 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-O 121.094 0.474 . . . . 0.0 111.729 177.262 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' D' D ' 43' ' ' GLY . . . . . . . . . . . . . . . 75.36 26.57 65.55 Favored Glycine 0 CA--C 1.531 1.077 0 C-N-CA 121.218 -0.515 . . . . 0.0 112.669 175.742 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' D' D ' 44' ' ' LYS . . . . . . . . . . . . . 98.8 mttt -136.56 129.35 30.76 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 117.142 0.471 . . . . 0.0 109.798 176.606 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' D' D ' 45' ' ' GLU . . . . . . . . . . . . . 73.0 tt0 -84.16 123.38 30.02 Favored 'General case' 0 C--N 1.329 -0.314 0 C-N-CA 120.788 -0.365 . . . . 0.0 110.8 -178.102 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' D' D ' 46' ' ' VAL . . . . . . . . . . . . . 11.3 p -117.22 127.29 74.79 Favored 'Isoleucine or valine' 0 C--O 1.233 0.196 0 N-CA-C 109.832 -0.433 . . . . 0.0 109.832 176.368 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' D' D ' 47' ' ' LYS . . . . . . . . . . . . . 34.3 mmtp -98.23 122.91 41.96 Favored 'General case' 0 C--N 1.327 -0.404 0 CA-C-N 115.927 -0.578 . . . . 0.0 110.659 177.165 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' D' D ' 48' ' ' PHE . . . . . . . . . . . . . 30.6 m-85 -108.32 131.79 54.37 Favored 'General case' 0 C--N 1.33 -0.276 0 N-CA-C 109.668 -0.493 . . . . 0.0 109.668 175.693 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' D' D ' 49' ' ' LYS . . . . . . . . . . . . . 60.1 tttm -108.82 136.12 48.9 Favored 'General case' 0 C--N 1.329 -0.316 0 N-CA-C 110.04 -0.355 . . . . 0.0 110.04 175.858 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' D' D ' 50' ' ' VAL . . . . . . . . . . . . . 45.3 t -77.63 107.05 8.71 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.343 0 N-CA-C 109.176 -0.675 . . . . 0.0 109.176 176.487 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' D' D ' 51' ' ' VAL . . . . . . . . . . . . . 45.0 t -70.96 -48.75 54.27 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.315 0 CA-C-N 116.132 -0.486 . . . . 0.0 109.781 -174.221 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' D' D ' 52' ' ' GLN . . . . . . . . . . . . . 62.2 tt0 -164.66 139.8 5.55 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 115.983 -0.553 . . . . 0.0 111.187 -176.614 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' D' D ' 53' ' ' ALA . . . . . . . . . . . . . . . -120.37 135.87 54.89 Favored 'General case' 0 C--N 1.332 -0.191 0 CA-C-N 116.009 -0.541 . . . . 0.0 109.868 174.342 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' D' D ' 54' ' ' TYR . . . . . . . . . . . . . 43.7 t80 -129.11 116.58 18.9 Favored Pre-proline 0 CA--C 1.536 0.413 0 CA-C-O 118.091 -0.957 . . . . 0.0 110.338 178.226 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' D' D ' 55' ' ' PRO . . . . . . . . . . . . . 73.8 Cg_endo -77.13 170.07 72.57 Favored 'Cis proline' 0 N--CA 1.501 1.94 0 CA-C-N 122.015 1.756 . . . . 0.0 111.56 -9.836 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' D' D ' 56' ' ' SER . . . . . . . . . . . . . 13.7 m -128.03 141.72 42.15 Favored Pre-proline 0 CA--C 1.536 0.41 0 CA-C-O 118.625 -0.702 . . . . 0.0 109.575 174.777 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' D' D ' 57' ' ' PRO . . . . . . . . . . . . . 49.8 Cg_endo -69.94 141.71 67.49 Favored 'Cis proline' 0 N--CA 1.5 1.859 0 CA-C-N 121.489 1.567 . . . . 0.0 111.689 -1.082 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' D' D ' 58' ' ' LEU . . . . . . . . . . . . . 28.1 tp -108.53 138.74 44.34 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-N 116.381 -0.372 . . . . 0.0 110.881 -177.989 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' D' D ' 59' ' ' ARG . . . . . . . . . . . . . 66.9 ttp85 -99.67 124.14 44.61 Favored 'General case' 0 C--N 1.328 -0.332 0 N-CA-C 109.099 -0.704 . . . . 0.0 109.099 173.323 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' D' D ' 60' ' ' VAL . . . . . . . . . . . . . 41.1 t -72.78 120.28 21.12 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.254 0 CA-C-O 120.964 0.411 . . . . 0.0 110.51 -175.066 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' D' D ' 61' ' ' GLU . . . . . . . . . . . . . 74.7 tt0 -131.09 156.79 44.62 Favored 'General case' 0 C--N 1.328 -0.331 0 N-CA-C 108.874 -0.787 . . . . 0.0 108.874 175.991 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' D' D ' 62' ' ' ASP . . . . . . . . . . . . . 53.1 m-20 -49.6 -30.37 8.67 Favored 'General case' 0 CA--C 1.534 0.336 0 N-CA-C 112.378 0.51 . . . . 0.0 112.378 -179.169 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' D' D ' 63' ' ' ARG . . . . . . . . . . . . . 94.2 mtt180 -72.5 -21.96 61.12 Favored 'General case' 0 CA--C 1.533 0.3 0 N-CA-C 113.118 0.784 . . . . 0.0 113.118 -175.217 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' D' D ' 64' ' ' THR . . . . . . . . . . . . . 34.2 m -66.57 139.78 57.93 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-O 120.871 0.367 . . . . 0.0 110.913 -176.257 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' D' D ' 65' ' ' LYS . . . . . . . . . . . . . 99.4 mttt -89.09 130.69 35.49 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.093 -0.503 . . . . 0.0 109.906 176.971 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' D' D ' 66' ' ' ILE . . . . . . . . . . . . . 4.0 mp -112.39 124.14 68.79 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.229 0 N-CA-C 109.518 -0.549 . . . . 0.0 109.518 178.517 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' D' D ' 67' ' ' THR . . . . . . . . . . . . . 24.4 m -119.94 137.34 54.11 Favored 'General case' 0 C--N 1.331 -0.208 0 CA-C-O 121.102 0.477 . . . . 0.0 110.877 -176.985 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' D' D ' 68' ' ' LEU . . . . . . . . . . . . . 17.3 tp -103.16 122.17 44.16 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 115.831 -0.622 . . . . 0.0 109.99 178.084 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' D' D ' 69' ' ' VAL . . . . . . . . . . . . . 44.7 t -102.17 127.24 55.91 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.366 0 CA-C-N 116.285 -0.416 . . . . 0.0 110.061 -179.47 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' D' D ' 70' ' ' THR . . . . . . . . . . . . . 18.1 m -85.29 -52.89 5.58 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.227 -0.442 . . . . 0.0 110.475 179.891 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' D' D ' 71' ' ' HIS . . . . . . . . . . . . . 53.5 m-70 -149.87 152.95 35.37 Favored Pre-proline 0 CA--C 1.531 0.244 0 CA-C-N 116.251 -0.431 . . . . 0.0 110.654 179.551 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' D' D ' 72' ' ' PRO . . . . . . . . . . . . . 90.7 Cg_endo -88.98 -24.17 0.79 Allowed 'Trans proline' 0 N--CA 1.491 1.331 0 C-N-CA 121.729 1.619 . . . . 0.0 112.94 176.492 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' D' D ' 73' ' ' VAL . . . . . . . . . . . . . 35.2 m -125.52 175.82 7.19 Favored 'Isoleucine or valine' 0 C--N 1.333 -0.152 0 CA-C-O 120.684 0.278 . . . . 0.0 110.254 -178.931 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' D' D ' 74' ' ' ASP . . . . . . . . . . . . . 17.9 t0 -99.85 123.73 44.4 Favored 'General case' 0 C--N 1.331 -0.233 0 N-CA-C 110.04 -0.356 . . . . 0.0 110.04 -178.242 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' D' D ' 75' ' ' VAL . . . . . 0.55 ' C ' HD12 ' D' ' 76' ' ' LEU . 43.3 t -117.96 122.82 70.62 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.197 0 CA-C-O 120.922 0.391 . . . . 0.0 110.494 -177.862 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' D' D ' 76' ' ' LEU . . . . . 0.55 HD12 ' C ' ' D' ' 75' ' ' VAL . 8.0 mp -124.42 149.33 46.87 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 115.848 -0.615 . . . . 0.0 109.737 176.25 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' D' D ' 77' ' ' GLU . . . . . . . . . . . . . 97.2 mt-10 -136.3 136.6 39.9 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-O 121.049 0.452 . . . . 0.0 111.138 -178.476 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' D' D ' 78' ' ' ALA . . . . . . . . . . . . . . . -119.23 128.75 54.49 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 115.707 -0.679 . . . . 0.0 109.803 176.511 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' D' D ' 79' ' ' LYS . . . . . 0.652 ' O ' HD13 ' D' ' 80' ' ' ILE . 32.9 ttmt -79.46 118.05 20.98 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-O 120.963 0.411 . . . . 0.0 110.986 -176.348 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' D' D ' 80' ' ' ILE . . . . . 0.652 HD13 ' O ' ' D' ' 79' ' ' LYS . 37.1 mm -139.2 104.37 2.16 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.272 0 N-CA-C 109.067 -0.716 . . . . 0.0 109.067 -178.848 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' D' D ' 81' ' ' LYS . . . . . . . . . . . . . 84.5 tttt -95.0 125.56 39.75 Favored 'General case' 0 C--N 1.329 -0.287 0 C-N-CA 120.758 -0.377 . . . . 0.0 110.944 -177.277 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' D' D ' 82' ' ' GLY . . . . . . . . . . . . . . . 89.03 42.2 5.69 Favored Glycine 0 CA--C 1.524 0.594 0 N-CA-C 111.237 -0.745 . . . . 0.0 111.237 176.401 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' D' D ' 83' ' ' ILE . . . . . . . . . . . . . 71.1 mt -65.4 131.51 31.18 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.273 0 N-CA-C 109.68 -0.489 . . . . 0.0 109.68 177.521 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' D' D ' 84' ' ' LYS . . . . . . . . . . . . . 48.6 tttp -89.97 -50.54 5.96 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.025 -0.534 . . . . 0.0 109.947 -179.117 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' D' D ' 85' ' ' ASP . . . . . . . . . . . . . 10.0 t70 -159.85 153.12 22.1 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 115.653 -0.703 . . . . 0.0 110.173 178.366 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' D' D ' 86' ' ' VAL . . . . . . . . . . . . . 41.3 t -127.4 132.63 69.23 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.244 0 CA-C-O 120.965 0.412 . . . . 0.0 110.48 -179.328 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' D' D ' 87' ' ' ILE . . . . . 0.492 HD12 ' N ' ' D' ' 87' ' ' ILE . 5.0 mp -119.95 122.83 69.55 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.238 0 N-CA-C 109.329 -0.619 . . . . 0.0 109.329 176.471 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' D' D ' 88' ' ' LEU . . . . . . . . . . . . . 86.1 mt -109.49 137.18 47.72 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-O 121.157 0.503 . . . . 0.0 111.307 -177.73 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' D' D ' 89' ' ' ASP . . . . . . . . . . . . . 8.6 t70 -131.48 156.47 45.6 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 115.598 -0.728 . . . . 0.0 109.29 176.499 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' D' D ' 90' ' ' GLU . . . . . . . . . . . . . 48.1 mp0 -50.85 -29.07 10.85 Favored 'General case' 0 C--N 1.327 -0.387 0 N-CA-C 112.544 0.572 . . . . 0.0 112.544 -171.177 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' D' D ' 91' ' ' ASN . . . . . . . . . . . . . 54.0 t30 -131.61 13.74 4.94 Favored 'General case' 0 N--CA 1.468 0.464 0 N-CA-C 113.307 0.854 . . . . 0.0 113.307 -176.228 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' D' D ' 92' ' ' LEU . . . . . . . . . . . . . 41.8 mt -147.82 148.72 31.2 Favored 'General case' 0 C--N 1.331 -0.204 0 CA-C-N 118.04 0.382 . . . . 0.0 110.55 -176.85 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' D' D ' 93' ' ' ILE . . . . . . . . . . . . . 72.3 mt -126.09 114.08 37.03 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.357 0 N-CA-C 109.063 -0.717 . . . . 0.0 109.063 175.845 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' D' D ' 94' ' ' VAL . . . . . . . . . . . . . 42.3 t -115.29 125.49 72.56 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.24 0 N-CA-C 109.816 -0.438 . . . . 0.0 109.816 -178.945 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' D' D ' 95' ' ' VAL . . . . . . . . . . . . . 44.6 t -119.29 133.24 66.77 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.283 0 CA-C-N 116.056 -0.52 . . . . 0.0 109.813 -179.83 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' D' D ' 96' ' ' ILE . . . . . . . . . . . . . 64.2 mt -111.7 126.0 69.05 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.358 0 N-CA-C 108.804 -0.813 . . . . 0.0 108.804 177.239 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' D' D ' 97' ' ' THR . . . . . . . . . . . . . 60.3 p -99.82 159.89 14.72 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-O 121.215 0.531 . . . . 0.0 111.388 -176.315 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' D' D ' 98' ' ' GLU . . . . . . . . . . . . . 81.0 tt0 -53.89 -26.28 24.23 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.043 -0.526 . . . . 0.0 112.12 179.254 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' D' D ' 99' ' ' GLU . . . . . . . . . . . . . 95.6 mt-10 -78.01 13.07 1.53 Allowed 'General case' 0 CA--C 1.536 0.432 0 N-CA-C 113.146 0.795 . . . . 0.0 113.146 -177.794 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' D' D ' 100' ' ' ASN . . . . . . . . . . . . . 3.0 m-20 60.47 37.74 19.61 Favored 'General case' 0 CA--C 1.529 0.167 0 CA-C-O 121.126 0.489 . . . . 0.0 110.961 -179.443 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' D' D ' 101' ' ' GLU . . . . . . . . . . . . . 83.4 tt0 -113.74 145.5 41.28 Favored 'General case' 0 C--N 1.332 -0.169 0 N-CA-C 109.45 -0.574 . . . . 0.0 109.45 176.097 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' D' D ' 102' ' ' VAL . . . . . . . . . . . . . 46.3 t -114.82 121.44 66.91 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.319 0 N-CA-C 109.615 -0.513 . . . . 0.0 109.615 -178.817 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' D' D ' 103' ' ' LEU . . . . . . . . . . . . . 39.0 mt -115.31 127.59 55.54 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 115.705 -0.68 . . . . 0.0 109.925 177.593 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' D' D ' 104' ' ' ILE . . . . . 0.417 HD13 HG11 ' D' ' 130' ' ' VAL . 68.4 mt -118.87 120.5 64.24 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.271 0 N-CA-C 110.164 -0.31 . . . . 0.0 110.164 -178.627 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' D' D ' 105' ' ' PHE . . . . . . . . . . . . . 54.8 m-85 -119.72 165.91 13.9 Favored 'General case' 0 C--N 1.331 -0.202 0 O-C-N 123.978 0.798 . . . . 0.0 109.542 179.268 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' D' D ' 106' ' ' ASN . . . . . . . . . . . . . 39.2 p-10 -97.32 -173.0 2.54 Favored 'General case' 0 C--N 1.329 -0.294 0 N-CA-C 109.683 -0.488 . . . . 0.0 109.683 172.597 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' D' D ' 107' ' ' GLN . . . . . . . . . . . . . 43.3 tp60 -58.77 -27.68 65.2 Favored 'General case' 0 CA--C 1.534 0.355 0 N-CA-C 111.78 0.289 . . . . 0.0 111.78 178.382 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' D' D ' 108' ' ' ASN . . . . . . . . . . . . . 9.2 t30 -84.54 9.6 13.15 Favored 'General case' 0 CA--C 1.536 0.415 0 N-CA-C 113.147 0.795 . . . . 0.0 113.147 -177.17 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' D' D ' 109' ' ' LEU . . . . . . . . . . . . . 18.8 mt 58.89 34.34 23.6 Favored 'General case' 0 CA--C 1.53 0.21 0 CA-C-O 120.942 0.401 . . . . 0.0 111.804 178.777 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' D' D ' 110' ' ' GLU . . . . . . . . . . . . . 70.7 mm-40 -107.25 141.52 38.44 Favored 'General case' 0 C--N 1.33 -0.275 0 N-CA-C 108.998 -0.742 . . . . 0.0 108.998 173.14 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' D' D ' 111' ' ' GLU . . . . . . . . . . . . . 52.1 tt0 -85.04 123.38 30.51 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-O 121.186 0.517 . . . . 0.0 111.07 -173.369 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' D' D ' 112' ' ' LEU . . . . . . . . . . . . . 30.4 mt -101.35 -43.23 6.02 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 115.625 -0.716 . . . . 0.0 110.89 178.852 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' D' D ' 113' ' ' TYR . . . . . . . . . . . . . 43.9 t80 -133.01 135.98 45.76 Favored 'General case' 0 C--N 1.332 -0.164 0 CA-C-O 120.784 0.326 . . . . 0.0 111.548 -176.367 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' D' D ' 114' ' ' ARG . . . . . . . . . . . . . 32.3 ttm180 -134.19 120.26 19.84 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-N 115.892 -0.594 . . . . 0.0 110.067 176.664 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' D' D ' 115' ' ' GLY . . . . . . . . . . . . . . . -150.01 159.73 28.22 Favored Glycine 0 CA--C 1.523 0.555 0 N-CA-C 110.825 -0.91 . . . . 0.0 110.825 178.659 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' D' D ' 116' ' ' LYS . . . . . . . . . . . . . 32.9 ttmt -136.05 139.7 43.27 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-O 120.817 0.341 . . . . 0.0 110.288 178.067 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' D' D ' 117' ' ' PHE . . . . . . . . . . . . . 20.4 m-85 -138.19 119.97 15.25 Favored 'General case' 0 C--N 1.331 -0.236 0 N-CA-C 109.911 -0.404 . . . . 0.0 109.911 -177.427 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' D' D ' 118' ' ' GLU . . . . . . . . . . . . . 96.1 mt-10 -55.51 -40.17 71.42 Favored 'General case' 0 C--N 1.329 -0.326 0 C-N-CA 120.916 -0.313 . . . . 0.0 110.915 -178.224 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' D' D ' 119' ' ' ASN . . . . . . . . . . . . . 78.3 m-20 -97.23 28.94 3.38 Favored 'General case' 0 C--N 1.331 -0.218 0 N-CA-C 112.35 0.5 . . . . 0.0 112.35 -174.795 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' D' D ' 120' ' ' LEU . . . . . . . . . . . . . 16.7 tp -58.18 119.97 7.81 Favored 'General case' 0 C--N 1.333 -0.131 0 N-CA-C 110.125 -0.324 . . . . 0.0 110.125 178.237 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' D' D ' 121' ' ' ASN . . . . . . . . . . . . . 66.2 t30 -114.01 -44.22 3.17 Favored 'General case' 0 C--N 1.331 -0.227 0 CA-C-N 116.511 -0.313 . . . . 0.0 111.273 -177.053 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' D' D ' 122' ' ' LYS . . . . . . . . . . . . . 59.8 mttm -146.7 154.5 41.5 Favored 'General case' 0 C--N 1.33 -0.241 0 C-N-CA 120.653 -0.419 . . . . 0.0 111.739 -176.434 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' D' D ' 123' ' ' VAL . . . . . . . . . . . . . 43.8 t -131.71 129.95 61.66 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.243 0 CA-C-N 115.971 -0.559 . . . . 0.0 109.731 175.221 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' D' D ' 124' ' ' LEU . . . . . . . . . . . . . 30.3 mt -118.92 133.7 55.66 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-N 116.31 -0.405 . . . . 0.0 110.623 -179.164 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' D' D ' 125' ' ' VAL . . . . . 0.426 HG22 HG23 ' D' ' 130' ' ' VAL . 45.3 t -129.01 124.41 60.81 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 N-CA-C 109.895 -0.409 . . . . 0.0 109.895 178.153 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' D' D ' 126' ' ' ARG . . . . . . . . . . . . . 44.1 mtp180 -148.87 130.92 15.33 Favored 'General case' 0 C--N 1.329 -0.296 0 N-CA-C 109.69 -0.485 . . . . 0.0 109.69 179.189 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' D' D ' 127' ' ' ASN . . . . . . . . . . . . . 37.2 t30 56.32 -152.54 0.38 Allowed 'General case' 0 CA--C 1.539 0.527 0 N-CA-C 109.742 -0.466 . . . . 0.0 109.742 -179.943 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' D' D ' 128' ' ' ASP . . . . . . . . . . . . . 12.3 p-10 -84.05 18.67 2.01 Favored 'General case' 0 CA--C 1.536 0.428 0 CA-C-N 118.506 0.594 . . . . 0.0 112.602 177.936 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' D' D ' 129' ' ' LEU . . . . . . . . . . . . . 15.3 tp -117.82 138.83 51.82 Favored 'General case' 0 C--O 1.232 0.181 0 O-C-N 122.172 -0.33 . . . . 0.0 110.164 179.632 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' D' D ' 130' ' ' VAL . . . . . 0.487 HG13 ' HB ' ' D' ' 141' ' ' ILE . 12.5 p -129.11 141.18 47.27 Favored 'Isoleucine or valine' 0 N--CA 1.462 0.171 0 CA-C-O 121.133 0.492 . . . . 0.0 110.248 179.891 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' D' D ' 131' ' ' VAL . . . . . . . . . . . . . 58.8 t -136.06 137.56 48.47 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.276 0 CA-C-N 115.85 -0.614 . . . . 0.0 110.555 -177.197 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' D' D ' 132' ' ' ILE . . . . . . . . . . . . . 74.4 mt -114.14 133.94 58.59 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.243 0 CA-C-N 115.881 -0.599 . . . . 0.0 109.441 179.296 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' D' D ' 133' ' ' ILE . . . . . . . . . . . . . 42.9 mm -116.29 122.23 69.27 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.243 0 CA-C-O 120.822 0.344 . . . . 0.0 110.8 -175.323 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' D' D ' 134' ' ' ASP . . . . . . . . . . . . . 7.2 p-10 -136.03 146.04 46.69 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.148 -0.478 . . . . 0.0 109.838 175.248 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' D' D ' 135' ' ' GLU . . . . . . . . . . . . . 80.6 tt0 -49.85 -22.97 1.65 Allowed 'General case' 0 C--N 1.328 -0.344 0 N-CA-C 113.076 0.769 . . . . 0.0 113.076 -171.464 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' D' D ' 136' ' ' GLN . . . . . . . . . . . . . 13.3 pt20 -100.9 -30.44 11.66 Favored 'General case' 0 N--CA 1.464 0.249 0 N-CA-C 112.674 0.62 . . . . 0.0 112.674 -175.587 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' D' D ' 137' ' ' LYS . . . . . . . . . . . . . 87.3 mttt -142.6 158.05 44.07 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-O 121.407 0.622 . . . . 0.0 112.129 -173.019 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' D' D ' 138' ' ' LEU . . . . . . . . . . . . . 4.6 tt -118.48 122.13 41.96 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-N 115.174 -0.921 . . . . 0.0 108.883 171.459 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' D' D ' 139' ' ' THR . . . . . . . . . . . . . 28.0 m -111.16 125.06 53.39 Favored 'General case' 0 C--N 1.332 -0.162 0 CA-C-O 120.644 0.259 . . . . 0.0 110.899 -176.71 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' D' D ' 140' ' ' LEU . . . . . 0.479 ' C ' HD23 ' D' ' 140' ' ' LEU . 7.7 tt -114.03 125.68 54.27 Favored 'General case' 0 C--N 1.327 -0.388 0 N-CA-C 109.294 -0.632 . . . . 0.0 109.294 -179.265 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' D' D ' 141' ' ' ILE . . . . . 0.487 ' HB ' HG13 ' D' ' 130' ' ' VAL . 19.7 mt -123.28 120.37 60.08 Favored 'Isoleucine or valine' 0 C--O 1.235 0.311 0 N-CA-C 109.715 -0.476 . . . . 0.0 109.715 -176.146 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' D' D ' 142' ' ' ARG . . . . . . . . . . . . . 61.2 ttt180 -114.51 127.24 55.7 Favored 'General case' 0 C--N 1.332 -0.177 0 CA-C-N 115.448 -0.796 . . . . 0.0 110.327 -176.347 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' D' D ' 143' ' ' THR . . . . . . . . . . . . . 28.7 p . . . . . 0 C--O 1.219 -0.516 0 CA-C-O 118.018 -0.992 . . . . 0.0 110.597 -179.68 . . . . . . . . 0 0 . 1 . 015 nuclear nobuild full ' E' E ' -3' ' ' GLU . . . . . . . . . . . . . 96.0 mt-10 . . . . . 0 N--CA 1.49 1.554 0 N-CA-C 109.382 -0.599 . . . . 0.0 109.382 . . . . . . . . . 0 0 . 1 . 015 nuclear nobuild full ' E' E ' -2' ' ' GLY . . . . . . . . . . . . . . . -73.08 143.57 33.45 Favored Glycine 0 CA--C 1.523 0.592 0 N-CA-C 110.706 -0.958 . . . . 0.0 110.706 178.918 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' E' E ' -1' ' ' VAL . . . . . . . . . . . . . 45.6 t -95.85 123.14 47.93 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.297 0 N-CA-C 109.851 -0.426 . . . . 0.0 109.851 179.934 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' E' E ' 0' ' ' ILE . . . . . . . . . . . . . 71.7 mt -127.36 140.07 50.14 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.242 0 CA-C-N 116.144 -0.48 . . . . 0.0 109.992 -178.343 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' E' E ' 1' ' ' MET . . . . . . . . . . . . . 25.8 ptm -93.54 134.48 35.77 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.063 -0.517 . . . . 0.0 110.629 179.437 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' E' E ' 2' ' ' SER . . . . . . . . . . . . . 4.9 p -126.67 130.28 50.11 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-O 121.103 0.478 . . . . 0.0 110.67 179.226 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' E' E ' 3' ' ' GLU . . . . . . . . . . . . . 79.8 tt0 -145.83 143.06 29.4 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 115.884 -0.598 . . . . 0.0 111.021 -178.003 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' E' E ' 4' ' ' LEU . . . . . 0.509 HD21 HD21 ' E' ' 6' ' ' LEU . 15.1 tp -123.59 135.37 53.93 Favored 'General case' 0 C--N 1.331 -0.217 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.281 177.359 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' E' E ' 5' ' ' LYS . . . . . . . . . . . . . 90.3 mttt -109.09 120.04 41.34 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.23 -0.441 . . . . 0.0 110.38 178.87 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' E' E ' 6' ' ' LEU . . . . . 0.509 HD21 HD21 ' E' ' 4' ' ' LEU . 59.4 mt -116.58 142.89 46.3 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 115.63 -0.713 . . . . 0.0 111.096 -177.815 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' E' E ' 7' ' ' LYS . . . . . . . . . . . . . 60.3 tttm -133.89 140.6 36.92 Favored Pre-proline 0 CA--C 1.534 0.338 0 CA-C-O 119.015 -0.517 . . . . 0.0 110.033 176.522 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' E' E ' 8' ' ' PRO . . . . . . . . . . . . . 98.1 Cg_endo -90.78 143.73 3.5 Favored 'Trans proline' 0 N--CA 1.49 1.314 0 C-N-CA 121.804 1.669 . . . . 0.0 111.866 178.247 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' E' E ' 9' ' ' LEU . . . . . . . . . . . . . 43.6 mt -84.08 -48.26 0.7 Allowed Pre-proline 0 CA--C 1.534 0.342 0 CA-C-O 118.683 -0.675 . . . . 0.0 112.389 -179.205 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' E' E ' 10' ' ' PRO . . . . . . . . . . . . . 88.1 Cg_endo -79.91 158.02 24.13 Favored 'Trans proline' 0 N--CA 1.496 1.642 0 C-N-CA 121.258 1.305 . . . . 0.0 111.845 177.408 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' E' E ' 11' ' ' LYS . . . . . . . . . . . . . 39.3 ttpt -88.0 94.84 9.91 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-O 120.863 0.363 . . . . 0.0 110.422 179.47 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' E' E ' 12' ' ' VAL . . . . . . . . . . . . . 12.4 p -143.15 143.47 24.86 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.286 0 CA-C-N 116.23 -0.441 . . . . 0.0 110.583 179.099 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' E' E ' 13' ' ' GLU . . . . . . . . . . . . . 70.6 mm-40 -84.4 132.62 34.56 Favored 'General case' 0 C--N 1.33 -0.254 0 N-CA-C 109.951 -0.388 . . . . 0.0 109.951 177.263 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' E' E ' 14' ' ' LEU . . . . . . . . . . . . . 48.8 mt -97.97 147.7 33.43 Favored Pre-proline 0 CA--C 1.532 0.278 0 CA-C-O 119.309 -0.376 . . . . 0.0 110.381 -178.151 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' E' E ' 15' ' ' PRO . . . . . . . . . . . . . 24.9 Cg_exo -62.69 161.72 27.49 Favored 'Trans proline' 0 N--CA 1.498 1.749 0 C-N-CA 121.25 1.3 . . . . 0.0 111.825 175.98 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' E' E ' 16' ' ' PRO . . . . . . . . . . . . . 31.2 Cg_exo -59.38 -39.51 76.21 Favored 'Trans proline' 0 N--CA 1.497 1.691 0 C-N-CA 121.422 1.414 . . . . 0.0 112.661 -178.219 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' E' E ' 17' ' ' ASP . . . . . . . . . . . . . 22.8 p-10 -88.71 11.28 18.03 Favored 'General case' 0 CA--C 1.535 0.387 0 N-CA-C 113.172 0.805 . . . . 0.0 113.172 -177.646 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' E' E ' 18' ' ' PHE . . . . . . . . . . . . . 43.5 t80 -57.82 -44.53 86.46 Favored 'General case' 0 C--N 1.335 -0.056 0 O-C-N 122.014 -0.429 . . . . 0.0 110.121 -178.059 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' E' E ' 19' ' ' VAL . . . . . . . . . . . . . 47.6 t -58.16 -41.52 80.99 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.336 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.309 -179.069 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' E' E ' 20' ' ' ASP . . . . . . . . . . . . . 76.2 m-20 -59.72 -42.35 92.89 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-O 120.851 0.358 . . . . 0.0 110.805 -177.655 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' E' E ' 21' ' ' VAL . . . . . . . . . . . . . 47.0 t -64.6 -47.87 87.2 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.294 0 CA-C-N 116.36 -0.382 . . . . 0.0 110.42 -178.194 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' E' E ' 22' ' ' ILE . . . . . 0.581 HG22 HD12 ' E' ' 26' ' ' LEU . 49.6 mm -56.05 -45.03 80.32 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.256 0 CA-C-O 120.727 0.299 . . . . 0.0 110.662 179.102 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' E' E ' 23' ' ' ARG . . . . . . . . . . . . . 59.4 ttp180 -54.09 -49.94 67.94 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-O 120.694 0.283 . . . . 0.0 111.388 -178.313 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' E' E ' 24' ' ' ILE . . . . . . . . . . . . . 71.2 mt -60.06 -44.59 95.25 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.271 0 CA-C-N 116.626 -0.261 . . . . 0.0 111.105 -178.044 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' E' E ' 25' ' ' LYS . . . . . . . . . . . . . 83.4 mttt -64.84 -37.91 89.21 Favored 'General case' 0 C--N 1.329 -0.308 0 N-CA-C 112.394 0.516 . . . . 0.0 112.394 -177.694 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' E' E ' 26' ' ' LEU . . . . . 0.581 HD12 HG22 ' E' ' 22' ' ' ILE . 50.0 mt -79.27 -42.19 26.42 Favored 'General case' 0 C--N 1.331 -0.221 0 N-CA-C 113.53 0.937 . . . . 0.0 113.53 -172.046 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' E' E ' 27' ' ' GLN . . . . . . . . . . . . . 11.1 pt20 -46.83 141.88 3.71 Favored 'General case' 0 N--CA 1.469 0.491 0 N-CA-C 112.905 0.705 . . . . 0.0 112.905 -173.772 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' E' E ' 28' ' ' GLY . . . . . . . . . . . . . . . 97.75 -26.26 23.96 Favored Glycine 0 CA--C 1.531 1.086 0 CA-C-N 115.418 -0.81 . . . . 0.0 112.184 -177.818 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' E' E ' 29' ' ' LYS . . . . . . . . . . . . . 69.5 mttm -97.77 155.12 17.18 Favored 'General case' 0 C--N 1.331 -0.222 0 CA-C-N 117.365 0.583 . . . . 0.0 110.976 178.249 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' E' E ' 30' ' ' THR . . . . . . . . . . . . . 19.2 m -106.79 137.12 45.42 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 115.931 -0.577 . . . . 0.0 109.727 175.149 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' E' E ' 31' ' ' VAL . . . . . . . . . . . . . 35.0 m -128.17 154.97 39.5 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.253 0 CA-C-O 120.973 0.416 . . . . 0.0 110.862 -177.691 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' E' E ' 32' ' ' ARG . . . . . . . . . . . . . 59.1 ttm-85 -127.24 146.1 50.54 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.04 -0.527 . . . . 0.0 110.327 -179.972 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' E' E ' 33' ' ' THR . . . . . . . . . . . . . 18.6 m -53.08 139.26 28.91 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.469 -0.332 . . . . 0.0 111.355 -177.861 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' E' E ' 34' ' ' GLY . . . . . . . . . . . . . . . 101.13 -17.13 56.44 Favored Glycine 0 CA--C 1.532 1.156 0 CA-C-O 119.674 -0.514 . . . . 0.0 113.243 -179.826 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' E' E ' 35' ' ' ASP . . . . . . . . . . . . . 78.8 m-20 -66.51 149.03 51.05 Favored 'General case' 0 C--O 1.23 0.071 0 CA-C-N 118.018 0.909 . . . . 0.0 111.198 178.542 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' E' E ' 36' ' ' VAL . . . . . . . . . . . . . 44.0 t -123.38 131.95 72.25 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.18 0 CA-C-N 115.865 -0.607 . . . . 0.0 109.786 177.985 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' E' E ' 37' ' ' ILE . . . . . . . . . . . . . 67.8 mt -121.91 140.65 45.21 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.21 0 CA-C-N 116.256 -0.429 . . . . 0.0 109.952 -178.936 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' E' E ' 38' ' ' GLY . . . . . . . . . . . . . . . -110.71 128.81 8.95 Favored Glycine 0 CA--C 1.527 0.802 0 N-CA-C 111.348 -0.701 . . . . 0.0 111.348 -179.528 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' E' E ' 39' ' ' ILE . . . . . . . . . . . . . 72.8 mt -123.83 134.25 67.0 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.207 0 N-CA-C 110.135 -0.32 . . . . 0.0 110.135 179.134 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' E' E ' 40' ' ' SER . . . . . . . . . . . . . 19.5 p -93.57 114.19 26.47 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.508 -0.314 . . . . 0.0 110.993 176.214 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' E' E ' 41' ' ' ILE . . . . . . . . . . . . . 44.7 mm -121.58 124.46 71.75 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.269 0 CA-C-O 120.789 0.328 . . . . 0.0 110.334 179.074 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' E' E ' 42' ' ' LEU . . . . . . . . . . . . . 57.7 mt 52.0 33.06 11.11 Favored 'General case' 0 C--N 1.331 -0.23 0 CA-C-N 116.254 -0.43 . . . . 0.0 111.933 177.359 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' E' E ' 43' ' ' GLY . . . . . . . . . . . . . . . 72.4 33.65 61.22 Favored Glycine 0 CA--C 1.529 0.932 0 C-N-CA 121.091 -0.576 . . . . 0.0 111.749 178.747 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' E' E ' 44' ' ' LYS . . . . . . . . . . . . . 21.1 tptm -138.86 131.23 28.54 Favored 'General case' 0 C--N 1.329 -0.3 0 N-CA-C 109.463 -0.569 . . . . 0.0 109.463 179.539 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' E' E ' 45' ' ' GLU . . . . . . . . . . . . . 80.9 tt0 -82.52 119.25 23.99 Favored 'General case' 0 C--N 1.328 -0.359 0 C-N-CA 120.795 -0.362 . . . . 0.0 110.941 -177.267 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' E' E ' 46' ' ' VAL . . . . . . . . . . . . . 7.4 p -119.97 126.44 75.29 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.18 0 N-CA-C 109.451 -0.574 . . . . 0.0 109.451 176.26 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' E' E ' 47' ' ' LYS . . . . . . . . . . . . . 63.2 mttp -99.97 129.53 46.05 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 115.898 -0.592 . . . . 0.0 111.206 178.916 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' E' E ' 48' ' ' PHE . . . . . . . . . . . . . 87.4 m-85 -112.01 131.8 55.18 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.062 -0.517 . . . . 0.0 110.191 177.162 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' E' E ' 49' ' ' LYS . . . . . . . . . . . . . 79.0 tttt -107.71 135.71 48.68 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.343 -0.39 . . . . 0.0 110.63 -179.666 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' E' E ' 50' ' ' VAL . . . . . . . . . . . . . 45.9 t -81.41 107.55 13.72 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.242 0 N-CA-C 109.123 -0.695 . . . . 0.0 109.123 175.406 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' E' E ' 51' ' ' VAL . . . . . . . . . . . . . 42.9 t -73.14 -50.85 29.01 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.346 0 CA-C-N 115.994 -0.548 . . . . 0.0 109.791 -174.399 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' E' E ' 52' ' ' GLN . . . . . . . . . . . . . 70.2 mt-30 -154.92 155.1 33.69 Favored 'General case' 0 C--N 1.331 -0.218 0 CA-C-O 121.135 0.493 . . . . 0.0 111.699 -179.332 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' E' E ' 53' ' ' ALA . . . . . 0.501 ' HB1' ' HB2' ' E' ' 58' ' ' LEU . . . -131.68 133.78 45.24 Favored 'General case' 0 C--N 1.33 -0.283 0 CA-C-N 115.364 -0.835 . . . . 0.0 109.886 175.629 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' E' E ' 54' ' ' TYR . . . . . . . . . . . . . 57.7 t80 -129.13 109.08 18.03 Favored Pre-proline 0 CA--C 1.534 0.344 0 CA-C-O 118.284 -0.865 . . . . 0.0 110.439 179.399 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' E' E ' 55' ' ' PRO . . . . . . . . . . . . . 72.8 Cg_endo -77.1 169.8 73.32 Favored 'Cis proline' 0 N--CA 1.498 1.746 0 CA-C-N 121.911 1.718 . . . . 0.0 112.356 -5.457 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' E' E ' 56' ' ' SER . . . . . . . . . . . . . 30.7 m -116.6 129.03 25.57 Favored Pre-proline 0 CA--C 1.538 0.516 0 CA-C-O 118.368 -0.825 . . . . 0.0 109.404 175.244 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' E' E ' 57' ' ' PRO . . . . . . . . . . . . . 42.6 Cg_endo -68.97 148.93 85.87 Favored 'Cis proline' 0 N--CA 1.498 1.771 0 CA-C-N 122.052 1.768 . . . . 0.0 111.815 -0.586 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' E' E ' 58' ' ' LEU . . . . . 0.501 ' HB2' ' HB1' ' E' ' 53' ' ' ALA . 23.5 tp -108.2 138.53 44.32 Favored 'General case' 0 C--N 1.331 -0.222 0 CA-C-N 116.101 -0.499 . . . . 0.0 110.667 -178.304 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' E' E ' 59' ' ' ARG . . . . . . . . . . . . . 60.6 ttt180 -103.44 131.33 50.63 Favored 'General case' 0 C--N 1.328 -0.346 0 N-CA-C 109.404 -0.591 . . . . 0.0 109.404 175.872 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' E' E ' 60' ' ' VAL . . . . . . . . . . . . . 42.1 t -89.71 119.0 36.1 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.287 0 C-N-CA 120.669 -0.412 . . . . 0.0 110.516 -176.483 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' E' E ' 61' ' ' GLU . . . . . . . . . . . . . 95.1 mt-10 -131.18 167.46 19.12 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.104 -0.498 . . . . 0.0 110.002 176.525 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' E' E ' 62' ' ' ASP . . . . . . . . . . . . . 80.5 m-20 -54.4 -32.71 57.77 Favored 'General case' 0 C--N 1.328 -0.365 0 N-CA-C 111.678 0.251 . . . . 0.0 111.678 -179.712 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' E' E ' 63' ' ' ARG . . . . . . . . . . . . . 11.1 ptm180 -85.7 6.41 27.81 Favored 'General case' 0 CA--C 1.536 0.423 0 N-CA-C 113.551 0.945 . . . . 0.0 113.551 -175.505 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' E' E ' 64' ' ' THR . . . . . . . . . . . . . 23.8 m -85.66 138.68 31.98 Favored 'General case' 0 C--N 1.332 -0.155 0 CA-C-N 118.237 0.472 . . . . 0.0 110.591 -179.09 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' E' E ' 65' ' ' LYS . . . . . . . . . . . . . 48.7 mtmt -87.68 129.78 35.02 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-O 120.949 0.404 . . . . 0.0 110.322 178.565 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' E' E ' 66' ' ' ILE . . . . . . . . . . . . . 58.8 mt -113.11 124.87 70.18 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.316 0 N-CA-C 109.504 -0.554 . . . . 0.0 109.504 179.73 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' E' E ' 67' ' ' THR . . . . . . . . . . . . . 17.8 m -115.48 137.78 51.7 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-O 121.077 0.465 . . . . 0.0 110.663 -177.582 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' E' E ' 68' ' ' LEU . . . . . . . . . . . . . 15.8 tp -104.34 136.13 44.5 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 115.817 -0.628 . . . . 0.0 110.772 -178.333 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' E' E ' 69' ' ' VAL . . . . . . . . . . . . . 46.7 t -82.81 155.14 3.87 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 N-CA-C 109.48 -0.563 . . . . 0.0 109.48 175.923 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' E' E ' 70' ' ' THR . . . . . . . . . . . . . 60.9 p -78.36 161.96 26.8 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-O 121.198 0.523 . . . . 0.0 111.139 -172.514 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' E' E ' 71' ' ' HIS . . . . . . . . . . . . . 23.6 m80 -108.55 170.91 4.97 Favored Pre-proline 0 CA--C 1.532 0.266 0 CA-C-N 115.357 -0.838 . . . . 0.0 110.324 -174.703 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' E' E ' 72' ' ' PRO . . . . . . . . . . . . . 23.9 Cg_exo -64.87 160.1 42.66 Favored 'Trans proline' 0 N--CA 1.495 1.58 0 C-N-CA 121.514 1.476 . . . . 0.0 111.507 175.883 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' E' E ' 73' ' ' VAL . . . . . . . . . . . . . 30.1 m -69.69 166.8 2.03 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.279 0 CA-C-O 120.905 0.383 . . . . 0.0 111.143 -172.999 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' E' E ' 74' ' ' ASP . . . . . . . . . . . . . 12.3 t70 -91.28 122.78 34.19 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 115.882 -0.599 . . . . 0.0 110.48 -174.048 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' E' E ' 75' ' ' VAL . . . . . . . . . . . . . 44.3 t -116.99 120.71 65.92 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.248 0 CA-C-O 121.14 0.495 . . . . 0.0 110.134 178.98 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' E' E ' 76' ' ' LEU . . . . . . . . . . . . . 16.5 mt -122.31 143.23 49.75 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 115.603 -0.726 . . . . 0.0 109.75 178.098 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' E' E ' 77' ' ' GLU . . . . . . . . . . . . . 96.0 mt-10 -136.89 135.51 37.88 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-O 121.048 0.451 . . . . 0.0 111.112 -177.804 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' E' E ' 78' ' ' ALA . . . . . . . . . . . . . . . -119.93 139.69 52.05 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 115.643 -0.708 . . . . 0.0 109.795 176.678 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' E' E ' 79' ' ' LYS . . . . . 0.707 ' O ' HD13 ' E' ' 80' ' ' ILE . 54.7 mttp -87.94 114.5 24.62 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.412 -0.358 . . . . 0.0 110.774 -177.058 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' E' E ' 80' ' ' ILE . . . . . 0.707 HD13 ' O ' ' E' ' 79' ' ' LYS . 33.4 mm -139.05 103.7 2.04 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.325 0 N-CA-C 109.252 -0.647 . . . . 0.0 109.252 -178.703 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' E' E ' 81' ' ' LYS . . . . . . . . . . . . . 37.9 ttpt -98.12 130.51 44.89 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-O 120.93 0.395 . . . . 0.0 110.547 -178.5 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' E' E ' 82' ' ' GLY . . . . . . . . . . . . . . . 89.15 42.13 5.67 Favored Glycine 0 CA--C 1.523 0.563 0 N-CA-C 111.142 -0.783 . . . . 0.0 111.142 178.053 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' E' E ' 83' ' ' ILE . . . . . . . . . . . . . 71.8 mt -72.43 135.38 27.91 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.291 0 N-CA-C 109.323 -0.621 . . . . 0.0 109.323 176.459 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' E' E ' 84' ' ' LYS . . . . . . . . . . . . . 31.4 ttpt -100.0 -50.67 3.92 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-O 120.888 0.375 . . . . 0.0 110.528 -177.062 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' E' E ' 85' ' ' ASP . . . . . . . . . . . . . 8.1 t70 -147.24 150.17 34.32 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.109 -0.496 . . . . 0.0 110.655 -178.783 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' E' E ' 86' ' ' VAL . . . . . . . . . . . . . 42.5 t -131.28 130.71 63.33 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.202 0 CA-C-O 120.993 0.425 . . . . 0.0 110.527 -179.333 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' E' E ' 87' ' ' ILE . . . . . . . . . . . . . 43.6 mm -118.59 125.59 74.5 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.189 0 N-CA-C 109.444 -0.576 . . . . 0.0 109.444 175.843 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' E' E ' 88' ' ' LEU . . . . . . . . . . . . . 17.2 tp -112.98 128.83 56.6 Favored 'General case' 0 C--N 1.331 -0.201 0 CA-C-O 120.924 0.392 . . . . 0.0 111.135 -176.949 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' E' E ' 89' ' ' ASP . . . . . . . . . . . . . 6.7 t70 -125.95 156.28 40.03 Favored 'General case' 0 C--N 1.331 -0.22 0 CA-C-N 115.988 -0.551 . . . . 0.0 109.927 177.172 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' E' E ' 90' ' ' GLU . . . . . . . . . . . . . 64.0 tt0 -45.73 -46.19 14.88 Favored 'General case' 0 N--CA 1.464 0.238 0 N-CA-C 112.988 0.736 . . . . 0.0 112.988 -172.166 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' E' E ' 91' ' ' ASN . . . . . . . . . . . . . 41.0 t30 -132.17 39.98 3.37 Favored 'General case' 0 C--N 1.332 -0.173 0 CA-C-O 121.124 0.488 . . . . 0.0 110.882 -177.647 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' E' E ' 92' ' ' LEU . . . . . . . . . . . . . 11.9 tp -165.39 138.14 4.36 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.243 -0.435 . . . . 0.0 110.168 -178.453 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' E' E ' 93' ' ' ILE . . . . . . . . . . . . . 70.8 mt -126.08 125.17 67.47 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.29 0 N-CA-C 109.905 -0.406 . . . . 0.0 109.905 -178.531 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' E' E ' 94' ' ' VAL . . . . . 0.631 HG21 HG21 ' E' ' 125' ' ' VAL . 43.7 t -122.87 126.61 74.06 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.187 0 N-CA-C 109.938 -0.393 . . . . 0.0 109.938 179.369 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' E' E ' 95' ' ' VAL . . . . . . . . . . . . . 43.7 t -121.43 133.79 66.83 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.317 0 CA-C-N 116.1 -0.5 . . . . 0.0 109.699 179.555 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' E' E ' 96' ' ' ILE . . . . . . . . . . . . . 68.4 mt -117.36 129.63 73.54 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.283 0 N-CA-C 109.348 -0.612 . . . . 0.0 109.348 -179.778 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' E' E ' 97' ' ' THR . . . . . . . . . . . . . 61.6 p -105.31 162.42 13.44 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-O 121.549 0.69 . . . . 0.0 111.896 -174.53 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' E' E ' 98' ' ' GLU . . . . . . . . . . . . . 13.1 mm-40 -53.8 -28.91 38.0 Favored 'General case' 0 CA--C 1.531 0.241 0 CA-C-N 115.727 -0.669 . . . . 0.0 112.121 179.254 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' E' E ' 99' ' ' GLU . . . . . . . . . . . . . 95.2 mt-10 -79.53 16.92 0.95 Allowed 'General case' 0 CA--C 1.535 0.402 0 N-CA-C 113.164 0.801 . . . . 0.0 113.164 -175.032 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' E' E ' 100' ' ' ASN . . . . . . . . . . . . . 4.0 m-20 62.11 38.12 14.07 Favored 'General case' 0 N--CA 1.463 0.208 0 CA-C-O 121.094 0.473 . . . . 0.0 110.84 177.935 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' E' E ' 101' ' ' GLU . . . . . . . . . . . . . 83.3 tt0 -120.41 143.04 48.67 Favored 'General case' 0 C--N 1.331 -0.203 0 CA-C-N 116.184 -0.462 . . . . 0.0 109.979 178.242 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' E' E ' 102' ' ' VAL . . . . . . . . . . . . . 43.1 t -115.03 127.71 72.48 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.282 0 CA-C-N 116.262 -0.426 . . . . 0.0 109.938 179.135 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' E' E ' 103' ' ' LEU . . . . . 0.507 HD12 ' N ' ' E' ' 103' ' ' LEU . 6.3 mp -116.34 131.53 56.92 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-N 115.676 -0.693 . . . . 0.0 109.786 175.954 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' E' E ' 104' ' ' ILE . . . . . . . . . . . . . 69.7 mt -118.74 123.69 71.94 Favored 'Isoleucine or valine' 0 C--O 1.234 0.269 0 N-CA-C 110.118 -0.327 . . . . 0.0 110.118 -179.004 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' E' E ' 105' ' ' PHE . . . . . . . . . . . . . 57.5 m-85 -124.6 164.28 20.17 Favored 'General case' 0 C--N 1.332 -0.191 0 O-C-N 124.07 0.856 . . . . 0.0 109.774 -179.725 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' E' E ' 106' ' ' ASN . . . . . . . . . . . . . 44.1 p-10 -96.71 -169.87 1.96 Allowed 'General case' 0 C--N 1.331 -0.199 0 N-CA-C 110.114 -0.328 . . . . 0.0 110.114 173.749 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' E' E ' 107' ' ' GLN . . . . . . . . . . . . . 46.5 tt0 -58.2 -30.04 66.15 Favored 'General case' 0 C--N 1.33 -0.279 0 N-CA-C 111.927 0.344 . . . . 0.0 111.927 -179.897 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' E' E ' 108' ' ' ASN . . . . . . . . . . . . . 11.9 t-20 -88.58 13.29 12.43 Favored 'General case' 0 CA--C 1.535 0.389 0 N-CA-C 113.037 0.754 . . . . 0.0 113.037 -176.578 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' E' E ' 109' ' ' LEU . . . . . . . . . . . . . 21.2 mt 57.06 33.81 23.92 Favored 'General case' 0 CA--C 1.53 0.196 0 N-CA-C 111.812 0.301 . . . . 0.0 111.812 179.01 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' E' E ' 110' ' ' GLU . . . . . . . . . . . . . 96.0 mt-10 -100.19 132.7 45.41 Favored 'General case' 0 C--N 1.329 -0.311 0 N-CA-C 109.171 -0.677 . . . . 0.0 109.171 174.688 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' E' E ' 111' ' ' GLU . . . . . . . . . . . . . 52.6 tt0 -74.79 121.84 22.39 Favored 'General case' 0 C--N 1.327 -0.385 0 CA-C-O 121.017 0.437 . . . . 0.0 110.875 -173.606 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' E' E ' 112' ' ' LEU . . . . . . . . . . . . . 73.4 mt -100.64 -46.12 5.28 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 115.872 -0.603 . . . . 0.0 110.61 179.519 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' E' E ' 113' ' ' TYR . . . . . . . . . . . . . 64.2 t80 -140.89 143.66 34.8 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.121 -0.491 . . . . 0.0 111.277 -177.237 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' E' E ' 114' ' ' ARG . . . . . . . . . . . . . 47.0 ptt85 -144.25 126.14 15.32 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.09 -0.504 . . . . 0.0 110.603 176.417 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' E' E ' 115' ' ' GLY . . . . . . . . . . . . . . . -150.03 147.52 17.83 Favored Glycine 0 CA--C 1.524 0.646 0 N-CA-C 111.11 -0.796 . . . . 0.0 111.11 179.203 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' E' E ' 116' ' ' LYS . . . . . . . . . . . . . 37.1 ttpt -118.72 135.53 54.44 Favored 'General case' 0 C--N 1.33 -0.264 0 N-CA-C 109.92 -0.4 . . . . 0.0 109.92 177.64 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' E' E ' 117' ' ' PHE . . . . . . . . . . . . . 43.0 m-85 -127.25 115.42 19.03 Favored 'General case' 0 C--N 1.331 -0.211 0 CA-C-N 116.215 -0.448 . . . . 0.0 109.914 -177.2 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' E' E ' 118' ' ' GLU . . . . . . . . . . . . . 96.1 mt-10 -53.99 -48.26 70.58 Favored 'General case' 0 C--N 1.33 -0.282 0 C-N-CA 121.005 -0.278 . . . . 0.0 111.344 -176.364 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' E' E ' 119' ' ' ASN . . . . . . . . . . . . . 65.7 m-80 -95.69 31.13 2.12 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 115.964 -0.562 . . . . 0.0 112.074 -174.828 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' E' E ' 120' ' ' LEU . . . . . . . . . . . . . 17.5 tp -53.23 119.92 5.34 Favored 'General case' 0 N--CA 1.463 0.215 0 CA-C-O 120.795 0.331 . . . . 0.0 110.909 179.421 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' E' E ' 121' ' ' ASN . . . . . . . . . . . . . 43.2 m-80 -114.13 -44.13 3.17 Favored 'General case' 0 C--N 1.333 -0.15 0 CA-C-N 116.273 -0.421 . . . . 0.0 111.102 -177.581 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' E' E ' 122' ' ' LYS . . . . . . . . . . . . . 18.7 mtpp -139.79 142.5 36.7 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.33 -0.395 . . . . 0.0 111.706 -174.876 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' E' E ' 123' ' ' VAL . . . . . . . . . . . . . 46.4 t -132.81 126.16 53.7 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.377 0 N-CA-C 109.339 -0.615 . . . . 0.0 109.339 172.953 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' E' E ' 124' ' ' LEU . . . . . . . . . . . . . 7.4 tp -129.09 130.94 47.13 Favored 'General case' 0 C--O 1.232 0.179 0 CA-C-O 120.939 0.4 . . . . 0.0 110.538 -178.114 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' E' E ' 125' ' ' VAL . . . . . 0.631 HG21 HG21 ' E' ' 94' ' ' VAL . 41.5 t -124.75 133.17 70.12 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.218 0 CA-C-N 116.014 -0.539 . . . . 0.0 109.884 179.345 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' E' E ' 126' ' ' ARG . . . . . . . . . . . . . 34.7 ttm180 -155.68 124.04 5.88 Favored 'General case' 0 C--N 1.328 -0.327 0 N-CA-C 109.619 -0.512 . . . . 0.0 109.619 179.06 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' E' E ' 127' ' ' ASN . . . . . . . . . . . . . 32.1 t30 57.97 -154.44 0.36 Allowed 'General case' 0 CA--C 1.538 0.487 0 N-CA-C 109.296 -0.631 . . . . 0.0 109.296 -175.936 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' E' E ' 128' ' ' ASP . . . . . . . . . . . . . 9.0 p-10 -80.94 16.5 1.45 Allowed 'General case' 0 CA--C 1.536 0.424 0 N-CA-C 112.51 0.559 . . . . 0.0 112.51 176.635 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' E' E ' 129' ' ' LEU . . . . . . . . . . . . . 26.3 tp -107.7 131.28 54.59 Favored 'General case' 0 C--O 1.232 0.155 0 O-C-N 122.019 -0.426 . . . . 0.0 110.014 177.865 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' E' E ' 130' ' ' VAL . . . . . . . . . . . . . 44.6 t -125.3 134.93 65.58 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.27 0 N-CA-C 109.843 -0.428 . . . . 0.0 109.843 -179.352 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' E' E ' 131' ' ' VAL . . . . . 0.437 HG22 HD12 ' E' ' 140' ' ' LEU . 43.4 t -134.05 133.42 56.01 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.252 0 CA-C-O 121.137 0.494 . . . . 0.0 110.252 178.388 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' E' E ' 132' ' ' ILE . . . . . . . . . . . . . 73.1 mt -119.63 132.96 67.95 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.252 0 CA-C-N 115.601 -0.727 . . . . 0.0 109.411 179.648 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' E' E ' 133' ' ' ILE . . . . . . . . . . . . . 42.8 mm -118.03 123.27 71.41 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.277 0 CA-C-O 120.886 0.374 . . . . 0.0 111.2 -174.029 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' E' E ' 134' ' ' ASP . . . . . . . . . . . . . 5.3 p-10 -127.38 151.6 48.58 Favored 'General case' 0 C--N 1.331 -0.227 0 CA-C-N 115.843 -0.617 . . . . 0.0 109.6 173.397 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' E' E ' 135' ' ' GLU . . . . . . . . . . . . . 43.2 tp10 -49.73 -26.38 3.76 Favored 'General case' 0 C--N 1.329 -0.314 0 N-CA-C 112.86 0.689 . . . . 0.0 112.86 -169.859 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' E' E ' 136' ' ' GLN . . . . . . . . . . . . . 97.3 mt-30 -102.9 -31.12 10.41 Favored 'General case' 0 N--CA 1.464 0.228 0 N-CA-C 112.851 0.686 . . . . 0.0 112.851 -174.345 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' E' E ' 137' ' ' LYS . . . . . . . . . . . . . 27.7 ttpp -144.17 153.91 42.59 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-O 121.223 0.535 . . . . 0.0 111.673 -166.689 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' E' E ' 138' ' ' LEU . . . . . 0.41 ' C ' HD23 ' E' ' 138' ' ' LEU . 6.8 tt -118.73 126.31 51.61 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 115.616 -0.72 . . . . 0.0 110.056 178.388 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' E' E ' 139' ' ' THR . . . . . . . . . . . . . 33.4 m -107.45 125.44 51.25 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.095 -179.901 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' E' E ' 140' ' ' LEU . . . . . 0.437 HD12 HG22 ' E' ' 131' ' ' VAL . 7.5 tp -113.91 120.25 40.06 Favored 'General case' 0 C--N 1.329 -0.299 0 N-CA-C 109.065 -0.717 . . . . 0.0 109.065 -179.948 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' E' E ' 141' ' ' ILE . . . . . . . . . . . . . 18.3 mt -120.99 126.09 74.8 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.268 0 CA-C-O 120.894 0.378 . . . . 0.0 110.459 -172.779 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' E' E ' 142' ' ' ARG . . . . . . . . . . . . . 77.9 mtp180 -109.12 130.65 55.48 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 115.651 -0.704 . . . . 0.0 109.977 176.571 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' E' E ' 143' ' ' THR . . . . . . . . . . . . . 58.9 p . . . . . 0 C--O 1.22 -0.453 0 CA-C-O 118.025 -0.988 . . . . 0.0 110.452 -179.937 . . . . . . . . 0 0 . 1 . 015 nuclear nobuild full ' F' F ' -3' ' ' GLU . . . . . . . . . . . . . 46.2 mp0 . . . . . 0 N--CA 1.491 1.617 0 N-CA-C 109.323 -0.621 . . . . 0.0 109.323 . . . . . . . . . 0 0 . 1 . 015 nuclear nobuild full ' F' F ' -2' ' ' GLY . . . . . . . . . . . . . . . -92.7 110.93 3.99 Favored Glycine 0 CA--C 1.524 0.622 0 N-CA-C 110.661 -0.976 . . . . 0.0 110.661 178.728 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' F' F ' -1' ' ' VAL . . . . . . . . . . . . . 45.9 t -88.01 138.77 18.49 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.341 0 N-CA-C 109.863 -0.421 . . . . 0.0 109.863 -179.668 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' F' F ' 0' ' ' ILE . . . . . . . . . . . . . 41.2 mm -94.18 124.98 46.86 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.328 0 CA-C-N 116.227 -0.442 . . . . 0.0 109.926 179.944 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' F' F ' 1' ' ' MET . . . . . . . . . . . . . 26.1 ptt? -81.57 128.45 33.93 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.126 -0.488 . . . . 0.0 111.126 -177.701 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' F' F ' 2' ' ' SER . . . . . . . . . . . . . 7.6 p -111.57 139.94 46.6 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.028 -0.533 . . . . 0.0 110.31 178.26 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' F' F ' 3' ' ' GLU . . . . . . . . . . . . . 81.1 tt0 -143.79 143.89 31.55 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.333 -0.394 . . . . 0.0 111.356 -176.836 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' F' F ' 4' ' ' LEU . . . . . . . . . . . . . 24.1 tp -124.52 129.87 51.42 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 115.872 -0.604 . . . . 0.0 109.87 175.305 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' F' F ' 5' ' ' LYS . . . . . . . . . . . . . 99.3 mttt -110.58 122.08 46.88 Favored 'General case' 0 C--O 1.234 0.26 0 CA-C-N 116.395 -0.366 . . . . 0.0 110.901 -179.513 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' F' F ' 6' ' ' LEU . . . . . . . . . . . . . 32.8 mt -114.52 146.69 40.42 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 115.342 -0.845 . . . . 0.0 110.263 -179.264 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' F' F ' 7' ' ' LYS . . . . . . . . . . . . . 36.7 ttmt -132.92 137.76 30.35 Favored Pre-proline 0 CA--C 1.534 0.338 0 CA-C-O 118.974 -0.536 . . . . 0.0 109.805 174.758 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' F' F ' 8' ' ' PRO . . . . . . . . . . . . . 83.6 Cg_endo -91.52 141.65 2.74 Favored 'Trans proline' 0 N--CA 1.49 1.305 0 C-N-CA 121.773 1.649 . . . . 0.0 112.014 179.359 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' F' F ' 9' ' ' LEU . . . . . . . . . . . . . 37.6 mt -78.44 -46.59 2.01 Favored Pre-proline 0 CA--C 1.534 0.328 0 CA-C-O 118.765 -0.636 . . . . 0.0 111.735 179.056 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' F' F ' 10' ' ' PRO . . . . . . . . . . . . . 91.1 Cg_endo -83.08 145.96 12.54 Favored 'Trans proline' 0 N--CA 1.494 1.54 0 C-N-CA 121.218 1.279 . . . . 0.0 111.52 173.452 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' F' F ' 11' ' ' LYS . . . . . . . . . . . . . 19.8 pttp -84.01 116.78 23.0 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-O 121.324 0.583 . . . . 0.0 110.545 177.988 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' F' F ' 12' ' ' VAL . . . . . . . . . . . . . 11.9 p -151.06 143.88 16.71 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.306 0 CA-C-N 115.662 -0.699 . . . . 0.0 110.274 -179.662 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' F' F ' 13' ' ' GLU . . . . . . . . . . . . . 43.3 mt-10 -83.13 117.16 22.69 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.517 -0.311 . . . . 0.0 110.26 178.53 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' F' F ' 14' ' ' LEU . . . . . . . . . . . . . 34.7 mt -98.41 142.31 24.38 Favored Pre-proline 0 CA--C 1.534 0.358 0 CA-C-O 118.997 -0.525 . . . . 0.0 109.853 -179.695 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' F' F ' 15' ' ' PRO . . . . . . . . . . . . . 26.4 Cg_exo -61.22 160.93 24.79 Favored 'Trans proline' 0 N--CA 1.497 1.724 0 C-N-CA 121.202 1.268 . . . . 0.0 111.828 178.282 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' F' F ' 16' ' ' PRO . . . . . . . . . . . . . 32.7 Cg_exo -59.55 -37.52 88.23 Favored 'Trans proline' 0 N--CA 1.497 1.684 0 C-N-CA 121.508 1.472 . . . . 0.0 112.633 -178.303 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' F' F ' 17' ' ' ASP . . . . . . . . . . . . . 13.6 p-10 -86.44 7.94 23.83 Favored 'General case' 0 CA--C 1.536 0.423 0 N-CA-C 113.132 0.79 . . . . 0.0 113.132 -177.989 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' F' F ' 18' ' ' PHE . . . . . . . . . . . . . 52.0 t80 -58.26 -43.8 88.05 Favored 'General case' 0 N--CA 1.457 -0.102 0 O-C-N 121.985 -0.447 . . . . 0.0 109.991 -179.55 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' F' F ' 19' ' ' VAL . . . . . . . . . . . . . 47.1 t -57.33 -40.86 76.65 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.324 0 CA-C-N 116.112 -0.494 . . . . 0.0 110.322 -179.626 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' F' F ' 20' ' ' ASP . . . . . . . . . . . . . 36.6 t0 -60.37 -43.56 96.46 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-O 120.769 0.319 . . . . 0.0 110.974 -178.258 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' F' F ' 21' ' ' VAL . . . . . . . . . . . . . 47.3 t -64.35 -45.94 94.53 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.279 0 C-N-CA 120.821 -0.352 . . . . 0.0 110.361 -178.382 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' F' F ' 22' ' ' ILE . . . . . 0.669 HG22 HD12 ' F' ' 26' ' ' LEU . 50.9 mm -56.21 -43.36 76.15 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.271 0 CA-C-O 120.768 0.318 . . . . 0.0 110.49 177.957 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' F' F ' 23' ' ' ARG . . . . . . . . . . . . . 58.8 ttp180 -55.26 -49.09 72.94 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-O 120.723 0.296 . . . . 0.0 111.182 179.693 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' F' F ' 24' ' ' ILE . . . . . . . . . . . . . 73.7 mt -59.32 -41.34 83.88 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.293 0 CA-C-N 116.447 -0.342 . . . . 0.0 111.042 -177.608 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' F' F ' 25' ' ' LYS . . . . . . . . . . . . . 48.0 mttm -69.04 -42.53 76.2 Favored 'General case' 0 C--N 1.328 -0.344 0 N-CA-C 112.696 0.628 . . . . 0.0 112.696 -178.056 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' F' F ' 26' ' ' LEU . . . . . 0.669 HD12 HG22 ' F' ' 22' ' ' ILE . 53.6 mt -79.47 -34.58 41.34 Favored 'General case' 0 C--N 1.331 -0.225 0 N-CA-C 113.72 1.007 . . . . 0.0 113.72 -170.451 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' F' F ' 27' ' ' GLN . . . . . . . . . . . . . 8.3 pt20 -46.67 138.37 6.1 Favored 'General case' 0 N--CA 1.469 0.486 0 N-CA-C 112.998 0.74 . . . . 0.0 112.998 -174.18 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' F' F ' 28' ' ' GLY . . . . . . . . . . . . . . . 100.23 -24.58 31.55 Favored Glycine 0 CA--C 1.533 1.163 0 CA-C-N 115.528 -0.76 . . . . 0.0 112.525 -177.963 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' F' F ' 29' ' ' LYS . . . . . . . . . . . . . 68.7 mttm -98.04 155.08 17.28 Favored 'General case' 0 C--O 1.232 0.177 0 CA-C-N 117.387 0.594 . . . . 0.0 111.337 179.637 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' F' F ' 30' ' ' THR . . . . . . . . . . . . . 29.5 m -105.92 139.43 40.49 Favored 'General case' 0 C--N 1.331 -0.218 0 CA-C-N 115.928 -0.578 . . . . 0.0 110.345 177.989 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' F' F ' 31' ' ' VAL . . . . . . . . . . . . . 34.4 m -129.9 156.71 42.33 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.271 0 CA-C-N 116.357 -0.383 . . . . 0.0 110.616 179.918 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' F' F ' 32' ' ' ARG . . . . . . . . . . . . . 68.1 mtm180 -131.68 152.41 50.89 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-O 121.099 0.476 . . . . 0.0 110.853 177.55 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' F' F ' 33' ' ' THR . . . . . . . . . . . . . 19.8 m -53.39 138.69 32.46 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.304 -0.407 . . . . 0.0 111.175 -179.534 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' F' F ' 34' ' ' GLY . . . . . . . . . . . . . . . 99.59 -17.21 57.91 Favored Glycine 0 CA--C 1.532 1.151 0 C-N-CA 121.211 -0.519 . . . . 0.0 113.268 178.869 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' F' F ' 35' ' ' ASP . . . . . . . . . . . . . 74.3 m-20 -66.83 149.87 49.95 Favored 'General case' 0 N--CA 1.462 0.145 0 CA-C-N 118.076 0.938 . . . . 0.0 111.191 178.98 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' F' F ' 36' ' ' VAL . . . . . . . . . . . . . 43.9 t -121.83 130.0 74.97 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.209 0 N-CA-C 109.607 -0.516 . . . . 0.0 109.607 177.018 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' F' F ' 37' ' ' ILE . . . . . . . . . . . . . 66.2 mt -121.29 138.48 51.52 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.245 0 CA-C-N 116.186 -0.461 . . . . 0.0 109.978 -178.627 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' F' F ' 38' ' ' GLY . . . . . . . . . . . . . . . -113.61 128.02 8.12 Favored Glycine 0 CA--C 1.524 0.652 0 N-CA-C 110.936 -0.866 . . . . 0.0 110.936 179.219 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' F' F ' 39' ' ' ILE . . . . . . . . . . . . . 78.4 mt -127.9 140.49 49.02 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.186 0 CA-C-O 120.789 0.328 . . . . 0.0 110.265 179.2 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' F' F ' 40' ' ' SER . . . . . . . . . . . . . 42.7 t -91.26 115.5 28.07 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.226 -0.443 . . . . 0.0 110.649 176.392 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' F' F ' 41' ' ' ILE . . . . . . . . . . . . . 44.8 mm -119.62 113.22 40.24 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.231 0 N-CA-C 109.961 -0.385 . . . . 0.0 109.961 178.439 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' F' F ' 42' ' ' LEU . . . . . . . . . . . . . 69.1 mt 57.62 36.1 26.39 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.415 -0.357 . . . . 0.0 111.498 179.5 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' F' F ' 43' ' ' GLY . . . . . . . . . . . . . . . 80.34 -10.2 44.35 Favored Glycine 0 CA--C 1.533 1.197 0 C-N-CA 121.289 -0.482 . . . . 0.0 113.517 177.306 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' F' F ' 44' ' ' LYS . . . . . . . . . . . . . 42.8 tttp -99.6 134.68 42.14 Favored 'General case' 0 C--N 1.333 -0.132 0 CA-C-N 117.831 0.816 . . . . 0.0 110.007 177.339 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' F' F ' 45' ' ' GLU . . . . . . . . . . . . . 83.8 tt0 -82.61 127.99 33.89 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-O 120.797 0.332 . . . . 0.0 110.838 -179.014 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' F' F ' 46' ' ' VAL . . . . . . . . . . . . . 10.7 p -121.63 126.11 74.32 Favored 'Isoleucine or valine' 0 C--N 1.333 -0.15 0 N-CA-C 109.639 -0.504 . . . . 0.0 109.639 175.759 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' F' F ' 47' ' ' LYS . . . . . . . . . . . . . 97.7 mttt -99.23 124.82 44.6 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.044 -0.525 . . . . 0.0 110.807 178.235 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' F' F ' 48' ' ' PHE . . . . . . . . . . . . . 32.6 m-85 -108.84 131.89 54.54 Favored 'General case' 0 C--N 1.33 -0.277 0 N-CA-C 109.798 -0.445 . . . . 0.0 109.798 176.548 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' F' F ' 49' ' ' LYS . . . . . . . . . . . . . 34.6 tttp -106.86 135.51 48.29 Favored 'General case' 0 C--N 1.328 -0.355 0 N-CA-C 109.849 -0.426 . . . . 0.0 109.849 177.518 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' F' F ' 50' ' ' VAL . . . . . . . . . . . . . 45.2 t -76.99 106.82 7.37 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.308 0 N-CA-C 109.438 -0.579 . . . . 0.0 109.438 178.027 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' F' F ' 51' ' ' VAL . . . . . . . . . . . . . 47.0 t -73.91 -47.87 41.19 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.324 0 CA-C-N 116.22 -0.446 . . . . 0.0 109.982 -175.009 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' F' F ' 52' ' ' GLN . . . . . . . . . . . . . 63.0 tt0 -159.75 143.85 14.7 Favored 'General case' 0 C--N 1.33 -0.275 0 C-N-CA 120.422 -0.511 . . . . 0.0 111.447 -177.874 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' F' F ' 53' ' ' ALA . . . . . . . . . . . . . . . -123.64 132.9 53.97 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 115.747 -0.66 . . . . 0.0 109.778 175.004 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' F' F ' 54' ' ' TYR . . . . . . . . . . . . . 25.9 t80 -129.2 111.59 18.21 Favored Pre-proline 0 CA--C 1.536 0.416 0 CA-C-O 118.13 -0.938 . . . . 0.0 110.386 178.931 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' F' F ' 55' ' ' PRO . . . . . . . . . . . . . 73.6 Cg_endo -77.26 161.25 93.12 Favored 'Cis proline' 0 N--CA 1.499 1.821 0 CA-C-N 121.943 1.729 . . . . 0.0 112.407 -6.835 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' F' F ' 56' ' ' SER . . . . . . . . . . . . . 60.8 m -108.76 130.78 22.32 Favored Pre-proline 0 CA--C 1.539 0.557 0 CA-C-O 118.434 -0.793 . . . . 0.0 109.487 175.304 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' F' F ' 57' ' ' PRO . . . . . . . . . . . . . 36.5 Cg_endo -66.31 163.13 70.1 Favored 'Cis proline' 0 N--CA 1.498 1.78 0 CA-C-N 121.972 1.74 . . . . 0.0 111.601 -1.3 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' F' F ' 58' ' ' LEU . . . . . . . . . . . . . 15.7 tp -129.37 138.98 51.84 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-O 121.026 0.441 . . . . 0.0 110.405 -178.131 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' F' F ' 59' ' ' ARG . . . . . . . . . . . . . 74.2 ttt180 -104.68 136.31 44.44 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 115.836 -0.62 . . . . 0.0 109.683 176.244 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' F' F ' 60' ' ' VAL . . . . . . . . . . . . . 43.3 t -85.35 116.72 29.14 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.262 0 C-N-CA 120.662 -0.415 . . . . 0.0 110.234 -178.345 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' F' F ' 61' ' ' GLU . . . . . . . . . . . . . 39.1 tp10 -131.06 155.54 46.72 Favored 'General case' 0 C--N 1.328 -0.362 0 N-CA-C 109.005 -0.739 . . . . 0.0 109.005 176.856 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' F' F ' 62' ' ' ASP . . . . . . . . . . . . . 13.9 t70 -51.04 -32.37 21.55 Favored 'General case' 0 C--N 1.327 -0.391 0 N-CA-C 112.011 0.374 . . . . 0.0 112.011 -178.868 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' F' F ' 63' ' ' ARG . . . . . . . . . . . . . 87.6 mtt180 -73.21 -22.06 60.52 Favored 'General case' 0 CA--C 1.534 0.335 0 N-CA-C 112.908 0.707 . . . . 0.0 112.908 -176.801 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' F' F ' 64' ' ' THR . . . . . . . . . . . . . 18.9 m -71.8 143.02 49.65 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-O 120.929 0.395 . . . . 0.0 110.88 -175.3 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' F' F ' 65' ' ' LYS . . . . . . . . . . . . . 91.4 mttt -87.71 129.91 34.99 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 115.973 -0.558 . . . . 0.0 110.049 178.809 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' F' F ' 66' ' ' ILE . . . . . . . . . . . . . 58.2 mt -115.9 125.57 73.08 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.226 0 N-CA-C 109.579 -0.526 . . . . 0.0 109.579 178.32 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' F' F ' 67' ' ' THR . . . . . . . . . . . . . 24.6 m -121.79 142.3 50.35 Favored 'General case' 0 C--N 1.331 -0.227 0 CA-C-O 121.008 0.432 . . . . 0.0 111.215 -176.246 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' F' F ' 68' ' ' LEU . . . . . . . . . . . . . 4.9 tt -106.59 125.06 50.52 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 115.743 -0.662 . . . . 0.0 109.85 178.173 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' F' F ' 69' ' ' VAL . . . . . . . . . . . . . 42.6 t -90.37 130.83 38.97 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.316 0 CA-C-O 120.837 0.351 . . . . 0.0 110.296 -178.675 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' F' F ' 70' ' ' THR . . . . . . . . . . . . . 68.2 p -85.55 -29.65 24.01 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.091 -0.504 . . . . 0.0 111.957 -179.235 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' F' F ' 71' ' ' HIS . . . . . . . . . . . . . 70.9 m-70 -65.04 151.66 93.03 Favored Pre-proline 0 C--O 1.234 0.244 0 C-N-CA 121.045 -0.262 . . . . 0.0 110.582 -178.411 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' F' F ' 72' ' ' PRO . . . . . . . . . . . . . 73.5 Cg_endo -83.74 -28.6 1.27 Allowed 'Trans proline' 0 N--CA 1.491 1.325 0 C-N-CA 121.627 1.551 . . . . 0.0 112.77 -179.598 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' F' F ' 73' ' ' VAL . . . . . . . . . . . . . 35.6 m -128.83 163.48 33.54 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.199 0 CA-C-O 120.902 0.382 . . . . 0.0 110.702 -179.372 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' F' F ' 74' ' ' ASP . . . . . . . . . . . . . 14.4 t0 -104.47 118.42 36.57 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.017 -0.538 . . . . 0.0 109.784 179.341 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' F' F ' 75' ' ' VAL . . . . . 0.568 ' C ' HD12 ' F' ' 76' ' ' LEU . 42.9 t -115.55 124.17 71.76 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.301 0 CA-C-O 120.965 0.412 . . . . 0.0 110.658 -177.466 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' F' F ' 76' ' ' LEU . . . . . 0.568 HD12 ' C ' ' F' ' 75' ' ' VAL . 8.7 mp -122.61 150.73 42.25 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-N 115.74 -0.664 . . . . 0.0 109.687 175.945 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' F' F ' 77' ' ' GLU . . . . . . . . . . . . . 98.9 mt-10 -135.59 141.47 45.14 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-O 121.183 0.516 . . . . 0.0 111.816 -175.984 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' F' F ' 78' ' ' ALA . . . . . . . . . . . . . . . -127.81 143.83 51.11 Favored 'General case' 0 C--N 1.331 -0.204 0 CA-C-N 115.518 -0.764 . . . . 0.0 109.82 175.868 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' F' F ' 79' ' ' LYS . . . . . 0.625 ' O ' HD13 ' F' ' 80' ' ' ILE . 37.8 mtmt -95.26 112.33 24.05 Favored 'General case' 0 C--N 1.33 -0.239 0 CA-C-O 120.738 0.304 . . . . 0.0 111.074 -176.89 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' F' F ' 80' ' ' ILE . . . . . 0.625 HD13 ' O ' ' F' ' 79' ' ' LYS . 39.3 mm -139.23 112.67 6.5 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.238 0 N-CA-C 109.404 -0.591 . . . . 0.0 109.404 -179.265 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' F' F ' 81' ' ' LYS . . . . . . . . . . . . . 56.3 pttt -106.67 131.48 53.76 Favored 'General case' 0 N--CA 1.464 0.242 0 CA-C-O 120.961 0.41 . . . . 0.0 111.389 -178.223 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' F' F ' 82' ' ' GLY . . . . . . . . . . . . . . . 89.13 41.95 5.72 Favored Glycine 0 CA--C 1.527 0.804 0 C-N-CA 121.018 -0.61 . . . . 0.0 111.813 176.154 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' F' F ' 83' ' ' ILE . . . . . . . . . . . . . 74.5 mt -77.13 137.9 21.55 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 N-CA-C 109.351 -0.611 . . . . 0.0 109.351 176.329 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' F' F ' 84' ' ' LYS . . . . . . . . . . . . . 19.3 ttpt -101.47 -46.85 4.86 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.431 -0.35 . . . . 0.0 110.527 -176.897 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' F' F ' 85' ' ' ASP . . . . . . . . . . . . . 13.7 t70 -143.72 146.6 33.29 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.448 -0.342 . . . . 0.0 110.479 -179.176 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' F' F ' 86' ' ' VAL . . . . . . . . . . . . . 44.7 t -128.96 128.86 67.81 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.215 0 CA-C-O 120.91 0.386 . . . . 0.0 110.405 -178.847 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' F' F ' 87' ' ' ILE . . . . . . . . . . . . . 44.7 mm -121.35 128.36 75.91 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.235 0 N-CA-C 109.359 -0.608 . . . . 0.0 109.359 177.903 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' F' F ' 88' ' ' LEU . . . . . . . . . . . . . 62.1 mt -120.21 139.26 52.92 Favored 'General case' 0 C--N 1.332 -0.194 0 CA-C-O 121.207 0.527 . . . . 0.0 111.882 -175.277 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' F' F ' 89' ' ' ASP . . . . . . . . . . . . . 13.4 t70 -133.61 154.92 50.52 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 115.423 -0.808 . . . . 0.0 109.436 175.394 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' F' F ' 90' ' ' GLU . . . . . . . . . . . . . 44.2 mt-10 -49.46 -36.78 23.7 Favored 'General case' 0 C--N 1.329 -0.294 0 N-CA-C 112.832 0.678 . . . . 0.0 112.832 -171.805 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' F' F ' 91' ' ' ASN . . . . . . . . . . . . . 9.1 m120 -127.1 22.11 6.69 Favored 'General case' 0 N--CA 1.468 0.449 0 N-CA-C 112.869 0.692 . . . . 0.0 112.869 -176.651 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' F' F ' 92' ' ' LEU . . . . . . . . . . . . . 5.8 mt -153.49 144.4 22.79 Favored 'General case' 0 C--N 1.331 -0.199 0 N-CA-C 109.573 -0.528 . . . . 0.0 109.573 -177.894 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' F' F ' 93' ' ' ILE . . . . . . . . . . . . . 71.2 mt -127.28 122.25 59.34 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.288 0 N-CA-C 109.407 -0.59 . . . . 0.0 109.407 178.41 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' F' F ' 94' ' ' VAL . . . . . . . . . . . . . 43.5 t -121.95 126.97 75.22 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.242 0 CA-C-O 120.911 0.386 . . . . 0.0 110.014 -179.821 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' F' F ' 95' ' ' VAL . . . . . . . . . . . . . 44.0 t -120.47 133.25 67.78 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.384 0 CA-C-N 115.963 -0.562 . . . . 0.0 109.662 179.671 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' F' F ' 96' ' ' ILE . . . . . . . . . . . . . 66.9 mt -114.99 124.54 71.75 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.231 0 N-CA-C 109.121 -0.696 . . . . 0.0 109.121 178.726 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' F' F ' 97' ' ' THR . . . . . . . . . . . . . 45.3 p -98.28 156.75 16.56 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-O 121.114 0.483 . . . . 0.0 111.474 -176.139 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' F' F ' 98' ' ' GLU . . . . . . . . . . . . . 96.7 mt-10 -54.09 -26.35 26.68 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 116.037 -0.529 . . . . 0.0 112.027 178.307 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' F' F ' 99' ' ' GLU . . . . . . . . . . . . . 34.6 tt0 -79.33 17.03 0.88 Allowed 'General case' 0 CA--C 1.538 0.51 0 N-CA-C 112.582 0.586 . . . . 0.0 112.582 -176.83 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' F' F ' 100' ' ' ASN . . . . . . . . . . . . . 2.0 m120 64.18 36.2 9.68 Favored 'General case' 0 CA--C 1.531 0.224 0 O-C-N 121.84 -0.538 . . . . 0.0 110.984 176.002 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' F' F ' 101' ' ' GLU . . . . . . . . . . . . . 79.1 tt0 -117.15 142.88 46.46 Favored 'General case' 0 C--O 1.231 0.099 0 N-CA-C 109.917 -0.401 . . . . 0.0 109.917 178.248 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' F' F ' 102' ' ' VAL . . . . . . . . . . . . . 43.4 t -115.56 125.16 72.66 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.312 0 N-CA-C 109.728 -0.471 . . . . 0.0 109.728 -179.848 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' F' F ' 103' ' ' LEU . . . . . . . . . . . . . 40.0 mt -117.08 131.06 57.01 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 115.972 -0.558 . . . . 0.0 110.606 178.256 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' F' F ' 104' ' ' ILE . . . . . 0.468 HD12 ' HB3' ' F' ' 113' ' ' TYR . 67.0 mt -117.19 120.08 63.87 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.221 0 CA-C-N 116.405 -0.361 . . . . 0.0 110.314 -179.477 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' F' F ' 105' ' ' PHE . . . . . . . . . . . . . 76.1 m-85 -121.58 167.4 12.93 Favored 'General case' 0 C--O 1.231 0.128 0 O-C-N 124.092 0.87 . . . . 0.0 109.688 178.238 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' F' F ' 106' ' ' ASN . . . . . . . . . . . . . 43.0 p-10 -104.09 -170.99 1.85 Allowed 'General case' 0 C--N 1.332 -0.172 0 N-CA-C 109.657 -0.497 . . . . 0.0 109.657 170.653 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' F' F ' 107' ' ' GLN . . . . . . . . . . . . . 50.3 tt0 -58.41 -29.98 66.51 Favored 'General case' 0 C--N 1.328 -0.338 0 N-CA-C 111.925 0.343 . . . . 0.0 111.925 179.735 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' F' F ' 108' ' ' ASN . . . . . . . . . . . . . 47.1 t30 -88.22 13.7 10.89 Favored 'General case' 0 CA--C 1.534 0.359 0 N-CA-C 112.91 0.707 . . . . 0.0 112.91 -176.484 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' F' F ' 109' ' ' LEU . . . . . . . . . . . . . 82.1 mt 57.2 33.6 23.55 Favored 'General case' 0 CA--C 1.529 0.173 0 N-CA-C 111.823 0.305 . . . . 0.0 111.823 176.875 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' F' F ' 110' ' ' GLU . . . . . . . . . . . . . 95.8 mt-10 -100.0 138.61 36.84 Favored 'General case' 0 C--N 1.331 -0.239 0 N-CA-C 109.339 -0.615 . . . . 0.0 109.339 175.616 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' F' F ' 111' ' ' GLU . . . . . . . . . . . . . 56.7 tt0 -75.49 121.9 23.05 Favored 'General case' 0 C--N 1.328 -0.338 0 C-N-CA 120.64 -0.424 . . . . 0.0 110.532 -175.727 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' F' F ' 112' ' ' LEU . . . . . . . . . . . . . 32.4 mt -104.36 -46.02 4.51 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.065 -0.516 . . . . 0.0 110.657 179.715 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' F' F ' 113' ' ' TYR . . . . . 0.468 ' HB3' HD12 ' F' ' 104' ' ' ILE . 58.8 t80 -143.16 141.06 31.06 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 116.247 -0.433 . . . . 0.0 111.295 -179.35 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' F' F ' 114' ' ' ARG . . . . . . . . . . . . . 39.0 ptt180 -137.81 123.76 20.16 Favored 'General case' 0 C--N 1.331 -0.203 0 CA-C-N 115.837 -0.619 . . . . 0.0 110.252 178.124 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' F' F ' 115' ' ' GLY . . . . . . . . . . . . . . . -150.08 160.94 28.74 Favored Glycine 0 CA--C 1.523 0.582 0 C-N-CA 120.565 -0.826 . . . . 0.0 111.472 -179.289 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' F' F ' 116' ' ' LYS . . . . . . . . . . . . . 32.5 ttpt -127.18 141.4 51.75 Favored 'General case' 0 C--N 1.33 -0.249 0 N-CA-C 109.838 -0.431 . . . . 0.0 109.838 176.487 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' F' F ' 117' ' ' PHE . . . . . . . . . . . . . 43.0 m-85 -141.17 113.82 8.28 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.408 -0.36 . . . . 0.0 110.061 -179.545 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' F' F ' 118' ' ' GLU . . . . . . . . . . . . . 95.9 mt-10 -55.6 -44.13 76.7 Favored 'General case' 0 C--N 1.329 -0.321 0 C-N-CA 120.867 -0.333 . . . . 0.0 111.093 -176.252 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' F' F ' 119' ' ' ASN . . . . . . . . . . . . . 3.5 m120 -98.72 31.11 3.03 Favored 'General case' 0 C--N 1.33 -0.246 0 N-CA-C 112.216 0.45 . . . . 0.0 112.216 -174.387 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' F' F ' 120' ' ' LEU . . . . . . . . . . . . . 17.5 tp -57.04 121.03 9.04 Favored 'General case' 0 N--CA 1.463 0.206 0 N-CA-C 110.092 -0.336 . . . . 0.0 110.092 177.475 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' F' F ' 121' ' ' ASN . . . . . . . . . . . . . 5.3 t30 -114.08 -44.11 3.18 Favored 'General case' 0 C--N 1.332 -0.182 0 C-N-CA 121.208 -0.197 . . . . 0.0 111.25 -176.75 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' F' F ' 122' ' ' LYS . . . . . . . . . . . . . 86.3 mttt -142.97 147.87 35.9 Favored 'General case' 0 C--N 1.332 -0.19 0 CA-C-O 121.164 0.507 . . . . 0.0 111.788 -178.986 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' F' F ' 123' ' ' VAL . . . . . . . . . . . . . 42.9 t -128.74 129.56 68.49 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.186 0 CA-C-N 115.729 -0.668 . . . . 0.0 109.553 174.823 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' F' F ' 124' ' ' LEU . . . . . . . . . . . . . 21.7 mt -123.81 135.32 53.71 Favored 'General case' 0 C--N 1.331 -0.212 0 CA-C-O 120.81 0.338 . . . . 0.0 110.679 -178.841 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' F' F ' 125' ' ' VAL . . . . . 0.439 ' O ' HG13 ' F' ' 125' ' ' VAL . 11.7 p -136.86 123.95 30.91 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.273 0 CA-C-N 116.233 -0.44 . . . . 0.0 110.214 178.0 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' F' F ' 126' ' ' ARG . . . . . . . . . . . . . 89.6 mtt180 -152.94 132.92 13.33 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.053 -0.521 . . . . 0.0 109.873 178.938 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' F' F ' 127' ' ' ASN . . . . . . . . . . . . . 3.9 m120 55.58 -151.76 0.38 Allowed 'General case' 0 CA--C 1.541 0.602 0 N-CA-C 109.898 -0.408 . . . . 0.0 109.898 179.38 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' F' F ' 128' ' ' ASP . . . . . . . . . . . . . 19.7 p-10 -81.35 15.3 2.05 Favored 'General case' 0 CA--C 1.536 0.417 0 CA-C-N 118.643 0.656 . . . . 0.0 112.764 178.675 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' F' F ' 129' ' ' LEU . . . . . . . . . . . . . 31.7 mt -111.05 131.14 55.31 Favored 'General case' 0 C--O 1.233 0.213 0 O-C-N 121.936 -0.477 . . . . 0.0 110.651 179.588 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' F' F ' 130' ' ' VAL . . . . . . . . . . . . . 41.2 t -122.15 133.64 67.85 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.223 0 N-CA-C 109.115 -0.698 . . . . 0.0 109.115 176.839 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' F' F ' 131' ' ' VAL . . . . . 0.417 HG22 HD12 ' F' ' 140' ' ' LEU . 42.6 t -135.73 137.4 49.3 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.213 0 CA-C-O 121.049 0.452 . . . . 0.0 110.694 -176.852 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' F' F ' 132' ' ' ILE . . . . . . . . . . . . . 67.7 mt -120.55 133.42 67.29 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.242 0 CA-C-N 115.748 -0.66 . . . . 0.0 109.604 179.732 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' F' F ' 133' ' ' ILE . . . . . . . . . . . . . 40.5 mm -119.8 120.6 63.79 Favored 'Isoleucine or valine' 0 C--O 1.234 0.269 0 CA-C-O 120.876 0.37 . . . . 0.0 110.949 -177.294 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' F' F ' 134' ' ' ASP . . . . . . . . . . . . . 7.2 p-10 -134.16 146.9 50.62 Favored 'General case' 0 C--N 1.329 -0.285 0 N-CA-C 109.497 -0.556 . . . . 0.0 109.497 174.562 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' F' F ' 135' ' ' GLU . . . . . . . . . . . . . 52.6 tt0 -49.86 -25.96 3.62 Favored 'General case' 0 C--N 1.328 -0.358 0 N-CA-C 112.948 0.722 . . . . 0.0 112.948 -170.145 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' F' F ' 136' ' ' GLN . . . . . . . . . . . . . 60.8 tp60 -99.2 -31.2 11.85 Favored 'General case' 0 C--N 1.332 -0.183 0 N-CA-C 112.384 0.512 . . . . 0.0 112.384 -174.767 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' F' F ' 137' ' ' LYS . . . . . . . . . . . . . 89.4 mttt -139.85 153.9 47.16 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-O 121.214 0.53 . . . . 0.0 111.532 -170.515 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' F' F ' 138' ' ' LEU . . . . . . . . . . . . . 4.3 tt -121.37 126.85 50.43 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 115.625 -0.716 . . . . 0.0 109.32 174.171 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' F' F ' 139' ' ' THR . . . . . . . . . . . . . 31.8 m -116.67 134.21 55.09 Favored 'General case' 0 N--CA 1.462 0.144 0 CA-C-O 120.891 0.377 . . . . 0.0 111.385 -176.338 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' F' F ' 140' ' ' LEU . . . . . 0.417 HD12 HG22 ' F' ' 131' ' ' VAL . 24.0 tp -120.99 122.65 40.6 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 115.387 -0.824 . . . . 0.0 109.167 179.721 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' F' F ' 141' ' ' ILE . . . . . . . . . . . . . 19.2 mt -119.87 125.24 74.09 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.323 0 CA-C-O 120.974 0.416 . . . . 0.0 110.278 -175.638 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' F' F ' 142' ' ' ARG . . . . . . . . . . . . . 43.1 mtm180 -107.59 124.67 50.29 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 115.205 -0.907 . . . . 0.0 110.134 178.948 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' F' F ' 143' ' ' THR . . . . . . . . . . . . . 21.5 p . . . . . 0 C--O 1.221 -0.443 0 CA-C-O 117.991 -1.004 . . . . 0.0 110.584 179.852 . . . . . . . . 0 0 . 1 . 016 nuclear nobuild full ' A' A ' -3' ' ' GLU . . . . . . . . . . . . . 44.6 tp10 . . . . . 0 N--CA 1.491 1.597 0 N-CA-C 109.307 -0.627 . . . . 0.0 109.307 . . . . . . . . . 0 0 . 1 . 016 nuclear nobuild full ' A' A ' -2' ' ' GLY . . . . . . . . . . . . . . . -82.98 149.96 27.19 Favored Glycine 0 CA--C 1.525 0.687 0 N-CA-C 111.043 -0.823 . . . . 0.0 111.043 179.678 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' -1' ' ' VAL . . . . . . . . . . . . . 45.0 t -92.81 133.3 34.52 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.288 0 N-CA-C 109.932 -0.395 . . . . 0.0 109.932 179.531 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 0' ' ' ILE . . . . . . . . . . . . . 67.1 mt -115.4 135.27 55.95 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.261 0 CA-C-N 116.298 -0.41 . . . . 0.0 110.124 -178.57 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 25.9 ptt? -82.2 146.72 29.37 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.085 -0.507 . . . . 0.0 110.606 179.18 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 5.0 p -107.82 131.01 54.93 Favored 'General case' 0 C--N 1.331 -0.226 0 CA-C-O 120.932 0.396 . . . . 0.0 110.362 178.455 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 95.5 mt-10 -141.85 142.42 33.12 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.115 -0.493 . . . . 0.0 111.242 -178.061 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 4' ' ' LEU . . . . . . . . . . . . . 18.1 tp -124.32 124.45 42.41 Favored 'General case' 0 C--N 1.331 -0.218 0 CA-C-N 115.757 -0.656 . . . . 0.0 109.848 175.718 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 5' ' ' LYS . . . . . 0.401 ' HB3' HG21 ' A' ' 69' ' ' VAL . 98.0 mttt -105.09 120.55 41.79 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.65 -179.7 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 37.8 mt -115.37 148.81 38.86 Favored 'General case' 0 C--N 1.332 -0.183 0 CA-C-N 115.624 -0.716 . . . . 0.0 110.237 -178.414 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 21.3 ttpt -129.83 135.53 27.64 Favored Pre-proline 0 CA--C 1.534 0.339 0 CA-C-O 118.851 -0.595 . . . . 0.0 109.443 174.276 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 8' ' ' PRO . . . . . . . . . . . . . 76.8 Cg_endo -91.54 135.54 1.72 Allowed 'Trans proline' 0 N--CA 1.489 1.239 0 C-N-CA 121.694 1.596 . . . . 0.0 111.683 177.52 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 48.6 mt -72.15 -47.24 10.99 Favored Pre-proline 0 CA--C 1.533 0.309 0 CA-C-O 118.594 -0.717 . . . . 0.0 112.171 -178.988 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 83.4 Cg_endo -80.8 148.65 17.75 Favored 'Trans proline' 0 N--CA 1.496 1.666 0 C-N-CA 121.217 1.278 . . . . 0.0 111.753 175.905 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 51.2 tptt -85.2 96.05 9.36 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.466 -0.334 . . . . 0.0 110.275 179.234 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 12.5 p -142.52 149.65 18.98 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.243 0 CA-C-N 116.25 -0.432 . . . . 0.0 110.692 -178.326 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 83.1 tt0 -89.92 129.48 36.27 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-N 116.163 -0.471 . . . . 0.0 110.551 179.378 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 14' ' ' LEU . . . . . . . . . . . . . 48.3 mt -98.44 153.06 38.16 Favored Pre-proline 0 CA--C 1.532 0.282 0 CA-C-N 116.425 -0.352 . . . . 0.0 110.888 -178.872 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 15' ' ' PRO . . . . . . . . . . . . . 30.1 Cg_exo -61.19 159.88 28.78 Favored 'Trans proline' 0 N--CA 1.497 1.705 0 C-N-CA 121.356 1.371 . . . . 0.0 111.963 176.627 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 16' ' ' PRO . . . . . . . . . . . . . 31.6 Cg_exo -59.72 -42.17 48.8 Favored 'Trans proline' 0 N--CA 1.495 1.613 0 C-N-CA 121.475 1.45 . . . . 0.0 112.648 -179.068 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 17' ' ' ASP . . . . . . . . . . . . . 13.1 p-10 -84.13 11.65 7.72 Favored 'General case' 0 CA--C 1.535 0.383 0 N-CA-C 113.129 0.789 . . . . 0.0 113.129 -177.676 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 18' ' ' PHE . . . . . 0.466 ' HE1' HD13 ' A' ' 41' ' ' ILE . 31.2 t80 -57.12 -45.04 83.81 Favored 'General case' 0 N--CA 1.458 -0.074 0 O-C-N 121.917 -0.489 . . . . 0.0 110.433 -178.408 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 19' ' ' VAL . . . . . . . . . . . . . 48.0 t -57.06 -41.06 76.85 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.245 0 CA-C-N 116.371 -0.377 . . . . 0.0 110.534 -178.711 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 68.8 m-20 -59.79 -43.38 94.43 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-O 120.899 0.381 . . . . 0.0 110.703 -178.342 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 45.4 t -64.34 -46.56 92.77 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.321 0 CA-C-N 116.281 -0.418 . . . . 0.0 110.56 -178.231 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 22' ' ' ILE . . . . . 0.63 HG22 HD12 ' A' ' 26' ' ' LEU . 50.6 mm -55.11 -47.07 77.63 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.222 0 C-N-CA 120.99 -0.284 . . . . 0.0 110.828 179.272 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 23' ' ' ARG . . . . . . . . . . . . . 56.5 ttp180 -54.12 -50.03 67.82 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-O 120.697 0.284 . . . . 0.0 111.329 -179.021 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 24' ' ' ILE . . . . . . . . . . . . . 74.0 mt -58.91 -42.31 85.52 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.239 0 CA-C-N 116.432 -0.349 . . . . 0.0 111.25 -178.157 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 61.9 mtpt -67.76 -41.77 82.8 Favored 'General case' 0 C--N 1.328 -0.354 0 N-CA-C 112.404 0.52 . . . . 0.0 112.404 -177.405 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 26' ' ' LEU . . . . . 0.63 HD12 HG22 ' A' ' 22' ' ' ILE . 49.2 mt -79.43 -37.38 37.21 Favored 'General case' 0 C--N 1.33 -0.28 0 N-CA-C 113.368 0.877 . . . . 0.0 113.368 -169.495 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 27' ' ' GLN . . . . . . . . . . . . . 9.9 pt20 -46.84 136.19 8.39 Favored 'General case' 0 N--CA 1.47 0.553 0 N-CA-C 112.728 0.64 . . . . 0.0 112.728 -176.09 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 99.72 -23.99 33.94 Favored Glycine 0 CA--C 1.534 1.252 0 CA-C-N 115.624 -0.716 . . . . 0.0 112.448 -176.633 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 28.8 mtpp -97.91 155.17 17.2 Favored 'General case' 0 C--O 1.233 0.209 0 CA-C-N 117.344 0.572 . . . . 0.0 111.005 179.983 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 30' ' ' THR . . . . . . . . . . . . . 33.8 m -105.53 138.03 42.39 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.143 -0.481 . . . . 0.0 110.118 176.848 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 35.2 m -129.95 149.48 33.65 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.271 0 CA-C-O 121.018 0.437 . . . . 0.0 110.933 -179.27 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 32' ' ' ARG . . . . . . . . . . . . . 29.5 ttm105 -130.05 148.01 51.86 Favored 'General case' 0 C--N 1.331 -0.239 0 CA-C-N 115.905 -0.589 . . . . 0.0 110.233 178.9 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 33' ' ' THR . . . . . . . . . . . . . 25.4 m -52.24 138.07 27.08 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.397 -0.365 . . . . 0.0 111.496 -177.58 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 100.28 -17.1 57.41 Favored Glycine 0 CA--C 1.533 1.161 0 CA-C-O 119.649 -0.528 . . . . 0.0 113.288 178.862 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 72.6 m-20 -65.85 149.85 49.52 Favored 'General case' 0 C--O 1.231 0.128 0 CA-C-N 118.053 0.927 . . . . 0.0 111.199 -179.965 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 45.6 t -119.8 129.3 75.57 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.275 0 CA-C-N 115.904 -0.589 . . . . 0.0 109.701 177.548 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 37' ' ' ILE . . . . . . . . . . . . . 63.8 mt -120.0 137.24 54.49 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.266 0 CA-C-N 116.162 -0.472 . . . . 0.0 109.797 -179.647 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . -116.45 128.86 8.14 Favored Glycine 0 CA--C 1.525 0.672 0 N-CA-C 110.848 -0.901 . . . . 0.0 110.848 179.948 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 39' ' ' ILE . . . . . . . . . . . . . 68.3 mt -126.66 129.94 71.62 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.169 0 N-CA-C 110.056 -0.349 . . . . 0.0 110.056 179.238 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 40' ' ' SER . . . . . . . . . . . . . 16.8 p -91.31 119.0 30.98 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.1 -0.5 . . . . 0.0 110.4 175.49 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 41' ' ' ILE . . . . . 0.466 HD13 ' HE1' ' A' ' 18' ' ' PHE . 70.2 mt -127.26 113.74 33.5 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.197 0 N-CA-C 110.113 -0.329 . . . . 0.0 110.113 -179.546 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 7.8 mp 56.62 39.25 29.89 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-O 121.247 0.546 . . . . 0.0 110.913 179.184 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . 79.38 -10.23 37.33 Favored Glycine 0 CA--C 1.533 1.172 0 C-N-CA 121.252 -0.499 . . . . 0.0 113.653 175.952 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 44' ' ' LYS . . . . . . . . . . . . . 78.7 tttt -98.27 126.49 43.78 Favored 'General case' 0 C--N 1.333 -0.11 0 CA-C-N 117.913 0.856 . . . . 0.0 110.094 177.882 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 77.3 tt0 -84.9 127.45 34.16 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.372 -0.376 . . . . 0.0 111.081 -179.427 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 46' ' ' VAL . . . . . . . . . . . . . 10.9 p -123.07 125.18 71.73 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.187 0 N-CA-C 110.085 -0.339 . . . . 0.0 110.085 175.874 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 99.1 mttt -99.34 127.88 45.41 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.057 -0.52 . . . . 0.0 111.024 177.248 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 48' ' ' PHE . . . . . . . . . . . . . 34.2 m-85 -112.49 131.91 55.34 Favored 'General case' 0 C--N 1.33 -0.279 0 N-CA-C 109.605 -0.517 . . . . 0.0 109.605 176.913 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 85.9 tttt -105.07 134.36 48.29 Favored 'General case' 0 C--N 1.328 -0.363 0 N-CA-C 110.084 -0.339 . . . . 0.0 110.084 177.562 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 50' ' ' VAL . . . . . . . . . . . . . 43.2 t -77.84 105.09 6.41 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.371 0 N-CA-C 109.491 -0.559 . . . . 0.0 109.491 177.908 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 51' ' ' VAL . . . . . . . . . . . . . 46.9 t -72.88 -47.99 46.81 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.335 0 CA-C-N 116.018 -0.537 . . . . 0.0 110.075 -174.145 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 52' ' ' GLN . . . . . . . . . . . . . 44.4 tt0 -158.44 135.53 9.91 Favored 'General case' 0 C--N 1.33 -0.27 0 C-N-CA 120.274 -0.571 . . . . 0.0 111.796 -177.954 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 53' ' ' ALA . . . . . 0.613 ' HB3' ' OG ' ' A' ' 56' ' ' SER . . . -110.23 129.44 55.72 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 115.839 -0.619 . . . . 0.0 109.649 175.032 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 54' ' ' TYR . . . . . . . . . . . . . 60.2 t80 -129.03 106.64 18.02 Favored Pre-proline 0 CA--C 1.535 0.378 0 CA-C-O 118.373 -0.823 . . . . 0.0 110.546 -178.437 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 55' ' ' PRO . . . . . . . . . . . . . 73.0 Cg_endo -77.13 168.94 75.59 Favored 'Cis proline' 0 N--CA 1.499 1.81 0 CA-C-N 121.67 1.632 . . . . 0.0 112.458 -5.766 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 56' ' ' SER . . . . . 0.613 ' OG ' ' HB3' ' A' ' 53' ' ' ALA . 74.3 m -118.01 134.42 23.31 Favored Pre-proline 0 CA--C 1.539 0.556 0 CA-C-O 118.486 -0.769 . . . . 0.0 109.473 174.494 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 57' ' ' PRO . . . . . . . . . . . . . 51.7 Cg_endo -70.78 146.98 85.78 Favored 'Cis proline' 0 N--CA 1.497 1.699 0 CA-C-N 121.88 1.707 . . . . 0.0 111.347 -1.911 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 58' ' ' LEU . . . . . . . . . . . . . 20.6 tp -108.0 136.3 47.93 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 116.39 -0.368 . . . . 0.0 110.86 -177.944 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 59' ' ' ARG . . . . . . . . . . . . . 55.8 ttp180 -104.31 117.94 35.42 Favored 'General case' 0 C--N 1.327 -0.389 0 N-CA-C 109.052 -0.721 . . . . 0.0 109.052 174.018 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 42.4 t -71.55 122.13 23.08 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.353 0 CA-C-N 116.353 -0.385 . . . . 0.0 110.698 -173.114 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 95.4 mt-10 -131.07 165.32 23.51 Favored 'General case' 0 C--N 1.331 -0.225 0 CA-C-N 115.795 -0.639 . . . . 0.0 110.033 177.28 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 62' ' ' ASP . . . . . . . . . . . . . 14.9 m-20 -55.19 -32.68 62.39 Favored 'General case' 0 C--N 1.329 -0.315 0 N-CA-C 111.758 0.281 . . . . 0.0 111.758 -179.252 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 63' ' ' ARG . . . . . . . . . . . . . 17.6 ptm180 -81.35 6.56 13.99 Favored 'General case' 0 CA--C 1.535 0.399 0 N-CA-C 113.524 0.935 . . . . 0.0 113.524 -176.512 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 34.4 m -91.41 136.16 33.31 Favored 'General case' 0 C--O 1.232 0.147 0 CA-C-N 118.26 0.482 . . . . 0.0 110.751 -179.754 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 65' ' ' LYS . . . . . . . . . . . . . 68.7 mttm -89.51 135.42 33.61 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.005 -0.543 . . . . 0.0 110.319 179.473 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 66' ' ' ILE . . . . . 0.475 HD12 ' N ' ' A' ' 66' ' ' ILE . 4.3 mp -116.45 127.42 74.06 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.282 0 N-CA-C 109.552 -0.536 . . . . 0.0 109.552 178.76 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 67' ' ' THR . . . . . . . . . . . . . 25.0 m -131.38 148.66 52.68 Favored 'General case' 0 N--CA 1.464 0.237 0 CA-C-O 121.137 0.494 . . . . 0.0 111.944 -175.376 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 68' ' ' LEU . . . . . 0.425 ' N ' HD12 ' A' ' 68' ' ' LEU . 8.5 mp -95.19 129.28 42.36 Favored 'General case' 0 C--N 1.331 -0.219 0 CA-C-N 115.629 -0.714 . . . . 0.0 109.909 175.356 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 69' ' ' VAL . . . . . 0.401 HG21 ' HB3' ' A' ' 5' ' ' LYS . 43.1 t -103.18 143.38 15.42 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.272 0 CA-C-O 120.873 0.368 . . . . 0.0 110.957 -176.935 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 70' ' ' THR . . . . . . . . . . . . . 12.0 m -84.85 130.94 34.58 Favored 'General case' 0 C--N 1.33 -0.27 0 N-CA-C 108.9 -0.778 . . . . 0.0 108.9 172.645 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 71' ' ' HIS . . . . . . . . . . . . . 1.8 m80 -135.44 174.94 4.0 Favored Pre-proline 0 CA--C 1.537 0.457 0 C-N-CA 121.049 -0.261 . . . . 0.0 111.367 -171.515 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 72' ' ' PRO . . . . . . . . . . . . . 22.5 Cg_exo -64.84 160.24 41.87 Favored 'Trans proline' 0 N--CA 1.496 1.632 0 C-N-CA 121.974 1.783 . . . . 0.0 112.671 -179.667 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 73' ' ' VAL . . . . . . . . . . . . . 33.0 m -69.72 -170.61 0.07 OUTLIER 'Isoleucine or valine' 0 C--N 1.33 -0.272 0 CA-C-N 115.767 -0.651 . . . . 0.0 110.481 -174.93 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 74' ' ' ASP . . . . . . . . . . . . . 13.3 t70 -77.17 118.77 20.02 Favored 'General case' 0 C--N 1.329 -0.316 0 C-N-CA 121.01 -0.276 . . . . 0.0 110.432 -170.146 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 75' ' ' VAL . . . . . 0.417 ' C ' HD12 ' A' ' 76' ' ' LEU . 41.4 t -124.91 124.11 67.08 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.206 0 CA-C-O 121.141 0.496 . . . . 0.0 110.691 -176.481 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 76' ' ' LEU . . . . . 0.417 HD12 ' C ' ' A' ' 75' ' ' VAL . 6.4 mp -122.1 150.14 42.58 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 115.586 -0.734 . . . . 0.0 109.22 173.841 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 77' ' ' GLU . . . . . . . . . . . . . 97.0 mt-10 -137.86 137.07 37.74 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-O 121.126 0.489 . . . . 0.0 111.237 -178.073 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 78' ' ' ALA . . . . . 0.485 ' HB2' HD21 ' A' ' 109' ' ' LEU . . . -125.06 129.61 50.6 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 115.708 -0.678 . . . . 0.0 109.532 175.803 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 79' ' ' LYS . . . . . 0.695 ' O ' HD13 ' A' ' 80' ' ' ILE . 39.2 ttpt -73.69 120.15 18.89 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-O 120.795 0.331 . . . . 0.0 110.575 -177.848 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 80' ' ' ILE . . . . . 0.695 HD13 ' O ' ' A' ' 79' ' ' LYS . 25.9 mm -139.34 98.48 1.15 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.326 0 N-CA-C 109.268 -0.642 . . . . 0.0 109.268 -178.238 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 81' ' ' LYS . . . . . . . . . . . . . 56.2 mtmt -95.75 127.22 41.59 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-O 120.982 0.42 . . . . 0.0 110.97 -177.896 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . 89.18 42.08 5.67 Favored Glycine 0 CA--C 1.525 0.675 0 N-CA-C 111.566 -0.614 . . . . 0.0 111.566 176.43 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 83' ' ' ILE . . . . . . . . . . . . . 69.0 mt -67.26 137.86 23.94 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.289 0 N-CA-C 109.657 -0.497 . . . . 0.0 109.657 176.871 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 84' ' ' LYS . . . . . . . . . . . . . 54.5 tttp -95.46 -49.91 5.22 Favored 'General case' 0 C--N 1.327 -0.395 0 CA-C-N 116.15 -0.477 . . . . 0.0 109.868 -179.031 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 85' ' ' ASP . . . . . . . . . . . . . 10.4 t70 -159.16 149.95 19.77 Favored 'General case' 0 C--N 1.327 -0.401 0 CA-C-N 115.589 -0.732 . . . . 0.0 110.239 178.605 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 86' ' ' VAL . . . . . . . . . . . . . 42.1 t -130.12 131.32 65.94 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.275 0 CA-C-O 120.898 0.38 . . . . 0.0 110.237 179.241 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 87' ' ' ILE . . . . . 0.49 HD12 ' N ' ' A' ' 87' ' ' ILE . 5.1 mp -119.07 129.01 75.77 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.281 0 CA-C-N 115.89 -0.596 . . . . 0.0 109.395 178.383 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 88' ' ' LEU . . . . . . . . . . . . . 13.3 tp -118.58 133.24 56.01 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-O 121.069 0.461 . . . . 0.0 111.302 -176.078 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 89' ' ' ASP . . . . . . . . . . . . . 12.8 t70 -130.92 159.03 38.63 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 115.637 -0.71 . . . . 0.0 109.38 175.109 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 95.8 mt-10 -47.41 -37.69 11.92 Favored 'General case' 0 C--N 1.33 -0.241 0 N-CA-C 113.029 0.751 . . . . 0.0 113.029 -172.362 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 91' ' ' ASN . . . . . . . . . . . . . 69.7 m-80 -132.11 36.38 3.65 Favored 'General case' 0 N--CA 1.464 0.235 0 N-CA-C 111.877 0.325 . . . . 0.0 111.877 -175.443 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 92' ' ' LEU . . . . . . . . . . . . . 19.3 tp -166.07 139.68 4.26 Favored 'General case' 0 C--N 1.332 -0.181 0 C-N-CA 120.836 -0.346 . . . . 0.0 110.99 -179.288 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 93' ' ' ILE . . . . . . . . . . . . . 68.9 mt -126.27 118.03 50.22 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.164 0 N-CA-C 109.089 -0.708 . . . . 0.0 109.089 177.625 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 94' ' ' VAL . . . . . . . . . . . . . 42.9 t -120.25 127.0 75.87 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.289 0 N-CA-C 109.903 -0.406 . . . . 0.0 109.903 -179.004 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 95' ' ' VAL . . . . . . . . . . . . . 42.7 t -120.89 134.04 65.6 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.311 0 CA-C-N 116.131 -0.486 . . . . 0.0 109.983 -179.435 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 96' ' ' ILE . . . . . . . . . . . . . 57.5 mt -115.42 127.62 72.92 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.324 0 N-CA-C 109.155 -0.683 . . . . 0.0 109.155 178.105 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 97' ' ' THR . . . . . . . . . . . . . 59.4 p -101.95 153.31 19.98 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-O 121.015 0.436 . . . . 0.0 110.955 -177.752 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 98' ' ' GLU . . . . . . . . . . . . . 96.4 mt-10 -53.9 -23.4 12.62 Favored 'General case' 0 CA--C 1.534 0.36 0 N-CA-C 112.297 0.481 . . . . 0.0 112.297 179.426 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 99' ' ' GLU . . . . . . . . . . . . . 95.0 mt-10 -78.79 15.27 1.1 Allowed 'General case' 0 CA--C 1.536 0.419 0 N-CA-C 113.121 0.785 . . . . 0.0 113.121 -177.536 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 100' ' ' ASN . . . . . . . . . . . . . 3.6 m-20 64.01 38.07 8.86 Favored 'General case' 0 N--CA 1.463 0.188 0 CA-C-O 120.972 0.415 . . . . 0.0 110.965 177.435 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 101' ' ' GLU . . . . . . . . . . . . . 83.4 tt0 -119.22 142.82 47.68 Favored 'General case' 0 C--N 1.332 -0.165 0 CA-C-N 116.177 -0.465 . . . . 0.0 109.876 176.551 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 102' ' ' VAL . . . . . . . . . . . . . 45.5 t -115.77 126.46 73.31 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.283 0 CA-C-N 116.117 -0.492 . . . . 0.0 109.759 -178.845 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 103' ' ' LEU . . . . . . . . . . . . . 46.6 mt -120.48 132.41 55.19 Favored 'General case' 0 C--N 1.331 -0.202 0 CA-C-N 115.992 -0.549 . . . . 0.0 110.517 178.313 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 104' ' ' ILE . . . . . . . . . . . . . 67.7 mt -118.95 122.43 69.33 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.256 0 CA-C-N 116.332 -0.395 . . . . 0.0 110.324 -178.48 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 105' ' ' PHE . . . . . . . . . . . . . 85.8 m-85 -123.99 165.06 18.1 Favored 'General case' 0 C--O 1.232 0.17 0 O-C-N 123.895 0.747 . . . . 0.0 109.892 -179.527 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 106' ' ' ASN . . . . . . . . . . . . . 46.8 p-10 -100.63 -171.36 2.0 Favored 'General case' 0 C--N 1.331 -0.21 0 N-CA-C 109.742 -0.466 . . . . 0.0 109.742 172.665 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 107' ' ' GLN . . . . . . . . . . . . . 29.4 tt0 -61.09 -29.85 70.0 Favored 'General case' 0 C--N 1.329 -0.285 0 N-CA-C 111.974 0.361 . . . . 0.0 111.974 -178.642 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 108' ' ' ASN . . . . . . . . . . . . . 3.8 t-20 -83.54 10.69 8.44 Favored 'General case' 0 CA--C 1.537 0.457 0 N-CA-C 113.014 0.746 . . . . 0.0 113.014 -178.303 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 109' ' ' LEU . . . . . 0.485 HD21 ' HB2' ' A' ' 78' ' ' ALA . 7.6 tp 57.72 37.72 27.32 Favored 'General case' 0 CA--C 1.529 0.172 0 CA-C-O 121.206 0.527 . . . . 0.0 111.341 179.277 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 110' ' ' GLU . . . . . . . . . . . . . 70.8 mm-40 -103.93 142.7 33.97 Favored 'General case' 0 C--N 1.33 -0.266 0 N-CA-C 109.33 -0.619 . . . . 0.0 109.33 174.071 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 111' ' ' GLU . . . . . . . . . . . . . 48.6 tt0 -79.14 121.94 25.63 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-N 116.454 -0.339 . . . . 0.0 110.893 -176.062 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 112' ' ' LEU . . . . . . . . . . . . . 44.1 mt -102.93 -46.12 4.76 Favored 'General case' 0 C--N 1.33 -0.239 0 CA-C-N 116.128 -0.487 . . . . 0.0 110.515 179.589 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 113' ' ' TYR . . . . . . . . . . . . . 63.9 t80 -140.59 145.02 36.17 Favored 'General case' 0 C--N 1.332 -0.182 0 CA-C-N 116.397 -0.365 . . . . 0.0 111.061 -179.682 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 114' ' ' ARG . . . . . . . . . . . . . 39.0 ptt180 -144.59 126.7 15.58 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.085 -0.507 . . . . 0.0 110.462 178.807 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 115' ' ' GLY . . . . . . . . . . . . . . . -150.05 150.75 22.85 Favored Glycine 0 CA--C 1.524 0.602 0 C-N-CA 120.682 -0.77 . . . . 0.0 111.192 179.654 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 116' ' ' LYS . . . . . . . . . . . . . 27.5 ttpp -123.45 135.77 54.26 Favored 'General case' 0 C--N 1.33 -0.274 0 N-CA-C 109.687 -0.486 . . . . 0.0 109.687 177.27 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 117' ' ' PHE . . . . . . . . . . . . . 36.2 m-85 -134.07 113.92 12.62 Favored 'General case' 0 C--N 1.33 -0.262 0 N-CA-C 110.037 -0.357 . . . . 0.0 110.037 -177.291 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 118' ' ' GLU . . . . . . . . . . . . . 83.5 tt0 -55.09 -44.72 75.16 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.383 -0.371 . . . . 0.0 111.185 -177.123 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 119' ' ' ASN . . . . . . . . . . . . . 85.2 m-20 -95.48 30.99 2.1 Favored 'General case' 0 C--N 1.33 -0.264 0 N-CA-C 112.214 0.45 . . . . 0.0 112.214 -175.649 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 120' ' ' LEU . . . . . . . . . . . . . 24.8 tp -57.63 122.16 12.08 Favored 'General case' 0 C--N 1.333 -0.132 0 N-CA-C 110.141 -0.318 . . . . 0.0 110.141 176.656 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 121' ' ' ASN . . . . . . . . . . . . . 61.5 m-20 -114.05 -43.99 3.19 Favored 'General case' 0 C--N 1.332 -0.187 0 CA-C-N 116.647 -0.251 . . . . 0.0 110.998 -176.773 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 122' ' ' LYS . . . . . . . . . . . . . 98.1 mttt -145.91 150.87 36.91 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-O 121.061 0.457 . . . . 0.0 111.505 -177.596 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 123' ' ' VAL . . . . . . . . . . . . . 43.5 t -128.75 131.16 68.72 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.253 0 CA-C-N 115.955 -0.566 . . . . 0.0 109.695 176.516 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 124' ' ' LEU . . . . . . . . . . . . . 34.0 mt -121.76 128.75 52.1 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.277 -0.419 . . . . 0.0 110.16 -179.547 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 125' ' ' VAL . . . . . 0.459 ' CG2' HG21 ' A' ' 87' ' ' ILE . 35.6 m -140.07 141.45 33.71 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 CA-C-O 120.862 0.363 . . . . 0.0 110.81 179.688 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 126' ' ' ARG . . . . . . . . . . . . . 51.0 ttp180 -161.29 129.66 4.4 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.07 -0.514 . . . . 0.0 110.622 177.502 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 127' ' ' ASN . . . . . . . . . . . . . 6.1 m120 52.77 -111.24 0.58 Allowed 'General case' 0 CA--C 1.544 0.741 0 CA-C-O 118.871 -0.585 . . . . 0.0 111.024 179.347 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 128' ' ' ASP . . . . . . . . . . . . . 11.9 p-10 -114.04 12.21 17.89 Favored 'General case' 0 N--CA 1.466 0.337 0 CA-C-N 119.892 1.224 . . . . 0.0 113.244 -177.747 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 129' ' ' LEU . . . . . . . . . . . . . 30.5 mt -107.7 134.11 51.15 Favored 'General case' 0 C--N 1.333 -0.147 0 O-C-N 121.968 -0.457 . . . . 0.0 110.136 178.013 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 130' ' ' VAL . . . . . . . . . . . . . 45.5 t -125.08 131.02 73.03 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.229 0 N-CA-C 109.58 -0.526 . . . . 0.0 109.58 178.759 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 131' ' ' VAL . . . . . 0.523 HG22 HD12 ' A' ' 140' ' ' LEU . 42.2 t -135.61 133.81 51.75 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.307 0 CA-C-O 120.999 0.428 . . . . 0.0 110.192 178.514 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 132' ' ' ILE . . . . . . . . . . . . . 74.6 mt -114.48 130.63 68.47 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.378 0 CA-C-N 115.81 -0.632 . . . . 0.0 109.308 179.44 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 133' ' ' ILE . . . . . . . . . . . . . 42.9 mm -114.56 119.24 60.96 Favored 'Isoleucine or valine' 0 C--O 1.234 0.263 0 CA-C-O 120.874 0.368 . . . . 0.0 110.748 -175.353 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 134' ' ' ASP . . . . . . . . . . . . . 9.6 p-10 -133.94 147.95 51.12 Favored 'General case' 0 C--N 1.331 -0.225 0 N-CA-C 109.678 -0.489 . . . . 0.0 109.678 176.282 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 135' ' ' GLU . . . . . . . . . . . . . 78.8 tt0 -49.9 -27.84 5.81 Favored 'General case' 0 C--N 1.328 -0.368 0 N-CA-C 112.833 0.679 . . . . 0.0 112.833 -173.698 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 136' ' ' GLN . . . . . . . . . . . . . 48.2 tt0 -79.05 -37.39 39.11 Favored 'General case' 0 C--O 1.233 0.229 0 N-CA-C 111.973 0.361 . . . . 0.0 111.973 -176.064 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 137' ' ' LYS . . . . . . . . . . . . . 51.8 pttt -166.32 175.46 8.22 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-O 121.689 0.756 . . . . 0.0 112.197 -171.129 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 138' ' ' LEU . . . . . 0.41 HD23 ' N ' ' A' ' 139' ' ' THR . 4.8 tt -119.46 128.45 54.02 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 114.877 -1.056 . . . . 0.0 109.757 178.7 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 139' ' ' THR . . . . . 0.41 ' N ' HD23 ' A' ' 138' ' ' LEU . 19.5 m -109.12 124.08 50.23 Favored 'General case' 0 C--N 1.331 -0.205 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.598 -179.496 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 140' ' ' LEU . . . . . 0.523 HD12 HG22 ' A' ' 131' ' ' VAL . 48.0 tp -112.09 120.43 41.82 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 115.982 -0.554 . . . . 0.0 109.574 -179.166 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 141' ' ' ILE . . . . . . . . . . . . . 19.1 mt -122.95 120.65 61.18 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.278 0 CA-C-O 120.993 0.425 . . . . 0.0 110.088 -176.198 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 142' ' ' ARG . . . . . . . . . . . . . 22.3 mtp-105 -97.59 121.23 39.25 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 115.463 -0.79 . . . . 0.0 109.976 176.49 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 143' ' ' THR . . . . . . . . . . . . . 48.2 p . . . . . 0 C--O 1.22 -0.459 0 CA-C-O 118.051 -0.976 . . . . 0.0 110.423 179.339 . . . . . . . . 0 0 . 1 . 016 nuclear nobuild full ' B' B ' -3' ' ' GLU . . . . . . . . . . . . . 96.0 mt-10 . . . . . 0 N--CA 1.49 1.542 0 N-CA-C 109.416 -0.587 . . . . 0.0 109.416 . . . . . . . . . 0 0 . 1 . 016 nuclear nobuild full ' B' B ' -2' ' ' GLY . . . . . . . . . . . . . . . -77.77 149.97 35.52 Favored Glycine 0 CA--C 1.525 0.701 0 N-CA-C 110.895 -0.882 . . . . 0.0 110.895 179.411 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' B' B ' -1' ' ' VAL . . . . . . . . . . . . . 44.9 t -88.08 131.05 36.66 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.277 0 CA-C-O 120.887 0.375 . . . . 0.0 110.252 -179.695 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' B' B ' 0' ' ' ILE . . . . . . . . . . . . . 72.6 mt -119.78 136.67 56.15 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.252 0 CA-C-N 116.003 -0.544 . . . . 0.0 109.79 179.532 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' B' B ' 1' ' ' MET . . . . . . . . . . . . . 25.4 ptp -78.13 134.65 37.65 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-O 121.012 0.434 . . . . 0.0 111.236 -177.614 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' B' B ' 2' ' ' SER . . . . . . . . . . . . . 2.3 p -131.02 125.18 32.61 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-N 115.918 -0.583 . . . . 0.0 110.017 177.271 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' B' B ' 3' ' ' GLU . . . . . . . . . . . . . 81.3 tt0 -140.94 142.46 34.36 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-N 116.172 -0.467 . . . . 0.0 111.158 -176.266 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' B' B ' 4' ' ' LEU . . . . . . . . . . . . . 11.4 tp -123.6 130.95 53.43 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 115.946 -0.57 . . . . 0.0 109.744 176.298 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' B' B ' 5' ' ' LYS . . . . . . . . . . . . . 91.5 mttt -110.87 121.43 45.33 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 116.31 -0.405 . . . . 0.0 110.729 -178.307 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' B' B ' 6' ' ' LEU . . . . . . . . . . . . . 55.9 mt -116.54 151.27 36.51 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 115.569 -0.741 . . . . 0.0 110.653 -178.856 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' B' B ' 7' ' ' LYS . . . . . . . . . . . . . 59.1 tttt -139.04 135.42 17.46 Favored Pre-proline 0 CA--C 1.535 0.396 0 CA-C-O 118.966 -0.54 . . . . 0.0 110.152 175.936 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' B' B ' 8' ' ' PRO . . . . . . . . . . . . . 94.7 Cg_endo -92.04 144.79 2.89 Favored 'Trans proline' 0 N--CA 1.49 1.274 0 C-N-CA 121.814 1.676 . . . . 0.0 111.632 177.359 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' B' B ' 9' ' ' LEU . . . . . . . . . . . . . 47.3 mt -86.54 -47.91 0.52 Allowed Pre-proline 0 CA--C 1.534 0.345 0 CA-C-O 118.701 -0.666 . . . . 0.0 112.646 -177.981 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' B' B ' 10' ' ' PRO . . . . . . . . . . . . . 97.3 Cg_endo -81.91 160.77 18.54 Favored 'Trans proline' 0 N--CA 1.495 1.616 0 C-N-CA 121.421 1.414 . . . . 0.0 112.063 177.802 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' B' B ' 11' ' ' LYS . . . . . . . . . . . . . 52.5 pttt -85.67 121.67 28.67 Favored 'General case' 0 C--N 1.331 -0.196 0 CA-C-O 120.953 0.406 . . . . 0.0 110.377 178.145 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' B' B ' 12' ' ' VAL . . . . . . . . . . . . . 12.5 p -151.09 144.81 16.7 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.251 0 CA-C-N 116.226 -0.443 . . . . 0.0 110.705 -179.971 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' B' B ' 13' ' ' GLU . . . . . . . . . . . . . 81.4 tt0 -91.88 108.98 20.32 Favored 'General case' 0 C--N 1.329 -0.325 0 N-CA-C 109.718 -0.475 . . . . 0.0 109.718 176.263 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' B' B ' 14' ' ' LEU . . . . . . . . . . . . . 81.2 mt -84.44 143.41 41.56 Favored Pre-proline 0 CA--C 1.534 0.343 0 CA-C-O 119.168 -0.444 . . . . 0.0 110.666 -175.923 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' B' B ' 15' ' ' PRO . . . . . . . . . . . . . 24.8 Cg_exo -63.06 163.33 22.97 Favored 'Trans proline' 0 N--CA 1.497 1.703 0 C-N-CA 121.301 1.334 . . . . 0.0 111.879 175.608 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' B' B ' 16' ' ' PRO . . . . . . . . . . . . . 29.6 Cg_exo -60.17 -39.17 71.28 Favored 'Trans proline' 0 N--CA 1.496 1.671 0 C-N-CA 121.478 1.452 . . . . 0.0 112.846 -178.105 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' B' B ' 17' ' ' ASP . . . . . . . . . . . . . 20.1 p-10 -90.74 12.5 18.96 Favored 'General case' 0 CA--C 1.536 0.423 0 N-CA-C 113.161 0.8 . . . . 0.0 113.161 -176.814 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' B' B ' 18' ' ' PHE . . . . . . . . . . . . . 33.9 t80 -56.21 -46.0 79.66 Favored 'General case' 0 C--N 1.334 -0.104 0 O-C-N 121.937 -0.477 . . . . 0.0 110.671 -178.364 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' B' B ' 19' ' ' VAL . . . . . . . . . . . . . 46.6 t -55.48 -43.54 72.64 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.277 0 CA-C-N 116.61 -0.268 . . . . 0.0 110.858 -177.931 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' B' B ' 20' ' ' ASP . . . . . . . . . . . . . 50.7 m-20 -60.01 -43.79 94.99 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-O 120.988 0.423 . . . . 0.0 111.017 -177.682 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' B' B ' 21' ' ' VAL . . . . . . . . . . . . . 45.1 t -64.38 -46.6 92.54 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.259 0 CA-C-N 116.401 -0.363 . . . . 0.0 110.573 -177.554 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' B' B ' 22' ' ' ILE . . . . . 0.45 HG22 HD12 ' B' ' 26' ' ' LEU . 50.7 mm -56.27 -44.5 79.7 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.206 0 C-N-CA 120.926 -0.31 . . . . 0.0 110.564 178.678 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' B' B ' 23' ' ' ARG . . . . . . . . . . . . . 55.7 ttp180 -53.36 -48.08 68.85 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-O 120.722 0.296 . . . . 0.0 111.396 -179.76 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' B' B ' 24' ' ' ILE . . . . . . . . . . . . . 71.4 mt -58.97 -44.53 91.27 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.251 0 CA-C-N 116.496 -0.32 . . . . 0.0 110.938 -179.228 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' B' B ' 25' ' ' LYS . . . . . . . . . . . . . 53.0 mttm -65.59 -35.27 80.33 Favored 'General case' 0 C--N 1.327 -0.404 0 N-CA-C 112.3 0.482 . . . . 0.0 112.3 -178.051 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' B' B ' 26' ' ' LEU . . . . . 0.45 HD12 HG22 ' B' ' 22' ' ' ILE . 56.1 mt -80.01 -46.02 17.36 Favored 'General case' 0 C--N 1.329 -0.31 0 N-CA-C 112.943 0.72 . . . . 0.0 112.943 -172.896 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' B' B ' 27' ' ' GLN . . . . . . . . . . . . . 11.2 pt20 -46.56 138.74 5.63 Favored 'General case' 0 N--CA 1.468 0.464 0 N-CA-C 112.677 0.621 . . . . 0.0 112.677 -174.909 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' B' B ' 28' ' ' GLY . . . . . . . . . . . . . . . 100.09 -24.92 30.24 Favored Glycine 0 CA--C 1.533 1.195 0 CA-C-N 115.599 -0.728 . . . . 0.0 112.412 -177.869 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' B' B ' 29' ' ' LYS . . . . . . . . . . . . . 67.9 mttm -97.72 155.08 17.18 Favored 'General case' 0 C--N 1.331 -0.198 0 CA-C-N 117.402 0.601 . . . . 0.0 111.145 179.656 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' B' B ' 30' ' ' THR . . . . . . . . . . . . . 28.9 m -106.04 133.34 50.9 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 115.861 -0.609 . . . . 0.0 109.778 175.008 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' B' B ' 31' ' ' VAL . . . . . . . . . . . . . 35.2 m -128.63 156.1 40.86 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.214 0 CA-C-N 116.437 -0.347 . . . . 0.0 110.693 -178.619 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' B' B ' 32' ' ' ARG . . . . . . . . . . . . . 72.2 ttt180 -132.73 148.03 52.33 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.036 -0.529 . . . . 0.0 110.351 178.929 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' B' B ' 33' ' ' THR . . . . . . . . . . . . . 19.6 m -52.64 138.09 29.27 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-O 120.858 0.361 . . . . 0.0 111.396 -178.25 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' B' B ' 34' ' ' GLY . . . . . . . . . . . . . . . 102.13 -17.24 54.51 Favored Glycine 0 CA--C 1.534 1.23 0 CA-C-N 116.074 -0.512 . . . . 0.0 113.235 179.286 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' B' B ' 35' ' ' ASP . . . . . . . . . . . . . 78.6 m-20 -66.91 151.17 48.09 Favored 'General case' 0 N--CA 1.462 0.158 0 CA-C-N 117.972 0.886 . . . . 0.0 111.052 178.715 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' B' B ' 36' ' ' VAL . . . . . . . . . . . . . 44.4 t -124.25 132.73 70.91 Favored 'Isoleucine or valine' 0 C--N 1.333 -0.145 0 CA-C-N 115.959 -0.564 . . . . 0.0 109.902 178.234 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' B' B ' 37' ' ' ILE . . . . . . . . . . . . . 68.5 mt -119.66 140.16 44.58 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.189 0 CA-C-N 116.063 -0.517 . . . . 0.0 109.96 -179.258 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' B' B ' 38' ' ' GLY . . . . . . . . . . . . . . . -116.95 128.84 8.07 Favored Glycine 0 CA--C 1.525 0.714 0 N-CA-C 111.043 -0.823 . . . . 0.0 111.043 179.598 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' B' B ' 39' ' ' ILE . . . . . . . . . . . . . 76.9 mt -128.89 139.68 51.26 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.248 0 N-CA-C 110.147 -0.316 . . . . 0.0 110.147 179.245 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' B' B ' 40' ' ' SER . . . . . . . . . . . . . 53.7 p -93.22 126.01 38.12 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.263 -0.426 . . . . 0.0 110.863 175.26 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' B' B ' 41' ' ' ILE . . . . . . . . . . . . . 68.6 mt -134.99 113.94 16.62 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.247 0 CA-C-O 120.826 0.346 . . . . 0.0 110.534 177.702 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' B' B ' 42' ' ' LEU . . . . . 0.516 ' O ' HD23 ' B' ' 42' ' ' LEU . 1.5 tt 56.33 47.84 18.3 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-O 121.52 0.676 . . . . 0.0 110.358 177.604 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' B' B ' 43' ' ' GLY . . . . . . . . . . . . . . . 72.2 -5.49 14.05 Favored Glycine 0 CA--C 1.536 1.351 0 C-N-CA 121.162 -0.542 . . . . 0.0 113.724 175.118 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' B' B ' 44' ' ' LYS . . . . . . . . . . . . . 80.6 tttt -108.85 135.04 50.71 Favored 'General case' 0 C--N 1.332 -0.181 0 CA-C-N 118.049 0.924 . . . . 0.0 110.19 -179.212 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' B' B ' 45' ' ' GLU . . . . . . . . . . . . . 84.1 tt0 -83.73 130.65 34.95 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-N 116.458 -0.337 . . . . 0.0 111.079 -179.075 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' B' B ' 46' ' ' VAL . . . . . . . . . . . . . 7.3 p -124.04 125.06 70.25 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.189 0 CA-C-O 121.002 0.43 . . . . 0.0 109.875 175.616 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' B' B ' 47' ' ' LYS . . . . . . . . . . . . . 91.9 mttt -100.08 131.46 46.02 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 115.951 -0.568 . . . . 0.0 111.031 176.529 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' B' B ' 48' ' ' PHE . . . . . . . . . . . . . 94.6 m-85 -113.08 131.88 55.64 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.057 -0.52 . . . . 0.0 109.644 175.341 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' B' B ' 49' ' ' LYS . . . . . . . . . . . . . 76.1 tttt -107.22 135.46 48.71 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.605 -0.27 . . . . 0.0 110.302 178.094 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' B' B ' 50' ' ' VAL . . . . . . . . . . . . . 43.9 t -81.16 107.48 13.48 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.315 0 N-CA-C 109.219 -0.66 . . . . 0.0 109.219 176.268 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' B' B ' 51' ' ' VAL . . . . . . . . . . . . . 40.4 t -74.88 -49.65 28.29 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.337 0 CA-C-N 115.982 -0.554 . . . . 0.0 110.14 -172.716 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' B' B ' 52' ' ' GLN . . . . . . . . . . . . . 85.8 mt-30 -154.34 152.98 30.87 Favored 'General case' 0 C--N 1.331 -0.199 0 C-N-CA 120.449 -0.5 . . . . 0.0 111.797 -177.304 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' B' B ' 53' ' ' ALA . . . . . 0.413 ' HB3' ' OG ' ' B' ' 56' ' ' SER . . . -130.35 130.5 44.51 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 115.339 -0.846 . . . . 0.0 109.643 175.016 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' B' B ' 54' ' ' TYR . . . . . . . . . . . . . 19.1 t80 -129.13 105.91 17.95 Favored Pre-proline 0 CA--C 1.534 0.357 0 CA-C-O 118.357 -0.83 . . . . 0.0 110.464 -179.572 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' B' B ' 55' ' ' PRO . . . . . . . . . . . . . 73.8 Cg_endo -77.2 170.06 72.49 Favored 'Cis proline' 0 N--CA 1.5 1.912 0 CA-C-N 121.673 1.633 . . . . 0.0 112.474 -5.98 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' B' B ' 56' ' ' SER . . . . . 0.413 ' OG ' ' HB3' ' B' ' 53' ' ' ALA . 36.0 m -116.42 134.16 22.89 Favored Pre-proline 0 CA--C 1.539 0.524 0 CA-C-O 118.461 -0.781 . . . . 0.0 109.606 175.17 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' B' B ' 57' ' ' PRO . . . . . . . . . . . . . 36.2 Cg_endo -67.07 166.53 62.35 Favored 'Cis proline' 0 N--CA 1.497 1.732 0 CA-C-N 121.856 1.698 . . . . 0.0 111.349 -3.727 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' B' B ' 58' ' ' LEU . . . . . . . . . . . . . 31.4 tp -130.77 138.04 49.75 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.239 -0.437 . . . . 0.0 110.512 -179.324 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' B' B ' 59' ' ' ARG . . . . . . . . . . . . . 59.8 ttm-85 -105.47 127.34 52.95 Favored 'General case' 0 C--N 1.327 -0.37 0 N-CA-C 109.148 -0.686 . . . . 0.0 109.148 175.0 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' B' B ' 60' ' ' VAL . . . . . . . . . . . . . 40.1 t -81.2 123.99 38.33 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.338 0 C-N-CA 120.651 -0.42 . . . . 0.0 110.872 -173.788 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' B' B ' 61' ' ' GLU . . . . . . . . . . . . . 95.7 mt-10 -131.0 162.55 29.52 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 115.691 -0.686 . . . . 0.0 109.666 176.251 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' B' B ' 62' ' ' ASP . . . . . . . . . . . . . 78.7 m-20 -54.85 -33.96 62.35 Favored 'General case' 0 C--N 1.328 -0.329 0 C-N-CA 121.015 -0.274 . . . . 0.0 111.646 -178.86 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' B' B ' 63' ' ' ARG . . . . . . . . . . . . . 7.3 mmm180 -76.18 -10.3 59.3 Favored 'General case' 0 CA--C 1.537 0.446 0 N-CA-C 113.186 0.81 . . . . 0.0 113.186 -176.74 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' B' B ' 64' ' ' THR . . . . . . . . . . . . . 30.0 m -72.27 145.32 47.98 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-O 121.004 0.43 . . . . 0.0 111.246 -175.915 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' B' B ' 65' ' ' LYS . . . . . . . . . . . . . 23.9 mtpp -89.58 127.52 35.9 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 115.878 -0.601 . . . . 0.0 110.265 178.491 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' B' B ' 66' ' ' ILE . . . . . . . . . . . . . 55.7 mt -114.77 129.93 70.07 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.245 0 N-CA-C 109.779 -0.452 . . . . 0.0 109.779 179.59 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' B' B ' 67' ' ' THR . . . . . . . . . . . . . 25.9 m -127.76 143.63 51.12 Favored 'General case' 0 C--N 1.332 -0.176 0 CA-C-O 121.171 0.51 . . . . 0.0 111.586 -176.842 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' B' B ' 68' ' ' LEU . . . . . . . . . . . . . 16.0 tp -100.95 125.47 47.53 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 115.59 -0.732 . . . . 0.0 109.622 175.666 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' B' B ' 69' ' ' VAL . . . . . . . . . . . . . 40.2 t -95.47 138.32 21.43 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.309 0 CA-C-O 120.895 0.379 . . . . 0.0 110.64 -176.264 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' B' B ' 70' ' ' THR . . . . . . . . . . . . . 25.7 m -108.09 150.46 27.15 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-N 115.881 -0.6 . . . . 0.0 110.794 -179.327 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' B' B ' 71' ' ' HIS . . . . . . . . . . . . . 47.8 m-70 -137.4 156.71 74.96 Favored Pre-proline 0 CA--C 1.532 0.269 0 CA-C-N 116.249 -0.432 . . . . 0.0 110.393 179.203 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' B' B ' 72' ' ' PRO . . . . . . . . . . . . . 57.9 Cg_endo -73.69 -30.0 10.06 Favored 'Trans proline' 0 N--CA 1.495 1.56 0 C-N-CA 121.274 1.316 . . . . 0.0 112.775 -176.424 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' B' B ' 73' ' ' VAL . . . . . . . . . . . . . 35.4 m -135.46 159.66 40.3 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.22 0 CA-C-O 120.854 0.359 . . . . 0.0 110.697 179.806 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' B' B ' 74' ' ' ASP . . . . . . . . . . . . . 18.6 t0 -104.09 115.43 30.42 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.001 -0.545 . . . . 0.0 109.893 179.245 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' B' B ' 75' ' ' VAL . . . . . . . . . . . . . 40.8 t -116.69 123.58 71.82 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.291 0 CA-C-O 121.086 0.47 . . . . 0.0 110.738 -176.271 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' B' B ' 76' ' ' LEU . . . . . . . . . . . . . 4.9 mp -125.19 146.63 49.42 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 115.635 -0.712 . . . . 0.0 109.516 176.273 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' B' B ' 77' ' ' GLU . . . . . . . . . . . . . 46.4 mt-10 -134.22 141.11 46.91 Favored 'General case' 0 C--N 1.331 -0.227 0 CA-C-O 120.944 0.402 . . . . 0.0 111.119 -178.513 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' B' B ' 78' ' ' ALA . . . . . 0.788 ' HB2' HD21 ' B' ' 109' ' ' LEU . . . -129.81 135.34 48.3 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 115.879 -0.601 . . . . 0.0 109.925 176.289 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' B' B ' 79' ' ' LYS . . . . . 0.553 ' O ' HD13 ' B' ' 80' ' ' ILE . 43.3 pttt -80.36 121.59 25.88 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-O 121.123 0.487 . . . . 0.0 111.18 -176.951 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' B' B ' 80' ' ' ILE . . . . . 0.553 HD13 ' O ' ' B' ' 79' ' ' LYS . 23.7 mm -139.45 112.26 5.87 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.327 0 N-CA-C 109.119 -0.697 . . . . 0.0 109.119 -179.018 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' B' B ' 81' ' ' LYS . . . . . . . . . . . . . 36.2 ttpt -100.45 123.08 44.2 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-O 120.911 0.386 . . . . 0.0 111.148 -178.363 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' B' B ' 82' ' ' GLY . . . . . . . . . . . . . . . 89.17 42.07 5.68 Favored Glycine 0 CA--C 1.527 0.792 0 C-N-CA 120.859 -0.686 . . . . 0.0 112.225 173.732 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' B' B ' 83' ' ' ILE . . . . . . . . . . . . . 69.2 mt -67.46 136.1 27.26 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.321 0 N-CA-C 109.689 -0.486 . . . . 0.0 109.689 175.993 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' B' B ' 84' ' ' LYS . . . . . . . . . . . . . 38.6 ttpt -104.48 -48.21 3.88 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-O 120.873 0.368 . . . . 0.0 110.584 -178.266 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' B' B ' 85' ' ' ASP . . . . . . . . . . . . . 13.8 t70 -143.37 146.64 33.68 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.06 -0.518 . . . . 0.0 110.631 -178.594 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' B' B ' 86' ' ' VAL . . . . . . . . . . . . . 44.7 t -131.08 132.69 63.42 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.268 0 CA-C-O 120.863 0.363 . . . . 0.0 110.389 -179.285 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' B' B ' 87' ' ' ILE . . . . . 0.496 ' N ' HD12 ' B' ' 87' ' ' ILE . 5.2 mp -123.97 128.09 73.95 Favored 'Isoleucine or valine' 0 C--O 1.233 0.187 0 CA-C-N 115.945 -0.571 . . . . 0.0 109.762 177.527 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' B' B ' 88' ' ' LEU . . . . . . . . . . . . . 18.8 tp -113.62 133.14 55.46 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.284 -0.416 . . . . 0.0 110.953 -177.901 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' B' B ' 89' ' ' ASP . . . . . . . . . . . . . 6.4 t0 -132.33 160.5 36.1 Favored 'General case' 0 C--N 1.331 -0.199 0 CA-C-N 116.171 -0.468 . . . . 0.0 109.848 177.955 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' B' B ' 90' ' ' GLU . . . . . . . . . . . . . 95.7 mt-10 -44.95 -47.29 11.38 Favored 'General case' 0 N--CA 1.465 0.28 0 N-CA-C 113.328 0.862 . . . . 0.0 113.328 -171.785 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' B' B ' 91' ' ' ASN . . . . . . . . . . . . . 77.7 m-20 -124.26 21.48 8.76 Favored 'General case' 0 N--CA 1.468 0.428 0 N-CA-C 112.809 0.67 . . . . 0.0 112.809 -176.237 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' B' B ' 92' ' ' LEU . . . . . . . . . . . . . 26.6 mt -148.23 145.96 28.46 Favored 'General case' 0 C--N 1.331 -0.208 0 CA-C-O 120.757 0.313 . . . . 0.0 110.872 -174.861 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' B' B ' 93' ' ' ILE . . . . . . . . . . . . . 71.7 mt -125.58 115.93 44.86 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.319 0 N-CA-C 108.898 -0.779 . . . . 0.0 108.898 176.683 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' B' B ' 94' ' ' VAL . . . . . . . . . . . . . 43.6 t -116.45 127.06 74.16 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.322 0 N-CA-C 109.95 -0.389 . . . . 0.0 109.95 -177.283 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' B' B ' 95' ' ' VAL . . . . . . . . . . . . . 43.7 t -122.56 134.4 65.86 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.265 0 CA-C-N 116.099 -0.5 . . . . 0.0 109.91 -179.318 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' B' B ' 96' ' ' ILE . . . . . . . . . . . . . 68.8 mt -118.07 126.75 75.15 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.287 0 N-CA-C 109.349 -0.611 . . . . 0.0 109.349 178.981 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' B' B ' 97' ' ' THR . . . . . . . . . . . . . 69.6 p -99.39 157.08 16.66 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-O 121.274 0.559 . . . . 0.0 111.495 -176.029 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' B' B ' 98' ' ' GLU . . . . . . . . . . . . . 12.1 pt-20 -53.82 -25.23 18.45 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 115.966 -0.561 . . . . 0.0 112.489 -179.275 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' B' B ' 99' ' ' GLU . . . . . . . . . . . . . 95.6 mt-10 -81.97 17.85 1.47 Allowed 'General case' 0 CA--C 1.535 0.366 0 N-CA-C 113.021 0.748 . . . . 0.0 113.021 -177.529 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' B' B ' 100' ' ' ASN . . . . . . . . . . . . . 3.2 m-20 61.75 37.96 15.34 Favored 'General case' 0 C--O 1.232 0.175 0 CA-C-O 120.955 0.407 . . . . 0.0 110.98 177.86 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' B' B ' 101' ' ' GLU . . . . . . . . . . . . . 83.9 tt0 -115.2 142.97 45.94 Favored 'General case' 0 C--N 1.331 -0.208 0 N-CA-C 109.709 -0.478 . . . . 0.0 109.709 176.35 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' B' B ' 102' ' ' VAL . . . . . . . . . . . . . 44.4 t -116.04 127.06 73.75 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.34 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.037 -177.247 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' B' B ' 103' ' ' LEU . . . . . . . . . . . . . 45.3 mt -120.44 131.12 54.63 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 115.828 -0.624 . . . . 0.0 110.243 177.081 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' B' B ' 104' ' ' ILE . . . . . 0.663 HD13 HG21 ' B' ' 130' ' ' VAL . 67.5 mt -119.68 121.47 66.3 Favored 'Isoleucine or valine' 0 C--O 1.234 0.285 0 CA-C-N 116.471 -0.331 . . . . 0.0 110.182 -178.791 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' B' B ' 105' ' ' PHE . . . . . . . . . . . . . 51.2 m-85 -123.38 163.95 19.81 Favored 'General case' 0 C--N 1.334 -0.089 0 O-C-N 123.838 0.711 . . . . 0.0 109.769 178.7 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' B' B ' 106' ' ' ASN . . . . . . . . . . . . . 43.3 p-10 -97.06 -169.95 1.95 Allowed 'General case' 0 C--N 1.331 -0.221 0 N-CA-C 110.096 -0.335 . . . . 0.0 110.096 174.845 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' B' B ' 107' ' ' GLN . . . . . . . . . . . . . 50.7 tt0 -59.55 -30.0 68.31 Favored 'General case' 0 C--N 1.328 -0.327 0 N-CA-C 111.886 0.328 . . . . 0.0 111.886 179.029 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' B' B ' 108' ' ' ASN . . . . . . . . . . . . . 65.9 t30 -82.56 7.09 15.52 Favored 'General case' 0 CA--C 1.536 0.421 0 N-CA-C 113.283 0.846 . . . . 0.0 113.283 -177.864 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' B' B ' 109' ' ' LEU . . . . . 0.788 HD21 ' HB2' ' B' ' 78' ' ' ALA . 11.9 tp 60.21 37.49 20.57 Favored 'General case' 0 C--N 1.331 -0.2 0 CA-C-O 121.112 0.482 . . . . 0.0 111.218 179.464 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' B' B ' 110' ' ' GLU . . . . . . . . . . . . . 70.9 mm-40 -103.61 148.43 26.01 Favored 'General case' 0 C--N 1.33 -0.264 0 N-CA-C 109.639 -0.504 . . . . 0.0 109.639 175.199 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' B' B ' 111' ' ' GLU . . . . . . . . . . . . . 62.6 tt0 -84.97 122.04 28.64 Favored 'General case' 0 C--N 1.327 -0.396 0 CA-C-O 120.893 0.377 . . . . 0.0 110.586 -176.75 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' B' B ' 112' ' ' LEU . . . . . . . . . . . . . 45.5 mt -109.57 -45.99 3.6 Favored 'General case' 0 C--N 1.332 -0.171 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.722 179.963 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' B' B ' 113' ' ' TYR . . . . . . . . . . . . . 55.5 t80 -133.33 139.12 46.68 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.328 -0.396 . . . . 0.0 110.872 -178.861 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' B' B ' 114' ' ' ARG . . . . . . . . . . . . . 34.7 ptt-85 -145.12 121.01 10.63 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.235 -0.438 . . . . 0.0 110.726 179.624 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' B' B ' 115' ' ' GLY . . . . . . . . . . . . . . . -150.24 159.2 28.01 Favored Glycine 0 CA--C 1.524 0.646 0 C-N-CA 120.871 -0.681 . . . . 0.0 111.439 178.88 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' B' B ' 116' ' ' LYS . . . . . . . . . . . . . 38.6 ttpt -125.59 130.71 52.2 Favored 'General case' 0 C--N 1.33 -0.251 0 N-CA-C 109.525 -0.546 . . . . 0.0 109.525 175.524 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' B' B ' 117' ' ' PHE . . . . . . . . . . . . . 44.5 m-85 -132.43 116.31 16.64 Favored 'General case' 0 C--N 1.331 -0.224 0 CA-C-O 120.934 0.397 . . . . 0.0 110.481 -174.535 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' B' B ' 118' ' ' GLU . . . . . . . . . . . . . 95.8 mt-10 -53.46 -45.03 69.37 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.374 -0.376 . . . . 0.0 111.503 -177.228 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' B' B ' 119' ' ' ASN . . . . . . . . . . . . . 4.6 m120 -97.12 29.72 3.03 Favored 'General case' 0 C--N 1.33 -0.249 0 N-CA-C 112.403 0.52 . . . . 0.0 112.403 -173.958 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' B' B ' 120' ' ' LEU . . . . . . . . . . . . . 17.8 tp -59.07 119.89 8.13 Favored 'General case' 0 C--N 1.331 -0.205 0 N-CA-C 110.067 -0.346 . . . . 0.0 110.067 177.647 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' B' B ' 121' ' ' ASN . . . . . . . . . . . . . 72.8 m-20 -114.07 -44.03 3.18 Favored 'General case' 0 C--N 1.332 -0.167 0 CA-C-N 116.493 -0.321 . . . . 0.0 111.162 -177.521 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' B' B ' 122' ' ' LYS . . . . . . . . . . . . . 97.8 mttt -143.77 151.37 39.9 Favored 'General case' 0 C--N 1.332 -0.162 0 CA-C-O 121.184 0.516 . . . . 0.0 111.748 -176.353 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' B' B ' 123' ' ' VAL . . . . . . . . . . . . . 45.1 t -128.38 126.71 66.19 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.22 0 CA-C-N 115.83 -0.623 . . . . 0.0 109.515 175.225 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' B' B ' 124' ' ' LEU . . . . . 0.425 ' N ' HD12 ' B' ' 124' ' ' LEU . 7.0 mp -114.36 131.61 56.49 Favored 'General case' 0 C--N 1.332 -0.186 0 CA-C-N 116.373 -0.376 . . . . 0.0 110.772 -178.179 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' B' B ' 125' ' ' VAL . . . . . . . . . . . . . 9.2 p -131.94 131.33 61.68 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.215 0 CA-C-N 116.151 -0.477 . . . . 0.0 109.855 178.024 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' B' B ' 126' ' ' ARG . . . . . . . . . . . . . 48.2 ttt180 -151.44 128.77 11.28 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-O 120.951 0.405 . . . . 0.0 110.772 178.74 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' B' B ' 127' ' ' ASN . . . . . . . . . . . . . 6.9 m120 52.1 -112.73 0.69 Allowed 'General case' 0 CA--C 1.545 0.756 0 CA-C-O 118.837 -0.601 . . . . 0.0 111.029 179.242 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' B' B ' 128' ' ' ASP . . . . . . . . . . . . . 10.9 p-10 -114.17 10.16 17.27 Favored 'General case' 0 N--CA 1.468 0.447 0 CA-C-N 119.934 1.243 . . . . 0.0 113.216 -177.288 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' B' B ' 129' ' ' LEU . . . . . . . . . . . . . 77.9 mt -118.43 149.81 40.62 Favored 'General case' 0 C--O 1.233 0.235 0 CA-C-N 118.212 0.46 . . . . 0.0 110.445 -178.605 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' B' B ' 130' ' ' VAL . . . . . 0.663 HG21 HD13 ' B' ' 104' ' ' ILE . 32.9 m -135.43 144.6 33.57 Favored 'Isoleucine or valine' 0 C--O 1.232 0.182 0 CA-C-O 121.326 0.584 . . . . 0.0 111.042 -179.876 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' B' B ' 131' ' ' VAL . . . . . 0.557 HG22 HD12 ' B' ' 140' ' ' LEU . 45.7 t -136.03 137.88 48.11 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.324 0 CA-C-N 115.595 -0.73 . . . . 0.0 109.901 179.013 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' B' B ' 132' ' ' ILE . . . . . . . . . . . . . 71.6 mt -112.32 130.35 66.19 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.337 0 N-CA-C 109.317 -0.623 . . . . 0.0 109.317 179.452 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' B' B ' 133' ' ' ILE . . . . . . . . . . . . . 38.9 mm -114.48 120.09 63.22 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.255 0 CA-C-O 120.752 0.31 . . . . 0.0 111.007 -174.513 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' B' B ' 134' ' ' ASP . . . . . . . . . . . . . 6.9 p-10 -130.93 146.3 52.3 Favored 'General case' 0 C--N 1.332 -0.194 0 N-CA-C 109.465 -0.568 . . . . 0.0 109.465 175.048 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' B' B ' 135' ' ' GLU . . . . . . . . . . . . . 33.6 tt0 -49.95 -27.49 5.41 Favored 'General case' 0 C--N 1.329 -0.323 0 N-CA-C 112.731 0.641 . . . . 0.0 112.731 -173.262 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' B' B ' 136' ' ' GLN . . . . . . . . . . . . . 98.7 mt-30 -79.4 -36.2 39.51 Favored 'General case' 0 C--N 1.331 -0.202 0 N-CA-C 112.175 0.435 . . . . 0.0 112.175 -176.86 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' B' B ' 137' ' ' LYS . . . . . . . . . . . . . 45.6 pttt -169.45 175.39 5.51 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-O 121.448 0.642 . . . . 0.0 112.148 -172.137 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' B' B ' 138' ' ' LEU . . . . . 0.429 ' C ' HD23 ' B' ' 138' ' ' LEU . 7.7 tt -118.18 129.5 55.55 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 115.266 -0.879 . . . . 0.0 110.355 -179.459 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' B' B ' 139' ' ' THR . . . . . . . . . . . . . 32.7 m -107.35 126.45 52.48 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 115.923 -0.58 . . . . 0.0 110.238 178.191 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' B' B ' 140' ' ' LEU . . . . . 0.557 HD12 HG22 ' B' ' 131' ' ' VAL . 12.3 tp -111.63 119.11 37.59 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 115.904 -0.589 . . . . 0.0 109.652 -176.602 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' B' B ' 141' ' ' ILE . . . . . 0.529 ' HB ' HG23 ' B' ' 130' ' ' VAL . 27.2 mt -121.71 121.47 64.47 Favored 'Isoleucine or valine' 0 C--O 1.234 0.245 0 CA-C-O 121.351 0.596 . . . . 0.0 110.525 -173.969 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' B' B ' 142' ' ' ARG . . . . . . . . . . . . . 0.5 OUTLIER -108.25 123.99 49.62 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 114.903 -1.044 . . . . 0.0 110.068 -179.794 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' B' B ' 143' ' ' THR . . . . . . . . . . . . . 40.3 p . . . . . 0 C--O 1.219 -0.516 0 CA-C-O 118.002 -0.999 . . . . 0.0 110.574 179.443 . . . . . . . . 0 0 . 1 . 016 nuclear nobuild full ' C' C ' -3' ' ' GLU . . . . . . . . . . . . . 96.0 mt-10 . . . . . 0 N--CA 1.489 1.524 0 N-CA-C 109.387 -0.598 . . . . 0.0 109.387 . . . . . . . . . 0 0 . 1 . 016 nuclear nobuild full ' C' C ' -2' ' ' GLY . . . . . . . . . . . . . . . -65.36 148.62 51.4 Favored Glycine 0 CA--C 1.524 0.602 0 N-CA-C 111.114 -0.795 . . . . 0.0 111.114 -179.435 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' C' C ' -1' ' ' VAL . . . . . . . . . . . . . 45.3 t -141.62 128.56 20.41 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.304 0 N-CA-C 109.934 -0.395 . . . . 0.0 109.934 179.452 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' C' C ' 0' ' ' ILE . . . . . . . . . . . . . 71.4 mt -120.43 128.96 76.05 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.27 0 CA-C-N 116.051 -0.522 . . . . 0.0 109.686 179.485 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' C' C ' 1' ' ' MET . . . . . . . . . . . . . 24.6 ptt? -82.56 127.43 33.33 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-O 120.919 0.39 . . . . 0.0 110.715 -179.14 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' C' C ' 2' ' ' SER . . . . . . . . . . . . . 2.9 p -107.97 144.91 34.6 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 116.035 -0.529 . . . . 0.0 110.691 -179.952 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' C' C ' 3' ' ' GLU . . . . . . . . . . . . . 45.0 mt-10 -140.12 143.1 36.05 Favored 'General case' 0 C--N 1.331 -0.227 0 CA-C-N 116.027 -0.533 . . . . 0.0 110.981 -179.656 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' C' C ' 4' ' ' LEU . . . . . 0.595 HD12 HD23 ' C' ' 58' ' ' LEU . 2.4 tt -124.57 124.35 42.05 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 115.65 -0.705 . . . . 0.0 109.535 177.075 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' C' C ' 5' ' ' LYS . . . . . . . . . . . . . 78.6 mttt -103.87 118.77 37.48 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.721 -178.564 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' C' C ' 6' ' ' LEU . . . . . . . . . . . . . 27.3 mt -116.79 147.96 41.61 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 115.566 -0.743 . . . . 0.0 110.317 -179.172 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' C' C ' 7' ' ' LYS . . . . . . . . . . . . . 81.2 tttt -134.87 139.87 33.49 Favored Pre-proline 0 CA--C 1.533 0.308 0 CA-C-O 119.124 -0.465 . . . . 0.0 109.957 175.643 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' C' C ' 8' ' ' PRO . . . . . . . . . . . . . 88.4 Cg_endo -91.34 137.74 2.12 Favored 'Trans proline' 0 N--CA 1.489 1.236 0 C-N-CA 121.722 1.615 . . . . 0.0 111.555 177.813 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' C' C ' 9' ' ' LEU . . . . . . . . . . . . . 68.0 mt -77.73 -47.79 2.3 Favored Pre-proline 0 CA--C 1.535 0.396 0 CA-C-O 118.634 -0.698 . . . . 0.0 112.444 -178.25 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' C' C ' 10' ' ' PRO . . . . . . . . . . . . . 88.9 Cg_endo -80.28 152.84 21.08 Favored 'Trans proline' 0 N--CA 1.497 1.678 0 C-N-CA 121.135 1.223 . . . . 0.0 112.03 177.006 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' C' C ' 11' ' ' LYS . . . . . . . . . . . . . 33.9 mmtp -85.65 97.57 10.19 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.354 -0.384 . . . . 0.0 110.396 177.851 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' C' C ' 12' ' ' VAL . . . . . . . . . . . . . 11.8 p -140.03 145.17 26.76 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.288 0 CA-C-N 116.107 -0.497 . . . . 0.0 110.308 179.778 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' C' C ' 13' ' ' GLU . . . . . . . . . . . . . 70.5 tt0 -84.27 116.16 22.83 Favored 'General case' 0 C--N 1.328 -0.333 0 N-CA-C 109.756 -0.461 . . . . 0.0 109.756 178.179 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' C' C ' 14' ' ' LEU . . . . . . . . . . . . . 19.0 mt -87.21 152.24 52.55 Favored Pre-proline 0 C--N 1.328 -0.33 0 CA-C-N 116.421 -0.354 . . . . 0.0 111.079 -175.131 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' C' C ' 15' ' ' PRO . . . . . . . . . . . . . 26.8 Cg_exo -61.95 161.61 25.2 Favored 'Trans proline' 0 N--CA 1.496 1.65 0 C-N-CA 121.443 1.428 . . . . 0.0 111.698 176.451 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' C' C ' 16' ' ' PRO . . . . . . . . . . . . . 24.0 Cg_exo -62.81 -38.14 50.74 Favored 'Trans proline' 0 N--CA 1.497 1.729 0 C-N-CA 121.485 1.457 . . . . 0.0 112.75 -179.248 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' C' C ' 17' ' ' ASP . . . . . . . . . . . . . 9.4 p-10 -93.88 15.84 15.7 Favored 'General case' 0 C--N 1.327 -0.388 0 N-CA-C 113.154 0.798 . . . . 0.0 113.154 -175.688 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' C' C ' 18' ' ' PHE . . . . . . . . . . . . . 38.2 t80 -57.06 -47.03 81.97 Favored 'General case' 0 C--N 1.334 -0.076 0 O-C-N 122.06 -0.4 . . . . 0.0 110.595 -176.998 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' C' C ' 19' ' ' VAL . . . . . . . . . . . . . 46.3 t -56.33 -46.28 81.69 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.323 0 CA-C-N 116.464 -0.335 . . . . 0.0 110.852 -176.261 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' C' C ' 20' ' ' ASP . . . . . . . . . . . . . 77.2 m-20 -60.08 -41.55 92.7 Favored 'General case' 0 C--N 1.329 -0.298 0 C-N-CA 120.939 -0.304 . . . . 0.0 111.159 -177.066 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' C' C ' 21' ' ' VAL . . . . . . . . . . . . . 44.5 t -64.04 -46.75 92.95 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.29 0 C-N-CA 120.759 -0.376 . . . . 0.0 110.383 -177.968 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' C' C ' 22' ' ' ILE . . . . . 0.597 HG22 HD12 ' C' ' 26' ' ' LEU . 51.5 mm -56.36 -46.32 81.8 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.218 0 C-N-CA 120.951 -0.3 . . . . 0.0 110.567 178.352 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' C' C ' 23' ' ' ARG . . . . . . . . . . . . . 56.4 ttp180 -52.88 -49.05 66.64 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-O 120.652 0.263 . . . . 0.0 111.558 -178.798 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' C' C ' 24' ' ' ILE . . . . . . . . . . . . . 71.3 mt -58.32 -47.75 86.84 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.341 0 CA-C-N 116.661 -0.245 . . . . 0.0 110.802 -178.187 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' C' C ' 25' ' ' LYS . . . . . . . . . . . . . 40.4 mmtt -60.76 -43.96 97.34 Favored 'General case' 0 C--N 1.329 -0.315 0 N-CA-C 112.129 0.418 . . . . 0.0 112.129 -177.959 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' C' C ' 26' ' ' LEU . . . . . 0.597 HD12 HG22 ' C' ' 22' ' ' ILE . 81.8 mt -80.88 -29.21 35.75 Favored 'General case' 0 C--N 1.33 -0.273 0 N-CA-C 113.392 0.886 . . . . 0.0 113.392 -170.721 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' C' C ' 27' ' ' GLN . . . . . . . . . . . . . 4.4 pt20 -45.87 134.53 7.78 Favored 'General case' 0 N--CA 1.467 0.423 0 N-CA-C 112.856 0.687 . . . . 0.0 112.856 -174.931 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' C' C ' 28' ' ' GLY . . . . . . . . . . . . . . . 101.11 -20.21 48.45 Favored Glycine 0 CA--C 1.533 1.191 0 CA-C-N 115.948 -0.569 . . . . 0.0 112.863 -179.038 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' C' C ' 29' ' ' LYS . . . . . . . . . . . . . 59.9 mtpt -97.53 155.08 17.11 Favored 'General case' 0 C--N 1.332 -0.17 0 CA-C-N 117.78 0.79 . . . . 0.0 111.153 179.84 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' C' C ' 30' ' ' THR . . . . . . . . . . . . . 42.6 m -107.38 138.41 43.63 Favored 'General case' 0 C--N 1.332 -0.164 0 CA-C-N 116.157 -0.474 . . . . 0.0 110.038 176.262 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' C' C ' 31' ' ' VAL . . . . . . . . . . . . . 35.0 m -131.33 160.61 42.19 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.252 0 CA-C-N 116.38 -0.373 . . . . 0.0 110.771 -178.928 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' C' C ' 32' ' ' ARG . . . . . . . . . . . . . 21.1 mtp-105 -132.99 153.3 51.6 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-O 121.37 0.605 . . . . 0.0 110.552 178.236 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' C' C ' 33' ' ' THR . . . . . . . . . . . . . 17.9 m -52.98 139.72 26.97 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.022 -0.536 . . . . 0.0 111.457 -177.817 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' C' C ' 34' ' ' GLY . . . . . . . . . . . . . . . 99.85 -17.06 57.87 Favored Glycine 0 CA--C 1.532 1.108 0 CA-C-O 119.623 -0.543 . . . . 0.0 113.447 177.678 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' C' C ' 35' ' ' ASP . . . . . . . . . . . . . 70.9 m-20 -64.23 148.85 49.19 Favored 'General case' 0 C--O 1.232 0.167 0 CA-C-N 118.004 0.902 . . . . 0.0 111.17 -179.833 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' C' C ' 36' ' ' VAL . . . . . . . . . . . . . 45.9 t -122.63 129.69 75.03 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.241 0 CA-C-N 115.794 -0.639 . . . . 0.0 109.629 178.117 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' C' C ' 37' ' ' ILE . . . . . . . . . . . . . 67.7 mt -121.82 140.23 46.44 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.278 0 CA-C-N 116.396 -0.365 . . . . 0.0 110.129 -178.146 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' C' C ' 38' ' ' GLY . . . . . . . . . . . . . . . -113.2 128.96 8.62 Favored Glycine 0 CA--C 1.526 0.745 0 N-CA-C 111.082 -0.807 . . . . 0.0 111.082 -179.845 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' C' C ' 39' ' ' ILE . . . . . . . . . . . . . 76.2 mt -124.24 142.64 40.35 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.205 0 N-CA-C 110.025 -0.361 . . . . 0.0 110.025 179.564 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' C' C ' 40' ' ' SER . . . . . 0.536 ' O ' HD13 ' C' ' 41' ' ' ILE . 89.7 p -91.3 120.47 32.22 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.361 -0.381 . . . . 0.0 111.067 177.888 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' C' C ' 41' ' ' ILE . . . . . 0.536 HD13 ' O ' ' C' ' 40' ' ' SER . 46.3 mm -130.16 114.96 30.9 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.242 0 CA-C-N 116.435 -0.348 . . . . 0.0 110.098 177.904 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' C' C ' 42' ' ' LEU . . . . . . . . . . . . . 49.0 mt 58.03 35.16 24.97 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.391 -0.368 . . . . 0.0 111.566 178.248 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' C' C ' 43' ' ' GLY . . . . . . . . . . . . . . . 77.89 -10.08 27.74 Favored Glycine 0 CA--C 1.533 1.203 0 C-N-CA 121.316 -0.469 . . . . 0.0 113.499 177.81 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' C' C ' 44' ' ' LYS . . . . . . . . . . . . . 68.4 mmtt -98.04 139.47 33.81 Favored 'General case' 0 C--N 1.333 -0.11 0 CA-C-N 117.96 0.88 . . . . 0.0 109.869 176.057 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' C' C ' 45' ' ' GLU . . . . . . . . . . . . . 82.2 tt0 -83.3 123.81 29.99 Favored 'General case' 0 C--N 1.329 -0.315 0 C-N-CA 120.936 -0.306 . . . . 0.0 110.713 179.536 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' C' C ' 46' ' ' VAL . . . . . . . . . . . . . 7.7 p -115.5 128.37 72.74 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.167 0 N-CA-C 109.511 -0.552 . . . . 0.0 109.511 177.441 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' C' C ' 47' ' ' LYS . . . . . . . . . . . . . 67.4 mttm -100.24 130.74 46.4 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 115.97 -0.559 . . . . 0.0 111.56 -179.927 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' C' C ' 48' ' ' PHE . . . . . . . . . . . . . 91.1 m-85 -115.31 131.91 56.78 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.079 -0.509 . . . . 0.0 109.714 175.813 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' C' C ' 49' ' ' LYS . . . . . . . . . . . . . 82.8 tttt -107.92 137.18 46.37 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.498 -0.319 . . . . 0.0 110.716 -179.478 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' C' C ' 50' ' ' VAL . . . . . . . . . . . . . 44.3 t -82.29 105.64 12.36 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.262 0 N-CA-C 109.543 -0.54 . . . . 0.0 109.543 176.288 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' C' C ' 51' ' ' VAL . . . . . . . . . . . . . 46.4 t -71.0 -52.89 24.08 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.333 0 CA-C-N 115.926 -0.579 . . . . 0.0 109.75 -174.914 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' C' C ' 52' ' ' GLN . . . . . . . . . . . . . 81.9 mt-30 -154.57 149.92 27.19 Favored 'General case' 0 C--N 1.331 -0.198 0 C-N-CA 120.41 -0.516 . . . . 0.0 111.58 -177.418 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' C' C ' 53' ' ' ALA . . . . . . . . . . . . . . . -122.89 130.69 53.17 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 115.41 -0.813 . . . . 0.0 109.43 174.833 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' C' C ' 54' ' ' TYR . . . . . . . . . . . . . 67.9 t80 -129.0 107.41 18.08 Favored Pre-proline 0 CA--C 1.533 0.318 0 CA-C-O 118.215 -0.898 . . . . 0.0 110.493 -179.416 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' C' C ' 55' ' ' PRO . . . . . . . . . . . . . 73.1 Cg_endo -77.09 170.05 72.67 Favored 'Cis proline' 0 N--CA 1.5 1.907 0 CA-C-N 121.726 1.652 . . . . 0.0 112.583 -5.07 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' C' C ' 56' ' ' SER . . . . . . . . . . . . . 32.5 m -115.71 132.12 23.33 Favored Pre-proline 0 CA--C 1.538 0.516 0 CA-C-O 118.429 -0.796 . . . . 0.0 109.515 175.428 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' C' C ' 57' ' ' PRO . . . . . . . . . . . . . 33.5 Cg_endo -65.76 166.26 55.41 Favored 'Cis proline' 0 N--CA 1.498 1.785 0 CA-C-N 121.971 1.74 . . . . 0.0 111.378 -2.583 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' C' C ' 58' ' ' LEU . . . . . 0.595 HD23 HD12 ' C' ' 4' ' ' LEU . 19.4 tp -130.5 138.58 50.31 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-O 121.018 0.437 . . . . 0.0 110.662 -179.919 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' C' C ' 59' ' ' ARG . . . . . . . . . . . . . 78.6 ttt-85 -103.61 128.4 50.9 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 115.579 -0.737 . . . . 0.0 109.47 175.767 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' C' C ' 60' ' ' VAL . . . . . . . . . . . . . 43.2 t -78.86 112.93 17.48 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.344 0 CA-C-O 120.817 0.342 . . . . 0.0 110.378 -177.114 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' C' C ' 61' ' ' GLU . . . . . . . . . . . . . 72.9 tt0 -130.95 157.01 44.11 Favored 'General case' 0 C--N 1.329 -0.314 0 N-CA-C 109.359 -0.608 . . . . 0.0 109.359 177.936 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' C' C ' 62' ' ' ASP . . . . . . . . . . . . . 9.5 t0 -51.7 -30.79 23.51 Favored 'General case' 0 C--N 1.326 -0.414 0 N-CA-C 112.213 0.449 . . . . 0.0 112.213 -177.479 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' C' C ' 63' ' ' ARG . . . . . . . . . . . . . 73.8 mtp180 -72.66 -22.06 60.99 Favored 'General case' 0 CA--C 1.532 0.288 0 N-CA-C 112.966 0.728 . . . . 0.0 112.966 -175.38 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' C' C ' 64' ' ' THR . . . . . . . . . . . . . 32.3 m -73.69 140.58 46.14 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-O 120.895 0.379 . . . . 0.0 110.829 -176.226 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' C' C ' 65' ' ' LYS . . . . . . . . . . . . . 42.1 mtmt -89.22 127.79 35.78 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.099 -0.501 . . . . 0.0 110.12 177.868 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' C' C ' 66' ' ' ILE . . . . . . . . . . . . . 64.8 mt -109.48 125.73 66.62 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.32 0 N-CA-C 109.427 -0.583 . . . . 0.0 109.427 179.152 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' C' C ' 67' ' ' THR . . . . . . . . . . . . . 23.1 m -124.81 142.29 51.53 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-O 121.277 0.56 . . . . 0.0 111.358 -174.9 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' C' C ' 68' ' ' LEU . . . . . . . . . . . . . 43.8 mt -95.25 127.73 41.54 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 115.59 -0.732 . . . . 0.0 109.894 176.123 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' C' C ' 69' ' ' VAL . . . . . . . . . . . . . 43.1 t -97.73 135.86 30.68 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.412 0 CA-C-N 116.233 -0.44 . . . . 0.0 110.157 -178.973 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' C' C ' 70' ' ' THR . . . . . . . . . . . . . 41.4 p -131.09 30.05 4.6 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.263 -0.426 . . . . 0.0 111.752 -179.579 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' C' C ' 71' ' ' HIS . . . . . . . . . . . . . 59.7 m80 -116.42 147.87 40.54 Favored Pre-proline 0 CA--C 1.531 0.225 0 N-CA-C 109.595 -0.52 . . . . 0.0 109.595 176.574 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' C' C ' 72' ' ' PRO . . . . . . . . . . . . . 98.3 Cg_endo -86.32 -28.85 0.58 Allowed 'Trans proline' 0 N--CA 1.491 1.361 0 C-N-CA 121.589 1.526 . . . . 0.0 112.793 -177.164 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' C' C ' 73' ' ' VAL . . . . . . . . . . . . . 34.8 m -130.92 155.57 42.04 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.272 0 CA-C-O 120.717 0.294 . . . . 0.0 110.799 -178.341 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' C' C ' 74' ' ' ASP . . . . . . . . . . . . . 35.6 t0 -102.83 118.06 36.0 Favored 'General case' 0 C--N 1.331 -0.199 0 N-CA-C 109.455 -0.572 . . . . 0.0 109.455 177.835 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' C' C ' 75' ' ' VAL . . . . . . . . . . . . . 39.9 t -118.63 123.88 72.25 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.245 0 CA-C-O 121.141 0.496 . . . . 0.0 110.795 -176.634 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' C' C ' 76' ' ' LEU . . . . . . . . . . . . . 6.7 mp -117.62 150.39 39.11 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 115.503 -0.771 . . . . 0.0 109.613 176.184 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' C' C ' 77' ' ' GLU . . . . . . . . . . . . . 47.2 mt-10 -134.62 132.32 38.85 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-O 120.963 0.411 . . . . 0.0 111.019 179.916 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' C' C ' 78' ' ' ALA . . . . . 0.776 ' HB2' HD21 ' C' ' 109' ' ' LEU . . . -124.66 127.76 47.8 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 115.838 -0.619 . . . . 0.0 109.919 177.05 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' C' C ' 79' ' ' LYS . . . . . 0.559 ' O ' HD13 ' C' ' 80' ' ' ILE . 14.4 ptpt -72.81 119.29 16.85 Favored 'General case' 0 C--N 1.331 -0.239 0 CA-C-O 121.239 0.543 . . . . 0.0 110.589 -178.772 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' C' C ' 80' ' ' ILE . . . . . 0.559 HD13 ' O ' ' C' ' 79' ' ' LYS . 24.1 mm -139.44 105.59 2.43 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.285 0 N-CA-C 109.213 -0.662 . . . . 0.0 109.213 -177.781 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' C' C ' 81' ' ' LYS . . . . . . . . . . . . . 55.9 pttt -98.91 126.83 44.68 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-O 121.032 0.444 . . . . 0.0 111.26 -177.205 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' C' C ' 82' ' ' GLY . . . . . . . . . . . . . . . 89.16 42.03 5.69 Favored Glycine 0 CA--C 1.526 0.754 0 CA-C-N 115.838 -0.619 . . . . 0.0 111.834 175.05 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' C' C ' 83' ' ' ILE . . . . . . . . . . . . . 67.3 mt -71.99 139.35 19.88 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.391 0 N-CA-C 109.551 -0.537 . . . . 0.0 109.551 176.57 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' C' C ' 84' ' ' LYS . . . . . . . . . . . . . 20.2 ttpp -102.28 -50.21 3.68 Favored 'General case' 0 C--N 1.331 -0.215 0 CA-C-O 120.895 0.378 . . . . 0.0 110.317 -178.857 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' C' C ' 85' ' ' ASP . . . . . . . . . . . . . 11.1 t70 -150.95 150.0 30.29 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.034 -0.53 . . . . 0.0 110.641 -179.184 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' C' C ' 86' ' ' VAL . . . . . . . . . . . . . 44.7 t -132.93 131.12 59.06 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.275 0 CA-C-O 120.89 0.376 . . . . 0.0 110.3 179.779 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' C' C ' 87' ' ' ILE . . . . . . . . . . . . . 40.3 mm -119.5 127.08 75.86 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.233 0 N-CA-C 109.359 -0.608 . . . . 0.0 109.359 177.457 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' C' C ' 88' ' ' LEU . . . . . . . . . . . . . 20.4 tp -113.03 132.15 55.5 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-O 120.973 0.416 . . . . 0.0 111.119 -177.209 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' C' C ' 89' ' ' ASP . . . . . . . . . . . . . 8.6 t70 -125.1 156.5 38.19 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 115.77 -0.65 . . . . 0.0 109.587 176.272 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' C' C ' 90' ' ' GLU . . . . . . . . . . . . . 95.4 mt-10 -47.02 -39.28 12.34 Favored 'General case' 0 C--N 1.329 -0.301 0 N-CA-C 113.007 0.743 . . . . 0.0 113.007 -172.167 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' C' C ' 91' ' ' ASN . . . . . . . . . . . . . 3.7 t-20 -132.09 34.8 3.77 Favored 'General case' 0 N--CA 1.464 0.251 0 N-CA-C 111.832 0.308 . . . . 0.0 111.832 -175.862 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' C' C ' 92' ' ' LEU . . . . . . . . . . . . . 11.4 tp -166.09 146.03 6.27 Favored 'General case' 0 C--N 1.332 -0.187 0 C-N-CA 120.755 -0.378 . . . . 0.0 111.058 -179.335 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' C' C ' 93' ' ' ILE . . . . . . . . . . . . . 64.4 mt -125.3 123.42 65.05 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.18 0 N-CA-C 109.575 -0.528 . . . . 0.0 109.575 178.622 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' C' C ' 94' ' ' VAL . . . . . 0.452 HG21 HG11 ' C' ' 125' ' ' VAL . 47.0 t -122.64 125.02 71.92 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.218 0 N-CA-C 109.887 -0.412 . . . . 0.0 109.887 178.806 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' C' C ' 95' ' ' VAL . . . . . . . . . . . . . 44.3 t -121.61 135.8 60.6 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.273 0 CA-C-N 116.068 -0.515 . . . . 0.0 110.049 -178.38 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' C' C ' 96' ' ' ILE . . . . . . . . . . . . . 64.9 mt -117.87 127.31 75.17 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.307 0 N-CA-C 109.647 -0.501 . . . . 0.0 109.647 -179.949 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' C' C ' 97' ' ' THR . . . . . . . . . . . . . 81.2 p -98.94 156.41 16.91 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-O 121.021 0.439 . . . . 0.0 110.984 -178.965 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' C' C ' 98' ' ' GLU . . . . . . . . . . . . . 14.2 pt-20 -55.58 -22.18 20.83 Favored 'General case' 0 CA--C 1.534 0.343 0 N-CA-C 112.603 0.594 . . . . 0.0 112.603 -178.736 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' C' C ' 99' ' ' GLU . . . . . . . . . . . . . 51.0 mp0 -81.22 15.49 1.92 Allowed 'General case' 0 CA--C 1.535 0.399 0 N-CA-C 112.95 0.722 . . . . 0.0 112.95 -178.881 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' C' C ' 100' ' ' ASN . . . . . . . . . . . . . 22.3 m-20 59.66 37.37 22.42 Favored 'General case' 0 C--N 1.332 -0.153 0 CA-C-O 121.026 0.441 . . . . 0.0 111.159 -179.428 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' C' C ' 101' ' ' GLU . . . . . . . . . . . . . 84.4 tt0 -111.91 142.35 44.41 Favored 'General case' 0 C--N 1.333 -0.132 0 N-CA-C 109.575 -0.528 . . . . 0.0 109.575 173.198 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' C' C ' 102' ' ' VAL . . . . . . . . . . . . . 44.3 t -114.95 127.93 72.31 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.249 0 CA-C-N 116.27 -0.423 . . . . 0.0 109.998 -177.025 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' C' C ' 103' ' ' LEU . . . . . . . . . . . . . 39.8 mt -117.01 131.56 56.92 Favored 'General case' 0 C--N 1.331 -0.216 0 CA-C-N 115.604 -0.726 . . . . 0.0 110.224 177.087 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' C' C ' 104' ' ' ILE . . . . . 0.5 HD12 ' HB3' ' C' ' 113' ' ' TYR . 66.8 mt -118.44 122.9 70.66 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.255 0 CA-C-N 116.491 -0.322 . . . . 0.0 110.155 -179.865 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' C' C ' 105' ' ' PHE . . . . . . . . . . . . . 89.7 m-85 -124.85 162.66 23.88 Favored 'General case' 0 N--CA 1.462 0.135 0 O-C-N 123.983 0.802 . . . . 0.0 110.3 -178.3 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' C' C ' 106' ' ' ASN . . . . . . . . . . . . . 41.3 p-10 -100.27 -169.95 1.8 Allowed 'General case' 0 C--N 1.331 -0.21 0 CA-C-N 116.309 -0.405 . . . . 0.0 109.934 174.018 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' C' C ' 107' ' ' GLN . . . . . . . . . . . . . 32.3 tt0 -58.49 -30.01 66.68 Favored 'General case' 0 CA--C 1.532 0.252 0 N-CA-C 111.998 0.37 . . . . 0.0 111.998 179.553 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' C' C ' 108' ' ' ASN . . . . . . . . . . . . . 10.7 t-20 -84.24 9.62 12.46 Favored 'General case' 0 CA--C 1.536 0.407 0 N-CA-C 113.114 0.783 . . . . 0.0 113.114 -176.787 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' C' C ' 109' ' ' LEU . . . . . 0.776 HD21 ' HB2' ' C' ' 78' ' ' ALA . 11.1 tp 56.13 35.85 26.39 Favored 'General case' 0 CA--C 1.531 0.225 0 CA-C-O 120.898 0.38 . . . . 0.0 111.266 -179.97 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' C' C ' 110' ' ' GLU . . . . . . . . . . . . . 42.8 mt-10 -103.17 147.62 26.79 Favored 'General case' 0 C--N 1.331 -0.22 0 N-CA-C 109.522 -0.547 . . . . 0.0 109.522 175.613 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' C' C ' 111' ' ' GLU . . . . . . . . . . . . . 50.9 tt0 -79.68 121.9 25.88 Favored 'General case' 0 C--N 1.327 -0.396 0 CA-C-O 120.822 0.344 . . . . 0.0 110.877 -175.838 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' C' C ' 112' ' ' LEU . . . . . . . . . . . . . 22.9 mt -106.03 -45.89 4.23 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-N 116.029 -0.532 . . . . 0.0 110.42 178.805 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' C' C ' 113' ' ' TYR . . . . . 0.5 ' HB3' HD12 ' C' ' 104' ' ' ILE . 53.4 t80 -136.26 138.79 42.17 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-O 120.905 0.383 . . . . 0.0 111.294 -178.849 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' C' C ' 114' ' ' ARG . . . . . . . . . . . . . 58.8 ttp180 -137.08 121.62 18.37 Favored 'General case' 0 C--N 1.331 -0.197 0 CA-C-N 115.775 -0.648 . . . . 0.0 110.221 178.164 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' C' C ' 115' ' ' GLY . . . . . . . . . . . . . . . -150.0 151.13 23.25 Favored Glycine 0 CA--C 1.523 0.584 0 N-CA-C 111.094 -0.802 . . . . 0.0 111.094 178.033 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' C' C ' 116' ' ' LYS . . . . . . . . . . . . . 72.6 tttt -130.01 133.19 46.6 Favored 'General case' 0 C--N 1.33 -0.261 0 N-CA-C 109.793 -0.447 . . . . 0.0 109.793 178.013 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' C' C ' 117' ' ' PHE . . . . . . . . . . . . . 23.1 m-85 -133.5 113.94 13.04 Favored 'General case' 0 C--N 1.331 -0.226 0 CA-C-O 120.884 0.373 . . . . 0.0 110.339 -174.136 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' C' C ' 118' ' ' GLU . . . . . . . . . . . . . 95.7 mt-10 -54.15 -50.43 66.98 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.396 -0.365 . . . . 0.0 111.179 -177.736 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' C' C ' 119' ' ' ASN . . . . . . . . . . . . . 35.6 m120 -89.67 29.64 1.13 Allowed 'General case' 0 C--N 1.33 -0.278 0 N-CA-C 112.261 0.467 . . . . 0.0 112.261 -174.922 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' C' C ' 120' ' ' LEU . . . . . . . . . . . . . 30.6 tp -57.95 121.22 10.05 Favored 'General case' 0 C--N 1.332 -0.162 0 N-CA-C 110.161 -0.311 . . . . 0.0 110.161 177.313 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' C' C ' 121' ' ' ASN . . . . . . . . . . . . . 32.1 m120 -114.11 -43.41 3.24 Favored 'General case' 0 C--N 1.331 -0.209 0 CA-C-N 116.326 -0.397 . . . . 0.0 111.017 -177.155 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' C' C ' 122' ' ' LYS . . . . . . . . . . . . . 67.9 mttm -138.68 144.34 39.57 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-O 121.152 0.501 . . . . 0.0 111.614 -175.909 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' C' C ' 123' ' ' VAL . . . . . . . . . . . . . 45.7 t -124.55 126.23 71.41 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.21 0 CA-C-N 115.715 -0.675 . . . . 0.0 109.448 176.146 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' C' C ' 124' ' ' LEU . . . . . . . . . . . . . 27.3 mt -123.18 131.0 53.52 Favored 'General case' 0 C--N 1.332 -0.166 0 CA-C-O 120.642 0.258 . . . . 0.0 110.683 -178.212 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' C' C ' 125' ' ' VAL . . . . . 0.452 HG11 HG21 ' C' ' 94' ' ' VAL . 35.1 m -136.31 134.41 49.84 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.288 0 CA-C-N 116.321 -0.4 . . . . 0.0 110.752 179.896 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' C' C ' 126' ' ' ARG . . . . . . . . . . . . . 95.7 mtt-85 -146.28 118.17 8.19 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.325 -0.398 . . . . 0.0 110.671 178.053 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' C' C ' 127' ' ' ASN . . . . . . . . . . . . . 34.8 m120 49.84 -104.97 0.16 Allowed 'General case' 0 CA--C 1.544 0.718 0 CA-C-O 119.202 -0.428 . . . . 0.0 111.78 177.599 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' C' C ' 128' ' ' ASP . . . . . . . . . . . . . 13.0 p-10 -114.23 13.5 17.94 Favored 'General case' 0 N--CA 1.467 0.408 0 CA-C-N 119.406 1.003 . . . . 0.0 113.263 -175.112 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' C' C ' 129' ' ' LEU . . . . . . . . . . . . . 24.4 tp -118.32 136.83 53.48 Favored 'General case' 0 C--N 1.332 -0.161 0 O-C-N 122.029 -0.42 . . . . 0.0 110.046 177.592 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' C' C ' 130' ' ' VAL . . . . . . . . . . . . . 42.4 t -125.09 136.56 60.47 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.196 0 CA-C-O 120.926 0.393 . . . . 0.0 110.025 -179.347 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' C' C ' 131' ' ' VAL . . . . . 0.485 HG22 HD12 ' C' ' 140' ' ' LEU . 41.8 t -136.02 135.26 50.46 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.291 0 CA-C-O 121.131 0.491 . . . . 0.0 110.167 178.022 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' C' C ' 132' ' ' ILE . . . . . . . . . . . . . 73.1 mt -117.08 129.85 72.95 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.323 0 CA-C-N 115.717 -0.674 . . . . 0.0 109.388 -179.295 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' C' C ' 133' ' ' ILE . . . . . . . . . . . . . 37.6 mm -115.46 120.3 64.31 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.301 0 CA-C-O 120.608 0.242 . . . . 0.0 111.047 -174.494 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' C' C ' 134' ' ' ASP . . . . . . . . . . . . . 7.5 p-10 -130.42 149.87 51.9 Favored 'General case' 0 C--N 1.333 -0.138 0 N-CA-C 109.944 -0.391 . . . . 0.0 109.944 174.655 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' C' C ' 135' ' ' GLU . . . . . . . . . . . . . 58.0 tt0 -49.92 -25.93 3.69 Favored 'General case' 0 C--N 1.327 -0.375 0 N-CA-C 113.088 0.773 . . . . 0.0 113.088 -170.889 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' C' C ' 136' ' ' GLN . . . . . . . . . . . . . 30.1 tt0 -95.38 -26.87 15.71 Favored 'General case' 0 CA--C 1.531 0.221 0 N-CA-C 112.765 0.654 . . . . 0.0 112.765 -172.472 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' C' C ' 137' ' ' LYS . . . . . . . . . . . . . 58.3 pttt -163.86 167.46 20.72 Favored 'General case' 0 C--O 1.233 0.193 0 CA-C-O 121.576 0.703 . . . . 0.0 112.162 -175.114 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' C' C ' 138' ' ' LEU . . . . . 0.413 HD23 ' C ' ' C' ' 138' ' ' LEU . 6.3 tt -117.12 128.43 55.12 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 115.029 -0.987 . . . . 0.0 109.928 179.712 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' C' C ' 139' ' ' THR . . . . . . . . . . . . . 27.7 m -108.24 124.83 50.9 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.156 -0.474 . . . . 0.0 110.402 179.236 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' C' C ' 140' ' ' LEU . . . . . 0.485 HD12 HG22 ' C' ' 131' ' ' VAL . 10.5 tp -111.21 120.47 42.38 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 115.853 -0.612 . . . . 0.0 109.355 -178.977 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' C' C ' 141' ' ' ILE . . . . . . . . . . . . . 18.9 mt -123.21 118.28 54.18 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.269 0 CA-C-O 121.118 0.485 . . . . 0.0 110.081 -174.862 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' C' C ' 142' ' ' ARG . . . . . . . . . . . . . 72.1 mtp180 -94.55 107.74 19.71 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 115.435 -0.802 . . . . 0.0 110.176 176.736 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' C' C ' 143' ' ' THR . . . . . . . . . . . . . 13.6 p . . . . . 0 C--O 1.22 -0.457 0 CA-C-O 117.967 -1.016 . . . . 0.0 110.507 -179.866 . . . . . . . . 0 0 . 1 . 016 nuclear nobuild full ' D' D ' -3' ' ' GLU . . . . . . . . . . . . . 95.8 mt-10 . . . . . 0 N--CA 1.488 1.473 0 N-CA-C 109.489 -0.56 . . . . 0.0 109.489 . . . . . . . . . 0 0 . 1 . 016 nuclear nobuild full ' D' D ' -2' ' ' GLY . . . . . . . . . . . . . . . -68.93 146.17 44.42 Favored Glycine 0 CA--C 1.526 0.722 0 N-CA-C 111.111 -0.796 . . . . 0.0 111.111 -179.558 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' D' D ' -1' ' ' VAL . . . . . . . . . . . . . 42.8 t -96.62 137.76 23.59 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.33 0 CA-C-O 120.8 0.333 . . . . 0.0 110.288 -179.937 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' D' D ' 0' ' ' ILE . . . . . . . . . . . . . 69.0 mt -113.01 132.63 61.28 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.24 0 CA-C-N 116.185 -0.461 . . . . 0.0 109.863 178.617 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' D' D ' 1' ' ' MET . . . . . . . . . . . . . 25.1 ptp -94.65 146.71 23.95 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.269 -0.423 . . . . 0.0 110.692 -179.546 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' D' D ' 2' ' ' SER . . . . . . . . . . . . . 3.9 p -118.16 129.96 55.83 Favored 'General case' 0 C--N 1.331 -0.216 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.613 179.076 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' D' D ' 3' ' ' GLU . . . . . . . . . . . . . 80.7 tt0 -146.6 142.93 28.45 Favored 'General case' 0 C--N 1.327 -0.396 0 CA-C-N 115.987 -0.551 . . . . 0.0 111.019 -178.658 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' D' D ' 4' ' ' LEU . . . . . . . . . . . . . 17.2 tp -124.3 132.27 53.56 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.01 -0.541 . . . . 0.0 110.056 177.171 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' D' D ' 5' ' ' LYS . . . . . . . . . . . . . 66.4 mttm -111.13 121.76 46.14 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 116.331 -0.395 . . . . 0.0 110.513 -179.176 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' D' D ' 6' ' ' LEU . . . . . . . . . . . . . 71.1 mt -117.2 151.43 36.9 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 115.668 -0.696 . . . . 0.0 110.94 -177.384 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' D' D ' 7' ' ' LYS . . . . . . . . . . . . . 74.9 tttt -142.5 141.72 21.47 Favored Pre-proline 0 CA--C 1.532 0.278 0 CA-C-N 116.18 -0.464 . . . . 0.0 109.952 174.005 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' D' D ' 8' ' ' PRO . . . . . . . . . . . . . 84.1 Cg_endo -90.76 144.8 3.7 Favored 'Trans proline' 0 N--CA 1.491 1.325 0 C-N-CA 121.74 1.627 . . . . 0.0 112.081 179.039 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' D' D ' 9' ' ' LEU . . . . . . . . . . . . . 40.9 mt -81.07 -47.18 1.14 Allowed Pre-proline 0 CA--C 1.533 0.292 0 CA-C-O 118.71 -0.662 . . . . 0.0 112.048 179.784 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' D' D ' 10' ' ' PRO . . . . . . . . . . . . . 88.1 Cg_endo -81.34 154.3 18.68 Favored 'Trans proline' 0 N--CA 1.497 1.711 0 C-N-CA 121.149 1.233 . . . . 0.0 111.643 175.223 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' D' D ' 11' ' ' LYS . . . . . . . . . . . . . 61.6 tttm -88.71 100.41 13.1 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.473 -0.331 . . . . 0.0 110.513 179.392 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' D' D ' 12' ' ' VAL . . . . . . . . . . . . . 12.3 p -144.92 146.44 19.98 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.233 0 CA-C-N 116.22 -0.446 . . . . 0.0 110.679 -179.516 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' D' D ' 13' ' ' GLU . . . . . . . . . . . . . 95.1 mt-10 -82.57 130.56 35.14 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 116.28 -0.418 . . . . 0.0 109.97 176.782 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' D' D ' 14' ' ' LEU . . . . . . . . . . . . . 16.8 mt -97.52 146.93 32.25 Favored Pre-proline 0 CA--C 1.533 0.303 0 CA-C-O 119.223 -0.418 . . . . 0.0 110.238 -178.476 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' D' D ' 15' ' ' PRO . . . . . . . . . . . . . 30.5 Cg_exo -60.43 159.36 27.68 Favored 'Trans proline' 0 N--CA 1.497 1.721 0 C-N-CA 121.328 1.352 . . . . 0.0 111.783 177.176 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' D' D ' 16' ' ' PRO . . . . . . . . . . . . . 39.4 Cg_exo -58.4 -41.04 69.67 Favored 'Trans proline' 0 N--CA 1.497 1.683 0 C-N-CA 121.472 1.448 . . . . 0.0 112.676 -178.261 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' D' D ' 17' ' ' ASP . . . . . . . . . . . . . 12.6 p-10 -87.82 13.01 11.55 Favored 'General case' 0 CA--C 1.535 0.404 0 N-CA-C 113.086 0.772 . . . . 0.0 113.086 -178.084 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' D' D ' 18' ' ' PHE . . . . . . . . . . . . . 46.6 t80 -58.26 -45.01 88.61 Favored 'General case' 0 C--N 1.334 -0.079 0 CA-C-O 120.935 0.398 . . . . 0.0 110.078 -178.542 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' D' D ' 19' ' ' VAL . . . . . . . . . . . . . 47.7 t -56.87 -41.2 75.64 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.249 0 CA-C-N 116.142 -0.481 . . . . 0.0 110.438 -178.805 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' D' D ' 20' ' ' ASP . . . . . . . . . . . . . 71.1 m-20 -60.39 -44.0 96.1 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-O 120.811 0.339 . . . . 0.0 111.071 -178.074 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' D' D ' 21' ' ' VAL . . . . . . . . . . . . . 46.1 t -64.22 -48.6 84.89 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 CA-C-N 116.353 -0.385 . . . . 0.0 110.484 -177.844 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' D' D ' 22' ' ' ILE . . . . . 0.666 HG22 HD12 ' D' ' 26' ' ' LEU . 50.6 mm -55.09 -47.92 76.62 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.241 0 CA-C-O 120.687 0.279 . . . . 0.0 110.829 179.356 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' D' D ' 23' ' ' ARG . . . . . . . . . . . . . 3.7 tmm_? -53.5 -53.38 52.33 Favored 'General case' 0 C--N 1.329 -0.313 0 N-CA-C 111.605 0.224 . . . . 0.0 111.605 -177.719 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' D' D ' 24' ' ' ILE . . . . . . . . . . . . . 72.2 mt -60.31 -41.86 88.64 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.28 0 N-CA-C 111.659 0.244 . . . . 0.0 111.659 -175.711 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' D' D ' 25' ' ' LYS . . . . . . . . . . . . . 53.0 mttm -67.79 -36.95 81.37 Favored 'General case' 0 C--N 1.328 -0.334 0 N-CA-C 112.147 0.425 . . . . 0.0 112.147 -177.707 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' D' D ' 26' ' ' LEU . . . . . 0.666 HD12 HG22 ' D' ' 22' ' ' ILE . 26.5 mt -79.46 -41.94 26.41 Favored 'General case' 0 C--N 1.33 -0.275 0 N-CA-C 112.798 0.666 . . . . 0.0 112.798 -173.617 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' D' D ' 27' ' ' GLN . . . . . . . . . . . . . 8.9 pt20 -46.0 138.57 4.99 Favored 'General case' 0 N--CA 1.47 0.554 0 N-CA-C 112.686 0.625 . . . . 0.0 112.686 -175.669 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' D' D ' 28' ' ' GLY . . . . . . . . . . . . . . . 100.79 -27.86 18.59 Favored Glycine 0 CA--C 1.53 1.02 0 CA-C-N 115.334 -0.848 . . . . 0.0 112.073 -176.086 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' D' D ' 29' ' ' LYS . . . . . . . . . . . . . 94.4 mttt -97.91 155.14 17.22 Favored 'General case' 0 C--O 1.232 0.164 0 CA-C-N 117.186 0.493 . . . . 0.0 111.01 178.796 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' D' D ' 30' ' ' THR . . . . . . . . . . . . . 25.2 m -103.96 139.39 39.18 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.167 -0.47 . . . . 0.0 110.33 176.935 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' D' D ' 31' ' ' VAL . . . . . . . . . . . . . 35.1 m -128.76 151.05 35.0 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.278 0 CA-C-O 121.047 0.451 . . . . 0.0 110.91 -178.922 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' D' D ' 32' ' ' ARG . . . . . . . . . . . . . 26.3 ttm180 -129.05 146.25 51.06 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 115.971 -0.559 . . . . 0.0 110.212 178.895 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' D' D ' 33' ' ' THR . . . . . . . . . . . . . 16.9 m -52.5 139.07 26.2 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.455 -0.339 . . . . 0.0 111.488 -177.301 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' D' D ' 34' ' ' GLY . . . . . . . . . . . . . . . 101.1 -17.21 56.38 Favored Glycine 0 CA--C 1.532 1.151 0 CA-C-O 119.702 -0.499 . . . . 0.0 113.242 179.962 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' D' D ' 35' ' ' ASP . . . . . . . . . . . . . 74.3 m-20 -66.08 149.65 49.94 Favored 'General case' 0 N--CA 1.461 0.095 0 CA-C-N 118.033 0.916 . . . . 0.0 111.15 179.176 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' D' D ' 36' ' ' VAL . . . . . . . . . . . . . 45.9 t -122.12 130.74 74.31 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.193 0 CA-C-N 115.838 -0.619 . . . . 0.0 109.776 177.947 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' D' D ' 37' ' ' ILE . . . . . . . . . . . . . 71.9 mt -121.13 140.13 46.2 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.218 0 CA-C-N 116.299 -0.409 . . . . 0.0 109.994 -179.149 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' D' D ' 38' ' ' GLY . . . . . . . . . . . . . . . -114.26 128.91 8.44 Favored Glycine 0 CA--C 1.526 0.767 0 N-CA-C 111.297 -0.721 . . . . 0.0 111.297 -178.685 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' D' D ' 39' ' ' ILE . . . . . . . . . . . . . 72.2 mt -123.51 135.63 62.69 Favored 'Isoleucine or valine' 0 C--N 1.333 -0.135 0 N-CA-C 109.963 -0.384 . . . . 0.0 109.963 178.268 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' D' D ' 40' ' ' SER . . . . . . . . . . . . . 23.1 t -92.71 123.12 35.76 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-N 116.521 -0.309 . . . . 0.0 111.018 176.786 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' D' D ' 41' ' ' ILE . . . . . . . . . . . . . 73.2 mt -132.21 112.9 20.49 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.167 0 CA-C-O 120.844 0.355 . . . . 0.0 110.315 177.511 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' D' D ' 42' ' ' LEU . . . . . 0.527 HD23 ' O ' ' D' ' 42' ' ' LEU . 1.4 tt 54.5 47.35 22.97 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-O 121.53 0.681 . . . . 0.0 110.647 178.237 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' D' D ' 43' ' ' GLY . . . . . . . . . . . . . . . 75.23 -10.1 11.51 Favored Glycine 0 CA--C 1.535 1.289 0 CA-C-O 119.692 -0.504 . . . . 0.0 113.796 175.274 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' D' D ' 44' ' ' LYS . . . . . . . . . . . . . 35.8 mmtm -99.79 132.65 45.01 Favored 'General case' 0 C--N 1.332 -0.165 0 CA-C-N 118.066 0.933 . . . . 0.0 110.378 -179.981 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' D' D ' 45' ' ' GLU . . . . . . . . . . . . . 80.3 tt0 -84.45 122.83 29.52 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.22 -0.446 . . . . 0.0 110.806 178.635 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' D' D ' 46' ' ' VAL . . . . . . . . . . . . . 7.7 p -117.19 124.27 72.81 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.199 0 N-CA-C 109.542 -0.54 . . . . 0.0 109.542 176.09 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' D' D ' 47' ' ' LYS . . . . . . . . . . . . . 57.7 mtmt -99.94 129.58 46.03 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 115.812 -0.631 . . . . 0.0 111.18 179.515 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' D' D ' 48' ' ' PHE . . . . . . . . . . . . . 91.3 m-85 -112.34 132.36 55.03 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-N 116.166 -0.47 . . . . 0.0 109.982 177.277 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' D' D ' 49' ' ' LYS . . . . . . . . . . . . . 76.1 tttt -105.84 135.54 47.09 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.348 -0.387 . . . . 0.0 110.41 179.581 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' D' D ' 50' ' ' VAL . . . . . . . . . . . . . 44.1 t -79.47 107.2 11.64 Favored 'Isoleucine or valine' 0 C--O 1.232 0.177 0 N-CA-C 109.324 -0.621 . . . . 0.0 109.324 175.717 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' D' D ' 51' ' ' VAL . . . . . . . . . . . . . 48.2 t -71.21 -51.69 32.54 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.344 0 CA-C-N 115.998 -0.547 . . . . 0.0 109.787 -174.376 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' D' D ' 52' ' ' GLN . . . . . . . . . . . . . 45.1 mt-30 -155.53 150.73 26.83 Favored 'General case' 0 C--N 1.331 -0.221 0 CA-C-O 121.18 0.514 . . . . 0.0 111.74 -177.467 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' D' D ' 53' ' ' ALA . . . . . . . . . . . . . . . -125.19 127.27 46.53 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 115.216 -0.902 . . . . 0.0 109.604 175.907 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' D' D ' 54' ' ' TYR . . . . . . . . . . . . . 62.6 t80 -126.37 107.32 24.02 Favored Pre-proline 0 CA--C 1.535 0.392 0 CA-C-O 118.321 -0.847 . . . . 0.0 110.689 -178.242 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' D' D ' 55' ' ' PRO . . . . . . . . . . . . . 74.1 Cg_endo -77.12 170.02 72.71 Favored 'Cis proline' 0 N--CA 1.499 1.836 0 CA-C-N 121.697 1.642 . . . . 0.0 112.355 -6.022 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' D' D ' 56' ' ' SER . . . . . . . . . . . . . 14.5 m -110.59 128.69 24.93 Favored Pre-proline 0 CA--C 1.539 0.526 0 CA-C-O 118.407 -0.806 . . . . 0.0 109.384 175.739 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' D' D ' 57' ' ' PRO . . . . . . . . . . . . . 61.2 Cg_endo -74.84 149.09 93.3 Favored 'Cis proline' 0 N--CA 1.496 1.639 0 CA-C-N 121.96 1.736 . . . . 0.0 111.716 -0.714 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' D' D ' 58' ' ' LEU . . . . . . . . . . . . . 27.9 tp -108.19 137.52 46.02 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.227 -0.442 . . . . 0.0 110.454 -179.04 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' D' D ' 59' ' ' ARG . . . . . . . . . . . . . 25.5 ttm180 -103.82 126.59 51.06 Favored 'General case' 0 C--N 1.327 -0.383 0 N-CA-C 109.394 -0.595 . . . . 0.0 109.394 176.029 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' D' D ' 60' ' ' VAL . . . . . . . . . . . . . 45.6 t -78.8 116.63 22.96 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.231 0 C-N-CA 120.684 -0.407 . . . . 0.0 110.409 -174.833 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' D' D ' 61' ' ' GLU . . . . . . . . . . . . . 94.7 mt-10 -131.06 163.1 28.36 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 116.0 -0.545 . . . . 0.0 109.849 177.795 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' D' D ' 62' ' ' ASP . . . . . . . . . . . . . 14.2 t0 -52.81 -32.99 47.06 Favored 'General case' 0 C--N 1.329 -0.296 0 N-CA-C 111.864 0.32 . . . . 0.0 111.864 -178.67 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' D' D ' 63' ' ' ARG . . . . . . . . . . . . . 77.2 mtt85 -73.64 -21.97 60.13 Favored 'General case' 0 C--N 1.33 -0.258 0 N-CA-C 113.076 0.769 . . . . 0.0 113.076 -176.061 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' D' D ' 64' ' ' THR . . . . . . . . . . . . . 31.4 m -66.14 138.39 57.69 Favored 'General case' 0 C--N 1.331 -0.211 0 CA-C-O 120.955 0.407 . . . . 0.0 111.14 -175.14 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' D' D ' 65' ' ' LYS . . . . . . . . . . . . . 93.2 mttt -89.01 136.62 32.92 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 115.763 -0.653 . . . . 0.0 109.827 176.969 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' D' D ' 66' ' ' ILE . . . . . . . . . . . . . 58.1 mt -115.8 127.21 73.46 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.294 0 N-CA-C 109.852 -0.425 . . . . 0.0 109.852 -179.181 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' D' D ' 67' ' ' THR . . . . . . . . . . . . . 26.5 m -126.45 147.57 49.78 Favored 'General case' 0 N--CA 1.463 0.215 0 CA-C-O 121.148 0.499 . . . . 0.0 111.362 -175.928 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' D' D ' 68' ' ' LEU . . . . . 0.473 ' N ' HD12 ' D' ' 68' ' ' LEU . 8.9 mp -102.43 137.83 40.15 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 115.869 -0.605 . . . . 0.0 110.454 177.389 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' D' D ' 69' ' ' VAL . . . . . . . . . . . . . 44.5 t -83.08 136.0 23.69 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 CA-C-N 116.409 -0.359 . . . . 0.0 110.364 179.414 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' D' D ' 70' ' ' THR . . . . . . . . . . . . . 10.4 t -107.69 -170.36 1.68 Allowed 'General case' 0 C--N 1.331 -0.233 0 CA-C-N 116.051 -0.522 . . . . 0.0 110.686 -178.444 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' D' D ' 71' ' ' HIS . . . . . . . . . . . . . 22.1 m-70 -64.96 168.34 7.51 Favored Pre-proline 0 CA--C 1.53 0.209 0 CA-C-N 116.364 -0.38 . . . . 0.0 110.333 179.396 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' D' D ' 72' ' ' PRO . . . . . 0.456 ' O ' HG13 ' D' ' 73' ' ' VAL . 18.6 Cg_exo -64.75 -30.18 59.34 Favored 'Trans proline' 0 N--CA 1.496 1.676 0 C-N-CA 121.23 1.287 . . . . 0.0 112.201 -179.152 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' D' D ' 73' ' ' VAL . . . . . 0.456 HG13 ' O ' ' D' ' 72' ' ' PRO . 3.5 m -153.77 100.7 0.15 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 CA-C-O 121.138 0.494 . . . . 0.0 110.992 175.1 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' D' D ' 74' ' ' ASP . . . . . . . . . . . . . 6.0 t70 -93.1 118.77 31.59 Favored 'General case' 0 C--N 1.327 -0.409 0 N-CA-C 108.691 -0.855 . . . . 0.0 108.691 173.136 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' D' D ' 75' ' ' VAL . . . . . 0.427 ' C ' HD12 ' D' ' 76' ' ' LEU . 36.6 t -111.44 126.8 68.86 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.313 0 CA-C-O 121.241 0.543 . . . . 0.0 111.312 -171.754 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' D' D ' 76' ' ' LEU . . . . . 0.427 HD12 ' C ' ' D' ' 75' ' ' VAL . 5.9 mp -125.97 145.53 50.25 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 115.363 -0.835 . . . . 0.0 109.531 174.672 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' D' D ' 77' ' ' GLU . . . . . . . . . . . . . 97.7 mt-10 -135.26 137.81 42.91 Favored 'General case' 0 N--CA 1.463 0.202 0 CA-C-O 120.982 0.42 . . . . 0.0 111.183 -179.468 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' D' D ' 78' ' ' ALA . . . . . 0.528 ' HB2' HD21 ' D' ' 109' ' ' LEU . . . -131.41 142.12 49.97 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 115.885 -0.598 . . . . 0.0 110.199 177.492 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' D' D ' 79' ' ' LYS . . . . . 0.558 ' O ' HD13 ' D' ' 80' ' ' ILE . 71.2 mmtt -82.05 122.2 27.52 Favored 'General case' 0 C--N 1.331 -0.239 0 CA-C-O 121.058 0.456 . . . . 0.0 111.276 -178.031 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' D' D ' 80' ' ' ILE . . . . . 0.558 HD13 ' O ' ' D' ' 79' ' ' LYS . 41.6 mm -139.17 118.94 13.97 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.304 0 N-CA-C 108.926 -0.768 . . . . 0.0 108.926 179.889 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' D' D ' 81' ' ' LYS . . . . . . . . . . . . . 47.5 pttt -112.28 125.56 54.29 Favored 'General case' 0 N--CA 1.464 0.269 0 CA-C-O 121.051 0.453 . . . . 0.0 111.381 -177.051 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' D' D ' 82' ' ' GLY . . . . . . . . . . . . . . . 88.52 42.22 5.86 Favored Glycine 0 CA--C 1.525 0.677 0 C-N-CA 120.825 -0.702 . . . . 0.0 111.689 173.659 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' D' D ' 83' ' ' ILE . . . . . . . . . . . . . 70.1 mt -63.55 138.64 22.63 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.33 0 CA-C-O 121.017 0.437 . . . . 0.0 110.206 179.343 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' D' D ' 84' ' ' LYS . . . . . . . . . . . . . 83.7 tttt -96.96 -50.3 4.68 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 115.792 -0.64 . . . . 0.0 109.718 179.306 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' D' D ' 85' ' ' ASP . . . . . . . . . . . . . 9.8 t70 -158.63 152.52 23.57 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 115.636 -0.711 . . . . 0.0 110.182 179.214 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' D' D ' 86' ' ' VAL . . . . . . . . . . . . . 43.4 t -130.48 130.13 64.93 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.297 0 CA-C-O 120.863 0.364 . . . . 0.0 110.429 -178.991 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' D' D ' 87' ' ' ILE . . . . . 0.493 HD12 ' N ' ' D' ' 87' ' ' ILE . 5.0 mp -119.6 126.13 75.02 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.261 0 N-CA-C 109.43 -0.582 . . . . 0.0 109.43 176.696 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' D' D ' 88' ' ' LEU . . . . . 0.452 ' CD1' HG21 ' C' ' 131' ' ' VAL . 12.9 tp -113.45 126.19 55.06 Favored 'General case' 0 C--N 1.331 -0.23 0 CA-C-O 120.987 0.422 . . . . 0.0 111.29 -176.636 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' D' D ' 89' ' ' ASP . . . . . . . . . . . . . 9.3 t0 -118.52 151.42 37.88 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 115.871 -0.604 . . . . 0.0 109.524 175.77 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' D' D ' 90' ' ' GLU . . . . . . . . . . . . . 95.4 mt-10 -48.63 -36.85 16.72 Favored 'General case' 0 C--N 1.33 -0.263 0 N-CA-C 112.782 0.66 . . . . 0.0 112.782 -173.054 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' D' D ' 91' ' ' ASN . . . . . . . . . . . . . 36.2 m120 -130.95 31.58 4.45 Favored 'General case' 0 N--CA 1.465 0.307 0 N-CA-C 112.022 0.378 . . . . 0.0 112.022 -176.711 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' D' D ' 92' ' ' LEU . . . . . . . . . . . . . 13.1 tp -166.14 139.38 4.12 Favored 'General case' 0 C--N 1.33 -0.274 0 N-CA-C 110.06 -0.348 . . . . 0.0 110.06 -179.818 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' D' D ' 93' ' ' ILE . . . . . . . . . . . . . 66.2 mt -125.01 124.15 67.02 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.255 0 N-CA-C 109.698 -0.482 . . . . 0.0 109.698 -178.435 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' D' D ' 94' ' ' VAL . . . . . 0.422 HG21 HG11 ' D' ' 125' ' ' VAL . 43.0 t -125.72 127.15 71.2 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.256 0 CA-C-O 121.023 0.44 . . . . 0.0 110.169 -179.367 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' D' D ' 95' ' ' VAL . . . . . . . . . . . . . 43.7 t -122.17 135.4 62.39 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.262 0 CA-C-N 115.893 -0.594 . . . . 0.0 109.856 179.845 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' D' D ' 96' ' ' ILE . . . . . . . . . . . . . 58.5 mt -115.43 129.29 71.95 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.323 0 N-CA-C 109.24 -0.652 . . . . 0.0 109.24 179.631 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' D' D ' 97' ' ' THR . . . . . . . . . . . . . 69.7 p -103.92 157.71 16.91 Favored 'General case' 0 C--N 1.331 -0.211 0 CA-C-O 121.381 0.61 . . . . 0.0 111.631 -176.522 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' D' D ' 98' ' ' GLU . . . . . . . . . . . . . 44.6 tp10 -53.77 -29.05 38.31 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 115.832 -0.622 . . . . 0.0 112.16 -178.871 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' D' D ' 99' ' ' GLU . . . . . . . . . . . . . 12.9 pt-20 -80.1 18.07 0.91 Allowed 'General case' 0 CA--C 1.534 0.359 0 N-CA-C 113.12 0.785 . . . . 0.0 113.12 -176.419 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' D' D ' 100' ' ' ASN . . . . . . . . . . . . . 4.6 m-20 62.91 38.13 11.53 Favored 'General case' 0 CA--C 1.529 0.151 0 CA-C-O 121.039 0.447 . . . . 0.0 110.897 177.773 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' D' D ' 101' ' ' GLU . . . . . . . . . . . . . 82.8 tt0 -114.71 142.07 46.99 Favored 'General case' 0 C--N 1.332 -0.173 0 CA-C-N 116.111 -0.495 . . . . 0.0 109.743 176.707 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' D' D ' 102' ' ' VAL . . . . . . . . . . . . . 44.8 t -115.84 125.97 73.18 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.312 0 N-CA-C 109.754 -0.462 . . . . 0.0 109.754 -179.49 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' D' D ' 103' ' ' LEU . . . . . . . . . . . . . 47.7 mt -117.15 130.31 56.53 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 115.746 -0.661 . . . . 0.0 110.295 177.777 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' D' D ' 104' ' ' ILE . . . . . 0.4 HD13 HG21 ' D' ' 130' ' ' VAL . 68.9 mt -120.06 121.35 65.64 Favored 'Isoleucine or valine' 0 C--O 1.235 0.316 0 N-CA-C 110.095 -0.335 . . . . 0.0 110.095 -179.139 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' D' D ' 105' ' ' PHE . . . . . . . . . . . . . 62.5 m-85 -122.69 162.65 21.57 Favored 'General case' 0 C--N 1.332 -0.159 0 O-C-N 123.924 0.765 . . . . 0.0 110.099 -178.902 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' D' D ' 106' ' ' ASN . . . . . 0.401 ' HB3' HD11 ' D' ' 112' ' ' LEU . 43.5 p30 -96.03 -171.63 2.37 Favored 'General case' 0 C--N 1.328 -0.348 0 N-CA-C 109.368 -0.604 . . . . 0.0 109.368 172.174 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' D' D ' 107' ' ' GLN . . . . . . . . . . . . . 45.8 tt0 -60.97 -29.9 69.94 Favored 'General case' 0 C--N 1.329 -0.325 0 N-CA-C 112.027 0.38 . . . . 0.0 112.027 -178.634 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' D' D ' 108' ' ' ASN . . . . . . . . . . . . . 6.7 t-20 -82.58 8.59 11.42 Favored 'General case' 0 CA--C 1.537 0.463 0 N-CA-C 113.15 0.796 . . . . 0.0 113.15 -178.069 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' D' D ' 109' ' ' LEU . . . . . 0.528 HD21 ' HB2' ' D' ' 78' ' ' ALA . 11.7 tp 61.67 37.92 15.61 Favored 'General case' 0 CA--C 1.53 0.182 0 CA-C-O 121.089 0.471 . . . . 0.0 111.324 178.122 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' D' D ' 110' ' ' GLU . . . . . . . . . . . . . 70.7 mm-40 -105.72 154.5 20.38 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.272 -0.422 . . . . 0.0 110.058 175.98 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' D' D ' 111' ' ' GLU . . . . . . . . . . . . . 44.4 mt-10 -83.61 122.19 28.25 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-O 120.852 0.358 . . . . 0.0 111.336 -177.88 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' D' D ' 112' ' ' LEU . . . . . 0.401 HD11 ' HB3' ' D' ' 106' ' ' ASN . 95.0 mt -106.25 -45.92 4.18 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.054 -0.521 . . . . 0.0 109.903 175.516 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' D' D ' 113' ' ' TYR . . . . . . . . . . . . . 59.9 t80 -140.0 139.95 36.14 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-N 116.26 -0.427 . . . . 0.0 110.808 179.602 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' D' D ' 114' ' ' ARG . . . . . . . . . . . . . 34.2 ptt180 -145.31 123.01 11.84 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.222 -0.445 . . . . 0.0 110.536 178.579 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' D' D ' 115' ' ' GLY . . . . . . . . . . . . . . . -150.12 156.91 26.97 Favored Glycine 0 CA--C 1.525 0.717 0 C-N-CA 120.694 -0.765 . . . . 0.0 111.641 179.516 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' D' D ' 116' ' ' LYS . . . . . . . . . . . . . 27.1 ttpp -128.44 133.13 48.48 Favored 'General case' 0 C--N 1.33 -0.259 0 N-CA-C 109.826 -0.435 . . . . 0.0 109.826 176.849 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' D' D ' 117' ' ' PHE . . . . . 0.439 ' HE2' HD13 ' D' ' 132' ' ' ILE . 31.4 m-85 -130.41 113.94 14.95 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-O 120.85 0.357 . . . . 0.0 110.237 -175.896 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' D' D ' 118' ' ' GLU . . . . . . . . . . . . . 95.9 mt-10 -52.97 -47.88 67.84 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.477 -0.328 . . . . 0.0 111.491 -176.981 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' D' D ' 119' ' ' ASN . . . . . . . . . . . . . 3.6 m-20 -94.96 31.01 1.95 Allowed 'General case' 0 C--N 1.329 -0.326 0 N-CA-C 112.338 0.496 . . . . 0.0 112.338 -174.131 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' D' D ' 120' ' ' LEU . . . . . . . . . . . . . 18.6 tp -55.96 124.5 17.91 Favored 'General case' 0 C--N 1.333 -0.146 0 CA-C-O 120.565 0.222 . . . . 0.0 110.507 176.86 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' D' D ' 121' ' ' ASN . . . . . . . . . . . . . 35.1 m120 -111.94 -44.0 3.51 Favored 'General case' 0 C--N 1.331 -0.222 0 CA-C-N 116.596 -0.275 . . . . 0.0 110.959 -177.605 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' D' D ' 122' ' ' LYS . . . . . . . . . . . . . 97.9 mttt -144.73 146.1 32.02 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-O 121.001 0.429 . . . . 0.0 111.621 -178.112 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' D' D ' 123' ' ' VAL . . . . . . . . . . . . . 45.6 t -125.69 125.28 68.25 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.26 0 N-CA-C 109.446 -0.575 . . . . 0.0 109.446 175.162 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' D' D ' 124' ' ' LEU . . . . . . . . . . . . . 49.3 mt -124.07 131.05 53.51 Favored 'General case' 0 C--N 1.331 -0.227 0 CA-C-O 120.676 0.274 . . . . 0.0 110.737 -178.169 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' D' D ' 125' ' ' VAL . . . . . 0.449 ' CG2' HG21 ' D' ' 87' ' ' ILE . 34.8 m -132.09 131.48 61.26 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.294 0 CA-C-N 116.274 -0.421 . . . . 0.0 110.389 179.285 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' D' D ' 126' ' ' ARG . . . . . . . . . . . . . 94.3 mtt180 -144.13 125.44 14.71 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-O 121.068 0.461 . . . . 0.0 111.12 -179.555 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' D' D ' 127' ' ' ASN . . . . . . . . . . . . . 6.7 m120 49.98 -109.53 0.38 Allowed 'General case' 0 CA--C 1.545 0.772 0 CA-C-O 118.972 -0.537 . . . . 0.0 111.685 177.334 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' D' D ' 128' ' ' ASP . . . . . . . . . . . . . 11.3 p-10 -114.15 8.72 17.01 Favored 'General case' 0 N--CA 1.469 0.479 0 CA-C-N 119.71 1.141 . . . . 0.0 113.224 -176.194 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' D' D ' 129' ' ' LEU . . . . . . . . . . . . . 58.4 mt -121.98 143.63 49.36 Favored 'General case' 0 C--N 1.333 -0.145 0 N-CA-C 109.483 -0.562 . . . . 0.0 109.483 177.357 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' D' D ' 130' ' ' VAL . . . . . 0.4 HG21 HD13 ' D' ' 104' ' ' ILE . 34.9 m -134.8 146.04 31.38 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.288 0 CA-C-O 121.229 0.537 . . . . 0.0 110.644 179.848 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' D' D ' 131' ' ' VAL . . . . . . . . . . . . . 43.1 t -136.03 139.84 45.09 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.396 0 CA-C-N 115.758 -0.655 . . . . 0.0 110.112 -179.789 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' D' D ' 132' ' ' ILE . . . . . 0.439 HD13 ' HE2' ' D' ' 117' ' ' PHE . 71.6 mt -114.59 130.95 68.08 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.322 0 N-CA-C 109.209 -0.663 . . . . 0.0 109.209 178.89 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' D' D ' 133' ' ' ILE . . . . . . . . . . . . . 40.3 mm -112.45 118.94 59.09 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.263 0 CA-C-N 116.438 -0.346 . . . . 0.0 110.763 -174.767 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' D' D ' 134' ' ' ASP . . . . . . . . . . . . . 6.6 p-10 -129.0 145.27 51.29 Favored 'General case' 0 C--N 1.331 -0.214 0 N-CA-C 109.396 -0.594 . . . . 0.0 109.396 175.984 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' D' D ' 135' ' ' GLU . . . . . . . . . . . . . 39.7 tp10 -49.95 -27.32 5.19 Favored 'General case' 0 C--O 1.235 0.315 0 N-CA-C 112.63 0.604 . . . . 0.0 112.63 -174.155 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' D' D ' 136' ' ' GLN . . . . . . . . . . . . . 95.4 mt-30 -76.88 -39.5 50.81 Favored 'General case' 0 C--O 1.235 0.319 0 CA-C-O 120.814 0.34 . . . . 0.0 111.893 -177.884 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' D' D ' 137' ' ' LYS . . . . . . . . . . . . . 55.0 pttt -170.01 176.91 4.51 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-O 121.475 0.655 . . . . 0.0 112.328 -171.825 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' D' D ' 138' ' ' LEU . . . . . 0.411 ' C ' HD23 ' D' ' 138' ' ' LEU . 6.8 tt -117.23 129.3 55.84 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 115.065 -0.97 . . . . 0.0 110.317 -178.515 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' D' D ' 139' ' ' THR . . . . . . . . . . . . . 35.6 m -109.08 124.88 51.47 Favored 'General case' 0 C--N 1.331 -0.219 0 CA-C-N 116.024 -0.535 . . . . 0.0 110.179 178.577 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' D' D ' 140' ' ' LEU . . . . . 0.457 ' C ' HD23 ' D' ' 140' ' ' LEU . 5.8 tt -111.29 122.14 47.08 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 115.781 -0.645 . . . . 0.0 109.308 -178.145 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' D' D ' 141' ' ' ILE . . . . . 0.43 ' N ' HD23 ' D' ' 140' ' ' LEU . 19.6 mt -122.79 118.55 55.37 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.221 0 CA-C-O 121.177 0.513 . . . . 0.0 110.201 -175.993 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' D' D ' 142' ' ' ARG . . . . . . . . . . . . . 92.6 mtt180 -92.77 120.45 33.16 Favored 'General case' 0 C--O 1.234 0.24 0 CA-C-N 115.223 -0.899 . . . . 0.0 109.823 176.865 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' D' D ' 143' ' ' THR . . . . . . . . . . . . . 67.1 p . . . . . 0 C--O 1.221 -0.428 0 CA-C-O 118.006 -0.997 . . . . 0.0 110.464 179.724 . . . . . . . . 0 0 . 1 . 016 nuclear nobuild full ' E' E ' -3' ' ' GLU . . . . . . . . . . . . . 43.1 mp0 . . . . . 0 N--CA 1.49 1.543 0 N-CA-C 109.243 -0.651 . . . . 0.0 109.243 . . . . . . . . . 0 0 . 1 . 016 nuclear nobuild full ' E' E ' -2' ' ' GLY . . . . . . . . . . . . . . . -89.41 126.86 8.43 Favored Glycine 0 CA--C 1.525 0.702 0 N-CA-C 110.895 -0.882 . . . . 0.0 110.895 179.304 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' E' E ' -1' ' ' VAL . . . . . . . . . . . . . 42.9 t -142.31 144.45 24.92 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.357 0 CA-C-O 120.885 0.374 . . . . 0.0 110.125 -179.414 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' E' E ' 0' ' ' ILE . . . . . . . . . . . . . 43.4 mm -113.39 145.02 19.84 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.226 0 CA-C-N 116.116 -0.493 . . . . 0.0 110.109 -179.985 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' E' E ' 1' ' ' MET . . . . . . . . . . . . . 25.2 ptp -143.05 163.61 32.35 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 116.312 -0.404 . . . . 0.0 110.754 -179.859 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' E' E ' 2' ' ' SER . . . . . . . . . . . . . 13.1 p -114.1 137.27 51.96 Favored 'General case' 0 C--N 1.331 -0.202 0 CA-C-O 121.087 0.47 . . . . 0.0 110.809 -177.98 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' E' E ' 3' ' ' GLU . . . . . . . . . . . . . 46.8 tt0 -152.46 145.63 24.65 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 116.059 -0.519 . . . . 0.0 111.152 -177.227 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' E' E ' 4' ' ' LEU . . . . . . . . . . . . . 18.4 tp -124.04 129.4 50.84 Favored 'General case' 0 C--N 1.331 -0.198 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.281 177.397 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' E' E ' 5' ' ' LYS . . . . . . . . . . . . . 67.6 mttm -108.24 123.1 48.26 Favored 'General case' 0 C--N 1.331 -0.215 0 CA-C-N 116.339 -0.391 . . . . 0.0 110.888 179.047 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' E' E ' 6' ' ' LEU . . . . . . . . . . . . . 33.7 mt -115.83 146.3 42.1 Favored 'General case' 0 N--CA 1.464 0.227 0 CA-C-N 115.641 -0.709 . . . . 0.0 110.155 179.132 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' E' E ' 7' ' ' LYS . . . . . . . . . . . . . 31.2 ttmt -128.32 136.76 29.57 Favored Pre-proline 0 CA--C 1.534 0.329 0 CA-C-O 118.88 -0.581 . . . . 0.0 109.585 174.912 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' E' E ' 8' ' ' PRO . . . . . . . . . . . . . 83.1 Cg_endo -92.0 141.51 2.47 Favored 'Trans proline' 0 N--CA 1.49 1.271 0 C-N-CA 121.719 1.613 . . . . 0.0 112.126 178.53 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' E' E ' 9' ' ' LEU . . . . . . . . . . . . . 20.3 mt -78.95 -46.91 1.72 Allowed Pre-proline 0 CA--C 1.534 0.359 0 CA-C-O 118.628 -0.701 . . . . 0.0 111.712 178.419 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' E' E ' 10' ' ' PRO . . . . . . . . . . . . . 91.5 Cg_endo -81.79 150.79 16.54 Favored 'Trans proline' 0 N--CA 1.495 1.615 0 C-N-CA 121.156 1.237 . . . . 0.0 111.539 174.645 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' E' E ' 11' ' ' LYS . . . . . . . . . . . . . 25.1 pttm -86.91 115.84 24.58 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-O 121.389 0.614 . . . . 0.0 110.742 179.423 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' E' E ' 12' ' ' VAL . . . . . . . . . . . . . 12.4 p -151.16 144.77 16.64 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.295 0 CA-C-N 115.822 -0.627 . . . . 0.0 110.341 177.496 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' E' E ' 13' ' ' GLU . . . . . . . . . . . . . 81.5 tt0 -92.83 114.18 26.67 Favored 'General case' 0 C--N 1.329 -0.32 0 N-CA-C 109.749 -0.463 . . . . 0.0 109.749 176.13 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' E' E ' 14' ' ' LEU . . . . . . . . . . . . . 27.9 mt -86.29 144.22 37.96 Favored Pre-proline 0 CA--C 1.533 0.301 0 CA-C-O 119.075 -0.488 . . . . 0.0 110.238 -176.508 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' E' E ' 15' ' ' PRO . . . . . . . . . . . . . 29.4 Cg_exo -60.34 162.62 16.83 Favored 'Trans proline' 0 N--CA 1.498 1.758 0 C-N-CA 121.271 1.314 . . . . 0.0 111.667 178.221 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' E' E ' 16' ' ' PRO . . . . . . . . . . . . . 33.0 Cg_exo -59.09 -38.86 84.7 Favored 'Trans proline' 0 N--CA 1.497 1.711 0 C-N-CA 121.511 1.474 . . . . 0.0 112.904 -176.892 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' E' E ' 17' ' ' ASP . . . . . . . . . . . . . 14.8 p-10 -83.94 1.67 42.41 Favored 'General case' 0 C--N 1.327 -0.383 0 N-CA-C 113.326 0.861 . . . . 0.0 113.326 -177.376 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' E' E ' 18' ' ' PHE . . . . . 0.405 ' CZ ' HD11 ' E' ' 22' ' ' ILE . 61.5 t80 -58.15 -46.4 85.73 Favored 'General case' 0 N--CA 1.457 -0.088 0 O-C-N 121.899 -0.5 . . . . 0.0 110.255 -178.048 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' E' E ' 19' ' ' VAL . . . . . . . . . . . . . 46.6 t -55.45 -43.02 70.39 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.264 0 CA-C-N 116.269 -0.423 . . . . 0.0 110.639 -178.082 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' E' E ' 20' ' ' ASP . . . . . . . . . . . . . 9.5 t0 -60.31 -43.15 96.61 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-O 120.803 0.335 . . . . 0.0 110.844 -178.588 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' E' E ' 21' ' ' VAL . . . . . . . . . . . . . 47.5 t -64.19 -45.88 95.06 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.299 0 C-N-CA 120.882 -0.327 . . . . 0.0 110.603 -177.851 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' E' E ' 22' ' ' ILE . . . . . 0.608 HG22 HD12 ' E' ' 26' ' ' LEU . 51.5 mm -55.53 -46.27 78.89 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.251 0 CA-C-O 120.822 0.344 . . . . 0.0 110.521 178.372 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' E' E ' 23' ' ' ARG . . . . . . . . . . . . . 60.0 ttp180 -53.31 -50.88 64.01 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.65 -0.25 . . . . 0.0 111.509 179.744 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' E' E ' 24' ' ' ILE . . . . . . . . . . . . . 73.7 mt -58.81 -42.9 86.87 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.27 0 CA-C-N 116.546 -0.297 . . . . 0.0 111.332 -176.737 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' E' E ' 25' ' ' LYS . . . . . . . . . . . . . 93.1 mttt -68.88 -38.59 79.79 Favored 'General case' 0 C--N 1.328 -0.332 0 N-CA-C 112.379 0.511 . . . . 0.0 112.379 -177.639 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' E' E ' 26' ' ' LEU . . . . . 0.608 HD12 HG22 ' E' ' 22' ' ' ILE . 78.3 mt -79.85 -38.81 31.96 Favored 'General case' 0 C--N 1.331 -0.236 0 N-CA-C 113.311 0.856 . . . . 0.0 113.311 -170.947 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' E' E ' 27' ' ' GLN . . . . . . . . . . . . . 10.3 pt20 -46.79 140.03 4.93 Favored 'General case' 0 N--CA 1.47 0.559 0 N-CA-C 112.643 0.609 . . . . 0.0 112.643 -175.376 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' E' E ' 28' ' ' GLY . . . . . . . . . . . . . . . 101.4 -26.02 26.06 Favored Glycine 0 CA--C 1.533 1.201 0 CA-C-N 115.57 -0.741 . . . . 0.0 112.174 -175.811 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' E' E ' 29' ' ' LYS . . . . . . . . . . . . . 88.0 mttt -97.51 155.06 17.11 Favored 'General case' 0 C--O 1.232 0.178 0 CA-C-N 117.374 0.587 . . . . 0.0 111.147 178.713 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' E' E ' 30' ' ' THR . . . . . . . . . . . . . 20.8 m -102.57 140.72 36.48 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 115.947 -0.57 . . . . 0.0 110.28 176.735 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' E' E ' 31' ' ' VAL . . . . . . . . . . . . . 34.9 m -128.4 147.48 32.94 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.25 0 CA-C-O 120.901 0.381 . . . . 0.0 110.64 -179.566 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' E' E ' 32' ' ' ARG . . . . . . . . . . . . . 68.8 ttt-85 -130.12 147.16 51.82 Favored 'General case' 0 C--N 1.331 -0.21 0 CA-C-N 116.07 -0.514 . . . . 0.0 110.415 179.541 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' E' E ' 33' ' ' THR . . . . . . . . . . . . . 22.9 m -52.46 139.36 25.28 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 116.458 -0.337 . . . . 0.0 111.594 -177.958 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' E' E ' 34' ' ' GLY . . . . . . . . . . . . . . . 97.48 -17.13 59.52 Favored Glycine 0 CA--C 1.533 1.179 0 C-N-CA 121.176 -0.535 . . . . 0.0 113.322 178.837 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' E' E ' 35' ' ' ASP . . . . . . . . . . . . . 77.1 m-20 -66.16 151.17 47.53 Favored 'General case' 0 C--O 1.231 0.087 0 CA-C-N 118.032 0.916 . . . . 0.0 111.057 179.838 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' E' E ' 36' ' ' VAL . . . . . . . . . . . . . 44.1 t -123.95 128.05 73.95 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.236 0 N-CA-C 109.678 -0.49 . . . . 0.0 109.678 177.038 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' E' E ' 37' ' ' ILE . . . . . . . . . . . . . 60.7 mt -120.78 137.5 54.31 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.26 0 CA-C-N 116.023 -0.535 . . . . 0.0 109.87 -179.473 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' E' E ' 38' ' ' GLY . . . . . . . . . . . . . . . -113.91 127.35 7.77 Favored Glycine 0 CA--C 1.526 0.748 0 N-CA-C 110.854 -0.898 . . . . 0.0 110.854 178.867 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' E' E ' 39' ' ' ILE . . . . . . . . . . . . . 72.7 mt -126.23 126.53 69.57 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.237 0 N-CA-C 110.005 -0.368 . . . . 0.0 110.005 179.451 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' E' E ' 40' ' ' SER . . . . . . . . . . . . . 80.2 p -93.33 123.1 36.38 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.398 -0.364 . . . . 0.0 111.052 176.423 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' E' E ' 41' ' ' ILE . . . . . . . . . . . . . 71.4 mt -137.3 127.97 39.38 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.215 0 CA-C-O 120.943 0.401 . . . . 0.0 110.21 177.11 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' E' E ' 42' ' ' LEU . . . . . . . . . . . . . 8.7 tp 58.47 35.15 24.5 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.045 -0.525 . . . . 0.0 111.522 179.257 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' E' E ' 43' ' ' GLY . . . . . . . . . . . . . . . 72.48 14.61 77.37 Favored Glycine 0 CA--C 1.535 1.285 0 C-N-CA 121.246 -0.502 . . . . 0.0 113.222 176.933 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' E' E ' 44' ' ' LYS . . . . . . . . . . . . . 72.0 mmtt -124.45 130.28 52.18 Favored 'General case' 0 N--CA 1.462 0.172 0 CA-C-N 117.89 0.845 . . . . 0.0 110.203 178.129 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' E' E ' 45' ' ' GLU . . . . . . . . . . . . . 79.1 tt0 -85.34 122.78 30.0 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 115.954 -0.567 . . . . 0.0 111.11 -179.812 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' E' E ' 46' ' ' VAL . . . . . 0.406 ' O ' HG13 ' E' ' 46' ' ' VAL . 10.9 p -118.82 123.0 70.79 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.197 0 N-CA-C 109.555 -0.535 . . . . 0.0 109.555 174.376 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' E' E ' 47' ' ' LYS . . . . . . . . . . . . . 68.1 mttm -99.33 126.93 45.28 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 115.984 -0.553 . . . . 0.0 111.014 179.114 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' E' E ' 48' ' ' PHE . . . . . . . . . . . . . 29.1 m-85 -111.09 131.82 54.77 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.116 -0.493 . . . . 0.0 109.944 177.446 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' E' E ' 49' ' ' LYS . . . . . . . . . . . . . 80.9 tttt -107.11 137.19 45.64 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.374 -0.376 . . . . 0.0 110.284 177.557 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' E' E ' 50' ' ' VAL . . . . . . . . . . . . . 42.9 t -74.15 106.72 4.19 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.345 0 N-CA-C 109.812 -0.44 . . . . 0.0 109.812 178.682 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' E' E ' 51' ' ' VAL . . . . . . . . . . . . . 46.1 t -70.75 -50.34 44.73 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.277 0 O-C-N 123.65 0.594 . . . . 0.0 109.704 -176.104 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' E' E ' 52' ' ' GLN . . . . . . . . . . . . . 56.3 tt0 -168.02 138.19 2.66 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 115.908 -0.587 . . . . 0.0 111.145 -179.19 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' E' E ' 53' ' ' ALA . . . . . . . . . . . . . . . -112.15 132.4 54.9 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 115.873 -0.603 . . . . 0.0 110.135 177.04 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' E' E ' 54' ' ' TYR . . . . . . . . . . . . . 22.9 t80 -127.97 107.22 20.1 Favored Pre-proline 0 CA--C 1.534 0.345 0 CA-C-O 118.285 -0.864 . . . . 0.0 110.364 179.778 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' E' E ' 55' ' ' PRO . . . . . . . . . . . . . 73.3 Cg_endo -77.06 170.05 72.7 Favored 'Cis proline' 0 N--CA 1.5 1.888 0 CA-C-N 121.682 1.637 . . . . 0.0 112.488 -5.286 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' E' E ' 56' ' ' SER . . . . . . . . . . . . . 70.5 m -115.54 129.93 24.73 Favored Pre-proline 0 CA--C 1.539 0.538 0 CA-C-O 118.427 -0.796 . . . . 0.0 109.35 175.391 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' E' E ' 57' ' ' PRO . . . . . . . . . . . . . 60.8 Cg_endo -74.34 150.61 95.81 Favored 'Cis proline' 0 N--CA 1.497 1.684 0 CA-C-N 121.952 1.733 . . . . 0.0 111.722 -0.31 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' E' E ' 58' ' ' LEU . . . . . . . . . . . . . 21.4 tp -109.02 138.11 45.88 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 116.299 -0.409 . . . . 0.0 110.85 -177.84 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' E' E ' 59' ' ' ARG . . . . . . . . . . . . . 78.0 ttt180 -101.75 125.88 48.5 Favored 'General case' 0 C--N 1.328 -0.339 0 N-CA-C 109.244 -0.65 . . . . 0.0 109.244 173.537 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' E' E ' 60' ' ' VAL . . . . . . . . . . . . . 46.8 t -77.81 114.64 18.6 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.308 0 C-N-CA 120.72 -0.392 . . . . 0.0 110.378 -176.88 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' E' E ' 61' ' ' GLU . . . . . . . . . . . . . 44.2 mt-10 -131.01 161.19 32.51 Favored 'General case' 0 C--N 1.332 -0.167 0 CA-C-N 115.933 -0.576 . . . . 0.0 110.012 177.663 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' E' E ' 62' ' ' ASP . . . . . . . . . . . . . 77.9 m-20 -54.4 -33.71 59.86 Favored 'General case' 0 C--N 1.328 -0.352 0 N-CA-C 112.088 0.403 . . . . 0.0 112.088 -175.798 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' E' E ' 63' ' ' ARG . . . . . . . . . . . . . 25.0 mmm180 -74.87 -17.21 60.62 Favored 'General case' 0 CA--C 1.535 0.391 0 N-CA-C 113.125 0.787 . . . . 0.0 113.125 -175.427 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' E' E ' 64' ' ' THR . . . . . . . . . . . . . 11.4 m -75.77 142.93 42.24 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-O 120.852 0.358 . . . . 0.0 110.865 -176.131 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' E' E ' 65' ' ' LYS . . . . . . . . . . . . . 95.6 mttt -89.63 139.76 30.23 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.111 -0.495 . . . . 0.0 110.531 179.938 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' E' E ' 66' ' ' ILE . . . . . . . . . . . . . 55.3 mt -113.81 133.37 59.99 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.287 0 N-CA-C 109.837 -0.431 . . . . 0.0 109.837 178.256 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' E' E ' 67' ' ' THR . . . . . . . . . . . . . 25.3 m -128.34 139.14 52.56 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-O 121.056 0.455 . . . . 0.0 111.166 -178.191 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' E' E ' 68' ' ' LEU . . . . . 0.489 HD12 ' N ' ' E' ' 68' ' ' LEU . 7.2 mp -100.31 124.46 45.8 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 115.826 -0.625 . . . . 0.0 109.853 176.411 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' E' E ' 69' ' ' VAL . . . . . . . . . . . . . 43.8 t -100.7 139.52 21.85 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.372 0 CA-C-N 116.118 -0.492 . . . . 0.0 110.409 -176.685 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' E' E ' 70' ' ' THR . . . . . . . . . . . . . 3.3 m -131.64 117.87 19.27 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.02 -0.536 . . . . 0.0 110.099 178.087 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' E' E ' 71' ' ' HIS . . . . . . . . . . . . . 2.1 m80 -96.5 160.01 30.54 Favored Pre-proline 0 C--N 1.327 -0.372 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.264 -179.21 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' E' E ' 72' ' ' PRO . . . . . . . . . . . . . 51.5 Cg_endo -69.73 -23.54 30.84 Favored 'Trans proline' 0 N--CA 1.497 1.691 0 C-N-CA 121.313 1.342 . . . . 0.0 112.822 -179.93 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' E' E ' 73' ' ' VAL . . . . . . . . . . . . . 34.7 m -118.28 147.44 21.75 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.172 0 CA-C-O 120.98 0.419 . . . . 0.0 110.616 -179.853 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' E' E ' 74' ' ' ASP . . . . . . . . . . . . . 9.7 t0 -104.33 120.39 41.09 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.025 -0.534 . . . . 0.0 109.822 179.104 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' E' E ' 75' ' ' VAL . . . . . . . . . . . . . 40.5 t -114.39 123.05 69.68 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.18 0 CA-C-O 121.055 0.455 . . . . 0.0 110.955 -175.4 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' E' E ' 76' ' ' LEU . . . . . . . . . . . . . 6.0 mp -123.34 146.71 47.72 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 115.657 -0.701 . . . . 0.0 109.591 175.632 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' E' E ' 77' ' ' GLU . . . . . . . . . . . . . 97.1 mt-10 -134.03 140.84 46.95 Favored 'General case' 0 N--CA 1.463 0.207 0 CA-C-O 121.167 0.508 . . . . 0.0 111.383 -178.418 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' E' E ' 78' ' ' ALA . . . . . . . . . . . . . . . -130.51 129.51 42.98 Favored 'General case' 0 C--N 1.332 -0.193 0 CA-C-N 115.684 -0.689 . . . . 0.0 109.751 175.849 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' E' E ' 79' ' ' LYS . . . . . 0.714 ' O ' HD13 ' E' ' 80' ' ' ILE . 37.3 mmtm -71.74 119.54 16.04 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-O 120.886 0.374 . . . . 0.0 110.981 -178.234 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' E' E ' 80' ' ' ILE . . . . . 0.714 HD13 ' O ' ' E' ' 79' ' ' LYS . 32.1 mm -139.31 99.91 1.32 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.259 0 N-CA-C 109.089 -0.708 . . . . 0.0 109.089 -178.213 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' E' E ' 81' ' ' LYS . . . . . . . . . . . . . 53.0 pttt -101.51 128.13 47.89 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-O 121.103 0.478 . . . . 0.0 111.31 -176.639 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' E' E ' 82' ' ' GLY . . . . . . . . . . . . . . . 89.21 41.95 5.7 Favored Glycine 0 CA--C 1.526 0.777 0 CA-C-N 115.799 -0.637 . . . . 0.0 111.66 177.2 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' E' E ' 83' ' ' ILE . . . . . . . . . . . . . 73.7 mt -68.94 144.66 13.95 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 CA-C-O 121.034 0.445 . . . . 0.0 110.234 179.078 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' E' E ' 84' ' ' LYS . . . . . . . . . . . . . 87.6 tttt -100.99 -51.77 3.46 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 115.792 -0.64 . . . . 0.0 109.993 -179.905 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' E' E ' 85' ' ' ASP . . . . . . . . . . . . . 7.9 t70 -160.44 154.69 23.33 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 115.597 -0.729 . . . . 0.0 110.057 179.459 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' E' E ' 86' ' ' VAL . . . . . . . . . . . . . 40.6 t -132.95 131.61 59.04 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.212 0 CA-C-O 121.06 0.457 . . . . 0.0 110.576 -178.588 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' E' E ' 87' ' ' ILE . . . . . . . . . . . . . 44.9 mm -119.45 128.23 75.86 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.208 0 CA-C-N 115.804 -0.634 . . . . 0.0 109.556 176.515 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' E' E ' 88' ' ' LEU . . . . . . . . . . . . . 84.2 mt -110.29 137.82 47.5 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-O 121.111 0.481 . . . . 0.0 111.499 -177.363 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' E' E ' 89' ' ' ASP . . . . . . . . . . . . . 10.9 t70 -127.07 153.23 46.24 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 115.502 -0.772 . . . . 0.0 109.074 174.436 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' E' E ' 90' ' ' GLU . . . . . . . . . . . . . 95.8 mt-10 -48.06 -36.91 13.9 Favored 'General case' 0 C--N 1.33 -0.244 0 N-CA-C 112.903 0.705 . . . . 0.0 112.903 -172.605 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' E' E ' 91' ' ' ASN . . . . . . . . . . . . . 27.6 m120 -132.06 32.03 4.08 Favored 'General case' 0 N--CA 1.465 0.277 0 N-CA-C 112.102 0.408 . . . . 0.0 112.102 -176.848 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' E' E ' 92' ' ' LEU . . . . . . . . . . . . . 8.1 tp -166.09 152.94 9.59 Favored 'General case' 0 C--N 1.33 -0.247 0 C-N-CA 120.897 -0.321 . . . . 0.0 110.81 -179.44 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' E' E ' 93' ' ' ILE . . . . . . . . . . . . . 73.0 mt -130.37 129.91 65.08 Favored 'Isoleucine or valine' 0 N--CA 1.462 0.166 0 N-CA-C 109.971 -0.381 . . . . 0.0 109.971 179.171 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' E' E ' 94' ' ' VAL . . . . . . . . . . . . . 44.7 t -122.56 125.0 71.97 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.246 0 N-CA-C 109.597 -0.52 . . . . 0.0 109.597 176.942 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' E' E ' 95' ' ' VAL . . . . . . . . . . . . . 43.5 t -120.66 134.52 63.82 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.295 0 CA-C-N 116.285 -0.416 . . . . 0.0 110.145 -177.929 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' E' E ' 96' ' ' ILE . . . . . . . . . . . . . 66.9 mt -115.83 129.4 72.25 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 N-CA-C 109.361 -0.607 . . . . 0.0 109.361 178.985 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' E' E ' 97' ' ' THR . . . . . . . . . . . . . 77.8 p -101.28 155.89 17.76 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-O 121.033 0.444 . . . . 0.0 111.111 -178.028 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' E' E ' 98' ' ' GLU . . . . . . . . . . . . . 12.8 pt-20 -54.05 -22.14 10.07 Favored 'General case' 0 CA--C 1.535 0.393 0 N-CA-C 112.613 0.598 . . . . 0.0 112.613 -179.256 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' E' E ' 99' ' ' GLU . . . . . . . . . . . . . 31.2 tt0 -83.38 18.15 1.9 Allowed 'General case' 0 CA--C 1.536 0.417 0 N-CA-C 112.79 0.663 . . . . 0.0 112.79 -177.333 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' E' E ' 100' ' ' ASN . . . . . . . . . . . . . 2.6 m-20 62.16 37.98 14.03 Favored 'General case' 0 CA--C 1.53 0.198 0 CA-C-O 121.011 0.434 . . . . 0.0 110.828 177.961 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' E' E ' 101' ' ' GLU . . . . . . . . . . . . . 81.4 tt0 -119.75 141.55 49.35 Favored 'General case' 0 C--N 1.332 -0.195 0 N-CA-C 109.765 -0.457 . . . . 0.0 109.765 177.684 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' E' E ' 102' ' ' VAL . . . . . . . . . . . . . 41.0 t -115.12 128.69 72.2 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.271 0 N-CA-C 110.216 -0.29 . . . . 0.0 110.216 -178.238 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' E' E ' 103' ' ' LEU . . . . . . . . . . . . . 7.0 mp -116.5 136.69 52.77 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 115.559 -0.746 . . . . 0.0 109.93 176.864 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' E' E ' 104' ' ' ILE . . . . . 0.498 HD12 ' HB3' ' E' ' 113' ' ' TYR . 68.2 mt -116.02 121.82 68.26 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.259 0 N-CA-C 109.766 -0.457 . . . . 0.0 109.766 179.742 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' E' E ' 105' ' ' PHE . . . . . . . . . . . . . 93.0 m-85 -123.33 165.76 16.44 Favored 'General case' 0 C--N 1.332 -0.163 0 O-C-N 124.281 0.988 . . . . 0.0 109.997 -177.713 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' E' E ' 106' ' ' ASN . . . . . . . . . . . . . 46.0 p-10 -104.0 -171.61 1.96 Allowed 'General case' 0 C--N 1.331 -0.197 0 N-CA-C 109.61 -0.515 . . . . 0.0 109.61 171.205 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' E' E ' 107' ' ' GLN . . . . . . . . . . . . . 20.7 tt0 -60.55 -24.37 65.35 Favored 'General case' 0 CA--C 1.534 0.35 0 N-CA-C 112.221 0.452 . . . . 0.0 112.221 179.831 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' E' E ' 108' ' ' ASN . . . . . . . . . . . . . 26.1 t30 -90.19 13.66 14.57 Favored 'General case' 0 CA--C 1.534 0.356 0 N-CA-C 112.978 0.733 . . . . 0.0 112.978 -178.609 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' E' E ' 109' ' ' LEU . . . . . . . . . . . . . 46.0 mt 56.73 35.24 25.91 Favored 'General case' 0 CA--C 1.53 0.206 0 CA-C-N 117.866 0.303 . . . . 0.0 111.557 177.511 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' E' E ' 110' ' ' GLU . . . . . . . . . . . . . 71.0 mm-40 -102.38 146.8 27.53 Favored 'General case' 0 C--N 1.33 -0.269 0 N-CA-C 109.906 -0.405 . . . . 0.0 109.906 176.926 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' E' E ' 111' ' ' GLU . . . . . . . . . . . . . 79.6 tt0 -82.29 124.73 30.23 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-O 120.953 0.406 . . . . 0.0 111.254 -175.993 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' E' E ' 112' ' ' LEU . . . . . . . . . . . . . 15.4 mt -108.38 -46.05 3.78 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 115.915 -0.584 . . . . 0.0 110.061 176.569 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' E' E ' 113' ' ' TYR . . . . . 0.498 ' HB3' HD12 ' E' ' 104' ' ' ILE . 48.3 t80 -142.55 145.06 33.22 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.169 -0.469 . . . . 0.0 111.317 -178.915 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' E' E ' 114' ' ' ARG . . . . . . . . . . . . . 55.1 ttp180 -151.02 125.26 9.38 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-O 121.065 0.459 . . . . 0.0 110.448 174.798 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' E' E ' 115' ' ' GLY . . . . . . . . . . . . . . . -150.13 155.65 26.34 Favored Glycine 0 CA--C 1.524 0.64 0 N-CA-C 110.67 -0.972 . . . . 0.0 110.67 178.374 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' E' E ' 116' ' ' LYS . . . . . . . . . . . . . 38.8 ttpt -114.9 140.29 49.1 Favored 'General case' 0 C--N 1.331 -0.197 0 O-C-N 122.593 -0.357 . . . . 0.0 110.338 179.14 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' E' E ' 117' ' ' PHE . . . . . . . . . . . . . 41.4 m-85 -133.95 114.59 13.43 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.2 -0.455 . . . . 0.0 110.17 -177.778 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' E' E ' 118' ' ' GLU . . . . . . . . . . . . . 70.8 mm-40 -51.28 -53.16 38.34 Favored 'General case' 0 C--N 1.33 -0.27 0 N-CA-C 111.837 0.31 . . . . 0.0 111.837 -175.925 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' E' E ' 119' ' ' ASN . . . . . . . . . . . . . 25.2 m120 -94.22 31.07 1.76 Allowed 'General case' 0 C--N 1.328 -0.334 0 N-CA-C 112.176 0.436 . . . . 0.0 112.176 -174.128 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' E' E ' 120' ' ' LEU . . . . . . . . . . . . . 12.9 tp -54.33 119.82 5.7 Favored 'General case' 0 N--CA 1.464 0.257 0 CA-C-O 120.749 0.309 . . . . 0.0 110.854 179.156 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' E' E ' 121' ' ' ASN . . . . . . . . . . . . . 88.8 m-20 -114.1 -44.03 3.18 Favored 'General case' 0 C--N 1.332 -0.176 0 CA-C-N 116.356 -0.384 . . . . 0.0 111.141 -178.036 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' E' E ' 122' ' ' LYS . . . . . . . . . . . . . 63.2 mtpt -140.63 148.61 41.14 Favored 'General case' 0 C--N 1.331 -0.211 0 CA-C-O 121.137 0.494 . . . . 0.0 111.682 -175.754 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' E' E ' 123' ' ' VAL . . . . . . . . . . . . . 43.5 t -131.27 126.45 58.81 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.261 0 CA-C-N 115.79 -0.641 . . . . 0.0 109.359 174.052 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' E' E ' 124' ' ' LEU . . . . . . . . . . . . . 41.1 mt -121.61 135.61 54.98 Favored 'General case' 0 C--N 1.331 -0.22 0 CA-C-N 116.496 -0.32 . . . . 0.0 110.565 -177.898 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' E' E ' 125' ' ' VAL . . . . . . . . . . . . . 11.6 p -134.0 129.26 54.11 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.277 0 CA-C-N 116.257 -0.429 . . . . 0.0 110.249 179.151 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' E' E ' 126' ' ' ARG . . . . . . . . . . . . . 52.1 mmm-85 -137.33 116.16 12.27 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.348 179.32 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' E' E ' 127' ' ' ASN . . . . . . . . . . . . . 7.1 m-80 52.65 -104.85 0.21 Allowed 'General case' 0 CA--C 1.543 0.689 0 CA-C-O 119.205 -0.426 . . . . 0.0 111.273 178.956 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' E' E ' 128' ' ' ASP . . . . . . . . . . . . . 10.9 p-10 -114.1 2.25 14.86 Favored 'General case' 0 N--CA 1.468 0.468 0 CA-C-N 119.48 1.036 . . . . 0.0 113.464 -176.458 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' E' E ' 129' ' ' LEU . . . . . . . . . . . . . 14.5 tp -105.36 135.1 47.36 Favored 'General case' 0 C--N 1.333 -0.146 0 CA-C-N 118.233 0.469 . . . . 0.0 110.012 179.018 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' E' E ' 130' ' ' VAL . . . . . . . . . . . . . 43.1 t -121.32 135.58 61.03 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.192 0 CA-C-O 120.897 0.379 . . . . 0.0 110.003 -178.288 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' E' E ' 131' ' ' VAL . . . . . . . . . . . . . 43.5 t -135.64 134.14 51.65 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.202 0 CA-C-O 120.991 0.424 . . . . 0.0 110.176 178.541 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' E' E ' 132' ' ' ILE . . . . . . . . . . . . . 71.5 mt -116.86 132.32 66.94 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.352 0 CA-C-N 115.713 -0.676 . . . . 0.0 109.357 179.748 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' E' E ' 133' ' ' ILE . . . . . . . . . . . . . 39.9 mm -116.0 119.26 61.37 Favored 'Isoleucine or valine' 0 C--O 1.234 0.25 0 CA-C-O 120.79 0.329 . . . . 0.0 111.029 -173.862 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' E' E ' 134' ' ' ASP . . . . . . . . . . . . . 10.4 p-10 -131.11 144.98 51.81 Favored 'General case' 0 C--N 1.332 -0.18 0 N-CA-C 109.454 -0.573 . . . . 0.0 109.454 174.584 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' E' E ' 135' ' ' GLU . . . . . . . . . . . . . 80.0 tt0 -49.8 -26.07 3.62 Favored 'General case' 0 C--N 1.328 -0.334 0 N-CA-C 112.95 0.722 . . . . 0.0 112.95 -171.656 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' E' E ' 136' ' ' GLN . . . . . . . . . . . . . 35.0 tt0 -80.9 -38.33 28.15 Favored 'General case' 0 C--O 1.234 0.256 0 N-CA-C 111.887 0.328 . . . . 0.0 111.887 -176.417 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' E' E ' 137' ' ' LYS . . . . . . . . . . . . . 15.3 pttp -162.02 171.56 17.37 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-O 121.602 0.715 . . . . 0.0 112.119 -172.423 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' E' E ' 138' ' ' LEU . . . . . 0.484 HD23 ' N ' ' E' ' 139' ' ' THR . 3.6 tt -114.07 126.51 55.19 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 114.864 -1.062 . . . . 0.0 109.744 179.171 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' E' E ' 139' ' ' THR . . . . . 0.484 ' N ' HD23 ' E' ' 138' ' ' LEU . 26.2 m -105.32 123.39 47.78 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.338 -0.392 . . . . 0.0 110.529 -179.858 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' E' E ' 140' ' ' LEU . . . . . 0.472 ' C ' HD23 ' E' ' 140' ' ' LEU . 7.6 tt -110.67 122.28 47.41 Favored 'General case' 0 C--N 1.327 -0.401 0 N-CA-C 109.251 -0.648 . . . . 0.0 109.251 -179.35 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' E' E ' 141' ' ' ILE . . . . . . . . . . . . . 19.7 mt -122.46 113.89 40.28 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.264 0 N-CA-C 109.786 -0.45 . . . . 0.0 109.786 -176.45 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' E' E ' 142' ' ' ARG . . . . . . . . . . . . . 67.8 ttp85 -103.05 129.7 49.94 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 115.416 -0.811 . . . . 0.0 110.831 -177.934 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' E' E ' 143' ' ' THR . . . . . . . . . . . . . 81.3 p . . . . . 0 C--O 1.22 -0.47 0 CA-C-O 117.873 -1.06 . . . . 0.0 110.834 179.463 . . . . . . . . 0 0 . 1 . 016 nuclear nobuild full ' F' F ' -3' ' ' GLU . . . . . . . . . . . . . 95.6 mt-10 . . . . . 0 N--CA 1.491 1.587 0 N-CA-C 109.307 -0.627 . . . . 0.0 109.307 . . . . . . . . . 0 0 . 1 . 016 nuclear nobuild full ' F' F ' -2' ' ' GLY . . . . . . . . . . . . . . . -62.71 131.29 43.52 Favored Glycine 0 CA--C 1.525 0.669 0 N-CA-C 111.222 -0.751 . . . . 0.0 111.222 -178.994 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' F' F ' -1' ' ' VAL . . . . . . . . . . . . . 44.7 t -96.54 140.75 16.7 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.27 0 N-CA-C 110.068 -0.345 . . . . 0.0 110.068 179.11 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' F' F ' 0' ' ' ILE . . . . . . . . . . . . . 67.3 mt -104.18 132.05 51.6 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.307 0 CA-C-N 116.261 -0.427 . . . . 0.0 109.982 -179.802 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' F' F ' 1' ' ' MET . . . . . . . . . . . . . 23.5 ptp -85.48 143.6 28.45 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.14 -0.482 . . . . 0.0 110.685 179.763 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' F' F ' 2' ' ' SER . . . . . . . . . . . . . 6.8 p -114.45 132.55 56.22 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.252 -0.431 . . . . 0.0 110.723 -179.566 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' F' F ' 3' ' ' GLU . . . . . . . . . . . . . 81.8 tt0 -141.35 141.06 33.87 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 115.963 -0.562 . . . . 0.0 111.032 -179.07 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' F' F ' 4' ' ' LEU . . . . . . . . . . . . . 15.2 tp -125.58 132.02 52.61 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.049 -0.523 . . . . 0.0 110.01 176.618 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' F' F ' 5' ' ' LYS . . . . . . . . . . . . . 65.1 mttm -111.61 120.18 41.21 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.249 -0.432 . . . . 0.0 110.606 -179.673 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' F' F ' 6' ' ' LEU . . . . . . . . . . . . . 67.1 mt -114.35 150.34 34.72 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 115.477 -0.783 . . . . 0.0 110.279 -178.609 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' F' F ' 7' ' ' LYS . . . . . . . . . . . . . 40.9 tttp -137.65 139.72 27.8 Favored Pre-proline 0 CA--C 1.534 0.353 0 CA-C-O 119.048 -0.501 . . . . 0.0 110.145 176.758 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' F' F ' 8' ' ' PRO . . . . . . . . . . . . . 94.0 Cg_endo -90.21 139.92 3.13 Favored 'Trans proline' 0 N--CA 1.489 1.263 0 C-N-CA 121.746 1.63 . . . . 0.0 111.662 177.575 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' F' F ' 9' ' ' LEU . . . . . . . . . . . . . 46.8 mt -78.7 -47.64 1.81 Allowed Pre-proline 0 CA--C 1.533 0.3 0 CA-C-O 118.652 -0.689 . . . . 0.0 112.181 -178.963 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' F' F ' 10' ' ' PRO . . . . . . . . . . . . . 92.1 Cg_endo -79.47 150.18 21.9 Favored 'Trans proline' 0 N--CA 1.496 1.647 0 C-N-CA 121.139 1.226 . . . . 0.0 111.766 175.95 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' F' F ' 11' ' ' LYS . . . . . . . . . . . . . 82.9 tttt -86.31 101.43 13.07 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.295 -0.411 . . . . 0.0 110.371 179.256 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' F' F ' 12' ' ' VAL . . . . . . . . . . . . . 12.5 p -146.64 149.84 15.55 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.255 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.76 -178.526 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' F' F ' 13' ' ' GLU . . . . . . . . . . . . . 70.7 mm-40 -79.87 126.64 31.25 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.152 -0.477 . . . . 0.0 110.098 177.112 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' F' F ' 14' ' ' LEU . . . . . . . . . . . . . 37.8 mt -97.53 144.48 28.03 Favored Pre-proline 0 CA--C 1.533 0.291 0 CA-C-O 119.012 -0.518 . . . . 0.0 110.038 179.464 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' F' F ' 15' ' ' PRO . . . . . . . . . . . . . 25.7 Cg_exo -62.01 153.97 65.23 Favored 'Trans proline' 0 N--CA 1.497 1.72 0 C-N-CA 121.204 1.27 . . . . 0.0 111.442 177.133 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' F' F ' 16' ' ' PRO . . . . . . . . . . . . . 31.2 Cg_exo -57.2 -38.84 94.14 Favored 'Trans proline' 0 N--CA 1.497 1.715 0 C-N-CA 121.412 1.408 . . . . 0.0 112.856 -179.244 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' F' F ' 17' ' ' ASP . . . . . . . . . . . . . 21.7 p-10 -85.98 9.63 16.45 Favored 'General case' 0 CA--C 1.537 0.444 0 N-CA-C 113.319 0.859 . . . . 0.0 113.319 -177.138 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' F' F ' 18' ' ' PHE . . . . . . . . . . . . . 43.3 t80 -58.47 -48.51 80.51 Favored 'General case' 0 N--CA 1.457 -0.109 0 O-C-N 121.971 -0.455 . . . . 0.0 110.153 -177.239 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' F' F ' 19' ' ' VAL . . . . . . . . . . . . . 14.0 p -54.46 -41.36 53.58 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.256 0 CA-C-N 116.378 -0.374 . . . . 0.0 111.284 -177.611 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' F' F ' 20' ' ' ASP . . . . . . . . . . . . . 73.3 m-20 -60.87 -45.95 92.52 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-O 120.823 0.344 . . . . 0.0 111.039 -177.806 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' F' F ' 21' ' ' VAL . . . . . . . . . . . . . 46.4 t -64.34 -46.92 91.71 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 C-N-CA 120.76 -0.376 . . . . 0.0 110.573 -177.103 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' F' F ' 22' ' ' ILE . . . . . 0.488 HG22 HD12 ' F' ' 26' ' ' LEU . 49.1 mm -56.21 -46.72 81.39 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.221 0 C-N-CA 120.917 -0.313 . . . . 0.0 110.647 179.347 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' F' F ' 23' ' ' ARG . . . . . . . . . . . . . 50.9 ttp180 -53.51 -48.42 69.02 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-O 120.639 0.257 . . . . 0.0 111.468 -178.477 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' F' F ' 24' ' ' ILE . . . . . . . . . . . . . 73.1 mt -59.58 -43.38 90.84 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.337 0 C-N-CA 121.072 -0.251 . . . . 0.0 111.05 -178.984 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' F' F ' 25' ' ' LYS . . . . . . . . . . . . . 53.5 mtmt -64.61 -39.1 93.11 Favored 'General case' 0 C--N 1.329 -0.307 0 N-CA-C 112.255 0.465 . . . . 0.0 112.255 -178.409 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' F' F ' 26' ' ' LEU . . . . . 0.488 HD12 HG22 ' F' ' 22' ' ' ILE . 63.3 mt -79.8 -40.59 28.27 Favored 'General case' 0 C--N 1.329 -0.298 0 N-CA-C 113.501 0.926 . . . . 0.0 113.501 -170.591 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' F' F ' 27' ' ' GLN . . . . . . . . . . . . . 10.6 pt20 -46.38 138.4 5.66 Favored 'General case' 0 N--CA 1.469 0.506 0 N-CA-C 112.995 0.739 . . . . 0.0 112.995 -173.821 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' F' F ' 28' ' ' GLY . . . . . . . . . . . . . . . 100.92 -26.88 23.05 Favored Glycine 0 CA--C 1.533 1.201 0 CA-C-N 115.611 -0.722 . . . . 0.0 112.185 -177.379 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' F' F ' 29' ' ' LYS . . . . . . . . . . . . . 83.1 mttt -97.98 155.12 17.25 Favored 'General case' 0 C--O 1.233 0.187 0 CA-C-N 117.329 0.564 . . . . 0.0 111.227 179.6 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' F' F ' 30' ' ' THR . . . . . . . . . . . . . 40.9 m -101.19 140.54 35.34 Favored 'General case' 0 C--N 1.33 -0.239 0 CA-C-N 116.01 -0.541 . . . . 0.0 110.375 177.755 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' F' F ' 31' ' ' VAL . . . . . . . . . . . . . 35.4 m -129.79 152.97 38.14 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.164 0 CA-C-N 116.313 -0.403 . . . . 0.0 110.327 178.673 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' F' F ' 32' ' ' ARG . . . . . . . . . . . . . 50.1 ttt180 -132.04 149.08 52.51 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-O 121.185 0.517 . . . . 0.0 110.277 178.529 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' F' F ' 33' ' ' THR . . . . . . . . . . . . . 19.5 m -52.46 137.63 29.34 Favored 'General case' 0 C--N 1.331 -0.212 0 CA-C-N 116.369 -0.378 . . . . 0.0 111.44 -178.218 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' F' F ' 34' ' ' GLY . . . . . . . . . . . . . . . 100.51 -17.15 57.11 Favored Glycine 0 CA--C 1.534 1.238 0 C-N-CA 121.172 -0.537 . . . . 0.0 113.188 179.532 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' F' F ' 35' ' ' ASP . . . . . . . . . . . . . 52.2 m-20 -64.54 151.04 45.59 Favored 'General case' 0 C--N 1.333 -0.115 0 CA-C-N 118.034 0.917 . . . . 0.0 111.19 -179.817 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' F' F ' 36' ' ' VAL . . . . . . . . . . . . . 44.7 t -127.85 130.92 70.12 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.199 0 CA-C-N 115.815 -0.629 . . . . 0.0 109.858 178.685 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' F' F ' 37' ' ' ILE . . . . . . . . . . . . . 66.0 mt -124.37 142.76 40.1 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.231 0 CA-C-N 116.282 -0.417 . . . . 0.0 110.033 -178.73 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' F' F ' 38' ' ' GLY . . . . . . . . . . . . . . . -111.98 128.84 8.77 Favored Glycine 0 CA--C 1.526 0.75 0 N-CA-C 111.036 -0.826 . . . . 0.0 111.036 179.133 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' F' F ' 39' ' ' ILE . . . . . . . . . . . . . 76.2 mt -125.14 135.68 63.26 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.224 0 N-CA-C 110.107 -0.331 . . . . 0.0 110.107 179.469 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' F' F ' 40' ' ' SER . . . . . . . . . . . . . 60.0 p -92.86 116.41 29.01 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.307 -0.406 . . . . 0.0 111.046 176.431 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' F' F ' 41' ' ' ILE . . . . . . . . . . . . . 44.5 mm -121.54 121.52 64.76 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.205 0 CA-C-O 120.86 0.362 . . . . 0.0 110.235 178.865 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' F' F ' 42' ' ' LEU . . . . . . . . . . . . . 60.3 mt 52.28 34.69 15.24 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.166 -0.47 . . . . 0.0 111.819 176.961 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' F' F ' 43' ' ' GLY . . . . . . . . . . . . . . . 72.98 32.56 60.61 Favored Glycine 0 CA--C 1.529 0.939 0 C-N-CA 121.047 -0.597 . . . . 0.0 112.064 177.869 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' F' F ' 44' ' ' LYS . . . . . . . . . . . . . 28.0 ttpp -139.92 132.96 29.51 Favored 'General case' 0 C--N 1.329 -0.322 0 N-CA-C 109.635 -0.506 . . . . 0.0 109.635 177.657 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' F' F ' 45' ' ' GLU . . . . . . . . . . . . . 79.5 tt0 -82.25 121.11 26.23 Favored 'General case' 0 C--N 1.328 -0.326 0 C-N-CA 120.928 -0.309 . . . . 0.0 111.134 -177.025 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' F' F ' 46' ' ' VAL . . . . . . . . . . . . . 7.5 p -120.88 127.03 75.89 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.254 0 N-CA-C 109.454 -0.572 . . . . 0.0 109.454 175.384 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' F' F ' 47' ' ' LYS . . . . . . . . . . . . . 69.0 mttm -100.02 129.93 46.13 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 115.96 -0.564 . . . . 0.0 111.159 179.338 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' F' F ' 48' ' ' PHE . . . . . . . . . . . . . 92.0 m-85 -113.18 131.81 55.73 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.233 -0.439 . . . . 0.0 110.002 177.489 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' F' F ' 49' ' ' LYS . . . . . . . . . . . . . 76.5 tttt -109.52 139.33 44.64 Favored 'General case' 0 C--N 1.331 -0.205 0 CA-C-N 116.409 -0.359 . . . . 0.0 110.581 178.839 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' F' F ' 50' ' ' VAL . . . . . . . . . . . . . 43.6 t -82.59 108.85 15.87 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.212 0 N-CA-C 109.528 -0.545 . . . . 0.0 109.528 176.251 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' F' F ' 51' ' ' VAL . . . . . . . . . . . . . 46.9 t -71.64 -53.68 19.74 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.338 0 CA-C-N 115.91 -0.586 . . . . 0.0 109.536 -175.316 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' F' F ' 52' ' ' GLN . . . . . . . . . . . . . 85.2 mt-30 -154.63 152.55 30.12 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-O 121.114 0.483 . . . . 0.0 111.481 -177.31 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' F' F ' 53' ' ' ALA . . . . . . . . . . . . . . . -129.79 133.3 46.89 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 115.496 -0.774 . . . . 0.0 109.858 175.156 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' F' F ' 54' ' ' TYR . . . . . . . . . . . . . 29.7 t80 -129.08 107.91 18.0 Favored Pre-proline 0 C--N 1.328 -0.331 0 CA-C-O 118.27 -0.871 . . . . 0.0 110.211 179.218 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' F' F ' 55' ' ' PRO . . . . . . . . . . . . . 73.9 Cg_endo -77.2 170.07 72.48 Favored 'Cis proline' 0 N--CA 1.501 1.916 0 CA-C-N 121.881 1.707 . . . . 0.0 112.549 -4.245 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' F' F ' 56' ' ' SER . . . . . . . . . . . . . 60.6 m -117.2 130.74 24.42 Favored Pre-proline 0 CA--C 1.538 0.495 0 CA-C-O 118.413 -0.803 . . . . 0.0 109.602 175.494 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' F' F ' 57' ' ' PRO . . . . . . . . . . . . . 31.3 Cg_endo -65.06 167.32 46.71 Favored 'Cis proline' 0 N--CA 1.498 1.749 0 CA-C-N 121.953 1.733 . . . . 0.0 111.542 -2.848 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' F' F ' 58' ' ' LEU . . . . . . . . . . . . . 18.2 tp -130.77 139.06 50.21 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.081 -0.509 . . . . 0.0 110.203 -179.81 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' F' F ' 59' ' ' ARG . . . . . . . . . . . . . 41.4 ttm180 -101.77 134.35 45.08 Favored 'General case' 0 C--N 1.326 -0.445 0 N-CA-C 109.276 -0.638 . . . . 0.0 109.276 174.523 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' F' F ' 60' ' ' VAL . . . . . . . . . . . . . 42.2 t -84.53 119.29 33.21 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.299 0 C-N-CA 120.569 -0.452 . . . . 0.0 110.161 -178.631 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' F' F ' 61' ' ' GLU . . . . . . . . . . . . . 70.5 tt0 -131.14 155.57 46.77 Favored 'General case' 0 C--N 1.327 -0.373 0 N-CA-C 109.094 -0.706 . . . . 0.0 109.094 176.276 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' F' F ' 62' ' ' ASP . . . . . . . . . . . . . 10.4 p-10 -52.49 -29.78 26.68 Favored 'General case' 0 C--N 1.326 -0.438 0 N-CA-C 112.064 0.394 . . . . 0.0 112.064 -177.72 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' F' F ' 63' ' ' ARG . . . . . . . . . . . . . 84.5 mtt-85 -75.5 -21.97 57.57 Favored 'General case' 0 CA--C 1.532 0.26 0 N-CA-C 113.092 0.775 . . . . 0.0 113.092 -175.902 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' F' F ' 64' ' ' THR . . . . . . . . . . . . . 31.5 m -67.07 146.47 54.28 Favored 'General case' 0 C--N 1.331 -0.227 0 CA-C-O 120.903 0.382 . . . . 0.0 111.195 -174.148 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' F' F ' 65' ' ' LYS . . . . . . . . . . . . . 68.3 mttm -88.63 127.65 35.57 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 115.954 -0.566 . . . . 0.0 110.036 177.691 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' F' F ' 66' ' ' ILE . . . . . . . . . . . . . 60.6 mt -115.02 127.43 72.58 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.322 0 N-CA-C 109.637 -0.505 . . . . 0.0 109.637 179.343 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' F' F ' 67' ' ' THR . . . . . . . . . . . . . 26.0 m -124.73 143.54 50.71 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-O 121.166 0.508 . . . . 0.0 111.357 -176.435 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' F' F ' 68' ' ' LEU . . . . . 0.474 HD23 ' C ' ' F' ' 68' ' ' LEU . 6.3 tt -96.45 121.72 38.57 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 115.557 -0.747 . . . . 0.0 109.525 175.473 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' F' F ' 69' ' ' VAL . . . . . . . . . . . . . 42.2 t -99.14 133.96 39.92 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.291 0 CA-C-O 120.89 0.376 . . . . 0.0 110.177 -177.668 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' F' F ' 70' ' ' THR . . . . . . . . . . . . . 24.2 m -131.52 134.4 46.08 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.01 -0.541 . . . . 0.0 110.474 -179.618 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' F' F ' 71' ' ' HIS . . . . . . . . . . . . . 10.5 m80 -131.31 164.12 44.62 Favored Pre-proline 0 C--N 1.33 -0.259 0 CA-C-N 116.006 -0.543 . . . . 0.0 109.864 179.794 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' F' F ' 72' ' ' PRO . . . . . . . . . . . . . 29.9 Cg_endo -65.05 -28.46 57.28 Favored 'Trans proline' 0 N--CA 1.495 1.582 0 C-N-CA 121.177 1.251 . . . . 0.0 112.257 179.212 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' F' F ' 73' ' ' VAL . . . . . . . . . . . . . 33.5 m -135.51 158.3 40.01 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.234 0 CA-C-O 121.044 0.449 . . . . 0.0 110.929 178.624 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' F' F ' 74' ' ' ASP . . . . . . . . . . . . . 12.9 t70 -98.75 118.35 35.29 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 115.697 -0.683 . . . . 0.0 109.463 176.505 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' F' F ' 75' ' ' VAL . . . . . . . . . . . . . 38.5 t -111.5 125.44 68.81 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.298 0 CA-C-O 121.083 0.468 . . . . 0.0 110.619 -176.351 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' F' F ' 76' ' ' LEU . . . . . . . . . . . . . 21.1 mt -129.5 147.98 51.36 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 115.575 -0.739 . . . . 0.0 109.765 178.793 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' F' F ' 77' ' ' GLU . . . . . . . . . . . . . 43.9 mp0 -135.57 136.49 41.16 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-O 120.981 0.419 . . . . 0.0 111.01 -179.301 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' F' F ' 78' ' ' ALA . . . . . 0.722 ' HB2' HD21 ' F' ' 109' ' ' LEU . . . -123.12 135.25 54.28 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 115.701 -0.681 . . . . 0.0 109.935 176.903 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' F' F ' 79' ' ' LYS . . . . . 0.724 ' O ' HD13 ' F' ' 80' ' ' ILE . 99.0 mttt -74.93 120.25 20.22 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-O 120.85 0.357 . . . . 0.0 110.801 -177.565 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' F' F ' 80' ' ' ILE . . . . . 0.724 HD13 ' O ' ' F' ' 79' ' ' LYS . 31.6 mm -139.19 104.6 2.23 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.241 0 N-CA-C 108.956 -0.757 . . . . 0.0 108.956 -178.635 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' F' F ' 81' ' ' LYS . . . . . . . . . . . . . 60.4 tttm -99.11 121.55 41.15 Favored 'General case' 0 C--N 1.327 -0.403 0 CA-C-O 120.881 0.372 . . . . 0.0 111.318 -175.47 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' F' F ' 82' ' ' GLY . . . . . . . . . . . . . . . 89.17 42.17 5.65 Favored Glycine 0 CA--C 1.525 0.681 0 C-N-CA 121.026 -0.607 . . . . 0.0 111.99 174.705 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' F' F ' 83' ' ' ILE . . . . . . . . . . . . . 71.7 mt -66.3 137.38 24.99 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.314 0 N-CA-C 109.65 -0.5 . . . . 0.0 109.65 175.909 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' F' F ' 84' ' ' LYS . . . . . . . . . . . . . 24.1 ttpp -102.38 -50.6 3.56 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-O 120.863 0.363 . . . . 0.0 110.464 -179.758 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' F' F ' 85' ' ' ASP . . . . . . . . . . . . . 8.6 t70 -149.41 151.33 33.86 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 115.976 -0.556 . . . . 0.0 110.648 -179.59 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' F' F ' 86' ' ' VAL . . . . . . . . . . . . . 44.0 t -131.34 132.84 62.76 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.248 0 CA-C-O 120.895 0.379 . . . . 0.0 110.547 -178.645 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' F' F ' 87' ' ' ILE . . . . . 0.497 HD12 ' N ' ' F' ' 87' ' ' ILE . 5.1 mp -121.94 129.93 75.01 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.289 0 N-CA-C 109.364 -0.606 . . . . 0.0 109.364 176.315 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' F' F ' 88' ' ' LEU . . . . . . . . . . . . . 13.9 tp -115.29 134.58 55.0 Favored 'General case' 0 C--N 1.332 -0.182 0 CA-C-O 121.182 0.515 . . . . 0.0 111.693 -175.366 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' F' F ' 89' ' ' ASP . . . . . . . . . . . . . 7.4 t0 -126.53 148.9 49.66 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 115.465 -0.788 . . . . 0.0 109.0 174.067 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' F' F ' 90' ' ' GLU . . . . . . . . . . . . . 93.5 mt-10 -49.38 -34.08 15.28 Favored 'General case' 0 C--N 1.329 -0.286 0 N-CA-C 112.625 0.602 . . . . 0.0 112.625 -173.769 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' F' F ' 91' ' ' ASN . . . . . . . . . . . . . 21.9 m120 -128.05 30.32 5.26 Favored 'General case' 0 N--CA 1.465 0.323 0 N-CA-C 112.187 0.44 . . . . 0.0 112.187 -176.974 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' F' F ' 92' ' ' LEU . . . . . . . . . . . . . 13.4 tp -166.19 147.57 6.68 Favored 'General case' 0 C--N 1.332 -0.179 0 CA-C-O 120.609 0.242 . . . . 0.0 110.52 -179.993 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' F' F ' 93' ' ' ILE . . . . . . . . . . . . . 70.4 mt -128.83 123.39 59.02 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.254 0 N-CA-C 109.541 -0.54 . . . . 0.0 109.541 179.416 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' F' F ' 94' ' ' VAL . . . . . 0.541 HG21 HG11 ' F' ' 125' ' ' VAL . 44.0 t -122.05 129.21 75.57 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.253 0 CA-C-O 120.884 0.373 . . . . 0.0 110.137 -179.424 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' F' F ' 95' ' ' VAL . . . . . . . . . . . . . 43.9 t -124.63 136.1 61.76 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.275 0 CA-C-N 116.04 -0.527 . . . . 0.0 110.054 -179.452 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' F' F ' 96' ' ' ILE . . . . . . . . . . . . . 59.6 mt -116.05 128.48 73.33 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.274 0 N-CA-C 109.255 -0.646 . . . . 0.0 109.255 178.783 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' F' F ' 97' ' ' THR . . . . . . . . . . . . . 82.6 p -102.89 156.63 17.53 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-O 121.156 0.503 . . . . 0.0 111.559 -175.845 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' F' F ' 98' ' ' GLU . . . . . . . . . . . . . 45.0 mt-10 -53.93 -26.04 23.39 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 116.099 -0.5 . . . . 0.0 112.179 179.395 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' F' F ' 99' ' ' GLU . . . . . . . . . . . . . 71.2 mm-40 -79.36 16.32 1.04 Allowed 'General case' 0 CA--C 1.535 0.377 0 N-CA-C 113.158 0.799 . . . . 0.0 113.158 -176.973 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' F' F ' 100' ' ' ASN . . . . . . . . . . . . . 2.1 m-20 62.11 32.78 17.35 Favored 'General case' 0 CA--C 1.531 0.232 0 CA-C-N 117.996 0.362 . . . . 0.0 111.555 178.412 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' F' F ' 101' ' ' GLU . . . . . . . . . . . . . 84.1 tt0 -112.56 144.71 41.59 Favored 'General case' 0 C--O 1.232 0.164 0 N-CA-C 109.735 -0.469 . . . . 0.0 109.735 175.412 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' F' F ' 102' ' ' VAL . . . . . . . . . . . . . 46.5 t -117.21 127.19 74.8 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.367 0 N-CA-C 109.67 -0.493 . . . . 0.0 109.67 -179.087 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' F' F ' 103' ' ' LEU . . . . . . . . . . . . . 27.9 mt -118.99 133.69 55.66 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 115.919 -0.582 . . . . 0.0 110.275 179.561 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' F' F ' 104' ' ' ILE . . . . . . . . . . . . . 70.5 mt -120.2 121.94 67.04 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.205 0 CA-C-N 116.469 -0.332 . . . . 0.0 110.295 -179.791 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' F' F ' 105' ' ' PHE . . . . . . . . . . . . . 81.4 m-85 -120.17 164.03 16.84 Favored 'General case' 0 C--N 1.332 -0.194 0 O-C-N 124.043 0.84 . . . . 0.0 109.681 179.504 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' F' F ' 106' ' ' ASN . . . . . . . . . . . . . 38.8 p-10 -97.41 -171.75 2.27 Favored 'General case' 0 C--N 1.331 -0.216 0 N-CA-C 109.957 -0.386 . . . . 0.0 109.957 174.091 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' F' F ' 107' ' ' GLN . . . . . . . . . . . . . 29.5 tt0 -60.01 -30.07 68.9 Favored 'General case' 0 C--N 1.33 -0.263 0 N-CA-C 111.986 0.365 . . . . 0.0 111.986 179.73 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' F' F ' 108' ' ' ASN . . . . . . . . . . . . . 44.6 t30 -82.71 6.04 19.3 Favored 'General case' 0 CA--C 1.536 0.433 0 N-CA-C 113.246 0.832 . . . . 0.0 113.246 -177.354 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' F' F ' 109' ' ' LEU . . . . . 0.722 HD21 ' HB2' ' F' ' 78' ' ' ALA . 12.6 tp 63.13 40.84 8.61 Favored 'General case' 0 C--O 1.233 0.189 0 CA-C-O 121.229 0.537 . . . . 0.0 111.091 178.107 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' F' F ' 110' ' ' GLU . . . . . . . . . . . . . 43.8 mt-10 -111.67 150.68 29.82 Favored 'General case' 0 C--N 1.33 -0.271 0 N-CA-C 109.814 -0.439 . . . . 0.0 109.814 174.639 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' F' F ' 111' ' ' GLU . . . . . . . . . . . . . 62.8 tt0 -84.75 121.98 28.46 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.389 -0.369 . . . . 0.0 110.956 -176.292 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' F' F ' 112' ' ' LEU . . . . . . . . . . . . . 57.7 mt -109.83 -46.02 3.55 Favored 'General case' 0 C--N 1.333 -0.144 0 CA-C-N 116.277 -0.419 . . . . 0.0 110.796 179.771 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' F' F ' 113' ' ' TYR . . . . . 0.415 ' HE2' HG21 ' A' ' 75' ' ' VAL . 61.0 t80 -132.99 140.56 47.83 Favored 'General case' 0 N--CA 1.464 0.271 0 CA-C-O 120.852 0.358 . . . . 0.0 110.745 -179.551 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' F' F ' 114' ' ' ARG . . . . . . . . . . . . . 36.0 ptt180 -143.99 123.46 13.17 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 115.848 -0.615 . . . . 0.0 110.347 178.384 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' F' F ' 115' ' ' GLY . . . . . . . . . . . . . . . -150.13 160.82 28.69 Favored Glycine 0 CA--C 1.525 0.661 0 N-CA-C 111.196 -0.762 . . . . 0.0 111.196 179.58 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' F' F ' 116' ' ' LYS . . . . . . . . . . . . . 76.8 tttt -130.5 140.6 50.51 Favored 'General case' 0 C--N 1.329 -0.287 0 N-CA-C 109.846 -0.428 . . . . 0.0 109.846 177.597 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' F' F ' 117' ' ' PHE . . . . . . . . . . . . . 30.8 m-85 -139.28 114.02 9.26 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.11 -0.495 . . . . 0.0 109.975 -177.222 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' F' F ' 118' ' ' GLU . . . . . . . . . . . . . 44.9 tp10 -52.05 -45.81 64.86 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.534 -0.303 . . . . 0.0 111.565 -176.927 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' F' F ' 119' ' ' ASN . . . . . . . . . . . . . 86.4 m-20 -98.52 31.14 2.96 Favored 'General case' 0 C--N 1.329 -0.299 0 N-CA-C 112.185 0.439 . . . . 0.0 112.185 -174.608 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' F' F ' 120' ' ' LEU . . . . . . . . . . . . . 17.5 tp -55.33 120.12 6.61 Favored 'General case' 0 N--CA 1.462 0.146 0 O-C-N 122.266 -0.271 . . . . 0.0 110.608 178.067 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' F' F ' 121' ' ' ASN . . . . . . . . . . . . . 89.1 m-20 -112.49 -44.09 3.41 Favored 'General case' 0 C--O 1.232 0.167 0 CA-C-N 116.579 -0.282 . . . . 0.0 111.219 -176.491 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' F' F ' 122' ' ' LYS . . . . . . . . . . . . . 92.4 mttt -146.68 150.24 35.02 Favored 'General case' 0 C--N 1.333 -0.138 0 C-N-CA 120.389 -0.524 . . . . 0.0 111.978 -177.862 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' F' F ' 123' ' ' VAL . . . . . . . . . . . . . 46.1 t -125.62 126.05 69.63 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.224 0 CA-C-N 115.726 -0.67 . . . . 0.0 109.53 175.471 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' F' F ' 124' ' ' LEU . . . . . . . . . . . . . 48.3 mt -115.97 132.99 56.49 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.399 -0.364 . . . . 0.0 110.363 -178.685 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' F' F ' 125' ' ' VAL . . . . . 0.541 HG11 HG21 ' F' ' 94' ' ' VAL . 34.9 m -131.73 137.1 55.83 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.211 0 CA-C-O 120.868 0.366 . . . . 0.0 111.074 -177.902 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' F' F ' 126' ' ' ARG . . . . . . . . . . . . . 96.7 mtt-85 -145.43 111.37 5.55 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.151 -0.477 . . . . 0.0 110.575 176.179 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' F' F ' 127' ' ' ASN . . . . . . . . . . . . . 6.2 m120 53.29 -104.91 0.22 Allowed 'General case' 0 CA--C 1.542 0.651 0 CA-C-O 119.07 -0.49 . . . . 0.0 111.193 178.869 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' F' F ' 128' ' ' ASP . . . . . . . . . . . . . 13.3 p-10 -113.66 3.22 15.53 Favored 'General case' 0 N--CA 1.469 0.495 0 CA-C-N 119.454 1.025 . . . . 0.0 113.378 -176.239 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' F' F ' 129' ' ' LEU . . . . . . . . . . . . . 17.2 tp -106.82 139.66 40.89 Favored 'General case' 0 C--N 1.334 -0.104 0 N-CA-C 109.787 -0.449 . . . . 0.0 109.787 177.853 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' F' F ' 130' ' ' VAL . . . . . . . . . . . . . 41.8 t -129.36 139.79 50.85 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.231 0 CA-C-O 121.064 0.459 . . . . 0.0 110.339 -177.565 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' F' F ' 131' ' ' VAL . . . . . . . . . . . . . 44.6 t -136.1 135.61 50.01 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.319 0 CA-C-N 116.015 -0.539 . . . . 0.0 109.838 176.915 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' F' F ' 132' ' ' ILE . . . . . . . . . . . . . 71.3 mt -117.57 134.05 62.4 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.292 0 CA-C-N 116.141 -0.481 . . . . 0.0 109.709 -178.681 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' F' F ' 133' ' ' ILE . . . . . . . . . . . . . 43.0 mm -115.3 123.24 70.67 Favored 'Isoleucine or valine' 0 C--O 1.233 0.217 0 CA-C-N 116.277 -0.42 . . . . 0.0 111.003 -175.054 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' F' F ' 134' ' ' ASP . . . . . . . . . . . . . 8.1 p-10 -134.87 145.48 48.32 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 115.892 -0.595 . . . . 0.0 109.505 173.952 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' F' F ' 135' ' ' GLU . . . . . . . . . . . . . 40.1 tp10 -49.9 -24.83 2.72 Favored 'General case' 0 CA--C 1.534 0.346 0 N-CA-C 112.737 0.643 . . . . 0.0 112.737 -173.901 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' F' F ' 136' ' ' GLN . . . . . . . . . . . . . 60.1 tt0 -81.91 -36.76 27.74 Favored 'General case' 0 C--O 1.234 0.243 0 N-CA-C 111.859 0.318 . . . . 0.0 111.859 -176.533 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' F' F ' 137' ' ' LYS . . . . . . . . . . . . . 20.0 pttp -168.18 175.36 6.59 Favored 'General case' 0 C--N 1.331 -0.201 0 CA-C-O 121.503 0.668 . . . . 0.0 111.984 -173.0 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' F' F ' 138' ' ' LEU . . . . . 0.418 HD23 ' C ' ' F' ' 138' ' ' LEU . 7.3 tt -118.94 129.79 55.36 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 115.107 -0.951 . . . . 0.0 110.15 179.563 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' F' F ' 139' ' ' THR . . . . . . . . . . . . . 37.7 m -110.39 130.02 55.64 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.104 -0.498 . . . . 0.0 110.508 -179.984 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' F' F ' 140' ' ' LEU . . . . . 0.446 HD23 ' N ' ' F' ' 141' ' ' ILE . 5.2 tt -115.38 123.98 50.04 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 115.855 -0.611 . . . . 0.0 109.755 -178.091 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' F' F ' 141' ' ' ILE . . . . . 0.446 ' N ' HD23 ' F' ' 140' ' ' LEU . 18.8 mt -123.4 124.69 70.32 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.184 0 N-CA-C 110.015 -0.365 . . . . 0.0 110.015 -174.379 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' F' F ' 142' ' ' ARG . . . . . . . . . . . . . 77.1 ttt180 -120.91 134.57 55.3 Favored 'General case' 0 C--O 1.234 0.259 0 CA-C-N 116.106 -0.497 . . . . 0.0 110.297 -178.823 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' F' F ' 143' ' ' THR . . . . . . . . . . . . . 21.5 p . . . . . 0 C--O 1.219 -0.533 0 CA-C-O 117.99 -1.005 . . . . 0.0 110.567 -179.607 . . . . . . . . 0 0 . 1 . 017 nuclear nobuild full ' A' A ' -3' ' ' GLU . . . . . . . . . . . . . 78.6 tt0 . . . . . 0 N--CA 1.489 1.491 0 N-CA-C 109.232 -0.655 . . . . 0.0 109.232 . . . . . . . . . 0 0 . 1 . 017 nuclear nobuild full ' A' A ' -2' ' ' GLY . . . . . . . . . . . . . . . -74.55 150.04 41.08 Favored Glycine 0 CA--C 1.525 0.691 0 N-CA-C 110.899 -0.88 . . . . 0.0 110.899 179.775 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' -1' ' ' VAL . . . . . . . . . . . . . 42.3 t -94.33 130.89 42.58 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.243 0 CA-C-O 120.906 0.384 . . . . 0.0 110.061 -179.536 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 0' ' ' ILE . . . . . . . . . . . . . 68.7 mt -119.35 131.91 70.67 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.214 0 CA-C-N 116.12 -0.491 . . . . 0.0 110.007 -179.709 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 26.5 ptm -94.34 134.04 37.26 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.238 -0.437 . . . . 0.0 110.344 178.179 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 7.1 p -117.95 131.61 56.49 Favored 'General case' 0 C--N 1.332 -0.172 0 CA-C-O 121.084 0.469 . . . . 0.0 110.598 179.307 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 95.6 mt-10 -141.23 141.41 34.03 Favored 'General case' 0 C--N 1.327 -0.406 0 CA-C-N 115.861 -0.609 . . . . 0.0 110.876 -179.096 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 4' ' ' LEU . . . . . 0.488 HD23 ' N ' ' A' ' 5' ' ' LYS . 3.7 tt -128.19 124.95 38.04 Favored 'General case' 0 C--N 1.33 -0.268 0 N-CA-C 109.679 -0.489 . . . . 0.0 109.679 176.887 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 5' ' ' LYS . . . . . 0.488 ' N ' HD23 ' A' ' 4' ' ' LEU . 63.0 mttp -107.7 122.61 47.08 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-O 120.625 0.25 . . . . 0.0 111.087 -179.189 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 25.2 mt -114.0 144.51 42.97 Favored 'General case' 0 C--O 1.232 0.145 0 CA-C-N 115.542 -0.754 . . . . 0.0 110.525 179.419 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 24.8 ttmt -126.52 139.38 34.56 Favored Pre-proline 0 CA--C 1.531 0.247 0 N-CA-C 109.537 -0.542 . . . . 0.0 109.537 173.224 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 8' ' ' PRO . . . . . . . . . . . . . 98.3 Cg_endo -91.5 141.76 2.76 Favored 'Trans proline' 0 N--CA 1.491 1.335 0 C-N-CA 121.715 1.61 . . . . 0.0 112.156 -179.674 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 56.3 mt -80.07 -47.22 1.39 Allowed Pre-proline 0 CA--C 1.534 0.364 0 CA-C-O 118.64 -0.695 . . . . 0.0 112.222 178.799 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 89.8 Cg_endo -80.98 153.79 19.36 Favored 'Trans proline' 0 N--CA 1.496 1.644 0 C-N-CA 121.168 1.245 . . . . 0.0 111.749 176.142 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 19.4 tptp -88.23 99.09 11.95 Favored 'General case' 0 C--N 1.33 -0.274 0 N-CA-C 110.005 -0.369 . . . . 0.0 110.005 179.303 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 12.7 p -142.34 148.54 20.09 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.258 0 CA-C-N 116.326 -0.397 . . . . 0.0 110.928 -177.766 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 84.2 tt0 -93.69 121.1 34.78 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.05 -0.523 . . . . 0.0 110.04 176.628 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 14' ' ' LEU . . . . . . . . . . . . . 46.6 mt -98.58 152.3 37.84 Favored Pre-proline 0 CA--C 1.533 0.29 0 CA-C-N 116.468 -0.333 . . . . 0.0 110.843 -178.309 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 15' ' ' PRO . . . . . . . . . . . . . 28.6 Cg_exo -61.03 158.65 33.24 Favored 'Trans proline' 0 N--CA 1.498 1.74 0 C-N-CA 121.3 1.333 . . . . 0.0 112.013 177.706 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 16' ' ' PRO . . . . . . . . . . . . . 29.5 Cg_exo -59.99 -36.08 91.04 Favored 'Trans proline' 0 N--CA 1.497 1.677 0 C-N-CA 121.443 1.429 . . . . 0.0 112.689 -179.919 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 17' ' ' ASP . . . . . . . . . . . . . 21.7 p-10 -85.84 8.72 19.02 Favored 'General case' 0 CA--C 1.536 0.406 0 N-CA-C 113.295 0.85 . . . . 0.0 113.295 -177.172 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 18' ' ' PHE . . . . . . . . . . . . . 41.9 t80 -58.09 -44.01 87.36 Favored 'General case' 0 N--CA 1.457 -0.087 0 O-C-N 122.03 -0.419 . . . . 0.0 110.102 -178.713 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 19' ' ' VAL . . . . . . . . . . . . . 48.5 t -56.15 -42.66 73.64 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.291 0 CA-C-N 116.275 -0.42 . . . . 0.0 110.457 -178.81 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 73.0 m-20 -59.89 -43.68 94.67 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-O 120.791 0.329 . . . . 0.0 110.885 -177.907 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 45.8 t -64.35 -45.57 95.61 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.292 0 C-N-CA 120.715 -0.394 . . . . 0.0 110.574 -177.466 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 22' ' ' ILE . . . . . 0.687 HG22 HD12 ' A' ' 26' ' ' LEU . 51.1 mm -55.36 -47.61 77.83 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.254 0 C-N-CA 120.921 -0.312 . . . . 0.0 110.73 179.26 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 23' ' ' ARG . . . . . . . . . . . . . 55.6 ttp180 -55.44 -49.1 73.34 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-O 120.704 0.288 . . . . 0.0 111.207 -178.48 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 24' ' ' ILE . . . . . . . . . . . . . 71.6 mt -58.99 -41.72 84.06 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.258 0 CA-C-N 116.529 -0.305 . . . . 0.0 111.351 -176.419 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 83.6 mttt -71.75 -41.1 68.86 Favored 'General case' 0 C--N 1.328 -0.346 0 N-CA-C 112.714 0.635 . . . . 0.0 112.714 -178.02 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 26' ' ' LEU . . . . . 0.687 HD12 HG22 ' A' ' 22' ' ' ILE . 34.2 mt -78.53 -32.58 48.03 Favored 'General case' 0 C--N 1.328 -0.343 0 N-CA-C 113.697 0.999 . . . . 0.0 113.697 -170.332 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 27' ' ' GLN . . . . . . . . . . . . . 10.2 pt20 -47.11 140.76 4.81 Favored 'General case' 0 N--CA 1.468 0.463 0 N-CA-C 112.771 0.656 . . . . 0.0 112.771 -175.873 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 99.62 -24.11 33.49 Favored Glycine 0 CA--C 1.534 1.222 0 CA-C-N 115.696 -0.684 . . . . 0.0 112.399 -178.047 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 57.2 mtpt -97.62 155.06 17.15 Favored 'General case' 0 C--N 1.333 -0.13 0 CA-C-N 117.531 0.666 . . . . 0.0 111.125 179.312 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 30' ' ' THR . . . . . . . . . . . . . 41.0 m -105.18 137.32 43.14 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 115.89 -0.595 . . . . 0.0 110.036 176.273 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 31' ' ' VAL . . . . . 0.429 HG21 HD11 ' A' ' 4' ' ' LEU . 34.7 m -129.08 152.27 36.96 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.213 0 CA-C-O 120.932 0.396 . . . . 0.0 110.932 -178.402 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 32' ' ' ARG . . . . . . . . . . . . . 68.3 ttp85 -130.28 148.51 52.12 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 115.94 -0.573 . . . . 0.0 110.477 179.924 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 33' ' ' THR . . . . . . . . . . . . . 25.0 m -52.99 139.3 28.17 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.308 -0.405 . . . . 0.0 111.435 -178.024 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 100.16 -17.12 57.49 Favored Glycine 0 CA--C 1.532 1.137 0 CA-C-O 119.698 -0.501 . . . . 0.0 113.342 179.437 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 77.8 m-20 -66.43 149.58 50.2 Favored 'General case' 0 C--N 1.334 -0.102 0 CA-C-N 118.055 0.927 . . . . 0.0 111.228 179.122 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 47.4 t -122.35 130.55 74.44 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.199 0 CA-C-N 115.881 -0.6 . . . . 0.0 109.729 177.922 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 37' ' ' ILE . . . . . . . . . . . . . 65.4 mt -122.56 140.24 46.98 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.282 0 CA-C-N 116.063 -0.517 . . . . 0.0 109.998 -178.196 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . -113.89 128.45 8.28 Favored Glycine 0 CA--C 1.525 0.71 0 N-CA-C 110.983 -0.847 . . . . 0.0 110.983 178.343 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 39' ' ' ILE . . . . . . . . . . . . . 73.9 mt -127.95 136.63 59.77 Favored 'Isoleucine or valine' 0 N--CA 1.462 0.175 0 N-CA-C 110.069 -0.345 . . . . 0.0 110.069 178.928 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 40' ' ' SER . . . . . . . . . . . . . 88.3 p -92.69 118.99 31.64 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.481 -0.327 . . . . 0.0 111.15 177.014 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 41' ' ' ILE . . . . . . . . . . . . . 45.2 mm -121.66 121.99 65.84 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.214 0 CA-C-N 116.438 -0.346 . . . . 0.0 110.232 178.327 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 38.1 mt 53.25 34.25 17.27 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.265 -0.425 . . . . 0.0 111.918 176.602 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . 75.72 27.51 62.81 Favored Glycine 0 CA--C 1.53 1.016 0 C-N-CA 121.077 -0.583 . . . . 0.0 112.594 176.646 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 44' ' ' LYS . . . . . . . . . . . . . 24.7 ttpp -140.33 133.44 29.51 Favored 'General case' 0 C--N 1.33 -0.25 0 N-CA-C 109.427 -0.583 . . . . 0.0 109.427 176.582 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 84.3 tt0 -82.85 126.12 32.09 Favored 'General case' 0 C--N 1.329 -0.318 0 C-N-CA 120.796 -0.361 . . . . 0.0 111.327 -176.325 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 46' ' ' VAL . . . . . . . . . . . . . 9.2 p -120.29 125.67 74.44 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.199 0 N-CA-C 109.166 -0.679 . . . . 0.0 109.166 173.975 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 95.5 mttt -99.2 127.67 45.21 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.085 -0.507 . . . . 0.0 110.807 179.076 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 48' ' ' PHE . . . . . . . . . . . . . 37.7 m-85 -111.39 131.89 54.85 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.075 -0.511 . . . . 0.0 109.998 178.486 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 80.4 tttt -106.61 134.86 49.09 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.45 -0.341 . . . . 0.0 110.164 177.469 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 50' ' ' VAL . . . . . . . . . . . . . 44.4 t -78.16 106.14 8.29 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.285 0 N-CA-C 109.559 -0.534 . . . . 0.0 109.559 177.949 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 51' ' ' VAL . . . . . . . . . . . . . 48.7 t -71.25 -49.96 44.61 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.303 0 CA-C-N 115.946 -0.57 . . . . 0.0 109.83 -175.457 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 52' ' ' GLN . . . . . . . . . . . . . 62.0 tt0 -158.55 139.63 13.09 Favored 'General case' 0 C--N 1.33 -0.28 0 C-N-CA 120.278 -0.569 . . . . 0.0 111.764 -177.82 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -115.5 131.52 56.91 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 115.569 -0.741 . . . . 0.0 109.739 174.976 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 54' ' ' TYR . . . . . . . . . . . . . 43.6 t80 -129.03 110.21 18.29 Favored Pre-proline 0 CA--C 1.535 0.397 0 CA-C-O 118.208 -0.901 . . . . 0.0 110.52 -179.334 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 55' ' ' PRO . . . . . . . . . . . . . 72.9 Cg_endo -77.1 169.95 72.9 Favored 'Cis proline' 0 N--CA 1.498 1.781 0 CA-C-N 121.913 1.719 . . . . 0.0 112.228 -5.067 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 56' ' ' SER . . . . . . . . . . . . . 15.0 m -113.64 127.88 26.34 Favored Pre-proline 0 CA--C 1.539 0.529 0 CA-C-O 118.446 -0.788 . . . . 0.0 109.633 176.616 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 57' ' ' PRO . . . . . . . . . . . . . 60.4 Cg_endo -74.11 149.55 94.17 Favored 'Cis proline' 0 N--CA 1.498 1.739 0 CA-C-N 122.002 1.751 . . . . 0.0 111.685 0.063 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 58' ' ' LEU . . . . . . . . . . . . . 32.0 tp -108.16 137.09 46.74 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.229 -0.441 . . . . 0.0 110.606 -178.253 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 59' ' ' ARG . . . . . . . . . . . . . 52.8 ttp180 -104.4 127.94 52.17 Favored 'General case' 0 C--N 1.328 -0.338 0 N-CA-C 109.24 -0.652 . . . . 0.0 109.24 175.345 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 42.2 t -83.5 121.26 36.01 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.259 0 C-N-CA 120.731 -0.388 . . . . 0.0 110.771 -173.758 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 95.8 mt-10 -131.12 165.02 24.18 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 115.667 -0.697 . . . . 0.0 109.627 175.749 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 62' ' ' ASP . . . . . . . . . . . . . 19.0 p-10 -53.78 -32.49 52.69 Favored 'General case' 0 C--N 1.329 -0.322 0 C-N-CA 121.035 -0.266 . . . . 0.0 111.663 179.428 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 63' ' ' ARG . . . . . . . . . . . . . 67.7 mtp180 -72.52 -22.08 61.09 Favored 'General case' 0 CA--C 1.532 0.282 0 N-CA-C 112.963 0.727 . . . . 0.0 112.963 -176.814 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 25.8 m -69.18 138.97 54.54 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-O 120.981 0.42 . . . . 0.0 110.876 -174.982 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 65' ' ' LYS . . . . . . . . . . . . . 90.8 mttt -88.56 127.78 35.55 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 115.964 -0.562 . . . . 0.0 109.854 178.673 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 66' ' ' ILE . . . . . . . . . . . . . 63.4 mt -112.47 129.01 68.79 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.189 0 N-CA-C 109.62 -0.511 . . . . 0.0 109.62 178.718 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 67' ' ' THR . . . . . . . . . . . . . 19.4 m -121.03 136.29 55.02 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.09 -0.504 . . . . 0.0 110.689 -177.311 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 68' ' ' LEU . . . . . . . . . . . . . 17.7 tp -106.06 124.94 50.38 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 115.938 -0.574 . . . . 0.0 110.342 178.753 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 69' ' ' VAL . . . . . . . . . . . . . 45.7 t -98.22 130.07 47.55 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.361 0 N-CA-C 109.639 -0.504 . . . . 0.0 109.639 177.621 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 70' ' ' THR . . . . . . . . . . . . . 4.7 m -107.16 109.26 21.05 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.308 -0.405 . . . . 0.0 110.809 -177.759 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 71' ' ' HIS . . . . . . . . . . . . . 30.4 m80 -149.93 158.39 37.06 Favored Pre-proline 0 C--N 1.33 -0.281 0 CA-C-N 116.048 -0.524 . . . . 0.0 110.439 177.096 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 72' ' ' PRO . . . . . . . . . . . . . 52.1 Cg_endo -84.11 -23.77 2.88 Favored 'Trans proline' 0 N--CA 1.49 1.315 0 C-N-CA 121.558 1.505 . . . . 0.0 113.044 179.269 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 73' ' ' VAL . . . . . . . . . . . . . 35.3 m -132.44 167.38 26.65 Favored 'Isoleucine or valine' 0 C--O 1.232 0.145 0 CA-C-O 121.006 0.431 . . . . 0.0 110.955 -179.028 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 74' ' ' ASP . . . . . . . . . . . . . 7.2 t70 -101.2 122.62 43.96 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 115.777 -0.647 . . . . 0.0 109.71 179.333 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 42.7 t -119.19 128.84 75.81 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.322 0 CA-C-O 121.188 0.518 . . . . 0.0 110.899 -176.342 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 76' ' ' LEU . . . . . . . . . . . . . 5.0 mp -124.56 145.63 49.48 Favored 'General case' 0 C--N 1.332 -0.161 0 CA-C-N 115.643 -0.708 . . . . 0.0 109.818 174.679 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 77' ' ' GLU . . . . . . . . . . . . . 97.5 mt-10 -136.15 133.04 36.78 Favored 'General case' 0 C--N 1.331 -0.226 0 CA-C-O 120.927 0.394 . . . . 0.0 111.3 -179.935 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 78' ' ' ALA . . . . . . . . . . . . . . . -121.53 139.62 53.26 Favored 'General case' 0 C--N 1.331 -0.197 0 CA-C-N 115.82 -0.627 . . . . 0.0 109.698 176.105 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 79' ' ' LYS . . . . . 0.622 ' O ' HD13 ' A' ' 80' ' ' ILE . 32.8 ttpt -76.96 119.85 21.27 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-O 120.889 0.376 . . . . 0.0 110.247 -179.919 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 80' ' ' ILE . . . . . 0.622 HD13 ' O ' ' A' ' 79' ' ' LYS . 22.9 mm -139.24 111.86 5.86 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.327 0 N-CA-C 109.007 -0.738 . . . . 0.0 109.007 -178.544 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 81' ' ' LYS . . . . . . . . . . . . . 79.0 tttt -115.77 129.09 56.31 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-O 120.902 0.382 . . . . 0.0 110.657 -177.138 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . 89.11 41.98 5.72 Favored Glycine 0 CA--C 1.525 0.704 0 N-CA-C 111.342 -0.703 . . . . 0.0 111.342 178.085 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 83' ' ' ILE . . . . . . . . . . . . . 75.9 mt -67.33 140.21 19.7 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.309 0 CA-C-O 120.902 0.382 . . . . 0.0 109.993 178.593 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 84' ' ' LYS . . . . . . . . . . . . . 71.6 tttt -99.71 -52.03 3.57 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.043 -0.526 . . . . 0.0 110.074 -179.901 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 85' ' ' ASP . . . . . . . . . . . . . 5.0 t70 -159.86 156.73 27.86 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 115.758 -0.656 . . . . 0.0 110.365 179.809 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 86' ' ' VAL . . . . . . . . . . . . . 40.7 t -131.13 132.87 63.22 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.228 0 CA-C-O 120.983 0.42 . . . . 0.0 110.744 -178.94 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 87' ' ' ILE . . . . . . . . . . . . . 43.9 mm -120.07 126.82 75.68 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.268 0 CA-C-N 115.771 -0.649 . . . . 0.0 109.361 177.08 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 88' ' ' LEU . . . . . . . . . . . . . 19.1 tp -114.84 134.33 55.22 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-O 120.944 0.402 . . . . 0.0 111.423 -176.8 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 89' ' ' ASP . . . . . . . . . . . . . 13.5 t70 -129.38 157.17 42.67 Favored 'General case' 0 C--N 1.331 -0.226 0 CA-C-N 115.787 -0.642 . . . . 0.0 109.606 176.719 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 60.2 mp0 -48.51 -35.96 14.24 Favored 'General case' 0 C--N 1.332 -0.192 0 N-CA-C 113.06 0.763 . . . . 0.0 113.06 -171.154 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 91' ' ' ASN . . . . . . . . . . . . . 27.6 t30 -130.65 18.35 5.21 Favored 'General case' 0 N--CA 1.47 0.534 0 N-CA-C 113.15 0.796 . . . . 0.0 113.15 -177.238 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 92' ' ' LEU . . . . . . . . . . . . . 22.6 mt -146.99 142.52 27.59 Favored 'General case' 0 C--N 1.331 -0.216 0 N-CA-C 110.221 -0.288 . . . . 0.0 110.221 -177.595 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 93' ' ' ILE . . . . . . . . . . . . . 71.9 mt -123.21 117.86 52.89 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.354 0 N-CA-C 109.312 -0.625 . . . . 0.0 109.312 177.695 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 94' ' ' VAL . . . . . . . . . . . . . 41.9 t -120.24 128.75 76.0 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.25 0 CA-C-O 120.959 0.409 . . . . 0.0 110.102 -178.987 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 95' ' ' VAL . . . . . . . . . . . . . 42.5 t -123.24 135.56 62.79 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.367 0 CA-C-N 115.933 -0.576 . . . . 0.0 109.77 179.616 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 96' ' ' ILE . . . . . . . . . . . . . 66.9 mt -114.17 130.94 67.53 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.36 0 N-CA-C 109.425 -0.583 . . . . 0.0 109.425 179.259 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 97' ' ' THR . . . . . . . . . . . . . 60.4 p -104.65 158.09 16.73 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-O 121.04 0.447 . . . . 0.0 111.267 -177.825 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 98' ' ' GLU . . . . . . . . . . . . . 97.3 mt-10 -53.98 -26.03 23.89 Favored 'General case' 0 C--N 1.328 -0.355 0 N-CA-C 112.371 0.508 . . . . 0.0 112.371 -179.763 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 99' ' ' GLU . . . . . . . . . . . . . 95.6 mt-10 -78.56 14.62 1.22 Allowed 'General case' 0 CA--C 1.536 0.417 0 N-CA-C 113.171 0.804 . . . . 0.0 113.171 -177.343 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 100' ' ' ASN . . . . . . . . . . . . . 3.6 m-20 62.17 37.94 14.02 Favored 'General case' 0 N--CA 1.462 0.172 0 CA-C-O 121.125 0.488 . . . . 0.0 110.894 178.818 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 101' ' ' GLU . . . . . . . . . . . . . 84.6 tt0 -115.36 144.24 44.07 Favored 'General case' 0 C--O 1.233 0.2 0 CA-C-N 116.047 -0.524 . . . . 0.0 109.807 176.584 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 102' ' ' VAL . . . . . . . . . . . . . 45.1 t -115.03 124.69 71.93 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.338 0 CA-C-N 116.067 -0.515 . . . . 0.0 109.94 -178.339 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 103' ' ' LEU . . . . . . . . . . . . . 23.2 mt -115.13 126.82 55.09 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 115.753 -0.658 . . . . 0.0 110.168 176.449 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 104' ' ' ILE . . . . . . . . . . . . . 72.6 mt -118.21 120.42 64.37 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.232 0 N-CA-C 109.983 -0.377 . . . . 0.0 109.983 179.438 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 105' ' ' PHE . . . . . . . . . . . . . 53.5 m-85 -120.32 162.33 19.63 Favored 'General case' 0 C--N 1.332 -0.178 0 CA-C-N 115.5 -0.773 . . . . 0.0 110.052 179.955 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 106' ' ' ASN . . . . . . . . . . . . . 43.1 p-10 -93.8 -169.83 2.19 Favored 'General case' 0 C--N 1.329 -0.311 0 N-CA-C 109.785 -0.45 . . . . 0.0 109.785 173.375 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 107' ' ' GLN . . . . . . . . . . . . . 48.6 tt0 -57.64 -30.03 65.06 Favored 'General case' 0 CA--C 1.532 0.268 0 N-CA-C 112.061 0.393 . . . . 0.0 112.061 179.37 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 108' ' ' ASN . . . . . . . . . . . . . 49.4 t30 -84.72 9.48 13.87 Favored 'General case' 0 CA--C 1.536 0.412 0 N-CA-C 113.251 0.834 . . . . 0.0 113.251 -177.131 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 109' ' ' LEU . . . . . . . . . . . . . 10.9 tp 58.28 37.03 26.03 Favored 'General case' 0 C--N 1.331 -0.23 0 CA-C-O 120.983 0.421 . . . . 0.0 111.28 179.167 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 110' ' ' GLU . . . . . . . . . . . . . 95.7 mt-10 -106.64 159.48 16.16 Favored 'General case' 0 C--N 1.332 -0.174 0 CA-C-O 120.811 0.338 . . . . 0.0 110.166 176.846 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 111' ' ' GLU . . . . . . . . . . . . . 80.4 tt0 -81.58 121.92 26.93 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.282 -0.417 . . . . 0.0 111.213 -175.646 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 112' ' ' LEU . . . . . . . . . . . . . 15.3 mt -110.29 -46.08 3.48 Favored 'General case' 0 C--N 1.331 -0.227 0 CA-C-N 116.064 -0.516 . . . . 0.0 109.829 175.238 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 113' ' ' TYR . . . . . 0.423 ' CE2' HG21 ' B' ' 75' ' ' VAL . 58.7 t80 -139.24 136.6 35.13 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.145 -0.48 . . . . 0.0 110.931 178.849 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 114' ' ' ARG . . . . . . . . . . . . . 63.3 ttt180 -140.3 122.06 15.4 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 116.095 -0.502 . . . . 0.0 110.187 178.117 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 115' ' ' GLY . . . . . . . . . . . . . . . -150.08 161.66 28.96 Favored Glycine 0 CA--C 1.525 0.703 0 C-N-CA 120.732 -0.747 . . . . 0.0 111.391 179.676 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 116' ' ' LYS . . . . . . . . . . . . . 39.8 ttpt -128.88 136.17 50.07 Favored 'General case' 0 C--N 1.33 -0.27 0 N-CA-C 109.869 -0.419 . . . . 0.0 109.869 177.179 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 117' ' ' PHE . . . . . . . . . . . . . 39.3 m-85 -134.55 113.88 12.23 Favored 'General case' 0 C--N 1.329 -0.285 0 N-CA-C 109.878 -0.416 . . . . 0.0 109.878 -178.012 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 118' ' ' GLU . . . . . . . . . . . . . 12.9 pt-20 -57.06 -39.29 74.64 Favored 'General case' 0 C--N 1.329 -0.313 0 C-N-CA 120.726 -0.39 . . . . 0.0 111.084 -176.415 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 119' ' ' ASN . . . . . . . . . . . . . 32.7 m120 -94.81 26.0 3.79 Favored 'General case' 0 C--N 1.331 -0.207 0 N-CA-C 112.644 0.609 . . . . 0.0 112.644 -174.558 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 120' ' ' LEU . . . . . . . . . . . . . 17.5 tp -58.55 125.01 21.58 Favored 'General case' 0 C--N 1.333 -0.139 0 CA-C-O 120.816 0.341 . . . . 0.0 110.227 178.973 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 121' ' ' ASN . . . . . . . . . . . . . 4.2 m120 -113.96 -44.16 3.19 Favored 'General case' 0 C--N 1.332 -0.186 0 CA-C-N 116.262 -0.426 . . . . 0.0 110.581 -179.141 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 122' ' ' LYS . . . . . . . . . . . . . 56.6 pttt -159.71 157.93 30.41 Favored 'General case' 0 C--N 1.332 -0.186 0 C-N-CA 120.525 -0.47 . . . . 0.0 111.671 -179.624 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 123' ' ' VAL . . . . . . . . . . . . . 43.7 t -129.99 136.78 58.11 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.229 0 CA-C-N 116.022 -0.535 . . . . 0.0 110.09 179.956 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 124' ' ' LEU . . . . . . . . . . . . . 78.4 mt -119.82 133.96 55.41 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.152 -0.476 . . . . 0.0 110.81 -178.93 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 125' ' ' VAL . . . . . . . . . . . . . 48.3 t -126.91 127.25 69.67 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.218 0 N-CA-C 109.482 -0.562 . . . . 0.0 109.482 176.671 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 126' ' ' ARG . . . . . . . . . . . . . 41.7 ttt180 -144.01 124.4 13.89 Favored 'General case' 0 C--N 1.33 -0.242 0 C-N-CA 120.763 -0.375 . . . . 0.0 110.834 -179.192 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 127' ' ' ASN . . . . . . . . . . . . . 3.5 m120 51.2 -106.63 0.26 Allowed 'General case' 0 CA--C 1.544 0.726 0 CA-C-O 118.934 -0.555 . . . . 0.0 111.311 179.916 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 128' ' ' ASP . . . . . . . . . . . . . 10.9 p-10 -114.09 0.4 14.28 Favored 'General case' 0 N--CA 1.467 0.407 0 CA-C-N 119.754 1.161 . . . . 0.0 113.463 -177.883 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 129' ' ' LEU . . . . . . . . . . . . . 30.6 mt -104.91 141.73 36.02 Favored 'General case' 0 C--O 1.232 0.161 0 CA-C-N 118.249 0.477 . . . . 0.0 110.668 -178.429 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 130' ' ' VAL . . . . . . . . . . . . . 46.2 t -123.42 133.59 68.73 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.274 0 CA-C-N 115.973 -0.558 . . . . 0.0 109.574 178.422 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 131' ' ' VAL . . . . . 0.445 HG22 HD12 ' A' ' 140' ' ' LEU . 44.4 t -133.86 135.8 54.69 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.27 0 CA-C-O 121.119 0.485 . . . . 0.0 110.162 179.451 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 132' ' ' ILE . . . . . . . . . . . . . 73.8 mt -113.41 130.94 66.5 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.289 0 CA-C-N 115.668 -0.696 . . . . 0.0 109.249 179.423 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 133' ' ' ILE . . . . . . . . . . . . . 42.1 mm -114.2 120.33 63.66 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.277 0 CA-C-O 120.888 0.375 . . . . 0.0 110.727 -176.356 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 134' ' ' ASP . . . . . . . . . . . . . 7.1 p-10 -132.36 145.96 51.62 Favored 'General case' 0 C--N 1.33 -0.255 0 N-CA-C 109.104 -0.702 . . . . 0.0 109.104 174.003 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 135' ' ' GLU . . . . . . . . . . . . . 41.8 tp10 -49.69 -24.66 2.39 Favored 'General case' 0 C--N 1.328 -0.34 0 N-CA-C 112.881 0.697 . . . . 0.0 112.881 -170.961 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 136' ' ' GLN . . . . . . . . . . . . . 54.1 tp60 -96.53 -34.08 11.59 Favored 'General case' 0 CA--C 1.53 0.18 0 N-CA-C 112.223 0.453 . . . . 0.0 112.223 -175.871 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 137' ' ' LYS . . . . . . . . . . . . . 65.3 mttt -141.22 156.57 45.89 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-O 121.31 0.576 . . . . 0.0 111.905 -169.551 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 138' ' ' LEU . . . . . 0.497 HD23 ' N ' ' A' ' 139' ' ' THR . 5.1 tt -119.41 122.9 42.81 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 115.392 -0.822 . . . . 0.0 109.042 172.028 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 139' ' ' THR . . . . . 0.497 ' N ' HD23 ' A' ' 138' ' ' LEU . 24.8 m -107.06 128.11 54.08 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.552 -0.295 . . . . 0.0 110.548 -178.107 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 140' ' ' LEU . . . . . 0.445 HD12 HG22 ' A' ' 131' ' ' VAL . 44.4 tp -113.32 119.73 38.69 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 115.74 -0.664 . . . . 0.0 109.417 -179.08 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 141' ' ' ILE . . . . . . . . . . . . . 19.3 mt -119.89 118.11 55.96 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.264 0 CA-C-O 121.006 0.431 . . . . 0.0 109.88 -176.713 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 142' ' ' ARG . . . . . . . . . . . . . 78.1 mtm180 -104.47 129.7 52.45 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 115.285 -0.871 . . . . 0.0 110.549 -178.693 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 143' ' ' THR . . . . . . . . . . . . . 77.1 p . . . . . 0 C--O 1.22 -0.466 0 CA-C-O 117.944 -1.027 . . . . 0.0 110.482 179.501 . . . . . . . . 0 0 . 1 . 017 nuclear nobuild full ' B' B ' -3' ' ' GLU . . . . . . . . . . . . . 95.6 mt-10 . . . . . 0 N--CA 1.49 1.543 0 N-CA-C 109.308 -0.627 . . . . 0.0 109.308 . . . . . . . . . 0 0 . 1 . 017 nuclear nobuild full ' B' B ' -2' ' ' GLY . . . . . . . . . . . . . . . -76.86 139.05 23.04 Favored Glycine 0 CA--C 1.524 0.595 0 N-CA-C 110.92 -0.872 . . . . 0.0 110.92 179.273 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' B' B ' -1' ' ' VAL . . . . . . . . . . . . . 45.3 t -141.42 132.03 26.41 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.258 0 N-CA-C 110.04 -0.356 . . . . 0.0 110.04 -179.899 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' B' B ' 0' ' ' ILE . . . . . . . . . . . . . 72.0 mt -119.77 128.09 75.9 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.2 0 CA-C-N 116.198 -0.455 . . . . 0.0 109.818 178.403 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' B' B ' 1' ' ' MET . . . . . . . . . . . . . 24.8 ptt? -81.79 124.59 29.79 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 116.256 -0.429 . . . . 0.0 110.539 179.625 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' B' B ' 2' ' ' SER . . . . . . . . . . . . . 12.5 p -123.97 132.64 53.74 Favored 'General case' 0 C--N 1.331 -0.207 0 CA-C-N 116.235 -0.439 . . . . 0.0 110.37 179.216 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' B' B ' 3' ' ' GLU . . . . . . . . . . . . . 43.6 mt-10 -140.52 145.02 36.28 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-N 115.751 -0.658 . . . . 0.0 110.999 -176.989 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' B' B ' 4' ' ' LEU . . . . . . . . . . . . . 23.1 tp -124.28 128.25 48.87 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.063 -0.517 . . . . 0.0 110.131 174.747 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' B' B ' 5' ' ' LYS . . . . . . . . . . . . . 63.8 mmtt -105.45 113.8 27.58 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 115.988 -0.551 . . . . 0.0 111.121 -179.202 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' B' B ' 6' ' ' LEU . . . . . . . . . . . . . 28.7 mt -113.71 137.48 51.55 Favored 'General case' 0 C--N 1.333 -0.147 0 O-C-N 124.034 0.834 . . . . 0.0 109.659 178.214 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' B' B ' 7' ' ' LYS . . . . . . . . . . . . . 57.7 tttp -123.2 137.95 29.14 Favored Pre-proline 0 CA--C 1.533 0.32 0 CA-C-O 118.853 -0.594 . . . . 0.0 109.862 177.333 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' B' B ' 8' ' ' PRO . . . . . . . . . . . . . 85.0 Cg_endo -90.41 137.2 2.44 Favored 'Trans proline' 0 N--CA 1.491 1.377 0 C-N-CA 121.625 1.55 . . . . 0.0 111.872 179.062 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' B' B ' 9' ' ' LEU . . . . . . . . . . . . . 39.5 mt -80.43 -48.57 1.23 Allowed Pre-proline 0 CA--C 1.535 0.374 0 CA-C-O 118.555 -0.736 . . . . 0.0 112.441 -179.69 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' B' B ' 10' ' ' PRO . . . . . . . . . . . . . 90.0 Cg_endo -78.88 156.21 27.0 Favored 'Trans proline' 0 N--CA 1.497 1.694 0 C-N-CA 121.183 1.256 . . . . 0.0 112.051 178.727 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' B' B ' 11' ' ' LYS . . . . . . . . . . . . . 60.6 mttp -82.71 93.13 7.32 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.353 -0.385 . . . . 0.0 110.333 178.476 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' B' B ' 12' ' ' VAL . . . . . . . . . . . . . 12.7 p -140.16 146.91 24.05 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.303 0 CA-C-N 116.296 -0.411 . . . . 0.0 110.718 -179.262 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' B' B ' 13' ' ' GLU . . . . . . . . . . . . . 84.7 tt0 -97.66 129.04 44.77 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.345 -0.389 . . . . 0.0 110.057 177.823 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' B' B ' 14' ' ' LEU . . . . . . . . . . . . . 27.3 mt -98.37 149.91 36.2 Favored Pre-proline 0 CA--C 1.532 0.282 0 CA-C-O 119.298 -0.382 . . . . 0.0 110.65 -177.12 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' B' B ' 15' ' ' PRO . . . . . . . . . . . . . 24.2 Cg_exo -63.68 160.57 35.87 Favored 'Trans proline' 0 N--CA 1.498 1.737 0 C-N-CA 121.366 1.377 . . . . 0.0 111.733 175.36 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' B' B ' 16' ' ' PRO . . . . . . . . . . . . . 30.4 Cg_exo -59.84 -35.81 92.86 Favored 'Trans proline' 0 N--CA 1.498 1.737 0 C-N-CA 121.47 1.447 . . . . 0.0 112.688 -178.589 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' B' B ' 17' ' ' ASP . . . . . . . . . . . . . 38.1 p30 -90.2 9.6 27.87 Favored 'General case' 0 CA--C 1.535 0.391 0 N-CA-C 113.367 0.877 . . . . 0.0 113.367 -177.553 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' B' B ' 18' ' ' PHE . . . . . . . . . . . . . 37.4 t80 -58.43 -46.38 86.61 Favored 'General case' 0 N--CA 1.458 -0.059 0 O-C-N 121.965 -0.459 . . . . 0.0 110.017 -177.598 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' B' B ' 19' ' ' VAL . . . . . . . . . . . . . 48.5 t -56.86 -41.72 76.63 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.399 0 CA-C-N 116.228 -0.442 . . . . 0.0 110.392 -178.176 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' B' B ' 20' ' ' ASP . . . . . . . . . . . . . 78.3 m-20 -60.14 -44.0 95.29 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-O 120.784 0.326 . . . . 0.0 111.0 -177.399 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' B' B ' 21' ' ' VAL . . . . . . . . . . . . . 48.0 t -64.5 -46.13 93.65 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.294 0 C-N-CA 120.765 -0.374 . . . . 0.0 110.468 -177.648 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' B' B ' 22' ' ' ILE . . . . . 0.536 HG22 HD12 ' B' ' 26' ' ' LEU . 50.1 mm -56.31 -44.73 80.48 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.25 0 C-N-CA 120.857 -0.337 . . . . 0.0 110.582 179.083 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' B' B ' 23' ' ' ARG . . . . . . . . . . . . . 59.6 ttp180 -54.49 -48.81 71.4 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-O 120.763 0.316 . . . . 0.0 111.17 -179.549 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' B' B ' 24' ' ' ILE . . . . . . . . . . . . . 74.2 mt -59.52 -41.1 83.69 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.247 0 CA-C-N 116.336 -0.393 . . . . 0.0 111.424 -176.66 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' B' B ' 25' ' ' LYS . . . . . . . . . . . . . 97.7 mttt -70.07 -43.33 71.38 Favored 'General case' 0 C--N 1.33 -0.273 0 N-CA-C 112.719 0.637 . . . . 0.0 112.719 -178.625 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' B' B ' 26' ' ' LEU . . . . . 0.536 HD12 HG22 ' B' ' 22' ' ' ILE . 92.2 mt -78.11 -34.23 50.12 Favored 'General case' 0 C--N 1.33 -0.26 0 N-CA-C 113.444 0.905 . . . . 0.0 113.444 -170.336 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' B' B ' 27' ' ' GLN . . . . . . . . . . . . . 6.6 pt20 -46.98 139.38 5.66 Favored 'General case' 0 N--CA 1.468 0.47 0 N-CA-C 112.755 0.65 . . . . 0.0 112.755 -175.95 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' B' B ' 28' ' ' GLY . . . . . . . . . . . . . . . 100.8 -23.95 33.79 Favored Glycine 0 CA--C 1.535 1.283 0 CA-C-N 115.671 -0.695 . . . . 0.0 112.384 -176.232 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' B' B ' 29' ' ' LYS . . . . . . . . . . . . . 45.4 mtmt -97.99 155.16 17.23 Favored 'General case' 0 C--O 1.231 0.1 0 CA-C-N 117.396 0.598 . . . . 0.0 111.037 178.804 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' B' B ' 30' ' ' THR . . . . . . . . . . . . . 32.0 m -105.05 137.7 42.39 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 116.043 -0.526 . . . . 0.0 110.236 177.978 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' B' B ' 31' ' ' VAL . . . . . . . . . . . . . 35.2 m -131.35 158.26 43.29 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.22 0 CA-C-O 120.865 0.364 . . . . 0.0 110.898 -179.153 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' B' B ' 32' ' ' ARG . . . . . . . . . . . . . 98.1 mtt180 -135.63 153.15 51.74 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-O 121.284 0.564 . . . . 0.0 110.77 178.245 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' B' B ' 33' ' ' THR . . . . . . . . . . . . . 19.8 m -53.6 140.67 28.05 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.153 -0.476 . . . . 0.0 111.441 -178.478 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' B' B ' 34' ' ' GLY . . . . . . . . . . . . . . . 99.29 -17.11 58.34 Favored Glycine 0 CA--C 1.532 1.109 0 CA-C-N 116.09 -0.505 . . . . 0.0 113.309 178.996 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' B' B ' 35' ' ' ASP . . . . . . . . . . . . . 78.2 m-20 -67.02 149.14 51.03 Favored 'General case' 0 N--CA 1.462 0.13 0 CA-C-N 118.036 0.918 . . . . 0.0 111.194 178.946 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' B' B ' 36' ' ' VAL . . . . . . . . . . . . . 45.7 t -119.48 129.84 74.8 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.197 0 CA-C-N 115.895 -0.593 . . . . 0.0 109.668 176.768 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' B' B ' 37' ' ' ILE . . . . . . . . . . . . . 65.1 mt -119.08 137.71 52.17 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.275 0 CA-C-N 116.125 -0.489 . . . . 0.0 109.968 -178.93 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' B' B ' 38' ' ' GLY . . . . . . . . . . . . . . . -113.34 127.77 8.04 Favored Glycine 0 CA--C 1.526 0.725 0 N-CA-C 110.873 -0.891 . . . . 0.0 110.873 179.43 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' B' B ' 39' ' ' ILE . . . . . . . . . . . . . 72.2 mt -125.6 131.55 71.94 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.27 0 N-CA-C 110.127 -0.323 . . . . 0.0 110.127 179.254 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' B' B ' 40' ' ' SER . . . . . . . . . . . . . 26.7 p -92.15 114.68 27.28 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.418 -0.356 . . . . 0.0 110.997 176.875 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' B' B ' 41' ' ' ILE . . . . . 0.443 HG22 HD13 ' B' ' 42' ' ' LEU . 44.1 mm -121.44 123.43 69.62 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.236 0 CA-C-N 116.483 -0.326 . . . . 0.0 110.33 179.714 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' B' B ' 42' ' ' LEU . . . . . 0.443 HD13 HG22 ' B' ' 41' ' ' ILE . 6.7 mp 52.94 34.53 17.02 Favored 'General case' 0 CA--C 1.533 0.29 0 CA-C-N 116.292 -0.413 . . . . 0.0 111.505 177.92 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' B' B ' 43' ' ' GLY . . . . . . . . . . . . . . . 72.67 30.48 63.96 Favored Glycine 0 CA--C 1.53 0.999 0 C-N-CA 121.199 -0.524 . . . . 0.0 112.211 177.888 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' B' B ' 44' ' ' LYS . . . . . . . . . . . . . 61.5 tttm -138.21 128.94 26.69 Favored 'General case' 0 C--N 1.329 -0.288 0 N-CA-C 109.585 -0.524 . . . . 0.0 109.585 178.132 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' B' B ' 45' ' ' GLU . . . . . . . . . . . . . 84.7 tt0 -83.28 122.0 27.85 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-O 120.817 0.342 . . . . 0.0 111.019 -177.153 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' B' B ' 46' ' ' VAL . . . . . . . . . . . . . 10.6 p -119.98 125.03 73.85 Favored 'Isoleucine or valine' 0 C--O 1.232 0.147 0 N-CA-C 109.444 -0.576 . . . . 0.0 109.444 174.651 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' B' B ' 47' ' ' LYS . . . . . . . . . . . . . 99.3 mttt -99.91 128.31 46.01 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.145 -0.479 . . . . 0.0 111.025 179.094 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' B' B ' 48' ' ' PHE . . . . . . . . . . . . . 26.7 m-85 -110.74 131.84 54.7 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 115.946 -0.57 . . . . 0.0 109.588 175.489 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' B' B ' 49' ' ' LYS . . . . . . . . . . . . . 60.8 tttm -105.62 135.42 47.05 Favored 'General case' 0 C--N 1.327 -0.37 0 N-CA-C 109.867 -0.42 . . . . 0.0 109.867 177.047 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' B' B ' 50' ' ' VAL . . . . . . . . . . . . . 47.3 t -79.99 104.99 8.93 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.326 0 N-CA-C 109.563 -0.532 . . . . 0.0 109.563 178.509 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' B' B ' 51' ' ' VAL . . . . . . . . . . . . . 46.4 t -69.88 -51.86 36.49 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.335 0 CA-C-N 115.945 -0.57 . . . . 0.0 109.8 -176.721 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' B' B ' 52' ' ' GLN . . . . . . . . . . . . . 92.4 mt-30 -151.88 151.36 31.18 Favored 'General case' 0 C--N 1.334 -0.105 0 C-N-CA 120.244 -0.582 . . . . 0.0 111.957 -179.456 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' B' B ' 53' ' ' ALA . . . . . . . . . . . . . . . -126.8 131.11 51.34 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 115.092 -0.958 . . . . 0.0 109.555 174.402 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' B' B ' 54' ' ' TYR . . . . . . . . . . . . . 30.2 t80 -129.12 109.67 18.1 Favored Pre-proline 0 C--N 1.328 -0.351 0 CA-C-O 118.201 -0.904 . . . . 0.0 110.31 178.902 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' B' B ' 55' ' ' PRO . . . . . . . . . . . . . 73.7 Cg_endo -77.28 168.3 77.18 Favored 'Cis proline' 0 N--CA 1.5 1.911 0 CA-C-N 121.985 1.745 . . . . 0.0 112.634 -3.558 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' B' B ' 56' ' ' SER . . . . . . . . . . . . . 13.5 m -114.63 125.84 28.64 Favored Pre-proline 0 CA--C 1.538 0.516 0 CA-C-O 118.368 -0.825 . . . . 0.0 109.241 174.907 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' B' B ' 57' ' ' PRO . . . . . . . . . . . . . 44.8 Cg_endo -68.67 168.38 63.03 Favored 'Cis proline' 0 N--CA 1.496 1.66 0 CA-C-N 122.041 1.764 . . . . 0.0 111.573 1.325 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' B' B ' 58' ' ' LEU . . . . . . . . . . . . . 26.9 tp -129.23 135.64 49.07 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.137 179.28 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' B' B ' 59' ' ' ARG . . . . . . . . . . . . . 69.8 ttt180 -104.16 124.27 48.8 Favored 'General case' 0 C--N 1.327 -0.388 0 N-CA-C 109.277 -0.638 . . . . 0.0 109.277 177.413 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' B' B ' 60' ' ' VAL . . . . . . . . . . . . . 46.5 t -73.2 115.45 14.1 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.234 0 C-N-CA 120.61 -0.436 . . . . 0.0 110.078 -175.488 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' B' B ' 61' ' ' GLU . . . . . . . . . . . . . 75.0 tt0 -131.02 155.08 47.46 Favored 'General case' 0 C--N 1.329 -0.314 0 N-CA-C 109.152 -0.685 . . . . 0.0 109.152 177.897 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' B' B ' 62' ' ' ASP . . . . . . . . . . . . . 13.6 t70 -52.0 -32.79 35.37 Favored 'General case' 0 C--N 1.327 -0.405 0 N-CA-C 111.946 0.351 . . . . 0.0 111.946 -177.732 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' B' B ' 63' ' ' ARG . . . . . . . . . . . . . 98.6 mtt180 -74.16 -22.14 59.56 Favored 'General case' 0 C--N 1.33 -0.272 0 N-CA-C 113.04 0.756 . . . . 0.0 113.04 -177.185 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' B' B ' 64' ' ' THR . . . . . . . . . . . . . 31.0 m -64.84 136.85 57.34 Favored 'General case' 0 C--N 1.331 -0.226 0 CA-C-O 120.725 0.298 . . . . 0.0 110.57 -176.843 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' B' B ' 65' ' ' LYS . . . . . . . . . . . . . 40.3 ttpt -88.66 124.6 34.24 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-O 121.079 0.466 . . . . 0.0 110.176 -179.976 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' B' B ' 66' ' ' ILE . . . . . . . . . . . . . 69.9 mt -108.09 126.59 64.66 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.298 0 N-CA-C 109.815 -0.439 . . . . 0.0 109.815 -177.906 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' B' B ' 67' ' ' THR . . . . . . . . . . . . . 42.1 m -120.69 139.93 52.34 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.039 -0.528 . . . . 0.0 110.769 -176.422 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' B' B ' 68' ' ' LEU . . . . . . . . . . . . . 19.8 tp -105.0 131.94 51.88 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 115.796 -0.638 . . . . 0.0 110.463 179.749 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' B' B ' 69' ' ' VAL . . . . . . . . . . . . . 43.1 t -92.81 129.89 42.7 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.315 0 CA-C-N 116.146 -0.479 . . . . 0.0 109.76 178.69 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' B' B ' 70' ' ' THR . . . . . 0.434 HG22 ' H ' ' B' ' 71' ' ' HIS . 2.3 m -107.96 166.71 10.51 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.835 -177.843 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' B' B ' 71' ' ' HIS . . . . . 0.434 ' H ' HG22 ' B' ' 70' ' ' THR . 17.2 m-70 -65.01 167.3 9.89 Favored Pre-proline 0 C--N 1.329 -0.295 0 CA-C-N 115.998 -0.546 . . . . 0.0 109.967 178.521 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' B' B ' 72' ' ' PRO . . . . . . . . . . . . . 18.5 Cg_exo -64.82 -30.09 58.63 Favored 'Trans proline' 0 N--CA 1.497 1.72 0 C-N-CA 121.167 1.244 . . . . 0.0 111.99 179.238 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' B' B ' 73' ' ' VAL . . . . . . . . . . . . . 17.2 m -149.51 138.39 15.16 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.263 0 CA-C-O 121.171 0.51 . . . . 0.0 110.78 174.747 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' B' B ' 74' ' ' ASP . . . . . . . . . . . . . 18.1 t0 -103.43 121.42 42.76 Favored 'General case' 0 C--N 1.328 -0.36 0 N-CA-C 108.955 -0.757 . . . . 0.0 108.955 175.441 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' B' B ' 75' ' ' VAL . . . . . 0.423 HG21 ' CE2' ' A' ' 113' ' ' TYR . 41.8 t -114.86 124.99 72.05 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.225 0 CA-C-O 121.135 0.493 . . . . 0.0 110.954 -175.017 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' B' B ' 76' ' ' LEU . . . . . . . . . . . . . 5.6 mp -125.13 147.37 49.05 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 115.394 -0.821 . . . . 0.0 109.492 175.069 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' B' B ' 77' ' ' GLU . . . . . . . . . . . . . 97.6 mt-10 -133.35 131.23 39.85 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-O 121.053 0.454 . . . . 0.0 111.165 -178.444 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' B' B ' 78' ' ' ALA . . . . . . . . . . . . . . . -117.67 139.08 51.5 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 115.67 -0.696 . . . . 0.0 109.662 176.822 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' B' B ' 79' ' ' LYS . . . . . 0.515 ' O ' HD13 ' B' ' 80' ' ' ILE . 9.4 mtpm? -87.34 117.88 26.41 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-O 120.948 0.404 . . . . 0.0 110.707 -178.501 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' B' B ' 80' ' ' ILE . . . . . 0.515 HD13 ' O ' ' B' ' 79' ' ' LYS . 25.2 mm -139.08 114.29 8.45 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.268 0 N-CA-C 108.979 -0.749 . . . . 0.0 108.979 -177.958 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' B' B ' 81' ' ' LYS . . . . . . . . . . . . . 53.8 tttp -103.92 127.3 51.45 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-O 120.812 0.339 . . . . 0.0 111.402 -175.718 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' B' B ' 82' ' ' GLY . . . . . . . . . . . . . . . 89.19 41.98 5.7 Favored Glycine 0 CA--C 1.527 0.843 0 C-N-CA 120.839 -0.696 . . . . 0.0 112.258 173.271 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' B' B ' 83' ' ' ILE . . . . . . . . . . . . . 69.7 mt -73.57 138.91 20.31 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.347 0 N-CA-C 109.571 -0.529 . . . . 0.0 109.571 176.961 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' B' B ' 84' ' ' LYS . . . . . . . . . . . . . 38.5 ttpt -103.52 -49.08 3.78 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-N 116.294 -0.412 . . . . 0.0 110.606 -177.828 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' B' B ' 85' ' ' ASP . . . . . . . . . . . . . 12.2 t70 -144.49 148.51 34.62 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.091 -0.504 . . . . 0.0 110.603 -178.532 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' B' B ' 86' ' ' VAL . . . . . . . . . . . . . 46.4 t -130.38 133.12 64.33 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.247 0 CA-C-O 120.87 0.367 . . . . 0.0 110.428 -179.189 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' B' B ' 87' ' ' ILE . . . . . 0.489 ' N ' HD12 ' B' ' 87' ' ' ILE . 5.0 mp -122.64 124.38 70.52 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.195 0 CA-C-N 115.935 -0.575 . . . . 0.0 109.522 176.617 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' B' B ' 88' ' ' LEU . . . . . . . . . . . . . 16.0 tp -109.74 129.61 55.6 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-O 120.866 0.365 . . . . 0.0 110.709 -178.629 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' B' B ' 89' ' ' ASP . . . . . . . . . . . . . 13.4 t70 -128.23 155.68 44.16 Favored 'General case' 0 C--N 1.331 -0.215 0 CA-C-N 116.12 -0.491 . . . . 0.0 110.031 178.122 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' B' B ' 90' ' ' GLU . . . . . . . . . . . . . 96.2 mt-10 -47.5 -36.84 10.84 Favored 'General case' 0 C--N 1.328 -0.357 0 N-CA-C 113.055 0.761 . . . . 0.0 113.055 -171.457 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' B' B ' 91' ' ' ASN . . . . . . . . . . . . . 66.0 m-80 -129.01 16.54 6.22 Favored 'General case' 0 N--CA 1.469 0.502 0 N-CA-C 113.285 0.846 . . . . 0.0 113.285 -176.435 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' B' B ' 92' ' ' LEU . . . . . . . . . . . . . 11.4 mt -148.73 144.89 27.37 Favored 'General case' 0 C--N 1.331 -0.198 0 CA-C-O 120.818 0.342 . . . . 0.0 110.248 -176.265 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' B' B ' 93' ' ' ILE . . . . . . . . . . . . . 72.3 mt -121.59 116.43 49.48 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.224 0 N-CA-C 108.838 -0.801 . . . . 0.0 108.838 174.946 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' B' B ' 94' ' ' VAL . . . . . . . . . . . . . 43.9 t -115.7 125.8 73.0 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.294 0 N-CA-C 109.68 -0.489 . . . . 0.0 109.68 -178.084 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' B' B ' 95' ' ' VAL . . . . . . . . . . . . . 41.9 t -120.8 132.74 69.55 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.315 0 CA-C-N 116.065 -0.516 . . . . 0.0 109.681 -179.636 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' B' B ' 96' ' ' ILE . . . . . . . . . . . . . 70.7 mt -114.31 125.27 71.57 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.353 0 N-CA-C 109.228 -0.656 . . . . 0.0 109.228 178.577 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' B' B ' 97' ' ' THR . . . . . . . . . . . . . 54.6 p -96.2 155.29 16.82 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-O 121.164 0.506 . . . . 0.0 111.115 -177.583 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' B' B ' 98' ' ' GLU . . . . . . . . . . . . . 12.6 pt-20 -55.4 -20.67 12.82 Favored 'General case' 0 C--N 1.328 -0.338 0 N-CA-C 112.707 0.632 . . . . 0.0 112.707 -179.396 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' B' B ' 99' ' ' GLU . . . . . . . . . . . . . 12.8 pt-20 -84.56 17.61 2.62 Favored 'General case' 0 CA--C 1.535 0.377 0 N-CA-C 113.117 0.784 . . . . 0.0 113.117 -178.7 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' B' B ' 100' ' ' ASN . . . . . . . . . . . . . 3.1 m-20 62.86 37.95 11.8 Favored 'General case' 0 N--CA 1.462 0.171 0 CA-C-O 121.084 0.468 . . . . 0.0 111.129 177.29 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' B' B ' 101' ' ' GLU . . . . . . . . . . . . . 84.6 tt0 -117.72 141.01 48.88 Favored 'General case' 0 C--N 1.332 -0.158 0 N-CA-C 109.77 -0.456 . . . . 0.0 109.77 175.358 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' B' B ' 102' ' ' VAL . . . . . . . . . . . . . 45.2 t -114.96 127.67 72.42 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.329 0 N-CA-C 109.991 -0.374 . . . . 0.0 109.991 -178.134 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' B' B ' 103' ' ' LEU . . . . . . . . . . . . . 29.4 mt -119.27 133.99 55.45 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 115.762 -0.653 . . . . 0.0 110.19 177.599 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' B' B ' 104' ' ' ILE . . . . . 0.409 ' CD1' HG11 ' B' ' 130' ' ' VAL . 69.8 mt -118.73 121.48 67.05 Favored 'Isoleucine or valine' 0 C--O 1.233 0.215 0 CA-C-N 116.52 -0.309 . . . . 0.0 110.272 -179.449 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' B' B ' 105' ' ' PHE . . . . . . . . . . . . . 90.1 m-85 -118.57 163.31 16.98 Favored 'General case' 0 C--O 1.232 0.143 0 O-C-N 124.116 0.885 . . . . 0.0 109.692 178.442 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' B' B ' 106' ' ' ASN . . . . . . . . . . . . . 44.6 p-10 -101.21 -170.64 1.87 Allowed 'General case' 0 C--N 1.33 -0.276 0 N-CA-C 110.185 -0.302 . . . . 0.0 110.185 174.1 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' B' B ' 107' ' ' GLN . . . . . . . . . . . . . 42.4 tt0 -57.49 -26.89 61.98 Favored 'General case' 0 C--N 1.328 -0.331 0 N-CA-C 112.325 0.491 . . . . 0.0 112.325 179.526 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' B' B ' 108' ' ' ASN . . . . . . . . . . . . . 21.4 t-20 -92.41 13.53 19.26 Favored 'General case' 0 CA--C 1.535 0.396 0 N-CA-C 113.144 0.794 . . . . 0.0 113.144 -176.43 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' B' B ' 109' ' ' LEU . . . . . 0.4 HD11 ' HB3' ' A' ' 140' ' ' LEU . 38.9 mt 57.26 32.92 22.54 Favored 'General case' 0 C--O 1.233 0.22 0 N-CA-C 112.013 0.375 . . . . 0.0 112.013 178.332 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' B' B ' 110' ' ' GLU . . . . . . . . . . . . . 70.7 mm-40 -103.21 140.19 37.69 Favored 'General case' 0 C--N 1.329 -0.303 0 N-CA-C 109.497 -0.557 . . . . 0.0 109.497 175.203 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' B' B ' 111' ' ' GLU . . . . . . . . . . . . . 52.7 tt0 -76.95 121.72 23.87 Favored 'General case' 0 C--N 1.326 -0.418 0 CA-C-N 116.426 -0.352 . . . . 0.0 110.512 -175.698 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' B' B ' 112' ' ' LEU . . . . . . . . . . . . . 85.6 mt -103.09 -45.77 4.83 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.13 -0.487 . . . . 0.0 110.522 178.841 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' B' B ' 113' ' ' TYR . . . . . . . . . . . . . 65.0 t80 -137.87 144.06 41.21 Favored 'General case' 0 C--N 1.331 -0.2 0 CA-C-N 116.188 -0.46 . . . . 0.0 111.29 -178.105 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' B' B ' 114' ' ' ARG . . . . . . . . . . . . . 37.3 ptt180 -145.59 125.47 13.52 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 115.994 -0.548 . . . . 0.0 110.513 177.429 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' B' B ' 115' ' ' GLY . . . . . . . . . . . . . . . -150.22 149.22 21.07 Favored Glycine 0 CA--C 1.525 0.668 0 N-CA-C 111.12 -0.792 . . . . 0.0 111.12 179.467 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' B' B ' 116' ' ' LYS . . . . . . . . . . . . . 7.4 ttpm? -114.49 137.6 51.65 Favored 'General case' 0 C--N 1.33 -0.265 0 N-CA-C 109.661 -0.496 . . . . 0.0 109.661 176.288 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' B' B ' 117' ' ' PHE . . . . . . . . . . . . . 39.0 m-85 -137.02 113.79 10.37 Favored 'General case' 0 C--N 1.329 -0.305 0 N-CA-C 109.962 -0.384 . . . . 0.0 109.962 -179.036 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' B' B ' 118' ' ' GLU . . . . . . . . . . . . . 96.3 mt-10 -57.91 -42.42 84.69 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.332 -0.395 . . . . 0.0 110.742 -176.371 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' B' B ' 119' ' ' ASN . . . . . . . . . . . . . 69.1 m-80 -97.22 31.1 2.55 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.207 -0.451 . . . . 0.0 112.094 -174.707 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' B' B ' 120' ' ' LEU . . . . . . . . . . . . . 24.2 tp -57.1 121.23 9.54 Favored 'General case' 0 C--N 1.333 -0.136 0 C-N-CA 120.944 -0.302 . . . . 0.0 110.429 177.969 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' B' B ' 121' ' ' ASN . . . . . . . . . . . . . 27.2 m-80 -103.43 -43.56 5.38 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.356 -0.384 . . . . 0.0 110.287 -179.556 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' B' B ' 122' ' ' LYS . . . . . . . . . . . . . 53.6 pttt -165.95 152.98 9.87 Favored 'General case' 0 C--N 1.331 -0.222 0 CA-C-O 121.186 0.517 . . . . 0.0 111.892 179.047 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' B' B ' 123' ' ' VAL . . . . . . . . . . . . . 45.1 t -119.71 132.46 69.39 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.261 0 CA-C-N 115.852 -0.613 . . . . 0.0 109.538 177.911 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' B' B ' 124' ' ' LEU . . . . . . . . . . . . . 6.5 mp -119.36 136.42 54.28 Favored 'General case' 0 C--N 1.332 -0.193 0 CA-C-N 116.156 -0.474 . . . . 0.0 110.673 -177.757 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' B' B ' 125' ' ' VAL . . . . . . . . . . . . . 46.0 t -119.2 131.89 70.62 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.273 0 CA-C-N 116.002 -0.545 . . . . 0.0 109.833 178.36 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' B' B ' 126' ' ' ARG . . . . . . . . . . . . . 40.7 mmt180 -133.27 99.14 4.44 Favored 'General case' 0 C--N 1.331 -0.21 0 CA-C-N 116.25 -0.432 . . . . 0.0 110.278 179.12 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' B' B ' 127' ' ' ASN . . . . . . . . . . . . . 34.3 t-20 53.42 -104.89 0.22 Allowed 'General case' 0 CA--C 1.542 0.65 0 CA-C-O 119.02 -0.514 . . . . 0.0 111.157 178.793 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' B' B ' 128' ' ' ASP . . . . . . . . . . . . . 19.5 p-10 -105.86 -3.09 22.3 Favored 'General case' 0 CA--C 1.537 0.468 0 CA-C-N 119.562 1.074 . . . . 0.0 113.684 -175.971 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' B' B ' 129' ' ' LEU . . . . . . . . . . . . . 60.2 mt -105.09 142.84 34.16 Favored 'General case' 0 C--N 1.332 -0.157 0 O-C-N 122.102 -0.374 . . . . 0.0 110.116 178.571 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' B' B ' 130' ' ' VAL . . . . . 0.409 HG11 ' CD1' ' B' ' 104' ' ' ILE . 42.9 t -121.27 135.88 60.02 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.213 0 N-CA-C 110.016 -0.365 . . . . 0.0 110.016 -178.582 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' B' B ' 131' ' ' VAL . . . . . . . . . . . . . 39.6 t -133.13 133.34 58.47 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.278 0 CA-C-O 120.932 0.396 . . . . 0.0 110.275 179.479 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' B' B ' 132' ' ' ILE . . . . . . . . . . . . . 73.1 mt -114.06 130.17 68.73 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.363 0 N-CA-C 109.263 -0.643 . . . . 0.0 109.263 178.604 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' B' B ' 133' ' ' ILE . . . . . . . . . . . . . 42.3 mm -111.98 119.61 60.46 Favored 'Isoleucine or valine' 0 C--O 1.234 0.247 0 CA-C-O 120.877 0.37 . . . . 0.0 110.878 -176.095 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' B' B ' 134' ' ' ASP . . . . . . . . . . . . . 7.4 p-10 -132.88 143.56 49.59 Favored 'General case' 0 C--N 1.33 -0.246 0 N-CA-C 109.312 -0.625 . . . . 0.0 109.312 175.449 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' B' B ' 135' ' ' GLU . . . . . . . . . . . . . 77.7 tt0 -49.99 -25.77 3.64 Favored 'General case' 0 C--N 1.327 -0.389 0 N-CA-C 112.697 0.629 . . . . 0.0 112.697 -174.599 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' B' B ' 136' ' ' GLN . . . . . . . . . . . . . 47.7 tt0 -85.54 -31.42 22.71 Favored 'General case' 0 C--O 1.233 0.192 0 N-CA-C 112.386 0.513 . . . . 0.0 112.386 -175.388 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' B' B ' 137' ' ' LYS . . . . . . . . . . . . . 18.2 ptpt -164.7 174.06 11.17 Favored 'General case' 0 C--O 1.233 0.205 0 CA-C-O 121.64 0.733 . . . . 0.0 112.193 -175.359 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' B' B ' 138' ' ' LEU . . . . . 0.409 HD23 ' N ' ' B' ' 139' ' ' THR . 6.5 tt -119.5 128.87 54.37 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 114.938 -1.028 . . . . 0.0 109.504 176.418 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' B' B ' 139' ' ' THR . . . . . 0.409 ' N ' HD23 ' B' ' 138' ' ' LEU . 25.4 m -108.1 126.0 52.24 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.315 -0.402 . . . . 0.0 110.467 -179.933 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' B' B ' 140' ' ' LEU . . . . . . . . . . . . . 17.2 tp -112.95 119.9 39.55 Favored 'General case' 0 C--N 1.331 -0.209 0 CA-C-N 115.791 -0.64 . . . . 0.0 109.304 -178.926 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' B' B ' 141' ' ' ILE . . . . . . . . . . . . . 19.2 mt -119.16 123.19 70.93 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.289 0 CA-C-O 120.884 0.373 . . . . 0.0 110.118 -173.845 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' B' B ' 142' ' ' ARG . . . . . . . . . . . . . 72.7 mtt180 -108.79 127.58 54.14 Favored 'General case' 0 C--N 1.331 -0.239 0 CA-C-N 115.439 -0.801 . . . . 0.0 110.027 -176.301 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' B' B ' 143' ' ' THR . . . . . . . . . . . . . 52.9 p . . . . . 0 C--O 1.221 -0.442 0 CA-C-O 117.992 -1.004 . . . . 0.0 110.576 179.804 . . . . . . . . 0 0 . 1 . 017 nuclear nobuild full ' C' C ' -3' ' ' GLU . . . . . . . . . . . . . 95.6 mt-10 . . . . . 0 N--CA 1.49 1.537 0 N-CA-C 109.344 -0.613 . . . . 0.0 109.344 . . . . . . . . . 0 0 . 1 . 017 nuclear nobuild full ' C' C ' -2' ' ' GLY . . . . . . . . . . . . . . . -67.29 105.67 1.43 Allowed Glycine 0 CA--C 1.524 0.647 0 N-CA-C 111.067 -0.813 . . . . 0.0 111.067 -179.559 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' C' C ' -1' ' ' VAL . . . . . . . . . . . . . 43.5 t -140.95 138.81 34.39 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.336 0 N-CA-C 109.991 -0.374 . . . . 0.0 109.991 179.093 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' C' C ' 0' ' ' ILE . . . . . . . . . . . . . 72.6 mt -107.26 130.24 59.73 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.289 0 CA-C-N 116.283 -0.417 . . . . 0.0 109.943 -179.505 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' C' C ' 1' ' ' MET . . . . . . . . . . . . . 25.8 ptm -84.04 131.49 34.81 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.106 -0.497 . . . . 0.0 110.468 178.937 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' C' C ' 2' ' ' SER . . . . . . . . . . . . . 55.2 p -117.04 146.0 43.36 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-N 116.291 -0.413 . . . . 0.0 110.554 -179.95 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' C' C ' 3' ' ' GLU . . . . . . . . . . . . . 42.7 mt-10 -140.37 141.07 35.64 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.039 -0.528 . . . . 0.0 111.013 -178.458 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' C' C ' 4' ' ' LEU . . . . . . . . . . . . . 19.0 tp -124.27 128.28 48.92 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 115.808 -0.633 . . . . 0.0 109.976 176.19 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' C' C ' 5' ' ' LYS . . . . . . . . . . . . . 99.1 mttt -110.36 123.43 49.83 Favored 'General case' 0 C--O 1.234 0.254 0 CA-C-O 120.672 0.272 . . . . 0.0 110.929 179.877 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' C' C ' 6' ' ' LEU . . . . . . . . . . . . . 52.4 mt -114.61 145.62 41.77 Favored 'General case' 0 C--N 1.332 -0.185 0 CA-C-N 115.559 -0.746 . . . . 0.0 110.146 178.586 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' C' C ' 7' ' ' LYS . . . . . . . . . . . . . 35.7 ttpt -127.36 141.41 40.78 Favored Pre-proline 0 CA--C 1.533 0.319 0 CA-C-O 119.071 -0.49 . . . . 0.0 109.711 175.286 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' C' C ' 8' ' ' PRO . . . . . . . . . . . . . 91.7 Cg_endo -91.69 138.56 2.1 Favored 'Trans proline' 0 N--CA 1.489 1.211 0 C-N-CA 121.718 1.612 . . . . 0.0 112.129 179.255 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' C' C ' 9' ' ' LEU . . . . . . . . . . . . . 67.8 mt -78.19 -47.16 2.12 Favored Pre-proline 0 C--N 1.329 -0.312 0 CA-C-O 118.714 -0.66 . . . . 0.0 111.826 178.189 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' C' C ' 10' ' ' PRO . . . . . . . . . . . . . 85.5 Cg_endo -81.14 151.61 18.19 Favored 'Trans proline' 0 N--CA 1.495 1.613 0 C-N-CA 121.14 1.226 . . . . 0.0 111.536 174.58 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' C' C ' 11' ' ' LYS . . . . . . . . . . . . . 66.7 tttt -88.33 98.85 11.82 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-O 120.836 0.351 . . . . 0.0 110.194 178.712 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' C' C ' 12' ' ' VAL . . . . . . . . . . . . . 13.2 p -140.03 147.14 23.93 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.285 0 CA-C-N 116.29 -0.414 . . . . 0.0 110.727 -178.463 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' C' C ' 13' ' ' GLU . . . . . . . . . . . . . 84.1 tt0 -88.96 123.82 33.66 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.21 -0.45 . . . . 0.0 109.908 176.978 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' C' C ' 14' ' ' LEU . . . . . . . . . . . . . 22.2 mt -98.14 152.29 37.94 Favored Pre-proline 0 C--N 1.329 -0.299 0 CA-C-N 116.402 -0.363 . . . . 0.0 110.84 -177.189 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' C' C ' 15' ' ' PRO . . . . . . . . . . . . . 25.6 Cg_exo -62.31 157.02 47.6 Favored 'Trans proline' 0 N--CA 1.498 1.761 0 C-N-CA 121.261 1.308 . . . . 0.0 111.713 176.116 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' C' C ' 16' ' ' PRO . . . . . . . . . . . . . 39.5 Cg_exo -58.72 -36.47 97.08 Favored 'Trans proline' 0 N--CA 1.498 1.776 0 C-N-CA 121.389 1.393 . . . . 0.0 112.65 -179.533 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' C' C ' 17' ' ' ASP . . . . . . . . . . . . . 16.6 p-10 -85.66 7.94 21.46 Favored 'General case' 0 CA--C 1.535 0.393 0 N-CA-C 113.23 0.826 . . . . 0.0 113.23 -177.641 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' C' C ' 18' ' ' PHE . . . . . . . . . . . . . 43.9 t80 -58.09 -46.8 84.89 Favored 'General case' 0 N--CA 1.456 -0.126 0 O-C-N 121.983 -0.448 . . . . 0.0 110.285 -176.876 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' C' C ' 19' ' ' VAL . . . . . 0.4 HG13 ' N ' ' C' ' 20' ' ' ASP . 14.7 p -55.48 -41.76 64.72 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.288 0 CA-C-N 116.523 -0.308 . . . . 0.0 111.029 -178.019 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' C' C ' 20' ' ' ASP . . . . . 0.4 ' N ' HG13 ' C' ' 19' ' ' VAL . 78.3 m-20 -61.4 -44.44 97.14 Favored 'General case' 0 C--N 1.329 -0.286 0 C-N-CA 120.935 -0.306 . . . . 0.0 111.231 -178.198 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' C' C ' 21' ' ' VAL . . . . . . . . . . . . . 47.6 t -64.11 -45.22 97.12 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.287 0 C-N-CA 120.715 -0.394 . . . . 0.0 110.447 -176.953 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' C' C ' 22' ' ' ILE . . . . . 0.41 HG22 HD12 ' C' ' 26' ' ' LEU . 51.0 mm -56.5 -46.25 82.27 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.227 0 C-N-CA 120.872 -0.331 . . . . 0.0 110.55 178.614 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' C' C ' 23' ' ' ARG . . . . . . . . . . . . . 56.1 ttp180 -54.89 -46.75 74.84 Favored 'General case' 0 C--N 1.329 -0.302 0 C-N-CA 121.057 -0.257 . . . . 0.0 111.384 -179.269 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' C' C ' 24' ' ' ILE . . . . . . . . . . . . . 79.7 mt -59.58 -43.87 91.97 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.303 0 C-N-CA 121.075 -0.25 . . . . 0.0 111.246 -177.987 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' C' C ' 25' ' ' LYS . . . . . . . . . . . . . 97.4 mttt -66.01 -42.1 90.12 Favored 'General case' 0 C--N 1.328 -0.361 0 N-CA-C 112.504 0.557 . . . . 0.0 112.504 -178.878 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' C' C ' 26' ' ' LEU . . . . . 0.41 HD12 HG22 ' C' ' 22' ' ' ILE . 93.0 mt -77.91 -38.79 44.88 Favored 'General case' 0 C--N 1.33 -0.254 0 N-CA-C 113.216 0.821 . . . . 0.0 113.216 -170.833 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' C' C ' 27' ' ' GLN . . . . . . . . . . . . . 9.9 pt20 -47.19 139.94 5.66 Favored 'General case' 0 N--CA 1.469 0.521 0 N-CA-C 112.709 0.633 . . . . 0.0 112.709 -176.137 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' C' C ' 28' ' ' GLY . . . . . . . . . . . . . . . 100.61 -26.15 25.69 Favored Glycine 0 CA--C 1.534 1.269 0 CA-C-N 115.598 -0.728 . . . . 0.0 112.14 -176.3 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' C' C ' 29' ' ' LYS . . . . . . . . . . . . . 37.9 mtmm -98.79 155.02 17.57 Favored 'General case' 0 C--N 1.332 -0.181 0 CA-C-N 117.295 0.547 . . . . 0.0 111.292 179.115 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' C' C ' 30' ' ' THR . . . . . . . . . . . . . 50.1 m -107.84 136.45 47.55 Favored 'General case' 0 C--N 1.332 -0.19 0 CA-C-N 116.147 -0.479 . . . . 0.0 109.991 176.349 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' C' C ' 31' ' ' VAL . . . . . . . . . . . . . 34.9 m -132.2 162.16 40.16 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.247 0 CA-C-N 116.302 -0.408 . . . . 0.0 111.036 -178.347 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' C' C ' 32' ' ' ARG . . . . . . . . . . . . . 81.6 mtt180 -132.29 152.43 51.38 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 115.989 -0.551 . . . . 0.0 110.591 178.654 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' C' C ' 33' ' ' THR . . . . . . . . . . . . . 28.8 m -53.61 140.18 29.63 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.299 -0.41 . . . . 0.0 111.237 -179.313 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' C' C ' 34' ' ' GLY . . . . . . . . . . . . . . . 100.49 -17.16 57.12 Favored Glycine 0 CA--C 1.532 1.139 0 CA-C-O 119.589 -0.562 . . . . 0.0 113.17 179.755 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' C' C ' 35' ' ' ASP . . . . . . . . . . . . . 72.1 m-20 -65.98 149.69 49.83 Favored 'General case' 0 N--CA 1.461 0.123 0 CA-C-N 118.127 0.963 . . . . 0.0 111.151 178.79 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' C' C ' 36' ' ' VAL . . . . . . . . . . . . . 43.5 t -122.6 130.82 74.23 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.213 0 CA-C-N 115.968 -0.56 . . . . 0.0 109.934 178.9 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' C' C ' 37' ' ' ILE . . . . . . . . . . . . . 69.3 mt -122.53 140.55 45.99 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.205 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.093 -178.928 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' C' C ' 38' ' ' GLY . . . . . . . . . . . . . . . -115.7 128.73 8.17 Favored Glycine 0 CA--C 1.525 0.708 0 N-CA-C 111.177 -0.769 . . . . 0.0 111.177 179.42 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' C' C ' 39' ' ' ILE . . . . . . . . . . . . . 72.9 mt -125.9 135.69 63.12 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.306 0 N-CA-C 110.136 -0.32 . . . . 0.0 110.136 179.245 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' C' C ' 40' ' ' SER . . . . . . . . . . . . . 9.7 t -93.32 114.08 26.43 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.343 -0.389 . . . . 0.0 111.132 177.268 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' C' C ' 41' ' ' ILE . . . . . . . . . . . . . 45.8 mm -122.58 119.55 58.46 Favored 'Isoleucine or valine' 0 CA--C 1.529 0.153 0 N-CA-C 110.07 -0.344 . . . . 0.0 110.07 178.758 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' C' C ' 42' ' ' LEU . . . . . . . . . . . . . 41.3 mt 57.39 34.06 24.15 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.394 -0.366 . . . . 0.0 111.916 177.479 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' C' C ' 43' ' ' GLY . . . . . . . . . . . . . . . 79.32 -10.13 37.37 Favored Glycine 0 CA--C 1.535 1.325 0 C-N-CA 121.271 -0.49 . . . . 0.0 113.485 177.312 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' C' C ' 44' ' ' LYS . . . . . . . . . . . . . 64.0 mmtt -100.46 134.72 42.99 Favored 'General case' 0 C--N 1.332 -0.156 0 CA-C-N 117.887 0.844 . . . . 0.0 110.079 175.878 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' C' C ' 45' ' ' GLU . . . . . . . . . . . . . 84.0 tt0 -85.18 131.57 34.41 Favored 'General case' 0 C--N 1.326 -0.425 0 CA-C-N 116.455 -0.339 . . . . 0.0 111.159 -179.279 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' C' C ' 46' ' ' VAL . . . . . . . . . . . . . 9.5 p -120.97 125.77 74.41 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.189 0 N-CA-C 109.585 -0.524 . . . . 0.0 109.585 174.428 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' C' C ' 47' ' ' LYS . . . . . . . . . . . . . 82.8 mttt -98.8 125.96 44.31 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 115.993 -0.549 . . . . 0.0 110.524 177.83 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' C' C ' 48' ' ' PHE . . . . . . . . . . . . . 31.0 m-85 -110.53 131.91 54.64 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.359 -0.382 . . . . 0.0 110.175 178.293 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' C' C ' 49' ' ' LYS . . . . . . . . . . . . . 58.5 tttt -105.92 132.42 52.05 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.251 -0.431 . . . . 0.0 109.97 177.677 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' C' C ' 50' ' ' VAL . . . . . . . . . . . . . 46.0 t -75.74 104.98 4.29 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.247 0 N-CA-C 109.14 -0.689 . . . . 0.0 109.14 176.552 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' C' C ' 51' ' ' VAL . . . . . . . . . . . . . 47.3 t -69.17 -48.51 68.43 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.324 0 CA-C-N 116.085 -0.507 . . . . 0.0 109.925 -173.418 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' C' C ' 52' ' ' GLN . . . . . . . . . . . . . 46.9 tt0 -168.33 146.83 4.34 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 115.95 -0.568 . . . . 0.0 111.381 -178.706 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' C' C ' 53' ' ' ALA . . . . . . . . . . . . . . . -122.61 136.54 54.91 Favored 'General case' 0 C--N 1.331 -0.209 0 CA-C-N 115.842 -0.617 . . . . 0.0 110.109 177.032 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' C' C ' 54' ' ' TYR . . . . . . . . . . . . . 58.3 t80 -129.12 112.11 18.37 Favored Pre-proline 0 CA--C 1.534 0.329 0 CA-C-O 118.081 -0.961 . . . . 0.0 110.202 177.55 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' C' C ' 55' ' ' PRO . . . . . . . . . . . . . 72.8 Cg_endo -77.31 170.14 72.16 Favored 'Cis proline' 0 N--CA 1.499 1.829 0 CA-C-N 122.015 1.755 . . . . 0.0 112.337 -6.283 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' C' C ' 56' ' ' SER . . . . . . . . . . . . . 25.5 m -122.25 135.65 25.67 Favored Pre-proline 0 CA--C 1.538 0.491 0 CA-C-O 118.513 -0.756 . . . . 0.0 109.537 175.049 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' C' C ' 57' ' ' PRO . . . . . . . . . . . . . 34.9 Cg_endo -66.29 160.85 75.13 Favored 'Cis proline' 0 N--CA 1.499 1.799 0 CA-C-N 121.864 1.701 . . . . 0.0 111.525 -2.839 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' C' C ' 58' ' ' LEU . . . . . . . . . . . . . 30.3 tp -127.57 136.4 51.64 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-O 121.118 0.485 . . . . 0.0 110.713 -178.101 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' C' C ' 59' ' ' ARG . . . . . . . . . . . . . 20.7 ttm180 -103.01 122.52 44.78 Favored 'General case' 0 C--N 1.327 -0.411 0 N-CA-C 108.919 -0.771 . . . . 0.0 108.919 173.936 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' C' C ' 60' ' ' VAL . . . . . . . . . . . . . 39.9 t -77.72 120.81 29.09 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.323 0 C-N-CA 120.561 -0.456 . . . . 0.0 110.349 -173.647 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' C' C ' 61' ' ' GLU . . . . . . . . . . . . . 96.3 mt-10 -131.13 165.5 23.15 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 115.679 -0.691 . . . . 0.0 109.567 176.807 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' C' C ' 62' ' ' ASP . . . . . . . . . . . . . 7.8 p-10 -53.09 -31.25 40.9 Favored 'General case' 0 C--N 1.329 -0.325 0 N-CA-C 111.912 0.338 . . . . 0.0 111.912 179.816 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' C' C ' 63' ' ' ARG . . . . . . . . . . . . . 87.6 mtt180 -71.77 -22.1 61.64 Favored 'General case' 0 CA--C 1.533 0.293 0 N-CA-C 112.962 0.727 . . . . 0.0 112.962 -176.307 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' C' C ' 64' ' ' THR . . . . . . . . . . . . . 32.9 m -74.48 136.6 42.26 Favored 'General case' 0 C--N 1.332 -0.192 0 CA-C-O 120.918 0.389 . . . . 0.0 110.832 -175.956 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' C' C ' 65' ' ' LYS . . . . . . . . . . . . . 96.0 mttt -89.36 133.88 34.31 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.023 -0.535 . . . . 0.0 109.977 179.013 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' C' C ' 66' ' ' ILE . . . . . . . . . . . . . 65.3 mt -115.48 130.56 69.87 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.266 0 N-CA-C 109.976 -0.379 . . . . 0.0 109.976 179.739 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' C' C ' 67' ' ' THR . . . . . . . . . . . . . 23.8 m -122.54 138.42 54.58 Favored 'General case' 0 C--N 1.331 -0.214 0 CA-C-N 115.929 -0.578 . . . . 0.0 110.516 -179.071 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' C' C ' 68' ' ' LEU . . . . . 0.437 HD23 ' C ' ' C' ' 68' ' ' LEU . 5.8 tt -106.24 124.34 49.44 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 115.959 -0.564 . . . . 0.0 110.173 178.795 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' C' C ' 69' ' ' VAL . . . . . 0.401 ' N ' HD23 ' C' ' 68' ' ' LEU . 46.6 t -98.1 128.82 49.14 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.283 0 N-CA-C 109.598 -0.519 . . . . 0.0 109.598 179.016 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' C' C ' 70' ' ' THR . . . . . . . . . . . . . 24.0 m -107.35 92.47 4.09 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.209 -0.45 . . . . 0.0 110.735 -177.976 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' C' C ' 71' ' ' HIS . . . . . . . . . . . . . 51.4 m80 -150.05 146.92 20.98 Favored Pre-proline 0 C--N 1.329 -0.319 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.195 177.377 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' C' C ' 72' ' ' PRO . . . . . . . . . . . . . 86.8 Cg_endo -91.1 -7.27 3.72 Favored 'Trans proline' 0 N--CA 1.492 1.44 0 C-N-CA 121.786 1.657 . . . . 0.0 113.831 178.215 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' C' C ' 73' ' ' VAL . . . . . . . . . . . . . 34.0 m -130.59 170.91 18.57 Favored 'Isoleucine or valine' 0 C--O 1.231 0.094 0 CA-C-O 120.894 0.378 . . . . 0.0 110.871 -176.762 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' C' C ' 74' ' ' ASP . . . . . . . . . . . . . 8.0 t70 -103.84 126.03 50.68 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.105 -0.498 . . . . 0.0 109.737 179.993 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' C' C ' 75' ' ' VAL . . . . . . . . . . . . . 40.5 t -121.13 127.95 75.95 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.345 0 CA-C-O 121.169 0.509 . . . . 0.0 110.957 -176.633 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' C' C ' 76' ' ' LEU . . . . . . . . . . . . . 5.2 mp -121.47 144.67 48.56 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 115.488 -0.778 . . . . 0.0 109.523 174.244 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' C' C ' 77' ' ' GLU . . . . . . . . . . . . . 47.1 mt-10 -133.92 137.84 45.15 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-O 121.033 0.444 . . . . 0.0 111.127 -177.629 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' C' C ' 78' ' ' ALA . . . . . 0.643 ' HB2' HD21 ' C' ' 109' ' ' LEU . . . -125.79 128.61 47.96 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 115.78 -0.646 . . . . 0.0 109.707 176.477 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' C' C ' 79' ' ' LYS . . . . . 0.622 ' O ' HD13 ' C' ' 80' ' ' ILE . 54.1 mtmt -77.45 122.72 25.59 Favored 'General case' 0 C--N 1.331 -0.214 0 CA-C-O 121.044 0.449 . . . . 0.0 110.667 -178.327 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' C' C ' 80' ' ' ILE . . . . . 0.622 HD13 ' O ' ' C' ' 79' ' ' LYS . 39.4 mm -139.05 114.16 8.36 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.356 0 N-CA-C 109.178 -0.675 . . . . 0.0 109.178 -177.779 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' C' C ' 81' ' ' LYS . . . . . . . . . . . . . 31.8 ttpt -101.4 121.99 42.92 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-O 120.821 0.343 . . . . 0.0 111.002 -177.461 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' C' C ' 82' ' ' GLY . . . . . . . . . . . . . . . 89.12 42.23 5.65 Favored Glycine 0 CA--C 1.527 0.786 0 C-N-CA 120.683 -0.77 . . . . 0.0 111.91 174.246 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' C' C ' 83' ' ' ILE . . . . . . . . . . . . . 73.4 mt -67.74 131.91 32.87 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.341 0 N-CA-C 109.468 -0.567 . . . . 0.0 109.468 175.944 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' C' C ' 84' ' ' LYS . . . . . . . . . . . . . 72.8 tttt -88.84 -53.26 4.69 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-O 121.046 0.451 . . . . 0.0 110.181 -178.22 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' C' C ' 85' ' ' ASP . . . . . . . . . . . . . 11.5 t70 -155.85 152.96 29.0 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 115.626 -0.715 . . . . 0.0 110.146 179.201 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' C' C ' 86' ' ' VAL . . . . . . . . . . . . . 46.6 t -128.65 130.59 68.9 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.252 0 CA-C-O 120.961 0.41 . . . . 0.0 110.564 -178.475 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' C' C ' 87' ' ' ILE . . . . . . . . . . . . . 45.0 mm -119.58 126.54 75.42 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.303 0 CA-C-N 115.781 -0.645 . . . . 0.0 109.612 177.453 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' C' C ' 88' ' ' LEU . . . . . . . . . . . . . 86.5 mt -111.15 139.34 46.61 Favored 'General case' 0 C--N 1.331 -0.214 0 CA-C-O 121.152 0.501 . . . . 0.0 111.286 -178.151 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' C' C ' 89' ' ' ASP . . . . . . . . . . . . . 46.8 t0 -130.57 162.94 28.18 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 115.462 -0.79 . . . . 0.0 109.457 176.864 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' C' C ' 90' ' ' GLU . . . . . . . . . . . . . 45.5 tp10 -44.99 -44.51 9.96 Favored 'General case' 0 N--CA 1.465 0.293 0 N-CA-C 113.222 0.823 . . . . 0.0 113.222 -170.874 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' C' C ' 91' ' ' ASN . . . . . . . . . . . . . 31.0 m120 -132.12 26.41 4.55 Favored 'General case' 0 N--CA 1.467 0.381 0 N-CA-C 112.473 0.546 . . . . 0.0 112.473 -178.478 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' C' C ' 92' ' ' LEU . . . . . . . . . . . . . 36.5 mt -146.58 144.87 29.86 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-O 120.736 0.303 . . . . 0.0 110.51 -176.931 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' C' C ' 93' ' ' ILE . . . . . . . . . . . . . 65.3 mt -124.18 115.07 43.75 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.311 0 N-CA-C 109.104 -0.702 . . . . 0.0 109.104 177.505 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' C' C ' 94' ' ' VAL . . . . . 0.516 HG11 HG11 ' C' ' 123' ' ' VAL . 46.6 t -115.89 126.4 73.39 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.218 0 N-CA-C 109.763 -0.458 . . . . 0.0 109.763 -179.382 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' C' C ' 95' ' ' VAL . . . . . . . . . . . . . 43.2 t -121.18 133.72 66.86 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.372 0 CA-C-N 116.047 -0.524 . . . . 0.0 109.935 -178.893 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' C' C ' 96' ' ' ILE . . . . . . . . . . . . . 67.8 mt -110.14 124.52 66.95 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.317 0 N-CA-C 108.939 -0.763 . . . . 0.0 108.939 177.637 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' C' C ' 97' ' ' THR . . . . . . . . . . . . . 82.7 p -97.8 155.01 17.23 Favored 'General case' 0 C--N 1.327 -0.395 0 CA-C-O 121.059 0.457 . . . . 0.0 111.025 -177.176 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' C' C ' 98' ' ' GLU . . . . . . . . . . . . . 84.2 tt0 -53.79 -23.22 11.36 Favored 'General case' 0 C--N 1.327 -0.399 0 N-CA-C 112.379 0.511 . . . . 0.0 112.379 -179.835 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' C' C ' 99' ' ' GLU . . . . . . . . . . . . . 68.9 mm-40 -82.26 15.05 2.58 Favored 'General case' 0 CA--C 1.536 0.412 0 N-CA-C 113.2 0.815 . . . . 0.0 113.2 -176.569 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' C' C ' 100' ' ' ASN . . . . . . . . . . . . . 3.0 m-20 62.83 33.5 15.18 Favored 'General case' 0 N--CA 1.465 0.276 0 CA-C-O 120.914 0.387 . . . . 0.0 111.535 179.336 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' C' C ' 101' ' ' GLU . . . . . . . . . . . . . 84.9 tt0 -113.12 145.88 40.17 Favored 'General case' 0 C--N 1.331 -0.225 0 N-CA-C 109.639 -0.504 . . . . 0.0 109.639 174.144 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' C' C ' 102' ' ' VAL . . . . . . . . . . . . . 44.9 t -114.87 123.56 70.68 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.316 0 N-CA-C 109.717 -0.475 . . . . 0.0 109.717 -178.484 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' C' C ' 103' ' ' LEU . . . . . . . . . . . . . 35.5 mt -115.29 132.74 56.52 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 115.804 -0.634 . . . . 0.0 109.82 178.888 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' C' C ' 104' ' ' ILE . . . . . . . . . . . . . 64.6 mt -123.86 121.56 62.54 Favored 'Isoleucine or valine' 0 C--O 1.234 0.248 0 N-CA-C 110.432 -0.21 . . . . 0.0 110.432 -179.241 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' C' C ' 105' ' ' PHE . . . . . . . . . . . . . 61.8 m-85 -118.91 165.29 14.25 Favored 'General case' 0 C--N 1.33 -0.254 0 O-C-N 124.104 0.878 . . . . 0.0 109.617 178.561 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' C' C ' 106' ' ' ASN . . . . . . . . . . . . . 40.9 p-10 -101.21 -169.9 1.76 Allowed 'General case' 0 C--N 1.33 -0.25 0 N-CA-C 109.857 -0.423 . . . . 0.0 109.857 173.627 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' C' C ' 107' ' ' GLN . . . . . . . . . . . . . 49.2 tt0 -56.42 -29.69 61.89 Favored 'General case' 0 CA--C 1.534 0.332 0 N-CA-C 111.823 0.305 . . . . 0.0 111.823 176.744 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' C' C ' 108' ' ' ASN . . . . . . . . . . . . . 8.0 t-20 -84.35 9.57 12.81 Favored 'General case' 0 CA--C 1.536 0.43 0 N-CA-C 113.205 0.816 . . . . 0.0 113.205 -176.684 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' C' C ' 109' ' ' LEU . . . . . 0.643 HD21 ' HB2' ' C' ' 78' ' ' ALA . 8.0 tp 56.05 36.55 27.59 Favored 'General case' 0 C--N 1.332 -0.167 0 CA-C-O 120.923 0.392 . . . . 0.0 111.339 179.442 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' C' C ' 110' ' ' GLU . . . . . . . . . . . . . 70.5 mm-40 -107.79 150.29 27.17 Favored 'General case' 0 C--N 1.333 -0.141 0 N-CA-C 110.07 -0.344 . . . . 0.0 110.07 176.876 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' C' C ' 111' ' ' GLU . . . . . . . . . . . . . 98.0 mt-10 -77.16 122.29 24.8 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-O 120.876 0.37 . . . . 0.0 111.051 -178.296 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' C' C ' 112' ' ' LEU . . . . . . . . . . . . . 17.9 mt -108.62 -46.0 3.75 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 115.988 -0.551 . . . . 0.0 110.388 177.08 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' C' C ' 113' ' ' TYR . . . . . . . . . . . . . 59.6 t80 -136.75 137.68 40.13 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.359 -0.382 . . . . 0.0 111.048 179.943 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' C' C ' 114' ' ' ARG . . . . . . . . . . . . . 72.4 mtm180 -141.44 122.08 14.25 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 115.998 -0.546 . . . . 0.0 110.482 178.111 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' C' C ' 115' ' ' GLY . . . . . . . . . . . . . . . -150.11 160.91 28.73 Favored Glycine 0 CA--C 1.525 0.708 0 N-CA-C 111.03 -0.828 . . . . 0.0 111.03 178.572 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' C' C ' 116' ' ' LYS . . . . . . . . . . . . . 72.5 tttt -134.27 133.43 40.79 Favored 'General case' 0 C--N 1.33 -0.266 0 N-CA-C 110.021 -0.363 . . . . 0.0 110.021 179.27 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' C' C ' 117' ' ' PHE . . . . . . . . . . . . . 31.2 m-85 -133.06 123.15 25.25 Favored 'General case' 0 C--N 1.331 -0.202 0 CA-C-O 120.932 0.396 . . . . 0.0 110.363 -174.457 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' C' C ' 118' ' ' GLU . . . . . . . . . . . . . 43.4 mt-10 -53.77 -48.54 69.65 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.459 -0.337 . . . . 0.0 111.4 -176.49 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' C' C ' 119' ' ' ASN . . . . . . . . . . . . . 67.5 m-80 -98.57 31.03 3.01 Favored 'General case' 0 C--N 1.329 -0.321 0 N-CA-C 112.255 0.465 . . . . 0.0 112.255 -174.098 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' C' C ' 120' ' ' LEU . . . . . . . . . . . . . 18.4 tp -56.6 120.27 7.49 Favored 'General case' 0 N--CA 1.462 0.15 0 C-N-CA 121.04 -0.264 . . . . 0.0 110.325 177.888 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' C' C ' 121' ' ' ASN . . . . . . . . . . . . . 9.8 t-20 -109.42 -44.03 3.98 Favored 'General case' 0 C--N 1.331 -0.219 0 CA-C-N 116.58 -0.282 . . . . 0.0 111.192 -175.646 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' C' C ' 122' ' ' LYS . . . . . . . . . . . . . 15.9 ptpt -154.77 153.54 31.39 Favored 'General case' 0 C--N 1.332 -0.187 0 CA-C-O 121.286 0.565 . . . . 0.0 112.019 -178.291 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' C' C ' 123' ' ' VAL . . . . . 0.516 HG11 HG11 ' C' ' 94' ' ' VAL . 45.6 t -121.68 130.89 74.2 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.224 0 CA-C-N 115.698 -0.683 . . . . 0.0 109.474 176.223 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' C' C ' 124' ' ' LEU . . . . . 0.429 HD12 ' N ' ' C' ' 124' ' ' LEU . 6.2 mp -121.4 140.02 52.69 Favored 'General case' 0 C--N 1.331 -0.215 0 CA-C-N 116.319 -0.401 . . . . 0.0 110.635 -178.05 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' C' C ' 125' ' ' VAL . . . . . 0.436 HG11 HG21 ' C' ' 94' ' ' VAL . 35.2 m -134.78 140.12 46.16 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.258 0 CA-C-N 116.334 -0.394 . . . . 0.0 110.453 178.237 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' C' C ' 126' ' ' ARG . . . . . . . . . . . . . 52.5 ttt85 -149.13 118.69 6.95 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-O 120.907 0.384 . . . . 0.0 110.615 178.322 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' C' C ' 127' ' ' ASN . . . . . . . . . . . . . 35.7 t30 50.83 -104.95 0.18 Allowed 'General case' 0 CA--C 1.542 0.668 0 CA-C-N 116.144 -0.48 . . . . 0.0 111.572 179.862 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' C' C ' 128' ' ' ASP . . . . . . . . . . . . . 11.8 p-10 -110.61 -0.17 17.34 Favored 'General case' 0 CA--C 1.536 0.413 0 CA-C-N 119.501 1.046 . . . . 0.0 113.658 -175.043 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' C' C ' 129' ' ' LEU . . . . . . . . . . . . . 88.0 mt -106.35 142.73 35.54 Favored 'General case' 0 C--O 1.232 0.138 0 CA-C-N 118.186 0.448 . . . . 0.0 110.838 -179.451 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' C' C ' 130' ' ' VAL . . . . . . . . . . . . . 47.0 t -122.04 135.91 60.63 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.302 0 N-CA-C 109.619 -0.511 . . . . 0.0 109.619 178.625 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' C' C ' 131' ' ' VAL . . . . . . . . . . . . . 42.9 t -133.48 137.1 53.64 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.269 0 CA-C-O 121.018 0.437 . . . . 0.0 110.624 -178.726 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' C' C ' 132' ' ' ILE . . . . . . . . . . . . . 74.3 mt -115.61 130.46 70.21 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.304 0 CA-C-N 115.642 -0.708 . . . . 0.0 109.262 178.762 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' C' C ' 133' ' ' ILE . . . . . . . . . . . . . 43.7 mm -116.62 121.32 67.4 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.215 0 CA-C-O 120.774 0.321 . . . . 0.0 111.04 -175.447 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' C' C ' 134' ' ' ASP . . . . . . . . . . . . . 8.2 p-10 -136.11 144.3 45.03 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 115.878 -0.601 . . . . 0.0 109.443 173.756 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' C' C ' 135' ' ' GLU . . . . . . . . . . . . . 42.2 tp10 -49.81 -23.85 2.08 Favored 'General case' 0 C--N 1.327 -0.395 0 N-CA-C 112.724 0.639 . . . . 0.0 112.724 -172.226 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' C' C ' 136' ' ' GLN . . . . . . . . . . . . . 50.5 tt0 -93.13 -36.77 12.48 Favored 'General case' 0 C--O 1.233 0.2 0 N-CA-C 112.082 0.401 . . . . 0.0 112.082 -176.468 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' C' C ' 137' ' ' LYS . . . . . . . . . . . . . 89.9 mttt -140.12 155.06 47.15 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-O 121.251 0.548 . . . . 0.0 111.648 -171.185 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' C' C ' 138' ' ' LEU . . . . . . . . . . . . . 5.2 tt -117.8 123.54 46.22 Favored 'General case' 0 C--N 1.329 -0.321 0 N-CA-C 108.881 -0.785 . . . . 0.0 108.881 171.544 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' C' C ' 139' ' ' THR . . . . . . . . . . . . . 31.2 m -113.35 131.11 56.09 Favored 'General case' 0 C--N 1.331 -0.215 0 CA-C-O 120.875 0.369 . . . . 0.0 111.05 -176.353 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' C' C ' 140' ' ' LEU . . . . . 0.476 ' C ' HD23 ' C' ' 140' ' ' LEU . 6.8 tt -116.61 122.67 45.3 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 115.333 -0.849 . . . . 0.0 108.914 -179.407 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' C' C ' 141' ' ' ILE . . . . . . . . . . . . . 19.5 mt -119.81 120.41 63.21 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.276 0 CA-C-O 120.929 0.395 . . . . 0.0 110.02 -176.239 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' C' C ' 142' ' ' ARG . . . . . . . . . . . . . 57.6 mtp180 -105.05 124.38 49.43 Favored 'General case' 0 C--N 1.331 -0.212 0 CA-C-N 115.431 -0.804 . . . . 0.0 110.014 179.319 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' C' C ' 143' ' ' THR . . . . . . . . . . . . . 21.3 p . . . . . 0 C--O 1.221 -0.44 0 CA-C-O 117.98 -1.009 . . . . 0.0 110.572 -179.248 . . . . . . . . 0 0 . 1 . 017 nuclear nobuild full ' D' D ' -3' ' ' GLU . . . . . . . . . . . . . 84.6 tt0 . . . . . 0 N--CA 1.489 1.504 0 N-CA-C 109.356 -0.609 . . . . 0.0 109.356 . . . . . . . . . 0 0 . 1 . 017 nuclear nobuild full ' D' D ' -2' ' ' GLY . . . . . . . . . . . . . . . -59.87 148.42 42.49 Favored Glycine 0 CA--C 1.524 0.601 0 N-CA-C 111.006 -0.838 . . . . 0.0 111.006 -179.31 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' D' D ' -1' ' ' VAL . . . . . . . . . . . . . 40.7 t -95.77 136.15 27.64 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.284 0 N-CA-C 109.897 -0.409 . . . . 0.0 109.897 179.851 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' D' D ' 0' ' ' ILE . . . . . . . . . . . . . 71.5 mt -111.22 140.22 31.53 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.241 0 CA-C-N 116.097 -0.501 . . . . 0.0 109.941 -179.085 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' D' D ' 1' ' ' MET . . . . . . . . . . . . . 25.1 ptp -141.82 145.59 34.89 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.109 -0.496 . . . . 0.0 110.495 -179.407 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' D' D ' 2' ' ' SER . . . . . . . . . . . . . 2.9 p -114.94 141.55 47.81 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.616 -179.437 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' D' D ' 3' ' ' GLU . . . . . . . . . . . . . 94.3 mt-10 -141.19 139.82 33.91 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.12 -0.491 . . . . 0.0 111.158 -178.798 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' D' D ' 4' ' ' LEU . . . . . . . . . . . . . 21.7 tp -123.27 128.96 50.69 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 115.869 -0.605 . . . . 0.0 109.763 174.799 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' D' D ' 5' ' ' LYS . . . . . . . . . . . . . 94.8 mttt -112.75 121.6 45.2 Favored 'General case' 0 C--O 1.235 0.302 0 CA-C-O 120.897 0.38 . . . . 0.0 111.014 -177.95 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' D' D ' 6' ' ' LEU . . . . . 0.454 HD23 ' HA ' ' D' ' 50' ' ' VAL . 61.9 mt -114.94 142.17 46.97 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-N 115.225 -0.898 . . . . 0.0 110.274 -179.185 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' D' D ' 7' ' ' LYS . . . . . . . . . . . . . 44.7 tttm -122.35 140.48 32.72 Favored Pre-proline 0 CA--C 1.533 0.291 0 CA-C-O 119.017 -0.516 . . . . 0.0 109.993 176.056 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' D' D ' 8' ' ' PRO . . . . . . . . . . . . . 96.9 Cg_endo -91.72 137.76 1.97 Allowed 'Trans proline' 0 N--CA 1.49 1.316 0 C-N-CA 121.83 1.687 . . . . 0.0 111.964 179.45 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' D' D ' 9' ' ' LEU . . . . . . . . . . . . . 26.3 mt -77.54 -48.28 2.34 Favored Pre-proline 0 CA--C 1.535 0.371 0 CA-C-O 118.675 -0.678 . . . . 0.0 112.341 -179.991 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' D' D ' 10' ' ' PRO . . . . . . . . . . . . . 87.0 Cg_endo -80.23 159.35 23.29 Favored 'Trans proline' 0 N--CA 1.497 1.685 0 C-N-CA 121.308 1.339 . . . . 0.0 112.219 177.961 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' D' D ' 11' ' ' LYS . . . . . . . . . . . . . 82.5 mttt -86.54 95.69 9.82 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.51 -0.314 . . . . 0.0 110.318 177.543 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' D' D ' 12' ' ' VAL . . . . . . . . . . . . . 12.4 p -142.2 147.55 21.26 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.324 0 CA-C-N 116.238 -0.437 . . . . 0.0 110.443 179.928 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' D' D ' 13' ' ' GLU . . . . . . . . . . . . . 45.5 tp10 -92.09 121.83 34.01 Favored 'General case' 0 C--N 1.328 -0.336 0 N-CA-C 109.985 -0.376 . . . . 0.0 109.985 177.797 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' D' D ' 14' ' ' LEU . . . . . . . . . . . . . 41.0 mt -93.02 138.15 23.41 Favored Pre-proline 0 C--N 1.329 -0.305 0 CA-C-O 118.88 -0.581 . . . . 0.0 110.073 -178.666 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' D' D ' 15' ' ' PRO . . . . . . . . . . . . . 28.7 Cg_exo -60.47 158.55 31.25 Favored 'Trans proline' 0 N--CA 1.498 1.782 0 C-N-CA 121.268 1.312 . . . . 0.0 111.953 178.995 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' D' D ' 16' ' ' PRO . . . . . . . . . . . . . 39.3 Cg_exo -58.91 -35.52 98.47 Favored 'Trans proline' 0 N--CA 1.498 1.766 0 C-N-CA 121.527 1.485 . . . . 0.0 112.894 -179.469 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' D' D ' 17' ' ' ASP . . . . . . . . . . . . . 15.8 p-10 -82.18 2.65 30.62 Favored 'General case' 0 CA--C 1.537 0.454 0 N-CA-C 113.296 0.85 . . . . 0.0 113.296 -177.682 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' D' D ' 18' ' ' PHE . . . . . . . . . . . . . 36.7 t80 -58.15 -47.08 84.45 Favored 'General case' 0 C--N 1.333 -0.115 0 O-C-N 121.933 -0.48 . . . . 0.0 110.019 -178.242 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' D' D ' 19' ' ' VAL . . . . . 0.425 HG13 ' N ' ' D' ' 20' ' ' ASP . 12.7 p -55.19 -41.73 62.03 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 CA-C-N 116.353 -0.385 . . . . 0.0 111.197 -178.094 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' D' D ' 20' ' ' ASP . . . . . 0.425 ' N ' HG13 ' D' ' 19' ' ' VAL . 7.7 t0 -60.91 -44.31 97.36 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-O 120.9 0.381 . . . . 0.0 110.827 -177.811 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' D' D ' 21' ' ' VAL . . . . . . . . . . . . . 45.5 t -64.62 -45.71 94.61 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.324 0 CA-C-N 116.326 -0.397 . . . . 0.0 110.41 -177.486 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' D' D ' 22' ' ' ILE . . . . . 0.671 HG22 HD12 ' D' ' 26' ' ' LEU . 49.5 mm -55.55 -47.73 78.31 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.264 0 C-N-CA 121.096 -0.242 . . . . 0.0 110.672 179.533 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' D' D ' 23' ' ' ARG . . . . . . . . . . . . . 47.0 ttp180 -55.15 -49.05 72.8 Favored 'General case' 0 C--N 1.331 -0.219 0 C-N-CA 121.042 -0.263 . . . . 0.0 111.155 -178.33 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' D' D ' 24' ' ' ILE . . . . . . . . . . . . . 71.4 mt -58.93 -43.97 89.85 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.281 0 C-N-CA 121.05 -0.26 . . . . 0.0 111.251 -176.308 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' D' D ' 25' ' ' LYS . . . . . . . . . . . . . 49.2 mttm -68.18 -41.05 82.05 Favored 'General case' 0 C--N 1.328 -0.332 0 N-CA-C 112.582 0.586 . . . . 0.0 112.582 -177.86 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' D' D ' 26' ' ' LEU . . . . . 0.671 HD12 HG22 ' D' ' 22' ' ' ILE . 36.1 mt -79.46 -33.49 42.32 Favored 'General case' 0 C--N 1.329 -0.311 0 N-CA-C 113.837 1.051 . . . . 0.0 113.837 -170.421 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' D' D ' 27' ' ' GLN . . . . . . . . . . . . . 10.6 pt20 -46.84 140.76 4.43 Favored 'General case' 0 N--CA 1.469 0.514 0 N-CA-C 112.956 0.725 . . . . 0.0 112.956 -174.247 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' D' D ' 28' ' ' GLY . . . . . . . . . . . . . . . 98.14 -24.15 33.05 Favored Glycine 0 CA--C 1.532 1.141 0 CA-C-N 115.571 -0.74 . . . . 0.0 112.427 -178.355 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' D' D ' 29' ' ' LYS . . . . . . . . . . . . . 48.9 mtpt -97.45 155.11 17.07 Favored 'General case' 0 C--N 1.333 -0.126 0 CA-C-N 117.425 0.612 . . . . 0.0 110.783 179.101 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' D' D ' 30' ' ' THR . . . . . . . . . . . . . 23.5 m -104.51 139.84 38.83 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.196 -0.456 . . . . 0.0 110.338 178.876 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' D' D ' 31' ' ' VAL . . . . . . . . . . . . . 34.4 m -130.98 150.28 34.44 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.303 0 CA-C-N 116.101 -0.5 . . . . 0.0 110.783 -179.176 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' D' D ' 32' ' ' ARG . . . . . . . . . . . . . 83.0 mtm180 -128.67 150.34 50.29 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 115.913 -0.585 . . . . 0.0 110.475 178.324 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' D' D ' 33' ' ' THR . . . . . . . . . . . . . 15.0 m -53.64 138.53 34.51 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.305 -0.407 . . . . 0.0 111.385 -178.036 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' D' D ' 34' ' ' GLY . . . . . . . . . . . . . . . 100.43 -17.23 57.07 Favored Glycine 0 CA--C 1.532 1.145 0 CA-C-O 119.67 -0.517 . . . . 0.0 113.192 179.589 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' D' D ' 35' ' ' ASP . . . . . . . . . . . . . 75.1 m-20 -66.35 149.8 49.84 Favored 'General case' 0 N--CA 1.461 0.085 0 CA-C-N 118.015 0.907 . . . . 0.0 111.087 178.838 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' D' D ' 36' ' ' VAL . . . . . . . . . . . . . 44.2 t -118.77 130.75 73.17 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.244 0 CA-C-N 115.908 -0.587 . . . . 0.0 109.839 178.08 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' D' D ' 37' ' ' ILE . . . . . . . . . . . . . 64.7 mt -119.72 138.12 51.38 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.233 0 N-CA-C 109.854 -0.425 . . . . 0.0 109.854 -179.723 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' D' D ' 38' ' ' GLY . . . . . . . . . . . . . . . -113.54 127.89 8.07 Favored Glycine 0 CA--C 1.525 0.661 0 N-CA-C 110.782 -0.927 . . . . 0.0 110.782 179.064 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' D' D ' 39' ' ' ILE . . . . . . . . . . . . . 78.0 mt -128.25 137.46 57.39 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.237 0 CA-C-O 120.814 0.34 . . . . 0.0 110.313 179.626 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' D' D ' 40' ' ' SER . . . . . . . . . . . . . 32.4 t -91.54 116.53 28.94 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.248 -0.433 . . . . 0.0 110.598 175.285 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' D' D ' 41' ' ' ILE . . . . . . . . . . . . . 44.0 mm -119.83 114.34 43.86 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.216 0 CA-C-O 120.886 0.374 . . . . 0.0 110.177 178.823 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' D' D ' 42' ' ' LEU . . . . . 0.545 HD23 ' O ' ' D' ' 42' ' ' LEU . 1.3 tt 52.27 46.23 27.02 Favored 'General case' 0 CA--C 1.532 0.262 0 CA-C-O 121.399 0.618 . . . . 0.0 111.036 177.527 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' D' D ' 43' ' ' GLY . . . . . . . . . . . . . . . 70.9 25.79 75.14 Favored Glycine 0 CA--C 1.532 1.109 0 C-N-CA 121.1 -0.571 . . . . 0.0 112.532 175.398 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' D' D ' 44' ' ' LYS . . . . . . . . . . . . . 85.9 tttt -136.01 129.65 32.35 Favored 'General case' 0 C--N 1.331 -0.221 0 CA-C-N 117.274 0.537 . . . . 0.0 109.975 179.323 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' D' D ' 45' ' ' GLU . . . . . . . . . . . . . 84.7 tt0 -82.47 119.33 24.07 Favored 'General case' 0 C--N 1.328 -0.355 0 C-N-CA 120.816 -0.354 . . . . 0.0 110.842 -179.275 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' D' D ' 46' ' ' VAL . . . . . . . . . . . . . 10.0 p -118.57 125.17 74.16 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.179 0 N-CA-C 109.425 -0.583 . . . . 0.0 109.425 175.391 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' D' D ' 47' ' ' LYS . . . . . . . . . . . . . 39.6 mtmt -98.73 126.77 44.45 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 115.953 -0.567 . . . . 0.0 110.729 177.809 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' D' D ' 48' ' ' PHE . . . . . . . . . . . . . 45.9 m-85 -111.2 131.95 54.71 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 115.747 -0.66 . . . . 0.0 109.928 178.532 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' D' D ' 49' ' ' LYS . . . . . . . . . . . . . 38.2 tttp -104.48 131.78 51.46 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.334 -0.394 . . . . 0.0 110.09 178.531 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' D' D ' 50' ' ' VAL . . . . . 0.454 ' HA ' HD23 ' D' ' 6' ' ' LEU . 45.7 t -77.04 105.33 5.79 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.33 0 N-CA-C 109.204 -0.665 . . . . 0.0 109.204 177.623 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' D' D ' 51' ' ' VAL . . . . . . . . . . . . . 48.8 t -71.27 -52.5 26.37 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.317 0 CA-C-N 116.064 -0.516 . . . . 0.0 109.683 -174.93 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' D' D ' 52' ' ' GLN . . . . . . . . . . . . . 89.4 mt-30 -153.7 151.17 29.33 Favored 'General case' 0 C--N 1.331 -0.239 0 CA-C-N 115.995 -0.548 . . . . 0.0 111.845 -178.308 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' D' D ' 53' ' ' ALA . . . . . . . . . . . . . . . -129.74 133.24 46.91 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 115.145 -0.934 . . . . 0.0 109.561 174.057 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' D' D ' 54' ' ' TYR . . . . . . . . . . . . . 44.0 t80 -129.08 112.04 18.42 Favored Pre-proline 0 CA--C 1.536 0.419 0 CA-C-O 118.107 -0.949 . . . . 0.0 110.124 178.122 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' D' D ' 55' ' ' PRO . . . . . . . . . . . . . 73.3 Cg_endo -77.19 167.56 79.31 Favored 'Cis proline' 0 N--CA 1.5 1.857 0 CA-C-N 121.907 1.717 . . . . 0.0 112.585 -5.875 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' D' D ' 56' ' ' SER . . . . . . . . . . . . . 13.6 m -117.34 134.09 23.14 Favored Pre-proline 0 CA--C 1.539 0.549 0 CA-C-O 118.483 -0.77 . . . . 0.0 109.292 174.204 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' D' D ' 57' ' ' PRO . . . . . . . . . . . . . 56.0 Cg_endo -70.68 147.7 87.16 Favored 'Cis proline' 0 N--CA 1.498 1.785 0 CA-C-N 121.844 1.694 . . . . 0.0 111.415 -1.608 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' D' D ' 58' ' ' LEU . . . . . . . . . . . . . 24.2 tp -107.84 138.14 44.62 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-O 120.896 0.379 . . . . 0.0 110.495 -179.139 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' D' D ' 59' ' ' ARG . . . . . . . . . . . . . 61.2 ttt180 -103.04 120.25 40.32 Favored 'General case' 0 C--N 1.327 -0.397 0 N-CA-C 108.981 -0.748 . . . . 0.0 108.981 174.812 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' D' D ' 60' ' ' VAL . . . . . . . . . . . . . 42.4 t -71.93 119.7 18.93 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.277 0 C-N-CA 120.615 -0.434 . . . . 0.0 110.198 -174.276 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' D' D ' 61' ' ' GLU . . . . . . . . . . . . . 81.3 tt0 -131.14 152.15 50.72 Favored 'General case' 0 C--N 1.328 -0.33 0 N-CA-C 109.268 -0.641 . . . . 0.0 109.268 178.166 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' D' D ' 62' ' ' ASP . . . . . . . . . . . . . 19.3 p-10 -54.48 -31.97 56.89 Favored 'General case' 0 N--CA 1.465 0.301 0 C-N-CA 120.751 -0.38 . . . . 0.0 111.835 -176.405 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' D' D ' 63' ' ' ARG . . . . . . . . . . . . . 77.6 mtp180 -72.32 -21.24 61.36 Favored 'General case' 0 CA--C 1.535 0.38 0 N-CA-C 112.816 0.673 . . . . 0.0 112.816 -177.514 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' D' D ' 64' ' ' THR . . . . . . . . . . . . . 33.1 m -72.26 146.91 46.92 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-O 120.926 0.393 . . . . 0.0 110.905 -176.238 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' D' D ' 65' ' ' LYS . . . . . . . . . . . . . 68.8 mttm -90.14 131.67 35.86 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.018 -0.537 . . . . 0.0 110.819 -179.229 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' D' D ' 66' ' ' ILE . . . . . . . . . . . . . 68.3 mt -118.2 130.52 72.94 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.24 0 N-CA-C 109.655 -0.498 . . . . 0.0 109.655 178.391 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' D' D ' 67' ' ' THR . . . . . . . . . . . . . 29.5 m -126.48 139.65 53.07 Favored 'General case' 0 C--N 1.332 -0.194 0 CA-C-O 121.169 0.509 . . . . 0.0 111.253 -177.537 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' D' D ' 68' ' ' LEU . . . . . . . . . . . . . 51.0 mt -103.83 132.77 49.77 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 115.733 -0.667 . . . . 0.0 110.121 176.62 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' D' D ' 69' ' ' VAL . . . . . . . . . . . . . 41.8 t -102.06 141.25 18.66 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.239 0 CA-C-N 116.358 -0.383 . . . . 0.0 110.562 -178.314 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' D' D ' 70' ' ' THR . . . . . . . . . . . . . 9.5 t -88.76 -179.81 6.07 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 115.959 -0.564 . . . . 0.0 110.628 179.989 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' D' D ' 71' ' ' HIS . . . . . . . . . . . . . 37.7 t-80 -103.08 103.51 34.69 Favored Pre-proline 0 CA--C 1.534 0.343 0 CA-C-O 119.049 -0.501 . . . . 0.0 110.926 -177.757 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' D' D ' 72' ' ' PRO . . . . . . . . . . . . . 74.3 Cg_endo -85.96 156.47 10.02 Favored 'Trans proline' 0 N--CA 1.492 1.39 0 C-N-CA 121.588 1.525 . . . . 0.0 112.436 178.483 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' D' D ' 73' ' ' VAL . . . . . . . . . . . . . 34.8 m -70.9 166.65 2.28 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.241 0 CA-C-N 116.295 -0.411 . . . . 0.0 110.716 179.985 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' D' D ' 74' ' ' ASP . . . . . . . . . . . . . 39.7 t0 -101.77 119.03 38.14 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.309 -0.405 . . . . 0.0 110.126 -179.836 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' D' D ' 75' ' ' VAL . . . . . . . . . . . . . 44.3 t -114.0 123.04 69.27 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.25 0 CA-C-O 121.131 0.491 . . . . 0.0 110.268 -179.451 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' D' D ' 76' ' ' LEU . . . . . . . . . . . . . 33.9 mt -123.4 141.58 51.85 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 115.616 -0.72 . . . . 0.0 109.511 178.535 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' D' D ' 77' ' ' GLU . . . . . . . . . . . . . 96.7 mt-10 -134.75 138.6 44.47 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-O 121.211 0.529 . . . . 0.0 111.375 -177.849 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' D' D ' 78' ' ' ALA . . . . . . . . . . . . . . . -125.11 137.31 54.18 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 115.556 -0.747 . . . . 0.0 109.581 175.809 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' D' D ' 79' ' ' LYS . . . . . 0.616 ' O ' HD13 ' D' ' 80' ' ' ILE . 65.0 mttp -80.17 117.91 21.39 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-O 120.864 0.364 . . . . 0.0 110.65 -179.017 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' D' D ' 80' ' ' ILE . . . . . 0.616 HD13 ' O ' ' D' ' 79' ' ' LYS . 40.7 mm -138.96 102.82 1.84 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.32 0 N-CA-C 109.135 -0.691 . . . . 0.0 109.135 -178.052 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' D' D ' 81' ' ' LYS . . . . . . . . . . . . . 78.1 tttt -99.49 128.37 45.6 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-O 120.889 0.376 . . . . 0.0 110.92 -176.195 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' D' D ' 82' ' ' GLY . . . . . . . . . . . . . . . 89.07 42.21 5.67 Favored Glycine 0 CA--C 1.526 0.743 0 C-N-CA 120.987 -0.625 . . . . 0.0 111.862 175.791 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' D' D ' 83' ' ' ILE . . . . . . . . . . . . . 70.1 mt -70.17 137.77 23.36 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.311 0 N-CA-C 109.358 -0.608 . . . . 0.0 109.358 175.874 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' D' D ' 84' ' ' LYS . . . . . . . . . . . . . 38.5 ttpt -99.57 -46.59 5.4 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.343 -0.39 . . . . 0.0 110.243 -178.541 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' D' D ' 85' ' ' ASP . . . . . . . . . . . . . 8.0 t70 -155.11 152.66 29.76 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.072 -0.513 . . . . 0.0 110.663 179.21 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' D' D ' 86' ' ' VAL . . . . . . . . . . . . . 44.0 t -128.57 134.82 63.87 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.19 0 CA-C-O 120.91 0.386 . . . . 0.0 110.347 179.843 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' D' D ' 87' ' ' ILE . . . . . . . . . . . . . 43.7 mm -119.73 125.34 74.23 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.228 0 CA-C-N 115.909 -0.587 . . . . 0.0 109.719 178.152 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' D' D ' 88' ' ' LEU . . . . . . . . . . . . . 14.7 tp -111.05 131.46 55.04 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-O 120.835 0.35 . . . . 0.0 110.96 -177.622 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' D' D ' 89' ' ' ASP . . . . . . . . . . . . . 13.6 t70 -133.1 157.44 45.28 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 116.151 -0.477 . . . . 0.0 110.039 177.737 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' D' D ' 90' ' ' GLU . . . . . . . . . . . . . 82.6 tt0 -46.18 -39.11 9.19 Favored 'General case' 0 C--N 1.331 -0.23 0 N-CA-C 113.127 0.788 . . . . 0.0 113.127 -172.146 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' D' D ' 91' ' ' ASN . . . . . . . . . . . . . 82.8 m-20 -130.75 22.76 5.01 Favored 'General case' 0 N--CA 1.469 0.488 0 N-CA-C 112.762 0.653 . . . . 0.0 112.762 -176.785 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' D' D ' 92' ' ' LEU . . . . . . . . . . . . . 37.6 mt -149.05 141.22 23.97 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-O 120.826 0.346 . . . . 0.0 110.581 -176.931 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' D' D ' 93' ' ' ILE . . . . . . . . . . . . . 69.5 mt -122.08 113.11 37.52 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.255 0 N-CA-C 108.638 -0.875 . . . . 0.0 108.638 174.895 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' D' D ' 94' ' ' VAL . . . . . 0.453 HG21 HG11 ' D' ' 125' ' ' VAL . 41.4 t -116.57 128.93 73.79 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.291 0 CA-C-O 120.949 0.404 . . . . 0.0 110.013 -176.955 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' D' D ' 95' ' ' VAL . . . . . . . . . . . . . 46.1 t -121.65 132.58 70.46 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.282 0 CA-C-N 116.021 -0.536 . . . . 0.0 109.808 -179.826 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' D' D ' 96' ' ' ILE . . . . . . . . . . . . . 62.8 mt -113.29 126.41 70.71 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.322 0 N-CA-C 109.074 -0.713 . . . . 0.0 109.074 178.482 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' D' D ' 97' ' ' THR . . . . . . . . . . . . . 81.0 p -101.79 156.91 17.22 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-O 121.085 0.469 . . . . 0.0 111.44 -175.262 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' D' D ' 98' ' ' GLU . . . . . . . . . . . . . 46.1 mt-10 -55.62 -25.35 38.29 Favored 'General case' 0 CA--C 1.533 0.298 0 N-CA-C 112.324 0.49 . . . . 0.0 112.324 178.783 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' D' D ' 99' ' ' GLU . . . . . . . . . . . . . 14.1 mm-40 -76.12 11.92 1.33 Allowed 'General case' 0 CA--C 1.537 0.467 0 N-CA-C 113.161 0.8 . . . . 0.0 113.161 -179.708 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' D' D ' 100' ' ' ASN . . . . . . . . . . . . . 3.2 m-20 62.72 38.0 12.22 Favored 'General case' 0 CA--C 1.529 0.147 0 CA-C-O 121.039 0.447 . . . . 0.0 110.949 179.113 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' D' D ' 101' ' ' GLU . . . . . . . . . . . . . 84.8 tt0 -117.69 145.29 44.51 Favored 'General case' 0 C--N 1.332 -0.155 0 N-CA-C 109.505 -0.554 . . . . 0.0 109.505 176.658 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' D' D ' 102' ' ' VAL . . . . . . . . . . . . . 42.2 t -115.8 124.45 72.22 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.337 0 CA-C-N 116.272 -0.422 . . . . 0.0 109.98 -178.406 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' D' D ' 103' ' ' LEU . . . . . . . . . . . . . 19.3 mt -115.17 127.85 55.8 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 115.69 -0.686 . . . . 0.0 110.129 176.87 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' D' D ' 104' ' ' ILE . . . . . 0.433 HD12 ' HB3' ' D' ' 113' ' ' TYR . 65.6 mt -119.95 120.32 62.83 Favored 'Isoleucine or valine' 0 C--O 1.233 0.223 0 N-CA-C 110.136 -0.32 . . . . 0.0 110.136 -179.496 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' D' D ' 105' ' ' PHE . . . . . . . . . . . . . 46.3 m-85 -120.44 164.2 16.75 Favored 'General case' 0 C--N 1.334 -0.109 0 O-C-N 123.885 0.741 . . . . 0.0 109.977 179.61 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' D' D ' 106' ' ' ASN . . . . . . . . . . . . . 43.4 p-10 -99.24 -169.79 1.81 Allowed 'General case' 0 C--N 1.332 -0.192 0 N-CA-C 110.1 -0.333 . . . . 0.0 110.1 174.883 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' D' D ' 107' ' ' GLN . . . . . . . . . . . . . 62.3 tt0 -57.37 -30.16 64.64 Favored 'General case' 0 C--N 1.33 -0.243 0 N-CA-C 112.121 0.415 . . . . 0.0 112.121 -179.581 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' D' D ' 108' ' ' ASN . . . . . . . . . . . . . 5.4 t30 -88.43 11.24 17.48 Favored 'General case' 0 CA--C 1.536 0.424 0 N-CA-C 113.304 0.853 . . . . 0.0 113.304 -176.405 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' D' D ' 109' ' ' LEU . . . . . . . . . . . . . 9.5 tp 60.63 36.07 19.76 Favored 'General case' 0 CA--C 1.531 0.213 0 O-C-N 122.141 -0.349 . . . . 0.0 111.446 178.452 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' D' D ' 110' ' ' GLU . . . . . . . . . . . . . 95.5 mt-10 -107.84 152.22 24.69 Favored 'General case' 0 C--N 1.331 -0.237 0 N-CA-C 109.836 -0.431 . . . . 0.0 109.836 176.495 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' D' D ' 111' ' ' GLU . . . . . . . . . . . . . 97.3 mt-10 -78.48 126.87 31.36 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-O 121.102 0.477 . . . . 0.0 111.661 -176.359 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' D' D ' 112' ' ' LEU . . . . . . . . . . . . . 30.9 mt -108.93 -46.03 3.69 Favored 'General case' 0 C--N 1.332 -0.181 0 CA-C-N 115.573 -0.74 . . . . 0.0 109.952 174.736 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' D' D ' 113' ' ' TYR . . . . . 0.433 ' HB3' HD12 ' D' ' 104' ' ' ILE . 50.8 t80 -140.45 137.45 33.92 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.095 -0.502 . . . . 0.0 110.91 -179.813 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' D' D ' 114' ' ' ARG . . . . . . . . . . . . . 60.2 ttp180 -142.15 119.09 11.24 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.262 -0.426 . . . . 0.0 110.416 178.701 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' D' D ' 115' ' ' GLY . . . . . . . . . . . . . . . -150.19 162.59 29.27 Favored Glycine 0 CA--C 1.525 0.687 0 N-CA-C 111.021 -0.832 . . . . 0.0 111.021 179.3 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' D' D ' 116' ' ' LYS . . . . . . . . . . . . . 35.0 ttmt -131.66 135.44 46.9 Favored 'General case' 0 C--N 1.33 -0.251 0 N-CA-C 110.024 -0.362 . . . . 0.0 110.024 177.221 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' D' D ' 117' ' ' PHE . . . . . . . . . . . . . 39.8 m-85 -132.2 120.78 22.69 Favored 'General case' 0 C--N 1.331 -0.211 0 CA-C-O 120.86 0.362 . . . . 0.0 110.46 -174.532 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' D' D ' 118' ' ' GLU . . . . . . . . . . . . . 95.9 mt-10 -53.97 -48.53 70.25 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.413 -0.358 . . . . 0.0 111.571 -175.438 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' D' D ' 119' ' ' ASN . . . . . . . . . . . . . 9.4 m120 -99.28 31.11 3.2 Favored 'General case' 0 C--N 1.329 -0.288 0 N-CA-C 112.201 0.445 . . . . 0.0 112.201 -173.771 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' D' D ' 120' ' ' LEU . . . . . . . . . . . . . 23.7 tp -54.88 127.7 29.83 Favored 'General case' 0 C--N 1.332 -0.169 0 CA-C-O 120.805 0.336 . . . . 0.0 110.8 179.544 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' D' D ' 121' ' ' ASN . . . . . . . . . . . . . 95.1 m-20 -111.11 -44.05 3.65 Favored 'General case' 0 C--O 1.233 0.211 0 CA-C-N 116.287 -0.415 . . . . 0.0 111.109 -177.496 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' D' D ' 122' ' ' LYS . . . . . . . . . . . . . 19.0 ptpt -164.34 166.99 20.28 Favored 'General case' 0 N--CA 1.463 0.176 0 CA-C-O 121.277 0.56 . . . . 0.0 112.149 -178.285 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' D' D ' 123' ' ' VAL . . . . . . . . . . . . . 45.5 t -131.49 139.36 50.89 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.207 0 CA-C-N 115.584 -0.735 . . . . 0.0 110.121 179.749 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' D' D ' 124' ' ' LEU . . . . . . . . . . . . . 37.2 mt -121.55 138.9 54.11 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-N 116.313 -0.403 . . . . 0.0 110.737 -179.151 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' D' D ' 125' ' ' VAL . . . . . 0.453 HG11 HG21 ' D' ' 94' ' ' VAL . 35.6 m -135.06 134.12 53.23 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.211 0 CA-C-N 116.585 -0.28 . . . . 0.0 110.939 178.922 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' D' D ' 126' ' ' ARG . . . . . . . . . . . . . 22.3 mtp-105 -148.87 118.31 6.92 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 116.523 -0.308 . . . . 0.0 111.048 177.0 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' D' D ' 127' ' ' ASN . . . . . . . . . . . . . 34.6 m120 48.97 -104.89 0.14 Allowed 'General case' 0 CA--C 1.545 0.76 0 CA-C-O 119.193 -0.432 . . . . 0.0 111.976 175.604 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' D' D ' 128' ' ' ASP . . . . . . . . . . . . . 19.2 p-10 -114.05 14.61 18.38 Favored 'General case' 0 N--CA 1.468 0.463 0 CA-C-N 119.407 1.003 . . . . 0.0 113.28 -174.968 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' D' D ' 129' ' ' LEU . . . . . . . . . . . . . 19.1 tp -123.62 139.22 54.22 Favored 'General case' 0 C--N 1.331 -0.233 0 N-CA-C 109.736 -0.468 . . . . 0.0 109.736 177.458 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' D' D ' 130' ' ' VAL . . . . . 0.549 HG13 ' HB ' ' D' ' 141' ' ' ILE . 13.4 p -131.91 140.54 47.78 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.202 0 CA-C-O 121.173 0.511 . . . . 0.0 110.317 179.523 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' D' D ' 131' ' ' VAL . . . . . . . . . . . . . 40.7 t -135.99 140.46 43.98 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.241 0 CA-C-N 115.864 -0.607 . . . . 0.0 110.493 -177.013 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' D' D ' 132' ' ' ILE . . . . . . . . . . . . . 73.4 mt -115.8 131.33 68.52 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.283 0 N-CA-C 109.188 -0.671 . . . . 0.0 109.188 177.501 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' D' D ' 133' ' ' ILE . . . . . . . . . . . . . 43.6 mm -115.12 119.63 62.32 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.191 0 CA-C-O 120.716 0.293 . . . . 0.0 110.752 -175.904 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' D' D ' 134' ' ' ASP . . . . . . . . . . . . . 8.0 p-10 -133.01 144.25 49.96 Favored 'General case' 0 C--N 1.331 -0.233 0 N-CA-C 109.425 -0.583 . . . . 0.0 109.425 175.896 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' D' D ' 135' ' ' GLU . . . . . . . . . . . . . 83.4 tt0 -49.93 -26.86 4.55 Favored 'General case' 0 C--N 1.327 -0.391 0 N-CA-C 112.779 0.659 . . . . 0.0 112.779 -173.63 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' D' D ' 136' ' ' GLN . . . . . . . . . . . . . 97.3 mt-30 -79.01 -36.89 40.44 Favored 'General case' 0 C--O 1.233 0.225 0 N-CA-C 112.448 0.536 . . . . 0.0 112.448 -178.122 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' D' D ' 137' ' ' LYS . . . . . . . . . . . . . 1.2 ptpm? -164.39 174.11 11.41 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-O 121.671 0.748 . . . . 0.0 112.223 -173.206 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' D' D ' 138' ' ' LEU . . . . . 0.413 HD23 ' N ' ' D' ' 139' ' ' THR . 5.7 tt -117.89 127.3 53.72 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 114.905 -1.043 . . . . 0.0 109.553 177.637 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' D' D ' 139' ' ' THR . . . . . 0.413 ' N ' HD23 ' D' ' 138' ' ' LEU . 42.4 m -106.42 123.61 48.34 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.354 -0.385 . . . . 0.0 110.152 179.301 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' D' D ' 140' ' ' LEU . . . . . . . . . . . . . 14.1 tp -110.61 118.41 36.13 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-N 115.723 -0.672 . . . . 0.0 109.33 -177.901 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' D' D ' 141' ' ' ILE . . . . . 0.549 ' HB ' HG13 ' D' ' 130' ' ' VAL . 19.4 mt -120.11 118.25 56.27 Favored 'Isoleucine or valine' 0 C--O 1.234 0.279 0 CA-C-O 121.045 0.45 . . . . 0.0 110.042 -176.632 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' D' D ' 142' ' ' ARG . . . . . . . . . . . . . 81.3 mtp180 -92.03 128.98 38.08 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 115.433 -0.803 . . . . 0.0 110.009 177.459 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' D' D ' 143' ' ' THR . . . . . 0.58 HG22 HG12 ' E' ' 73' ' ' VAL . 63.6 p . . . . . 0 C--O 1.221 -0.431 0 CA-C-O 117.965 -1.017 . . . . 0.0 110.424 -179.701 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' E' E ' -3' ' ' GLU . . . . . . . . . . . . . 95.9 mt-10 . . . . . 0 N--CA 1.491 1.606 0 N-CA-C 109.344 -0.613 . . . . 0.0 109.344 . . . . . . . . . 0 0 . 1 . 017 nuclear nobuild full ' E' E ' -2' ' ' GLY . . . . . . . . . . . . . . . -80.19 145.63 27.05 Favored Glycine 0 CA--C 1.525 0.666 0 N-CA-C 111.142 -0.783 . . . . 0.0 111.142 -179.799 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' E' E ' -1' ' ' VAL . . . . . . . . . . . . . 45.1 t -96.42 137.37 24.48 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.303 0 N-CA-C 109.872 -0.418 . . . . 0.0 109.872 179.144 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' E' E ' 0' ' ' ILE . . . . . . . . . . . . . 43.0 mm -108.47 134.36 50.61 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.265 0 CA-C-N 116.357 -0.383 . . . . 0.0 110.419 -178.698 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' E' E ' 1' ' ' MET . . . . . . . . . . . . . 25.2 ptp -87.2 142.43 27.91 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.079 -0.509 . . . . 0.0 110.318 178.816 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' E' E ' 2' ' ' SER . . . . . . . . . . . . . 2.7 p -123.53 126.45 46.72 Favored 'General case' 0 C--N 1.331 -0.215 0 CA-C-O 121.138 0.494 . . . . 0.0 110.856 -179.995 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' E' E ' 3' ' ' GLU . . . . . . . . . . . . . 84.2 tt0 -141.53 138.23 32.58 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 115.699 -0.682 . . . . 0.0 110.882 -179.911 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' E' E ' 4' ' ' LEU . . . . . . . . . . . . . 13.6 tp -123.47 127.13 47.95 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.113 -0.494 . . . . 0.0 109.983 176.78 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' E' E ' 5' ' ' LYS . . . . . . . . . . . . . 91.5 mttt -107.2 121.24 44.14 Favored 'General case' 0 C--N 1.331 -0.23 0 CA-C-N 116.442 -0.345 . . . . 0.0 110.627 178.844 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' E' E ' 6' ' ' LEU . . . . . . . . . . . . . 30.6 mt -115.97 147.05 41.59 Favored 'General case' 0 C--N 1.331 -0.222 0 CA-C-N 115.529 -0.76 . . . . 0.0 110.385 -179.147 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' E' E ' 7' ' ' LYS . . . . . . . . . . . . . 36.9 ttmt -133.18 137.93 30.48 Favored Pre-proline 0 CA--C 1.535 0.384 0 CA-C-O 119.028 -0.51 . . . . 0.0 109.928 176.246 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' E' E ' 8' ' ' PRO . . . . . . . . . . . . . 85.9 Cg_endo -90.63 143.97 3.67 Favored 'Trans proline' 0 N--CA 1.49 1.314 0 C-N-CA 121.798 1.665 . . . . 0.0 111.84 178.805 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' E' E ' 9' ' ' LEU . . . . . . . . . . . . . 57.8 mt -81.15 -48.47 1.07 Allowed Pre-proline 0 CA--C 1.534 0.335 0 CA-C-O 118.669 -0.682 . . . . 0.0 112.385 -178.915 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' E' E ' 10' ' ' PRO . . . . . . . . . . . . . 86.0 Cg_endo -80.41 154.24 21.27 Favored 'Trans proline' 0 N--CA 1.496 1.637 0 C-N-CA 121.281 1.321 . . . . 0.0 111.934 177.169 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' E' E ' 11' ' ' LYS . . . . . . . . . . . . . 46.8 pttt -85.06 111.01 19.35 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-O 121.543 0.687 . . . . 0.0 110.426 177.415 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' E' E ' 12' ' ' VAL . . . . . . . . . . . . . 12.7 p -151.09 151.0 12.86 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.276 0 CA-C-N 115.769 -0.65 . . . . 0.0 110.858 -179.196 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' E' E ' 13' ' ' GLU . . . . . . . . . . . . . 95.2 mt-10 -94.26 120.93 35.22 Favored 'General case' 0 C--N 1.329 -0.32 0 N-CA-C 109.827 -0.434 . . . . 0.0 109.827 175.842 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' E' E ' 14' ' ' LEU . . . . . . . . . . . . . 27.4 mt -97.35 150.96 37.37 Favored Pre-proline 0 CA--C 1.532 0.265 0 CA-C-O 119.333 -0.365 . . . . 0.0 110.735 -177.916 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' E' E ' 15' ' ' PRO . . . . . . . . . . . . . 28.0 Cg_exo -60.86 159.5 28.9 Favored 'Trans proline' 0 N--CA 1.497 1.735 0 C-N-CA 121.339 1.359 . . . . 0.0 111.977 178.055 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' E' E ' 16' ' ' PRO . . . . . . . . . . . . . 27.5 Cg_exo -60.14 -37.22 85.2 Favored 'Trans proline' 0 N--CA 1.496 1.661 0 C-N-CA 121.464 1.443 . . . . 0.0 112.497 -179.006 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' E' E ' 17' ' ' ASP . . . . . . . . . . . . . 19.6 p-10 -86.84 10.26 16.61 Favored 'General case' 0 CA--C 1.537 0.455 0 N-CA-C 113.144 0.794 . . . . 0.0 113.144 -177.89 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' E' E ' 18' ' ' PHE . . . . . . . . . . . . . 59.7 t80 -57.56 -45.66 84.89 Favored 'General case' 0 N--CA 1.458 -0.059 0 O-C-N 122.059 -0.401 . . . . 0.0 110.275 -178.075 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' E' E ' 19' ' ' VAL . . . . . . . . . . . . . 14.4 p -56.35 -41.46 71.4 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.307 0 CA-C-N 116.499 -0.318 . . . . 0.0 110.858 -178.832 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' E' E ' 20' ' ' ASP . . . . . . . . . . . . . 67.0 m-20 -60.78 -41.17 94.99 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-O 120.762 0.315 . . . . 0.0 110.7 -179.54 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' E' E ' 21' ' ' VAL . . . . . . . . . . . . . 50.0 t -64.02 -43.91 97.69 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.323 0 CA-C-N 116.346 -0.388 . . . . 0.0 110.148 -178.359 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' E' E ' 22' ' ' ILE . . . . . 0.641 HG22 HD12 ' E' ' 26' ' ' LEU . 46.2 mm -55.8 -49.15 76.45 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.227 0 C-N-CA 120.889 -0.324 . . . . 0.0 110.705 178.373 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' E' E ' 23' ' ' ARG . . . . . . . . . . . . . 30.7 ttp180 -54.86 -50.28 69.04 Favored 'General case' 0 C--N 1.33 -0.261 0 C-N-CA 121.013 -0.275 . . . . 0.0 111.466 -178.452 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' E' E ' 24' ' ' ILE . . . . . . . . . . . . . 75.0 mt -58.77 -46.43 90.79 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.293 0 C-N-CA 120.988 -0.285 . . . . 0.0 111.132 -176.308 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' E' E ' 25' ' ' LYS . . . . . . . . . . . . . 8.5 mtpm? -67.17 -42.31 84.5 Favored 'General case' 0 C--N 1.328 -0.366 0 N-CA-C 112.283 0.475 . . . . 0.0 112.283 -176.607 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' E' E ' 26' ' ' LEU . . . . . 0.641 HD12 HG22 ' E' ' 22' ' ' ILE . 42.3 mt -80.11 -29.72 39.0 Favored 'General case' 0 C--N 1.33 -0.252 0 N-CA-C 113.326 0.861 . . . . 0.0 113.326 -171.957 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' E' E ' 27' ' ' GLN . . . . . . . . . . . . . 6.0 pt20 -45.99 134.49 8.06 Favored 'General case' 0 N--CA 1.467 0.406 0 N-CA-C 112.78 0.659 . . . . 0.0 112.78 -174.38 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' E' E ' 28' ' ' GLY . . . . . . . . . . . . . . . 99.78 -21.94 42.67 Favored Glycine 0 CA--C 1.535 1.325 0 CA-C-N 115.815 -0.629 . . . . 0.0 112.477 -177.428 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' E' E ' 29' ' ' LYS . . . . . . . . . . . . . 9.1 mtpm? -97.39 155.16 17.03 Favored 'General case' 0 C--N 1.331 -0.2 0 CA-C-N 117.542 0.671 . . . . 0.0 110.875 179.63 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' E' E ' 30' ' ' THR . . . . . . . . . . . . . 37.8 m -102.42 139.03 38.57 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 115.929 -0.578 . . . . 0.0 110.424 177.997 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' E' E ' 31' ' ' VAL . . . . . . . . . . . . . 35.4 m -126.26 150.3 31.76 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.266 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.127 179.028 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' E' E ' 32' ' ' ARG . . . . . . . . . . . . . 66.9 ttt-85 -136.04 148.4 48.34 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-O 121.06 0.457 . . . . 0.0 110.332 179.377 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' E' E ' 33' ' ' THR . . . . . . . . . . . . . 28.0 m -52.84 138.27 29.95 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.35 -0.386 . . . . 0.0 111.515 -177.195 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' E' E ' 34' ' ' GLY . . . . . . . . . . . . . . . 98.44 -17.04 59.06 Favored Glycine 0 CA--C 1.533 1.189 0 CA-C-N 116.141 -0.482 . . . . 0.0 113.316 178.536 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' E' E ' 35' ' ' ASP . . . . . . . . . . . . . 81.2 m-20 -66.66 149.31 50.7 Favored 'General case' 0 C--O 1.231 0.131 0 CA-C-N 117.976 0.888 . . . . 0.0 111.312 179.85 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' E' E ' 36' ' ' VAL . . . . . . . . . . . . . 47.0 t -118.79 129.41 75.04 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.233 0 CA-C-N 115.745 -0.661 . . . . 0.0 109.674 176.679 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' E' E ' 37' ' ' ILE . . . . . . . . . . . . . 70.3 mt -120.17 138.46 50.64 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.26 0 N-CA-C 109.82 -0.437 . . . . 0.0 109.82 179.909 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' E' E ' 38' ' ' GLY . . . . . . . . . . . . . . . -111.9 128.57 8.65 Favored Glycine 0 CA--C 1.525 0.689 0 N-CA-C 111.055 -0.818 . . . . 0.0 111.055 179.384 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' E' E ' 39' ' ' ILE . . . . . . . . . . . . . 73.8 mt -127.59 135.98 61.72 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.189 0 CA-C-O 120.731 0.3 . . . . 0.0 110.267 179.186 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' E' E ' 40' ' ' SER . . . . . . . . . . . . . 91.0 p -92.99 116.24 28.87 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.278 -0.419 . . . . 0.0 110.733 174.429 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' E' E ' 41' ' ' ILE . . . . . . . . . . . . . 44.0 mm -121.1 123.17 69.43 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.216 0 CA-C-N 116.552 -0.294 . . . . 0.0 110.431 179.588 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' E' E ' 42' ' ' LEU . . . . . . . . . . . . . 47.0 mt 52.27 33.27 12.29 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.303 -0.408 . . . . 0.0 111.951 176.919 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' E' E ' 43' ' ' GLY . . . . . . . . . . . . . . . 74.15 31.69 59.27 Favored Glycine 0 CA--C 1.528 0.88 0 C-N-CA 121.135 -0.555 . . . . 0.0 112.159 177.711 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' E' E ' 44' ' ' LYS . . . . . . . . . . . . . 67.6 tttt -139.58 135.54 33.48 Favored 'General case' 0 C--N 1.329 -0.308 0 N-CA-C 109.674 -0.491 . . . . 0.0 109.674 177.747 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' E' E ' 45' ' ' GLU . . . . . . . . . . . . . 83.6 tt0 -82.16 120.92 25.95 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-O 120.861 0.362 . . . . 0.0 110.971 -177.098 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' E' E ' 46' ' ' VAL . . . . . . . . . . . . . 7.6 p -124.58 125.04 69.46 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.179 0 N-CA-C 109.41 -0.589 . . . . 0.0 109.41 176.277 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' E' E ' 47' ' ' LYS . . . . . . . . . . . . . 96.1 mttt -101.08 134.5 43.99 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.019 -0.537 . . . . 0.0 111.31 177.768 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' E' E ' 48' ' ' PHE . . . . . . . . . . . . . 88.5 m-85 -115.19 132.89 56.46 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 115.88 -0.6 . . . . 0.0 109.965 176.553 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' E' E ' 49' ' ' LYS . . . . . . . . . . . . . 83.3 tttt -105.33 136.91 43.99 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 116.347 -0.388 . . . . 0.0 109.987 177.303 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' E' E ' 50' ' ' VAL . . . . . . . . . . . . . 43.1 t -80.42 109.92 15.42 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.277 0 N-CA-C 109.353 -0.61 . . . . 0.0 109.353 176.821 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' E' E ' 51' ' ' VAL . . . . . . . . . . . . . 53.4 t -68.91 -47.33 76.46 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.24 0 CA-C-N 115.898 -0.592 . . . . 0.0 109.889 -174.777 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' E' E ' 52' ' ' GLN . . . . . . . . . . . . . 48.7 tt0 -167.85 141.77 3.46 Favored 'General case' 0 C--N 1.331 -0.219 0 C-N-CA 120.342 -0.543 . . . . 0.0 111.672 -179.688 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' E' E ' 53' ' ' ALA . . . . . . . . . . . . . . . -111.58 131.49 55.22 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 115.55 -0.75 . . . . 0.0 109.675 175.742 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' E' E ' 54' ' ' TYR . . . . . . . . . . . . . 50.6 t80 -127.67 106.48 20.8 Favored Pre-proline 0 CA--C 1.536 0.418 0 CA-C-O 118.319 -0.848 . . . . 0.0 110.438 -179.61 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' E' E ' 55' ' ' PRO . . . . . . . . . . . . . 73.4 Cg_endo -77.02 170.02 72.83 Favored 'Cis proline' 0 N--CA 1.499 1.836 0 CA-C-N 121.696 1.641 . . . . 0.0 112.607 -2.91 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' E' E ' 56' ' ' SER . . . . . . . . . . . . . 13.6 m -109.49 121.19 43.1 Favored Pre-proline 0 CA--C 1.539 0.537 0 CA-C-O 118.381 -0.819 . . . . 0.0 109.563 177.22 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' E' E ' 57' ' ' PRO . . . . . . . . . . . . . 61.1 Cg_endo -74.36 169.3 74.38 Favored 'Cis proline' 0 N--CA 1.497 1.686 0 CA-C-N 122.049 1.767 . . . . 0.0 112.073 0.97 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' E' E ' 58' ' ' LEU . . . . . . . . . . . . . 26.3 tp -128.13 136.16 50.78 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 115.999 -0.546 . . . . 0.0 110.014 179.755 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' E' E ' 59' ' ' ARG . . . . . . . . . . . . . 39.4 ttm180 -101.2 124.99 47.77 Favored 'General case' 0 C--N 1.326 -0.425 0 CA-C-N 115.89 -0.595 . . . . 0.0 109.467 178.512 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' E' E ' 60' ' ' VAL . . . . . . . . . . . . . 42.9 t -80.04 116.56 24.36 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.207 0 C-N-CA 120.57 -0.452 . . . . 0.0 110.353 -175.691 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' E' E ' 61' ' ' GLU . . . . . . . . . . . . . 95.6 mt-10 -131.04 166.07 21.85 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 115.792 -0.64 . . . . 0.0 110.045 178.765 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' E' E ' 62' ' ' ASP . . . . . . . . . . . . . 81.1 m-20 -54.94 -32.6 61.46 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.505 -0.316 . . . . 0.0 111.763 -179.991 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' E' E ' 63' ' ' ARG . . . . . . . . . . . . . 16.8 ptp180 -85.5 7.71 21.88 Favored 'General case' 0 CA--C 1.535 0.402 0 N-CA-C 113.536 0.939 . . . . 0.0 113.536 -175.751 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' E' E ' 64' ' ' THR . . . . . . . . . . . . . 34.0 m -94.35 141.79 28.16 Favored 'General case' 0 C--N 1.332 -0.166 0 CA-C-N 118.156 0.435 . . . . 0.0 110.587 -177.969 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' E' E ' 65' ' ' LYS . . . . . . . . . . . . . 98.3 mttt -88.87 126.8 35.54 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.09 -0.504 . . . . 0.0 110.195 179.234 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' E' E ' 66' ' ' ILE . . . . . . . . . . . . . 59.4 mt -114.23 126.45 71.75 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.292 0 N-CA-C 109.542 -0.54 . . . . 0.0 109.542 178.23 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' E' E ' 67' ' ' THR . . . . . . . . . . . . . 20.6 m -119.46 134.83 55.03 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-O 120.944 0.402 . . . . 0.0 110.481 -178.497 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' E' E ' 68' ' ' LEU . . . . . 0.481 ' C ' HD23 ' E' ' 68' ' ' LEU . 6.4 tt -103.95 119.01 38.03 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 115.886 -0.597 . . . . 0.0 110.113 179.247 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' E' E ' 69' ' ' VAL . . . . . . . . . . . . . 47.2 t -102.32 141.53 18.3 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.371 0 CA-C-N 115.988 -0.551 . . . . 0.0 109.711 179.248 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' E' E ' 70' ' ' THR . . . . . . . . . . . . . 7.8 t -130.25 129.8 43.77 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-O 121.025 0.441 . . . . 0.0 110.437 -179.872 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' E' E ' 71' ' ' HIS . . . . . . . . . . . . . 33.3 m80 -132.25 154.87 81.77 Favored Pre-proline 0 C--N 1.33 -0.272 0 CA-C-N 115.822 -0.626 . . . . 0.0 110.011 179.205 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' E' E ' 72' ' ' PRO . . . . . . . . . . . . . 86.6 Cg_endo -87.13 21.37 1.07 Allowed 'Trans proline' 0 N--CA 1.492 1.39 0 C-N-CA 121.534 1.489 . . . . 0.0 113.075 179.369 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' E' E ' 73' ' ' VAL . . . . . 0.58 HG12 HG22 ' D' ' 143' ' ' THR . 26.7 m -130.5 149.28 33.4 Favored 'Isoleucine or valine' 0 C--O 1.232 0.136 0 CA-C-O 121.06 0.457 . . . . 0.0 110.968 -179.985 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' E' E ' 74' ' ' ASP . . . . . . . . . . . . . 19.6 t0 -112.33 119.13 37.23 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 115.738 -0.665 . . . . 0.0 109.521 177.646 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' E' E ' 75' ' ' VAL . . . . . . . . . . . . . 43.8 t -110.63 126.53 67.96 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.258 0 CA-C-O 121.141 0.496 . . . . 0.0 111.0 -174.983 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' E' E ' 76' ' ' LEU . . . . . . . . . . . . . 23.0 mt -128.76 144.52 51.19 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 115.456 -0.793 . . . . 0.0 109.475 176.379 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' E' E ' 77' ' ' GLU . . . . . . . . . . . . . 98.0 mt-10 -131.72 139.33 48.97 Favored 'General case' 0 C--N 1.332 -0.163 0 CA-C-O 121.117 0.484 . . . . 0.0 111.622 -177.07 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' E' E ' 78' ' ' ALA . . . . . . . . . . . . . . . -126.68 129.41 48.39 Favored 'General case' 0 C--N 1.331 -0.196 0 CA-C-N 115.573 -0.74 . . . . 0.0 109.685 175.693 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' E' E ' 79' ' ' LYS . . . . . 0.602 ' O ' HD13 ' E' ' 80' ' ' ILE . 51.8 pttt -75.85 121.09 22.11 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-O 121.471 0.653 . . . . 0.0 110.997 -177.996 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' E' E ' 80' ' ' ILE . . . . . 0.602 HD13 ' O ' ' E' ' 79' ' ' LYS . 41.2 mm -139.28 107.52 3.26 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.224 0 CA-C-N 115.531 -0.759 . . . . 0.0 109.111 -177.131 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' E' E ' 81' ' ' LYS . . . . . . . . . . . . . 31.7 ttpt -103.61 126.94 51.06 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-O 120.838 0.351 . . . . 0.0 111.111 -177.199 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' E' E ' 82' ' ' GLY . . . . . . . . . . . . . . . 89.03 42.01 5.74 Favored Glycine 0 CA--C 1.526 0.722 0 C-N-CA 120.8 -0.714 . . . . 0.0 111.716 174.977 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' E' E ' 83' ' ' ILE . . . . . . . . . . . . . 70.8 mt -65.48 138.97 22.11 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.356 0 CA-C-O 120.931 0.396 . . . . 0.0 110.033 179.194 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' E' E ' 84' ' ' LYS . . . . . . . . . . . . . 57.0 tttp -98.72 -50.27 4.3 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 115.964 -0.562 . . . . 0.0 109.893 179.043 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' E' E ' 85' ' ' ASP . . . . . . . . . . . . . 5.3 t70 -157.92 153.4 26.16 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 115.647 -0.706 . . . . 0.0 110.228 178.696 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' E' E ' 86' ' ' VAL . . . . . . . . . . . . . 44.6 t -128.39 131.77 68.7 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.208 0 CA-C-O 121.014 0.435 . . . . 0.0 110.559 -178.838 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' E' E ' 87' ' ' ILE . . . . . . . . . . . . . 4.9 mp -117.99 123.3 71.46 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.253 0 CA-C-N 115.743 -0.662 . . . . 0.0 109.245 175.149 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' E' E ' 88' ' ' LEU . . . . . . . . . . . . . 13.0 tp -111.08 130.98 55.44 Favored 'General case' 0 C--N 1.331 -0.198 0 CA-C-O 120.99 0.424 . . . . 0.0 111.032 -177.328 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' E' E ' 89' ' ' ASP . . . . . . . . . . . . . 13.2 t70 -126.65 153.12 45.81 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 115.867 -0.606 . . . . 0.0 109.451 176.51 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' E' E ' 90' ' ' GLU . . . . . . . . . . . . . 80.4 tt0 -47.81 -33.42 7.25 Favored 'General case' 0 C--N 1.331 -0.23 0 N-CA-C 112.866 0.691 . . . . 0.0 112.866 -172.271 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' E' E ' 91' ' ' ASN . . . . . . . . . . . . . 3.8 p30 -129.14 14.55 6.22 Favored 'General case' 0 N--CA 1.469 0.509 0 N-CA-C 113.349 0.87 . . . . 0.0 113.349 -175.905 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' E' E ' 92' ' ' LEU . . . . . . . . . . . . . 34.9 mt -149.42 147.17 27.95 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-O 120.796 0.331 . . . . 0.0 110.508 -176.355 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' E' E ' 93' ' ' ILE . . . . . . . . . . . . . 71.7 mt -125.07 117.17 49.25 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.274 0 N-CA-C 109.319 -0.623 . . . . 0.0 109.319 177.696 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' E' E ' 94' ' ' VAL . . . . . . . . . . . . . 46.6 t -116.39 125.85 73.6 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.273 0 N-CA-C 109.753 -0.462 . . . . 0.0 109.753 -179.897 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' E' E ' 95' ' ' VAL . . . . . . . . . . . . . 38.7 t -122.74 132.93 70.32 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.293 0 CA-C-N 116.113 -0.494 . . . . 0.0 109.838 -179.097 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' E' E ' 96' ' ' ILE . . . . . . . . . . . . . 59.4 mt -114.53 129.57 70.37 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.327 0 N-CA-C 109.224 -0.658 . . . . 0.0 109.224 178.451 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' E' E ' 97' ' ' THR . . . . . . . . . . . . . 68.1 p -101.51 157.79 16.56 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-O 121.001 0.429 . . . . 0.0 110.968 -177.762 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' E' E ' 98' ' ' GLU . . . . . . . . . . . . . 44.6 mt-10 -53.81 -25.01 17.34 Favored 'General case' 0 C--N 1.329 -0.298 0 N-CA-C 112.489 0.551 . . . . 0.0 112.489 179.982 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' E' E ' 99' ' ' GLU . . . . . . . . . . . . . 96.4 mt-10 -78.1 14.69 1.08 Allowed 'General case' 0 CA--C 1.536 0.42 0 N-CA-C 113.331 0.863 . . . . 0.0 113.331 -177.052 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' E' E ' 100' ' ' ASN . . . . . . . . . . . . . 2.2 m-20 63.06 34.43 13.82 Favored 'General case' 0 N--CA 1.464 0.264 0 CA-C-N 117.909 0.322 . . . . 0.0 111.352 178.032 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' E' E ' 101' ' ' GLU . . . . . . . . . . . . . 81.4 tt0 -116.49 144.23 44.59 Favored 'General case' 0 C--N 1.332 -0.189 0 N-CA-C 109.582 -0.525 . . . . 0.0 109.582 175.195 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' E' E ' 102' ' ' VAL . . . . . . . . . . . . . 46.2 t -118.94 127.47 75.79 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.257 0 N-CA-C 109.864 -0.421 . . . . 0.0 109.864 -178.269 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' E' E ' 103' ' ' LEU . . . . . 0.506 HD12 ' N ' ' E' ' 103' ' ' LEU . 6.1 mp -118.39 135.8 54.12 Favored 'General case' 0 C--N 1.332 -0.188 0 CA-C-N 115.829 -0.623 . . . . 0.0 110.112 177.26 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' E' E ' 104' ' ' ILE . . . . . 0.408 HD13 HG21 ' E' ' 130' ' ' VAL . 66.2 mt -119.46 122.0 67.84 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.265 0 N-CA-C 110.147 -0.316 . . . . 0.0 110.147 -179.723 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' E' E ' 105' ' ' PHE . . . . . . . . . . . . . 73.7 m-85 -118.84 163.67 16.55 Favored 'General case' 0 C--N 1.33 -0.245 0 O-C-N 123.991 0.807 . . . . 0.0 109.405 179.353 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' E' E ' 106' ' ' ASN . . . . . . . . . . . . . 47.6 p-10 -96.64 -170.93 2.15 Favored 'General case' 0 C--N 1.331 -0.201 0 N-CA-C 109.803 -0.443 . . . . 0.0 109.803 172.714 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' E' E ' 107' ' ' GLN . . . . . . . . . . . . . 42.1 tt0 -59.73 -27.62 66.64 Favored 'General case' 0 C--N 1.327 -0.373 0 N-CA-C 112.104 0.409 . . . . 0.0 112.104 -179.963 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' E' E ' 108' ' ' ASN . . . . . . . . . . . . . 6.9 t-20 -88.14 13.9 10.33 Favored 'General case' 0 CA--C 1.536 0.418 0 N-CA-C 112.874 0.694 . . . . 0.0 112.874 -178.161 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' E' E ' 109' ' ' LEU . . . . . . . . . . . . . 42.0 mt 57.25 32.3 21.51 Favored 'General case' 0 CA--C 1.529 0.172 0 N-CA-C 112.013 0.375 . . . . 0.0 112.013 178.697 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' E' E ' 110' ' ' GLU . . . . . . . . . . . . . 95.1 mt-10 -101.18 140.02 36.05 Favored 'General case' 0 C--N 1.33 -0.261 0 N-CA-C 109.125 -0.694 . . . . 0.0 109.125 174.269 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' E' E ' 111' ' ' GLU . . . . . . . . . . . . . 44.7 tt0 -82.43 121.91 27.34 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-O 120.948 0.404 . . . . 0.0 110.69 -174.605 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' E' E ' 112' ' ' LEU . . . . . . . . . . . . . 14.0 mt -102.12 -45.18 5.23 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 115.909 -0.587 . . . . 0.0 110.547 179.338 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' E' E ' 113' ' ' TYR . . . . . . . . . . . . . 57.4 t80 -134.8 143.51 47.12 Favored 'General case' 0 C--N 1.331 -0.218 0 CA-C-N 116.387 -0.37 . . . . 0.0 111.078 -177.536 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' E' E ' 114' ' ' ARG . . . . . . . . . . . . . 35.1 ptt180 -147.06 125.49 12.36 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.18 -0.463 . . . . 0.0 110.727 177.863 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' E' E ' 115' ' ' GLY . . . . . . . . . . . . . . . -150.15 162.97 29.38 Favored Glycine 0 CA--C 1.523 0.572 0 N-CA-C 110.834 -0.907 . . . . 0.0 110.834 -179.927 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' E' E ' 116' ' ' LYS . . . . . . . . . . . . . 30.7 ttmt -132.06 138.97 48.37 Favored 'General case' 0 C--N 1.329 -0.305 0 O-C-N 122.59 -0.359 . . . . 0.0 110.051 177.922 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' E' E ' 117' ' ' PHE . . . . . . . . . . . . . 28.0 m-85 -137.09 114.78 11.22 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-O 120.875 0.369 . . . . 0.0 110.038 -175.938 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' E' E ' 118' ' ' GLU . . . . . . . . . . . . . 96.8 mt-10 -54.27 -43.03 70.64 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.458 -0.337 . . . . 0.0 111.333 -176.679 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' E' E ' 119' ' ' ASN . . . . . . . . . . . . . 59.2 m-80 -98.9 31.06 3.1 Favored 'General case' 0 C--N 1.331 -0.215 0 CA-C-N 116.222 -0.444 . . . . 0.0 112.159 -174.257 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' E' E ' 120' ' ' LEU . . . . . . . . . . . . . 25.1 tp -57.03 119.82 6.96 Favored 'General case' 0 C--N 1.333 -0.127 0 C-N-CA 121.028 -0.269 . . . . 0.0 110.322 177.937 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' E' E ' 121' ' ' ASN . . . . . . . . . . . . . 9.9 t-20 -114.14 -44.14 3.16 Favored 'General case' 0 C--N 1.332 -0.182 0 CA-C-N 116.545 -0.298 . . . . 0.0 111.192 -177.28 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' E' E ' 122' ' ' LYS . . . . . . . . . . . . . 61.8 mtpt -144.29 152.59 41.0 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-O 121.048 0.451 . . . . 0.0 111.561 -176.814 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' E' E ' 123' ' ' VAL . . . . . . . . . . . . . 43.5 t -132.32 131.89 60.64 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.238 0 CA-C-N 116.01 -0.541 . . . . 0.0 109.808 175.983 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' E' E ' 124' ' ' LEU . . . . . . . . . . . . . 52.6 mt -120.15 133.12 55.58 Favored 'General case' 0 C--N 1.331 -0.213 0 CA-C-N 116.275 -0.421 . . . . 0.0 110.624 -179.339 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' E' E ' 125' ' ' VAL . . . . . . . . . . . . . 43.3 t -127.83 120.34 53.8 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.188 0 N-CA-C 109.788 -0.449 . . . . 0.0 109.788 177.818 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' E' E ' 126' ' ' ARG . . . . . . . . . . . . . 51.2 mtp180 -148.87 138.86 22.16 Favored 'General case' 0 C--N 1.329 -0.323 0 N-CA-C 109.661 -0.496 . . . . 0.0 109.661 179.615 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' E' E ' 127' ' ' ASN . . . . . . . . . . . . . 4.9 p-10 48.67 -151.13 0.14 Allowed 'General case' 0 CA--C 1.54 0.585 0 CA-C-O 119.434 -0.317 . . . . 0.0 111.024 177.353 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' E' E ' 128' ' ' ASP . . . . . . . . . . . . . 13.3 p-10 -84.14 22.84 1.14 Allowed 'General case' 0 CA--C 1.534 0.332 0 CA-C-N 118.541 0.61 . . . . 0.0 112.416 178.653 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' E' E ' 129' ' ' LEU . . . . . . . . . . . . . 15.0 tp -127.08 140.4 52.31 Favored 'General case' 0 C--O 1.233 0.2 0 O-C-N 122.072 -0.393 . . . . 0.0 110.354 -179.398 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' E' E ' 130' ' ' VAL . . . . . 0.495 HG23 ' HB ' ' E' ' 141' ' ' ILE . 30.9 m -129.5 142.81 42.98 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.218 0 CA-C-O 121.001 0.429 . . . . 0.0 110.468 179.297 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' E' E ' 131' ' ' VAL . . . . . 0.525 HG22 HD12 ' E' ' 140' ' ' LEU . 39.8 t -136.1 138.92 46.65 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.234 0 CA-C-N 116.118 -0.492 . . . . 0.0 110.545 -177.77 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' E' E ' 132' ' ' ILE . . . . . . . . . . . . . 73.8 mt -117.18 132.22 67.61 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.289 0 N-CA-C 109.347 -0.612 . . . . 0.0 109.347 177.761 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' E' E ' 133' ' ' ILE . . . . . . . . . . . . . 35.2 mm -115.65 122.39 69.32 Favored 'Isoleucine or valine' 0 C--O 1.234 0.278 0 CA-C-O 120.656 0.265 . . . . 0.0 111.06 -174.766 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' E' E ' 134' ' ' ASP . . . . . . . . . . . . . 7.5 p-10 -135.15 146.44 48.78 Favored 'General case' 0 C--N 1.329 -0.31 0 N-CA-C 109.374 -0.602 . . . . 0.0 109.374 174.812 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' E' E ' 135' ' ' GLU . . . . . . . . . . . . . 84.4 tt0 -49.91 -26.37 4.06 Favored 'General case' 0 CA--C 1.532 0.285 0 N-CA-C 112.721 0.637 . . . . 0.0 112.721 -174.242 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' E' E ' 136' ' ' GLN . . . . . . . . . . . . . 24.9 tt0 -77.64 -38.56 47.63 Favored 'General case' 0 C--O 1.234 0.28 0 CA-C-O 120.896 0.379 . . . . 0.0 111.933 -177.01 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' E' E ' 137' ' ' LYS . . . . . . . . . . . . . 17.4 ptpt -166.83 176.47 7.05 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-O 121.496 0.665 . . . . 0.0 111.621 -173.364 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' E' E ' 138' ' ' LEU . . . . . 0.425 ' C ' HD23 ' E' ' 138' ' ' LEU . 7.4 tt -119.62 128.07 53.53 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 115.243 -0.89 . . . . 0.0 109.954 177.83 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' E' E ' 139' ' ' THR . . . . . . . . . . . . . 36.9 m -105.94 125.85 51.49 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.245 -0.434 . . . . 0.0 110.372 179.869 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' E' E ' 140' ' ' LEU . . . . . 0.525 HD12 HG22 ' E' ' 131' ' ' VAL . 21.3 tp -113.08 119.52 38.12 Favored 'General case' 0 C--N 1.329 -0.306 0 N-CA-C 109.018 -0.734 . . . . 0.0 109.018 -179.137 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' E' E ' 141' ' ' ILE . . . . . 0.495 ' HB ' HG23 ' E' ' 130' ' ' VAL . 19.5 mt -119.17 121.64 67.18 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.309 0 CA-C-O 121.042 0.449 . . . . 0.0 110.012 -175.944 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' E' E ' 142' ' ' ARG . . . . . . . . . . . . . 78.9 mtp180 -109.97 115.76 30.38 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 115.126 -0.943 . . . . 0.0 109.901 -177.748 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' E' E ' 143' ' ' THR . . . . . . . . . . . . . 34.9 p . . . . . 0 C--O 1.219 -0.51 0 CA-C-O 118.037 -0.983 . . . . 0.0 110.649 -178.24 . . . . . . . . 0 0 . 1 . 017 nuclear nobuild full ' F' F ' -3' ' ' GLU . . . . . . . . . . . . . 70.4 mm-40 . . . . . 0 N--CA 1.49 1.573 0 N-CA-C 109.484 -0.562 . . . . 0.0 109.484 . . . . . . . . . 0 0 . 1 . 017 nuclear nobuild full ' F' F ' -2' ' ' GLY . . . . . . . . . . . . . . . -70.32 150.01 47.95 Favored Glycine 0 CA--C 1.525 0.67 0 N-CA-C 110.91 -0.876 . . . . 0.0 110.91 179.111 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' F' F ' -1' ' ' VAL . . . . . . . . . . . . . 45.8 t -94.03 129.89 43.72 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.328 0 N-CA-C 109.851 -0.426 . . . . 0.0 109.851 179.878 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' F' F ' 0' ' ' ILE . . . . . . . . . . . . . 43.6 mm -116.91 133.88 62.21 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.259 0 CA-C-N 116.249 -0.432 . . . . 0.0 110.283 -178.986 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' F' F ' 1' ' ' MET . . . . . . . . . . . . . 24.6 ptp -80.85 138.27 36.19 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.018 -0.537 . . . . 0.0 110.683 -179.947 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' F' F ' 2' ' ' SER . . . . . . . . . . . . . 50.6 p -123.7 141.06 52.37 Favored 'General case' 0 C--N 1.332 -0.184 0 CA-C-O 120.986 0.422 . . . . 0.0 110.534 178.968 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' F' F ' 3' ' ' GLU . . . . . . . . . . . . . 84.7 tt0 -142.01 140.45 32.67 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.041 -0.527 . . . . 0.0 111.376 -178.777 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' F' F ' 4' ' ' LEU . . . . . . . . . . . . . 67.9 mt -120.16 134.0 55.36 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.042 -0.526 . . . . 0.0 110.2 176.253 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' F' F ' 5' ' ' LYS . . . . . . . . . . . . . 68.1 mttm -109.97 119.85 40.6 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.303 -0.408 . . . . 0.0 110.275 178.194 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' F' F ' 6' ' ' LEU . . . . . . . . . . . . . 57.1 mt -114.51 147.51 39.28 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 115.382 -0.826 . . . . 0.0 110.472 -178.109 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' F' F ' 7' ' ' LYS . . . . . . . . . . . . . 56.4 tttm -136.84 137.14 22.52 Favored Pre-proline 0 CA--C 1.534 0.34 0 CA-C-O 118.901 -0.571 . . . . 0.0 109.962 176.78 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' F' F ' 8' ' ' PRO . . . . . . . . . . . . . 97.3 Cg_endo -91.97 141.98 2.55 Favored 'Trans proline' 0 N--CA 1.488 1.2 0 C-N-CA 121.688 1.592 . . . . 0.0 111.776 177.397 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' F' F ' 9' ' ' LEU . . . . . . . . . . . . . 21.9 mt -79.79 -47.3 1.46 Allowed Pre-proline 0 CA--C 1.532 0.274 0 CA-C-O 118.697 -0.668 . . . . 0.0 111.92 -178.94 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' F' F ' 10' ' ' PRO . . . . . . . . . . . . . 96.0 Cg_endo -81.66 140.61 11.83 Favored 'Trans proline' 0 N--CA 1.494 1.55 0 C-N-CA 121.188 1.258 . . . . 0.0 111.509 175.254 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' F' F ' 11' ' ' LYS . . . . . . . . . . . . . 46.3 tptt -79.94 98.09 7.01 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-O 120.863 0.363 . . . . 0.0 110.184 179.726 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' F' F ' 12' ' ' VAL . . . . . . . . . . . . . 12.7 p -138.16 145.81 27.98 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.245 0 CA-C-N 116.132 -0.485 . . . . 0.0 110.542 -179.357 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' F' F ' 13' ' ' GLU . . . . . . . . . . . . . 84.6 tt0 -83.56 126.13 32.49 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.353 -0.385 . . . . 0.0 110.403 179.515 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' F' F ' 14' ' ' LEU . . . . . . . . . . . . . 15.5 mt -98.13 149.86 36.15 Favored Pre-proline 0 CA--C 1.532 0.284 0 CA-C-N 116.338 -0.392 . . . . 0.0 110.352 -178.593 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' F' F ' 15' ' ' PRO . . . . . . . . . . . . . 25.8 Cg_exo -62.51 164.11 19.03 Favored 'Trans proline' 0 N--CA 1.496 1.628 0 C-N-CA 121.277 1.318 . . . . 0.0 111.916 176.001 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' F' F ' 16' ' ' PRO . . . . . . . . . . . . . 27.6 Cg_exo -60.32 -41.84 46.86 Favored 'Trans proline' 0 N--CA 1.498 1.748 0 C-N-CA 121.439 1.426 . . . . 0.0 112.842 -177.974 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' F' F ' 17' ' ' ASP . . . . . . . . . . . . . 7.9 p-10 -88.67 11.09 18.45 Favored 'General case' 0 C--N 1.327 -0.376 0 N-CA-C 113.249 0.833 . . . . 0.0 113.249 -176.679 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' F' F ' 18' ' ' PHE . . . . . . . . . . . . . 49.2 t80 -57.18 -42.72 81.69 Favored 'General case' 0 C--N 1.334 -0.07 0 O-C-N 121.922 -0.486 . . . . 0.0 110.25 -178.816 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' F' F ' 19' ' ' VAL . . . . . . . . . . . . . 47.7 t -57.52 -43.05 82.3 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.321 0 CA-C-N 116.144 -0.48 . . . . 0.0 110.36 -179.092 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' F' F ' 20' ' ' ASP . . . . . . . . . . . . . 8.6 t70 -59.85 -41.13 90.74 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-O 120.873 0.368 . . . . 0.0 110.726 -178.217 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' F' F ' 21' ' ' VAL . . . . . . . . . . . . . 51.1 t -64.36 -47.2 90.58 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.332 0 CA-C-N 116.323 -0.398 . . . . 0.0 110.392 -178.2 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' F' F ' 22' ' ' ILE . . . . . 0.446 HG22 HD12 ' F' ' 26' ' ' LEU . 50.5 mm -55.93 -45.37 80.0 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.202 0 C-N-CA 120.928 -0.309 . . . . 0.0 110.662 179.201 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' F' F ' 23' ' ' ARG . . . . . . . . . . . . . 36.1 ttp180 -53.83 -50.7 65.62 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-O 120.675 0.274 . . . . 0.0 111.428 -178.999 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' F' F ' 24' ' ' ILE . . . . . . . . . . . . . 71.5 mt -60.31 -41.36 86.83 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.264 0 CA-C-N 116.514 -0.312 . . . . 0.0 111.314 -177.18 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' F' F ' 25' ' ' LYS . . . . . . . . . . . . . 82.3 mttt -66.39 -39.02 88.81 Favored 'General case' 0 C--N 1.33 -0.265 0 N-CA-C 112.354 0.502 . . . . 0.0 112.354 -178.674 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' F' F ' 26' ' ' LEU . . . . . 0.446 HD12 HG22 ' F' ' 22' ' ' ILE . 75.7 mt -78.42 -41.9 31.64 Favored 'General case' 0 C--N 1.33 -0.278 0 N-CA-C 113.005 0.742 . . . . 0.0 113.005 -173.39 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' F' F ' 27' ' ' GLN . . . . . . . . . . . . . 9.1 pt20 -46.91 142.1 3.66 Favored 'General case' 0 N--CA 1.47 0.538 0 N-CA-C 112.694 0.627 . . . . 0.0 112.694 -175.377 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' F' F ' 28' ' ' GLY . . . . . . . . . . . . . . . 98.94 -29.77 11.09 Favored Glycine 0 CA--C 1.531 1.087 0 CA-C-N 115.514 -0.766 . . . . 0.0 111.96 -177.477 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' F' F ' 29' ' ' LYS . . . . . . . . . . . . . 8.7 mtpm? -98.66 155.14 17.47 Favored 'General case' 0 C--O 1.232 0.167 0 CA-C-O 121.013 0.435 . . . . 0.0 110.955 179.264 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' F' F ' 30' ' ' THR . . . . . . . . . . . . . 29.7 m -97.28 138.4 34.82 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.151 -0.477 . . . . 0.0 109.947 175.682 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' F' F ' 31' ' ' VAL . . . . . . . . . . . . . 35.3 m -124.94 151.45 30.56 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.257 0 CA-C-N 116.289 -0.414 . . . . 0.0 110.82 -178.47 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' F' F ' 32' ' ' ARG . . . . . . . . . . . . . 61.5 mtp180 -135.3 152.19 51.26 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-O 121.398 0.618 . . . . 0.0 110.717 176.82 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' F' F ' 33' ' ' THR . . . . . . . . . . . . . 8.4 m -54.0 138.3 37.48 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 115.973 -0.558 . . . . 0.0 111.18 -179.085 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' F' F ' 34' ' ' GLY . . . . . . . . . . . . . . . 101.57 -17.08 55.79 Favored Glycine 0 CA--C 1.532 1.139 0 CA-C-O 119.539 -0.59 . . . . 0.0 113.293 178.768 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' F' F ' 35' ' ' ASP . . . . . . . . . . . . . 74.2 m-20 -65.27 148.81 51.04 Favored 'General case' 0 N--CA 1.461 0.113 0 CA-C-N 118.134 0.967 . . . . 0.0 111.25 179.869 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' F' F ' 36' ' ' VAL . . . . . . . . . . . . . 44.8 t -122.48 129.84 74.96 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.16 0 CA-C-N 115.741 -0.663 . . . . 0.0 109.793 178.308 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' F' F ' 37' ' ' ILE . . . . . . . . . . . . . 70.4 mt -122.71 140.18 47.28 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.185 0 CA-C-N 116.233 -0.439 . . . . 0.0 109.96 -179.813 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' F' F ' 38' ' ' GLY . . . . . . . . . . . . . . . -114.0 128.78 8.42 Favored Glycine 0 CA--C 1.525 0.679 0 N-CA-C 111.211 -0.756 . . . . 0.0 111.211 -179.973 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' F' F ' 39' ' ' ILE . . . . . . . . . . . . . 72.4 mt -126.25 130.27 72.03 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.214 0 N-CA-C 109.746 -0.465 . . . . 0.0 109.746 178.539 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' F' F ' 40' ' ' SER . . . . . 0.558 ' O ' HD13 ' F' ' 41' ' ' ILE . 83.7 p -93.45 121.62 35.04 Favored 'General case' 0 C--N 1.331 -0.227 0 C-N-CA 120.945 -0.302 . . . . 0.0 111.456 178.826 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' F' F ' 41' ' ' ILE . . . . . 0.558 HD13 ' O ' ' F' ' 40' ' ' SER . 44.5 mm -133.4 129.13 55.99 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.181 0 CA-C-N 116.427 -0.351 . . . . 0.0 110.163 177.813 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' F' F ' 42' ' ' LEU . . . . . 0.481 ' HG ' HG22 ' F' ' 41' ' ' ILE . 70.3 mt 57.6 32.99 22.67 Favored 'General case' 0 C--N 1.33 -0.249 0 N-CA-C 112.023 0.379 . . . . 0.0 112.023 176.93 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' F' F ' 43' ' ' GLY . . . . . . . . . . . . . . . 77.46 -10.12 24.6 Favored Glycine 0 CA--C 1.533 1.205 0 C-N-CA 121.108 -0.568 . . . . 0.0 113.553 177.502 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' F' F ' 44' ' ' LYS . . . . . . . . . . . . . 37.6 mmtm -103.25 136.31 43.26 Favored 'General case' 0 C--O 1.232 0.173 0 CA-C-N 117.988 0.894 . . . . 0.0 110.051 176.638 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' F' F ' 45' ' ' GLU . . . . . . . . . . . . . 35.1 tp10 -84.58 127.56 34.13 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.344 -0.389 . . . . 0.0 110.628 -179.805 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' F' F ' 46' ' ' VAL . . . . . . . . . . . . . 5.8 p -115.22 126.67 72.85 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.223 0 N-CA-C 109.212 -0.662 . . . . 0.0 109.212 176.23 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' F' F ' 47' ' ' LYS . . . . . . . . . . . . . 63.4 mttm -100.14 128.99 46.12 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 115.791 -0.641 . . . . 0.0 110.924 -179.482 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' F' F ' 48' ' ' PHE . . . . . . . . . . . . . 95.6 m-85 -113.73 131.83 56.04 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.358 -0.383 . . . . 0.0 110.324 177.884 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' F' F ' 49' ' ' LYS . . . . . . . . . . . . . 80.0 tttt -108.06 139.01 43.34 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.357 -0.383 . . . . 0.0 110.633 178.214 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' F' F ' 50' ' ' VAL . . . . . . . . . . . . . 45.0 t -82.11 107.33 14.0 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.343 0 N-CA-C 109.224 -0.658 . . . . 0.0 109.224 175.011 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' F' F ' 51' ' ' VAL . . . . . . . . . . . . . 50.3 t -72.25 -51.87 27.42 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.258 0 CA-C-N 116.103 -0.499 . . . . 0.0 109.757 -174.753 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' F' F ' 52' ' ' GLN . . . . . . . . . . . . . 90.7 mt-30 -153.84 153.23 31.73 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-O 121.296 0.57 . . . . 0.0 111.722 -178.564 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' F' F ' 53' ' ' ALA . . . . . . . . . . . . . . . -129.98 132.64 46.37 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 115.252 -0.885 . . . . 0.0 109.635 173.825 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' F' F ' 54' ' ' TYR . . . . . . . . . . . . . 41.1 t80 -129.09 110.58 18.24 Favored Pre-proline 0 CA--C 1.536 0.406 0 CA-C-O 118.231 -0.89 . . . . 0.0 110.555 179.974 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' F' F ' 55' ' ' PRO . . . . . . . . . . . . . 74.4 Cg_endo -77.21 169.37 74.35 Favored 'Cis proline' 0 N--CA 1.5 1.869 0 CA-C-N 121.823 1.687 . . . . 0.0 112.165 -7.971 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' F' F ' 56' ' ' SER . . . . . . . . . . . . . 13.6 m -117.84 135.03 23.22 Favored Pre-proline 0 CA--C 1.538 0.487 0 CA-C-O 118.515 -0.755 . . . . 0.0 109.599 174.809 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' F' F ' 57' ' ' PRO . . . . . . . . . . . . . 58.8 Cg_endo -73.18 162.01 92.69 Favored 'Cis proline' 0 N--CA 1.498 1.736 0 CA-C-N 121.898 1.714 . . . . 0.0 111.412 -2.656 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' F' F ' 58' ' ' LEU . . . . . . . . . . . . . 23.9 tp -130.88 139.64 50.13 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-O 121.003 0.43 . . . . 0.0 110.936 -179.673 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' F' F ' 59' ' ' ARG . . . . . . . . . . . . . 35.7 ttm180 -97.84 125.22 42.59 Favored 'General case' 0 C--N 1.327 -0.399 0 N-CA-C 109.087 -0.708 . . . . 0.0 109.087 173.052 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' F' F ' 60' ' ' VAL . . . . . . . . . . . . . 43.4 t -79.44 119.86 29.59 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.262 0 C-N-CA 120.599 -0.44 . . . . 0.0 110.426 -175.144 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' F' F ' 61' ' ' GLU . . . . . . . . . . . . . 95.2 mt-10 -131.08 169.93 15.21 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 115.792 -0.64 . . . . 0.0 109.742 176.592 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' F' F ' 62' ' ' ASP . . . . . . . . . . . . . 80.1 m-20 -52.8 -32.37 43.66 Favored 'General case' 0 C--N 1.329 -0.305 0 N-CA-C 111.948 0.351 . . . . 0.0 111.948 -178.417 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' F' F ' 63' ' ' ARG . . . . . . . . . . . . . 85.4 mtt180 -72.29 -22.06 61.26 Favored 'General case' 0 CA--C 1.533 0.308 0 N-CA-C 113.019 0.748 . . . . 0.0 113.019 -175.661 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' F' F ' 64' ' ' THR . . . . . . . . . . . . . 33.1 m -68.72 135.43 51.29 Favored 'General case' 0 C--N 1.331 -0.229 0 CA-C-O 120.995 0.426 . . . . 0.0 111.049 -175.099 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' F' F ' 65' ' ' LYS . . . . . . . . . . . . . 63.3 mttm -89.95 136.47 33.02 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 115.912 -0.585 . . . . 0.0 110.064 177.922 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' F' F ' 66' ' ' ILE . . . . . . . . . . . . . 60.1 mt -118.29 129.95 73.86 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.185 0 N-CA-C 109.851 -0.426 . . . . 0.0 109.851 179.06 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' F' F ' 67' ' ' THR . . . . . . . . . . . . . 24.2 m -124.88 142.26 51.57 Favored 'General case' 0 C--N 1.332 -0.186 0 CA-C-O 121.103 0.477 . . . . 0.0 110.9 -178.878 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' F' F ' 68' ' ' LEU . . . . . 0.478 HD23 ' C ' ' F' ' 68' ' ' LEU . 7.1 tt -98.78 123.0 42.73 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 115.944 -0.571 . . . . 0.0 109.822 177.396 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' F' F ' 69' ' ' VAL . . . . . . . . . . . . . 41.3 t -103.18 123.44 56.64 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.304 0 CA-C-N 116.354 -0.385 . . . . 0.0 110.817 -176.774 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' F' F ' 70' ' ' THR . . . . . . . . . . . . . 18.2 m -109.46 109.64 20.53 Favored 'General case' 0 C--N 1.33 -0.247 0 N-CA-C 109.298 -0.63 . . . . 0.0 109.298 172.979 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' F' F ' 71' ' ' HIS . . . . . . . . . . . . . 2.0 m-70 -146.15 174.47 3.4 Favored Pre-proline 0 CA--C 1.536 0.409 0 C-N-CA 120.807 -0.357 . . . . 0.0 110.775 -175.617 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' F' F ' 72' ' ' PRO . . . . . . . . . . . . . 18.9 Cg_exo -64.87 160.09 42.73 Favored 'Trans proline' 0 N--CA 1.494 1.516 0 C-N-CA 121.594 1.529 . . . . 0.0 111.745 177.712 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' F' F ' 73' ' ' VAL . . . . . . . . . . . . . 33.1 m -69.78 175.6 0.58 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.284 0 CA-C-N 116.291 -0.413 . . . . 0.0 110.112 -178.061 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' F' F ' 74' ' ' ASP . . . . . . . . . . . . . 14.4 t0 -92.85 117.49 30.08 Favored 'General case' 0 C--N 1.331 -0.227 0 C-N-CA 120.735 -0.386 . . . . 0.0 110.3 -173.729 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' F' F ' 75' ' ' VAL . . . . . . . . . . . . . 41.8 t -113.72 120.43 63.56 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.287 0 CA-C-O 121.101 0.477 . . . . 0.0 110.075 -179.785 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' F' F ' 76' ' ' LEU . . . . . . . . . . . . . 15.4 mt -125.17 144.17 50.58 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 115.728 -0.669 . . . . 0.0 109.686 178.129 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' F' F ' 77' ' ' GLU . . . . . . . . . . . . . 97.4 mt-10 -134.6 132.69 39.35 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-O 121.151 0.501 . . . . 0.0 110.981 -176.855 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' F' F ' 78' ' ' ALA . . . . . . . . . . . . . . . -116.33 127.29 54.56 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 115.658 -0.701 . . . . 0.0 109.719 177.309 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' F' F ' 79' ' ' LYS . . . . . 0.623 ' O ' HD13 ' F' ' 80' ' ' ILE . 52.5 mtmt -78.39 116.31 18.71 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-O 120.85 0.357 . . . . 0.0 110.691 -177.586 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' F' F ' 80' ' ' ILE . . . . . 0.623 HD13 ' O ' ' F' ' 79' ' ' LYS . 40.1 mm -139.14 106.25 2.83 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.295 0 N-CA-C 109.003 -0.74 . . . . 0.0 109.003 -177.313 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' F' F ' 81' ' ' LYS . . . . . . . . . . . . . 44.3 tptt -98.05 124.17 42.42 Favored 'General case' 0 C--N 1.328 -0.355 0 C-N-CA 120.788 -0.365 . . . . 0.0 110.806 -175.95 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' F' F ' 82' ' ' GLY . . . . . . . . . . . . . . . 89.09 42.24 5.66 Favored Glycine 0 CA--C 1.524 0.648 0 C-N-CA 120.756 -0.735 . . . . 0.0 111.798 175.423 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' F' F ' 83' ' ' ILE . . . . . . . . . . . . . 75.7 mt -66.45 141.09 18.45 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.286 0 N-CA-C 109.815 -0.439 . . . . 0.0 109.815 177.122 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' F' F ' 84' ' ' LYS . . . . . . . . . . . . . 41.6 tttp -95.4 -53.42 3.77 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 115.93 -0.577 . . . . 0.0 110.361 -178.775 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' F' F ' 85' ' ' ASP . . . . . . . . . . . . . 12.9 t70 -153.21 151.98 30.69 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 115.714 -0.675 . . . . 0.0 110.419 -179.711 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' F' F ' 86' ' ' VAL . . . . . . . . . . . . . 44.6 t -127.22 130.68 71.01 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.266 0 CA-C-O 120.951 0.405 . . . . 0.0 110.406 -179.113 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' F' F ' 87' ' ' ILE . . . . . 0.498 HD12 ' N ' ' F' ' 87' ' ' ILE . 5.0 mp -122.03 129.02 75.74 Favored 'Isoleucine or valine' 0 C--O 1.233 0.206 0 CA-C-N 115.932 -0.576 . . . . 0.0 109.604 176.954 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' F' F ' 88' ' ' LEU . . . . . . . . . . . . . 18.5 tp -112.32 128.36 56.26 Favored 'General case' 0 C--N 1.332 -0.183 0 CA-C-O 121.03 0.443 . . . . 0.0 110.983 -179.0 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' F' F ' 89' ' ' ASP . . . . . . . . . . . . . 6.5 t0 -117.28 152.1 35.56 Favored 'General case' 0 C--N 1.329 -0.3 0 N-CA-C 109.093 -0.706 . . . . 0.0 109.093 175.63 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' F' F ' 90' ' ' GLU . . . . . . . . . . . . . 84.3 tt0 -48.86 -30.57 5.96 Favored 'General case' 0 C--N 1.329 -0.299 0 N-CA-C 112.83 0.678 . . . . 0.0 112.83 -172.534 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' F' F ' 91' ' ' ASN . . . . . . . . . . . . . 7.3 m120 -130.55 15.78 5.43 Favored 'General case' 0 N--CA 1.468 0.468 0 N-CA-C 113.308 0.855 . . . . 0.0 113.308 -177.051 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' F' F ' 92' ' ' LEU . . . . . . . . . . . . . 55.7 mt -149.96 149.59 30.62 Favored 'General case' 0 C--N 1.332 -0.195 0 CA-C-N 117.964 0.347 . . . . 0.0 110.764 -176.396 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' F' F ' 93' ' ' ILE . . . . . . . . . . . . . 68.2 mt -122.16 119.63 59.01 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.244 0 N-CA-C 108.985 -0.746 . . . . 0.0 108.985 176.631 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' F' F ' 94' ' ' VAL . . . . . 0.452 HG21 HG21 ' F' ' 125' ' ' VAL . 47.6 t -120.67 127.31 75.91 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.254 0 CA-C-O 121.008 0.432 . . . . 0.0 110.016 -178.785 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' F' F ' 95' ' ' VAL . . . . . . . . . . . . . 40.4 t -122.87 134.84 64.84 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.342 0 CA-C-N 115.809 -0.632 . . . . 0.0 109.876 -179.754 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' F' F ' 96' ' ' ILE . . . . . 0.528 HD11 ' HB ' ' F' ' 123' ' ' VAL . 59.1 mt -114.48 125.65 71.83 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.379 0 N-CA-C 108.947 -0.76 . . . . 0.0 108.947 178.266 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' F' F ' 97' ' ' THR . . . . . . . . . . . . . 73.9 p -98.91 155.23 17.51 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-O 121.221 0.534 . . . . 0.0 111.438 -175.585 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' F' F ' 98' ' ' GLU . . . . . . . . . . . . . 22.1 pt-20 -54.26 -21.76 10.01 Favored 'General case' 0 CA--C 1.534 0.353 0 N-CA-C 112.568 0.581 . . . . 0.0 112.568 179.339 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' F' F ' 99' ' ' GLU . . . . . . . . . . . . . 34.7 tt0 -83.74 18.11 2.07 Favored 'General case' 0 CA--C 1.539 0.542 0 N-CA-C 112.394 0.516 . . . . 0.0 112.394 -177.548 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' F' F ' 100' ' ' ASN . . . . . . . . . . . . . 3.6 m-20 62.04 37.98 14.37 Favored 'General case' 0 C--O 1.232 0.183 0 CA-C-O 121.161 0.505 . . . . 0.0 111.029 177.247 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' F' F ' 101' ' ' GLU . . . . . . . . . . . . . 84.2 tt0 -118.13 143.36 46.55 Favored 'General case' 0 C--N 1.331 -0.219 0 CA-C-N 116.147 -0.479 . . . . 0.0 109.998 176.836 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' F' F ' 102' ' ' VAL . . . . . . . . . . . . . 44.8 t -114.9 125.54 72.25 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.345 0 N-CA-C 109.822 -0.436 . . . . 0.0 109.822 -179.268 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' F' F ' 103' ' ' LEU . . . . . . . . . . . . . 21.2 mt -118.79 129.45 55.25 Favored 'General case' 0 C--N 1.331 -0.223 0 CA-C-N 115.791 -0.64 . . . . 0.0 110.28 178.116 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' F' F ' 104' ' ' ILE . . . . . . . . . . . . . 67.4 mt -118.63 121.56 67.3 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.251 0 N-CA-C 109.974 -0.38 . . . . 0.0 109.974 178.575 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' F' F ' 105' ' ' PHE . . . . . . . . . . . . . 52.7 m-85 -120.74 163.59 17.88 Favored 'General case' 0 C--N 1.332 -0.176 0 O-C-N 123.978 0.799 . . . . 0.0 109.623 179.647 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' F' F ' 106' ' ' ASN . . . . . . . . . . . . . 48.7 p-10 -97.67 -173.45 2.63 Favored 'General case' 0 C--N 1.328 -0.34 0 N-CA-C 109.618 -0.512 . . . . 0.0 109.618 171.887 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' F' F ' 107' ' ' GLN . . . . . . . . . . . . . 47.2 tt0 -58.57 -26.56 63.72 Favored 'General case' 0 C--N 1.329 -0.317 0 N-CA-C 112.349 0.5 . . . . 0.0 112.349 -178.543 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' F' F ' 108' ' ' ASN . . . . . . . . . . . . . 8.3 t-20 -89.63 14.07 12.55 Favored 'General case' 0 CA--C 1.535 0.379 0 N-CA-C 112.96 0.726 . . . . 0.0 112.96 -176.725 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' F' F ' 109' ' ' LEU . . . . . . . . . . . . . 48.9 mt 57.56 38.98 28.08 Favored 'General case' 0 C--N 1.332 -0.154 0 CA-C-O 121.163 0.506 . . . . 0.0 111.504 178.01 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' F' F ' 110' ' ' GLU . . . . . . . . . . . . . 95.9 mt-10 -104.05 161.03 14.34 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.076 -0.511 . . . . 0.0 109.958 176.466 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' F' F ' 111' ' ' GLU . . . . . . . . . . . . . 84.6 tt0 -89.64 122.33 32.67 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-O 120.905 0.383 . . . . 0.0 110.922 -177.869 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' F' F ' 112' ' ' LEU . . . . . . . . . . . . . 14.0 mt -112.1 -46.04 3.24 Favored 'General case' 0 C--N 1.332 -0.195 0 CA-C-N 116.071 -0.513 . . . . 0.0 110.419 178.029 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' F' F ' 113' ' ' TYR . . . . . . . . . . . . . 54.3 t80 -140.84 134.61 30.37 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.286 -0.416 . . . . 0.0 110.921 179.85 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' F' F ' 114' ' ' ARG . . . . . . . . . . . . . 43.4 ttp180 -141.71 122.49 14.37 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.489 -0.323 . . . . 0.0 110.479 177.782 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' F' F ' 115' ' ' GLY . . . . . . . . . . . . . . . -150.16 146.94 16.6 Favored Glycine 0 CA--C 1.526 0.72 0 N-CA-C 111.193 -0.763 . . . . 0.0 111.193 178.998 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' F' F ' 116' ' ' LYS . . . . . . . . . . . . . 33.2 ttpt -115.2 133.76 55.75 Favored 'General case' 0 C--N 1.33 -0.24 0 N-CA-C 109.776 -0.453 . . . . 0.0 109.776 176.228 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' F' F ' 117' ' ' PHE . . . . . . . . . . . . . 52.3 m-85 -131.77 114.59 14.92 Favored 'General case' 0 C--N 1.332 -0.184 0 CA-C-O 120.924 0.392 . . . . 0.0 110.279 -176.298 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' F' F ' 118' ' ' GLU . . . . . . . . . . . . . 84.4 tt0 -54.26 -45.39 72.4 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.443 -0.344 . . . . 0.0 111.539 -176.015 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' F' F ' 119' ' ' ASN . . . . . . . . . . . . . 9.2 m120 -97.54 30.94 2.7 Favored 'General case' 0 C--N 1.33 -0.281 0 N-CA-C 112.178 0.436 . . . . 0.0 112.178 -174.934 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' F' F ' 120' ' ' LEU . . . . . . . . . . . . . 23.9 tp -58.01 126.95 29.68 Favored 'General case' 0 C--N 1.333 -0.148 0 CA-C-O 120.76 0.314 . . . . 0.0 110.304 178.411 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' F' F ' 121' ' ' ASN . . . . . . . . . . . . . 20.8 t-20 -109.77 -44.0 3.92 Favored 'General case' 0 C--N 1.332 -0.181 0 CA-C-N 116.376 -0.374 . . . . 0.0 110.946 -177.987 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' F' F ' 122' ' ' LYS . . . . . . . . . . . . . 18.8 ptpt -161.29 159.72 28.91 Favored 'General case' 0 C--N 1.333 -0.136 0 CA-C-O 121.141 0.496 . . . . 0.0 111.82 -179.33 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' F' F ' 123' ' ' VAL . . . . . 0.528 ' HB ' HD11 ' F' ' 96' ' ' ILE . 45.8 t -127.27 135.59 63.02 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.199 0 CA-C-N 115.867 -0.606 . . . . 0.0 109.749 177.15 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' F' F ' 124' ' ' LEU . . . . . . . . . . . . . 6.5 mp -118.53 130.41 55.9 Favored 'General case' 0 C--N 1.331 -0.22 0 CA-C-N 116.37 -0.377 . . . . 0.0 110.636 -179.22 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' F' F ' 125' ' ' VAL . . . . . 0.568 HG22 HG23 ' F' ' 130' ' ' VAL . 44.6 t -131.69 127.71 59.4 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.236 0 CA-C-N 116.331 -0.395 . . . . 0.0 110.17 179.371 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' F' F ' 126' ' ' ARG . . . . . . . . . . . . . 78.7 mtt180 -149.98 133.63 16.72 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-O 120.95 0.405 . . . . 0.0 110.889 177.154 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' F' F ' 127' ' ' ASN . . . . . . . . . . . . . 9.4 m120 52.48 -118.28 1.29 Allowed 'General case' 0 CA--C 1.545 0.77 0 CA-C-O 118.657 -0.687 . . . . 0.0 110.798 178.826 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' F' F ' 128' ' ' ASP . . . . . . . . . . . . . 8.2 p-10 -113.26 13.55 19.17 Favored 'General case' 0 N--CA 1.469 0.477 0 CA-C-N 120.107 1.321 . . . . 0.0 112.838 -179.624 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' F' F ' 129' ' ' LEU . . . . . . . . . . . . . 13.5 tp -116.26 139.2 50.62 Favored 'General case' 0 C--O 1.233 0.187 0 N-CA-C 109.832 -0.433 . . . . 0.0 109.832 179.121 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' F' F ' 130' ' ' VAL . . . . . 0.568 HG23 HG22 ' F' ' 125' ' ' VAL . 13.0 p -134.06 141.22 44.44 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.196 0 CA-C-O 121.1 0.476 . . . . 0.0 110.554 -179.326 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' F' F ' 131' ' ' VAL . . . . . . . . . . . . . 35.3 m -136.06 147.45 28.16 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.362 0 CA-C-N 115.963 -0.562 . . . . 0.0 110.801 179.212 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' F' F ' 132' ' ' ILE . . . . . . . . . . . . . 71.0 mt -118.43 131.05 72.33 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.373 0 CA-C-N 115.736 -0.665 . . . . 0.0 109.285 -179.873 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' F' F ' 133' ' ' ILE . . . . . . . . . . . . . 43.4 mm -115.6 121.81 68.08 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.241 0 CA-C-O 120.753 0.311 . . . . 0.0 110.708 -175.979 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' F' F ' 134' ' ' ASP . . . . . . . . . . . . . 7.6 p-10 -133.88 149.15 51.32 Favored 'General case' 0 C--N 1.331 -0.212 0 N-CA-C 109.586 -0.524 . . . . 0.0 109.586 174.562 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' F' F ' 135' ' ' GLU . . . . . . . . . . . . . 84.9 tt0 -49.84 -24.33 2.38 Favored 'General case' 0 C--N 1.326 -0.423 0 N-CA-C 112.949 0.722 . . . . 0.0 112.949 -170.869 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' F' F ' 136' ' ' GLN . . . . . . . . . . . . . 48.5 tt0 -104.68 -25.57 12.65 Favored 'General case' 0 N--CA 1.465 0.297 0 N-CA-C 112.846 0.684 . . . . 0.0 112.846 -174.484 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' F' F ' 137' ' ' LYS . . . . . . . . . . . . . 88.5 mttt -141.62 151.72 43.36 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-O 121.169 0.509 . . . . 0.0 111.777 -171.23 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' F' F ' 138' ' ' LEU . . . . . . . . . . . . . 5.0 tt -120.04 120.27 35.81 Favored 'General case' 0 C--N 1.329 -0.29 0 N-CA-C 109.151 -0.685 . . . . 0.0 109.151 172.502 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' F' F ' 139' ' ' THR . . . . . . . . . . . . . 40.6 m -110.92 131.15 55.29 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.416 -0.356 . . . . 0.0 110.792 -176.956 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' F' F ' 140' ' ' LEU . . . . . 0.485 HD23 ' C ' ' F' ' 140' ' ' LEU . 8.0 tt -116.26 123.77 48.53 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 115.769 -0.651 . . . . 0.0 109.309 -179.671 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' F' F ' 141' ' ' ILE . . . . . 0.566 ' HB ' HG13 ' F' ' 130' ' ' VAL . 19.2 mt -122.54 121.1 62.77 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.295 0 CA-C-O 121.08 0.467 . . . . 0.0 110.072 -175.811 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' F' F ' 142' ' ' ARG . . . . . . . . . . . . . 65.8 ttt180 -109.98 129.23 55.7 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 115.318 -0.855 . . . . 0.0 110.364 -178.992 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' F' F ' 143' ' ' THR . . . . . . . . . . . . . 81.3 p . . . . . 0 C--O 1.219 -0.505 0 CA-C-O 117.915 -1.04 . . . . 0.0 110.484 178.927 . . . . . . . . 0 0 . 1 . 018 nuclear nobuild full ' A' A ' -3' ' ' GLU . . . . . . . . . . . . . 83.7 tt0 . . . . . 0 N--CA 1.489 1.508 0 N-CA-C 109.367 -0.605 . . . . 0.0 109.367 . . . . . . . . . 0 0 . 1 . 018 nuclear nobuild full ' A' A ' -2' ' ' GLY . . . . . . . . . . . . . . . -67.64 150.05 51.13 Favored Glycine 0 CA--C 1.526 0.759 0 N-CA-C 110.956 -0.858 . . . . 0.0 110.956 179.358 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' -1' ' ' VAL . . . . . . . . . . . . . 46.9 t -95.55 131.43 42.36 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.292 0 CA-C-O 120.891 0.377 . . . . 0.0 109.997 179.864 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 0' ' ' ILE . . . . . . . . . . . . . 70.0 mt -119.01 138.1 50.83 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.208 0 CA-C-N 116.156 -0.474 . . . . 0.0 110.184 -179.397 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 25.1 ptt? -143.48 145.37 32.53 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.02 -0.536 . . . . 0.0 110.443 178.867 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 2' ' ' SER . . . . . 0.415 ' HB2' HD11 ' A' ' 58' ' ' LEU . 79.0 p -123.8 150.6 44.28 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 116.265 -0.425 . . . . 0.0 110.625 -179.102 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 44.5 mp0 -138.2 141.26 40.01 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.098 -0.501 . . . . 0.0 110.882 -178.523 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 4' ' ' LEU . . . . . . . . . . . . . 15.1 tp -126.77 131.05 51.38 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 115.939 -0.573 . . . . 0.0 110.077 177.274 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 5' ' ' LYS . . . . . . . . . . . . . 68.9 mttm -114.04 121.52 44.12 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-O 120.901 0.381 . . . . 0.0 110.923 -179.164 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 6' ' ' LEU . . . . . 0.433 HD23 ' HA ' ' A' ' 50' ' ' VAL . 63.7 mt -115.45 141.05 48.57 Favored 'General case' 0 C--N 1.331 -0.227 0 CA-C-N 115.237 -0.892 . . . . 0.0 110.046 179.686 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 86.3 tttt -121.0 136.87 25.95 Favored Pre-proline 0 CA--C 1.533 0.308 0 CA-C-O 118.867 -0.587 . . . . 0.0 109.751 177.032 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 8' ' ' PRO . . . . . . . . . . . . . 93.0 Cg_endo -89.03 131.91 2.25 Favored 'Trans proline' 0 N--CA 1.491 1.327 0 C-N-CA 121.699 1.599 . . . . 0.0 111.921 179.088 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 57.1 mt -70.95 -47.91 14.57 Favored Pre-proline 0 CA--C 1.533 0.321 0 CA-C-O 118.575 -0.726 . . . . 0.0 112.211 -179.985 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 71.5 Cg_endo -77.77 153.13 29.5 Favored 'Trans proline' 0 N--CA 1.496 1.626 0 C-N-CA 121.14 1.227 . . . . 0.0 111.913 176.528 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 58.7 tttm -87.18 89.71 8.09 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-O 120.842 0.353 . . . . 0.0 110.266 179.634 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 12.1 p -139.34 148.01 23.93 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.245 0 CA-C-N 116.231 -0.441 . . . . 0.0 110.707 -178.072 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 95.6 mt-10 -90.89 128.53 36.79 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.141 -0.481 . . . . 0.0 110.026 177.248 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 14' ' ' LEU . . . . . . . . . . . . . 24.0 mt -98.0 152.55 38.11 Favored Pre-proline 0 CA--C 1.532 0.267 0 CA-C-O 119.512 -0.28 . . . . 0.0 110.801 -178.586 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 15' ' ' PRO . . . . . . . . . . . . . 25.5 Cg_exo -62.09 159.06 36.07 Favored 'Trans proline' 0 N--CA 1.497 1.727 0 C-N-CA 121.281 1.321 . . . . 0.0 112.165 177.513 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 16' ' ' PRO . . . . . . . . . . . . . 37.5 Cg_exo -58.35 -45.02 33.37 Favored 'Trans proline' 0 N--CA 1.498 1.792 0 C-N-CA 121.437 1.425 . . . . 0.0 112.866 -178.863 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 17' ' ' ASP . . . . . . . . . . . . . 19.8 p-10 -85.32 12.9 7.28 Favored 'General case' 0 C--N 1.326 -0.435 0 N-CA-C 113.14 0.793 . . . . 0.0 113.14 -177.016 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 18' ' ' PHE . . . . . . . . . . . . . 42.6 t80 -58.36 -46.79 85.61 Favored 'General case' 0 CA--C 1.523 -0.078 0 O-C-N 122.096 -0.378 . . . . 0.0 110.162 -177.963 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 19' ' ' VAL . . . . . . . . . . . . . 14.0 p -55.92 -40.23 61.43 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.347 0 CA-C-N 116.227 -0.442 . . . . 0.0 111.104 -178.345 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 78.3 m-20 -61.15 -45.18 95.69 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-O 120.783 0.325 . . . . 0.0 111.093 -177.977 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 60.7 t -64.66 -47.02 90.6 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 C-N-CA 120.781 -0.368 . . . . 0.0 110.591 -177.919 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 22' ' ' ILE . . . . . 0.53 HG22 HD12 ' A' ' 26' ' ' LEU . 50.5 mm -56.89 -43.35 80.18 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.189 0 C-N-CA 120.829 -0.348 . . . . 0.0 110.483 179.142 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 23' ' ' ARG . . . . . . . . . . . . . 43.2 ttp180 -54.71 -49.38 70.86 Favored 'General case' 0 C--N 1.33 -0.257 0 C-N-CA 121.143 -0.223 . . . . 0.0 111.309 -178.727 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 24' ' ' ILE . . . . . . . . . . . . . 73.2 mt -59.25 -39.84 79.78 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.244 0 C-N-CA 120.869 -0.332 . . . . 0.0 110.751 -178.699 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 8.3 mtpm? -66.05 -41.82 90.33 Favored 'General case' 0 C--N 1.327 -0.385 0 N-CA-C 112.276 0.473 . . . . 0.0 112.276 -179.253 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 26' ' ' LEU . . . . . 0.53 HD12 HG22 ' A' ' 22' ' ' ILE . 67.0 mt -80.75 -36.07 32.46 Favored 'General case' 0 C--N 1.331 -0.228 0 N-CA-C 113.881 1.067 . . . . 0.0 113.881 -171.134 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 27' ' ' GLN . . . . . . . . . . . . . 8.9 pt20 -46.85 141.49 3.97 Favored 'General case' 0 N--CA 1.47 0.527 0 N-CA-C 112.81 0.67 . . . . 0.0 112.81 -175.17 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 98.64 -24.21 33.07 Favored Glycine 0 CA--C 1.533 1.201 0 CA-C-N 115.673 -0.694 . . . . 0.0 112.354 -176.886 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 60.5 mttp -98.07 155.22 17.23 Favored 'General case' 0 C--O 1.232 0.16 0 CA-C-N 117.45 0.625 . . . . 0.0 110.901 179.167 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 30' ' ' THR . . . . . . . . . . . . . 30.9 m -104.51 136.71 43.56 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.161 -0.472 . . . . 0.0 109.88 176.25 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 33.9 m -129.27 152.51 37.35 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.194 0 CA-C-O 120.987 0.423 . . . . 0.0 110.975 -178.683 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 32' ' ' ARG . . . . . . . . . . . . . 94.2 mtt180 -129.34 152.3 49.05 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-O 121.32 0.581 . . . . 0.0 110.614 179.943 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 33' ' ' THR . . . . . . . . . . . . . 21.4 m -53.63 139.75 31.01 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-N 116.162 -0.472 . . . . 0.0 111.202 -179.297 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 98.62 -17.09 58.88 Favored Glycine 0 CA--C 1.534 1.263 0 C-N-CA 121.106 -0.569 . . . . 0.0 113.269 178.844 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 58.7 m-20 -64.14 149.7 47.18 Favored 'General case' 0 C--O 1.231 0.11 0 CA-C-N 117.997 0.898 . . . . 0.0 111.369 -179.609 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 45.6 t -119.46 126.55 75.44 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.288 0 CA-C-N 115.458 -0.792 . . . . 0.0 109.538 177.896 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 37' ' ' ILE . . . . . . . . . . . . . 69.4 mt -120.71 138.34 51.52 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.226 0 CA-C-N 116.397 -0.365 . . . . 0.0 110.05 -179.072 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . -118.67 128.77 7.84 Favored Glycine 0 CA--C 1.525 0.66 0 N-CA-C 110.98 -0.848 . . . . 0.0 110.98 179.467 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 39' ' ' ILE . . . . . . . . . . . . . 70.8 mt -123.21 134.58 65.8 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.184 0 N-CA-C 109.938 -0.393 . . . . 0.0 109.938 178.228 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 40' ' ' SER . . . . . . . . . . . . . 23.2 t -91.49 120.54 32.4 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 116.272 -0.422 . . . . 0.0 111.04 178.72 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 41' ' ' ILE . . . . . . . . . . . . . 71.4 mt -127.5 116.38 43.39 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.234 0 CA-C-N 116.41 -0.359 . . . . 0.0 110.16 177.392 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 42' ' ' LEU . . . . . 0.532 ' O ' HD23 ' A' ' 42' ' ' LEU . 1.3 tt 49.58 47.65 22.41 Favored 'General case' 0 CA--C 1.533 0.311 0 CA-C-O 121.468 0.652 . . . . 0.0 111.43 177.166 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . 71.24 21.73 78.51 Favored Glycine 0 CA--C 1.532 1.094 0 C-N-CA 121.102 -0.571 . . . . 0.0 112.862 174.632 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 44' ' ' LYS . . . . . . . . . . . . . 85.3 tttt -135.14 126.43 28.3 Favored 'General case' 0 C--N 1.331 -0.222 0 CA-C-N 117.636 0.718 . . . . 0.0 109.881 178.959 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 84.9 tt0 -84.72 125.82 32.86 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.485 -0.325 . . . . 0.0 111.176 -178.682 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 46' ' ' VAL . . . . . 0.425 HG13 ' O ' ' A' ' 46' ' ' VAL . 10.3 p -113.34 123.25 68.8 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.252 0 N-CA-C 109.144 -0.687 . . . . 0.0 109.144 174.072 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 88.6 mttt -98.98 122.94 42.9 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 115.92 -0.582 . . . . 0.0 110.857 179.726 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 48' ' ' PHE . . . . . . . . . . . . . 31.0 m-85 -108.76 131.87 54.53 Favored 'General case' 0 C--N 1.329 -0.3 0 N-CA-C 109.71 -0.478 . . . . 0.0 109.71 176.924 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 76.6 tttt -106.57 130.62 54.3 Favored 'General case' 0 C--N 1.328 -0.33 0 N-CA-C 109.964 -0.384 . . . . 0.0 109.964 178.239 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 50' ' ' VAL . . . . . 0.433 ' HA ' HD23 ' A' ' 6' ' ' LEU . 45.5 t -74.82 105.29 3.75 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.305 0 N-CA-C 109.366 -0.605 . . . . 0.0 109.366 178.433 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 51' ' ' VAL . . . . . . . . . . . . . 48.2 t -70.35 -54.01 20.42 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.303 0 N-CA-C 109.475 -0.565 . . . . 0.0 109.475 -175.916 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 52' ' ' GLN . . . . . . . . . . . . . 89.9 mt-30 -153.73 150.15 28.23 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 115.856 -0.611 . . . . 0.0 111.79 -178.129 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -127.21 131.57 50.61 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 115.041 -0.981 . . . . 0.0 109.524 173.5 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 54' ' ' TYR . . . . . . . . . . . . . 14.5 t80 -129.06 110.24 18.25 Favored Pre-proline 0 C--N 1.329 -0.304 0 CA-C-O 118.198 -0.906 . . . . 0.0 110.234 177.453 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 55' ' ' PRO . . . . . . . . . . . . . 75.4 Cg_endo -77.31 170.22 71.94 Favored 'Cis proline' 0 N--CA 1.5 1.861 0 CA-C-N 121.958 1.735 . . . . 0.0 112.492 -5.927 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 56' ' ' SER . . . . . . . . . . . . . 14.1 m -123.91 138.9 31.34 Favored Pre-proline 0 CA--C 1.537 0.462 0 CA-C-O 118.499 -0.762 . . . . 0.0 109.401 173.532 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 57' ' ' PRO . . . . . . . . . . . . . 39.3 Cg_endo -67.67 144.28 71.07 Favored 'Cis proline' 0 N--CA 1.499 1.797 0 CA-C-N 121.695 1.641 . . . . 0.0 111.61 -2.627 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 58' ' ' LEU . . . . . 0.415 HD11 ' HB2' ' A' ' 2' ' ' SER . 15.7 tp -107.16 136.92 46.17 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-O 120.934 0.397 . . . . 0.0 110.629 -176.841 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 59' ' ' ARG . . . . . . . . . . . . . 56.5 ttp180 -103.73 124.9 49.73 Favored 'General case' 0 C--N 1.327 -0.378 0 N-CA-C 109.272 -0.64 . . . . 0.0 109.272 176.229 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 43.9 t -77.87 116.42 21.39 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 C-N-CA 120.73 -0.388 . . . . 0.0 110.745 -173.306 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 95.2 mt-10 -131.02 161.1 32.72 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 115.699 -0.682 . . . . 0.0 109.531 175.028 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 62' ' ' ASP . . . . . . . . . . . . . 70.0 m-20 -52.36 -31.67 34.77 Favored 'General case' 0 C--N 1.328 -0.349 0 N-CA-C 112.179 0.437 . . . . 0.0 112.179 -178.001 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 63' ' ' ARG . . . . . . . . . . . . . 87.5 mtt180 -70.92 -22.07 62.29 Favored 'General case' 0 CA--C 1.533 0.301 0 N-CA-C 113.038 0.755 . . . . 0.0 113.038 -174.942 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 27.8 m -68.43 137.16 54.28 Favored 'General case' 0 C--N 1.332 -0.188 0 CA-C-O 120.925 0.393 . . . . 0.0 111.061 -175.482 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 65' ' ' LYS . . . . . . . . . . . . . 90.5 mttt -88.92 127.62 35.66 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 115.984 -0.553 . . . . 0.0 109.772 177.832 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 66' ' ' ILE . . . . . . . . . . . . . 65.4 mt -118.06 130.24 73.22 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.278 0 CA-C-O 120.773 0.32 . . . . 0.0 110.236 -177.502 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 67' ' ' THR . . . . . . . . . . . . . 31.4 m -125.55 139.82 53.27 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-O 121.064 0.459 . . . . 0.0 110.967 -178.844 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 68' ' ' LEU . . . . . 0.499 ' N ' HD12 ' A' ' 68' ' ' LEU . 7.1 mp -105.82 133.57 50.35 Favored 'General case' 0 C--N 1.331 -0.211 0 CA-C-N 115.941 -0.572 . . . . 0.0 110.442 177.264 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 69' ' ' VAL . . . . . . . . . . . . . 43.1 t -97.81 140.22 18.38 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.37 0 CA-C-N 115.947 -0.57 . . . . 0.0 110.318 -179.29 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 70' ' ' THR . . . . . . . . . . . . . 18.1 p -130.51 -51.19 1.08 Allowed 'General case' 0 C--N 1.331 -0.228 0 CA-C-N 116.269 -0.423 . . . . 0.0 110.597 -179.256 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 71' ' ' HIS . . . . . . . . . . . . . 75.3 m80 -77.76 139.31 62.31 Favored Pre-proline 0 CA--C 1.533 0.323 0 CA-C-O 118.667 -0.683 . . . . 0.0 109.964 179.912 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 72' ' ' PRO . . . . . . . . . . . . . 11.4 Cg_exo -65.85 -30.11 49.55 Favored 'Trans proline' 0 N--CA 1.498 1.762 0 C-N-CA 120.998 1.132 . . . . 0.0 112.313 177.841 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 73' ' ' VAL . . . . . . . . . . . . . 35.4 m -147.93 169.91 3.45 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.243 0 CA-C-N 116.511 -0.313 . . . . 0.0 110.659 -179.292 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 74' ' ' ASP . . . . . . . . . . . . . 31.6 t0 -100.2 118.87 37.41 Favored 'General case' 0 C--N 1.33 -0.264 0 N-CA-C 109.717 -0.475 . . . . 0.0 109.717 177.908 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 40.9 t -114.74 123.87 70.84 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.249 0 CA-C-O 121.083 0.468 . . . . 0.0 110.776 -177.253 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 76' ' ' LEU . . . . . . . . . . . . . 5.5 mp -120.96 144.35 48.53 Favored 'General case' 0 C--N 1.331 -0.226 0 CA-C-N 115.667 -0.697 . . . . 0.0 109.59 175.185 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 77' ' ' GLU . . . . . . . . . . . . . 97.8 mt-10 -133.96 138.01 45.19 Favored 'General case' 0 C--N 1.331 -0.213 0 CA-C-O 121.112 0.482 . . . . 0.0 111.445 -178.95 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 78' ' ' ALA . . . . . . . . . . . . . . . -127.12 142.05 51.61 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 115.579 -0.737 . . . . 0.0 109.745 177.314 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 79' ' ' LYS . . . . . 0.645 ' O ' HD13 ' A' ' 80' ' ' ILE . 47.3 pttt -85.79 120.78 27.58 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-O 121.23 0.538 . . . . 0.0 110.967 -178.218 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 80' ' ' ILE . . . . . 0.645 HD13 ' O ' ' A' ' 79' ' ' LYS . 37.0 mm -139.2 114.9 8.9 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.312 0 CA-C-N 115.768 -0.651 . . . . 0.0 109.411 -179.159 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 81' ' ' LYS . . . . . . . . . . . . . 97.7 mttt -107.4 126.96 53.14 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-O 120.804 0.335 . . . . 0.0 111.011 -179.178 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . 89.05 42.17 5.69 Favored Glycine 0 CA--C 1.525 0.683 0 C-N-CA 120.845 -0.693 . . . . 0.0 111.65 175.526 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 83' ' ' ILE . . . . . . . . . . . . . 69.7 mt -69.91 138.2 22.56 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.309 0 CA-C-O 120.901 0.381 . . . . 0.0 110.042 178.514 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 84' ' ' LYS . . . . . . . . . . . . . 63.4 tttm -94.5 -54.05 3.67 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-N 115.945 -0.57 . . . . 0.0 110.07 -179.104 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 85' ' ' ASP . . . . . . . . . . . . . 7.2 t70 -158.01 154.95 28.52 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 115.652 -0.704 . . . . 0.0 110.412 -179.969 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 86' ' ' VAL . . . . . . . . . . . . . 40.0 t -131.94 132.32 61.5 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.259 0 CA-C-O 120.914 0.388 . . . . 0.0 110.576 179.473 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 87' ' ' ILE . . . . . 0.493 HD12 ' N ' ' A' ' 87' ' ' ILE . 5.1 mp -118.9 128.37 75.73 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.281 0 CA-C-N 115.816 -0.629 . . . . 0.0 109.414 176.044 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 88' ' ' LEU . . . . . . . . . . . . . 16.9 tp -110.95 134.6 52.45 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-O 121.138 0.494 . . . . 0.0 111.414 -176.234 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 89' ' ' ASP . . . . . . . . . . . . . 12.9 t70 -127.14 149.75 49.81 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 115.602 -0.727 . . . . 0.0 109.36 175.129 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 83.6 tt0 -48.89 -32.57 9.15 Favored 'General case' 0 C--N 1.33 -0.264 0 N-CA-C 112.606 0.595 . . . . 0.0 112.606 -173.357 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 91' ' ' ASN . . . . . . . . . . . . . 79.2 m-20 -131.18 29.67 4.62 Favored 'General case' 0 N--CA 1.465 0.316 0 N-CA-C 112.216 0.45 . . . . 0.0 112.216 -176.368 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 92' ' ' LEU . . . . . . . . . . . . . 8.1 tp -166.21 148.83 7.07 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-O 120.784 0.326 . . . . 0.0 110.602 179.299 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 93' ' ' ILE . . . . . . . . . . . . . 69.9 mt -126.74 122.99 61.92 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.277 0 N-CA-C 109.487 -0.56 . . . . 0.0 109.487 178.931 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 94' ' ' VAL . . . . . . . . . . . . . 42.8 t -121.27 127.6 75.81 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.265 0 N-CA-C 110.084 -0.339 . . . . 0.0 110.084 -179.442 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 95' ' ' VAL . . . . . . . . . . . . . 43.4 t -125.66 136.0 62.19 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.239 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.228 -179.294 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 96' ' ' ILE . . . . . . . . . . . . . 51.6 mt -115.86 129.42 72.25 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 N-CA-C 109.112 -0.699 . . . . 0.0 109.112 178.495 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 97' ' ' THR . . . . . . . . . . . . . 81.7 p -101.21 159.06 15.57 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-O 121.105 0.479 . . . . 0.0 111.16 -178.024 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 98' ' ' GLU . . . . . . . . . . . . . 84.8 tt0 -53.85 -28.37 35.47 Favored 'General case' 0 CA--C 1.533 0.312 0 CA-C-N 116.208 -0.451 . . . . 0.0 112.152 -178.797 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 99' ' ' GLU . . . . . . . . . . . . . 96.0 mt-10 -79.04 14.61 1.35 Allowed 'General case' 0 CA--C 1.535 0.375 0 N-CA-C 113.22 0.822 . . . . 0.0 113.22 -176.316 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 100' ' ' ASN . . . . . . . . . . . . . 3.3 m-20 61.54 33.23 18.51 Favored 'General case' 0 N--CA 1.464 0.24 0 CA-C-N 118.067 0.394 . . . . 0.0 111.639 -179.833 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 101' ' ' GLU . . . . . . . . . . . . . 84.9 tt0 -107.61 144.2 34.99 Favored 'General case' 0 C--O 1.232 0.143 0 N-CA-C 109.607 -0.516 . . . . 0.0 109.607 173.08 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 102' ' ' VAL . . . . . . . . . . . . . 42.7 t -114.93 126.07 72.41 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.304 0 CA-C-N 116.294 -0.412 . . . . 0.0 110.009 -177.627 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 103' ' ' LEU . . . . . . . . . . . . . 21.2 mt -115.72 129.7 56.57 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 115.79 -0.641 . . . . 0.0 109.889 177.324 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 104' ' ' ILE . . . . . 0.612 HD13 HG11 ' A' ' 130' ' ' VAL . 68.3 mt -118.49 121.51 67.24 Favored 'Isoleucine or valine' 0 C--O 1.235 0.297 0 N-CA-C 110.13 -0.322 . . . . 0.0 110.13 179.274 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 105' ' ' PHE . . . . . . . . . . . . . 78.3 m-85 -118.92 164.47 15.4 Favored 'General case' 0 C--N 1.333 -0.126 0 O-C-N 124.129 0.893 . . . . 0.0 109.757 -179.499 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 106' ' ' ASN . . . . . . . . . . . . . 42.3 p-10 -101.66 -170.83 1.88 Allowed 'General case' 0 C--N 1.331 -0.221 0 N-CA-C 110.039 -0.356 . . . . 0.0 110.039 173.54 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 107' ' ' GLN . . . . . . . . . . . . . 59.4 tt0 -57.67 -28.69 64.0 Favored 'General case' 0 CA--C 1.534 0.341 0 N-CA-C 111.894 0.331 . . . . 0.0 111.894 177.243 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 108' ' ' ASN . . . . . . . . . . . . . 50.1 t30 -82.94 3.28 30.61 Favored 'General case' 0 CA--C 1.536 0.415 0 N-CA-C 113.353 0.872 . . . . 0.0 113.353 -176.447 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 109' ' ' LEU . . . . . . . . . . . . . 11.5 tp 62.66 39.6 11.09 Favored 'General case' 0 CA--C 1.529 0.172 0 CA-C-O 121.115 0.483 . . . . 0.0 111.051 178.378 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 110' ' ' GLU . . . . . . . . . . . . . 95.5 mt-10 -114.28 150.32 34.61 Favored 'General case' 0 C--N 1.331 -0.198 0 CA-C-N 116.366 -0.379 . . . . 0.0 110.278 176.31 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 111' ' ' GLU . . . . . . . . . . . . . 45.6 mt-10 -76.07 123.62 26.08 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 116.359 -0.382 . . . . 0.0 110.894 -179.739 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 112' ' ' LEU . . . . . . . . . . . . . 16.3 mt -110.04 -46.05 3.52 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.142 -0.481 . . . . 0.0 110.178 176.665 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 113' ' ' TYR . . . . . . . . . . . . . 41.0 t80 -134.79 136.73 42.77 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.235 -0.439 . . . . 0.0 110.659 -179.682 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 114' ' ' ARG . . . . . . . . . . . . . 65.8 ttp85 -141.37 123.25 15.36 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.406 -0.361 . . . . 0.0 110.569 178.014 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 115' ' ' GLY . . . . . . . . . . . . . . . -150.14 163.04 29.39 Favored Glycine 0 CA--C 1.523 0.556 0 N-CA-C 111.054 -0.819 . . . . 0.0 111.054 -179.192 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 116' ' ' LYS . . . . . . . . . . . . . 57.1 tttm -131.56 136.63 47.98 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-O 120.781 0.324 . . . . 0.0 110.188 178.656 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 117' ' ' PHE . . . . . . . . . . . . . 36.2 m-85 -136.34 115.58 12.55 Favored 'General case' 0 C--N 1.331 -0.209 0 CA-C-N 116.245 -0.434 . . . . 0.0 110.283 -176.062 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 118' ' ' GLU . . . . . . . . . . . . . 45.4 mp0 -56.48 -44.46 80.64 Favored 'General case' 0 C--N 1.327 -0.381 0 C-N-CA 120.781 -0.368 . . . . 0.0 111.098 -175.194 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 119' ' ' ASN . . . . . . . . . . . . . 11.4 m120 -98.01 30.97 2.85 Favored 'General case' 0 C--N 1.33 -0.259 0 N-CA-C 112.194 0.442 . . . . 0.0 112.194 -174.011 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 120' ' ' LEU . . . . . . . . . . . . . 21.9 tp -57.64 123.29 15.11 Favored 'General case' 0 C--N 1.332 -0.163 0 C-N-CA 120.854 -0.338 . . . . 0.0 110.379 177.941 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 121' ' ' ASN . . . . . . . . . . . . . 34.6 m120 -114.09 -44.08 3.18 Favored 'General case' 0 C--O 1.233 0.191 0 CA-C-N 116.548 -0.296 . . . . 0.0 111.002 -177.561 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 122' ' ' LYS . . . . . . . . . . . . . 98.3 mttt -144.49 149.16 35.49 Favored 'General case' 0 C--N 1.331 -0.198 0 CA-C-O 121.152 0.501 . . . . 0.0 111.621 -176.365 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 123' ' ' VAL . . . . . . . . . . . . . 47.3 t -129.67 128.55 65.77 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.276 0 CA-C-N 115.733 -0.667 . . . . 0.0 109.538 175.952 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 124' ' ' LEU . . . . . . . . . . . . . 75.0 mt -119.72 134.83 55.08 Favored 'General case' 0 C--N 1.331 -0.219 0 CA-C-N 116.48 -0.327 . . . . 0.0 110.443 -178.213 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 125' ' ' VAL . . . . . . . . . . . . . 12.4 p -140.13 130.93 30.6 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.223 0 CA-C-O 120.878 0.37 . . . . 0.0 110.97 -179.76 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 126' ' ' ARG . . . . . . . . . . . . . 72.8 mtt180 -152.55 134.1 14.53 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 115.822 -0.626 . . . . 0.0 109.674 175.848 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 127' ' ' ASN . . . . . . . . . . . . . 31.5 m120 55.74 -147.77 0.51 Allowed 'General case' 0 CA--C 1.542 0.647 0 N-CA-C 109.729 -0.471 . . . . 0.0 109.729 -178.855 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 128' ' ' ASP . . . . . . . . . . . . . 9.3 p-10 -87.23 14.62 7.45 Favored 'General case' 0 CA--C 1.536 0.409 0 CA-C-N 118.809 0.732 . . . . 0.0 112.934 178.641 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 129' ' ' LEU . . . . . . . . . . . . . 80.5 mt -110.89 138.21 47.57 Favored 'General case' 0 C--O 1.233 0.216 0 O-C-N 121.974 -0.454 . . . . 0.0 110.273 179.575 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 130' ' ' VAL . . . . . 0.612 HG11 HD13 ' A' ' 104' ' ' ILE . 14.4 p -134.03 142.14 41.97 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.176 0 CA-C-O 121.177 0.513 . . . . 0.0 110.847 -178.937 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 131' ' ' VAL . . . . . 0.558 HG22 HD12 ' A' ' 140' ' ' LEU . 44.5 t -135.76 138.51 47.7 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.228 0 CA-C-N 115.876 -0.602 . . . . 0.0 110.243 -178.923 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 132' ' ' ILE . . . . . . . . . . . . . 72.6 mt -115.87 132.39 65.48 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.298 0 CA-C-N 115.948 -0.569 . . . . 0.0 109.488 -179.856 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 133' ' ' ILE . . . . . . . . . . . . . 39.0 mm -116.9 117.37 55.18 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.21 0 CA-C-N 116.5 -0.318 . . . . 0.0 110.624 -176.333 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 134' ' ' ASP . . . . . . . . . . . . . 7.2 p-10 -128.63 151.43 49.5 Favored 'General case' 0 C--N 1.331 -0.204 0 N-CA-C 109.629 -0.508 . . . . 0.0 109.629 175.252 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 135' ' ' GLU . . . . . . . . . . . . . 45.8 tp10 -49.92 -28.16 6.31 Favored 'General case' 0 C--N 1.327 -0.398 0 N-CA-C 112.748 0.647 . . . . 0.0 112.748 -171.056 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 136' ' ' GLN . . . . . . . . . . . . . 76.9 mt-30 -103.45 -22.95 13.58 Favored 'General case' 0 N--CA 1.464 0.254 0 N-CA-C 113.144 0.794 . . . . 0.0 113.144 -173.874 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 137' ' ' LYS . . . . . . . . . . . . . 94.9 mttt -141.93 147.19 36.65 Favored 'General case' 0 C--N 1.331 -0.224 0 CA-C-O 121.376 0.608 . . . . 0.0 112.007 -168.695 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 138' ' ' LEU . . . . . . . . . . . . . 10.5 tp -111.66 118.3 35.29 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 115.193 -0.912 . . . . 0.0 108.863 172.326 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 139' ' ' THR . . . . . . . . . . . . . 24.9 m -111.98 125.61 54.25 Favored 'General case' 0 N--CA 1.463 0.21 0 CA-C-O 120.695 0.283 . . . . 0.0 110.882 -176.819 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 140' ' ' LEU . . . . . 0.558 HD12 HG22 ' A' ' 131' ' ' VAL . 11.6 tp -114.03 122.96 48.51 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 115.664 -0.698 . . . . 0.0 109.23 179.534 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 141' ' ' ILE . . . . . 0.515 ' HB ' HG13 ' A' ' 130' ' ' VAL . 20.3 mt -123.15 122.66 66.01 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.243 0 CA-C-O 120.997 0.427 . . . . 0.0 110.3 -175.778 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 142' ' ' ARG . . . . . . . . . . . . . 84.2 mtp180 -106.91 123.22 47.86 Favored 'General case' 0 C--N 1.331 -0.22 0 CA-C-N 115.264 -0.88 . . . . 0.0 110.068 179.252 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 143' ' ' THR . . . . . . . . . . . . . 26.6 p . . . . . 0 C--O 1.221 -0.428 0 CA-C-O 117.939 -1.029 . . . . 0.0 110.58 179.742 . . . . . . . . 0 0 . 1 . 018 nuclear nobuild full ' B' B ' -3' ' ' GLU . . . . . . . . . . . . . 95.6 mt-10 . . . . . 0 N--CA 1.49 1.543 0 N-CA-C 109.423 -0.584 . . . . 0.0 109.423 . . . . . . . . . 0 0 . 1 . 018 nuclear nobuild full ' B' B ' -2' ' ' GLY . . . . . . . . . . . . . . . -73.27 140.25 28.14 Favored Glycine 0 CA--C 1.526 0.768 0 N-CA-C 111.095 -0.802 . . . . 0.0 111.095 -179.778 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' B' B ' -1' ' ' VAL . . . . . . . . . . . . . 43.2 t -141.83 137.34 31.16 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.349 0 N-CA-C 109.998 -0.371 . . . . 0.0 109.998 179.36 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' B' B ' 0' ' ' ILE . . . . . . . . . . . . . 70.8 mt -114.04 133.83 58.83 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.246 0 CA-C-O 120.896 0.379 . . . . 0.0 110.069 -179.557 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' B' B ' 1' ' ' MET . . . . . . . . . . . . . 25.8 ptt? -143.76 177.95 8.16 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.002 -0.545 . . . . 0.0 110.557 -179.322 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' B' B ' 2' ' ' SER . . . . . . . . . . . . . 2.8 p -124.88 127.59 47.36 Favored 'General case' 0 C--N 1.332 -0.178 0 CA-C-O 120.901 0.382 . . . . 0.0 110.606 -179.042 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' B' B ' 3' ' ' GLU . . . . . . . . . . . . . 84.6 tt0 -142.64 142.55 32.1 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 115.981 -0.554 . . . . 0.0 111.193 -178.297 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' B' B ' 4' ' ' LEU . . . . . . . . . . . . . 13.4 tp -123.05 131.01 53.52 Favored 'General case' 0 C--N 1.331 -0.209 0 CA-C-N 115.757 -0.656 . . . . 0.0 110.143 177.109 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' B' B ' 5' ' ' LYS . . . . . . . . . . . . . 94.6 mttt -107.72 121.8 45.44 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.232 -0.44 . . . . 0.0 110.433 178.727 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' B' B ' 6' ' ' LEU . . . . . . . . . . . . . 44.4 mt -115.88 148.18 40.25 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 115.554 -0.748 . . . . 0.0 110.195 -179.283 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' B' B ' 7' ' ' LYS . . . . . . . . . . . . . 83.4 tttt -135.35 140.31 34.02 Favored Pre-proline 0 CA--C 1.535 0.388 0 CA-C-O 119.092 -0.48 . . . . 0.0 110.118 176.335 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' B' B ' 8' ' ' PRO . . . . . . . . . . . . . 88.8 Cg_endo -92.04 143.71 2.74 Favored 'Trans proline' 0 N--CA 1.491 1.345 0 C-N-CA 121.718 1.612 . . . . 0.0 111.653 177.689 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' B' B ' 9' ' ' LEU . . . . . . . . . . . . . 75.3 mt -81.8 -47.67 1.0 Allowed Pre-proline 0 CA--C 1.535 0.384 0 CA-C-O 118.611 -0.709 . . . . 0.0 112.303 -179.321 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' B' B ' 10' ' ' PRO . . . . . . . . . . . . . 95.1 Cg_endo -79.61 154.48 23.84 Favored 'Trans proline' 0 N--CA 1.496 1.662 0 C-N-CA 121.125 1.217 . . . . 0.0 111.869 176.412 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' B' B ' 11' ' ' LYS . . . . . . . . . . . . . 62.2 tttm -88.46 102.79 15.25 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-N 116.378 -0.374 . . . . 0.0 110.439 179.058 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' B' B ' 12' ' ' VAL . . . . . . . . . . . . . 12.8 p -149.67 144.29 17.82 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.319 0 CA-C-N 116.294 -0.412 . . . . 0.0 110.875 179.945 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' B' B ' 13' ' ' GLU . . . . . . . . . . . . . 95.8 mt-10 -79.62 131.99 36.14 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.14 -0.482 . . . . 0.0 110.062 177.468 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' B' B ' 14' ' ' LEU . . . . . . . . . . . . . 26.6 mt -98.67 147.97 33.91 Favored Pre-proline 0 CA--C 1.534 0.337 0 CA-C-O 119.252 -0.404 . . . . 0.0 110.623 -177.955 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' B' B ' 15' ' ' PRO . . . . . . . . . . . . . 24.7 Cg_exo -62.88 158.26 43.88 Favored 'Trans proline' 0 N--CA 1.498 1.772 0 C-N-CA 121.328 1.352 . . . . 0.0 111.779 176.828 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' B' B ' 16' ' ' PRO . . . . . . . . . . . . . 33.6 Cg_exo -59.2 -39.31 79.87 Favored 'Trans proline' 0 N--CA 1.498 1.748 0 C-N-CA 121.508 1.472 . . . . 0.0 112.714 -177.581 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' B' B ' 17' ' ' ASP . . . . . . . . . . . . . 24.1 p-10 -89.12 11.9 17.25 Favored 'General case' 0 C--N 1.328 -0.358 0 N-CA-C 113.154 0.798 . . . . 0.0 113.154 -177.411 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' B' B ' 18' ' ' PHE . . . . . . . . . . . . . 44.2 t80 -58.09 -45.82 86.53 Favored 'General case' 0 C--N 1.335 -0.056 0 O-C-N 121.993 -0.442 . . . . 0.0 110.081 -178.458 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' B' B ' 19' ' ' VAL . . . . . . . . . . . . . 13.7 p -56.57 -40.52 69.23 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.297 0 CA-C-N 116.15 -0.477 . . . . 0.0 110.878 -179.219 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' B' B ' 20' ' ' ASP . . . . . . . . . . . . . 9.8 t70 -60.53 -44.78 95.71 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-O 120.768 0.318 . . . . 0.0 111.032 -177.766 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' B' B ' 21' ' ' VAL . . . . . . . . . . . . . 46.9 t -64.3 -47.83 88.04 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.282 0 C-N-CA 120.676 -0.41 . . . . 0.0 110.377 -177.891 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' B' B ' 22' ' ' ILE . . . . . 0.468 HG22 HD12 ' B' ' 26' ' ' LEU . 51.1 mm -55.92 -46.16 80.23 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.261 0 CA-C-O 120.672 0.273 . . . . 0.0 110.589 179.813 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' B' B ' 23' ' ' ARG . . . . . . . . . . . . . 60.4 ttp180 -54.38 -50.88 66.48 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.779 -0.191 . . . . 0.0 111.39 -178.281 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' B' B ' 24' ' ' ILE . . . . . . . . . . . . . 75.6 mt -59.8 -42.47 89.05 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.298 0 C-N-CA 121.036 -0.266 . . . . 0.0 110.939 -177.686 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' B' B ' 25' ' ' LYS . . . . . . . . . . . . . 60.3 mtpt -64.6 -39.38 93.62 Favored 'General case' 0 C--N 1.328 -0.333 0 N-CA-C 112.232 0.456 . . . . 0.0 112.232 -177.898 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' B' B ' 26' ' ' LEU . . . . . 0.468 HD12 HG22 ' B' ' 22' ' ' ILE . 55.7 mt -79.0 -43.5 24.23 Favored 'General case' 0 C--N 1.33 -0.268 0 N-CA-C 113.089 0.774 . . . . 0.0 113.089 -172.454 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' B' B ' 27' ' ' GLN . . . . . . . . . . . . . 10.3 pt20 -46.55 139.31 5.17 Favored 'General case' 0 N--CA 1.469 0.475 0 N-CA-C 112.841 0.682 . . . . 0.0 112.841 -174.084 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' B' B ' 28' ' ' GLY . . . . . . . . . . . . . . . 100.23 -28.06 17.47 Favored Glycine 0 CA--C 1.533 1.192 0 CA-C-N 115.43 -0.805 . . . . 0.0 112.083 -176.215 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' B' B ' 29' ' ' LYS . . . . . . . . . . . . . 55.5 mtmt -98.88 155.16 17.53 Favored 'General case' 0 C--O 1.233 0.226 0 CA-C-N 117.085 0.442 . . . . 0.0 111.248 178.494 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' B' B ' 30' ' ' THR . . . . . . . . . . . . . 35.2 m -104.35 140.39 37.96 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.13 -0.486 . . . . 0.0 110.115 176.305 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' B' B ' 31' ' ' VAL . . . . . . . . . . . . . 35.2 m -129.08 156.61 41.78 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.274 0 CA-C-N 116.321 -0.399 . . . . 0.0 110.627 -179.575 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' B' B ' 32' ' ' ARG . . . . . . . . . . . . . 62.7 ttt180 -133.37 148.64 51.85 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.066 -0.516 . . . . 0.0 110.143 179.076 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' B' B ' 33' ' ' THR . . . . . . . . . . . . . 18.0 m -53.05 139.11 29.14 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.43 -0.35 . . . . 0.0 111.414 -177.248 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' B' B ' 34' ' ' GLY . . . . . . . . . . . . . . . 100.94 -17.19 56.64 Favored Glycine 0 CA--C 1.532 1.142 0 CA-C-O 119.571 -0.572 . . . . 0.0 113.281 179.085 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' B' B ' 35' ' ' ASP . . . . . . . . . . . . . 79.4 m-20 -66.28 149.3 50.56 Favored 'General case' 0 C--N 1.334 -0.09 0 CA-C-N 118.119 0.959 . . . . 0.0 111.077 179.04 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' B' B ' 36' ' ' VAL . . . . . . . . . . . . . 44.3 t -121.71 129.88 75.1 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.204 0 CA-C-N 115.92 -0.582 . . . . 0.0 109.826 178.523 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' B' B ' 37' ' ' ILE . . . . . . . . . . . . . 65.8 mt -120.8 138.69 50.43 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.254 0 N-CA-C 109.982 -0.377 . . . . 0.0 109.982 -179.534 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' B' B ' 38' ' ' GLY . . . . . . . . . . . . . . . -111.61 128.87 8.84 Favored Glycine 0 CA--C 1.526 0.723 0 N-CA-C 111.07 -0.812 . . . . 0.0 111.07 -179.94 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' B' B ' 39' ' ' ILE . . . . . . . . . . . . . 72.3 mt -123.11 138.52 52.82 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.188 0 N-CA-C 110.165 -0.309 . . . . 0.0 110.165 179.161 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' B' B ' 40' ' ' SER . . . . . 0.465 ' O ' HD13 ' B' ' 41' ' ' ILE . 32.9 t -93.22 117.13 29.71 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.481 -0.327 . . . . 0.0 110.981 175.636 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' B' B ' 41' ' ' ILE . . . . . 0.465 HD13 ' O ' ' B' ' 40' ' ' SER . 47.7 mm -125.68 122.96 63.49 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.262 0 CA-C-O 120.844 0.354 . . . . 0.0 110.586 178.694 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' B' B ' 42' ' ' LEU . . . . . . . . . . . . . 65.3 mt 52.61 33.63 14.06 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.185 -0.462 . . . . 0.0 111.881 177.368 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' B' B ' 43' ' ' GLY . . . . . . . . . . . . . . . 73.19 31.19 61.79 Favored Glycine 0 CA--C 1.529 0.963 0 C-N-CA 121.09 -0.576 . . . . 0.0 112.194 177.951 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' B' B ' 44' ' ' LYS . . . . . . . . . . . . . 40.3 ttpt -138.57 133.72 32.91 Favored 'General case' 0 C--N 1.329 -0.303 0 N-CA-C 109.663 -0.495 . . . . 0.0 109.663 178.098 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' B' B ' 45' ' ' GLU . . . . . . . . . . . . . 78.0 tt0 -83.2 118.55 23.68 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-O 120.918 0.39 . . . . 0.0 110.814 -177.598 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' B' B ' 46' ' ' VAL . . . . . . . . . . . . . 7.4 p -117.18 128.08 74.6 Favored 'Isoleucine or valine' 0 N--CA 1.462 0.159 0 N-CA-C 109.611 -0.514 . . . . 0.0 109.611 177.917 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' B' B ' 47' ' ' LYS . . . . . . . . . . . . . 32.3 mmtp -98.93 129.5 45.26 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 115.96 -0.564 . . . . 0.0 111.357 178.721 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' B' B ' 48' ' ' PHE . . . . . . . . . . . . . 90.5 m-85 -114.08 131.83 56.25 Favored 'General case' 0 C--N 1.329 -0.296 0 N-CA-C 109.378 -0.601 . . . . 0.0 109.378 173.966 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' B' B ' 49' ' ' LYS . . . . . . . . . . . . . 59.5 tttm -108.28 138.54 44.39 Favored 'General case' 0 C--N 1.329 -0.308 0 N-CA-C 110.315 -0.254 . . . . 0.0 110.315 179.359 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' B' B ' 50' ' ' VAL . . . . . . . . . . . . . 44.8 t -78.99 107.88 11.96 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.299 0 N-CA-C 109.226 -0.657 . . . . 0.0 109.226 176.529 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' B' B ' 51' ' ' VAL . . . . . . . . . . . . . 52.9 t -73.04 -48.17 45.14 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.271 0 CA-C-N 115.938 -0.574 . . . . 0.0 110.225 -173.573 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' B' B ' 52' ' ' GLN . . . . . . . . . . . . . 45.3 tt0 -162.62 145.17 10.87 Favored 'General case' 0 C--N 1.332 -0.192 0 C-N-CA 120.303 -0.559 . . . . 0.0 111.554 -177.711 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' B' B ' 53' ' ' ALA . . . . . . . . . . . . . . . -121.1 133.89 55.23 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 115.821 -0.627 . . . . 0.0 110.044 176.76 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' B' B ' 54' ' ' TYR . . . . . . . . . . . . . 33.9 t80 -129.01 106.97 18.02 Favored Pre-proline 0 CA--C 1.534 0.342 0 CA-C-O 118.303 -0.856 . . . . 0.0 110.355 179.435 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' B' B ' 55' ' ' PRO . . . . . . . . . . . . . 73.8 Cg_endo -77.13 169.27 74.69 Favored 'Cis proline' 0 N--CA 1.5 1.858 0 CA-C-N 121.812 1.683 . . . . 0.0 112.503 -4.478 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' B' B ' 56' ' ' SER . . . . . . . . . . . . . 67.4 m -115.3 128.07 26.26 Favored Pre-proline 0 CA--C 1.539 0.543 0 CA-C-O 118.454 -0.784 . . . . 0.0 109.466 175.891 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' B' B ' 57' ' ' PRO . . . . . . . . . . . . . 40.0 Cg_endo -67.84 167.38 62.69 Favored 'Cis proline' 0 N--CA 1.496 1.666 0 CA-C-N 121.984 1.744 . . . . 0.0 111.648 -0.845 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' B' B ' 58' ' ' LEU . . . . . . . . . . . . . 31.4 tp -129.85 136.71 49.87 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.187 -0.46 . . . . 0.0 110.334 179.674 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' B' B ' 59' ' ' ARG . . . . . . . . . . . . . 53.6 ttp180 -103.06 128.3 49.98 Favored 'General case' 0 C--N 1.326 -0.417 0 N-CA-C 109.16 -0.682 . . . . 0.0 109.16 176.898 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' B' B ' 60' ' ' VAL . . . . . . . . . . . . . 42.1 t -84.05 127.64 39.6 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.185 0 C-N-CA 120.533 -0.467 . . . . 0.0 110.622 -174.139 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' B' B ' 61' ' ' GLU . . . . . . . . . . . . . 96.0 mt-10 -129.9 159.13 37.55 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 115.558 -0.747 . . . . 0.0 109.611 176.969 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' B' B ' 62' ' ' ASP . . . . . . . . . . . . . 6.8 t0 -53.5 -32.47 50.49 Favored 'General case' 0 C--N 1.328 -0.363 0 N-CA-C 111.88 0.326 . . . . 0.0 111.88 -178.58 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' B' B ' 63' ' ' ARG . . . . . . . . . . . . . 28.7 ptt180 -90.04 6.23 43.24 Favored 'General case' 0 CA--C 1.537 0.476 0 N-CA-C 113.878 1.066 . . . . 0.0 113.878 -175.633 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' B' B ' 64' ' ' THR . . . . . . . . . . . . . 25.7 m -75.11 147.23 40.74 Favored 'General case' 0 C--N 1.331 -0.206 0 CA-C-O 121.006 0.432 . . . . 0.0 111.069 -177.854 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' B' B ' 65' ' ' LYS . . . . . . . . . . . . . 25.2 mtpp -84.94 126.71 33.74 Favored 'General case' 0 C--N 1.331 -0.227 0 CA-C-N 115.893 -0.594 . . . . 0.0 110.208 179.453 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' B' B ' 66' ' ' ILE . . . . . . . . . . . . . 60.4 mt -121.94 132.17 71.51 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.235 0 N-CA-C 110.151 -0.314 . . . . 0.0 110.151 -179.426 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' B' B ' 67' ' ' THR . . . . . . . . . . . . . 29.6 m -130.11 141.55 50.68 Favored 'General case' 0 C--N 1.332 -0.154 0 CA-C-O 121.02 0.438 . . . . 0.0 111.184 -179.458 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' B' B ' 68' ' ' LEU . . . . . 0.488 HD12 ' N ' ' B' ' 68' ' ' LEU . 7.0 mp -103.02 124.26 48.19 Favored 'General case' 0 C--N 1.332 -0.195 0 CA-C-N 115.942 -0.572 . . . . 0.0 110.427 177.013 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' B' B ' 69' ' ' VAL . . . . . . . . . . . . . 46.2 t -103.08 128.45 56.02 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.284 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.169 179.606 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' B' B ' 70' ' ' THR . . . . . . . . . . . . . 30.9 p -138.43 153.83 48.86 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.389 -0.369 . . . . 0.0 110.813 178.188 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' B' B ' 71' ' ' HIS . . . . . . . . . . . . . 77.0 m-70 -149.98 82.06 6.68 Favored Pre-proline 0 C--N 1.328 -0.327 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.349 177.992 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' B' B ' 72' ' ' PRO . . . . . . . . . . . . . 92.2 Cg_endo -86.98 160.05 8.76 Favored 'Trans proline' 0 N--CA 1.49 1.32 0 C-N-CA 121.676 1.584 . . . . 0.0 112.599 -178.225 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' B' B ' 73' ' ' VAL . . . . . . . . . . . . . 27.1 m -99.84 159.32 3.65 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.251 0 CA-C-N 116.096 -0.502 . . . . 0.0 110.365 178.764 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' B' B ' 74' ' ' ASP . . . . . . . . . . . . . 36.3 t0 -97.78 116.26 29.65 Favored 'General case' 0 C--N 1.329 -0.289 0 N-CA-C 109.732 -0.47 . . . . 0.0 109.732 -179.28 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' B' B ' 75' ' ' VAL . . . . . . . . . . . . . 42.0 t -112.38 122.15 66.07 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.171 0 CA-C-O 121.112 0.482 . . . . 0.0 110.388 -177.97 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' B' B ' 76' ' ' LEU . . . . . . . . . . . . . 14.7 mt -124.82 133.7 53.02 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 115.537 -0.756 . . . . 0.0 109.2 177.422 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' B' B ' 77' ' ' GLU . . . . . . . . . . . . . 35.9 tt0 -131.91 136.89 47.73 Favored 'General case' 0 C--N 1.331 -0.222 0 CA-C-O 121.013 0.435 . . . . 0.0 110.98 -176.25 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' B' B ' 78' ' ' ALA . . . . . . . . . . . . . . . -123.87 139.81 53.6 Favored 'General case' 0 C--N 1.331 -0.219 0 CA-C-N 115.947 -0.57 . . . . 0.0 110.214 178.08 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' B' B ' 79' ' ' LYS . . . . . 0.626 ' O ' HD13 ' B' ' 80' ' ' ILE . 50.0 pttt -73.37 118.15 15.98 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-O 121.292 0.567 . . . . 0.0 110.453 179.402 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' B' B ' 80' ' ' ILE . . . . . 0.626 HD13 ' O ' ' B' ' 79' ' ' LYS . 38.0 mm -139.22 109.68 4.4 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.346 0 CA-C-N 115.906 -0.588 . . . . 0.0 109.718 -177.734 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' B' B ' 81' ' ' LYS . . . . . . . . . . . . . 67.6 mttm -110.76 130.6 55.53 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-O 120.948 0.404 . . . . 0.0 110.927 -179.67 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' B' B ' 82' ' ' GLY . . . . . . . . . . . . . . . 89.05 42.22 5.68 Favored Glycine 0 CA--C 1.525 0.698 0 C-N-CA 120.971 -0.633 . . . . 0.0 111.655 175.527 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' B' B ' 83' ' ' ILE . . . . . . . . . . . . . 71.9 mt -66.91 132.35 32.27 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.317 0 N-CA-C 109.672 -0.492 . . . . 0.0 109.672 177.688 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' B' B ' 84' ' ' LYS . . . . . . . . . . . . . 44.9 tttp -96.37 -52.72 3.87 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-O 121.091 0.472 . . . . 0.0 110.227 -178.742 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' B' B ' 85' ' ' ASP . . . . . . . . . . . . . 7.3 t70 -150.98 149.41 29.56 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 115.647 -0.706 . . . . 0.0 110.118 179.422 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' B' B ' 86' ' ' VAL . . . . . . . . . . . . . 43.2 t -128.6 128.77 68.31 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.292 0 CA-C-O 120.887 0.375 . . . . 0.0 110.529 -178.307 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' B' B ' 87' ' ' ILE . . . . . . . . . . . . . 43.7 mm -120.3 125.2 73.93 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.224 0 CA-C-N 116.002 -0.545 . . . . 0.0 109.968 176.251 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' B' B ' 88' ' ' LEU . . . . . . . . . . . . . 19.2 tp -109.64 130.04 55.54 Favored 'General case' 0 C--N 1.331 -0.225 0 CA-C-O 120.967 0.413 . . . . 0.0 111.141 -178.086 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' B' B ' 89' ' ' ASP . . . . . . . . . . . . . 12.7 t70 -123.12 151.6 41.91 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 115.827 -0.624 . . . . 0.0 109.583 176.0 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' B' B ' 90' ' ' GLU . . . . . . . . . . . . . 96.8 mt-10 -47.08 -36.56 8.32 Favored 'General case' 0 C--N 1.33 -0.253 0 N-CA-C 112.993 0.738 . . . . 0.0 112.993 -173.061 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' B' B ' 91' ' ' ASN . . . . . . . . . . . . . 3.4 p-10 -130.47 19.69 5.23 Favored 'General case' 0 N--CA 1.467 0.421 0 N-CA-C 113.051 0.76 . . . . 0.0 113.051 -177.668 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' B' B ' 92' ' ' LEU . . . . . . . . . . . . . 16.5 mt -148.89 143.16 26.05 Favored 'General case' 0 C--N 1.332 -0.169 0 N-CA-C 109.982 -0.377 . . . . 0.0 109.982 -177.336 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' B' B ' 93' ' ' ILE . . . . . . . . . . . . . 70.7 mt -120.09 118.03 55.55 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.328 0 N-CA-C 109.314 -0.624 . . . . 0.0 109.314 178.003 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' B' B ' 94' ' ' VAL . . . . . . . . . . . . . 48.4 t -119.22 123.5 71.44 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.207 0 N-CA-C 109.901 -0.407 . . . . 0.0 109.901 -179.304 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' B' B ' 95' ' ' VAL . . . . . . . . . . . . . 44.3 t -122.4 132.83 70.32 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.397 0 CA-C-N 115.916 -0.584 . . . . 0.0 109.876 -179.439 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' B' B ' 96' ' ' ILE . . . . . . . . . . . . . 67.0 mt -112.78 126.77 70.22 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.287 0 N-CA-C 109.12 -0.696 . . . . 0.0 109.12 178.265 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' B' B ' 97' ' ' THR . . . . . . . . . . . . . 68.2 p -99.6 152.72 19.72 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-O 120.877 0.37 . . . . 0.0 110.929 -178.543 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' B' B ' 98' ' ' GLU . . . . . . . . . . . . . 45.0 mt-10 -53.87 -24.23 15.19 Favored 'General case' 0 CA--C 1.533 0.324 0 N-CA-C 112.346 0.498 . . . . 0.0 112.346 179.927 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' B' B ' 99' ' ' GLU . . . . . . . . . . . . . 31.1 tt0 -79.27 15.54 1.19 Allowed 'General case' 0 CA--C 1.539 0.549 0 N-CA-C 112.697 0.629 . . . . 0.0 112.697 -177.306 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' B' B ' 100' ' ' ASN . . . . . . . . . . . . . 3.8 m-20 63.56 38.0 9.99 Favored 'General case' 0 CA--C 1.531 0.213 0 CA-C-O 121.006 0.432 . . . . 0.0 111.107 177.366 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' B' B ' 101' ' ' GLU . . . . . . . . . . . . . 85.0 tt0 -118.95 143.26 47.13 Favored 'General case' 0 C--N 1.331 -0.202 0 CA-C-N 116.042 -0.526 . . . . 0.0 109.909 176.014 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' B' B ' 102' ' ' VAL . . . . . . . . . . . . . 45.0 t -114.99 126.29 72.53 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.273 0 CA-C-N 116.262 -0.427 . . . . 0.0 109.946 -177.534 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' B' B ' 103' ' ' LEU . . . . . . . . . . . . . 21.2 mt -116.0 129.38 56.35 Favored 'General case' 0 C--N 1.331 -0.201 0 CA-C-N 115.848 -0.614 . . . . 0.0 110.555 178.263 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' B' B ' 104' ' ' ILE . . . . . . . . . . . . . 66.9 mt -118.82 119.55 61.37 Favored 'Isoleucine or valine' 0 C--O 1.233 0.215 0 CA-C-N 116.443 -0.344 . . . . 0.0 110.109 179.216 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' B' B ' 105' ' ' PHE . . . . . . . . . . . . . 66.8 m-85 -120.72 164.69 16.17 Favored 'General case' 0 C--N 1.331 -0.212 0 O-C-N 123.972 0.795 . . . . 0.0 109.878 178.741 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' B' B ' 106' ' ' ASN . . . . . . . . . . . . . 46.0 p-10 -101.08 -171.49 2.01 Favored 'General case' 0 N--CA 1.463 0.215 0 N-CA-C 110.267 -0.272 . . . . 0.0 110.267 174.605 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' B' B ' 107' ' ' GLN . . . . . . . . . . . . . 60.3 tt0 -59.47 -29.37 67.77 Favored 'General case' 0 CA--C 1.531 0.225 0 N-CA-C 112.021 0.378 . . . . 0.0 112.021 -179.347 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' B' B ' 108' ' ' ASN . . . . . . . . . . . . . 17.9 t30 -86.59 10.01 16.78 Favored 'General case' 0 CA--C 1.536 0.426 0 N-CA-C 113.189 0.811 . . . . 0.0 113.189 -177.115 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' B' B ' 109' ' ' LEU . . . . . . . . . . . . . 12.9 tp 59.68 41.65 18.24 Favored 'General case' 0 C--N 1.331 -0.198 0 CA-C-O 121.25 0.548 . . . . 0.0 110.897 178.318 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' B' B ' 110' ' ' GLU . . . . . . . . . . . . . 70.9 mm-40 -108.07 156.79 18.88 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.138 -0.483 . . . . 0.0 109.866 176.133 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' B' B ' 111' ' ' GLU . . . . . . . . . . . . . 84.9 tt0 -84.39 121.96 28.28 Favored 'General case' 0 C--N 1.329 -0.298 0 C-N-CA 120.845 -0.342 . . . . 0.0 110.79 -178.566 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' B' B ' 112' ' ' LEU . . . . . . . . . . . . . 28.4 mt -110.58 -46.18 3.42 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 116.16 -0.473 . . . . 0.0 110.547 178.169 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' B' B ' 113' ' ' TYR . . . . . . . . . . . . . 54.0 t80 -142.17 134.24 27.44 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.357 -0.383 . . . . 0.0 111.249 -179.941 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' B' B ' 114' ' ' ARG . . . . . . . . . . . . . 29.9 ttm180 -135.28 124.27 24.21 Favored 'General case' 0 C--N 1.329 -0.292 0 N-CA-C 109.839 -0.43 . . . . 0.0 109.839 175.44 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' B' B ' 115' ' ' GLY . . . . . . . . . . . . . . . -150.03 151.64 23.67 Favored Glycine 0 CA--C 1.523 0.569 0 C-N-CA 120.754 -0.736 . . . . 0.0 111.325 179.213 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' B' B ' 116' ' ' LYS . . . . . . . . . . . . . 39.1 ttpt -121.94 136.43 54.92 Favored 'General case' 0 C--N 1.328 -0.333 0 N-CA-C 109.662 -0.495 . . . . 0.0 109.662 177.744 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' B' B ' 117' ' ' PHE . . . . . . . . . . . . . 40.6 m-85 -135.2 113.76 11.66 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-O 121.082 0.468 . . . . 0.0 110.074 -176.861 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' B' B ' 118' ' ' GLU . . . . . . . . . . . . . 97.0 mt-10 -53.86 -43.78 69.82 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.073 -0.512 . . . . 0.0 111.662 -174.256 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' B' B ' 119' ' ' ASN . . . . . . . . . . . . . 5.6 p30 -104.63 31.13 4.91 Favored 'General case' 0 C--N 1.33 -0.257 0 N-CA-C 112.244 0.461 . . . . 0.0 112.244 -173.942 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' B' B ' 120' ' ' LEU . . . . . . . . . . . . . 13.7 tp -53.48 126.05 20.14 Favored 'General case' 0 N--CA 1.464 0.238 0 CA-C-O 120.469 0.176 . . . . 0.0 110.8 177.72 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' B' B ' 121' ' ' ASN . . . . . . . . . . . . . 77.3 m-20 -114.1 -44.12 3.17 Favored 'General case' 0 N--CA 1.462 0.173 0 C-N-CA 121.195 -0.202 . . . . 0.0 111.283 -176.843 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' B' B ' 122' ' ' LYS . . . . . . . . . . . . . 62.2 mtpt -142.1 145.69 34.57 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-O 121.121 0.486 . . . . 0.0 111.727 -176.775 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' B' B ' 123' ' ' VAL . . . . . . . . . . . . . 44.0 t -127.24 127.52 69.35 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.264 0 N-CA-C 109.21 -0.663 . . . . 0.0 109.21 174.909 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' B' B ' 124' ' ' LEU . . . . . . . . . . . . . 51.1 mt -128.03 136.38 51.18 Favored 'General case' 0 C--N 1.331 -0.196 0 CA-C-O 120.853 0.358 . . . . 0.0 111.097 -177.216 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' B' B ' 125' ' ' VAL . . . . . . . . . . . . . 11.1 p -133.97 133.65 56.11 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.249 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.027 177.304 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' B' B ' 126' ' ' ARG . . . . . . . . . . . . . 77.0 mtp85 -146.64 126.47 13.52 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-O 120.86 0.362 . . . . 0.0 111.073 -179.275 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' B' B ' 127' ' ' ASN . . . . . . . . . . . . . 7.6 m-80 49.23 -105.21 0.15 Allowed 'General case' 0 CA--C 1.545 0.76 0 CA-C-O 119.036 -0.507 . . . . 0.0 111.784 178.162 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' B' B ' 128' ' ' ASP . . . . . . . . . . . . . 15.9 p-10 -114.09 3.02 15.11 Favored 'General case' 0 CA--C 1.535 0.396 0 CA-C-N 119.552 1.069 . . . . 0.0 113.546 -176.36 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' B' B ' 129' ' ' LEU . . . . . . . . . . . . . 52.8 mt -111.48 140.85 45.73 Favored 'General case' 0 C--N 1.333 -0.114 0 O-C-N 121.972 -0.455 . . . . 0.0 110.522 -179.078 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' B' B ' 130' ' ' VAL . . . . . . . . . . . . . 46.5 t -122.98 134.85 64.9 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.326 0 N-CA-C 109.401 -0.592 . . . . 0.0 109.401 177.839 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' B' B ' 131' ' ' VAL . . . . . . . . . . . . . 39.3 t -134.36 138.06 50.53 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.223 0 CA-C-O 121.187 0.518 . . . . 0.0 110.45 -179.002 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' B' B ' 132' ' ' ILE . . . . . . . . . . . . . 70.7 mt -116.76 130.19 72.04 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.339 0 CA-C-N 115.556 -0.747 . . . . 0.0 109.388 179.508 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' B' B ' 133' ' ' ILE . . . . . . . . . . . . . 40.4 mm -112.2 119.25 59.72 Favored 'Isoleucine or valine' 0 C--O 1.233 0.221 0 CA-C-O 120.855 0.36 . . . . 0.0 110.67 -177.241 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' B' B ' 134' ' ' ASP . . . . . . . . . . . . . 7.2 p-10 -134.13 148.78 51.01 Favored 'General case' 0 C--N 1.331 -0.206 0 CA-C-N 116.103 -0.499 . . . . 0.0 109.76 177.156 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' B' B ' 135' ' ' GLU . . . . . . . . . . . . . 42.8 tp10 -49.9 -30.0 9.33 Favored 'General case' 0 C--N 1.328 -0.36 0 N-CA-C 112.576 0.584 . . . . 0.0 112.576 -173.523 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' B' B ' 136' ' ' GLN . . . . . . . . . . . . . 43.2 tp60 -80.18 -34.91 37.13 Favored 'General case' 0 C--N 1.33 -0.251 0 N-CA-C 112.282 0.475 . . . . 0.0 112.282 -175.046 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' B' B ' 137' ' ' LYS . . . . . . . . . . . . . 40.0 pttt -170.0 174.2 5.64 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-O 121.452 0.644 . . . . 0.0 112.179 -170.512 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' B' B ' 138' ' ' LEU . . . . . . . . . . . . . 6.1 tt -118.0 128.21 54.56 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 115.186 -0.915 . . . . 0.0 109.9 178.969 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' B' B ' 139' ' ' THR . . . . . . . . . . . . . 34.0 m -106.27 127.76 53.48 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.261 -0.427 . . . . 0.0 110.396 -179.87 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' B' B ' 140' ' ' LEU . . . . . 0.461 ' C ' HD23 ' B' ' 140' ' ' LEU . 5.5 tt -113.88 121.02 42.71 Favored 'General case' 0 C--N 1.328 -0.351 0 N-CA-C 109.149 -0.686 . . . . 0.0 109.149 -178.922 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' B' B ' 141' ' ' ILE . . . . . 0.416 ' N ' HD23 ' B' ' 140' ' ' LEU . 19.1 mt -119.88 116.81 51.65 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.303 0 N-CA-C 109.814 -0.439 . . . . 0.0 109.814 -176.604 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' B' B ' 142' ' ' ARG . . . . . . . . . . . . . 68.5 ttt180 -108.18 131.97 54.11 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 115.417 -0.81 . . . . 0.0 110.463 -177.092 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' B' B ' 143' ' ' THR . . . . . . . . . . . . . 35.2 p . . . . . 0 C--O 1.22 -0.45 0 CA-C-O 117.936 -1.03 . . . . 0.0 110.522 179.092 . . . . . . . . 0 0 . 1 . 018 nuclear nobuild full ' C' C ' -3' ' ' GLU . . . . . . . . . . . . . 85.4 tt0 . . . . . 0 N--CA 1.49 1.564 0 N-CA-C 109.393 -0.595 . . . . 0.0 109.393 . . . . . . . . . 0 0 . 1 . 018 nuclear nobuild full ' C' C ' -2' ' ' GLY . . . . . . . . . . . . . . . -79.46 135.98 16.38 Favored Glycine 0 CA--C 1.526 0.726 0 N-CA-C 111.035 -0.826 . . . . 0.0 111.035 179.411 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' C' C ' -1' ' ' VAL . . . . . . . . . . . . . 42.9 t -141.48 143.08 28.07 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.237 0 N-CA-C 110.067 -0.346 . . . . 0.0 110.067 179.559 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' C' C ' 0' ' ' ILE . . . . . . . . . . . . . 44.8 mm -106.88 138.19 33.92 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.194 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.422 -179.165 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' C' C ' 1' ' ' MET . . . . . . . . . . . . . 25.2 ptp -88.58 162.81 16.16 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 116.049 -0.523 . . . . 0.0 110.635 179.927 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' C' C ' 2' ' ' SER . . . . . . . . . . . . . 12.6 p -119.87 143.2 48.05 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-O 121.024 0.44 . . . . 0.0 110.906 -179.646 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' C' C ' 3' ' ' GLU . . . . . . . . . . . . . 95.8 mt-10 -141.0 142.44 34.26 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 115.863 -0.608 . . . . 0.0 110.961 -178.356 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' C' C ' 4' ' ' LEU . . . . . . . . . . . . . 16.2 tp -122.73 127.05 48.7 Favored 'General case' 0 C--N 1.331 -0.207 0 CA-C-N 116.103 -0.499 . . . . 0.0 109.719 175.402 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' C' C ' 5' ' ' LYS . . . . . . . . . . . . . 52.5 mttp -108.07 122.12 46.23 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-O 120.763 0.315 . . . . 0.0 110.995 -179.109 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' C' C ' 6' ' ' LEU . . . . . . . . . . . . . 27.6 mt -116.21 151.81 34.98 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 115.543 -0.753 . . . . 0.0 110.522 179.863 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' C' C ' 7' ' ' LYS . . . . . . . . . . . . . 74.2 tttt -144.02 139.56 16.11 Favored Pre-proline 0 CA--C 1.534 0.331 0 CA-C-O 119.124 -0.465 . . . . 0.0 109.949 173.569 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' C' C ' 8' ' ' PRO . . . . . . . . . . . . . 80.3 Cg_endo -90.65 141.54 3.23 Favored 'Trans proline' 0 N--CA 1.491 1.364 0 C-N-CA 121.66 1.573 . . . . 0.0 111.72 176.764 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' C' C ' 9' ' ' LEU . . . . . . . . . . . . . 54.6 mt -73.78 -47.97 6.66 Favored Pre-proline 0 CA--C 1.535 0.392 0 CA-C-O 118.665 -0.683 . . . . 0.0 112.472 -178.519 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' C' C ' 10' ' ' PRO . . . . . . . . . . . . . 88.1 Cg_endo -80.66 152.3 19.73 Favored 'Trans proline' 0 N--CA 1.497 1.677 0 C-N-CA 121.313 1.342 . . . . 0.0 111.99 177.422 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' C' C ' 11' ' ' LYS . . . . . . . . . . . . . 73.8 mmtt -82.49 102.0 11.06 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-O 120.929 0.395 . . . . 0.0 110.222 177.524 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' C' C ' 12' ' ' VAL . . . . . . . . . . . . . 12.9 p -141.31 146.4 23.53 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 CA-C-N 116.136 -0.483 . . . . 0.0 110.466 -179.225 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' C' C ' 13' ' ' GLU . . . . . . . . . . . . . 85.0 tt0 -85.19 124.44 31.84 Favored 'General case' 0 C--N 1.329 -0.306 0 N-CA-C 109.93 -0.396 . . . . 0.0 109.93 177.429 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' C' C ' 14' ' ' LEU . . . . . . . . . . . . . 48.8 mt -93.12 142.8 25.81 Favored Pre-proline 0 CA--C 1.533 0.314 0 CA-C-O 119.072 -0.49 . . . . 0.0 110.379 -177.453 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' C' C ' 15' ' ' PRO . . . . . . . . . . . . . 35.6 Cg_exo -60.22 162.1 17.94 Favored 'Trans proline' 0 N--CA 1.496 1.665 0 C-N-CA 121.353 1.369 . . . . 0.0 112.034 176.887 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' C' C ' 16' ' ' PRO . . . . . . . . . . . . . 38.3 Cg_exo -58.2 -42.33 57.87 Favored 'Trans proline' 0 N--CA 1.496 1.632 0 C-N-CA 121.507 1.472 . . . . 0.0 112.897 -176.399 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' C' C ' 17' ' ' ASP . . . . . . . . . . . . . 15.2 p-10 -92.87 13.03 21.68 Favored 'General case' 0 C--N 1.327 -0.383 0 N-CA-C 113.239 0.829 . . . . 0.0 113.239 -175.966 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' C' C ' 18' ' ' PHE . . . . . . . . . . . . . 41.8 t80 -57.71 -43.98 85.59 Favored 'General case' 0 C--O 1.231 0.1 0 CA-C-O 121.073 0.463 . . . . 0.0 110.08 -178.188 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' C' C ' 19' ' ' VAL . . . . . . . . . . . . . 44.9 t -59.47 -42.39 87.66 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.346 0 CA-C-N 116.122 -0.49 . . . . 0.0 110.21 -179.259 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' C' C ' 20' ' ' ASP . . . . . . . . . . . . . 78.5 m-20 -59.69 -42.66 93.46 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-O 120.732 0.301 . . . . 0.0 110.951 -177.361 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' C' C ' 21' ' ' VAL . . . . . . . . . . . . . 43.7 t -64.58 -46.8 91.46 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.318 0 C-N-CA 120.79 -0.364 . . . . 0.0 110.315 -177.755 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' C' C ' 22' ' ' ILE . . . . . 0.488 HG22 HD12 ' C' ' 26' ' ' LEU . 24.5 mm -59.32 -40.1 80.58 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.276 0 C-N-CA 120.869 -0.332 . . . . 0.0 110.362 -179.017 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' C' C ' 23' ' ' ARG . . . . . . . . . . . . . 55.8 ttp180 -55.36 -50.04 70.72 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-O 121.038 0.447 . . . . 0.0 110.736 178.335 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' C' C ' 24' ' ' ILE . . . . . . . . . . . . . 78.0 mt -60.21 -46.06 95.2 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.327 0 CA-C-N 116.005 -0.543 . . . . 0.0 111.595 -177.379 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' C' C ' 25' ' ' LYS . . . . . . . . . . . . . 17.7 ptpt -67.47 -39.15 85.28 Favored 'General case' 0 CA--C 1.534 0.358 0 C-N-CA 120.584 -0.446 . . . . 0.0 111.94 -173.71 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' C' C ' 26' ' ' LEU . . . . . 0.488 HD12 HG22 ' C' ' 22' ' ' ILE . 21.8 mt -79.49 -31.66 42.33 Favored 'General case' 0 C--N 1.33 -0.255 0 N-CA-C 113.045 0.757 . . . . 0.0 113.045 -174.765 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' C' C ' 27' ' ' GLN . . . . . . . . . . . . . 4.5 pt20 -45.9 135.48 7.14 Favored 'General case' 0 CA--C 1.536 0.436 0 N-CA-C 112.78 0.659 . . . . 0.0 112.78 -175.083 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' C' C ' 28' ' ' GLY . . . . . . . . . . . . . . . 97.06 -21.14 47.83 Favored Glycine 0 CA--C 1.534 1.264 0 CA-C-N 115.985 -0.552 . . . . 0.0 112.683 -177.822 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' C' C ' 29' ' ' LYS . . . . . . . . . . . . . 61.7 mttp -97.53 155.14 17.08 Favored 'General case' 0 C--N 1.331 -0.213 0 CA-C-N 117.522 0.661 . . . . 0.0 110.963 -178.984 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' C' C ' 30' ' ' THR . . . . . . . . . . . . . 13.9 m -104.02 139.72 38.74 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.337 177.989 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' C' C ' 31' ' ' VAL . . . . . . . . . . . . . 34.0 m -131.61 157.35 43.15 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.206 0 CA-C-N 116.234 -0.439 . . . . 0.0 110.856 -179.151 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' C' C ' 32' ' ' ARG . . . . . . . . . . . . . 81.7 mtt85 -133.65 150.7 51.57 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-N 115.957 -0.565 . . . . 0.0 110.744 176.828 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' C' C ' 33' ' ' THR . . . . . . . . . . . . . 33.5 m -53.41 139.98 28.95 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.206 -0.452 . . . . 0.0 111.282 -178.944 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' C' C ' 34' ' ' GLY . . . . . . . . . . . . . . . 98.65 -16.98 59.02 Favored Glycine 0 CA--C 1.532 1.125 0 CA-C-O 119.638 -0.535 . . . . 0.0 113.329 178.332 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' C' C ' 35' ' ' ASP . . . . . . . . . . . . . 76.9 m-20 -64.3 149.08 48.86 Favored 'General case' 0 C--O 1.231 0.125 0 CA-C-N 118.054 0.927 . . . . 0.0 111.225 -179.865 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' C' C ' 36' ' ' VAL . . . . . . . . . . . . . 46.2 t -121.07 129.66 75.46 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.211 0 CA-C-N 115.777 -0.647 . . . . 0.0 109.816 178.644 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' C' C ' 37' ' ' ILE . . . . . . . . . . . . . 72.1 mt -123.23 139.98 48.27 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.276 0 CA-C-N 116.182 -0.463 . . . . 0.0 109.994 -179.77 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' C' C ' 38' ' ' GLY . . . . . . . . . . . . . . . -108.91 128.67 9.15 Favored Glycine 0 CA--C 1.526 0.736 0 N-CA-C 111.317 -0.713 . . . . 0.0 111.317 -179.302 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' C' C ' 39' ' ' ILE . . . . . . . . . . . . . 77.7 mt -128.34 135.36 62.82 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.187 0 CA-C-O 120.757 0.313 . . . . 0.0 110.185 178.535 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' C' C ' 40' ' ' SER . . . . . . . . . . . . . 32.6 p -92.78 117.03 29.57 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.324 -0.398 . . . . 0.0 110.822 175.377 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' C' C ' 41' ' ' ILE . . . . . . . . . . . . . 45.7 mm -121.12 112.91 37.66 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.21 0 CA-C-O 120.794 0.331 . . . . 0.0 110.186 178.686 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' C' C ' 42' ' ' LEU . . . . . 0.424 ' O ' HD23 ' C' ' 42' ' ' LEU . 2.0 tt 55.58 48.56 18.4 Favored 'General case' 0 CA--C 1.533 0.307 0 CA-C-O 121.538 0.685 . . . . 0.0 110.098 178.643 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' C' C ' 43' ' ' GLY . . . . . . . . . . . . . . . 71.77 -5.48 11.92 Favored Glycine 0 CA--C 1.536 1.359 0 C-N-CA 121.125 -0.559 . . . . 0.0 113.766 175.642 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' C' C ' 44' ' ' LYS . . . . . . . . . . . . . 25.6 tptp -103.34 132.97 49.17 Favored 'General case' 0 C--O 1.231 0.126 0 CA-C-N 117.975 0.888 . . . . 0.0 110.031 -178.716 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' C' C ' 45' ' ' GLU . . . . . . . . . . . . . 82.5 tt0 -82.34 119.7 24.48 Favored 'General case' 0 C--N 1.329 -0.32 0 C-N-CA 120.808 -0.357 . . . . 0.0 110.78 -178.476 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' C' C ' 46' ' ' VAL . . . . . . . . . . . . . 7.2 p -122.8 124.52 70.65 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.21 0 N-CA-C 109.42 -0.585 . . . . 0.0 109.42 177.283 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' C' C ' 47' ' ' LYS . . . . . . . . . . . . . 53.7 mtmt -100.88 132.0 46.49 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.073 -0.512 . . . . 0.0 111.124 177.201 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' C' C ' 48' ' ' PHE . . . . . . . . . . . . . 84.3 m-85 -109.42 134.17 52.17 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 115.87 -0.605 . . . . 0.0 110.417 179.741 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' C' C ' 49' ' ' LYS . . . . . . . . . . . . . 87.5 tttt -105.3 134.36 48.54 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 115.844 -0.616 . . . . 0.0 110.05 178.589 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' C' C ' 50' ' ' VAL . . . . . . . . . . . . . 44.6 t -77.87 106.69 8.62 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.243 0 N-CA-C 109.147 -0.686 . . . . 0.0 109.147 174.873 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' C' C ' 51' ' ' VAL . . . . . . . . . . . . . 45.8 t -68.71 -46.63 79.37 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.308 0 CA-C-N 116.107 -0.497 . . . . 0.0 110.018 -172.59 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' C' C ' 52' ' ' GLN . . . . . . . . . . . . . 45.0 tt0 -171.39 145.25 2.09 Favored 'General case' 0 C--N 1.331 -0.207 0 C-N-CA 120.229 -0.588 . . . . 0.0 111.662 -179.361 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' C' C ' 53' ' ' ALA . . . . . . . . . . . . . . . -116.63 132.1 56.77 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 115.766 -0.652 . . . . 0.0 110.013 176.459 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' C' C ' 54' ' ' TYR . . . . . . . . . . . . . 48.2 t80 -129.11 108.87 18.03 Favored Pre-proline 0 CA--C 1.535 0.39 0 CA-C-O 118.264 -0.874 . . . . 0.0 110.242 177.983 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' C' C ' 55' ' ' PRO . . . . . . . . . . . . . 72.4 Cg_endo -77.11 168.5 76.83 Favored 'Cis proline' 0 N--CA 1.498 1.774 0 CA-C-N 121.865 1.702 . . . . 0.0 112.504 -3.823 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' C' C ' 56' ' ' SER . . . . . . . . . . . . . 50.2 m -115.71 130.49 24.31 Favored Pre-proline 0 CA--C 1.538 0.501 0 CA-C-O 118.456 -0.783 . . . . 0.0 109.373 174.446 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' C' C ' 57' ' ' PRO . . . . . . . . . . . . . 54.8 Cg_endo -70.0 165.3 77.7 Favored 'Cis proline' 0 N--CA 1.497 1.732 0 CA-C-N 121.918 1.721 . . . . 0.0 111.432 0.606 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' C' C ' 58' ' ' LEU . . . . . . . . . . . . . 29.3 tp -129.73 137.51 50.61 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-O 120.908 0.385 . . . . 0.0 110.419 -179.957 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' C' C ' 59' ' ' ARG . . . . . . . . . . . . . 64.7 ttp85 -106.98 125.72 51.38 Favored 'General case' 0 C--N 1.328 -0.332 0 N-CA-C 109.328 -0.619 . . . . 0.0 109.328 176.917 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' C' C ' 60' ' ' VAL . . . . . . . . . . . . . 45.0 t -75.48 115.97 17.66 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.288 0 CA-C-O 120.878 0.37 . . . . 0.0 110.656 -173.884 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' C' C ' 61' ' ' GLU . . . . . . . . . . . . . 39.1 tp10 -131.05 154.76 47.89 Favored 'General case' 0 C--N 1.33 -0.263 0 N-CA-C 109.062 -0.718 . . . . 0.0 109.062 176.77 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' C' C ' 62' ' ' ASP . . . . . . . . . . . . . 83.4 m-20 -50.86 -32.33 20.01 Favored 'General case' 0 C--N 1.326 -0.444 0 N-CA-C 112.162 0.43 . . . . 0.0 112.162 -176.612 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' C' C ' 63' ' ' ARG . . . . . . . . . . . . . 75.4 mtt85 -72.37 -22.19 61.18 Favored 'General case' 0 C--N 1.33 -0.261 0 N-CA-C 113.154 0.798 . . . . 0.0 113.154 -175.627 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' C' C ' 64' ' ' THR . . . . . . . . . . . . . 33.3 m -68.81 140.36 55.26 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-O 120.86 0.362 . . . . 0.0 110.697 -176.778 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' C' C ' 65' ' ' LYS . . . . . . . . . . . . . 97.2 mttt -88.08 134.64 33.71 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.045 -0.525 . . . . 0.0 109.989 179.159 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' C' C ' 66' ' ' ILE . . . . . . . . . . . . . 53.7 mt -111.09 129.84 65.64 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.238 0 N-CA-C 109.607 -0.516 . . . . 0.0 109.607 -178.248 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' C' C ' 67' ' ' THR . . . . . . . . . . . . . 34.6 m -123.69 140.24 53.19 Favored 'General case' 0 C--N 1.331 -0.223 0 CA-C-O 121.079 0.466 . . . . 0.0 111.295 -175.724 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' C' C ' 68' ' ' LEU . . . . . 0.465 HD12 ' N ' ' C' ' 68' ' ' LEU . 8.2 mp -101.4 122.88 44.55 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 115.667 -0.697 . . . . 0.0 110.1 176.077 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' C' C ' 69' ' ' VAL . . . . . . . . . . . . . 46.2 t -101.67 134.4 42.19 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.325 0 N-CA-C 109.878 -0.416 . . . . 0.0 109.878 179.592 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' C' C ' 70' ' ' THR . . . . . . . . . . . . . 15.9 p -132.79 120.41 21.57 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 116.243 -0.435 . . . . 0.0 110.646 179.433 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' C' C ' 71' ' ' HIS . . . . . . . . . . . . . 40.7 m80 -121.3 154.68 59.02 Favored Pre-proline 0 C--N 1.33 -0.282 0 CA-C-N 116.005 -0.543 . . . . 0.0 109.656 177.49 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' C' C ' 72' ' ' PRO . . . . . . . . . . . . . 58.3 Cg_endo -72.74 -30.14 11.96 Favored 'Trans proline' 0 N--CA 1.495 1.579 0 C-N-CA 121.152 1.234 . . . . 0.0 112.538 -177.002 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' C' C ' 73' ' ' VAL . . . . . . . . . . . . . 21.1 m -153.61 160.3 2.94 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.27 0 CA-C-O 121.137 0.494 . . . . 0.0 111.038 179.198 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' C' C ' 74' ' ' ASP . . . . . . . . . . . . . 7.0 t0 -107.95 122.92 47.81 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 115.572 -0.74 . . . . 0.0 109.371 175.251 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' C' C ' 75' ' ' VAL . . . . . . . . . . . . . 40.1 t -112.52 121.32 64.63 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.231 0 CA-C-O 121.128 0.49 . . . . 0.0 110.676 -177.69 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' C' C ' 76' ' ' LEU . . . . . 0.469 ' N ' HD12 ' C' ' 76' ' ' LEU . 6.4 mp -119.57 148.48 43.26 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 115.573 -0.74 . . . . 0.0 109.621 176.309 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' C' C ' 77' ' ' GLU . . . . . . . . . . . . . 98.0 mt-10 -137.84 133.58 34.1 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-O 121.108 0.48 . . . . 0.0 111.129 -177.988 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' C' C ' 78' ' ' ALA . . . . . 0.663 ' HB2' HD21 ' C' ' 109' ' ' LEU . . . -118.74 128.0 54.08 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 115.674 -0.693 . . . . 0.0 109.672 176.724 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' C' C ' 79' ' ' LYS . . . . . 0.563 ' O ' HD13 ' C' ' 80' ' ' ILE . 61.7 mttp -83.87 114.94 22.01 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-O 121.05 0.452 . . . . 0.0 110.897 -176.072 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' C' C ' 80' ' ' ILE . . . . . 0.563 HD13 ' O ' ' C' ' 79' ' ' LYS . 43.7 mm -139.26 107.33 3.19 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.28 0 N-CA-C 109.025 -0.731 . . . . 0.0 109.025 -178.023 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' C' C ' 81' ' ' LYS . . . . . . . . . . . . . 77.4 tttt -95.34 127.41 41.37 Favored 'General case' 0 C--N 1.328 -0.369 0 C-N-CA 120.676 -0.409 . . . . 0.0 110.687 -177.837 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' C' C ' 82' ' ' GLY . . . . . . . . . . . . . . . 89.29 42.03 5.65 Favored Glycine 0 CA--C 1.524 0.645 0 C-N-CA 120.749 -0.738 . . . . 0.0 111.744 176.426 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' C' C ' 83' ' ' ILE . . . . . . . . . . . . . 67.9 mt -68.39 139.28 20.92 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.324 0 N-CA-C 109.47 -0.567 . . . . 0.0 109.47 176.586 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' C' C ' 84' ' ' LYS . . . . . . . . . . . . . 68.5 tttt -98.42 -54.14 3.13 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.112 -0.495 . . . . 0.0 110.704 -176.009 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' C' C ' 85' ' ' ASP . . . . . . . . . . . . . 6.9 t70 -152.14 155.31 37.6 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 115.885 -0.598 . . . . 0.0 110.353 -177.883 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' C' C ' 86' ' ' VAL . . . . . . . . . . . . . 40.3 t -133.17 132.23 58.48 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.254 0 CA-C-O 121.017 0.437 . . . . 0.0 110.729 -178.485 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' C' C ' 87' ' ' ILE . . . . . . . . . . . . . 45.1 mm -117.63 122.28 69.47 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.276 0 CA-C-N 115.776 -0.647 . . . . 0.0 109.325 174.431 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' C' C ' 88' ' ' LEU . . . . . . . . . . . . . 13.4 tp -113.04 130.75 56.04 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-O 120.992 0.425 . . . . 0.0 110.998 -176.219 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' C' C ' 89' ' ' ASP . . . . . . . . . . . . . 11.7 t70 -128.65 160.24 33.06 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 115.888 -0.597 . . . . 0.0 109.863 178.38 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' C' C ' 90' ' ' GLU . . . . . . . . . . . . . 83.3 tt0 -46.23 -41.13 12.45 Favored 'General case' 0 CA--C 1.532 0.282 0 N-CA-C 113.073 0.768 . . . . 0.0 113.073 -172.041 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' C' C ' 91' ' ' ASN . . . . . . . . . . . . . 25.6 m120 -132.05 27.55 4.53 Favored 'General case' 0 N--CA 1.467 0.409 0 N-CA-C 112.44 0.533 . . . . 0.0 112.44 -177.451 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' C' C ' 92' ' ' LEU . . . . . . . . . . . . . 12.2 mt -149.98 141.17 23.11 Favored 'General case' 0 C--N 1.33 -0.265 0 N-CA-C 110.221 -0.288 . . . . 0.0 110.221 -177.43 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' C' C ' 93' ' ' ILE . . . . . . . . . . . . . 73.0 mt -124.5 113.63 37.22 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.284 0 N-CA-C 109.075 -0.713 . . . . 0.0 109.075 176.887 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' C' C ' 94' ' ' VAL . . . . . . . . . . . . . 45.0 t -116.6 126.49 74.08 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.247 0 N-CA-C 109.806 -0.442 . . . . 0.0 109.806 -179.388 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' C' C ' 95' ' ' VAL . . . . . . . . . . . . . 40.2 t -124.38 136.63 59.89 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.325 0 CA-C-N 116.28 -0.418 . . . . 0.0 110.056 -178.687 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' C' C ' 96' ' ' ILE . . . . . . . . . . . . . 61.4 mt -116.55 130.55 71.19 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.361 0 N-CA-C 109.221 -0.659 . . . . 0.0 109.221 179.112 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' C' C ' 97' ' ' THR . . . . . . . . . . . . . 71.4 p -98.37 159.99 14.58 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-O 120.908 0.385 . . . . 0.0 110.619 -178.346 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' C' C ' 98' ' ' GLU . . . . . . . . . . . . . 12.8 pt-20 -53.99 -19.27 4.45 Favored 'General case' 0 CA--C 1.535 0.367 0 N-CA-C 112.801 0.667 . . . . 0.0 112.801 -179.266 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' C' C ' 99' ' ' GLU . . . . . . . . . . . . . 37.1 tt0 -85.67 16.34 4.02 Favored 'General case' 0 CA--C 1.539 0.545 0 N-CA-C 112.567 0.58 . . . . 0.0 112.567 -177.259 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' C' C ' 100' ' ' ASN . . . . . . . . . . . . . 3.4 m-20 61.14 38.06 17.18 Favored 'General case' 0 CA--C 1.529 0.17 0 O-C-N 121.818 -0.551 . . . . 0.0 110.971 178.564 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' C' C ' 101' ' ' GLU . . . . . . . . . . . . . 82.0 tt0 -116.12 143.24 45.74 Favored 'General case' 0 C--N 1.331 -0.207 0 N-CA-C 109.444 -0.576 . . . . 0.0 109.444 175.831 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' C' C ' 102' ' ' VAL . . . . . . . . . . . . . 44.4 t -117.66 128.41 74.87 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.263 0 CA-C-O 120.972 0.415 . . . . 0.0 110.098 -177.609 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' C' C ' 103' ' ' LEU . . . . . . . . . . . . . 25.0 mt -118.38 136.35 53.8 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 115.564 -0.743 . . . . 0.0 109.752 176.164 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' C' C ' 104' ' ' ILE . . . . . . . . . . . . . 69.2 mt -118.19 121.34 66.99 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.244 0 N-CA-C 109.844 -0.428 . . . . 0.0 109.844 179.725 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' C' C ' 105' ' ' PHE . . . . . . . . . . . . . 53.9 m-85 -118.11 161.31 20.06 Favored 'General case' 0 C--N 1.333 -0.139 0 O-C-N 124.183 0.927 . . . . 0.0 109.836 -179.328 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' C' C ' 106' ' ' ASN . . . . . . . . . . . . . 44.7 p-10 -98.82 -171.04 2.03 Favored 'General case' 0 C--N 1.33 -0.246 0 N-CA-C 110.049 -0.352 . . . . 0.0 110.049 175.427 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' C' C ' 107' ' ' GLN . . . . . . . . . . . . . 41.0 tt0 -58.29 -30.13 66.39 Favored 'General case' 0 C--N 1.329 -0.284 0 N-CA-C 111.968 0.358 . . . . 0.0 111.968 -179.459 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' C' C ' 108' ' ' ASN . . . . . . . . . . . . . 12.9 t30 -86.17 8.78 19.68 Favored 'General case' 0 CA--C 1.535 0.398 0 N-CA-C 113.475 0.917 . . . . 0.0 113.475 -175.954 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' C' C ' 109' ' ' LEU . . . . . 0.663 HD21 ' HB2' ' C' ' 78' ' ' ALA . 11.9 tp 62.96 38.55 11.06 Favored 'General case' 0 CA--C 1.53 0.185 0 CA-C-O 121.073 0.464 . . . . 0.0 111.301 177.752 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' C' C ' 110' ' ' GLU . . . . . . . . . . . . . 70.7 mm-40 -109.16 157.43 18.78 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 116.37 -0.377 . . . . 0.0 110.114 176.211 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' C' C ' 111' ' ' GLU . . . . . . . . . . . . . 98.5 mt-10 -86.35 124.24 32.48 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-O 120.806 0.336 . . . . 0.0 111.263 -178.401 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' C' C ' 112' ' ' LEU . . . . . . . . . . . . . 13.5 mt -111.14 -45.99 3.37 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 115.982 -0.554 . . . . 0.0 110.711 178.479 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' C' C ' 113' ' ' TYR . . . . . . . . . . . . . 61.6 t80 -135.85 142.45 44.79 Favored 'General case' 0 N--CA 1.464 0.256 0 C-N-CA 120.749 -0.381 . . . . 0.0 111.532 -178.224 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' C' C ' 114' ' ' ARG . . . . . . . . . . . . . 51.3 mtt85 -135.75 125.88 26.2 Favored 'General case' 0 C--N 1.331 -0.21 0 CA-C-N 115.996 -0.547 . . . . 0.0 109.937 179.684 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' C' C ' 115' ' ' GLY . . . . . . . . . . . . . . . -150.13 155.06 26.04 Favored Glycine 0 CA--C 1.524 0.65 0 C-N-CA 120.643 -0.789 . . . . 0.0 111.296 177.886 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' C' C ' 116' ' ' LYS . . . . . . . . . . . . . 36.1 ttpt -129.98 136.07 49.02 Favored 'General case' 0 C--N 1.331 -0.224 0 N-CA-C 109.64 -0.504 . . . . 0.0 109.64 175.875 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' C' C ' 117' ' ' PHE . . . . . . . . . . . . . 40.0 m-85 -137.7 113.92 10.08 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-O 120.927 0.394 . . . . 0.0 110.313 -176.033 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' C' C ' 118' ' ' GLU . . . . . . . . . . . . . 95.7 mt-10 -56.0 -46.4 78.74 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.388 -0.369 . . . . 0.0 110.976 -176.321 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' C' C ' 119' ' ' ASN . . . . . . . . . . . . . 71.0 m-80 -95.86 31.03 2.19 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.102 -0.499 . . . . 0.0 112.002 -174.99 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' C' C ' 120' ' ' LEU . . . . . . . . . . . . . 12.2 tp -56.7 119.96 7.02 Favored 'General case' 0 C--N 1.333 -0.144 0 C-N-CA 120.993 -0.283 . . . . 0.0 110.278 178.284 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' C' C ' 121' ' ' ASN . . . . . . . . . . . . . 56.3 m-20 -114.08 -44.2 3.17 Favored 'General case' 0 C--N 1.331 -0.226 0 CA-C-N 116.491 -0.322 . . . . 0.0 110.983 -176.883 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' C' C ' 122' ' ' LYS . . . . . . . . . . . . . 92.5 mttt -143.26 145.21 32.54 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-O 121.126 0.489 . . . . 0.0 111.688 -178.133 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' C' C ' 123' ' ' VAL . . . . . . . . . . . . . 43.8 t -124.75 126.2 71.11 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.262 0 CA-C-N 115.735 -0.666 . . . . 0.0 109.325 174.997 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' C' C ' 124' ' ' LEU . . . . . . . . . . . . . 74.4 mt -115.13 129.45 56.67 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.507 -0.315 . . . . 0.0 110.379 -177.122 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' C' C ' 125' ' ' VAL . . . . . . . . . . . . . 43.6 t -127.9 122.6 58.99 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.225 0 CA-C-N 116.282 -0.417 . . . . 0.0 109.898 178.851 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' C' C ' 126' ' ' ARG . . . . . . . . . . . . . 80.9 mtt85 -151.99 135.6 16.18 Favored 'General case' 0 C--N 1.33 -0.255 0 N-CA-C 109.748 -0.464 . . . . 0.0 109.748 178.267 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' C' C ' 127' ' ' ASN . . . . . . . . . . . . . 3.1 m120 55.99 -154.99 0.3 Allowed 'General case' 0 CA--C 1.539 0.549 0 N-CA-C 109.644 -0.502 . . . . 0.0 109.644 -179.282 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' C' C ' 128' ' ' ASP . . . . . . . . . . . . . 9.3 p-10 -84.88 21.47 1.58 Allowed 'General case' 0 CA--C 1.535 0.384 0 CA-C-N 118.432 0.56 . . . . 0.0 112.199 175.831 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' C' C ' 129' ' ' LEU . . . . . . . . . . . . . 12.8 tp -116.42 137.76 51.9 Favored 'General case' 0 C--O 1.234 0.254 0 CA-C-O 120.91 0.386 . . . . 0.0 110.381 -179.676 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' C' C ' 130' ' ' VAL . . . . . . . . . . . . . 42.8 t -124.33 136.8 59.32 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.204 0 CA-C-N 116.079 -0.509 . . . . 0.0 110.049 -178.864 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' C' C ' 131' ' ' VAL . . . . . . . . . . . . . 44.6 t -136.02 137.79 48.24 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.292 0 CA-C-O 120.946 0.403 . . . . 0.0 110.329 179.181 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' C' C ' 132' ' ' ILE . . . . . . . . . . . . . 72.4 mt -121.26 134.09 65.74 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.247 0 CA-C-N 116.064 -0.516 . . . . 0.0 109.795 -179.027 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' C' C ' 133' ' ' ILE . . . . . . . . . . . . . 42.9 mm -117.2 121.56 67.97 Favored 'Isoleucine or valine' 0 C--O 1.233 0.228 0 CA-C-O 120.834 0.349 . . . . 0.0 111.156 -176.275 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' C' C ' 134' ' ' ASP . . . . . . . . . . . . . 6.9 p-10 -133.47 147.12 51.65 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 115.78 -0.645 . . . . 0.0 109.52 174.003 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' C' C ' 135' ' ' GLU . . . . . . . . . . . . . 83.3 tt0 -50.05 -25.05 3.05 Favored 'General case' 0 C--N 1.327 -0.373 0 N-CA-C 112.96 0.726 . . . . 0.0 112.96 -171.247 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' C' C ' 136' ' ' GLN . . . . . . . . . . . . . 95.6 mm-40 -93.46 -35.03 13.17 Favored 'General case' 0 C--N 1.33 -0.267 0 N-CA-C 112.633 0.605 . . . . 0.0 112.633 -176.379 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' C' C ' 137' ' ' LYS . . . . . . . . . . . . . 50.0 mtmt -146.2 154.74 42.1 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-O 121.303 0.573 . . . . 0.0 112.056 -169.13 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' C' C ' 138' ' ' LEU . . . . . 0.423 HD23 ' C ' ' C' ' 138' ' ' LEU . 5.5 tt -116.81 123.45 47.15 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 115.349 -0.841 . . . . 0.0 109.16 175.151 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' C' C ' 139' ' ' THR . . . . . . . . . . . . . 30.7 m -111.57 129.71 55.98 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 116.483 -0.326 . . . . 0.0 110.97 -175.939 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' C' C ' 140' ' ' LEU . . . . . 0.473 ' C ' HD23 ' C' ' 140' ' ' LEU . 7.4 tt -117.77 124.36 48.24 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 115.747 -0.66 . . . . 0.0 109.449 -179.624 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' C' C ' 141' ' ' ILE . . . . . . . . . . . . . 19.0 mt -122.43 120.54 61.35 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.277 0 N-CA-C 109.909 -0.404 . . . . 0.0 109.909 -175.972 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' C' C ' 142' ' ' ARG . . . . . . . . . . . . . 78.3 ttt-85 -111.24 131.2 55.32 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 115.84 -0.618 . . . . 0.0 110.099 -178.086 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' C' C ' 143' ' ' THR . . . . . . . . . . . . . 41.4 p . . . . . 0 C--O 1.219 -0.518 0 CA-C-O 117.96 -1.019 . . . . 0.0 110.618 -179.365 . . . . . . . . 0 0 . 1 . 018 nuclear nobuild full ' D' D ' -3' ' ' GLU . . . . . . . . . . . . . 22.2 pt-20 . . . . . 0 N--CA 1.493 1.679 0 N-CA-C 110.155 -0.313 . . . . 0.0 110.155 . . . . . . . . . 0 0 . 1 . 018 nuclear nobuild full ' D' D ' -2' ' ' GLY . . . . . . . . . . . . . . . -66.39 140.41 39.15 Favored Glycine 0 CA--C 1.526 0.744 0 N-CA-C 110.887 -0.885 . . . . 0.0 110.887 179.896 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' D' D ' -1' ' ' VAL . . . . . . . . . . . . . 43.7 t -141.32 133.91 29.67 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.305 0 N-CA-C 110.023 -0.362 . . . . 0.0 110.023 -179.853 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' D' D ' 0' ' ' ILE . . . . . . . . . . . . . 44.3 mm -117.41 133.35 64.44 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.238 0 CA-C-N 116.326 -0.397 . . . . 0.0 110.33 179.791 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' D' D ' 1' ' ' MET . . . . . . . . . . . . . 26.0 ptt? -84.23 133.64 34.57 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.135 -0.484 . . . . 0.0 110.635 -179.782 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' D' D ' 2' ' ' SER . . . . . . . . . . . . . 79.5 p -124.57 145.2 49.73 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.312 -0.404 . . . . 0.0 110.522 179.571 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' D' D ' 3' ' ' GLU . . . . . . . . . . . . . 84.9 tt0 -140.22 138.4 35.06 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.063 -0.517 . . . . 0.0 110.987 -178.647 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' D' D ' 4' ' ' LEU . . . . . 0.491 HD21 HG13 ' D' ' 50' ' ' VAL . 4.9 tt -124.25 130.23 52.15 Favored 'General case' 0 C--N 1.332 -0.187 0 CA-C-N 115.96 -0.564 . . . . 0.0 110.137 178.309 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' D' D ' 5' ' ' LYS . . . . . 0.415 ' N ' HD23 ' D' ' 4' ' ' LEU . 67.6 mttm -109.65 122.58 47.78 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.455 -0.339 . . . . 0.0 111.017 -178.739 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' D' D ' 6' ' ' LEU . . . . . 0.453 HD23 ' HA ' ' D' ' 50' ' ' VAL . 79.6 mt -115.38 149.78 37.41 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 115.369 -0.832 . . . . 0.0 110.331 179.793 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' D' D ' 7' ' ' LYS . . . . . . . . . . . . . 64.1 tttm -137.45 137.07 21.29 Favored Pre-proline 0 CA--C 1.534 0.338 0 CA-C-O 119.014 -0.517 . . . . 0.0 110.087 176.587 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' D' D ' 8' ' ' PRO . . . . . . . . . . . . . 93.1 Cg_endo -92.01 141.73 2.49 Favored 'Trans proline' 0 N--CA 1.49 1.3 0 C-N-CA 121.823 1.682 . . . . 0.0 111.491 176.701 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' D' D ' 9' ' ' LEU . . . . . . . . . . . . . 66.7 mt -75.86 -47.48 3.84 Favored Pre-proline 0 CA--C 1.533 0.292 0 CA-C-O 118.74 -0.648 . . . . 0.0 112.219 -178.439 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' D' D ' 10' ' ' PRO . . . . . . . . . . . . . 98.6 Cg_endo -81.74 149.04 16.04 Favored 'Trans proline' 0 N--CA 1.495 1.612 0 C-N-CA 121.184 1.256 . . . . 0.0 111.852 175.542 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' D' D ' 11' ' ' LYS . . . . . . . . . . . . . 24.3 tptp -88.86 100.53 13.24 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-O 120.764 0.316 . . . . 0.0 110.399 179.539 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' D' D ' 12' ' ' VAL . . . . . . . . . . . . . 11.4 p -139.62 142.23 33.19 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.233 0 CA-C-N 116.358 -0.383 . . . . 0.0 110.548 -179.206 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' D' D ' 13' ' ' GLU . . . . . . . . . . . . . 43.1 mp0 -78.17 122.44 25.65 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 116.3 -0.409 . . . . 0.0 110.165 178.041 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' D' D ' 14' ' ' LEU . . . . . . . . . . . . . 35.8 mt -98.4 153.44 38.02 Favored Pre-proline 0 CA--C 1.532 0.285 0 CA-C-N 116.462 -0.336 . . . . 0.0 110.51 -179.283 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' D' D ' 15' ' ' PRO . . . . . . . . . . . . . 33.5 Cg_exo -60.56 157.41 36.92 Favored 'Trans proline' 0 N--CA 1.496 1.653 0 C-N-CA 121.256 1.304 . . . . 0.0 111.792 176.801 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' D' D ' 16' ' ' PRO . . . . . . . . . . . . . 36.2 Cg_exo -58.83 -37.39 94.05 Favored 'Trans proline' 0 N--CA 1.498 1.737 0 C-N-CA 121.376 1.384 . . . . 0.0 112.654 -178.177 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' D' D ' 17' ' ' ASP . . . . . . . . . . . . . 7.1 p-10 -88.46 9.94 21.9 Favored 'General case' 0 CA--C 1.534 0.355 0 N-CA-C 113.284 0.846 . . . . 0.0 113.284 -176.832 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' D' D ' 18' ' ' PHE . . . . . . . . . . . . . 19.8 t80 -57.72 -45.06 86.25 Favored 'General case' 0 C--N 1.334 -0.091 0 O-C-N 121.916 -0.49 . . . . 0.0 110.041 -177.653 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' D' D ' 19' ' ' VAL . . . . . . . . . . . . . 48.0 t -57.61 -43.15 82.82 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.286 0 CA-C-N 116.273 -0.421 . . . . 0.0 110.548 -178.521 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' D' D ' 20' ' ' ASP . . . . . . . . . . . . . 82.5 m-20 -60.15 -42.56 95.15 Favored 'General case' 0 C--N 1.33 -0.258 0 C-N-CA 120.837 -0.345 . . . . 0.0 111.112 -176.789 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' D' D ' 21' ' ' VAL . . . . . . . . . . . . . 45.6 t -64.73 -46.28 92.67 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.33 0 C-N-CA 120.807 -0.357 . . . . 0.0 110.347 -177.863 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' D' D ' 22' ' ' ILE . . . . . . . . . . . . . 50.5 mm -56.91 -42.98 79.61 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.229 0 C-N-CA 120.815 -0.354 . . . . 0.0 110.441 178.379 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' D' D ' 23' ' ' ARG . . . . . . . . . . . . . 54.7 ttp180 -53.5 -47.39 69.9 Favored 'General case' 0 C--N 1.33 -0.266 0 O-C-N 122.32 -0.237 . . . . 0.0 111.339 -179.208 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' D' D ' 24' ' ' ILE . . . . . . . . . . . . . 71.7 mt -60.02 -43.41 92.52 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.342 0 C-N-CA 120.933 -0.307 . . . . 0.0 110.698 179.541 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' D' D ' 25' ' ' LYS . . . . . . . . . . . . . 89.0 mttt -61.73 -38.09 86.62 Favored 'General case' 0 C--N 1.328 -0.343 0 N-CA-C 112.379 0.511 . . . . 0.0 112.379 -179.564 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' D' D ' 26' ' ' LEU . . . . . . . . . . . . . 86.3 mt -77.99 -46.63 20.52 Favored 'General case' 0 C--N 1.329 -0.32 0 N-CA-C 112.702 0.63 . . . . 0.0 112.702 -171.719 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' D' D ' 27' ' ' GLN . . . . . . . . . . . . . 11.2 pt20 -47.03 137.76 7.25 Favored 'General case' 0 N--CA 1.47 0.556 0 N-CA-C 112.75 0.648 . . . . 0.0 112.75 -175.839 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' D' D ' 28' ' ' GLY . . . . . . . . . . . . . . . 101.14 -26.86 23.1 Favored Glycine 0 CA--C 1.531 1.092 0 CA-C-N 115.591 -0.731 . . . . 0.0 112.312 -178.454 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' D' D ' 29' ' ' LYS . . . . . . . . . . . . . 87.4 mttt -99.67 155.14 17.77 Favored 'General case' 0 C--N 1.332 -0.182 0 CA-C-N 117.398 0.599 . . . . 0.0 111.385 179.707 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' D' D ' 30' ' ' THR . . . . . . . . . . . . . 22.2 m -101.07 135.38 42.63 Favored 'General case' 0 C--N 1.33 -0.239 0 CA-C-N 116.099 -0.501 . . . . 0.0 109.662 174.119 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' D' D ' 31' ' ' VAL . . . . . . . . . . . . . 34.3 m -127.48 156.33 39.12 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.226 0 CA-C-O 120.866 0.365 . . . . 0.0 111.14 -177.644 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' D' D ' 32' ' ' ARG . . . . . . . . . . . . . 72.8 mtt85 -132.93 149.35 52.25 Favored 'General case' 0 C--O 1.233 0.186 0 CA-C-N 115.724 -0.671 . . . . 0.0 110.838 178.864 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' D' D ' 33' ' ' THR . . . . . 0.432 HG23 ' HA ' ' D' ' 52' ' ' GLN . 23.7 m -53.8 140.46 29.97 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.07 -0.514 . . . . 0.0 111.146 -179.784 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' D' D ' 34' ' ' GLY . . . . . . . . . . . . . . . 99.7 -17.08 57.99 Favored Glycine 0 CA--C 1.531 1.047 0 C-N-CA 121.105 -0.569 . . . . 0.0 113.31 178.753 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' D' D ' 35' ' ' ASP . . . . . . . . . . . . . 75.8 m-20 -62.15 147.63 47.03 Favored 'General case' 0 N--CA 1.461 0.125 0 CA-C-N 118.054 0.927 . . . . 0.0 111.156 179.683 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' D' D ' 36' ' ' VAL . . . . . . . . . . . . . 46.5 t -124.63 129.12 73.79 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.234 0 CA-C-N 115.659 -0.7 . . . . 0.0 109.721 178.883 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' D' D ' 37' ' ' ILE . . . . . . . . . . . . . 68.0 mt -120.74 137.6 53.95 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.229 0 N-CA-C 109.857 -0.423 . . . . 0.0 109.857 -179.706 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' D' D ' 38' ' ' GLY . . . . . . . . . . . . . . . -111.5 128.74 8.8 Favored Glycine 0 CA--C 1.525 0.666 0 N-CA-C 111.018 -0.833 . . . . 0.0 111.018 179.606 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' D' D ' 39' ' ' ILE . . . . . . . . . . . . . 69.6 mt -125.44 126.64 70.89 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.228 0 N-CA-C 109.849 -0.426 . . . . 0.0 109.849 178.782 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' D' D ' 40' ' ' SER . . . . . . . . . . . . . 46.6 t -93.4 120.45 33.69 Favored 'General case' 0 C--N 1.33 -0.262 0 C-N-CA 120.825 -0.35 . . . . 0.0 110.88 176.158 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' D' D ' 41' ' ' ILE . . . . . . . . . . . . . 71.1 mt -132.88 125.47 52.32 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.186 0 CA-C-O 120.749 0.309 . . . . 0.0 110.316 178.589 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' D' D ' 42' ' ' LEU . . . . . . . . . . . . . 61.4 mt 57.5 34.39 24.54 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.098 -0.501 . . . . 0.0 111.891 177.296 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' D' D ' 43' ' ' GLY . . . . . . . . . . . . . . . 78.52 -10.11 31.88 Favored Glycine 0 CA--C 1.535 1.295 0 C-N-CA 121.192 -0.528 . . . . 0.0 113.463 176.975 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' D' D ' 44' ' ' LYS . . . . . . . . . . . . . 52.7 mtmt -101.76 130.25 48.13 Favored 'General case' 0 C--N 1.333 -0.14 0 CA-C-N 117.884 0.842 . . . . 0.0 110.066 176.65 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' D' D ' 45' ' ' GLU . . . . . . . . . . . . . 38.9 tp10 -85.53 130.33 34.6 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.4 -0.364 . . . . 0.0 110.777 -179.924 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' D' D ' 46' ' ' VAL . . . . . . . . . . . . . 7.2 p -121.61 129.46 75.5 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.235 0 N-CA-C 109.631 -0.507 . . . . 0.0 109.631 176.298 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' D' D ' 47' ' ' LYS . . . . . . . . . . . . . 98.5 mttt -101.03 130.44 47.03 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 115.892 -0.595 . . . . 0.0 111.119 178.387 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' D' D ' 48' ' ' PHE . . . . . . . . . . . . . 95.3 m-85 -113.41 131.83 55.85 Favored 'General case' 0 C--N 1.33 -0.244 0 N-CA-C 109.831 -0.433 . . . . 0.0 109.831 176.211 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' D' D ' 49' ' ' LYS . . . . . . . . . . . . . 81.8 tttt -110.5 139.11 46.05 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.402 -0.363 . . . . 0.0 110.63 179.454 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' D' D ' 50' ' ' VAL . . . . . 0.491 HG13 HD21 ' D' ' 4' ' ' LEU . 42.5 t -83.53 108.13 15.76 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.276 0 N-CA-C 109.4 -0.593 . . . . 0.0 109.4 175.59 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' D' D ' 51' ' ' VAL . . . . . . . . . . . . . 48.8 t -70.37 -48.26 61.36 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.314 0 CA-C-N 116.039 -0.528 . . . . 0.0 109.851 -173.816 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' D' D ' 52' ' ' GLN . . . . . 0.432 ' HA ' HG23 ' D' ' 33' ' ' THR . 14.0 pt20 -167.79 157.6 10.24 Favored 'General case' 0 C--N 1.331 -0.201 0 C-N-CA 120.115 -0.634 . . . . 0.0 112.017 -179.864 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' D' D ' 53' ' ' ALA . . . . . 0.656 ' HB3' ' OG ' ' D' ' 56' ' ' SER . . . -133.85 135.28 43.62 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 115.314 -0.857 . . . . 0.0 109.97 177.317 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' D' D ' 54' ' ' TYR . . . . . . . . . . . . . 13.8 t80 -129.01 111.69 18.47 Favored Pre-proline 0 CA--C 1.535 0.39 0 CA-C-O 118.24 -0.886 . . . . 0.0 110.133 179.163 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' D' D ' 55' ' ' PRO . . . . . . . . . . . . . 73.4 Cg_endo -77.12 170.21 72.21 Favored 'Cis proline' 0 N--CA 1.501 1.93 0 CA-C-N 121.899 1.714 . . . . 0.0 112.127 -7.587 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' D' D ' 56' ' ' SER . . . . . 0.656 ' OG ' ' HB3' ' D' ' 53' ' ' ALA . 66.0 m -129.71 140.64 39.23 Favored Pre-proline 0 CA--C 1.538 0.499 0 CA-C-O 118.71 -0.662 . . . . 0.0 109.489 174.52 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' D' D ' 57' ' ' PRO . . . . . . . . . . . . . 38.3 Cg_endo -68.05 156.31 87.46 Favored 'Cis proline' 0 N--CA 1.499 1.836 0 CA-C-N 121.559 1.592 . . . . 0.0 111.723 -2.018 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' D' D ' 58' ' ' LEU . . . . . . . . . . . . . 32.4 tp -128.75 138.86 52.34 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.252 -0.431 . . . . 0.0 110.778 -176.664 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' D' D ' 59' ' ' ARG . . . . . . . . . . . . . 60.1 ttt180 -100.48 120.36 39.88 Favored 'General case' 0 C--N 1.327 -0.4 0 N-CA-C 108.904 -0.776 . . . . 0.0 108.904 173.413 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' D' D ' 60' ' ' VAL . . . . . . . . . . . . . 43.3 t -72.63 126.38 33.12 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.252 0 C-N-CA 120.67 -0.412 . . . . 0.0 110.279 -174.084 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' D' D ' 61' ' ' GLU . . . . . . . . . . . . . 95.5 mt-10 -130.39 162.88 28.12 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 115.85 -0.613 . . . . 0.0 109.687 178.567 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' D' D ' 62' ' ' ASP . . . . . . . . . . . . . 5.2 t70 -53.34 -32.08 47.44 Favored 'General case' 0 C--N 1.328 -0.353 0 N-CA-C 111.782 0.29 . . . . 0.0 111.782 -179.638 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' D' D ' 63' ' ' ARG . . . . . . . . . . . . . 34.4 ptt180 -84.07 4.26 30.98 Favored 'General case' 0 CA--C 1.537 0.456 0 N-CA-C 113.779 1.029 . . . . 0.0 113.779 -174.926 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' D' D ' 64' ' ' THR . . . . . . . . . . . . . 35.4 m -86.93 139.61 30.45 Favored 'General case' 0 C--N 1.332 -0.186 0 CA-C-N 118.211 0.46 . . . . 0.0 110.713 -178.659 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' D' D ' 65' ' ' LYS . . . . . . . . . . . . . 67.5 mttm -90.14 134.05 34.51 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.252 -0.431 . . . . 0.0 110.581 -179.443 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' D' D ' 66' ' ' ILE . . . . . . . . . . . . . 58.8 mt -116.35 134.32 60.15 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.201 0 CA-C-O 120.897 0.379 . . . . 0.0 110.002 -179.719 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' D' D ' 67' ' ' THR . . . . . . . . . . . . . 34.6 m -125.31 141.46 52.07 Favored 'General case' 0 C--N 1.332 -0.17 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.92 -178.344 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' D' D ' 68' ' ' LEU . . . . . 0.426 ' C ' HD23 ' D' ' 68' ' ' LEU . 5.3 tt -105.93 124.03 48.92 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.002 -0.544 . . . . 0.0 110.128 178.468 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' D' D ' 69' ' ' VAL . . . . . 0.415 ' N ' HD23 ' D' ' 68' ' ' LEU . 44.4 t -102.82 140.3 21.49 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.24 0 CA-C-N 116.352 -0.385 . . . . 0.0 110.578 -177.237 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' D' D ' 70' ' ' THR . . . . . . . . . . . . . 11.2 p -140.83 -45.24 0.39 Allowed 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 116.265 -0.425 . . . . 0.0 110.964 178.846 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' D' D ' 71' ' ' HIS . . . . . . . . . . . . . 62.7 m80 -99.5 101.21 12.53 Favored Pre-proline 0 CA--C 1.534 0.348 0 CA-C-O 118.955 -0.545 . . . . 0.0 110.415 -177.977 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' D' D ' 72' ' ' PRO . . . . . . . . . . . . . 33.1 Cg_endo -64.82 -29.91 58.68 Favored 'Trans proline' 0 N--CA 1.5 1.87 0 C-N-CA 121.275 1.317 . . . . 0.0 112.407 -178.423 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' D' D ' 73' ' ' VAL . . . . . . . . . . . . . 27.7 m -75.21 -177.63 0.3 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.316 0 C-N-CA 120.948 -0.301 . . . . 0.0 110.468 178.651 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' D' D ' 74' ' ' ASP . . . . . . . . . . . . . 10.3 t0 -103.68 117.98 35.66 Favored 'General case' 0 C--N 1.33 -0.242 0 N-CA-C 109.796 -0.446 . . . . 0.0 109.796 179.821 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' D' D ' 75' ' ' VAL . . . . . . . . . . . . . 45.4 t -113.52 122.86 68.46 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.227 0 CA-C-O 121.173 0.511 . . . . 0.0 110.474 -178.756 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' D' D ' 76' ' ' LEU . . . . . . . . . . . . . 24.5 mt -122.71 138.04 54.73 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 115.398 -0.819 . . . . 0.0 109.035 176.451 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' D' D ' 77' ' ' GLU . . . . . . . . . . . . . 58.6 tt0 -136.84 135.34 37.83 Favored 'General case' 0 C--N 1.331 -0.197 0 CA-C-O 121.027 0.441 . . . . 0.0 110.995 -177.133 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' D' D ' 78' ' ' ALA . . . . . 0.576 ' HB2' HD21 ' D' ' 109' ' ' LEU . . . -122.47 137.67 54.8 Favored 'General case' 0 C--N 1.331 -0.203 0 CA-C-N 115.862 -0.608 . . . . 0.0 109.926 178.517 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' D' D ' 79' ' ' LYS . . . . . 0.59 ' O ' HD13 ' D' ' 80' ' ' ILE . 54.2 mtmt -81.97 120.41 25.21 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-O 120.884 0.374 . . . . 0.0 110.483 179.831 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' D' D ' 80' ' ' ILE . . . . . 0.59 HD13 ' O ' ' D' ' 79' ' ' LYS . 42.6 mm -138.99 112.55 6.76 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.344 0 N-CA-C 109.254 -0.647 . . . . 0.0 109.254 -177.423 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' D' D ' 81' ' ' LYS . . . . . . . . . . . . . 9.3 mtmp? -103.33 126.88 50.72 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-O 120.91 0.386 . . . . 0.0 111.259 -177.158 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' D' D ' 82' ' ' GLY . . . . . . . . . . . . . . . 89.18 42.06 5.68 Favored Glycine 0 CA--C 1.525 0.712 0 C-N-CA 120.989 -0.624 . . . . 0.0 111.645 174.795 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' D' D ' 83' ' ' ILE . . . . . . . . . . . . . 72.5 mt -69.92 134.71 29.65 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.331 0 N-CA-C 109.501 -0.555 . . . . 0.0 109.501 176.347 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' D' D ' 84' ' ' LYS . . . . . . . . . . . . . 35.7 ttpt -98.65 -54.11 3.12 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-O 121.057 0.456 . . . . 0.0 110.423 -178.811 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' D' D ' 85' ' ' ASP . . . . . . . . . . . . . 10.6 t70 -148.53 149.94 32.5 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 115.758 -0.656 . . . . 0.0 110.387 -178.168 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' D' D ' 86' ' ' VAL . . . . . . . . . . . . . 40.7 t -127.41 129.51 70.58 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.252 0 CA-C-O 120.813 0.339 . . . . 0.0 110.474 -178.906 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' D' D ' 87' ' ' ILE . . . . . . . . . . . . . 43.7 mm -119.49 130.87 73.48 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.255 0 CA-C-N 115.98 -0.554 . . . . 0.0 109.61 177.305 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' D' D ' 88' ' ' LEU . . . . . . . . . . . . . 19.3 tp -115.42 135.79 53.75 Favored 'General case' 0 C--N 1.331 -0.205 0 CA-C-O 120.952 0.406 . . . . 0.0 111.544 -175.797 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' D' D ' 89' ' ' ASP . . . . . . . . . . . . . 13.3 t70 -128.67 156.97 42.6 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-N 115.755 -0.657 . . . . 0.0 109.537 176.091 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' D' D ' 90' ' ' GLU . . . . . . . . . . . . . 70.8 mm-40 -46.96 -38.53 10.79 Favored 'General case' 0 N--CA 1.465 0.305 0 N-CA-C 113.035 0.754 . . . . 0.0 113.035 -171.102 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' D' D ' 91' ' ' ASN . . . . . . . . . . . . . 59.7 m-80 -131.97 20.0 4.54 Favored 'General case' 0 N--CA 1.467 0.413 0 N-CA-C 112.968 0.729 . . . . 0.0 112.968 -177.421 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' D' D ' 92' ' ' LEU . . . . . 0.408 HD21 HG21 ' D' ' 143' ' ' THR . 15.8 mt -147.04 143.93 28.73 Favored 'General case' 0 C--N 1.331 -0.213 0 N-CA-C 110.141 -0.318 . . . . 0.0 110.141 -176.654 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' D' D ' 93' ' ' ILE . . . . . . . . . . . . . 75.2 mt -123.55 119.5 57.44 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.285 0 N-CA-C 109.294 -0.632 . . . . 0.0 109.294 179.035 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' D' D ' 94' ' ' VAL . . . . . 0.475 HG21 HG11 ' D' ' 125' ' ' VAL . 46.5 t -118.35 125.09 74.04 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.208 0 CA-C-O 120.988 0.423 . . . . 0.0 109.912 -178.57 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' D' D ' 95' ' ' VAL . . . . . . . . . . . . . 47.0 t -118.72 131.98 69.91 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.344 0 CA-C-N 115.862 -0.608 . . . . 0.0 109.643 -179.564 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' D' D ' 96' ' ' ILE . . . . . . . . . . . . . 68.7 mt -112.61 126.79 70.04 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.328 0 N-CA-C 109.184 -0.672 . . . . 0.0 109.184 178.354 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' D' D ' 97' ' ' THR . . . . . . . . . . . . . 78.4 p -97.63 159.64 14.8 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-O 121.28 0.562 . . . . 0.0 111.214 -176.678 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' D' D ' 98' ' ' GLU . . . . . . . . . . . . . 85.4 tt0 -53.96 -27.48 31.5 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 115.906 -0.588 . . . . 0.0 112.202 -179.061 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' D' D ' 99' ' ' GLU . . . . . . . . . . . . . 95.2 mt-10 -82.32 15.4 2.47 Favored 'General case' 0 CA--C 1.535 0.403 0 N-CA-C 113.14 0.793 . . . . 0.0 113.14 -176.581 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' D' D ' 100' ' ' ASN . . . . . . . . . . . . . 4.1 m-20 62.2 35.63 15.41 Favored 'General case' 0 C--N 1.331 -0.212 0 CA-C-O 120.949 0.404 . . . . 0.0 111.441 179.675 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' D' D ' 101' ' ' GLU . . . . . . . . . . . . . 84.2 tt0 -109.04 143.83 37.84 Favored 'General case' 0 C--N 1.331 -0.203 0 N-CA-C 109.595 -0.521 . . . . 0.0 109.595 173.227 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' D' D ' 102' ' ' VAL . . . . . . . . . . . . . 43.0 t -114.94 125.24 72.21 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.292 0 CA-C-N 116.206 -0.452 . . . . 0.0 109.944 -177.399 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' D' D ' 103' ' ' LEU . . . . . . . . . . . . . 16.8 mt -116.13 130.18 56.68 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 115.877 -0.601 . . . . 0.0 110.256 177.532 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' D' D ' 104' ' ' ILE . . . . . . . . . . . . . 70.9 mt -116.98 121.94 68.92 Favored 'Isoleucine or valine' 0 C--O 1.235 0.299 0 N-CA-C 110.286 -0.265 . . . . 0.0 110.286 179.83 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' D' D ' 105' ' ' PHE . . . . . . . . . . . . . 86.7 m-85 -121.67 163.47 18.95 Favored 'General case' 0 CA--C 1.528 0.134 0 O-C-N 124.052 0.845 . . . . 0.0 109.885 179.0 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' D' D ' 106' ' ' ASN . . . . . . . . . . . . . 40.6 p-10 -96.72 -169.94 1.97 Allowed 'General case' 0 C--N 1.33 -0.274 0 N-CA-C 109.913 -0.403 . . . . 0.0 109.913 173.075 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' D' D ' 107' ' ' GLN . . . . . . . . . . . . . 34.3 tt0 -60.59 -30.09 69.6 Favored 'General case' 0 CA--C 1.532 0.269 0 C-N-CA 121.014 -0.275 . . . . 0.0 111.628 179.565 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' D' D ' 108' ' ' ASN . . . . . . . . . . . . . 4.0 t-20 -82.67 4.79 23.5 Favored 'General case' 0 CA--C 1.536 0.421 0 N-CA-C 113.355 0.872 . . . . 0.0 113.355 -178.454 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' D' D ' 109' ' ' LEU . . . . . 0.576 HD21 ' HB2' ' D' ' 78' ' ' ALA . 7.4 tp 63.87 36.69 10.13 Favored 'General case' 0 CA--C 1.53 0.185 0 O-C-N 122.13 -0.356 . . . . 0.0 111.467 177.492 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' D' D ' 110' ' ' GLU . . . . . . . . . . . . . 95.5 mt-10 -105.13 154.49 20.11 Favored 'General case' 0 C--N 1.331 -0.222 0 N-CA-C 109.887 -0.412 . . . . 0.0 109.887 176.401 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' D' D ' 111' ' ' GLU . . . . . . . . . . . . . 83.6 tt0 -80.46 124.87 29.29 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-O 120.952 0.406 . . . . 0.0 110.928 -176.506 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' D' D ' 112' ' ' LEU . . . . . . . . . . . . . 31.8 mt -111.89 -46.08 3.27 Favored 'General case' 0 C--N 1.331 -0.216 0 CA-C-N 115.995 -0.548 . . . . 0.0 110.511 178.355 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' D' D ' 113' ' ' TYR . . . . . . . . . . . . . 58.1 t80 -142.21 140.35 32.3 Favored 'General case' 0 C--N 1.328 -0.331 0 C-N-CA 120.792 -0.363 . . . . 0.0 111.242 -179.644 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' D' D ' 114' ' ' ARG . . . . . . . . . . . . . 33.6 ttp180 -136.82 126.48 25.4 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.202 -0.454 . . . . 0.0 110.419 176.975 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' D' D ' 115' ' ' GLY . . . . . . . . . . . . . . . -150.05 158.93 27.89 Favored Glycine 0 CA--C 1.524 0.636 0 N-CA-C 110.78 -0.928 . . . . 0.0 110.78 178.164 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' D' D ' 116' ' ' LYS . . . . . . . . . . . . . 79.3 tttt -136.02 131.75 35.38 Favored 'General case' 0 C--N 1.328 -0.331 0 N-CA-C 109.925 -0.398 . . . . 0.0 109.925 178.879 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' D' D ' 117' ' ' PHE . . . . . . . . . . . . . 32.4 m-85 -132.72 117.56 18.0 Favored 'General case' 0 N--CA 1.463 0.214 0 CA-C-O 120.929 0.395 . . . . 0.0 110.599 -173.72 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' D' D ' 118' ' ' GLU . . . . . . . . . . . . . 46.5 tp10 -52.88 -50.96 62.79 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.296 -0.411 . . . . 0.0 111.393 -177.577 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' D' D ' 119' ' ' ASN . . . . . . . . . . . . . 79.4 m-20 -93.61 31.07 1.62 Allowed 'General case' 0 C--N 1.33 -0.27 0 N-CA-C 112.202 0.445 . . . . 0.0 112.202 -173.783 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' D' D ' 120' ' ' LEU . . . . . . . . . . . . . 20.2 tp -58.36 124.58 20.01 Favored 'General case' 0 C--N 1.332 -0.195 0 N-CA-C 110.075 -0.343 . . . . 0.0 110.075 177.474 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' D' D ' 121' ' ' ASN . . . . . . . . . . . . . 4.4 m-20 -114.03 -44.09 3.18 Favored 'General case' 0 C--N 1.331 -0.213 0 CA-C-N 116.56 -0.291 . . . . 0.0 110.963 -178.143 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' D' D ' 122' ' ' LYS . . . . . . . . . . . . . 85.1 mttt -146.45 149.98 34.74 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-O 121.156 0.503 . . . . 0.0 111.902 -176.414 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' D' D ' 123' ' ' VAL . . . . . 0.433 ' C ' HD12 ' D' ' 124' ' ' LEU . 44.1 t -124.91 128.88 73.47 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.299 0 N-CA-C 109.211 -0.663 . . . . 0.0 109.211 172.873 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' D' D ' 124' ' ' LEU . . . . . 0.433 HD12 ' C ' ' D' ' 123' ' ' VAL . 6.6 mp -121.89 135.96 54.91 Favored 'General case' 0 C--N 1.332 -0.176 0 CA-C-N 116.609 -0.269 . . . . 0.0 110.732 -176.273 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' D' D ' 125' ' ' VAL . . . . . 0.475 HG11 HG21 ' D' ' 94' ' ' VAL . 35.5 m -136.72 130.21 45.96 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.193 0 CA-C-O 120.955 0.407 . . . . 0.0 110.983 178.734 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' D' D ' 126' ' ' ARG . . . . . . . . . . . . . 95.2 mtt180 -151.69 130.19 12.19 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 115.911 -0.586 . . . . 0.0 109.802 176.901 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' D' D ' 127' ' ' ASN . . . . . . . . . . . . . 4.1 m120 56.6 -152.38 0.39 Allowed 'General case' 0 CA--C 1.539 0.536 0 N-CA-C 109.764 -0.458 . . . . 0.0 109.764 179.68 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' D' D ' 128' ' ' ASP . . . . . . . . . . . . . 15.4 p-10 -80.47 14.59 1.96 Allowed 'General case' 0 CA--C 1.536 0.423 0 N-CA-C 112.876 0.695 . . . . 0.0 112.876 178.662 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' D' D ' 129' ' ' LEU . . . . . 0.541 HD13 ' NE ' ' D' ' 142' ' ' ARG . 11.6 tp -114.17 132.63 56.02 Favored 'General case' 0 N--CA 1.46 0.045 0 CA-C-N 118.09 0.404 . . . . 0.0 109.911 179.049 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' D' D ' 130' ' ' VAL . . . . . 0.404 HG23 ' HB ' ' D' ' 141' ' ' ILE . 34.5 m -132.07 142.39 42.97 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.193 0 CA-C-O 121.086 0.469 . . . . 0.0 110.157 176.763 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' D' D ' 131' ' ' VAL . . . . . . . . . . . . . 34.4 m -136.14 148.79 27.41 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 CA-C-O 121.191 0.519 . . . . 0.0 111.21 -179.255 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' D' D ' 132' ' ' ILE . . . . . . . . . . . . . 75.2 mt -115.44 130.66 69.65 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.383 0 CA-C-N 115.4 -0.818 . . . . 0.0 109.024 178.307 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' D' D ' 133' ' ' ILE . . . . . . . . . . . . . 42.3 mm -115.27 115.2 48.66 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.197 0 CA-C-O 120.884 0.373 . . . . 0.0 110.753 -175.993 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' D' D ' 134' ' ' ASP . . . . . . . . . . . . . 6.1 p-10 -125.88 145.51 50.22 Favored 'General case' 0 C--N 1.333 -0.12 0 N-CA-C 109.371 -0.603 . . . . 0.0 109.371 174.95 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' D' D ' 135' ' ' GLU . . . . . . . . . . . . . 46.2 tp10 -49.75 -26.58 3.98 Favored 'General case' 0 C--N 1.327 -0.388 0 N-CA-C 112.761 0.652 . . . . 0.0 112.761 -169.318 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' D' D ' 136' ' ' GLN . . . . . . . . . . . . . 99.1 mm-40 -92.95 -39.74 10.97 Favored 'General case' 0 C--N 1.332 -0.179 0 N-CA-C 112.293 0.479 . . . . 0.0 112.293 -177.126 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' D' D ' 137' ' ' LYS . . . . . . . . . . . . . 28.0 mtpp -137.99 155.02 49.28 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-O 121.277 0.56 . . . . 0.0 111.698 -170.015 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' D' D ' 138' ' ' LEU . . . . . . . . . . . . . 5.3 tt -116.06 125.34 52.29 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 115.547 -0.752 . . . . 0.0 109.286 174.407 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' D' D ' 139' ' ' THR . . . . . . . . . . . . . 39.9 m -110.67 129.65 55.77 Favored 'General case' 0 C--N 1.332 -0.183 0 CA-C-N 116.406 -0.361 . . . . 0.0 110.993 -177.6 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' D' D ' 140' ' ' LEU . . . . . 0.469 ' C ' HD23 ' D' ' 140' ' ' LEU . 6.5 tt -111.17 123.59 50.5 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 115.499 -0.773 . . . . 0.0 109.322 -179.502 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' D' D ' 141' ' ' ILE . . . . . 0.415 ' N ' HD23 ' D' ' 140' ' ' LEU . 18.8 mt -125.36 118.38 52.4 Favored 'Isoleucine or valine' 0 C--O 1.234 0.255 0 CA-C-O 120.964 0.411 . . . . 0.0 110.404 -177.199 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' D' D ' 142' ' ' ARG . . . . . 0.541 ' NE ' HD13 ' D' ' 129' ' ' LEU . 15.9 mmt180 -102.91 122.75 45.19 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 115.425 -0.807 . . . . 0.0 109.777 175.079 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' D' D ' 143' ' ' THR . . . . . 0.408 HG21 HD21 ' D' ' 92' ' ' LEU . 2.5 p . . . . . 0 C--O 1.22 -0.487 0 CA-C-O 117.983 -1.008 . . . . 0.0 110.568 179.898 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' E' E ' -3' ' ' GLU . . . . . . . . . . . . . 95.8 mt-10 . . . . . 0 N--CA 1.489 1.52 0 N-CA-C 109.366 -0.605 . . . . 0.0 109.366 . . . . . . . . . 0 0 . 1 . 018 nuclear nobuild full ' E' E ' -2' ' ' GLY . . . . . . . . . . . . . . . -70.42 150.03 47.83 Favored Glycine 0 CA--C 1.526 0.719 0 N-CA-C 111.001 -0.84 . . . . 0.0 111.001 179.524 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' E' E ' -1' ' ' VAL . . . . . . . . . . . . . 48.1 t -94.91 138.91 19.7 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.29 0 N-CA-C 110.008 -0.367 . . . . 0.0 110.008 -179.897 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' E' E ' 0' ' ' ILE . . . . . . . . . . . . . 69.7 mt -106.33 140.78 23.34 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.23 0 CA-C-O 121.048 0.451 . . . . 0.0 110.276 -178.465 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' E' E ' 1' ' ' MET . . . . . . . . . . . . . 25.9 ptt? -78.34 135.35 37.46 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 115.804 -0.634 . . . . 0.0 111.083 -178.844 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' E' E ' 2' ' ' SER . . . . . . . . . . . . . 3.9 p -127.32 136.38 51.85 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.141 -0.481 . . . . 0.0 110.287 178.305 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' E' E ' 3' ' ' GLU . . . . . . . . . . . . . 30.4 tp10 -139.14 139.75 37.71 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.244 -0.435 . . . . 0.0 110.79 -176.215 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' E' E ' 4' ' ' LEU . . . . . . . . . . . . . 18.1 tp -126.01 130.79 51.88 Favored 'General case' 0 C--N 1.332 -0.184 0 N-CA-C 109.881 -0.415 . . . . 0.0 109.881 174.809 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' E' E ' 5' ' ' LYS . . . . . . . . . . . . . 99.3 mttt -116.33 123.98 48.99 Favored 'General case' 0 C--O 1.235 0.297 0 CA-C-O 120.734 0.302 . . . . 0.0 111.192 -178.236 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' E' E ' 6' ' ' LEU . . . . . 0.404 HD23 ' HA ' ' E' ' 50' ' ' VAL . 50.8 mt -113.98 147.11 39.14 Favored 'General case' 0 N--CA 1.461 0.117 0 CA-C-N 115.437 -0.801 . . . . 0.0 110.272 178.837 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' E' E ' 7' ' ' LYS . . . . . . . . . . . . . 82.2 tttt -129.37 141.02 40.36 Favored Pre-proline 0 CA--C 1.533 0.302 0 CA-C-O 119.137 -0.459 . . . . 0.0 109.883 175.031 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' E' E ' 8' ' ' PRO . . . . . . . . . . . . . 90.0 Cg_endo -91.84 146.17 3.13 Favored 'Trans proline' 0 N--CA 1.49 1.272 0 C-N-CA 121.916 1.744 . . . . 0.0 112.163 179.392 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' E' E ' 9' ' ' LEU . . . . . . . . . . . . . 37.1 mt -86.79 -49.23 0.48 Allowed Pre-proline 0 CA--C 1.535 0.376 0 CA-C-O 118.682 -0.675 . . . . 0.0 112.562 178.818 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' E' E ' 10' ' ' PRO . . . . . . . . . . . . . 97.2 Cg_endo -77.93 161.65 29.87 Favored 'Trans proline' 0 N--CA 1.497 1.725 0 C-N-CA 121.256 1.304 . . . . 0.0 112.444 -179.665 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' E' E ' 11' ' ' LYS . . . . . . . . . . . . . 25.1 tptp -86.93 95.44 9.9 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-N 116.231 -0.441 . . . . 0.0 110.085 177.536 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' E' E ' 12' ' ' VAL . . . . . . . . . . . . . 12.5 p -142.18 147.63 21.2 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 CA-C-N 116.313 -0.403 . . . . 0.0 110.838 -179.008 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' E' E ' 13' ' ' GLU . . . . . . . . . . . . . 95.9 mt-10 -93.81 122.6 36.45 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.029 -0.532 . . . . 0.0 110.128 177.507 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' E' E ' 14' ' ' LEU . . . . . . . . . . . . . 22.3 mt -97.65 151.26 37.51 Favored Pre-proline 0 CA--C 1.533 0.301 0 CA-C-O 119.329 -0.367 . . . . 0.0 110.464 -178.714 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' E' E ' 15' ' ' PRO . . . . . . . . . . . . . 37.8 Cg_exo -59.46 156.06 38.25 Favored 'Trans proline' 0 N--CA 1.498 1.775 0 C-N-CA 121.241 1.294 . . . . 0.0 111.835 178.391 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' E' E ' 16' ' ' PRO . . . . . . . . . . . . . 31.4 Cg_exo -56.83 -38.99 94.57 Favored 'Trans proline' 0 N--CA 1.497 1.711 0 C-N-CA 121.333 1.355 . . . . 0.0 112.475 -179.856 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' E' E ' 17' ' ' ASP . . . . . . . . . . . . . 23.1 p-10 -93.48 20.18 7.56 Favored 'General case' 0 C--N 1.329 -0.324 0 N-CA-C 112.665 0.617 . . . . 0.0 112.665 -178.242 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' E' E ' 18' ' ' PHE . . . . . 0.53 ' CZ ' HD11 ' E' ' 22' ' ' ILE . 62.5 t80 -57.11 -41.6 79.28 Favored 'General case' 0 C--O 1.227 -0.101 0 O-C-N 122.051 -0.405 . . . . 0.0 110.308 -178.329 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' E' E ' 19' ' ' VAL . . . . . . . . . . . . . 52.2 t -54.91 -45.82 75.84 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.289 0 CA-C-N 116.396 -0.365 . . . . 0.0 110.815 -178.912 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' E' E ' 20' ' ' ASP . . . . . . . . . . . . . 80.8 m-20 -60.28 -41.4 93.25 Favored 'General case' 0 C--N 1.331 -0.222 0 C-N-CA 120.905 -0.318 . . . . 0.0 110.886 -178.165 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' E' E ' 21' ' ' VAL . . . . . . . . . . . . . 47.9 t -63.92 -47.15 91.89 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.306 0 C-N-CA 120.736 -0.386 . . . . 0.0 110.398 -177.931 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' E' E ' 22' ' ' ILE . . . . . 0.615 HG22 HD12 ' E' ' 26' ' ' LEU . 51.3 mm -57.18 -43.83 82.4 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.197 0 C-N-CA 120.856 -0.338 . . . . 0.0 110.529 179.158 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' E' E ' 23' ' ' ARG . . . . . . . . . . . . . 28.7 ttp180 -54.56 -48.24 72.3 Favored 'General case' 0 C--N 1.331 -0.201 0 C-N-CA 121.082 -0.247 . . . . 0.0 111.286 -179.472 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' E' E ' 24' ' ' ILE . . . . . . . . . . . . . 72.9 mt -58.52 -44.44 89.18 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.377 0 C-N-CA 120.959 -0.297 . . . . 0.0 110.708 -177.92 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' E' E ' 25' ' ' LYS . . . . . . . . . . . . . 24.5 mtpp -64.68 -44.01 91.71 Favored 'General case' 0 C--N 1.329 -0.291 0 N-CA-C 112.456 0.539 . . . . 0.0 112.456 -178.046 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' E' E ' 26' ' ' LEU . . . . . 0.615 HD12 HG22 ' E' ' 22' ' ' ILE . 79.1 mt -84.03 -25.29 30.02 Favored 'General case' 0 C--N 1.329 -0.289 0 N-CA-C 113.388 0.884 . . . . 0.0 113.388 -171.667 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' E' E ' 27' ' ' GLN . . . . . . . . . . . . . 6.1 pt20 -46.13 135.84 7.32 Favored 'General case' 0 N--CA 1.467 0.416 0 N-CA-C 112.757 0.651 . . . . 0.0 112.757 -174.41 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' E' E ' 28' ' ' GLY . . . . . . . . . . . . . . . 98.86 -22.3 41.67 Favored Glycine 0 CA--C 1.535 1.291 0 CA-C-N 115.792 -0.64 . . . . 0.0 112.516 -177.474 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' E' E ' 29' ' ' LYS . . . . . . . . . . . . . 8.2 mtpm? -97.53 155.08 17.11 Favored 'General case' 0 C--N 1.331 -0.2 0 CA-C-N 117.474 0.637 . . . . 0.0 110.925 179.523 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' E' E ' 30' ' ' THR . . . . . . . . . . . . . 22.3 m -109.77 139.27 45.02 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.337 177.115 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' E' E ' 31' ' ' VAL . . . . . . . . . . . . . 35.1 m -128.35 157.7 40.67 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.266 0 CA-C-N 116.254 -0.43 . . . . 0.0 110.505 -179.528 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' E' E ' 32' ' ' ARG . . . . . . . . . . . . . 53.0 ttp180 -132.21 150.92 52.04 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-O 121.198 0.523 . . . . 0.0 110.579 179.139 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' E' E ' 33' ' ' THR . . . . . . . . . . . . . 27.6 m -52.81 138.88 28.37 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.264 -0.425 . . . . 0.0 111.471 -177.812 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' E' E ' 34' ' ' GLY . . . . . . . . . . . . . . . 99.36 -17.23 58.1 Favored Glycine 0 CA--C 1.532 1.142 0 CA-C-N 116.151 -0.477 . . . . 0.0 113.2 179.087 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' E' E ' 35' ' ' ASP . . . . . . . . . . . . . 78.7 m-20 -67.46 149.39 50.27 Favored 'General case' 0 C--N 1.334 -0.085 0 CA-C-N 118.059 0.929 . . . . 0.0 111.204 178.539 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' E' E ' 36' ' ' VAL . . . . . . . . . . . . . 43.4 t -119.27 129.1 75.69 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.216 0 CA-C-N 115.945 -0.57 . . . . 0.0 109.582 176.785 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' E' E ' 37' ' ' ILE . . . . . . . . . . . . . 64.3 mt -118.19 138.35 49.19 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 CA-C-N 116.178 -0.464 . . . . 0.0 109.76 -178.967 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' E' E ' 38' ' ' GLY . . . . . . . . . . . . . . . -116.51 127.64 7.57 Favored Glycine 0 CA--C 1.523 0.567 0 N-CA-C 110.88 -0.888 . . . . 0.0 110.88 179.097 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' E' E ' 39' ' ' ILE . . . . . . . . . . . . . 72.0 mt -127.22 126.78 68.49 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.214 0 N-CA-C 110.136 -0.32 . . . . 0.0 110.136 179.135 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' E' E ' 40' ' ' SER . . . . . . . . . . . . . 53.8 p -92.52 122.41 34.93 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.374 -0.375 . . . . 0.0 110.826 176.632 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' E' E ' 41' ' ' ILE . . . . . . . . . . . . . 70.6 mt -132.22 130.55 60.64 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.228 0 CA-C-O 120.808 0.337 . . . . 0.0 110.22 177.502 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' E' E ' 42' ' ' LEU . . . . . . . . . . . . . 64.7 mt 56.87 32.94 22.32 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 116.144 -0.48 . . . . 0.0 111.959 178.176 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' E' E ' 43' ' ' GLY . . . . . . . . . . . . . . . 72.95 23.69 77.39 Favored Glycine 0 CA--C 1.531 1.039 0 C-N-CA 121.067 -0.587 . . . . 0.0 112.71 177.717 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' E' E ' 44' ' ' LYS . . . . . . . . . . . . . 99.4 mttt -138.66 128.65 25.34 Favored 'General case' 0 C--N 1.331 -0.206 0 CA-C-N 117.404 0.602 . . . . 0.0 109.861 178.051 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' E' E ' 45' ' ' GLU . . . . . . . . . . . . . 44.0 tp10 -85.55 132.36 34.2 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.42 -0.354 . . . . 0.0 111.539 -176.835 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' E' E ' 46' ' ' VAL . . . . . . . . . . . . . 8.8 p -121.92 127.93 75.52 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.186 0 N-CA-C 109.343 -0.614 . . . . 0.0 109.343 172.81 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' E' E ' 47' ' ' LYS . . . . . . . . . . . . . 55.4 mtmt -98.42 127.21 44.25 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.142 -0.481 . . . . 0.0 110.833 177.781 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' E' E ' 48' ' ' PHE . . . . . . . . . . . . . 43.0 m-85 -114.21 131.9 56.3 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 115.925 -0.58 . . . . 0.0 109.683 177.333 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' E' E ' 49' ' ' LYS . . . . . . . . . . . . . 75.8 tttt -105.81 134.81 48.33 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 116.417 -0.356 . . . . 0.0 110.102 178.483 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' E' E ' 50' ' ' VAL . . . . . 0.404 ' HA ' HD23 ' E' ' 6' ' ' LEU . 45.8 t -78.7 107.15 10.64 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.339 0 N-CA-C 109.245 -0.65 . . . . 0.0 109.245 177.752 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' E' E ' 51' ' ' VAL . . . . . . . . . . . . . 48.4 t -73.56 -51.11 26.43 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.316 0 CA-C-N 116.152 -0.476 . . . . 0.0 109.769 -174.567 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' E' E ' 52' ' ' GLN . . . . . . . . . . . . . 90.4 mt-30 -152.77 149.61 28.53 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-O 121.249 0.547 . . . . 0.0 111.963 -177.803 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' E' E ' 53' ' ' ALA . . . . . . . . . . . . . . . -130.46 130.63 44.48 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 114.978 -1.01 . . . . 0.0 109.243 173.143 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' E' E ' 54' ' ' TYR . . . . . . . . . . . . . 6.9 t80 -129.14 109.33 18.03 Favored Pre-proline 0 CA--C 1.534 0.361 0 CA-C-O 118.203 -0.903 . . . . 0.0 110.138 179.011 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' E' E ' 55' ' ' PRO . . . . . . . . . . . . . 74.1 Cg_endo -77.07 170.08 72.61 Favored 'Cis proline' 0 N--CA 1.5 1.895 0 CA-C-N 122.012 1.754 . . . . 0.0 112.593 -4.795 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' E' E ' 56' ' ' SER . . . . . . . . . . . . . 13.6 m -116.39 132.67 23.2 Favored Pre-proline 0 CA--C 1.539 0.546 0 CA-C-O 118.359 -0.829 . . . . 0.0 109.579 176.058 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' E' E ' 57' ' ' PRO . . . . . . . . . . . . . 48.3 Cg_endo -70.57 165.34 79.21 Favored 'Cis proline' 0 N--CA 1.496 1.663 0 CA-C-N 121.975 1.741 . . . . 0.0 111.536 -2.572 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' E' E ' 58' ' ' LEU . . . . . . . . . . . . . 22.5 tp -129.9 138.19 50.79 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.2 -0.455 . . . . 0.0 110.273 -179.563 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' E' E ' 59' ' ' ARG . . . . . . . . . . . . . 53.9 ttp180 -105.83 136.24 45.83 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-N 115.924 -0.58 . . . . 0.0 109.463 176.684 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' E' E ' 60' ' ' VAL . . . . . . . . . . . . . 39.9 t -89.62 116.34 30.88 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.264 0 CA-C-O 121.04 0.448 . . . . 0.0 110.638 -175.172 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' E' E ' 61' ' ' GLU . . . . . . . . . . . . . 95.6 mt-10 -131.05 173.28 11.16 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 115.552 -0.749 . . . . 0.0 109.455 175.501 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' E' E ' 62' ' ' ASP . . . . . . . . . . . . . 58.8 m-20 -53.72 -33.96 57.33 Favored 'General case' 0 C--N 1.328 -0.347 0 N-CA-C 111.778 0.288 . . . . 0.0 111.778 -178.821 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' E' E ' 63' ' ' ARG . . . . . . . . . . . . . 26.2 mmm180 -76.57 -17.81 59.01 Favored 'General case' 0 CA--C 1.533 0.317 0 N-CA-C 113.224 0.824 . . . . 0.0 113.224 -176.28 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' E' E ' 64' ' ' THR . . . . . . . . . . . . . 19.0 m -68.95 136.16 52.11 Favored 'General case' 0 C--N 1.331 -0.208 0 CA-C-O 120.896 0.379 . . . . 0.0 110.707 -174.919 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' E' E ' 65' ' ' LYS . . . . . . . . . . . . . 43.4 mtpt -90.06 122.33 32.95 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.098 -0.501 . . . . 0.0 109.9 179.946 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' E' E ' 66' ' ' ILE . . . . . . . . . . . . . 62.3 mt -113.83 131.95 64.23 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.234 0 CA-C-O 120.896 0.379 . . . . 0.0 110.35 -176.975 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' E' E ' 67' ' ' THR . . . . . . . . . . . . . 41.4 m -126.84 139.42 53.1 Favored 'General case' 0 C--O 1.234 0.24 0 CA-C-N 115.923 -0.58 . . . . 0.0 110.59 179.137 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' E' E ' 68' ' ' LEU . . . . . 0.429 ' C ' HD23 ' E' ' 68' ' ' LEU . 5.4 tt -107.05 124.25 49.38 Favored 'General case' 0 C--N 1.327 -0.397 0 CA-C-N 115.787 -0.642 . . . . 0.0 109.894 177.461 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' E' E ' 69' ' ' VAL . . . . . 0.406 ' N ' HD23 ' E' ' 68' ' ' LEU . 44.2 t -99.95 129.46 50.57 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.379 0 N-CA-C 109.644 -0.502 . . . . 0.0 109.644 -179.251 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' E' E ' 70' ' ' THR . . . . . 0.486 HG23 ' O ' ' E' ' 70' ' ' THR . 7.5 t -145.71 115.92 7.47 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-O 121.191 0.519 . . . . 0.0 111.167 -178.76 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' E' E ' 71' ' ' HIS . . . . . . . . . . . . . 17.4 t-80 -144.8 66.27 13.04 Favored Pre-proline 0 CA--C 1.534 0.363 0 CA-C-N 115.886 -0.597 . . . . 0.0 110.205 176.063 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' E' E ' 72' ' ' PRO . . . . . . . . . . . . . 73.5 Cg_endo -94.6 158.06 1.93 Allowed 'Trans proline' 0 N--CA 1.487 1.131 0 C-N-CA 122.154 1.902 . . . . 0.0 112.516 -178.724 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' E' E ' 73' ' ' VAL . . . . . . . . . . . . . 35.1 m -70.04 156.54 7.09 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.302 0 CA-C-N 116.1 -0.5 . . . . 0.0 109.882 176.487 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' E' E ' 74' ' ' ASP . . . . . . . . . . . . . 19.5 t0 -95.41 115.05 26.89 Favored 'General case' 0 C--N 1.332 -0.191 0 N-CA-C 109.764 -0.458 . . . . 0.0 109.764 -178.493 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' E' E ' 75' ' ' VAL . . . . . 0.452 ' C ' HD12 ' E' ' 76' ' ' LEU . 38.4 t -118.6 126.39 75.14 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.218 0 CA-C-O 121.0 0.428 . . . . 0.0 110.655 -176.547 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' E' E ' 76' ' ' LEU . . . . . 0.452 HD12 ' C ' ' E' ' 75' ' ' VAL . 5.8 mp -127.32 147.48 50.25 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 115.646 -0.707 . . . . 0.0 109.863 177.125 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' E' E ' 77' ' ' GLU . . . . . . . . . . . . . 96.3 mt-10 -134.21 133.33 40.77 Favored 'General case' 0 C--N 1.332 -0.19 0 CA-C-O 121.078 0.466 . . . . 0.0 111.27 -178.748 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' E' E ' 78' ' ' ALA . . . . . 0.441 ' HB2' HD21 ' E' ' 109' ' ' LEU . . . -122.3 141.29 51.68 Favored 'General case' 0 C--N 1.331 -0.221 0 CA-C-N 115.7 -0.682 . . . . 0.0 109.739 176.347 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' E' E ' 79' ' ' LYS . . . . . 0.588 ' O ' HD13 ' E' ' 80' ' ' ILE . 82.3 tttt -84.5 117.51 23.73 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-O 120.889 0.376 . . . . 0.0 110.641 -178.262 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' E' E ' 80' ' ' ILE . . . . . 0.588 HD13 ' O ' ' E' ' 79' ' ' LYS . 42.9 mm -137.95 110.74 7.15 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.381 0 N-CA-C 108.953 -0.758 . . . . 0.0 108.953 -178.858 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' E' E ' 81' ' ' LYS . . . . . . . . . . . . . 55.3 pttt -100.18 125.91 46.38 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-O 120.895 0.378 . . . . 0.0 111.336 -176.589 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' E' E ' 82' ' ' GLY . . . . . . . . . . . . . . . 87.85 42.17 6.11 Favored Glycine 0 CA--C 1.525 0.683 0 C-N-CA 120.825 -0.702 . . . . 0.0 111.714 175.072 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' E' E ' 83' ' ' ILE . . . . . . . . . . . . . 73.4 mt -66.77 127.35 28.07 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.271 0 N-CA-C 109.508 -0.552 . . . . 0.0 109.508 177.548 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' E' E ' 84' ' ' LYS . . . . . . . . . . . . . 59.8 tttt -82.58 -48.44 10.97 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 115.928 -0.578 . . . . 0.0 110.145 -178.25 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' E' E ' 85' ' ' ASP . . . . . . . . . . . . . 33.2 t0 -163.94 159.03 20.4 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 115.851 -0.613 . . . . 0.0 110.653 179.022 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' E' E ' 86' ' ' VAL . . . . . 0.446 ' O ' HD13 ' E' ' 87' ' ' ILE . 43.2 t -129.33 136.25 59.86 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.27 0 CA-C-O 121.031 0.443 . . . . 0.0 110.55 -179.606 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' E' E ' 87' ' ' ILE . . . . . 0.446 HD13 ' O ' ' E' ' 86' ' ' VAL . 44.0 mm -123.18 128.55 75.01 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.227 0 CA-C-N 115.821 -0.627 . . . . 0.0 109.685 176.605 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' E' E ' 88' ' ' LEU . . . . . . . . . . . . . 17.4 tp -111.89 133.84 53.83 Favored 'General case' 0 N--CA 1.464 0.227 0 CA-C-O 121.052 0.453 . . . . 0.0 111.43 -175.539 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' E' E ' 89' ' ' ASP . . . . . . . . . . . . . 13.8 t70 -125.66 157.49 37.13 Favored 'General case' 0 C--N 1.331 -0.222 0 CA-C-N 115.688 -0.687 . . . . 0.0 109.679 176.252 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' E' E ' 90' ' ' GLU . . . . . . . . . . . . . 84.1 tt0 -45.56 -42.71 11.31 Favored 'General case' 0 N--CA 1.465 0.314 0 N-CA-C 113.087 0.773 . . . . 0.0 113.087 -171.632 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' E' E ' 91' ' ' ASN . . . . . . . . . . . . . 3.3 t-20 -132.16 25.78 4.55 Favored 'General case' 0 N--CA 1.468 0.446 0 N-CA-C 112.464 0.542 . . . . 0.0 112.464 -178.703 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' E' E ' 92' ' ' LEU . . . . . . . . . . . . . 28.5 mt -149.34 145.22 26.9 Favored 'General case' 0 C--N 1.331 -0.213 0 CA-C-O 120.721 0.296 . . . . 0.0 110.202 -177.376 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' E' E ' 93' ' ' ILE . . . . . . . . . . . . . 66.0 mt -123.71 121.12 61.64 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.292 0 N-CA-C 109.327 -0.62 . . . . 0.0 109.327 178.798 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' E' E ' 94' ' ' VAL . . . . . . . . . . . . . 46.8 t -117.52 126.67 74.82 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.282 0 N-CA-C 109.655 -0.498 . . . . 0.0 109.655 179.956 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' E' E ' 95' ' ' VAL . . . . . . . . . . . . . 38.8 t -121.47 134.15 65.73 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.331 0 CA-C-N 116.102 -0.499 . . . . 0.0 109.731 -178.872 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' E' E ' 96' ' ' ILE . . . . . 0.581 HD11 ' HB ' ' E' ' 123' ' ' VAL . 65.3 mt -113.81 127.07 71.36 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.33 0 N-CA-C 109.267 -0.642 . . . . 0.0 109.267 178.674 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' E' E ' 97' ' ' THR . . . . . . . . . . . . . 68.5 p -98.09 152.38 19.38 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-O 121.108 0.48 . . . . 0.0 111.102 -178.311 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' E' E ' 98' ' ' GLU . . . . . . . . . . . . . 85.0 tt0 -53.95 -23.44 13.08 Favored 'General case' 0 CA--C 1.535 0.377 0 N-CA-C 112.313 0.486 . . . . 0.0 112.313 179.738 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' E' E ' 99' ' ' GLU . . . . . . . . . . . . . 36.6 tt0 -80.94 18.08 1.08 Allowed 'General case' 0 CA--C 1.54 0.571 0 N-CA-C 112.5 0.556 . . . . 0.0 112.5 -177.012 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' E' E ' 100' ' ' ASN . . . . . . . . . . . . . 2.5 m-20 61.54 37.92 16.02 Favored 'General case' 0 CA--C 1.53 0.206 0 O-C-N 121.869 -0.519 . . . . 0.0 110.997 178.365 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' E' E ' 101' ' ' GLU . . . . . . . . . . . . . 85.1 tt0 -119.71 140.71 50.25 Favored 'General case' 0 C--N 1.332 -0.19 0 CA-C-N 116.099 -0.5 . . . . 0.0 109.66 176.703 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' E' E ' 102' ' ' VAL . . . . . . . . . . . . . 41.7 t -115.58 127.86 73.01 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.257 0 N-CA-C 109.732 -0.47 . . . . 0.0 109.732 -177.581 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' E' E ' 103' ' ' LEU . . . . . . . . . . . . . 5.0 mp -124.1 137.94 54.5 Favored 'General case' 0 C--N 1.331 -0.216 0 CA-C-N 116.33 -0.396 . . . . 0.0 110.607 177.506 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' E' E ' 104' ' ' ILE . . . . . . . . . . . . . 64.3 mt -117.63 126.3 74.63 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.274 0 CA-C-N 115.892 -0.594 . . . . 0.0 109.927 -178.893 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' E' E ' 105' ' ' PHE . . . . . . . . . . . . . 98.9 m-85 -120.86 161.35 21.69 Favored 'General case' 0 C--N 1.332 -0.18 0 O-C-N 124.046 0.841 . . . . 0.0 110.275 -179.008 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' E' E ' 106' ' ' ASN . . . . . . . . . . . . . 43.6 p-10 -99.0 -169.8 1.83 Allowed 'General case' 0 CA--C 1.532 0.284 0 CA-C-N 116.351 -0.386 . . . . 0.0 110.123 175.128 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' E' E ' 107' ' ' GLN . . . . . . . . . . . . . 20.4 tt0 -56.33 -30.05 62.1 Favored 'General case' 0 C--N 1.329 -0.303 0 N-CA-C 111.811 0.3 . . . . 0.0 111.811 179.732 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' E' E ' 108' ' ' ASN . . . . . . . . . . . . . 13.1 t30 -90.72 14.1 14.36 Favored 'General case' 0 CA--C 1.535 0.396 0 N-CA-C 113.197 0.814 . . . . 0.0 113.197 -175.889 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' E' E ' 109' ' ' LEU . . . . . 0.441 HD21 ' HB2' ' E' ' 78' ' ' ALA . 11.0 tp 54.88 36.0 25.64 Favored 'General case' 0 C--N 1.332 -0.191 0 CA-C-O 120.829 0.347 . . . . 0.0 111.506 178.501 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' E' E ' 110' ' ' GLU . . . . . . . . . . . . . 70.6 mm-40 -101.29 151.33 22.02 Favored 'General case' 0 C--N 1.33 -0.271 0 N-CA-C 109.808 -0.442 . . . . 0.0 109.808 176.514 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' E' E ' 111' ' ' GLU . . . . . . . . . . . . . 44.0 tp10 -78.52 122.03 25.35 Favored 'General case' 0 C--N 1.329 -0.296 0 C-N-CA 120.698 -0.401 . . . . 0.0 110.825 -176.901 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' E' E ' 112' ' ' LEU . . . . . . . . . . . . . 15.3 mt -110.58 -45.97 3.45 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.115 -0.493 . . . . 0.0 110.428 177.837 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' E' E ' 113' ' ' TYR . . . . . . . . . . . . . 55.7 t80 -137.27 137.22 38.8 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 116.402 -0.363 . . . . 0.0 110.862 -179.585 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' E' E ' 114' ' ' ARG . . . . . . . . . . . . . 56.0 ttp180 -143.45 119.71 10.85 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.422 -0.354 . . . . 0.0 110.413 179.03 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' E' E ' 115' ' ' GLY . . . . . . . . . . . . . . . -150.16 153.75 25.26 Favored Glycine 0 CA--C 1.525 0.704 0 N-CA-C 111.075 -0.81 . . . . 0.0 111.075 178.376 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' E' E ' 116' ' ' LYS . . . . . . . . . . . . . 27.5 ttpp -116.97 143.7 45.42 Favored 'General case' 0 C--N 1.33 -0.262 0 N-CA-C 109.955 -0.387 . . . . 0.0 109.955 177.662 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' E' E ' 117' ' ' PHE . . . . . . . . . . . . . 51.2 m-85 -139.19 114.63 9.78 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-O 120.935 0.397 . . . . 0.0 110.204 -178.24 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' E' E ' 118' ' ' GLU . . . . . . . . . . . . . 95.6 mt-10 -53.61 -50.15 66.28 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.472 -0.331 . . . . 0.0 111.411 -175.558 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' E' E ' 119' ' ' ASN . . . . . . . . . . . . . 2.6 m120 -93.63 31.02 1.63 Allowed 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.192 -0.458 . . . . 0.0 112.158 -175.222 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' E' E ' 120' ' ' LEU . . . . . . . . . . . . . 16.2 tp -57.11 122.89 13.46 Favored 'General case' 0 C--N 1.333 -0.14 0 CA-C-O 120.721 0.296 . . . . 0.0 110.277 178.563 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' E' E ' 121' ' ' ASN . . . . . . . . . . . . . 13.7 m120 -112.13 -44.17 3.45 Favored 'General case' 0 C--N 1.332 -0.185 0 CA-C-N 116.395 -0.366 . . . . 0.0 110.991 -177.183 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' E' E ' 122' ' ' LYS . . . . . . . . . . . . . 80.2 mttt -146.2 145.7 30.53 Favored 'General case' 0 C--N 1.332 -0.194 0 C-N-CA 120.575 -0.45 . . . . 0.0 111.832 -177.282 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' E' E ' 123' ' ' VAL . . . . . 0.581 ' HB ' HD11 ' E' ' 96' ' ' ILE . 46.9 t -127.89 123.83 61.66 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.291 0 N-CA-C 108.883 -0.784 . . . . 0.0 108.883 171.96 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' E' E ' 124' ' ' LEU . . . . . . . . . . . . . 69.0 mt -132.66 145.9 51.44 Favored 'General case' 0 C--N 1.331 -0.2 0 CA-C-O 121.048 0.451 . . . . 0.0 111.492 -175.036 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' E' E ' 125' ' ' VAL . . . . . 0.565 HG23 HG22 ' E' ' 130' ' ' VAL . 11.9 p -135.17 137.41 50.33 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.238 0 CA-C-N 115.834 -0.621 . . . . 0.0 110.395 178.915 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' E' E ' 126' ' ' ARG . . . . . . . . . . . . . 25.3 mmt180 -140.35 124.64 17.73 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 115.976 -0.556 . . . . 0.0 110.206 178.605 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' E' E ' 127' ' ' ASN . . . . . . . . . . . . . 14.9 m-80 51.4 -106.67 0.27 Allowed 'General case' 0 CA--C 1.543 0.695 0 CA-C-O 118.976 -0.535 . . . . 0.0 111.36 179.739 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' E' E ' 128' ' ' ASP . . . . . . . . . . . . . 14.8 p-10 -114.07 5.93 16.21 Favored 'General case' 0 N--CA 1.468 0.43 0 CA-C-N 119.723 1.147 . . . . 0.0 113.468 -176.948 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' E' E ' 129' ' ' LEU . . . . . . . . . . . . . 15.8 tp -111.56 134.5 53.09 Favored 'General case' 0 C--N 1.333 -0.138 0 CA-C-N 118.261 0.482 . . . . 0.0 110.472 -179.492 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' E' E ' 130' ' ' VAL . . . . . 0.565 HG22 HG23 ' E' ' 125' ' ' VAL . 45.0 t -118.66 134.84 60.99 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.183 0 N-CA-C 109.523 -0.547 . . . . 0.0 109.523 178.657 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' E' E ' 131' ' ' VAL . . . . . . . . . . . . . 39.4 t -136.05 141.01 42.87 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.258 0 CA-C-O 121.119 0.485 . . . . 0.0 110.704 -178.525 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' E' E ' 132' ' ' ILE . . . . . . . . . . . . . 71.5 mt -117.96 132.54 67.5 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.279 0 CA-C-N 115.457 -0.792 . . . . 0.0 109.413 178.669 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' E' E ' 133' ' ' ILE . . . . . . . . . . . . . 44.0 mm -115.8 121.97 68.5 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.246 0 CA-C-O 120.747 0.308 . . . . 0.0 110.675 -176.769 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' E' E ' 134' ' ' ASP . . . . . . . . . . . . . 7.3 p-10 -134.37 149.68 50.84 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.02 -0.536 . . . . 0.0 109.795 175.47 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' E' E ' 135' ' ' GLU . . . . . . . . . . . . . 42.9 tp10 -49.78 -26.71 4.13 Favored 'General case' 0 C--N 1.327 -0.383 0 N-CA-C 112.85 0.685 . . . . 0.0 112.85 -170.442 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' E' E ' 136' ' ' GLN . . . . . . . . . . . . . 55.3 mt-30 -102.78 -25.67 13.43 Favored 'General case' 0 N--CA 1.466 0.367 0 N-CA-C 112.888 0.699 . . . . 0.0 112.888 -174.532 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' E' E ' 137' ' ' LYS . . . . . . . . . . . . . 82.7 mttt -143.21 153.31 42.7 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-O 121.23 0.538 . . . . 0.0 111.714 -170.239 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' E' E ' 138' ' ' LEU . . . . . 0.426 ' C ' HD23 ' E' ' 138' ' ' LEU . 5.8 tt -118.29 121.15 39.7 Favored 'General case' 0 C--N 1.328 -0.352 0 N-CA-C 108.744 -0.836 . . . . 0.0 108.744 171.667 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' E' E ' 139' ' ' THR . . . . . . . . . . . . . 23.8 m -109.27 128.19 54.88 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.452 -0.34 . . . . 0.0 110.54 -176.344 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' E' E ' 140' ' ' LEU . . . . . 0.478 ' C ' HD23 ' E' ' 140' ' ' LEU . 7.1 tt -114.37 122.12 45.69 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 115.724 -0.671 . . . . 0.0 109.494 -178.835 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' E' E ' 141' ' ' ILE . . . . . . . . . . . . . 19.1 mt -122.84 116.81 49.9 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.288 0 N-CA-C 109.601 -0.518 . . . . 0.0 109.601 -176.897 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' E' E ' 142' ' ' ARG . . . . . . . . . . . . . 71.5 ttt180 -101.52 120.67 40.67 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 115.671 -0.695 . . . . 0.0 110.458 -179.107 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' E' E ' 143' ' ' THR . . . . . 0.497 HG22 HG12 ' F' ' 73' ' ' VAL . 16.4 p . . . . . 0 C--O 1.22 -0.472 0 CA-C-O 118.009 -0.996 . . . . 0.0 110.469 179.678 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' F' F ' -3' ' ' GLU . . . . . . . . . . . . . 70.5 mm-40 . . . . . 0 N--CA 1.49 1.574 0 N-CA-C 109.467 -0.568 . . . . 0.0 109.467 . . . . . . . . . 0 0 . 1 . 018 nuclear nobuild full ' F' F ' -2' ' ' GLY . . . . . . . . . . . . . . . -75.39 149.95 39.55 Favored Glycine 0 CA--C 1.527 0.806 0 N-CA-C 111.04 -0.824 . . . . 0.0 111.04 179.953 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' F' F ' -1' ' ' VAL . . . . . . . . . . . . . 43.9 t -88.41 126.26 41.69 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.292 0 N-CA-C 109.871 -0.418 . . . . 0.0 109.871 179.742 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' F' F ' 0' ' ' ILE . . . . . . . . . . . . . 70.8 mt -122.65 130.62 74.37 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.229 0 CA-C-N 116.264 -0.426 . . . . 0.0 110.268 -177.971 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' F' F ' 1' ' ' MET . . . . . . . . . . . . . 25.5 ptp -95.77 149.42 21.52 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.054 -0.521 . . . . 0.0 110.371 177.642 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' F' F ' 2' ' ' SER . . . . . . . . . . . . . 4.9 p -124.28 132.8 53.59 Favored 'General case' 0 C--N 1.332 -0.188 0 CA-C-O 120.908 0.385 . . . . 0.0 110.803 179.754 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' F' F ' 3' ' ' GLU . . . . . . . . . . . . . 85.2 tt0 -142.61 140.38 31.64 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.155 -0.475 . . . . 0.0 111.225 -179.119 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' F' F ' 4' ' ' LEU . . . . . 0.446 HD21 HD21 ' F' ' 6' ' ' LEU . 14.9 tp -125.55 135.09 51.88 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.03 -0.532 . . . . 0.0 110.049 177.163 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' F' F ' 5' ' ' LYS . . . . . . . . . . . . . 69.0 mttm -112.43 120.73 42.65 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.237 -0.438 . . . . 0.0 110.58 178.764 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' F' F ' 6' ' ' LEU . . . . . 0.446 HD21 HD21 ' F' ' 4' ' ' LEU . 73.4 mt -114.93 146.06 41.56 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 115.294 -0.866 . . . . 0.0 110.043 -179.968 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' F' F ' 7' ' ' LYS . . . . . . . . . . . . . 53.4 tttm -133.88 140.2 35.71 Favored Pre-proline 0 CA--C 1.534 0.334 0 CA-C-O 119.115 -0.469 . . . . 0.0 110.245 177.576 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' F' F ' 8' ' ' PRO . . . . . . . . . . . . . 94.4 Cg_endo -91.95 139.07 2.07 Favored 'Trans proline' 0 N--CA 1.489 1.22 0 C-N-CA 121.668 1.578 . . . . 0.0 111.537 176.798 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' F' F ' 9' ' ' LEU . . . . . . . . . . . . . 56.5 mt -71.57 -47.9 12.46 Favored Pre-proline 0 C--N 1.329 -0.315 0 CA-C-O 118.613 -0.708 . . . . 0.0 112.176 -178.889 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' F' F ' 10' ' ' PRO . . . . . . . . . . . . . 97.4 Cg_endo -79.46 157.9 25.55 Favored 'Trans proline' 0 N--CA 1.495 1.616 0 C-N-CA 121.197 1.264 . . . . 0.0 112.291 177.061 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' F' F ' 11' ' ' LYS . . . . . . . . . . . . . 6.6 tmtm? -87.21 97.28 10.68 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.256 178.756 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' F' F ' 12' ' ' VAL . . . . . . . . . . . . . 13.0 p -143.63 146.62 20.93 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.23 0 CA-C-N 116.301 -0.408 . . . . 0.0 110.778 179.607 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' F' F ' 13' ' ' GLU . . . . . . . . . . . . . 94.5 mt-10 -82.71 135.12 35.1 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.079 -0.509 . . . . 0.0 110.256 178.23 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' F' F ' 14' ' ' LEU . . . . . . . . . . . . . 15.2 mt -98.18 141.59 23.21 Favored Pre-proline 0 CA--C 1.534 0.328 0 CA-C-O 118.887 -0.578 . . . . 0.0 110.099 179.536 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' F' F ' 15' ' ' PRO . . . . . . . . . . . . . 26.0 Cg_exo -62.24 159.92 33.09 Favored 'Trans proline' 0 N--CA 1.496 1.658 0 C-N-CA 121.297 1.331 . . . . 0.0 111.711 176.113 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' F' F ' 16' ' ' PRO . . . . . . . . . . . . . 39.6 Cg_exo -58.42 -41.23 67.64 Favored 'Trans proline' 0 N--CA 1.496 1.657 0 C-N-CA 121.499 1.466 . . . . 0.0 112.907 -177.313 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' F' F ' 17' ' ' ASP . . . . . . . . . . . . . 24.2 p-10 -84.71 6.99 22.06 Favored 'General case' 0 CA--C 1.538 0.498 0 N-CA-C 113.261 0.837 . . . . 0.0 113.261 -177.38 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' F' F ' 18' ' ' PHE . . . . . . . . . . . . . 41.2 t80 -57.83 -45.72 85.78 Favored 'General case' 0 C--N 1.334 -0.099 0 O-C-N 122.012 -0.43 . . . . 0.0 110.161 -177.798 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' F' F ' 19' ' ' VAL . . . . . . . . . . . . . 48.7 t -56.71 -44.37 81.28 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.304 0 CA-C-N 116.298 -0.41 . . . . 0.0 110.559 -178.101 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' F' F ' 20' ' ' ASP . . . . . . . . . . . . . 29.2 m-20 -59.67 -42.06 92.01 Favored 'General case' 0 C--N 1.329 -0.296 0 C-N-CA 120.896 -0.322 . . . . 0.0 111.089 -177.711 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' F' F ' 21' ' ' VAL . . . . . . . . . . . . . 46.9 t -63.48 -45.63 97.34 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.285 0 C-N-CA 120.824 -0.35 . . . . 0.0 110.17 -177.738 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' F' F ' 22' ' ' ILE . . . . . 0.611 HG22 HD12 ' F' ' 26' ' ' LEU . 51.7 mm -55.56 -48.2 77.73 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 C-N-CA 121.085 -0.246 . . . . 0.0 110.679 178.568 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' F' F ' 23' ' ' ARG . . . . . . . . . . . . . 41.5 ttp180 -54.97 -47.46 74.53 Favored 'General case' 0 C--N 1.328 -0.339 0 C-N-CA 121.074 -0.25 . . . . 0.0 111.395 -177.937 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' F' F ' 24' ' ' ILE . . . . . . . . . . . . . 82.5 mt -58.8 -45.72 91.25 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.29 0 C-N-CA 121.144 -0.222 . . . . 0.0 111.341 -177.442 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' F' F ' 25' ' ' LYS . . . . . . . . . . . . . 93.0 mttt -67.78 -42.68 81.3 Favored 'General case' 0 C--N 1.328 -0.333 0 N-CA-C 112.538 0.57 . . . . 0.0 112.538 -177.56 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' F' F ' 26' ' ' LEU . . . . . 0.611 HD12 HG22 ' F' ' 22' ' ' ILE . 94.6 mt -77.68 -37.76 49.0 Favored 'General case' 0 C--N 1.329 -0.287 0 N-CA-C 113.288 0.848 . . . . 0.0 113.288 -170.128 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' F' F ' 27' ' ' GLN . . . . . . . . . . . . . 10.3 pt20 -47.19 137.95 7.49 Favored 'General case' 0 N--CA 1.468 0.451 0 N-CA-C 112.698 0.629 . . . . 0.0 112.698 -174.917 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' F' F ' 28' ' ' GLY . . . . . . . . . . . . . . . 100.77 -26.21 25.47 Favored Glycine 0 CA--C 1.533 1.184 0 CA-C-N 115.533 -0.758 . . . . 0.0 112.26 -177.435 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' F' F ' 29' ' ' LYS . . . . . . . . . . . . . 91.4 mttt -97.79 155.06 17.21 Favored 'General case' 0 C--N 1.332 -0.167 0 CA-C-N 117.375 0.588 . . . . 0.0 110.946 178.101 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' F' F ' 30' ' ' THR . . . . . . . . . . . . . 26.2 m -106.06 138.44 42.25 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.006 -0.543 . . . . 0.0 110.152 177.244 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' F' F ' 31' ' ' VAL . . . . . . . . . . . . . 34.1 m -128.64 157.1 41.34 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.267 0 CA-C-N 116.343 -0.39 . . . . 0.0 110.722 -178.792 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' F' F ' 32' ' ' ARG . . . . . . . . . . . . . 98.6 mtt180 -130.15 150.28 51.48 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-O 121.243 0.544 . . . . 0.0 110.654 177.824 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' F' F ' 33' ' ' THR . . . . . . . . . . . . . 15.2 m -53.66 138.34 35.09 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.217 -0.447 . . . . 0.0 111.187 -178.787 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' F' F ' 34' ' ' GLY . . . . . . . . . . . . . . . 100.88 -17.05 56.91 Favored Glycine 0 CA--C 1.532 1.15 0 CA-C-O 119.614 -0.548 . . . . 0.0 113.287 179.381 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' F' F ' 35' ' ' ASP . . . . . . . . . . . . . 73.5 m-20 -65.25 149.43 49.95 Favored 'General case' 0 C--O 1.231 0.13 0 CA-C-N 118.049 0.924 . . . . 0.0 111.264 179.49 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' F' F ' 36' ' ' VAL . . . . . . . . . . . . . 46.6 t -123.13 131.91 72.36 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.171 0 CA-C-N 115.88 -0.6 . . . . 0.0 110.038 178.884 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' F' F ' 37' ' ' ILE . . . . . . . . . . . . . 67.5 mt -123.67 142.66 39.58 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.28 0 CA-C-N 116.156 -0.475 . . . . 0.0 109.811 -179.959 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' F' F ' 38' ' ' GLY . . . . . . . . . . . . . . . -113.09 128.78 8.56 Favored Glycine 0 CA--C 1.527 0.791 0 N-CA-C 111.335 -0.706 . . . . 0.0 111.335 -179.574 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' F' F ' 39' ' ' ILE . . . . . . . . . . . . . 72.0 mt -126.61 127.3 70.1 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.18 0 N-CA-C 109.829 -0.434 . . . . 0.0 109.829 177.862 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' F' F ' 40' ' ' SER . . . . . . . . . . . . . 42.3 t -93.42 116.43 28.97 Favored 'General case' 0 C--N 1.329 -0.29 0 C-N-CA 120.918 -0.313 . . . . 0.0 110.836 175.815 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' F' F ' 41' ' ' ILE . . . . . . . . . . . . . 44.2 mm -122.78 121.91 64.55 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.188 0 CA-C-O 120.934 0.397 . . . . 0.0 110.362 179.853 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' F' F ' 42' ' ' LEU . . . . . 0.541 ' O ' HD23 ' F' ' 42' ' ' LEU . 1.3 tt 54.94 46.44 24.37 Favored 'General case' 0 C--N 1.331 -0.211 0 CA-C-O 121.366 0.603 . . . . 0.0 110.686 177.118 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' F' F ' 43' ' ' GLY . . . . . . . . . . . . . . . 70.5 10.05 65.99 Favored Glycine 0 CA--C 1.534 1.259 0 C-N-CA 121.232 -0.509 . . . . 0.0 113.32 174.522 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' F' F ' 44' ' ' LYS . . . . . . . . . . . . . 43.1 tptt -124.83 127.18 46.76 Favored 'General case' 0 C--N 1.333 -0.146 0 CA-C-N 117.986 0.893 . . . . 0.0 109.767 -178.715 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' F' F ' 45' ' ' GLU . . . . . . . . . . . . . 36.9 tp10 -83.43 127.43 33.68 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-O 120.875 0.369 . . . . 0.0 110.943 -177.148 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' F' F ' 46' ' ' VAL . . . . . . . . . . . . . 7.5 p -124.32 130.59 73.59 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.194 0 N-CA-C 109.491 -0.559 . . . . 0.0 109.491 176.191 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' F' F ' 47' ' ' LYS . . . . . . . . . . . . . 30.0 mtpp -100.7 131.21 46.71 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.054 -0.521 . . . . 0.0 111.221 178.292 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' F' F ' 48' ' ' PHE . . . . . . . . . . . . . 89.1 m-85 -113.26 131.91 55.73 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.242 -0.435 . . . . 0.0 110.367 178.118 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' F' F ' 49' ' ' LYS . . . . . . . . . . . . . 82.1 tttt -107.31 137.21 45.78 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.169 -0.469 . . . . 0.0 110.412 178.492 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' F' F ' 50' ' ' VAL . . . . . 0.404 ' HA ' HD23 ' F' ' 6' ' ' LEU . 47.6 t -80.32 106.89 12.08 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.316 0 N-CA-C 109.138 -0.689 . . . . 0.0 109.138 175.061 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' F' F ' 51' ' ' VAL . . . . . . . . . . . . . 55.2 t -70.51 -48.22 60.58 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.286 0 CA-C-N 116.114 -0.494 . . . . 0.0 109.932 -173.373 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' F' F ' 52' ' ' GLN . . . . . . . . . . . . . 21.4 pt20 -164.64 158.92 18.42 Favored 'General case' 0 C--N 1.331 -0.229 0 C-N-CA 120.156 -0.618 . . . . 0.0 111.859 -179.505 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' F' F ' 53' ' ' ALA . . . . . . . . . . . . . . . -135.46 135.86 40.85 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 115.361 -0.836 . . . . 0.0 110.495 179.347 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' F' F ' 54' ' ' TYR . . . . . . . . . . . . . 59.6 t80 -128.98 110.52 18.4 Favored Pre-proline 0 CA--C 1.534 0.345 0 CA-C-O 118.225 -0.893 . . . . 0.0 110.211 177.232 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' F' F ' 55' ' ' PRO . . . . . . . . . . . . . 72.6 Cg_endo -77.15 166.27 82.72 Favored 'Cis proline' 0 N--CA 1.5 1.859 0 CA-C-N 121.988 1.746 . . . . 0.0 112.322 -6.0 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' F' F ' 56' ' ' SER . . . . . . . . . . . . . 43.5 m -116.03 130.09 24.69 Favored Pre-proline 0 CA--C 1.538 0.488 0 CA-C-O 118.387 -0.816 . . . . 0.0 109.293 174.059 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' F' F ' 57' ' ' PRO . . . . . . . . . . . . . 37.6 Cg_endo -66.72 163.64 70.72 Favored 'Cis proline' 0 N--CA 1.498 1.788 0 CA-C-N 122.054 1.769 . . . . 0.0 111.701 -0.172 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' F' F ' 58' ' ' LEU . . . . . . . . . . . . . 24.7 tp -129.37 137.38 50.92 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.349 -179.025 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' F' F ' 59' ' ' ARG . . . . . . . . . . . . . 74.8 ttt180 -105.18 128.59 53.47 Favored 'General case' 0 C--N 1.327 -0.391 0 N-CA-C 109.272 -0.64 . . . . 0.0 109.272 175.657 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' F' F ' 60' ' ' VAL . . . . . . . . . . . . . 45.5 t -79.01 123.09 35.52 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.306 0 C-N-CA 120.686 -0.405 . . . . 0.0 110.347 -175.432 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' F' F ' 61' ' ' GLU . . . . . . . . . . . . . 95.4 mt-10 -131.09 162.75 29.17 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 115.732 -0.667 . . . . 0.0 109.949 177.894 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' F' F ' 62' ' ' ASP . . . . . . . . . . . . . 16.7 p-10 -56.8 -32.84 66.08 Favored 'General case' 0 C--N 1.328 -0.342 0 C-N-CA 120.941 -0.304 . . . . 0.0 111.522 179.329 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' F' F ' 63' ' ' ARG . . . . . . . . . . . . . 17.0 ptm180 -82.9 5.4 21.98 Favored 'General case' 0 CA--C 1.537 0.462 0 N-CA-C 113.558 0.947 . . . . 0.0 113.558 -176.602 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' F' F ' 64' ' ' THR . . . . . . . . . . . . . 19.4 m -88.53 141.97 28.09 Favored 'General case' 0 C--O 1.231 0.126 0 CA-C-N 118.235 0.471 . . . . 0.0 110.753 -177.66 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' F' F ' 65' ' ' LYS . . . . . . . . . . . . . 97.7 mttt -87.4 125.64 34.39 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.264 -0.425 . . . . 0.0 109.918 178.514 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' F' F ' 66' ' ' ILE . . . . . . . . . . . . . 59.0 mt -116.36 124.92 73.11 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.336 0 N-CA-C 109.712 -0.477 . . . . 0.0 109.712 179.708 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' F' F ' 67' ' ' THR . . . . . . . . . . . . . 19.6 m -123.8 146.03 48.64 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-O 121.043 0.449 . . . . 0.0 111.247 -176.231 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' F' F ' 68' ' ' LEU . . . . . . . . . . . . . 49.8 mt -99.05 134.34 42.03 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 115.77 -0.65 . . . . 0.0 110.486 177.637 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' F' F ' 69' ' ' VAL . . . . . . . . . . . . . 46.6 t -101.86 135.11 40.18 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.328 0 CA-C-N 115.878 -0.601 . . . . 0.0 109.913 179.039 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' F' F ' 70' ' ' THR . . . . . . . . . . . . . 7.7 t -132.01 177.27 7.68 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.073 -0.512 . . . . 0.0 110.3 -179.294 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' F' F ' 71' ' ' HIS . . . . . . . . . . . . . 93.9 m-70 -64.96 150.06 95.72 Favored Pre-proline 0 C--N 1.331 -0.219 0 CA-C-N 116.414 -0.357 . . . . 0.0 110.212 -179.124 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' F' F ' 72' ' ' PRO . . . . . . . . . . . . . 66.8 Cg_endo -74.97 -30.13 7.54 Favored 'Trans proline' 0 N--CA 1.495 1.574 0 C-N-CA 121.321 1.347 . . . . 0.0 112.542 -176.821 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' F' F ' 73' ' ' VAL . . . . . 0.497 HG12 HG22 ' E' ' 143' ' ' THR . 31.0 m -140.09 146.03 25.42 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.226 0 CA-C-O 121.096 0.474 . . . . 0.0 111.213 179.234 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' F' F ' 74' ' ' ASP . . . . . . . . . . . . . 9.6 t0 -101.9 120.86 41.07 Favored 'General case' 0 C--N 1.327 -0.383 0 N-CA-C 109.042 -0.725 . . . . 0.0 109.042 174.724 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' F' F ' 75' ' ' VAL . . . . . . . . . . . . . 40.5 t -109.39 123.16 65.06 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.288 0 CA-C-O 121.207 0.527 . . . . 0.0 110.779 -175.939 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' F' F ' 76' ' ' LEU . . . . . . . . . . . . . 15.4 mt -129.55 144.25 51.19 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 115.477 -0.783 . . . . 0.0 109.127 177.101 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' F' F ' 77' ' ' GLU . . . . . . . . . . . . . 56.2 tt0 -138.86 139.99 38.31 Favored 'General case' 0 C--N 1.332 -0.184 0 C-N-CA 120.671 -0.411 . . . . 0.0 111.269 -175.148 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' F' F ' 78' ' ' ALA . . . . . 0.481 ' HB2' HD21 ' F' ' 109' ' ' LEU . . . -124.4 140.02 53.35 Favored 'General case' 0 C--N 1.331 -0.229 0 CA-C-N 115.947 -0.57 . . . . 0.0 110.308 178.217 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' F' F ' 79' ' ' LYS . . . . . 0.624 ' O ' HD13 ' F' ' 80' ' ' ILE . 3.9 mptp? -82.75 116.36 22.07 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-N 116.427 -0.351 . . . . 0.0 110.685 -178.529 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' F' F ' 80' ' ' ILE . . . . . 0.624 HD13 ' O ' ' F' ' 79' ' ' LYS . 40.0 mm -139.2 107.04 3.08 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.279 0 N-CA-C 109.391 -0.596 . . . . 0.0 109.391 -178.855 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' F' F ' 81' ' ' LYS . . . . . . . . . . . . . 99.3 mttt -105.19 133.61 49.68 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-O 120.902 0.382 . . . . 0.0 110.975 -179.037 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' F' F ' 82' ' ' GLY . . . . . . . . . . . . . . . 88.9 42.23 5.73 Favored Glycine 0 CA--C 1.524 0.63 0 N-CA-C 111.228 -0.749 . . . . 0.0 111.228 176.549 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' F' F ' 83' ' ' ILE . . . . . . . . . . . . . 72.8 mt -72.56 135.91 26.74 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.336 0 N-CA-C 109.964 -0.384 . . . . 0.0 109.964 179.382 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' F' F ' 84' ' ' LYS . . . . . . . . . . . . . 54.7 tttp -98.4 -53.96 3.19 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 115.971 -0.559 . . . . 0.0 110.329 -178.535 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' F' F ' 85' ' ' ASP . . . . . . . . . . . . . 7.4 t0 -149.6 148.31 29.18 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 115.85 -0.613 . . . . 0.0 110.327 -178.808 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' F' F ' 86' ' ' VAL . . . . . . . . . . . . . 42.3 t -129.79 129.39 66.18 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.274 0 CA-C-O 120.906 0.384 . . . . 0.0 110.456 -179.527 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' F' F ' 87' ' ' ILE . . . . . . . . . . . . . 45.6 mm -118.66 125.96 74.82 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.268 0 CA-C-N 116.006 -0.543 . . . . 0.0 109.734 175.809 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' F' F ' 88' ' ' LEU . . . . . . . . . . . . . 38.5 mt -113.02 136.82 52.27 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-O 121.12 0.486 . . . . 0.0 111.303 -177.973 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' F' F ' 89' ' ' ASP . . . . . . . . . . . . . 7.6 t70 -134.85 155.29 50.92 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 115.687 -0.688 . . . . 0.0 109.618 175.538 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' F' F ' 90' ' ' GLU . . . . . . . . . . . . . 95.7 mt-10 -48.78 -33.15 9.82 Favored 'General case' 0 C--N 1.329 -0.324 0 N-CA-C 112.927 0.714 . . . . 0.0 112.927 -172.542 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' F' F ' 91' ' ' ASN . . . . . . . . . . . . . 27.9 t30 -130.44 18.86 5.29 Favored 'General case' 0 N--CA 1.469 0.493 0 N-CA-C 113.063 0.764 . . . . 0.0 113.063 -176.056 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' F' F ' 92' ' ' LEU . . . . . . . . . . . . . 12.0 mt -151.66 143.63 23.83 Favored 'General case' 0 C--N 1.333 -0.151 0 N-CA-C 109.976 -0.379 . . . . 0.0 109.976 -177.225 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' F' F ' 93' ' ' ILE . . . . . . . . . . . . . 71.9 mt -128.82 118.11 46.24 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 N-CA-C 109.278 -0.638 . . . . 0.0 109.278 176.086 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' F' F ' 94' ' ' VAL . . . . . . . . . . . . . 44.5 t -120.84 127.02 75.89 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.344 0 N-CA-C 109.998 -0.371 . . . . 0.0 109.998 -178.538 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' F' F ' 95' ' ' VAL . . . . . . . . . . . . . 44.0 t -123.14 134.11 67.16 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.33 0 CA-C-N 116.064 -0.516 . . . . 0.0 109.95 -179.593 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' F' F ' 96' ' ' ILE . . . . . . . . . . . . . 52.8 mt -113.61 127.54 70.9 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.345 0 N-CA-C 109.006 -0.738 . . . . 0.0 109.006 178.391 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' F' F ' 97' ' ' THR . . . . . . . . . . . . . 66.1 p -99.42 157.15 16.62 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-O 121.204 0.526 . . . . 0.0 111.069 -177.142 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' F' F ' 98' ' ' GLU . . . . . . . . . . . . . 81.9 tt0 -53.98 -27.87 34.22 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 116.127 -0.488 . . . . 0.0 112.056 179.909 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' F' F ' 99' ' ' GLU . . . . . . . . . . . . . 95.9 mt-10 -76.92 12.54 1.32 Allowed 'General case' 0 CA--C 1.536 0.404 0 N-CA-C 113.329 0.863 . . . . 0.0 113.329 -176.737 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' F' F ' 100' ' ' ASN . . . . . . . . . . . . . 3.9 m-20 63.57 34.61 12.37 Favored 'General case' 0 CA--C 1.531 0.248 0 CA-C-O 120.964 0.412 . . . . 0.0 111.369 179.328 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' F' F ' 101' ' ' GLU . . . . . . . . . . . . . 84.0 tt0 -113.96 145.6 41.29 Favored 'General case' 0 C--N 1.333 -0.133 0 N-CA-C 109.52 -0.548 . . . . 0.0 109.52 173.607 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' F' F ' 102' ' ' VAL . . . . . . . . . . . . . 43.9 t -118.12 128.93 75.13 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.253 0 CA-C-O 120.849 0.356 . . . . 0.0 110.096 -177.802 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' F' F ' 103' ' ' LEU . . . . . . . . . . . . . 48.4 mt -115.84 130.43 56.83 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 115.479 -0.782 . . . . 0.0 109.823 178.372 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' F' F ' 104' ' ' ILE . . . . . . . . . . . . . 62.5 mt -119.87 121.59 66.43 Favored 'Isoleucine or valine' 0 C--O 1.233 0.23 0 N-CA-C 110.152 -0.314 . . . . 0.0 110.152 179.597 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' F' F ' 105' ' ' PHE . . . . . . . . . . . . . 30.8 m-85 -124.25 165.78 17.03 Favored 'General case' 0 C--N 1.333 -0.149 0 O-C-N 123.936 0.773 . . . . 0.0 109.521 178.152 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' F' F ' 106' ' ' ASN . . . . . . . . . . . . . 44.1 p-10 -96.99 -170.0 1.96 Allowed 'General case' 0 C--N 1.329 -0.29 0 N-CA-C 109.861 -0.422 . . . . 0.0 109.861 172.858 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' F' F ' 107' ' ' GLN . . . . . . . . . . . . . 47.8 tt0 -60.1 -30.14 69.05 Favored 'General case' 0 CA--C 1.532 0.286 0 N-CA-C 111.873 0.323 . . . . 0.0 111.873 179.532 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' F' F ' 108' ' ' ASN . . . . . . . . . . . . . 7.1 t-20 -82.5 8.19 12.34 Favored 'General case' 0 CA--C 1.537 0.457 0 N-CA-C 113.219 0.822 . . . . 0.0 113.219 -178.31 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' F' F ' 109' ' ' LEU . . . . . 0.481 HD21 ' HB2' ' F' ' 78' ' ' ALA . 11.0 tp 59.76 37.45 22.07 Favored 'General case' 0 CA--C 1.529 0.17 0 CA-C-O 120.977 0.418 . . . . 0.0 111.294 178.255 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' F' F ' 110' ' ' GLU . . . . . . . . . . . . . 70.7 mm-40 -104.04 163.68 12.22 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.416 -0.356 . . . . 0.0 110.109 177.228 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' F' F ' 111' ' ' GLU . . . . . . . . . . . . . 83.6 tt0 -84.86 124.18 31.31 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-N 116.328 -0.397 . . . . 0.0 111.053 -177.215 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' F' F ' 112' ' ' LEU . . . . . . . . . . . . . 15.3 mt -112.64 -46.06 3.18 Favored 'General case' 0 C--N 1.331 -0.197 0 CA-C-N 116.051 -0.522 . . . . 0.0 110.014 175.163 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' F' F ' 113' ' ' TYR . . . . . . . . . . . . . 57.7 t80 -148.25 137.91 22.28 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.228 -0.442 . . . . 0.0 111.036 179.775 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' F' F ' 114' ' ' ARG . . . . . . . . . . . . . 31.1 mtp180 -137.13 123.77 21.05 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.346 -0.388 . . . . 0.0 109.995 174.713 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' F' F ' 115' ' ' GLY . . . . . . . . . . . . . . . -149.46 160.15 28.34 Favored Glycine 0 CA--C 1.523 0.544 0 N-CA-C 110.832 -0.907 . . . . 0.0 110.832 -179.658 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' F' F ' 116' ' ' LYS . . . . . . . . . . . . . 72.5 tttt -133.32 133.64 42.79 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-O 120.844 0.354 . . . . 0.0 110.184 179.622 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' F' F ' 117' ' ' PHE . . . . . . . . . . . . . 23.6 m-85 -132.1 115.64 16.01 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.192 -0.458 . . . . 0.0 109.843 -175.459 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' F' F ' 118' ' ' GLU . . . . . . . . . . . . . 85.2 tt0 -55.4 -40.09 70.99 Favored 'General case' 0 C--N 1.329 -0.324 0 C-N-CA 120.902 -0.319 . . . . 0.0 111.213 -177.152 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' F' F ' 119' ' ' ASN . . . . . . . . . . . . . 4.5 m-80 -97.8 30.99 2.77 Favored 'General case' 0 C--N 1.33 -0.282 0 N-CA-C 112.173 0.434 . . . . 0.0 112.173 -176.084 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' F' F ' 120' ' ' LEU . . . . . . . . . . . . . 11.7 tp -56.54 122.31 11.7 Favored 'General case' 0 C--N 1.333 -0.146 0 C-N-CA 121.065 -0.254 . . . . 0.0 110.641 178.991 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' F' F ' 121' ' ' ASN . . . . . . . . . . . . . 10.5 t-20 -108.16 -44.14 4.22 Favored 'General case' 0 C--O 1.233 0.192 0 CA-C-N 116.578 -0.283 . . . . 0.0 111.05 -177.859 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' F' F ' 122' ' ' LYS . . . . . . . . . . . . . 55.7 pttt -165.94 161.73 17.73 Favored 'General case' 0 C--N 1.332 -0.17 0 C-N-CA 120.398 -0.521 . . . . 0.0 112.218 -179.223 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' F' F ' 123' ' ' VAL . . . . . . . . . . . . . 44.1 t -131.36 137.38 55.61 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.202 0 CA-C-N 115.809 -0.632 . . . . 0.0 109.956 178.959 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' F' F ' 124' ' ' LEU . . . . . . . . . . . . . 88.4 mt -122.38 136.8 54.97 Favored 'General case' 0 C--N 1.331 -0.223 0 CA-C-N 116.498 -0.319 . . . . 0.0 110.944 -179.47 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' F' F ' 125' ' ' VAL . . . . . . . . . . . . . 44.3 t -126.12 129.27 72.19 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.217 0 CA-C-N 116.096 -0.502 . . . . 0.0 109.849 178.576 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' F' F ' 126' ' ' ARG . . . . . . . . . . . . . 27.3 mmt85 -139.85 118.12 12.03 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.408 -0.36 . . . . 0.0 110.701 179.122 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' F' F ' 127' ' ' ASN . . . . . . . . . . . . . 4.9 m-20 49.66 -105.0 0.16 Allowed 'General case' 0 CA--C 1.545 0.759 0 CA-C-O 119.052 -0.499 . . . . 0.0 111.678 178.438 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' F' F ' 128' ' ' ASP . . . . . . . . . . . . . 17.5 p-10 -114.0 1.21 14.6 Favored 'General case' 0 N--CA 1.468 0.429 0 CA-C-N 119.571 1.078 . . . . 0.0 113.401 -178.046 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' F' F ' 129' ' ' LEU . . . . . . . . . . . . . 62.1 mt -107.32 142.86 36.44 Favored 'General case' 0 C--N 1.333 -0.131 0 N-CA-C 109.782 -0.451 . . . . 0.0 109.782 179.508 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' F' F ' 130' ' ' VAL . . . . . . . . . . . . . 41.9 t -129.5 140.31 49.43 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.287 0 CA-C-O 120.911 0.386 . . . . 0.0 110.066 -179.12 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' F' F ' 131' ' ' VAL . . . . . 0.426 HG12 HD12 ' F' ' 140' ' ' LEU . 34.8 m -135.93 142.0 40.23 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.267 0 CA-C-O 121.151 0.5 . . . . 0.0 110.838 178.882 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' F' F ' 132' ' ' ILE . . . . . . . . . . . . . 73.7 mt -118.61 134.0 63.64 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.259 0 CA-C-N 115.649 -0.705 . . . . 0.0 109.37 -179.78 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' F' F ' 133' ' ' ILE . . . . . . . . . . . . . 38.7 mm -116.79 122.51 70.11 Favored 'Isoleucine or valine' 0 C--O 1.234 0.278 0 CA-C-O 120.828 0.347 . . . . 0.0 111.077 -175.161 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' F' F ' 134' ' ' ASP . . . . . . . . . . . . . 6.1 p-10 -134.2 147.24 50.7 Favored 'General case' 0 C--N 1.332 -0.183 0 CA-C-N 115.87 -0.605 . . . . 0.0 109.577 172.693 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' F' F ' 135' ' ' GLU . . . . . . . . . . . . . 81.9 tt0 -49.94 -23.91 2.25 Favored 'General case' 0 C--N 1.328 -0.369 0 N-CA-C 113.088 0.773 . . . . 0.0 113.088 -170.147 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' F' F ' 136' ' ' GLN . . . . . . . . . . . . . 47.6 tt0 -104.69 -26.27 12.37 Favored 'General case' 0 CA--C 1.531 0.238 0 N-CA-C 112.748 0.648 . . . . 0.0 112.748 -174.625 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' F' F ' 137' ' ' LYS . . . . . . . . . . . . . 7.2 ttpm? -143.87 150.14 37.99 Favored 'General case' 0 C--N 1.332 -0.167 0 CA-C-O 121.36 0.6 . . . . 0.0 111.781 -170.5 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' F' F ' 138' ' ' LEU . . . . . . . . . . . . . 5.7 tt -116.87 126.62 53.29 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 115.466 -0.788 . . . . 0.0 109.241 175.183 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' F' F ' 139' ' ' THR . . . . . . . . . . . . . 26.4 m -112.44 128.27 56.27 Favored 'General case' 0 C--N 1.331 -0.208 0 CA-C-N 116.592 -0.276 . . . . 0.0 110.82 -178.106 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' F' F ' 140' ' ' LEU . . . . . 0.426 HD12 HG12 ' F' ' 131' ' ' VAL . 36.5 tp -112.71 120.24 40.85 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 115.573 -0.739 . . . . 0.0 109.263 179.783 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' F' F ' 141' ' ' ILE . . . . . . . . . . . . . 19.3 mt -119.83 119.73 61.17 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.28 0 N-CA-C 109.863 -0.421 . . . . 0.0 109.863 -175.009 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' F' F ' 142' ' ' ARG . . . . . . . . . . . . . 78.9 mtp180 -108.9 130.11 55.43 Favored 'General case' 0 C--N 1.331 -0.23 0 CA-C-N 115.556 -0.747 . . . . 0.0 110.624 -177.948 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' F' F ' 143' ' ' THR . . . . . . . . . . . . . 26.5 p . . . . . 0 C--O 1.22 -0.485 0 CA-C-O 118.106 -0.95 . . . . 0.0 110.532 -179.238 . . . . . . . . 0 0 . 1 . 019 nuclear nobuild full ' A' A ' -3' ' ' GLU . . . . . . . . . . . . . 84.5 tt0 . . . . . 0 N--CA 1.491 1.577 0 N-CA-C 109.463 -0.569 . . . . 0.0 109.463 . . . . . . . . . 0 0 . 1 . 019 nuclear nobuild full ' A' A ' -2' ' ' GLY . . . . . . . . . . . . . . . -64.75 145.38 49.38 Favored Glycine 0 CA--C 1.524 0.62 0 N-CA-C 111.0 -0.84 . . . . 0.0 111.0 -179.969 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' -1' ' ' VAL . . . . . . . . . . . . . 43.4 t -96.09 132.65 39.79 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.34 0 N-CA-C 110.125 -0.324 . . . . 0.0 110.125 -179.618 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 0' ' ' ILE . . . . . . . . . . . . . 46.8 mm -119.01 137.88 51.54 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.207 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.306 179.701 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 14.9 ptm -77.82 129.11 35.03 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 115.932 -0.576 . . . . 0.0 110.49 -179.982 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 3.9 p -129.17 127.35 41.17 Favored 'General case' 0 C--N 1.332 -0.176 0 CA-C-O 121.149 0.5 . . . . 0.0 110.692 -178.597 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 95.7 mt-10 -141.26 144.36 34.63 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 115.593 -0.731 . . . . 0.0 110.996 -176.55 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 4' ' ' LEU . . . . . . . . . . . . . 21.8 tp -122.46 125.6 46.15 Favored 'General case' 0 C--N 1.331 -0.206 0 CA-C-N 115.919 -0.582 . . . . 0.0 109.758 174.431 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 5' ' ' LYS . . . . . . . . . . . . . 90.5 mttt -104.64 120.95 42.52 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.341 -0.391 . . . . 0.0 110.685 -179.51 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 65.9 mt -117.82 147.27 43.19 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 115.575 -0.739 . . . . 0.0 110.7 -178.08 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 56.6 tttt -140.31 139.37 20.66 Favored Pre-proline 0 CA--C 1.533 0.314 0 CA-C-O 119.066 -0.492 . . . . 0.0 109.953 175.103 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 8' ' ' PRO . . . . . . . . . . . . . 94.1 Cg_endo -91.81 146.63 3.18 Favored 'Trans proline' 0 N--CA 1.49 1.319 0 C-N-CA 121.623 1.549 . . . . 0.0 111.834 178.119 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 59.1 mt -78.64 -47.18 1.87 Allowed Pre-proline 0 CA--C 1.534 0.359 0 CA-C-O 118.724 -0.655 . . . . 0.0 112.029 179.96 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 87.8 Cg_endo -81.34 151.37 17.68 Favored 'Trans proline' 0 N--CA 1.495 1.609 0 C-N-CA 121.195 1.264 . . . . 0.0 111.939 175.774 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 34.4 mmtp -84.26 100.43 11.21 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.445 -0.343 . . . . 0.0 110.347 177.703 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 12.5 p -140.28 143.73 29.02 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.275 0 CA-C-N 116.233 -0.439 . . . . 0.0 110.545 -179.794 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 15.0 pt-20 -89.62 130.84 35.86 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.198 -0.455 . . . . 0.0 110.224 177.72 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 14' ' ' LEU . . . . . . . . . . . . . 35.0 mt -98.24 153.72 37.95 Favored Pre-proline 0 C--O 1.234 0.241 0 CA-C-N 116.377 -0.374 . . . . 0.0 111.16 -176.5 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 15' ' ' PRO . . . . . . . . . . . . . 24.8 Cg_exo -63.0 165.44 16.59 Favored 'Trans proline' 0 N--CA 1.496 1.667 0 C-N-CA 121.37 1.38 . . . . 0.0 111.806 174.657 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 16' ' ' PRO . . . . . . . . . . . . . 26.5 Cg_exo -60.71 -46.32 17.36 Favored 'Trans proline' 0 N--CA 1.498 1.763 0 C-N-CA 121.48 1.454 . . . . 0.0 112.912 -177.649 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 17' ' ' ASP . . . . . . . . . . . . . 22.4 p-10 -86.06 11.31 11.96 Favored 'General case' 0 C--N 1.327 -0.412 0 N-CA-C 113.207 0.817 . . . . 0.0 113.207 -176.508 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 18' ' ' PHE . . . . . . . . . . . . . 37.5 t80 -57.03 -40.5 76.86 Favored 'General case' 0 C--N 1.334 -0.091 0 O-C-N 121.877 -0.514 . . . . 0.0 110.461 -179.215 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 19' ' ' VAL . . . . . . . . . . . . . 47.7 t -56.91 -44.06 81.63 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.285 0 CA-C-N 116.344 -0.389 . . . . 0.0 110.412 -179.683 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 18.1 t70 -59.79 -41.55 91.42 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-O 120.892 0.377 . . . . 0.0 110.702 -178.031 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 47.5 t -63.76 -47.74 89.63 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.308 0 CA-C-N 116.422 -0.353 . . . . 0.0 110.487 -178.021 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 22' ' ' ILE . . . . . 0.53 HG22 HD12 ' A' ' 26' ' ' LEU . 50.6 mm -56.16 -44.61 79.58 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.201 0 C-N-CA 120.863 -0.335 . . . . 0.0 110.656 179.07 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 23' ' ' ARG . . . . . . . . . . . . . 51.2 ttp180 -53.62 -49.1 68.59 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-O 120.715 0.293 . . . . 0.0 111.462 -179.393 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 24' ' ' ILE . . . . . . . . . . . . . 71.8 mt -59.24 -44.63 92.45 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.268 0 CA-C-N 116.441 -0.345 . . . . 0.0 111.157 -178.329 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 79.3 mttt -64.06 -41.38 97.37 Favored 'General case' 0 C--N 1.329 -0.318 0 N-CA-C 112.377 0.51 . . . . 0.0 112.377 -177.554 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 26' ' ' LEU . . . . . 0.53 HD12 HG22 ' A' ' 22' ' ' ILE . 65.2 mt -79.48 -42.34 25.51 Favored 'General case' 0 C--N 1.329 -0.307 0 N-CA-C 113.147 0.795 . . . . 0.0 113.147 -171.108 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 27' ' ' GLN . . . . . . . . . . . . . 10.2 pt20 -46.58 138.43 5.91 Favored 'General case' 0 N--CA 1.469 0.491 0 N-CA-C 112.816 0.673 . . . . 0.0 112.816 -175.533 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 100.77 -25.65 27.56 Favored Glycine 0 CA--C 1.531 1.086 0 CA-C-N 115.498 -0.774 . . . . 0.0 112.387 -178.515 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 85.6 mttt -98.68 155.22 17.43 Favored 'General case' 0 C--O 1.233 0.197 0 CA-C-N 117.428 0.614 . . . . 0.0 111.467 179.47 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 30' ' ' THR . . . . . . . . . . . . . 29.9 m -100.79 137.14 39.57 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 115.836 -0.62 . . . . 0.0 109.748 175.125 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 34.0 m -128.81 151.77 36.04 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.24 0 CA-C-O 120.829 0.347 . . . . 0.0 111.076 -177.602 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 32' ' ' ARG . . . . . . . . . . . . . 75.5 mtp180 -131.08 150.23 52.24 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-O 121.294 0.569 . . . . 0.0 110.541 177.241 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 33' ' ' THR . . . . . . . . . . . . . 17.6 m -53.17 138.2 32.2 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.163 -0.471 . . . . 0.0 111.471 -178.611 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 102.07 -17.23 54.63 Favored Glycine 0 CA--C 1.531 1.06 0 CA-C-O 119.67 -0.517 . . . . 0.0 113.333 178.06 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 79.7 m-20 -65.82 146.07 55.2 Favored 'General case' 0 C--O 1.231 0.107 0 CA-C-N 118.075 0.938 . . . . 0.0 110.98 179.268 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 46.9 t -121.19 129.19 75.9 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.197 0 CA-C-N 115.943 -0.571 . . . . 0.0 109.806 178.603 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 37' ' ' ILE . . . . . . . . . . . . . 67.7 mt -119.62 138.23 50.92 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.228 0 CA-C-N 116.211 -0.45 . . . . 0.0 109.835 -179.522 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . -112.15 128.68 8.66 Favored Glycine 0 CA--C 1.525 0.682 0 N-CA-C 111.034 -0.826 . . . . 0.0 111.034 179.963 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 39' ' ' ILE . . . . . . . . . . . . . 72.3 mt -127.41 127.18 68.72 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.206 0 N-CA-C 109.848 -0.427 . . . . 0.0 109.848 178.453 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 40' ' ' SER . . . . . . . . . . . . . 45.7 t -92.72 124.88 37.05 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.476 -0.329 . . . . 0.0 110.79 177.0 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 41' ' ' ILE . . . . . . . . . . . . . 73.9 mt -128.67 116.41 41.22 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.158 0 CA-C-O 120.92 0.391 . . . . 0.0 110.186 178.261 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 42' ' ' LEU . . . . . 0.538 ' O ' HD23 ' A' ' 42' ' ' LEU . 1.3 tt 54.91 46.71 23.83 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-O 121.441 0.639 . . . . 0.0 110.616 177.835 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . 75.97 -10.05 15.87 Favored Glycine 0 CA--C 1.533 1.194 0 CA-C-N 116.042 -0.526 . . . . 0.0 113.667 174.35 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 44' ' ' LYS . . . . . . . . . . . . . 46.6 mtmt -104.41 126.92 51.94 Favored 'General case' 0 C--N 1.332 -0.175 0 CA-C-N 118.178 0.989 . . . . 0.0 110.328 179.224 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 39.5 tp10 -84.83 134.25 34.3 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-O 120.96 0.409 . . . . 0.0 111.34 -177.699 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 46' ' ' VAL . . . . . . . . . . . . . 7.4 p -127.81 130.65 70.14 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.175 0 CA-C-N 116.085 -0.507 . . . . 0.0 109.851 176.075 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 97.7 mttt -100.89 131.54 46.72 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.146 -0.479 . . . . 0.0 111.452 177.59 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 48' ' ' PHE . . . . . . . . . . . . . 90.4 m-85 -113.9 131.77 56.17 Favored 'General case' 0 C--N 1.33 -0.278 0 N-CA-C 109.535 -0.542 . . . . 0.0 109.535 175.246 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 45.3 tttp -108.07 137.23 46.41 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-O 120.715 0.293 . . . . 0.0 110.736 179.405 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 50' ' ' VAL . . . . . . . . . . . . . 45.0 t -78.91 107.04 10.87 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.236 0 N-CA-C 109.157 -0.683 . . . . 0.0 109.157 175.163 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 51' ' ' VAL . . . . . . . . . . . . . 47.5 t -73.23 -47.68 45.94 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.356 0 CA-C-N 116.263 -0.426 . . . . 0.0 110.053 -173.555 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 52' ' ' GLN . . . . . . . . . . . . . 62.0 tt0 -162.69 141.96 9.04 Favored 'General case' 0 C--N 1.331 -0.201 0 C-N-CA 120.158 -0.617 . . . . 0.0 111.838 -178.129 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -114.92 130.7 56.96 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 115.65 -0.705 . . . . 0.0 109.9 176.057 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 54' ' ' TYR . . . . . . . . . . . . . 37.9 t80 -129.15 107.44 17.85 Favored Pre-proline 0 CA--C 1.534 0.338 0 CA-C-O 118.292 -0.861 . . . . 0.0 110.52 -179.726 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 55' ' ' PRO . . . . . . . . . . . . . 72.4 Cg_endo -77.2 169.98 72.71 Favored 'Cis proline' 0 N--CA 1.499 1.85 0 CA-C-N 121.778 1.671 . . . . 0.0 112.562 -5.145 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 56' ' ' SER . . . . . . . . . . . . . 16.1 m -115.34 133.21 22.76 Favored Pre-proline 0 CA--C 1.538 0.506 0 CA-C-O 118.457 -0.782 . . . . 0.0 109.494 174.764 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 57' ' ' PRO . . . . . . . . . . . . . 56.0 Cg_endo -71.62 147.98 89.3 Favored 'Cis proline' 0 N--CA 1.497 1.71 0 CA-C-N 121.851 1.697 . . . . 0.0 111.502 -2.171 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 58' ' ' LEU . . . . . . . . . . . . . 22.2 tp -108.05 137.11 46.61 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-O 120.926 0.393 . . . . 0.0 110.74 -177.952 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 59' ' ' ARG . . . . . . . . . . . . . 77.2 ttt180 -102.89 122.05 43.76 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-N 115.882 -0.599 . . . . 0.0 109.401 175.714 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 43.3 t -79.31 119.81 29.33 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.254 0 C-N-CA 120.633 -0.427 . . . . 0.0 110.331 -176.3 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 75.3 tt0 -130.88 158.72 39.45 Favored 'General case' 0 C--N 1.328 -0.33 0 N-CA-C 109.059 -0.719 . . . . 0.0 109.059 177.435 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 62' ' ' ASP . . . . . . . . . . . . . 68.4 m-20 -50.98 -31.11 16.93 Favored 'General case' 0 C--N 1.327 -0.381 0 N-CA-C 112.211 0.448 . . . . 0.0 112.211 -178.65 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 63' ' ' ARG . . . . . . . . . . . . . 7.1 ptp180 -86.25 4.63 38.01 Favored 'General case' 0 CA--C 1.535 0.383 0 N-CA-C 113.728 1.01 . . . . 0.0 113.728 -175.579 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 17.9 m -86.65 141.85 28.65 Favored 'General case' 0 C--N 1.332 -0.162 0 CA-C-N 118.188 0.449 . . . . 0.0 110.371 -178.667 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 65' ' ' LYS . . . . . . . . . . . . . 37.3 ttpt -89.08 130.74 35.48 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-O 121.0 0.428 . . . . 0.0 110.607 -177.94 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 66' ' ' ILE . . . . . . . . . . . . . 64.7 mt -111.78 131.52 62.93 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.288 0 N-CA-C 109.857 -0.423 . . . . 0.0 109.857 -179.104 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 67' ' ' THR . . . . . . . . . . . . . 28.5 m -125.7 138.25 53.87 Favored 'General case' 0 C--N 1.332 -0.166 0 CA-C-O 121.059 0.457 . . . . 0.0 110.865 -177.928 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 68' ' ' LEU . . . . . 0.496 ' N ' HD12 ' A' ' 68' ' ' LEU . 6.8 mp -102.19 133.13 47.55 Favored 'General case' 0 C--N 1.33 -0.239 0 CA-C-N 115.889 -0.596 . . . . 0.0 110.332 178.132 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 69' ' ' VAL . . . . . . . . . . . . . 45.3 t -98.51 141.57 16.1 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.331 0 CA-C-N 116.065 -0.516 . . . . 0.0 110.097 179.27 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 70' ' ' THR . . . . . . . . . . . . . 76.6 p -129.97 158.21 40.2 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.283 -179.501 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 71' ' ' HIS . . . . . . . . . . . . . 20.8 m-70 -71.41 152.64 94.07 Favored Pre-proline 0 C--N 1.329 -0.314 0 CA-C-N 116.049 -0.523 . . . . 0.0 110.738 -178.782 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 72' ' ' PRO . . . . . . . . . . . . . 91.7 Cg_endo -83.36 -21.04 4.62 Favored 'Trans proline' 0 N--CA 1.494 1.521 0 C-N-CA 121.502 1.468 . . . . 0.0 113.195 -179.94 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 73' ' ' VAL . . . . . . . . . . . . . 35.2 m -88.98 161.38 2.7 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.278 0 CA-C-O 120.81 0.338 . . . . 0.0 110.705 -178.679 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 74' ' ' ASP . . . . . . . . . . . . . 23.9 t0 -101.78 115.92 31.59 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.181 -0.463 . . . . 0.0 109.839 -179.677 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 42.3 t -115.78 124.54 72.29 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.204 0 CA-C-O 121.073 0.463 . . . . 0.0 110.906 -175.712 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 76' ' ' LEU . . . . . . . . . . . . . 5.0 mp -121.08 137.17 54.78 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 115.625 -0.716 . . . . 0.0 109.336 174.162 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 77' ' ' GLU . . . . . 0.442 ' HG2' HG23 ' F' ' 139' ' ' THR . 96.9 mt-10 -131.75 133.11 44.42 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-O 120.967 0.413 . . . . 0.0 111.141 -178.568 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 78' ' ' ALA . . . . . . . . . . . . . . . -122.39 137.74 54.76 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 115.813 -0.631 . . . . 0.0 109.923 176.971 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 79' ' ' LYS . . . . . 0.577 ' O ' HD13 ' A' ' 80' ' ' ILE . 99.2 mttt -75.92 117.25 17.45 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-O 120.983 0.421 . . . . 0.0 110.285 179.541 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 80' ' ' ILE . . . . . 0.577 HD13 ' O ' ' A' ' 79' ' ' LYS . 42.8 mm -139.1 102.6 1.76 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.394 0 N-CA-C 109.382 -0.599 . . . . 0.0 109.382 -176.888 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 81' ' ' LYS . . . . . . . . . . . . . 97.1 mttt -99.7 131.35 45.74 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-O 120.981 0.42 . . . . 0.0 111.198 -177.704 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . 89.02 42.1 5.72 Favored Glycine 0 CA--C 1.526 0.742 0 CA-C-N 115.893 -0.594 . . . . 0.0 111.779 174.866 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 83' ' ' ILE . . . . . . . . . . . . . 70.5 mt -69.3 136.62 25.89 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.354 0 N-CA-C 109.833 -0.432 . . . . 0.0 109.833 178.068 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 84' ' ' LYS . . . . . . . . . . . . . 59.5 tttt -99.11 -53.7 3.18 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.115 -0.493 . . . . 0.0 110.285 -178.395 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 85' ' ' ASP . . . . . . . . . . . . . 8.6 t70 -155.12 154.65 32.69 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 115.857 -0.611 . . . . 0.0 110.4 179.841 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 86' ' ' VAL . . . . . . . . . . . . . 42.2 t -129.41 132.0 66.9 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.225 0 CA-C-O 120.942 0.401 . . . . 0.0 110.642 -178.756 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 87' ' ' ILE . . . . . 0.496 HD12 ' N ' ' A' ' 87' ' ' ILE . 5.0 mp -119.62 126.81 75.68 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.219 0 CA-C-N 115.975 -0.557 . . . . 0.0 109.566 176.81 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 88' ' ' LEU . . . . . . . . . . . . . 66.8 mt -107.02 135.29 48.83 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-O 121.075 0.464 . . . . 0.0 111.322 -177.949 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 89' ' ' ASP . . . . . . . . . . . . . 13.1 t70 -127.89 152.15 48.2 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 115.758 -0.655 . . . . 0.0 109.536 175.532 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 83.3 tt0 -47.28 -39.68 15.06 Favored 'General case' 0 C--N 1.33 -0.266 0 N-CA-C 112.792 0.664 . . . . 0.0 112.792 -172.978 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 91' ' ' ASN . . . . . . . . . . . . . 29.0 p30 -132.03 34.95 3.77 Favored 'General case' 0 N--CA 1.464 0.245 0 N-CA-C 111.695 0.257 . . . . 0.0 111.695 -177.673 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 92' ' ' LEU . . . . . . . . . . . . . 8.0 tp -166.11 147.0 6.59 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-O 120.73 0.3 . . . . 0.0 110.533 -178.718 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 93' ' ' ILE . . . . . . . . . . . . . 74.6 mt -129.72 122.92 55.99 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.267 0 N-CA-C 109.545 -0.539 . . . . 0.0 109.545 179.881 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 94' ' ' VAL . . . . . . . . . . . . . 40.3 t -121.06 128.06 76.0 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.271 0 CA-C-O 120.854 0.359 . . . . 0.0 110.051 -179.519 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 95' ' ' VAL . . . . . . . . . . . . . 42.0 t -120.12 134.29 64.12 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.314 0 CA-C-N 116.031 -0.531 . . . . 0.0 109.804 179.695 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 96' ' ' ILE . . . . . . . . . . . . . 63.3 mt -111.18 128.77 67.42 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.409 0 N-CA-C 109.166 -0.679 . . . . 0.0 109.166 178.856 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 97' ' ' THR . . . . . . . . . . . . . 75.8 p -100.82 157.63 16.57 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-O 121.343 0.592 . . . . 0.0 111.283 -177.412 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 98' ' ' GLU . . . . . . . . . . . . . 84.7 tt0 -53.92 -28.16 35.12 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.001 -0.545 . . . . 0.0 112.066 -179.478 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 99' ' ' GLU . . . . . . . . . . . . . 44.9 mp0 -80.58 17.73 1.07 Allowed 'General case' 0 CA--C 1.534 0.34 0 N-CA-C 112.984 0.735 . . . . 0.0 112.984 -176.339 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 100' ' ' ASN . . . . . . . . . . . . . 4.1 m-20 61.51 37.97 16.08 Favored 'General case' 0 CA--C 1.529 0.157 0 CA-C-O 121.063 0.459 . . . . 0.0 110.938 178.459 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 101' ' ' GLU . . . . . . . . . . . . . 84.9 tt0 -117.83 144.72 45.13 Favored 'General case' 0 C--N 1.331 -0.232 0 N-CA-C 109.671 -0.492 . . . . 0.0 109.671 176.307 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 102' ' ' VAL . . . . . . . . . . . . . 45.6 t -114.98 126.2 72.51 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.257 0 CA-C-O 120.887 0.375 . . . . 0.0 110.152 -177.483 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 103' ' ' LEU . . . . . . . . . . . . . 42.5 mt -114.3 130.98 56.67 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-N 115.592 -0.731 . . . . 0.0 109.822 176.614 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 104' ' ' ILE . . . . . 0.675 HD13 HG11 ' A' ' 130' ' ' VAL . 67.7 mt -122.37 120.96 62.55 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.236 0 N-CA-C 110.436 -0.209 . . . . 0.0 110.436 -177.312 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 105' ' ' PHE . . . . . . . . . . . . . 43.8 m-85 -123.83 166.63 15.28 Favored 'General case' 0 C--N 1.332 -0.193 0 O-C-N 124.041 0.838 . . . . 0.0 109.798 179.64 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 106' ' ' ASN . . . . . . . . . . . . . 41.2 p-10 -96.21 -169.91 2.0 Favored 'General case' 0 C--N 1.329 -0.302 0 N-CA-C 109.377 -0.601 . . . . 0.0 109.377 171.545 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 107' ' ' GLN . . . . . . . . . . . . . 48.0 tt0 -59.61 -30.04 68.42 Favored 'General case' 0 CA--C 1.532 0.256 0 C-N-CA 120.74 -0.384 . . . . 0.0 111.644 177.688 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 108' ' ' ASN . . . . . . . . . . . . . 13.9 t30 -81.89 6.32 16.18 Favored 'General case' 0 CA--C 1.537 0.476 0 N-CA-C 113.178 0.807 . . . . 0.0 113.178 -178.145 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 109' ' ' LEU . . . . . . . . . . . . . 8.9 tp 61.88 36.94 15.65 Favored 'General case' 0 C--O 1.232 0.155 0 O-C-N 122.123 -0.36 . . . . 0.0 111.526 176.567 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 110' ' ' GLU . . . . . . . . . . . . . 96.0 mt-10 -104.99 149.61 25.62 Favored 'General case' 0 C--N 1.33 -0.267 0 N-CA-C 110.032 -0.358 . . . . 0.0 110.032 176.018 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 111' ' ' GLU . . . . . . . . . . . . . 98.8 mt-10 -76.61 122.62 24.9 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-O 120.99 0.424 . . . . 0.0 111.222 -178.101 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 112' ' ' LEU . . . . . . . . . . . . . 16.1 mt -110.78 -45.94 3.42 Favored 'General case' 0 C--N 1.332 -0.177 0 CA-C-N 115.953 -0.567 . . . . 0.0 110.188 176.986 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 113' ' ' TYR . . . . . 0.412 ' HB3' HD12 ' A' ' 104' ' ' ILE . 34.5 t80 -138.65 140.69 38.96 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.859 179.381 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 114' ' ' ARG . . . . . . . . . . . . . 78.3 mtp180 -143.05 122.4 13.07 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.078 -0.51 . . . . 0.0 110.355 179.074 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 115' ' ' GLY . . . . . . . . . . . . . . . -150.12 153.79 25.29 Favored Glycine 0 CA--C 1.525 0.67 0 N-CA-C 111.22 -0.752 . . . . 0.0 111.22 179.73 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 116' ' ' LYS . . . . . . . . . . . . . 40.3 ttpt -126.47 129.46 48.73 Favored 'General case' 0 C--N 1.331 -0.226 0 N-CA-C 109.72 -0.474 . . . . 0.0 109.72 178.778 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 117' ' ' PHE . . . . . 0.412 ' HE2' HD13 ' A' ' 132' ' ' ILE . 41.6 m-85 -130.56 114.96 16.11 Favored 'General case' 0 C--N 1.333 -0.15 0 CA-C-O 120.851 0.358 . . . . 0.0 110.631 -174.155 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 118' ' ' GLU . . . . . . . . . . . . . 84.7 tt0 -53.93 -46.69 71.6 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.418 -0.355 . . . . 0.0 111.379 -177.875 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 119' ' ' ASN . . . . . . . . . . . . . 33.0 m120 -94.77 30.44 2.06 Favored 'General case' 0 C--N 1.329 -0.299 0 N-CA-C 112.241 0.46 . . . . 0.0 112.241 -175.197 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 120' ' ' LEU . . . . . . . . . . . . . 17.1 tp -58.47 123.4 16.06 Favored 'General case' 0 C--N 1.332 -0.153 0 N-CA-C 110.204 -0.295 . . . . 0.0 110.204 177.575 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 121' ' ' ASN . . . . . . . . . . . . . 14.7 m120 -113.77 -44.19 3.21 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-N 116.678 -0.237 . . . . 0.0 110.989 -178.399 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 122' ' ' LYS . . . . . . . . . . . . . 97.3 mttt -148.28 150.31 33.42 Favored 'General case' 0 C--N 1.331 -0.236 0 C-N-CA 120.549 -0.46 . . . . 0.0 111.523 -178.04 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 123' ' ' VAL . . . . . . . . . . . . . 43.9 t -130.13 132.23 65.4 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.185 0 CA-C-N 115.967 -0.561 . . . . 0.0 109.55 175.825 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 124' ' ' LEU . . . . . . . . . . . . . 17.6 tp -127.62 136.9 52.27 Favored 'General case' 0 C--N 1.332 -0.162 0 CA-C-O 120.808 0.337 . . . . 0.0 110.621 -178.188 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 125' ' ' VAL . . . . . . . . . . . . . 11.4 p -125.59 128.05 72.07 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.22 0 CA-C-N 116.112 -0.495 . . . . 0.0 110.252 178.978 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 126' ' ' ARG . . . . . . . . . . . . . 51.8 mmm-85 -140.84 123.9 16.46 Favored 'General case' 0 C--N 1.33 -0.269 0 N-CA-C 109.19 -0.67 . . . . 0.0 109.19 178.909 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 127' ' ' ASN . . . . . . . . . . . . . 37.1 t30 57.25 -150.99 0.43 Allowed 'General case' 0 CA--C 1.539 0.546 0 N-CA-C 109.56 -0.533 . . . . 0.0 109.56 -179.074 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 128' ' ' ASP . . . . . . . . . . . . . 19.5 p-10 -83.57 14.75 3.54 Favored 'General case' 0 CA--C 1.537 0.46 0 CA-C-N 118.637 0.653 . . . . 0.0 112.694 177.024 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 129' ' ' LEU . . . . . . . . . . . . . 40.2 mt -114.1 145.09 42.1 Favored 'General case' 0 C--O 1.231 0.119 0 O-C-N 121.975 -0.453 . . . . 0.0 109.83 179.06 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 130' ' ' VAL . . . . . 0.675 HG11 HD13 ' A' ' 104' ' ' ILE . 12.3 p -133.73 144.98 34.24 Favored 'Isoleucine or valine' 0 C--O 1.233 0.206 0 CA-C-O 121.248 0.547 . . . . 0.0 110.756 -176.914 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 131' ' ' VAL . . . . . 0.548 HG22 HD12 ' A' ' 140' ' ' LEU . 45.3 t -134.36 137.35 51.74 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.303 0 CA-C-N 115.707 -0.679 . . . . 0.0 110.063 179.695 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 132' ' ' ILE . . . . . 0.412 HD13 ' HE2' ' A' ' 117' ' ' PHE . 72.1 mt -116.53 132.82 65.05 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.367 0 CA-C-N 115.757 -0.656 . . . . 0.0 109.336 179.47 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 133' ' ' ILE . . . . . . . . . . . . . 42.6 mm -114.55 120.18 63.52 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.259 0 CA-C-O 120.693 0.282 . . . . 0.0 110.879 -175.356 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 134' ' ' ASP . . . . . . . . . . . . . 8.4 p-10 -130.62 143.25 50.62 Favored 'General case' 0 C--N 1.33 -0.244 0 N-CA-C 109.351 -0.611 . . . . 0.0 109.351 174.732 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 135' ' ' GLU . . . . . . . . . . . . . 39.6 tp10 -50.0 -26.32 4.18 Favored 'General case' 0 C--N 1.328 -0.328 0 N-CA-C 112.89 0.7 . . . . 0.0 112.89 -171.939 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 136' ' ' GLN . . . . . . . . . . . . . 97.0 mt-30 -80.43 -35.1 35.52 Favored 'General case' 0 C--N 1.331 -0.218 0 N-CA-C 112.022 0.378 . . . . 0.0 112.022 -176.962 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 137' ' ' LYS . . . . . . . . . . . . . 49.7 pttt -167.64 172.61 9.19 Favored 'General case' 0 C--N 1.331 -0.219 0 CA-C-O 121.478 0.656 . . . . 0.0 112.052 -173.828 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 138' ' ' LEU . . . . . 0.411 HD23 ' N ' ' A' ' 139' ' ' THR . 6.1 tt -113.99 129.81 56.58 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 115.164 -0.925 . . . . 0.0 110.114 -179.48 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 139' ' ' THR . . . . . 0.411 ' N ' HD23 ' A' ' 138' ' ' LEU . 24.8 m -108.63 126.41 52.93 Favored 'General case' 0 C--N 1.332 -0.179 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.568 179.964 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 140' ' ' LEU . . . . . 0.548 HD12 HG22 ' A' ' 131' ' ' VAL . 11.1 tp -114.26 122.89 48.14 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-N 115.753 -0.658 . . . . 0.0 109.404 -178.846 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 141' ' ' ILE . . . . . 0.473 ' HB ' HG13 ' A' ' 130' ' ' VAL . 19.9 mt -121.48 120.38 61.69 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.273 0 CA-C-O 120.954 0.407 . . . . 0.0 109.94 -176.41 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 142' ' ' ARG . . . . . . . . . . . . . 72.0 mtp180 -110.61 118.03 35.12 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 115.327 -0.851 . . . . 0.0 110.64 -177.405 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 143' ' ' THR . . . . . . . . . . . . . 33.7 p . . . . . 0 C--O 1.219 -0.502 0 CA-C-O 117.891 -1.052 . . . . 0.0 110.533 179.929 . . . . . . . . 0 0 . 1 . 019 nuclear nobuild full ' B' B ' -3' ' ' GLU . . . . . . . . . . . . . 45.3 mp0 . . . . . 0 N--CA 1.489 1.511 0 N-CA-C 109.28 -0.637 . . . . 0.0 109.28 . . . . . . . . . 0 0 . 1 . 019 nuclear nobuild full ' B' B ' -2' ' ' GLY . . . . . . . . . . . . . . . -69.55 138.5 30.45 Favored Glycine 0 CA--C 1.524 0.643 0 N-CA-C 111.082 -0.807 . . . . 0.0 111.082 -179.69 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' B' B ' -1' ' ' VAL . . . . . . . . . . . . . 44.7 t -142.16 143.92 25.81 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.351 0 CA-C-O 120.871 0.367 . . . . 0.0 110.064 179.899 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' B' B ' 0' ' ' ILE . . . . . . . . . . . . . 69.4 mt -91.52 133.15 34.01 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.281 0 CA-C-N 116.246 -0.434 . . . . 0.0 109.85 179.371 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' B' B ' 1' ' ' MET . . . . . . . . . . . . . 25.2 ptp -78.74 138.13 38.09 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.199 -0.455 . . . . 0.0 111.146 -177.57 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' B' B ' 2' ' ' SER . . . . . . . . . . . . . 7.3 p -122.99 134.4 54.33 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 116.017 -0.538 . . . . 0.0 110.358 178.091 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' B' B ' 3' ' ' GLU . . . . . . . . . . . . . 94.5 mt-10 -140.71 142.96 34.79 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.112 -0.495 . . . . 0.0 111.022 -177.943 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' B' B ' 4' ' ' LEU . . . . . . . . . . . . . 17.7 tp -127.85 127.86 44.2 Favored 'General case' 0 C--N 1.331 -0.205 0 CA-C-N 116.087 -0.506 . . . . 0.0 109.865 175.538 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' B' B ' 5' ' ' LYS . . . . . . . . . . . . . 98.6 mttt -109.02 122.74 47.89 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-O 120.487 0.184 . . . . 0.0 110.87 -179.673 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' B' B ' 6' ' ' LEU . . . . . . . . . . . . . 53.6 mt -114.94 143.89 44.44 Favored 'General case' 0 N--CA 1.463 0.215 0 O-C-N 123.8 0.688 . . . . 0.0 110.946 179.679 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' B' B ' 7' ' ' LYS . . . . . . . . . . . . . 84.3 tttt -129.88 135.47 27.55 Favored Pre-proline 0 CA--C 1.535 0.366 0 CA-C-O 118.811 -0.614 . . . . 0.0 109.643 175.226 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' B' B ' 8' ' ' PRO . . . . . . . . . . . . . 71.8 Cg_endo -90.48 142.85 3.59 Favored 'Trans proline' 0 N--CA 1.492 1.396 0 C-N-CA 121.578 1.519 . . . . 0.0 112.421 179.726 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' B' B ' 9' ' ' LEU . . . . . . . . . . . . . 19.5 mt -87.08 -49.64 0.46 Allowed Pre-proline 0 CA--C 1.535 0.386 0 CA-C-O 118.669 -0.682 . . . . 0.0 112.477 -179.399 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' B' B ' 10' ' ' PRO . . . . . . . . . . . . . 95.7 Cg_endo -79.12 163.03 25.64 Favored 'Trans proline' 0 N--CA 1.496 1.657 0 C-N-CA 121.317 1.344 . . . . 0.0 112.315 -178.995 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' B' B ' 11' ' ' LYS . . . . . . . . . . . . . 26.5 tptp -87.09 104.06 15.98 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.404 178.604 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' B' B ' 12' ' ' VAL . . . . . . . . . . . . . 12.5 p -147.83 147.09 17.57 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.231 0 CA-C-N 116.31 -0.404 . . . . 0.0 110.684 -179.661 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' B' B ' 13' ' ' GLU . . . . . . . . . . . . . 84.7 tt0 -100.34 124.57 45.99 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.158 -0.474 . . . . 0.0 110.079 177.447 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' B' B ' 14' ' ' LEU . . . . . 0.404 HD13 ' CD2' ' B' ' 18' ' ' PHE . 30.3 mt -98.93 151.46 37.4 Favored Pre-proline 0 CA--C 1.533 0.291 0 CA-C-O 119.311 -0.376 . . . . 0.0 111.228 -176.329 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' B' B ' 15' ' ' PRO . . . . . . . . . . . . . 24.2 Cg_exo -63.84 162.25 29.46 Favored 'Trans proline' 0 N--CA 1.498 1.792 0 C-N-CA 121.372 1.382 . . . . 0.0 111.97 175.625 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' B' B ' 16' ' ' PRO . . . . . . . . . . . . . 24.7 Cg_exo -62.41 -37.91 56.82 Favored 'Trans proline' 0 N--CA 1.497 1.694 0 C-N-CA 121.409 1.406 . . . . 0.0 112.469 179.235 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' B' B ' 17' ' ' ASP . . . . . . . . . . . . . 10.0 p-10 -85.25 12.33 8.28 Favored 'General case' 0 CA--C 1.536 0.423 0 N-CA-C 113.012 0.745 . . . . 0.0 113.012 -178.303 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' B' B ' 18' ' ' PHE . . . . . 0.404 ' CD2' HD13 ' B' ' 14' ' ' LEU . 18.7 t80 -56.8 -41.55 77.94 Favored 'General case' 0 C--N 1.334 -0.095 0 O-C-N 121.899 -0.5 . . . . 0.0 110.358 -179.183 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' B' B ' 19' ' ' VAL . . . . . . . . . . . . . 46.8 t -55.63 -41.08 62.99 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.205 0 CA-C-N 116.5 -0.318 . . . . 0.0 110.577 -179.45 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' B' B ' 20' ' ' ASP . . . . . . . . . . . . . 74.6 m-20 -59.33 -41.49 89.26 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-O 121.015 0.436 . . . . 0.0 110.427 179.942 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' B' B ' 21' ' ' VAL . . . . . . . . . . . . . 47.9 t -64.11 -46.0 94.92 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.306 0 CA-C-N 116.136 -0.484 . . . . 0.0 110.386 179.936 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' B' B ' 22' ' ' ILE . . . . . 0.468 HG22 HD12 ' B' ' 26' ' ' LEU . 51.2 mm -53.98 -60.02 1.66 Allowed 'Isoleucine or valine' 0 CA--C 1.53 0.191 0 C-N-CA 120.959 -0.296 . . . . 0.0 111.42 -178.324 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' B' B ' 23' ' ' ARG . . . . . . . . . . . . . 6.0 ptm180 -54.84 -44.75 74.2 Favored 'General case' 0 CA--C 1.53 0.184 0 C-N-CA 120.513 -0.475 . . . . 0.0 111.853 -174.244 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' B' B ' 24' ' ' ILE . . . . . . . . . . . . . 81.0 mt -61.03 -45.12 99.18 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.268 0 C-N-CA 120.836 -0.346 . . . . 0.0 111.663 -176.67 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' B' B ' 25' ' ' LYS . . . . . . . . . . . . . 72.1 mmtt -68.78 -42.56 77.22 Favored 'General case' 0 C--N 1.33 -0.267 0 N-CA-C 112.355 0.502 . . . . 0.0 112.355 -177.186 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' B' B ' 26' ' ' LEU . . . . . 0.468 HD12 HG22 ' B' ' 22' ' ' ILE . 83.0 mt -79.4 -33.97 42.26 Favored 'General case' 0 C--N 1.33 -0.275 0 N-CA-C 113.679 0.992 . . . . 0.0 113.679 -168.571 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' B' B ' 27' ' ' GLN . . . . . . . . . . . . . 10.6 pt20 -46.7 141.27 3.95 Favored 'General case' 0 N--CA 1.469 0.504 0 N-CA-C 112.785 0.661 . . . . 0.0 112.785 -175.577 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' B' B ' 28' ' ' GLY . . . . . . . . . . . . . . . 101.59 -27.16 21.73 Favored Glycine 0 CA--C 1.531 1.077 0 CA-C-N 115.612 -0.722 . . . . 0.0 112.205 -177.389 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' B' B ' 29' ' ' LYS . . . . . . . . . . . . . 68.0 mttm -97.48 155.09 17.09 Favored 'General case' 0 C--O 1.232 0.155 0 CA-C-N 117.451 0.625 . . . . 0.0 111.07 178.051 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' B' B ' 30' ' ' THR . . . . . . . . . . . . . 29.8 m -107.38 139.63 41.57 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.032 -0.531 . . . . 0.0 110.294 177.719 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' B' B ' 31' ' ' VAL . . . . . . . . . . . . . 34.5 m -129.25 152.97 38.0 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.212 0 CA-C-N 116.211 -0.45 . . . . 0.0 110.658 -179.256 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' B' B ' 32' ' ' ARG . . . . . . . . . . . . . 57.8 ttt180 -130.78 151.11 51.58 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-O 121.119 0.485 . . . . 0.0 110.243 178.798 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' B' B ' 33' ' ' THR . . . . . . . . . . . . . 21.6 m -52.12 137.16 28.39 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.366 -0.379 . . . . 0.0 111.676 -176.705 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' B' B ' 34' ' ' GLY . . . . . . . . . . . . . . . 100.61 -17.21 56.92 Favored Glycine 0 CA--C 1.532 1.154 0 CA-C-N 116.042 -0.526 . . . . 0.0 113.39 178.283 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' B' B ' 35' ' ' ASP . . . . . . . . . . . . . 78.3 m-20 -67.4 151.22 47.8 Favored 'General case' 0 C--O 1.231 0.129 0 CA-C-N 118.002 0.901 . . . . 0.0 111.244 179.141 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' B' B ' 36' ' ' VAL . . . . . . . . . . . . . 45.8 t -120.66 130.12 74.88 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.252 0 CA-C-N 115.996 -0.547 . . . . 0.0 109.806 177.429 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' B' B ' 37' ' ' ILE . . . . . . . . . . . . . 63.0 mt -119.53 138.24 50.81 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.256 0 CA-C-N 116.16 -0.473 . . . . 0.0 109.743 -179.132 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' B' B ' 38' ' ' GLY . . . . . . . . . . . . . . . -116.02 128.72 8.13 Favored Glycine 0 CA--C 1.526 0.724 0 N-CA-C 111.096 -0.802 . . . . 0.0 111.096 -179.765 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' B' B ' 39' ' ' ILE . . . . . . . . . . . . . 74.8 mt -130.58 131.0 65.16 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.237 0 N-CA-C 110.134 -0.321 . . . . 0.0 110.134 178.878 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' B' B ' 40' ' ' SER . . . . . . . . . . . . . 68.2 p -92.79 115.22 27.91 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 116.418 -0.355 . . . . 0.0 110.911 176.47 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' B' B ' 41' ' ' ILE . . . . . . . . . . . . . 44.0 mm -122.07 128.86 75.7 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.232 0 CA-C-N 116.476 -0.329 . . . . 0.0 110.276 -179.934 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' B' B ' 42' ' ' LEU . . . . . . . . . . . . . 49.9 mt 55.32 33.52 20.91 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.24 -0.436 . . . . 0.0 111.825 177.263 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' B' B ' 43' ' ' GLY . . . . . . . . . . . . . . . 72.56 27.62 69.09 Favored Glycine 0 CA--C 1.531 1.052 0 C-N-CA 121.203 -0.522 . . . . 0.0 112.393 177.646 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' B' B ' 44' ' ' LYS . . . . . . . . . . . . . 49.4 tptt -141.9 128.32 20.05 Favored 'General case' 0 C--N 1.331 -0.227 0 N-CA-C 109.65 -0.5 . . . . 0.0 109.65 177.832 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' B' B ' 45' ' ' GLU . . . . . . . . . . . . . 44.1 tp10 -82.93 128.06 34.1 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-O 120.891 0.377 . . . . 0.0 111.323 -176.147 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' B' B ' 46' ' ' VAL . . . . . . . . . . . . . 8.5 p -121.86 128.08 75.59 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.255 0 N-CA-C 109.5 -0.556 . . . . 0.0 109.5 174.765 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' B' B ' 47' ' ' LYS . . . . . . . . . . . . . 52.0 mtpt -98.86 127.26 44.74 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.011 -0.54 . . . . 0.0 110.616 177.41 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' B' B ' 48' ' ' PHE . . . . . . . . . . . . . 46.1 m-85 -111.05 131.84 54.74 Favored 'General case' 0 C--N 1.329 -0.309 0 N-CA-C 109.667 -0.494 . . . . 0.0 109.667 177.082 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' B' B ' 49' ' ' LYS . . . . . . . . . . . . . 77.5 tttt -104.71 133.32 49.75 Favored 'General case' 0 C--N 1.328 -0.327 0 N-CA-C 109.926 -0.398 . . . . 0.0 109.926 178.225 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' B' B ' 50' ' ' VAL . . . . . . . . . . . . . 42.3 t -77.76 105.45 6.8 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.28 0 N-CA-C 109.38 -0.6 . . . . 0.0 109.38 178.169 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' B' B ' 51' ' ' VAL . . . . . . . . . . . . . 49.8 t -73.02 -47.28 48.7 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.372 0 CA-C-N 116.061 -0.518 . . . . 0.0 109.879 -174.693 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' B' B ' 52' ' ' GLN . . . . . . . . . . . . . 62.1 tt0 -158.97 138.43 11.59 Favored 'General case' 0 C--N 1.33 -0.274 0 C-N-CA 120.417 -0.513 . . . . 0.0 111.486 -178.241 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' B' B ' 53' ' ' ALA . . . . . . . . . . . . . . . -117.13 130.7 56.8 Favored 'General case' 0 C--N 1.332 -0.193 0 CA-C-N 115.687 -0.688 . . . . 0.0 109.632 172.058 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' B' B ' 54' ' ' TYR . . . . . . . . . . . . . 57.9 t80 -129.18 112.17 18.29 Favored Pre-proline 0 CA--C 1.536 0.432 0 CA-C-O 118.189 -0.91 . . . . 0.0 110.359 178.933 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' B' B ' 55' ' ' PRO . . . . . . . . . . . . . 74.3 Cg_endo -77.11 168.89 75.76 Favored 'Cis proline' 0 N--CA 1.5 1.9 0 CA-C-N 121.973 1.74 . . . . 0.0 112.156 -6.002 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' B' B ' 56' ' ' SER . . . . . . . . . . . . . 13.5 m -116.6 134.88 22.84 Favored Pre-proline 0 CA--C 1.538 0.492 0 CA-C-O 118.478 -0.772 . . . . 0.0 109.456 175.881 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' B' B ' 57' ' ' PRO . . . . . . . . . . . . . 56.0 Cg_endo -72.11 146.73 86.87 Favored 'Cis proline' 0 N--CA 1.497 1.728 0 CA-C-N 121.842 1.694 . . . . 0.0 111.496 -2.229 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' B' B ' 58' ' ' LEU . . . . . . . . . . . . . 25.0 tp -108.35 136.81 47.36 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.378 -0.374 . . . . 0.0 110.832 -177.667 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' B' B ' 59' ' ' ARG . . . . . . . . . . . . . 29.0 ttm180 -100.51 125.9 46.89 Favored 'General case' 0 C--N 1.328 -0.34 0 N-CA-C 109.371 -0.603 . . . . 0.0 109.371 175.521 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' B' B ' 60' ' ' VAL . . . . . . . . . . . . . 40.8 t -78.04 121.73 31.44 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.247 0 C-N-CA 120.828 -0.349 . . . . 0.0 110.848 -174.798 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' B' B ' 61' ' ' GLU . . . . . . . . . . . . . 42.9 mt-10 -130.96 154.05 48.55 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 115.744 -0.662 . . . . 0.0 109.822 175.308 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' B' B ' 62' ' ' ASP . . . . . . . . . . . . . 19.8 p-10 -53.72 -33.64 56.26 Favored 'General case' 0 C--N 1.327 -0.397 0 N-CA-C 111.843 0.312 . . . . 0.0 111.843 -177.792 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' B' B ' 63' ' ' ARG . . . . . . . . . . . . . 36.5 mmt180 -75.66 -18.61 59.59 Favored 'General case' 0 CA--C 1.535 0.371 0 N-CA-C 113.099 0.778 . . . . 0.0 113.099 -175.969 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' B' B ' 64' ' ' THR . . . . . . . . . . . . . 24.0 m -67.2 147.91 52.46 Favored 'General case' 0 C--N 1.332 -0.172 0 CA-C-N 117.724 0.238 . . . . 0.0 110.48 -177.06 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' B' B ' 65' ' ' LYS . . . . . . . . . . . . . 98.4 mttt -87.61 122.95 31.95 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-O 120.937 0.398 . . . . 0.0 110.116 -179.648 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' B' B ' 66' ' ' ILE . . . . . . . . . . . . . 63.4 mt -108.57 120.27 59.64 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.26 0 N-CA-C 109.581 -0.526 . . . . 0.0 109.581 179.183 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' B' B ' 67' ' ' THR . . . . . . . . . . . . . 4.6 m -109.36 140.69 42.73 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-O 121.338 0.59 . . . . 0.0 111.132 -173.511 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' B' B ' 68' ' ' LEU . . . . . . . . . . . . . 7.0 tt -104.38 126.07 51.16 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 115.202 -0.908 . . . . 0.0 110.121 -178.926 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' B' B ' 69' ' ' VAL . . . . . . . . . . . . . 45.1 t -82.91 155.18 3.85 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.19 0 CA-C-N 115.931 -0.577 . . . . 0.0 109.966 178.887 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' B' B ' 70' ' ' THR . . . . . . . . . . . . . 74.4 p -74.66 161.66 29.47 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-O 121.097 0.475 . . . . 0.0 110.274 -172.835 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' B' B ' 71' ' ' HIS . . . . . . . . . . . . . 25.3 m-70 -124.92 174.04 4.23 Favored Pre-proline 0 C--N 1.33 -0.263 0 CA-C-N 115.656 -0.702 . . . . 0.0 110.28 -169.776 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' B' B ' 72' ' ' PRO . . . . . . . . . . . . . 26.3 Cg_exo -64.79 160.38 40.99 Favored 'Trans proline' 0 N--CA 1.494 1.548 0 C-N-CA 121.522 1.481 . . . . 0.0 110.632 171.339 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' B' B ' 73' ' ' VAL . . . . . . . . . . . . . 34.2 m -69.51 167.65 1.76 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.368 0 C-N-CA 120.762 -0.375 . . . . 0.0 110.377 -168.316 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' B' B ' 74' ' ' ASP . . . . . . . . . . . . . 26.4 t0 -78.85 123.89 27.68 Favored 'General case' 0 C--N 1.331 -0.205 0 CA-C-N 116.259 -0.428 . . . . 0.0 111.156 -165.058 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' B' B ' 75' ' ' VAL . . . . . . . . . . . . . 47.0 t -119.7 118.83 58.5 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.218 0 CA-C-N 116.138 -0.483 . . . . 0.0 110.098 -179.571 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' B' B ' 76' ' ' LEU . . . . . . . . . . . . . 23.8 mt -124.33 145.37 49.46 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 115.63 -0.714 . . . . 0.0 109.688 -179.966 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' B' B ' 77' ' ' GLU . . . . . . . . . . . . . 96.0 mt-10 -136.42 134.94 38.28 Favored 'General case' 0 C--N 1.331 -0.227 0 CA-C-O 121.056 0.455 . . . . 0.0 111.184 -178.606 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' B' B ' 78' ' ' ALA . . . . . . . . . . . . . . . -123.57 131.23 53.57 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 115.611 -0.722 . . . . 0.0 109.701 176.462 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' B' B ' 79' ' ' LYS . . . . . 0.608 ' O ' HD13 ' B' ' 80' ' ' ILE . 97.3 mttt -77.32 120.33 22.19 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-O 121.043 0.449 . . . . 0.0 111.266 -175.389 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' B' B ' 80' ' ' ILE . . . . . 0.608 HD13 ' O ' ' B' ' 79' ' ' LYS . 25.9 mm -139.27 101.14 1.49 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.256 0 N-CA-C 109.015 -0.735 . . . . 0.0 109.015 179.11 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' B' B ' 81' ' ' LYS . . . . . . . . . . . . . 68.6 tttt -93.06 124.6 37.15 Favored 'General case' 0 C--N 1.328 -0.332 0 C-N-CA 120.776 -0.37 . . . . 0.0 110.993 -177.01 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' B' B ' 82' ' ' GLY . . . . . . . . . . . . . . . 89.2 42.14 5.65 Favored Glycine 0 CA--C 1.524 0.641 0 C-N-CA 120.738 -0.744 . . . . 0.0 111.416 176.288 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' B' B ' 83' ' ' ILE . . . . . . . . . . . . . 72.1 mt -64.45 137.76 24.31 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.352 0 N-CA-C 109.91 -0.404 . . . . 0.0 109.91 177.884 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' B' B ' 84' ' ' LYS . . . . . . . . . . . . . 80.2 tttt -93.51 -51.38 4.98 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 115.932 -0.576 . . . . 0.0 110.001 -179.426 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' B' B ' 85' ' ' ASP . . . . . . . . . . . . . 9.9 t70 -159.87 153.59 22.78 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 115.514 -0.766 . . . . 0.0 110.062 179.558 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' B' B ' 86' ' ' VAL . . . . . . . . . . . . . 43.9 t -129.94 132.15 65.8 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.212 0 CA-C-O 121.021 0.438 . . . . 0.0 110.479 -179.166 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' B' B ' 87' ' ' ILE . . . . . . . . . . . . . 43.5 mm -120.12 125.38 74.17 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.265 0 CA-C-N 115.665 -0.698 . . . . 0.0 109.221 177.132 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' B' B ' 88' ' ' LEU . . . . . . . . . . . . . 12.0 tp -114.51 127.92 56.06 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-O 121.021 0.439 . . . . 0.0 111.254 -176.788 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' B' B ' 89' ' ' ASP . . . . . . . . . . . . . 11.2 t70 -117.81 153.66 33.1 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 115.702 -0.681 . . . . 0.0 109.407 175.931 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' B' B ' 90' ' ' GLU . . . . . . . . . . . . . 84.6 tt0 -47.78 -35.5 10.12 Favored 'General case' 0 C--N 1.33 -0.282 0 N-CA-C 112.869 0.692 . . . . 0.0 112.869 -172.836 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' B' B ' 91' ' ' ASN . . . . . . . . . . . . . 18.3 p-10 -132.06 31.36 4.16 Favored 'General case' 0 N--CA 1.466 0.326 0 N-CA-C 112.256 0.465 . . . . 0.0 112.256 -175.808 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' B' B ' 92' ' ' LEU . . . . . . . . . . . . . 6.7 tp -166.13 145.1 5.9 Favored 'General case' 0 C--N 1.331 -0.213 0 C-N-CA 120.934 -0.307 . . . . 0.0 110.54 -179.619 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' B' B ' 93' ' ' ILE . . . . . . . . . . . . . 68.8 mt -123.14 123.36 67.67 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.264 0 N-CA-C 109.704 -0.48 . . . . 0.0 109.704 -179.413 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' B' B ' 94' ' ' VAL . . . . . . . . . . . . . 43.5 t -121.38 124.96 73.04 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.239 0 CA-C-O 120.967 0.413 . . . . 0.0 110.024 179.689 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' B' B ' 95' ' ' VAL . . . . . . . . . . . . . 45.9 t -119.68 133.4 66.58 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.283 0 CA-C-N 115.917 -0.583 . . . . 0.0 109.928 -179.071 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' B' B ' 96' ' ' ILE . . . . . 0.666 HD11 ' HB ' ' B' ' 123' ' ' VAL . 61.8 mt -114.59 126.38 72.12 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.366 0 N-CA-C 109.467 -0.568 . . . . 0.0 109.467 178.988 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' B' B ' 97' ' ' THR . . . . . . . . . . . . . 67.4 p -95.94 156.21 16.43 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-O 120.99 0.424 . . . . 0.0 110.812 -179.267 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' B' B ' 98' ' ' GLU . . . . . . . . . . . . . 40.1 tp10 -53.92 -28.66 38.19 Favored 'General case' 0 C--N 1.329 -0.287 0 N-CA-C 112.144 0.424 . . . . 0.0 112.144 -178.401 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' B' B ' 99' ' ' GLU . . . . . . . . . . . . . 14.7 pt-20 -81.54 17.25 1.45 Allowed 'General case' 0 CA--C 1.535 0.373 0 N-CA-C 113.326 0.862 . . . . 0.0 113.326 -176.19 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' B' B ' 100' ' ' ASN . . . . . . . . . . . . . 4.9 m-20 64.89 34.65 9.0 Favored 'General case' 0 N--CA 1.463 0.216 0 CA-C-O 120.793 0.33 . . . . 0.0 111.678 176.959 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' B' B ' 101' ' ' GLU . . . . . . . . . . . . . 84.5 tt0 -108.84 141.78 40.38 Favored 'General case' 0 C--N 1.331 -0.2 0 N-CA-C 109.642 -0.503 . . . . 0.0 109.642 172.226 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' B' B ' 102' ' ' VAL . . . . . . . . . . . . . 46.3 t -114.96 125.9 72.41 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.308 0 N-CA-C 109.967 -0.382 . . . . 0.0 109.967 -177.846 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' B' B ' 103' ' ' LEU . . . . . . . . . . . . . 57.4 mt -117.26 129.79 56.14 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 115.845 -0.616 . . . . 0.0 110.13 177.944 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' B' B ' 104' ' ' ILE . . . . . 0.57 HD13 HG11 ' B' ' 130' ' ' VAL . 67.8 mt -118.31 120.84 65.6 Favored 'Isoleucine or valine' 0 C--O 1.234 0.289 0 N-CA-C 110.161 -0.311 . . . . 0.0 110.161 -178.976 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' B' B ' 105' ' ' PHE . . . . . . . . . . . . . 74.6 m-85 -123.53 165.16 17.6 Favored 'General case' 0 C--N 1.333 -0.15 0 O-C-N 123.92 0.763 . . . . 0.0 109.836 -179.252 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' B' B ' 106' ' ' ASN . . . . . . . . . . . . . 46.7 p-10 -99.51 -170.77 1.95 Allowed 'General case' 0 C--N 1.33 -0.274 0 N-CA-C 109.788 -0.449 . . . . 0.0 109.788 171.832 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' B' B ' 107' ' ' GLN . . . . . . . . . . . . . 51.0 tt0 -57.58 -27.64 62.87 Favored 'General case' 0 C--N 1.327 -0.373 0 N-CA-C 112.305 0.483 . . . . 0.0 112.305 -178.944 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' B' B ' 108' ' ' ASN . . . . . . . . . . . . . 14.4 t30 -93.5 14.31 19.11 Favored 'General case' 0 CA--C 1.535 0.379 0 N-CA-C 113.0 0.741 . . . . 0.0 113.0 -175.43 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' B' B ' 109' ' ' LEU . . . . . . . . . . . . . 71.1 mt 59.12 37.7 24.04 Favored 'General case' 0 C--N 1.332 -0.189 0 CA-C-O 121.067 0.461 . . . . 0.0 111.377 177.596 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' B' B ' 110' ' ' GLU . . . . . . . . . . . . . 43.4 mt-10 -103.46 163.43 12.29 Favored 'General case' 0 C--N 1.331 -0.225 0 CA-C-N 116.388 -0.369 . . . . 0.0 110.223 177.331 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' B' B ' 111' ' ' GLU . . . . . . . . . . . . . 82.6 tt0 -84.58 124.9 31.94 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-O 120.94 0.4 . . . . 0.0 111.243 -177.22 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' B' B ' 112' ' ' LEU . . . . . . . . . . . . . 20.0 mt -113.02 -45.99 3.14 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 115.905 -0.589 . . . . 0.0 109.6 172.84 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' B' B ' 113' ' ' TYR . . . . . 0.487 ' HB3' HD12 ' B' ' 104' ' ' ILE . 34.9 t80 -150.64 137.04 18.72 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.02 -0.536 . . . . 0.0 110.821 179.097 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' B' B ' 114' ' ' ARG . . . . . . . . . . . . . 57.0 mtm180 -140.39 124.4 17.46 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-O 120.733 0.302 . . . . 0.0 110.306 175.242 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' B' B ' 115' ' ' GLY . . . . . . . . . . . . . . . -150.15 162.9 29.36 Favored Glycine 0 CA--C 1.523 0.566 0 N-CA-C 110.632 -0.987 . . . . 0.0 110.632 -179.555 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' B' B ' 116' ' ' LYS . . . . . . . . . . . . . 82.7 tttt -133.37 130.83 39.32 Favored 'General case' 0 C--N 1.33 -0.278 0 N-CA-C 109.918 -0.401 . . . . 0.0 109.918 178.553 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' B' B ' 117' ' ' PHE . . . . . . . . . . . . . 46.5 m-85 -125.79 118.43 25.51 Favored 'General case' 0 C--N 1.331 -0.227 0 CA-C-O 121.015 0.436 . . . . 0.0 110.49 -174.862 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' B' B ' 118' ' ' GLU . . . . . . . . . . . . . 44.5 tp10 -52.83 -49.38 65.82 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.397 -0.365 . . . . 0.0 111.572 -176.979 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' B' B ' 119' ' ' ASN . . . . . . . . . . . . . 20.4 m120 -95.76 31.21 2.12 Favored 'General case' 0 C--N 1.33 -0.253 0 N-CA-C 112.11 0.411 . . . . 0.0 112.11 -174.803 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' B' B ' 120' ' ' LEU . . . . . . . . . . . . . 13.7 tp -55.04 123.38 13.4 Favored 'General case' 0 N--CA 1.462 0.134 0 CA-C-O 120.711 0.291 . . . . 0.0 110.769 178.282 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' B' B ' 121' ' ' ASN . . . . . . . . . . . . . 60.5 t30 -113.58 -44.01 3.25 Favored 'General case' 0 C--N 1.332 -0.184 0 CA-C-N 116.337 -0.392 . . . . 0.0 110.822 -177.742 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' B' B ' 122' ' ' LYS . . . . . . . . . . . . . 97.8 mttt -148.53 150.72 33.87 Favored 'General case' 0 C--N 1.331 -0.229 0 CA-C-O 121.119 0.485 . . . . 0.0 111.562 -178.434 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' B' B ' 123' ' ' VAL . . . . . 0.666 ' HB ' HD11 ' B' ' 96' ' ' ILE . 47.4 t -131.74 129.35 61.19 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.224 0 N-CA-C 109.325 -0.62 . . . . 0.0 109.325 174.812 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' B' B ' 124' ' ' LEU . . . . . . . . . . . . . 67.3 mt -130.87 142.65 50.39 Favored 'General case' 0 C--N 1.331 -0.203 0 CA-C-O 120.959 0.409 . . . . 0.0 110.769 -177.438 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' B' B ' 125' ' ' VAL . . . . . . . . . . . . . 12.1 p -135.7 138.32 48.07 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.255 0 CA-C-N 116.005 -0.543 . . . . 0.0 110.555 179.946 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' B' B ' 126' ' ' ARG . . . . . . . . . . . . . 75.3 mtt180 -148.08 121.95 9.35 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 115.838 -0.619 . . . . 0.0 109.393 178.04 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' B' B ' 127' ' ' ASN . . . . . . . . . . . . . 71.6 m-80 57.04 -147.44 0.52 Allowed 'General case' 0 CA--C 1.541 0.614 0 N-CA-C 109.602 -0.518 . . . . 0.0 109.602 -178.278 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' B' B ' 128' ' ' ASP . . . . . . . . . . . . . 23.1 p-10 -83.44 12.62 5.3 Favored 'General case' 0 CA--C 1.537 0.464 0 CA-C-N 118.845 0.748 . . . . 0.0 112.989 179.199 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' B' B ' 129' ' ' LEU . . . . . . . . . . . . . 19.6 tp -109.03 136.45 48.53 Favored 'General case' 0 C--O 1.231 0.084 0 N-CA-C 109.747 -0.464 . . . . 0.0 109.747 178.32 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' B' B ' 130' ' ' VAL . . . . . 0.57 HG11 HD13 ' B' ' 104' ' ' ILE . 12.3 p -131.3 141.76 45.12 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.213 0 CA-C-O 120.982 0.42 . . . . 0.0 110.637 -178.806 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' B' B ' 131' ' ' VAL . . . . . 0.553 HG22 HD12 ' B' ' 140' ' ' LEU . 41.5 t -136.14 138.37 47.3 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 CA-C-N 116.021 -0.536 . . . . 0.0 110.495 -178.741 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' B' B ' 132' ' ' ILE . . . . . . . . . . . . . 73.1 mt -116.79 133.64 62.82 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.323 0 CA-C-N 115.591 -0.731 . . . . 0.0 109.244 178.448 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' B' B ' 133' ' ' ILE . . . . . . . . . . . . . 41.1 mm -115.94 120.81 65.9 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.268 0 CA-C-O 120.714 0.293 . . . . 0.0 111.018 -175.521 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' B' B ' 134' ' ' ASP . . . . . . . . . . . . . 7.5 p-10 -131.98 144.98 51.19 Favored 'General case' 0 C--N 1.33 -0.262 0 N-CA-C 109.433 -0.58 . . . . 0.0 109.433 175.124 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' B' B ' 135' ' ' GLU . . . . . . . . . . . . . 83.7 tt0 -50.06 -26.23 4.2 Favored 'General case' 0 C--N 1.328 -0.348 0 N-CA-C 112.861 0.689 . . . . 0.0 112.861 -173.682 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' B' B ' 136' ' ' GLN . . . . . . . . . . . . . 97.1 mt-30 -78.51 -35.8 45.81 Favored 'General case' 0 C--O 1.234 0.245 0 N-CA-C 112.058 0.392 . . . . 0.0 112.058 -177.465 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' B' B ' 137' ' ' LYS . . . . . . . . . . . . . 56.2 pttt -170.0 173.66 5.89 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-O 121.426 0.631 . . . . 0.0 111.907 -172.613 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' B' B ' 138' ' ' LEU . . . . . 0.422 ' C ' HD23 ' B' ' 138' ' ' LEU . 8.2 tt -116.31 130.14 56.63 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 115.415 -0.811 . . . . 0.0 110.136 179.557 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' B' B ' 139' ' ' THR . . . . . . . . . . . . . 25.8 m -108.07 124.35 50.07 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.069 -0.514 . . . . 0.0 110.501 179.995 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' B' B ' 140' ' ' LEU . . . . . 0.553 HD12 HG22 ' B' ' 131' ' ' VAL . 49.7 tp -113.08 121.07 43.48 Favored 'General case' 0 C--N 1.328 -0.351 0 N-CA-C 109.094 -0.706 . . . . 0.0 109.094 -179.241 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' B' B ' 141' ' ' ILE . . . . . 0.494 ' HB ' HG13 ' B' ' 130' ' ' VAL . 19.0 mt -121.23 121.1 63.95 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.309 0 CA-C-O 120.985 0.422 . . . . 0.0 110.189 -175.261 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' B' B ' 142' ' ' ARG . . . . . . . . . . . . . 61.4 mtp180 -105.21 120.81 42.45 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 115.15 -0.932 . . . . 0.0 109.985 179.363 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' B' B ' 143' ' ' THR . . . . . . . . . . . . . 35.9 p . . . . . 0 C--O 1.22 -0.486 0 CA-C-O 118.065 -0.969 . . . . 0.0 110.604 -179.697 . . . . . . . . 0 0 . 1 . 019 nuclear nobuild full ' C' C ' -3' ' ' GLU . . . . . . . . . . . . . 84.8 tt0 . . . . . 0 N--CA 1.49 1.541 0 N-CA-C 109.278 -0.638 . . . . 0.0 109.278 . . . . . . . . . 0 0 . 1 . 019 nuclear nobuild full ' C' C ' -2' ' ' GLY . . . . . . . . . . . . . . . -78.59 149.98 34.13 Favored Glycine 0 CA--C 1.526 0.742 0 N-CA-C 111.007 -0.837 . . . . 0.0 111.007 179.391 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' C' C ' -1' ' ' VAL . . . . . . . . . . . . . 43.1 t -94.92 137.46 23.22 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.303 0 N-CA-C 109.998 -0.371 . . . . 0.0 109.998 179.591 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' C' C ' 0' ' ' ILE . . . . . . . . . . . . . 43.8 mm -104.55 131.92 52.4 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.282 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.201 -179.348 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' C' C ' 1' ' ' MET . . . . . . . . . . . . . 26.4 ptm -78.43 139.13 38.75 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.022 -0.535 . . . . 0.0 110.948 -179.286 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' C' C ' 2' ' ' SER . . . . . . . . . . . . . 3.1 p -117.91 127.96 54.36 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.351 177.474 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' C' C ' 3' ' ' GLU . . . . . . . . . . . . . 84.8 tt0 -141.24 141.61 33.99 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 115.89 -0.595 . . . . 0.0 110.954 -178.891 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' C' C ' 4' ' ' LEU . . . . . . . . . . . . . 19.2 tp -126.14 129.08 48.35 Favored 'General case' 0 C--N 1.331 -0.216 0 CA-C-N 115.866 -0.606 . . . . 0.0 110.257 177.73 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' C' C ' 5' ' ' LYS . . . . . . . . . . . . . 66.9 mttm -105.35 120.96 42.88 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.255 -0.429 . . . . 0.0 110.543 178.728 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' C' C ' 6' ' ' LEU . . . . . . . . . . . . . 55.1 mt -116.56 146.53 42.57 Favored 'General case' 0 C--N 1.331 -0.23 0 O-C-N 123.831 0.707 . . . . 0.0 110.109 -179.703 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' C' C ' 7' ' ' LYS . . . . . . . . . . . . . 49.8 tttp -126.83 137.67 30.99 Favored Pre-proline 0 CA--C 1.534 0.329 0 CA-C-O 118.901 -0.571 . . . . 0.0 109.912 175.664 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' C' C ' 8' ' ' PRO . . . . . . . . . . . . . 89.8 Cg_endo -92.1 131.72 1.17 Allowed 'Trans proline' 0 N--CA 1.489 1.257 0 C-N-CA 121.661 1.574 . . . . 0.0 111.673 178.016 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' C' C ' 9' ' ' LEU . . . . . . . . . . . . . 64.8 mt -70.98 -46.59 15.0 Favored Pre-proline 0 CA--C 1.533 0.303 0 CA-C-O 118.808 -0.615 . . . . 0.0 112.191 -179.053 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' C' C ' 10' ' ' PRO . . . . . . . . . . . . . 85.8 Cg_endo -81.79 147.89 15.47 Favored 'Trans proline' 0 N--CA 1.495 1.617 0 C-N-CA 121.237 1.291 . . . . 0.0 111.574 174.26 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' C' C ' 11' ' ' LYS . . . . . . . . . . . . . 60.7 tttm -88.14 96.54 10.57 Favored 'General case' 0 C--N 1.33 -0.254 0 C-N-CA 120.862 -0.335 . . . . 0.0 110.455 179.145 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' C' C ' 12' ' ' VAL . . . . . . . . . . . . . 12.5 p -140.06 146.78 24.35 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.321 0 CA-C-N 116.241 -0.436 . . . . 0.0 110.512 -179.79 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' C' C ' 13' ' ' GLU . . . . . . . . . . . . . 81.4 tt0 -85.86 125.8 33.57 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.243 -0.435 . . . . 0.0 110.008 177.949 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' C' C ' 14' ' ' LEU . . . . . . . . . . . . . 17.6 mt -96.94 149.63 35.94 Favored Pre-proline 0 CA--C 1.532 0.263 0 CA-C-O 119.262 -0.399 . . . . 0.0 110.366 -178.708 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' C' C ' 15' ' ' PRO . . . . . . . . . . . . . 26.1 Cg_exo -61.76 160.65 28.01 Favored 'Trans proline' 0 N--CA 1.497 1.732 0 C-N-CA 121.23 1.287 . . . . 0.0 111.852 177.496 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' C' C ' 16' ' ' PRO . . . . . . . . . . . . . 34.0 Cg_exo -59.5 -34.01 97.07 Favored 'Trans proline' 0 N--CA 1.498 1.754 0 C-N-CA 121.437 1.425 . . . . 0.0 112.714 -178.127 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' C' C ' 17' ' ' ASP . . . . . . . . . . . . . 18.5 p-10 -87.88 3.58 47.91 Favored 'General case' 0 CA--C 1.536 0.435 0 N-CA-C 113.409 0.892 . . . . 0.0 113.409 -177.042 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' C' C ' 18' ' ' PHE . . . . . . . . . . . . . 43.3 t80 -58.18 -46.5 85.64 Favored 'General case' 0 C--N 1.334 -0.091 0 O-C-N 122.046 -0.409 . . . . 0.0 110.098 -177.689 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' C' C ' 19' ' ' VAL . . . . . . . . . . . . . 47.8 t -56.75 -43.0 78.59 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.372 0 CA-C-N 116.27 -0.423 . . . . 0.0 110.608 -177.895 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' C' C ' 20' ' ' ASP . . . . . . . . . . . . . 67.7 m-20 -59.66 -43.0 94.11 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-O 120.786 0.327 . . . . 0.0 110.813 -177.549 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' C' C ' 21' ' ' VAL . . . . . . . . . . . . . 46.2 t -64.01 -45.41 96.78 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.32 0 C-N-CA 120.818 -0.353 . . . . 0.0 110.425 -177.848 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' C' C ' 22' ' ' ILE . . . . . 0.547 HG22 HD12 ' C' ' 26' ' ' LEU . 51.8 mm -54.96 -48.44 75.26 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.276 0 C-N-CA 120.993 -0.283 . . . . 0.0 110.743 179.032 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' C' C ' 23' ' ' ARG . . . . . . . . . . . . . 54.3 ttp180 -54.65 -47.93 72.93 Favored 'General case' 0 C--N 1.33 -0.258 0 C-N-CA 121.022 -0.271 . . . . 0.0 111.355 -178.328 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' C' C ' 24' ' ' ILE . . . . . . . . . . . . . 74.2 mt -59.11 -42.89 87.98 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.34 0 C-N-CA 121.184 -0.206 . . . . 0.0 111.208 -177.901 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' C' C ' 25' ' ' LYS . . . . . . . . . . . . . 73.9 mmtt -66.68 -41.37 88.21 Favored 'General case' 0 C--N 1.328 -0.335 0 N-CA-C 112.253 0.464 . . . . 0.0 112.253 -178.428 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' C' C ' 26' ' ' LEU . . . . . 0.547 HD12 HG22 ' C' ' 22' ' ' ILE . 83.1 mt -79.22 -38.76 34.9 Favored 'General case' 0 C--N 1.328 -0.332 0 N-CA-C 113.283 0.845 . . . . 0.0 113.283 -169.872 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' C' C ' 27' ' ' GLN . . . . . . . . . . . . . 10.4 pt20 -47.06 140.05 5.28 Favored 'General case' 0 N--CA 1.468 0.444 0 N-CA-C 112.78 0.659 . . . . 0.0 112.78 -175.831 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' C' C ' 28' ' ' GLY . . . . . . . . . . . . . . . 99.15 -25.7 27.21 Favored Glycine 0 CA--C 1.533 1.159 0 CA-C-N 115.687 -0.688 . . . . 0.0 112.297 -177.013 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' C' C ' 29' ' ' LYS . . . . . . . . . . . . . 87.5 mttt -97.89 155.11 17.22 Favored 'General case' 0 C--N 1.331 -0.199 0 CA-C-N 117.357 0.579 . . . . 0.0 111.053 179.362 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' C' C ' 30' ' ' THR . . . . . . . . . . . . . 26.2 m -103.79 138.3 40.59 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.133 -0.485 . . . . 0.0 110.1 176.696 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' C' C ' 31' ' ' VAL . . . . . . . . . . . . . 34.4 m -129.85 151.14 35.39 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.201 0 CA-C-O 120.868 0.366 . . . . 0.0 110.986 -178.429 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' C' C ' 32' ' ' ARG . . . . . . . . . . . . . 71.3 mtt85 -127.91 149.19 50.42 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 115.971 -0.558 . . . . 0.0 110.489 178.743 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' C' C ' 33' ' ' THR . . . . . . . . . . . . . 30.3 m -53.18 138.76 30.85 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.43 -0.35 . . . . 0.0 111.375 -179.175 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' C' C ' 34' ' ' GLY . . . . . . . . . . . . . . . 100.23 -17.2 57.32 Favored Glycine 0 CA--C 1.533 1.159 0 C-N-CA 121.307 -0.473 . . . . 0.0 113.223 179.266 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' C' C ' 35' ' ' ASP . . . . . . . . . . . . . 76.2 m-20 -66.63 149.3 50.69 Favored 'General case' 0 N--CA 1.462 0.151 0 CA-C-N 117.967 0.883 . . . . 0.0 111.155 179.361 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' C' C ' 36' ' ' VAL . . . . . . . . . . . . . 44.6 t -119.3 128.99 75.83 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.26 0 CA-C-N 115.845 -0.616 . . . . 0.0 109.674 177.929 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' C' C ' 37' ' ' ILE . . . . . . . . . . . . . 65.6 mt -119.83 138.28 50.95 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.271 0 CA-C-N 116.151 -0.477 . . . . 0.0 109.804 -179.466 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' C' C ' 38' ' ' GLY . . . . . . . . . . . . . . . -116.9 128.71 8.02 Favored Glycine 0 CA--C 1.525 0.667 0 N-CA-C 111.121 -0.792 . . . . 0.0 111.121 -179.653 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' C' C ' 39' ' ' ILE . . . . . . . . . . . . . 70.7 mt -127.0 127.05 69.35 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.256 0 N-CA-C 109.961 -0.385 . . . . 0.0 109.961 178.268 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' C' C ' 40' ' ' SER . . . . . . . . . . . . . 59.6 p -91.41 113.94 26.34 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.561 -0.29 . . . . 0.0 110.988 177.773 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' C' C ' 41' ' ' ILE . . . . . . . . . . . . . 45.5 mm -123.3 128.14 74.69 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.248 0 CA-C-N 116.408 -0.36 . . . . 0.0 110.063 179.694 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' C' C ' 42' ' ' LEU . . . . . . . . . . . . . 69.8 mt 58.02 33.86 23.63 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 116.194 -0.457 . . . . 0.0 111.779 176.934 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' C' C ' 43' ' ' GLY . . . . . . . . . . . . . . . 73.11 21.81 79.5 Favored Glycine 0 CA--C 1.533 1.195 0 C-N-CA 121.227 -0.511 . . . . 0.0 112.89 177.623 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' C' C ' 44' ' ' LYS . . . . . . . . . . . . . 67.6 mttm -138.25 130.54 28.88 Favored 'General case' 0 C--N 1.332 -0.16 0 CA-C-N 117.41 0.605 . . . . 0.0 109.919 177.548 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' C' C ' 45' ' ' GLU . . . . . . . . . . . . . 43.5 tp10 -84.06 127.26 33.78 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.367 -0.379 . . . . 0.0 111.413 -177.545 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' C' C ' 46' ' ' VAL . . . . . . . . . . . . . 8.9 p -116.06 127.3 73.7 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.282 0 N-CA-C 109.249 -0.648 . . . . 0.0 109.249 173.312 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' C' C ' 47' ' ' LYS . . . . . . . . . . . . . 64.8 mttp -98.07 126.16 43.38 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 116.104 -0.498 . . . . 0.0 110.787 178.715 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' C' C ' 48' ' ' PHE . . . . . . . . . . . . . 34.2 m-85 -110.82 131.88 54.67 Favored 'General case' 0 C--N 1.328 -0.345 0 N-CA-C 109.453 -0.573 . . . . 0.0 109.453 177.159 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' C' C ' 49' ' ' LYS . . . . . . . . . . . . . 45.2 tttp -105.65 133.27 50.67 Favored 'General case' 0 C--N 1.328 -0.354 0 N-CA-C 110.085 -0.339 . . . . 0.0 110.085 178.831 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' C' C ' 50' ' ' VAL . . . . . . . . . . . . . 46.2 t -75.79 102.4 2.83 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.324 0 N-CA-C 109.189 -0.671 . . . . 0.0 109.189 176.669 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' C' C ' 51' ' ' VAL . . . . . . . . . . . . . 47.0 t -70.03 -48.18 64.22 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.279 0 CA-C-N 116.005 -0.543 . . . . 0.0 109.895 -174.293 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' C' C ' 52' ' ' GLN . . . . . . . . . . . . . 62.0 tt0 -160.14 138.92 10.54 Favored 'General case' 0 C--N 1.33 -0.252 0 C-N-CA 120.382 -0.527 . . . . 0.0 111.631 -178.8 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' C' C ' 53' ' ' ALA . . . . . 0.447 ' HB3' ' OG ' ' C' ' 56' ' ' SER . . . -111.55 130.97 55.57 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 115.665 -0.698 . . . . 0.0 109.806 176.012 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' C' C ' 54' ' ' TYR . . . . . . . . . . . . . 45.7 t80 -128.93 107.32 18.19 Favored Pre-proline 0 CA--C 1.535 0.395 0 CA-C-O 118.335 -0.841 . . . . 0.0 110.54 -179.04 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' C' C ' 55' ' ' PRO . . . . . . . . . . . . . 73.7 Cg_endo -77.12 170.04 72.65 Favored 'Cis proline' 0 N--CA 1.499 1.81 0 CA-C-N 121.784 1.673 . . . . 0.0 112.355 -6.158 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' C' C ' 56' ' ' SER . . . . . 0.447 ' OG ' ' HB3' ' C' ' 53' ' ' ALA . 69.8 m -117.06 132.33 23.52 Favored Pre-proline 0 CA--C 1.539 0.544 0 CA-C-O 118.492 -0.766 . . . . 0.0 109.476 175.371 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' C' C ' 57' ' ' PRO . . . . . . . . . . . . . 44.2 Cg_endo -69.35 147.4 83.72 Favored 'Cis proline' 0 N--CA 1.498 1.767 0 CA-C-N 121.909 1.718 . . . . 0.0 111.335 -1.46 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' C' C ' 58' ' ' LEU . . . . . . . . . . . . . 27.0 tp -107.06 136.63 46.59 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.372 -0.377 . . . . 0.0 110.68 -178.017 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' C' C ' 59' ' ' ARG . . . . . . . . . . . . . 75.4 ttt180 -102.12 120.79 41.02 Favored 'General case' 0 C--N 1.325 -0.482 0 N-CA-C 109.364 -0.606 . . . . 0.0 109.364 176.27 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' C' C ' 60' ' ' VAL . . . . . . . . . . . . . 40.8 t -74.31 122.09 26.9 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.268 0 C-N-CA 120.633 -0.427 . . . . 0.0 110.09 -176.021 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' C' C ' 61' ' ' GLU . . . . . . . . . . . . . 32.4 tp10 -130.72 157.78 41.87 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 115.994 -0.548 . . . . 0.0 109.759 -178.409 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' C' C ' 62' ' ' ASP . . . . . . . . . . . . . 35.7 m-20 -53.22 -32.5 48.51 Favored 'General case' 0 C--N 1.326 -0.417 0 N-CA-C 111.762 0.282 . . . . 0.0 111.762 179.947 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' C' C ' 63' ' ' ARG . . . . . . . . . . . . . 9.5 ptm180 -86.25 6.56 29.07 Favored 'General case' 0 CA--C 1.535 0.397 0 N-CA-C 113.551 0.945 . . . . 0.0 113.551 -177.522 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' C' C ' 64' ' ' THR . . . . . . . . . . . . . 37.6 m -83.58 137.87 33.64 Favored 'General case' 0 C--N 1.332 -0.166 0 CA-C-N 118.095 0.407 . . . . 0.0 110.569 -178.144 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' C' C ' 65' ' ' LYS . . . . . . . . . . . . . 53.4 mtmt -89.67 127.27 35.9 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 116.016 -0.538 . . . . 0.0 110.279 178.232 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' C' C ' 66' ' ' ILE . . . . . . . . . . . . . 64.1 mt -113.52 125.72 70.84 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.288 0 N-CA-C 109.413 -0.588 . . . . 0.0 109.413 178.957 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' C' C ' 67' ' ' THR . . . . . . . . . . . . . 20.9 m -125.21 143.67 50.83 Favored 'General case' 0 C--N 1.331 -0.208 0 CA-C-O 121.139 0.495 . . . . 0.0 111.221 -175.858 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' C' C ' 68' ' ' LEU . . . . . 0.433 HD12 ' N ' ' C' ' 68' ' ' LEU . 7.8 mp -97.34 132.81 42.71 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 115.738 -0.665 . . . . 0.0 110.129 176.471 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' C' C ' 69' ' ' VAL . . . . . . . . . . . . . 43.1 t -89.94 120.56 38.94 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.38 0 CA-C-N 116.242 -0.435 . . . . 0.0 110.073 179.303 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' C' C ' 70' ' ' THR . . . . . . . . . . . . . 20.5 m -135.12 146.76 49.13 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.059 -0.519 . . . . 0.0 110.496 -178.922 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' C' C ' 71' ' ' HIS . . . . . . . . . . . . . 34.7 t60 -125.23 73.34 66.69 Favored Pre-proline 0 CA--C 1.535 0.367 0 CA-C-N 116.246 -0.434 . . . . 0.0 110.285 179.104 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' C' C ' 72' ' ' PRO . . . . . . . . . . . . . 90.4 Cg_endo -90.2 154.17 4.67 Favored 'Trans proline' 0 N--CA 1.489 1.232 0 C-N-CA 121.946 1.764 . . . . 0.0 112.256 179.788 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' C' C ' 73' ' ' VAL . . . . . . . . . . . . . 35.8 m -76.39 168.55 1.98 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.306 0 CA-C-N 116.151 -0.477 . . . . 0.0 110.354 178.955 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' C' C ' 74' ' ' ASP . . . . . . . . . . . . . 29.4 t0 -101.06 117.53 35.2 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.253 -0.43 . . . . 0.0 110.071 -178.802 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' C' C ' 75' ' ' VAL . . . . . . . . . . . . . 43.5 t -111.48 120.95 63.13 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.241 0 CA-C-O 120.992 0.425 . . . . 0.0 110.315 -179.266 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' C' C ' 76' ' ' LEU . . . . . . . . . . . . . 29.5 mt -123.42 145.41 48.81 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 115.869 -0.605 . . . . 0.0 109.604 179.212 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' C' C ' 77' ' ' GLU . . . . . . . . . . . . . 45.4 mt-10 -136.83 135.47 37.96 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-O 121.035 0.445 . . . . 0.0 111.149 -177.25 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' C' C ' 78' ' ' ALA . . . . . 0.573 ' HB2' HD21 ' C' ' 109' ' ' LEU . . . -122.17 125.84 47.0 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 115.615 -0.721 . . . . 0.0 109.465 176.862 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' C' C ' 79' ' ' LYS . . . . . 0.58 ' O ' HD13 ' C' ' 80' ' ' ILE . 47.4 pttt -78.63 119.86 22.49 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-O 121.437 0.637 . . . . 0.0 111.208 -175.781 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' C' C ' 80' ' ' ILE . . . . . 0.58 HD13 ' O ' ' C' ' 79' ' ' LYS . 38.8 mm -139.39 110.25 4.57 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.246 0 CA-C-N 115.478 -0.783 . . . . 0.0 108.993 -179.832 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' C' C ' 81' ' ' LYS . . . . . . . . . . . . . 25.1 mtpp -97.77 123.99 41.94 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-O 120.894 0.378 . . . . 0.0 111.097 -177.977 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' C' C ' 82' ' ' GLY . . . . . . . . . . . . . . . 89.19 42.22 5.63 Favored Glycine 0 CA--C 1.527 0.839 0 C-N-CA 120.85 -0.691 . . . . 0.0 111.604 175.8 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' C' C ' 83' ' ' ILE . . . . . . . . . . . . . 69.2 mt -65.24 136.58 26.45 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.35 0 N-CA-C 109.732 -0.469 . . . . 0.0 109.732 177.477 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' C' C ' 84' ' ' LYS . . . . . . . . . . . . . 26.9 ttmt -88.64 -48.74 7.33 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.136 -0.484 . . . . 0.0 110.114 -179.508 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' C' C ' 85' ' ' ASP . . . . . . . . . . . . . 4.6 t70 -162.97 157.69 21.34 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 115.799 -0.637 . . . . 0.0 110.537 179.311 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' C' C ' 86' ' ' VAL . . . . . . . . . . . . . 41.1 t -130.22 133.81 63.56 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.277 0 CA-C-O 120.984 0.421 . . . . 0.0 110.469 -178.535 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' C' C ' 87' ' ' ILE . . . . . 0.498 ' N ' HD12 ' C' ' 87' ' ' ILE . 5.0 mp -119.36 125.97 74.91 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.257 0 CA-C-N 115.848 -0.615 . . . . 0.0 109.474 176.993 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' C' C ' 88' ' ' LEU . . . . . . . . . . . . . 54.5 mt -110.52 135.6 50.94 Favored 'General case' 0 C--N 1.332 -0.187 0 CA-C-O 120.998 0.427 . . . . 0.0 111.495 -176.776 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' C' C ' 89' ' ' ASP . . . . . . . . . . . . . 9.0 t70 -131.46 153.16 50.04 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 115.777 -0.647 . . . . 0.0 109.554 174.802 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' C' C ' 90' ' ' GLU . . . . . . . . . . . . . 95.4 mt-10 -48.33 -38.58 19.46 Favored 'General case' 0 C--N 1.33 -0.274 0 N-CA-C 112.666 0.617 . . . . 0.0 112.666 -172.858 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' C' C ' 91' ' ' ASN . . . . . . . . . . . . . 19.0 p30 -132.02 36.82 3.64 Favored 'General case' 0 N--CA 1.463 0.221 0 CA-C-O 120.807 0.336 . . . . 0.0 111.404 -177.294 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' C' C ' 92' ' ' LEU . . . . . . . . . . . . . 13.1 tp -166.07 142.85 5.18 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.578 -0.283 . . . . 0.0 110.626 -179.155 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' C' C ' 93' ' ' ILE . . . . . . . . . . . . . 67.0 mt -127.47 122.16 58.79 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.262 0 N-CA-C 109.461 -0.57 . . . . 0.0 109.461 178.741 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' C' C ' 94' ' ' VAL . . . . . 0.423 HG21 HG21 ' C' ' 125' ' ' VAL . 44.9 t -120.8 125.47 74.1 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.228 0 N-CA-C 109.757 -0.46 . . . . 0.0 109.757 179.252 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' C' C ' 95' ' ' VAL . . . . . . . . . . . . . 45.1 t -119.87 132.61 69.13 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.264 0 CA-C-N 116.015 -0.538 . . . . 0.0 109.77 -179.642 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' C' C ' 96' ' ' ILE . . . . . . . . . . . . . 65.9 mt -113.48 125.19 70.71 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.34 0 N-CA-C 109.106 -0.702 . . . . 0.0 109.106 179.025 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' C' C ' 97' ' ' THR . . . . . . . . . . . . . 73.0 p -99.74 151.43 21.24 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-O 121.118 0.485 . . . . 0.0 111.183 -177.185 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' C' C ' 98' ' ' GLU . . . . . . . . . . . . . 85.6 tt0 -53.87 -24.98 17.69 Favored 'General case' 0 C--N 1.33 -0.265 0 N-CA-C 112.343 0.497 . . . . 0.0 112.343 -179.603 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' C' C ' 99' ' ' GLU . . . . . . . . . . . . . 71.1 mm-40 -79.31 16.35 1.02 Allowed 'General case' 0 CA--C 1.534 0.356 0 N-CA-C 113.033 0.753 . . . . 0.0 113.033 -178.102 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' C' C ' 100' ' ' ASN . . . . . . . . . . . . . 4.5 m-20 64.19 37.95 8.49 Favored 'General case' 0 C--O 1.233 0.222 0 CA-C-O 121.0 0.428 . . . . 0.0 111.076 177.326 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' C' C ' 101' ' ' GLU . . . . . . . . . . . . . 84.2 tt0 -118.29 143.65 46.43 Favored 'General case' 0 C--N 1.333 -0.145 0 CA-C-N 116.1 -0.5 . . . . 0.0 109.795 176.711 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' C' C ' 102' ' ' VAL . . . . . . . . . . . . . 42.8 t -115.04 126.11 72.54 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.335 0 CA-C-N 116.434 -0.348 . . . . 0.0 110.063 -178.689 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' C' C ' 103' ' ' LEU . . . . . 0.434 HD23 ' HG3' ' C' ' 114' ' ' ARG . 15.1 mt -115.57 126.87 54.76 Favored 'General case' 0 C--N 1.331 -0.205 0 CA-C-N 115.484 -0.78 . . . . 0.0 110.028 176.873 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' C' C ' 104' ' ' ILE . . . . . . . . . . . . . 68.4 mt -119.22 121.11 65.8 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.275 0 N-CA-C 110.293 -0.262 . . . . 0.0 110.293 -179.973 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' C' C ' 105' ' ' PHE . . . . . . . . . . . . . 35.7 m-85 -125.35 167.05 15.47 Favored 'General case' 0 C--N 1.334 -0.105 0 O-C-N 123.838 0.711 . . . . 0.0 110.166 179.788 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' C' C ' 106' ' ' ASN . . . . . . . . . . . . . 41.3 p-10 -99.95 -169.79 1.79 Allowed 'General case' 0 C--N 1.33 -0.254 0 N-CA-C 110.01 -0.367 . . . . 0.0 110.01 174.399 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' C' C ' 107' ' ' GLN . . . . . . . . . . . . . 46.5 tt0 -58.36 -29.46 66.01 Favored 'General case' 0 C--N 1.329 -0.318 0 N-CA-C 112.006 0.373 . . . . 0.0 112.006 179.421 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' C' C ' 108' ' ' ASN . . . . . . . . . . . . . 10.3 t30 -86.75 13.01 9.51 Favored 'General case' 0 CA--C 1.536 0.435 0 N-CA-C 113.051 0.76 . . . . 0.0 113.051 -177.977 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' C' C ' 109' ' ' LEU . . . . . 0.573 HD21 ' HB2' ' C' ' 78' ' ' ALA . 7.9 tp 55.67 37.83 29.37 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-O 120.947 0.403 . . . . 0.0 111.36 178.277 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' C' C ' 110' ' ' GLU . . . . . . . . . . . . . 96.0 mt-10 -103.04 156.85 17.39 Favored 'General case' 0 C--N 1.33 -0.255 0 N-CA-C 109.832 -0.433 . . . . 0.0 109.832 175.947 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' C' C ' 111' ' ' GLU . . . . . . . . . . . . . 84.6 tt0 -84.31 121.99 28.29 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-O 120.952 0.406 . . . . 0.0 111.127 -176.852 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' C' C ' 112' ' ' LEU . . . . . . . . . . . . . 27.2 mt -105.72 -46.11 4.23 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-N 115.979 -0.555 . . . . 0.0 110.057 176.586 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' C' C ' 113' ' ' TYR . . . . . . . . . . . . . 59.6 t80 -145.49 138.88 26.42 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.048 -0.523 . . . . 0.0 110.856 -179.689 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' C' C ' 114' ' ' ARG . . . . . 0.434 ' HG3' HD23 ' C' ' 103' ' ' LEU . 27.1 ttm180 -141.88 126.29 17.7 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.32 -0.4 . . . . 0.0 110.266 176.965 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' C' C ' 115' ' ' GLY . . . . . . . . . . . . . . . -150.21 160.82 28.7 Favored Glycine 0 CA--C 1.524 0.597 0 N-CA-C 111.101 -0.799 . . . . 0.0 111.101 179.333 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' C' C ' 116' ' ' LYS . . . . . . . . . . . . . 38.9 ttpt -130.39 134.18 46.95 Favored 'General case' 0 C--N 1.33 -0.253 0 N-CA-C 110.035 -0.357 . . . . 0.0 110.035 177.24 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' C' C ' 117' ' ' PHE . . . . . 0.414 ' HE2' HD13 ' C' ' 132' ' ' ILE . 47.5 m-85 -126.99 118.64 24.9 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.333 -0.394 . . . . 0.0 110.464 -176.337 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' C' C ' 118' ' ' GLU . . . . . . . . . . . . . 95.9 mt-10 -51.86 -51.61 55.48 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.39 -0.368 . . . . 0.0 111.697 -175.629 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' C' C ' 119' ' ' ASN . . . . . . . . . . . . . 70.5 m-80 -98.03 31.01 2.84 Favored 'General case' 0 C--N 1.329 -0.294 0 N-CA-C 112.19 0.441 . . . . 0.0 112.19 -173.485 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' C' C ' 120' ' ' LEU . . . . . 0.477 HD23 ' C ' ' C' ' 120' ' ' LEU . 6.5 tt -56.27 121.3 9.2 Favored 'General case' 0 C--N 1.333 -0.129 0 CA-C-O 120.727 0.299 . . . . 0.0 110.562 178.751 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' C' C ' 121' ' ' ASN . . . . . . . . . . . . . 74.5 m-20 -114.03 -44.12 3.18 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 116.364 -0.38 . . . . 0.0 111.159 -176.44 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' C' C ' 122' ' ' LYS . . . . . . . . . . . . . 55.2 mtmt -142.87 150.73 40.24 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-O 121.149 0.499 . . . . 0.0 111.513 -176.379 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' C' C ' 123' ' ' VAL . . . . . . . . . . . . . 45.8 t -130.38 133.46 63.84 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.228 0 CA-C-N 115.863 -0.608 . . . . 0.0 109.653 177.812 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' C' C ' 124' ' ' LEU . . . . . . . . . . . . . 30.1 mt -125.14 127.78 47.38 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.468 -0.333 . . . . 0.0 110.416 -179.852 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' C' C ' 125' ' ' VAL . . . . . 0.423 HG21 HG21 ' C' ' 94' ' ' VAL . 43.0 t -132.57 131.09 60.04 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.262 0 CA-C-N 116.183 -0.462 . . . . 0.0 109.97 -179.829 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' C' C ' 126' ' ' ARG . . . . . . . . . . . . . 78.1 mtt180 -145.95 119.77 9.28 Favored 'General case' 0 C--N 1.331 -0.22 0 CA-C-N 116.348 -0.387 . . . . 0.0 110.79 178.88 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' C' C ' 127' ' ' ASN . . . . . . . . . . . . . 64.1 t30 51.12 -105.75 0.22 Allowed 'General case' 0 CA--C 1.543 0.696 0 CA-C-O 119.023 -0.513 . . . . 0.0 111.476 179.188 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' C' C ' 128' ' ' ASP . . . . . . . . . . . . . 16.1 p-10 -114.08 5.27 15.96 Favored 'General case' 0 N--CA 1.469 0.483 0 CA-C-N 119.602 1.092 . . . . 0.0 113.442 -177.084 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' C' C ' 129' ' ' LEU . . . . . 0.47 HD22 ' NH1' ' C' ' 142' ' ' ARG . 26.1 mt -105.01 133.22 50.17 Favored 'General case' 0 C--N 1.332 -0.184 0 N-CA-C 109.555 -0.535 . . . . 0.0 109.555 177.703 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' C' C ' 130' ' ' VAL . . . . . . . . . . . . . 46.3 t -128.11 132.02 68.85 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.287 0 CA-C-O 120.881 0.372 . . . . 0.0 110.218 -178.508 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' C' C ' 131' ' ' VAL . . . . . 0.472 HG12 HD12 ' C' ' 140' ' ' LEU . 35.2 m -136.15 138.69 46.86 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.228 0 CA-C-O 121.15 0.5 . . . . 0.0 111.059 177.246 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' C' C ' 132' ' ' ILE . . . . . 0.414 HD13 ' HE2' ' C' ' 117' ' ' PHE . 71.4 mt -116.4 131.55 68.62 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.303 0 CA-C-N 115.67 -0.695 . . . . 0.0 109.26 179.189 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' C' C ' 133' ' ' ILE . . . . . . . . . . . . . 33.3 mm -115.09 120.66 65.24 Favored 'Isoleucine or valine' 0 C--O 1.234 0.255 0 CA-C-O 120.762 0.315 . . . . 0.0 111.316 -173.958 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' C' C ' 134' ' ' ASP . . . . . . . . . . . . . 10.0 p-10 -132.94 148.43 52.28 Favored 'General case' 0 C--N 1.33 -0.255 0 N-CA-C 109.538 -0.542 . . . . 0.0 109.538 175.066 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' C' C ' 135' ' ' GLU . . . . . . . . . . . . . 85.3 tt0 -49.94 -25.37 3.21 Favored 'General case' 0 C--N 1.328 -0.355 0 N-CA-C 112.864 0.691 . . . . 0.0 112.864 -172.281 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' C' C ' 136' ' ' GLN . . . . . . . . . . . . . 97.5 mt-30 -84.16 -37.83 21.43 Favored 'General case' 0 C--O 1.234 0.245 0 N-CA-C 112.305 0.483 . . . . 0.0 112.305 -176.588 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' C' C ' 137' ' ' LYS . . . . . . . . . . . . . 22.7 pttm -162.16 174.71 12.55 Favored 'General case' 0 C--N 1.331 -0.224 0 CA-C-O 121.507 0.67 . . . . 0.0 112.402 -170.634 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' C' C ' 138' ' ' LEU . . . . . . . . . . . . . 7.0 tt -122.6 128.1 50.25 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 114.903 -1.044 . . . . 0.0 109.918 178.558 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' C' C ' 139' ' ' THR . . . . . . . . . . . . . 30.1 m -104.15 124.05 48.39 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.121 -0.491 . . . . 0.0 110.236 179.012 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' C' C ' 140' ' ' LEU . . . . . 0.476 HD11 ' NH2' ' C' ' 142' ' ' ARG . 19.4 tp -109.25 119.56 39.87 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 115.719 -0.673 . . . . 0.0 109.674 -177.808 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' C' C ' 141' ' ' ILE . . . . . . . . . . . . . 19.0 mt -121.15 120.93 63.55 Favored 'Isoleucine or valine' 0 C--O 1.235 0.297 0 CA-C-O 120.986 0.422 . . . . 0.0 110.235 -175.093 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' C' C ' 142' ' ' ARG . . . . . 0.476 ' NH2' HD11 ' C' ' 140' ' ' LEU . 1.1 mpt_? -109.94 127.03 54.51 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 115.312 -0.858 . . . . 0.0 110.08 -179.296 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' C' C ' 143' ' ' THR . . . . . 0.409 ' HA ' HG12 ' D' ' 73' ' ' VAL . 40.7 p . . . . . 0 C--O 1.22 -0.464 0 CA-C-O 118.013 -0.994 . . . . 0.0 110.621 179.145 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' D' D ' -3' ' ' GLU . . . . . . . . . . . . . 85.0 tt0 . . . . . 0 N--CA 1.489 1.51 0 N-CA-C 109.335 -0.617 . . . . 0.0 109.335 . . . . . . . . . 0 0 . 1 . 019 nuclear nobuild full ' D' D ' -2' ' ' GLY . . . . . . . . . . . . . . . -87.58 138.91 15.58 Favored Glycine 0 CA--C 1.525 0.664 0 N-CA-C 111.34 -0.704 . . . . 0.0 111.34 -178.3 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' D' D ' -1' ' ' VAL . . . . . . . . . . . . . 44.8 t -96.82 138.33 22.17 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 N-CA-C 110.075 -0.342 . . . . 0.0 110.075 178.812 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' D' D ' 0' ' ' ILE . . . . . . . . . . . . . 46.2 mm -109.33 132.82 56.42 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.276 0 CA-C-N 116.296 -0.411 . . . . 0.0 110.06 179.193 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' D' D ' 1' ' ' MET . . . . . . . . . . . . . 24.6 ptp -143.81 145.76 32.59 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.185 -0.461 . . . . 0.0 110.478 -179.91 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' D' D ' 2' ' ' SER . . . . . . . . . . . . . 7.6 p -131.03 130.11 42.88 Favored 'General case' 0 C--O 1.232 0.16 0 CA-C-O 121.124 0.488 . . . . 0.0 110.917 -178.63 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' D' D ' 3' ' ' GLU . . . . . . . . . . . . . 43.6 mp0 -137.85 142.19 40.75 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 115.619 -0.719 . . . . 0.0 110.571 -178.991 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' D' D ' 4' ' ' LEU . . . . . . . . . . . . . 4.2 tt -123.9 123.13 39.74 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 115.753 -0.658 . . . . 0.0 109.78 177.24 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' D' D ' 5' ' ' LYS . . . . . . . . . . . . . 63.6 mttp -102.63 121.51 42.54 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-O 120.77 0.319 . . . . 0.0 110.825 -179.984 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' D' D ' 6' ' ' LEU . . . . . . . . . . . . . 64.7 mt -114.37 148.3 37.84 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 115.553 -0.748 . . . . 0.0 110.614 179.836 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' D' D ' 7' ' ' LYS . . . . . . . . . . . . . 22.7 ttmm -139.82 141.32 27.17 Favored Pre-proline 0 CA--C 1.534 0.339 0 N-CA-C 109.811 -0.44 . . . . 0.0 109.811 174.826 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' D' D ' 8' ' ' PRO . . . . . . . . . . . . . 96.4 Cg_endo -91.22 139.16 2.41 Favored 'Trans proline' 0 N--CA 1.49 1.316 0 C-N-CA 121.694 1.596 . . . . 0.0 111.663 177.988 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' D' D ' 9' ' ' LEU . . . . . . . . . . . . . 49.2 mt -78.28 -45.84 2.13 Favored Pre-proline 0 CA--C 1.533 0.313 0 CA-C-O 118.838 -0.601 . . . . 0.0 111.788 -179.655 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' D' D ' 10' ' ' PRO . . . . . . . . . . . . . 74.7 Cg_endo -84.63 150.75 11.51 Favored 'Trans proline' 0 N--CA 1.495 1.604 0 C-N-CA 121.224 1.283 . . . . 0.0 111.364 171.804 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' D' D ' 11' ' ' LYS . . . . . . . . . . . . . 19.8 pttp -83.47 117.28 22.98 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-O 121.385 0.612 . . . . 0.0 110.423 178.4 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' D' D ' 12' ' ' VAL . . . . . . . . . . . . . 12.3 p -151.05 148.58 14.84 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.271 0 CA-C-N 115.837 -0.62 . . . . 0.0 110.625 -179.965 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' D' D ' 13' ' ' GLU . . . . . . . . . . . . . 44.7 mp0 -91.07 121.59 33.0 Favored 'General case' 0 C--N 1.328 -0.346 0 N-CA-C 109.866 -0.42 . . . . 0.0 109.866 176.663 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' D' D ' 14' ' ' LEU . . . . . 0.42 HD22 ' CD1' ' D' ' 18' ' ' PHE . 15.7 mt -98.09 147.8 33.6 Favored Pre-proline 0 CA--C 1.533 0.3 0 CA-C-O 119.23 -0.414 . . . . 0.0 110.627 -177.801 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' D' D ' 15' ' ' PRO . . . . . . . . . . . . . 24.4 Cg_exo -63.33 162.41 27.11 Favored 'Trans proline' 0 N--CA 1.497 1.685 0 C-N-CA 121.39 1.393 . . . . 0.0 111.813 175.877 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' D' D ' 16' ' ' PRO . . . . . . . . . . . . . 27.8 Cg_exo -60.27 -33.94 94.21 Favored 'Trans proline' 0 N--CA 1.497 1.723 0 C-N-CA 121.495 1.463 . . . . 0.0 112.687 -178.724 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' D' D ' 17' ' ' ASP . . . . . . . . . . . . . 23.1 p-10 -90.07 6.73 41.11 Favored 'General case' 0 CA--C 1.536 0.421 0 N-CA-C 113.447 0.906 . . . . 0.0 113.447 -176.936 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' D' D ' 18' ' ' PHE . . . . . 0.42 ' CD1' HD22 ' D' ' 14' ' ' LEU . 53.4 t80 -58.04 -42.87 86.31 Favored 'General case' 0 C--N 1.335 -0.036 0 O-C-N 122.045 -0.409 . . . . 0.0 110.171 -178.777 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' D' D ' 19' ' ' VAL . . . . . . . . . . . . . 47.3 t -56.6 -43.46 78.74 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 CA-C-N 116.236 -0.438 . . . . 0.0 110.514 -179.27 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' D' D ' 20' ' ' ASP . . . . . . . . . . . . . 79.3 m-20 -60.26 -42.02 94.48 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-O 120.696 0.284 . . . . 0.0 110.923 -178.276 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' D' D ' 21' ' ' VAL . . . . . . . . . . . . . 46.3 t -64.12 -48.38 86.04 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.294 0 C-N-CA 120.854 -0.339 . . . . 0.0 110.517 -177.871 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' D' D ' 22' ' ' ILE . . . . . 0.502 HG22 HD12 ' D' ' 26' ' ' LEU . 50.3 mm -55.97 -45.45 80.15 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.218 0 CA-C-O 120.867 0.365 . . . . 0.0 110.577 179.087 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' D' D ' 23' ' ' ARG . . . . . . . . . . . . . 53.7 ttp180 -54.13 -49.93 68.07 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.602 -0.272 . . . . 0.0 111.427 -178.86 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' D' D ' 24' ' ' ILE . . . . . . . . . . . . . 77.5 mt -59.78 -41.5 85.73 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.267 0 C-N-CA 121.172 -0.211 . . . . 0.0 111.253 -178.065 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' D' D ' 25' ' ' LYS . . . . . . . . . . . . . 73.2 mmtt -63.51 -42.56 98.48 Favored 'General case' 0 C--N 1.328 -0.346 0 N-CA-C 112.015 0.376 . . . . 0.0 112.015 -179.695 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' D' D ' 26' ' ' LEU . . . . . 0.502 HD12 HG22 ' D' ' 22' ' ' ILE . 74.5 mt -79.87 -40.19 28.88 Favored 'General case' 0 C--N 1.329 -0.311 0 N-CA-C 113.344 0.868 . . . . 0.0 113.344 -170.856 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' D' D ' 27' ' ' GLN . . . . . . . . . . . . . 8.6 pt20 -46.67 140.94 4.12 Favored 'General case' 0 N--CA 1.47 0.526 0 N-CA-C 112.785 0.661 . . . . 0.0 112.785 -174.923 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' D' D ' 28' ' ' GLY . . . . . . . . . . . . . . . 98.57 -27.6 18.84 Favored Glycine 0 CA--C 1.533 1.186 0 CA-C-N 115.527 -0.761 . . . . 0.0 112.123 -177.87 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' D' D ' 29' ' ' LYS . . . . . . . . . . . . . 67.3 mttm -98.39 155.14 17.38 Favored 'General case' 0 C--O 1.232 0.181 0 CA-C-N 117.229 0.515 . . . . 0.0 111.044 179.636 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' D' D ' 30' ' ' THR . . . . . . . . . . . . . 37.9 m -100.7 137.65 38.81 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.075 -0.511 . . . . 0.0 110.062 176.095 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' D' D ' 31' ' ' VAL . . . . . . . . . . . . . 34.6 m -128.4 157.31 40.88 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.282 0 CA-C-O 120.992 0.425 . . . . 0.0 110.716 -178.953 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' D' D ' 32' ' ' ARG . . . . . . . . . . . . . 94.2 mtt180 -133.72 151.26 51.57 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 115.74 -0.664 . . . . 0.0 110.446 177.832 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' D' D ' 33' ' ' THR . . . . . . . . . . . . . 30.0 m -53.12 138.52 31.03 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.496 -0.32 . . . . 0.0 111.317 -179.339 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' D' D ' 34' ' ' GLY . . . . . . . . . . . . . . . 101.28 -17.13 56.19 Favored Glycine 0 CA--C 1.533 1.17 0 CA-C-O 119.593 -0.559 . . . . 0.0 113.305 179.124 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' D' D ' 35' ' ' ASP . . . . . . . . . . . . . 67.9 m-20 -65.26 148.95 50.79 Favored 'General case' 0 N--CA 1.461 0.122 0 CA-C-N 118.039 0.92 . . . . 0.0 110.987 179.332 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' D' D ' 36' ' ' VAL . . . . . . . . . . . . . 44.7 t -124.23 130.86 73.54 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.25 0 CA-C-N 115.858 -0.61 . . . . 0.0 109.916 179.49 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' D' D ' 37' ' ' ILE . . . . . . . . . . . . . 65.4 mt -119.7 138.19 51.12 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.267 0 CA-C-N 116.195 -0.457 . . . . 0.0 109.787 179.396 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' D' D ' 38' ' ' GLY . . . . . . . . . . . . . . . -114.33 128.72 8.34 Favored Glycine 0 CA--C 1.524 0.637 0 N-CA-C 111.096 -0.801 . . . . 0.0 111.096 -179.699 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' D' D ' 39' ' ' ILE . . . . . . . . . . . . . 72.7 mt -127.34 131.03 70.84 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.282 0 N-CA-C 109.863 -0.421 . . . . 0.0 109.863 178.373 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' D' D ' 40' ' ' SER . . . . . . . . . . . . . 51.8 p -91.92 121.1 33.2 Favored 'General case' 0 C--N 1.329 -0.292 0 C-N-CA 120.894 -0.322 . . . . 0.0 110.81 176.348 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' D' D ' 41' ' ' ILE . . . . . . . . . . . . . 71.9 mt -130.02 119.29 46.68 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.201 0 CA-C-O 120.833 0.349 . . . . 0.0 110.295 179.918 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' D' D ' 42' ' ' LEU . . . . . . . . . . . . . 83.5 mt 58.15 33.41 23.14 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.073 -0.512 . . . . 0.0 111.874 177.551 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' D' D ' 43' ' ' GLY . . . . . . . . . . . . . . . 82.57 -10.1 56.8 Favored Glycine 0 CA--C 1.533 1.216 0 C-N-CA 121.22 -0.514 . . . . 0.0 113.468 176.746 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' D' D ' 44' ' ' LYS . . . . . . . . . . . . . 68.2 tttt -103.34 129.51 50.39 Favored 'General case' 0 C--N 1.332 -0.167 0 CA-C-N 117.948 0.874 . . . . 0.0 109.851 176.885 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' D' D ' 45' ' ' GLU . . . . . . . . . . . . . 39.9 tp10 -84.22 131.14 34.78 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-O 120.816 0.341 . . . . 0.0 110.99 -179.47 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' D' D ' 46' ' ' VAL . . . . . . . . . . . . . 7.3 p -120.99 129.03 76.13 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.191 0 N-CA-C 109.69 -0.485 . . . . 0.0 109.69 176.793 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' D' D ' 47' ' ' LYS . . . . . . . . . . . . . 65.2 mmtt -99.59 126.6 45.61 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 115.87 -0.605 . . . . 0.0 110.931 177.075 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' D' D ' 48' ' ' PHE . . . . . . . . . . . . . 95.8 m-85 -108.78 131.74 54.66 Favored 'General case' 0 C--N 1.328 -0.328 0 N-CA-C 109.399 -0.593 . . . . 0.0 109.399 175.193 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' D' D ' 49' ' ' LYS . . . . . . . . . . . . . 74.3 tttt -109.01 135.48 50.11 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.467 -0.333 . . . . 0.0 110.501 179.934 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' D' D ' 50' ' ' VAL . . . . . . . . . . . . . 43.7 t -78.72 106.05 8.95 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.293 0 N-CA-C 109.187 -0.671 . . . . 0.0 109.187 175.73 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' D' D ' 51' ' ' VAL . . . . . . . . . . . . . 52.9 t -68.8 -47.63 75.23 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.315 0 CA-C-N 116.077 -0.511 . . . . 0.0 109.992 -173.251 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' D' D ' 52' ' ' GLN . . . . . . . . . . . . . 62.8 tt0 -170.18 144.2 2.57 Favored 'General case' 0 C--N 1.33 -0.271 0 C-N-CA 120.262 -0.575 . . . . 0.0 111.839 -178.996 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' D' D ' 53' ' ' ALA . . . . . . . . . . . . . . . -116.46 134.32 55.0 Favored 'General case' 0 C--N 1.331 -0.213 0 CA-C-N 115.641 -0.709 . . . . 0.0 109.831 175.948 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' D' D ' 54' ' ' TYR . . . . . . . . . . . . . 48.7 t80 -129.06 112.82 18.52 Favored Pre-proline 0 CA--C 1.534 0.343 0 CA-C-O 118.194 -0.908 . . . . 0.0 110.442 178.578 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' D' D ' 55' ' ' PRO . . . . . . . . . . . . . 74.0 Cg_endo -77.18 167.86 78.5 Favored 'Cis proline' 0 N--CA 1.499 1.84 0 CA-C-N 122.002 1.751 . . . . 0.0 112.14 -7.727 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' D' D ' 56' ' ' SER . . . . . . . . . . . . . 13.6 m -117.11 140.64 27.34 Favored Pre-proline 0 CA--C 1.537 0.454 0 CA-C-O 118.674 -0.679 . . . . 0.0 109.741 174.802 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' D' D ' 57' ' ' PRO . . . . . . . . . . . . . 38.2 Cg_endo -68.0 159.95 82.92 Favored 'Cis proline' 0 N--CA 1.498 1.786 0 CA-C-N 121.596 1.606 . . . . 0.0 111.139 -3.544 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' D' D ' 58' ' ' LEU . . . . . . . . . . . . . 20.7 tp -129.6 137.16 50.55 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-O 120.995 0.426 . . . . 0.0 110.473 -178.136 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' D' D ' 59' ' ' ARG . . . . . . . . . . . . . 41.7 ttp180 -104.57 126.6 51.81 Favored 'General case' 0 C--N 1.327 -0.379 0 N-CA-C 109.24 -0.652 . . . . 0.0 109.24 175.342 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' D' D ' 60' ' ' VAL . . . . . . . . . . . . . 41.4 t -80.06 123.45 36.87 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.291 0 C-N-CA 120.676 -0.409 . . . . 0.0 110.649 -173.411 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' D' D ' 61' ' ' GLU . . . . . . . . . . . . . 95.9 mt-10 -131.05 164.19 25.97 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 115.782 -0.645 . . . . 0.0 109.78 177.34 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' D' D ' 62' ' ' ASP . . . . . . . . . . . . . 76.4 m-20 -53.19 -32.5 48.29 Favored 'General case' 0 C--N 1.328 -0.345 0 N-CA-C 111.81 0.3 . . . . 0.0 111.81 -179.981 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' D' D ' 63' ' ' ARG . . . . . . . . . . . . . 95.7 mtt180 -74.48 -21.99 59.3 Favored 'General case' 0 CA--C 1.533 0.294 0 N-CA-C 112.945 0.72 . . . . 0.0 112.945 -176.986 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' D' D ' 64' ' ' THR . . . . . . . . . . . . . 26.8 m -64.84 137.17 57.61 Favored 'General case' 0 C--N 1.331 -0.223 0 CA-C-O 120.965 0.412 . . . . 0.0 110.572 -175.599 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' D' D ' 65' ' ' LYS . . . . . . . . . . . . . 39.8 ttpt -89.14 123.78 33.72 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 115.903 -0.589 . . . . 0.0 110.317 -179.721 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' D' D ' 66' ' ' ILE . . . . . . . . . . . . . 62.7 mt -111.48 130.2 65.46 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.261 0 N-CA-C 109.94 -0.393 . . . . 0.0 109.94 -178.564 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' D' D ' 67' ' ' THR . . . . . . . . . . . . . 8.1 m -130.1 146.97 51.79 Favored 'General case' 0 C--N 1.332 -0.192 0 CA-C-O 121.068 0.461 . . . . 0.0 111.231 -176.663 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' D' D ' 68' ' ' LEU . . . . . . . . . . . . . 54.0 mt -99.35 135.36 40.88 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 115.836 -0.62 . . . . 0.0 110.266 177.47 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' D' D ' 69' ' ' VAL . . . . . . . . . . . . . 42.0 t -96.04 140.14 17.75 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.299 0 CA-C-N 116.408 -0.36 . . . . 0.0 110.351 179.839 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' D' D ' 70' ' ' THR . . . . . . . . . . . . . 7.0 t -98.45 163.47 12.67 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.226 -0.443 . . . . 0.0 110.719 -179.586 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' D' D ' 71' ' ' HIS . . . . . . . . . . . . . 30.4 m80 -86.98 158.21 53.36 Favored Pre-proline 0 C--N 1.33 -0.253 0 CA-C-N 116.16 -0.473 . . . . 0.0 110.878 -178.718 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' D' D ' 72' ' ' PRO . . . . . . . . . . . . . 46.3 Cg_endo -69.8 158.97 55.1 Favored 'Trans proline' 0 N--CA 1.495 1.581 0 C-N-CA 121.404 1.402 . . . . 0.0 112.184 179.271 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' D' D ' 73' ' ' VAL . . . . . 0.409 HG12 ' HA ' ' C' ' 143' ' ' THR . 34.6 m -72.92 149.66 8.43 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.278 0 CA-C-N 116.095 -0.502 . . . . 0.0 110.874 -179.522 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' D' D ' 74' ' ' ASP . . . . . . . . . . . . . 23.6 t0 -96.84 124.66 40.88 Favored 'General case' 0 C--N 1.33 -0.264 0 N-CA-C 109.548 -0.538 . . . . 0.0 109.548 178.516 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' D' D ' 75' ' ' VAL . . . . . . . . . . . . . 40.6 t -114.31 122.88 69.31 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.258 0 CA-C-O 121.064 0.459 . . . . 0.0 110.7 -177.524 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' D' D ' 76' ' ' LEU . . . . . . . . . . . . . 5.5 mp -124.76 152.41 43.86 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 115.653 -0.703 . . . . 0.0 109.608 175.951 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' D' D ' 77' ' ' GLU . . . . . . . . . . . . . 98.4 mt-10 -137.35 139.66 40.95 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-O 121.068 0.461 . . . . 0.0 111.34 -177.669 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' D' D ' 78' ' ' ALA . . . . . 0.723 ' HB2' HD21 ' D' ' 109' ' ' LEU . . . -125.58 137.99 53.92 Favored 'General case' 0 C--N 1.331 -0.217 0 CA-C-N 115.711 -0.677 . . . . 0.0 109.841 176.778 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' D' D ' 79' ' ' LYS . . . . . 0.652 ' O ' HD13 ' D' ' 80' ' ' ILE . 68.8 mttm -88.94 115.82 26.77 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.39 -0.368 . . . . 0.0 110.848 -177.747 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' D' D ' 80' ' ' ILE . . . . . 0.652 HD13 ' O ' ' D' ' 79' ' ' LYS . 36.2 mm -139.18 111.7 5.8 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.267 0 N-CA-C 109.153 -0.684 . . . . 0.0 109.153 -177.863 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' D' D ' 81' ' ' LYS . . . . . . . . . . . . . 39.7 ttpt -100.7 126.85 47.27 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-O 120.928 0.394 . . . . 0.0 111.279 -176.558 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' D' D ' 82' ' ' GLY . . . . . . . . . . . . . . . 89.18 42.15 5.65 Favored Glycine 0 CA--C 1.526 0.746 0 N-CA-C 111.534 -0.626 . . . . 0.0 111.534 175.548 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' D' D ' 83' ' ' ILE . . . . . . . . . . . . . 67.8 mt -68.26 139.4 20.77 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.348 0 CA-C-O 120.849 0.357 . . . . 0.0 110.111 179.008 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' D' D ' 84' ' ' LYS . . . . . . . . . . . . . 30.3 ttmt -96.66 -53.64 3.49 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.041 -0.527 . . . . 0.0 109.949 179.467 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' D' D ' 85' ' ' ASP . . . . . . . . . . . . . 7.1 t70 -155.41 152.63 29.27 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 115.507 -0.77 . . . . 0.0 110.117 -179.53 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' D' D ' 86' ' ' VAL . . . . . . . . . . . . . 41.6 t -130.13 132.52 65.22 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.215 0 CA-C-O 120.879 0.371 . . . . 0.0 110.533 -179.476 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' D' D ' 87' ' ' ILE . . . . . . . . . . . . . 45.0 mm -119.37 127.61 75.85 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.263 0 CA-C-N 115.902 -0.59 . . . . 0.0 109.643 177.271 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' D' D ' 88' ' ' LEU . . . . . . . . . . . . . 14.7 tp -110.45 131.3 55.17 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.377 -0.374 . . . . 0.0 110.967 -178.16 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' D' D ' 89' ' ' ASP . . . . . . . . . . . . . 13.3 t70 -124.82 152.2 44.22 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.033 -0.531 . . . . 0.0 109.821 177.611 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' D' D ' 90' ' ' GLU . . . . . . . . . . . . . 96.2 mt-10 -48.56 -34.65 11.82 Favored 'General case' 0 C--N 1.328 -0.368 0 N-CA-C 112.605 0.595 . . . . 0.0 112.605 -173.878 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' D' D ' 91' ' ' ASN . . . . . . . . . . . . . 33.6 m120 -132.05 30.99 4.21 Favored 'General case' 0 CA--C 1.531 0.219 0 N-CA-C 112.167 0.432 . . . . 0.0 112.167 -176.179 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' D' D ' 92' ' ' LEU . . . . . . . . . . . . . 10.8 tp -166.06 149.35 7.49 Favored 'General case' 0 C--N 1.331 -0.215 0 CA-C-O 120.795 0.331 . . . . 0.0 111.089 -179.749 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' D' D ' 93' ' ' ILE . . . . . . . . . . . . . 72.6 mt -126.25 120.23 56.13 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.22 0 N-CA-C 109.298 -0.63 . . . . 0.0 109.298 177.426 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' D' D ' 94' ' ' VAL . . . . . 0.711 HG21 HG11 ' D' ' 125' ' ' VAL . 45.1 t -120.39 127.19 75.89 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.233 0 CA-C-O 120.818 0.342 . . . . 0.0 110.092 -178.637 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' D' D ' 95' ' ' VAL . . . . . . . . . . . . . 43.9 t -122.91 134.22 66.7 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.341 0 CA-C-N 116.123 -0.489 . . . . 0.0 109.98 -179.062 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' D' D ' 96' ' ' ILE . . . . . . . . . . . . . 60.9 mt -115.97 128.15 73.34 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.317 0 N-CA-C 109.478 -0.564 . . . . 0.0 109.478 179.143 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' D' D ' 97' ' ' THR . . . . . . . . . . . . . 66.9 p -100.98 154.01 19.05 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-O 121.138 0.494 . . . . 0.0 111.011 -178.171 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' D' D ' 98' ' ' GLU . . . . . . . . . . . . . 96.4 mt-10 -56.94 -23.86 48.5 Favored 'General case' 0 CA--C 1.533 0.325 0 N-CA-C 112.469 0.544 . . . . 0.0 112.469 -178.736 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' D' D ' 99' ' ' GLU . . . . . . . . . . . . . 71.1 mm-40 -80.5 18.08 0.99 Allowed 'General case' 0 CA--C 1.533 0.324 0 N-CA-C 112.961 0.726 . . . . 0.0 112.961 -178.699 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' D' D ' 100' ' ' ASN . . . . . . . . . . . . . 3.8 m-20 64.09 38.12 8.62 Favored 'General case' 0 N--CA 1.463 0.191 0 CA-C-O 121.063 0.459 . . . . 0.0 111.049 176.899 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' D' D ' 101' ' ' GLU . . . . . . . . . . . . . 84.5 tt0 -116.68 143.07 46.08 Favored 'General case' 0 C--N 1.332 -0.162 0 CA-C-N 116.068 -0.515 . . . . 0.0 109.884 177.125 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' D' D ' 102' ' ' VAL . . . . . . . . . . . . . 43.5 t -114.99 126.93 72.71 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.287 0 CA-C-N 116.275 -0.42 . . . . 0.0 109.891 -178.801 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' D' D ' 103' ' ' LEU . . . . . . . . . . . . . 44.9 mt -118.16 134.28 55.14 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 115.668 -0.696 . . . . 0.0 109.632 179.532 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' D' D ' 104' ' ' ILE . . . . . . . . . . . . . 73.2 mt -126.11 122.81 62.48 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.266 0 C-N-CA 121.213 -0.195 . . . . 0.0 110.562 -176.819 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' D' D ' 105' ' ' PHE . . . . . . . . . . . . . 49.7 m-85 -127.36 165.94 18.79 Favored 'General case' 0 C--N 1.333 -0.112 0 O-C-N 123.993 0.808 . . . . 0.0 110.075 -179.781 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' D' D ' 106' ' ' ASN . . . . . . . . . . . . . 45.7 p-10 -101.85 -170.01 1.76 Allowed 'General case' 0 C--N 1.331 -0.227 0 N-CA-C 109.94 -0.392 . . . . 0.0 109.94 174.379 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' D' D ' 107' ' ' GLN . . . . . . . . . . . . . 39.0 tt0 -58.72 -30.1 67.19 Favored 'General case' 0 C--N 1.33 -0.269 0 N-CA-C 111.996 0.369 . . . . 0.0 111.996 179.73 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' D' D ' 108' ' ' ASN . . . . . . . . . . . . . 11.3 t-20 -83.55 7.99 15.5 Favored 'General case' 0 CA--C 1.534 0.357 0 N-CA-C 113.238 0.829 . . . . 0.0 113.238 -176.836 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' D' D ' 109' ' ' LEU . . . . . 0.723 HD21 ' HB2' ' D' ' 78' ' ' ALA . 12.8 tp 61.29 38.55 16.35 Favored 'General case' 0 CA--C 1.529 0.154 0 CA-C-O 120.999 0.428 . . . . 0.0 111.028 178.388 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' D' D ' 110' ' ' GLU . . . . . . . . . . . . . 95.5 mt-10 -108.21 152.81 24.09 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 116.396 -0.365 . . . . 0.0 110.373 177.937 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' D' D ' 111' ' ' GLU . . . . . . . . . . . . . 94.9 mt-10 -77.69 125.31 29.14 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-O 120.913 0.387 . . . . 0.0 111.123 -179.543 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' D' D ' 112' ' ' LEU . . . . . . . . . . . . . 83.4 mt -107.99 -45.36 3.99 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 115.975 -0.557 . . . . 0.0 109.664 173.297 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' D' D ' 113' ' ' TYR . . . . . . . . . . . . . 64.6 t80 -147.31 141.55 26.21 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.133 -0.485 . . . . 0.0 111.555 -179.252 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' D' D ' 114' ' ' ARG . . . . . . . . . . . . . 65.3 mtt180 -139.36 124.65 19.07 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 115.874 -0.603 . . . . 0.0 110.3 173.69 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' D' D ' 115' ' ' GLY . . . . . . . . . . . . . . . -150.06 157.43 27.21 Favored Glycine 0 CA--C 1.525 0.683 0 N-CA-C 110.862 -0.895 . . . . 0.0 110.862 178.69 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' D' D ' 116' ' ' LYS . . . . . . . . . . . . . 39.7 ttpt -129.12 139.04 52.12 Favored 'General case' 0 C--N 1.329 -0.322 0 N-CA-C 110.103 -0.332 . . . . 0.0 110.103 178.195 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' D' D ' 117' ' ' PHE . . . . . . . . . . . . . 47.9 m-85 -132.15 116.01 16.46 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.283 -0.417 . . . . 0.0 110.489 -176.196 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' D' D ' 118' ' ' GLU . . . . . . . . . . . . . 84.7 tt0 -51.95 -52.93 46.88 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.407 -0.36 . . . . 0.0 111.659 -176.853 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' D' D ' 119' ' ' ASN . . . . . . . . . . . . . 96.3 m-20 -93.65 31.14 1.62 Allowed 'General case' 0 C--N 1.329 -0.29 0 N-CA-C 112.227 0.454 . . . . 0.0 112.227 -174.525 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' D' D ' 120' ' ' LEU . . . . . . . . . . . . . 15.8 tp -54.08 122.1 9.48 Favored 'General case' 0 N--CA 1.464 0.231 0 O-C-N 122.289 -0.257 . . . . 0.0 110.671 177.562 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' D' D ' 121' ' ' ASN . . . . . . . . . . . . . 26.7 m120 -114.09 -44.02 3.18 Favored 'General case' 0 C--O 1.232 0.166 0 CA-C-N 116.595 -0.275 . . . . 0.0 111.188 -175.977 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' D' D ' 122' ' ' LYS . . . . . . . . . . . . . 44.4 mtmt -145.68 146.52 31.32 Favored 'General case' 0 C--N 1.331 -0.215 0 C-N-CA 120.538 -0.465 . . . . 0.0 111.665 -176.471 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' D' D ' 123' ' ' VAL . . . . . . . . . . . . . 44.0 t -129.02 130.5 68.31 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.275 0 CA-C-N 115.849 -0.614 . . . . 0.0 109.53 176.096 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' D' D ' 124' ' ' LEU . . . . . . . . . . . . . 14.9 tp -128.34 135.34 49.45 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-O 120.78 0.324 . . . . 0.0 110.612 -178.555 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' D' D ' 125' ' ' VAL . . . . . 0.711 HG11 HG21 ' D' ' 94' ' ' VAL . 34.9 m -133.61 141.0 45.44 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.195 0 CA-C-N 116.328 -0.396 . . . . 0.0 111.031 -178.719 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' D' D ' 126' ' ' ARG . . . . . . . . . . . . . 78.2 mtt180 -149.41 125.19 10.49 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.554 176.267 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' D' D ' 127' ' ' ASN . . . . . . . . . . . . . 18.8 t-20 52.51 -111.37 0.58 Allowed 'General case' 0 CA--C 1.545 0.755 0 CA-C-O 118.734 -0.65 . . . . 0.0 111.046 178.849 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' D' D ' 128' ' ' ASP . . . . . . . . . . . . . 21.5 p-10 -114.15 10.7 17.4 Favored 'General case' 0 N--CA 1.468 0.454 0 CA-C-N 120.044 1.293 . . . . 0.0 113.081 -179.747 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' D' D ' 129' ' ' LEU . . . . . . . . . . . . . 13.1 tp -107.29 135.77 48.25 Favored 'General case' 0 C--N 1.332 -0.165 0 N-CA-C 109.877 -0.416 . . . . 0.0 109.877 178.914 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' D' D ' 130' ' ' VAL . . . . . . . . . . . . . 44.3 t -123.79 136.16 61.12 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.239 0 CA-C-O 120.869 0.366 . . . . 0.0 110.023 -178.127 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' D' D ' 131' ' ' VAL . . . . . . . . . . . . . 43.4 t -133.87 133.71 56.35 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.258 0 CA-C-O 121.027 0.441 . . . . 0.0 110.059 177.561 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' D' D ' 132' ' ' ILE . . . . . . . . . . . . . 71.6 mt -118.01 131.51 70.55 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.335 0 CA-C-N 115.724 -0.671 . . . . 0.0 109.604 -179.273 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' D' D ' 133' ' ' ILE . . . . . . . . . . . . . 36.8 mm -116.19 124.33 72.35 Favored 'Isoleucine or valine' 0 C--O 1.233 0.197 0 CA-C-O 120.804 0.335 . . . . 0.0 111.106 -175.062 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' D' D ' 134' ' ' ASP . . . . . . . . . . . . . 11.6 p-10 -135.22 151.33 50.52 Favored 'General case' 0 C--N 1.332 -0.18 0 CA-C-N 116.104 -0.498 . . . . 0.0 109.916 174.603 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' D' D ' 135' ' ' GLU . . . . . . . . . . . . . 84.6 tt0 -49.95 -26.24 4.01 Favored 'General case' 0 C--O 1.236 0.354 0 N-CA-C 113.571 0.952 . . . . 0.0 113.571 -168.493 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' D' D ' 136' ' ' GLN . . . . . . . . . . . . . 14.3 pt20 -100.15 -19.55 16.39 Favored 'General case' 0 N--CA 1.466 0.352 0 N-CA-C 113.314 0.857 . . . . 0.0 113.314 -172.491 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' D' D ' 137' ' ' LYS . . . . . . . . . . . . . 56.8 pttt -165.88 170.54 13.69 Favored 'General case' 0 C--O 1.232 0.139 0 CA-C-O 121.645 0.736 . . . . 0.0 112.344 -176.693 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' D' D ' 138' ' ' LEU . . . . . . . . . . . . . 7.2 tt -121.23 127.67 51.67 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 114.919 -1.037 . . . . 0.0 109.827 178.938 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' D' D ' 139' ' ' THR . . . . . . . . . . . . . 42.1 m -106.18 126.71 52.55 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.089 -0.505 . . . . 0.0 110.331 179.895 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' D' D ' 140' ' ' LEU . . . . . 0.464 ' C ' HD23 ' D' ' 140' ' ' LEU . 5.7 tt -110.74 122.49 47.94 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 115.748 -0.66 . . . . 0.0 109.27 -179.203 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' D' D ' 141' ' ' ILE . . . . . 0.438 ' N ' HD23 ' D' ' 140' ' ' LEU . 19.1 mt -122.21 116.16 48.32 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.294 0 N-CA-C 109.867 -0.42 . . . . 0.0 109.867 -175.176 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' D' D ' 142' ' ' ARG . . . . . . . . . . . . . 58.9 ttp180 -108.75 129.29 55.37 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 115.64 -0.709 . . . . 0.0 110.507 -178.784 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' D' D ' 143' ' ' THR . . . . . . . . . . . . . 70.2 p . . . . . 0 C--O 1.22 -0.475 0 CA-C-O 118.223 -0.894 . . . . 0.0 110.894 179.695 . . . . . . . . 0 0 . 1 . 019 nuclear nobuild full ' E' E ' -3' ' ' GLU . . . . . . . . . . . . . 70.4 mm-40 . . . . . 0 N--CA 1.489 1.518 0 N-CA-C 109.317 -0.623 . . . . 0.0 109.317 . . . . . . . . . 0 0 . 1 . 019 nuclear nobuild full ' E' E ' -2' ' ' GLY . . . . . . . . . . . . . . . -85.78 124.82 7.02 Favored Glycine 0 CA--C 1.524 0.63 0 N-CA-C 111.013 -0.835 . . . . 0.0 111.013 179.999 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' E' E ' -1' ' ' VAL . . . . . . . . . . . . . 43.3 t -141.81 135.92 30.17 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.337 0 N-CA-C 110.074 -0.343 . . . . 0.0 110.074 179.673 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' E' E ' 0' ' ' ILE . . . . . . . . . . . . . 67.3 mt -116.33 143.32 26.7 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.195 0 CA-C-N 116.245 -0.434 . . . . 0.0 109.933 179.996 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' E' E ' 1' ' ' MET . . . . . . . . . . . . . 26.0 ptm -87.2 142.32 27.99 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.083 -0.508 . . . . 0.0 110.583 179.845 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' E' E ' 2' ' ' SER . . . . . . . . . . . . . 2.1 p -130.29 123.51 30.21 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.026 178.504 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' E' E ' 3' ' ' GLU . . . . . . . . . . . . . 89.2 mt-10 -139.29 140.75 37.71 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.016 -0.538 . . . . 0.0 111.103 -175.374 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' E' E ' 4' ' ' LEU . . . . . . . . . . . . . 16.0 tp -122.89 124.93 44.35 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 115.785 -0.643 . . . . 0.0 109.506 173.979 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' E' E ' 5' ' ' LYS . . . . . . . . . . . . . 60.7 mttp -108.83 120.26 41.98 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 116.397 -0.365 . . . . 0.0 110.573 -179.265 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' E' E ' 6' ' ' LEU . . . . . . . . . . . . . 54.1 mt -113.91 143.43 44.71 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 115.402 -0.817 . . . . 0.0 110.041 -178.796 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' E' E ' 7' ' ' LYS . . . . . . . . . . . . . 78.4 tttt -122.71 135.77 26.04 Favored Pre-proline 0 CA--C 1.535 0.388 0 CA-C-O 118.84 -0.6 . . . . 0.0 109.542 176.087 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' E' E ' 8' ' ' PRO . . . . . . . . . . . . . 72.4 Cg_endo -88.9 131.54 2.27 Favored 'Trans proline' 0 N--CA 1.49 1.309 0 C-N-CA 121.566 1.511 . . . . 0.0 111.814 178.938 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' E' E ' 9' ' ' LEU . . . . . . . . . . . . . 73.9 mt -70.36 -51.22 13.55 Favored Pre-proline 0 C--N 1.329 -0.313 0 CA-C-O 118.694 -0.67 . . . . 0.0 111.817 -178.703 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' E' E ' 10' ' ' PRO . . . . . . . . . . . . . 70.3 Cg_endo -74.66 151.24 41.08 Favored 'Trans proline' 0 N--CA 1.497 1.713 0 C-N-CA 121.076 1.184 . . . . 0.0 111.891 175.226 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' E' E ' 11' ' ' LYS . . . . . . . . . . . . . 70.6 mmtt -83.92 89.11 7.16 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-O 120.879 0.371 . . . . 0.0 110.42 178.511 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' E' E ' 12' ' ' VAL . . . . . . . . . . . . . 12.2 p -140.06 144.81 27.32 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.276 0 CA-C-N 116.024 -0.535 . . . . 0.0 110.359 179.877 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' E' E ' 13' ' ' GLU . . . . . . . . . . . . . 84.9 tt0 -91.79 130.62 37.53 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.275 -0.42 . . . . 0.0 110.241 178.626 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' E' E ' 14' ' ' LEU . . . . . . . . . . . . . 19.9 mt -97.65 152.98 38.45 Favored Pre-proline 0 C--N 1.33 -0.251 0 CA-C-N 116.258 -0.428 . . . . 0.0 110.796 -177.509 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' E' E ' 15' ' ' PRO . . . . . . . . . . . . . 27.9 Cg_exo -60.81 159.28 29.51 Favored 'Trans proline' 0 N--CA 1.497 1.692 0 C-N-CA 121.334 1.356 . . . . 0.0 111.795 176.833 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' E' E ' 16' ' ' PRO . . . . . . . . . . . . . 38.6 Cg_exo -58.48 -37.04 96.58 Favored 'Trans proline' 0 N--CA 1.497 1.727 0 C-N-CA 121.362 1.374 . . . . 0.0 112.704 -178.211 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' E' E ' 17' ' ' ASP . . . . . . . . . . . . . 10.5 p-10 -94.47 15.43 17.83 Favored 'General case' 0 C--N 1.328 -0.345 0 N-CA-C 113.063 0.764 . . . . 0.0 113.063 -177.088 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' E' E ' 18' ' ' PHE . . . . . . . . . . . . . 51.9 t80 -58.03 -44.34 87.28 Favored 'General case' 0 N--CA 1.46 0.06 0 O-C-N 122.0 -0.437 . . . . 0.0 110.085 -178.788 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' E' E ' 19' ' ' VAL . . . . . . . . . . . . . 47.4 t -56.61 -40.83 71.52 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.344 0 CA-C-N 116.255 -0.43 . . . . 0.0 110.35 -179.764 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' E' E ' 20' ' ' ASP . . . . . . . . . . . . . 70.1 m-20 -60.07 -42.69 95.09 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-O 120.801 0.334 . . . . 0.0 110.85 -178.274 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' E' E ' 21' ' ' VAL . . . . . . . . . . . . . 47.5 t -65.38 -52.02 57.0 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.278 0 C-N-CA 120.828 -0.349 . . . . 0.0 110.613 -178.334 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' E' E ' 22' ' ' ILE . . . . . . . . . . . . . 48.7 mm -54.32 -54.57 20.49 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.231 0 CA-C-O 120.743 0.306 . . . . 0.0 111.24 -177.493 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' E' E ' 23' ' ' ARG . . . . . . . . . . . . . 14.4 ptm180 -61.34 -45.29 95.04 Favored 'General case' 0 CA--C 1.532 0.275 0 N-CA-C 112.166 0.432 . . . . 0.0 112.166 -173.656 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' E' E ' 24' ' ' ILE . . . . . . . . . . . . . 73.0 mt -61.85 -38.53 80.78 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.209 0 O-C-N 122.138 -0.352 . . . . 0.0 111.224 -175.474 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' E' E ' 25' ' ' LYS . . . . . . . . . . . . . 66.6 mttm -72.33 -43.81 63.56 Favored 'General case' 0 C--N 1.331 -0.237 0 N-CA-C 112.077 0.399 . . . . 0.0 112.077 -178.971 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' E' E ' 26' ' ' LEU . . . . . . . . . . . . . 56.4 mt -87.03 -8.19 57.38 Favored 'General case' 0 CA--C 1.533 0.303 0 N-CA-C 113.835 1.05 . . . . 0.0 113.835 -173.627 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' E' E ' 27' ' ' GLN . . . . . . . . . . . . . 3.4 pt20 -46.59 143.13 2.82 Favored 'General case' 0 N--CA 1.467 0.412 0 O-C-N 121.592 -0.692 . . . . 0.0 112.451 -179.706 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' E' E ' 28' ' ' GLY . . . . . . . . . . . . . . . 100.07 -22.49 39.92 Favored Glycine 0 CA--C 1.533 1.212 0 CA-C-N 115.885 -0.598 . . . . 0.0 112.467 -177.953 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' E' E ' 29' ' ' LYS . . . . . . . . . . . . . 34.8 mmtp -89.6 154.98 19.55 Favored 'General case' 0 C--O 1.233 0.186 0 CA-C-N 117.599 0.699 . . . . 0.0 110.632 177.994 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' E' E ' 30' ' ' THR . . . . . . . . . . . . . 9.1 m -107.95 139.77 42.07 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.093 -0.503 . . . . 0.0 110.17 178.269 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' E' E ' 31' ' ' VAL . . . . . . . . . . . . . 35.0 m -127.91 152.87 36.55 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.263 0 CA-C-O 120.929 0.395 . . . . 0.0 110.755 -178.963 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' E' E ' 32' ' ' ARG . . . . . . . . . . . . . 83.5 mtt180 -131.68 150.31 52.19 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.025 -0.534 . . . . 0.0 110.366 177.565 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' E' E ' 33' ' ' THR . . . . . . . . . . . . . 22.0 m -52.8 138.64 28.88 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.366 -0.379 . . . . 0.0 111.457 -178.383 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' E' E ' 34' ' ' GLY . . . . . . . . . . . . . . . 100.16 -17.13 57.47 Favored Glycine 0 CA--C 1.532 1.101 0 CA-C-N 116.18 -0.464 . . . . 0.0 113.28 179.485 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' E' E ' 35' ' ' ASP . . . . . . . . . . . . . 77.0 m-20 -67.97 149.51 49.65 Favored 'General case' 0 N--CA 1.462 0.125 0 CA-C-N 117.989 0.894 . . . . 0.0 111.183 178.683 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' E' E ' 36' ' ' VAL . . . . . . . . . . . . . 44.6 t -120.95 128.81 76.13 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.219 0 CA-C-N 116.063 -0.517 . . . . 0.0 109.688 176.775 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' E' E ' 37' ' ' ILE . . . . . . . . . . . . . 62.9 mt -119.08 138.4 49.93 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 CA-C-N 116.089 -0.505 . . . . 0.0 109.923 -178.539 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' E' E ' 38' ' ' GLY . . . . . . . . . . . . . . . -116.42 128.14 7.81 Favored Glycine 0 CA--C 1.526 0.757 0 N-CA-C 110.937 -0.865 . . . . 0.0 110.937 179.285 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' E' E ' 39' ' ' ILE . . . . . . . . . . . . . 73.5 mt -128.82 131.07 68.7 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.216 0 N-CA-C 110.066 -0.346 . . . . 0.0 110.066 178.893 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' E' E ' 40' ' ' SER . . . . . . . . . . . . . 46.8 t -91.79 113.94 26.34 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.392 -0.367 . . . . 0.0 110.965 177.908 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' E' E ' 41' ' ' ILE . . . . . . . . . . . . . 45.9 mm -123.24 123.45 67.76 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.22 0 N-CA-C 109.835 -0.431 . . . . 0.0 109.835 179.467 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' E' E ' 42' ' ' LEU . . . . . . . . . . . . . 68.7 mt 57.85 34.85 24.84 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.307 -0.406 . . . . 0.0 111.683 177.94 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' E' E ' 43' ' ' GLY . . . . . . . . . . . . . . . 78.94 -10.22 34.22 Favored Glycine 0 CA--C 1.534 1.219 0 C-N-CA 121.248 -0.501 . . . . 0.0 113.43 177.094 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' E' E ' 44' ' ' LYS . . . . . . . . . . . . . 30.4 ttmt -102.83 129.36 49.48 Favored 'General case' 0 N--CA 1.461 0.078 0 CA-C-N 117.982 0.891 . . . . 0.0 110.157 177.103 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' E' E ' 45' ' ' GLU . . . . . . . . . . . . . 39.9 tp10 -84.18 127.54 34.0 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 116.283 -0.417 . . . . 0.0 110.93 -179.662 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' E' E ' 46' ' ' VAL . . . . . . . . . . . . . 9.2 p -119.27 125.9 74.86 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.22 0 N-CA-C 109.675 -0.491 . . . . 0.0 109.675 176.468 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' E' E ' 47' ' ' LYS . . . . . . . . . . . . . 62.8 mttp -99.23 126.81 45.12 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.023 -0.535 . . . . 0.0 110.889 177.266 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' E' E ' 48' ' ' PHE . . . . . . . . . . . . . 41.1 m-85 -110.55 131.87 54.68 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.035 -0.529 . . . . 0.0 109.805 177.138 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' E' E ' 49' ' ' LYS . . . . . . . . . . . . . 78.9 tttt -105.95 132.24 52.29 Favored 'General case' 0 C--N 1.328 -0.351 0 N-CA-C 110.074 -0.343 . . . . 0.0 110.074 177.887 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' E' E ' 50' ' ' VAL . . . . . . . . . . . . . 46.6 t -77.1 107.55 8.68 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.331 0 N-CA-C 109.449 -0.574 . . . . 0.0 109.449 178.023 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' E' E ' 51' ' ' VAL . . . . . . . . . . . . . 46.6 t -71.55 -52.71 24.22 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.339 0 N-CA-C 109.545 -0.539 . . . . 0.0 109.545 -175.943 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' E' E ' 52' ' ' GLN . . . . . . . . . . . . . 83.3 mt-30 -154.74 152.5 29.96 Favored 'General case' 0 C--N 1.331 -0.207 0 CA-C-O 121.252 0.549 . . . . 0.0 111.66 -178.105 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' E' E ' 53' ' ' ALA . . . . . . . . . . . . . . . -130.2 131.96 45.8 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 115.313 -0.858 . . . . 0.0 109.545 174.141 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' E' E ' 54' ' ' TYR . . . . . . . . . . . . . 59.8 t80 -129.04 110.29 18.28 Favored Pre-proline 0 CA--C 1.535 0.374 0 CA-C-O 118.205 -0.902 . . . . 0.0 110.32 179.457 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' E' E ' 55' ' ' PRO . . . . . . . . . . . . . 73.9 Cg_endo -77.16 169.82 73.18 Favored 'Cis proline' 0 N--CA 1.5 1.865 0 CA-C-N 121.987 1.745 . . . . 0.0 112.153 -5.638 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' E' E ' 56' ' ' SER . . . . . . . . . . . . . 13.7 m -115.89 132.44 23.2 Favored Pre-proline 0 CA--C 1.538 0.488 0 CA-C-O 118.458 -0.782 . . . . 0.0 109.155 175.416 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' E' E ' 57' ' ' PRO . . . . . . . . . . . . . 50.9 Cg_endo -69.75 164.12 80.01 Favored 'Cis proline' 0 N--CA 1.498 1.753 0 CA-C-N 121.928 1.724 . . . . 0.0 111.684 0.166 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' E' E ' 58' ' ' LEU . . . . . . . . . . . . . 36.8 tp -129.82 139.4 51.24 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.079 179.821 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' E' E ' 59' ' ' ARG . . . . . . . . . . . . . 26.6 ttm180 -103.83 139.11 39.47 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.246 -0.434 . . . . 0.0 110.05 178.983 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' E' E ' 60' ' ' VAL . . . . . . . . . . . . . 42.9 t -86.64 111.22 21.18 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.196 0 CA-C-O 120.84 0.352 . . . . 0.0 110.34 -177.991 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' E' E ' 61' ' ' GLU . . . . . . . . . . . . . 81.3 tt0 -131.17 154.44 48.37 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 115.845 -0.616 . . . . 0.0 109.58 177.407 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' E' E ' 62' ' ' ASP . . . . . . . . . . . . . 9.4 p-10 -52.82 -23.74 7.55 Favored 'General case' 0 C--N 1.326 -0.433 0 N-CA-C 112.467 0.543 . . . . 0.0 112.467 -179.579 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' E' E ' 63' ' ' ARG . . . . . . . . . . . . . 23.8 mmm180 -84.72 -14.22 49.03 Favored 'General case' 0 CA--C 1.534 0.349 0 N-CA-C 113.443 0.905 . . . . 0.0 113.443 -177.066 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' E' E ' 64' ' ' THR . . . . . . . . . . . . . 14.0 m -76.58 151.84 36.15 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-O 120.937 0.399 . . . . 0.0 111.05 -176.066 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' E' E ' 65' ' ' LYS . . . . . . . . . . . . . 45.7 mtpt -90.49 118.7 30.16 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.134 179.063 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' E' E ' 66' ' ' ILE . . . . . . . . . . . . . 72.0 mt -117.62 124.67 73.37 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.219 0 N-CA-C 109.741 -0.466 . . . . 0.0 109.741 -178.344 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' E' E ' 67' ' ' THR . . . . . . . . . . . . . 27.4 m -132.1 151.06 51.98 Favored 'General case' 0 C--N 1.332 -0.182 0 CA-C-O 121.269 0.557 . . . . 0.0 111.876 -173.437 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' E' E ' 68' ' ' LEU . . . . . . . . . . . . . 78.9 mt -98.66 127.99 44.79 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-N 115.548 -0.751 . . . . 0.0 110.126 175.474 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' E' E ' 69' ' ' VAL . . . . . . . . . . . . . 44.3 t -102.57 144.93 12.87 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.268 0 CA-C-N 116.05 -0.523 . . . . 0.0 110.193 -178.729 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' E' E ' 70' ' ' THR . . . . . 0.465 HG23 ' O ' ' E' ' 70' ' ' THR . 8.0 t -131.79 122.62 26.1 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-O 120.924 0.392 . . . . 0.0 110.675 178.645 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' E' E ' 71' ' ' HIS . . . . . . . . . . . . . 32.0 m80 -139.73 160.78 59.72 Favored Pre-proline 0 C--N 1.33 -0.274 0 CA-C-N 116.055 -0.521 . . . . 0.0 109.867 177.796 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' E' E ' 72' ' ' PRO . . . . . . . . . . . . . 4.2 Cg_exo -71.82 -30.11 14.62 Favored 'Trans proline' 0 N--CA 1.495 1.577 0 C-N-CA 121.255 1.303 . . . . 0.0 112.286 -176.765 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' E' E ' 73' ' ' VAL . . . . . . . . . . . . . 31.5 m -155.17 162.25 1.87 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.217 0 CA-C-O 121.174 0.511 . . . . 0.0 111.097 -178.641 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' E' E ' 74' ' ' ASP . . . . . . . . . . . . . 16.6 t0 -106.94 122.55 46.64 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 115.496 -0.775 . . . . 0.0 109.232 174.273 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' E' E ' 75' ' ' VAL . . . . . 0.492 ' C ' HD12 ' E' ' 76' ' ' LEU . 41.2 t -117.83 125.68 74.31 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.294 0 CA-C-O 121.112 0.482 . . . . 0.0 110.809 -176.916 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' E' E ' 76' ' ' LEU . . . . . 0.492 HD12 ' C ' ' E' ' 75' ' ' VAL . 6.1 mp -127.37 151.11 49.21 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-N 115.566 -0.743 . . . . 0.0 109.62 176.437 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' E' E ' 77' ' ' GLU . . . . . . . . . . . . . 97.0 mt-10 -136.48 136.03 39.1 Favored 'General case' 0 C--N 1.332 -0.171 0 CA-C-O 121.068 0.461 . . . . 0.0 111.26 -177.4 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' E' E ' 78' ' ' ALA . . . . . . . . . . . . . . . -121.05 138.85 53.98 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-N 115.737 -0.665 . . . . 0.0 109.819 176.838 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' E' E ' 79' ' ' LYS . . . . . 0.576 ' O ' HD13 ' E' ' 80' ' ' ILE . 99.7 mttt -83.59 118.85 24.09 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-O 120.951 0.405 . . . . 0.0 111.0 -176.982 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' E' E ' 80' ' ' ILE . . . . . 0.576 HD13 ' O ' ' E' ' 79' ' ' LYS . 42.0 mm -139.25 115.43 9.5 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.2 0 N-CA-C 109.346 -0.613 . . . . 0.0 109.346 -178.229 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' E' E ' 81' ' ' LYS . . . . . . . . . . . . . 64.7 mttm -109.44 125.51 52.51 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-O 120.854 0.359 . . . . 0.0 111.09 -177.705 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' E' E ' 82' ' ' GLY . . . . . . . . . . . . . . . 89.09 42.12 5.69 Favored Glycine 0 CA--C 1.523 0.582 0 C-N-CA 120.774 -0.727 . . . . 0.0 111.419 175.994 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' E' E ' 83' ' ' ILE . . . . . . . . . . . . . 72.9 mt -66.06 133.31 31.14 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.297 0 CA-C-O 120.942 0.401 . . . . 0.0 110.01 178.181 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' E' E ' 84' ' ' LYS . . . . . . . . . . . . . 85.9 tttt -91.67 -53.14 4.42 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-N 115.936 -0.574 . . . . 0.0 109.97 -179.633 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' E' E ' 85' ' ' ASP . . . . . . . . . . . . . 13.3 t70 -156.24 151.02 26.03 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 115.553 -0.749 . . . . 0.0 110.059 179.402 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' E' E ' 86' ' ' VAL . . . . . . . . . . . . . 43.3 t -125.87 129.63 72.44 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.287 0 CA-C-O 120.937 0.399 . . . . 0.0 110.439 -178.986 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' E' E ' 87' ' ' ILE . . . . . . . . . . . . . 44.5 mm -118.28 126.15 74.82 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.208 0 CA-C-N 115.979 -0.555 . . . . 0.0 109.714 177.008 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' E' E ' 88' ' ' LEU . . . . . . . . . . . . . 14.2 tp -108.8 131.08 55.32 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-O 120.972 0.415 . . . . 0.0 111.004 -177.591 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' E' E ' 89' ' ' ASP . . . . . . . . . . . . . 7.7 t70 -119.61 154.07 34.52 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 115.787 -0.642 . . . . 0.0 109.5 176.781 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' E' E ' 90' ' ' GLU . . . . . . . . . . . . . 82.4 tt0 -46.28 -43.57 15.8 Favored 'General case' 0 N--CA 1.464 0.263 0 N-CA-C 112.871 0.693 . . . . 0.0 112.871 -173.106 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' E' E ' 91' ' ' ASN . . . . . . . . . . . . . 16.0 t-20 -132.15 39.11 3.44 Favored 'General case' 0 C--N 1.331 -0.217 0 CA-C-O 120.907 0.384 . . . . 0.0 111.195 -178.815 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' E' E ' 92' ' ' LEU . . . . . . . . . . . . . 10.5 tp -166.08 147.26 6.72 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 116.526 -0.307 . . . . 0.0 110.386 -178.708 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' E' E ' 93' ' ' ILE . . . . . . . . . . . . . 65.8 mt -128.78 123.49 59.31 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.214 0 N-CA-C 109.483 -0.562 . . . . 0.0 109.483 -178.972 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' E' E ' 94' ' ' VAL . . . . . 0.647 HG21 HG11 ' E' ' 125' ' ' VAL . 44.1 t -124.24 129.36 74.07 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.216 0 CA-C-O 121.021 0.438 . . . . 0.0 110.035 -179.841 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' E' E ' 95' ' ' VAL . . . . . . . . . . . . . 42.5 t -122.04 135.83 60.89 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.328 0 CA-C-N 115.881 -0.599 . . . . 0.0 109.926 -178.906 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' E' E ' 96' ' ' ILE . . . . . . . . . . . . . 62.0 mt -111.92 126.7 69.33 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.355 0 N-CA-C 109.215 -0.661 . . . . 0.0 109.215 178.068 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' E' E ' 97' ' ' THR . . . . . . . . . . . . . 68.3 p -97.16 155.91 16.63 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-O 121.168 0.509 . . . . 0.0 111.134 -178.176 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' E' E ' 98' ' ' GLU . . . . . . . . . . . . . 82.6 tt0 -53.86 -25.88 21.89 Favored 'General case' 0 C--N 1.327 -0.372 0 N-CA-C 112.304 0.483 . . . . 0.0 112.304 -178.941 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' E' E ' 99' ' ' GLU . . . . . . . . . . . . . 71.2 mm-40 -81.56 16.16 1.83 Allowed 'General case' 0 CA--C 1.536 0.413 0 N-CA-C 113.137 0.791 . . . . 0.0 113.137 -176.74 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' E' E ' 100' ' ' ASN . . . . . . . . . . . . . 3.5 m-20 62.89 34.33 14.37 Favored 'General case' 0 CA--C 1.531 0.227 0 CA-C-O 120.909 0.385 . . . . 0.0 111.519 178.644 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' E' E ' 101' ' ' GLU . . . . . . . . . . . . . 84.6 tt0 -112.65 143.63 43.52 Favored 'General case' 0 C--N 1.334 -0.093 0 N-CA-C 109.69 -0.485 . . . . 0.0 109.69 173.422 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' E' E ' 102' ' ' VAL . . . . . . . . . . . . . 45.6 t -115.21 129.43 71.47 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.322 0 CA-C-N 116.49 -0.323 . . . . 0.0 110.297 -177.414 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' E' E ' 103' ' ' LEU . . . . . . . . . . . . . 51.1 mt -117.85 130.75 56.45 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-N 115.7 -0.682 . . . . 0.0 110.415 177.31 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' E' E ' 104' ' ' ILE . . . . . . . . . . . . . 70.7 mt -117.45 122.86 70.88 Favored 'Isoleucine or valine' 0 C--O 1.233 0.226 0 N-CA-C 110.154 -0.313 . . . . 0.0 110.154 178.373 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' E' E ' 105' ' ' PHE . . . . . . . . . . . . . 74.3 m-85 -123.6 164.36 19.19 Favored 'General case' 0 C--O 1.232 0.132 0 O-C-N 123.905 0.753 . . . . 0.0 109.876 -179.781 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' E' E ' 106' ' ' ASN . . . . . 0.415 ' HB3' HD11 ' E' ' 112' ' ' LEU . 43.5 p-10 -99.07 -170.02 1.86 Allowed 'General case' 0 C--N 1.33 -0.254 0 N-CA-C 109.738 -0.467 . . . . 0.0 109.738 172.381 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' E' E ' 107' ' ' GLN . . . . . . . . . . . . . 48.8 tt0 -57.91 -29.8 65.4 Favored 'General case' 0 C--N 1.329 -0.298 0 N-CA-C 112.025 0.38 . . . . 0.0 112.025 179.982 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' E' E ' 108' ' ' ASN . . . . . . . . . . . . . 22.5 t30 -88.69 13.14 12.99 Favored 'General case' 0 CA--C 1.535 0.388 0 N-CA-C 113.094 0.776 . . . . 0.0 113.094 -176.024 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' E' E ' 109' ' ' LEU . . . . . . . . . . . . . 38.4 mt 57.43 36.18 26.77 Favored 'General case' 0 C--N 1.333 -0.149 0 CA-C-O 120.941 0.4 . . . . 0.0 111.566 177.811 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' E' E ' 110' ' ' GLU . . . . . . . . . . . . . 95.6 mt-10 -100.56 155.26 17.95 Favored 'General case' 0 C--N 1.33 -0.258 0 N-CA-C 109.72 -0.474 . . . . 0.0 109.72 176.191 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' E' E ' 111' ' ' GLU . . . . . . . . . . . . . 84.4 tt0 -82.26 121.91 27.25 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-O 120.883 0.373 . . . . 0.0 110.92 -177.707 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' E' E ' 112' ' ' LEU . . . . . 0.415 HD11 ' HB3' ' E' ' 106' ' ' ASN . 75.2 mt -107.9 -45.99 3.87 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.017 -0.538 . . . . 0.0 110.047 176.416 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' E' E ' 113' ' ' TYR . . . . . . . . . . . . . 63.3 t80 -143.28 135.76 27.32 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.153 -0.476 . . . . 0.0 111.52 -179.395 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' E' E ' 114' ' ' ARG . . . . . . . . . . . . . 21.4 ttm180 -131.13 123.88 29.52 Favored 'General case' 0 C--N 1.331 -0.201 0 CA-C-N 115.775 -0.648 . . . . 0.0 109.623 173.529 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' E' E ' 115' ' ' GLY . . . . . . . . . . . . . . . -150.0 156.41 26.73 Favored Glycine 0 CA--C 1.523 0.539 0 N-CA-C 110.85 -0.9 . . . . 0.0 110.85 178.531 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' E' E ' 116' ' ' LYS . . . . . . . . . . . . . 55.6 tttt -132.68 140.31 48.08 Favored 'General case' 0 C--N 1.329 -0.309 0 O-C-N 122.646 -0.326 . . . . 0.0 110.16 179.245 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' E' E ' 117' ' ' PHE . . . . . . . . . . . . . 18.2 m-85 -139.63 113.82 8.95 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-O 120.887 0.375 . . . . 0.0 110.091 -176.194 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' E' E ' 118' ' ' GLU . . . . . . . . . . . . . 83.2 tt0 -53.3 -47.43 69.22 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.453 -0.339 . . . . 0.0 111.573 -175.84 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' E' E ' 119' ' ' ASN . . . . . . . . . . . . . 74.4 m-20 -95.15 31.12 1.98 Allowed 'General case' 0 C--N 1.332 -0.196 0 N-CA-C 112.265 0.468 . . . . 0.0 112.265 -174.45 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' E' E ' 120' ' ' LEU . . . . . . . . . . . . . 22.1 tp -55.85 122.95 12.66 Favored 'General case' 0 C--N 1.333 -0.136 0 CA-C-O 120.724 0.297 . . . . 0.0 110.52 177.146 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' E' E ' 121' ' ' ASN . . . . . . . . . . . . . 62.7 t30 -112.2 -44.08 3.46 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-N 116.362 -0.381 . . . . 0.0 110.718 -177.977 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' E' E ' 122' ' ' LYS . . . . . . . . . . . . . 98.0 mttt -143.45 144.76 32.15 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-O 120.96 0.409 . . . . 0.0 111.661 -177.476 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' E' E ' 123' ' ' VAL . . . . . . . . . . . . . 46.7 t -123.61 122.37 64.77 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.284 0 N-CA-C 109.136 -0.69 . . . . 0.0 109.136 173.826 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' E' E ' 124' ' ' LEU . . . . . 0.512 HD12 ' N ' ' E' ' 124' ' ' LEU . 5.6 mp -120.59 132.3 55.08 Favored 'General case' 0 C--N 1.331 -0.203 0 CA-C-N 116.483 -0.326 . . . . 0.0 110.389 -177.155 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' E' E ' 125' ' ' VAL . . . . . 0.647 HG11 HG21 ' E' ' 94' ' ' VAL . 35.1 m -135.56 138.74 47.7 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.314 0 CA-C-N 116.379 -0.373 . . . . 0.0 110.736 179.279 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' E' E ' 126' ' ' ARG . . . . . . . . . . . . . 32.8 ptt-85 -150.19 125.23 9.95 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 116.088 -0.506 . . . . 0.0 110.178 177.926 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' E' E ' 127' ' ' ASN . . . . . . . . . . . . . 85.5 m-20 55.07 -123.38 2.03 Favored 'General case' 0 CA--C 1.546 0.804 0 CA-C-O 118.529 -0.748 . . . . 0.0 110.209 -178.191 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' E' E ' 128' ' ' ASP . . . . . . . . . . . . . 23.3 p-10 -106.07 12.29 30.51 Favored 'General case' 0 CA--C 1.536 0.431 0 CA-C-N 120.235 1.379 . . . . 0.0 113.088 179.349 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' E' E ' 129' ' ' LEU . . . . . 0.442 HD23 ' N ' ' E' ' 130' ' ' VAL . 5.0 tt -106.14 132.63 51.98 Favored 'General case' 0 C--O 1.231 0.121 0 N-CA-C 109.653 -0.499 . . . . 0.0 109.653 179.079 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' E' E ' 130' ' ' VAL . . . . . 0.478 HG13 HG12 ' E' ' 125' ' ' VAL . 46.4 t -122.05 136.32 59.3 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.248 0 CA-C-O 120.894 0.378 . . . . 0.0 110.185 -177.926 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' E' E ' 131' ' ' VAL . . . . . 0.515 HG22 HD12 ' E' ' 140' ' ' LEU . 42.1 t -135.11 135.5 52.46 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.19 0 CA-C-O 121.128 0.49 . . . . 0.0 110.076 177.668 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' E' E ' 132' ' ' ILE . . . . . . . . . . . . . 74.7 mt -118.1 132.34 68.21 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.338 0 CA-C-N 115.746 -0.661 . . . . 0.0 109.532 -178.86 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' E' E ' 133' ' ' ILE . . . . . . . . . . . . . 37.5 mm -116.88 121.9 68.78 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.205 0 CA-C-O 120.78 0.324 . . . . 0.0 111.075 -174.694 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' E' E ' 134' ' ' ASP . . . . . . . . . . . . . 10.2 p-10 -135.23 149.84 49.96 Favored 'General case' 0 C--N 1.331 -0.221 0 CA-C-N 116.03 -0.532 . . . . 0.0 109.767 175.225 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' E' E ' 135' ' ' GLU . . . . . . . . . . . . . 85.1 tt0 -49.92 -26.67 4.36 Favored 'General case' 0 C--N 1.329 -0.318 0 N-CA-C 113.019 0.748 . . . . 0.0 113.019 -172.159 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' E' E ' 136' ' ' GLN . . . . . . . . . . . . . 99.7 mm-40 -85.55 -32.11 22.33 Favored 'General case' 0 C--O 1.235 0.299 0 N-CA-C 112.401 0.519 . . . . 0.0 112.401 -174.935 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' E' E ' 137' ' ' LYS . . . . . . . . . . . . . 55.7 pttt -168.54 174.07 7.04 Favored 'General case' 0 C--N 1.332 -0.186 0 CA-C-O 121.5 0.667 . . . . 0.0 112.257 -171.008 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' E' E ' 138' ' ' LEU . . . . . 0.438 ' C ' HD23 ' E' ' 138' ' ' LEU . 8.7 tt -121.88 130.1 53.09 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 115.032 -0.985 . . . . 0.0 110.264 179.8 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' E' E ' 139' ' ' THR . . . . . . . . . . . . . 38.0 m -108.3 130.27 55.19 Favored 'General case' 0 C--N 1.331 -0.23 0 CA-C-N 116.163 -0.471 . . . . 0.0 110.653 -179.546 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' E' E ' 140' ' ' LEU . . . . . 0.515 HD12 HG22 ' E' ' 131' ' ' VAL . 12.3 tp -116.34 121.8 43.02 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 115.724 -0.671 . . . . 0.0 109.332 -179.271 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' E' E ' 141' ' ' ILE . . . . . . . . . . . . . 18.9 mt -120.57 121.65 65.98 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.288 0 CA-C-O 120.976 0.417 . . . . 0.0 110.296 -175.152 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' E' E ' 142' ' ' ARG . . . . . . . . . . . . . 66.4 mtp180 -108.93 130.86 55.46 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 115.264 -0.88 . . . . 0.0 110.438 179.906 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' E' E ' 143' ' ' THR . . . . . . . . . . . . . 19.1 p . . . . . 0 C--O 1.221 -0.417 0 CA-C-O 117.988 -1.006 . . . . 0.0 110.492 178.782 . . . . . . . . 0 0 . 1 . 019 nuclear nobuild full ' F' F ' -3' ' ' GLU . . . . . . . . . . . . . 84.6 tt0 . . . . . 0 N--CA 1.49 1.56 0 N-CA-C 109.473 -0.566 . . . . 0.0 109.473 . . . . . . . . . 0 0 . 1 . 019 nuclear nobuild full ' F' F ' -2' ' ' GLY . . . . . . . . . . . . . . . -68.54 136.97 30.2 Favored Glycine 0 CA--C 1.524 0.627 0 N-CA-C 110.658 -0.977 . . . . 0.0 110.658 178.539 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' F' F ' -1' ' ' VAL . . . . . . . . . . . . . 43.3 t -95.65 133.83 35.3 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.297 0 N-CA-C 110.003 -0.369 . . . . 0.0 110.003 -179.58 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' F' F ' 0' ' ' ILE . . . . . . . . . . . . . 71.5 mt -109.84 123.57 65.84 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.266 0 CA-C-N 116.169 -0.469 . . . . 0.0 110.037 -179.093 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' F' F ' 1' ' ' MET . . . . . . . . . . . . . 16.0 ptm -89.34 132.78 34.78 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.098 -0.501 . . . . 0.0 110.594 -179.987 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' F' F ' 2' ' ' SER . . . . . . . . . . . . . 11.7 p -118.77 132.77 56.15 Favored 'General case' 0 C--N 1.332 -0.182 0 CA-C-O 121.006 0.431 . . . . 0.0 110.824 -179.335 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' F' F ' 3' ' ' GLU . . . . . . . . . . . . . 95.6 mt-10 -141.3 141.08 33.94 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 115.779 -0.646 . . . . 0.0 110.823 -179.284 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' F' F ' 4' ' ' LEU . . . . . . . . . . . . . 12.5 tp -129.38 131.05 46.74 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.235 -0.439 . . . . 0.0 110.267 177.115 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' F' F ' 5' ' ' LYS . . . . . . . . . . . . . 98.7 mttt -113.77 121.62 44.62 Favored 'General case' 0 C--O 1.234 0.247 0 CA-C-N 116.505 -0.316 . . . . 0.0 110.825 -179.708 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' F' F ' 6' ' ' LEU . . . . . 0.442 HD23 ' HA ' ' F' ' 50' ' ' VAL . 66.7 mt -114.05 145.08 42.08 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-N 115.478 -0.783 . . . . 0.0 110.007 179.372 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' F' F ' 7' ' ' LYS . . . . . . . . . . . . . 27.2 ttpp -126.72 141.22 39.7 Favored Pre-proline 0 CA--C 1.534 0.329 0 CA-C-O 119.059 -0.496 . . . . 0.0 109.804 176.134 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' F' F ' 8' ' ' PRO . . . . . . . . . . . . . 97.8 Cg_endo -92.07 137.2 1.76 Allowed 'Trans proline' 0 N--CA 1.49 1.295 0 C-N-CA 121.799 1.666 . . . . 0.0 111.897 178.801 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' F' F ' 9' ' ' LEU . . . . . . . . . . . . . 63.0 mt -75.64 -46.93 4.15 Favored Pre-proline 0 CA--C 1.535 0.384 0 CA-C-O 118.764 -0.636 . . . . 0.0 112.076 179.255 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' F' F ' 10' ' ' PRO . . . . . . . . . . . . . 71.1 Cg_endo -83.44 158.29 14.64 Favored 'Trans proline' 0 N--CA 1.497 1.691 0 C-N-CA 121.294 1.329 . . . . 0.0 112.179 175.583 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' F' F ' 11' ' ' LYS . . . . . . . . . . . . . 37.0 mmtm -79.19 105.33 10.44 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.396 -0.365 . . . . 0.0 110.167 176.044 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' F' F ' 12' ' ' VAL . . . . . . . . . . . . . 12.7 p -145.58 141.18 22.22 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.312 0 CA-C-O 120.833 0.349 . . . . 0.0 110.863 -179.602 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' F' F ' 13' ' ' GLU . . . . . . . . . . . . . 15.2 mm-40 -95.45 124.82 39.67 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.202 -0.454 . . . . 0.0 109.874 175.378 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' F' F ' 14' ' ' LEU . . . . . . . . . . . . . 44.6 mt -96.79 151.49 37.88 Favored Pre-proline 0 C--N 1.328 -0.332 0 CA-C-N 116.411 -0.359 . . . . 0.0 110.497 -177.131 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' F' F ' 15' ' ' PRO . . . . . . . . . . . . . 35.4 Cg_exo -59.3 158.49 26.37 Favored 'Trans proline' 0 N--CA 1.497 1.716 0 C-N-CA 121.27 1.313 . . . . 0.0 111.795 178.715 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' F' F ' 16' ' ' PRO . . . . . . . . . . . . . 37.1 Cg_exo -59.03 -37.75 91.42 Favored 'Trans proline' 0 N--CA 1.497 1.677 0 C-N-CA 121.472 1.448 . . . . 0.0 112.516 -179.485 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' F' F ' 17' ' ' ASP . . . . . . . . . . . . . 18.2 p-10 -89.04 14.02 11.63 Favored 'General case' 0 CA--C 1.536 0.406 0 N-CA-C 112.984 0.735 . . . . 0.0 112.984 -178.77 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' F' F ' 18' ' ' PHE . . . . . 0.502 ' CZ ' HD11 ' F' ' 22' ' ' ILE . 53.0 t80 -58.4 -45.25 88.74 Favored 'General case' 0 N--CA 1.457 -0.082 0 O-C-N 121.975 -0.453 . . . . 0.0 110.122 -177.487 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' F' F ' 19' ' ' VAL . . . . . 0.402 HG13 ' N ' ' F' ' 20' ' ' ASP . 14.6 p -55.15 -41.39 59.89 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.243 0 CA-C-N 116.512 -0.313 . . . . 0.0 111.066 -177.96 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' F' F ' 20' ' ' ASP . . . . . 0.402 ' N ' HG13 ' F' ' 19' ' ' VAL . 68.5 m-20 -60.5 -44.47 95.95 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-O 120.83 0.348 . . . . 0.0 110.852 -179.19 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' F' F ' 21' ' ' VAL . . . . . . . . . . . . . 50.4 t -64.07 -48.37 86.2 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.308 0 CA-C-N 116.43 -0.35 . . . . 0.0 110.568 -177.478 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' F' F ' 22' ' ' ILE . . . . . 0.72 HG22 HD12 ' F' ' 26' ' ' LEU . 49.0 mm -58.01 -43.55 85.21 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.288 0 C-N-CA 120.926 -0.309 . . . . 0.0 110.754 -178.885 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' F' F ' 23' ' ' ARG . . . . . . . . . . . . . 55.7 ttp180 -55.92 -47.56 77.29 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-O 120.654 0.264 . . . . 0.0 110.832 -179.98 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' F' F ' 24' ' ' ILE . . . . . . . . . . . . . 69.0 mt -60.49 -41.03 86.17 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.29 0 CA-C-N 116.578 -0.283 . . . . 0.0 111.643 -178.473 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' F' F ' 25' ' ' LYS . . . . . 0.621 ' HE3' HD13 ' F' ' 22' ' ' ILE . 14.9 ptpt -74.13 -35.14 64.08 Favored 'General case' 0 CA--C 1.534 0.327 0 N-CA-C 112.317 0.488 . . . . 0.0 112.317 -175.063 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' F' F ' 26' ' ' LEU . . . . . 0.72 HD12 HG22 ' F' ' 22' ' ' ILE . 22.7 mt -80.66 -38.89 28.27 Favored 'General case' 0 C--N 1.327 -0.378 0 N-CA-C 113.31 0.855 . . . . 0.0 113.31 -173.662 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' F' F ' 27' ' ' GLN . . . . . . . . . . . . . 10.0 pt20 -46.47 141.23 3.74 Favored 'General case' 0 N--CA 1.47 0.528 0 N-CA-C 112.784 0.661 . . . . 0.0 112.784 -174.411 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' F' F ' 28' ' ' GLY . . . . . . . . . . . . . . . 101.14 -25.92 26.52 Favored Glycine 0 CA--C 1.532 1.122 0 CA-C-N 115.464 -0.789 . . . . 0.0 112.262 -176.477 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' F' F ' 29' ' ' LYS . . . . . . . . . . . . . 55.5 mtpt -98.04 155.04 17.31 Favored 'General case' 0 C--N 1.332 -0.161 0 CA-C-N 117.483 0.642 . . . . 0.0 111.183 178.827 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' F' F ' 30' ' ' THR . . . . . . . . . . . . . 29.9 m -103.63 138.97 39.56 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 115.988 -0.551 . . . . 0.0 109.964 176.127 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' F' F ' 31' ' ' VAL . . . . . . . . . . . . . 35.0 m -129.46 156.25 41.78 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.235 0 CA-C-N 116.382 -0.372 . . . . 0.0 110.972 -178.26 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' F' F ' 32' ' ' ARG . . . . . . . . . . . . . 93.6 mtm-85 -133.31 148.41 51.9 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 115.731 -0.668 . . . . 0.0 110.248 177.439 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' F' F ' 33' ' ' THR . . . . . . . . . . . . . 19.0 m -53.03 140.03 26.35 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.411 -0.359 . . . . 0.0 111.372 -178.442 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' F' F ' 34' ' ' GLY . . . . . . . . . . . . . . . 100.33 -17.14 57.3 Favored Glycine 0 CA--C 1.532 1.144 0 CA-C-O 119.609 -0.55 . . . . 0.0 113.251 179.765 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' F' F ' 35' ' ' ASP . . . . . . . . . . . . . 73.3 m-20 -65.66 149.28 50.36 Favored 'General case' 0 N--CA 1.462 0.151 0 CA-C-N 118.04 0.92 . . . . 0.0 111.094 179.435 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' F' F ' 36' ' ' VAL . . . . . . . . . . . . . 45.6 t -124.83 131.31 72.8 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.174 0 CA-C-N 115.963 -0.562 . . . . 0.0 109.801 178.335 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' F' F ' 37' ' ' ILE . . . . . . . . . . . . . 65.1 mt -122.09 140.0 47.35 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.224 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.027 -178.678 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' F' F ' 38' ' ' GLY . . . . . . . . . . . . . . . -113.76 128.63 8.39 Favored Glycine 0 CA--C 1.524 0.639 0 N-CA-C 110.888 -0.885 . . . . 0.0 110.888 178.329 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' F' F ' 39' ' ' ILE . . . . . . . . . . . . . 71.8 mt -127.52 133.97 66.64 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.197 0 N-CA-C 110.093 -0.336 . . . . 0.0 110.093 179.439 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' F' F ' 40' ' ' SER . . . . . . . . . . . . . 20.4 t -92.35 124.26 36.28 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.376 -0.375 . . . . 0.0 111.298 178.381 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' F' F ' 41' ' ' ILE . . . . . . . . . . . . . 68.9 mt -134.35 121.9 38.46 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.236 0 N-CA-C 110.058 -0.349 . . . . 0.0 110.058 176.436 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' F' F ' 42' ' ' LEU . . . . . . . . . . . . . 45.0 mt 58.84 35.13 24.11 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.087 -0.506 . . . . 0.0 111.694 177.942 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' F' F ' 43' ' ' GLY . . . . . . . . . . . . . . . 74.35 13.13 81.78 Favored Glycine 0 CA--C 1.534 1.231 0 C-N-CA 121.135 -0.555 . . . . 0.0 113.371 176.964 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' F' F ' 44' ' ' LYS . . . . . . . . . . . . . 94.9 mttt -126.21 130.98 52.03 Favored 'General case' 0 C--N 1.332 -0.155 0 CA-C-N 117.847 0.824 . . . . 0.0 109.785 177.191 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' F' F ' 45' ' ' GLU . . . . . . . . . . . . . 83.9 tt0 -84.81 130.5 34.66 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-O 120.887 0.375 . . . . 0.0 111.39 -178.391 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' F' F ' 46' ' ' VAL . . . . . . . . . . . . . 9.8 p -117.96 128.26 75.09 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.236 0 N-CA-C 109.566 -0.531 . . . . 0.0 109.566 174.508 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' F' F ' 47' ' ' LYS . . . . . . . . . . . . . 92.3 mttt -98.13 124.29 42.61 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.157 -0.474 . . . . 0.0 110.693 177.846 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' F' F ' 48' ' ' PHE . . . . . . . . . . . . . 33.5 m-85 -108.43 131.79 54.43 Favored 'General case' 0 C--N 1.329 -0.32 0 N-CA-C 109.571 -0.529 . . . . 0.0 109.571 175.866 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' F' F ' 49' ' ' LYS . . . . . . . . . . . . . 46.6 tttm -108.58 134.2 51.67 Favored 'General case' 0 C--N 1.331 -0.227 0 CA-C-N 116.342 -0.39 . . . . 0.0 110.202 177.678 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' F' F ' 50' ' ' VAL . . . . . 0.442 ' HA ' HD23 ' F' ' 6' ' ' LEU . 45.0 t -78.74 105.68 8.38 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.342 0 N-CA-C 109.368 -0.604 . . . . 0.0 109.368 177.227 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' F' F ' 51' ' ' VAL . . . . . . . . . . . . . 47.8 t -69.68 -52.78 28.65 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.276 0 N-CA-C 109.534 -0.543 . . . . 0.0 109.534 -175.903 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' F' F ' 52' ' ' GLN . . . . . . . . . . . . . 87.8 mt-30 -153.54 151.12 29.42 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 115.889 -0.596 . . . . 0.0 111.544 -178.634 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' F' F ' 53' ' ' ALA . . . . . . . . . . . . . . . -128.82 134.17 48.25 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 115.021 -0.99 . . . . 0.0 109.493 175.089 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' F' F ' 54' ' ' TYR . . . . . . . . . . . . . 84.3 t80 -129.12 111.47 18.31 Favored Pre-proline 0 CA--C 1.535 0.401 0 CA-C-O 118.15 -0.929 . . . . 0.0 110.387 -179.862 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' F' F ' 55' ' ' PRO . . . . . . . . . . . . . 73.4 Cg_endo -77.07 169.18 75.01 Favored 'Cis proline' 0 N--CA 1.5 1.879 0 CA-C-N 121.94 1.729 . . . . 0.0 112.303 -5.952 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' F' F ' 56' ' ' SER . . . . . . . . . . . . . 13.7 m -116.76 128.16 26.21 Favored Pre-proline 0 CA--C 1.538 0.509 0 CA-C-O 118.366 -0.826 . . . . 0.0 109.274 174.686 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' F' F ' 57' ' ' PRO . . . . . . . . . . . . . 37.2 Cg_endo -66.68 165.44 64.93 Favored 'Cis proline' 0 N--CA 1.496 1.647 0 CA-C-N 122.023 1.758 . . . . 0.0 111.78 0.259 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' F' F ' 58' ' ' LEU . . . . . . . . . . . . . 26.6 tp -130.08 135.85 48.69 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.155 -0.475 . . . . 0.0 110.276 179.296 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' F' F ' 59' ' ' ARG . . . . . . . . . . . . . 58.2 ttt-85 -103.82 125.02 49.97 Favored 'General case' 0 C--N 1.327 -0.406 0 N-CA-C 109.278 -0.638 . . . . 0.0 109.278 175.39 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' F' F ' 60' ' ' VAL . . . . . . . . . . . . . 47.6 t -76.86 117.81 22.36 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.318 0 C-N-CA 120.756 -0.378 . . . . 0.0 110.362 -175.127 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' F' F ' 61' ' ' GLU . . . . . . . . . . . . . 95.6 mt-10 -130.95 166.44 20.95 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 115.728 -0.669 . . . . 0.0 109.661 177.917 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' F' F ' 62' ' ' ASP . . . . . . . . . . . . . 82.0 m-20 -53.97 -32.58 54.41 Favored 'General case' 0 C--N 1.329 -0.312 0 C-N-CA 121.012 -0.275 . . . . 0.0 111.688 179.651 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' F' F ' 63' ' ' ARG . . . . . . . . . . . . . 49.8 ptt85 -78.41 -1.0 31.38 Favored 'General case' 0 CA--C 1.537 0.46 0 N-CA-C 113.781 1.03 . . . . 0.0 113.781 -175.838 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' F' F ' 64' ' ' THR . . . . . . . . . . . . . 34.3 m -86.6 134.75 33.61 Favored 'General case' 0 C--O 1.232 0.161 0 CA-C-N 118.164 0.438 . . . . 0.0 110.808 -177.158 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' F' F ' 65' ' ' LYS . . . . . . . . . . . . . 90.9 mttt -90.01 128.11 36.2 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.01 -0.541 . . . . 0.0 110.211 178.208 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' F' F ' 66' ' ' ILE . . . . . . . . . . . . . 63.3 mt -114.04 130.93 67.38 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.252 0 N-CA-C 109.886 -0.412 . . . . 0.0 109.886 -179.682 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' F' F ' 67' ' ' THR . . . . . . . . . . . . . 30.5 m -125.5 143.57 50.94 Favored 'General case' 0 C--N 1.331 -0.227 0 CA-C-N 116.013 -0.54 . . . . 0.0 111.113 -177.977 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' F' F ' 68' ' ' LEU . . . . . . . . . . . . . 20.6 tp -101.48 123.87 46.22 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 115.687 -0.688 . . . . 0.0 110.118 177.431 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' F' F ' 69' ' ' VAL . . . . . . . . . . . . . 44.4 t -101.37 126.74 55.15 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.309 0 CA-C-N 116.281 -0.418 . . . . 0.0 110.034 -179.25 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' F' F ' 70' ' ' THR . . . . . . . . . . . . . 9.0 m -87.93 -39.1 15.03 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.132 -0.485 . . . . 0.0 111.035 -178.871 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' F' F ' 71' ' ' HIS . . . . . . . . . . . . . 98.3 m-70 -74.84 151.17 86.56 Favored Pre-proline 0 C--N 1.33 -0.257 0 CA-C-N 116.481 -0.327 . . . . 0.0 111.099 -176.503 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' F' F ' 72' ' ' PRO . . . . . . . . . . . . . 85.7 Cg_endo -91.81 -4.89 3.88 Favored 'Trans proline' 0 N--CA 1.493 1.462 0 C-N-CA 121.859 1.706 . . . . 0.0 113.866 178.394 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' F' F ' 73' ' ' VAL . . . . . . . . . . . . . 34.3 m -120.26 161.87 19.39 Favored 'Isoleucine or valine' 0 N--CA 1.462 0.164 0 CA-C-O 120.893 0.378 . . . . 0.0 111.002 -177.573 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' F' F ' 74' ' ' ASP . . . . . . . . . . . . . 33.0 t0 -100.79 124.08 45.92 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 115.842 -0.617 . . . . 0.0 110.233 -178.923 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' F' F ' 75' ' ' VAL . . . . . . . . . . . . . 42.5 t -118.1 123.17 71.25 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.24 0 CA-C-O 121.027 0.441 . . . . 0.0 110.594 -178.294 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' F' F ' 76' ' ' LEU . . . . . 0.516 HD12 ' N ' ' F' ' 76' ' ' LEU . 5.5 mp -121.94 147.89 45.47 Favored 'General case' 0 C--N 1.331 -0.217 0 CA-C-N 115.744 -0.662 . . . . 0.0 109.686 175.661 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' F' F ' 77' ' ' GLU . . . . . . . . . . . . . 96.4 mt-10 -137.63 132.17 32.61 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-O 121.005 0.431 . . . . 0.0 111.165 -178.712 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' F' F ' 78' ' ' ALA . . . . . . . . . . . . . . . -115.33 131.01 57.07 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 115.744 -0.662 . . . . 0.0 109.859 177.17 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' F' F ' 79' ' ' LYS . . . . . 0.623 ' O ' HD13 ' F' ' 80' ' ' ILE . 34.3 tptt -85.75 117.42 24.62 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-O 120.798 0.332 . . . . 0.0 110.955 -176.71 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' F' F ' 80' ' ' ILE . . . . . 0.623 HD13 ' O ' ' F' ' 79' ' ' LYS . 39.1 mm -139.23 107.46 3.26 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.272 0 N-CA-C 109.227 -0.657 . . . . 0.0 109.227 -179.314 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' F' F ' 81' ' ' LYS . . . . . . . . . . . . . 38.8 ttpt -89.08 121.47 31.45 Favored 'General case' 0 C--N 1.328 -0.334 0 C-N-CA 120.865 -0.334 . . . . 0.0 111.084 -177.207 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' F' F ' 82' ' ' GLY . . . . . . . . . . . . . . . 89.21 42.19 5.64 Favored Glycine 0 CA--C 1.525 0.698 0 C-N-CA 120.561 -0.828 . . . . 0.0 111.651 174.239 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' F' F ' 83' ' ' ILE . . . . . . . . . . . . . 73.9 mt -65.45 139.79 20.75 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.306 0 N-CA-C 109.623 -0.51 . . . . 0.0 109.623 176.997 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' F' F ' 84' ' ' LYS . . . . . . . . . . . . . 84.3 tttt -94.72 -53.27 3.93 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.028 -0.533 . . . . 0.0 110.49 -176.773 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' F' F ' 85' ' ' ASP . . . . . . . . . . . . . 9.3 t70 -154.12 153.1 31.25 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 115.787 -0.642 . . . . 0.0 110.313 -179.39 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' F' F ' 86' ' ' VAL . . . . . . . . . . . . . 44.4 t -130.79 131.12 64.66 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.247 0 CA-C-O 120.846 0.355 . . . . 0.0 110.616 -179.009 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' F' F ' 87' ' ' ILE . . . . . 0.497 HD12 ' N ' ' F' ' 87' ' ' ILE . 5.1 mp -123.13 126.57 73.76 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.249 0 CA-C-N 115.992 -0.549 . . . . 0.0 109.566 176.892 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' F' F ' 88' ' ' LEU . . . . . . . . . . . . . 53.7 mt -113.18 137.76 50.98 Favored 'General case' 0 C--N 1.331 -0.224 0 CA-C-O 121.12 0.486 . . . . 0.0 111.649 -175.963 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' F' F ' 89' ' ' ASP . . . . . . . . . . . . . 12.3 t0 -133.23 150.76 51.93 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 115.592 -0.731 . . . . 0.0 109.279 174.973 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' F' F ' 90' ' ' GLU . . . . . . . . . . . . . 82.9 tt0 -48.18 -38.01 17.15 Favored 'General case' 0 C--N 1.33 -0.258 0 N-CA-C 112.827 0.677 . . . . 0.0 112.827 -173.385 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' F' F ' 91' ' ' ASN . . . . . . . . . . . . . 26.5 m120 -128.44 32.93 4.77 Favored 'General case' 0 N--CA 1.466 0.361 0 N-CA-C 111.794 0.294 . . . . 0.0 111.794 -177.077 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' F' F ' 92' ' ' LEU . . . . . . . . . . . . . 19.3 tp -166.13 138.9 4.01 Favored 'General case' 0 C--N 1.33 -0.259 0 N-CA-C 110.2 -0.296 . . . . 0.0 110.2 -179.438 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' F' F ' 93' ' ' ILE . . . . . . . . . . . . . 71.0 mt -126.36 122.46 61.3 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.279 0 N-CA-C 109.666 -0.494 . . . . 0.0 109.666 178.368 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' F' F ' 94' ' ' VAL . . . . . 0.558 HG21 HG11 ' F' ' 125' ' ' VAL . 43.8 t -120.78 126.25 75.01 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.265 0 N-CA-C 109.887 -0.412 . . . . 0.0 109.887 179.995 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' F' F ' 95' ' ' VAL . . . . . . . . . . . . . 42.7 t -121.45 133.77 66.92 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.282 0 CA-C-N 115.939 -0.573 . . . . 0.0 109.665 179.849 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' F' F ' 96' ' ' ILE . . . . . . . . . . . . . 60.9 mt -115.5 126.66 73.12 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.323 0 N-CA-C 109.363 -0.606 . . . . 0.0 109.363 179.039 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' F' F ' 97' ' ' THR . . . . . . . . . . . . . 80.8 p -96.5 156.52 16.31 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-O 120.863 0.363 . . . . 0.0 110.765 -179.191 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' F' F ' 98' ' ' GLU . . . . . . . . . . . . . 40.8 tp10 -53.82 -25.54 19.97 Favored 'General case' 0 CA--C 1.533 0.317 0 N-CA-C 112.111 0.411 . . . . 0.0 112.111 -179.461 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' F' F ' 99' ' ' GLU . . . . . . . . . . . . . 18.1 tp10 -80.05 17.42 1.0 Allowed 'General case' 0 CA--C 1.538 0.503 0 N-CA-C 112.858 0.688 . . . . 0.0 112.858 -177.732 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' F' F ' 100' ' ' ASN . . . . . . . . . . . . . 3.6 m-20 63.1 35.59 12.83 Favored 'General case' 0 CA--C 1.531 0.233 0 CA-C-O 120.882 0.372 . . . . 0.0 111.435 176.39 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' F' F ' 101' ' ' GLU . . . . . . . . . . . . . 83.9 tt0 -113.19 142.06 46.23 Favored 'General case' 0 C--N 1.332 -0.173 0 N-CA-C 109.866 -0.42 . . . . 0.0 109.866 175.355 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' F' F ' 102' ' ' VAL . . . . . . . . . . . . . 45.8 t -115.01 126.17 72.53 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.266 0 N-CA-C 109.896 -0.409 . . . . 0.0 109.896 -178.537 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' F' F ' 103' ' ' LEU . . . . . . . . . . . . . 58.2 mt -116.1 133.85 55.57 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 115.685 -0.689 . . . . 0.0 109.796 177.798 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' F' F ' 104' ' ' ILE . . . . . . . . . . . . . 73.8 mt -121.53 119.41 58.87 Favored 'Isoleucine or valine' 0 C--O 1.233 0.23 0 N-CA-C 110.211 -0.292 . . . . 0.0 110.211 -178.939 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' F' F ' 105' ' ' PHE . . . . . . . . . . . . . 35.5 m-85 -121.79 168.2 12.11 Favored 'General case' 0 C--N 1.332 -0.153 0 O-C-N 124.222 0.951 . . . . 0.0 109.907 -179.968 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' F' F ' 106' ' ' ASN . . . . . . . . . . . . . 45.5 p-10 -102.56 -170.03 1.75 Allowed 'General case' 0 C--N 1.33 -0.273 0 N-CA-C 109.509 -0.552 . . . . 0.0 109.509 171.917 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' F' F ' 107' ' ' GLN . . . . . . . . . . . . . 57.1 tt0 -58.21 -26.1 62.4 Favored 'General case' 0 CA--C 1.534 0.337 0 N-CA-C 112.162 0.43 . . . . 0.0 112.162 179.024 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' F' F ' 108' ' ' ASN . . . . . . . . . . . . . 5.6 t-20 -91.16 13.29 17.43 Favored 'General case' 0 CA--C 1.536 0.426 0 N-CA-C 112.974 0.731 . . . . 0.0 112.974 -176.729 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' F' F ' 109' ' ' LEU . . . . . . . . . . . . . 67.7 mt 57.17 35.44 26.24 Favored 'General case' 0 CA--C 1.53 0.178 0 CA-C-O 120.714 0.292 . . . . 0.0 111.543 177.795 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' F' F ' 110' ' ' GLU . . . . . . . . . . . . . 70.8 mm-40 -102.75 149.27 24.63 Favored 'General case' 0 C--N 1.33 -0.282 0 N-CA-C 109.897 -0.409 . . . . 0.0 109.897 176.249 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' F' F ' 111' ' ' GLU . . . . . . . . . . . . . 98.6 mt-10 -81.47 121.97 26.94 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-O 120.997 0.427 . . . . 0.0 111.38 -176.644 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' F' F ' 112' ' ' LEU . . . . . . . . . . . . . 44.7 mt -105.52 -45.69 4.38 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 115.852 -0.613 . . . . 0.0 109.905 175.94 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' F' F ' 113' ' ' TYR . . . . . . . . . . . . . 61.5 t80 -141.92 140.86 32.91 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 115.976 -0.556 . . . . 0.0 110.761 179.928 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' F' F ' 114' ' ' ARG . . . . . . . . . . . . . 71.7 mtm180 -145.17 121.0 10.59 Favored 'General case' 0 C--N 1.331 -0.226 0 CA-C-N 116.358 -0.383 . . . . 0.0 110.557 177.65 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' F' F ' 115' ' ' GLY . . . . . . . . . . . . . . . -150.13 162.67 29.28 Favored Glycine 0 CA--C 1.525 0.677 0 N-CA-C 110.908 -0.877 . . . . 0.0 110.908 -179.603 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' F' F ' 116' ' ' LYS . . . . . . . . . . . . . 1.9 ttmp? -126.43 136.0 52.1 Favored 'General case' 0 C--N 1.33 -0.267 0 N-CA-C 109.933 -0.395 . . . . 0.0 109.933 176.47 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' F' F ' 117' ' ' PHE . . . . . . . . . . . . . 60.6 m-85 -128.91 115.13 17.38 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.237 -0.438 . . . . 0.0 110.264 -176.519 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' F' F ' 118' ' ' GLU . . . . . . . . . . . . . 84.5 tt0 -51.83 -49.16 63.38 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 116.431 -0.349 . . . . 0.0 111.742 -175.718 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' F' F ' 119' ' ' ASN . . . . . . . . . . . . . 5.2 m120 -98.8 31.08 3.06 Favored 'General case' 0 C--N 1.33 -0.249 0 N-CA-C 112.126 0.417 . . . . 0.0 112.126 -174.053 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' F' F ' 120' ' ' LEU . . . . . . . . . . . . . 19.1 tp -54.5 121.29 8.07 Favored 'General case' 0 N--CA 1.462 0.157 0 CA-C-O 120.671 0.272 . . . . 0.0 110.959 179.056 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' F' F ' 121' ' ' ASN . . . . . . . . . . . . . 6.6 t-20 -113.97 -44.08 3.19 Favored 'General case' 0 C--N 1.333 -0.113 0 CA-C-N 116.536 -0.302 . . . . 0.0 111.008 -177.352 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' F' F ' 122' ' ' LYS . . . . . . . . . . . . . 95.8 mttt -146.9 151.36 36.93 Favored 'General case' 0 C--N 1.331 -0.209 0 CA-C-O 121.064 0.459 . . . . 0.0 111.734 -178.416 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' F' F ' 123' ' ' VAL . . . . . . . . . . . . . 46.1 t -129.52 124.41 59.54 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.325 0 N-CA-C 109.181 -0.674 . . . . 0.0 109.181 173.058 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' F' F ' 124' ' ' LEU . . . . . 0.5 HD12 ' N ' ' F' ' 124' ' ' LEU . 6.1 mp -117.1 138.79 51.4 Favored 'General case' 0 C--N 1.331 -0.215 0 CA-C-O 120.818 0.342 . . . . 0.0 110.492 -176.699 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' F' F ' 125' ' ' VAL . . . . . 0.652 HG12 HG23 ' F' ' 130' ' ' VAL . 35.2 m -135.16 140.06 45.84 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.238 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.996 -179.514 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' F' F ' 126' ' ' ARG . . . . . . . . . . . . . 6.7 ptm85 -139.86 118.98 12.69 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 115.938 -0.574 . . . . 0.0 109.966 176.052 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' F' F ' 127' ' ' ASN . . . . . . . . . . . . . 29.9 m120 52.55 -107.65 0.35 Allowed 'General case' 0 CA--C 1.544 0.747 0 CA-C-O 118.968 -0.539 . . . . 0.0 111.053 -178.221 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' F' F ' 128' ' ' ASP . . . . . . . . . . . . . 9.5 p-10 -114.17 3.9 15.36 Favored 'General case' 0 N--CA 1.467 0.4 0 CA-C-N 119.746 1.157 . . . . 0.0 113.476 -178.378 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' F' F ' 129' ' ' LEU . . . . . . . . . . . . . 10.4 tp -105.04 141.81 35.94 Favored 'General case' 0 C--O 1.232 0.142 0 N-CA-C 109.619 -0.512 . . . . 0.0 109.619 179.413 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' F' F ' 130' ' ' VAL . . . . . 0.652 HG23 HG12 ' F' ' 125' ' ' VAL . 14.5 p -133.12 143.4 39.44 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.249 0 CA-C-O 121.312 0.577 . . . . 0.0 111.5 -175.538 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' F' F ' 131' ' ' VAL . . . . . . . . . . . . . 43.8 t -136.06 137.58 48.45 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.232 0 CA-C-N 115.591 -0.732 . . . . 0.0 109.949 177.882 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' F' F ' 132' ' ' ILE . . . . . . . . . . . . . 69.6 mt -114.21 134.08 58.23 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.257 0 CA-C-N 116.075 -0.511 . . . . 0.0 109.628 -179.215 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' F' F ' 133' ' ' ILE . . . . . . . . . . . . . 43.2 mm -117.92 119.53 61.79 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.238 0 CA-C-O 121.007 0.432 . . . . 0.0 110.819 -176.549 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' F' F ' 134' ' ' ASP . . . . . . . . . . . . . 7.3 p-10 -132.84 144.68 50.37 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 115.77 -0.65 . . . . 0.0 109.329 174.834 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' F' F ' 135' ' ' GLU . . . . . . . . . . . . . 85.5 tt0 -49.86 -25.04 2.8 Favored 'General case' 0 C--N 1.328 -0.332 0 N-CA-C 112.942 0.719 . . . . 0.0 112.942 -170.745 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' F' F ' 136' ' ' GLN . . . . . . . . . . . . . 97.4 mt-30 -94.09 -34.47 12.97 Favored 'General case' 0 C--N 1.331 -0.221 0 N-CA-C 112.112 0.412 . . . . 0.0 112.112 -176.953 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' F' F ' 137' ' ' LYS . . . . . . . . . . . . . 78.6 mttt -139.91 153.21 46.91 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-O 121.247 0.546 . . . . 0.0 111.702 -170.149 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' F' F ' 138' ' ' LEU . . . . . 0.441 HD23 ' C ' ' F' ' 138' ' ' LEU . 6.6 tt -117.56 123.07 45.35 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 115.53 -0.759 . . . . 0.0 108.973 170.94 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' F' F ' 139' ' ' THR . . . . . 0.442 HG23 ' HG2' ' A' ' 77' ' ' GLU . 31.3 m -114.55 128.58 56.4 Favored 'General case' 0 C--N 1.331 -0.218 0 CA-C-N 116.327 -0.397 . . . . 0.0 111.053 -175.537 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' F' F ' 140' ' ' LEU . . . . . 0.479 HD23 ' C ' ' F' ' 140' ' ' LEU . 7.3 tt -114.18 125.08 53.53 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 115.619 -0.719 . . . . 0.0 109.308 179.634 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' F' F ' 141' ' ' ILE . . . . . 0.49 ' HB ' HG13 ' F' ' 130' ' ' VAL . 19.0 mt -124.72 119.78 57.07 Favored 'Isoleucine or valine' 0 C--O 1.235 0.31 0 CA-C-O 121.005 0.431 . . . . 0.0 110.52 -175.301 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' F' F ' 142' ' ' ARG . . . . . . . . . . . . . 94.1 mtt180 -94.69 125.25 39.22 Favored 'General case' 0 C--N 1.332 -0.182 0 CA-C-N 115.249 -0.887 . . . . 0.0 109.387 174.527 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' F' F ' 143' ' ' THR . . . . . . . . . . . . . 45.1 p . . . . . 0 C--O 1.221 -0.437 0 CA-C-O 117.982 -1.009 . . . . 0.0 110.61 179.58 . . . . . . . . 0 0 . 1 . 020 nuclear nobuild full ' A' A ' -3' ' ' GLU . . . . . . . . . . . . . 46.3 tp10 . . . . . 0 N--CA 1.49 1.571 0 N-CA-C 109.356 -0.609 . . . . 0.0 109.356 . . . . . . . . . 0 0 . 1 . 020 nuclear nobuild full ' A' A ' -2' ' ' GLY . . . . . . . . . . . . . . . -64.82 149.95 51.49 Favored Glycine 0 CA--C 1.523 0.564 0 N-CA-C 110.83 -0.908 . . . . 0.0 110.83 179.7 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' -1' ' ' VAL . . . . . . . . . . . . . 43.9 t -95.78 133.98 34.92 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.298 0 N-CA-C 109.974 -0.38 . . . . 0.0 109.974 -179.605 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 0' ' ' ILE . . . . . . . . . . . . . 42.9 mm -108.17 128.27 63.75 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.325 0 CA-C-N 116.211 -0.449 . . . . 0.0 109.893 179.856 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 24.0 ptm -86.57 125.23 33.65 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-O 121.053 0.454 . . . . 0.0 110.722 -178.531 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 59.9 p -117.14 145.99 43.46 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 115.93 -0.577 . . . . 0.0 110.063 178.511 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 95.6 mt-10 -139.95 142.75 36.36 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-O 121.08 0.467 . . . . 0.0 111.385 -177.423 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 4' ' ' LEU . . . . . 0.423 HD21 HD23 ' A' ' 58' ' ' LEU . 39.0 mt -120.86 127.52 51.96 Favored 'General case' 0 C--N 1.331 -0.215 0 CA-C-N 115.603 -0.726 . . . . 0.0 110.043 174.978 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 5' ' ' LYS . . . . . . . . . . . . . 88.8 mttt -108.9 119.43 39.54 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-O 120.862 0.363 . . . . 0.0 110.498 176.364 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 45.6 mt -115.55 146.73 41.47 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 115.297 -0.865 . . . . 0.0 110.234 -179.199 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 75.4 tttt -135.91 136.25 22.93 Favored Pre-proline 0 CA--C 1.534 0.328 0 CA-C-O 118.981 -0.533 . . . . 0.0 110.247 176.125 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 8' ' ' PRO . . . . . . . . . . . . . 89.1 Cg_endo -90.81 141.86 3.17 Favored 'Trans proline' 0 N--CA 1.491 1.361 0 C-N-CA 121.553 1.502 . . . . 0.0 111.526 176.281 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 65.1 mt -73.4 -47.42 7.5 Favored Pre-proline 0 CA--C 1.533 0.313 0 CA-C-O 118.711 -0.661 . . . . 0.0 112.235 -178.266 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 83.2 Cg_endo -80.95 153.11 19.21 Favored 'Trans proline' 0 N--CA 1.495 1.608 0 C-N-CA 121.268 1.312 . . . . 0.0 111.767 175.558 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 24.7 ttpp -86.99 102.57 14.52 Favored 'General case' 0 C--N 1.329 -0.295 0 C-N-CA 120.772 -0.371 . . . . 0.0 110.174 178.588 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 11.8 p -141.33 144.05 26.86 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.291 0 CA-C-N 116.275 -0.42 . . . . 0.0 110.368 -179.412 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 95.3 mt-10 -84.5 129.84 34.81 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.062 178.635 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 14' ' ' LEU . . . . . . . . . . . . . 34.7 mt -98.66 148.54 34.69 Favored Pre-proline 0 CA--C 1.533 0.327 0 CA-C-O 119.229 -0.415 . . . . 0.0 110.629 -177.938 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 15' ' ' PRO . . . . . . . . . . . . . 24.5 Cg_exo -63.51 163.64 23.34 Favored 'Trans proline' 0 N--CA 1.498 1.758 0 C-N-CA 121.382 1.388 . . . . 0.0 111.978 175.992 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 16' ' ' PRO . . . . . . . . . . . . . 25.6 Cg_exo -61.29 -39.91 53.79 Favored 'Trans proline' 0 N--CA 1.496 1.651 0 C-N-CA 121.544 1.496 . . . . 0.0 112.836 -178.511 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 17' ' ' ASP . . . . . . . . . . . . . 7.9 p-10 -83.64 4.57 27.88 Favored 'General case' 0 CA--C 1.535 0.394 0 N-CA-C 113.344 0.868 . . . . 0.0 113.344 -176.973 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 18' ' ' PHE . . . . . . . . . . . . . 39.7 t80 -57.28 -46.66 82.89 Favored 'General case' 0 N--CA 1.457 -0.098 0 O-C-N 121.943 -0.473 . . . . 0.0 110.471 -176.494 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 19' ' ' VAL . . . . . . . . . . . . . 45.9 t -56.05 -47.15 80.71 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.362 0 CA-C-N 116.477 -0.328 . . . . 0.0 110.831 -176.527 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 49.3 m-20 -60.13 -41.09 91.95 Favored 'General case' 0 C--N 1.329 -0.302 0 C-N-CA 120.921 -0.312 . . . . 0.0 111.158 -176.954 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 56.1 t -64.74 -45.3 95.56 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.255 0 C-N-CA 120.746 -0.382 . . . . 0.0 110.504 -177.78 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 22' ' ' ILE . . . . . 0.583 HG22 HD12 ' A' ' 26' ' ' LEU . 51.2 mm -56.49 -45.05 81.89 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.235 0 C-N-CA 121.031 -0.268 . . . . 0.0 110.385 178.027 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 23' ' ' ARG . . . . . . . . . . . . . 45.3 ttp180 -53.99 -48.8 70.02 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-O 120.611 0.243 . . . . 0.0 111.375 -179.629 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 24' ' ' ILE . . . . . . . . . . . . . 70.7 mt -60.55 -43.26 94.09 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.349 0 CA-C-O 120.634 0.254 . . . . 0.0 111.025 -178.217 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 74.5 mttt -64.97 -36.48 84.52 Favored 'General case' 0 C--N 1.328 -0.367 0 N-CA-C 112.069 0.396 . . . . 0.0 112.069 -178.804 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 26' ' ' LEU . . . . . 0.583 HD12 HG22 ' A' ' 22' ' ' ILE . 42.6 mt -79.72 -44.19 21.23 Favored 'General case' 0 C--N 1.33 -0.269 0 N-CA-C 113.413 0.894 . . . . 0.0 113.413 -173.396 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 27' ' ' GLN . . . . . . . . . . . . . 11.3 pt20 -46.95 140.08 5.08 Favored 'General case' 0 N--CA 1.469 0.48 0 N-CA-C 112.833 0.679 . . . . 0.0 112.833 -173.619 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 97.55 -26.65 22.18 Favored Glycine 0 CA--C 1.534 1.24 0 CA-C-N 115.525 -0.761 . . . . 0.0 112.169 -176.062 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 65.5 mttm -97.58 155.17 17.09 Favored 'General case' 0 C--O 1.233 0.214 0 CA-C-N 117.108 0.454 . . . . 0.0 110.939 179.009 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 30' ' ' THR . . . . . . . . . . . . . 29.0 m -95.58 136.3 36.15 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.06 -0.518 . . . . 0.0 110.293 176.669 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 35.5 m -121.24 138.87 50.21 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.239 0 CA-C-N 116.352 -0.386 . . . . 0.0 110.612 -179.79 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 32' ' ' ARG . . . . . . . . . . . . . 48.0 tpt85 -134.08 139.11 45.75 Favored 'General case' 0 C--N 1.326 -0.428 0 CA-C-N 115.878 -0.601 . . . . 0.0 110.086 -178.822 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 33' ' ' THR . . . . . . . . . . . . . 19.7 m -51.67 140.58 18.42 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-O 120.922 0.391 . . . . 0.0 111.642 -175.475 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 99.13 -17.34 58.17 Favored Glycine 0 CA--C 1.533 1.181 0 CA-C-N 116.006 -0.543 . . . . 0.0 113.024 -179.372 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 82.0 m-20 -64.95 147.97 52.41 Favored 'General case' 0 C--O 1.231 0.096 0 CA-C-N 118.02 0.91 . . . . 0.0 111.088 179.079 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 46.0 t -120.39 128.18 75.97 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.166 0 CA-C-N 115.712 -0.676 . . . . 0.0 109.66 177.835 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 37' ' ' ILE . . . . . . . . . . . . . 66.9 mt -120.74 138.47 51.09 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.273 0 N-CA-C 109.782 -0.451 . . . . 0.0 109.782 -179.572 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . -114.29 128.68 8.33 Favored Glycine 0 CA--C 1.526 0.762 0 N-CA-C 110.935 -0.866 . . . . 0.0 110.935 179.53 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 39' ' ' ILE . . . . . . . . . . . . . 73.3 mt -126.62 127.01 69.83 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.246 0 N-CA-C 109.936 -0.394 . . . . 0.0 109.936 179.05 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 40' ' ' SER . . . . . . . . . . . . . 45.8 t -93.12 123.24 36.25 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.558 -0.292 . . . . 0.0 110.996 177.31 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 41' ' ' ILE . . . . . . . . . . . . . 73.0 mt -131.16 123.01 52.67 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.21 0 CA-C-O 120.92 0.391 . . . . 0.0 110.059 177.715 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 10.9 tp 56.35 36.8 28.1 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.072 -0.513 . . . . 0.0 111.339 178.847 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . 79.01 -10.08 35.39 Favored Glycine 0 CA--C 1.534 1.227 0 C-N-CA 121.21 -0.519 . . . . 0.0 113.641 175.963 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 44' ' ' LYS . . . . . . . . . . . . . 83.4 tttt -101.15 128.3 47.3 Favored 'General case' 0 C--N 1.334 -0.091 0 CA-C-N 117.968 0.884 . . . . 0.0 109.975 177.699 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 41.2 tp10 -84.94 130.63 34.61 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.373 -0.376 . . . . 0.0 110.921 -178.995 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 46' ' ' VAL . . . . . . . . . . . . . 7.4 p -121.82 132.07 71.69 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.199 0 N-CA-C 109.651 -0.5 . . . . 0.0 109.651 176.419 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 94.1 mttt -100.88 131.1 46.92 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.083 -0.508 . . . . 0.0 111.281 178.982 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 48' ' ' PHE . . . . . . . . . . . . . 92.1 m-85 -115.5 131.88 56.8 Favored 'General case' 0 C--N 1.33 -0.244 0 N-CA-C 109.759 -0.46 . . . . 0.0 109.759 175.598 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 54.4 tttm -108.32 139.32 43.19 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.693 -0.23 . . . . 0.0 110.425 178.022 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 50' ' ' VAL . . . . . . . . . . . . . 44.9 t -79.04 107.84 11.96 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.355 0 N-CA-C 109.262 -0.644 . . . . 0.0 109.262 175.909 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 51' ' ' VAL . . . . . . . . . . . . . 49.2 t -72.06 -48.62 48.82 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.324 0 CA-C-N 116.023 -0.535 . . . . 0.0 109.909 -174.324 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 52' ' ' GLN . . . . . . . . . . . . . 61.8 tt0 -162.95 144.45 9.95 Favored 'General case' 0 C--N 1.331 -0.238 0 C-N-CA 120.345 -0.542 . . . . 0.0 111.917 -178.52 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -121.66 132.61 54.75 Favored 'General case' 0 C--N 1.331 -0.196 0 CA-C-N 115.717 -0.674 . . . . 0.0 109.827 175.913 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 54' ' ' TYR . . . . . . . . . . . . . 22.5 t80 -129.16 110.94 18.2 Favored Pre-proline 0 CA--C 1.535 0.396 0 CA-C-O 118.101 -0.952 . . . . 0.0 110.656 177.787 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 55' ' ' PRO . . . . . . . . . . . . . 71.1 Cg_endo -75.94 170.04 72.86 Favored 'Cis proline' 0 N--CA 1.501 1.929 0 CA-C-N 121.898 1.714 . . . . 0.0 112.578 -7.908 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 56' ' ' SER . . . . . . . . . . . . . 66.3 m -118.36 132.53 23.75 Favored Pre-proline 0 CA--C 1.54 0.58 0 CA-C-O 118.439 -0.791 . . . . 0.0 110.079 178.257 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 57' ' ' PRO . . . . . . . . . . . . . 75.9 Cg_endo -79.22 149.73 84.03 Favored 'Cis proline' 0 N--CA 1.495 1.601 0 CA-C-N 121.932 1.726 . . . . 0.0 111.535 -4.922 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 58' ' ' LEU . . . . . 0.423 HD23 HD21 ' A' ' 4' ' ' LEU . 30.6 tp -108.84 140.89 41.66 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.303 -0.408 . . . . 0.0 110.929 -177.817 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 59' ' ' ARG . . . . . . . . . . . . . 78.2 ttt180 -94.06 119.02 32.34 Favored 'General case' 0 C--N 1.328 -0.331 0 N-CA-C 108.809 -0.812 . . . . 0.0 108.809 170.862 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 45.8 t -72.87 120.3 21.28 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.322 0 C-N-CA 120.55 -0.46 . . . . 0.0 110.667 -173.462 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 95.3 mt-10 -131.14 162.68 29.36 Favored 'General case' 0 C--N 1.331 -0.239 0 CA-C-N 115.63 -0.714 . . . . 0.0 109.78 176.945 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 62' ' ' ASP . . . . . . . . . . . . . 12.6 p-10 -54.28 -31.4 53.69 Favored 'General case' 0 C--N 1.329 -0.315 0 N-CA-C 112.185 0.439 . . . . 0.0 112.185 -177.693 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 63' ' ' ARG . . . . . . . . . . . . . 15.2 mmm180 -71.01 -21.81 62.24 Favored 'General case' 0 C--N 1.329 -0.285 0 N-CA-C 113.02 0.748 . . . . 0.0 113.02 -175.787 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 30.3 m -69.76 140.36 53.41 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-O 120.788 0.327 . . . . 0.0 110.997 -175.679 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 65' ' ' LYS . . . . . . . . . . . . . 12.1 mptt -88.91 134.7 33.87 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.154 -0.475 . . . . 0.0 109.836 179.731 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 66' ' ' ILE . . . . . . . . . . . . . 61.1 mt -117.91 131.81 69.57 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.302 0 CA-C-O 120.844 0.354 . . . . 0.0 110.321 -179.067 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 67' ' ' THR . . . . . . . . . . . . . 19.1 m -128.01 135.5 49.98 Favored 'General case' 0 C--N 1.331 -0.23 0 CA-C-N 116.112 -0.495 . . . . 0.0 110.507 178.517 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 68' ' ' LEU . . . . . 0.484 ' N ' HD12 ' A' ' 68' ' ' LEU . 8.5 mp -107.01 131.39 54.12 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 115.939 -0.573 . . . . 0.0 110.296 177.731 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 69' ' ' VAL . . . . . . . . . . . . . 44.7 t -97.82 116.54 40.66 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.32 0 CA-C-O 121.025 0.44 . . . . 0.0 109.91 178.591 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 70' ' ' THR . . . . . . . . . . . . . 2.8 m -145.06 -43.88 0.23 Allowed 'General case' 0 C--N 1.327 -0.389 0 CA-C-N 115.737 -0.665 . . . . 0.0 110.0 179.437 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 71' ' ' HIS . . . . . . . . . . . . . 96.1 m-70 -134.01 151.7 77.17 Favored Pre-proline 0 C--N 1.33 -0.274 0 CA-C-N 115.864 -0.607 . . . . 0.0 109.928 176.819 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 72' ' ' PRO . . . . . . . . . . . . . 61.0 Cg_endo -73.7 -12.19 24.31 Favored 'Trans proline' 0 N--CA 1.498 1.739 0 C-N-CA 121.346 1.364 . . . . 0.0 113.505 -179.583 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 73' ' ' VAL . . . . . . . . . . . . . 35.2 m -123.88 169.18 15.55 Favored 'Isoleucine or valine' 0 N--CA 1.461 0.108 0 CA-C-O 120.77 0.319 . . . . 0.0 110.395 -178.595 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 74' ' ' ASP . . . . . . . . . . . . . 36.1 t0 -92.86 121.43 34.22 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.228 -0.442 . . . . 0.0 109.998 -177.988 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 40.2 t -118.26 122.64 70.08 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.262 0 CA-C-O 120.922 0.392 . . . . 0.0 110.791 -176.745 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 76' ' ' LEU . . . . . . . . . . . . . 5.6 mp -122.54 146.43 47.42 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 115.869 -0.605 . . . . 0.0 109.832 175.572 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 77' ' ' GLU . . . . . . . . . . . . . 97.9 mt-10 -134.94 141.59 46.31 Favored 'General case' 0 C--N 1.331 -0.218 0 CA-C-O 121.04 0.448 . . . . 0.0 111.419 -179.241 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 78' ' ' ALA . . . . . . . . . . . . . . . -130.62 140.27 50.41 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-N 115.682 -0.69 . . . . 0.0 109.858 175.581 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 79' ' ' LYS . . . . . 0.589 ' O ' HD13 ' A' ' 80' ' ' ILE . 53.0 mttm -87.49 122.77 31.64 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-O 120.994 0.426 . . . . 0.0 111.239 -177.606 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 80' ' ' ILE . . . . . 0.589 HD13 ' O ' ' A' ' 79' ' ' LYS . 39.8 mm -139.2 109.26 4.16 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.298 0 N-CA-C 108.994 -0.743 . . . . 0.0 108.994 179.37 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 81' ' ' LYS . . . . . . . . . . . . . 78.2 tttt -97.8 123.37 41.73 Favored 'General case' 0 C--N 1.329 -0.3 0 C-N-CA 120.788 -0.365 . . . . 0.0 110.935 -176.949 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . 89.17 42.21 5.64 Favored Glycine 0 CA--C 1.526 0.741 0 C-N-CA 120.759 -0.734 . . . . 0.0 111.705 175.292 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 83' ' ' ILE . . . . . . . . . . . . . 71.1 mt -66.12 138.52 22.86 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.218 0 N-CA-C 109.736 -0.468 . . . . 0.0 109.736 177.178 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 84' ' ' LYS . . . . . . . . . . . . . 78.5 tttt -96.17 -52.9 3.83 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.031 -0.531 . . . . 0.0 110.405 -179.192 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 85' ' ' ASP . . . . . . . . . . . . . 7.1 t70 -154.19 153.7 32.23 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 115.906 -0.588 . . . . 0.0 110.567 -178.977 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 86' ' ' VAL . . . . . . . . . . . . . 42.6 t -131.77 131.32 62.13 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.242 0 CA-C-O 120.984 0.421 . . . . 0.0 110.468 -179.821 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 87' ' ' ILE . . . . . 0.498 HD12 ' N ' ' A' ' 87' ' ' ILE . 5.0 mp -119.06 127.91 75.82 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.224 0 N-CA-C 109.301 -0.629 . . . . 0.0 109.301 176.25 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 88' ' ' LEU . . . . . . . . . . . . . 84.8 mt -117.32 138.82 51.52 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-O 121.149 0.499 . . . . 0.0 111.857 -177.071 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 89' ' ' ASP . . . . . . . . . . . . . 13.7 t70 -134.13 157.75 45.4 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-N 115.375 -0.829 . . . . 0.0 109.19 175.014 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 74.0 tt0 -47.5 -38.13 13.28 Favored 'General case' 0 C--N 1.33 -0.244 0 N-CA-C 112.772 0.656 . . . . 0.0 112.772 -172.785 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 91' ' ' ASN . . . . . . . . . . . . . 13.5 p-10 -132.09 35.97 3.68 Favored 'General case' 0 C--N 1.331 -0.207 0 N-CA-C 111.866 0.321 . . . . 0.0 111.866 -176.604 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 92' ' ' LEU . . . . . . . . . . . . . 13.1 tp -163.73 141.72 7.49 Favored 'General case' 0 C--N 1.332 -0.168 0 C-N-CA 120.85 -0.34 . . . . 0.0 110.934 -179.051 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 93' ' ' ILE . . . . . . . . . . . . . 74.8 mt -126.59 120.83 57.19 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.245 0 N-CA-C 109.461 -0.57 . . . . 0.0 109.461 178.268 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 94' ' ' VAL . . . . . 0.48 HG21 HG11 ' A' ' 125' ' ' VAL . 43.7 t -120.96 127.17 75.91 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.271 0 N-CA-C 109.873 -0.418 . . . . 0.0 109.873 179.306 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 95' ' ' VAL . . . . . . . . . . . . . 44.4 t -123.42 134.79 65.29 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.283 0 CA-C-N 116.137 -0.483 . . . . 0.0 109.92 -178.908 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 96' ' ' ILE . . . . . . . . . . . . . 65.3 mt -116.51 128.69 73.79 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.294 0 N-CA-C 109.286 -0.635 . . . . 0.0 109.286 179.157 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 97' ' ' THR . . . . . . . . . . . . . 74.1 p -100.7 156.07 17.54 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-O 121.206 0.527 . . . . 0.0 111.177 -177.606 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 98' ' ' GLU . . . . . . . . . . . . . 79.8 tt0 -54.02 -26.26 25.47 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.166 -0.47 . . . . 0.0 112.129 -178.808 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 99' ' ' GLU . . . . . . . . . . . . . 95.4 mt-10 -81.83 16.62 1.76 Allowed 'General case' 0 CA--C 1.535 0.374 0 N-CA-C 113.232 0.826 . . . . 0.0 113.232 -175.814 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 100' ' ' ASN . . . . . . . . . . . . . 3.7 m-20 62.97 36.03 12.87 Favored 'General case' 0 N--CA 1.464 0.243 0 CA-C-O 120.906 0.384 . . . . 0.0 111.345 178.548 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 101' ' ' GLU . . . . . . . . . . . . . 84.2 tt0 -112.33 144.4 41.82 Favored 'General case' 0 C--N 1.332 -0.188 0 CA-C-N 116.126 -0.488 . . . . 0.0 109.858 173.549 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 102' ' ' VAL . . . . . . . . . . . . . 48.1 t -116.19 128.05 73.61 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.283 0 CA-C-N 116.325 -0.398 . . . . 0.0 110.128 -178.324 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 103' ' ' LEU . . . . . . . . . . . . . 21.3 mt -118.97 131.86 56.04 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 115.693 -0.685 . . . . 0.0 110.094 177.475 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 104' ' ' ILE . . . . . 0.494 ' CD1' HG11 ' A' ' 130' ' ' VAL . 70.1 mt -120.76 123.39 70.17 Favored 'Isoleucine or valine' 0 C--O 1.234 0.248 0 N-CA-C 110.398 -0.223 . . . . 0.0 110.398 -179.735 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 105' ' ' PHE . . . . . . . . . . . . . 66.5 m-85 -122.92 166.15 15.52 Favored 'General case' 0 C--O 1.232 0.162 0 O-C-N 123.915 0.759 . . . . 0.0 109.942 -179.486 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 106' ' ' ASN . . . . . . . . . . . . . 38.0 p-10 -103.71 -171.08 1.88 Allowed 'General case' 0 C--N 1.331 -0.235 0 N-CA-C 109.951 -0.389 . . . . 0.0 109.951 172.662 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 107' ' ' GLN . . . . . . . . . . . . . 62.0 tt0 -59.85 -24.83 64.54 Favored 'General case' 0 CA--C 1.533 0.324 0 N-CA-C 112.156 0.428 . . . . 0.0 112.156 177.199 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 108' ' ' ASN . . . . . . . . . . . . . 28.5 t30 -84.51 4.16 33.18 Favored 'General case' 0 CA--C 1.538 0.498 0 N-CA-C 113.16 0.8 . . . . 0.0 113.16 -178.022 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 109' ' ' LEU . . . . . . . . . . . . . 12.0 tp 60.88 37.68 18.28 Favored 'General case' 0 CA--C 1.531 0.232 0 CA-C-O 120.943 0.401 . . . . 0.0 111.209 179.669 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 110' ' ' GLU . . . . . . . . . . . . . 15.1 mm-40 -106.55 150.14 26.44 Favored 'General case' 0 C--N 1.329 -0.294 0 N-CA-C 109.958 -0.386 . . . . 0.0 109.958 176.598 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 111' ' ' GLU . . . . . . . . . . . . . 43.3 tp10 -80.16 121.91 26.16 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-O 120.889 0.376 . . . . 0.0 110.043 179.776 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 112' ' ' LEU . . . . . . . . . . . . . 14.8 mt -108.34 -45.62 3.87 Favored 'General case' 0 C--N 1.331 -0.201 0 CA-C-N 116.07 -0.514 . . . . 0.0 110.142 178.511 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 113' ' ' TYR . . . . . . . . . . . . . 64.0 t80 -137.29 139.36 40.87 Favored 'General case' 0 C--N 1.331 -0.211 0 CA-C-N 116.248 -0.433 . . . . 0.0 111.221 -179.805 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 114' ' ' ARG . . . . . . . . . . . . . 32.4 ttm180 -140.95 124.26 16.61 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 115.888 -0.596 . . . . 0.0 110.275 177.509 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 115' ' ' GLY . . . . . . . . . . . . . . . -149.98 158.39 27.64 Favored Glycine 0 CA--C 1.524 0.61 0 N-CA-C 110.938 -0.865 . . . . 0.0 110.938 178.967 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 116' ' ' LYS . . . . . . . . . . . . . 77.5 tttt -136.65 133.61 36.42 Favored 'General case' 0 C--N 1.329 -0.311 0 N-CA-C 110.097 -0.335 . . . . 0.0 110.097 178.636 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 117' ' ' PHE . . . . . . . . . . . . . 9.7 m-85 -138.08 118.98 14.23 Favored 'General case' 0 C--N 1.33 -0.25 0 C-N-CA 120.754 -0.379 . . . . 0.0 110.103 -174.208 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 118' ' ' GLU . . . . . . . . . . . . . 70.6 mm-40 -55.18 -43.65 74.53 Favored 'General case' 0 C--N 1.33 -0.279 0 C-N-CA 120.847 -0.341 . . . . 0.0 111.027 -177.935 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 119' ' ' ASN . . . . . . . . . . . . . 65.7 m-80 -93.71 28.41 2.36 Favored 'General case' 0 C--N 1.329 -0.288 0 N-CA-C 112.414 0.524 . . . . 0.0 112.414 -174.248 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 120' ' ' LEU . . . . . . . . . . . . . 19.2 tp -58.65 120.25 8.57 Favored 'General case' 0 C--N 1.333 -0.128 0 N-CA-C 110.028 -0.36 . . . . 0.0 110.028 177.263 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 121' ' ' ASN . . . . . . . . . . . . . 10.4 t-20 -112.46 -44.13 3.41 Favored 'General case' 0 C--O 1.232 0.148 0 CA-C-N 116.655 -0.248 . . . . 0.0 111.058 -176.274 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 122' ' ' LYS . . . . . . . . . . . . . 82.8 mttt -144.52 147.46 33.26 Favored 'General case' 0 C--N 1.332 -0.162 0 CA-C-O 121.177 0.513 . . . . 0.0 111.793 -177.928 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 123' ' ' VAL . . . . . . . . . . . . . 45.8 t -123.24 128.64 74.98 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.193 0 CA-C-N 115.759 -0.655 . . . . 0.0 109.459 175.139 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 124' ' ' LEU . . . . . . . . . . . . . 52.5 mt -123.6 141.09 52.35 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-O 120.798 0.332 . . . . 0.0 110.854 -177.063 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 125' ' ' VAL . . . . . 0.48 HG11 HG21 ' A' ' 94' ' ' VAL . 34.8 m -135.11 140.93 44.2 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.259 0 CA-C-N 116.287 -0.415 . . . . 0.0 110.992 179.446 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 126' ' ' ARG . . . . . . . . . . . . . 77.6 mtp85 -144.91 111.01 5.5 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 115.975 -0.557 . . . . 0.0 110.396 176.47 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 127' ' ' ASN . . . . . . . . . . . . . 55.8 t30 52.3 -108.54 0.4 Allowed 'General case' 0 CA--C 1.545 0.765 0 CA-C-O 118.83 -0.605 . . . . 0.0 111.344 179.691 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 128' ' ' ASP . . . . . . . . . . . . . 22.9 p-10 -108.09 5.8 26.34 Favored 'General case' 0 N--CA 1.468 0.464 0 CA-C-N 119.876 1.216 . . . . 0.0 113.485 -177.79 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 129' ' ' LEU . . . . . . . . . . . . . 12.1 tp -104.99 138.33 41.37 Favored 'General case' 0 C--N 1.332 -0.175 0 N-CA-C 109.883 -0.414 . . . . 0.0 109.883 178.692 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 130' ' ' VAL . . . . . 0.494 HG11 ' CD1' ' A' ' 104' ' ' ILE . 41.5 t -121.76 137.99 53.53 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.23 0 N-CA-C 110.081 -0.34 . . . . 0.0 110.081 -178.584 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 131' ' ' VAL . . . . . 0.5 HG22 HD12 ' A' ' 140' ' ' LEU . 40.0 t -134.71 136.23 52.58 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.248 0 CA-C-O 121.036 0.446 . . . . 0.0 110.45 -179.476 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 132' ' ' ILE . . . . . . . . . . . . . 75.0 mt -118.21 130.69 72.69 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.273 0 CA-C-N 115.738 -0.665 . . . . 0.0 109.49 179.436 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 133' ' ' ILE . . . . . . . . . . . . . 43.0 mm -117.75 123.33 71.55 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.261 0 CA-C-O 120.985 0.422 . . . . 0.0 111.063 -175.907 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 134' ' ' ASP . . . . . . . . . . . . . 7.7 p-10 -135.01 148.18 49.88 Favored 'General case' 0 C--N 1.331 -0.223 0 CA-C-N 115.849 -0.614 . . . . 0.0 109.517 173.92 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 135' ' ' GLU . . . . . . . . . . . . . 43.6 tp10 -49.89 -24.71 2.64 Favored 'General case' 0 C--N 1.326 -0.416 0 N-CA-C 112.797 0.665 . . . . 0.0 112.797 -172.01 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 136' ' ' GLN . . . . . . . . . . . . . 59.7 tp60 -101.11 -27.49 13.22 Favored 'General case' 0 CA--C 1.53 0.211 0 N-CA-C 112.668 0.618 . . . . 0.0 112.668 -174.863 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 137' ' ' LYS . . . . . . . . . . . . . 81.5 mttt -142.36 152.99 43.43 Favored 'General case' 0 C--N 1.332 -0.188 0 CA-C-O 121.17 0.51 . . . . 0.0 111.685 -171.661 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 138' ' ' LEU . . . . . . . . . . . . . 4.7 tt -120.22 122.27 40.56 Favored 'General case' 0 C--N 1.328 -0.346 0 N-CA-C 109.011 -0.737 . . . . 0.0 109.011 171.675 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 139' ' ' THR . . . . . . . . . . . . . 32.8 m -112.62 128.6 56.42 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 116.376 -0.374 . . . . 0.0 110.787 -176.835 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 140' ' ' LEU . . . . . 0.5 HD12 HG22 ' A' ' 131' ' ' VAL . 15.0 tp -115.85 121.63 42.96 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 115.522 -0.763 . . . . 0.0 109.264 -179.292 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 141' ' ' ILE . . . . . . . . . . . . . 19.3 mt -119.29 120.15 62.87 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.266 0 CA-C-O 120.888 0.375 . . . . 0.0 110.354 -174.613 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 142' ' ' ARG . . . . . . . . . . . . . 73.1 mtm180 -106.48 127.51 53.36 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-N 115.498 -0.774 . . . . 0.0 110.166 179.629 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 143' ' ' THR . . . . . . . . . . . . . 77.3 p . . . . . 0 C--O 1.221 -0.398 0 CA-C-O 117.922 -1.037 . . . . 0.0 110.577 -179.419 . . . . . . . . 0 0 . 1 . 020 nuclear nobuild full ' B' B ' -3' ' ' GLU . . . . . . . . . . . . . 70.5 mm-40 . . . . . 0 N--CA 1.49 1.541 0 N-CA-C 109.432 -0.581 . . . . 0.0 109.432 . . . . . . . . . 0 0 . 1 . 020 nuclear nobuild full ' B' B ' -2' ' ' GLY . . . . . . . . . . . . . . . -69.99 119.54 8.95 Favored Glycine 0 CA--C 1.524 0.656 0 N-CA-C 111.035 -0.826 . . . . 0.0 111.035 -179.67 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' B' B ' -1' ' ' VAL . . . . . . . . . . . . . 45.4 t -96.91 142.62 13.76 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.306 0 CA-C-O 120.87 0.367 . . . . 0.0 110.052 179.904 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' B' B ' 0' ' ' ILE . . . . . . . . . . . . . 70.9 mt -97.67 134.61 35.14 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.283 0 CA-C-N 116.084 -0.507 . . . . 0.0 109.929 -179.733 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' B' B ' 1' ' ' MET . . . . . . . . . . . . . 25.2 ptp -86.7 141.26 29.04 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.114 -0.494 . . . . 0.0 110.574 -179.928 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' B' B ' 2' ' ' SER . . . . . . . . . . . . . 36.4 p -107.88 157.74 17.93 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.687 -179.003 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' B' B ' 3' ' ' GLU . . . . . . . . . . . . . 95.2 mt-10 -140.52 145.96 37.52 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-O 121.026 0.441 . . . . 0.0 111.484 -177.106 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' B' B ' 4' ' ' LEU . . . . . . . . . . . . . 17.2 tp -125.47 131.03 52.93 Favored 'General case' 0 C--N 1.332 -0.191 0 CA-C-N 115.82 -0.627 . . . . 0.0 109.859 175.264 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' B' B ' 5' ' ' LYS . . . . . . . . . . . . . 98.6 mttt -108.55 120.86 43.67 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.42 -0.354 . . . . 0.0 110.837 -179.256 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' B' B ' 6' ' ' LEU . . . . . . . . . . . . . 55.2 mt -114.64 148.71 37.76 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 115.35 -0.841 . . . . 0.0 110.225 -179.728 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' B' B ' 7' ' ' LYS . . . . . . . . . . . . . 58.9 tttp -138.47 140.86 29.38 Favored Pre-proline 0 CA--C 1.535 0.379 0 CA-C-O 119.132 -0.461 . . . . 0.0 110.015 175.139 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' B' B ' 8' ' ' PRO . . . . . . . . . . . . . 90.1 Cg_endo -91.98 142.27 2.58 Favored 'Trans proline' 0 N--CA 1.489 1.247 0 C-N-CA 121.76 1.64 . . . . 0.0 111.922 178.229 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' B' B ' 9' ' ' LEU . . . . . . . . . . . . . 68.8 mt -74.22 -47.35 6.09 Favored Pre-proline 0 CA--C 1.533 0.316 0 CA-C-O 118.64 -0.695 . . . . 0.0 112.105 179.244 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' B' B ' 10' ' ' PRO . . . . . . . . . . . . . 84.0 Cg_endo -80.77 150.39 18.61 Favored 'Trans proline' 0 N--CA 1.495 1.6 0 C-N-CA 121.242 1.295 . . . . 0.0 111.816 175.49 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' B' B ' 11' ' ' LYS . . . . . . . . . . . . . 62.3 mtpt -86.67 97.46 10.58 Favored 'General case' 0 C--N 1.331 -0.229 0 CA-C-O 120.82 0.343 . . . . 0.0 110.362 178.74 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' B' B ' 12' ' ' VAL . . . . . . . . . . . . . 12.6 p -142.67 148.91 19.36 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.259 0 CA-C-N 116.102 -0.499 . . . . 0.0 110.568 -179.186 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' B' B ' 13' ' ' GLU . . . . . . . . . . . . . 82.3 tt0 -87.29 131.5 34.22 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 116.307 -0.406 . . . . 0.0 110.09 178.144 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' B' B ' 14' ' ' LEU . . . . . . . . . . . . . 28.0 mt -96.23 150.9 37.76 Favored Pre-proline 0 CA--C 1.532 0.263 0 CA-C-O 119.376 -0.345 . . . . 0.0 110.62 -178.225 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' B' B ' 15' ' ' PRO . . . . . . . . . . . . . 28.4 Cg_exo -60.75 159.43 28.71 Favored 'Trans proline' 0 N--CA 1.497 1.702 0 C-N-CA 121.307 1.338 . . . . 0.0 111.832 177.228 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' B' B ' 16' ' ' PRO . . . . . . . . . . . . . 38.5 Cg_exo -57.94 -45.0 35.2 Favored 'Trans proline' 0 N--CA 1.498 1.776 0 C-N-CA 121.452 1.435 . . . . 0.0 113.061 -176.73 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' B' B ' 17' ' ' ASP . . . . . . . . . . . . . 22.7 p-10 -87.64 12.47 12.54 Favored 'General case' 0 CA--C 1.536 0.413 0 N-CA-C 113.138 0.792 . . . . 0.0 113.138 -177.303 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' B' B ' 18' ' ' PHE . . . . . . . . . . . . . 48.2 t80 -58.26 -42.69 86.99 Favored 'General case' 0 N--CA 1.457 -0.092 0 O-C-N 122.054 -0.404 . . . . 0.0 110.178 -178.297 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' B' B ' 19' ' ' VAL . . . . . . . . . . . . . 46.3 t -56.94 -43.83 81.33 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 CA-C-N 116.308 -0.405 . . . . 0.0 110.533 -178.384 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' B' B ' 20' ' ' ASP . . . . . . . . . . . . . 36.8 m-20 -59.94 -41.95 92.94 Favored 'General case' 0 C--N 1.33 -0.276 0 C-N-CA 120.924 -0.31 . . . . 0.0 110.908 -177.964 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' B' B ' 21' ' ' VAL . . . . . . . . . . . . . 48.9 t -64.29 -46.65 92.63 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.27 0 C-N-CA 120.661 -0.416 . . . . 0.0 110.376 -177.78 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' B' B ' 22' ' ' ILE . . . . . 0.511 HG22 HD12 ' B' ' 26' ' ' LEU . 51.3 mm -56.32 -45.28 81.37 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.275 0 C-N-CA 120.955 -0.298 . . . . 0.0 110.577 179.036 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' B' B ' 23' ' ' ARG . . . . . . . . . . . . . 51.7 ttp180 -54.65 -48.58 72.14 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-O 120.584 0.23 . . . . 0.0 111.224 -178.472 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' B' B ' 24' ' ' ILE . . . . . . . . . . . . . 72.0 mt -59.96 -44.38 94.43 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.268 0 CA-C-N 116.599 -0.273 . . . . 0.0 111.293 -177.675 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' B' B ' 25' ' ' LYS . . . . . . . . . . . . . 35.9 mttm -63.99 -42.16 97.27 Favored 'General case' 0 C--N 1.33 -0.277 0 N-CA-C 112.341 0.496 . . . . 0.0 112.341 -178.82 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' B' B ' 26' ' ' LEU . . . . . 0.511 HD12 HG22 ' B' ' 22' ' ' ILE . 92.0 mt -78.42 -42.2 30.82 Favored 'General case' 0 C--N 1.328 -0.35 0 N-CA-C 113.162 0.801 . . . . 0.0 113.162 -170.911 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' B' B ' 27' ' ' GLN . . . . . . . . . . . . . 4.1 pt20 -47.51 140.93 5.45 Favored 'General case' 0 N--CA 1.468 0.459 0 N-CA-C 112.708 0.633 . . . . 0.0 112.708 -174.726 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' B' B ' 28' ' ' GLY . . . . . . . . . . . . . . . 100.7 -26.93 22.8 Favored Glycine 0 CA--C 1.533 1.168 0 CA-C-N 115.564 -0.744 . . . . 0.0 112.205 -177.521 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' B' B ' 29' ' ' LYS . . . . . . . . . . . . . 99.5 mttt -98.71 155.08 17.51 Favored 'General case' 0 C--N 1.332 -0.168 0 CA-C-N 117.379 0.59 . . . . 0.0 111.269 179.32 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' B' B ' 30' ' ' THR . . . . . . . . . . . . . 34.6 m -103.57 135.65 44.77 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 115.75 -0.659 . . . . 0.0 109.763 174.925 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' B' B ' 31' ' ' VAL . . . . . . . . . . . . . 35.4 m -130.86 161.21 41.25 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.245 0 CA-C-N 116.379 -0.373 . . . . 0.0 110.775 -178.805 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' B' B ' 32' ' ' ARG . . . . . . . . . . . . . 70.5 mtm180 -133.75 151.98 51.75 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 115.848 -0.615 . . . . 0.0 110.981 179.748 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' B' B ' 33' ' ' THR . . . . . . . . . . . . . 20.7 m -53.5 139.53 30.87 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.199 -0.455 . . . . 0.0 111.29 -178.758 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' B' B ' 34' ' ' GLY . . . . . . . . . . . . . . . 100.5 -17.01 57.34 Favored Glycine 0 CA--C 1.531 1.086 0 CA-C-O 119.584 -0.565 . . . . 0.0 113.224 178.9 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' B' B ' 35' ' ' ASP . . . . . . . . . . . . . 71.9 m-20 -64.78 148.29 51.5 Favored 'General case' 0 C--O 1.232 0.147 0 CA-C-N 118.183 0.992 . . . . 0.0 111.251 179.639 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' B' B ' 36' ' ' VAL . . . . . . . . . . . . . 46.3 t -117.92 128.41 75.05 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.22 0 CA-C-N 115.527 -0.76 . . . . 0.0 109.739 178.52 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' B' B ' 37' ' ' ILE . . . . . . . . . . . . . 69.8 mt -121.91 138.99 50.32 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.26 0 CA-C-N 116.259 -0.428 . . . . 0.0 109.977 -179.306 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' B' B ' 38' ' ' GLY . . . . . . . . . . . . . . . -114.22 128.97 8.48 Favored Glycine 0 CA--C 1.526 0.742 0 N-CA-C 111.176 -0.769 . . . . 0.0 111.176 -179.203 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' B' B ' 39' ' ' ILE . . . . . . . . . . . . . 75.6 mt -124.06 134.54 66.29 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.253 0 CA-C-O 120.765 0.317 . . . . 0.0 110.164 179.077 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' B' B ' 40' ' ' SER . . . . . . . . . . . . . 53.3 p -92.88 115.95 28.59 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 116.39 -0.368 . . . . 0.0 111.052 176.345 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' B' B ' 41' ' ' ILE . . . . . . . . . . . . . 44.7 mm -121.42 120.78 62.91 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.257 0 CA-C-O 120.775 0.321 . . . . 0.0 110.305 178.461 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' B' B ' 42' ' ' LEU . . . . . . . . . . . . . 62.6 mt 51.75 35.39 15.13 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-N 116.252 -0.431 . . . . 0.0 111.799 176.688 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' B' B ' 43' ' ' GLY . . . . . . . . . . . . . . . 73.88 31.79 59.7 Favored Glycine 0 CA--C 1.528 0.872 0 C-N-CA 121.073 -0.584 . . . . 0.0 112.141 177.706 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' B' B ' 44' ' ' LYS . . . . . . . . . . . . . 23.6 tptm -136.85 128.0 27.9 Favored 'General case' 0 C--N 1.329 -0.293 0 N-CA-C 109.397 -0.594 . . . . 0.0 109.397 177.736 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' B' B ' 45' ' ' GLU . . . . . . . . . . . . . 81.8 tt0 -82.73 117.42 22.64 Favored 'General case' 0 C--N 1.327 -0.373 0 C-N-CA 120.917 -0.313 . . . . 0.0 110.702 -178.356 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' B' B ' 46' ' ' VAL . . . . . . . . . . . . . 7.3 p -115.84 128.58 73.06 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.192 0 N-CA-C 109.412 -0.588 . . . . 0.0 109.412 176.284 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' B' B ' 47' ' ' LYS . . . . . . . . . . . . . 68.6 mttm -99.55 126.93 45.6 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 115.788 -0.642 . . . . 0.0 110.991 179.451 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' B' B ' 48' ' ' PHE . . . . . . . . . . . . . 91.1 m-85 -111.3 131.93 54.77 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-N 116.078 -0.51 . . . . 0.0 109.816 176.996 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' B' B ' 49' ' ' LYS . . . . . . . . . . . . . 83.5 tttt -106.56 134.97 48.88 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-N 116.365 -0.379 . . . . 0.0 110.269 178.6 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' B' B ' 50' ' ' VAL . . . . . . . . . . . . . 45.3 t -78.92 105.59 8.45 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.329 0 N-CA-C 108.993 -0.743 . . . . 0.0 108.993 175.328 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' B' B ' 51' ' ' VAL . . . . . . . . . . . . . 49.0 t -70.1 -53.42 23.58 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.387 0 N-CA-C 109.479 -0.563 . . . . 0.0 109.479 -174.208 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' B' B ' 52' ' ' GLN . . . . . . . . . . . . . 91.7 mt-30 -153.88 152.51 30.72 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 115.947 -0.57 . . . . 0.0 111.695 -177.617 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' B' B ' 53' ' ' ALA . . . . . . . . . . . . . . . -128.2 132.93 48.81 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 115.313 -0.858 . . . . 0.0 109.62 174.87 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' B' B ' 54' ' ' TYR . . . . . . . . . . . . . 58.2 t80 -129.05 107.61 18.01 Favored Pre-proline 0 CA--C 1.534 0.33 0 CA-C-O 118.219 -0.896 . . . . 0.0 110.354 179.767 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' B' B ' 55' ' ' PRO . . . . . . . . . . . . . 73.8 Cg_endo -77.22 169.75 73.32 Favored 'Cis proline' 0 N--CA 1.501 1.926 0 CA-C-N 121.839 1.692 . . . . 0.0 112.863 -4.419 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' B' B ' 56' ' ' SER . . . . . . . . . . . . . 50.6 m -117.59 132.0 23.81 Favored Pre-proline 0 CA--C 1.539 0.537 0 CA-C-O 118.352 -0.832 . . . . 0.0 109.548 174.361 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' B' B ' 57' ' ' PRO . . . . . . . . . . . . . 32.4 Cg_endo -65.21 164.99 57.4 Favored 'Cis proline' 0 N--CA 1.498 1.769 0 CA-C-N 122.027 1.76 . . . . 0.0 111.554 -2.615 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' B' B ' 58' ' ' LEU . . . . . . . . . . . . . 25.0 tp -129.4 137.51 50.96 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-O 120.997 0.427 . . . . 0.0 110.518 -178.284 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' B' B ' 59' ' ' ARG . . . . . . . . . . . . . 75.0 ttt180 -103.4 127.71 50.7 Favored 'General case' 0 C--N 1.326 -0.443 0 CA-C-N 115.731 -0.668 . . . . 0.0 109.225 175.169 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' B' B ' 60' ' ' VAL . . . . . . . . . . . . . 45.6 t -82.07 116.77 26.9 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.232 0 C-N-CA 120.553 -0.459 . . . . 0.0 110.39 -175.928 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' B' B ' 61' ' ' GLU . . . . . . . . . . . . . 70.6 mm-40 -131.14 162.14 30.57 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 115.905 -0.589 . . . . 0.0 109.877 176.618 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' B' B ' 62' ' ' ASP . . . . . . . . . . . . . 43.7 m-20 -53.15 -32.36 47.22 Favored 'General case' 0 C--N 1.328 -0.331 0 N-CA-C 111.807 0.299 . . . . 0.0 111.807 -179.694 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' B' B ' 63' ' ' ARG . . . . . . . . . . . . . 23.7 mmt180 -71.14 -21.94 62.13 Favored 'General case' 0 CA--C 1.532 0.282 0 N-CA-C 112.858 0.688 . . . . 0.0 112.858 -175.99 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' B' B ' 64' ' ' THR . . . . . . . . . . . . . 26.1 m -77.4 140.95 40.01 Favored 'General case' 0 C--N 1.331 -0.226 0 CA-C-O 121.0 0.429 . . . . 0.0 110.877 -175.315 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' B' B ' 65' ' ' LYS . . . . . . . . . . . . . 3.0 mptp? -89.75 134.67 34.05 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 115.976 -0.556 . . . . 0.0 110.233 179.753 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' B' B ' 66' ' ' ILE . . . . . . . . . . . . . 58.9 mt -114.28 129.0 71.04 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.229 0 N-CA-C 109.649 -0.5 . . . . 0.0 109.649 178.083 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' B' B ' 67' ' ' THR . . . . . . . . . . . . . 32.6 m -124.79 139.65 53.65 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-O 121.001 0.429 . . . . 0.0 111.014 -177.128 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' B' B ' 68' ' ' LEU . . . . . . . . . . . . . 6.8 mp -102.76 124.0 47.48 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 115.886 -0.597 . . . . 0.0 110.171 176.196 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' B' B ' 69' ' ' VAL . . . . . . . . . . . . . 44.3 t -101.54 112.54 34.92 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.284 0 CA-C-N 116.345 -0.389 . . . . 0.0 110.021 -179.855 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' B' B ' 70' ' ' THR . . . . . . . . . . . . . 41.3 p -150.02 165.05 33.89 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.142 -0.481 . . . . 0.0 110.678 179.696 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' B' B ' 71' ' ' HIS . . . . . . . . . . . . . 1.5 t60 -140.4 68.09 31.98 Favored Pre-proline 0 CA--C 1.536 0.417 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.326 178.653 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' B' B ' 72' ' ' PRO . . . . . . . . . . . . . 58.6 Cg_endo -90.67 160.08 4.25 Favored 'Trans proline' 0 N--CA 1.489 1.249 0 C-N-CA 121.959 1.772 . . . . 0.0 112.603 -178.467 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' B' B ' 73' ' ' VAL . . . . . . . . . . . . . 30.4 m -105.12 167.0 3.07 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.269 0 CA-C-N 116.016 -0.538 . . . . 0.0 110.06 178.023 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' B' B ' 74' ' ' ASP . . . . . . . . . . . . . 25.2 t0 -103.44 116.42 32.36 Favored 'General case' 0 C--N 1.33 -0.273 0 N-CA-C 109.819 -0.438 . . . . 0.0 109.819 -178.691 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' B' B ' 75' ' ' VAL . . . . . . . . . . . . . 41.7 t -111.34 122.23 65.39 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.243 0 CA-C-O 121.042 0.448 . . . . 0.0 110.355 -178.354 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' B' B ' 76' ' ' LEU . . . . . . . . . . . . . 35.8 mt -119.09 138.69 52.7 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 115.665 -0.698 . . . . 0.0 109.39 177.341 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' B' B ' 77' ' ' GLU . . . . . . . . . . . . . 46.3 mt-10 -134.32 136.37 43.43 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-O 121.14 0.495 . . . . 0.0 111.265 -176.914 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' B' B ' 78' ' ' ALA . . . . . . . . . . . . . . . -125.87 137.55 53.75 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 115.602 -0.726 . . . . 0.0 109.768 176.258 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' B' B ' 79' ' ' LYS . . . . . . . . . . . . . 93.5 mttt -81.73 119.1 23.43 Favored 'General case' 0 C--N 1.329 -0.311 0 C-N-CA 120.811 -0.356 . . . . 0.0 110.438 -179.16 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' B' B ' 80' ' ' ILE . . . . . . . . . . . . . 29.5 mm -134.65 118.46 26.04 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.292 0 CA-C-N 115.721 -0.672 . . . . 0.0 109.234 -176.652 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' B' B ' 81' ' ' LYS . . . . . . . . . . . . . 17.8 ttpt -108.67 123.92 49.73 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-O 120.818 0.342 . . . . 0.0 111.13 -177.073 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' B' B ' 82' ' ' GLY . . . . . . . . . . . . . . . 89.08 42.19 5.68 Favored Glycine 0 CA--C 1.526 0.779 0 C-N-CA 120.838 -0.696 . . . . 0.0 111.816 173.88 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' B' B ' 83' ' ' ILE . . . . . . . . . . . . . 69.9 mt -67.55 138.41 22.78 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.369 0 N-CA-C 109.883 -0.414 . . . . 0.0 109.883 177.969 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' B' B ' 84' ' ' LYS . . . . . . . . . . . . . 39.8 ttpt -100.39 -52.09 3.46 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-O 121.103 0.477 . . . . 0.0 110.046 179.643 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' B' B ' 85' ' ' ASP . . . . . . . . . . . . . 6.5 t70 -153.04 152.35 31.26 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 115.69 -0.687 . . . . 0.0 110.393 -179.955 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' B' B ' 86' ' ' VAL . . . . . . . . . . . . . 41.2 t -129.07 131.73 67.75 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.207 0 CA-C-O 120.871 0.367 . . . . 0.0 110.426 -179.61 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' B' B ' 87' ' ' ILE . . . . . . . . . . . . . 44.3 mm -119.28 126.37 75.28 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.238 0 N-CA-C 109.301 -0.629 . . . . 0.0 109.301 176.251 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' B' B ' 88' ' ' LEU . . . . . 0.434 HD13 HG21 ' A' ' 131' ' ' VAL . 81.3 mt -120.95 137.22 54.72 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-O 121.236 0.541 . . . . 0.0 111.706 -176.23 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' B' B ' 89' ' ' ASP . . . . . . . . . . . . . 5.2 t0 -133.09 154.83 50.2 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 115.452 -0.795 . . . . 0.0 109.054 174.823 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' B' B ' 90' ' ' GLU . . . . . . . . . . . . . 84.2 tt0 -48.84 -30.92 6.33 Favored 'General case' 0 C--N 1.33 -0.273 0 N-CA-C 112.804 0.668 . . . . 0.0 112.804 -172.891 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' B' B ' 91' ' ' ASN . . . . . . . . . . . . . 78.2 m-20 -131.54 28.78 4.6 Favored 'General case' 0 N--CA 1.466 0.343 0 N-CA-C 112.521 0.563 . . . . 0.0 112.521 -174.46 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' B' B ' 92' ' ' LEU . . . . . . . . . . . . . 16.9 tp -166.11 143.07 5.22 Favored 'General case' 0 C--N 1.331 -0.217 0 C-N-CA 120.765 -0.374 . . . . 0.0 110.923 179.794 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' B' B ' 93' ' ' ILE . . . . . . . . . . . . . 72.3 mt -125.13 123.83 66.17 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.242 0 N-CA-C 109.633 -0.506 . . . . 0.0 109.633 178.548 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' B' B ' 94' ' ' VAL . . . . . 0.591 HG21 HG11 ' B' ' 125' ' ' VAL . 44.1 t -125.41 127.54 71.92 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.238 0 CA-C-O 121.016 0.436 . . . . 0.0 109.996 178.126 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' B' B ' 95' ' ' VAL . . . . . . . . . . . . . 46.1 t -120.7 134.87 62.76 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.312 0 CA-C-N 115.944 -0.571 . . . . 0.0 109.765 179.872 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' B' B ' 96' ' ' ILE . . . . . . . . . . . . . 67.9 mt -115.46 128.46 72.67 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.273 0 N-CA-C 109.416 -0.587 . . . . 0.0 109.416 178.898 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' B' B ' 97' ' ' THR . . . . . . . . . . . . . 74.5 p -102.7 159.11 15.75 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-O 121.283 0.563 . . . . 0.0 111.308 -177.103 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' B' B ' 98' ' ' GLU . . . . . . . . . . . . . 45.0 mt-10 -53.95 -25.01 18.53 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.049 -0.523 . . . . 0.0 112.276 179.736 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' B' B ' 99' ' ' GLU . . . . . . . . . . . . . 33.7 tt0 -80.69 17.37 1.15 Allowed 'General case' 0 CA--C 1.538 0.494 0 N-CA-C 112.519 0.563 . . . . 0.0 112.519 -176.485 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' B' B ' 100' ' ' ASN . . . . . . . . . . . . . 2.4 m-20 60.72 37.97 18.61 Favored 'General case' 0 N--CA 1.463 0.181 0 O-C-N 121.801 -0.562 . . . . 0.0 110.883 179.392 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' B' B ' 101' ' ' GLU . . . . . . . . . . . . . 84.7 tt0 -116.19 144.13 44.59 Favored 'General case' 0 C--N 1.332 -0.169 0 CA-C-N 116.215 -0.448 . . . . 0.0 109.895 178.133 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' B' B ' 102' ' ' VAL . . . . . . . . . . . . . 44.8 t -116.51 127.07 74.22 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.234 0 CA-C-O 120.963 0.411 . . . . 0.0 109.907 -178.724 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' B' B ' 103' ' ' LEU . . . . . . . . . . . . . 51.1 mt -113.33 129.95 56.4 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 115.431 -0.804 . . . . 0.0 110.063 178.2 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' B' B ' 104' ' ' ILE . . . . . 0.41 HD12 ' HB3' ' B' ' 113' ' ' TYR . 67.7 mt -118.82 120.08 62.99 Favored 'Isoleucine or valine' 0 C--O 1.234 0.249 0 N-CA-C 110.213 -0.291 . . . . 0.0 110.213 -179.418 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' B' B ' 105' ' ' PHE . . . . . . . . . . . . . 38.6 m-85 -124.04 163.69 20.91 Favored 'General case' 0 C--N 1.332 -0.168 0 CA-C-N 115.537 -0.756 . . . . 0.0 109.55 178.404 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' B' B ' 106' ' ' ASN . . . . . . . . . . . . . 41.5 p-10 -95.92 -171.68 2.4 Favored 'General case' 0 C--N 1.33 -0.262 0 N-CA-C 109.955 -0.387 . . . . 0.0 109.955 173.949 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' B' B ' 107' ' ' GLN . . . . . . . . . . . . . 39.3 tt0 -59.86 -30.05 68.71 Favored 'General case' 0 C--N 1.328 -0.341 0 N-CA-C 111.806 0.299 . . . . 0.0 111.806 179.782 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' B' B ' 108' ' ' ASN . . . . . . . . . . . . . 3.7 t-20 -83.66 7.54 17.15 Favored 'General case' 0 CA--C 1.535 0.398 0 N-CA-C 113.275 0.843 . . . . 0.0 113.275 -177.366 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' B' B ' 109' ' ' LEU . . . . . . . . . . . . . 12.2 tp 63.01 39.88 9.75 Favored 'General case' 0 C--O 1.232 0.179 0 CA-C-O 121.116 0.484 . . . . 0.0 111.371 176.971 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' B' B ' 110' ' ' GLU . . . . . . . . . . . . . 95.9 mt-10 -108.88 163.44 13.28 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.28 -0.418 . . . . 0.0 110.381 177.064 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' B' B ' 111' ' ' GLU . . . . . . . . . . . . . 82.6 tt0 -84.65 123.63 30.57 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.193 -0.458 . . . . 0.0 111.037 -178.552 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' B' B ' 112' ' ' LEU . . . . . . . . . . . . . 22.7 mt -113.08 -46.02 3.13 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.094 -0.503 . . . . 0.0 110.257 174.374 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' B' B ' 113' ' ' TYR . . . . . 0.41 ' HB3' HD12 ' B' ' 104' ' ' ILE . 53.7 t80 -146.72 140.22 25.74 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.333 -0.394 . . . . 0.0 111.199 -179.998 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' B' B ' 114' ' ' ARG . . . . . . . . . . . . . 33.6 mtp180 -141.7 123.25 15.03 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.381 -0.372 . . . . 0.0 110.276 175.483 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' B' B ' 115' ' ' GLY . . . . . . . . . . . . . . . -150.08 161.08 28.79 Favored Glycine 0 CA--C 1.523 0.576 0 C-N-CA 120.7 -0.762 . . . . 0.0 111.364 179.922 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' B' B ' 116' ' ' LYS . . . . . . . . . . . . . 38.6 ttpt -126.9 138.08 53.25 Favored 'General case' 0 C--N 1.33 -0.25 0 N-CA-C 109.929 -0.397 . . . . 0.0 109.929 177.661 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' B' B ' 117' ' ' PHE . . . . . . . . . . . . . 35.7 m-85 -136.35 113.81 10.86 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-O 120.752 0.311 . . . . 0.0 110.347 -176.556 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' B' B ' 118' ' ' GLU . . . . . . . . . . . . . 44.2 mt-10 -54.83 -45.63 74.49 Favored 'General case' 0 C--N 1.329 -0.29 0 C-N-CA 120.942 -0.303 . . . . 0.0 111.27 -176.986 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' B' B ' 119' ' ' ASN . . . . . . . . . . . . . 34.7 m120 -93.78 28.78 2.25 Favored 'General case' 0 C--N 1.329 -0.287 0 O-C-N 123.554 0.534 . . . . 0.0 112.381 -173.688 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' B' B ' 120' ' ' LEU . . . . . . . . . . . . . 17.9 tp -57.37 119.9 7.26 Favored 'General case' 0 C--N 1.333 -0.141 0 C-N-CA 120.957 -0.297 . . . . 0.0 110.317 177.82 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' B' B ' 121' ' ' ASN . . . . . . . . . . . . . 45.8 t-20 -113.32 -44.06 3.28 Favored 'General case' 0 C--N 1.332 -0.19 0 CA-C-N 116.651 -0.25 . . . . 0.0 111.191 -177.164 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' B' B ' 122' ' ' LYS . . . . . . . . . . . . . 98.7 mttt -143.89 146.37 32.95 Favored 'General case' 0 C--N 1.332 -0.182 0 CA-C-O 121.087 0.47 . . . . 0.0 111.698 -178.351 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' B' B ' 123' ' ' VAL . . . . . . . . . . . . . 47.4 t -127.85 126.08 66.1 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.234 0 CA-C-N 115.756 -0.657 . . . . 0.0 109.375 175.075 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' B' B ' 124' ' ' LEU . . . . . . . . . . . . . 31.2 mt -125.6 134.7 51.83 Favored 'General case' 0 C--N 1.331 -0.212 0 CA-C-O 120.799 0.333 . . . . 0.0 110.675 -178.604 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' B' B ' 125' ' ' VAL . . . . . 0.721 HG12 HG23 ' B' ' 130' ' ' VAL . 35.1 m -132.15 144.22 37.74 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.244 0 CA-C-N 116.075 -0.511 . . . . 0.0 110.801 -179.213 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' B' B ' 126' ' ' ARG . . . . . 0.583 ' NH2' HD23 ' B' ' 129' ' ' LEU . 34.3 ptt-85 -152.51 120.49 6.18 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-O 121.328 0.585 . . . . 0.0 111.147 176.0 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' B' B ' 127' ' ' ASN . . . . . . . . . . . . . 82.3 m-20 52.82 -106.24 0.28 Allowed 'General case' 0 CA--C 1.542 0.637 0 CA-C-N 115.457 -0.792 . . . . 0.0 111.284 -179.439 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' B' B ' 128' ' ' ASP . . . . . . . . . . . . . 16.3 p-10 -114.1 0.87 14.42 Favored 'General case' 0 N--CA 1.468 0.445 0 CA-C-N 119.585 1.084 . . . . 0.0 113.372 -176.239 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' B' B ' 129' ' ' LEU . . . . . 0.583 HD23 ' NH2' ' B' ' 126' ' ' ARG . 18.0 tp -109.71 139.8 44.32 Favored 'General case' 0 C--N 1.332 -0.159 0 N-CA-C 109.699 -0.482 . . . . 0.0 109.699 -179.513 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' B' B ' 130' ' ' VAL . . . . . 0.721 HG23 HG12 ' B' ' 125' ' ' VAL . 13.2 p -134.39 143.1 38.94 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.2 0 CA-C-O 121.229 0.537 . . . . 0.0 110.9 -177.958 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' B' B ' 131' ' ' VAL . . . . . . . . . . . . . 42.9 t -135.97 139.79 45.27 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.246 0 CA-C-N 115.753 -0.658 . . . . 0.0 110.319 179.024 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' B' B ' 132' ' ' ILE . . . . . . . . . . . . . 72.9 mt -117.29 133.85 62.74 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.264 0 CA-C-N 115.599 -0.728 . . . . 0.0 109.481 179.7 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' B' B ' 133' ' ' ILE . . . . . . . . . . . . . 37.3 mm -115.47 124.21 71.74 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.224 0 CA-C-O 120.681 0.277 . . . . 0.0 110.965 -175.877 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' B' B ' 134' ' ' ASP . . . . . . . . . . . . . 9.6 p-10 -136.13 150.68 49.18 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-N 115.996 -0.547 . . . . 0.0 109.837 174.975 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' B' B ' 135' ' ' GLU . . . . . . . . . . . . . 46.7 tp10 -49.88 -28.95 7.26 Favored 'General case' 0 C--N 1.327 -0.393 0 N-CA-C 112.675 0.62 . . . . 0.0 112.675 -172.111 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' B' B ' 136' ' ' GLN . . . . . . . . . . . . . 58.7 tt0 -86.74 -31.55 20.89 Favored 'General case' 0 C--N 1.331 -0.233 0 N-CA-C 112.562 0.579 . . . . 0.0 112.562 -173.394 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' B' B ' 137' ' ' LYS . . . . . . . . . . . . . 56.9 pttt -166.09 174.66 9.12 Favored 'General case' 0 C--O 1.232 0.143 0 CA-C-O 121.545 0.688 . . . . 0.0 112.498 -172.649 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' B' B ' 138' ' ' LEU . . . . . 0.416 HD23 ' N ' ' B' ' 139' ' ' THR . 5.9 tt -120.54 129.84 53.98 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 114.932 -1.031 . . . . 0.0 109.811 179.048 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' B' B ' 139' ' ' THR . . . . . 0.416 ' N ' HD23 ' B' ' 138' ' ' LEU . 28.2 m -108.51 125.85 52.27 Favored 'General case' 0 C--N 1.331 -0.22 0 CA-C-N 116.272 -0.422 . . . . 0.0 110.357 179.446 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' B' B ' 140' ' ' LEU . . . . . 0.482 ' C ' HD23 ' B' ' 140' ' ' LEU . 8.0 tt -113.94 121.7 44.72 Favored 'General case' 0 C--N 1.329 -0.315 0 N-CA-C 109.156 -0.683 . . . . 0.0 109.156 -179.171 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' B' B ' 141' ' ' ILE . . . . . 0.421 ' HB ' HG13 ' B' ' 130' ' ' VAL . 19.0 mt -121.64 119.66 59.5 Favored 'Isoleucine or valine' 0 C--O 1.234 0.26 0 CA-C-O 120.949 0.404 . . . . 0.0 110.074 -176.193 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' B' B ' 142' ' ' ARG . . . . . . . . . . . . . 46.2 ttp180 -107.48 129.79 54.91 Favored 'General case' 0 C--N 1.332 -0.163 0 CA-C-N 115.198 -0.91 . . . . 0.0 110.772 -178.779 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' B' B ' 143' ' ' THR . . . . . . . . . . . . . 38.1 p . . . . . 0 C--O 1.22 -0.468 0 CA-C-O 118.044 -0.979 . . . . 0.0 110.516 178.969 . . . . . . . . 0 0 . 1 . 020 nuclear nobuild full ' C' C ' -3' ' ' GLU . . . . . . . . . . . . . 95.8 mt-10 . . . . . 0 N--CA 1.491 1.619 0 N-CA-C 109.292 -0.633 . . . . 0.0 109.292 . . . . . . . . . 0 0 . 1 . 020 nuclear nobuild full ' C' C ' -2' ' ' GLY . . . . . . . . . . . . . . . -74.2 144.6 33.54 Favored Glycine 0 CA--C 1.526 0.731 0 N-CA-C 111.005 -0.838 . . . . 0.0 111.005 -179.667 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' C' C ' -1' ' ' VAL . . . . . . . . . . . . . 45.4 t -96.2 131.28 43.38 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.282 0 N-CA-C 109.726 -0.472 . . . . 0.0 109.726 178.857 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' C' C ' 0' ' ' ILE . . . . . . . . . . . . . 44.0 mm -115.08 136.97 50.07 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.239 0 CA-C-N 116.323 -0.399 . . . . 0.0 110.365 -178.466 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' C' C ' 1' ' ' MET . . . . . . . . . . . . . 23.7 ptp -143.96 149.11 36.28 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 115.964 -0.562 . . . . 0.0 110.648 179.853 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' C' C ' 2' ' ' SER . . . . . . . . . . . . . 16.6 p -111.04 135.95 50.78 Favored 'General case' 0 C--N 1.332 -0.164 0 CA-C-O 121.014 0.435 . . . . 0.0 110.52 179.696 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' C' C ' 3' ' ' GLU . . . . . . . . . . . . . 95.5 mt-10 -141.48 141.29 33.65 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 115.978 -0.555 . . . . 0.0 111.089 -179.078 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' C' C ' 4' ' ' LEU . . . . . . . . . . . . . 15.3 tp -126.0 127.53 46.04 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 115.931 -0.577 . . . . 0.0 110.032 176.892 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' C' C ' 5' ' ' LYS . . . . . . . . . . . . . 86.8 mttt -106.5 120.57 42.26 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 116.438 -0.347 . . . . 0.0 110.776 178.162 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' C' C ' 6' ' ' LEU . . . . . 0.437 HD23 ' HA ' ' C' ' 50' ' ' VAL . 27.9 mt -115.05 148.82 38.4 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-N 115.295 -0.866 . . . . 0.0 110.381 179.772 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' C' C ' 7' ' ' LYS . . . . . . . . . . . . . 25.7 ttpp -134.62 133.18 21.13 Favored Pre-proline 0 CA--C 1.534 0.331 0 CA-C-O 118.791 -0.623 . . . . 0.0 110.04 176.875 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' C' C ' 8' ' ' PRO . . . . . . . . . . . . . 59.1 Cg_endo -89.7 135.81 2.53 Favored 'Trans proline' 0 N--CA 1.489 1.229 0 C-N-CA 121.69 1.593 . . . . 0.0 111.586 176.656 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' C' C ' 9' ' ' LEU . . . . . . . . . . . . . 34.2 mt -75.36 -47.47 4.33 Favored Pre-proline 0 CA--C 1.534 0.345 0 CA-C-O 118.581 -0.724 . . . . 0.0 112.085 -177.234 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' C' C ' 10' ' ' PRO . . . . . . . . . . . . . 71.8 Cg_endo -78.65 146.82 21.58 Favored 'Trans proline' 0 N--CA 1.495 1.609 0 C-N-CA 121.052 1.168 . . . . 0.0 111.684 175.143 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' C' C ' 11' ' ' LYS . . . . . . . . . . . . . 21.3 tptm -85.92 99.62 11.54 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-O 120.84 0.352 . . . . 0.0 110.349 -178.625 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' C' C ' 12' ' ' VAL . . . . . . . . . . . . . 12.6 p -143.65 150.12 17.5 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.264 0 CA-C-N 116.207 -0.451 . . . . 0.0 110.665 -179.172 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' C' C ' 13' ' ' GLU . . . . . . . . . . . . . 81.2 tt0 -84.55 127.67 34.18 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.281 -0.418 . . . . 0.0 110.13 178.582 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' C' C ' 14' ' ' LEU . . . . . . . . . . . . . 43.7 mt -96.63 150.03 36.51 Favored Pre-proline 0 CA--C 1.532 0.284 0 CA-C-O 119.368 -0.349 . . . . 0.0 110.627 -178.136 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' C' C ' 15' ' ' PRO . . . . . . . . . . . . . 28.0 Cg_exo -61.23 158.95 32.7 Favored 'Trans proline' 0 N--CA 1.497 1.701 0 C-N-CA 121.26 1.307 . . . . 0.0 111.97 177.754 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' C' C ' 16' ' ' PRO . . . . . . . . . . . . . 26.4 Cg_exo -60.79 -39.34 63.47 Favored 'Trans proline' 0 N--CA 1.496 1.671 0 C-N-CA 121.433 1.422 . . . . 0.0 112.732 -179.128 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' C' C ' 17' ' ' ASP . . . . . . . . . . . . . 19.3 p-10 -87.84 12.76 12.22 Favored 'General case' 0 CA--C 1.535 0.385 0 N-CA-C 113.171 0.804 . . . . 0.0 113.171 -177.006 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' C' C ' 18' ' ' PHE . . . . . . . . . . . . . 42.7 t80 -58.29 -45.39 88.05 Favored 'General case' 0 C--N 1.333 -0.117 0 O-C-N 122.135 -0.353 . . . . 0.0 110.089 -177.754 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' C' C ' 19' ' ' VAL . . . . . . . . . . . . . 47.8 t -55.87 -43.25 73.84 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.355 0 CA-C-N 116.523 -0.308 . . . . 0.0 110.779 -177.356 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' C' C ' 20' ' ' ASP . . . . . . . . . . . . . 7.5 t70 -60.09 -47.29 86.5 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-O 120.799 0.333 . . . . 0.0 111.009 -176.676 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' C' C ' 21' ' ' VAL . . . . . . . . . . . . . 46.4 t -64.4 -43.06 96.99 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.259 0 C-N-CA 120.663 -0.415 . . . . 0.0 110.408 -177.1 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' C' C ' 22' ' ' ILE . . . . . . . . . . . . . 43.9 mm -55.76 -48.31 78.2 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.346 0 N-CA-C 110.438 -0.208 . . . . 0.0 110.438 178.488 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' C' C ' 23' ' ' ARG . . . . . . . . . . . . . 53.8 ttp180 -54.97 -44.48 74.43 Favored 'General case' 0 C--N 1.332 -0.175 0 C-N-CA 120.911 -0.316 . . . . 0.0 111.221 -177.988 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' C' C ' 24' ' ' ILE . . . . . . . . . . . . . 75.0 mt -59.23 -46.9 91.89 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.253 0 CA-C-O 120.721 0.296 . . . . 0.0 110.938 -179.658 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' C' C ' 25' ' ' LYS . . . . . . . . . . . . . 44.2 mtmt -64.63 -38.62 91.63 Favored 'General case' 0 C--N 1.328 -0.331 0 N-CA-C 112.483 0.549 . . . . 0.0 112.483 -177.61 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' C' C ' 26' ' ' LEU . . . . . . . . . . . . . 81.1 mt -79.02 -44.74 21.62 Favored 'General case' 0 C--N 1.33 -0.259 0 N-CA-C 113.268 0.84 . . . . 0.0 113.268 -172.282 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' C' C ' 27' ' ' GLN . . . . . . . . . . . . . 11.6 pt20 -47.01 140.39 4.92 Favored 'General case' 0 N--CA 1.467 0.423 0 N-CA-C 112.812 0.671 . . . . 0.0 112.812 -173.548 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' C' C ' 28' ' ' GLY . . . . . . . . . . . . . . . 98.21 -27.09 20.91 Favored Glycine 0 CA--C 1.533 1.199 0 CA-C-N 115.513 -0.767 . . . . 0.0 112.103 -176.774 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' C' C ' 29' ' ' LYS . . . . . . . . . . . . . 29.2 mtpp -98.0 155.18 17.22 Favored 'General case' 0 C--O 1.232 0.154 0 CA-C-N 117.149 0.474 . . . . 0.0 111.072 179.246 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' C' C ' 30' ' ' THR . . . . . . . . . . . . . 28.7 m -100.37 139.59 35.82 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 115.991 -0.55 . . . . 0.0 110.361 177.307 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' C' C ' 31' ' ' VAL . . . . . . . . . . . . . 35.0 m -130.41 149.84 33.99 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.285 0 CA-C-N 116.319 -0.401 . . . . 0.0 110.759 -179.619 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' C' C ' 32' ' ' ARG . . . . . . . . . . . . . 72.2 mtp180 -132.68 154.09 50.48 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-O 121.198 0.523 . . . . 0.0 110.821 177.07 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' C' C ' 33' ' ' THR . . . . . 0.437 HG23 ' HA ' ' C' ' 52' ' ' GLN . 15.3 m -53.5 136.96 37.32 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-N 116.022 -0.536 . . . . 0.0 111.239 -179.026 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' C' C ' 34' ' ' GLY . . . . . . . . . . . . . . . 101.15 -16.99 56.63 Favored Glycine 0 CA--C 1.532 1.142 0 CA-C-O 119.641 -0.533 . . . . 0.0 113.346 178.24 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' C' C ' 35' ' ' ASP . . . . . . . . . . . . . 61.5 m-20 -64.53 149.61 48.35 Favored 'General case' 0 N--CA 1.461 0.116 0 CA-C-N 118.081 0.941 . . . . 0.0 111.1 179.599 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' C' C ' 36' ' ' VAL . . . . . . . . . . . . . 46.0 t -126.34 130.69 71.93 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.277 0 CA-C-N 115.82 -0.627 . . . . 0.0 109.812 178.682 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' C' C ' 37' ' ' ILE . . . . . . . . . . . . . 68.3 mt -122.2 139.39 49.3 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.259 0 CA-C-N 116.137 -0.483 . . . . 0.0 109.952 -179.458 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' C' C ' 38' ' ' GLY . . . . . . . . . . . . . . . -113.34 128.84 8.55 Favored Glycine 0 CA--C 1.527 0.782 0 N-CA-C 110.908 -0.877 . . . . 0.0 110.908 179.294 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' C' C ' 39' ' ' ILE . . . . . . . . . . . . . 72.7 mt -125.07 129.56 73.3 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.212 0 N-CA-C 109.828 -0.434 . . . . 0.0 109.828 179.091 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' C' C ' 40' ' ' SER . . . . . . . . . . . . . 85.7 p -92.97 121.13 33.99 Favored 'General case' 0 C--N 1.329 -0.294 0 C-N-CA 120.915 -0.314 . . . . 0.0 110.946 176.803 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' C' C ' 41' ' ' ILE . . . . . . . . . . . . . 74.5 mt -131.78 122.47 49.73 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.19 0 CA-C-O 120.756 0.312 . . . . 0.0 110.179 178.363 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' C' C ' 42' ' ' LEU . . . . . . . . . . . . . 82.2 mt 57.5 34.18 24.25 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.146 -0.479 . . . . 0.0 111.756 178.59 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' C' C ' 43' ' ' GLY . . . . . . . . . . . . . . . 80.39 -10.14 45.11 Favored Glycine 0 CA--C 1.534 1.264 0 C-N-CA 121.262 -0.494 . . . . 0.0 113.447 176.879 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' C' C ' 44' ' ' LYS . . . . . . . . . . . . . 96.6 mttt -99.19 129.16 45.41 Favored 'General case' 0 C--N 1.333 -0.127 0 CA-C-N 117.917 0.858 . . . . 0.0 110.052 177.327 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' C' C ' 45' ' ' GLU . . . . . . . . . . . . . 37.7 tp10 -85.18 126.92 34.04 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.414 -0.357 . . . . 0.0 110.481 179.321 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' C' C ' 46' ' ' VAL . . . . . . . . . . . . . 7.4 p -119.23 130.69 73.59 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.227 0 CA-C-O 121.203 0.525 . . . . 0.0 109.824 177.484 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' C' C ' 47' ' ' LYS . . . . . . . . . . . . . 44.6 mmtm -99.09 128.4 45.22 Favored 'General case' 0 C--N 1.331 -0.23 0 CA-C-N 115.719 -0.673 . . . . 0.0 111.281 177.746 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' C' C ' 48' ' ' PHE . . . . . . . . . . . . . 95.5 m-85 -112.3 131.8 55.31 Favored 'General case' 0 C--N 1.33 -0.251 0 N-CA-C 109.634 -0.506 . . . . 0.0 109.634 174.676 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' C' C ' 49' ' ' LYS . . . . . . . . . . . . . 79.7 tttt -107.94 137.53 45.77 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.417 -0.356 . . . . 0.0 110.222 179.103 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' C' C ' 50' ' ' VAL . . . . . 0.437 ' HA ' HD23 ' C' ' 6' ' ' LEU . 44.8 t -82.04 107.72 14.35 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.289 0 N-CA-C 109.389 -0.597 . . . . 0.0 109.389 177.065 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' C' C ' 51' ' ' VAL . . . . . . . . . . . . . 51.8 t -69.58 -47.45 71.51 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.335 0 CA-C-N 116.029 -0.532 . . . . 0.0 109.893 -174.335 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' C' C ' 52' ' ' GLN . . . . . 0.437 ' HA ' HG23 ' C' ' 33' ' ' THR . 61.3 tt0 -169.74 144.43 2.86 Favored 'General case' 0 C--N 1.331 -0.217 0 C-N-CA 120.288 -0.565 . . . . 0.0 111.648 -179.978 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' C' C ' 53' ' ' ALA . . . . . . . . . . . . . . . -114.51 134.85 54.71 Favored 'General case' 0 C--N 1.331 -0.227 0 CA-C-N 115.627 -0.715 . . . . 0.0 110.117 176.429 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' C' C ' 54' ' ' TYR . . . . . . . . . . . . . 51.0 t80 -128.99 112.08 18.55 Favored Pre-proline 0 CA--C 1.536 0.408 0 CA-C-O 118.189 -0.91 . . . . 0.0 110.453 178.809 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' C' C ' 55' ' ' PRO . . . . . . . . . . . . . 72.7 Cg_endo -77.15 169.36 74.43 Favored 'Cis proline' 0 N--CA 1.5 1.9 0 CA-C-N 122.053 1.769 . . . . 0.0 112.2 -6.336 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' C' C ' 56' ' ' SER . . . . . . . . . . . . . 14.7 m -117.23 135.87 23.25 Favored Pre-proline 0 CA--C 1.538 0.509 0 CA-C-O 118.591 -0.718 . . . . 0.0 109.605 175.272 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' C' C ' 57' ' ' PRO . . . . . . . . . . . . . 49.1 Cg_endo -70.17 146.76 83.92 Favored 'Cis proline' 0 N--CA 1.496 1.653 0 CA-C-N 121.724 1.651 . . . . 0.0 111.355 -3.484 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' C' C ' 58' ' ' LEU . . . . . . . . . . . . . 17.2 tp -107.81 135.87 48.49 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-O 120.847 0.356 . . . . 0.0 110.798 -177.329 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' C' C ' 59' ' ' ARG . . . . . . . . . . . . . 42.4 ttp180 -102.44 119.85 39.51 Favored 'General case' 0 C--N 1.328 -0.349 0 N-CA-C 108.971 -0.752 . . . . 0.0 108.971 174.418 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' C' C ' 60' ' ' VAL . . . . . . . . . . . . . 41.2 t -76.2 122.73 30.97 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.238 0 C-N-CA 120.661 -0.415 . . . . 0.0 110.674 -173.289 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' C' C ' 61' ' ' GLU . . . . . . . . . . . . . 88.3 mt-10 -131.09 163.13 28.32 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 115.938 -0.573 . . . . 0.0 109.749 175.962 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' C' C ' 62' ' ' ASP . . . . . . . . . . . . . 11.4 p-10 -53.87 -30.4 45.59 Favored 'General case' 0 C--N 1.328 -0.339 0 N-CA-C 111.85 0.315 . . . . 0.0 111.85 178.751 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' C' C ' 63' ' ' ARG . . . . . . . . . . . . . 77.8 mtp180 -71.58 -22.08 61.78 Favored 'General case' 0 CA--C 1.533 0.308 0 N-CA-C 112.952 0.723 . . . . 0.0 112.952 -175.958 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' C' C ' 64' ' ' THR . . . . . . . . . . . . . 31.0 m -71.46 141.79 50.22 Favored 'General case' 0 C--N 1.331 -0.213 0 CA-C-O 120.859 0.362 . . . . 0.0 111.381 -174.173 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' C' C ' 65' ' ' LYS . . . . . . . . . . . . . 2.4 mptp? -88.96 129.66 35.59 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 115.925 -0.579 . . . . 0.0 109.849 177.416 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' C' C ' 66' ' ' ILE . . . . . . . . . . . . . 66.8 mt -116.68 127.84 74.2 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.268 0 N-CA-C 109.913 -0.402 . . . . 0.0 109.913 179.615 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' C' C ' 67' ' ' THR . . . . . . . . . . . . . 32.2 m -127.89 143.69 51.1 Favored 'General case' 0 C--N 1.332 -0.164 0 CA-C-N 116.16 -0.473 . . . . 0.0 111.0 -177.25 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' C' C ' 68' ' ' LEU . . . . . . . . . . . . . 28.2 mt -104.44 134.52 47.5 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 115.877 -0.602 . . . . 0.0 110.404 177.435 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' C' C ' 69' ' ' VAL . . . . . . . . . . . . . 44.1 t -100.31 104.62 16.41 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 CA-C-N 116.275 -0.421 . . . . 0.0 110.075 179.432 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' C' C ' 70' ' ' THR . . . . . . . . . . . . . 8.9 t -149.99 159.0 44.73 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 115.985 -0.552 . . . . 0.0 110.235 178.495 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' C' C ' 71' ' ' HIS . . . . . . . . . . . . . 10.8 t60 -128.49 79.43 74.22 Favored Pre-proline 0 CA--C 1.534 0.365 0 CA-C-N 116.73 -0.214 . . . . 0.0 111.151 -177.713 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' C' C ' 72' ' ' PRO . . . . . . . . . . . . . 66.7 Cg_endo -93.91 159.2 2.24 Favored 'Trans proline' 0 C--N 1.314 -1.241 0 C-N-CA 122.09 1.86 . . . . 0.0 111.537 175.114 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' C' C ' 73' ' ' VAL . . . . . . . . . . . . . 31.5 m -104.76 148.17 9.7 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.231 0 CA-C-O 121.069 0.462 . . . . 0.0 110.741 178.671 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' C' C ' 74' ' ' ASP . . . . . . . . . . . . . 13.7 t0 -97.46 119.64 36.37 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 115.58 -0.736 . . . . 0.0 109.437 178.436 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' C' C ' 75' ' ' VAL . . . . . . . . . . . . . 43.0 t -109.75 122.52 64.49 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.221 0 CA-C-O 121.036 0.446 . . . . 0.0 110.402 -177.906 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' C' C ' 76' ' ' LEU . . . . . . . . . . . . . 28.7 mt -123.1 140.53 52.93 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 115.612 -0.722 . . . . 0.0 109.678 178.568 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' C' C ' 77' ' ' GLU . . . . . . . . . . . . . 97.2 mt-10 -132.83 135.67 45.78 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-O 121.082 0.468 . . . . 0.0 111.12 -179.267 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' C' C ' 78' ' ' ALA . . . . . . . . . . . . . . . -124.55 133.92 53.15 Favored 'General case' 0 C--O 1.233 0.221 0 CA-C-N 115.807 -0.633 . . . . 0.0 109.903 177.013 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' C' C ' 79' ' ' LYS . . . . . 0.683 ' O ' HD13 ' C' ' 80' ' ' ILE . 61.3 mtpt -79.15 118.31 20.98 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-O 120.874 0.369 . . . . 0.0 110.747 -178.068 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' C' C ' 80' ' ' ILE . . . . . 0.683 HD13 ' O ' ' C' ' 79' ' ' LYS . 34.7 mm -139.18 105.98 2.7 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.285 0 N-CA-C 108.886 -0.783 . . . . 0.0 108.886 -178.462 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' C' C ' 81' ' ' LYS . . . . . . . . . . . . . 23.2 tptm -98.99 126.52 44.71 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-O 120.849 0.357 . . . . 0.0 111.137 -175.715 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' C' C ' 82' ' ' GLY . . . . . . . . . . . . . . . 89.17 42.07 5.68 Favored Glycine 0 CA--C 1.526 0.758 0 C-N-CA 120.755 -0.736 . . . . 0.0 111.798 174.816 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' C' C ' 83' ' ' ILE . . . . . . . . . . . . . 72.5 mt -69.73 136.22 26.62 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.338 0 N-CA-C 109.648 -0.501 . . . . 0.0 109.648 177.182 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' C' C ' 84' ' ' LYS . . . . . . . . . . . . . 22.9 ttmt -94.7 -54.1 3.62 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-O 121.123 0.487 . . . . 0.0 110.121 -179.759 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' C' C ' 85' ' ' ASP . . . . . . . . . . . . . 7.6 t70 -152.31 148.09 27.11 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 115.604 -0.725 . . . . 0.0 110.352 -179.005 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' C' C ' 86' ' ' VAL . . . . . . . . . . . . . 45.3 t -126.9 129.32 71.34 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.275 0 CA-C-O 120.976 0.417 . . . . 0.0 110.225 179.999 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' C' C ' 87' ' ' ILE . . . . . 0.498 ' N ' HD12 ' C' ' 87' ' ' ILE . 5.1 mp -118.32 129.41 74.67 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.239 0 CA-C-N 115.898 -0.592 . . . . 0.0 109.524 177.403 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' C' C ' 88' ' ' LEU . . . . . . . . . . . . . 26.9 mt -111.14 140.15 45.92 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-O 120.96 0.409 . . . . 0.0 111.312 -177.277 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' C' C ' 89' ' ' ASP . . . . . . . . . . . . . 36.0 t0 -132.16 157.39 44.4 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 115.811 -0.631 . . . . 0.0 109.542 177.314 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' C' C ' 90' ' ' GLU . . . . . . . . . . . . . 40.5 mp0 -49.66 -34.09 17.45 Favored 'General case' 0 C--N 1.331 -0.222 0 N-CA-C 112.914 0.709 . . . . 0.0 112.914 -171.448 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' C' C ' 91' ' ' ASN . . . . . . . . . . . . . 26.2 m120 -130.23 16.22 5.58 Favored 'General case' 0 N--CA 1.469 0.492 0 N-CA-C 113.256 0.836 . . . . 0.0 113.256 -177.225 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' C' C ' 92' ' ' LEU . . . . . . . . . . . . . 28.9 mt -148.12 149.76 32.61 Favored 'General case' 0 C--N 1.332 -0.188 0 CA-C-O 120.798 0.332 . . . . 0.0 110.763 -175.568 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' C' C ' 93' ' ' ILE . . . . . . . . . . . . . 68.1 mt -126.01 118.25 51.18 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.292 0 N-CA-C 109.041 -0.725 . . . . 0.0 109.041 175.648 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' C' C ' 94' ' ' VAL . . . . . 0.542 HG21 HG11 ' C' ' 125' ' ' VAL . 44.5 t -117.61 125.54 74.15 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.255 0 CA-C-O 121.034 0.445 . . . . 0.0 109.956 -178.727 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' C' C ' 95' ' ' VAL . . . . . . . . . . . . . 42.3 t -120.1 134.64 62.93 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.307 0 CA-C-N 115.859 -0.61 . . . . 0.0 109.852 -178.94 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' C' C ' 96' ' ' ILE . . . . . . . . . . . . . 64.9 mt -114.17 126.03 71.59 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.279 0 N-CA-C 109.016 -0.735 . . . . 0.0 109.016 177.432 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' C' C ' 97' ' ' THR . . . . . . . . . . . . . 76.2 p -100.87 157.49 16.68 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-O 120.908 0.385 . . . . 0.0 111.093 -176.317 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' C' C ' 98' ' ' GLU . . . . . . . . . . . . . 13.0 pt-20 -53.96 -22.57 10.61 Favored 'General case' 0 CA--C 1.535 0.366 0 N-CA-C 112.279 0.474 . . . . 0.0 112.279 178.019 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' C' C ' 99' ' ' GLU . . . . . . . . . . . . . 95.3 mt-10 -78.18 12.51 1.83 Allowed 'General case' 0 CA--C 1.536 0.434 0 N-CA-C 113.022 0.749 . . . . 0.0 113.022 179.605 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' C' C ' 100' ' ' ASN . . . . . . . . . . . . . 2.1 m-20 61.87 38.07 14.86 Favored 'General case' 0 CA--C 1.53 0.207 0 CA-C-O 121.028 0.442 . . . . 0.0 110.923 179.48 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' C' C ' 101' ' ' GLU . . . . . . . . . . . . . 42.0 mt-10 -111.17 148.71 32.17 Favored 'General case' 0 CA--C 1.521 -0.17 0 CA-C-N 115.988 -0.551 . . . . 0.0 110.494 176.019 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' C' C ' 102' ' ' VAL . . . . . . . . . . . . . 46.6 t -114.85 120.9 65.76 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.293 0 CA-C-N 115.487 -0.779 . . . . 0.0 109.126 177.114 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' C' C ' 103' ' ' LEU . . . . . . . . . . . . . 22.1 mt -111.56 126.12 54.65 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 115.68 -0.691 . . . . 0.0 109.994 177.851 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' C' C ' 104' ' ' ILE . . . . . 0.543 HD12 ' HB3' ' C' ' 113' ' ' TYR . 68.4 mt -111.94 114.21 46.39 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.325 0 N-CA-C 109.58 -0.526 . . . . 0.0 109.58 179.318 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' C' C ' 105' ' ' PHE . . . . . . . . . . . . . 95.6 m-85 -117.23 163.12 16.78 Favored 'General case' 0 C--N 1.332 -0.169 0 O-C-N 124.056 0.847 . . . . 0.0 109.956 -179.796 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' C' C ' 106' ' ' ASN . . . . . . . . . . . . . 51.1 p-10 -104.05 -170.73 1.82 Allowed 'General case' 0 C--N 1.328 -0.362 0 N-CA-C 109.661 -0.496 . . . . 0.0 109.661 171.805 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' C' C ' 107' ' ' GLN . . . . . . . . . . . . . 45.4 tt0 -58.39 -28.9 65.6 Favored 'General case' 0 C--N 1.328 -0.35 0 N-CA-C 112.071 0.397 . . . . 0.0 112.071 178.513 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' C' C ' 108' ' ' ASN . . . . . . . . . . . . . 48.6 t30 -89.49 6.86 39.01 Favored 'General case' 0 CA--C 1.536 0.427 0 N-CA-C 113.202 0.815 . . . . 0.0 113.202 -175.857 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' C' C ' 109' ' ' LEU . . . . . . . . . . . . . 89.0 mt 59.09 31.94 21.74 Favored 'General case' 0 C--N 1.332 -0.157 0 N-CA-C 112.034 0.383 . . . . 0.0 112.034 175.968 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' C' C ' 110' ' ' GLU . . . . . . . . . . . . . 14.0 pt-20 -106.09 144.22 33.11 Favored 'General case' 0 C--N 1.332 -0.165 0 N-CA-C 109.616 -0.513 . . . . 0.0 109.616 173.867 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' C' C ' 111' ' ' GLU . . . . . . . . . . . . . 54.5 tt0 -66.79 121.95 16.59 Favored 'General case' 0 C--N 1.327 -0.412 0 CA-C-N 116.12 -0.491 . . . . 0.0 111.528 -172.281 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' C' C ' 112' ' ' LEU . . . . . . . . . . . . . 10.7 mt -101.41 -46.16 5.09 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.039 -0.528 . . . . 0.0 109.653 174.009 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' C' C ' 113' ' ' TYR . . . . . 0.543 ' HB3' HD12 ' C' ' 104' ' ' ILE . 64.0 t80 -148.48 140.55 23.98 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.059 -0.519 . . . . 0.0 111.133 178.023 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' C' C ' 114' ' ' ARG . . . . . . . . . . . . . 29.6 ttm180 -137.61 126.12 23.54 Favored 'General case' 0 C--N 1.329 -0.289 0 N-CA-C 109.819 -0.438 . . . . 0.0 109.819 175.803 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' C' C ' 115' ' ' GLY . . . . . . . . . . . . . . . -150.12 161.56 28.94 Favored Glycine 0 CA--C 1.522 0.505 0 N-CA-C 110.753 -0.939 . . . . 0.0 110.753 -179.089 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' C' C ' 116' ' ' LYS . . . . . . . . . . . . . 26.4 ttpp -127.84 134.35 49.42 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-O 120.755 0.312 . . . . 0.0 110.363 -179.614 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' C' C ' 117' ' ' PHE . . . . . . . . . . . . . 59.2 m-85 -134.37 113.91 12.39 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.249 -0.432 . . . . 0.0 109.982 -178.932 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' C' C ' 118' ' ' GLU . . . . . . . . . . . . . 44.4 mp0 -58.06 -39.47 78.56 Favored 'General case' 0 C--N 1.328 -0.332 0 C-N-CA 120.629 -0.429 . . . . 0.0 110.745 -175.649 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' C' C ' 119' ' ' ASN . . . . . . . . . . . . . 3.5 m120 -100.06 30.73 3.62 Favored 'General case' 0 C--N 1.329 -0.286 0 N-CA-C 112.169 0.433 . . . . 0.0 112.169 -175.341 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' C' C ' 120' ' ' LEU . . . . . . . . . . . . . 18.5 tp -58.85 119.85 7.94 Favored 'General case' 0 C--N 1.332 -0.157 0 N-CA-C 110.029 -0.36 . . . . 0.0 110.029 178.279 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' C' C ' 121' ' ' ASN . . . . . . . . . . . . . 87.0 m-20 -114.16 -44.16 3.16 Favored 'General case' 0 C--N 1.333 -0.137 0 CA-C-N 116.493 -0.322 . . . . 0.0 111.302 -178.272 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' C' C ' 122' ' ' LYS . . . . . . . . . . . . . 62.1 mtpt -143.51 151.27 40.07 Favored 'General case' 0 C--N 1.33 -0.239 0 CA-C-O 120.973 0.416 . . . . 0.0 111.532 -175.258 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' C' C ' 123' ' ' VAL . . . . . . . . . . . . . 43.6 t -135.2 135.16 52.55 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.245 0 CA-C-N 116.143 -0.48 . . . . 0.0 109.866 176.059 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' C' C ' 124' ' ' LEU . . . . . . . . . . . . . 55.8 mt -126.0 141.88 51.77 Favored 'General case' 0 C--N 1.331 -0.221 0 CA-C-O 120.897 0.38 . . . . 0.0 110.839 -177.962 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' C' C ' 125' ' ' VAL . . . . . 0.542 HG11 HG21 ' C' ' 94' ' ' VAL . 34.9 m -135.93 138.72 47.17 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.201 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.74 179.039 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' C' C ' 126' ' ' ARG . . . . . . . . . . . . . 46.6 ptt85 -152.53 131.08 12.23 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-O 120.849 0.357 . . . . 0.0 110.774 175.873 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' C' C ' 127' ' ' ASN . . . . . . . . . . . . . 89.7 m-20 50.71 -115.43 0.86 Allowed 'General case' 0 CA--C 1.546 0.797 0 CA-C-O 118.67 -0.681 . . . . 0.0 111.177 -179.77 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' C' C ' 128' ' ' ASP . . . . . . . . . . . . . 8.7 p-10 -114.11 16.06 18.19 Favored 'General case' 0 CA--C 1.536 0.433 0 CA-C-N 120.17 1.35 . . . . 0.0 112.848 -179.884 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' C' C ' 129' ' ' LEU . . . . . . . . . . . . . 5.7 tt -111.96 136.75 50.89 Favored 'General case' 0 C--O 1.234 0.252 0 N-CA-C 110.024 -0.361 . . . . 0.0 110.024 -179.617 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' C' C ' 130' ' ' VAL . . . . . . . . . . . . . 43.2 t -117.99 135.88 56.97 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.185 0 CA-C-N 116.39 -0.368 . . . . 0.0 110.109 -177.442 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' C' C ' 131' ' ' VAL . . . . . . . . . . . . . 43.4 t -133.79 133.78 56.51 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.214 0 CA-C-O 120.938 0.399 . . . . 0.0 110.289 178.513 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' C' C ' 132' ' ' ILE . . . . . . . . . . . . . 70.6 mt -119.82 133.31 66.99 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.233 0 N-CA-C 109.513 -0.551 . . . . 0.0 109.513 -179.567 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' C' C ' 133' ' ' ILE . . . . . . . . . . . . . 40.9 mm -117.77 120.78 65.7 Favored 'Isoleucine or valine' 0 C--O 1.234 0.266 0 CA-C-O 120.801 0.334 . . . . 0.0 111.102 -175.301 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' C' C ' 134' ' ' ASP . . . . . . . . . . . . . 6.9 p-10 -132.43 148.0 52.39 Favored 'General case' 0 C--N 1.33 -0.251 0 N-CA-C 109.708 -0.478 . . . . 0.0 109.708 176.322 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' C' C ' 135' ' ' GLU . . . . . . . . . . . . . 41.6 tp10 -49.98 -29.42 8.5 Favored 'General case' 0 C--N 1.327 -0.387 0 N-CA-C 112.648 0.61 . . . . 0.0 112.648 -173.667 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' C' C ' 136' ' ' GLN . . . . . . . . . . . . . 93.9 mt-30 -79.96 -33.32 39.63 Favored 'General case' 0 C--O 1.234 0.268 0 N-CA-C 112.321 0.489 . . . . 0.0 112.321 -175.302 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' C' C ' 137' ' ' LYS . . . . . . . . . . . . . 46.8 pttt -169.93 174.65 5.49 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-O 121.403 0.621 . . . . 0.0 112.31 -172.451 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' C' C ' 138' ' ' LEU . . . . . 0.411 HD23 ' N ' ' C' ' 139' ' ' THR . 5.2 tt -116.12 129.88 56.54 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 115.116 -0.947 . . . . 0.0 109.951 179.499 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' C' C ' 139' ' ' THR . . . . . 0.411 ' N ' HD23 ' C' ' 138' ' ' LEU . 27.0 m -108.39 126.61 53.07 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-N 116.318 -0.401 . . . . 0.0 110.366 179.855 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' C' C ' 140' ' ' LEU . . . . . . . . . . . . . 14.3 tp -114.44 121.37 43.33 Favored 'General case' 0 C--N 1.33 -0.273 0 N-CA-C 109.048 -0.723 . . . . 0.0 109.048 -179.463 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' C' C ' 141' ' ' ILE . . . . . . . . . . . . . 19.5 mt -119.91 115.6 47.91 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.279 0 CA-C-O 120.978 0.418 . . . . 0.0 109.906 -175.888 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' C' C ' 142' ' ' ARG . . . . . . . . . . . . . 84.2 mtm180 -105.29 132.04 51.99 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 115.243 -0.889 . . . . 0.0 110.841 -175.933 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' C' C ' 143' ' ' THR . . . . . . . . . . . . . 29.8 p . . . . . 0 C--O 1.221 -0.411 0 CA-C-O 118.188 -0.911 . . . . 0.0 110.844 179.495 . . . . . . . . 0 0 . 1 . 020 nuclear nobuild full ' D' D ' -3' ' ' GLU . . . . . . . . . . . . . 95.8 mt-10 . . . . . 0 N--CA 1.49 1.528 0 N-CA-C 109.369 -0.604 . . . . 0.0 109.369 . . . . . . . . . 0 0 . 1 . 020 nuclear nobuild full ' D' D ' -2' ' ' GLY . . . . . . . . . . . . . . . -77.63 115.81 4.35 Favored Glycine 0 CA--C 1.525 0.69 0 N-CA-C 111.161 -0.776 . . . . 0.0 111.161 -179.286 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' D' D ' -1' ' ' VAL . . . . . . . . . . . . . 43.2 t -141.57 138.22 32.22 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.328 0 N-CA-C 109.961 -0.385 . . . . 0.0 109.961 178.846 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' D' D ' 0' ' ' ILE . . . . . . . . . . . . . 73.5 mt -106.63 117.5 52.54 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.258 0 N-CA-C 109.761 -0.459 . . . . 0.0 109.761 179.192 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' D' D ' 1' ' ' MET . . . . . . . . . . . . . 25.6 ptm -85.17 144.68 28.03 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.583 -179.466 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' D' D ' 2' ' ' SER . . . . . . . . . . . . . 6.8 p -127.5 134.68 49.78 Favored 'General case' 0 C--N 1.333 -0.151 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.718 -179.248 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' D' D ' 3' ' ' GLU . . . . . . . . . . . . . 95.6 mt-10 -140.22 138.23 34.92 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.03 -0.532 . . . . 0.0 110.897 179.236 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' D' D ' 4' ' ' LEU . . . . . 0.414 HD21 HD21 ' D' ' 6' ' ' LEU . 17.2 tp -122.86 128.33 50.21 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 115.911 -0.586 . . . . 0.0 110.249 178.095 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' D' D ' 5' ' ' LYS . . . . . . . . . . . . . 67.6 mttm -105.54 121.4 43.88 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.382 -0.372 . . . . 0.0 110.468 178.219 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' D' D ' 6' ' ' LEU . . . . . 0.414 HD21 HD21 ' D' ' 4' ' ' LEU . 73.8 mt -117.65 149.46 40.68 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 115.622 -0.717 . . . . 0.0 110.778 -178.78 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' D' D ' 7' ' ' LYS . . . . . . . . . . . . . 35.5 ttpt -139.55 139.41 22.29 Favored Pre-proline 0 CA--C 1.535 0.376 0 CA-C-O 119.136 -0.459 . . . . 0.0 110.135 175.704 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' D' D ' 8' ' ' PRO . . . . . . . . . . . . . 94.0 Cg_endo -92.09 144.06 2.76 Favored 'Trans proline' 0 N--CA 1.49 1.267 0 C-N-CA 121.778 1.652 . . . . 0.0 111.659 177.053 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' D' D ' 9' ' ' LEU . . . . . . . . . . . . . 45.1 mt -80.25 -48.23 1.29 Allowed Pre-proline 0 CA--C 1.534 0.349 0 CA-C-O 118.665 -0.683 . . . . 0.0 112.445 -178.602 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' D' D ' 10' ' ' PRO . . . . . . . . . . . . . 86.1 Cg_endo -79.75 152.61 22.52 Favored 'Trans proline' 0 N--CA 1.496 1.632 0 C-N-CA 121.213 1.276 . . . . 0.0 112.055 177.318 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' D' D ' 11' ' ' LYS . . . . . . . . . . . . . 90.2 mttt -85.38 97.85 10.22 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.483 -0.326 . . . . 0.0 110.534 178.374 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' D' D ' 12' ' ' VAL . . . . . . . . . . . . . 12.1 p -144.32 143.12 23.57 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.288 0 CA-C-N 116.222 -0.445 . . . . 0.0 110.524 179.743 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' D' D ' 13' ' ' GLU . . . . . . . . . . . . . 45.8 mp0 -81.89 127.01 32.57 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.342 -0.39 . . . . 0.0 110.037 176.956 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' D' D ' 14' ' ' LEU . . . . . . . . . . . . . 22.5 mt -97.28 144.79 28.53 Favored Pre-proline 0 CA--C 1.533 0.311 0 CA-C-O 119.019 -0.515 . . . . 0.0 110.11 -179.688 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' D' D ' 15' ' ' PRO . . . . . . . . . . . . . 29.8 Cg_exo -59.95 160.32 22.38 Favored 'Trans proline' 0 N--CA 1.497 1.709 0 C-N-CA 121.241 1.294 . . . . 0.0 112.085 179.079 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' D' D ' 16' ' ' PRO . . . . . . . . . . . . . 31.6 Cg_exo -59.3 -37.83 88.56 Favored 'Trans proline' 0 N--CA 1.497 1.691 0 C-N-CA 121.452 1.434 . . . . 0.0 112.905 -177.424 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' D' D ' 17' ' ' ASP . . . . . . . . . . . . . 13.7 p-10 -85.33 4.17 36.34 Favored 'General case' 0 CA--C 1.537 0.46 0 N-CA-C 113.301 0.852 . . . . 0.0 113.301 -177.204 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' D' D ' 18' ' ' PHE . . . . . . . . . . . . . 48.2 t80 -58.29 -47.17 84.52 Favored 'General case' 0 C--N 1.334 -0.102 0 O-C-N 122.03 -0.419 . . . . 0.0 110.151 -177.275 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' D' D ' 19' ' ' VAL . . . . . . . . . . . . . 47.5 t -56.72 -42.94 78.26 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.356 0 CA-C-N 116.335 -0.393 . . . . 0.0 110.504 -177.789 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' D' D ' 20' ' ' ASP . . . . . . . . . . . . . 53.4 m-20 -59.82 -41.79 92.07 Favored 'General case' 0 C--N 1.328 -0.333 0 C-N-CA 120.913 -0.315 . . . . 0.0 110.896 -177.851 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' D' D ' 21' ' ' VAL . . . . . . . . . . . . . 47.7 t -64.63 -46.26 92.97 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.275 0 C-N-CA 120.811 -0.356 . . . . 0.0 110.491 -178.06 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' D' D ' 22' ' ' ILE . . . . . 0.45 HG22 HD12 ' D' ' 26' ' ' LEU . 46.8 mm -57.75 -40.44 75.69 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.317 0 C-N-CA 120.745 -0.382 . . . . 0.0 110.615 179.726 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' D' D ' 23' ' ' ARG . . . . . . . . . . . . . 59.1 ttp180 -55.69 -49.97 71.55 Favored 'General case' 0 C--N 1.331 -0.219 0 CA-C-O 120.969 0.414 . . . . 0.0 110.843 178.11 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' D' D ' 24' ' ' ILE . . . . . . . . . . . . . 74.1 mt -61.36 -40.26 85.57 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.324 0 CA-C-N 115.918 -0.583 . . . . 0.0 111.925 -176.666 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' D' D ' 25' ' ' LYS . . . . . . . . . . . . . 7.7 ptmm? -72.19 -36.46 69.23 Favored 'General case' 0 CA--C 1.531 0.239 0 C-N-CA 120.534 -0.466 . . . . 0.0 111.882 -176.145 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' D' D ' 26' ' ' LEU . . . . . 0.45 HD12 HG22 ' D' ' 22' ' ' ILE . 77.0 mt -77.7 -40.25 41.96 Favored 'General case' 0 C--N 1.33 -0.243 0 N-CA-C 113.194 0.813 . . . . 0.0 113.194 -173.23 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' D' D ' 27' ' ' GLN . . . . . . . . . . . . . 10.5 pt20 -47.53 137.12 9.26 Favored 'General case' 0 N--CA 1.471 0.58 0 N-CA-C 112.661 0.615 . . . . 0.0 112.661 -175.901 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' D' D ' 28' ' ' GLY . . . . . . . . . . . . . . . 99.63 -24.84 30.58 Favored Glycine 0 CA--C 1.533 1.21 0 CA-C-N 115.545 -0.752 . . . . 0.0 112.304 -176.345 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' D' D ' 29' ' ' LYS . . . . . . . . . . . . . 72.9 mmtt -98.11 155.18 17.26 Favored 'General case' 0 C--N 1.331 -0.218 0 CA-C-N 117.318 0.559 . . . . 0.0 111.232 179.352 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' D' D ' 30' ' ' THR . . . . . . . . . . . . . 24.4 m -105.79 135.85 46.47 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 115.784 -0.643 . . . . 0.0 109.859 175.342 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' D' D ' 31' ' ' VAL . . . . . . . . . . . . . 34.8 m -130.83 155.52 41.96 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.276 0 CA-C-O 120.994 0.426 . . . . 0.0 110.926 -178.225 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' D' D ' 32' ' ' ARG . . . . . . . . . . . . . 84.8 mtm180 -131.65 150.78 52.03 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.012 -0.54 . . . . 0.0 110.863 179.143 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' D' D ' 33' ' ' THR . . . . . . . . . . . . . 20.8 m -53.5 140.37 28.36 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.111 -0.495 . . . . 0.0 111.293 -179.09 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' D' D ' 34' ' ' GLY . . . . . . . . . . . . . . . 98.99 -17.17 58.55 Favored Glycine 0 CA--C 1.533 1.189 0 C-N-CA 121.103 -0.57 . . . . 0.0 113.207 179.699 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' D' D ' 35' ' ' ASP . . . . . . . . . . . . . 69.1 m-20 -65.47 148.87 50.99 Favored 'General case' 0 C--O 1.232 0.138 0 CA-C-N 118.013 0.907 . . . . 0.0 111.122 178.99 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' D' D ' 36' ' ' VAL . . . . . . . . . . . . . 45.7 t -122.97 130.03 74.72 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.251 0 CA-C-N 115.774 -0.648 . . . . 0.0 109.704 178.594 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' D' D ' 37' ' ' ILE . . . . . . . . . . . . . 69.7 mt -120.12 137.93 52.33 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.276 0 N-CA-C 109.767 -0.457 . . . . 0.0 109.767 179.442 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' D' D ' 38' ' ' GLY . . . . . . . . . . . . . . . -112.52 128.79 8.65 Favored Glycine 0 CA--C 1.526 0.724 0 N-CA-C 111.11 -0.796 . . . . 0.0 111.11 -179.078 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' D' D ' 39' ' ' ILE . . . . . . . . . . . . . 75.8 mt -124.23 135.55 63.33 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.261 0 CA-C-O 120.795 0.331 . . . . 0.0 110.164 178.999 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' D' D ' 40' ' ' SER . . . . . . . . . . . . . 23.0 t -92.71 120.74 33.41 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.321 -0.399 . . . . 0.0 110.723 176.142 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' D' D ' 41' ' ' ILE . . . . . . . . . . . . . 70.3 mt -132.09 118.16 35.89 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.23 0 N-CA-C 110.107 -0.331 . . . . 0.0 110.107 178.272 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' D' D ' 42' ' ' LEU . . . . . . . . . . . . . 5.4 mp 56.11 36.96 28.32 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.179 -0.464 . . . . 0.0 111.326 179.315 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' D' D ' 43' ' ' GLY . . . . . . . . . . . . . . . 77.48 -10.07 24.99 Favored Glycine 0 CA--C 1.533 1.209 0 C-N-CA 121.279 -0.486 . . . . 0.0 113.531 176.54 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' D' D ' 44' ' ' LYS . . . . . . . . . . . . . 61.9 mttp -97.19 135.96 38.39 Favored 'General case' 0 C--N 1.333 -0.123 0 CA-C-N 117.993 0.897 . . . . 0.0 110.151 177.398 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' D' D ' 45' ' ' GLU . . . . . . . . . . . . . 80.8 tt0 -85.2 126.9 34.03 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.282 -0.417 . . . . 0.0 110.758 179.817 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' D' D ' 46' ' ' VAL . . . . . . . . . . . . . 7.1 p -121.15 127.13 75.81 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.224 0 N-CA-C 109.597 -0.52 . . . . 0.0 109.597 175.895 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' D' D ' 47' ' ' LYS . . . . . . . . . . . . . 58.4 mttm -100.63 129.48 46.56 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 115.862 -0.608 . . . . 0.0 111.139 178.051 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' D' D ' 48' ' ' PHE . . . . . . . . . . . . . 92.5 m-85 -111.12 131.75 54.84 Favored 'General case' 0 C--N 1.329 -0.319 0 N-CA-C 109.61 -0.515 . . . . 0.0 109.61 174.807 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' D' D ' 49' ' ' LYS . . . . . . . . . . . . . 83.3 tttt -108.82 138.15 45.62 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.414 -0.357 . . . . 0.0 110.486 179.76 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' D' D ' 50' ' ' VAL . . . . . . . . . . . . . 44.9 t -80.3 109.56 14.93 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.285 0 N-CA-C 109.292 -0.632 . . . . 0.0 109.292 176.141 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' D' D ' 51' ' ' VAL . . . . . . . . . . . . . 51.2 t -71.81 -47.14 57.94 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.273 0 CA-C-N 115.988 -0.551 . . . . 0.0 109.97 -174.084 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' D' D ' 52' ' ' GLN . . . . . . . . . . . . . 47.6 tt0 -170.93 145.09 2.29 Favored 'General case' 0 C--N 1.33 -0.28 0 C-N-CA 120.433 -0.507 . . . . 0.0 111.439 -179.8 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' D' D ' 53' ' ' ALA . . . . . . . . . . . . . . . -121.14 136.18 55.02 Favored 'General case' 0 C--N 1.331 -0.227 0 CA-C-N 115.903 -0.589 . . . . 0.0 110.474 178.499 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' D' D ' 54' ' ' TYR . . . . . . . . . . . . . 35.6 t80 -129.16 113.59 18.49 Favored Pre-proline 0 CA--C 1.536 0.406 0 CA-C-O 118.24 -0.886 . . . . 0.0 110.117 176.142 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' D' D ' 55' ' ' PRO . . . . . . . . . . . . . 72.8 Cg_endo -77.29 170.08 72.35 Favored 'Cis proline' 0 N--CA 1.499 1.825 0 CA-C-N 122.037 1.763 . . . . 0.0 112.057 -6.089 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' D' D ' 56' ' ' SER . . . . . . . . . . . . . 17.5 m -122.51 134.1 24.74 Favored Pre-proline 0 CA--C 1.538 0.508 0 CA-C-O 118.519 -0.753 . . . . 0.0 109.496 175.204 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' D' D ' 57' ' ' PRO . . . . . . . . . . . . . 38.4 Cg_endo -67.2 145.54 73.63 Favored 'Cis proline' 0 N--CA 1.498 1.777 0 CA-C-N 121.834 1.691 . . . . 0.0 111.562 -1.67 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' D' D ' 58' ' ' LEU . . . . . . . . . . . . . 23.7 tp -106.25 136.05 46.65 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.263 -0.426 . . . . 0.0 110.736 -177.626 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' D' D ' 59' ' ' ARG . . . . . . . . . . . . . 42.1 ttm180 -103.28 127.83 50.5 Favored 'General case' 0 C--N 1.328 -0.367 0 N-CA-C 109.247 -0.649 . . . . 0.0 109.247 174.945 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' D' D ' 60' ' ' VAL . . . . . . . . . . . . . 45.5 t -84.18 120.28 34.73 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.242 0 C-N-CA 120.689 -0.404 . . . . 0.0 110.37 -175.916 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' D' D ' 61' ' ' GLU . . . . . . . . . . . . . 43.9 mt-10 -131.11 167.19 19.53 Favored 'General case' 0 C--N 1.331 -0.214 0 CA-C-N 115.735 -0.666 . . . . 0.0 109.858 177.391 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' D' D ' 62' ' ' ASP . . . . . . . . . . . . . 13.3 t70 -53.81 -32.57 53.19 Favored 'General case' 0 C--N 1.327 -0.377 0 N-CA-C 111.776 0.287 . . . . 0.0 111.776 -179.879 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' D' D ' 63' ' ' ARG . . . . . . . . . . . . . 26.5 ptt180 -82.99 3.79 28.65 Favored 'General case' 0 CA--C 1.536 0.434 0 N-CA-C 113.793 1.034 . . . . 0.0 113.793 -175.629 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' D' D ' 64' ' ' THR . . . . . . . . . . . . . 38.0 m -86.98 135.12 33.4 Favored 'General case' 0 C--N 1.333 -0.148 0 CA-C-N 118.117 0.417 . . . . 0.0 110.584 -178.343 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' D' D ' 65' ' ' LYS . . . . . . . . . . . . . 93.4 mttt -90.24 129.54 36.48 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.066 -0.515 . . . . 0.0 110.237 178.917 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' D' D ' 66' ' ' ILE . . . . . . . . . . . . . 63.4 mt -112.67 129.52 68.12 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.314 0 N-CA-C 109.725 -0.472 . . . . 0.0 109.725 179.641 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' D' D ' 67' ' ' THR . . . . . . . . . . . . . 29.3 m -124.02 138.11 54.5 Favored 'General case' 0 C--N 1.331 -0.204 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.807 -178.267 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' D' D ' 68' ' ' LEU . . . . . 0.496 ' N ' HD12 ' D' ' 68' ' ' LEU . 7.8 mp -102.49 129.73 49.1 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-N 115.845 -0.616 . . . . 0.0 110.219 178.2 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' D' D ' 69' ' ' VAL . . . . . . . . . . . . . 45.4 t -98.46 126.36 51.58 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 N-CA-C 109.86 -0.422 . . . . 0.0 109.86 179.476 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' D' D ' 70' ' ' THR . . . . . 0.435 HG23 ' N ' ' D' ' 71' ' ' HIS . 6.9 t -149.96 -39.83 0.14 Allowed 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 116.277 -0.419 . . . . 0.0 111.035 -178.74 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' D' D ' 71' ' ' HIS . . . . . 0.435 ' N ' HG23 ' D' ' 70' ' ' THR . 46.7 m-70 -125.77 86.48 57.47 Favored Pre-proline 0 CA--C 1.533 0.298 0 CA-C-N 116.389 -0.369 . . . . 0.0 110.576 -178.382 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' D' D ' 72' ' ' PRO . . . . . . . . . . . . . 14.2 Cg_exo -64.99 -30.0 57.06 Favored 'Trans proline' 0 N--CA 1.496 1.669 0 C-N-CA 121.517 1.478 . . . . 0.0 112.585 -177.276 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' D' D ' 73' ' ' VAL . . . . . . . . . . . . . 30.7 m -76.0 160.15 5.1 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.325 0 CA-C-O 121.067 0.46 . . . . 0.0 111.253 -177.038 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' D' D ' 74' ' ' ASP . . . . . . . . . . . . . 8.3 t0 -101.54 118.42 36.91 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 115.696 -0.684 . . . . 0.0 109.598 178.539 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' D' D ' 75' ' ' VAL . . . . . . . . . . . . . 40.8 t -110.2 123.71 66.33 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.244 0 CA-C-O 120.99 0.424 . . . . 0.0 110.481 -177.179 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' D' D ' 76' ' ' LEU . . . . . . . . . . . . . 30.0 mt -128.49 147.41 50.68 Favored 'General case' 0 C--N 1.331 -0.22 0 CA-C-N 115.794 -0.639 . . . . 0.0 110.066 178.854 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' D' D ' 77' ' ' GLU . . . . . . . . . . . . . 97.1 mt-10 -136.75 140.65 42.73 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-O 120.98 0.419 . . . . 0.0 110.99 -177.95 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' D' D ' 78' ' ' ALA . . . . . 0.674 ' HB2' HD21 ' D' ' 109' ' ' LEU . . . -125.67 127.39 46.19 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 115.799 -0.637 . . . . 0.0 109.748 176.878 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' D' D ' 79' ' ' LYS . . . . . 0.581 ' O ' HD13 ' D' ' 80' ' ' ILE . 48.8 mmtm -71.59 119.37 15.66 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-O 120.849 0.357 . . . . 0.0 110.848 -178.096 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' D' D ' 80' ' ' ILE . . . . . 0.581 HD13 ' O ' ' D' ' 79' ' ' LYS . 41.3 mm -139.09 112.73 6.75 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.289 0 N-CA-C 108.885 -0.783 . . . . 0.0 108.885 -179.298 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' D' D ' 81' ' ' LYS . . . . . . . . . . . . . 83.2 tttt -102.65 123.67 46.79 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-O 120.833 0.349 . . . . 0.0 111.205 -174.534 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' D' D ' 82' ' ' GLY . . . . . . . . . . . . . . . 89.22 41.99 5.68 Favored Glycine 0 CA--C 1.526 0.747 0 C-N-CA 120.824 -0.703 . . . . 0.0 112.064 173.702 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' D' D ' 83' ' ' ILE . . . . . . . . . . . . . 67.6 mt -68.25 139.63 20.39 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.311 0 N-CA-C 109.802 -0.444 . . . . 0.0 109.802 177.249 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' D' D ' 84' ' ' LYS . . . . . . . . . . . . . 39.7 ttpt -102.62 -47.9 4.29 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.165 -0.47 . . . . 0.0 110.295 -179.081 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' D' D ' 85' ' ' ASP . . . . . . . . . . . . . 7.5 t70 -152.31 151.04 30.4 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.068 -0.515 . . . . 0.0 110.552 179.903 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' D' D ' 86' ' ' VAL . . . . . . . . . . . . . 42.0 t -129.04 131.5 68.02 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.241 0 CA-C-O 120.917 0.389 . . . . 0.0 110.394 179.513 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' D' D ' 87' ' ' ILE . . . . . 0.499 HD12 ' N ' ' D' ' 87' ' ' ILE . 5.1 mp -118.64 127.35 75.62 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.245 0 N-CA-C 109.472 -0.566 . . . . 0.0 109.472 177.506 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' D' D ' 88' ' ' LEU . . . . . . . . . . . . . 20.6 tp -111.66 123.45 50.26 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.382 -0.372 . . . . 0.0 110.691 -176.963 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' D' D ' 89' ' ' ASP . . . . . . . . . . . . . 12.8 t70 -121.23 156.14 33.1 Favored 'General case' 0 C--N 1.332 -0.184 0 CA-C-N 116.419 -0.355 . . . . 0.0 110.235 -179.983 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' D' D ' 90' ' ' GLU . . . . . . . . . . . . . 68.1 tt0 -46.04 -45.7 16.22 Favored 'General case' 0 N--CA 1.465 0.291 0 N-CA-C 112.972 0.73 . . . . 0.0 112.972 -171.832 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' D' D ' 91' ' ' ASN . . . . . . . . . . . . . 8.4 t-20 -129.59 34.76 4.29 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-O 120.709 0.29 . . . . 0.0 111.665 -176.039 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' D' D ' 92' ' ' LEU . . . . . . . . . . . . . 7.0 tp -166.14 146.38 6.33 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-O 120.944 0.402 . . . . 0.0 110.554 179.68 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' D' D ' 93' ' ' ILE . . . . . . . . . . . . . 66.7 mt -122.26 123.0 67.8 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.366 0 N-CA-C 109.13 -0.693 . . . . 0.0 109.13 179.146 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' D' D ' 94' ' ' VAL . . . . . . . . . . . . . 43.1 t -119.33 128.19 75.84 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.246 0 CA-C-O 120.839 0.352 . . . . 0.0 110.053 -178.122 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' D' D ' 95' ' ' VAL . . . . . . . . . . . . . 42.4 t -123.12 132.59 71.11 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.302 0 CA-C-N 116.043 -0.526 . . . . 0.0 109.882 179.474 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' D' D ' 96' ' ' ILE . . . . . . . . . . . . . 67.5 mt -116.2 127.87 73.67 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.312 0 N-CA-C 109.268 -0.642 . . . . 0.0 109.268 179.077 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' D' D ' 97' ' ' THR . . . . . . . . . . . . . 70.0 p -99.76 158.27 15.91 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-O 121.029 0.442 . . . . 0.0 111.026 -177.664 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' D' D ' 98' ' ' GLU . . . . . . . . . . . . . 44.8 tp10 -54.03 -26.13 24.89 Favored 'General case' 0 CA--C 1.534 0.34 0 CA-C-N 116.224 -0.444 . . . . 0.0 111.916 179.058 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' D' D ' 99' ' ' GLU . . . . . . . . . . . . . 34.5 tt0 -76.3 11.47 1.54 Allowed 'General case' 0 CA--C 1.539 0.533 0 N-CA-C 112.765 0.654 . . . . 0.0 112.765 -177.512 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' D' D ' 100' ' ' ASN . . . . . . . . . . . . . 2.1 m-20 62.81 32.15 16.07 Favored 'General case' 0 CA--C 1.532 0.277 0 O-C-N 121.705 -0.622 . . . . 0.0 111.555 178.983 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' D' D ' 101' ' ' GLU . . . . . . . . . . . . . 78.5 tt0 -109.75 144.66 37.85 Favored 'General case' 0 C--O 1.234 0.241 0 N-CA-C 109.631 -0.507 . . . . 0.0 109.631 172.887 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' D' D ' 102' ' ' VAL . . . . . . . . . . . . . 44.6 t -116.13 128.2 73.5 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.248 0 CA-C-N 116.432 -0.349 . . . . 0.0 110.134 -178.592 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' D' D ' 103' ' ' LEU . . . . . . . . . . . . . 21.1 mt -116.2 130.52 56.83 Favored 'General case' 0 C--N 1.331 -0.208 0 CA-C-N 115.717 -0.674 . . . . 0.0 110.163 176.973 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' D' D ' 104' ' ' ILE . . . . . 0.58 HD13 HG21 ' D' ' 130' ' ' VAL . 66.9 mt -116.82 120.5 65.22 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.299 0 N-CA-C 110.018 -0.364 . . . . 0.0 110.018 179.621 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' D' D ' 105' ' ' PHE . . . . . . . . . . . . . 62.8 m-85 -120.8 165.12 15.59 Favored 'General case' 0 C--N 1.333 -0.123 0 O-C-N 123.893 0.746 . . . . 0.0 109.807 178.777 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' D' D ' 106' ' ' ASN . . . . . . . . . . . . . 42.9 p-10 -98.94 -170.05 1.87 Allowed 'General case' 0 C--N 1.331 -0.229 0 N-CA-C 109.936 -0.394 . . . . 0.0 109.936 173.549 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' D' D ' 107' ' ' GLN . . . . . . . . . . . . . 48.7 tt0 -60.5 -30.03 69.46 Favored 'General case' 0 C--N 1.329 -0.289 0 N-CA-C 111.955 0.354 . . . . 0.0 111.955 179.946 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' D' D ' 108' ' ' ASN . . . . . . . . . . . . . 6.6 t-20 -83.27 6.78 18.46 Favored 'General case' 0 CA--C 1.536 0.425 0 N-CA-C 113.223 0.824 . . . . 0.0 113.223 -178.371 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' D' D ' 109' ' ' LEU . . . . . 0.674 HD21 ' HB2' ' D' ' 78' ' ' ALA . 10.2 tp 62.41 37.69 13.41 Favored 'General case' 0 CA--C 1.529 0.167 0 O-C-N 122.087 -0.383 . . . . 0.0 111.377 178.244 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' D' D ' 110' ' ' GLU . . . . . . . . . . . . . 70.7 mm-40 -105.89 162.24 13.75 Favored 'General case' 0 C--N 1.33 -0.255 0 N-CA-C 109.765 -0.457 . . . . 0.0 109.765 176.014 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' D' D ' 111' ' ' GLU . . . . . . . . . . . . . 83.9 tt0 -86.67 127.45 34.95 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-O 120.938 0.399 . . . . 0.0 111.208 -176.357 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' D' D ' 112' ' ' LEU . . . . . . . . . . . . . 15.6 mt -113.03 -46.09 3.13 Favored 'General case' 0 C--N 1.331 -0.197 0 CA-C-N 115.953 -0.567 . . . . 0.0 110.418 176.579 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' D' D ' 113' ' ' TYR . . . . . 0.563 ' HB3' HD12 ' D' ' 104' ' ' ILE . 38.2 t80 -143.06 138.73 30.13 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.269 -0.423 . . . . 0.0 111.26 -179.295 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' D' D ' 114' ' ' ARG . . . . . . . . . . . . . 27.4 ttm180 -137.42 122.61 19.24 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.338 -0.392 . . . . 0.0 109.968 174.908 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' D' D ' 115' ' ' GLY . . . . . . . . . . . . . . . -150.07 163.1 29.38 Favored Glycine 0 CA--C 1.526 0.775 0 N-CA-C 111.115 -0.794 . . . . 0.0 111.115 179.031 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' D' D ' 116' ' ' LYS . . . . . . . . . . . . . 88.2 tttt -131.69 138.19 48.59 Favored 'General case' 0 C--N 1.33 -0.241 0 N-CA-C 110.046 -0.353 . . . . 0.0 110.046 178.628 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' D' D ' 117' ' ' PHE . . . . . 0.423 ' HE2' HD13 ' D' ' 132' ' ' ILE . 27.6 m-85 -139.05 113.96 9.32 Favored 'General case' 0 C--N 1.331 -0.205 0 CA-C-N 116.26 -0.427 . . . . 0.0 109.963 -176.657 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' D' D ' 118' ' ' GLU . . . . . . . . . . . . . 70.7 mm-40 -54.5 -47.78 72.65 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.564 -0.289 . . . . 0.0 111.542 -174.982 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' D' D ' 119' ' ' ASN . . . . . . . . . . . . . 29.5 m120 -93.59 31.06 1.61 Allowed 'General case' 0 C--N 1.329 -0.315 0 N-CA-C 112.15 0.426 . . . . 0.0 112.15 -174.319 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' D' D ' 120' ' ' LEU . . . . . . . . . . . . . 10.3 tp -56.06 120.69 7.89 Favored 'General case' 0 C--N 1.333 -0.139 0 C-N-CA 121.078 -0.249 . . . . 0.0 110.584 177.864 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' D' D ' 121' ' ' ASN . . . . . . . . . . . . . 36.2 m120 -113.78 -44.05 3.22 Favored 'General case' 0 C--O 1.233 0.204 0 CA-C-N 116.575 -0.284 . . . . 0.0 111.178 -177.582 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' D' D ' 122' ' ' LYS . . . . . . . . . . . . . 98.3 mttt -145.72 150.11 35.65 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-O 121.081 0.467 . . . . 0.0 111.945 -177.978 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' D' D ' 123' ' ' VAL . . . . . . . . . . . . . 44.0 t -127.67 127.56 68.6 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.166 0 CA-C-N 115.811 -0.631 . . . . 0.0 109.485 175.292 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' D' D ' 124' ' ' LEU . . . . . 0.429 HD13 ' HB2' ' E' ' 88' ' ' LEU . 35.6 mt -118.02 136.59 53.44 Favored 'General case' 0 C--N 1.332 -0.161 0 CA-C-N 116.426 -0.352 . . . . 0.0 110.606 -179.231 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' D' D ' 125' ' ' VAL . . . . . . . . . . . . . 34.9 m -121.82 141.95 40.16 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.223 0 CA-C-N 116.128 -0.487 . . . . 0.0 110.608 -179.293 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' D' D ' 126' ' ' ARG . . . . . . . . . . . . . 36.5 ptt180 -148.05 114.78 6.04 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-O 121.292 0.567 . . . . 0.0 110.462 177.725 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' D' D ' 127' ' ' ASN . . . . . . . . . . . . . 60.6 t30 49.48 -107.74 0.26 Allowed 'General case' 0 CA--C 1.546 0.823 0 CA-C-O 118.967 -0.539 . . . . 0.0 111.432 -178.516 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' D' D ' 128' ' ' ASP . . . . . . . . . . . . . 20.4 p-10 -114.08 4.98 15.85 Favored 'General case' 0 N--CA 1.469 0.482 0 CA-C-N 119.813 1.188 . . . . 0.0 113.264 179.726 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' D' D ' 129' ' ' LEU . . . . . . . . . . . . . 25.1 mt -108.82 152.75 24.46 Favored 'General case' 0 C--O 1.233 0.222 0 N-CA-C 109.349 -0.612 . . . . 0.0 109.349 178.332 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' D' D ' 130' ' ' VAL . . . . . 0.58 HG21 HD13 ' D' ' 104' ' ' ILE . 33.3 m -139.34 150.17 22.84 Favored 'Isoleucine or valine' 0 N--CA 1.462 0.153 0 CA-C-O 121.462 0.649 . . . . 0.0 111.804 -177.756 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' D' D ' 131' ' ' VAL . . . . . 0.753 HG22 HD12 ' D' ' 140' ' ' LEU . 43.4 t -136.09 138.49 47.21 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.267 0 CA-C-N 115.321 -0.854 . . . . 0.0 109.891 177.277 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' D' D ' 132' ' ' ILE . . . . . 0.423 HD13 ' HE2' ' D' ' 117' ' ' PHE . 70.6 mt -118.03 133.97 63.14 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.305 0 CA-C-N 116.086 -0.506 . . . . 0.0 109.702 -178.538 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' D' D ' 133' ' ' ILE . . . . . . . . . . . . . 42.9 mm -115.07 124.06 71.34 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.287 0 CA-C-N 116.399 -0.364 . . . . 0.0 110.846 -175.643 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' D' D ' 134' ' ' ASP . . . . . . . . . . . . . 8.9 p-10 -136.6 146.58 46.23 Favored 'General case' 0 C--N 1.332 -0.166 0 N-CA-C 109.651 -0.5 . . . . 0.0 109.651 174.227 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' D' D ' 135' ' ' GLU . . . . . . . . . . . . . 45.7 tp10 -49.9 -28.4 6.58 Favored 'General case' 0 C--N 1.328 -0.346 0 N-CA-C 112.874 0.694 . . . . 0.0 112.874 -172.05 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' D' D ' 136' ' ' GLN . . . . . . . . . . . . . 36.5 tt0 -80.48 -35.6 34.56 Favored 'General case' 0 C--N 1.331 -0.21 0 N-CA-C 112.236 0.458 . . . . 0.0 112.236 -176.048 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' D' D ' 137' ' ' LYS . . . . . . . . . . . . . 58.5 pttt -167.05 172.59 9.98 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-O 121.61 0.719 . . . . 0.0 112.193 -171.994 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' D' D ' 138' ' ' LEU . . . . . . . . . . . . . 5.0 tt -115.8 128.39 55.8 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 115.046 -0.979 . . . . 0.0 109.847 179.749 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' D' D ' 139' ' ' THR . . . . . . . . . . . . . 38.5 m -109.62 130.25 55.53 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.303 -0.408 . . . . 0.0 110.377 -179.459 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' D' D ' 140' ' ' LEU . . . . . 0.753 HD12 HG22 ' D' ' 131' ' ' VAL . 10.0 tp -118.46 127.54 53.75 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.025 -0.534 . . . . 0.0 109.914 -178.26 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' D' D ' 141' ' ' ILE . . . . . 0.475 ' HB ' HG23 ' D' ' 130' ' ' VAL . 19.0 mt -125.71 121.64 60.41 Favored 'Isoleucine or valine' 0 C--O 1.234 0.28 0 N-CA-C 109.898 -0.408 . . . . 0.0 109.898 -176.043 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' D' D ' 142' ' ' ARG . . . . . . . . . . . . . 73.9 mtm180 -115.42 123.48 48.73 Favored 'General case' 0 N--CA 1.463 0.179 0 CA-C-N 116.132 -0.485 . . . . 0.0 109.872 -179.463 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' D' D ' 143' ' ' THR . . . . . . . . . . . . . 25.2 p . . . . . 0 C--O 1.219 -0.526 0 CA-C-O 118.047 -0.977 . . . . 0.0 110.57 -179.263 . . . . . . . . 0 0 . 1 . 020 nuclear nobuild full ' E' E ' -3' ' ' GLU . . . . . . . . . . . . . 95.8 mt-10 . . . . . 0 N--CA 1.49 1.553 0 N-CA-C 109.427 -0.583 . . . . 0.0 109.427 . . . . . . . . . 0 0 . 1 . 020 nuclear nobuild full ' E' E ' -2' ' ' GLY . . . . . . . . . . . . . . . -62.05 127.36 40.44 Favored Glycine 0 CA--C 1.524 0.602 0 N-CA-C 111.166 -0.774 . . . . 0.0 111.166 -178.657 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' E' E ' -1' ' ' VAL . . . . . . . . . . . . . 44.1 t -96.58 140.92 16.38 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 N-CA-C 109.772 -0.455 . . . . 0.0 109.772 178.568 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' E' E ' 0' ' ' ILE . . . . . . . . . . . . . 43.7 mm -88.34 144.42 9.2 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.272 0 CA-C-N 116.266 -0.425 . . . . 0.0 110.508 -177.804 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' E' E ' 1' ' ' MET . . . . . . . . . . . . . 24.5 ptp -76.94 170.31 16.73 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.081 -0.509 . . . . 0.0 110.407 179.311 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' E' E ' 2' ' ' SER . . . . . 0.432 ' OG ' HG23 ' E' ' 64' ' ' THR . 87.3 p -131.08 158.5 40.22 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-O 121.042 0.449 . . . . 0.0 111.173 -177.367 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' E' E ' 3' ' ' GLU . . . . . . . . . . . . . 47.6 mp0 -138.74 144.7 39.6 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 115.855 -0.611 . . . . 0.0 110.986 -178.468 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' E' E ' 4' ' ' LEU . . . . . . . . . . . . . 16.8 tp -125.02 125.13 43.38 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 115.809 -0.632 . . . . 0.0 109.931 176.298 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' E' E ' 5' ' ' LYS . . . . . . . . . . . . . 69.2 mttm -106.39 121.71 44.79 Favored 'General case' 0 C--N 1.331 -0.224 0 CA-C-N 116.362 -0.381 . . . . 0.0 110.634 179.078 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' E' E ' 6' ' ' LEU . . . . . . . . . . . . . 77.1 mt -118.65 147.87 43.32 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 115.492 -0.776 . . . . 0.0 110.522 179.768 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' E' E ' 7' ' ' LYS . . . . . . . . . . . . . 84.9 tttt -140.25 142.46 29.93 Favored Pre-proline 0 C--N 1.329 -0.316 0 N-CA-C 109.666 -0.494 . . . . 0.0 109.666 175.687 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' E' E ' 8' ' ' PRO . . . . . . . . . . . . . 85.1 Cg_endo -90.86 147.45 3.87 Favored 'Trans proline' 0 N--CA 1.492 1.391 0 C-N-CA 121.779 1.653 . . . . 0.0 112.081 179.584 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' E' E ' 9' ' ' LEU . . . . . . . . . . . . . 37.4 mt -84.03 -47.69 0.72 Allowed Pre-proline 0 C--N 1.329 -0.301 0 CA-C-O 118.598 -0.715 . . . . 0.0 112.012 178.929 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' E' E ' 10' ' ' PRO . . . . . . . . . . . . . 97.3 Cg_endo -80.76 154.42 20.27 Favored 'Trans proline' 0 N--CA 1.495 1.602 0 C-N-CA 121.124 1.216 . . . . 0.0 111.667 176.052 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' E' E ' 11' ' ' LYS . . . . . . . . . . . . . 58.2 mtpt -88.71 100.99 13.56 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-O 120.804 0.335 . . . . 0.0 110.471 -179.969 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' E' E ' 12' ' ' VAL . . . . . . . . . . . . . 12.3 p -139.6 143.94 29.67 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.224 0 CA-C-N 116.18 -0.464 . . . . 0.0 110.62 -179.225 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' E' E ' 13' ' ' GLU . . . . . . . . . . . . . 45.5 mp0 -90.98 117.41 29.55 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.31 -0.405 . . . . 0.0 110.018 177.254 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' E' E ' 14' ' ' LEU . . . . . 0.46 HD22 ' CE1' ' E' ' 18' ' ' PHE . 25.3 mt -97.93 155.3 37.23 Favored Pre-proline 0 C--N 1.329 -0.283 0 CA-C-N 116.334 -0.394 . . . . 0.0 111.03 -176.832 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' E' E ' 15' ' ' PRO . . . . . . . . . . . . . 32.9 Cg_exo -60.46 161.27 21.0 Favored 'Trans proline' 0 N--CA 1.496 1.676 0 C-N-CA 121.316 1.344 . . . . 0.0 112.048 177.067 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' E' E ' 16' ' ' PRO . . . . . . . . . . . . . 24.6 Cg_exo -61.82 -34.88 81.45 Favored 'Trans proline' 0 N--CA 1.497 1.725 0 C-N-CA 121.472 1.448 . . . . 0.0 112.753 -178.954 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' E' E ' 17' ' ' ASP . . . . . . . . . . . . . 15.7 p-10 -88.38 11.65 16.27 Favored 'General case' 0 CA--C 1.534 0.336 0 N-CA-C 113.24 0.829 . . . . 0.0 113.24 -176.408 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' E' E ' 18' ' ' PHE . . . . . 0.46 ' CE1' HD22 ' E' ' 14' ' ' LEU . 37.3 t80 -56.91 -45.53 82.57 Favored 'General case' 0 C--O 1.231 0.118 0 O-C-N 122.024 -0.423 . . . . 0.0 110.334 -178.377 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' E' E ' 19' ' ' VAL . . . . . 0.408 HG13 ' N ' ' E' ' 20' ' ' ASP . 13.2 p -56.55 -41.57 73.58 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.317 0 CA-C-N 116.544 -0.298 . . . . 0.0 110.898 -179.013 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' E' E ' 20' ' ' ASP . . . . . 0.408 ' N ' HG13 ' E' ' 19' ' ' VAL . 78.1 m-20 -61.05 -43.12 99.37 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-O 120.837 0.351 . . . . 0.0 110.889 -178.545 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' E' E ' 21' ' ' VAL . . . . . . . . . . . . . 48.8 t -64.3 -44.86 97.34 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.319 0 C-N-CA 120.797 -0.361 . . . . 0.0 110.448 -176.952 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' E' E ' 22' ' ' ILE . . . . . 0.609 HG22 HD12 ' E' ' 26' ' ' LEU . 49.8 mm -55.2 -50.62 62.74 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.247 0 C-N-CA 121.151 -0.22 . . . . 0.0 110.716 178.72 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' E' E ' 23' ' ' ARG . . . . . . . . . . . . . 37.8 ttp180 -55.21 -48.65 73.57 Favored 'General case' 0 C--N 1.329 -0.311 0 C-N-CA 120.949 -0.3 . . . . 0.0 111.567 -177.778 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' E' E ' 24' ' ' ILE . . . . . . . . . . . . . 75.4 mt -58.91 -43.72 89.21 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 C-N-CA 121.054 -0.258 . . . . 0.0 111.368 -176.126 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' E' E ' 25' ' ' LYS . . . . . . . . . . . . . 93.1 mttt -69.34 -39.62 78.04 Favored 'General case' 0 C--N 1.33 -0.268 0 N-CA-C 112.556 0.576 . . . . 0.0 112.556 -178.302 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' E' E ' 26' ' ' LEU . . . . . 0.609 HD12 HG22 ' E' ' 22' ' ' ILE . 79.2 mt -78.98 -33.49 45.07 Favored 'General case' 0 C--N 1.331 -0.219 0 N-CA-C 113.673 0.99 . . . . 0.0 113.673 -170.745 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' E' E ' 27' ' ' GLN . . . . . . . . . . . . . 6.3 pt20 -46.4 137.42 6.5 Favored 'General case' 0 N--CA 1.469 0.5 0 N-CA-C 112.861 0.689 . . . . 0.0 112.861 -174.406 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' E' E ' 28' ' ' GLY . . . . . . . . . . . . . . . 99.99 -23.73 34.89 Favored Glycine 0 CA--C 1.533 1.198 0 CA-C-N 115.68 -0.691 . . . . 0.0 112.53 -177.448 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' E' E ' 29' ' ' LYS . . . . . . . . . . . . . 97.7 mttt -97.59 155.13 17.11 Favored 'General case' 0 C--O 1.233 0.235 0 CA-C-N 117.459 0.63 . . . . 0.0 111.132 179.512 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' E' E ' 30' ' ' THR . . . . . . . . . . . . . 27.0 m -103.28 138.52 39.95 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.085 -0.507 . . . . 0.0 110.272 177.545 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' E' E ' 31' ' ' VAL . . . . . . . . . . . . . 34.9 m -130.23 156.73 42.54 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.239 0 CA-C-N 116.385 -0.371 . . . . 0.0 110.879 -178.923 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' E' E ' 32' ' ' ARG . . . . . . . . . . . . . 79.0 mtm180 -136.1 150.4 49.1 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-O 121.32 0.581 . . . . 0.0 110.819 178.112 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' E' E ' 33' ' ' THR . . . . . . . . . . . . . 17.6 m -53.55 141.43 25.54 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.128 -0.487 . . . . 0.0 111.27 -178.625 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' E' E ' 34' ' ' GLY . . . . . . . . . . . . . . . 99.64 -17.08 58.06 Favored Glycine 0 CA--C 1.532 1.149 0 CA-C-O 119.699 -0.501 . . . . 0.0 113.275 179.609 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' E' E ' 35' ' ' ASP . . . . . . . . . . . . . 76.6 m-20 -66.03 147.69 52.95 Favored 'General case' 0 C--O 1.23 0.071 0 CA-C-N 118.054 0.927 . . . . 0.0 111.152 179.054 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' E' E ' 36' ' ' VAL . . . . . . . . . . . . . 46.4 t -122.54 127.97 75.2 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.204 0 CA-C-N 115.83 -0.623 . . . . 0.0 109.649 177.803 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' E' E ' 37' ' ' ILE . . . . . . . . . . . . . 68.2 mt -119.31 138.66 49.28 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.239 0 CA-C-N 116.247 -0.433 . . . . 0.0 109.928 -179.499 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' E' E ' 38' ' ' GLY . . . . . . . . . . . . . . . -110.34 128.58 8.9 Favored Glycine 0 CA--C 1.525 0.7 0 N-CA-C 111.025 -0.83 . . . . 0.0 111.025 179.891 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' E' E ' 39' ' ' ILE . . . . . . . . . . . . . 75.4 mt -126.13 139.34 51.83 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.2 0 N-CA-C 110.027 -0.36 . . . . 0.0 110.027 178.835 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' E' E ' 40' ' ' SER . . . . . 0.432 ' O ' HD13 ' E' ' 41' ' ' ILE . 31.0 t -92.28 116.66 29.16 Favored 'General case' 0 C--N 1.329 -0.297 0 C-N-CA 120.935 -0.306 . . . . 0.0 110.936 176.107 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' E' E ' 41' ' ' ILE . . . . . 0.432 HD13 ' O ' ' E' ' 40' ' ' SER . 46.0 mm -124.59 115.96 46.06 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.157 0 N-CA-C 110.112 -0.329 . . . . 0.0 110.112 178.584 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' E' E ' 42' ' ' LEU . . . . . . . . . . . . . 70.4 mt 57.58 33.43 23.24 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-N 116.196 -0.457 . . . . 0.0 111.793 179.437 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' E' E ' 43' ' ' GLY . . . . . . . . . . . . . . . 81.78 -10.05 53.44 Favored Glycine 0 CA--C 1.534 1.261 0 C-N-CA 121.26 -0.495 . . . . 0.0 113.435 177.043 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' E' E ' 44' ' ' LYS . . . . . . . . . . . . . 53.1 mtpt -100.45 140.45 34.68 Favored 'General case' 0 C--N 1.333 -0.134 0 CA-C-N 117.892 0.846 . . . . 0.0 110.198 178.321 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' E' E ' 45' ' ' GLU . . . . . . . . . . . . . 80.7 tt0 -83.98 126.05 32.65 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.464 -0.334 . . . . 0.0 110.985 -178.752 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' E' E ' 46' ' ' VAL . . . . . . . . . . . . . 7.6 p -120.68 124.37 72.27 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.224 0 N-CA-C 109.409 -0.589 . . . . 0.0 109.409 175.836 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' E' E ' 47' ' ' LYS . . . . . . . . . . . . . 93.1 mttt -100.51 128.5 46.55 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.011 -0.54 . . . . 0.0 111.132 178.027 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' E' E ' 48' ' ' PHE . . . . . . . . . . . . . 93.5 m-85 -109.56 131.96 54.58 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.249 -0.432 . . . . 0.0 110.015 176.499 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' E' E ' 49' ' ' LYS . . . . . . . . . . . . . 80.0 tttt -107.49 134.59 50.3 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.312 -0.403 . . . . 0.0 110.293 179.53 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' E' E ' 50' ' ' VAL . . . . . . . . . . . . . 46.2 t -77.13 110.01 12.31 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.304 0 N-CA-C 109.287 -0.635 . . . . 0.0 109.287 176.393 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' E' E ' 51' ' ' VAL . . . . . . . . . . . . . 48.4 t -74.28 -47.08 42.29 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.278 0 CA-C-N 116.073 -0.512 . . . . 0.0 110.233 -173.852 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' E' E ' 52' ' ' GLN . . . . . . . . . . . . . 61.9 tt0 -168.01 140.08 3.0 Favored 'General case' 0 C--N 1.331 -0.228 0 C-N-CA 120.409 -0.516 . . . . 0.0 111.351 -177.942 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' E' E ' 53' ' ' ALA . . . . . . . . . . . . . . . -117.18 134.46 54.75 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 115.798 -0.637 . . . . 0.0 110.179 175.62 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' E' E ' 54' ' ' TYR . . . . . . . . . . . . . 55.5 t80 -129.05 112.69 18.53 Favored Pre-proline 0 CA--C 1.535 0.375 0 CA-C-O 118.146 -0.93 . . . . 0.0 110.378 177.877 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' E' E ' 55' ' ' PRO . . . . . . . . . . . . . 74.0 Cg_endo -77.09 168.13 77.89 Favored 'Cis proline' 0 N--CA 1.5 1.902 0 CA-C-N 122.14 1.8 . . . . 0.0 112.273 -6.925 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' E' E ' 56' ' ' SER . . . . . . . . . . . . . 15.5 m -116.89 133.79 23.04 Favored Pre-proline 0 CA--C 1.538 0.506 0 CA-C-O 118.414 -0.803 . . . . 0.0 109.572 175.198 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' E' E ' 57' ' ' PRO . . . . . . . . . . . . . 39.4 Cg_endo -67.54 161.11 79.13 Favored 'Cis proline' 0 N--CA 1.497 1.716 0 CA-C-N 121.864 1.701 . . . . 0.0 111.29 -1.695 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' E' E ' 58' ' ' LEU . . . . . . . . . . . . . 21.3 tp -125.99 138.39 53.74 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-O 120.969 0.414 . . . . 0.0 110.46 -178.967 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' E' E ' 59' ' ' ARG . . . . . . . . . . . . . 74.6 ttt180 -103.25 127.0 50.7 Favored 'General case' 0 C--N 1.327 -0.4 0 CA-C-N 115.737 -0.665 . . . . 0.0 109.355 176.249 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' E' E ' 60' ' ' VAL . . . . . . . . . . . . . 41.8 t -77.35 116.74 21.21 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.26 0 C-N-CA 120.672 -0.411 . . . . 0.0 110.156 -176.441 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' E' E ' 61' ' ' GLU . . . . . . . . . . . . . 95.7 mt-10 -131.15 162.17 30.5 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 115.907 -0.588 . . . . 0.0 110.145 178.423 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' E' E ' 62' ' ' ASP . . . . . . . . . . . . . 79.3 m-20 -54.79 -32.67 60.5 Favored 'General case' 0 C--N 1.328 -0.346 0 C-N-CA 121.065 -0.254 . . . . 0.0 111.667 -179.851 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' E' E ' 63' ' ' ARG . . . . . . . . . . . . . 10.8 ptm180 -82.6 6.82 16.47 Favored 'General case' 0 CA--C 1.534 0.354 0 N-CA-C 113.744 1.016 . . . . 0.0 113.744 -175.887 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' E' E ' 64' ' ' THR . . . . . 0.432 HG23 ' OG ' ' E' ' 2' ' ' SER . 27.6 m -93.43 140.14 29.91 Favored 'General case' 0 C--O 1.232 0.133 0 CA-C-N 118.16 0.436 . . . . 0.0 110.486 -179.62 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' E' E ' 65' ' ' LYS . . . . . . . . . . . . . 68.3 mttm -88.62 124.2 33.83 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.277 -0.42 . . . . 0.0 110.008 179.558 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' E' E ' 66' ' ' ILE . . . . . . . . . . . . . 56.5 mt -113.58 129.8 68.74 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.253 0 N-CA-C 109.815 -0.439 . . . . 0.0 109.815 -179.814 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' E' E ' 67' ' ' THR . . . . . . . . . . . . . 19.0 m -127.21 133.97 50.18 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-O 121.245 0.545 . . . . 0.0 110.767 179.949 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' E' E ' 68' ' ' LEU . . . . . . . . . . . . . 21.7 tp -108.27 122.85 47.8 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 115.737 -0.665 . . . . 0.0 109.72 176.55 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' E' E ' 69' ' ' VAL . . . . . . . . . . . . . 44.6 t -100.89 102.52 13.57 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.209 0 N-CA-C 109.723 -0.473 . . . . 0.0 109.723 179.236 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' E' E ' 70' ' ' THR . . . . . . . . . . . . . 14.5 m -150.23 -44.32 0.13 Allowed 'General case' 0 C--N 1.33 -0.265 0 CA-C-O 121.093 0.473 . . . . 0.0 111.333 178.889 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' E' E ' 71' ' ' HIS . . . . . . . . . . . . . 26.3 m80 -106.52 170.29 5.91 Favored Pre-proline 0 CA--C 1.535 0.369 0 CA-C-N 115.598 -0.728 . . . . 0.0 112.462 -168.031 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' E' E ' 72' ' ' PRO . . . . . . . . . . . . . 23.1 Cg_exo -64.93 160.33 41.78 Favored 'Trans proline' 0 N--CA 1.497 1.72 0 C-N-CA 122.096 1.864 . . . . 0.0 111.943 174.44 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' E' E ' 73' ' ' VAL . . . . . . . . . . . . . 34.3 m -69.49 -173.51 0.1 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.277 0 CA-C-N 116.133 -0.485 . . . . 0.0 110.293 -173.804 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' E' E ' 74' ' ' ASP . . . . . . . . . . . . . 13.9 t70 -77.35 114.98 16.73 Favored 'General case' 0 C--N 1.328 -0.338 0 C-N-CA 120.362 -0.535 . . . . 0.0 110.274 -168.414 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' E' E ' 75' ' ' VAL . . . . . . . . . . . . . 46.8 t -119.38 117.91 55.63 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.273 0 CA-C-O 121.16 0.505 . . . . 0.0 109.733 -179.654 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' E' E ' 76' ' ' LEU . . . . . . . . . . . . . 15.2 mt -124.59 148.57 47.78 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 115.459 -0.791 . . . . 0.0 109.613 -178.329 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' E' E ' 77' ' ' GLU . . . . . . . . . . . . . 45.3 mt-10 -138.77 135.46 34.7 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-O 121.15 0.5 . . . . 0.0 111.266 -177.604 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' E' E ' 78' ' ' ALA . . . . . 0.569 ' HB2' HD21 ' E' ' 109' ' ' LEU . . . -121.78 129.24 52.52 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 115.562 -0.745 . . . . 0.0 109.622 175.708 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' E' E ' 79' ' ' LYS . . . . . 0.652 ' O ' HD13 ' E' ' 80' ' ' ILE . 48.7 mttm -75.83 117.84 18.0 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-O 121.008 0.433 . . . . 0.0 110.875 -178.55 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' E' E ' 80' ' ' ILE . . . . . 0.652 HD13 ' O ' ' E' ' 79' ' ' LYS . 38.4 mm -139.14 102.5 1.73 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.261 0 N-CA-C 108.908 -0.775 . . . . 0.0 108.908 -177.95 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' E' E ' 81' ' ' LYS . . . . . . . . . . . . . 53.5 mttp -96.31 127.82 42.66 Favored 'General case' 0 C--N 1.327 -0.397 0 C-N-CA 120.783 -0.367 . . . . 0.0 111.305 -176.489 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' E' E ' 82' ' ' GLY . . . . . . . . . . . . . . . 89.14 42.18 5.66 Favored Glycine 0 CA--C 1.525 0.703 0 C-N-CA 120.714 -0.755 . . . . 0.0 111.867 173.588 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' E' E ' 83' ' ' ILE . . . . . . . . . . . . . 70.7 mt -70.95 135.0 28.98 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.358 0 N-CA-C 109.477 -0.564 . . . . 0.0 109.477 177.186 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' E' E ' 84' ' ' LYS . . . . . . . . . . . . . 31.1 ttpt -94.34 -51.64 4.7 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-O 121.023 0.44 . . . . 0.0 110.212 -177.521 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' E' E ' 85' ' ' ASP . . . . . . . . . . . . . 8.9 t70 -149.49 149.31 30.57 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 115.696 -0.684 . . . . 0.0 110.068 -179.383 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' E' E ' 86' ' ' VAL . . . . . . . . . . . . . 39.6 t -132.3 133.65 59.99 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.244 0 CA-C-O 120.959 0.409 . . . . 0.0 110.502 -179.671 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' E' E ' 87' ' ' ILE . . . . . 0.5 ' N ' HD12 ' E' ' 87' ' ' ILE . 5.0 mp -118.94 123.48 71.56 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 N-CA-C 109.206 -0.665 . . . . 0.0 109.206 176.717 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' E' E ' 88' ' ' LEU . . . . . 0.429 ' HB2' HD13 ' D' ' 124' ' ' LEU . 14.0 tp -109.43 119.52 39.72 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.401 -0.363 . . . . 0.0 110.475 -179.068 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' E' E ' 89' ' ' ASP . . . . . . . . . . . . . 6.6 t70 -112.28 153.92 26.43 Favored 'General case' 0 C--N 1.33 -0.28 0 N-CA-C 109.628 -0.508 . . . . 0.0 109.628 178.249 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' E' E ' 90' ' ' GLU . . . . . . . . . . . . . 82.0 tt0 -47.76 -36.86 12.22 Favored 'General case' 0 C--N 1.329 -0.296 0 N-CA-C 112.685 0.624 . . . . 0.0 112.685 -173.364 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' E' E ' 91' ' ' ASN . . . . . . . . . . . . . 13.2 p30 -131.97 32.19 4.08 Favored 'General case' 0 N--CA 1.465 0.285 0 N-CA-C 112.29 0.478 . . . . 0.0 112.29 -175.79 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' E' E ' 92' ' ' LEU . . . . . . . . . . . . . 6.4 tp -166.02 144.68 5.87 Favored 'General case' 0 C--N 1.332 -0.183 0 C-N-CA 120.686 -0.406 . . . . 0.0 111.016 -179.656 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' E' E ' 93' ' ' ILE . . . . . . . . . . . . . 62.3 mt -119.82 119.87 61.59 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.24 0 N-CA-C 109.346 -0.613 . . . . 0.0 109.346 -179.787 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' E' E ' 94' ' ' VAL . . . . . . . . . . . . . 45.5 t -122.22 126.44 74.3 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.293 0 CA-C-O 120.849 0.357 . . . . 0.0 110.212 -178.984 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' E' E ' 95' ' ' VAL . . . . . . . . . . . . . 42.9 t -123.65 134.23 66.99 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.209 0 CA-C-N 116.109 -0.496 . . . . 0.0 110.093 -179.356 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' E' E ' 96' ' ' ILE . . . . . . . . . . . . . 66.6 mt -117.13 127.54 74.69 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.257 0 N-CA-C 109.509 -0.552 . . . . 0.0 109.509 178.634 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' E' E ' 97' ' ' THR . . . . . . . . . . . . . 82.0 p -99.28 157.33 16.46 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-O 121.13 0.491 . . . . 0.0 111.282 -177.433 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' E' E ' 98' ' ' GLU . . . . . . . . . . . . . 96.7 mt-10 -54.62 -26.45 32.89 Favored 'General case' 0 C--N 1.328 -0.328 0 N-CA-C 112.236 0.458 . . . . 0.0 112.236 -179.829 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' E' E ' 99' ' ' GLU . . . . . . . . . . . . . 95.7 mt-10 -78.22 14.7 1.11 Allowed 'General case' 0 CA--C 1.536 0.43 0 N-CA-C 113.1 0.778 . . . . 0.0 113.1 -177.425 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' E' E ' 100' ' ' ASN . . . . . . . . . . . . . 4.5 m-20 63.47 38.03 10.19 Favored 'General case' 0 C--O 1.232 0.149 0 CA-C-O 121.055 0.455 . . . . 0.0 110.951 178.11 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' E' E ' 101' ' ' GLU . . . . . . . . . . . . . 83.3 tt0 -119.24 141.31 49.03 Favored 'General case' 0 C--N 1.332 -0.192 0 N-CA-C 109.601 -0.518 . . . . 0.0 109.601 176.178 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' E' E ' 102' ' ' VAL . . . . . . . . . . . . . 41.8 t -115.03 130.9 68.76 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.271 0 CA-C-O 120.812 0.339 . . . . 0.0 110.407 -177.527 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' E' E ' 103' ' ' LEU . . . . . . . . . . . . . 27.1 mt -119.29 130.89 55.64 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 115.454 -0.794 . . . . 0.0 109.992 176.725 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' E' E ' 104' ' ' ILE . . . . . 0.456 HD11 HG11 ' E' ' 130' ' ' VAL . 72.4 mt -119.65 123.56 71.26 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.252 0 N-CA-C 110.096 -0.335 . . . . 0.0 110.096 179.506 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' E' E ' 105' ' ' PHE . . . . . . . . . . . . . 66.9 m-85 -124.86 162.99 23.16 Favored 'General case' 0 C--N 1.332 -0.159 0 O-C-N 123.735 0.647 . . . . 0.0 110.482 -177.792 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' E' E ' 106' ' ' ASN . . . . . . . . . . . . . 40.6 p-10 -100.7 -169.98 1.79 Allowed 'General case' 0 CA--C 1.531 0.218 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.263 175.592 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' E' E ' 107' ' ' GLN . . . . . . . . . . . . . 47.2 tt0 -59.09 -29.97 67.74 Favored 'General case' 0 CA--C 1.531 0.232 0 N-CA-C 112.017 0.377 . . . . 0.0 112.017 179.917 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' E' E ' 108' ' ' ASN . . . . . . . . . . . . . 12.2 t-20 -86.01 9.62 16.57 Favored 'General case' 0 CA--C 1.534 0.348 0 N-CA-C 113.275 0.842 . . . . 0.0 113.275 -177.087 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' E' E ' 109' ' ' LEU . . . . . 0.569 HD21 ' HB2' ' E' ' 78' ' ' ALA . 12.1 tp 57.76 40.11 26.55 Favored 'General case' 0 CA--C 1.529 0.169 0 CA-C-O 121.206 0.527 . . . . 0.0 111.012 178.33 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' E' E ' 110' ' ' GLU . . . . . . . . . . . . . 95.5 mt-10 -108.32 156.93 18.83 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.202 -0.454 . . . . 0.0 109.99 175.953 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' E' E ' 111' ' ' GLU . . . . . . . . . . . . . 35.5 tt0 -81.61 122.08 27.15 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-O 120.892 0.377 . . . . 0.0 110.744 -177.304 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' E' E ' 112' ' ' LEU . . . . . . . . . . . . . 16.8 mt -107.74 -45.94 3.91 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 115.991 -0.549 . . . . 0.0 110.219 175.996 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' E' E ' 113' ' ' TYR . . . . . . . . . . . . . 63.2 t80 -139.5 135.08 33.13 Favored 'General case' 0 C--N 1.332 -0.19 0 C-N-CA 120.814 -0.355 . . . . 0.0 111.456 179.624 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' E' E ' 114' ' ' ARG . . . . . . . . . . . . . 19.4 ttm180 -133.76 123.85 25.61 Favored 'General case' 0 C--N 1.331 -0.224 0 CA-C-N 115.811 -0.631 . . . . 0.0 109.72 175.58 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' E' E ' 115' ' ' GLY . . . . . . . . . . . . . . . -150.11 141.36 8.72 Favored Glycine 0 CA--C 1.524 0.655 0 N-CA-C 111.272 -0.731 . . . . 0.0 111.272 178.906 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' E' E ' 116' ' ' LYS . . . . . . . . . . . . . 17.1 ttpp -116.57 130.72 56.9 Favored 'General case' 0 C--N 1.332 -0.194 0 N-CA-C 109.748 -0.464 . . . . 0.0 109.748 177.443 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' E' E ' 117' ' ' PHE . . . . . . . . . . . . . 38.6 m-85 -130.58 114.04 14.96 Favored 'General case' 0 C--N 1.331 -0.213 0 CA-C-O 120.782 0.325 . . . . 0.0 110.211 -175.696 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' E' E ' 118' ' ' GLU . . . . . . . . . . . . . 96.0 mt-10 -55.54 -41.49 73.29 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.406 -0.361 . . . . 0.0 111.102 -176.695 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' E' E ' 119' ' ' ASN . . . . . . . . . . . . . 34.7 m-80 -99.57 30.96 3.36 Favored 'General case' 0 C--N 1.33 -0.268 0 N-CA-C 112.121 0.415 . . . . 0.0 112.121 -174.123 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' E' E ' 120' ' ' LEU . . . . . . . . . . . . . 13.7 tp -55.33 121.3 8.61 Favored 'General case' 0 C--N 1.333 -0.115 0 CA-C-O 120.747 0.308 . . . . 0.0 110.736 178.382 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' E' E ' 121' ' ' ASN . . . . . . . . . . . . . 72.0 m-80 -112.51 -44.13 3.4 Favored 'General case' 0 C--N 1.332 -0.175 0 CA-C-N 116.316 -0.402 . . . . 0.0 110.841 -178.145 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' E' E ' 122' ' ' LYS . . . . . . . . . . . . . 35.4 mtmm -147.47 147.05 29.78 Favored 'General case' 0 C--N 1.331 -0.231 0 C-N-CA 120.6 -0.44 . . . . 0.0 111.783 -177.985 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' E' E ' 123' ' ' VAL . . . . . . . . . . . . . 45.5 t -123.94 127.27 73.54 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.233 0 CA-C-N 115.88 -0.6 . . . . 0.0 109.562 176.133 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' E' E ' 124' ' ' LEU . . . . . . . . . . . . . 51.5 mt -119.73 136.36 54.46 Favored 'General case' 0 C--N 1.331 -0.23 0 CA-C-N 116.355 -0.384 . . . . 0.0 110.673 -177.743 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' E' E ' 125' ' ' VAL . . . . . . . . . . . . . 12.1 p -133.31 135.25 56.58 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.265 0 CA-C-O 120.749 0.309 . . . . 0.0 110.392 178.505 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' E' E ' 126' ' ' ARG . . . . . . . . . . . . . 95.8 mtt-85 -144.5 120.9 10.97 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-N 116.093 -0.503 . . . . 0.0 110.566 179.139 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' E' E ' 127' ' ' ASN . . . . . . . . . . . . . 94.9 m-20 50.4 -108.02 0.31 Allowed 'General case' 0 CA--C 1.544 0.721 0 CA-C-O 118.854 -0.593 . . . . 0.0 111.428 179.662 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' E' E ' 128' ' ' ASP . . . . . . . . . . . . . 11.0 p-10 -114.08 6.85 16.54 Favored 'General case' 0 CA--C 1.536 0.436 0 CA-C-N 119.796 1.18 . . . . 0.0 113.417 -177.776 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' E' E ' 129' ' ' LEU . . . . . . . . . . . . . 6.1 mp -110.75 150.04 29.66 Favored 'General case' 0 C--O 1.233 0.189 0 CA-C-N 118.206 0.457 . . . . 0.0 110.435 178.666 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' E' E ' 130' ' ' VAL . . . . . 0.456 HG11 HD11 ' E' ' 104' ' ' ILE . 40.6 t -130.86 140.98 47.35 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.237 0 CA-C-N 116.271 -0.422 . . . . 0.0 110.406 -178.213 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' E' E ' 131' ' ' VAL . . . . . . . . . . . . . 41.3 t -134.92 135.88 52.51 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 CA-C-N 116.096 -0.502 . . . . 0.0 109.806 177.835 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' E' E ' 132' ' ' ILE . . . . . . . . . . . . . 71.3 mt -119.29 133.68 65.32 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.25 0 N-CA-C 109.737 -0.468 . . . . 0.0 109.737 -179.842 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' E' E ' 133' ' ' ILE . . . . . . . . . . . . . 41.8 mm -115.9 123.58 71.35 Favored 'Isoleucine or valine' 0 C--O 1.233 0.223 0 CA-C-N 116.39 -0.368 . . . . 0.0 110.663 -176.867 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' E' E ' 134' ' ' ASP . . . . . . . . . . . . . 10.1 p-10 -134.88 150.14 50.4 Favored 'General case' 0 C--N 1.331 -0.237 0 N-CA-C 109.75 -0.463 . . . . 0.0 109.75 175.332 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' E' E ' 135' ' ' GLU . . . . . . . . . . . . . 40.6 tp10 -49.95 -27.29 5.14 Favored 'General case' 0 C--N 1.328 -0.347 0 N-CA-C 112.809 0.67 . . . . 0.0 112.809 -171.581 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' E' E ' 136' ' ' GLN . . . . . . . . . . . . . 43.4 tt0 -89.99 -29.97 18.09 Favored 'General case' 0 C--O 1.234 0.266 0 N-CA-C 112.619 0.6 . . . . 0.0 112.619 -173.388 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' E' E ' 137' ' ' LYS . . . . . . . . . . . . . 52.2 pttt -163.86 173.02 13.23 Favored 'General case' 0 C--N 1.332 -0.179 0 CA-C-O 121.528 0.68 . . . . 0.0 112.448 -173.238 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' E' E ' 138' ' ' LEU . . . . . . . . . . . . . 6.4 tt -121.15 129.94 53.49 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 115.03 -0.986 . . . . 0.0 109.928 178.579 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' E' E ' 139' ' ' THR . . . . . . . . . . . . . 27.9 m -111.78 129.49 56.11 Favored 'General case' 0 C--N 1.331 -0.211 0 CA-C-N 116.315 -0.402 . . . . 0.0 110.676 -178.856 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' E' E ' 140' ' ' LEU . . . . . . . . . . . . . 8.7 tp -117.14 120.7 39.1 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 115.748 -0.66 . . . . 0.0 109.363 -177.989 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' E' E ' 141' ' ' ILE . . . . . . . . . . . . . 19.4 mt -119.49 121.42 66.33 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.239 0 CA-C-O 120.818 0.342 . . . . 0.0 110.219 -175.701 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' E' E ' 142' ' ' ARG . . . . . . . . . . . . . 75.1 mtp180 -111.85 130.4 55.83 Favored 'General case' 0 C--N 1.331 -0.222 0 CA-C-N 115.556 -0.747 . . . . 0.0 110.185 -178.666 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' E' E ' 143' ' ' THR . . . . . . . . . . . . . 39.9 p . . . . . 0 C--O 1.219 -0.506 0 CA-C-O 118.011 -0.995 . . . . 0.0 110.598 179.953 . . . . . . . . 0 0 . 1 . 020 nuclear nobuild full ' F' F ' -3' ' ' GLU . . . . . . . . . . . . . 80.1 tt0 . . . . . 0 N--CA 1.49 1.563 0 N-CA-C 109.239 -0.652 . . . . 0.0 109.239 . . . . . . . . . 0 0 . 1 . 020 nuclear nobuild full ' F' F ' -2' ' ' GLY . . . . . . . . . . . . . . . -102.66 138.93 14.2 Favored Glycine 0 CA--C 1.524 0.639 0 N-CA-C 111.025 -0.83 . . . . 0.0 111.025 -179.947 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' F' F ' -1' ' ' VAL . . . . . . . . . . . . . 46.7 t -96.39 138.16 22.37 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.284 0 N-CA-C 109.776 -0.453 . . . . 0.0 109.776 178.702 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' F' F ' 0' ' ' ILE . . . . . . . . . . . . . 70.5 mt -96.2 139.71 18.67 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.269 0 CA-C-N 116.319 -0.401 . . . . 0.0 110.101 -178.24 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' F' F ' 1' ' ' MET . . . . . . . . . . . . . 26.1 ptt? -77.05 130.35 37.3 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.04 -0.527 . . . . 0.0 110.441 -179.557 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' F' F ' 2' ' ' SER . . . . . . . . . . . . . 6.2 p -108.34 139.38 43.13 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-N 116.1 -0.5 . . . . 0.0 110.805 -178.536 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' F' F ' 3' ' ' GLU . . . . . . . . . . . . . 33.1 tp10 -139.18 133.58 31.6 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 115.723 -0.671 . . . . 0.0 110.194 -178.102 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' F' F ' 4' ' ' LEU . . . . . . . . . . . . . 19.7 tp -125.15 127.59 47.08 Favored 'General case' 0 C--N 1.331 -0.196 0 N-CA-C 110.071 -0.344 . . . . 0.0 110.071 175.23 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' F' F ' 5' ' ' LYS . . . . . . . . . . . . . 98.7 mttt -111.14 121.39 45.18 Favored 'General case' 0 C--O 1.235 0.302 0 CA-C-O 120.831 0.348 . . . . 0.0 110.827 179.378 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' F' F ' 6' ' ' LEU . . . . . . . . . . . . . 60.4 mt -114.46 143.31 45.15 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 115.369 -0.832 . . . . 0.0 109.898 179.549 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' F' F ' 7' ' ' LYS . . . . . . . . . . . . . 80.6 tttt -123.43 134.23 25.08 Favored Pre-proline 0 CA--C 1.534 0.339 0 CA-C-O 118.893 -0.575 . . . . 0.0 109.812 175.96 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' F' F ' 8' ' ' PRO . . . . . . . . . . . . . 94.4 Cg_endo -92.03 136.57 1.69 Allowed 'Trans proline' 0 N--CA 1.489 1.261 0 C-N-CA 121.607 1.538 . . . . 0.0 111.703 177.722 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' F' F ' 9' ' ' LEU . . . . . . . . . . . . . 63.0 mt -79.32 -47.53 1.57 Allowed Pre-proline 0 CA--C 1.533 0.301 0 CA-C-O 118.61 -0.71 . . . . 0.0 112.1 -179.486 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' F' F ' 10' ' ' PRO . . . . . . . . . . . . . 90.1 Cg_endo -80.9 149.82 18.04 Favored 'Trans proline' 0 N--CA 1.496 1.63 0 C-N-CA 121.207 1.271 . . . . 0.0 111.87 176.502 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' F' F ' 11' ' ' LYS . . . . . . . . . . . . . 45.3 tttp -88.25 111.2 21.39 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-O 120.753 0.311 . . . . 0.0 110.371 178.99 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' F' F ' 12' ' ' VAL . . . . . . . . . . . . . 12.4 p -145.52 146.78 19.24 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.299 0 CA-C-O 120.898 0.38 . . . . 0.0 110.801 -178.645 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' F' F ' 13' ' ' GLU . . . . . . . . . . . . . 70.3 mm-40 -88.22 108.95 19.55 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.084 -0.507 . . . . 0.0 110.382 175.384 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' F' F ' 14' ' ' LEU . . . . . . . . . . . . . 38.9 mt -91.75 147.04 34.23 Favored Pre-proline 0 C--N 1.328 -0.361 0 CA-C-N 116.125 -0.489 . . . . 0.0 110.012 -179.439 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' F' F ' 15' ' ' PRO . . . . . . . . . . . . . 36.3 Cg_exo -58.37 157.42 26.51 Favored 'Trans proline' 0 N--CA 1.497 1.705 0 C-N-CA 121.237 1.291 . . . . 0.0 111.823 179.024 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' F' F ' 16' ' ' PRO . . . . . . . . . . . . . 36.9 Cg_exo -58.22 -36.79 97.45 Favored 'Trans proline' 0 N--CA 1.497 1.73 0 C-N-CA 121.384 1.389 . . . . 0.0 112.876 -178.505 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' F' F ' 17' ' ' ASP . . . . . . . . . . . . . 8.7 p-10 -83.51 12.19 5.98 Favored 'General case' 0 CA--C 1.536 0.412 0 N-CA-C 113.146 0.795 . . . . 0.0 113.146 -177.803 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' F' F ' 18' ' ' PHE . . . . . . . . . . . . . 45.6 t80 -56.78 -45.86 81.88 Favored 'General case' 0 N--CA 1.457 -0.096 0 O-C-N 122.007 -0.433 . . . . 0.0 110.424 -178.566 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' F' F ' 19' ' ' VAL . . . . . . . . . . . . . 15.0 p -54.85 -41.04 55.24 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.273 0 CA-C-N 116.549 -0.296 . . . . 0.0 111.175 -178.176 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' F' F ' 20' ' ' ASP . . . . . . . . . . . . . 73.7 m-20 -60.72 -45.25 94.99 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-O 120.814 0.34 . . . . 0.0 111.075 -178.429 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' F' F ' 21' ' ' VAL . . . . . . . . . . . . . 47.6 t -64.64 -46.97 90.83 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.328 0 C-N-CA 120.65 -0.42 . . . . 0.0 110.574 -177.273 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' F' F ' 22' ' ' ILE . . . . . 0.622 HG22 HD12 ' F' ' 26' ' ' LEU . 50.8 mm -56.46 -45.73 81.97 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.271 0 CA-C-O 120.875 0.369 . . . . 0.0 110.462 179.443 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' F' F ' 23' ' ' ARG . . . . . . . . . . . . . 32.3 ttp180 -53.64 -49.03 68.78 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.655 -0.248 . . . . 0.0 111.369 -179.076 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' F' F ' 24' ' ' ILE . . . . . . . . . . . . . 67.8 mt -59.27 -48.27 87.55 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.336 0 C-N-CA 121.039 -0.265 . . . . 0.0 111.193 -177.361 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' F' F ' 25' ' ' LYS . . . . . . . . . . . . . 98.8 mttt -64.35 -36.23 83.45 Favored 'General case' 0 C--N 1.329 -0.286 0 N-CA-C 112.538 0.57 . . . . 0.0 112.538 -177.029 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' F' F ' 26' ' ' LEU . . . . . 0.622 HD12 HG22 ' F' ' 22' ' ' ILE . 53.4 mt -77.47 -43.77 31.19 Favored 'General case' 0 C--N 1.33 -0.259 0 N-CA-C 112.869 0.692 . . . . 0.0 112.869 -173.169 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' F' F ' 27' ' ' GLN . . . . . . . . . . . . . 10.9 pt20 -47.4 137.91 8.1 Favored 'General case' 0 N--CA 1.468 0.439 0 N-CA-C 112.714 0.635 . . . . 0.0 112.714 -175.424 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' F' F ' 28' ' ' GLY . . . . . . . . . . . . . . . 101.02 -26.45 24.63 Favored Glycine 0 CA--C 1.533 1.165 0 CA-C-N 115.587 -0.733 . . . . 0.0 112.235 -176.998 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' F' F ' 29' ' ' LYS . . . . . . . . . . . . . 66.7 mmtt -98.14 155.1 17.31 Favored 'General case' 0 C--O 1.233 0.217 0 CA-C-N 117.311 0.556 . . . . 0.0 111.26 178.792 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' F' F ' 30' ' ' THR . . . . . . . . . . . . . 26.9 m -107.95 139.8 42.04 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 115.882 -0.599 . . . . 0.0 110.152 176.741 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' F' F ' 31' ' ' VAL . . . . . . . . . . . . . 34.7 m -129.5 157.67 42.19 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.267 0 CA-C-N 116.373 -0.376 . . . . 0.0 111.08 -178.121 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' F' F ' 32' ' ' ARG . . . . . . . . . . . . . 88.7 mtt180 -131.03 149.02 52.8 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 115.7 -0.682 . . . . 0.0 110.34 177.01 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' F' F ' 33' ' ' THR . . . . . . . . . . . . . 14.1 m -53.5 138.47 33.72 Favored 'General case' 0 C--N 1.332 -0.189 0 CA-C-N 116.489 -0.323 . . . . 0.0 111.271 -177.949 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' F' F ' 34' ' ' GLY . . . . . . . . . . . . . . . 100.72 -17.04 57.06 Favored Glycine 0 CA--C 1.532 1.139 0 CA-C-O 119.632 -0.538 . . . . 0.0 113.298 179.326 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' F' F ' 35' ' ' ASP . . . . . . . . . . . . . 54.1 m-20 -63.0 150.63 41.93 Favored 'General case' 0 C--O 1.233 0.206 0 CA-C-N 118.121 0.961 . . . . 0.0 111.316 -179.926 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' F' F ' 36' ' ' VAL . . . . . . . . . . . . . 45.3 t -123.33 129.48 74.79 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.232 0 CA-C-N 115.76 -0.655 . . . . 0.0 109.822 178.582 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' F' F ' 37' ' ' ILE . . . . . . . . . . . . . 67.5 mt -124.84 140.41 48.08 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.257 0 CA-C-N 116.304 -0.407 . . . . 0.0 110.183 -179.096 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' F' F ' 38' ' ' GLY . . . . . . . . . . . . . . . -118.65 128.71 7.81 Favored Glycine 0 CA--C 1.525 0.689 0 N-CA-C 111.181 -0.768 . . . . 0.0 111.181 179.322 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' F' F ' 39' ' ' ILE . . . . . . . . . . . . . 77.4 mt -127.36 141.25 46.83 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.276 0 N-CA-C 110.234 -0.284 . . . . 0.0 110.234 179.218 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' F' F ' 40' ' ' SER . . . . . . . . . . . . . 76.8 p -92.48 119.11 31.66 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.445 -0.343 . . . . 0.0 110.995 176.068 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' F' F ' 41' ' ' ILE . . . . . . . . . . . . . 43.8 mm -121.05 118.74 57.22 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.195 0 CA-C-N 116.463 -0.335 . . . . 0.0 110.141 178.125 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' F' F ' 42' ' ' LEU . . . . . . . . . . . . . 64.5 mt 52.05 34.42 13.97 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.308 -0.405 . . . . 0.0 111.907 177.194 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' F' F ' 43' ' ' GLY . . . . . . . . . . . . . . . 76.74 28.8 58.52 Favored Glycine 0 CA--C 1.53 1.028 0 C-N-CA 121.185 -0.531 . . . . 0.0 112.523 176.693 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' F' F ' 44' ' ' LYS . . . . . . . . . . . . . 7.8 ttpm? -140.52 131.28 25.79 Favored 'General case' 0 C--N 1.33 -0.242 0 N-CA-C 109.289 -0.634 . . . . 0.0 109.289 176.316 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' F' F ' 45' ' ' GLU . . . . . . . . . . . . . 81.3 tt0 -82.4 126.71 32.5 Favored 'General case' 0 C--N 1.328 -0.332 0 C-N-CA 120.865 -0.334 . . . . 0.0 111.263 -175.806 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' F' F ' 46' ' ' VAL . . . . . . . . . . . . . 10.4 p -118.2 124.96 73.88 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.2 0 N-CA-C 109.532 -0.544 . . . . 0.0 109.532 175.091 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' F' F ' 47' ' ' LYS . . . . . . . . . . . . . 62.0 mttp -99.14 125.53 44.71 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 115.866 -0.606 . . . . 0.0 110.942 178.105 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' F' F ' 48' ' ' PHE . . . . . . . . . . . . . 33.7 m-85 -110.26 131.91 54.64 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.037 -0.529 . . . . 0.0 109.921 177.384 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' F' F ' 49' ' ' LYS . . . . . . . . . . . . . 43.0 tttp -107.67 132.99 52.74 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 116.31 -0.404 . . . . 0.0 109.975 176.402 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' F' F ' 50' ' ' VAL . . . . . . . . . . . . . 44.0 t -76.81 107.82 8.71 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.312 0 N-CA-C 109.483 -0.562 . . . . 0.0 109.483 178.701 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' F' F ' 51' ' ' VAL . . . . . . . . . . . . . 44.7 t -72.43 -50.42 35.31 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.289 0 CA-C-N 116.022 -0.535 . . . . 0.0 109.825 -174.747 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' F' F ' 52' ' ' GLN . . . . . . . . . . . . . 62.8 tt0 -159.06 144.61 16.25 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 115.836 -0.62 . . . . 0.0 111.501 -176.908 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' F' F ' 53' ' ' ALA . . . . . . . . . . . . . . . -123.25 132.43 54.02 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 115.524 -0.762 . . . . 0.0 109.931 175.971 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' F' F ' 54' ' ' TYR . . . . . . . . . . . . . 67.7 t80 -129.13 112.81 18.43 Favored Pre-proline 0 CA--C 1.536 0.407 0 CA-C-O 118.154 -0.927 . . . . 0.0 110.261 177.351 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' F' F ' 55' ' ' PRO . . . . . . . . . . . . . 74.4 Cg_endo -77.05 166.97 81.17 Favored 'Cis proline' 0 N--CA 1.501 1.919 0 CA-C-N 122.09 1.782 . . . . 0.0 112.467 -5.4 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' F' F ' 56' ' ' SER . . . . . . . . . . . . . 13.7 m -114.05 124.99 29.96 Favored Pre-proline 0 CA--C 1.539 0.535 0 CA-C-O 118.369 -0.824 . . . . 0.0 109.381 176.506 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' F' F ' 57' ' ' PRO . . . . . . . . . . . . . 39.5 Cg_endo -67.16 166.24 64.07 Favored 'Cis proline' 0 N--CA 1.498 1.751 0 CA-C-N 122.065 1.773 . . . . 0.0 111.556 0.939 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' F' F ' 58' ' ' LEU . . . . . . . . . . . . . 24.0 tp -127.46 135.0 49.81 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.227 -0.442 . . . . 0.0 110.365 179.958 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' F' F ' 59' ' ' ARG . . . . . . . . . . . . . 57.4 ttp180 -106.63 123.1 47.61 Favored 'General case' 0 C--N 1.328 -0.358 0 N-CA-C 109.244 -0.65 . . . . 0.0 109.244 177.129 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' F' F ' 60' ' ' VAL . . . . . . . . . . . . . 44.5 t -78.12 122.22 32.57 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.347 0 C-N-CA 120.753 -0.379 . . . . 0.0 110.546 -174.049 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' F' F ' 61' ' ' GLU . . . . . . . . . . . . . 95.5 mt-10 -131.06 164.92 24.36 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-N 115.804 -0.635 . . . . 0.0 109.784 176.293 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' F' F ' 62' ' ' ASP . . . . . . . . . . . . . 80.5 m-20 -53.94 -32.66 54.4 Favored 'General case' 0 C--N 1.328 -0.342 0 C-N-CA 121.027 -0.269 . . . . 0.0 111.646 -179.663 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' F' F ' 63' ' ' ARG . . . . . . . . . . . . . 24.4 mmt180 -73.07 -21.39 60.79 Favored 'General case' 0 CA--C 1.533 0.32 0 N-CA-C 113.034 0.753 . . . . 0.0 113.034 -177.519 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' F' F ' 64' ' ' THR . . . . . . . . . . . . . 30.9 m -68.08 137.35 54.91 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-O 120.882 0.373 . . . . 0.0 111.009 -174.201 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' F' F ' 65' ' ' LYS . . . . . . . . . . . . . 97.9 mttt -90.36 132.17 35.73 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.038 -0.528 . . . . 0.0 109.992 178.525 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' F' F ' 66' ' ' ILE . . . . . . . . . . . . . 64.2 mt -119.51 131.39 72.25 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.264 0 CA-C-O 120.934 0.397 . . . . 0.0 110.071 -179.822 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' F' F ' 67' ' ' THR . . . . . . . . . . . . . 22.9 m -123.39 139.03 54.45 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 115.96 -0.563 . . . . 0.0 110.651 -179.412 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' F' F ' 68' ' ' LEU . . . . . 0.478 HD23 ' C ' ' F' ' 68' ' ' LEU . 6.3 tt -107.68 121.13 44.08 Favored 'General case' 0 C--N 1.331 -0.225 0 CA-C-N 116.108 -0.496 . . . . 0.0 110.506 179.673 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' F' F ' 69' ' ' VAL . . . . . . . . . . . . . 46.8 t -102.77 116.99 47.47 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.345 0 N-CA-C 109.594 -0.521 . . . . 0.0 109.594 177.808 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' F' F ' 70' ' ' THR . . . . . . . . . . . . . 7.3 t -150.08 -33.86 0.18 Allowed 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.392 -0.367 . . . . 0.0 111.785 -178.831 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' F' F ' 71' ' ' HIS . . . . . . . . . . . . . 64.5 m-70 -111.69 91.44 14.76 Favored Pre-proline 0 CA--C 1.533 0.3 0 CA-C-O 119.462 -0.304 . . . . 0.0 111.152 -176.361 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' F' F ' 72' ' ' PRO . . . . . . . . . . . . . 30.5 Cg_endo -78.26 -23.04 9.21 Favored 'Trans proline' 0 N--CA 1.494 1.508 0 C-N-CA 121.24 1.293 . . . . 0.0 112.743 175.832 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' F' F ' 73' ' ' VAL . . . . . . . . . . . . . 35.6 m -122.83 178.24 3.32 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.219 0 N-CA-C 109.747 -0.464 . . . . 0.0 109.747 177.314 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' F' F ' 74' ' ' ASP . . . . . . . . . . . . . 12.0 t0 -96.43 117.19 30.37 Favored 'General case' 0 C--N 1.332 -0.192 0 C-N-CA 120.743 -0.383 . . . . 0.0 110.065 -176.284 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' F' F ' 75' ' ' VAL . . . . . . . . . . . . . 41.9 t -116.99 122.21 69.54 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.253 0 CA-C-O 120.985 0.421 . . . . 0.0 110.522 -178.043 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' F' F ' 76' ' ' LEU . . . . . . . . . . . . . 6.2 mp -119.85 144.96 47.08 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 115.675 -0.693 . . . . 0.0 109.782 176.51 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' F' F ' 77' ' ' GLU . . . . . . . . . . . . . 46.3 mt-10 -136.11 136.75 40.38 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-O 121.082 0.468 . . . . 0.0 111.351 -179.278 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' F' F ' 78' ' ' ALA . . . . . . . . . . . . . . . -123.97 132.27 53.68 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-N 115.68 -0.691 . . . . 0.0 109.7 175.873 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' F' F ' 79' ' ' LYS . . . . . 0.618 ' O ' HD13 ' F' ' 80' ' ' ILE . 62.1 mttp -81.17 117.37 21.66 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-O 120.925 0.393 . . . . 0.0 110.669 -178.814 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' F' F ' 80' ' ' ILE . . . . . 0.618 HD13 ' O ' ' F' ' 79' ' ' LYS . 40.3 mm -139.04 112.25 6.44 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.37 0 N-CA-C 109.13 -0.693 . . . . 0.0 109.13 -177.002 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' F' F ' 81' ' ' LYS . . . . . . . . . . . . . 79.0 tttt -102.08 127.49 48.96 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-O 120.852 0.358 . . . . 0.0 111.071 -177.668 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' F' F ' 82' ' ' GLY . . . . . . . . . . . . . . . 89.07 42.15 5.69 Favored Glycine 0 CA--C 1.525 0.691 0 C-N-CA 120.872 -0.68 . . . . 0.0 112.037 174.481 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' F' F ' 83' ' ' ILE . . . . . . . . . . . . . 68.7 mt -71.6 136.93 24.73 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.351 0 N-CA-C 109.281 -0.637 . . . . 0.0 109.281 175.684 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' F' F ' 84' ' ' LYS . . . . . . . . . . . . . 27.7 ttpp -94.94 -48.92 5.79 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-O 121.03 0.443 . . . . 0.0 110.047 -178.717 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' F' F ' 85' ' ' ASP . . . . . . . . . . . . . 10.0 t70 -154.57 153.38 31.32 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 115.756 -0.656 . . . . 0.0 110.562 -179.682 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' F' F ' 86' ' ' VAL . . . . . . . . . . . . . 41.9 t -128.98 133.47 66.01 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.202 0 CA-C-O 121.043 0.449 . . . . 0.0 110.243 179.201 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' F' F ' 87' ' ' ILE . . . . . . . . . . . . . 43.9 mm -117.77 123.69 72.04 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.263 0 CA-C-N 115.777 -0.647 . . . . 0.0 109.277 177.21 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' F' F ' 88' ' ' LEU . . . . . . . . . . . . . 14.7 tp -115.02 125.28 53.4 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-O 121.147 0.498 . . . . 0.0 111.44 -175.701 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' F' F ' 89' ' ' ASP . . . . . . . . . . . . . 13.2 t70 -118.4 154.78 31.86 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 115.525 -0.761 . . . . 0.0 109.147 174.185 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' F' F ' 90' ' ' GLU . . . . . . . . . . . . . 96.0 mt-10 -48.7 -39.92 26.35 Favored 'General case' 0 C--N 1.329 -0.302 0 N-CA-C 112.717 0.636 . . . . 0.0 112.717 -172.187 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' F' F ' 91' ' ' ASN . . . . . . . . . . . . . 21.8 p30 -132.15 38.09 3.52 Favored 'General case' 0 N--CA 1.464 0.259 0 CA-C-O 120.815 0.341 . . . . 0.0 111.477 -178.291 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' F' F ' 92' ' ' LEU . . . . . . . . . . . . . 18.4 tp -165.64 137.99 4.15 Favored 'General case' 0 C--N 1.329 -0.298 0 N-CA-C 110.25 -0.278 . . . . 0.0 110.25 -179.996 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' F' F ' 93' ' ' ILE . . . . . . . . . . . . . 71.5 mt -125.02 126.49 71.24 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.23 0 N-CA-C 109.91 -0.404 . . . . 0.0 109.91 -176.956 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' F' F ' 94' ' ' VAL . . . . . 0.472 HG21 HG11 ' F' ' 125' ' ' VAL . 44.0 t -125.05 128.47 73.04 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.207 0 N-CA-C 109.915 -0.402 . . . . 0.0 109.915 178.212 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' F' F ' 95' ' ' VAL . . . . . . . . . . . . . 44.0 t -120.14 133.4 67.0 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.302 0 CA-C-N 116.096 -0.502 . . . . 0.0 109.749 179.001 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' F' F ' 96' ' ' ILE . . . . . . . . . . . . . 64.3 mt -115.66 128.11 73.02 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.293 0 N-CA-C 109.462 -0.57 . . . . 0.0 109.462 179.545 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' F' F ' 97' ' ' THR . . . . . . . . . . . . . 72.7 p -103.74 157.76 16.85 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-O 121.331 0.586 . . . . 0.0 111.516 -176.392 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' F' F ' 98' ' ' GLU . . . . . . . . . . . . . 70.8 mm-40 -53.9 -26.02 23.04 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 115.994 -0.548 . . . . 0.0 112.397 179.709 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' F' F ' 99' ' ' GLU . . . . . . . . . . . . . 36.1 tt0 -79.99 16.99 1.05 Allowed 'General case' 0 CA--C 1.538 0.51 0 N-CA-C 112.588 0.588 . . . . 0.0 112.588 -176.441 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' F' F ' 100' ' ' ASN . . . . . . . . . . . . . 2.6 m-20 60.85 37.76 18.34 Favored 'General case' 0 C--O 1.232 0.165 0 O-C-N 121.761 -0.587 . . . . 0.0 110.95 178.454 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' F' F ' 101' ' ' GLU . . . . . . . . . . . . . 84.2 tt0 -116.37 144.38 44.34 Favored 'General case' 0 C--N 1.331 -0.225 0 CA-C-N 115.99 -0.55 . . . . 0.0 109.679 176.852 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' F' F ' 102' ' ' VAL . . . . . . . . . . . . . 44.6 t -117.63 126.37 74.68 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.357 0 CA-C-N 116.24 -0.436 . . . . 0.0 109.839 -178.257 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' F' F ' 103' ' ' LEU . . . . . . . . . . . . . 40.7 mt -116.39 129.22 56.13 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 115.717 -0.674 . . . . 0.0 110.121 176.692 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' F' F ' 104' ' ' ILE . . . . . . . . . . . . . 72.2 mt -116.62 122.08 69.09 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.257 0 N-CA-C 110.136 -0.32 . . . . 0.0 110.136 -179.596 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' F' F ' 105' ' ' PHE . . . . . . . . . . . . . 58.6 m-85 -121.21 166.38 14.07 Favored 'General case' 0 C--N 1.332 -0.162 0 O-C-N 124.087 0.867 . . . . 0.0 109.837 -178.968 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' F' F ' 106' ' ' ASN . . . . . . . . . . . . . 42.1 p-10 -102.79 -170.83 1.85 Allowed 'General case' 0 C--N 1.331 -0.231 0 N-CA-C 110.011 -0.366 . . . . 0.0 110.011 172.501 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' F' F ' 107' ' ' GLN . . . . . . . . . . . . . 45.4 tt0 -59.58 -30.16 68.46 Favored 'General case' 0 C--N 1.328 -0.358 0 N-CA-C 111.903 0.335 . . . . 0.0 111.903 179.106 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' F' F ' 108' ' ' ASN . . . . . . . . . . . . . 12.3 t-20 -81.84 6.19 16.45 Favored 'General case' 0 CA--C 1.537 0.467 0 N-CA-C 113.221 0.822 . . . . 0.0 113.221 -177.768 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' F' F ' 109' ' ' LEU . . . . . . . . . . . . . 9.7 tp 61.6 36.82 16.59 Favored 'General case' 0 CA--C 1.53 0.178 0 CA-C-O 120.905 0.383 . . . . 0.0 111.369 178.816 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' F' F ' 110' ' ' GLU . . . . . . . . . . . . . 43.0 mt-10 -106.36 158.44 16.88 Favored 'General case' 0 C--N 1.33 -0.264 0 N-CA-C 109.623 -0.51 . . . . 0.0 109.623 175.805 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' F' F ' 111' ' ' GLU . . . . . . . . . . . . . 44.1 mp0 -87.07 121.97 30.26 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-O 121.106 0.479 . . . . 0.0 111.212 -177.985 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' F' F ' 112' ' ' LEU . . . . . . . . . . . . . 42.9 mt -101.19 -45.95 5.2 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 115.611 -0.722 . . . . 0.0 110.095 175.768 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' F' F ' 113' ' ' TYR . . . . . . . . . . . . . 64.3 t80 -141.79 137.28 31.44 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.049 -0.523 . . . . 0.0 111.613 -178.054 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' F' F ' 114' ' ' ARG . . . . . . . . . . . . . 92.3 mtt180 -129.06 123.65 32.84 Favored 'General case' 0 C--N 1.331 -0.23 0 N-CA-C 109.3 -0.63 . . . . 0.0 109.3 175.245 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' F' F ' 115' ' ' GLY . . . . . . . . . . . . . . . -150.06 157.68 27.33 Favored Glycine 0 CA--C 1.525 0.661 0 C-N-CA 120.447 -0.882 . . . . 0.0 111.807 -179.835 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' F' F ' 116' ' ' LYS . . . . . . . . . . . . . 39.7 ttpt -128.72 140.7 51.61 Favored 'General case' 0 C--N 1.33 -0.263 0 N-CA-C 109.848 -0.427 . . . . 0.0 109.848 176.695 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' F' F ' 117' ' ' PHE . . . . . . . . . . . . . 47.2 m-85 -139.56 114.28 9.33 Favored 'General case' 0 C--N 1.329 -0.283 0 C-N-CA 120.836 -0.346 . . . . 0.0 110.334 -178.257 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' F' F ' 118' ' ' GLU . . . . . . . . . . . . . 84.4 tt0 -53.58 -45.87 70.13 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.523 -0.308 . . . . 0.0 111.405 -176.489 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' F' F ' 119' ' ' ASN . . . . . . . . . . . . . 85.4 m-20 -97.51 31.03 2.66 Favored 'General case' 0 C--N 1.331 -0.22 0 N-CA-C 112.182 0.438 . . . . 0.0 112.182 -174.86 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' F' F ' 120' ' ' LEU . . . . . . . . . . . . . 22.8 tp -57.51 120.44 8.28 Favored 'General case' 0 C--N 1.332 -0.174 0 CA-C-O 120.638 0.256 . . . . 0.0 110.326 178.146 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' F' F ' 121' ' ' ASN . . . . . . . . . . . . . 35.1 m120 -114.13 -44.13 3.17 Favored 'General case' 0 C--N 1.332 -0.188 0 CA-C-N 116.62 -0.263 . . . . 0.0 111.159 -177.521 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' F' F ' 122' ' ' LYS . . . . . . . . . . . . . 92.8 mttt -144.43 150.16 37.23 Favored 'General case' 0 C--N 1.332 -0.189 0 C-N-CA 120.598 -0.441 . . . . 0.0 111.646 -177.448 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' F' F ' 123' ' ' VAL . . . . . . . . . . . . . 42.5 t -132.91 129.32 57.76 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.267 0 N-CA-C 109.526 -0.546 . . . . 0.0 109.526 174.044 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' F' F ' 124' ' ' LEU . . . . . . . . . . . . . 80.4 mt -127.92 144.28 51.1 Favored 'General case' 0 C--N 1.331 -0.209 0 CA-C-O 120.754 0.311 . . . . 0.0 111.23 -176.87 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' F' F ' 125' ' ' VAL . . . . . 0.63 HG12 HG23 ' F' ' 130' ' ' VAL . 34.6 m -132.49 143.95 38.3 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.182 0 CA-C-N 116.173 -0.467 . . . . 0.0 111.18 -179.584 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' F' F ' 126' ' ' ARG . . . . . . . . . . . . . 76.7 mtp85 -145.58 116.49 7.78 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 116.006 -0.543 . . . . 0.0 110.408 176.406 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' F' F ' 127' ' ' ASN . . . . . . . . . . . . . 88.2 m-20 51.52 -104.84 0.19 Allowed 'General case' 0 CA--C 1.544 0.729 0 CA-C-O 119.087 -0.483 . . . . 0.0 111.283 179.824 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' F' F ' 128' ' ' ASP . . . . . . . . . . . . . 11.7 p-10 -114.03 0.19 14.25 Favored 'General case' 0 N--CA 1.468 0.463 0 CA-C-N 119.619 1.1 . . . . 0.0 113.318 -178.079 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' F' F ' 129' ' ' LEU . . . . . . . . . . . . . 17.2 tp -104.93 140.32 38.34 Favored 'General case' 0 C--N 1.332 -0.187 0 N-CA-C 109.565 -0.531 . . . . 0.0 109.565 178.463 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' F' F ' 130' ' ' VAL . . . . . 0.63 HG23 HG12 ' F' ' 125' ' ' VAL . 13.1 p -133.71 143.37 38.91 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.236 0 CA-C-O 121.257 0.551 . . . . 0.0 110.663 -179.357 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' F' F ' 131' ' ' VAL . . . . . 0.498 HG22 HD12 ' F' ' 140' ' ' LEU . 43.4 t -134.67 138.86 48.76 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.259 0 CA-C-N 115.766 -0.652 . . . . 0.0 110.162 -179.372 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' F' F ' 132' ' ' ILE . . . . . . . . . . . . . 69.5 mt -115.26 133.02 62.83 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.345 0 CA-C-N 115.625 -0.716 . . . . 0.0 109.078 179.003 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' F' F ' 133' ' ' ILE . . . . . . . . . . . . . 41.5 mm -117.13 123.55 71.95 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.211 0 CA-C-O 120.727 0.299 . . . . 0.0 110.949 -174.664 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' F' F ' 134' ' ' ASP . . . . . . . . . . . . . 8.1 p-10 -136.68 147.24 46.71 Favored 'General case' 0 C--N 1.331 -0.202 0 N-CA-C 109.654 -0.498 . . . . 0.0 109.654 174.13 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' F' F ' 135' ' ' GLU . . . . . . . . . . . . . 38.6 tp10 -49.89 -26.42 4.08 Favored 'General case' 0 C--N 1.328 -0.334 0 N-CA-C 112.709 0.633 . . . . 0.0 112.709 -172.348 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' F' F ' 136' ' ' GLN . . . . . . . . . . . . . 65.5 tp60 -81.9 -39.07 24.36 Favored 'General case' 0 C--O 1.233 0.21 0 N-CA-C 112.077 0.399 . . . . 0.0 112.077 -176.764 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' F' F ' 137' ' ' LYS . . . . . . . . . . . . . 50.4 pttt -161.48 172.24 16.78 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-O 121.484 0.659 . . . . 0.0 112.2 -171.303 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' F' F ' 138' ' ' LEU . . . . . 0.4 ' C ' HD23 ' F' ' 138' ' ' LEU . 7.2 tt -119.58 129.82 54.83 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 115.111 -0.949 . . . . 0.0 109.664 178.584 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' F' F ' 139' ' ' THR . . . . . . . . . . . . . 21.6 m -109.34 126.64 53.6 Favored 'General case' 0 C--N 1.331 -0.21 0 CA-C-N 116.24 -0.436 . . . . 0.0 110.4 -179.677 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' F' F ' 140' ' ' LEU . . . . . 0.498 HD12 HG22 ' F' ' 131' ' ' VAL . 25.6 tp -112.09 120.06 40.56 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 115.73 -0.668 . . . . 0.0 109.417 -178.665 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' F' F ' 141' ' ' ILE . . . . . 0.499 ' HB ' HG13 ' F' ' 130' ' ' VAL . 19.5 mt -120.91 122.95 69.11 Favored 'Isoleucine or valine' 0 C--O 1.235 0.307 0 CA-C-O 121.022 0.439 . . . . 0.0 110.108 -175.591 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' F' F ' 142' ' ' ARG . . . . . . . . . . . . . 76.9 mtt180 -113.24 131.96 55.7 Favored 'General case' 0 C--O 1.233 0.206 0 CA-C-N 115.302 -0.863 . . . . 0.0 109.961 -175.969 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' F' F ' 143' ' ' THR . . . . . . . . . . . . . 52.0 p . . . . . 0 C--O 1.221 -0.418 0 CA-C-O 118.024 -0.989 . . . . 0.0 110.408 178.275 . . . . . . . . 0 0 . 1 stop_ save_